<SEC-DOCUMENT>0001178913-14-002913.txt : 20140911
<SEC-HEADER>0001178913-14-002913.hdr.sgml : 20140911
<ACCEPTANCE-DATETIME>20140911161451
ACCESSION NUMBER:		0001178913-14-002913
CONFORMED SUBMISSION TYPE:	10-K
PUBLIC DOCUMENT COUNT:		29
CONFORMED PERIOD OF REPORT:	20140630
FILED AS OF DATE:		20140911
DATE AS OF CHANGE:		20140911

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			PLURISTEM THERAPEUTICS INC
		CENTRAL INDEX KEY:			0001158780
		STANDARD INDUSTRIAL CLASSIFICATION:	BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
		IRS NUMBER:				980351734
		STATE OF INCORPORATION:			NV
		FISCAL YEAR END:			0630

	FILING VALUES:
		FORM TYPE:		10-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-31392
		FILM NUMBER:		141098322

	BUSINESS ADDRESS:	
		STREET 1:		MATAM ADVANCED TECHNOLOGY PARK
		STREET 2:		BUILDING NO. 5
		CITY:			HAIFA
		STATE:			L3
		ZIP:			31905
		BUSINESS PHONE:		972-74-710-7171

	MAIL ADDRESS:	
		STREET 1:		MATAM ADVANCED TECHNOLOGY PARK
		STREET 2:		BUILDING NO. 5
		CITY:			HAIFA
		STATE:			L3
		ZIP:			31905

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	PLURISTEM LIFE SYSTEMS INC
		DATE OF NAME CHANGE:	20030701

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	AI SOFTWARE INC
		DATE OF NAME CHANGE:	20010906
</SEC-HEADER>
<DOCUMENT>
<TYPE>10-K
<SEQUENCE>1
<FILENAME>zk1415514.htm
<DESCRIPTION>10-K
<TEXT>
<html>
<head>
    <title>zk1415514.htm</title>
    <!--Licensed to: zk global-->
    <!--Document Created using EDGARizer 2020 5.5.0.0-->
    <!--Copyright 1995 - 2014 Thomson Reuters. All rights reserved.-->
</head>
<body bgcolor="#ffffff" style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">
<div>
<hr style="MARGIN-TOP: -5px; COLOR: #000000" noshade size="4">
<hr style="MARGIN-TOP: -10px; COLOR: #000000" noshade size="1">
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 14pt; FONT-WEIGHT: bold">UNITED STATES</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 14pt; FONT-WEIGHT: bold">SECURITIES AND EXCHANGE COMMISSION</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Washington, D.C. 20549</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 14pt; FONT-WEIGHT: bold">FORM 10-K</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">(Mark One)</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline;" face="Wingdings">x</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"><font id="TAB1" style="MARGIN-LEFT: 36pt"></font>For the fiscal year ended&#160;<font style="DISPLAY: inline; FONT-WEIGHT: bold; TEXT-DECORATION: underline">June 30, 2014</font></font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline;" face="Wingdings">o</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"><font id="TAB1" style="MARGIN-LEFT: 36pt"></font>For the transition period from&#160;[&#160;&#160;&#160;] to&#160;[&#160;&#160;&#160;]</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 36pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Commission file number&#160;<font style="DISPLAY: inline; FONT-WEIGHT: bold; TEXT-DECORATION: underline">001-31392</font></font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 36pt; MARGIN-RIGHT: 0pt" align="left">&#160;</div>

<div>
<table cellpadding="0" cellspacing="0" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr>
<td valign="top" width="80%" style="BORDER-BOTTOM: black 2px solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 16pt; FONT-WEIGHT: bold">PLURISTEM THERAPEUTICS INC.</font></div>
</td>
</tr><tr>
<td valign="top" width="80%" style="TEXT-ALIGN: center">
<div style="TEXT-ALIGN: center; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(Exact name of registrant as specified in its charter)</font></div>
</td>
</tr></table>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div>
<table cellpadding="0" cellspacing="0" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr>
<td valign="top" width="40%" style="BORDER-BOTTOM: black 2px solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Nevada</font></div>
</td>
<td valign="top" width="2%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="top" width="38%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: center">
<div style="TEXT-ALIGN: center; TEXT-INDENT: 0pt; DISPLAY: block"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">98-0351734</font></div>
</td>
</tr><tr>
<td valign="top" width="40%" style="TEXT-ALIGN: center">
<div style="TEXT-ALIGN: center; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(State or other jurisdiction of incorporation or organization)</font></div>
</td>
<td valign="top" width="2%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="top" width="38%" style="TEXT-ALIGN: center">
<div style="TEXT-ALIGN: center; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(I.R.S. Employer Identification No.)</font></div>
</td>
</tr></table>
</div>

<div style="TEXT-ALIGN: center; TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div>
<table cellpadding="0" cellspacing="0" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr>
<td valign="top" width="40%" style="BORDER-BOTTOM: black 2px solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">MATAM Advanced Technology Park,</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Building No. 5, Haifa, Israel</font></div>
</td>
<td valign="top" width="2%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="top" width="38%" style="BORDER-BOTTOM: black 2px solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">31905</font></div>
</td>
</tr><tr>
<td valign="top" width="40%" style="TEXT-ALIGN: center">
<div style="TEXT-ALIGN: center; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(Address of principal executive offices)</font></div>
</td>
<td valign="top" width="2%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="top" width="38%" style="TEXT-ALIGN: center">
<div style="TEXT-ALIGN: center; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(Zip Code)</font></div>
</td>
</tr></table>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Registrant's telephone number&#160;&#160;<font style="DISPLAY: inline; FONT-WEIGHT: bold; TEXT-DECORATION: underline">011-972-74-7108759</font></font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Securities registered pursuant to Section 12(b) of the Act:</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left">&#160;</div>

<div>
<table cellpadding="0" cellspacing="0" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr>
<td valign="top" width="40%" style="BORDER-BOTTOM: black 2px solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Title of each class</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Common Stock, par value $0.00001</font></div>
</td>
<td valign="top" width="2%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="top" width="38%" style="BORDER-BOTTOM: black 2px solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Name of each exchange on which registered</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Nasdaq Capital Market</font></div>
</td>
</tr></table>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Securities registered pursuant to Section 12(g) of the Act:</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left">&#160;</div>

<div>
<table cellpadding="0" cellspacing="0" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr>
<td valign="top" width="80%" style="BORDER-BOTTOM: black 2px solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">None.</font></div>
</td>
</tr><tr>
<td valign="top" width="80%" style="TEXT-ALIGN: center">
<div style="TEXT-ALIGN: center; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(Title of class)</font></div>
</td>
</tr><tr>
<td valign="top" width="80%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr></table>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Indicate by check mark if the registrant is a well-known seasoned issuer, as defined in Rule&#160;405 of the Securities Act.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;</font></div>

<div style="TEXT-ALIGN: center; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Yes <font style="DISPLAY: inline;" face="Wingdings">o<font id="TAB2" style="LETTER-SPACING: 9pt">&#160;&#160;&#160;</font></font>No <font style="DISPLAY: inline;" face="Wingdings">x</font></font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Indicate by check mark if the registrant is not required to file reports pursuant to Section&#160;13 or Section&#160;15(d) of the Act.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;</font></div>

<div style="TEXT-ALIGN: center; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Yes <font style="DISPLAY: inline;" face="Wingdings">o<font id="TAB2" style="LETTER-SPACING: 9pt">&#160;&#160;&#160;</font></font>No <font style="DISPLAY: inline;" face="Wingdings">x</font></font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Indicate by check mark whether the registrant (1)&#160;has filed all reports required to be filed by Section&#160;13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12&#160;months (or for such shorter period that the registrant was required to file such reports), and (2)&#160;has been subject to such filing requirements for the past 90 days.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-ALIGN: center; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Yes <font style="DISPLAY: inline;" face="Wingdings">x<font id="TAB2" style="LETTER-SPACING: 9pt">&#160;&#160;&#160;</font></font>No <font style="DISPLAY: inline;" face="Wingdings">o</font></font></div>

<div style="TEXT-ALIGN: center; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">&#160;</div>

<div id="PGBRK" style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div id="FTR">
<div id="GLFTR" style="WIDTH: 100%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>

<div id="PN" style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
<div style="TEXT-ALIGN: center; WIDTH: 100%"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>

<div style="TEXT-ALIGN: center; WIDTH: 100%">
<hr style="COLOR: black" noshade size="2">
</div>
</div>

<div id="HDR">
<div id="GLHDR" style="WIDTH: 100%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Indicate by check mark whether the registrant has submitted electronically and posted on its corporate Website, if any, every Interactive Data File required to be submitted and posted pursuant to Rule&#160;405 of Regulation&#160;S-T during the preceding 12&#160;months (or for such shorter period that the registrant was required to submit and post such files).&#160;&#160;&#160;&#160;</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;</font></div>

<div style="TEXT-ALIGN: center; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline;" face="Wingdings">x</font>&#160;Yes<font id="TAB2" style="LETTER-SPACING: 9pt">&#160;&#160;&#160;</font><font id="TAB2" style="LETTER-SPACING: 9pt">&#160;&#160;&#160;</font><font style="DISPLAY: inline;" face="Wingdings">o</font>&#160;No</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Indicate by check mark if disclosure of delinquent filers pursuant to Item&#160;405 of Regulation&#160;S-K is not contained herein, and will not be contained, to the best of registrant's knowledge, in definitive proxy or information statements incorporated by reference in Part&#160;III of this Form 10-K or any amendment to this Form 10-K.&#160;&#160;<font style="DISPLAY: inline;" face="Wingdings">x</font></font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer or a non-accelerated filer. See definition of "accelerated filer and large accelerated filer" in Rule 12b-2 of the Exchange Act. (Check one):</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Large accelerated filer&#160;<font style="DISPLAY: inline;" face="Wingdings">o</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; Accelerated filer&#160;<font style="DISPLAY: inline;" face="Wingdings">x</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Non-accelerated filer <font style="DISPLAY: inline;" face="Wingdings">o</font></font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Smaller reporting company <font style="DISPLAY: inline;" face="Wingdings">o</font></font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Indicate by check mark whether the registrant is a shell company (as defined in Rule&#160;12b-2 of the Act).&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;</font></div>

<div style="TEXT-ALIGN: center; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Yes&#160;<font style="DISPLAY: inline;" face="Wingdings">o<font id="TAB2" style="LETTER-SPACING: 9pt">&#160;&#160;&#160;</font></font>No&#160;<font style="DISPLAY: inline;" face="Wingdings">x</font></font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">State the aggregate market value of the voting and non-voting common equity held by non-affiliates computed by reference to the price at which the common equity was last sold, or the average bid and asked prices of such common equity, as of the last business day of the registrant's most recently completed second fiscal quarter.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">$214,202,402</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Indicate the number of shares outstanding of each of the registrant's classes of common stock, as of the latest practicable date.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">69,278,512 as of September 2, 2014</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left">&#160;</div>

<div id="PGBRK" style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div id="FTR">
<div id="GLFTR" style="WIDTH: 100%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>

<div id="PN" style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
<div style="TEXT-ALIGN: center; WIDTH: 100%"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">2</font></div>

<div style="TEXT-ALIGN: center; WIDTH: 100%">
<hr style="COLOR: black" noshade size="2">
</div>
</div>

<div id="HDR">
<div id="GLHDR" style="WIDTH: 100%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">TABLE OF CONTENTS</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block">
<div align="left">
<table cellpadding="2" cellspacing="0" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr>
<td valign="top" width="10%" style="TEXT-ALIGN: left; TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="top" width="85%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="right" valign="top" width="5%">
<div style="TEXT-ALIGN: center; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline; TEXT-DECORATION: underline">Page</font></font></font></div>
</td>
</tr><tr>
<td valign="top" width="10%" style="TEXT-ALIGN: left; TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div style="TEXT-ALIGN: left; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><a href="#p1">PART I</a></font></div>
</td>
<td valign="top" width="85%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="top" width="5%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">2</font></div>
</td>
</tr><tr>
<td align="left" valign="top" width="10%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><a href="#1">Item&#160;1.</a></font></div>
</td>
<td align="left" valign="top" width="85%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><a href="#1">Business.</a></font></div>
</td>
<td align="right" valign="top" width="5%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">2</font></div>
</td>
</tr><tr>
<td align="left" valign="top" width="10%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><a href="#1b">Item 1A.</a></font></div>
</td>
<td align="left" valign="top" width="85%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><a href="#1b">Risk Factors.</a></font></div>
</td>
<td align="right" valign="top" width="5%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">11</font></div>
</td>
</tr><tr bgcolor="white">
<td align="left" valign="top" width="10%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><a href="#1b">Item 1B.</a></font></div>
</td>
<td align="left" valign="top" width="85%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><a href="#1b">Unresolved Staff Comments.</a></font></div>
</td>
<td align="right" valign="top" width="5%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">23</font></div>
</td>
</tr><tr bgcolor="white">
<td align="left" valign="top" width="10%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><a href="#2">Item&#160;2.</a></font></div>
</td>
<td align="left" valign="top" width="85%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><a href="#2">Properties.</a></font></div>
</td>
<td align="right" valign="top" width="5%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">23</font></div>
</td>
</tr><tr bgcolor="white">
<td align="left" valign="top" width="10%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><a href="#3">Item 3.</a></font></div>
</td>
<td align="left" valign="top" width="85%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><a href="#3">Legal Proceedings.</a></font></div>
</td>
<td align="right" valign="top" width="5%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">23</font></div>
</td>
</tr><tr bgcolor="white">
<td align="left" valign="top" width="10%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><a href="#4">Item 4.</a></font></div>
</td>
<td align="left" valign="top" width="85%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><a href="#4">Mine Safety Disclosures.</a></font></div>
</td>
<td align="right" valign="top" width="5%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">23</font></div>
</td>
</tr><tr bgcolor="white">
<td valign="top" width="10%" style="TEXT-ALIGN: left; TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div style="TEXT-ALIGN: left; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><a href="#par2">PART II</a></font></div>
</td>
<td align="right" valign="top" width="85%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></div>
</td>
<td valign="top" width="5%">
<div style="TEXT-ALIGN: right; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">23</font></font></div>
</td>
</tr><tr bgcolor="white">
<td align="left" valign="top" width="10%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><a href="#5">Item 5.</a></font></div>
</td>
<td align="left" valign="top" width="85%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><a href="#5">Market for Registrant's Common Equity, Related Stockholder Matters and Issuer Purchases of Equity Securities.</a></font></div>
</td>
<td align="right" valign="top" width="5%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">23</font></div>
</td>
</tr><tr bgcolor="white">
<td align="left" valign="top" width="10%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><a href="#6">Item 6.</a></font></div>
</td>
<td align="left" valign="top" width="85%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><a href="#6">Selected financial data.</a></font></div>
</td>
<td align="right" valign="top" width="5%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">25</font></div>
</td>
</tr><tr bgcolor="white">
<td align="left" valign="top" width="10%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><a href="#7">Item 7.</a></font></div>
</td>
<td align="left" valign="top" width="85%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><a href="#7">Management's Discussion and Analysis of Financial Condition and Results of Operations.</a></font></div>
</td>
<td align="right" valign="top" width="5%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">26</font></div>
</td>
</tr><tr bgcolor="white">
<td align="left" valign="top" width="10%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><a href="#7a">Item 7A.</a></font></div>
</td>
<td align="left" valign="top" width="85%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><a href="#7a">Quantitative and Qualitative Disclosures About Market Risk.</a></font></div>
</td>
<td align="right" valign="top" width="5%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">33</font></div>
</td>
</tr><tr bgcolor="white">
<td align="left" valign="top" width="10%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><a href="#8">Item 8.</a></font></div>
</td>
<td align="left" valign="top" width="85%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><a href="#8">Financial Statements and Supplementary Data.</a></font></div>
</td>
<td align="right" valign="top" width="5%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">34</font></div>
</td>
</tr><tr bgcolor="white">
<td align="left" valign="top" width="10%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><a href="#9">Item 9.</a></font></div>
</td>
<td align="left" valign="top" width="85%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><a href="#9">Changes in and Disagreements With Accountants on Accounting and Financial Disclosure.</a></font></div>
</td>
<td align="right" valign="top" width="5%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">35</font></div>
</td>
</tr><tr bgcolor="white">
<td align="left" valign="top" width="10%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><a href="#9a">Item 9A.</a></font></div>
</td>
<td align="left" valign="top" width="85%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><a href="#9a">Controls and Procedures</a></font></div>
</td>
<td align="right" valign="top" width="5%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">35</font></div>
</td>
</tr><tr bgcolor="white">
<td align="left" valign="top" width="10%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><a href="#9b">Item 9B.</a></font></div>
</td>
<td align="left" valign="top" width="85%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><a href="#9b">Other Information</a></font></div>
</td>
<td align="right" valign="top" width="5%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">36</font></div>
</td>
</tr><tr bgcolor="white">
<td valign="top" width="10%" style="TEXT-ALIGN: left; TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div style="TEXT-ALIGN: left; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><a href="#p3">PART III</a></font></div>
</td>
<td align="right" valign="top" width="85%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></div>
</td>
<td valign="top" width="5%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">37</font></font></div>
</td>
</tr><tr bgcolor="white">
<td align="left" valign="top" width="10%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><a href="#10">Item 10.</a></font></div>
</td>
<td align="left" valign="top" width="85%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><a href="#10">Directors, Executive Officers and Corporate Governance.</a></font></div>
</td>
<td align="right" valign="top" width="5%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">37</font></div>
</td>
</tr><tr bgcolor="white">
<td align="left" valign="top" width="10%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><a href="#11">Item&#160;11.</a></font></div>
</td>
<td align="left" valign="top" width="85%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><a href="#11">Executive Compensation.</a></font></div>
</td>
<td align="right" valign="top" width="5%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">42</font></div>
</td>
</tr><tr bgcolor="white">
<td align="left" valign="top" width="10%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><a href="#12">Item 12.</a></font></div>
</td>
<td align="left" valign="top" width="85%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><a href="#12">Security Ownership of Certain Beneficial Owners and Management and Related Stockholders Matters.</a></font></div>
</td>
<td align="right" valign="top" width="5%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">50</font></div>
</td>
</tr><tr bgcolor="white">
<td align="left" valign="top" width="10%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><a href="#13">Item 13.</a></font></div>
</td>
<td align="left" valign="top" width="85%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><a href="#13">Certain Relationships and Related Transactions and Director Independence.</a></font></div>
</td>
<td align="right" valign="top" width="5%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">52</font></div>
</td>
</tr><tr bgcolor="white">
<td align="left" valign="top" width="10%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><a href="#14">Item 14.</a></font></div>
</td>
<td align="left" valign="top" width="85%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><a href="#14">Principal Accounting Fees and Services</a></font></div>
</td>
<td align="right" valign="top" width="5%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">52</font></div>
</td>
</tr><tr bgcolor="white">
<td valign="top" width="10%" style="TEXT-ALIGN: left; TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div style="TEXT-ALIGN: left; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><a href="#p4">PART IV</a></font></div>
</td>
<td align="right" valign="top" width="85%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></div>
</td>
<td valign="top" width="5%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">54</font></font></div>
</td>
</tr><tr bgcolor="white">
<td align="left" valign="top" width="10%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><a href="#15">Item 15.</a></font></div>
</td>
<td align="left" valign="top" width="85%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><a href="#15">Exhibits.</a></font></div>
</td>
<td align="right" valign="top" width="5%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">54</font></div>
</td>
</tr></table>
</div>

<div id="PGBRK" style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div id="FTR">&#160;</div>

<div>
<div id="GLFTR" style="WIDTH: 100%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>

<div id="PN" style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
<div style="TEXT-ALIGN: center; WIDTH: 100%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">i</font></div>

<div style="TEXT-ALIGN: center; WIDTH: 100%">
<hr style="COLOR: black" noshade size="2">
</div>
</div>

<div id="HDR">
<div id="GLHDR" style="WIDTH: 100%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>
</div>

<br>
<font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Our financial statements are stated in thousands United States Dollars (US$) and are prepared in accordance with United States Generally Accepted Accounting Principles (U.S. GAAP).</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">In this annual report, unless otherwise specified, all dollar amounts are expressed in United States dollars.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">As used in this annual report, the terms "we", "us", "our", "the Company", and "Pluristem" mean Pluristem Therapeutics Inc. and our wholly owned Israeli subsidiary, unless otherwise indicated or required by the context.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">CAUTIONARY NOTE REGARDING FORWARD-LOOKING STATEMENTS</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 36pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">The statements contained in this Annual Report on Form 10-K (Annual Report) that are not historical facts are "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995 and other federal securities laws. Such forward-looking statements may be identified by, among other things, the use of forward-looking terminology such as "believes," "intends," "plans," "expects," "may," "will," "should," or "anticipates" or the negative thereof or other variations thereon or comparable terminology, and similar expressions are intended to identify forward-looking statements.&#160;&#160;We remind readers that forward-looking statements are merely predictions and therefore inherently subject to uncertainties and other factors and involve known and unknown risks that could cause the actual results, performance, levels of activity, or our achievements, or industry results, to be materially different from any future results, performance, levels of activity, or our achievements, or industry results, expressed or implied by such forward-looking statements. Such forward-looking statements appear in Item 1 &#8211; "Business" and Item 7 &#8211; "Management's discussion and Analysis of Financial Condition and Results of Operations," (especially in the section titled "Outlook") as well as elsewhere in this Annual Report and include, among other statements, statements regarding the following:</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div>
<table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td style="WIDTH: 18pt">
<div style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline;" face="Symbol, serif">&#183;</font></font></div>
</td>
<td>
<div align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">the expected development and potential benefits from our products in treating various medical conditions;</font></div>
</td>
</tr></table>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">
<table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td style="WIDTH: 18pt">
<div style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline;" face="Symbol, serif">&#183;</font></font></div>
</td>
<td>
<div style="TEXT-ALIGN: justify; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">the exclusive license agreements we entered into with United Therapeutics Corporation (United) and CHA Bio&amp;Diostech (CHA)</font> <font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">and clinical trials to be conducted according to such agreements;</font></div>
</td>
</tr></table>
</div>

<div>&#160;</div>

<div>
<table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td style="WIDTH: 18pt">
<div style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline;" face="Symbol, serif">&#183;</font></font></div>
</td>
<td>
<div align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">the prospects of entering into additional license agreements, or other forms of cooperation with other companies and medical institutions;</font></div>
</td>
</tr></table>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div>
<table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td style="WIDTH: 18pt">
<div style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline;" face="Symbol, serif">&#183;</font></font></div>
</td>
<td>
<div align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">our pre-clinical and clinical trials plans, including timing of conclusion of trials;</font></div>
</td>
</tr></table>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div>
<table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td style="WIDTH: 18pt">
<div style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline;" face="Symbol, serif">&#183;</font></font></div>
</td>
<td>
<div align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">our belief that PLX cells may be effective in supporting bone marrow transplantation and in treating bone marrow suppression from radiation and chemotherapy;</font></div>
</td>
</tr></table>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div>
<table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td style="WIDTH: 18pt">
<div style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline;" face="Symbol, serif">&#183;</font></font></div>
</td>
<td>
<div align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">achieving regulatory approvals;</font></div>
</td>
</tr></table>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div>
<table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td style="WIDTH: 18pt">
<div style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline;" face="Symbol, serif">&#183;</font></font></div>
</td>
<td>
<div align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">developing capabilities for new clinical indications of placenta expanded cells (PLX);</font></div>
</td>
</tr></table>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div>
<table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td style="WIDTH: 18pt">
<div style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline;" face="Symbol, serif">&#183;</font></font></div>
</td>
<td>
<div align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">our expectation to compete based upon our intellectual property portfolio, our in-house manufacturing efficiencies and the efficacy of our products;</font></div>
</td>
</tr></table>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div>
<table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td style="WIDTH: 18pt">
<div style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline;" face="Symbol, serif">&#183;</font></font></div>
</td>
<td>
<div align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">the potential market demand for our products;</font></div>
</td>
</tr></table>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div>
<table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td style="WIDTH: 18pt">
<div style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline;" face="Symbol, serif">&#183;</font></font></div>
</td>
<td>
<div align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">our expectation that in the upcoming years our research and development expenses, net, will continue to be our major operating expense;</font></div>
</td>
</tr></table>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div>
<table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td style="WIDTH: 18pt">
<div style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline;" face="Symbol, serif">&#183;</font></font></div>
</td>
<td>
<div align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">our expectations regarding our short- and long-term capital requirements;</font></div>
</td>
</tr></table>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div>
<table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td style="WIDTH: 18pt">
<div style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline;" face="Symbol, serif">&#183;</font></font></div>
</td>
<td>
<div align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">our outlook for the coming months and future periods, including but not limited to our expectations regarding future revenue and expenses; and</font></div>
</td>
</tr></table>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div>
<table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td style="WIDTH: 18pt">
<div style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline;" face="Symbol, serif">&#183;</font></font></div>
</td>
<td>
<div align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">information with respect to any other plans and strategies for our business.</font></div>
</td>
</tr></table>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div id="PGBRK" style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div id="FTR">
<div id="GLFTR" style="WIDTH: 100%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>

<div id="PN" style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
<div style="TEXT-ALIGN: center; WIDTH: 100%">&#160;</div>

<div style="TEXT-ALIGN: center; WIDTH: 100%">
<hr style="COLOR: black" noshade size="2">
</div>
</div>

<div id="HDR">
<div id="GLHDR" style="WIDTH: 100%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 36pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">The factors discussed herein, including those risks described in Item 1A. "Risk Factors", and expressed from time to time in our filings with the Securities and Exchange Commission (SEC) could cause actual results and developments to be materially different from those expressed in or implied by such statements.&#160;&#160;In addition, historic results of scientific research, clinical and preclinical trials do not guarantee that the conclusions of future research or trials would not suggest different conclusions. Also, historic results referred to in this Annual Report would be interpreted differently in light of additional research, clinical and preclinical trials results. The forward-looking statements are made only as of the date of this filing, and except as required by law we undertake no obligation to publicly update such forward-looking statements to reflect subsequent events or circumstances.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"><a name="p1">PART I</a></font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"><a name="1">Item&#160;1.&#160;&#160;&#160;&#160;Business.</a></font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Our Current Business</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 36pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">We are a bio-therapeutics company developing off-the-shelf allogeneic cell therapy products for the treatment of multiple ischemic and inflammatory conditions, with our lead indications focusing on cardiovascular, orthopedic, pulmonary, hematological, and women&#8217;s health diseases.&#160;&#160;Our patented PLX (PLacental eXpanded) cells function as a platform that releases a number of therapeutic proteins in response to various local and systemic inflammatory and ischemic signals, generated by the patient&#8217;s own body. PLX cells are grown using our proprietary 3D micro-environment technology that produces a product that requires no tissue matching prior to administration.&#160;&#160;</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 36pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">We were incorporated as a Nevada corporation in 2001. We have a wholly owned subsidiary in Israel called Pluristem Ltd. We operate in one segment and our operations are focused on the research, development, clinical trials and manufacturing of cell therapeutics and related technologies.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 36pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Our strategy is to develop and produce cell therapy products for the treatment of multiple disorders using several methods of administration, such as intravenous and intramuscular injections.&#160;&#160;We plan to execute this strategy independently, using our own personnel, and through relationships with research and clinical institutions or in collaboration with other companies, such as United Therapeutics Corporation (United) and CHA Bio&amp;Diostech (CHA). We have built a Good Manufacturing Practices (GMP) grade facility and we are planning to have in-house production capacity to grow clinical-grade PLX cells in commercial quantities.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Scientific Background</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 36pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Cell therapy is an emerging and promising field within the regenerative medicine area.&#160;&#160;The characteristics and properties of cells vary as a function of tissue source and growth conditions.&#160;&#160;The human placenta from which our PLX cells are derived provides an uncontroversial source of non-embryonic, adult cells and represents a new approach in the cell therapy field. The different factors that PLX cells release suggest that the cells can be used therapeutically for a variety of ischemic, inflammatory, autoimmune and hematological disorders.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 36pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">PLX cells do not require tissue matching prior to administration.&#160;&#160;This allows for the development of ready-to-use allogeneic "off-the-shelf" products.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Our Technology</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 36pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">We develop and intend to commercialize cell therapy production technologies and products that are derived from the human placenta. Our PLX cells are adherent stromal cells (ASCs) that are expanded using a proprietary three dimensional (3D) process.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 36pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">This system utilizes a synthetic scaffold to create an artificial 3D environment where placental-derived stromal cells can grow. Our 3D process enables the large scale production of reproducible, high quality cell products, and is capable of manufacturing large numbers of PLX doses originating from different placentas. Additionally, our manufacturing process has demonstrated batch-to-batch consistency, an important manufacturing challenge for biological products.</font></div>

<div id="PGBRK" style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div id="FTR">
<div id="GLFTR" style="WIDTH: 100%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>

<div id="PN" style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
<div style="TEXT-ALIGN: center; WIDTH: 100%"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">3</font></div>

<div style="TEXT-ALIGN: center; WIDTH: 100%">
<hr style="COLOR: black" noshade size="2">
</div>
</div>

<div id="HDR">
<div id="GLHDR" style="WIDTH: 100%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Product Candidates</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 36pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Our primary objective is to be the leading provider of allogeneic cell therapy products that are true off the shelf products that do not require any matching prior to administration. From the physician and patient&#8217;s perspective, our PLX products are delivered in a vial and are administered using a standard needle and syringe. Our PLX products are in clinical stage development for multiple indications such as cardiovascular, orthopedic, pulmonary, and women&#8217;s health diseases.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 36pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Our business model for commercialization and revenue generation includes, but is not limited, to the following activities that we may conduct with both pharmaceutical and medical device companies: partnerships, licensing deals, and joint ventures. To date, we have two strategic relationships, one with United for the licensing of PLX cells for the Pulmonary Arterial Hypertension (PAH), and a second strategic partnership with CHA in South Korea for both Intermittent Claudication (IC) and Critical Limb Ischemia (CLI). CHA is planning to conduct PLX clinical studies in South Korea, and, following regulatory approval, a joint venture equally owned with us will be established to market PLX products in South Korea. Currently, Pluristem&#8217;s PLX cells are being used in a United-sponsored PAH trial in Australia, and in South Korean sites participating in our international IC study through our partnership with CHA.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 36pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">These relationships are intended to leverage our expertise in manufacturing high quality, adult, placenta-derived cells, using our proprietary, scalable, efficient 3D cell manufacturing platform that supports the cost-effective mass production of PLX cells. Our policy for these partnerships is to retain control of the manufacturing of PLX cell products and their associated intellectual property.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 36pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline; FONT-SIZE: 10pt">We believe that using the placenta as a unique&#160;&#160;cell source, combined with our innovative research, development and high quality manufacturing capabilities, will be the "engine" that drives this platform technology towards the successful development of many PLX cell therapy products</font>.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Our Clinical Development Product Candidates</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 36pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline; FONT-WEIGHT: bold">Peripheral and Cardiovascular Diseases &#8211;</font> We are investigating using PLX-PAD cells for treatments for multiple types of peripheral arterial disease from early stage IC to CLI.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 36pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">We have completed two Phase I safety/dose-finding clinical trials for CLI, one in the United States and one in Germany. These CLI trials demonstrated that no blood or genetic matching is required and that the administration of PLX-PAD cells is safe, even if two doses are administered to patients from the same placental source. In addition, PLX-PAD cells are potentially effective in reducing amputation in CLI patients. Generally, the U.S. Food and Drug Administration (FDA) and the European Medicines Agencies (EMA) require the primary endpoint for pivotal CLI clinical trials to be Amputation Free Survival (AFS) at one year. The two studies we conducted suggest an AFS one-year rate of 85% versus the 66% as published for patients treated with currently approved methods of treatment.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 36pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Following our successful Phase I trials in CLI, a large international Phase II, double-blind, randomized, placebo-controlled, 4 arms trial was initiated in the United States, Germany, Israel and South Korea to assess the safety and efficacy of PLX-PAD in 150 patients suffering from IC. Similar to the Phase I studies in CLI, PLX-PAD cells are administered intramuscularly into the patient&#8217;s affected leg. The primary efficacy endpoint for the study is the patient&#8217;s maximal walking distance on a treadmill.&#160;&#160;In June 2013, the study was put on hold by the FDA (but subsequently lifted), following the occurrence of a serious hypersensitivity reaction in a patient participating in the study.&#160;&#160;We suspended the study in the other countries that were part of the study at the time of the clinical hold imposed by the FDA in June 2013 (Clinical Hold) (i.e., Germany and Israel), and provided the competent authorities from the different countries a comprehensive analysis of the hypersensitivity reactions that occurred with PLX-PAD in completed and ongoing studies. Following information submitted to the FDA, the FDA, the Paul Ehrlich Institute (PEI) and the Israeli Ministry of Health (MOH) lifted the Clinical Hold during September and October 2013.</font></div>

<div id="PGBRK" style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div id="FTR">
<div id="GLFTR" style="WIDTH: 100%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>

<div id="PN" style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
<div style="TEXT-ALIGN: center; WIDTH: 100%"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">4</font></div>

<div style="TEXT-ALIGN: center; WIDTH: 100%">
<hr style="COLOR: black" noshade size="2">
</div>
</div>

<div id="HDR">
<div id="GLHDR" style="WIDTH: 100%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-INDENT: 36pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline; FONT-WEIGHT: bold">Orthopedic Diseases &#8211;</font> A Phase I/II, randomized, double-blind, placebo-controlled study to assess the safety and efficacy of intramuscular injections of allogeneic PLX-PAD cells for the regeneration of injured gluteal musculature (GM) after total hip replacement is being conducted in Germany under the approval of the PEI. In this study, PLX-PAD cells or placebo were injected into the traumatized gluteal muscle during the total hip replacement. On July 11, 2013, we announced that enrollment for this clinical trial was completed. On January 21, 2014, we announced that the study met its primary efficacy endpoint, namely the change in maximal voluntary isometric contraction force of the gluteal muscle at six months after total hip replacement patients treated with PLX-PAD had a greater improved change of maximal voluntary muscle contraction force than the placebo group (p=0.0067). The one-year safety follow-up of all the patients was completed at the beginning of July 2014. The study is expected to be concluded with second year safety follow up expected in July 2015.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 36pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline; FONT-WEIGHT: bold">Pulmonary Diseases &#8211;</font> We have out-licensed to United PLX-PAD for the treatment of PAH. A Phase I study was initiated in Australia in patients suffering from PAH during the second quarter of 2013.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div style="TEXT-INDENT: 36pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline; FONT-WEIGHT: bold">Acute Radiation Syndrome (ARS)</font>&#160;&#8211; Following positive data from the use of PLX-RAD cells in animals in stimulating hematopoiesis in diseased or injured bone marrow, we intend to pursue the development of PLX- RAD, for enhancing the engraftment of hematopoietic stem cells after bone marrow transplant. Additionally, on July 26, 2012 we received an invitation from the National Institute of Allergy and Infectious Diseases (NIAID), Department of Health and Human Services, to submit our PLX cells to the agency for evaluation in models of ARS.&#160;&#160; Through today we have conducted with the NIAID multiple animal research using PLX-RAD cells for the treatment of ARS.</font></div>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;</font></div>
</div>

<div style="TEXT-INDENT: 36pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline; FONT-WEIGHT: bold">Pre-eclampsia</font> - Following promising results in a pre-clinical model of pre-eclampsia, we decided to engage in studies in preeclampsia with severe features. We applied to the FDA for an orphan drug designation and we are discussing with the FDA to evaluate the requirements to initiate a clinical trial of our PLX product for this indication.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 36pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline; FONT-WEIGHT: bold">Rotator-cuff Repair</font> - Following promising results of a pre-clinical model of tendon injury, we have decided to conduct a multinational study in patients undergoing surgical repair of the rotator-cuff. We are working on the regulatory requirements to initiate this study.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Regulatory and Clinical Affairs Strategy</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-INDENT: 36pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Our cell therapy development strategy is to hold open discussions with regulators at all stages of development from preclinical trials to more advanced regulatory stages. We utilize this strategy in working with the FDA as well as the EMA, Germany&#8217;s PEI and the MOH, and working with the Ministry of Food and Drug Safety (MFDS) of South Korea and the Australian regulatory authorities via our collaborators.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="FONT-STYLE: italic; DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Intellectual Property</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-INDENT: 36pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">We understand that our success will depend, in part, on maintaining our intellectual property, and therefore we are committed to protecting our technology and product candidates with patents and other methods described below.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-INDENT: 36pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">We are the sole owner of 30 issued patents and more than 120 patent applications in the U.S., Europe, China and Japan, as well as in additional countries worldwide, including in the Far East, Israel and South America.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 36pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Based on the well-established understanding that the characteristics and therapeutic potential of a cell product are largely determined by the source of the cells and by the methods and conditions used during their culturing, our patent portfolio includes different types of claims that protect the various unique aspects of our technology.</font></div>

<div style="TEXT-INDENT: 36pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left">&#160;</div>

<div id="PGBRK" style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div id="FTR">
<div id="GLFTR" style="WIDTH: 100%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>

<div id="PN" style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
<div style="TEXT-ALIGN: center; WIDTH: 100%"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">5</font></div>

<div style="TEXT-ALIGN: center; WIDTH: 100%">
<hr style="COLOR: black" noshade size="2">
</div>
</div>

<div id="HDR">
<div id="GLHDR" style="WIDTH: 100%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Our multi-national portfolio of patent and patent applications include the following claims:</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div>
<table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td style="WIDTH: 36pt">
<div><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160; </font></div>
</td>
<td style="WIDTH: 18pt">
<div style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline;" face="Symbol, serif">&#183;</font></font></div>
</td>
<td>
<div align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Our proprietary expansion methods and devices for 3D stromal cells;</font></div>
</td>
</tr></table>
</div>

<div>
<table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td style="WIDTH: 36pt">
<div><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160; </font></div>
</td>
<td style="WIDTH: 18pt">
<div style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline;" face="Symbol, serif">&#183;</font></font></div>
</td>
<td>
<div align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Composition of matter claims on the cells;</font></div>
</td>
</tr></table>
</div>

<div>
<table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td style="WIDTH: 36pt">
<div><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160; </font></div>
</td>
<td style="WIDTH: 18pt">
<div style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline;" face="Symbol, serif">&#183;</font></font></div>
</td>
<td>
<div align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">The therapeutic use of PLX cells for the treatment of a variety of medical conditions; and</font></div>
</td>
</tr></table>
</div>

<div>
<table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td style="WIDTH: 36pt">
<div><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160; </font></div>
</td>
<td style="WIDTH: 18pt">
<div style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline;" face="Symbol, serif">&#183;</font></font></div>
</td>
<td>
<div align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Cell-culture devices.</font></div>
</td>
</tr></table>
</div>

<div>
<table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td style="WIDTH: 54pt">
<div><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160; </font></div>
</td>
<td>&#160;</td>
</tr></table>
</div>

<div style="TEXT-INDENT: 36pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Through our experience with ASC-based product development, we have developed expertise and know-how in this field and have established procedures for manufacturing clinical-grade PLX cells in our facilities. Certain aspects of our manufacturing process are covered by patents and patent applications. In addition, specific aspects of our technology are retained as know-how and trade secrets that are protected by our confidentiality agreements with our employees, consultants, contractors, manufacturers and advisors. These agreements generally provide for protection of confidential information, restrictions on the use of materials, and assignment to Pluristem of inventions conceived during the course of performing services for us.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 36pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">The following table provides a description of our key patents and patent applications and is not intended to represent an assessment of claims, limitations or scope.&#160;&#160;There is a risk that our patents will be invalidated, and that our pending patent applications will not result in issued patents.&#160;&#160;We also cannot be certain that we will not infringe on any patents that may be issued to others.&#160;&#160;See <font style="FONT-STYLE: italic; DISPLAY: inline">"Risk Factors - We must further protect and develop our technology and products in order to become a profitable company"</font>.&#160;&#160;The expiration dates of these patents, based on filing dates, range from 2019 to 2033. Actual expiration dates will be determined according to extensions received based on the Drug Price Competition and Patent Term Restoration Act of 1984 (P.L. 98-417), commonly known as the "Hatch-Waxman" Act, that permits extensions of pharmaceutical patents to reflect regulatory delays encountered in obtaining FDA market approval.&#160;&#160;The Hatch-Waxman Act is based on a U.S. federal law and therefore only relevant to U.S. patents.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline; FONT-WEIGHT: bold">Pluristem's Patent Portfolio </font></font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div align="left">
<table cellpadding="3" cellspacing="0" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr>
<td align="left" valign="top" width="33%" style="BORDER-BOTTOM: black 2px solid; BORDER-LEFT: #000000 2px solid; BORDER-TOP: #000000 2px solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Patent Name</font></div>
</td>
<td align="left" valign="top" width="34%" style="BORDER-BOTTOM: black 2px solid; BORDER-LEFT: black 2px solid; BORDER-TOP: #000000 2px solid; BORDER-RIGHT: black 2px solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Pending Jurisdictions</font></div>
</td>
<td align="left" valign="top" width="33%" style="BORDER-BOTTOM: black 2px solid; BORDER-TOP: #000000 2px solid; BORDER-RIGHT: #000000 2px solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Granted Jurisdictions</font></div>
</td>
</tr><tr>
<td align="left" valign="top" width="33%" style="BORDER-BOTTOM: black 2px solid; BORDER-LEFT: #000000 2px solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">METHOD AND APPARATUS FOR MAINTENANCE AND EXPANSION OF HAEMATOPOIETIC STEM CELLS AND/OR PROGENITOR CELLS</font></div>
</td>
<td align="left" valign="top" width="34%" style="BORDER-BOTTOM: black 2px solid; BORDER-LEFT: black 2px solid; BORDER-RIGHT: black 2px solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">United States, Europe, Mexico</font></div>
</td>
<td align="left" valign="top" width="33%" style="BORDER-BOTTOM: black 2px solid; BORDER-RIGHT: #000000 2px solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">United States, Japan, Europe, Mexico, Australia, South Africa, Israel, Russia, New Zealand, India, China, Hong Kong, Canada</font></div>
</td>
</tr><tr>
<td align="left" valign="top" width="33%" style="BORDER-BOTTOM: black 2px solid; BORDER-LEFT: #000000 2px solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">METHODS FOR CELL EXPANSION AND USES OF CELLS AND CONDITIONED MEDIA PRODUCED THEREBY FOR THERAPY</font></div>
</td>
<td align="left" valign="top" width="34%" style="BORDER-BOTTOM: black 2px solid; BORDER-LEFT: black 2px solid; BORDER-RIGHT: black 2px solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">United States, Japan, Europe, Mexico, Israel,&#160;&#160;&#160;China, Hong Kong, Canada, Brazil, Korea, Singapore</font></div>
</td>
<td align="left" valign="top" width="33%" style="BORDER-BOTTOM: black 2px solid; BORDER-RIGHT: #000000 2px solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Russia, South Africa, Australia, India</font></div>
</td>
</tr><tr>
<td align="left" valign="top" width="33%" style="BORDER-BOTTOM: black 2px solid; BORDER-LEFT: #000000 2px solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">ADHERENT CELLS FROM PLACENTA TISSUE AND USE THEREOF IN THERAPY</font></div>
</td>
<td align="left" valign="top" width="34%" style="BORDER-BOTTOM: black 2px solid; BORDER-LEFT: black 2px solid; BORDER-RIGHT: black 2px solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">United States, Europe, Mexico, Australia,&#160;&#160;Israel,&#160;&#160;India, China, Hong Kong, Canada, Brazil, Singapore, Russia</font></div>
</td>
<td align="left" valign="top" width="33%" style="BORDER-BOTTOM: black 2px solid; BORDER-RIGHT: #000000 2px solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">United States, South Africa</font></div>
</td>
</tr><tr>
<td align="left" valign="top" width="33%" style="BORDER-BOTTOM: black 2px solid; BORDER-LEFT: #000000 2px solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">ADHERENT CELLS FROM ADIPOSE OR PLACENTA TISSUES AND USE THEREOF IN THERAPY</font></div>
</td>
<td align="left" valign="top" width="34%" style="BORDER-BOTTOM: black 2px solid; BORDER-LEFT: black 2px solid; BORDER-RIGHT: black 2px solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">United States, Japan, Europe, Mexico, Australia,&#160;&#160;Israel,&#160;&#160;India, China, Canada, Korea, Brazil,&#160;&#160;Russia, Hong Kong,</font></div>
</td>
<td align="left" valign="top" width="33%" style="BORDER-BOTTOM: black 2px solid; BORDER-RIGHT: #000000 2px solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Europe, United States, Hong Kong, Singapore, South Africa, Australia,</font></div>
</td>
</tr><tr>
<td align="left" valign="top" width="33%" style="BORDER-BOTTOM: black 2px solid; BORDER-LEFT: #000000 2px solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">METHODS OF TREATING INFLAMMATORY COLON DISEASES</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block">&#160;</div>
</td>
<td align="left" valign="top" width="34%" style="BORDER-BOTTOM: black 2px solid; BORDER-LEFT: black 2px solid; BORDER-RIGHT: black 2px solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">United States, Australia, Brazil, Canada, China, Europe, Hong Kong, Israel</font></div>
</td>
<td align="left" valign="top" width="33%" style="BORDER-BOTTOM: black 2px solid; BORDER-RIGHT: #000000 2px solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Russia, South Africa</font></div>
</td>
</tr><tr>
<td align="left" valign="top" width="33%" style="BORDER-BOTTOM: black 2px solid; BORDER-LEFT: #000000 2px solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">METHODS OF SELECTION OF CELLS FOR TRANSPLANTATION</font></div>
</td>
<td align="left" valign="top" width="34%" style="BORDER-BOTTOM: black 2px solid; BORDER-LEFT: black 2px solid; BORDER-RIGHT: black 2px solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">United States, Europe, Israel, Hong Kong</font></div>
</td>
<td valign="top" width="33%" style="BORDER-BOTTOM: black 2px solid; BORDER-RIGHT: #000000 2px solid"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr>
<td align="left" valign="top" width="33%" style="BORDER-BOTTOM: black 2px solid; BORDER-LEFT: #000000 2px solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">ADHERENT CELLS FROM PLACENTA TISSUE AND USE THEREOF IN THERAPY</font></div>
</td>
<td align="left" valign="top" width="34%" style="BORDER-BOTTOM: black 2px solid; BORDER-LEFT: black 2px solid; BORDER-RIGHT: black 2px solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">United States, Europe, Israel, Hong Kong</font></div>
</td>
<td valign="top" width="33%" style="BORDER-BOTTOM: black 2px solid; BORDER-RIGHT: #000000 2px solid"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr>
<td align="left" valign="top" width="33%" style="BORDER-BOTTOM: black 2px solid; BORDER-LEFT: #000000 2px solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">ADHERENT STROMAL CELLS DERIVED FROM PLANCENTAS OF MULTIPLE DONORS AND USES THEREOF</font></div>
</td>
<td align="left" valign="top" width="34%" style="BORDER-BOTTOM: black 2px solid; BORDER-LEFT: black 2px solid; BORDER-RIGHT: black 2px solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">United States, Europe, Israel, Hong Kong</font></div>
</td>
<td valign="top" width="33%" style="BORDER-BOTTOM: black 2px solid; BORDER-RIGHT: #000000 2px solid"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr>
<td align="left" valign="top" width="33%" style="BORDER-BOTTOM: black 2px solid; BORDER-LEFT: #000000 2px solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">ADHERENT CELLS FROM PLACENTA AND USE OF SAME IN DISEASE TREATMENT</font></div>
</td>
<td align="left" valign="top" width="34%" style="BORDER-BOTTOM: black 2px solid; BORDER-LEFT: black 2px solid; BORDER-RIGHT: black 2px solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">United States, Australia, Canada, China, Europe, Hong Kong, Israel, India, Mexico, New-Zealand</font></div>
</td>
<td align="left" valign="top" width="33%" style="BORDER-BOTTOM: black 2px solid; BORDER-RIGHT: #000000 2px solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">South Africa</font></div>
</td>
</tr><tr>
<td align="left" valign="top" width="33%" style="BORDER-BOTTOM: black 2px solid; BORDER-LEFT: #000000 2px solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">METHODS AND SYSTEMS FOR HARVESTING ADHERENT STROMAL CELLS</font></div>
</td>
<td align="left" valign="top" width="34%" style="BORDER-BOTTOM: black 2px solid; BORDER-LEFT: black 2px solid; BORDER-RIGHT: black 2px solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">United States, Australia, Canada, China, Europe, Hong Kong, Israel, India, Korea, Mexico, Singapore, South Africa</font></div>
</td>
<td valign="top" width="33%" style="BORDER-BOTTOM: black 2px solid; BORDER-RIGHT: #000000 2px solid"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr>
<td align="left" valign="top" width="33%" style="BORDER-BOTTOM: black 2px solid; BORDER-LEFT: #000000 2px solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">METHODS FOR TREATING RADIATION OR CHEMICAL INJURY</font></div>
</td>
<td align="left" valign="top" width="34%" style="BORDER-BOTTOM: black 2px solid; BORDER-LEFT: black 2px solid; BORDER-RIGHT: black 2px solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">United States, Europe, Hong Kong, Israel, Korea, Japan</font></div>
</td>
<td valign="top" width="33%" style="BORDER-BOTTOM: black 2px solid; BORDER-RIGHT: #000000 2px solid"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr>
<td align="left" valign="top" width="33%" style="BORDER-BOTTOM: #000000 2px solid; BORDER-LEFT: #000000 2px solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">SKELETAL MUSCLE REGENERATION USING MESENCHYMAL STEM CELLS</font></div>
</td>
<td align="left" valign="top" width="34%" style="BORDER-BOTTOM: #000000 2px solid; BORDER-LEFT: black 2px solid; BORDER-RIGHT: black 2px solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">United States, Europe, Israel, Hong Kong</font></div>
</td>
<td valign="top" width="33%" style="BORDER-BOTTOM: #000000 2px solid; BORDER-RIGHT: #000000 2px solid"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr></table>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">___________</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">A comment to the table: In some cases, a jurisdiction is listed as both pending and granted for a single patent family. This is due to pending continuation or divisional applications of the granted case. </font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left">&#160;</div>

<div id="PGBRK" style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div id="FTR">
<div id="GLFTR" style="WIDTH: 100%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>

<div id="PN" style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
<div style="TEXT-ALIGN: center; WIDTH: 100%"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">6</font></div>

<div style="TEXT-ALIGN: center; WIDTH: 100%">
<hr style="COLOR: black" noshade size="2">
</div>
</div>

<div id="HDR">
<div id="GLHDR" style="WIDTH: 100%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="FONT-STYLE: italic; DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Research and Development</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 36pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Our research and development expenses were $24,938,000, $19,906,000 and $12,685,000 in fiscal years 2014, 2013 and 2012, respectively, before deducting the participation by the Office of the Chief Scientist (OCS) and grants by third parties.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline; TEXT-DECORATION: underline">Foundational Research</font></font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 36pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Our initial technology, the PluriX&#8482; Bioreactor system, was invented at the Technion - Israel Institute of Technology's Rappaport Faculty of Medicine, in collaboration with researchers from the Weizmann Institute of Science. This technology has been further significantly developed by our research and development teams over the years.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline; TEXT-DECORATION: underline">Ongoing Research and Development Plans</font></font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 36pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">In July 2007, we entered into a five year collaborative research agreement with the Berlin-Brandenburg Center for Regenerative Therapies at Charit&#233; - University Medicine Berlin (Charit&#233;). In August 2012, we extended our collaborative research agreement with Charit&#233; for a period of five years through 2017. We and Charit&#233; are collaborating on a variety of indications utilizing PLX cells. According to the agreement, we will be the exclusive owner of the technology and any products produced as a result of the collaboration. The Charit&#233; will receive up to 1% royalties from new developments that have been achieved during the joint development.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 36pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">In recent years we have also engaged in research and development projects with other leading research institutions such as Hadassah University Medical Center (Hadassah) in Jerusalem, Israel and the Texas A&amp;M Health Science Center (Texas A&amp;M) in Round Rock, Texas.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 36pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">We use the services of Texas A&amp;M for conducting a pre-clinical trial with PLX cells in a mice model of pre-eclampsia.&#160;We have no current or ongoing obligations to Texas A&amp;M.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 36pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">We used the services of Hadassah to conduct pre-clinical trials from 2011 through 2013, mainly in the field of radiation. We have no current or ongoing obligations to Hadassah.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div id="PGBRK" style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div id="FTR">
<div id="GLFTR" style="WIDTH: 100%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>

<div id="PN" style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
<div style="TEXT-ALIGN: center; WIDTH: 100%"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">7</font></div>

<div style="TEXT-ALIGN: center; WIDTH: 100%">
<hr style="COLOR: black" noshade size="2">
</div>
</div>

<div id="HDR">
<div id="GLHDR" style="WIDTH: 100%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>
</div>

<div style="TEXT-INDENT: 36pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;</font></div>

<div style="TEXT-INDENT: 36pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">On June 19, 2011, we entered into an exclusive license agreement (the United Agreement) with United for the use of our PLX cells to develop and commercialize a cell-based product for the treatment of PAH.&#160;&#160;The United Agreement provides that United will receive exclusive worldwide license rights for the development and commercialization of our PLX cell-based product to treat PAH.&#160;&#160;The United Agreement further provides for the following consideration payable to us: (i) an upfront payment of $7 million paid in August 2011, which includes a $5 million non-refundable upfront payment and a $2 million advance payment on the development ; (ii) up to $37.5 million upon reaching certain regulatory milestones with respect to the development of a product to treat PAH; (iii) reimbursement of up to $10 million of certain of our expenses if we establish a GMP manufacturing facility in North America; (iv) reimbursement of certain costs in connection with the development of the product; and (v) following commercialization of the product, royalties at a mid-single digit percent and the purchase of commercial supplies of the developed product from us at a specified margin over our cost.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 36pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">The United Agreement became effective on August 2, 2011, and will continue until the later of a few events, including termination of all patents relating to the collaboration, upon certain government action or if the parties do not develop any product under the United Agreement.&#160;&#160;United may unilaterally terminate the United Agreement at any time and without cause.&#160;&#160;In such event, United shall pay us certain costs and expenses of winding down any non-cancellable commitments made by us prior to the date of termination and cease all development activities in connection with the United Agreement.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 36pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"><font style="BACKGROUND-COLOR: #ffffff; DISPLAY: inline">On June 26, 2013, we entered into an exclusive out-license and commercialization agreement (the CHA Agreement) with CHA, for conducting clinical trials and commercialization of our PLX-PAD product in South Korea in connection with two indications: the treatment of CLI and IC. Under the terms of the CHA Agreement, </font>CHA will bear the costs of conducting the clinical trials for the agreed upon indications, and we will continue to retain rights to our proprietary manufacturing technology and cell-related intellectual property.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 36pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"><font style="BACKGROUND-COLOR: #ffffff; DISPLAY: inline">The first clinical study to be performed as part of the CHA Agreement will be a Phase II trial in IC. This study was approved in November 2013 by South Korea&#8217;s MFDS.</font></font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 36pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"><font style="BACKGROUND-COLOR: #ffffff; DISPLAY: inline">Upon the first regulatory approval for a PLX product in South Korea, for the specified indications, we and CHA will establish an equally owned joint venture. The purpose of the joint venture will be to commercialize PLX cell products in South Korea. Additionally, we will be able to use the data generated by CHA to pursue the development of PLX product candidates outside of South Korea.</font></font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 36pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"><font style="BACKGROUND-COLOR: #ffffff; DISPLAY: inline">In addition, and as contemplated by the CHA Agreement, in December 2013, we and CHA executed the mutual investment pursuant to which we issued 2,500,000 shares of our common stock in consideration for 1,011,504 shares of CHA, which reflects total consideration to each of us and CHA of approximately $10,414,000.</font></font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 36pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">The term of the CHA Agreement extends from June 24, 2013 until the later of the expiration, lapse, cancellation, abandonment or invalidation of the last valid patent claim covering the development of the product indications.&#160;&#160;The CHA Agreement contains customary termination provisions, including in the event the parties do not reach an agreement upon development plan for conducting the clinical trials.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 36pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Upon termination of the CHA Agreement, the license granted thereunder will terminate and all rights included therein will revert to us, whereupon we will be free to enter into agreements with any other third parties for the granting of a license in or outside South Korea or to deal in any other manner with such rights as it shall see fit in our sole discretion.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 36pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">We plan to continue to collaborate with universities and academic institutions and corporate partners worldwide to fully leverage our expertise and explore the use of our cells in other indications.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="FONT-STYLE: italic; DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">In-House Clinical Manufacturing</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 36pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">We have the in-house capability to perform clinical cell manufacturing. Our new state-of-the-art GMP grade manufacturing facility in Haifa has been in use since February 2013 for the main purpose of clinical grade large scale manufacturing. The facility&#8217;s new automated manufacturing process and products were approved for production of PLX-PAD for clinical use by the FDA, PEI, Korean MFDS and the Israeli MOH after submission of a comprehensive comparability study. Furthermore, the site was inspected and approved by a qualified person representing PEI, approving that the site and production processes meet the current GMP for the purpose of manufacturing PLX-PAD.&#160;&#160;Following the clinical approval of the facility, we are moving forward with our planned clinical trials based on cells coming from the new, efficient and improved manufacturing processes.</font></div>

<div style="TEXT-INDENT: 36pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left">&#160;</div>

<div id="PGBRK" style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div id="FTR">
<div id="GLFTR" style="WIDTH: 100%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>

<div id="PN" style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
<div style="TEXT-ALIGN: center; WIDTH: 100%"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">8</font></div>

<div style="TEXT-ALIGN: center; WIDTH: 100%">
<hr style="COLOR: black" noshade size="2">
</div>
</div>

<div id="HDR">
<div id="GLHDR" style="WIDTH: 100%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 36pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">We receive the human placentas used for our research and manufacturing activities from various hospitals in Israel after receiving a written informed consent by the mother and pathogen clearance. Any medical waste related to the use of placentas is treated in compliance with local environmental laws and standards.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Government Regulation</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 36pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">The development, manufacturing, and marketing of our cell therapy product candidates are subject to the laws and regulations of governmental authorities in the United States and the European Union as well as other countries in which our products will be marketed in the future. Specifically, the FDA in the United States and the EMA in Europe must approve new drug and cell therapy products before they may be marketed.&#160;&#160;Furthermore, various governmental statutes and regulations also govern or influence testing, manufacturing, safety, labeling, storage and record keeping related to such products and their marketing. Governments in other countries have similar requirements for testing and marketing.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 36pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">The process of obtaining these approvals and the subsequent compliance with appropriate statutes and regulations require the expenditure of substantial time, resources and money. There can be no assurance that our product candidates will ultimately receive marketing approval.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 36pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">There are several stages every drug has to go through during its development process. Among these are:</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div>
<table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td style="WIDTH: 18pt">
<div><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160; </font></div>
</td>
<td style="WIDTH: 18pt">
<div style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline;" face="Symbol, serif">&#183;</font></font></div>
</td>
<td>
<div align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Performance of nonclinical laboratory and animal studies to assess a drug's biological activity and to identify potential safety problems, and to characterize and document the product's chemistry, manufacturing controls, formulation, and stability. In accordance with regulatory requirements nonclinical safety and toxicity studies are conducted under&#160;Good Laboratory Practice requirements&#160;to ensure their quality and reliability.</font></div>
</td>
</tr></table>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div>
<table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td style="WIDTH: 18pt">
<div><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160; </font></div>
</td>
<td style="WIDTH: 18pt">
<div style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline;" face="Symbol, serif">&#183;</font></font></div>
</td>
<td>
<div align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Conducting adequate and well-controlled human clinical trials in compliance with Good Clinical Practice (GCP) to establish the safety and efficacy of the product for its intended indication;</font></div>
</td>
</tr></table>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div>
<table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td style="WIDTH: 18pt">
<div><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160; </font></div>
</td>
<td style="WIDTH: 18pt">
<div style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline;" face="Symbol, serif">&#183;</font></font></div>
</td>
<td>
<div align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">The manufacture of the product according to cGMP regulations and standards; and</font></div>
</td>
</tr></table>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div>
<table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td style="WIDTH: 18pt">
<div><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160; </font></div>
</td>
<td style="WIDTH: 18pt">
<div style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline;" face="Symbol, serif">&#183;</font></font></div>
</td>
<td>
<div align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Potential post-marketing clinical testing and surveillance of the product after marketing approval, which can result in additional conditions on the approvals or suspension of clinical use.</font></div>
</td>
</tr></table>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Approval of a drug for clinical studies in humans and approval of marketing is a sovereign decision of states, delegated to national, or, in case of the European Union, international regulatory competent authorities.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline; TEXT-DECORATION: underline">Regulatory Process in the United States</font></font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 36pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">In the United States, our product candidates are subject to regulation as a biological product under the Public Health Service Act and the Federal Food, Drug and Cosmetic Act. The FDA, regulating the approval of clinical trials and marketing applications in the United States, generally requires the following steps prior to approving a new biological product either for clinical studies or for commercial sale:</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div>
<table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td style="WIDTH: 18pt">
<div style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline;" face="Symbol, serif">&#183;</font></font></div>
</td>
<td>
<div align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Submission of an Investigational New Drug Application, which must become effective before clinical testing in humans can begin;</font></div>
</td>
</tr></table>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div>
<table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td style="WIDTH: 18pt">
<div style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline;" face="Symbol, serif">&#183;</font></font></div>
</td>
<td>
<div align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Obtaining approval of Institutional Review Boards (IRBs) of research institutions or other clinical sites to introduce the biologic drug candidate into humans in clinical trials;</font></div>
</td>
</tr></table>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div>
<table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td style="WIDTH: 18pt">
<div style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline;" face="Symbol, serif">&#183;</font></font></div>
</td>
<td>
<div align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Submission to the FDA of a Biologics License Application (BLA) for marketing authorization of the product which must include adequate results of pre-clinical testing and clinical trials;</font></div>
</td>
</tr></table>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div id="PGBRK" style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div id="FTR">
<div id="GLFTR" style="WIDTH: 100%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>

<div id="PN" style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
<div style="TEXT-ALIGN: center; WIDTH: 100%"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">9</font></div>

<div style="TEXT-ALIGN: center; WIDTH: 100%">
<hr style="COLOR: black" noshade size="2">
</div>
</div>

<div id="HDR">
<div id="GLHDR" style="WIDTH: 100%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div>
<table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td style="WIDTH: 18pt">
<div style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline;" face="Symbol, serif">&#183;</font></font></div>
</td>
<td>
<div align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">FDA review of the BLA in order to determine, among other things, whether the product is safe and effective for its intended uses; and</font></div>
</td>
</tr></table>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div>
<table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td style="WIDTH: 18pt">
<div style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline;" face="Symbol, serif">&#183;</font></font></div>
</td>
<td>
<div align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">FDA inspection and approval of the product manufacturing facility at which the product will be manufactured.</font></div>
</td>
</tr></table>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline; TEXT-DECORATION: underline">Regulatory Process in Europe</font></font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;</font></div>

<div style="TEXT-ALIGN: justify; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">In the European Union, our investigational cellular products are regulated under the Advanced Therapy Medicinal Product regulation, a regulation specific to cell and tissue products.This European Union regulation requires:</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div>
<table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td style="WIDTH: 18pt">
<div style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline;" face="Symbol, serif">&#183;</font></font></div>
</td>
<td>
<div align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Filing a Clinical Trial Application with the various member states or a centralized procedure (a Voluntary Harmonisation), which makes it possible to obtain a coordinated assessment of an application for a clinical trial that is to take place in several European countries;</font></div>
</td>
</tr></table>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div>
<table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td style="WIDTH: 18pt">
<div style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline;" face="Symbol, serif">&#183;</font></font></div>
</td>
<td>
<div align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Obtaining approval of affiliated Ethic Committees of research institutions or other clinical sites to introduce the biologic drug candidate into humans in clinical trials;</font></div>
</td>
</tr></table>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div>
<table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td style="WIDTH: 18pt">
<div style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline;" face="Symbol, serif">&#183;</font></font></div>
</td>
<td>
<div align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Adequate and well-controlled clinical trials to establish the safety and efficacy of the product for its intended use; and</font></div>
</td>
</tr></table>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div>
<table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td style="WIDTH: 18pt">
<div style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline;" face="Symbol, serif">&#183;</font></font></div>
</td>
<td>
<div align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Since our investigational cellular products are regulated under the Advanced Therapy Medicinal Product regulation, the application for marketing authorization to the EMA is mandatory within the 28 member states of the EU. EMA is expected to review and approve the Marketing Authorization Application.</font></div>
</td>
</tr></table>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline; TEXT-DECORATION: underline">Other Regulation</font></font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">We expect to have to obtain approval for clinical studies and ultimately for marketing of each of our products from regulatory authorities in countries outside the United States and the European Union, prior to the commencement of marketing of the product in those countries. The approval procedure varies among countries, and may involve additional preclinical testing and clinical trials.&#160;&#160;The requirements and time required may differ from that required for FDA or EMA approval. Each country may impose certain procedures and requirements of its own. In most other countries outside the United States and the European Union, they are willing to consider requests for marketing approval only after the product had been approved for marketing by either the FDA or the EMA.&#160;&#160;The decision regarding marketing approval is made following the submission of a dossier that is thoroughly assessed and critically addressed.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline; TEXT-DECORATION: underline">Clinical trials</font></font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 36pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Typically, both in the United States and the European Union, clinical testing involves a three-phase process although the phases may overlap. In Phase&#160;I, clinical trials are conducted with a small number of healthy volunteers or patients and are designed to provide information about product safety and to evaluate the pattern of drug distribution and metabolism within the body. In Phase&#160;II, clinical trials are conducted with groups of patients afflicted with a specific disease in order to determine preliminary efficacy, optimal dosages and expanded evidence of safety. In some cases, an initial trial is conducted in diseased patients to assess both preliminary efficacy and preliminary safety and patterns of drug metabolism and distribution, in which case it is referred to as a Phase&#160;I/II trial. Phase&#160;III clinical trials are generally large-scale, multi-center, controlled trials conducted with patients afflicted with a target disease in order to provide statistically valid proof of efficacy, as well as safety and potency. In some circumstances, the FDA or the EMA may require Phase&#160;IV or post-marketing trials if it feels that additional information needs to be collected about the drug after it is on the market.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 36pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">During all phases of clinical development, regulatory agencies require extensive monitoring and auditing of all clinical activities, clinical data and clinical trial investigators to minimize risks. The sponsor of a clinical trial is required to submit an annual safety report to the relevant regulatory agencies, in which serious adverse events must be reported. An agency may, at its discretion, re-evaluate, alter, suspend, or terminate the testing based upon the data which have been accumulated to that point and its assessment of the risk/benefit ratio to the patient.</font></div>

<div style="TEXT-INDENT: 36pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left">&#160;</div>

<div id="PGBRK" style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div id="FTR">
<div id="GLFTR" style="WIDTH: 100%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>

<div id="PN" style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
<div style="TEXT-ALIGN: center; WIDTH: 100%"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">10</font></div>

<div style="TEXT-ALIGN: center; WIDTH: 100%">
<hr style="COLOR: black" noshade size="2">
</div>
</div>

<div id="HDR">
<div id="GLHDR" style="WIDTH: 100%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="FONT-STYLE: italic; DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Employees</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 36pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">We presently employ a total of 160 full-time employees and 9 part-time employees, of whom 142 full-time employees and 9 part-time employees are engaged in research, manufacturing and clinical trials.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="FONT-STYLE: italic; DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Competition</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 36pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">The regenerative medicine field is characterized by intense competition as global pharma players are becoming more engaged in the cell therapy field. The cellular therapeutics industry is subject to technological changes that can be rapid and important. We face competition from both allogeneic and autologous cell therapy companies, academic, commercial and research institutions, pharmaceutical companies, biopharmaceutical companies, and governmental agencies. Some of the clinical indications we currently have under development are also being investigated in preclinical and clinical programs by others.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 36pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">There are multiple participants in the cell therapy field such as Aastrom Biosciences Inc., Athersys Inc., <font style="BACKGROUND-COLOR: #ffffff; DISPLAY: inline">Capricor Therapeutics, Inc.,</font> <font style="BACKGROUND-COLOR: #ffffff; DISPLAY: inline">Cytori Therapeutics, Inc.</font>, Mesoblast LTD, <font style="BACKGROUND-COLOR: #ffffff; DISPLAY: inline">Tigenix NV, </font>and <font style="BACKGROUND-COLOR: #ffffff; DISPLAY: inline">Celgene Corporation</font>. Among other things, we expect to compete based upon our intellectual property portfolio, our in-house manufacturing efficiencies and the efficacy of our products.&#160;&#160;Our ability to compete successfully will depend on our continued ability to attract and retain experienced and skilled executive, scientific and clinical development personnel to identify and develop viable cellular therapeutic candidates and exploit these products commercially.<font style="BACKGROUND-COLOR: #ffffff; DISPLAY: inline"> Given the magnitude of the potential opportunity for stem cell therapy, we expect competition in this area to intensify.</font></font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="FONT-STYLE: italic; DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Available Information</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 36pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Additional information about us is contained on our Internet website at www.pluristem.com. Information on our website is not incorporated by reference into this report. Under the "SEC Filings" and &#8220;Financial Information&#8221; sections, under the "Investors" section of our website, we make available free of charge our Annual Reports on Form 10-K, Quarterly Reports on Form 10-Q, Current Reports on Form 8-K, and amendments to those reports filed or furnished pursuant to Section 13(a) of the Securities Exchange Act of 1934, as amended (Exchange Act), as soon as reasonably practicable after we electronically file such material with, or furnish it to, the SEC.&#160;&#160;Our reports filed with the SEC are also made available to read and copy at the SEC's Public Reference Room at 100 F Street, NE, Washington, D.C. 20549.&#160;&#160;You may obtain information about the Public Reference Room by calling the SEC at 1-800-SEC-0330.&#160;&#160;Reports filed with the SEC are also made available on its website at www.sec.gov.&#160;&#160;The following Corporate Governance documents are also posted on our website: Code of Business Conduct and Ethics, and the Charters for each of the Committees of our Board of Directors.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Item 1A. Risk Factors.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="FONT-STYLE: italic; DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">The following risk factors, among others, could affect our actual results of operations and could cause our actual results to differ materially from those expressed in forward-looking statements made by us. These forward-looking statements are based on current expectations and except as required by law we assume no obligation to update this information. You should carefully consider the risks described below and elsewhere in this Annual Report before making an investment decision. Our business, financial condition or results of operations could be materially adversely affected by any of these risks. Our common stock is considered speculative and the trading price of our common stock could decline due to any of these risks, and you may lose all or part of your investment. The following risk factors are not the only risk factors facing our Company. Additional risks and uncertainties not presently known to us or that we currently deem immaterial may also affect our business.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left">&#160;</div>

<div id="PGBRK" style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div id="FTR">
<div id="GLFTR" style="WIDTH: 100%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>

<div id="PN" style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
<div style="TEXT-ALIGN: center; WIDTH: 100%"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">11</font></div>

<div style="TEXT-ALIGN: center; WIDTH: 100%">
<hr style="COLOR: black" noshade size="2">
</div>
</div>

<div id="HDR">
<div id="GLHDR" style="WIDTH: 100%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"><font style="FONT-STYLE: italic; DISPLAY: inline">Our likelihood of profitability depends on our ability to license and/or develop and commercialize products based on our cell production technology, which is currently in the development stage. If we are unable to complete the development and commercialization of our cell therapy products successfully, our likelihood of profitability will be limited severely</font>.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">We are engaged in the business of developing cell therapy products. We have not realized a profit from our operations to date and there is little likelihood that we will realize any profits in the short or medium term. Any profitability in the future from our business will be dependent upon successful commercialization of our potential cell therapy products and/or licensing of our products, which will require significant additional research and development as well as substantial clinical trials.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="FONT-STYLE: italic; DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">If we are not able to successfully license and/or develop and commercialize our cell therapy product candidates and obtain the necessary regulatory approvals, we may not generate sufficient revenues to continue our business operations.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">So far, the products we are developing have completed only one Phase I/II clinical trial of Gluteal Musculature rehabilitation after total hip arthroplasty (efficacy, ongoing for safety) and one Phase I clinical trial for CLI.&#160;&#160;Our early stage cell therapy product candidates may fail to perform as we expect. Moreover, even if our cell therapy product candidates successfully perform as expected, in later stages of development they may fail to show the desired safety and efficacy traits despite having progressed successfully through pre-clinical or initial clinical testing.&#160;&#160;We will need to devote significant additional research and development, financial resources and personnel to develop commercially viable products and obtain the necessary regulatory approvals.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">If our cell therapy product candidates do not prove to be safe and effective in clinical trials, we will not obtain the required regulatory approvals. If we fail to obtain such approvals, we may not generate sufficient revenues to continue our business operations.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Even if we obtain regulatory approval of a product, that approval may be subject to limitations on the indicated uses for which it may be marketed. Even after granting regulatory approval, the FDA and regulatory agencies in other countries continue to regulate marketed products, manufacturers and manufacturing facilities, which may create additional regulatory barriers and burdens. Later discovery of previously unknown problems with a product, manufacturer or facility, may result in restrictions on the product or manufacturer, including a withdrawal of the product from the market. Further, regulatory agencies may establish additional regulations that could prevent or delay regulatory approval of our products.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="FONT-STYLE: italic; DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">We cannot market and sell our cell therapy product candidates in the United States or Europe or in other countries if we fail to obtain the necessary regulatory approvals or licensure.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">We cannot sell our cell therapy product candidates until regulatory agencies grant marketing approval, or licensure. The process of obtaining regulatory approval is lengthy, expensive and uncertain. It is likely to take at least several years to obtain the required regulatory approvals for our cell therapy product candidates, or we may never gain the necessary approvals. Any difficulties that we encounter in obtaining regulatory approval may have a substantial adverse impact on our operations and cause our stock price to decline significantly.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">To obtain marketing approvals in the United States and Europe for cell therapy product candidates we must, among other requirements, complete carefully controlled and well-designed clinical trials sufficient to demonstrate to the FDA and the EMA that the cell therapy product candidates is safe and effective for each disease for which we seek approval.&#160;&#160;So far, we have successfully conducted Phase I/II and Phase I clinical trials for our PLX-PAD product, which currently is our only product that is the subject of clinical trials.&#160;&#160;Several factors could prevent completion or cause significant delay of these trials, including an inability to enroll the required number of patients or failure to demonstrate adequately that cell therapy product candidates are safe and effective for use in humans. Negative or inconclusive results from or adverse medical events during a clinical trial could cause the clinical trial to be repeated or a program to be terminated, even if other studies or trials relating to the program are successful. The FDA or the EMA can place a clinical trial on hold if, among other reasons, it finds that patients enrolled in the trial are or would be exposed to an unreasonable and significant risk of illness or injury. If safety concerns develop, we, the FDA, or the EMA could stop our trials before completion.</font></div>

<div id="PGBRK" style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div id="FTR">
<div id="GLFTR" style="WIDTH: 100%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>

<div id="PN" style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
<div style="TEXT-ALIGN: center; WIDTH: 100%"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">12</font></div>

<div style="TEXT-ALIGN: center; WIDTH: 100%">
<hr style="COLOR: black" noshade size="2">
</div>
</div>

<div id="HDR">
<div id="GLHDR" style="WIDTH: 100%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="FONT-STYLE: italic; DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Future sales of our shares may cause the prevailing market price of our shares to decrease.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Future sales of our common stock, or the perception that such sales may occur, could cause immediate dilution and adversely affect the market price of our common stock.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;<font style="FONT-STYLE: italic; DISPLAY: inline; FONT-WEIGHT: bold">If we are not able to conduct our clinical trials properly and on schedule, marketing approval by FDA, EMA and other regulatory authorities may be delayed or denied.</font></font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">The completion of our clinical trials may be delayed or terminated for many reasons.&#160;&#160;For instance, in June 2013, we received the Clinical Hold notification with respect to our United States Phase II IC study due to a serious allergic reaction in a case which required hospitalization.&#160;&#160;This Clinical Hold, which was lifted in September 2013, resulted in delays in our clinical trials plan for IC in the United States, Europe and Israel as well as the extension of the development period for which we received funds from United from 6.5 years to 11.5 years. Our clinical trials may be delayed or terminated due to other reasons, such as:</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div>
<table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td style="WIDTH: 18pt">
<div><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160; </font></div>
</td>
<td style="WIDTH: 18pt">
<div style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline;" face="Symbol, serif">&#183;</font></font></div>
</td>
<td>
<div align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">The FDA or the EMA does not grant permission to proceed or places additional trials on clinical hold;</font></div>
</td>
</tr></table>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div>
<table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td style="WIDTH: 18pt">
<div><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160; </font></div>
</td>
<td style="WIDTH: 18pt">
<div style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline;" face="Symbol, serif">&#183;</font></font></div>
</td>
<td>
<div align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Subjects do not enroll in our trials at the rate we expect;</font></div>
</td>
</tr></table>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div>
<table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td style="WIDTH: 18pt">
<div><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160; </font></div>
</td>
<td style="WIDTH: 18pt">
<div style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline;" face="Symbol, serif">&#183;</font></font></div>
</td>
<td>
<div align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">The regulators may ask to increase subject&#8217;s population in the clinical trials;</font></div>
</td>
</tr></table>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div>
<table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td style="WIDTH: 18pt">
<div><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160; </font></div>
</td>
<td style="WIDTH: 18pt">
<div style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline;" face="Symbol, serif">&#183;</font></font></div>
</td>
<td>
<div align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Subjects experience an unacceptable rate or severity of adverse side effects;</font></div>
</td>
</tr></table>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div>
<table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td style="WIDTH: 18pt">
<div><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160; </font></div>
</td>
<td style="WIDTH: 18pt">
<div style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline;" face="Symbol, serif">&#183;</font></font></div>
</td>
<td>
<div align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Third-party clinical investigators do not perform our clinical trials on our anticipated schedule or consistent with the clinical trial protocol, GCP and regulatory requirements, or other third parties do not perform data collection and analysis in a timely or accurate manner;</font></div>
</td>
</tr></table>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div>
<table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td style="WIDTH: 18pt">
<div><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160; </font></div>
</td>
<td style="WIDTH: 18pt">
<div style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline;" face="Symbol, serif">&#183;</font></font></div>
</td>
<td>
<div align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Inspections of clinical trial sites by the FDA, EMA, KFDA and other regulatory authorities find regulatory violations that require us to undertake corrective action, suspend or terminate one or more sites, or prohibit us from using some or all of the data in support of our marketing applications; or</font></div>
</td>
</tr></table>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div>
<table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td style="WIDTH: 18pt">
<div><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160; </font></div>
</td>
<td style="WIDTH: 18pt">
<div style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline;" face="Symbol, serif">&#183;</font></font></div>
</td>
<td>
<div align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">One or more IRBs suspends or terminates the trial at an investigational site, precludes enrollment of additional subjects, or withdraws its approval of the trial.</font></div>
</td>
</tr></table>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Our development costs will increase if we have material delays in our clinical trials, or if we are required to modify, suspend, terminate or repeat a clinical trial. If we are unable to conduct our clinical trials properly and on schedule, marketing approval may be delayed or denied by the FDA, EMA and other regulatory authorities.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="FONT-STYLE: italic; DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">We may need to raise additional financing to support the research, development and manufacturing of our cell therapy products and our products in the future but we cannot be sure we will be able to obtain additional financing on terms favorable to us when needed.&#160;&#160;If we are unable to obtain additional financing to meet our needs, our operations may be adversely affected or terminated.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">It is highly likely that we will need to raise significant additional capital in the future.&#160;&#160;Although we were successful in raising capital in the past, our current financial resources are limited and may not be sufficient to finance our operations until we become profitable, if that ever happens.&#160;&#160;It is likely that we will need to raise additional funds in the near future in order to satisfy our working capital and capital expenditure requirements.&#160;&#160;Therefore, we are dependent on our ability to sell our common stock for funds, receive grants or to otherwise raise capital. There can be no assurance that we will be able to obtain financing. Any sale of our common stock in the future will result in dilution to existing stockholders and could adversely affect the market price of our common stock. Also, we may not be able to borrow or raise additional capital in the future to meet our needs or to otherwise provide the capital necessary to conduct the development and commercialization of our potential cell therapy products, which could result in the loss of some or all of one's investment in our common stock.</font></div>

<div id="PGBRK" style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div id="FTR">
<div id="GLFTR" style="WIDTH: 100%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>

<div id="PN" style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
<div style="TEXT-ALIGN: center; WIDTH: 100%"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">13</font></div>

<div style="TEXT-ALIGN: center; WIDTH: 100%">
<hr style="COLOR: black" noshade size="2">
</div>
</div>

<div id="HDR">
<div id="GLHDR" style="WIDTH: 100%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="FONT-STYLE: italic; DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Favorable results from compassionate use treatment or initial interim results from a clinical trial do not ensure that later clinical trials will be successful and success in early stage clinical trials does not ensure success in later-stage clinical trials.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">PLX cells have been administered as part of compassionate use treatments, which permit the administration of the PLX cells outside of clinical trials.&#160;&#160;No assurance can be given that any positive results are attributable to the PLX cells, or that administration of PLX cells to other patients will have positive results. Compassionate use is a term that is used to refer to the use of an investigational drug outside of a clinical trial to treat a patient with a serious or immediately life-threatening disease or condition who has no comparable or satisfactory alternative treatment options. Regulators often allow compassionate use on a case-by-case basis for an individual patient or for defined groups of patients with similar treatment needs.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">There is no assurance that we will obtain regulatory approval for PLX cells. We will only obtain regulatory approval to commercialize a product candidate if we can demonstrate to the satisfaction of the FDA or the applicable non-U.S. regulatory authorities, in well-designed and conducted clinical trials, that the product candidate is safe and effective and that the product candidate, including the cell production methodology, otherwise meets the appropriate standards required for approval. Clinical trials can be lengthy, complex and extremely expensive processes with uncertain results. A failure of one or more clinical trials may occur at any stage of testing.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Success in early clinical trials does not ensure that later clinical trials will be successful, and initial results from a clinical trial do not necessarily predict final results. While results from treating patients through compassionate use have in certain cases been successful, we cannot be assured that further trials will ultimately be successful. Results of further clinical trials may be disappointing.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Even if early stage clinical trials are successful, we may need to conduct additional clinical trials for product candidates with patients receiving the drug for longer periods before we are able to seek approvals to market and sell these product candidates from the FDA and regulatory authorities outside the United States. Even if we are able to obtain approval for our product candidates through an accelerated approval review program, we may still be required to conduct clinical trials after such an approval.&#160;&#160;If we are not successful in commercializing any of our lead product candidates, or are significantly delayed in doing so, our business will be materially harmed.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="FONT-STYLE: italic; DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">We may not successfully maintain our existing exclusive out-licensing agreements with United and CHA, or establish new collaborative and licensing arrangements, which could adversely affect our ability to develop and commercialize our product candidates.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">One of the elements of our business strategy is to license our technology to other companies. Our business strategy includes establishing collaborations and licensing agreements with one or more pharmaceutical or biotechnology companies. To date, we have two strategic relationships, one with United for the licensing of PLX cells for the PAH indication. The second strategic partnership is with CHA for both the IC and CLI indications in Korea. CHA will conduct PLX clinical studies in South Korea, and, following approval, a joint venture equally owned by both parties will be established to market PLX products in South Korea. Currently, our PLX cells are being in used in a United sponsored PAH trial in Australia, and our PLX cells are also being used in Korean sites participating to our International IC study through our partnership with CHA. Notwithstanding, we may not be able to further establish or maintain such licensing and collaboration arrangements necessary to develop and commercialize our product candidates. Even if we are able to maintain or establish licensing or collaboration arrangements, these arrangements may not be on favorable terms and may contain provisions that will restrict our ability to develop, test and market our product candidates. Any failure to maintain or establish licensing or collaboration arrangements on favorable terms could adversely affect our business prospects, financial condition or ability to develop and commercialize our product candidates.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Our agreements with our collaborators and licensees may have provisions that give rise to disputes regarding the rights and obligations of the parties. These and other possible disagreements could lead to termination of the agreement or delays in collaborative research, development, supply, or commercialization of certain product candidates, or could require or result in litigation or arbitration. Moreover, disagreements could arise with our collaborators over rights to intellectual property or our rights to share in any of the future revenues of products developed by our collaborators. These kinds of disagreements could result in costly and time-consuming litigation. Any such conflicts with our collaborators could reduce our ability to obtain future collaboration agreements and could have a negative impact on our relationship with existing collaborators.</font></div>

<div id="PGBRK" style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div id="FTR">
<div id="GLFTR" style="WIDTH: 100%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>

<div id="PN" style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
<div style="TEXT-ALIGN: center; WIDTH: 100%"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">14</font></div>

<div style="TEXT-ALIGN: center; WIDTH: 100%">
<hr style="COLOR: black" noshade size="2">
</div>
</div>

<div id="HDR">
<div id="GLHDR" style="WIDTH: 100%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="FONT-STYLE: italic; DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">We may not be able to secure and maintain research institutions to conduct our clinical trials.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">We rely on research institutions to conduct our clinical trials. Specifically, the limited number of centers experienced with cell therapy product candidates heightens our dependence on such research institutions. Our reliance upon research institutions, including hospitals and clinics, provides us with less control over the timing and cost of clinical trials and the ability to recruit subjects. If we are unable to reach agreements with suitable research institutions on acceptable terms, or if any resulting agreement is terminated, we may be unable to quickly replace the research institution with another qualified institution on acceptable terms. We may not be able to secure and maintain suitable research institutions to conduct our clinical trials.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="FONT-STYLE: italic; DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">We have limited experience in conducting and managing human trials. If we fail in the conduct of such trials, our business will be materially harmed.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Even though we conducted Phase I/II and Phase I trials for our PLX-PAD product and have recruited employees who are experienced in managing and conducting clinical trials, we have limited experience in this area.&#160;&#160;We will need to expand our experience and rely on consultants in order to obtain regulatory approvals for our therapeutic product candidates.&#160;&#160;The failure to successfully conduct clinical trials could materially harm our business.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="FONT-STYLE: italic; DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">The trend towards consolidation in the pharmaceutical and biotechnology industries may adversely affect us.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">There is a trend towards consolidation in the pharmaceutical and biotechnology industries. This consolidation trend may result in the remaining companies having greater financial resources and technical discovery capabilities, thus intensifying competition in these industries. This trend may also result in fewer potential collaborators or licensees for our therapeutic product candidates. Also, if a consolidating company is already doing business with our competitors, we may lose existing licensees or collaborators as a result of such consolidation.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">This trend may adversely affect our ability to enter into license agreements or agreements for the development and commercialization of our product candidates, and as a result may materially harm our business.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="FONT-STYLE: italic; DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Our product development programs are based on novel technologies and are inherently risky.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">We are subject to the risks of failure inherent in the development of products based on new technologies. The novel nature of our therapeutics creates significant challenges in regards to product development and optimization, manufacturing, government regulation, third-party reimbursement and market acceptance. For example, the FDA, the EMA and other countries&#8217; regulatory authorities have relatively limited experience with cell therapies. Very few cell therapy products have been approved by regulatory authorities to date for commercial sale, and the pathway to regulatory approval for our cell therapy product candidates may accordingly be more complex and lengthy. As a result, the development and commercialization pathway for our therapies may be subject to increased uncertainty, as compared to the pathway for new conventional drugs.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="FONT-STYLE: italic; DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">There are very few drugs and limited therapies that the FDA or EMA have approved as treatments for some of the disease indications we are pursuing. This could complicate and delay FDA, EMA or other countries&#8217; regulatory authorities approval of our biologic drug candidates.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">There are very few drugs and limited therapies currently approved for treatment of CLI, IC, ARS or PH.&#160;&#160;As a result, the clinical efficacy endpoints, or the criteria to measure the intended results of treatment may be difficult to determine. This will increase the difficulty of our obtaining FDA, EMA or other countries&#8217; regulatory authorities approval to market our products.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="FONT-STYLE: italic; DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;</font></div>

<div id="PGBRK" style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div id="FTR">
<div id="GLFTR" style="WIDTH: 100%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>

<div id="PN" style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
<div style="TEXT-ALIGN: center; WIDTH: 100%"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">15</font></div>

<div style="TEXT-ALIGN: center; WIDTH: 100%">
<hr style="COLOR: black" noshade size="2">
</div>
</div>

<div id="HDR">
<div id="GLHDR" style="WIDTH: 100%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="FONT-STYLE: italic; DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Our cell therapy drug candidates represent new classes of therapy that the marketplace may not understand or accept.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Even if we successfully develop and obtain regulatory approval for our cell therapy candidates, the market may not understand or accept them. We are developing cell therapy product candidates that represent novel treatments and will compete with a number of more conventional products and therapies manufactured and marketed by others, including major pharmaceutical companies. The degree of market acceptance of any of our developed and potential products will depend on a number of factors, including:</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div>
<table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td style="WIDTH: 18pt">
<div><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160; </font></div>
</td>
<td style="WIDTH: 18pt">
<div style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline;" face="Symbol, serif">&#183;</font></font></div>
</td>
<td>
<div align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">the clinical safety and effectiveness of our cell therapy drug candidates and their perceived advantage over alternative treatment methods, if any;</font></div>
</td>
</tr></table>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div>
<table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td style="WIDTH: 18pt">
<div><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160; </font></div>
</td>
<td style="WIDTH: 18pt">
<div style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline;" face="Symbol, serif">&#183;</font></font></div>
</td>
<td>
<div align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">adverse events involving our cell therapy product candidates or the products or product candidates of others that are cell-based; and</font></div>
</td>
</tr></table>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div>
<table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td style="WIDTH: 18pt">
<div><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160; </font></div>
</td>
<td style="WIDTH: 18pt">
<div style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline;" face="Symbol, serif">&#183;</font></font></div>
</td>
<td>
<div align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">the cost of our products and the reimbursement policies of government and private third-party payers.</font></div>
</td>
</tr></table>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">If the health care community does not accept our potential products for any of the foregoing reasons, or for any other reason, it could affect our sales, having a material adverse effect on our business, financial condition and results of operations.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="FONT-STYLE: italic; DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">If our processing and storage facility or our clinical manufacturing facilities are damaged or destroyed, our business and prospects would be adversely affected.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">If our processing and storage facility,<font style="FONT-STYLE: italic; DISPLAY: inline">&#160;</font>our clinical manufacturing facilities or the equipment in such facilities were to be damaged or destroyed, the loss of some or all of the stored units of our cell therapy drug candidates would force us to delay or halt our clinical trial processes. &#160;We have two clinical manufacturing facilities located in Haifa, Israel. If these facilities or the equipment in them are significantly damaged or destroyed, we may not be able to quickly or inexpensively replace our manufacturing capacity.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="FONT-STYLE: italic; DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">The clinical manufacturing process for cell therapy products is complex and requires meeting high regulatory standards; We have limited manufacturing experience and know-how.&#160;&#160;Any delay or problem in the clinical manufacturing of PLX may result in a material adverse effect on our business.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Our facility and its commercial scale manufacturing process have received approval from the FDA, EMA, Germany&#8217;s PEI, and the Korean MFDS. However, the clinical manufacturing process is complex and we have no experience in manufacturing our product candidates at a commercial level. There can be no guarantee that we will be able to successfully develop and manufacture our product candidates in a manner that is cost-effective or commercially viable, or that our development and manufacturing capabilities might not take much longer than currently anticipated to be ready for the market.&#160;&#160;In addition, if we fail to maintain regulatory approvals for our manufacturing facilities, we may suffer delays in our ability to manufacture our product candidates.&#160;&#160;This may result in a material adverse effect on our business.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="FONT-STYLE: italic; DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">We are dependent upon third-party suppliers for raw materials needed to manufacture PLX; if any of these third parties fails or is unable to perform in a timely manner, our ability to manufacture and deliver will be compromised.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">In addition to the placenta used in the clinical manufacturing process of PLX we require certain raw materials. These items must be manufactured and supplied to us in sufficient quantities and in compliance with cGMP. To meet these requirements, we have entered into supply agreements with firms that manufacture these raw materials to cGMP standards. Our requirements for these items are expected to increase if and when we transition to the manufacture of commercial quantities of our cell-based drug candidates.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">In addition, as we proceed with our clinical trial efforts, we must be able to continuously demonstrate to the FDA, EMA and other regulatory authorities that we can manufacture our cell therapy product candidates with consistent characteristics. Accordingly, we are materially dependent on these suppliers for supply of cGMP-grade materials of consistent quality. Our ability to complete ongoing clinical trials may be negatively affected in the event that we are forced to seek and validate a replacement source for any of these critical materials.</font></div>

<div id="PGBRK" style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div id="FTR">
<div id="GLFTR" style="WIDTH: 100%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>

<div id="PN" style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
<div style="TEXT-ALIGN: center; WIDTH: 100%"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">16</font></div>

<div style="TEXT-ALIGN: center; WIDTH: 100%">
<hr style="COLOR: black" noshade size="2">
</div>
</div>

<div id="HDR">
<div id="GLHDR" style="WIDTH: 100%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="FONT-STYLE: italic; DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">If we encounter problems or delays in the research and development of our potential cell therapy products, we may not be able to raise sufficient capital to finance our operations during the period required to resolve such problems or delays.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Our cell therapy products are currently in the development stage and we anticipate that we will continue to incur substantial operating expenses and incur net losses until we have successfully completed all necessary research and clinical trials.&#160;&#160;We, and any of our potential collaborators, may encounter problems and delays relating to research and development, regulatory approval and intellectual property rights of our technology.&#160;&#160;Our research and development programs may not be successful, and our cell culture technology may not facilitate the production of cells outside the human body with the expected result.&#160;&#160;Our cell therapy products may not prove to be safe and efficacious in clinical trials.&#160;&#160;If any of these events occur, we may not have adequate resources to continue operations for the period required to resolve the issue delaying commercialization and we may not be able to raise capital to finance our continued operation during the period required for resolution of that issue.&#160;&#160;Accordingly, we may be forced to discontinue or suspend our operations.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="FONT-STYLE: italic; DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Existing government programs and tax benefits may be terminated.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">We have received certain Israeli government approvals under certain programs and may in the future utilize certain tax benefits in Israel by virtue of these programs. To remain eligible for such tax benefits, we must continue to meet certain conditions. If we fail to comply with these conditions in the future, the benefits we receive could be canceled and have to pay additional taxes. We cannot guarantee that these programs and tax benefits will be continued in the future, at their current levels or at all. If these programs and tax benefits are ended, our business, financial condition and results of operations could be materially adversely affected.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="FONT-STYLE: italic; DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Because we received grants from the OCS, we are subject to on-going restrictions.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">We have received royalty-bearing grants from the OCS, for research and development programs that meet specified criteria. The terms of the OCS&#8217;s grants limit our ability to transfer know-how developed under an approved research and development program outside of Israel, regardless of whether the royalties are fully paid. Any non-Israeli citizen, resident or entity that, among other things, becomes a holder of 5% or more of our share capital or voting rights, is entitled to appoint one or more of our directors or our Chief Executive Officer (CEO), serves as a director of our Company or as our CEO is generally required to notify the same to the OCS and to undertake to observe the law governing the grant programs of the OCS, the principal restrictions of which are the transferability limits described above. For more information, see &#8220;Item 7. Management's Discussion and Analysis of Financial Condition and Results of Operations - Liquidity and Capital Resources&#8221;.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="FONT-STYLE: italic; DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">We have limited operating history, which raises doubts with respect to our ability to generate revenues in the future.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">We have a limited operating history in our business of developing and commercializing cell production technology.&#160;&#160;Until we entered into the United Agreement, we did not generate any revenues.&#160;&#160;It is not clear when we will generate additional revenues or whether we will experience further delays in recognizing revenues such as resulted from the Clinical Hold.&#160;&#160;Our primary source of funds has been the sale of our common stock and government grants.&#160;&#160;We cannot give assurances that we will be able to generate any significant revenues or income in the future.&#160;&#160;There is no assurance that we will ever be profitable.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="FONT-STYLE: italic; DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">If we do not keep pace with our competitors and with technological and market changes, our technology and products may become obsolete and our business may suffer.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">The cellular therapeutics industry, of which we are a part, is very competitive and is subject to technological changes that can be rapid and intense. We have faced, and will continue to face, intense competition from biotechnology, pharmaceutical and biopharmaceutical companies, academic and research institutions and governmental agencies engaged in cellular therapeutic and drug discovery activities or funding, both in the United States and internationally. Some of these competitors are pursuing the development of cellular therapeutics, drugs and other therapies that target the same diseases and conditions that we target in our clinical and pre-clinical programs.</font></div>

<div id="PGBRK" style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div id="FTR">
<div id="GLFTR" style="WIDTH: 100%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>

<div id="PN" style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
<div style="TEXT-ALIGN: center; WIDTH: 100%"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">17</font></div>

<div style="TEXT-ALIGN: center; WIDTH: 100%">
<hr style="COLOR: black" noshade size="2">
</div>
</div>

<div id="HDR">
<div id="GLHDR" style="WIDTH: 100%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Many of our competitors have greater resources, more product candidates and have developed product candidates and processes that directly compete with our products.&#160;&#160;Our competitors may have developed, or could develop in the future, new products that compete with our products or even render our products obsolete.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="FONT-STYLE: italic; DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">We depend to a significant extent on certain key personnel, the loss of any of whom may materially and adversely affect our Company.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Our success depends to a significant extent on the continued services of certain highly qualified scientific and management personnel, in particular, Zami Aberman, our CEO and Chairman, and Yaky Yanay, our Chief Operating Officer (COO) and President.&#160;&#160;We face competition for qualified personnel from numerous industry sources, and there can be no assurance that we will be able to attract and retain qualified personnel on acceptable terms.&#160;&#160;The loss of service of any of our key personnel could have a material adverse effect on our operations or financial condition.&#160;&#160;In the event of the loss of services of such personnel, no assurance can be given that we will be able to obtain the services of adequate replacement personnel.&#160;&#160;We do not maintain key person insurance on the lives of any of our officers or employees.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="FONT-STYLE: italic; DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">The patent approval process is complex and we cannot be sure that our pending patent applications or future patent applications will be approved.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">The patent position of biotechnology and pharmaceutical companies generally is highly uncertain, involves complex legal and factual questions and has in recent years been the subject of much litigation. As a result, the issuance, scope, validity, enforceability and commercial value of our and any future licensors' patent rights are highly uncertain.&#160;&#160;Our pending and future patent applications may not result in patents being issued which protect our technology or products or which effectively prevent others from commercializing competitive technologies and products. Changes in either the patent laws or interpretation of the patent laws in the United States and other countries may diminish the value of our patents or narrow the scope of our patent protection. The laws of foreign countries may not protect our rights to the same extent as the laws of the United States and we may not be able to obtain meaningful patent protection for any of our commercial products either in or outside the United States.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">No assurance can be given that the scope of any patent protection granted will exclude competitors or provide us with competitive advantages, that any of the patents that have been or may be issued to us will be held valid if subsequently challenged, or that other parties will not claim rights to or ownership of our patents or other proprietary rights that we hold.&#160;&#160;Furthermore, there can be no assurance that others have not developed or will not develop similar products, duplicate any of our technology or products or design around any patents that have been or may be issued to us or any future licensors.&#160;&#160;Since patent applications in the United States and in Europe are not publicly disclosed until patents are issued, there can be no assurance that others did not first file applications for products covered by our pending patent applications, nor can we be certain that we will not infringe any patents that may be issued to others.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="FONT-STYLE: italic; DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Third parties may initiate legal proceedings alleging that we are infringing their intellectual property rights, the outcome of which would be uncertain and could have a material adverse effect on our business.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Our commercial success depends upon our ability and the ability of our collaborators to develop, manufacture, market and sell our product candidates and use our proprietary technologies without infringing the proprietary rights of third parties. We have yet to conduct comprehensive freedom-to-operate searches to determine whether our proposed business activities or use of certain of the patent rights owned by us would infringe patents issued to third parties. We may become party to, or threatened with, future adversarial proceedings or litigation regarding intellectual property rights with respect to our products and technology, including interference proceedings before the U.S. Patent and Trademark Office. Third parties may assert infringement claims against us based on existing patents or patents that may be granted in the future. If we are found to infringe a third party's intellectual property rights, we could be required to obtain a license from such third party to continue developing and marketing our products and technology. However, we may not be able to obtain any required license on commercially reasonable terms or at all. Even if we were able to obtain a license, it could be non-exclusive, thereby giving our competitors access to the same technologies licensed to us. We could be forced, including by court order, to cease commercializing the infringing technology or product. In addition, we could be found liable for monetary damages. A finding of infringement could prevent us from commercializing our product candidates or force us to cease some of our business operations, which could materially harm our business. For example, we are aware of issued third party patents directed to placental stem cells and their use for therapy and in treating various diseases.&#160;&#160;We may need to seek a license for one or more of these patents.&#160;&#160;No assurances can be given that such a license will be available on commercially reasonable terms, if at all.&#160;&#160;Claims that we have misappropriated the confidential information or trade secrets of third parties could have a similar negative impact on our business.</font></div>

<div id="PGBRK" style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div id="FTR">
<div id="GLFTR" style="WIDTH: 100%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>

<div id="PN" style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
<div style="TEXT-ALIGN: center; WIDTH: 100%"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">18</font></div>

<div style="TEXT-ALIGN: center; WIDTH: 100%">
<hr style="COLOR: black" noshade size="2">
</div>
</div>

<div id="HDR">
<div id="GLHDR" style="WIDTH: 100%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Even if resolved in our favor, litigation or other legal proceedings relating to intellectual property claims may cause us to incur significant expenses, and could distract our technical and management personnel from their normal responsibilities. In addition, there could be public announcements of the results of hearings, motions or other interim proceedings or developments and if securities analysts or investors perceive these results to be negative, it could have a substantial adverse effect on the price of our common stock. Such litigation or proceedings could substantially increase our operating losses and reduce the resources available for development activities or any future sales, marketing or distribution activities. We may not have sufficient financial or other resources to adequately conduct such litigation or proceedings. Some of our competitors are able to sustain the costs of such litigation or proceedings more effectively than we can because of their greater financial resources. Uncertainties resulting from the initiation and continuation of patent litigation or other proceedings could have a material adverse effect on our ability to compete in the marketplace.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="FONT-STYLE: italic; DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">The market for our products will be heavily dependent on third party reimbursement policies.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Our ability to successfully commercialize our product candidates will depend on the extent to which government healthcare programs, as well as private health insurers, health maintenance organizations and other third party payers will pay for our products and related treatments.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Reimbursement by third party payers depends on a number of factors, including the payer&#8217;s determination that use of the product is safe and effective, not experimental or investigational, medically necessary, appropriate for the specific patient and cost-effective.&#160;&#160;Reimbursement in the United States or foreign countries may not be available or maintained for any of our product candidates. &#160;If we do not obtain approvals for adequate third party reimbursements, we may not be able to establish or maintain price levels sufficient to realize an appropriate return on our investment in product development. &#160;Any limits on reimbursement from third party payers may reduce the demand for, or negatively affect the price of, our products. &#160;The lack of reimbursement for these procedures by insurance payers has negatively affected the market for our products in this indication in the past.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Managing and reducing health care costs has been a general concern of federal and state governments in the United States and of foreign governments. &#160;In addition, third party payers are increasingly challenging the price and cost-effectiveness of medical products and services, and many limit reimbursement for newly approved health care products. &#160;In particular, third party payers may limit the indications for which they will reimburse patients who use any products that we may develop. &#160;Cost control initiatives could decrease the price for products that we may develop, which would result in lower product revenues to us.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="FONT-STYLE: italic; DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Our success depends in large part on our ability to develop and protect our technology and our cell therapy products.&#160;&#160;If our patents and proprietary rights agreements do not provide sufficient protection for our technology and our cell therapy products, our business and competitive position will suffer.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Our success will also depend in part on our ability to develop our technology and commercialize cell therapy products without infringing the proprietary rights of others.&#160;&#160;We have not conducted full freedom of use patent searches and no assurance can be given that patents do not exist or could not be filed which would have an adverse affect on our ability to develop our technology or maintain our competitive position with respect to our potential cell therapy products.&#160;&#160;If our technology components, devices, designs, products, processes or other subject matter are claimed under other existing United States or foreign patents or are otherwise protected by third party proprietary rights, we may be subject to infringement actions.&#160;&#160;In such event, we may challenge the validity of such patents or other proprietary rights or we may be required to obtain licenses from such companies in order to develop, manufacture or market our technology or products.&#160;&#160;There can be no assurances that we would be able to obtain such licenses or that such licenses, if available, could be obtained on commercially reasonable terms.&#160;&#160;Furthermore, the failure to either develop a commercially viable alternative or obtain such licenses could result in delays in marketing our proposed products or the inability to proceed with the development, manufacture or sale of products requiring such licenses, which could have a material adverse effect on our business, financial condition and results of operations.&#160;&#160;If we are required to defend ourselves against charges of patent infringement or to protect our proprietary rights against third parties, substantial costs will be incurred regardless of whether we are successful.&#160;&#160;Such proceedings are typically protracted with no certainty of success.&#160;&#160;An adverse outcome could subject us to significant liabilities to third parties and force us to curtail or cease our development of our technology and the commercialization our potential cell therapy products.</font></div>

<div id="PGBRK" style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div id="FTR">
<div id="GLFTR" style="WIDTH: 100%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>

<div id="PN" style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
<div style="TEXT-ALIGN: center; WIDTH: 100%"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">19</font></div>

<div style="TEXT-ALIGN: center; WIDTH: 100%">
<hr style="COLOR: black" noshade size="2">
</div>
</div>

<div id="HDR">
<div id="GLHDR" style="WIDTH: 100%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">We have built the ability to manufacture clinical grade ASCs in-house. Through our experience with ASC-based product development, we have developed expertise and know-how in this field. To protect these expertise and know-how, our policies require confidentiality agreements with our employees, consultants, contractors, manufacturers and advisors. These agreements generally provide for protection of confidential information, restrictions on the use of materials and assignment of inventions conceived during the course of performance for us. These agreements might not effectively prevent disclosure of our confidential information.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="FONT-STYLE: italic; DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">We must further protect and develop our technology and products in order to become a profitable company.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">The initial patent underlying our technology will expire in approximately 2019.&#160;&#160;If we do not complete the development of our technology and products in development by then, or create additional sufficient layers of patents or other intellectual property right, other companies may use the technology to develop competing products.&#160;&#160;If this happens, we may lose our competitive position and our business would likely suffer.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Furthermore, the scope of our patents may not be sufficiently broad to offer meaningful protection.&#160;&#160;In addition, our patents could be successfully challenged, invalidated or circumvented so that our patent rights would not create an effective competitive barrier.&#160;&#160;We also intend to seek patent protection for any of our potential cell therapy products once we have completed their development.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">We also rely on trade secrets and unpatentable know-how that we seek to protect, in part, by confidentiality agreements with our employees, consultants, suppliers and licensees.&#160;&#160;These agreements may be breached, and we might not have adequate remedies for any breach.&#160;&#160;If this were to occur, our business and competitive position would suffer.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="FONT-STYLE: italic; DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">The price of our common stock may fluctuate significantly.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">The market for our shares of common stock may fluctuate significantly. A number of events and factors may have an adverse impact on the market price of our common stock, such as:</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div>
<table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td style="WIDTH: 18pt">
<div><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160; </font></div>
</td>
<td style="WIDTH: 18pt">
<div style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#8226;</font></div>
</td>
<td>
<div align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">results of our clinical trials or adverse events associated with our products;</font></div>
</td>
</tr></table>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div>
<table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td style="WIDTH: 18pt">
<div><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160; </font></div>
</td>
<td style="WIDTH: 18pt">
<div style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#8226;</font></div>
</td>
<td>
<div align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">the amount of our cash resources and our ability to obtain additional funding;</font></div>
</td>
</tr></table>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div>
<table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td style="WIDTH: 18pt">
<div><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160; </font></div>
</td>
<td style="WIDTH: 18pt">
<div style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#8226;</font></div>
</td>
<td>
<div align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">changes in our revenues, expense levels or operating results;</font></div>
</td>
</tr></table>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div>
<table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td style="WIDTH: 18pt">
<div><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160; </font></div>
</td>
<td style="WIDTH: 18pt">
<div style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#8226;</font></div>
</td>
<td>
<div align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">entering into or terminating strategic relationships;</font></div>
</td>
</tr></table>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div>
<table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td style="WIDTH: 18pt">
<div><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160; </font></div>
</td>
<td style="WIDTH: 18pt">
<div style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#8226;</font></div>
</td>
<td>
<div align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">announcements of technical or product developments by us or our competitors;</font></div>
</td>
</tr></table>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div>
<table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td style="WIDTH: 18pt">
<div><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160; </font></div>
</td>
<td style="WIDTH: 18pt">
<div style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#8226;</font></div>
</td>
<td>
<div align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">market conditions for pharmaceutical and biotechnology stocks in particular;</font></div>
</td>
</tr></table>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div>
<table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td style="WIDTH: 18pt">
<div><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160; </font></div>
</td>
<td style="WIDTH: 18pt">
<div style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#8226;</font></div>
</td>
<td>
<div align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">changes in laws and governmental regulations, including changes in tax, healthcare, competition and patent laws;</font></div>
</td>
</tr></table>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div>
<table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td style="WIDTH: 18pt">
<div><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160; </font></div>
</td>
<td style="WIDTH: 18pt">
<div style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#8226;</font></div>
</td>
<td>
<div align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">disputes concerning patents or proprietary rights;</font></div>
</td>
</tr></table>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div id="PGBRK" style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div id="FTR">
<div id="GLFTR" style="WIDTH: 100%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>

<div id="PN" style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
<div style="TEXT-ALIGN: center; WIDTH: 100%"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">20</font></div>

<div style="TEXT-ALIGN: center; WIDTH: 100%">
<hr style="COLOR: black" noshade size="2">
</div>
</div>

<div id="HDR">
<div id="GLHDR" style="WIDTH: 100%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div>
<table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td style="WIDTH: 18pt">
<div><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160; </font></div>
</td>
<td style="WIDTH: 18pt">
<div style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#8226;</font></div>
</td>
<td>
<div align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">new accounting pronouncements or regulatory rulings;</font></div>
</td>
</tr></table>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div>
<table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td style="WIDTH: 18pt">
<div><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160; </font></div>
</td>
<td style="WIDTH: 18pt">
<div style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#8226;</font></div>
</td>
<td>
<div align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">public announcements regarding medical advances in the treatment of the disease states that we are targeting;</font></div>
</td>
</tr></table>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div>
<table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td style="WIDTH: 18pt">
<div><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160; </font></div>
</td>
<td style="WIDTH: 18pt">
<div style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#8226;</font></div>
</td>
<td>
<div align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">patent or proprietary rights developments;</font></div>
</td>
</tr></table>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div>
<table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td style="WIDTH: 18pt">
<div><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160; </font></div>
</td>
<td style="WIDTH: 18pt">
<div style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#8226;</font></div>
</td>
<td>
<div align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">regulatory actions that may impact our products;</font></div>
</td>
</tr></table>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div>
<table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td style="WIDTH: 18pt">
<div><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160; </font></div>
</td>
<td style="WIDTH: 18pt">
<div style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#8226;</font></div>
</td>
<td>
<div align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">disruptions in our manufacturing processes; and</font></div>
</td>
</tr></table>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div>
<table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td style="WIDTH: 18pt">
<div><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160; </font></div>
</td>
<td style="WIDTH: 18pt">
<div style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#8226;</font></div>
</td>
<td>
<div align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">competition.</font></div>
</td>
</tr></table>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">In addition, a market downturn in general and/or in the biopharmaceutical sector in particular, may adversely affect the market price of our securities, which may not necessarily reflect the actual or perceived value of our Company.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="FONT-STYLE: italic; DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">We are exposed to fluctuations in currency exchange rates.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">A significant portion of our business is conducted outside the United States. Therefore, we are exposed to currency exchange fluctuations in other currencies such as the Euro and the New Israeli Shekel (NIS) because a portion of our expenses in Israel and Europe are paid in NIS and Euros, respectively, which subjects us to the risks of foreign currency fluctuations. Our primary expenses paid in NIS are employee salaries, fees for consultants and subcontractors and lease payments on our Israeli facilities. During 2014, we entered into forward contracts to hedge against some of the risk of changes in future cash flows from payments of payroll and related expenses denominated in NIS.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="FONT-STYLE: italic; DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">The dollar cost of our operations in Israel will increase to the extent increases in the rate of inflation in Israel are not offset by a devaluation of the NIS in relation to the dollar, which would harm our results of operations.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Since a considerable portion of our expenses such as employees' salaries are linked to an extent to the rate of inflation in Israel, the dollar cost of our operations is influenced by the extent to which any increase in the rate of inflation in Israel is or is not offset by the devaluation of the NIS in relation to the dollar. As a result, we are exposed to the risk that the NIS, after adjustment for inflation in Israel, will appreciate in relation to the dollar. In that event, the dollar cost of our operations in Israel will increase and our dollar-measured results of operations will be adversely affected. We cannot predict whether the NIS will appreciate against the dollar or vice versa in the future. Any increase in the rate of inflation in Israel, unless the increase is offset on a timely basis by a devaluation of the NIS in relation to the dollar, will increase labor and other costs, which will increase the dollar cost of our operations in Israel and harm our results of operations.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="FONT-STYLE: italic; DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Potential product liability claims could adversely affect our future earnings and financial condition.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">We face an inherent business risk of exposure to product liability claims in the event that the use of our products results in adverse effects.&#160;&#160;We may not be able to maintain adequate levels of insurance for these liabilities at reasonable cost and/or reasonable terms.&#160;&#160;Excessive insurance costs or uninsured claims would add to our future operating expenses and adversely affect our financial condition.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="FONT-STYLE: italic; DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Our principal research and development and manufacturing facilities are located in Israel and the unstable military and political conditions of Israel may cause interruption or suspension of our business operations without warning.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Our principal research and development and manufacturing facilities are located in Israel.&#160;&#160;As a result, we are directly influenced by the political, economic and military conditions affecting Israel.&#160;&#160;Since the establishment of the State of Israel in 1948, a number of armed conflicts have taken place between Israel and its Arab neighbors. During July and August 2014 and November 2012, Israel was engaged in an armed conflict with a militia group and political party which controls the Gaza Strip, and during the summer of 2006, Israel was engaged in an armed conflict with Hezbollah, a Lebanese Islamist Shiite militia group and political party. These conflicts involved missile strikes against civilian targets in various parts of Israel, including areas in which our employees and some of our consultants are located, and negatively affected business conditions in Israel.</font></div>

<div id="PGBRK" style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div id="FTR">
<div id="GLFTR" style="WIDTH: 100%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>

<div id="PN" style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
<div style="TEXT-ALIGN: center; WIDTH: 100%"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">21</font></div>

<div style="TEXT-ALIGN: center; WIDTH: 100%">
<hr style="COLOR: black" noshade size="2">
</div>
</div>

<div id="HDR">
<div id="GLHDR" style="WIDTH: 100%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">In addition, Israeli-based companies and companies doing business with Israel, have been the subject of an economic boycott by members of the Arab League and certain other predominantly Muslim countries since Israel's establishment.&#160;&#160;Although Israel has entered into various agreements with certain Arab countries and the Palestinian Authority, and various declarations have been signed in connection with efforts to resolve some of the economic and political problems in the Middle East, we cannot predict whether or in what manner these problems will be resolved. Wars and acts of terrorism have resulted in significant damage to the Israeli economy, including reducing the level of foreign and local investment.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Furthermore, certain of our officers and employees may be obligated to perform annual reserve duty in the Israel Defense Forces and are subject to being called up for active military duty at any time.&#160;&#160;All Israeli male citizens who have served in the army are subject to an obligation to perform reserve duty until they are between 40 and 49 years old, depending upon the nature of their military service.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="FONT-STYLE: italic; DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Our cash may be subject to a risk of loss and we may be exposed to fluctuations in the market values of our portfolio investments and in interest rates.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Our assets include a significant component of cash.&#160;&#160;We adhere to an investment policy set by our investment committee which aims to preserve our financial assets, maintain adequate liquidity and maximize returns.&#160;&#160;We believe that our cash is held in institutions whose credit risk is minimal and that the value and liquidity of our deposits are accurately reflected in our consolidated financial statements as of June 30, 2014.&#160;&#160;Currently, we hold part of our current assets in bank deposits and part is invested in bonds, government bonds and a combination of corporate bonds and relatively low risk stocks.&#160;&#160;However, nearly all of our cash and bank deposits are not insured by the Federal Deposit Insurance Corporation, or the FDIC,&#160;or similar governmental deposit insurance outside the United States.&#160;&#160;Therefore, our cash and any bank deposits that we now hold or may acquire in the future may be subject to risks, including the risk of loss or of reduced value or liquidity, particularly in light of the increased volatility and worldwide pressures in the financial and banking sectors. In the future, should we determine that there is a decline in value of any of our portfolio securities which is not temporary in nature, this would result in a loss being recognized in our consolidated statements of operations.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="FONT-STYLE: italic; DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Our marketable securities include our investment in CHA shares as part of the license agreement signed with CHA in June 2013.&#160;&#160;We agreed to hold such&#160;&#160;shares until no earlier than December 31, 2014 and may be exposed to fluctuations in the market values thereof.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">As part of the CHA Agreement, in June 2013 the parties invested in each other&#8217;s equity. We received 1,011,504 of CHA shares valued at $10.4 million and we agreed to hold the shares until December 31, 2014 before selling any such shares in the open market. As of June 30, 2014, the CHA shares&#8217; value was $13 million, but we have no assurance as to market value until we sell the shares and therefore we are exposed to fluctuations in the shares&#8217; price.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="FONT-STYLE: italic; DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Although our internal control over financial reporting was considered effective as of June 30, 2014, there is no assurance that our internal control over financial reporting will continue to be effective in the future, which could result in our financial statements being unreliable, government investigations or loss of investor confidence in our financial reports.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Pursuant to Section 404 of the Sarbanes-Oxley Act of 2002, we are required to furnish an annual report by our management assessing the effectiveness of our internal control over financial reporting. This assessment must include disclosure of any material weaknesses in our internal control over financial reporting identified by management. In addition, our independent registered public accounting firm must annually provide an opinion on the effectiveness of our internal control over financial reporting.&#160;&#160;Management's report as of the end of fiscal year 2014 concluded that our internal control over financial reporting was effective.&#160;&#160;In addition, our registered independent public accounting firm provided an opinion that our internal control over financial reporting was effective as of the end of fiscal year 2014.&#160;&#160;There is, however, no assurance that we will be able to maintain such effective internal control over financial reporting in the future. Ineffective internal control over financial reporting can result in errors or other problems in our financial statements. In the future, if we or our registered independent public accounting firm are unable to assert that our internal controls are effective, our investors could lose confidence in the accuracy and completeness of our financial reports, which in turn could cause our stock price to decline. Failure to maintain effective internal control over financial reporting could also result in investigation or sanctions by regulatory authorities.</font></div>

<div id="PGBRK" style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div id="FTR">
<div id="GLFTR" style="WIDTH: 100%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>

<div id="PN" style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
<div style="TEXT-ALIGN: center; WIDTH: 100%"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">22</font></div>

<div style="TEXT-ALIGN: center; WIDTH: 100%">
<hr style="COLOR: black" noshade size="2">
</div>
</div>

<div id="HDR">
<div id="GLHDR" style="WIDTH: 100%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="FONT-STYLE: italic; DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Because substantially all of our officers and directors are located in non-U.S. jurisdictions, you may have no effective recourse against the management for misconduct and may not be able to enforce judgment and civil liabilities against our officers, directors, experts and agents.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Substantially all of our directors and officers are nationals and/or residents of countries other than the United States, and all or a substantial portion of their assets are located outside the United States.&#160;&#160;As a result, it may be difficult for you to enforce within the United States any judgments obtained against our officers or directors, including judgments predicated upon the civil liability provisions of the securities laws of the United States or any U.S. state.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="FONT-STYLE: italic; DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Because we do not intend to pay any dividends on our common stock, investors seeking dividend income should not purchase shares of our common stock.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">We have not declared or paid any dividends on our common stock since our inception, and we do not anticipate paying any such dividends for the foreseeable future.&#160;&#160;Investors seeking dividend income should not invest in our common stock.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"><a name="1b">Item 1B.&#160;&#160;Unresolved Staff Comments.</a></font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Not Applicable.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"><a name="2">Item&#160;2.&#160;&#160;&#160;&#160;Properties.</a></font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 36pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Our principal executive, new manufacturing and research and development offices are located at MATAM Advanced Technology Park, Building No. 5, Haifa, Israel 31905, where we occupy approximately 2,990 square meters. Our monthly rent payment for these leased facilities as of July 2014 was 182,000 NIS (approximately $52,000). For the fiscal year ended June 30, 2014, we paid $550,318 for rent for such facilities. In addition, we rent a facility that is located at MATAM Advanced Technology Park, Building No. 20, Haifa, Israel 31905, where we occupy approximately 1,280 square meters. Our monthly rent payment for the leased facilities in Building No. 20 as of July 2014 was 77,000 NIS (approximately $22,000). For the fiscal year ended June 30, 2014, we paid $262,120 for rent for such facilities. We believe that the current space we have, including our current improvement plans, is adequate to meet our current and near future needs.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"><a name="3">Item 3.&#160;&#160;&#160; Legal Proceedings.</a></font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">None.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"><a name="4">Item 4.&#160;&#160; &#160;Mine Safety Disclosures.</a></font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Not applicable.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"><a name="par2">PART II</a></font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"><a name="5">Item 5.&#160;&#160;&#160; Market for Registrant's Common Equity, Related Stockholder Matters and Issuer Purchases of Equity Securities.</a></font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Our shares trade on the NASDAQ Capital Market under the symbol PSTI and in the Tel Aviv Stock Exchange under the ticker symbol PLTR.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left">&#160;</div>

<div id="PGBRK" style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div id="FTR">
<div id="GLFTR" style="WIDTH: 100%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>

<div id="PN" style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
<div style="TEXT-ALIGN: center; WIDTH: 100%"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">23</font></div>

<div style="TEXT-ALIGN: center; WIDTH: 100%">
<hr style="COLOR: black" noshade size="2">
</div>
</div>

<div id="HDR">
<div id="GLHDR" style="WIDTH: 100%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">The following table sets forth, for the periods indicated, the high and low sales prices of our common stock, as reported on NASDAQ website and may not necessarily represent actual transactions.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-ALIGN: center">
<table cellpadding="0" cellspacing="0" width="60%" style="TEXT-ALIGN: center; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr style="TEXT-ALIGN: center;">
<td align="left" valign="bottom" width="70%" style="BORDER-BOTTOM: black 2px solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Quarter Ended</font></div>
</td>
<td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;</font></td>
<td colspan="2" valign="bottom" width="13%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: center">
<div style="TEXT-ALIGN: center; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">High</font></div>
</td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;</font></td>
<td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;</font></td>
<td colspan="2" valign="bottom" width="13%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: center">
<div style="TEXT-ALIGN: center; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Low</font></div>
</td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;</font></td>
</tr><tr bgcolor="#cceeff">
<td align="left" colspan="8" valign="bottom" width="99%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Fiscal Year Ended June 30, 2013</font></div>
</td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;</font></td>
</tr><tr bgcolor="white">
<td align="left" valign="bottom" width="70%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">September 30, 2012</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></td>
<td valign="bottom" width="12%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">4.75</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></td>
<td valign="bottom" width="12%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">2.38</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
</tr><tr bgcolor="#cceeff">
<td align="left" valign="bottom" width="70%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">December 31, 2012</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></td>
<td valign="bottom" width="12%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">4.07</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></td>
<td valign="bottom" width="12%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">2.85</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
</tr><tr bgcolor="white">
<td align="left" valign="bottom" width="70%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">March 31, 2013</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></td>
<td valign="bottom" width="12%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">3.46</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></td>
<td valign="bottom" width="12%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">3.05</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
</tr><tr bgcolor="#cceeff">
<td align="left" valign="bottom" width="70%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">June 30, 2013</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></td>
<td valign="bottom" width="12%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">3.34</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></td>
<td valign="bottom" width="12%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">2.68</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
</tr><tr bgcolor="white">
<td align="left" colspan="8" valign="bottom" width="99%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Fiscal Year Ended June 30, 2014</font></div>
</td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;</font></td>
</tr><tr bgcolor="#cceeff">
<td align="left" valign="bottom" width="70%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">September 30, 2013</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></td>
<td valign="bottom" width="12%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">3.48</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></td>
<td valign="bottom" width="12%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">2.93</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
</tr><tr bgcolor="white">
<td align="left" valign="bottom" width="70%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">December 31, 2013</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></td>
<td valign="bottom" width="12%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">3.70</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></td>
<td valign="bottom" width="12%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">3.19</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
</tr><tr bgcolor="#cceeff">
<td align="left" valign="bottom" width="70%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">March 31, 2014</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></td>
<td valign="bottom" width="12%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">4.47</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></td>
<td valign="bottom" width="12%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">3.58</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
</tr><tr bgcolor="white">
<td align="left" valign="bottom" width="70%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">June 30, 2014</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></td>
<td valign="bottom" width="12%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">3.90</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></td>
<td valign="bottom" width="12%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">3.11</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
</tr></table>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">On September 2, 2014, the per share closing price of our common stock, as reported on NASDAQ website, was $2.83.&#160;&#160;As of September 2, 2014, there were 100 holders of record, and 69,278,512 of our common shares were issued and outstanding.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">American Stock Transfer and Trust Company, LLC is the registrar and transfer agent for our common shares.&#160;&#160;Their address is 6201 15th Avenue, 2nd Floor, Brooklyn, NY 11219, telephone: (718) 921-8261, (800) 937-5449.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Comparative Stock Performance Graph</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 36pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">The following graph shows how an initial investment of $100 in our common stock would have compared to an equal investment in the Nasdaq Composite Index and to a peer group index (comprised of: Athersys, Inc.; Cytori Therapeutics, Inc.; Capricor Therapeutics, Inc. and Mesoblast, Ltd.) (the Current Peer Group) during the period from July 1, 2009 through June 30, 2014. The performance shown is not necessarily indicative of future price performance.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 36pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">In our previous annual report on Form 10-K we used a different peer group index, comprised of Aastrom Biosciences, Inc.; Athersys, Inc.; Cytori Therapeutics, Inc.; Geron Corporation; Osiris Therapeutics, Inc.; and Neostem, Inc. (the Previous Peer Group).&#160;We changed the composition of the peer group to companies that are actively involved in the allogeneic cell therapy.&#160;&#160;Accordingly, we excluded autologous cell therapy companies or embryonic cell therapy companies as well as companies&#160;that have sold their cell therapy business.&#160;&#160;We believe that the Current Peer Group consists&#160;of public companies whose business is the closest to our business in the stem cell space.</font></div>

<div style="TEXT-INDENT: 36pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left">&#160;</div>

<div id="PGBRK" style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div id="FTR">
<div id="GLFTR" style="WIDTH: 100%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>

<div id="PN" style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
<div style="TEXT-ALIGN: center; WIDTH: 100%"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">24</font></div>

<div style="TEXT-ALIGN: center; WIDTH: 100%">
<hr style="COLOR: black" noshade size="2">
</div>
</div>

<div id="HDR">
<div id="GLHDR" style="WIDTH: 100%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-ALIGN: center; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="FONT-STYLE: italic; DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"><img src="plu.jpg" alt=""></font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="FONT-STYLE: italic; DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Dividend Policy</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 36pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">We have not paid any cash dividends on our common stock and have no present intention of doing so. Our current policy is to retain earnings, if any, for use in our operations and in the development of our business. Our future dividend policy will be determined from time to time by our Board of Directors.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="FONT-STYLE: italic; DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Recent Sales of Unregistered Securities</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 36pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">In May 2014, we granted 13,105 restricted stock units to IR consultants for services rendered.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 36pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">The above issuance was exempt under Section 4(a)(2) of the Securities Act of 1933, as amended.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"><a name="6">Item 6.&#160;&#160; &#160;Selected Financial Data.</a></font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 36pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">The selected data presented below under the captions "Statements of Operations Data," "Statements of Cash Flows Data" and "Balance Sheet Data" for, and as of the end of, each of the fiscal years in the five-year period ended June 30, 2014, are derived from, and should be read in conjunction with, our audited consolidated financial statements.</font></div>

<div style="TEXT-INDENT: 36pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left">&#160;</div>

<div id="PGBRK" style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div id="FTR">
<div id="GLFTR" style="WIDTH: 100%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>

<div id="PN" style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
<div style="TEXT-ALIGN: center; WIDTH: 100%"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">25</font></div>

<div style="TEXT-ALIGN: center; WIDTH: 100%">
<hr style="COLOR: black" noshade size="2">
</div>
</div>

<div id="HDR">
<div id="GLHDR" style="WIDTH: 100%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 36pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">The information contained in this table should also be read in conjunction with "Management's Discussion and Analysis of Financial Condition and Results of Operations" and the financial statements and related notes thereto included elsewhere in this report (in thousands of dollars except share and per share data):</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div>
<div align="left">
<table cellpadding="0" cellspacing="0" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr>
<td valign="bottom" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;</font></td>
<td colspan="2" valign="bottom" style="BORDER-BOTTOM: black 2px solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"><font style="DISPLAY: inline">2014</font></font></div>
</td>
<td nowrap valign="bottom" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;</font></td>
<td valign="bottom" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;</font></td>
<td colspan="2" valign="bottom" style="BORDER-BOTTOM: black 2px solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"><font style="DISPLAY: inline">2013</font></font></div>
</td>
<td nowrap valign="bottom" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;</font></td>
<td valign="bottom" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;</font></td>
<td colspan="2" valign="bottom" style="BORDER-BOTTOM: black 2px solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"><font style="DISPLAY: inline">2012</font></font></div>
</td>
<td nowrap valign="bottom" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;</font></td>
<td valign="bottom" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;</font></td>
<td colspan="2" valign="bottom" style="BORDER-BOTTOM: black 2px solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"><font style="DISPLAY: inline">2011</font></font></div>
</td>
<td nowrap valign="bottom" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;</font></td>
<td valign="bottom" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;</font></td>
<td colspan="2" valign="bottom" style="BORDER-BOTTOM: black 2px solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"><font style="DISPLAY: inline">2010</font></font></div>
</td>
<td nowrap valign="bottom" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;</font></td>
</tr><tr bgcolor="#cceeff">
<td align="left" valign="bottom">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Statements of Operations Data:</font></div>
</td>
<td valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td colspan="2" valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td nowrap valign="bottom" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td colspan="2" valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td nowrap valign="bottom" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td colspan="2" valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td nowrap valign="bottom" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td colspan="2" valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td nowrap valign="bottom" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td colspan="2" valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td nowrap valign="bottom" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
</tr><tr bgcolor="white">
<td align="left" valign="bottom" width="40%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Revenues</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">379</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">679</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">716</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
</tr><tr bgcolor="#cceeff">
<td align="left" valign="bottom" width="40%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Cost of revenues</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">11</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">20</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">21</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
</tr><tr bgcolor="white">
<td align="left" valign="bottom" width="40%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Gross profit</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">368</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">659</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">695</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
</tr><tr bgcolor="#cceeff">
<td align="left" valign="bottom" width="40%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Research and development expenses</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">24,938</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">19,906</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">12,685</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">8,311</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">6,123</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
</tr><tr bgcolor="white">
<td align="left" valign="bottom" width="40%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Participation by the OCS and other parties</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">5,396</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">2,673</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">3,527</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">1,682</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">1,822</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
</tr><tr bgcolor="#cceeff">
<td align="left" valign="bottom" width="40%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Research and development expenses, net</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">19,542</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">17,233</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">9,158</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">6,629</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">4,301</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
</tr><tr bgcolor="white">
<td align="left" valign="bottom" width="40%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">General and administrative expenses</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">8,676</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">5,649</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">6,568</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">4,485</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">3,138</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
</tr><tr bgcolor="#cceeff">
<td align="left" valign="bottom" width="40%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Operating loss</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">27,850</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">22,223</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">15,031</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">11,114</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">7,439</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
</tr><tr bgcolor="white">
<td align="left" valign="bottom" width="40%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Financial income (expenses), net</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">918</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">1,068</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">237</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">266</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(14</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font></td>
</tr><tr bgcolor="#cceeff">
<td align="left" valign="bottom" width="40%" style="PADDING-BOTTOM: 4px">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Net loss for the period</font></div>
</td>
<td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">26,932</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">21,155</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">14,794</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">10,848</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">7,453</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
</tr><tr bgcolor="white">
<td align="left" valign="bottom" width="40%" style="PADDING-BOTTOM: 4px">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Basic and diluted net loss per share</font></div>
</td>
<td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">0.42</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">0.38</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">0.34</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">0.35</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">0.44</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
</tr><tr bgcolor="#cceeff">
<td valign="bottom" width="40%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
</tr><tr bgcolor="white">
<td align="left" valign="bottom" width="40%" style="PADDING-BOTTOM: 4px">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Weighted average number of shares used in </font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">computing basic and diluted net loss&#160;per share</font></div>
</td>
<td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">63,514,405</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">55,481,357</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">44,031,866</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">31,198,825</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">17,004,998</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
</tr><tr bgcolor="#cceeff">
<td valign="bottom" width="40%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
</tr><tr bgcolor="white">
<td align="left" valign="bottom" width="40%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Statements of Cash Flows Data:</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
</tr><tr bgcolor="#cceeff">
<td align="left" valign="bottom" width="40%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Net cash used in operating activities</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">19,121</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">16,887</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">3,275</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">5,755</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">5,408</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
</tr><tr bgcolor="white">
<td align="left" valign="bottom" width="40%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Net cash provided by (used in) investing activities</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">1,983</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(19,799</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(30,797</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(36</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(1,296</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font></td>
</tr><tr bgcolor="#cceeff">
<td align="left" valign="bottom" width="40%" style="PADDING-BOTTOM: 2px">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Net cash provided by financing activities</font></div>
</td>
<td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">12,624</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">36,304</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">632</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">47,037</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">5,948</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
</tr><tr bgcolor="white">
<td align="left" valign="bottom" width="40%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Net increase (decrease) in cash</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(4,514</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(382</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(33,440</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">41,246</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(756</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font></td>
</tr><tr bgcolor="#cceeff">
<td align="left" valign="bottom" width="40%" style="PADDING-BOTTOM: 2px">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Cash and cash equivalents at beginning of year</font></div>
</td>
<td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">9,007</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">9,389</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">42,829</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">1,583</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">2,339</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
</tr><tr bgcolor="white">
<td align="left" valign="bottom" width="40%" style="PADDING-BOTTOM: 4px">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Cash and cash equivalents at end of year</font></div>
</td>
<td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">4,493</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">9,007</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">9,389</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">42,829</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">1,583</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
</tr><tr bgcolor="#cceeff">
<td valign="bottom" width="40%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
</tr><tr bgcolor="white">
<td align="left" valign="bottom" width="40%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Balance Sheet Data:</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
</tr><tr bgcolor="#cceeff">
<td align="left" valign="bottom" width="40%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Cash, cash equivalents, short-term bank deposits, restricted cash and short-term deposits, and marketable securities</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">58,819</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">54,213</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">37,809</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">42,829</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">2,496</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
</tr><tr bgcolor="white">
<td align="left" valign="bottom" width="40%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Current assets</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">61,987</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">55,085</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">38,192</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">43,297</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">3,605</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
</tr><tr bgcolor="#cceeff">
<td align="left" valign="bottom" width="40%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Long-term assets</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">12,036</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">13,231</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">9,228</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">2,719</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">2,017</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
</tr><tr bgcolor="white">
<td align="left" valign="bottom" width="40%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Total assets</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">74,023</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">68,316</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">47,420</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">46,016</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">5,622</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
</tr><tr bgcolor="#cceeff">
<td align="left" valign="bottom" width="40%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Current liabilities</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">7,397</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">5,921</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">5,522</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">2,018</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">1,281</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
</tr><tr bgcolor="white">
<td align="left" valign="bottom" width="40%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Long-term liabilities</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">4,503</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">4,929</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">4,156</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">576</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">360</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
</tr><tr bgcolor="#cceeff">
<td align="left" valign="bottom" width="40%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Stockholders&#8217; equity</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">62,123</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">57,466</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">37,742</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">43,422</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">3,981</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
</tr></table>
</div>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"><a name="7">Item 7.&#160;&#160;&#160;&#160;Management's Discussion and Analysis of Financial Condition and Results of Operations.</a></font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 36pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">We are a bio-therapeutics company developing off-the-shelf allogeneic cell therapy products for the treatment of multiple ischemic and inflammatory conditions, with our lead indications focusing on cardiovascular, orthopedic, pulmonary, hematological, and women&#8217;s health diseases.&#160;&#160;Our patented PLX (PLacental eXpanded) cells function as a platform that releases a number of therapeutic proteins in response to various local and systemic inflammatory and ischemic signals, generated by the patient&#8217;s own body. PLX cells are grown using our proprietary 3D micro-environment technology that produces a product that requires no tissue matching prior to administration.&#160;&#160;</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 36pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">We were incorporated as a Nevada corporation in 2001. We have a wholly owned subsidiary in Israel called Pluristem Ltd. We operate in one segment and our operations are focused on the research, development, clinical trials and manufacturing of cell therapeutics and related technologies.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 36pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Our strategy is to develop and produce cell therapy products for the treatment of multiple disorders using several methods of administration, such as intravenous and intramuscular injections.&#160;&#160;We plan to execute this strategy independently, using our own personnel, and through relationships with research and clinical institutions or in collaboration with other companies, such as United and CHA.&#160;&#160;We have built Good Manufacturing Practices grade facility and we are planning to have in-house production capacity to grow clinical grade PLX cells in commercial quantities.</font></div>

<div style="TEXT-INDENT: 36pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left">&#160;</div>

<div id="PGBRK" style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div id="FTR">
<div id="GLFTR" style="WIDTH: 100%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>

<div id="PN" style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
<div style="TEXT-ALIGN: center; WIDTH: 100%"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">26</font></div>

<div style="TEXT-ALIGN: center; WIDTH: 100%">
<hr style="COLOR: black" noshade size="2">
</div>
</div>

<div id="HDR">
<div id="GLHDR" style="WIDTH: 100%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="FONT-STYLE: italic; DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">RESULTS OF OPERATIONS &#8211; YEAR ENDED JUNE 30, 2014 COMPARED TO YEAR ENDED JUNE 30, 2013 AND YEAR ENDED JUNE 30, 2013 COMPARED TO YEAR ENDED JUNE 30, 2012.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Revenues</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 36pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Revenues decreased by 44% from $679,000 for the year ended June 30, 2013 to $379,000 for the year ended June 30, 2014. All such revenues were derived from the United Agreement.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 36pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Revenues decreased by 5% from $716,000 for the year ended June 30, 2012 to $679,000 for the year ended June 30, 2013. All such revenues were derived from the United Agreement.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 36pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">These reductions in the years ended June 30, 2013 and 2014 are due to a re-evaluation we did for the development period under the United Agreement in light of the Clinical Hold. In June 2013, we received notification from the FDA that our United States Phase II IC study had been placed on Clinical Hold due to a serious allergic reaction in a case which required hospitalization.&#160;&#160;In September 2013, the FDA lifted the Clinical Hold. In June 2013, following the Clinical Hold, we extended the development period for which we received funds from United from 6.5 years to 11.5 years. The license fee will be recognized on a straight line basis as revenue over the estimated development period.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Cost of revenues</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 36pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Cost of revenues decreased by 45% from $20,000 for the year ended June 30, 2013 to $11,000 for the year ended June 30, 2014.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 36pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Cost of revenues decreased by 5% from $21,000 for the year ended June 30, 2012 to $20,000 for the year ended June 30, 2013.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 36pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;All such cost of revenues is derived from the United Agreement and reflects the royalties we are obligated to pay the OCS. The reductions in the years ended June 30, 2013 and 2014 are a result of the re-evaluation we did for the development period under the United Agreement. As described above, following the Clinical Hold we extended the development period for which we received funds from United from 6.5 years to 11.5 years.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Research and Development net</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 36pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Research and development net costs (costs less participation and grants by the OCS and other parties), for the year ended June 30, 2014 increased by 13% to $19,542,000 from $17,233,000 for the year ended June 30, 2013.&#160;&#160;This increase is attributed to the material increase in our in-house research and development activity, increase in our salaries due to, among other things, an increase of 45 employees as compared to the average number of employees in the year ended June 2013, an increase in our depreciation expenses and an increase in our rent and maintenance expenses, offset by an increase in OCS participation. This increase in OCS participation is attributable to the fact that due to a delay in the approval of the OCS grant for 2013, we recognized $5,396,000 in fiscal year 2014 compared to $2,673,000 in fiscal year 2013.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 36pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Research and development net costs (costs less participation and grants by the OCS and other parties), for the year ended June 30, 2013 increased by 88% to $17,233,000 from $9,158,000 for the year ended June 30, 2012.&#160;&#160;This increase is mainly due to the increase in our research and development activities during the fiscal year 2013, and more specifically is attributed to the increase in our clinical trials expenses, salaries, lab materials expenses and consultants and subcontractor expenses, including hiring 46 new employees since June 30, 2012.</font></div>

<div style="TEXT-INDENT: 36pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left">&#160;</div>

<div id="PGBRK" style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div id="FTR">
<div id="GLFTR" style="WIDTH: 100%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>

<div id="PN" style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
<div style="TEXT-ALIGN: center; WIDTH: 100%"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">27</font></div>

<div style="TEXT-ALIGN: center; WIDTH: 100%">
<hr style="COLOR: black" noshade size="2">
</div>
</div>

<div id="HDR">
<div id="GLHDR" style="WIDTH: 100%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">General and Administrative</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 36pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">General and administrative expenses increased by 54% from $5,649,000 for the year ended June 30, 2013 to $8,676,000 for the year ended June 30, 2014.&#160;&#160;This is primarily driven by an increase in stock-based compensation expenses related to our employees and directors, due to timing of grants made to directors, and an increase in our salaries due to, among other things, an increase of 6 employees as compared to the average number of employees in the year ended June 2013.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 36pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">General and administrative expenses decreased by 14% from $6,568,000 for the year ended June 30, 2012 to $5,649,000 for the year ended June 30, 2013.&#160;&#160;This decrease is mainly due to a decrease in stock-based compensation expenses related to our employees and consultants.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Financial Income, net</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 36pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Financial income decreased from $1,068,000 for the year ended June 30, 2013 to $918,000 for the year ended June 30, 2014. The decrease is mainly due to a decrease in gains from hedging instruments and interest income on deposits over the past fiscal year, offset by an increase in our gain from marketable securities.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 36pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Financial income increased from $237,000 for the year ended June 30, 2012 to $1,068,000 for the year ended June 30, 2013. The increase is mainly due to an increase in gains from hedging instruments and changes in exchange rates over the past fiscal year.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Net Loss</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 36pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Net loss for the year ended June 30, 2014 was $26,932,000 as compared to a net loss of $21,155,000 for the year ended June 30, 2013. Net loss per share for the year ended June 30, 2014 was $0.42, as compared to $0.38 for the year ended June 30, 2013.&#160;&#160;The net loss per share increased as a result of the increase in our net loss, offset by the increase in our weighted average number of shares due to the issuance of additional shares, mainly the shares issued to CHA in December 2013 and the shares issued under an At Market Issuance Sales Agreement (ATM Agreement).</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 36pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Net loss for the year ended June 30, 2013 was $21,155,000 as compared to net loss of $14,794,000 for the year ended June 30, 2012. Net loss per share for the year ended June 30, 2013 was $0.38, as compared to $0.34 for the year ended June 30, 2012.&#160;&#160;The net loss per share increased as a result of the increase in our net loss, offset by the increase in our weighted average number of shares due to the issuance of additional shares, mainly as part of a public offering we consummated in September 2012.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Liquidity and Capital Resources</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 36pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">As of June 30, 2014, our total current assets were $61,987,000 and our total current liabilities were $7,397,000. On June 30, 2014, we had a working capital surplus of $54,590,000 and an accumulated deficit of $113,834,000.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 36pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">As of June 30, 2013, our total current assets were $55,085,000 and our total current liabilities were $5,921,000. On June 30, 2013, we had a working capital surplus of $49,164,000 and an accumulated deficit of $86,902,000.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 36pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Our cash and cash equivalents as of June 30, 2014 amounted to $4,493,000.&#160;&#160;This is a decrease of $4,514,000 from the $9,007,000 reported as of June 30, 2013. Cash balances decreased in the year ended June 30, 2014 for the reasons presented below:</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 36pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Operating activities used cash of $19,121,000 in the year ended June 30, 2014. Cash used by operating activities in the year ended June 30, 2014 primarily consisted of payments of salaries to our employees, and payments of fees to our consultants, suppliers, subcontractors, and professional services providers including the costs of clinical studies, offset by an OCS grant.</font></div>

<div id="PGBRK" style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div id="FTR">
<div id="GLFTR" style="WIDTH: 100%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>

<div id="PN" style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
<div style="TEXT-ALIGN: center; WIDTH: 100%"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">28</font></div>

<div style="TEXT-ALIGN: center; WIDTH: 100%">
<hr style="COLOR: black" noshade size="2">
</div>
</div>

<div id="HDR">
<div id="GLHDR" style="WIDTH: 100%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 36pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Investing activities provided cash of $1,983,000 in the year ended June 30, 2014. The investing activities consisted primarily of withdrawal of $7,421,000 of short-term deposits and proceeds of $6,867,000 from the sale and redemption of marketable securities, offset by investing $10,851,000 in marketable securities and the purchase of property and equipment for $1,573,000.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 36pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Financing activities generated cash in the amount of $12,624,000 during the year ended June 30, 2014. The financing activities are primarily attributable to net proceeds of $10,644,000 from issuing shares of our common stock under the ATM Agreement as described below, and from exercises of warrants by shareholders.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 36pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">From July 1, 2013 through June 30, 2014, a total of 2,517,907 warrants were exercised via &#8220;cashless&#8221; exercise, resulting in the issuance of 1,469,584 shares of common stock to investors of the Company.&#160;&#160;In addition, 1,432,584 warrants were exercised for cash and resulted in the issuance of 1,432,584 shares of common stock to investors of the Company. The aggregate cash consideration received was $1,968,000. From July 1, 2013 through June 30, 2014, a total of 65,000 warrants were exercised via a &#8220;cashless&#8221; exercise, resulting in the issuance of 36,970 shares of common stock to our consultants.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"><font id="TAB1" style="MARGIN-LEFT: 36pt"></font>Our cash and cash equivalents as of June 30, 2013 amounted to $9,007,000.&#160;&#160;This is a decrease of $382,000 from the $9,389,000 reported as of June 30, 2012. Cash balances decreased in the year ended June 30, 2013 for the reasons presented below:</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 36pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Operating activities used cash of $16,887,000 in the year ended June 30, 2013. Cash used by operating activities in the year ended June 30, 2013 primarily consisted payments of salaries to our employees, and payments of fees to our consultants, subcontractors and professional services providers including costs of the clinical studies, offset by an OCS grant.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 36pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Investing activities used cash of $19,799,000 in the year ended June 30, 2013. The investing activities consisted primarily of investing $10,202,000 in short term deposits and $8,534,000 in marketable securities and purchasing equipment and paying for the construction of our new facilities in the amount of $4,309,000, offset by proceeds from the sale of available for sale marketable securities of $1,848,000 and redemption of available for sale marketable securities of $529,000.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 36pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Financing activities generated cash in the amount of $36,304,000 during the year ended June 30, 2013. Net proceeds from the public offering we closed in September 2012 were $34,106,000, as described below.&#160;&#160;The remainder of the cash generated in the year ended June 30, 2013 from financing activities, is from exercises of warrants by shareholders and exercises of options by employees and consultants.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 36pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">From July 1, 2012 through June 30, 2013, a total of 682,213 warrants were exercised via &#8220;cashless&#8221; exercise, resulting in the issuance of 420,199 shares of common stock to investors of the Company.&#160;&#160;In addition, 1,201,160 warrants were exercised for cash and resulted in the issuance of 1,201,160 shares of common stock to investors of the Company. The aggregate cash consideration received was $2,009,000. In August 2012, a total of 36,000 warrants were exercised via &#8220;cashless&#8221; exercise, resulting in the issuance of 26,299 shares of common stock to consultants of the Company.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 36pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">On September 19, 2012, we closed a firm commitment underwritten public offering of 8,000,000 units, at a purchase price of $4.00 per unit, with each unit consisting of one share of our common stock and one warrant to purchase 0.35 shares of common stock, at an exercise price of $5.00 per share. The warrants sold in the offering are currently exercisable and will expire on September 19, 2017. We also granted the underwriters a 30-day option to purchase up to 1,200,000 shares of common stock and/or warrants to purchase up to 420,000 shares of common stock, which option was fully exercised. The aggregate net proceeds to us from the offering, including from the exercise in full of the option, were approximately $34 million, before the exercise of any warrants and after deducting underwriting commissions and discounts and our offering expenses.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 36pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">During the years that ended June 30, 2014, 2013 and 2012 we received approximately $3,243,000, $1,452,000 and $3,156,000, respectively, from the OCS towards our research and development expenses.</font></div>

<div id="PGBRK" style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div id="FTR">
<div id="GLFTR" style="WIDTH: 100%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>

<div id="PN" style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
<div style="TEXT-ALIGN: center; WIDTH: 100%"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">29</font></div>

<div style="TEXT-ALIGN: center; WIDTH: 100%">
<hr style="COLOR: black" noshade size="2">
</div>
</div>

<div id="HDR">
<div id="GLHDR" style="WIDTH: 100%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 36pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">According to the OCS grant terms, we are required to pay royalties at a rate of 3% - 4% on sales of products and services derived from technology developed using this and other OCS grants until 100% of the dollar-linked grants amount plus interest are repaid. In the absence of such sales, no payment is required.&#160;&#160;During the year ended June 30, 2014, we paid royalties to the OCS in the aggregate amount of $14,000. The OCS may impose certain conditions on any arrangement under which the OCS permits the Company to transfer technology or development out of Israel or outsource manufacturing out of Israel. While the grant is given to the Company over a certain period of time (usually a year), the requirements and restrictions under the Israeli Law for the Encouragement of Industrial Research and Development, 1984 continue and do not have a set expiration period, except for the royalties, which requirement to pay them expires after payment in full.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 36pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">In addition, the European authorities approved a research grant under the European Commission&#8217;s Seventh Framework Program (FP7) in the amount of approximately &#8364;92,955 for a period of 5 years which began on January 1, 2011.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 36pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">In December 2012, we entered into the ATM Agreement with MLV &amp; Co. LLC (MLV), which provides that, upon the terms and subject to the conditions and limitations set forth in the ATM Agreement, we may elect, from time to time, to issue and sell shares of common stock having an aggregate offering price of up to $95 million through MLV as a sales agent. We are not obligated to make any sales of common stock under the ATM Agreement.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 36pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">During the year ended June 30, 2014, we issued 2,596,032 shares of common stock and raised approximately $10,644,000, net of issuance expenses of $195,000, under the ATM Agreement. On September 11, 2014 we notified MLV of the termination of&#160;&#160;the ATM Agreement.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 36pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">In February 2013, MTM &#8211; Scientific Industries Center Haifa Ltd. (MTM), our landlord, participated by contributing an amount of NIS 2,990,000 (approximately $816,000) toward the cost of constructing our new facility.&#160;&#160;Such participation is being made pursuant to our lease agreement with MTM, and is recognized by ratably deducting from our monthly rent payment over the rent period. We recognized participation of $93,000 in fiscal year 2014.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 36pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">In accordance with the CHA Agreement, in December, 2013, we issued to CHA 2,500,000 shares of our common stock in consideration for the issuance to us of 1,011,504 common shares of CHA, which reflected total consideration of approximately $10,414,000 to each of us and CHA. Each of us and CHA agreed not to sell the other party's shares for at least one year. The parties also agreed to give an irrevocable proxy to the other party&#8217;s management with respect to the shares issued.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 36pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Our investment in CHA shares is presented as &#8220;Marketable securities&#8221; on our balance sheet and classified as available-for-sale. As of June 30, 2014, the fair value of our investment in CHA shares amounted to approximately $13 million, and other comprehensive income includes unrealized gains of $1,562,000 related to the increase in the fair value of CHA shares. If we decide to sell our investment in CHA shares, we will reclassify the unrealized gains or losses in our statement of operations.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 36pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">We adhere to an investment policy set by our investment committee which aims to preserve our financial assets, maintain adequate liquidity and maximize return while minimizing exposure to the NIS.&#160;&#160;Such policy further provides that we should hold most of our current assets in bank deposits and the remainder of our current assets is to be invested in government bonds and a combination of corporate bonds and relatively low risk stocks.&#160;&#160;As of today, the currency of our financial portfolio is mainly in U.S. dollars and we use forward and options contracts in order to hedge our exposures to currencies other than the U.S. dollar.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Outlook</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 36pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">We have accumulated a deficit of $113,834,000 since our inception in May 2001.&#160;&#160;We do not expect to generate any revenues from sales of products in the next twelve months.&#160;&#160;Our products will likely not be ready for sale for at least three years, if at all.&#160;&#160;Our cash needs will increase in the foreseeable future.&#160;&#160;We expect to generate revenues, which in the short and medium terms will unlikely exceed our costs of operations, from the sale of licenses to use our technology or products, as we have in the United Agreement.&#160;&#160;Our management believes that we may need to raise additional funds before we have cash flow from operations that can materially decrease our dependence on our existing cash and other liquidity resources. We are continually looking for sources of funding, including non-diluting sources such as the OCS grants, other sales of our common stock or sales of the marketable securities we hold.</font></div>

<div id="PGBRK" style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div id="FTR">
<div id="GLFTR" style="WIDTH: 100%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>

<div id="PN" style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
<div style="TEXT-ALIGN: center; WIDTH: 100%"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">30</font></div>

<div style="TEXT-ALIGN: center; WIDTH: 100%">
<hr style="COLOR: black" noshade size="2">
</div>
</div>

<div id="HDR">
<div id="GLHDR" style="WIDTH: 100%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-INDENT: 36pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">The OCS has supported our activity in the past eight years. Our last program, for the ninth year, was approved by the OCS in June 2014 and relates to a NIS 14,601,000 (approximately $4,187,000) grant. The grant will be used to cover research and development expenses for the period January 1, 2014 to December 31, 2014.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 36pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">In addition, the European authorities approved a research grant under the FP7 in the amount of approximately &#8364;92,955 for a period of 5 years which began on January 1, 2011.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 36pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">We believe that we have sufficient cash to fund our operations for at least the next 12 months.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Application of Critical Accounting Policies</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 36pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Our significant accounting policies are more fully described in Note 2 to our consolidated financial statements appearing in this Annual Report. We believe that the accounting policies below are critical for one to fully understand and evaluate our financial condition and results of operations.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-INDENT: 36pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">The discussion and analysis of our financial condition and results of operations is based on our financial statements, which we prepared in accordance with U.S. generally accepted accounting principles. The preparation of these financial statements requires us to make estimates and assumptions that affect the reported amounts of assets and liabilities, as well as the reported revenues and expenses during the reporting periods. On an ongoing basis, we evaluate such estimates and judgments, including those described in greater detail below. We base our estimates on historical experience and on various other factors that we believe are reasonable under the circumstances. Actual results may differ from these estimates under different assumptions or conditions.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Revenue Recognition from the United Agreement</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block">&#160;</div>

<div style="TEXT-INDENT: 36pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">We recognize revenue pursuant to the License Agreement with United in accordance with ASC 605-25, "Revenue Recognition, Multiple-Element Arrangements".</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-INDENT: 36pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Pursuant to ASC 605-25, each deliverable is evaluated to determine whether it qualifies as a separate unit of accounting based on whether the deliverable has &#8220;stand-alone value&#8221; to the customer. The arrangement&#8217;s consideration that is fixed or determinable is then allocated to each separate unit of accounting based on the relative selling price of each deliverable. In general, the consideration allocated to each unit of accounting is recognized as the related goods or services are delivered, limited to the consideration that is not contingent upon future deliverables.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-INDENT: 36pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">We received an up-front, non-refundable license payment of $5,000,000. Additional payments totaling $37,500,000 are subject to the achievement of certain regulatory milestones by United.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-INDENT: 36pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Since the deliverables in the United agreement do not have stand-alone value, none of them qualifies as a separate unit of accounting. Accordingly, the non-refundable upfront license fee of $5,000,000 is deferred and recognized on a straight line basis over the related performance period which is the development period in accordance with Staff Accounting Bulletin (&#8220;SAB&#8221;) No. 104, "Revenue Recognition". We assessed the remaining performance period under the United agreement at 8.5 years as of June 30, 2014.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-INDENT: 36pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">The additional regulatory milestones payments will be recognized upon the achievement of futures events by United, in accordance with ASC 450-30-25, &#8220;Gain Contingencies". As of June 30, 2014, no regulatory milestones were achieved.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-INDENT: 36pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">We also received an advance payment for the development of $2,000,000 that will be deductible against development expenses as it accrued. The upfront payment which was received and has not yet fully recognized in the statement of operations, is included in the balance sheet as advance payment. Part of the expenses related to the development, on a cost basis, shall be repaid to the Company by United according to the applicable license agreement. We are deducting the payments from research and development expenses in accordance with ASC 730-20, "Research and Development Agreements". As of June 30, 2014, we deducted an amount of approximately $1,753,000.</font></div>

<div id="PGBRK" style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div id="FTR">
<div id="GLFTR" style="WIDTH: 100%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>

<div id="PN" style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
<div style="TEXT-ALIGN: center; WIDTH: 100%"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">31</font></div>

<div style="TEXT-ALIGN: center; WIDTH: 100%">
<hr style="COLOR: black" noshade size="2">
</div>
</div>

<div id="HDR">
<div id="GLHDR" style="WIDTH: 100%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Stock-based compensation</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-INDENT: 36pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Stock-based compensation is considered critical accounting policy due to the significant expenses of restricted stock units which were granted to our employees, directors and consultants. In fiscal year 2014, we recorded stock-based compensation expenses related to restricted stock units in the amount of $5,840,000.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-INDENT: 36pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">In accordance with ASC 718, "Compensation-Stock Compensation" (ASC 718), restricted shares units to employees and directors are measured at their fair value on the grant date. All restricted shares units granted in 2014 and 2013 were granted for no consideration; therefore their fair value was equal to the share price at the date of grant, based on the close trading price of our shares known at the grant date. The restricted shares units to non-employees consultants are remeasured in any future vesting period for the unvested portion of the grants.</font></div>

<div style="TEXT-INDENT: 36pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left">&#160;</div>

<div style="TEXT-INDENT: 36pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">The value of the portion of the award that is ultimately expected to vest is recognized as an expense over the requisite service periods in our consolidated statements of operations. We have graded vesting based on the accelerated method over the requisite service period of each of the awards. The expected pre-vesting forfeiture rate affects the number of the shares. Based on our historical experience, the pre-vesting forfeiture rate per grant is 7% for the shares granted to employees and 0% for the shares granted to our directors, officers and non-employees consultants.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline; FONT-WEIGHT: bold">Marketable Securities</font></font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-INDENT: 36pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Marketable securities consist of corporate bonds, government bonds and stocks. We determine the appropriate classification of marketable securities at the time of purchase and re-evaluate such designation at each balance sheet date. In accordance with ASC No. 320, "Investment Debt and Equity Securities," we classify marketable securities as available-for-sale. Available-for-sale securities are stated at fair value, with unrealized gains and losses reported in accumulated other comprehensive income (loss), a separate component of stockholders' equity. Realized gains and losses on sales of marketable securities, as determined on a specific identification basis, are included in financial income. The amortized cost of marketable securities is adjusted for amortization of premium and accretion of discount to maturity, both of which, together with interest, are included in financial income.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-INDENT: 36pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Marketable securities are classified within Level 1 or Level 2 because marketable securities are valued using quoted market prices or alternative pricing sources and models utilizing market observable inputs.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-INDENT: 36pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">We recognize an impairment charge when a decline in the fair value of our investments is below the cost basis and is judged to be other-than-temporary. Factors considered in making such a determination include the duration and severity of the impairment, the reason for the decline in value, the potential recovery period and our intent to sell, including whether it is more likely than not that we will be required to sell the investment before recovery of cost basis. As such, we did not recognize any impairment charges on outstanding securities during the year ended June 30, 2014.</font></div>

<div style="TEXT-INDENT: 36pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left">&#160;</div>

<div id="PGBRK" style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div id="FTR">
<div id="GLFTR" style="WIDTH: 100%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>

<div id="PN" style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
<div style="TEXT-ALIGN: center; WIDTH: 100%"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">32</font></div>

<div style="TEXT-ALIGN: center; WIDTH: 100%">
<hr style="COLOR: black" noshade size="2">
</div>
</div>

<div id="HDR">
<div id="GLHDR" style="WIDTH: 100%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Research and Development Expenses, Net <font style="FONT-STYLE: italic; DISPLAY: inline">&#160;</font></font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 36pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">We expect our research and development expenses to remain our primary expense in the near future as we continue to develop our product candidates. Our research and development expenses consist primarily of clinical trials expenses, consultant and subcontractor expenses, payroll and related expenses, lab material expenses, stock based compensation expenses, rent and maintenance expenses and patent expenses. The following table provides a breakdown of the related costs for fiscal years 2012 through 2014 (in thousands of dollars):</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div align="center">
<table cellpadding="0" cellspacing="0" width="60%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr>
<td valign="bottom" width="55%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;</font></td>
<td colspan="10" valign="bottom" width="43%" style="BORDER-BOTTOM: black 2px solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Year ended June 30,</font></div>
</td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;</font></td>
</tr><tr>
<td valign="bottom" width="55%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;</font></td>
<td colspan="2" valign="bottom" width="13%" style="BORDER-BOTTOM: black 2px solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">2012</font></div>
</td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;</font></td>
<td valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;</font></td>
<td colspan="2" valign="bottom" width="13%" style="BORDER-BOTTOM: black 2px solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">2013</font></div>
</td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;</font></td>
<td valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;</font></td>
<td colspan="2" valign="bottom" width="13%" style="BORDER-BOTTOM: black 2px solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">2014</font></div>
</td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;</font></td>
</tr><tr bgcolor="#cceeff">
<td align="left" valign="bottom" width="55%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Clinical trials expenses</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></td>
<td valign="bottom" width="12%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">779</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></td>
<td valign="bottom" width="12%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">1,900</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></td>
<td valign="bottom" width="12%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">2,440</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
</tr><tr bgcolor="white">
<td align="left" valign="bottom" width="55%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Consultants and subcontractor expenses</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="12%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">2,224</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="12%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">3,562</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="12%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">2,108</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
</tr><tr bgcolor="#cceeff">
<td align="left" valign="bottom" width="55%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Payroll and related expenses</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="12%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">3,927</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="12%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">5,672</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="12%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">7,846</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
</tr><tr bgcolor="white">
<td align="left" valign="bottom" width="55%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Materials expenses</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="12%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">2,665</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="12%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">3,824</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="12%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">5,624</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
</tr><tr bgcolor="#cceeff">
<td align="left" valign="bottom" width="55%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Stock based compensation expenses</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="12%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">1,402</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="12%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">993</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="12%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">1,260</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
</tr><tr bgcolor="white">
<td align="left" valign="bottom" width="55%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Depreciation expenses</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="12%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">402</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="12%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">955</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="12%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">1,785</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
</tr><tr bgcolor="#cceeff">
<td align="left" valign="bottom" width="55%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Rent and maintenance expenses</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="12%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">628</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="12%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">1,362</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="12%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">1,808</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
</tr><tr bgcolor="white">
<td align="left" valign="bottom" width="55%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Patent expenses</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="12%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">335</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="12%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">673</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="12%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">572</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
</tr><tr bgcolor="#cceeff">
<td align="left" valign="bottom" width="55%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Other R&amp;D expenses</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="12%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">323</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="12%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">965</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="12%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">1,495</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
</tr><tr bgcolor="white">
<td align="left" valign="bottom" width="55%" style="PADDING-BOTTOM: 2px">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Total expenses</font></div>
</td>
<td valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="12%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">12,685</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="12%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">19,906</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="12%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">24,938</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
</tr><tr bgcolor="#cceeff">
<td align="left" valign="bottom" width="55%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Less: OCS and others participation</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="12%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(3,527</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="12%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(2,673</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="12%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(5,396</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font></td>
</tr><tr bgcolor="white">
<td align="left" valign="bottom" width="55%" style="PADDING-BOTTOM: 2px">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Research and Development Expenses, Net</font></div>
</td>
<td valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></td>
<td valign="bottom" width="12%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">9,158</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></td>
<td valign="bottom" width="12%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">17,233</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></td>
<td valign="bottom" width="12%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">19,542</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
</tr></table>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block">&#160;</div>

<div style="TEXT-INDENT: 36pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">We invest heavily in research and development. Research and development expenses, net, were our major operating expenses, representing between 58% - 75% of the total operating expenses for each of our fiscal years 2012, 2013 and 2014. We expect that in the upcoming years our research and development expenses, net, will continue to be our major operating expense.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Contractual Obligations</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">The following summarizes our contractual obligations and other commitments on June 30, 2014, and the effect such obligations could have on our liquidity and cash flow in future periods:</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div align="left">
<table cellpadding="0" cellspacing="0" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr>
<td valign="bottom" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td colspan="2" valign="bottom" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td nowrap valign="bottom" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="left" valign="bottom" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;</font></td>
<td align="left" colspan="14" valign="bottom" style="BORDER-BOTTOM: black 2px solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Payments due by period</font></div>
</td>
<td nowrap valign="bottom" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;</font></td>
</tr><tr>
<td valign="bottom" style="BORDER-BOTTOM: black 2px solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Contractual Obligations</font></div>
</div>
</td>
<td valign="bottom" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;</font></td>
<td colspan="2" valign="bottom" style="BORDER-BOTTOM: black 2px solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Total</font></div>
</div>
</td>
<td nowrap valign="bottom" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;</font></td>
<td valign="bottom" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;</font></td>
<td colspan="2" valign="bottom" style="BORDER-BOTTOM: black 2px solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Less than 1 year</font></div>
</div>
</td>
<td nowrap valign="bottom" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;</font></td>
<td valign="bottom" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;</font></td>
<td colspan="2" valign="bottom" style="BORDER-BOTTOM: black 2px solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">1-3 years</font></div>
</div>
</td>
<td nowrap valign="bottom" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;</font></td>
<td valign="bottom" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;</font></td>
<td colspan="2" valign="bottom" style="BORDER-BOTTOM: black 2px solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">3-5 years</font></div>
</div>
</td>
<td nowrap valign="bottom" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;</font></td>
<td valign="bottom" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;</font></td>
<td colspan="2" valign="bottom" style="BORDER-BOTTOM: black 2px solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">More than 5 years</font></div>
</div>
</td>
<td nowrap valign="bottom" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;</font></td>
</tr><tr bgcolor="#cceeff">
<td align="left" valign="bottom" width="40%">
<div style="TEXT-INDENT: -9pt; DISPLAY: block; MARGIN-LEFT: 9pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Operating lease obligations</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">1,764,000</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">807,000</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">957,000</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
</tr><tr bgcolor="white">
<td align="left" valign="bottom" width="40%">
<div style="TEXT-INDENT: -9pt; DISPLAY: block; MARGIN-LEFT: 9pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Minimum purchase requirements</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">487,000</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">487,000</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font id="TAB1" style="MARGIN-LEFT: 36pt"></font>-</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
</tr><tr bgcolor="#cceeff">
<td align="left" valign="bottom" width="40%" style="PADDING-BOTTOM: 4px">
<div style="TEXT-INDENT: -9pt; DISPLAY: block; MARGIN-LEFT: 9pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Accrued Severance Pay, net</font></div>
</td>
<td valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">167,000</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">167,000</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;</font></td>
</tr><tr bgcolor="white">
<td align="left" valign="bottom" width="40%" style="PADDING-BOTTOM: 4px">
<div style="TEXT-INDENT: -9pt; DISPLAY: block; MARGIN-LEFT: 9pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Total</font></div>
</td>
<td valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">$</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">2,481,000</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;</font></td>
<td valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">$</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">1,294,000</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;</font></td>
<td valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">$</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">957,000</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;</font></td>
<td valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">$</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">-</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;</font></td>
<td valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">$</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">167,000</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;</font></td>
</tr></table>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Off Balance Sheet Arrangements</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Our Company has no off balance sheet arrangements.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"><a name="7a">Item 7A. Quantitative and Qualitative Disclosures About Market Risk.</a></font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 36pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">We are exposed to a variety of risks, including changes in interest rates, foreign currency exchange rates, changes in the value of our marketable securities and inflation.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 36pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">As of June 30, 2014, we had $4.5 million in cash and cash equivalents, $24.3 million in short-term bank deposits and restricted deposits and $30 million in marketable securities.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-ALIGN: justify; TEXT-INDENT: 36pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">We adhere to an investment policy set by our investment committee, which aims to preserve our financial assets, maintain adequate liquidity and maximize return while minimizing exposure to the NIS.&#160;&#160;Such policy further provides that we should hold most of our current assets in bank deposits and the remainder of our current assets should be invested in government bonds and a combination of corporate bonds and relatively low risk stocks.&#160;&#160;As of today, the currency of our financial portfolio is mainly in U.S. dollars and we use forward and options contracts in order to hedge our exposures to currencies other than the U.S. dollar.</font></div>

<div style="TEXT-INDENT: 36pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left">&#160;</div>

<div id="PGBRK" style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div id="FTR">
<div id="GLFTR" style="WIDTH: 100%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>

<div id="PN" style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
<div style="TEXT-ALIGN: center; WIDTH: 100%"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">33</font></div>

<div style="TEXT-ALIGN: center; WIDTH: 100%">
<hr style="COLOR: black" noshade size="2">
</div>
</div>

<div id="HDR">
<div id="GLHDR" style="WIDTH: 100%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Interest Rate Risk</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 36pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">We invest a major portion of our cash surplus in bank deposits in banks in Israel. Since the bank deposits typically carry fixed interest rates, financial income over the holding period is not sensitive to changes in interest rates. However, our interest gains from future deposits may decline in the future as a result of changes in the financial markets. In addition, our income from marketable securities is exposed to market risks resulting from changes in interest rates.&#160;&#160;In any event, given the historic low levels of the interest rate, we estimate that a further decline in the interest rate we are receiving will not result in a material adverse effect to our business.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Foreign Currency Exchange Risk and Inflation</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 36pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">A significant portion of our expenditures, including salaries, lab materials, consultants' fees and office expenses relate to our operations in Israel.&#160;&#160;The cost of those Israeli operations, as expressed in U.S. dollars, is influenced by the extent to which any increase in the rate of inflation in Israel is not offset (or is offset on a lagging basis) by a devaluation of the NIS in relation to the U.S. dollar.&#160;&#160;If the U.S. dollar declines in value in relation to the NIS, it will become more expensive for us to fund our operations in Israel. In addition, as of June 30, 2014, we own net balances in NIS of approximately $7,259,000, Assuming a 10% appreciation of the NIS against the U.S. dollar, we would experience exchange rate gain of approximately $807,000, while assuming a 10% devaluation of the NIS against the U.S. dollars, we would experience an exchange rate loss of approximately $660,000, in both cases excluding the effect of our hedging transactions (as described below).</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 36pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">The exchange rate of the U.S. dollar to the NIS, based on exchange rates published by the Bank of Israel, was as follows:</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div align="center">
<table cellpadding="0" cellspacing="0" width="60%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr>
<td valign="bottom" width="55%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;</font></td>
<td colspan="10" valign="bottom" width="43%" style="BORDER-BOTTOM: black 2px solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Year Ended June 30,</font></div>
</div>
</td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;</font></td>
</tr><tr>
<td valign="bottom" width="55%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;</font></td>
<td colspan="2" valign="bottom" width="13%" style="BORDER-BOTTOM: black 2px solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">2012</font></div>
</div>
</td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;</font></td>
<td valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;</font></td>
<td colspan="2" valign="bottom" width="13%" style="BORDER-BOTTOM: black 2px solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">2013</font></div>
</div>
</td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;</font></td>
<td valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;</font></td>
<td colspan="2" valign="bottom" width="13%" style="BORDER-BOTTOM: black 2px solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">2014</font></div>
</div>
</td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;</font></td>
</tr><tr bgcolor="#cceeff">
<td align="left" valign="bottom" width="55%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Average rate for period</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="12%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">3.716</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="12%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">3.794</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="12%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">3.518</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
</tr><tr bgcolor="white">
<td align="left" valign="bottom" width="55%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Rate at period-end</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="12%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">3.923</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="12%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">3.618</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="12%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">3.438</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
</tr></table>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-INDENT: 36pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">We use currency hedging transactions of options and forwards to decrease the risk of financial exposure from fluctuations in the exchange rate of the U.S. dollar against the NIS.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 36pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Since November 2013, we have entered into forward contracts to hedge against the risk of overall changes in future cash flow from payments of payroll and related expenses denominated in NIS. As of June 30, 2014, we had forward contracts in place to hedge future payroll and related expenses in NIS in the notional principal amount of approximately $2,820,000, and the net unrealized gain on the effective portion of these cash flow hedges was $23,000. The forward contracts on our future NIS payroll and related expenses will settle by December 2014.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 36pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">We own 1,011,504 common shares of CHA, which are presented in our financial statements as marketable securities. The shares are listed on the KOSDAQ and the shares' price is denominated in KRW. We are exposed to changes in the market price of CHA shares, as well as to exchange rates fluctuations in the KRW currency compared to the U.S dollar. In February 2014, we entered into a forward contract with a notional principal of $11 million, to hedge against the foreign currency risk between the KRW and the U.S. dollar.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-INDENT: 36pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">For the year ended June 30, 2014, our net loss from hedging transactions that are non-designated and consist primarily of options strategies to minimize the risk associated with the foreign exchange effects of monetary assets and liabilities denominated in NIS were $70,000.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"><a name="8">Item 8.&#160;&#160;&#160;&#160;Financial Statements and Supplementary Data.</a></font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Our financial statements are stated in thousands United States dollars (US$) and are prepared in accordance with U.S. GAAP.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">The following audited consolidated financial statements are filed as part of this Annual Report:</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Reports of Independent Registered Public Accounting Firm, dated September 11, 2014.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Consolidated Balance Sheets.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Consolidated Statements of Operations.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Consolidated Statements of Comprehensive Loss.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Statements of Changes in Equity.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Consolidated Statements of Cash Flows.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Notes to the Consolidated Financial Statements.</font></div>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left">&#160;</div>

<div id="PGBRK" style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div id="FTR">
<div id="GLFTR" style="WIDTH: 100%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>

<div id="PN" style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
<div style="TEXT-ALIGN: center; WIDTH: 100%"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">34</font></div>

<div style="TEXT-ALIGN: center; WIDTH: 100%">
<hr style="COLOR: black" noshade size="2">
</div>
</div>

<div id="HDR">
<div id="GLHDR" style="WIDTH: 100%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">
<div style="TEXT-ALIGN: center; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">PLURISTEM THERAPEUTICS INC. AND ITS SUBSIDIARY</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block">&#160;</div>

<div style="TEXT-ALIGN: center; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">CONSOLIDATED FINANCIAL STATEMENTS</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-ALIGN: center; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;&#160;As of June 30, 2014</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div id="PGBRK" style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div id="FTR">
<div id="GLFTR" style="WIDTH: 100%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>

<div id="PN" style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
<div style="TEXT-ALIGN: center; WIDTH: 100%"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>

<div style="TEXT-ALIGN: center; WIDTH: 100%">
<hr style="COLOR: black" noshade size="3">
</div>
</div>

<div id="HDR">
<div id="GLHDR" style="WIDTH: 100%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>
</div>

<div style="TEXT-ALIGN: center; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;</font></div>

<div style="TEXT-ALIGN: center; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">PLURISTEM THERAPEUTICS INC. AND ITS SUBSIDIARY</font></div>

<div style="TEXT-ALIGN: center; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">CONSOLIDATED FINANCIAL STATEMENTS</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 11.15pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">As of June 30, 2014</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 11.15pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;U.S. DOLLARS IN THOUSANDS</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 11.15pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"><font style="DISPLAY: inline; TEXT-DECORATION: underline">INDEX</font></font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block">&#160;</div>

<div>
<table cellpadding="0" cellspacing="0" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr>
<td valign="top" width="93%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="top" width="7%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: center; TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div style="TEXT-ALIGN: center; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"><font style="DISPLAY: inline">Page</font></font></div>
</td>
</tr><tr>
<td valign="top" width="93%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="top" width="7%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr>
<td valign="top" width="93%" style="TEXT-ALIGN: left; TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div style="TEXT-ALIGN: left; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><a href="#f1">Reports of Independent Registered Public Accounting Firm</a></font></div>
</td>
<td valign="top" width="7%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 7.6pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">F-2-F-3</font></div>
</td>
</tr><tr>
<td valign="top" width="93%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="top" width="7%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr>
<td valign="top" width="93%" style="TEXT-ALIGN: left; TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div style="TEXT-ALIGN: left; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><a href="#f2">Consolidated Balance Sheets</a></font></div>
</td>
<td valign="top" width="7%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 7.6pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">F-4-F-5</font></div>
</td>
</tr><tr>
<td valign="top" width="93%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="top" width="7%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr>
<td valign="top" width="93%" style="TEXT-ALIGN: left; TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div style="TEXT-ALIGN: left; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><a href="#f3">Consolidated Statements of Operations</a></font></div>
</td>
<td valign="top" width="7%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 7.6pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">F-6</font></div>
</td>
</tr><tr>
<td valign="top" width="93%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="top" width="7%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr>
<td valign="top" width="93%" style="TEXT-ALIGN: left; TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div style="TEXT-ALIGN: left; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><a href="#f4">Consolidated Statements of Comprehensive Loss</a></font></div>
</td>
<td valign="top" width="7%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 7.6pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">F-7</font></div>
</td>
</tr><tr>
<td valign="top" width="93%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="top" width="7%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr>
<td valign="top" width="93%" style="TEXT-ALIGN: left; TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div style="TEXT-ALIGN: left; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><a href="#f5">Statements of Changes in&#160;&#160;Equity</a></font></div>
</td>
<td valign="top" width="7%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 7.6pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">F-8-F-10</font></div>
</td>
</tr><tr>
<td valign="top" width="93%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="top" width="7%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr>
<td valign="top" width="93%" style="TEXT-ALIGN: left; TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div style="TEXT-ALIGN: left; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><a href="#f6">Consolidated Statements of Cash Flows</a></font></div>
</td>
<td valign="top" width="7%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 7.6pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">F-11-F-12</font></div>
</td>
</tr><tr>
<td valign="top" width="93%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="top" width="7%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr>
<td valign="top" width="93%" style="TEXT-ALIGN: left; TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div style="TEXT-ALIGN: left; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><a href="#f7">Notes to Consolidated Financial Statements</a></font></div>
</td>
<td valign="top" width="7%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 7.6pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">F-13-F-36</font></div>
</td>
</tr></table>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div id="PGBRK" style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div id="FTR">
<div id="GLFTR" style="WIDTH: 100%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>

<div id="PN" style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
<div style="TEXT-ALIGN: center; WIDTH: 100%"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>

<div style="TEXT-ALIGN: center; WIDTH: 100%">
<hr style="COLOR: black" noshade size="3">
</div>
</div>

<div id="HDR">
<div id="GLHDR" style="WIDTH: 100%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div align="center">
<table bgcolor="white" cellpadding="0" cellspacing="0" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr>
<td width="79%"><font style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;<img src="ey.jpg" alt=""></font></td>
<td valign="top" width="21%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline; FONT-WEIGHT: bold"><a name="f1">Kost </a>Forer Gabbay &amp; Kasierer</font></font></font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt">2 Pal-Yam Ave.<font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline; FONT-SIZE: 10pt">Haifa 330905, Israel</font></font></font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Tel:&#160;&#160;972 (4)8654021</font></font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Fax: 972(3)<font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;</font>5633439</font></font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">www.ey.com</font></font></div>
</td>
</tr></table>
</div>

<div>&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">REPORT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM</font></div>

<div style="TEXT-ALIGN: center; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">To The Board of Directors and Stockholders Of</font></div>

<div style="TEXT-ALIGN: center; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">&#160;</div>

<div style="TEXT-ALIGN: center; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">PLURISTEM THERAPEUTICS INC.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">We have audited the accompanying consolidated balance sheets of Pluristem Therapeutics Inc. and its subsidiary (the "Company") as of June 30, 2014 and 2013, and the related consolidated statements of operations, comprehensive loss, changes in stockholders' equity and cash flows for each of the three years in the period ended June 30, 2014. These consolidated financial statements are the responsibility of the Company's management. Our responsibility is to express an opinion on these financial statements based on our audits.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">We conducted our audits in accordance with the standards of the Public Company Accounting Oversight Board (United States). Those standards require that we plan and perform the audit to obtain reasonable assurance about whether the financial statements are free of material misstatement. An audit includes examining, on a test basis, evidence supporting the amounts and disclosures in the financial statements.&#160;&#160;An audit also includes assessing the accounting principles used and significant estimates made by management, as well as evaluating the overall financial statement presentation. We believe that our audits provide a reasonable basis for our opinion.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">In our opinion, the consolidated financial statements referred to above present fairly, in all material respects, the consolidated financial position of the Company as of June 30, 2014 and 2013, and the consolidated results of its operations and its cash flows for each of the three years in the period ended June 30, 2014, in conformity with U.S. generally accepted accounting principles.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">We also have audited, in accordance with the standards of the Public Company Accounting Oversight Board (United States), the Company's internal control over financial reporting as of June 30, 2014, based on criteria established in Internal Control-Integrated Framework issued by the Committee of Sponsoring Organizations of the Treadway Commission 1992 framework and our report dated <font style="DISPLAY: inline; FONT-FAMILY: Times New Roman">September 11, </font>2014<font style="DISPLAY: inline; FONT-FAMILY: Times New Roman">, </font>expressed an unqualified opinion thereon.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left">
<div align="center">
<table bgcolor="white" cellpadding="0" cellspacing="0" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr>
<td valign="bottom" width="50%">
<div><font style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Haifa, Israel</font></div>

<div>September 11, 2014</div>
</td>
<td width="50%" style="TEXT-ALIGN: center">
<div style="TEXT-ALIGN: center">
<div style="TEXT-ALIGN: center"><font style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt">/s/ Kost Forer Gabbay &amp; Kasierer</font></font></div>
</div>

<div style="TEXT-ALIGN: center"><font style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Kost Forer Gabbay &amp; Kasierer</font></div>

<div>A Member of Ernst &amp; Young Global</div>
</td>
</tr></table>
</div>

<div>&#160;</div>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left">&#160;</div>

<div id="PGBRK" style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div id="FTR">
<div id="GLFTR" style="WIDTH: 100%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>

<div id="PN" style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
<div style="TEXT-ALIGN: center; WIDTH: 100%"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">F - 2</font></div>

<div style="TEXT-ALIGN: center; WIDTH: 100%">
<hr style="COLOR: black" noshade size="3">
</div>
</div>

<div id="HDR">
<div id="GLHDR" style="WIDTH: 100%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="DISPLAY: inline; FONT-SIZE: 10pt">&#160;&#160;</font></font><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font><br>
<div align="center">
<table bgcolor="white" cellpadding="0" cellspacing="0" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr>
<td width="79%"><font style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;<img src="ey.jpg" alt=""></font></td>
<td valign="top" width="21%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline; FONT-WEIGHT: bold">Kost Forer Gabbay &amp; Kasierer</font></font></font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt">2 Pal-Yam Ave.<font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline; FONT-SIZE: 10pt">Haifa 330905, Israel</font></font></font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Tel:&#160;&#160;972 (4)8654021</font></font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Fax: 972(3)<font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;</font>5633439</font></font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">www.ey.com</font></font></div>
</td>
</tr></table>
</div>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">REPORT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM</font></div>

<div style="TEXT-ALIGN: center; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">To The Board of Directors and Stockholders Of</font></div>

<div style="TEXT-ALIGN: center; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">PLURISTEM THERAPEUTICS INC.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">We have audited Pluristem Therapeutics Inc. internal control over financial reporting as of June 30, 2014, based on criteria established in Internal Control&#8212;Integrated Framework issued by the Committee of Sponsoring Organizations of the Treadway Commission 1992 framework (the COSO criteria). Pluristem Therapeutics Inc. and its subsidiary's management is responsible for maintaining effective internal control over financial reporting, and for its assessment of the effectiveness of&#160;&#160;internal control over financial reporting included in the accompanying Management&#8217;s Report on Internal Control over Financial Reporting. Our responsibility is to express an opinion on the company&#8217;s internal control over financial reporting based on our audit.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">We conducted our audit in accordance with the standards of the Public Company Accounting Oversight Board (United States). Those standards require that we plan and perform the audit to obtain reasonable assurance about whether effective internal control over financial reporting was maintained in all material respects. Our audit included obtaining an understanding of internal control over financial reporting, assessing the risk that a material weakness exists, testing and evaluating the design and operating effectiveness of internal control based on the assessed risk, and performing such other procedures as we considered necessary in the circumstances. We believe that our audit provides a reasonable basis for our opinion.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">A company&#8217;s internal control over financial reporting is a process designed to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles. A company&#8217;s internal control over financial reporting includes those policies and procedures that (1) pertain to the maintenance of records that, in reasonable detail, accurately and fairly reflect the transactions and dispositions of the assets of the company; (2) provide reasonable assurance that transactions are recorded as necessary to permit preparation of financial statements in accordance with generally accepted accounting principles, and that receipts and expenditures of the company are being made only in accordance with authorizations of management and directors of the company; and (3) provide reasonable assurance regarding prevention or timely detection of unauthorized acquisition, use, or disposition of the company&#8217;s assets that could have a material effect on the financial statements.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Because of its inherent limitations, internal control over financial reporting may not prevent or detect misstatements. Also, projections of any evaluation of effectiveness to future periods are subject to the risk that controls may become inadequate because of changes in conditions, or that the degree of compliance with the policies or procedures may deteriorate.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">In our opinion, Pluristem Therapeutics Inc. maintained, in all material respects, effective internal control over financial reporting as of June 30, 2014, based on the COSO criteria.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">We also have audited, in accordance with the standards of the Public Company Accounting Oversight Board (United States), the consolidated balance sheets of Pluristem Therapeutics Inc. and its subsidiary as of June 30, 2014 and 2013 and the related consolidated statements of operations, comprehensive loss, stockholders&#8217; equity and cash flows for each of the three years in the period ended June 30, 2014 of Pluristem Therapeutics Inc. and its subsidiary and our report dated September 11, 2014 expressed an unqualified opinion thereon.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block">
<div align="center">
<table bgcolor="white" cellpadding="0" cellspacing="0" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr>
<td valign="bottom" width="50%">
<div><font style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Haifa, Israel</font></div>

<div>September 11, 2014</div>
</td>
<td width="50%" style="TEXT-ALIGN: center">
<div style="TEXT-ALIGN: center"><font style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt">/s/ <font style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Kost Forer Gabbay &amp; Kasierer</font></font></div>

<div style="TEXT-ALIGN: center"><font style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Kost Forer Gabbay &amp; Kasierer</font></div>

<div>A Member of Ernst &amp; Young Global</div>
</td>
</tr></table>
</div>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div id="PGBRK" style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div id="FTR">
<div id="GLFTR" style="WIDTH: 100%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>

<div id="PN" style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
<div style="TEXT-ALIGN: center; WIDTH: 100%"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">F - 3</font></div>

<div style="TEXT-ALIGN: center; WIDTH: 100%">
<hr style="COLOR: black" noshade size="3">
</div>
</div>

<div id="HDR">
<div id="GLHDR" style="WIDTH: 100%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block">
<div style="TEXT-ALIGN: right; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">PLURISTEM THERAPEUTICS INC. AND ITS SUBSIDIARY</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 33.3pt" align="right">&#160;</div>

<div>
<table cellpadding="0" cellspacing="0" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr>
<td valign="top" width="81%" style="BORDER-BOTTOM: black 2px solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">CONSOLIDATED BALANCE <a name="f2">SHEETS</a></font></div>
</div>
</td>
</tr><tr>
<td align="left" valign="top" width="81%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 11.15pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">U.S. Dollars in thousands&#160;&#160;(except share and per share data)</font></div>
</td>
</tr></table>
</div>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block">&#160;</div>

<div align="left">
<table cellpadding="0" cellspacing="0" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr>
<td valign="bottom" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td colspan="2" valign="bottom" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td nowrap valign="bottom" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;</font></td>
<td colspan="6" valign="bottom" style="BORDER-BOTTOM: black 2px solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 2.85pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">June 30,</font></div>
</td>
<td nowrap valign="bottom" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;</font></td>
</tr><tr>
<td valign="bottom" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;</font></td>
<td colspan="2" valign="bottom" style="BORDER-BOTTOM: black 2px solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 2.85pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Note</font></div>
</td>
<td nowrap valign="bottom" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;</font></td>
<td valign="bottom" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;</font></td>
<td colspan="2" valign="bottom" style="BORDER-BOTTOM: black 2px solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 2.85pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">2014</font></div>
</td>
<td nowrap valign="bottom" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;</font></td>
<td valign="bottom" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;</font></td>
<td colspan="2" valign="bottom" style="BORDER-BOTTOM: black 2px solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 2.85pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">2013</font></div>
</td>
<td nowrap valign="bottom" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;</font></td>
</tr><tr bgcolor="#cceeff">
<td align="left" valign="bottom">
<div style="TEXT-INDENT: -18pt; DISPLAY: block; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 14.15pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">ASSETS</font></div>
</td>
<td valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td colspan="2" valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td nowrap valign="bottom" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td colspan="2" valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td nowrap valign="bottom" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td colspan="2" valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td nowrap valign="bottom" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
</tr><tr bgcolor="white">
<td valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td colspan="2" valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td nowrap valign="bottom" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td colspan="2" valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td nowrap valign="bottom" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td colspan="2" valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td nowrap valign="bottom" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
</tr><tr bgcolor="#cceeff">
<td align="left" valign="bottom">
<div style="TEXT-INDENT: -18pt; DISPLAY: block; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 14.15pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">CURRENT ASSETS:</font></div>
</td>
<td valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td colspan="2" valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td nowrap valign="bottom" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td colspan="2" valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td nowrap valign="bottom" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td colspan="2" valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td nowrap valign="bottom" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
</tr><tr bgcolor="white">
<td valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td colspan="2" valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td nowrap valign="bottom" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td colspan="2" valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td nowrap valign="bottom" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td colspan="2" valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td nowrap valign="bottom" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
</tr><tr bgcolor="#cceeff">
<td align="left" valign="bottom">
<div style="TEXT-INDENT: -18pt; DISPLAY: block; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 14.15pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Cash and cash equivalents</font></div>
</td>
<td valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td colspan="2" valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td nowrap valign="bottom" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="left" valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></td>
<td valign="bottom" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">4,493</font></td>
<td nowrap valign="bottom" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="left" valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></td>
<td valign="bottom" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">9,007</font></td>
<td nowrap valign="bottom" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
</tr><tr bgcolor="white">
<td align="left" valign="bottom">
<div style="TEXT-INDENT: -18pt; DISPLAY: block; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 14.15pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Short-term bank deposits</font></div>
</td>
<td valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td colspan="2" valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td nowrap valign="bottom" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="left" valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">19,451</font></td>
<td nowrap valign="bottom" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="left" valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">31,449</font></td>
<td nowrap valign="bottom" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
</tr><tr bgcolor="#cceeff">
<td align="left" valign="bottom" width="64%">
<div style="TEXT-INDENT: -18pt; DISPLAY: block; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 14.15pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Restricted cash and short term bank deposits</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">2f</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">4,914</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">316</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
</tr><tr bgcolor="white">
<td align="left" valign="bottom" width="64%">
<div style="TEXT-INDENT: -18pt; DISPLAY: block; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 14.15pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Marketable securities</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">3</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">29,961</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">13,441</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
</tr><tr bgcolor="#cceeff">
<td align="left" valign="bottom" width="64%">
<div style="TEXT-INDENT: -18pt; DISPLAY: block; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 14.15pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Account receivable from OCS</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">2,263</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">273</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
</tr><tr bgcolor="white">
<td align="left" valign="bottom" width="64%" style="PADDING-BOTTOM: 2px">
<div style="TEXT-INDENT: -18pt; DISPLAY: block; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 14.15pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Other current assets</font></div>
</td>
<td valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right; PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">905</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">599</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
</tr><tr bgcolor="#cceeff">
<td align="left" valign="bottom" width="64%" style="PADDING-BOTTOM: 2px">
<div style="TEXT-INDENT: -18pt; DISPLAY: block; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 14.15pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline; TEXT-DECORATION: underline">Total</font> current assets</font></div>
</td>
<td valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right; PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">61,987</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">55,085</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
</tr><tr bgcolor="white">
<td valign="bottom" width="64%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
</tr><tr bgcolor="#cceeff">
<td align="left" valign="bottom" width="64%">
<div style="TEXT-INDENT: -18pt; DISPLAY: block; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 14.15pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">LONG-TERM ASSETS:</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
</tr><tr bgcolor="white">
<td valign="bottom" width="64%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
</tr><tr bgcolor="#cceeff">
<td align="left" valign="bottom" width="64%">
<div style="TEXT-INDENT: -18pt; DISPLAY: block; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 14.15pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Long-term deposits and restricted bank deposits</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">2g</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left">&#160;</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">304</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">421</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
</tr><tr bgcolor="white">
<td align="left" valign="bottom" width="64%">
<div style="TEXT-INDENT: -18pt; DISPLAY: block; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 14.15pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Severance pay fund</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">901</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">905</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
</tr><tr bgcolor="#cceeff">
<td align="left" valign="bottom" width="64%">
<div style="TEXT-INDENT: -18pt; DISPLAY: block; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 14.15pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Property and equipment, net</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">5</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">10,823</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">11,866</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
</tr><tr bgcolor="white">
<td align="left" valign="bottom" width="64%" style="PADDING-BOTTOM: 2px">
<div style="TEXT-INDENT: -18pt; DISPLAY: block; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 14.15pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Other long term assets</font></div>
</td>
<td valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right; PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">8</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">39</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
</tr><tr bgcolor="#cceeff">
<td align="left" valign="bottom" width="64%" style="PADDING-BOTTOM: 4px">
<div style="TEXT-INDENT: -18pt; DISPLAY: block; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 14.15pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline; TEXT-DECORATION: underline">Total</font> long-term assets</font></div>
</td>
<td valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right; PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">12,<font style="DISPLAY: inline; FONT-SIZE: 10pt">036</font></font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">13,231</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
</tr><tr bgcolor="white">
<td valign="bottom" width="64%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
</tr><tr bgcolor="#cceeff">
<td align="left" valign="bottom" width="64%" style="PADDING-BOTTOM: 4px">
<div style="TEXT-INDENT: -18pt; DISPLAY: block; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 14.15pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline"><font style="TEXT-DECORATION: underline">Total</font> </font>assets</font></div>
</td>
<td valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right; PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">74,023</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">68,316</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
</tr></table>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-ALIGN: center; TEXT-INDENT: 0pt; DISPLAY: block">
<div style="TEXT-ALIGN: center; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">The accompanying notes are an integral part of the consolidated financial statements.</font></div>

<div id="PGBRK" style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div id="FTR">
<div id="GLFTR" style="WIDTH: 100%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>

<div id="PN" style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
<div style="TEXT-ALIGN: center; WIDTH: 100%"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">F - 4</font></div>

<div style="TEXT-ALIGN: center; WIDTH: 100%">
<hr style="COLOR: black" noshade size="3">
</div>
</div>

<div id="HDR">
<div id="GLHDR" style="WIDTH: 100%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>

<div>&#160;</div>
</div>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block">
<div style="TEXT-INDENT: 0pt; DISPLAY: block">
<div style="TEXT-ALIGN: right; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">PLURISTEM THERAPEUTICS INC. AND ITS SUBSIDIARY</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 33.3pt" align="right">&#160;</div>

<div>
<table cellpadding="0" cellspacing="0" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr>
<td valign="top" width="81%" style="BORDER-BOTTOM: black 2px solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">CONSOLIDATED BALANCE SHEETS</font></div>
</div>
</td>
</tr><tr>
<td align="left" valign="top" width="81%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 11.15pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">U.S. Dollars in thousands&#160;&#160;(except share and per share data)</font></div>
</td>
</tr></table>
</div>
</div>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block">&#160;</div>

<div align="left">
<table cellpadding="0" cellspacing="0" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr>
<td valign="bottom" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td colspan="2" valign="bottom" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td nowrap valign="bottom" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;</font></td>
<td colspan="6" valign="bottom" style="BORDER-BOTTOM: black 2px solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 2.85pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">June 30,</font></div>
</td>
<td nowrap valign="bottom" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;</font></td>
</tr><tr>
<td valign="bottom" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;</font></td>
<td colspan="2" valign="bottom" style="BORDER-BOTTOM: black 2px solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 2.85pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Note</font></div>
</td>
<td nowrap valign="bottom" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;</font></td>
<td valign="bottom" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;</font></td>
<td colspan="2" valign="bottom" style="BORDER-BOTTOM: black 2px solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 2.85pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">2014</font></div>
</td>
<td nowrap valign="bottom" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;</font></td>
<td valign="bottom" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;</font></td>
<td colspan="2" valign="bottom" style="BORDER-BOTTOM: black 2px solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 2.85pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">2013</font></div>
</td>
<td nowrap valign="bottom" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;</font></td>
</tr><tr bgcolor="#cceeff">
<td align="left" valign="bottom">
<div style="TEXT-INDENT: -18pt; DISPLAY: block; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 14.15pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">LIABILITIES AND STOCKHOLDERS&#8217; EQUITY</font></div>
</td>
<td valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td colspan="2" valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td nowrap valign="bottom" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td colspan="2" valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td nowrap valign="bottom" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td colspan="2" valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td nowrap valign="bottom" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
</tr><tr bgcolor="white">
<td valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td colspan="2" valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td nowrap valign="bottom" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td colspan="2" valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td nowrap valign="bottom" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td colspan="2" valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td nowrap valign="bottom" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
</tr><tr bgcolor="#cceeff">
<td align="left" valign="bottom">
<div style="TEXT-INDENT: -18pt; DISPLAY: block; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 14.15pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">CURRENT LIABILITIES</font></div>
</td>
<td valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td colspan="2" valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td nowrap valign="bottom" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td colspan="2" valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td nowrap valign="bottom" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td colspan="2" valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td nowrap valign="bottom" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
</tr><tr bgcolor="white">
<td valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td colspan="2" valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td nowrap valign="bottom" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td colspan="2" valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td nowrap valign="bottom" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td colspan="2" valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td nowrap valign="bottom" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
</tr><tr bgcolor="#cceeff">
<td align="left" valign="bottom">
<div style="TEXT-INDENT: -18pt; DISPLAY: block; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 14.15pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Trade payables</font></div>
</td>
<td valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td colspan="2" valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td nowrap valign="bottom" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="right" valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></td>
<td valign="bottom" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">3,465</font></td>
<td nowrap valign="bottom" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="right" valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></td>
<td valign="bottom" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">2,837</font></td>
<td nowrap valign="bottom" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
</tr><tr bgcolor="white">
<td align="left" valign="bottom">
<div style="TEXT-INDENT: -18pt; DISPLAY: block; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 14.15pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Accrued expenses</font></div>
</td>
<td valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td colspan="2" valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td nowrap valign="bottom" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="right" valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">915</font></td>
<td nowrap valign="bottom" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="right" valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">1,040</font></td>
<td nowrap valign="bottom" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
</tr><tr bgcolor="#cceeff">
<td align="left" valign="bottom" width="64%">
<div style="TEXT-INDENT: -18pt; DISPLAY: block; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 14.15pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Deferred revenues</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">1d, 2i</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">379</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">379</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
</tr><tr bgcolor="white">
<td align="left" valign="bottom" width="64%">
<div style="TEXT-INDENT: -18pt; DISPLAY: block; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 14.15pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Advance payment from United Therapeutics</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">1d, 2i</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">247</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">393</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
</tr><tr bgcolor="#cceeff">
<td align="left" valign="bottom" width="64%" style="PADDING-BOTTOM: 2px">
<div style="TEXT-INDENT: -18pt; DISPLAY: block; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 14.15pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Other accounts payable</font></div>
</td>
<td valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: center; PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">6</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">2,391</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">1,272</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
</tr><tr bgcolor="white">
<td align="left" valign="bottom" width="64%" style="PADDING-BOTTOM: 2px">
<div style="TEXT-INDENT: -18pt; DISPLAY: block; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 14.15pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline; TEXT-DECORATION: underline">Total</font> current liabilities</font></div>
</td>
<td valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right; PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">7,397</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">5,921</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
</tr><tr bgcolor="#cceeff">
<td valign="bottom" width="64%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
</tr><tr bgcolor="white">
<td align="left" valign="bottom" width="64%">
<div style="TEXT-INDENT: -18pt; DISPLAY: block; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 14.15pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">LONG-TERM LIABILITIES</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
</tr><tr bgcolor="#cceeff">
<td valign="bottom" width="64%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
</tr><tr bgcolor="white">
<td align="left" valign="bottom" width="64%">
<div style="TEXT-INDENT: -18pt; DISPLAY: block; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 14.15pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Deferred revenues</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">1d, 2i</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">2,847</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">3,226</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
</tr><tr bgcolor="#cceeff">
<td align="left" valign="bottom" width="64%">
<div style="TEXT-INDENT: -18pt; DISPLAY: block; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 14.15pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Accrued severance pay</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">1,068</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">1,023</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
</tr><tr bgcolor="white">
<td align="left" valign="bottom" width="64%" style="PADDING-BOTTOM: 2px">
<div style="TEXT-INDENT: -18pt; DISPLAY: block; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 14.15pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Other long term liabilities</font></div>
</td>
<td valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right; PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">588</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">680</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
</tr><tr bgcolor="#cceeff">
<td align="left" valign="bottom" width="64%" style="PADDING-BOTTOM: 2px">
<div style="TEXT-INDENT: -18pt; DISPLAY: block; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 14.15pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline; TEXT-DECORATION: underline">Total</font> long term liabilities</font></div>
</td>
<td valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right; PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">4,503</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">4,929</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
</tr><tr bgcolor="white">
<td valign="bottom" width="64%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
</tr><tr bgcolor="#cceeff">
<td align="left" valign="bottom" width="64%">
<div style="TEXT-INDENT: -18pt; DISPLAY: block; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 14.15pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">COMMITMENTS AND CONTINGENCIES</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">7</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
</tr><tr bgcolor="white">
<td valign="bottom" width="64%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
</tr><tr bgcolor="#cceeff">
<td align="left" valign="bottom" width="64%">
<div style="TEXT-INDENT: -18pt; DISPLAY: block; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 14.15pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">STOCKHOLDERS&#8217; EQUITY</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
</tr><tr bgcolor="white">
<td valign="bottom" width="64%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
</tr><tr bgcolor="#cceeff">
<td align="left" valign="bottom" width="64%">
<div style="TEXT-INDENT: -18pt; DISPLAY: block; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 14.15pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Share capital:</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">8</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
</tr><tr bgcolor="white">
<td align="left" valign="bottom" width="64%">
<div style="TEXT-INDENT: -18pt; DISPLAY: block; MARGIN-LEFT: 9pt; MARGIN-RIGHT: 14.15pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;&#160;&#160;&#160;&#160;Common stock&#160;&#160;$0.00001 par value:</font></div>

<div style="TEXT-INDENT: -18pt; DISPLAY: block; MARGIN-LEFT: 9pt; MARGIN-RIGHT: 14.15pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;&#160;&#160;&#160;&#160;Authorized: 200,000,000 shares</font></div>

<div style="TEXT-INDENT: -18pt; DISPLAY: block; MARGIN-LEFT: 9pt; MARGIN-RIGHT: 14.15pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;&#160;&#160;&#160;&#160;Issued and outstanding:&#160;&#160;68,601,452<font style="DISPLAY: inline; FONT-SIZE: 10pt">&#160;</font>shares as of <br>
June 30, 2014, 59,196,617 shares as of June 30, 2013;</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-(*</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-(*</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font></td>
</tr><tr bgcolor="#cceeff">
<td align="left" valign="bottom" width="64%">
<div style="TEXT-INDENT: -18pt; DISPLAY: block; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 14.15pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Additional paid-in capital</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">172,998</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">144,109</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
</tr><tr bgcolor="white">
<td align="left" valign="bottom" width="64%">
<div style="TEXT-INDENT: -18pt; DISPLAY: block; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 14.15pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Accumulated deficit</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(113,834</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(86,902</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font></td>
</tr><tr bgcolor="#cceeff">
<td align="left" valign="bottom" width="64%" style="PADDING-BOTTOM: 2px">
<div style="TEXT-INDENT: -18pt; DISPLAY: block; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 14.15pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Other comprehensive income</font></div>
</td>
<td valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right; PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">2,959</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">259</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
</tr><tr bgcolor="white">
<td valign="bottom" width="64%" style="PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right; PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">62,123</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">57,466</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
</tr><tr bgcolor="#cceeff">
<td valign="bottom" width="64%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
</tr><tr bgcolor="white">
<td valign="bottom" width="64%" style="PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right; PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">74,023</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">68,316</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
</tr></table>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div>
<table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td style="WIDTH: 27pt">
<div style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">(*)</font></div>
</td>
<td>
<div align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Less than $1.</font></div>
</td>
</tr></table>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block">&#160;</div>

<div style="TEXT-ALIGN: right; TEXT-INDENT: 0pt; DISPLAY: block">
<div style="TEXT-ALIGN: center; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">The accompanying notes are an integral part of the consolidated financial statements.</font></div>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block">&#160;</div>

<div id="PGBRK" style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div id="FTR">
<div id="GLFTR" style="WIDTH: 100%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>

<div id="PN" style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
<div style="TEXT-ALIGN: center; WIDTH: 100%"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">F - 5</font></div>

<div style="TEXT-ALIGN: center; WIDTH: 100%">
<hr style="COLOR: black" noshade size="3">
</div>
</div>

<div id="HDR">
<div id="GLHDR" style="WIDTH: 100%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
<div style="TEXT-INDENT: 0pt; DISPLAY: block">
<div style="TEXT-INDENT: 0pt; DISPLAY: block">
<div style="TEXT-ALIGN: right; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">PLURISTEM THERAPEUTICS INC. AND ITS SUBSIDIARY</font></div>

<div>
<table cellpadding="0" cellspacing="0" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr>
<td valign="top" width="81%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr>
<td valign="top" width="81%" style="BORDER-BOTTOM: black 2px solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">CONSOLIDATED STATEMENTS <a name="f3">OF&#160;&#160;</a>OPERATIONS</font></div>
</div>
</td>
</tr><tr>
<td align="left" valign="top" width="81%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 11.15pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">U.S. Dollars in thousands (except share and per share data)</font></div>
</td>
</tr></table>
</div>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block">&#160;</div>
</div>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block">
<div align="left">
<table cellpadding="0" cellspacing="0" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr>
<td valign="bottom" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td colspan="2" valign="bottom" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td nowrap valign="bottom" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;</font></td>
<td colspan="10" valign="bottom" style="BORDER-BOTTOM: black 2px solid">
<div style="TEXT-INDENT: -9pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: -8.2pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Year ended June 30,</font></div>
</td>
<td nowrap valign="bottom" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;</font></td>
</tr><tr>
<td valign="bottom" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;</font></td>
<td colspan="2" valign="bottom" style="BORDER-BOTTOM: black 2px solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Note</font></div>
</td>
<td nowrap valign="bottom" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;</font></td>
<td valign="bottom" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;</font></td>
<td colspan="2" valign="bottom" style="BORDER-BOTTOM: black 2px solid">
<div style="TEXT-INDENT: -9pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: -8.2pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">2014</font></div>
</td>
<td nowrap valign="bottom" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;</font></td>
<td valign="bottom" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;</font></td>
<td colspan="2" valign="bottom" style="BORDER-BOTTOM: black 2px solid">
<div align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">2013</font></div>
</td>
<td nowrap valign="bottom" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;</font></td>
<td valign="bottom" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;</font></td>
<td colspan="2" valign="bottom" style="BORDER-BOTTOM: black 2px solid">
<div style="TEXT-INDENT: -9pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: -8.2pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">2012</font></div>
</td>
<td nowrap valign="bottom" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;</font></td>
</tr><tr>
<td valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td colspan="2" valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td nowrap valign="bottom" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td colspan="2" valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td nowrap valign="bottom" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td colspan="2" valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td nowrap valign="bottom" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td colspan="2" valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td nowrap valign="bottom" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
</tr><tr bgcolor="#cceeff">
<td align="left" valign="bottom" width="52%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Revenues</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">1d, 2i</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">379</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">679</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">716</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
</tr><tr bgcolor="white">
<td align="left" valign="bottom" width="52%" style="PADDING-BOTTOM: 2px">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Cost of revenues</font></div>
</td>
<td valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right; PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(11</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font></td>
<td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(20</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font></td>
<td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(21</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font></td>
</tr><tr bgcolor="#cceeff">
<td align="left" valign="bottom" width="52%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Gross profit</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">368</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">659</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">695</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
</tr><tr bgcolor="white">
<td valign="bottom" width="52%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
</tr><tr bgcolor="#cceeff">
<td align="left" valign="bottom" width="52%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Research and development expenses</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(24,938</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)&#160;</font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(19,906</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)&#160;</font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(12,685</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font></td>
</tr><tr bgcolor="white">
<td align="left" valign="bottom" width="52%" style="PADDING-BOTTOM: 2px">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Less participation by the Office of the Chief Scientist and other parties</font></div>
</td>
<td valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right; PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">5,396</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">2,673</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">3,527</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
</tr><tr bgcolor="#cceeff">
<td align="left" valign="bottom" width="52%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Research and development expenses, net</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(19,542</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(17,233</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(9,158</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font></td>
</tr><tr bgcolor="white">
<td align="left" valign="bottom" width="52%" style="PADDING-BOTTOM: 2px">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">General and administrative expenses</font></div>
</td>
<td valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right; PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(8,676</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font></td>
<td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(5,649</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font></td>
<td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(6,568</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font></td>
</tr><tr bgcolor="#cceeff">
<td valign="bottom" width="52%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
</tr><tr bgcolor="white">
<td align="left" valign="bottom" width="52%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline; FONT-SIZE: 10pt">Operating </font>loss</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(27,850</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(22,223</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(15,031</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font></td>
</tr><tr bgcolor="#cceeff">
<td valign="bottom" width="52%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
</tr><tr bgcolor="white">
<td align="left" valign="bottom" width="52%" style="PADDING-BOTTOM: 2px">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Financial income, net</font></div>
</td>
<td valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: center; PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">9</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">918</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">1,068</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">237</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
</tr><tr bgcolor="#cceeff">
<td valign="bottom" width="52%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
</tr><tr bgcolor="white">
<td align="left" valign="bottom" width="52%" style="PADDING-BOTTOM: 4px">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Net loss</font></div>
</td>
<td valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right; PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(26,932</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font></td>
<td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(21,155</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font></td>
<td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(14,794</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font></td>
</tr><tr bgcolor="#cceeff">
<td valign="bottom" width="52%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
</tr><tr bgcolor="white">
<td align="left" valign="bottom" width="52%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Loss per share:</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
</tr><tr bgcolor="#cceeff">
<td align="left" valign="bottom" width="52%" style="PADDING-BOTTOM: 4px">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Basic and diluted net loss per share</font></div>
</td>
<td valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right; PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(0.42</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font></td>
<td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(0.38</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font></td>
<td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(0.34</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font></td>
</tr><tr bgcolor="white">
<td valign="bottom" width="52%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
</tr><tr bgcolor="#cceeff">
<td align="left" valign="bottom" width="52%" style="PADDING-BOTTOM: 4px">
<div style="TEXT-INDENT: 0pt; DISPLAY: block"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Weighted average number of <br>
shares used&#160;&#160;in computing basic <br>
and diluted net loss per share</font></div>
</td>
<td valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right; PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">63,514,405</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">55,481,357</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">44,031,866</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
</tr></table>
</div>

<div align="left">&#160;</div>
</div>

<div style="TEXT-ALIGN: center; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">The accompanying notes are an integral part of the consolidated financial statements.</font></div>

<div>&#160;</div>

<div id="PGBRK" style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div id="FTR">
<div id="GLFTR" style="WIDTH: 100%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>

<div id="PN" style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
<div style="TEXT-ALIGN: center; WIDTH: 100%"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">F - 6</font></div>

<div style="TEXT-ALIGN: center; WIDTH: 100%">
<hr style="COLOR: black" noshade size="3">
</div>
</div>

<div id="HDR">
<div id="GLHDR" style="WIDTH: 100%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">
<div style="TEXT-ALIGN: right; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">PLURISTEM THERAPEUTICS INC. AND ITS SUBSIDIARY</font></div>

<div>
<table cellpadding="0" cellspacing="0" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr>
<td valign="top" width="81%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr>
<td valign="top" width="81%" style="BORDER-BOTTOM: black 2px solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">CONSOLIDATED STATEMENTS <a name="f4">OF </a>COMPREHENSIVE&#160;&#160;LOSS</font></div>
</div>
</td>
</tr><tr>
<td align="left" valign="top" width="81%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 11.15pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">U.S. Dollars in thousands&#160;&#160;(except share and per share data)</font></div>
</td>
</tr></table>
</div>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block">&#160;</div>

<div>
<div align="left">
<table cellpadding="0" cellspacing="0" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr>
<td valign="bottom" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td colspan="10" valign="bottom" style="BORDER-BOTTOM: black 2px solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Year ended June 30,</font></font></div>
</td>
<td nowrap valign="bottom" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
</tr><tr>
<td valign="bottom" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;</font></td>
<td colspan="2" valign="bottom" style="BORDER-BOTTOM: black 2px solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 3.6pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">2014</font></div>
</td>
<td nowrap valign="bottom" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;</font></td>
<td valign="bottom" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;</font></td>
<td colspan="2" valign="bottom" style="BORDER-BOTTOM: black 2px solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 3.6pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">2013</font></div>
</td>
<td nowrap valign="bottom" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;</font></td>
<td valign="bottom" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;</font></td>
<td colspan="2" valign="bottom" style="BORDER-BOTTOM: black 2px solid">
<div style="TEXT-INDENT: -9pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: -8.2pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">2012</font></div>
</td>
<td nowrap valign="bottom" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;</font></td>
</tr><tr>
<td valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td colspan="2" valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td nowrap valign="bottom" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td colspan="2" valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td nowrap valign="bottom" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td colspan="2" valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td nowrap valign="bottom" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
</tr><tr bgcolor="#cceeff">
<td align="left" valign="bottom" width="64%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Net loss</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(26,932</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(21,155</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(14,794</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font></td>
</tr><tr bgcolor="white">
<td align="left" valign="bottom" width="64%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Other comprehensive income (loss), net:</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
</tr><tr bgcolor="#cceeff">
<td align="left" valign="bottom" width="64%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Unrealized gain on derivative instruments</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">23</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
</tr><tr bgcolor="white">
<td align="left" valign="bottom" width="64%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Unrealized gain (loss) on available-for-sale marketable securities, net</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">3,404</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">415</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(127</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font></td>
</tr><tr bgcolor="#cceeff">
<td align="left" valign="bottom" width="64%" style="PADDING-BOTTOM: 2px">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Reclassification adjustment of available-<br>
for-sale marketable securities losses <br>
realized in net loss, net</font></div>
</td>
<td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(727</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font></td>
<td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(26</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font></td>
<td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(3</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font></td>
</tr><tr bgcolor="white">
<td align="left" valign="bottom" width="64%" style="PADDING-BOTTOM: 4px">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Total comprehensive loss</font></div>
</td>
<td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(24,232</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font></td>
<td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(20,766</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font></td>
<td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(14,924</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font></td>
</tr></table>
</div>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
<div style="TEXT-ALIGN: center; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">The accompanying notes are an integral part of the consolidated financial statements.</font></div>

<div style="TEXT-ALIGN: left; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">&#160;</div>

<div id="PGBRK" style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div id="FTR">
<div id="GLFTR" style="WIDTH: 100%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>

<div id="PN" style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
<div style="TEXT-ALIGN: center; WIDTH: 100%"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">F - 7</font></div>

<div style="TEXT-ALIGN: center; WIDTH: 100%">
<hr style="COLOR: black" noshade size="3">
</div>
</div>

<div id="HDR">
<div id="GLHDR" style="WIDTH: 100%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>
</div>

<div style="TEXT-ALIGN: center; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">&#160;</div>

<div style="TEXT-ALIGN: center; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div style="TEXT-ALIGN: right; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">PLURISTEM THERAPEUTICS INC. AND ITS SUBSIDIARY</font><br>
</div>

<div>
<table cellpadding="0" cellspacing="0" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr>
<td valign="top" width="111%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr>
<td valign="top" width="111%" style="BORDER-BOTTOM: black 2px solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">STATEMENTS OF CHANGES <a name="f5">IN&#160;&#160;</a>EQUITY</font></div>
</div>
</td>
</tr><tr>
<td align="left" valign="top" width="111%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 11.15pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">U.S. Dollars in thousands (except share and per share data)</font></div>
</td>
</tr></table>
</div>
</div>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div align="left">
<table cellpadding="0" cellspacing="0" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr>
<td valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;</font></td>
<td colspan="6" valign="bottom">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 5.75pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Common Stock</font></div>
</td>
<td nowrap valign="bottom" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;</font></td>
<td valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;</font></td>
<td colspan="2" valign="bottom">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 3.5pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Additional Paid-in</font></div>
</td>
<td nowrap valign="bottom" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;</font></td>
<td valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;</font></td>
<td colspan="2" valign="bottom">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 3.5pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Accumulated Other Comprehensive</font></div>
</td>
<td nowrap valign="bottom" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;</font></td>
<td valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;</font></td>
<td colspan="2" valign="bottom">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 5.75pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Accumulated</font></div>
</td>
<td nowrap valign="bottom" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;</font></td>
<td valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;</font></td>
<td colspan="2" valign="bottom">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 3.6pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Total Stockholders&#8217;</font></div>
</td>
<td nowrap valign="bottom" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;</font></td>
</tr><tr>
<td valign="bottom" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;</font></td>
<td colspan="2" valign="bottom" style="BORDER-BOTTOM: black 2px solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Shares</font></div>
</div>
</td>
<td nowrap valign="bottom" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;</font></td>
<td valign="bottom" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;</font></td>
<td colspan="2" valign="bottom" style="BORDER-BOTTOM: black 2px solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Amount</font></div>
</div>
</td>
<td nowrap valign="bottom" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;</font></td>
<td valign="bottom" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;</font></td>
<td colspan="2" valign="bottom" style="BORDER-BOTTOM: black 2px solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Capital</font></div>
</div>
</td>
<td nowrap valign="bottom" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;</font></td>
<td valign="bottom" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;</font></td>
<td colspan="2" valign="bottom" style="BORDER-BOTTOM: black 2px solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Loss</font></div>
</div>
</td>
<td nowrap valign="bottom" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;</font></td>
<td valign="bottom" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;</font></td>
<td colspan="2" valign="bottom" style="BORDER-BOTTOM: black 2px solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Deficit</font></div>
</div>
</td>
<td nowrap valign="bottom" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;</font></td>
<td valign="bottom" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;</font></td>
<td colspan="2" valign="bottom" style="BORDER-BOTTOM: black 2px solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Equity</font></div>
</div>
</td>
<td nowrap valign="bottom" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;</font></td>
</tr><tr bgcolor="white">
<td align="left" valign="bottom" width="28%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;</font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
</tr><tr bgcolor="#cceeff">
<td align="left" valign="bottom" width="28%">
<div style="TEXT-INDENT: -18pt; DISPLAY: block; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Balance as of July 1, 2011</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">42,443,185</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(*</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">94,375</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(50,953</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">43,422</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
</tr><tr bgcolor="white">
<td align="left" valign="bottom" width="28%">
<div style="TEXT-INDENT: -18pt; DISPLAY: block; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Exercise of options by employees and consultants</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">74,800</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(*</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">89</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">89</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
</tr><tr bgcolor="#cceeff">
<td align="left" valign="bottom" width="28%">
<div style="TEXT-INDENT: -18pt; DISPLAY: block; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Exercise of warrants by investors and finders</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">523,835</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(*</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">556</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">556</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
</tr><tr bgcolor="white">
<td align="left" valign="bottom" width="28%">
<div style="TEXT-INDENT: -18pt; DISPLAY: block; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Stock based compensation to employees, directors and non-employees consultants</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">1,906,231</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(*</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">4,927</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">4,927</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
</tr><tr bgcolor="#cceeff">
<td align="left" valign="bottom" width="28%">
<div style="TEXT-INDENT: -18pt; DISPLAY: block; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Stock based compensation to contractor</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">1,500,000</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(*</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">3,672</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">3,672</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
</tr><tr bgcolor="white">
<td align="left" valign="bottom" width="28%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Other comprehensive loss</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(130</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(130</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font></td>
</tr><tr bgcolor="#cceeff">
<td align="left" valign="bottom" width="28%" style="PADDING-BOTTOM: 2px">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Net loss for the period</font></div>
</td>
<td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(14,794</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font></td>
<td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(14,794</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font></td>
</tr><tr bgcolor="white">
<td align="left" valign="bottom" width="28%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
</tr><tr bgcolor="#cceeff">
<td align="left" valign="bottom" width="28%" style="PADDING-BOTTOM: 4px">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Balance as of June 30, 2012</font></div>
</td>
<td valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">46,448,051</font> </td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(*</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font></td>
<td valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">103,619</font> </td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(130</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font></td>
<td valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(65,747</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font></td>
<td valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">37,742</font> </td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
</tr><tr bgcolor="white">
<td align="left" valign="bottom" width="28%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
</tr><tr bgcolor="white">
<td align="left" valign="bottom" width="28%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(*)&#160;&#160;Less than $1</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
</tr></table>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
<div style="TEXT-ALIGN: center; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">The accompanying notes are an integral part of the consolidated financial statements.</font></div>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div id="PGBRK" style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div id="FTR">
<div id="GLFTR" style="WIDTH: 100%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>

<div id="PN" style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
<div style="TEXT-ALIGN: center; WIDTH: 100%"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">F - 8</font></div>

<div style="TEXT-ALIGN: center; WIDTH: 100%">
<hr style="COLOR: black" noshade size="3">
</div>
</div>

<div id="HDR">
<div id="GLHDR" style="WIDTH: 100%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block">
<div style="TEXT-ALIGN: right; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">PLURISTEM THERAPEUTICS INC. AND ITS SUBSIDIARY</font><br>
</div>

<div>
<table cellpadding="0" cellspacing="0" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr>
<td valign="top" width="111%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr>
<td valign="top" width="111%" style="BORDER-BOTTOM: black 2px solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">STATEMENTS OF CHANGES IN&#160;&#160;EQUITY</font></div>
</div>
</td>
</tr><tr>
<td align="left" valign="top" width="111%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 11.15pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">U.S. Dollars in thousands (except share and per share data)</font></div>
</td>
</tr></table>

<br>
</div>
</div>

<div align="left">
<table cellpadding="0" cellspacing="0" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr>
<td valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;</font></td>
<td colspan="6" valign="bottom">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 5.75pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Common Stock</font></div>
</td>
<td nowrap valign="bottom" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;</font></td>
<td valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;</font></td>
<td colspan="2" valign="bottom">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 3.5pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Additional Paid-in</font></div>
</td>
<td nowrap valign="bottom" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;</font></td>
<td valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;</font></td>
<td colspan="2" valign="bottom">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 3.5pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Accumulated Other Comprehensive</font></div>
</td>
<td nowrap valign="bottom" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;</font></td>
<td valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;</font></td>
<td colspan="2" valign="bottom">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 5.75pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Accumulated</font></div>
</td>
<td nowrap valign="bottom" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;</font></td>
<td valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;</font></td>
<td colspan="2" valign="bottom">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 3.6pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Total Stockholders&#8217;</font></div>
</td>
<td nowrap valign="bottom" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;</font></td>
</tr><tr>
<td valign="bottom" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;</font></td>
<td colspan="2" valign="bottom" style="BORDER-BOTTOM: black 2px solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Shares</font></div>
</div>
</td>
<td nowrap valign="bottom" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;</font></td>
<td valign="bottom" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;</font></td>
<td colspan="2" valign="bottom" style="BORDER-BOTTOM: black 2px solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Amount</font></div>
</div>
</td>
<td nowrap valign="bottom" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;</font></td>
<td valign="bottom" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;</font></td>
<td colspan="2" valign="bottom" style="BORDER-BOTTOM: black 2px solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Capital</font></div>
</div>
</td>
<td nowrap valign="bottom" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;</font></td>
<td valign="bottom" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;</font></td>
<td colspan="2" valign="bottom" style="BORDER-BOTTOM: black 2px solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Income (Loss)</font></div>
</div>
</td>
<td nowrap valign="bottom" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;</font></td>
<td valign="bottom" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;</font></td>
<td colspan="2" valign="bottom" style="BORDER-BOTTOM: black 2px solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Deficit</font></div>
</div>
</td>
<td nowrap valign="bottom" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;</font></td>
<td valign="bottom" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;</font></td>
<td colspan="2" valign="bottom" style="BORDER-BOTTOM: black 2px solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Equity</font></div>
</div>
</td>
<td nowrap valign="bottom" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;</font></td>
</tr><tr bgcolor="white">
<td align="left" valign="bottom" width="28%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;</font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
</tr><tr bgcolor="#cceeff">
<td align="left" valign="bottom" width="28%">
<div style="TEXT-INDENT: -18pt; DISPLAY: block; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Balance as of July 1, 2012</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">46,448,051</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(*</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">103,619</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(130</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(65,747</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">37,742</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
</tr><tr bgcolor="white">
<td align="left" valign="bottom" width="28%">
<div style="TEXT-INDENT: -18pt; DISPLAY: block; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Issuance of common stock and warrants related to </font></div>

<div style="TEXT-INDENT: -18pt; DISPLAY: block; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;September 2012 public </font></div>

<div style="TEXT-INDENT: -18pt; DISPLAY: block; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;offering,&#160;&#160;net of issuance costs of $2,694</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">9,200,000</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(*</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">34,106</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">34,106</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
</tr><tr bgcolor="#cceeff">
<td align="left" valign="bottom" width="28%">
<div style="TEXT-INDENT: -18pt; DISPLAY: block; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Exercise of options&#160;&#160;and warrants by employees and consultants</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">176,867</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(*</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">176</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">176</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
</tr><tr bgcolor="white">
<td align="left" valign="bottom" width="28%">
<div style="TEXT-INDENT: -18pt; DISPLAY: block; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Exercise of warrants by investors and finders</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">1,621,359</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(*</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">2,009</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">2,009</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
</tr><tr bgcolor="#cceeff">
<td align="left" valign="bottom" width="28%">
<div style="TEXT-INDENT: -18pt; DISPLAY: block; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Stock based compensation to employees, directors and non-employee consultants</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">1,750,340</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(*</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">2,799</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">2,799</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
</tr><tr bgcolor="white">
<td align="left" valign="bottom" width="28%">
<div style="TEXT-INDENT: -18pt; DISPLAY: block; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Stock based compensation to contractor</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">1,400</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">1,400</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
</tr><tr bgcolor="#cceeff">
<td align="left" valign="bottom" width="28%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Other comprehensive income</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">389</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">389</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
</tr><tr bgcolor="white">
<td align="left" valign="bottom" width="28%" style="PADDING-BOTTOM: 2px">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Net loss for the period</font></div>
</td>
<td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(21,155</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font></td>
<td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(21,155</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font></td>
</tr><tr bgcolor="#cceeff">
<td align="left" valign="bottom" width="28%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
</tr><tr bgcolor="white">
<td align="left" valign="bottom" width="28%" style="PADDING-BOTTOM: 4px">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Balance as of June 30, 2013</font></div>
</td>
<td valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">59,196,617</font> </td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(*</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font></td>
<td valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">144,109</font> </td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">259</font> </td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(86,902</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font></td>
<td valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">57,466</font> </td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
</tr><tr bgcolor="white">
<td align="left" valign="bottom" width="28%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
</tr><tr bgcolor="white">
<td align="left" valign="bottom" width="28%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(*)&#160;&#160;Less than $1</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
</tr></table>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
<div style="TEXT-ALIGN: center; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">The accompanying notes are an integral part of the consolidated financial statements.</font></div>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div id="PGBRK" style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div id="FTR">
<div id="GLFTR" style="WIDTH: 100%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>

<div id="PN" style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
<div style="TEXT-ALIGN: center; WIDTH: 100%"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">F - 9</font></div>

<div style="TEXT-ALIGN: center; WIDTH: 100%">
<hr style="COLOR: black" noshade size="3">
</div>
</div>

<div id="HDR">
<div id="GLHDR" style="WIDTH: 100%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block">
<div style="TEXT-ALIGN: right; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;</font></div>

<div style="TEXT-ALIGN: right; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">PLURISTEM THERAPEUTICS INC. AND ITS SUBSIDIARY</font><br>
</div>

<div>
<table cellpadding="0" cellspacing="0" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr>
<td valign="top" width="111%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr>
<td valign="top" width="111%" style="BORDER-BOTTOM: black 2px solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">STATEMENTS OF CHANGES IN&#160;&#160;EQUITY</font></div>
</div>
</td>
</tr><tr>
<td align="left" valign="top" width="111%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 11.15pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">U.S. Dollars in thousands (except share and per share data)</font></div>
</td>
</tr></table>

<br>
</div>
</div>

<div align="left">
<table cellpadding="0" cellspacing="0" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr>
<td valign="bottom" width="28%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;</font></td>
<td colspan="6" valign="bottom" width="22%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 5.75pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Common Stock</font></div>
</td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;</font></td>
<td colspan="2" valign="bottom" width="10%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 3.5pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Additional Paid-in</font></div>
</td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;</font></td>
<td colspan="2" valign="bottom" width="10%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 3.5pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Accumulated Other Comprehensive</font></div>
</td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;</font></td>
<td colspan="2" valign="bottom" width="10%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 5.75pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Accumulated</font></div>
</td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;</font></td>
<td colspan="2" valign="bottom" width="10%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 3.6pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Total Stockholders&#8217;</font></div>
</td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;</font></td>
</tr><tr>
<td valign="bottom" width="28%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;</font></td>
<td colspan="2" valign="bottom" width="10%" style="BORDER-BOTTOM: black 2px solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Shares</font></div>
</div>
</td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;</font></td>
<td valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;</font></td>
<td colspan="2" valign="bottom" width="10%" style="BORDER-BOTTOM: black 2px solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Amount</font></div>
</div>
</td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;</font></td>
<td valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;</font></td>
<td colspan="2" valign="bottom" width="10%" style="BORDER-BOTTOM: black 2px solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Capital</font></div>
</div>
</td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;</font></td>
<td valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;</font></td>
<td colspan="2" valign="bottom" width="10%" style="BORDER-BOTTOM: black 2px solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Income</font></div>
</div>
</td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;</font></td>
<td valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;</font></td>
<td colspan="2" valign="bottom" width="10%" style="BORDER-BOTTOM: black 2px solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Deficit</font></div>
</div>
</td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;</font></td>
<td valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;</font></td>
<td colspan="2" valign="bottom" width="10%" style="BORDER-BOTTOM: black 2px solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Equity</font></div>
</div>
</td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;</font></td>
</tr><tr bgcolor="white">
<td align="left" valign="bottom" width="28%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;</font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
</tr><tr bgcolor="#cceeff">
<td align="left" valign="bottom" width="28%">
<div style="TEXT-INDENT: -18pt; DISPLAY: block; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Balance as of July 1, 2013</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">59,196,617</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(*</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">144,109</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">259</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(86,902</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">57,466</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
</tr><tr bgcolor="white">
<td align="left" valign="bottom" width="28%">
<div style="TEXT-INDENT: -18pt; DISPLAY: block; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Issuance of common stock under ATM Agreement,&#160;&#160;net of issuance costs of $195 (Note 8g)</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">2,596,032</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(*</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">10,644</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">10,644</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
</tr><tr bgcolor="#cceeff">
<td align="left" valign="bottom" width="28%">
<div style="TEXT-INDENT: -18pt; DISPLAY: block; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Exercise of options&#160;&#160;and warrants by employees and&#160;&#160;non-employee consultants</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">53,470</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(*</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">12</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">12</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
</tr><tr bgcolor="white">
<td align="left" valign="bottom" width="28%">
<div style="TEXT-INDENT: -18pt; DISPLAY: block; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Exercise of warrants by investors and finders</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">2,902,168</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(*</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">1,968</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">1,968</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
</tr><tr bgcolor="#cceeff">
<td align="left" valign="bottom" width="28%">
<div style="TEXT-INDENT: -18pt; DISPLAY: block; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Stock based compensation to employees, directors and non-employee consultants</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">1,353,165</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(*</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">5,851</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">5,851</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
</tr><tr bgcolor="white">
<td align="left" valign="bottom" width="28%">
<div style="TEXT-INDENT: -18pt; DISPLAY: block; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Issuance of common stock under CHA Agreement (Note 1d)</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">2,500,000</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(*</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">10,414</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">10,414</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
</tr><tr bgcolor="#cceeff">
<td align="left" valign="bottom" width="28%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Other comprehensive income, net</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">2,700</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">2,700</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
</tr><tr bgcolor="white">
<td align="left" valign="bottom" width="28%" style="PADDING-BOTTOM: 2px">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Net loss</font></div>
</td>
<td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(26,932</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font></td>
<td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(26,932</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font></td>
</tr><tr bgcolor="#cceeff">
<td align="left" valign="bottom" width="28%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
</tr><tr bgcolor="white">
<td align="left" valign="bottom" width="28%" style="PADDING-BOTTOM: 4px">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Balance as of June 30, 2014</font></div>
</td>
<td valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">68,601,452</font> </td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(*</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font></td>
<td valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">172,998</font> </td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">2,959</font> </td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(113,834</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font></td>
<td valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">62,123</font> </td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
</tr><tr bgcolor="white">
<td align="left" valign="bottom" width="28%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
</tr><tr bgcolor="white">
<td align="left" valign="bottom" width="28%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(*)&#160;&#160;Less than $1</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
</tr></table>
</div>

<div>&#160;</div>

<div style="TEXT-ALIGN: center; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">The accompanying notes are an integral part of the consolidated financial statements.</font></div>

<div>&#160;</div>

<div id="PGBRK" style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div id="FTR">
<div id="GLFTR" style="WIDTH: 100%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>

<div id="PN" style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
<div style="TEXT-ALIGN: center; WIDTH: 100%"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">F - 10</font></div>

<div style="TEXT-ALIGN: center; WIDTH: 100%">
<hr style="COLOR: black" noshade size="3">
</div>
</div>

<div id="HDR">
<div id="GLHDR" style="WIDTH: 100%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>
</div>

<div>&#160;</div>

<div>
<div align="right"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">PLURISTEM THERAPEUTICS INC. AND ITS SUBSIDIARY</font><br>
</div>

<div>
<table cellpadding="0" cellspacing="0" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr>
<td valign="top" width="85%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr>
<td valign="top" width="85%" style="BORDER-BOTTOM: black 2px solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">CONSOLIDATED STATEMENTS OF <a name="f6">CASH </a>FLOWS</font></div>
</div>
</td>
</tr><tr>
<td align="left" valign="top" width="85%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 11.15pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">U.S. Dollars in thousands</font></div>
</td>
</tr></table>
</div>
</div>

<div>&#160;</div>

<div>
<div>
<div align="left">
<table cellpadding="0" cellspacing="0" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr>
<td valign="bottom" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;</font></td>
<td colspan="10" valign="bottom" style="BORDER-BOTTOM: black 2px solid">
<div style="TEXT-INDENT: 9pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 3.6pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Year ended June 30,</font></div>
</td>
<td nowrap valign="bottom" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;</font></td>
</tr><tr>
<td valign="bottom" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;</font></td>
<td colspan="2" valign="bottom" style="BORDER-BOTTOM: black 2px solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 11.15pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">2014</font></div>
</td>
<td nowrap valign="bottom" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;</font></td>
<td valign="bottom" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;</font></td>
<td colspan="2" valign="bottom" style="BORDER-BOTTOM: black 2px solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 3.6pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">2013</font></div>
</td>
<td nowrap valign="bottom" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;</font></td>
<td valign="bottom" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;</font></td>
<td colspan="2" valign="bottom" style="BORDER-BOTTOM: black 2px solid">
<div align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">2012</font></div>
</td>
<td nowrap valign="bottom" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;</font></td>
</tr><tr>
<td valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td colspan="2" valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td nowrap valign="bottom" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td colspan="2" valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td nowrap valign="bottom" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td colspan="2" valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td nowrap valign="bottom" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
</tr><tr bgcolor="#cceeff">
<td valign="bottom" style="TEXT-ALIGN: left; TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div style="TEXT-ALIGN: left; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">CASH FLOWS FROM OPERATING ACTIVITIES:</font></div>
</td>
<td valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td colspan="2" valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td nowrap valign="bottom" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td colspan="2" valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td nowrap valign="bottom" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td colspan="2" valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td nowrap valign="bottom" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
</tr><tr bgcolor="white">
<td valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td colspan="2" valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td nowrap valign="bottom" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td colspan="2" valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td nowrap valign="bottom" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td colspan="2" valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td nowrap valign="bottom" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
</tr><tr bgcolor="#cceeff">
<td align="left" valign="bottom" width="64%">
<div style="TEXT-INDENT: -18pt; DISPLAY: block; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 14.15pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Net loss</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(26,932</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(21,155</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(14,794</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font></td>
</tr><tr bgcolor="white">
<td valign="bottom" width="64%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
</tr><tr bgcolor="#cceeff">
<td valign="bottom" width="64%" style="TEXT-ALIGN: left; TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div style="TEXT-ALIGN: left; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Adjustments to reconcile net loss to net cash used in operating activities:</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
</tr><tr bgcolor="white">
<td valign="bottom" width="64%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
</tr><tr bgcolor="#cceeff">
<td valign="bottom" width="64%" style="TEXT-ALIGN: left; TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div style="TEXT-ALIGN: left; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Depreciation</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">1,902</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">1,033</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">435</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
</tr><tr bgcolor="white">
<td align="left" valign="bottom" width="64%">
<div style="TEXT-INDENT: -18pt; DISPLAY: block; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 14.15pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Loss on property and equipment</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">85</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">1</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
</tr><tr bgcolor="#cceeff">
<td valign="bottom" width="64%" style="TEXT-ALIGN: left; TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div style="TEXT-ALIGN: left; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Accretion of discount, amortization of premium and changes in accrued interest of marketable securities</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">1,282</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">154</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">17</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
</tr><tr bgcolor="white">
<td valign="bottom" width="64%" style="TEXT-ALIGN: left; TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div style="TEXT-ALIGN: left; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Gain from sale of investments of available-for-sale marketable securities</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(727</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(26</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(3</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font></td>
</tr><tr bgcolor="#cceeff">
<td valign="bottom" width="64%" style="TEXT-ALIGN: left; TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div style="TEXT-ALIGN: left; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Stock-based compensation to employees, directors and non-employees consultants</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">5,851</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">2,799</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">4,927</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
</tr><tr bgcolor="white">
<td align="left" valign="bottom" width="64%">
<div style="TEXT-INDENT: -18pt; DISPLAY: block; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 14.15pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Increase in OCS receivables</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(1,990</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(70</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(230</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font></td>
</tr><tr bgcolor="#cceeff">
<td align="left" valign="bottom" width="64%">
<div style="TEXT-INDENT: -18pt; DISPLAY: block; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 14.15pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Decrease (increase) in other accounts receivable</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(143</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(233</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">64</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
</tr><tr bgcolor="white">
<td align="left" valign="bottom" width="64%">
<div style="TEXT-INDENT: -18pt; DISPLAY: block; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 14.15pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Decrease (increase) in prepaid expenses</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(108</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(237</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">269</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
</tr><tr bgcolor="#cceeff">
<td align="left" valign="bottom" width="64%">
<div style="TEXT-INDENT: -18pt; DISPLAY: block; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 14.15pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Increase (decrease) in trade payables</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">1,257</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">1,335</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(424</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font></td>
</tr><tr bgcolor="white">
<td align="left" valign="bottom" width="64%">
<div style="TEXT-INDENT: -9pt; DISPLAY: block; MARGIN-LEFT: 9pt; MARGIN-RIGHT: 14.15pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Increase in other accounts payable and&#160;&#160;accrued expenses</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">902</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">1,556</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">958</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
</tr><tr bgcolor="#cceeff">
<td align="left" valign="bottom" width="64%">
<div style="TEXT-INDENT: -9pt; DISPLAY: block; MARGIN-LEFT: 9pt; MARGIN-RIGHT: 14.15pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Increase (decrease) in deferred revenues</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(379</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(679</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">4,284</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
</tr><tr bgcolor="white">
<td align="left" valign="bottom" width="64%">
<div style="TEXT-INDENT: -9pt; DISPLAY: block; MARGIN-LEFT: 9pt; MARGIN-RIGHT: 14.15pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Increase (decrease) in advance payment from United Therapeutics</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(146</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(1,183</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">1,576</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
</tr><tr bgcolor="#cceeff">
<td align="left" valign="bottom" width="64%">
<div style="TEXT-INDENT: -9pt; DISPLAY: block; MARGIN-LEFT: 9pt; MARGIN-RIGHT: 14.15pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Increase in interest receivable on short-term deposits</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(36</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(140</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(395</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font></td>
</tr><tr bgcolor="white">
<td valign="bottom" width="64%" style="TEXT-ALIGN: left; TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div style="TEXT-ALIGN: left; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Linkage differences and interest on short and long-term&#160;&#160;restricted lease deposit</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">12</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(30</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">35</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
</tr><tr bgcolor="#cceeff">
<td valign="bottom" width="64%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px; TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div style="TEXT-ALIGN: left; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Accrued severance pay, net</font></div>
</td>
<td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">49</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(11</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font></td>
<td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">5</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
</tr><tr bgcolor="white">
<td valign="bottom" width="64%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px; TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div style="TEXT-ALIGN: left; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Net cash used in operating activities</font></div>
</td>
<td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(19,121</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font></td>
<td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(16,887</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font></td>
<td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(3,275</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font></td>
</tr><tr bgcolor="#cceeff">
<td valign="bottom" width="64%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
</tr><tr bgcolor="white">
<td align="left" valign="bottom" width="64%">
<div style="TEXT-INDENT: -18pt; DISPLAY: block; MARGIN-LEFT: 18pt; MARGIN-RIGHT: -5.4pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">CASH FLOWS FROM INVESTING ACTIVITIES:</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
</tr><tr bgcolor="#cceeff">
<td valign="bottom" width="64%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
</tr><tr bgcolor="white">
<td align="left" valign="bottom" width="64%">
<div style="TEXT-INDENT: -18pt; DISPLAY: block; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 14.15pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Purchase of property and equipment</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(1,573</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(4,309</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(1,480</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font></td>
</tr><tr bgcolor="#cceeff">
<td align="left" valign="bottom" width="64%">
<div style="TEXT-INDENT: -18pt; DISPLAY: block; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 14.15pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Repayment of (Investment in) short-term deposits</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">7,421</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(10,202</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(21,031</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font></td>
</tr><tr bgcolor="white">
<td align="left" valign="bottom" width="64%">
<div style="TEXT-INDENT: -18pt; DISPLAY: block; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 14.15pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Investment in long-term deposits</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(3</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(1,125</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font></td>
</tr><tr bgcolor="#cceeff">
<td align="left" valign="bottom" width="64%">
<div style="TEXT-INDENT: -18pt; DISPLAY: block; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 14.15pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Repayment of long-term restricted deposit</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">122</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">869</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">6</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
</tr><tr bgcolor="white">
<td align="left" valign="bottom" width="64%">
<div style="TEXT-INDENT: -18pt; DISPLAY: block; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 14.15pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Proceeds from sale of available-for-sale marketable securities</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">6,113</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">1,848</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">884</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
</tr><tr bgcolor="#cceeff">
<td align="left" valign="bottom" width="64%">
<div style="TEXT-INDENT: -18pt; DISPLAY: block; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 14.15pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Proceeds from redemption of available-for-sale marketable securities</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">754</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">529</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">114</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
</tr><tr bgcolor="white">
<td align="left" valign="bottom" width="64%" style="PADDING-BOTTOM: 2px">
<div style="TEXT-INDENT: -18pt; DISPLAY: block; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 14.15pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Investment in available-for-sale marketable securities</font></div>
</td>
<td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(10,851</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font></td>
<td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(8,534</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font></td>
<td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(8,165</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font></td>
</tr><tr bgcolor="#cceeff">
<td align="left" valign="bottom" width="64%" style="PADDING-BOTTOM: 2px">
<div style="TEXT-INDENT: -18pt; DISPLAY: block; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 14.15pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Net cash provided by (used in) investing activities</font></div>
</td>
<td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">1,983</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(19,799</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font></td>
<td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(30,797</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font></td>
</tr></table>
</div>

<div>&#160;</div>

<div>
<div style="TEXT-ALIGN: center; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">The accompanying notes are an integral part of the consolidated financial statements.</font></div>

<div>&#160;</div>

<div id="PGBRK" style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div id="FTR">
<div id="GLFTR" style="WIDTH: 100%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>

<div id="PN" style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
<div style="TEXT-ALIGN: center; WIDTH: 100%"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">F - 11</font></div>

<div style="TEXT-ALIGN: center; WIDTH: 100%">
<hr style="COLOR: black" noshade size="3">
</div>
</div>

<div id="HDR">
<div id="GLHDR" style="WIDTH: 100%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>
</div>

<div>&#160;</div>

<div>
<div align="right"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">PLURISTEM THERAPEUTICS INC. AND ITS SUBSIDIARY</font><br>
</div>

<div>
<table cellpadding="0" cellspacing="0" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr>
<td valign="top" width="85%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr>
<td valign="top" width="85%" style="BORDER-BOTTOM: black 2px solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">CONSOLIDATED STATEMENTS OF CASH FLOWS</font></div>
</div>
</td>
</tr><tr>
<td align="left" valign="top" width="85%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 11.15pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">U.S. Dollars in thousands</font></div>
</td>
</tr></table>
</div>
</div>
</div>

<div>&#160;</div>

<div align="left">
<table cellpadding="0" cellspacing="0" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr>
<td valign="bottom" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td colspan="10" valign="bottom" style="BORDER-BOTTOM: black 2px solid">
<div style="TEXT-INDENT: 9pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 3.6pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Year ended June 30,</font></font></div>
</td>
<td nowrap valign="bottom" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
</tr><tr>
<td valign="bottom" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td colspan="2" valign="bottom" style="BORDER-BOTTOM: black 2px solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 11.15pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">2014</font></font></div>
</td>
<td nowrap valign="bottom" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td colspan="2" valign="bottom" style="BORDER-BOTTOM: black 2px solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 11.15pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">2013</font></font></div>
</td>
<td nowrap valign="bottom" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td colspan="2" valign="bottom" style="BORDER-BOTTOM: black 2px solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 11.15pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">2012</font></font></div>
</td>
<td nowrap valign="bottom" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
</tr><tr>
<td valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td colspan="2" valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td nowrap valign="bottom" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td colspan="2" valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td nowrap valign="bottom" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td colspan="2" valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td nowrap valign="bottom" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
</tr><tr bgcolor="#cceeff">
<td align="left" valign="bottom">
<div style="TEXT-INDENT: -18pt; DISPLAY: block; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 14.15pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">CASH FLOWS FROM FINANCING ACTIVITIES:</font></div>
</td>
<td valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td colspan="2" valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td nowrap valign="bottom" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td colspan="2" valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td nowrap valign="bottom" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td colspan="2" valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td nowrap valign="bottom" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
</tr><tr bgcolor="white">
<td align="left" valign="bottom" width="64%">
<div style="TEXT-INDENT: -18pt; DISPLAY: block; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 14.15pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Issuance of common stock and warrants, net of issuance costs</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">10,644</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">34,106</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
</tr><tr bgcolor="#cceeff">
<td align="left" valign="bottom" width="64%" style="PADDING-BOTTOM: 2px">
<div style="TEXT-INDENT: -18pt; DISPLAY: block; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 14.15pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Exercise of warrants and options</font></div>
</td>
<td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">1,980</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">2,198</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">632</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
</tr><tr bgcolor="white">
<td align="left" valign="bottom" width="64%" style="PADDING-BOTTOM: 2px">
<div style="TEXT-INDENT: -18pt; DISPLAY: block; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 14.15pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Net cash provided by financing activities</font></div>
</td>
<td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">12,624</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">36,304</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">632</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
</tr><tr bgcolor="#cceeff">
<td valign="bottom" width="64%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
</tr><tr bgcolor="white">
<td align="left" valign="bottom" width="64%">
<div style="TEXT-INDENT: -9pt; DISPLAY: block; MARGIN-LEFT: 9pt; MARGIN-RIGHT: 14.15pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Decrease in cash and cash equivalents</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(4,514</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(382</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(33,440</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font></td>
</tr><tr bgcolor="#cceeff">
<td align="left" valign="bottom" width="64%" style="PADDING-BOTTOM: 2px">
<div style="TEXT-INDENT: -9pt; DISPLAY: block; MARGIN-LEFT: 9pt; MARGIN-RIGHT: 14.15pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Cash and cash equivalents at the beginning of the period</font></div>
</td>
<td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">9,007</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">9,389</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">42,829</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
</tr><tr bgcolor="white">
<td align="left" valign="bottom" width="64%" style="PADDING-BOTTOM: 4px">
<div style="TEXT-INDENT: -9pt; DISPLAY: block; MARGIN-LEFT: 9pt; MARGIN-RIGHT: 14.15pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Cash and cash equivalents at the end of the period</font></div>
</td>
<td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">4,493</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">9,007</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">9,389</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
</tr></table>
</div>
</div>
</div>

<div align="left">
<table cellpadding="0" cellspacing="0" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr>
<td valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td colspan="2" valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td nowrap valign="bottom" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td colspan="2" valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td nowrap valign="bottom" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td colspan="2" valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td nowrap valign="bottom" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
</tr><tr bgcolor="#cceeff">
<td align="left" valign="bottom">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 9pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">(a) Supplemental disclosure of cash flow activities:</font></div>
</td>
<td valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td colspan="2" valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td nowrap valign="bottom" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td colspan="2" valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td nowrap valign="bottom" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td colspan="2" valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td nowrap valign="bottom" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
</tr><tr bgcolor="white">
<td valign="bottom" style="TEXT-ALIGN: left; TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div style="TEXT-ALIGN: left; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;&#160;&#160; Cash paid during the period for:</font></div>
</td>
<td valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td colspan="2" valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td nowrap valign="bottom" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td colspan="2" valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td nowrap valign="bottom" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td colspan="2" valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td nowrap valign="bottom" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
</tr><tr bgcolor="#cceeff">
<td valign="bottom" width="64%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 4px; TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div style="TEXT-ALIGN: left; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;&#160;&#160;&#160;Taxes paid due to non-deductible expenses</font></div>
</td>
<td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">48</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">18</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">14</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
</tr></table>
</div>

<div align="left">
<table cellpadding="0" cellspacing="0" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr>
<td valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td colspan="2" valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td nowrap valign="bottom" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td colspan="2" valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td nowrap valign="bottom" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td colspan="2" valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td nowrap valign="bottom" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
</tr><tr bgcolor="#cceeff">
<td align="left" valign="bottom">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 9pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">(b) Supplemental disclosure of non-cash activities:</font></div>
</td>
<td valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td colspan="2" valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td nowrap valign="bottom" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td colspan="2" valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td nowrap valign="bottom" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td colspan="2" valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td nowrap valign="bottom" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
</tr><tr bgcolor="white">
<td align="left" valign="bottom" width="64%" style="PADDING-BOTTOM: 4px">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 9pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Purchase of property and equipment in credit</font></div>
</td>
<td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">243</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">872</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">738</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
</tr><tr bgcolor="#cceeff">
<td align="left" valign="bottom" width="64%" style="PADDING-BOTTOM: 4px">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 9pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Issuance of shares in consideration of new facility construction</font></div>
</td>
<td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">1,400</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">3,672</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
</tr><tr bgcolor="white">
<td align="left" valign="bottom" width="64%" style="PADDING-BOTTOM: 4px">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 9pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Other receivables resulting from issuance of shares</font></div>
</td>
<td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">13</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
</tr><tr bgcolor="#cceeff">
<td align="left" valign="bottom" width="64%" style="PADDING-BOTTOM: 4px">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 9pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Issuance of common stock under CHA Agreement (Note 1d)</font></div>
</td>
<td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">10,414</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
</tr></table>
</div>

<div>&#160;</div>

<div>
<div style="TEXT-ALIGN: center; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">The accompanying notes are an integral part of the consolidated financial statements.</font></div>
</div>

<div>&#160;</div>

<div id="PGBRK" style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div id="FTR">
<div id="GLFTR" style="WIDTH: 100%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>

<div id="PN" style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
<div style="TEXT-ALIGN: center; WIDTH: 100%"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">F - 12</font></div>

<div style="TEXT-ALIGN: center; WIDTH: 100%">
<hr style="COLOR: black" noshade size="3">
</div>
</div>

<div id="HDR">
<div id="GLHDR" style="WIDTH: 100%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>
</div>

<div>&#160;</div>

<div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: -45pt; MARGIN-RIGHT: 0.15pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">PLURISTEM THERAPEUTICS INC. AND ITS SUBSIDIARY</font></div>

<div>
<table cellpadding="0" cellspacing="0" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr>
<td valign="top" width="87%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr>
<td valign="top" width="87%" style="BORDER-BOTTOM: black 2px solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">NOTES TO CONSOLIDATED <a name="f7">FINANCIAL </a>STATEMENTS</font></div>
</div>
</td>
</tr><tr>
<td align="left" valign="top" width="87%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 11.15pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">U.S. Dollars in thousands (except share and per share amounts)</font></div>
</td>
</tr></table>
</div>
</div>

<div>&#160;</div>

<div>
<div style="TEXT-ALIGN: left; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">NOTE 1:-GENERAL</font></div>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div>
<table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td style="WIDTH: 18pt">
<div style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">a.</font></div>
</td>
<td>
<div align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Pluristem Therapeutics Inc., a Nevada corporation, was incorporated on May 11, 2001. Pluristem Therapeutics Inc. has a wholly owned subsidiary, Pluristem Ltd. (the &#8220;Subsidiary&#8221;), which is incorporated under the laws of the State of Israel. Pluristem Therapeutics Inc. and the Subsidiary are referred to as the &#8220;Company&#8221; or &#8220;Pluristem&#8221;.</font></div>
</td>
</tr></table>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div>
<table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td style="WIDTH: 18pt">
<div style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">b.</font></div>
</td>
<td>
<div align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">The Company is a bio-therapeutics company developing off-the-shelf allogeneic cell therapy products for the treatment of multiple ischemic and inflammatory conditions. The Company has sustained operating losses and expects such losses to continue in the foreseeable future. The Company's accumulated losses aggregated to $113,834 through June 30, 2014 and incurred a net loss of $26,932 for the year ended June 30, 2014.</font></div>

<div align="justify">&#160;</div>

<div align="justify">
<div style="TEXT-ALIGN: justify; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">The Company plans to continue to finance its operations with sales of equity securities, entering into licensing technology agreements such as the United Therapeutics Corporation (&#8220;United Therapeutics&#8221; or &#8220;United&#8221;) and CHA&#160;Bio&amp;Diostech (&#8220;CHA&#8221;) agreements, and from grants to support its research and development activity. In the longer term, the Company plans to finance its operations from revenues from sales of products.</font></div>
</div>
</td>
</tr></table>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div>
<table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td style="WIDTH: 18pt">
<div style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">c.</font></div>
</td>
<td>
<div align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Since December 10, 2007, the Company&#8217;s shares of common stock have been traded on the NASDAQ Capital Market under the symbol "PSTI".</font></div>
</td>
</tr></table>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 5.9pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">On December 19, 2010, the Company&#8217;s shares began trading also on the Tel-Aviv Stock Exchange under the symbol &#8220;PLTR&#8221;.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div>
<table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td style="WIDTH: 18pt">
<div style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">d.</font></div>
</td>
<td>
<div align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">License Agreements:</font></div>
</td>
</tr></table>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 5.9pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 5.9pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline; TEXT-DECORATION: underline">United Agreement</font></font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 5.9pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">On June 19, 2011, the Company entered into an exclusive license agreement (the &#8220;United Agreement&#8221;) with United Therapeutics for the use of the Company's PLX cells to develop and commercialize a cell-based product for the treatment of Pulmonary Hypertension (&#8220;PAH&#8221;).&#160;&#160;The United Agreement provides that United Therapeutics will receive exclusive worldwide license rights for the development and commercialization of the Company's PLX cell-based product to treat PAH.&#160;&#160;The United Agreement further provides for the following consideration payable to the Company: (i) an upfront payment of $7,000 paid in August 2011, which includes a $5,000 non-refundable upfront payment and a $2,000 advance payment on the development; (ii) up to $37,500 upon reaching certain regulatory milestones with respect to the development of a product to treat PAH; (iii) reimbursement of up to $10,000 of certain of the Company's expenses if the Company establishes a GMP manufacturing facility in North America; (iv) reimbursement of certain costs in connection with the development of the product; and (v) following commercialization of the product, royalties at a mid-single digit percent and the purchase of commercial supplies of the developed product from the Company at a specified margin over the Company&#8217;s cost.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 5.9pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">The United Agreement became effective on August 2, 2011, and will continue until the later of a few events, including termination of all patents relating to the collaboration, upon certain government action or if the parties do not develop any product under the United Agreement.&#160;&#160;United may unilaterally terminate the United Agreement at any time and without cause.&#160;&#160;In such event, United Therapeutics shall pay the Company certain costs and expenses of winding down any non-cancellable commitments made by the Company prior to the date of termination and cease all development activities in connection with the United Agreement.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 5.9pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline; TEXT-DECORATION: underline">CHA Agreement</font></font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 5.9pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">On June 26, 2013, Pluristem entered into an exclusive license and commercialization agreement (the &#8220;CHA Agreement&#8221;) with CHA, for conducting clinical trials and commercialization of Pluristem's PLX-PAD product in South Korea in connection with two indications: the treatment of Critical Limb Ischemia, and Intermediate Claudication (the &#8220;Indications&#8221;). Under the terms of the CHA Agreement, CHA will receive exclusive rights in South Korea for conducting clinical trials with respect to the Indications, CHA will bear the costs of conducting the clinical trials for the agreed upon indications, and the Company&#160;will continue to retain nights to its proprietary manufacturing technology and cell-related intellectual property.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div id="PGBRK" style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div id="FTR">
<div id="GLFTR" style="WIDTH: 100%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>

<div id="PN" style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
<div style="TEXT-ALIGN: center; WIDTH: 100%"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">F - 13</font></div>

<div style="TEXT-ALIGN: center; WIDTH: 100%">
<hr style="COLOR: black" noshade size="3">
</div>
</div>

<div id="HDR">
<div id="GLHDR" style="WIDTH: 100%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: -45pt; MARGIN-RIGHT: 0.15pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">PLURISTEM THERAPEUTICS INC. AND ITS SUBSIDIARY</font></div>

<div>
<table cellpadding="0" cellspacing="0" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr>
<td valign="top" width="87%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr>
<td valign="top" width="87%" style="BORDER-BOTTOM: black 2px solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">NOTES TO CONSOLIDATED FINANCIAL STATEMENTS</font></div>
</div>
</td>
</tr><tr>
<td align="left" valign="top" width="87%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 11.15pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">U.S. Dollars in thousands (except share and per share amounts)</font></div>
</td>
</tr></table>
</div>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 5.9pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">NOTE 1:-GENERAL (CONT.)</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 5.9pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">The first clinical study to be performed as part of the CHA Agreement will be a Phase II trial in Intermittent Claudication. This study was approved in November 2013 by South Korea&#8217;s Ministry of Food and Drug Safety.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 5.9pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Upon the first regulatory approval for a PLX product in South Korea, for the specified indications, Pluristem and CHA will establish an equally owned joint venture. The purpose of the joint venture will be to commercialize PLX cell products in South Korea.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 5.9pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Pluristem will be able to use the data generated by CHA to pursue the development of PLX product candidates outside of South Korea.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 5.9pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">In addition, and as contemplated by the CHA Agreement, in December 2013, Pluristem and CHA executed the mutual investment pursuant to which Pluristem issued 2,500,000 shares of its common stock in consideration for 1,011,504 shares of CHA, which reflects total consideration to each of Pluristem and CHA of approximately $10,414. The investment in CHA shares is presented as &#8220;Marketable Securities&#8221; and classified as available-for-sale in accordance with ASC 320 &#8211; &#8220;Investments - Debt and Equity Securities&#8221; (Note 3). The CHA Agreement contains customary termination provisions, including in the event the parties do not reach an agreement upon development plan for conducting the clinical trials. Upon termination of this CHA Agreement, the license granted thereunder will terminate and all rights included therein will revert to the Company, whereupon the Company will be free to enter into agreements with any other third parties for the granting of a license in or outside South Korea or to deal in any other manner with such rights as it shall see fit at its sole discretion.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 5.9pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Each party has agreed to hold the other party&#8217;s shares for at least one year before selling any of such shares. The parties also agreed to give an irrevocable proxy to the other party&#8217;s management with respect to the voting power of the shares issued.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div>
<div style="TEXT-ALIGN: left; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">NOTE 2:-SIGNIFICANT ACCOUNTING POLICIES</font></div>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-ALIGN: justify; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">The consolidated financial statements have been prepared in accordance with United States generally accepted accounting principles ("U.S. GAAP") applied on consistent basis.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div>
<table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td style="WIDTH: 18pt">
<div style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">a.</font></div>
</td>
<td>
<div align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Use of estimates</font></div>
</td>
</tr></table>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div>
<table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td style="WIDTH: 18pt">
<div><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160; </font></div>
</td>
<td>
<div align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">The preparation of financial statements in conformity with generally accepted accounting principles requires management to make estimates, judgments, and assumptions that are reasonable based upon information available at the time they are made. These estimates, judgments and assumptions can affect the amounts reported in the financial statements and accompanying notes. Actual results could differ from those estimates.</font></div>
</td>
</tr></table>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div>
<table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td style="WIDTH: 18pt">
<div style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">b.</font></div>
</td>
<td>
<div align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Functional currency of the Subsidiary</font></div>
</td>
</tr></table>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div>
<table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td style="WIDTH: 19pt">
<div><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160; </font></div>
</td>
<td>
<div align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">The Subsidiary's revenues are generated and determined in U.S. Dollars ("dollars"). In addition, most of the financing of the Subsidiary's operations has been made in dollars. The Company's management believes that the dollar is the primary currency of the economic environment in which the Subsidiary operates. Thus, management believe that the functional currency of the Subsidiary is the dollar. Accordingly, monetary accounts maintained in currencies other than the dollar are remeasured into dollars in accordance with ASC 830, "Foreign Currency Matters". All transaction gains and losses from the remeasurement of monetary balance sheet items are reflected in the statement of operations as financial income or expenses, as appropriate.</font></div>
</td>
</tr></table>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div>
<table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td style="WIDTH: 18pt">
<div style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">c.</font></div>
</td>
<td>
<div align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Principles of consolidation</font></div>
</td>
</tr></table>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div>
<table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td style="WIDTH: 18pt">
<div><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160; </font></div>
</td>
<td>
<div align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">The consolidated financial statements include the accounts of Pluristem Therapeutics Inc. and its Subsidiary. Intercompany transactions and balances have been eliminated upon consolidation.</font></div>
</td>
</tr></table>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div id="PGBRK" style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div id="FTR">
<div id="GLFTR" style="WIDTH: 100%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>

<div id="PN" style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
<div style="TEXT-ALIGN: center; WIDTH: 100%"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">F - 14</font></div>

<div style="TEXT-ALIGN: center; WIDTH: 100%">
<hr style="COLOR: black" noshade size="3">
</div>
</div>

<div id="HDR">
<div id="GLHDR" style="WIDTH: 100%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: -45pt; MARGIN-RIGHT: 0.15pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">PLURISTEM THERAPEUTICS INC. AND ITS SUBSIDIARY</font></div>

<div>
<table cellpadding="0" cellspacing="0" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr>
<td valign="top" width="87%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr>
<td valign="top" width="87%" style="BORDER-BOTTOM: black 2px solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">NOTES TO CONSOLIDATED FINANCIAL STATEMENTS</font></div>
</div>
</td>
</tr><tr>
<td align="left" valign="top" width="87%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 11.15pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">U.S. Dollars in thousands (except share and per share amounts)</font></div>
</td>
</tr></table>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-ALIGN: left; TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div style="TEXT-ALIGN: left; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">NOTE 2:-SIGNIFICANT ACCOUNTING POLICIES (CONT.)</font></div>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div>
<table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td style="WIDTH: 18pt">
<div style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">d.</font></div>
</td>
<td>
<div align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Cash and cash equivalents</font></div>
</td>
</tr></table>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div>
<table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td style="WIDTH: 19pt">
<div><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160; </font></div>
</td>
<td>
<div align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Cash equivalents are short-term highly liquid investments that are readily convertible to cash with maturities of three months or less at the date acquired.</font></div>
</td>
</tr></table>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div align="center">
<table border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td style="WIDTH: 18pt">
<div style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">e.</font></div>
</td>
<td>
<div align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Short-term bank deposit</font></div>
</td>
</tr></table>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Bank deposits with original maturities of more than three months but less than one year are presented as part of short-term investments. Deposits are presented at their cost which approximates market values including accrued interest. Interest on deposits is recorded as financial income.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div align="center">
<table border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td style="WIDTH: 18pt">
<div style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">f.</font></div>
</td>
<td>
<div align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Restricted cash and short-term deposits</font></div>
</td>
</tr></table>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 36pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Short-term restricted deposits and restricted cash used to secure derivative transactions are presented at cost.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div align="center">
<table border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td style="WIDTH: 18pt">
<div style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">g.</font></div>
</td>
<td>
<div align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Long-term restricted deposits</font></div>
</td>
</tr></table>
</div>

<div>&#160;</div>

<div>
<table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td style="WIDTH: 18pt">
<div><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160; </font></div>
</td>
<td>
<div align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Long-term restricted deposits with maturities of more than one year used to secure operating lease agreement are presented at cost which approximates market values including accrued interest.</font></div>
</td>
</tr></table>
</div>

<div>&#160;</div>

<div align="center">
<table border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td style="WIDTH: 18pt">
<div style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">h.</font></div>
</td>
<td>
<div align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Marketable Securities</font></div>
</td>
</tr></table>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">The Company accounts for its investments in marketable securities in accordance with ASC 320-"Investments &#8211; Debt and Equity Securities". The Company determines the classification of marketable securities at the time of purchase and re-evaluates such designations as of each balance sheet date. The Company classifies all of its marketable securities as available-for-sale. Available-for-sale marketable securities are carried at fair value, with the unrealized gain and loss reported at "accumulated other comprehensive income (loss)" in the statement of changes in stockholders' equity.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 437pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Realized gain and loss on sales of marketable securities are included in the Company's "Financial income, net" and are derived using the specific identification basis for determining the cost of marketable securities. The amortized cost of available for sale marketable securities is adjusted for amortization of premiums and accretion of discount to maturity. Such amortization, together with interest on available for sale marketable securities, is included in the "Financial income, net".</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 437pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">The Company recognizes an impairment charge when a decline in the fair value of its available-for-sale marketable securities below the cost basis is judged to be other-than-temporary. The Company considers various factors in determining whether to recognize an impairment charge, including the length of time the investment has been in a loss position, the extent to which the fair value has been less than the Company's cost basis, the investment&#8217;s financial condition and the near-term prospects of the issuer. ASC 320-10-35, &#8220;Investments - Debt and Equity Securities&#8221;, requires another-than-temporary impairment for debt securities to be separated into (a)&#160;the amount representing the credit loss and (b)&#160;the amount related to all other factors (provided that the Company does not intend to sell the security and it is not more likely than not that it will be required to sell it before recovery). For securities that are deemed other-than-temporarily impaired, the amount of impairment is recognized in "financial income, net", in the statement of operations and is limited to the amount related to credit loss, while impairment related to other factors is recognized in other comprehensive income (loss).</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 437pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">During 2014, 2013 and 2012, no impairment losses been identified.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div id="PGBRK" style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div id="FTR">
<div id="GLFTR" style="WIDTH: 100%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>

<div id="PN" style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
<div style="TEXT-ALIGN: center; WIDTH: 100%"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">F - 15</font></div>

<div style="TEXT-ALIGN: center; WIDTH: 100%">
<hr style="COLOR: black" noshade size="3">
</div>
</div>

<div id="HDR">
<div id="GLHDR" style="WIDTH: 100%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: -45pt; MARGIN-RIGHT: 0.15pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">PLURISTEM THERAPEUTICS INC. AND ITS SUBSIDIARY</font></div>

<div>
<table cellpadding="0" cellspacing="0" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr>
<td valign="top" width="87%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr>
<td valign="top" width="87%" style="BORDER-BOTTOM: black 2px solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">NOTES TO CONSOLIDATED FINANCIAL STATEMENTS</font></div>
</div>
</td>
</tr><tr>
<td align="left" valign="top" width="87%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 11.15pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">U.S. Dollars in thousands (except share and per share amounts)</font></div>
</td>
</tr></table>
</div>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block">&#160;</div>

<div>
<div style="TEXT-ALIGN: left; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">NOTE 2:-SIGNIFICANT ACCOUNTING POLICIES (CONT.)</font></div>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div align="center">
<table border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td style="WIDTH: 18pt">
<div style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">i.</font></div>
</td>
<td>
<div align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Revenue Recognition from the license Agreement with United Therapeutics</font></div>
</td>
</tr></table>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 437pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">The Company recognizes revenue pursuant to the License Agreement with United Therapeutics in accordance with ASC 605-25, "Revenue Recognition, Multiple-Element Arrangements".</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 437pt"><br>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Pursuant to ASC 605-25, each deliverable is evaluated to determine whether it qualifies as a separate unit of accounting based on whether the deliverable has &#8220;stand-alone value&#8221; to the customer. The arrangement&#8217;s consideration that is fixed or determinable is then allocated to each separate unit of accounting based on the relative selling price of each deliverable. In general, the consideration allocated to each unit of accounting is recognized as the related goods or services are delivered, limited to the consideration that is not contingent upon future deliverables.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 437pt"><br>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">The Company received an up-front, non-refundable license payment of $5,000. Additional payments totaling $37,500 are subject to the achievement of certain regulatory milestones by United Therapeutics.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 437pt"><br>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Since the deliverables in the United Agreement do not have stand-alone value, none of them qualifies as a separate unit of accounting. Accordingly, the non-refundable upfront license fee of $5,000 is deferred and recognized on a straight line basis over the related performance period which is the development period in accordance with Staff Accounting Bulletin (&#8220;SAB&#8221;) 104, "Revenue Recognition". The remaining performance period is 8.5 years as of June 30, 2014.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 437pt"><br>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">The additional regulatory milestones payments will be recognized upon the achievement of futures events by United Therapeutics, in accordance with ASC 450-30-25, &#8220;Gain Contingencies". As of June 30, 2014, no regulatory millstones were achieved.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 437pt"><br>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">The Company also received an advanced payment for the development, of $2,000 that will be deductible against development expenses as it incurred. The upfront payment which was received and has not yet fully recognized in the statement of operations, is included in the balance sheet as advance payment. Part of the expenses related to the development, on a cost basis, shall be repaid to the Company by United Therapeutics according to the applicable license agreement. The Company is deducting the payments from its research and development expenses in accordance with ASC 730-20, "Research and Development Agreements". As of June 30, 2014, the Company deducted an amount of approximately $1,753.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block">&#160;</div>

<div>
<table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td style="WIDTH: 18pt">
<div style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">j.</font></div>
</td>
<td>
<div align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Property and Equipment</font></div>
</td>
</tr></table>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div>
<table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td style="WIDTH: 18pt">
<div><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160; </font></div>
</td>
<td>
<div align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Property and equipment are stated at cost, net of accumulated depreciation. Depreciation is calculated by the straight-line method over the estimated useful lives of the assets, at the following annual rates:</font></div>
</td>
</tr></table>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="MARGIN-LEFT: 18pt" align="left">
<table cellpadding="0" cellspacing="0" width="80%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr>
<td valign="top" width="44%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="top" width="28%" style="BORDER-BOTTOM: black 2px solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div style="TEXT-INDENT: 0pt; DISPLAY: block"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">%</font></div>
</div>
</td>
<td valign="top" width="28%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr bgcolor="#cceeff">
<td align="left" valign="top" width="44%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Laboratory equipment</font></div>
</td>
<td align="left" valign="top" width="28%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: -12.3pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">10-15</font></div>
</td>
<td valign="top" width="28%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr bgcolor="white">
<td align="left" valign="top" width="44%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Computers and peripheral equipment</font></div>
</td>
<td align="left" valign="top" width="28%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: -12.3pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">33</font></div>
</td>
<td valign="top" width="28%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr bgcolor="#cceeff">
<td align="left" valign="top" width="44%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Office furniture and equipment</font></div>
</td>
<td align="left" valign="top" width="28%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: -12.3pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">6-15</font></div>
</td>
<td valign="top" width="28%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr bgcolor="white">
<td align="left" valign="top" width="44%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Vehicles</font></div>
</td>
<td align="left" colspan="2" valign="top" width="15%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: -12.3pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">15</font></div>
</td>
</tr><tr bgcolor="#cceeff">
<td align="left" valign="top" width="44%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Leasehold improvements</font></div>
</td>
<td align="left" colspan="2" valign="top" width="56%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: -12.3pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">The shorter of the expected </font><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">useful life or the </font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: -12.3pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">reasonable assumed </font><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">term of the lease.</font></div>
</td>
</tr></table>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div id="PGBRK" style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div id="FTR">
<div id="GLFTR" style="WIDTH: 100%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>

<div id="PN" style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
<div style="TEXT-ALIGN: center; WIDTH: 100%"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">F - 16</font></div>

<div style="TEXT-ALIGN: center; WIDTH: 100%">
<hr style="COLOR: black" noshade size="3">
</div>
</div>

<div id="HDR">
<div id="GLHDR" style="WIDTH: 100%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: -45pt; MARGIN-RIGHT: 0.15pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">PLURISTEM THERAPEUTICS INC. AND ITS SUBSIDIARY</font></div>

<div>
<table cellpadding="0" cellspacing="0" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr>
<td valign="top" width="87%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr>
<td valign="top" width="87%" style="BORDER-BOTTOM: black 2px solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">NOTES TO CONSOLIDATED FINANCIAL STATEMENTS</font></div>
</div>
</td>
</tr><tr>
<td align="left" valign="top" width="87%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 11.15pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">U.S. Dollars in thousands (except share and per share amounts)</font></div>
</td>
</tr></table>
</div>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block">&#160;</div>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">NOTE 2:-SIGNIFICANT ACCOUNTING POLICIES (CONT.)</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div align="center">
<table border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td style="WIDTH: 18pt">
<div style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">k.</font></div>
</td>
<td>
<div align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Impairment of long-lived assets</font></div>
</td>
</tr></table>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div>
<table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td style="WIDTH: 18pt">
<div><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160; </font></div>
</td>
<td>
<div align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">The Company's long-lived assets are reviewed for impairment in accordance with ASC 360, "Property, Plant and Equipment", whenever events or changes in circumstances indicate that the carrying amount of an asset may not be recoverable. Recoverability of assets to be held and used is measured by a comparison of the carrying amount of the assets to the future undiscounted cash flows expected to be generated by the assets. If such assets are considered to be impaired, the impairment to be recognized is measured by the amount by which the carrying amount of the assets exceeds the fair value of the assets. During 2014, 2013 and 2012, no impairment losses been identified.</font></div>
</td>
</tr></table>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div>
<table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td style="WIDTH: 18pt">
<div style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">l.</font></div>
</td>
<td>
<div align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Accounting for stock-based compensation</font></div>
</td>
</tr></table>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">The Company accounts for stock-based compensation in accordance with ASC 718, "Compensation-Stock Compensation" (&#8220;ASC 718&#8221;) and ASC 505-50 "Equity-Based Payments to Non-Employees". ASC 718 requires companies to estimate the fair value of equity-based payment awards on the date of grant using an option-pricing model. The Company estimates the fair value of stock options granted using the Black-Scholes-Merton option-pricing model. The Company accounts for employee&#8217;s share-based payment awards classified as equity awards using the grant-date fair value method. The fair value of share-based payment transactions is recognized as an expense over the requisite service period, net of estimated forfeitures. The Company estimates forfeitures based on historical experience and anticipated future conditions. The Company elected to recognize compensation cost for an award with service conditions and goals achievement that has a graded vesting schedule using the accelerated method based on the multiple-option award approach.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">During fiscal years 2014, 2013 and 2012 there were no options grants to employees or directors.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 437pt"><br>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">The assumptions below are relevant to restricted shares units granted in 2014, 2013 and 2012:</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">In accordance with <font style="DISPLAY: inline; FONT-SIZE: 10pt">ASC 718</font>, restricted shares or restricted shares units are measured at their fair value. All restricted shares and restricted shares units to employees, directors and non-employees granted in 20142013 and 2012 were granted for no consideration; therefore, their fair value was equal to the share price at the date of grant.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 437pt"><br>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">The expected pre-vesting forfeiture rate affects the number of exercisable shares. Based on Company&#8217;s historical experience, the pre-vesting forfeiture rate per grant for shares granted to employees is 7% for year ended June 30, 2014 and 2013 and 5% for the year ended June 30, 2012, and 0% for the options and shares granted to directors and officers and consultants of the Company.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 437pt"><br>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">The fair value of all restricted shares and restricted shares units was determined based on the close trading price of the Company's shares known at the grant date. The weighted average grant date fair value of share granted during years 2014, 2013 and 2012 was $3.53, $3.43 and $2.54, respectively.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block">&#160;</div>

<div align="center">
<table border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td style="WIDTH: 18pt">
<div style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">m.</font></div>
</td>
<td>
<div align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Research and Development expenses and grants</font></div>
</td>
</tr></table>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div>
<table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td style="WIDTH: 19pt">
<div><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160; </font></div>
</td>
<td>
<div align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Research and development expenses, net of participations, are charged to the statement of operations as incurred.</font></div>
</td>
</tr></table>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div>
<table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td style="WIDTH: 19pt">
<div><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160; </font></div>
</td>
<td>
<div align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Research and development grants from the government of Israel and other parties for funding approved research and development projects are recognized at the time the Company is entitled to such grants, on the basis of the cost incurred and applied as a deduction from research and development costs.</font></div>
</td>
</tr></table>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div id="PGBRK" style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div id="FTR">
<div id="GLFTR" style="WIDTH: 100%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>

<div id="PN" style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
<div style="TEXT-ALIGN: center; WIDTH: 100%"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">F - 17</font></div>

<div style="TEXT-ALIGN: center; WIDTH: 100%">
<hr style="COLOR: black" noshade size="3">
</div>
</div>

<div id="HDR">
<div id="GLHDR" style="WIDTH: 100%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">
<div style="TEXT-INDENT: 0pt; DISPLAY: block">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: -45pt; MARGIN-RIGHT: 0.15pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">PLURISTEM THERAPEUTICS INC. AND ITS SUBSIDIARY</font></div>

<div>
<table cellpadding="0" cellspacing="0" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr>
<td valign="top" width="87%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr>
<td valign="top" width="87%" style="BORDER-BOTTOM: black 2px solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">NOTES TO CONSOLIDATED FINANCIAL STATEMENTS</font></div>
</div>
</td>
</tr><tr>
<td align="left" valign="top" width="87%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 11.15pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">U.S. Dollars in thousands (except share and per share amounts)</font></div>
</td>
</tr></table>
</div>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block">&#160;</div>
</div>
</div>

<div style="TEXT-ALIGN: left; TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div style="TEXT-ALIGN: left; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">NOTE 2:-SIGNIFICANT ACCOUNTING POLICIES (CONT.)</font></div>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div align="center">
<table border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td style="WIDTH: 18pt">
<div style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">n.</font></div>
</td>
<td>
<div align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Loss per share</font></div>
</td>
</tr></table>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div>
<table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td style="WIDTH: 19pt">
<div><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160; </font></div>
</td>
<td>
<div align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Basic and dilutive net loss per share is computed based on the weighted average number of shares of common stock outstanding during each year. All outstanding stock options and unvested restricted stock units have been excluded from the calculation of the diluted loss per common share because all such securities are anti-dilutive for each of the periods presented.</font></div>
</td>
</tr></table>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div align="center">
<table border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td style="WIDTH: 18pt">
<div style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">o.</font></div>
</td>
<td>
<div align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Income taxes</font></div>
</td>
</tr></table>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div>
<table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td style="WIDTH: 19pt">
<div><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160; </font></div>
</td>
<td>
<div align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">The Company accounts for income taxes in accordance with ASC 740, "Income Taxes". This Topic prescribes the use of the liability method, whereby deferred tax assets and liability account balances are determined based on differences between financial reporting and tax bases of assets and liabilities and are measured using the enacted tax rates and laws that will be in effect when the differences are expected to reverse. The Company provides a valuation allowance, if necessary, to reduce deferred tax assets to their estimated realizable value.</font></div>
</td>
</tr></table>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div>
<table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td style="WIDTH: 19pt">
<div><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160; </font></div>
</td>
<td>
<div align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">ASC 740 establishes a single model to address accounting for uncertain tax positions. ASC 740 clarified the accounting for income taxes by prescribing the minimum recognition threshold a tax position is required to meet before being recognized in the financial statements.</font></div>
</td>
</tr></table>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div align="center">
<table border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td style="WIDTH: 18pt">
<div style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">p.</font></div>
</td>
<td>
<div align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Concentration of credit risk</font></div>
</td>
</tr></table>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div>
<table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td style="WIDTH: 19pt">
<div><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160; </font></div>
</td>
<td>
<div align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Financial instruments that potentially subject the Company to concentrations of credit risk consist principally of cash and cash equivalents, short-term deposits, long-term deposits, restricted deposits and marketable securities.</font></div>
</td>
</tr></table>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div>
<table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td style="WIDTH: 19pt">
<div><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160; </font></div>
</td>
<td>
<div align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">The majority of the Company&#8217;s cash and cash equivalents and short-term and long-term deposits are invested in dollar instruments of major banks in Israel. Generally, these deposits may be redeemed upon demand and therefore bear minimal risk.</font></div>
</td>
</tr></table>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div>
<table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td style="WIDTH: 18pt">
<div><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160; </font></div>
</td>
<td>
<div align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">The Company invests its surplus cash in cash deposits and marketable securities in financial institutions and has established guidelines, approved by the Company&#8217;s Investment Committee, relating to diversification and maturities to maintain safety and liquidity of the investments.</font></div>
</td>
</tr></table>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div>
<table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td style="WIDTH: 18pt">
<div><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160; </font></div>
</td>
<td>
<div align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">The Company holds an investment portfolio consisting of corporate bonds, government bonds, stocks and index linked notes. The Company intends, and has the ability, to hold such investments until recovery of temporary declines in market value or maturity; accordingly, as of June&#160;30, 2014, the Company believes the losses associated with its investments are temporary and no impairment loss was recognized during 2014. However, the Company can provide no assurance that it will recover declines in the market value of its investments.</font></div>
</td>
</tr></table>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div align="center">
<table border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td style="WIDTH: 17pt">
<div>
<div style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">q.</font></font></div>
</div>
</td>
<td>
<div align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Severance pay</font></div>
</td>
</tr></table>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div>
<table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td style="WIDTH: 19pt">
<div><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160; </font></div>
</td>
<td>
<div align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">The Subsidiary's liability for severance pay is calculated pursuant to Israeli Severance Pay Law, 1963 (the &#8220;Severance Pay Law&#8221;)&#160;&#160;based on the most recent salary of the employees multiplied by the number of years of employment, as of the balance sheet date. Employees are entitled to one month's salary for each year of employment or a portion thereof.</font></div>

<div align="justify">&#160;</div>

<div align="justify">
<div style="TEXT-ALIGN: justify; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">The Company&#8217;s liability for all of its employees is fully provided by monthly deposits with insurance policies and by an accrual. The value of these policies is recorded as an asset in the Company's balance sheet.</font></div>
</div>
</td>
</tr></table>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div>
<table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td style="WIDTH: 19pt">
<div><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160; </font></div>
</td>
<td>
<div align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">The deposited funds include profits or losses accumulated up to the balance sheet date. The deposited funds may be withdrawn only upon the fulfillment of the obligation pursuant to Israeli severance pay law or labor agreements. The value of the deposited funds is based on the cash surrendered value of these policies, and includes immaterial profits or losses.</font></div>
</td>
</tr></table>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div id="PGBRK" style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div id="FTR">
<div id="GLFTR" style="WIDTH: 100%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>

<div id="PN" style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
<div style="TEXT-ALIGN: center; WIDTH: 100%"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">F - 18</font></div>

<div style="TEXT-ALIGN: center; WIDTH: 100%">
<hr style="COLOR: black" noshade size="3">
</div>
</div>

<div id="HDR">
<div id="GLHDR" style="WIDTH: 100%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: -45pt; MARGIN-RIGHT: 0.15pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">PLURISTEM THERAPEUTICS INC. AND ITS SUBSIDIARY</font></div>

<div>
<table cellpadding="0" cellspacing="0" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr>
<td valign="top" width="87%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr>
<td valign="top" width="87%" style="BORDER-BOTTOM: black 2px solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">NOTES TO CONSOLIDATED FINANCIAL STATEMENTS</font></div>
</div>
</td>
</tr><tr>
<td align="left" valign="top" width="87%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 11.15pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">U.S. Dollars in thousands (except share and per share amounts)</font></div>
</td>
</tr></table>
</div>
</div>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">NOTE 2:-SIGNIFICANT ACCOUNTING POLICIES (CONT.)</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Since November 2011, the Company&#8217;s agreements with new employees in Israel, are subject to Section 14 of the Severance Pay Law. The Company&#8217;s contributions for severance pay have replaced its severance obligation. Upon contribution of the full amount of the employee&#8217;s monthly salary for each year of employment, no additional calculations is conducted between the parties regarding the matter of severance pay and no additional payments is made by the Company to the employee. Further, the related obligation and amounts deposited on behalf of the employee for such obligation are not stated on the balance sheet, as the Company is legally released from the obligation to employees once the deposit amounts have been paid.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div>
<table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td style="WIDTH: 19pt">
<div><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160; </font></div>
</td>
<td>
<div align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Severance expenses for the years ended December 31, 2014, 2013 and 2012, were $534, $329 and $275, respectively.</font></div>
</td>
</tr></table>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div align="center">
<table border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td style="WIDTH: 18pt">
<div style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">r.</font></div>
</td>
<td>
<div align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Fair value of financial instruments</font></div>
</td>
</tr></table>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div>
<table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td style="WIDTH: 19pt">
<div><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160; </font></div>
</td>
<td>
<div align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">The carrying amounts of the Company's financial instruments, including cash and cash equivalents, short-term and restricted bank deposits, trade payable and other accounts payable and accrued liabilities, approximate fair value because of their generally short term maturities.</font></div>
</td>
</tr></table>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div>
<table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td style="WIDTH: 19pt">
<div><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160; </font></div>
</td>
<td>
<div align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">The Company measures its investments in marketable securities and derivative instruments at fair value under ASC 820, &#8220;Fair Value Measurements and Disclosures&#8221; (&#8220;ASC 820&#8221;). Fair value is an exit price, representing the amount that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants. As such, fair value is a market-based measurement that should be determined based on assumptions that market participants would use in pricing an asset or a liability. As a basis for considering such assumptions, ASC 820 establishes a three-tier value hierarchy, which prioritizes the inputs used in the valuation methodologies in measuring fair value:</font></div>
</td>
</tr></table>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div>
<table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td style="WIDTH: 19pt">
<div><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160; </font></div>
</td>
<td>
<div align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline; FONT-WEIGHT: bold">Level 1 -</font> Quoted prices (unadjusted) in active markets for identical assets or liabilities that the Company can access at the measurement date;</font></div>
</td>
</tr></table>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div>
<table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td style="WIDTH: 19pt">
<div><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160; </font></div>
</td>
<td>
<div align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline; FONT-WEIGHT: bold">Level 2 - </font>Inputs other than quoted prices included within Level 1 that are observable for the asset or liability, either directly or indirectly.; and</font></div>
</td>
</tr></table>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div>
<table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td style="WIDTH: 19pt">
<div><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160; </font></div>
</td>
<td>
<div align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline; FONT-WEIGHT: bold">Level 3 - </font>Unobservable inputs for the asset or liability.</font></div>
</td>
</tr></table>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div>
<table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td style="WIDTH: 19pt">
<div><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160; </font></div>
</td>
<td>
<div align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">The fair value hierarchy also requires an entity to maximize the use of observable inputs and minimize the use of unobservable inputs when measuring fair value. The Company categorized each of its fair value measurements in one of these three levels of hierarchy.</font></div>
</td>
</tr></table>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div id="PGBRK" style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div id="FTR">
<div id="GLFTR" style="WIDTH: 100%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>

<div id="PN" style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
<div style="TEXT-ALIGN: center; WIDTH: 100%"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">F - 19</font></div>

<div style="TEXT-ALIGN: center; WIDTH: 100%">
<hr style="COLOR: black" noshade size="3">
</div>
</div>

<div id="HDR">
<div id="GLHDR" style="WIDTH: 100%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: -45pt; MARGIN-RIGHT: 0.15pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">PLURISTEM THERAPEUTICS INC. AND ITS SUBSIDIARY</font></div>

<div>
<table cellpadding="0" cellspacing="0" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr>
<td valign="top" width="87%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr>
<td valign="top" width="87%" style="BORDER-BOTTOM: black 2px solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">NOTES TO CONSOLIDATED FINANCIAL STATEMENTS</font></div>
</div>
</td>
</tr><tr>
<td align="left" valign="top" width="87%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 11.15pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">U.S. Dollars in thousands (except share and per share amounts)</font></div>
</td>
</tr></table>
</div>
</div>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">NOTE 2:-SIGNIFICANT ACCOUNTING POLICIES (CONT.)</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div align="center">
<table border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td style="WIDTH: 18pt">
<div style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">s.</font></div>
</td>
<td>
<div align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Derivative financial instruments</font></div>
</td>
</tr></table>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">The Company uses forward contracts and options strategies (&#8220;derivative instruments&#8221;) primarily to manage exposure to foreign currency. The Company accounts for derivatives and hedging based on ASC 815, &#8220;Derivatives and Hedging&#8221; (&#8220;ASC 815&#8221;). ASC 815 requires the Company to recognize all derivative instruments as either assets or liabilities on the balance sheet at fair value. The accounting for changes in the fair value (i.e., gains or losses) of derivative instruments depends on whether it has been designated and qualifies as part of a hedging relationship and further, on the type of hedging relationship. For those derivative instruments that are designated and qualify as hedging instruments, the Company must designate the hedging instrument, based upon the exposure being hedged, as a fair value hedge, cash flow hedge, or a hedge of a net investment in a foreign operation.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">If the derivative instruments meet the definition of a hedge and are so designated, depending on the nature of the hedge, changes in the fair value of such derivatives will either be offset against the change in fair value of the hedged assets, liabilities, or firm commitments through earnings, or recognized in other comprehensive income until the hedged item is recognized in the statement of operations.<font style="DISPLAY: inline; FONT-SIZE: 10pt">&#160;</font>The ineffective portion of a derivative&#8217;s change in fair value is recognized in the statement of operations.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"><font style="FONT-STYLE: italic; DISPLAY: inline; FONT-FAMILY: Times New Roman">Cash Flow Hedges</font>. The Company entered into forward contracts to hedge against the risk of overall changes in future cash flow from payments of payroll and related expenses denominated in New Israeli Shekels (NIS). The Company measured the fair value of the contracts in accordance with ASC 820 (classified as level 2). The gain or loss on the effective portion of a cash flow hedge is initially reported as a component of accumulated other comprehensive income and subsequently reclassified into operating expenses in the same period or periods in which the payroll and related expenses are recognized, or reclassified into &#8220;Financial income, net&#8221;, if the hedged transaction becomes probable of not occurring. Any gain or loss after a hedge is no longer designated, because it is no longer probable of occurring or it is related to an ineffective portion of a cash flow hedge is recognized in the statement of operations immediately. As of June 30, 2014, the Company had forward contracts in place to hedge future payroll and related expenses in NIS of approximately $2,820, with fair value of approximately $24. The net unrealized gain on the effective portion of these cash flow hedges was $23. The net gain realized in statement of operations during the year ended June 30, 2014, resulting from the cash flow hedge transactions,&#160;&#160;amounted to approximately $48. The forward contracts on the Company&#8217;s future NIS payroll and related expenses will settle by December 2014. On June 30, 2013, the Company did not have contracts designated and qualifies as cash flow hedge.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 437pt"><br>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"><font style="FONT-STYLE: italic; DISPLAY: inline; FONT-FAMILY: Times New Roman">Fair Value Hedges</font>. The Company entered into forward contracts designated as fair value hedges to hedge foreign currency risks for its investment denominated in currencies other than the U.S. dollar. The Company measured the fair value of the contracts in accordance with ASC 820 (classified as level 2). Gains and losses on these contracts are recognized in "Financial income, net", along with the offsetting losses and gains of the related hedged items.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">In connection with the investment in CHA shares (see Note 1d), an available-for-sale marketable security denominated in Korean Won, the Company entered into a forward contract to hedge against the foreign currency risk between the Korean Won and the U.S. dollar. The notional principal of this contract is $11,000 as of June 30, 2014 with fair value of approximately $(889).</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">The changes in fair value of the available-for-sale CHA shares attributable to the foreign currency risk being hedged are reflected in the statement of operations in "Financial income, net" (not in other comprehensive income). Other changes in fair value of the available-for-sale CHA shares continue to follow ASC 320-&#8220;Investments-Debt and Equity Securities&#8221;, accounting and are reflected in other comprehensive income.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div id="PGBRK" style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div id="FTR">
<div id="GLFTR" style="WIDTH: 100%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>

<div id="PN" style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
<div style="TEXT-ALIGN: center; WIDTH: 100%"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">F - 20</font></div>

<div style="TEXT-ALIGN: center; WIDTH: 100%">
<hr style="COLOR: black" noshade size="3">
</div>
</div>

<div id="HDR">
<div id="GLHDR" style="WIDTH: 100%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: -45pt; MARGIN-RIGHT: 0.15pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">PLURISTEM THERAPEUTICS INC. AND ITS SUBSIDIARY</font></div>

<div>
<table cellpadding="0" cellspacing="0" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr>
<td valign="top" width="87%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr>
<td valign="top" width="87%" style="BORDER-BOTTOM: black 2px solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">NOTES TO CONSOLIDATED FINANCIAL STATEMENTS</font></div>
</div>
</td>
</tr><tr>
<td align="left" valign="top" width="87%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 11.15pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">U.S. Dollars in thousands (except share and per share amounts)</font></div>
</td>
</tr></table>
</div>
</div>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
</div>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">NOTE 2:-SIGNIFICANT ACCOUNTING POLICIES (CONT.)</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"><font style="FONT-STYLE: italic; DISPLAY: inline; FONT-FAMILY: Times New Roman">Other Derivatives</font>. Other derivatives that are non-designated consist primarily of options strategies to minimize the risk associated with the foreign exchange effects of monetary assets and liabilities denominated in NIS. The Company measured the fair value of the contracts in accordance with ASC 820 (classified as level 2). The net gains (losses) recognized in &#8220;Financial income, net&#8221; during the year ended June 30, 2014, 2013 and 2012 were ($70), $231 and ($145), respectively.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block">&#160;</div>

<div align="center">
<table border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td style="WIDTH: 18pt">
<div style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline; FONT-WEIGHT: bold">t.</font></font></div>
</td>
<td>
<div align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline; FONT-WEIGHT: bold">Comprehensive income</font><font style="DISPLAY: inline; FONT-SIZE: 10pt">:</font></font></div>
</td>
</tr></table>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">The Company accounts for comprehensive income (loss) in accordance with ASC No. 220, &#8220;Comprehensive Income&#8221;. Comprehensive income generally represents all changes in shareholders&#8217; equity during the period except those resulting from investments by, or distributions to, shareholders. The Company determined that its items of other comprehensive income relate to gains and losses on cash flow hedging derivative instruments and unrealized gains and losses on available for sale marketable securities.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block">&#160;</div>

<div>
<div align="right">
<table cellpadding="0" cellspacing="0" width="97%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr>
<td valign="bottom" width="64%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td colspan="10" valign="bottom" width="34%" style="BORDER-BOTTOM: black 2px solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Year ended June 30, 2014</font></div>
</td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
</tr><tr>
<td valign="bottom" width="64%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td colspan="2" valign="bottom" width="10%" style="BORDER-BOTTOM: black 2px solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Unrealized</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">gains</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">on marketable</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">securities</font></div>
</td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td colspan="2" valign="bottom" width="10%" style="BORDER-BOTTOM: black 2px solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Unrealized</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">gains</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">on cash flow</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">hedges</font></div>
</td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td colspan="2" valign="bottom" width="10%" style="BORDER-BOTTOM: black 2px solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Total</font></div>
</td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
</tr><tr bgcolor="#cceeff">
<td valign="bottom" width="64%" style="TEXT-ALIGN: left; TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div style="TEXT-ALIGN: left; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Beginning balance</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">259</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">259</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
</tr><tr bgcolor="white">
<td valign="bottom" width="64%" style="TEXT-ALIGN: left; TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div style="TEXT-ALIGN: left; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Other comprehensive income before reclassifications</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">3,404</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">23</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">3,427</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
</tr><tr bgcolor="#cceeff">
<td valign="bottom" width="64%" style="TEXT-ALIGN: left; TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div style="TEXT-ALIGN: left; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Amounts reclassified from accumulated other comprehensive loss</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(727</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(727</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font></td>
</tr><tr bgcolor="white">
<td valign="bottom" width="64%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px; TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div style="TEXT-ALIGN: left; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Net current-period other comprehensive income</font></div>
</td>
<td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">2,677</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">23</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">2,700</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
</tr><tr bgcolor="#cceeff">
<td valign="bottom" width="64%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 4px; TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div style="TEXT-ALIGN: left; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Ending balance</font></div>
</td>
<td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">2,936</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">23</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">2,959</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
</tr></table>
</div>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block">&#160;</div>

<div align="center">
<table border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td style="WIDTH: 18pt">
<div style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">u.</font></div>
</td>
<td>
<div align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Recent Accounting Pronouncement</font></div>
</td>
</tr></table>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">In May 2014, the FASB issued Accounting Standards Update No. 2014-09 (&#8220;ASU 2014-09&#8221;), "Revenue from Contracts with Customers". ASU 2014-09 supersedes the revenue recognition requirements in &#8220;Revenue Recognition (Topic 605)&#8221;, and requires entities to recognize revenue when it transfers promised goods or services to customers in an amount that reflects the consideration to which the entity expects to be entitled to in exchange for those goods or services. ASU 2014-09 is effective for annual reporting periods beginning after December 15, 2016, including interim periods within that reporting period. Early adoption is not permitted. The Company is currently in the process of evaluating the impact of the adoption of ASU 2014-09 on its consolidated financial statements.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div id="PGBRK" style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div id="FTR">
<div id="GLFTR" style="WIDTH: 100%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>

<div id="PN" style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
<div style="TEXT-ALIGN: center; WIDTH: 100%"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">F - 21</font></div>

<div style="TEXT-ALIGN: center; WIDTH: 100%">
<hr style="COLOR: black" noshade size="3">
</div>
</div>

<div id="HDR">
<div id="GLHDR" style="WIDTH: 100%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: -45pt; MARGIN-RIGHT: 0.15pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">PLURISTEM THERAPEUTICS INC. AND ITS SUBSIDIARY</font></div>

<div>
<table cellpadding="0" cellspacing="0" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr>
<td valign="top" width="87%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr>
<td valign="top" width="87%" style="BORDER-BOTTOM: black 2px solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">NOTES TO CONSOLIDATED FINANCIAL STATEMENTS</font></div>
</div>
</td>
</tr><tr>
<td align="left" valign="top" width="87%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 11.15pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">U.S. Dollars in thousands (except share and per share amounts)</font></div>
</td>
</tr></table>

<br>
</div>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">NOTE 3:- MARKETABLE SECURITIES</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">As of June 30, 2014, all of the Company&#8217;s marketable securities were classified as available-for-sale.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left">&#160;</div>

<div>
<div align="left">
<table cellpadding="0" cellspacing="0" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr>
<td valign="bottom" width="20%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;</font></td>
<td colspan="14" valign="bottom" width="38%" style="BORDER-BOTTOM: black 2px solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">June 30, 2014</font></div>
</td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;</font></td>
<td colspan="14" valign="bottom" width="38%" style="BORDER-BOTTOM: black 2px solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">June 30,2013</font></div>
</td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
</tr><tr>
<td valign="bottom" width="20%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;</font></td>
<td colspan="2" valign="bottom" width="8%" style="BORDER-BOTTOM: black 2px solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Amortized cost</font></div>
</td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;</font></td>
<td valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;</font></td>
<td colspan="2" valign="bottom" width="8%" style="BORDER-BOTTOM: black 2px solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Gross</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">unrealized</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">gain</font></div>
</td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;</font></td>
<td valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;</font></td>
<td colspan="2" valign="bottom" width="8%" style="BORDER-BOTTOM: black 2px solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Gross</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">unrealized</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">loss</font></div>
</td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;</font></td>
<td valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;</font></td>
<td colspan="2" valign="bottom" width="8%" style="BORDER-BOTTOM: black 2px solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Fair</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">value</font></div>
</td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;</font></td>
<td valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;</font></td>
<td colspan="2" valign="bottom" width="8%" style="BORDER-BOTTOM: black 2px solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Amortized cost</font></div>
</td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;</font></td>
<td valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;</font></td>
<td colspan="2" valign="bottom" width="8%" style="BORDER-BOTTOM: black 2px solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Gross</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">unrealized</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">gain</font></div>
</td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;</font></td>
<td valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;</font></td>
<td colspan="2" valign="bottom" width="8%" style="BORDER-BOTTOM: black 2px solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Gross</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">unrealized</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">loss</font></div>
</td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;</font></td>
<td valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;</font></td>
<td colspan="2" valign="bottom" width="8%" style="BORDER-BOTTOM: black 2px solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Fair</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">value</font></div>
</td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;</font></td>
</tr><tr bgcolor="#cceeff">
<td valign="bottom" width="20%" style="TEXT-ALIGN: left; TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div style="TEXT-ALIGN: left; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Available-for-sale - matures within one year:</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td colspan="2" valign="bottom" width="8%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td colspan="2" valign="bottom" width="8%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td colspan="2" valign="bottom" width="8%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td colspan="2" valign="bottom" width="8%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td colspan="2" valign="bottom" width="8%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td colspan="2" valign="bottom" width="8%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td colspan="2" valign="bottom" width="8%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td colspan="2" valign="bottom" width="8%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
</tr><tr bgcolor="white">
<td valign="bottom" width="20%" style="TEXT-ALIGN: left; TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div style="TEXT-ALIGN: left; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Stock and index linked notes</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></td>
<td valign="bottom" width="7%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">18,881</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></td>
<td valign="bottom" width="7%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">2,522</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></td>
<td valign="bottom" width="7%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(23</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></td>
<td valign="bottom" width="7%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">21,380</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></td>
<td valign="bottom" width="7%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">4,023</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></td>
<td valign="bottom" width="7%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">234</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></td>
<td valign="bottom" width="7%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(180</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></td>
<td valign="bottom" width="7%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">4,077</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
</tr><tr bgcolor="#cceeff">
<td valign="bottom" width="20%" style="TEXT-ALIGN: left; TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div style="TEXT-ALIGN: left; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Government debentures &#8211; fixed interest rate</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="7%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">97</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="7%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">9</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="7%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="7%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">106</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="7%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">329</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="7%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">21</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="7%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="7%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">350</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
</tr><tr bgcolor="white">
<td valign="bottom" width="20%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px; TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div style="TEXT-ALIGN: left; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Corporate debentures &#8211; fixed interest rate</font></div>
</td>
<td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="7%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">452</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="7%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">54</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="7%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="7%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">506</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="7%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">508</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="7%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">30</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="7%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(9</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font></td>
<td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="7%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">529</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
</tr><tr bgcolor="#cceeff">
<td valign="bottom" width="20%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></td>
<td valign="bottom" width="7%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">19,430</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></td>
<td valign="bottom" width="7%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">2,585</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></td>
<td valign="bottom" width="7%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(23</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></td>
<td valign="bottom" width="7%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">21,992</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></td>
<td valign="bottom" width="7%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">4,860</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></td>
<td valign="bottom" width="7%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">285</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></td>
<td valign="bottom" width="7%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(189</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></td>
<td valign="bottom" width="7%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">4,956</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
</tr><tr bgcolor="white">
<td valign="bottom" width="20%" style="TEXT-ALIGN: left; TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div style="TEXT-ALIGN: left; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Available-for-sale - matures after one year through five years:</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="7%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="7%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="7%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="7%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="7%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="7%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="7%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="7%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
</tr><tr bgcolor="#cceeff">
<td valign="bottom" width="20%" style="TEXT-ALIGN: left; TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div style="TEXT-ALIGN: left; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Government debentures &#8211; fixed interest rate</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="7%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">2,595</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="7%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">98</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="7%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(1</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="7%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">2,692</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="7%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">1,602</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="7%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">49</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="7%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(12</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="7%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">1,639</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
</tr><tr bgcolor="white">
<td valign="bottom" width="20%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px; TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div style="TEXT-ALIGN: left; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Corporate debentures &#8211; fixed interest rate</font></div>
</td>
<td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="7%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">4,906</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="7%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">263</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="7%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(5</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font></td>
<td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="7%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">5,164</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="7%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">4,976</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="7%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">162</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="7%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(77</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font></td>
<td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="7%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">5,061</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
</tr><tr bgcolor="#cceeff">
<td valign="bottom" width="20%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></td>
<td valign="bottom" width="7%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">7,501</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></td>
<td valign="bottom" width="7%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">361</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></td>
<td valign="bottom" width="7%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(6</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></td>
<td valign="bottom" width="7%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">7,856</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></td>
<td valign="bottom" width="7%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">6,578</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></td>
<td valign="bottom" width="7%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">211</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></td>
<td valign="bottom" width="7%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(89</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></td>
<td valign="bottom" width="7%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">6,700</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
</tr><tr bgcolor="white">
<td valign="bottom" width="20%" style="TEXT-ALIGN: left; TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div style="TEXT-ALIGN: left; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Available-for-sale - matures after five years through ten years:</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="7%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="7%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="7%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="7%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="7%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="7%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="7%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="7%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
</tr><tr bgcolor="#cceeff">
<td valign="bottom" width="20%" style="TEXT-ALIGN: left; TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div style="TEXT-ALIGN: left; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Government debentures &#8211; fixed interest rate</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="7%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="7%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="7%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="7%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="7%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">955</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="7%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">45</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="7%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(14</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="7%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">986</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
</tr><tr bgcolor="white">
<td valign="bottom" width="20%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px; TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div style="TEXT-ALIGN: left; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Corporate debentures &#8211; fixed interest rate</font></div>
</td>
<td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="7%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">94</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="7%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">19</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="7%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="7%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">113</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="7%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">789</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="7%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">29</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="7%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(19</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font></td>
<td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="7%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">799</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
</tr><tr bgcolor="#cceeff">
<td valign="bottom" width="20%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></td>
<td valign="bottom" width="7%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">94</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></td>
<td valign="bottom" width="7%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">19</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></td>
<td valign="bottom" width="7%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></td>
<td valign="bottom" width="7%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">113</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></td>
<td valign="bottom" width="7%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">1,744</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></td>
<td valign="bottom" width="7%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">74</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></td>
<td valign="bottom" width="7%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(33</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font></td>
<td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></td>
<td valign="bottom" width="7%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">1,785</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
</tr><tr bgcolor="white">
<td valign="bottom" width="20%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 4px; TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div style="TEXT-ALIGN: left; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Total</font></div>
</td>
<td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></td>
<td valign="bottom" width="7%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">27,025</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></td>
<td valign="bottom" width="7%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">2,965</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></td>
<td valign="bottom" width="7%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(29</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font></td>
<td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></td>
<td valign="bottom" width="7%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">29,961</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></td>
<td valign="bottom" width="7%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">13,182</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></td>
<td valign="bottom" width="7%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">570</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></td>
<td valign="bottom" width="7%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(311</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font></td>
<td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></td>
<td valign="bottom" width="7%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">13,441</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
</tr></table>
</div>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block">&#160;</div>

<div id="PGBRK" style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">The following table presents gross unrealized losses and fair values for those investments that were in an unrealized loss position as of June 30, 2014 and June 30, 2013, and the length of time that those investments have been in a continuous loss position:</font></div>

<div style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">&#160;</div>

<div align="left">
<table cellpadding="0" cellspacing="0" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr>
<td valign="bottom" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;</font></td>
<td colspan="6" valign="bottom" style="BORDER-BOTTOM: black 2px solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Less than 12 months</font></div>
</td>
<td nowrap valign="bottom" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;</font></td>
<td valign="bottom" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;</font></td>
<td colspan="6" valign="bottom" style="BORDER-BOTTOM: black 2px solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">12 months or greater</font></div>
</td>
<td nowrap valign="bottom" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;</font></td>
</tr><tr>
<td valign="bottom" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;</font></td>
<td colspan="2" valign="bottom" style="BORDER-BOTTOM: black 2px solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Fair Value</font></div>
</td>
<td nowrap valign="bottom" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;</font></td>
<td valign="bottom" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;</font></td>
<td colspan="2" valign="bottom" style="BORDER-BOTTOM: black 2px solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Gross</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">unrealized loss</font></div>
</td>
<td nowrap valign="bottom" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;</font></td>
<td valign="bottom" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;</font></td>
<td colspan="2" valign="bottom" style="BORDER-BOTTOM: black 2px solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Fair Value</font></div>
</td>
<td nowrap valign="bottom" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;</font></td>
<td valign="bottom" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;</font></td>
<td colspan="2" valign="bottom" style="BORDER-BOTTOM: black 2px solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Gross</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">unrealized loss</font></div>
</td>
<td nowrap valign="bottom" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;</font></td>
</tr><tr bgcolor="#cceeff">
<td valign="bottom" width="52%" style="TEXT-ALIGN: left; TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div style="TEXT-ALIGN: left; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">As of June 30, 2014</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">851</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(17</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">463</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(12</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font></td>
</tr><tr bgcolor="white">
<td valign="bottom" width="52%" style="TEXT-ALIGN: left; TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div style="TEXT-ALIGN: left; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">As of June 30, 2013</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">5,122</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(302</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">32</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(9</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font></td>
</tr></table>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">The Company typically invests in highly-rated securities. When evaluating the investments for other-than-temporary impairment, the Company reviews factors such as the length of time and extent to which fair value has been below cost basis, the financial condition of the issuer and any changes thereto, and the Company's intent to sell, or whether it is more likely than not it will be required to sell, the investment before recovery of the investment's amortized cost basis. Based on the above factors, the Company concluded that unrealized losses on all available-for-sale securities were not other-than-temporary and no credit loss was present for any of its investments. As such, the Company did not recognize any impairment charges on outstanding securities during the year ended June 30, 2014.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">As of June 30, 2014 and 2013, interest receivable amounted to $98 and $20 respectively.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div id="PGBRK" style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div id="FTR">
<div id="GLFTR" style="WIDTH: 100%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>

<div id="PN" style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
<div style="TEXT-ALIGN: center; WIDTH: 100%"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">F - 22</font></div>

<div style="TEXT-ALIGN: center; WIDTH: 100%">
<hr style="COLOR: black" noshade size="3">
</div>
</div>

<div id="HDR">
<div id="GLHDR" style="WIDTH: 100%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">
<div style="TEXT-INDENT: 0pt; DISPLAY: block">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: -45pt; MARGIN-RIGHT: 0.15pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">PLURISTEM THERAPEUTICS INC. AND ITS SUBSIDIARY</font></div>

<div>
<table cellpadding="0" cellspacing="0" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr>
<td valign="top" width="87%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr>
<td valign="top" width="87%" style="BORDER-BOTTOM: black 2px solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">NOTES TO CONSOLIDATED FINANCIAL STATEMENTS</font></div>
</div>
</td>
</tr><tr>
<td align="left" valign="top" width="87%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 11.15pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">U.S. Dollars in thousands (except share and per share amounts)</font></div>
</td>
</tr></table>

<br>
<font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">NOTE 4:- FAIR VALUE OF FINANCIAL INSTRUMENTS</font></div>
</div>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div align="right">
<table cellpadding="0" cellspacing="0" width="97%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr>
<td valign="bottom" width="28%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;</font></td>
<td colspan="10" valign="bottom" width="34%" style="BORDER-BOTTOM: black 2px solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">June 30, 2014</font></div>
</td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;</font></td>
<td valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;</font></td>
<td colspan="10" valign="bottom" width="34%" style="BORDER-BOTTOM: black 2px solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">June 30, 2013</font></div>
</td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;</font></td>
</tr><tr>
<td valign="bottom" width="28%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;</font></td>
<td colspan="2" valign="bottom" width="10%" style="BORDER-BOTTOM: black 2px solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Level 1</font></div>
</td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;</font></td>
<td valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;</font></td>
<td colspan="2" valign="bottom" width="10%" style="BORDER-BOTTOM: black 2px solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Level 2</font></div>
</td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;</font></td>
<td valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;</font></td>
<td colspan="2" valign="bottom" width="10%" style="BORDER-BOTTOM: black 2px solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Level 3</font></div>
</td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;</font></td>
<td valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;</font></td>
<td colspan="2" valign="bottom" width="10%" style="BORDER-BOTTOM: black 2px solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Level 1</font></div>
</td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;</font></td>
<td valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;</font></td>
<td colspan="2" valign="bottom" width="10%" style="BORDER-BOTTOM: black 2px solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Level 2</font></div>
</td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;</font></td>
<td valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;</font></td>
<td colspan="2" valign="bottom" width="10%" style="BORDER-BOTTOM: black 2px solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Level 3</font></div>
</td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;</font></td>
</tr><tr bgcolor="#cceeff">
<td valign="bottom" width="28%" style="TEXT-ALIGN: left; TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div style="TEXT-ALIGN: left; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Marketable securities</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">20,530</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">9,431</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">6,311</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">7,130</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
</tr><tr bgcolor="white">
<td valign="bottom" width="28%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px; TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div style="TEXT-ALIGN: left; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Foreign currency derivative instruments</font></div>
</td>
<td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(842</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font></td>
<td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">93</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
</tr><tr bgcolor="#cceeff">
<td valign="bottom" width="28%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 4px; TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div style="TEXT-ALIGN: left; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Total</font></div>
</td>
<td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">20,530</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">8,589</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">6,311</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">7,223</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
</tr></table>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div align="right">
<table cellpadding="0" cellspacing="0" width="97%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr>
<td valign="bottom" width="49%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td colspan="4" valign="bottom" width="26%" style="BORDER-BOTTOM: black 2px solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">June 30, 2014</font></div>
</td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;</font></td>
<td valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;</font></td>
<td colspan="6" valign="bottom" width="22%" style="BORDER-BOTTOM: black 2px solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">June 30, 2013</font></div>
</td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;</font></td>
</tr><tr>
<td valign="bottom" width="49%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" width="15%" style="BORDER-BOTTOM: black 2px solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Balance Sheet location</font></div>
</td>
<td valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;</font></td>
<td colspan="2" valign="bottom" width="10%" style="BORDER-BOTTOM: black 2px solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Fair Value</font></div>
</td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;</font></td>
<td valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;</font></td>
<td colspan="2" valign="bottom" width="10%" style="BORDER-BOTTOM: black 2px solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Balance Sheet location</font></div>
</td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;</font></td>
<td valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;</font></td>
<td colspan="2" valign="bottom" width="10%" style="BORDER-BOTTOM: black 2px solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Fair Value</font></div>
</td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;</font></td>
</tr><tr bgcolor="#cceeff">
<td valign="bottom" width="49%" style="TEXT-ALIGN: left; TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div style="TEXT-ALIGN: left; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Derivatives designated as cash flow hedge instruments</font></div>
</td>
<td valign="bottom" width="15%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 1.6pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Other current assets</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">24</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
</tr><tr bgcolor="white">
<td valign="bottom" width="49%" style="TEXT-ALIGN: left; TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="15%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td colspan="2" valign="bottom" width="10%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
</tr><tr bgcolor="#cceeff">
<td valign="bottom" width="49%" style="TEXT-ALIGN: left; TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div style="TEXT-ALIGN: left; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Derivatives not designated as hedge instruments</font></div>
</td>
<td valign="bottom" width="15%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 1.6pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Other current assets</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">23</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td colspan="2" valign="bottom" width="10%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Other current assets</font></div>
</td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">93</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
</tr><tr bgcolor="white">
<td valign="bottom" width="49%" style="TEXT-ALIGN: left; TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="15%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
</tr><tr bgcolor="#cceeff">
<td valign="bottom" width="49%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px; TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div style="TEXT-ALIGN: left; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Derivatives designated as fair value hedge instruments</font></div>
</td>
<td valign="bottom" width="15%" style="PADDING-BOTTOM: 2px">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 1.6pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Other current liabilities</font></div>
</td>
<td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(889</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font></td>
<td valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right; PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
</tr><tr bgcolor="white">
<td valign="bottom" width="49%" style="TEXT-ALIGN: left; TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="15%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
</tr><tr bgcolor="#cceeff">
<td valign="bottom" width="49%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 4px; TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div style="TEXT-ALIGN: left; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Total</font></div>
</td>
<td valign="bottom" width="15%" style="PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(842</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font></td>
<td valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right; PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">93</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
</tr></table>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-ALIGN: left; TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div style="TEXT-ALIGN: left; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">NOTE 5:-PROPERTY AND EQUIPMENT, NET</font></div>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div align="right">
<table cellpadding="0" cellspacing="0" width="97%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr>
<td valign="bottom" width="76%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;</font></td>
<td colspan="6" valign="bottom" width="22%" style="BORDER-BOTTOM: black 2px solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">June 30,</font></div>
</td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;</font></td>
</tr><tr>
<td align="left" valign="bottom" width="76%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;</font></td>
<td colspan="2" valign="bottom" width="10%" style="BORDER-BOTTOM: black 2px solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">2014</font></div>
</td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;</font></td>
<td valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;</font></td>
<td colspan="2" valign="bottom" width="10%" style="BORDER-BOTTOM: black 2px solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">2013</font></div>
</td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;</font></td>
</tr><tr bgcolor="#cceeff">
<td align="left" valign="bottom" width="76%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Cost:</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td colspan="2" valign="bottom" width="10%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td colspan="2" valign="bottom" width="10%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
</tr><tr bgcolor="white">
<td align="left" valign="bottom" width="76%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Laboratory equipment</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">6,088</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">5,709</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
</tr><tr bgcolor="#cceeff">
<td align="left" valign="bottom" width="76%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Computers and peripheral equipment</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">708</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">535</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
</tr><tr bgcolor="white">
<td align="left" valign="bottom" width="76%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Office furniture and equipment</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">611</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">534</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
</tr><tr bgcolor="#cceeff">
<td align="left" valign="bottom" width="76%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Leasehold improvements</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">7,453</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">7,369</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
</tr><tr bgcolor="white">
<td align="left" valign="bottom" width="76%" style="PADDING-BOTTOM: 2px">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Vehicles</font></div>
</td>
<td valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">95</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">68</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
</tr><tr bgcolor="#cceeff">
<td align="left" valign="bottom" width="76%" style="PADDING-BOTTOM: 2px">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;Total Cost</font></div>
</td>
<td valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">14,955</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">14,215</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
</tr><tr bgcolor="white">
<td align="left" valign="bottom" width="76%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Accumulated depreciation:</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
</tr><tr bgcolor="#cceeff">
<td align="left" valign="bottom" width="76%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Laboratory equipment</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">2,042</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">1,306</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
</tr><tr bgcolor="white">
<td align="left" valign="bottom" width="76%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Computers and peripheral equipment</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">430</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">280</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
</tr><tr bgcolor="#cceeff">
<td align="left" valign="bottom" width="76%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Office furniture and equipment</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">176</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">91</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
</tr><tr bgcolor="white">
<td align="left" valign="bottom" width="76%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Leasehold improvements</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">1,475</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">642</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
</tr><tr bgcolor="#cceeff">
<td align="left" valign="bottom" width="76%" style="PADDING-BOTTOM: 2px">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Vehicles</font></div>
</td>
<td valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">9</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">30</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
</tr><tr bgcolor="white">
<td align="left" valign="bottom" width="76%" style="PADDING-BOTTOM: 2px">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;Total accumulated depreciation</font></div>
</td>
<td valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">4,132</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">2,349</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
</tr><tr bgcolor="#cceeff">
<td align="left" valign="bottom" width="76%" style="PADDING-BOTTOM: 4px">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Property and equipment, net</font></div>
</td>
<td valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">10,823</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">11,866</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
</tr></table>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 45pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Depreciation expenses amounted to $1,902, $1,033 and $435 for the years ended June 30, 2014, 2013 and 2012, respectively.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div id="PGBRK" style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div id="FTR">
<div id="GLFTR" style="WIDTH: 100%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>

<div id="PN" style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
<div style="TEXT-ALIGN: center; WIDTH: 100%"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">F - 23</font></div>

<div style="TEXT-ALIGN: center; WIDTH: 100%">
<hr style="COLOR: black" noshade size="3">
</div>
</div>

<div id="HDR">
<div id="GLHDR" style="WIDTH: 100%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: -45pt; MARGIN-RIGHT: 0.15pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">PLURISTEM THERAPEUTICS INC. AND ITS SUBSIDIARY</font></div>

<div>
<table cellpadding="0" cellspacing="0" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr>
<td valign="top" width="87%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr>
<td valign="top" width="87%" style="BORDER-BOTTOM: black 2px solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">NOTES TO CONSOLIDATED FINANCIAL STATEMENTS</font></div>
</div>
</td>
</tr><tr>
<td align="left" valign="top" width="87%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 11.15pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">U.S. Dollars in thousands (except share and per share amounts)</font></div>
</td>
</tr></table>
</div>
</div>

<div>&#160;</div>

<div>
<div style="TEXT-ALIGN: left; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">NOTE 6:-OTHER ACCOUNTS PAYABLE</font></div>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div align="right">
<table cellpadding="0" cellspacing="0" width="97%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr>
<td valign="bottom" width="76%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;</font></td>
<td colspan="6" valign="bottom" width="22%" style="BORDER-BOTTOM: black 2px solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">June 30,</font></div>
</td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;</font></td>
<td valign="bottom" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr>
<td align="left" valign="bottom" width="76%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;</font></td>
<td colspan="2" valign="bottom" width="10%" style="BORDER-BOTTOM: black 2px solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">2014</font></div>
</td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;</font></td>
<td valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;</font></td>
<td colspan="4" valign="bottom" width="11%" style="BORDER-BOTTOM: black 2px solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">2013</font></div>
</td>
</tr><tr bgcolor="#cceeff">
<td align="left" valign="bottom" width="76%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Accrued payroll</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">424</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">353</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
</tr><tr bgcolor="white">
<td align="left" valign="bottom" width="76%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Payroll institutions</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">302</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">324</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
</tr><tr bgcolor="#cceeff">
<td align="left" valign="bottom" width="76%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Accrued vacation</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">673</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">506</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
</tr><tr bgcolor="white">
<td align="left" valign="bottom" width="76%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Advanced payment from lessor</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">89</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">89</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
</tr><tr bgcolor="#cceeff">
<td align="left" valign="bottom" width="76%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Derivatives designated as a fair value hedge instruments</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">889</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
</tr><tr bgcolor="white">
<td align="left" valign="bottom" width="76%" style="PADDING-BOTTOM: 2px">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Other payables</font></div>
</td>
<td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">14</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
</tr><tr bgcolor="#cceeff">
<td align="left" valign="bottom" width="76%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">2,391</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">1,272</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
</tr></table>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-ALIGN: left; TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div style="TEXT-ALIGN: left; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">NOTE 7:-COMMITMENTS AND CONTINGENCIES</font></div>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div align="center">
<table border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td style="WIDTH: 18pt">
<div style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">a.</font></div>
</td>
<td>
<div align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">The facilities of the Subsidiary are rented under operating lease agreements, which expire on various dates, the latest of which is in 2017. In January 2013 the Subsidiary received from the lessor a non-refundable payment, which payment represents the lessor participation in the leasehold improvements, of approximately $816. The payment is deductible against lease expenses as it is incurred. The lessor upfront payment is included the in balance sheet as advance payment and recognized as a deduction from lease expenses over the lease term.</font></div>

<div align="justify">&#160;</div>

<div align="justify">
<div style="TEXT-ALIGN: justify; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">The Company recognizes rent expense, net of lessor participation, under such arrangements on a straight-line basis over the lease term.</font></div>

<div style="TEXT-ALIGN: justify; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">&#160;</div>

<div style="TEXT-ALIGN: justify; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div style="TEXT-ALIGN: justify; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">As of June&#160;30, 2014 aggregate minimum lease commitments under non-cancelable operating lease agreements are as follows:</font></div>
</div>
</div>
</td>
</tr></table>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-ALIGN: left; TEXT-INDENT: 0pt; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 0pt" align="left">
<table cellpadding="0" cellspacing="0" width="50%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr bgcolor="#cceeff">
<td align="left" valign="bottom" width="88%">
<div style="TEXT-INDENT: -9pt; DISPLAY: block; MARGIN-LEFT: 9pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Year ending June 30,</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td colspan="2" valign="bottom" width="10%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
</tr><tr bgcolor="white">
<td align="left" valign="bottom" width="88%">
<div style="TEXT-INDENT: -9pt; DISPLAY: block; MARGIN-LEFT: 9pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">2015</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">667</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
</tr><tr bgcolor="#cceeff">
<td align="left" valign="bottom" width="88%">
<div style="TEXT-INDENT: -9pt; DISPLAY: block; MARGIN-LEFT: 9pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">2016</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">497</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
</tr><tr bgcolor="white">
<td align="left" valign="bottom" width="88%" style="PADDING-BOTTOM: 2px">
<div style="TEXT-INDENT: -9pt; DISPLAY: block; MARGIN-LEFT: 9pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">2017</font></div>
</td>
<td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">349</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
</tr><tr bgcolor="#cceeff">
<td align="left" valign="bottom" width="88%" style="PADDING-BOTTOM: 4px">
<div style="TEXT-INDENT: -9pt; DISPLAY: block; MARGIN-LEFT: 9pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Total</font></div>
</td>
<td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">1,513</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
</tr></table>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 36pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Lease expenses amounted to $720, $678 and $382 for the years ended June 30, 2014, 2013 and 2012, respectively.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">The Subsidiary has issued a bank guarantee in favor of the lessors for $388.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div id="PGBRK" style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div id="FTR">
<div id="GLFTR" style="WIDTH: 100%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>

<div id="PN" style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
<div style="TEXT-ALIGN: center; WIDTH: 100%"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">F - 24</font></div>

<div style="TEXT-ALIGN: center; WIDTH: 100%">
<hr style="COLOR: black" noshade size="3">
</div>
</div>

<div id="HDR">
<div id="GLHDR" style="WIDTH: 100%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>
</div>

<div>&#160;</div>

<div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: -45pt; MARGIN-RIGHT: 0.15pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">PLURISTEM THERAPEUTICS INC. AND ITS SUBSIDIARY</font></div>

<div>
<table cellpadding="0" cellspacing="0" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr>
<td valign="top" width="87%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr>
<td valign="top" width="87%" style="BORDER-BOTTOM: black 2px solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">NOTES TO CONSOLIDATED FINANCIAL STATEMENTS</font></div>
</div>
</td>
</tr><tr>
<td align="left" valign="top" width="87%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 11.15pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">U.S. Dollars in thousands (except share and per share amounts)</font></div>
</td>
</tr></table>
</div>
</div>
</div>

<div>&#160;</div>

<div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">NOTE 7:-COMMITMENTS AND CONTINGENCIES (CONT.)</font></div>
</div>

<div>&#160;</div>

<div align="center">
<table border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td style="WIDTH: 18pt">
<div style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">b.</font></div>
</td>
<td>
<div align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">The Subsidiary leases several motor vehicles under operating lease agreements, which expire in various dates during years 2014 through April 2017.</font></div>
</td>
</tr></table>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">As of June&#160;30, 2014, future aggregate minimum lease commitments under non-cancelable operating lease agreements are as follows:</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="MARGIN-LEFT: 18pt" align="left">
<table cellpadding="0" cellspacing="0" width="50%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr bgcolor="#cceeff">
<td align="left" valign="bottom" width="88%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Year ending June 30,</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td colspan="2" valign="bottom" width="10%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
</tr><tr bgcolor="white">
<td align="left" valign="bottom" width="88%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">2015</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">140</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
</tr><tr bgcolor="#cceeff">
<td align="left" valign="bottom" width="88%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">2016</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">85</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
</tr><tr bgcolor="white">
<td align="left" valign="bottom" width="88%" style="PADDING-BOTTOM: 2px">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">2017</font></div>
</td>
<td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">26</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
</tr><tr bgcolor="#cceeff">
<td align="left" valign="bottom" width="88%" style="PADDING-BOTTOM: 2px">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Total</font></div>
</td>
<td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">251</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
</tr></table>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Lease expenses amounted to $244, $215 and $176 for the years ended June 30, 2014, 2013 and 2012, respectively.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div align="center">
<table border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td style="WIDTH: 18pt">
<div style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">c.</font></div>
</td>
<td>
<div align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">An amount of $4,805 of cash and deposits was pledged by the Subsidiary to secure the hedging transactions, credit line and Bank guarantees.</font></div>
</td>
</tr></table>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div align="center">
<table border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td style="WIDTH: 18pt">
<div style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">d.</font></div>
</td>
<td>
<div align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Under the Law for the Encouragement of Industrial Research and Development, 1984, (the &#8220;Research Law&#8221;), research and development programs that meet specified criteria and are approved by a governmental committee of the OCS are eligible for grants of up to 50% of the project&#8217;s expenditures, as determined by the research committee, in exchange for the payment of royalties from the sale of products developed under the program. Regulations under the Research Law generally provide for the payment of royalties to the Chief Scientist of 3% to 4% on sales of products and services derived from a technology developed using these grants until 100% of the dollar-linked grant is repaid. The Company&#8217;s obligation to pay these royalties is contingent on its actual sale of such products and services. In the absence of such sales, no payment is required. Outstanding balance of the grants will be subject to interest at a rate equal to the 12 month LIBOR applicable to dollar deposits that is published on the first business day of each calendar year. Following the full repayment of the grant, there is no further liability for royalties.</font></div>
</td>
</tr></table>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Through June 30, 2014, total grants obtained aggregated to approximately $14,125. Through June 30, 2014, total royalties paid and accrued amounted to $53. As of June 30, 2014, the Company's contingent liability in respect to royalties to the OCS amounted $14,072, not include LIBOR interest as described above.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div>
<div style="TEXT-ALIGN: left; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">NOTE 8: - STOCKHOLDERS' EQUITY</font></div>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">The Company's authorized common stock consists of 200,000,000 shares with a par value of $0.00001 per share.&#160;&#160;All shares have equal voting rights and are entitled to one vote per share in all matters to be voted upon by stockholders. The shares have no pre-emptive, subscription, conversion or redemption rights and may be issued only as fully paid and non-assessable shares. Holders of the common stock are entitled to equal ratable rights to dividends and distributions with respect to the common stock, as may be declared by the Board of Directors out of funds legally available.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">The Company's authorized preferred stock consists of 10,000,000 shares of preferred stock, par value $0.00001 per share, with series, rights, preferences, privileges and restrictions as may be designated from time to time by the Company&#8217;s Board of Directors.&#160;&#160;No shares of preferred stock have been issued.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block">
<table border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td style="WIDTH: 18pt">
<div style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">a.</font></font></div>
</div>
</td>
<td>
<div align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">From July 2011 through June 2012, a total of 406,783 warrants were exercised via &#8220;cashless&#8221; exercise, resulting in the issuance of 168,424 shares of common stock to investors of the Company. &#160;In addition 355,411 warrants were exercised for cash and resulted in the issuance of 355,411 shares of common stock to investors of the Company. The aggregate cash consideration received was $556.</font></div>
</td>
</tr></table>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block">&#160;</div>

<div align="center">
<table border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td style="WIDTH: 18pt">
<div style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">b.</font></div>
</td>
<td>
<div align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">From July 2012 through June 2013, a total of 682,213 warrants were exercised via &#8220;cashless&#8221; exercise, resulting in the issuance of 420,199 shares of common stock to investors of the Company. &#160;In addition 1,201,160 warrants were exercised for cash and resulted in the issuance of 1,201,160 shares of common stock to investors of the Company. The aggregate cash consideration received was $2,009. In August, 2012, a total of 36,000 warrants were exercised via a &#8220;cashless&#8221; exercise, resulting in the issuance of 26,299 shares of common stock to consultants of the Company.</font></div>
</td>
</tr></table>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div id="PGBRK" style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div id="FTR">
<div id="GLFTR" style="WIDTH: 100%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>

<div id="PN" style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
<div style="TEXT-ALIGN: center; WIDTH: 100%"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">F - 25</font></div>

<div style="TEXT-ALIGN: center; WIDTH: 100%">
<hr style="COLOR: black" noshade size="3">
</div>
</div>

<div id="HDR">
<div id="GLHDR" style="WIDTH: 100%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
<div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: -45pt; MARGIN-RIGHT: 0.15pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">PLURISTEM THERAPEUTICS INC. AND ITS SUBSIDIARY</font></div>

<div>
<table cellpadding="0" cellspacing="0" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr>
<td valign="top" width="87%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr>
<td valign="top" width="87%" style="BORDER-BOTTOM: black 2px solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">NOTES TO CONSOLIDATED FINANCIAL STATEMENTS</font></div>
</div>
</td>
</tr><tr>
<td align="left" valign="top" width="87%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 11.15pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">U.S. Dollars in thousands (except share and per share amounts)</font></div>
</td>
</tr></table>
</div>
</div>
</div>

<div>&#160;</div>
</div>

<div style="TEXT-ALIGN: left; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">NOTE 8: - STOCKHOLDERS' EQUITY (CONT.)</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div align="center">
<table border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td style="WIDTH: 18pt">
<div style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">c.</font></div>
</td>
<td>
<div align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">From July 2013 through June 2014, a total of 2,517,907 warrants were exercised via &#8220;cashless&#8221; exercise, resulting in the issuance of 1,469,584 shares of common stock to investors of the Company. &#160;In addition, 1,432,584 warrants were exercised for cash and resulted in the issuance of 1,432,584 shares of common stock to investors of the Company. The aggregate cash consideration received was $1,968. From July 2013 through June 2014, a total of 65,000 warrants were exercised via a &#8220;cashless&#8221; exercise, resulting in the issuance of 36,970 shares of common stock to a consultant of the Company.</font></div>
</td>
</tr></table>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div align="center">
<table border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td style="WIDTH: 18pt">
<div style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">d.</font></div>
</td>
<td>
<div align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">As part of the agreement for building the new Company's facility with Biopharmax Group Ltd. ("Biopharmax"), the Company issued 1,500,000 shares of common stock to Biopharmax during fiscal year 2012.</font></div>
</td>
</tr></table>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block">&#160;</div>

<div align="center">
<table border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td style="WIDTH: 18pt">
<div style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">e.</font></div>
</td>
<td>
<div align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">In December 2013, as part of the CHA Agreement, Pluristem and CHA executed the mutual investment pursuant to which Pluristem issued 2,500,000 shares of its common stock in consideration for 1,011,504 shares of CHA, which reflects total consideration to each of Pluristem and CHA of approximately $10,414 (see Note 1d).</font></div>
</td>
</tr></table>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div align="center">
<table border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td style="WIDTH: 18pt">
<div style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">f.</font></div>
</td>
<td>
<div align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">On September 19, 2012, the Company closed a firm commitment underwritten public offering of 8,000,000 units, at a purchase price of $4.00 per unit, with each unit consisting of one share of the Company's common stock and one warrant to purchase 0.35 shares of common stock, at a purchase price of $5.00 per share. The warrants sold in the offering became exercisable on March 19, 2013 and expire on September 19, 2017. The Company has also granted the underwriters a 30-day option to purchase up to 1,200,000 shares of common stock and/or warrants to purchase up to 420,000 shares of common stock. As of September 24, 2012 the underwriters fully exercised their option. The aggregate net proceeds to the Company from the offering, including from the exercise in full of the option, were $34,106, before the exercise of any warrants and after deducting underwriting commissions and discounts and offering expenses of the Company. The warrants can be exercised only for full shares of common stock.&#160;&#160;As to any fraction of a share which the warrant holder would otherwise be entitled to purchase upon such exercise, the Company shall pay a cash adjustment in respect of such fraction in an amount equal to such fraction multiplied by the fair market value less the exercise price.</font></div>
</td>
</tr></table>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div align="center">
<table border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td style="WIDTH: 18pt">
<div style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">g.</font></div>
</td>
<td>
<div align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Following a shelf registration on Form S-3 filed and declared effective in October 2011, the Company entered in December 2012 into an At Market Issuance Sales Agreement (&#8220;ATM Agreement&#8221;) with an underwriter, which provides that, upon the terms and subject to the conditions and limitations set forth in the ATM Agreement, the Company may elect, from time to time, to issue and sell shares of common stock having an aggregate offering price of up to $95,000 through the underwriter as a sales agent. The Company is not obligated to make any sales of common stock under the ATM Agreement.</font></div>
</td>
</tr></table>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">During the year ended June 30, 2014, the Company issued 2,596,032<font style="DISPLAY: inline; FONT-SIZE: 10pt">&#160;</font>shares of common stock for aggregate consideration of approximately $ 10,644, net of issuance costs of $195, under the ATM Agreement.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 0pt" align="justify">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">On September 11, 2014, the Company notified the underwriter of the termination of the ATM Agreement.</font></div>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 437pt"><br>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Options, warrants and restricted stock units to employees, directors and consultants:</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 437pt"><br>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">The Company has approved incentive option plan from 2005 (the &#8220;Plan&#8221;).&#160;&#160;Under the Plan, options, restricted stock and restricted stock units (the &#8220;Awards&#8221;) may be granted to the Company&#8217;s officers, directors, employees and consultants.&#160;&#160;Any Awards that are cancelled or forfeited before expiration become available for future grants.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">As of June 30, 2014, the number of shares of common stock authorized for issuance under the Plan amounted to 13,256,713. As of June 30, 2014, 1,205,080 shares are available for future grant under the Plan.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div id="PGBRK" style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div id="FTR">
<div id="GLFTR" style="WIDTH: 100%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>

<div id="PN" style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
<div style="TEXT-ALIGN: center; WIDTH: 100%"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">F - 26</font></div>

<div style="TEXT-ALIGN: center; WIDTH: 100%">
<hr style="COLOR: black" noshade size="3">
</div>
</div>

<div id="HDR">
<div id="GLHDR" style="WIDTH: 100%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">
<div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: -45pt; MARGIN-RIGHT: 0.15pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">PLURISTEM THERAPEUTICS INC. AND ITS SUBSIDIARY</font></div>

<div>
<table cellpadding="0" cellspacing="0" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr>
<td valign="top" width="87%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr>
<td valign="top" width="87%" style="BORDER-BOTTOM: black 2px solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">NOTES TO CONSOLIDATED FINANCIAL STATEMENTS</font></div>
</div>
</td>
</tr><tr>
<td align="left" valign="top" width="87%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 11.15pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">U.S. Dollars in thousands (except share and per share amounts)</font></div>
</td>
</tr></table>
</div>
</div>
</div>

<div>&#160;</div>
</div>

<div style="TEXT-ALIGN: left; TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div style="TEXT-ALIGN: left; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"><font style="DISPLAY: inline; FONT-SIZE: 10pt">NOTE 8: - STOCKHOLDERS' EQUITY </font>(CONT.)</font></div>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Options, warrants and restricted stock units to employees, directors and consultants:</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div align="center">
<div style="TEXT-ALIGN: left; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<table border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td align="right" style="WIDTH: 18pt">
<div style="TEXT-ALIGN: left; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">a.</font></div>
</td>
<td align="left">
<div style="TEXT-ALIGN: left; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Options to employees and directors:</font></div>
</td>
</tr></table>
</div>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">The Company accounted for its options to employees and directors under the fair value method in accordance with ASC 718. A summary of the Company&#8217;s share option activity for options granted to employees and directors under the Plans is as follows:</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div align="right">
<table cellpadding="0" cellspacing="0" width="97%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr>
<td valign="bottom" width="52%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;</font></td>
<td colspan="14" valign="bottom" width="46%" style="BORDER-BOTTOM: black 2px solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Year ended June 30, 2014</font></div>
</td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;</font></td>
</tr><tr>
<td valign="bottom" width="52%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;</font></td>
<td colspan="2" valign="bottom" width="10%" style="BORDER-BOTTOM: black 2px solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Number</font></div>
</div>
</td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;</font></td>
<td valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;</font></td>
<td colspan="2" valign="bottom" width="10%" style="BORDER-BOTTOM: black 2px solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Weighted Average Exercise Price</font></div>
</div>
</td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;</font></td>
<td valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;</font></td>
<td colspan="2" valign="bottom" width="10%" style="BORDER-BOTTOM: black 2px solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Weighted Average Remaining Contractual Terms (in years)</font></div>
</div>
</td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;</font></td>
<td valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;</font></td>
<td colspan="2" valign="bottom" width="10%" style="BORDER-BOTTOM: black 2px solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Aggregate Intrinsic Value Price</font></div>
</div>
</td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;</font></td>
</tr><tr bgcolor="#cceeff">
<td valign="bottom" width="52%" style="TEXT-ALIGN: left; TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div style="TEXT-ALIGN: left; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Options outstanding at beginning of period</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">1,958,156</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">4.03</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td colspan="2" valign="bottom" width="10%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td colspan="2" valign="bottom" width="10%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
</tr><tr bgcolor="white">
<td valign="bottom" width="52%" style="TEXT-ALIGN: left; TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div style="TEXT-ALIGN: left; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Options exercised</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(15,000</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">0.83</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td colspan="2" valign="bottom" width="10%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td colspan="2" valign="bottom" width="10%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
</tr><tr bgcolor="#cceeff">
<td valign="bottom" width="52%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px; TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div style="TEXT-ALIGN: left; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Options forfeited</font></div>
</td>
<td valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(81,057</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font></td>
<td valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">11.59</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td colspan="2" valign="bottom" width="10%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td colspan="2" valign="bottom" width="10%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
</tr><tr bgcolor="white">
<td valign="bottom" width="52%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 4px; TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div style="TEXT-ALIGN: left; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Options outstanding at end of the period</font></div>
</td>
<td valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">1,862,099</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">3.73</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">3.13</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">1,046</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
</tr><tr bgcolor="#cceeff">
<td valign="bottom" width="52%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 4px; TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div style="TEXT-ALIGN: left; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Options exercisable at the end of the period</font></div>
</td>
<td valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">1,862,099</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">3.73</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">3.13</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">1,046</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
</tr><tr bgcolor="white">
<td valign="bottom" width="52%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 4px; TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div style="TEXT-ALIGN: left; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Options vested</font></div>
</td>
<td valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">1,862,099</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">3.73</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">3.13</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">1,046</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
</tr></table>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Intrinsic value of exercisable options (the difference between the Company&#8217;s closing stock price on the last trading day in the period and the exercise price, multiplied by the number of in-the-money options) represents the amount that would have been received by the employees and directors option holders had all option holders exercised their options on June 30, 2014. This amount changes based on the fair market value of the Company&#8217;s common stock.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div>
<div style="TEXT-ALIGN: left; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<table border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td align="right" style="WIDTH: 18pt">
<div style="TEXT-ALIGN: left; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">b.</font></div>
</td>
<td align="left">
<div style="TEXT-ALIGN: left; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Options and warrants to non-employees:</font></div>
</td>
</tr></table>
</div>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div>
<table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td style="WIDTH: 18pt">
<div><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160; </font></div>
</td>
<td>
<div align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">A summary of the Company&#8217;s activity related to options and warrants to consultants is as follows:</font></div>
</td>
</tr></table>
</div>

<div>&#160;</div>

<div align="right">
<table cellpadding="0" cellspacing="0" width="97%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr>
<td valign="bottom" width="52%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;</font></td>
<td colspan="14" valign="bottom" width="46%" style="BORDER-BOTTOM: black 2px solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Year ended&#160;June 30, 2014</font></div>
</td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;</font></td>
</tr><tr>
<td valign="bottom" width="52%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;</font></td>
<td colspan="2" valign="bottom" width="10%" style="BORDER-BOTTOM: black 2px solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Number</font></div>
</div>
</td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;</font></td>
<td valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;</font></td>
<td colspan="2" valign="bottom" width="10%" style="BORDER-BOTTOM: black 2px solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Weighted Average Exercise Price</font></div>
</div>
</td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;</font></td>
<td valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;</font></td>
<td colspan="2" valign="bottom" width="10%" style="BORDER-BOTTOM: black 2px solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Weighted Average Remaining Contractual Terms (in years)</font></div>
</div>
</td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;</font></td>
<td valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;</font></td>
<td colspan="2" valign="bottom" width="10%" style="BORDER-BOTTOM: black 2px solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Aggregate Intrinsic Value Price</font></div>
</div>
</td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;</font></td>
</tr><tr bgcolor="#cceeff">
<td valign="bottom" width="52%" style="TEXT-ALIGN: left; TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div style="TEXT-ALIGN: left; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Options and warrants outstanding at beginning of period</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">315,500</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">4.44</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td colspan="2" valign="bottom" width="10%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td colspan="2" valign="bottom" width="10%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
</tr><tr bgcolor="white">
<td valign="bottom" width="52%" style="TEXT-ALIGN: left; TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div style="TEXT-ALIGN: left; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Options granted</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">3,000</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">0.00</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td colspan="2" valign="bottom" width="10%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td colspan="2" valign="bottom" width="10%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
</tr><tr bgcolor="#cceeff">
<td valign="bottom" width="52%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px; TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div style="TEXT-ALIGN: left; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Options and warrants exercised</font></div>
</td>
<td valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(66,500</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font></td>
<td valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">1.39</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td colspan="2" valign="bottom" width="10%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td colspan="2" valign="bottom" width="10%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
</tr><tr bgcolor="white">
<td valign="bottom" width="52%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 4px; TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div style="TEXT-ALIGN: left; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Options and warrants outstanding at end of the period</font></div>
</td>
<td valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">252,000</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">5.19</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">3.96</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">331</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
</tr><tr bgcolor="#cceeff">
<td valign="bottom" width="52%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 4px; TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div style="TEXT-ALIGN: left; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Options and warrants exercisable at the end of the period</font></div>
</td>
<td valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">251,000</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">5.21</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">3.93</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">328</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
</tr><tr bgcolor="white">
<td valign="bottom" width="52%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 4px; TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div style="TEXT-ALIGN: left; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Options and warrants vested&#160;&#160;and expected to vest</font></div>
</td>
<td valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">252,000</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">5.19</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">3.96</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">331</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
</tr></table>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div id="PGBRK" style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div id="FTR">
<div id="GLFTR" style="WIDTH: 100%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>

<div id="PN" style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
<div style="TEXT-ALIGN: center; WIDTH: 100%"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">F - 27</font></div>

<div style="TEXT-ALIGN: center; WIDTH: 100%">
<hr style="COLOR: black" noshade size="3">
</div>
</div>

<div id="HDR">
<div id="GLHDR" style="WIDTH: 100%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">
<div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: -45pt; MARGIN-RIGHT: 0.15pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">PLURISTEM THERAPEUTICS INC. AND ITS SUBSIDIARY</font></div>

<div>
<table cellpadding="0" cellspacing="0" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr>
<td valign="top" width="87%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr>
<td valign="top" width="87%" style="BORDER-BOTTOM: black 2px solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">NOTES TO CONSOLIDATED FINANCIAL STATEMENTS</font></div>
</div>
</td>
</tr><tr>
<td align="left" valign="top" width="87%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 11.15pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">U.S. Dollars in thousands (except share and per share amounts)</font></div>
</td>
</tr></table>
</div>
</div>
</div>

<div><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;</font></div>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"><font style="DISPLAY: inline; FONT-SIZE: 10pt">NOTE 8: - STOCKHOLDERS' EQUITY </font>(CONT.)</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Options, warrants and restricted stock units to employees, directors and consultants:</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div>
<table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td style="WIDTH: 18pt">
<div><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160; </font></div>
</td>
<td width="1837">
<div align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Compensation expenses related to options and warrants granted to consultants were recorded as follows:</font></div>
</td>
</tr></table>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="MARGIN-LEFT: 36pt" align="left">
<table cellpadding="0" cellspacing="0" width="80%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr>
<td valign="bottom" width="64%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;</font></td>
<td colspan="10" valign="bottom" width="34%" style="BORDER-BOTTOM: black 2px solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Year ended&#160;June 30,</font></div>
</td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;</font></td>
</tr><tr>
<td valign="bottom" width="64%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;</font></td>
<td colspan="2" valign="bottom" width="10%" style="BORDER-BOTTOM: black 2px solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">2014</font></div>
</td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;</font></td>
<td valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;</font></td>
<td colspan="2" valign="bottom" width="10%" style="BORDER-BOTTOM: black 2px solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">2013</font></div>
</td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;</font></td>
<td valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;</font></td>
<td colspan="2" valign="bottom" width="10%" style="BORDER-BOTTOM: black 2px solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">2012</font></div>
</td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;</font></td>
</tr><tr bgcolor="white">
<td valign="bottom" width="64%" style="TEXT-ALIGN: left; TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
</tr><tr bgcolor="#cceeff">
<td valign="bottom" width="64%" style="TEXT-ALIGN: left; TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div style="TEXT-ALIGN: left; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Research and development expenses</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">11</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">26</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">19</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
</tr><tr bgcolor="white">
<td valign="bottom" width="64%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px; TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div style="TEXT-ALIGN: left; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">General and administrative expenses</font></div>
</td>
<td valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font id="TAB1" style="MARGIN-LEFT: 9.3pt"></font>37</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
</tr><tr bgcolor="#cceeff">
<td valign="bottom" width="64%" style="PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">11</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">26</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">56</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
</tr></table>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Future expenses related to options and warrants granted to consultants for an average time of approximately 3 months are <font style="DISPLAY: inline; FONT-SIZE: 10pt">$</font>1.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div>
<div style="TEXT-ALIGN: left; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<table border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td align="right" style="WIDTH: 18pt">
<div style="TEXT-ALIGN: left; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">c.</font></div>
</td>
<td align="left">
<div style="TEXT-ALIGN: left; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Restricted stock units to employees and directors:</font></div>
</td>
</tr></table>
</div>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">The following table summarizes the activities for unvested restricted stock units granted to employees and directors for the year ended June 30, 2014:</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div align="center">
<table cellpadding="0" cellspacing="0" width="60%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr>
<td valign="bottom" width="88%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;</font></td>
<td colspan="2" valign="bottom" width="10%" style="BORDER-BOTTOM: black 2px solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Number</font></div>
</div>
</td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;</font></td>
</tr><tr bgcolor="white">
<td valign="bottom" width="88%" style="TEXT-ALIGN: left; TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
</tr><tr bgcolor="#cceeff">
<td valign="bottom" width="88%" style="TEXT-ALIGN: left; TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div style="TEXT-ALIGN: left; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Unvested at the beginning of period</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">1,660,525</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
</tr><tr bgcolor="white">
<td valign="bottom" width="88%" style="TEXT-ALIGN: left; TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div style="TEXT-ALIGN: left; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Granted</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">1,256,940</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
</tr><tr bgcolor="#cceeff">
<td valign="bottom" width="88%" style="TEXT-ALIGN: left; TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div style="TEXT-ALIGN: left; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Forfeited</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(44,183</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font></td>
</tr><tr bgcolor="white">
<td valign="bottom" width="88%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px; TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div style="TEXT-ALIGN: left; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Vested</font></div>
</td>
<td valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(1,283,850</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font></td>
</tr><tr bgcolor="#cceeff">
<td valign="bottom" width="88%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 4px; TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div style="TEXT-ALIGN: left; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Unvested at the end of the period</font></div>
</td>
<td valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">1,589,432</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
</tr><tr bgcolor="white">
<td valign="bottom" width="88%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 4px; TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div style="TEXT-ALIGN: left; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Expected to vest after June 30, 2014</font></div>
</td>
<td valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">1,522,024</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
</tr></table>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Compensation expenses related to restricted stock units granted to employees and directors were recorded as follows:</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="MARGIN-LEFT: 36pt" align="left">
<table cellpadding="0" cellspacing="0" width="80%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr>
<td valign="bottom" width="64%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;</font></td>
<td colspan="10" valign="bottom" width="34%" style="BORDER-BOTTOM: black 2px solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Year ended&#160;June 30,</font></div>
</td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;</font></td>
<td valign="bottom" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr>
<td valign="bottom" width="64%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;</font></td>
<td colspan="2" valign="bottom" width="10%" style="BORDER-BOTTOM: black 2px solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">2014</font></div>
</td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;</font></td>
<td valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;</font></td>
<td colspan="2" valign="bottom" width="10%" style="BORDER-BOTTOM: black 2px solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">2013</font></div>
</td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;</font></td>
<td valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;</font></td>
<td colspan="4" valign="bottom" width="11%" style="BORDER-BOTTOM: black 2px solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">2012</font></div>
</td>
</tr><tr bgcolor="#cceeff">
<td valign="bottom" width="64%" style="TEXT-ALIGN: left; TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div style="TEXT-ALIGN: left; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Research and development expenses</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">1,172</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">711</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">1,163</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
</tr><tr bgcolor="white">
<td valign="bottom" width="64%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px; TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div style="TEXT-ALIGN: left; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">General and administrative expenses</font></div>
</td>
<td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">4,390</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">1,529</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">3,487</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
</tr><tr bgcolor="#cceeff">
<td valign="bottom" width="64%" style="PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">5,562</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">2,240</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">4,650</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
</tr></table>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 36pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Future expenses related to restricted stock units granted to employees and directors for an average time of approximately two years is $2,447.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div id="PGBRK" style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div id="FTR">
<div id="GLFTR" style="WIDTH: 100%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>

<div id="PN" style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
<div style="TEXT-ALIGN: center; WIDTH: 100%"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">F - 28</font></div>

<div style="TEXT-ALIGN: center; WIDTH: 100%">
<hr style="COLOR: black" noshade size="3">
</div>
</div>

<div id="HDR">
<div id="GLHDR" style="WIDTH: 100%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: -45pt; MARGIN-RIGHT: 0.15pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">PLURISTEM THERAPEUTICS INC. AND ITS SUBSIDIARY</font></div>

<div>
<table cellpadding="0" cellspacing="0" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr>
<td valign="top" width="87%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr>
<td valign="top" width="87%" style="BORDER-BOTTOM: black 2px solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">NOTES TO CONSOLIDATED FINANCIAL STATEMENTS</font></div>
</div>
</td>
</tr><tr>
<td align="left" valign="top" width="87%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 11.15pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">U.S. Dollars in thousands (except share and per share amounts)</font></div>
</td>
</tr></table>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-ALIGN: left; TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div style="TEXT-ALIGN: left; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"><font style="DISPLAY: inline; FONT-SIZE: 10pt">NOTE 8: - STOCKHOLDERS' EQUITY </font>(CONT.)</font></div>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-ALIGN: left; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Options, warrants and restricted stock units to employees, directors and consultants (cont.):</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-ALIGN: left; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<table border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td align="right" style="WIDTH: 18pt">
<div style="TEXT-ALIGN: left; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">d.</font></div>
</td>
<td align="left">
<div style="TEXT-ALIGN: left; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Restricted stock units to consultants:</font></div>
</td>
</tr></table>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">The following table summarizes the activities for unvested restricted stock units and restricted stock granted to consultants for the year ended June 30, 2014:</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="MARGIN-LEFT: 18pt" align="left">
<table cellpadding="0" cellspacing="0" width="50%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr>
<td valign="bottom" width="84%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;</font></td>
<td colspan="2" valign="bottom" width="14%" style="BORDER-BOTTOM: black 2px solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Number</font></div>
</div>
</td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;</font></td>
</tr><tr bgcolor="#cceeff">
<td valign="bottom" width="84%" style="TEXT-ALIGN: left; TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div style="TEXT-ALIGN: left; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Unvested at the beginning of period</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="13%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
</tr><tr bgcolor="white">
<td valign="bottom" width="84%" style="TEXT-ALIGN: left; TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div style="TEXT-ALIGN: left; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Granted</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="13%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">84,565</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
</tr><tr bgcolor="#cceeff">
<td valign="bottom" width="84%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px; TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div style="TEXT-ALIGN: left; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Vested</font></div>
</td>
<td valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="13%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(69,315</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font></td>
</tr><tr bgcolor="white">
<td valign="bottom" width="84%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 4px; TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div style="TEXT-ALIGN: left; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Unvested at the end of the period</font></div>
</td>
<td valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="13%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">15,250</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
</tr></table>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block">&#160;</div>

<div style="TEXT-ALIGN: left; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Compensation expenses related to restricted stock units granted to consultants were recorded as follows:</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="MARGIN-LEFT: 18pt" align="left">
<table cellpadding="0" cellspacing="0" width="80%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr>
<td valign="bottom" width="64%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;</font></td>
<td colspan="10" valign="bottom" width="34%" style="BORDER-BOTTOM: black 2px solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Year ended&#160;June 30,</font></div>
</td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;</font></td>
</tr><tr>
<td valign="bottom" width="64%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;</font></td>
<td colspan="2" valign="bottom" width="10%" style="BORDER-BOTTOM: black 2px solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">2014</font></div>
</td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;</font></td>
<td valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;</font></td>
<td colspan="2" valign="bottom" width="10%" style="BORDER-BOTTOM: black 2px solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">2013</font></div>
</td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;</font></td>
<td valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;</font></td>
<td colspan="2" valign="bottom" width="10%" style="BORDER-BOTTOM: black 2px solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">2012</font></div>
</td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;</font></td>
</tr><tr bgcolor="#cceeff">
<td valign="bottom" width="64%" style="TEXT-ALIGN: left; TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div style="TEXT-ALIGN: left; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Research and development expenses</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">201</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">255</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">201</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
</tr><tr bgcolor="white">
<td valign="bottom" width="64%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px; TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div style="TEXT-ALIGN: left; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">General and administrative expenses</font></div>
</td>
<td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">77</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">278</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">20</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
</tr><tr bgcolor="#cceeff">
<td valign="bottom" width="64%" style="PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">278</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">533</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">221</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
</tr></table>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div id="PGBRK" style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div id="FTR">
<div id="GLFTR" style="WIDTH: 100%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>

<div id="PN" style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
<div style="TEXT-ALIGN: center; WIDTH: 100%"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">F - 29</font></div>

<div style="TEXT-ALIGN: center; WIDTH: 100%">
<hr style="COLOR: black" noshade size="3">
</div>
</div>

<div id="HDR">
<div id="GLHDR" style="WIDTH: 100%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;</font><br>
&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: -45pt; MARGIN-RIGHT: 0.15pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">PLURISTEM THERAPEUTICS INC. AND ITS SUBSIDIARY</font></div>

<div>
<table cellpadding="0" cellspacing="0" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr>
<td valign="top" width="87%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr>
<td valign="top" width="87%" style="BORDER-BOTTOM: black 2px solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">NOTES TO CONSOLIDATED FINANCIAL STATEMENTS</font></div>
</div>
</td>
</tr><tr>
<td align="left" valign="top" width="87%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 11.15pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">U.S. Dollars in thousands (except share and per share amounts)</font></div>
</td>
</tr></table>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"><font style="DISPLAY: inline; FONT-SIZE: 10pt">NOTE 8: - STOCKHOLDERS' EQUITY </font>(CONT.)</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 18pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 22.5pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Summary of warrants and options:</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">The following table sets forth a summary of all the warrants and options outstanding as of June 30, 2014:</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 0pt" align="left">&#160;</div>
</div>

<div align="left">
<table cellpadding="0" cellspacing="0" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr>
<td valign="bottom" style="BORDER-BOTTOM: black 2px solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div style="TEXT-INDENT: 0pt; DISPLAY: block">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Warrants / Options</font></div>
</div>
</td>
<td valign="bottom" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td colspan="2" valign="bottom" style="BORDER-BOTTOM: black 2px solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline; FONT-WEIGHT: bold">Exercise Price</font> <font style="DISPLAY: inline; FONT-WEIGHT: bold">per Share</font></font></div>
</div>
</td>
<td nowrap valign="bottom" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;</font></td>
<td colspan="2" valign="bottom" style="BORDER-BOTTOM: black 2px solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Options and Warrants for Common Stock</font></div>
</div>
</td>
<td nowrap valign="bottom" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;</font></td>
<td valign="bottom" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td colspan="2" valign="bottom" style="BORDER-BOTTOM: black 2px solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline; FONT-WEIGHT: bold">Options and Warrants</font> <font style="DISPLAY: inline; FONT-WEIGHT: bold">Exercisable</font></font></div>
</div>
</td>
<td nowrap valign="bottom" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td colspan="2" valign="bottom" style="BORDER-BOTTOM: black 2px solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline; FONT-WEIGHT: bold">Weighted Average Remaining Contractual Terms</font><font style="DISPLAY: inline; FONT-WEIGHT: bold">(in years)</font></font></div>
</div>
</td>
<td nowrap valign="bottom" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
</tr><tr bgcolor="#cceeff">
<td valign="bottom" width="52%" style="TEXT-ALIGN: left; TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div style="TEXT-ALIGN: left; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Warrants:</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">1.40</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">474,322</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">474,322</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">0.82</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
</tr><tr bgcolor="white">
<td valign="bottom" width="52%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">1.50</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">878,174</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">878,174</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">0.06</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
</tr><tr bgcolor="#cceeff">
<td valign="bottom" width="52%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">1.60</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">131,221</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">131,221</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">0.78</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
</tr><tr bgcolor="white">
<td valign="bottom" width="52%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">1.80</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">727,401</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">727,401</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">0.30</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
</tr><tr bgcolor="#cceeff">
<td valign="bottom" width="52%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">1.90</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">43,103</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">43,103</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">0.08</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
</tr><tr bgcolor="white">
<td valign="bottom" width="52%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">4.20</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">5,060,000</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">5,060,000</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">2.09</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
</tr><tr bgcolor="#cceeff">
<td valign="bottom" width="52%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">5.00</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">3,219,983</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">3,219,983</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">3.22</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
</tr><tr bgcolor="white">
<td valign="bottom" width="52%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px; TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div style="TEXT-ALIGN: left; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Total warrants</font></div>
</td>
<td valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">10,534,204</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;</font></td>
<td valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">10,534,204</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;</font></td>
<td valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
</tr><tr bgcolor="#cceeff">
<td valign="bottom" width="52%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
</tr><tr bgcolor="white">
<td valign="bottom" width="52%" style="TEXT-ALIGN: left; TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div style="TEXT-ALIGN: left; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Options:</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">0.00</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">101,000</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">100,000</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">5.19</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
</tr><tr bgcolor="#cceeff">
<td valign="bottom" width="52%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">0.62</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">398,500</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">398,500</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">4.25</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
</tr><tr bgcolor="white">
<td valign="bottom" width="52%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">1.04</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">30,000</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">30,000</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">4.16</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
</tr><tr bgcolor="#cceeff">
<td valign="bottom" width="52%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">2.97</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">20,000</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">20,000</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">3.86</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
</tr><tr bgcolor="white">
<td valign="bottom" width="52%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">3.50</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">900,000</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">900,000</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">2.58</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
</tr><tr bgcolor="#cceeff">
<td valign="bottom" width="52%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">3.72</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">15,000</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">15,000</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">2.49</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
</tr><tr bgcolor="white">
<td valign="bottom" width="52%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">3.80</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">16,050</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">16,050</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">2.53</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
</tr><tr bgcolor="#cceeff">
<td valign="bottom" width="52%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">4.00</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">42,500</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">42,500</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">2.30</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
</tr><tr bgcolor="white">
<td valign="bottom" width="52%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">4.38 - $ 4.40</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">417,299</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">417,299</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">3.28</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
</tr><tr bgcolor="#cceeff">
<td valign="bottom" width="52%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">6.80</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">36,250</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">36,250</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">3.37</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
</tr><tr bgcolor="white">
<td valign="bottom" width="52%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">8.20</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">30,000</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">30,000</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">2.40</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
</tr><tr bgcolor="#cceeff">
<td valign="bottom" width="52%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">20.00</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">107,500</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">107,500</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">2.88</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
</tr><tr bgcolor="white">
<td valign="bottom" width="52%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 4px; TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div style="TEXT-ALIGN: left; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Total options</font></div>
</td>
<td valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">2,114,099</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;</font></td>
<td valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">2,113,099</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;</font></td>
<td valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
</tr><tr bgcolor="#cceeff">
<td valign="bottom" width="52%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px; TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div style="TEXT-ALIGN: left; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Total warrants and options</font></font></div>
</td>
<td valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;12,648,303</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;</font></td>
<td valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;12,647,303</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;</font></td>
<td valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
</tr></table>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">This summary does not include 1,604,682 restricted stock units that are not vested as of June 30, 2014.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div id="PGBRK" style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div id="FTR">
<div id="GLFTR" style="WIDTH: 100%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>

<div id="PN" style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
<div style="TEXT-ALIGN: center; WIDTH: 100%"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">F - 30</font></div>

<div style="TEXT-ALIGN: center; WIDTH: 100%">
<hr style="COLOR: black" noshade size="3">
</div>
</div>

<div id="HDR">
<div id="GLHDR" style="WIDTH: 100%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: -45pt; MARGIN-RIGHT: 0.15pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">PLURISTEM THERAPEUTICS INC. AND ITS SUBSIDIARY</font></div>

<div>
<table cellpadding="0" cellspacing="0" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr>
<td valign="top" width="87%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr>
<td valign="top" width="87%" style="BORDER-BOTTOM: black 2px solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">NOTES TO CONSOLIDATED FINANCIAL STATEMENTS</font></div>
</div>
</td>
</tr><tr>
<td align="left" valign="top" width="87%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 11.15pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">U.S. Dollars in thousands (except share and per share amounts)</font></div>
</td>
</tr></table>
</div>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div>
<div style="TEXT-ALIGN: left; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">NOTE 9:-FINANCIAL INCOME, NET</font></div>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div align="left">
<table cellpadding="0" cellspacing="0" width="80%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr>
<td valign="bottom" width="64%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;</font></td>
<td colspan="10" valign="bottom" width="34%" style="BORDER-BOTTOM: black 2px solid">
<div style="TEXT-INDENT: -9pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Year ended June 30,</font></div>
</td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;</font></td>
</tr><tr>
<td valign="bottom" width="64%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;</font></td>
<td colspan="2" valign="bottom" width="10%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: center; TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div style="TEXT-ALIGN: center; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">2014</font></div>
</td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;</font></td>
<td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;</font></td>
<td colspan="2" valign="bottom" width="10%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: center; TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div style="TEXT-ALIGN: center; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">2013</font></div>
</td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;</font></td>
<td valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;</font></td>
<td colspan="2" valign="bottom" width="10%" style="BORDER-BOTTOM: black 2px solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 7.45pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">2012</font></div>
</td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;</font></td>
</tr><tr>
<td valign="bottom" width="64%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td colspan="2" valign="bottom" width="10%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td colspan="2" valign="bottom" width="10%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td colspan="2" valign="bottom" width="10%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
</tr><tr bgcolor="#cceeff">
<td valign="bottom" width="64%" style="TEXT-ALIGN: left; TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div style="TEXT-ALIGN: left; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Foreign currency translation differences, net</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">407</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">497</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(98</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font></td>
</tr><tr bgcolor="white">
<td align="left" valign="bottom" width="64%">
<div style="TEXT-INDENT: -9pt; DISPLAY: block; MARGIN-LEFT: 9pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Bank commissions</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(36</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(29</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(12</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font></td>
</tr><tr bgcolor="#cceeff">
<td align="left" valign="bottom" width="64%">
<div style="TEXT-INDENT: -9pt; DISPLAY: block; MARGIN-LEFT: 9pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Interest income on deposits</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">246</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">539</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">575</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
</tr><tr bgcolor="white">
<td align="left" valign="bottom" width="64%">
<div style="TEXT-INDENT: -9pt; DISPLAY: block; MARGIN-LEFT: 9pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Gain (Loss) related to marketable securities</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">384</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(79</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">89</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
</tr><tr bgcolor="#cceeff">
<td align="left" valign="bottom" width="64%" style="PADDING-BOTTOM: 2px">
<div style="TEXT-INDENT: -9pt; DISPLAY: block; MARGIN-LEFT: 9pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Gain (loss) from&#160;&#160;derivatives</font></div>
</td>
<td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(83</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font></td>
<td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">140</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(317</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font></td>
</tr><tr bgcolor="white">
<td valign="bottom" width="64%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
</tr><tr bgcolor="#cceeff">
<td valign="bottom" width="64%" style="PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">918</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">1,068</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">237</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
</tr></table>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div>
<div style="TEXT-ALIGN: left; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">NOTE 10:-TAXES ON INCOME</font></div>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div>
<table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td style="WIDTH: 27pt">
<div style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">A.</font></div>
</td>
<td>
<div align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Tax laws applicable to the companies:</font></div>
</td>
</tr></table>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div>
<table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td style="WIDTH: 27pt">
<div><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160; </font></div>
</td>
<td style="WIDTH: 18pt">
<div style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline; FONT-SIZE: 10pt">1.</font></font></div>
</td>
<td>
<div align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Pluristem Therapeutics Inc. is taxed under U.S. tax laws.</font></div>
</td>
</tr></table>
</div>

<div>
<table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td style="WIDTH: 27pt">
<div><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160; </font></div>
</td>
<td style="WIDTH: 18pt">
<div style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline; FONT-SIZE: 10pt">2.</font></font></div>
</td>
<td>
<div align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Pluristem Ltd. is taxed under Israeli tax laws.</font></div>
</td>
</tr></table>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div>
<table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td style="WIDTH: 27pt">
<div style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">B.</font></div>
</td>
<td>
<div align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Tax assessments:</font></div>
</td>
</tr></table>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 27pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">The Subsidiary has not received final tax assessments since its incorporation; however, the assessments of the Subsidiary are deemed final through 2009.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 27pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div>
<table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td style="WIDTH: 27pt">
<div style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">C.</font></div>
</td>
<td>
<div align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Tax rates applicable to the Company:-</font></div>
</td>
</tr></table>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div>
<table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td style="WIDTH: 28.349pt">
<div><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160; </font></div>
</td>
<td style="WIDTH: 18pt">
<div style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">1.</font></div>
</td>
<td>
<div align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Pluristem Therapeutics Inc.:</font></div>
</td>
</tr></table>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 45pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">The tax rates applicable to Pluristem Therapeutics Inc., a Nevada corporation, are corporate (progressive) tax at the rate of up to 35%, excluding state tax and local tax if any, which rates depend on the state and city in which Pluristem Therapeutics Inc. conducts its business.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 45pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div>
<table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td style="WIDTH: 28.349pt">
<div><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160; </font></div>
</td>
<td style="WIDTH: 18pt">
<div style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">2.</font></div>
</td>
<td>
<div align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">The Subsidiary:</font></div>
</td>
</tr></table>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 45pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 45pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Taxable income of Israeli companies is subject to tax at the rate of 25% in 2012, 2013 and 26.5% in 2014.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div id="PGBRK" style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div id="FTR">
<div id="GLFTR" style="WIDTH: 100%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>

<div id="PN" style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
<div style="TEXT-ALIGN: center; WIDTH: 100%"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">F - 31</font></div>

<div style="TEXT-ALIGN: center; WIDTH: 100%">
<hr style="COLOR: black" noshade size="3">
</div>
</div>

<div id="HDR">
<div id="GLHDR" style="WIDTH: 100%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block">
<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: -45pt; MARGIN-RIGHT: 0.15pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">PLURISTEM THERAPEUTICS INC. AND ITS SUBSIDIARY</font></div>

<div>
<table cellpadding="0" cellspacing="0" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr>
<td valign="top" width="87%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr>
<td valign="top" width="87%" style="BORDER-BOTTOM: black 2px solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">NOTES TO CONSOLIDATED FINANCIAL STATEMENTS</font></div>
</div>
</td>
</tr><tr>
<td align="left" valign="top" width="87%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 11.15pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">U.S. Dollars in thousands (except share and per share amounts)</font></div>
</td>
</tr></table>
</div>
</div>
</div>

<div>&#160;</div>

<div style="TEXT-ALIGN: left; TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div style="TEXT-ALIGN: left; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">NOTE 10:-TAXES ON INCOME (CONT.)</font></div>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div>
<table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td style="WIDTH: 27pt">
<div style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">C.</font></div>
</td>
<td>
<div align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Tax rates applicable to the Company: (cont:)</font></div>
</td>
</tr></table>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 27pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Tax Benefits Under the Law for Encouragement of Capital Investments.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 437pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 27pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">According to the Law for Encouragement of Capital Investments, 1959 (the "Encouragement Law"), the Subsidiary is entitled to various tax benefits due to "Beneficiary Enterprise" status granted to its enterprise, as implied by the Encouragement Law. The principal benefits by virtue of the Encouragement Law are:</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 27pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 27pt; MARGIN-RIGHT: 0pt" align="justify"><font style="FONT-STYLE: italic; DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Tax benefits and reduced tax rates:</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 437pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 27pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">On July 7, 2010, the Subsidiary has received a letter of approval (the "Ruling") from the Israeli Tax Authority. According to the Ruling, the Subsidiary's expansion program of its plant was granted the status of a "Beneficiary Enterprise" under the "Alternative Track" (the "2007 Program"). The Subsidiary chose the year 2007 as the election year of the 2007 Program.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 437pt"><br>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 27pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Under the 2007 Program "Alternative Track", the Subsidiary, which was located in a National Priority Zone "B" with respect to the year 2007, is tax exempt in the first six years of the benefit period and subject to tax at the reduced rate of 10%-25% for a period of one to four years for the remaining benefit period (dependent on the level of foreign investments).</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 437pt"><br>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 27pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">On June 6, 2013, the Subsidiary informed the Israeli Tax Authority that it has chosen the year 2012 as an election year to the expansion of its Beneficiary Enterprise program (the "2012 Program").</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 437pt"><br>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 27pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Under the 2012 Program, the Subsidiary, which was located in the "Other National Priority Zone" with respect to the year 2012, would be tax exempt in the first two years of the benefit period and subject to tax at the reduced rate of 10%-25% for a period of five to eight years for the remaining benefit period (dependent on the level of foreign investments).</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 437pt"><br>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 27pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Following the enactment of Amendment No. 60 to the Encouragement<font style="DISPLAY: inline; FONT-WEIGHT: bold">&#160;</font>Law, subsequent to April 1, 2005, companies whose election year entitled them to a Beneficiary Enterprise status are required, among others, to make a minimum qualifying investment. This condition requires an investment in the acquisition of productive assets such as machinery and equipment, which must be carried out within three years. The minimum qualifying investment required for setting up a plant is NIS&#160;300,000, linked to the Israeli CPI in accordance with the guidelines of the Israeli tax authorities. As for plant expansion, the minimum qualifying investment is the higher of NIS&#160;300,000, linked to the Israeli CPI as stated above, and an amount equivalent to the "qualifying percentage" of the value of the productive assets. Productive assets that are used by the plant but not owned by it will also be viewed as productive assets.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 27pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">The qualifying percentage of the value of the productive assets is as follows:</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="MARGIN-LEFT: 27pt" align="center">
<table cellpadding="0" cellspacing="0" width="60%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr>
<td valign="bottom" width="49%" style="BORDER-BOTTOM: black 2px solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">The value of productive</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">assets before the expansion</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">(NIS in millions)</font></div>
</td>
<td valign="top" width="2%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="top" width="49%" style="BORDER-BOTTOM: black 2px solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">The new proportion </font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">that the required</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;investment bears </font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">to the value of </font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">productive assets</font></div>
</td>
</tr><tr>
<td valign="top" width="49%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="top" width="2%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="top" width="49%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr bgcolor="#cceeff">
<td valign="top" width="49%" style="TEXT-ALIGN: left; TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div style="TEXT-ALIGN: left; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Up to NIS&#160;140</font></div>
</td>
<td valign="top" width="2%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="top" width="49%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">12%</font></div>
</td>
</tr><tr bgcolor="white">
<td valign="top" width="49%" style="TEXT-ALIGN: left; TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div style="TEXT-ALIGN: left; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">NIS&#160;140 - NIS&#160;500</font></div>
</td>
<td valign="top" width="2%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="top" width="49%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">7%</font></div>
</td>
</tr><tr bgcolor="#cceeff">
<td valign="top" width="49%" style="TEXT-ALIGN: left; TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div style="TEXT-ALIGN: left; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">More than NIS&#160;500</font></div>
</td>
<td valign="top" width="2%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="top" width="49%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">5%</font></div>
</td>
</tr></table>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div id="PGBRK" style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div id="FTR">
<div id="GLFTR" style="WIDTH: 100%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>

<div id="PN" style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
<div style="TEXT-ALIGN: center; WIDTH: 100%"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">F - 32</font></div>

<div style="TEXT-ALIGN: center; WIDTH: 100%">
<hr style="COLOR: black" noshade size="3">
</div>
</div>

<div id="HDR">
<div id="GLHDR" style="WIDTH: 100%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: -45pt; MARGIN-RIGHT: 0.15pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">PLURISTEM THERAPEUTICS INC. AND ITS SUBSIDIARY</font></div>

<div>
<table cellpadding="0" cellspacing="0" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr>
<td valign="top" width="87%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr>
<td valign="top" width="87%" style="BORDER-BOTTOM: black 2px solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">NOTES TO CONSOLIDATED FINANCIAL STATEMENTS</font></div>
</div>
</td>
</tr><tr>
<td align="left" valign="top" width="87%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 11.15pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">U.S. Dollars in thousands (except share and per share amounts)</font></div>
</td>
</tr></table>
</div>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div>
<div style="TEXT-ALIGN: left; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">NOTE 10:-TAXES ON INCOME (CONT.)</font></div>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div>
<table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td style="WIDTH: 27pt">
<div style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">C.</font></div>
</td>
<td>
<div align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Tax rates applicable to the Company: (cont:)</font></div>
</td>
</tr></table>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 45pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 27pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">The income qualifying for tax benefits under the alternative track is the taxable income of a &#8220;beneficiary company&#8221; that has met certain conditions as determined by the Encouragement<font style="DISPLAY: inline; FONT-WEIGHT: bold">&#160;</font>Law, and which is derived from an industrial enterprise. The Encouragement<font style="DISPLAY: inline; FONT-WEIGHT: bold">&#160;</font>Law specifies the types of qualifying income that is entitled to tax benefits under the alternative track both in respect of an industrial enterprise and of a hotel, whereby income from an industrial enterprise includes, among others, revenues from the production and development of software products and revenues from industrial research and development activities performed for a foreign resident (and approved by the Head of the Administration of Industrial Research and Development).</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 437pt"><br>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 27pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">As stated above, the Subsidiary's 2007 Program and 2012 Program were granted the status of a "Beneficiary Enterprise", in accordance with the Encouragement<font style="DISPLAY: inline; FONT-WEIGHT: bold">&#160;</font>Law, under the alternative benefits track. Accordingly, income derived from the Beneficiary Enterprise is subject to the benefits and conditions stated above.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 437pt"><br>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 27pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">In respect of expansion programs pursuant to Amendment No. 60 to the Encouragement<font style="DISPLAY: inline; FONT-WEIGHT: bold">&#160;</font>Law, the benefit period starts at the later of the election year and the first year the Company earns taxable income provided that 12 years have not passed since the beginning of the election year and for companies in development area A - 14 years since the beginning of the election year. The benefit period for the Subsidiary's 2007 Program will expire in 2018 (12 years since the beginning of the election year&#8211; 2007).The benefit period for the Subsidiary's 2012 Program would expire in 2023 (12 years since the beginning of the election year &#8211; 2012).</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 437pt"><br>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 27pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">If a dividend is distributed out of tax exempt profits, as above, the Subsidiary will become liable for tax at the rate applicable to its profits from the Beneficiary Enterprise in the year in which the income was earned, (tax at the rate of 10- 25%, dependent on the level of foreign investments) and to A withholding tax rate of 15% (or lower, under an applicable tax treaty).</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 437pt"><br>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 27pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">As for Beneficiary Enterprises pursuant to Amendment No. 60 to the Encouragement<font style="DISPLAY: inline; FONT-WEIGHT: bold">&#160;</font>Law, the basic condition for receiving the benefits under this track is that the enterprise contributes to Israeli economic growth and is a competitive factor for the gross domestic product. In order to comply with this condition, the Encouragement<font style="DISPLAY: inline; FONT-WEIGHT: bold">&#160;</font>Law prescribes various requirements regarding industrial enterprises.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 437pt"><br>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 27pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">As for industrial enterprises, in each tax year during the benefit period, one of the following conditions must be met:</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div align="center">
<table border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
</table>
</div>

<div>
<table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td style="WIDTH: 27pt">
<div><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160; </font></div>
</td>
<td style="WIDTH: 18pt">
<div style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">1.</font></div>
</td>
<td>
<div align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">The industrial enterprise's main field of activity is biotechnology or nanotechnology as approved by the Head of the Administration of Industrial Research and Development, prior to the approval of the relevant program.</font></div>
</td>
</tr></table>
</div>

<div>
<table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td style="WIDTH: 27pt">
<div><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160; </font></div>
</td>
<td style="WIDTH: 18pt">
<div style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">2.</font></div>
</td>
<td>
<div align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">The industrial enterprise's sales revenues in a specific market during the tax year do not exceed 75% of its total sales for that tax year. A "market" is defined as a separate country or customs territory.</font></div>
</td>
</tr></table>
</div>

<div>
<table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td style="WIDTH: 27pt">
<div><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160; </font></div>
</td>
<td style="WIDTH: 18pt">
<div style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">3.</font></div>
</td>
<td>
<div align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">At least 25% of the industrial enterprise's overall revenues during the tax year were generated from the enterprise's sales in a specific market with a population of at least 12 million.</font></div>
</td>
</tr></table>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 27pt; MARGIN-RIGHT: 0pt" align="justify"><font style="FONT-STYLE: italic; DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Accelerated depreciation:</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 437pt"><br>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 27pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">The Subsidiary is eligible for deduction of accelerated depreciation on buildings, machinery and equipment used by the beneficiary enterprise at a rate of 200% (or 400% for buildings) from the first year of the asset's operation.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div id="PGBRK" style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div id="FTR">
<div id="GLFTR" style="WIDTH: 100%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>

<div id="PN" style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
<div style="TEXT-ALIGN: center; WIDTH: 100%"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">F - 33</font></div>

<div style="TEXT-ALIGN: center; WIDTH: 100%">
<hr style="COLOR: black" noshade size="3">
</div>
</div>

<div id="HDR">
<div id="GLHDR" style="WIDTH: 100%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: -45pt; MARGIN-RIGHT: 0.15pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">PLURISTEM THERAPEUTICS INC. AND ITS SUBSIDIARY</font></div>

<div>
<table cellpadding="0" cellspacing="0" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr>
<td valign="top" width="87%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr>
<td valign="top" width="87%" style="BORDER-BOTTOM: black 2px solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">NOTES TO CONSOLIDATED FINANCIAL STATEMENTS</font></div>
</div>
</td>
</tr><tr>
<td align="left" valign="top" width="87%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 11.15pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">U.S. Dollars in thousands (except share and per share amounts)</font></div>
</td>
</tr></table>
</div>
</div>

<div>&#160;</div>

<div style="TEXT-ALIGN: left; TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div style="TEXT-ALIGN: left; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">NOTE 10:-TAXES ON INCOME (CONT.)</font></div>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div>
<table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td style="WIDTH: 27pt">
<div style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">C.</font></div>
</td>
<td>
<div align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Tax rates applicable to the Company: (cont:)</font></div>
</td>
</tr></table>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 27pt; MARGIN-RIGHT: 0pt" align="justify"><font style="FONT-STYLE: italic; DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Conditions for the entitlement to the benefits:</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 437pt"><br>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 27pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">The abovementioned benefits are conditional upon the fulfillment of the conditions stipulated by the Encouragement<font style="DISPLAY: inline; FONT-WEIGHT: bold">&#160;</font>Law, regulations promulgated thereunder, and the Ruling with respect to the beneficiary enterprise. Non-compliance with the conditions may cancel all or part of the benefits and refund of the amount of the benefits, including interest. The management believes that the Subsidiary is meeting the aforementioned conditions.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 437pt"><br>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 27pt; MARGIN-RIGHT: 0pt" align="justify"><font style="FONT-STYLE: italic; DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Amendment to the&#160;&#160;Encouragement Law:</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 437pt"><br>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 27pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Effective January 2011, the Knesset (Israeli parliament) enacted a reform to the Encouragement Law. According to the reform a flat rate tax would apply to companies eligible for the &#8220;Preferred Enterprise&#8221; status. In order to be eligible for a Preferred Enterprise status, a company must meet minimum requirements to establish that it contributes to the country&#8217;s economic growth and is a competitive factor for the Gross Domestic Product (a competitive enterprise).</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 437pt"><br>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 27pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Israeli companies which currently benefit from an Approved or Privileged Enterprise status and meet the criteria for qualification as a Preferred Enterprise can elect to apply the new Preferred Enterprise benefits by waiving their benefits under the Approved and Privileged Enterprise status.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 437pt"><br>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 27pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Benefits granted to a Preferred Enterprise include reduced tax rates. Following the enactment of the National Priorities Law, effective January 1, 2014, the reduced tax rate is 9% in the Development Area A regions and 16% in other regions. Preferred Enterprises in peripheral regions are also eligible for Investment Center grants, as well as the applicable reduced tax rates.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 437pt"><br>
</div>

<div style="TEXT-ALIGN: justify; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 27pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">A distribution from a Preferred Enterprise out of the &#8220;Preferred Income&#8221; through December 31, 2013, was </font><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">subject to 15% withholding tax for Israeli-resident individuals and non-Israeli residents (subject to applicable treaty rates) and effective January 1, 2014, subject to 20% withholding tax for Israeli-resident individuals and non-Israeli residents (subject to applicable treaty rates).</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 437pt"><br>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 27pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">A distribution from a Preferred Enterprise out of the &#8220;Preferred Income&#8221; would be exempt from withholding tax for an Israeli-resident company.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 437pt"><br>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 27pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">The Subsidiary did not apply the Amendment. The Subsidiary may choose to apply the Amendment in the future<font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">.</font></font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div id="PGBRK" style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div id="FTR">
<div id="GLFTR" style="WIDTH: 100%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>

<div id="PN" style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
<div style="TEXT-ALIGN: center; WIDTH: 100%"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">F - 34</font></div>

<div style="TEXT-ALIGN: center; WIDTH: 100%">
<hr style="COLOR: black" noshade size="3">
</div>
</div>

<div id="HDR">
<div id="GLHDR" style="WIDTH: 100%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: -45pt; MARGIN-RIGHT: 0.15pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">PLURISTEM THERAPEUTICS INC. AND ITS SUBSIDIARY</font></div>

<div>
<table cellpadding="0" cellspacing="0" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr>
<td valign="top" width="87%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr>
<td valign="top" width="87%" style="BORDER-BOTTOM: black 2px solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">NOTES TO CONSOLIDATED FINANCIAL STATEMENTS</font></div>
</div>
</td>
</tr><tr>
<td align="left" valign="top" width="87%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 11.15pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">U.S. Dollars in thousands (except share and per share amounts)</font></div>
</td>
</tr></table>

<br>
</div>
</div>

<div style="TEXT-ALIGN: left; TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div style="TEXT-ALIGN: left; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">NOTE 10:-TAXES ON INCOME (CONT.)</font></div>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div align="justify">
<table border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td align="right" style="WIDTH: 27pt">
<div align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">D.&#160;</font></div>
</td>
<td align="left">
<div align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Carryforward losses for tax purposes</font></div>
</td>
</tr></table>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 27pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">As of June&#160;30, 2014, the Company had U.S. federal net operating loss carryforward for income tax purposes in the amount of approximately $22,730. Net operating loss carryforward arising in taxable years<font style="DISPLAY: inline; FONT-SIZE: 10pt">,</font> can be carried forward and offset against taxable income for 20 years and expiring between 2022 and 2034.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 437pt"><br>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 27pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Utilization of U.S. net operating losses may be subject to substantial annual limitations due to the "change in ownership" provisions of the Internal Revenue Code of 1986 and similar state provisions. The annual limitation may result in the expiration of net operating losses before utilization.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 437pt"><br>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 27pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">The Subsidiary in Israel has accumulated losses for tax purposes as of June&#160;30, 2014, in the amount of approximately $48,340, which may be carried forward and offset against taxable business income and business capital gain in the future for an indefinite period.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 437pt"><br>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 27pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Deferred income taxes:</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 437pt"><br>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 27pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Deferred income taxes reflect the net tax effects of temporary differences between the carrying amounts of assets and liabilities for financial reporting purposes and the amounts used for income tax purposes. Significant components of the Company's deferred tax assets are as follows:</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div align="right">
<table cellpadding="0" cellspacing="0" width="95%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr>
<td valign="bottom" width="76%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;</font></td>
<td colspan="6" valign="bottom" width="22%" style="BORDER-BOTTOM: black 2px solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">June 30,</font></div>
</td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;</font></td>
</tr><tr>
<td valign="bottom" width="76%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;</font></td>
<td colspan="2" valign="bottom" width="10%" style="BORDER-BOTTOM: black 2px solid">
<div style="TEXT-INDENT: -18pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">2014</font></div>
</td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;</font></td>
<td valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;</font></td>
<td colspan="2" valign="bottom" width="10%" style="BORDER-BOTTOM: black 2px solid">
<div style="TEXT-INDENT: -18pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">2013</font></div>
</td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;</font></td>
</tr><tr bgcolor="#cceeff">
<td align="left" valign="bottom" width="76%">
<div style="TEXT-INDENT: -9pt; DISPLAY: block; MARGIN-LEFT: 9pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Deferred tax assets:</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td colspan="2" valign="bottom" width="10%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td colspan="2" valign="bottom" width="10%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
</tr><tr bgcolor="white">
<td align="left" valign="bottom" width="76%">
<div style="TEXT-INDENT: -9pt; DISPLAY: block; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">U.S. net operating loss carryforward</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">7,955</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">7,106</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
</tr><tr bgcolor="#cceeff">
<td valign="bottom" width="76%">
<div style="TEXT-INDENT: -9pt; DISPLAY: block; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Israeli net operating loss carryforward</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">12,810</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">8,543</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
</tr><tr bgcolor="white">
<td valign="bottom" width="76%" style="PADDING-BOTTOM: 2px">
<div style="TEXT-INDENT: -9pt; DISPLAY: block; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Allowances and reserves</font></div>
</td>
<td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">237</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">156</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
</tr><tr bgcolor="#cceeff">
<td valign="bottom" width="76%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
</tr><tr bgcolor="white">
<td valign="bottom" width="76%">
<div style="TEXT-INDENT: -9pt; DISPLAY: block; MARGIN-LEFT: 9pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Total deferred tax assets before valuation allowance</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">21,002</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">15,805</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
</tr><tr bgcolor="#cceeff">
<td valign="bottom" width="76%" style="PADDING-BOTTOM: 2px">
<div style="TEXT-INDENT: -9pt; DISPLAY: block; MARGIN-LEFT: 9pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Valuation allowance</font></div>
</td>
<td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(21,002</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font></td>
<td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(15,805</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font></td>
</tr><tr bgcolor="white">
<td valign="bottom" width="76%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
</tr><tr bgcolor="#cceeff">
<td valign="bottom" width="76%" style="PADDING-BOTTOM: 4px">
<div style="TEXT-INDENT: -9pt; DISPLAY: block; MARGIN-LEFT: 9pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Net deferred tax asset</font></div>
</td>
<td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
</tr></table>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 446pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 27pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">As of June&#160;30, 2014 and 2013, the Company has provided full valuation allowances in respect of deferred tax assets resulting from tax loss carryforward and other temporary differences, since they have a history of operating losses and current uncertainty concerning its ability to realize these deferred tax assets in the future.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 437pt"><br>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 27pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">The Company accounts for its income tax uncertainties in accordance with ASC&#160;740 which clarifies the accounting for uncertainties in income taxes recognized in a Company&#8217;s financial statements and prescribes a recognition threshold and measurement attribute for the financial statement recognition and measurement of a tax position taken or expected to be taken in a tax return.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 437pt"><br>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 27pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">As of June&#160;30, 2014 and 2013, there were no unrecognized tax benefits that if recognized would affect the annual effective tax rate.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div id="PGBRK" style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div id="FTR">
<div id="GLFTR" style="WIDTH: 100%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>

<div id="PN" style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
<div style="TEXT-ALIGN: center; WIDTH: 100%"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">F - 35</font></div>

<div style="TEXT-ALIGN: center; WIDTH: 100%">
<hr style="COLOR: black" noshade size="3">
</div>
</div>

<div id="HDR">
<div id="GLHDR" style="WIDTH: 100%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: -45pt; MARGIN-RIGHT: 0.15pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">PLURISTEM THERAPEUTICS INC. AND ITS SUBSIDIARY</font></div>

<div>
<table cellpadding="0" cellspacing="0" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr>
<td valign="top" width="87%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr>
<td valign="top" width="87%" style="BORDER-BOTTOM: black 2px solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">NOTES TO CONSOLIDATED FINANCIAL STATEMENTS</font></div>
</div>
</td>
</tr><tr>
<td align="left" valign="top" width="87%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 11.15pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">U.S. Dollars in thousands (except share and per share amounts)</font></div>
</td>
</tr></table>
</div>

<div>&#160;</div>
</div>

<div style="TEXT-ALIGN: left; TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div style="TEXT-ALIGN: left; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">NOTE 11:-TAXES ON INCOME (CONT.)</font></div>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: -9pt" align="justify">
<table border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td align="right" style="WIDTH: 18pt">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: -9pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">D.&#160;</font></div>
</td>
<td align="left">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: -9pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Carryforward losses for tax purposes: (cont. :)</font></div>
</td>
</tr></table>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div>
<div style="TEXT-ALIGN: left; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Reconciliation of the theoretical tax expense (benefit) to the actual tax expense (benefit):</font></div>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 45pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;</font></div>

<div style="TEXT-ALIGN: justify; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">In 2012, 2013 and 2014, the main reconciling item of the statutory tax rate of the Company (25% to 35% in 2012, 2013 and 2014) to the effective tax rate (0%) is tax loss carryforwards, stock-based compensation and other deferred tax assets for which a full valuation allowance was provided.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div id="PGBRK" style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div id="FTR">
<div id="GLFTR" style="WIDTH: 100%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>

<div id="PN" style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
<div style="TEXT-ALIGN: center; WIDTH: 100%"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">F - 36</font></div>

<div style="TEXT-ALIGN: center; WIDTH: 100%">
<hr style="COLOR: black" noshade size="3">
</div>
</div>

<div id="HDR">
<div id="GLHDR" style="WIDTH: 100%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Quarterly Information (unaudited)</font></div>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 36pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">The following unaudited quarterly financial information includes, in management's opinion, all the normal and recurring adjustments necessary to fairly state the results of operations and related information for the periods presented (in thousands of dollars except share and per share data).</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div align="left">
<table cellpadding="0" cellspacing="0" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr>
<td valign="bottom" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;</font></td>
<td colspan="2" valign="bottom" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: center">
<div style="TEXT-ALIGN: center; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">September 30,</font></div>

<div style="TEXT-ALIGN: center; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">2013</font></div>
</td>
<td nowrap valign="bottom" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;</font></td>
<td align="left" valign="bottom" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;</font></td>
<td colspan="2" valign="bottom" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: center">
<div style="TEXT-ALIGN: center; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">December 31,</font></div>

<div style="TEXT-ALIGN: center; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">2013</font></div>
</td>
<td nowrap valign="bottom" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;</font></td>
<td align="left" valign="bottom" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;</font></td>
<td colspan="2" valign="bottom" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: center">
<div style="TEXT-ALIGN: center; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">March 31,</font></div>

<div style="TEXT-ALIGN: center; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">2014</font></div>
</td>
<td nowrap valign="bottom" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;</font></td>
<td align="left" valign="bottom" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;</font></td>
<td colspan="2" valign="bottom" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: center">
<div style="TEXT-ALIGN: center; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">June 30,</font></div>

<div style="TEXT-ALIGN: center; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">2014</font></div>
</td>
<td nowrap valign="bottom" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;</font></td>
</tr><tr bgcolor="#cceeff">
<td valign="bottom" width="52%" style="TEXT-ALIGN: left; TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div style="TEXT-ALIGN: left; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Revenues</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">95</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">95</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">95</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">94</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
</tr><tr bgcolor="white">
<td valign="bottom" width="52%" style="TEXT-ALIGN: left; TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div style="TEXT-ALIGN: left; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Gross profit</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">92</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">92</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">92</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">92</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
</tr><tr bgcolor="#cceeff">
<td valign="bottom" width="52%" style="TEXT-ALIGN: left; TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div style="TEXT-ALIGN: left; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Operating expenses</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">4,952</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">7,082</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">9,379</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">6,805</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
</tr><tr bgcolor="white">
<td valign="bottom" width="52%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px; TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div style="TEXT-ALIGN: left; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Operating loss</font></div>
</td>
<td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">4,860</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">6,990</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">9,287</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">6,713</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
</tr><tr bgcolor="#cceeff">
<td valign="bottom" width="52%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 4px; TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div style="TEXT-ALIGN: left; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Net loss</font></div>
</td>
<td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">4,755</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">6,705</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">9,276</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">6,196</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
</tr><tr bgcolor="white">
<td valign="bottom" width="52%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 4px; TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div style="TEXT-ALIGN: left; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Basic and diluted net loss per share</font></div>
</td>
<td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">0.08</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">0.11</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">0.14</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">0.09</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
</tr></table>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block">&#160;</div>

<div align="left">
<table cellpadding="0" cellspacing="0" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr>
<td valign="bottom" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;</font></td>
<td colspan="2" valign="bottom" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: center">
<div style="TEXT-ALIGN: center; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">September 30,</font></div>

<div style="TEXT-ALIGN: center; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">2012</font></div>
</td>
<td nowrap valign="bottom" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;</font></td>
<td align="left" valign="bottom" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;</font></td>
<td colspan="2" valign="bottom" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: center">
<div style="TEXT-ALIGN: center; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">December 31,</font></div>

<div style="TEXT-ALIGN: center; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">2012</font></div>
</td>
<td nowrap valign="bottom" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;</font></td>
<td align="left" valign="bottom" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;</font></td>
<td colspan="2" valign="bottom" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: center">
<div style="TEXT-ALIGN: center; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">March 31,</font></div>

<div style="TEXT-ALIGN: center; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">2013</font></div>
</td>
<td nowrap valign="bottom" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;</font></td>
<td align="left" valign="bottom" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;</font></td>
<td colspan="2" valign="bottom" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: center">
<div style="TEXT-ALIGN: center; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">June 30,</font></div>

<div style="TEXT-ALIGN: center; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">2013</font></div>
</td>
<td nowrap valign="bottom" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;</font></td>
</tr><tr bgcolor="#cceeff">
<td valign="bottom" width="52%" style="TEXT-ALIGN: left; TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div style="TEXT-ALIGN: left; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Revenues</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">195</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">195</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">194</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">95</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
</tr><tr bgcolor="white">
<td valign="bottom" width="52%" style="TEXT-ALIGN: left; TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div style="TEXT-ALIGN: left; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Gross profit</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">189</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">189</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">188</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">93</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
</tr><tr bgcolor="#cceeff">
<td valign="bottom" width="52%" style="TEXT-ALIGN: left; TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div style="TEXT-ALIGN: left; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Operating expenses</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">4,379</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">5,073</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">6,121</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">7,309</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
</tr><tr bgcolor="white">
<td valign="bottom" width="52%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px; TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div style="TEXT-ALIGN: left; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Operating loss</font></div>
</td>
<td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">4,190</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">4,884</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">5,933</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">7,216</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
</tr><tr bgcolor="#cceeff">
<td valign="bottom" width="52%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 4px; TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div style="TEXT-ALIGN: left; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Net loss</font></div>
</td>
<td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">3,995</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">4,490</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">5,680</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">6,990</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
</tr><tr bgcolor="white">
<td valign="bottom" width="52%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 4px; TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div style="TEXT-ALIGN: left; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Basic and diluted net loss per share</font></div>
</td>
<td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">0.08</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">0.08</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">0.10</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">0.12</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
</tr></table>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"><a name="9">Item 9.&#160;&#160;&#160;&#160;Changes in and Disagreements with Accountants on Accounting and Financial Disclosure.</a></font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">None.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"><a name="9a">Item 9A.&#160;Controls and Procedures.</a></font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="FONT-STYLE: italic; DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Evaluation of Disclosure Controls and Procedures</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 36pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">We conducted an evaluation under the supervision of our CEO and Chief Financial Officer (CFO) (our principal executive officer and principal financial officer, respectively), regarding the effectiveness of our disclosure controls and procedures (as defined in Rules 13a-15(e) and 15d-15(e) under the Exchange Act) as of June 30, 2014. Based on the aforementioned evaluation, management has concluded that our disclosure controls and procedures were effective as of June 30, 2014.</font></div>

<div id="PGBRK" style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div id="FTR">
<div id="GLFTR" style="WIDTH: 100%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>

<div id="PN" style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
<div style="TEXT-ALIGN: center; WIDTH: 100%"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">35</font></div>

<div style="TEXT-ALIGN: center; WIDTH: 100%">
<hr style="COLOR: black" noshade size="2">
</div>
</div>

<div id="HDR">
<div id="GLHDR" style="WIDTH: 100%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="FONT-STYLE: italic; DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Management's Report on Internal Control over Financial Reporting</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 36pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Our management is responsible for establishing and maintaining adequate internal control over financial reporting. Our internal control over financial reporting has been designed to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles generally accepted in the United States of America.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 36pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Our internal control over financial reporting includes policies and procedures that pertain to the maintenance of records that, in reasonable detail, accurately and fairly reflect transactions and dispositions of our assets; provide reasonable assurance that transactions are recorded as necessary to permit preparation of financial statements in accordance with accounting principles generally accepted in the United States of America, and that receipts and expenditures are being made only in accordance with authorization of our management and directors; and provide reasonable assurance regarding prevention or timely detection of unauthorized acquisition, use or disposition of our assets that could have a material effect on our financial statements.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 36pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Because of its inherent limitations, internal control over financial reporting may not prevent or detect misstatements. Therefore, even those systems determined to be effective can provide only reasonable assurance with respect to financial statement preparation and presentation. Projections of any evaluation of effectiveness to future periods are subject to the risk that controls may become inadequate because of changes in conditions, or that the degree of compliance with the policies or procedures may deteriorate.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 36pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Management assessed the effectiveness of our internal control over financial reporting on June 30, 2014. In making this assessment, management used the criteria set forth by the Committee of Sponsoring Organizations of the Treadway Commission 1992 framework (COSO) in <font style="FONT-STYLE: italic; DISPLAY: inline">Internal Control&#8212;Integrated Framework</font>. Based on that assessment under those criteria, management has determined that, as of June 30, 2014, our internal control over financial reporting was effective.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 36pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Kost Forer Gabbay &amp; Kasierer, a member of Ernst &amp; Young Global, an independent registered public accounting firm, who audited our consolidated financial statements included elsewhere in this Annual Report, has also issued an attestation report on our internal control over financial reporting, which is included elsewhere in this Annual Report.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="FONT-STYLE: italic; DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Changes in Internal Control Over Financial Reporting</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 36pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">There have been no changes in our internal control over financial reporting (as such term is defined in Rules&#160;13a-15(f) and 15d-15(f) under the Exchange Act) during the fourth quarter of fiscal year 2014 that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"><a name="9b">Item 9B.&#160;Other Information.</a></font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">None.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left">&#160;</div>

<div id="PGBRK" style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div id="FTR">
<div id="GLFTR" style="WIDTH: 100%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>

<div id="PN" style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
<div style="TEXT-ALIGN: center; WIDTH: 100%"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">36</font></div>

<div style="TEXT-ALIGN: center; WIDTH: 100%">
<hr style="COLOR: black" noshade size="2">
</div>
</div>

<div id="HDR">
<div id="GLHDR" style="WIDTH: 100%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"><a name="p3">PART III</a></font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"><a name="10">Item 10.&#160;&#160;Directors, Executive Officers and Corporate Governance.</a></font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">As of June 30, 2014, our directors and executive officers, their ages, positions held, and duration of such, are as follows:</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div align="left">
<table cellpadding="2" cellspacing="0" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr>
<td align="left" valign="bottom" width="19%" style="BORDER-BOTTOM: black 2px solid; BORDER-LEFT: black 2px solid; BORDER-TOP: black 2px solid; BORDER-RIGHT: black 2px solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Name</font></div>
</td>
<td align="left" valign="bottom" width="50%" style="BORDER-BOTTOM: black 2px solid; BORDER-TOP: black 2px solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Position Held With Company</font></div>
</td>
<td align="left" valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid; BORDER-LEFT: black 2px solid; BORDER-TOP: black 2px solid; BORDER-RIGHT: black 2px solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Age</font></div>
</td>
<td align="left" valign="bottom" width="22%" style="BORDER-BOTTOM: black 2px solid; BORDER-TOP: black 2px solid; BORDER-RIGHT: black 2px solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Date First Elected or Appointed</font></div>
</td>
</tr><tr bgcolor="#cceeff">
<td align="left" valign="top" width="19%" style="BORDER-BOTTOM: black 2px solid; BORDER-LEFT: black 2px solid; BORDER-RIGHT: black 2px solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Zami Aberman</font></div>
</td>
<td align="left" valign="bottom" width="50%" style="BORDER-BOTTOM: black 2px solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">President (until February 2014)</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">CEO, Director</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">and Chairman of the Board of Directors</font></div>
</td>
<td valign="top" width="9%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left; BORDER-LEFT: black 2px solid; TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; BORDER-RIGHT: black 2px solid"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">60</font></td>
<td align="left" valign="bottom" width="22%" style="BORDER-BOTTOM: black 2px solid; BORDER-RIGHT: black 2px solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">September 26, 2005</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">November 21, 2005</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">April 3, 2006</font></div>
</td>
</tr><tr bgcolor="white">
<td align="left" valign="top" width="19%" style="BORDER-BOTTOM: black 2px solid; BORDER-LEFT: black 2px solid; BORDER-RIGHT: black 2px solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Yaky Yanay</font></div>
</td>
<td align="left" valign="bottom" width="50%" style="BORDER-BOTTOM: black 2px solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">CFO, Secretary</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">and Executive Vice President (until February 2014)</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">President and COO</font></div>
</td>
<td valign="top" width="9%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left; BORDER-LEFT: black 2px solid; TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; BORDER-RIGHT: black 2px solid"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">43</font></td>
<td align="left" valign="bottom" width="22%" style="BORDER-BOTTOM: black 2px solid; BORDER-RIGHT: black 2px solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">November 1, 2006</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">March 17, 2013</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">February 4, 2014</font></div>
</td>
</tr><tr bgcolor="#cceeff">
<td align="left" valign="bottom" width="19%" style="BORDER-BOTTOM: black 2px solid; BORDER-LEFT: black 2px solid; BORDER-RIGHT: black 2px solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Boaz Gur-Lavie</font></div>
</td>
<td align="left" valign="bottom" width="50%" style="BORDER-BOTTOM: black 2px solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">CFO, Secretary</font></div>
</td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left; BORDER-LEFT: black 2px solid; TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; BORDER-RIGHT: black 2px solid"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">41</font></td>
<td align="left" valign="bottom" width="22%" style="BORDER-BOTTOM: black 2px solid; BORDER-RIGHT: black 2px solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">February 4, 2014</font></div>
</td>
</tr><tr bgcolor="white">
<td align="left" valign="bottom" width="19%" style="BORDER-BOTTOM: black 2px solid; BORDER-LEFT: black 2px solid; BORDER-RIGHT: black 2px solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Nachum Rosman</font></div>
</td>
<td align="left" valign="bottom" width="50%" style="BORDER-BOTTOM: black 2px solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Director</font></div>
</td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left; BORDER-LEFT: black 2px solid; TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; BORDER-RIGHT: black 2px solid"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">68</font></td>
<td align="left" valign="bottom" width="22%" style="BORDER-BOTTOM: black 2px solid; BORDER-RIGHT: black 2px solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">October 9, 2007</font></div>
</td>
</tr><tr bgcolor="#cceeff">
<td align="left" valign="bottom" width="19%" style="BORDER-BOTTOM: black 2px solid; BORDER-LEFT: black 2px solid; BORDER-RIGHT: black 2px solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Doron Shorrer</font></div>
</td>
<td align="left" valign="bottom" width="50%" style="BORDER-BOTTOM: black 2px solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Director</font></div>
</td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left; BORDER-LEFT: black 2px solid; TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; BORDER-RIGHT: black 2px solid"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">61</font></td>
<td align="left" valign="bottom" width="22%" style="BORDER-BOTTOM: black 2px solid; BORDER-RIGHT: black 2px solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">October 2, 2003</font></div>
</td>
</tr><tr bgcolor="white">
<td align="left" valign="bottom" width="19%" style="BORDER-BOTTOM: black 2px solid; BORDER-LEFT: black 2px solid; BORDER-RIGHT: black 2px solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Hava Meretzki</font></div>
</td>
<td align="left" valign="bottom" width="50%" style="BORDER-BOTTOM: black 2px solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Director</font></div>
</td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left; BORDER-LEFT: black 2px solid; TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; BORDER-RIGHT: black 2px solid"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">45</font></td>
<td align="left" valign="bottom" width="22%" style="BORDER-BOTTOM: black 2px solid; BORDER-RIGHT: black 2px solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">October 2, 2003</font></div>
</td>
</tr><tr bgcolor="#cceeff">
<td align="left" valign="bottom" width="19%" style="BORDER-BOTTOM: black 2px solid; BORDER-LEFT: black 2px solid; BORDER-RIGHT: black 2px solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Isaac Braun</font></div>
</td>
<td align="left" valign="bottom" width="50%" style="BORDER-BOTTOM: black 2px solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Director</font></div>
</td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left; BORDER-LEFT: black 2px solid; TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; BORDER-RIGHT: black 2px solid"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">61</font></td>
<td align="left" valign="bottom" width="22%" style="BORDER-BOTTOM: black 2px solid; BORDER-RIGHT: black 2px solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">July 6, 2005</font></div>
</td>
</tr><tr bgcolor="white">
<td align="left" valign="bottom" width="19%" style="BORDER-BOTTOM: black 2px solid; BORDER-LEFT: black 2px solid; BORDER-RIGHT: black 2px solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Israel Ben-Yoram</font></div>
</td>
<td align="left" valign="bottom" width="50%" style="BORDER-BOTTOM: black 2px solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Director</font></div>
</td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left; BORDER-LEFT: black 2px solid; TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; BORDER-RIGHT: black 2px solid"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">53</font></td>
<td align="left" valign="bottom" width="22%" style="BORDER-BOTTOM: black 2px solid; BORDER-RIGHT: black 2px solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">January 26, 2005</font></div>
</td>
</tr><tr bgcolor="#cceeff">
<td align="left" valign="bottom" width="19%" style="BORDER-BOTTOM: black 2px solid; BORDER-LEFT: black 2px solid; BORDER-RIGHT: black 2px solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Mark Germain</font></div>
</td>
<td align="left" valign="bottom" width="50%" style="BORDER-BOTTOM: black 2px solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Director</font></div>
</td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left; BORDER-LEFT: black 2px solid; TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; BORDER-RIGHT: black 2px solid"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">64</font></td>
<td align="left" valign="bottom" width="22%" style="BORDER-BOTTOM: black 2px solid; BORDER-RIGHT: black 2px solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">May 17, 2007</font></div>
</td>
</tr><tr bgcolor="white">
<td align="left" valign="bottom" width="19%" style="BORDER-BOTTOM: black 2px solid; BORDER-LEFT: black 2px solid; BORDER-RIGHT: black 2px solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Moria Kwiat</font></div>
</td>
<td align="left" valign="bottom" width="50%" style="BORDER-BOTTOM: black 2px solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Director</font></div>
</td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left; BORDER-LEFT: black 2px solid; TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; BORDER-RIGHT: black 2px solid"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">35</font></td>
<td align="left" valign="bottom" width="22%" style="BORDER-BOTTOM: black 2px solid; BORDER-RIGHT: black 2px solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">May 15, 2012</font></div>
</td>
</tr></table>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="FONT-STYLE: italic; DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Business Experience</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 36pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">The following is a brief account of the education and business experience of each director and executive officer during at least the past five years, indicating each person's principal occupation during the period, and the name and principal business of the organization by which they were employed.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Zami Aberman</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 36pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"><font id="TAB1" style="MARGIN-LEFT: 0.55pt"></font>Mr. Aberman joined the Company in September 2005 and has served since then as CEO and until February 2014 as President of the Company.&#160;&#160;He changed the Company&#8217;s strategy towards cellular therapeutics. Mr. Aberman&#8217;s vision to use the maternal section of the Placenta (Decidua) as a source for cell therapy, combined with the Company&#8217;s 3D culturing technology, led to the development of our products. Since November 2005, Mr. Aberman has served as a director of the Company, and since April 2006, as Chairman of the Board. He has 25 years of experience in marketing and management in the high technology industry. Mr. Aberman has held positions of CEO and Chairman positions in companies in Israel, the United States, Europe, Japan and Korea.&#160;&#160;Mr. Aberman operated within high-tech global companies in the fields of automatic optical inspection, network security, video over IP, software, chip design and robotics. He serves as the Chairman of Rose Hitech Ltd., a private investment company. He served in the past as the Chairman of VLScom Ltd., a private company specializing in video compression for HDTV and video over IP and as a director of Ori Software Ltd., a company involved in data management.&#160;&#160;Prior to that, Mr. Aberman served as the President and CEO of Elbit Vision System Ltd. (EVSNF.OB), a company engaged in automatic optical inspection.&#160;&#160;Prior to his service with the Company, Mr. Aberman served as President and CEO of Netect Ltd., specializing in the field of internet security software and was the Co-Founder, President and CEO of Associative Computing Ltd., which developed an associative parallel processor for real-time video processing. He also served as Chairman of Display Inspection Systems Inc., specializing in laser based inspection machines and as President and CEO of Robomatix Technologies Ltd.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 36pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">In 1992, Mr. Aberman was awarded the Rothschild Prize for excellence in his field from the President of the State of Israel.&#160;&#160;Mr. Aberman holds a B.Sc. in Mechanical Engineering from Ben Gurion University in Israel.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 36pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">We believe that Mr. Aberman&#8217;s qualifications to sit on our Board of Directors include his years of experience in the financial markets in Israel and globally, as well as his experience in serving as the CEO of publicly traded entities.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Yaky Yanay</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 36pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Mr. Yaky Yanay was appointed as Pluristem&#8217;s President and COO in February 2014.&#160;&#160;Until February 2014, he served as Pluristem&#8217;s Chief Financial Officer and Secretary since November 2006, and Executive Vice President since March 2013.&#160;&#160;&#160;Prior to joining Pluristem, Mr. Yanay was the Chief Financial Officer of Elbit Vision Systems Ltd., a public company. Prior to that Mr. Yanay served as manager of audit groups of the technology sector at Ernst &amp; Young Israel.&#160;&#160;Mr. Yanay founded and served as Chairman of the &#8220;The Life Science Forum&#8221; in Israel and he is a member of the board of directors of Israel Advanced Technologies Industries (IATI), the largest umbrella organization in Israel for companies, organizations, and individuals in the high tech and life science sectors. Mr. Yanay holds a bachelor&#8217;s degree with honors in business administration and accounting and is a Certified Public Accountant in Israel.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div id="PGBRK" style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div id="FTR">
<div id="GLFTR" style="WIDTH: 100%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>

<div id="PN" style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
<div style="TEXT-ALIGN: center; WIDTH: 100%"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">37</font></div>

<div style="TEXT-ALIGN: center; WIDTH: 100%">
<hr style="COLOR: black" noshade size="2">
</div>
</div>

<div id="HDR">
<div id="GLHDR" style="WIDTH: 100%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Boaz Gur-Lavie</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 36pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Boaz Gur-Lavie was appointed to the position of CFO and Secretary in February 2014. Prior to joining Pluristem, Mr. Gur-Lavie was CFO of Abbott Informatics Division, responsible for different Abbott Informatics brands and STARLIMS, a global software organization which helps laboratories optimize data accessibility, integrity, defensibility and long-term value. Before that, he served as VP Finance of STARLIMS, a software company that had been traded on the NASDAQ and Tel-Aviv Stock Exchange prior to being acquired by Abbott. Mr. Gur-Lavie previously served as assistant controller at ECI Telecom. Prior to that he served as a senior manager on the ERS team of Deloitte Israel. He also served as a lecturer at Ben Gurion University. Mr. Gur-Lavie holds a Master&#8217;s Degree in finance and a Bachelor&#8217;s Degree in economy and accounting from the University of Ben-Gurion. He is a Certified Public Accountant in Israel.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Nachum Rosman</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 36pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Mr. Rosman became a director of the Company in October 2007. He provides management and consulting services to startup companies in the financial, organizational and human resource aspects of their operations.&#160;&#160;Mr. Rosman also serves as a director at several privately held companies.&#160;&#160;Throughout his career, Mr. Rosman held CEO and CFO positions in Israel, the United States and England.&#160;&#160;In these positions he was responsible, among other things, for finance management, fund raising, acquisitions and technology sales.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 36pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Mr. Rosman holds a B.Sc. in Management Engineering and an M.Sc. in Operations Research from the Technion, Haifa, Israel.&#160;&#160;Mr. Rosman also participated in a Ph.D. program in Investments and Financing at the Tel Aviv University, Israel.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 36pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">We believe that Mr. Rosman&#8217;s qualifications to sit on our Board of Directors include his years of experience in the high-tech industry, as well as his knowledge and familiarity with corporate finance.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Doron Shorrer</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 36pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Mr. Shorrer became a director of the Company in October 2003.&#160;&#160;Mr. Shorrer was one of the Company&#8217;s founders and served as its first Chairman until 2006.&#160;&#160;Mr. Shorrer also serves as a director of other companies: Provident Fund for employees of the Israel Electric Company Ltd. and for Hebrew University employees, and Massad Bank from the International Bank group.&#160;&#160;Between 1999 and 2004 he was Chairman of the Boards of Phoenix Insurance Company, one of the largest insurance companies in Israel, and of Mivtachim Pension Funds Group, the largest pension fund in Israel. Prior to serving in these positions, Mr. Shorrer held senior positions that included Arbitrator at the Claims Resolution Tribunal for Dormant Accounts in Switzerland; Economic and Financial Advisor, Commissioner of Insurance and Capital Markets for the State of Israel; Member of the board of directors of &#8220;Nechasim&#8221; of the State of Israel; Member Committee for the Examination of Structural Changes in the Capital Market (The Brodet Committee); General Director of the Ministry of Transport; Founder and managing partner of an accounting firm with offices in Jerusalem, Tel-Aviv and Haifa; Member of the Lecture Staff of the Hebrew University Business Administration School; Chairman of Amal School Chain; Chairman of a Public Committee for Telecommunications; and Economic Consultant to the Ministry of Energy.&#160;&#160;Among many areas of expertise, Mr. Shorrer formulates implements and administers business planning in the private and institutional sector in addition to consulting on economic, accounting and taxation issues to a large audience ranging from private concerns to government ministries.</font></div>

<div style="TEXT-INDENT: 36pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left">&#160;</div>

<div id="PGBRK" style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div id="FTR">
<div id="GLFTR" style="WIDTH: 100%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>

<div id="PN" style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
<div style="TEXT-ALIGN: center; WIDTH: 100%"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">38</font></div>

<div style="TEXT-ALIGN: center; WIDTH: 100%">
<hr style="COLOR: black" noshade size="2">
</div>
</div>

<div id="HDR">
<div id="GLHDR" style="WIDTH: 100%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 36pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Mr. Shorrer holds a B.A. in Economics and Accounting and an M.A. in Business Administration (specialization in finance and banking) from the Hebrew University of Jerusalem and is a Certified Public Accountant (ISR).</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 36pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">We believe that Mr. Shorrer&#8217;s qualifications to sit on our Board of Directors include his years of experience in the high-tech industry, his vast skill and expertise in accounting and economics, as well as his knowledge and familiarity with corporate finance.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Hava Meretzki</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 36pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Ms. Meretzki became a director of the Company in October, 2003. Ms. Meretzki is an attorney and is a partner in Meretzki law firm in Haifa, Israel.&#160;&#160;Ms. Meretzki specializes in civil, trade and labor law, and is presently the Chairman of the National Council of the Israel Bar Association. Ms. Meretzki received a Bachelors Degree in Law from the Hebrew University in 1991 and was admitted to the Israel Bar Association in 1993.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 36pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">We believe that Ms. Meretzki&#8217;s qualifications to sit on our Board include her years of experience with legal and corporate governance matters.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Isaac Braun</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 36pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Mr. Braun became a director of the Company in July, 2005.&#160;&#160;Mr. Braun is a business veteran with entrepreneurial, industrial and manufacturing experience.&#160;&#160;He is a co-founder and has been a board member of several hi-tech start-ups in the areas of e-commerce, security, messaging, search engines and biotechnology.&#160;&#160;Mr. Braun is involved with advising private companies on raising capital and business development.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 36pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">We believe that Mr. Braun&#8217;s qualifications to sit on our Board of Directors include his years of experience in the high-tech industry, as well as his knowledge and familiarity with corporate finance.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Israel Ben-Yoram</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 36pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Mr. Ben-Yoram became a director of the Company in January 2005.&#160;&#160;He has been a director and partner in the accounting firm of Mor, Ben-Yoram and Partners in Israel since 1985.&#160;&#160;In addition, since 1992, Mr. Ben-Yoram has been a shareholder and has served as the head director of Mor, Ben-Yoram Ltd., a private company in Israel in parallel to the operation of Mor, Ben-Yoram and Partners.&#160;&#160;This company provides management services, economic consulting services and other professional services to businesses. Furthermore, Mr. Ben-Yoram is the CEO of Eshed Dash Ltd. and Zonbit Ltd. During 2003-2004 Mr. Ben-Yoram served as a director of Brainstorm Cell Therapeutics Inc. (BCLI) and Smart Energy solutions, Inc. (SMGY), both of which were traded on the NASDAQ.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 36pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Mr. Ben-Yoram received a B.A. in accounting from the University of Tel Aviv, an M.A. in Economics from the Hebrew University of Jerusalem, an LL.B. and an MBA from Tel Aviv University and an LL.M. from Bar Ilan University. In addition, Mr. Ben-Yoram is qualified in arbitration and in mediation.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 36pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">We believe that Mr. Ben-Yoram&#8217;s qualifications to sit on our Board of Directors include his years of experience in the high-tech industry, his experience serving as a director of NASDAQ companies, as well as his knowledge and familiarity with corporate finance and accounting.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Mark Germain</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 36pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Mr. Germain became a director of the Company in May 2007.&#160;&#160;Between May 2007 and February 2009, Mr. Germain served as Co-Chairman of our Board.&#160;&#160;For more than five years, Mr. Germain has been a merchant banker serving primarily the biotech and life sciences industries.&#160;&#160;He has been involved as a founder, director, Chairman of the board of, and/or investor in, over twenty companies in the biotech field, and assisted many of them in arranging corporate partnerships, acquiring technology, entering into mergers and acquisitions, and executing financings and going public transactions.&#160;&#160;He graduated from New York University School of Law in 1975, Order of the Coif, and was a partner in a New York law firm practicing corporate and securities law before leaving in 1986. Since then, and until he entered the biotech field in 1991, he served in senior executive capacities, including as president of a public company, which was sold in 1991.&#160;&#160;In addition to being a Director of the Company, Mr. Germain is a director of ChromaDex, Inc. (CDXB.OB), a publicly traded company. Mr. Germain also serves as a director of the following companies that were reporting companies in the past: Stem Cell Innovations, Inc., Omnimmune Corp. and Collexis Holdings, Inc.&#160;&#160;He is also a co-founder and director of a number of private companies in and outside the biotechnology field.</font></div>

<div style="TEXT-INDENT: 36pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left">&#160;</div>

<div id="PGBRK" style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div id="FTR">
<div id="GLFTR" style="WIDTH: 100%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>

<div id="PN" style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
<div style="TEXT-ALIGN: center; WIDTH: 100%"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">39</font></div>

<div style="TEXT-ALIGN: center; WIDTH: 100%">
<hr style="COLOR: black" noshade size="2">
</div>
</div>

<div id="HDR">
<div id="GLHDR" style="WIDTH: 100%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 36pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">We believe that Mr. Germain&#8217;s qualifications to sit on our Board of Directors include his years of experience in the biotech industry, his experience serving as a director of public companies, as well as his knowledge and familiarity with corporate finance.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Moria Kwiat</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 36pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Dr. Kwiat became a director of the Company in May 2012.&#160;&#160;Dr. Kwiat holds a B.Sc and an M.Sc. in Biotechnology from Tel Aviv University, and a Ph.D. from the Tel Aviv University Center for Nanoscience and Nanotechnology. Dr. Kwiat served as a teaching assistant at Tel Aviv University from 2003 through 2012. Currently, Dr. Kwiat is a postdoc fellow at the Faculty of Chemistry of Tel Aviv University, working on the development of new generation of biosensors based on nano-materials.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 36pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">We believe that Dr. Kwiat&#8217;s qualifications to sit on our Board of Directors include her knowledge and experience as a scientist and a researcher in the fields of biotechnology, microbiology and nanotechnology.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">There are no family relationships between any of the directors or officers named above.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="FONT-STYLE: italic; DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Audit Committee and Audit Committee Financial Expert</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 36pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">The members of our Audit Committee are Doron Shorrer, Nachum Rosman and Israel Ben-Yoram.&#160;&#160;Doron Shorrer is the Chairman of the Audit Committee, and our Board of Directors has determined that Israel Ben-Yoram is an "Audit Committee financial expert" and that all members of the Audit Committee are "independent" as defined by the rules of the SEC and the NASDAQ rules and regulations. The Audit Committee operates under a written charter that is posted on our website at www.pluristem.com. The information on our website is not incorporated by reference into this Annual Report.<font style="FONT-STYLE: italic; DISPLAY: inline">&#160;</font>The primary responsibilities of our Audit Committee include:</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div>
<table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td style="WIDTH: 18pt">
<div style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline;" face="Symbol, serif">&#183;</font></font></div>
</td>
<td>
<div align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Appointing, compensating and retaining our registered independent public accounting firm;</font></div>
</td>
</tr></table>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div>
<table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td style="WIDTH: 18pt">
<div style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline;" face="Symbol, serif">&#183;</font></font></div>
</td>
<td>
<div align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Overseeing the work performed by any outside accounting firm;</font></div>
</td>
</tr></table>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div>
<table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td style="WIDTH: 18pt">
<div style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline;" face="Symbol, serif">&#183;</font></font></div>
</td>
<td>
<div align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Assisting the Board in fulfilling its responsibilities by reviewing: (i) the financial reports provided by us to the SEC, our stockholders or to the general public, and (ii) our internal financial and accounting controls; and</font></div>
</td>
</tr></table>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div>
<table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td style="WIDTH: 18pt">
<div style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline;" face="Symbol, serif">&#183;</font></font></div>
</td>
<td>
<div align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Recommending, establishing and monitoring procedures designed to improve the quality and reliability of the disclosure of our financial condition and results of operations.</font></div>
</td>
</tr></table>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Our Audit Committee held six meetings from July 1, 2013 through June 30, 2014 (Fiscal 2014).</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="FONT-STYLE: italic; DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Compensation Committee</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 36pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">The members of our Compensation Committee are Doron Shorrer, Nachum Rosman and Israel Ben-Yoram. The Board has determined that all of the members of the Compensation Committee are "independent" as defined by the rules of the SEC and NASDAQ rules and regulations. The Compensation Committee operates under a written charter that is posted on our website at www.pluristem.com. The information on our website is not incorporated by reference into this Annual Report. The primary responsibilities of our Compensation Committee include:</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div>
<table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td style="WIDTH: 18pt">
<div style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline;" face="Symbol, serif">&#183;</font></font></div>
</td>
<td>
<div align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Reviewing and recommending to our Board of the annual base compensation, the annual incentive bonus, equity compensation, employment agreements and any other benefits of our executive officers;</font></div>
</td>
</tr></table>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div id="PGBRK" style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div id="FTR">
<div id="GLFTR" style="WIDTH: 100%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>

<div id="PN" style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
<div style="TEXT-ALIGN: center; WIDTH: 100%"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">40</font></div>

<div style="TEXT-ALIGN: center; WIDTH: 100%">
<hr style="COLOR: black" noshade size="2">
</div>
</div>

<div id="HDR">
<div id="GLHDR" style="WIDTH: 100%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div>
<table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td style="WIDTH: 18pt">
<div style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline;" face="Symbol, serif">&#183;</font></font></div>
</td>
<td>
<div align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Administering our equity based plans and making recommendations to our Board with respect to our incentive&#8211;compensation plans and equity&#8211;based plans; and</font></div>
</td>
</tr></table>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div>
<table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td style="WIDTH: 18pt">
<div style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline;" face="Symbol, serif">&#183;</font></font></div>
</td>
<td>
<div align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Annually reviewing and making recommendations to our Board with respect to the compensation policy for such other officers as directed by our Board.</font></div>
</td>
</tr></table>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Our Compensation Committee held three meetings during Fiscal 2014.&#160;&#160;The Compensation Committee did not receive advice from or retain any consultants during Fiscal 2014.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="FONT-STYLE: italic; DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Compensation Committee Interlocks and Insider Participation</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 36pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">During the fiscal year ended June 30, 2014, Mr. Shorrer, Mr. Rosman, and Mr. Ben-Yoram served as the members of our Compensation Committee.&#160;&#160;None of the members of our Compensation Committee is, or has been, an officer or employee of ours or of our subsidiary.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 36pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">During the last year, none of our executive officers served as: (1) a member of the compensation committee (or other committee of the board of directors performing equivalent functions or, in the absence of any such committee, the entire board of directors) of another entity, one of whose executive officers served on the compensation committee; (2) a director of another entity, one of whose executive officers served on the compensation committee; or (3) a member of the compensation committee (or other committee of the board of directors performing equivalent functions or, in the absence of any such committee, the entire board of directors) of another entity, one of whose executive officers served as a director on our Board of Directors.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="FONT-STYLE: italic; DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Nominating/Corporate Governance; Director Candidates.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 36pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">The Company does not have a Nominating Committee or Corporate Governance Committee or any committees of a similar nature, nor any charter governing the nomination process.&#160;&#160;Our Board does not believe that such committees are needed for a company our size.&#160;&#160;However, our independent directors will consider stockholder suggestions for additions to our Board.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="FONT-STYLE: italic; DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Code of Ethics</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 36pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Our Board of Directors has adopted a Code of Business Conduct and Ethics that applies to, among other persons, members of our Board of Directors, our officers including our CEO (being our principal executive officer) and our CFO (being our principal financial and accounting officer) and our employees.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 36pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Our Code of Business Conduct and Ethics is posted on our Internet website at www.pluristem.com. The information on our website is not incorporated by reference into this Annual Report.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="FONT-STYLE: italic; DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Section 16(a) Beneficial Ownership Reporting Compliance</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 36pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Section 16(a) of the Exchange Act requires our executive officers and directors, and persons who own more than 10% of our common stock, to file reports regarding ownership of, and transactions in, our securities with the SEC and to provide us with copies of those filings. Based solely on our review of the copies of such forms received by us, or written representations from certain reporting persons, we believe that during fiscal year ended June 30, 2014, all filing requirements applicable to our officers, directors and ten percent beneficial owners were complied with.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left">&#160;</div>

<div id="PGBRK" style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div id="FTR">
<div id="GLFTR" style="WIDTH: 100%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>

<div id="PN" style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
<div style="TEXT-ALIGN: center; WIDTH: 100%"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">41</font></div>

<div style="TEXT-ALIGN: center; WIDTH: 100%">
<hr style="COLOR: black" noshade size="2">
</div>
</div>

<div id="HDR">
<div id="GLHDR" style="WIDTH: 100%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: normal">&#160;</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"><a name="11">Item&#160;11.&#160;&#160;Executive Compensation.</a></font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="FONT-STYLE: italic; DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">EXECUTIVE COMPENSATION AND RELATED INFORMATION</font></div>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Compensation Discussion and Analysis</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 36pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">The Compensation Committee of our Board of Directors is comprised solely of independent directors as defined by NASDAQ, outside directors as defined by Section 162(m) of the Internal Revenue Code and non-employee directors as defined by Rule 16b-3 under the Exchange Act. The Compensation Committee has the authority and responsibility to review and make recommendations to the Board of Directors regarding the compensation of our CEO and other executive officers.&#160;&#160;Our named executive officers for Fiscal 2014 are those three individuals listed in the "<font style="FONT-STYLE: italic; DISPLAY: inline">2014 Summary Compensation Table</font>" below. Other information concerning the structure, roles and responsibilities of our Compensation Committee is set forth in "<font style="FONT-STYLE: italic; DISPLAY: inline">Board Meetings and Committees&#8212;Compensation Committee</font>" section of this Annual Report.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 36pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">At our 2013 shareholders meeting, we provided our shareholders with the opportunity to cast an advisory vote on executive compensation. Over 84% of the votes cast on this "2013 say-on-pay vote" were voted in favor of the proposal. We have considered the 2013 say-on-pay vote and we believe that overwhelming support from our shareholders for the 2013 say-on-pay vote proposal indicates that our shareholders are supportive of our approach to executive compensation. At our 2013 shareholders meeting, our shareholders also voted in favor of the proposal to hold say-on-pay votes every two years. Consequently, there was no say-on-pay vote in fiscal year 2014, and the next say-on-pay vote will be at our 2015 shareholder meeting. We will continue to consider the outcome of our say-on-pay votes when making compensation decisions regarding our named executive officers.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 36pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">A discussion of the policies and decisions that shape our executive compensation program, including the specific objectives and elements, is set forth below.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Executive Compensation Objectives and Philosophy</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 36pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">The objective of our executive compensation program is to attract, retain and motivate talented executives who are critical for our continued growth and success and to align the interests of these executives with those of our shareholders. To this end, our compensation programs for executive officers are designed to achieve the following objectives:</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div>
<table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td style="WIDTH: 36pt">
<div><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160; </font></div>
</td>
<td style="WIDTH: 18pt">
<div style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline;" face="Symbol, serif">&#183;</font></font></div>
</td>
<td>
<div align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">attract, hire, and retain talented and experienced executives;</font></div>
</td>
</tr></table>
</div>

<div>
<table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td style="WIDTH: 36pt">
<div><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160; </font></div>
</td>
<td style="WIDTH: 18pt">
<div style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline;" face="Symbol, serif">&#183;</font></font></div>
</td>
<td>
<div align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">motivate, reward and retain executives whose knowledge, skills and performance are critical to our success;</font></div>
</td>
</tr></table>
</div>

<div>
<table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td style="WIDTH: 36pt">
<div><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160; </font></div>
</td>
<td style="WIDTH: 18pt">
<div style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline;" face="Symbol, serif">&#183;</font></font></div>
</td>
<td>
<div align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">ensure fairness among the executive management team by recognizing the contributions each executive makes to our success and the tenure of each team member as a factor in achieving such success;</font></div>
</td>
</tr></table>
</div>

<div>
<table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td style="WIDTH: 36pt">
<div><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160; </font></div>
</td>
<td style="WIDTH: 18pt">
<div style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline;" face="Symbol, serif">&#183;</font></font></div>
</td>
<td>
<div align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">focus executive behavior on achievement of our corporate objectives and strategy;</font></div>
</td>
</tr></table>
</div>

<div>
<table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td style="WIDTH: 36pt">
<div><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160; </font></div>
</td>
<td style="WIDTH: 18pt">
<div style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline;" face="Symbol, serif">&#183;</font></font></div>
</td>
<td>
<div align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">build a mechanism of "pay for performance"; and</font></div>
</td>
</tr></table>
</div>

<div>
<table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td style="WIDTH: 36pt">
<div><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160; </font></div>
</td>
<td style="WIDTH: 18pt">
<div style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline;" face="Symbol, serif">&#183;</font></font></div>
</td>
<td>
<div align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">align the interests of management and shareholders by providing management with longer-term incentives through equity ownership.</font></div>
</td>
</tr></table>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 36pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">The Compensation Committee reviews the allocation of compensation components regularly to ensure alignment with strategic and operating goals, competitive market practices and legislative changes. The Compensation Committee does not apply a specific formula to determine the allocation between cash and non-cash forms of compensation. Certain compensation components, such as base salaries, benefits and perquisites, are intended primarily to attract, hire, and retain well-qualified executives. Other compensation elements, such as long-term incentive opportunities, are designed to motivate and reward performance.&#160;&#160;Long-term incentives are intended to reward our long-term performance and executing our business strategy, and to strongly align named executive officers' interests with those of shareholders.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 36pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">With respect to equity compensation, the Compensation Committee makes awards to executives under our stock option plans and other plans as approved by the Board of Directors. Executive compensation is paid or granted based on such matters as the Compensation Committee deems appropriate, including our financial and operating performance, the alignment of the interests of the executive officers and our shareholders, the performance of our common stock and our ability to attract and retain qualified individuals.</font></div>

<div style="TEXT-INDENT: 36pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left">&#160;</div>

<div id="PGBRK" style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div id="FTR">
<div id="GLFTR" style="WIDTH: 100%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>

<div id="PN" style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
<div style="TEXT-ALIGN: center; WIDTH: 100%"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">42</font></div>

<div style="TEXT-ALIGN: center; WIDTH: 100%">
<hr style="COLOR: black" noshade size="2">
</div>
</div>

<div id="HDR">
<div id="GLHDR" style="WIDTH: 100%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Elements of Executive Officer Compensation</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 36pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Our executive officer compensation program is comprised of: (i) base salary or monthly compensation; (ii) performance based bonus; (iii) long-term equity incentive compensation in the form of periodic stock option and restricted stock unit (RSU) grants; and (iv) benefits and perquisites.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 36pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">In establishing overall executive compensation levels and making specific compensation decisions for our executive officers in 2014, the Compensation Committee considered a number of criteria, including the executive's position, scope of responsibilities, prior base salary and annual incentive awards and expected contribution. With respect to Mr. Boaz Gur-Lavie, our new CFO, the Compensation Committee considered, among other factors, the compensation levels for executives in similar positions in other biotech companies in Israel as well as companies that compete with us around the world, Mr. Gur-Lavie&#8217;s experience and acquaintance with the space we operate in and complimentary capabilities he brings to our existing management team.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 36pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Generally, our Compensation Committee reviews and, as appropriate, approves compensation arrangements for our named executive officers, from time to time but not less than once a year.&#160;&#160;The Compensation Committee also takes into consideration the CEO's recommendations for executive compensation of the COO and the CFO. The CEO generally presents these recommendations at the time of our Compensation Committee's review of executive compensation arrangements.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Base Salary</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 36pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">The Compensation Committee performs a review of base salaries / monthly compensation for our named executive officers from time to time as appropriate. In determining salaries, the Compensation Committee members also take into consideration their understanding of the compensation practices of comparable companies (based on size and stage of development), especially in Israel, where our named executive officers reside; independent third party market data such as compensation surveys to industry, including information relating to peer companies; individual experience and performance adjusted to reflect individual roles; and contribution to our clinical, regulatory, commercial and operational performance.&#160;&#160;In determining the base salary of our new CFO, the Compensation Committee considered, among other factors, the salary levels for CFOs in other biotech companies in Israel and in our competitors around the world, as well as Mr. Gur-Lavie&#8217;s experience and acquaintance with the space we operate in and complimentary capabilities he brings to our existing management team.&#160;&#160;None of the factors above has a dominant weight in determining the compensation of our executive officers, and our Compensation Committee considers the factors as a whole when considering such compensation.&#160;&#160;In addition, our Compensation Committee may, from time to time, use comparative data regarding compensation paid by peer companies in order to obtain a general understanding of current trends in compensation practices and ranges of amounts being awarded by other public companies, and not as part of an analysis or a formula.&#160;&#160;We may also change the base salary / monthly compensation of an executive officer at other times due to market conditions, as we did in our fiscal year ended June 30, 2011, when our CEO and COO participated in a voluntary reduction of their compensation. We believe that a competitive base salary / monthly compensation is a necessary element of any compensation program that is designed to attract and retain talented and experienced executives. We also believe that attractive base salaries can motivate and reward executives for their overall performance. Base salaries / monthly compensation are established in part based on the individual experience, skills and expected contributions of our executives and our executives' performance during the prior year. Compensation adjustments are made occasionally based on changes in an executive's level of responsibility, Company progress or on changed local and specific executive employment market conditions. In Fiscal 2014 (as well as in the fiscal year ended June 30, 2013), our CEO&#8217;s and CFO&#8217;s salaries and monthly compensation did not change from the previous year as we believe they do not deviate materially from the range of salaries received by our executive officers' respective counterparts in companies in the biotechnology industry and other comparable companies in Israel.&#160;&#160;We did not conduct any analysis of salaries and monthly compensation received by our executive officers' respective counterparts in companies in the biotechnology industry and other comparable companies in Israel in the fiscal year ended June 30, 2013 and Fiscal 2014.</font></div>

<div style="TEXT-INDENT: 36pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left">&#160;</div>

<div id="PGBRK" style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div id="FTR">
<div id="GLFTR" style="WIDTH: 100%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>

<div id="PN" style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
<div style="TEXT-ALIGN: center; WIDTH: 100%"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">43</font></div>

<div style="TEXT-ALIGN: center; WIDTH: 100%">
<hr style="COLOR: black" noshade size="2">
</div>
</div>

<div id="HDR">
<div id="GLHDR" style="WIDTH: 100%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Performance Based Bonus</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 36pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Given the nature of our business, the determination of incentives for our executives is generally tied to success in promoting our Company's development.&#160;&#160;We are continually seeking non-dilutive sources of funding.&#160;&#160;In addition, a key component of our strategy is to develop and manufacture cell therapy products for the treatment of multiple disorders through collaboration with other companies, such as United, and entering into licensing agreements with such companies, such as the United Agreement or our agreement with CHA.&#160;&#160;Therefore, in order to reward our CEO and COO, each of them is entitled to a bonus calculated as a percentage of amounts received by us from non-dilutive funding received, among other things, from corporate partnering and strategic deals (e.g., the United Agreement). This is designed to support our business strategy to enter into multiple license agreements with pharmaceutical companies. The performance based bonus percentages are as follows: Mr. Zami Aberman &#8211; 1.5% of amounts received by us from non dilutive funding and strategic deals, and Mr. Yaky Yanay &#8211; 1% of such amounts. The difference in the percentage of the performance based bonus was determined based on the Compensation Committee's assessment of the contribution and role of each of them in completing the licensing and strategic agreements. In addition, our executives may be entitled, from time to time, to a discretionary bonus that is in the Compensation Committee sole discretion.&#160;&#160;For instance, in fiscal year 2013, the Compensation Committee resolved, subject to Board approval, the each of Mr. Aberman and Mr. Yanay will be entitled to a cash bonus in the gross amount of $75,000 due to our performance and achievements, including entering into the TA 100 index, closing of a financing round and completion of the manufacturing facility according to plans.&#160;&#160;We paid no bonuses to our named executive officers in fiscal year 2014.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Long-term Equity Incentive Compensation</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 36pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Long-term incentive compensation allows the executive officers to share in any appreciation in the value of our common stock. The Compensation Committee believes that stock participation aligns executive officers&#8217; interests with those of our shareholders. The amounts of the awards are designed to reward past performance and create incentives to meet long-term objectives. Awards are made at a level expected to be competitive within the biotechnology industry, as well as with Israeli based companies.&#160;&#160;We do not have a formula relating to, and did not conduct any analysis of, the level of awards that is competitive within the biotechnology industry and Israeli based companies.&#160;&#160;In determining the amount of each grant, the Compensation Committee also takes into account the number of shares held by the executive prior to the grant. Awards are made on a discretionary basis and not pursuant to specific criteria set out in advance.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 36pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">RSU awards provide our executive officers with the right to purchase shares of our common stock at a par value of $0.00001, subject to continued employment with our Company and, in the case of our CFO, financial and operational goals achievement. In recent years we granted our executive officers RSU awards.&#160;&#160;We chose to grant RSU awards and not options because RSU awards, once vested, always have an immediate financial value to the holder thereof, unlike options where the exercise price might be below the current market price of the shares and therefore not have any intrinsic value to the holder thereof.&#160;&#160;In the past, due to the high volatility of our stock price, options we granted were out of the money, and many of them still are.&#160;&#160;In addition, because vested RSU awards always have financial value, as opposed to options, we were able to limit the number of securities issued to our executive officers and other employees, directors and consultants.&#160;&#160;RSUs generally vest over two years or upon goals achievement. Our CEO and COO are entitled to acceleration of the vesting of their stock options and RSUs in the following circumstances: (1) if we terminate their employment, they will be entitled to acceleration of 100% of any unvested options and RSU and (2) if they resign, they will be entitled to acceleration of 50% of any unvested options and RSUs. In addition, our CEO is entitled to an acceleration of 100% of any unvested options and RSUs in the event of change in control. All grants are approved by our Board of Directors.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Benefits and Perquisites</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 36pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Generally, benefits available to our named executive officers are available to all employees on similar terms and include welfare benefits, paid time-off, life and disability insurance and other customary or mandatory social benefits in Israel.&#160;&#160;We provide our named executive officers with a phone and a Company car which are customary benefits in Israel to managers and officers.&#160;&#160;Our CEO and COO are also entitled to receive, once a year, a fixed sum equal to the amount of the monthly compensation to such executive officer.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 36pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">In addition, in the event of termination of our CEO&#8217;s consulting agreement, he will be entitled to receive an adjustment fee that equals the monthly consulting fees multiplied by 3 plus the number of years the Consulting Agreement is in force from the second year, but in any event no more than nine years in the aggregate. Our COO may be entitled to a severance payment that equals a month&#8217;s compensation for each twelve-month period of employment or otherwise providing services to the Company.</font></div>

<div style="TEXT-INDENT: 36pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left">&#160;</div>

<div id="PGBRK" style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div id="FTR">
<div id="GLFTR" style="WIDTH: 100%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>

<div id="PN" style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
<div style="TEXT-ALIGN: center; WIDTH: 100%"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">44</font></div>

<div style="TEXT-ALIGN: center; WIDTH: 100%">
<hr style="COLOR: black" noshade size="2">
</div>
</div>

<div id="HDR">
<div id="GLHDR" style="WIDTH: 100%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 36pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">We do not believe that the benefits and perquisites described above deviate materially from the customary practice for compensation of executive officers by other companies similar in size and stage of development in Israel.&#160;&#160;These benefits represent a relatively small portion of the executive officers' total compensation.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Compensation Committee Report</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 36pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">The Compensation Committee has reviewed and discussed the foregoing Compensation Discussion and Analysis required by Item 402(b) of Regulation S-K with our management and, based on such review and discussions, the Compensation Committee recommended to our Board of Directors that the Compensation Discussion and Analysis be included in this Annual Report.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div align="left">
<table cellpadding="0" cellspacing="0" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr>
<td valign="top" width="50%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="top" width="50%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Compensation Committee Members:</font></div>
</td>
</tr><tr>
<td valign="top" width="50%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="top" width="50%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr>
<td valign="top" width="50%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="top" width="50%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Doron Shorrer</font></div>
</td>
</tr><tr>
<td valign="top" width="50%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="top" width="50%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Nachum Rosman</font></div>
</td>
</tr><tr>
<td valign="top" width="50%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="top" width="50%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Israel Ben-Yoram</font></div>
</td>
</tr></table>
</div>

<div style="TEXT-INDENT: 36pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;</font></div>

<div style="TEXT-INDENT: 36pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">The following table shows the particulars of compensation paid to our CEO, COO and CFO for the fiscal years ended June 30, 2014, 2013 and 2012.&#160;&#160;We do not currently have any other executive officers, nor did we during the fiscal years ended June 30, 2014, 2013, and 2012.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">SUMMARY COMPENSATION TABLE</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div align="left">
<div align="left">
<div align="left">
<table cellpadding="0" cellspacing="0" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr>
<td align="left" rowspan="2" valign="bottom" width="18%" style="BORDER-BOTTOM: black 2px solid"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Name</font>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">and Principal Position</font></font></div>
</td>
<td align="left" valign="bottom" width="1%">&#160;</td>
<td align="left" rowspan="2" valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Fiscal Year</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;</font></td>
<td align="left" colspan="2" rowspan="2" valign="bottom" width="10%" style="BORDER-BOTTOM: black 2px solid"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Salary</font>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">($) (1)</font></div>
</td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;</font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;</font></td>
<td align="left" colspan="2" rowspan="2" valign="bottom" width="10%" style="BORDER-BOTTOM: black 2px solid"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Bonus</font>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">($)(2)</font></div>
</td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;</font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;</font></td>
<td align="left" colspan="2" rowspan="2" valign="bottom" width="10%" style="BORDER-BOTTOM: black 2px solid"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Stock-based Awards</font>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">($)(3)</font></div>
</td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;</font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;</font></td>
<td align="left" colspan="2" rowspan="2" valign="bottom" width="10%" style="BORDER-BOTTOM: black 2px solid"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Non-Equity Incentive Plan Compensation</font>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">($)(4)</font></div>
</td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;</font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;</font></td>
<td align="left" colspan="2" rowspan="2" valign="bottom" width="10%" style="BORDER-BOTTOM: black 2px solid"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">All</font>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Other Compensation <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">($)(5)</font></font></div>
</td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;</font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;</font></td>
<td align="left" colspan="2" rowspan="2" valign="bottom" width="10%" style="BORDER-BOTTOM: black 2px solid"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Total</font>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">($)</font></div>
</td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;</font></td>
</tr><tr>
<td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;</font></td>
<td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;</font></td>
<td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;</font></td>
<td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;</font></td>
<td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;</font></td>
<td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;</font></td>
<td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;</font></td>
</tr><tr>
<td valign="bottom" width="18%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td colspan="2" valign="bottom" width="10%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td colspan="2" valign="bottom" width="10%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td colspan="2" valign="bottom" width="10%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td colspan="2" valign="bottom" width="10%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;</font></td>
<td align="left" colspan="2" valign="bottom" width="10%">&#160;</td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td colspan="2" valign="bottom" width="10%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
</tr><tr bgcolor="#cceeff">
<td align="left" valign="bottom" width="18%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Zami Aberman</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">2014</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">524,200</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(6)</font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">492,000</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">19,347</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">1,035,547</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
</tr><tr bgcolor="#cceeff">
<td align="left" valign="bottom" width="18%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">CEO</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">2013</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">488,910</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(6)</font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">75,000</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">1,078,000</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">21,042</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">1,662,952</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
</tr><tr bgcolor="#cceeff">
<td valign="bottom" width="18%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">2012</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">495,623</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(6)</font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">899,500</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(8)</font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">75,000</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">21,771</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(9)</font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">1,491,894</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
</tr><tr bgcolor="white">
<td align="left" valign="bottom" width="18%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Yaky Yanay</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">2014</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">269,969</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(7)&#160;</font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">492,000</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">27,694</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">789,663</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
</tr><tr bgcolor="white">
<td align="left" valign="bottom" width="18%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">CFO (until February 2014);</font></font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;<font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">2013</font></font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;251,329</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;75,000</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;770,000</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;-</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;27,951</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;1,124,280</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
</tr><tr bgcolor="white">
<td align="left" valign="bottom" width="18%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">COO</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">2012</font></font></div>
</div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right">253,752</td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right">-</td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right">642,500</td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(8)&#160;</font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">50,175</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right">27,231</td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right">973,658</td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
</tr><tr bgcolor="#cceeff">
<td align="left" valign="bottom" width="18%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Boaz Gur-Lavie CFO</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="right" valign="bottom" width="9%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">2014</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">129,877</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">203,950</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">18,704</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">352,531</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
</tr></table>
</div>
</div>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">(1)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Salary payments which were in NIS, were translated into US$ at the then current exchange rate for each payment.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">(2)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Represents discretionary bonus paid in connection with the performance and achievements of the Company in fiscal 2013.</font></div>

<div id="PGBRK" style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div id="FTR">
<div id="GLFTR" style="WIDTH: 100%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>

<div id="PN" style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
<div style="TEXT-ALIGN: center; WIDTH: 100%"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">45</font></div>

<div style="TEXT-ALIGN: center; WIDTH: 100%">
<hr style="COLOR: black" noshade size="2">
</div>
</div>

<div id="HDR">
<div id="GLHDR" style="WIDTH: 100%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">(3)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;The fair value recognized for the stock-based awards was determined as of the grant date in accordance with ASC 718. Assumptions used in the calculations for these amounts are included in Note 2(l) to our consolidated financial statements for Fiscal 2014 included elsewhere in this Annual Report.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">(4)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Represents bonus paid in connection with our entry into the United Agreement.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">(5)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Represents cost to us in connection with the car and a mobile phone made available to Mr. Aberman, Mr. Yanay and Mr. Gur-Lavie. The Company also pays the tax associated with this benefit which is grossed up and part of the amount in the Salary column in the table above.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">(6)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Includes $20,474, $19,728 and $20,208 paid to Mr. Aberman as compensation for services as a director in fiscal 2014, 2013, and 2012, respectively.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">(7)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Includes $164,245 paid to Mr. Yanay for his services as our CFO and $105,724 for Mr. Yanay&#8217;s services as our COO.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">(8)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;This amount is different from the amount reported previously in the Company&#8217;s Annual Report on Form 10-K for its fiscal year ended June 30, 2012 and the Company&#8217;s Proxy Statement filed on March 29, 2013.&#160;&#160;The amount previously reported aggregated the stock based awards compensation for both fiscal years 2011 and 2012.&#160;&#160;The amount reported herein represents the stock based awards compensation in the fiscal year ended June 30, 2012.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">(9)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;In the Company&#8217;s Annual Report on Form 10-K for its fiscal year ended June 30, 2012 and the Company&#8217;s Proxy Statement filed on March 29, 2013 the amount reported was $0.&#160;&#160;This amount was changed in order to include Mr. Aberman&#8217;s use of Company car and cell phone, which expense is reported herein.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">We have the following written agreements and other arrangements concerning compensation with our executive officers:</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div>
<table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td style="WIDTH: 36pt">
<div style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">(a)</font></div>
</td>
<td>
<div align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Mr. Aberman is engaged with us as a consultant and receives a monthly consulting fee of $31,250. In addition, Mr. Aberman is entitled once a year to receive an additional amount that equals the monthly consulting fee. The U.S. dollar rate will be not less then 4.35 NIS per $.&#160;&#160;All amounts above are paid plus value added tax.&#160;&#160;Mr. Aberman is also entitled to one and a half percent (1.5%) from amounts received by us from non diluting funding and strategic deals.</font></div>
</td>
</tr></table>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div>
<table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td style="WIDTH: 36pt">
<div style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;(b)</font></div>
</td>
<td>
<div align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Mr. Yanay's monthly salary is 53,125 NIS. In addition, Mr. Yanay is entitled once a year to receive an additional amount that equals his monthly salary.&#160;&#160;Mr. Yanay is provided with a cellular phone and a Company car pursuant to the terms of his agreement.&#160;&#160;Furthermore, Mr. Yanay is entitled to a bonus of one percent (1.0%) from amounts received by us from non diluting funding and strategic deals.&#160;&#160;As of August 2011, Mr. Yanay has been engaged with us as a consultant, in addition to being an employee.&#160;&#160;For his services as a consultant he receives a monthly consulting fee.&#160;&#160;In addition, he continues to receive salary as an employee, but in an amount that was reduced by the consulting fee so the total cost to us did not change as a result of this change.</font></div>
</td>
</tr></table>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div>
<table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td style="WIDTH: 36pt">
<div style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">(c)</font></div>
</td>
<td>
<div align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Mr. Gur-Lavie&#8217;s monthly salary is 40,000 NIS. In addition, Mr. Gur-Lavie is provided with a cellular phone and a Company car pursuant to the terms of his agreement.</font></div>
</td>
</tr></table>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div>
<div style="TEXT-ALIGN: left; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="FONT-STYLE: italic; DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Potential Payments Upon Termination or Change-in-Control</font></div>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 36pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">We have no plans or arrangements in respect of remuneration received or that may be received by our executive officers to compensate such officers in the event of termination of employment (as a result of resignation, retirement, change-in- control) or a change of responsibilities following a change-in-control, except for the following: (i) in the event of termination of Mr. Aberman&#8217;s Consulting Agreement, he will be entitled to receive an adjustment fee that equals the monthly consulting fees multiplied by 3 plus the number of years the Consulting Agreement has been in force as of the second year, but in any event no more than nine years in the aggregate; (ii) Mr. Yanay may be entitled, under Israeli law and practice, to a severance payment that equals a month's salary for each twelve-month period of employment with the Company and (iii) Mr. Gur-Lavie is entitled to severance pay upon termination of employment for any reason, including retirement, based on 8.333% of his monthly base salary, according to section 14 of the Severance Pay Law, 1963.</font></div>

<div style="TEXT-INDENT: 36pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left">&#160;</div>

<div id="PGBRK" style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div id="FTR">
<div id="GLFTR" style="WIDTH: 100%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>

<div id="PN" style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
<div style="TEXT-ALIGN: center; WIDTH: 100%"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">46</font></div>

<div style="TEXT-ALIGN: center; WIDTH: 100%">
<hr style="COLOR: black" noshade size="2">
</div>
</div>

<div id="HDR">
<div id="GLHDR" style="WIDTH: 100%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 36pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">In addition, Mr. Aberman and Mr. Yanay are entitled to acceleration of the vesting of their stock options and restricted stock in the following circumstances: (1) if we terminate their employment, they will be entitled to acceleration of 100% of any unvested options and restricted stock and (2) if they resign, they will be entitled to acceleration of 50% of any unvested options and restricted stock. In addition, Mr. Aberman is entitled to acceleration of 100% of any unvested options and restricted stock in case of our change in control or merger into another company.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 36pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">The following table displays the value of what our named executive officers would have received from us had their employment been terminated, or a change in control of us happened on June 30, 2014. Mr. Gur-Lavie is not entitled to any payments upon termination or change-in-control.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div align="left">
<table cellpadding="0" cellspacing="0" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr>
<td valign="bottom" style="BORDER-BOTTOM: black 2px solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Officer</font></div>
</div>
</td>
<td valign="bottom" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td colspan="2" valign="bottom" style="BORDER-BOTTOM: black 2px solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Salary</font></div>
</div>
</td>
<td nowrap valign="bottom" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td colspan="2" valign="bottom" style="BORDER-BOTTOM: black 2px solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Accelerated Vesting of Options and Restricted Stock Units (1)</font></div>
</div>
</td>
<td nowrap valign="bottom" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td colspan="2" valign="bottom" style="BORDER-BOTTOM: black 2px solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Total</font></div>
</div>
</td>
<td nowrap valign="bottom" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
</tr><tr>
<td valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td colspan="2" valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td nowrap valign="bottom" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td colspan="2" valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td nowrap valign="bottom" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td colspan="2" valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td nowrap valign="bottom" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
</tr><tr bgcolor="#cceeff">
<td align="left" valign="bottom">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Zami Aberman</font></div>
</td>
<td valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td colspan="2" valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td nowrap valign="bottom" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td colspan="2" valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td nowrap valign="bottom" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td colspan="2" valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td nowrap valign="bottom" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
</tr><tr bgcolor="#cceeff">
<td align="left" valign="bottom" width="64%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;&#160;Terminated due to officer resignation</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">355,857</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">448,500</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(2)</font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">804,357</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
</tr><tr bgcolor="#cceeff">
<td align="left" valign="bottom" width="64%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;&#160;Terminated due to discharge of officer</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">355,857</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">897,000</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(3)</font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">1,252,857</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
</tr><tr bgcolor="#cceeff">
<td align="left" valign="bottom" width="64%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;&#160;Change in control</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">897,000</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(3)</font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">897,000</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
</tr><tr bgcolor="white">
<td valign="bottom" width="64%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
</tr><tr bgcolor="#cceeff">
<td align="left" valign="bottom" width="64%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Yaky Yanay</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
</tr><tr bgcolor="#cceeff">
<td align="left" valign="bottom" width="64%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;&#160;Terminated due to officer resignation</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">119,173</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">370,500</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(2)</font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">489,673</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
</tr><tr bgcolor="#cceeff">
<td align="left" valign="bottom" width="64%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;&#160;Terminated due to discharge of officer</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">119,173</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">741,000</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(3)</font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">860,173</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
</tr></table>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div>
<table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td style="WIDTH: 36pt">
<div style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">(1)</font></div>
</td>
<td>
<div align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Value shown represents the difference between the closing market price of our shares of common stock on June 30, 2014 of $3.12 per share and the applicable purchase price of each grant.</font></div>
</td>
</tr></table>
</div>

<div>
<table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td style="WIDTH: 36pt">
<div style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">(2)</font></div>
</td>
<td>
<div align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">50% of all unvested options and RSUs issued under the applicable equity incentive plans vest upon a termination without cause under the terms of those plans.</font></div>
</td>
</tr></table>
</div>

<div>
<table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td style="WIDTH: 36pt">
<div style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">(3)</font></div>
</td>
<td>
<div align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">All unvested options and RSUs issued under the applicable equity incentive plans vest upon a change of control under the terms of those plans.</font></div>
</td>
</tr></table>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="FONT-STYLE: italic; DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Pension, Retirement or Similar Benefit Plans</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 36pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">We have no arrangements or plans under which we provide pension, retirement or similar benefits for directors or executive officers. Our directors and executive officers may receive stock options, RSUs or restricted shares at the discretion of our Board in the future.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Grants of Plan-Based Awards</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">The following table shows grants of plan-based equity awards made to our named executive officers during the fiscal year ended June 30, 2014:</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div align="left">
<div align="left">
<table cellpadding="0" cellspacing="0" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr>
<td valign="bottom" width="65%" style="BORDER-BOTTOM: black 2px solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Name &amp; Principal Position</font></div>
</div>
</td>
<td valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;</font></td>
<td valign="bottom" width="10%" style="BORDER-BOTTOM: black 2px solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Grant Date</font></div>
</div>
</td>
<td valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;</font></td>
<td colspan="2" valign="bottom" width="10%" style="BORDER-BOTTOM: black 2px solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">All Other Stock Awards:</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Number of Shares of Stock or Units #</font></div>
</div>
</td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;</font></td>
<td valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;</font></td>
<td colspan="2" valign="bottom" width="10%" style="BORDER-BOTTOM: black 2px solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Grant Date Fair Value of Stock and Option Awards ($)</font></div>
</div>
</td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;</font></td>
</tr><tr bgcolor="#cceeff">
<td align="left" valign="bottom" width="65%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Zami Aberman</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="left" valign="bottom" width="10%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">12/26/13</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">150,000</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(1)</font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">492,000</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
</tr><tr bgcolor="white">
<td valign="bottom" width="65%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="10%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
</tr><tr bgcolor="#cceeff">
<td align="left" valign="bottom" width="65%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Yaky Yanay</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="left" valign="bottom" width="10%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">12/26/13</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">150,000</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(1)</font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">492,000</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
</tr><tr bgcolor="white">
<td valign="bottom" width="65%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="10%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
</tr><tr bgcolor="#cceeff">
<td align="left" valign="bottom" width="65%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Boaz Gur Lavie</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="left" valign="bottom" width="10%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">11/04/13</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">30,000</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(2)</font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">97,800</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
</tr><tr bgcolor="#cceeff">
<td align="left" valign="bottom" width="65%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="left" valign="bottom" width="10%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">02/04/14</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">27,500</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(3)</font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">106,150</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
</tr></table>
</div>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div>
<table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td style="WIDTH: 36pt">
<div style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">(1)</font></div>
</td>
<td>
<div align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Grant of RSUs was made pursuant to our 2005 equity incentive plan. The grant vests over a two-year period from the date of grant, as follows: 37,500 RSUs vested on June 26, 2014 and 112,500 RSUs vest in six installment of 18,750 shares on each of September 26, 2014, December 26, 2014, March 26, 2015, June 26, 2015 and December 26, 2015.</font></div>
</td>
</tr></table>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div>
<table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td style="WIDTH: 36pt">
<div style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">(2)</font></div>
</td>
<td>
<div align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Grant of RSUs was made pursuant to our 2005 equity incentive plan. The grant vests as follows: 4,500 RSUs vested on November 5, 2013, 3,000 RSUs vested on May 4, 2014, and 7,500 RSUs vest in two installment of 3,750 shares on each of August 4, 2014 and November 4, 2014. 15,000 RSUs will vest upon achievement of certain operational and financial goals.</font></div>
</td>
</tr></table>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div>
<div style="TEXT-ALIGN: justify; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<table border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td align="right" style="WIDTH: 36pt">
<div style="TEXT-ALIGN: justify; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">(3)&#160;</font></div>
</td>
<td align="left">
<div style="TEXT-ALIGN: justify; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Grant of RSUs was made pursuant to our 2005 equity incentive plan. 5,000 RSUs vests over a two-year period from the date of grant, as follows: 1,250 RSUs vested on August 4, 2014 and&#160; 3,750 RSUs vest in six installment of 6,25 shares on each of November 4, 2014,&#160; February 4, 2015, May 4, 2015, August 4, 2015, November 4, 2015 and February 4, 2016. 22,500 RSUs will vest upon achievement of certain operational and financial goals.</font></div>
</td>
</tr></table>
</div>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div id="PGBRK" style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div id="FTR">
<div id="GLFTR" style="WIDTH: 100%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>

<div id="PN" style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
<div style="TEXT-ALIGN: center; WIDTH: 100%"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">47</font></div>

<div style="TEXT-ALIGN: center; WIDTH: 100%">
<hr style="COLOR: black" noshade size="2">
</div>
</div>

<div id="HDR">
<div id="GLHDR" style="WIDTH: 100%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div>
<table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td style="WIDTH: 36pt">
<div><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160; </font></div>
</td>
<td>
<div align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Outstanding Equity Awards at the End of Fiscal 2014</font></div>
</td>
</tr></table>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">The following table presents the outstanding equity awards held as of June 30, 2014 by our executive officers:</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div align="left">
<table cellpadding="0" cellspacing="0" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr>
<td colspan="7" valign="top" width="100%" style="BORDER-BOTTOM: black 2px solid; BORDER-LEFT: black 2px solid; BORDER-TOP: black 2px solid; BORDER-RIGHT: black 2px solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Number of Securities Underlying Unexercised</font></div>
</td>
</tr><tr>
<td valign="top" width="10%" style="BORDER-BOTTOM: black 2px solid; BORDER-LEFT: black 2px solid"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td colspan="4" valign="top" width="60%" style="BORDER-BOTTOM: black 2px solid; BORDER-LEFT: black 2px solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Option Awards</font></div>
</td>
<td colspan="2" valign="top" width="30%" style="BORDER-BOTTOM: black 2px solid; BORDER-LEFT: black 2px solid; BORDER-RIGHT: black 2px solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Stock Awards</font></div>
</td>
</tr><tr>
<td align="left" valign="top" width="10%" style="BORDER-BOTTOM: black 2px solid; BORDER-LEFT: black 2px solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Name</font></div>
</td>
<td valign="top" width="14%" style="BORDER-BOTTOM: black 2px solid; BORDER-LEFT: black 2px solid; BORDER-RIGHT: black 2px solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Number of securities underlying unexercised options (#) exercisable</font></div>
</td>
<td valign="top" width="16%" style="BORDER-BOTTOM: black 2px solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: -5.4pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Number of securities underlying unexercised options (#)&#160;&#160;unexercisable</font></div>
</td>
<td valign="top" width="16%" style="BORDER-BOTTOM: black 2px solid; BORDER-LEFT: black 2px solid; BORDER-RIGHT: black 2px solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Option exercise price($)</font></div>
</td>
<td valign="top" width="14%" style="BORDER-BOTTOM: black 2px solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Option expiration date</font></div>
</td>
<td valign="top" width="14%" style="BORDER-BOTTOM: black 2px solid; BORDER-LEFT: black 2px solid; BORDER-RIGHT: black 2px solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Number of shares that have not vested (#)</font></div>
</td>
<td valign="top" width="16%" style="BORDER-BOTTOM: black 2px solid; BORDER-RIGHT: black 2px solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Market value of shares that have not vested ($)</font></div>
</td>
</tr><tr>
<td align="left" rowspan="7" valign="top" width="10%" style="BORDER-BOTTOM: black 2px solid; BORDER-LEFT: black 2px solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Zami Aberman</font></div>
</td>
<td valign="top" width="14%" style="BORDER-BOTTOM: black 2px solid; BORDER-LEFT: black 2px solid; BORDER-RIGHT: black 2px solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 12.6pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">22,500</font></div>
</td>
<td valign="top" width="16%" style="BORDER-BOTTOM: black 2px solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font></div>
</td>
<td valign="top" width="16%" style="BORDER-BOTTOM: black 2px solid; BORDER-LEFT: black 2px solid; BORDER-RIGHT: black 2px solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 12.6pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">4.40</font></div>
</td>
<td valign="top" width="14%" style="BORDER-BOTTOM: black 2px solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 13.7pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">1/16/2016</font></div>
</td>
<td valign="top" width="14%" style="BORDER-BOTTOM: black 2px solid; BORDER-LEFT: black 2px solid; BORDER-RIGHT: black 2px solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font></div>
</td>
<td valign="top" width="16%" style="BORDER-BOTTOM: black 2px solid; BORDER-RIGHT: black 2px solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font></div>
</td>
</tr><tr>
<td valign="top" width="10%" style="BORDER-BOTTOM: black 2px solid; BORDER-LEFT: black 2px solid; BORDER-RIGHT: black 2px solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 12.6pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">30,000</font></div>
</td>
<td valign="top" width="14%" style="BORDER-BOTTOM: black 2px solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font></div>
</td>
<td valign="top" width="16%" style="BORDER-BOTTOM: black 2px solid; BORDER-LEFT: black 2px solid; BORDER-RIGHT: black 2px solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 12.6pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">4.00</font></div>
</td>
<td valign="top" width="16%" style="BORDER-BOTTOM: black 2px solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 13.7pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">10/30/2016</font></div>
</td>
<td valign="top" width="14%" style="BORDER-BOTTOM: black 2px solid; BORDER-LEFT: black 2px solid; BORDER-RIGHT: black 2px solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font></div>
</td>
<td valign="top" width="14%" style="BORDER-BOTTOM: black 2px solid; BORDER-RIGHT: black 2px solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font></div>
</td>
</tr><tr>
<td valign="top" width="10%" style="BORDER-BOTTOM: black 2px solid; BORDER-LEFT: black 2px solid; BORDER-RIGHT: black 2px solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 12.6pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">250,000</font></div>
</td>
<td valign="top" width="14%" style="BORDER-BOTTOM: black 2px solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font></div>
</td>
<td valign="top" width="16%" style="BORDER-BOTTOM: black 2px solid; BORDER-LEFT: black 2px solid; BORDER-RIGHT: black 2px solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 12.6pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">3.50</font></div>
</td>
<td valign="top" width="16%" style="BORDER-BOTTOM: black 2px solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 13.7pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">1/23/2017</font></div>
</td>
<td valign="top" width="14%" style="BORDER-BOTTOM: black 2px solid; BORDER-LEFT: black 2px solid; BORDER-RIGHT: black 2px solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font></div>
</td>
<td valign="top" width="14%" style="BORDER-BOTTOM: black 2px solid; BORDER-RIGHT: black 2px solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font></div>
</td>
</tr><tr>
<td valign="top" width="10%" style="BORDER-BOTTOM: black 2px solid; BORDER-LEFT: black 2px solid; BORDER-RIGHT: black 2px solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 12.6pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">105,000</font></div>
</td>
<td valign="top" width="14%" style="BORDER-BOTTOM: black 2px solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font></div>
</td>
<td valign="top" width="16%" style="BORDER-BOTTOM: black 2px solid; BORDER-LEFT: black 2px solid; BORDER-RIGHT: black 2px solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 12.6pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">4.38</font></div>
</td>
<td valign="top" width="16%" style="BORDER-BOTTOM: black 2px solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 13.7pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">12/25/2017</font></div>
</td>
<td valign="top" width="14%" style="BORDER-BOTTOM: black 2px solid; BORDER-LEFT: black 2px solid; BORDER-RIGHT: black 2px solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font></div>
</td>
<td valign="top" width="14%" style="BORDER-BOTTOM: black 2px solid; BORDER-RIGHT: black 2px solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font></div>
</td>
</tr><tr>
<td valign="top" width="10%" style="BORDER-BOTTOM: black 2px solid; BORDER-LEFT: black 2px solid; BORDER-RIGHT: black 2px solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 12.6pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">110,000</font></div>
</td>
<td valign="top" width="14%" style="BORDER-BOTTOM: black 2px solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font></div>
</td>
<td valign="top" width="16%" style="BORDER-BOTTOM: black 2px solid; BORDER-LEFT: black 2px solid; BORDER-RIGHT: black 2px solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 12.6pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">0.62</font></div>
</td>
<td valign="top" width="16%" style="BORDER-BOTTOM: black 2px solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 13.7pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">10/30/2018</font></div>
</td>
<td valign="top" width="14%" style="BORDER-BOTTOM: black 2px solid; BORDER-LEFT: black 2px solid; BORDER-RIGHT: black 2px solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font></div>
</td>
<td valign="top" width="14%" style="BORDER-BOTTOM: black 2px solid; BORDER-RIGHT: black 2px solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font></div>
</td>
</tr><tr>
<td valign="top" width="10%" style="BORDER-BOTTOM: black 2px solid; BORDER-LEFT: black 2px solid; BORDER-RIGHT: black 2px solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font></div>
</td>
<td valign="top" width="14%" style="BORDER-BOTTOM: black 2px solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font></div>
</td>
<td valign="top" width="16%" style="BORDER-BOTTOM: black 2px solid; BORDER-LEFT: black 2px solid; BORDER-RIGHT: black 2px solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0.6pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font></div>
</td>
<td valign="top" width="16%" style="BORDER-BOTTOM: black 2px solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font></div>
</td>
<td valign="top" width="14%" style="BORDER-BOTTOM: black 2px solid; BORDER-LEFT: black 2px solid; BORDER-RIGHT: black 2px solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">175,000 (1)</font></div>
</td>
<td valign="top" width="14%" style="BORDER-BOTTOM: black 2px solid; BORDER-RIGHT: black 2px solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$546,000</font></div>
</td>
</tr><tr>
<td valign="top" width="10%" style="BORDER-BOTTOM: black 2px solid; BORDER-LEFT: black 2px solid; BORDER-RIGHT: black 2px solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font></div>
</td>
<td valign="top" width="14%" style="BORDER-BOTTOM: black 2px solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font></div>
</td>
<td valign="top" width="16%" style="BORDER-BOTTOM: black 2px solid; BORDER-LEFT: black 2px solid; BORDER-RIGHT: black 2px solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0.6pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font></div>
</td>
<td valign="top" width="16%" style="BORDER-BOTTOM: black 2px solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font></div>
</td>
<td valign="top" width="14%" style="BORDER-BOTTOM: black 2px solid; BORDER-LEFT: black 2px solid; BORDER-RIGHT: black 2px solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">112,500 (2)</font></div>
</td>
<td valign="top" width="14%" style="BORDER-BOTTOM: black 2px solid; BORDER-RIGHT: black 2px solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$351,000</font></div>
</td>
</tr><tr>
<td align="left" rowspan="6" valign="top" width="10%" style="BORDER-BOTTOM: black 2px solid; BORDER-LEFT: black 2px solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Yaky Yanay</font></div>
</td>
<td valign="top" width="14%" style="BORDER-BOTTOM: black 2px solid; BORDER-LEFT: black 2px solid; BORDER-RIGHT: black 2px solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 12.6pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">62,500</font></div>
</td>
<td valign="top" width="16%" style="BORDER-BOTTOM: black 2px solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font></div>
</td>
<td valign="top" width="16%" style="BORDER-BOTTOM: black 2px solid; BORDER-LEFT: black 2px solid; BORDER-RIGHT: black 2px solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 12.6pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">4.38</font></div>
</td>
<td valign="top" width="14%" style="BORDER-BOTTOM: black 2px solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 13.7pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">12/25/2017</font></div>
</td>
<td valign="top" width="14%" style="BORDER-BOTTOM: black 2px solid; BORDER-LEFT: black 2px solid; BORDER-RIGHT: black 2px solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font></div>
</td>
<td valign="top" width="16%" style="BORDER-BOTTOM: black 2px solid; BORDER-RIGHT: black 2px solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font></div>
</td>
</tr><tr>
<td valign="top" width="10%" style="BORDER-BOTTOM: black 2px solid; BORDER-LEFT: black 2px solid; BORDER-RIGHT: black 2px solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 12.6pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">12,500</font></div>
</td>
<td valign="top" width="14%" style="BORDER-BOTTOM: black 2px solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font></div>
</td>
<td valign="top" width="16%" style="BORDER-BOTTOM: black 2px solid; BORDER-LEFT: black 2px solid; BORDER-RIGHT: black 2px solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 12.6pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">4.00</font></div>
</td>
<td valign="top" width="16%" style="BORDER-BOTTOM: black 2px solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 13.7pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">9/17/2016</font></div>
</td>
<td valign="top" width="14%" style="BORDER-BOTTOM: black 2px solid; BORDER-LEFT: black 2px solid; BORDER-RIGHT: black 2px solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font></div>
</td>
<td valign="top" width="14%" style="BORDER-BOTTOM: black 2px solid; BORDER-RIGHT: black 2px solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font></div>
</td>
</tr><tr>
<td valign="top" width="10%" style="BORDER-BOTTOM: black 2px solid; BORDER-LEFT: black 2px solid; BORDER-RIGHT: black 2px solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 12.6pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">50,000</font></div>
</td>
<td valign="top" width="14%" style="BORDER-BOTTOM: black 2px solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font></div>
</td>
<td valign="top" width="16%" style="BORDER-BOTTOM: black 2px solid; BORDER-LEFT: black 2px solid; BORDER-RIGHT: black 2px solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 12.6pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">3.50</font></div>
</td>
<td valign="top" width="16%" style="BORDER-BOTTOM: black 2px solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 13.7pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">1/23/2017</font></div>
</td>
<td valign="top" width="14%" style="BORDER-BOTTOM: black 2px solid; BORDER-LEFT: black 2px solid; BORDER-RIGHT: black 2px solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font></div>
</td>
<td valign="top" width="14%" style="BORDER-BOTTOM: black 2px solid; BORDER-RIGHT: black 2px solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font></div>
</td>
</tr><tr>
<td valign="top" width="10%" style="BORDER-BOTTOM: black 2px solid; BORDER-LEFT: black 2px solid; BORDER-RIGHT: black 2px solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 12.6pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">55,000</font></div>
</td>
<td valign="top" width="14%" style="BORDER-BOTTOM: black 2px solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font></div>
</td>
<td valign="top" width="16%" style="BORDER-BOTTOM: black 2px solid; BORDER-LEFT: black 2px solid; BORDER-RIGHT: black 2px solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 12.6pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">0.62</font></div>
</td>
<td valign="top" width="16%" style="BORDER-BOTTOM: black 2px solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 13.7pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">10/30/2018</font></div>
</td>
<td valign="top" width="14%" style="BORDER-BOTTOM: black 2px solid; BORDER-LEFT: black 2px solid; BORDER-RIGHT: black 2px solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font></div>
</td>
<td valign="top" width="14%" style="BORDER-BOTTOM: black 2px solid; BORDER-RIGHT: black 2px solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font></div>
</td>
</tr><tr>
<td valign="top" width="10%" style="BORDER-BOTTOM: black 2px solid; BORDER-LEFT: black 2px solid; BORDER-RIGHT: black 2px solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font></div>
</td>
<td valign="top" width="14%" style="BORDER-BOTTOM: black 2px solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font></div>
</td>
<td valign="top" width="16%" style="BORDER-BOTTOM: black 2px solid; BORDER-LEFT: black 2px solid; BORDER-RIGHT: black 2px solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font></div>
</td>
<td valign="top" width="16%" style="BORDER-BOTTOM: black 2px solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font></div>
</td>
<td valign="top" width="14%" style="BORDER-BOTTOM: black 2px solid; BORDER-LEFT: black 2px solid; BORDER-RIGHT: black 2px solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">125,000 (3)</font></div>
</td>
<td valign="top" width="14%" style="BORDER-BOTTOM: black 2px solid; BORDER-RIGHT: black 2px solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$390,000</font></div>
</td>
</tr><tr>
<td valign="top" width="10%" style="BORDER-BOTTOM: black 2px solid; BORDER-LEFT: black 2px solid; BORDER-RIGHT: black 2px solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font></div>
</td>
<td valign="top" width="14%" style="BORDER-BOTTOM: black 2px solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font></div>
</td>
<td valign="top" width="16%" style="BORDER-BOTTOM: black 2px solid; BORDER-LEFT: black 2px solid; BORDER-RIGHT: black 2px solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font></div>
</td>
<td valign="top" width="16%" style="BORDER-BOTTOM: black 2px solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font></div>
</td>
<td valign="top" width="14%" style="BORDER-BOTTOM: black 2px solid; BORDER-LEFT: black 2px solid; BORDER-RIGHT: black 2px solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">112,500 (4)</font></div>
</td>
<td valign="top" width="14%" style="BORDER-BOTTOM: black 2px solid; BORDER-RIGHT: black 2px solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$351,000</font></div>
</td>
</tr><tr>
<td align="left" rowspan="2" valign="top" width="10%" style="BORDER-BOTTOM: black 2px solid; BORDER-LEFT: black 2px solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Boaz</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Gur-Lavie</font></div>
</td>
<td valign="top" width="14%" style="BORDER-BOTTOM: black 2px solid; BORDER-LEFT: black 2px solid; BORDER-RIGHT: black 2px solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font></div>
</td>
<td valign="top" width="16%" style="BORDER-BOTTOM: black 2px solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font></div>
</td>
<td valign="top" width="16%" style="BORDER-BOTTOM: black 2px solid; BORDER-LEFT: black 2px solid; BORDER-RIGHT: black 2px solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font></div>
</td>
<td valign="top" width="14%" style="BORDER-BOTTOM: black 2px solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font></div>
</td>
<td valign="top" width="14%" style="BORDER-BOTTOM: black 2px solid; BORDER-LEFT: black 2px solid; BORDER-RIGHT: black 2px solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">14,750 (5)</font></div>
</td>
<td valign="top" width="16%" style="BORDER-BOTTOM: black 2px solid; BORDER-RIGHT: black 2px solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$46,020</font></div>
</td>
</tr><tr>
<td valign="top" width="10%" style="BORDER-BOTTOM: black 2px solid; BORDER-LEFT: black 2px solid; BORDER-RIGHT: black 2px solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font></div>
</td>
<td valign="top" width="14%" style="BORDER-BOTTOM: black 2px solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font></div>
</td>
<td valign="top" width="16%" style="BORDER-BOTTOM: black 2px solid; BORDER-LEFT: black 2px solid; BORDER-RIGHT: black 2px solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font></div>
</td>
<td valign="top" width="16%" style="BORDER-BOTTOM: black 2px solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font></div>
</td>
<td valign="top" width="14%" style="BORDER-BOTTOM: black 2px solid; BORDER-LEFT: black 2px solid; BORDER-RIGHT: black 2px solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">26,000 (6)</font></div>
</td>
<td valign="top" width="14%" style="BORDER-BOTTOM: black 2px solid; BORDER-RIGHT: black 2px solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$81,120</font></div>
</td>
</tr></table>
</div>

<div>&#160;</div>

<div>
<table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td style="WIDTH: 18pt">
<div><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160; </font></div>
</td>
<td style="WIDTH: 36pt">
<div style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">(1)</font></div>
</td>
<td>
<div align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">175,000 restricted shares vest in four installments of 43,750 shares on each of September 27, 2014, December 27, 2014, March 27, 2015 and June 27, 2015.</font></div>
</td>
</tr></table>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div>
<table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td style="WIDTH: 18pt">
<div><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160; </font></div>
</td>
<td style="WIDTH: 36pt">
<div style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">(2)</font></div>
</td>
<td>
<div align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">112,500 restricted shares vest in six installments of 18,750 shares on each of September 26, 2014, December 26, 2014, March 26, 2015, June 26, 2015, September 26, 2015 and December 26, 2015.</font></div>
</td>
</tr></table>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div>
<table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td style="WIDTH: 18pt">
<div><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160; </font></div>
</td>
<td style="WIDTH: 36pt">
<div style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">(3)</font></div>
</td>
<td>
<div align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">125,000 restricted shares vest in four installments of 31,250 shares on each of September 27, 2014, December 27, 2014, March 27, 2015 and June 27, 2015.</font></div>
</td>
</tr></table>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div>
<table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td style="WIDTH: 18pt">
<div><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160; </font></div>
</td>
<td style="WIDTH: 36pt">
<div style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">(4)</font></div>
</td>
<td>
<div align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">112,500 restricted shares vest in six installments of 18,750 shares on each of September 26, 2014, December 26, 2014, March 26, 2015, June 26, 2015, September 26, 2015 and December 26, 2015.</font></div>
</td>
</tr></table>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div id="PGBRK" style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div id="FTR">
<div id="GLFTR" style="WIDTH: 100%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>

<div id="PN" style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
<div style="TEXT-ALIGN: center; WIDTH: 100%"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">48</font></div>

<div style="TEXT-ALIGN: center; WIDTH: 100%">
<hr style="COLOR: black" noshade size="2">
</div>
</div>

<div id="HDR">
<div id="GLHDR" style="WIDTH: 100%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">
<table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td style="WIDTH: 18pt">
<div><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160; </font></div>
</td>
<td style="WIDTH: 36pt">
<div style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">(5)</font></div>
</td>
<td>
<div align="left">
<div style="TEXT-ALIGN: justify; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">7,500 restricted shares vest in two installments of 3,750 shares on each of August 4, 2014 and November 4, 2014. 7,250 restricted shares will vest upon goals achievement.</font></font></div>
</div>
</td>
</tr></table>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">
<table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td style="WIDTH: 18pt">
<div><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160; </font></div>
</td>
<td style="WIDTH: 36pt">
<div style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">(6)</font></font></div>
</div>
</td>
<td>
<div align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">5,000 RSUs vests over a two-year period from the date of grant, as follows: 1,250 RSUs vested on&#160;&#160;&#160;&#160;&#160;August 4, 2014 and&#160;&#160;3,750 RSUs vest in six installments of 6,25 shares on each of November 4, 2014,&#160;&#160;February 4, 2015, May 4, 2015, August 4, 2015, November 4, 2015 and February 4, 2016. 21,000 RSUs will vest upon goals achievement.</font></div>
</td>
</tr></table>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;</font></div>

<div>
<div style="TEXT-ALIGN: left; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Option Exercises and Stock Vested Table</font></div>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">The following table presents the option exercises and stock vested awards during fiscal year 2014 by our executive officers:</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div align="center">
<table cellpadding="2" cellspacing="0" width="80%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr>
<td valign="bottom" width="52%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td colspan="6" valign="bottom" width="22%" style="BORDER-BOTTOM: black 2px solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Option Awards</font></div>
</td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td colspan="6" valign="bottom" width="22%" style="BORDER-BOTTOM: black 2px solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Stock Awards</font></div>
</td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
</tr><tr>
<td align="left" valign="bottom" width="52%" style="BORDER-BOTTOM: black 2px solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Name</font></div>
</td>
<td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="left" colspan="2" valign="bottom" width="10%" style="BORDER-BOTTOM: black 2px solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Number of Shares Acquired on Exercise (#)</font></div>
</td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="left" colspan="2" valign="bottom" width="10%" style="BORDER-BOTTOM: black 2px solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Value Realized on Exercise ($)</font></div>
</td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="left" colspan="2" valign="bottom" width="10%" style="BORDER-BOTTOM: black 2px solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Number of Shares Acquired on Vesting (#)</font></div>
</td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="left" colspan="2" valign="bottom" width="10%" style="BORDER-BOTTOM: black 2px solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Value Realized on Vesting ($)</font></div>
</td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
</tr><tr bgcolor="#cceeff">
<td align="left" valign="bottom" width="52%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Zami Aberman</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">300,000</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">989,875</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
</tr><tr bgcolor="white">
<td align="left" valign="bottom" width="52%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Yaky Yanay</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">225,000</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">740,375</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
</tr><tr bgcolor="#cceeff">
<td align="left" valign="bottom" width="52%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Boaz Gur-Lavie</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">16,750</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">63,370</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
</tr></table>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Long-Term Incentive Plans-Awards in Last Fiscal Year</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">We have no long-term incentive plans, other than the stock option plans described below under Item 12.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Compensation of Directors</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">The following table provides information regarding compensation earned by, awarded or paid to each person for serving as a director who is not an executive officer during Fiscal 2014:</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-ALIGN: center">
<table cellpadding="0" cellspacing="0" width="80%" style="TEXT-ALIGN: center; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr style="TEXT-ALIGN: center;">
<td align="left" valign="bottom" width="64%" style="BORDER-BOTTOM: black 2px solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Name</font></div>
</td>
<td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;</font></td>
<td colspan="2" valign="bottom" width="10%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: center">
<div style="TEXT-ALIGN: center; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Fees Earned or Paid in Cash ($)</font></div>
</td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;</font></td>
<td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;</font></td>
<td colspan="2" valign="bottom" width="10%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: center">
<div style="TEXT-ALIGN: center; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Stock-based Awards ($) (1)</font></div>
</td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;</font></td>
<td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;</font></td>
<td colspan="2" valign="bottom" width="10%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: center">
<div style="TEXT-ALIGN: center; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Total ($)</font></div>
</td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;</font></td>
</tr><tr bgcolor="#cceeff">
<td align="left" valign="bottom" width="64%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Mark Germain</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">16,480</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font id="TAB1" style="MARGIN-LEFT: 16.6pt"></font>213,200</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(2)</font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">229,680</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
</tr><tr bgcolor="white">
<td align="left" valign="bottom" width="64%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Nachum Rosman</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">27,342</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font id="TAB1" style="MARGIN-LEFT: 26.05pt"></font>164,000</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">191,342</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
</tr><tr bgcolor="#cceeff">
<td align="left" valign="bottom" width="64%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Doron Shorrer</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">24,936</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font id="TAB1" style="MARGIN-LEFT: 26.05pt"></font>164,000</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">188,936</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
</tr><tr bgcolor="white">
<td align="left" valign="bottom" width="64%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Hava Meretzki</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">21,854</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font id="TAB1" style="MARGIN-LEFT: 26.05pt"></font>114,800</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">136,654</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
</tr><tr bgcolor="#cceeff">
<td align="left" valign="bottom" width="64%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Isaac Braun</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">23,636</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font id="TAB1" style="MARGIN-LEFT: 26.05pt"></font>114,800</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">138,436</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
</tr><tr bgcolor="white">
<td align="left" valign="bottom" width="64%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Israel Ben-Yoram</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">28,996</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font id="TAB1" style="MARGIN-LEFT: 26.05pt"></font>164,000</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">192,996</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
</tr><tr bgcolor="#cceeff">
<td align="left" valign="bottom" width="64%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Moria Kwiat</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">23,644</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font id="TAB1" style="MARGIN-LEFT: 26.05pt"></font>114,800</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">138,444</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
</tr></table>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div>
<table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td style="WIDTH: 2.25pt">
<div><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160; </font></div>
</td>
<td style="WIDTH: 36pt">
<div style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">(1)</font></div>
</td>
<td>
<div align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">The fair value recognized for the stock-based awards was determined as of the grant date in accordance with ASC 718. Assumptions used in the calculations for these amounts are included in Note 2(l) to our consolidated financial statements for Fiscal 2014 included elsewhere in this Annual Report.</font></div>
</td>
</tr></table>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div>
<table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td style="WIDTH: 2.25pt">
<div><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160; </font></div>
</td>
<td style="WIDTH: 36pt">
<div style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">(2)</font></div>
</td>
<td>
<div align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Includes 30,000 RSUs granted to Mark Germain as an award for his contribution for M&amp;A activities.</font></div>
</td>
</tr></table>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 36pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">We reimburse our directors for expenses incurred in connection with attending board meetings and provide the following compensation for directors: annual compensation of $12,500; meeting participation fees of $935 per in-person meeting; and for meeting participation by telephone, $435 per meeting. On May 17, 2007, the Board decided that the dollar rate would be not less then 4.25 NIS per dollar. The directors are also entitled to two and a half percent (2.5%) in cash based on amounts received by us from non-diluting funding and strategic deals.</font></div>

<div style="TEXT-INDENT: 36pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left">&#160;</div>

<div id="PGBRK" style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div id="FTR">
<div id="GLFTR" style="WIDTH: 100%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>

<div id="PN" style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
<div style="TEXT-ALIGN: center; WIDTH: 100%"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">49</font></div>

<div style="TEXT-ALIGN: center; WIDTH: 100%">
<hr style="COLOR: black" noshade size="2">
</div>
</div>

<div id="HDR">
<div id="GLHDR" style="WIDTH: 100%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 36pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">During Fiscal 2014 we paid a total of $166,888 to directors as compensation. This amount does not include compensation to Mr. Aberman in his capacity as a director, which is reflected in the Summary Compensation Table for Fiscal 2014 above. As of June 30, 2014, we granted our directors (not including the Chairman) 3,202,145 options, restricted shares and RSUs of which 2,220,704 were exercisable or vested, as the case may be.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 36pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">The vesting of directors' stock options, RSUs and restricted stock accelerates in the following circumstances: (1) termination of a director's position by the stockholders will result in the acceleration of 100% of any unvested options, RSUs and restricted stock and (2) termination of a director's position by resignation will result in the acceleration of 50% of any unvested options and, RSUs restricted stock.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 36pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Other than as described in the preceding four paragraphs, we have no present formal plan for compensating our directors for their service in their capacity as directors. Directors are entitled to reimbursement for reasonable travel and other out-of-pocket expenses incurred in connection with attendance at meetings of our Board. The Board may award special remuneration to any director undertaking any special services on our behalf other than services ordinarily required of a director. Other than indicated above, no director received and/or accrued any compensation for his or her services as a director, including committee participation and/or special assignments during Fiscal 2014.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"><a name="12">Item 12. Security Ownership of Certain Beneficial Owners and Management and Related Stockholders Matters.</a></font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 36pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">The following table sets forth certain information, to the best knowledge and belief of the Company, as of August&#160;25, 2014(unless provided herein otherwise), with respect to holdings of our common stock by (1) each person known by us to be the beneficial owner of more than 5% of the total number of shares of our common stock outstanding as of such date; (2) each of our directors; (3) each of our executive officers; and (4) all of our directors and our executive officers as a group.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div align="left">
<table cellpadding="0" cellspacing="0" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr>
<td align="left" valign="bottom" style="BORDER-BOTTOM: black 2px solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline">Name and Address of Beneficial Owner</font></font></div>
</td>
<td align="left" valign="bottom" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="left" colspan="2" valign="bottom" style="BORDER-BOTTOM: black 2px solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline">Beneficial Number of Shares</font>(1)</font></div>
</td>
<td nowrap valign="bottom" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="left" valign="bottom" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="left" colspan="2" valign="bottom" style="BORDER-BOTTOM: black 2px solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline">Percentage</font></font></div>
</td>
<td nowrap valign="bottom" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
</tr><tr>
<td align="left" valign="bottom" style="BORDER-BOTTOM: black 2px solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline">Directors and Named Executive Officers</font></font></div>
</td>
<td valign="bottom" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td colspan="2" valign="bottom" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td nowrap valign="bottom" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td colspan="2" valign="bottom" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td nowrap valign="bottom" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
</tr><tr>
<td valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td colspan="2" valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td nowrap valign="bottom" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td colspan="2" valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td nowrap valign="bottom" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
</tr><tr bgcolor="#cceeff">
<td align="left" valign="bottom" width="76%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Zami Aberman</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">CEO, Chairman of the Board and Director</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">2,007,798</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(2)</font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">2.9</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">%</font></td>
</tr><tr bgcolor="white">
<td valign="bottom" width="76%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
</tr><tr bgcolor="#cceeff">
<td align="left" valign="bottom" width="76%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Israel Ben-Yoram</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Director</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">311,534</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(3)</font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">*</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
</tr><tr bgcolor="white">
<td valign="bottom" width="76%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
</tr><tr bgcolor="#cceeff">
<td align="left" valign="bottom" width="76%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Isaac Braun</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Director</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">353,506</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(4)</font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">*</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
</tr><tr bgcolor="white">
<td valign="bottom" width="76%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
</tr><tr bgcolor="#cceeff">
<td align="left" valign="bottom" width="76%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Mark Germain</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Director</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">539,261</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(5)</font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">*</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
</tr><tr bgcolor="white">
<td valign="bottom" width="76%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
</tr><tr bgcolor="#cceeff">
<td align="left" valign="bottom" width="76%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Boaz Gur-Lavie</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">CFO and Secretary</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">40,500</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">*</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
</tr><tr bgcolor="white">
<td valign="bottom" width="76%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
</tr><tr bgcolor="#cceeff">
<td align="left" valign="bottom" width="76%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Moria Kwiat</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Director</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">31,875</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">*</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
</tr><tr bgcolor="white">
<td valign="bottom" width="76%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
</tr><tr bgcolor="#cceeff">
<td align="left" valign="bottom" width="76%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Hava Meretzki</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Director</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">353,083</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(6)</font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">*</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
</tr><tr bgcolor="white">
<td valign="bottom" width="76%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
</tr><tr bgcolor="#cceeff">
<td align="left" valign="bottom" width="76%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Nachum Rosman</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Director</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">213,716</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(7)</font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">*</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
</tr><tr bgcolor="white">
<td valign="bottom" width="76%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
</tr><tr bgcolor="#cceeff">
<td align="left" valign="bottom" width="76%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Doron Shorrer</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Director</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">516,583</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(8)</font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">*</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
</tr><tr bgcolor="white">
<td valign="bottom" width="76%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
</tr><tr bgcolor="#cceeff">
<td align="left" valign="bottom" width="76%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Yaky Yanay</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">President and COO</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">1,062,116</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(9)</font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">1.53</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">%</font></td>
</tr><tr bgcolor="white">
<td valign="bottom" width="76%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
</tr><tr bgcolor="#cceeff">
<td align="left" valign="bottom" width="76%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-DECORATION: underline"><font style="DISPLAY: inline">Directors and Executive Officers as a group (10 persons)</font></font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">5,429,972</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(10)</font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">7.7</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">%</font></td>
</tr></table>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">_________________</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">* = less than 1%</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left">&#160;</div>

<div id="PGBRK" style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div id="FTR">
<div id="GLFTR" style="WIDTH: 100%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>

<div id="PN" style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
<div style="TEXT-ALIGN: center; WIDTH: 100%"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">50</font></div>

<div style="TEXT-ALIGN: center; WIDTH: 100%">
<hr style="COLOR: black" noshade size="2">
</div>
</div>

<div id="HDR">
<div id="GLHDR" style="WIDTH: 100%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">(1)&#160;&#160;Based on 69,245,762 shares of common stock issued and outstanding as of August 25, 2014. Except as otherwise indicated, we believe that the beneficial owners of the common stock listed above, based on information furnished by such owners, have sole investment and voting power with respect to such shares, subject to community property laws where applicable. Beneficial ownership is determined in accordance with the rules of the SEC and generally includes voting or investment power with respect to securities. Shares of common stock subject to options, warrants or right to purchase or through the conversion of a security currently exercisable or convertible, or exercisable or convertible within 60 days, are reflected in the table above and are deemed outstanding for purposes of computing the percentage ownership of the person holding such option or warrants, but are not deemed outstanding for purposes of computing the percentage ownership of any other person.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">(2)&#160;&#160;Includes options to acquire 517,500 shares.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">(3)&#160;&#160;Includes options to acquire 66,776 shares.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">(4)&#160;&#160;Includes options to acquire 93,923 shares.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">(5)&#160;&#160;Includes options to acquire 307,500 shares.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">(6)&#160;&#160;Includes options to acquire 93,500 shares.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">(7)&#160;&#160;Includes options to acquire 63,750 shares.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">(8)&#160;&#160;Includes options to acquire 114,500 shares.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">(9)&#160;&#160;Includes options to acquire 180,000 shares.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">(10)&#160;&#160;Includes options to acquire 1,437,449 shares.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Equity Compensation Plan Information</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 36pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">On November 25, 2003, our Board of Directors adopted the 2003 Plan.&#160;&#160;The 2003 Plan has expired, and we do not grant additional options under it.&#160;&#160;Under the 2003 Plan, options were granted to our officers, directors, employees and consultants or the officers, directors, employees and consultants of our subsidiary. As of today, there are 1,199 options that were granted and still outstanding under the 2003 Plan.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 36pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">On November 21, 2005, our Board of Directors adopted the 2005 Plan. Under the 2005 Plan, options may be granted to our officers, directors, employees and consultants or the officers, directors, employees and consultants of our subsidiary.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 36pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">At our annual meeting of our stockholders held on January 21, 2009, our stockholders approved the adoption of the Amended and Restated 2005 Stock Option Plan of the Company, amending the 2005 Plan in order to: (i) increase the number of shares of common stock authorized for issuance thereunder from 1,990,000 to be equal to 16% of the number of shares of common stock issued and outstanding on a fully diluted basis immediately prior to the grant of securities; (ii) allow the issuance of shares of common stock and units for such shares of common stock; and (iii) set the termination date of the 2005 Plan to December 31, 2018.</font></div>

<div id="PGBRK" style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div id="FTR">
<div id="GLFTR" style="WIDTH: 100%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>

<div id="PN" style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
<div style="TEXT-ALIGN: center; WIDTH: 100%"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">51</font></div>

<div style="TEXT-ALIGN: center; WIDTH: 100%">
<hr style="COLOR: black" noshade size="2">
</div>
</div>

<div id="HDR">
<div id="GLHDR" style="WIDTH: 100%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 36pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">The following table summarizes certain information regarding our equity compensation plans as of June 30, 2014:</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div align="left">
<table cellpadding="0" cellspacing="0" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr>
<td align="left" valign="bottom" width="64%" style="BORDER-BOTTOM: black 2px solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Plan Category</font></div>
</td>
<td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="left" colspan="2" valign="bottom" width="10%" style="BORDER-BOTTOM: black 2px solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Number of securities to be issued upon exercise of outstanding options, warrants and rights</font></div>
</td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="left" colspan="2" valign="bottom" width="10%" style="BORDER-BOTTOM: black 2px solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Weighted-average exercise price of outstanding options, warrants and rights</font></div>
</td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="left" colspan="2" valign="bottom" width="10%" style="BORDER-BOTTOM: black 2px solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Number of securities remaining available for future issuance under equity compensation plans</font></div>
</td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
</tr><tr bgcolor="#cceeff">
<td align="left" valign="bottom" width="64%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Equity compensation plan approved by security holders</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">2,114,099</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(1)</font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">3.90</font> </td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">1,205,080</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
</tr></table>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block">&#160;</div>

<div>
<table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td style="WIDTH: 18pt">
<div><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160; </font></div>
</td>
<td style="WIDTH: 18pt">
<div style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">(1)</font></div>
</td>
<td>
<div align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Consists of (i) 2,112,900 options granted under the 2005 Plan; and (ii) 1,199 options granted under the 2003 Plan. As of June 30, 2014, there are 1,205,080 shares of our common stock available for future grant under the 2005 Plan.</font></div>
</td>
</tr></table>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"><a name="13">Item 13.&#160;&#160;Certain Relationships and Related Transactions and Director Independence.</a></font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 36pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">No director, executive officer, principal shareholder holding at least 5% of our common shares, or any family member thereof, had any material interest, direct or indirect, in any transaction, or proposed transaction, during Fiscal 2014, in which the amount involved in the transaction exceeded or exceeds $120,000.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 36pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">The Board of Directors has determined that Doron Shorrer, Nachum Rosman and Israel Ben-Yoram are "independent" as defined by the rules of the SEC and the NASDAQ rules and regulations.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"><a name="14">Item 14.&#160;&#160;Principal Accounting Fees and Services</a></font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">The fees for services provided by Kost Forer Gabbay &amp; Kasierer, a member of Ernst &amp; Young Global, to the Company in the last two fiscal years were as follows:</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div align="left">
<table cellpadding="0" cellspacing="0" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr>
<td valign="bottom" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="bottom" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="left" colspan="2" valign="bottom" style="BORDER-BOTTOM: black 2px solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Twelve months ended on June 30, 2014</font></div>
</td>
<td nowrap valign="bottom" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="left" valign="bottom" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="left" colspan="2" valign="bottom" style="BORDER-BOTTOM: black 2px solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Twelve months ended on June 30, 2013</font></div>
</td>
<td nowrap valign="bottom" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
</tr><tr>
<td valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td colspan="2" valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td nowrap valign="bottom" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td colspan="2" valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td nowrap valign="bottom" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
</tr><tr bgcolor="#cceeff">
<td align="left" valign="bottom" width="76%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: -0.9pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Audit Fees&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">103,000</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">95,000</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
</tr><tr bgcolor="white">
<td valign="bottom" width="76%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
</tr><tr bgcolor="#cceeff">
<td align="left" valign="bottom">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Audit-Related Fees&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font></div>
</td>
<td align="left" valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="left" colspan="2" valign="bottom">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">None</font></div>
</td>
<td nowrap valign="bottom" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="left" valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="left" colspan="2" valign="bottom">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">None</font></div>
</td>
<td nowrap valign="bottom" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
</tr><tr bgcolor="white">
<td valign="bottom" width="76%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
</tr><tr bgcolor="#cceeff">
<td align="left" valign="bottom" width="76%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Tax Fees&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">5,000</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">16,113</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
</tr><tr bgcolor="white">
<td valign="bottom" width="76%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
</tr><tr bgcolor="#cceeff">
<td align="left" valign="bottom" width="76%" style="PADDING-BOTTOM: 2px">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">All Other Fees&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font></div>
</td>
<td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline">12,742</font></font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline">119,883</font></font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
</tr><tr bgcolor="white">
<td valign="bottom" width="76%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
</tr><tr bgcolor="#cceeff">
<td align="left" valign="bottom" width="76%" style="PADDING-BOTTOM: 4px">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Total Fees&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font></div>
</td>
<td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline">120,742</font></font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline">230,996</font></font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
</tr></table>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"><font style="FONT-STYLE: italic; DISPLAY: inline">Audit Fees</font>. These fees were comprised of professional services rendered in connection with the audit of our consolidated financial statements for our Annual Report, the review of our quarterly consolidated financial statements for our quarterly reports on Form 10-Q and assistance with review of our response to SEC comments on our Annual Report on Form 10-K for the fiscal year ended June 30, 2013.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"><font style="FONT-STYLE: italic; DISPLAY: inline">Tax Fees.</font> These fees relate to our tax compliance, tax planning and fees relating to obtaining a pre-ruling with the Israeli Tax Authorities.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left">&#160;</div>

<div id="PGBRK" style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div id="FTR">
<div id="GLFTR" style="WIDTH: 100%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>

<div id="PN" style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
<div style="TEXT-ALIGN: center; WIDTH: 100%"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">52</font></div>

<div style="TEXT-ALIGN: center; WIDTH: 100%">
<hr style="COLOR: black" noshade size="2">
</div>
</div>

<div id="HDR">
<div id="GLHDR" style="WIDTH: 100%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"><font style="FONT-STYLE: italic; DISPLAY: inline">All Other Fees</font>. These fees were comprised of fees related to assistance in preparation of OCS applications as well as fees related to the ATM Agreement, and review of the registration statement on S-8 that we filed with the SEC in June 2014.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">SEC rules require that before Kost Forer Gabbay &amp; Kasierer, a member of Ernst &amp; Young Global, is engaged by us to render any auditing or permitted non-audit related service, the engagement be:</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div>
<table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td style="WIDTH: 36pt">
<div style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">1.</font></div>
</td>
<td>
<div align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">pre-approved by our Audit Committee; or</font></div>
</td>
</tr></table>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div>
<table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td style="WIDTH: 36pt">
<div style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">2.</font></div>
</td>
<td>
<div align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">entered into pursuant to pre-approval policies and procedures established by the Audit Committee, provided the policies and procedures are detailed as to the particular service, the Audit Committee is informed of each service, and such policies and procedures do not include delegation of the Audit Committee's responsibilities to management.</font></div>
</td>
</tr></table>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">The Audit Committee pre-approves all services provided by our independent registered public accounting firm. All of the above services and fees were reviewed and approved by the Audit Committee before the services were rendered.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">The Audit Committee has considered the nature and amount of fees billed by Kost Forer Gabbay &amp; Kasierer, a member of Ernst &amp; Young Global, and believes that the provision of services for activities unrelated to the audit is compatible with maintaining Kost Forer Gabbay &amp; Kasierer's independence.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div id="PGBRK" style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div id="FTR">
<div id="GLFTR" style="WIDTH: 100%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>

<div id="PN" style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
<div style="TEXT-ALIGN: center; WIDTH: 100%"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">53</font></div>

<div style="TEXT-ALIGN: center; WIDTH: 100%">
<hr style="COLOR: black" noshade size="2">
</div>
</div>

<div id="HDR">
<div id="GLHDR" style="WIDTH: 100%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"><a name="p4">PART IV</a></font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"><a name="15">Item 15.&#160;&#160;Exhibits.</a></font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div>
<table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td style="WIDTH: 36pt">
<div style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">3.1</font></div>
</td>
<td>
<div align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Composite Copy of the Company&#8217;s Articles of Incorporation as amended on May 22, 2014 (incorporated by reference to Exhibit 4.1 of our Registration Statement on Form S-8 filed June 5, 2014).</font></div>
</td>
</tr></table>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div>
<table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td style="WIDTH: 36pt">
<div style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">3.2</font></div>
</td>
<td>
<div align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Amended By-laws (incorporated by reference to Exhibit 3.1 of our quarterly report on Form 10-Q filed February 9, 2012).</font></div>
</td>
</tr></table>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div>
<table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td style="WIDTH: 36pt">
<div style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">4.1</font></div>
</td>
<td>
<div align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Form of Common Stock Purchase Warrant dated October 18, 2010 (incorporated by reference to Exhibit 4.1 of our current report on Form 8-K filed on October 12, 2010).</font></div>
</td>
</tr></table>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div>
<table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td style="WIDTH: 36pt">
<div style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">4.2</font></div>
</td>
<td>
<div align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Form of Warrant Agreement by and between Pluristem Therapeutics Inc. and&#160;&#160;American Stock Transfer &amp; Trust Company, LLC (including the form of Warrant certificate) (incorporate by reference to Exhibit 4.2 of our quarterly report on Form 10-Q filed on February 9, 2011).</font></div>
</td>
</tr></table>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div>
<table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td style="WIDTH: 36pt">
<div style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">10.1</font></div>
</td>
<td>
<div align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Consulting Agreement dated September 26, 2005 between Pluristem Ltd. and Rose High Tech Ltd. (incorporated by reference to Exhibit 10.25 of our quarterly report on Form 10-QSB filed February 9, 2006).+</font></div>
</td>
</tr></table>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div>
<table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td style="WIDTH: 36pt">
<div style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">10.2</font></div>
</td>
<td>
<div align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Summary of Lease Agreement dated January 22, 2003, by and between Pluristem Ltd. and MTM &#8211; Scientific Industries Center Haifa Ltd., as supplemented on December 11, 2005, June 12, 2007 and July 19, 2011 (incorporated by reference to Exhibit 10.2 of our annual report on Form 10-K filed September 12, 2011).</font></div>
</td>
</tr></table>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div>
<table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td style="WIDTH: 36pt">
<div style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">10.3</font></div>
</td>
<td>
<div align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Summary of Supplement to the Lease Agreement by and between Pluristem Ltd. and MTM &#8211; Scientific Industries Center Haifa Ltd dated July 31, 2012 (incorporated by reference to Exhibit 10.3 of our annual report on Form 10-K filed on September 11, 2013).</font></div>
</td>
</tr></table>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div>
<table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td style="WIDTH: 36pt">
<div style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">10.4</font></div>
</td>
<td>
<div align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Summary of Supplement to the Lease Agreement by and between Pluristem Ltd. and MTM &#8211; Scientific Industries Center Haifa Ltd dated December 31, 2012 (incorporated by reference to Exhibit 10.4 of our annual report on Form 10-K filed on September 11, 2013).</font></div>
</td>
</tr></table>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div>
<table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td style="WIDTH: 36pt">
<div style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">10.5</font></div>
</td>
<td>
<div align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Assignment Agreement dated May 15, 2007 between Pluristem Therapeutics Inc. and each of Technion Research and Development Foundation Ltd., Shai Meretzki, Dr. Shoshana Merchav (incorporated by reference to Exhibit 10.1 of our current report on Form 8-K filed on May 24, 2007).</font></div>
</td>
</tr></table>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div>
<table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td style="WIDTH: 36pt">
<div style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">10.6</font></div>
</td>
<td>
<div align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Assignment Agreement dated May 15, 2007 between Pluristem Therapeutics Inc. and Yeda Research and Development Ltd. in (incorporated by reference to Exhibit 10.2 of our current report on Form 8-K filed on May 24, 2007).</font></div>
</td>
</tr></table>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div>
<table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td style="WIDTH: 36pt">
<div style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">10.7^</font></div>
</td>
<td>
<div align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Exclusive License Agreement dated June 19, 2011, between Pluristem Ltd. and United Therapeutics Corporation (incorporated by reference to Exhibit 10.5 of our annual report on Form 10-K filed on September 12, 2011).</font></div>
</td>
</tr></table>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div>
<table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td style="WIDTH: 36pt">
<div style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">10.8</font></div>
</td>
<td>
<div align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Exclusive License and Commercialization Agreement dated June 26, 2013, between Pluristem Ltd. and CHA Bio&amp;Diostech (incorporated by reference to Exhibit 10.8 of our annual report on Form 10-K filed on September 11, 2013).</font></div>
</td>
</tr></table>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div>
<table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td style="WIDTH: 36pt">
<div style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">10.9</font></div>
</td>
<td>
<div align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Summary of Directors&#8217; Ongoing Compensation. (incorporated by reference to Exhibit 10.8 of our annual report on Form 10-K filed September 12, 2011). +</font></div>
</td>
</tr></table>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div>
<table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td style="WIDTH: 36pt">
<div style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">10.10</font></div>
</td>
<td>
<div align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">2003 Stock Option Plan (incorporated by reference to Exhibit 4.1 of our registration statement on Form S-8 filed on December 29, 2003) (Registration no. 333-111591). +</font></div>
</td>
</tr></table>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div id="PGBRK" style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div id="FTR">
<div id="GLFTR" style="WIDTH: 100%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>

<div id="PN" style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
<div style="TEXT-ALIGN: center; WIDTH: 100%"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">54</font></div>

<div style="TEXT-ALIGN: center; WIDTH: 100%">
<hr style="COLOR: black" noshade size="2">
</div>
</div>

<div id="HDR">
<div id="GLHDR" style="WIDTH: 100%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div>
<table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td style="WIDTH: 36pt">
<div style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">10.11</font></div>
</td>
<td>
<div align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">The Amended and Restated 2005 Stock Option Plan (incorporated by reference to Exhibit 10.1 of our current report on Form 8-K filed on January 23, 2009). +</font></div>
</td>
</tr></table>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div>
<table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td style="WIDTH: 36pt">
<div style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">10.12</font></div>
</td>
<td>
<div align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Form of Stock Option Agreement under the Amended and Restated 2005 Stock Option Plan. (incorporated by reference to Exhibit 10.4 of our annual report on Form 10-K filed on September 23, 2009). +</font></div>
</td>
</tr></table>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div>
<table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td style="WIDTH: 36pt">
<div style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">10.13</font></div>
</td>
<td>
<div align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Form of Restricted Stock Agreement under the Amended and Restated 2005 Stock Option Plan. (incorporated by reference to Exhibit 10.16 of our annual report on Form 10-K filed on September 23, 2009). +</font></div>
</td>
</tr></table>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div>
<table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td style="WIDTH: 36pt">
<div style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">10.14</font></div>
</td>
<td>
<div align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Form of Restricted Stock Agreement (Israeli directors and officers) under the Amended and Restated 2005 Stock Option Plan. (incorporated by reference to Exhibit 10.17 of our annual report on Form 10-K filed on September 23, 2009). +</font></div>
</td>
</tr></table>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div>
<table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td style="WIDTH: 36pt">
<div style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">10.15</font></div>
</td>
<td>
<div align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Summary of an Agreement for Design and Construction of a Manufacturing Facility of Bio-pharmaceutical Products dated October 30, 2011 (incorporated by reference to Exhibit 10.1 of our quarterly report on Form 10-Q filed on February 9, 2012).</font></div>
</td>
</tr></table>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div>
<table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td style="WIDTH: 36pt">
<div style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">10.16*</font></div>
</td>
<td>
<div align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Letter of Approval Number 37245 to Pluristem Ltd. from Israel&#8217;s Office of the Chief Scientist (translation from Hebrew).</font></div>
</td>
</tr></table>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div>
<table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td style="WIDTH: 36pt">
<div style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">10.17*</font></div>
</td>
<td>
<div align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Letter of Approval Number 38481 to Pluristem Ltd. from Israel&#8217;s Office of the Chief Scientist (translation from Hebrew).</font></div>
</td>
</tr></table>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div>
<table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td style="WIDTH: 36pt">
<div style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">10.18*</font></div>
</td>
<td>
<div align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Letter of Approval Number 40100 to Pluristem Ltd. from Israel&#8217;s Office of the Chief Scientist (translation from Hebrew).</font></div>
</td>
</tr></table>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div>
<table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td style="WIDTH: 36pt">
<div style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">10.19*</font></div>
</td>
<td>
<div align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Letter of Approval Number 41702 to Pluristem Ltd. from Israel&#8217;s Office of the Chief Scientist (translation from Hebrew).</font></div>
</td>
</tr></table>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div>
<table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td style="WIDTH: 36pt">
<div style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">10.20*</font></div>
</td>
<td>
<div align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Letter of Approval Number 42075 to Pluristem Ltd. from Israel&#8217;s Office of the Chief Scientist (translation from Hebrew).</font></div>
</td>
</tr></table>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div>
<table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td style="WIDTH: 36pt">
<div style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">10.21*</font></div>
</td>
<td>
<div align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Letter of Approval Number 43729 to Pluristem Ltd. from Israel&#8217;s Office of the Chief Scientist (translation from Hebrew).</font></div>
</td>
</tr></table>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div>
<table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td style="WIDTH: 36pt">
<div style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">10.22*</font></div>
</td>
<td>
<div align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Letter of Approval Number 44056 to Pluristem Ltd. from Israel&#8217;s Office of the Chief Scientist (translation from Hebrew).</font></div>
</td>
</tr></table>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div>
<table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td style="WIDTH: 36pt">
<div style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">10.23*</font></div>
</td>
<td>
<div align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Letter of Approval Number 45703 to Pluristem Ltd. from Israel&#8217;s Office of the Chief Scientist (translation from Hebrew).</font></div>
</td>
</tr></table>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div>
<table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td style="WIDTH: 36pt">
<div style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">10.24*</font></div>
</td>
<td>
<div align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Letter of Approval Number 46927 to Pluristem Ltd. from Israel&#8217;s Office of the Chief Scientist (translation from Hebrew).</font></div>
</td>
</tr></table>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div>
<table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td style="WIDTH: 36pt">
<div style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">10.25*</font></div>
</td>
<td>
<div align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Letter of Approval Number 47578 to Pluristem Ltd. from Israel&#8217;s Office of the Chief Scientist (translation from Hebrew).</font></div>
</td>
</tr></table>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div>
<table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td style="WIDTH: 36pt">
<div style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">10.26*</font></div>
</td>
<td>
<div align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Letter of Approval Number 48070 to Pluristem Ltd. from Israel&#8217;s Office of the Chief Scientist (translation from Hebrew).</font></div>
</td>
</tr></table>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div>
<table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td style="WIDTH: 36pt">
<div style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">10.27*</font></div>
</td>
<td>
<div align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Letter of Approval Number 49845 to Pluristem Ltd. from Israel&#8217;s Office of the Chief Scientist (translation from Hebrew).</font></div>
</td>
</tr></table>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div id="PGBRK" style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div id="FTR">
<div id="GLFTR" style="WIDTH: 100%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>

<div id="PN" style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
<div style="TEXT-ALIGN: center; WIDTH: 100%"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">55</font></div>

<div style="TEXT-ALIGN: center; WIDTH: 100%">
<hr style="COLOR: black" noshade size="2">
</div>
</div>

<div id="HDR">
<div id="GLHDR" style="WIDTH: 100%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div>
<table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td style="WIDTH: 36pt">
<div style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">10.28*</font></div>
</td>
<td>
<div align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Letter of Approval Number 50435 to Pluristem Ltd. from Israel&#8217;s Office of the Chief Scientist (translation from Hebrew).</font></div>
</td>
</tr></table>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div>
<table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td style="WIDTH: 36pt">
<div style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">10.29*</font></div>
</td>
<td>
<div align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Letter of Approval Number 52103 to Pluristem Ltd. from Israel&#8217;s Office of the Chief Scientist (translation from Hebrew).</font></div>
</td>
</tr></table>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div>
<table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td style="WIDTH: 36pt">
<div style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">10.30*</font></div>
</td>
<td>
<div align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Letter of Approval Number 52802 to Pluristem Ltd. from Israel&#8217;s Office of the Chief Scientist (translation from Hebrew).</font></div>
</td>
</tr></table>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div>
<table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td style="WIDTH: 36pt">
<div style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">21.1</font></div>
</td>
<td>
<div align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">List of Subsidiaries of the Company (incorporated by reference to Exhibit 21.1 of our annual report on Form 10-K filed on September 29, 2008).</font></div>
</td>
</tr></table>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div>
<table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td style="WIDTH: 36pt">
<div style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">23.1*</font></div>
</td>
<td>
<div align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Consent of Kost Forer Gabbay &amp; Kasierer, A member of Ernst &amp; Young Global.</font></div>
</td>
</tr></table>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div>
<table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td style="WIDTH: 36pt">
<div style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">31.1*</font></div>
</td>
<td>
<div align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Certification pursuant to Rule 13a-14(a)/15d-14(a) of Zami Aberman.</font></div>
</td>
</tr></table>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div>
<table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td style="WIDTH: 36pt">
<div style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">31.2*</font></div>
</td>
<td>
<div align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Certification pursuant to Rule 13a-14(a)/15d-14(a) of Boaz Gur-Lavie.</font></div>
</td>
</tr></table>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div>
<table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td style="WIDTH: 36pt">
<div style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">32.1**</font></div>
</td>
<td>
<div align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Certification pursuant to 18 U.S.C. Section 1350 of Zami Aberman.</font></div>
</td>
</tr></table>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div>
<table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td style="WIDTH: 36pt">
<div style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">32.2**</font></div>
</td>
<td>
<div align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Certification pursuant to 18 U.S.C. Section 1350 of Boaz Gur-Lavie.</font></div>
</td>
</tr></table>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div>
<table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td style="WIDTH: 36pt">
<div style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">101 *</font></div>
</td>
<td>
<div align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">The following materials from our Annual Report on Form 10-K for the fiscal year ended June 30, 2014 formatted in XBRL (eXtensible Business Reporting Language): (i) the Consolidated Balance Sheets, (ii) the Consolidated Statements of Operations, (iii) the Consolidated Statements of Comprehensive Loss, (iv) the Statements of Changes in Equity, (v) the Consolidated Statements of Cash Flows, and (vi) the Notes to the Consolidated Financial Statements, tagged as blocks of text and in detail.</font></div>
</td>
</tr></table>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">* Filed herewith.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">** Furnished herewith.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">+ Management contract or compensation plan.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">^ Confidential treatment granted as to certain portions.</font></div>

<div id="PGBRK" style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div id="FTR">
<div id="GLFTR" style="WIDTH: 100%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>

<div id="PN" style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
<div style="TEXT-ALIGN: center; WIDTH: 100%"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">56</font></div>

<div style="TEXT-ALIGN: center; WIDTH: 100%">
<hr style="COLOR: black" noshade size="2">
</div>
</div>

<div id="HDR">
<div id="GLHDR" style="WIDTH: 100%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">SIGNATURES</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Pursuant to the requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Pluristem Therapeutics Inc.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">By: <font style="DISPLAY: inline; TEXT-DECORATION: underline">/s/ Zami Aberman</font></font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Zami Aberman, Chief Executive Officer</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Dated:&#160;&#160;September 11, 2014</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">By:<font style="DISPLAY: inline; TEXT-DECORATION: underline"> /s/ </font><font style="DISPLAY: inline; TEXT-DECORATION: underline">Boaz Gur-Lavie</font></font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Boaz Gur-Lavie, Chief Financial Officer</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Dated: September 11, 2014</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Pursuant to the requirements of the Securities Exchange Act of 1934, this report has been signed below by the following persons on behalf of the registrant and in the capacities and on the dates indicated.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">By: <font style="DISPLAY: inline; TEXT-DECORATION: underline">/s/ Zami Aberman</font></font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Zami Aberman, Chief Executive Officer</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">(Principal Executive Officer)</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Chairman of the Board and Director</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Dated:&#160;&#160;September 11, 2014</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">By: <font style="DISPLAY: inline; TEXT-DECORATION: underline">/s/ Israel Ben-Yoram</font></font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Israel Ben-Yoram, Director</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Dated: September 11, 2014</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">By:&#160;<font style="DISPLAY: inline; TEXT-DECORATION: underline">/s/ Is</font><font style="DISPLAY: inline; TEXT-DECORATION: underline">aac Braun</font></font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Isaac Braun, Director</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Dated: September 11, 2014</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">By: <font style="DISPLAY: inline; TEXT-DECORATION: underline">/s/ </font><font style="DISPLAY: inline; TEXT-DECORATION: underline">Mark Germain</font></font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Mark Germain, Director</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Dated: September 11, 2014</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">By: <font style="DISPLAY: inline; TEXT-DECORATION: underline">/s/ Moria Kwiat</font></font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Moria Kwiat, Director</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Dated: September 11, 2014</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">By: <font style="DISPLAY: inline; TEXT-DECORATION: underline">/s/ Hava Meretzki</font></font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Hava Meretzki, Director</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Dated: September 11, 2014</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">By: <font style="DISPLAY: inline; TEXT-DECORATION: underline">/s/ Nachum Rosman</font></font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Nachum Rosman, Director</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Dated: September 11, 2014</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">By: <font style="DISPLAY: inline; TEXT-DECORATION: underline">/s/ Doron Shorrer</font></font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Doron Shorrer, Director</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Dated: September 11, 2014</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">By:&#160;<font style="DISPLAY: inline; TEXT-DECORATION: underline">/s/ Boaz Gur-Lavie</font></font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Boaz Gur-Lavie, Chief Financial Officer</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">(Principal Financial and Accounting Officer)</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Dated: September 11, 2014</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-ALIGN: center; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">57</div>

<div>
<hr style="MARGIN-TOP: -5px; COLOR: #000000" noshade size="1">
<hr style="MARGIN-TOP: -13px; COLOR: #000000" noshade size="4">
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;</font></div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.16
<SEQUENCE>2
<FILENAME>exhibit_10-16.htm
<DESCRIPTION>EXHIBIT 10.16
<TEXT>
<html>
<head>
    <title>exhibit_10-16.htm</title>
    <!--Licensed to: zk global-->
    <!--Document Created using EDGARizer 2020 5.5.0.0-->
    <!--Copyright 1995 - 2014 Thomson Reuters. All rights reserved.-->
</head>
<body bgcolor="#ffffff" style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">
<div>
<hr style="MARGIN-TOP: -5px; COLOR: #000000" noshade size="4">
<hr style="MARGIN-TOP: -10px; COLOR: #000000" noshade size="1">
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"><font style="DISPLAY: inline; TEXT-DECORATION: underline">Exhibit 10.16</font></font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;&#160;</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">[Translation from Hebrew]</font></div>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">State of Israel</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Ministry of Trade and Industry</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Industrial Research and Development Administration</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Office of Chief Scientist</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;</font></div>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Jerusalem</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Letter of Approval Number: <font style="DISPLAY: inline; FONT-WEIGHT: bold">37245</font></font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">(Fiscal regulation: <font style="DISPLAY: inline; FONT-WEIGHT: bold">38020101</font>)</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Group: <font style="DISPLAY: inline; FONT-WEIGHT: bold">13</font></font></div>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;<font style="DISPLAY: inline; FONT-WEIGHT: bold">&#160;</font></font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">To</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Pluristem Ltd.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">POB &#8211; 15105</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Haifa 31905</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left">&#160;</div>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"><font style="DISPLAY: inline; TEXT-DECORATION: underline">Letter of Approval</font></font></div>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;</font></div>
</div>

<div>
<table cellpadding="0" cellspacing="0" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr>
<td align="left" valign="middle" width="4%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="top" width="2%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">1.</font></div>
</td>
<td align="left" valign="top" width="94%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">We hereby inform you that the research committee, by virtue of its authority according to Article 17 of the Law for the Encouragement of Research and Development in the Industry, 5744-1984 (hereinafter: the &#8220;R&amp;D Law&#8221;), has resolved in its meeting on <font style="DISPLAY: inline; FONT-WEIGHT: bold">27/06/2006</font> to approve the program as submitted by you on <font style="DISPLAY: inline; FONT-WEIGHT: bold">30/04/2006</font>, which subject matter is:</font></div>
</td>
</tr></table>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;</font></div>
</div>

<div>
<table cellpadding="0" cellspacing="0" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr>
<td valign="middle" width="6%" style="TEXT-ALIGN: left; TEXT-INDENT: 0pt; PADDING-LEFT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">&#160;</td>
<td align="left" valign="top" width="3%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">a.</font></div>
</td>
<td valign="top" width="91%" style="TEXT-ALIGN: left; TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div style="TEXT-ALIGN: left; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Subject of approved program:&#160;<font style="DISPLAY: inline; FONT-WEIGHT: bold">Technology development of mesenchyme cell enrichment</font>.</font></div>
</td>
</tr></table>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;</font></div>
</div>

<div>
<table cellpadding="0" cellspacing="0" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr>
<td align="left" valign="middle" width="6%">&#160;</td>
<td align="left" valign="top" width="3%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">b.</font></div>
</td>
<td align="left" valign="top" width="91%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Performing the approved program:&#160;<font style="DISPLAY: inline; FONT-WEIGHT: bold">Pluristem Ltd.</font></font></div>
</td>
</tr></table>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;</font></div>
</div>

<div>
<table cellpadding="0" cellspacing="0" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr>
<td align="left" valign="middle" width="6%">&#160;</td>
<td align="left" valign="top" width="3%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="top" width="91%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Registration Number: <font style="DISPLAY: inline; FONT-WEIGHT: bold">513371666</font></font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(hereinafter - the &#8220;Approved Program&#8221;)</font></div>
</div>
</td>
</tr></table>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;</font></div>
</div>

<div>
<table cellpadding="0" cellspacing="0" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr>
<td align="left" valign="middle" width="4%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="top" width="2%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">2.</font></div>
</td>
<td valign="top" width="94%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">a. The research and development expenses approved for the performance of the approved program will be in an amount of up to: <font style="DISPLAY: inline; FONT-WEIGHT: bold">NIS</font><font style="DISPLAY: inline; FONT-WEIGHT: bold">4,292,696</font>.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">In words:<font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font><font style="DISPLAY: inline; FONT-WEIGHT: bold">Four million, two hundred and ninety-two thousand, six hundred and ninety-six NIS.</font></font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">b. The rate of grant approved is&#160;<font style="DISPLAY: inline; FONT-WEIGHT: bold">50%</font>&#160;of the development expenses (addition with respect to a national priority zone A/ line of confrontation), which is up to an amount of <font style="DISPLAY: inline; FONT-WEIGHT: bold">NIS&#160;2,146,348</font>.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">In words: <font style="DISPLAY: inline; FONT-WEIGHT: bold">Two million, one hundred forty-six thousand, three hundred forty-eight NIS</font>.</font></div>
</div>
</td>
</tr></table>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;</font></div>
</div>

<div>
<table cellpadding="0" cellspacing="0" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr>
<td align="left" valign="middle" width="4%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="top" width="2%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">3.</font></div>
</td>
<td align="left" valign="top" width="94%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">The approval is conditioned upon fulfillment of the provisions of the law, regulations, rules and procedures promulgated thereunder and subject to the following terms:</font></div>
</td>
</tr></table>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;</font></div>
</div>

<div>
<div>
<table cellpadding="0" cellspacing="0" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr>
<td align="left" valign="middle" width="6%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="top" width="3%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">a.</font></div>
</td>
<td align="left" valign="top" width="91%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">The approved program will be performed as detailed in your request within a period of 12 months &#8211; from <font style="FONT-WEIGHT: bold">01/4/2006</font> and until <font style="FONT-WEIGHT: bold">31/3/2007</font> (hereinafter: the &#8220;Performance Period&#8221;).</font></div>
</td>
</tr></table>
</div>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;</font></div>
</div>

<div>
<div>
<table cellpadding="0" cellspacing="0" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr>
<td align="left" valign="middle" width="6%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="top" width="3%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">b.</font></div>
</td>
<td align="left" valign="top" width="91%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(1) You must inform the Office of the Chief Scientist about every change in the control of the recipient of the grant in the company&#8217;s shares and/or in one of the following controlling means: (a)&#160;the right to vote in the company&#8217;s general meetings; (b)&#160;the right to appoint directors in the company; (c)&#160;the right to participate in the company&#8217;s profits.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(2) Transferring any percentage of the controlling means stated in subsection (1)&#160;to a non-Israeli resident or to a foreign company, which make the non-Israeli resident or foreign company an interested party as defined in the Securities Law, 1968, requires notification to Office of the Chief Scientist and a written undertaking of the non-Israeli resident or the foreign company to the R&amp;D Law.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">The letter of approval shall be signed in the form existing in the office of the Chief Scientist and in the website of the Ministry of Industry, Trade and Employment.</font></div>
</div>
</td>
</tr></table>
</div>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;</font></div>

<div id="PGBRK" style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div id="FTR">
<div id="GLFTR" style="WIDTH: 100%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>

<div id="PN" style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
<div style="TEXT-ALIGN: center; WIDTH: 100%"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>

<div style="TEXT-ALIGN: center; WIDTH: 100%">
<hr style="COLOR: black" noshade size="2">
</div>
</div>

<div id="HDR">
<div id="GLHDR" style="WIDTH: 100%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left">&#160;</div>
</div>

<div>
<table cellpadding="0" cellspacing="0" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr>
<td align="left" valign="middle" width="6%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="top" width="3%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">c.</font></div>
</td>
<td align="left" valign="top" width="91%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Additional terms:</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Royalties shall be paid on Company&#8217;s income derived from Ex vivo expanded cells within the PlurixTM bioreactor required for BMT.</font></div>
</td>
</tr></table>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;</font></div>
</div>

<div>
<table cellpadding="0" cellspacing="0" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr>
<td align="left" valign="middle" width="6%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="top" width="3%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">d.</font></div>
</td>
<td align="left" valign="top" width="91%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">See the appendix in the matter of intellectual property.</font></div>
</td>
</tr></table>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;</font></div>
</div>

<div>
<table cellpadding="0" cellspacing="0" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr>
<td align="left" valign="middle" width="6%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="top" width="3%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">e.</font></div>
</td>
<td align="left" valign="top" width="91%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">In the event of pledging the company&#8217;s assets to an Israeli bank against credit, the company must ensure that the pledge shall be subject to the R&amp;D Law.</font></div>
</td>
</tr></table>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div style="TEXT-INDENT: 0pt; DISPLAY: block"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;</font></div>
</div>

<div>
<table cellpadding="0" cellspacing="0" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr>
<td align="left" valign="middle" width="6%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="top" width="3%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">f.</font></div>
</td>
<td align="left" valign="top" width="91%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">If the plan is connected to an agreement with an academic institution or an academic implementation company, the company must ensure that the agreement is subject to the provisions of the R&amp;D Law.</font></div>
</td>
</tr></table>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;</font></div>
</div>

<div>
<table cellpadding="0" cellspacing="0" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr>
<td align="left" valign="top" width="36%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="top" width="33%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Sincerely,</font></div>
</td>
</tr><tr>
<td align="left" valign="top" width="36%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="top" width="33%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr>
<td align="left" valign="top" width="36%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="top" width="33%" style="BORDER-BOTTOM: black 2px solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">/s/ Dr. Eli Ofer</font></div>
</td>
</tr><tr>
<td align="left" valign="top" width="36%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="top" width="33%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Dr. Eli Ofer</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">The Chief Scientist</font></div>
</td>
</tr></table>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block">&#160;</div>

<div>
<hr style="MARGIN-TOP: -5px; COLOR: #000000" noshade size="1">
<hr style="MARGIN-TOP: -13px; COLOR: #000000" noshade size="4">
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.17
<SEQUENCE>3
<FILENAME>exhibit_10-17.htm
<DESCRIPTION>EXHIBIT 10.17
<TEXT>
<html>
<head>
    <title>exhibit_10-17.htm</title>
    <!--Licensed to: zk global-->
    <!--Document Created using EDGARizer 2020 5.5.0.0-->
    <!--Copyright 1995 - 2014 Thomson Reuters. All rights reserved.-->
</head>
<body bgcolor="#ffffff" style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">
<div>
<hr style="MARGIN-TOP: -5px; COLOR: #000000" noshade size="4">
<hr style="MARGIN-TOP: -10px; COLOR: #000000" noshade size="1">
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"><font style="DISPLAY: inline; TEXT-DECORATION: underline">Exhibit 10.17</font></font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;&#160;</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">[Translation from Hebrew]</font></div>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">State of Israel</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Ministry of Trade and Industry</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Industrial Research and Development Administration</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Office of Chief Scientist</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;</font></div>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Jerusalem</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Letter of Approval Number: <font style="DISPLAY: inline; FONT-WEIGHT: bold">38481</font></font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">(Fiscal regulation: <font style="DISPLAY: inline; FONT-WEIGHT: bold">38020101</font>)</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Group: <font style="DISPLAY: inline; FONT-WEIGHT: bold">13</font></font></div>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;<font style="DISPLAY: inline; FONT-WEIGHT: bold">&#160;</font></font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">To</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Pluristem Ltd.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">POB &#8211; 15105</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Haifa 31905</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left">&#160;</div>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"><font style="DISPLAY: inline; TEXT-DECORATION: underline">Letter of Approval</font></font></div>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;</font></div>
</div>

<div>
<table cellpadding="0" cellspacing="0" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr>
<td align="left" valign="middle" width="4%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="top" width="2%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">1.</font></div>
</td>
<td align="left" valign="top" width="94%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">We hereby inform you that the research committee, by virtue of its authority according to Article 17 of the Law for the Encouragement of Research and Development in the Industry, 5744-1984 (hereinafter: the &#8220;R&amp;D Law&#8221;), has resolved in its meeting on <font style="DISPLAY: inline; FONT-WEIGHT: bold">01/05/2007</font> to approve the program as submitted by you on <font style="DISPLAY: inline; FONT-WEIGHT: bold">27/02/2007</font>, which subject matter is:</font></div>
</td>
</tr></table>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;</font></div>
</div>

<div>
<table cellpadding="0" cellspacing="0" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr>
<td align="left" valign="middle" width="6%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="top" width="3%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">a.</font></div>
</td>
<td align="left" valign="top" width="91%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Subject of approved program:&#160;<font style="DISPLAY: inline; FONT-WEIGHT: bold">Development of PLX-1 MSC 3D cultures to improve absorption of umbilical cord blood transfusion with BMT.</font></font></div>
</td>
</tr></table>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;</font></div>
</div>

<div>
<table cellpadding="0" cellspacing="0" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr>
<td align="left" valign="middle" width="6%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="top" width="3%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">b.</font></div>
</td>
<td align="left" valign="top" width="91%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Performing the approved program:&#160;<font style="DISPLAY: inline; FONT-WEIGHT: bold">Pluristem Ltd.</font></font></div>
</td>
</tr></table>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;</font></div>
</div>

<div>
<table cellpadding="0" cellspacing="0" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr>
<td align="left" valign="middle" width="6%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="top" width="3%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="top" width="91%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Registration Number: <font style="DISPLAY: inline; FONT-WEIGHT: bold">513371666</font></font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(hereinafter - the &#8220;Approved Program&#8221;)</font></div>
</div>
</td>
</tr></table>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;</font></div>

<div>
<table cellpadding="0" cellspacing="0" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr>
<td align="left" valign="middle" width="4%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="top" width="2%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">2.</font></div>
</td>
<td valign="top" width="94%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">a. The research and development expenses approved for the performance of the approved program will be in an amount of up to: <font style="DISPLAY: inline; FONT-WEIGHT: bold">NIS</font><font style="DISPLAY: inline; FONT-WEIGHT: bold">6,665,926</font>.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">In words:<font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font><font style="DISPLAY: inline; FONT-WEIGHT: bold">Six million, six hundred and sixty-five thousand, nine hundred twenty six NIS.</font></font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">b. The rate of grant approved is&#160;<font style="DISPLAY: inline; FONT-WEIGHT: bold">50%</font>&#160;of the development expenses (addition with respect to a national priority zone A/ line of confrontation), which is up to an amount of <font style="DISPLAY: inline; FONT-WEIGHT: bold">NIS&#160;3,332,963</font>.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">In words: <font style="DISPLAY: inline; FONT-WEIGHT: bold">Three million, three hundred thirty-two thousand, nine hundred and sixty-three NIS</font>.</font></div>
</div>
</td>
</tr></table>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;</font></div>
</div>

<div>
<table cellpadding="0" cellspacing="0" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr>
<td align="left" valign="middle" width="4%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="top" width="2%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">3.</font></div>
</td>
<td align="left" valign="top" width="94%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">The approval is conditioned upon fulfillment of the provisions of the law, regulations, rules and procedures promulgated thereunder and subject to the following terms:</font></div>
</td>
</tr></table>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;</font></div>
</div>

<div>
<table cellpadding="0" cellspacing="0" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr>
<td align="left" valign="middle" width="6%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="top" width="3%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">a.</font></div>
</td>
<td align="left" valign="top" width="91%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">The approved program will be performed as detailed in your request within a period of 12 months &#8211; from <font style="DISPLAY: inline; FONT-WEIGHT: bold">01/3/2007</font> and until <font style="DISPLAY: inline; FONT-WEIGHT: bold">29/2/2008</font> (hereinafter: the &#8220;Performance Period&#8221;).</font></div>
</td>
</tr></table>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;</font></div>
</div>

<div>
<table cellpadding="0" cellspacing="0" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr>
<td align="left" valign="middle" width="6%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="top" width="3%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">b.</font></div>
</td>
<td align="left" valign="top" width="91%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(1) You must inform the Office of the Chief Scientist about every change in the control of the recipient of the grant in the company&#8217;s shares and/or in one of the following controlling means: (a)&#160;the right to vote in the company&#8217;s general meetings; (b)&#160;the right to appoint directors in the company; (c)&#160;the right to participate in the company&#8217;s profits.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(2) Transferring any percentage of the controlling means stated in subsection (1)&#160;to a non-Israeli resident or to a foreign company, which make the non-Israeli resident or foreign company an interested party as defined in the Securities Law, 1968, requires notification to Office of the Chief Scientist and a written undertaking of the non-Israeli resident or the foreign company to the R&amp;D Law.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">The letter of approval shall be signed in the form existing in the office of the Chief Scientist and in the website of the Ministry of Industry, Trade and Employment.</font></div>
</div>
</td>
</tr></table>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;</font></div>

<div id="PGBRK" style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div id="FTR">
<div id="GLFTR" style="WIDTH: 100%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>

<div id="PN" style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
<div style="TEXT-ALIGN: center; WIDTH: 100%"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>

<div style="TEXT-ALIGN: center; WIDTH: 100%">
<hr style="COLOR: black" noshade size="2">
</div>
</div>

<div id="HDR">
<div id="GLHDR" style="WIDTH: 100%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left">&#160;</div>
</div>

<div>
<table cellpadding="0" cellspacing="0" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr>
<td align="left" valign="middle" width="6%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="top" width="3%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">c.</font></div>
</td>
<td align="left" valign="top" width="91%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Additional terms:</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Royalties shall be paid on Company&#8217;s income from treatments based on PLX-1.</font></div>
</td>
</tr></table>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;</font></div>
</div>

<div>
<table cellpadding="0" cellspacing="0" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr>
<td align="left" valign="middle" width="6%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="top" width="3%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">d.</font></div>
</td>
<td align="left" valign="top" width="91%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">See the appendix in the matter of intellectual property.</font></div>
</td>
</tr></table>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;</font></div>
</div>

<div>
<table cellpadding="0" cellspacing="0" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr>
<td align="left" valign="middle" width="6%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="top" width="3%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">e.</font></div>
</td>
<td align="left" valign="top" width="91%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">In the event of pledging the company&#8217;s assets to an Israeli bank against credit, the company must ensure that the pledge shall be subject to the R&amp;D Law.</font></div>
</td>
</tr></table>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div style="TEXT-INDENT: 0pt; DISPLAY: block"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;</font></div>
</div>

<div>
<table cellpadding="0" cellspacing="0" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr>
<td align="left" valign="middle" width="6%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="top" width="3%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">f.</font></div>
</td>
<td align="left" valign="top" width="91%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">If the plan is connected to an agreement with an academic institution or an academic implementation company, the company must ensure that the agreement is subject to the provisions of the R&amp;D Law.</font></div>
</td>
</tr></table>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;</font></div>
</div>

<div>
<table cellpadding="0" cellspacing="0" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr>
<td align="left" valign="top" width="36%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="top" width="33%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Sincerely,</font></div>
</td>
</tr><tr>
<td align="left" valign="top" width="36%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="top" width="33%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr>
<td align="left" valign="top" width="36%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="top" width="33%" style="BORDER-BOTTOM: black 2px solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">/s/ Dr. Eli Ofer</font></div>
</td>
</tr><tr>
<td align="left" valign="top" width="36%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="top" width="33%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Dr. Eli Ofer</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">The Chief Scientist</font></div>
</td>
</tr></table>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
<hr style="MARGIN-TOP: -5px; COLOR: #000000" noshade size="1">
<hr style="MARGIN-TOP: -13px; COLOR: #000000" noshade size="4">
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.18
<SEQUENCE>4
<FILENAME>exhibit_10-18.htm
<DESCRIPTION>EXHIBIT 10.18
<TEXT>
<html>
<head>
    <title>exhibit_10-18.htm</title>
    <!--Licensed to: zk global-->
    <!--Document Created using EDGARizer 2020 5.5.0.0-->
    <!--Copyright 1995 - 2014 Thomson Reuters. All rights reserved.-->
</head>
<body bgcolor="#ffffff" style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">
<div>
<hr style="MARGIN-TOP: -5px; COLOR: #000000" noshade size="4">
<hr style="MARGIN-TOP: -10px; COLOR: #000000" noshade size="1">
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"><font style="DISPLAY: inline; TEXT-DECORATION: underline">Exhibit 10.18</font></font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;&#160;</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">[Translation from Hebrew]</font></div>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">State of Israel</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Ministry of Trade and Industry</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Industrial Research and Development Administration</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Office of Chief Scientist</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;</font></div>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Jerusalem</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Letter of Approval Number: <font style="DISPLAY: inline; FONT-WEIGHT: bold">40100</font></font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">(Fiscal regulation: <font style="DISPLAY: inline; FONT-WEIGHT: bold">38020101</font>)</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Group: <font style="DISPLAY: inline; FONT-WEIGHT: bold">13</font></font></div>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;<font style="DISPLAY: inline; FONT-WEIGHT: bold">&#160;</font></font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">To</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Pluristem Ltd.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">POB &#8211; 15105</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Haifa 31905</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left">&#160;</div>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"><font style="DISPLAY: inline; TEXT-DECORATION: underline">Letter of Approval</font></font></div>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;</font></div>
</div>

<div>
<table cellpadding="0" cellspacing="0" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr>
<td align="left" valign="middle" width="4%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="top" width="2%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">1.</font></div>
</td>
<td align="left" valign="top" width="94%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">We hereby inform you that the research committee, by virtue of its authority according to Article 17 of the Law for the Encouragement of Research and Development in the Industry, 5744-1984 (hereinafter: the &#8220;R&amp;D Law&#8221;), has resolved in its meeting on <font style="DISPLAY: inline; FONT-WEIGHT: bold">25/11/2008</font> to approve the program as submitted by you on <font style="DISPLAY: inline; FONT-WEIGHT: bold">31/03/2008</font>, which subject matter is:</font></div>
</td>
</tr></table>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;</font></div>
</div>

<div>
<table cellpadding="0" cellspacing="0" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr>
<td align="left" valign="middle" width="6%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="top" width="2%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">a.</font></div>
</td>
<td align="left" valign="top" width="92%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Subject of approved program:&#160;<font style="DISPLAY: inline; FONT-WEIGHT: bold">PLX for implant absorption and PAD treatment.</font></font></div>
</td>
</tr></table>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;</font></div>
</div>

<div>
<table cellpadding="0" cellspacing="0" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr>
<td align="left" valign="middle" width="6%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="top" width="2%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">b.</font></div>
</td>
<td align="left" valign="top" width="92%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Performing the approved program:&#160;<font style="DISPLAY: inline; FONT-WEIGHT: bold">Pluristem Ltd.</font></font></div>
</td>
</tr></table>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;</font></div>
</div>

<div>
<table cellpadding="0" cellspacing="0" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr>
<td align="left" valign="middle" width="6%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="top" width="2%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="top" width="92%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Registration Number: <font style="DISPLAY: inline; FONT-WEIGHT: bold">513371666</font></font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(hereinafter - the &#8220;Approved Program&#8221;)</font></div>
</div>
</td>
</tr></table>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;</font></div>

<div>
<table cellpadding="0" cellspacing="0" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr>
<td align="left" valign="middle" width="4%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="top" width="2%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">2.</font></div>
</td>
<td valign="top" width="94%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">a. The research and development expenses approved for the performance of the approved program will be in an amount of up to: <font style="DISPLAY: inline; FONT-WEIGHT: bold">NIS</font><font style="DISPLAY: inline; FONT-WEIGHT: bold">12,408,241</font>.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">In words:<font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font><font style="DISPLAY: inline; FONT-WEIGHT: bold">Twelve million, four hundred and eight thousand, two hundred forty-one NIS.</font></font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">b. The rate of grant approved is&#160;<font style="DISPLAY: inline; FONT-WEIGHT: bold">50%</font>&#160;of the development expenses (addition with respect to a national priority zone A/ line of confrontation), which is up to an amount of <font style="DISPLAY: inline; FONT-WEIGHT: bold">NIS&#160;6,204,121</font>.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">In words: <font style="DISPLAY: inline; FONT-WEIGHT: bold">Six million, two hundred and four thousand, one hundred and twenty NIS</font>.</font></div>
</div>
</td>
</tr></table>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;</font></div>
</div>

<div>
<table cellpadding="0" cellspacing="0" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr>
<td align="left" valign="middle" width="4%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="top" width="2%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">3.</font></div>
</td>
<td align="left" valign="top" width="94%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">The approval is conditioned upon fulfillment of the provisions of the law, regulations, rules and procedures promulgated thereunder and subject to the following terms:</font></div>
</td>
</tr></table>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;</font></div>
</div>

<div>
<table cellpadding="0" cellspacing="0" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr>
<td align="left" valign="middle" width="6%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="top" width="2%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">a.</font></div>
</td>
<td align="left" valign="top" width="92%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">The approved program will be performed as detailed in your request within a period of 12 months &#8211; from <font style="DISPLAY: inline; FONT-WEIGHT: bold">01/3/2008</font> and until <font style="DISPLAY: inline; FONT-WEIGHT: bold">28/2/2009</font> (hereinafter: the &#8220;Performance Period&#8221;).</font></div>
</td>
</tr></table>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;</font></div>
</div>

<div>
<table cellpadding="0" cellspacing="0" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr>
<td align="left" valign="middle" width="6%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="top" width="2%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">b.</font></div>
</td>
<td align="left" valign="top" width="92%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(1) You must inform the Office of the Chief Scientist about every change in the control of the recipient of the grant in the company&#8217;s shares and/or in one of the following controlling means: (a)&#160;the right to vote in the company&#8217;s general meetings; (b)&#160;the right to appoint directors in the company; (c)&#160;the right to participate in the company&#8217;s profits.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(2) Transferring any percentage of the controlling means stated in subsection (1)&#160;to a non-Israeli resident or to a foreign company, which make the non-Israeli resident or foreign company an interested party as defined in the Securities Law, 1968, requires notification to Office of the Chief Scientist and a written undertaking of the non-Israeli resident or the foreign company to the R&amp;D Law.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">The letter of approval shall be signed in the form existing in the office of the Chief Scientist and in the website of the Ministry of Industry, Trade and Employment.</font></div>
</div>
</td>
</tr></table>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;</font></div>

<div id="PGBRK" style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div id="FTR">
<div id="GLFTR" style="WIDTH: 100%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>

<div id="PN" style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
<div style="TEXT-ALIGN: center; WIDTH: 100%"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>

<div style="TEXT-ALIGN: center; WIDTH: 100%">
<hr style="COLOR: black" noshade size="2">
</div>
</div>

<div id="HDR">
<div id="GLHDR" style="WIDTH: 100%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left">&#160;</div>
</div>

<div>
<table cellpadding="0" cellspacing="0" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr>
<td align="left" valign="middle" width="6%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="top" width="2%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">c.</font></div>
</td>
<td align="left" valign="top" width="92%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Additional terms:</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Payment upon performance.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Royalties shall be paid on Company&#8217;s income.</font></div>
</td>
</tr></table>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;</font></div>
</div>

<div>
<table cellpadding="0" cellspacing="0" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr>
<td align="left" valign="middle" width="6%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="top" width="2%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">d.</font></div>
</td>
<td align="left" valign="top" width="92%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">See the appendix in the matter of intellectual property.</font></div>
</td>
</tr></table>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;</font></div>
</div>

<div>
<table cellpadding="0" cellspacing="0" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr>
<td align="left" valign="middle" width="6%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="top" width="2%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">e.</font></div>
</td>
<td align="left" valign="top" width="92%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">In the event of pledging the company&#8217;s assets to an Israeli bank against credit, the company must ensure that the pledge shall be subject to the R&amp;D Law.</font></div>
</td>
</tr></table>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div style="TEXT-INDENT: 0pt; DISPLAY: block"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;</font></div>
</div>

<div>
<table cellpadding="0" cellspacing="0" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr>
<td align="left" valign="middle" width="6%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="top" width="2%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">f.</font></div>
</td>
<td align="left" valign="top" width="92%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">If the plan is connected to an agreement with an academic institution or an academic implementation company, the company must ensure that the agreement is subject to the provisions of the R&amp;D Law.</font></div>
</td>
</tr></table>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;</font></div>
</div>

<div>
<table cellpadding="0" cellspacing="0" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr>
<td align="left" valign="top" width="36%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="top" width="33%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Sincerely,</font></div>
</td>
</tr><tr>
<td align="left" valign="top" width="36%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="top" width="33%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr>
<td align="left" valign="top" width="36%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="top" width="33%" style="BORDER-BOTTOM: black 2px solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">/s/ Dr. Eli Ofer</font></div>
</td>
</tr><tr>
<td align="left" valign="top" width="36%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="top" width="33%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Dr. Eli Ofer</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">The Chief Scientist</font></div>
</td>
</tr></table>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block">&#160;</div>

<div>
<hr style="MARGIN-TOP: -5px; COLOR: #000000" noshade size="1">
<hr style="MARGIN-TOP: -13px; COLOR: #000000" noshade size="4">
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.19
<SEQUENCE>5
<FILENAME>exhibit_10-19.htm
<DESCRIPTION>EXHIBIT 10.19
<TEXT>
<html>
<head>
    <title>exhibit_10-19.htm</title>
    <!--Licensed to: zk global-->
    <!--Document Created using EDGARizer 2020 5.5.0.0-->
    <!--Copyright 1995 - 2014 Thomson Reuters. All rights reserved.-->
</head>
<body bgcolor="#ffffff" style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">
<div>
<hr style="MARGIN-TOP: -5px; COLOR: #000000" noshade size="4">
<hr style="MARGIN-TOP: -10px; COLOR: #000000" noshade size="1">
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"><font style="DISPLAY: inline; TEXT-DECORATION: underline">Exhibit 10.19</font></font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;&#160;</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">[Translation from Hebrew]</font></div>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">State of Israel</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Ministry of Trade and Industry</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Industrial Research and Development Administration</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Office of Chief Scientist</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;</font></div>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Jerusalem</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Letter of Approval Number: <font style="DISPLAY: inline; FONT-WEIGHT: bold">41702</font></font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">(Fiscal regulation: <font style="DISPLAY: inline; FONT-WEIGHT: bold">38020101</font>)</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Group: <font style="DISPLAY: inline; FONT-WEIGHT: bold">13</font></font></div>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;<font style="DISPLAY: inline; FONT-WEIGHT: bold">&#160;</font></font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">To</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Pluristem Ltd.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">POB &#8211; 15105</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Haifa 31905</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left">&#160;</div>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"><font style="DISPLAY: inline; TEXT-DECORATION: underline">Letter of Approval</font></font></div>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;</font></div>
</div>

<div>
<table cellpadding="0" cellspacing="0" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr>
<td align="left" valign="middle" width="4%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="top" width="2%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">1.</font></div>
</td>
<td align="left" valign="top" width="94%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">We hereby inform you that the research committee, by virtue of its authority according to Article 17 of the Law for the Encouragement of Research and Development in the Industry, 5744-1984 (hereinafter: the &#8220;R&amp;D Law&#8221;), has resolved in its meeting on <font style="DISPLAY: inline; FONT-WEIGHT: bold">26/05/2009</font> to approve the program as submitted by you on <font style="DISPLAY: inline; FONT-WEIGHT: bold">08/03/2009</font>, which subject matter is:</font></div>
</td>
</tr></table>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;</font></div>
</div>

<div>
<table cellpadding="0" cellspacing="0" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr>
<td align="left" valign="middle" width="6%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="top" width="2%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">a.</font></div>
</td>
<td align="left" valign="top" width="92%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Subject of approved program:&#160;<font style="DISPLAY: inline; FONT-WEIGHT: bold">Treatment with mesenchyme placental cells grown in a culture.</font></font></div>
</td>
</tr></table>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;</font></div>
</div>

<div>
<table cellpadding="0" cellspacing="0" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr>
<td align="left" valign="middle" width="6%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="top" width="2%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">b.</font></div>
</td>
<td align="left" valign="top" width="92%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Performing the approved program:&#160;<font style="DISPLAY: inline; FONT-WEIGHT: bold">Pluristem Ltd.</font></font></div>
</td>
</tr></table>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;</font></div>
</div>

<div>
<table cellpadding="0" cellspacing="0" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr>
<td align="left" valign="middle" width="4%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="top" width="4%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="top" width="92%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Registration Number: <font style="DISPLAY: inline; FONT-WEIGHT: bold">513371666</font></font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(hereinafter - the &#8220;Approved Program&#8221;)</font></div>
</div>
</td>
</tr></table>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;</font></div>

<div>
<table cellpadding="0" cellspacing="0" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr>
<td align="left" valign="middle" width="4%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="top" width="2%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">2.</font></div>
</td>
<td valign="top" width="94%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">a. The research and development expenses approved for the performance of the approved program will be in an amount of up to: <font style="DISPLAY: inline; FONT-WEIGHT: bold">NIS</font><font style="DISPLAY: inline; FONT-WEIGHT: bold">14,659,687</font>.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">In words:<font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font><font style="DISPLAY: inline; FONT-WEIGHT: bold">Fourteen million, six hundred fifty-nine thousand six hundred eighty-seven NIS.</font></font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">b. The rate of grant approved is&#160;<font style="DISPLAY: inline; FONT-WEIGHT: bold">50%</font>&#160;of the development expenses (addition with respect to a national priority zone A/ line of confrontation), which is up to an amount of <font style="DISPLAY: inline; FONT-WEIGHT: bold">NIS&#160;7,329,844</font>.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">In words: <font style="DISPLAY: inline; FONT-WEIGHT: bold">Seven million, three hundred and twenty-nine thousand, eight hundred and forty-four NIS</font>.</font></div>
</div>
</td>
</tr></table>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;</font></div>
</div>

<div>
<table cellpadding="0" cellspacing="0" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr>
<td align="left" valign="middle" width="4%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="top" width="2%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">3.</font></div>
</td>
<td align="left" valign="top" width="94%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">The approval is conditioned upon fulfillment of the provisions of the law, regulations, rules and procedures promulgated thereunder and subject to the following terms:</font></div>
</td>
</tr></table>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;</font></div>
</div>

<div>
<table cellpadding="0" cellspacing="0" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr>
<td align="left" valign="middle" width="6%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="top" width="2%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">a.</font></div>
</td>
<td align="left" valign="top" width="92%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">The approved program will be performed as detailed in your request within a period of 12 months &#8211; from <font style="DISPLAY: inline; FONT-WEIGHT: bold">01/3/2009</font> and until <font style="DISPLAY: inline; FONT-WEIGHT: bold">28/2/2010</font> (hereinafter: the &#8220;Performance Period&#8221;).</font></div>
</td>
</tr></table>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;</font></div>
</div>

<div>
<table cellpadding="0" cellspacing="0" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr>
<td align="left" valign="middle" width="6%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="top" width="2%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">b.</font></div>
</td>
<td align="left" valign="top" width="92%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(1) You must inform the Office of the Chief Scientist about every change in the control of the recipient of the grant in the company&#8217;s shares and/or in one of the following controlling means: (a)&#160;the right to vote in the company&#8217;s general meetings; (b)&#160;the right to appoint directors in the company; (c)&#160;the right to participate in the company&#8217;s profits.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(2) Transferring any percentage of the controlling means stated in subsection (1)&#160;to a non-Israeli resident or to a foreign company, which make the non-Israeli resident or foreign company an interested party as defined in the Securities Law, 1968, requires notification to Office of the Chief Scientist and a written undertaking of the non-Israeli resident or the foreign company to the R&amp;D Law.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">The letter of approval shall be signed in the form existing in the office of the Chief Scientist and in the website of the Ministry of Industry, Trade and Employment.</font></div>
</div>
</td>
</tr></table>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;</font></div>

<div id="PGBRK" style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div id="FTR">
<div id="GLFTR" style="WIDTH: 100%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>

<div id="PN" style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
<div style="TEXT-ALIGN: center; WIDTH: 100%"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>

<div style="TEXT-ALIGN: center; WIDTH: 100%">
<hr style="COLOR: black" noshade size="2">
</div>
</div>

<div id="HDR">
<div id="GLHDR" style="WIDTH: 100%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left">&#160;</div>
</div>

<div>
<table cellpadding="0" cellspacing="0" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr>
<td align="left" valign="middle" width="6%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="top" width="2%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">c.</font></div>
</td>
<td align="left" valign="top" width="92%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Additional terms:</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Royalties shall be paid on Company&#8217;s income.</font></div>
</td>
</tr></table>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;</font></div>
</div>

<div>
<table cellpadding="0" cellspacing="0" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr>
<td align="left" valign="middle" width="6%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="top" width="2%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">d.</font></div>
</td>
<td align="left" valign="top" width="92%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">See the appendix in the matter of intellectual property.</font></div>
</td>
</tr></table>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;</font></div>
</div>

<div>
<table cellpadding="0" cellspacing="0" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr>
<td align="left" valign="middle" width="6%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="top" width="2%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">e.</font></div>
</td>
<td align="left" valign="top" width="92%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">In the event of pledging the company&#8217;s assets to an Israeli bank against credit, the company must ensure that the pledge shall be subject to the R&amp;D Law.</font></div>
</td>
</tr></table>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div style="TEXT-INDENT: 0pt; DISPLAY: block"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;</font></div>
</div>

<div>
<table cellpadding="0" cellspacing="0" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr>
<td align="left" valign="middle" width="6%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="top" width="2%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">f.</font></div>
</td>
<td align="left" valign="top" width="92%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">If the plan is connected to an agreement with an academic institution or an academic implementation company, the company must ensure that the agreement is subject to the provisions of the R&amp;D Law.</font></div>
</td>
</tr></table>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;</font></div>
</div>

<div>
<table cellpadding="0" cellspacing="0" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr>
<td align="left" valign="top" width="36%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="top" width="33%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Sincerely,</font></div>
</td>
</tr><tr>
<td align="left" valign="top" width="36%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="top" width="33%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr>
<td align="left" valign="top" width="36%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="top" width="33%" style="BORDER-BOTTOM: black 2px solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">/s/ Dr. Eli Ofer</font></div>
</td>
</tr><tr>
<td align="left" valign="top" width="36%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="top" width="33%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Dr. Eli Ofer</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">The Chief Scientist</font></div>
</td>
</tr></table>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block">&#160;</div>

<div>
<hr style="MARGIN-TOP: -5px; COLOR: #000000" noshade size="1">
<hr style="MARGIN-TOP: -13px; COLOR: #000000" noshade size="4">
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.20
<SEQUENCE>6
<FILENAME>exhibit_10-20.htm
<DESCRIPTION>EXHIBIT 10.20
<TEXT>
<html>
<head>
    <title>exhibit_10-20.htm</title>
    <!--Licensed to: zk global-->
    <!--Document Created using EDGARizer 2020 5.5.0.0-->
    <!--Copyright 1995 - 2014 Thomson Reuters. All rights reserved.-->
</head>
<body bgcolor="#ffffff" style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">
<div>
<hr style="MARGIN-TOP: -5px; COLOR: #000000" noshade size="4">
<hr style="MARGIN-TOP: -10px; COLOR: #000000" noshade size="1">
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"><font style="DISPLAY: inline; TEXT-DECORATION: underline">Exhibit 10.20</font></font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;&#160;</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">[Translation from Hebrew]</font></font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;</font></div>

</div>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">State of Israel</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Ministry of Trade and Industry</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Industrial Research and Development Administration</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Office of Chief Scientist</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;</font></div>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Jerusalem</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Letter of Approval Number: <font style="DISPLAY: inline; FONT-WEIGHT: bold">42075</font></font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">(Fiscal regulation: <font style="DISPLAY: inline; FONT-WEIGHT: bold">38020101</font>)</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Group: <font style="DISPLAY: inline; FONT-WEIGHT: bold">13</font></font></div>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;<font style="DISPLAY: inline; FONT-WEIGHT: bold">&#160;</font></font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">To</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Pluristem Ltd.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">POB &#8211; 15105</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Haifa 31905</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left">&#160;</div>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"><font style="DISPLAY: inline; TEXT-DECORATION: underline">Letter of Approval</font></font></div>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;</font></div>
</div>

<div>
<table cellpadding="0" cellspacing="0" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr>
<td align="left" valign="middle" width="4%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="top" width="2%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">1.</font></div>
</td>
<td align="left" valign="top" width="94%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">We hereby inform you that the research committee, by virtue of its authority according to Article 17 of the Law for the Encouragement of Research and Development in the Industry, 5744-1984 (hereinafter: the &#8220;R&amp;D Law&#8221;), has resolved in its meeting on <font style="DISPLAY: inline; FONT-WEIGHT: bold">26/05/2009</font> to approve the program as submitted by you on <font style="DISPLAY: inline; FONT-WEIGHT: bold">26/05/2009</font>, which subject matter is:</font></div>
</td>
</tr></table>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;</font></div>
</div>

<div>
<table cellpadding="0" cellspacing="0" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr>
<td align="left" valign="middle" width="6%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="top" width="2%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">a.</font></div>
</td>
<td align="left" valign="top" width="92%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Subject of approved program:&#160;<font style="DISPLAY: inline; FONT-WEIGHT: bold">Treatment with mesenchyme placental cells grown in a culture.</font></font></div>
</td>
</tr></table>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;</font></div>
</div>

<div>
<table cellpadding="0" cellspacing="0" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr>
<td align="left" valign="middle" width="6%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="top" width="2%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">b.</font></div>
</td>
<td align="left" valign="top" width="92%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Performing the approved program:&#160;<font style="DISPLAY: inline; FONT-WEIGHT: bold">Pluristem Ltd.</font></font></div>
</td>
</tr></table>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;</font></div>
</div>

<div>
<table cellpadding="0" cellspacing="0" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr>
<td align="left" valign="middle" width="6%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="top" width="2%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="top" width="92%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Registration Number: <font style="DISPLAY: inline; FONT-WEIGHT: bold">513371666</font></font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(hereinafter - the &#8220;Approved Program&#8221;)</font></div>
</div>
</td>
</tr></table>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;</font></div>

<div>
<table cellpadding="0" cellspacing="0" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr>
<td align="left" valign="middle" width="4%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="top" width="2%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">2.</font></div>
</td>
<td valign="top" width="94%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">a. The research and development expenses approved for the performance of the approved program will be in an amount of up to: <font style="DISPLAY: inline; FONT-WEIGHT: bold">NIS</font><font style="DISPLAY: inline; FONT-WEIGHT: bold">3,266,800</font>.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">In words:<font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font><font style="DISPLAY: inline; FONT-WEIGHT: bold">Three million two hundred and six thousand and eight hundred NIS.</font></font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">b. The rate of grant approved is&#160;<font style="DISPLAY: inline; FONT-WEIGHT: bold">30%</font>&#160;of the development expenses (addition with respect to a national priority zone A/ line of confrontation), which is up to an amount of <font style="DISPLAY: inline; FONT-WEIGHT: bold">NIS&#160;980,040</font>.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">In words: <font style="DISPLAY: inline; FONT-WEIGHT: bold">Nine hundred eighty thousand, forty NIS.</font></font></div>
</div>
</td>
</tr></table>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;</font></div>
</div>

<div>
<table cellpadding="0" cellspacing="0" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr>
<td align="left" valign="middle" width="4%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="top" width="2%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">3.</font></div>
</td>
<td align="left" valign="top" width="94%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">The approval is conditioned upon fulfillment of the provisions of the law, regulations, rules and procedures promulgated thereunder and subject to the following terms:</font></div>
</td>
</tr></table>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;</font></div>
</div>

<div>
<table cellpadding="0" cellspacing="0" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr>
<td align="left" valign="middle" width="6%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="top" width="2%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">a.</font></div>
</td>
<td align="left" valign="top" width="92%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">The approved program will be performed as detailed in your request within a period of 12 months &#8211; from <font style="DISPLAY: inline; FONT-WEIGHT: bold">01/3/2009</font> and until <font style="DISPLAY: inline; FONT-WEIGHT: bold">28/2/2010</font> (hereinafter: the &#8220;Performance Period&#8221;).</font></div>
</td>
</tr></table>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;</font></div>
</div>

<div>
<table cellpadding="0" cellspacing="0" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr>
<td align="left" valign="middle" width="6%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="top" width="2%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">b.</font></div>
</td>
<td align="left" valign="top" width="92%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(1) You must inform the Office of the Chief Scientist about every change in the control of the recipient of the grant in the company&#8217;s shares and/or in one of the following controlling means: (a)&#160;the right to vote in the company&#8217;s general meetings; (b)&#160;the right to appoint directors in the company; (c)&#160;the right to participate in the company&#8217;s profits.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(2) Transferring any percentage of the controlling means stated in subsection (1)&#160;to a non-Israeli resident or to a foreign company, which make the non-Israeli resident or foreign company an interested party as defined in the Securities Law, 1968, requires notification to Office of the Chief Scientist and a written undertaking of the non-Israeli resident or the foreign company to the R&amp;D Law.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">The letter of approval shall be signed in the form existing in the office of the Chief Scientist and in the website of the Ministry of Industry, Trade and Employment.</font></div>
</div>
</td>
</tr></table>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;</font></div>

<div id="PGBRK" style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div id="FTR">
<div id="GLFTR" style="WIDTH: 100%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>

<div id="PN" style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
<div style="TEXT-ALIGN: center; WIDTH: 100%"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>

<div style="TEXT-ALIGN: center; WIDTH: 100%">
<hr style="COLOR: black" noshade size="2">
</div>
</div>

<div id="HDR">
<div id="GLHDR" style="WIDTH: 100%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left">&#160;</div>
</div>

<div>
<table cellpadding="0" cellspacing="0" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr>
<td align="left" valign="middle" width="6%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="top" width="2%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">c.</font></div>
</td>
<td align="left" valign="top" width="92%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Additional terms:</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Royalties shall be paid on Company&#8217;s income.</font></div>
</td>
</tr></table>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;</font></div>
</div>

<div>
<table cellpadding="0" cellspacing="0" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr>
<td align="left" valign="middle" width="6%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="top" width="2%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">d.</font></div>
</td>
<td align="left" valign="top" width="92%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">See the appendix in the matter of intellectual property.</font></div>
</td>
</tr></table>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;</font></div>
</div>

<div>
<table cellpadding="0" cellspacing="0" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr>
<td align="left" valign="middle" width="6%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="top" width="2%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">e.</font></div>
</td>
<td align="left" valign="top" width="92%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">In the event of pledging the company&#8217;s assets to an Israeli bank against credit, the company must ensure that the pledge shall be subject to the R&amp;D Law.</font></div>
</td>
</tr></table>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div style="TEXT-INDENT: 0pt; DISPLAY: block"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;</font></div>
</div>

<div>
<table cellpadding="0" cellspacing="0" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr>
<td align="left" valign="middle" width="6%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="top" width="2%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">f.</font></div>
</td>
<td align="left" valign="top" width="92%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">If the plan is connected to an agreement with an academic institution or an academic implementation company, the company must ensure that the agreement is subject to the provisions of the R&amp;D Law.</font></div>
</td>
</tr></table>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;</font></div>
</div>

<div>
<table cellpadding="0" cellspacing="0" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr>
<td align="left" valign="top" width="36%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="top" width="33%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Sincerely,</font></div>
</td>
</tr><tr>
<td align="left" valign="top" width="36%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="top" width="33%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr>
<td align="left" valign="top" width="36%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="top" width="33%" style="BORDER-BOTTOM: black 2px solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">/s/ Dr. Eli Ofer</font></div>
</td>
</tr><tr>
<td align="left" valign="top" width="36%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="top" width="33%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Dr. Eli Ofer</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">The Chief Scientist</font></div>
</td>
</tr></table>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div>
<hr style="MARGIN-TOP: -5px; COLOR: #000000" noshade size="1">
<hr style="MARGIN-TOP: -13px; COLOR: #000000" noshade size="4">
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.21
<SEQUENCE>7
<FILENAME>exhibit_10-21.htm
<DESCRIPTION>EXHIBIT 10.21
<TEXT>
<html>
<head>
    <title>exhibit_10-21.htm</title>
    <!--Licensed to: zk global-->
    <!--Document Created using EDGARizer 2020 5.5.0.0-->
    <!--Copyright 1995 - 2014 Thomson Reuters. All rights reserved.-->
</head>
<body bgcolor="#ffffff" style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">
<div>
<hr style="MARGIN-TOP: -5px; COLOR: #000000" noshade size="4">
<hr style="MARGIN-TOP: -10px; COLOR: #000000" noshade size="1">
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"><font style="DISPLAY: inline; TEXT-DECORATION: underline">Exhibit 10.21</font></font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;&#160;</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">[Translation from Hebrew]</font></div>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">State of Israel</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Ministry of Trade and Industry</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Industrial Research and Development Administration</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Office of Chief Scientist</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;</font></div>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Jerusalem</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Letter of Approval Number: <font style="DISPLAY: inline; FONT-WEIGHT: bold">43729</font></font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">(Fiscal regulation: <font style="DISPLAY: inline; FONT-WEIGHT: bold">38020101</font>)</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Group: <font style="DISPLAY: inline; FONT-WEIGHT: bold">13</font></font></div>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;<font style="DISPLAY: inline; FONT-WEIGHT: bold">&#160;</font></font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">To</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Pluristem Ltd.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">POB &#8211; 15105</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Haifa 31905</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left">&#160;</div>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"><font style="DISPLAY: inline; TEXT-DECORATION: underline">Letter of Approval</font></font></div>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;</font></div>
</div>

<div>
<table cellpadding="0" cellspacing="0" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr>
<td align="left" valign="middle" width="4%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="top" width="2%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">1.</font></div>
</td>
<td align="left" valign="top" width="94%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">We hereby inform you that the research committee, by virtue of its authority according to Article 17 of the Law for the Encouragement of Research and Development in the Industry, 5744-1984 (hereinafter: the &#8220;R&amp;D Law&#8221;), has resolved in its meeting on <font style="DISPLAY: inline; FONT-WEIGHT: bold">31/05/2010</font> to approve the program as submitted by you on <font style="DISPLAY: inline; FONT-WEIGHT: bold">28/03/2010</font>, which subject matter is:</font></div>
</td>
</tr></table>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;</font></div>
</div>

<div>
<table cellpadding="0" cellspacing="0" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr>
<td align="left" valign="middle" width="6%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="top" width="3%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">a.</font></div>
</td>
<td align="left" valign="top" width="91%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Subject of approved program:&#160;<font style="DISPLAY: inline; FONT-WEIGHT: bold">Treatment with semi-mesenchyme placental cells grown in a 3D culture.</font></font></div>
</td>
</tr></table>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;</font></div>
</div>

<div>
<table cellpadding="0" cellspacing="0" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr>
<td align="left" valign="middle" width="6%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="top" width="3%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">b.</font></div>
</td>
<td align="left" valign="top" width="91%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Performing the approved program:&#160;<font style="DISPLAY: inline; FONT-WEIGHT: bold">Pluristem Ltd.</font></font></div>
</td>
</tr></table>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;</font></div>
</div>

<div>
<table cellpadding="0" cellspacing="0" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr>
<td align="left" valign="middle" width="6%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="top" width="3%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="top" width="91%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Registration Number: <font style="DISPLAY: inline; FONT-WEIGHT: bold">513371666 </font></font>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline; FONT-WEIGHT: bold"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: normal">(hereinafter - the &#8220;Approved Program&#8221;)</font></font></font></div>
</div>
</td>
</tr></table>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;</font></div>

<div>
<table cellpadding="0" cellspacing="0" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr>
<td align="left" valign="middle" width="4%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="top" width="2%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">2.</font></div>
</td>
<td valign="top" width="94%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">a. The research and development expenses approved for the performance of the approved program will be in an amount of up to: <font style="DISPLAY: inline; FONT-WEIGHT: bold">NIS</font><font style="DISPLAY: inline; FONT-WEIGHT: bold">16,873,786</font>.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">In words:<font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font><font style="DISPLAY: inline; FONT-WEIGHT: bold">Sixteen million, eight hundred seventy-three thousand, seven hundred and eighty-six NIS</font>.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">b. The rate of grant approved is&#160;<font style="DISPLAY: inline; FONT-WEIGHT: bold">50%</font>&#160;of the development expenses (addition with respect to a national priority zone A/ line of confrontation), which is up to an amount of <font style="DISPLAY: inline; FONT-WEIGHT: bold">NIS&#160;8,436,893</font>.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">In words: <font style="DISPLAY: inline; FONT-WEIGHT: bold">Eight million, four hundred thirty-six thousand, eight hundred and ninety-three NIS</font>.</font></div>
</div>
</td>
</tr></table>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;</font></div>
</div>

<div>
<table cellpadding="0" cellspacing="0" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr>
<td align="left" valign="middle" width="4%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="top" width="2%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">3.</font></div>
</td>
<td align="left" valign="top" width="94%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">The approval is conditioned upon fulfillment of the provisions of the law, regulations, rules and procedures promulgated thereunder and subject to the following terms:</font></div>
</td>
</tr></table>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;</font></div>
</div>

<div>
<table cellpadding="0" cellspacing="0" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr>
<td align="left" valign="middle" width="6%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="top" width="3%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">a.</font></div>
</td>
<td align="left" valign="top" width="91%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">The approved program will be performed as detailed in your request within a period of 12 months &#8211; from <font style="DISPLAY: inline; FONT-WEIGHT: bold">01/3/2010</font> and until <font style="DISPLAY: inline; FONT-WEIGHT: bold">28/2/2011</font> (hereinafter: the &#8220;Performance Period&#8221;).</font></div>
</td>
</tr></table>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;</font></div>
</div>

<div>
<table cellpadding="0" cellspacing="0" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr>
<td align="left" valign="middle" width="6%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="top" width="3%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">b.</font></div>
</td>
<td align="left" valign="top" width="91%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(1) You must inform the Office of the Chief Scientist about every change in the control of the recipient of the grant in the company&#8217;s shares and/or in one of the following controlling means: (a)&#160;the right to vote in the company&#8217;s general meetings; (b)&#160;the right to appoint directors in the company; (c)&#160;the right to participate in the company&#8217;s profits.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(2) Transferring any percentage of the controlling means stated in subsection (1)&#160;to a non-Israeli resident or to a foreign company, which make the non-Israeli resident or foreign company an interested party as defined in the Securities Law, 1968, requires notification to Office of the Chief Scientist and a written undertaking of the non-Israeli resident or the foreign company to the R&amp;D Law.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">The letter of approval shall be signed in the form existing in the office of the Chief Scientist and in the website of the Ministry of Industry, Trade and Employment.</font></div>
</div>
</td>
</tr></table>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;</font></div>

<div id="PGBRK" style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div id="FTR">
<div id="GLFTR" style="WIDTH: 100%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>

<div id="PN" style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
<div style="TEXT-ALIGN: center; WIDTH: 100%"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>

<div style="TEXT-ALIGN: center; WIDTH: 100%">
<hr style="COLOR: black" noshade size="2">
</div>
</div>

<div id="HDR">
<div id="GLHDR" style="WIDTH: 100%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left">&#160;</div>
</div>

<div>
<table cellpadding="0" cellspacing="0" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr>
<td align="left" valign="middle" width="6%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="top" width="3%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">c.</font></div>
</td>
<td align="left" valign="top" width="91%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Additional terms:</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Payment upon performance.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Royalties shall be paid on Company&#8217;s income.</font></div>
</td>
</tr></table>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;</font></div>
</div>

<div>
<table cellpadding="0" cellspacing="0" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr>
<td align="left" valign="middle" width="6%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="top" width="3%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">d.</font></div>
</td>
<td align="left" valign="top" width="91%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">See the appendix in the matter of intellectual property.</font></div>
</td>
</tr></table>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;</font></div>
</div>

<div>
<table cellpadding="0" cellspacing="0" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr>
<td align="left" valign="middle" width="6%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="top" width="3%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">e.</font></div>
</td>
<td align="left" valign="top" width="91%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">In the event of pledging the company&#8217;s assets to an Israeli bank against credit, the company must ensure that the pledge shall be subject to the R&amp;D Law.</font></div>
</td>
</tr></table>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div style="TEXT-INDENT: 0pt; DISPLAY: block"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;</font></div>
</div>

<div>
<table cellpadding="0" cellspacing="0" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr>
<td align="left" valign="middle" width="6%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="top" width="3%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">f.</font></div>
</td>
<td align="left" valign="top" width="91%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">If the plan is connected to an agreement with an academic institution or an academic implementation company, the company must ensure that the agreement is subject to the provisions of the R&amp;D Law.</font></div>
</td>
</tr></table>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;</font></div>
</div>

<div>
<table cellpadding="0" cellspacing="0" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr>
<td align="left" valign="top" width="36%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="top" width="33%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Sincerely,</font></div>
</td>
</tr><tr>
<td align="left" valign="top" width="36%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="top" width="33%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr>
<td align="left" valign="top" width="36%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="top" width="33%" style="BORDER-BOTTOM: black 2px solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">/s/ Dr. Eli Ofer</font></div>
</td>
</tr><tr>
<td align="left" valign="top" width="36%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="top" width="33%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Dr. Eli Ofer</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">The Chief Scientist</font></div>
</td>
</tr></table>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div>
<hr style="MARGIN-TOP: -5px; COLOR: #000000" noshade size="1">
<hr style="MARGIN-TOP: -13px; COLOR: #000000" noshade size="4">
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.22
<SEQUENCE>8
<FILENAME>exhibit_10-22.htm
<DESCRIPTION>EXHIBIT 10.22
<TEXT>
<html>
<head>
    <title>exhibit_10-22.htm</title>
    <!--Licensed to: zk global-->
    <!--Document Created using EDGARizer 2020 5.5.0.0-->
    <!--Copyright 1995 - 2014 Thomson Reuters. All rights reserved.-->
</head>
<body bgcolor="#ffffff" style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">
<div>
<hr style="MARGIN-TOP: -5px; COLOR: #000000" noshade size="4">
<hr style="MARGIN-TOP: -10px; COLOR: #000000" noshade size="1">
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"><font style="DISPLAY: inline; TEXT-DECORATION: underline">Exhibit 10.22</font></font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;&#160;</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">[Translation from Hebrew]</font></div>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">State of Israel</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Ministry of Trade and Industry</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Industrial Research and Development Administration</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Office of Chief Scientist</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;</font></div>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Jerusalem</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Letter of Approval Number: <font style="DISPLAY: inline; FONT-WEIGHT: bold">44056</font></font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">(Fiscal regulation: <font style="DISPLAY: inline; FONT-WEIGHT: bold">38020101</font>)</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Group: <font style="DISPLAY: inline; FONT-WEIGHT: bold">13</font></font></div>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;<font style="DISPLAY: inline; FONT-WEIGHT: bold">&#160;</font></font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">To</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Pluristem Ltd.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">POB &#8211; 15105</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Haifa 31905</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left">&#160;</div>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"><font style="DISPLAY: inline; TEXT-DECORATION: underline">Letter of Approval</font></font></div>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;</font></div>
</div>

<div>
<table cellpadding="0" cellspacing="0" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr>
<td align="left" valign="middle" width="4%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="top" width="2%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">1.</font></div>
</td>
<td align="left" valign="top" width="94%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">We hereby inform you that the research committee, by virtue of its authority according to Article 17 of the Law for the Encouragement of Research and Development in the Industry, 5744-1984 (hereinafter: the &#8220;R&amp;D Law&#8221;), has resolved in its meeting on <font style="DISPLAY: inline; FONT-WEIGHT: bold">31/05/2010</font> to approve the program as submitted by you on <font style="DISPLAY: inline; FONT-WEIGHT: bold">31/05/2010</font>, which subject matter is:</font></div>
</td>
</tr></table>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;</font></div>
</div>

<div>
<table cellpadding="0" cellspacing="0" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr>
<td align="left" valign="middle" width="6%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="top" width="2%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">a.</font></div>
</td>
<td align="left" valign="top" width="92%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Subject of approved program:&#160;<font style="DISPLAY: inline; FONT-WEIGHT: bold">Treatment with semi-mesenchyme placental cells grown in a 3D culture.</font></font></div>
</td>
</tr></table>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;</font></div>
</div>

<div>
<table cellpadding="0" cellspacing="0" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr>
<td align="left" valign="middle" width="6%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="top" width="2%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">b.</font></div>
</td>
<td align="left" valign="top" width="92%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Performing the approved program:&#160;<font style="DISPLAY: inline; FONT-WEIGHT: bold">Pluristem Ltd.</font></font></div>
</td>
</tr></table>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;</font></div>
</div>

<div>
<table cellpadding="0" cellspacing="0" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr>
<td align="left" valign="middle" width="6%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="top" width="2%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="top" width="92%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Registration Number: <font style="DISPLAY: inline; FONT-WEIGHT: bold">513371666 </font></font>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline; FONT-WEIGHT: bold"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: normal">(hereinafter - the &#8220;Approved Program&#8221;)</font></font></font></div>
</div>
</td>
</tr></table>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">&#160;</div>

<div>
<table cellpadding="0" cellspacing="0" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr>
<td align="left" valign="middle" width="4%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="top" width="2%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">2.</font></div>
</td>
<td valign="top" width="94%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">a. The research and development expenses approved for the performance of the approved program will be in an amount of up to: <font style="DISPLAY: inline; FONT-WEIGHT: bold">NIS</font><font style="DISPLAY: inline; FONT-WEIGHT: bold">3,286,250</font>.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">In words:<font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font><font style="DISPLAY: inline; FONT-WEIGHT: bold">Three million two hundred eighty-six thousand two hundred and fifty NIS.</font></font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">b. The rate of grant approved is&#160;<font style="DISPLAY: inline; FONT-WEIGHT: bold">30%</font>&#160;of the development expenses (addition with respect to a national priority zone A/ line of confrontation), which is up to an amount of <font style="DISPLAY: inline; FONT-WEIGHT: bold">NIS&#160;985,875</font>.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">In words: <font style="DISPLAY: inline; FONT-WEIGHT: bold">Nine hundred and eighty-five thousand, eight hundred seventy-five NIS</font>.</font></div>
</div>
</td>
</tr></table>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;</font></div>
</div>

<div>
<table cellpadding="0" cellspacing="0" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr>
<td align="left" valign="middle" width="4%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="top" width="2%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">3.</font></div>
</td>
<td align="left" valign="top" width="94%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">The approval is conditioned upon fulfillment of the provisions of the law, regulations, rules and procedures promulgated thereunder and subject to the following terms:</font></div>
</td>
</tr></table>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;</font></div>
</div>

<div>
<table cellpadding="0" cellspacing="0" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr>
<td align="left" valign="middle" width="6%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="top" width="2%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">a.</font></div>
</td>
<td align="left" valign="top" width="92%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">The approved program will be performed as detailed in your request within a period of 12 months &#8211; from <font style="DISPLAY: inline; FONT-WEIGHT: bold">01/3/2010</font> and until <font style="DISPLAY: inline; FONT-WEIGHT: bold">28/2/2011</font> (hereinafter: the &#8220;Performance Period&#8221;).</font></div>
</td>
</tr></table>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;</font></div>
</div>

<div>
<table cellpadding="0" cellspacing="0" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr>
<td align="left" valign="middle" width="6%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="top" width="2%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">b.</font></div>
</td>
<td align="left" valign="top" width="92%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(1) You must inform the Office of the Chief Scientist about every change in the control of the recipient of the grant in the company&#8217;s shares and/or in one of the following controlling means: (a)&#160;the right to vote in the company&#8217;s general meetings; (b)&#160;the right to appoint directors in the company; (c)&#160;the right to participate in the company&#8217;s profits.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(2) Transferring any percentage of the controlling means stated in subsection (1)&#160;to a non-Israeli resident or to a foreign company, which make the non-Israeli resident or foreign company an interested party as defined in the Securities Law, 1968, requires notification to Office of the Chief Scientist and a written undertaking of the non-Israeli resident or the foreign company to the R&amp;D Law.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">The letter of approval shall be signed in the form existing in the office of the Chief Scientist and in the website of the Ministry of Industry, Trade and Employment.</font></div>
</div>
</td>
</tr></table>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;</font></div>

<div id="PGBRK" style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div id="FTR">
<div id="GLFTR" style="WIDTH: 100%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>

<div id="PN" style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
<div style="TEXT-ALIGN: center; WIDTH: 100%"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>

<div style="TEXT-ALIGN: center; WIDTH: 100%">
<hr style="COLOR: black" noshade size="2">
</div>
</div>

<div id="HDR">
<div id="GLHDR" style="WIDTH: 100%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left">&#160;</div>
</div>

<div>
<table cellpadding="0" cellspacing="0" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr>
<td align="left" valign="middle" width="6%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="top" width="2%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">c.</font></div>
</td>
<td align="left" valign="top" width="92%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Additional terms:</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Payment upon performance.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Royalties shall be paid on Company&#8217;s income.</font></div>
</td>
</tr></table>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;</font></div>
</div>

<div>
<table cellpadding="0" cellspacing="0" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr>
<td align="left" valign="middle" width="6%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="top" width="2%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">d.</font></div>
</td>
<td align="left" valign="top" width="92%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">See the appendix in the matter of intellectual property.</font></div>
</td>
</tr></table>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;</font></div>
</div>

<div>
<table cellpadding="0" cellspacing="0" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr>
<td align="left" valign="middle" width="6%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="top" width="2%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">e.</font></div>
</td>
<td align="left" valign="top" width="92%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">In the event of pledging the company&#8217;s assets to an Israeli bank against credit, the company must ensure that the pledge shall be subject to the R&amp;D Law.</font></div>
</td>
</tr></table>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div style="TEXT-INDENT: 0pt; DISPLAY: block"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;</font></div>
</div>

<div>
<table cellpadding="0" cellspacing="0" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr>
<td align="left" valign="middle" width="6%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="top" width="2%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">f.</font></div>
</td>
<td align="left" valign="top" width="92%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">If the plan is connected to an agreement with an academic institution or an academic implementation company, the company must ensure that the agreement is subject to the provisions of the R&amp;D Law.</font></div>
</td>
</tr></table>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;</font></div>
</div>

<div>
<table cellpadding="0" cellspacing="0" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr>
<td align="left" valign="top" width="36%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="top" width="33%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Sincerely,</font></div>
</td>
</tr><tr>
<td align="left" valign="top" width="36%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="top" width="33%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr>
<td align="left" valign="top" width="36%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="top" width="33%" style="BORDER-BOTTOM: black 2px solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">/s/ Dr. Eli Ofer</font></div>
</td>
</tr><tr>
<td align="left" valign="top" width="36%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="top" width="33%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Dr. Eli Ofer</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">The Chief Scientist</font></div>
</td>
</tr></table>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div>
<hr style="MARGIN-TOP: -5px; COLOR: #000000" noshade size="1">
<hr style="MARGIN-TOP: -13px; COLOR: #000000" noshade size="4">
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.23
<SEQUENCE>9
<FILENAME>exhibit_10-23.htm
<DESCRIPTION>EXHIBIT 10.23
<TEXT>
<html>
<head>
    <title>exhibit_10-23.htm</title>
    <!--Licensed to: zk global-->
    <!--Document Created using EDGARizer 2020 5.5.0.0-->
    <!--Copyright 1995 - 2014 Thomson Reuters. All rights reserved.-->
</head>
<body bgcolor="#ffffff" style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">
<div>
<hr style="MARGIN-TOP: -5px; COLOR: #000000" noshade size="4">
<hr style="MARGIN-TOP: -10px; COLOR: #000000" noshade size="1">
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"><font style="DISPLAY: inline; TEXT-DECORATION: underline">Exhibit 10.23</font></font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;&#160;</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">[Translation from Hebrew]</font></div>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">State of Israel</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Ministry of Trade and Industry</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Industrial Research and Development Administration</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Office of Chief Scientist</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;</font></div>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Jerusalem</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Letter of Approval Number: <font style="DISPLAY: inline; FONT-WEIGHT: bold">45703</font></font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">(Fiscal regulation: <font style="DISPLAY: inline; FONT-WEIGHT: bold">38020101</font>)</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Group: <font style="DISPLAY: inline; FONT-WEIGHT: bold">13</font></font></div>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;<font style="DISPLAY: inline; FONT-WEIGHT: bold">&#160;</font></font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">To</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Pluristem Ltd.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">POB &#8211; 15105</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Haifa 31905</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left">&#160;</div>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"><font style="DISPLAY: inline; TEXT-DECORATION: underline">Letter of Approval</font></font></div>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;</font></div>
</div>

<div>
<table cellpadding="0" cellspacing="0" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr>
<td align="left" valign="middle" width="4%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="top" width="2%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">1.</font></div>
</td>
<td align="left" valign="top" width="94%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">We hereby inform you that the research committee, by virtue of its authority according to Article 17 of the Law for the Encouragement of Research and Development in the Industry, 5744-1984 (hereinafter: the &#8220;R&amp;D Law&#8221;), has resolved in its meeting on <font style="DISPLAY: inline; FONT-WEIGHT: bold">09/01/2012</font> to approve the program as submitted by you on <font style="DISPLAY: inline; FONT-WEIGHT: bold">30/03/2011</font>, which subject matter is:</font></div>
</td>
</tr></table>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;</font></div>
</div>

<div>
<table cellpadding="0" cellspacing="0" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr>
<td align="left" valign="middle" width="6%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="top" width="2%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">a.</font></div>
</td>
<td align="left" valign="top" width="92%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Subject of approved program:&#160;<font style="DISPLAY: inline; FONT-WEIGHT: bold">Treatment with semi-mesenchyme placental cells grown in a 3D culture.</font></font></div>
</td>
</tr></table>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;</font></div>
</div>

<div>
<table cellpadding="0" cellspacing="0" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr>
<td align="left" valign="middle" width="6%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="top" width="2%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">b.</font></div>
</td>
<td align="left" valign="top" width="92%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Performing the approved program:&#160;<font style="DISPLAY: inline; FONT-WEIGHT: bold">Pluristem Ltd.</font></font></div>
</td>
</tr></table>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;</font></div>
</div>

<div>
<table cellpadding="0" cellspacing="0" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr>
<td align="left" valign="middle" width="6%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="top" width="2%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="top" width="92%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Registration Number: <font style="DISPLAY: inline; FONT-WEIGHT: bold">513371666</font></font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(hereinafter - the &#8220;Approved Program&#8221;)</font></div>
</div>
</td>
</tr></table>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;</font></div>

<div>
<table cellpadding="0" cellspacing="0" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr>
<td align="left" valign="middle" width="4%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="top" width="2%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">2.</font></div>
</td>
<td valign="top" width="94%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">a. The research and development expenses approved for the performance of the approved program will be in an amount of up to: <font style="DISPLAY: inline; FONT-WEIGHT: bold">NIS</font><font style="DISPLAY: inline; FONT-WEIGHT: bold">16,161,964</font>.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">In words:<font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font><font style="DISPLAY: inline; FONT-WEIGHT: bold">Sixteen million, one hundred sixty-one thousand, nine hundred and sixty-four NIS</font>.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">b. The rate of grant approved is&#160;<font style="DISPLAY: inline; FONT-WEIGHT: bold">50%</font>&#160;of the development expenses (addition with respect to a national priority zone A/ line of confrontation), which is up to an amount of <font style="DISPLAY: inline; FONT-WEIGHT: bold">NIS&#160;8,080,982</font>.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">In words: <font style="DISPLAY: inline; FONT-WEIGHT: bold">Eight million, eighty thousand, nine hundred and eighty-two NIS</font>.</font></div>
</div>
</td>
</tr></table>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;</font></div>
</div>

<div>
<table cellpadding="0" cellspacing="0" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr>
<td align="left" valign="middle" width="4%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="top" width="2%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">3.</font></div>
</td>
<td align="left" valign="top" width="94%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">The approval is conditioned upon fulfillment of the provisions of the law, regulations, rules and procedures promulgated thereunder and subject to the following terms:</font></div>
</td>
</tr></table>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;</font></div>
</div>

<div>
<table cellpadding="0" cellspacing="0" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr>
<td align="left" valign="middle" width="6%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="top" width="2%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">a.</font></div>
</td>
<td align="left" valign="top" width="92%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">The approved program will be performed as detailed in your request within a period of 12 months &#8211; from <font style="DISPLAY: inline; FONT-WEIGHT: bold">01/3/2011</font> and until <font style="DISPLAY: inline; FONT-WEIGHT: bold">29/2/2012</font> (hereinafter: the &#8220;Performance Period&#8221;).</font></div>
</td>
</tr></table>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;</font></div>
</div>

<div>
<table cellpadding="0" cellspacing="0" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr>
<td align="left" valign="middle" width="6%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="top" width="2%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">b.</font></div>
</td>
<td align="left" valign="top" width="92%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(1) You must inform the Office of the Chief Scientist about every change in the control of the recipient of the grant in the company&#8217;s shares and/or in one of the following controlling means: (a)&#160;the right to vote in the company&#8217;s general meetings; (b)&#160;the right to appoint directors in the company; (c)&#160;the right to participate in the company&#8217;s profits.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(2) Transferring any percentage of the controlling means stated in subsection (1)&#160;to a non-Israeli resident or to a foreign company, which make the non-Israeli resident or foreign company an interested party as defined in the Securities Law, 1968, requires notification to Office of the Chief Scientist and a written undertaking of the non-Israeli resident or the foreign company to the R&amp;D Law.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">The letter of approval shall be signed in the form existing in the office of the Chief Scientist and in the website of the Ministry of Industry, Trade and Employment.</font></div>
</div>
</td>
</tr></table>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;</font></div>

<div id="PGBRK" style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div id="FTR">
<div id="GLFTR" style="WIDTH: 100%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>

<div id="PN" style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
<div style="TEXT-ALIGN: center; WIDTH: 100%"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>

<div style="TEXT-ALIGN: center; WIDTH: 100%">
<hr style="COLOR: black" noshade size="2">
</div>
</div>

<div id="HDR">
<div id="GLHDR" style="WIDTH: 100%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left">&#160;</div>
</div>

<div>
<table cellpadding="0" cellspacing="0" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr>
<td align="left" valign="middle" width="6%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="top" width="2%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">c.</font></div>
</td>
<td align="left" valign="top" width="92%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Additional terms:</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Royalties shall be paid on Company&#8217;s income.</font></div>
</td>
</tr></table>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;</font></div>
</div>

<div>
<table cellpadding="0" cellspacing="0" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr>
<td align="left" valign="middle" width="6%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="top" width="2%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">d.</font></div>
</td>
<td align="left" valign="top" width="92%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">See the appendix in the matter of intellectual property.</font></div>
</td>
</tr></table>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;</font></div>
</div>

<div>
<table cellpadding="0" cellspacing="0" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr>
<td align="left" valign="middle" width="6%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="top" width="2%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">e.</font></div>
</td>
<td align="left" valign="top" width="92%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">In the event of pledging the company&#8217;s assets to an Israeli bank against credit, the company must ensure that the pledge shall be subject to the R&amp;D Law.</font></div>
</td>
</tr></table>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div style="TEXT-INDENT: 0pt; DISPLAY: block"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;</font></div>
</div>

<div>
<table cellpadding="0" cellspacing="0" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr>
<td align="left" valign="middle" width="6%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="top" width="2%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">f.</font></div>
</td>
<td align="left" valign="top" width="92%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">If the plan is connected to an agreement with an academic institution or an academic implementation company, the company must ensure that the agreement is subject to the provisions of the R&amp;D Law.</font></div>
</td>
</tr></table>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;</font></div>
</div>

<div>
<table cellpadding="0" cellspacing="0" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr>
<td align="left" valign="top" width="36%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="top" width="33%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Sincerely,</font></div>
</td>
</tr><tr>
<td align="left" valign="top" width="36%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="top" width="33%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr>
<td align="left" valign="top" width="36%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="top" width="33%" style="BORDER-BOTTOM: black 2px solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">/s/ Avi Hason</font></div>
</td>
</tr><tr>
<td align="left" valign="top" width="36%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="top" width="33%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Avi Hason</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">The Chief Scientist</font></div>
</td>
</tr></table>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block">&#160;</div>

<div>
<hr style="MARGIN-TOP: -5px; COLOR: #000000" noshade size="1">
<hr style="MARGIN-TOP: -13px; COLOR: #000000" noshade size="4">
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.24
<SEQUENCE>10
<FILENAME>exhibit_10-24.htm
<DESCRIPTION>EXHIBIT 10.24
<TEXT>
<html>
<head>
    <title>exhibit_10-24.htm</title>
    <!--Licensed to: zk global-->
    <!--Document Created using EDGARizer 2020 5.5.0.0-->
    <!--Copyright 1995 - 2014 Thomson Reuters. All rights reserved.-->
</head>
<body bgcolor="#ffffff" style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">
<div>
<hr style="MARGIN-TOP: -5px; COLOR: #000000" noshade size="4">
<hr style="MARGIN-TOP: -10px; COLOR: #000000" noshade size="1">
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"><font style="DISPLAY: inline; TEXT-DECORATION: underline">Exhibit 10.24</font></font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;&#160;</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">[Translation from Hebrew]</font></div>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">State of Israel</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Ministry of Trade and Industry</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Industrial Research and Development Administration</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Office of Chief Scientist</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;</font></div>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Jerusalem</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Letter of Approval Number: <font style="DISPLAY: inline; FONT-WEIGHT: bold">46927</font></font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">(Fiscal regulation: <font style="DISPLAY: inline; FONT-WEIGHT: bold">38020101</font>)</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Group: <font style="DISPLAY: inline; FONT-WEIGHT: bold">13</font></font></div>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;<font style="DISPLAY: inline; FONT-WEIGHT: bold">&#160;</font></font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">To</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Pluristem Ltd.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">POB &#8211; 15105</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Haifa 31905</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left">&#160;</div>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"><font style="DISPLAY: inline; TEXT-DECORATION: underline">Letter of Approval</font></font></div>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;</font></div>
</div>

<div>
<table cellpadding="0" cellspacing="0" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr>
<td align="left" valign="middle" width="4%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="top" width="2%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">1.</font></div>
</td>
<td align="left" valign="top" width="94%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">We hereby inform you that the research committee, by virtue of its authority according to Article 17 of the Law for the Encouragement of Research and Development in the Industry, 5744-1984 (hereinafter: the &#8220;R&amp;D Law&#8221;), has resolved in its meeting on <font style="DISPLAY: inline; FONT-WEIGHT: bold">09/01/2012</font> to approve the program as submitted by you on <font style="DISPLAY: inline; FONT-WEIGHT: bold">01/12/2011</font>, which subject matter is:</font></div>
</td>
</tr></table>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;</font></div>
</div>

<div>
<table cellpadding="0" cellspacing="0" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr>
<td align="left" valign="middle" width="6%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="top" width="2%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">a.</font></div>
</td>
<td align="left" valign="top" width="92%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Subject of approved program:&#160;<font style="DISPLAY: inline; FONT-WEIGHT: bold">Treatment with semi-mesenchyme placental cells grown in a 3D culture.</font></font></div>
</td>
</tr></table>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;</font></div>
</div>

<div>
<table cellpadding="0" cellspacing="0" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr>
<td align="left" valign="middle" width="6%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="top" width="2%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">b.</font></div>
</td>
<td align="left" valign="top" width="92%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Performing the approved program:&#160;<font style="DISPLAY: inline; FONT-WEIGHT: bold">Pluristem Ltd.</font></font></div>
</td>
</tr></table>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;</font></div>
</div>

<div>
<table cellpadding="0" cellspacing="0" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr>
<td align="left" valign="middle" width="6%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="top" width="2%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="top" width="92%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Registration Number: <font style="DISPLAY: inline; FONT-WEIGHT: bold">513371666</font></font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(hereinafter - the &#8220;Approved Program&#8221;)</font></div>
</div>
</td>
</tr></table>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;</font></div>

<div>
<table cellpadding="0" cellspacing="0" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr>
<td align="left" valign="middle" width="4%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="top" width="2%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">2.</font></div>
</td>
<td valign="top" width="94%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">a. The research and development expenses approved for the performance of the approved program will be in an amount of up to: <font style="DISPLAY: inline; FONT-WEIGHT: bold">NIS</font><font style="DISPLAY: inline; FONT-WEIGHT: bold">3,056,720</font>.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">In words:<font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font><font style="DISPLAY: inline; FONT-WEIGHT: bold">Three million, fifty six thousand, seven hundred and twenty NIS</font>.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">b. The rate of grant approved is&#160;<font style="DISPLAY: inline; FONT-WEIGHT: bold">30%</font>&#160;of the development expenses (addition with respect to a national priority zone A/ line of confrontation), which is up to an amount of <font style="DISPLAY: inline; FONT-WEIGHT: bold">NIS&#160;917,016</font>.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">In words: <font style="DISPLAY: inline; FONT-WEIGHT: bold">Nine hundred and seventeen thousand, and sixteen NIS</font>.</font></div>
</div>
</td>
</tr></table>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;</font></div>
</div>

<div>
<table cellpadding="0" cellspacing="0" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr>
<td align="left" valign="middle" width="4%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="top" width="2%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">3.</font></div>
</td>
<td align="left" valign="top" width="94%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">The approval is conditioned upon fulfillment of the provisions of the law, regulations, rules and procedures promulgated thereunder and subject to the following terms:</font></div>
</td>
</tr></table>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;</font></div>
</div>

<div>
<table cellpadding="0" cellspacing="0" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr>
<td align="left" valign="middle" width="6%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="top" width="2%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">a.</font></div>
</td>
<td align="left" valign="top" width="92%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">The approved program will be performed as detailed in your request within a period of 12 months &#8211; from <font style="DISPLAY: inline; FONT-WEIGHT: bold">01/3/2011</font> and until <font style="DISPLAY: inline; FONT-WEIGHT: bold">29/2/2012</font> (hereinafter: the &#8220;Performance Period&#8221;).</font></div>
</td>
</tr></table>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;</font></div>
</div>

<div>
<table cellpadding="0" cellspacing="0" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr>
<td align="left" valign="middle" width="6%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="top" width="2%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">b.</font></div>
</td>
<td align="left" valign="top" width="92%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(1) You must inform the Office of the Chief Scientist about every change in the control of the recipient of the grant in the company&#8217;s shares and/or in one of the following controlling means: (a)&#160;the right to vote in the company&#8217;s general meetings; (b)&#160;the right to appoint directors in the company; (c)&#160;the right to participate in the company&#8217;s profits.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(2) Transferring any percentage of the controlling means stated in subsection (1)&#160;to a non-Israeli resident or to a foreign company, which make the non-Israeli resident or foreign company an interested party as defined in the Securities Law, 1968, requires notification to Office of the Chief Scientist and a written undertaking of the non-Israeli resident or the foreign company to the R&amp;D Law.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">The letter of approval shall be signed in the form existing in the office of the Chief Scientist and in the website of the Ministry of Industry, Trade and Employment.</font></div>
</div>
</td>
</tr></table>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;</font></div>

<div id="PGBRK" style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div id="FTR">
<div id="GLFTR" style="WIDTH: 100%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>

<div id="PN" style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
<div style="TEXT-ALIGN: center; WIDTH: 100%"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>

<div style="TEXT-ALIGN: center; WIDTH: 100%">
<hr style="COLOR: black" noshade size="2">
</div>
</div>

<div id="HDR">
<div id="GLHDR" style="WIDTH: 100%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left">&#160;</div>
</div>

<div>
<table cellpadding="0" cellspacing="0" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr>
<td align="left" valign="middle" width="6%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="top" width="2%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">c.</font></div>
</td>
<td align="left" valign="top" width="92%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Additional terms:</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Royalties shall be paid on Company&#8217;s income.</font></div>
</td>
</tr></table>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;</font></div>
</div>

<div>
<table cellpadding="0" cellspacing="0" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr>
<td align="left" valign="middle" width="6%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="top" width="2%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">d.</font></div>
</td>
<td align="left" valign="top" width="92%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">See the appendix in the matter of intellectual property.</font></div>
</td>
</tr></table>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;</font></div>
</div>

<div>
<table cellpadding="0" cellspacing="0" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr>
<td align="left" valign="middle" width="6%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="top" width="2%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">e.</font></div>
</td>
<td align="left" valign="top" width="92%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">In the event of pledging the company&#8217;s assets to an Israeli bank against credit, the company must ensure that the pledge shall be subject to the R&amp;D Law.</font></div>
</td>
</tr></table>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div style="TEXT-INDENT: 0pt; DISPLAY: block"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;</font></div>
</div>

<div>
<table cellpadding="0" cellspacing="0" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr>
<td align="left" valign="middle" width="6%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="top" width="2%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">f.</font></div>
</td>
<td align="left" valign="top" width="92%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">If the plan is connected to an agreement with an academic institution or an academic implementation company, the company must ensure that the agreement is subject to the provisions of the R&amp;D Law.</font></div>
</td>
</tr></table>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;</font></div>
</div>

<div>
<table cellpadding="0" cellspacing="0" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr>
<td align="left" valign="top" width="36%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="top" width="33%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Sincerely,</font></div>
</td>
</tr><tr>
<td align="left" valign="top" width="36%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="top" width="33%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr>
<td align="left" valign="top" width="36%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="top" width="33%" style="BORDER-BOTTOM: black 2px solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">/s/ Avi Hason</font></div>
</td>
</tr><tr>
<td align="left" valign="top" width="36%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="top" width="33%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Avi Hason</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">The Chief Scientist</font></div>
</td>
</tr></table>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block">&#160;</div>

<div>
<hr style="MARGIN-TOP: -5px; COLOR: #000000" noshade size="1">
<hr style="MARGIN-TOP: -13px; COLOR: #000000" noshade size="4">
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.25
<SEQUENCE>11
<FILENAME>exhibit_10-25.htm
<DESCRIPTION>EXHIBIT 10.25
<TEXT>
<html>
<head>
    <title>exhibit_10-25.htm</title>
    <!--Licensed to: zk global-->
    <!--Document Created using EDGARizer 2020 5.5.0.0-->
    <!--Copyright 1995 - 2014 Thomson Reuters. All rights reserved.-->
</head>
<body bgcolor="#ffffff" style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">
<div>
<hr style="MARGIN-TOP: -5px; COLOR: #000000" noshade size="4">
<hr style="MARGIN-TOP: -10px; COLOR: #000000" noshade size="1">
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"><font style="DISPLAY: inline; TEXT-DECORATION: underline">Exhibit 10.25</font></font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;&#160;</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">[Translation from Hebrew]</font></div>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">State of Israel</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Ministry of Trade and Industry</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Industrial Research and Development Administration</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Office of Chief Scientist</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;</font></div>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Jerusalem</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Letter of Approval Number: <font style="DISPLAY: inline; FONT-WEIGHT: bold">47578</font></font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">(Fiscal regulation: <font style="DISPLAY: inline; FONT-WEIGHT: bold">38020101</font>)</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Group: <font style="DISPLAY: inline; FONT-WEIGHT: bold">13</font></font></div>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;<font style="DISPLAY: inline; FONT-WEIGHT: bold">&#160;</font></font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">To</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Pluristem Ltd.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">POB &#8211; 15105</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Haifa 31905</font></div>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"><font style="DISPLAY: inline; TEXT-DECORATION: underline">Letter of Approval</font></font></div>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;</font></div>
</div>

<div>
<table cellpadding="0" cellspacing="0" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr>
<td align="left" valign="middle" width="3%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="top" width="3%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">1.</font></div>
</td>
<td align="left" valign="top" width="66%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">We hereby inform you that the research committee, by virtue of its authority according to Article 17 of the Law for the Encouragement of Research and Development in the Industry, 5744-1984 (hereinafter: the &#8220;R&amp;D Law&#8221;), has resolved in its meeting on <font style="DISPLAY: inline; FONT-WEIGHT: bold">18/04/2012</font> to approve the program as submitted by you on <font style="DISPLAY: inline; FONT-WEIGHT: bold">31/01/2012</font>, which subject matter is:</font></div>
</td>
</tr></table>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;</font></div>
</div>

<div>
<table cellpadding="0" cellspacing="0" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr>
<td align="left" valign="middle" width="8%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="top" width="2%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">a.</font></div>
</td>
<td align="left" valign="top" width="90%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Subject of approved program:&#160;<font style="DISPLAY: inline; FONT-WEIGHT: bold">Treatment with semi-mesenchyme placental cells grown in a 3D culture.</font></font></div>
</td>
</tr></table>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;</font></div>
</div>

<div>
<table cellpadding="0" cellspacing="0" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr>
<td align="left" valign="middle" width="8%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="top" width="2%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">b.</font></div>
</td>
<td align="left" valign="top" width="90%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Performing the approved program:&#160;<font style="DISPLAY: inline; FONT-WEIGHT: bold">Pluristem Ltd.</font></font></div>
</td>
</tr></table>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;</font></div>
</div>

<div>
<table cellpadding="0" cellspacing="0" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr>
<td align="left" valign="middle" width="8%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="top" width="2%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="top" width="90%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Registration Number: <font style="DISPLAY: inline; FONT-WEIGHT: bold">513371666</font></font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-WEIGHT: bold"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: normal">(hereinafter - the &#8220;Approved Program&#8221;)</font></font></div>
</div>
</td>
</tr></table>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;</font></div>

<div>
<table cellpadding="0" cellspacing="0" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr>
<td align="left" valign="middle" width="3%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="top" width="3%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">2.</font></div>
</td>
<td valign="top" width="66%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">a. The research and development expenses approved for the performance of the approved program will be in an amount of up to: <font style="DISPLAY: inline; FONT-WEIGHT: bold">NIS</font><font style="DISPLAY: inline; FONT-WEIGHT: bold">20,893,367</font>.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">In words:<font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font><font style="DISPLAY: inline; FONT-WEIGHT: bold">Twenty million, eight hundred ninety-three thousand, three hundred and sixty-seven NIS</font>.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">b. The rate of grant approved is&#160;<font style="DISPLAY: inline; FONT-WEIGHT: bold">50%</font>&#160;of the development expenses (addition with respect to a national priority zone A/ line of confrontation), which is up to an amount of <font style="DISPLAY: inline; FONT-WEIGHT: bold">NIS&#160;10,446,684</font>.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">In words: <font style="DISPLAY: inline; FONT-WEIGHT: bold">Ten million, four hundred forty-six thousand, six hundred eighty-four NIS</font>.</font></div>
</div>
</td>
</tr></table>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;</font></div>
</div>

<div>
<table cellpadding="0" cellspacing="0" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr>
<td align="left" valign="middle" width="3%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="top" width="3%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">3.</font></div>
</td>
<td align="left" valign="top" width="66%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">The approval is conditioned upon fulfillment of the provisions of the law, regulations, rules and procedures promulgated thereunder and subject to the following terms:</font></div>
</td>
</tr></table>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;</font></div>
</div>

<div>
<table cellpadding="0" cellspacing="0" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr>
<td align="left" valign="middle" width="8%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="top" width="2%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">a.</font></div>
</td>
<td align="left" valign="top" width="90%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">The approved program will be performed as detailed in your request within a period of 10 months &#8211; from <font style="DISPLAY: inline; FONT-WEIGHT: bold">01/3/2012</font> and until <font style="DISPLAY: inline; FONT-WEIGHT: bold">31/12/2012</font> (hereinafter: the &#8220;Performance Period&#8221;).</font></div>
</td>
</tr></table>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;</font></div>
</div>

<div>
<table cellpadding="0" cellspacing="0" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr>
<td align="left" valign="middle" width="8%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="top" width="2%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">b.</font></div>
</td>
<td align="left" valign="top" width="90%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(1) You must inform the Office of the Chief Scientist about every change in the control of the recipient of the grant in the company&#8217;s shares and/or in one of the following controlling means: (a)&#160;the right to vote in the company&#8217;s general meetings; (b)&#160;the right to appoint directors in the company; (c)&#160;the right to participate in the company&#8217;s profits.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(2) Transferring any percentage of the controlling means stated in subsection (1)&#160;to a non-Israeli resident or to a foreign company, which make the non-Israeli resident or foreign company an interested party as defined in the Securities Law, 1968, requires notification to Office of the Chief Scientist and a written undertaking of the non-Israeli resident or the foreign company to the R&amp;D Law.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">The letter of approval shall be signed in the form existing in the office of the Chief Scientist and in the website of the Ministry of Industry, Trade and Employment.</font></div>
</div>
</td>
</tr></table>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;</font></div>

<div id="PGBRK" style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div id="FTR">
<div id="GLFTR" style="WIDTH: 100%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>

<div id="PN" style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
<div style="TEXT-ALIGN: center; WIDTH: 100%"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>

<div style="TEXT-ALIGN: center; WIDTH: 100%">
<hr style="COLOR: black" noshade size="2">
</div>
</div>

<div id="HDR">
<div id="GLHDR" style="WIDTH: 100%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>
</div>
</div>

<div>&#160;</div>

<div>
<table cellpadding="0" cellspacing="0" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr>
<td align="left" valign="middle" width="8%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="top" width="2%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">c.</font></div>
</td>
<td align="left" valign="top" width="90%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Additional terms:</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Royalties shall be paid on Company&#8217;s income.</font></div>
</td>
</tr></table>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;</font></div>
</div>

<div>
<table cellpadding="0" cellspacing="0" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr>
<td align="left" valign="middle" width="8%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="top" width="2%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">d.</font></div>
</td>
<td align="left" valign="top" width="90%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">See the appendix in the matter of intellectual property.</font></div>
</td>
</tr></table>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;</font></div>
</div>

<div>
<table cellpadding="0" cellspacing="0" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr>
<td align="left" valign="middle" width="8%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="top" width="2%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">e.</font></div>
</td>
<td align="left" valign="top" width="90%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">In the event of pledging the company&#8217;s assets to an Israeli bank against credit, the company must ensure that the pledge shall be subject to the R&amp;D Law.</font></div>
</td>
</tr></table>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div style="TEXT-INDENT: 0pt; DISPLAY: block"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;</font></div>
</div>

<div>
<table cellpadding="0" cellspacing="0" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr>
<td align="left" valign="middle" width="8%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="top" width="2%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">f.</font></div>
</td>
<td align="left" valign="top" width="90%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">If the plan is connected to an agreement with an academic institution or an academic implementation company, the company must ensure that the agreement is subject to the provisions of the R&amp;D Law.</font></div>
</td>
</tr></table>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;</font></div>
</div>

<div align="left">
<table cellpadding="0" cellspacing="0" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr>
<td align="left" valign="top" width="50%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="top" width="50%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Sincerely,</font></div>
</td>
</tr><tr>
<td align="left" valign="top" width="50%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="top" width="50%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr>
<td align="left" valign="top" width="50%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="top" width="50%" style="BORDER-BOTTOM: black 2px solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">/s/ Avi Hason</font></div>
</td>
</tr><tr>
<td align="left" valign="top" width="50%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="top" width="50%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Avi Hason</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">The Chief Scientist</font></div>
</td>
</tr></table>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block">&#160;</div>

<div>
<hr style="MARGIN-TOP: -5px; COLOR: #000000" noshade size="1">
<hr style="MARGIN-TOP: -13px; COLOR: #000000" noshade size="4">
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.26
<SEQUENCE>12
<FILENAME>exhibit_10-26.htm
<DESCRIPTION>EXHIBIT 10.26
<TEXT>
<html>
<head>
    <title>exhibit_10-26.htm</title>
    <!--Licensed to: zkg-->
    <!--Document Created using EDGARizer 2020 5.5.0.0-->
    <!--Copyright 1995 - 2014 Thomson Reuters. All rights reserved.-->
</head>
<body bgcolor="#ffffff" style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">
<div>
<hr style="MARGIN-TOP: -5px; COLOR: #000000" noshade size="4">
<hr style="MARGIN-TOP: -10px; COLOR: #000000" noshade size="1">
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"><font style="DISPLAY: inline; TEXT-DECORATION: underline">Exhibit 10.26</font></font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;&#160;</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">[Translation from Hebrew]</font></div>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">State of Israel</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Ministry of Economy</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Industrial Research and Development Administration</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Office of Chief Scientist</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;</font></div>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Jerusalem</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Letter of Approval Number: <font style="DISPLAY: inline; FONT-WEIGHT: bold">48070</font></font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">(Fiscal regulation: <font style="DISPLAY: inline; FONT-WEIGHT: bold">38020101</font>)</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Group: <font style="DISPLAY: inline; FONT-WEIGHT: bold">13</font></font></div>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;<font style="DISPLAY: inline; FONT-WEIGHT: bold">&#160;</font></font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">To</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Pluristem Ltd.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">POB &#8211; 15105</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Haifa 31905</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left">&#160;</div>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"><font style="DISPLAY: inline; TEXT-DECORATION: underline">Letter of Approval-</font></font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"><font style="DISPLAY: inline; TEXT-DECORATION: underline">Replace the Letter of Approval dated June 5, </font><font style="DISPLAY: inline; TEXT-DECORATION: underline">2012.</font></font></div>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;</font></div>
</div>

<div>
<table cellpadding="0" cellspacing="0" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr>
<td align="left" valign="middle" width="3%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="top" width="3%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">1.</font></div>
</td>
<td align="left" valign="top" width="66%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">We hereby inform you that the research committee, by virtue of its authority according to Article 17 of the Law for the Encouragement of Research and Development in the Industry, 5744-1984 (hereinafter: the &#8220;R&amp;D Law&#8221;), has resolved in its meeting on <font style="DISPLAY: inline; FONT-WEIGHT: bold">12/12/2012</font> to approve the program as submitted by you on <font style="DISPLAY: inline; FONT-WEIGHT: bold">18/04/2012</font>, which subject matter is:</font></div>
</td>
</tr></table>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;</font></div>
</div>

<div>
<table cellpadding="0" cellspacing="0" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr>
<td align="left" valign="middle" width="8%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="top" width="2%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">a.</font></div>
</td>
<td align="left" valign="top" width="90%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Subject of approved program:&#160;<font style="DISPLAY: inline; FONT-WEIGHT: bold">Treatment with semi-mesenchyme placental cells grown in a 3D culture.</font></font></div>
</td>
</tr></table>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;</font></div>
</div>

<div>
<table cellpadding="0" cellspacing="0" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr>
<td align="left" valign="middle" width="8%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="top" width="2%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">b.</font></div>
</td>
<td align="left" valign="top" width="90%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Performing the approved program:&#160;<font style="DISPLAY: inline; FONT-WEIGHT: bold">Pluristem Ltd.</font></font></div>
</td>
</tr></table>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;</font></div>
</div>

<div>
<table cellpadding="0" cellspacing="0" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr>
<td align="left" valign="middle" width="8%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="top" width="2%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="top" width="90%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Registration Number: <font style="DISPLAY: inline; FONT-WEIGHT: bold">513371666</font></font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(hereinafter - the &#8220;Approved Program&#8221;)</font></div>
</div>
</td>
</tr></table>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;</font></div>

<div>
<table cellpadding="0" cellspacing="0" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr>
<td align="left" valign="middle" width="3%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="top" width="3%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">2.</font></div>
</td>
<td valign="top" width="66%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">a. The research and development expenses approved for the performance of the approved program will be in an amount of up to: <font style="DISPLAY: inline; FONT-WEIGHT: bold">NIS</font><font style="DISPLAY: inline; FONT-WEIGHT: bold">1,700,000</font>.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">In words:<font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font><font style="DISPLAY: inline; FONT-WEIGHT: bold">One million and seven hundred thousand NIS.</font></font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">b. The rate of grant approved is&#160;<font style="DISPLAY: inline; FONT-WEIGHT: bold">30%</font>&#160;of the development expenses (addition with respect to a national priority zone A/ line of confrontation), which is up to an amount of <font style="DISPLAY: inline; FONT-WEIGHT: bold">NIS&#160;510,000</font>.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">In words: <font style="DISPLAY: inline; FONT-WEIGHT: bold">Five hundred and ten thousand NIS</font>.</font></div>
</div>
</td>
</tr></table>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;</font></div>
</div>

<div>
<table cellpadding="0" cellspacing="0" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr>
<td align="left" valign="middle" width="3%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="top" width="3%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">3.</font></div>
</td>
<td align="left" valign="top" width="66%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">The approval is conditioned upon fulfillment of the provisions of the law, regulations, rules and procedures promulgated thereunder and subject to the following terms:</font></div>
</td>
</tr></table>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;</font></div>
</div>

<div>
<table cellpadding="0" cellspacing="0" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr>
<td align="left" valign="middle" width="8%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="top" width="2%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">a.</font></div>
</td>
<td align="left" valign="top" width="90%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">The approved program will be performed as detailed in your request within a period of 10 months &#8211; from <font style="DISPLAY: inline; FONT-WEIGHT: bold">01/3/2012</font> and until <font style="DISPLAY: inline; FONT-WEIGHT: bold">31/12/2012</font> (hereinafter: the &#8220;Performance Period&#8221;).</font></div>
</td>
</tr></table>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;</font></div>
</div>

<div>
<table cellpadding="0" cellspacing="0" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr>
<td align="left" valign="middle" width="8%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="top" width="2%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">b.</font></div>
</td>
<td align="left" valign="top" width="90%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(1) You must inform the Office of the Chief Scientist about every change in the control of the recipient of the grant in the company&#8217;s shares and/or in one of the following controlling means: (a)&#160;the right to vote in the company&#8217;s general meetings; (b)&#160;the right to appoint directors in the company; (c)&#160;the right to participate in the company&#8217;s profits.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(2) Transferring any percentage of the controlling means stated in subsection (1)&#160;to a non-Israeli resident or to a foreign company, which make the non-Israeli resident or foreign company an interested party as defined in the Securities Law, 1968, requires notification to Office of the Chief Scientist and a written undertaking of the non-Israeli resident or the foreign company to the R&amp;D Law.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">The letter of approval shall be signed in the form existing in the office of the Chief Scientist and in the website of the Ministry of Industry, Trade and Employment.</font></div>
</div>
</td>
</tr></table>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;</font></div>

<div id="PGBRK" style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div id="FTR">
<div id="GLFTR" style="WIDTH: 100%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>

<div id="PN" style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
<div style="TEXT-ALIGN: center; WIDTH: 100%"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>

<div style="TEXT-ALIGN: center; WIDTH: 100%">
<hr style="COLOR: black" noshade size="2">
</div>
</div>

<div id="HDR">
<div id="GLHDR" style="WIDTH: 100%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>
</div>
</div>

<div>&#160;</div>

<div>
<table cellpadding="0" cellspacing="0" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr>
<td align="left" valign="middle" width="8%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="top" width="2%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">c.</font></div>
</td>
<td align="left" valign="top" width="90%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Additional terms:</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Royalties shall be paid on Company&#8217;s income.</font></div>
</td>
</tr></table>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;</font></div>
</div>

<div>
<table cellpadding="0" cellspacing="0" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr>
<td align="left" valign="middle" width="8%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="top" width="2%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">d.</font></div>
</td>
<td align="left" valign="top" width="90%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">See the appendix in the matter of intellectual property.</font></div>
</td>
</tr></table>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;</font></div>
</div>

<div>
<table cellpadding="0" cellspacing="0" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr>
<td align="left" valign="middle" width="8%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="top" width="2%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">e.</font></div>
</td>
<td align="left" valign="top" width="90%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">In the event of pledging the company&#8217;s assets to an Israeli bank against credit, the company must ensure that the pledge shall be subject to the R&amp;D Law.</font></div>
</td>
</tr></table>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div style="TEXT-INDENT: 0pt; DISPLAY: block"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;</font></div>
</div>

<div>
<table cellpadding="0" cellspacing="0" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr>
<td align="left" valign="middle" width="8%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="top" width="2%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">f.</font></div>
</td>
<td align="left" valign="top" width="90%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">If the plan is connected to an agreement with an academic institution or an academic implementation company, the company must ensure that the agreement is subject to the provisions of the R&amp;D Law.</font></div>
</td>
</tr></table>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;</font></div>

<table cellpadding="0" cellspacing="0" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr>
<td align="left" valign="middle" width="3%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="top" width="3%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">4.</font></div>
</td>
<td align="left" valign="top" width="66%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">This letter of approval, which replace the previously letter of approval dated June 5<font style="DISPLAY: inline; FONT-SIZE: 70%; VERTICAL-ALIGN: text-top">th</font>, 2012, include 1,360,673 NIS previous grant and a reduction of 850,673 NIS.</font></div>
</td>
</tr></table>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left">&#160;</div>
</div>

<div align="left">
<table cellpadding="0" cellspacing="0" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr>
<td align="left" valign="top" width="50%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="top" width="50%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Sincerely,</font></div>
</td>
</tr><tr>
<td align="left" valign="top" width="50%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="top" width="50%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr>
<td align="left" valign="top" width="50%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="top" width="50%" style="BORDER-BOTTOM: black 2px solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">/s/ Avi Hason</font></div>
</td>
</tr><tr>
<td align="left" valign="top" width="50%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="top" width="50%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Avi Hason</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">The Chief Scientist</font></div>
</td>
</tr></table>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block">&#160;</div>

<div>
<hr style="MARGIN-TOP: -5px; COLOR: #000000" noshade size="1">
<hr style="MARGIN-TOP: -13px; COLOR: #000000" noshade size="4">
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.27
<SEQUENCE>13
<FILENAME>exhibit_10-27.htm
<DESCRIPTION>EXHIBIT 10.27
<TEXT>
<html>
<head>
    <title>exhibit_10-27.htm</title>
    <!--Licensed to: zk global-->
    <!--Document Created using EDGARizer 2020 5.5.0.0-->
    <!--Copyright 1995 - 2014 Thomson Reuters. All rights reserved.-->
</head>
<body bgcolor="#ffffff" style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">
<div>
<hr style="MARGIN-TOP: -5px; COLOR: #000000" noshade size="4">
<hr style="MARGIN-TOP: -10px; COLOR: #000000" noshade size="1">
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"><font style="DISPLAY: inline; TEXT-DECORATION: underline">Exhibit 10.27</font></font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;&#160;</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">[Translation from Hebrew]</font></div>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">State of Israel</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Ministry of Economy</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Industrial Research and Development Administration</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Office of Chief Scientist</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;</font></div>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Jerusalem</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Letter of Approval Number: <font style="DISPLAY: inline; FONT-WEIGHT: bold">49845</font></font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">(Fiscal regulation: <font style="DISPLAY: inline; FONT-WEIGHT: bold">38020101</font>)</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Group: <font style="DISPLAY: inline; FONT-WEIGHT: bold">13</font></font></div>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;<font style="DISPLAY: inline; FONT-WEIGHT: bold">&#160;</font></font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">To</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Pluristem Ltd.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">POB &#8211; 15105</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Haifa 31905</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left">&#160;</div>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"><font style="DISPLAY: inline; TEXT-DECORATION: underline">Letter of Approval</font></font></div>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;</font></div>
</div>

<div>
<table cellpadding="0" cellspacing="0" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr>
<td align="left" valign="middle" width="4%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="top" width="3%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">1.</font></div>
</td>
<td align="left" valign="top" width="93%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">We hereby inform you that the research committee, by virtue of its authority according to Article 17 of the Law for the Encouragement of Research and Development in the Industry, 5744-1984 (hereinafter: the &#8220;R&amp;D Law&#8221;), has resolved in its meeting on <font style="DISPLAY: inline; FONT-WEIGHT: bold">11/04/2013</font> to approve the program as submitted by you on <font style="DISPLAY: inline; FONT-WEIGHT: bold">29/01/2013</font>, which subject matter is:</font></div>
</td>
</tr></table>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;</font></div>
</div>

<div>
<table cellpadding="0" cellspacing="0" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr>
<td align="left" valign="middle" width="7%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="top" width="3%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">a.</font></div>
</td>
<td align="left" valign="top" width="90%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Subject of approved program:&#160;<font style="DISPLAY: inline; FONT-WEIGHT: bold">Treatment with semi-mesenchyme placental cells grown in a 3D culture.</font></font></div>
</td>
</tr></table>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;</font></div>
</div>

<div>
<table cellpadding="0" cellspacing="0" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr>
<td align="left" valign="middle" width="7%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="top" width="3%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">b.</font></div>
</td>
<td align="left" valign="top" width="90%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Performing the approved program:&#160;<font style="DISPLAY: inline; FONT-WEIGHT: bold">Pluristem Ltd.</font></font></div>
</td>
</tr></table>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;</font></div>
</div>

<div>
<table cellpadding="0" cellspacing="0" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr>
<td align="left" valign="middle" width="7%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="top" width="3%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="top" width="90%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Registration Number: <font style="DISPLAY: inline; FONT-WEIGHT: bold">513371666</font></font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-WEIGHT: bold"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: normal">(hereinafter - the &#8220;Approved Program&#8221;)</font></font></div>
</div>
</td>
</tr></table>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;</font></div>

<div>
<table cellpadding="0" cellspacing="0" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr>
<td align="left" valign="middle" width="4%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="top" width="3%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">2.</font></div>
</td>
<td valign="top" width="93%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">a. The research and development expenses approved for the performance of the approved program will be in an amount of up to: <font style="DISPLAY: inline; FONT-WEIGHT: bold">NIS</font><font style="DISPLAY: inline; FONT-WEIGHT: bold">20,835,003</font>.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">In words:<font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font><font style="DISPLAY: inline; FONT-WEIGHT: bold">Twenty million, eight hundred thirty-five thousand and three NIS</font>.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">b. The rate of grant approved is&#160;<font style="DISPLAY: inline; FONT-WEIGHT: bold">50%</font>&#160;of the development expenses (addition with respect to a national priority zone A/ line of confrontation), which is up to an amount of <font style="DISPLAY: inline; FONT-WEIGHT: bold">NIS&#160;10,417,502</font>.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">In words: <font style="DISPLAY: inline; FONT-WEIGHT: bold">Ten million, four hundred and seventeen thousand, five hundred and two NIS</font>.</font></div>
</div>
</td>
</tr></table>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;</font></div>
</div>

<div>
<table cellpadding="0" cellspacing="0" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr>
<td align="left" valign="middle" width="4%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="top" width="3%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">3.</font></div>
</td>
<td align="left" valign="top" width="93%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">The approval is conditioned upon fulfillment of the provisions of the law, regulations, rules and procedures promulgated thereunder and subject to the following terms:</font></div>
</td>
</tr></table>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;</font></div>
</div>

<div>
<table cellpadding="0" cellspacing="0" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr>
<td align="left" valign="middle" width="7%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="top" width="3%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">a.</font></div>
</td>
<td align="left" valign="top" width="90%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">The approved program will be performed as detailed in your request within a period of 10 months &#8211; from <font style="DISPLAY: inline; FONT-WEIGHT: bold">01/1/2013</font> and until <font style="DISPLAY: inline; FONT-WEIGHT: bold">31/12/2013</font> (hereinafter: the &#8220;Performance Period&#8221;).</font></div>
</td>
</tr></table>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;</font></div>
</div>

<div>
<table cellpadding="0" cellspacing="0" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr>
<td align="left" valign="middle" width="7%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="top" width="3%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">b.</font></div>
</td>
<td align="left" valign="top" width="90%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(1) You must inform the Office of the Chief Scientist about every change in the control of the recipient of the grant in the company&#8217;s shares and/or in one of the following controlling means: (a)&#160;the right to vote in the company&#8217;s general meetings; (b)&#160;the right to appoint directors in the company; (c)&#160;the right to participate in the company&#8217;s profits.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(2) Transferring any percentage of the controlling means stated in subsection (1)&#160;to a non-Israeli resident or to a foreign company, which make the non-Israeli resident or foreign company an interested party as defined in the Securities Law, 1968, requires notification to Office of the Chief Scientist and a written undertaking of the non-Israeli resident or the foreign company to the R&amp;D Law.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">The letter of approval shall be signed in the form existing in the office of the Chief Scientist and in the website of the Ministry of Industry, Trade and Employment.</font></div>
</div>
</td>
</tr></table>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;</font></div>

<div id="PGBRK" style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div id="FTR">
<div id="GLFTR" style="WIDTH: 100%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>

<div id="PN" style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
<div style="TEXT-ALIGN: center; WIDTH: 100%"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>

<div style="TEXT-ALIGN: center; WIDTH: 100%">
<hr style="COLOR: black" noshade size="2">
</div>
</div>

<div id="HDR">
<div id="GLHDR" style="WIDTH: 100%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>
</div>
</div>

<div>&#160;</div>

<div>
<table cellpadding="0" cellspacing="0" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr>
<td align="left" valign="middle" width="7%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="top" width="3%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">c.</font></div>
</td>
<td align="left" valign="top" width="90%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Additional terms:</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Royalties shall be paid on Company&#8217;s income.</font></div>
</td>
</tr></table>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;</font></div>
</div>

<div>
<table cellpadding="0" cellspacing="0" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr>
<td align="left" valign="middle" width="7%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="top" width="3%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">d.</font></div>
</td>
<td align="left" valign="top" width="90%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">See the appendix in the matter of intellectual property.</font></div>
</td>
</tr></table>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;</font></div>
</div>

<div>
<table cellpadding="0" cellspacing="0" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr>
<td align="left" valign="middle" width="7%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="top" width="3%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">e.</font></div>
</td>
<td align="left" valign="top" width="90%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">In the event of pledging the company&#8217;s assets to an Israeli bank against credit, the company must ensure that the pledge shall be subject to the R&amp;D Law.</font></div>
</td>
</tr></table>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div style="TEXT-INDENT: 0pt; DISPLAY: block"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;</font></div>
</div>

<div>
<table cellpadding="0" cellspacing="0" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr>
<td align="left" valign="middle" width="7%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="top" width="3%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">f.</font></div>
</td>
<td align="left" valign="top" width="90%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">If the plan is connected to an agreement with an academic institution or an academic implementation company, the company must ensure that the agreement is subject to the provisions of the R&amp;D Law.</font></div>
</td>
</tr></table>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;</font></div>
</div>

<div align="left">
<table cellpadding="0" cellspacing="0" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr>
<td align="left" valign="top" width="50%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="top" width="50%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Sincerely,</font></div>
</td>
</tr><tr>
<td align="left" valign="top" width="50%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="top" width="50%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr>
<td align="left" valign="top" width="50%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="top" width="50%" style="BORDER-BOTTOM: black 2px solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">/s/ Avi Hason</font></div>
</td>
</tr><tr>
<td align="left" valign="top" width="50%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="top" width="50%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Avi Hason</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">The Chief Scientist</font></div>
</td>
</tr></table>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block">&#160;</div>

<div>
<hr style="MARGIN-TOP: -5px; COLOR: #000000" noshade size="1">
<hr style="MARGIN-TOP: -13px; COLOR: #000000" noshade size="4">
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.28
<SEQUENCE>14
<FILENAME>exhibit_10-28.htm
<DESCRIPTION>EXHIBIT 10.28
<TEXT>
<html>
<head>
    <title>exhibit_10-28.htm</title>
    <!--Licensed to: zk global-->
    <!--Document Created using EDGARizer 2020 5.5.0.0-->
    <!--Copyright 1995 - 2014 Thomson Reuters. All rights reserved.-->
</head>
<body bgcolor="#ffffff" style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">
<div>
<hr style="MARGIN-TOP: -5px; COLOR: #000000" noshade size="4">
<hr style="MARGIN-TOP: -10px; COLOR: #000000" noshade size="1">
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"><font style="DISPLAY: inline; TEXT-DECORATION: underline">Exhibit 10.28</font></font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;&#160;</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">[Translation from Hebrew]</font></div>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">State of Israel</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Ministry of Economy</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Industrial Research and Development Administration</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Office of Chief Scientist</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;</font></div>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Jerusalem</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Letter of Approval Number: <font style="DISPLAY: inline; FONT-WEIGHT: bold">50435</font></font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">(Fiscal regulation: <font style="DISPLAY: inline; FONT-WEIGHT: bold">38020101</font>)</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Group: <font style="DISPLAY: inline; FONT-WEIGHT: bold">13</font></font></div>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;<font style="DISPLAY: inline; FONT-WEIGHT: bold">&#160;</font></font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">To</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Pluristem Ltd.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">POB &#8211; 15105</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Haifa 31905</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left">&#160;</div>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"><font style="DISPLAY: inline; TEXT-DECORATION: underline">Letter of Approval</font></font></div>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;</font></div>
</div>

<div>
<table cellpadding="0" cellspacing="0" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr>
<td align="left" valign="middle" width="4%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="top" width="2%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">1.</font></div>
</td>
<td align="left" valign="top" width="94%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">We hereby inform you that the research committee, by virtue of its authority according to Article 17 of the Law for the Encouragement of Research and Development in the Industry, 5744-1984 (hereinafter: the &#8220;R&amp;D Law&#8221;), has resolved in its meeting on <font style="DISPLAY: inline; FONT-WEIGHT: bold">11/04/2013</font> to approve the program as submitted by you on <font style="DISPLAY: inline; FONT-WEIGHT: bold">24/04/2013</font>, which subject matter is:</font></div>
</td>
</tr></table>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;</font></div>
</div>

<div>
<table cellpadding="0" cellspacing="0" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr>
<td align="left" valign="middle" width="6%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="top" width="3%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">a.</font></div>
</td>
<td align="left" valign="top" width="91%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Subject of approved program:&#160;<font style="DISPLAY: inline; FONT-WEIGHT: bold">Treatment with semi-mesenchyme placental cells grown in a 3D culture.</font></font></div>
</td>
</tr></table>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;</font></div>
</div>

<div>
<table cellpadding="0" cellspacing="0" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr>
<td align="left" valign="middle" width="6%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="top" width="3%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">b.</font></div>
</td>
<td align="left" valign="top" width="91%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Performing the approved program:&#160;<font style="DISPLAY: inline; FONT-WEIGHT: bold">Pluristem Ltd.</font></font></div>
</td>
</tr></table>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;</font></div>
</div>

<div>
<table cellpadding="0" cellspacing="0" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr>
<td align="left" valign="middle" width="6%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="top" width="3%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="top" width="91%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Registration Number: <font style="DISPLAY: inline; FONT-WEIGHT: bold">513371666</font></font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(hereinafter - the &#8220;Approved Program&#8221;)</font></div>
</div>
</td>
</tr></table>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;</font></div>

<div>
<table cellpadding="0" cellspacing="0" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr>
<td align="left" valign="middle" width="4%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="top" width="2%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">2.</font></div>
</td>
<td valign="top" width="94%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">a. The research and development expenses approved for the performance of the approved program will be in an amount of up to: <font style="DISPLAY: inline; FONT-WEIGHT: bold">NIS</font><font style="DISPLAY: inline; FONT-WEIGHT: bold">5,275,000</font>.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">In words:<font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font><font style="DISPLAY: inline; FONT-WEIGHT: bold">Five million two hundred seventy-five thousand NIS</font>.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">b. The rate of grant approved is&#160;<font style="DISPLAY: inline; FONT-WEIGHT: bold">30%</font>&#160;of the development expenses (addition with respect to a national priority zone A/ line of confrontation), which is up to an amount of <font style="DISPLAY: inline; FONT-WEIGHT: bold">NIS&#160;1,582,500</font>.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">In words: <font style="DISPLAY: inline; FONT-WEIGHT: bold">One</font> <font style="DISPLAY: inline; FONT-WEIGHT: bold">million, five hundred eighty-two thousand five hundred NIS</font>.</font></div>
</div>
</td>
</tr></table>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;</font></div>
</div>

<div>
<table cellpadding="0" cellspacing="0" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr>
<td align="left" valign="middle" width="4%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="top" width="2%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">3.</font></div>
</td>
<td align="left" valign="top" width="94%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">The approval is conditioned upon fulfillment of the provisions of the law, regulations, rules and procedures promulgated thereunder and subject to the following terms:</font></div>
</td>
</tr></table>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;</font></div>
</div>

<div>
<table cellpadding="0" cellspacing="0" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr>
<td align="left" valign="middle" width="6%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="top" width="3%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">a.</font></div>
</td>
<td align="left" valign="top" width="91%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">The approved program will be performed as detailed in your request within a period of 10 months &#8211; from <font style="DISPLAY: inline; FONT-WEIGHT: bold">01/1/2013</font> and until <font style="DISPLAY: inline; FONT-WEIGHT: bold">31/12/2013</font> (hereinafter: the &#8220;Performance Period&#8221;).</font></div>
</td>
</tr></table>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;</font></div>
</div>

<div>
<table cellpadding="0" cellspacing="0" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr>
<td align="left" valign="middle" width="6%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="top" width="3%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">b.</font></div>
</td>
<td align="left" valign="top" width="91%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(1) You must inform the Office of the Chief Scientist about every change in the control of the recipient of the grant in the company&#8217;s shares and/or in one of the following controlling means: (a)&#160;the right to vote in the company&#8217;s general meetings; (b)&#160;the right to appoint directors in the company; (c)&#160;the right to participate in the company&#8217;s profits.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(2) Transferring any percentage of the controlling means stated in subsection (1)&#160;to a non-Israeli resident or to a foreign company, which make the non-Israeli resident or foreign company an interested party as defined in the Securities Law, 1968, requires notification to Office of the Chief Scientist and a written undertaking of the non-Israeli resident or the foreign company to the R&amp;D Law.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">The letter of approval shall be signed in the form existing in the office of the Chief Scientist and in the website of the Ministry of Industry, Trade and Employment.</font></div>
</div>
</td>
</tr></table>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;</font></div>

<div id="PGBRK" style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div id="FTR">
<div id="GLFTR" style="WIDTH: 100%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>

<div id="PN" style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
<div style="TEXT-ALIGN: center; WIDTH: 100%"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>

<div style="TEXT-ALIGN: center; WIDTH: 100%">
<hr style="COLOR: black" noshade size="2">
</div>
</div>

<div id="HDR">
<div id="GLHDR" style="WIDTH: 100%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>
</div>
</div>

<div>&#160;</div>

<div>
<table cellpadding="0" cellspacing="0" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr>
<td align="left" valign="middle" width="6%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="top" width="3%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">c.</font></div>
</td>
<td align="left" valign="top" width="91%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Additional terms:</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Royalties shall be paid on Company&#8217;s income.</font></div>
</td>
</tr></table>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;</font></div>
</div>

<div>
<table cellpadding="0" cellspacing="0" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr>
<td align="left" valign="middle" width="6%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="top" width="3%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">d.</font></div>
</td>
<td align="left" valign="top" width="91%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">See the appendix in the matter of intellectual property.</font></div>
</td>
</tr></table>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;</font></div>
</div>

<div>
<table cellpadding="0" cellspacing="0" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr>
<td align="left" valign="middle" width="6%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="top" width="3%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">e.</font></div>
</td>
<td align="left" valign="top" width="91%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">In the event of pledging the company&#8217;s assets to an Israeli bank against credit, the company must ensure that the pledge shall be subject to the R&amp;D Law.</font></div>
</td>
</tr></table>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div style="TEXT-INDENT: 0pt; DISPLAY: block"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;</font></div>
</div>

<div>
<table cellpadding="0" cellspacing="0" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr>
<td align="left" valign="middle" width="6%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="top" width="3%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">f.</font></div>
</td>
<td align="left" valign="top" width="91%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">If the plan is connected to an agreement with an academic institution or an academic implementation company, the company must ensure that the agreement is subject to the provisions of the R&amp;D Law.</font></div>
</td>
</tr></table>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;</font></div>
</div>

<div align="left">
<table cellpadding="0" cellspacing="0" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr>
<td align="left" valign="top" width="50%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="top" width="50%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Sincerely,</font></div>
</td>
</tr><tr>
<td align="left" valign="top" width="50%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="top" width="50%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr>
<td align="left" valign="top" width="50%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="top" width="50%" style="BORDER-BOTTOM: black 2px solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">/s/ Avi Hason</font></div>
</td>
</tr><tr>
<td align="left" valign="top" width="50%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="top" width="50%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Avi Hason</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">The Chief Scientist</font></div>
</td>
</tr></table>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block">&#160;</div>

<div>
<hr style="MARGIN-TOP: -5px; COLOR: #000000" noshade size="1">
<hr style="MARGIN-TOP: -13px; COLOR: #000000" noshade size="4">
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.29
<SEQUENCE>15
<FILENAME>exhibit_10-29.htm
<DESCRIPTION>EXHIBIT 10.29
<TEXT>
<html>
<head>
    <title>exhibit_10-29.htm</title>
    <!--Licensed to: zk global-->
    <!--Document Created using EDGARizer 2020 5.5.0.0-->
    <!--Copyright 1995 - 2014 Thomson Reuters. All rights reserved.-->
</head>
<body bgcolor="#ffffff" style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">
<div>
<hr style="MARGIN-TOP: -5px; COLOR: #000000" noshade size="4">
<hr style="MARGIN-TOP: -10px; COLOR: #000000" noshade size="1">
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"><font style="DISPLAY: inline; TEXT-DECORATION: underline">Exhibit 10.29</font></font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;&#160;</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">[Translation from Hebrew]</font></div>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">State of Israel</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Ministry of Economy</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Industrial Research and Development Administration</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Office of Chief Scientist</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;</font></div>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Jerusalem</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Letter of Approval Number: <font style="DISPLAY: inline; FONT-WEIGHT: bold">52103</font></font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">(Fiscal regulation: <font style="DISPLAY: inline; FONT-WEIGHT: bold">38020101</font>)</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Group: <font style="DISPLAY: inline; FONT-WEIGHT: bold">13</font></font></div>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;<font style="DISPLAY: inline; FONT-WEIGHT: bold">&#160;</font></font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">To</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Pluristem Ltd.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">POB &#8211; 15105</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Haifa 31905</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left">&#160;</div>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"><font style="DISPLAY: inline; TEXT-DECORATION: underline">Letter of Approval</font></font></div>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;</font></div>
</div>

<div>
<table cellpadding="0" cellspacing="0" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr>
<td align="left" valign="middle" width="4%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="top" width="3%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">1.</font></div>
</td>
<td align="left" valign="top" width="93%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">We hereby inform you that the research committee, by virtue of its authority according to Article 17 of the Law for the Encouragement of Research and Development in the Industry, 5744-1984 (hereinafter: the &#8220;R&amp;D Law&#8221;), has resolved in its meeting on <font style="DISPLAY: inline; FONT-WEIGHT: bold">7/04/14</font> to approve the program as submitted by you on <font style="DISPLAY: inline; FONT-WEIGHT: bold">16/01/2014</font>, which subject matter is:</font></div>
</td>
</tr></table>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;</font></div>
</div>

<div>
<table cellpadding="0" cellspacing="0" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr>
<td align="left" valign="middle" width="7%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="top" width="3%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">a.</font></div>
</td>
<td align="left" valign="top" width="90%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Subject of approved program:&#160;<font style="DISPLAY: inline; FONT-WEIGHT: bold">Treatment with semi-mesenchyme placental cells grown in a 3D culture.</font></font></div>
</td>
</tr></table>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;</font></div>
</div>

<div>
<table cellpadding="0" cellspacing="0" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr>
<td align="left" valign="middle" width="7%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="top" width="3%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">b.</font></div>
</td>
<td align="left" valign="top" width="90%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Performing the approved program:&#160;<font style="DISPLAY: inline; FONT-WEIGHT: bold">Pluristem Ltd.</font></font></div>
</td>
</tr></table>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;</font></div>
</div>

<div>
<table cellpadding="0" cellspacing="0" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr>
<td align="left" valign="middle" width="7%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="top" width="3%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="top" width="90%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Registration Number: <font style="DISPLAY: inline; FONT-WEIGHT: bold">513371666</font></font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(hereinafter - the &#8220;Approved Program&#8221;)</font></div>
</div>
</td>
</tr></table>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;</font></div>

<div>
<table cellpadding="0" cellspacing="0" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr>
<td align="left" valign="middle" width="4%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="top" width="3%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">2.</font></div>
</td>
<td valign="top" width="93%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">a. The research and development expenses approved for the performance of the approved program will be in an amount of up to: <font style="DISPLAY: inline; FONT-WEIGHT: bold">NIS</font><font style="DISPLAY: inline; FONT-WEIGHT: bold">26,112,823</font>.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">In words: <font style="DISPLAY: inline; FONT-WEIGHT: bold">Twenty six million, one hundred and twelve thousand, eight hundred and twenty-three NIS</font>.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">b. The rate of grant approved is&#160;<font style="DISPLAY: inline; FONT-WEIGHT: bold">50%</font>&#160;of the development expenses (addition with respect to a national priority zone A/ line of confrontation), which is up to an amount of <font style="DISPLAY: inline; FONT-WEIGHT: bold">NIS&#160;13,056,412</font>.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">In words: <font style="DISPLAY: inline; FONT-WEIGHT: bold">Thirteen million fifty-six thousand, four hundred and sixteen NIS</font>.</font></div>
</div>
</td>
</tr></table>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;</font></div>
</div>

<div>
<table cellpadding="0" cellspacing="0" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr>
<td align="left" valign="middle" width="4%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="top" width="3%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">3.</font></div>
</td>
<td align="left" valign="top" width="93%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">The approval is conditioned upon fulfillment of the provisions of the law, regulations, rules and procedures promulgated thereunder and subject to the following terms:</font></div>
</td>
</tr></table>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;</font></div>
</div>

<div>
<table cellpadding="0" cellspacing="0" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr>
<td align="left" valign="middle" width="7%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="top" width="3%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">a.</font></div>
</td>
<td align="left" valign="top" width="90%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">The approved program will be performed as detailed in your request within a period of 10 months &#8211; from <font style="DISPLAY: inline; FONT-WEIGHT: bold">01/1/2014</font> and until <font style="DISPLAY: inline; FONT-WEIGHT: bold">31/12/2014</font> (hereinafter: the &#8220;Performance Period&#8221;).</font></div>
</td>
</tr></table>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;</font></div>
</div>

<div>
<table cellpadding="0" cellspacing="0" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr>
<td align="left" valign="middle" width="7%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="top" width="3%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">b.</font></div>
</td>
<td align="left" valign="top" width="90%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(1) You must inform the Office of the Chief Scientist about every change in the control of the recipient of the grant in the company&#8217;s shares and/or in one of the following controlling means: (a)&#160;the right to vote in the company&#8217;s general meetings; (b)&#160;the right to appoint directors in the company; (c)&#160;the right to participate in the company&#8217;s profits.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(2) Transferring any percentage of the controlling means stated in subsection (1)&#160;to a non-Israeli resident or to a foreign company, which make the non-Israeli resident or foreign company an interested party as defined in the Securities Law, 1968, requires notification to Office of the Chief Scientist and a written undertaking of the non-Israeli resident or the foreign company to the R&amp;D Law.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">The letter of approval shall be signed in the form existing in the office of the Chief Scientist and in the website of the Ministry of Industry, Trade and Employment.</font></div>
</div>
</td>
</tr></table>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;</font></div>

<div id="PGBRK" style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div id="FTR">
<div id="GLFTR" style="WIDTH: 100%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>

<div id="PN" style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
<div style="TEXT-ALIGN: center; WIDTH: 100%"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>

<div style="TEXT-ALIGN: center; WIDTH: 100%">
<hr style="COLOR: black" noshade size="2">
</div>
</div>

<div id="HDR">
<div id="GLHDR" style="WIDTH: 100%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>
</div>
</div>

<div>&#160;</div>

<div>
<table cellpadding="0" cellspacing="0" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr>
<td align="left" valign="middle" width="7%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="top" width="3%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">c.</font></div>
</td>
<td align="left" valign="top" width="90%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Additional terms:</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Royalties shall be paid on Company&#8217;s income.</font></div>
</td>
</tr></table>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;</font></div>
</div>

<div>
<table cellpadding="0" cellspacing="0" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr>
<td align="left" valign="middle" width="7%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="top" width="3%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">d.</font></div>
</td>
<td align="left" valign="top" width="90%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">See the appendix in the matter of intellectual property.</font></div>
</td>
</tr></table>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;</font></div>
</div>

<div>
<table cellpadding="0" cellspacing="0" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr>
<td align="left" valign="middle" width="7%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="top" width="3%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">e.</font></div>
</td>
<td align="left" valign="top" width="90%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">In the event of pledging the company&#8217;s assets to an Israeli bank against credit, the company must ensure that the pledge shall be subject to the R&amp;D Law.</font></div>
</td>
</tr></table>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div style="TEXT-INDENT: 0pt; DISPLAY: block"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;</font></div>
</div>

<div>
<table cellpadding="0" cellspacing="0" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr>
<td align="left" valign="middle" width="7%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="top" width="3%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">f.</font></div>
</td>
<td align="left" valign="top" width="90%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">If the plan is connected to an agreement with an academic institution or an academic implementation company, the company must ensure that the agreement is subject to the provisions of the R&amp;D Law.</font></div>
</td>
</tr></table>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;</font></div>
</div>

<div align="left">
<table cellpadding="0" cellspacing="0" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr>
<td align="left" valign="top" width="50%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="top" width="50%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Sincerely,</font></div>
</td>
</tr><tr>
<td align="left" valign="top" width="50%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="top" width="50%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr>
<td align="left" valign="top" width="50%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="top" width="50%" style="BORDER-BOTTOM: black 2px solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">/s/ Avi Hason</font></div>
</td>
</tr><tr>
<td align="left" valign="top" width="50%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="top" width="50%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Avi Hason</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">The Chief Scientist</font></div>
</td>
</tr></table>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block">&#160;</div>

<div>
<hr style="MARGIN-TOP: -5px; COLOR: #000000" noshade size="1">
<hr style="MARGIN-TOP: -13px; COLOR: #000000" noshade size="4">
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.30
<SEQUENCE>16
<FILENAME>exhibit_10-30.htm
<DESCRIPTION>EXHIBIT 10.30
<TEXT>
<html>
<head>
    <title>exhibit_10-30.htm</title>
    <!--Licensed to: zk global-->
    <!--Document Created using EDGARizer 2020 5.5.0.0-->
    <!--Copyright 1995 - 2014 Thomson Reuters. All rights reserved.-->
</head>
<body bgcolor="#ffffff" style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">
<div>
<hr style="MARGIN-TOP: -5px; COLOR: #000000" noshade size="4">
<hr style="MARGIN-TOP: -10px; COLOR: #000000" noshade size="1">
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"><font style="DISPLAY: inline; TEXT-DECORATION: underline">Exhibit 10.30</font></font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;&#160;</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">[Translation from Hebrew]</font></div>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">State of Israel</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Ministry of Economy</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Industrial Research and Development Administration</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Office of Chief Scientist</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;</font></div>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Jerusalem</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Letter of Approval Number: <font style="DISPLAY: inline; FONT-WEIGHT: bold">52802</font></font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">(Fiscal regulation: <font style="DISPLAY: inline; FONT-WEIGHT: bold">38020101</font>)</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Group: <font style="DISPLAY: inline; FONT-WEIGHT: bold">13</font></font></div>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;<font style="DISPLAY: inline; FONT-WEIGHT: bold">&#160;</font></font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">To</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Pluristem Ltd.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">POB &#8211; 15105</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Haifa 31905</font></div>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"><font style="DISPLAY: inline; TEXT-DECORATION: underline">Letter of Approval</font></font></div>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;</font></div>
</div>

<div>
<table cellpadding="0" cellspacing="0" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr>
<td align="left" valign="middle" width="4%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="top" width="3%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">1.</font></div>
</td>
<td align="left" valign="top" width="93%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">We hereby inform you that the research committee, by virtue of its authority according to Article 17 of the Law for the Encouragement of Research and Development in the Industry, 5744-1984 (hereinafter: the &#8220;R&amp;D Law&#8221;), has resolved in its meeting on <font style="DISPLAY: inline; FONT-WEIGHT: bold">7/04/2014</font> to approve the program as submitted by you on <font style="DISPLAY: inline; FONT-WEIGHT: bold">7/04/2014</font>, which subject matter is:</font></div>
</td>
</tr></table>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;</font></div>
</div>

<div>
<table cellpadding="0" cellspacing="0" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr>
<td align="left" valign="middle" width="7%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="top" width="4%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">a.</font></div>
</td>
<td align="left" valign="top" width="89%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Subject of approved program:&#160;<font style="DISPLAY: inline; FONT-WEIGHT: bold">Treatment with semi-mesenchyme placental cells grown in a 3D culture.</font></font></div>
</td>
</tr></table>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;</font></div>
</div>

<div>
<table cellpadding="0" cellspacing="0" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr>
<td align="left" valign="middle" width="7%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="top" width="4%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">b.</font></div>
</td>
<td align="left" valign="top" width="89%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Performing the approved program:&#160;<font style="DISPLAY: inline; FONT-WEIGHT: bold">Pluristem Ltd.</font></font></div>
</td>
</tr></table>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;</font></div>
</div>

<div>
<table cellpadding="0" cellspacing="0" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr>
<td align="left" valign="middle" width="7%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="top" width="4%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="top" width="89%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Registration Number: <font style="DISPLAY: inline; FONT-WEIGHT: bold">513371666</font></font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(hereinafter - the &#8220;Approved Program&#8221;)</font></div>
</div>
</td>
</tr></table>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;</font></div>

<div>
<table cellpadding="0" cellspacing="0" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr>
<td align="left" valign="middle" width="4%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="top" width="3%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">2.</font></div>
</td>
<td valign="top" width="93%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">a. The research and development expenses approved for the performance of the approved program will be in an amount of up to: <font style="DISPLAY: inline; FONT-WEIGHT: bold">NIS</font><font style="DISPLAY: inline; FONT-WEIGHT: bold">5,148,000</font>.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">In words:<font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font><font style="DISPLAY: inline; FONT-WEIGHT: bold">Five million one hundred and forty-eight thousand NIS</font>.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">b. The rate of grant approved is&#160;<font style="DISPLAY: inline; FONT-WEIGHT: bold">30%</font>&#160;of the development expenses (addition with respect to a national priority zone A/ line of confrontation), which is up to an amount of <font style="DISPLAY: inline; FONT-WEIGHT: bold">NIS&#160;1,544,400</font>.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">In words: <font style="DISPLAY: inline; FONT-WEIGHT: bold">One</font> <font style="DISPLAY: inline; FONT-WEIGHT: bold">million, five hundred forty-four thousand four hundred NIS</font>.</font></div>
</div>
</td>
</tr></table>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;</font></div>
</div>

<div>
<table cellpadding="0" cellspacing="0" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr>
<td align="left" valign="middle" width="4%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="top" width="3%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">3.</font></div>
</td>
<td align="left" valign="top" width="93%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">The approval is conditioned upon fulfillment of the provisions of the law, regulations, rules and procedures promulgated thereunder and subject to the following terms:</font></div>
</td>
</tr></table>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;</font></div>
</div>

<div>
<table cellpadding="0" cellspacing="0" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr>
<td align="left" valign="middle" width="7%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="top" width="4%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">a.</font></div>
</td>
<td align="left" valign="top" width="89%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">The approved program will be performed as detailed in your request within a period of 10 months &#8211; from <font style="DISPLAY: inline; FONT-WEIGHT: bold">01/1/2014</font> and until <font style="DISPLAY: inline; FONT-WEIGHT: bold">31/12/2014</font> (hereinafter: the &#8220;Performance Period&#8221;).</font></div>
</td>
</tr></table>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;</font></div>
</div>

<div>
<table cellpadding="0" cellspacing="0" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr>
<td align="left" valign="middle" width="7%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="top" width="4%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">b.</font></div>
</td>
<td align="left" valign="top" width="89%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(1) You must inform the Office of the Chief Scientist about every change in the control of the recipient of the grant in the company&#8217;s shares and/or in one of the following controlling means: (a)&#160;the right to vote in the company&#8217;s general meetings; (b)&#160;the right to appoint directors in the company; (c)&#160;the right to participate in the company&#8217;s profits.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(2) Transferring any percentage of the controlling means stated in subsection (1)&#160;to a non-Israeli resident or to a foreign company, which make the non-Israeli resident or foreign company an interested party as defined in the Securities Law, 1968, requires notification to Office of the Chief Scientist and a written undertaking of the non-Israeli resident or the foreign company to the R&amp;D Law.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">The letter of approval shall be signed in the form existing in the office of the Chief Scientist and in the website of the Ministry of Industry, Trade and Employment.</font></div>
</div>
</td>
</tr></table>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;</font></div>

<div id="PGBRK" style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div id="FTR">
<div id="GLFTR" style="WIDTH: 100%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>

<div id="PN" style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
<div style="TEXT-ALIGN: center; WIDTH: 100%"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>

<div style="TEXT-ALIGN: center; WIDTH: 100%">
<hr style="COLOR: black" noshade size="2">
</div>
</div>

<div id="HDR">
<div id="GLHDR" style="WIDTH: 100%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>
</div>
</div>

<div>&#160;</div>

<div>
<table cellpadding="0" cellspacing="0" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr>
<td align="left" valign="middle" width="7%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="top" width="4%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">c.</font></div>
</td>
<td align="left" valign="top" width="89%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Additional terms:</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Royalties shall be paid on Company&#8217;s income.</font></div>
</td>
</tr></table>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;</font></div>
</div>

<div>
<table cellpadding="0" cellspacing="0" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr>
<td align="left" valign="middle" width="7%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="top" width="4%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">d.</font></div>
</td>
<td align="left" valign="top" width="89%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">See the appendix in the matter of intellectual property.</font></div>
</td>
</tr></table>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;</font></div>
</div>

<div>
<table cellpadding="0" cellspacing="0" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr>
<td align="left" valign="middle" width="7%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="top" width="4%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">e.</font></div>
</td>
<td align="left" valign="top" width="89%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">In the event of pledging the company&#8217;s assets to an Israeli bank against credit, the company must ensure that the pledge shall be subject to the R&amp;D Law.</font></div>
</td>
</tr></table>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div style="TEXT-INDENT: 0pt; DISPLAY: block"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;</font></div>
</div>

<div>
<table cellpadding="0" cellspacing="0" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr>
<td align="left" valign="middle" width="7%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="top" width="4%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">f.</font></div>
</td>
<td align="left" valign="top" width="89%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">If the plan is connected to an agreement with an academic institution or an academic implementation company, the company must ensure that the agreement is subject to the provisions of the R&amp;D Law.</font></div>
</td>
</tr></table>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;</font></div>
</div>

<div align="left">
<table cellpadding="0" cellspacing="0" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr>
<td align="left" valign="top" width="50%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="top" width="50%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Sincerely,</font></div>
</td>
</tr><tr>
<td align="left" valign="top" width="50%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="top" width="50%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr>
<td align="left" valign="top" width="50%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="top" width="50%" style="BORDER-BOTTOM: black 2px solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">/s/ Avi Hason</font></div>
</td>
</tr><tr>
<td align="left" valign="top" width="50%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="top" width="50%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Avi Hason</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">The Chief Scientist</font></div>
</td>
</tr></table>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block">&#160;</div>

<div>
<hr style="MARGIN-TOP: -5px; COLOR: #000000" noshade size="1">
<hr style="MARGIN-TOP: -13px; COLOR: #000000" noshade size="4">
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-23.1
<SEQUENCE>17
<FILENAME>exhibit_23-1.htm
<DESCRIPTION>EXHIBIT 23.1
<TEXT>
<html>
<head>
    <title>exhibit_23-1.htm</title>
    <!--Licensed to: zk global-->
    <!--Document Created using EDGARizer 2020 5.5.0.0-->
    <!--Copyright 1995 - 2014 Thomson Reuters. All rights reserved.-->
</head>
<body bgcolor="#ffffff" style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">
<div>
<hr style="MARGIN-TOP: -5px; COLOR: #000000" noshade size="4">
<hr style="MARGIN-TOP: -10px; COLOR: #000000" noshade size="1">
</div>

<div style="TEXT-ALIGN: right; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline; FONT-WEIGHT: bold; TEXT-DECORATION: underline">Exhibit 23.1</font></font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-ALIGN: center; TEXT-INDENT: 0pt; DISPLAY: block"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline; TEXT-DECORATION: underline">CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM</font></font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 45pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">We consent to the incorporation by reference in the Registration Statements on Form S-3 (Registration No. 333-171334, 333-170859, 333-151761, and 333-177009) and in the Registration Statements on Form S-8 (Registration No. 333-173777, 333-162577, 333-111591 and 333-196537) of Pluristem Therapeutics Inc. of our reports dated September&#160;11, 2014, with respect to the consolidated financial statements of Pluristem Therapeutics Inc., and the effectiveness of internal control over financial reporting of Pluristem Therapeutics Inc., included in this Annual Report of Pluristem Therapeutics Inc. (Form 10-K) for the year ended June 30, 2014 f<font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">iled with the Securities and Exchange Commission.</font></font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div align="center">
<table bgcolor="white" cellpadding="0" cellspacing="0" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr>
<td width="50%"><font style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td width="50%">
<div style="TEXT-ALIGN: left; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline; TEXT-DECORATION: underline">/s/ Kost Forer Gabbay &amp; Kasierer</font></font></font></div>

<div style="TEXT-ALIGN: left; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Kost Forer Gabbay &amp; Kasierer</font></font></div>

<div style="TEXT-ALIGN: left; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">A member of Ernst &amp; Young Global</font></font></div>
</td>
</tr></table>
</div>

<div>&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Haifa, Israel</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">September 11, 2014</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left">&#160;</div>

<div>
<hr style="MARGIN-TOP: -5px; COLOR: #000000" noshade size="1">
<hr style="MARGIN-TOP: -13px; COLOR: #000000" noshade size="4">
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;</font></div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-31.1
<SEQUENCE>18
<FILENAME>exhibit_31-1.htm
<DESCRIPTION>EXHIBIT 31.1
<TEXT>
<html>
<head>
    <title>exhibit_31-1.htm</title>
    <!--Licensed to: zk global-->
    <!--Document Created using EDGARizer 2020 5.5.0.0-->
    <!--Copyright 1995 - 2014 Thomson Reuters. All rights reserved.-->
</head>
<body bgcolor="#ffffff" style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">
<div>
<hr style="MARGIN-TOP: -5px; COLOR: #000000" noshade size="4">
<hr style="MARGIN-TOP: -10px; COLOR: #000000" noshade size="1">
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline; FONT-WEIGHT: bold; TEXT-DECORATION: underline">Exhibit 31.1</font></font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">CERTIFICATIONS</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">I, Zami Aberman, certify that:</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div>
<table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td style="WIDTH: 36pt">
<div style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">1.</font></div>
</td>
<td>
<div align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">I have reviewed this annual report on Form 10-K for the year ended June 30, 2014, of Pluristem Therapeutics Inc.;</font></div>
</td>
</tr></table>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div>
<table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td style="WIDTH: 36pt">
<div style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">2.</font></div>
</td>
<td>
<div align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;</font></div>
</td>
</tr></table>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div>
<table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td style="WIDTH: 36pt">
<div style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">3.</font></div>
</td>
<td>
<div align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;</font></div>
</td>
</tr></table>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div>
<table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td style="WIDTH: 36pt">
<div style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">4.</font></div>
</td>
<td>
<div align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">The registrant's other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) and have:</font></div>
</td>
</tr></table>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div>
<table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td style="WIDTH: 36pt">
<div><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160; </font></div>
</td>
<td style="WIDTH: 36pt">
<div style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">(a)</font></div>
</td>
<td>
<div align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;</font></div>
</td>
</tr></table>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div>
<table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td style="WIDTH: 36pt">
<div><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160; </font></div>
</td>
<td style="WIDTH: 36pt">
<div style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">(b)</font></div>
</td>
<td>
<div align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;</font></div>
</td>
</tr></table>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div>
<table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td style="WIDTH: 36pt">
<div><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160; </font></div>
</td>
<td style="WIDTH: 36pt">
<div style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">(c)</font></div>
</td>
<td>
<div align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Evaluated the effectiveness of the registrant's disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and</font></div>
</td>
</tr></table>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div>
<table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td style="WIDTH: 36pt">
<div><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160; </font></div>
</td>
<td style="WIDTH: 36pt">
<div style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">(d)</font></div>
</td>
<td>
<div align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Disclosed in this report any change in the registrant's internal control over financial reporting that occurred during the registrant's most recent fiscal quarter (the registrant's fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant's internal control over financial reporting; and</font></div>
</td>
</tr></table>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div>
<table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td style="WIDTH: 36pt">
<div style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">5.</font></div>
</td>
<td>
<div align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">The registrant's other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant's auditors and the audit committee of the registrant's board of directors (or persons performing the equivalent functions):</font></div>
</td>
</tr></table>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div>
<table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td style="WIDTH: 36pt">
<div><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160; </font></div>
</td>
<td style="WIDTH: 36pt">
<div style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">(a)</font></div>
</td>
<td>
<div align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant's ability to record, process, summarize and report financial information; and</font></div>
</td>
</tr></table>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div>
<table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td style="WIDTH: 36pt">
<div><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160; </font></div>
</td>
<td style="WIDTH: 36pt">
<div style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">(b)</font></div>
</td>
<td>
<div align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal control over financial reporting.</font></div>
</td>
</tr></table>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Dated: September 11, 2014</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left">&#160;</div>

<div align="center">
<table bgcolor="white" cellpadding="0" cellspacing="0" width="100%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr>
<td width="50%"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;</font></td>
<td width="50%"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"> </font>
<div style="TEXT-ALIGN: left; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline; TEXT-DECORATION: underline">/s/ Zami Aberman</font></font></font></div>

<div style="TEXT-ALIGN: left; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Zami Aberman</font></font></div>

<div style="TEXT-ALIGN: left; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Chief Executive Officer</font></font></div>

<div style="TEXT-ALIGN: left; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">(Principal Executive Officer)</font></font></div>
</td>
</tr></table>
</div>

<div>&#160;</div>

<div>
<hr style="MARGIN-TOP: -5px; COLOR: #000000" noshade size="1">
<hr style="MARGIN-TOP: -13px; COLOR: #000000" noshade size="4">
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;</font></div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-31.2
<SEQUENCE>19
<FILENAME>exhibit_31-2.htm
<DESCRIPTION>EXHIBIT 31.2
<TEXT>
<html>
<head>
    <title>exhibit_31-2.htm</title>
    <!--Licensed to: zk global-->
    <!--Document Created using EDGARizer 2020 5.5.0.0-->
    <!--Copyright 1995 - 2014 Thomson Reuters. All rights reserved.-->
</head>
<body bgcolor="#ffffff" style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">
<div>
<hr style="MARGIN-TOP: -5px; COLOR: #000000" noshade size="4">
<hr style="MARGIN-TOP: -10px; COLOR: #000000" noshade size="1">
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline; FONT-WEIGHT: bold; TEXT-DECORATION: underline">Exhibit 31.2</font></font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">CERTIFICATIONS</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">I, Boaz Gur-Lavie, certify that:</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div>
<table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td style="WIDTH: 36pt">
<div style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">1.</font></div>
</td>
<td>
<div align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">I have reviewed this annual report on Form 10-K for the year ended June 30, 2014, of Pluristem Therapeutics Inc.;</font></div>
</td>
</tr></table>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div>
<table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td style="WIDTH: 36pt">
<div style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">2.</font></div>
</td>
<td>
<div align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;</font></div>
</td>
</tr></table>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div>
<table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td style="WIDTH: 36pt">
<div style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">3.</font></div>
</td>
<td>
<div align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;</font></div>
</td>
</tr></table>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div>
<table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td style="WIDTH: 36pt">
<div style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">4.</font></div>
</td>
<td>
<div align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">The registrant's other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) and have:</font></div>
</td>
</tr></table>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div>
<table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td style="WIDTH: 36pt">
<div><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160; </font></div>
</td>
<td style="WIDTH: 36pt">
<div style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">(a)</font></div>
</td>
<td>
<div align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;</font></div>
</td>
</tr></table>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div>
<table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td style="WIDTH: 36pt">
<div><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160; </font></div>
</td>
<td style="WIDTH: 36pt">
<div style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">(b)</font></div>
</td>
<td>
<div align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;</font></div>
</td>
</tr></table>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div>
<table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td style="WIDTH: 36pt">
<div><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160; </font></div>
</td>
<td style="WIDTH: 36pt">
<div style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">(c)</font></div>
</td>
<td>
<div align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Evaluated the effectiveness of the registrant's disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and</font></div>
</td>
</tr></table>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div>
<table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td style="WIDTH: 36pt">
<div><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160; </font></div>
</td>
<td style="WIDTH: 36pt">
<div style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">(d)</font></div>
</td>
<td>
<div align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Disclosed in this report any change in the registrant's internal control over financial reporting that occurred during the registrant's most recent fiscal quarter (the registrant's fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant's internal control over financial reporting; and</font></div>
</td>
</tr></table>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div>
<table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td style="WIDTH: 36pt">
<div style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">5.</font></div>
</td>
<td>
<div align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">The registrant's other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant's auditors and the audit committee of the registrant's board of directors (or persons performing the equivalent functions):</font></div>
</td>
</tr></table>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div>
<table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td style="WIDTH: 36pt">
<div><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160; </font></div>
</td>
<td style="WIDTH: 36pt">
<div style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">(a)</font></div>
</td>
<td>
<div align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant's ability to record, process, summarize and report financial information; and</font></div>
</td>
</tr></table>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div>
<table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td style="WIDTH: 36pt">
<div><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160; </font></div>
</td>
<td style="WIDTH: 36pt">
<div style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">(b)</font></div>
</td>
<td>
<div align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal control over financial reporting.</font></div>
</td>
</tr></table>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Dated: September 11, 2014</font></div>

<div>&#160;</div>

<div align="center">
<table bgcolor="white" cellpadding="0" cellspacing="0" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr>
<td width="50%"><font style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td width="50%">

<div style="TEXT-ALIGN: left; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline; TEXT-DECORATION: underline">/s/ Boaz Gur-Lavie</font></font></font></div>

<div style="TEXT-ALIGN: left; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Boaz Gur-Lavie</font></font></div>

<div style="TEXT-ALIGN: left; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Chief Financial Officer and Secretary</font></font></div>

<div style="TEXT-ALIGN: left; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(Principal Financial Officer)</font></font></div>
</td>
</tr></table>
</div>

<div>&#160;</div>

<div>
<hr style="MARGIN-TOP: -5px; COLOR: #000000" noshade size="1">
<hr style="MARGIN-TOP: -13px; COLOR: #000000" noshade size="4">
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;</font></div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-32.1
<SEQUENCE>20
<FILENAME>exhibit_32-1.htm
<DESCRIPTION>EXHIBIT 32.1
<TEXT>
<html>
<head>
    <title>exhibit_32-1.htm</title>
    <!--Licensed to: zk global-->
    <!--Document Created using EDGARizer 2020 5.5.0.0-->
    <!--Copyright 1995 - 2014 Thomson Reuters. All rights reserved.-->
</head>
<body bgcolor="#ffffff" style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">
<div>
<hr style="MARGIN-TOP: -5px; COLOR: #000000" noshade size="4">
<hr style="MARGIN-TOP: -10px; COLOR: #000000" noshade size="1">
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline; FONT-WEIGHT: bold; TEXT-DECORATION: underline">Exhibit 32.1</font></font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">CERTIFICATION PURSUANT TO</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">18 U.S.C. SECTION 1350</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">In connection with the Annual Report on Form 10-K of Pluristem Therapeutics Inc. (the "Company") for the period ended June 30, 2014, as filed with the Securities and Exchange Commission on the date hereof (the "Report"), the undersigned, as the Chief Executive Officer of the Company, hereby certifies pursuant to 18 U.S.C. Section 1350,&#160;&#160;that, to my knowledge:</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div>
<table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td style="WIDTH: 36pt">
<div style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">(1)</font></div>
</td>
<td>
<div align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">The Report fully complies with the requirements of section 13(a) or 15(d) of the Securities Exchange Act of 1934; and</font></div>
</td>
</tr></table>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div>
<table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td style="WIDTH: 36pt">
<div style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">(2)</font></div>
</td>
<td>
<div align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">The information contained in the Report fairly presents, in all material respects, the financial condition and result of operations of the Company.</font></div>
</td>
</tr></table>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Dated: September 11, 2014</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left">&#160;</div>

<div align="center">
<table bgcolor="white" cellpadding="0" cellspacing="0" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr>
<td width="50%"><font style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td width="50%">

<div style="TEXT-ALIGN: left; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline; TEXT-DECORATION: underline">/s/ Zami Aberman</font></font></font></div>

<div style="TEXT-ALIGN: left; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Zami Aberman</font></font></div>

<div style="TEXT-ALIGN: left; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Chief Executive Officer</font></font></div>
</td>
</tr></table>
</div>

<div>&#160;</div>

<div>
<hr style="MARGIN-TOP: -5px; COLOR: #000000" noshade size="1">
<hr style="MARGIN-TOP: -13px; COLOR: #000000" noshade size="4">
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-ALIGN: left; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;</font></div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-32.2
<SEQUENCE>21
<FILENAME>exhibit_32-2.htm
<DESCRIPTION>EXHIBIT 32.2
<TEXT>
<html>
<head>
    <title>exhibit_32-2.htm</title>
    <!--Licensed to: zk global-->
    <!--Document Created using EDGARizer 2020 5.5.0.0-->
    <!--Copyright 1995 - 2014 Thomson Reuters. All rights reserved.-->
</head>
<body bgcolor="#ffffff" style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">
<div>
<hr style="MARGIN-TOP: -5px; COLOR: #000000" noshade size="4">
<hr style="MARGIN-TOP: -10px; COLOR: #000000" noshade size="1">
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline; FONT-WEIGHT: bold; TEXT-DECORATION: underline">Exhibit 32.2</font></font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">CERTIFICATION PURSUANT TO</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">18 U.S.C. SECTION 1350</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">In connection with the Annual Report on Form 10-K of Pluristem Therapeutics Inc. (the "Company")&#160;&#160;for the period ended June 30, 2014, as filed with the Securities and Exchange Commission on the date hereof (the "Report"), the undersigned, as the Chief Financial Officer of the Company, hereby certifies pursuant to 18 U.S.C. Section 1350 that, to my knowledge:</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div>
<table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td style="WIDTH: 36pt">
<div style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">(1)</font></div>
</td>
<td>
<div align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">The Report fully complies with the requirements of section 13(a) or 15(d) of the Securities Exchange Act of 1934; and</font></div>
</td>
</tr></table>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div>
<table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td style="WIDTH: 36pt">
<div style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">(2)</font></div>
</td>
<td>
<div align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">The information contained in the Report fairly presents, in all material respects, the financial condition and result of operations of the Company.</font></div>
</td>
</tr></table>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Dated: September 11, 2014</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left">
<div align="center">
<table bgcolor="white" cellpadding="0" cellspacing="0" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr>
<td width="50%"><font style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td width="50%">

<div style="TEXT-ALIGN: left; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline; TEXT-DECORATION: underline">/s/ Boaz Gur-Lavie</font></font></font></div>

<div style="TEXT-ALIGN: left; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Boaz Gur-Lavie</font></font></div>

<div style="TEXT-ALIGN: left; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Chief Financial Officer</font></font></div>
</td>
</tr></table>
</div>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div>
<hr style="MARGIN-TOP: -5px; COLOR: #000000" noshade size="1">
<hr style="MARGIN-TOP: -13px; COLOR: #000000" noshade size="4">
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>22
<FILENAME>ey.jpg
<TEXT>
begin 644 ey.jpg
M_]C_X``02D9)1@`!`0$`8`!@``#_X0!F17AI9@``34T`*@````@`!`$:``4`
M```!````/@$;``4````!````1@$H``,````!``(```$Q``(````0````3@``
M``````!@`````0```&`````!4&%I;G0N3D54('8U+C`P`/_;`$,``0$!`0$!
M`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!
M`0$!`0$!`0$!`0$!`?_;`$,!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!
M`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`?_``!$(`(,`
M<P,!(@`"$0$#$0'_Q``?```!!0$!`0$!`0```````````0(#!`4&!P@)"@O_
MQ`"U$``"`0,#`@0#!04$!````7T!`@,`!!$%$B$Q008346$'(G$4,H&1H0@C
M0K'!%5+1\"0S8G*""0H6%Q@9&B4F)R@I*C0U-C<X.3I#1$5&1TA)2E-45597
M6%E:8V1E9F=H:6IS='5V=WAY>H.$A8:'B(F*DI.4E9:7F)F:HJ.DI::GJ*FJ
MLK.TM;:WN+FZPL/$Q<;'R,G*TM/4U=;7V-G:X>+CY.7FY^CIZO'R\_3U]O?X
M^?K_Q``?`0`#`0$!`0$!`0$!`````````0(#!`4&!P@)"@O_Q`"U$0`"`0($
M!`,$!P4$!``!`G<``0(#$00%(3$&$D%1!V%Q$R(R@0@40I&AL<$)(S-2\!5B
M<M$*%B0TX27Q%Q@9&B8G*"DJ-38W.#DZ0T1%1D=(24I35%565UA96F-D969G
M:&EJ<W1U=G=X>7J"@X2%AH>(B8J2DY25EI>8F9JBHZ2EIJ>HJ:JRL[2UMK>X
MN;K"P\3%QL?(R<K2T]35UM?8V=KBX^3EYN?HZ>KR\_3U]O?X^?K_V@`,`P$`
M`A$#$0`_`/[^****`"BBB@`HHHH`****`"BBL76_$>@^&[87>O:OI^DP.)/*
M:^NHH'N6B3S)(K2%F\Z\G"X(M[6.:=R5"1LS*#S8S&X/+L)B,?F&+PV!P.$H
MSQ&+QF,KTL+A,+0I1<JE?$8BO.%&C1IQ3E.I4G&$(IN4DD5"$ZDXTZ<)5*DY
M*,(0BYSG)NRC&,4W*3>B23;>QM45\V^)/VD?#UEYD'AC2KS79APM[>EM)TW#
MQDI-%')%+J=P8I,"6VN+/32X!"7*D[A\_P#B/XP_$#Q-O2XUN32[1RI^P:`'
MTFW&$,;J;B.635)XI@29K>[U&YMV).V)%P@_@OQC_:5_19\)?K>!P7%];Q0X
MCPZG&.2^&M&CGN$5;X::Q'%5;$8/A6%%5+K$_4<WS'&X:$)R_L^K4]E2J_H&
M2^&/%>;\E2>#658:5FZ^9N5"?+N^7"1C/%N5OAYZ-.$FTO:)7:^X/$GQ!\&^
M$BT>O:_8VETOEYTZ)FO-4Q,I:)VTVR6XO8X9`/EN9H8[5<KOF0,#7S_XD_:7
M<[H?"/A\+]PKJ'B)]W0L)4&DZ;<#(8;6AN&U@$=);/)POR@`!T`')/`QR3DG
MZDDD^I.32U_E)XQ_M<O'GC;ZWEOA;DG#_A#DM7FITL?3A3XOXQ=)WA*^;9Q@
MZ6187VL/>2P?#,<9A)R?L,SE.$*Q^M9+X/\`#^!Y*N;5\3G%=6;IMO!X*ZUT
MHT9NO.S_`)\4X32]ZDDW$_4/PMJ-QJ_AGPYJUWY?VO5-"TC4;KRE*1?:+W3[
M>YF\M"6*1^9*VQ2S;5P,G&:*H>`O^1&\%_\`8I^'/_3/9T5_TF9=4G5R_`U:
MDG.I4P>%J3F]Y3G0A*4GYRDVWYL_F:JDJE1)62G-)=DI-)'64445V$!1110`
M45Y=XE^,G@#PSYD4VLIJU]&I)T[0`FJ3[DF,,D,ES'+'I=K<Q,&:2UO=0M;@
M(NX1,&3=\_\`B;]H_P`27_G6_AC3;/0(&WHE_=8U75,"4-%<0I+'%IEH[QC9
M-;7%GJR+N8QW&[8Z_P`M>,7TT?HV>!OUK"<;^)V25N(,+*=*?"/"\WQ5Q1'$
MT[WPN+RS)?K4<EK-)N,N(,1E&'=K>WYG&,OJ\EX(XGS[DG@<KKQP\TI+&8M?
M5,(XO[<*M?E]NO\`L'C6E_=M<^R+R]L]/MIKV_NK:QL[=/,N+N\GBMK:"/(&
M^:>9DBB3)`W.ZC)`SDUXOXF^/_@;1/.@TN2Y\3WT9GC"Z8GE::L\0&P2ZK<A
M(I;:<G$=WI4.K1D`L`5P3\4:UX@USQ'<_;-=U:_U:=7EDB-[<RSQVQG(,J6<
M#-Y%E"Q`_<6D<,(``6,#BL8D`$D@`#))X``ZDD]`*_RE\8/VQ_%&9RQ&5>!'
MAG@^'Z%1SHT.)_$*JLYSN<*GNTZN%X6R7$TLIRW&4W9Q^MYWQ)A9RERRPK4;
MS_6LF\%\+2Y:N?YI/$R5G+"Y<O84$UJU/%5X.M5@]O<H86:2OSZZ>X>)?C]X
MZUSS(=-DM?#%B_G*(M,3S]1:&9`GEW&JW:LXEA(+0W6F6ND3!F);.$"^,75W
M=7]S+>WUU<WUY.09[R\GENKN=E&T-/<SO)-,P'&Z1V;'>M+3?#?B/681<:/X
M?US5K<L$^T:9I.H7\"L<X#S6EO+$G0\NZC@\\5Z%IWP-^)=_)`LF@QZ;!.(V
M%WJ.IZ9''$DF#NGMK:ZNM2B,8.9(C8^<N"OE%_E/\,\48+Z=_P!*S%PQ?$F0
M>.WB3@:M5U</1EPSGV7<"X.M'][SX3`83+LJX(RRO*+BU.A0PU>M&-*/-45.
MFH_>86IP#PE!T\-B<@RRHERR:Q6'J8^:^&TZDZE;'58]^:4HIMO2[/(Z*^F-
M,_9F\03+)_;/B;1].88\K^S+2]UI7Y&?,^U'03'\N<;?-P<<$9KO=/\`V:_"
M,"0MJ6M>(;^X3_7"WDT^PLICG/%N;&[NX@1P0-18]P0>:_0N#_V6/TP>*'3E
MF7"'#'`M"K)*.(XPXTR5I4Y04U6J87A.IQ5F%&-W[-TJN"ABHS3YL.H6F_.Q
MOBOP;A+JEC,5CY+>."P5?>]K*>+6$IR[WC-Q:^U?0^*J`<LJ#EW.$0?><^BK
MU8\]`#7Z+Z;\'_AKI4KS6WA+3YFD!5DU26^UN##`@A;;6;J_MTX)^Y$N.,8P
M,=UIVE:7H\'V72--L-+M=Q;[-IUG;V,&X]6\FVCBCW'N=N:_J?@[]B[Q57]C
M5\0/'+A_*E'V4L1@>#N$LQX@]KO[:C1S3.LSX:^KVT5+$3R?$\VKEA8['R>-
M\;<+'F67Y#B*NZC4QN,IX>W9RI4*6*YO.*K1MTDS&\#Q2P>"O"$$\<D,T/A?
MP_%-#*C1RQ2QZ3:))')&X#I(C@JZ,`RL"K`$$45U%%?[ZX:BL-AL/AHR<EAZ
M%*@I-6<E2IQIJ32T3:C=I'\^RES2E*UN:3E;U=PKC_$GC_P=X2RFOZ_8V=R/
M+/\`9Z.]YJFV8,8I/[,LDN+]8'VD?:7MUME)7S)DW+G8U?1+76XA;WUQJB6N
MUU>WT[5M1T;S6?`WS76D7-C?R`)OC\@WGV1UD8RV\DBQ/'S^G?#3P!I4<4=G
MX/T`F&0S13WFG0:E>)*2I+K?:DMW>;MRAO\`7\/EQ\[,3\YQ-_KO4P[PW!JX
M5P>*K+E6<\3_`-KYEA\OE:;]K_JUE7]E5,YBI*G'ZO\`ZUY"VISG]97LXPK=
M.%^HJ7-C?K<X+_ESA?8TY5-M/K-;VJH]7S?5,1LERZWCXGJ?[0^H:M</IWP[
M\(7FJW@&Y9=0@N+^X_=%VG4:#H4DD\B&)3)'/_:T;H,F6TX('FVHZ'\>/B%#
M(VIV'B.YLR4CDTZ_>Q\,6)4R-+&6T>]FT:&Z,)&!</:7-R@"!YB2,_=BJJ*J
M(H5%`554!555&%55&``````,`<"EK^5>,_HF\:^+WMJ'C)])_P`6LTR.OR^U
MX-\*L+D'A!P=7IW;K8''X+"8?BG/\YRVHW>.'SOB7,L32:BUCI2ITG3^LP/%
MV!R:TLEX6RBE7C>V-S:6(SG&Q>G+.G.<L)AZ%5=94,+2B]?W:N[_`!+IW[-W
MC2X>!M1U3P_IUO)M,_EW%]?7UN"?G'V9+&"SED4<@)J01CQYB]1WFF?LR:/'
MY@UKQ7JE\"O[HZ386>CM&VX'+F]DUY9%VAE*A(SDA@PQ@_3U%</!_P"SB^AU
MP<J52CX183B+&T^7GQO&&?<2<1NOR5/:1=7+,=FKR%.Z49>QRBBJM->SJJI!
MR3TQGB7QGC;IYQ/#0=[0P>'PV&Y;JSM5A1^L>:O6=GJK'CVG_`?X:6,<(ET:
MYU.>$@_:M0U;4C)*1M_UUO97-EI[C(R5^Q!3N8$;<*/0M-\*>%]%G^TZ/X;T
M'2KG#`W.G:1I]E<$,"K9GMK>.4[E)#9<E@2&SDUOT5_4W"7A9X9<`1A#@7PZ
MX%X,C3C.$/\`57A+(>'VHU'S5%S95@,))^TE[]5MMU)WG-RDVSY3&9MFF8-O
M'YEC\<VT_P#:\7B,3LK+^-4GLM%V6BT"BBBOO#SPHHHH`****`"BBB@#F-<\
M;>#?#%Q#:>)/%OACP]=7$/VB"VUS7M*TFXGM][Q>?##?W=O))#YD;Q^:BLF]
M'3=N4@8O_"VOA5_T4SX??^%GX<_^65?SQ_\`!;+_`)+_`/"K_LCT/_J:>*Z_
M&2@#^[?_`(6U\*O^BF?#[_PL_#G_`,LJWI_&'A*VT6#Q)<^*?#EOX=NF5+;7
MY];TR+1;AW=XT6#59+I;&9GDBEC58YV+/&Z@%D8#^"JOV1_X)Q?$KPO\:/AY
M\2OV`_C!=J?#7Q%TC6-:^%&H7`ADGT+Q+"IU;4]/TK[02OV^TO;6#QWX?@VK
M"-0TKQ`L[2'4HH'`/Z)O^%M?"K_HIGP^_P#"S\.?_+*NMT?7-%\0V2ZEH&KZ
M7KFG/))$E_H]_::G9/+$=LL:W5E+/`TD3?+(@D+(>&`-?PM?%3X:^*/@[\1?
M&'PQ\9V9LO$O@O6[O1=2C`;R9_)*R6>HV;L`9=.U:PEM=4TV?`%Q87EM.`!(
M!7ZV?\$=OVF!X-^(&M_LY>)[TIX?^)<TOB'P-)/+M@T[QWIFGG^T]-7=A(U\
M5:#8Q;&9QG4_#^GV=M$]QJS$@'])$T\-M#+<7$L5O;V\4DT\\SK%###$A>66
M660JD<4:*SR2.RHB*68@`FN#_P"%M?"K_HIGP^_\+/PY_P#+*OS>_P""M/[2
M[_"/X(0?"3PU?"#QM\;4O])OC"Y%SI7PYM%2/Q1=';GRG\0R7%MX9MUF54NM
M/N_$,ENXN-.RO\MD:22ND42/))(ZQQQQJSO([D*B(B@LSLQ"JJ@EB0`"30!_
M>EH7C'PCXH>XB\,^*?#GB*2T2.2[CT+6],U=[5)2RQ/<)I]U<-"DC(ZQM(%#
ME&"DE3CHZ^$O^">W[+:?LP_`72K#7+&.#XF^/OLOB[XBS,@^U6-[<6^='\)/
M)R?+\*:=,;2XB5Y(#KUSKMW;2-!=QX^[:`"BBB@`HHHH`****`/YHO\`@ME_
MR7_X5?\`9'H?_4T\5U^9?[.%WH%A^T/\!K[Q7<Z/9>%K+XS_``NN_$MYXAFL
MK?0+30+?QQH<VLW.N7&I,FG0:/!IR7,NIS7[K91623O=,L"R$?II_P`%LO\`
MDO\`\*O^R/0_^IIXKK\=-)TG5=?U73-"T+3-0UK6]:U"STG1]'TFRN=1U75M
M5U&YCL]/TS3-/LXYKN_U"_NYH;6SL[6&6YNKF6.""-Y752`?V4?\+6_8$_Z*
M3^Q__P"%C\%__EC7;_#[Q5^R9XP\1P6'PJ\1_L[>*?%UA!+J]M9_#[5_AKK?
MB.SMK1XHIM3@M_#EQ<ZG;P6TES!'+>QHD<+SQ(\JM*@;^0__`(9/_:F_Z-J^
M/_\`X9OXB_\`S.5^F/\`P2B^!?QM^'7[4-]X@^(/P=^*G@307^%OBS3TUOQE
M\/?%OAC2&O[G5O"\EO8KJ6MZ18V;7D\=O/)#;"8S2I!,Z(RQN5`/H;_@L)^R
MO_PDWA73/VG/!VFE]=\%P6GA[XFV]I"#)J/A":X\K0_$LD<>'EN/#.HW7]FZ
MC*(YIGT34[:XGEM]/\.,:_GB\.^(=:\):_HGBGPYJ-QI'B'PWJ^G:[H>JVA5
M;K3=7TF[AO\`3KZW+JZ>=:W<$,\>]'0L@#JRDJ?[RM=T/2/$^B:QX;\0:=:Z
MOH/B#2[_`$76M*O8Q-9ZEI.J6LMCJ%A=Q'B2WN[2>:WF0_>CD89&:_BV_:]_
M9YU+]F'X\>,/A?<M-<Z%%*GB#P-JD[(\NK^"-:EN)-#N9V3;F]LC!=Z'JC&*
M!9-6TF_EMXOLCV[N`<]^TE^T'XR_:<^*NK?%3QJL-I>WUAI6D:9HMG/--IGA
M_1M(M%A@TS2_/_>1VTU[)?ZQ<*0!)J>JW]Q@&8BONO\`X)/_`++!^,7QA;XR
M>*]/\[X>_!F^M+ZQCN(PUKK_`,1RBW?A^P"NFV:#PS&4\3W^QPT-\GAN":.:
MUU&=1^8?@CP;XA^(GC'PQX#\)V#:GXF\8:[I?AS0[%6$8N-3U>\BLK199F_=
MV]NLLRR75U*5@M;9);F=TAB=A_:_^SA\#?#G[.7P;\%_"7PWLGC\.Z<KZUJX
MB$4WB'Q/?G[7XAUZX&/,'V_49)C9PRO*]CID=CIJRO#91&@#W&BBB@`HHHH`
M****`"BBB@#^:+_@ME_R7_X5?]D>A_\`4T\5U^7?P&\7Z-\/OCE\&?'WB-[B
M/P]X(^*_P[\7Z[):0-=7<>C>&O%^CZSJCVMJI5KFX6QLIVA@5E::0+&""V:_
M;7_@K#^S7\=_C5\9_ASK_P`*OAAXG\<:-I7PPBT?4=0T.W@FM[34U\5^([TV
M4S2W$+"86MW;SX"D;)D.<Y`_+#_A@;]L?_HWOX@_^`-G_P#)U`'[^?\`#WG]
MCC_H,?$'_P`(2\_^3*/^'O/[''_08^(/_A"7G_R97X!_\,#?MC_]&]_$'_P!
ML_\`Y.H_X8&_;'_Z-[^(/_@#9_\`R=0!_6E\!?CY\/OVD/`8^(_PSN-5N?#)
MUG4=!$NLZ9)I-Y_:&EK;/=K]DEDE;R@+N'9+NP^6P!MK^=S_`(+.?\G7^&?^
MR(^$?_4O^(-?KY_P3#^%OQ"^$'[,:>$/B9X3U7P;XF'Q!\6:H=&UF*.*\_L^
M]AT=;2ZV122KY4Y@F"'?D^6V0*_/S_@J?^R_^T!\9?VC]`\5_"[X5>*O&WAV
MV^$WAK1+C5]%MK>:TBU:T\3>-;NYL6:6YA;SX;;4+*9P%("7$9#$D@`'YD?L
M,?\`)W_[._\`V5#PY_Z/:O[2J_E2_9#_`&,?VI?`W[3GP0\7^+?@CXVT'PSX
M>^(.AZIK>LW]I:I9Z;I]O,S3W5RZ7;LL48Y8JC'VK^JV@`HHHH`****`"BBB
M@`HHHH`**_(#]KOX5S_%W]MSPEX>MOA+X*^,L^E_LH:KXCC\,>.?'_B;X;Z;
M8/8_%N&Q37].\0>%;*\U"36K5]373[2QG^R630:I=WLE[!/8V^ZW^Q/\>?%F
MFZ7^RK\'-3\0R:Q;>*;7]J73/&MUXLFFU36;+Q-\*/$VG7VD>'/"WB>;7-33
M6?#NA:/K5U;VVHR7.IOJ&DZ?!)&=*BM'T^U`/UTI-PV[LC;C=NR-NW&<YZ8Q
MSGICFOY^_&OQ^\4_&;X777Q!\3Z/X4M?&WBW]@G]H+5[GQ;X;M];TO4[.WT+
M]H"/PC;:/I)'B"YL(-&O=.L+6\OA+9W-_/J"&2'48+.1[-NW_:"^,GQD\>?#
M;XH^%M(U;P-X:^$OP:\1_LL?#_6=`ET_6I?B/XKO?%5Y\.O$,NMV^M0:U9Z=
MI6EM=W4>G1:;/H^HVNL:!%K7F-'=I%.@!^YU%?CKX6^-GQ:TGX@:W\-O@KI?
MPK\':O\`%+]O#]J?P+K.K:[X=\3:WI\L?@WP=X=\1OXPO[*/Q?:7%QXFGC2Y
MGO([*[T[2+^>UL;:+3K"%KAI>J\-_M:?M'_$!O@_\-?#\GPC\*_%#5[_`/:&
M@\?>+_$&A>(=6\':JW[/_B,Z%]A\*^'K7Q!I6H12>)U9+O5FEUAIM,LX;J\L
M8XD*01@'ZP45\'>$_P!J77'_`&%O#G[2?C?4M!T/QAKOAB"6.:T\(:SXCT1_
M%FL^*Y?"OAVPM?!^F>(=,UC44U#4)=/M3:P^([+RFFDO+B^AM()MNM^R#\?/
MB=\6=:^-O@/XKZ*-.\2_![7O!=C'?7/@V3X>:WJ6G>-O##>(K9/$7@P>-?B#
M9:1J=BT<J1RZ9XIO;+4--GL+E8H9C,9`#[;HK\1/V</VD_C/\&/AW\"KOQ==
M^$?B#\+?B;:?M5W>EZ#IMEKB_%;3-8^%6I_$3X@76H:GK]]K6I6OB5M=N]/O
MM*N4ATC3X](M;S1W=I[F.>:^Q_%/[2_[6?Q4_9O^-&H:WHW_``COA7Q#^SLG
MQ6TCXB:;\+_&O@>P\.R7=_I\>J_#C1-<O?%%W%XH76?#.J&^\,^/;.[LSYVE
MZP9M%O[*2)H0#]TZ*_)#1Y?V@[+]IW]D2RUGXG^#M5L&_9]\4>);W3]'\%Z]
M;Z=JGAVPO_"\VN65II<GC>Z@D\6:GX<FT[3=$\0L9UT^YM[^YDL+VVOTM;7D
MO!7[='[3OB7P+XR^+#_#VWG\`ZM\&_C9\1/"VICX9>*M)\.?#;7?A]::E?>#
M=-U'QQ>:[/I7Q*TO7;;3VT_79["S\/3VGB=C8VS0VJ1K=@'[.45X!^S=JOQH
M\2?#;2/&'QKUCP%J.L>,],\.^*M"L/`.@ZOHMCX?T77/#>DZ@='U&75]9U>7
M5=0M[Z>Z,E]`;:!P=T<8B>."V]_H`****`/C;]H'X8?L7?$OQ/J&L_M#6?@+
M4_$WPU\&Z9?:K<>)_%>JZ%/X7\$:IK=W%I5_J4%CKFE6\6CWVO7-W;6U]=0R
M)-?2/:"8L!$*GQ#\"_L)1>!(/`GQ&T[X)Z3X"^!FL:0D>B:IJ>FZ!IO@36_&
M5B-=TZQFEM[ZPFCN_&6GRC6+K2[B>?\`X2FW8:AJ5KJ"@2CS3]LG]D/Q7^T+
M\5_A5JGAZ:&S\#>(-`O?AO\`M!3?;X+.]N/A]H?B[P[\3O!T5G`\L5Q?2KXN
MT.[M,VBRW5F-3$B>1;RW5S#\\^%OV0?VB/!?P_\`@E\1_$O@3PU\;/BYX*^+
M?C/QM\3_`(0:SXK\.V-AXYTS4OA_IWPC\&WUOXJUM+WPQ)J_A#0?"NC^)M+M
MM1"6RW.N:GM-G?Q-9N`?66J>%O\`@GSX+\+^%](UG6?@[X=\(^(/A3KWA'PB
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M;;3X-.B-M?F[`/9/`?CC]CBTTOP%\6?&EY\(/A-XWU[7_'GQZTNUO_C#I>LP
M0>)_'=]<?#KQAXQTSQ!%K5KH/B%=?33DTNZ^Q6TFFV4Z7$%M96US9W,ZYG[3
MGPW_`&2A\+K'P;?^(OV<O`^M:SJOB#XH?#[4?BWK4^J::)O&FIIJOC_QAH5G
M:>./#FNZQ;:Y:375]':VFK3^$]3U*#3(-1TN^TZ!;9/"O@E^Q1\3-$L?`%G\
M3?A_X9U&+PO^Q-\6/A&;?4=3\,Z[#IWQ4\5?%K6?$&BVUK']JNH\S^$=8O`V
MNP`V5JMY<V4MW%,[1GYY^.GPA^)?[/WP;O+[X@>`_A_XMM_'/['WP[^!)U#Q
M+X_\)6?B+X6^/_`MOJ4<FD^"])U*'4]1\:RZPU_:7FC6/@-IKJ76K.*2\;3+
M"T&J$`_6;PE\+?@9X!_9V^%/[.GC?6/#7C7P%XAT?0_`V@?\)8MG!9?$G6KB
M&7Q3;/I=IY\D0U+4+JUNO$>AVEC>3W]@+2*XL;R:XL!>4GP:TW]D;X0QO)\&
MM4^'WAJ+XIR:[<-/IOBZ;4(_%<OP@MKFS\4W:W.K:QJ"R/X+@GNCXDNTDB-N
M\\EYJTLDTWGMR'Q[^#GQ#^(7[*7@70OAY:QV?QJ^&B?!WQ_\.XM2FM].&G^/
M?`#Z+)+;W4U_+;6]K*^E-KVEN+J:&+S+DPW!\II$;XC\,_\`!.3XMZ+H'QS\
M`0Z_90>&W^!5OX1^"6H7^L)<QR>//B#IGP_UCXS/?K%]JU'2-/UGQ7\/9=,F
MNY;81G1_%MW+I]M<0I):6@!]D_#+PG_P3U^'":E\</AE=_`[3K2POKCP=JGQ
M#T_QM9:]IFE:GXGN6@N-+N]2OM>U73])U+7_`+3]G,S_`&6[U+2;B&!9YM'E
MA1N2^&I_8ET7XB?$#X<?#+P+\-+?P%X^_9TU;XF>/?B;I7B>PN?AQJ/P^N?'
MWB'P#K7A".YEU*YTO1]%MM3L_$MWKL>G7FC:+IDD0C>U:Z662P^<M4_9%^./
MQ,MO'GB75?@7X(^#MOXLU?\`9A\.R_!C0O&'A+6M*UC0_A%XJ>_\8^--8NM)
M%IX<6%]$N&TOP]I(FN=9N-(6>UOH(KD1B\]@_:F_9!^(7Q.\8?%K_A5OA_PS
MX?\`"GB#]D[PC\.O#$4-UIF@Z3>>.?#7[1,WQ=U3PI)I.GO;3V%EXET:*2TN
MM5:V@TN6YUJ<7=UN-V5`._\`@MX?_8[^,'B\^`/AE\.?!FO>&?V1+GP)XI^%
M_C70/$K^(-%M]=^*#:KXQO7T.\T[5+J6Y?2M4\-V;ZK'K^H:D7UE&MY=/M#I
M:&?WZR_9'_9NTW4O'^KZ;\(_#&GZA\4-#U[PUXWFL?[2M(]5T/Q3L/B/3K6U
MM[^.UT&'6VCCDU)O#T&E2W<L:2RR-(BL/)?V3_AO\2O#GQ1_:'^)GCSX-^'_
M`(':=\5;+X*#PYX&\/>*/"WBB"PF\$>%O$.BZ\ES<^$[:QTZ*=;F\LGS':+#
M*LVVVN;Q8)):^YZ`,W1](T[P_I&E:#H]JMEI&B:;8Z1I=DCRR)::=IMK%9V-
MJDDSRS.MO;0Q1*\LDDK!`9'=B6.E110`4444`%%%%`!1110`50OM*TO5&L6U
M/3;#46TR^AU336OK.WNVT_4K976WU&Q-Q'(;2^@6658;N#R[B)9'"2*';)10
8!?HHHH`****`"BBB@`HHHH`****`/__9
`
end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>23
<FILENAME>plu.jpg
<TEXT>
begin 644 plu.jpg
M_]C_X``02D9)1@`!`0$`8`!@``#_X0!F17AI9@``34T`*@````@`!`$:``4`
M```!````/@$;``4````!````1@$H``,````!``(```$Q``(````0````3@``
M``````!@`````0```&`````!4&%I;G0N3D54('8U+C`P`/_;`$,``@$!`@$!
M`@("`@("`@(#!0,#`P,#!@0$`P4'!@<'!P8'!P@)"PD("`H(!P<*#0H*"PP,
M#`P'"0X/#0P."PP,#/_;`$,!`@("`P,#!@,#!@P(!P@,#`P,#`P,#`P,#`P,
M#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#/_``!$(`:X"
M!0,!(@`"$0$#$0'_Q``?```!!0$!`0$!`0```````````0(#!`4&!P@)"@O_
MQ`"U$``"`0,#`@0#!04$!````7T!`@,`!!$%$B$Q008346$'(G$4,H&1H0@C
M0K'!%5+1\"0S8G*""0H6%Q@9&B4F)R@I*C0U-C<X.3I#1$5&1TA)2E-45597
M6%E:8V1E9F=H:6IS='5V=WAY>H.$A8:'B(F*DI.4E9:7F)F:HJ.DI::GJ*FJ
MLK.TM;:WN+FZPL/$Q<;'R,G*TM/4U=;7V-G:X>+CY.7FY^CIZO'R\_3U]O?X
M^?K_Q``?`0`#`0$!`0$!`0$!`````````0(#!`4&!P@)"@O_Q`"U$0`"`0($
M!`,$!P4$!``!`G<``0(#$00%(3$&$D%1!V%Q$R(R@0@40I&AL<$)(S-2\!5B
M<M$*%B0TX27Q%Q@9&B8G*"DJ-38W.#DZ0T1%1D=(24I35%565UA96F-D969G
M:&EJ<W1U=G=X>7J"@X2%AH>(B8J2DY25EI>8F9JBHZ2EIJ>HJ:JRL[2UMK>X
MN;K"P\3%QL?(R<K2T]35UM?8V=KBX^3EYN?HZ>KR\_3U]O?X^?K_V@`,`P$`
M`A$#$0`_`/VF@@UWQQXY\?22>/O$/AG2_#.K16,$%C;Z8((H?[,LKEY'>XM9
M7SON)"27P`!P,<Y?P8US2OVB_"EQKO@/X_>(/%^C6M]<:9+>:4=!NH8[FWE:
M*6(LE@1E64^Q!5AE6!*:_P"%]*\<^$_C_H>NZ=JVK:+K6J&PO[33$+WDT$N@
MZ9'((@.2X5B0%R3C@$X!B_8D^)5]\6?#6K:XDFKZUX8O/LK:'XCUKPE/X7U;
M6XA$0QN+2>*"1MA`*3BW@CD67Y$VKO<`V#IL:_$A/!I^.OB$>+Y-.;6%T/S-
M`_M)K%95B:Z%O]A\PP"1T0R;=H9U7.2!4/A$6?Q`\3:_HN@?'S6]<UGPK<+:
M:W86$_AZYNM'F90PBN8TL2T+E2"%<`D'.*^;?@E\-OC_`*)_P5!^'GB+Q[\.
M/`5M977@3Q?%K_B70?%VH:M`)+G4/#\D,9,NC6L:2J+2&&"V:3+V\5Q(92]N
M5GY_X7_`+XJ>-?@9)X<TJ7Q'H'CGP7\"?$'PYUK4]1T&;3H=7\67?V-[6_MY
M)D1+J-)(+N;S8/,AS?%2X<,H`/K+X;"S^,NDW6H>#_CYK?BNPL;N73[FYT>?
MP]?0V]S$VV6!VBL6"R(P(9"0RG@@5T7_``J#Q#_T53Q[_P"`FB__`"OKR[]C
M#2K_`,1?&3QWXWM=*\1>&_!VK^'?#GA^PTC6=#N-'N(K_3?[16\F$-PB2E"E
MS:0K)L\MQ9AHV="&KZ-H`X/_`(5!XA_Z*IX]_P#`31?_`)7T?\*@\0_]%4\>
M_P#@)HO_`,KZI:-%KO@WX]:1H]UXMUSQ#IFLZ'J=\\&HV]B@MY;>XT](S&UO
M;Q-C;<R`ABV?E[C)])H`X/\`X5!XA_Z*IX]_\!-%_P#E?1_PJ#Q#_P!%4\>_
M^`FB_P#ROKO**`.#_P"%0>(?^BJ>/?\`P$T7_P"5]'_"H/$/_15/'O\`X":+
M_P#*^N\HH`X/_A4'B'_HJGCW_P`!-%_^5]'_``J#Q#_T53Q[_P"`FB__`"OK
MO**`.#_X5!XA_P"BJ>/?_`31?_E?1_PJ#Q#_`-%4\>_^`FB__*^N\HH`X/\`
MX5!XA_Z*IX]_\!-%_P#E?1_PJ#Q#_P!%4\>_^`FB_P#ROKO**`.#_P"%0>(?
M^BJ>/?\`P$T7_P"5]'_"H/$/_15/'O\`X":+_P#*^N\HH`X/_A4'B'_HJGCW
M_P`!-%_^5]'_``J#Q#_T53Q[_P"`FB__`"OKO**`.#_X5!XA_P"BJ>/?_`31
M?_E?1_PJ#Q#_`-%4\>_^`FB__*^N\HH`X/\`X5!XA_Z*IX]_\!-%_P#E?1_P
MJ#Q#_P!%4\>_^`FB_P#ROKO**`.#_P"%0>(?^BJ>/?\`P$T7_P"5]'_"H/$/
M_15/'O\`X":+_P#*^N\HH`X/_A4'B'_HJGCW_P`!-%_^5]'_``J#Q#_T53Q[
M_P"`FB__`"OKO**`.#_X5!XA_P"BJ>/?_`31?_E?1_PJ#Q#_`-%4\>_^`FB_
M_*^N\HH`X/\`X5!XA_Z*IX]_\!-%_P#E?1_PJ#Q#_P!%4\>_^`FB_P#ROKO*
M*`.#_P"%0>(?^BJ>/?\`P$T7_P"5]'_"H/$/_15/'O\`X":+_P#*^N\HH`X/
M_A4'B'_HJGCW_P`!-%_^5]'_``J#Q#_T53Q[_P"`FB__`"OKO**`.#_X5!XA
M_P"BJ>/?_`31?_E?1_PJ#Q#_`-%4\>_^`FB__*^N\HH`X/\`X5!XA_Z*IX]_
M\!-%_P#E?1_PJ#Q#_P!%4\>_^`FB_P#ROKO**`.#_P"%0>(?^BJ>/?\`P$T7
M_P"5]'_"H/$/_15/'O\`X":+_P#*^N\HH`X/_A4'B'_HJGCW_P`!-%_^5]'_
M``J#Q#_T53Q[_P"`FB__`"OKO**`.#_X5!XA_P"BJ>/?_`31?_E?1_PJ#Q#_
M`-%4\>_^`FB__*^N\HH`X/\`X5!XA_Z*IX]_\!-%_P#E?1_PJ#Q#_P!%4\>_
M^`FB_P#ROKO**`.#_P"%0>(?^BJ>/?\`P$T7_P"5]'_"H/$/_15/'O\`X":+
M_P#*^N\HH`X/_A4'B'_HJGCW_P`!-%_^5]'_``J#Q#_T53Q[_P"`FB__`"OK
MO**`.#_X5!XA_P"BJ>/?_`31?_E?1_PJ#Q#_`-%4\>_^`FB__*^N\HH`X/\`
MX5!XA_Z*IX]_\!-%_P#E?1_PJ#Q#_P!%4\>_^`FB_P#ROKO**`.#_P"%0>(?
M^BJ>/?\`P$T7_P"5]'_"H/$/_15/'O\`X":+_P#*^N\HH`X/_A4'B'_HJGCW
M_P`!-%_^5]'_``J#Q#_T53Q[_P"`FB__`"OKO**`.#_X5!XA_P"BJ>/?_`31
M?_E?1_PJ#Q#_`-%4\>_^`FB__*^N\HH`X3X)ZCJS:IXVTG5=:OM?/AW74L;6
M[O(;>.X:)].L;G:_D1QQG$EQ)@A`<8!SC-%)\(/^2@_%3_L:(/\`TRZ710`?
M"#_DH/Q4_P"QH@_],NEUV>BZ+9^&]&M-.TZTM=/T_3X4MK6UMHEBAMHD4*D:
M(H`554`!0````*XSX0?\E!^*G_8T0?\`IETNN\H`****`"BBB@#@_$/_`"<]
MX/\`^Q7US_TKT>N\K@_$/_)SW@__`+%?7/\`TKT>N\H`****`"BBB@`HHHH`
M****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`H
MHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BB
MB@`HHHH`****`.#^$'_)0?BI_P!C1!_Z9=+HH^$'_)0?BI_V-$'_`*9=+HH`
M/A!_R4'XJ?\`8T0?^F72Z[RN#^$'_)0?BI_V-$'_`*9=+KO*`"BBB@`HHHH`
MX/Q#_P`G/>#_`/L5]<_]*]'KO*X/Q#_R<]X/_P"Q7US_`-*]'KO*`"BBB@`H
MHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BB
MB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****
M`"BBB@`HHHH`****`"BBB@#@_A!_R4'XJ?\`8T0?^F72Z*/A!_R4'XJ?]C1!
M_P"F72Z*`.5U.SU+4_#OQ\M-%\0VWA/6K[53:Z=K-QM\O3;J30=,2&8[N#MD
M93CU]:J_L6Z)8_#JV\6>#8M-\3:)JNC7ZZCJ5AJGBNX\40+->[YWGM;VY=K@
MQRRF5BDHB8,"PB174MU?PWT>T\0>+?BY8W]K;7UE=^)(HI[>XB66*9#HFE@J
MRL"&4C@@C!J]^SK^SKX._94^#^C>!O`N@Z3X>\/:)`L4<%A86]DL\FT![B1(
M(XXS-(PWNX0;F).*`/"O%>G^*/AW_P`%*?!#RW/B'1?"?C6>_AMC9^-=4U^W
M\120Z7+.T%[I-U%]DT:&*0R/'/9R,97@MXW:,2B%O"_V?M.^)?[!GP=\9:%X
MPL_%WB_]H+PO\&M4\166J1_%WQ-XVT/Q3/8Q0JTLEKJBQVVGW=Q>>68XT@;]
MWYX20JLJU]Y>%/V??`7@3XD:[XRT/P1X0T;QAXHV_P!LZY8Z-;6^I:OM&%^T
M7"())L#IO8XI/A5^SWX`^!-OK$/@?P/X/\&P^(;MK_5$T/1K;3EU*X88::<0
MHHED(ZN^2?6@#R#]C*YU/P[\</B%X4M]8\0^)/!EGX?\.>(+#5=8UVXUB9]2
MU#^T6OH4DGD=TC$<%E,L2D1(+O$:H@"CZ.KG_AI\)?"GP7\.R:/X.\,>'O">
MD2W,MZ]EHVG0V%L\\K;Y93'$JJ7=B69L98\DDUT%`'D^G^+-0\3_`+4?AM;[
MPQKOAQ;7PQK0C;4);.07>;O2<E/L\\I`&!G>%^\,9YQZQ7!^(?\`DY[P?_V*
M^N?^E>CUWE`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!
M7E/CG]N3X1_#3Q;?:%KOCW0--U?37\JZM9)6+P/@':<`C."..U>K5^%__!15
M@/VX/B8"0#_;+_\`H"UY>:X^>%IQG!)W=M3[?@7ABAG>+J8?$3<5&/-[MKWN
MEU3[G[1?"'X\^#OCWI-W?>#?$.F^(;2PF$%Q):.6\ERH8!@0",@Y'8\^AKKJ
M^`/^"!=[#)\,?B);K+&T\>JVLC1A@656A8*Q'H2K`'_9/I7W_73@<0Z]"-62
MU?\`F>-Q/E-/+,SJX&DVXP:LWOJD^GJ%%%%=9X(4444`%%%%`!1110`4444`
M%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4
M444`<'\(/^2@_%3_`+&B#_TRZ711\(/^2@_%3_L:(/\`TRZ710`?"#_DH/Q4
M_P"QH@_],NEUWE<'\(/^2@_%3_L:(/\`TRZ77>4`%%%%`!1110!P?B'_`).>
M\'_]BOKG_I7H]=Y7!^(?^3GO!_\`V*^N?^E>CUWE`!1110`4444`%%%%`!11
M10`4444`%%%%`!1110`4444`%%%%`'.?%WXIZ1\$OAEKGBS79Q;Z3H-H]W.W
M&Y\#Y47/5W8A5'=F`[U\@_\`!-'X#R_'OQ#XN_:`^(ND6-[JOCZZD31;.Z@6
M:*RLU;!=5<'KL6-&Z[(R<G>:K_MZ>([[]M7]JOPM^SKX;NI8]$TR5-:\9W<!
MR(8U`81$^JHR\<@R3Q`X*&OMSPUX<L?!_AVPTG3+6*RTW3+=+6U@C&$AB10J
MJ/8``5YJ7UC$7?PP_&77[MO4^RG)Y1E*IQ=J^)2;[QI)^ZO)S:O_`(4NY\-?
MM@_L_:[^PE\8$^/WP@L%710=GC#PY;KLMY8"P+RJBC"QG`+8'[MP'`*E@/L#
MX!?'CP[^TG\+-,\7>&+L76FZDGS(V!+:2@#?#*H^[(A.".AX()!!/77EG#J-
MI+;W$44]O.ACDCD4,DBD8*D'@@C@@U^?/C_PUK7_``2%_:'/C#P[;WFI_`OQ
MO=+%J^F1Y<Z'.3P4ST*\F,G[RYC;D(YFHOJDW4C_``WNOY7W7EW^\VPTUG^&
MCA*K_P!KIK]W)_\`+R*^PW_,OL/JO=?1GZ%45F^#?&.E_$+PKI^N:)?6^IZ3
MJL"W-I=0-NCFC89##_`\@\'!K2KTTTU='Q,X2C)QDK-;H****9(4444`%%%%
M`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`
M%%%%`!1110!P?P@_Y*#\5/\`L:(/_3+I=%'P@_Y*#\5/^QH@_P#3+I=%`!\(
M/^2@_%3_`+&B#_TRZ77>5Y!_PL-?A)I7QY\5/INH:PGAS56U,V-BF^YO!#H&
MFR>7&.[MMP/<UL?LQ?$WQ5\5_A])JWBFQ\$0R7%U+)IUWX1\0MKFDW]BSLUN
MZ3M#"QD$119/DV%P60E6`4`]'HKP2P_;1N9OVV&^#XTSP3K,JAVNG\.^,DU+
M6O#48M6N8Y]8TQ[>)K&&9/)2)EFF9WN$P@3,@P_`?_!271=7TS4/$'B33=+T
M#P3>>"+_`.)7AG5K;6A>R:SX=L?(^TW<\1AB2V=1<V[A$EF0QSQDR*VY%`/I
M>BO)OV<_VC]4^+7C#Q/X6\4>'--\*>+?#5II^L2:?9:RVJQOINH&Y%E.TC00
M%)6-I<H\81E1XF"R2+ASZS0!P?B'_DY[P?\`]BOKG_I7H]=Y7D^G_$_PU\1?
MVH_#<?A[Q#H>NOIWAC6ENET^_BNC;%KO2=H<(QVD[6QG&=I]#7K%`!1110`4
M444`%%%%`!1110`4444`%%%%`!1110`4444`%>7_`+8W[2NG_LG_`+/^N>,+
MPQ2W=M']GTRV<X^V7C@B*/UQG+-CHB,>U>H5\$^.2?\`@I9_P4+M_#46;SX4
M?!B3S]38?-;ZI?;L&,D<,&=-@]8X9B#\PKCQM>4(*-/XI:+_`#^6Y]#PYEM+
M$XAUL5I0I+GF_);17G)VBO6_0]0_X)7?LU:A\*_A%?>//%GFW'C[XH3?VSJ4
MTX_?10NS/%&?1FWM(PP.9`I'R"OJ:@``````45MAZ$:--4X]/ZN>?FV95<?B
MYXNMO)[=$MDEY)62\D%9'C_P%H_Q2\%ZGX=U^P@U/1M7@:WNK:8965#^H(."
M",$$`@@@&M>BM6DU9G#"I*$E.#LUJFMTS\^/A%XWUO\`X)+_`+0:_#GQC=W6
MH?!?QA<O-X>UF;+#2)&(RKD<*`2!(HP.1*`,L#^@L,R7,*21NLD<@#*RG*L#
MT(/<5P_[1W[/'AS]J'X3ZEX0\36QELKU=T,Z`>=8S@'9/&3T=2?H02#D$@_*
M7[$'[0_B/]DKXO?\,Z_%VYP]N0O@_7)"1#?0,2(X-[?PMC$>>58&(\A0/,IM
MX2:I2^!_"^S_`)7Y=ON/M,9".>X:6.HJV*IJ]2*_Y>17_+R*_F7VTM_B74^Y
MZ***]0^("BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB
M@`HHHH`****`"BBB@`HHHH`****`.#^$'_)0?BI_V-$'_IETNBCX0?\`)0?B
MI_V-$'_IETNB@#/\%Z=J&K>(/B_;Z5J(TC49?$L(M[PVZW"P/_8NE$$QL0'7
ML1D$@G!!P1E_L@?!WQ1\/_"]_P"(_'D_AS_A/?&Z6M]K]KX>T4:/I=I<)%MV
MK!]INF><!MDD[7$GF^4F-JJJCI/A!_R4'XJ?]C1!_P"F72Z[R@#R"_\`V=O$
MWC;]IK0_'/BKQ7H5YHG@:XNKGPII6D:%<Z;>6S7-H]K,M_=M>RI>H4<LJ+;P
M('5'(9HT9>#^'O\`P34T;1O`NI>$O$^J:9XA\*6O@C4/AGX9LK71?L,NB^&[
MU81<6<TC32BYD86]NOF(L";+>,&(L"[?3=%`'E7[.?[.VI_";7M>\2>*O$&F
M>*_&GB&TL=(N=4L=&.E1-I]@;C[%`8FGG8NINKAW?S-K/,Y5(E(0>JT44`<'
MXA_Y.>\'_P#8KZY_Z5Z/7>5P?B'_`).>\'_]BOKG_I7H]=Y0`4444`%%%%`!
M1110`4444`%%%%`!1110`4444`%%%1WEY#I]I+<7$L<$$"&221V"I&H&2Q)X
M``YS1<:5]$?/7_!2[]JJ;]F?X`26VAR2-XW\9R'2-!AAR9ED<`23J!SF-6&W
M&?WCQC&":W/V`/V58?V2?V=-+T*:.-O$6H_\3'7)QAFDNG`RF[NL:X0=CM)Z
ML:^>OV7K.7_@H?\`MTZY\9-2BDE^'WPXE_LKPE!*I"7%POS";:?XAN\XY&0T
ML(R=E?>5>;A?W]5XE[;1].K^;_`^PSQ_V;@H9-#XW:=7_$U[L/\`MQ.[7\S?
M8****](^."BBB@`KQ3]N;]C'1_VR_A,^ESM%I_B72MUQH>J[?FLY\#Y&(Y,3
MX`8#T##E17M=%9U:4:D'":NF=>!QU?!XB&)PTN6<7=/^NG1KJM#Y*_X)W_MG
M:SXLU:^^#OQ4633/BIX/S;AKE@&UN!!]\'H\JKAB1GS$(D!/S8^M:^8?^"B/
M[$5U\>]*L?'?@65M'^*_@W;<Z7>0,(GU!(R7%NS=-X.2C'@$E3\K$C;_`."?
MW[;UK^UMX`GL=7B72/B%X8_T;7M*D4Q.'4[#.B'D(S`@KU1\J>-I;BPU65*?
MU:L[O[+[K_-?CN?29Q@:&-P[SC+X\JO:K!?\NY/JO[DGMV?N]CZ#HHHKT3Y`
M****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`H
MHHH`****`"BBB@#@_A!_R4'XJ?\`8T0?^F72Z*/A!_R4'XJ?]C1!_P"F72Z*
M`#X0?\E!^*G_`&-$'_IETNN\K@_A!_R4'XJ?]C1!_P"F72Z[R@`HHHH`****
M`.#\0_\`)SW@_P#[%?7/_2O1Z[RN#\0_\G/>#_\`L5]<_P#2O1Z[R@`HHHH`
M****`"BBB@`HHHH`****`"BBB@`HHHH`*^0/^"K'QUU:3P_H/P2\$DS^-OBI
M,MG(J-@VM@S;7+$?=60AE)Z"-)B<<5]2?$CXA:5\)_`.L>)M<N5M-(T.TDO+
MJ4XR$1<X`/5CT`ZDD`<FOC__`()G_#W5OVA_BUXL_:2\96S)>^(YY=/\+VTF
M2+&S4[&=,]@H$(88SMF)^_7GXZ;G;#0>LM_*/5_HCZSAJA3H*IG&)5X4;<J>
MTJC^"/FE\4O)>9]2?LX_`O2?V:_@KX?\%Z,H:UT6V$<DVW:UW,?FEF;W=RS8
M[9`'`%=O117=""C%1BM$?,XC$5*]65:J[RDVV^[>K844451B%%%%`!1110`5
M\7?\%`/V5/$/PV\?P?M!?!]&M/&7A_\`?:]IL*$QZU;`?/(4'WVV##KU=1N&
M'0;OM&BN?$X>-:')+3L^J?='JY-F];+L0J]))IJTHO:47O%KL_P>NZ/+_P!D
M;]JOP]^U]\'[+Q1H3K#<#$.IZ>SAIM-N0,M&WJIZJV,,I!X.0/4*^!/VG_A#
MK_\`P3<^.S?'#X8V#W/@/695B\8^'8?EAA#/_K$4<*A8DJV/W4AQ]QRH^U?@
M]\7M`^._PXTKQ7X9ODO]&U>(2PR#AT/1HW7^%U8%64]"#66$Q$I-T:VDX_BN
MZ_K1GH9[E%*E".88!MX>IMWA+K"7FNC^TM5U.FHHHKM/F@HHHH`****`"BBB
M@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`X/X0?
M\E!^*G_8T0?^F72Z*/A!_P`E!^*G_8T0?^F72Z*`(_A7>0Z?XW^+-Q<2QP00
M>)HI)))&"I&HT32R6)/``'.36G\&/CWX)_:+\*7&N^`_%6A>+]&M;ZXTR6\T
MJ\2ZACN;>5HI8BR$C*LI]B"K#*L">!U_POI7CGPG\?\`0]=T[5M6T76M4-A?
MVFF(7O)H)=!TR.01`<EPK$@+DG'`)P#%^Q)\2K[XL^&M6UQ)-7UKPQ>?96T/
MQ'K7A*?POJVMQ"(AC<6D\4$C;"`4G%O!'(LOR)M7>X!Z3I/QN\%Z_P#$O4?!
M5AXO\+WOC'2(%NK[08-5@EU.RA8D+)+;JQE1"00&90"0:Y?X*?MN_!?]I3Q5
M<:%\.?B]\+_'^MVEHU_/I_AOQ58ZK=PVZNB-,T4$KNL8>2-2Y&`9%&<L,^#^
M'/BGI7QW_P""C^E:%-\/OB1X.T?X/ZGJIT#4;CP!KUCI_BG6;FTG2^O?MPLU
MT];%8I+A$>:X)O+F4NJ`);R7'#?!/X-^/_#7[-?Q!^"/PD\4_%+6_A_H7PPU
M3PIX:UGXB>%1X?U3P]K<=LEIIMM9*VFV!OK01>9(URR2C?'$!,^]@@!]O?#;
MXO>$OC+I-UJ'@_Q1X=\5V%C=RZ?<W.CZE#?0V]S$VV6!VB9@LB,"&0D,IX(%
M=%7SE^QAI5_XB^,GCOQO:Z5XB\-^#M7\.^'/#]AI&LZ'<:/<17^F_P!HK>3"
M&X1)2A2YM(5DV>6XLPT;.A#5]&T`<'XA_P"3GO!__8KZY_Z5Z/7>5Y/I_A/4
M/#'[4?AMK[Q/KOB-;KPQK1C74(K.,6F+O2<A/L\$1(.1G>6^Z,8YSZQ0`444
M4`%%%%`!1110`4444`%%%%`!1110`445YY^U3^T-IG[+?P)U_P`::GLD_LR#
M;9VS-M-[=/\`+#",<_,Y&2.BAFZ`U$YQA%SD[)&^&PU3$5HT**O*322[MZ(^
M8/\`@HKXRU+]K#]H3PG^S;X3NI(X+F:/5O&%W"<BTMTQ(L;=OE3$F#P7>`9S
MFOL_P3X-TWX=^$-+T'1[6.RTK1[6.SM($&%BC10JCWX'7N>:^7_^"4_[/6I^
M%OA[JWQ6\9;[CQY\5ICJD\LRXD@M'8O&@'\/F$^80,#:8EP-E?6=<>!A*5\1
M46L_P71?J_-GTG$V)ITO9Y1A7>G0NFUM*H_CEZ7]V/DO,****[SY0****`"B
MBB@`HHHH`****`*VLZ-:>(M(NM/O[:"]L;Z)H+BWF0/'-&P*LC*>"""00?6O
MS[NX=9_X([?M%?:(5O\`4_@#X^O`)$^:9]`N2.W?<H''>6)<<O&"/T-KGOBO
M\*]"^-GP]U7PMXEL(M1T76(3#<0OU]0ZG^%U8!E8<@@$=*Y,7AG42G!VG'9_
MH_)]3W\ASF.#E*AB8\]"II./ETE'M*.Z?RZFMH&OV/BK0[/4],N[>_T[4(4N
M+:X@</%/&P#*ZL.""""#5NO@#]G'XIZ]_P`$Q/CTOP9^(]])=_#3Q!.\WA+Q
M#-\L5IN?[CGHB%B`Z](W(;[CEJ^_P00"""#3PN)5:+NK26C79_ULS//,FE@*
MRY)<]*:YH36TH_HUM);I_(****ZCQ`HHHH`****`"BBB@`HHHH`****`"BBB
M@`HHHH`****`"BBB@`HHJO>ZQ::;<VL-Q<P037TAAMTD<*T[A68JH/4[58X'
M8&E*26K"Y8HHHI@%%%%`'!_"#_DH/Q4_[&B#_P!,NET4?"#_`)*#\5/^QH@_
M],NET4`'P@_Y*#\5/^QH@_\`3+I==GHNBV?AO1K33M.M+73]/T^%+:UM;:)8
MH;:)%"I&B*`%55``4````"N,^$'_`"4'XJ?]C1!_Z9=+KO*`"BBB@`HHHH`X
M/Q#_`,G/>#_^Q7US_P!*]'KO*X/Q#_R<]X/_`.Q7US_TKT>N\H`****`"BBB
M@`HHHH`****`"BBB@`HHHH`*^"_C?*__``4A_;]TWX;VK-<_##X22_;_`!%(
MAS#?W@.TPDCKEOW('4`7#"O>?^"C'[5O_#*?[.][>Z=)N\6^(F.E:!`HW2&X
M<8:8*.2(U);H1N\M3]ZC_@G/^RE_PRG^SO966HQ[O%OB)AJNOSL=TAN'&5A+
M'DB-2%ZD;O,8?>KS<3^_JK#+9:R_1?/?T/L<F7]F8"><2TJ2O"EZV]^?_;J=
MD_YGY'O442PQJB*J(@"JJC`4#L*6BBO2/CFPHHHH`****`"BBB@`HHHH`***
M*`"BBB@#S;]JW]E[PY^UO\(;[PIXAB"&3,UA?(H,VFW(!"3)ZXSAEZ,I(XSD
M?./[`W[4/B+X+?$F7]GCXPRFV\3:+B'PUJLSDQ:O;=(X@Y^\2H_=L>6`*'#H
M`WVO7RQ_P5J_9^T3XE?LQ:KXQE62Q\5>`(AJ.E:E;G9/'B1=T18<E3U'.58`
M@]0?.QE)P?UFE\45KYKL_P!&?6\.XZGB(_V+CM:55KE>[IS>BDO)[275:[H^
MIZ*_*;P'_P`%TOB#X6\&Z=IVJ^%_#VOW]C`L,NH2S2PRWA48WNJ_+O(ZD8!.
M3@=*_0[X:?M>?#CXE^'-.N[3QSX+-Y>6T<TUG'KEL\ML[)N:-EW!@5.1R!TZ
M56%S/#U](/7ST(SO@S-<KM+$T[Q;:3C[RTZZ:J_2]CTNBHK.^AU&W6:WFBGB
M;.'C8,IP<=14M=Z9\LU;1A1110(****`"BBB@`HJAXH\4:=X)\.WNKZO>V^G
M:9IT33W-S.X2.%`.23_G-9/PY^,7AGXL^`;/Q1H&L6=_H5\,QW6[RU4YP58-
M@HP/!5@"/2M%2FX<ZB[7M>VE^U^Y#J04N1M7WMUMW.EHK$O_`(F^&]*E6.Z\
M0Z';2,-P66^B0D>N"W2L.^_::^&VEQ-)=?$+P/;1H<,TNNVJ!3G&"2_K51P]
M67PQ;^3)E7IQWDE\SMZ*\POOVV?@_ITPCD^)W@1F(W9BUJWE7\U8C/MUK#OO
M^"C?P0TZ)GD^(^@,JG!\KS)3^`5"3^%=$<LQDOAI2?\`VZ_\C&6/PT=ZD5\U
M_F>UT5\^7_\`P52^`>G3".3X@0,S#=F+2;^5?S6`C/MUK#OO^"PGP+M(6>/Q
M!JUTP.-D6CW`8^_S*!^M;QR/,9;4)_\`@+_R,99O@5O6C_X$O\SZ?HKY7TS_
M`(+`_"CQ!J8M-+L_&>J.0"6@TM0B?[Q>1<?4\5Y]^T;_`,%594A;3_"=M<Z2
M9DR&>-;C4Y1CG9$I9(^_S$M[$5X>9UI8&O'!U*<I5I;4XJ\WY\JU2\W9>8_[
M5PGLW54TTNI]<?%KX]>%O@GIOGZ_J<4$SKNBM(_WES/_`+J#G'^T<+ZD5\4?
M'W]KC4_C!\1M(UG3H9-'M/#<HETV)G#N)-P8ROVR=JC;R`!CG))XSX4?M9>#
MO#^JMKFJ?"_XF?$+6I'WRWNH6ZF))>O$>9-Q`QR[$],!:XW]I[_@HIXS\2_%
MG1[G2O":_#RVT"1;H:1=6H,M^[#.ZY#1IO1E/"$8YSR<$<U;P]XISR/LJSCA
MH;\MU)Z:KF:>][:)675GC8SB'#*GS*5]5HD_S=D?J7\)OB-:?%GX=Z3X@LBH
MBU&`.Z`Y\F0?*\?_``%PP]\9KHJX/]F/X@S?%7X&>'?$4_AJ7PE-J]L)WTYX
MUC"$D_.H'\#XW*2`2K`^Y[RN^-"M12HXAISCI)K9M:.V_4^EHU%.$9K6Z3"B
MBBF:'!_"#_DH/Q4_[&B#_P!,NET4?"#_`)*#\5/^QH@_],NET4`'P@_Y*#\5
M/^QH@_\`3+I==Y7!_"#_`)*#\5/^QH@_],NEUWE`!1110`4444`<'XA_Y.>\
M'_\`8KZY_P"E>CUWE<'XA_Y.>\'_`/8KZY_Z5Z/7>4`%%%%`!1110`4444`%
M%%%`!1110`4DLJPQL[LJ(@+,S'`4#N:6ODS_`(*L?M"ZGX6^'ND_"GP;ON/'
MGQ6F&EP10MB2"T=@DCD_P^83Y8)P-IE;(V5AB:\:--U)=/Q[+YGI91EE3,,7
M#"4M')ZM[)+5R?DE=L\^^"$3_P#!2']OW4OB1=*US\,/A)+]@\.QN,PW]X#N
M$P!ZY;]\3U`%NIK[TKSS]E;]GK3/V6_@3H'@O3-DO]F0;KRY5=IO;I_FFF.>
M?F<G`/10J]`*]#K/!4)4X7G\4M7Z]OEL=O$69T\7B5##:4:2Y*:_NKJ_.3O)
M^;\@HHHKK/`"BBB@`K/\2^+=*\&:?'=ZQJ5AI=K+-';I-=SK"C2R,%1`6(!9
MF(`'4FM"OR5_X*K_`!MUOXN?M,ZKX<L-9;6_#7A)XK>"WL(7$%G<LH$BR$9#
MS"3*[NG&T8((KV\@R:698GV/-RI*[?EM]^O4\K.,T6!H>UM=MV2/UJHKX!^%
M'[1_[2O[(WP\TA?'WPSU'QIX2CMD>.Z@DWZGI\.WA9C'O(V+CB5`1T+YX'O?
MP+_X*=_"'XZ-#;1>(E\-:O+A?L&NJ+-]WHLA)B8D\`!]Q]!3Q?#^+I)SII5(
M+[4'S+YVU7S%ALYP]1J%1N$GTDK/Y7T?R/H.BDBE6:-71E='`964Y!![BEKP
MSUKA1110`4444`%>:_MA_"[5?C5^S'XT\*Z&MN^KZYIS6]JLTGEQL^Y3@MVZ
M=:]*HJ*D%.+@]GH=&%Q,\/6A7I[P::OW3NC\=F_X(N_'(@C^SO#?/_473_"O
MMV#_`((Z_!#6/"FFIJ'A2XL-86TB6]GL=7N@'F"+O8*SL@!8'HH')X]/JRBO
M.H9-AJ5_=YK][/\`0^PS3Q$SK&\G[SV?+?X.:-[VWU=]M#XJO?\`@AW\/-,N
M&N?#7C3XB>'+INC17T#J,#CI$K>O\7?M4?\`P[&^+W@S+^$_VFO&\*)_J[6_
M2XDB!'(S_I++V4?ZOIGZ5]LT5I_9>&^S&WHVOR9Q+C;.7I4K<Z_OQA+_`-*B
MSXF_X41^VIX#Q_97Q;\$^);6/@0W]JBROCIDM:D]`/\`EIU)^M`^+?[;G@7"
MWGPU^'_BNW7AI;:YC20^F`+I#U/_`#S/3M7VS11_9]OAJ37SO^=Q_P"M;E_'
MPE"?_</E?WP<3XE_X>2_'#P6`/$_[,?BV5%^_<:9)</&@ZYP+>0=U'+CG/T#
MX/\`@MYX,T"9(?%GP]^(_AJ5CM^>SA=5/OODC;L>BD\=*^UF8(I9B%51DD\`
M5\U_M'_\%/OAK\&[B70M,>3X@^)Y6\A=)T;$\9<\;))L%!DY!5`[`\%:Z\'E
M&8XF?L\+-R?^%.WJ]+>K9S8GB3(*4>?&8)1\XU9Q^Y2Y_N2*'A?_`(+)?`3Q
M%L%SXFU/17?`"WNCW)P>."8D<#KUSC@^V5^+/_!7_P""OP[\.?:M*U^7Q?J,
MJY@L=-@=68]M\DJJJ#/7JP_NFO$KW]C#XM_\%`M8AU7QYH?A/X2^$FE$\5C;
M:/"=5E&2<L<>:&.3GS70`G(CKW7PO_P1_P#@)H/AB+3KOPC<:W,H_>7UYJET
MES,?4F%XU7Z*H'ZUV8C`U\%*/M:E.J^L8\RMZR5UZVN<U''</XU/DI8BBNDF
MZ<ONBU%_>?`_[='[=7Q)_:(TW2(]<M+3PWX0U,/=V.CV-TLK3!&V^9<L#O9@
M<@!E0<9"=ZR/^"<_P&\$_M6_'=_"GB]O$<!EL)KFT_LV6*)&:/!/FNX8XVDX
M"KUQDXR#ZU_P4!_X)5W?@3QSH(^#/@CQ!J6DW=F[:@([AKI89@X"C,C;AE>>
MI_I7#_LJ?L(?M(^#OB]!J?A?2[SX?:S9VLSPZKJL:"U/`S"WRR`[QP`4(XYQ
MU'+/C?/*-9X?#Q5.E=>["*VTO:35VWW;N?9X?PXX,Q.4?6ZE93KN+M.K/E=[
MNW-3C)I)=DGIK9GVK8?\$7/@M:1LLD7BJZ).0TNJ8(]OE116W8?\$A_@/9R(
MTGA2^NP@P5EUF\`?CJ=DBGWXQ7F`_;'_`&I/V<LI\1_@U#XTTNW.&U/PZQ\Q
ME[R-Y/FJ!WPT<?X=:[?X3_\`!9;X,_$&X6SUF]UCP1J0;RWAUBR;RE<=5\V+
M>J@>K[.G:NQ<98N3Y9XB<7V;<?\`)'Q%7PTJTX.KA\-"M!?:I\M1?<KM?-([
M&P_X);?`738V2/X?6C!CD^;J5[*?S>8D?2MNP_X)[_!33I4>/X;>&6:,8'FV
MYE!XQR&)!_&O0O"GQ?\`"?COP[+K&B>)O#^KZ5`N^6\L]0BF@B'JSJQ"_CBO
M(OB#^V_'J>MGP]\-='N/&.NR943K&WV2+_:XP7`/4Y5>^XBN3,>+:F%@I8C$
MRUV7-)N7HDVV?.5<MPM"7+.C&+73E2?W6.DUG]EOX'?#G09[[4_A]\-M/L(3
MNDGO=%M&4''0,Z$Y..%'4]!FO'=9^('A[XA:\^B_!KX4>%[RZB_=OK,N@V\4
M-LIXW*"@"C'0R$>FPUU_AC]CK7OBMK,6N_%O7[G59U.Z+2+679!`/[I9<`#L
M1&!Z[S7OWACPIIG@K1H=.TBPM=-L8!\D-O&(T'O@=2>Y/)KPY8S.\R^*<J%)
M^=ZC7XJ'XOT%'"P>T%%>BO\`\`\$^$?[`.F:=?+K'CJ[C\0ZI(WF&SA7RK&%
MNN,``N`>V%7MM(KZ%T[3K?2+&*UM+>&UMH%"110H$CC4=`%'`'L*FHKNP&5X
M;!IJA&S>[>LF^[D]7\V=5.E&"M%!7!_%;]F7P-\;?%>@:WXH\/6.K:EX;E\V
MSEE!Y')$<@'$D8;Y@CY&1TP6![RBO5I5JE*7/3DT^Z=MQU*4*BY9I->84445
MD6%%%%`'!_"#_DH/Q4_[&B#_`-,NET4?"#_DH/Q4_P"QH@_],NET4`<KJ=GJ
M6I^'?CY::+XAMO">M7VJFUT[6;C;Y>FW4F@Z8D,QW<';(RG'KZU5_8MT2Q^'
M5MXL\&Q:;XFT35=&OUU'4K#5/%=QXH@6:]WSO/:WMR[7!CEE,K%)1$P8%A$B
MNI;J_AOH]IX@\6_%RQO[6VOK*[\2113V]Q$LL4R'1-+!5E8$,I'!!&#5[]G7
M]G7P=^RI\']&\#>!=!TGP]X>T2!8HX+"PM[)9Y-H#W$B01QQF:1AO=P@W,2<
M4`>+Z6LOB'_@H-;6_@/QGXPU5?"INI?B:EYJMW?:'!'<6\C:=I,,#2"SM;U'
MFAN";>,3K;0Q_:"?M,+MX?\`#/\`:(^*'A+X/R>/]*@\1Z]XL\8_`?7_`(CZ
M[HVH:[-?V^D^*;3[&+/3[:"5FBM4=I;V`QP1I$38[F0N69OL#PU^Q%\%_!?Q
MEE^(VC?"'X7Z3\0IKNYOY/$]GX5L8-9>XN1(+B8W:1"8R2B64.Y?+B1]Q.XY
MZSP9\'?"/PXU/7[WP[X5\-Z#>>*KK[=K4^G:9#:RZQ<;=OG7+1J#-)M`&Y\G
M'&<4`>*?L97.I^'?CA\0O"EOK'B'Q)X,L_#_`(<\06&JZQKMQK$SZEJ']HM?
M0I)/([I&(X+*98E(B07>(U1`%'T=7/\`PT^$OA3X+^'9-'\'>&/#WA/2);F6
M]>RT;3H;"V>>5M\LICB55+NQ+,V,L>22:Z"@#R?3_%FH>)_VH_#:WWAC7?#B
MVOAC6A&VH2V<@N\W>DY*?9YY2`,#.\+]X8SSCUBN#\0_\G/>#_\`L5]<_P#2
MO1Z[R@`HHHH`****`"BBB@`HHHH`****`,SQMXRTWX=^$-4U[6+J.RTK1[62
M\NYW.%BC12S'WX'3N:^,/^"=7@W4OVL/VA/%G[27BRUDC@N9I-)\'VDPR+2W
M3,;2+V^5,QY'!=YSC.*G_P""F'Q"U;]H?XM>$_V;?!MRR7OB.>+4/%%S'DBQ
MLU.]4?'8*#,5.,[80/OU]@?#?X>Z5\)_`.C^&=#MEM-(T.TCL[6(8R$1<9)'
M5CU)ZDDD\FO-?^T8C^[3_&7_``/S/L8_\)64<VU;%+YQI7_]R-?^`KS-NBBB
MO2/C@HHHH`***\N_:]_:FT7]DCX.7OB;5"EQ?/FWTJPW8?4+D@[4]D'WF;LH
M/4D`[8?#U*]2-&DKRD[)&5:M"E!U*CLEJV>9?\%$OVO-2^%&EZ?\.?`*RW_Q
M0\<8MK*&WYETZ&0E//\`9R<A,X`PSD@)SVO[$W['6D_LF_!Z'2'6WU+Q%JCQ
MWNN:@R[_`+5<J=RA2W.R,_<Z'.6P"QKS7_@G;^RUK5OJ>H?&KXF![SXB^-<W
M%M'.I#:1:N.%"G[CLF!MZI&%3@EQ7UG7M9EB*>&I?V=A7=)WG)?:DNB_NQZ=
MWJ>7@*$Z]3Z]B%9O2*?V8_\`R3Z]EH%>2_'7]AGX6_M%":;Q)X3T]M3FR3J5
MD/LE[N_O&2/!<CT?</:O6J*\;#XFK0G[2C)Q?=.QZE:A3JQY*L5)=FKGQ)-_
MP3Z^,7[,$K77P/\`BK>7.EQ$LOA[7R&B(S]U<JT)8YZ[(C_M=,3:5_P5!\9?
M`G4(=+^._P`*]:\-.6\L:QI,9ELYF]55F*-CC)29NOW>@K[5JOJNDVFO:=-9
MWUK;WMG<+LE@GC62.5?1E;((]C7L_P!N1KZ9A2C4_O+W9_>M'\TSR_[)=+7!
MU'#R?O1^Y[?)HX?X*_M4_#W]H:U63P?XKTG6)BNYK19#%>1CU:!PL@'!Y*XX
MZUZ!7S%\:O\`@DU\*?BA=MJ.B6E[X"UQ6\R*[T*3RH5?L3`<H`/^F>P^]>?_
M`/"$_M9?LAG=HNM:=\:O"UL>+:^R=15!U/SL)=WH%EE`Q]WK1_9N!Q&N#K\K
M_EJ>Z_E)>Z_G8/KV+H?[U2NOYH:_?%ZKY7/MVBODKX7?\%>?`^IZR-#^(FB>
M(/AAXBB(2:#4[:22WC8]BP42)S_?C4#UKZA\'>.-%^(>AQ:IH&K:;K6G3_ZN
MYL;E+B%O8,A(S[5YV,RS%81_[13<?/H_1K1_)G=A<?A\0OW,T_+JO5;HU***
M*X#K"BBB@`HJ'4=2MM'L)KN\N(+6UMD,DLTSB..)0,EF8\``=S7RO\;/^"KW
MA+P[KQ\,_#32=1^*?BV=O+AATI&:S#_]=%#-+C@_NE92/XQ7;@LNQ.+ERX>#
ME;=]%ZMZ+YLY<5CJ&&CS5I)7V[OT6[^1]67%Q':0/+*Z111*7=W(54`&223T
M`%?,'QZ_X*K>`_AOJX\/^#+>\^)GBZ=S#!8Z(#);F7LIF4-O/M$KGZ5Y]!^Q
MY\<_VV9X[[XU^,'\&^%96$B>%=#*ARN<A7P2@..C2-,PY&%KZ?\`@)^RGX!_
M9HTC[+X.\.66FRNNV:]8&:\N?]^9LN1GG:"%'8"O4^K9=@_]XG[:?\L7:*]9
M]?\`MU?,\_V^-Q/\&/LH]Y*\OE'I\_N/EY?V</VA?VZ2+CXI>)5^&?@FYY_X
M1S21BYN(_P"[(H)ZC_GL[8(_U8KZ2_9W_8R^'7[+UBB^$_#]O#J.S9+JEUBX
MOY_7,K#*@]U0*OM7J5%<F,SK$5X>QC:%/^6*LOGU?S;.C#971I2]J[SG_-+5
M_+M\K!1117DGI!145_?0Z78S75S*D%O;1M++(YPL:J,EB>P`&:\@^(?[<O@;
MP;H5K/IUX_B/4-0B62VL;$$N=P^42$C]V>@*D%Q_=KBQN987"1Y\3445YO7Y
M+=_(F4XQ^)GL;.$4LQ"JHR2>`*^7/VL/B1\(/B%>MHDW@;1/BAXGG/DQ"*R6
M5HFQC`N$!D)']V,GI@E:G7X<?%7]K)Q-XLO7\#>$)CD:7;J5N+A/1E/)R.\A
M`!Y"5[9\)?@-X6^">F^1H&F103.NV6[D_>7,_P#O.><?[(POH!7ARQ6/S)<N
M%A[*D_MS5Y/_``P>WK+[@H8K$0FJF'DX-=4VG\K'QU\(_P#@DY<S:=J&HA=)
M^'EQJ`9K:VCMY-3EM\]`WF3;@@X^4RD\<X--T']G[]K3]CYKAO`^J^!OB+HC
MR&5K"2SAM)YO=LB)NG0"=O8>OWQ16^#X8P>&?M*7-[3K._O/]+>221[N!SZO
M1J3JXB,:[GNZL>=O_MY^\OE)'P]IO_!8'5OA3>1V/QF^#WC'P7.6\O[;:0M)
M;RM_>59A'\O^[(_MFO>O@_\`\%"O@W\<#%%HGCS18KV7@6>HR'3[@M_=59@N
M\_[FZO8=0T^WU:REMKN"&ZMIUVR12H'20>A!X(^M>"_%S_@E[\$/C$99;OP3
M8Z+>RY/VK1&;3V4GJ=D>(B?=D->C[/&4_AFIKS5G]Z_R/3^N</XK^/0G0EWI
MRYX_^`SU2])'OZ.LJ*RL&5AD$'((]:6OAE_^"5OQ(^`\C7'P4^.&OZ-#'DQ:
M3K)9K5CU&\Q@Q-^-OZ_2D/[3W[6W[-W'CKX5:;\1](MQE]0T#BXD`ZL?(W[0
M!SS;K^70^ORA_'IN/FO>7X:_@'^J]'$:Y;BZ=3^[)^SG]T[)_*3/N>BOD7X7
M_P#!:/X1^+;O[#XG3Q#X"U2-O+EBU2Q:6%'_`+N^'<P^KHF*XG7?^"\?@O3-
M<O;6U\$>(;^VMIY(HKE+R!5N$5B!(!S@,!GJ>M.6:X1)2YT13X'SV<W3CAI7
M7>R7R;=G\FS[PHKS+]D?]IS3OVN/@U;>,=,TR]TBWGNIK1K:Z=7=6C;!.5X(
M((/;O]3Z;7;3J1G%3B[IGSF+PM7#5I8>O'EE%M-=F@HHHJSG.#^$'_)0?BI_
MV-$'_IETNBCX0?\`)0?BI_V-$'_IETNB@`^$'_)0?BI_V-$'_IETNN\K@_A!
M_P`E!^*G_8T0?^F72Z[R@`HHHH`****`.#\0_P#)SW@__L5]<_\`2O1Z[RN#
M\0_\G/>#_P#L5]<_]*]'KO*`"BBB@`HHHH`****`"BBB@`KB/VCOCKI/[-GP
M5\0>--98-:Z+;&2.'=M:[F/RQ0K[NY5<]LDG@&N*_;:_;:TG]B;PGHFJ:KHF
MI:X-<O'M(HK21(_+VIO+,6_```>OX_#7Q5_;*LO^"H/[2_PI^'\^EZGX=\!'
M5UEU"T:=99M1GPV,E<!5"`H"#D>:[8)`%>;C<QA2O2@_?=DEYO;_`#/LN'.$
M<5CN7&UX-897E*5U\,;N22O>[M9:;ZGTE_P2G^!6K2>']>^-OC8&?QM\5)FO
M(V=<&UL&;<@4'[JR$*P'01I"!CD5]?U'9V<.GVD5O;Q1P00((XXT4*D:@8"@
M#@`#C%25UX:@J--4UT_%]6>#G.:3S#&3Q4U:^R6T8K2,5Y)604445N>6%%%!
M.`2>`*`,GQYXZTGX9^#=2\0:[>PZ=I&D0-<W5Q*<+&BC\R3T`'))`&217Q/^
MSCX&U;_@I)^T6_QC\:V<UO\`#GPM<-;>$]%GYCN71@?,9>C`,`SGHSA4R5C(
MJ+XW^+M3_P""GW[2B?"_PG>3V_PI\%W"W/B;5[=ODU*16P$1NC#(98QR"0\F
M&"K7W%X0\(Z;X!\+:?HFC6<.GZ5I4"6UK;1#"0QJ,!1^'<\GJ>:^E?\`PEX>
MW_+^HOG"#_*4E\TNS9X*_P"%"O?_`)<P?_@<E^<8_B_0T:***^:/>"BBB@`H
MHHH`****`.7^*/P4\(_&S1O[/\6^'-(\06J@A!>6RR/#GJ4?[R'W4@U\O>,/
M^"24'@C6Y==^"_C[Q)\.=8/(MC<R3V<F.B%@1(%ZYWF4'TK[)HKT<%FV+PJY
M:,VHO=/6+]4[K\#AQ66X;$.]6";[[-?-:GQ$/VIOVE/V3/W7Q/\`A]!\0_#U
MOP^NZ!@2A>[OY:[0!_MQ19_O5[#\"/\`@I?\(?CV8+>T\2QZ!JTV`-/UL"RE
M+'HJN28G)/0*Y/M7OE>*_M(?L!?#3]I32-0.I^'M/TWQ!=1.(=:L81#=0RD?
M+(^PJ)L'JLF<CC(ZCT%C<NQ+MBJ7LV_M4]OG!Z?<UZ'&\)C:&N'J<Z_EGO\`
M*2U^],ZYOVG_`(?1>/\`5_#$OB[1+?6=!M5O;^*>Y6)+>(]S(V$RO!8!LJ&!
M(&:\!^+?_!5[1KCQ(?"WP>\.:G\4/%4V4C>UAD6PB;INR!OD4'J5"ICGS,5\
M>^!?^"4_Q&\1_M%W/@;5;)]-TC3"LUYKPC9K)K4D[9(6./,=P"%3@@@[MNUB
M/U/^#WP+\)?`+PM'H_A'0M/T6S55$A@B`EN6`QOE?[TC>[$FN_'X+*<N<6I.
MO)I-*]HKS;6NNZBM;;LX\'BLRQJDG%44FU>UWZ*^FG5_<CY.TW]A#XO?M?WT
M&K?'SQQ<:5HQ<2Q^$]#D58X\'(#E<Q*0>_[UL'[X-?4_P3_9P\$?LZZ"-/\`
M!WAW3M%C90LTT:;[FYQWDF;+OS_>)`[8KMZSO$GC'2/!UI]HU?5-/TN#KON[
MA(5/XL1FO!S#.Z]:'+4DH4U]E>[%?+]7=^9ZV%RVAAW[1*\NLI:O[WM\K(T:
M*\7\:?M\?#KPF6CMK^\UVX7@1Z?;%@3V&]]JG\":YG_AJ7XH?$WY?!/PTGMK
M>3A+S5681L/[PW>6@_[Z;\>E?'5N)LNA+V=.?M)=H)S?_DJ:^]G4Z\-D[^FI
M]'5B^+OB1X?\!0F36];TO2EQD"YN4C9OHI.3^`KPO_A0?QH^*.&\4_$.+0+2
M7K:Z2IWJ/[I\ORP?Q=OQZ5M>$?\`@GQX#T287&K'5O$EVQW.U[=%$9O7;'M/
MX,S5G_:>95_]UPO*N]22C_Y+'F?Y![2;^&/WB^+O^"@W@+0IC;Z4=5\1W;':
MB65J51F]-TFTGZJ&K$_X:`^,WQ1^7PI\.X]"M).EUJS'<!_>'F>6#^"M^/6O
M<_"/PU\/>`(1'HFB:7I0Q@FVMDC9OJP&3^)K;H_LS,Z_^]8KE7:G%1_\FES/
M\@]G-_%+[CX@_:;\,_%G0]&L8_$_BF^UF;62^_3=)CD^S1QJ!GS-BHIR6`"[
M3GGGCGH?^"=6E6FF>+-7L]6\-20ZQY8NK'4;BS<,BC"R1AF&%/((VX)&[).`
M*^OJ*\^AP?&EF,<P59RY>DO>>UOB;O?K=+0A8:T^>X4445]F=(4444`%%%%`
M!1110!R?Q.^`_@KXT61M_%GA70/$*%=JM?64<TD?^XY&Y#[J0:_'#QQ_P3D^
M,5MXUUF/2_AIXB.F1WTZVGEHK)Y(D;9@ELD;<<FOV[HKS<=EE+%6<M&NUC['
MACC7&Y*IQHI3C*VDF[*U]DFK7OJ?-W_!*?X3>)/@M^R19Z)XJT>[T/5EU2[G
M-K<@"0(SC:Q`)ZXKZ1HHKLH452IQIK9*Q\[FF83QV+J8RHDG-N32VU[!1116
MQP'!_"#_`)*#\5/^QH@_],NET4?"#_DH/Q4_[&B#_P!,NET4`'P@_P"2@_%3
M_L:(/_3+I==Y7D'_``L-?A)I7QY\5/INH:PGAS56U,V-BF^YO!#H&FR>7&.[
MMMP/<UL?LQ?$WQ5\5_A])JWBFQ\$0R7%U+)IUWX1\0MKFDW]BSLUNZ3M#"QD
M$119/DV%P60E6`4`]'HKRGP#^TI>>,/VN?'/PLN_"TVCKX1\-:1XEM]2EU".
M9]2BO[W5K0#R44B(*=*:129&9EG7<D;*5KPK]AK_`(*N3_M7?LX:K\8M>T[X
M,:%\.]"\(OXHU<^&/B@_B?7/#S+;I=-9ZC9G3+6*UD2#S3)FX8H\87:P8NH!
M]ET5Y-^SG^T?JGQ:\8>)_"WBCPYIOA3Q;X:M-/UB33[+66U6-]-U`W(LIVD:
M"`I*QM+E'C",J/$P621<.?6:`.#\0_\`)SW@_P#[%?7/_2O1Z[RO)]/^)_AK
MXB_M1^&X_#WB'0]=?3O#&M+=+I]_%=&V+7>D[0X1CM)VMC.,[3Z&O6*`"BBB
M@`HHHH`****`"LOQIXVT?X=>&+S6M>U.RT?2=/3S+B[NY5BBB7W8^IX`ZDD`
M<UXU^U]_P4*\$?LE0#3;B23Q)XTNP%LO#NG,'N9&;[GFD`^4I)&,@LV?E5N:
M\'\&_L6_%']OOQ1:>,?V@]2N_#_A2%_/TSP38.T!13T\T`YCR."6)F()&8\`
M5PUL9:7LJ*YI_@O5]/3<^FR[AWFHK'9E/V-#HVKRGY0CN_\`$[175]#R;]O'
MX]:Y_P`%-M3L/#_PA\"^)/$?ASP9=R33:TELRK=2N@4!5(`C7:"1O.]L_=7'
M/(?L-_L-_%SX??M;^`M;UOP%KVF:3IFJ+/=74\:K'`@1LL3NK]8?`7P_T/X7
M>%+/0O#NE6.BZ18)L@M+2(1QQCN<#J2>23DDY))-;%<;R?VE55ZTVY73TT6A
M]''Q">%P4LKR[#J-%J45S-N7O7NVTTKN[=DK+;8****]H_-@HHHH`*^0_P#@
MH=^TSKGB'Q)8?`CX8,;KQWXP`AU.XA?`TBT=<LK,/N,R99FZI'DXRZD>F?MW
M?MAV?[)/PH-Q;)'?^,-=)M-!TX#>TTQX\UE')C3()`^\2J\;LCF_^">/['MY
M\#/#5_XU\:O)J/Q/\;DW>K7-P0\MDCMO\@-_>)(:0C@L`.0@)^@RVA#"T?[2
MQ*O9VA%_:DNK_NQZ]WH>+CZT\14^HT';^=K[,>R_O2Z=EJ>F?LJ?LSZ'^RC\
M'M/\*:*HFDB'G7]ZRA9-0N6`WRMZ#@!5YVJ%&3C)](HHKQ*]>I6J2JU7>4G=
ML]:C1A2@J=-62T2"BFSSI;0O)*Z1QQ@LS,<*H'4DGH*\.^/_`.W!X=^&=G#;
M^'[W3_$6L?:HQ/#`YDBBA#9D/F+\N\@;0`3@MDC`P?+S#,\-@J3K8F:BOQ?H
MMV_0<ZD8J\F>YT5\\?\`#Q'1=3`.D>#_`!?J*GD'R(UR.A/RL_?BE_X;,\::
MK\NE_!OQ5/G($DIF5%(YP<08Z>XKS?\`6K*W\-1R](R?Y19'UB'<^AJ*^>1\
M>OC=K)_XE_PLM;;<1M^UW!&,],[G3\>GX4G_``D/[1^M+G^P?"&CDC./,1B,
M'I_KI.O7_"E_K)1?\.C5EZ4Y?JD'MUT3^X^AZ*^>3X"_:*UHD3>,_"NF1-D,
ML4"LV/4?Z.?I]X&@?LV_%[62#J'Q<N+;=@M]D@<8]<;2G_U_:G_;F(E_"P=1
M^O)'\Y![5](O\#Z&I))%AC9W941!DDG``]:^>?\`AAW7M37&K?%KQ?J.1@_-
M(H/.1]Z9NE.C_P""<7A*[E$FI:_XMU&123\]U$`<]>L9/)]#2_M'-9?#@[>M
M2*_)2#GJ?R_B>VZC\0_#^D,1=Z[H]J00")KV-#DC..3Z5@:C^TK\/M+4F7QG
MX;<`9_<W\<QZX_@)KB-._P"">_PUL0/-L=4O,#_EM?N,_P#?&VK^L_L3>`8?
M#5_#HOAO3K;4Y8)$M9[N:>X2&0J0KD.YR`><>U*=?/'%RC2I+R<I-_A%+\0;
MJ]D<G??\%$?#6C_$S6;.:.:\\-6EN@LKRSB+RW4X/[P88J-IS@'C_5DY(889
M_P`-D>-_B/\`+X"^&FI7<3_ZN]U'<(#Z9V[4'_?VN.T#_@G'XG\,ZW9ZC9^*
MM&CN["9+B%C;2,%=6#`X/!&1TKZ]AW^2GF;?,P-VW[N>^/:O'RFEGV+YUCZC
MHJ]THQBVT[NRDW*UMEI>UM69TU5E?G=CYS_X55\>/BG@Z[XRL/"%E)UM]-'[
MZ/\`&/!/_?TUH^&_^">7A&"[%WXBU+7?%-Z_^L:XN3#')_WS\_\`X^:]]HKV
MH<,8%M3Q"=67>I)R_!^[^!HJ$.NOJ<SX+^#/A/X=A3HGA[2=.D3I+';J9C]9
M#EC^)KIJ**]RC0ITH\E**BNR5E^!JDEH@HHHK484444`%%%%`!1110`4444`
M%%%%`!1110`445F>&O&.G>+K>[DL9RYT^Y>TNHY$:*6VE3JKHP#+D$,,C#*R
ML,JP):3M<=C3HK-\)>+K#QQHJ:EI<S7-A,[+#/Y;*DX5BN]"0-\9QE77*L,%
M2003I4--.S!H****0C@_A!_R4'XJ?]C1!_Z9=+HH^$'_`"4'XJ?]C1!_Z9=+
MHH`S_!>G:AJWB#XOV^E:B-(U&7Q+"+>\-NMPL#_V+I1!,;$!U[$9!()P0<$9
M?[('P=\4?#_PO?\`B/QY/X<_X3WQNEK?:_:^'M%&CZ7:7"1;=JP?:;IGG`;9
M).UQ)YOE)C:JJHZ3X0?\E!^*G_8T0?\`IETNN\H`^>/`_P"RW\5/#G[=WB7X
MN:C\2?A_?^'?$VCV?AN;P];^`[RVO8=,L;G5+FR5;YM7D3[2LFJ.)I3:[)5B
M4)#"233[[]B"^^,'B3QKJOQ:\2Z%XJG\4^$]3\!0VWA_09]#LH=$OV1IX[F*
M:]N_M5S^[11-NC55W!8EWN6^A**`/*OV<_V=M3^$VO:]XD\5>(-,\5^-/$-I
M8Z1<ZI8Z,=*B;3[`W'V*`Q-/.Q=3=7#N_F;6>9RJ1*0@]5HHH`X/Q#_R<]X/
M_P"Q7US_`-*]'KO*X/Q#_P`G/>#_`/L5]<_]*]'KO*`"BBB@`HHKPG]K[_@H
M-X&_9$LOL=_.^O>+[E1]C\/Z>P:ZE+?=,AY$2$XY8%C_``JV,5G5K0I1<ZCL
MCLP&7XG&UEA\+!SF^B_/R7=O1=3V3Q?XQTGP!X;O-9US4K+2-*L(S+<7=W,L
M4,*^K,W`]/<\5\3?$+]O'XC?MK>+;SP-^SAI-Q:Z5$WDZEXVOXS!#;*>IBW`
M^5D<@D&4C)5%(W5#X5_8\^*G_!0GQ-9^+OCY?W7A7P9!()]+\$V#-!(5[&8=
M8R0<%FS*<L!Y0P*^U_A[\.=!^$_A*ST'PUI-CHFCV"[8+6TB$<:>IXZL3R6.
M23R237!>OB=KPA_Y,_\`)?B?4*.6Y-\7+B,2NF]*#\_^?DEV^%>=CQ#]CS_@
MG#X0_9;N3X@OYIO&7Q`O"TEWX@U(%Y$D;E_(5B=F23ER2[9.6P=H^B:**[J-
M"%*/)35D?,YAF6)QU9XC%S<Y/J_R2V271+1!1116IPA1110`5RWQJ^,>A?`+
MX9:MXL\1W0M=+TF$R-C!DG<\)$@/WG=L*!ZGL,FNEO;V'3;.:YN9HK>WMT,D
MLLC!$C4#)9B>``.23TK\[/B'\4M,_P""C?[1JOK>M1:'\!OAY=;B9I3"WB*Z
M'4(H^=V<=E!*1$GY6DKTLOPE*?-B,7/DHTU><GI9=$K]7LOOZ'G9CC70BH4U
M>I+2*_-OR6[.\_8C^#FN_M<?&>?]H?XE6I2%G*>#=(D^:*S@5CLF`/9,G8<#
M<Y>3`^0G[;KYSO/VX;2_:/0?AAX-U/Q'):1K!!Y=N8+2W11A=J*"P0`8P0@`
M^E1?\*9^,WQU&_QAXK@\(:3-RVG:7S)CNK;&P0?]J1\>GK\UFG&=/'UW]0IR
MJI:14%:$4MESNT?5J]V3@:,</3Y(7E)ZR?=O=M_EY'K'Q+_:2\%?"82)K.O6
M<=W'_P`ND!\^YSZ%$R5^K8'O7E$O[7WC;XOS-;?#/P)>36[':-4U,;85YZX!
M$8(]Y&^E=Q\-/V*O`'PV,<PTD:U?)S]IU0BX.?4)@1CGH=N1ZUZM#$EO$D<:
M+''&`JJHP%`Z`#L*\[ZKFV*_CU51C_+#67SG)63](_,[.6I+=V]/\SYRA_8^
M\9_%V9+GXF^.[VZ@8ACIFF';"O?J0$!''2,_7O7.^//^";4^J^)YY=`U;3-*
MT@!4M[>5)990`HRSN3RQ;)]!D`8`KZQHK.KP=E=6'+6@Y.]W)R;D_65[V\EI
MY`\-!K5'GW[-7PKUGX+_``X7P_J^J6NJI:3NUH\*,GE1-\Q0YZX<L1_O8[5Z
M#117T&$PL,/1C0I?#%65W?1>;-8Q25D%%%%=!04444`%%%%`!1110`4444`%
M%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`445X#^VO\`M]>'?V2=
M*BTRWA/B3Q[JRA=+T&V)>1F8X22;;DJA;@`?,YX4=67;#X>I6FJ=)7;*A!R=
MHH[C]IO]J?PA^R=\/9?$'BN_$0?*65C#AKO490,^7$F>>V6.%7/)'%?(GP2^
M&OQ<_;L^+`^,_B:TL?#'A:SB*:'X9F,L,>OP`2)Y4[)M<QM'+*OFR!@QD($1
MC)4]?^S'^P-XC^,/Q"C^+G[0L_\`;GB>X*S:7X<EP;/2(P=R"2/E<CM$,J#D
MN7<G;]I*`H````X`':O4E7I8.+IT+2F]'+HNZC^K^XW<XTU:.K[_`.7^9D^"
M?$T'BSPY!=P6EWI^,PR6ES#Y4UI(AVM$R]/E(QE258892RD$ZU%%>-)J^ASL
M****0C@_A!_R4'XJ?]C1!_Z9=+HH^$'_`"4'XJ?]C1!_Z9=+HH`/A!_R4'XJ
M?]C1!_Z9=+KO*X/X0?\`)0?BI_V-$'_IETNN\H`****`"BBB@#@_$/\`R<]X
M/_[%?7/_`$KT>N\K@_$/_)SW@_\`[%?7/_2O1Z[R@`K/\5>+-,\#>';S5]:U
M"STK2M/C,US=W4JQ0P(/XF9B`!7CO[7O_!0#P)^R!IQM]4N6UKQ5<*#9^'[!
M@UW,3]TR'D1(3CYFY/\`"K8(KY^\*?LH_%C_`(*+Z[:>*OCI?WG@[P%%()],
M\%V!:"65?X6F!Y0D=6?,IRP`B!%<-;&VE[*BN:?;HO5]/S/I<NX=<Z*QV83]
MC0Z-KWI^4([R?GI%=66OB/\`M]?$']LGQA=^!/V;M(G2RB;R=2\:WT1AM[1#
MU:+</W8(SAF!D;G;&"`U>M?L@?\`!-GPC^S/>CQ)J\\OC?XAW3&>YU[4@9&B
ME;EC`K$["3UD8F0Y/S`';7N?PX^&?A_X0^$+30/#&D6.B:/8KMAM;6,(@]6/
M=F/4LQ+$\DDUN4J6#]Y5:[YI?@O1?KN:8_B)*B\#E4/8T7OK><_.<NO^%6BN
MS"BBBN\^6"BL;Q!\1?#_`(3W?VKKNCZ:4Z_:KV.$C_OHBN$\4?MM?"WPC&6N
M_%]@V.GD)),#_P`"52OZUQULPPM)\M6I&+\VE^I+G%;L]4HKY%^*W_!7OX?>
M%!:R:#<'5G@F!N[:0Q1FXA(((C?S"4D!*L-R%6`*Y7.]?$9_^"Q6K:W+#I,'
MB/P_H<4LLD\^LW&F7,S1H[$I"B)&^-@.-QC8X"]3D@>+G)*6'HU*J:?P0DUI
M;2]K:WTZ/770I*3^&+?HC]'=<\06'AC3I+S4KVTT^TB^_-<RK%&OU9B`*\8\
M=?M\^$-"O?L'AZWU'QAJCG9'#81%8G;TWD9/U16%?(EE^U-\"/$%Y'JOQ"^)
MGC'QM?AO^/6WTRZBAC'4KND`.WV39UZ5K_%K_@K'\*_AG\(M4TKX,:!?6/B6
M]B%O;W\NFI#';!A\TK.S&21U'W0P(W8))`P8H91Q+CYJ$**PT6]Y+FDO.VD5
M\W+T,ZE/$J#DH-6\KOY(V_'?[3/CW]K_`.*L_P`'[6PBTZ2\.W5K"WB8)8P*
M07-Y*QR%&0&0`$DA"N3BO??A5_P3H\"^`+>`ZFMQXAGA`PDO^CVJG_9B0]/9
MF8>U?&O["G_!0#X5?LK_``UN(K?PK\0_$_CC7)1=>(-36RMV$K$DB-'\]G,:
MDGE@"S,S'&0H]S_X?)0ZBZG2O@U\2=0CFP(&^SA3*QX`PJMWXX)_I7IXS@*G
M&LHR4Z_+]JI)--]6H:0BNRM>V[.?`Y?B91]MBH^^^G9=%YOOTOL?9.@^'=/\
M+:;'9:98VFG6D7W(;:%8HU^BJ`*N5\5?\/5?B)J2D:5^S'\2=0D0_O%_TE0@
M['Y;-OUQ0?\`@H?\>]78&P_9A\3VRSC$(NY[@%"1C+[K=.,^NWC\Z[XY)B8I
M+EBDO[T5^IZ:PTUT_%'VK17Q2/VP/VK]7!%A^S_IUL8_O_:[E@&STQNF3^OX
M4?\`"\?VW-9_X]_A!\/K""XX1YKR(R0@]R#J&<C_`'/PJO[)J+XIP7_;\?\`
M,/J[ZM?>C[6JKIVN6>KSW<5I=6]S+83?9[E(Y`S6\FU6V.!]UMK*V#SA@>A%
M?&1US]N+62!_8WPXTGRO]N%O-S_VU?ICVZ]^W&3^&_VR=8^)NHW6F:_X('B"
MST_RM0^P1P+'$I^>&UE9X?+>;#%T!+-&KDED67YZAE*=[UH?^!?\`:P_]Y?>
M?H!8ZY9ZG>WEM;75O<7&G2+%=1QR!FMW*!PK@?=)5E;!YPP/0BK5?`GP+_X*
MI'X`B/P9\8?AUJW@NZL+E[:?5+&.2>&6XR'DDF60F1G;>)&D625G\P-C#`G[
M0^$WQS\'_';0!J?@_P`1Z5X@LP`7-I.&DA)Z"1#AXV]G`/M7/C,NKX=WG'W>
MCW3^:T(J490W6AU=%%%<!D%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!
M1110`4444`%%%%`!1110`45'>7D.GVDMQ<2QP00(9)))&"I&H&2Q)X``Y)-?
M#?QS_;0\9_MI_$*Z^%/[/7FQV"?N]=\9Y:*"VB)PWDR`91.H#CYW(/EC`WGK
MPF"GB)/ET2W;V2\_\NII3IN;T.S_`&Q/^"A]YX>\:#X6?!JQ_P"$P^*&H.;9
MWMT$UMHK?Q%L_*TJC)(8[(\$N>"IVOV*?^">-G\!]4E\<^.K[_A,_BKJS&>[
MU2Y8SQV#N/F6$OR7[&4X)'"A5R#W'['G[$GA']CCP8;/18CJ&O7R#^U-;N$'
MVF^;J5'7RX@>B`XX!)9LL?8ZZL1C84X/#X32+WEUE_DNR^\N=1)<E/;OW"BB
MBO*,`HHHH`****`.#^$'_)0?BI_V-$'_`*9=+HH^$'_)0?BI_P!C1!_Z9=+H
MH`C^%=Y#I_C?XLW%Q+'!!!XFBDDDD8*D:C1-+)8D\``<Y-:?P8^/?@G]HOPI
M<:[X#\5:%XOT:UOKC3);S2KQ+J&.YMY6BEB+(2,JRGV(*L,JP)X'7_"^E>.?
M"?Q_T/7=.U;5M%UK5#87]IIB%[R:"70=,CD$0')<*Q("Y)QP"<`Q?L2?$J^^
M+/AK5M<235]:\,7GV5M#\1ZUX2G\+ZMK<0B(8W%I/%!(VP@%)Q;P1R++\B;5
MWN`>M6'C_0=5\::EX;M=;TBY\1:-;07E_I<5Y&][8P3F002RP@[XTD,4H1F`
M#&)\$[3BGX1^+WA+X@>)M?T70/%'AW7-9\*W"VFMV%AJ4-S=:/,RAA%<QHQ:
M%RI!"N`2#G%?+7P8^(^C67_!73XF)IW@SXCZ3I7B#P7H?AR#57^&NNV&BWFK
MV.K>)KK4#]O>R2T*E;R"07)E\JX,Z^7)(QQ7FWPO^`7Q4\:_`R3PYI4OB/0/
M'/@OX$^(/ASK6IZCH,VG0ZOXLN_L;VM_;R3(B74:207<WFP>9#F^*EPX90`?
M=WPV^+WA+XRZ3=:AX/\`%'AWQ786-W+I]S<Z/J4-]#;W,3;98':)F"R(P(9"
M0RG@@5KZ_K=OX9T*]U*\=H[33X'N9V52Y5$4LQ`').`>!R:^??V,-*O_`!%\
M9/'?C>UTKQ%X;\':OX=\.>'[#2-9T.XT>XBO]-_M%;R80W")*4*7-I"LFSRW
M%F&C9T(:O:/C.C2?![Q8J[PS:->`;1EL^0_0=S4R=DV:48*52,9;-H^5+_\`
MX*M?"?5OB?HOC&"3Q*V@Z)I&HZ7=S_V6V4GN9]/DB4#=DC;;2Y(X!VC^(5S/
MQ._X*3>-/VL-3F\)?L^Z3-IEGL"ZKXQUL+:V^F*PYVELI$0,_,VYSAMB9`:O
MBM?@-J5_X$L;2UN[K3T6/S9K-0WF:B05+2E2R@$9`4$9QMW$'`':>&O^"5/Q
M<^(GPYTCQ3HMKI>O6&IQ-/!:/J9@N%`8C:RS+&%)(/1OQKCX?5+.>:D\7&G)
M-W7*TXI;)R;4;ONGMV::7T]3,\GRZ57$4L.ZO))QA>\EY2<$ES;-VO972=VM
M?K7]F_X4_L\_L;7S>*O&/Q0\)^-?B/</]HNM9OM3CO);>8\L8(@SNK9_Y:-F
M0]<J#MKT'Q?_`,%A?@5X6#"#Q'J.MNO1=/TN9MWT,@0?F:^,_"?[.4_P3C5/
M'7[)GB+Q2\/$EW8:Y?NB]]VV`R1D8]3CWKUCX>?ME?LM^!;Q+/6/@;+X2U!!
MG=?^&[6\:/KSO=C+W/\`#_(5]I2X15&'+AXRG'O!PU_\FF_O5SY',>+\/CJ[
MK8^M+G?\R<;>235DEV6AU/B'_@NOX0EN3;>&O`OBK7+A\^6)'C@)]]J[R?H/
M3K65+_P4O_:"^(QV>#_@-JZ02_=N)M-O)57/3YRJQ_G7T#\,O^"A'[/VJVR6
M^B>,_#FB(^`8;BU?2U4\G!\Q$7UYSCWKV3PC\2_#GQ`A$N@^(-$UN,C<&L+Z
M*Y7'KE&/%>=B<%"CI6P\_P#MZ4H_^DJ'YA1QN$J_PFI?]O7_`"/A&3Q#^W-\
M5"/)T&Q\-6<IX:2:RM6CSCMYGF\`Y^Z>A[\&M+^P!^U3\4OF\4?%71K&WE^]
M"VHW%U(F2#C:(MN!D\!^H_&OT2HKA<L-_P!`\'_B3G_Z6Y'0ZD?Y5]U_S/S^
MT3_@B/K6I!7\2?&;5YPWWX+'3F51]&:<C_QP5V?AO_@AO\)M.<2ZKK7CC7)S
M][SKZ&*,_@D0;_QX]*^SJ*WI9C7I+EHM07]V,8_DD-5YK9V]-#Y(\=_\$;?A
M+K&D:?9>'M+;P\R7/FW]Z]S<7MS<1!6`B02R%$RS#+!<X7UP1:^'W_!)_P`$
M_#3XDZ-K]JNDZO;6+E;O3M4T:WN(+F,HP#+N!VR*Q#!L'.,'G!'U;5#Q3XHT
M[P3X;O\`6-6O(-/TO3('N;JYF;;'!&@+,Q/H`*XZSJUZL:E2<I26WO2_*]GT
MMH9SJOXI2V\SQ[]I'4OA/^R#\(=3\7:EX,\(P^4ODVEK!I-M%+J-R0?+A7"=
MR"2>=JAF[5Y%_P`$X_V3[[7]?NOCE\1-.M(_%'B8F?0M.%L(H=&M6^[(D?1&
M9<!!U5.22SG'+_"/PSJ/_!4O]I=_B'XEM)[?X0>!KAK?P_I<ZD+JLP()9UZ'
M)"M)VX2/D!B/O4`*````.@KZ7&U7E^'>#B[U9KWW_*ND%Y_S?<>%AW+'5EBI
M_P`./P+N_P"9_E'[PHHHKY@]L****`"BBB@`ID%M%;;_`"HXX_,8NVU0-S'J
M3CJ?>GT47`RO%'@71/'&D7>GZUH^EZM87X"W-O>6J3Q3@#`WJP(;';/2OE+X
ML_\`!'_PM+KQ\1_"CQ'KGPL\31'?"UC<226F>I`&X2QY(_A?:/[AZ5]A45UX
M;'5Z#O2DUY='ZK9FD*LH_"SX2_X:A_:5_8GS#\4_!</Q+\)6I(;Q#HO^OBC'
M5W9%P`!S^^B0D_QU[]^SK_P40^%'[3/D6VA^)(=/UJ<#&D:L!9WF[^ZH)V2G
MVC9Z]OKP']HK_@F?\)?VCQ/=7_A]-`UR?+?VIHNVTG9O[SJ`8Y"3U+H6]"*[
M/K.$KZ5X<C[QV^<7^C1ISTY?$K>:_P`CWZBOA,_`_P#:C_8C/F>!/$]O\7_!
MMJ<C2-4!-Y%&/X55WWC`X`BE.3SY?:NT^#'_``5^\"^)M9_L#XBZ5K'PM\40
ML(Y[?587:U5_0R;0\9[_`+U%`_O&HGE51Q<\.U4C_=W7K'="=!VO#5>7^1]<
M453\/^(M/\6:/;ZCI5_9:GI]TN^&YM)EFAF7U5U)##W!JY7F--.S,&%%%%(`
MHHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`*Q?B)\1M#^$W@V^\0>)-3M-
M'T;38_,N+JX;:B#L!W9B>`H!))``).*Y;]I7]J#PC^RE\/9?$/BS4%@C.4L[
M.+#76HR@?ZN),\GIDG"J#DD"OD7X??`GX@?\%2_&ECXZ^*ZW?A7X464OGZ%X
M7@D:.34%_AD8\':PZS$!F!(C"*=P]'"8'GC[>L^6FNO5^45U?X+J;4Z5US2T
M7];%?7?&OQ&_X*Z^+;C0_"YO_`OP+TZX\N_U.5-MSKA4YV`9PQ[B,$HG#.6;
M8M?:GP+^`OA;]G'X?6OAGPCI<.FZ;;?,Y'S374F`&EE?J[G')/8`#```Z+PK
MX5TSP/X<LM'T:PM=,TO3HE@MK6VC$<4"#HJJ.`*OTL7CO:15*DN6FME^K[O^
MD%2KS>[%604445YYB%%%%`!1110`4444`<'\(/\`DH/Q4_[&B#_TRZ711\(/
M^2@_%3_L:(/_`$RZ710`?"#_`)*#\5/^QH@_],NEUV>BZ+9^&]&M-.TZTM=/
MT_3X4MK6UMHEBAMHD4*D:(H`554`!0````*XSX0?\E!^*G_8T0?^F72Z[R@`
MHHHH`****`.#\0_\G/>#_P#L5]<_]*]'KO*X/Q#_`,G/>#_^Q7US_P!*]'KO
M*`"J>M^'M/\`$MD;;4K&SU"W;DQ7,*RH?P8$5<HIIM.Z$TFK,\C\:_L%_!KQ
M_O.H_#CPLKR9W/96@L7;/<M!L.??.:\G\6_\$8?@YKDQFTH^*_#,Z'=&;#4_
M,$;=O]>LC8!]"#[U]:45Z5#.L?1TIUI+RN[?<]#@K95@ZOQTHOY*_P!Y\8#_
M`()E?$SX>_-X%_:&\8Z?"G$=E?K-)"!UR=LVS.?^F?<_B'PE^VI\,#FW\1^`
M?B!`G*131Q0NPZ8),<!SW^^?KVK[/HKK_P!8<1+^/"%3_%"-_O23_$Y_[$H1
M_@RG#TD_R;:/C`_MR?M&?#3CQE^SQ=ZHL?\`K9=`GD=5`ZL/+%R,=_O8QW[U
M9TG_`(+0^!M-O$L_%_@WQYX2O6^\L]E'*B>N<NC\?[E?8U5]5T>SUVS:VOK2
MVO;=_O13Q+(C?4$$4?VC@)_QL*D^\92C^#YD'U'&0_AXAO\`Q13_`!7*SP'2
MO^"J7P+UC0[B]B\;1QO;1-*UK-87,-P^!]Q0T8#,>P4GK]<?,7B_]I_7_P#@
MK'\1]`^%?AZUD\%^$VEDU'7YI+M9)KNWBD^0`8&2$V$1@']XV3\L>ZOK/X[_
M`/!/'X5_'#PC?V)\*:'X=U6X3-OJVDV$=K<V\H!VN=@42+V*OD$=P0&'EW[`
M/_!,"+]FCQ9/XM\87=EK'B>UEEATI+5F-M91G*>>=P!:1U)P",(#W8_+ZV!Q
M.38>A4Q5'F5:/P*5G9V=FK63MW>UE\_.Q=#-*U6&'J\KI/XG&ZNNJ=[M7\M_
MR^J/AW\/M'^%/@?2_#F@646GZ/H\"VUK`G1%'<GJ6)R2QY)))R2:V:**^-G.
M4I.4G=L^GC%12C%62"BBBI*"BBB@`HHHH`****`"BBB@`HHHH`*XKXS_`+.G
M@?\`:%T4V'C/PSI6O0JNV.2>+;<0#_IG,N)(_P#@+"NUHJX5)0DI0=FNPTVG
M='P_K_\`P2X\;?L]ZS/KO[/OQ-U7P[([^<^A:M*9+2X([%@I1^F`)8FZ\N.M
M-T/_`(*@>/?V<]6M]$_:#^&6J:&7;RDU[1XO,M9SSSM+&-^F28Y21_<Z"ON*
MJFN:#8^)])GT_4[*TU&PNEV36US"LT,R_P!UD8$$>Q%>FLT]I[N+@I^>TOO6
M_P`[FZK\VE17_,Y/X*_M)>!/VB-'^V^#/$^E:[&JAY889-MS;@]/,A;$D?\`
MP)17;U\E?&O_`()!>`?%^L?V_P"`-1U;X7>*(6\V"YTB5C:H_P#>$6X-&?\`
MKDZ`>AKA9_C'^U5^Q!`Z>,/#EG\9/"-H"1JFGLQO(D'=V1/,``Y+2Q-_OX%-
M8"A7_P!TJ:_RRT?R>S_`/91E_#?R9]WT5\I^%_\`@L/\(?%W@C[9#J-SI7B!
MRL2:/JT36VV0\9>=0T2Q*<DL"6VJ<(6*H?9_"_[7'PN\6QQ+8_$?P)=7#@`Q
M1:[;%]V<8"EPV,\#(YKDJY?B:7\2FU\C.5*<=T>BT54T?7[#Q#;>?I][:7T)
MQ^\MYEE7GIRI(JW7(U;<S"BBBD`4444`%%%%`!1110`5X-^VI^WMX:_9%T6*
MQ6,^(?'.JJ%TO0+9BTTC,<*\NW)2,MP.-SGA0>2O#_MC_P#!0^X\(^+U^%_P
M@L/^$R^*>I.;7%NHFMM&;')<_=:51DE2=D>"9"-I4Z/[%7_!.^V^">M2^/OB
M#??\)G\5=68W%SJ%RQGBTUV'*PEN2^.#(0#@;5"KG=ZU#!TZ,%B,9L]H]9?Y
M1\^O0Z(TU%<]3Y+O_P``XG]FO]@KQ-\=/B%#\7/VAY?[8\03[9=*\,2+_HFD
MQYW(LL>2!CJ(>0#DR%F+`?:JJ$4*H"JHP`.`*6BN/%XRIB)*4]EHDMDNR1G4
MJ.;U"BBBN4S"BBB@`HHHH`****`"BBB@#@_A!_R4'XJ?]C1!_P"F72Z*/A!_
MR4'XJ?\`8T0?^F72Z*`#X0?\E!^*G_8T0?\`IETNN\K@_A!_R4'XJ?\`8T0?
M^F72Z[R@`HHHH`****`.#\0_\G/>#_\`L5]<_P#2O1Z[RN#\0_\`)SW@_P#[
M%?7/_2O1Z[R@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@
M`HHHH`****`"BBB@`HHHH`****`"JFO7-Y9Z+=2Z=:Q7M^D;&W@DF\E)7Q\J
ML^#M7/4@$@9P">*MT4TP1\\?$3_@GWX2\<[_`!)JF@>'?$GCF:8W=_+>6ODV
M>K9"AK;:N3"@"J(Y%RZE0SF7=()*6N?\$E/@)XDMPY\#2:7.Z@DVNK7:%..F
MWS2G!/4#MZ5]*45VQS+%124:C5NS:_I&JK36S/C;6/\`@A]\)9[@7&E:UX\T
M.Y3.QK;4865<C'\<);IGHPZFJG_#IKQ;X9;/A3]HGXD:"J]%9II!UZ'R[B,$
M'"]NWX#[4HK99SC.L[^J3_-,KZS4[GQ4/V._VJ_!HSX?_:#LM2*<I_:]JS!C
MUYWQS]SCOQ^5*VG_`+</@D;1??#7Q@4XW!8HM_09^Y!]>W\A7VI11_:LW\=.
M$O6*_2P>W?5)_(^*S^U7^UUX.(;7O@-H.IHIY_LF[W%AUXV7$W8'MUQ]"?\`
M#T_XA^%>/%?[-GQ"TI$'S3P>?)&W')&ZV5<#*_QGK^%?:E%'U[#R^.A'Y.2_
M5A[6#W@OQ/C&Q_X+?_#.TNOLVO>%?B%H%V,[EFT^!E7G'_/8-UR/N]OPKM/#
MG_!7[X":]L6;Q=>:7(YP%O-(NQSG'+)&RCUR3CFOI2^T^WU2W,-U!#<Q$Y*2
MH'4_@:XOQ%^R]\-/%RL-4^'O@G4"XQNGT2V=QQC(8ID''<'(H]M@)?%2E'TD
MG^<0YJ3WBU\_^`>?G_@I'\(I];TI;7QSX6N-)U!O(FN6U`0364K$>67AD"GR
MCDAG!RAVEEV[W3Q3X\_MK^,?VQ/B%=?"?]G@.\`_=:YXR!,=O:1$X;R9`/D3
M@CS!EW(/EC@.?4?B;_P3#^$WCS6M/M;7X?Z!I&FE_M&H7MG)+;W#*K*5MXDC
M8*N\@[I#]U`54;GWIZ/\!_V?-._9DGN-`\(:786?@J^+7:QAB;NQN?E!5I&R
M\\;CD-(Q>,KMRR,HCWA5P%)>TI1<IK92M;U=MWV6B^>]J5*/O15WYF)^QO\`
ML/\`A/\`8X\(-;Z4AU/Q'J"#^U-;N$'VB\;.2J]?+B!Y"`]@6+'FO:***\FO
M7J5INI4=VSGE)R=V%%%%9$A1110`4444`%%%%`!1110`4444`<'\(/\`DH/Q
M4_[&B#_TRZ711\(/^2@_%3_L:(/_`$RZ710`?"#_`)*#\5/^QH@_],NEU#^U
M#X?USQ;\(;G2O#>MP:'K5_>6B0F34Y-+.H(MQ')-9)=1!I;=YX$EB$T2M)'O
MWJ"5J;X0?\E!^*G_`&-$'_IETNM/XV_!O0/VA/A)XC\$^*+&WU'0?%&GS:=>
M0S6\4XV2H4+!)4>,LN<KN5@"!D'I0!R'[&4&CZ!\&5\,Z+9>)-*M/!5]-H!T
M[6]8;6;C33`%VPK>-)*\\01D*-)(SA6"MM92B_&_[/VG?$O]@SX.^,M"\86?
MB[Q?^T%X7^#6J>(K+5(_B[XF\;:'XIGL8H5:62UU18[;3[NXO/+,<:0-^[\\
M)(565:_0KP)X!T+X6^#].\.^&-%TGPYX?T>%;:PTS2[..SL[*(=(XHHP$11V
M50`*QOA5^SWX`^!-OK$/@?P/X/\`!L/B&[:_U1-#T:VTY=2N&&&FG$**)9".
MKODGUH`\@_8RN=3\._'#XA>%+?6/$/B3P99^'_#GB"PU76-=N-8F?4M0_M%K
MZ%))Y'=(Q'!93+$I$2"[Q&J(`H^CJY_X:?"7PI\%_#LFC^#O#'A[PGI$MS+>
MO9:-IT-A;//*V^64QQ*JEW8EF;&6/))-=!0!Y/I_BS4/$_[4?AM;[PQKOAQ;
M7PQK0C;4);.07>;O2<E/L\\I`&!G>%^\,9YQZQ7!^(?^3GO!_P#V*^N?^E>C
MUWE`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`44
M44`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!111
M0`4444`%%%%`!1110`4444`%%%%`!1110!P?P@_Y*#\5/^QH@_\`3+I=%'P@
M_P"2@_%3_L:(/_3+I=%`!\(/^2@_%3_L:(/_`$RZ77>5P?P@_P"2@_%3_L:(
M/_3+I==Y0`4444`%%%%`'!^(?^3GO!__`&*^N?\`I7H]=Y7!^(?^3GO!_P#V
M*^N?^E>CUWE`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`
M!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%
M%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110!P?P@_Y*#\5/^QH@_\`
M3+I=%'P@_P"2@_%3_L:(/_3+I=%`!\(/^2@_%3_L:(/_`$RZ77>5P?P@_P"2
M@_%3_L:(/_3+I==Y0`45SOQ?^(:_"3X4^)?%3Z;J&L)X<TRXU,V-BF^YO!#$
MTGEQCN[;<#W-<U^S%\3?%7Q7^'TFK>*;'P1#)<74LFG7?A'Q"VN:3?V+.S6[
MI.T,+&01%%D^387!9"58!0#T>BBB@#@_$/\`R<]X/_[%?7/_`$KT>N\KQ#Q'
M^T=\/%_:/\+W1\>>#!:V?AW6K:>;^V[;RX97NM**1LV_"LPCD(4\D1MC[IQV
M?_#5'PP_Z*/X"_\`"@M/_CE`'>45P?\`PU1\,/\`HH_@+_PH+3_XY1_PU1\,
M/^BC^`O_``H+3_XY0!WE%<'_`,-4?##_`**/X"_\*"T_^.4?\-4?##_HH_@+
M_P`*"T_^.4`=Y17!_P##5'PP_P"BC^`O_"@M/_CE'_#5'PP_Z*/X"_\`"@M/
M_CE`'>45P?\`PU1\,/\`HH_@+_PH+3_XY1_PU1\,/^BC^`O_``H+3_XY0!WE
M%<'_`,-4?##_`**/X"_\*"T_^.5A_#_]L?P!XET&XN=3\<^!=-N8M2O[5(FU
MRV0O##>30PRX9\XDBCCD!Z$."."*`/6**X/_`(:H^&'_`$4?P%_X4%I_\<H_
MX:H^&'_11_`7_A06G_QR@#O**X/_`(:H^&'_`$4?P%_X4%I_\<H_X:H^&'_1
M1_`7_A06G_QR@#O**X/_`(:H^&'_`$4?P%_X4%I_\<H_X:H^&'_11_`7_A06
MG_QR@#O**X/_`(:H^&'_`$4?P%_X4%I_\<H_X:H^&'_11_`7_A06G_QR@#O*
M*X/_`(:H^&'_`$4?P%_X4%I_\<K#^('[8_@#PUH-O<Z9XY\"ZE<RZE86KQ+K
MELY2&:\AAFEPKYQ'%))(3T`0D\`T`>L45P?_``U1\,/^BC^`O_"@M/\`XY1_
MPU1\,/\`HH_@+_PH+3_XY0!WE%<'_P`-4?##_HH_@+_PH+3_`..4?\-4?##_
M`**/X"_\*"T_^.4`=Y17!_\`#5'PP_Z*/X"_\*"T_P#CE'_#5'PP_P"BC^`O
M_"@M/_CE`'>45P?_``U1\,/^BC^`O_"@M/\`XY1_PU1\,/\`HH_@+_PH+3_X
MY0!WE%<'_P`-4?##_HH_@+_PH+3_`..4?\-4?##_`**/X"_\*"T_^.4`=Y17
MD]A^V/X`N?B1JVE2^.?`L>E66FV5U;WIURV"W$TLMVLL08OM)C6&%B!R/.&>
M"M;G_#5'PP_Z*/X"_P#"@M/_`(Y0!WE%<'_PU1\,/^BC^`O_``H+3_XY1_PU
M1\,/^BC^`O\`PH+3_P".4`=Y17!_\-4?##_HH_@+_P`*"T_^.4?\-4?##_HH
M_@+_`,*"T_\`CE`'>45P?_#5'PP_Z*/X"_\`"@M/_CE'_#5'PP_Z*/X"_P#"
M@M/_`(Y0!WE%<'_PU1\,/^BC^`O_``H+3_XY1_PU1\,/^BC^`O\`PH+3_P".
M4`=Y17!_\-4?##_HH_@+_P`*"T_^.5A_#/\`;'\`>*_AOX?U75O'/@72M5U/
M3;:ZO;)]<MHVLYI(E:2(JS[E*L2N&Y&.>:`/6**X/_AJCX8?]%'\!?\`A06G
M_P`<H_X:H^&'_11_`7_A06G_`,<H`[RBN#_X:H^&'_11_`7_`(4%I_\`'*/^
M&J/AA_T4?P%_X4%I_P#'*`.\HK@_^&J/AA_T4?P%_P"%!:?_`!RC_AJCX8?]
M%'\!?^%!:?\`QR@#O**X/_AJCX8?]%'\!?\`A06G_P`<H_X:H^&'_11_`7_A
M06G_`,<H`[RBN#_X:H^&'_11_`7_`(4%I_\`'*IR?M.^%->\<^$M#\,^)O"O
MB.ZU_4I;6YAL-4ANIK:!+&ZN/-"QN2!YD$:$D8_>>I%`'I%%%%`!1110!P?P
M@_Y*#\5/^QH@_P#3+I=%'P@_Y*#\5/\`L:(/_3+I=%`!\(/^2@_%3_L:(/\`
MTRZ77>5P?P@_Y*#\5/\`L:(/_3+I==Y0!G^*].U#5O#MW;Z5J(TC494Q;WAM
MUN%@?.03&Q`=>Q&02"<$'!'E_P"R!\'?%'P_\+W_`(C\>3^'/^$]\;I:WVOV
MOA[11H^EVEPD6W:L'VFZ9YP&V23M<2>;Y28VJJJ/8*\6_:K_`&O]3_99`NS\
M'?B=X[T%8;=I=8\.7?A]+:&XGN/L\=IY=_JEK</.TAB`$<+JWGQA69MRJ`=S
M\%/V>_`'[-?A6XT+X<^!O!_@#1+N[:_GT_PWHUMI5I-<,B(TS10(B-(4CC4N
M1DB-1G"C'85Q_CCXMQ^#O'VB:$FGW-_)J%C?:M>O!'-*]E9VJ(&=8XHW:65Y
MIH$2$;6<-(R[C&4-#]GC]HO1OVD/AQJ'B?2K'5]'LM+UW6/#UU#JT<4,\-SI
M>HW&GW)(21U"&:UD*G=DH5)"G*@`[^BO!/&O[>NG_"[X-Z=X_P#$7@CQE!X/
MFT_^W=5UFTB@-EX:TIVE,-Y=_:9()B3"B/)#;13RPF0!EVXD;IO&7[7&@^"O
MC+:^$)](\07,#7MKI-_KT"6W]E:-J%V$-G97!>99S+.)(]IBAD1?,0.Z%T#`
M'JM%>5:#^UQH/B#XX+X*CTCQ!##<W5UIFG^()4MAI.J:C:H[W=A#B8W'G0I'
M(6+P)&?+<)(Y1PI\"/VM]#^/^KVT.F:-K^FZ=KFE#7_#.J7QM#9^+]+(@S?V
M1@GED\D&YMP1.D,G[Y&"%65B`>JT444`%%%<W\4OB=:_"OP[%>S6.I:O>7MP
MMEI^F:=&DE[J=PP9EAB#LB;MJ.Q9W1$1'9F55)`!TE%>?:_\<;W0/@A:^*KS
MPAK>BZYJ,EO9VWAK5I[<7J7MQ<);0V\TEF]U"H,CJ6DB>543<_(4U0O/VH(M
M"_:#TCX?:UX)\;:))XFDN(="UR:.RN=*UB2""2XE53;7,MQ;A8HB=]U#"A+Q
MH&,CJA`/4**\J^"W[7&@_&_QU<Z'8:1X@TL2V3ZMHE_J"6RVOBC3TD2*2]L_
M*FDD$2RR1J1.D+_.C!"CJQIZ_P#M9W&B^$=3UVR^'WC+Q5I]GJE_9PC0EMFD
M:TLI5@N;V0WDMM$BK-YVR-))))HXO,B63)50#V&BO#O%7_!0'P1HGA'PMXCT
MNUUWQ3X9\2:#:>+)]6TJ.W%MH6B72Y@U.[\^:)_(?D`0K+*`KL8PB,R]9J7[
M3&B:5^T_H7PHETSQ"-=\0:)J>NVM\UD(]-,5A)IR3QB5V#.__$TMB#&CQ\2*
M75T*T`>BT5Y5H/[7&@^(/C@O@J/2/$$,-S=76F:?X@E2V&DZIJ-JCO=V$.)C
M<>="D<A8O`D9\MPDCE'"^JT`%%%%`!17`Z[\=VLOBK;>%=(\'^+/%+17$5OK
M.J:9]B33_#AE3>AN6N+F*1R4*,4MHYY%62-F558$R^)?C'=:7\0=7T'2?#.I
M^)9]"T2+5KN.QGABN'DGG>.WMHOM#1P,[+#<NQ>=/+"1Y!\U2`#N:*\1T+]N
M?1]?^%^HZW'X-\=P>(]-U\^$V\'SV]E'K%SJX@2X-E#*;G[!*1$^XS)=FW79
M(#*&C<+T+?M.Z9K/[/\`:>.]#L+N_;5+B/3+'2[D^3.=1>\%E]DF,8E\LQW.
M4E90XC$<C?,JDT`>FT5Y3+^UIIFE?'S1?`6L>&/%WA^3Q5=76G^'=:U""VCT
M[Q!>6L,\]Q;0*L[72LD%M-*'F@CCD1-T;R"H/A;^V7X=^*OB74]/M]&\4:=!
M!IDNN:/>W%K%-%XJTV)UCEO+".WEEG=%D=$V2Q12L9$*QLKHS`'KM%>9_!G]
MJ71OCC\(]3\8:5HOBF"VTKQ!JOAJ73Y[%9-0:\T[4Y],F`CA>0;&N+=RKE@!
M&0\GE@-MU_V;?COI'[4?[/G@CXD^'[;4K/0O'NAV>OZ?!J$:1W<,%S"DT:RJ
MCNBR!7`8*[`'."1S0!VM%%%`!1537]>L_"VA7NJ:C<Q66GZ;`]U=7$K;8X(D
M4L[L>P"@DGT%<K\)OC!>?$VSU2[OO!/B_P`%6%BR-:7/B`642ZM`R;O/B2"Y
MEEB4="ERD,JGK&.M`':T5X3XT_;A'PU^"VC?$+6?ASXYN/"&IVAU.[U/2%M+
MI=%LG=C;RSVTLT-\\LD1A8P6UM/(KS!`'*EJZ'QE^UQH/@KXRVOA"?2/$%S`
MU[:Z3?Z]`EM_96C:A=A#9V5P7F6<RSB2/:8H9$7S$#NA=`P!ZK17!>+OC@_A
MOQ[JFB6?A[5]?.B:1;ZC=C3D,EPTUU<F"UMHD8+&Q?RIW=WE1851&?"/O7C-
M!_;NT#Q'\--5U>V\+^+SXIT;Q!_PB-UX*(L/[=36OLT=V-/WBZ-B9#;2I-YG
MVKR=C;C*`#@`]PHKQ7QA^W;X1\&_!7POX[ETOQ7>:3XHUS3_``\L5K8(\VF7
M=WJ]OH^RZ8R"&,PWMRB2*)&<A)3&LFQL:G[3'[6FF?LKZ//K7B#PQXNO?"FD
M6HU#7_$-A!;?V=X;L_GS<W!FGCDD5?+.Y+5)Y$!5F158,0#U:BBB@`HHKB_C
M)\9U^$]I9PV7AOQ%XT\0:H)6L-!T(6HOKU8@#*X:ZG@MXT3<@+RS(NZ1%R6=
M00#M**X[Q;\6)?#EOX-B31KLZMXRU&"QBT^YD$<ED#"]Q<-,T0E0&&"*4\$H
M\@2,./,5JY'1OVQ]+B^)/B#POXK\)^,O`%[H&AW/B;[3K4=G/97NEVSQI-=)
M-97-RL85I`!'<>5,X21DC949@`>OT5YO\"_VF-.^-[Z[;R:#XB\'ZIX?6&YN
M=.U\6J7)L[@2-;7H^SSS((9EBD*AF61=C+(D;J5'&>-?V]=/^%WP;T[Q_P"(
MO!'C*#P?-I_]NZKK-I%`;+PUI3M*8;R[^TR03$F%$>2&VBGEA,@#+MQ(P![W
M17E7C+]KC0?!7QEM?"$^D>(+F!KVUTF_UZ!+;^RM&U"["&SLK@O,LYEG$D>T
MQ0R(OF('="Z!M#P3^TQHGCO]HOQ=\,[73/$-IKG@[1M/UVYN;VR%O:7=O>W6
MH6L?D%F\QB)=,N<LT:HRF-D:16R`#T6BO+_A[^U!%XQ^.%]\/=6\$^-O!OB&
MWTV76;,ZM'93VFJ6,<L4+SQS65S<)'^\F51'<&&5]LC+&RHS#U"@`HHHH`**
MX'0?CNWBOXK2^'M*\'^+-0T:TDN+6Z\5Q_8DT6VNH>'MB'N5NI'#;DWQ6[Q*
MZ.C2*RD54U[X^:G:7GC--!\!^(_&J^#[FWT_[-HUU90WFH73VXN)4C%]-;6^
MR..6V&_[0<O(Z$*8F)`/2:*\.?\`;T\.:A\(O#GBO0_"_CCQ)/XG:^^RZ#9V
M5O;ZJD5C.T-].RW,\,1B@9<EDE;S0R&#SO,CW=OJ?QWTZY\/^`M1\/QIKT/Q
M%N[5-)=)&2-[66!KI[DL$;"I:QR.-P`=_+CW*9`0`=U17C7AW]MOPY=?$'5_
M#?B30O%7@&]T_P`/W/BVT?Q#!;1)JVCVS0K<WT20SRRQ)$]Q"KQW*0S*7'[O
M'-:'PK_:QT[XGZ;X@9_"OC30-7\._99)=%O[2";4;BVNV86=U&EK-,HAGV.0
M7=&C"/YRP['V@'JM%>4>`?VP?#?Q)_9%\*?&33-.U]M!\:Z%9:YI&EO!$-6N
MA>1))!;>6)#$)VWJI'F^6IR2X12XZ?\`9Z^->E?M*?`+P/\`$;0K?4+31/'_
M`(?L/$FGP7\:1W<-O>6T=Q$DJHSHL@210P5V`(.&(Y(!3^$'_)0?BI_V-$'_
M`*9=+HH^$'_)0?BI_P!C1!_Z9=+HH`/A!_R4'XJ?]C1!_P"F72Z[RN#^$'_)
M0?BI_P!C1!_Z9=+KO*`"O-/C/\(=:^+'Q;^&LS75G#X)\(ZA<>(-6MO.(N-2
MOXHA'IT)C,3*UNCS37+-YD;K-9VF`ZM)M]+HH`\J\):=XBO_`!7\3?&MIHT,
MNNRC^P?#-CJ]S-IMO=P6*2&,RR"*5H(Y[Z:ZS/'#(6@$#A)`J+7A/P%^"/QG
M^&_[/7C#X<^.?#/@JQ/Q*\<ZS?0WWA'Q/J&L&ULM=UF_U/45G:73K/[*;:TN
M)(8IP[>;-Y9Q"653]ET4`?,G[:OPK^.?Q-^(_@S2_`>@?"[6?A'HL:ZAKFCZ
MUXOO?#U[KM_%+FVMG:'2;Y!I\6Q)61"CSR>6C%(8Y([E/'?[$FL^*OC]XCGC
M3P^_@'QQXU\/_$?6;J74;A-6MM6T2/34M;>&V6$Q/#(=)LF:0W"%-CKY4GF9
M7Z<HH`^8_AA^Q)K/A+XY:1-?)X?'@?P1XX\0_$;P]=0:C<2:K<ZGK:ZDMU#<
M6YA6***+^UKTJZSRE]Z#RXO+RTO[*O[$]U\*_CW=^/M8TC2?#;:7I%[X<\.Z
M+I7B_5_$-E86=U<VLMP\8O5BBLTD&G6&VSM8%B@,4FUW\PFOI>B@`HHHH`*\
M3_;A_9<3]IWPCX18:!X6\877@77I-?MO#?B><P:'XA,NE:AI<EI>N+:Y*PF'
M4I7X@D^>-`59=P/ME%`'SO\``G]G[5_AOJ'P\\$:@]Q?:-X`74_%$ERL;I90
M7=Y=726.FVS;522VL[>YNXEC(W1I!9,0&*FFVG[*^M:G^W>GQ17PE\._`D&G
MO*M[KWA^^-QK_P`1;=['[+%;:NC6$(CCMV$4D>+FX8&WC"M&F]7^BJ*`/CKX
M0?LD>,OV5O!NBWT&G:'?:E\'?`<_PP^&ZZ7=7>H2ZC:7=QI_EW6H1M!&+<J]
MA8B15,ZK'%-*95#%%ZG]K7X`_%Z7X$>!?AI\%H?!<_A2UC33O%[^(?%-YHFI
MZAID,2(+2UN8=/OMKW1W">X=/,6/>(R)91/!ZKX<_:S\`>+/CKJ7PXL/$%K/
MXJTN+?+;C_5R.,^9#&_W7EC`!=!RH)ZE7"^CUK6H5*32J1:NDU=6T>S]#.E6
MA43=-IV=M.ZZ'R9\>?V&/$OQJ;5HH](\%:3IWQ;^&]A\-?'UDFMW;1^'["W:
M^D_XEC+:)]LQ_:5Y"OF"S)4QR?*5\H[7Q:^%?QKU_P#X*'>`/B%H?A7X6W7@
M#P3H>K^&FGOO&U_:ZQ>0:M/HL]Q="T32984DMVTN14A^TD3B5&,L&"M=G^TE
M^V=9_LY_%#P?X03P)XZ\<:QXOTK5M=`\/#31'I6GZ9)8I=W-P;R\MB0IU&WP
MD`EE8!\(2`##\./V[?"WQI\8V5CX(T7Q7XQT&XL]-O+KQ+IEM`VEZ:NHV\%U
M8B17F6Z<2V]S%+YD$$L4:$F5X\&LC0X_X8?L2:SX2^.6D37R>'QX'\$>./$/
MQ&\/74&HW$FJW.IZVNI+=0W%N85BBBB_M:]*NL\I?>@\N+R\M].5\M:1_P`%
M1K7_`(1KXVZQXA^"WQB\&Z9^S_I-YJ?BN?5)/#LX26WTNWU7[%`MGJT[2W$E
ME=0R(<"'DJ\J."M?4&GWJ:C807$88)<1K(H;@@$9&?>@"6BBB@#Y0\;?\$])
M]8_:\U/QWING>%+<^(?%VF>-;CQ?)/CQ/HCV=KI-G-I%FGV1E^PWMOI,:SL;
ME&Q-*NQ\HT?HGA;P-JOC+X!^/M3O/!VA>(M;^)\MY=3>&?%DLMEIU]9O$+2U
ML;T-;W#0QO8Q0B:,V\@$DDV8R6;/M=%`'R%X0_8.\6?#WX/>%YM%T_P19>)_
M`OCZ3Q_X8\&6^JS6OA7PZ)=+N--DT>VNX[$2I:B.\NY5D-F=LDYVPJ@5%[7X
M&_LZ7GPQUWP1X0FMY)=,\*W.M>/=5O(EF6SN-<U>_O)O)A=^)8T>^U)RAY3_
M`$1]JDICZ(HH`^9_`/PS^.^I_MWZKXR\>Z)\,;[X>637.F>$'T[QC>F^\.Z>
MT9)N'T]])6.>_NI4B$KF]6."':D08K*]UE_LO_L6^+OV=8?#MQ_9_@^^N_@Q
MX`O/AW\/(4UV[1-:LI7L9E?49#:'[&S-IME$WE1W94+)("Q;RJ^K**`/E?\`
M8\^&G[0'[.OP,\>Z7JW@GX.WOB34/%VM>*]"M[3XA:D;&[.L:[>:E<6]S.VB
M![<6T=WL22.&?SVC^98`<CK_`/@FC\&?B#^S9^Q9\/\`X:_$?3O!MGK'PZT.
MP\-6]SX;UVYU6VU2"TM(81=.9[.U:"1W5_W(60*`I\UB2%]YHH`***XK]HCX
M[Z/^S/\`!W6?&^OV^HW6DZ((?/BL(TDN'\V>.%0JNR*?GD7.6'&:F<U&+E+1
M(VP]"I6JQHTE>4FDEW;=DOFQO[37P2M/VF/V;OB%\-[^\N=/L?B#X:U'PW<7
M5OM,UM'>6LENTB;@1N59"1D$9`X-?/GA+]E#Q'\-O#GC>SB\->&/!Q^,EY8>
M'[OP[X(EFFT72X!+>/J6LM.+6V>*]N[2:3?(R\30VJ>9(Y\QT^&?_!:+X6_%
M3XC^'_"]AH'C^VO_`!'J-OI=M+<V-HL*2SRK&A<K<LP7<PR0I(':OKNLJ&)I
M5DW2E>QVYGDV-R^488VFX.6JOU1\Y?MS_LGZM^TXWAC2M$\'_#B&72(I1IOC
MZ_O3%XF^'DS-$?M&C0?V?,C2,(8PV;FW4[%#K*H*&AX[_8DUGQ5\?O$<\:>'
MW\`^./&OA_XCZS=2ZC<)JUMJVB1Z:EK;PVRPF)X9#I-DS2&X0IL=?*D\S*^P
M?'']H"Q^"0T:S70_$?BSQ)XEEF@T;0-"MXI;[4GAA::3YYI(K>"-47!EN9HH
M@[QH7WR(K/L?VC/"47AO5-0U[5K'P;/X=TK^V]>L/$%Y;V5WX?L?,N(OM5V#
M(5BMR]I<A9]QAD$$C([*I-;GF'GL>D?%%_V;O'WBCX=Z9X9MOB[X]NYM3T:V
M\9S7=EIM@I\NULOM:QQ23Q^58PQ2O`J#=/YBDQF1I%\_\%?LC_$VT^`?@2;5
M="\$#XJ?#'QM)XSLO-\;W>HV?BV[FT^[L[FZO[]=(MFMYIEU&\^2&QDBB"0[
M%VXCC^@M>_:>^&OA7Q'KFC:I\0_`VFZOX8L[G4=8L;K7K6&YTFVM[>"YN)[B
M-G#0Q1075M*[N`J1W$3L0LBDMO\`]J/X9:7X-M_$=U\1?`EMX>NM5;0X=4EU
M^T2RFU!9F@:S68R;&N!,K1F('>'4KC((H`^</CQ^QA\4K+]C_P`+_#/X:Z1\
M.-8O)/&]OX_\0WGB#Q3?:/#;WL?BNW\32P6JQ:=>--'/<"YAWN8O)4QL$DR8
MUZ#]JSX>_M'?&;Q'\/;?2/"WP?N_`NGVD.K>+_#UYX_U#3I-6UA'#Q68NDT2
MX\W387592?+@EN7$8=8HDDBN/?/%W[07@+X?^,(/#NO>-_"&B>(+H6S0Z9?Z
MQ;VUY*+EYH[<K$[AR)7MYU3`^=H)`N2C`<5\#/V]_A9^T5^T!\2OA?X6\7:'
M?^-_A9J;:;J^EIJEG+=2[+>TDGN(88Y6E,$,UXMI*[HGEW4,T1&5!(!['17S
M[^QW_P`%%O#'[8=CX=EM_"GC3P%/XR\,+XU\.6OBC^S1-KNBDVZF^B^Q7ERJ
M(K75NK),8Y5,JY0`YKU?PC\>/`WC_P`!WWBK0?&?A/6_"^ER3Q7FL6&KV]S8
M6CP$B=9)T<QH8R"'#,"I!SB@#JZ^=OVVOV,T_:/\=^#_`!3'X4\">.[OPUI6
MJ>'SHGC&8QZ4(-1NM+N'OEVVMR6NK:32H'B3:@8L_P"\C;;(OINJ_M4?##0O
MA?I/CB^^(_@*R\%Z\KOIFOS^(+2/2]15()KES#<F012!8+>>4E6.(X)&^ZC$
M1_&C]HG3/@]8Z$D&C^(/&6N>*Y9(="T3P]#%/=ZJT<#SN5DFDBMH8Q&G,UQ-
M%"&>-2X:1%8`Y/X`?"?5_"_C31-/UJ^UK7;?X4>#['PG9:WJBNEQK][)#`]]
M?/P$E+);V8$JCB1[M`1\PKRY/^">-Y\3->^-;:WX7^'_`,*]"^+OA;6_"FKZ
M7X(OVO(_%<NHL<Z[J+-86;+J"H\R87S21<2%YI,)L^@;[]I;P9X4T_06\7Z[
MI7P_U/Q(62QTGQ-J-KIU_/(MS!:LB(TA$I%Q<VT0:)G5FN8`K-YL>[9T_P",
M7A'5OB5?>"[3Q5X;NO&.F6J7UYH46I0OJ=I;NQ5)I+<-YB1L00&90"00#0!\
M[I^SSXW6V\6:MXHT[2(/&OQ>M-#^'NH+X:OKR^LK#0[%[]Y+MKAX8&AE>"^U
M!A^[`CEDMXA+*=KG0_;5^%?QS^)OQ'\&:7X#T#X7:S\(]%C74-<T?6O%][X>
MO==OXI<VUL[0Z3?(-/BV)*R(4>>3RT8I#')'<^T/^T?\.XO#%IK;>/?!:Z+?
M^'[CQ9;7YUNV%K<:-;K$T^II)OVM9Q+/`7N`3&@FC)8;USK^!?B?X:^*%M?3
M>&?$6A>(H=+NWL+R33+^*[6TN$`+PR&-B$D4$91L$9&1S0!\_P#CO]B36?%7
MQ^\1SQIX??P#XX\:^'_B/K-U+J-PFK6VK:)'IJ6MO#;+"8GAD.DV3-(;A"FQ
MU\J3S,J_X?\`PK^->F?\%'?&'Q'U;PK\+;?X?>)_#>F>$4FM/&U_<:S!;:9>
MZS=07AM&TF.$RS_VG&CP?:=L/E,1-/D"OIFB@#YU_9O_`&5]:^'W[47C#XB7
M/A+X=_#*S\0P7=M>:-X+OC>0^+[J:[2X76]29K"S*WX`E3"^:2+B3?-)A-GT
M5110`4444`?(/@#]A.;]GCX]WGCZRT30;?3?#>M>)/&$NMZ+ON?%GC--5FU6
M^DT6[@6T7-I;W.HM)`L=Q*SR00?(C!S)Z%XE^`FKZW^QI_PBNH_#GX:_%+7/
M$<JZKXB\->-]1>#0+V\N+K[;<[Y#97Q98;ALPJ;=@!%$`4"J1[Y10!\G:9^Q
M'X[^%OA;X5ZCX:U+P[XF\9^`-(U_PRPUW49[.RMM,UF[M;AXX)(K:5I!9"RM
M(H4DC4RQP!7EC9FDKO?V:?@%%\(]?\->%[.UOD\*?!+P5IW@?P[/<I+']M;R
M(/M$P#$B15AMK!%D!8JYNDW9W@^Z44`?&G@/]DWXT_';2_C=I7Q_TGX:11_%
M[PQJ?A>+5?"WC&^U%M$TV='@M],M[*;2K4)&L4\TLURUS)++<<A$B,45OZ%\
M,_@Y\4/AW<^.?B/+X>^'FJ?%CQ)I.B^&X-(7Q3>VNB3V.ESW;12R7W]GR2Q2
M.-1O)2BV;A6\N+S'`\X?1-%`'Q9^SA_P3Z^*=E^QQ\'O`7C'Q[<_"[Q1\$]!
M7PYIUW\.]4T_7;+7T73X+07MP-9T-C;S82=%2!"4CN)09I/,VI[G_P`$^_V>
MM>_9,_8?^$_PS\4:^?$WB#P)X5T_1+Z^7RC"98+=(S%`4@@W6\6WRHFDC$K1
M1QF4O(7=O8**`.#^$'_)0?BI_P!C1!_Z9=+HH^$'_)0?BI_V-$'_`*9=+HH`
M/A!_R4'XJ?\`8T0?^F72Z[RN#^$'_)0?BI_V-$'_`*9=+KO*`"BBB@`HHHH`
M****`"BBB@`HHHH`****`//_`-IC]G#1?VJ?AA)X3U^_US3]-EN8[EI-+N5@
MF8IG"G<KJR'/*LI&0#P0"/G#_AQC\)?^AB^(O_@?9?\`R+7V?17J8/.L=A8>
MRP]5QCO9'!B<KPF(G[2M34GW9^<7AG_@B'=R_'G4K+6-?G7X;V\?G6E];/$N
MI79;<!`5*E4=,`LY0JP*[1DL$]._X<8_"7_H8OB+_P"!]E_\BU]GT5WUN+,T
MJ-/VK5DEII\_5]3BI<.9?!->S3N[ZZ_+T/E'QA_P3$TKQ/\`&+X)R2ZOXAN_
M`7PI\+>)=&GB_P"$JU+3=5U&?4;S1YX%E>R:$7-H$L;I98)6\HAH%\IP/DZ/
MXK_LI>)?%?Q_\%ZMX8M?"7@S2/"E_I]S_P`)'I%_<V>MRZ=:[5;0Y[-83;WE
MG.C7*[Y9P(!(C1P><B3K]%T5\_4J2J3<YN[;N_5GLPA&$5"*LEHCY7^+?[#O
MBSQ[\'OVU/#UGJ/AV*]_:.AO(_#3S3S+%8F;PAIVB+]L(B)C`N;21SY0E_=,
MAY8E!]/Z+9OIVCVEO(59[>%(V*\@D*`<>U6:*@L****`"BBB@`HHHH`****`
M"BBB@#SO]J']F?0_VL_A7+X0\0ZAKNG:9+<QW32:3=+;S,R9PK%D=60YY5E(
MR`>"`1\9_M$?\$-/#'AGX/:Q??#:[\;^(/&MN8#IUAJ&IV*6UQF>,2[B88@,
M0F1A^\7E1UZ']$**X\3@*%>[J1UM:_4^BR;BO,\L4882JU!2YN7[+>ET^MG:
MSLUH?C;\./\`@D)\:-9^(>@6GBCP5=:9X:N=2MHM6N[?6]-::UM#*HFD0"9R
M66/<0`C<@?*>E?7"?\$&OA#$ZLOB7XE*RG((U"R!!]?^/2OMJBN6ADF%IIIK
MF]?^!8]S,O$K/,7*,H5%2MTA=)^MW(\.^*W[-NMZ-XG^&OC/X?)I.L^+?A;H
MFH>'+*T\3:K<6L&K:?>QVGG1RW<44[Q3&;3K)_.,$IPD@V_.2/'?VR?V%_BU
M^T)X;^,,VC7'PZC\0?&WX2_\*XU);W4KRWL]!D@FUB6UEA*6TCW*L-7:*1V$
M)!A$BQG<81]IT5ZJ5E9'P<YN3<I:MGRA\5_V#/$GCCX7?MLZ58W/A>#6/VE;
M6YM?#UU+)*HM5?PC8Z+$M\ZQ%D5;JWN),1B7$<H8?,S(+'[;W["&H?'S1/`;
MZ':MJEMX+T34/#\OA%/B'K7@+2-6MKU;)&:6[TB-YB(4LRB0O$\3)<2AE!VL
MOU/13)/C_P#:H_X)\^*_C9<_'N\T"Y\*Z5>_$OX':=\-/#DES>7#2Z3J-O/K
MDK223"%G6WW:C9D2)ND+0,3&"J%O6?@;\#_%7PC_`&I_C3KTX\/WW@SXIZM8
M^)K:Z2]F35+"]ATC3=*>S>V,)B>$IIPF%P+@-NF,9A`3S&]GHH`^0_V4?^"6
MEG\"/^"<T'PFO-;UFS\?:O\`#8>"-8\3VGB34M5?3)GT\6TKZ6]ZY:TMTE_>
MQ0PI#&I52(E/%0^&_P#@GIK>H_LG>/O`5W;W/@G6O$NO:;JPU/3/BWXF\1WF
MMC3Y[*6/SM1ODCOM/6=+-;=XK:23RHG)24MS7V%10!\F>%OV$];?PA\`;:?P
M_P"&O#3?#+XFWGCS7-.F\<:MXT^T"72M:MA+%J6I6R7-Q<M=:C;S'SE0)MDV
MN2B!O1_VK_V;M5^*/BC0/&GA:.QNO%GAG1-:\.1V=YKM]H,5_I^JI;?:8DU&
MR5[BQG$ME9R)<Q1O)'Y3!0I<.OME%`'R7^S=^P=XV^&7Q4^"GB3Q?XEM?%LO
MPTT/QW87-SJ>LW^M:E;R:[K.G7MA!#=W@:>XCM+.UELS/,Z2,JQX3#LJ=)\/
M/V2?%_AOXTZ-+?ZG8GPAX0\:Z[X\L-3BU>:76==GU==31]-O8&MUCCL[5=2`
MB*3R%A968*1^3EOI"B@#\TOC5_P3J^*?PW_8KU[0TMO#_B#3OA?^S#XX^$F@
MVNASWE_KGB:XNK72_L,PMOLR*LDB:8Z-!&TA$CQA&D#GR_LC]FSX+>(_"7Q'
M\2^-/$RZ5IEUK^A:+X=MM&TF[DGL+>WTUKYTNBLD,1CN)OMY1T`<(EK`HD?;
MFO9:*`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@#@_A!_P`E!^*G_8T0
M?^F72Z*/A!_R4'XJ?]C1!_Z9=+HH`/A!_P`E!^*G_8T0?^F72Z[RN#^$'_)0
M?BI_V-$'_IETNN\H`****`"BBB@`HHHH`****`"BBB@`HHHH`**Y7XR?"#3?
MCAX+?0M5NM2M+-YDF+V4PBD)7.`=RL"O/0@]CU`->,ZM_P`$V/!5EI=S-;7W
MC"]N88F>*W6]M4:=P"0@9H0`2<#)(`SS7D8_%X^E.V&H*<;;N?*_2W*S.<II
M^ZK_`#/<=.^)VBZK\1=1\*P7:OK6EVL=W/#C[J.>.?4`H2.PD7UXWZ_/O1_V
M&/B-_:]H-0\*71T\3+]H$&J62S&/<-VTF0@-C."01GL:]\_X=G>`_P#H+>+O
M_`JW_P#C%>#EF?9QB8R;P5K/[4G#1[;PUMU:^Y&-.M4E]G]/T/5O&'[07@_P
M#\8_!WP_UC6H['Q=X_MM0N]`L'@E;^T([$0&Z(D"F-"@NH/E=E9M_P`H;:V.
M?UO]M/X9>&_@C=_$>^\3+;^"[#7+CPY<:D;"Z(AOK?4Y-*GC,8C\P+'>12HT
MNWRU2-I2WE`R5XY\=?V&-:\7?'[X3CP[+?P:#X(\!>+--@\1W-U%+<:-K%SJ
M/AV\TR0H2KR#?I]PQ"(4V0F-]H=0WD_@#]ASX^^//@?X`\&:O;_#[P+%8:]X
M]\7^)/[;M9_$^GSW6M:QJOV.Q2UM+^S,R"PU6[D:264HC^1B-I!NB^QI2DX)
MS5G;57O9]5?KZG2GIJ?9OQ1_:C\$?!OQA8Z!K^JWD6K7MO\`;6@L]*O-0^P6
MN7'VN[:WBD6SMLQNOVBX,<6Y"N_/%84O[='PSM_CEKOP[EU?6X/$/AB^M=+U
M6XE\,ZI'HMA>7,%M<6]K)JIMQ8">2*\M2L7VC>3.BA=QQ7SS<?!GXZ0_!'P&
M+/P[KUE\?-`T6/PH/B%:ZIIBZ==BQNY0+G6+$SXET^\CACN%B@6:YC_M"5%%
MI(K2AWQ!_9Z^)GCWQY^UE\.XO`GB33/#WQZUNRNM)\?Q:OI<6G:;9GPWHFEW
M$J(MRU^E[#)9W3Q#[)L+Q1GS5#!AH,^L_$WQW\)^#OC!X7\!:EJRVOBSQG;7
MEWHUD;>9A>):JC3_`+T*8D8*^X([*SJDA0,(Y"N+\7/VM_`7P-\1+I7B/5=0
M@NT@6[N_L6BWVI0Z1;MYFVYOI;:&2.RMSY,N)KEHXSY;?-Q7S)^TW^RW^T'X
M_P#CCXT^*GAB^\'60\+ZOHESX4\,RZ4U]K>OV6D!YGA@OY=1BL=->_>^U2V8
MO;2-Y,L1>52%$/H_B_PK\1/@M\4/C'?>'?AYK'Q+M?C#)!J.GR1ZQIUO;^'[
MB+1X-/-G=K=3Q.EHS6B2@VRW#&2[G)11\Q`/>/B%\7_#'PI\#?\`"2^(=;L-
M,T-I+>&*[=]RW,MQ(D5O%$%R99)9)(TC1`S2.ZJH)8`I\*?BYHGQH\+#5]"?
M4Q;K)Y,UOJ>E7>DWUI)L23RY[2[CBN('V2(VV2-6VNIQ@BOGW3?V?M:A_9(_
M9XMO#0\5:YJ7P(O=+F?3=:)TO4/$RV.FW.CSI<>>`K2$3O<QLQ$4DL$#B38R
MR4W]H+P5XN_:(N_!/B+Q/\%M1\2>$+*#4+6\^'&JW>BW-V+Z=]->PU>Z9[HV
MB&R:"_79;W$[@7*2Q[Y$6-0#ZIHKX&\0?\$\_'OB3X@7&I>+;-/'/B#2OA/\
M//#5KXL%W%9W%]KNEZOJTVJW<`$JR6TIAN8Y!(-IVW+HCD^8M<E\<OV=+WX-
M?$SP/X<O?AW9ZAX`U7]IFYU+PCX3LFL8[34-)F^'&HM=1Q0M(L,8EU(:H[17
M!C$CO(7PDH8@'Z345\6:E^R?XNL/AG\-K+Q3X$3XJ^$]%D\1K/\`#\II:Q:2
MU]J\-UH,C&YG2`IHUDDEIF%W?YQ+$KO&@+/$7[)WC`?%GX`RZ[X$'QA\8>!M
M!\.V6O>-/%$.DS^&+2XLYR;S4;*&6X:_LM9SYLZ36MJ8Y2UM'+*!$K0`'U+X
M*^/GA;X@>/;KPMIMY?+XCL="L/$MSIU[I=W8W%M87TUW#;2R+/&A1GDL;I3&
MV)$\KYE4,I;L:_+W]EK_`()8>,?A!IWAW4#\,/#GAKXI:M^SCH?@6Q\>P6FC
MWE]\._%MAIVJ6<]U/(9/.D:2"[L+=9;3SQ(ECY<I2)(RWU=_P3*_9YNOV</A
MCXITBYT3XD:`]]KKWK6_BI?"T,4TAAC62XL8?#R1VR02NI<F:*.XDD9WD7+9
MH`^E*H>*?$,?A30+G49K>]NH+0!Y4M83-,$R`S!!\S;1EB%!8A3M#'`/%_M/
M?LU:)^U?\+9/"/B&_P!=T[39;F.Z:32KI8)F9,X5MRNK(<\JRD9`/!`(^7/%
M/_!##X8:7H%S/IFI_$C5=04`06QU:P@61R0`6=K3Y4&=S$!F"@[59L*>_"T,
M+-)UJCB[[<M_QNC6G&#^)V^1]CWGQ,TB%]#2VN1J<OB,JVGI9$3FXAPI:X!!
MP(45E9I"<?,H&6=%;?KX%F_X(4^"M*ET)GUWQIJ\4@$&KBVO+2VDC=L8N(?,
MA8&-3G=&Q+E3N5BR^6_2I_P0C^$<;JR^)/B2K*<@C4+($'U_X]*Z9X7`*UJ[
M_P#`/_MBW3I?S?A_P3WKXH_MR?#3X,?&=/`/B/6-8LO$2Z7:ZU=-%X;U.ZTW
M2[*YFN8+>>\U"&W>SLTDEM+A%-Q-'DQ'U&?6Z^._%_\`P3JOOBK^V;XEEUW6
M/%</P;O/A3X8\&7>GK/IMS;>-WL[_7GN+/4#/!+>!8XKNU<O"]N)?M#JS2`,
MBW+']B?Q%=?$_P#:]\7:=8:;X5^(/Q*N6M/AYXRFC@O+G3(9/"6C6'VB(;F:
M%!J%FQDC(0R_9(BP9%B:O(:5]#!GUQ5&[\0V]EX@LM,>.^:YOXIIHGCLII+=
M5B*!A),JF*-CYB[5=E9\/M#;'V_'7[,7[(.O?"7]EKQEIFC>'_B3H_BO3?$T
M7BK1[+Q2WA2TCO[^V$,C"R705BM(;:\,4D4CSQ13N;F9Y`"V:3X@_L??%7Q/
MXV\)ZSH-P/#7BF_^%WQ%LM1\1&X@N1X:\2:]<Z'/8J$+;IT@:UG1&5601V2*
MQ7<@9"/M2BOA?7_V,_%GBCX0>.5\)_#U?AIHUUK7@O7=,\`E],2:[U'0O$G]
MK:GJ'G6L[VYFU**.WB5I9%8M;))-L:1PN=XU_9A\8^/?!'QJO/%'P=\7ZT?'
MWQ@MO%6B^&H+WP_J$%S9#PII6G>;J]K=W\=G<V0GMKB.6V\R202+%+$C>7'.
MH!]4_'O]L?P#^S1XO\-:!XMO?$$6K^+;>]O=.MM)\,:IK;&VLVMDNKF8V5O,
M+:")KRVWRSF.,>:#NP#CT70=>LO%.AV6IZ;=V]_IVI0)=6MS!()(KB)U#)(C
M#AE92""."#7R+X\_8L\<_%#XS?LW7"2/\*=!\#?#+7_#WBF+P`VF+IMA/=-X
M<":+;)>6TCBQ=;&[5)+>&*2-+6/$D)95;'_:4_8,U27]HOX2WF@V'Q`N/AA\
M.],T+1_#.A>";;PK$?"-S8W4YDO)9]83[5%;26C6ENPTR5)S%;R(5D$@"@'V
M[17QUK_[)?BR;_@J+;?$[63\1]>T@WJ2>';O0X/"T&C^&+`:5%;3V&H37*+K
M;QS7:SW'EV<CPLTL)>-3$6;O?^">W[*H_9ZT'XA:OK?A73M'\:>,?B#XMU6?
M4`89[R^TNY\2:G>Z<K3(S$0_9[I95AW`1M<2DHLCR9`/1?!'[5?@3XD_$.[\
M,Z#J]WJE_9SSV;W<&E7C:5)<P/+'<6L>H>5]CEN87@F62".9I8S&V]5Q7H=?
M&/[.GP1^._P/^)GP2\#V.I>,X?AU\-K*71O%MW>W.@7>A>,K*.RU%+6]1S&=
M9759+I].EG#&*VPDNTR$LTG-_`O]@35?@C_P3-^!'@ZY^&5CJNI>'[+2KKXK
M^!K9-+N;GQ\T6@S6$MC//<S+:7#1W+64@,L_E-%IZ0AA'M``/O*BOC30_P!F
M7XE?"[QA\(_%?]AS>+'\,:)XY\.R:/87-G:R:#::[JVGWNEV^Z69(VM["UL(
M[-VC+NP1'1'Y%?-7PP_9-\9)JMA\*[CP4!\4_#O[+'PU\.6FJF:PNA\.=?AE
M\2VZ:I\\P20VLZ,PDMFD<F/:@9)&-`'ZP4444`%%%%`!1110`4444`%%%%`!
M1110`4444`<'\(/^2@_%3_L:(/\`TRZ711\(/^2@_%3_`+&B#_TRZ710`?"#
M_DH/Q4_[&B#_`-,NEUWE>>2?#3QCH7C3Q-J7AWQ/X9LK+Q+?QZC);:CX=GO9
M8)%L[:U($D=[""I6V5L%,@L>3Q4__"/?$_\`Z'#P%_X2%W_\LZ`.\HK@_P#A
M'OB?_P!#AX"_\)"[_P#EG1_PCWQ/_P"AP\!?^$A=_P#RSH`[RBN#_P"$>^)_
M_0X>`O\`PD+O_P"6='_"/?$__H</`7_A(7?_`,LZ`.\HK@_^$>^)_P#T.'@+
M_P`)"[_^6='_``CWQ/\`^AP\!?\`A(7?_P`LZ`.\HK@_^$>^)_\`T.'@+_PD
M+O\`^6='_"/?$_\`Z'#P%_X2%W_\LZ`.\HK@_P#A'OB?_P!#AX"_\)"[_P#E
MG1_PCWQ/_P"AP\!?^$A=_P#RSH`[RBN#_P"$>^)__0X>`O\`PD+O_P"6='_"
M/?$__H</`7_A(7?_`,LZ`.\HK@_^$>^)_P#T.'@+_P`)"[_^6='_``CWQ/\`
M^AP\!?\`A(7?_P`LZ`.\HK@_^$>^)_\`T.'@+_PD+O\`^6='_"/?$_\`Z'#P
M%_X2%W_\LZ`.\HK@_P#A'OB?_P!#AX"_\)"[_P#EG1_PCWQ/_P"AP\!?^$A=
M_P#RSH`[RBN#_P"$>^)__0X>`O\`PD+O_P"6='_"/?$__H</`7_A(7?_`,LZ
M`.\HK@_^$>^)_P#T.'@+_P`)"[_^6='_``CWQ/\`^AP\!?\`A(7?_P`LZ`.\
MHK@_^$>^)_\`T.'@+_PD+O\`^6='_"/?$_\`Z'#P%_X2%W_\LZ`.\HK@_P#A
M'OB?_P!#AX"_\)"[_P#EG1_PCWQ/_P"AP\!?^$A=_P#RSH`[RBN#_P"$>^)_
M_0X>`O\`PD+O_P"6='_"/?$__H</`7_A(7?_`,LZ`.\HK@_^$>^)_P#T.'@+
M_P`)"[_^6='_``CWQ/\`^AP\!?\`A(7?_P`LZ`.\HK@_^$>^)_\`T.'@+_PD
M+O\`^6='_"/?$_\`Z'#P%_X2%W_\LZ`.\HK@_P#A'OB?_P!#AX"_\)"[_P#E
MG1_PCWQ/_P"AP\!?^$A=_P#RSH`[RBN#_P"$>^)__0X>`O\`PD+O_P"6='_"
M/?$__H</`7_A(7?_`,LZ`.\HK@_^$>^)_P#T.'@+_P`)"[_^6='_``CWQ/\`
M^AP\!?\`A(7?_P`LZ`.\HK@_^$>^)_\`T.'@+_PD+O\`^6='_"/?$_\`Z'#P
M%_X2%W_\LZ`.\HK@_P#A'OB?_P!#AX"_\)"[_P#EG1_PCWQ/_P"AP\!?^$A=
M_P#RSH`[RBN#_P"$>^)__0X>`O\`PD+O_P"6='_"/?$__H</`7_A(7?_`,LZ
M`.\HK@_^$>^)_P#T.'@+_P`)"[_^6='_``CWQ/\`^AP\!?\`A(7?_P`LZ`.\
MHK@_^$>^)_\`T.'@+_PD+O\`^6='_"/?$_\`Z'#P%_X2%W_\LZ`.\HK@_P#A
M'OB?_P!#AX"_\)"[_P#EG1_PCWQ/_P"AP\!?^$A=_P#RSH`[RBN#_P"$>^)_
M_0X>`O\`PD+O_P"6='_"/?$__H</`7_A(7?_`,LZ`.\HK@_^$>^)_P#T.'@+
M_P`)"[_^6='_``CWQ/\`^AP\!?\`A(7?_P`LZ`.\HK@_^$>^)_\`T.'@+_PD
M+O\`^6='_"/?$_\`Z'#P%_X2%W_\LZ`.\HK@_P#A'OB?_P!#AX"_\)"[_P#E
MG1_PCWQ/_P"AP\!?^$A=_P#RSH`[RBN#_P"$>^)__0X>`O\`PD+O_P"6='_"
M/?$__H</`7_A(7?_`,LZ`.\HK@_^$>^)_P#T.'@+_P`)"[_^6='_``CWQ/\`
M^AP\!?\`A(7?_P`LZ`#X0?\`)0?BI_V-$'_IETNBK_PI\`:GX)D\1W>LZK8:
COJ?B35!J4\EEI[V,$6VTMK546-YIF^[;*Q)<Y+'@"B@#_]D_
`
end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.INS
<SEQUENCE>24
<FILENAME>psti-20140630.xml
<DESCRIPTION>INSTANCE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" standalone="no"?>
<!--Created by Z-K Global Ltd. ("ZKG")-->
<!--produced on 2014-09-10 @ 8:21 AM-->
<xbrl xmlns:country="http://xbrl.sec.gov/country/2013-01-31" xmlns:currency="http://xbrl.sec.gov/currency/2014-01-31" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:psti="http://www.pluristem.com/20140630" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xhtml="http://www.w3.org/1999/xhtml" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:dei="http://xbrl.sec.gov/dei/2014-01-31" xmlns:invest="http://xbrl.sec.gov/invest/2013-01-31" xmlns:us-gaap="http://fasb.org/us-gaap/2014-01-31" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns="http://www.xbrl.org/2003/instance">
  <link:schemaRef xlink:type="simple" xlink:href="psti-20140630.xsd" />
  <dei:AmendmentFlag id="AmendmentFlag.869.0.0.0.0.0.0" contextRef="from-2013-07-01-to-2014-06-30.869.0.0.0.0.0.0.0">false</dei:AmendmentFlag>
  <dei:CurrentFiscalYearEndDate id="CurrentFiscalYearEndDate.869.0.0.0.0.0.0" contextRef="from-2013-07-01-to-2014-06-30.869.0.0.0.0.0.0.0">--06-30</dei:CurrentFiscalYearEndDate>
  <dei:DocumentFiscalPeriodFocus id="DocumentFiscalPeriodFocus.869.0.0.0.0.0.0" contextRef="from-2013-07-01-to-2014-06-30.869.0.0.0.0.0.0.0">FY</dei:DocumentFiscalPeriodFocus>
  <dei:DocumentFiscalYearFocus id="DocumentFiscalYearFocus.869.0.0.0.0.0.0" contextRef="from-2013-07-01-to-2014-06-30.869.0.0.0.0.0.0.0">2014</dei:DocumentFiscalYearFocus>
  <dei:DocumentPeriodEndDate id="DocumentPeriodEndDate.869.0.0.0.0.0.0" contextRef="from-2013-07-01-to-2014-06-30.869.0.0.0.0.0.0.0">2014-06-30</dei:DocumentPeriodEndDate>
  <dei:DocumentType id="DocumentType.869.0.0.0.0.0.0" contextRef="from-2013-07-01-to-2014-06-30.869.0.0.0.0.0.0.0">10-K</dei:DocumentType>
  <dei:EntityCentralIndexKey id="EntityCentralIndexKey.869.0.0.0.0.0.0" contextRef="from-2013-07-01-to-2014-06-30.869.0.0.0.0.0.0.0">0001158780</dei:EntityCentralIndexKey>
  <dei:EntityCommonStockSharesOutstanding id="EntityCommonStockSharesOutstanding.877.0.0.0.0.0.0" contextRef="as-of-2014-09-02.877.0.0.0.0.0.0.0" unitRef="shares" decimals="INF">69278512</dei:EntityCommonStockSharesOutstanding>
  <dei:EntityCurrentReportingStatus id="EntityCurrentReportingStatus.869.0.0.0.0.0.0" contextRef="from-2013-07-01-to-2014-06-30.869.0.0.0.0.0.0.0">Yes</dei:EntityCurrentReportingStatus>
  <dei:EntityFilerCategory id="EntityFilerCategory.869.0.0.0.0.0.0" contextRef="from-2013-07-01-to-2014-06-30.869.0.0.0.0.0.0.0">Accelerated Filer</dei:EntityFilerCategory>
  <dei:EntityPublicFloat id="EntityPublicFloat.873.0.0.0.0.0.0" contextRef="as-of-2013-12-31.873.0.0.0.0.0.0.0" unitRef="USD" decimals="0">214202402</dei:EntityPublicFloat>
  <dei:EntityRegistrantName id="EntityRegistrantName.869.0.0.0.0.0.0" contextRef="from-2013-07-01-to-2014-06-30.869.0.0.0.0.0.0.0">PLURISTEM THERAPEUTICS INC</dei:EntityRegistrantName>
  <dei:EntityVoluntaryFilers id="EntityVoluntaryFilers.869.0.0.0.0.0.0" contextRef="from-2013-07-01-to-2014-06-30.869.0.0.0.0.0.0.0">No</dei:EntityVoluntaryFilers>
  <dei:EntityWellKnownSeasonedIssuer id="EntityWellKnownSeasonedIssuer.869.0.0.0.0.0.0" contextRef="from-2013-07-01-to-2014-06-30.869.0.0.0.0.0.0.0">No</dei:EntityWellKnownSeasonedIssuer>
  <invest:DerivativeNotionalAmount id="DerivativeNotionalAmount.872.17830.1333.2365.1594.1352.1619" contextRef="as-of-2014-06-30.872.0.17830.1333.2365.1594.1352.1619" unitRef="USD" decimals="-3">2820000</invest:DerivativeNotionalAmount>
  <invest:DerivativeNotionalAmount id="DerivativeNotionalAmount.872.17845.1333.2365.1594.1352.1619" contextRef="as-of-2014-06-30.872.0.17845.1333.2365.1594.1352.1619" unitRef="USD" decimals="-3">11000000</invest:DerivativeNotionalAmount>
  <psti:AdvancePaymentForDeveplomentCosts id="AdvancePaymentForDeveplomentCosts.869.0.0.0.0.0.0" contextRef="from-2013-07-01-to-2014-06-30.869.0.0.0.0.0.0.0" unitRef="USD" decimals="-3">2000000</psti:AdvancePaymentForDeveplomentCosts>
  <psti:AggregateGrantsReceived id="AggregateGrantsReceived.872.0.0.0.0.0.0" contextRef="as-of-2014-06-30.872.0.0.0.0.0.0.0" unitRef="USD" decimals="-3">14125000</psti:AggregateGrantsReceived>
  <psti:AmortizationOfDiscountAndPremiumAndChangesInAccruedInterestFromMarketableSecurities id="AmortizationOfDiscountAndPremiumAndChangesInAccruedInterestFromMarketableSecurities.869.0.0.0.0.0.0" contextRef="from-2013-07-01-to-2014-06-30.869.0.0.0.0.0.0.0" unitRef="USD" decimals="-3">1282000</psti:AmortizationOfDiscountAndPremiumAndChangesInAccruedInterestFromMarketableSecurities>
  <psti:AmortizationOfDiscountAndPremiumAndChangesInAccruedInterestFromMarketableSecurities id="AmortizationOfDiscountAndPremiumAndChangesInAccruedInterestFromMarketableSecurities.870.0.0.0.0.0.0" contextRef="from-2012-07-01-to-2013-06-30.870.0.0.0.0.0.0.0" unitRef="USD" decimals="-3">154000</psti:AmortizationOfDiscountAndPremiumAndChangesInAccruedInterestFromMarketableSecurities>
  <psti:AmortizationOfDiscountAndPremiumAndChangesInAccruedInterestFromMarketableSecurities id="AmortizationOfDiscountAndPremiumAndChangesInAccruedInterestFromMarketableSecurities.871.0.0.0.0.0.0" contextRef="from-2011-07-01-to-2012-06-30.871.0.0.0.0.0.0.0" unitRef="USD" decimals="-3">17000</psti:AmortizationOfDiscountAndPremiumAndChangesInAccruedInterestFromMarketableSecurities>
  <psti:AvailableForSaleMarketableSecuritiesNumber id="AvailableForSaleMarketableSecuritiesNumber.872.0.0.0.0.0.0" contextRef="as-of-2014-06-30.872.0.0.0.0.0.0.0" unitRef="shares" decimals="0">1011504</psti:AvailableForSaleMarketableSecuritiesNumber>
  <psti:BusinessCombinationContingentConsiderationReceivableUponCertainRegulatoryMilestones id="BusinessCombinationContingentConsiderationReceivableUponCertainRegulatoryMilestones.869.0.0.0.0.0.0" contextRef="from-2013-07-01-to-2014-06-30.869.0.0.0.0.0.0.0" unitRef="USD" decimals="-3">37500000</psti:BusinessCombinationContingentConsiderationReceivableUponCertainRegulatoryMilestones>
  <psti:GovernmentAndThirdPartyGrantsReceived id="GovernmentAndThirdPartyGrantsReceived.869.0.0.0.0.0.0" contextRef="from-2013-07-01-to-2014-06-30.869.0.0.0.0.0.0.0" unitRef="USD" decimals="-3">5396000</psti:GovernmentAndThirdPartyGrantsReceived>
  <psti:GovernmentAndThirdPartyGrantsReceived id="GovernmentAndThirdPartyGrantsReceived.870.0.0.0.0.0.0" contextRef="from-2012-07-01-to-2013-06-30.870.0.0.0.0.0.0.0" unitRef="USD" decimals="-3">2673000</psti:GovernmentAndThirdPartyGrantsReceived>
  <psti:GovernmentAndThirdPartyGrantsReceived id="GovernmentAndThirdPartyGrantsReceived.871.0.0.0.0.0.0" contextRef="from-2011-07-01-to-2012-06-30.871.0.0.0.0.0.0.0" unitRef="USD" decimals="-3">3527000</psti:GovernmentAndThirdPartyGrantsReceived>
  <psti:InterestOnShortTermBankCreditAndBankExpenses id="InterestOnShortTermBankCreditAndBankExpenses.869.0.0.0.0.0.0" contextRef="from-2013-07-01-to-2014-06-30.869.0.0.0.0.0.0.0" unitRef="USD" decimals="-3">36000</psti:InterestOnShortTermBankCreditAndBankExpenses>
  <psti:InterestOnShortTermBankCreditAndBankExpenses id="InterestOnShortTermBankCreditAndBankExpenses.870.0.0.0.0.0.0" contextRef="from-2012-07-01-to-2013-06-30.870.0.0.0.0.0.0.0" unitRef="USD" decimals="-3">29000</psti:InterestOnShortTermBankCreditAndBankExpenses>
  <psti:InterestOnShortTermBankCreditAndBankExpenses id="InterestOnShortTermBankCreditAndBankExpenses.871.0.0.0.0.0.0" contextRef="from-2011-07-01-to-2012-06-30.871.0.0.0.0.0.0.0" unitRef="USD" decimals="-3">12000</psti:InterestOnShortTermBankCreditAndBankExpenses>
  <psti:LeaseholdImprovementsAnnualRateOfDepreciationDescription id="LeaseholdImprovementsAnnualRateOfDepreciationDescription.869.25578.4261.0.0.0.0" contextRef="from-2013-07-01-to-2014-06-30.869.0.25578.4261.0.0.0.0">The shorter of the expected useful life or the reasonable assumed term of the lease.</psti:LeaseholdImprovementsAnnualRateOfDepreciationDescription>
  <psti:LinkageDifferencesAndInterestOnShortAndLongTermRestrictedLeaseDeposit id="LinkageDifferencesAndInterestOnShortAndLongTermRestrictedLeaseDeposit.869.0.0.0.0.0.0" contextRef="from-2013-07-01-to-2014-06-30.869.0.0.0.0.0.0.0" unitRef="USD" decimals="-3">12000</psti:LinkageDifferencesAndInterestOnShortAndLongTermRestrictedLeaseDeposit>
  <psti:LinkageDifferencesAndInterestOnShortAndLongTermRestrictedLeaseDeposit id="LinkageDifferencesAndInterestOnShortAndLongTermRestrictedLeaseDeposit.870.0.0.0.0.0.0" contextRef="from-2012-07-01-to-2013-06-30.870.0.0.0.0.0.0.0" unitRef="USD" decimals="-3">-30000</psti:LinkageDifferencesAndInterestOnShortAndLongTermRestrictedLeaseDeposit>
  <psti:LinkageDifferencesAndInterestOnShortAndLongTermRestrictedLeaseDeposit id="LinkageDifferencesAndInterestOnShortAndLongTermRestrictedLeaseDeposit.871.0.0.0.0.0.0" contextRef="from-2011-07-01-to-2012-06-30.871.0.0.0.0.0.0.0" unitRef="USD" decimals="-3">35000</psti:LinkageDifferencesAndInterestOnShortAndLongTermRestrictedLeaseDeposit>
  <psti:LongTermRestrictedDepositPolicyTextBlock id="LongTermRestrictedDepositPolicyTextBlock.869.0.0.0.0.0.0" contextRef="from-2013-07-01-to-2014-06-30.869.0.0.0.0.0.0.0">&lt;!--DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd" --&gt;&lt;div&gt; &lt;div&gt;&lt;!--StartFragment--&gt; &lt;div style="text-align: center"&gt; &lt;table style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman" cellspacing="0" cellpadding="0" width="100%" border="0"&gt; &lt;tr valign="top"&gt; &lt;td style="WIDTH: 18pt"&gt; &lt;div style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt"&gt; g.&lt;/div&gt; &lt;/td&gt; &lt;td&gt; &lt;div style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; text-align: justify"&gt; Long-term restricted deposits&lt;/div&gt; &lt;/td&gt; &lt;/tr&gt; &lt;/table&gt; &lt;/div&gt; &lt;div&gt;&amp;nbsp;&lt;/div&gt; &lt;div&gt; &lt;table style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman" cellspacing="0" cellpadding="0" width="100%" align="center" border="0"&gt; &lt;tr valign="top"&gt; &lt;td style="WIDTH: 18pt"&gt; &lt;div style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/div&gt; &lt;/td&gt; &lt;td&gt; &lt;div style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; text-align: justify"&gt; Long-term restricted deposits with maturities of more than one year used to secure operating lease agreement are presented at cost which approximates market values including accrued interest.&lt;/div&gt; &lt;/td&gt; &lt;/tr&gt; &lt;/table&gt; &lt;/div&gt; &lt;!--EndFragment--&gt;&lt;/div&gt; &lt;/div&gt;</psti:LongTermRestrictedDepositPolicyTextBlock>
  <psti:OperatingLeasedAssetsParticipationFromLessor id="OperatingLeasedAssetsParticipationFromLessor.869.3008.4261.0.0.0.0" contextRef="from-2013-07-01-to-2014-06-30.869.0.3008.4261.0.0.0.0" unitRef="USD" decimals="-3">816000</psti:OperatingLeasedAssetsParticipationFromLessor>
  <psti:OtherAccountsPayablePayrollInstitutions id="OtherAccountsPayablePayrollInstitutions.872.0.0.0.0.0.0" contextRef="as-of-2014-06-30.872.0.0.0.0.0.0.0" unitRef="USD" decimals="-3">302000</psti:OtherAccountsPayablePayrollInstitutions>
  <psti:OtherAccountsPayablePayrollInstitutions id="OtherAccountsPayablePayrollInstitutions.874.0.0.0.0.0.0" contextRef="as-of-2013-06-30.874.0.0.0.0.0.0.0" unitRef="USD" decimals="-3">324000</psti:OtherAccountsPayablePayrollInstitutions>
  <psti:PercentageOfQualifiedExpenditures id="PercentageOfQualifiedExpenditures.869.0.0.0.0.0.0" contextRef="from-2013-07-01-to-2014-06-30.869.0.0.0.0.0.0.0" unitRef="pure" decimals="1">0.5</psti:PercentageOfQualifiedExpenditures>
  <psti:PropertyPlantAndEquipmentAnnualRateOfDepreciation id="PropertyPlantAndEquipmentAnnualRateOfDepreciation.869.3840.4261.3370.4349.0.0" contextRef="from-2013-07-01-to-2014-06-30.869.0.3840.4261.3370.4349.0.0" unitRef="pure" decimals="1">0.1</psti:PropertyPlantAndEquipmentAnnualRateOfDepreciation>
  <psti:PropertyPlantAndEquipmentAnnualRateOfDepreciation id="PropertyPlantAndEquipmentAnnualRateOfDepreciation.869.3840.4261.3361.4349.0.0" contextRef="from-2013-07-01-to-2014-06-30.869.0.3840.4261.3361.4349.0.0" unitRef="pure" decimals="2">0.15</psti:PropertyPlantAndEquipmentAnnualRateOfDepreciation>
  <psti:PropertyPlantAndEquipmentAnnualRateOfDepreciation id="PropertyPlantAndEquipmentAnnualRateOfDepreciation.869.3650.4261.3370.4349.0.0" contextRef="from-2013-07-01-to-2014-06-30.869.0.3650.4261.3370.4349.0.0" unitRef="pure" decimals="2">0.06</psti:PropertyPlantAndEquipmentAnnualRateOfDepreciation>
  <psti:PropertyPlantAndEquipmentAnnualRateOfDepreciation id="PropertyPlantAndEquipmentAnnualRateOfDepreciation.869.3650.4261.3361.4349.0.0" contextRef="from-2013-07-01-to-2014-06-30.869.0.3650.4261.3361.4349.0.0" unitRef="pure" decimals="2">0.15</psti:PropertyPlantAndEquipmentAnnualRateOfDepreciation>
  <psti:PropertyPlantAndEquipmentAnnualRateOfDepreciation id="PropertyPlantAndEquipmentAnnualRateOfDepreciation.869.1163.4261.0.0.0.0" contextRef="from-2013-07-01-to-2014-06-30.869.0.1163.4261.0.0.0.0" unitRef="pure" decimals="2">0.33</psti:PropertyPlantAndEquipmentAnnualRateOfDepreciation>
  <psti:PropertyPlantAndEquipmentAnnualRateOfDepreciation id="PropertyPlantAndEquipmentAnnualRateOfDepreciation.869.5488.4261.0.0.0.0" contextRef="from-2013-07-01-to-2014-06-30.869.0.5488.4261.0.0.0.0" unitRef="pure" decimals="2">0.15</psti:PropertyPlantAndEquipmentAnnualRateOfDepreciation>
  <psti:PropertyPlantAndEquipmentEstimatedUsefulLivesRateTableTextBlock id="PropertyPlantAndEquipmentEstimatedUsefulLivesRateTableTextBlock.869.0.0.0.0.0.0" contextRef="from-2013-07-01-to-2014-06-30.869.0.0.0.0.0.0.0">&lt;!--DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd" --&gt;&lt;div&gt; &lt;div&gt;&lt;!--StartFragment--&gt; &lt;div&gt; &lt;table style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman" cellspacing="0" cellpadding="0" width="100%" align="center" border="0"&gt; &lt;tr valign="top"&gt; &lt;td style="WIDTH: 18pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td&gt; &lt;div style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; text-align: justify"&gt; Property and equipment are stated at cost, net of accumulated depreciation. Depreciation is calculated by the straight-line method over the estimated useful lives of the assets, at the following annual rates:&lt;/div&gt; &lt;/td&gt; &lt;/tr&gt; &lt;/table&gt; &lt;/div&gt; &lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"&gt; &amp;nbsp;&lt;/div&gt; &lt;div style="MARGIN-LEFT: 18pt; text-align: left"&gt; &lt;table style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman" cellspacing="0" cellpadding="0" width="80%"&gt; &lt;tr&gt; &lt;td valign="top" width="44%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 2px solid" valign="top" width="28%"&gt; &lt;div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt"&gt; %&lt;/div&gt; &lt;/td&gt; &lt;td valign="top" width="28%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr bgcolor="#cceeff"&gt; &lt;td valign="top" width="44%" align="left"&gt; &lt;div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"&gt; Laboratory equipment&lt;/div&gt; &lt;/td&gt; &lt;td valign="top" width="28%" align="left"&gt; &lt;div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: -12.3pt; text-align: left; TEXT-INDENT: 0pt"&gt; 10-15&lt;/div&gt; &lt;/td&gt; &lt;td valign="top" width="28%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr bgcolor="white"&gt; &lt;td valign="top" width="44%" align="left"&gt; &lt;div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"&gt; Computers and peripheral equipment&lt;/div&gt; &lt;/td&gt; &lt;td valign="top" width="28%" align="left"&gt; &lt;div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: -12.3pt; text-align: left; TEXT-INDENT: 0pt"&gt; 33&lt;/div&gt; &lt;/td&gt; &lt;td valign="top" width="28%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr bgcolor="#cceeff"&gt; &lt;td valign="top" width="44%" align="left"&gt; &lt;div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"&gt; Office furniture and equipment&lt;/div&gt; &lt;/td&gt; &lt;td valign="top" width="28%" align="left"&gt; &lt;div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: -12.3pt; text-align: left; TEXT-INDENT: 0pt"&gt; 6-15&lt;/div&gt; &lt;/td&gt; &lt;td valign="top" width="28%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr bgcolor="white"&gt; &lt;td valign="top" width="44%" align="left"&gt; &lt;div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"&gt; Vehicles&lt;/div&gt; &lt;/td&gt; &lt;td valign="top" width="15%" colspan="2" align="left"&gt; &lt;div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: -12.3pt; text-align: left; TEXT-INDENT: 0pt"&gt; 15&lt;/div&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr bgcolor="#cceeff"&gt; &lt;td valign="top" width="44%" align="left"&gt; &lt;div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"&gt; Leasehold improvements&lt;/div&gt; &lt;/td&gt; &lt;td valign="top" width="56%" colspan="2" align="left"&gt; &lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: -12.3pt; text-align: left; TEXT-INDENT: 0pt"&gt; &lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; The shorter of the expected&lt;/font&gt; &lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; useful life or the&lt;/font&gt;&lt;/div&gt; &lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: -12.3pt; text-align: left; TEXT-INDENT: 0pt"&gt; &lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; reasonable assumed&lt;/font&gt; &lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; term of the lease.&lt;/font&gt;&lt;/div&gt; &lt;/td&gt; &lt;/tr&gt; &lt;/table&gt; &lt;/div&gt; &lt;!--EndFragment--&gt;&lt;/div&gt; &lt;/div&gt;</psti:PropertyPlantAndEquipmentEstimatedUsefulLivesRateTableTextBlock>
  <psti:QualifyingPercentageOfValueOfProductiveAssetsTableTextBlock id="QualifyingPercentageOfValueOfProductiveAssetsTableTextBlock.869.0.0.0.0.0.0" contextRef="from-2013-07-01-to-2014-06-30.869.0.0.0.0.0.0.0">&lt;!--DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd" --&gt;&lt;div&gt; &lt;div&gt;&lt;!--StartFragment--&gt; &lt;div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; MARGIN-LEFT: 27pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"&gt; The qualifying percentage of the value of the productive assets is as follows:&lt;/div&gt; &lt;div style="DISPLAY: block; TEXT-INDENT: 0pt"&gt;&lt;br /&gt; &lt;/div&gt; &lt;div style="MARGIN-LEFT: 27pt; text-align: center"&gt; &lt;table style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman" cellspacing="0" cellpadding="0" width="60%"&gt; &lt;tr&gt; &lt;td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="49%"&gt; &lt;div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"&gt; The value of productive&lt;/div&gt; &lt;div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"&gt; assets before the expansion&lt;/div&gt; &lt;div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"&gt; (NIS in millions)&lt;/div&gt; &lt;/td&gt; &lt;td valign="top" width="2%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 2px solid" valign="top" width="49%"&gt; &lt;div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"&gt; The new proportion&lt;/div&gt; &lt;div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"&gt; that the required&lt;/div&gt; &lt;div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"&gt; &amp;nbsp;investment bears&lt;/div&gt; &lt;div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"&gt; to the value of&lt;/div&gt; &lt;div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"&gt; productive assets&lt;/div&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td valign="top" width="49%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td valign="top" width="2%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td valign="top" width="49%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr bgcolor="#cceeff"&gt; &lt;td style="TEXT-ALIGN: left; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt" valign="top" width="49%"&gt; &lt;div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: left; TEXT-INDENT: 0pt"&gt; Up to NIS&amp;nbsp;140&lt;/div&gt; &lt;/td&gt; &lt;td valign="top" width="2%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td valign="top" width="49%"&gt; &lt;div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"&gt; 12%&lt;/div&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr bgcolor="white"&gt; &lt;td style="TEXT-ALIGN: left; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt" valign="top" width="49%"&gt; &lt;div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: left; TEXT-INDENT: 0pt"&gt; NIS&amp;nbsp;140 - NIS&amp;nbsp;500&lt;/div&gt; &lt;/td&gt; &lt;td valign="top" width="2%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td valign="top" width="49%"&gt; &lt;div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"&gt; 7%&lt;/div&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr bgcolor="#cceeff"&gt; &lt;td style="TEXT-ALIGN: left; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt" valign="top" width="49%"&gt; &lt;div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: left; TEXT-INDENT: 0pt"&gt; More than NIS&amp;nbsp;500&lt;/div&gt; &lt;/td&gt; &lt;td valign="top" width="2%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td valign="top" width="49%"&gt; &lt;div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"&gt; 5%&lt;/div&gt; &lt;/td&gt; &lt;/tr&gt; &lt;/table&gt; &lt;/div&gt; &lt;!--EndFragment--&gt;&lt;/div&gt; &lt;/div&gt;</psti:QualifyingPercentageOfValueOfProductiveAssetsTableTextBlock>
  <psti:ReclassFromResearchAndDevelopmentExpenseToCostOfRevenues id="ReclassFromResearchAndDevelopmentExpenseToCostOfRevenues.872.0.0.0.0.0.0" contextRef="as-of-2014-06-30.872.0.0.0.0.0.0.0" unitRef="USD" decimals="-3">1753000</psti:ReclassFromResearchAndDevelopmentExpenseToCostOfRevenues>
  <psti:RemainingDeferredRevenueRecognitionPeriodForIntangibleAsset id="RemainingDeferredRevenueRecognitionPeriodForIntangibleAsset.869.0.0.0.0.0.0" contextRef="from-2013-07-01-to-2014-06-30.869.0.0.0.0.0.0.0">P8Y6M</psti:RemainingDeferredRevenueRecognitionPeriodForIntangibleAsset>
  <psti:ResearchAndDevelopmentExpensesAndGrantsPolicyTextBlock id="ResearchAndDevelopmentExpensesAndGrantsPolicyTextBlock.869.0.0.0.0.0.0" contextRef="from-2013-07-01-to-2014-06-30.869.0.0.0.0.0.0.0">&lt;!--DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd" --&gt;&lt;div&gt; &lt;div&gt;&lt;!--StartFragment--&gt; &lt;div style="text-align: center"&gt; &lt;table style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman" cellspacing="0" cellpadding="0" width="100%" border="0"&gt; &lt;tr valign="top"&gt; &lt;td style="WIDTH: 18pt"&gt; &lt;div style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt"&gt; m.&lt;/div&gt; &lt;/td&gt; &lt;td&gt; &lt;div style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; text-align: justify"&gt; Research and Development expenses and grants&lt;/div&gt; &lt;/td&gt; &lt;/tr&gt; &lt;/table&gt; &lt;/div&gt; &lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"&gt; &amp;nbsp;&lt;/div&gt; &lt;div&gt; &lt;table style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman" cellspacing="0" cellpadding="0" width="100%" align="center" border="0"&gt; &lt;tr valign="top"&gt; &lt;td style="WIDTH: 19pt"&gt; &lt;div style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/div&gt; &lt;/td&gt; &lt;td&gt; &lt;div style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; text-align: justify"&gt; Research and development expenses, net of participations, are charged to the statement of operations as incurred.&lt;/div&gt; &lt;/td&gt; &lt;/tr&gt; &lt;/table&gt; &lt;/div&gt; &lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"&gt; &amp;nbsp;&lt;/div&gt; &lt;div&gt; &lt;table style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman" cellspacing="0" cellpadding="0" width="100%" align="center" border="0"&gt; &lt;tr valign="top"&gt; &lt;td style="WIDTH: 19pt"&gt; &lt;div style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/div&gt; &lt;/td&gt; &lt;td&gt; &lt;div style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; text-align: justify"&gt; Research and development grants from the government of Israel and other parties for funding approved research and development projects are recognized at the time the Company is entitled to such grants, on the basis of the cost incurred and applied as a deduction from research and development costs.&lt;/div&gt; &lt;/td&gt; &lt;/tr&gt; &lt;/table&gt; &lt;/div&gt; &lt;!--EndFragment--&gt;&lt;/div&gt; &lt;/div&gt;</psti:ResearchAndDevelopmentExpensesAndGrantsPolicyTextBlock>
  <psti:ResearchAndDevelopmentExpensesNet id="ResearchAndDevelopmentExpensesNet.869.0.0.0.0.0.0" contextRef="from-2013-07-01-to-2014-06-30.869.0.0.0.0.0.0.0" unitRef="USD" decimals="-3">19542000</psti:ResearchAndDevelopmentExpensesNet>
  <psti:ResearchAndDevelopmentExpensesNet id="ResearchAndDevelopmentExpensesNet.870.0.0.0.0.0.0" contextRef="from-2012-07-01-to-2013-06-30.870.0.0.0.0.0.0.0" unitRef="USD" decimals="-3">17233000</psti:ResearchAndDevelopmentExpensesNet>
  <psti:ResearchAndDevelopmentExpensesNet id="ResearchAndDevelopmentExpensesNet.871.0.0.0.0.0.0" contextRef="from-2011-07-01-to-2012-06-30.871.0.0.0.0.0.0.0" unitRef="USD" decimals="-3">9158000</psti:ResearchAndDevelopmentExpensesNet>
  <psti:ResearchAndDevelopmentMilestoneRevenueReceivable id="ResearchAndDevelopmentMilestoneRevenueReceivable.869.0.0.0.0.0.0" contextRef="from-2013-07-01-to-2014-06-30.869.0.0.0.0.0.0.0" unitRef="USD" decimals="-3">37500000</psti:ResearchAndDevelopmentMilestoneRevenueReceivable>
  <psti:RoyaltiesAmountPaidAndAccrued id="RoyaltiesAmountPaidAndAccrued.872.0.0.0.0.0.0" contextRef="as-of-2014-06-30.872.0.0.0.0.0.0.0" unitRef="USD" decimals="-3">53000</psti:RoyaltiesAmountPaidAndAccrued>
  <psti:RoyaltyRatePayableOnGrantsReceived id="RoyaltyRatePayableOnGrantsReceived.869.0.0.0.0.0.0" contextRef="from-2013-07-01-to-2014-06-30.869.0.0.0.0.0.0.0" unitRef="pure" decimals="0">1</psti:RoyaltyRatePayableOnGrantsReceived>
  <psti:RoyaltyRateSales id="RoyaltyRateSales.869.3370.4349.0.0.0.0" contextRef="from-2013-07-01-to-2014-06-30.869.0.3370.4349.0.0.0.0" unitRef="pure" decimals="2">0.03</psti:RoyaltyRateSales>
  <psti:RoyaltyRateSales id="RoyaltyRateSales.869.3361.4349.0.0.0.0" contextRef="from-2013-07-01-to-2014-06-30.869.0.3361.4349.0.0.0.0" unitRef="pure" decimals="2">0.04</psti:RoyaltyRateSales>
  <psti:SeverancePayPolicyTextBlock id="SeverancePayPolicyTextBlock.869.0.0.0.0.0.0" contextRef="from-2013-07-01-to-2014-06-30.869.0.0.0.0.0.0.0">&lt;!--DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd" --&gt;&lt;div&gt; &lt;div&gt;&lt;!--StartFragment--&gt; &lt;div style="text-align: center"&gt; &lt;table style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman" cellspacing="0" cellpadding="0" width="100%" border="0"&gt; &lt;tr valign="top"&gt; &lt;td style="WIDTH: 17pt"&gt; &lt;div style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt"&gt; q.&lt;/div&gt; &lt;/td&gt; &lt;td&gt; &lt;div style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; text-align: justify"&gt; Severance pay&lt;/div&gt; &lt;/td&gt; &lt;/tr&gt; &lt;/table&gt; &lt;/div&gt; &lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"&gt; &amp;nbsp;&lt;/div&gt; &lt;div&gt; &lt;table style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman" cellspacing="0" cellpadding="0" width="100%" align="center" border="0"&gt; &lt;tr valign="top"&gt; &lt;td style="WIDTH: 19pt"&gt; &lt;div style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/div&gt; &lt;/td&gt; &lt;td&gt; &lt;div style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; text-align: justify"&gt; The Subsidiary&amp;#39;s liability for severance pay is calculated pursuant to Israeli Severance Pay Law, 1963 (the "Severance Pay Law")&amp;nbsp;&amp;nbsp;based on the most recent salary of the employees multiplied by the number of years of employment, as of the balance sheet date. Employees are entitled to one month&amp;#39;s salary for each year of employment or a portion thereof.&lt;/div&gt; &lt;div style="text-align: justify"&gt;&amp;nbsp;&lt;/div&gt; &lt;div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-ALIGN: justify; TEXT-INDENT: 0pt"&gt; The Company&amp;#39;s liability for all of its employees is fully provided by monthly deposits with insurance policies and by an accrual. The value of these policies is recorded as an asset in the Company&amp;#39;s balance sheet.&lt;/div&gt; &lt;/td&gt; &lt;/tr&gt; &lt;/table&gt; &lt;/div&gt; &lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"&gt; &amp;nbsp;&lt;/div&gt; &lt;div&gt; &lt;table style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman" cellspacing="0" cellpadding="0" width="100%" align="center" border="0"&gt; &lt;tr valign="top"&gt; &lt;td style="WIDTH: 19pt"&gt; &lt;div style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/div&gt; &lt;/td&gt; &lt;td&gt; &lt;div style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; text-align: justify"&gt; The deposited funds include profits or losses accumulated up to the balance sheet date. The deposited funds may be withdrawn only upon the fulfillment of the obligation pursuant to Israeli severance pay law or labor agreements. The value of the deposited funds is based on the cash surrendered value of these policies, and includes immaterial profits or losses.&lt;/div&gt; &lt;/td&gt; &lt;/tr&gt; &lt;/table&gt; &lt;/div&gt; &lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"&gt; &amp;nbsp;&lt;/div&gt; &lt;div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"&gt; Since November 2011, the Company&amp;#39;s agreements with new employees in Israel, are subject to Section 14 of the Severance Pay Law. The Company&amp;#39;s contributions for severance pay have replaced its severance obligation. Upon contribution of the full amount of the employee&amp;#39;s monthly salary for each year of employment, no additional calculations is conducted between the parties regarding the matter of severance pay and no additional payments is made by the Company to the employee. Further, the related obligation and amounts deposited on behalf of the employee for such obligation are not stated on the balance sheet, as the Company is legally released from the obligation to employees once the deposit amounts have been paid.&lt;/div&gt; &lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"&gt; &amp;nbsp;&lt;/div&gt; &lt;div&gt; &lt;table style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman" cellspacing="0" cellpadding="0" width="100%" align="center" border="0"&gt; &lt;tr valign="top"&gt; &lt;td style="WIDTH: 19pt"&gt; &lt;div style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/div&gt; &lt;/td&gt; &lt;td&gt; &lt;div style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; text-align: justify"&gt; Severance expenses for the years ended December 31, 2014, 2013 and 2012, were $534, $329 and $275, respectively.&lt;/div&gt; &lt;/td&gt; &lt;/tr&gt; &lt;/table&gt; &lt;/div&gt; &lt;!--EndFragment--&gt;&lt;/div&gt; &lt;/div&gt;</psti:SeverancePayPolicyTextBlock>
  <psti:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsExpectedToVest id="ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsExpectedToVest.872.4568.367.0.0.0.0" contextRef="as-of-2014-06-30.872.0.4568.367.0.0.0.0" unitRef="shares" decimals="INF">1522024</psti:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsExpectedToVest>
  <psti:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsForfeituresRate id="SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsForfeituresRate.869.25661.5277.0.0.0.0" contextRef="from-2013-07-01-to-2014-06-30.869.0.25661.5277.0.0.0.0" unitRef="pure" decimals="2">0.07</psti:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsForfeituresRate>
  <psti:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsForfeituresRate id="SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsForfeituresRate.870.25661.5277.0.0.0.0" contextRef="from-2012-07-01-to-2013-06-30.870.0.25661.5277.0.0.0.0" unitRef="pure" decimals="2">0.07</psti:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsForfeituresRate>
  <psti:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsForfeituresRate id="SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsForfeituresRate.871.25661.5277.0.0.0.0" contextRef="from-2011-07-01-to-2012-06-30.871.0.25661.5277.0.0.0.0" unitRef="pure" decimals="2">0.05</psti:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsForfeituresRate>
  <psti:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsForfeituresRate id="SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsForfeituresRate.869.3316.5277.0.0.0.0" contextRef="from-2013-07-01-to-2014-06-30.869.0.3316.5277.0.0.0.0" unitRef="pure" decimals="0">0</psti:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsForfeituresRate>
  <psti:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsForfeituresRate id="SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsForfeituresRate.870.3316.5277.0.0.0.0" contextRef="from-2012-07-01-to-2013-06-30.870.0.3316.5277.0.0.0.0" unitRef="pure" decimals="0">0</psti:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsForfeituresRate>
  <psti:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsForfeituresRate id="SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsForfeituresRate.871.3316.5277.0.0.0.0" contextRef="from-2011-07-01-to-2012-06-30.871.0.3316.5277.0.0.0.0" unitRef="pure" decimals="0">0</psti:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsForfeituresRate>
  <psti:SharebasedCompensationArrangementWarrantsExercised id="SharebasedCompensationArrangementWarrantsExercised.869.25814.1048.0.0.0.0" contextRef="from-2013-07-01-to-2014-06-30.869.0.25814.1048.0.0.0.0" unitRef="shares" decimals="INF">1432584</psti:SharebasedCompensationArrangementWarrantsExercised>
  <psti:SharebasedCompensationArrangementWarrantsExercised id="SharebasedCompensationArrangementWarrantsExercised.870.25814.1048.0.0.0.0" contextRef="from-2012-07-01-to-2013-06-30.870.0.25814.1048.0.0.0.0" unitRef="shares" decimals="INF">1201160</psti:SharebasedCompensationArrangementWarrantsExercised>
  <psti:SharebasedCompensationArrangementWarrantsExercised id="SharebasedCompensationArrangementWarrantsExercised.871.25814.1048.0.0.0.0" contextRef="from-2011-07-01-to-2012-06-30.871.0.25814.1048.0.0.0.0" unitRef="shares" decimals="INF">355411</psti:SharebasedCompensationArrangementWarrantsExercised>
  <psti:SharebasedGoodsAndNonemployeesServicesTransactionWarrantsAndOptionsExercised id="SharebasedGoodsAndNonemployeesServicesTransactionWarrantsAndOptionsExercised.869.0.0.0.0.0.0" contextRef="from-2013-07-01-to-2014-06-30.869.0.0.0.0.0.0.0" unitRef="shares" decimals="INF">66500</psti:SharebasedGoodsAndNonemployeesServicesTransactionWarrantsAndOptionsExercised>
  <psti:SharebasedGoodsAndNonemployeesServicesTransactionWarrantsAndOptionsGranted id="SharebasedGoodsAndNonemployeesServicesTransactionWarrantsAndOptionsGranted.869.0.0.0.0.0.0" contextRef="from-2013-07-01-to-2014-06-30.869.0.0.0.0.0.0.0" unitRef="shares" decimals="INF">3000</psti:SharebasedGoodsAndNonemployeesServicesTransactionWarrantsAndOptionsGranted>
  <psti:SharebasedGoodsAndNonemployeesServicesTransactionWarrantsAndOptionsNumber id="SharebasedGoodsAndNonemployeesServicesTransactionWarrantsAndOptionsNumber.872.0.0.0.0.0.0" contextRef="as-of-2014-06-30.872.0.0.0.0.0.0.0" unitRef="shares" decimals="INF">252000</psti:SharebasedGoodsAndNonemployeesServicesTransactionWarrantsAndOptionsNumber>
  <psti:SharebasedGoodsAndNonemployeesServicesTransactionWarrantsAndOptionsNumber id="SharebasedGoodsAndNonemployeesServicesTransactionWarrantsAndOptionsNumber.874.0.0.0.0.0.0" contextRef="as-of-2013-06-30.874.0.0.0.0.0.0.0" unitRef="shares" decimals="INF">315500</psti:SharebasedGoodsAndNonemployeesServicesTransactionWarrantsAndOptionsNumber>
  <psti:SharebasedGoodsAndNonemployeesServicesTransactionWarrantsAndOptionsNumberExercisable id="SharebasedGoodsAndNonemployeesServicesTransactionWarrantsAndOptionsNumberExercisable.872.0.0.0.0.0.0" contextRef="as-of-2014-06-30.872.0.0.0.0.0.0.0" unitRef="shares" decimals="INF">251000</psti:SharebasedGoodsAndNonemployeesServicesTransactionWarrantsAndOptionsNumberExercisable>
  <psti:SharebasedGoodsAndNonemployeesServicesTransactionWarrantsAndOptionsNumberVestedAndExpectedToVest id="SharebasedGoodsAndNonemployeesServicesTransactionWarrantsAndOptionsNumberVestedAndExpectedToVest.872.0.0.0.0.0.0" contextRef="as-of-2014-06-30.872.0.0.0.0.0.0.0" unitRef="shares" decimals="INF">252000</psti:SharebasedGoodsAndNonemployeesServicesTransactionWarrantsAndOptionsNumberVestedAndExpectedToVest>
  <psti:ShortTermBankDepositPolicyTextBlock id="ShortTermBankDepositPolicyTextBlock.869.0.0.0.0.0.0" contextRef="from-2013-07-01-to-2014-06-30.869.0.0.0.0.0.0.0">&lt;!--DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd" --&gt;&lt;div&gt; &lt;div&gt;&lt;!--StartFragment--&gt; &lt;div style="text-align: center"&gt; &lt;table style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman" cellspacing="0" cellpadding="0" width="100%" border="0"&gt; &lt;tr valign="top"&gt; &lt;td style="WIDTH: 18pt"&gt; &lt;div style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt"&gt; e.&lt;/div&gt; &lt;/td&gt; &lt;td&gt; &lt;div style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; text-align: justify"&gt; Short-term bank deposit&lt;/div&gt; &lt;/td&gt; &lt;/tr&gt; &lt;/table&gt; &lt;/div&gt; &lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"&gt; &amp;nbsp;&lt;/div&gt; &lt;div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"&gt; Bank deposits with original maturities of more than three months but less than one year are presented as part of short-term investments. Deposits are presented at their cost which approximates market values including accrued interest. Interest on deposits is recorded as financial income.&lt;/div&gt; &lt;!--EndFragment--&gt;&lt;/div&gt; &lt;/div&gt;</psti:ShortTermBankDepositPolicyTextBlock>
  <psti:StockIssuedDuringPeriodSharesStockOptionsAndWarrantsExercised id="StockIssuedDuringPeriodSharesStockOptionsAndWarrantsExercised.869.1115.5114.0.0.0.0" contextRef="from-2013-07-01-to-2014-06-30.869.0.1115.5114.0.0.0.0" unitRef="shares" decimals="INF">53470</psti:StockIssuedDuringPeriodSharesStockOptionsAndWarrantsExercised>
  <psti:StockIssuedDuringPeriodSharesStockOptionsAndWarrantsExercised id="StockIssuedDuringPeriodSharesStockOptionsAndWarrantsExercised.870.1115.5114.0.0.0.0" contextRef="from-2012-07-01-to-2013-06-30.870.0.1115.5114.0.0.0.0" unitRef="shares" decimals="INF">176867</psti:StockIssuedDuringPeriodSharesStockOptionsAndWarrantsExercised>
  <psti:StockIssuedDuringPeriodSharesStockOptionsAndWarrantsExercised id="StockIssuedDuringPeriodSharesStockOptionsAndWarrantsExercised.871.1115.5114.0.0.0.0" contextRef="from-2011-07-01-to-2012-06-30.871.0.1115.5114.0.0.0.0" unitRef="shares" decimals="INF">74800</psti:StockIssuedDuringPeriodSharesStockOptionsAndWarrantsExercised>
  <psti:StockIssuedDuringPeriodSharesStockWarrantsExercised id="StockIssuedDuringPeriodSharesStockWarrantsExercised.869.1115.5114.0.0.0.0" contextRef="from-2013-07-01-to-2014-06-30.869.0.1115.5114.0.0.0.0" unitRef="shares" decimals="INF">2902168</psti:StockIssuedDuringPeriodSharesStockWarrantsExercised>
  <psti:StockIssuedDuringPeriodSharesStockWarrantsExercised id="StockIssuedDuringPeriodSharesStockWarrantsExercised.870.1115.5114.0.0.0.0" contextRef="from-2012-07-01-to-2013-06-30.870.0.1115.5114.0.0.0.0" unitRef="shares" decimals="INF">1621359</psti:StockIssuedDuringPeriodSharesStockWarrantsExercised>
  <psti:StockIssuedDuringPeriodSharesStockWarrantsExercised id="StockIssuedDuringPeriodSharesStockWarrantsExercised.871.1115.5114.0.0.0.0" contextRef="from-2011-07-01-to-2012-06-30.871.0.1115.5114.0.0.0.0" unitRef="shares" decimals="INF">523835</psti:StockIssuedDuringPeriodSharesStockWarrantsExercised>
  <psti:StockIssuedDuringPeriodValueStockOptionsAndWarrantsExercised id="StockIssuedDuringPeriodValueStockOptionsAndWarrantsExercised.869.1115.5114.0.0.0.0" xsi:nil="true" contextRef="from-2013-07-01-to-2014-06-30.869.0.1115.5114.0.0.0.0" unitRef="USD" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" />
  <psti:StockIssuedDuringPeriodValueStockOptionsAndWarrantsExercised id="StockIssuedDuringPeriodValueStockOptionsAndWarrantsExercised.870.1115.5114.0.0.0.0" xsi:nil="true" contextRef="from-2012-07-01-to-2013-06-30.870.0.1115.5114.0.0.0.0" unitRef="USD" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" />
  <psti:StockIssuedDuringPeriodValueStockOptionsAndWarrantsExercised id="StockIssuedDuringPeriodValueStockOptionsAndWarrantsExercised.871.1115.5114.0.0.0.0" xsi:nil="true" contextRef="from-2011-07-01-to-2012-06-30.871.0.1115.5114.0.0.0.0" unitRef="USD" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" />
  <psti:StockIssuedDuringPeriodValueStockOptionsAndWarrantsExercised id="StockIssuedDuringPeriodValueStockOptionsAndWarrantsExercised.869.499.5114.0.0.0.0" contextRef="from-2013-07-01-to-2014-06-30.869.0.499.5114.0.0.0.0" unitRef="USD" decimals="-3">12000</psti:StockIssuedDuringPeriodValueStockOptionsAndWarrantsExercised>
  <psti:StockIssuedDuringPeriodValueStockOptionsAndWarrantsExercised id="StockIssuedDuringPeriodValueStockOptionsAndWarrantsExercised.870.499.5114.0.0.0.0" contextRef="from-2012-07-01-to-2013-06-30.870.0.499.5114.0.0.0.0" unitRef="USD" decimals="-3">176000</psti:StockIssuedDuringPeriodValueStockOptionsAndWarrantsExercised>
  <psti:StockIssuedDuringPeriodValueStockOptionsAndWarrantsExercised id="StockIssuedDuringPeriodValueStockOptionsAndWarrantsExercised.871.499.5114.0.0.0.0" contextRef="from-2011-07-01-to-2012-06-30.871.0.499.5114.0.0.0.0" unitRef="USD" decimals="-3">89000</psti:StockIssuedDuringPeriodValueStockOptionsAndWarrantsExercised>
  <psti:StockIssuedDuringPeriodValueStockOptionsAndWarrantsExercised id="StockIssuedDuringPeriodValueStockOptionsAndWarrantsExercised.869.478.5114.0.0.0.0" xsi:nil="true" contextRef="from-2013-07-01-to-2014-06-30.869.0.478.5114.0.0.0.0" unitRef="USD" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" />
  <psti:StockIssuedDuringPeriodValueStockOptionsAndWarrantsExercised id="StockIssuedDuringPeriodValueStockOptionsAndWarrantsExercised.870.478.5114.0.0.0.0" xsi:nil="true" contextRef="from-2012-07-01-to-2013-06-30.870.0.478.5114.0.0.0.0" unitRef="USD" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" />
  <psti:StockIssuedDuringPeriodValueStockOptionsAndWarrantsExercised id="StockIssuedDuringPeriodValueStockOptionsAndWarrantsExercised.871.478.5114.0.0.0.0" xsi:nil="true" contextRef="from-2011-07-01-to-2012-06-30.871.0.478.5114.0.0.0.0" unitRef="USD" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" />
  <psti:StockIssuedDuringPeriodValueStockOptionsAndWarrantsExercised id="StockIssuedDuringPeriodValueStockOptionsAndWarrantsExercised.869.4619.5114.0.0.0.0" xsi:nil="true" contextRef="from-2013-07-01-to-2014-06-30.869.0.4619.5114.0.0.0.0" unitRef="USD" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" />
  <psti:StockIssuedDuringPeriodValueStockOptionsAndWarrantsExercised id="StockIssuedDuringPeriodValueStockOptionsAndWarrantsExercised.870.4619.5114.0.0.0.0" xsi:nil="true" contextRef="from-2012-07-01-to-2013-06-30.870.0.4619.5114.0.0.0.0" unitRef="USD" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" />
  <psti:StockIssuedDuringPeriodValueStockOptionsAndWarrantsExercised id="StockIssuedDuringPeriodValueStockOptionsAndWarrantsExercised.871.4619.5114.0.0.0.0" xsi:nil="true" contextRef="from-2011-07-01-to-2012-06-30.871.0.4619.5114.0.0.0.0" unitRef="USD" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" />
  <psti:StockIssuedDuringPeriodValueStockOptionsAndWarrantsExercised id="StockIssuedDuringPeriodValueStockOptionsAndWarrantsExercised.869.0.0.0.0.0.0" contextRef="from-2013-07-01-to-2014-06-30.869.0.0.0.0.0.0.0" unitRef="USD" decimals="-3">12000</psti:StockIssuedDuringPeriodValueStockOptionsAndWarrantsExercised>
  <psti:StockIssuedDuringPeriodValueStockOptionsAndWarrantsExercised id="StockIssuedDuringPeriodValueStockOptionsAndWarrantsExercised.870.0.0.0.0.0.0" contextRef="from-2012-07-01-to-2013-06-30.870.0.0.0.0.0.0.0" unitRef="USD" decimals="-3">176000</psti:StockIssuedDuringPeriodValueStockOptionsAndWarrantsExercised>
  <psti:StockIssuedDuringPeriodValueStockOptionsAndWarrantsExercised id="StockIssuedDuringPeriodValueStockOptionsAndWarrantsExercised.871.0.0.0.0.0.0" contextRef="from-2011-07-01-to-2012-06-30.871.0.0.0.0.0.0.0" unitRef="USD" decimals="-3">89000</psti:StockIssuedDuringPeriodValueStockOptionsAndWarrantsExercised>
  <psti:StockIssuedDuringPeriodValueStockWarrantsExercised id="StockIssuedDuringPeriodValueStockWarrantsExercised.869.1115.5114.0.0.0.0" xsi:nil="true" contextRef="from-2013-07-01-to-2014-06-30.869.0.1115.5114.0.0.0.0" unitRef="USD" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" />
  <psti:StockIssuedDuringPeriodValueStockWarrantsExercised id="StockIssuedDuringPeriodValueStockWarrantsExercised.870.1115.5114.0.0.0.0" xsi:nil="true" contextRef="from-2012-07-01-to-2013-06-30.870.0.1115.5114.0.0.0.0" unitRef="USD" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" />
  <psti:StockIssuedDuringPeriodValueStockWarrantsExercised id="StockIssuedDuringPeriodValueStockWarrantsExercised.871.1115.5114.0.0.0.0" xsi:nil="true" contextRef="from-2011-07-01-to-2012-06-30.871.0.1115.5114.0.0.0.0" unitRef="USD" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" />
  <psti:StockIssuedDuringPeriodValueStockWarrantsExercised id="StockIssuedDuringPeriodValueStockWarrantsExercised.869.499.5114.0.0.0.0" contextRef="from-2013-07-01-to-2014-06-30.869.0.499.5114.0.0.0.0" unitRef="USD" decimals="-3">1968000</psti:StockIssuedDuringPeriodValueStockWarrantsExercised>
  <psti:StockIssuedDuringPeriodValueStockWarrantsExercised id="StockIssuedDuringPeriodValueStockWarrantsExercised.870.499.5114.0.0.0.0" contextRef="from-2012-07-01-to-2013-06-30.870.0.499.5114.0.0.0.0" unitRef="USD" decimals="-3">2009000</psti:StockIssuedDuringPeriodValueStockWarrantsExercised>
  <psti:StockIssuedDuringPeriodValueStockWarrantsExercised id="StockIssuedDuringPeriodValueStockWarrantsExercised.871.499.5114.0.0.0.0" contextRef="from-2011-07-01-to-2012-06-30.871.0.499.5114.0.0.0.0" unitRef="USD" decimals="-3">556000</psti:StockIssuedDuringPeriodValueStockWarrantsExercised>
  <psti:StockIssuedDuringPeriodValueStockWarrantsExercised id="StockIssuedDuringPeriodValueStockWarrantsExercised.869.478.5114.0.0.0.0" xsi:nil="true" contextRef="from-2013-07-01-to-2014-06-30.869.0.478.5114.0.0.0.0" unitRef="USD" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" />
  <psti:StockIssuedDuringPeriodValueStockWarrantsExercised id="StockIssuedDuringPeriodValueStockWarrantsExercised.870.478.5114.0.0.0.0" xsi:nil="true" contextRef="from-2012-07-01-to-2013-06-30.870.0.478.5114.0.0.0.0" unitRef="USD" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" />
  <psti:StockIssuedDuringPeriodValueStockWarrantsExercised id="StockIssuedDuringPeriodValueStockWarrantsExercised.871.478.5114.0.0.0.0" xsi:nil="true" contextRef="from-2011-07-01-to-2012-06-30.871.0.478.5114.0.0.0.0" unitRef="USD" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" />
  <psti:StockIssuedDuringPeriodValueStockWarrantsExercised id="StockIssuedDuringPeriodValueStockWarrantsExercised.869.4619.5114.0.0.0.0" xsi:nil="true" contextRef="from-2013-07-01-to-2014-06-30.869.0.4619.5114.0.0.0.0" unitRef="USD" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" />
  <psti:StockIssuedDuringPeriodValueStockWarrantsExercised id="StockIssuedDuringPeriodValueStockWarrantsExercised.870.4619.5114.0.0.0.0" xsi:nil="true" contextRef="from-2012-07-01-to-2013-06-30.870.0.4619.5114.0.0.0.0" unitRef="USD" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" />
  <psti:StockIssuedDuringPeriodValueStockWarrantsExercised id="StockIssuedDuringPeriodValueStockWarrantsExercised.871.4619.5114.0.0.0.0" xsi:nil="true" contextRef="from-2011-07-01-to-2012-06-30.871.0.4619.5114.0.0.0.0" unitRef="USD" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" />
  <psti:StockIssuedDuringPeriodValueStockWarrantsExercised id="StockIssuedDuringPeriodValueStockWarrantsExercised.869.0.0.0.0.0.0" contextRef="from-2013-07-01-to-2014-06-30.869.0.0.0.0.0.0.0" unitRef="USD" decimals="-3">1968000</psti:StockIssuedDuringPeriodValueStockWarrantsExercised>
  <psti:StockIssuedDuringPeriodValueStockWarrantsExercised id="StockIssuedDuringPeriodValueStockWarrantsExercised.870.0.0.0.0.0.0" contextRef="from-2012-07-01-to-2013-06-30.870.0.0.0.0.0.0.0" unitRef="USD" decimals="-3">2009000</psti:StockIssuedDuringPeriodValueStockWarrantsExercised>
  <psti:StockIssuedDuringPeriodValueStockWarrantsExercised id="StockIssuedDuringPeriodValueStockWarrantsExercised.871.0.0.0.0.0.0" contextRef="from-2011-07-01-to-2012-06-30.871.0.0.0.0.0.0.0" unitRef="USD" decimals="-3">556000</psti:StockIssuedDuringPeriodValueStockWarrantsExercised>
  <psti:WarrantsAndOptionsAggregateIntrinsicValue id="WarrantsAndOptionsAggregateIntrinsicValue.872.0.0.0.0.0.0" contextRef="as-of-2014-06-30.872.0.0.0.0.0.0.0" unitRef="USD" decimals="-3">331000</psti:WarrantsAndOptionsAggregateIntrinsicValue>
  <psti:WarrantsAndOptionsAggregateIntrinsicValueExercisable id="WarrantsAndOptionsAggregateIntrinsicValueExercisable.872.0.0.0.0.0.0" contextRef="as-of-2014-06-30.872.0.0.0.0.0.0.0" unitRef="USD" decimals="-3">328000</psti:WarrantsAndOptionsAggregateIntrinsicValueExercisable>
  <psti:WarrantsAndOptionsAggregateIntrinsicValueVestedAndExpectedToVest id="WarrantsAndOptionsAggregateIntrinsicValueVestedAndExpectedToVest.872.0.0.0.0.0.0" contextRef="as-of-2014-06-30.872.0.0.0.0.0.0.0" unitRef="USD" decimals="-3">331000</psti:WarrantsAndOptionsAggregateIntrinsicValueVestedAndExpectedToVest>
  <psti:WarrantsAndOptionsExercisedWeightedAverageExercisePrice id="WarrantsAndOptionsExercisedWeightedAverageExercisePrice.869.0.0.0.0.0.0" contextRef="from-2013-07-01-to-2014-06-30.869.0.0.0.0.0.0.0" unitRef="USD_per_share" decimals="2">1.39</psti:WarrantsAndOptionsExercisedWeightedAverageExercisePrice>
  <psti:WarrantsAndOptionsGrantedWeightedAverageExercisePrice id="WarrantsAndOptionsGrantedWeightedAverageExercisePrice.869.0.0.0.0.0.0" contextRef="from-2013-07-01-to-2014-06-30.869.0.0.0.0.0.0.0" unitRef="USD_per_share" decimals="2">0.00</psti:WarrantsAndOptionsGrantedWeightedAverageExercisePrice>
  <psti:WarrantsAndOptionsWeightedAverageExercisePrice id="WarrantsAndOptionsWeightedAverageExercisePrice.872.0.0.0.0.0.0" contextRef="as-of-2014-06-30.872.0.0.0.0.0.0.0" unitRef="USD_per_share" decimals="2">5.19</psti:WarrantsAndOptionsWeightedAverageExercisePrice>
  <psti:WarrantsAndOptionsWeightedAverageExercisePrice id="WarrantsAndOptionsWeightedAverageExercisePrice.874.0.0.0.0.0.0" contextRef="as-of-2013-06-30.874.0.0.0.0.0.0.0" unitRef="USD_per_share" decimals="2">4.44</psti:WarrantsAndOptionsWeightedAverageExercisePrice>
  <psti:WarrantsAndOptionsWeightedAverageExercisePriceExcercisable id="WarrantsAndOptionsWeightedAverageExercisePriceExcercisable.872.0.0.0.0.0.0" contextRef="as-of-2014-06-30.872.0.0.0.0.0.0.0" unitRef="USD_per_share" decimals="2">5.21</psti:WarrantsAndOptionsWeightedAverageExercisePriceExcercisable>
  <psti:WarrantsAndOptionsWeightedAverageExercisePriceVestedAndExpectedToVest id="WarrantsAndOptionsWeightedAverageExercisePriceVestedAndExpectedToVest.872.0.0.0.0.0.0" contextRef="as-of-2014-06-30.872.0.0.0.0.0.0.0" unitRef="USD_per_share" decimals="2">5.19</psti:WarrantsAndOptionsWeightedAverageExercisePriceVestedAndExpectedToVest>
  <psti:WarrantsAndOptionsWeightedAverageRemainingContractualTerm id="WarrantsAndOptionsWeightedAverageRemainingContractualTerm.869.0.0.0.0.0.0" contextRef="from-2013-07-01-to-2014-06-30.869.0.0.0.0.0.0.0">P3Y11M16D</psti:WarrantsAndOptionsWeightedAverageRemainingContractualTerm>
  <psti:WarrantsAndOptionsWeightedAverageRemainingContractualTermExercisable id="WarrantsAndOptionsWeightedAverageRemainingContractualTermExercisable.869.0.0.0.0.0.0" contextRef="from-2013-07-01-to-2014-06-30.869.0.0.0.0.0.0.0">P3Y11M5D</psti:WarrantsAndOptionsWeightedAverageRemainingContractualTermExercisable>
  <psti:WarrantsAndOptionsWeightedAverageRemainingContractualTermVestedAndExpectedToVest id="WarrantsAndOptionsWeightedAverageRemainingContractualTermVestedAndExpectedToVest.869.0.0.0.0.0.0" contextRef="from-2013-07-01-to-2014-06-30.869.0.0.0.0.0.0.0">P3Y11M16D</psti:WarrantsAndOptionsWeightedAverageRemainingContractualTermVestedAndExpectedToVest>
  <us-gaap:AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock id="AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock.869.0.0.0.0.0.0" contextRef="from-2013-07-01-to-2014-06-30.869.0.0.0.0.0.0.0">&lt;!--DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd" --&gt;&lt;div&gt; &lt;div&gt;&lt;!--StartFragment--&gt; &lt;div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: left; TEXT-INDENT: 0pt"&gt; NOTE 6:-OTHER ACCOUNTS PAYABLE&lt;/div&gt; &lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"&gt; &amp;nbsp;&lt;/div&gt; &lt;div style="text-align: right"&gt; &lt;table style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman" cellspacing="0" cellpadding="0" width="97%"&gt; &lt;tr&gt; &lt;td style="PADDING-BOTTOM: 2px" valign="bottom" width="76%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-WEIGHT: bold; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="22%" colspan="6"&gt; &lt;div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"&gt; June 30,&lt;/div&gt; &lt;/td&gt; &lt;td style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-WEIGHT: bold; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="PADDING-BOTTOM: 2px" valign="bottom"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td style="PADDING-BOTTOM: 2px" valign="bottom" width="76%" align="left"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-WEIGHT: bold; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="10%" colspan="2"&gt; &lt;div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"&gt; 2014&lt;/div&gt; &lt;/td&gt; &lt;td style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-WEIGHT: bold; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-WEIGHT: bold; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="11%" colspan="4"&gt; &lt;div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"&gt; 2013&lt;/div&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr bgcolor="#cceeff"&gt; &lt;td valign="bottom" width="76%" align="left"&gt; &lt;div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"&gt; Accrued payroll&lt;/div&gt; &lt;/td&gt; &lt;td valign="bottom" width="1%" align="right"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%"&gt;$&lt;/td&gt; &lt;td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%"&gt;424&lt;/td&gt; &lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td valign="bottom" width="1%" align="right"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%"&gt;$&lt;/td&gt; &lt;td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%"&gt;353&lt;/td&gt; &lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr bgcolor="white"&gt; &lt;td valign="bottom" width="76%" align="left"&gt; &lt;div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"&gt; Payroll institutions&lt;/div&gt; &lt;/td&gt; &lt;td valign="bottom" width="1%" align="right"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%"&gt;302&lt;/td&gt; &lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td valign="bottom" width="1%" align="right"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%"&gt;324&lt;/td&gt; &lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr bgcolor="#cceeff"&gt; &lt;td valign="bottom" width="76%" align="left"&gt; &lt;div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"&gt; Accrued vacation&lt;/div&gt; &lt;/td&gt; &lt;td valign="bottom" width="1%" align="right"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%"&gt;673&lt;/td&gt; &lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td valign="bottom" width="1%" align="right"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%"&gt;506&lt;/td&gt; &lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr bgcolor="white"&gt; &lt;td valign="bottom" width="76%" align="left"&gt; &lt;div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"&gt; Advanced payment from lessor&lt;/div&gt; &lt;/td&gt; &lt;td valign="bottom" width="1%" align="right"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%"&gt;89&lt;/td&gt; &lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td valign="bottom" width="1%" align="right"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%"&gt;89&lt;/td&gt; &lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr bgcolor="#cceeff"&gt; &lt;td valign="bottom" width="76%" align="left"&gt; &lt;div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"&gt; Derivatives designated as a fair value hedge instruments&lt;/div&gt; &lt;/td&gt; &lt;td valign="bottom" width="1%" align="right"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%"&gt;889&lt;/td&gt; &lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td valign="bottom" width="1%" align="right"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%"&gt;-&lt;/td&gt; &lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr bgcolor="white"&gt; &lt;td style="PADDING-BOTTOM: 2px" valign="bottom" width="76%" align="left"&gt; &lt;div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"&gt; Other payables&lt;/div&gt; &lt;/td&gt; &lt;td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%" align="right"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 2px solid; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%"&gt;14&lt;/td&gt; &lt;td style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%" align="right"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 2px solid; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%"&gt;-&lt;/td&gt; &lt;td style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr bgcolor="#cceeff"&gt; &lt;td style="PADDING-BOTTOM: 2px" valign="bottom" width="76%" align="left"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 2px solid; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%"&gt;$&lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 2px solid; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%"&gt;2,391&lt;/td&gt; &lt;td style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 2px solid; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%"&gt;$&lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 2px solid; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%"&gt;1,272&lt;/td&gt; &lt;td style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;/tr&gt; &lt;/table&gt; &lt;/div&gt; &lt;!--EndFragment--&gt;&lt;/div&gt; &lt;/div&gt;</us-gaap:AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock>
  <us-gaap:AccountsPayableCurrent id="AccountsPayableCurrent.872.0.0.0.0.0.0" contextRef="as-of-2014-06-30.872.0.0.0.0.0.0.0" unitRef="USD" decimals="-3">3465000</us-gaap:AccountsPayableCurrent>
  <us-gaap:AccountsPayableCurrent id="AccountsPayableCurrent.874.0.0.0.0.0.0" contextRef="as-of-2013-06-30.874.0.0.0.0.0.0.0" unitRef="USD" decimals="-3">2837000</us-gaap:AccountsPayableCurrent>
  <us-gaap:AccountsPayableOtherCurrent id="AccountsPayableOtherCurrent.872.0.0.0.0.0.0" contextRef="as-of-2014-06-30.872.0.0.0.0.0.0.0" unitRef="USD" decimals="-3">2391000</us-gaap:AccountsPayableOtherCurrent>
  <us-gaap:AccountsPayableOtherCurrent id="AccountsPayableOtherCurrent.874.0.0.0.0.0.0" contextRef="as-of-2013-06-30.874.0.0.0.0.0.0.0" unitRef="USD" decimals="-3">1272000</us-gaap:AccountsPayableOtherCurrent>
  <us-gaap:AccountsReceivableNetCurrent id="AccountsReceivableNetCurrent.872.0.0.0.0.0.0" contextRef="as-of-2014-06-30.872.0.0.0.0.0.0.0" unitRef="USD" decimals="-3">2263000</us-gaap:AccountsReceivableNetCurrent>
  <us-gaap:AccountsReceivableNetCurrent id="AccountsReceivableNetCurrent.874.0.0.0.0.0.0" contextRef="as-of-2013-06-30.874.0.0.0.0.0.0.0" unitRef="USD" decimals="-3">273000</us-gaap:AccountsReceivableNetCurrent>
  <us-gaap:AccruedLiabilitiesCurrent id="AccruedLiabilitiesCurrent.872.0.0.0.0.0.0" contextRef="as-of-2014-06-30.872.0.0.0.0.0.0.0" unitRef="USD" decimals="-3">915000</us-gaap:AccruedLiabilitiesCurrent>
  <us-gaap:AccruedLiabilitiesCurrent id="AccruedLiabilitiesCurrent.874.0.0.0.0.0.0" contextRef="as-of-2013-06-30.874.0.0.0.0.0.0.0" unitRef="USD" decimals="-3">1040000</us-gaap:AccruedLiabilitiesCurrent>
  <us-gaap:AccruedVacationCurrent id="AccruedVacationCurrent.872.0.0.0.0.0.0" contextRef="as-of-2014-06-30.872.0.0.0.0.0.0.0" unitRef="USD" decimals="-3">673000</us-gaap:AccruedVacationCurrent>
  <us-gaap:AccruedVacationCurrent id="AccruedVacationCurrent.874.0.0.0.0.0.0" contextRef="as-of-2013-06-30.874.0.0.0.0.0.0.0" unitRef="USD" decimals="-3">506000</us-gaap:AccruedVacationCurrent>
  <us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment id="AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment.872.3840.4261.0.0.0.0" contextRef="as-of-2014-06-30.872.0.3840.4261.0.0.0.0" unitRef="USD" decimals="-3">2042000</us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment>
  <us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment id="AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment.874.3840.4261.0.0.0.0" contextRef="as-of-2013-06-30.874.0.3840.4261.0.0.0.0" unitRef="USD" decimals="-3">1306000</us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment>
  <us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment id="AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment.872.1163.4261.0.0.0.0" contextRef="as-of-2014-06-30.872.0.1163.4261.0.0.0.0" unitRef="USD" decimals="-3">430000</us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment>
  <us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment id="AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment.874.1163.4261.0.0.0.0" contextRef="as-of-2013-06-30.874.0.1163.4261.0.0.0.0" unitRef="USD" decimals="-3">280000</us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment>
  <us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment id="AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment.872.3650.4261.0.0.0.0" contextRef="as-of-2014-06-30.872.0.3650.4261.0.0.0.0" unitRef="USD" decimals="-3">176000</us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment>
  <us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment id="AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment.874.3650.4261.0.0.0.0" contextRef="as-of-2013-06-30.874.0.3650.4261.0.0.0.0" unitRef="USD" decimals="-3">91000</us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment>
  <us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment id="AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment.872.3017.4261.0.0.0.0" contextRef="as-of-2014-06-30.872.0.3017.4261.0.0.0.0" unitRef="USD" decimals="-3">1475000</us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment>
  <us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment id="AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment.874.3017.4261.0.0.0.0" contextRef="as-of-2013-06-30.874.0.3017.4261.0.0.0.0" unitRef="USD" decimals="-3">642000</us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment>
  <us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment id="AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment.872.5488.4261.0.0.0.0" contextRef="as-of-2014-06-30.872.0.5488.4261.0.0.0.0" unitRef="USD" decimals="-3">9000</us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment>
  <us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment id="AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment.874.5488.4261.0.0.0.0" contextRef="as-of-2013-06-30.874.0.5488.4261.0.0.0.0" unitRef="USD" decimals="-3">30000</us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment>
  <us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment id="AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment.872.0.0.0.0.0.0" contextRef="as-of-2014-06-30.872.0.0.0.0.0.0.0" unitRef="USD" decimals="-3">4132000</us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment>
  <us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment id="AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment.874.0.0.0.0.0.0" contextRef="as-of-2013-06-30.874.0.0.0.0.0.0.0" unitRef="USD" decimals="-3">2349000</us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment>
  <us-gaap:AccumulatedOtherComprehensiveIncomeLossCumulativeChangesInNetGainLossFromCashFlowHedgesEffectNetOfTax id="AccumulatedOtherComprehensiveIncomeLossCumulativeChangesInNetGainLossFromCashFlowHedgesEffectNetOfTax.872.17830.1333.2365.1594.1352.1619" contextRef="as-of-2014-06-30.872.0.17830.1333.2365.1594.1352.1619" unitRef="USD" decimals="-3">23000</us-gaap:AccumulatedOtherComprehensiveIncomeLossCumulativeChangesInNetGainLossFromCashFlowHedgesEffectNetOfTax>
  <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax id="AccumulatedOtherComprehensiveIncomeLossNetOfTax.872.0.0.0.0.0.0" contextRef="as-of-2014-06-30.872.0.0.0.0.0.0.0" unitRef="USD" decimals="-3">2959000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
  <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax id="AccumulatedOtherComprehensiveIncomeLossNetOfTax.874.0.0.0.0.0.0" contextRef="as-of-2013-06-30.874.0.0.0.0.0.0.0" unitRef="USD" decimals="-3">259000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
  <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax id="AccumulatedOtherComprehensiveIncomeLossNetOfTax.872.477.5114.0.0.0.0" contextRef="as-of-2014-06-30.872.0.477.5114.0.0.0.0" unitRef="USD" decimals="-3">2936000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
  <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax id="AccumulatedOtherComprehensiveIncomeLossNetOfTax.874.477.5114.0.0.0.0" contextRef="as-of-2013-06-30.874.0.477.5114.0.0.0.0" unitRef="USD" decimals="-3">259000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
  <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax id="AccumulatedOtherComprehensiveIncomeLossNetOfTax.872.484.5114.0.0.0.0" contextRef="as-of-2014-06-30.872.0.484.5114.0.0.0.0" unitRef="USD" decimals="-3">23000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
  <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax id="AccumulatedOtherComprehensiveIncomeLossNetOfTax.874.484.5114.0.0.0.0" xsi:nil="true" contextRef="as-of-2013-06-30.874.0.484.5114.0.0.0.0" unitRef="USD" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" />
  <us-gaap:AdditionalPaidInCapital id="AdditionalPaidInCapital.872.0.0.0.0.0.0" contextRef="as-of-2014-06-30.872.0.0.0.0.0.0.0" unitRef="USD" decimals="-3">172998000</us-gaap:AdditionalPaidInCapital>
  <us-gaap:AdditionalPaidInCapital id="AdditionalPaidInCapital.874.0.0.0.0.0.0" contextRef="as-of-2013-06-30.874.0.0.0.0.0.0.0" unitRef="USD" decimals="-3">144109000</us-gaap:AdditionalPaidInCapital>
  <us-gaap:AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts id="AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts.869.0.0.0.0.0.0" contextRef="from-2013-07-01-to-2014-06-30.869.0.0.0.0.0.0.0" unitRef="USD" decimals="-3">195000</us-gaap:AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts>
  <us-gaap:AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts id="AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts.870.0.0.0.0.0.0" contextRef="from-2012-07-01-to-2013-06-30.870.0.0.0.0.0.0.0" unitRef="USD" decimals="-3">2694000</us-gaap:AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts>
  <us-gaap:AllocatedShareBasedCompensationExpense id="AllocatedShareBasedCompensationExpense.869.25537.367.4543.2652.0.0" contextRef="from-2013-07-01-to-2014-06-30.869.0.25537.367.4543.2652.0.0" unitRef="USD" decimals="-3">11000</us-gaap:AllocatedShareBasedCompensationExpense>
  <us-gaap:AllocatedShareBasedCompensationExpense id="AllocatedShareBasedCompensationExpense.870.25537.367.4543.2652.0.0" contextRef="from-2012-07-01-to-2013-06-30.870.0.25537.367.4543.2652.0.0" unitRef="USD" decimals="-3">26000</us-gaap:AllocatedShareBasedCompensationExpense>
  <us-gaap:AllocatedShareBasedCompensationExpense id="AllocatedShareBasedCompensationExpense.871.25537.367.4543.2652.0.0" contextRef="from-2011-07-01-to-2012-06-30.871.0.25537.367.4543.2652.0.0" unitRef="USD" decimals="-3">19000</us-gaap:AllocatedShareBasedCompensationExpense>
  <us-gaap:AllocatedShareBasedCompensationExpense id="AllocatedShareBasedCompensationExpense.869.25537.367.2476.2652.0.0" xsi:nil="true" contextRef="from-2013-07-01-to-2014-06-30.869.0.25537.367.2476.2652.0.0" unitRef="USD" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" />
  <us-gaap:AllocatedShareBasedCompensationExpense id="AllocatedShareBasedCompensationExpense.870.25537.367.2476.2652.0.0" xsi:nil="true" contextRef="from-2012-07-01-to-2013-06-30.870.0.25537.367.2476.2652.0.0" unitRef="USD" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" />
  <us-gaap:AllocatedShareBasedCompensationExpense id="AllocatedShareBasedCompensationExpense.871.25537.367.2476.2652.0.0" contextRef="from-2011-07-01-to-2012-06-30.871.0.25537.367.2476.2652.0.0" unitRef="USD" decimals="-3">37000</us-gaap:AllocatedShareBasedCompensationExpense>
  <us-gaap:AllocatedShareBasedCompensationExpense id="AllocatedShareBasedCompensationExpense.869.4568.367.4543.2652.0.0" contextRef="from-2013-07-01-to-2014-06-30.869.0.4568.367.4543.2652.0.0" unitRef="USD" decimals="-3">1172000</us-gaap:AllocatedShareBasedCompensationExpense>
  <us-gaap:AllocatedShareBasedCompensationExpense id="AllocatedShareBasedCompensationExpense.870.4568.367.4543.2652.0.0" contextRef="from-2012-07-01-to-2013-06-30.870.0.4568.367.4543.2652.0.0" unitRef="USD" decimals="-3">711000</us-gaap:AllocatedShareBasedCompensationExpense>
  <us-gaap:AllocatedShareBasedCompensationExpense id="AllocatedShareBasedCompensationExpense.871.4568.367.4543.2652.0.0" contextRef="from-2011-07-01-to-2012-06-30.871.0.4568.367.4543.2652.0.0" unitRef="USD" decimals="-3">1163000</us-gaap:AllocatedShareBasedCompensationExpense>
  <us-gaap:AllocatedShareBasedCompensationExpense id="AllocatedShareBasedCompensationExpense.869.4568.367.2476.2652.0.0" contextRef="from-2013-07-01-to-2014-06-30.869.0.4568.367.2476.2652.0.0" unitRef="USD" decimals="-3">4390000</us-gaap:AllocatedShareBasedCompensationExpense>
  <us-gaap:AllocatedShareBasedCompensationExpense id="AllocatedShareBasedCompensationExpense.870.4568.367.2476.2652.0.0" contextRef="from-2012-07-01-to-2013-06-30.870.0.4568.367.2476.2652.0.0" unitRef="USD" decimals="-3">1529000</us-gaap:AllocatedShareBasedCompensationExpense>
  <us-gaap:AllocatedShareBasedCompensationExpense id="AllocatedShareBasedCompensationExpense.871.4568.367.2476.2652.0.0" contextRef="from-2011-07-01-to-2012-06-30.871.0.4568.367.2476.2652.0.0" unitRef="USD" decimals="-3">3487000</us-gaap:AllocatedShareBasedCompensationExpense>
  <us-gaap:AllocatedShareBasedCompensationExpense id="AllocatedShareBasedCompensationExpense.869.25537.367.0.0.0.0" contextRef="from-2013-07-01-to-2014-06-30.869.0.25537.367.0.0.0.0" unitRef="USD" decimals="-3">11000</us-gaap:AllocatedShareBasedCompensationExpense>
  <us-gaap:AllocatedShareBasedCompensationExpense id="AllocatedShareBasedCompensationExpense.870.25537.367.0.0.0.0" contextRef="from-2012-07-01-to-2013-06-30.870.0.25537.367.0.0.0.0" unitRef="USD" decimals="-3">26000</us-gaap:AllocatedShareBasedCompensationExpense>
  <us-gaap:AllocatedShareBasedCompensationExpense id="AllocatedShareBasedCompensationExpense.871.25537.367.0.0.0.0" contextRef="from-2011-07-01-to-2012-06-30.871.0.25537.367.0.0.0.0" unitRef="USD" decimals="-3">56000</us-gaap:AllocatedShareBasedCompensationExpense>
  <us-gaap:AllocatedShareBasedCompensationExpense id="AllocatedShareBasedCompensationExpense.869.4568.367.0.0.0.0" contextRef="from-2013-07-01-to-2014-06-30.869.0.4568.367.0.0.0.0" unitRef="USD" decimals="-3">5562000</us-gaap:AllocatedShareBasedCompensationExpense>
  <us-gaap:AllocatedShareBasedCompensationExpense id="AllocatedShareBasedCompensationExpense.870.4568.367.0.0.0.0" contextRef="from-2012-07-01-to-2013-06-30.870.0.4568.367.0.0.0.0" unitRef="USD" decimals="-3">2240000</us-gaap:AllocatedShareBasedCompensationExpense>
  <us-gaap:AllocatedShareBasedCompensationExpense id="AllocatedShareBasedCompensationExpense.871.4568.367.0.0.0.0" contextRef="from-2011-07-01-to-2012-06-30.871.0.4568.367.0.0.0.0" unitRef="USD" decimals="-3">4650000</us-gaap:AllocatedShareBasedCompensationExpense>
  <us-gaap:AllocatedShareBasedCompensationExpense id="AllocatedShareBasedCompensationExpense.869.4568.367.4543.2652.25535.5039" contextRef="from-2013-07-01-to-2014-06-30.869.0.4568.367.4543.2652.25535.5039" unitRef="USD" decimals="-3">201000</us-gaap:AllocatedShareBasedCompensationExpense>
  <us-gaap:AllocatedShareBasedCompensationExpense id="AllocatedShareBasedCompensationExpense.870.4568.367.4543.2652.25535.5039" contextRef="from-2012-07-01-to-2013-06-30.870.0.4568.367.4543.2652.25535.5039" unitRef="USD" decimals="-3">255000</us-gaap:AllocatedShareBasedCompensationExpense>
  <us-gaap:AllocatedShareBasedCompensationExpense id="AllocatedShareBasedCompensationExpense.871.4568.367.4543.2652.25535.5039" contextRef="from-2011-07-01-to-2012-06-30.871.0.4568.367.4543.2652.25535.5039" unitRef="USD" decimals="-3">201000</us-gaap:AllocatedShareBasedCompensationExpense>
  <us-gaap:AllocatedShareBasedCompensationExpense id="AllocatedShareBasedCompensationExpense.869.4568.367.2476.2652.25535.5039" contextRef="from-2013-07-01-to-2014-06-30.869.0.4568.367.2476.2652.25535.5039" unitRef="USD" decimals="-3">77000</us-gaap:AllocatedShareBasedCompensationExpense>
  <us-gaap:AllocatedShareBasedCompensationExpense id="AllocatedShareBasedCompensationExpense.870.4568.367.2476.2652.25535.5039" contextRef="from-2012-07-01-to-2013-06-30.870.0.4568.367.2476.2652.25535.5039" unitRef="USD" decimals="-3">278000</us-gaap:AllocatedShareBasedCompensationExpense>
  <us-gaap:AllocatedShareBasedCompensationExpense id="AllocatedShareBasedCompensationExpense.871.4568.367.2476.2652.25535.5039" contextRef="from-2011-07-01-to-2012-06-30.871.0.4568.367.2476.2652.25535.5039" unitRef="USD" decimals="-3">20000</us-gaap:AllocatedShareBasedCompensationExpense>
  <us-gaap:AllocatedShareBasedCompensationExpense id="AllocatedShareBasedCompensationExpense.869.25535.5039.0.0.0.0" contextRef="from-2013-07-01-to-2014-06-30.869.0.25535.5039.0.0.0.0" unitRef="USD" decimals="-3">278000</us-gaap:AllocatedShareBasedCompensationExpense>
  <us-gaap:AllocatedShareBasedCompensationExpense id="AllocatedShareBasedCompensationExpense.870.25535.5039.0.0.0.0" contextRef="from-2012-07-01-to-2013-06-30.870.0.25535.5039.0.0.0.0" unitRef="USD" decimals="-3">533000</us-gaap:AllocatedShareBasedCompensationExpense>
  <us-gaap:AllocatedShareBasedCompensationExpense id="AllocatedShareBasedCompensationExpense.871.25535.5039.0.0.0.0" contextRef="from-2011-07-01-to-2012-06-30.871.0.25535.5039.0.0.0.0" unitRef="USD" decimals="-3">221000</us-gaap:AllocatedShareBasedCompensationExpense>
  <us-gaap:Assets id="Assets.872.0.0.0.0.0.0" contextRef="as-of-2014-06-30.872.0.0.0.0.0.0.0" unitRef="USD" decimals="-3">74023000</us-gaap:Assets>
  <us-gaap:Assets id="Assets.874.0.0.0.0.0.0" contextRef="as-of-2013-06-30.874.0.0.0.0.0.0.0" unitRef="USD" decimals="-3">68316000</us-gaap:Assets>
  <us-gaap:AssetsCurrent id="AssetsCurrent.872.0.0.0.0.0.0" contextRef="as-of-2014-06-30.872.0.0.0.0.0.0.0" unitRef="USD" decimals="-3">61987000</us-gaap:AssetsCurrent>
  <us-gaap:AssetsCurrent id="AssetsCurrent.874.0.0.0.0.0.0" contextRef="as-of-2013-06-30.874.0.0.0.0.0.0.0" unitRef="USD" decimals="-3">55085000</us-gaap:AssetsCurrent>
  <us-gaap:AssetsNoncurrent id="AssetsNoncurrent.872.0.0.0.0.0.0" contextRef="as-of-2014-06-30.872.0.0.0.0.0.0.0" unitRef="USD" decimals="-3">12036000</us-gaap:AssetsNoncurrent>
  <us-gaap:AssetsNoncurrent id="AssetsNoncurrent.874.0.0.0.0.0.0" contextRef="as-of-2013-06-30.874.0.0.0.0.0.0.0" unitRef="USD" decimals="-3">13231000</us-gaap:AssetsNoncurrent>
  <us-gaap:AvailableForSaleEquitySecuritiesAccumulatedGrossUnrealizedGainBeforeTax id="AvailableForSaleEquitySecuritiesAccumulatedGrossUnrealizedGainBeforeTax.872.1910.3302.25532.4349.0.0" contextRef="as-of-2014-06-30.872.0.1910.3302.25532.4349.0.0" unitRef="USD" decimals="-3">2522000</us-gaap:AvailableForSaleEquitySecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
  <us-gaap:AvailableForSaleEquitySecuritiesAccumulatedGrossUnrealizedGainBeforeTax id="AvailableForSaleEquitySecuritiesAccumulatedGrossUnrealizedGainBeforeTax.874.1910.3302.25532.4349.0.0" contextRef="as-of-2013-06-30.874.0.1910.3302.25532.4349.0.0" unitRef="USD" decimals="-3">234000</us-gaap:AvailableForSaleEquitySecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
  <us-gaap:AvailableForSaleEquitySecuritiesAccumulatedGrossUnrealizedGainBeforeTax id="AvailableForSaleEquitySecuritiesAccumulatedGrossUnrealizedGainBeforeTax.872.25540.3302.25531.4349.0.0" contextRef="as-of-2014-06-30.872.0.25540.3302.25531.4349.0.0" unitRef="USD" decimals="-3">98000</us-gaap:AvailableForSaleEquitySecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
  <us-gaap:AvailableForSaleEquitySecuritiesAccumulatedGrossUnrealizedGainBeforeTax id="AvailableForSaleEquitySecuritiesAccumulatedGrossUnrealizedGainBeforeTax.874.25540.3302.25531.4349.0.0" contextRef="as-of-2013-06-30.874.0.25540.3302.25531.4349.0.0" unitRef="USD" decimals="-3">49000</us-gaap:AvailableForSaleEquitySecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
  <us-gaap:AvailableForSaleEquitySecuritiesAccumulatedGrossUnrealizedGainBeforeTax id="AvailableForSaleEquitySecuritiesAccumulatedGrossUnrealizedGainBeforeTax.872.25540.3302.25530.4349.0.0" xsi:nil="true" contextRef="as-of-2014-06-30.872.0.25540.3302.25530.4349.0.0" unitRef="USD" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" />
  <us-gaap:AvailableForSaleEquitySecuritiesAccumulatedGrossUnrealizedGainBeforeTax id="AvailableForSaleEquitySecuritiesAccumulatedGrossUnrealizedGainBeforeTax.874.25540.3302.25530.4349.0.0" contextRef="as-of-2013-06-30.874.0.25540.3302.25530.4349.0.0" unitRef="USD" decimals="-3">45000</us-gaap:AvailableForSaleEquitySecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
  <us-gaap:AvailableForSaleEquitySecuritiesAccumulatedGrossUnrealizedGainBeforeTax id="AvailableForSaleEquitySecuritiesAccumulatedGrossUnrealizedGainBeforeTax.872.25540.3302.25532.4349.0.0" contextRef="as-of-2014-06-30.872.0.25540.3302.25532.4349.0.0" unitRef="USD" decimals="-3">9000</us-gaap:AvailableForSaleEquitySecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
  <us-gaap:AvailableForSaleEquitySecuritiesAccumulatedGrossUnrealizedGainBeforeTax id="AvailableForSaleEquitySecuritiesAccumulatedGrossUnrealizedGainBeforeTax.874.25540.3302.25532.4349.0.0" contextRef="as-of-2013-06-30.874.0.25540.3302.25532.4349.0.0" unitRef="USD" decimals="-3">21000</us-gaap:AvailableForSaleEquitySecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
  <us-gaap:AvailableForSaleEquitySecuritiesAccumulatedGrossUnrealizedGainBeforeTax id="AvailableForSaleEquitySecuritiesAccumulatedGrossUnrealizedGainBeforeTax.872.1263.3302.25532.4349.0.0" contextRef="as-of-2014-06-30.872.0.1263.3302.25532.4349.0.0" unitRef="USD" decimals="-3">54000</us-gaap:AvailableForSaleEquitySecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
  <us-gaap:AvailableForSaleEquitySecuritiesAccumulatedGrossUnrealizedGainBeforeTax id="AvailableForSaleEquitySecuritiesAccumulatedGrossUnrealizedGainBeforeTax.874.1263.3302.25532.4349.0.0" contextRef="as-of-2013-06-30.874.0.1263.3302.25532.4349.0.0" unitRef="USD" decimals="-3">30000</us-gaap:AvailableForSaleEquitySecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
  <us-gaap:AvailableForSaleEquitySecuritiesAccumulatedGrossUnrealizedGainBeforeTax id="AvailableForSaleEquitySecuritiesAccumulatedGrossUnrealizedGainBeforeTax.872.1263.3302.25531.4349.0.0" contextRef="as-of-2014-06-30.872.0.1263.3302.25531.4349.0.0" unitRef="USD" decimals="-3">263000</us-gaap:AvailableForSaleEquitySecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
  <us-gaap:AvailableForSaleEquitySecuritiesAccumulatedGrossUnrealizedGainBeforeTax id="AvailableForSaleEquitySecuritiesAccumulatedGrossUnrealizedGainBeforeTax.874.1263.3302.25531.4349.0.0" contextRef="as-of-2013-06-30.874.0.1263.3302.25531.4349.0.0" unitRef="USD" decimals="-3">162000</us-gaap:AvailableForSaleEquitySecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
  <us-gaap:AvailableForSaleEquitySecuritiesAccumulatedGrossUnrealizedGainBeforeTax id="AvailableForSaleEquitySecuritiesAccumulatedGrossUnrealizedGainBeforeTax.872.1263.3302.25530.4349.0.0" contextRef="as-of-2014-06-30.872.0.1263.3302.25530.4349.0.0" unitRef="USD" decimals="-3">19000</us-gaap:AvailableForSaleEquitySecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
  <us-gaap:AvailableForSaleEquitySecuritiesAccumulatedGrossUnrealizedGainBeforeTax id="AvailableForSaleEquitySecuritiesAccumulatedGrossUnrealizedGainBeforeTax.874.1263.3302.25530.4349.0.0" contextRef="as-of-2013-06-30.874.0.1263.3302.25530.4349.0.0" unitRef="USD" decimals="-3">29000</us-gaap:AvailableForSaleEquitySecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
  <us-gaap:AvailableForSaleEquitySecuritiesAccumulatedGrossUnrealizedGainBeforeTax id="AvailableForSaleEquitySecuritiesAccumulatedGrossUnrealizedGainBeforeTax.872.25532.4349.0.0.0.0" contextRef="as-of-2014-06-30.872.0.25532.4349.0.0.0.0" unitRef="USD" decimals="-3">2585000</us-gaap:AvailableForSaleEquitySecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
  <us-gaap:AvailableForSaleEquitySecuritiesAccumulatedGrossUnrealizedGainBeforeTax id="AvailableForSaleEquitySecuritiesAccumulatedGrossUnrealizedGainBeforeTax.874.25532.4349.0.0.0.0" contextRef="as-of-2013-06-30.874.0.25532.4349.0.0.0.0" unitRef="USD" decimals="-3">285000</us-gaap:AvailableForSaleEquitySecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
  <us-gaap:AvailableForSaleEquitySecuritiesAccumulatedGrossUnrealizedGainBeforeTax id="AvailableForSaleEquitySecuritiesAccumulatedGrossUnrealizedGainBeforeTax.872.25531.4349.0.0.0.0" contextRef="as-of-2014-06-30.872.0.25531.4349.0.0.0.0" unitRef="USD" decimals="-3">361000</us-gaap:AvailableForSaleEquitySecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
  <us-gaap:AvailableForSaleEquitySecuritiesAccumulatedGrossUnrealizedGainBeforeTax id="AvailableForSaleEquitySecuritiesAccumulatedGrossUnrealizedGainBeforeTax.874.25531.4349.0.0.0.0" contextRef="as-of-2013-06-30.874.0.25531.4349.0.0.0.0" unitRef="USD" decimals="-3">211000</us-gaap:AvailableForSaleEquitySecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
  <us-gaap:AvailableForSaleEquitySecuritiesAccumulatedGrossUnrealizedGainBeforeTax id="AvailableForSaleEquitySecuritiesAccumulatedGrossUnrealizedGainBeforeTax.872.25530.4349.0.0.0.0" contextRef="as-of-2014-06-30.872.0.25530.4349.0.0.0.0" unitRef="USD" decimals="-3">19000</us-gaap:AvailableForSaleEquitySecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
  <us-gaap:AvailableForSaleEquitySecuritiesAccumulatedGrossUnrealizedGainBeforeTax id="AvailableForSaleEquitySecuritiesAccumulatedGrossUnrealizedGainBeforeTax.874.25530.4349.0.0.0.0" contextRef="as-of-2013-06-30.874.0.25530.4349.0.0.0.0" unitRef="USD" decimals="-3">74000</us-gaap:AvailableForSaleEquitySecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
  <us-gaap:AvailableForSaleEquitySecuritiesAccumulatedGrossUnrealizedGainBeforeTax id="AvailableForSaleEquitySecuritiesAccumulatedGrossUnrealizedGainBeforeTax.872.0.0.0.0.0.0" contextRef="as-of-2014-06-30.872.0.0.0.0.0.0.0" unitRef="USD" decimals="-3">2965000</us-gaap:AvailableForSaleEquitySecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
  <us-gaap:AvailableForSaleEquitySecuritiesAccumulatedGrossUnrealizedGainBeforeTax id="AvailableForSaleEquitySecuritiesAccumulatedGrossUnrealizedGainBeforeTax.874.0.0.0.0.0.0" contextRef="as-of-2013-06-30.874.0.0.0.0.0.0.0" unitRef="USD" decimals="-3">570000</us-gaap:AvailableForSaleEquitySecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
  <us-gaap:AvailableForSaleEquitySecuritiesAccumulatedGrossUnrealizedLossBeforeTax id="AvailableForSaleEquitySecuritiesAccumulatedGrossUnrealizedLossBeforeTax.872.1910.3302.25532.4349.0.0" contextRef="as-of-2014-06-30.872.0.1910.3302.25532.4349.0.0" unitRef="USD" decimals="-3">23000</us-gaap:AvailableForSaleEquitySecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
  <us-gaap:AvailableForSaleEquitySecuritiesAccumulatedGrossUnrealizedLossBeforeTax id="AvailableForSaleEquitySecuritiesAccumulatedGrossUnrealizedLossBeforeTax.874.1910.3302.25532.4349.0.0" contextRef="as-of-2013-06-30.874.0.1910.3302.25532.4349.0.0" unitRef="USD" decimals="-3">180000</us-gaap:AvailableForSaleEquitySecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
  <us-gaap:AvailableForSaleEquitySecuritiesAccumulatedGrossUnrealizedLossBeforeTax id="AvailableForSaleEquitySecuritiesAccumulatedGrossUnrealizedLossBeforeTax.872.25540.3302.25531.4349.0.0" contextRef="as-of-2014-06-30.872.0.25540.3302.25531.4349.0.0" unitRef="USD" decimals="-3">1000</us-gaap:AvailableForSaleEquitySecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
  <us-gaap:AvailableForSaleEquitySecuritiesAccumulatedGrossUnrealizedLossBeforeTax id="AvailableForSaleEquitySecuritiesAccumulatedGrossUnrealizedLossBeforeTax.874.25540.3302.25531.4349.0.0" contextRef="as-of-2013-06-30.874.0.25540.3302.25531.4349.0.0" unitRef="USD" decimals="-3">12000</us-gaap:AvailableForSaleEquitySecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
  <us-gaap:AvailableForSaleEquitySecuritiesAccumulatedGrossUnrealizedLossBeforeTax id="AvailableForSaleEquitySecuritiesAccumulatedGrossUnrealizedLossBeforeTax.872.25540.3302.25530.4349.0.0" xsi:nil="true" contextRef="as-of-2014-06-30.872.0.25540.3302.25530.4349.0.0" unitRef="USD" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" />
  <us-gaap:AvailableForSaleEquitySecuritiesAccumulatedGrossUnrealizedLossBeforeTax id="AvailableForSaleEquitySecuritiesAccumulatedGrossUnrealizedLossBeforeTax.874.25540.3302.25530.4349.0.0" contextRef="as-of-2013-06-30.874.0.25540.3302.25530.4349.0.0" unitRef="USD" decimals="-3">14000</us-gaap:AvailableForSaleEquitySecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
  <us-gaap:AvailableForSaleEquitySecuritiesAccumulatedGrossUnrealizedLossBeforeTax id="AvailableForSaleEquitySecuritiesAccumulatedGrossUnrealizedLossBeforeTax.872.25540.3302.25532.4349.0.0" xsi:nil="true" contextRef="as-of-2014-06-30.872.0.25540.3302.25532.4349.0.0" unitRef="USD" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" />
  <us-gaap:AvailableForSaleEquitySecuritiesAccumulatedGrossUnrealizedLossBeforeTax id="AvailableForSaleEquitySecuritiesAccumulatedGrossUnrealizedLossBeforeTax.874.25540.3302.25532.4349.0.0" xsi:nil="true" contextRef="as-of-2013-06-30.874.0.25540.3302.25532.4349.0.0" unitRef="USD" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" />
  <us-gaap:AvailableForSaleEquitySecuritiesAccumulatedGrossUnrealizedLossBeforeTax id="AvailableForSaleEquitySecuritiesAccumulatedGrossUnrealizedLossBeforeTax.872.1263.3302.25532.4349.0.0" xsi:nil="true" contextRef="as-of-2014-06-30.872.0.1263.3302.25532.4349.0.0" unitRef="USD" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" />
  <us-gaap:AvailableForSaleEquitySecuritiesAccumulatedGrossUnrealizedLossBeforeTax id="AvailableForSaleEquitySecuritiesAccumulatedGrossUnrealizedLossBeforeTax.874.1263.3302.25532.4349.0.0" contextRef="as-of-2013-06-30.874.0.1263.3302.25532.4349.0.0" unitRef="USD" decimals="-3">9000</us-gaap:AvailableForSaleEquitySecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
  <us-gaap:AvailableForSaleEquitySecuritiesAccumulatedGrossUnrealizedLossBeforeTax id="AvailableForSaleEquitySecuritiesAccumulatedGrossUnrealizedLossBeforeTax.872.1263.3302.25531.4349.0.0" contextRef="as-of-2014-06-30.872.0.1263.3302.25531.4349.0.0" unitRef="USD" decimals="-3">5000</us-gaap:AvailableForSaleEquitySecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
  <us-gaap:AvailableForSaleEquitySecuritiesAccumulatedGrossUnrealizedLossBeforeTax id="AvailableForSaleEquitySecuritiesAccumulatedGrossUnrealizedLossBeforeTax.874.1263.3302.25531.4349.0.0" contextRef="as-of-2013-06-30.874.0.1263.3302.25531.4349.0.0" unitRef="USD" decimals="-3">77000</us-gaap:AvailableForSaleEquitySecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
  <us-gaap:AvailableForSaleEquitySecuritiesAccumulatedGrossUnrealizedLossBeforeTax id="AvailableForSaleEquitySecuritiesAccumulatedGrossUnrealizedLossBeforeTax.872.1263.3302.25530.4349.0.0" xsi:nil="true" contextRef="as-of-2014-06-30.872.0.1263.3302.25530.4349.0.0" unitRef="USD" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" />
  <us-gaap:AvailableForSaleEquitySecuritiesAccumulatedGrossUnrealizedLossBeforeTax id="AvailableForSaleEquitySecuritiesAccumulatedGrossUnrealizedLossBeforeTax.874.1263.3302.25530.4349.0.0" contextRef="as-of-2013-06-30.874.0.1263.3302.25530.4349.0.0" unitRef="USD" decimals="-3">19000</us-gaap:AvailableForSaleEquitySecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
  <us-gaap:AvailableForSaleEquitySecuritiesAccumulatedGrossUnrealizedLossBeforeTax id="AvailableForSaleEquitySecuritiesAccumulatedGrossUnrealizedLossBeforeTax.872.25532.4349.0.0.0.0" contextRef="as-of-2014-06-30.872.0.25532.4349.0.0.0.0" unitRef="USD" decimals="-3">23000</us-gaap:AvailableForSaleEquitySecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
  <us-gaap:AvailableForSaleEquitySecuritiesAccumulatedGrossUnrealizedLossBeforeTax id="AvailableForSaleEquitySecuritiesAccumulatedGrossUnrealizedLossBeforeTax.874.25532.4349.0.0.0.0" contextRef="as-of-2013-06-30.874.0.25532.4349.0.0.0.0" unitRef="USD" decimals="-3">189000</us-gaap:AvailableForSaleEquitySecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
  <us-gaap:AvailableForSaleEquitySecuritiesAccumulatedGrossUnrealizedLossBeforeTax id="AvailableForSaleEquitySecuritiesAccumulatedGrossUnrealizedLossBeforeTax.872.25531.4349.0.0.0.0" contextRef="as-of-2014-06-30.872.0.25531.4349.0.0.0.0" unitRef="USD" decimals="-3">6000</us-gaap:AvailableForSaleEquitySecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
  <us-gaap:AvailableForSaleEquitySecuritiesAccumulatedGrossUnrealizedLossBeforeTax id="AvailableForSaleEquitySecuritiesAccumulatedGrossUnrealizedLossBeforeTax.874.25531.4349.0.0.0.0" contextRef="as-of-2013-06-30.874.0.25531.4349.0.0.0.0" unitRef="USD" decimals="-3">89000</us-gaap:AvailableForSaleEquitySecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
  <us-gaap:AvailableForSaleEquitySecuritiesAccumulatedGrossUnrealizedLossBeforeTax id="AvailableForSaleEquitySecuritiesAccumulatedGrossUnrealizedLossBeforeTax.872.25530.4349.0.0.0.0" xsi:nil="true" contextRef="as-of-2014-06-30.872.0.25530.4349.0.0.0.0" unitRef="USD" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" />
  <us-gaap:AvailableForSaleEquitySecuritiesAccumulatedGrossUnrealizedLossBeforeTax id="AvailableForSaleEquitySecuritiesAccumulatedGrossUnrealizedLossBeforeTax.874.25530.4349.0.0.0.0" contextRef="as-of-2013-06-30.874.0.25530.4349.0.0.0.0" unitRef="USD" decimals="-3">33000</us-gaap:AvailableForSaleEquitySecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
  <us-gaap:AvailableForSaleEquitySecuritiesAccumulatedGrossUnrealizedLossBeforeTax id="AvailableForSaleEquitySecuritiesAccumulatedGrossUnrealizedLossBeforeTax.872.0.0.0.0.0.0" contextRef="as-of-2014-06-30.872.0.0.0.0.0.0.0" unitRef="USD" decimals="-3">29000</us-gaap:AvailableForSaleEquitySecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
  <us-gaap:AvailableForSaleEquitySecuritiesAccumulatedGrossUnrealizedLossBeforeTax id="AvailableForSaleEquitySecuritiesAccumulatedGrossUnrealizedLossBeforeTax.874.0.0.0.0.0.0" contextRef="as-of-2013-06-30.874.0.0.0.0.0.0.0" unitRef="USD" decimals="-3">311000</us-gaap:AvailableForSaleEquitySecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
  <us-gaap:AvailableForSaleSecurities id="AvailableForSaleSecurities.872.1910.3302.25532.4349.0.0" contextRef="as-of-2014-06-30.872.0.1910.3302.25532.4349.0.0" unitRef="USD" decimals="-3">21380000</us-gaap:AvailableForSaleSecurities>
  <us-gaap:AvailableForSaleSecurities id="AvailableForSaleSecurities.874.1910.3302.25532.4349.0.0" contextRef="as-of-2013-06-30.874.0.1910.3302.25532.4349.0.0" unitRef="USD" decimals="-3">4077000</us-gaap:AvailableForSaleSecurities>
  <us-gaap:AvailableForSaleSecurities id="AvailableForSaleSecurities.872.25540.3302.25531.4349.0.0" contextRef="as-of-2014-06-30.872.0.25540.3302.25531.4349.0.0" unitRef="USD" decimals="-3">2692000</us-gaap:AvailableForSaleSecurities>
  <us-gaap:AvailableForSaleSecurities id="AvailableForSaleSecurities.874.25540.3302.25531.4349.0.0" contextRef="as-of-2013-06-30.874.0.25540.3302.25531.4349.0.0" unitRef="USD" decimals="-3">1639000</us-gaap:AvailableForSaleSecurities>
  <us-gaap:AvailableForSaleSecurities id="AvailableForSaleSecurities.872.25540.3302.25530.4349.0.0" xsi:nil="true" contextRef="as-of-2014-06-30.872.0.25540.3302.25530.4349.0.0" unitRef="USD" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" />
  <us-gaap:AvailableForSaleSecurities id="AvailableForSaleSecurities.874.25540.3302.25530.4349.0.0" contextRef="as-of-2013-06-30.874.0.25540.3302.25530.4349.0.0" unitRef="USD" decimals="-3">986000</us-gaap:AvailableForSaleSecurities>
  <us-gaap:AvailableForSaleSecurities id="AvailableForSaleSecurities.872.25540.3302.25532.4349.0.0" contextRef="as-of-2014-06-30.872.0.25540.3302.25532.4349.0.0" unitRef="USD" decimals="-3">106000</us-gaap:AvailableForSaleSecurities>
  <us-gaap:AvailableForSaleSecurities id="AvailableForSaleSecurities.874.25540.3302.25532.4349.0.0" contextRef="as-of-2013-06-30.874.0.25540.3302.25532.4349.0.0" unitRef="USD" decimals="-3">350000</us-gaap:AvailableForSaleSecurities>
  <us-gaap:AvailableForSaleSecurities id="AvailableForSaleSecurities.872.1263.3302.25532.4349.0.0" contextRef="as-of-2014-06-30.872.0.1263.3302.25532.4349.0.0" unitRef="USD" decimals="-3">506000</us-gaap:AvailableForSaleSecurities>
  <us-gaap:AvailableForSaleSecurities id="AvailableForSaleSecurities.874.1263.3302.25532.4349.0.0" contextRef="as-of-2013-06-30.874.0.1263.3302.25532.4349.0.0" unitRef="USD" decimals="-3">529000</us-gaap:AvailableForSaleSecurities>
  <us-gaap:AvailableForSaleSecurities id="AvailableForSaleSecurities.872.1263.3302.25531.4349.0.0" contextRef="as-of-2014-06-30.872.0.1263.3302.25531.4349.0.0" unitRef="USD" decimals="-3">5164000</us-gaap:AvailableForSaleSecurities>
  <us-gaap:AvailableForSaleSecurities id="AvailableForSaleSecurities.874.1263.3302.25531.4349.0.0" contextRef="as-of-2013-06-30.874.0.1263.3302.25531.4349.0.0" unitRef="USD" decimals="-3">5061000</us-gaap:AvailableForSaleSecurities>
  <us-gaap:AvailableForSaleSecurities id="AvailableForSaleSecurities.872.1263.3302.25530.4349.0.0" contextRef="as-of-2014-06-30.872.0.1263.3302.25530.4349.0.0" unitRef="USD" decimals="-3">113000</us-gaap:AvailableForSaleSecurities>
  <us-gaap:AvailableForSaleSecurities id="AvailableForSaleSecurities.874.1263.3302.25530.4349.0.0" contextRef="as-of-2013-06-30.874.0.1263.3302.25530.4349.0.0" unitRef="USD" decimals="-3">799000</us-gaap:AvailableForSaleSecurities>
  <us-gaap:AvailableForSaleSecurities id="AvailableForSaleSecurities.872.25532.4349.0.0.0.0" contextRef="as-of-2014-06-30.872.0.25532.4349.0.0.0.0" unitRef="USD" decimals="-3">21992000</us-gaap:AvailableForSaleSecurities>
  <us-gaap:AvailableForSaleSecurities id="AvailableForSaleSecurities.874.25532.4349.0.0.0.0" contextRef="as-of-2013-06-30.874.0.25532.4349.0.0.0.0" unitRef="USD" decimals="-3">4956000</us-gaap:AvailableForSaleSecurities>
  <us-gaap:AvailableForSaleSecurities id="AvailableForSaleSecurities.872.25531.4349.0.0.0.0" contextRef="as-of-2014-06-30.872.0.25531.4349.0.0.0.0" unitRef="USD" decimals="-3">7856000</us-gaap:AvailableForSaleSecurities>
  <us-gaap:AvailableForSaleSecurities id="AvailableForSaleSecurities.874.25531.4349.0.0.0.0" contextRef="as-of-2013-06-30.874.0.25531.4349.0.0.0.0" unitRef="USD" decimals="-3">6700000</us-gaap:AvailableForSaleSecurities>
  <us-gaap:AvailableForSaleSecurities id="AvailableForSaleSecurities.872.25530.4349.0.0.0.0" contextRef="as-of-2014-06-30.872.0.25530.4349.0.0.0.0" unitRef="USD" decimals="-3">113000</us-gaap:AvailableForSaleSecurities>
  <us-gaap:AvailableForSaleSecurities id="AvailableForSaleSecurities.874.25530.4349.0.0.0.0" contextRef="as-of-2013-06-30.874.0.25530.4349.0.0.0.0" unitRef="USD" decimals="-3">1785000</us-gaap:AvailableForSaleSecurities>
  <us-gaap:AvailableForSaleSecurities id="AvailableForSaleSecurities.872.0.0.0.0.0.0" contextRef="as-of-2014-06-30.872.0.0.0.0.0.0.0" unitRef="USD" decimals="-3">29961000</us-gaap:AvailableForSaleSecurities>
  <us-gaap:AvailableForSaleSecurities id="AvailableForSaleSecurities.874.0.0.0.0.0.0" contextRef="as-of-2013-06-30.874.0.0.0.0.0.0.0" unitRef="USD" decimals="-3">13441000</us-gaap:AvailableForSaleSecurities>
  <us-gaap:AvailableForSaleSecuritiesAmortizedCost id="AvailableForSaleSecuritiesAmortizedCost.872.1910.3302.25532.4349.0.0" contextRef="as-of-2014-06-30.872.0.1910.3302.25532.4349.0.0" unitRef="USD" decimals="-3">18881000</us-gaap:AvailableForSaleSecuritiesAmortizedCost>
  <us-gaap:AvailableForSaleSecuritiesAmortizedCost id="AvailableForSaleSecuritiesAmortizedCost.874.1910.3302.25532.4349.0.0" contextRef="as-of-2013-06-30.874.0.1910.3302.25532.4349.0.0" unitRef="USD" decimals="-3">4023000</us-gaap:AvailableForSaleSecuritiesAmortizedCost>
  <us-gaap:AvailableForSaleSecuritiesAmortizedCost id="AvailableForSaleSecuritiesAmortizedCost.872.25540.3302.25531.4349.0.0" contextRef="as-of-2014-06-30.872.0.25540.3302.25531.4349.0.0" unitRef="USD" decimals="-3">2595000</us-gaap:AvailableForSaleSecuritiesAmortizedCost>
  <us-gaap:AvailableForSaleSecuritiesAmortizedCost id="AvailableForSaleSecuritiesAmortizedCost.874.25540.3302.25531.4349.0.0" contextRef="as-of-2013-06-30.874.0.25540.3302.25531.4349.0.0" unitRef="USD" decimals="-3">1602000</us-gaap:AvailableForSaleSecuritiesAmortizedCost>
  <us-gaap:AvailableForSaleSecuritiesAmortizedCost id="AvailableForSaleSecuritiesAmortizedCost.872.25540.3302.25530.4349.0.0" xsi:nil="true" contextRef="as-of-2014-06-30.872.0.25540.3302.25530.4349.0.0" unitRef="USD" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" />
  <us-gaap:AvailableForSaleSecuritiesAmortizedCost id="AvailableForSaleSecuritiesAmortizedCost.874.25540.3302.25530.4349.0.0" contextRef="as-of-2013-06-30.874.0.25540.3302.25530.4349.0.0" unitRef="USD" decimals="-3">955000</us-gaap:AvailableForSaleSecuritiesAmortizedCost>
  <us-gaap:AvailableForSaleSecuritiesAmortizedCost id="AvailableForSaleSecuritiesAmortizedCost.872.25540.3302.25532.4349.0.0" contextRef="as-of-2014-06-30.872.0.25540.3302.25532.4349.0.0" unitRef="USD" decimals="-3">97000</us-gaap:AvailableForSaleSecuritiesAmortizedCost>
  <us-gaap:AvailableForSaleSecuritiesAmortizedCost id="AvailableForSaleSecuritiesAmortizedCost.874.25540.3302.25532.4349.0.0" contextRef="as-of-2013-06-30.874.0.25540.3302.25532.4349.0.0" unitRef="USD" decimals="-3">329000</us-gaap:AvailableForSaleSecuritiesAmortizedCost>
  <us-gaap:AvailableForSaleSecuritiesAmortizedCost id="AvailableForSaleSecuritiesAmortizedCost.872.1263.3302.25532.4349.0.0" contextRef="as-of-2014-06-30.872.0.1263.3302.25532.4349.0.0" unitRef="USD" decimals="-3">452000</us-gaap:AvailableForSaleSecuritiesAmortizedCost>
  <us-gaap:AvailableForSaleSecuritiesAmortizedCost id="AvailableForSaleSecuritiesAmortizedCost.874.1263.3302.25532.4349.0.0" contextRef="as-of-2013-06-30.874.0.1263.3302.25532.4349.0.0" unitRef="USD" decimals="-3">508000</us-gaap:AvailableForSaleSecuritiesAmortizedCost>
  <us-gaap:AvailableForSaleSecuritiesAmortizedCost id="AvailableForSaleSecuritiesAmortizedCost.872.1263.3302.25531.4349.0.0" contextRef="as-of-2014-06-30.872.0.1263.3302.25531.4349.0.0" unitRef="USD" decimals="-3">4906000</us-gaap:AvailableForSaleSecuritiesAmortizedCost>
  <us-gaap:AvailableForSaleSecuritiesAmortizedCost id="AvailableForSaleSecuritiesAmortizedCost.874.1263.3302.25531.4349.0.0" contextRef="as-of-2013-06-30.874.0.1263.3302.25531.4349.0.0" unitRef="USD" decimals="-3">4976000</us-gaap:AvailableForSaleSecuritiesAmortizedCost>
  <us-gaap:AvailableForSaleSecuritiesAmortizedCost id="AvailableForSaleSecuritiesAmortizedCost.872.1263.3302.25530.4349.0.0" contextRef="as-of-2014-06-30.872.0.1263.3302.25530.4349.0.0" unitRef="USD" decimals="-3">94000</us-gaap:AvailableForSaleSecuritiesAmortizedCost>
  <us-gaap:AvailableForSaleSecuritiesAmortizedCost id="AvailableForSaleSecuritiesAmortizedCost.874.1263.3302.25530.4349.0.0" contextRef="as-of-2013-06-30.874.0.1263.3302.25530.4349.0.0" unitRef="USD" decimals="-3">789000</us-gaap:AvailableForSaleSecuritiesAmortizedCost>
  <us-gaap:AvailableForSaleSecuritiesAmortizedCost id="AvailableForSaleSecuritiesAmortizedCost.872.25532.4349.0.0.0.0" contextRef="as-of-2014-06-30.872.0.25532.4349.0.0.0.0" unitRef="USD" decimals="-3">19430000</us-gaap:AvailableForSaleSecuritiesAmortizedCost>
  <us-gaap:AvailableForSaleSecuritiesAmortizedCost id="AvailableForSaleSecuritiesAmortizedCost.874.25532.4349.0.0.0.0" contextRef="as-of-2013-06-30.874.0.25532.4349.0.0.0.0" unitRef="USD" decimals="-3">4860000</us-gaap:AvailableForSaleSecuritiesAmortizedCost>
  <us-gaap:AvailableForSaleSecuritiesAmortizedCost id="AvailableForSaleSecuritiesAmortizedCost.872.25531.4349.0.0.0.0" contextRef="as-of-2014-06-30.872.0.25531.4349.0.0.0.0" unitRef="USD" decimals="-3">7501000</us-gaap:AvailableForSaleSecuritiesAmortizedCost>
  <us-gaap:AvailableForSaleSecuritiesAmortizedCost id="AvailableForSaleSecuritiesAmortizedCost.874.25531.4349.0.0.0.0" contextRef="as-of-2013-06-30.874.0.25531.4349.0.0.0.0" unitRef="USD" decimals="-3">6578000</us-gaap:AvailableForSaleSecuritiesAmortizedCost>
  <us-gaap:AvailableForSaleSecuritiesAmortizedCost id="AvailableForSaleSecuritiesAmortizedCost.872.25530.4349.0.0.0.0" contextRef="as-of-2014-06-30.872.0.25530.4349.0.0.0.0" unitRef="USD" decimals="-3">94000</us-gaap:AvailableForSaleSecuritiesAmortizedCost>
  <us-gaap:AvailableForSaleSecuritiesAmortizedCost id="AvailableForSaleSecuritiesAmortizedCost.874.25530.4349.0.0.0.0" contextRef="as-of-2013-06-30.874.0.25530.4349.0.0.0.0" unitRef="USD" decimals="-3">1744000</us-gaap:AvailableForSaleSecuritiesAmortizedCost>
  <us-gaap:AvailableForSaleSecuritiesAmortizedCost id="AvailableForSaleSecuritiesAmortizedCost.872.0.0.0.0.0.0" contextRef="as-of-2014-06-30.872.0.0.0.0.0.0.0" unitRef="USD" decimals="-3">27025000</us-gaap:AvailableForSaleSecuritiesAmortizedCost>
  <us-gaap:AvailableForSaleSecuritiesAmortizedCost id="AvailableForSaleSecuritiesAmortizedCost.874.0.0.0.0.0.0" contextRef="as-of-2013-06-30.874.0.0.0.0.0.0.0" unitRef="USD" decimals="-3">13182000</us-gaap:AvailableForSaleSecuritiesAmortizedCost>
  <us-gaap:AvailableForSaleSecuritiesContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss id="AvailableForSaleSecuritiesContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss.872.0.0.0.0.0.0" contextRef="as-of-2014-06-30.872.0.0.0.0.0.0.0" unitRef="USD" decimals="-3">12000</us-gaap:AvailableForSaleSecuritiesContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss>
  <us-gaap:AvailableForSaleSecuritiesContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss id="AvailableForSaleSecuritiesContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss.874.0.0.0.0.0.0" contextRef="as-of-2013-06-30.874.0.0.0.0.0.0.0" unitRef="USD" decimals="-3">9000</us-gaap:AvailableForSaleSecuritiesContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss>
  <us-gaap:AvailableForSaleSecuritiesContinuousUnrealizedLossPositionFairValueTableTextBlock id="AvailableForSaleSecuritiesContinuousUnrealizedLossPositionFairValueTableTextBlock.869.0.0.0.0.0.0" contextRef="from-2013-07-01-to-2014-06-30.869.0.0.0.0.0.0.0">&lt;!--DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd" --&gt;&lt;div&gt; &lt;div&gt;&lt;!--StartFragment--&gt; &lt;div style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt"&gt; The following table presents gross unrealized losses and fair values for those investments that were in an unrealized loss position as of June 30, 2014 and June 30, 2013, and the length of time that those investments have been in a continuous loss position:&lt;/div&gt; &lt;div style="MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt"&gt; &amp;nbsp;&lt;/div&gt; &lt;div style="text-align: left"&gt; &lt;table style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman" cellspacing="0" cellpadding="0" width="100%"&gt; &lt;tr&gt; &lt;td style="PADDING-BOTTOM: 2px" valign="bottom"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="PADDING-BOTTOM: 2px" valign="bottom"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-WEIGHT: bold; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 2px solid" valign="bottom" colspan="6"&gt; &lt;div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"&gt; Less than 12 months&lt;/div&gt; &lt;/td&gt; &lt;td style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-WEIGHT: bold; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="PADDING-BOTTOM: 2px" valign="bottom"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-WEIGHT: bold; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 2px solid" valign="bottom" colspan="6"&gt; &lt;div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"&gt; 12 months or greater&lt;/div&gt; &lt;/td&gt; &lt;td style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-WEIGHT: bold; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td style="PADDING-BOTTOM: 2px" valign="bottom"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="PADDING-BOTTOM: 2px" valign="bottom"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-WEIGHT: bold; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 2px solid" valign="bottom" colspan="2"&gt; &lt;div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"&gt; Fair Value&lt;/div&gt; &lt;/td&gt; &lt;td style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-WEIGHT: bold; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="PADDING-BOTTOM: 2px" valign="bottom"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-WEIGHT: bold; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 2px solid" valign="bottom" colspan="2"&gt; &lt;div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"&gt; Gross&lt;/div&gt; &lt;div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"&gt; unrealized loss&lt;/div&gt; &lt;/td&gt; &lt;td style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-WEIGHT: bold; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="PADDING-BOTTOM: 2px" valign="bottom"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-WEIGHT: bold; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 2px solid" valign="bottom" colspan="2"&gt; &lt;div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"&gt; Fair Value&lt;/div&gt; &lt;/td&gt; &lt;td style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-WEIGHT: bold; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="PADDING-BOTTOM: 2px" valign="bottom"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-WEIGHT: bold; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 2px solid" valign="bottom" colspan="2"&gt; &lt;div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"&gt; Gross&lt;/div&gt; &lt;div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"&gt; unrealized loss&lt;/div&gt; &lt;/td&gt; &lt;td style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-WEIGHT: bold; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr bgcolor="#cceeff"&gt; &lt;td style="TEXT-ALIGN: left; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt" valign="bottom" width="52%"&gt; &lt;div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: left; TEXT-INDENT: 0pt"&gt; As of June 30, 2014&lt;/div&gt; &lt;/td&gt; &lt;td valign="bottom" width="1%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%"&gt;$&lt;/td&gt; &lt;td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%"&gt;851&lt;/td&gt; &lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td valign="bottom" width="1%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%"&gt;$&lt;/td&gt; &lt;td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%"&gt;(17&lt;/td&gt; &lt;td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"&gt;)&lt;/td&gt; &lt;td valign="bottom" width="1%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%"&gt;$&lt;/td&gt; &lt;td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%"&gt;463&lt;/td&gt; &lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td valign="bottom" width="1%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%"&gt;$&lt;/td&gt; &lt;td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%"&gt;(12&lt;/td&gt; &lt;td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"&gt;)&lt;/td&gt; &lt;/tr&gt; &lt;tr bgcolor="white"&gt; &lt;td style="TEXT-ALIGN: left; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt" valign="bottom" width="52%"&gt; &lt;div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: left; TEXT-INDENT: 0pt"&gt; As of June 30, 2013&lt;/div&gt; &lt;/td&gt; &lt;td valign="bottom" width="1%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%"&gt;$&lt;/td&gt; &lt;td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%"&gt;5,122&lt;/td&gt; &lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td valign="bottom" width="1%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%"&gt;$&lt;/td&gt; &lt;td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%"&gt;(302&lt;/td&gt; &lt;td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"&gt;)&lt;/td&gt; &lt;td valign="bottom" width="1%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%"&gt;$&lt;/td&gt; &lt;td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%"&gt;32&lt;/td&gt; &lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td valign="bottom" width="1%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%"&gt;$&lt;/td&gt; &lt;td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%"&gt;(9&lt;/td&gt; &lt;td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"&gt;)&lt;/td&gt; &lt;/tr&gt; &lt;/table&gt; &lt;/div&gt; &lt;!--EndFragment--&gt;&lt;/div&gt; &lt;/div&gt;</us-gaap:AvailableForSaleSecuritiesContinuousUnrealizedLossPositionFairValueTableTextBlock>
  <us-gaap:AvailableForSaleSecuritiesContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss id="AvailableForSaleSecuritiesContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss.872.0.0.0.0.0.0" contextRef="as-of-2014-06-30.872.0.0.0.0.0.0.0" unitRef="USD" decimals="-3">17000</us-gaap:AvailableForSaleSecuritiesContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss>
  <us-gaap:AvailableForSaleSecuritiesContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss id="AvailableForSaleSecuritiesContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss.874.0.0.0.0.0.0" contextRef="as-of-2013-06-30.874.0.0.0.0.0.0.0" unitRef="USD" decimals="-3">302000</us-gaap:AvailableForSaleSecuritiesContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss>
  <us-gaap:AvailableForSaleSecuritiesContinuousUnrealizedLossPositionLessThanTwelveMonthsFairValue id="AvailableForSaleSecuritiesContinuousUnrealizedLossPositionLessThanTwelveMonthsFairValue.872.0.0.0.0.0.0" contextRef="as-of-2014-06-30.872.0.0.0.0.0.0.0" unitRef="USD" decimals="-3">851000</us-gaap:AvailableForSaleSecuritiesContinuousUnrealizedLossPositionLessThanTwelveMonthsFairValue>
  <us-gaap:AvailableForSaleSecuritiesContinuousUnrealizedLossPositionLessThanTwelveMonthsFairValue id="AvailableForSaleSecuritiesContinuousUnrealizedLossPositionLessThanTwelveMonthsFairValue.874.0.0.0.0.0.0" contextRef="as-of-2013-06-30.874.0.0.0.0.0.0.0" unitRef="USD" decimals="-3">5122000</us-gaap:AvailableForSaleSecuritiesContinuousUnrealizedLossPositionLessThanTwelveMonthsFairValue>
  <us-gaap:AvailableForSaleSecuritiesContinuousUnrealizedLossPositionTwelveMonthsOrLongerFairValue id="AvailableForSaleSecuritiesContinuousUnrealizedLossPositionTwelveMonthsOrLongerFairValue.872.0.0.0.0.0.0" contextRef="as-of-2014-06-30.872.0.0.0.0.0.0.0" unitRef="USD" decimals="-3">463000</us-gaap:AvailableForSaleSecuritiesContinuousUnrealizedLossPositionTwelveMonthsOrLongerFairValue>
  <us-gaap:AvailableForSaleSecuritiesContinuousUnrealizedLossPositionTwelveMonthsOrLongerFairValue id="AvailableForSaleSecuritiesContinuousUnrealizedLossPositionTwelveMonthsOrLongerFairValue.874.0.0.0.0.0.0" contextRef="as-of-2013-06-30.874.0.0.0.0.0.0.0" unitRef="USD" decimals="-3">32000</us-gaap:AvailableForSaleSecuritiesContinuousUnrealizedLossPositionTwelveMonthsOrLongerFairValue>
  <us-gaap:AvailableForSaleSecuritiesTextBlock id="AvailableForSaleSecuritiesTextBlock.869.0.0.0.0.0.0" contextRef="from-2013-07-01-to-2014-06-30.869.0.0.0.0.0.0.0">&lt;!--DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd" --&gt;&lt;div&gt; &lt;div&gt;&lt;!--StartFragment--&gt; &lt;div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"&gt; As of June 30, 2014, all of the Company&amp;#39;s marketable securities were classified as available-for-sale.&lt;/div&gt; &lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"&gt; &amp;nbsp;&lt;/div&gt; &lt;div style="text-align: left"&gt; &lt;table style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman" cellspacing="0" cellpadding="0" width="100%"&gt; &lt;tr&gt; &lt;td style="PADDING-BOTTOM: 2px" valign="bottom" width="20%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-WEIGHT: bold; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="38%" colspan="14"&gt; &lt;div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"&gt; June 30, 2014&lt;/div&gt; &lt;/td&gt; &lt;td style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-WEIGHT: bold; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="38%" colspan="14"&gt; &lt;div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"&gt; June 30,2013&lt;/div&gt; &lt;/td&gt; &lt;td style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td style="PADDING-BOTTOM: 2px" valign="bottom" width="20%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-WEIGHT: bold; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="8%" colspan="2"&gt; &lt;div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"&gt; Amortized cost&lt;/div&gt; &lt;/td&gt; &lt;td style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-WEIGHT: bold; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-WEIGHT: bold; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="8%" colspan="2"&gt; &lt;div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"&gt; Gross&lt;/div&gt; &lt;div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"&gt; unrealized&lt;/div&gt; &lt;div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"&gt; gain&lt;/div&gt; &lt;/td&gt; &lt;td style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-WEIGHT: bold; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-WEIGHT: bold; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="8%" colspan="2"&gt; &lt;div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"&gt; Gross&lt;/div&gt; &lt;div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"&gt; unrealized&lt;/div&gt; &lt;div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"&gt; loss&lt;/div&gt; &lt;/td&gt; &lt;td style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-WEIGHT: bold; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-WEIGHT: bold; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="8%" colspan="2"&gt; &lt;div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"&gt; Fair&lt;/div&gt; &lt;div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"&gt; value&lt;/div&gt; &lt;/td&gt; &lt;td style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-WEIGHT: bold; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-WEIGHT: bold; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="8%" colspan="2"&gt; &lt;div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"&gt; Amortized cost&lt;/div&gt; &lt;/td&gt; &lt;td style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-WEIGHT: bold; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-WEIGHT: bold; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="8%" colspan="2"&gt; &lt;div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"&gt; Gross&lt;/div&gt; &lt;div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"&gt; unrealized&lt;/div&gt; &lt;div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"&gt; gain&lt;/div&gt; &lt;/td&gt; &lt;td style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-WEIGHT: bold; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-WEIGHT: bold; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="8%" colspan="2"&gt; &lt;div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"&gt; Gross&lt;/div&gt; &lt;div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"&gt; unrealized&lt;/div&gt; &lt;div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"&gt; loss&lt;/div&gt; &lt;/td&gt; &lt;td style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-WEIGHT: bold; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-WEIGHT: bold; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="8%" colspan="2"&gt; &lt;div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"&gt; Fair&lt;/div&gt; &lt;div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"&gt; value&lt;/div&gt; &lt;/td&gt; &lt;td style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-WEIGHT: bold; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr bgcolor="#cceeff"&gt; &lt;td style="TEXT-ALIGN: left; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt" valign="bottom" width="20%"&gt; &lt;div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: left; TEXT-INDENT: 0pt"&gt; Available-for-sale - matures within one year:&lt;/div&gt; &lt;/td&gt; &lt;td valign="bottom" width="1%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td valign="bottom" width="8%" colspan="2"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td valign="bottom" width="1%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td valign="bottom" width="8%" colspan="2"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td valign="bottom" width="1%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td valign="bottom" width="8%" colspan="2"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td valign="bottom" width="1%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td valign="bottom" width="8%" colspan="2"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td valign="bottom" width="1%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td valign="bottom" width="8%" colspan="2"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td valign="bottom" width="1%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td valign="bottom" width="8%" colspan="2"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td valign="bottom" width="1%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td valign="bottom" width="8%" colspan="2"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td valign="bottom" width="1%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td valign="bottom" width="8%" colspan="2"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr bgcolor="white"&gt; &lt;td style="TEXT-ALIGN: left; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt" valign="bottom" width="20%"&gt; &lt;div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: left; TEXT-INDENT: 0pt"&gt; Stock and index linked notes&lt;/div&gt; &lt;/td&gt; &lt;td valign="bottom" width="1%" align="right"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%"&gt;$&lt;/td&gt; &lt;td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="7%"&gt;18,881&lt;/td&gt; &lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td valign="bottom" width="1%" align="right"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%"&gt;$&lt;/td&gt; &lt;td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="7%"&gt;2,522&lt;/td&gt; &lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td valign="bottom" width="1%" align="right"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%"&gt;$&lt;/td&gt; &lt;td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="7%"&gt;(23&lt;/td&gt; &lt;td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"&gt;)&lt;/td&gt; &lt;td valign="bottom" width="1%" align="right"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%"&gt;$&lt;/td&gt; &lt;td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="7%"&gt;21,380&lt;/td&gt; &lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td valign="bottom" width="1%" align="right"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%"&gt;$&lt;/td&gt; &lt;td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="7%"&gt;4,023&lt;/td&gt; &lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td valign="bottom" width="1%" align="right"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%"&gt;$&lt;/td&gt; &lt;td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="7%"&gt;234&lt;/td&gt; &lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td valign="bottom" width="1%" align="right"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%"&gt;$&lt;/td&gt; &lt;td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="7%"&gt;(180&lt;/td&gt; &lt;td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"&gt;)&lt;/td&gt; &lt;td valign="bottom" width="1%" align="right"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%"&gt;$&lt;/td&gt; &lt;td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="7%"&gt;4,077&lt;/td&gt; &lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr bgcolor="#cceeff"&gt; &lt;td style="TEXT-ALIGN: left; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt" valign="bottom" width="20%"&gt; &lt;div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: left; TEXT-INDENT: 0pt"&gt; Government debentures - fixed interest rate&lt;/div&gt; &lt;/td&gt; &lt;td valign="bottom" width="1%" align="right"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="7%"&gt;97&lt;/td&gt; &lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td valign="bottom" width="1%" align="right"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="7%"&gt;9&lt;/td&gt; &lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td valign="bottom" width="1%" align="right"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="7%"&gt;-&lt;/td&gt; &lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td valign="bottom" width="1%" align="right"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="7%"&gt;106&lt;/td&gt; &lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td valign="bottom" width="1%" align="right"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="7%"&gt;329&lt;/td&gt; &lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td valign="bottom" width="1%" align="right"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="7%"&gt;21&lt;/td&gt; &lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td valign="bottom" width="1%" align="right"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="7%"&gt;-&lt;/td&gt; &lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td valign="bottom" width="1%" align="right"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="7%"&gt;350&lt;/td&gt; &lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr bgcolor="white"&gt; &lt;td style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt" valign="bottom" width="20%"&gt; &lt;div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: left; TEXT-INDENT: 0pt"&gt; Corporate debentures - fixed interest rate&lt;/div&gt; &lt;/td&gt; &lt;td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%" align="right"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 2px solid; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="7%"&gt;452&lt;/td&gt; &lt;td style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%" align="right"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 2px solid; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="7%"&gt;54&lt;/td&gt; &lt;td style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%" align="right"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 2px solid; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="7%"&gt;-&lt;/td&gt; &lt;td style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%" align="right"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 2px solid; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="7%"&gt;506&lt;/td&gt; &lt;td style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%" align="right"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 2px solid; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="7%"&gt;508&lt;/td&gt; &lt;td style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%" align="right"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 2px solid; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="7%"&gt;30&lt;/td&gt; &lt;td style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%" align="right"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 2px solid; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="7%"&gt;(9&lt;/td&gt; &lt;td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"&gt;)&lt;/td&gt; &lt;td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%" align="right"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 2px solid; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="7%"&gt;529&lt;/td&gt; &lt;td style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr bgcolor="#cceeff"&gt; &lt;td valign="bottom" width="20%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td valign="bottom" width="1%" align="right"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%"&gt;$&lt;/td&gt; &lt;td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="7%"&gt;19,430&lt;/td&gt; &lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td valign="bottom" width="1%" align="right"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%"&gt;$&lt;/td&gt; &lt;td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="7%"&gt;2,585&lt;/td&gt; &lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td valign="bottom" width="1%" align="right"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%"&gt;$&lt;/td&gt; &lt;td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="7%"&gt;(23&lt;/td&gt; &lt;td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"&gt;)&lt;/td&gt; &lt;td valign="bottom" width="1%" align="right"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%"&gt;$&lt;/td&gt; &lt;td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="7%"&gt;21,992&lt;/td&gt; &lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td valign="bottom" width="1%" align="right"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%"&gt;$&lt;/td&gt; &lt;td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="7%"&gt;4,860&lt;/td&gt; &lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td valign="bottom" width="1%" align="right"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%"&gt;$&lt;/td&gt; &lt;td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="7%"&gt;285&lt;/td&gt; &lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td valign="bottom" width="1%" align="right"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%"&gt;$&lt;/td&gt; &lt;td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="7%"&gt;(189&lt;/td&gt; &lt;td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"&gt;)&lt;/td&gt; &lt;td valign="bottom" width="1%" align="right"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%"&gt;$&lt;/td&gt; &lt;td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="7%"&gt;4,956&lt;/td&gt; &lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr bgcolor="white"&gt; &lt;td style="TEXT-ALIGN: left; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt" valign="bottom" width="20%"&gt; &lt;div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: left; TEXT-INDENT: 0pt"&gt; Available-for-sale - matures after one year through five years:&lt;/div&gt; &lt;/td&gt; &lt;td valign="bottom" width="1%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: right" valign="bottom" width="7%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td valign="bottom" width="1%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: right" valign="bottom" width="7%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td valign="bottom" width="1%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: right" valign="bottom" width="7%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td valign="bottom" width="1%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: right" valign="bottom" width="7%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td valign="bottom" width="1%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: right" valign="bottom" width="7%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td valign="bottom" width="1%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: right" valign="bottom" width="7%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td valign="bottom" width="1%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: right" valign="bottom" width="7%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td valign="bottom" width="1%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: right" valign="bottom" width="7%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr bgcolor="#cceeff"&gt; &lt;td style="TEXT-ALIGN: left; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt" valign="bottom" width="20%"&gt; &lt;div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: left; TEXT-INDENT: 0pt"&gt; Government debentures - fixed interest rate&lt;/div&gt; &lt;/td&gt; &lt;td valign="bottom" width="1%" align="right"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="7%"&gt;2,595&lt;/td&gt; &lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td valign="bottom" width="1%" align="right"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="7%"&gt;98&lt;/td&gt; &lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td valign="bottom" width="1%" align="right"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="7%"&gt;(1&lt;/td&gt; &lt;td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"&gt;)&lt;/td&gt; &lt;td valign="bottom" width="1%" align="right"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="7%"&gt;2,692&lt;/td&gt; &lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td valign="bottom" width="1%" align="right"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="7%"&gt;1,602&lt;/td&gt; &lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td valign="bottom" width="1%" align="right"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="7%"&gt;49&lt;/td&gt; &lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td valign="bottom" width="1%" align="right"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="7%"&gt;(12&lt;/td&gt; &lt;td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"&gt;)&lt;/td&gt; &lt;td valign="bottom" width="1%" align="right"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="7%"&gt;1,639&lt;/td&gt; &lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr bgcolor="white"&gt; &lt;td style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt" valign="bottom" width="20%"&gt; &lt;div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: left; TEXT-INDENT: 0pt"&gt; Corporate debentures - fixed interest rate&lt;/div&gt; &lt;/td&gt; &lt;td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%" align="right"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 2px solid; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="7%"&gt;4,906&lt;/td&gt; &lt;td style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%" align="right"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 2px solid; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="7%"&gt;263&lt;/td&gt; &lt;td style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%" align="right"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 2px solid; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="7%"&gt;(5&lt;/td&gt; &lt;td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"&gt;)&lt;/td&gt; &lt;td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%" align="right"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 2px solid; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="7%"&gt;5,164&lt;/td&gt; &lt;td style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%" align="right"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 2px solid; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="7%"&gt;4,976&lt;/td&gt; &lt;td style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%" align="right"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 2px solid; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="7%"&gt;162&lt;/td&gt; &lt;td style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%" align="right"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 2px solid; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="7%"&gt;(77&lt;/td&gt; &lt;td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"&gt;)&lt;/td&gt; &lt;td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%" align="right"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 2px solid; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="7%"&gt;5,061&lt;/td&gt; &lt;td style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr bgcolor="#cceeff"&gt; &lt;td valign="bottom" width="20%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td valign="bottom" width="1%" align="right"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%"&gt;$&lt;/td&gt; &lt;td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="7%"&gt;7,501&lt;/td&gt; &lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td valign="bottom" width="1%" align="right"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%"&gt;$&lt;/td&gt; &lt;td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="7%"&gt;361&lt;/td&gt; &lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td valign="bottom" width="1%" align="right"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%"&gt;$&lt;/td&gt; &lt;td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="7%"&gt;(6&lt;/td&gt; &lt;td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"&gt;)&lt;/td&gt; &lt;td valign="bottom" width="1%" align="right"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%"&gt;$&lt;/td&gt; &lt;td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="7%"&gt;7,856&lt;/td&gt; &lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td valign="bottom" width="1%" align="right"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%"&gt;$&lt;/td&gt; &lt;td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="7%"&gt;6,578&lt;/td&gt; &lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td valign="bottom" width="1%" align="right"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%"&gt;$&lt;/td&gt; &lt;td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="7%"&gt;211&lt;/td&gt; &lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td valign="bottom" width="1%" align="right"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%"&gt;$&lt;/td&gt; &lt;td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="7%"&gt;(89&lt;/td&gt; &lt;td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"&gt;)&lt;/td&gt; &lt;td valign="bottom" width="1%" align="right"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%"&gt;$&lt;/td&gt; &lt;td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="7%"&gt;6,700&lt;/td&gt; &lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr bgcolor="white"&gt; &lt;td style="TEXT-ALIGN: left; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt" valign="bottom" width="20%"&gt; &lt;div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: left; TEXT-INDENT: 0pt"&gt; Available-for-sale - matures after five years through ten years:&lt;/div&gt; &lt;/td&gt; &lt;td valign="bottom" width="1%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: right" valign="bottom" width="7%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td valign="bottom" width="1%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: right" valign="bottom" width="7%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td valign="bottom" width="1%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: right" valign="bottom" width="7%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td valign="bottom" width="1%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: right" valign="bottom" width="7%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td valign="bottom" width="1%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: right" valign="bottom" width="7%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td valign="bottom" width="1%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: right" valign="bottom" width="7%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td valign="bottom" width="1%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: right" valign="bottom" width="7%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td valign="bottom" width="1%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: right" valign="bottom" width="7%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr bgcolor="#cceeff"&gt; &lt;td style="TEXT-ALIGN: left; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt" valign="bottom" width="20%"&gt; &lt;div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: left; TEXT-INDENT: 0pt"&gt; Government debentures - fixed interest rate&lt;/div&gt; &lt;/td&gt; &lt;td valign="bottom" width="1%" align="right"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="7%"&gt;-&lt;/td&gt; &lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td valign="bottom" width="1%" align="right"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="7%"&gt;-&lt;/td&gt; &lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td valign="bottom" width="1%" align="right"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="7%"&gt;-&lt;/td&gt; &lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td valign="bottom" width="1%" align="right"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="7%"&gt;-&lt;/td&gt; &lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td valign="bottom" width="1%" align="right"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="7%"&gt;955&lt;/td&gt; &lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td valign="bottom" width="1%" align="right"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="7%"&gt;45&lt;/td&gt; &lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td valign="bottom" width="1%" align="right"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="7%"&gt;(14&lt;/td&gt; &lt;td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"&gt;)&lt;/td&gt; &lt;td valign="bottom" width="1%" align="right"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="7%"&gt;986&lt;/td&gt; &lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr bgcolor="white"&gt; &lt;td style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt" valign="bottom" width="20%"&gt; &lt;div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: left; TEXT-INDENT: 0pt"&gt; Corporate debentures - fixed interest rate&lt;/div&gt; &lt;/td&gt; &lt;td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%" align="right"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 2px solid; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="7%"&gt;94&lt;/td&gt; &lt;td style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%" align="right"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 2px solid; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="7%"&gt;19&lt;/td&gt; &lt;td style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%" align="right"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 2px solid; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="7%"&gt;-&lt;/td&gt; &lt;td style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%" align="right"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 2px solid; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="7%"&gt;113&lt;/td&gt; &lt;td style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%" align="right"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 2px solid; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="7%"&gt;789&lt;/td&gt; &lt;td style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%" align="right"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 2px solid; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="7%"&gt;29&lt;/td&gt; &lt;td style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%" align="right"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 2px solid; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="7%"&gt;(19&lt;/td&gt; &lt;td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"&gt;)&lt;/td&gt; &lt;td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%" align="right"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 2px solid; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="7%"&gt;799&lt;/td&gt; &lt;td style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr bgcolor="#cceeff"&gt; &lt;td style="PADDING-BOTTOM: 2px" valign="bottom" width="20%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%" align="right"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 2px solid; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%"&gt;$&lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 2px solid; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="7%"&gt;94&lt;/td&gt; &lt;td style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%" align="right"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 2px solid; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%"&gt;$&lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 2px solid; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="7%"&gt;19&lt;/td&gt; &lt;td style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%" align="right"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 2px solid; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%"&gt;$&lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 2px solid; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="7%"&gt;-&lt;/td&gt; &lt;td style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%" align="right"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 2px solid; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%"&gt;$&lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 2px solid; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="7%"&gt;113&lt;/td&gt; &lt;td style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%" align="right"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 2px solid; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%"&gt;$&lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 2px solid; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="7%"&gt;1,744&lt;/td&gt; &lt;td style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%" align="right"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 2px solid; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%"&gt;$&lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 2px solid; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="7%"&gt;74&lt;/td&gt; &lt;td style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%" align="right"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 2px solid; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%"&gt;$&lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 2px solid; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="7%"&gt;(33&lt;/td&gt; &lt;td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"&gt;)&lt;/td&gt; &lt;td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%" align="right"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 2px solid; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%"&gt;$&lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 2px solid; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="7%"&gt;1,785&lt;/td&gt; &lt;td style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr bgcolor="white"&gt; &lt;td style="PADDING-BOTTOM: 4px; TEXT-ALIGN: left; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt" valign="bottom" width="20%"&gt; &lt;div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: left; TEXT-INDENT: 0pt"&gt; Total&lt;/div&gt; &lt;/td&gt; &lt;td style="PADDING-BOTTOM: 4px" valign="bottom" width="1%" align="right"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 4px double; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%"&gt;$&lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 4px double; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="7%"&gt;27,025&lt;/td&gt; &lt;td style="PADDING-BOTTOM: 4px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="PADDING-BOTTOM: 4px" valign="bottom" width="1%" align="right"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 4px double; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%"&gt;$&lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 4px double; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="7%"&gt;2,965&lt;/td&gt; &lt;td style="PADDING-BOTTOM: 4px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="PADDING-BOTTOM: 4px" valign="bottom" width="1%" align="right"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 4px double; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%"&gt;$&lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 4px double; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="7%"&gt;(29&lt;/td&gt; &lt;td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; PADDING-BOTTOM: 4px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"&gt;)&lt;/td&gt; &lt;td style="PADDING-BOTTOM: 4px" valign="bottom" width="1%" align="right"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 4px double; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%"&gt;$&lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 4px double; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="7%"&gt;29,961&lt;/td&gt; &lt;td style="PADDING-BOTTOM: 4px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="PADDING-BOTTOM: 4px" valign="bottom" width="1%" align="right"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 4px double; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%"&gt;$&lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 4px double; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="7%"&gt;13,182&lt;/td&gt; &lt;td style="PADDING-BOTTOM: 4px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="PADDING-BOTTOM: 4px" valign="bottom" width="1%" align="right"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 4px double; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%"&gt;$&lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 4px double; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="7%"&gt;570&lt;/td&gt; &lt;td style="PADDING-BOTTOM: 4px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="PADDING-BOTTOM: 4px" valign="bottom" width="1%" align="right"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 4px double; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%"&gt;$&lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 4px double; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="7%"&gt;(311&lt;/td&gt; &lt;td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; PADDING-BOTTOM: 4px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"&gt;)&lt;/td&gt; &lt;td style="PADDING-BOTTOM: 4px" valign="bottom" width="1%" align="right"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 4px double; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%"&gt;$&lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 4px double; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="7%"&gt;13,441&lt;/td&gt; &lt;td style="PADDING-BOTTOM: 4px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;/tr&gt; &lt;/table&gt; &lt;/div&gt; &lt;!--EndFragment--&gt;&lt;/div&gt; &lt;/div&gt;</us-gaap:AvailableForSaleSecuritiesTextBlock>
  <us-gaap:CapitalExpendituresIncurredButNotYetPaid id="CapitalExpendituresIncurredButNotYetPaid.869.0.0.0.0.0.0" contextRef="from-2013-07-01-to-2014-06-30.869.0.0.0.0.0.0.0" unitRef="USD" decimals="-3">243000</us-gaap:CapitalExpendituresIncurredButNotYetPaid>
  <us-gaap:CapitalExpendituresIncurredButNotYetPaid id="CapitalExpendituresIncurredButNotYetPaid.870.0.0.0.0.0.0" contextRef="from-2012-07-01-to-2013-06-30.870.0.0.0.0.0.0.0" unitRef="USD" decimals="-3">872000</us-gaap:CapitalExpendituresIncurredButNotYetPaid>
  <us-gaap:CapitalExpendituresIncurredButNotYetPaid id="CapitalExpendituresIncurredButNotYetPaid.871.0.0.0.0.0.0" contextRef="from-2011-07-01-to-2012-06-30.871.0.0.0.0.0.0.0" unitRef="USD" decimals="-3">738000</us-gaap:CapitalExpendituresIncurredButNotYetPaid>
  <us-gaap:CashAndCashEquivalentsAtCarryingValue id="CashAndCashEquivalentsAtCarryingValue.872.0.0.0.0.0.0" contextRef="as-of-2014-06-30.872.0.0.0.0.0.0.0" unitRef="USD" decimals="-3">4493000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
  <us-gaap:CashAndCashEquivalentsAtCarryingValue id="CashAndCashEquivalentsAtCarryingValue.874.0.0.0.0.0.0" contextRef="as-of-2013-06-30.874.0.0.0.0.0.0.0" unitRef="USD" decimals="-3">9007000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
  <us-gaap:CashAndCashEquivalentsAtCarryingValue id="CashAndCashEquivalentsAtCarryingValue.875.0.0.0.0.0.0" contextRef="as-of-2011-06-30.875.0.0.0.0.0.0.0" unitRef="USD" decimals="-3">42829000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
  <us-gaap:CashAndCashEquivalentsAtCarryingValue id="CashAndCashEquivalentsAtCarryingValue.876.0.0.0.0.0.0" contextRef="as-of-2012-06-30.876.0.0.0.0.0.0.0" unitRef="USD" decimals="-3">9389000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
  <us-gaap:CashAndCashEquivalentsPeriodIncreaseDecrease id="CashAndCashEquivalentsPeriodIncreaseDecrease.869.0.0.0.0.0.0" contextRef="from-2013-07-01-to-2014-06-30.869.0.0.0.0.0.0.0" unitRef="USD" decimals="-3">-4514000</us-gaap:CashAndCashEquivalentsPeriodIncreaseDecrease>
  <us-gaap:CashAndCashEquivalentsPeriodIncreaseDecrease id="CashAndCashEquivalentsPeriodIncreaseDecrease.870.0.0.0.0.0.0" contextRef="from-2012-07-01-to-2013-06-30.870.0.0.0.0.0.0.0" unitRef="USD" decimals="-3">-382000</us-gaap:CashAndCashEquivalentsPeriodIncreaseDecrease>
  <us-gaap:CashAndCashEquivalentsPeriodIncreaseDecrease id="CashAndCashEquivalentsPeriodIncreaseDecrease.871.0.0.0.0.0.0" contextRef="from-2011-07-01-to-2012-06-30.871.0.0.0.0.0.0.0" unitRef="USD" decimals="-3">-33440000</us-gaap:CashAndCashEquivalentsPeriodIncreaseDecrease>
  <us-gaap:CashAndCashEquivalentsPolicyTextBlock id="CashAndCashEquivalentsPolicyTextBlock.869.0.0.0.0.0.0" contextRef="from-2013-07-01-to-2014-06-30.869.0.0.0.0.0.0.0">&lt;!--DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd" --&gt;&lt;div&gt; &lt;div&gt;&lt;!--StartFragment--&gt; &lt;div&gt; &lt;table style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman" cellspacing="0" cellpadding="0" width="100%" align="center" border="0"&gt; &lt;tr valign="top"&gt; &lt;td style="WIDTH: 18pt"&gt; &lt;div style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt"&gt; d.&lt;/div&gt; &lt;/td&gt; &lt;td&gt; &lt;div style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; text-align: justify"&gt; Cash and cash equivalents&lt;/div&gt; &lt;/td&gt; &lt;/tr&gt; &lt;/table&gt; &lt;/div&gt; &lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"&gt; &amp;nbsp;&lt;/div&gt; &lt;div&gt; &lt;table style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman" cellspacing="0" cellpadding="0" width="100%" align="center" border="0"&gt; &lt;tr valign="top"&gt; &lt;td style="WIDTH: 19pt"&gt; &lt;div style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/div&gt; &lt;/td&gt; &lt;td&gt; &lt;div style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; text-align: justify"&gt; Cash equivalents are short-term highly liquid investments that are readily convertible to cash with maturities of three months or less at the date acquired.&lt;/div&gt; &lt;/td&gt; &lt;/tr&gt; &lt;/table&gt; &lt;/div&gt; &lt;!--EndFragment--&gt;&lt;/div&gt; &lt;/div&gt;</us-gaap:CashAndCashEquivalentsPolicyTextBlock>
  <us-gaap:CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy id="CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy.869.0.0.0.0.0.0" contextRef="from-2013-07-01-to-2014-06-30.869.0.0.0.0.0.0.0">&lt;!--DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd" --&gt;&lt;div&gt; &lt;div&gt;&lt;!--StartFragment--&gt; &lt;div style="text-align: center"&gt; &lt;table style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman" cellspacing="0" cellpadding="0" width="100%" border="0"&gt; &lt;tr valign="top"&gt; &lt;td style="WIDTH: 18pt"&gt; &lt;div style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt"&gt; f.&lt;/div&gt; &lt;/td&gt; &lt;td&gt; &lt;div style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; text-align: justify"&gt; Restricted cash and short-term deposits&lt;/div&gt; &lt;/td&gt; &lt;/tr&gt; &lt;/table&gt; &lt;/div&gt; &lt;div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; MARGIN-LEFT: 36pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"&gt; &amp;nbsp;&lt;/div&gt; &lt;div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"&gt; Short-term restricted deposits and restricted cash used to secure derivative transactions are presented at cost.&lt;/div&gt; &lt;!--EndFragment--&gt;&lt;/div&gt; &lt;/div&gt;</us-gaap:CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy>
  <us-gaap:CashFlowHedgesDerivativeInstrumentsAtFairValueNet id="CashFlowHedgesDerivativeInstrumentsAtFairValueNet.872.17830.1333.2365.1594.1352.1619" contextRef="as-of-2014-06-30.872.0.17830.1333.2365.1594.1352.1619" unitRef="USD" decimals="-3">24000</us-gaap:CashFlowHedgesDerivativeInstrumentsAtFairValueNet>
  <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1 id="ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1.969.25814.1048.0.0.0.0" contextRef="as-of-2012-09-19.969.0.25814.1048.0.0.0.0" unitRef="USD_per_share" decimals="INF">5.00</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1>
  <us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight id="ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight.969.25814.1048.0.0.0.0" contextRef="as-of-2012-09-19.969.0.25814.1048.0.0.0.0" unitRef="shares" decimals="INF">0.35</us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight>
  <us-gaap:ClassOfWarrantOrRightOutstanding id="ClassOfWarrantOrRightOutstanding.969.25815.1048.0.0.0.0" contextRef="as-of-2012-09-19.969.0.25815.1048.0.0.0.0" unitRef="shares" decimals="INF">1200000</us-gaap:ClassOfWarrantOrRightOutstanding>
  <us-gaap:ClassOfWarrantOrRightOutstanding id="ClassOfWarrantOrRightOutstanding.969.25744.1048.0.0.0.0" contextRef="as-of-2012-09-19.969.0.25744.1048.0.0.0.0" unitRef="shares" decimals="INF">420000</us-gaap:ClassOfWarrantOrRightOutstanding>
  <us-gaap:CommitmentsAndContingencies id="CommitmentsAndContingencies.872.0.0.0.0.0.0" xsi:nil="true" contextRef="as-of-2014-06-30.872.0.0.0.0.0.0.0" unitRef="USD" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" />
  <us-gaap:CommitmentsAndContingencies id="CommitmentsAndContingencies.874.0.0.0.0.0.0" xsi:nil="true" contextRef="as-of-2013-06-30.874.0.0.0.0.0.0.0" unitRef="USD" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" />
  <us-gaap:CommitmentsAndContingenciesDisclosureTextBlock id="CommitmentsAndContingenciesDisclosureTextBlock.869.0.0.0.0.0.0" contextRef="from-2013-07-01-to-2014-06-30.869.0.0.0.0.0.0.0">&lt;!--DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd" --&gt;&lt;div&gt; &lt;div&gt;&lt;!--StartFragment--&gt; &lt;div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: left; TEXT-INDENT: 0pt"&gt; NOTE 7:-COMMITMENTS AND CONTINGENCIES&lt;/div&gt; &lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"&gt; &amp;nbsp;&lt;/div&gt; &lt;div style="text-align: center"&gt; &lt;table style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman" cellspacing="0" cellpadding="0" width="100%" border="0"&gt; &lt;tr valign="top"&gt; &lt;td style="WIDTH: 18pt"&gt; &lt;div style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt"&gt; a.&lt;/div&gt; &lt;/td&gt; &lt;td&gt; &lt;div style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; text-align: justify"&gt; The facilities of the Subsidiary are rented under operating lease agreements, which expire on various dates, the latest of which is in 2017. In January 2013 the Subsidiary received from the lessor a non-refundable payment, which payment represents the lessor participation in the leasehold improvements, of approximately $816. The payment is deductible against lease expenses as it is incurred. The lessor upfront payment is included the in balance sheet as advance payment and recognized as a deduction from lease expenses over the lease term.&lt;/div&gt; &lt;div style="text-align: justify"&gt;&amp;nbsp;&lt;/div&gt; &lt;div style="text-align: justify"&gt; &lt;div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: justify; TEXT-INDENT: 0pt"&gt; The Company recognizes rent expense, net of lessor participation, under such arrangements on a straight-line basis over the lease term.&lt;/div&gt; &lt;div style="TEXT-ALIGN: justify; MARGIN-LEFT: 0pt; DISPLAY: block; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt"&gt; &amp;nbsp;&lt;/div&gt; &lt;div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: justify; TEXT-INDENT: 0pt"&gt; As of June&amp;nbsp;30, 2014 aggregate minimum lease commitments under non-cancelable operating lease agreements are as follows:&lt;/div&gt; &lt;/div&gt; &lt;/td&gt; &lt;/tr&gt; &lt;/table&gt; &lt;/div&gt; &lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"&gt; &amp;nbsp;&lt;/div&gt; &lt;div style="MARGIN-LEFT: 18pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-ALIGN: left; TEXT-INDENT: 0pt"&gt; &lt;table style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman" cellspacing="0" cellpadding="0" width="50%"&gt; &lt;tr bgcolor="#cceeff"&gt; &lt;td valign="bottom" width="88%" align="left"&gt; &lt;div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 9pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: -9pt"&gt; Year ending June 30,&lt;/div&gt; &lt;/td&gt; &lt;td valign="bottom" width="1%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td valign="bottom" width="10%" colspan="2"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr bgcolor="white"&gt; &lt;td valign="bottom" width="88%" align="left"&gt; &lt;div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 9pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: -9pt"&gt; 2015&lt;/div&gt; &lt;/td&gt; &lt;td valign="bottom" width="1%" align="right"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%"&gt;$&lt;/td&gt; &lt;td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%"&gt;667&lt;/td&gt; &lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr bgcolor="#cceeff"&gt; &lt;td valign="bottom" width="88%" align="left"&gt; &lt;div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 9pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: -9pt"&gt; 2016&lt;/div&gt; &lt;/td&gt; &lt;td valign="bottom" width="1%" align="right"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%"&gt;497&lt;/td&gt; &lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr bgcolor="white"&gt; &lt;td style="PADDING-BOTTOM: 2px" valign="bottom" width="88%" align="left"&gt; &lt;div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 9pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: -9pt"&gt; 2017&lt;/div&gt; &lt;/td&gt; &lt;td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%" align="right"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 2px solid; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%"&gt;349&lt;/td&gt; &lt;td style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr bgcolor="#cceeff"&gt; &lt;td style="PADDING-BOTTOM: 4px" valign="bottom" width="88%" align="left"&gt; &lt;div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 9pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: -9pt"&gt; Total&lt;/div&gt; &lt;/td&gt; &lt;td style="PADDING-BOTTOM: 4px" valign="bottom" width="1%" align="right"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 4px double; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%"&gt;$&lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 4px double; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%"&gt;1,513&lt;/td&gt; &lt;td style="PADDING-BOTTOM: 4px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;/tr&gt; &lt;/table&gt; &lt;/div&gt; &lt;div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; MARGIN-LEFT: 36pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"&gt; &amp;nbsp;&lt;/div&gt; &lt;div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"&gt; Lease expenses amounted to $720, $678 and $382 for the years ended June 30, 2014, 2013 and 2012, respectively.&lt;/div&gt; &lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"&gt; &amp;nbsp;&lt;/div&gt; &lt;div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"&gt; The Subsidiary has issued a bank guarantee in favor of the lessors for $388.&lt;/div&gt; &lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"&gt; &amp;nbsp;&lt;/div&gt; &lt;div style="text-align: center"&gt; &lt;table style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman" cellspacing="0" cellpadding="0" width="100%" border="0"&gt; &lt;tr valign="top"&gt; &lt;td style="WIDTH: 18pt"&gt; &lt;div style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt"&gt; b.&lt;/div&gt; &lt;/td&gt; &lt;td&gt; &lt;div style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; text-align: justify"&gt; The Subsidiary leases several motor vehicles under operating lease agreements, which expire in various dates during years 2014 through April 2017.&lt;/div&gt; &lt;/td&gt; &lt;/tr&gt; &lt;/table&gt; &lt;/div&gt; &lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"&gt; &amp;nbsp;&lt;/div&gt; &lt;div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"&gt; As of June&amp;nbsp;30, 2014, future aggregate minimum lease commitments under non-cancelable operating lease agreements are as follows:&lt;/div&gt; &lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"&gt; &amp;nbsp;&lt;/div&gt; &lt;div style="MARGIN-LEFT: 18pt; text-align: left"&gt; &lt;table style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman" cellspacing="0" cellpadding="0" width="50%"&gt; &lt;tr bgcolor="#cceeff"&gt; &lt;td valign="bottom" width="88%" align="left"&gt; &lt;div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"&gt; Year ending June 30,&lt;/div&gt; &lt;/td&gt; &lt;td valign="bottom" width="1%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td valign="bottom" width="10%" colspan="2"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr bgcolor="white"&gt; &lt;td valign="bottom" width="88%" align="left"&gt; &lt;div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"&gt; 2015&lt;/div&gt; &lt;/td&gt; &lt;td valign="bottom" width="1%" align="right"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%"&gt;$&lt;/td&gt; &lt;td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%"&gt;140&lt;/td&gt; &lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr bgcolor="#cceeff"&gt; &lt;td valign="bottom" width="88%" align="left"&gt; &lt;div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"&gt; 2016&lt;/div&gt; &lt;/td&gt; &lt;td valign="bottom" width="1%" align="right"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%"&gt;85&lt;/td&gt; &lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr bgcolor="white"&gt; &lt;td style="PADDING-BOTTOM: 2px" valign="bottom" width="88%" align="left"&gt; &lt;div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"&gt; 2017&lt;/div&gt; &lt;/td&gt; &lt;td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%" align="right"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 2px solid; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%"&gt;26&lt;/td&gt; &lt;td style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr bgcolor="#cceeff"&gt; &lt;td style="PADDING-BOTTOM: 2px" valign="bottom" width="88%" align="left"&gt; &lt;div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"&gt; Total&lt;/div&gt; &lt;/td&gt; &lt;td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%" align="right"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 2px solid; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%"&gt;$&lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 2px solid; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%"&gt;251&lt;/td&gt; &lt;td style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;/tr&gt; &lt;/table&gt; &lt;/div&gt; &lt;div style="DISPLAY: block; TEXT-INDENT: 0pt"&gt;&amp;nbsp;&lt;/div&gt; &lt;div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"&gt; Lease expenses amounted to $244, $215 and $176 for the years ended June 30, 2014, 2013 and 2012, respectively.&lt;/div&gt; &lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"&gt; &amp;nbsp;&lt;/div&gt; &lt;div style="text-align: center"&gt; &lt;table style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman" cellspacing="0" cellpadding="0" width="100%" border="0"&gt; &lt;tr valign="top"&gt; &lt;td style="WIDTH: 18pt"&gt; &lt;div style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt"&gt; c.&lt;/div&gt; &lt;/td&gt; &lt;td&gt; &lt;div style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; text-align: justify"&gt; An amount of $4,805 of cash and deposits was pledged by the Subsidiary to secure the hedging transactions, credit line and Bank guarantees.&lt;/div&gt; &lt;/td&gt; &lt;/tr&gt; &lt;/table&gt; &lt;/div&gt; &lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"&gt; &amp;nbsp;&lt;/div&gt; &lt;div style="text-align: center"&gt; &lt;table style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman" cellspacing="0" cellpadding="0" width="100%" border="0"&gt; &lt;tr valign="top"&gt; &lt;td style="WIDTH: 18pt"&gt; &lt;div style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt"&gt; d.&lt;/div&gt; &lt;/td&gt; &lt;td&gt; &lt;div style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; text-align: justify"&gt; Under the Law for the Encouragement of Industrial Research and Development, 1984, (the "Research Law"), research and development programs that meet specified criteria and are approved by a governmental committee of the OCS are eligible for grants of up to 50% of the project&amp;#39;s expenditures, as determined by the research committee, in exchange for the payment of royalties from the sale of products developed under the program. Regulations under the Research Law generally provide for the payment of royalties to the Chief Scientist of 3% to 4% on sales of products and services derived from a technology developed using these grants until 100% of the dollar-linked grant is repaid. The Company&amp;#39;s obligation to pay these royalties is contingent on its actual sale of such products and services. In the absence of such sales, no payment is required. Outstanding balance of the grants will be subject to interest at a rate equal to the 12 month LIBOR applicable to dollar deposits that is published on the first business day of each calendar year. Following the full repayment of the grant, there is no further liability for royalties.&lt;/div&gt; &lt;/td&gt; &lt;/tr&gt; &lt;/table&gt; &lt;/div&gt; &lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"&gt; &amp;nbsp;&lt;/div&gt; &lt;div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"&gt; Through June 30, 2014, total grants obtained aggregated to approximately $14,125. Through June 30, 2014, total royalties paid and accrued amounted to $53. As of June 30, 2014, the Company&amp;#39;s contingent liability in respect to royalties to the OCS amounted $14,072, not include LIBOR interest as described above.&lt;/div&gt; &lt;!--EndFragment--&gt;&lt;/div&gt; &lt;/div&gt;</us-gaap:CommitmentsAndContingenciesDisclosureTextBlock>
  <us-gaap:CommonStockParOrStatedValuePerShare id="CommonStockParOrStatedValuePerShare.872.0.0.0.0.0.0" contextRef="as-of-2014-06-30.872.0.0.0.0.0.0.0" unitRef="USD_per_share" decimals="INF">0.00001</us-gaap:CommonStockParOrStatedValuePerShare>
  <us-gaap:CommonStockParOrStatedValuePerShare id="CommonStockParOrStatedValuePerShare.874.0.0.0.0.0.0" contextRef="as-of-2013-06-30.874.0.0.0.0.0.0.0" unitRef="USD_per_share" decimals="INF">0.00001</us-gaap:CommonStockParOrStatedValuePerShare>
  <us-gaap:CommonStockSharesAuthorized id="CommonStockSharesAuthorized.872.0.0.0.0.0.0" contextRef="as-of-2014-06-30.872.0.0.0.0.0.0.0" unitRef="shares" decimals="INF">200000000</us-gaap:CommonStockSharesAuthorized>
  <us-gaap:CommonStockSharesAuthorized id="CommonStockSharesAuthorized.874.0.0.0.0.0.0" contextRef="as-of-2013-06-30.874.0.0.0.0.0.0.0" unitRef="shares" decimals="INF">200000000</us-gaap:CommonStockSharesAuthorized>
  <us-gaap:CommonStockSharesIssued id="CommonStockSharesIssued.872.0.0.0.0.0.0" contextRef="as-of-2014-06-30.872.0.0.0.0.0.0.0" unitRef="shares" decimals="INF">68601452</us-gaap:CommonStockSharesIssued>
  <us-gaap:CommonStockSharesIssued id="CommonStockSharesIssued.874.0.0.0.0.0.0" contextRef="as-of-2013-06-30.874.0.0.0.0.0.0.0" unitRef="shares" decimals="INF">59196617</us-gaap:CommonStockSharesIssued>
  <us-gaap:CommonStockSharesOutstanding id="CommonStockSharesOutstanding.872.0.0.0.0.0.0" contextRef="as-of-2014-06-30.872.0.0.0.0.0.0.0" unitRef="shares" decimals="INF">68601452</us-gaap:CommonStockSharesOutstanding>
  <us-gaap:CommonStockSharesOutstanding id="CommonStockSharesOutstanding.874.0.0.0.0.0.0" contextRef="as-of-2013-06-30.874.0.0.0.0.0.0.0" unitRef="shares" decimals="INF">59196617</us-gaap:CommonStockSharesOutstanding>
  <us-gaap:CommonStockSharesOutstanding id="CommonStockSharesOutstanding.872.1115.5114.0.0.0.0" contextRef="as-of-2014-06-30.872.0.1115.5114.0.0.0.0" unitRef="shares" decimals="INF">68601452</us-gaap:CommonStockSharesOutstanding>
  <us-gaap:CommonStockSharesOutstanding id="CommonStockSharesOutstanding.874.1115.5114.0.0.0.0" contextRef="as-of-2013-06-30.874.0.1115.5114.0.0.0.0" unitRef="shares" decimals="INF">59196617</us-gaap:CommonStockSharesOutstanding>
  <us-gaap:CommonStockSharesOutstanding id="CommonStockSharesOutstanding.875.1115.5114.0.0.0.0" contextRef="as-of-2011-06-30.875.0.1115.5114.0.0.0.0" unitRef="shares" decimals="INF">42443185</us-gaap:CommonStockSharesOutstanding>
  <us-gaap:CommonStockSharesOutstanding id="CommonStockSharesOutstanding.876.1115.5114.0.0.0.0" contextRef="as-of-2012-06-30.876.0.1115.5114.0.0.0.0" unitRef="shares" decimals="INF">46448051</us-gaap:CommonStockSharesOutstanding>
  <us-gaap:CommonStockValue id="CommonStockValue.872.0.0.0.0.0.0" xsi:nil="true" contextRef="as-of-2014-06-30.872.0.0.0.0.0.0.0" unitRef="USD" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" />
  <us-gaap:CommonStockValue id="CommonStockValue.874.0.0.0.0.0.0" xsi:nil="true" contextRef="as-of-2013-06-30.874.0.0.0.0.0.0.0" unitRef="USD" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" />
  <us-gaap:ComprehensiveIncomeNetOfTax id="ComprehensiveIncomeNetOfTax.869.0.0.0.0.0.0" contextRef="from-2013-07-01-to-2014-06-30.869.0.0.0.0.0.0.0" unitRef="USD" decimals="-3">-24232000</us-gaap:ComprehensiveIncomeNetOfTax>
  <us-gaap:ComprehensiveIncomeNetOfTax id="ComprehensiveIncomeNetOfTax.870.0.0.0.0.0.0" contextRef="from-2012-07-01-to-2013-06-30.870.0.0.0.0.0.0.0" unitRef="USD" decimals="-3">-20766000</us-gaap:ComprehensiveIncomeNetOfTax>
  <us-gaap:ComprehensiveIncomeNetOfTax id="ComprehensiveIncomeNetOfTax.871.0.0.0.0.0.0" contextRef="from-2011-07-01-to-2012-06-30.871.0.0.0.0.0.0.0" unitRef="USD" decimals="-3">-14924000</us-gaap:ComprehensiveIncomeNetOfTax>
  <us-gaap:ComprehensiveIncomePolicyPolicyTextBlock id="ComprehensiveIncomePolicyPolicyTextBlock.869.0.0.0.0.0.0" contextRef="from-2013-07-01-to-2014-06-30.869.0.0.0.0.0.0.0">&lt;!--DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd" --&gt;&lt;div&gt; &lt;div&gt;&lt;!--StartFragment--&gt; &lt;div style="text-align: center"&gt; &lt;table style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman" cellspacing="0" cellpadding="0" width="100%" border="0"&gt; &lt;tr valign="top"&gt; &lt;td style="WIDTH: 18pt"&gt; &lt;div style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt"&gt; t.&lt;/div&gt; &lt;/td&gt; &lt;td&gt; &lt;div style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; text-align: justify"&gt; &lt;font style="FONT-WEIGHT: bold; DISPLAY: inline"&gt;Comprehensive income&lt;/font&gt;&lt;font style="FONT-SIZE: 10pt; DISPLAY: inline"&gt;:&lt;/font&gt;&lt;/div&gt; &lt;/td&gt; &lt;/tr&gt; &lt;/table&gt; &lt;/div&gt; &lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"&gt; &amp;nbsp;&lt;/div&gt; &lt;div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"&gt; The Company accounts for comprehensive income (loss) in accordance with ASC No. 220, "Comprehensive Income". Comprehensive income generally represents all changes in shareholders&amp;#39; equity during the period except those resulting from investments by, or distributions to, shareholders. The Company determined that its items of other comprehensive income relate to gains and losses on cash flow hedging derivative instruments and unrealized gains and losses on available for sale marketable securities.&lt;/div&gt; &lt;div style="DISPLAY: block; TEXT-INDENT: 0pt"&gt;&amp;nbsp;&lt;/div&gt; &lt;div style="text-align: right"&gt; &lt;table style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman" cellspacing="0" cellpadding="0" width="97%"&gt; &lt;tr&gt; &lt;td style="PADDING-BOTTOM: 2px" valign="bottom" width="64%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="34%" colspan="10"&gt; &lt;div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"&gt; Year ended June 30, 2014&lt;/div&gt; &lt;/td&gt; &lt;td style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td style="PADDING-BOTTOM: 2px" valign="bottom" width="64%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="10%" colspan="2"&gt; &lt;div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"&gt; Unrealized&lt;/div&gt; &lt;div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"&gt; gains&lt;/div&gt; &lt;div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"&gt; on marketable&lt;/div&gt; &lt;div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"&gt; securities&lt;/div&gt; &lt;/td&gt; &lt;td style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="10%" colspan="2"&gt; &lt;div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"&gt; Unrealized&lt;/div&gt; &lt;div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"&gt; gains&lt;/div&gt; &lt;div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"&gt; on cash flow&lt;/div&gt; &lt;div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"&gt; hedges&lt;/div&gt; &lt;/td&gt; &lt;td style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="10%" colspan="2"&gt; &lt;div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"&gt; Total&lt;/div&gt; &lt;/td&gt; &lt;td style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr bgcolor="#cceeff"&gt; &lt;td style="TEXT-ALIGN: left; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt" valign="bottom" width="64%"&gt; &lt;div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: left; TEXT-INDENT: 0pt"&gt; Beginning balance&lt;/div&gt; &lt;/td&gt; &lt;td valign="bottom" width="1%" align="right"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%"&gt;$&lt;/td&gt; &lt;td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%"&gt;259&lt;/td&gt; &lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td valign="bottom" width="1%" align="right"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%"&gt;$&lt;/td&gt; &lt;td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%"&gt;-&lt;/td&gt; &lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td valign="bottom" width="1%" align="right"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%"&gt;$&lt;/td&gt; &lt;td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%"&gt;259&lt;/td&gt; &lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr bgcolor="white"&gt; &lt;td style="TEXT-ALIGN: left; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt" valign="bottom" width="64%"&gt; &lt;div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: left; TEXT-INDENT: 0pt"&gt; Other comprehensive income before reclassifications&lt;/div&gt; &lt;/td&gt; &lt;td valign="bottom" width="1%" align="right"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%"&gt;3,404&lt;/td&gt; &lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td valign="bottom" width="1%" align="right"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%"&gt;23&lt;/td&gt; &lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td valign="bottom" width="1%" align="right"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%"&gt;3,427&lt;/td&gt; &lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr bgcolor="#cceeff"&gt; &lt;td style="TEXT-ALIGN: left; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt" valign="bottom" width="64%"&gt; &lt;div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: left; TEXT-INDENT: 0pt"&gt; Amounts reclassified from accumulated other comprehensive loss&lt;/div&gt; &lt;/td&gt; &lt;td valign="bottom" width="1%" align="right"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%"&gt;(727&lt;/td&gt; &lt;td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"&gt;)&lt;/td&gt; &lt;td valign="bottom" width="1%" align="right"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%"&gt;-&lt;/td&gt; &lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td valign="bottom" width="1%" align="right"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%"&gt;(727&lt;/td&gt; &lt;td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"&gt;)&lt;/td&gt; &lt;/tr&gt; &lt;tr bgcolor="white"&gt; &lt;td style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt" valign="bottom" width="64%"&gt; &lt;div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: left; TEXT-INDENT: 0pt"&gt; Net current-period other comprehensive income&lt;/div&gt; &lt;/td&gt; &lt;td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%" align="right"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 2px solid; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%"&gt;2,677&lt;/td&gt; &lt;td style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%" align="right"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 2px solid; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%"&gt;23&lt;/td&gt; &lt;td style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%" align="right"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 2px solid; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%"&gt;2,700&lt;/td&gt; &lt;td style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr bgcolor="#cceeff"&gt; &lt;td style="PADDING-BOTTOM: 4px; TEXT-ALIGN: left; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt" valign="bottom" width="64%"&gt; &lt;div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: left; TEXT-INDENT: 0pt"&gt; Ending balance&lt;/div&gt; &lt;/td&gt; &lt;td style="PADDING-BOTTOM: 4px" valign="bottom" width="1%" align="right"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 4px double; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%"&gt;$&lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 4px double; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%"&gt;2,936&lt;/td&gt; &lt;td style="PADDING-BOTTOM: 4px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="PADDING-BOTTOM: 4px" valign="bottom" width="1%" align="right"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 4px double; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%"&gt;$&lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 4px double; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%"&gt;23&lt;/td&gt; &lt;td style="PADDING-BOTTOM: 4px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="PADDING-BOTTOM: 4px" valign="bottom" width="1%" align="right"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 4px double; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%"&gt;$&lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 4px double; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%"&gt;2,959&lt;/td&gt; &lt;td style="PADDING-BOTTOM: 4px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;/tr&gt; &lt;/table&gt; &lt;/div&gt; &lt;!--EndFragment--&gt;&lt;/div&gt; &lt;/div&gt;</us-gaap:ComprehensiveIncomePolicyPolicyTextBlock>
  <us-gaap:ConcentrationRiskCreditRisk id="ConcentrationRiskCreditRisk.869.0.0.0.0.0.0" contextRef="from-2013-07-01-to-2014-06-30.869.0.0.0.0.0.0.0">&lt;!--DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd" --&gt;&lt;div&gt; &lt;div&gt;&lt;!--StartFragment--&gt; &lt;div style="text-align: center"&gt; &lt;table style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman" cellspacing="0" cellpadding="0" width="100%" border="0"&gt; &lt;tr valign="top"&gt; &lt;td style="WIDTH: 18pt"&gt; &lt;div style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt"&gt; p.&lt;/div&gt; &lt;/td&gt; &lt;td&gt; &lt;div style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; text-align: justify"&gt; Concentration of credit risk&lt;/div&gt; &lt;/td&gt; &lt;/tr&gt; &lt;/table&gt; &lt;/div&gt; &lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"&gt; &amp;nbsp;&lt;/div&gt; &lt;div&gt; &lt;table style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman" cellspacing="0" cellpadding="0" width="100%" align="center" border="0"&gt; &lt;tr valign="top"&gt; &lt;td style="WIDTH: 19pt"&gt; &lt;div style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/div&gt; &lt;/td&gt; &lt;td&gt; &lt;div style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; text-align: justify"&gt; Financial instruments that potentially subject the Company to concentrations of credit risk consist principally of cash and cash equivalents, short-term deposits, long-term deposits, restricted deposits and marketable securities.&lt;/div&gt; &lt;/td&gt; &lt;/tr&gt; &lt;/table&gt; &lt;/div&gt; &lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"&gt; &amp;nbsp;&lt;/div&gt; &lt;div&gt; &lt;table style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman" cellspacing="0" cellpadding="0" width="100%" align="center" border="0"&gt; &lt;tr valign="top"&gt; &lt;td style="WIDTH: 19pt"&gt; &lt;div style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/div&gt; &lt;/td&gt; &lt;td&gt; &lt;div style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; text-align: justify"&gt; The majority of the Company&amp;#39;s cash and cash equivalents and short-term and long-term deposits are invested in dollar instruments of major banks in Israel. Generally, these deposits may be redeemed upon demand and therefore bear minimal risk.&lt;/div&gt; &lt;/td&gt; &lt;/tr&gt; &lt;/table&gt; &lt;/div&gt; &lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"&gt; &amp;nbsp;&lt;/div&gt; &lt;div&gt; &lt;table style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman" cellspacing="0" cellpadding="0" width="100%" align="center" border="0"&gt; &lt;tr valign="top"&gt; &lt;td style="WIDTH: 18pt"&gt; &lt;div style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/div&gt; &lt;/td&gt; &lt;td&gt; &lt;div style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; text-align: justify"&gt; The Company invests its surplus cash in cash deposits and marketable securities in financial institutions and has established guidelines, approved by the Company&amp;#39;s Investment Committee, relating to diversification and maturities to maintain safety and liquidity of the investments.&lt;/div&gt; &lt;/td&gt; &lt;/tr&gt; &lt;/table&gt; &lt;/div&gt; &lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"&gt; &amp;nbsp;&lt;/div&gt; &lt;div&gt; &lt;table style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman" cellspacing="0" cellpadding="0" width="100%" align="center" border="0"&gt; &lt;tr valign="top"&gt; &lt;td style="WIDTH: 18pt"&gt; &lt;div style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/div&gt; &lt;/td&gt; &lt;td&gt; &lt;div style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; text-align: justify"&gt; The Company holds an investment portfolio consisting of corporate bonds, government bonds, stocks and index linked notes. The Company intends, and has the ability, to hold such investments until recovery of temporary declines in market value or maturity; accordingly, as of June&amp;nbsp;30, 2014, the Company believes the losses associated with its investments are temporary and no impairment loss was recognized during 2014. However, the Company can provide no assurance that it will recover declines in the market value of its investments.&lt;/div&gt; &lt;/td&gt; &lt;/tr&gt; &lt;/table&gt; &lt;/div&gt; &lt;!--EndFragment--&gt;&lt;/div&gt; &lt;/div&gt;</us-gaap:ConcentrationRiskCreditRisk>
  <us-gaap:ConsolidationPolicyTextBlock id="ConsolidationPolicyTextBlock.869.0.0.0.0.0.0" contextRef="from-2013-07-01-to-2014-06-30.869.0.0.0.0.0.0.0">&lt;!--DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd" --&gt;&lt;div&gt; &lt;div&gt;&lt;!--StartFragment--&gt; &lt;div&gt; &lt;table style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman" cellspacing="0" cellpadding="0" width="100%" align="center" border="0"&gt; &lt;tr valign="top"&gt; &lt;td style="WIDTH: 18pt"&gt; &lt;div style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt"&gt; c.&lt;/div&gt; &lt;/td&gt; &lt;td&gt; &lt;div style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; text-align: justify"&gt; Principles of consolidation&lt;/div&gt; &lt;/td&gt; &lt;/tr&gt; &lt;/table&gt; &lt;/div&gt; &lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"&gt; &amp;nbsp;&lt;/div&gt; &lt;div&gt; &lt;table style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman" cellspacing="0" cellpadding="0" width="100%" align="center" border="0"&gt; &lt;tr valign="top"&gt; &lt;td style="WIDTH: 18pt"&gt; &lt;div style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/div&gt; &lt;/td&gt; &lt;td&gt; &lt;div style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; text-align: justify"&gt; The consolidated financial statements include the accounts of Pluristem Therapeutics Inc. and its Subsidiary. Intercompany transactions and balances have been eliminated upon consolidation.&lt;/div&gt; &lt;/td&gt; &lt;/tr&gt; &lt;/table&gt; &lt;/div&gt; &lt;!--EndFragment--&gt;&lt;/div&gt; &lt;/div&gt;</us-gaap:ConsolidationPolicyTextBlock>
  <us-gaap:ConversionOfStockSharesConverted1 id="ConversionOfStockSharesConverted1.869.25814.1048.0.0.0.0" contextRef="from-2013-07-01-to-2014-06-30.869.0.25814.1048.0.0.0.0" unitRef="shares" decimals="INF">2517907</us-gaap:ConversionOfStockSharesConverted1>
  <us-gaap:ConversionOfStockSharesConverted1 id="ConversionOfStockSharesConverted1.870.25814.1048.0.0.0.0" contextRef="from-2012-07-01-to-2013-06-30.870.0.25814.1048.0.0.0.0" unitRef="shares" decimals="INF">682213</us-gaap:ConversionOfStockSharesConverted1>
  <us-gaap:ConversionOfStockSharesConverted1 id="ConversionOfStockSharesConverted1.871.25814.1048.0.0.0.0" contextRef="from-2011-07-01-to-2012-06-30.871.0.25814.1048.0.0.0.0" unitRef="shares" decimals="INF">406783</us-gaap:ConversionOfStockSharesConverted1>
  <us-gaap:ConversionOfStockSharesConverted1 id="ConversionOfStockSharesConverted1.869.25816.1048.0.0.0.0" contextRef="from-2013-07-01-to-2014-06-30.869.0.25816.1048.0.0.0.0" unitRef="shares" decimals="INF">65000</us-gaap:ConversionOfStockSharesConverted1>
  <us-gaap:ConversionOfStockSharesConverted1 id="ConversionOfStockSharesConverted1.970.25816.1048.0.0.0.0" contextRef="from-2012-08-01-to-2012-08-31.970.0.25816.1048.0.0.0.0" unitRef="shares" decimals="INF">36000</us-gaap:ConversionOfStockSharesConverted1>
  <us-gaap:ConversionOfStockSharesIssued1 id="ConversionOfStockSharesIssued1.869.25814.1048.0.0.0.0" contextRef="from-2013-07-01-to-2014-06-30.869.0.25814.1048.0.0.0.0" unitRef="shares" decimals="INF">1469584</us-gaap:ConversionOfStockSharesIssued1>
  <us-gaap:ConversionOfStockSharesIssued1 id="ConversionOfStockSharesIssued1.870.25814.1048.0.0.0.0" contextRef="from-2012-07-01-to-2013-06-30.870.0.25814.1048.0.0.0.0" unitRef="shares" decimals="INF">420199</us-gaap:ConversionOfStockSharesIssued1>
  <us-gaap:ConversionOfStockSharesIssued1 id="ConversionOfStockSharesIssued1.871.25814.1048.0.0.0.0" contextRef="from-2011-07-01-to-2012-06-30.871.0.25814.1048.0.0.0.0" unitRef="shares" decimals="INF">168424</us-gaap:ConversionOfStockSharesIssued1>
  <us-gaap:ConversionOfStockSharesIssued1 id="ConversionOfStockSharesIssued1.869.25816.1048.0.0.0.0" contextRef="from-2013-07-01-to-2014-06-30.869.0.25816.1048.0.0.0.0" unitRef="shares" decimals="INF">36970</us-gaap:ConversionOfStockSharesIssued1>
  <us-gaap:ConversionOfStockSharesIssued1 id="ConversionOfStockSharesIssued1.970.25816.1048.0.0.0.0" contextRef="from-2012-08-01-to-2012-08-31.970.0.25816.1048.0.0.0.0" unitRef="shares" decimals="INF">26299</us-gaap:ConversionOfStockSharesIssued1>
  <us-gaap:CostOfRevenue id="CostOfRevenue.869.0.0.0.0.0.0" contextRef="from-2013-07-01-to-2014-06-30.869.0.0.0.0.0.0.0" unitRef="USD" decimals="-3">11000</us-gaap:CostOfRevenue>
  <us-gaap:CostOfRevenue id="CostOfRevenue.870.0.0.0.0.0.0" contextRef="from-2012-07-01-to-2013-06-30.870.0.0.0.0.0.0.0" unitRef="USD" decimals="-3">20000</us-gaap:CostOfRevenue>
  <us-gaap:CostOfRevenue id="CostOfRevenue.871.0.0.0.0.0.0" contextRef="from-2011-07-01-to-2012-06-30.871.0.0.0.0.0.0.0" unitRef="USD" decimals="-3">21000</us-gaap:CostOfRevenue>
  <us-gaap:CustomerAdvancesCurrent id="CustomerAdvancesCurrent.872.0.0.0.0.0.0" contextRef="as-of-2014-06-30.872.0.0.0.0.0.0.0" unitRef="USD" decimals="-3">247000</us-gaap:CustomerAdvancesCurrent>
  <us-gaap:CustomerAdvancesCurrent id="CustomerAdvancesCurrent.874.0.0.0.0.0.0" contextRef="as-of-2013-06-30.874.0.0.0.0.0.0.0" unitRef="USD" decimals="-3">393000</us-gaap:CustomerAdvancesCurrent>
  <us-gaap:DeferredRentCreditCurrent id="DeferredRentCreditCurrent.872.0.0.0.0.0.0" contextRef="as-of-2014-06-30.872.0.0.0.0.0.0.0" unitRef="USD" decimals="-3">89000</us-gaap:DeferredRentCreditCurrent>
  <us-gaap:DeferredRentCreditCurrent id="DeferredRentCreditCurrent.874.0.0.0.0.0.0" contextRef="as-of-2013-06-30.874.0.0.0.0.0.0.0" unitRef="USD" decimals="-3">89000</us-gaap:DeferredRentCreditCurrent>
  <us-gaap:DeferredRevenueAdditions id="DeferredRevenueAdditions.869.0.0.0.0.0.0" contextRef="from-2013-07-01-to-2014-06-30.869.0.0.0.0.0.0.0" unitRef="USD" decimals="-3">5000000</us-gaap:DeferredRevenueAdditions>
  <us-gaap:DeferredRevenueCurrent id="DeferredRevenueCurrent.872.0.0.0.0.0.0" contextRef="as-of-2014-06-30.872.0.0.0.0.0.0.0" unitRef="USD" decimals="-3">379000</us-gaap:DeferredRevenueCurrent>
  <us-gaap:DeferredRevenueCurrent id="DeferredRevenueCurrent.874.0.0.0.0.0.0" contextRef="as-of-2013-06-30.874.0.0.0.0.0.0.0" unitRef="USD" decimals="-3">379000</us-gaap:DeferredRevenueCurrent>
  <us-gaap:DeferredRevenueNoncurrent id="DeferredRevenueNoncurrent.872.0.0.0.0.0.0" contextRef="as-of-2014-06-30.872.0.0.0.0.0.0.0" unitRef="USD" decimals="-3">2847000</us-gaap:DeferredRevenueNoncurrent>
  <us-gaap:DeferredRevenueNoncurrent id="DeferredRevenueNoncurrent.874.0.0.0.0.0.0" contextRef="as-of-2013-06-30.874.0.0.0.0.0.0.0" unitRef="USD" decimals="-3">3226000</us-gaap:DeferredRevenueNoncurrent>
  <us-gaap:DeferredTaxAssetsGross id="DeferredTaxAssetsGross.872.0.0.0.0.0.0" contextRef="as-of-2014-06-30.872.0.0.0.0.0.0.0" unitRef="USD" decimals="-3">21002000</us-gaap:DeferredTaxAssetsGross>
  <us-gaap:DeferredTaxAssetsGross id="DeferredTaxAssetsGross.874.0.0.0.0.0.0" contextRef="as-of-2013-06-30.874.0.0.0.0.0.0.0" unitRef="USD" decimals="-3">15805000</us-gaap:DeferredTaxAssetsGross>
  <us-gaap:DeferredTaxAssetsNet id="DeferredTaxAssetsNet.872.0.0.0.0.0.0" xsi:nil="true" contextRef="as-of-2014-06-30.872.0.0.0.0.0.0.0" unitRef="USD" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" />
  <us-gaap:DeferredTaxAssetsNet id="DeferredTaxAssetsNet.874.0.0.0.0.0.0" xsi:nil="true" contextRef="as-of-2013-06-30.874.0.0.0.0.0.0.0" unitRef="USD" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" />
  <us-gaap:DeferredTaxAssetsOperatingLossCarryforwardsDomestic id="DeferredTaxAssetsOperatingLossCarryforwardsDomestic.872.0.0.0.0.0.0" contextRef="as-of-2014-06-30.872.0.0.0.0.0.0.0" unitRef="USD" decimals="-3">7955000</us-gaap:DeferredTaxAssetsOperatingLossCarryforwardsDomestic>
  <us-gaap:DeferredTaxAssetsOperatingLossCarryforwardsDomestic id="DeferredTaxAssetsOperatingLossCarryforwardsDomestic.874.0.0.0.0.0.0" contextRef="as-of-2013-06-30.874.0.0.0.0.0.0.0" unitRef="USD" decimals="-3">7106000</us-gaap:DeferredTaxAssetsOperatingLossCarryforwardsDomestic>
  <us-gaap:DeferredTaxAssetsOperatingLossCarryforwardsForeign id="DeferredTaxAssetsOperatingLossCarryforwardsForeign.872.0.0.0.0.0.0" contextRef="as-of-2014-06-30.872.0.0.0.0.0.0.0" unitRef="USD" decimals="-3">12810000</us-gaap:DeferredTaxAssetsOperatingLossCarryforwardsForeign>
  <us-gaap:DeferredTaxAssetsOperatingLossCarryforwardsForeign id="DeferredTaxAssetsOperatingLossCarryforwardsForeign.874.0.0.0.0.0.0" contextRef="as-of-2013-06-30.874.0.0.0.0.0.0.0" unitRef="USD" decimals="-3">8543000</us-gaap:DeferredTaxAssetsOperatingLossCarryforwardsForeign>
  <us-gaap:DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals id="DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals.872.0.0.0.0.0.0" contextRef="as-of-2014-06-30.872.0.0.0.0.0.0.0" unitRef="USD" decimals="-3">237000</us-gaap:DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals>
  <us-gaap:DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals id="DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals.874.0.0.0.0.0.0" contextRef="as-of-2013-06-30.874.0.0.0.0.0.0.0" unitRef="USD" decimals="-3">156000</us-gaap:DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals>
  <us-gaap:DeferredTaxAssetsValuationAllowance id="DeferredTaxAssetsValuationAllowance.872.0.0.0.0.0.0" contextRef="as-of-2014-06-30.872.0.0.0.0.0.0.0" unitRef="USD" decimals="-3">21002000</us-gaap:DeferredTaxAssetsValuationAllowance>
  <us-gaap:DeferredTaxAssetsValuationAllowance id="DeferredTaxAssetsValuationAllowance.874.0.0.0.0.0.0" contextRef="as-of-2013-06-30.874.0.0.0.0.0.0.0" unitRef="USD" decimals="-3">15805000</us-gaap:DeferredTaxAssetsValuationAllowance>
  <us-gaap:DefinedBenefitPlanAssetsForPlanBenefitsNoncurrent id="DefinedBenefitPlanAssetsForPlanBenefitsNoncurrent.872.0.0.0.0.0.0" contextRef="as-of-2014-06-30.872.0.0.0.0.0.0.0" unitRef="USD" decimals="-3">901000</us-gaap:DefinedBenefitPlanAssetsForPlanBenefitsNoncurrent>
  <us-gaap:DefinedBenefitPlanAssetsForPlanBenefitsNoncurrent id="DefinedBenefitPlanAssetsForPlanBenefitsNoncurrent.874.0.0.0.0.0.0" contextRef="as-of-2013-06-30.874.0.0.0.0.0.0.0" unitRef="USD" decimals="-3">905000</us-gaap:DefinedBenefitPlanAssetsForPlanBenefitsNoncurrent>
  <us-gaap:Depreciation id="Depreciation.869.0.0.0.0.0.0" contextRef="from-2013-07-01-to-2014-06-30.869.0.0.0.0.0.0.0" unitRef="USD" decimals="-3">1902000</us-gaap:Depreciation>
  <us-gaap:Depreciation id="Depreciation.870.0.0.0.0.0.0" contextRef="from-2012-07-01-to-2013-06-30.870.0.0.0.0.0.0.0" unitRef="USD" decimals="-3">1033000</us-gaap:Depreciation>
  <us-gaap:Depreciation id="Depreciation.871.0.0.0.0.0.0" contextRef="from-2011-07-01-to-2012-06-30.871.0.0.0.0.0.0.0" unitRef="USD" decimals="-3">435000</us-gaap:Depreciation>
  <us-gaap:DerivativeAssetsLiabilitiesAtFairValueNet id="DerivativeAssetsLiabilitiesAtFairValueNet.872.2136.2043.2032.2040.0.0" xsi:nil="true" contextRef="as-of-2014-06-30.872.0.2136.2043.2032.2040.0.0" unitRef="USD" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" />
  <us-gaap:DerivativeAssetsLiabilitiesAtFairValueNet id="DerivativeAssetsLiabilitiesAtFairValueNet.874.2136.2043.2032.2040.0.0" xsi:nil="true" contextRef="as-of-2013-06-30.874.0.2136.2043.2032.2040.0.0" unitRef="USD" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" />
  <us-gaap:DerivativeAssetsLiabilitiesAtFairValueNet id="DerivativeAssetsLiabilitiesAtFairValueNet.872.2135.2043.2032.2040.0.0" contextRef="as-of-2014-06-30.872.0.2135.2043.2032.2040.0.0" unitRef="USD" decimals="-3">-842000</us-gaap:DerivativeAssetsLiabilitiesAtFairValueNet>
  <us-gaap:DerivativeAssetsLiabilitiesAtFairValueNet id="DerivativeAssetsLiabilitiesAtFairValueNet.874.2135.2043.2032.2040.0.0" contextRef="as-of-2013-06-30.874.0.2135.2043.2032.2040.0.0" unitRef="USD" decimals="-3">93000</us-gaap:DerivativeAssetsLiabilitiesAtFairValueNet>
  <us-gaap:DerivativeAssetsLiabilitiesAtFairValueNet id="DerivativeAssetsLiabilitiesAtFairValueNet.872.2137.2043.2032.2040.0.0" xsi:nil="true" contextRef="as-of-2014-06-30.872.0.2137.2043.2032.2040.0.0" unitRef="USD" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" />
  <us-gaap:DerivativeAssetsLiabilitiesAtFairValueNet id="DerivativeAssetsLiabilitiesAtFairValueNet.874.2137.2043.2032.2040.0.0" xsi:nil="true" contextRef="as-of-2013-06-30.874.0.2137.2043.2032.2040.0.0" unitRef="USD" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" />
  <us-gaap:DerivativeAssetsLiabilitiesAtFairValueNet id="DerivativeAssetsLiabilitiesAtFairValueNet.872.3743.736.979.1619.1352.2543" contextRef="as-of-2014-06-30.872.0.3743.736.979.1619.1352.2543" unitRef="USD" decimals="-3">24000</us-gaap:DerivativeAssetsLiabilitiesAtFairValueNet>
  <us-gaap:DerivativeAssetsLiabilitiesAtFairValueNet id="DerivativeAssetsLiabilitiesAtFairValueNet.874.3743.736.979.1619.1352.2543" xsi:nil="true" contextRef="as-of-2013-06-30.874.0.3743.736.979.1619.1352.2543" unitRef="USD" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" />
  <us-gaap:DerivativeAssetsLiabilitiesAtFairValueNet id="DerivativeAssetsLiabilitiesAtFairValueNet.872.3728.736.2158.1619.1352.2543" contextRef="as-of-2014-06-30.872.0.3728.736.2158.1619.1352.2543" unitRef="USD" decimals="-3">-889000</us-gaap:DerivativeAssetsLiabilitiesAtFairValueNet>
  <us-gaap:DerivativeAssetsLiabilitiesAtFairValueNet id="DerivativeAssetsLiabilitiesAtFairValueNet.874.3728.736.2158.1619.1352.2543" xsi:nil="true" contextRef="as-of-2013-06-30.874.0.3728.736.2158.1619.1352.2543" unitRef="USD" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" />
  <us-gaap:DerivativeAssetsLiabilitiesAtFairValueNet id="DerivativeAssetsLiabilitiesAtFairValueNet.872.3743.736.3619.2543.0.0" contextRef="as-of-2014-06-30.872.0.3743.736.3619.2543.0.0" unitRef="USD" decimals="-3">23000</us-gaap:DerivativeAssetsLiabilitiesAtFairValueNet>
  <us-gaap:DerivativeAssetsLiabilitiesAtFairValueNet id="DerivativeAssetsLiabilitiesAtFairValueNet.874.3743.736.3619.2543.0.0" contextRef="as-of-2013-06-30.874.0.3743.736.3619.2543.0.0" unitRef="USD" decimals="-3">93000</us-gaap:DerivativeAssetsLiabilitiesAtFairValueNet>
  <us-gaap:DerivativeAssetsLiabilitiesAtFairValueNet id="DerivativeAssetsLiabilitiesAtFairValueNet.872.0.0.0.0.0.0" contextRef="as-of-2014-06-30.872.0.0.0.0.0.0.0" unitRef="USD" decimals="-3">-842000</us-gaap:DerivativeAssetsLiabilitiesAtFairValueNet>
  <us-gaap:DerivativeAssetsLiabilitiesAtFairValueNet id="DerivativeAssetsLiabilitiesAtFairValueNet.874.0.0.0.0.0.0" contextRef="as-of-2013-06-30.874.0.0.0.0.0.0.0" unitRef="USD" decimals="-3">93000</us-gaap:DerivativeAssetsLiabilitiesAtFairValueNet>
  <us-gaap:DerivativeInstrumentsGainLossRecognizedInOtherComprehensiveIncomeEffectivePortionNet id="DerivativeInstrumentsGainLossRecognizedInOtherComprehensiveIncomeEffectivePortionNet.869.17830.1333.2365.1594.1352.1619" contextRef="from-2013-07-01-to-2014-06-30.869.0.17830.1333.2365.1594.1352.1619" unitRef="USD" decimals="-3">48000</us-gaap:DerivativeInstrumentsGainLossRecognizedInOtherComprehensiveIncomeEffectivePortionNet>
  <us-gaap:DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet id="DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet.869.0.0.0.0.0.0" contextRef="from-2013-07-01-to-2014-06-30.869.0.0.0.0.0.0.0" unitRef="USD" decimals="-3">-83000</us-gaap:DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet>
  <us-gaap:DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet id="DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet.870.0.0.0.0.0.0" contextRef="from-2012-07-01-to-2013-06-30.870.0.0.0.0.0.0.0" unitRef="USD" decimals="-3">140000</us-gaap:DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet>
  <us-gaap:DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet id="DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet.871.0.0.0.0.0.0" contextRef="from-2011-07-01-to-2012-06-30.871.0.0.0.0.0.0.0" unitRef="USD" decimals="-3">-317000</us-gaap:DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet>
  <us-gaap:DerivativeLiabilitiesCurrent id="DerivativeLiabilitiesCurrent.872.0.0.0.0.0.0" contextRef="as-of-2014-06-30.872.0.0.0.0.0.0.0" unitRef="USD" decimals="-3">889000</us-gaap:DerivativeLiabilitiesCurrent>
  <us-gaap:DerivativeLiabilitiesCurrent id="DerivativeLiabilitiesCurrent.874.0.0.0.0.0.0" xsi:nil="true" contextRef="as-of-2013-06-30.874.0.0.0.0.0.0.0" unitRef="USD" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" />
  <us-gaap:DerivativesPolicyTextBlock id="DerivativesPolicyTextBlock.869.0.0.0.0.0.0" contextRef="from-2013-07-01-to-2014-06-30.869.0.0.0.0.0.0.0">&lt;!--DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd" --&gt;&lt;div&gt; &lt;div&gt;&lt;!--StartFragment--&gt; &lt;div style="text-align: center"&gt; &lt;table style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman" cellspacing="0" cellpadding="0" width="100%" border="0"&gt; &lt;tr valign="top"&gt; &lt;td style="WIDTH: 18pt"&gt; &lt;div style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt"&gt; s.&lt;/div&gt; &lt;/td&gt; &lt;td&gt; &lt;div style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; text-align: justify"&gt; Derivative financial instruments&lt;/div&gt; &lt;/td&gt; &lt;/tr&gt; &lt;/table&gt; &lt;/div&gt; &lt;div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"&gt; &amp;nbsp;&lt;/div&gt; &lt;div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"&gt; The Company uses forward contracts and options strategies ("derivative instruments") primarily to manage exposure to foreign currency. The Company accounts for derivatives and hedging based on ASC 815, "Derivatives and Hedging" ("ASC 815"). ASC 815 requires the Company to recognize all derivative instruments as either assets or liabilities on the balance sheet at fair value. The accounting for changes in the fair value (i.e., gains or losses) of derivative instruments depends on whether it has been designated and qualifies as part of a hedging relationship and further, on the type of hedging relationship. For those derivative instruments that are designated and qualify as hedging instruments, the Company must designate the hedging instrument, based upon the exposure being hedged, as a fair value hedge, cash flow hedge, or a hedge of a net investment in a foreign operation.&lt;/div&gt; &lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"&gt; &amp;nbsp;&lt;/div&gt; &lt;div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"&gt; If the derivative instruments meet the definition of a hedge and are so designated, depending on the nature of the hedge, changes in the fair value of such derivatives will either be offset against the change in fair value of the hedged assets, liabilities, or firm commitments through earnings, or recognized in other comprehensive income until the hedged item is recognized in the statement of operations.&lt;font style="FONT-SIZE: 10pt; DISPLAY: inline"&gt;&amp;nbsp;&lt;/font&gt; The ineffective portion of a derivative&amp;#39;s change in fair value is recognized in the statement of operations.&lt;/div&gt; &lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"&gt; &amp;nbsp;&lt;/div&gt; &lt;div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"&gt; &lt;font style="FONT-FAMILY: Times New Roman; FONT-STYLE: italic; DISPLAY: inline"&gt; Cash Flow Hedges&lt;/font&gt;. The Company entered into forward contracts to hedge against the risk of overall changes in future cash flow from payments of payroll and related expenses denominated in New Israeli Shekels (NIS). The Company measured the fair value of the contracts in accordance with ASC 820 (classified as level 2). The gain or loss on the effective portion of a cash flow hedge is initially reported as a component of accumulated other comprehensive income and subsequently reclassified into operating expenses in the same period or periods in which the payroll and related expenses are recognized, or reclassified into "Financial income, net", if the hedged transaction becomes probable of not occurring. Any gain or loss after a hedge is no longer designated, because it is no longer probable of occurring or it is related to an ineffective portion of a cash flow hedge is recognized in the statement of operations immediately. As of June 30, 2014, the Company had forward contracts in place to hedge future payroll and related expenses in NIS of approximately $2,820, with fair value of approximately $24. The net unrealized gain on the effective portion of these cash flow hedges was $23. The net gain realized in statement of operations during the year ended June 30, 2014, resulting from the cash flow hedge transactions,&amp;nbsp;&amp;nbsp;amounted to approximately $48. The forward contracts on the Company&amp;#39;s future NIS payroll and related expenses will settle by December 2014. On June 30, 2013, the Company did not have contracts designated and qualifies as cash flow hedge.&lt;/div&gt; &lt;div style="MARGIN-LEFT: 437pt; DISPLAY: block; TEXT-INDENT: 0pt"&gt; &lt;br /&gt; &lt;/div&gt; &lt;div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"&gt; &lt;font style="FONT-FAMILY: Times New Roman; FONT-STYLE: italic; DISPLAY: inline"&gt; Fair Value Hedges&lt;/font&gt;. The Company entered into forward contracts designated as fair value hedges to hedge foreign currency risks for its investment denominated in currencies other than the U.S. dollar. The Company measured the fair value of the contracts in accordance with ASC 820 (classified as level 2). Gains and losses on these contracts are recognized in "Financial income, net", along with the offsetting losses and gains of the related hedged items.&lt;/div&gt; &lt;div style="DISPLAY: block; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"&gt; &amp;nbsp;&lt;/div&gt; &lt;div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"&gt; In connection with the investment in CHA shares (see Note 1d), an available-for-sale marketable security denominated in Korean Won, the Company entered into a forward contract to hedge against the foreign currency risk between the Korean Won and the U.S. dollar. The notional principal of this contract is $11,000 as of June 30, 2014 with fair value of approximately $(889).&lt;/div&gt; &lt;div style="DISPLAY: block; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"&gt; &amp;nbsp;&lt;/div&gt; &lt;div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"&gt; The changes in fair value of the available-for-sale CHA shares attributable to the foreign currency risk being hedged are reflected in the statement of operations in "Financial income, net" (not in other comprehensive income). Other changes in fair value of the available-for-sale CHA shares continue to follow ASC 320-"Investments-Debt and Equity Securities", accounting and are reflected in other comprehensive income.&lt;/div&gt; &lt;div style="DISPLAY: block; TEXT-INDENT: 0pt"&gt;&lt;br /&gt; &lt;/div&gt; &lt;div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"&gt; &lt;font style="FONT-FAMILY: Times New Roman; FONT-STYLE: italic; DISPLAY: inline"&gt; Other Derivatives&lt;/font&gt;. Other derivatives that are non-designated consist primarily of options strategies to minimize the risk associated with the foreign exchange effects of monetary assets and liabilities denominated in NIS. The Company measured the fair value of the contracts in accordance with ASC 820 (classified as level 2). The net gains (losses) recognized in "Financial income, net" during the year ended June 30, 2014, 2013 and 2012 were ($70), $231 and ($145), respectively.&lt;/div&gt; &lt;!--EndFragment--&gt;&lt;/div&gt; &lt;/div&gt;</us-gaap:DerivativesPolicyTextBlock>
  <us-gaap:EarningsPerShareBasicAndDiluted id="EarningsPerShareBasicAndDiluted.869.0.0.0.0.0.0" contextRef="from-2013-07-01-to-2014-06-30.869.0.0.0.0.0.0.0" unitRef="USD_per_share" decimals="2">-0.42</us-gaap:EarningsPerShareBasicAndDiluted>
  <us-gaap:EarningsPerShareBasicAndDiluted id="EarningsPerShareBasicAndDiluted.870.0.0.0.0.0.0" contextRef="from-2012-07-01-to-2013-06-30.870.0.0.0.0.0.0.0" unitRef="USD_per_share" decimals="2">-0.38</us-gaap:EarningsPerShareBasicAndDiluted>
  <us-gaap:EarningsPerShareBasicAndDiluted id="EarningsPerShareBasicAndDiluted.871.0.0.0.0.0.0" contextRef="from-2011-07-01-to-2012-06-30.871.0.0.0.0.0.0.0" unitRef="USD_per_share" decimals="2">-0.34</us-gaap:EarningsPerShareBasicAndDiluted>
  <us-gaap:EarningsPerSharePolicyTextBlock id="EarningsPerSharePolicyTextBlock.869.0.0.0.0.0.0" contextRef="from-2013-07-01-to-2014-06-30.869.0.0.0.0.0.0.0">&lt;!--DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd" --&gt;&lt;div&gt; &lt;div&gt;&lt;!--StartFragment--&gt; &lt;div style="text-align: center"&gt; &lt;table style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman" cellspacing="0" cellpadding="0" width="100%" border="0"&gt; &lt;tr valign="top"&gt; &lt;td style="WIDTH: 18pt"&gt; &lt;div style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt"&gt; n.&lt;/div&gt; &lt;/td&gt; &lt;td&gt; &lt;div style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; text-align: justify"&gt; Loss per share&lt;/div&gt; &lt;/td&gt; &lt;/tr&gt; &lt;/table&gt; &lt;/div&gt; &lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"&gt; &amp;nbsp;&lt;/div&gt; &lt;div&gt; &lt;table style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman" cellspacing="0" cellpadding="0" width="100%" align="center" border="0"&gt; &lt;tr valign="top"&gt; &lt;td style="WIDTH: 19pt"&gt; &lt;div style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/div&gt; &lt;/td&gt; &lt;td&gt; &lt;div style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; text-align: justify"&gt; Basic and dilutive net loss per share is computed based on the weighted average number of shares of common stock outstanding during each year. All outstanding stock options and unvested restricted stock units have been excluded from the calculation of the diluted loss per common share because all such securities are anti-dilutive for each of the periods presented.&lt;/div&gt; &lt;/td&gt; &lt;/tr&gt; &lt;/table&gt; &lt;/div&gt; &lt;!--EndFragment--&gt;&lt;/div&gt; &lt;/div&gt;</us-gaap:EarningsPerSharePolicyTextBlock>
  <us-gaap:EffectiveIncomeTaxRateContinuingOperations id="EffectiveIncomeTaxRateContinuingOperations.869.0.0.0.0.0.0" contextRef="from-2013-07-01-to-2014-06-30.869.0.0.0.0.0.0.0" unitRef="pure" decimals="0">0</us-gaap:EffectiveIncomeTaxRateContinuingOperations>
  <us-gaap:EffectiveIncomeTaxRateContinuingOperations id="EffectiveIncomeTaxRateContinuingOperations.870.0.0.0.0.0.0" contextRef="from-2012-07-01-to-2013-06-30.870.0.0.0.0.0.0.0" unitRef="pure" decimals="0">0</us-gaap:EffectiveIncomeTaxRateContinuingOperations>
  <us-gaap:EffectiveIncomeTaxRateContinuingOperations id="EffectiveIncomeTaxRateContinuingOperations.871.0.0.0.0.0.0" contextRef="from-2011-07-01-to-2012-06-30.871.0.0.0.0.0.0.0" unitRef="pure" decimals="0">0</us-gaap:EffectiveIncomeTaxRateContinuingOperations>
  <us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate id="EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate.869.3370.4349.0.0.0.0" contextRef="from-2013-07-01-to-2014-06-30.869.0.3370.4349.0.0.0.0" unitRef="pure" decimals="2">0.25</us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate>
  <us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate id="EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate.870.3370.4349.0.0.0.0" contextRef="from-2012-07-01-to-2013-06-30.870.0.3370.4349.0.0.0.0" unitRef="pure" decimals="2">0.25</us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate>
  <us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate id="EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate.871.3370.4349.0.0.0.0" contextRef="from-2011-07-01-to-2012-06-30.871.0.3370.4349.0.0.0.0" unitRef="pure" decimals="2">0.25</us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate>
  <us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate id="EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate.869.3361.4349.0.0.0.0" contextRef="from-2013-07-01-to-2014-06-30.869.0.3361.4349.0.0.0.0" unitRef="pure" decimals="2">0.35</us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate>
  <us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate id="EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate.870.3361.4349.0.0.0.0" contextRef="from-2012-07-01-to-2013-06-30.870.0.3361.4349.0.0.0.0" unitRef="pure" decimals="2">0.35</us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate>
  <us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate id="EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate.871.3361.4349.0.0.0.0" contextRef="from-2011-07-01-to-2012-06-30.871.0.3361.4349.0.0.0.0" unitRef="pure" decimals="2">0.35</us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate>
  <us-gaap:EmployeeRelatedLiabilitiesCurrent id="EmployeeRelatedLiabilitiesCurrent.872.0.0.0.0.0.0" contextRef="as-of-2014-06-30.872.0.0.0.0.0.0.0" unitRef="USD" decimals="-3">424000</us-gaap:EmployeeRelatedLiabilitiesCurrent>
  <us-gaap:EmployeeRelatedLiabilitiesCurrent id="EmployeeRelatedLiabilitiesCurrent.874.0.0.0.0.0.0" contextRef="as-of-2013-06-30.874.0.0.0.0.0.0.0" unitRef="USD" decimals="-3">353000</us-gaap:EmployeeRelatedLiabilitiesCurrent>
  <us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized id="EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized.872.25537.367.0.0.0.0" contextRef="as-of-2014-06-30.872.0.25537.367.0.0.0.0" unitRef="USD" decimals="-3">1000</us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized>
  <us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized id="EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized.872.4568.367.0.0.0.0" contextRef="as-of-2014-06-30.872.0.4568.367.0.0.0.0" unitRef="USD" decimals="-3">2447000</us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized>
  <us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1 id="EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1.869.25537.367.0.0.0.0" contextRef="from-2013-07-01-to-2014-06-30.869.0.25537.367.0.0.0.0">P3M</us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1>
  <us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1 id="EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1.869.4568.367.0.0.0.0" contextRef="from-2013-07-01-to-2014-06-30.869.0.4568.367.0.0.0.0">P2Y</us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1>
  <us-gaap:FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTableTextBlock id="FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTableTextBlock.869.0.0.0.0.0.0" contextRef="from-2013-07-01-to-2014-06-30.869.0.0.0.0.0.0.0">&lt;!--DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd" --&gt;&lt;div&gt; &lt;div&gt;&lt;!--StartFragment--&gt; &lt;div style="text-align: right"&gt; &lt;table style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman" cellspacing="0" cellpadding="0" width="97%"&gt; &lt;tr&gt; &lt;td style="PADDING-BOTTOM: 2px" valign="bottom" width="28%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-WEIGHT: bold; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="34%" colspan="10"&gt; &lt;div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"&gt; June 30, 2014&lt;/div&gt; &lt;/td&gt; &lt;td style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-WEIGHT: bold; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-WEIGHT: bold; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="34%" colspan="10"&gt; &lt;div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"&gt; June 30, 2013&lt;/div&gt; &lt;/td&gt; &lt;td style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-WEIGHT: bold; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td style="PADDING-BOTTOM: 2px" valign="bottom" width="28%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-WEIGHT: bold; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="10%" colspan="2"&gt; &lt;div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"&gt; Level 1&lt;/div&gt; &lt;/td&gt; &lt;td style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-WEIGHT: bold; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-WEIGHT: bold; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="10%" colspan="2"&gt; &lt;div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"&gt; Level 2&lt;/div&gt; &lt;/td&gt; &lt;td style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-WEIGHT: bold; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-WEIGHT: bold; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="10%" colspan="2"&gt; &lt;div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"&gt; Level 3&lt;/div&gt; &lt;/td&gt; &lt;td style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-WEIGHT: bold; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-WEIGHT: bold; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="10%" colspan="2"&gt; &lt;div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"&gt; Level 1&lt;/div&gt; &lt;/td&gt; &lt;td style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-WEIGHT: bold; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-WEIGHT: bold; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="10%" colspan="2"&gt; &lt;div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"&gt; Level 2&lt;/div&gt; &lt;/td&gt; &lt;td style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-WEIGHT: bold; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-WEIGHT: bold; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="10%" colspan="2"&gt; &lt;div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"&gt; Level 3&lt;/div&gt; &lt;/td&gt; &lt;td style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-WEIGHT: bold; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr bgcolor="#cceeff"&gt; &lt;td style="TEXT-ALIGN: left; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt" valign="bottom" width="28%"&gt; &lt;div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: left; TEXT-INDENT: 0pt"&gt; Marketable securities&lt;/div&gt; &lt;/td&gt; &lt;td valign="bottom" width="1%" align="right"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%"&gt;$&lt;/td&gt; &lt;td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%"&gt;20,530&lt;/td&gt; &lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td valign="bottom" width="1%" align="right"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%"&gt;$&lt;/td&gt; &lt;td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%"&gt;9,431&lt;/td&gt; &lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td valign="bottom" width="1%" align="right"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%"&gt;-&lt;/td&gt; &lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td valign="bottom" width="1%" align="right"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%"&gt;$&lt;/td&gt; &lt;td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%"&gt;6,311&lt;/td&gt; &lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td valign="bottom" width="1%" align="right"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%"&gt;$&lt;/td&gt; &lt;td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%"&gt;7,130&lt;/td&gt; &lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td valign="bottom" width="1%" align="right"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%"&gt;-&lt;/td&gt; &lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr bgcolor="white"&gt; &lt;td style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt" valign="bottom" width="28%"&gt; &lt;div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: left; TEXT-INDENT: 0pt"&gt; Foreign currency derivative instruments&lt;/div&gt; &lt;/td&gt; &lt;td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%" align="right"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 2px solid; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%"&gt;-&lt;/td&gt; &lt;td style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%" align="right"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 2px solid; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%"&gt;(842&lt;/td&gt; &lt;td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"&gt;)&lt;/td&gt; &lt;td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%" align="right"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 2px solid; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%"&gt;-&lt;/td&gt; &lt;td style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%" align="right"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 2px solid; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%"&gt;-&lt;/td&gt; &lt;td style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%" align="right"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 2px solid; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%"&gt;93&lt;/td&gt; &lt;td style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%" align="right"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 2px solid; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%"&gt;-&lt;/td&gt; &lt;td style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr bgcolor="#cceeff"&gt; &lt;td style="PADDING-BOTTOM: 4px; TEXT-ALIGN: left; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt" valign="bottom" width="28%"&gt; &lt;div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: left; TEXT-INDENT: 0pt"&gt; Total&lt;/div&gt; &lt;/td&gt; &lt;td style="PADDING-BOTTOM: 4px" valign="bottom" width="1%" align="right"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 4px double; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%"&gt;$&lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 4px double; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%"&gt;20,530&lt;/td&gt; &lt;td style="PADDING-BOTTOM: 4px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="PADDING-BOTTOM: 4px" valign="bottom" width="1%" align="right"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 4px double; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%"&gt;$&lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 4px double; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%"&gt;8,589&lt;/td&gt; &lt;td style="PADDING-BOTTOM: 4px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="PADDING-BOTTOM: 4px" valign="bottom" width="1%" align="right"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 4px double; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%"&gt;$&lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 4px double; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%"&gt;-&lt;/td&gt; &lt;td style="PADDING-BOTTOM: 4px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="PADDING-BOTTOM: 4px" valign="bottom" width="1%" align="right"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 4px double; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%"&gt;$&lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 4px double; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%"&gt;6,311&lt;/td&gt; &lt;td style="PADDING-BOTTOM: 4px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="PADDING-BOTTOM: 4px" valign="bottom" width="1%" align="right"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 4px double; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%"&gt;$&lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 4px double; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%"&gt;7,223&lt;/td&gt; &lt;td style="PADDING-BOTTOM: 4px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="PADDING-BOTTOM: 4px" valign="bottom" width="1%" align="right"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 4px double; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%"&gt;$&lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 4px double; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%"&gt;-&lt;/td&gt; &lt;td style="PADDING-BOTTOM: 4px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;/tr&gt; &lt;/table&gt; &lt;/div&gt; &lt;!--EndFragment--&gt;&lt;/div&gt; &lt;/div&gt;</us-gaap:FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTableTextBlock>
  <us-gaap:FairValueDisclosuresTextBlock id="FairValueDisclosuresTextBlock.869.0.0.0.0.0.0" contextRef="from-2013-07-01-to-2014-06-30.869.0.0.0.0.0.0.0">&lt;!--DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd" --&gt;&lt;div&gt; &lt;div&gt;&lt;!--StartFragment--&gt; &lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; FONT-WEIGHT: bold; DISPLAY: inline"&gt; NOTE 4:- FAIR VALUE OF FINANCIAL INSTRUMENTS&lt;/font&gt; &lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"&gt; &amp;nbsp;&lt;/div&gt; &lt;div style="text-align: right"&gt; &lt;table style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman" cellspacing="0" cellpadding="0" width="97%"&gt; &lt;tr&gt; &lt;td style="PADDING-BOTTOM: 2px" valign="bottom" width="28%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-WEIGHT: bold; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="34%" colspan="10"&gt; &lt;div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"&gt; June 30, 2014&lt;/div&gt; &lt;/td&gt; &lt;td style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-WEIGHT: bold; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-WEIGHT: bold; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="34%" colspan="10"&gt; &lt;div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"&gt; June 30, 2013&lt;/div&gt; &lt;/td&gt; &lt;td style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-WEIGHT: bold; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td style="PADDING-BOTTOM: 2px" valign="bottom" width="28%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-WEIGHT: bold; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="10%" colspan="2"&gt; &lt;div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"&gt; Level 1&lt;/div&gt; &lt;/td&gt; &lt;td style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-WEIGHT: bold; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-WEIGHT: bold; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="10%" colspan="2"&gt; &lt;div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"&gt; Level 2&lt;/div&gt; &lt;/td&gt; &lt;td style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-WEIGHT: bold; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-WEIGHT: bold; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="10%" colspan="2"&gt; &lt;div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"&gt; Level 3&lt;/div&gt; &lt;/td&gt; &lt;td style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-WEIGHT: bold; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-WEIGHT: bold; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="10%" colspan="2"&gt; &lt;div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"&gt; Level 1&lt;/div&gt; &lt;/td&gt; &lt;td style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-WEIGHT: bold; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-WEIGHT: bold; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="10%" colspan="2"&gt; &lt;div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"&gt; Level 2&lt;/div&gt; &lt;/td&gt; &lt;td style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-WEIGHT: bold; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-WEIGHT: bold; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="10%" colspan="2"&gt; &lt;div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"&gt; Level 3&lt;/div&gt; &lt;/td&gt; &lt;td style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-WEIGHT: bold; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr bgcolor="#cceeff"&gt; &lt;td style="TEXT-ALIGN: left; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt" valign="bottom" width="28%"&gt; &lt;div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: left; TEXT-INDENT: 0pt"&gt; Marketable securities&lt;/div&gt; &lt;/td&gt; &lt;td valign="bottom" width="1%" align="right"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%"&gt;$&lt;/td&gt; &lt;td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%"&gt;20,530&lt;/td&gt; &lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td valign="bottom" width="1%" align="right"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%"&gt;$&lt;/td&gt; &lt;td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%"&gt;9,431&lt;/td&gt; &lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td valign="bottom" width="1%" align="right"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%"&gt;-&lt;/td&gt; &lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td valign="bottom" width="1%" align="right"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%"&gt;$&lt;/td&gt; &lt;td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%"&gt;6,311&lt;/td&gt; &lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td valign="bottom" width="1%" align="right"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%"&gt;$&lt;/td&gt; &lt;td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%"&gt;7,130&lt;/td&gt; &lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td valign="bottom" width="1%" align="right"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%"&gt;-&lt;/td&gt; &lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr bgcolor="white"&gt; &lt;td style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt" valign="bottom" width="28%"&gt; &lt;div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: left; TEXT-INDENT: 0pt"&gt; Foreign currency derivative instruments&lt;/div&gt; &lt;/td&gt; &lt;td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%" align="right"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 2px solid; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%"&gt;-&lt;/td&gt; &lt;td style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%" align="right"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 2px solid; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%"&gt;(842&lt;/td&gt; &lt;td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"&gt;)&lt;/td&gt; &lt;td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%" align="right"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 2px solid; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%"&gt;-&lt;/td&gt; &lt;td style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%" align="right"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 2px solid; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%"&gt;-&lt;/td&gt; &lt;td style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%" align="right"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 2px solid; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%"&gt;93&lt;/td&gt; &lt;td style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%" align="right"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 2px solid; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%"&gt;-&lt;/td&gt; &lt;td style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr bgcolor="#cceeff"&gt; &lt;td style="PADDING-BOTTOM: 4px; TEXT-ALIGN: left; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt" valign="bottom" width="28%"&gt; &lt;div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: left; TEXT-INDENT: 0pt"&gt; Total&lt;/div&gt; &lt;/td&gt; &lt;td style="PADDING-BOTTOM: 4px" valign="bottom" width="1%" align="right"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 4px double; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%"&gt;$&lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 4px double; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%"&gt;20,530&lt;/td&gt; &lt;td style="PADDING-BOTTOM: 4px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="PADDING-BOTTOM: 4px" valign="bottom" width="1%" align="right"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 4px double; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%"&gt;$&lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 4px double; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%"&gt;8,589&lt;/td&gt; &lt;td style="PADDING-BOTTOM: 4px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="PADDING-BOTTOM: 4px" valign="bottom" width="1%" align="right"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 4px double; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%"&gt;$&lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 4px double; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%"&gt;-&lt;/td&gt; &lt;td style="PADDING-BOTTOM: 4px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="PADDING-BOTTOM: 4px" valign="bottom" width="1%" align="right"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 4px double; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%"&gt;$&lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 4px double; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%"&gt;6,311&lt;/td&gt; &lt;td style="PADDING-BOTTOM: 4px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="PADDING-BOTTOM: 4px" valign="bottom" width="1%" align="right"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 4px double; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%"&gt;$&lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 4px double; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%"&gt;7,223&lt;/td&gt; &lt;td style="PADDING-BOTTOM: 4px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="PADDING-BOTTOM: 4px" valign="bottom" width="1%" align="right"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 4px double; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%"&gt;$&lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 4px double; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%"&gt;-&lt;/td&gt; &lt;td style="PADDING-BOTTOM: 4px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;/tr&gt; &lt;/table&gt; &lt;/div&gt; &lt;div style="DISPLAY: block; TEXT-INDENT: 0pt"&gt;&lt;br /&gt; &lt;/div&gt; &lt;div style="text-align: right"&gt; &lt;table style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman" cellspacing="0" cellpadding="0" width="97%"&gt; &lt;tr&gt; &lt;td style="PADDING-BOTTOM: 2px" valign="bottom" width="49%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="26%" colspan="4"&gt; &lt;div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"&gt; June 30, 2014&lt;/div&gt; &lt;/td&gt; &lt;td style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-WEIGHT: bold; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-WEIGHT: bold; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="22%" colspan="6"&gt; &lt;div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"&gt; June 30, 2013&lt;/div&gt; &lt;/td&gt; &lt;td style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-WEIGHT: bold; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td style="PADDING-BOTTOM: 2px" valign="bottom" width="49%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="15%"&gt; &lt;div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"&gt; Balance Sheet location&lt;/div&gt; &lt;/td&gt; &lt;td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-WEIGHT: bold; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="10%" colspan="2"&gt; &lt;div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"&gt; Fair Value&lt;/div&gt; &lt;/td&gt; &lt;td style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-WEIGHT: bold; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-WEIGHT: bold; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="10%" colspan="2"&gt; &lt;div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"&gt; Balance Sheet location&lt;/div&gt; &lt;/td&gt; &lt;td style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-WEIGHT: bold; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-WEIGHT: bold; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="10%" colspan="2"&gt; &lt;div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"&gt; Fair Value&lt;/div&gt; &lt;/td&gt; &lt;td style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-WEIGHT: bold; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr bgcolor="#cceeff"&gt; &lt;td style="TEXT-ALIGN: left; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt" valign="bottom" width="49%"&gt; &lt;div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: left; TEXT-INDENT: 0pt"&gt; Derivatives designated as cash flow hedge instruments&lt;/div&gt; &lt;/td&gt; &lt;td valign="bottom" width="15%"&gt; &lt;div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 1.6pt; text-align: center; TEXT-INDENT: 0pt"&gt; Other current assets&lt;/div&gt; &lt;/td&gt; &lt;td valign="bottom" width="1%" align="right"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%"&gt;$&lt;/td&gt; &lt;td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%"&gt;24&lt;/td&gt; &lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td valign="bottom" width="1%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%"&gt;-&lt;/td&gt; &lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td valign="bottom" width="1%" align="left"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%"&gt;$&lt;/td&gt; &lt;td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%"&gt;-&lt;/td&gt; &lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr bgcolor="white"&gt; &lt;td style="TEXT-ALIGN: left; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt" valign="bottom" width="49%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td valign="bottom" width="15%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td valign="bottom" width="1%" align="right"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td valign="bottom" width="1%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td valign="bottom" width="10%" colspan="2"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td valign="bottom" width="1%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr bgcolor="#cceeff"&gt; &lt;td style="TEXT-ALIGN: left; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt" valign="bottom" width="49%"&gt; &lt;div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: left; TEXT-INDENT: 0pt"&gt; Derivatives not designated as hedge instruments&lt;/div&gt; &lt;/td&gt; &lt;td valign="bottom" width="15%"&gt; &lt;div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 1.6pt; text-align: center; TEXT-INDENT: 0pt"&gt; Other current assets&lt;/div&gt; &lt;/td&gt; &lt;td valign="bottom" width="1%" align="right"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%"&gt;23&lt;/td&gt; &lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td valign="bottom" width="1%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td valign="bottom" width="10%" colspan="2"&gt; &lt;div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"&gt; Other current assets&lt;/div&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td valign="bottom" width="1%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%"&gt;93&lt;/td&gt; &lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr bgcolor="white"&gt; &lt;td style="TEXT-ALIGN: left; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt" valign="bottom" width="49%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td valign="bottom" width="15%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td valign="bottom" width="1%" align="right"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td valign="bottom" width="1%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td valign="bottom" width="1%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr bgcolor="#cceeff"&gt; &lt;td style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt" valign="bottom" width="49%"&gt; &lt;div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: left; TEXT-INDENT: 0pt"&gt; Derivatives designated as fair value hedge instruments&lt;/div&gt; &lt;/td&gt; &lt;td style="PADDING-BOTTOM: 2px" valign="bottom" width="15%"&gt; &lt;div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 1.6pt; text-align: center; TEXT-INDENT: 0pt"&gt; Other current liabilities&lt;/div&gt; &lt;/td&gt; &lt;td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%" align="right"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 2px solid; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%"&gt;(889&lt;/td&gt; &lt;td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"&gt;)&lt;/td&gt; &lt;td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; PADDING-BOTTOM: 2px; TEXT-ALIGN: right" valign="bottom" width="9%"&gt;-&lt;/td&gt; &lt;td style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 2px solid; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%"&gt;-&lt;/td&gt; &lt;td style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr bgcolor="white"&gt; &lt;td style="TEXT-ALIGN: left; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt" valign="bottom" width="49%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td valign="bottom" width="15%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td valign="bottom" width="1%" align="right"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td valign="bottom" width="1%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td valign="bottom" width="1%" align="left"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr bgcolor="#cceeff"&gt; &lt;td style="PADDING-BOTTOM: 4px; TEXT-ALIGN: left; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt" valign="bottom" width="49%"&gt; &lt;div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: left; TEXT-INDENT: 0pt"&gt; Total&lt;/div&gt; &lt;/td&gt; &lt;td style="PADDING-BOTTOM: 4px" valign="bottom" width="15%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="PADDING-BOTTOM: 4px" valign="bottom" width="1%" align="right"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 4px double; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%"&gt;$&lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 4px double; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%"&gt;(842&lt;/td&gt; &lt;td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; PADDING-BOTTOM: 4px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"&gt;)&lt;/td&gt; &lt;td style="PADDING-BOTTOM: 4px" valign="bottom" width="1%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="PADDING-BOTTOM: 4px; TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="PADDING-BOTTOM: 4px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="PADDING-BOTTOM: 4px" valign="bottom" width="1%" align="left"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 4px double; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%"&gt;$&lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 4px double; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%"&gt;93&lt;/td&gt; &lt;td style="PADDING-BOTTOM: 4px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;/tr&gt; &lt;/table&gt; &lt;/div&gt; &lt;!--EndFragment--&gt;&lt;/div&gt; &lt;/div&gt;</us-gaap:FairValueDisclosuresTextBlock>
  <us-gaap:FairValueHedgesAtFairValueNet id="FairValueHedgesAtFairValueNet.872.17845.1333.2365.1594.1352.1619" contextRef="as-of-2014-06-30.872.0.17845.1333.2365.1594.1352.1619" unitRef="USD" decimals="-3">-889000</us-gaap:FairValueHedgesAtFairValueNet>
  <us-gaap:FairValueNetAssetLiability id="FairValueNetAssetLiability.872.2136.2043.2032.2040.0.0" contextRef="as-of-2014-06-30.872.0.2136.2043.2032.2040.0.0" unitRef="USD" decimals="-3">20530000</us-gaap:FairValueNetAssetLiability>
  <us-gaap:FairValueNetAssetLiability id="FairValueNetAssetLiability.874.2136.2043.2032.2040.0.0" contextRef="as-of-2013-06-30.874.0.2136.2043.2032.2040.0.0" unitRef="USD" decimals="-3">6311000</us-gaap:FairValueNetAssetLiability>
  <us-gaap:FairValueNetAssetLiability id="FairValueNetAssetLiability.872.2135.2043.2032.2040.0.0" contextRef="as-of-2014-06-30.872.0.2135.2043.2032.2040.0.0" unitRef="USD" decimals="-3">8589000</us-gaap:FairValueNetAssetLiability>
  <us-gaap:FairValueNetAssetLiability id="FairValueNetAssetLiability.874.2135.2043.2032.2040.0.0" contextRef="as-of-2013-06-30.874.0.2135.2043.2032.2040.0.0" unitRef="USD" decimals="-3">7223000</us-gaap:FairValueNetAssetLiability>
  <us-gaap:FairValueNetAssetLiability id="FairValueNetAssetLiability.872.2137.2043.2032.2040.0.0" xsi:nil="true" contextRef="as-of-2014-06-30.872.0.2137.2043.2032.2040.0.0" unitRef="USD" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" />
  <us-gaap:FairValueNetAssetLiability id="FairValueNetAssetLiability.874.2137.2043.2032.2040.0.0" xsi:nil="true" contextRef="as-of-2013-06-30.874.0.2137.2043.2032.2040.0.0" unitRef="USD" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" />
  <us-gaap:FairValueOfFinancialInstrumentsPolicy id="FairValueOfFinancialInstrumentsPolicy.869.0.0.0.0.0.0" contextRef="from-2013-07-01-to-2014-06-30.869.0.0.0.0.0.0.0">&lt;!--DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd" --&gt;&lt;div&gt; &lt;div&gt;&lt;!--StartFragment--&gt; &lt;div style="text-align: center"&gt; &lt;table style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman" cellspacing="0" cellpadding="0" width="100%" border="0"&gt; &lt;tr valign="top"&gt; &lt;td style="WIDTH: 18pt"&gt; &lt;div style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt"&gt; r.&lt;/div&gt; &lt;/td&gt; &lt;td&gt; &lt;div style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; text-align: justify"&gt; Fair value of financial instruments&lt;/div&gt; &lt;/td&gt; &lt;/tr&gt; &lt;/table&gt; &lt;/div&gt; &lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"&gt; &amp;nbsp;&lt;/div&gt; &lt;div&gt; &lt;table style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman" cellspacing="0" cellpadding="0" width="100%" align="center" border="0"&gt; &lt;tr valign="top"&gt; &lt;td style="WIDTH: 19pt"&gt; &lt;div style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/div&gt; &lt;/td&gt; &lt;td&gt; &lt;div style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; text-align: justify"&gt; The carrying amounts of the Company&amp;#39;s financial instruments, including cash and cash equivalents, short-term and restricted bank deposits, trade payable and other accounts payable and accrued liabilities, approximate fair value because of their generally short term maturities.&lt;/div&gt; &lt;/td&gt; &lt;/tr&gt; &lt;/table&gt; &lt;/div&gt; &lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"&gt; &amp;nbsp;&lt;/div&gt; &lt;div&gt; &lt;table style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman" cellspacing="0" cellpadding="0" width="100%" align="center" border="0"&gt; &lt;tr valign="top"&gt; &lt;td style="WIDTH: 19pt"&gt; &lt;div style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/div&gt; &lt;/td&gt; &lt;td&gt; &lt;div style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; text-align: justify"&gt; The Company measures its investments in marketable securities and derivative instruments at fair value under ASC 820, "Fair Value Measurements and Disclosures" ("ASC 820"). Fair value is an exit price, representing the amount that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants. As such, fair value is a market-based measurement that should be determined based on assumptions that market participants would use in pricing an asset or a liability. As a basis for considering such assumptions, ASC 820 establishes a three-tier value hierarchy, which prioritizes the inputs used in the valuation methodologies in measuring fair value:&lt;/div&gt; &lt;/td&gt; &lt;/tr&gt; &lt;/table&gt; &lt;/div&gt; &lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"&gt; &amp;nbsp;&lt;/div&gt; &lt;div&gt; &lt;table style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman" cellspacing="0" cellpadding="0" width="100%" align="center" border="0"&gt; &lt;tr valign="top"&gt; &lt;td style="WIDTH: 19pt"&gt; &lt;div style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/div&gt; &lt;/td&gt; &lt;td&gt; &lt;div style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; text-align: justify"&gt; &lt;font style="FONT-WEIGHT: bold; DISPLAY: inline"&gt;Level 1 -&lt;/font&gt; Quoted prices (unadjusted) in active markets for identical assets or liabilities that the Company can access at the measurement date;&lt;/div&gt; &lt;/td&gt; &lt;/tr&gt; &lt;/table&gt; &lt;/div&gt; &lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"&gt; &amp;nbsp;&lt;/div&gt; &lt;div&gt; &lt;table style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman" cellspacing="0" cellpadding="0" width="100%" align="center" border="0"&gt; &lt;tr valign="top"&gt; &lt;td style="WIDTH: 19pt"&gt; &lt;div style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/div&gt; &lt;/td&gt; &lt;td&gt; &lt;div style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; text-align: justify"&gt; &lt;font style="FONT-WEIGHT: bold; DISPLAY: inline"&gt;Level 2 -&lt;/font&gt; Inputs other than quoted prices included within Level 1 that are observable for the asset or liability, either directly or indirectly.; and&lt;/div&gt; &lt;/td&gt; &lt;/tr&gt; &lt;/table&gt; &lt;/div&gt; &lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"&gt; &amp;nbsp;&lt;/div&gt; &lt;div&gt; &lt;table style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman" cellspacing="0" cellpadding="0" width="100%" align="center" border="0"&gt; &lt;tr valign="top"&gt; &lt;td style="WIDTH: 19pt"&gt; &lt;div style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/div&gt; &lt;/td&gt; &lt;td&gt; &lt;div style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; text-align: justify"&gt; &lt;font style="FONT-WEIGHT: bold; DISPLAY: inline"&gt;Level 3 -&lt;/font&gt; Unobservable inputs for the asset or liability.&lt;/div&gt; &lt;/td&gt; &lt;/tr&gt; &lt;/table&gt; &lt;/div&gt; &lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"&gt; &amp;nbsp;&lt;/div&gt; &lt;div&gt; &lt;table style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman" cellspacing="0" cellpadding="0" width="100%" align="center" border="0"&gt; &lt;tr valign="top"&gt; &lt;td style="WIDTH: 19pt"&gt; &lt;div style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/div&gt; &lt;/td&gt; &lt;td&gt; &lt;div style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; text-align: justify"&gt; The fair value hierarchy also requires an entity to maximize the use of observable inputs and minimize the use of unobservable inputs when measuring fair value. The Company categorized each of its fair value measurements in one of these three levels of hierarchy.&lt;/div&gt; &lt;/td&gt; &lt;/tr&gt; &lt;/table&gt; &lt;/div&gt; &lt;!--EndFragment--&gt;&lt;/div&gt; &lt;/div&gt;</us-gaap:FairValueOfFinancialInstrumentsPolicy>
  <us-gaap:ForeignCurrencyTransactionGainLossBeforeTax id="ForeignCurrencyTransactionGainLossBeforeTax.869.0.0.0.0.0.0" contextRef="from-2013-07-01-to-2014-06-30.869.0.0.0.0.0.0.0" unitRef="USD" decimals="-3">407000</us-gaap:ForeignCurrencyTransactionGainLossBeforeTax>
  <us-gaap:ForeignCurrencyTransactionGainLossBeforeTax id="ForeignCurrencyTransactionGainLossBeforeTax.870.0.0.0.0.0.0" contextRef="from-2012-07-01-to-2013-06-30.870.0.0.0.0.0.0.0" unitRef="USD" decimals="-3">497000</us-gaap:ForeignCurrencyTransactionGainLossBeforeTax>
  <us-gaap:ForeignCurrencyTransactionGainLossBeforeTax id="ForeignCurrencyTransactionGainLossBeforeTax.871.0.0.0.0.0.0" contextRef="from-2011-07-01-to-2012-06-30.871.0.0.0.0.0.0.0" unitRef="USD" decimals="-3">-98000</us-gaap:ForeignCurrencyTransactionGainLossBeforeTax>
  <us-gaap:ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock id="ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock.869.0.0.0.0.0.0" contextRef="from-2013-07-01-to-2014-06-30.869.0.0.0.0.0.0.0">&lt;!--DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd" --&gt;&lt;div&gt; &lt;div&gt;&lt;!--StartFragment--&gt; &lt;div&gt; &lt;table style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman" cellspacing="0" cellpadding="0" width="100%" align="center" border="0"&gt; &lt;tr valign="top"&gt; &lt;td style="WIDTH: 18pt"&gt; &lt;div style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt"&gt; b.&lt;/div&gt; &lt;/td&gt; &lt;td&gt; &lt;div style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; text-align: justify"&gt; Functional currency of the Subsidiary&lt;/div&gt; &lt;/td&gt; &lt;/tr&gt; &lt;/table&gt; &lt;/div&gt; &lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"&gt; &amp;nbsp;&lt;/div&gt; &lt;div&gt; &lt;table style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman" cellspacing="0" cellpadding="0" width="100%" align="center" border="0"&gt; &lt;tr valign="top"&gt; &lt;td style="WIDTH: 19pt"&gt; &lt;div style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/div&gt; &lt;/td&gt; &lt;td&gt; &lt;div style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; text-align: justify"&gt; The Subsidiary&amp;#39;s revenues are generated and determined in U.S. Dollars ("dollars"). In addition, most of the financing of the Subsidiary&amp;#39;s operations has been made in dollars. The Company&amp;#39;s management believes that the dollar is the primary currency of the economic environment in which the Subsidiary operates. Thus, management believe that the functional currency of the Subsidiary is the dollar. Accordingly, monetary accounts maintained in currencies other than the dollar are remeasured into dollars in accordance with ASC 830, "Foreign Currency Matters". All transaction gains and losses from the remeasurement of monetary balance sheet items are reflected in the statement of operations as financial income or expenses, as appropriate.&lt;/div&gt; &lt;/td&gt; &lt;/tr&gt; &lt;/table&gt; &lt;/div&gt; &lt;!--EndFragment--&gt;&lt;/div&gt; &lt;/div&gt;</us-gaap:ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock>
  <us-gaap:GainLossOnDerivativeInstrumentsNetPretax id="GainLossOnDerivativeInstrumentsNetPretax.869.0.0.0.0.0.0" contextRef="from-2013-07-01-to-2014-06-30.869.0.0.0.0.0.0.0" unitRef="USD" decimals="-3">-70000</us-gaap:GainLossOnDerivativeInstrumentsNetPretax>
  <us-gaap:GainLossOnDerivativeInstrumentsNetPretax id="GainLossOnDerivativeInstrumentsNetPretax.870.0.0.0.0.0.0" contextRef="from-2012-07-01-to-2013-06-30.870.0.0.0.0.0.0.0" unitRef="USD" decimals="-3">231000</us-gaap:GainLossOnDerivativeInstrumentsNetPretax>
  <us-gaap:GainLossOnDerivativeInstrumentsNetPretax id="GainLossOnDerivativeInstrumentsNetPretax.871.0.0.0.0.0.0" contextRef="from-2011-07-01-to-2012-06-30.871.0.0.0.0.0.0.0" unitRef="USD" decimals="-3">-145000</us-gaap:GainLossOnDerivativeInstrumentsNetPretax>
  <us-gaap:GainLossOnSaleOfPropertyPlantEquipment id="GainLossOnSaleOfPropertyPlantEquipment.869.0.0.0.0.0.0" contextRef="from-2013-07-01-to-2014-06-30.869.0.0.0.0.0.0.0" unitRef="USD" decimals="-3">-85000</us-gaap:GainLossOnSaleOfPropertyPlantEquipment>
  <us-gaap:GainLossOnSaleOfPropertyPlantEquipment id="GainLossOnSaleOfPropertyPlantEquipment.870.0.0.0.0.0.0" xsi:nil="true" contextRef="from-2012-07-01-to-2013-06-30.870.0.0.0.0.0.0.0" unitRef="USD" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" />
  <us-gaap:GainLossOnSaleOfPropertyPlantEquipment id="GainLossOnSaleOfPropertyPlantEquipment.871.0.0.0.0.0.0" contextRef="from-2011-07-01-to-2012-06-30.871.0.0.0.0.0.0.0" unitRef="USD" decimals="-3">-1000</us-gaap:GainLossOnSaleOfPropertyPlantEquipment>
  <us-gaap:GeneralAndAdministrativeExpense id="GeneralAndAdministrativeExpense.869.0.0.0.0.0.0" contextRef="from-2013-07-01-to-2014-06-30.869.0.0.0.0.0.0.0" unitRef="USD" decimals="-3">8676000</us-gaap:GeneralAndAdministrativeExpense>
  <us-gaap:GeneralAndAdministrativeExpense id="GeneralAndAdministrativeExpense.870.0.0.0.0.0.0" contextRef="from-2012-07-01-to-2013-06-30.870.0.0.0.0.0.0.0" unitRef="USD" decimals="-3">5649000</us-gaap:GeneralAndAdministrativeExpense>
  <us-gaap:GeneralAndAdministrativeExpense id="GeneralAndAdministrativeExpense.871.0.0.0.0.0.0" contextRef="from-2011-07-01-to-2012-06-30.871.0.0.0.0.0.0.0" unitRef="USD" decimals="-3">6568000</us-gaap:GeneralAndAdministrativeExpense>
  <us-gaap:GrossProfit id="GrossProfit.869.0.0.0.0.0.0" contextRef="from-2013-07-01-to-2014-06-30.869.0.0.0.0.0.0.0" unitRef="USD" decimals="-3">368000</us-gaap:GrossProfit>
  <us-gaap:GrossProfit id="GrossProfit.870.0.0.0.0.0.0" contextRef="from-2012-07-01-to-2013-06-30.870.0.0.0.0.0.0.0" unitRef="USD" decimals="-3">659000</us-gaap:GrossProfit>
  <us-gaap:GrossProfit id="GrossProfit.871.0.0.0.0.0.0" contextRef="from-2011-07-01-to-2012-06-30.871.0.0.0.0.0.0.0" unitRef="USD" decimals="-3">695000</us-gaap:GrossProfit>
  <us-gaap:GuaranteeObligationsCurrentCarryingValue id="GuaranteeObligationsCurrentCarryingValue.872.3008.4261.0.0.0.0" contextRef="as-of-2014-06-30.872.0.3008.4261.0.0.0.0" unitRef="USD" decimals="-3">388000</us-gaap:GuaranteeObligationsCurrentCarryingValue>
  <us-gaap:ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock id="ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock.869.0.0.0.0.0.0" contextRef="from-2013-07-01-to-2014-06-30.869.0.0.0.0.0.0.0">&lt;!--DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd" --&gt;&lt;div&gt; &lt;div&gt;&lt;!--StartFragment--&gt; &lt;div style="text-align: center"&gt; &lt;table style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman" cellspacing="0" cellpadding="0" width="100%" border="0"&gt; &lt;tr valign="top"&gt; &lt;td style="WIDTH: 18pt"&gt; &lt;div style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt"&gt; k.&lt;/div&gt; &lt;/td&gt; &lt;td&gt; &lt;div style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; text-align: justify"&gt; Impairment of long-lived assets&lt;/div&gt; &lt;/td&gt; &lt;/tr&gt; &lt;/table&gt; &lt;/div&gt; &lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"&gt; &amp;nbsp;&lt;/div&gt; &lt;div&gt; &lt;table style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman" cellspacing="0" cellpadding="0" width="100%" align="center" border="0"&gt; &lt;tr valign="top"&gt; &lt;td style="WIDTH: 18pt"&gt; &lt;div style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/div&gt; &lt;/td&gt; &lt;td&gt; &lt;div style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; text-align: justify"&gt; The Company&amp;#39;s long-lived assets are reviewed for impairment in accordance with ASC 360, "Property, Plant and Equipment", whenever events or changes in circumstances indicate that the carrying amount of an asset may not be recoverable. Recoverability of assets to be held and used is measured by a comparison of the carrying amount of the assets to the future undiscounted cash flows expected to be generated by the assets. If such assets are considered to be impaired, the impairment to be recognized is measured by the amount by which the carrying amount of the assets exceeds the fair value of the assets. During 2014, 2013 and 2012, no impairment losses been identified.&lt;/div&gt; &lt;/td&gt; &lt;/tr&gt; &lt;/table&gt; &lt;/div&gt; &lt;!--EndFragment--&gt;&lt;/div&gt; &lt;/div&gt;</us-gaap:ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock>
  <us-gaap:IncomeTaxDisclosureTextBlock id="IncomeTaxDisclosureTextBlock.869.0.0.0.0.0.0" contextRef="from-2013-07-01-to-2014-06-30.869.0.0.0.0.0.0.0">&lt;!--DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd" --&gt;&lt;div&gt; &lt;div&gt;&lt;!--StartFragment--&gt; &lt;div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: left; TEXT-INDENT: 0pt"&gt; NOTE 10:-TAXES ON INCOME&lt;/div&gt; &lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"&gt; &amp;nbsp;&lt;/div&gt; &lt;div&gt; &lt;table style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman" cellspacing="0" cellpadding="0" width="100%" align="center" border="0"&gt; &lt;tr valign="top"&gt; &lt;td style="WIDTH: 27pt"&gt; &lt;div style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt"&gt; A.&lt;/div&gt; &lt;/td&gt; &lt;td&gt; &lt;div style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; text-align: justify"&gt; Tax laws applicable to the companies:&lt;/div&gt; &lt;/td&gt; &lt;/tr&gt; &lt;/table&gt; &lt;/div&gt; &lt;div style="DISPLAY: block; TEXT-INDENT: 0pt"&gt;&lt;br /&gt; &lt;/div&gt; &lt;div&gt; &lt;table style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman" cellspacing="0" cellpadding="0" width="100%" align="center" border="0"&gt; &lt;tr valign="top"&gt; &lt;td style="WIDTH: 27pt"&gt; &lt;div style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/div&gt; &lt;/td&gt; &lt;td style="WIDTH: 18pt"&gt; &lt;div style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt"&gt; 1.&lt;/div&gt; &lt;/td&gt; &lt;td&gt; &lt;div style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; text-align: justify"&gt; Pluristem Therapeutics Inc. is taxed under U.S. tax laws.&lt;/div&gt; &lt;/td&gt; &lt;/tr&gt; &lt;/table&gt; &lt;/div&gt; &lt;div&gt; &lt;table style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman" cellspacing="0" cellpadding="0" width="100%" align="center" border="0"&gt; &lt;tr valign="top"&gt; &lt;td style="WIDTH: 27pt"&gt; &lt;div style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/div&gt; &lt;/td&gt; &lt;td style="WIDTH: 18pt"&gt; &lt;div style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt"&gt; 2.&lt;/div&gt; &lt;/td&gt; &lt;td&gt; &lt;div style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; text-align: justify"&gt; Pluristem Ltd. is taxed under Israeli tax laws.&lt;/div&gt; &lt;/td&gt; &lt;/tr&gt; &lt;/table&gt; &lt;/div&gt; &lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"&gt; &amp;nbsp;&lt;/div&gt; &lt;div&gt; &lt;table style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman" cellspacing="0" cellpadding="0" width="100%" align="center" border="0"&gt; &lt;tr valign="top"&gt; &lt;td style="WIDTH: 27pt"&gt; &lt;div style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt"&gt; B.&lt;/div&gt; &lt;/td&gt; &lt;td&gt; &lt;div style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; text-align: justify"&gt; Tax assessments:&lt;/div&gt; &lt;/td&gt; &lt;/tr&gt; &lt;/table&gt; &lt;/div&gt; &lt;div style="DISPLAY: block; TEXT-INDENT: 0pt"&gt;&amp;nbsp;&lt;/div&gt; &lt;div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; MARGIN-LEFT: 27pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"&gt; The Subsidiary has not received final tax assessments since its incorporation; however, the assessments of the Subsidiary are deemed final through 2009.&lt;/div&gt; &lt;div style="DISPLAY: block; MARGIN-LEFT: 27pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"&gt; &amp;nbsp;&lt;/div&gt; &lt;div&gt; &lt;table style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman" cellspacing="0" cellpadding="0" width="100%" align="center" border="0"&gt; &lt;tr valign="top"&gt; &lt;td style="WIDTH: 27pt"&gt; &lt;div style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt"&gt; C.&lt;/div&gt; &lt;/td&gt; &lt;td&gt; &lt;div style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; text-align: justify"&gt; Tax rates applicable to the Company:-&lt;/div&gt; &lt;/td&gt; &lt;/tr&gt; &lt;/table&gt; &lt;/div&gt; &lt;div style="DISPLAY: block; TEXT-INDENT: 0pt"&gt;&lt;br /&gt; &lt;/div&gt; &lt;div&gt; &lt;table style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman" cellspacing="0" cellpadding="0" width="100%" align="center" border="0"&gt; &lt;tr valign="top"&gt; &lt;td style="WIDTH: 28.349pt"&gt; &lt;div style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/div&gt; &lt;/td&gt; &lt;td style="WIDTH: 18pt"&gt; &lt;div style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt"&gt; 1.&lt;/div&gt; &lt;/td&gt; &lt;td&gt; &lt;div style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; text-align: justify"&gt; Pluristem Therapeutics Inc.:&lt;/div&gt; &lt;/td&gt; &lt;/tr&gt; &lt;/table&gt; &lt;/div&gt; &lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"&gt; &amp;nbsp;&lt;/div&gt; &lt;div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; MARGIN-LEFT: 45pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"&gt; The tax rates applicable to Pluristem Therapeutics Inc., a Nevada corporation, are corporate (progressive) tax at the rate of up to 35%, excluding state tax and local tax if any, which rates depend on the state and city in which Pluristem Therapeutics Inc. conducts its business.&lt;/div&gt; &lt;div style="DISPLAY: block; MARGIN-LEFT: 45pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"&gt; &amp;nbsp;&lt;/div&gt; &lt;div&gt; &lt;table style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman" cellspacing="0" cellpadding="0" width="100%" align="center" border="0"&gt; &lt;tr valign="top"&gt; &lt;td style="WIDTH: 28.349pt"&gt; &lt;div style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/div&gt; &lt;/td&gt; &lt;td style="WIDTH: 18pt"&gt; &lt;div style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt"&gt; 2.&lt;/div&gt; &lt;/td&gt; &lt;td&gt; &lt;div style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; text-align: justify"&gt; The Subsidiary:&lt;/div&gt; &lt;/td&gt; &lt;/tr&gt; &lt;/table&gt; &lt;/div&gt; &lt;div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; MARGIN-LEFT: 45pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"&gt; &amp;nbsp;&lt;/div&gt; &lt;div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; MARGIN-LEFT: 45pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"&gt; Taxable income of Israeli companies is subject to tax at the rate of 25% in 2012, 2013 and 26.5% in 2014.&lt;/div&gt; &lt;div style="DISPLAY: block; TEXT-INDENT: 0pt"&gt;&lt;br /&gt; &lt;/div&gt; &lt;div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; MARGIN-LEFT: 27pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"&gt; Tax Benefits Under the Law for Encouragement of Capital Investments.&lt;/div&gt; &lt;div style="DISPLAY: block; MARGIN-LEFT: 437pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"&gt; &amp;nbsp;&lt;/div&gt; &lt;div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; MARGIN-LEFT: 27pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"&gt; According to the Law for Encouragement of Capital Investments, 1959 (the "Encouragement Law"), the Subsidiary is entitled to various tax benefits due to "Beneficiary Enterprise" status granted to its enterprise, as implied by the Encouragement Law. The principal benefits by virtue of the Encouragement Law are:&lt;/div&gt; &lt;div style="DISPLAY: block; MARGIN-LEFT: 27pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"&gt; &amp;nbsp;&lt;/div&gt; &lt;div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-STYLE: italic; MARGIN-LEFT: 27pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"&gt; Tax benefits and reduced tax rates:&lt;/div&gt; &lt;div style="DISPLAY: block; MARGIN-LEFT: 437pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"&gt; &amp;nbsp;&lt;/div&gt; &lt;div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; MARGIN-LEFT: 27pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"&gt; On July 7, 2010, the Subsidiary has received a letter of approval (the "Ruling") from the Israeli Tax Authority. According to the Ruling, the Subsidiary&amp;#39;s expansion program of its plant was granted the status of a "Beneficiary Enterprise" under the "Alternative Track" (the "2007 Program"). The Subsidiary chose the year 2007 as the election year of the 2007 Program.&lt;/div&gt; &lt;div style="MARGIN-LEFT: 437pt; DISPLAY: block; TEXT-INDENT: 0pt"&gt; &lt;br /&gt; &lt;/div&gt; &lt;div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; MARGIN-LEFT: 27pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"&gt; Under the 2007 Program "Alternative Track", the Subsidiary, which was located in a National Priority Zone "B" with respect to the year 2007, is tax exempt in the first six years of the benefit period and subject to tax at the reduced rate of 10%-25% for a period of one to four years for the remaining benefit period (dependent on the level of foreign investments).&lt;/div&gt; &lt;div style="MARGIN-LEFT: 437pt; DISPLAY: block; TEXT-INDENT: 0pt"&gt; &lt;br /&gt; &lt;/div&gt; &lt;div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; MARGIN-LEFT: 27pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"&gt; On June 6, 2013, the Subsidiary informed the Israeli Tax Authority that it has chosen the year 2012 as an election year to the expansion of its Beneficiary Enterprise program (the "2012 Program").&lt;/div&gt; &lt;div style="MARGIN-LEFT: 437pt; DISPLAY: block; TEXT-INDENT: 0pt"&gt; &lt;br /&gt; &lt;/div&gt; &lt;div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; MARGIN-LEFT: 27pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"&gt; Under the 2012 Program, the Subsidiary, which was located in the "Other National Priority Zone" with respect to the year 2012, would be tax exempt in the first two years of the benefit period and subject to tax at the reduced rate of 10%-25% for a period of five to eight years for the remaining benefit period (dependent on the level of foreign investments).&lt;/div&gt; &lt;div style="MARGIN-LEFT: 437pt; DISPLAY: block; TEXT-INDENT: 0pt"&gt; &lt;br /&gt; &lt;/div&gt; &lt;div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; MARGIN-LEFT: 27pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"&gt; Following the enactment of Amendment No. 60 to the Encouragement&lt;font style="FONT-WEIGHT: bold; DISPLAY: inline"&gt;&amp;nbsp;&lt;/font&gt; Law, subsequent to April 1, 2005, companies whose election year entitled them to a Beneficiary Enterprise status are required, among others, to make a minimum qualifying investment. This condition requires an investment in the acquisition of productive assets such as machinery and equipment, which must be carried out within three years. The minimum qualifying investment required for setting up a plant is NIS&amp;nbsp;300,000, linked to the Israeli CPI in accordance with the guidelines of the Israeli tax authorities. As for plant expansion, the minimum qualifying investment is the higher of NIS&amp;nbsp;300,000, linked to the Israeli CPI as stated above, and an amount equivalent to the "qualifying percentage" of the value of the productive assets. Productive assets that are used by the plant but not owned by it will also be viewed as productive assets.&lt;/div&gt; &lt;div style="DISPLAY: block; TEXT-INDENT: 0pt"&gt;&lt;br /&gt; &lt;/div&gt; &lt;div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; MARGIN-LEFT: 27pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"&gt; The qualifying percentage of the value of the productive assets is as follows:&lt;/div&gt; &lt;div style="DISPLAY: block; TEXT-INDENT: 0pt"&gt;&lt;br /&gt; &lt;/div&gt; &lt;div style="MARGIN-LEFT: 27pt; text-align: center"&gt; &lt;table style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman" cellspacing="0" cellpadding="0" width="60%"&gt; &lt;tr&gt; &lt;td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="49%"&gt; &lt;div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"&gt; The value of productive&lt;/div&gt; &lt;div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"&gt; assets before the expansion&lt;/div&gt; &lt;div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"&gt; (NIS in millions)&lt;/div&gt; &lt;/td&gt; &lt;td valign="top" width="2%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 2px solid" valign="top" width="49%"&gt; &lt;div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"&gt; The new proportion&lt;/div&gt; &lt;div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"&gt; that the required&lt;/div&gt; &lt;div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"&gt; &amp;nbsp;investment bears&lt;/div&gt; &lt;div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"&gt; to the value of&lt;/div&gt; &lt;div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"&gt; productive assets&lt;/div&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td valign="top" width="49%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td valign="top" width="2%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td valign="top" width="49%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr bgcolor="#cceeff"&gt; &lt;td style="TEXT-ALIGN: left; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt" valign="top" width="49%"&gt; &lt;div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: left; TEXT-INDENT: 0pt"&gt; Up to NIS&amp;nbsp;140&lt;/div&gt; &lt;/td&gt; &lt;td valign="top" width="2%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td valign="top" width="49%"&gt; &lt;div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"&gt; 12%&lt;/div&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr bgcolor="white"&gt; &lt;td style="TEXT-ALIGN: left; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt" valign="top" width="49%"&gt; &lt;div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: left; TEXT-INDENT: 0pt"&gt; NIS&amp;nbsp;140 - NIS&amp;nbsp;500&lt;/div&gt; &lt;/td&gt; &lt;td valign="top" width="2%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td valign="top" width="49%"&gt; &lt;div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"&gt; 7%&lt;/div&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr bgcolor="#cceeff"&gt; &lt;td style="TEXT-ALIGN: left; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt" valign="top" width="49%"&gt; &lt;div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: left; TEXT-INDENT: 0pt"&gt; More than NIS&amp;nbsp;500&lt;/div&gt; &lt;/td&gt; &lt;td valign="top" width="2%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td valign="top" width="49%"&gt; &lt;div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"&gt; 5%&lt;/div&gt; &lt;/td&gt; &lt;/tr&gt; &lt;/table&gt; &lt;/div&gt; &lt;div style="DISPLAY: block; TEXT-INDENT: 0pt"&gt;&lt;br /&gt; &lt;/div&gt; &lt;div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; MARGIN-LEFT: 27pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"&gt; The income qualifying for tax benefits under the alternative track is the taxable income of a "beneficiary company" that has met certain conditions as determined by the Encouragement&lt;font style="FONT-WEIGHT: bold; DISPLAY: inline"&gt;&amp;nbsp;&lt;/font&gt; Law, and which is derived from an industrial enterprise. The Encouragement&lt;font style="FONT-WEIGHT: bold; DISPLAY: inline"&gt;&amp;nbsp;&lt;/font&gt; Law specifies the types of qualifying income that is entitled to tax benefits under the alternative track both in respect of an industrial enterprise and of a hotel, whereby income from an industrial enterprise includes, among others, revenues from the production and development of software products and revenues from industrial research and development activities performed for a foreign resident (and approved by the Head of the Administration of Industrial Research and Development).&lt;/div&gt; &lt;div style="MARGIN-LEFT: 437pt; DISPLAY: block; TEXT-INDENT: 0pt"&gt; &lt;br /&gt; &lt;/div&gt; &lt;div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; MARGIN-LEFT: 27pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"&gt; As stated above, the Subsidiary&amp;#39;s 2007 Program and 2012 Program were granted the status of a "Beneficiary Enterprise", in accordance with the Encouragement&lt;font style="FONT-WEIGHT: bold; DISPLAY: inline"&gt;&amp;nbsp;&lt;/font&gt; Law, under the alternative benefits track. Accordingly, income derived from the Beneficiary Enterprise is subject to the benefits and conditions stated above.&lt;/div&gt; &lt;div style="MARGIN-LEFT: 437pt; DISPLAY: block; TEXT-INDENT: 0pt"&gt; &lt;br /&gt; &lt;/div&gt; &lt;div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; MARGIN-LEFT: 27pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"&gt; In respect of expansion programs pursuant to Amendment No. 60 to the Encouragement&lt;font style="FONT-WEIGHT: bold; DISPLAY: inline"&gt;&amp;nbsp;&lt;/font&gt; Law, the benefit period starts at the later of the election year and the first year the Company earns taxable income provided that 12 years have not passed since the beginning of the election year and for companies in development area A - 14 years since the beginning of the election year. The benefit period for the Subsidiary&amp;#39;s 2007 Program will expire in 2018 (12 years since the beginning of the election year- 2007).The benefit period for the Subsidiary&amp;#39;s 2012 Program would expire in 2023 (12 years since the beginning of the election year - 2012).&lt;/div&gt; &lt;div style="MARGIN-LEFT: 437pt; DISPLAY: block; TEXT-INDENT: 0pt"&gt; &lt;br /&gt; &lt;/div&gt; &lt;div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; MARGIN-LEFT: 27pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"&gt; If a dividend is distributed out of tax exempt profits, as above, the Subsidiary will become liable for tax at the rate applicable to its profits from the Beneficiary Enterprise in the year in which the income was earned, (tax at the rate of 10- 25%, dependent on the level of foreign investments) and to A withholding tax rate of 15% (or lower, under an applicable tax treaty).&lt;/div&gt; &lt;div style="MARGIN-LEFT: 437pt; DISPLAY: block; TEXT-INDENT: 0pt"&gt; &lt;br /&gt; &lt;/div&gt; &lt;div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; MARGIN-LEFT: 27pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"&gt; As for Beneficiary Enterprises pursuant to Amendment No. 60 to the Encouragement&lt;font style="FONT-WEIGHT: bold; DISPLAY: inline"&gt;&amp;nbsp;&lt;/font&gt; Law, the basic condition for receiving the benefits under this track is that the enterprise contributes to Israeli economic growth and is a competitive factor for the gross domestic product. In order to comply with this condition, the Encouragement&lt;font style="FONT-WEIGHT: bold; DISPLAY: inline"&gt;&amp;nbsp;&lt;/font&gt; Law prescribes various requirements regarding industrial enterprises.&lt;/div&gt; &lt;div style="MARGIN-LEFT: 437pt; DISPLAY: block; TEXT-INDENT: 0pt"&gt; &lt;br /&gt; &lt;/div&gt; &lt;div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; MARGIN-LEFT: 27pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"&gt; As for industrial enterprises, in each tax year during the benefit period, one of the following conditions must be met:&lt;/div&gt; &lt;div style="DISPLAY: block; TEXT-INDENT: 0pt"&gt;&lt;br /&gt; &lt;/div&gt; &lt;div&gt; &lt;table style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman" cellspacing="0" cellpadding="0" width="100%" align="center" border="0"&gt; &lt;tr valign="top"&gt; &lt;td style="WIDTH: 27pt"&gt; &lt;div style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/div&gt; &lt;/td&gt; &lt;td style="WIDTH: 18pt"&gt; &lt;div style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt"&gt; 1.&lt;/div&gt; &lt;/td&gt; &lt;td&gt; &lt;div style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; text-align: justify"&gt; The industrial enterprise&amp;#39;s main field of activity is biotechnology or nanotechnology as approved by the Head of the Administration of Industrial Research and Development, prior to the approval of the relevant program.&lt;/div&gt; &lt;/td&gt; &lt;/tr&gt; &lt;/table&gt; &lt;/div&gt; &lt;div&gt; &lt;table style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman" cellspacing="0" cellpadding="0" width="100%" align="center" border="0"&gt; &lt;tr valign="top"&gt; &lt;td style="WIDTH: 27pt"&gt; &lt;div style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/div&gt; &lt;/td&gt; &lt;td style="WIDTH: 18pt"&gt; &lt;div style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt"&gt; 2.&lt;/div&gt; &lt;/td&gt; &lt;td&gt; &lt;div style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; text-align: justify"&gt; The industrial enterprise&amp;#39;s sales revenues in a specific market during the tax year do not exceed 75% of its total sales for that tax year. A "market" is defined as a separate country or customs territory.&lt;/div&gt; &lt;/td&gt; &lt;/tr&gt; &lt;/table&gt; &lt;/div&gt; &lt;div&gt; &lt;table style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman" cellspacing="0" cellpadding="0" width="100%" align="center" border="0"&gt; &lt;tr valign="top"&gt; &lt;td style="WIDTH: 27pt"&gt; &lt;div style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/div&gt; &lt;/td&gt; &lt;td style="WIDTH: 18pt"&gt; &lt;div style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt"&gt; 3.&lt;/div&gt; &lt;/td&gt; &lt;td&gt; &lt;div style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; text-align: justify"&gt; At least 25% of the industrial enterprise&amp;#39;s overall revenues during the tax year were generated from the enterprise&amp;#39;s sales in a specific market with a population of at least 12 million.&lt;/div&gt; &lt;/td&gt; &lt;/tr&gt; &lt;/table&gt; &lt;/div&gt; &lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"&gt; &amp;nbsp;&lt;/div&gt; &lt;div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-STYLE: italic; MARGIN-LEFT: 27pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"&gt; Accelerated depreciation:&lt;/div&gt; &lt;div style="MARGIN-LEFT: 437pt; DISPLAY: block; TEXT-INDENT: 0pt"&gt; &lt;br /&gt; &lt;/div&gt; &lt;div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; MARGIN-LEFT: 27pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"&gt; The Subsidiary is eligible for deduction of accelerated depreciation on buildings, machinery and equipment used by the beneficiary enterprise at a rate of 200% (or 400% for buildings) from the first year of the asset&amp;#39;s operation.&lt;/div&gt; &lt;div style="DISPLAY: block; TEXT-INDENT: 0pt"&gt;&lt;br /&gt; &lt;/div&gt; &lt;div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-STYLE: italic; MARGIN-LEFT: 27pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"&gt; Conditions for the entitlement to the benefits:&lt;/div&gt; &lt;div style="MARGIN-LEFT: 437pt; DISPLAY: block; TEXT-INDENT: 0pt"&gt; &lt;br /&gt; &lt;/div&gt; &lt;div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; MARGIN-LEFT: 27pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"&gt; The abovementioned benefits are conditional upon the fulfillment of the conditions stipulated by the Encouragement&lt;font style="FONT-WEIGHT: bold; DISPLAY: inline"&gt;&amp;nbsp;&lt;/font&gt; Law, regulations promulgated thereunder, and the Ruling with respect to the beneficiary enterprise. Non-compliance with the conditions may cancel all or part of the benefits and refund of the amount of the benefits, including interest. The management believes that the Subsidiary is meeting the aforementioned conditions.&lt;/div&gt; &lt;div style="MARGIN-LEFT: 437pt; DISPLAY: block; TEXT-INDENT: 0pt"&gt; &lt;br /&gt; &lt;/div&gt; &lt;div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-STYLE: italic; MARGIN-LEFT: 27pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"&gt; Amendment to the&amp;nbsp;&amp;nbsp;Encouragement Law:&lt;/div&gt; &lt;div style="MARGIN-LEFT: 437pt; DISPLAY: block; TEXT-INDENT: 0pt"&gt; &lt;br /&gt; &lt;/div&gt; &lt;div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; MARGIN-LEFT: 27pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"&gt; Effective January 2011, the Knesset (Israeli parliament) enacted a reform to the Encouragement Law. According to the reform a flat rate tax would apply to companies eligible for the "Preferred Enterprise" status. In order to be eligible for a Preferred Enterprise status, a company must meet minimum requirements to establish that it contributes to the country&amp;#39;s economic growth and is a competitive factor for the Gross Domestic Product (a competitive enterprise).&lt;/div&gt; &lt;div style="MARGIN-LEFT: 437pt; DISPLAY: block; TEXT-INDENT: 0pt"&gt; &lt;br /&gt; &lt;/div&gt; &lt;div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; MARGIN-LEFT: 27pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"&gt; Israeli companies which currently benefit from an Approved or Privileged Enterprise status and meet the criteria for qualification as a Preferred Enterprise can elect to apply the new Preferred Enterprise benefits by waiving their benefits under the Approved and Privileged Enterprise status.&lt;/div&gt; &lt;div style="MARGIN-LEFT: 437pt; DISPLAY: block; TEXT-INDENT: 0pt"&gt; &lt;br /&gt; &lt;/div&gt; &lt;div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; MARGIN-LEFT: 27pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"&gt; Benefits granted to a Preferred Enterprise include reduced tax rates. Following the enactment of the National Priorities Law, effective January 1, 2014, the reduced tax rate is 9% in the Development Area A regions and 16% in other regions. Preferred Enterprises in peripheral regions are also eligible for Investment Center grants, as well as the applicable reduced tax rates.&lt;/div&gt; &lt;div style="MARGIN-LEFT: 437pt; DISPLAY: block; TEXT-INDENT: 0pt"&gt; &lt;br /&gt; &lt;/div&gt; &lt;div style="TEXT-ALIGN: justify; MARGIN-LEFT: 27pt; DISPLAY: block; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt"&gt; &lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; DISPLAY: inline"&gt; A distribution from a Preferred Enterprise out of the "Preferred Income" through December 31, 2013, was&lt;/font&gt; &lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; DISPLAY: inline"&gt; subject to 15% withholding tax for Israeli-resident individuals and non-Israeli residents (subject to applicable treaty rates) and effective January 1, 2014, subject to 20% withholding tax for Israeli-resident individuals and non-Israeli residents (subject to applicable treaty rates).&lt;/font&gt;&lt;/div&gt; &lt;div style="MARGIN-LEFT: 437pt; DISPLAY: block; TEXT-INDENT: 0pt"&gt; &lt;br /&gt; &lt;/div&gt; &lt;div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; MARGIN-LEFT: 27pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"&gt; A distribution from a Preferred Enterprise out of the "Preferred Income" would be exempt from withholding tax for an Israeli-resident company.&lt;/div&gt; &lt;div style="MARGIN-LEFT: 437pt; DISPLAY: block; TEXT-INDENT: 0pt"&gt; &lt;br /&gt; &lt;/div&gt; &lt;div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; MARGIN-LEFT: 27pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"&gt; The Subsidiary did not apply the Amendment. The Subsidiary may choose to apply the Amendment in the future &lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; DISPLAY: inline"&gt; .&lt;/font&gt;&lt;/div&gt; &lt;div style="DISPLAY: block; TEXT-INDENT: 0pt"&gt;&lt;br /&gt; &lt;/div&gt; &lt;div style="text-align: justify"&gt; &lt;table style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman" cellspacing="0" cellpadding="0" width="100%" border="0"&gt; &lt;tr valign="top"&gt; &lt;td style="WIDTH: 27pt" align="right"&gt; &lt;div style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; text-align: justify"&gt; D.&amp;nbsp;&lt;/div&gt; &lt;/td&gt; &lt;td align="left"&gt; &lt;div style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; text-align: justify"&gt; Carryforward losses for tax purposes&lt;/div&gt; &lt;/td&gt; &lt;/tr&gt; &lt;/table&gt; &lt;/div&gt; &lt;div style="DISPLAY: block; TEXT-INDENT: 0pt"&gt;&lt;br /&gt; &lt;/div&gt; &lt;div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; MARGIN-LEFT: 27pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"&gt; As of June&amp;nbsp;30, 2014, the Company had U.S. federal net operating loss carryforward for income tax purposes in the amount of approximately $22,730. Net operating loss carryforward arising in taxable years&lt;font style="FONT-SIZE: 10pt; DISPLAY: inline"&gt;,&lt;/font&gt; can be carried forward and offset against taxable income for 20 years and expiring between 2022 and 2034.&lt;/div&gt; &lt;div style="MARGIN-LEFT: 437pt; DISPLAY: block; TEXT-INDENT: 0pt"&gt; &lt;br /&gt; &lt;/div&gt; &lt;div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; MARGIN-LEFT: 27pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"&gt; Utilization of U.S. net operating losses may be subject to substantial annual limitations due to the "change in ownership" provisions of the Internal Revenue Code of 1986 and similar state provisions. The annual limitation may result in the expiration of net operating losses before utilization.&lt;/div&gt; &lt;div style="MARGIN-LEFT: 437pt; DISPLAY: block; TEXT-INDENT: 0pt"&gt; &lt;br /&gt; &lt;/div&gt; &lt;div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; MARGIN-LEFT: 27pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"&gt; The Subsidiary in Israel has accumulated losses for tax purposes as of June&amp;nbsp;30, 2014, in the amount of approximately $48,340, which may be carried forward and offset against taxable business income and business capital gain in the future for an indefinite period.&lt;/div&gt; &lt;div style="MARGIN-LEFT: 437pt; DISPLAY: block; TEXT-INDENT: 0pt"&gt; &lt;br /&gt; &lt;/div&gt; &lt;div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; MARGIN-LEFT: 27pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"&gt; Deferred income taxes:&lt;/div&gt; &lt;div style="MARGIN-LEFT: 437pt; DISPLAY: block; TEXT-INDENT: 0pt"&gt; &lt;br /&gt; &lt;/div&gt; &lt;div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; MARGIN-LEFT: 27pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"&gt; Deferred income taxes reflect the net tax effects of temporary differences between the carrying amounts of assets and liabilities for financial reporting purposes and the amounts used for income tax purposes. Significant components of the Company&amp;#39;s deferred tax assets are as follows:&lt;/div&gt; &lt;div style="DISPLAY: block; TEXT-INDENT: 0pt"&gt;&lt;br /&gt; &lt;/div&gt; &lt;div style="text-align: right"&gt; &lt;table style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman" cellspacing="0" cellpadding="0" width="95%"&gt; &lt;tr&gt; &lt;td style="PADDING-BOTTOM: 2px" valign="bottom" width="76%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-WEIGHT: bold; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="22%" colspan="6"&gt; &lt;div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"&gt; June 30,&lt;/div&gt; &lt;/td&gt; &lt;td style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-WEIGHT: bold; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td style="PADDING-BOTTOM: 2px" valign="bottom" width="76%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-WEIGHT: bold; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="10%" colspan="2"&gt; &lt;div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: -18pt"&gt; 2014&lt;/div&gt; &lt;/td&gt; &lt;td style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-WEIGHT: bold; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-WEIGHT: bold; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="10%" colspan="2"&gt; &lt;div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: -18pt"&gt; 2013&lt;/div&gt; &lt;/td&gt; &lt;td style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-WEIGHT: bold; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr bgcolor="#cceeff"&gt; &lt;td valign="bottom" width="76%" align="left"&gt; &lt;div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 9pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: -9pt"&gt; Deferred tax assets:&lt;/div&gt; &lt;/td&gt; &lt;td valign="bottom" width="1%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td valign="bottom" width="10%" colspan="2"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td valign="bottom" width="1%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td valign="bottom" width="10%" colspan="2"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr bgcolor="white"&gt; &lt;td valign="bottom" width="76%" align="left"&gt; &lt;div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: -9pt"&gt; U.S. net operating loss carryforward&lt;/div&gt; &lt;/td&gt; &lt;td valign="bottom" width="1%" align="right"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%"&gt;$&lt;/td&gt; &lt;td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%"&gt;7,955&lt;/td&gt; &lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td valign="bottom" width="1%" align="right"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%"&gt;$&lt;/td&gt; &lt;td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%"&gt;7,106&lt;/td&gt; &lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr bgcolor="#cceeff"&gt; &lt;td valign="bottom" width="76%"&gt; &lt;div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: -9pt"&gt; Israeli net operating loss carryforward&lt;/div&gt; &lt;/td&gt; &lt;td valign="bottom" width="1%" align="right"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%"&gt;12,810&lt;/td&gt; &lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td valign="bottom" width="1%" align="right"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%"&gt;8,543&lt;/td&gt; &lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr bgcolor="white"&gt; &lt;td style="PADDING-BOTTOM: 2px" valign="bottom" width="76%"&gt; &lt;div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: -9pt"&gt; Allowances and reserves&lt;/div&gt; &lt;/td&gt; &lt;td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%" align="right"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 2px solid; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%"&gt;237&lt;/td&gt; &lt;td style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%" align="right"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 2px solid; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%"&gt;156&lt;/td&gt; &lt;td style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr bgcolor="#cceeff"&gt; &lt;td valign="bottom" width="76%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td valign="bottom" width="1%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td valign="bottom" width="1%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr bgcolor="white"&gt; &lt;td valign="bottom" width="76%"&gt; &lt;div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 9pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: -9pt"&gt; Total deferred tax assets before valuation allowance&lt;/div&gt; &lt;/td&gt; &lt;td valign="bottom" width="1%" align="right"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%"&gt;21,002&lt;/td&gt; &lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td valign="bottom" width="1%" align="right"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%"&gt;15,805&lt;/td&gt; &lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr bgcolor="#cceeff"&gt; &lt;td style="PADDING-BOTTOM: 2px" valign="bottom" width="76%"&gt; &lt;div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 9pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: -9pt"&gt; Valuation allowance&lt;/div&gt; &lt;/td&gt; &lt;td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%" align="right"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 2px solid; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%"&gt;(21,002&lt;/td&gt; &lt;td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"&gt;)&lt;/td&gt; &lt;td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%" align="right"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 2px solid; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%"&gt;(15,805&lt;/td&gt; &lt;td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"&gt;)&lt;/td&gt; &lt;/tr&gt; &lt;tr bgcolor="white"&gt; &lt;td valign="bottom" width="76%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td valign="bottom" width="1%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td valign="bottom" width="1%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr bgcolor="#cceeff"&gt; &lt;td style="PADDING-BOTTOM: 4px" valign="bottom" width="76%"&gt; &lt;div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 9pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: -9pt"&gt; Net deferred tax asset&lt;/div&gt; &lt;/td&gt; &lt;td style="PADDING-BOTTOM: 4px" valign="bottom" width="1%" align="right"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 4px double; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%"&gt;$&lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 4px double; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%"&gt;-&lt;/td&gt; &lt;td style="PADDING-BOTTOM: 4px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="PADDING-BOTTOM: 4px" valign="bottom" width="1%" align="right"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 4px double; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%"&gt;$&lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 4px double; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%"&gt;-&lt;/td&gt; &lt;td style="PADDING-BOTTOM: 4px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;/tr&gt; &lt;/table&gt; &lt;/div&gt; &lt;div style="DISPLAY: block; MARGIN-LEFT: 446pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"&gt; &amp;nbsp;&lt;/div&gt; &lt;div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; MARGIN-LEFT: 27pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"&gt; As of June&amp;nbsp;30, 2014 and 2013, the Company has provided full valuation allowances in respect of deferred tax assets resulting from tax loss carryforward and other temporary differences, since they have a history of operating losses and current uncertainty concerning its ability to realize these deferred tax assets in the future.&lt;/div&gt; &lt;div style="MARGIN-LEFT: 437pt; DISPLAY: block; TEXT-INDENT: 0pt"&gt; &lt;br /&gt; &lt;/div&gt; &lt;div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; MARGIN-LEFT: 27pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"&gt; The Company accounts for its income tax uncertainties in accordance with ASC&amp;nbsp;740 which clarifies the accounting for uncertainties in income taxes recognized in a Company&amp;#39;s financial statements and prescribes a recognition threshold and measurement attribute for the financial statement recognition and measurement of a tax position taken or expected to be taken in a tax return.&lt;/div&gt; &lt;div style="MARGIN-LEFT: 437pt; DISPLAY: block; TEXT-INDENT: 0pt"&gt; &lt;br /&gt; &lt;/div&gt; &lt;div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; MARGIN-LEFT: 27pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"&gt; As of June&amp;nbsp;30, 2014 and 2013, there were no unrecognized tax benefits that if recognized would affect the annual effective tax rate.&lt;/div&gt; &lt;div style="DISPLAY: block; TEXT-INDENT: 0pt"&gt;&lt;br /&gt; &lt;/div&gt; &lt;div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: left; TEXT-INDENT: 0pt"&gt; Reconciliation of the theoretical tax expense (benefit) to the actual tax expense (benefit):&lt;/div&gt; &lt;div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; MARGIN-LEFT: 45pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"&gt; &amp;nbsp;&lt;/div&gt; &lt;div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: justify; TEXT-INDENT: 0pt"&gt; In 2012, 2013 and 2014, the main reconciling item of the statutory tax rate of the Company (25% to 35% in 2012, 2013 and 2014) to the effective tax rate (0%) is tax loss carryforwards, stock-based compensation and other deferred tax assets for which a full valuation allowance was provided.&lt;/div&gt; &lt;!--EndFragment--&gt;&lt;/div&gt; &lt;/div&gt;</us-gaap:IncomeTaxDisclosureTextBlock>
  <us-gaap:IncomeTaxesPaid id="IncomeTaxesPaid.869.0.0.0.0.0.0" contextRef="from-2013-07-01-to-2014-06-30.869.0.0.0.0.0.0.0" unitRef="USD" decimals="-3">48000</us-gaap:IncomeTaxesPaid>
  <us-gaap:IncomeTaxesPaid id="IncomeTaxesPaid.870.0.0.0.0.0.0" contextRef="from-2012-07-01-to-2013-06-30.870.0.0.0.0.0.0.0" unitRef="USD" decimals="-3">18000</us-gaap:IncomeTaxesPaid>
  <us-gaap:IncomeTaxesPaid id="IncomeTaxesPaid.871.0.0.0.0.0.0" contextRef="from-2011-07-01-to-2012-06-30.871.0.0.0.0.0.0.0" unitRef="USD" decimals="-3">14000</us-gaap:IncomeTaxesPaid>
  <us-gaap:IncomeTaxPolicyTextBlock id="IncomeTaxPolicyTextBlock.869.0.0.0.0.0.0" contextRef="from-2013-07-01-to-2014-06-30.869.0.0.0.0.0.0.0">&lt;!--DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd" --&gt;&lt;div&gt; &lt;div&gt;&lt;!--StartFragment--&gt; &lt;div style="text-align: center"&gt; &lt;table style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman" cellspacing="0" cellpadding="0" width="100%" border="0"&gt; &lt;tr valign="top"&gt; &lt;td style="WIDTH: 18pt"&gt; &lt;div style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt"&gt; o.&lt;/div&gt; &lt;/td&gt; &lt;td&gt; &lt;div style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; text-align: justify"&gt; Income taxes&lt;/div&gt; &lt;/td&gt; &lt;/tr&gt; &lt;/table&gt; &lt;/div&gt; &lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"&gt; &amp;nbsp;&lt;/div&gt; &lt;div&gt; &lt;table style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman" cellspacing="0" cellpadding="0" width="100%" align="center" border="0"&gt; &lt;tr valign="top"&gt; &lt;td style="WIDTH: 19pt"&gt; &lt;div style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/div&gt; &lt;/td&gt; &lt;td&gt; &lt;div style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; text-align: justify"&gt; The Company accounts for income taxes in accordance with ASC 740, "Income Taxes". This Topic prescribes the use of the liability method, whereby deferred tax assets and liability account balances are determined based on differences between financial reporting and tax bases of assets and liabilities and are measured using the enacted tax rates and laws that will be in effect when the differences are expected to reverse. The Company provides a valuation allowance, if necessary, to reduce deferred tax assets to their estimated realizable value.&lt;/div&gt; &lt;/td&gt; &lt;/tr&gt; &lt;/table&gt; &lt;/div&gt; &lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"&gt; &amp;nbsp;&lt;/div&gt; &lt;div&gt; &lt;table style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman" cellspacing="0" cellpadding="0" width="100%" align="center" border="0"&gt; &lt;tr valign="top"&gt; &lt;td style="WIDTH: 19pt"&gt; &lt;div style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/div&gt; &lt;/td&gt; &lt;td&gt; &lt;div style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; text-align: justify"&gt; ASC 740 establishes a single model to address accounting for uncertain tax positions. ASC 740 clarified the accounting for income taxes by prescribing the minimum recognition threshold a tax position is required to meet before being recognized in the financial statements.&lt;/div&gt; &lt;/td&gt; &lt;/tr&gt; &lt;/table&gt; &lt;/div&gt; &lt;!--EndFragment--&gt;&lt;/div&gt; &lt;/div&gt;</us-gaap:IncomeTaxPolicyTextBlock>
  <us-gaap:IncreaseDecreaseInAccountsPayable id="IncreaseDecreaseInAccountsPayable.869.0.0.0.0.0.0" contextRef="from-2013-07-01-to-2014-06-30.869.0.0.0.0.0.0.0" unitRef="USD" decimals="-3">1257000</us-gaap:IncreaseDecreaseInAccountsPayable>
  <us-gaap:IncreaseDecreaseInAccountsPayable id="IncreaseDecreaseInAccountsPayable.870.0.0.0.0.0.0" contextRef="from-2012-07-01-to-2013-06-30.870.0.0.0.0.0.0.0" unitRef="USD" decimals="-3">1335000</us-gaap:IncreaseDecreaseInAccountsPayable>
  <us-gaap:IncreaseDecreaseInAccountsPayable id="IncreaseDecreaseInAccountsPayable.871.0.0.0.0.0.0" contextRef="from-2011-07-01-to-2012-06-30.871.0.0.0.0.0.0.0" unitRef="USD" decimals="-3">-424000</us-gaap:IncreaseDecreaseInAccountsPayable>
  <us-gaap:IncreaseDecreaseInAccountsReceivable id="IncreaseDecreaseInAccountsReceivable.869.0.0.0.0.0.0" contextRef="from-2013-07-01-to-2014-06-30.869.0.0.0.0.0.0.0" unitRef="USD" decimals="-3">143000</us-gaap:IncreaseDecreaseInAccountsReceivable>
  <us-gaap:IncreaseDecreaseInAccountsReceivable id="IncreaseDecreaseInAccountsReceivable.870.0.0.0.0.0.0" contextRef="from-2012-07-01-to-2013-06-30.870.0.0.0.0.0.0.0" unitRef="USD" decimals="-3">233000</us-gaap:IncreaseDecreaseInAccountsReceivable>
  <us-gaap:IncreaseDecreaseInAccountsReceivable id="IncreaseDecreaseInAccountsReceivable.871.0.0.0.0.0.0" contextRef="from-2011-07-01-to-2012-06-30.871.0.0.0.0.0.0.0" unitRef="USD" decimals="-3">-64000</us-gaap:IncreaseDecreaseInAccountsReceivable>
  <us-gaap:IncreaseDecreaseInAccruedInterestReceivableNet id="IncreaseDecreaseInAccruedInterestReceivableNet.869.0.0.0.0.0.0" contextRef="from-2013-07-01-to-2014-06-30.869.0.0.0.0.0.0.0" unitRef="USD" decimals="-3">36000</us-gaap:IncreaseDecreaseInAccruedInterestReceivableNet>
  <us-gaap:IncreaseDecreaseInAccruedInterestReceivableNet id="IncreaseDecreaseInAccruedInterestReceivableNet.870.0.0.0.0.0.0" contextRef="from-2012-07-01-to-2013-06-30.870.0.0.0.0.0.0.0" unitRef="USD" decimals="-3">140000</us-gaap:IncreaseDecreaseInAccruedInterestReceivableNet>
  <us-gaap:IncreaseDecreaseInAccruedInterestReceivableNet id="IncreaseDecreaseInAccruedInterestReceivableNet.871.0.0.0.0.0.0" contextRef="from-2011-07-01-to-2012-06-30.871.0.0.0.0.0.0.0" unitRef="USD" decimals="-3">395000</us-gaap:IncreaseDecreaseInAccruedInterestReceivableNet>
  <us-gaap:IncreaseDecreaseInCustomerAdvances id="IncreaseDecreaseInCustomerAdvances.869.0.0.0.0.0.0" contextRef="from-2013-07-01-to-2014-06-30.869.0.0.0.0.0.0.0" unitRef="USD" decimals="-3">-146000</us-gaap:IncreaseDecreaseInCustomerAdvances>
  <us-gaap:IncreaseDecreaseInCustomerAdvances id="IncreaseDecreaseInCustomerAdvances.870.0.0.0.0.0.0" contextRef="from-2012-07-01-to-2013-06-30.870.0.0.0.0.0.0.0" unitRef="USD" decimals="-3">-1183000</us-gaap:IncreaseDecreaseInCustomerAdvances>
  <us-gaap:IncreaseDecreaseInCustomerAdvances id="IncreaseDecreaseInCustomerAdvances.871.0.0.0.0.0.0" contextRef="from-2011-07-01-to-2012-06-30.871.0.0.0.0.0.0.0" unitRef="USD" decimals="-3">1576000</us-gaap:IncreaseDecreaseInCustomerAdvances>
  <us-gaap:IncreaseDecreaseInDeferredRevenue id="IncreaseDecreaseInDeferredRevenue.869.0.0.0.0.0.0" contextRef="from-2013-07-01-to-2014-06-30.869.0.0.0.0.0.0.0" unitRef="USD" decimals="-3">-379000</us-gaap:IncreaseDecreaseInDeferredRevenue>
  <us-gaap:IncreaseDecreaseInDeferredRevenue id="IncreaseDecreaseInDeferredRevenue.870.0.0.0.0.0.0" contextRef="from-2012-07-01-to-2013-06-30.870.0.0.0.0.0.0.0" unitRef="USD" decimals="-3">-679000</us-gaap:IncreaseDecreaseInDeferredRevenue>
  <us-gaap:IncreaseDecreaseInDeferredRevenue id="IncreaseDecreaseInDeferredRevenue.871.0.0.0.0.0.0" contextRef="from-2011-07-01-to-2012-06-30.871.0.0.0.0.0.0.0" unitRef="USD" decimals="-3">4284000</us-gaap:IncreaseDecreaseInDeferredRevenue>
  <us-gaap:IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities id="IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities.869.0.0.0.0.0.0" contextRef="from-2013-07-01-to-2014-06-30.869.0.0.0.0.0.0.0" unitRef="USD" decimals="-3">902000</us-gaap:IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities>
  <us-gaap:IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities id="IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities.870.0.0.0.0.0.0" contextRef="from-2012-07-01-to-2013-06-30.870.0.0.0.0.0.0.0" unitRef="USD" decimals="-3">1556000</us-gaap:IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities>
  <us-gaap:IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities id="IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities.871.0.0.0.0.0.0" contextRef="from-2011-07-01-to-2012-06-30.871.0.0.0.0.0.0.0" unitRef="USD" decimals="-3">958000</us-gaap:IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities>
  <us-gaap:IncreaseDecreaseInOtherReceivables id="IncreaseDecreaseInOtherReceivables.869.0.0.0.0.0.0" contextRef="from-2013-07-01-to-2014-06-30.869.0.0.0.0.0.0.0" unitRef="USD" decimals="-3">1990000</us-gaap:IncreaseDecreaseInOtherReceivables>
  <us-gaap:IncreaseDecreaseInOtherReceivables id="IncreaseDecreaseInOtherReceivables.870.0.0.0.0.0.0" contextRef="from-2012-07-01-to-2013-06-30.870.0.0.0.0.0.0.0" unitRef="USD" decimals="-3">70000</us-gaap:IncreaseDecreaseInOtherReceivables>
  <us-gaap:IncreaseDecreaseInOtherReceivables id="IncreaseDecreaseInOtherReceivables.871.0.0.0.0.0.0" contextRef="from-2011-07-01-to-2012-06-30.871.0.0.0.0.0.0.0" unitRef="USD" decimals="-3">230000</us-gaap:IncreaseDecreaseInOtherReceivables>
  <us-gaap:IncreaseDecreaseInPensionAndPostretirementObligations id="IncreaseDecreaseInPensionAndPostretirementObligations.869.0.0.0.0.0.0" contextRef="from-2013-07-01-to-2014-06-30.869.0.0.0.0.0.0.0" unitRef="USD" decimals="-3">49000</us-gaap:IncreaseDecreaseInPensionAndPostretirementObligations>
  <us-gaap:IncreaseDecreaseInPensionAndPostretirementObligations id="IncreaseDecreaseInPensionAndPostretirementObligations.870.0.0.0.0.0.0" contextRef="from-2012-07-01-to-2013-06-30.870.0.0.0.0.0.0.0" unitRef="USD" decimals="-3">-11000</us-gaap:IncreaseDecreaseInPensionAndPostretirementObligations>
  <us-gaap:IncreaseDecreaseInPensionAndPostretirementObligations id="IncreaseDecreaseInPensionAndPostretirementObligations.871.0.0.0.0.0.0" contextRef="from-2011-07-01-to-2012-06-30.871.0.0.0.0.0.0.0" unitRef="USD" decimals="-3">5000</us-gaap:IncreaseDecreaseInPensionAndPostretirementObligations>
  <us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets id="IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets.869.0.0.0.0.0.0" contextRef="from-2013-07-01-to-2014-06-30.869.0.0.0.0.0.0.0" unitRef="USD" decimals="-3">108000</us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets>
  <us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets id="IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets.870.0.0.0.0.0.0" contextRef="from-2012-07-01-to-2013-06-30.870.0.0.0.0.0.0.0" unitRef="USD" decimals="-3">237000</us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets>
  <us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets id="IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets.871.0.0.0.0.0.0" contextRef="from-2011-07-01-to-2012-06-30.871.0.0.0.0.0.0.0" unitRef="USD" decimals="-3">-269000</us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets>
  <us-gaap:IncreaseDecreaseInRestrictedCashAndInvestments id="IncreaseDecreaseInRestrictedCashAndInvestments.869.0.0.0.0.0.0" contextRef="from-2013-07-01-to-2014-06-30.869.0.0.0.0.0.0.0" unitRef="USD" decimals="-3">-122000</us-gaap:IncreaseDecreaseInRestrictedCashAndInvestments>
  <us-gaap:IncreaseDecreaseInRestrictedCashAndInvestments id="IncreaseDecreaseInRestrictedCashAndInvestments.870.0.0.0.0.0.0" contextRef="from-2012-07-01-to-2013-06-30.870.0.0.0.0.0.0.0" unitRef="USD" decimals="-3">-869000</us-gaap:IncreaseDecreaseInRestrictedCashAndInvestments>
  <us-gaap:IncreaseDecreaseInRestrictedCashAndInvestments id="IncreaseDecreaseInRestrictedCashAndInvestments.871.0.0.0.0.0.0" contextRef="from-2011-07-01-to-2012-06-30.871.0.0.0.0.0.0.0" unitRef="USD" decimals="-3">-6000</us-gaap:IncreaseDecreaseInRestrictedCashAndInvestments>
  <us-gaap:InterestIncomeDepositsWithFinancialInstitutions id="InterestIncomeDepositsWithFinancialInstitutions.869.0.0.0.0.0.0" contextRef="from-2013-07-01-to-2014-06-30.869.0.0.0.0.0.0.0" unitRef="USD" decimals="-3">246000</us-gaap:InterestIncomeDepositsWithFinancialInstitutions>
  <us-gaap:InterestIncomeDepositsWithFinancialInstitutions id="InterestIncomeDepositsWithFinancialInstitutions.870.0.0.0.0.0.0" contextRef="from-2012-07-01-to-2013-06-30.870.0.0.0.0.0.0.0" unitRef="USD" decimals="-3">539000</us-gaap:InterestIncomeDepositsWithFinancialInstitutions>
  <us-gaap:InterestIncomeDepositsWithFinancialInstitutions id="InterestIncomeDepositsWithFinancialInstitutions.871.0.0.0.0.0.0" contextRef="from-2011-07-01-to-2012-06-30.871.0.0.0.0.0.0.0" unitRef="USD" decimals="-3">575000</us-gaap:InterestIncomeDepositsWithFinancialInstitutions>
  <us-gaap:InterestReceivable id="InterestReceivable.872.0.0.0.0.0.0" contextRef="as-of-2014-06-30.872.0.0.0.0.0.0.0" unitRef="USD" decimals="-3">98000</us-gaap:InterestReceivable>
  <us-gaap:InterestReceivable id="InterestReceivable.874.0.0.0.0.0.0" contextRef="as-of-2013-06-30.874.0.0.0.0.0.0.0" unitRef="USD" decimals="-3">20000</us-gaap:InterestReceivable>
  <us-gaap:InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock id="InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock.869.0.0.0.0.0.0" contextRef="from-2013-07-01-to-2014-06-30.869.0.0.0.0.0.0.0">&lt;!--DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd" --&gt;&lt;div&gt; &lt;div&gt;&lt;!--StartFragment--&gt; &lt;div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"&gt; NOTE 3:- MARKETABLE SECURITIES&lt;/div&gt; &lt;div style="DISPLAY: block; TEXT-INDENT: 0pt"&gt;&lt;br /&gt; &lt;/div&gt; &lt;div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"&gt; As of June 30, 2014, all of the Company&amp;#39;s marketable securities were classified as available-for-sale.&lt;/div&gt; &lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"&gt; &amp;nbsp;&lt;/div&gt; &lt;div style="text-align: left"&gt; &lt;table style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman" cellspacing="0" cellpadding="0" width="100%"&gt; &lt;tr&gt; &lt;td style="PADDING-BOTTOM: 2px" valign="bottom" width="20%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-WEIGHT: bold; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="38%" colspan="14"&gt; &lt;div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"&gt; June 30, 2014&lt;/div&gt; &lt;/td&gt; &lt;td style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-WEIGHT: bold; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="38%" colspan="14"&gt; &lt;div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"&gt; June 30,2013&lt;/div&gt; &lt;/td&gt; &lt;td style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td style="PADDING-BOTTOM: 2px" valign="bottom" width="20%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-WEIGHT: bold; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="8%" colspan="2"&gt; &lt;div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"&gt; Amortized cost&lt;/div&gt; &lt;/td&gt; &lt;td style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-WEIGHT: bold; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-WEIGHT: bold; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="8%" colspan="2"&gt; &lt;div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"&gt; Gross&lt;/div&gt; &lt;div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"&gt; unrealized&lt;/div&gt; &lt;div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"&gt; gain&lt;/div&gt; &lt;/td&gt; &lt;td style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-WEIGHT: bold; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-WEIGHT: bold; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="8%" colspan="2"&gt; &lt;div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"&gt; Gross&lt;/div&gt; &lt;div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"&gt; unrealized&lt;/div&gt; &lt;div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"&gt; loss&lt;/div&gt; &lt;/td&gt; &lt;td style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-WEIGHT: bold; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-WEIGHT: bold; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="8%" colspan="2"&gt; &lt;div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"&gt; Fair&lt;/div&gt; &lt;div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"&gt; value&lt;/div&gt; &lt;/td&gt; &lt;td style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-WEIGHT: bold; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-WEIGHT: bold; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="8%" colspan="2"&gt; &lt;div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"&gt; Amortized cost&lt;/div&gt; &lt;/td&gt; &lt;td style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-WEIGHT: bold; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-WEIGHT: bold; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="8%" colspan="2"&gt; &lt;div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"&gt; Gross&lt;/div&gt; &lt;div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"&gt; unrealized&lt;/div&gt; &lt;div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"&gt; gain&lt;/div&gt; &lt;/td&gt; &lt;td style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-WEIGHT: bold; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-WEIGHT: bold; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="8%" colspan="2"&gt; &lt;div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"&gt; Gross&lt;/div&gt; &lt;div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"&gt; unrealized&lt;/div&gt; &lt;div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"&gt; loss&lt;/div&gt; &lt;/td&gt; &lt;td style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-WEIGHT: bold; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-WEIGHT: bold; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="8%" colspan="2"&gt; &lt;div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"&gt; Fair&lt;/div&gt; &lt;div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"&gt; value&lt;/div&gt; &lt;/td&gt; &lt;td style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-WEIGHT: bold; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr bgcolor="#cceeff"&gt; &lt;td style="TEXT-ALIGN: left; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt" valign="bottom" width="20%"&gt; &lt;div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: left; TEXT-INDENT: 0pt"&gt; Available-for-sale - matures within one year:&lt;/div&gt; &lt;/td&gt; &lt;td valign="bottom" width="1%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td valign="bottom" width="8%" colspan="2"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td valign="bottom" width="1%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td valign="bottom" width="8%" colspan="2"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td valign="bottom" width="1%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td valign="bottom" width="8%" colspan="2"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td valign="bottom" width="1%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td valign="bottom" width="8%" colspan="2"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td valign="bottom" width="1%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td valign="bottom" width="8%" colspan="2"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td valign="bottom" width="1%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td valign="bottom" width="8%" colspan="2"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td valign="bottom" width="1%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td valign="bottom" width="8%" colspan="2"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td valign="bottom" width="1%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td valign="bottom" width="8%" colspan="2"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr bgcolor="white"&gt; &lt;td style="TEXT-ALIGN: left; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt" valign="bottom" width="20%"&gt; &lt;div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: left; TEXT-INDENT: 0pt"&gt; Stock and index linked notes&lt;/div&gt; &lt;/td&gt; &lt;td valign="bottom" width="1%" align="right"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%"&gt;$&lt;/td&gt; &lt;td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="7%"&gt;18,881&lt;/td&gt; &lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td valign="bottom" width="1%" align="right"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%"&gt;$&lt;/td&gt; &lt;td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="7%"&gt;2,522&lt;/td&gt; &lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td valign="bottom" width="1%" align="right"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%"&gt;$&lt;/td&gt; &lt;td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="7%"&gt;(23&lt;/td&gt; &lt;td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"&gt;)&lt;/td&gt; &lt;td valign="bottom" width="1%" align="right"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%"&gt;$&lt;/td&gt; &lt;td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="7%"&gt;21,380&lt;/td&gt; &lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td valign="bottom" width="1%" align="right"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%"&gt;$&lt;/td&gt; &lt;td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="7%"&gt;4,023&lt;/td&gt; &lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td valign="bottom" width="1%" align="right"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%"&gt;$&lt;/td&gt; &lt;td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="7%"&gt;234&lt;/td&gt; &lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td valign="bottom" width="1%" align="right"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%"&gt;$&lt;/td&gt; &lt;td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="7%"&gt;(180&lt;/td&gt; &lt;td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"&gt;)&lt;/td&gt; &lt;td valign="bottom" width="1%" align="right"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%"&gt;$&lt;/td&gt; &lt;td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="7%"&gt;4,077&lt;/td&gt; &lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr bgcolor="#cceeff"&gt; &lt;td style="TEXT-ALIGN: left; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt" valign="bottom" width="20%"&gt; &lt;div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: left; TEXT-INDENT: 0pt"&gt; Government debentures - fixed interest rate&lt;/div&gt; &lt;/td&gt; &lt;td valign="bottom" width="1%" align="right"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="7%"&gt;97&lt;/td&gt; &lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td valign="bottom" width="1%" align="right"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="7%"&gt;9&lt;/td&gt; &lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td valign="bottom" width="1%" align="right"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="7%"&gt;-&lt;/td&gt; &lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td valign="bottom" width="1%" align="right"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="7%"&gt;106&lt;/td&gt; &lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td valign="bottom" width="1%" align="right"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="7%"&gt;329&lt;/td&gt; &lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td valign="bottom" width="1%" align="right"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="7%"&gt;21&lt;/td&gt; &lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td valign="bottom" width="1%" align="right"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="7%"&gt;-&lt;/td&gt; &lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td valign="bottom" width="1%" align="right"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="7%"&gt;350&lt;/td&gt; &lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr bgcolor="white"&gt; &lt;td style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt" valign="bottom" width="20%"&gt; &lt;div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: left; TEXT-INDENT: 0pt"&gt; Corporate debentures - fixed interest rate&lt;/div&gt; &lt;/td&gt; &lt;td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%" align="right"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 2px solid; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="7%"&gt;452&lt;/td&gt; &lt;td style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%" align="right"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 2px solid; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="7%"&gt;54&lt;/td&gt; &lt;td style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%" align="right"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 2px solid; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="7%"&gt;-&lt;/td&gt; &lt;td style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%" align="right"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 2px solid; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="7%"&gt;506&lt;/td&gt; &lt;td style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%" align="right"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 2px solid; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="7%"&gt;508&lt;/td&gt; &lt;td style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%" align="right"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 2px solid; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="7%"&gt;30&lt;/td&gt; &lt;td style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%" align="right"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 2px solid; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="7%"&gt;(9&lt;/td&gt; &lt;td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"&gt;)&lt;/td&gt; &lt;td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%" align="right"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 2px solid; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="7%"&gt;529&lt;/td&gt; &lt;td style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr bgcolor="#cceeff"&gt; &lt;td valign="bottom" width="20%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td valign="bottom" width="1%" align="right"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%"&gt;$&lt;/td&gt; &lt;td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="7%"&gt;19,430&lt;/td&gt; &lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td valign="bottom" width="1%" align="right"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%"&gt;$&lt;/td&gt; &lt;td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="7%"&gt;2,585&lt;/td&gt; &lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td valign="bottom" width="1%" align="right"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%"&gt;$&lt;/td&gt; &lt;td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="7%"&gt;(23&lt;/td&gt; &lt;td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"&gt;)&lt;/td&gt; &lt;td valign="bottom" width="1%" align="right"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%"&gt;$&lt;/td&gt; &lt;td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="7%"&gt;21,992&lt;/td&gt; &lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td valign="bottom" width="1%" align="right"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%"&gt;$&lt;/td&gt; &lt;td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="7%"&gt;4,860&lt;/td&gt; &lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td valign="bottom" width="1%" align="right"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%"&gt;$&lt;/td&gt; &lt;td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="7%"&gt;285&lt;/td&gt; &lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td valign="bottom" width="1%" align="right"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%"&gt;$&lt;/td&gt; &lt;td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="7%"&gt;(189&lt;/td&gt; &lt;td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"&gt;)&lt;/td&gt; &lt;td valign="bottom" width="1%" align="right"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%"&gt;$&lt;/td&gt; &lt;td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="7%"&gt;4,956&lt;/td&gt; &lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr bgcolor="white"&gt; &lt;td style="TEXT-ALIGN: left; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt" valign="bottom" width="20%"&gt; &lt;div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: left; TEXT-INDENT: 0pt"&gt; Available-for-sale - matures after one year through five years:&lt;/div&gt; &lt;/td&gt; &lt;td valign="bottom" width="1%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: right" valign="bottom" width="7%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td valign="bottom" width="1%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: right" valign="bottom" width="7%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td valign="bottom" width="1%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: right" valign="bottom" width="7%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td valign="bottom" width="1%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: right" valign="bottom" width="7%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td valign="bottom" width="1%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: right" valign="bottom" width="7%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td valign="bottom" width="1%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: right" valign="bottom" width="7%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td valign="bottom" width="1%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: right" valign="bottom" width="7%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td valign="bottom" width="1%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: right" valign="bottom" width="7%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr bgcolor="#cceeff"&gt; &lt;td style="TEXT-ALIGN: left; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt" valign="bottom" width="20%"&gt; &lt;div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: left; TEXT-INDENT: 0pt"&gt; Government debentures - fixed interest rate&lt;/div&gt; &lt;/td&gt; &lt;td valign="bottom" width="1%" align="right"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="7%"&gt;2,595&lt;/td&gt; &lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td valign="bottom" width="1%" align="right"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="7%"&gt;98&lt;/td&gt; &lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td valign="bottom" width="1%" align="right"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="7%"&gt;(1&lt;/td&gt; &lt;td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"&gt;)&lt;/td&gt; &lt;td valign="bottom" width="1%" align="right"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="7%"&gt;2,692&lt;/td&gt; &lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td valign="bottom" width="1%" align="right"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="7%"&gt;1,602&lt;/td&gt; &lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td valign="bottom" width="1%" align="right"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="7%"&gt;49&lt;/td&gt; &lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td valign="bottom" width="1%" align="right"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="7%"&gt;(12&lt;/td&gt; &lt;td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"&gt;)&lt;/td&gt; &lt;td valign="bottom" width="1%" align="right"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="7%"&gt;1,639&lt;/td&gt; &lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr bgcolor="white"&gt; &lt;td style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt" valign="bottom" width="20%"&gt; &lt;div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: left; TEXT-INDENT: 0pt"&gt; Corporate debentures - fixed interest rate&lt;/div&gt; &lt;/td&gt; &lt;td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%" align="right"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 2px solid; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="7%"&gt;4,906&lt;/td&gt; &lt;td style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%" align="right"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 2px solid; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="7%"&gt;263&lt;/td&gt; &lt;td style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%" align="right"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 2px solid; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="7%"&gt;(5&lt;/td&gt; &lt;td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"&gt;)&lt;/td&gt; &lt;td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%" align="right"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 2px solid; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="7%"&gt;5,164&lt;/td&gt; &lt;td style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%" align="right"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 2px solid; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="7%"&gt;4,976&lt;/td&gt; &lt;td style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%" align="right"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 2px solid; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="7%"&gt;162&lt;/td&gt; &lt;td style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%" align="right"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 2px solid; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="7%"&gt;(77&lt;/td&gt; &lt;td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"&gt;)&lt;/td&gt; &lt;td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%" align="right"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 2px solid; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="7%"&gt;5,061&lt;/td&gt; &lt;td style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr bgcolor="#cceeff"&gt; &lt;td valign="bottom" width="20%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td valign="bottom" width="1%" align="right"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%"&gt;$&lt;/td&gt; &lt;td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="7%"&gt;7,501&lt;/td&gt; &lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td valign="bottom" width="1%" align="right"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%"&gt;$&lt;/td&gt; &lt;td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="7%"&gt;361&lt;/td&gt; &lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td valign="bottom" width="1%" align="right"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%"&gt;$&lt;/td&gt; &lt;td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="7%"&gt;(6&lt;/td&gt; &lt;td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"&gt;)&lt;/td&gt; &lt;td valign="bottom" width="1%" align="right"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%"&gt;$&lt;/td&gt; &lt;td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="7%"&gt;7,856&lt;/td&gt; &lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td valign="bottom" width="1%" align="right"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%"&gt;$&lt;/td&gt; &lt;td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="7%"&gt;6,578&lt;/td&gt; &lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td valign="bottom" width="1%" align="right"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%"&gt;$&lt;/td&gt; &lt;td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="7%"&gt;211&lt;/td&gt; &lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td valign="bottom" width="1%" align="right"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%"&gt;$&lt;/td&gt; &lt;td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="7%"&gt;(89&lt;/td&gt; &lt;td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"&gt;)&lt;/td&gt; &lt;td valign="bottom" width="1%" align="right"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%"&gt;$&lt;/td&gt; &lt;td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="7%"&gt;6,700&lt;/td&gt; &lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr bgcolor="white"&gt; &lt;td style="TEXT-ALIGN: left; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt" valign="bottom" width="20%"&gt; &lt;div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: left; TEXT-INDENT: 0pt"&gt; Available-for-sale - matures after five years through ten years:&lt;/div&gt; &lt;/td&gt; &lt;td valign="bottom" width="1%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: right" valign="bottom" width="7%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td valign="bottom" width="1%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: right" valign="bottom" width="7%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td valign="bottom" width="1%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: right" valign="bottom" width="7%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td valign="bottom" width="1%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: right" valign="bottom" width="7%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td valign="bottom" width="1%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: right" valign="bottom" width="7%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td valign="bottom" width="1%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: right" valign="bottom" width="7%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td valign="bottom" width="1%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: right" valign="bottom" width="7%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td valign="bottom" width="1%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: right" valign="bottom" width="7%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr bgcolor="#cceeff"&gt; &lt;td style="TEXT-ALIGN: left; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt" valign="bottom" width="20%"&gt; &lt;div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: left; TEXT-INDENT: 0pt"&gt; Government debentures - fixed interest rate&lt;/div&gt; &lt;/td&gt; &lt;td valign="bottom" width="1%" align="right"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="7%"&gt;-&lt;/td&gt; &lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td valign="bottom" width="1%" align="right"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="7%"&gt;-&lt;/td&gt; &lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td valign="bottom" width="1%" align="right"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="7%"&gt;-&lt;/td&gt; &lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td valign="bottom" width="1%" align="right"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="7%"&gt;-&lt;/td&gt; &lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td valign="bottom" width="1%" align="right"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="7%"&gt;955&lt;/td&gt; &lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td valign="bottom" width="1%" align="right"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="7%"&gt;45&lt;/td&gt; &lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td valign="bottom" width="1%" align="right"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="7%"&gt;(14&lt;/td&gt; &lt;td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"&gt;)&lt;/td&gt; &lt;td valign="bottom" width="1%" align="right"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="7%"&gt;986&lt;/td&gt; &lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr bgcolor="white"&gt; &lt;td style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt" valign="bottom" width="20%"&gt; &lt;div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: left; TEXT-INDENT: 0pt"&gt; Corporate debentures - fixed interest rate&lt;/div&gt; &lt;/td&gt; &lt;td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%" align="right"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 2px solid; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="7%"&gt;94&lt;/td&gt; &lt;td style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%" align="right"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 2px solid; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="7%"&gt;19&lt;/td&gt; &lt;td style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%" align="right"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 2px solid; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="7%"&gt;-&lt;/td&gt; &lt;td style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%" align="right"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 2px solid; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="7%"&gt;113&lt;/td&gt; &lt;td style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%" align="right"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 2px solid; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="7%"&gt;789&lt;/td&gt; &lt;td style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%" align="right"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 2px solid; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="7%"&gt;29&lt;/td&gt; &lt;td style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%" align="right"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 2px solid; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="7%"&gt;(19&lt;/td&gt; &lt;td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"&gt;)&lt;/td&gt; &lt;td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%" align="right"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 2px solid; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="7%"&gt;799&lt;/td&gt; &lt;td style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr bgcolor="#cceeff"&gt; &lt;td style="PADDING-BOTTOM: 2px" valign="bottom" width="20%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%" align="right"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 2px solid; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%"&gt;$&lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 2px solid; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="7%"&gt;94&lt;/td&gt; &lt;td style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%" align="right"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 2px solid; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%"&gt;$&lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 2px solid; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="7%"&gt;19&lt;/td&gt; &lt;td style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%" align="right"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 2px solid; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%"&gt;$&lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 2px solid; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="7%"&gt;-&lt;/td&gt; &lt;td style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%" align="right"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 2px solid; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%"&gt;$&lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 2px solid; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="7%"&gt;113&lt;/td&gt; &lt;td style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%" align="right"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 2px solid; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%"&gt;$&lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 2px solid; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="7%"&gt;1,744&lt;/td&gt; &lt;td style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%" align="right"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 2px solid; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%"&gt;$&lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 2px solid; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="7%"&gt;74&lt;/td&gt; &lt;td style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%" align="right"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 2px solid; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%"&gt;$&lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 2px solid; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="7%"&gt;(33&lt;/td&gt; &lt;td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"&gt;)&lt;/td&gt; &lt;td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%" align="right"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 2px solid; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%"&gt;$&lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 2px solid; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="7%"&gt;1,785&lt;/td&gt; &lt;td style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr bgcolor="white"&gt; &lt;td style="PADDING-BOTTOM: 4px; TEXT-ALIGN: left; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt" valign="bottom" width="20%"&gt; &lt;div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: left; TEXT-INDENT: 0pt"&gt; Total&lt;/div&gt; &lt;/td&gt; &lt;td style="PADDING-BOTTOM: 4px" valign="bottom" width="1%" align="right"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 4px double; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%"&gt;$&lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 4px double; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="7%"&gt;27,025&lt;/td&gt; &lt;td style="PADDING-BOTTOM: 4px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="PADDING-BOTTOM: 4px" valign="bottom" width="1%" align="right"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 4px double; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%"&gt;$&lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 4px double; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="7%"&gt;2,965&lt;/td&gt; &lt;td style="PADDING-BOTTOM: 4px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="PADDING-BOTTOM: 4px" valign="bottom" width="1%" align="right"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 4px double; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%"&gt;$&lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 4px double; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="7%"&gt;(29&lt;/td&gt; &lt;td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; PADDING-BOTTOM: 4px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"&gt;)&lt;/td&gt; &lt;td style="PADDING-BOTTOM: 4px" valign="bottom" width="1%" align="right"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 4px double; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%"&gt;$&lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 4px double; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="7%"&gt;29,961&lt;/td&gt; &lt;td style="PADDING-BOTTOM: 4px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="PADDING-BOTTOM: 4px" valign="bottom" width="1%" align="right"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 4px double; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%"&gt;$&lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 4px double; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="7%"&gt;13,182&lt;/td&gt; &lt;td style="PADDING-BOTTOM: 4px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="PADDING-BOTTOM: 4px" valign="bottom" width="1%" align="right"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 4px double; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%"&gt;$&lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 4px double; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="7%"&gt;570&lt;/td&gt; &lt;td style="PADDING-BOTTOM: 4px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="PADDING-BOTTOM: 4px" valign="bottom" width="1%" align="right"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 4px double; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%"&gt;$&lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 4px double; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="7%"&gt;(311&lt;/td&gt; &lt;td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; PADDING-BOTTOM: 4px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"&gt;)&lt;/td&gt; &lt;td style="PADDING-BOTTOM: 4px" valign="bottom" width="1%" align="right"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 4px double; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%"&gt;$&lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 4px double; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="7%"&gt;13,441&lt;/td&gt; &lt;td style="PADDING-BOTTOM: 4px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;/tr&gt; &lt;/table&gt; &lt;/div&gt; &lt;div style="DISPLAY: block; TEXT-INDENT: 0pt"&gt;&amp;nbsp;&lt;/div&gt; &lt;div style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt"&gt; The following table presents gross unrealized losses and fair values for those investments that were in an unrealized loss position as of June 30, 2014 and June 30, 2013, and the length of time that those investments have been in a continuous loss position:&lt;/div&gt; &lt;div style="MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt"&gt; &amp;nbsp;&lt;/div&gt; &lt;div style="text-align: left"&gt; &lt;table style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman" cellspacing="0" cellpadding="0" width="100%"&gt; &lt;tr&gt; &lt;td style="PADDING-BOTTOM: 2px" valign="bottom"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="PADDING-BOTTOM: 2px" valign="bottom"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-WEIGHT: bold; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 2px solid" valign="bottom" colspan="6"&gt; &lt;div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"&gt; Less than 12 months&lt;/div&gt; &lt;/td&gt; &lt;td style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-WEIGHT: bold; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="PADDING-BOTTOM: 2px" valign="bottom"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-WEIGHT: bold; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 2px solid" valign="bottom" colspan="6"&gt; &lt;div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"&gt; 12 months or greater&lt;/div&gt; &lt;/td&gt; &lt;td style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-WEIGHT: bold; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td style="PADDING-BOTTOM: 2px" valign="bottom"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="PADDING-BOTTOM: 2px" valign="bottom"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-WEIGHT: bold; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 2px solid" valign="bottom" colspan="2"&gt; &lt;div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"&gt; Fair Value&lt;/div&gt; &lt;/td&gt; &lt;td style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-WEIGHT: bold; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="PADDING-BOTTOM: 2px" valign="bottom"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-WEIGHT: bold; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 2px solid" valign="bottom" colspan="2"&gt; &lt;div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"&gt; Gross&lt;/div&gt; &lt;div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"&gt; unrealized loss&lt;/div&gt; &lt;/td&gt; &lt;td style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-WEIGHT: bold; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="PADDING-BOTTOM: 2px" valign="bottom"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-WEIGHT: bold; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 2px solid" valign="bottom" colspan="2"&gt; &lt;div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"&gt; Fair Value&lt;/div&gt; &lt;/td&gt; &lt;td style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-WEIGHT: bold; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="PADDING-BOTTOM: 2px" valign="bottom"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-WEIGHT: bold; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 2px solid" valign="bottom" colspan="2"&gt; &lt;div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"&gt; Gross&lt;/div&gt; &lt;div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"&gt; unrealized loss&lt;/div&gt; &lt;/td&gt; &lt;td style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-WEIGHT: bold; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr bgcolor="#cceeff"&gt; &lt;td style="TEXT-ALIGN: left; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt" valign="bottom" width="52%"&gt; &lt;div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: left; TEXT-INDENT: 0pt"&gt; As of June 30, 2014&lt;/div&gt; &lt;/td&gt; &lt;td valign="bottom" width="1%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%"&gt;$&lt;/td&gt; &lt;td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%"&gt;851&lt;/td&gt; &lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td valign="bottom" width="1%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%"&gt;$&lt;/td&gt; &lt;td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%"&gt;(17&lt;/td&gt; &lt;td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"&gt;)&lt;/td&gt; &lt;td valign="bottom" width="1%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%"&gt;$&lt;/td&gt; &lt;td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%"&gt;463&lt;/td&gt; &lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td valign="bottom" width="1%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%"&gt;$&lt;/td&gt; &lt;td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%"&gt;(12&lt;/td&gt; &lt;td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"&gt;)&lt;/td&gt; &lt;/tr&gt; &lt;tr bgcolor="white"&gt; &lt;td style="TEXT-ALIGN: left; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt" valign="bottom" width="52%"&gt; &lt;div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: left; TEXT-INDENT: 0pt"&gt; As of June 30, 2013&lt;/div&gt; &lt;/td&gt; &lt;td valign="bottom" width="1%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%"&gt;$&lt;/td&gt; &lt;td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%"&gt;5,122&lt;/td&gt; &lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td valign="bottom" width="1%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%"&gt;$&lt;/td&gt; &lt;td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%"&gt;(302&lt;/td&gt; &lt;td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"&gt;)&lt;/td&gt; &lt;td valign="bottom" width="1%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%"&gt;$&lt;/td&gt; &lt;td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%"&gt;32&lt;/td&gt; &lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td valign="bottom" width="1%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%"&gt;$&lt;/td&gt; &lt;td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%"&gt;(9&lt;/td&gt; &lt;td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"&gt;)&lt;/td&gt; &lt;/tr&gt; &lt;/table&gt; &lt;/div&gt; &lt;div style="DISPLAY: block; TEXT-INDENT: 0pt"&gt;&lt;br /&gt; &lt;/div&gt; &lt;div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"&gt; The Company typically invests in highly-rated securities. When evaluating the investments for other-than-temporary impairment, the Company reviews factors such as the length of time and extent to which fair value has been below cost basis, the financial condition of the issuer and any changes thereto, and the Company&amp;#39;s intent to sell, or whether it is more likely than not it will be required to sell, the investment before recovery of the investment&amp;#39;s amortized cost basis. Based on the above factors, the Company concluded that unrealized losses on all available-for-sale securities were not other-than-temporary and no credit loss was present for any of its investments. As such, the Company did not recognize any impairment charges on outstanding securities during the year ended June 30, 2014.&lt;/div&gt; &lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"&gt; &amp;nbsp;&lt;/div&gt; &lt;div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"&gt; As of June 30, 2014 and 2013, interest receivable amounted to $98 and $20 respectively.&lt;/div&gt; &lt;!--EndFragment--&gt;&lt;/div&gt; &lt;/div&gt;</us-gaap:InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock>
  <us-gaap:LiabilitiesAndStockholdersEquity id="LiabilitiesAndStockholdersEquity.872.0.0.0.0.0.0" contextRef="as-of-2014-06-30.872.0.0.0.0.0.0.0" unitRef="USD" decimals="-3">74023000</us-gaap:LiabilitiesAndStockholdersEquity>
  <us-gaap:LiabilitiesAndStockholdersEquity id="LiabilitiesAndStockholdersEquity.874.0.0.0.0.0.0" contextRef="as-of-2013-06-30.874.0.0.0.0.0.0.0" unitRef="USD" decimals="-3">68316000</us-gaap:LiabilitiesAndStockholdersEquity>
  <us-gaap:LiabilitiesCurrent id="LiabilitiesCurrent.872.0.0.0.0.0.0" contextRef="as-of-2014-06-30.872.0.0.0.0.0.0.0" unitRef="USD" decimals="-3">7397000</us-gaap:LiabilitiesCurrent>
  <us-gaap:LiabilitiesCurrent id="LiabilitiesCurrent.874.0.0.0.0.0.0" contextRef="as-of-2013-06-30.874.0.0.0.0.0.0.0" unitRef="USD" decimals="-3">5921000</us-gaap:LiabilitiesCurrent>
  <us-gaap:LiabilitiesNoncurrent id="LiabilitiesNoncurrent.872.0.0.0.0.0.0" contextRef="as-of-2014-06-30.872.0.0.0.0.0.0.0" unitRef="USD" decimals="-3">4503000</us-gaap:LiabilitiesNoncurrent>
  <us-gaap:LiabilitiesNoncurrent id="LiabilitiesNoncurrent.874.0.0.0.0.0.0" contextRef="as-of-2013-06-30.874.0.0.0.0.0.0.0" unitRef="USD" decimals="-3">4929000</us-gaap:LiabilitiesNoncurrent>
  <us-gaap:LicensesRevenue id="LicensesRevenue.890.0.0.0.0.0.0" contextRef="from-2011-08-01-to-2011-08-31.890.0.0.0.0.0.0.0" unitRef="USD" decimals="-3">7000000</us-gaap:LicensesRevenue>
  <us-gaap:LongTermInvestments id="LongTermInvestments.872.0.0.0.0.0.0" contextRef="as-of-2014-06-30.872.0.0.0.0.0.0.0" unitRef="USD" decimals="-3">304000</us-gaap:LongTermInvestments>
  <us-gaap:LongTermInvestments id="LongTermInvestments.874.0.0.0.0.0.0" contextRef="as-of-2013-06-30.874.0.0.0.0.0.0.0" unitRef="USD" decimals="-3">421000</us-gaap:LongTermInvestments>
  <us-gaap:MarketableSecuritiesCurrent id="MarketableSecuritiesCurrent.872.0.0.0.0.0.0" contextRef="as-of-2014-06-30.872.0.0.0.0.0.0.0" unitRef="USD" decimals="-3">29961000</us-gaap:MarketableSecuritiesCurrent>
  <us-gaap:MarketableSecuritiesCurrent id="MarketableSecuritiesCurrent.874.0.0.0.0.0.0" contextRef="as-of-2013-06-30.874.0.0.0.0.0.0.0" unitRef="USD" decimals="-3">13441000</us-gaap:MarketableSecuritiesCurrent>
  <us-gaap:MarketableSecuritiesCurrent id="MarketableSecuritiesCurrent.872.2136.2043.2032.2040.0.0" contextRef="as-of-2014-06-30.872.0.2136.2043.2032.2040.0.0" unitRef="USD" decimals="-3">20530000</us-gaap:MarketableSecuritiesCurrent>
  <us-gaap:MarketableSecuritiesCurrent id="MarketableSecuritiesCurrent.874.2136.2043.2032.2040.0.0" contextRef="as-of-2013-06-30.874.0.2136.2043.2032.2040.0.0" unitRef="USD" decimals="-3">6311000</us-gaap:MarketableSecuritiesCurrent>
  <us-gaap:MarketableSecuritiesCurrent id="MarketableSecuritiesCurrent.872.2135.2043.2032.2040.0.0" contextRef="as-of-2014-06-30.872.0.2135.2043.2032.2040.0.0" unitRef="USD" decimals="-3">9431000</us-gaap:MarketableSecuritiesCurrent>
  <us-gaap:MarketableSecuritiesCurrent id="MarketableSecuritiesCurrent.874.2135.2043.2032.2040.0.0" contextRef="as-of-2013-06-30.874.0.2135.2043.2032.2040.0.0" unitRef="USD" decimals="-3">7130000</us-gaap:MarketableSecuritiesCurrent>
  <us-gaap:MarketableSecuritiesCurrent id="MarketableSecuritiesCurrent.872.2137.2043.2032.2040.0.0" xsi:nil="true" contextRef="as-of-2014-06-30.872.0.2137.2043.2032.2040.0.0" unitRef="USD" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" />
  <us-gaap:MarketableSecuritiesCurrent id="MarketableSecuritiesCurrent.874.2137.2043.2032.2040.0.0" xsi:nil="true" contextRef="as-of-2013-06-30.874.0.2137.2043.2032.2040.0.0" unitRef="USD" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" />
  <us-gaap:MarketableSecuritiesGainLoss id="MarketableSecuritiesGainLoss.869.0.0.0.0.0.0" contextRef="from-2013-07-01-to-2014-06-30.869.0.0.0.0.0.0.0" unitRef="USD" decimals="-3">384000</us-gaap:MarketableSecuritiesGainLoss>
  <us-gaap:MarketableSecuritiesGainLoss id="MarketableSecuritiesGainLoss.870.0.0.0.0.0.0" contextRef="from-2012-07-01-to-2013-06-30.870.0.0.0.0.0.0.0" unitRef="USD" decimals="-3">-79000</us-gaap:MarketableSecuritiesGainLoss>
  <us-gaap:MarketableSecuritiesGainLoss id="MarketableSecuritiesGainLoss.871.0.0.0.0.0.0" contextRef="from-2011-07-01-to-2012-06-30.871.0.0.0.0.0.0.0" unitRef="USD" decimals="-3">89000</us-gaap:MarketableSecuritiesGainLoss>
  <us-gaap:MarketableSecuritiesPolicy id="MarketableSecuritiesPolicy.869.0.0.0.0.0.0" contextRef="from-2013-07-01-to-2014-06-30.869.0.0.0.0.0.0.0">&lt;!--DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd" --&gt;&lt;div&gt; &lt;div&gt;&lt;!--StartFragment--&gt; &lt;div style="text-align: center"&gt; &lt;table style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman" cellspacing="0" cellpadding="0" width="100%" border="0"&gt; &lt;tr valign="top"&gt; &lt;td style="WIDTH: 18pt"&gt; &lt;div style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt"&gt; h.&lt;/div&gt; &lt;/td&gt; &lt;td&gt; &lt;div style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; text-align: justify"&gt; Marketable Securities&lt;/div&gt; &lt;/td&gt; &lt;/tr&gt; &lt;/table&gt; &lt;/div&gt; &lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"&gt; &amp;nbsp;&lt;/div&gt; &lt;div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"&gt; The Company accounts for its investments in marketable securities in accordance with ASC 320-"Investments - Debt and Equity Securities". The Company determines the classification of marketable securities at the time of purchase and re-evaluates such designations as of each balance sheet date. The Company classifies all of its marketable securities as available-for-sale. Available-for-sale marketable securities are carried at fair value, with the unrealized gain and loss reported at "accumulated other comprehensive income (loss)" in the statement of changes in stockholders&amp;#39; equity.&lt;/div&gt; &lt;div style="DISPLAY: block; MARGIN-LEFT: 437pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"&gt; &amp;nbsp;&lt;/div&gt; &lt;div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"&gt; Realized gain and loss on sales of marketable securities are included in the Company&amp;#39;s "Financial income, net" and are derived using the specific identification basis for determining the cost of marketable securities. The amortized cost of available for sale marketable securities is adjusted for amortization of premiums and accretion of discount to maturity. Such amortization, together with interest on available for sale marketable securities, is included in the "Financial income, net".&lt;/div&gt; &lt;div style="DISPLAY: block; MARGIN-LEFT: 437pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"&gt; &amp;nbsp;&lt;/div&gt; &lt;div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"&gt; The Company recognizes an impairment charge when a decline in the fair value of its available-for-sale marketable securities below the cost basis is judged to be other-than-temporary. The Company considers various factors in determining whether to recognize an impairment charge, including the length of time the investment has been in a loss position, the extent to which the fair value has been less than the Company&amp;#39;s cost basis, the investment&amp;#39;s financial condition and the near-term prospects of the issuer. ASC 320-10-35, "Investments - Debt and Equity Securities", requires another-than-temporary impairment for debt securities to be separated into (a)&amp;nbsp;the amount representing the credit loss and (b)&amp;nbsp;the amount related to all other factors (provided that the Company does not intend to sell the security and it is not more likely than not that it will be required to sell it before recovery). For securities that are deemed other-than-temporarily impaired, the amount of impairment is recognized in "financial income, net", in the statement of operations and is limited to the amount related to credit loss, while impairment related to other factors is recognized in other comprehensive income (loss).&lt;/div&gt; &lt;div style="DISPLAY: block; MARGIN-LEFT: 437pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"&gt; &amp;nbsp;&lt;/div&gt; &lt;div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"&gt; During 2014, 2013 and 2012, no impairment losses been identified.&lt;/div&gt; &lt;!--EndFragment--&gt;&lt;/div&gt; &lt;/div&gt;</us-gaap:MarketableSecuritiesPolicy>
  <us-gaap:MarketableSecuritiesRealizedGainLoss id="MarketableSecuritiesRealizedGainLoss.869.0.0.0.0.0.0" contextRef="from-2013-07-01-to-2014-06-30.869.0.0.0.0.0.0.0" unitRef="USD" decimals="-3">727000</us-gaap:MarketableSecuritiesRealizedGainLoss>
  <us-gaap:MarketableSecuritiesRealizedGainLoss id="MarketableSecuritiesRealizedGainLoss.870.0.0.0.0.0.0" contextRef="from-2012-07-01-to-2013-06-30.870.0.0.0.0.0.0.0" unitRef="USD" decimals="-3">26000</us-gaap:MarketableSecuritiesRealizedGainLoss>
  <us-gaap:MarketableSecuritiesRealizedGainLoss id="MarketableSecuritiesRealizedGainLoss.871.0.0.0.0.0.0" contextRef="from-2011-07-01-to-2012-06-30.871.0.0.0.0.0.0.0" unitRef="USD" decimals="-3">3000</us-gaap:MarketableSecuritiesRealizedGainLoss>
  <us-gaap:NetCashProvidedByUsedInFinancingActivitiesContinuingOperations id="NetCashProvidedByUsedInFinancingActivitiesContinuingOperations.869.0.0.0.0.0.0" contextRef="from-2013-07-01-to-2014-06-30.869.0.0.0.0.0.0.0" unitRef="USD" decimals="-3">12624000</us-gaap:NetCashProvidedByUsedInFinancingActivitiesContinuingOperations>
  <us-gaap:NetCashProvidedByUsedInFinancingActivitiesContinuingOperations id="NetCashProvidedByUsedInFinancingActivitiesContinuingOperations.870.0.0.0.0.0.0" contextRef="from-2012-07-01-to-2013-06-30.870.0.0.0.0.0.0.0" unitRef="USD" decimals="-3">36304000</us-gaap:NetCashProvidedByUsedInFinancingActivitiesContinuingOperations>
  <us-gaap:NetCashProvidedByUsedInFinancingActivitiesContinuingOperations id="NetCashProvidedByUsedInFinancingActivitiesContinuingOperations.871.0.0.0.0.0.0" contextRef="from-2011-07-01-to-2012-06-30.871.0.0.0.0.0.0.0" unitRef="USD" decimals="-3">632000</us-gaap:NetCashProvidedByUsedInFinancingActivitiesContinuingOperations>
  <us-gaap:NetCashProvidedByUsedInInvestingActivitiesContinuingOperations id="NetCashProvidedByUsedInInvestingActivitiesContinuingOperations.869.0.0.0.0.0.0" contextRef="from-2013-07-01-to-2014-06-30.869.0.0.0.0.0.0.0" unitRef="USD" decimals="-3">1983000</us-gaap:NetCashProvidedByUsedInInvestingActivitiesContinuingOperations>
  <us-gaap:NetCashProvidedByUsedInInvestingActivitiesContinuingOperations id="NetCashProvidedByUsedInInvestingActivitiesContinuingOperations.870.0.0.0.0.0.0" contextRef="from-2012-07-01-to-2013-06-30.870.0.0.0.0.0.0.0" unitRef="USD" decimals="-3">-19799000</us-gaap:NetCashProvidedByUsedInInvestingActivitiesContinuingOperations>
  <us-gaap:NetCashProvidedByUsedInInvestingActivitiesContinuingOperations id="NetCashProvidedByUsedInInvestingActivitiesContinuingOperations.871.0.0.0.0.0.0" contextRef="from-2011-07-01-to-2012-06-30.871.0.0.0.0.0.0.0" unitRef="USD" decimals="-3">-30797000</us-gaap:NetCashProvidedByUsedInInvestingActivitiesContinuingOperations>
  <us-gaap:NetCashProvidedByUsedInOperatingActivitiesContinuingOperations id="NetCashProvidedByUsedInOperatingActivitiesContinuingOperations.869.0.0.0.0.0.0" contextRef="from-2013-07-01-to-2014-06-30.869.0.0.0.0.0.0.0" unitRef="USD" decimals="-3">-19121000</us-gaap:NetCashProvidedByUsedInOperatingActivitiesContinuingOperations>
  <us-gaap:NetCashProvidedByUsedInOperatingActivitiesContinuingOperations id="NetCashProvidedByUsedInOperatingActivitiesContinuingOperations.870.0.0.0.0.0.0" contextRef="from-2012-07-01-to-2013-06-30.870.0.0.0.0.0.0.0" unitRef="USD" decimals="-3">-16887000</us-gaap:NetCashProvidedByUsedInOperatingActivitiesContinuingOperations>
  <us-gaap:NetCashProvidedByUsedInOperatingActivitiesContinuingOperations id="NetCashProvidedByUsedInOperatingActivitiesContinuingOperations.871.0.0.0.0.0.0" contextRef="from-2011-07-01-to-2012-06-30.871.0.0.0.0.0.0.0" unitRef="USD" decimals="-3">-3275000</us-gaap:NetCashProvidedByUsedInOperatingActivitiesContinuingOperations>
  <us-gaap:NetIncomeLoss id="NetIncomeLoss.869.0.0.0.0.0.0" contextRef="from-2013-07-01-to-2014-06-30.869.0.0.0.0.0.0.0" unitRef="USD" decimals="-3">-26932000</us-gaap:NetIncomeLoss>
  <us-gaap:NetIncomeLoss id="NetIncomeLoss.870.0.0.0.0.0.0" contextRef="from-2012-07-01-to-2013-06-30.870.0.0.0.0.0.0.0" unitRef="USD" decimals="-3">-21155000</us-gaap:NetIncomeLoss>
  <us-gaap:NetIncomeLoss id="NetIncomeLoss.871.0.0.0.0.0.0" contextRef="from-2011-07-01-to-2012-06-30.871.0.0.0.0.0.0.0" unitRef="USD" decimals="-3">-14794000</us-gaap:NetIncomeLoss>
  <us-gaap:NetIncomeLoss id="NetIncomeLoss.869.1115.5114.0.0.0.0" xsi:nil="true" contextRef="from-2013-07-01-to-2014-06-30.869.0.1115.5114.0.0.0.0" unitRef="USD" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" />
  <us-gaap:NetIncomeLoss id="NetIncomeLoss.870.1115.5114.0.0.0.0" xsi:nil="true" contextRef="from-2012-07-01-to-2013-06-30.870.0.1115.5114.0.0.0.0" unitRef="USD" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" />
  <us-gaap:NetIncomeLoss id="NetIncomeLoss.871.1115.5114.0.0.0.0" xsi:nil="true" contextRef="from-2011-07-01-to-2012-06-30.871.0.1115.5114.0.0.0.0" unitRef="USD" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" />
  <us-gaap:NetIncomeLoss id="NetIncomeLoss.869.499.5114.0.0.0.0" xsi:nil="true" contextRef="from-2013-07-01-to-2014-06-30.869.0.499.5114.0.0.0.0" unitRef="USD" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" />
  <us-gaap:NetIncomeLoss id="NetIncomeLoss.870.499.5114.0.0.0.0" xsi:nil="true" contextRef="from-2012-07-01-to-2013-06-30.870.0.499.5114.0.0.0.0" unitRef="USD" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" />
  <us-gaap:NetIncomeLoss id="NetIncomeLoss.871.499.5114.0.0.0.0" xsi:nil="true" contextRef="from-2011-07-01-to-2012-06-30.871.0.499.5114.0.0.0.0" unitRef="USD" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" />
  <us-gaap:NetIncomeLoss id="NetIncomeLoss.869.478.5114.0.0.0.0" xsi:nil="true" contextRef="from-2013-07-01-to-2014-06-30.869.0.478.5114.0.0.0.0" unitRef="USD" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" />
  <us-gaap:NetIncomeLoss id="NetIncomeLoss.870.478.5114.0.0.0.0" xsi:nil="true" contextRef="from-2012-07-01-to-2013-06-30.870.0.478.5114.0.0.0.0" unitRef="USD" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" />
  <us-gaap:NetIncomeLoss id="NetIncomeLoss.871.478.5114.0.0.0.0" xsi:nil="true" contextRef="from-2011-07-01-to-2012-06-30.871.0.478.5114.0.0.0.0" unitRef="USD" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" />
  <us-gaap:NetIncomeLoss id="NetIncomeLoss.869.4619.5114.0.0.0.0" contextRef="from-2013-07-01-to-2014-06-30.869.0.4619.5114.0.0.0.0" unitRef="USD" decimals="-3">-26932000</us-gaap:NetIncomeLoss>
  <us-gaap:NetIncomeLoss id="NetIncomeLoss.870.4619.5114.0.0.0.0" contextRef="from-2012-07-01-to-2013-06-30.870.0.4619.5114.0.0.0.0" unitRef="USD" decimals="-3">-21155000</us-gaap:NetIncomeLoss>
  <us-gaap:NetIncomeLoss id="NetIncomeLoss.871.4619.5114.0.0.0.0" contextRef="from-2011-07-01-to-2012-06-30.871.0.4619.5114.0.0.0.0" unitRef="USD" decimals="-3">-14794000</us-gaap:NetIncomeLoss>
  <us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock id="NewAccountingPronouncementsPolicyPolicyTextBlock.869.0.0.0.0.0.0" contextRef="from-2013-07-01-to-2014-06-30.869.0.0.0.0.0.0.0">&lt;!--DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd" --&gt;&lt;div&gt; &lt;div&gt;&lt;!--StartFragment--&gt; &lt;div style="text-align: center"&gt; &lt;table style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman" cellspacing="0" cellpadding="0" width="100%" border="0"&gt; &lt;tr valign="top"&gt; &lt;td style="WIDTH: 18pt"&gt; &lt;div style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt"&gt; u.&lt;/div&gt; &lt;/td&gt; &lt;td&gt; &lt;div style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; text-align: justify"&gt; Recent Accounting Pronouncement&lt;/div&gt; &lt;/td&gt; &lt;/tr&gt; &lt;/table&gt; &lt;/div&gt; &lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"&gt; &amp;nbsp;&lt;/div&gt; &lt;div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"&gt; In May 2014, the FASB issued Accounting Standards Update No. 2014-09 ("ASU 2014-09"), "Revenue from Contracts with Customers". ASU 2014-09 supersedes the revenue recognition requirements in "Revenue Recognition (Topic 605)", and requires entities to recognize revenue when it transfers promised goods or services to customers in an amount that reflects the consideration to which the entity expects to be entitled to in exchange for those goods or services. ASU 2014-09 is effective for annual reporting periods beginning after December 15, 2016, including interim periods within that reporting period. Early adoption is not permitted. The Company is currently in the process of evaluating the impact of the adoption of ASU 2014-09 on its consolidated financial statements.&lt;/div&gt; &lt;!--EndFragment--&gt;&lt;/div&gt; &lt;/div&gt;</us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock>
  <us-gaap:NoncashOrPartNoncashAcquisitionInvestmentsAcquired1 id="NoncashOrPartNoncashAcquisitionInvestmentsAcquired1.869.0.0.0.0.0.0" contextRef="from-2013-07-01-to-2014-06-30.869.0.0.0.0.0.0.0" unitRef="USD" decimals="-3">10414000</us-gaap:NoncashOrPartNoncashAcquisitionInvestmentsAcquired1>
  <us-gaap:NoncashOrPartNoncashAcquisitionInvestmentsAcquired1 id="NoncashOrPartNoncashAcquisitionInvestmentsAcquired1.870.0.0.0.0.0.0" xsi:nil="true" contextRef="from-2012-07-01-to-2013-06-30.870.0.0.0.0.0.0.0" unitRef="USD" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" />
  <us-gaap:NoncashOrPartNoncashAcquisitionInvestmentsAcquired1 id="NoncashOrPartNoncashAcquisitionInvestmentsAcquired1.871.0.0.0.0.0.0" xsi:nil="true" contextRef="from-2011-07-01-to-2012-06-30.871.0.0.0.0.0.0.0" unitRef="USD" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" />
  <us-gaap:NonoperatingIncomeExpense id="NonoperatingIncomeExpense.869.0.0.0.0.0.0" contextRef="from-2013-07-01-to-2014-06-30.869.0.0.0.0.0.0.0" unitRef="USD" decimals="-3">918000</us-gaap:NonoperatingIncomeExpense>
  <us-gaap:NonoperatingIncomeExpense id="NonoperatingIncomeExpense.870.0.0.0.0.0.0" contextRef="from-2012-07-01-to-2013-06-30.870.0.0.0.0.0.0.0" unitRef="USD" decimals="-3">1068000</us-gaap:NonoperatingIncomeExpense>
  <us-gaap:NonoperatingIncomeExpense id="NonoperatingIncomeExpense.871.0.0.0.0.0.0" contextRef="from-2011-07-01-to-2012-06-30.871.0.0.0.0.0.0.0" unitRef="USD" decimals="-3">237000</us-gaap:NonoperatingIncomeExpense>
  <us-gaap:OperatingIncomeLoss id="OperatingIncomeLoss.869.0.0.0.0.0.0" contextRef="from-2013-07-01-to-2014-06-30.869.0.0.0.0.0.0.0" unitRef="USD" decimals="-3">-27850000</us-gaap:OperatingIncomeLoss>
  <us-gaap:OperatingIncomeLoss id="OperatingIncomeLoss.870.0.0.0.0.0.0" contextRef="from-2012-07-01-to-2013-06-30.870.0.0.0.0.0.0.0" unitRef="USD" decimals="-3">-22223000</us-gaap:OperatingIncomeLoss>
  <us-gaap:OperatingIncomeLoss id="OperatingIncomeLoss.871.0.0.0.0.0.0" contextRef="from-2011-07-01-to-2012-06-30.871.0.0.0.0.0.0.0" unitRef="USD" decimals="-3">-15031000</us-gaap:OperatingIncomeLoss>
  <us-gaap:OperatingLeasesFutureMinimumPaymentsDue id="OperatingLeasesFutureMinimumPaymentsDue.872.3008.4261.0.0.0.0" contextRef="as-of-2014-06-30.872.0.3008.4261.0.0.0.0" unitRef="USD" decimals="-3">1513000</us-gaap:OperatingLeasesFutureMinimumPaymentsDue>
  <us-gaap:OperatingLeasesFutureMinimumPaymentsDue id="OperatingLeasesFutureMinimumPaymentsDue.872.395.4261.0.0.0.0" contextRef="as-of-2014-06-30.872.0.395.4261.0.0.0.0" unitRef="USD" decimals="-3">251000</us-gaap:OperatingLeasesFutureMinimumPaymentsDue>
  <us-gaap:OperatingLeasesFutureMinimumPaymentsDueCurrent id="OperatingLeasesFutureMinimumPaymentsDueCurrent.872.3008.4261.0.0.0.0" contextRef="as-of-2014-06-30.872.0.3008.4261.0.0.0.0" unitRef="USD" decimals="-3">667000</us-gaap:OperatingLeasesFutureMinimumPaymentsDueCurrent>
  <us-gaap:OperatingLeasesFutureMinimumPaymentsDueCurrent id="OperatingLeasesFutureMinimumPaymentsDueCurrent.872.395.4261.0.0.0.0" contextRef="as-of-2014-06-30.872.0.395.4261.0.0.0.0" unitRef="USD" decimals="-3">140000</us-gaap:OperatingLeasesFutureMinimumPaymentsDueCurrent>
  <us-gaap:OperatingLeasesFutureMinimumPaymentsDueInThreeYears id="OperatingLeasesFutureMinimumPaymentsDueInThreeYears.872.3008.4261.0.0.0.0" contextRef="as-of-2014-06-30.872.0.3008.4261.0.0.0.0" unitRef="USD" decimals="-3">349000</us-gaap:OperatingLeasesFutureMinimumPaymentsDueInThreeYears>
  <us-gaap:OperatingLeasesFutureMinimumPaymentsDueInThreeYears id="OperatingLeasesFutureMinimumPaymentsDueInThreeYears.872.395.4261.0.0.0.0" contextRef="as-of-2014-06-30.872.0.395.4261.0.0.0.0" unitRef="USD" decimals="-3">26000</us-gaap:OperatingLeasesFutureMinimumPaymentsDueInThreeYears>
  <us-gaap:OperatingLeasesFutureMinimumPaymentsDueInTwoYears id="OperatingLeasesFutureMinimumPaymentsDueInTwoYears.872.3008.4261.0.0.0.0" contextRef="as-of-2014-06-30.872.0.3008.4261.0.0.0.0" unitRef="USD" decimals="-3">497000</us-gaap:OperatingLeasesFutureMinimumPaymentsDueInTwoYears>
  <us-gaap:OperatingLeasesFutureMinimumPaymentsDueInTwoYears id="OperatingLeasesFutureMinimumPaymentsDueInTwoYears.872.395.4261.0.0.0.0" contextRef="as-of-2014-06-30.872.0.395.4261.0.0.0.0" unitRef="USD" decimals="-3">85000</us-gaap:OperatingLeasesFutureMinimumPaymentsDueInTwoYears>
  <us-gaap:OperatingLeasesRentExpenseNet id="OperatingLeasesRentExpenseNet.869.3008.4261.0.0.0.0" contextRef="from-2013-07-01-to-2014-06-30.869.0.3008.4261.0.0.0.0" unitRef="USD" decimals="-3">720000</us-gaap:OperatingLeasesRentExpenseNet>
  <us-gaap:OperatingLeasesRentExpenseNet id="OperatingLeasesRentExpenseNet.870.3008.4261.0.0.0.0" contextRef="from-2012-07-01-to-2013-06-30.870.0.3008.4261.0.0.0.0" unitRef="USD" decimals="-3">678000</us-gaap:OperatingLeasesRentExpenseNet>
  <us-gaap:OperatingLeasesRentExpenseNet id="OperatingLeasesRentExpenseNet.871.3008.4261.0.0.0.0" contextRef="from-2011-07-01-to-2012-06-30.871.0.3008.4261.0.0.0.0" unitRef="USD" decimals="-3">382000</us-gaap:OperatingLeasesRentExpenseNet>
  <us-gaap:OperatingLeasesRentExpenseNet id="OperatingLeasesRentExpenseNet.869.395.4261.0.0.0.0" contextRef="from-2013-07-01-to-2014-06-30.869.0.395.4261.0.0.0.0" unitRef="USD" decimals="-3">244000</us-gaap:OperatingLeasesRentExpenseNet>
  <us-gaap:OperatingLeasesRentExpenseNet id="OperatingLeasesRentExpenseNet.870.395.4261.0.0.0.0" contextRef="from-2012-07-01-to-2013-06-30.870.0.395.4261.0.0.0.0" unitRef="USD" decimals="-3">215000</us-gaap:OperatingLeasesRentExpenseNet>
  <us-gaap:OperatingLeasesRentExpenseNet id="OperatingLeasesRentExpenseNet.871.395.4261.0.0.0.0" contextRef="from-2011-07-01-to-2012-06-30.871.0.395.4261.0.0.0.0" unitRef="USD" decimals="-3">176000</us-gaap:OperatingLeasesRentExpenseNet>
  <us-gaap:OperatingLossCarryforwards id="OperatingLossCarryforwards.872.2877.2667.0.0.0.0" contextRef="as-of-2014-06-30.872.0.2877.2667.0.0.0.0" unitRef="USD" decimals="-3">22730000</us-gaap:OperatingLossCarryforwards>
  <us-gaap:OperatingLossCarryforwards id="OperatingLossCarryforwards.872.2580.2667.0.0.0.0" contextRef="as-of-2014-06-30.872.0.2580.2667.0.0.0.0" unitRef="USD" decimals="-3">48340000</us-gaap:OperatingLossCarryforwards>
  <us-gaap:OperatingLossCarryforwardsExpirationDate id="OperatingLossCarryforwardsExpirationDate.869.2877.2667.1754.5240.0.0" contextRef="from-2013-07-01-to-2014-06-30.869.0.2877.2667.1754.5240.0.0">2022-12-31</us-gaap:OperatingLossCarryforwardsExpirationDate>
  <us-gaap:OperatingLossCarryforwardsExpirationDate id="OperatingLossCarryforwardsExpirationDate.869.2877.2667.2979.5240.0.0" contextRef="from-2013-07-01-to-2014-06-30.869.0.2877.2667.2979.5240.0.0">2034-12-31</us-gaap:OperatingLossCarryforwardsExpirationDate>
  <us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock id="OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock.869.0.0.0.0.0.0" contextRef="from-2013-07-01-to-2014-06-30.869.0.0.0.0.0.0.0">&lt;!--DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd" --&gt;&lt;div&gt; &lt;div&gt;&lt;!--StartFragment--&gt; &lt;div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: left; TEXT-INDENT: 0pt"&gt; NOTE 1:-GENERAL&lt;/div&gt; &lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"&gt; &amp;nbsp;&lt;/div&gt; &lt;div&gt; &lt;table style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman" cellspacing="0" cellpadding="0" width="100%" align="center" border="0"&gt; &lt;tr valign="top"&gt; &lt;td style="WIDTH: 18pt"&gt; &lt;div style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt"&gt; a.&lt;/div&gt; &lt;/td&gt; &lt;td&gt; &lt;div style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; text-align: justify"&gt; Pluristem Therapeutics Inc., a Nevada corporation, was incorporated on May 11, 2001. Pluristem Therapeutics Inc. has a wholly owned subsidiary, Pluristem Ltd. (the "Subsidiary"), which is incorporated under the laws of the State of Israel. Pluristem Therapeutics Inc. and the Subsidiary are referred to as the "Company" or "Pluristem".&lt;/div&gt; &lt;/td&gt; &lt;/tr&gt; &lt;/table&gt; &lt;/div&gt; &lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"&gt; &amp;nbsp;&lt;/div&gt; &lt;div&gt; &lt;table style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman" cellspacing="0" cellpadding="0" width="100%" align="center" border="0"&gt; &lt;tr valign="top"&gt; &lt;td style="WIDTH: 18pt"&gt; &lt;div style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt"&gt; b.&lt;/div&gt; &lt;/td&gt; &lt;td&gt; &lt;div style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; text-align: justify"&gt; The Company is a bio-therapeutics company developing off-the-shelf allogeneic cell therapy products for the treatment of multiple ischemic and inflammatory conditions. The Company has sustained operating losses and expects such losses to continue in the foreseeable future. The Company&amp;#39;s accumulated losses aggregated to $113,834 through June 30, 2014 and incurred a net loss of $26,932 for the year ended June 30, 2014.&lt;/div&gt; &lt;div style="text-align: justify"&gt;&amp;nbsp;&lt;/div&gt; &lt;div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-ALIGN: justify; TEXT-INDENT: 0pt"&gt; The Company plans to continue to finance its operations with sales of equity securities, entering into licensing technology agreements such as the United Therapeutics Corporation ("United Therapeutics" or "United") and CHA&amp;nbsp;Bio&amp;amp;Diostech ("CHA") agreements, and from grants to support its research and development activity. In the longer term, the Company plans to finance its operations from revenues from sales of products.&lt;/div&gt; &lt;/td&gt; &lt;/tr&gt; &lt;/table&gt; &lt;/div&gt; &lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"&gt; &amp;nbsp;&lt;/div&gt; &lt;div&gt; &lt;table style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman" cellspacing="0" cellpadding="0" width="100%" align="center" border="0"&gt; &lt;tr valign="top"&gt; &lt;td style="WIDTH: 18pt"&gt; &lt;div style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt"&gt; c.&lt;/div&gt; &lt;/td&gt; &lt;td&gt; &lt;div style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; text-align: justify"&gt; Since December 10, 2007, the Company&amp;#39;s shares of common stock have been traded on the NASDAQ Capital Market under the symbol "PSTI".&lt;/div&gt; &lt;/td&gt; &lt;/tr&gt; &lt;/table&gt; &lt;/div&gt; &lt;div style="DISPLAY: block; TEXT-INDENT: 0pt"&gt;&lt;br /&gt; &lt;/div&gt; &lt;div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 5.9pt; text-align: justify; TEXT-INDENT: 0pt"&gt; On December 19, 2010, the Company&amp;#39;s shares began trading also on the Tel-Aviv Stock Exchange under the symbol "PLTR".&lt;/div&gt; &lt;div style="DISPLAY: block; TEXT-INDENT: 0pt"&gt;&lt;br /&gt; &lt;/div&gt; &lt;div&gt; &lt;table style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman" cellspacing="0" cellpadding="0" width="100%" align="center" border="0"&gt; &lt;tr valign="top"&gt; &lt;td style="WIDTH: 18pt"&gt; &lt;div style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt"&gt; d.&lt;/div&gt; &lt;/td&gt; &lt;td&gt; &lt;div style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; text-align: left"&gt; License Agreements:&lt;/div&gt; &lt;/td&gt; &lt;/tr&gt; &lt;/table&gt; &lt;/div&gt; &lt;div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 5.9pt; text-align: left; TEXT-INDENT: 0pt"&gt; &amp;nbsp;&lt;/div&gt; &lt;div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 5.9pt; text-align: left; TEXT-DECORATION: underline; TEXT-INDENT: 0pt"&gt; United Agreement&lt;/div&gt; &lt;div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 5.9pt; text-align: justify; TEXT-INDENT: 0pt"&gt; On June 19, 2011, the Company entered into an exclusive license agreement (the "United Agreement") with United Therapeutics for the use of the Company&amp;#39;s PLX cells to develop and commercialize a cell-based product for the treatment of Pulmonary Hypertension ("PAH").&amp;nbsp;&amp;nbsp;The United Agreement provides that United Therapeutics will receive exclusive worldwide license rights for the development and commercialization of the Company&amp;#39;s PLX cell-based product to treat PAH.&amp;nbsp;&amp;nbsp;The United Agreement further provides for the following consideration payable to the Company: (i) an upfront payment of $7,000 paid in August 2011, which includes a $5,000 non-refundable upfront payment and a $2,000 advance payment on the development; (ii) up to $37,500 upon reaching certain regulatory milestones with respect to the development of a product to treat PAH; (iii) reimbursement of up to $10,000 of certain of the Company&amp;#39;s expenses if the Company establishes a GMP manufacturing facility in North America; (iv) reimbursement of certain costs in connection with the development of the product; and (v) following commercialization of the product, royalties at a mid-single digit percent and the purchase of commercial supplies of the developed product from the Company at a specified margin over the Company&amp;#39;s cost.&lt;/div&gt; &lt;div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 5.9pt; text-align: justify; TEXT-INDENT: 0pt"&gt; The United Agreement became effective on August 2, 2011, and will continue until the later of a few events, including termination of all patents relating to the collaboration, upon certain government action or if the parties do not develop any product under the United Agreement.&amp;nbsp;&amp;nbsp;United may unilaterally terminate the United Agreement at any time and without cause.&amp;nbsp;&amp;nbsp;In such event, United Therapeutics shall pay the Company certain costs and expenses of winding down any non-cancellable commitments made by the Company prior to the date of termination and cease all development activities in connection with the United Agreement.&lt;/div&gt; &lt;div style="DISPLAY: block; TEXT-INDENT: 0pt"&gt;&lt;br /&gt; &lt;/div&gt; &lt;div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 5.9pt; text-align: justify; TEXT-DECORATION: underline; TEXT-INDENT: 0pt"&gt; CHA Agreement&lt;/div&gt; &lt;div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 5.9pt; text-align: justify; TEXT-INDENT: 0pt"&gt; On June 26, 2013, Pluristem entered into an exclusive license and commercialization agreement (the "CHA Agreement") with CHA, for conducting clinical trials and commercialization of Pluristem&amp;#39;s PLX-PAD product in South Korea in connection with two indications: the treatment of Critical Limb Ischemia, and Intermediate Claudication (the "Indications"). Under the terms of the CHA Agreement, CHA will receive exclusive rights in South Korea for conducting clinical trials with respect to the Indications, CHA will bear the costs of conducting the clinical trials for the agreed upon indications, and the Company&amp;nbsp;will continue to retain nights to its proprietary manufacturing technology and cell-related intellectual property.&lt;/div&gt; &lt;div style="DISPLAY: block; TEXT-INDENT: 0pt"&gt;&lt;br /&gt; &lt;/div&gt; &lt;div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 5.9pt; text-align: justify; TEXT-INDENT: 0pt"&gt; The first clinical study to be performed as part of the CHA Agreement will be a Phase II trial in Intermittent Claudication. This study was approved in November 2013 by South Korea&amp;#39;s Ministry of Food and Drug Safety.&lt;/div&gt; &lt;div style="DISPLAY: block; TEXT-INDENT: 0pt"&gt;&lt;br /&gt; &lt;/div&gt; &lt;div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 5.9pt; text-align: justify; TEXT-INDENT: 0pt"&gt; Upon the first regulatory approval for a PLX product in South Korea, for the specified indications, Pluristem and CHA will establish an equally owned joint venture. The purpose of the joint venture will be to commercialize PLX cell products in South Korea.&lt;/div&gt; &lt;div style="DISPLAY: block; TEXT-INDENT: 0pt"&gt;&lt;br /&gt; &lt;/div&gt; &lt;div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 5.9pt; text-align: justify; TEXT-INDENT: 0pt"&gt; Pluristem will be able to use the data generated by CHA to pursue the development of PLX product candidates outside of South Korea.&lt;/div&gt; &lt;div style="DISPLAY: block; TEXT-INDENT: 0pt"&gt;&lt;br /&gt; &lt;/div&gt; &lt;div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 5.9pt; text-align: justify; TEXT-INDENT: 0pt"&gt; In addition, and as contemplated by the CHA Agreement, in December 2013, Pluristem and CHA executed the mutual investment pursuant to which Pluristem issued 2,500,000 shares of its common stock in consideration for 1,011,504 shares of CHA, which reflects total consideration to each of Pluristem and CHA of approximately $10,414. The investment in CHA shares is presented as "Marketable Securities" and classified as available-for-sale in accordance with ASC 320 - "Investments - Debt and Equity Securities" (Note 3). The CHA Agreement contains customary termination provisions, including in the event the parties do not reach an agreement upon development plan for conducting the clinical trials. Upon termination of this CHA Agreement, the license granted thereunder will terminate and all rights included therein will revert to the Company, whereupon the Company will be free to enter into agreements with any other third parties for the granting of a license in or outside South Korea or to deal in any other manner with such rights as it shall see fit at its sole discretion.&lt;/div&gt; &lt;div style="DISPLAY: block; TEXT-INDENT: 0pt"&gt;&lt;br /&gt; &lt;/div&gt; &lt;div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 5.9pt; text-align: justify; TEXT-INDENT: 0pt"&gt; Each party has agreed to hold the other party&amp;#39;s shares for at least one year before selling any of such shares. The parties also agreed to give an irrevocable proxy to the other party&amp;#39;s management with respect to the voting power of the shares issued.&lt;/div&gt; &lt;!--EndFragment--&gt;&lt;/div&gt; &lt;/div&gt;</us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock>
  <us-gaap:OtherAccruedLiabilitiesCurrent id="OtherAccruedLiabilitiesCurrent.872.0.0.0.0.0.0" contextRef="as-of-2014-06-30.872.0.0.0.0.0.0.0" unitRef="USD" decimals="-3">14000</us-gaap:OtherAccruedLiabilitiesCurrent>
  <us-gaap:OtherAccruedLiabilitiesCurrent id="OtherAccruedLiabilitiesCurrent.874.0.0.0.0.0.0" xsi:nil="true" contextRef="as-of-2013-06-30.874.0.0.0.0.0.0.0" unitRef="USD" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" />
  <us-gaap:OtherAssetsCurrent id="OtherAssetsCurrent.872.0.0.0.0.0.0" contextRef="as-of-2014-06-30.872.0.0.0.0.0.0.0" unitRef="USD" decimals="-3">905000</us-gaap:OtherAssetsCurrent>
  <us-gaap:OtherAssetsCurrent id="OtherAssetsCurrent.874.0.0.0.0.0.0" contextRef="as-of-2013-06-30.874.0.0.0.0.0.0.0" unitRef="USD" decimals="-3">599000</us-gaap:OtherAssetsCurrent>
  <us-gaap:OtherAssetsNoncurrent id="OtherAssetsNoncurrent.872.0.0.0.0.0.0" contextRef="as-of-2014-06-30.872.0.0.0.0.0.0.0" unitRef="USD" decimals="-3">8000</us-gaap:OtherAssetsNoncurrent>
  <us-gaap:OtherAssetsNoncurrent id="OtherAssetsNoncurrent.874.0.0.0.0.0.0" contextRef="as-of-2013-06-30.874.0.0.0.0.0.0.0" unitRef="USD" decimals="-3">39000</us-gaap:OtherAssetsNoncurrent>
  <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax id="OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax.869.477.5114.0.0.0.0" contextRef="from-2013-07-01-to-2014-06-30.869.0.477.5114.0.0.0.0" unitRef="USD" decimals="-3">3404000</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax>
  <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax id="OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax.869.484.5114.0.0.0.0" contextRef="from-2013-07-01-to-2014-06-30.869.0.484.5114.0.0.0.0" unitRef="USD" decimals="-3">23000</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax>
  <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax id="OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax.869.0.0.0.0.0.0" contextRef="from-2013-07-01-to-2014-06-30.869.0.0.0.0.0.0.0" unitRef="USD" decimals="-3">3427000</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax>
  <us-gaap:OtherComprehensiveIncomeLossNetOfTax id="OtherComprehensiveIncomeLossNetOfTax.869.477.5114.0.0.0.0" contextRef="from-2013-07-01-to-2014-06-30.869.0.477.5114.0.0.0.0" unitRef="USD" decimals="-3">2677000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
  <us-gaap:OtherComprehensiveIncomeLossNetOfTax id="OtherComprehensiveIncomeLossNetOfTax.869.484.5114.0.0.0.0" contextRef="from-2013-07-01-to-2014-06-30.869.0.484.5114.0.0.0.0" unitRef="USD" decimals="-3">23000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
  <us-gaap:OtherComprehensiveIncomeLossNetOfTax id="OtherComprehensiveIncomeLossNetOfTax.869.1115.5114.0.0.0.0" xsi:nil="true" contextRef="from-2013-07-01-to-2014-06-30.869.0.1115.5114.0.0.0.0" unitRef="USD" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" />
  <us-gaap:OtherComprehensiveIncomeLossNetOfTax id="OtherComprehensiveIncomeLossNetOfTax.870.1115.5114.0.0.0.0" xsi:nil="true" contextRef="from-2012-07-01-to-2013-06-30.870.0.1115.5114.0.0.0.0" unitRef="USD" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" />
  <us-gaap:OtherComprehensiveIncomeLossNetOfTax id="OtherComprehensiveIncomeLossNetOfTax.871.1115.5114.0.0.0.0" xsi:nil="true" contextRef="from-2011-07-01-to-2012-06-30.871.0.1115.5114.0.0.0.0" unitRef="USD" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" />
  <us-gaap:OtherComprehensiveIncomeLossNetOfTax id="OtherComprehensiveIncomeLossNetOfTax.869.499.5114.0.0.0.0" xsi:nil="true" contextRef="from-2013-07-01-to-2014-06-30.869.0.499.5114.0.0.0.0" unitRef="USD" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" />
  <us-gaap:OtherComprehensiveIncomeLossNetOfTax id="OtherComprehensiveIncomeLossNetOfTax.870.499.5114.0.0.0.0" xsi:nil="true" contextRef="from-2012-07-01-to-2013-06-30.870.0.499.5114.0.0.0.0" unitRef="USD" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" />
  <us-gaap:OtherComprehensiveIncomeLossNetOfTax id="OtherComprehensiveIncomeLossNetOfTax.871.499.5114.0.0.0.0" xsi:nil="true" contextRef="from-2011-07-01-to-2012-06-30.871.0.499.5114.0.0.0.0" unitRef="USD" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" />
  <us-gaap:OtherComprehensiveIncomeLossNetOfTax id="OtherComprehensiveIncomeLossNetOfTax.869.478.5114.0.0.0.0" contextRef="from-2013-07-01-to-2014-06-30.869.0.478.5114.0.0.0.0" unitRef="USD" decimals="-3">2700000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
  <us-gaap:OtherComprehensiveIncomeLossNetOfTax id="OtherComprehensiveIncomeLossNetOfTax.870.478.5114.0.0.0.0" contextRef="from-2012-07-01-to-2013-06-30.870.0.478.5114.0.0.0.0" unitRef="USD" decimals="-3">389000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
  <us-gaap:OtherComprehensiveIncomeLossNetOfTax id="OtherComprehensiveIncomeLossNetOfTax.871.478.5114.0.0.0.0" contextRef="from-2011-07-01-to-2012-06-30.871.0.478.5114.0.0.0.0" unitRef="USD" decimals="-3">-130000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
  <us-gaap:OtherComprehensiveIncomeLossNetOfTax id="OtherComprehensiveIncomeLossNetOfTax.869.4619.5114.0.0.0.0" xsi:nil="true" contextRef="from-2013-07-01-to-2014-06-30.869.0.4619.5114.0.0.0.0" unitRef="USD" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" />
  <us-gaap:OtherComprehensiveIncomeLossNetOfTax id="OtherComprehensiveIncomeLossNetOfTax.870.4619.5114.0.0.0.0" xsi:nil="true" contextRef="from-2012-07-01-to-2013-06-30.870.0.4619.5114.0.0.0.0" unitRef="USD" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" />
  <us-gaap:OtherComprehensiveIncomeLossNetOfTax id="OtherComprehensiveIncomeLossNetOfTax.871.4619.5114.0.0.0.0" xsi:nil="true" contextRef="from-2011-07-01-to-2012-06-30.871.0.4619.5114.0.0.0.0" unitRef="USD" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" />
  <us-gaap:OtherComprehensiveIncomeLossNetOfTax id="OtherComprehensiveIncomeLossNetOfTax.869.0.0.0.0.0.0" contextRef="from-2013-07-01-to-2014-06-30.869.0.0.0.0.0.0.0" unitRef="USD" decimals="-3">2700000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
  <us-gaap:OtherComprehensiveIncomeLossNetOfTax id="OtherComprehensiveIncomeLossNetOfTax.870.0.0.0.0.0.0" contextRef="from-2012-07-01-to-2013-06-30.870.0.0.0.0.0.0.0" unitRef="USD" decimals="-3">389000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
  <us-gaap:OtherComprehensiveIncomeLossNetOfTax id="OtherComprehensiveIncomeLossNetOfTax.871.0.0.0.0.0.0" contextRef="from-2011-07-01-to-2012-06-30.871.0.0.0.0.0.0.0" unitRef="USD" decimals="-3">-130000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
  <us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax id="OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax.869.0.0.0.0.0.0" contextRef="from-2013-07-01-to-2014-06-30.869.0.0.0.0.0.0.0" unitRef="USD" decimals="-3">727000</us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax>
  <us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax id="OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax.870.0.0.0.0.0.0" contextRef="from-2012-07-01-to-2013-06-30.870.0.0.0.0.0.0.0" unitRef="USD" decimals="-3">26000</us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax>
  <us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax id="OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax.871.0.0.0.0.0.0" contextRef="from-2011-07-01-to-2012-06-30.871.0.0.0.0.0.0.0" unitRef="USD" decimals="-3">3000</us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax>
  <us-gaap:OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodNetOfTax id="OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodNetOfTax.869.0.0.0.0.0.0" contextRef="from-2013-07-01-to-2014-06-30.869.0.0.0.0.0.0.0" unitRef="USD" decimals="-3">23000</us-gaap:OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodNetOfTax>
  <us-gaap:OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodNetOfTax id="OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodNetOfTax.870.0.0.0.0.0.0" xsi:nil="true" contextRef="from-2012-07-01-to-2013-06-30.870.0.0.0.0.0.0.0" unitRef="USD" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" />
  <us-gaap:OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodNetOfTax id="OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodNetOfTax.871.0.0.0.0.0.0" xsi:nil="true" contextRef="from-2011-07-01-to-2012-06-30.871.0.0.0.0.0.0.0" unitRef="USD" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" />
  <us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax id="OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax.869.0.0.0.0.0.0" contextRef="from-2013-07-01-to-2014-06-30.869.0.0.0.0.0.0.0" unitRef="USD" decimals="-3">3404000</us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax>
  <us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax id="OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax.870.0.0.0.0.0.0" contextRef="from-2012-07-01-to-2013-06-30.870.0.0.0.0.0.0.0" unitRef="USD" decimals="-3">415000</us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax>
  <us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax id="OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax.871.0.0.0.0.0.0" contextRef="from-2011-07-01-to-2012-06-30.871.0.0.0.0.0.0.0" unitRef="USD" decimals="-3">-127000</us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax>
  <us-gaap:OtherIncomeAndOtherExpenseDisclosureTextBlock id="OtherIncomeAndOtherExpenseDisclosureTextBlock.869.0.0.0.0.0.0" contextRef="from-2013-07-01-to-2014-06-30.869.0.0.0.0.0.0.0">&lt;!--DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd" --&gt;&lt;div&gt; &lt;div&gt;&lt;!--StartFragment--&gt; &lt;div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: left; TEXT-INDENT: 0pt"&gt; NOTE 9:-FINANCIAL INCOME, NET&lt;/div&gt; &lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"&gt; &amp;nbsp;&lt;/div&gt; &lt;div style="text-align: left"&gt; &lt;table style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman" cellspacing="0" cellpadding="0" width="80%"&gt; &lt;tr&gt; &lt;td style="PADDING-BOTTOM: 2px" valign="bottom" width="64%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-WEIGHT: bold; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="34%" colspan="10"&gt; &lt;div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: -9pt"&gt; Year ended June 30,&lt;/div&gt; &lt;/td&gt; &lt;td style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-WEIGHT: bold; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td style="PADDING-BOTTOM: 2px" valign="bottom" width="64%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%" align="right"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-WEIGHT: bold; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: center; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt" valign="bottom" width="10%" colspan="2"&gt; &lt;div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: center; TEXT-INDENT: 0pt"&gt; 2014&lt;/div&gt; &lt;/td&gt; &lt;td style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-WEIGHT: bold; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%" align="right"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-WEIGHT: bold; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: center; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt" valign="bottom" width="10%" colspan="2"&gt; &lt;div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: center; TEXT-INDENT: 0pt"&gt; 2013&lt;/div&gt; &lt;/td&gt; &lt;td style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-WEIGHT: bold; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-WEIGHT: bold; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="10%" colspan="2"&gt; &lt;div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 7.45pt; text-align: center; TEXT-INDENT: 0pt"&gt; 2012&lt;/div&gt; &lt;/td&gt; &lt;td style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-WEIGHT: bold; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td valign="bottom" width="64%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td valign="bottom" width="1%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td valign="bottom" width="10%" colspan="2"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td valign="bottom" width="1%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td valign="bottom" width="10%" colspan="2"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td valign="bottom" width="1%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td valign="bottom" width="10%" colspan="2"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr bgcolor="#cceeff"&gt; &lt;td style="TEXT-ALIGN: left; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt" valign="bottom" width="64%"&gt; &lt;div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: left; TEXT-INDENT: 0pt"&gt; Foreign currency translation differences, net&lt;/div&gt; &lt;/td&gt; &lt;td valign="bottom" width="1%" align="right"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%"&gt;$&lt;/td&gt; &lt;td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%"&gt;407&lt;/td&gt; &lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td valign="bottom" width="1%" align="right"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%"&gt;$&lt;/td&gt; &lt;td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%"&gt;497&lt;/td&gt; &lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td valign="bottom" width="1%" align="right"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%"&gt;$&lt;/td&gt; &lt;td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%"&gt;(98&lt;/td&gt; &lt;td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"&gt;)&lt;/td&gt; &lt;/tr&gt; &lt;tr bgcolor="white"&gt; &lt;td valign="bottom" width="64%" align="left"&gt; &lt;div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 9pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: -9pt"&gt; Bank commissions&lt;/div&gt; &lt;/td&gt; &lt;td valign="bottom" width="1%" align="right"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%"&gt;(36&lt;/td&gt; &lt;td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"&gt;)&lt;/td&gt; &lt;td valign="bottom" width="1%" align="right"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%"&gt;(29&lt;/td&gt; &lt;td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"&gt;)&lt;/td&gt; &lt;td valign="bottom" width="1%" align="right"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%"&gt;(12&lt;/td&gt; &lt;td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"&gt;)&lt;/td&gt; &lt;/tr&gt; &lt;tr bgcolor="#cceeff"&gt; &lt;td valign="bottom" width="64%" align="left"&gt; &lt;div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 9pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: -9pt"&gt; Interest income on deposits&lt;/div&gt; &lt;/td&gt; &lt;td valign="bottom" width="1%" align="right"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%"&gt;246&lt;/td&gt; &lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td valign="bottom" width="1%" align="right"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%"&gt;539&lt;/td&gt; &lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td valign="bottom" width="1%" align="right"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%"&gt;575&lt;/td&gt; &lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr bgcolor="white"&gt; &lt;td valign="bottom" width="64%" align="left"&gt; &lt;div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 9pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: -9pt"&gt; Gain (Loss) related to marketable securities&lt;/div&gt; &lt;/td&gt; &lt;td valign="bottom" width="1%" align="right"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%"&gt;384&lt;/td&gt; &lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td valign="bottom" width="1%" align="right"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%"&gt;(79&lt;/td&gt; &lt;td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"&gt;)&lt;/td&gt; &lt;td valign="bottom" width="1%" align="right"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%"&gt;89&lt;/td&gt; &lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr bgcolor="#cceeff"&gt; &lt;td style="PADDING-BOTTOM: 2px" valign="bottom" width="64%" align="left"&gt; &lt;div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 9pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: -9pt"&gt; Gain (loss) from&amp;nbsp;&amp;nbsp;derivatives&lt;/div&gt; &lt;/td&gt; &lt;td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%" align="right"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 2px solid; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%"&gt;(83&lt;/td&gt; &lt;td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"&gt;)&lt;/td&gt; &lt;td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%" align="right"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 2px solid; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%"&gt;140&lt;/td&gt; &lt;td style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%" align="right"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 2px solid; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%"&gt;(317&lt;/td&gt; &lt;td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"&gt;)&lt;/td&gt; &lt;/tr&gt; &lt;tr bgcolor="white"&gt; &lt;td valign="bottom" width="64%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td valign="bottom" width="1%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td valign="bottom" width="1%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td valign="bottom" width="1%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr bgcolor="#cceeff"&gt; &lt;td style="PADDING-BOTTOM: 4px" valign="bottom" width="64%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="PADDING-BOTTOM: 4px" valign="bottom" width="1%" align="right"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 4px double; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%"&gt;$&lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 4px double; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%"&gt;918&lt;/td&gt; &lt;td style="PADDING-BOTTOM: 4px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="PADDING-BOTTOM: 4px" valign="bottom" width="1%" align="right"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 4px double; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%"&gt;$&lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 4px double; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%"&gt;1,068&lt;/td&gt; &lt;td style="PADDING-BOTTOM: 4px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="PADDING-BOTTOM: 4px" valign="bottom" width="1%" align="right"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 4px double; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%"&gt;$&lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 4px double; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%"&gt;237&lt;/td&gt; &lt;td style="PADDING-BOTTOM: 4px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;/tr&gt; &lt;/table&gt; &lt;/div&gt; &lt;!--EndFragment--&gt;&lt;/div&gt; &lt;/div&gt;</us-gaap:OtherIncomeAndOtherExpenseDisclosureTextBlock>
  <us-gaap:OtherLiabilitiesNoncurrent id="OtherLiabilitiesNoncurrent.872.0.0.0.0.0.0" contextRef="as-of-2014-06-30.872.0.0.0.0.0.0.0" unitRef="USD" decimals="-3">588000</us-gaap:OtherLiabilitiesNoncurrent>
  <us-gaap:OtherLiabilitiesNoncurrent id="OtherLiabilitiesNoncurrent.874.0.0.0.0.0.0" contextRef="as-of-2013-06-30.874.0.0.0.0.0.0.0" unitRef="USD" decimals="-3">680000</us-gaap:OtherLiabilitiesNoncurrent>
  <us-gaap:OtherSignificantNoncashTransactionValueOfConsiderationGiven1 id="OtherSignificantNoncashTransactionValueOfConsiderationGiven1.869.0.0.0.0.0.0" xsi:nil="true" contextRef="from-2013-07-01-to-2014-06-30.869.0.0.0.0.0.0.0" unitRef="USD" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" />
  <us-gaap:OtherSignificantNoncashTransactionValueOfConsiderationGiven1 id="OtherSignificantNoncashTransactionValueOfConsiderationGiven1.870.0.0.0.0.0.0" xsi:nil="true" contextRef="from-2012-07-01-to-2013-06-30.870.0.0.0.0.0.0.0" unitRef="USD" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" />
  <us-gaap:OtherSignificantNoncashTransactionValueOfConsiderationGiven1 id="OtherSignificantNoncashTransactionValueOfConsiderationGiven1.871.0.0.0.0.0.0" contextRef="from-2011-07-01-to-2012-06-30.871.0.0.0.0.0.0.0" unitRef="USD" decimals="-3">13000</us-gaap:OtherSignificantNoncashTransactionValueOfConsiderationGiven1>
  <us-gaap:PaymentsForProceedsFromLongtermInvestments id="PaymentsForProceedsFromLongtermInvestments.869.0.0.0.0.0.0" contextRef="from-2013-07-01-to-2014-06-30.869.0.0.0.0.0.0.0" unitRef="USD" decimals="-3">3000</us-gaap:PaymentsForProceedsFromLongtermInvestments>
  <us-gaap:PaymentsForProceedsFromLongtermInvestments id="PaymentsForProceedsFromLongtermInvestments.870.0.0.0.0.0.0" xsi:nil="true" contextRef="from-2012-07-01-to-2013-06-30.870.0.0.0.0.0.0.0" unitRef="USD" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" />
  <us-gaap:PaymentsForProceedsFromLongtermInvestments id="PaymentsForProceedsFromLongtermInvestments.871.0.0.0.0.0.0" contextRef="from-2011-07-01-to-2012-06-30.871.0.0.0.0.0.0.0" unitRef="USD" decimals="-3">1125000</us-gaap:PaymentsForProceedsFromLongtermInvestments>
  <us-gaap:PaymentsForProceedsFromShortTermInvestments id="PaymentsForProceedsFromShortTermInvestments.869.0.0.0.0.0.0" contextRef="from-2013-07-01-to-2014-06-30.869.0.0.0.0.0.0.0" unitRef="USD" decimals="-3">-7421000</us-gaap:PaymentsForProceedsFromShortTermInvestments>
  <us-gaap:PaymentsForProceedsFromShortTermInvestments id="PaymentsForProceedsFromShortTermInvestments.870.0.0.0.0.0.0" contextRef="from-2012-07-01-to-2013-06-30.870.0.0.0.0.0.0.0" unitRef="USD" decimals="-3">10202000</us-gaap:PaymentsForProceedsFromShortTermInvestments>
  <us-gaap:PaymentsForProceedsFromShortTermInvestments id="PaymentsForProceedsFromShortTermInvestments.871.0.0.0.0.0.0" contextRef="from-2011-07-01-to-2012-06-30.871.0.0.0.0.0.0.0" unitRef="USD" decimals="-3">21031000</us-gaap:PaymentsForProceedsFromShortTermInvestments>
  <us-gaap:PaymentsToAcquireAvailableForSaleSecurities id="PaymentsToAcquireAvailableForSaleSecurities.869.0.0.0.0.0.0" contextRef="from-2013-07-01-to-2014-06-30.869.0.0.0.0.0.0.0" unitRef="USD" decimals="-3">10851000</us-gaap:PaymentsToAcquireAvailableForSaleSecurities>
  <us-gaap:PaymentsToAcquireAvailableForSaleSecurities id="PaymentsToAcquireAvailableForSaleSecurities.870.0.0.0.0.0.0" contextRef="from-2012-07-01-to-2013-06-30.870.0.0.0.0.0.0.0" unitRef="USD" decimals="-3">8534000</us-gaap:PaymentsToAcquireAvailableForSaleSecurities>
  <us-gaap:PaymentsToAcquireAvailableForSaleSecurities id="PaymentsToAcquireAvailableForSaleSecurities.871.0.0.0.0.0.0" contextRef="from-2011-07-01-to-2012-06-30.871.0.0.0.0.0.0.0" unitRef="USD" decimals="-3">8165000</us-gaap:PaymentsToAcquireAvailableForSaleSecurities>
  <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment id="PaymentsToAcquirePropertyPlantAndEquipment.869.0.0.0.0.0.0" contextRef="from-2013-07-01-to-2014-06-30.869.0.0.0.0.0.0.0" unitRef="USD" decimals="-3">1573000</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
  <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment id="PaymentsToAcquirePropertyPlantAndEquipment.870.0.0.0.0.0.0" contextRef="from-2012-07-01-to-2013-06-30.870.0.0.0.0.0.0.0" unitRef="USD" decimals="-3">4309000</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
  <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment id="PaymentsToAcquirePropertyPlantAndEquipment.871.0.0.0.0.0.0" contextRef="from-2011-07-01-to-2012-06-30.871.0.0.0.0.0.0.0" unitRef="USD" decimals="-3">1480000</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
  <us-gaap:PledgedAssetsNotSeparatelyReportedOtherFinancialInstruments id="PledgedAssetsNotSeparatelyReportedOtherFinancialInstruments.872.0.0.0.0.0.0" contextRef="as-of-2014-06-30.872.0.0.0.0.0.0.0" unitRef="USD" decimals="-3">4805000</us-gaap:PledgedAssetsNotSeparatelyReportedOtherFinancialInstruments>
  <us-gaap:PostemploymentBenefitsLiabilityNoncurrent id="PostemploymentBenefitsLiabilityNoncurrent.872.0.0.0.0.0.0" contextRef="as-of-2014-06-30.872.0.0.0.0.0.0.0" unitRef="USD" decimals="-3">1068000</us-gaap:PostemploymentBenefitsLiabilityNoncurrent>
  <us-gaap:PostemploymentBenefitsLiabilityNoncurrent id="PostemploymentBenefitsLiabilityNoncurrent.874.0.0.0.0.0.0" contextRef="as-of-2013-06-30.874.0.0.0.0.0.0.0" unitRef="USD" decimals="-3">1023000</us-gaap:PostemploymentBenefitsLiabilityNoncurrent>
  <us-gaap:PostemploymentBenefitsPeriodExpense id="PostemploymentBenefitsPeriodExpense.869.0.0.0.0.0.0" contextRef="from-2013-07-01-to-2014-06-30.869.0.0.0.0.0.0.0" unitRef="USD" decimals="-3">534000</us-gaap:PostemploymentBenefitsPeriodExpense>
  <us-gaap:PostemploymentBenefitsPeriodExpense id="PostemploymentBenefitsPeriodExpense.870.0.0.0.0.0.0" contextRef="from-2012-07-01-to-2013-06-30.870.0.0.0.0.0.0.0" unitRef="USD" decimals="-3">329000</us-gaap:PostemploymentBenefitsPeriodExpense>
  <us-gaap:PostemploymentBenefitsPeriodExpense id="PostemploymentBenefitsPeriodExpense.871.0.0.0.0.0.0" contextRef="from-2011-07-01-to-2012-06-30.871.0.0.0.0.0.0.0" unitRef="USD" decimals="-3">275000</us-gaap:PostemploymentBenefitsPeriodExpense>
  <us-gaap:PreferredStockParOrStatedValuePerShare id="PreferredStockParOrStatedValuePerShare.872.0.0.0.0.0.0" contextRef="as-of-2014-06-30.872.0.0.0.0.0.0.0" unitRef="USD_per_share" decimals="INF">0.00001</us-gaap:PreferredStockParOrStatedValuePerShare>
  <us-gaap:PreferredStockSharesAuthorized id="PreferredStockSharesAuthorized.872.0.0.0.0.0.0" contextRef="as-of-2014-06-30.872.0.0.0.0.0.0.0" unitRef="shares" decimals="INF">10000000</us-gaap:PreferredStockSharesAuthorized>
  <us-gaap:ProceedsFromCustomers id="ProceedsFromCustomers.890.0.0.0.0.0.0" contextRef="from-2011-08-01-to-2011-08-31.890.0.0.0.0.0.0.0" unitRef="USD" decimals="-3">2000000</us-gaap:ProceedsFromCustomers>
  <us-gaap:ProceedsFromIssuanceOfCommonStock id="ProceedsFromIssuanceOfCommonStock.869.0.0.0.0.0.0" contextRef="from-2013-07-01-to-2014-06-30.869.0.0.0.0.0.0.0" unitRef="USD" decimals="-3">10644000</us-gaap:ProceedsFromIssuanceOfCommonStock>
  <us-gaap:ProceedsFromIssuanceOfCommonStock id="ProceedsFromIssuanceOfCommonStock.870.0.0.0.0.0.0" contextRef="from-2012-07-01-to-2013-06-30.870.0.0.0.0.0.0.0" unitRef="USD" decimals="-3">34106000</us-gaap:ProceedsFromIssuanceOfCommonStock>
  <us-gaap:ProceedsFromIssuanceOfCommonStock id="ProceedsFromIssuanceOfCommonStock.871.0.0.0.0.0.0" xsi:nil="true" contextRef="from-2011-07-01-to-2012-06-30.871.0.0.0.0.0.0.0" unitRef="USD" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" />
  <us-gaap:ProceedsFromIssuanceOfCommonStock id="ProceedsFromIssuanceOfCommonStock.968.0.0.0.0.0.0" contextRef="from-2012-09-18-to-2012-09-19.968.0.0.0.0.0.0.0" unitRef="USD" decimals="-3">34106000</us-gaap:ProceedsFromIssuanceOfCommonStock>
  <us-gaap:ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions id="ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions.869.0.0.0.0.0.0" contextRef="from-2013-07-01-to-2014-06-30.869.0.0.0.0.0.0.0" unitRef="USD" decimals="-3">1980000</us-gaap:ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions>
  <us-gaap:ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions id="ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions.870.0.0.0.0.0.0" contextRef="from-2012-07-01-to-2013-06-30.870.0.0.0.0.0.0.0" unitRef="USD" decimals="-3">2198000</us-gaap:ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions>
  <us-gaap:ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions id="ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions.871.0.0.0.0.0.0" contextRef="from-2011-07-01-to-2012-06-30.871.0.0.0.0.0.0.0" unitRef="USD" decimals="-3">632000</us-gaap:ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions>
  <us-gaap:ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities id="ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities.869.0.0.0.0.0.0" contextRef="from-2013-07-01-to-2014-06-30.869.0.0.0.0.0.0.0" unitRef="USD" decimals="-3">754000</us-gaap:ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities>
  <us-gaap:ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities id="ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities.870.0.0.0.0.0.0" contextRef="from-2012-07-01-to-2013-06-30.870.0.0.0.0.0.0.0" unitRef="USD" decimals="-3">529000</us-gaap:ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities>
  <us-gaap:ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities id="ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities.871.0.0.0.0.0.0" contextRef="from-2011-07-01-to-2012-06-30.871.0.0.0.0.0.0.0" unitRef="USD" decimals="-3">114000</us-gaap:ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities>
  <us-gaap:ProceedsFromSaleOfAvailableForSaleSecurities id="ProceedsFromSaleOfAvailableForSaleSecurities.869.0.0.0.0.0.0" contextRef="from-2013-07-01-to-2014-06-30.869.0.0.0.0.0.0.0" unitRef="USD" decimals="-3">6113000</us-gaap:ProceedsFromSaleOfAvailableForSaleSecurities>
  <us-gaap:ProceedsFromSaleOfAvailableForSaleSecurities id="ProceedsFromSaleOfAvailableForSaleSecurities.870.0.0.0.0.0.0" contextRef="from-2012-07-01-to-2013-06-30.870.0.0.0.0.0.0.0" unitRef="USD" decimals="-3">1848000</us-gaap:ProceedsFromSaleOfAvailableForSaleSecurities>
  <us-gaap:ProceedsFromSaleOfAvailableForSaleSecurities id="ProceedsFromSaleOfAvailableForSaleSecurities.871.0.0.0.0.0.0" contextRef="from-2011-07-01-to-2012-06-30.871.0.0.0.0.0.0.0" unitRef="USD" decimals="-3">884000</us-gaap:ProceedsFromSaleOfAvailableForSaleSecurities>
  <us-gaap:ProceedsFromWarrantExercises id="ProceedsFromWarrantExercises.870.0.0.0.0.0.0" contextRef="from-2012-07-01-to-2013-06-30.870.0.0.0.0.0.0.0" unitRef="USD" decimals="-3">2009000</us-gaap:ProceedsFromWarrantExercises>
  <us-gaap:ProceedsFromWarrantExercises id="ProceedsFromWarrantExercises.871.0.0.0.0.0.0" contextRef="from-2011-07-01-to-2012-06-30.871.0.0.0.0.0.0.0" unitRef="USD" decimals="-3">556000</us-gaap:ProceedsFromWarrantExercises>
  <us-gaap:ProceedsFromWarrantExercises id="ProceedsFromWarrantExercises.869.25814.1048.0.0.0.0" contextRef="from-2013-07-01-to-2014-06-30.869.0.25814.1048.0.0.0.0" unitRef="USD" decimals="-3">1968000</us-gaap:ProceedsFromWarrantExercises>
  <us-gaap:ProceedsFromWarrantExercises id="ProceedsFromWarrantExercises.870.25814.1048.0.0.0.0" contextRef="from-2012-07-01-to-2013-06-30.870.0.25814.1048.0.0.0.0" unitRef="USD" decimals="-3">2009000</us-gaap:ProceedsFromWarrantExercises>
  <us-gaap:ProceedsFromWarrantExercises id="ProceedsFromWarrantExercises.871.25814.1048.0.0.0.0" contextRef="from-2011-07-01-to-2012-06-30.871.0.25814.1048.0.0.0.0" unitRef="USD" decimals="-3">556000</us-gaap:ProceedsFromWarrantExercises>
  <us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock id="PropertyPlantAndEquipmentDisclosureTextBlock.869.0.0.0.0.0.0" contextRef="from-2013-07-01-to-2014-06-30.869.0.0.0.0.0.0.0">&lt;!--DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd" --&gt;&lt;div&gt; &lt;div&gt;&lt;!--StartFragment--&gt; &lt;div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: left; TEXT-INDENT: 0pt"&gt; NOTE 5:-PROPERTY AND EQUIPMENT, NET&lt;/div&gt; &lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"&gt; &amp;nbsp;&lt;/div&gt; &lt;div style="text-align: right"&gt; &lt;table style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman" cellspacing="0" cellpadding="0" width="97%"&gt; &lt;tr&gt; &lt;td style="PADDING-BOTTOM: 2px" valign="bottom" width="76%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-WEIGHT: bold; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="22%" colspan="6"&gt; &lt;div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"&gt; June 30,&lt;/div&gt; &lt;/td&gt; &lt;td style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-WEIGHT: bold; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td style="PADDING-BOTTOM: 2px" valign="bottom" width="76%" align="left"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-WEIGHT: bold; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="10%" colspan="2"&gt; &lt;div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"&gt; 2014&lt;/div&gt; &lt;/td&gt; &lt;td style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-WEIGHT: bold; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-WEIGHT: bold; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="10%" colspan="2"&gt; &lt;div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"&gt; 2013&lt;/div&gt; &lt;/td&gt; &lt;td style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-WEIGHT: bold; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr bgcolor="#cceeff"&gt; &lt;td valign="bottom" width="76%" align="left"&gt; &lt;div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"&gt; Cost:&lt;/div&gt; &lt;/td&gt; &lt;td valign="bottom" width="1%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td valign="bottom" width="10%" colspan="2"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td valign="bottom" width="1%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td valign="bottom" width="10%" colspan="2"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr bgcolor="white"&gt; &lt;td valign="bottom" width="76%" align="left"&gt; &lt;div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"&gt; Laboratory equipment&lt;/div&gt; &lt;/td&gt; &lt;td valign="bottom" width="1%" align="right"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%"&gt;$&lt;/td&gt; &lt;td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%"&gt;6,088&lt;/td&gt; &lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td valign="bottom" width="1%" align="right"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%"&gt;$&lt;/td&gt; &lt;td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%"&gt;5,709&lt;/td&gt; &lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr bgcolor="#cceeff"&gt; &lt;td valign="bottom" width="76%" align="left"&gt; &lt;div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"&gt; Computers and peripheral equipment&lt;/div&gt; &lt;/td&gt; &lt;td valign="bottom" width="1%" align="right"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%"&gt;708&lt;/td&gt; &lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td valign="bottom" width="1%" align="right"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%"&gt;535&lt;/td&gt; &lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr bgcolor="white"&gt; &lt;td valign="bottom" width="76%" align="left"&gt; &lt;div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"&gt; Office furniture and equipment&lt;/div&gt; &lt;/td&gt; &lt;td valign="bottom" width="1%" align="right"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%"&gt;611&lt;/td&gt; &lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td valign="bottom" width="1%" align="right"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%"&gt;534&lt;/td&gt; &lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr bgcolor="#cceeff"&gt; &lt;td valign="bottom" width="76%" align="left"&gt; &lt;div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"&gt; Leasehold improvements&lt;/div&gt; &lt;/td&gt; &lt;td valign="bottom" width="1%" align="right"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%"&gt;7,453&lt;/td&gt; &lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td valign="bottom" width="1%" align="right"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%"&gt;7,369&lt;/td&gt; &lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr bgcolor="white"&gt; &lt;td style="PADDING-BOTTOM: 2px" valign="bottom" width="76%" align="left"&gt; &lt;div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"&gt; Vehicles&lt;/div&gt; &lt;/td&gt; &lt;td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 2px solid; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%"&gt;95&lt;/td&gt; &lt;td style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 2px solid; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%"&gt;68&lt;/td&gt; &lt;td style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr bgcolor="#cceeff"&gt; &lt;td style="PADDING-BOTTOM: 2px" valign="bottom" width="76%" align="left"&gt; &lt;div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"&gt; &amp;nbsp;Total Cost&lt;/div&gt; &lt;/td&gt; &lt;td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 2px solid; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%"&gt;14,955&lt;/td&gt; &lt;td style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 2px solid; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%"&gt;14,215&lt;/td&gt; &lt;td style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr bgcolor="white"&gt; &lt;td valign="bottom" width="76%" align="left"&gt; &lt;div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"&gt; Accumulated depreciation:&lt;/div&gt; &lt;/td&gt; &lt;td valign="bottom" width="1%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td valign="bottom" width="1%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr bgcolor="#cceeff"&gt; &lt;td valign="bottom" width="76%" align="left"&gt; &lt;div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"&gt; Laboratory equipment&lt;/div&gt; &lt;/td&gt; &lt;td valign="bottom" width="1%" align="right"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%"&gt;2,042&lt;/td&gt; &lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td valign="bottom" width="1%" align="right"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%"&gt;1,306&lt;/td&gt; &lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr bgcolor="white"&gt; &lt;td valign="bottom" width="76%" align="left"&gt; &lt;div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"&gt; Computers and peripheral equipment&lt;/div&gt; &lt;/td&gt; &lt;td valign="bottom" width="1%" align="right"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%"&gt;430&lt;/td&gt; &lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td valign="bottom" width="1%" align="right"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%"&gt;280&lt;/td&gt; &lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr bgcolor="#cceeff"&gt; &lt;td valign="bottom" width="76%" align="left"&gt; &lt;div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"&gt; Office furniture and equipment&lt;/div&gt; &lt;/td&gt; &lt;td valign="bottom" width="1%" align="right"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%"&gt;176&lt;/td&gt; &lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td valign="bottom" width="1%" align="right"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%"&gt;91&lt;/td&gt; &lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr bgcolor="white"&gt; &lt;td valign="bottom" width="76%" align="left"&gt; &lt;div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"&gt; Leasehold improvements&lt;/div&gt; &lt;/td&gt; &lt;td valign="bottom" width="1%" align="right"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%"&gt;1,475&lt;/td&gt; &lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td valign="bottom" width="1%" align="right"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%"&gt;642&lt;/td&gt; &lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr bgcolor="#cceeff"&gt; &lt;td style="PADDING-BOTTOM: 2px" valign="bottom" width="76%" align="left"&gt; &lt;div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"&gt; Vehicles&lt;/div&gt; &lt;/td&gt; &lt;td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 2px solid; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%"&gt;9&lt;/td&gt; &lt;td style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 2px solid; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%"&gt;30&lt;/td&gt; &lt;td style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr bgcolor="white"&gt; &lt;td style="PADDING-BOTTOM: 2px" valign="bottom" width="76%" align="left"&gt; &lt;div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"&gt; &amp;nbsp;Total accumulated depreciation&lt;/div&gt; &lt;/td&gt; &lt;td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 2px solid; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%"&gt;4,132&lt;/td&gt; &lt;td style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 2px solid; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%"&gt;2,349&lt;/td&gt; &lt;td style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr bgcolor="#cceeff"&gt; &lt;td style="PADDING-BOTTOM: 4px" valign="bottom" width="76%" align="left"&gt; &lt;div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"&gt; Property and equipment, net&lt;/div&gt; &lt;/td&gt; &lt;td style="PADDING-BOTTOM: 4px" valign="bottom" width="1%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 4px double; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%"&gt;$&lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 4px double; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%"&gt;10,823&lt;/td&gt; &lt;td style="PADDING-BOTTOM: 4px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="PADDING-BOTTOM: 4px" valign="bottom" width="1%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 4px double; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%"&gt;$&lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 4px double; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%"&gt;11,866&lt;/td&gt; &lt;td style="PADDING-BOTTOM: 4px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;/tr&gt; &lt;/table&gt; &lt;/div&gt; &lt;div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; MARGIN-LEFT: 45pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"&gt; &amp;nbsp;&lt;/div&gt; &lt;div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"&gt; Depreciation expenses amounted to $1,902, $1,033 and $435 for the years ended June 30, 2014, 2013 and 2012, respectively.&lt;/div&gt; &lt;!--EndFragment--&gt;&lt;/div&gt; &lt;/div&gt;</us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock>
  <us-gaap:PropertyPlantAndEquipmentGross id="PropertyPlantAndEquipmentGross.872.3840.4261.0.0.0.0" contextRef="as-of-2014-06-30.872.0.3840.4261.0.0.0.0" unitRef="USD" decimals="-3">6088000</us-gaap:PropertyPlantAndEquipmentGross>
  <us-gaap:PropertyPlantAndEquipmentGross id="PropertyPlantAndEquipmentGross.874.3840.4261.0.0.0.0" contextRef="as-of-2013-06-30.874.0.3840.4261.0.0.0.0" unitRef="USD" decimals="-3">5709000</us-gaap:PropertyPlantAndEquipmentGross>
  <us-gaap:PropertyPlantAndEquipmentGross id="PropertyPlantAndEquipmentGross.872.1163.4261.0.0.0.0" contextRef="as-of-2014-06-30.872.0.1163.4261.0.0.0.0" unitRef="USD" decimals="-3">708000</us-gaap:PropertyPlantAndEquipmentGross>
  <us-gaap:PropertyPlantAndEquipmentGross id="PropertyPlantAndEquipmentGross.874.1163.4261.0.0.0.0" contextRef="as-of-2013-06-30.874.0.1163.4261.0.0.0.0" unitRef="USD" decimals="-3">535000</us-gaap:PropertyPlantAndEquipmentGross>
  <us-gaap:PropertyPlantAndEquipmentGross id="PropertyPlantAndEquipmentGross.872.3650.4261.0.0.0.0" contextRef="as-of-2014-06-30.872.0.3650.4261.0.0.0.0" unitRef="USD" decimals="-3">611000</us-gaap:PropertyPlantAndEquipmentGross>
  <us-gaap:PropertyPlantAndEquipmentGross id="PropertyPlantAndEquipmentGross.874.3650.4261.0.0.0.0" contextRef="as-of-2013-06-30.874.0.3650.4261.0.0.0.0" unitRef="USD" decimals="-3">534000</us-gaap:PropertyPlantAndEquipmentGross>
  <us-gaap:PropertyPlantAndEquipmentGross id="PropertyPlantAndEquipmentGross.872.3017.4261.0.0.0.0" contextRef="as-of-2014-06-30.872.0.3017.4261.0.0.0.0" unitRef="USD" decimals="-3">7453000</us-gaap:PropertyPlantAndEquipmentGross>
  <us-gaap:PropertyPlantAndEquipmentGross id="PropertyPlantAndEquipmentGross.874.3017.4261.0.0.0.0" contextRef="as-of-2013-06-30.874.0.3017.4261.0.0.0.0" unitRef="USD" decimals="-3">7369000</us-gaap:PropertyPlantAndEquipmentGross>
  <us-gaap:PropertyPlantAndEquipmentGross id="PropertyPlantAndEquipmentGross.872.5488.4261.0.0.0.0" contextRef="as-of-2014-06-30.872.0.5488.4261.0.0.0.0" unitRef="USD" decimals="-3">95000</us-gaap:PropertyPlantAndEquipmentGross>
  <us-gaap:PropertyPlantAndEquipmentGross id="PropertyPlantAndEquipmentGross.874.5488.4261.0.0.0.0" contextRef="as-of-2013-06-30.874.0.5488.4261.0.0.0.0" unitRef="USD" decimals="-3">68000</us-gaap:PropertyPlantAndEquipmentGross>
  <us-gaap:PropertyPlantAndEquipmentGross id="PropertyPlantAndEquipmentGross.872.0.0.0.0.0.0" contextRef="as-of-2014-06-30.872.0.0.0.0.0.0.0" unitRef="USD" decimals="-3">14955000</us-gaap:PropertyPlantAndEquipmentGross>
  <us-gaap:PropertyPlantAndEquipmentGross id="PropertyPlantAndEquipmentGross.874.0.0.0.0.0.0" contextRef="as-of-2013-06-30.874.0.0.0.0.0.0.0" unitRef="USD" decimals="-3">14215000</us-gaap:PropertyPlantAndEquipmentGross>
  <us-gaap:PropertyPlantAndEquipmentNet id="PropertyPlantAndEquipmentNet.872.0.0.0.0.0.0" contextRef="as-of-2014-06-30.872.0.0.0.0.0.0.0" unitRef="USD" decimals="-3">10823000</us-gaap:PropertyPlantAndEquipmentNet>
  <us-gaap:PropertyPlantAndEquipmentNet id="PropertyPlantAndEquipmentNet.874.0.0.0.0.0.0" contextRef="as-of-2013-06-30.874.0.0.0.0.0.0.0" unitRef="USD" decimals="-3">11866000</us-gaap:PropertyPlantAndEquipmentNet>
  <us-gaap:PropertyPlantAndEquipmentPolicyTextBlock id="PropertyPlantAndEquipmentPolicyTextBlock.869.0.0.0.0.0.0" contextRef="from-2013-07-01-to-2014-06-30.869.0.0.0.0.0.0.0">&lt;!--DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd" --&gt;&lt;div&gt; &lt;div&gt;&lt;!--StartFragment--&gt; &lt;div&gt; &lt;table style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman" cellspacing="0" cellpadding="0" width="100%" align="center" border="0"&gt; &lt;tr valign="top"&gt; &lt;td style="WIDTH: 18pt"&gt; &lt;div style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt"&gt; j.&lt;/div&gt; &lt;/td&gt; &lt;td&gt; &lt;div style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; text-align: justify"&gt; Property and Equipment&lt;/div&gt; &lt;/td&gt; &lt;/tr&gt; &lt;/table&gt; &lt;/div&gt; &lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"&gt; &amp;nbsp;&lt;/div&gt; &lt;div&gt; &lt;table style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman" cellspacing="0" cellpadding="0" width="100%" align="center" border="0"&gt; &lt;tr valign="top"&gt; &lt;td style="WIDTH: 18pt"&gt; &lt;div style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/div&gt; &lt;/td&gt; &lt;td&gt; &lt;div style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; text-align: justify"&gt; Property and equipment are stated at cost, net of accumulated depreciation. Depreciation is calculated by the straight-line method over the estimated useful lives of the assets, at the following annual rates:&lt;/div&gt; &lt;/td&gt; &lt;/tr&gt; &lt;/table&gt; &lt;/div&gt; &lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"&gt; &amp;nbsp;&lt;/div&gt; &lt;div style="MARGIN-LEFT: 18pt; text-align: left"&gt; &lt;table style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman" cellspacing="0" cellpadding="0" width="80%"&gt; &lt;tr&gt; &lt;td valign="top" width="44%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 2px solid" valign="top" width="28%"&gt; &lt;div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt"&gt; %&lt;/div&gt; &lt;/td&gt; &lt;td valign="top" width="28%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr bgcolor="#cceeff"&gt; &lt;td valign="top" width="44%" align="left"&gt; &lt;div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"&gt; Laboratory equipment&lt;/div&gt; &lt;/td&gt; &lt;td valign="top" width="28%" align="left"&gt; &lt;div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: -12.3pt; text-align: left; TEXT-INDENT: 0pt"&gt; 10-15&lt;/div&gt; &lt;/td&gt; &lt;td valign="top" width="28%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr bgcolor="white"&gt; &lt;td valign="top" width="44%" align="left"&gt; &lt;div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"&gt; Computers and peripheral equipment&lt;/div&gt; &lt;/td&gt; &lt;td valign="top" width="28%" align="left"&gt; &lt;div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: -12.3pt; text-align: left; TEXT-INDENT: 0pt"&gt; 33&lt;/div&gt; &lt;/td&gt; &lt;td valign="top" width="28%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr bgcolor="#cceeff"&gt; &lt;td valign="top" width="44%" align="left"&gt; &lt;div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"&gt; Office furniture and equipment&lt;/div&gt; &lt;/td&gt; &lt;td valign="top" width="28%" align="left"&gt; &lt;div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: -12.3pt; text-align: left; TEXT-INDENT: 0pt"&gt; 6-15&lt;/div&gt; &lt;/td&gt; &lt;td valign="top" width="28%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr bgcolor="white"&gt; &lt;td valign="top" width="44%" align="left"&gt; &lt;div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"&gt; Vehicles&lt;/div&gt; &lt;/td&gt; &lt;td valign="top" width="15%" colspan="2" align="left"&gt; &lt;div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: -12.3pt; text-align: left; TEXT-INDENT: 0pt"&gt; 15&lt;/div&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr bgcolor="#cceeff"&gt; &lt;td valign="top" width="44%" align="left"&gt; &lt;div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"&gt; Leasehold improvements&lt;/div&gt; &lt;/td&gt; &lt;td valign="top" width="56%" colspan="2" align="left"&gt; &lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: -12.3pt; text-align: left; TEXT-INDENT: 0pt"&gt; &lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; The shorter of the expected&lt;/font&gt; &lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; useful life or the&lt;/font&gt;&lt;/div&gt; &lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: -12.3pt; text-align: left; TEXT-INDENT: 0pt"&gt; &lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; reasonable assumed&lt;/font&gt; &lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; term of the lease.&lt;/font&gt;&lt;/div&gt; &lt;/td&gt; &lt;/tr&gt; &lt;/table&gt; &lt;/div&gt; &lt;!--EndFragment--&gt;&lt;/div&gt; &lt;/div&gt;</us-gaap:PropertyPlantAndEquipmentPolicyTextBlock>
  <us-gaap:PropertyPlantAndEquipmentTextBlock id="PropertyPlantAndEquipmentTextBlock.869.0.0.0.0.0.0" contextRef="from-2013-07-01-to-2014-06-30.869.0.0.0.0.0.0.0">&lt;!--DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd" --&gt;&lt;div&gt; &lt;div&gt;&lt;!--StartFragment--&gt; &lt;div style="text-align: right"&gt; &lt;table style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman" cellspacing="0" cellpadding="0" width="97%"&gt; &lt;tr&gt; &lt;td style="PADDING-BOTTOM: 2px" valign="bottom" width="76%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-WEIGHT: bold; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="22%" colspan="6"&gt; &lt;div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"&gt; June 30,&lt;/div&gt; &lt;/td&gt; &lt;td style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-WEIGHT: bold; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td style="PADDING-BOTTOM: 2px" valign="bottom" width="76%" align="left"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-WEIGHT: bold; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="10%" colspan="2"&gt; &lt;div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"&gt; 2014&lt;/div&gt; &lt;/td&gt; &lt;td style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-WEIGHT: bold; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-WEIGHT: bold; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="10%" colspan="2"&gt; &lt;div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"&gt; 2013&lt;/div&gt; &lt;/td&gt; &lt;td style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-WEIGHT: bold; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr bgcolor="#cceeff"&gt; &lt;td valign="bottom" width="76%" align="left"&gt; &lt;div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"&gt; Cost:&lt;/div&gt; &lt;/td&gt; &lt;td valign="bottom" width="1%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td valign="bottom" width="10%" colspan="2"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td valign="bottom" width="1%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td valign="bottom" width="10%" colspan="2"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr bgcolor="white"&gt; &lt;td valign="bottom" width="76%" align="left"&gt; &lt;div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"&gt; Laboratory equipment&lt;/div&gt; &lt;/td&gt; &lt;td valign="bottom" width="1%" align="right"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%"&gt;$&lt;/td&gt; &lt;td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%"&gt;6,088&lt;/td&gt; &lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td valign="bottom" width="1%" align="right"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%"&gt;$&lt;/td&gt; &lt;td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%"&gt;5,709&lt;/td&gt; &lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr bgcolor="#cceeff"&gt; &lt;td valign="bottom" width="76%" align="left"&gt; &lt;div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"&gt; Computers and peripheral equipment&lt;/div&gt; &lt;/td&gt; &lt;td valign="bottom" width="1%" align="right"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%"&gt;708&lt;/td&gt; &lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td valign="bottom" width="1%" align="right"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%"&gt;535&lt;/td&gt; &lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr bgcolor="white"&gt; &lt;td valign="bottom" width="76%" align="left"&gt; &lt;div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"&gt; Office furniture and equipment&lt;/div&gt; &lt;/td&gt; &lt;td valign="bottom" width="1%" align="right"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%"&gt;611&lt;/td&gt; &lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td valign="bottom" width="1%" align="right"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%"&gt;534&lt;/td&gt; &lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr bgcolor="#cceeff"&gt; &lt;td valign="bottom" width="76%" align="left"&gt; &lt;div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"&gt; Leasehold improvements&lt;/div&gt; &lt;/td&gt; &lt;td valign="bottom" width="1%" align="right"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%"&gt;7,453&lt;/td&gt; &lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td valign="bottom" width="1%" align="right"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%"&gt;7,369&lt;/td&gt; &lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr bgcolor="white"&gt; &lt;td style="PADDING-BOTTOM: 2px" valign="bottom" width="76%" align="left"&gt; &lt;div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"&gt; Vehicles&lt;/div&gt; &lt;/td&gt; &lt;td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 2px solid; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%"&gt;95&lt;/td&gt; &lt;td style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 2px solid; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%"&gt;68&lt;/td&gt; &lt;td style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr bgcolor="#cceeff"&gt; &lt;td style="PADDING-BOTTOM: 2px" valign="bottom" width="76%" align="left"&gt; &lt;div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"&gt; &amp;nbsp;Total Cost&lt;/div&gt; &lt;/td&gt; &lt;td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 2px solid; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%"&gt;14,955&lt;/td&gt; &lt;td style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 2px solid; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%"&gt;14,215&lt;/td&gt; &lt;td style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr bgcolor="white"&gt; &lt;td valign="bottom" width="76%" align="left"&gt; &lt;div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"&gt; Accumulated depreciation:&lt;/div&gt; &lt;/td&gt; &lt;td valign="bottom" width="1%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td valign="bottom" width="1%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr bgcolor="#cceeff"&gt; &lt;td valign="bottom" width="76%" align="left"&gt; &lt;div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"&gt; Laboratory equipment&lt;/div&gt; &lt;/td&gt; &lt;td valign="bottom" width="1%" align="right"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%"&gt;2,042&lt;/td&gt; &lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td valign="bottom" width="1%" align="right"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%"&gt;1,306&lt;/td&gt; &lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr bgcolor="white"&gt; &lt;td valign="bottom" width="76%" align="left"&gt; &lt;div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"&gt; Computers and peripheral equipment&lt;/div&gt; &lt;/td&gt; &lt;td valign="bottom" width="1%" align="right"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%"&gt;430&lt;/td&gt; &lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td valign="bottom" width="1%" align="right"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%"&gt;280&lt;/td&gt; &lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr bgcolor="#cceeff"&gt; &lt;td valign="bottom" width="76%" align="left"&gt; &lt;div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"&gt; Office furniture and equipment&lt;/div&gt; &lt;/td&gt; &lt;td valign="bottom" width="1%" align="right"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%"&gt;176&lt;/td&gt; &lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td valign="bottom" width="1%" align="right"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%"&gt;91&lt;/td&gt; &lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr bgcolor="white"&gt; &lt;td valign="bottom" width="76%" align="left"&gt; &lt;div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"&gt; Leasehold improvements&lt;/div&gt; &lt;/td&gt; &lt;td valign="bottom" width="1%" align="right"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%"&gt;1,475&lt;/td&gt; &lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td valign="bottom" width="1%" align="right"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%"&gt;642&lt;/td&gt; &lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr bgcolor="#cceeff"&gt; &lt;td style="PADDING-BOTTOM: 2px" valign="bottom" width="76%" align="left"&gt; &lt;div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"&gt; Vehicles&lt;/div&gt; &lt;/td&gt; &lt;td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 2px solid; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%"&gt;9&lt;/td&gt; &lt;td style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 2px solid; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%"&gt;30&lt;/td&gt; &lt;td style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr bgcolor="white"&gt; &lt;td style="PADDING-BOTTOM: 2px" valign="bottom" width="76%" align="left"&gt; &lt;div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"&gt; &amp;nbsp;Total accumulated depreciation&lt;/div&gt; &lt;/td&gt; &lt;td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 2px solid; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%"&gt;4,132&lt;/td&gt; &lt;td style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 2px solid; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%"&gt;2,349&lt;/td&gt; &lt;td style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr bgcolor="#cceeff"&gt; &lt;td style="PADDING-BOTTOM: 4px" valign="bottom" width="76%" align="left"&gt; &lt;div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"&gt; Property and equipment, net&lt;/div&gt; &lt;/td&gt; &lt;td style="PADDING-BOTTOM: 4px" valign="bottom" width="1%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 4px double; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%"&gt;$&lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 4px double; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%"&gt;10,823&lt;/td&gt; &lt;td style="PADDING-BOTTOM: 4px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="PADDING-BOTTOM: 4px" valign="bottom" width="1%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 4px double; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%"&gt;$&lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 4px double; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%"&gt;11,866&lt;/td&gt; &lt;td style="PADDING-BOTTOM: 4px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;/tr&gt; &lt;/table&gt; &lt;/div&gt; &lt;!--EndFragment--&gt;&lt;/div&gt; &lt;/div&gt;</us-gaap:PropertyPlantAndEquipmentTextBlock>
  <us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax id="ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax.869.477.5114.0.0.0.0" contextRef="from-2013-07-01-to-2014-06-30.869.0.477.5114.0.0.0.0" unitRef="USD" decimals="-3">727000</us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax>
  <us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax id="ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax.869.484.5114.0.0.0.0" xsi:nil="true" contextRef="from-2013-07-01-to-2014-06-30.869.0.484.5114.0.0.0.0" unitRef="USD" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" />
  <us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax id="ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax.869.0.0.0.0.0.0" contextRef="from-2013-07-01-to-2014-06-30.869.0.0.0.0.0.0.0" unitRef="USD" decimals="-3">727000</us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax>
  <us-gaap:ReimbursementRevenue id="ReimbursementRevenue.869.0.0.0.0.0.0" contextRef="from-2013-07-01-to-2014-06-30.869.0.0.0.0.0.0.0" unitRef="USD" decimals="-3">10000000</us-gaap:ReimbursementRevenue>
  <us-gaap:ResearchAndDevelopmentExpense id="ResearchAndDevelopmentExpense.869.0.0.0.0.0.0" contextRef="from-2013-07-01-to-2014-06-30.869.0.0.0.0.0.0.0" unitRef="USD" decimals="-3">24938000</us-gaap:ResearchAndDevelopmentExpense>
  <us-gaap:ResearchAndDevelopmentExpense id="ResearchAndDevelopmentExpense.870.0.0.0.0.0.0" contextRef="from-2012-07-01-to-2013-06-30.870.0.0.0.0.0.0.0" unitRef="USD" decimals="-3">19906000</us-gaap:ResearchAndDevelopmentExpense>
  <us-gaap:ResearchAndDevelopmentExpense id="ResearchAndDevelopmentExpense.871.0.0.0.0.0.0" contextRef="from-2011-07-01-to-2012-06-30.871.0.0.0.0.0.0.0" unitRef="USD" decimals="-3">12685000</us-gaap:ResearchAndDevelopmentExpense>
  <us-gaap:RestrictedCashAndCashEquivalentsAtCarryingValue id="RestrictedCashAndCashEquivalentsAtCarryingValue.872.0.0.0.0.0.0" contextRef="as-of-2014-06-30.872.0.0.0.0.0.0.0" unitRef="USD" decimals="-3">4914000</us-gaap:RestrictedCashAndCashEquivalentsAtCarryingValue>
  <us-gaap:RestrictedCashAndCashEquivalentsAtCarryingValue id="RestrictedCashAndCashEquivalentsAtCarryingValue.874.0.0.0.0.0.0" contextRef="as-of-2013-06-30.874.0.0.0.0.0.0.0" unitRef="USD" decimals="-3">316000</us-gaap:RestrictedCashAndCashEquivalentsAtCarryingValue>
  <us-gaap:RetainedEarningsAccumulatedDeficit id="RetainedEarningsAccumulatedDeficit.872.0.0.0.0.0.0" contextRef="as-of-2014-06-30.872.0.0.0.0.0.0.0" unitRef="USD" decimals="-3">-113834000</us-gaap:RetainedEarningsAccumulatedDeficit>
  <us-gaap:RetainedEarningsAccumulatedDeficit id="RetainedEarningsAccumulatedDeficit.874.0.0.0.0.0.0" contextRef="as-of-2013-06-30.874.0.0.0.0.0.0.0" unitRef="USD" decimals="-3">-86902000</us-gaap:RetainedEarningsAccumulatedDeficit>
  <us-gaap:RevenueFromGrants id="RevenueFromGrants.890.0.0.0.0.0.0" contextRef="from-2011-08-01-to-2011-08-31.890.0.0.0.0.0.0.0" unitRef="USD" decimals="-3">5000000</us-gaap:RevenueFromGrants>
  <us-gaap:RevenueRecognitionPolicyTextBlock id="RevenueRecognitionPolicyTextBlock.869.0.0.0.0.0.0" contextRef="from-2013-07-01-to-2014-06-30.869.0.0.0.0.0.0.0">&lt;!--DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd" --&gt;&lt;div&gt; &lt;div&gt;&lt;!--StartFragment--&gt; &lt;div style="text-align: center"&gt; &lt;table style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman" cellspacing="0" cellpadding="0" width="100%" border="0"&gt; &lt;tr valign="top"&gt; &lt;td style="WIDTH: 18pt"&gt; &lt;div style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt"&gt; i.&lt;/div&gt; &lt;/td&gt; &lt;td&gt; &lt;div style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; text-align: justify"&gt; Revenue Recognition from the license Agreement with United Therapeutics&lt;/div&gt; &lt;/td&gt; &lt;/tr&gt; &lt;/table&gt; &lt;/div&gt; &lt;div style="DISPLAY: block; MARGIN-LEFT: 437pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"&gt; &amp;nbsp;&lt;/div&gt; &lt;div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"&gt; The Company recognizes revenue pursuant to the License Agreement with United Therapeutics in accordance with ASC 605-25, "Revenue Recognition, Multiple-Element Arrangements".&lt;/div&gt; &lt;div style="MARGIN-LEFT: 437pt; DISPLAY: block; TEXT-INDENT: 0pt"&gt; &lt;br /&gt; &lt;/div&gt; &lt;div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"&gt; Pursuant to ASC 605-25, each deliverable is evaluated to determine whether it qualifies as a separate unit of accounting based on whether the deliverable has "stand-alone value" to the customer. The arrangement&amp;#39;s consideration that is fixed or determinable is then allocated to each separate unit of accounting based on the relative selling price of each deliverable. In general, the consideration allocated to each unit of accounting is recognized as the related goods or services are delivered, limited to the consideration that is not contingent upon future deliverables.&lt;/div&gt; &lt;div style="MARGIN-LEFT: 437pt; DISPLAY: block; TEXT-INDENT: 0pt"&gt; &lt;br /&gt; &lt;/div&gt; &lt;div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"&gt; The Company received an up-front, non-refundable license payment of $5,000. Additional payments totaling $37,500 are subject to the achievement of certain regulatory milestones by United Therapeutics.&lt;/div&gt; &lt;div style="MARGIN-LEFT: 437pt; DISPLAY: block; TEXT-INDENT: 0pt"&gt; &lt;br /&gt; &lt;/div&gt; &lt;div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"&gt; Since the deliverables in the United Agreement do not have stand-alone value, none of them qualifies as a separate unit of accounting. Accordingly, the non-refundable upfront license fee of $5,000 is deferred and recognized on a straight line basis over the related performance period which is the development period in accordance with Staff Accounting Bulletin ("SAB") 104, "Revenue Recognition". The remaining performance period is 8.5 years as of June 30, 2014.&lt;/div&gt; &lt;div style="MARGIN-LEFT: 437pt; DISPLAY: block; TEXT-INDENT: 0pt"&gt; &lt;br /&gt; &lt;/div&gt; &lt;div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"&gt; The additional regulatory milestones payments will be recognized upon the achievement of futures events by United Therapeutics, in accordance with ASC 450-30-25, "Gain Contingencies". As of June 30, 2014, no regulatory millstones were achieved.&lt;/div&gt; &lt;div style="MARGIN-LEFT: 437pt; DISPLAY: block; TEXT-INDENT: 0pt"&gt; &lt;br /&gt; &lt;/div&gt; &lt;div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"&gt; The Company also received an advanced payment for the development, of $2,000 that will be deductible against development expenses as it incurred. The upfront payment which was received and has not yet fully recognized in the statement of operations, is included in the balance sheet as advance payment. Part of the expenses related to the development, on a cost basis, shall be repaid to the Company by United Therapeutics according to the applicable license agreement. The Company is deducting the payments from its research and development expenses in accordance with ASC 730-20, "Research and Development Agreements". As of June 30, 2014, the Company deducted an amount of approximately $1,753.&lt;/div&gt; &lt;!--EndFragment--&gt;&lt;/div&gt; &lt;/div&gt;</us-gaap:RevenueRecognitionPolicyTextBlock>
  <us-gaap:Revenues id="Revenues.869.0.0.0.0.0.0" contextRef="from-2013-07-01-to-2014-06-30.869.0.0.0.0.0.0.0" unitRef="USD" decimals="-3">379000</us-gaap:Revenues>
  <us-gaap:Revenues id="Revenues.870.0.0.0.0.0.0" contextRef="from-2012-07-01-to-2013-06-30.870.0.0.0.0.0.0.0" unitRef="USD" decimals="-3">679000</us-gaap:Revenues>
  <us-gaap:Revenues id="Revenues.871.0.0.0.0.0.0" contextRef="from-2011-07-01-to-2012-06-30.871.0.0.0.0.0.0.0" unitRef="USD" decimals="-3">716000</us-gaap:Revenues>
  <us-gaap:RoyaltyGuaranteesCommitmentsAmount id="RoyaltyGuaranteesCommitmentsAmount.872.0.0.0.0.0.0" contextRef="as-of-2014-06-30.872.0.0.0.0.0.0.0" unitRef="USD" decimals="-3">14072000</us-gaap:RoyaltyGuaranteesCommitmentsAmount>
  <us-gaap:ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock id="ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock.869.0.0.0.0.0.0" contextRef="from-2013-07-01-to-2014-06-30.869.0.0.0.0.0.0.0">&lt;!--DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd" --&gt;&lt;div&gt; &lt;div&gt;&lt;!--StartFragment--&gt; &lt;div style="text-align: right"&gt; &lt;table style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman" cellspacing="0" cellpadding="0" width="97%"&gt; &lt;tr&gt; &lt;td style="PADDING-BOTTOM: 2px" valign="bottom" width="76%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-WEIGHT: bold; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="22%" colspan="6"&gt; &lt;div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"&gt; June 30,&lt;/div&gt; &lt;/td&gt; &lt;td style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-WEIGHT: bold; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="PADDING-BOTTOM: 2px" valign="bottom"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td style="PADDING-BOTTOM: 2px" valign="bottom" width="76%" align="left"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-WEIGHT: bold; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="10%" colspan="2"&gt; &lt;div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"&gt; 2014&lt;/div&gt; &lt;/td&gt; &lt;td style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-WEIGHT: bold; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-WEIGHT: bold; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="11%" colspan="4"&gt; &lt;div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"&gt; 2013&lt;/div&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr bgcolor="#cceeff"&gt; &lt;td valign="bottom" width="76%" align="left"&gt; &lt;div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"&gt; Accrued payroll&lt;/div&gt; &lt;/td&gt; &lt;td valign="bottom" width="1%" align="right"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%"&gt;$&lt;/td&gt; &lt;td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%"&gt;424&lt;/td&gt; &lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td valign="bottom" width="1%" align="right"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%"&gt;$&lt;/td&gt; &lt;td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%"&gt;353&lt;/td&gt; &lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr bgcolor="white"&gt; &lt;td valign="bottom" width="76%" align="left"&gt; &lt;div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"&gt; Payroll institutions&lt;/div&gt; &lt;/td&gt; &lt;td valign="bottom" width="1%" align="right"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%"&gt;302&lt;/td&gt; &lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td valign="bottom" width="1%" align="right"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%"&gt;324&lt;/td&gt; &lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr bgcolor="#cceeff"&gt; &lt;td valign="bottom" width="76%" align="left"&gt; &lt;div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"&gt; Accrued vacation&lt;/div&gt; &lt;/td&gt; &lt;td valign="bottom" width="1%" align="right"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%"&gt;673&lt;/td&gt; &lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td valign="bottom" width="1%" align="right"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%"&gt;506&lt;/td&gt; &lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr bgcolor="white"&gt; &lt;td valign="bottom" width="76%" align="left"&gt; &lt;div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"&gt; Advanced payment from lessor&lt;/div&gt; &lt;/td&gt; &lt;td valign="bottom" width="1%" align="right"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%"&gt;89&lt;/td&gt; &lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td valign="bottom" width="1%" align="right"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%"&gt;89&lt;/td&gt; &lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr bgcolor="#cceeff"&gt; &lt;td valign="bottom" width="76%" align="left"&gt; &lt;div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"&gt; Derivatives designated as a fair value hedge instruments&lt;/div&gt; &lt;/td&gt; &lt;td valign="bottom" width="1%" align="right"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%"&gt;889&lt;/td&gt; &lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td valign="bottom" width="1%" align="right"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%"&gt;-&lt;/td&gt; &lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr bgcolor="white"&gt; &lt;td style="PADDING-BOTTOM: 2px" valign="bottom" width="76%" align="left"&gt; &lt;div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"&gt; Other payables&lt;/div&gt; &lt;/td&gt; &lt;td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%" align="right"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 2px solid; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%"&gt;14&lt;/td&gt; &lt;td style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%" align="right"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 2px solid; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%"&gt;-&lt;/td&gt; &lt;td style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr bgcolor="#cceeff"&gt; &lt;td style="PADDING-BOTTOM: 2px" valign="bottom" width="76%" align="left"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 2px solid; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%"&gt;$&lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 2px solid; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%"&gt;2,391&lt;/td&gt; &lt;td style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 2px solid; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%"&gt;$&lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 2px solid; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%"&gt;1,272&lt;/td&gt; &lt;td style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;/tr&gt; &lt;/table&gt; &lt;/div&gt; &lt;!--EndFragment--&gt;&lt;/div&gt; &lt;/div&gt;</us-gaap:ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock>
  <us-gaap:ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock id="ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock.869.0.0.0.0.0.0" contextRef="from-2013-07-01-to-2014-06-30.869.0.0.0.0.0.0.0">&lt;!--DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd" --&gt;&lt;div&gt; &lt;div&gt;&lt;!--StartFragment--&gt; &lt;div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"&gt; The Company determined that its items of other comprehensive income relate to gains and losses on cash flow hedging derivative instruments and unrealized gains and losses on available for sale marketable securities.&lt;/div&gt; &lt;div style="DISPLAY: block; TEXT-INDENT: 0pt"&gt;&amp;nbsp;&lt;/div&gt; &lt;div style="text-align: right"&gt; &lt;table style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman" cellspacing="0" cellpadding="0" width="97%"&gt; &lt;tr&gt; &lt;td style="PADDING-BOTTOM: 2px" valign="bottom" width="64%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="34%" colspan="10"&gt; &lt;div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"&gt; Year ended June 30, 2014&lt;/div&gt; &lt;/td&gt; &lt;td style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td style="PADDING-BOTTOM: 2px" valign="bottom" width="64%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="10%" colspan="2"&gt; &lt;div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"&gt; Unrealized&lt;/div&gt; &lt;div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"&gt; gains&lt;/div&gt; &lt;div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"&gt; on marketable&lt;/div&gt; &lt;div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"&gt; securities&lt;/div&gt; &lt;/td&gt; &lt;td style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="10%" colspan="2"&gt; &lt;div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"&gt; Unrealized&lt;/div&gt; &lt;div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"&gt; gains&lt;/div&gt; &lt;div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"&gt; on cash flow&lt;/div&gt; &lt;div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"&gt; hedges&lt;/div&gt; &lt;/td&gt; &lt;td style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="10%" colspan="2"&gt; &lt;div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"&gt; Total&lt;/div&gt; &lt;/td&gt; &lt;td style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr bgcolor="#cceeff"&gt; &lt;td style="TEXT-ALIGN: left; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt" valign="bottom" width="64%"&gt; &lt;div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: left; TEXT-INDENT: 0pt"&gt; Beginning balance&lt;/div&gt; &lt;/td&gt; &lt;td valign="bottom" width="1%" align="right"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%"&gt;$&lt;/td&gt; &lt;td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%"&gt;259&lt;/td&gt; &lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td valign="bottom" width="1%" align="right"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%"&gt;$&lt;/td&gt; &lt;td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%"&gt;-&lt;/td&gt; &lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td valign="bottom" width="1%" align="right"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%"&gt;$&lt;/td&gt; &lt;td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%"&gt;259&lt;/td&gt; &lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr bgcolor="white"&gt; &lt;td style="TEXT-ALIGN: left; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt" valign="bottom" width="64%"&gt; &lt;div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: left; TEXT-INDENT: 0pt"&gt; Other comprehensive income before reclassifications&lt;/div&gt; &lt;/td&gt; &lt;td valign="bottom" width="1%" align="right"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%"&gt;3,404&lt;/td&gt; &lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td valign="bottom" width="1%" align="right"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%"&gt;23&lt;/td&gt; &lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td valign="bottom" width="1%" align="right"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%"&gt;3,427&lt;/td&gt; &lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr bgcolor="#cceeff"&gt; &lt;td style="TEXT-ALIGN: left; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt" valign="bottom" width="64%"&gt; &lt;div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: left; TEXT-INDENT: 0pt"&gt; Amounts reclassified from accumulated other comprehensive loss&lt;/div&gt; &lt;/td&gt; &lt;td valign="bottom" width="1%" align="right"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%"&gt;(727&lt;/td&gt; &lt;td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"&gt;)&lt;/td&gt; &lt;td valign="bottom" width="1%" align="right"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%"&gt;-&lt;/td&gt; &lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td valign="bottom" width="1%" align="right"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%"&gt;(727&lt;/td&gt; &lt;td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"&gt;)&lt;/td&gt; &lt;/tr&gt; &lt;tr bgcolor="white"&gt; &lt;td style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt" valign="bottom" width="64%"&gt; &lt;div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: left; TEXT-INDENT: 0pt"&gt; Net current-period other comprehensive income&lt;/div&gt; &lt;/td&gt; &lt;td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%" align="right"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 2px solid; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%"&gt;2,677&lt;/td&gt; &lt;td style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%" align="right"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 2px solid; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%"&gt;23&lt;/td&gt; &lt;td style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%" align="right"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 2px solid; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%"&gt;2,700&lt;/td&gt; &lt;td style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr bgcolor="#cceeff"&gt; &lt;td style="PADDING-BOTTOM: 4px; TEXT-ALIGN: left; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt" valign="bottom" width="64%"&gt; &lt;div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: left; TEXT-INDENT: 0pt"&gt; Ending balance&lt;/div&gt; &lt;/td&gt; &lt;td style="PADDING-BOTTOM: 4px" valign="bottom" width="1%" align="right"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 4px double; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%"&gt;$&lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 4px double; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%"&gt;2,936&lt;/td&gt; &lt;td style="PADDING-BOTTOM: 4px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="PADDING-BOTTOM: 4px" valign="bottom" width="1%" align="right"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 4px double; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%"&gt;$&lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 4px double; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%"&gt;23&lt;/td&gt; &lt;td style="PADDING-BOTTOM: 4px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="PADDING-BOTTOM: 4px" valign="bottom" width="1%" align="right"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 4px double; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%"&gt;$&lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 4px double; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%"&gt;2,959&lt;/td&gt; &lt;td style="PADDING-BOTTOM: 4px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;/tr&gt; &lt;/table&gt; &lt;/div&gt; &lt;!--EndFragment--&gt;&lt;/div&gt; &lt;/div&gt;</us-gaap:ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock>
  <us-gaap:ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock id="ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock.869.0.0.0.0.0.0" contextRef="from-2013-07-01-to-2014-06-30.869.0.0.0.0.0.0.0">&lt;!--DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd" --&gt;&lt;div&gt; &lt;div&gt;&lt;!--StartFragment--&gt; &lt;div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; MARGIN-LEFT: 27pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"&gt; Deferred income taxes reflect the net tax effects of temporary differences between the carrying amounts of assets and liabilities for financial reporting purposes and the amounts used for income tax purposes. Significant components of the Company&amp;#39;s deferred tax assets are as follows:&lt;/div&gt; &lt;div style="DISPLAY: block; TEXT-INDENT: 0pt"&gt;&lt;br /&gt; &lt;/div&gt; &lt;div style="text-align: right"&gt; &lt;table style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman" cellspacing="0" cellpadding="0" width="95%"&gt; &lt;tr&gt; &lt;td style="PADDING-BOTTOM: 2px" valign="bottom" width="76%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-WEIGHT: bold; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="22%" colspan="6"&gt; &lt;div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"&gt; June 30,&lt;/div&gt; &lt;/td&gt; &lt;td style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-WEIGHT: bold; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td style="PADDING-BOTTOM: 2px" valign="bottom" width="76%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-WEIGHT: bold; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="10%" colspan="2"&gt; &lt;div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: -18pt"&gt; 2014&lt;/div&gt; &lt;/td&gt; &lt;td style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-WEIGHT: bold; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-WEIGHT: bold; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="10%" colspan="2"&gt; &lt;div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: -18pt"&gt; 2013&lt;/div&gt; &lt;/td&gt; &lt;td style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-WEIGHT: bold; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr bgcolor="#cceeff"&gt; &lt;td valign="bottom" width="76%" align="left"&gt; &lt;div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 9pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: -9pt"&gt; Deferred tax assets:&lt;/div&gt; &lt;/td&gt; &lt;td valign="bottom" width="1%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td valign="bottom" width="10%" colspan="2"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td valign="bottom" width="1%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td valign="bottom" width="10%" colspan="2"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr bgcolor="white"&gt; &lt;td valign="bottom" width="76%" align="left"&gt; &lt;div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: -9pt"&gt; U.S. net operating loss carryforward&lt;/div&gt; &lt;/td&gt; &lt;td valign="bottom" width="1%" align="right"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%"&gt;$&lt;/td&gt; &lt;td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%"&gt;7,955&lt;/td&gt; &lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td valign="bottom" width="1%" align="right"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%"&gt;$&lt;/td&gt; &lt;td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%"&gt;7,106&lt;/td&gt; &lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr bgcolor="#cceeff"&gt; &lt;td valign="bottom" width="76%"&gt; &lt;div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: -9pt"&gt; Israeli net operating loss carryforward&lt;/div&gt; &lt;/td&gt; &lt;td valign="bottom" width="1%" align="right"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%"&gt;12,810&lt;/td&gt; &lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td valign="bottom" width="1%" align="right"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%"&gt;8,543&lt;/td&gt; &lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr bgcolor="white"&gt; &lt;td style="PADDING-BOTTOM: 2px" valign="bottom" width="76%"&gt; &lt;div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: -9pt"&gt; Allowances and reserves&lt;/div&gt; &lt;/td&gt; &lt;td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%" align="right"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 2px solid; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%"&gt;237&lt;/td&gt; &lt;td style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%" align="right"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 2px solid; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%"&gt;156&lt;/td&gt; &lt;td style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr bgcolor="#cceeff"&gt; &lt;td valign="bottom" width="76%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td valign="bottom" width="1%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td valign="bottom" width="1%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr bgcolor="white"&gt; &lt;td valign="bottom" width="76%"&gt; &lt;div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 9pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: -9pt"&gt; Total deferred tax assets before valuation allowance&lt;/div&gt; &lt;/td&gt; &lt;td valign="bottom" width="1%" align="right"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%"&gt;21,002&lt;/td&gt; &lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td valign="bottom" width="1%" align="right"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%"&gt;15,805&lt;/td&gt; &lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr bgcolor="#cceeff"&gt; &lt;td style="PADDING-BOTTOM: 2px" valign="bottom" width="76%"&gt; &lt;div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 9pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: -9pt"&gt; Valuation allowance&lt;/div&gt; &lt;/td&gt; &lt;td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%" align="right"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 2px solid; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%"&gt;(21,002&lt;/td&gt; &lt;td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"&gt;)&lt;/td&gt; &lt;td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%" align="right"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 2px solid; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%"&gt;(15,805&lt;/td&gt; &lt;td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"&gt;)&lt;/td&gt; &lt;/tr&gt; &lt;tr bgcolor="white"&gt; &lt;td valign="bottom" width="76%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td valign="bottom" width="1%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td valign="bottom" width="1%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr bgcolor="#cceeff"&gt; &lt;td style="PADDING-BOTTOM: 4px" valign="bottom" width="76%"&gt; &lt;div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 9pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: -9pt"&gt; Net deferred tax asset&lt;/div&gt; &lt;/td&gt; &lt;td style="PADDING-BOTTOM: 4px" valign="bottom" width="1%" align="right"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 4px double; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%"&gt;$&lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 4px double; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%"&gt;-&lt;/td&gt; &lt;td style="PADDING-BOTTOM: 4px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="PADDING-BOTTOM: 4px" valign="bottom" width="1%" align="right"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 4px double; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%"&gt;$&lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 4px double; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%"&gt;-&lt;/td&gt; &lt;td style="PADDING-BOTTOM: 4px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;/tr&gt; &lt;/table&gt; &lt;/div&gt; &lt;!--EndFragment--&gt;&lt;/div&gt; &lt;/div&gt;</us-gaap:ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock>
  <us-gaap:ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock id="ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock.869.0.0.0.0.0.0" contextRef="from-2013-07-01-to-2014-06-30.869.0.0.0.0.0.0.0">&lt;!--DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd" --&gt;&lt;div&gt; &lt;div&gt;&lt;!--StartFragment--&gt; &lt;div style="text-align: right"&gt; &lt;table style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman" cellspacing="0" cellpadding="0" width="97%"&gt; &lt;tr&gt; &lt;td style="PADDING-BOTTOM: 2px" valign="bottom" width="49%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="26%" colspan="4"&gt; &lt;div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"&gt; June 30, 2014&lt;/div&gt; &lt;/td&gt; &lt;td style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-WEIGHT: bold; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-WEIGHT: bold; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="22%" colspan="6"&gt; &lt;div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"&gt; June 30, 2013&lt;/div&gt; &lt;/td&gt; &lt;td style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-WEIGHT: bold; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td style="PADDING-BOTTOM: 2px" valign="bottom" width="49%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="15%"&gt; &lt;div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"&gt; Balance Sheet location&lt;/div&gt; &lt;/td&gt; &lt;td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-WEIGHT: bold; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="10%" colspan="2"&gt; &lt;div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"&gt; Fair Value&lt;/div&gt; &lt;/td&gt; &lt;td style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-WEIGHT: bold; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-WEIGHT: bold; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="10%" colspan="2"&gt; &lt;div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"&gt; Balance Sheet location&lt;/div&gt; &lt;/td&gt; &lt;td style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-WEIGHT: bold; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-WEIGHT: bold; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="10%" colspan="2"&gt; &lt;div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"&gt; Fair Value&lt;/div&gt; &lt;/td&gt; &lt;td style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-WEIGHT: bold; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr bgcolor="#cceeff"&gt; &lt;td style="TEXT-ALIGN: left; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt" valign="bottom" width="49%"&gt; &lt;div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: left; TEXT-INDENT: 0pt"&gt; Derivatives designated as cash flow hedge instruments&lt;/div&gt; &lt;/td&gt; &lt;td valign="bottom" width="15%"&gt; &lt;div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 1.6pt; text-align: center; TEXT-INDENT: 0pt"&gt; Other current assets&lt;/div&gt; &lt;/td&gt; &lt;td valign="bottom" width="1%" align="right"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%"&gt;$&lt;/td&gt; &lt;td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%"&gt;24&lt;/td&gt; &lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td valign="bottom" width="1%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%"&gt;-&lt;/td&gt; &lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td valign="bottom" width="1%" align="left"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%"&gt;$&lt;/td&gt; &lt;td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%"&gt;-&lt;/td&gt; &lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr bgcolor="white"&gt; &lt;td style="TEXT-ALIGN: left; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt" valign="bottom" width="49%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td valign="bottom" width="15%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td valign="bottom" width="1%" align="right"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td valign="bottom" width="1%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td valign="bottom" width="10%" colspan="2"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td valign="bottom" width="1%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr bgcolor="#cceeff"&gt; &lt;td style="TEXT-ALIGN: left; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt" valign="bottom" width="49%"&gt; &lt;div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: left; TEXT-INDENT: 0pt"&gt; Derivatives not designated as hedge instruments&lt;/div&gt; &lt;/td&gt; &lt;td valign="bottom" width="15%"&gt; &lt;div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 1.6pt; text-align: center; TEXT-INDENT: 0pt"&gt; Other current assets&lt;/div&gt; &lt;/td&gt; &lt;td valign="bottom" width="1%" align="right"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%"&gt;23&lt;/td&gt; &lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td valign="bottom" width="1%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td valign="bottom" width="10%" colspan="2"&gt; &lt;div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"&gt; Other current assets&lt;/div&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td valign="bottom" width="1%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%"&gt;93&lt;/td&gt; &lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr bgcolor="white"&gt; &lt;td style="TEXT-ALIGN: left; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt" valign="bottom" width="49%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td valign="bottom" width="15%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td valign="bottom" width="1%" align="right"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td valign="bottom" width="1%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td valign="bottom" width="1%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr bgcolor="#cceeff"&gt; &lt;td style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt" valign="bottom" width="49%"&gt; &lt;div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: left; TEXT-INDENT: 0pt"&gt; Derivatives designated as fair value hedge instruments&lt;/div&gt; &lt;/td&gt; &lt;td style="PADDING-BOTTOM: 2px" valign="bottom" width="15%"&gt; &lt;div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 1.6pt; text-align: center; TEXT-INDENT: 0pt"&gt; Other current liabilities&lt;/div&gt; &lt;/td&gt; &lt;td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%" align="right"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 2px solid; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%"&gt;(889&lt;/td&gt; &lt;td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"&gt;)&lt;/td&gt; &lt;td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; PADDING-BOTTOM: 2px; TEXT-ALIGN: right" valign="bottom" width="9%"&gt;-&lt;/td&gt; &lt;td style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 2px solid; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%"&gt;-&lt;/td&gt; &lt;td style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr bgcolor="white"&gt; &lt;td style="TEXT-ALIGN: left; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt" valign="bottom" width="49%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td valign="bottom" width="15%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td valign="bottom" width="1%" align="right"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td valign="bottom" width="1%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td valign="bottom" width="1%" align="left"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr bgcolor="#cceeff"&gt; &lt;td style="PADDING-BOTTOM: 4px; TEXT-ALIGN: left; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt" valign="bottom" width="49%"&gt; &lt;div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: left; TEXT-INDENT: 0pt"&gt; Total&lt;/div&gt; &lt;/td&gt; &lt;td style="PADDING-BOTTOM: 4px" valign="bottom" width="15%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="PADDING-BOTTOM: 4px" valign="bottom" width="1%" align="right"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 4px double; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%"&gt;$&lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 4px double; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%"&gt;(842&lt;/td&gt; &lt;td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; PADDING-BOTTOM: 4px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"&gt;)&lt;/td&gt; &lt;td style="PADDING-BOTTOM: 4px" valign="bottom" width="1%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="PADDING-BOTTOM: 4px; TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="PADDING-BOTTOM: 4px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="PADDING-BOTTOM: 4px" valign="bottom" width="1%" align="left"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 4px double; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%"&gt;$&lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 4px double; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%"&gt;93&lt;/td&gt; &lt;td style="PADDING-BOTTOM: 4px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;/tr&gt; &lt;/table&gt; &lt;/div&gt; &lt;!--EndFragment--&gt;&lt;/div&gt; &lt;/div&gt;</us-gaap:ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock>
  <us-gaap:ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock id="ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock.869.25537.367.0.0.0.0" contextRef="from-2013-07-01-to-2014-06-30.869.0.25537.367.0.0.0.0">&lt;!--DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd" --&gt;&lt;div&gt; &lt;div&gt;&lt;!--StartFragment--&gt; &lt;div&gt; &lt;table style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman" cellspacing="0" cellpadding="0" width="100%" align="center" border="0"&gt; &lt;tr valign="top"&gt; &lt;td style="WIDTH: 18pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td width="1837"&gt; &lt;div style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; text-align: justify"&gt; Compensation expenses related to options and warrants granted to consultants were recorded as follows:&lt;/div&gt; &lt;/td&gt; &lt;/tr&gt; &lt;/table&gt; &lt;/div&gt; &lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"&gt; &amp;nbsp;&lt;/div&gt; &lt;div style="MARGIN-LEFT: 36pt; text-align: left"&gt; &lt;table style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman" cellspacing="0" cellpadding="0" width="80%"&gt; &lt;tr&gt; &lt;td style="PADDING-BOTTOM: 2px" valign="bottom" width="64%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-WEIGHT: bold; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="34%" colspan="10"&gt; &lt;div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"&gt; Year ended&amp;nbsp;June 30,&lt;/div&gt; &lt;/td&gt; &lt;td style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-WEIGHT: bold; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td style="PADDING-BOTTOM: 2px" valign="bottom" width="64%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-WEIGHT: bold; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="10%" colspan="2"&gt; &lt;div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"&gt; 2014&lt;/div&gt; &lt;/td&gt; &lt;td style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-WEIGHT: bold; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-WEIGHT: bold; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="10%" colspan="2"&gt; &lt;div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"&gt; 2013&lt;/div&gt; &lt;/td&gt; &lt;td style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-WEIGHT: bold; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-WEIGHT: bold; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="10%" colspan="2"&gt; &lt;div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"&gt; 2012&lt;/div&gt; &lt;/td&gt; &lt;td style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-WEIGHT: bold; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr bgcolor="white"&gt; &lt;td style="TEXT-ALIGN: left; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt" valign="bottom" width="64%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td valign="bottom" width="1%" align="right"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td valign="bottom" width="1%" align="right"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td valign="bottom" width="1%" align="right"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr bgcolor="#cceeff"&gt; &lt;td style="TEXT-ALIGN: left; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt" valign="bottom" width="64%"&gt; &lt;div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: left; TEXT-INDENT: 0pt"&gt; Research and development expenses&lt;/div&gt; &lt;/td&gt; &lt;td valign="bottom" width="1%" align="right"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%"&gt;$&lt;/td&gt; &lt;td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%"&gt;11&lt;/td&gt; &lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td valign="bottom" width="1%" align="right"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%"&gt;$&lt;/td&gt; &lt;td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%"&gt;26&lt;/td&gt; &lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td valign="bottom" width="1%" align="right"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%"&gt;$&lt;/td&gt; &lt;td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%"&gt;19&lt;/td&gt; &lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr bgcolor="white"&gt; &lt;td style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt" valign="bottom" width="64%"&gt; &lt;div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: left; TEXT-INDENT: 0pt"&gt; General and administrative expenses&lt;/div&gt; &lt;/td&gt; &lt;td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%" align="right"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 2px solid; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%"&gt;-&lt;/td&gt; &lt;td style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%" align="right"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 2px solid; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%"&gt;37&lt;/td&gt; &lt;td style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr bgcolor="#cceeff"&gt; &lt;td style="PADDING-BOTTOM: 4px" valign="bottom" width="64%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="PADDING-BOTTOM: 4px" valign="bottom" width="1%" align="right"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 4px double; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%"&gt;$&lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 4px double; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%"&gt;11&lt;/td&gt; &lt;td style="PADDING-BOTTOM: 4px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="PADDING-BOTTOM: 4px" valign="bottom" width="1%" align="right"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 4px double; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%"&gt;$&lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 4px double; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%"&gt;26&lt;/td&gt; &lt;td style="PADDING-BOTTOM: 4px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="PADDING-BOTTOM: 4px" valign="bottom" width="1%" align="right"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 4px double; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%"&gt;$&lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 4px double; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%"&gt;56&lt;/td&gt; &lt;td style="PADDING-BOTTOM: 4px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;/tr&gt; &lt;/table&gt; &lt;/div&gt; &lt;!--EndFragment--&gt;&lt;/div&gt; &lt;/div&gt;</us-gaap:ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock>
  <us-gaap:ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock id="ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock.869.4568.367.0.0.0.0" contextRef="from-2013-07-01-to-2014-06-30.869.0.4568.367.0.0.0.0">&lt;!--DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd" --&gt;&lt;div&gt; &lt;div&gt;&lt;!--StartFragment--&gt; &lt;div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"&gt; Compensation expenses related to restricted stock units granted to employees and directors were recorded as follows:&lt;/div&gt; &lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"&gt; &amp;nbsp;&lt;/div&gt; &lt;div style="MARGIN-LEFT: 36pt; text-align: left"&gt; &lt;table style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman" cellspacing="0" cellpadding="0" width="80%"&gt; &lt;tr&gt; &lt;td style="PADDING-BOTTOM: 2px" valign="bottom" width="64%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-WEIGHT: bold; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="34%" colspan="10"&gt; &lt;div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"&gt; Year ended&amp;nbsp;June 30,&lt;/div&gt; &lt;/td&gt; &lt;td style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-WEIGHT: bold; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="PADDING-BOTTOM: 2px" valign="bottom"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td style="PADDING-BOTTOM: 2px" valign="bottom" width="64%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-WEIGHT: bold; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="10%" colspan="2"&gt; &lt;div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"&gt; 2014&lt;/div&gt; &lt;/td&gt; &lt;td style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-WEIGHT: bold; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-WEIGHT: bold; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="10%" colspan="2"&gt; &lt;div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"&gt; 2013&lt;/div&gt; &lt;/td&gt; &lt;td style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-WEIGHT: bold; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-WEIGHT: bold; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="11%" colspan="4"&gt; &lt;div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"&gt; 2012&lt;/div&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr bgcolor="#cceeff"&gt; &lt;td style="TEXT-ALIGN: left; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt" valign="bottom" width="64%"&gt; &lt;div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: left; TEXT-INDENT: 0pt"&gt; Research and development expenses&lt;/div&gt; &lt;/td&gt; &lt;td valign="bottom" width="1%" align="right"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%"&gt;$&lt;/td&gt; &lt;td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%"&gt;1,172&lt;/td&gt; &lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td valign="bottom" width="1%" align="right"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%"&gt;$&lt;/td&gt; &lt;td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%"&gt;711&lt;/td&gt; &lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td valign="bottom" width="1%" align="right"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%"&gt;$&lt;/td&gt; &lt;td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%"&gt;1,163&lt;/td&gt; &lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr bgcolor="white"&gt; &lt;td style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt" valign="bottom" width="64%"&gt; &lt;div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: left; TEXT-INDENT: 0pt"&gt; General and administrative expenses&lt;/div&gt; &lt;/td&gt; &lt;td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%" align="right"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 2px solid; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%"&gt;4,390&lt;/td&gt; &lt;td style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%" align="right"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 2px solid; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%"&gt;1,529&lt;/td&gt; &lt;td style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%" align="right"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 2px solid; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%"&gt;3,487&lt;/td&gt; &lt;td style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr bgcolor="#cceeff"&gt; &lt;td style="PADDING-BOTTOM: 4px" valign="bottom" width="64%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="PADDING-BOTTOM: 4px" valign="bottom" width="1%" align="right"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 4px double; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%"&gt;$&lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 4px double; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%"&gt;5,562&lt;/td&gt; &lt;td style="PADDING-BOTTOM: 4px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="PADDING-BOTTOM: 4px" valign="bottom" width="1%" align="right"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 4px double; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%"&gt;$&lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 4px double; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%"&gt;2,240&lt;/td&gt; &lt;td style="PADDING-BOTTOM: 4px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="PADDING-BOTTOM: 4px" valign="bottom" width="1%" align="right"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 4px double; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%"&gt;$&lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 4px double; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%"&gt;4,650&lt;/td&gt; &lt;td style="PADDING-BOTTOM: 4px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;/tr&gt; &lt;/table&gt; &lt;/div&gt; &lt;!--EndFragment--&gt;&lt;/div&gt; &lt;/div&gt;</us-gaap:ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock>
  <us-gaap:ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock id="ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock.869.25534.367.0.0.0.0" contextRef="from-2013-07-01-to-2014-06-30.869.0.25534.367.0.0.0.0">&lt;!--DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd" --&gt;&lt;div&gt; &lt;div&gt;&lt;!--StartFragment--&gt; &lt;div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: left; TEXT-INDENT: 0pt"&gt; Compensation expenses related to restricted stock units granted to consultants were recorded as follows:&lt;/div&gt; &lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"&gt; &amp;nbsp;&lt;/div&gt; &lt;div style="MARGIN-LEFT: 18pt; text-align: left"&gt; &lt;table style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman" cellspacing="0" cellpadding="0" width="80%"&gt; &lt;tr&gt; &lt;td style="PADDING-BOTTOM: 2px" valign="bottom" width="64%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-WEIGHT: bold; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="34%" colspan="10"&gt; &lt;div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"&gt; Year ended&amp;nbsp;June 30,&lt;/div&gt; &lt;/td&gt; &lt;td style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-WEIGHT: bold; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td style="PADDING-BOTTOM: 2px" valign="bottom" width="64%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-WEIGHT: bold; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="10%" colspan="2"&gt; &lt;div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"&gt; 2014&lt;/div&gt; &lt;/td&gt; &lt;td style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-WEIGHT: bold; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-WEIGHT: bold; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="10%" colspan="2"&gt; &lt;div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"&gt; 2013&lt;/div&gt; &lt;/td&gt; &lt;td style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-WEIGHT: bold; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-WEIGHT: bold; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="10%" colspan="2"&gt; &lt;div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"&gt; 2012&lt;/div&gt; &lt;/td&gt; &lt;td style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-WEIGHT: bold; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr bgcolor="#cceeff"&gt; &lt;td style="TEXT-ALIGN: left; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt" valign="bottom" width="64%"&gt; &lt;div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: left; TEXT-INDENT: 0pt"&gt; Research and development expenses&lt;/div&gt; &lt;/td&gt; &lt;td valign="bottom" width="1%" align="right"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%"&gt;$&lt;/td&gt; &lt;td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%"&gt;201&lt;/td&gt; &lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td valign="bottom" width="1%" align="right"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%"&gt;$&lt;/td&gt; &lt;td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%"&gt;255&lt;/td&gt; &lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td valign="bottom" width="1%" align="right"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%"&gt;$&lt;/td&gt; &lt;td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%"&gt;201&lt;/td&gt; &lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr bgcolor="white"&gt; &lt;td style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt" valign="bottom" width="64%"&gt; &lt;div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: left; TEXT-INDENT: 0pt"&gt; General and administrative expenses&lt;/div&gt; &lt;/td&gt; &lt;td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%" align="right"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 2px solid; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%"&gt;77&lt;/td&gt; &lt;td style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%" align="right"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 2px solid; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%"&gt;278&lt;/td&gt; &lt;td style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%" align="right"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 2px solid; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%"&gt;20&lt;/td&gt; &lt;td style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr bgcolor="#cceeff"&gt; &lt;td style="PADDING-BOTTOM: 4px" valign="bottom" width="64%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="PADDING-BOTTOM: 4px" valign="bottom" width="1%" align="right"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 4px double; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%"&gt;$&lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 4px double; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%"&gt;278&lt;/td&gt; &lt;td style="PADDING-BOTTOM: 4px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="PADDING-BOTTOM: 4px" valign="bottom" width="1%" align="right"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 4px double; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%"&gt;$&lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 4px double; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%"&gt;533&lt;/td&gt; &lt;td style="PADDING-BOTTOM: 4px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="PADDING-BOTTOM: 4px" valign="bottom" width="1%" align="right"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 4px double; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%"&gt;$&lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 4px double; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%"&gt;221&lt;/td&gt; &lt;td style="PADDING-BOTTOM: 4px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;/tr&gt; &lt;/table&gt; &lt;/div&gt; &lt;!--EndFragment--&gt;&lt;/div&gt; &lt;/div&gt;</us-gaap:ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock>
  <us-gaap:ScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesTableTextBlock id="ScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesTableTextBlock.869.3008.4261.0.0.0.0" contextRef="from-2013-07-01-to-2014-06-30.869.0.3008.4261.0.0.0.0">&lt;!--DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd" --&gt;&lt;div&gt; &lt;div&gt;&lt;!--StartFragment--&gt; &lt;div style="text-align: center"&gt; &lt;table style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman" cellspacing="0" cellpadding="0" width="100%" border="0"&gt; &lt;tr valign="top"&gt; &lt;td&gt; &lt;div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-ALIGN: justify; TEXT-INDENT: 0pt"&gt; As of June&amp;nbsp;30, 2014 aggregate minimum lease commitments under non-cancelable operating lease agreements are as follows:&lt;/div&gt; &lt;/td&gt; &lt;/tr&gt; &lt;/table&gt; &lt;/div&gt; &lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"&gt; &amp;nbsp;&lt;/div&gt; &lt;div style="MARGIN-LEFT: 18pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-ALIGN: left; TEXT-INDENT: 0pt"&gt; &lt;table style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman" cellspacing="0" cellpadding="0" width="50%"&gt; &lt;tr bgcolor="#cceeff"&gt; &lt;td valign="bottom" width="88%" align="left"&gt; &lt;div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 9pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: -9pt"&gt; Year ending June 30,&lt;/div&gt; &lt;/td&gt; &lt;td valign="bottom" width="1%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td valign="bottom" width="10%" colspan="2"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr bgcolor="white"&gt; &lt;td valign="bottom" width="88%" align="left"&gt; &lt;div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 9pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: -9pt"&gt; 2015&lt;/div&gt; &lt;/td&gt; &lt;td valign="bottom" width="1%" align="right"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%"&gt;$&lt;/td&gt; &lt;td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%"&gt;667&lt;/td&gt; &lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr bgcolor="#cceeff"&gt; &lt;td valign="bottom" width="88%" align="left"&gt; &lt;div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 9pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: -9pt"&gt; 2016&lt;/div&gt; &lt;/td&gt; &lt;td valign="bottom" width="1%" align="right"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%"&gt;497&lt;/td&gt; &lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr bgcolor="white"&gt; &lt;td style="PADDING-BOTTOM: 2px" valign="bottom" width="88%" align="left"&gt; &lt;div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 9pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: -9pt"&gt; 2017&lt;/div&gt; &lt;/td&gt; &lt;td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%" align="right"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 2px solid; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%"&gt;349&lt;/td&gt; &lt;td style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr bgcolor="#cceeff"&gt; &lt;td style="PADDING-BOTTOM: 4px" valign="bottom" width="88%" align="left"&gt; &lt;div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 9pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: -9pt"&gt; Total&lt;/div&gt; &lt;/td&gt; &lt;td style="PADDING-BOTTOM: 4px" valign="bottom" width="1%" align="right"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 4px double; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%"&gt;$&lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 4px double; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%"&gt;1,513&lt;/td&gt; &lt;td style="PADDING-BOTTOM: 4px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;/tr&gt; &lt;/table&gt; &lt;/div&gt; &lt;!--EndFragment--&gt;&lt;/div&gt; &lt;/div&gt;</us-gaap:ScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesTableTextBlock>
  <us-gaap:ScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesTableTextBlock id="ScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesTableTextBlock.869.395.4261.0.0.0.0" contextRef="from-2013-07-01-to-2014-06-30.869.0.395.4261.0.0.0.0">&lt;!--DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd" --&gt;&lt;div&gt; &lt;div&gt;&lt;!--StartFragment--&gt; &lt;div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"&gt; As of June&amp;nbsp;30, 2014, future aggregate minimum lease commitments under non-cancelable operating lease agreements are as follows:&lt;/div&gt; &lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"&gt; &amp;nbsp;&lt;/div&gt; &lt;div style="MARGIN-LEFT: 18pt; text-align: left"&gt; &lt;table style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman" cellspacing="0" cellpadding="0" width="50%"&gt; &lt;tr bgcolor="#cceeff"&gt; &lt;td valign="bottom" width="88%" align="left"&gt; &lt;div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"&gt; Year ending June 30,&lt;/div&gt; &lt;/td&gt; &lt;td valign="bottom" width="1%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td valign="bottom" width="10%" colspan="2"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr bgcolor="white"&gt; &lt;td valign="bottom" width="88%" align="left"&gt; &lt;div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"&gt; 2015&lt;/div&gt; &lt;/td&gt; &lt;td valign="bottom" width="1%" align="right"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%"&gt;$&lt;/td&gt; &lt;td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%"&gt;140&lt;/td&gt; &lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr bgcolor="#cceeff"&gt; &lt;td valign="bottom" width="88%" align="left"&gt; &lt;div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"&gt; 2016&lt;/div&gt; &lt;/td&gt; &lt;td valign="bottom" width="1%" align="right"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%"&gt;85&lt;/td&gt; &lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr bgcolor="white"&gt; &lt;td style="PADDING-BOTTOM: 2px" valign="bottom" width="88%" align="left"&gt; &lt;div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"&gt; 2017&lt;/div&gt; &lt;/td&gt; &lt;td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%" align="right"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 2px solid; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%"&gt;26&lt;/td&gt; &lt;td style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr bgcolor="#cceeff"&gt; &lt;td style="PADDING-BOTTOM: 2px" valign="bottom" width="88%" align="left"&gt; &lt;div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"&gt; Total&lt;/div&gt; &lt;/td&gt; &lt;td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%" align="right"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 2px solid; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%"&gt;$&lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 2px solid; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%"&gt;251&lt;/td&gt; &lt;td style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;/tr&gt; &lt;/table&gt; &lt;/div&gt; &lt;!--EndFragment--&gt;&lt;/div&gt; &lt;/div&gt;</us-gaap:ScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesTableTextBlock>
  <us-gaap:ScheduleOfNonvestedRestrictedStockUnitsActivityTableTextBlock id="ScheduleOfNonvestedRestrictedStockUnitsActivityTableTextBlock.869.4568.367.0.0.0.0" contextRef="from-2013-07-01-to-2014-06-30.869.0.4568.367.0.0.0.0">&lt;!--DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd" --&gt;&lt;div&gt; &lt;div&gt;&lt;!--StartFragment--&gt; &lt;div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"&gt; The following table summarizes the activities for unvested restricted stock units granted to employees and directors for the year ended June 30, 2014:&lt;/div&gt; &lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"&gt; &amp;nbsp;&lt;/div&gt; &lt;div style="text-align: center"&gt; &lt;table style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman" cellspacing="0" cellpadding="0" width="60%"&gt; &lt;tr&gt; &lt;td style="PADDING-BOTTOM: 2px" valign="bottom" width="88%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-WEIGHT: bold; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="10%" colspan="2"&gt; &lt;div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"&gt; Number&lt;/div&gt; &lt;/td&gt; &lt;td style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-WEIGHT: bold; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr bgcolor="white"&gt; &lt;td style="TEXT-ALIGN: left; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt" valign="bottom" width="88%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td valign="bottom" width="1%" align="right"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr bgcolor="#cceeff"&gt; &lt;td style="TEXT-ALIGN: left; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt" valign="bottom" width="88%"&gt; &lt;div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: left; TEXT-INDENT: 0pt"&gt; Unvested at the beginning of period&lt;/div&gt; &lt;/td&gt; &lt;td valign="bottom" width="1%" align="right"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%"&gt;1,660,525&lt;/td&gt; &lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr bgcolor="white"&gt; &lt;td style="TEXT-ALIGN: left; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt" valign="bottom" width="88%"&gt; &lt;div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: left; TEXT-INDENT: 0pt"&gt; Granted&lt;/div&gt; &lt;/td&gt; &lt;td valign="bottom" width="1%" align="right"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%"&gt;1,256,940&lt;/td&gt; &lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr bgcolor="#cceeff"&gt; &lt;td style="TEXT-ALIGN: left; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt" valign="bottom" width="88%"&gt; &lt;div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: left; TEXT-INDENT: 0pt"&gt; Forfeited&lt;/div&gt; &lt;/td&gt; &lt;td valign="bottom" width="1%" align="right"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%"&gt;(44,183&lt;/td&gt; &lt;td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"&gt;)&lt;/td&gt; &lt;/tr&gt; &lt;tr bgcolor="white"&gt; &lt;td style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt" valign="bottom" width="88%"&gt; &lt;div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: left; TEXT-INDENT: 0pt"&gt; Vested&lt;/div&gt; &lt;/td&gt; &lt;td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 2px solid; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%"&gt;(1,283,850&lt;/td&gt; &lt;td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"&gt;)&lt;/td&gt; &lt;/tr&gt; &lt;tr bgcolor="#cceeff"&gt; &lt;td style="PADDING-BOTTOM: 4px; TEXT-ALIGN: left; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt" valign="bottom" width="88%"&gt; &lt;div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: left; TEXT-INDENT: 0pt"&gt; Unvested at the end of the period&lt;/div&gt; &lt;/td&gt; &lt;td style="PADDING-BOTTOM: 4px" valign="bottom" width="1%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 4px double; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%"&gt;1,589,432&lt;/td&gt; &lt;td style="PADDING-BOTTOM: 4px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr bgcolor="white"&gt; &lt;td style="PADDING-BOTTOM: 4px; TEXT-ALIGN: left; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt" valign="bottom" width="88%"&gt; &lt;div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: left; TEXT-INDENT: 0pt"&gt; Expected to vest after June 30, 2014&lt;/div&gt; &lt;/td&gt; &lt;td style="PADDING-BOTTOM: 4px" valign="bottom" width="1%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 4px double; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%"&gt;1,522,024&lt;/td&gt; &lt;td style="PADDING-BOTTOM: 4px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;/tr&gt; &lt;/table&gt; &lt;/div&gt; &lt;!--EndFragment--&gt;&lt;/div&gt; &lt;/div&gt;</us-gaap:ScheduleOfNonvestedRestrictedStockUnitsActivityTableTextBlock>
  <us-gaap:ScheduleOfNonvestedRestrictedStockUnitsActivityTableTextBlock id="ScheduleOfNonvestedRestrictedStockUnitsActivityTableTextBlock.869.25534.367.0.0.0.0" contextRef="from-2013-07-01-to-2014-06-30.869.0.25534.367.0.0.0.0">&lt;!--DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd" --&gt;&lt;div&gt; &lt;div&gt;&lt;!--StartFragment--&gt; &lt;div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"&gt; The following table summarizes the activities for unvested restricted stock units and restricted stock granted to consultants for the year ended June 30, 2014:&lt;/div&gt; &lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"&gt; &amp;nbsp;&lt;/div&gt; &lt;div style="MARGIN-LEFT: 18pt; text-align: left"&gt; &lt;table style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman" cellspacing="0" cellpadding="0" width="50%"&gt; &lt;tr&gt; &lt;td style="PADDING-BOTTOM: 2px" valign="bottom" width="84%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-WEIGHT: bold; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="14%" colspan="2"&gt; &lt;div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"&gt; Number&lt;/div&gt; &lt;/td&gt; &lt;td style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-WEIGHT: bold; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr bgcolor="#cceeff"&gt; &lt;td style="TEXT-ALIGN: left; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt" valign="bottom" width="84%"&gt; &lt;div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: left; TEXT-INDENT: 0pt"&gt; Unvested at the beginning of period&lt;/div&gt; &lt;/td&gt; &lt;td valign="bottom" width="1%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="13%"&gt;-&lt;/td&gt; &lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr bgcolor="white"&gt; &lt;td style="TEXT-ALIGN: left; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt" valign="bottom" width="84%"&gt; &lt;div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: left; TEXT-INDENT: 0pt"&gt; Granted&lt;/div&gt; &lt;/td&gt; &lt;td valign="bottom" width="1%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="13%"&gt;84,565&lt;/td&gt; &lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr bgcolor="#cceeff"&gt; &lt;td style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt" valign="bottom" width="84%"&gt; &lt;div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: left; TEXT-INDENT: 0pt"&gt; Vested&lt;/div&gt; &lt;/td&gt; &lt;td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 2px solid; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="13%"&gt;(69,315&lt;/td&gt; &lt;td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"&gt;)&lt;/td&gt; &lt;/tr&gt; &lt;tr bgcolor="white"&gt; &lt;td style="PADDING-BOTTOM: 4px; TEXT-ALIGN: left; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt" valign="bottom" width="84%"&gt; &lt;div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: left; TEXT-INDENT: 0pt"&gt; Unvested at the end of the period&lt;/div&gt; &lt;/td&gt; &lt;td style="PADDING-BOTTOM: 4px" valign="bottom" width="1%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 4px double; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="13%"&gt;15,250&lt;/td&gt; &lt;td style="PADDING-BOTTOM: 4px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;/tr&gt; &lt;/table&gt; &lt;/div&gt; &lt;!--EndFragment--&gt;&lt;/div&gt; &lt;/div&gt;</us-gaap:ScheduleOfNonvestedRestrictedStockUnitsActivityTableTextBlock>
  <us-gaap:ScheduleOfOtherNonoperatingIncomeExpenseTableTextBlock id="ScheduleOfOtherNonoperatingIncomeExpenseTableTextBlock.869.0.0.0.0.0.0" contextRef="from-2013-07-01-to-2014-06-30.869.0.0.0.0.0.0.0">&lt;!--DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd" --&gt;&lt;div&gt; &lt;div&gt;&lt;!--StartFragment--&gt; &lt;div style="text-align: left"&gt; &lt;table style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman" cellspacing="0" cellpadding="0" width="80%"&gt; &lt;tr&gt; &lt;td style="PADDING-BOTTOM: 2px" valign="bottom" width="64%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-WEIGHT: bold; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="34%" colspan="10"&gt; &lt;div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: -9pt"&gt; Year ended June 30,&lt;/div&gt; &lt;/td&gt; &lt;td style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-WEIGHT: bold; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td style="PADDING-BOTTOM: 2px" valign="bottom" width="64%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%" align="right"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-WEIGHT: bold; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: center; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt" valign="bottom" width="10%" colspan="2"&gt; &lt;div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: center; TEXT-INDENT: 0pt"&gt; 2014&lt;/div&gt; &lt;/td&gt; &lt;td style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-WEIGHT: bold; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%" align="right"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-WEIGHT: bold; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: center; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt" valign="bottom" width="10%" colspan="2"&gt; &lt;div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: center; TEXT-INDENT: 0pt"&gt; 2013&lt;/div&gt; &lt;/td&gt; &lt;td style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-WEIGHT: bold; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-WEIGHT: bold; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="10%" colspan="2"&gt; &lt;div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 7.45pt; text-align: center; TEXT-INDENT: 0pt"&gt; 2012&lt;/div&gt; &lt;/td&gt; &lt;td style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-WEIGHT: bold; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td valign="bottom" width="64%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td valign="bottom" width="1%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td valign="bottom" width="10%" colspan="2"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td valign="bottom" width="1%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td valign="bottom" width="10%" colspan="2"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td valign="bottom" width="1%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td valign="bottom" width="10%" colspan="2"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr bgcolor="#cceeff"&gt; &lt;td style="TEXT-ALIGN: left; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt" valign="bottom" width="64%"&gt; &lt;div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: left; TEXT-INDENT: 0pt"&gt; Foreign currency translation differences, net&lt;/div&gt; &lt;/td&gt; &lt;td valign="bottom" width="1%" align="right"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%"&gt;$&lt;/td&gt; &lt;td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%"&gt;407&lt;/td&gt; &lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td valign="bottom" width="1%" align="right"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%"&gt;$&lt;/td&gt; &lt;td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%"&gt;497&lt;/td&gt; &lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td valign="bottom" width="1%" align="right"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%"&gt;$&lt;/td&gt; &lt;td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%"&gt;(98&lt;/td&gt; &lt;td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"&gt;)&lt;/td&gt; &lt;/tr&gt; &lt;tr bgcolor="white"&gt; &lt;td valign="bottom" width="64%" align="left"&gt; &lt;div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 9pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: -9pt"&gt; Bank commissions&lt;/div&gt; &lt;/td&gt; &lt;td valign="bottom" width="1%" align="right"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%"&gt;(36&lt;/td&gt; &lt;td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"&gt;)&lt;/td&gt; &lt;td valign="bottom" width="1%" align="right"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%"&gt;(29&lt;/td&gt; &lt;td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"&gt;)&lt;/td&gt; &lt;td valign="bottom" width="1%" align="right"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%"&gt;(12&lt;/td&gt; &lt;td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"&gt;)&lt;/td&gt; &lt;/tr&gt; &lt;tr bgcolor="#cceeff"&gt; &lt;td valign="bottom" width="64%" align="left"&gt; &lt;div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 9pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: -9pt"&gt; Interest income on deposits&lt;/div&gt; &lt;/td&gt; &lt;td valign="bottom" width="1%" align="right"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%"&gt;246&lt;/td&gt; &lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td valign="bottom" width="1%" align="right"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%"&gt;539&lt;/td&gt; &lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td valign="bottom" width="1%" align="right"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%"&gt;575&lt;/td&gt; &lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr bgcolor="white"&gt; &lt;td valign="bottom" width="64%" align="left"&gt; &lt;div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 9pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: -9pt"&gt; Gain (Loss) related to marketable securities&lt;/div&gt; &lt;/td&gt; &lt;td valign="bottom" width="1%" align="right"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%"&gt;384&lt;/td&gt; &lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td valign="bottom" width="1%" align="right"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%"&gt;(79&lt;/td&gt; &lt;td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"&gt;)&lt;/td&gt; &lt;td valign="bottom" width="1%" align="right"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%"&gt;89&lt;/td&gt; &lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr bgcolor="#cceeff"&gt; &lt;td style="PADDING-BOTTOM: 2px" valign="bottom" width="64%" align="left"&gt; &lt;div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 9pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: -9pt"&gt; Gain (loss) from&amp;nbsp;&amp;nbsp;derivatives&lt;/div&gt; &lt;/td&gt; &lt;td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%" align="right"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 2px solid; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%"&gt;(83&lt;/td&gt; &lt;td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"&gt;)&lt;/td&gt; &lt;td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%" align="right"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 2px solid; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%"&gt;140&lt;/td&gt; &lt;td style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%" align="right"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 2px solid; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%"&gt;(317&lt;/td&gt; &lt;td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"&gt;)&lt;/td&gt; &lt;/tr&gt; &lt;tr bgcolor="white"&gt; &lt;td valign="bottom" width="64%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td valign="bottom" width="1%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td valign="bottom" width="1%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td valign="bottom" width="1%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr bgcolor="#cceeff"&gt; &lt;td style="PADDING-BOTTOM: 4px" valign="bottom" width="64%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="PADDING-BOTTOM: 4px" valign="bottom" width="1%" align="right"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 4px double; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%"&gt;$&lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 4px double; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%"&gt;918&lt;/td&gt; &lt;td style="PADDING-BOTTOM: 4px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="PADDING-BOTTOM: 4px" valign="bottom" width="1%" align="right"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 4px double; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%"&gt;$&lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 4px double; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%"&gt;1,068&lt;/td&gt; &lt;td style="PADDING-BOTTOM: 4px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="PADDING-BOTTOM: 4px" valign="bottom" width="1%" align="right"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 4px double; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%"&gt;$&lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 4px double; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%"&gt;237&lt;/td&gt; &lt;td style="PADDING-BOTTOM: 4px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;/tr&gt; &lt;/table&gt; &lt;/div&gt; &lt;!--EndFragment--&gt;&lt;/div&gt; &lt;/div&gt;</us-gaap:ScheduleOfOtherNonoperatingIncomeExpenseTableTextBlock>
  <us-gaap:ScheduleOfShareBasedCompensationActivityTableTextBlock id="ScheduleOfShareBasedCompensationActivityTableTextBlock.869.0.0.0.0.0.0" contextRef="from-2013-07-01-to-2014-06-30.869.0.0.0.0.0.0.0">&lt;!--DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd" --&gt;&lt;div&gt; &lt;div&gt;&lt;!--StartFragment--&gt; &lt;div&gt; &lt;table style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman" cellspacing="0" cellpadding="0" width="100%" align="center" border="0"&gt; &lt;tr valign="top"&gt; &lt;td style="WIDTH: 18pt"&gt;&amp;nbsp;&lt;/td&gt; &lt;td&gt; &lt;div style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; text-align: left"&gt; A summary of the Company&amp;#39;s activity related to options and warrants to consultants is as follows:&lt;/div&gt; &lt;/td&gt; &lt;/tr&gt; &lt;/table&gt; &lt;/div&gt; &lt;div&gt;&amp;nbsp;&lt;/div&gt; &lt;div style="text-align: right"&gt; &lt;table style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman" cellspacing="0" cellpadding="0" width="97%"&gt; &lt;tr&gt; &lt;td style="PADDING-BOTTOM: 2px" valign="bottom" width="52%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-WEIGHT: bold; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="46%" colspan="14"&gt; &lt;div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"&gt; Year ended&amp;nbsp;June 30, 2014&lt;/div&gt; &lt;/td&gt; &lt;td style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-WEIGHT: bold; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td style="PADDING-BOTTOM: 2px" valign="bottom" width="52%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-WEIGHT: bold; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="10%" colspan="2"&gt; &lt;div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"&gt; Number&lt;/div&gt; &lt;/td&gt; &lt;td style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-WEIGHT: bold; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-WEIGHT: bold; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="10%" colspan="2"&gt; &lt;div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"&gt; Weighted Average Exercise Price&lt;/div&gt; &lt;/td&gt; &lt;td style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-WEIGHT: bold; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-WEIGHT: bold; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="10%" colspan="2"&gt; &lt;div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"&gt; Weighted Average Remaining Contractual Terms (in years)&lt;/div&gt; &lt;/td&gt; &lt;td style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-WEIGHT: bold; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-WEIGHT: bold; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="10%" colspan="2"&gt; &lt;div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"&gt; Aggregate Intrinsic Value Price&lt;/div&gt; &lt;/td&gt; &lt;td style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-WEIGHT: bold; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr bgcolor="#cceeff"&gt; &lt;td style="TEXT-ALIGN: left; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt" valign="bottom" width="52%"&gt; &lt;div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: left; TEXT-INDENT: 0pt"&gt; Options and warrants outstanding at beginning of period&lt;/div&gt; &lt;/td&gt; &lt;td valign="bottom" width="1%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%"&gt;315,500&lt;/td&gt; &lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td valign="bottom" width="1%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%"&gt;$&lt;/td&gt; &lt;td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%"&gt;4.44&lt;/td&gt; &lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td valign="bottom" width="1%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td valign="bottom" width="10%" colspan="2"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td valign="bottom" width="1%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td valign="bottom" width="10%" colspan="2"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr bgcolor="white"&gt; &lt;td style="TEXT-ALIGN: left; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt" valign="bottom" width="52%"&gt; &lt;div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: left; TEXT-INDENT: 0pt"&gt; Options granted&lt;/div&gt; &lt;/td&gt; &lt;td valign="bottom" width="1%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%"&gt;3,000&lt;/td&gt; &lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td valign="bottom" width="1%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%"&gt;$&lt;/td&gt; &lt;td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%"&gt;0.00&lt;/td&gt; &lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td valign="bottom" width="1%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td valign="bottom" width="10%" colspan="2"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td valign="bottom" width="1%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td valign="bottom" width="10%" colspan="2"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr bgcolor="#cceeff"&gt; &lt;td style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt" valign="bottom" width="52%"&gt; &lt;div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: left; TEXT-INDENT: 0pt"&gt; Options and warrants exercised&lt;/div&gt; &lt;/td&gt; &lt;td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 2px solid; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%"&gt;(66,500&lt;/td&gt; &lt;td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"&gt;)&lt;/td&gt; &lt;td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 2px solid; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%"&gt;$&lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 2px solid; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%"&gt;1.39&lt;/td&gt; &lt;td style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="PADDING-BOTTOM: 2px" valign="bottom" width="10%" colspan="2"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="PADDING-BOTTOM: 2px" valign="bottom" width="10%" colspan="2"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr bgcolor="white"&gt; &lt;td style="PADDING-BOTTOM: 4px; TEXT-ALIGN: left; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt" valign="bottom" width="52%"&gt; &lt;div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: left; TEXT-INDENT: 0pt"&gt; Options and warrants outstanding at end of the period&lt;/div&gt; &lt;/td&gt; &lt;td style="PADDING-BOTTOM: 4px" valign="bottom" width="1%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 4px double; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%"&gt;252,000&lt;/td&gt; &lt;td style="PADDING-BOTTOM: 4px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="PADDING-BOTTOM: 4px" valign="bottom" width="1%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 4px double; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%"&gt;$&lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 4px double; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%"&gt;5.19&lt;/td&gt; &lt;td style="PADDING-BOTTOM: 4px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="PADDING-BOTTOM: 4px" valign="bottom" width="1%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 4px double; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%"&gt;3.96&lt;/td&gt; &lt;td style="PADDING-BOTTOM: 4px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="PADDING-BOTTOM: 4px" valign="bottom" width="1%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 4px double; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%"&gt;$&lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 4px double; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%"&gt;331&lt;/td&gt; &lt;td style="PADDING-BOTTOM: 4px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr bgcolor="#cceeff"&gt; &lt;td style="PADDING-BOTTOM: 4px; TEXT-ALIGN: left; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt" valign="bottom" width="52%"&gt; &lt;div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: left; TEXT-INDENT: 0pt"&gt; Options and warrants exercisable at the end of the period&lt;/div&gt; &lt;/td&gt; &lt;td style="PADDING-BOTTOM: 4px" valign="bottom" width="1%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 4px double; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%"&gt;251,000&lt;/td&gt; &lt;td style="PADDING-BOTTOM: 4px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="PADDING-BOTTOM: 4px" valign="bottom" width="1%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 4px double; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%"&gt;$&lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 4px double; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%"&gt;5.21&lt;/td&gt; &lt;td style="PADDING-BOTTOM: 4px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="PADDING-BOTTOM: 4px" valign="bottom" width="1%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 4px double; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%"&gt;3.93&lt;/td&gt; &lt;td style="PADDING-BOTTOM: 4px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="PADDING-BOTTOM: 4px" valign="bottom" width="1%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 4px double; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%"&gt;$&lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 4px double; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%"&gt;328&lt;/td&gt; &lt;td style="PADDING-BOTTOM: 4px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr bgcolor="white"&gt; &lt;td style="PADDING-BOTTOM: 4px; TEXT-ALIGN: left; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt" valign="bottom" width="52%"&gt; &lt;div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: left; TEXT-INDENT: 0pt"&gt; Options and warrants vested&amp;nbsp;&amp;nbsp;and expected to vest&lt;/div&gt; &lt;/td&gt; &lt;td style="PADDING-BOTTOM: 4px" valign="bottom" width="1%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 4px double; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%"&gt;252,000&lt;/td&gt; &lt;td style="PADDING-BOTTOM: 4px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="PADDING-BOTTOM: 4px" valign="bottom" width="1%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 4px double; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%"&gt;$&lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 4px double; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%"&gt;5.19&lt;/td&gt; &lt;td style="PADDING-BOTTOM: 4px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="PADDING-BOTTOM: 4px" valign="bottom" width="1%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 4px double; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%"&gt;3.96&lt;/td&gt; &lt;td style="PADDING-BOTTOM: 4px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="PADDING-BOTTOM: 4px" valign="bottom" width="1%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 4px double; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%"&gt;$&lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 4px double; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%"&gt;331&lt;/td&gt; &lt;td style="PADDING-BOTTOM: 4px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;/tr&gt; &lt;/table&gt; &lt;/div&gt; &lt;!--EndFragment--&gt;&lt;/div&gt; &lt;/div&gt;</us-gaap:ScheduleOfShareBasedCompensationActivityTableTextBlock>
  <us-gaap:ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTextBlock id="ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTextBlock.869.0.0.0.0.0.0" contextRef="from-2013-07-01-to-2014-06-30.869.0.0.0.0.0.0.0">&lt;!--DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd" --&gt;&lt;div&gt; &lt;div&gt;&lt;!--StartFragment--&gt; &lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"&gt; &lt;div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"&gt; The following table sets forth a summary of all the warrants and options outstanding as of June 30, 2014:&lt;/div&gt; &lt;div style="DISPLAY: block; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"&gt; &amp;nbsp;&lt;/div&gt; &lt;/div&gt; &lt;div style="text-align: left"&gt; &lt;table style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman" cellspacing="0" cellpadding="0" width="100%"&gt; &lt;tr&gt; &lt;td style="BORDER-BOTTOM: black 2px solid" valign="bottom"&gt; &lt;div style="MARGIN-LEFT: 0pt; DISPLAY: block; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt"&gt; &lt;div style="DISPLAY: block; TEXT-INDENT: 0pt"&gt;&amp;nbsp;&lt;/div&gt; &lt;div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"&gt; Warrants / Options&lt;/div&gt; &lt;/div&gt; &lt;/td&gt; &lt;td style="PADDING-BOTTOM: 2px" valign="bottom"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 2px solid" valign="bottom" colspan="2"&gt; &lt;div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"&gt; &lt;font style="FONT-WEIGHT: bold; DISPLAY: inline"&gt;Exercise Price&lt;/font&gt; &lt;font style="FONT-WEIGHT: bold; DISPLAY: inline"&gt;per Share&lt;/font&gt;&lt;/div&gt; &lt;/td&gt; &lt;td style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="PADDING-BOTTOM: 2px" valign="bottom"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-WEIGHT: bold; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 2px solid" valign="bottom" colspan="2"&gt; &lt;div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"&gt; Options and Warrants for Common Stock&lt;/div&gt; &lt;/td&gt; &lt;td style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-WEIGHT: bold; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="PADDING-BOTTOM: 2px" valign="bottom"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 2px solid" valign="bottom" colspan="2"&gt; &lt;div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"&gt; &lt;font style="FONT-WEIGHT: bold; DISPLAY: inline"&gt;Options and Warrants&lt;/font&gt; &lt;font style="FONT-WEIGHT: bold; DISPLAY: inline"&gt;Exercisable&lt;/font&gt;&lt;/div&gt; &lt;/td&gt; &lt;td style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="PADDING-BOTTOM: 2px" valign="bottom"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 2px solid" valign="bottom" colspan="2"&gt; &lt;div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"&gt; &lt;font style="FONT-WEIGHT: bold; DISPLAY: inline"&gt;Weighted Average Remaining Contractual Terms&lt;/font&gt;&lt;font style="FONT-WEIGHT: bold; DISPLAY: inline"&gt;(in years)&lt;/font&gt;&lt;/div&gt; &lt;/td&gt; &lt;td style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr bgcolor="#cceeff"&gt; &lt;td style="TEXT-ALIGN: left; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt" valign="bottom" width="52%"&gt; &lt;div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: left; TEXT-INDENT: 0pt"&gt; Warrants:&lt;/div&gt; &lt;/td&gt; &lt;td valign="bottom" width="1%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%"&gt;$&lt;/td&gt; &lt;td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%"&gt;1.40&lt;/td&gt; &lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td valign="bottom" width="1%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%"&gt;474,322&lt;/td&gt; &lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td valign="bottom" width="1%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%"&gt;474,322&lt;/td&gt; &lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td valign="bottom" width="1%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%"&gt;0.82&lt;/td&gt; &lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr bgcolor="white"&gt; &lt;td valign="bottom" width="52%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td valign="bottom" width="1%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%"&gt;$&lt;/td&gt; &lt;td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%"&gt;1.50&lt;/td&gt; &lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td valign="bottom" width="1%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%"&gt;878,174&lt;/td&gt; &lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td valign="bottom" width="1%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%"&gt;878,174&lt;/td&gt; &lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td valign="bottom" width="1%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%"&gt;0.06&lt;/td&gt; &lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr bgcolor="#cceeff"&gt; &lt;td valign="bottom" width="52%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td valign="bottom" width="1%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%"&gt;$&lt;/td&gt; &lt;td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%"&gt;1.60&lt;/td&gt; &lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td valign="bottom" width="1%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%"&gt;131,221&lt;/td&gt; &lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td valign="bottom" width="1%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%"&gt;131,221&lt;/td&gt; &lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td valign="bottom" width="1%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%"&gt;0.78&lt;/td&gt; &lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr bgcolor="white"&gt; &lt;td valign="bottom" width="52%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td valign="bottom" width="1%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%"&gt;$&lt;/td&gt; &lt;td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%"&gt;1.80&lt;/td&gt; &lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td valign="bottom" width="1%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%"&gt;727,401&lt;/td&gt; &lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td valign="bottom" width="1%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%"&gt;727,401&lt;/td&gt; &lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td valign="bottom" width="1%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%"&gt;0.30&lt;/td&gt; &lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr bgcolor="#cceeff"&gt; &lt;td valign="bottom" width="52%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td valign="bottom" width="1%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%"&gt;$&lt;/td&gt; &lt;td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%"&gt;1.90&lt;/td&gt; &lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td valign="bottom" width="1%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%"&gt;43,103&lt;/td&gt; &lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td valign="bottom" width="1%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%"&gt;43,103&lt;/td&gt; &lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td valign="bottom" width="1%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%"&gt;0.08&lt;/td&gt; &lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr bgcolor="white"&gt; &lt;td valign="bottom" width="52%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td valign="bottom" width="1%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%"&gt;$&lt;/td&gt; &lt;td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%"&gt;4.20&lt;/td&gt; &lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td valign="bottom" width="1%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%"&gt;5,060,000&lt;/td&gt; &lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td valign="bottom" width="1%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%"&gt;5,060,000&lt;/td&gt; &lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td valign="bottom" width="1%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%"&gt;2.09&lt;/td&gt; &lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr bgcolor="#cceeff"&gt; &lt;td style="PADDING-BOTTOM: 2px" valign="bottom" width="52%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 2px solid; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%"&gt;$&lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 2px solid; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%"&gt;5.00&lt;/td&gt; &lt;td style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 2px solid; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%"&gt;3,219,983&lt;/td&gt; &lt;td style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 2px solid; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%"&gt;3,219,983&lt;/td&gt; &lt;td style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 2px solid; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%"&gt;3.22&lt;/td&gt; &lt;td style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr bgcolor="white"&gt; &lt;td style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt" valign="bottom" width="52%"&gt; &lt;div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: left; TEXT-INDENT: 0pt"&gt; Total warrants&lt;/div&gt; &lt;/td&gt; &lt;td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-WEIGHT: bold; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-WEIGHT: bold; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 2px solid; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; TEXT-ALIGN: right" valign="bottom" width="9%"&gt;10,534,204&lt;/td&gt; &lt;td style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-WEIGHT: bold; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-WEIGHT: bold; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-WEIGHT: bold; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 2px solid; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; TEXT-ALIGN: right" valign="bottom" width="9%"&gt;10,534,204&lt;/td&gt; &lt;td style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-WEIGHT: bold; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr bgcolor="#cceeff"&gt; &lt;td valign="bottom" width="52%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td valign="bottom" width="1%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td valign="bottom" width="1%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td valign="bottom" width="1%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td valign="bottom" width="1%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr bgcolor="white"&gt; &lt;td style="TEXT-ALIGN: left; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt" valign="bottom" width="52%"&gt; &lt;div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: left; TEXT-INDENT: 0pt"&gt; Options:&lt;/div&gt; &lt;/td&gt; &lt;td valign="bottom" width="1%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%"&gt;$&lt;/td&gt; &lt;td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%"&gt;0.00&lt;/td&gt; &lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td valign="bottom" width="1%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%"&gt;101,000&lt;/td&gt; &lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td valign="bottom" width="1%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%"&gt;100,000&lt;/td&gt; &lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td valign="bottom" width="1%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%"&gt;5.19&lt;/td&gt; &lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr bgcolor="#cceeff"&gt; &lt;td valign="bottom" width="52%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td valign="bottom" width="1%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%"&gt;$&lt;/td&gt; &lt;td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%"&gt;0.62&lt;/td&gt; &lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td valign="bottom" width="1%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%"&gt;398,500&lt;/td&gt; &lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td valign="bottom" width="1%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%"&gt;398,500&lt;/td&gt; &lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td valign="bottom" width="1%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%"&gt;4.25&lt;/td&gt; &lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr bgcolor="white"&gt; &lt;td valign="bottom" width="52%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td valign="bottom" width="1%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%"&gt;$&lt;/td&gt; &lt;td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%"&gt;1.04&lt;/td&gt; &lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td valign="bottom" width="1%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%"&gt;30,000&lt;/td&gt; &lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td valign="bottom" width="1%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%"&gt;30,000&lt;/td&gt; &lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td valign="bottom" width="1%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%"&gt;4.16&lt;/td&gt; &lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr bgcolor="#cceeff"&gt; &lt;td valign="bottom" width="52%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td valign="bottom" width="1%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%"&gt;$&lt;/td&gt; &lt;td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%"&gt;2.97&lt;/td&gt; &lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td valign="bottom" width="1%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%"&gt;20,000&lt;/td&gt; &lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td valign="bottom" width="1%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%"&gt;20,000&lt;/td&gt; &lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td valign="bottom" width="1%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%"&gt;3.86&lt;/td&gt; &lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr bgcolor="white"&gt; &lt;td valign="bottom" width="52%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td valign="bottom" width="1%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%"&gt;$&lt;/td&gt; &lt;td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%"&gt;3.50&lt;/td&gt; &lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td valign="bottom" width="1%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%"&gt;900,000&lt;/td&gt; &lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td valign="bottom" width="1%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%"&gt;900,000&lt;/td&gt; &lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td valign="bottom" width="1%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%"&gt;2.58&lt;/td&gt; &lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr bgcolor="#cceeff"&gt; &lt;td valign="bottom" width="52%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td valign="bottom" width="1%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%"&gt;$&lt;/td&gt; &lt;td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%"&gt;3.72&lt;/td&gt; &lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td valign="bottom" width="1%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%"&gt;15,000&lt;/td&gt; &lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td valign="bottom" width="1%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%"&gt;15,000&lt;/td&gt; &lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td valign="bottom" width="1%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%"&gt;2.49&lt;/td&gt; &lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr bgcolor="white"&gt; &lt;td valign="bottom" width="52%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td valign="bottom" width="1%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%"&gt;$&lt;/td&gt; &lt;td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%"&gt;3.80&lt;/td&gt; &lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td valign="bottom" width="1%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%"&gt;16,050&lt;/td&gt; &lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td valign="bottom" width="1%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%"&gt;16,050&lt;/td&gt; &lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td valign="bottom" width="1%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%"&gt;2.53&lt;/td&gt; &lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr bgcolor="#cceeff"&gt; &lt;td valign="bottom" width="52%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td valign="bottom" width="1%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%"&gt;$&lt;/td&gt; &lt;td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%"&gt;4.00&lt;/td&gt; &lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td valign="bottom" width="1%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%"&gt;42,500&lt;/td&gt; &lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td valign="bottom" width="1%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%"&gt;42,500&lt;/td&gt; &lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td valign="bottom" width="1%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%"&gt;2.30&lt;/td&gt; &lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr bgcolor="white"&gt; &lt;td valign="bottom" width="52%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td valign="bottom" width="1%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%"&gt;$&lt;/td&gt; &lt;td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%"&gt;4.38 - $ 4.40&lt;/td&gt; &lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td valign="bottom" width="1%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%"&gt;417,299&lt;/td&gt; &lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td valign="bottom" width="1%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%"&gt;417,299&lt;/td&gt; &lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td valign="bottom" width="1%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%"&gt;3.28&lt;/td&gt; &lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr bgcolor="#cceeff"&gt; &lt;td valign="bottom" width="52%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td valign="bottom" width="1%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%"&gt;$&lt;/td&gt; &lt;td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%"&gt;6.80&lt;/td&gt; &lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td valign="bottom" width="1%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%"&gt;36,250&lt;/td&gt; &lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td valign="bottom" width="1%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%"&gt;36,250&lt;/td&gt; &lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td valign="bottom" width="1%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%"&gt;3.37&lt;/td&gt; &lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr bgcolor="white"&gt; &lt;td valign="bottom" width="52%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td valign="bottom" width="1%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%"&gt;$&lt;/td&gt; &lt;td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%"&gt;8.20&lt;/td&gt; &lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td valign="bottom" width="1%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%"&gt;30,000&lt;/td&gt; &lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td valign="bottom" width="1%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%"&gt;30,000&lt;/td&gt; &lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td valign="bottom" width="1%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%"&gt;2.40&lt;/td&gt; &lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr bgcolor="#cceeff"&gt; &lt;td style="PADDING-BOTTOM: 2px" valign="bottom" width="52%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 2px solid; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%"&gt;$&lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 2px solid; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%"&gt;20.00&lt;/td&gt; &lt;td style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 2px solid; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%"&gt;107,500&lt;/td&gt; &lt;td style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 2px solid; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%"&gt;107,500&lt;/td&gt; &lt;td style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 2px solid; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%"&gt;2.88&lt;/td&gt; &lt;td style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr bgcolor="white"&gt; &lt;td style="PADDING-BOTTOM: 4px; TEXT-ALIGN: left; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt" valign="bottom" width="52%"&gt; &lt;div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: left; TEXT-INDENT: 0pt"&gt; Total options&lt;/div&gt; &lt;/td&gt; &lt;td style="PADDING-BOTTOM: 4px" valign="bottom" width="1%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="PADDING-BOTTOM: 4px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="PADDING-BOTTOM: 4px" valign="bottom" width="1%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-WEIGHT: bold; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-WEIGHT: bold; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 4px double; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; TEXT-ALIGN: right" valign="bottom" width="9%"&gt;2,114,099&lt;/td&gt; &lt;td style="PADDING-BOTTOM: 4px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-WEIGHT: bold; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="PADDING-BOTTOM: 4px" valign="bottom" width="1%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-WEIGHT: bold; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-WEIGHT: bold; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 4px double; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; TEXT-ALIGN: right" valign="bottom" width="9%"&gt;2,113,099&lt;/td&gt; &lt;td style="PADDING-BOTTOM: 4px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-WEIGHT: bold; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="PADDING-BOTTOM: 4px" valign="bottom" width="1%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="PADDING-BOTTOM: 4px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr bgcolor="#cceeff"&gt; &lt;td style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt" valign="bottom" width="52%"&gt; &lt;div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: left; TEXT-INDENT: 0pt"&gt; Total warrants and options&lt;/div&gt; &lt;/td&gt; &lt;td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-WEIGHT: bold; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-WEIGHT: bold; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 2px solid; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&amp;nbsp;12,648,303&lt;/td&gt; &lt;td style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-WEIGHT: bold; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-WEIGHT: bold; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-WEIGHT: bold; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 2px solid; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&amp;nbsp;12,647,303&lt;/td&gt; &lt;td style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-WEIGHT: bold; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;/tr&gt; &lt;/table&gt; &lt;/div&gt; &lt;!--EndFragment--&gt;&lt;/div&gt; &lt;/div&gt;</us-gaap:ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTextBlock>
  <us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock id="ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock.869.0.0.0.0.0.0" contextRef="from-2013-07-01-to-2014-06-30.869.0.0.0.0.0.0.0">&lt;!--DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd" --&gt;&lt;div&gt; &lt;div&gt;&lt;!--StartFragment--&gt; &lt;div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"&gt; The Company accounted for its options to employees and directors under the fair value method in accordance with ASC 718. A summary of the Company&amp;#39;s share option activity for options granted to employees and directors under the Plans is as follows:&lt;/div&gt; &lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"&gt; &amp;nbsp;&lt;/div&gt; &lt;div style="text-align: right"&gt; &lt;table style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman" cellspacing="0" cellpadding="0" width="97%"&gt; &lt;tr&gt; &lt;td style="PADDING-BOTTOM: 2px" valign="bottom" width="52%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-WEIGHT: bold; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="46%" colspan="14"&gt; &lt;div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"&gt; Year ended June 30, 2014&lt;/div&gt; &lt;/td&gt; &lt;td style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-WEIGHT: bold; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td style="PADDING-BOTTOM: 2px" valign="bottom" width="52%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-WEIGHT: bold; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="10%" colspan="2"&gt; &lt;div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"&gt; Number&lt;/div&gt; &lt;/td&gt; &lt;td style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-WEIGHT: bold; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-WEIGHT: bold; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="10%" colspan="2"&gt; &lt;div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"&gt; Weighted Average Exercise Price&lt;/div&gt; &lt;/td&gt; &lt;td style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-WEIGHT: bold; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-WEIGHT: bold; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="10%" colspan="2"&gt; &lt;div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"&gt; Weighted Average Remaining Contractual Terms (in years)&lt;/div&gt; &lt;/td&gt; &lt;td style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-WEIGHT: bold; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-WEIGHT: bold; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="10%" colspan="2"&gt; &lt;div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"&gt; Aggregate Intrinsic Value Price&lt;/div&gt; &lt;/td&gt; &lt;td style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-WEIGHT: bold; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr bgcolor="#cceeff"&gt; &lt;td style="TEXT-ALIGN: left; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt" valign="bottom" width="52%"&gt; &lt;div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: left; TEXT-INDENT: 0pt"&gt; Options outstanding at beginning of period&lt;/div&gt; &lt;/td&gt; &lt;td valign="bottom" width="1%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%"&gt;1,958,156&lt;/td&gt; &lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td valign="bottom" width="1%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%"&gt;$&lt;/td&gt; &lt;td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%"&gt;4.03&lt;/td&gt; &lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td valign="bottom" width="1%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td valign="bottom" width="10%" colspan="2"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td valign="bottom" width="1%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td valign="bottom" width="10%" colspan="2"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr bgcolor="white"&gt; &lt;td style="TEXT-ALIGN: left; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt" valign="bottom" width="52%"&gt; &lt;div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: left; TEXT-INDENT: 0pt"&gt; Options exercised&lt;/div&gt; &lt;/td&gt; &lt;td valign="bottom" width="1%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%"&gt;(15,000&lt;/td&gt; &lt;td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"&gt;)&lt;/td&gt; &lt;td valign="bottom" width="1%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%"&gt;$&lt;/td&gt; &lt;td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%"&gt;0.83&lt;/td&gt; &lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td valign="bottom" width="1%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td valign="bottom" width="10%" colspan="2"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td valign="bottom" width="1%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td valign="bottom" width="10%" colspan="2"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr bgcolor="#cceeff"&gt; &lt;td style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt" valign="bottom" width="52%"&gt; &lt;div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: left; TEXT-INDENT: 0pt"&gt; Options forfeited&lt;/div&gt; &lt;/td&gt; &lt;td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 2px solid; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%"&gt;(81,057&lt;/td&gt; &lt;td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"&gt;)&lt;/td&gt; &lt;td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 2px solid; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%"&gt;$&lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 2px solid; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%"&gt;11.59&lt;/td&gt; &lt;td style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="PADDING-BOTTOM: 2px" valign="bottom" width="10%" colspan="2"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="PADDING-BOTTOM: 2px" valign="bottom" width="10%" colspan="2"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr bgcolor="white"&gt; &lt;td style="PADDING-BOTTOM: 4px; TEXT-ALIGN: left; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt" valign="bottom" width="52%"&gt; &lt;div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: left; TEXT-INDENT: 0pt"&gt; Options outstanding at end of the period&lt;/div&gt; &lt;/td&gt; &lt;td style="PADDING-BOTTOM: 4px" valign="bottom" width="1%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 4px double; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%"&gt;1,862,099&lt;/td&gt; &lt;td style="PADDING-BOTTOM: 4px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="PADDING-BOTTOM: 4px" valign="bottom" width="1%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 4px double; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%"&gt;$&lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 4px double; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%"&gt;3.73&lt;/td&gt; &lt;td style="PADDING-BOTTOM: 4px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="PADDING-BOTTOM: 4px" valign="bottom" width="1%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 4px double; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%"&gt;3.13&lt;/td&gt; &lt;td style="PADDING-BOTTOM: 4px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="PADDING-BOTTOM: 4px" valign="bottom" width="1%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 4px double; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%"&gt;$&lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 4px double; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%"&gt;1,046&lt;/td&gt; &lt;td style="PADDING-BOTTOM: 4px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr bgcolor="#cceeff"&gt; &lt;td style="PADDING-BOTTOM: 4px; TEXT-ALIGN: left; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt" valign="bottom" width="52%"&gt; &lt;div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: left; TEXT-INDENT: 0pt"&gt; Options exercisable at the end of the period&lt;/div&gt; &lt;/td&gt; &lt;td style="PADDING-BOTTOM: 4px" valign="bottom" width="1%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 4px double; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%"&gt;1,862,099&lt;/td&gt; &lt;td style="PADDING-BOTTOM: 4px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="PADDING-BOTTOM: 4px" valign="bottom" width="1%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 4px double; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%"&gt;$&lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 4px double; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%"&gt;3.73&lt;/td&gt; &lt;td style="PADDING-BOTTOM: 4px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="PADDING-BOTTOM: 4px" valign="bottom" width="1%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 4px double; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%"&gt;3.13&lt;/td&gt; &lt;td style="PADDING-BOTTOM: 4px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="PADDING-BOTTOM: 4px" valign="bottom" width="1%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 4px double; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%"&gt;$&lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 4px double; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%"&gt;1,046&lt;/td&gt; &lt;td style="PADDING-BOTTOM: 4px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr bgcolor="white"&gt; &lt;td style="PADDING-BOTTOM: 4px; TEXT-ALIGN: left; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt" valign="bottom" width="52%"&gt; &lt;div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: left; TEXT-INDENT: 0pt"&gt; Options vested&lt;/div&gt; &lt;/td&gt; &lt;td style="PADDING-BOTTOM: 4px" valign="bottom" width="1%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 4px double; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%"&gt;1,862,099&lt;/td&gt; &lt;td style="PADDING-BOTTOM: 4px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="PADDING-BOTTOM: 4px" valign="bottom" width="1%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 4px double; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%"&gt;$&lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 4px double; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%"&gt;3.73&lt;/td&gt; &lt;td style="PADDING-BOTTOM: 4px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="PADDING-BOTTOM: 4px" valign="bottom" width="1%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 4px double; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%"&gt;3.13&lt;/td&gt; &lt;td style="PADDING-BOTTOM: 4px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="PADDING-BOTTOM: 4px" valign="bottom" width="1%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 4px double; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%"&gt;$&lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 4px double; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%"&gt;1,046&lt;/td&gt; &lt;td style="PADDING-BOTTOM: 4px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;/tr&gt; &lt;/table&gt; &lt;/div&gt; &lt;!--EndFragment--&gt;&lt;/div&gt; &lt;/div&gt;</us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock>
  <us-gaap:ShareBasedCompensation id="ShareBasedCompensation.869.0.0.0.0.0.0" contextRef="from-2013-07-01-to-2014-06-30.869.0.0.0.0.0.0.0" unitRef="USD" decimals="-3">5851000</us-gaap:ShareBasedCompensation>
  <us-gaap:ShareBasedCompensation id="ShareBasedCompensation.870.0.0.0.0.0.0" contextRef="from-2012-07-01-to-2013-06-30.870.0.0.0.0.0.0.0" unitRef="USD" decimals="-3">2799000</us-gaap:ShareBasedCompensation>
  <us-gaap:ShareBasedCompensation id="ShareBasedCompensation.871.0.0.0.0.0.0" contextRef="from-2011-07-01-to-2012-06-30.871.0.0.0.0.0.0.0" unitRef="USD" decimals="-3">4927000</us-gaap:ShareBasedCompensation>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod id="ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod.869.4568.367.0.0.0.0" contextRef="from-2013-07-01-to-2014-06-30.869.0.4568.367.0.0.0.0" unitRef="shares" decimals="INF">44183</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod id="ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod.869.4568.367.0.0.0.0" contextRef="from-2013-07-01-to-2014-06-30.869.0.4568.367.0.0.0.0" unitRef="shares" decimals="INF">1256940</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod id="ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod.869.25535.5039.0.0.0.0" contextRef="from-2013-07-01-to-2014-06-30.869.0.25535.5039.0.0.0.0" unitRef="shares" decimals="INF">84565</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue id="ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue.869.0.0.0.0.0.0" contextRef="from-2013-07-01-to-2014-06-30.869.0.0.0.0.0.0.0" unitRef="USD_per_share" decimals="2">3.53</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue id="ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue.870.0.0.0.0.0.0" contextRef="from-2012-07-01-to-2013-06-30.870.0.0.0.0.0.0.0" unitRef="USD_per_share" decimals="2">3.43</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue id="ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue.871.0.0.0.0.0.0" contextRef="from-2011-07-01-to-2012-06-30.871.0.0.0.0.0.0.0" unitRef="USD_per_share" decimals="2">2.54</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber id="ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber.872.4568.367.0.0.0.0" contextRef="as-of-2014-06-30.872.0.4568.367.0.0.0.0" unitRef="shares" decimals="INF">1589432</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber id="ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber.874.4568.367.0.0.0.0" contextRef="as-of-2013-06-30.874.0.4568.367.0.0.0.0" unitRef="shares" decimals="INF">1660525</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber id="ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber.872.25535.5039.0.0.0.0" contextRef="as-of-2014-06-30.872.0.25535.5039.0.0.0.0" unitRef="shares" decimals="INF">15250</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber id="ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber.874.25535.5039.0.0.0.0" xsi:nil="true" contextRef="as-of-2013-06-30.874.0.25535.5039.0.0.0.0" unitRef="shares" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" />
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod id="ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod.869.4568.367.0.0.0.0" contextRef="from-2013-07-01-to-2014-06-30.869.0.4568.367.0.0.0.0" unitRef="shares" decimals="INF">1283850</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod id="ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod.869.25535.5039.0.0.0.0" contextRef="from-2013-07-01-to-2014-06-30.869.0.25535.5039.0.0.0.0" unitRef="shares" decimals="INF">69315</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized id="ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized.872.0.0.0.0.0.0" contextRef="as-of-2014-06-30.872.0.0.0.0.0.0.0" unitRef="shares" decimals="INF">13256713</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant id="ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant.872.0.0.0.0.0.0" contextRef="as-of-2014-06-30.872.0.0.0.0.0.0.0" unitRef="shares" decimals="INF">1205080</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant>
  <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1 id="SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1.872.0.0.0.0.0.0" contextRef="as-of-2014-06-30.872.0.0.0.0.0.0.0" unitRef="USD" decimals="-3">1046000</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber id="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber.872.0.0.0.0.0.0" contextRef="as-of-2014-06-30.872.0.0.0.0.0.0.0" unitRef="shares" decimals="INF">1862099</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice id="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice.872.0.0.0.0.0.0" contextRef="as-of-2014-06-30.872.0.0.0.0.0.0.0" unitRef="USD_per_share" decimals="2">3.73</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice>
  <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1 id="SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1.869.0.0.0.0.0.0" contextRef="from-2013-07-01-to-2014-06-30.869.0.0.0.0.0.0.0">P3Y1M17D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice id="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice.869.0.0.0.0.0.0" contextRef="from-2013-07-01-to-2014-06-30.869.0.0.0.0.0.0.0" unitRef="USD_per_share" decimals="2">11.59</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod id="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod.869.0.0.0.0.0.0" contextRef="from-2013-07-01-to-2014-06-30.869.0.0.0.0.0.0.0" unitRef="shares" decimals="INF">81057</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue id="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue.872.0.0.0.0.0.0" contextRef="as-of-2014-06-30.872.0.0.0.0.0.0.0" unitRef="USD" decimals="-3">1046000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber id="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber.872.0.0.0.0.0.0" contextRef="as-of-2014-06-30.872.0.0.0.0.0.0.0" unitRef="shares" decimals="INF">1862099</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber id="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber.874.0.0.0.0.0.0" contextRef="as-of-2013-06-30.874.0.0.0.0.0.0.0" unitRef="shares" decimals="INF">1958156</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice id="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice.872.0.0.0.0.0.0" contextRef="as-of-2014-06-30.872.0.0.0.0.0.0.0" unitRef="USD_per_share" decimals="2">3.73</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice id="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice.874.0.0.0.0.0.0" contextRef="as-of-2013-06-30.874.0.0.0.0.0.0.0" unitRef="USD_per_share" decimals="2">4.03</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice id="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice.872.5496.367.25746.5031.0.0" contextRef="as-of-2014-06-30.872.0.5496.367.25746.5031.0.0" unitRef="USD_per_share" decimals="2">1.40</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice id="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice.872.5496.367.25747.5031.0.0" contextRef="as-of-2014-06-30.872.0.5496.367.25747.5031.0.0" unitRef="USD_per_share" decimals="2">1.50</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice id="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice.872.5496.367.25748.5031.0.0" contextRef="as-of-2014-06-30.872.0.5496.367.25748.5031.0.0" unitRef="USD_per_share" decimals="2">1.60</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice id="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice.872.5496.367.25750.5031.0.0" contextRef="as-of-2014-06-30.872.0.5496.367.25750.5031.0.0" unitRef="USD_per_share" decimals="2">1.80</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice id="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice.872.5496.367.25749.5031.0.0" contextRef="as-of-2014-06-30.872.0.5496.367.25749.5031.0.0" unitRef="USD_per_share" decimals="2">1.90</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice id="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice.872.5496.367.25751.5031.0.0" contextRef="as-of-2014-06-30.872.0.5496.367.25751.5031.0.0" unitRef="USD_per_share" decimals="2">4.20</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice id="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice.872.5496.367.25752.5031.0.0" contextRef="as-of-2014-06-30.872.0.5496.367.25752.5031.0.0" unitRef="USD_per_share" decimals="2">5.00</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice id="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice.872.1835.367.25733.5031.0.0" contextRef="as-of-2014-06-30.872.0.1835.367.25733.5031.0.0" unitRef="USD_per_share" decimals="2">0.00</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice id="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice.872.1835.367.25734.5031.0.0" contextRef="as-of-2014-06-30.872.0.1835.367.25734.5031.0.0" unitRef="USD_per_share" decimals="2">0.62</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice id="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice.872.1835.367.25735.5031.0.0" contextRef="as-of-2014-06-30.872.0.1835.367.25735.5031.0.0" unitRef="USD_per_share" decimals="2">1.04</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice id="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice.872.1835.367.25736.5031.0.0" contextRef="as-of-2014-06-30.872.0.1835.367.25736.5031.0.0" unitRef="USD_per_share" decimals="2">2.97</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice id="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice.872.1835.367.25737.5031.0.0" contextRef="as-of-2014-06-30.872.0.1835.367.25737.5031.0.0" unitRef="USD_per_share" decimals="2">3.50</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice id="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice.872.1835.367.25738.5031.0.0" contextRef="as-of-2014-06-30.872.0.1835.367.25738.5031.0.0" unitRef="USD_per_share" decimals="2">3.72</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice id="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice.872.1835.367.25745.5031.0.0" contextRef="as-of-2014-06-30.872.0.1835.367.25745.5031.0.0" unitRef="USD_per_share" decimals="2">3.80</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice id="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice.872.1835.367.25739.5031.0.0" contextRef="as-of-2014-06-30.872.0.1835.367.25739.5031.0.0" unitRef="USD_per_share" decimals="2">4.00</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice id="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice.872.1835.367.25741.5031.0.0" contextRef="as-of-2014-06-30.872.0.1835.367.25741.5031.0.0" unitRef="USD_per_share" decimals="2">6.80</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice id="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice.872.1835.367.25742.5031.0.0" contextRef="as-of-2014-06-30.872.0.1835.367.25742.5031.0.0" unitRef="USD_per_share" decimals="2">8.20</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice id="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice.872.1835.367.25743.5031.0.0" contextRef="as-of-2014-06-30.872.0.1835.367.25743.5031.0.0" unitRef="USD_per_share" decimals="2">20.00</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice>
  <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2 id="SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2.869.0.0.0.0.0.0" contextRef="from-2013-07-01-to-2014-06-30.869.0.0.0.0.0.0.0">P3Y1M17D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2>
  <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2 id="SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2.869.5496.367.25746.5031.0.0" contextRef="from-2013-07-01-to-2014-06-30.869.0.5496.367.25746.5031.0.0">P9M26D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2>
  <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2 id="SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2.869.5496.367.25747.5031.0.0" contextRef="from-2013-07-01-to-2014-06-30.869.0.5496.367.25747.5031.0.0">P22D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2>
  <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2 id="SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2.869.5496.367.25748.5031.0.0" contextRef="from-2013-07-01-to-2014-06-30.869.0.5496.367.25748.5031.0.0">P9M11D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2>
  <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2 id="SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2.869.5496.367.25750.5031.0.0" contextRef="from-2013-07-01-to-2014-06-30.869.0.5496.367.25750.5031.0.0">P3M18D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2>
  <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2 id="SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2.869.5496.367.25749.5031.0.0" contextRef="from-2013-07-01-to-2014-06-30.869.0.5496.367.25749.5031.0.0">P29D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2>
  <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2 id="SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2.869.5496.367.25751.5031.0.0" contextRef="from-2013-07-01-to-2014-06-30.869.0.5496.367.25751.5031.0.0">P2Y1M2D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2>
  <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2 id="SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2.869.5496.367.25752.5031.0.0" contextRef="from-2013-07-01-to-2014-06-30.869.0.5496.367.25752.5031.0.0">P3Y2M19D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2>
  <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2 id="SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2.869.1835.367.25745.5031.0.0" contextRef="from-2013-07-01-to-2014-06-30.869.0.1835.367.25745.5031.0.0">P2Y6M11D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2>
  <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2 id="SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2.869.1835.367.25738.5031.0.0" contextRef="from-2013-07-01-to-2014-06-30.869.0.1835.367.25738.5031.0.0">P2Y5M27D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2>
  <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2 id="SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2.869.1835.367.25737.5031.0.0" contextRef="from-2013-07-01-to-2014-06-30.869.0.1835.367.25737.5031.0.0">P2Y6M29D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2>
  <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2 id="SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2.869.1835.367.25736.5031.0.0" contextRef="from-2013-07-01-to-2014-06-30.869.0.1835.367.25736.5031.0.0">P3Y10M10D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2>
  <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2 id="SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2.869.1835.367.25733.5031.0.0" contextRef="from-2013-07-01-to-2014-06-30.869.0.1835.367.25733.5031.0.0">P5Y2M9D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2>
  <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2 id="SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2.869.1835.367.25734.5031.0.0" contextRef="from-2013-07-01-to-2014-06-30.869.0.1835.367.25734.5031.0.0">P4Y3M</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2>
  <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2 id="SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2.869.1835.367.25735.5031.0.0" contextRef="from-2013-07-01-to-2014-06-30.869.0.1835.367.25735.5031.0.0">P4Y1M28D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2>
  <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2 id="SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2.869.1835.367.25739.5031.0.0" contextRef="from-2013-07-01-to-2014-06-30.869.0.1835.367.25739.5031.0.0">P2Y3M18D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2>
  <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2 id="SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2.869.1835.367.25740.5031.0.0" contextRef="from-2013-07-01-to-2014-06-30.869.0.1835.367.25740.5031.0.0">P3Y3M11D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2>
  <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2 id="SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2.869.1835.367.25741.5031.0.0" contextRef="from-2013-07-01-to-2014-06-30.869.0.1835.367.25741.5031.0.0">P3Y4M13D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2>
  <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2 id="SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2.869.1835.367.25742.5031.0.0" contextRef="from-2013-07-01-to-2014-06-30.869.0.1835.367.25742.5031.0.0">P2Y4M24D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2>
  <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2 id="SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2.869.1835.367.25743.5031.0.0" contextRef="from-2013-07-01-to-2014-06-30.869.0.1835.367.25743.5031.0.0">P2Y10M17D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue id="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue.872.0.0.0.0.0.0" contextRef="as-of-2014-06-30.872.0.0.0.0.0.0.0" unitRef="USD" decimals="-3">1046000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue>
  <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1 id="SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1.869.0.0.0.0.0.0" contextRef="from-2013-07-01-to-2014-06-30.869.0.0.0.0.0.0.0">P3Y1M17D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber id="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber.872.0.0.0.0.0.0" contextRef="as-of-2014-06-30.872.0.0.0.0.0.0.0" unitRef="shares" decimals="INF">1862099</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice id="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice.872.0.0.0.0.0.0" contextRef="as-of-2014-06-30.872.0.0.0.0.0.0.0" unitRef="USD_per_share" decimals="2">3.73</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice>
  <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice id="ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice.869.0.0.0.0.0.0" contextRef="from-2013-07-01-to-2014-06-30.869.0.0.0.0.0.0.0" unitRef="USD_per_share" decimals="2">0.83</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice>
  <us-gaap:ShareBasedCompensationOptionAndIncentivePlansPolicy id="ShareBasedCompensationOptionAndIncentivePlansPolicy.869.0.0.0.0.0.0" contextRef="from-2013-07-01-to-2014-06-30.869.0.0.0.0.0.0.0">&lt;!--DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd" --&gt;&lt;div&gt; &lt;div&gt;&lt;!--StartFragment--&gt; &lt;div&gt; &lt;table style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman" cellspacing="0" cellpadding="0" width="100%" align="center" border="0"&gt; &lt;tr valign="top"&gt; &lt;td style="WIDTH: 18pt"&gt; &lt;div style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt"&gt; l.&lt;/div&gt; &lt;/td&gt; &lt;td&gt; &lt;div style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; text-align: justify"&gt; Accounting for stock-based compensation&lt;/div&gt; &lt;/td&gt; &lt;/tr&gt; &lt;/table&gt; &lt;/div&gt; &lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"&gt; &amp;nbsp;&lt;/div&gt; &lt;div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"&gt; The Company accounts for stock-based compensation in accordance with ASC 718, "Compensation-Stock Compensation" ("ASC 718") and ASC 505-50 "Equity-Based Payments to Non-Employees". ASC 718 requires companies to estimate the fair value of equity-based payment awards on the date of grant using an option-pricing model. The Company estimates the fair value of stock options granted using the Black-Scholes-Merton option-pricing model. The Company accounts for employee&amp;#39;s share-based payment awards classified as equity awards using the grant-date fair value method. The fair value of share-based payment transactions is recognized as an expense over the requisite service period, net of estimated forfeitures. The Company estimates forfeitures based on historical experience and anticipated future conditions. The Company elected to recognize compensation cost for an award with service conditions and goals achievement that has a graded vesting schedule using the accelerated method based on the multiple-option award approach.&lt;/div&gt; &lt;div style="DISPLAY: block; TEXT-INDENT: 0pt"&gt;&lt;br /&gt; &lt;/div&gt; &lt;div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"&gt; During fiscal years 2014, 2013 and 2012 there were no options grants to employees or directors.&lt;/div&gt; &lt;div style="MARGIN-LEFT: 437pt; DISPLAY: block; TEXT-INDENT: 0pt"&gt; &lt;br /&gt; &lt;/div&gt; &lt;div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"&gt; The assumptions below are relevant to restricted shares units granted in 2014, 2013 and 2012:&lt;/div&gt; &lt;div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"&gt; In accordance with &lt;font style="FONT-SIZE: 10pt; DISPLAY: inline"&gt;ASC 718&lt;/font&gt;, restricted shares or restricted shares units are measured at their fair value. All restricted shares and restricted shares units to employees, directors and non-employees granted in 20142013 and 2012 were granted for no consideration; therefore, their fair value was equal to the share price at the date of grant.&lt;/div&gt; &lt;div style="MARGIN-LEFT: 437pt; DISPLAY: block; TEXT-INDENT: 0pt"&gt; &lt;br /&gt; &lt;/div&gt; &lt;div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"&gt; The expected pre-vesting forfeiture rate affects the number of exercisable shares. Based on Company&amp;#39;s historical experience, the pre-vesting forfeiture rate per grant for shares granted to employees is 7% for year ended June 30, 2014 and 2013 and 5% for the year ended June 30, 2012, and 0% for the options and shares granted to directors and officers and consultants of the Company.&lt;/div&gt; &lt;div style="MARGIN-LEFT: 437pt; DISPLAY: block; TEXT-INDENT: 0pt"&gt; &lt;br /&gt; &lt;/div&gt; &lt;div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"&gt; The fair value of all restricted shares and restricted shares units was determined based on the close trading price of the Company&amp;#39;s shares known at the grant date. The weighted average grant date fair value of share granted during years 2014, 2013 and 2012 was $3.53, $3.43 and $2.54, respectively.&lt;/div&gt; &lt;!--EndFragment--&gt;&lt;/div&gt; &lt;/div&gt;</us-gaap:ShareBasedCompensationOptionAndIncentivePlansPolicy>
  <us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit id="ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit.869.1835.367.25740.5031.0.0" contextRef="from-2013-07-01-to-2014-06-30.869.0.1835.367.25740.5031.0.0" unitRef="USD_per_share" decimals="2">4.38</us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit>
  <us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions id="ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions.872.1835.367.25733.5031.0.0" contextRef="as-of-2014-06-30.872.0.1835.367.25733.5031.0.0" unitRef="shares" decimals="INF">100000</us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions>
  <us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions id="ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions.872.1835.367.25734.5031.0.0" contextRef="as-of-2014-06-30.872.0.1835.367.25734.5031.0.0" unitRef="shares" decimals="INF">398500</us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions>
  <us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions id="ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions.872.1835.367.25735.5031.0.0" contextRef="as-of-2014-06-30.872.0.1835.367.25735.5031.0.0" unitRef="shares" decimals="INF">30000</us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions>
  <us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions id="ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions.872.1835.367.25736.5031.0.0" contextRef="as-of-2014-06-30.872.0.1835.367.25736.5031.0.0" unitRef="shares" decimals="INF">20000</us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions>
  <us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions id="ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions.872.1835.367.25737.5031.0.0" contextRef="as-of-2014-06-30.872.0.1835.367.25737.5031.0.0" unitRef="shares" decimals="INF">900000</us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions>
  <us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions id="ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions.872.1835.367.25738.5031.0.0" contextRef="as-of-2014-06-30.872.0.1835.367.25738.5031.0.0" unitRef="shares" decimals="INF">15000</us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions>
  <us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions id="ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions.872.1835.367.25745.5031.0.0" contextRef="as-of-2014-06-30.872.0.1835.367.25745.5031.0.0" unitRef="shares" decimals="INF">16050</us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions>
  <us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions id="ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions.872.1835.367.25739.5031.0.0" contextRef="as-of-2014-06-30.872.0.1835.367.25739.5031.0.0" unitRef="shares" decimals="INF">42500</us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions>
  <us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions id="ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions.872.1835.367.25740.5031.0.0" contextRef="as-of-2014-06-30.872.0.1835.367.25740.5031.0.0" unitRef="shares" decimals="INF">417299</us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions>
  <us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions id="ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions.872.1835.367.25741.5031.0.0" contextRef="as-of-2014-06-30.872.0.1835.367.25741.5031.0.0" unitRef="shares" decimals="INF">36250</us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions>
  <us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions id="ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions.872.1835.367.25742.5031.0.0" contextRef="as-of-2014-06-30.872.0.1835.367.25742.5031.0.0" unitRef="shares" decimals="INF">30000</us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions>
  <us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions id="ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions.872.1835.367.25743.5031.0.0" contextRef="as-of-2014-06-30.872.0.1835.367.25743.5031.0.0" unitRef="shares" decimals="INF">107500</us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions>
  <us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions id="ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions.872.5496.367.25746.5031.0.0" contextRef="as-of-2014-06-30.872.0.5496.367.25746.5031.0.0" unitRef="shares" decimals="INF">474322</us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions>
  <us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions id="ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions.872.5496.367.25747.5031.0.0" contextRef="as-of-2014-06-30.872.0.5496.367.25747.5031.0.0" unitRef="shares" decimals="INF">878174</us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions>
  <us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions id="ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions.872.5496.367.25748.5031.0.0" contextRef="as-of-2014-06-30.872.0.5496.367.25748.5031.0.0" unitRef="shares" decimals="INF">131221</us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions>
  <us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions id="ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions.872.5496.367.25750.5031.0.0" contextRef="as-of-2014-06-30.872.0.5496.367.25750.5031.0.0" unitRef="shares" decimals="INF">727401</us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions>
  <us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions id="ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions.872.5496.367.25749.5031.0.0" contextRef="as-of-2014-06-30.872.0.5496.367.25749.5031.0.0" unitRef="shares" decimals="INF">43103</us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions>
  <us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions id="ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions.872.5496.367.25751.5031.0.0" contextRef="as-of-2014-06-30.872.0.5496.367.25751.5031.0.0" unitRef="shares" decimals="INF">5060000</us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions>
  <us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions id="ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions.872.5496.367.25752.5031.0.0" contextRef="as-of-2014-06-30.872.0.5496.367.25752.5031.0.0" unitRef="shares" decimals="INF">3219983</us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions>
  <us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions id="ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions.872.5496.367.0.0.0.0" contextRef="as-of-2014-06-30.872.0.5496.367.0.0.0.0" unitRef="shares" decimals="INF">10534204</us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions>
  <us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions id="ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions.872.1835.367.0.0.0.0" contextRef="as-of-2014-06-30.872.0.1835.367.0.0.0.0" unitRef="shares" decimals="INF">2113099</us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions>
  <us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions id="ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions.872.0.0.0.0.0.0" contextRef="as-of-2014-06-30.872.0.0.0.0.0.0.0" unitRef="shares" decimals="0">12647303</us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions>
  <us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions id="ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions.872.1835.367.25733.5031.0.0" contextRef="as-of-2014-06-30.872.0.1835.367.25733.5031.0.0" unitRef="shares" decimals="INF">101000</us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions>
  <us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions id="ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions.872.1835.367.25734.5031.0.0" contextRef="as-of-2014-06-30.872.0.1835.367.25734.5031.0.0" unitRef="shares" decimals="INF">398500</us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions>
  <us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions id="ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions.872.1835.367.25735.5031.0.0" contextRef="as-of-2014-06-30.872.0.1835.367.25735.5031.0.0" unitRef="shares" decimals="INF">30000</us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions>
  <us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions id="ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions.872.1835.367.25736.5031.0.0" contextRef="as-of-2014-06-30.872.0.1835.367.25736.5031.0.0" unitRef="shares" decimals="INF">20000</us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions>
  <us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions id="ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions.872.1835.367.25737.5031.0.0" contextRef="as-of-2014-06-30.872.0.1835.367.25737.5031.0.0" unitRef="shares" decimals="INF">900000</us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions>
  <us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions id="ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions.872.1835.367.25738.5031.0.0" contextRef="as-of-2014-06-30.872.0.1835.367.25738.5031.0.0" unitRef="shares" decimals="INF">15000</us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions>
  <us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions id="ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions.872.1835.367.25745.5031.0.0" contextRef="as-of-2014-06-30.872.0.1835.367.25745.5031.0.0" unitRef="shares" decimals="INF">16050</us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions>
  <us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions id="ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions.872.1835.367.25739.5031.0.0" contextRef="as-of-2014-06-30.872.0.1835.367.25739.5031.0.0" unitRef="shares" decimals="INF">42500</us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions>
  <us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions id="ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions.872.1835.367.25740.5031.0.0" contextRef="as-of-2014-06-30.872.0.1835.367.25740.5031.0.0" unitRef="shares" decimals="INF">417299</us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions>
  <us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions id="ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions.872.1835.367.25741.5031.0.0" contextRef="as-of-2014-06-30.872.0.1835.367.25741.5031.0.0" unitRef="shares" decimals="INF">36250</us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions>
  <us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions id="ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions.872.1835.367.25742.5031.0.0" contextRef="as-of-2014-06-30.872.0.1835.367.25742.5031.0.0" unitRef="shares" decimals="INF">30000</us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions>
  <us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions id="ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions.872.1835.367.25743.5031.0.0" contextRef="as-of-2014-06-30.872.0.1835.367.25743.5031.0.0" unitRef="shares" decimals="INF">107500</us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions>
  <us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions id="ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions.872.5496.367.25746.5031.0.0" contextRef="as-of-2014-06-30.872.0.5496.367.25746.5031.0.0" unitRef="shares" decimals="INF">474322</us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions>
  <us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions id="ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions.872.5496.367.25747.5031.0.0" contextRef="as-of-2014-06-30.872.0.5496.367.25747.5031.0.0" unitRef="shares" decimals="INF">878174</us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions>
  <us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions id="ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions.872.5496.367.25748.5031.0.0" contextRef="as-of-2014-06-30.872.0.5496.367.25748.5031.0.0" unitRef="shares" decimals="INF">131221</us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions>
  <us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions id="ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions.872.5496.367.25750.5031.0.0" contextRef="as-of-2014-06-30.872.0.5496.367.25750.5031.0.0" unitRef="shares" decimals="INF">727401</us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions>
  <us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions id="ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions.872.5496.367.25749.5031.0.0" contextRef="as-of-2014-06-30.872.0.5496.367.25749.5031.0.0" unitRef="shares" decimals="INF">43103</us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions>
  <us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions id="ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions.872.5496.367.25751.5031.0.0" contextRef="as-of-2014-06-30.872.0.5496.367.25751.5031.0.0" unitRef="shares" decimals="INF">5060000</us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions>
  <us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions id="ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions.872.5496.367.25752.5031.0.0" contextRef="as-of-2014-06-30.872.0.5496.367.25752.5031.0.0" unitRef="shares" decimals="INF">3219983</us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions>
  <us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions id="ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions.872.5496.367.0.0.0.0" contextRef="as-of-2014-06-30.872.0.5496.367.0.0.0.0" unitRef="shares" decimals="INF">10534204</us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions>
  <us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions id="ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions.872.1835.367.0.0.0.0" contextRef="as-of-2014-06-30.872.0.1835.367.0.0.0.0" unitRef="shares" decimals="INF">2114099</us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions>
  <us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions id="ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions.872.0.0.0.0.0.0" contextRef="as-of-2014-06-30.872.0.0.0.0.0.0.0" unitRef="shares" decimals="0">12648303</us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions>
  <us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit id="ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit.869.1835.367.25740.5031.0.0" contextRef="from-2013-07-01-to-2014-06-30.869.0.1835.367.25740.5031.0.0" unitRef="USD_per_share" decimals="2">4.40</us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit>
  <us-gaap:SharesIssuedPricePerShare id="SharesIssuedPricePerShare.969.0.0.0.0.0.0" contextRef="as-of-2012-09-19.969.0.0.0.0.0.0.0" unitRef="USD_per_share" decimals="2">4.00</us-gaap:SharesIssuedPricePerShare>
  <us-gaap:ShortTermInvestments id="ShortTermInvestments.872.0.0.0.0.0.0" contextRef="as-of-2014-06-30.872.0.0.0.0.0.0.0" unitRef="USD" decimals="-3">19451000</us-gaap:ShortTermInvestments>
  <us-gaap:ShortTermInvestments id="ShortTermInvestments.874.0.0.0.0.0.0" contextRef="as-of-2013-06-30.874.0.0.0.0.0.0.0" unitRef="USD" decimals="-3">31449000</us-gaap:ShortTermInvestments>
  <us-gaap:SignificantAccountingPoliciesTextBlock id="SignificantAccountingPoliciesTextBlock.869.0.0.0.0.0.0" contextRef="from-2013-07-01-to-2014-06-30.869.0.0.0.0.0.0.0">&lt;!--DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd" --&gt;&lt;div&gt; &lt;div&gt;&lt;!--StartFragment--&gt; &lt;div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: left; TEXT-INDENT: 0pt"&gt; NOTE 2:-SIGNIFICANT ACCOUNTING POLICIES&lt;/div&gt; &lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"&gt; &amp;nbsp;&lt;/div&gt; &lt;div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: justify; TEXT-INDENT: 0pt"&gt; The consolidated financial statements have been prepared in accordance with United States generally accepted accounting principles ("U.S. GAAP") applied on consistent basis.&lt;/div&gt; &lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"&gt; &amp;nbsp;&lt;/div&gt; &lt;div&gt; &lt;table style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman" cellspacing="0" cellpadding="0" width="100%" align="center" border="0"&gt; &lt;tr valign="top"&gt; &lt;td style="WIDTH: 18pt"&gt; &lt;div style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt"&gt; a.&lt;/div&gt; &lt;/td&gt; &lt;td&gt; &lt;div style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; text-align: justify"&gt; Use of estimates&lt;/div&gt; &lt;/td&gt; &lt;/tr&gt; &lt;/table&gt; &lt;/div&gt; &lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"&gt; &amp;nbsp;&lt;/div&gt; &lt;div&gt; &lt;table style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman" cellspacing="0" cellpadding="0" width="100%" align="center" border="0"&gt; &lt;tr valign="top"&gt; &lt;td style="WIDTH: 18pt"&gt; &lt;div style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/div&gt; &lt;/td&gt; &lt;td&gt; &lt;div style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; text-align: justify"&gt; The preparation of financial statements in conformity with generally accepted accounting principles requires management to make estimates, judgments, and assumptions that are reasonable based upon information available at the time they are made. These estimates, judgments and assumptions can affect the amounts reported in the financial statements and accompanying notes. Actual results could differ from those estimates.&lt;/div&gt; &lt;/td&gt; &lt;/tr&gt; &lt;/table&gt; &lt;/div&gt; &lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"&gt; &amp;nbsp;&lt;/div&gt; &lt;div&gt; &lt;table style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman" cellspacing="0" cellpadding="0" width="100%" align="center" border="0"&gt; &lt;tr valign="top"&gt; &lt;td style="WIDTH: 18pt"&gt; &lt;div style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt"&gt; b.&lt;/div&gt; &lt;/td&gt; &lt;td&gt; &lt;div style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; text-align: justify"&gt; Functional currency of the Subsidiary&lt;/div&gt; &lt;/td&gt; &lt;/tr&gt; &lt;/table&gt; &lt;/div&gt; &lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"&gt; &amp;nbsp;&lt;/div&gt; &lt;div&gt; &lt;table style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman" cellspacing="0" cellpadding="0" width="100%" align="center" border="0"&gt; &lt;tr valign="top"&gt; &lt;td style="WIDTH: 19pt"&gt; &lt;div style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/div&gt; &lt;/td&gt; &lt;td&gt; &lt;div style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; text-align: justify"&gt; The Subsidiary&amp;#39;s revenues are generated and determined in U.S. Dollars ("dollars"). In addition, most of the financing of the Subsidiary&amp;#39;s operations has been made in dollars. The Company&amp;#39;s management believes that the dollar is the primary currency of the economic environment in which the Subsidiary operates. Thus, management believe that the functional currency of the Subsidiary is the dollar. Accordingly, monetary accounts maintained in currencies other than the dollar are remeasured into dollars in accordance with ASC 830, "Foreign Currency Matters". All transaction gains and losses from the remeasurement of monetary balance sheet items are reflected in the statement of operations as financial income or expenses, as appropriate.&lt;/div&gt; &lt;/td&gt; &lt;/tr&gt; &lt;/table&gt; &lt;/div&gt; &lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"&gt; &amp;nbsp;&lt;/div&gt; &lt;div&gt; &lt;table style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman" cellspacing="0" cellpadding="0" width="100%" align="center" border="0"&gt; &lt;tr valign="top"&gt; &lt;td style="WIDTH: 18pt"&gt; &lt;div style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt"&gt; c.&lt;/div&gt; &lt;/td&gt; &lt;td&gt; &lt;div style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; text-align: justify"&gt; Principles of consolidation&lt;/div&gt; &lt;/td&gt; &lt;/tr&gt; &lt;/table&gt; &lt;/div&gt; &lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"&gt; &amp;nbsp;&lt;/div&gt; &lt;div&gt; &lt;table style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman" cellspacing="0" cellpadding="0" width="100%" align="center" border="0"&gt; &lt;tr valign="top"&gt; &lt;td style="WIDTH: 18pt"&gt; &lt;div style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/div&gt; &lt;/td&gt; &lt;td&gt; &lt;div style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; text-align: justify"&gt; The consolidated financial statements include the accounts of Pluristem Therapeutics Inc. and its Subsidiary. Intercompany transactions and balances have been eliminated upon consolidation.&lt;/div&gt; &lt;/td&gt; &lt;/tr&gt; &lt;/table&gt; &lt;/div&gt; &lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"&gt; &amp;nbsp;&lt;/div&gt; &lt;div&gt; &lt;table style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman" cellspacing="0" cellpadding="0" width="100%" align="center" border="0"&gt; &lt;tr valign="top"&gt; &lt;td style="WIDTH: 18pt"&gt; &lt;div style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt"&gt; d.&lt;/div&gt; &lt;/td&gt; &lt;td&gt; &lt;div style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; text-align: justify"&gt; Cash and cash equivalents&lt;/div&gt; &lt;/td&gt; &lt;/tr&gt; &lt;/table&gt; &lt;/div&gt; &lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"&gt; &amp;nbsp;&lt;/div&gt; &lt;div&gt; &lt;table style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman" cellspacing="0" cellpadding="0" width="100%" align="center" border="0"&gt; &lt;tr valign="top"&gt; &lt;td style="WIDTH: 19pt"&gt; &lt;div style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/div&gt; &lt;/td&gt; &lt;td&gt; &lt;div style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; text-align: justify"&gt; Cash equivalents are short-term highly liquid investments that are readily convertible to cash with maturities of three months or less at the date acquired.&lt;/div&gt; &lt;/td&gt; &lt;/tr&gt; &lt;/table&gt; &lt;/div&gt; &lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"&gt; &amp;nbsp;&lt;/div&gt; &lt;div style="text-align: center"&gt; &lt;table style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman" cellspacing="0" cellpadding="0" width="100%" border="0"&gt; &lt;tr valign="top"&gt; &lt;td style="WIDTH: 18pt"&gt; &lt;div style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt"&gt; e.&lt;/div&gt; &lt;/td&gt; &lt;td&gt; &lt;div style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; text-align: justify"&gt; Short-term bank deposit&lt;/div&gt; &lt;/td&gt; &lt;/tr&gt; &lt;/table&gt; &lt;/div&gt; &lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"&gt; &amp;nbsp;&lt;/div&gt; &lt;div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"&gt; Bank deposits with original maturities of more than three months but less than one year are presented as part of short-term investments. Deposits are presented at their cost which approximates market values including accrued interest. Interest on deposits is recorded as financial income.&lt;/div&gt; &lt;div style="DISPLAY: block; TEXT-INDENT: 0pt"&gt;&lt;br /&gt; &lt;/div&gt; &lt;div style="text-align: center"&gt; &lt;table style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman" cellspacing="0" cellpadding="0" width="100%" border="0"&gt; &lt;tr valign="top"&gt; &lt;td style="WIDTH: 18pt"&gt; &lt;div style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt"&gt; f.&lt;/div&gt; &lt;/td&gt; &lt;td&gt; &lt;div style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; text-align: justify"&gt; Restricted cash and short-term deposits&lt;/div&gt; &lt;/td&gt; &lt;/tr&gt; &lt;/table&gt; &lt;/div&gt; &lt;div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; MARGIN-LEFT: 36pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"&gt; &amp;nbsp;&lt;/div&gt; &lt;div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"&gt; Short-term restricted deposits and restricted cash used to secure derivative transactions are presented at cost.&lt;/div&gt; &lt;div style="DISPLAY: block; TEXT-INDENT: 0pt"&gt;&lt;br /&gt; &lt;/div&gt; &lt;div style="text-align: center"&gt; &lt;table style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman" cellspacing="0" cellpadding="0" width="100%" border="0"&gt; &lt;tr valign="top"&gt; &lt;td style="WIDTH: 18pt"&gt; &lt;div style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt"&gt; g.&lt;/div&gt; &lt;/td&gt; &lt;td&gt; &lt;div style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; text-align: justify"&gt; Long-term restricted deposits&lt;/div&gt; &lt;/td&gt; &lt;/tr&gt; &lt;/table&gt; &lt;/div&gt; &lt;div&gt;&amp;nbsp;&lt;/div&gt; &lt;div&gt; &lt;table style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman" cellspacing="0" cellpadding="0" width="100%" align="center" border="0"&gt; &lt;tr valign="top"&gt; &lt;td style="WIDTH: 18pt"&gt; &lt;div style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/div&gt; &lt;/td&gt; &lt;td&gt; &lt;div style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; text-align: justify"&gt; Long-term restricted deposits with maturities of more than one year used to secure operating lease agreement are presented at cost which approximates market values including accrued interest.&lt;/div&gt; &lt;/td&gt; &lt;/tr&gt; &lt;/table&gt; &lt;/div&gt; &lt;div&gt;&amp;nbsp;&lt;/div&gt; &lt;div style="text-align: center"&gt; &lt;table style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman" cellspacing="0" cellpadding="0" width="100%" border="0"&gt; &lt;tr valign="top"&gt; &lt;td style="WIDTH: 18pt"&gt; &lt;div style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt"&gt; h.&lt;/div&gt; &lt;/td&gt; &lt;td&gt; &lt;div style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; text-align: justify"&gt; Marketable Securities&lt;/div&gt; &lt;/td&gt; &lt;/tr&gt; &lt;/table&gt; &lt;/div&gt; &lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"&gt; &amp;nbsp;&lt;/div&gt; &lt;div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"&gt; The Company accounts for its investments in marketable securities in accordance with ASC 320-"Investments - Debt and Equity Securities". The Company determines the classification of marketable securities at the time of purchase and re-evaluates such designations as of each balance sheet date. The Company classifies all of its marketable securities as available-for-sale. Available-for-sale marketable securities are carried at fair value, with the unrealized gain and loss reported at "accumulated other comprehensive income (loss)" in the statement of changes in stockholders&amp;#39; equity.&lt;/div&gt; &lt;div style="DISPLAY: block; MARGIN-LEFT: 437pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"&gt; &amp;nbsp;&lt;/div&gt; &lt;div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"&gt; Realized gain and loss on sales of marketable securities are included in the Company&amp;#39;s "Financial income, net" and are derived using the specific identification basis for determining the cost of marketable securities. The amortized cost of available for sale marketable securities is adjusted for amortization of premiums and accretion of discount to maturity. Such amortization, together with interest on available for sale marketable securities, is included in the "Financial income, net".&lt;/div&gt; &lt;div style="DISPLAY: block; MARGIN-LEFT: 437pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"&gt; &amp;nbsp;&lt;/div&gt; &lt;div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"&gt; The Company recognizes an impairment charge when a decline in the fair value of its available-for-sale marketable securities below the cost basis is judged to be other-than-temporary. The Company considers various factors in determining whether to recognize an impairment charge, including the length of time the investment has been in a loss position, the extent to which the fair value has been less than the Company&amp;#39;s cost basis, the investment&amp;#39;s financial condition and the near-term prospects of the issuer. ASC 320-10-35, "Investments - Debt and Equity Securities", requires another-than-temporary impairment for debt securities to be separated into (a)&amp;nbsp;the amount representing the credit loss and (b)&amp;nbsp;the amount related to all other factors (provided that the Company does not intend to sell the security and it is not more likely than not that it will be required to sell it before recovery). For securities that are deemed other-than-temporarily impaired, the amount of impairment is recognized in "financial income, net", in the statement of operations and is limited to the amount related to credit loss, while impairment related to other factors is recognized in other comprehensive income (loss).&lt;/div&gt; &lt;div style="DISPLAY: block; MARGIN-LEFT: 437pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"&gt; &amp;nbsp;&lt;/div&gt; &lt;div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"&gt; During 2014, 2013 and 2012, no impairment losses been identified.&lt;/div&gt; &lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"&gt; &amp;nbsp;&lt;/div&gt; &lt;div style="text-align: center"&gt; &lt;table style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman" cellspacing="0" cellpadding="0" width="100%" border="0"&gt; &lt;tr valign="top"&gt; &lt;td style="WIDTH: 18pt"&gt; &lt;div style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt"&gt; i.&lt;/div&gt; &lt;/td&gt; &lt;td&gt; &lt;div style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; text-align: justify"&gt; Revenue Recognition from the license Agreement with United Therapeutics&lt;/div&gt; &lt;/td&gt; &lt;/tr&gt; &lt;/table&gt; &lt;/div&gt; &lt;div style="DISPLAY: block; MARGIN-LEFT: 437pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"&gt; &amp;nbsp;&lt;/div&gt; &lt;div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"&gt; The Company recognizes revenue pursuant to the License Agreement with United Therapeutics in accordance with ASC 605-25, "Revenue Recognition, Multiple-Element Arrangements".&lt;/div&gt; &lt;div style="MARGIN-LEFT: 437pt; DISPLAY: block; TEXT-INDENT: 0pt"&gt; &lt;br /&gt; &lt;/div&gt; &lt;div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"&gt; Pursuant to ASC 605-25, each deliverable is evaluated to determine whether it qualifies as a separate unit of accounting based on whether the deliverable has "stand-alone value" to the customer. The arrangement&amp;#39;s consideration that is fixed or determinable is then allocated to each separate unit of accounting based on the relative selling price of each deliverable. In general, the consideration allocated to each unit of accounting is recognized as the related goods or services are delivered, limited to the consideration that is not contingent upon future deliverables.&lt;/div&gt; &lt;div style="MARGIN-LEFT: 437pt; DISPLAY: block; TEXT-INDENT: 0pt"&gt; &lt;br /&gt; &lt;/div&gt; &lt;div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"&gt; The Company received an up-front, non-refundable license payment of $5,000. Additional payments totaling $37,500 are subject to the achievement of certain regulatory milestones by United Therapeutics.&lt;/div&gt; &lt;div style="MARGIN-LEFT: 437pt; DISPLAY: block; TEXT-INDENT: 0pt"&gt; &lt;br /&gt; &lt;/div&gt; &lt;div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"&gt; Since the deliverables in the United Agreement do not have stand-alone value, none of them qualifies as a separate unit of accounting. Accordingly, the non-refundable upfront license fee of $5,000 is deferred and recognized on a straight line basis over the related performance period which is the development period in accordance with Staff Accounting Bulletin ("SAB") 104, "Revenue Recognition". The remaining performance period is 8.5 years as of June 30, 2014.&lt;/div&gt; &lt;div style="MARGIN-LEFT: 437pt; DISPLAY: block; TEXT-INDENT: 0pt"&gt; &lt;br /&gt; &lt;/div&gt; &lt;div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"&gt; The additional regulatory milestones payments will be recognized upon the achievement of futures events by United Therapeutics, in accordance with ASC 450-30-25, "Gain Contingencies". As of June 30, 2014, no regulatory millstones were achieved.&lt;/div&gt; &lt;div style="MARGIN-LEFT: 437pt; DISPLAY: block; TEXT-INDENT: 0pt"&gt; &lt;br /&gt; &lt;/div&gt; &lt;div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"&gt; The Company also received an advanced payment for the development, of $2,000 that will be deductible against development expenses as it incurred. The upfront payment which was received and has not yet fully recognized in the statement of operations, is included in the balance sheet as advance payment. Part of the expenses related to the development, on a cost basis, shall be repaid to the Company by United Therapeutics according to the applicable license agreement. The Company is deducting the payments from its research and development expenses in accordance with ASC 730-20, "Research and Development Agreements". As of June 30, 2014, the Company deducted an amount of approximately $1,753.&lt;/div&gt; &lt;div style="DISPLAY: block; TEXT-INDENT: 0pt"&gt;&amp;nbsp;&lt;/div&gt; &lt;div&gt; &lt;table style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman" cellspacing="0" cellpadding="0" width="100%" align="center" border="0"&gt; &lt;tr valign="top"&gt; &lt;td style="WIDTH: 18pt"&gt; &lt;div style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt"&gt; j.&lt;/div&gt; &lt;/td&gt; &lt;td&gt; &lt;div style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; text-align: justify"&gt; Property and Equipment&lt;/div&gt; &lt;/td&gt; &lt;/tr&gt; &lt;/table&gt; &lt;/div&gt; &lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"&gt; &amp;nbsp;&lt;/div&gt; &lt;div&gt; &lt;table style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman" cellspacing="0" cellpadding="0" width="100%" align="center" border="0"&gt; &lt;tr valign="top"&gt; &lt;td style="WIDTH: 18pt"&gt; &lt;div style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/div&gt; &lt;/td&gt; &lt;td&gt; &lt;div style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; text-align: justify"&gt; Property and equipment are stated at cost, net of accumulated depreciation. Depreciation is calculated by the straight-line method over the estimated useful lives of the assets, at the following annual rates:&lt;/div&gt; &lt;/td&gt; &lt;/tr&gt; &lt;/table&gt; &lt;/div&gt; &lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"&gt; &amp;nbsp;&lt;/div&gt; &lt;div style="MARGIN-LEFT: 18pt; text-align: left"&gt; &lt;table style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman" cellspacing="0" cellpadding="0" width="80%"&gt; &lt;tr&gt; &lt;td valign="top" width="44%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 2px solid" valign="top" width="28%"&gt; &lt;div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt"&gt; %&lt;/div&gt; &lt;/td&gt; &lt;td valign="top" width="28%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr bgcolor="#cceeff"&gt; &lt;td valign="top" width="44%" align="left"&gt; &lt;div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"&gt; Laboratory equipment&lt;/div&gt; &lt;/td&gt; &lt;td valign="top" width="28%" align="left"&gt; &lt;div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: -12.3pt; text-align: left; TEXT-INDENT: 0pt"&gt; 10-15&lt;/div&gt; &lt;/td&gt; &lt;td valign="top" width="28%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr bgcolor="white"&gt; &lt;td valign="top" width="44%" align="left"&gt; &lt;div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"&gt; Computers and peripheral equipment&lt;/div&gt; &lt;/td&gt; &lt;td valign="top" width="28%" align="left"&gt; &lt;div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: -12.3pt; text-align: left; TEXT-INDENT: 0pt"&gt; 33&lt;/div&gt; &lt;/td&gt; &lt;td valign="top" width="28%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr bgcolor="#cceeff"&gt; &lt;td valign="top" width="44%" align="left"&gt; &lt;div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"&gt; Office furniture and equipment&lt;/div&gt; &lt;/td&gt; &lt;td valign="top" width="28%" align="left"&gt; &lt;div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: -12.3pt; text-align: left; TEXT-INDENT: 0pt"&gt; 6-15&lt;/div&gt; &lt;/td&gt; &lt;td valign="top" width="28%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr bgcolor="white"&gt; &lt;td valign="top" width="44%" align="left"&gt; &lt;div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"&gt; Vehicles&lt;/div&gt; &lt;/td&gt; &lt;td valign="top" width="15%" colspan="2" align="left"&gt; &lt;div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: -12.3pt; text-align: left; TEXT-INDENT: 0pt"&gt; 15&lt;/div&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr bgcolor="#cceeff"&gt; &lt;td valign="top" width="44%" align="left"&gt; &lt;div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"&gt; Leasehold improvements&lt;/div&gt; &lt;/td&gt; &lt;td valign="top" width="56%" colspan="2" align="left"&gt; &lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: -12.3pt; text-align: left; TEXT-INDENT: 0pt"&gt; &lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; The shorter of the expected&lt;/font&gt; &lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; useful life or the&lt;/font&gt;&lt;/div&gt; &lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: -12.3pt; text-align: left; TEXT-INDENT: 0pt"&gt; &lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; reasonable assumed&lt;/font&gt; &lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; term of the lease.&lt;/font&gt;&lt;/div&gt; &lt;/td&gt; &lt;/tr&gt; &lt;/table&gt; &lt;/div&gt; &lt;div style="DISPLAY: block; TEXT-INDENT: 0pt"&gt;&lt;br /&gt; &lt;/div&gt; &lt;div style="text-align: center"&gt; &lt;table style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman" cellspacing="0" cellpadding="0" width="100%" border="0"&gt; &lt;tr valign="top"&gt; &lt;td style="WIDTH: 18pt"&gt; &lt;div style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt"&gt; k.&lt;/div&gt; &lt;/td&gt; &lt;td&gt; &lt;div style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; text-align: justify"&gt; Impairment of long-lived assets&lt;/div&gt; &lt;/td&gt; &lt;/tr&gt; &lt;/table&gt; &lt;/div&gt; &lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"&gt; &amp;nbsp;&lt;/div&gt; &lt;div&gt; &lt;table style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman" cellspacing="0" cellpadding="0" width="100%" align="center" border="0"&gt; &lt;tr valign="top"&gt; &lt;td style="WIDTH: 18pt"&gt; &lt;div style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/div&gt; &lt;/td&gt; &lt;td&gt; &lt;div style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; text-align: justify"&gt; The Company&amp;#39;s long-lived assets are reviewed for impairment in accordance with ASC 360, "Property, Plant and Equipment", whenever events or changes in circumstances indicate that the carrying amount of an asset may not be recoverable. Recoverability of assets to be held and used is measured by a comparison of the carrying amount of the assets to the future undiscounted cash flows expected to be generated by the assets. If such assets are considered to be impaired, the impairment to be recognized is measured by the amount by which the carrying amount of the assets exceeds the fair value of the assets. During 2014, 2013 and 2012, no impairment losses been identified.&lt;/div&gt; &lt;/td&gt; &lt;/tr&gt; &lt;/table&gt; &lt;/div&gt; &lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"&gt; &amp;nbsp;&lt;/div&gt; &lt;div&gt; &lt;table style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman" cellspacing="0" cellpadding="0" width="100%" align="center" border="0"&gt; &lt;tr valign="top"&gt; &lt;td style="WIDTH: 18pt"&gt; &lt;div style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt"&gt; l.&lt;/div&gt; &lt;/td&gt; &lt;td&gt; &lt;div style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; text-align: justify"&gt; Accounting for stock-based compensation&lt;/div&gt; &lt;/td&gt; &lt;/tr&gt; &lt;/table&gt; &lt;/div&gt; &lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"&gt; &amp;nbsp;&lt;/div&gt; &lt;div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"&gt; The Company accounts for stock-based compensation in accordance with ASC 718, "Compensation-Stock Compensation" ("ASC 718") and ASC 505-50 "Equity-Based Payments to Non-Employees". ASC 718 requires companies to estimate the fair value of equity-based payment awards on the date of grant using an option-pricing model. The Company estimates the fair value of stock options granted using the Black-Scholes-Merton option-pricing model. The Company accounts for employee&amp;#39;s share-based payment awards classified as equity awards using the grant-date fair value method. The fair value of share-based payment transactions is recognized as an expense over the requisite service period, net of estimated forfeitures. The Company estimates forfeitures based on historical experience and anticipated future conditions. The Company elected to recognize compensation cost for an award with service conditions and goals achievement that has a graded vesting schedule using the accelerated method based on the multiple-option award approach.&lt;/div&gt; &lt;div style="DISPLAY: block; TEXT-INDENT: 0pt"&gt;&lt;br /&gt; &lt;/div&gt; &lt;div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"&gt; During fiscal years 2014, 2013 and 2012 there were no options grants to employees or directors.&lt;/div&gt; &lt;div style="MARGIN-LEFT: 437pt; DISPLAY: block; TEXT-INDENT: 0pt"&gt; &lt;br /&gt; &lt;/div&gt; &lt;div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"&gt; The assumptions below are relevant to restricted shares units granted in 2014, 2013 and 2012:&lt;/div&gt; &lt;div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"&gt; In accordance with &lt;font style="FONT-SIZE: 10pt; DISPLAY: inline"&gt;ASC 718&lt;/font&gt;, restricted shares or restricted shares units are measured at their fair value. All restricted shares and restricted shares units to employees, directors and non-employees granted in 20142013 and 2012 were granted for no consideration; therefore, their fair value was equal to the share price at the date of grant.&lt;/div&gt; &lt;div style="MARGIN-LEFT: 437pt; DISPLAY: block; TEXT-INDENT: 0pt"&gt; &lt;br /&gt; &lt;/div&gt; &lt;div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"&gt; The expected pre-vesting forfeiture rate affects the number of exercisable shares. Based on Company&amp;#39;s historical experience, the pre-vesting forfeiture rate per grant for shares granted to employees is 7% for year ended June 30, 2014 and 2013 and 5% for the year ended June 30, 2012, and 0% for the options and shares granted to directors and officers and consultants of the Company.&lt;/div&gt; &lt;div style="MARGIN-LEFT: 437pt; DISPLAY: block; TEXT-INDENT: 0pt"&gt; &lt;br /&gt; &lt;/div&gt; &lt;div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"&gt; The fair value of all restricted shares and restricted shares units was determined based on the close trading price of the Company&amp;#39;s shares known at the grant date. The weighted average grant date fair value of share granted during years 2014, 2013 and 2012 was $3.53, $3.43 and $2.54, respectively.&lt;/div&gt; &lt;div style="DISPLAY: block; TEXT-INDENT: 0pt"&gt;&amp;nbsp;&lt;/div&gt; &lt;div style="text-align: center"&gt; &lt;table style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman" cellspacing="0" cellpadding="0" width="100%" border="0"&gt; &lt;tr valign="top"&gt; &lt;td style="WIDTH: 18pt"&gt; &lt;div style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt"&gt; m.&lt;/div&gt; &lt;/td&gt; &lt;td&gt; &lt;div style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; text-align: justify"&gt; Research and Development expenses and grants&lt;/div&gt; &lt;/td&gt; &lt;/tr&gt; &lt;/table&gt; &lt;/div&gt; &lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"&gt; &amp;nbsp;&lt;/div&gt; &lt;div&gt; &lt;table style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman" cellspacing="0" cellpadding="0" width="100%" align="center" border="0"&gt; &lt;tr valign="top"&gt; &lt;td style="WIDTH: 19pt"&gt; &lt;div style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/div&gt; &lt;/td&gt; &lt;td&gt; &lt;div style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; text-align: justify"&gt; Research and development expenses, net of participations, are charged to the statement of operations as incurred.&lt;/div&gt; &lt;/td&gt; &lt;/tr&gt; &lt;/table&gt; &lt;/div&gt; &lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"&gt; &amp;nbsp;&lt;/div&gt; &lt;div&gt; &lt;table style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman" cellspacing="0" cellpadding="0" width="100%" align="center" border="0"&gt; &lt;tr valign="top"&gt; &lt;td style="WIDTH: 19pt"&gt; &lt;div style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/div&gt; &lt;/td&gt; &lt;td&gt; &lt;div style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; text-align: justify"&gt; Research and development grants from the government of Israel and other parties for funding approved research and development projects are recognized at the time the Company is entitled to such grants, on the basis of the cost incurred and applied as a deduction from research and development costs.&lt;/div&gt; &lt;/td&gt; &lt;/tr&gt; &lt;/table&gt; &lt;/div&gt; &lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"&gt; &amp;nbsp;&lt;/div&gt; &lt;div style="text-align: center"&gt; &lt;table style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman" cellspacing="0" cellpadding="0" width="100%" border="0"&gt; &lt;tr valign="top"&gt; &lt;td style="WIDTH: 18pt"&gt; &lt;div style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt"&gt; n.&lt;/div&gt; &lt;/td&gt; &lt;td&gt; &lt;div style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; text-align: justify"&gt; Loss per share&lt;/div&gt; &lt;/td&gt; &lt;/tr&gt; &lt;/table&gt; &lt;/div&gt; &lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"&gt; &amp;nbsp;&lt;/div&gt; &lt;div&gt; &lt;table style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman" cellspacing="0" cellpadding="0" width="100%" align="center" border="0"&gt; &lt;tr valign="top"&gt; &lt;td style="WIDTH: 19pt"&gt; &lt;div style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/div&gt; &lt;/td&gt; &lt;td&gt; &lt;div style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; text-align: justify"&gt; Basic and dilutive net loss per share is computed based on the weighted average number of shares of common stock outstanding during each year. All outstanding stock options and unvested restricted stock units have been excluded from the calculation of the diluted loss per common share because all such securities are anti-dilutive for each of the periods presented.&lt;/div&gt; &lt;/td&gt; &lt;/tr&gt; &lt;/table&gt; &lt;/div&gt; &lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"&gt; &amp;nbsp;&lt;/div&gt; &lt;div style="text-align: center"&gt; &lt;table style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman" cellspacing="0" cellpadding="0" width="100%" border="0"&gt; &lt;tr valign="top"&gt; &lt;td style="WIDTH: 18pt"&gt; &lt;div style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt"&gt; o.&lt;/div&gt; &lt;/td&gt; &lt;td&gt; &lt;div style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; text-align: justify"&gt; Income taxes&lt;/div&gt; &lt;/td&gt; &lt;/tr&gt; &lt;/table&gt; &lt;/div&gt; &lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"&gt; &amp;nbsp;&lt;/div&gt; &lt;div&gt; &lt;table style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman" cellspacing="0" cellpadding="0" width="100%" align="center" border="0"&gt; &lt;tr valign="top"&gt; &lt;td style="WIDTH: 19pt"&gt; &lt;div style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/div&gt; &lt;/td&gt; &lt;td&gt; &lt;div style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; text-align: justify"&gt; The Company accounts for income taxes in accordance with ASC 740, "Income Taxes". This Topic prescribes the use of the liability method, whereby deferred tax assets and liability account balances are determined based on differences between financial reporting and tax bases of assets and liabilities and are measured using the enacted tax rates and laws that will be in effect when the differences are expected to reverse. The Company provides a valuation allowance, if necessary, to reduce deferred tax assets to their estimated realizable value.&lt;/div&gt; &lt;/td&gt; &lt;/tr&gt; &lt;/table&gt; &lt;/div&gt; &lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"&gt; &amp;nbsp;&lt;/div&gt; &lt;div&gt; &lt;table style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman" cellspacing="0" cellpadding="0" width="100%" align="center" border="0"&gt; &lt;tr valign="top"&gt; &lt;td style="WIDTH: 19pt"&gt; &lt;div style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/div&gt; &lt;/td&gt; &lt;td&gt; &lt;div style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; text-align: justify"&gt; ASC 740 establishes a single model to address accounting for uncertain tax positions. ASC 740 clarified the accounting for income taxes by prescribing the minimum recognition threshold a tax position is required to meet before being recognized in the financial statements.&lt;/div&gt; &lt;/td&gt; &lt;/tr&gt; &lt;/table&gt; &lt;/div&gt; &lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"&gt; &amp;nbsp;&lt;/div&gt; &lt;div style="text-align: center"&gt; &lt;table style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman" cellspacing="0" cellpadding="0" width="100%" border="0"&gt; &lt;tr valign="top"&gt; &lt;td style="WIDTH: 18pt"&gt; &lt;div style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt"&gt; p.&lt;/div&gt; &lt;/td&gt; &lt;td&gt; &lt;div style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; text-align: justify"&gt; Concentration of credit risk&lt;/div&gt; &lt;/td&gt; &lt;/tr&gt; &lt;/table&gt; &lt;/div&gt; &lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"&gt; &amp;nbsp;&lt;/div&gt; &lt;div&gt; &lt;table style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman" cellspacing="0" cellpadding="0" width="100%" align="center" border="0"&gt; &lt;tr valign="top"&gt; &lt;td style="WIDTH: 19pt"&gt; &lt;div style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/div&gt; &lt;/td&gt; &lt;td&gt; &lt;div style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; text-align: justify"&gt; Financial instruments that potentially subject the Company to concentrations of credit risk consist principally of cash and cash equivalents, short-term deposits, long-term deposits, restricted deposits and marketable securities.&lt;/div&gt; &lt;/td&gt; &lt;/tr&gt; &lt;/table&gt; &lt;/div&gt; &lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"&gt; &amp;nbsp;&lt;/div&gt; &lt;div&gt; &lt;table style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman" cellspacing="0" cellpadding="0" width="100%" align="center" border="0"&gt; &lt;tr valign="top"&gt; &lt;td style="WIDTH: 19pt"&gt; &lt;div style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/div&gt; &lt;/td&gt; &lt;td&gt; &lt;div style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; text-align: justify"&gt; The majority of the Company&amp;#39;s cash and cash equivalents and short-term and long-term deposits are invested in dollar instruments of major banks in Israel. Generally, these deposits may be redeemed upon demand and therefore bear minimal risk.&lt;/div&gt; &lt;/td&gt; &lt;/tr&gt; &lt;/table&gt; &lt;/div&gt; &lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"&gt; &amp;nbsp;&lt;/div&gt; &lt;div&gt; &lt;table style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman" cellspacing="0" cellpadding="0" width="100%" align="center" border="0"&gt; &lt;tr valign="top"&gt; &lt;td style="WIDTH: 18pt"&gt; &lt;div style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/div&gt; &lt;/td&gt; &lt;td&gt; &lt;div style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; text-align: justify"&gt; The Company invests its surplus cash in cash deposits and marketable securities in financial institutions and has established guidelines, approved by the Company&amp;#39;s Investment Committee, relating to diversification and maturities to maintain safety and liquidity of the investments.&lt;/div&gt; &lt;/td&gt; &lt;/tr&gt; &lt;/table&gt; &lt;/div&gt; &lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"&gt; &amp;nbsp;&lt;/div&gt; &lt;div&gt; &lt;table style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman" cellspacing="0" cellpadding="0" width="100%" align="center" border="0"&gt; &lt;tr valign="top"&gt; &lt;td style="WIDTH: 18pt"&gt; &lt;div style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/div&gt; &lt;/td&gt; &lt;td&gt; &lt;div style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; text-align: justify"&gt; The Company holds an investment portfolio consisting of corporate bonds, government bonds, stocks and index linked notes. The Company intends, and has the ability, to hold such investments until recovery of temporary declines in market value or maturity; accordingly, as of June&amp;nbsp;30, 2014, the Company believes the losses associated with its investments are temporary and no impairment loss was recognized during 2014. However, the Company can provide no assurance that it will recover declines in the market value of its investments.&lt;/div&gt; &lt;/td&gt; &lt;/tr&gt; &lt;/table&gt; &lt;/div&gt; &lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"&gt; &amp;nbsp;&lt;/div&gt; &lt;div style="text-align: center"&gt; &lt;table style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman" cellspacing="0" cellpadding="0" width="100%" border="0"&gt; &lt;tr valign="top"&gt; &lt;td style="WIDTH: 17pt"&gt; &lt;div style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt"&gt; q.&lt;/div&gt; &lt;/td&gt; &lt;td&gt; &lt;div style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; text-align: justify"&gt; Severance pay&lt;/div&gt; &lt;/td&gt; &lt;/tr&gt; &lt;/table&gt; &lt;/div&gt; &lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"&gt; &amp;nbsp;&lt;/div&gt; &lt;div&gt; &lt;table style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman" cellspacing="0" cellpadding="0" width="100%" align="center" border="0"&gt; &lt;tr valign="top"&gt; &lt;td style="WIDTH: 19pt"&gt; &lt;div style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/div&gt; &lt;/td&gt; &lt;td&gt; &lt;div style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; text-align: justify"&gt; The Subsidiary&amp;#39;s liability for severance pay is calculated pursuant to Israeli Severance Pay Law, 1963 (the "Severance Pay Law")&amp;nbsp;&amp;nbsp;based on the most recent salary of the employees multiplied by the number of years of employment, as of the balance sheet date. Employees are entitled to one month&amp;#39;s salary for each year of employment or a portion thereof.&lt;/div&gt; &lt;div style="text-align: justify"&gt;&amp;nbsp;&lt;/div&gt; &lt;div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-ALIGN: justify; TEXT-INDENT: 0pt"&gt; The Company&amp;#39;s liability for all of its employees is fully provided by monthly deposits with insurance policies and by an accrual. The value of these policies is recorded as an asset in the Company&amp;#39;s balance sheet.&lt;/div&gt; &lt;/td&gt; &lt;/tr&gt; &lt;/table&gt; &lt;/div&gt; &lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"&gt; &amp;nbsp;&lt;/div&gt; &lt;div&gt; &lt;table style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman" cellspacing="0" cellpadding="0" width="100%" align="center" border="0"&gt; &lt;tr valign="top"&gt; &lt;td style="WIDTH: 19pt"&gt; &lt;div style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/div&gt; &lt;/td&gt; &lt;td&gt; &lt;div style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; text-align: justify"&gt; The deposited funds include profits or losses accumulated up to the balance sheet date. The deposited funds may be withdrawn only upon the fulfillment of the obligation pursuant to Israeli severance pay law or labor agreements. The value of the deposited funds is based on the cash surrendered value of these policies, and includes immaterial profits or losses.&lt;/div&gt; &lt;/td&gt; &lt;/tr&gt; &lt;/table&gt; &lt;/div&gt; &lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"&gt; &amp;nbsp;&lt;/div&gt; &lt;div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"&gt; Since November 2011, the Company&amp;#39;s agreements with new employees in Israel, are subject to Section 14 of the Severance Pay Law. The Company&amp;#39;s contributions for severance pay have replaced its severance obligation. Upon contribution of the full amount of the employee&amp;#39;s monthly salary for each year of employment, no additional calculations is conducted between the parties regarding the matter of severance pay and no additional payments is made by the Company to the employee. Further, the related obligation and amounts deposited on behalf of the employee for such obligation are not stated on the balance sheet, as the Company is legally released from the obligation to employees once the deposit amounts have been paid.&lt;/div&gt; &lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"&gt; &amp;nbsp;&lt;/div&gt; &lt;div&gt; &lt;table style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman" cellspacing="0" cellpadding="0" width="100%" align="center" border="0"&gt; &lt;tr valign="top"&gt; &lt;td style="WIDTH: 19pt"&gt; &lt;div style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/div&gt; &lt;/td&gt; &lt;td&gt; &lt;div style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; text-align: justify"&gt; Severance expenses for the years ended December 31, 2014, 2013 and 2012, were $534, $329 and $275, respectively.&lt;/div&gt; &lt;/td&gt; &lt;/tr&gt; &lt;/table&gt; &lt;/div&gt; &lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"&gt; &amp;nbsp;&lt;/div&gt; &lt;div style="text-align: center"&gt; &lt;table style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman" cellspacing="0" cellpadding="0" width="100%" border="0"&gt; &lt;tr valign="top"&gt; &lt;td style="WIDTH: 18pt"&gt; &lt;div style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt"&gt; r.&lt;/div&gt; &lt;/td&gt; &lt;td&gt; &lt;div style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; text-align: justify"&gt; Fair value of financial instruments&lt;/div&gt; &lt;/td&gt; &lt;/tr&gt; &lt;/table&gt; &lt;/div&gt; &lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"&gt; &amp;nbsp;&lt;/div&gt; &lt;div&gt; &lt;table style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman" cellspacing="0" cellpadding="0" width="100%" align="center" border="0"&gt; &lt;tr valign="top"&gt; &lt;td style="WIDTH: 19pt"&gt; &lt;div style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/div&gt; &lt;/td&gt; &lt;td&gt; &lt;div style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; text-align: justify"&gt; The carrying amounts of the Company&amp;#39;s financial instruments, including cash and cash equivalents, short-term and restricted bank deposits, trade payable and other accounts payable and accrued liabilities, approximate fair value because of their generally short term maturities.&lt;/div&gt; &lt;/td&gt; &lt;/tr&gt; &lt;/table&gt; &lt;/div&gt; &lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"&gt; &amp;nbsp;&lt;/div&gt; &lt;div&gt; &lt;table style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman" cellspacing="0" cellpadding="0" width="100%" align="center" border="0"&gt; &lt;tr valign="top"&gt; &lt;td style="WIDTH: 19pt"&gt; &lt;div style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/div&gt; &lt;/td&gt; &lt;td&gt; &lt;div style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; text-align: justify"&gt; The Company measures its investments in marketable securities and derivative instruments at fair value under ASC 820, "Fair Value Measurements and Disclosures" ("ASC 820"). Fair value is an exit price, representing the amount that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants. As such, fair value is a market-based measurement that should be determined based on assumptions that market participants would use in pricing an asset or a liability. As a basis for considering such assumptions, ASC 820 establishes a three-tier value hierarchy, which prioritizes the inputs used in the valuation methodologies in measuring fair value:&lt;/div&gt; &lt;/td&gt; &lt;/tr&gt; &lt;/table&gt; &lt;/div&gt; &lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"&gt; &amp;nbsp;&lt;/div&gt; &lt;div&gt; &lt;table style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman" cellspacing="0" cellpadding="0" width="100%" align="center" border="0"&gt; &lt;tr valign="top"&gt; &lt;td style="WIDTH: 19pt"&gt; &lt;div style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/div&gt; &lt;/td&gt; &lt;td&gt; &lt;div style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; text-align: justify"&gt; &lt;font style="FONT-WEIGHT: bold; DISPLAY: inline"&gt;Level 1 -&lt;/font&gt; Quoted prices (unadjusted) in active markets for identical assets or liabilities that the Company can access at the measurement date;&lt;/div&gt; &lt;/td&gt; &lt;/tr&gt; &lt;/table&gt; &lt;/div&gt; &lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"&gt; &amp;nbsp;&lt;/div&gt; &lt;div&gt; &lt;table style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman" cellspacing="0" cellpadding="0" width="100%" align="center" border="0"&gt; &lt;tr valign="top"&gt; &lt;td style="WIDTH: 19pt"&gt; &lt;div style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/div&gt; &lt;/td&gt; &lt;td&gt; &lt;div style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; text-align: justify"&gt; &lt;font style="FONT-WEIGHT: bold; DISPLAY: inline"&gt;Level 2 -&lt;/font&gt; Inputs other than quoted prices included within Level 1 that are observable for the asset or liability, either directly or indirectly.; and&lt;/div&gt; &lt;/td&gt; &lt;/tr&gt; &lt;/table&gt; &lt;/div&gt; &lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"&gt; &amp;nbsp;&lt;/div&gt; &lt;div&gt; &lt;table style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman" cellspacing="0" cellpadding="0" width="100%" align="center" border="0"&gt; &lt;tr valign="top"&gt; &lt;td style="WIDTH: 19pt"&gt; &lt;div style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/div&gt; &lt;/td&gt; &lt;td&gt; &lt;div style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; text-align: justify"&gt; &lt;font style="FONT-WEIGHT: bold; DISPLAY: inline"&gt;Level 3 -&lt;/font&gt; Unobservable inputs for the asset or liability.&lt;/div&gt; &lt;/td&gt; &lt;/tr&gt; &lt;/table&gt; &lt;/div&gt; &lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"&gt; &amp;nbsp;&lt;/div&gt; &lt;div&gt; &lt;table style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman" cellspacing="0" cellpadding="0" width="100%" align="center" border="0"&gt; &lt;tr valign="top"&gt; &lt;td style="WIDTH: 19pt"&gt; &lt;div style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/div&gt; &lt;/td&gt; &lt;td&gt; &lt;div style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; text-align: justify"&gt; The fair value hierarchy also requires an entity to maximize the use of observable inputs and minimize the use of unobservable inputs when measuring fair value. The Company categorized each of its fair value measurements in one of these three levels of hierarchy.&lt;/div&gt; &lt;/td&gt; &lt;/tr&gt; &lt;/table&gt; &lt;/div&gt; &lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"&gt; &amp;nbsp;&lt;/div&gt; &lt;div style="text-align: center"&gt; &lt;table style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman" cellspacing="0" cellpadding="0" width="100%" border="0"&gt; &lt;tr valign="top"&gt; &lt;td style="WIDTH: 18pt"&gt; &lt;div style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt"&gt; s.&lt;/div&gt; &lt;/td&gt; &lt;td&gt; &lt;div style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; text-align: justify"&gt; Derivative financial instruments&lt;/div&gt; &lt;/td&gt; &lt;/tr&gt; &lt;/table&gt; &lt;/div&gt; &lt;div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"&gt; &amp;nbsp;&lt;/div&gt; &lt;div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"&gt; The Company uses forward contracts and options strategies ("derivative instruments") primarily to manage exposure to foreign currency. The Company accounts for derivatives and hedging based on ASC 815, "Derivatives and Hedging" ("ASC 815"). ASC 815 requires the Company to recognize all derivative instruments as either assets or liabilities on the balance sheet at fair value. The accounting for changes in the fair value (i.e., gains or losses) of derivative instruments depends on whether it has been designated and qualifies as part of a hedging relationship and further, on the type of hedging relationship. For those derivative instruments that are designated and qualify as hedging instruments, the Company must designate the hedging instrument, based upon the exposure being hedged, as a fair value hedge, cash flow hedge, or a hedge of a net investment in a foreign operation.&lt;/div&gt; &lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"&gt; &amp;nbsp;&lt;/div&gt; &lt;div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"&gt; If the derivative instruments meet the definition of a hedge and are so designated, depending on the nature of the hedge, changes in the fair value of such derivatives will either be offset against the change in fair value of the hedged assets, liabilities, or firm commitments through earnings, or recognized in other comprehensive income until the hedged item is recognized in the statement of operations.&lt;font style="FONT-SIZE: 10pt; DISPLAY: inline"&gt;&amp;nbsp;&lt;/font&gt; The ineffective portion of a derivative&amp;#39;s change in fair value is recognized in the statement of operations.&lt;/div&gt; &lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"&gt; &amp;nbsp;&lt;/div&gt; &lt;div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"&gt; &lt;font style="FONT-FAMILY: Times New Roman; FONT-STYLE: italic; DISPLAY: inline"&gt; Cash Flow Hedges&lt;/font&gt;. The Company entered into forward contracts to hedge against the risk of overall changes in future cash flow from payments of payroll and related expenses denominated in New Israeli Shekels (NIS). The Company measured the fair value of the contracts in accordance with ASC 820 (classified as level 2). The gain or loss on the effective portion of a cash flow hedge is initially reported as a component of accumulated other comprehensive income and subsequently reclassified into operating expenses in the same period or periods in which the payroll and related expenses are recognized, or reclassified into "Financial income, net", if the hedged transaction becomes probable of not occurring. Any gain or loss after a hedge is no longer designated, because it is no longer probable of occurring or it is related to an ineffective portion of a cash flow hedge is recognized in the statement of operations immediately. As of June 30, 2014, the Company had forward contracts in place to hedge future payroll and related expenses in NIS of approximately $2,820, with fair value of approximately $24. The net unrealized gain on the effective portion of these cash flow hedges was $23. The net gain realized in statement of operations during the year ended June 30, 2014, resulting from the cash flow hedge transactions,&amp;nbsp;&amp;nbsp;amounted to approximately $48. The forward contracts on the Company&amp;#39;s future NIS payroll and related expenses will settle by December 2014. On June 30, 2013, the Company did not have contracts designated and qualifies as cash flow hedge.&lt;/div&gt; &lt;div style="MARGIN-LEFT: 437pt; DISPLAY: block; TEXT-INDENT: 0pt"&gt; &lt;br /&gt; &lt;/div&gt; &lt;div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"&gt; &lt;font style="FONT-FAMILY: Times New Roman; FONT-STYLE: italic; DISPLAY: inline"&gt; Fair Value Hedges&lt;/font&gt;. The Company entered into forward contracts designated as fair value hedges to hedge foreign currency risks for its investment denominated in currencies other than the U.S. dollar. The Company measured the fair value of the contracts in accordance with ASC 820 (classified as level 2). Gains and losses on these contracts are recognized in "Financial income, net", along with the offsetting losses and gains of the related hedged items.&lt;/div&gt; &lt;div style="DISPLAY: block; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"&gt; &amp;nbsp;&lt;/div&gt; &lt;div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"&gt; In connection with the investment in CHA shares (see Note 1d), an available-for-sale marketable security denominated in Korean Won, the Company entered into a forward contract to hedge against the foreign currency risk between the Korean Won and the U.S. dollar. The notional principal of this contract is $11,000 as of June 30, 2014 with fair value of approximately $(889).&lt;/div&gt; &lt;div style="DISPLAY: block; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"&gt; &amp;nbsp;&lt;/div&gt; &lt;div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"&gt; The changes in fair value of the available-for-sale CHA shares attributable to the foreign currency risk being hedged are reflected in the statement of operations in "Financial income, net" (not in other comprehensive income). Other changes in fair value of the available-for-sale CHA shares continue to follow ASC 320-"Investments-Debt and Equity Securities", accounting and are reflected in other comprehensive income.&lt;/div&gt; &lt;div style="DISPLAY: block; TEXT-INDENT: 0pt"&gt;&lt;br /&gt; &lt;/div&gt; &lt;div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"&gt; &lt;font style="FONT-FAMILY: Times New Roman; FONT-STYLE: italic; DISPLAY: inline"&gt; Other Derivatives&lt;/font&gt;. Other derivatives that are non-designated consist primarily of options strategies to minimize the risk associated with the foreign exchange effects of monetary assets and liabilities denominated in NIS. The Company measured the fair value of the contracts in accordance with ASC 820 (classified as level 2). The net gains (losses) recognized in "Financial income, net" during the year ended June 30, 2014, 2013 and 2012 were ($70), $231 and ($145), respectively.&lt;/div&gt; &lt;div style="DISPLAY: block; TEXT-INDENT: 0pt"&gt;&amp;nbsp;&lt;/div&gt; &lt;div style="text-align: center"&gt; &lt;table style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman" cellspacing="0" cellpadding="0" width="100%" border="0"&gt; &lt;tr valign="top"&gt; &lt;td style="WIDTH: 18pt"&gt; &lt;div style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt"&gt; t.&lt;/div&gt; &lt;/td&gt; &lt;td&gt; &lt;div style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; text-align: justify"&gt; &lt;font style="FONT-WEIGHT: bold; DISPLAY: inline"&gt;Comprehensive income&lt;/font&gt;&lt;font style="FONT-SIZE: 10pt; DISPLAY: inline"&gt;:&lt;/font&gt;&lt;/div&gt; &lt;/td&gt; &lt;/tr&gt; &lt;/table&gt; &lt;/div&gt; &lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"&gt; &amp;nbsp;&lt;/div&gt; &lt;div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"&gt; The Company accounts for comprehensive income (loss) in accordance with ASC No. 220, "Comprehensive Income". Comprehensive income generally represents all changes in shareholders&amp;#39; equity during the period except those resulting from investments by, or distributions to, shareholders. The Company determined that its items of other comprehensive income relate to gains and losses on cash flow hedging derivative instruments and unrealized gains and losses on available for sale marketable securities.&lt;/div&gt; &lt;div style="DISPLAY: block; TEXT-INDENT: 0pt"&gt;&amp;nbsp;&lt;/div&gt; &lt;div style="text-align: right"&gt; &lt;table style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman" cellspacing="0" cellpadding="0" width="97%"&gt; &lt;tr&gt; &lt;td style="PADDING-BOTTOM: 2px" valign="bottom" width="64%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="34%" colspan="10"&gt; &lt;div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"&gt; Year ended June 30, 2014&lt;/div&gt; &lt;/td&gt; &lt;td style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td style="PADDING-BOTTOM: 2px" valign="bottom" width="64%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="10%" colspan="2"&gt; &lt;div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"&gt; Unrealized&lt;/div&gt; &lt;div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"&gt; gains&lt;/div&gt; &lt;div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"&gt; on marketable&lt;/div&gt; &lt;div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"&gt; securities&lt;/div&gt; &lt;/td&gt; &lt;td style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="10%" colspan="2"&gt; &lt;div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"&gt; Unrealized&lt;/div&gt; &lt;div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"&gt; gains&lt;/div&gt; &lt;div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"&gt; on cash flow&lt;/div&gt; &lt;div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"&gt; hedges&lt;/div&gt; &lt;/td&gt; &lt;td style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="10%" colspan="2"&gt; &lt;div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"&gt; Total&lt;/div&gt; &lt;/td&gt; &lt;td style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr bgcolor="#cceeff"&gt; &lt;td style="TEXT-ALIGN: left; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt" valign="bottom" width="64%"&gt; &lt;div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: left; TEXT-INDENT: 0pt"&gt; Beginning balance&lt;/div&gt; &lt;/td&gt; &lt;td valign="bottom" width="1%" align="right"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%"&gt;$&lt;/td&gt; &lt;td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%"&gt;259&lt;/td&gt; &lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td valign="bottom" width="1%" align="right"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%"&gt;$&lt;/td&gt; &lt;td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%"&gt;-&lt;/td&gt; &lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td valign="bottom" width="1%" align="right"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%"&gt;$&lt;/td&gt; &lt;td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%"&gt;259&lt;/td&gt; &lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr bgcolor="white"&gt; &lt;td style="TEXT-ALIGN: left; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt" valign="bottom" width="64%"&gt; &lt;div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: left; TEXT-INDENT: 0pt"&gt; Other comprehensive income before reclassifications&lt;/div&gt; &lt;/td&gt; &lt;td valign="bottom" width="1%" align="right"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%"&gt;3,404&lt;/td&gt; &lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td valign="bottom" width="1%" align="right"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%"&gt;23&lt;/td&gt; &lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td valign="bottom" width="1%" align="right"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%"&gt;3,427&lt;/td&gt; &lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr bgcolor="#cceeff"&gt; &lt;td style="TEXT-ALIGN: left; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt" valign="bottom" width="64%"&gt; &lt;div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: left; TEXT-INDENT: 0pt"&gt; Amounts reclassified from accumulated other comprehensive loss&lt;/div&gt; &lt;/td&gt; &lt;td valign="bottom" width="1%" align="right"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%"&gt;(727&lt;/td&gt; &lt;td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"&gt;)&lt;/td&gt; &lt;td valign="bottom" width="1%" align="right"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%"&gt;-&lt;/td&gt; &lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td valign="bottom" width="1%" align="right"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%"&gt;(727&lt;/td&gt; &lt;td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"&gt;)&lt;/td&gt; &lt;/tr&gt; &lt;tr bgcolor="white"&gt; &lt;td style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt" valign="bottom" width="64%"&gt; &lt;div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: left; TEXT-INDENT: 0pt"&gt; Net current-period other comprehensive income&lt;/div&gt; &lt;/td&gt; &lt;td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%" align="right"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 2px solid; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%"&gt;2,677&lt;/td&gt; &lt;td style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%" align="right"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 2px solid; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%"&gt;23&lt;/td&gt; &lt;td style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%" align="right"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 2px solid; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%"&gt;2,700&lt;/td&gt; &lt;td style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr bgcolor="#cceeff"&gt; &lt;td style="PADDING-BOTTOM: 4px; TEXT-ALIGN: left; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt" valign="bottom" width="64%"&gt; &lt;div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: left; TEXT-INDENT: 0pt"&gt; Ending balance&lt;/div&gt; &lt;/td&gt; &lt;td style="PADDING-BOTTOM: 4px" valign="bottom" width="1%" align="right"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 4px double; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%"&gt;$&lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 4px double; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%"&gt;2,936&lt;/td&gt; &lt;td style="PADDING-BOTTOM: 4px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="PADDING-BOTTOM: 4px" valign="bottom" width="1%" align="right"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 4px double; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%"&gt;$&lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 4px double; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%"&gt;23&lt;/td&gt; &lt;td style="PADDING-BOTTOM: 4px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="PADDING-BOTTOM: 4px" valign="bottom" width="1%" align="right"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 4px double; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%"&gt;$&lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 4px double; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%"&gt;2,959&lt;/td&gt; &lt;td style="PADDING-BOTTOM: 4px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;/tr&gt; &lt;/table&gt; &lt;/div&gt; &lt;div style="DISPLAY: block; TEXT-INDENT: 0pt"&gt;&amp;nbsp;&lt;/div&gt; &lt;div style="text-align: center"&gt; &lt;table style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman" cellspacing="0" cellpadding="0" width="100%" border="0"&gt; &lt;tr valign="top"&gt; &lt;td style="WIDTH: 18pt"&gt; &lt;div style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt"&gt; u.&lt;/div&gt; &lt;/td&gt; &lt;td&gt; &lt;div style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; text-align: justify"&gt; Recent Accounting Pronouncement&lt;/div&gt; &lt;/td&gt; &lt;/tr&gt; &lt;/table&gt; &lt;/div&gt; &lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"&gt; &amp;nbsp;&lt;/div&gt; &lt;div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"&gt; In May 2014, the FASB issued Accounting Standards Update No. 2014-09 ("ASU 2014-09"), "Revenue from Contracts with Customers". ASU 2014-09 supersedes the revenue recognition requirements in "Revenue Recognition (Topic 605)", and requires entities to recognize revenue when it transfers promised goods or services to customers in an amount that reflects the consideration to which the entity expects to be entitled to in exchange for those goods or services. ASU 2014-09 is effective for annual reporting periods beginning after December 15, 2016, including interim periods within that reporting period. Early adoption is not permitted. The Company is currently in the process of evaluating the impact of the adoption of ASU 2014-09 on its consolidated financial statements.&lt;/div&gt; &lt;!--EndFragment--&gt;&lt;/div&gt; &lt;/div&gt;</us-gaap:SignificantAccountingPoliciesTextBlock>
  <us-gaap:StockholdersEquity id="StockholdersEquity.872.0.0.0.0.0.0" contextRef="as-of-2014-06-30.872.0.0.0.0.0.0.0" unitRef="USD" decimals="-3">62123000</us-gaap:StockholdersEquity>
  <us-gaap:StockholdersEquity id="StockholdersEquity.874.0.0.0.0.0.0" contextRef="as-of-2013-06-30.874.0.0.0.0.0.0.0" unitRef="USD" decimals="-3">57466000</us-gaap:StockholdersEquity>
  <us-gaap:StockholdersEquity id="StockholdersEquity.875.0.0.0.0.0.0" contextRef="as-of-2011-06-30.875.0.0.0.0.0.0.0" unitRef="USD" decimals="-3">43422000</us-gaap:StockholdersEquity>
  <us-gaap:StockholdersEquity id="StockholdersEquity.876.0.0.0.0.0.0" contextRef="as-of-2012-06-30.876.0.0.0.0.0.0.0" unitRef="USD" decimals="-3">37742000</us-gaap:StockholdersEquity>
  <us-gaap:StockholdersEquity id="StockholdersEquity.872.1115.5114.0.0.0.0" xsi:nil="true" contextRef="as-of-2014-06-30.872.0.1115.5114.0.0.0.0" unitRef="USD" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" />
  <us-gaap:StockholdersEquity id="StockholdersEquity.874.1115.5114.0.0.0.0" xsi:nil="true" contextRef="as-of-2013-06-30.874.0.1115.5114.0.0.0.0" unitRef="USD" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" />
  <us-gaap:StockholdersEquity id="StockholdersEquity.875.1115.5114.0.0.0.0" xsi:nil="true" contextRef="as-of-2011-06-30.875.0.1115.5114.0.0.0.0" unitRef="USD" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" />
  <us-gaap:StockholdersEquity id="StockholdersEquity.876.1115.5114.0.0.0.0" xsi:nil="true" contextRef="as-of-2012-06-30.876.0.1115.5114.0.0.0.0" unitRef="USD" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" />
  <us-gaap:StockholdersEquity id="StockholdersEquity.872.499.5114.0.0.0.0" contextRef="as-of-2014-06-30.872.0.499.5114.0.0.0.0" unitRef="USD" decimals="-3">172998000</us-gaap:StockholdersEquity>
  <us-gaap:StockholdersEquity id="StockholdersEquity.874.499.5114.0.0.0.0" contextRef="as-of-2013-06-30.874.0.499.5114.0.0.0.0" unitRef="USD" decimals="-3">144109000</us-gaap:StockholdersEquity>
  <us-gaap:StockholdersEquity id="StockholdersEquity.875.499.5114.0.0.0.0" contextRef="as-of-2011-06-30.875.0.499.5114.0.0.0.0" unitRef="USD" decimals="-3">94375000</us-gaap:StockholdersEquity>
  <us-gaap:StockholdersEquity id="StockholdersEquity.876.499.5114.0.0.0.0" contextRef="as-of-2012-06-30.876.0.499.5114.0.0.0.0" unitRef="USD" decimals="-3">103619000</us-gaap:StockholdersEquity>
  <us-gaap:StockholdersEquity id="StockholdersEquity.872.478.5114.0.0.0.0" contextRef="as-of-2014-06-30.872.0.478.5114.0.0.0.0" unitRef="USD" decimals="-3">2959000</us-gaap:StockholdersEquity>
  <us-gaap:StockholdersEquity id="StockholdersEquity.874.478.5114.0.0.0.0" contextRef="as-of-2013-06-30.874.0.478.5114.0.0.0.0" unitRef="USD" decimals="-3">259000</us-gaap:StockholdersEquity>
  <us-gaap:StockholdersEquity id="StockholdersEquity.875.478.5114.0.0.0.0" xsi:nil="true" contextRef="as-of-2011-06-30.875.0.478.5114.0.0.0.0" unitRef="USD" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" />
  <us-gaap:StockholdersEquity id="StockholdersEquity.876.478.5114.0.0.0.0" contextRef="as-of-2012-06-30.876.0.478.5114.0.0.0.0" unitRef="USD" decimals="-3">-130000</us-gaap:StockholdersEquity>
  <us-gaap:StockholdersEquity id="StockholdersEquity.872.4619.5114.0.0.0.0" contextRef="as-of-2014-06-30.872.0.4619.5114.0.0.0.0" unitRef="USD" decimals="-3">-113834000</us-gaap:StockholdersEquity>
  <us-gaap:StockholdersEquity id="StockholdersEquity.874.4619.5114.0.0.0.0" contextRef="as-of-2013-06-30.874.0.4619.5114.0.0.0.0" unitRef="USD" decimals="-3">-86902000</us-gaap:StockholdersEquity>
  <us-gaap:StockholdersEquity id="StockholdersEquity.875.4619.5114.0.0.0.0" contextRef="as-of-2011-06-30.875.0.4619.5114.0.0.0.0" unitRef="USD" decimals="-3">-50953000</us-gaap:StockholdersEquity>
  <us-gaap:StockholdersEquity id="StockholdersEquity.876.4619.5114.0.0.0.0" contextRef="as-of-2012-06-30.876.0.4619.5114.0.0.0.0" unitRef="USD" decimals="-3">-65747000</us-gaap:StockholdersEquity>
  <us-gaap:StockholdersEquityNoteDisclosureTextBlock id="StockholdersEquityNoteDisclosureTextBlock.869.0.0.0.0.0.0" contextRef="from-2013-07-01-to-2014-06-30.869.0.0.0.0.0.0.0">&lt;!--DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd" --&gt;&lt;div&gt; &lt;div&gt;&lt;!--StartFragment--&gt; &lt;div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: left; TEXT-INDENT: 0pt"&gt; NOTE 8: - STOCKHOLDERS&amp;#39; EQUITY&lt;/div&gt; &lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"&gt; &amp;nbsp;&lt;/div&gt; &lt;div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"&gt; The Company&amp;#39;s authorized common stock consists of 200,000,000 shares with a par value of $0.00001 per share.&amp;nbsp;&amp;nbsp;All shares have equal voting rights and are entitled to one vote per share in all matters to be voted upon by stockholders. The shares have no pre-emptive, subscription, conversion or redemption rights and may be issued only as fully paid and non-assessable shares. Holders of the common stock are entitled to equal ratable rights to dividends and distributions with respect to the common stock, as may be declared by the Board of Directors out of funds legally available.&lt;/div&gt; &lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"&gt; &amp;nbsp;&lt;/div&gt; &lt;div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"&gt; The Company&amp;#39;s authorized preferred stock consists of 10,000,000 shares of preferred stock, par value $0.00001 per share, with series, rights, preferences, privileges and restrictions as may be designated from time to time by the Company&amp;#39;s Board of Directors.&amp;nbsp;&amp;nbsp;No shares of preferred stock have been issued.&lt;/div&gt; &lt;div style="DISPLAY: block; TEXT-INDENT: 0pt"&gt;&amp;nbsp;&lt;/div&gt; &lt;div style="DISPLAY: block; TEXT-INDENT: 0pt"&gt; &lt;table style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman" cellspacing="0" cellpadding="0" width="100%" border="0"&gt; &lt;tr valign="top"&gt; &lt;td style="WIDTH: 18pt"&gt; &lt;div style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt"&gt; a.&lt;/div&gt; &lt;/td&gt; &lt;td&gt; &lt;div style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; text-align: justify"&gt; From July 2011 through June 2012, a total of 406,783 warrants were exercised via "cashless" exercise, resulting in the issuance of 168,424 shares of common stock to investors of the Company. &amp;nbsp;In addition 355,411 warrants were exercised for cash and resulted in the issuance of 355,411 shares of common stock to investors of the Company. The aggregate cash consideration received was $556.&lt;/div&gt; &lt;/td&gt; &lt;/tr&gt; &lt;/table&gt; &lt;/div&gt; &lt;div style="DISPLAY: block; TEXT-INDENT: 0pt"&gt;&amp;nbsp;&lt;/div&gt; &lt;div style="text-align: center"&gt; &lt;table style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman" cellspacing="0" cellpadding="0" width="100%" border="0"&gt; &lt;tr valign="top"&gt; &lt;td style="WIDTH: 18pt"&gt; &lt;div style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt"&gt; b.&lt;/div&gt; &lt;/td&gt; &lt;td&gt; &lt;div style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; text-align: justify"&gt; From July 2012 through June 2013, a total of 682,213 warrants were exercised via "cashless" exercise, resulting in the issuance of 420,199 shares of common stock to investors of the Company. &amp;nbsp;In addition 1,201,160 warrants were exercised for cash and resulted in the issuance of 1,201,160 shares of common stock to investors of the Company. The aggregate cash consideration received was $2,009. In August, 2012, a total of 36,000 warrants were exercised via a "cashless" exercise, resulting in the issuance of 26,299 shares of common stock to consultants of the Company.&lt;/div&gt; &lt;/td&gt; &lt;/tr&gt; &lt;/table&gt; &lt;/div&gt; &lt;div style="DISPLAY: block; TEXT-INDENT: 0pt"&gt;&lt;br /&gt; &lt;/div&gt; &lt;div style="text-align: center"&gt; &lt;table style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman" cellspacing="0" cellpadding="0" width="100%" border="0"&gt; &lt;tr valign="top"&gt; &lt;td style="WIDTH: 18pt"&gt; &lt;div style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt"&gt; c.&lt;/div&gt; &lt;/td&gt; &lt;td&gt; &lt;div style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; text-align: justify"&gt; From July 2013 through June 2014, a total of 2,517,907 warrants were exercised via "cashless" exercise, resulting in the issuance of 1,469,584 shares of common stock to investors of the Company. &amp;nbsp;In addition, 1,432,584 warrants were exercised for cash and resulted in the issuance of 1,432,584 shares of common stock to investors of the Company. The aggregate cash consideration received was $1,968. From July 2013 through June 2014, a total of 65,000 warrants were exercised via a "cashless" exercise, resulting in the issuance of 36,970 shares of common stock to a consultant of the Company.&lt;/div&gt; &lt;/td&gt; &lt;/tr&gt; &lt;/table&gt; &lt;/div&gt; &lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"&gt; &amp;nbsp;&lt;/div&gt; &lt;div style="text-align: center"&gt; &lt;table style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman" cellspacing="0" cellpadding="0" width="100%" border="0"&gt; &lt;tr valign="top"&gt; &lt;td style="WIDTH: 18pt"&gt; &lt;div style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt"&gt; d.&lt;/div&gt; &lt;/td&gt; &lt;td&gt; &lt;div style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; text-align: justify"&gt; As part of the agreement for building the new Company&amp;#39;s facility with Biopharmax Group Ltd. ("Biopharmax"), the Company issued 1,500,000 shares of common stock to Biopharmax during fiscal year 2012.&lt;/div&gt; &lt;/td&gt; &lt;/tr&gt; &lt;/table&gt; &lt;/div&gt; &lt;div style="DISPLAY: block; TEXT-INDENT: 0pt"&gt;&amp;nbsp;&lt;/div&gt; &lt;div style="text-align: center"&gt; &lt;table style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman" cellspacing="0" cellpadding="0" width="100%" border="0"&gt; &lt;tr valign="top"&gt; &lt;td style="WIDTH: 18pt"&gt; &lt;div style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt"&gt; e.&lt;/div&gt; &lt;/td&gt; &lt;td&gt; &lt;div style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; text-align: justify"&gt; In December 2013, as part of the CHA Agreement, Pluristem and CHA executed the mutual investment pursuant to which Pluristem issued 2,500,000 shares of its common stock in consideration for 1,011,504 shares of CHA, which reflects total consideration to each of Pluristem and CHA of approximately $10,414 (see Note 1d).&lt;/div&gt; &lt;/td&gt; &lt;/tr&gt; &lt;/table&gt; &lt;/div&gt; &lt;div style="DISPLAY: block; TEXT-INDENT: 0pt"&gt;&lt;br /&gt; &lt;/div&gt; &lt;div style="text-align: center"&gt; &lt;table style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman" cellspacing="0" cellpadding="0" width="100%" border="0"&gt; &lt;tr valign="top"&gt; &lt;td style="WIDTH: 18pt"&gt; &lt;div style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt"&gt; f.&lt;/div&gt; &lt;/td&gt; &lt;td&gt; &lt;div style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; text-align: justify"&gt; On September 19, 2012, the Company closed a firm commitment underwritten public offering of 8,000,000 units, at a purchase price of $4.00 per unit, with each unit consisting of one share of the Company&amp;#39;s common stock and one warrant to purchase 0.35 shares of common stock, at a purchase price of $5.00 per share. The warrants sold in the offering became exercisable on March 19, 2013 and expire on September 19, 2017. The Company has also granted the underwriters a 30-day option to purchase up to 1,200,000 shares of common stock and/or warrants to purchase up to 420,000 shares of common stock. As of September 24, 2012 the underwriters fully exercised their option. The aggregate net proceeds to the Company from the offering, including from the exercise in full of the option, were $34,106, before the exercise of any warrants and after deducting underwriting commissions and discounts and offering expenses of the Company. The warrants can be exercised only for full shares of common stock.&amp;nbsp;&amp;nbsp;As to any fraction of a share which the warrant holder would otherwise be entitled to purchase upon such exercise, the Company shall pay a cash adjustment in respect of such fraction in an amount equal to such fraction multiplied by the fair market value less the exercise price.&lt;/div&gt; &lt;/td&gt; &lt;/tr&gt; &lt;/table&gt; &lt;/div&gt; &lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"&gt; &amp;nbsp;&lt;/div&gt; &lt;div style="text-align: center"&gt; &lt;table style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman" cellspacing="0" cellpadding="0" width="100%" border="0"&gt; &lt;tr valign="top"&gt; &lt;td style="WIDTH: 18pt"&gt; &lt;div style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt"&gt; g.&lt;/div&gt; &lt;/td&gt; &lt;td&gt; &lt;div style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; text-align: justify"&gt; Following a shelf registration on Form S-3 filed and declared effective in October 2011, the Company entered in December 2012 into an At Market Issuance Sales Agreement ("ATM Agreement") with an underwriter, which provides that, upon the terms and subject to the conditions and limitations set forth in the ATM Agreement, the Company may elect, from time to time, to issue and sell shares of common stock having an aggregate offering price of up to $95,000 through the underwriter as a sales agent. The Company is not obligated to make any sales of common stock under the ATM Agreement.&lt;/div&gt; &lt;/td&gt; &lt;/tr&gt; &lt;/table&gt; &lt;/div&gt; &lt;div style="DISPLAY: block; TEXT-INDENT: 0pt"&gt;&lt;br /&gt; &lt;/div&gt; &lt;div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"&gt; During the year ended June 30, 2014, the Company issued 2,596,032&lt;font style="FONT-SIZE: 10pt; DISPLAY: inline"&gt;&amp;nbsp;&lt;/font&gt; shares of common stock for aggregate consideration of approximately $ 10,644, net of issuance costs of $195, under the ATM Agreement.&lt;/div&gt; &lt;div style="MARGIN-LEFT: 437pt; DISPLAY: block; TEXT-INDENT: 0pt"&gt; &lt;br /&gt; &lt;/div&gt; &lt;div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"&gt; On September 11, 2014, the Company notified the underwriter of the termination of the ATM Agreement.&lt;/div&gt; &lt;div style="MARGIN-LEFT: 437pt; DISPLAY: block; TEXT-INDENT: 0pt"&gt; &lt;br /&gt; &lt;/div&gt; &lt;div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"&gt; Options, warrants and restricted stock units to employees, directors and consultants:&lt;/div&gt; &lt;div style="MARGIN-LEFT: 437pt; DISPLAY: block; TEXT-INDENT: 0pt"&gt; &lt;br /&gt; &lt;/div&gt; &lt;div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"&gt; The Company has approved incentive option plan from 2005 (the "Plan").&amp;nbsp;&amp;nbsp;Under the Plan, options, restricted stock and restricted stock units (the "Awards") may be granted to the Company&amp;#39;s officers, directors, employees and consultants.&amp;nbsp;&amp;nbsp;Any Awards that are cancelled or forfeited before expiration become available for future grants.&lt;/div&gt; &lt;div style="DISPLAY: block; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"&gt; &amp;nbsp;&lt;/div&gt; &lt;div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"&gt; As of June 30, 2014, the number of shares of common stock authorized for issuance under the Plan amounted to 13,256,713. As of June 30, 2014, 1,205,080 shares are available for future grant under the Plan.&lt;/div&gt; &lt;div style="DISPLAY: block; TEXT-INDENT: 0pt"&gt;&lt;br /&gt; &lt;/div&gt; &lt;div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"&gt; Options, warrants and restricted stock units to employees, directors and consultants:&lt;/div&gt; &lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"&gt; &amp;nbsp;&lt;/div&gt; &lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-ALIGN: left; TEXT-INDENT: 0pt"&gt; &lt;table style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman" cellspacing="0" cellpadding="0" width="100%" border="0"&gt; &lt;tr valign="top"&gt; &lt;td style="WIDTH: 18pt" align="right"&gt; &lt;div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: left; TEXT-INDENT: 0pt"&gt; a.&lt;/div&gt; &lt;/td&gt; &lt;td align="left"&gt; &lt;div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: left; TEXT-INDENT: 0pt"&gt; Options to employees and directors:&lt;/div&gt; &lt;/td&gt; &lt;/tr&gt; &lt;/table&gt; &lt;/div&gt; &lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"&gt; &amp;nbsp;&lt;/div&gt; &lt;div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"&gt; The Company accounted for its options to employees and directors under the fair value method in accordance with ASC 718. A summary of the Company&amp;#39;s share option activity for options granted to employees and directors under the Plans is as follows:&lt;/div&gt; &lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"&gt; &amp;nbsp;&lt;/div&gt; &lt;div style="text-align: right"&gt; &lt;table style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman" cellspacing="0" cellpadding="0" width="97%"&gt; &lt;tr&gt; &lt;td style="PADDING-BOTTOM: 2px" valign="bottom" width="52%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-WEIGHT: bold; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="46%" colspan="14"&gt; &lt;div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"&gt; Year ended June 30, 2014&lt;/div&gt; &lt;/td&gt; &lt;td style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-WEIGHT: bold; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td style="PADDING-BOTTOM: 2px" valign="bottom" width="52%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-WEIGHT: bold; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="10%" colspan="2"&gt; &lt;div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"&gt; Number&lt;/div&gt; &lt;/td&gt; &lt;td style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-WEIGHT: bold; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-WEIGHT: bold; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="10%" colspan="2"&gt; &lt;div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"&gt; Weighted Average Exercise Price&lt;/div&gt; &lt;/td&gt; &lt;td style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-WEIGHT: bold; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-WEIGHT: bold; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="10%" colspan="2"&gt; &lt;div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"&gt; Weighted Average Remaining Contractual Terms (in years)&lt;/div&gt; &lt;/td&gt; &lt;td style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-WEIGHT: bold; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-WEIGHT: bold; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="10%" colspan="2"&gt; &lt;div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"&gt; Aggregate Intrinsic Value Price&lt;/div&gt; &lt;/td&gt; &lt;td style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-WEIGHT: bold; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr bgcolor="#cceeff"&gt; &lt;td style="TEXT-ALIGN: left; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt" valign="bottom" width="52%"&gt; &lt;div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: left; TEXT-INDENT: 0pt"&gt; Options outstanding at beginning of period&lt;/div&gt; &lt;/td&gt; &lt;td valign="bottom" width="1%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%"&gt;1,958,156&lt;/td&gt; &lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td valign="bottom" width="1%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%"&gt;$&lt;/td&gt; &lt;td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%"&gt;4.03&lt;/td&gt; &lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td valign="bottom" width="1%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td valign="bottom" width="10%" colspan="2"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td valign="bottom" width="1%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td valign="bottom" width="10%" colspan="2"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr bgcolor="white"&gt; &lt;td style="TEXT-ALIGN: left; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt" valign="bottom" width="52%"&gt; &lt;div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: left; TEXT-INDENT: 0pt"&gt; Options exercised&lt;/div&gt; &lt;/td&gt; &lt;td valign="bottom" width="1%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%"&gt;(15,000&lt;/td&gt; &lt;td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"&gt;)&lt;/td&gt; &lt;td valign="bottom" width="1%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%"&gt;$&lt;/td&gt; &lt;td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%"&gt;0.83&lt;/td&gt; &lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td valign="bottom" width="1%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td valign="bottom" width="10%" colspan="2"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td valign="bottom" width="1%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td valign="bottom" width="10%" colspan="2"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr bgcolor="#cceeff"&gt; &lt;td style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt" valign="bottom" width="52%"&gt; &lt;div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: left; TEXT-INDENT: 0pt"&gt; Options forfeited&lt;/div&gt; &lt;/td&gt; &lt;td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 2px solid; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%"&gt;(81,057&lt;/td&gt; &lt;td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"&gt;)&lt;/td&gt; &lt;td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 2px solid; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%"&gt;$&lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 2px solid; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%"&gt;11.59&lt;/td&gt; &lt;td style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="PADDING-BOTTOM: 2px" valign="bottom" width="10%" colspan="2"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="PADDING-BOTTOM: 2px" valign="bottom" width="10%" colspan="2"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr bgcolor="white"&gt; &lt;td style="PADDING-BOTTOM: 4px; TEXT-ALIGN: left; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt" valign="bottom" width="52%"&gt; &lt;div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: left; TEXT-INDENT: 0pt"&gt; Options outstanding at end of the period&lt;/div&gt; &lt;/td&gt; &lt;td style="PADDING-BOTTOM: 4px" valign="bottom" width="1%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 4px double; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%"&gt;1,862,099&lt;/td&gt; &lt;td style="PADDING-BOTTOM: 4px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="PADDING-BOTTOM: 4px" valign="bottom" width="1%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 4px double; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%"&gt;$&lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 4px double; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%"&gt;3.73&lt;/td&gt; &lt;td style="PADDING-BOTTOM: 4px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="PADDING-BOTTOM: 4px" valign="bottom" width="1%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 4px double; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%"&gt;3.13&lt;/td&gt; &lt;td style="PADDING-BOTTOM: 4px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="PADDING-BOTTOM: 4px" valign="bottom" width="1%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 4px double; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%"&gt;$&lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 4px double; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%"&gt;1,046&lt;/td&gt; &lt;td style="PADDING-BOTTOM: 4px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr bgcolor="#cceeff"&gt; &lt;td style="PADDING-BOTTOM: 4px; TEXT-ALIGN: left; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt" valign="bottom" width="52%"&gt; &lt;div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: left; TEXT-INDENT: 0pt"&gt; Options exercisable at the end of the period&lt;/div&gt; &lt;/td&gt; &lt;td style="PADDING-BOTTOM: 4px" valign="bottom" width="1%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 4px double; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%"&gt;1,862,099&lt;/td&gt; &lt;td style="PADDING-BOTTOM: 4px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="PADDING-BOTTOM: 4px" valign="bottom" width="1%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 4px double; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%"&gt;$&lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 4px double; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%"&gt;3.73&lt;/td&gt; &lt;td style="PADDING-BOTTOM: 4px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="PADDING-BOTTOM: 4px" valign="bottom" width="1%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 4px double; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%"&gt;3.13&lt;/td&gt; &lt;td style="PADDING-BOTTOM: 4px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="PADDING-BOTTOM: 4px" valign="bottom" width="1%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 4px double; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%"&gt;$&lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 4px double; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%"&gt;1,046&lt;/td&gt; &lt;td style="PADDING-BOTTOM: 4px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr bgcolor="white"&gt; &lt;td style="PADDING-BOTTOM: 4px; TEXT-ALIGN: left; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt" valign="bottom" width="52%"&gt; &lt;div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: left; TEXT-INDENT: 0pt"&gt; Options vested&lt;/div&gt; &lt;/td&gt; &lt;td style="PADDING-BOTTOM: 4px" valign="bottom" width="1%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 4px double; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%"&gt;1,862,099&lt;/td&gt; &lt;td style="PADDING-BOTTOM: 4px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="PADDING-BOTTOM: 4px" valign="bottom" width="1%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 4px double; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%"&gt;$&lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 4px double; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%"&gt;3.73&lt;/td&gt; &lt;td style="PADDING-BOTTOM: 4px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="PADDING-BOTTOM: 4px" valign="bottom" width="1%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 4px double; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%"&gt;3.13&lt;/td&gt; &lt;td style="PADDING-BOTTOM: 4px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="PADDING-BOTTOM: 4px" valign="bottom" width="1%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 4px double; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%"&gt;$&lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 4px double; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%"&gt;1,046&lt;/td&gt; &lt;td style="PADDING-BOTTOM: 4px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;/tr&gt; &lt;/table&gt; &lt;/div&gt; &lt;div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"&gt; &amp;nbsp;&lt;/div&gt; &lt;div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"&gt; Intrinsic value of exercisable options (the difference between the Company&amp;#39;s closing stock price on the last trading day in the period and the exercise price, multiplied by the number of in-the-money options) represents the amount that would have been received by the employees and directors option holders had all option holders exercised their options on June 30, 2014. This amount changes based on the fair market value of the Company&amp;#39;s common stock.&lt;/div&gt; &lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"&gt; &amp;nbsp;&lt;/div&gt; &lt;div style="TEXT-ALIGN: left; MARGIN-LEFT: 0pt; DISPLAY: block; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt"&gt; &lt;table style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman" cellspacing="0" cellpadding="0" width="100%" border="0"&gt; &lt;tr valign="top"&gt; &lt;td style="WIDTH: 18pt" align="right"&gt; &lt;div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: left; TEXT-INDENT: 0pt"&gt; b.&lt;/div&gt; &lt;/td&gt; &lt;td align="left"&gt; &lt;div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: left; TEXT-INDENT: 0pt"&gt; Options and warrants to non-employees:&lt;/div&gt; &lt;/td&gt; &lt;/tr&gt; &lt;/table&gt; &lt;/div&gt; &lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"&gt; &amp;nbsp;&lt;/div&gt; &lt;div&gt; &lt;table style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman" cellspacing="0" cellpadding="0" width="100%" align="center" border="0"&gt; &lt;tr valign="top"&gt; &lt;td style="WIDTH: 18pt"&gt; &lt;div style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/div&gt; &lt;/td&gt; &lt;td&gt; &lt;div style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; text-align: left"&gt; A summary of the Company&amp;#39;s activity related to options and warrants to consultants is as follows:&lt;/div&gt; &lt;/td&gt; &lt;/tr&gt; &lt;/table&gt; &lt;/div&gt; &lt;div&gt;&amp;nbsp;&lt;/div&gt; &lt;div style="text-align: right"&gt; &lt;table style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman" cellspacing="0" cellpadding="0" width="97%"&gt; &lt;tr&gt; &lt;td style="PADDING-BOTTOM: 2px" valign="bottom" width="52%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-WEIGHT: bold; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="46%" colspan="14"&gt; &lt;div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"&gt; Year ended&amp;nbsp;June 30, 2014&lt;/div&gt; &lt;/td&gt; &lt;td style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-WEIGHT: bold; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td style="PADDING-BOTTOM: 2px" valign="bottom" width="52%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-WEIGHT: bold; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="10%" colspan="2"&gt; &lt;div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"&gt; Number&lt;/div&gt; &lt;/td&gt; &lt;td style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-WEIGHT: bold; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-WEIGHT: bold; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="10%" colspan="2"&gt; &lt;div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"&gt; Weighted Average Exercise Price&lt;/div&gt; &lt;/td&gt; &lt;td style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-WEIGHT: bold; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-WEIGHT: bold; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="10%" colspan="2"&gt; &lt;div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"&gt; Weighted Average Remaining Contractual Terms (in years)&lt;/div&gt; &lt;/td&gt; &lt;td style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-WEIGHT: bold; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-WEIGHT: bold; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="10%" colspan="2"&gt; &lt;div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"&gt; Aggregate Intrinsic Value Price&lt;/div&gt; &lt;/td&gt; &lt;td style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-WEIGHT: bold; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr bgcolor="#cceeff"&gt; &lt;td style="TEXT-ALIGN: left; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt" valign="bottom" width="52%"&gt; &lt;div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: left; TEXT-INDENT: 0pt"&gt; Options and warrants outstanding at beginning of period&lt;/div&gt; &lt;/td&gt; &lt;td valign="bottom" width="1%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%"&gt;315,500&lt;/td&gt; &lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td valign="bottom" width="1%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%"&gt;$&lt;/td&gt; &lt;td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%"&gt;4.44&lt;/td&gt; &lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td valign="bottom" width="1%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td valign="bottom" width="10%" colspan="2"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td valign="bottom" width="1%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td valign="bottom" width="10%" colspan="2"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr bgcolor="white"&gt; &lt;td style="TEXT-ALIGN: left; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt" valign="bottom" width="52%"&gt; &lt;div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: left; TEXT-INDENT: 0pt"&gt; Options granted&lt;/div&gt; &lt;/td&gt; &lt;td valign="bottom" width="1%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%"&gt;3,000&lt;/td&gt; &lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td valign="bottom" width="1%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%"&gt;$&lt;/td&gt; &lt;td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%"&gt;0.00&lt;/td&gt; &lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td valign="bottom" width="1%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td valign="bottom" width="10%" colspan="2"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td valign="bottom" width="1%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td valign="bottom" width="10%" colspan="2"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr bgcolor="#cceeff"&gt; &lt;td style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt" valign="bottom" width="52%"&gt; &lt;div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: left; TEXT-INDENT: 0pt"&gt; Options and warrants exercised&lt;/div&gt; &lt;/td&gt; &lt;td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 2px solid; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%"&gt;(66,500&lt;/td&gt; &lt;td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"&gt;)&lt;/td&gt; &lt;td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 2px solid; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%"&gt;$&lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 2px solid; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%"&gt;1.39&lt;/td&gt; &lt;td style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="PADDING-BOTTOM: 2px" valign="bottom" width="10%" colspan="2"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="PADDING-BOTTOM: 2px" valign="bottom" width="10%" colspan="2"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr bgcolor="white"&gt; &lt;td style="PADDING-BOTTOM: 4px; TEXT-ALIGN: left; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt" valign="bottom" width="52%"&gt; &lt;div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: left; TEXT-INDENT: 0pt"&gt; Options and warrants outstanding at end of the period&lt;/div&gt; &lt;/td&gt; &lt;td style="PADDING-BOTTOM: 4px" valign="bottom" width="1%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 4px double; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%"&gt;252,000&lt;/td&gt; &lt;td style="PADDING-BOTTOM: 4px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="PADDING-BOTTOM: 4px" valign="bottom" width="1%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 4px double; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%"&gt;$&lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 4px double; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%"&gt;5.19&lt;/td&gt; &lt;td style="PADDING-BOTTOM: 4px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="PADDING-BOTTOM: 4px" valign="bottom" width="1%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 4px double; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%"&gt;3.96&lt;/td&gt; &lt;td style="PADDING-BOTTOM: 4px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="PADDING-BOTTOM: 4px" valign="bottom" width="1%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 4px double; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%"&gt;$&lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 4px double; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%"&gt;331&lt;/td&gt; &lt;td style="PADDING-BOTTOM: 4px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr bgcolor="#cceeff"&gt; &lt;td style="PADDING-BOTTOM: 4px; TEXT-ALIGN: left; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt" valign="bottom" width="52%"&gt; &lt;div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: left; TEXT-INDENT: 0pt"&gt; Options and warrants exercisable at the end of the period&lt;/div&gt; &lt;/td&gt; &lt;td style="PADDING-BOTTOM: 4px" valign="bottom" width="1%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 4px double; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%"&gt;251,000&lt;/td&gt; &lt;td style="PADDING-BOTTOM: 4px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="PADDING-BOTTOM: 4px" valign="bottom" width="1%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 4px double; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%"&gt;$&lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 4px double; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%"&gt;5.21&lt;/td&gt; &lt;td style="PADDING-BOTTOM: 4px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="PADDING-BOTTOM: 4px" valign="bottom" width="1%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 4px double; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%"&gt;3.93&lt;/td&gt; &lt;td style="PADDING-BOTTOM: 4px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="PADDING-BOTTOM: 4px" valign="bottom" width="1%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 4px double; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%"&gt;$&lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 4px double; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%"&gt;328&lt;/td&gt; &lt;td style="PADDING-BOTTOM: 4px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr bgcolor="white"&gt; &lt;td style="PADDING-BOTTOM: 4px; TEXT-ALIGN: left; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt" valign="bottom" width="52%"&gt; &lt;div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: left; TEXT-INDENT: 0pt"&gt; Options and warrants vested&amp;nbsp;&amp;nbsp;and expected to vest&lt;/div&gt; &lt;/td&gt; &lt;td style="PADDING-BOTTOM: 4px" valign="bottom" width="1%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 4px double; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%"&gt;252,000&lt;/td&gt; &lt;td style="PADDING-BOTTOM: 4px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="PADDING-BOTTOM: 4px" valign="bottom" width="1%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 4px double; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%"&gt;$&lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 4px double; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%"&gt;5.19&lt;/td&gt; &lt;td style="PADDING-BOTTOM: 4px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="PADDING-BOTTOM: 4px" valign="bottom" width="1%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 4px double; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%"&gt;3.96&lt;/td&gt; &lt;td style="PADDING-BOTTOM: 4px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="PADDING-BOTTOM: 4px" valign="bottom" width="1%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 4px double; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%"&gt;$&lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 4px double; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%"&gt;331&lt;/td&gt; &lt;td style="PADDING-BOTTOM: 4px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;/tr&gt; &lt;/table&gt; &lt;/div&gt; &lt;div style="DISPLAY: block; TEXT-INDENT: 0pt"&gt;&lt;br /&gt; &lt;/div&gt; &lt;div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"&gt; Options, warrants and restricted stock units to employees, directors and consultants:&lt;/div&gt; &lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"&gt; &amp;nbsp;&lt;/div&gt; &lt;div&gt; &lt;table style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman" cellspacing="0" cellpadding="0" width="100%" align="center" border="0"&gt; &lt;tr valign="top"&gt; &lt;td style="WIDTH: 18pt"&gt; &lt;div style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/div&gt; &lt;/td&gt; &lt;td width="1837"&gt; &lt;div style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; text-align: justify"&gt; Compensation expenses related to options and warrants granted to consultants were recorded as follows:&lt;/div&gt; &lt;/td&gt; &lt;/tr&gt; &lt;/table&gt; &lt;/div&gt; &lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"&gt; &amp;nbsp;&lt;/div&gt; &lt;div style="MARGIN-LEFT: 36pt; text-align: left"&gt; &lt;table style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman" cellspacing="0" cellpadding="0" width="80%"&gt; &lt;tr&gt; &lt;td style="PADDING-BOTTOM: 2px" valign="bottom" width="64%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-WEIGHT: bold; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="34%" colspan="10"&gt; &lt;div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"&gt; Year ended&amp;nbsp;June 30,&lt;/div&gt; &lt;/td&gt; &lt;td style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-WEIGHT: bold; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td style="PADDING-BOTTOM: 2px" valign="bottom" width="64%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-WEIGHT: bold; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="10%" colspan="2"&gt; &lt;div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"&gt; 2014&lt;/div&gt; &lt;/td&gt; &lt;td style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-WEIGHT: bold; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-WEIGHT: bold; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="10%" colspan="2"&gt; &lt;div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"&gt; 2013&lt;/div&gt; &lt;/td&gt; &lt;td style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-WEIGHT: bold; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-WEIGHT: bold; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="10%" colspan="2"&gt; &lt;div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"&gt; 2012&lt;/div&gt; &lt;/td&gt; &lt;td style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-WEIGHT: bold; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr bgcolor="white"&gt; &lt;td style="TEXT-ALIGN: left; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt" valign="bottom" width="64%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td valign="bottom" width="1%" align="right"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td valign="bottom" width="1%" align="right"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td valign="bottom" width="1%" align="right"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr bgcolor="#cceeff"&gt; &lt;td style="TEXT-ALIGN: left; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt" valign="bottom" width="64%"&gt; &lt;div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: left; TEXT-INDENT: 0pt"&gt; Research and development expenses&lt;/div&gt; &lt;/td&gt; &lt;td valign="bottom" width="1%" align="right"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%"&gt;$&lt;/td&gt; &lt;td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%"&gt;11&lt;/td&gt; &lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td valign="bottom" width="1%" align="right"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%"&gt;$&lt;/td&gt; &lt;td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%"&gt;26&lt;/td&gt; &lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td valign="bottom" width="1%" align="right"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%"&gt;$&lt;/td&gt; &lt;td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%"&gt;19&lt;/td&gt; &lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr bgcolor="white"&gt; &lt;td style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt" valign="bottom" width="64%"&gt; &lt;div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: left; TEXT-INDENT: 0pt"&gt; General and administrative expenses&lt;/div&gt; &lt;/td&gt; &lt;td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%" align="right"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 2px solid; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%"&gt;-&lt;/td&gt; &lt;td style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%" align="right"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 2px solid; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%"&gt;37&lt;/td&gt; &lt;td style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr bgcolor="#cceeff"&gt; &lt;td style="PADDING-BOTTOM: 4px" valign="bottom" width="64%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="PADDING-BOTTOM: 4px" valign="bottom" width="1%" align="right"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 4px double; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%"&gt;$&lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 4px double; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%"&gt;11&lt;/td&gt; &lt;td style="PADDING-BOTTOM: 4px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="PADDING-BOTTOM: 4px" valign="bottom" width="1%" align="right"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 4px double; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%"&gt;$&lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 4px double; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%"&gt;26&lt;/td&gt; &lt;td style="PADDING-BOTTOM: 4px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="PADDING-BOTTOM: 4px" valign="bottom" width="1%" align="right"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 4px double; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%"&gt;$&lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 4px double; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%"&gt;56&lt;/td&gt; &lt;td style="PADDING-BOTTOM: 4px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;/tr&gt; &lt;/table&gt; &lt;/div&gt; &lt;div style="DISPLAY: block; TEXT-INDENT: 0pt"&gt;&amp;nbsp;&lt;/div&gt; &lt;div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"&gt; Future expenses related to options and warrants granted to consultants for an average time of approximately 3 months are &lt;font style="FONT-SIZE: 10pt; DISPLAY: inline"&gt;$&lt;/font&gt;1.&lt;/div&gt; &lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"&gt; &amp;nbsp;&lt;/div&gt; &lt;div style="TEXT-ALIGN: left; MARGIN-LEFT: 0pt; DISPLAY: block; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt"&gt; &lt;table style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman" cellspacing="0" cellpadding="0" width="100%" border="0"&gt; &lt;tr valign="top"&gt; &lt;td style="WIDTH: 18pt" align="right"&gt; &lt;div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: left; TEXT-INDENT: 0pt"&gt; c.&lt;/div&gt; &lt;/td&gt; &lt;td align="left"&gt; &lt;div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: left; TEXT-INDENT: 0pt"&gt; Restricted stock units to employees and directors:&lt;/div&gt; &lt;/td&gt; &lt;/tr&gt; &lt;/table&gt; &lt;/div&gt; &lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"&gt; &amp;nbsp;&lt;/div&gt; &lt;div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"&gt; The following table summarizes the activities for unvested restricted stock units granted to employees and directors for the year ended June 30, 2014:&lt;/div&gt; &lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"&gt; &amp;nbsp;&lt;/div&gt; &lt;div style="text-align: center"&gt; &lt;table style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman" cellspacing="0" cellpadding="0" width="60%"&gt; &lt;tr&gt; &lt;td style="PADDING-BOTTOM: 2px" valign="bottom" width="88%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-WEIGHT: bold; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="10%" colspan="2"&gt; &lt;div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"&gt; Number&lt;/div&gt; &lt;/td&gt; &lt;td style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-WEIGHT: bold; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr bgcolor="white"&gt; &lt;td style="TEXT-ALIGN: left; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt" valign="bottom" width="88%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td valign="bottom" width="1%" align="right"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr bgcolor="#cceeff"&gt; &lt;td style="TEXT-ALIGN: left; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt" valign="bottom" width="88%"&gt; &lt;div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: left; TEXT-INDENT: 0pt"&gt; Unvested at the beginning of period&lt;/div&gt; &lt;/td&gt; &lt;td valign="bottom" width="1%" align="right"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%"&gt;1,660,525&lt;/td&gt; &lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr bgcolor="white"&gt; &lt;td style="TEXT-ALIGN: left; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt" valign="bottom" width="88%"&gt; &lt;div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: left; TEXT-INDENT: 0pt"&gt; Granted&lt;/div&gt; &lt;/td&gt; &lt;td valign="bottom" width="1%" align="right"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%"&gt;1,256,940&lt;/td&gt; &lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr bgcolor="#cceeff"&gt; &lt;td style="TEXT-ALIGN: left; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt" valign="bottom" width="88%"&gt; &lt;div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: left; TEXT-INDENT: 0pt"&gt; Forfeited&lt;/div&gt; &lt;/td&gt; &lt;td valign="bottom" width="1%" align="right"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%"&gt;(44,183&lt;/td&gt; &lt;td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"&gt;)&lt;/td&gt; &lt;/tr&gt; &lt;tr bgcolor="white"&gt; &lt;td style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt" valign="bottom" width="88%"&gt; &lt;div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: left; TEXT-INDENT: 0pt"&gt; Vested&lt;/div&gt; &lt;/td&gt; &lt;td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 2px solid; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%"&gt;(1,283,850&lt;/td&gt; &lt;td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"&gt;)&lt;/td&gt; &lt;/tr&gt; &lt;tr bgcolor="#cceeff"&gt; &lt;td style="PADDING-BOTTOM: 4px; TEXT-ALIGN: left; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt" valign="bottom" width="88%"&gt; &lt;div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: left; TEXT-INDENT: 0pt"&gt; Unvested at the end of the period&lt;/div&gt; &lt;/td&gt; &lt;td style="PADDING-BOTTOM: 4px" valign="bottom" width="1%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 4px double; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%"&gt;1,589,432&lt;/td&gt; &lt;td style="PADDING-BOTTOM: 4px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr bgcolor="white"&gt; &lt;td style="PADDING-BOTTOM: 4px; TEXT-ALIGN: left; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt" valign="bottom" width="88%"&gt; &lt;div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: left; TEXT-INDENT: 0pt"&gt; Expected to vest after June 30, 2014&lt;/div&gt; &lt;/td&gt; &lt;td style="PADDING-BOTTOM: 4px" valign="bottom" width="1%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 4px double; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%"&gt;1,522,024&lt;/td&gt; &lt;td style="PADDING-BOTTOM: 4px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;/tr&gt; &lt;/table&gt; &lt;/div&gt; &lt;div style="DISPLAY: block; TEXT-INDENT: 0pt"&gt;&amp;nbsp;&lt;/div&gt; &lt;div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"&gt; Compensation expenses related to restricted stock units granted to employees and directors were recorded as follows:&lt;/div&gt; &lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"&gt; &amp;nbsp;&lt;/div&gt; &lt;div style="MARGIN-LEFT: 36pt; text-align: left"&gt; &lt;table style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman" cellspacing="0" cellpadding="0" width="80%"&gt; &lt;tr&gt; &lt;td style="PADDING-BOTTOM: 2px" valign="bottom" width="64%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-WEIGHT: bold; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="34%" colspan="10"&gt; &lt;div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"&gt; Year ended&amp;nbsp;June 30,&lt;/div&gt; &lt;/td&gt; &lt;td style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-WEIGHT: bold; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="PADDING-BOTTOM: 2px" valign="bottom"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td style="PADDING-BOTTOM: 2px" valign="bottom" width="64%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-WEIGHT: bold; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="10%" colspan="2"&gt; &lt;div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"&gt; 2014&lt;/div&gt; &lt;/td&gt; &lt;td style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-WEIGHT: bold; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-WEIGHT: bold; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="10%" colspan="2"&gt; &lt;div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"&gt; 2013&lt;/div&gt; &lt;/td&gt; &lt;td style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-WEIGHT: bold; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-WEIGHT: bold; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="11%" colspan="4"&gt; &lt;div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"&gt; 2012&lt;/div&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr bgcolor="#cceeff"&gt; &lt;td style="TEXT-ALIGN: left; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt" valign="bottom" width="64%"&gt; &lt;div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: left; TEXT-INDENT: 0pt"&gt; Research and development expenses&lt;/div&gt; &lt;/td&gt; &lt;td valign="bottom" width="1%" align="right"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%"&gt;$&lt;/td&gt; &lt;td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%"&gt;1,172&lt;/td&gt; &lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td valign="bottom" width="1%" align="right"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%"&gt;$&lt;/td&gt; &lt;td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%"&gt;711&lt;/td&gt; &lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td valign="bottom" width="1%" align="right"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%"&gt;$&lt;/td&gt; &lt;td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%"&gt;1,163&lt;/td&gt; &lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr bgcolor="white"&gt; &lt;td style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt" valign="bottom" width="64%"&gt; &lt;div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: left; TEXT-INDENT: 0pt"&gt; General and administrative expenses&lt;/div&gt; &lt;/td&gt; &lt;td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%" align="right"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 2px solid; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%"&gt;4,390&lt;/td&gt; &lt;td style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%" align="right"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 2px solid; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%"&gt;1,529&lt;/td&gt; &lt;td style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%" align="right"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 2px solid; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%"&gt;3,487&lt;/td&gt; &lt;td style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr bgcolor="#cceeff"&gt; &lt;td style="PADDING-BOTTOM: 4px" valign="bottom" width="64%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="PADDING-BOTTOM: 4px" valign="bottom" width="1%" align="right"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 4px double; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%"&gt;$&lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 4px double; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%"&gt;5,562&lt;/td&gt; &lt;td style="PADDING-BOTTOM: 4px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="PADDING-BOTTOM: 4px" valign="bottom" width="1%" align="right"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 4px double; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%"&gt;$&lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 4px double; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%"&gt;2,240&lt;/td&gt; &lt;td style="PADDING-BOTTOM: 4px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="PADDING-BOTTOM: 4px" valign="bottom" width="1%" align="right"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 4px double; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%"&gt;$&lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 4px double; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%"&gt;4,650&lt;/td&gt; &lt;td style="PADDING-BOTTOM: 4px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;/tr&gt; &lt;/table&gt; &lt;/div&gt; &lt;div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; MARGIN-LEFT: 36pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"&gt; &amp;nbsp;&lt;/div&gt; &lt;div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"&gt; Future expenses related to restricted stock units granted to employees and directors for an average time of approximately two years is $2,447.&lt;/div&gt; &lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"&gt; &amp;nbsp;&lt;/div&gt; &lt;div style="TEXT-ALIGN: left; MARGIN-LEFT: 0pt; DISPLAY: block; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt"&gt; &lt;table style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman" cellspacing="0" cellpadding="0" width="100%" border="0"&gt; &lt;tr valign="top"&gt; &lt;td style="WIDTH: 18pt" align="right"&gt; &lt;div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: left; TEXT-INDENT: 0pt"&gt; d.&lt;/div&gt; &lt;/td&gt; &lt;td align="left"&gt; &lt;div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: left; TEXT-INDENT: 0pt"&gt; Restricted stock units to consultants:&lt;/div&gt; &lt;/td&gt; &lt;/tr&gt; &lt;/table&gt; &lt;/div&gt; &lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"&gt; &amp;nbsp;&lt;/div&gt; &lt;div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"&gt; The following table summarizes the activities for unvested restricted stock units and restricted stock granted to consultants for the year ended June 30, 2014:&lt;/div&gt; &lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"&gt; &amp;nbsp;&lt;/div&gt; &lt;div style="MARGIN-LEFT: 18pt; text-align: left"&gt; &lt;table style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman" cellspacing="0" cellpadding="0" width="50%"&gt; &lt;tr&gt; &lt;td style="PADDING-BOTTOM: 2px" valign="bottom" width="84%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-WEIGHT: bold; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="14%" colspan="2"&gt; &lt;div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"&gt; Number&lt;/div&gt; &lt;/td&gt; &lt;td style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-WEIGHT: bold; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr bgcolor="#cceeff"&gt; &lt;td style="TEXT-ALIGN: left; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt" valign="bottom" width="84%"&gt; &lt;div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: left; TEXT-INDENT: 0pt"&gt; Unvested at the beginning of period&lt;/div&gt; &lt;/td&gt; &lt;td valign="bottom" width="1%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="13%"&gt;-&lt;/td&gt; &lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr bgcolor="white"&gt; &lt;td style="TEXT-ALIGN: left; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt" valign="bottom" width="84%"&gt; &lt;div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: left; TEXT-INDENT: 0pt"&gt; Granted&lt;/div&gt; &lt;/td&gt; &lt;td valign="bottom" width="1%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="13%"&gt;84,565&lt;/td&gt; &lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr bgcolor="#cceeff"&gt; &lt;td style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt" valign="bottom" width="84%"&gt; &lt;div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: left; TEXT-INDENT: 0pt"&gt; Vested&lt;/div&gt; &lt;/td&gt; &lt;td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 2px solid; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="13%"&gt;(69,315&lt;/td&gt; &lt;td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"&gt;)&lt;/td&gt; &lt;/tr&gt; &lt;tr bgcolor="white"&gt; &lt;td style="PADDING-BOTTOM: 4px; TEXT-ALIGN: left; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt" valign="bottom" width="84%"&gt; &lt;div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: left; TEXT-INDENT: 0pt"&gt; Unvested at the end of the period&lt;/div&gt; &lt;/td&gt; &lt;td style="PADDING-BOTTOM: 4px" valign="bottom" width="1%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 4px double; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="13%"&gt;15,250&lt;/td&gt; &lt;td style="PADDING-BOTTOM: 4px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;/tr&gt; &lt;/table&gt; &lt;/div&gt; &lt;div style="DISPLAY: block; TEXT-INDENT: 0pt"&gt;&amp;nbsp;&lt;/div&gt; &lt;div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: left; TEXT-INDENT: 0pt"&gt; Compensation expenses related to restricted stock units granted to consultants were recorded as follows:&lt;/div&gt; &lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"&gt; &amp;nbsp;&lt;/div&gt; &lt;div style="MARGIN-LEFT: 18pt; text-align: left"&gt; &lt;table style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman" cellspacing="0" cellpadding="0" width="80%"&gt; &lt;tr&gt; &lt;td style="PADDING-BOTTOM: 2px" valign="bottom" width="64%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-WEIGHT: bold; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="34%" colspan="10"&gt; &lt;div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"&gt; Year ended&amp;nbsp;June 30,&lt;/div&gt; &lt;/td&gt; &lt;td style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-WEIGHT: bold; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td style="PADDING-BOTTOM: 2px" valign="bottom" width="64%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-WEIGHT: bold; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="10%" colspan="2"&gt; &lt;div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"&gt; 2014&lt;/div&gt; &lt;/td&gt; &lt;td style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-WEIGHT: bold; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-WEIGHT: bold; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="10%" colspan="2"&gt; &lt;div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"&gt; 2013&lt;/div&gt; &lt;/td&gt; &lt;td style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-WEIGHT: bold; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-WEIGHT: bold; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="10%" colspan="2"&gt; &lt;div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"&gt; 2012&lt;/div&gt; &lt;/td&gt; &lt;td style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-WEIGHT: bold; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr bgcolor="#cceeff"&gt; &lt;td style="TEXT-ALIGN: left; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt" valign="bottom" width="64%"&gt; &lt;div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: left; TEXT-INDENT: 0pt"&gt; Research and development expenses&lt;/div&gt; &lt;/td&gt; &lt;td valign="bottom" width="1%" align="right"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%"&gt;$&lt;/td&gt; &lt;td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%"&gt;201&lt;/td&gt; &lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td valign="bottom" width="1%" align="right"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%"&gt;$&lt;/td&gt; &lt;td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%"&gt;255&lt;/td&gt; &lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td valign="bottom" width="1%" align="right"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%"&gt;$&lt;/td&gt; &lt;td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%"&gt;201&lt;/td&gt; &lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr bgcolor="white"&gt; &lt;td style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt" valign="bottom" width="64%"&gt; &lt;div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: left; TEXT-INDENT: 0pt"&gt; General and administrative expenses&lt;/div&gt; &lt;/td&gt; &lt;td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%" align="right"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 2px solid; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%"&gt;77&lt;/td&gt; &lt;td style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%" align="right"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 2px solid; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%"&gt;278&lt;/td&gt; &lt;td style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%" align="right"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 2px solid; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%"&gt;20&lt;/td&gt; &lt;td style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr bgcolor="#cceeff"&gt; &lt;td style="PADDING-BOTTOM: 4px" valign="bottom" width="64%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="PADDING-BOTTOM: 4px" valign="bottom" width="1%" align="right"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 4px double; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%"&gt;$&lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 4px double; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%"&gt;278&lt;/td&gt; &lt;td style="PADDING-BOTTOM: 4px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="PADDING-BOTTOM: 4px" valign="bottom" width="1%" align="right"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 4px double; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%"&gt;$&lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 4px double; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%"&gt;533&lt;/td&gt; &lt;td style="PADDING-BOTTOM: 4px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="PADDING-BOTTOM: 4px" valign="bottom" width="1%" align="right"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 4px double; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%"&gt;$&lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 4px double; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%"&gt;221&lt;/td&gt; &lt;td style="PADDING-BOTTOM: 4px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;/tr&gt; &lt;/table&gt; &lt;/div&gt; &lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"&gt; &amp;nbsp;&lt;/div&gt; &lt;div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 22.5pt; text-align: left; TEXT-INDENT: 18pt"&gt; Summary of warrants and options:&lt;/div&gt; &lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"&gt; &amp;nbsp;&lt;/div&gt; &lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"&gt; &lt;div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"&gt; The following table sets forth a summary of all the warrants and options outstanding as of June 30, 2014:&lt;/div&gt; &lt;div style="DISPLAY: block; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"&gt; &amp;nbsp;&lt;/div&gt; &lt;/div&gt; &lt;div style="text-align: left"&gt; &lt;table style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman" cellspacing="0" cellpadding="0" width="100%"&gt; &lt;tr&gt; &lt;td style="BORDER-BOTTOM: black 2px solid" valign="bottom"&gt; &lt;div style="MARGIN-LEFT: 0pt; DISPLAY: block; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt"&gt; &lt;div style="DISPLAY: block; TEXT-INDENT: 0pt"&gt;&amp;nbsp;&lt;/div&gt; &lt;div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"&gt; Warrants / Options&lt;/div&gt; &lt;/div&gt; &lt;/td&gt; &lt;td style="PADDING-BOTTOM: 2px" valign="bottom"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 2px solid" valign="bottom" colspan="2"&gt; &lt;div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"&gt; &lt;font style="FONT-WEIGHT: bold; DISPLAY: inline"&gt;Exercise Price&lt;/font&gt; &lt;font style="FONT-WEIGHT: bold; DISPLAY: inline"&gt;per Share&lt;/font&gt;&lt;/div&gt; &lt;/td&gt; &lt;td style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="PADDING-BOTTOM: 2px" valign="bottom"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-WEIGHT: bold; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 2px solid" valign="bottom" colspan="2"&gt; &lt;div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"&gt; Options and Warrants for Common Stock&lt;/div&gt; &lt;/td&gt; &lt;td style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-WEIGHT: bold; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="PADDING-BOTTOM: 2px" valign="bottom"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 2px solid" valign="bottom" colspan="2"&gt; &lt;div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"&gt; &lt;font style="FONT-WEIGHT: bold; DISPLAY: inline"&gt;Options and Warrants&lt;/font&gt; &lt;font style="FONT-WEIGHT: bold; DISPLAY: inline"&gt;Exercisable&lt;/font&gt;&lt;/div&gt; &lt;/td&gt; &lt;td style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="PADDING-BOTTOM: 2px" valign="bottom"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 2px solid" valign="bottom" colspan="2"&gt; &lt;div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"&gt; &lt;font style="FONT-WEIGHT: bold; DISPLAY: inline"&gt;Weighted Average Remaining Contractual Terms&lt;/font&gt;&lt;font style="FONT-WEIGHT: bold; DISPLAY: inline"&gt;(in years)&lt;/font&gt;&lt;/div&gt; &lt;/td&gt; &lt;td style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr bgcolor="#cceeff"&gt; &lt;td style="TEXT-ALIGN: left; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt" valign="bottom" width="52%"&gt; &lt;div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: left; TEXT-INDENT: 0pt"&gt; Warrants:&lt;/div&gt; &lt;/td&gt; &lt;td valign="bottom" width="1%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%"&gt;$&lt;/td&gt; &lt;td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%"&gt;1.40&lt;/td&gt; &lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td valign="bottom" width="1%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%"&gt;474,322&lt;/td&gt; &lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td valign="bottom" width="1%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%"&gt;474,322&lt;/td&gt; &lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td valign="bottom" width="1%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%"&gt;0.82&lt;/td&gt; &lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr bgcolor="white"&gt; &lt;td valign="bottom" width="52%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td valign="bottom" width="1%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%"&gt;$&lt;/td&gt; &lt;td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%"&gt;1.50&lt;/td&gt; &lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td valign="bottom" width="1%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%"&gt;878,174&lt;/td&gt; &lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td valign="bottom" width="1%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%"&gt;878,174&lt;/td&gt; &lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td valign="bottom" width="1%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%"&gt;0.06&lt;/td&gt; &lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr bgcolor="#cceeff"&gt; &lt;td valign="bottom" width="52%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td valign="bottom" width="1%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%"&gt;$&lt;/td&gt; &lt;td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%"&gt;1.60&lt;/td&gt; &lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td valign="bottom" width="1%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%"&gt;131,221&lt;/td&gt; &lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td valign="bottom" width="1%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%"&gt;131,221&lt;/td&gt; &lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td valign="bottom" width="1%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%"&gt;0.78&lt;/td&gt; &lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr bgcolor="white"&gt; &lt;td valign="bottom" width="52%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td valign="bottom" width="1%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%"&gt;$&lt;/td&gt; &lt;td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%"&gt;1.80&lt;/td&gt; &lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td valign="bottom" width="1%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%"&gt;727,401&lt;/td&gt; &lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td valign="bottom" width="1%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%"&gt;727,401&lt;/td&gt; &lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td valign="bottom" width="1%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%"&gt;0.30&lt;/td&gt; &lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr bgcolor="#cceeff"&gt; &lt;td valign="bottom" width="52%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td valign="bottom" width="1%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%"&gt;$&lt;/td&gt; &lt;td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%"&gt;1.90&lt;/td&gt; &lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td valign="bottom" width="1%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%"&gt;43,103&lt;/td&gt; &lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td valign="bottom" width="1%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%"&gt;43,103&lt;/td&gt; &lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td valign="bottom" width="1%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%"&gt;0.08&lt;/td&gt; &lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr bgcolor="white"&gt; &lt;td valign="bottom" width="52%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td valign="bottom" width="1%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%"&gt;$&lt;/td&gt; &lt;td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%"&gt;4.20&lt;/td&gt; &lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td valign="bottom" width="1%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%"&gt;5,060,000&lt;/td&gt; &lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td valign="bottom" width="1%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%"&gt;5,060,000&lt;/td&gt; &lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td valign="bottom" width="1%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%"&gt;2.09&lt;/td&gt; &lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr bgcolor="#cceeff"&gt; &lt;td style="PADDING-BOTTOM: 2px" valign="bottom" width="52%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 2px solid; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%"&gt;$&lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 2px solid; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%"&gt;5.00&lt;/td&gt; &lt;td style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 2px solid; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%"&gt;3,219,983&lt;/td&gt; &lt;td style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 2px solid; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%"&gt;3,219,983&lt;/td&gt; &lt;td style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 2px solid; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%"&gt;3.22&lt;/td&gt; &lt;td style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr bgcolor="white"&gt; &lt;td style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt" valign="bottom" width="52%"&gt; &lt;div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: left; TEXT-INDENT: 0pt"&gt; Total warrants&lt;/div&gt; &lt;/td&gt; &lt;td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-WEIGHT: bold; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-WEIGHT: bold; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 2px solid; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; TEXT-ALIGN: right" valign="bottom" width="9%"&gt;10,534,204&lt;/td&gt; &lt;td style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-WEIGHT: bold; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-WEIGHT: bold; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-WEIGHT: bold; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 2px solid; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; TEXT-ALIGN: right" valign="bottom" width="9%"&gt;10,534,204&lt;/td&gt; &lt;td style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-WEIGHT: bold; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr bgcolor="#cceeff"&gt; &lt;td valign="bottom" width="52%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td valign="bottom" width="1%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td valign="bottom" width="1%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td valign="bottom" width="1%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td valign="bottom" width="1%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr bgcolor="white"&gt; &lt;td style="TEXT-ALIGN: left; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt" valign="bottom" width="52%"&gt; &lt;div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: left; TEXT-INDENT: 0pt"&gt; Options:&lt;/div&gt; &lt;/td&gt; &lt;td valign="bottom" width="1%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%"&gt;$&lt;/td&gt; &lt;td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%"&gt;0.00&lt;/td&gt; &lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td valign="bottom" width="1%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%"&gt;101,000&lt;/td&gt; &lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td valign="bottom" width="1%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%"&gt;100,000&lt;/td&gt; &lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td valign="bottom" width="1%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%"&gt;5.19&lt;/td&gt; &lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr bgcolor="#cceeff"&gt; &lt;td valign="bottom" width="52%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td valign="bottom" width="1%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%"&gt;$&lt;/td&gt; &lt;td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%"&gt;0.62&lt;/td&gt; &lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td valign="bottom" width="1%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%"&gt;398,500&lt;/td&gt; &lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td valign="bottom" width="1%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%"&gt;398,500&lt;/td&gt; &lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td valign="bottom" width="1%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%"&gt;4.25&lt;/td&gt; &lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr bgcolor="white"&gt; &lt;td valign="bottom" width="52%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td valign="bottom" width="1%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%"&gt;$&lt;/td&gt; &lt;td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%"&gt;1.04&lt;/td&gt; &lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td valign="bottom" width="1%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%"&gt;30,000&lt;/td&gt; &lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td valign="bottom" width="1%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%"&gt;30,000&lt;/td&gt; &lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td valign="bottom" width="1%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%"&gt;4.16&lt;/td&gt; &lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr bgcolor="#cceeff"&gt; &lt;td valign="bottom" width="52%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td valign="bottom" width="1%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%"&gt;$&lt;/td&gt; &lt;td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%"&gt;2.97&lt;/td&gt; &lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td valign="bottom" width="1%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%"&gt;20,000&lt;/td&gt; &lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td valign="bottom" width="1%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%"&gt;20,000&lt;/td&gt; &lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td valign="bottom" width="1%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%"&gt;3.86&lt;/td&gt; &lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr bgcolor="white"&gt; &lt;td valign="bottom" width="52%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td valign="bottom" width="1%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%"&gt;$&lt;/td&gt; &lt;td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%"&gt;3.50&lt;/td&gt; &lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td valign="bottom" width="1%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%"&gt;900,000&lt;/td&gt; &lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td valign="bottom" width="1%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%"&gt;900,000&lt;/td&gt; &lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td valign="bottom" width="1%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%"&gt;2.58&lt;/td&gt; &lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr bgcolor="#cceeff"&gt; &lt;td valign="bottom" width="52%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td valign="bottom" width="1%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%"&gt;$&lt;/td&gt; &lt;td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%"&gt;3.72&lt;/td&gt; &lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td valign="bottom" width="1%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%"&gt;15,000&lt;/td&gt; &lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td valign="bottom" width="1%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%"&gt;15,000&lt;/td&gt; &lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td valign="bottom" width="1%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%"&gt;2.49&lt;/td&gt; &lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr bgcolor="white"&gt; &lt;td valign="bottom" width="52%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td valign="bottom" width="1%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%"&gt;$&lt;/td&gt; &lt;td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%"&gt;3.80&lt;/td&gt; &lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td valign="bottom" width="1%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%"&gt;16,050&lt;/td&gt; &lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td valign="bottom" width="1%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%"&gt;16,050&lt;/td&gt; &lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td valign="bottom" width="1%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%"&gt;2.53&lt;/td&gt; &lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr bgcolor="#cceeff"&gt; &lt;td valign="bottom" width="52%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td valign="bottom" width="1%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%"&gt;$&lt;/td&gt; &lt;td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%"&gt;4.00&lt;/td&gt; &lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td valign="bottom" width="1%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%"&gt;42,500&lt;/td&gt; &lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td valign="bottom" width="1%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%"&gt;42,500&lt;/td&gt; &lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td valign="bottom" width="1%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%"&gt;2.30&lt;/td&gt; &lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr bgcolor="white"&gt; &lt;td valign="bottom" width="52%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td valign="bottom" width="1%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%"&gt;$&lt;/td&gt; &lt;td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%"&gt;4.38 - $ 4.40&lt;/td&gt; &lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td valign="bottom" width="1%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%"&gt;417,299&lt;/td&gt; &lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td valign="bottom" width="1%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%"&gt;417,299&lt;/td&gt; &lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td valign="bottom" width="1%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%"&gt;3.28&lt;/td&gt; &lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr bgcolor="#cceeff"&gt; &lt;td valign="bottom" width="52%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td valign="bottom" width="1%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%"&gt;$&lt;/td&gt; &lt;td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%"&gt;6.80&lt;/td&gt; &lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td valign="bottom" width="1%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%"&gt;36,250&lt;/td&gt; &lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td valign="bottom" width="1%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%"&gt;36,250&lt;/td&gt; &lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td valign="bottom" width="1%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%"&gt;3.37&lt;/td&gt; &lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr bgcolor="white"&gt; &lt;td valign="bottom" width="52%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td valign="bottom" width="1%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%"&gt;$&lt;/td&gt; &lt;td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%"&gt;8.20&lt;/td&gt; &lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td valign="bottom" width="1%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%"&gt;30,000&lt;/td&gt; &lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td valign="bottom" width="1%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%"&gt;30,000&lt;/td&gt; &lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td valign="bottom" width="1%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%"&gt;2.40&lt;/td&gt; &lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr bgcolor="#cceeff"&gt; &lt;td style="PADDING-BOTTOM: 2px" valign="bottom" width="52%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 2px solid; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%"&gt;$&lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 2px solid; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%"&gt;20.00&lt;/td&gt; &lt;td style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 2px solid; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%"&gt;107,500&lt;/td&gt; &lt;td style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 2px solid; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%"&gt;107,500&lt;/td&gt; &lt;td style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 2px solid; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%"&gt;2.88&lt;/td&gt; &lt;td style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr bgcolor="white"&gt; &lt;td style="PADDING-BOTTOM: 4px; TEXT-ALIGN: left; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt" valign="bottom" width="52%"&gt; &lt;div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: left; TEXT-INDENT: 0pt"&gt; Total options&lt;/div&gt; &lt;/td&gt; &lt;td style="PADDING-BOTTOM: 4px" valign="bottom" width="1%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="PADDING-BOTTOM: 4px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="PADDING-BOTTOM: 4px" valign="bottom" width="1%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-WEIGHT: bold; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-WEIGHT: bold; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 4px double; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; TEXT-ALIGN: right" valign="bottom" width="9%"&gt;2,114,099&lt;/td&gt; &lt;td style="PADDING-BOTTOM: 4px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-WEIGHT: bold; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="PADDING-BOTTOM: 4px" valign="bottom" width="1%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-WEIGHT: bold; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-WEIGHT: bold; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 4px double; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; TEXT-ALIGN: right" valign="bottom" width="9%"&gt;2,113,099&lt;/td&gt; &lt;td style="PADDING-BOTTOM: 4px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-WEIGHT: bold; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="PADDING-BOTTOM: 4px" valign="bottom" width="1%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="PADDING-BOTTOM: 4px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr bgcolor="#cceeff"&gt; &lt;td style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt" valign="bottom" width="52%"&gt; &lt;div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: left; TEXT-INDENT: 0pt"&gt; Total warrants and options&lt;/div&gt; &lt;/td&gt; &lt;td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-WEIGHT: bold; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-WEIGHT: bold; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 2px solid; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&amp;nbsp;12,648,303&lt;/td&gt; &lt;td style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-WEIGHT: bold; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-WEIGHT: bold; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-WEIGHT: bold; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 2px solid; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&amp;nbsp;12,647,303&lt;/td&gt; &lt;td style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-WEIGHT: bold; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;td style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/font&gt; &lt;/td&gt; &lt;/tr&gt; &lt;/table&gt; &lt;/div&gt; &lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"&gt; &amp;nbsp;&lt;/div&gt; &lt;div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"&gt; This summary does not include 1,604,682 restricted stock units that are not vested as of June 30, 2014.&lt;/div&gt; &lt;!--EndFragment--&gt;&lt;/div&gt; &lt;/div&gt;</us-gaap:StockholdersEquityNoteDisclosureTextBlock>
  <us-gaap:StockIssued1 id="StockIssued1.869.0.0.0.0.0.0" xsi:nil="true" contextRef="from-2013-07-01-to-2014-06-30.869.0.0.0.0.0.0.0" unitRef="USD" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" />
  <us-gaap:StockIssued1 id="StockIssued1.870.0.0.0.0.0.0" contextRef="from-2012-07-01-to-2013-06-30.870.0.0.0.0.0.0.0" unitRef="USD" decimals="-3">1400000</us-gaap:StockIssued1>
  <us-gaap:StockIssued1 id="StockIssued1.871.0.0.0.0.0.0" contextRef="from-2011-07-01-to-2012-06-30.871.0.0.0.0.0.0.0" unitRef="USD" decimals="-3">3672000</us-gaap:StockIssued1>
  <us-gaap:StockIssuedDuringPeriodSharesIssuedForServices id="StockIssuedDuringPeriodSharesIssuedForServices.870.1115.5114.0.0.0.0" xsi:nil="true" contextRef="from-2012-07-01-to-2013-06-30.870.0.1115.5114.0.0.0.0" unitRef="shares" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" />
  <us-gaap:StockIssuedDuringPeriodSharesIssuedForServices id="StockIssuedDuringPeriodSharesIssuedForServices.871.1115.5114.0.0.0.0" contextRef="from-2011-07-01-to-2012-06-30.871.0.1115.5114.0.0.0.0" unitRef="shares" decimals="INF">1500000</us-gaap:StockIssuedDuringPeriodSharesIssuedForServices>
  <us-gaap:StockIssuedDuringPeriodSharesIssuedForServices id="StockIssuedDuringPeriodSharesIssuedForServices.871.25817.5039.0.0.0.0" contextRef="from-2011-07-01-to-2012-06-30.871.0.25817.5039.0.0.0.0" unitRef="shares" decimals="INF">1500000</us-gaap:StockIssuedDuringPeriodSharesIssuedForServices>
  <us-gaap:StockIssuedDuringPeriodSharesNewIssues id="StockIssuedDuringPeriodSharesNewIssues.869.0.0.0.0.0.0" contextRef="from-2013-07-01-to-2014-06-30.869.0.0.0.0.0.0.0" unitRef="shares" decimals="INF">2596032</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
  <us-gaap:StockIssuedDuringPeriodSharesNewIssues id="StockIssuedDuringPeriodSharesNewIssues.968.0.0.0.0.0.0" contextRef="from-2012-09-18-to-2012-09-19.968.0.0.0.0.0.0.0" unitRef="shares" decimals="0">8000000</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
  <us-gaap:StockIssuedDuringPeriodSharesNewIssues id="StockIssuedDuringPeriodSharesNewIssues.869.1115.5114.0.0.0.0" contextRef="from-2013-07-01-to-2014-06-30.869.0.1115.5114.0.0.0.0" unitRef="shares" decimals="INF">2596032</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
  <us-gaap:StockIssuedDuringPeriodSharesNewIssues id="StockIssuedDuringPeriodSharesNewIssues.870.1115.5114.0.0.0.0" contextRef="from-2012-07-01-to-2013-06-30.870.0.1115.5114.0.0.0.0" unitRef="shares" decimals="INF">9200000</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
  <us-gaap:StockIssuedDuringPeriodSharesOther id="StockIssuedDuringPeriodSharesOther.869.25814.1048.0.0.0.0" contextRef="from-2013-07-01-to-2014-06-30.869.0.25814.1048.0.0.0.0" unitRef="shares" decimals="INF">1432584</us-gaap:StockIssuedDuringPeriodSharesOther>
  <us-gaap:StockIssuedDuringPeriodSharesOther id="StockIssuedDuringPeriodSharesOther.870.25814.1048.0.0.0.0" contextRef="from-2012-07-01-to-2013-06-30.870.0.25814.1048.0.0.0.0" unitRef="shares" decimals="INF">1201160</us-gaap:StockIssuedDuringPeriodSharesOther>
  <us-gaap:StockIssuedDuringPeriodSharesOther id="StockIssuedDuringPeriodSharesOther.871.25814.1048.0.0.0.0" contextRef="from-2011-07-01-to-2012-06-30.871.0.25814.1048.0.0.0.0" unitRef="shares" decimals="INF">355411</us-gaap:StockIssuedDuringPeriodSharesOther>
  <us-gaap:StockIssuedDuringPeriodSharesPurchaseOfAssets id="StockIssuedDuringPeriodSharesPurchaseOfAssets.869.1115.5114.0.0.0.0" contextRef="from-2013-07-01-to-2014-06-30.869.0.1115.5114.0.0.0.0" unitRef="shares" decimals="INF">2500000</us-gaap:StockIssuedDuringPeriodSharesPurchaseOfAssets>
  <us-gaap:StockIssuedDuringPeriodSharesPurchaseOfAssets id="StockIssuedDuringPeriodSharesPurchaseOfAssets.869.0.0.0.0.0.0" contextRef="from-2013-07-01-to-2014-06-30.869.0.0.0.0.0.0.0" unitRef="shares" decimals="INF">2500000</us-gaap:StockIssuedDuringPeriodSharesPurchaseOfAssets>
  <us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation id="StockIssuedDuringPeriodSharesShareBasedCompensation.869.1115.5114.0.0.0.0" contextRef="from-2013-07-01-to-2014-06-30.869.0.1115.5114.0.0.0.0" unitRef="shares" decimals="INF">1353165</us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation>
  <us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation id="StockIssuedDuringPeriodSharesShareBasedCompensation.870.1115.5114.0.0.0.0" contextRef="from-2012-07-01-to-2013-06-30.870.0.1115.5114.0.0.0.0" unitRef="shares" decimals="INF">1750340</us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation>
  <us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation id="StockIssuedDuringPeriodSharesShareBasedCompensation.871.1115.5114.0.0.0.0" contextRef="from-2011-07-01-to-2012-06-30.871.0.1115.5114.0.0.0.0" unitRef="shares" decimals="INF">19060231</us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation>
  <us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised id="StockIssuedDuringPeriodSharesStockOptionsExercised.869.0.0.0.0.0.0" contextRef="from-2013-07-01-to-2014-06-30.869.0.0.0.0.0.0.0" unitRef="shares" decimals="INF">15000</us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised>
  <us-gaap:StockIssuedDuringPeriodValueIssuedForServices id="StockIssuedDuringPeriodValueIssuedForServices.870.499.5114.0.0.0.0" contextRef="from-2012-07-01-to-2013-06-30.870.0.499.5114.0.0.0.0" unitRef="USD" decimals="-3">1400000</us-gaap:StockIssuedDuringPeriodValueIssuedForServices>
  <us-gaap:StockIssuedDuringPeriodValueIssuedForServices id="StockIssuedDuringPeriodValueIssuedForServices.871.499.5114.0.0.0.0" contextRef="from-2011-07-01-to-2012-06-30.871.0.499.5114.0.0.0.0" unitRef="USD" decimals="-3">3672000</us-gaap:StockIssuedDuringPeriodValueIssuedForServices>
  <us-gaap:StockIssuedDuringPeriodValueIssuedForServices id="StockIssuedDuringPeriodValueIssuedForServices.870.1115.5114.0.0.0.0" xsi:nil="true" contextRef="from-2012-07-01-to-2013-06-30.870.0.1115.5114.0.0.0.0" unitRef="USD" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" />
  <us-gaap:StockIssuedDuringPeriodValueIssuedForServices id="StockIssuedDuringPeriodValueIssuedForServices.871.1115.5114.0.0.0.0" xsi:nil="true" contextRef="from-2011-07-01-to-2012-06-30.871.0.1115.5114.0.0.0.0" unitRef="USD" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" />
  <us-gaap:StockIssuedDuringPeriodValueIssuedForServices id="StockIssuedDuringPeriodValueIssuedForServices.870.478.5114.0.0.0.0" xsi:nil="true" contextRef="from-2012-07-01-to-2013-06-30.870.0.478.5114.0.0.0.0" unitRef="USD" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" />
  <us-gaap:StockIssuedDuringPeriodValueIssuedForServices id="StockIssuedDuringPeriodValueIssuedForServices.871.478.5114.0.0.0.0" xsi:nil="true" contextRef="from-2011-07-01-to-2012-06-30.871.0.478.5114.0.0.0.0" unitRef="USD" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" />
  <us-gaap:StockIssuedDuringPeriodValueIssuedForServices id="StockIssuedDuringPeriodValueIssuedForServices.870.4619.5114.0.0.0.0" xsi:nil="true" contextRef="from-2012-07-01-to-2013-06-30.870.0.4619.5114.0.0.0.0" unitRef="USD" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" />
  <us-gaap:StockIssuedDuringPeriodValueIssuedForServices id="StockIssuedDuringPeriodValueIssuedForServices.871.4619.5114.0.0.0.0" xsi:nil="true" contextRef="from-2011-07-01-to-2012-06-30.871.0.4619.5114.0.0.0.0" unitRef="USD" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" />
  <us-gaap:StockIssuedDuringPeriodValueIssuedForServices id="StockIssuedDuringPeriodValueIssuedForServices.870.0.0.0.0.0.0" contextRef="from-2012-07-01-to-2013-06-30.870.0.0.0.0.0.0.0" unitRef="USD" decimals="-3">1400000</us-gaap:StockIssuedDuringPeriodValueIssuedForServices>
  <us-gaap:StockIssuedDuringPeriodValueIssuedForServices id="StockIssuedDuringPeriodValueIssuedForServices.871.0.0.0.0.0.0" contextRef="from-2011-07-01-to-2012-06-30.871.0.0.0.0.0.0.0" unitRef="USD" decimals="-3">3672000</us-gaap:StockIssuedDuringPeriodValueIssuedForServices>
  <us-gaap:StockIssuedDuringPeriodValueNewIssues id="StockIssuedDuringPeriodValueNewIssues.869.1115.5114.0.0.0.0" xsi:nil="true" contextRef="from-2013-07-01-to-2014-06-30.869.0.1115.5114.0.0.0.0" unitRef="USD" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" />
  <us-gaap:StockIssuedDuringPeriodValueNewIssues id="StockIssuedDuringPeriodValueNewIssues.870.1115.5114.0.0.0.0" xsi:nil="true" contextRef="from-2012-07-01-to-2013-06-30.870.0.1115.5114.0.0.0.0" unitRef="USD" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" />
  <us-gaap:StockIssuedDuringPeriodValueNewIssues id="StockIssuedDuringPeriodValueNewIssues.869.499.5114.0.0.0.0" contextRef="from-2013-07-01-to-2014-06-30.869.0.499.5114.0.0.0.0" unitRef="USD" decimals="-3">10644000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
  <us-gaap:StockIssuedDuringPeriodValueNewIssues id="StockIssuedDuringPeriodValueNewIssues.870.499.5114.0.0.0.0" contextRef="from-2012-07-01-to-2013-06-30.870.0.499.5114.0.0.0.0" unitRef="USD" decimals="-3">34106000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
  <us-gaap:StockIssuedDuringPeriodValueNewIssues id="StockIssuedDuringPeriodValueNewIssues.869.478.5114.0.0.0.0" xsi:nil="true" contextRef="from-2013-07-01-to-2014-06-30.869.0.478.5114.0.0.0.0" unitRef="USD" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" />
  <us-gaap:StockIssuedDuringPeriodValueNewIssues id="StockIssuedDuringPeriodValueNewIssues.870.478.5114.0.0.0.0" xsi:nil="true" contextRef="from-2012-07-01-to-2013-06-30.870.0.478.5114.0.0.0.0" unitRef="USD" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" />
  <us-gaap:StockIssuedDuringPeriodValueNewIssues id="StockIssuedDuringPeriodValueNewIssues.869.4619.5114.0.0.0.0" xsi:nil="true" contextRef="from-2013-07-01-to-2014-06-30.869.0.4619.5114.0.0.0.0" unitRef="USD" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" />
  <us-gaap:StockIssuedDuringPeriodValueNewIssues id="StockIssuedDuringPeriodValueNewIssues.870.4619.5114.0.0.0.0" xsi:nil="true" contextRef="from-2012-07-01-to-2013-06-30.870.0.4619.5114.0.0.0.0" unitRef="USD" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" />
  <us-gaap:StockIssuedDuringPeriodValueNewIssues id="StockIssuedDuringPeriodValueNewIssues.869.0.0.0.0.0.0" contextRef="from-2013-07-01-to-2014-06-30.869.0.0.0.0.0.0.0" unitRef="USD" decimals="-3">10644000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
  <us-gaap:StockIssuedDuringPeriodValueNewIssues id="StockIssuedDuringPeriodValueNewIssues.870.0.0.0.0.0.0" contextRef="from-2012-07-01-to-2013-06-30.870.0.0.0.0.0.0.0" unitRef="USD" decimals="-3">34106000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
  <us-gaap:StockIssuedDuringPeriodValuePurchaseOfAssets id="StockIssuedDuringPeriodValuePurchaseOfAssets.869.1115.5114.0.0.0.0" xsi:nil="true" contextRef="from-2013-07-01-to-2014-06-30.869.0.1115.5114.0.0.0.0" unitRef="USD" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" />
  <us-gaap:StockIssuedDuringPeriodValuePurchaseOfAssets id="StockIssuedDuringPeriodValuePurchaseOfAssets.869.499.5114.0.0.0.0" contextRef="from-2013-07-01-to-2014-06-30.869.0.499.5114.0.0.0.0" unitRef="USD" decimals="-3">10414000</us-gaap:StockIssuedDuringPeriodValuePurchaseOfAssets>
  <us-gaap:StockIssuedDuringPeriodValuePurchaseOfAssets id="StockIssuedDuringPeriodValuePurchaseOfAssets.869.478.5114.0.0.0.0" xsi:nil="true" contextRef="from-2013-07-01-to-2014-06-30.869.0.478.5114.0.0.0.0" unitRef="USD" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" />
  <us-gaap:StockIssuedDuringPeriodValuePurchaseOfAssets id="StockIssuedDuringPeriodValuePurchaseOfAssets.869.4619.5114.0.0.0.0" xsi:nil="true" contextRef="from-2013-07-01-to-2014-06-30.869.0.4619.5114.0.0.0.0" unitRef="USD" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" />
  <us-gaap:StockIssuedDuringPeriodValuePurchaseOfAssets id="StockIssuedDuringPeriodValuePurchaseOfAssets.869.0.0.0.0.0.0" contextRef="from-2013-07-01-to-2014-06-30.869.0.0.0.0.0.0.0" unitRef="USD" decimals="-3">10414000</us-gaap:StockIssuedDuringPeriodValuePurchaseOfAssets>
  <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation id="StockIssuedDuringPeriodValueShareBasedCompensation.869.1115.5114.0.0.0.0" xsi:nil="true" contextRef="from-2013-07-01-to-2014-06-30.869.0.1115.5114.0.0.0.0" unitRef="USD" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" />
  <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation id="StockIssuedDuringPeriodValueShareBasedCompensation.870.1115.5114.0.0.0.0" xsi:nil="true" contextRef="from-2012-07-01-to-2013-06-30.870.0.1115.5114.0.0.0.0" unitRef="USD" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" />
  <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation id="StockIssuedDuringPeriodValueShareBasedCompensation.871.1115.5114.0.0.0.0" xsi:nil="true" contextRef="from-2011-07-01-to-2012-06-30.871.0.1115.5114.0.0.0.0" unitRef="USD" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" />
  <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation id="StockIssuedDuringPeriodValueShareBasedCompensation.869.499.5114.0.0.0.0" contextRef="from-2013-07-01-to-2014-06-30.869.0.499.5114.0.0.0.0" unitRef="USD" decimals="-3">5851000</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
  <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation id="StockIssuedDuringPeriodValueShareBasedCompensation.870.499.5114.0.0.0.0" contextRef="from-2012-07-01-to-2013-06-30.870.0.499.5114.0.0.0.0" unitRef="USD" decimals="-3">2799000</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
  <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation id="StockIssuedDuringPeriodValueShareBasedCompensation.871.499.5114.0.0.0.0" contextRef="from-2011-07-01-to-2012-06-30.871.0.499.5114.0.0.0.0" unitRef="USD" decimals="-3">4927000</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
  <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation id="StockIssuedDuringPeriodValueShareBasedCompensation.869.478.5114.0.0.0.0" xsi:nil="true" contextRef="from-2013-07-01-to-2014-06-30.869.0.478.5114.0.0.0.0" unitRef="USD" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" />
  <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation id="StockIssuedDuringPeriodValueShareBasedCompensation.870.478.5114.0.0.0.0" xsi:nil="true" contextRef="from-2012-07-01-to-2013-06-30.870.0.478.5114.0.0.0.0" unitRef="USD" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" />
  <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation id="StockIssuedDuringPeriodValueShareBasedCompensation.871.478.5114.0.0.0.0" xsi:nil="true" contextRef="from-2011-07-01-to-2012-06-30.871.0.478.5114.0.0.0.0" unitRef="USD" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" />
  <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation id="StockIssuedDuringPeriodValueShareBasedCompensation.869.4619.5114.0.0.0.0" xsi:nil="true" contextRef="from-2013-07-01-to-2014-06-30.869.0.4619.5114.0.0.0.0" unitRef="USD" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" />
  <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation id="StockIssuedDuringPeriodValueShareBasedCompensation.870.4619.5114.0.0.0.0" xsi:nil="true" contextRef="from-2012-07-01-to-2013-06-30.870.0.4619.5114.0.0.0.0" unitRef="USD" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" />
  <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation id="StockIssuedDuringPeriodValueShareBasedCompensation.871.4619.5114.0.0.0.0" xsi:nil="true" contextRef="from-2011-07-01-to-2012-06-30.871.0.4619.5114.0.0.0.0" unitRef="USD" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" />
  <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation id="StockIssuedDuringPeriodValueShareBasedCompensation.869.0.0.0.0.0.0" contextRef="from-2013-07-01-to-2014-06-30.869.0.0.0.0.0.0.0" unitRef="USD" decimals="-3">5851000</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
  <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation id="StockIssuedDuringPeriodValueShareBasedCompensation.870.0.0.0.0.0.0" contextRef="from-2012-07-01-to-2013-06-30.870.0.0.0.0.0.0.0" unitRef="USD" decimals="-3">2799000</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
  <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation id="StockIssuedDuringPeriodValueShareBasedCompensation.871.0.0.0.0.0.0" contextRef="from-2011-07-01-to-2012-06-30.871.0.0.0.0.0.0.0" unitRef="USD" decimals="-3">4927000</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
  <us-gaap:UseOfEstimates id="UseOfEstimates.869.0.0.0.0.0.0" contextRef="from-2013-07-01-to-2014-06-30.869.0.0.0.0.0.0.0">&lt;!--DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd" --&gt;&lt;div&gt; &lt;div&gt;&lt;!--StartFragment--&gt; &lt;div&gt; &lt;table style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman" cellspacing="0" cellpadding="0" width="100%" align="center" border="0"&gt; &lt;tr valign="top"&gt; &lt;td style="WIDTH: 18pt"&gt; &lt;div style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt"&gt; a.&lt;/div&gt; &lt;/td&gt; &lt;td&gt; &lt;div style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; text-align: justify"&gt; Use of estimates&lt;/div&gt; &lt;/td&gt; &lt;/tr&gt; &lt;/table&gt; &lt;/div&gt; &lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"&gt; &amp;nbsp;&lt;/div&gt; &lt;div&gt; &lt;table style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman" cellspacing="0" cellpadding="0" width="100%" align="center" border="0"&gt; &lt;tr valign="top"&gt; &lt;td style="WIDTH: 18pt"&gt; &lt;div style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; DISPLAY: inline"&gt; &amp;nbsp;&lt;/div&gt; &lt;/td&gt; &lt;td&gt; &lt;div style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; text-align: justify"&gt; The preparation of financial statements in conformity with generally accepted accounting principles requires management to make estimates, judgments, and assumptions that are reasonable based upon information available at the time they are made. These estimates, judgments and assumptions can affect the amounts reported in the financial statements and accompanying notes. Actual results could differ from those estimates.&lt;/div&gt; &lt;/td&gt; &lt;/tr&gt; &lt;/table&gt; &lt;/div&gt; &lt;!--EndFragment--&gt;&lt;/div&gt; &lt;/div&gt;</us-gaap:UseOfEstimates>
  <us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted id="WeightedAverageNumberOfShareOutstandingBasicAndDiluted.869.0.0.0.0.0.0" contextRef="from-2013-07-01-to-2014-06-30.869.0.0.0.0.0.0.0" unitRef="shares" decimals="0">63514405</us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted>
  <us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted id="WeightedAverageNumberOfShareOutstandingBasicAndDiluted.870.0.0.0.0.0.0" contextRef="from-2012-07-01-to-2013-06-30.870.0.0.0.0.0.0.0" unitRef="shares" decimals="0">55481357</us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted>
  <us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted id="WeightedAverageNumberOfShareOutstandingBasicAndDiluted.871.0.0.0.0.0.0" contextRef="from-2011-07-01-to-2012-06-30.871.0.0.0.0.0.0.0" unitRef="shares" decimals="0">44031866</us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted>
  <xbrli:unit id="shares">
    <xbrli:measure>xbrli:shares</xbrli:measure>
  </xbrli:unit>
  <xbrli:unit id="USD">
    <xbrli:measure>iso4217:USD</xbrli:measure>
  </xbrli:unit>
  <xbrli:unit id="pure">
    <xbrli:measure>xbrli:pure</xbrli:measure>
  </xbrli:unit>
  <xbrli:unit id="USD_per_share">
    <xbrli:divide>
      <xbrli:unitNumerator>
        <xbrli:measure>iso4217:USD</xbrli:measure>
      </xbrli:unitNumerator>
      <xbrli:unitDenominator>
        <xbrli:measure>xbrli:shares</xbrli:measure>
      </xbrli:unitDenominator>
    </xbrli:divide>
  </xbrli:unit>
  <xbrli:context id="from-2013-07-01-to-2014-06-30.869.0.5496.367.25752.5031.0.0">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001158780</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis" xmlns:xbrldi="http://xbrl.org/2006/xbrldi">us-gaap:WarrantMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis" xmlns:xbrldi="http://xbrl.org/2006/xbrldi">psti:ExercisePriceRangeSevenMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2013-07-01</xbrli:startDate>
      <xbrli:endDate>2014-06-30</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="from-2013-07-01-to-2014-06-30.869.0.5496.367.25751.5031.0.0">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001158780</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis" xmlns:xbrldi="http://xbrl.org/2006/xbrldi">us-gaap:WarrantMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis" xmlns:xbrldi="http://xbrl.org/2006/xbrldi">psti:ExercisePriceRangeSixMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2013-07-01</xbrli:startDate>
      <xbrli:endDate>2014-06-30</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="from-2013-07-01-to-2014-06-30.869.0.5496.367.25750.5031.0.0">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001158780</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis" xmlns:xbrldi="http://xbrl.org/2006/xbrldi">us-gaap:WarrantMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis" xmlns:xbrldi="http://xbrl.org/2006/xbrldi">psti:ExercisePriceRangeFiveMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2013-07-01</xbrli:startDate>
      <xbrli:endDate>2014-06-30</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="from-2013-07-01-to-2014-06-30.869.0.5496.367.25749.5031.0.0">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001158780</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis" xmlns:xbrldi="http://xbrl.org/2006/xbrldi">us-gaap:WarrantMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis" xmlns:xbrldi="http://xbrl.org/2006/xbrldi">psti:ExercisePriceRangeFourMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2013-07-01</xbrli:startDate>
      <xbrli:endDate>2014-06-30</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="from-2013-07-01-to-2014-06-30.869.0.5496.367.25748.5031.0.0">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001158780</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis" xmlns:xbrldi="http://xbrl.org/2006/xbrldi">us-gaap:WarrantMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis" xmlns:xbrldi="http://xbrl.org/2006/xbrldi">psti:ExercisePriceRangeThreeMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2013-07-01</xbrli:startDate>
      <xbrli:endDate>2014-06-30</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="from-2013-07-01-to-2014-06-30.869.0.5496.367.25747.5031.0.0">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001158780</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis" xmlns:xbrldi="http://xbrl.org/2006/xbrldi">us-gaap:WarrantMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis" xmlns:xbrldi="http://xbrl.org/2006/xbrldi">psti:ExercisePriceRangeTwoMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2013-07-01</xbrli:startDate>
      <xbrli:endDate>2014-06-30</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="from-2013-07-01-to-2014-06-30.869.0.5496.367.25746.5031.0.0">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001158780</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis" xmlns:xbrldi="http://xbrl.org/2006/xbrldi">us-gaap:WarrantMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis" xmlns:xbrldi="http://xbrl.org/2006/xbrldi">psti:ExercisePriceRangeOneMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2013-07-01</xbrli:startDate>
      <xbrli:endDate>2014-06-30</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="from-2013-07-01-to-2014-06-30.869.0.5488.4261.0.0.0.0">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001158780</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis" xmlns:xbrldi="http://xbrl.org/2006/xbrldi">us-gaap:VehiclesMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2013-07-01</xbrli:startDate>
      <xbrli:endDate>2014-06-30</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="from-2013-07-01-to-2014-06-30.869.0.499.5114.0.0.0.0">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001158780</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis" xmlns:xbrldi="http://xbrl.org/2006/xbrldi">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2013-07-01</xbrli:startDate>
      <xbrli:endDate>2014-06-30</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="from-2013-07-01-to-2014-06-30.869.0.484.5114.0.0.0.0">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001158780</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis" xmlns:xbrldi="http://xbrl.org/2006/xbrldi">us-gaap:AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2013-07-01</xbrli:startDate>
      <xbrli:endDate>2014-06-30</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="from-2013-07-01-to-2014-06-30.869.0.478.5114.0.0.0.0">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001158780</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis" xmlns:xbrldi="http://xbrl.org/2006/xbrldi">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2013-07-01</xbrli:startDate>
      <xbrli:endDate>2014-06-30</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="from-2013-07-01-to-2014-06-30.869.0.477.5114.0.0.0.0">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001158780</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis" xmlns:xbrldi="http://xbrl.org/2006/xbrldi">us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2013-07-01</xbrli:startDate>
      <xbrli:endDate>2014-06-30</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="from-2013-07-01-to-2014-06-30.869.0.4619.5114.0.0.0.0">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001158780</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis" xmlns:xbrldi="http://xbrl.org/2006/xbrldi">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2013-07-01</xbrli:startDate>
      <xbrli:endDate>2014-06-30</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="from-2013-07-01-to-2014-06-30.869.0.4568.367.4543.2652.25535.5039">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001158780</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis" xmlns:xbrldi="http://xbrl.org/2006/xbrldi">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis" xmlns:xbrldi="http://xbrl.org/2006/xbrldi">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:ShareBasedGoodsAndNonemployeeServicesTransactionBySupplierAxis" xmlns:xbrldi="http://xbrl.org/2006/xbrldi">psti:ConsultantsMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2013-07-01</xbrli:startDate>
      <xbrli:endDate>2014-06-30</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="from-2013-07-01-to-2014-06-30.869.0.4568.367.4543.2652.0.0">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001158780</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis" xmlns:xbrldi="http://xbrl.org/2006/xbrldi">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis" xmlns:xbrldi="http://xbrl.org/2006/xbrldi">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2013-07-01</xbrli:startDate>
      <xbrli:endDate>2014-06-30</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="from-2013-07-01-to-2014-06-30.869.0.4568.367.2476.2652.25535.5039">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001158780</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis" xmlns:xbrldi="http://xbrl.org/2006/xbrldi">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis" xmlns:xbrldi="http://xbrl.org/2006/xbrldi">us-gaap:GeneralAndAdministrativeExpenseMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:ShareBasedGoodsAndNonemployeeServicesTransactionBySupplierAxis" xmlns:xbrldi="http://xbrl.org/2006/xbrldi">psti:ConsultantsMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2013-07-01</xbrli:startDate>
      <xbrli:endDate>2014-06-30</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="from-2013-07-01-to-2014-06-30.869.0.4568.367.2476.2652.0.0">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001158780</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis" xmlns:xbrldi="http://xbrl.org/2006/xbrldi">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis" xmlns:xbrldi="http://xbrl.org/2006/xbrldi">us-gaap:GeneralAndAdministrativeExpenseMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2013-07-01</xbrli:startDate>
      <xbrli:endDate>2014-06-30</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="from-2013-07-01-to-2014-06-30.869.0.4568.367.0.0.0.0">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001158780</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis" xmlns:xbrldi="http://xbrl.org/2006/xbrldi">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2013-07-01</xbrli:startDate>
      <xbrli:endDate>2014-06-30</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="from-2013-07-01-to-2014-06-30.869.0.395.4261.0.0.0.0">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001158780</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis" xmlns:xbrldi="http://xbrl.org/2006/xbrldi">us-gaap:AutomobilesMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2013-07-01</xbrli:startDate>
      <xbrli:endDate>2014-06-30</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="from-2013-07-01-to-2014-06-30.869.0.3840.4261.3370.4349.0.0">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001158780</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis" xmlns:xbrldi="http://xbrl.org/2006/xbrldi">us-gaap:OtherMachineryAndEquipmentMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:RangeAxis" xmlns:xbrldi="http://xbrl.org/2006/xbrldi">us-gaap:MinimumMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2013-07-01</xbrli:startDate>
      <xbrli:endDate>2014-06-30</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="from-2013-07-01-to-2014-06-30.869.0.3840.4261.3361.4349.0.0">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001158780</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis" xmlns:xbrldi="http://xbrl.org/2006/xbrldi">us-gaap:OtherMachineryAndEquipmentMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:RangeAxis" xmlns:xbrldi="http://xbrl.org/2006/xbrldi">us-gaap:MaximumMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2013-07-01</xbrli:startDate>
      <xbrli:endDate>2014-06-30</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="from-2013-07-01-to-2014-06-30.869.0.3650.4261.3370.4349.0.0">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001158780</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis" xmlns:xbrldi="http://xbrl.org/2006/xbrldi">us-gaap:OfficeEquipmentMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:RangeAxis" xmlns:xbrldi="http://xbrl.org/2006/xbrldi">us-gaap:MinimumMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2013-07-01</xbrli:startDate>
      <xbrli:endDate>2014-06-30</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="from-2013-07-01-to-2014-06-30.869.0.3650.4261.3361.4349.0.0">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001158780</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis" xmlns:xbrldi="http://xbrl.org/2006/xbrldi">us-gaap:OfficeEquipmentMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:RangeAxis" xmlns:xbrldi="http://xbrl.org/2006/xbrldi">us-gaap:MaximumMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2013-07-01</xbrli:startDate>
      <xbrli:endDate>2014-06-30</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="from-2013-07-01-to-2014-06-30.869.0.3370.4349.0.0.0.0">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001158780</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:RangeAxis" xmlns:xbrldi="http://xbrl.org/2006/xbrldi">us-gaap:MinimumMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2013-07-01</xbrli:startDate>
      <xbrli:endDate>2014-06-30</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="from-2013-07-01-to-2014-06-30.869.0.3361.4349.0.0.0.0">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001158780</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:RangeAxis" xmlns:xbrldi="http://xbrl.org/2006/xbrldi">us-gaap:MaximumMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2013-07-01</xbrli:startDate>
      <xbrli:endDate>2014-06-30</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="from-2013-07-01-to-2014-06-30.869.0.3316.5277.0.0.0.0">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001158780</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:TitleOfIndividualAxis" xmlns:xbrldi="http://xbrl.org/2006/xbrldi">us-gaap:ManagementMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2013-07-01</xbrli:startDate>
      <xbrli:endDate>2014-06-30</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="from-2013-07-01-to-2014-06-30.869.0.3008.4261.0.0.0.0">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001158780</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis" xmlns:xbrldi="http://xbrl.org/2006/xbrldi">us-gaap:LandAndBuildingMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2013-07-01</xbrli:startDate>
      <xbrli:endDate>2014-06-30</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="from-2013-07-01-to-2014-06-30.869.0.2877.2667.2979.5240.0.0">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001158780</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis" xmlns:xbrldi="http://xbrl.org/2006/xbrldi">us-gaap:InternalRevenueServiceIRSMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:TaxPeriodAxis" xmlns:xbrldi="http://xbrl.org/2006/xbrldi">us-gaap:LatestTaxYearMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2013-07-01</xbrli:startDate>
      <xbrli:endDate>2014-06-30</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="from-2013-07-01-to-2014-06-30.869.0.2877.2667.1754.5240.0.0">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001158780</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis" xmlns:xbrldi="http://xbrl.org/2006/xbrldi">us-gaap:InternalRevenueServiceIRSMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:TaxPeriodAxis" xmlns:xbrldi="http://xbrl.org/2006/xbrldi">us-gaap:EarliestTaxYearMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2013-07-01</xbrli:startDate>
      <xbrli:endDate>2014-06-30</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="from-2013-07-01-to-2014-06-30.869.0.25816.1048.0.0.0.0">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001158780</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis" xmlns:xbrldi="http://xbrl.org/2006/xbrldi">psti:ConsultantWarrantsMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2013-07-01</xbrli:startDate>
      <xbrli:endDate>2014-06-30</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="from-2013-07-01-to-2014-06-30.869.0.25814.1048.0.0.0.0">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001158780</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis" xmlns:xbrldi="http://xbrl.org/2006/xbrldi">psti:InvestorWarrantsMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2013-07-01</xbrli:startDate>
      <xbrli:endDate>2014-06-30</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="from-2013-07-01-to-2014-06-30.869.0.25661.5277.0.0.0.0">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001158780</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:TitleOfIndividualAxis" xmlns:xbrldi="http://xbrl.org/2006/xbrldi">psti:EmployeesMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2013-07-01</xbrli:startDate>
      <xbrli:endDate>2014-06-30</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="from-2013-07-01-to-2014-06-30.869.0.25578.4261.0.0.0.0">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001158780</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis" xmlns:xbrldi="http://xbrl.org/2006/xbrldi">psti:LeaseholdImprovementsOfNewFacilityConstructionMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2013-07-01</xbrli:startDate>
      <xbrli:endDate>2014-06-30</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="from-2013-07-01-to-2014-06-30.869.0.25537.367.4543.2652.0.0">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001158780</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis" xmlns:xbrldi="http://xbrl.org/2006/xbrldi">psti:EquityOptionsAndWarrantsMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis" xmlns:xbrldi="http://xbrl.org/2006/xbrldi">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2013-07-01</xbrli:startDate>
      <xbrli:endDate>2014-06-30</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="from-2013-07-01-to-2014-06-30.869.0.25537.367.2476.2652.0.0">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001158780</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis" xmlns:xbrldi="http://xbrl.org/2006/xbrldi">psti:EquityOptionsAndWarrantsMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis" xmlns:xbrldi="http://xbrl.org/2006/xbrldi">us-gaap:GeneralAndAdministrativeExpenseMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2013-07-01</xbrli:startDate>
      <xbrli:endDate>2014-06-30</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="from-2013-07-01-to-2014-06-30.869.0.25537.367.0.0.0.0">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001158780</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis" xmlns:xbrldi="http://xbrl.org/2006/xbrldi">psti:EquityOptionsAndWarrantsMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2013-07-01</xbrli:startDate>
      <xbrli:endDate>2014-06-30</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="from-2013-07-01-to-2014-06-30.869.0.25535.5039.0.0.0.0">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001158780</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:ShareBasedGoodsAndNonemployeeServicesTransactionBySupplierAxis" xmlns:xbrldi="http://xbrl.org/2006/xbrldi">psti:ConsultantsMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2013-07-01</xbrli:startDate>
      <xbrli:endDate>2014-06-30</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="from-2013-07-01-to-2014-06-30.869.0.25534.367.0.0.0.0">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001158780</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis" xmlns:xbrldi="http://xbrl.org/2006/xbrldi">psti:ConsultantRestrictedStockUnitsMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2013-07-01</xbrli:startDate>
      <xbrli:endDate>2014-06-30</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="from-2013-07-01-to-2014-06-30.869.0.1835.367.25745.5031.0.0">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001158780</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis" xmlns:xbrldi="http://xbrl.org/2006/xbrldi">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis" xmlns:xbrldi="http://xbrl.org/2006/xbrldi">psti:ExercisePriceRangeTwelveMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2013-07-01</xbrli:startDate>
      <xbrli:endDate>2014-06-30</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="from-2013-07-01-to-2014-06-30.869.0.1835.367.25743.5031.0.0">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001158780</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis" xmlns:xbrldi="http://xbrl.org/2006/xbrldi">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis" xmlns:xbrldi="http://xbrl.org/2006/xbrldi">psti:OptionsExercisePriceRangeElevenMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2013-07-01</xbrli:startDate>
      <xbrli:endDate>2014-06-30</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="from-2013-07-01-to-2014-06-30.869.0.1835.367.25742.5031.0.0">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001158780</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis" xmlns:xbrldi="http://xbrl.org/2006/xbrldi">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis" xmlns:xbrldi="http://xbrl.org/2006/xbrldi">psti:OptionsExercisePriceRangeTenMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2013-07-01</xbrli:startDate>
      <xbrli:endDate>2014-06-30</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="from-2013-07-01-to-2014-06-30.869.0.1835.367.25741.5031.0.0">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001158780</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis" xmlns:xbrldi="http://xbrl.org/2006/xbrldi">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis" xmlns:xbrldi="http://xbrl.org/2006/xbrldi">psti:OptionsExercisePriceRangeNineMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2013-07-01</xbrli:startDate>
      <xbrli:endDate>2014-06-30</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="from-2013-07-01-to-2014-06-30.869.0.1835.367.25740.5031.0.0">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001158780</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis" xmlns:xbrldi="http://xbrl.org/2006/xbrldi">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis" xmlns:xbrldi="http://xbrl.org/2006/xbrldi">psti:OptionsExercisePriceRangeEightMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2013-07-01</xbrli:startDate>
      <xbrli:endDate>2014-06-30</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="from-2013-07-01-to-2014-06-30.869.0.1835.367.25739.5031.0.0">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001158780</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis" xmlns:xbrldi="http://xbrl.org/2006/xbrldi">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis" xmlns:xbrldi="http://xbrl.org/2006/xbrldi">psti:OptionsExercisePriceRangeSevenMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2013-07-01</xbrli:startDate>
      <xbrli:endDate>2014-06-30</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="from-2013-07-01-to-2014-06-30.869.0.1835.367.25738.5031.0.0">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001158780</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis" xmlns:xbrldi="http://xbrl.org/2006/xbrldi">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis" xmlns:xbrldi="http://xbrl.org/2006/xbrldi">psti:OptionsExercisePriceRangeSixMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2013-07-01</xbrli:startDate>
      <xbrli:endDate>2014-06-30</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="from-2013-07-01-to-2014-06-30.869.0.1835.367.25737.5031.0.0">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001158780</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis" xmlns:xbrldi="http://xbrl.org/2006/xbrldi">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis" xmlns:xbrldi="http://xbrl.org/2006/xbrldi">psti:OptionsExercisePriceRangeFiveMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2013-07-01</xbrli:startDate>
      <xbrli:endDate>2014-06-30</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="from-2013-07-01-to-2014-06-30.869.0.1835.367.25736.5031.0.0">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001158780</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis" xmlns:xbrldi="http://xbrl.org/2006/xbrldi">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis" xmlns:xbrldi="http://xbrl.org/2006/xbrldi">psti:OptionsExercisePriceRangeFourMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2013-07-01</xbrli:startDate>
      <xbrli:endDate>2014-06-30</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="from-2013-07-01-to-2014-06-30.869.0.1835.367.25735.5031.0.0">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001158780</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis" xmlns:xbrldi="http://xbrl.org/2006/xbrldi">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis" xmlns:xbrldi="http://xbrl.org/2006/xbrldi">psti:OptionsExercisePriceRangeThreeMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2013-07-01</xbrli:startDate>
      <xbrli:endDate>2014-06-30</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="from-2013-07-01-to-2014-06-30.869.0.1835.367.25734.5031.0.0">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001158780</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis" xmlns:xbrldi="http://xbrl.org/2006/xbrldi">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis" xmlns:xbrldi="http://xbrl.org/2006/xbrldi">psti:OptionsExercisePriceRangeTwoMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2013-07-01</xbrli:startDate>
      <xbrli:endDate>2014-06-30</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="from-2013-07-01-to-2014-06-30.869.0.1835.367.25733.5031.0.0">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001158780</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis" xmlns:xbrldi="http://xbrl.org/2006/xbrldi">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis" xmlns:xbrldi="http://xbrl.org/2006/xbrldi">psti:OptionsExercisePriceRangeOneMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2013-07-01</xbrli:startDate>
      <xbrli:endDate>2014-06-30</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="from-2013-07-01-to-2014-06-30.869.0.17830.1333.2365.1594.1352.1619">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001158780</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:CurrencyAxis" xmlns:xbrldi="http://xbrl.org/2006/xbrldi">currency:ILS</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis" xmlns:xbrldi="http://xbrl.org/2006/xbrldi">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis" xmlns:xbrldi="http://xbrl.org/2006/xbrldi">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2013-07-01</xbrli:startDate>
      <xbrli:endDate>2014-06-30</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="from-2013-07-01-to-2014-06-30.869.0.1163.4261.0.0.0.0">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001158780</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis" xmlns:xbrldi="http://xbrl.org/2006/xbrldi">us-gaap:ComputerEquipmentMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2013-07-01</xbrli:startDate>
      <xbrli:endDate>2014-06-30</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="from-2013-07-01-to-2014-06-30.869.0.1115.5114.0.0.0.0">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001158780</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis" xmlns:xbrldi="http://xbrl.org/2006/xbrldi">us-gaap:CommonStockMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2013-07-01</xbrli:startDate>
      <xbrli:endDate>2014-06-30</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="from-2013-07-01-to-2014-06-30.869.0.0.0.0.0.0.0">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001158780</xbrli:identifier>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2013-07-01</xbrli:startDate>
      <xbrli:endDate>2014-06-30</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="from-2012-09-18-to-2012-09-19.968.0.0.0.0.0.0.0">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001158780</xbrli:identifier>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2012-09-18</xbrli:startDate>
      <xbrli:endDate>2012-09-19</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="from-2012-08-01-to-2012-08-31.970.0.25816.1048.0.0.0.0">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001158780</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis" xmlns:xbrldi="http://xbrl.org/2006/xbrldi">psti:ConsultantWarrantsMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2012-08-01</xbrli:startDate>
      <xbrli:endDate>2012-08-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="from-2012-07-01-to-2013-06-30.870.0.499.5114.0.0.0.0">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001158780</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis" xmlns:xbrldi="http://xbrl.org/2006/xbrldi">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2012-07-01</xbrli:startDate>
      <xbrli:endDate>2013-06-30</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="from-2012-07-01-to-2013-06-30.870.0.478.5114.0.0.0.0">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001158780</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis" xmlns:xbrldi="http://xbrl.org/2006/xbrldi">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2012-07-01</xbrli:startDate>
      <xbrli:endDate>2013-06-30</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="from-2012-07-01-to-2013-06-30.870.0.4619.5114.0.0.0.0">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001158780</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis" xmlns:xbrldi="http://xbrl.org/2006/xbrldi">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2012-07-01</xbrli:startDate>
      <xbrli:endDate>2013-06-30</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="from-2012-07-01-to-2013-06-30.870.0.4568.367.4543.2652.25535.5039">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001158780</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis" xmlns:xbrldi="http://xbrl.org/2006/xbrldi">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis" xmlns:xbrldi="http://xbrl.org/2006/xbrldi">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:ShareBasedGoodsAndNonemployeeServicesTransactionBySupplierAxis" xmlns:xbrldi="http://xbrl.org/2006/xbrldi">psti:ConsultantsMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2012-07-01</xbrli:startDate>
      <xbrli:endDate>2013-06-30</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="from-2012-07-01-to-2013-06-30.870.0.4568.367.4543.2652.0.0">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001158780</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis" xmlns:xbrldi="http://xbrl.org/2006/xbrldi">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis" xmlns:xbrldi="http://xbrl.org/2006/xbrldi">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2012-07-01</xbrli:startDate>
      <xbrli:endDate>2013-06-30</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="from-2012-07-01-to-2013-06-30.870.0.4568.367.2476.2652.25535.5039">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001158780</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis" xmlns:xbrldi="http://xbrl.org/2006/xbrldi">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis" xmlns:xbrldi="http://xbrl.org/2006/xbrldi">us-gaap:GeneralAndAdministrativeExpenseMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:ShareBasedGoodsAndNonemployeeServicesTransactionBySupplierAxis" xmlns:xbrldi="http://xbrl.org/2006/xbrldi">psti:ConsultantsMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2012-07-01</xbrli:startDate>
      <xbrli:endDate>2013-06-30</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="from-2012-07-01-to-2013-06-30.870.0.4568.367.2476.2652.0.0">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001158780</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis" xmlns:xbrldi="http://xbrl.org/2006/xbrldi">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis" xmlns:xbrldi="http://xbrl.org/2006/xbrldi">us-gaap:GeneralAndAdministrativeExpenseMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2012-07-01</xbrli:startDate>
      <xbrli:endDate>2013-06-30</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="from-2012-07-01-to-2013-06-30.870.0.4568.367.0.0.0.0">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001158780</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis" xmlns:xbrldi="http://xbrl.org/2006/xbrldi">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2012-07-01</xbrli:startDate>
      <xbrli:endDate>2013-06-30</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="from-2012-07-01-to-2013-06-30.870.0.395.4261.0.0.0.0">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001158780</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis" xmlns:xbrldi="http://xbrl.org/2006/xbrldi">us-gaap:AutomobilesMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2012-07-01</xbrli:startDate>
      <xbrli:endDate>2013-06-30</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="from-2012-07-01-to-2013-06-30.870.0.3370.4349.0.0.0.0">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001158780</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:RangeAxis" xmlns:xbrldi="http://xbrl.org/2006/xbrldi">us-gaap:MinimumMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2012-07-01</xbrli:startDate>
      <xbrli:endDate>2013-06-30</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="from-2012-07-01-to-2013-06-30.870.0.3361.4349.0.0.0.0">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001158780</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:RangeAxis" xmlns:xbrldi="http://xbrl.org/2006/xbrldi">us-gaap:MaximumMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2012-07-01</xbrli:startDate>
      <xbrli:endDate>2013-06-30</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="from-2012-07-01-to-2013-06-30.870.0.3316.5277.0.0.0.0">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001158780</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:TitleOfIndividualAxis" xmlns:xbrldi="http://xbrl.org/2006/xbrldi">us-gaap:ManagementMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2012-07-01</xbrli:startDate>
      <xbrli:endDate>2013-06-30</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="from-2012-07-01-to-2013-06-30.870.0.3008.4261.0.0.0.0">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001158780</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis" xmlns:xbrldi="http://xbrl.org/2006/xbrldi">us-gaap:LandAndBuildingMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2012-07-01</xbrli:startDate>
      <xbrli:endDate>2013-06-30</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="from-2012-07-01-to-2013-06-30.870.0.25814.1048.0.0.0.0">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001158780</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis" xmlns:xbrldi="http://xbrl.org/2006/xbrldi">psti:InvestorWarrantsMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2012-07-01</xbrli:startDate>
      <xbrli:endDate>2013-06-30</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="from-2012-07-01-to-2013-06-30.870.0.25661.5277.0.0.0.0">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001158780</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:TitleOfIndividualAxis" xmlns:xbrldi="http://xbrl.org/2006/xbrldi">psti:EmployeesMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2012-07-01</xbrli:startDate>
      <xbrli:endDate>2013-06-30</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="from-2012-07-01-to-2013-06-30.870.0.25537.367.4543.2652.0.0">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001158780</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis" xmlns:xbrldi="http://xbrl.org/2006/xbrldi">psti:EquityOptionsAndWarrantsMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis" xmlns:xbrldi="http://xbrl.org/2006/xbrldi">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2012-07-01</xbrli:startDate>
      <xbrli:endDate>2013-06-30</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="from-2012-07-01-to-2013-06-30.870.0.25537.367.2476.2652.0.0">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001158780</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis" xmlns:xbrldi="http://xbrl.org/2006/xbrldi">psti:EquityOptionsAndWarrantsMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis" xmlns:xbrldi="http://xbrl.org/2006/xbrldi">us-gaap:GeneralAndAdministrativeExpenseMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2012-07-01</xbrli:startDate>
      <xbrli:endDate>2013-06-30</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="from-2012-07-01-to-2013-06-30.870.0.25537.367.0.0.0.0">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001158780</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis" xmlns:xbrldi="http://xbrl.org/2006/xbrldi">psti:EquityOptionsAndWarrantsMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2012-07-01</xbrli:startDate>
      <xbrli:endDate>2013-06-30</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="from-2012-07-01-to-2013-06-30.870.0.25535.5039.0.0.0.0">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001158780</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:ShareBasedGoodsAndNonemployeeServicesTransactionBySupplierAxis" xmlns:xbrldi="http://xbrl.org/2006/xbrldi">psti:ConsultantsMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2012-07-01</xbrli:startDate>
      <xbrli:endDate>2013-06-30</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="from-2012-07-01-to-2013-06-30.870.0.1115.5114.0.0.0.0">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001158780</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis" xmlns:xbrldi="http://xbrl.org/2006/xbrldi">us-gaap:CommonStockMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2012-07-01</xbrli:startDate>
      <xbrli:endDate>2013-06-30</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="from-2012-07-01-to-2013-06-30.870.0.0.0.0.0.0.0">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001158780</xbrli:identifier>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2012-07-01</xbrli:startDate>
      <xbrli:endDate>2013-06-30</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="from-2011-08-01-to-2011-08-31.890.0.0.0.0.0.0.0">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001158780</xbrli:identifier>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2011-08-01</xbrli:startDate>
      <xbrli:endDate>2011-08-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="from-2011-07-01-to-2012-06-30.871.0.499.5114.0.0.0.0">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001158780</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis" xmlns:xbrldi="http://xbrl.org/2006/xbrldi">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2011-07-01</xbrli:startDate>
      <xbrli:endDate>2012-06-30</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="from-2011-07-01-to-2012-06-30.871.0.478.5114.0.0.0.0">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001158780</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis" xmlns:xbrldi="http://xbrl.org/2006/xbrldi">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2011-07-01</xbrli:startDate>
      <xbrli:endDate>2012-06-30</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="from-2011-07-01-to-2012-06-30.871.0.4619.5114.0.0.0.0">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001158780</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis" xmlns:xbrldi="http://xbrl.org/2006/xbrldi">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2011-07-01</xbrli:startDate>
      <xbrli:endDate>2012-06-30</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="from-2011-07-01-to-2012-06-30.871.0.4568.367.4543.2652.25535.5039">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001158780</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis" xmlns:xbrldi="http://xbrl.org/2006/xbrldi">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis" xmlns:xbrldi="http://xbrl.org/2006/xbrldi">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:ShareBasedGoodsAndNonemployeeServicesTransactionBySupplierAxis" xmlns:xbrldi="http://xbrl.org/2006/xbrldi">psti:ConsultantsMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2011-07-01</xbrli:startDate>
      <xbrli:endDate>2012-06-30</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="from-2011-07-01-to-2012-06-30.871.0.4568.367.4543.2652.0.0">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001158780</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis" xmlns:xbrldi="http://xbrl.org/2006/xbrldi">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis" xmlns:xbrldi="http://xbrl.org/2006/xbrldi">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2011-07-01</xbrli:startDate>
      <xbrli:endDate>2012-06-30</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="from-2011-07-01-to-2012-06-30.871.0.4568.367.2476.2652.25535.5039">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001158780</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis" xmlns:xbrldi="http://xbrl.org/2006/xbrldi">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis" xmlns:xbrldi="http://xbrl.org/2006/xbrldi">us-gaap:GeneralAndAdministrativeExpenseMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:ShareBasedGoodsAndNonemployeeServicesTransactionBySupplierAxis" xmlns:xbrldi="http://xbrl.org/2006/xbrldi">psti:ConsultantsMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2011-07-01</xbrli:startDate>
      <xbrli:endDate>2012-06-30</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="from-2011-07-01-to-2012-06-30.871.0.4568.367.2476.2652.0.0">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001158780</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis" xmlns:xbrldi="http://xbrl.org/2006/xbrldi">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis" xmlns:xbrldi="http://xbrl.org/2006/xbrldi">us-gaap:GeneralAndAdministrativeExpenseMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2011-07-01</xbrli:startDate>
      <xbrli:endDate>2012-06-30</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="from-2011-07-01-to-2012-06-30.871.0.4568.367.0.0.0.0">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001158780</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis" xmlns:xbrldi="http://xbrl.org/2006/xbrldi">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2011-07-01</xbrli:startDate>
      <xbrli:endDate>2012-06-30</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="from-2011-07-01-to-2012-06-30.871.0.395.4261.0.0.0.0">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001158780</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis" xmlns:xbrldi="http://xbrl.org/2006/xbrldi">us-gaap:AutomobilesMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2011-07-01</xbrli:startDate>
      <xbrli:endDate>2012-06-30</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="from-2011-07-01-to-2012-06-30.871.0.3370.4349.0.0.0.0">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001158780</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:RangeAxis" xmlns:xbrldi="http://xbrl.org/2006/xbrldi">us-gaap:MinimumMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2011-07-01</xbrli:startDate>
      <xbrli:endDate>2012-06-30</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="from-2011-07-01-to-2012-06-30.871.0.3361.4349.0.0.0.0">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001158780</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:RangeAxis" xmlns:xbrldi="http://xbrl.org/2006/xbrldi">us-gaap:MaximumMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2011-07-01</xbrli:startDate>
      <xbrli:endDate>2012-06-30</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="from-2011-07-01-to-2012-06-30.871.0.3316.5277.0.0.0.0">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001158780</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:TitleOfIndividualAxis" xmlns:xbrldi="http://xbrl.org/2006/xbrldi">us-gaap:ManagementMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2011-07-01</xbrli:startDate>
      <xbrli:endDate>2012-06-30</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="from-2011-07-01-to-2012-06-30.871.0.3008.4261.0.0.0.0">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001158780</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis" xmlns:xbrldi="http://xbrl.org/2006/xbrldi">us-gaap:LandAndBuildingMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2011-07-01</xbrli:startDate>
      <xbrli:endDate>2012-06-30</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="from-2011-07-01-to-2012-06-30.871.0.25817.5039.0.0.0.0">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001158780</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:ShareBasedGoodsAndNonemployeeServicesTransactionBySupplierAxis" xmlns:xbrldi="http://xbrl.org/2006/xbrldi">psti:BiopharmaxMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2011-07-01</xbrli:startDate>
      <xbrli:endDate>2012-06-30</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="from-2011-07-01-to-2012-06-30.871.0.25814.1048.0.0.0.0">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001158780</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis" xmlns:xbrldi="http://xbrl.org/2006/xbrldi">psti:InvestorWarrantsMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2011-07-01</xbrli:startDate>
      <xbrli:endDate>2012-06-30</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="from-2011-07-01-to-2012-06-30.871.0.25661.5277.0.0.0.0">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001158780</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:TitleOfIndividualAxis" xmlns:xbrldi="http://xbrl.org/2006/xbrldi">psti:EmployeesMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2011-07-01</xbrli:startDate>
      <xbrli:endDate>2012-06-30</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="from-2011-07-01-to-2012-06-30.871.0.25537.367.4543.2652.0.0">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001158780</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis" xmlns:xbrldi="http://xbrl.org/2006/xbrldi">psti:EquityOptionsAndWarrantsMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis" xmlns:xbrldi="http://xbrl.org/2006/xbrldi">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2011-07-01</xbrli:startDate>
      <xbrli:endDate>2012-06-30</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="from-2011-07-01-to-2012-06-30.871.0.25537.367.2476.2652.0.0">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001158780</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis" xmlns:xbrldi="http://xbrl.org/2006/xbrldi">psti:EquityOptionsAndWarrantsMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis" xmlns:xbrldi="http://xbrl.org/2006/xbrldi">us-gaap:GeneralAndAdministrativeExpenseMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2011-07-01</xbrli:startDate>
      <xbrli:endDate>2012-06-30</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="from-2011-07-01-to-2012-06-30.871.0.25537.367.0.0.0.0">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001158780</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis" xmlns:xbrldi="http://xbrl.org/2006/xbrldi">psti:EquityOptionsAndWarrantsMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2011-07-01</xbrli:startDate>
      <xbrli:endDate>2012-06-30</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="from-2011-07-01-to-2012-06-30.871.0.25535.5039.0.0.0.0">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001158780</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:ShareBasedGoodsAndNonemployeeServicesTransactionBySupplierAxis" xmlns:xbrldi="http://xbrl.org/2006/xbrldi">psti:ConsultantsMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2011-07-01</xbrli:startDate>
      <xbrli:endDate>2012-06-30</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="from-2011-07-01-to-2012-06-30.871.0.1115.5114.0.0.0.0">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001158780</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis" xmlns:xbrldi="http://xbrl.org/2006/xbrldi">us-gaap:CommonStockMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2011-07-01</xbrli:startDate>
      <xbrli:endDate>2012-06-30</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="from-2011-07-01-to-2012-06-30.871.0.0.0.0.0.0.0">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001158780</xbrli:identifier>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2011-07-01</xbrli:startDate>
      <xbrli:endDate>2012-06-30</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="as-of-2014-09-02.877.0.0.0.0.0.0.0">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001158780</xbrli:identifier>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2014-09-02</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="as-of-2014-06-30.872.0.5496.367.25752.5031.0.0">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001158780</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis" xmlns:xbrldi="http://xbrl.org/2006/xbrldi">us-gaap:WarrantMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis" xmlns:xbrldi="http://xbrl.org/2006/xbrldi">psti:ExercisePriceRangeSevenMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2014-06-30</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="as-of-2014-06-30.872.0.5496.367.25751.5031.0.0">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001158780</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis" xmlns:xbrldi="http://xbrl.org/2006/xbrldi">us-gaap:WarrantMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis" xmlns:xbrldi="http://xbrl.org/2006/xbrldi">psti:ExercisePriceRangeSixMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2014-06-30</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="as-of-2014-06-30.872.0.5496.367.25750.5031.0.0">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001158780</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis" xmlns:xbrldi="http://xbrl.org/2006/xbrldi">us-gaap:WarrantMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis" xmlns:xbrldi="http://xbrl.org/2006/xbrldi">psti:ExercisePriceRangeFiveMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2014-06-30</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="as-of-2014-06-30.872.0.5496.367.25749.5031.0.0">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001158780</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis" xmlns:xbrldi="http://xbrl.org/2006/xbrldi">us-gaap:WarrantMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis" xmlns:xbrldi="http://xbrl.org/2006/xbrldi">psti:ExercisePriceRangeFourMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2014-06-30</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="as-of-2014-06-30.872.0.5496.367.25748.5031.0.0">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001158780</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis" xmlns:xbrldi="http://xbrl.org/2006/xbrldi">us-gaap:WarrantMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis" xmlns:xbrldi="http://xbrl.org/2006/xbrldi">psti:ExercisePriceRangeThreeMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2014-06-30</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="as-of-2014-06-30.872.0.5496.367.25747.5031.0.0">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001158780</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis" xmlns:xbrldi="http://xbrl.org/2006/xbrldi">us-gaap:WarrantMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis" xmlns:xbrldi="http://xbrl.org/2006/xbrldi">psti:ExercisePriceRangeTwoMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2014-06-30</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="as-of-2014-06-30.872.0.5496.367.25746.5031.0.0">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001158780</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis" xmlns:xbrldi="http://xbrl.org/2006/xbrldi">us-gaap:WarrantMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis" xmlns:xbrldi="http://xbrl.org/2006/xbrldi">psti:ExercisePriceRangeOneMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2014-06-30</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="as-of-2014-06-30.872.0.5496.367.0.0.0.0">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001158780</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis" xmlns:xbrldi="http://xbrl.org/2006/xbrldi">us-gaap:WarrantMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2014-06-30</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="as-of-2014-06-30.872.0.5488.4261.0.0.0.0">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001158780</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis" xmlns:xbrldi="http://xbrl.org/2006/xbrldi">us-gaap:VehiclesMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2014-06-30</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="as-of-2014-06-30.872.0.499.5114.0.0.0.0">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001158780</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis" xmlns:xbrldi="http://xbrl.org/2006/xbrldi">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2014-06-30</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="as-of-2014-06-30.872.0.484.5114.0.0.0.0">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001158780</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis" xmlns:xbrldi="http://xbrl.org/2006/xbrldi">us-gaap:AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2014-06-30</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="as-of-2014-06-30.872.0.478.5114.0.0.0.0">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001158780</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis" xmlns:xbrldi="http://xbrl.org/2006/xbrldi">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2014-06-30</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="as-of-2014-06-30.872.0.477.5114.0.0.0.0">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001158780</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis" xmlns:xbrldi="http://xbrl.org/2006/xbrldi">us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2014-06-30</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="as-of-2014-06-30.872.0.4619.5114.0.0.0.0">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001158780</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis" xmlns:xbrldi="http://xbrl.org/2006/xbrldi">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2014-06-30</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="as-of-2014-06-30.872.0.4568.367.0.0.0.0">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001158780</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis" xmlns:xbrldi="http://xbrl.org/2006/xbrldi">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2014-06-30</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="as-of-2014-06-30.872.0.395.4261.0.0.0.0">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001158780</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis" xmlns:xbrldi="http://xbrl.org/2006/xbrldi">us-gaap:AutomobilesMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2014-06-30</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="as-of-2014-06-30.872.0.3840.4261.0.0.0.0">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001158780</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis" xmlns:xbrldi="http://xbrl.org/2006/xbrldi">us-gaap:OtherMachineryAndEquipmentMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2014-06-30</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="as-of-2014-06-30.872.0.3743.736.979.1619.1352.2543">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001158780</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis" xmlns:xbrldi="http://xbrl.org/2006/xbrldi">us-gaap:OtherCurrentAssetsMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis" xmlns:xbrldi="http://xbrl.org/2006/xbrldi">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis" xmlns:xbrldi="http://xbrl.org/2006/xbrldi">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2014-06-30</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="as-of-2014-06-30.872.0.3743.736.3619.2543.0.0">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001158780</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis" xmlns:xbrldi="http://xbrl.org/2006/xbrldi">us-gaap:OtherCurrentAssetsMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis" xmlns:xbrldi="http://xbrl.org/2006/xbrldi">us-gaap:NondesignatedMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2014-06-30</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="as-of-2014-06-30.872.0.3728.736.2158.1619.1352.2543">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001158780</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis" xmlns:xbrldi="http://xbrl.org/2006/xbrldi">us-gaap:OtherCurrentLiabilitiesMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis" xmlns:xbrldi="http://xbrl.org/2006/xbrldi">us-gaap:FairValueHedgingMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis" xmlns:xbrldi="http://xbrl.org/2006/xbrldi">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2014-06-30</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="as-of-2014-06-30.872.0.3650.4261.0.0.0.0">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001158780</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis" xmlns:xbrldi="http://xbrl.org/2006/xbrldi">us-gaap:OfficeEquipmentMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2014-06-30</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="as-of-2014-06-30.872.0.3017.4261.0.0.0.0">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001158780</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis" xmlns:xbrldi="http://xbrl.org/2006/xbrldi">us-gaap:LeaseholdImprovementsMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2014-06-30</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="as-of-2014-06-30.872.0.3008.4261.0.0.0.0">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001158780</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis" xmlns:xbrldi="http://xbrl.org/2006/xbrldi">us-gaap:LandAndBuildingMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2014-06-30</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="as-of-2014-06-30.872.0.2877.2667.0.0.0.0">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001158780</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis" xmlns:xbrldi="http://xbrl.org/2006/xbrldi">us-gaap:InternalRevenueServiceIRSMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2014-06-30</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="as-of-2014-06-30.872.0.2580.2667.0.0.0.0">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001158780</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis" xmlns:xbrldi="http://xbrl.org/2006/xbrldi">us-gaap:IsraelTaxAuthorityMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2014-06-30</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="as-of-2014-06-30.872.0.25540.3302.25532.4349.0.0">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001158780</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:MajorTypesOfDebtAndEquitySecuritiesAxis" xmlns:xbrldi="http://xbrl.org/2006/xbrldi">psti:GovernmentDebtSecuritiesMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:RangeAxis" xmlns:xbrldi="http://xbrl.org/2006/xbrldi">psti:AvailableForSaleSecuritiesMaturesWithinOneYearMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2014-06-30</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="as-of-2014-06-30.872.0.25540.3302.25531.4349.0.0">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001158780</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:MajorTypesOfDebtAndEquitySecuritiesAxis" xmlns:xbrldi="http://xbrl.org/2006/xbrldi">psti:GovernmentDebtSecuritiesMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:RangeAxis" xmlns:xbrldi="http://xbrl.org/2006/xbrldi">psti:AvailableForSaleSecuritiesMaturesAfterOneYearThroughFiveYearsMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2014-06-30</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="as-of-2014-06-30.872.0.25540.3302.25530.4349.0.0">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001158780</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:MajorTypesOfDebtAndEquitySecuritiesAxis" xmlns:xbrldi="http://xbrl.org/2006/xbrldi">psti:GovernmentDebtSecuritiesMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:RangeAxis" xmlns:xbrldi="http://xbrl.org/2006/xbrldi">psti:AvailableForSaleSecuritiesMaturesAfterFiveYearsThroughTenYearsMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2014-06-30</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="as-of-2014-06-30.872.0.25537.367.0.0.0.0">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001158780</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis" xmlns:xbrldi="http://xbrl.org/2006/xbrldi">psti:EquityOptionsAndWarrantsMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2014-06-30</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="as-of-2014-06-30.872.0.25535.5039.0.0.0.0">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001158780</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:ShareBasedGoodsAndNonemployeeServicesTransactionBySupplierAxis" xmlns:xbrldi="http://xbrl.org/2006/xbrldi">psti:ConsultantsMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2014-06-30</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="as-of-2014-06-30.872.0.25532.4349.0.0.0.0">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001158780</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:RangeAxis" xmlns:xbrldi="http://xbrl.org/2006/xbrldi">psti:AvailableForSaleSecuritiesMaturesWithinOneYearMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2014-06-30</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="as-of-2014-06-30.872.0.25531.4349.0.0.0.0">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001158780</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:RangeAxis" xmlns:xbrldi="http://xbrl.org/2006/xbrldi">psti:AvailableForSaleSecuritiesMaturesAfterOneYearThroughFiveYearsMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2014-06-30</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="as-of-2014-06-30.872.0.25530.4349.0.0.0.0">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001158780</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:RangeAxis" xmlns:xbrldi="http://xbrl.org/2006/xbrldi">psti:AvailableForSaleSecuritiesMaturesAfterFiveYearsThroughTenYearsMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2014-06-30</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="as-of-2014-06-30.872.0.2137.2043.2032.2040.0.0">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001158780</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis" xmlns:xbrldi="http://xbrl.org/2006/xbrldi">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis" xmlns:xbrldi="http://xbrl.org/2006/xbrldi">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2014-06-30</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="as-of-2014-06-30.872.0.2136.2043.2032.2040.0.0">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001158780</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis" xmlns:xbrldi="http://xbrl.org/2006/xbrldi">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis" xmlns:xbrldi="http://xbrl.org/2006/xbrldi">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2014-06-30</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="as-of-2014-06-30.872.0.2135.2043.2032.2040.0.0">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001158780</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis" xmlns:xbrldi="http://xbrl.org/2006/xbrldi">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis" xmlns:xbrldi="http://xbrl.org/2006/xbrldi">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2014-06-30</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="as-of-2014-06-30.872.0.1910.3302.25532.4349.0.0">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001158780</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:MajorTypesOfDebtAndEquitySecuritiesAxis" xmlns:xbrldi="http://xbrl.org/2006/xbrldi">us-gaap:EquitySecuritiesMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:RangeAxis" xmlns:xbrldi="http://xbrl.org/2006/xbrldi">psti:AvailableForSaleSecuritiesMaturesWithinOneYearMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2014-06-30</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="as-of-2014-06-30.872.0.1835.367.25745.5031.0.0">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001158780</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis" xmlns:xbrldi="http://xbrl.org/2006/xbrldi">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis" xmlns:xbrldi="http://xbrl.org/2006/xbrldi">psti:ExercisePriceRangeTwelveMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2014-06-30</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="as-of-2014-06-30.872.0.1835.367.25743.5031.0.0">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001158780</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis" xmlns:xbrldi="http://xbrl.org/2006/xbrldi">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis" xmlns:xbrldi="http://xbrl.org/2006/xbrldi">psti:OptionsExercisePriceRangeElevenMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2014-06-30</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="as-of-2014-06-30.872.0.1835.367.25742.5031.0.0">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001158780</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis" xmlns:xbrldi="http://xbrl.org/2006/xbrldi">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis" xmlns:xbrldi="http://xbrl.org/2006/xbrldi">psti:OptionsExercisePriceRangeTenMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2014-06-30</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="as-of-2014-06-30.872.0.1835.367.25741.5031.0.0">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001158780</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis" xmlns:xbrldi="http://xbrl.org/2006/xbrldi">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis" xmlns:xbrldi="http://xbrl.org/2006/xbrldi">psti:OptionsExercisePriceRangeNineMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2014-06-30</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="as-of-2014-06-30.872.0.1835.367.25740.5031.0.0">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001158780</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis" xmlns:xbrldi="http://xbrl.org/2006/xbrldi">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis" xmlns:xbrldi="http://xbrl.org/2006/xbrldi">psti:OptionsExercisePriceRangeEightMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2014-06-30</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="as-of-2014-06-30.872.0.1835.367.25739.5031.0.0">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001158780</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis" xmlns:xbrldi="http://xbrl.org/2006/xbrldi">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis" xmlns:xbrldi="http://xbrl.org/2006/xbrldi">psti:OptionsExercisePriceRangeSevenMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2014-06-30</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="as-of-2014-06-30.872.0.1835.367.25738.5031.0.0">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001158780</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis" xmlns:xbrldi="http://xbrl.org/2006/xbrldi">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis" xmlns:xbrldi="http://xbrl.org/2006/xbrldi">psti:OptionsExercisePriceRangeSixMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2014-06-30</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="as-of-2014-06-30.872.0.1835.367.25737.5031.0.0">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001158780</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis" xmlns:xbrldi="http://xbrl.org/2006/xbrldi">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis" xmlns:xbrldi="http://xbrl.org/2006/xbrldi">psti:OptionsExercisePriceRangeFiveMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2014-06-30</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="as-of-2014-06-30.872.0.1835.367.25736.5031.0.0">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001158780</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis" xmlns:xbrldi="http://xbrl.org/2006/xbrldi">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis" xmlns:xbrldi="http://xbrl.org/2006/xbrldi">psti:OptionsExercisePriceRangeFourMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2014-06-30</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="as-of-2014-06-30.872.0.1835.367.25735.5031.0.0">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001158780</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis" xmlns:xbrldi="http://xbrl.org/2006/xbrldi">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis" xmlns:xbrldi="http://xbrl.org/2006/xbrldi">psti:OptionsExercisePriceRangeThreeMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2014-06-30</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="as-of-2014-06-30.872.0.1835.367.25734.5031.0.0">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001158780</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis" xmlns:xbrldi="http://xbrl.org/2006/xbrldi">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis" xmlns:xbrldi="http://xbrl.org/2006/xbrldi">psti:OptionsExercisePriceRangeTwoMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2014-06-30</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="as-of-2014-06-30.872.0.1835.367.25733.5031.0.0">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001158780</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis" xmlns:xbrldi="http://xbrl.org/2006/xbrldi">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis" xmlns:xbrldi="http://xbrl.org/2006/xbrldi">psti:OptionsExercisePriceRangeOneMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2014-06-30</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="as-of-2014-06-30.872.0.1835.367.0.0.0.0">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001158780</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis" xmlns:xbrldi="http://xbrl.org/2006/xbrldi">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2014-06-30</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="as-of-2014-06-30.872.0.17845.1333.2365.1594.1352.1619">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001158780</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:CurrencyAxis" xmlns:xbrldi="http://xbrl.org/2006/xbrldi">currency:KRW</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis" xmlns:xbrldi="http://xbrl.org/2006/xbrldi">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis" xmlns:xbrldi="http://xbrl.org/2006/xbrldi">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2014-06-30</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="as-of-2014-06-30.872.0.17830.1333.2365.1594.1352.1619">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001158780</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:CurrencyAxis" xmlns:xbrldi="http://xbrl.org/2006/xbrldi">currency:ILS</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis" xmlns:xbrldi="http://xbrl.org/2006/xbrldi">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis" xmlns:xbrldi="http://xbrl.org/2006/xbrldi">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2014-06-30</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="as-of-2014-06-30.872.0.1263.3302.25532.4349.0.0">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001158780</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:MajorTypesOfDebtAndEquitySecuritiesAxis" xmlns:xbrldi="http://xbrl.org/2006/xbrldi">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:RangeAxis" xmlns:xbrldi="http://xbrl.org/2006/xbrldi">psti:AvailableForSaleSecuritiesMaturesWithinOneYearMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2014-06-30</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="as-of-2014-06-30.872.0.1263.3302.25531.4349.0.0">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001158780</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:MajorTypesOfDebtAndEquitySecuritiesAxis" xmlns:xbrldi="http://xbrl.org/2006/xbrldi">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:RangeAxis" xmlns:xbrldi="http://xbrl.org/2006/xbrldi">psti:AvailableForSaleSecuritiesMaturesAfterOneYearThroughFiveYearsMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2014-06-30</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="as-of-2014-06-30.872.0.1263.3302.25530.4349.0.0">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001158780</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:MajorTypesOfDebtAndEquitySecuritiesAxis" xmlns:xbrldi="http://xbrl.org/2006/xbrldi">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:RangeAxis" xmlns:xbrldi="http://xbrl.org/2006/xbrldi">psti:AvailableForSaleSecuritiesMaturesAfterFiveYearsThroughTenYearsMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2014-06-30</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="as-of-2014-06-30.872.0.1163.4261.0.0.0.0">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001158780</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis" xmlns:xbrldi="http://xbrl.org/2006/xbrldi">us-gaap:ComputerEquipmentMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2014-06-30</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="as-of-2014-06-30.872.0.1115.5114.0.0.0.0">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001158780</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis" xmlns:xbrldi="http://xbrl.org/2006/xbrldi">us-gaap:CommonStockMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2014-06-30</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="as-of-2014-06-30.872.0.0.0.0.0.0.0">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001158780</xbrli:identifier>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2014-06-30</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="as-of-2013-12-31.873.0.0.0.0.0.0.0">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001158780</xbrli:identifier>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2013-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="as-of-2013-06-30.874.0.5488.4261.0.0.0.0">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001158780</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis" xmlns:xbrldi="http://xbrl.org/2006/xbrldi">us-gaap:VehiclesMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2013-06-30</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="as-of-2013-06-30.874.0.499.5114.0.0.0.0">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001158780</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis" xmlns:xbrldi="http://xbrl.org/2006/xbrldi">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2013-06-30</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="as-of-2013-06-30.874.0.484.5114.0.0.0.0">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001158780</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis" xmlns:xbrldi="http://xbrl.org/2006/xbrldi">us-gaap:AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2013-06-30</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="as-of-2013-06-30.874.0.478.5114.0.0.0.0">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001158780</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis" xmlns:xbrldi="http://xbrl.org/2006/xbrldi">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2013-06-30</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="as-of-2013-06-30.874.0.477.5114.0.0.0.0">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001158780</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis" xmlns:xbrldi="http://xbrl.org/2006/xbrldi">us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2013-06-30</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="as-of-2013-06-30.874.0.4619.5114.0.0.0.0">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001158780</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis" xmlns:xbrldi="http://xbrl.org/2006/xbrldi">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2013-06-30</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="as-of-2013-06-30.874.0.4568.367.0.0.0.0">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001158780</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis" xmlns:xbrldi="http://xbrl.org/2006/xbrldi">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2013-06-30</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="as-of-2013-06-30.874.0.3840.4261.0.0.0.0">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001158780</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis" xmlns:xbrldi="http://xbrl.org/2006/xbrldi">us-gaap:OtherMachineryAndEquipmentMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2013-06-30</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="as-of-2013-06-30.874.0.3743.736.979.1619.1352.2543">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001158780</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis" xmlns:xbrldi="http://xbrl.org/2006/xbrldi">us-gaap:OtherCurrentAssetsMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis" xmlns:xbrldi="http://xbrl.org/2006/xbrldi">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis" xmlns:xbrldi="http://xbrl.org/2006/xbrldi">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2013-06-30</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="as-of-2013-06-30.874.0.3743.736.3619.2543.0.0">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001158780</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis" xmlns:xbrldi="http://xbrl.org/2006/xbrldi">us-gaap:OtherCurrentAssetsMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis" xmlns:xbrldi="http://xbrl.org/2006/xbrldi">us-gaap:NondesignatedMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2013-06-30</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="as-of-2013-06-30.874.0.3728.736.2158.1619.1352.2543">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001158780</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis" xmlns:xbrldi="http://xbrl.org/2006/xbrldi">us-gaap:OtherCurrentLiabilitiesMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis" xmlns:xbrldi="http://xbrl.org/2006/xbrldi">us-gaap:FairValueHedgingMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis" xmlns:xbrldi="http://xbrl.org/2006/xbrldi">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2013-06-30</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="as-of-2013-06-30.874.0.3650.4261.0.0.0.0">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001158780</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis" xmlns:xbrldi="http://xbrl.org/2006/xbrldi">us-gaap:OfficeEquipmentMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2013-06-30</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="as-of-2013-06-30.874.0.3017.4261.0.0.0.0">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001158780</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis" xmlns:xbrldi="http://xbrl.org/2006/xbrldi">us-gaap:LeaseholdImprovementsMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2013-06-30</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="as-of-2013-06-30.874.0.25540.3302.25532.4349.0.0">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001158780</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:MajorTypesOfDebtAndEquitySecuritiesAxis" xmlns:xbrldi="http://xbrl.org/2006/xbrldi">psti:GovernmentDebtSecuritiesMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:RangeAxis" xmlns:xbrldi="http://xbrl.org/2006/xbrldi">psti:AvailableForSaleSecuritiesMaturesWithinOneYearMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2013-06-30</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="as-of-2013-06-30.874.0.25540.3302.25531.4349.0.0">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001158780</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:MajorTypesOfDebtAndEquitySecuritiesAxis" xmlns:xbrldi="http://xbrl.org/2006/xbrldi">psti:GovernmentDebtSecuritiesMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:RangeAxis" xmlns:xbrldi="http://xbrl.org/2006/xbrldi">psti:AvailableForSaleSecuritiesMaturesAfterOneYearThroughFiveYearsMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2013-06-30</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="as-of-2013-06-30.874.0.25540.3302.25530.4349.0.0">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001158780</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:MajorTypesOfDebtAndEquitySecuritiesAxis" xmlns:xbrldi="http://xbrl.org/2006/xbrldi">psti:GovernmentDebtSecuritiesMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:RangeAxis" xmlns:xbrldi="http://xbrl.org/2006/xbrldi">psti:AvailableForSaleSecuritiesMaturesAfterFiveYearsThroughTenYearsMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2013-06-30</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="as-of-2013-06-30.874.0.25535.5039.0.0.0.0">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001158780</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:ShareBasedGoodsAndNonemployeeServicesTransactionBySupplierAxis" xmlns:xbrldi="http://xbrl.org/2006/xbrldi">psti:ConsultantsMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2013-06-30</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="as-of-2013-06-30.874.0.25532.4349.0.0.0.0">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001158780</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:RangeAxis" xmlns:xbrldi="http://xbrl.org/2006/xbrldi">psti:AvailableForSaleSecuritiesMaturesWithinOneYearMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2013-06-30</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="as-of-2013-06-30.874.0.25531.4349.0.0.0.0">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001158780</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:RangeAxis" xmlns:xbrldi="http://xbrl.org/2006/xbrldi">psti:AvailableForSaleSecuritiesMaturesAfterOneYearThroughFiveYearsMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2013-06-30</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="as-of-2013-06-30.874.0.25530.4349.0.0.0.0">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001158780</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:RangeAxis" xmlns:xbrldi="http://xbrl.org/2006/xbrldi">psti:AvailableForSaleSecuritiesMaturesAfterFiveYearsThroughTenYearsMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2013-06-30</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="as-of-2013-06-30.874.0.2137.2043.2032.2040.0.0">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001158780</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis" xmlns:xbrldi="http://xbrl.org/2006/xbrldi">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis" xmlns:xbrldi="http://xbrl.org/2006/xbrldi">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2013-06-30</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="as-of-2013-06-30.874.0.2136.2043.2032.2040.0.0">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001158780</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis" xmlns:xbrldi="http://xbrl.org/2006/xbrldi">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis" xmlns:xbrldi="http://xbrl.org/2006/xbrldi">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2013-06-30</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="as-of-2013-06-30.874.0.2135.2043.2032.2040.0.0">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001158780</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis" xmlns:xbrldi="http://xbrl.org/2006/xbrldi">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis" xmlns:xbrldi="http://xbrl.org/2006/xbrldi">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2013-06-30</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="as-of-2013-06-30.874.0.1910.3302.25532.4349.0.0">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001158780</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:MajorTypesOfDebtAndEquitySecuritiesAxis" xmlns:xbrldi="http://xbrl.org/2006/xbrldi">us-gaap:EquitySecuritiesMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:RangeAxis" xmlns:xbrldi="http://xbrl.org/2006/xbrldi">psti:AvailableForSaleSecuritiesMaturesWithinOneYearMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2013-06-30</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="as-of-2013-06-30.874.0.1263.3302.25532.4349.0.0">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001158780</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:MajorTypesOfDebtAndEquitySecuritiesAxis" xmlns:xbrldi="http://xbrl.org/2006/xbrldi">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:RangeAxis" xmlns:xbrldi="http://xbrl.org/2006/xbrldi">psti:AvailableForSaleSecuritiesMaturesWithinOneYearMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2013-06-30</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="as-of-2013-06-30.874.0.1263.3302.25531.4349.0.0">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001158780</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:MajorTypesOfDebtAndEquitySecuritiesAxis" xmlns:xbrldi="http://xbrl.org/2006/xbrldi">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:RangeAxis" xmlns:xbrldi="http://xbrl.org/2006/xbrldi">psti:AvailableForSaleSecuritiesMaturesAfterOneYearThroughFiveYearsMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2013-06-30</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="as-of-2013-06-30.874.0.1263.3302.25530.4349.0.0">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001158780</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:MajorTypesOfDebtAndEquitySecuritiesAxis" xmlns:xbrldi="http://xbrl.org/2006/xbrldi">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:RangeAxis" xmlns:xbrldi="http://xbrl.org/2006/xbrldi">psti:AvailableForSaleSecuritiesMaturesAfterFiveYearsThroughTenYearsMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2013-06-30</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="as-of-2013-06-30.874.0.1163.4261.0.0.0.0">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001158780</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis" xmlns:xbrldi="http://xbrl.org/2006/xbrldi">us-gaap:ComputerEquipmentMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2013-06-30</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="as-of-2013-06-30.874.0.1115.5114.0.0.0.0">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001158780</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis" xmlns:xbrldi="http://xbrl.org/2006/xbrldi">us-gaap:CommonStockMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2013-06-30</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="as-of-2013-06-30.874.0.0.0.0.0.0.0">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001158780</xbrli:identifier>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2013-06-30</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="as-of-2012-09-19.969.0.25815.1048.0.0.0.0">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001158780</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis" xmlns:xbrldi="http://xbrl.org/2006/xbrldi">psti:UnderwritersOptionMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2012-09-19</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="as-of-2012-09-19.969.0.25814.1048.0.0.0.0">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001158780</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis" xmlns:xbrldi="http://xbrl.org/2006/xbrldi">psti:InvestorWarrantsMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2012-09-19</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="as-of-2012-09-19.969.0.25744.1048.0.0.0.0">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001158780</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis" xmlns:xbrldi="http://xbrl.org/2006/xbrldi">psti:UnderwriterWarrantsMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2012-09-19</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="as-of-2012-09-19.969.0.0.0.0.0.0.0">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001158780</xbrli:identifier>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2012-09-19</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="as-of-2012-06-30.876.0.499.5114.0.0.0.0">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001158780</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis" xmlns:xbrldi="http://xbrl.org/2006/xbrldi">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2012-06-30</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="as-of-2012-06-30.876.0.478.5114.0.0.0.0">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001158780</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis" xmlns:xbrldi="http://xbrl.org/2006/xbrldi">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2012-06-30</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="as-of-2012-06-30.876.0.4619.5114.0.0.0.0">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001158780</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis" xmlns:xbrldi="http://xbrl.org/2006/xbrldi">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2012-06-30</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="as-of-2012-06-30.876.0.1115.5114.0.0.0.0">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001158780</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis" xmlns:xbrldi="http://xbrl.org/2006/xbrldi">us-gaap:CommonStockMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2012-06-30</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="as-of-2012-06-30.876.0.0.0.0.0.0.0">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001158780</xbrli:identifier>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2012-06-30</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="as-of-2011-06-30.875.0.499.5114.0.0.0.0">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001158780</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis" xmlns:xbrldi="http://xbrl.org/2006/xbrldi">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2011-06-30</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="as-of-2011-06-30.875.0.478.5114.0.0.0.0">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001158780</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis" xmlns:xbrldi="http://xbrl.org/2006/xbrldi">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2011-06-30</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="as-of-2011-06-30.875.0.4619.5114.0.0.0.0">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001158780</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis" xmlns:xbrldi="http://xbrl.org/2006/xbrldi">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2011-06-30</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="as-of-2011-06-30.875.0.1115.5114.0.0.0.0">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001158780</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis" xmlns:xbrldi="http://xbrl.org/2006/xbrldi">us-gaap:CommonStockMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2011-06-30</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="as-of-2011-06-30.875.0.0.0.0.0.0.0">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001158780</xbrli:identifier>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2011-06-30</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
</xbrl>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>25
<FILENAME>psti-20140630.xsd
<DESCRIPTION>TAXONOMY EXTENSION SCHEMA
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" standalone="no"?>
<!--Created by Z-K Global Ltd. ("ZKG")-->
<!--produced on 2014-09-10 @ 8:21 AM-->
<xsd:schema targetNamespace="http://www.pluristem.com/20140630" elementFormDefault="qualified" xmlns:psti="http://www.pluristem.com/20140630" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:nonnum="http://www.xbrl.org/dtr/type/non-numeric" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:num="http://www.xbrl.org/dtr/type/numeric" xmlns:xsd="http://www.w3.org/2001/XMLSchema">
  <xsd:annotation>
    <xsd:appinfo>
      <link:linkbaseRef xlink:role="http://www.xbrl.org/2003/role/calculationLinkbaseRef" xlink:href="psti-20140630_cal.xml" xlink:type="simple" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" />
      <link:linkbaseRef xlink:role="http://www.xbrl.org/2003/role/definitionLinkbaseRef" xlink:href="psti-20140630_def.xml" xlink:type="simple" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" />
      <link:linkbaseRef xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:href="psti-20140630_lab.xml" xlink:type="simple" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" />
      <link:linkbaseRef xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:href="psti-20140630_pre.xml" xlink:type="simple" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" />
      <link:roleType roleURI="http://www.pluristem.com/role/CommitmentsAndContingencies" id="psti-cac1" xmlns:link="http://www.xbrl.org/2003/linkbase">
        <link:definition>107 - Disclosure - COMMITMENTS AND CONTINGENCIES</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:labelLink</link:usedOn>
        <link:usedOn>link:referenceLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.pluristem.com/role/CommitmentsAndContingenciesCommitmentToSuppliersAndContractorDetails" id="psti-cacctsacd1" xmlns:link="http://www.xbrl.org/2003/linkbase">
        <link:definition>40702 - Disclosure - COMMITMENTS AND CONTINGENCIES (Commitment to Suppliers and Contractor) (Details)</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:labelLink</link:usedOn>
        <link:usedOn>link:referenceLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.pluristem.com/role/CommitmentsAndContingenciesOtherDetails" id="psti-cacod" xmlns:link="http://www.xbrl.org/2003/linkbase">
        <link:definition>40703 - Disclosure - COMMITMENTS AND CONTINGENCIES (Other) (Details)</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:labelLink</link:usedOn>
        <link:usedOn>link:referenceLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.pluristem.com/role/CommitmentsAndContingenciesOperatingLeaseDetails" id="psti-cacold1" xmlns:link="http://www.xbrl.org/2003/linkbase">
        <link:definition>40701 - Disclosure - COMMITMENTS AND CONTINGENCIES (Operating Lease) (Details)</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:labelLink</link:usedOn>
        <link:usedOn>link:referenceLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.pluristem.com/role/CommitmentsAndContingenciesTables" id="psti-cact1" xmlns:link="http://www.xbrl.org/2003/linkbase">
        <link:definition>307 - Disclosure - COMMITMENTS AND CONTINGENCIES (Tables)</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:labelLink</link:usedOn>
        <link:usedOn>link:referenceLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.pluristem.com/role/ConsolidatedBalanceSheets" id="psti-cbs1" xmlns:link="http://www.xbrl.org/2003/linkbase">
        <link:definition>002 - Statement - CONSOLIDATED BALANCE SHEETS</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:labelLink</link:usedOn>
        <link:usedOn>link:referenceLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.pluristem.com/role/ConsolidatedBalanceSheetsParenthetical" id="psti-cbsp1" xmlns:link="http://www.xbrl.org/2003/linkbase">
        <link:definition>003 - Statement - CONSOLIDATED BALANCE SHEETS (PARENTHETICAL)</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:labelLink</link:usedOn>
        <link:usedOn>link:referenceLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.pluristem.com/role/ConsolidatedStatementsOfCashFlows" id="psti-csocf1" xmlns:link="http://www.xbrl.org/2003/linkbase">
        <link:definition>008 - Statement - CONSOLIDATED STATEMENTS OF CASH FLOWS</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:labelLink</link:usedOn>
        <link:usedOn>link:referenceLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.pluristem.com/role/ConsolidatedStatementsOfComprehensiveLoss" id="psti-csocl1" xmlns:link="http://www.xbrl.org/2003/linkbase">
        <link:definition>005 - Statement - CONSOLIDATED STATEMENTS OF COMPREHENSIVE LOSS</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:labelLink</link:usedOn>
        <link:usedOn>link:referenceLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.pluristem.com/role/ConsolidatedStatementsOfOperations" id="psti-csoo1" xmlns:link="http://www.xbrl.org/2003/linkbase">
        <link:definition>004 - Statement - CONSOLIDATED STATEMENTS OF OPERATIONS</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:labelLink</link:usedOn>
        <link:usedOn>link:referenceLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.pluristem.com/role/DocumentAndEntityInformation" id="psti-daei1" xmlns:link="http://www.xbrl.org/2003/linkbase">
        <link:definition>001 - Document - Document and Entity Information</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:labelLink</link:usedOn>
        <link:usedOn>link:referenceLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.pluristem.com/role/FinancialIncomeNet" id="psti-fin" xmlns:link="http://www.xbrl.org/2003/linkbase">
        <link:definition>109 - Disclosure - FINANCIAL INCOME, NET</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:labelLink</link:usedOn>
        <link:usedOn>link:referenceLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.pluristem.com/role/FinancialIncomeNetDetails" id="psti-find" xmlns:link="http://www.xbrl.org/2003/linkbase">
        <link:definition>40901 - Disclosure - FINANCIAL INCOME, NET (Details)</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:labelLink</link:usedOn>
        <link:usedOn>link:referenceLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.pluristem.com/role/FinancialIncomeNetTables" id="psti-fint" xmlns:link="http://www.xbrl.org/2003/linkbase">
        <link:definition>309 - Disclosure - FINANCIAL INCOME, NET (Tables)</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:labelLink</link:usedOn>
        <link:usedOn>link:referenceLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.pluristem.com/role/FairValueOfFinancialInstruments" id="psti-fvofi12" xmlns:link="http://www.xbrl.org/2003/linkbase">
        <link:definition>104 - Disclosure - FAIR VALUE OF FINANCIAL INSTRUMENTS</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:labelLink</link:usedOn>
        <link:usedOn>link:referenceLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.pluristem.com/role/FairValueOfFinancialInstrumentsScheduleOfFairValueOfFinancialInstrumentsDetails" id="psti-fvofisofvofid1" xmlns:link="http://www.xbrl.org/2003/linkbase">
        <link:definition>40401 - Disclosure - FAIR VALUE OF FINANCIAL INSTRUMENTS (Schedule of Fair Value of Financial Instruments) (Details)</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:labelLink</link:usedOn>
        <link:usedOn>link:referenceLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.pluristem.com/role/FairValueOfFinancialInstrumentsScheduleOfFairValueOfHedgingInstrumentsDetails" id="psti-fvofisofvohid" xmlns:link="http://www.xbrl.org/2003/linkbase">
        <link:definition>40402 - Disclosure - FAIR VALUE OF FINANCIAL INSTRUMENTS (Schedule of the Fair Value of Hedging Instruments) (Details)</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:labelLink</link:usedOn>
        <link:usedOn>link:referenceLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.pluristem.com/role/FairValueOfFinancialInstrumentsTables" id="psti-fvofit1" xmlns:link="http://www.xbrl.org/2003/linkbase">
        <link:definition>304 - Disclosure - FAIR VALUE OF FINANCIAL INSTRUMENTS (Tables)</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:labelLink</link:usedOn>
        <link:usedOn>link:referenceLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.pluristem.com/role/General" id="psti-g1" xmlns:link="http://www.xbrl.org/2003/linkbase">
        <link:definition>101 - Disclosure - GENERAL</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:labelLink</link:usedOn>
        <link:usedOn>link:referenceLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.pluristem.com/role/GeneralDetails" id="psti-gd" xmlns:link="http://www.xbrl.org/2003/linkbase">
        <link:definition>40101 - Disclosure - GENERAL (Details)</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:labelLink</link:usedOn>
        <link:usedOn>link:referenceLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.pluristem.com/role/MarketableSecurities" id="psti-ms" xmlns:link="http://www.xbrl.org/2003/linkbase">
        <link:definition>103 - Disclosure - MARKETABLE SECURITIES</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:labelLink</link:usedOn>
        <link:usedOn>link:referenceLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.pluristem.com/role/MarketableSecuritiesScheduleOfAvailableforsaleMarketableSecuritiesDetails" id="psti-mssoamsd1" xmlns:link="http://www.xbrl.org/2003/linkbase">
        <link:definition>40301 - Disclosure - MARKETABLE SECURITIES (Schedule of Available-for-sale Marketable Securities) (Details)</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:labelLink</link:usedOn>
        <link:usedOn>link:referenceLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.pluristem.com/role/MarketableSecuritiesScheduleOfInvestmentsInUnrealizedLossDetails" id="psti-mssoiiuld" xmlns:link="http://www.xbrl.org/2003/linkbase">
        <link:definition>40302 - Disclosure - MARKETABLE SECURITIES (Schedule of Investments in Unrealized Loss) (Details)</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:labelLink</link:usedOn>
        <link:usedOn>link:referenceLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.pluristem.com/role/MarketableSecuritiesTables" id="psti-mst1" xmlns:link="http://www.xbrl.org/2003/linkbase">
        <link:definition>303 - Disclosure - MARKETABLE SECURITIES (Tables)</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:labelLink</link:usedOn>
        <link:usedOn>link:referenceLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.pluristem.com/role/OtherAccountsPayable" id="psti-oap1" xmlns:link="http://www.xbrl.org/2003/linkbase">
        <link:definition>106 - Disclosure - OTHER ACCOUNTS PAYABLE</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:labelLink</link:usedOn>
        <link:usedOn>link:referenceLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.pluristem.com/role/OtherAccountsPayableDetails" id="psti-oapd1" xmlns:link="http://www.xbrl.org/2003/linkbase">
        <link:definition>40601 - Disclosure - OTHER ACCOUNTS PAYABLE (Details)</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:labelLink</link:usedOn>
        <link:usedOn>link:referenceLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.pluristem.com/role/OtherAccountsPayableTables" id="psti-oapt1" xmlns:link="http://www.xbrl.org/2003/linkbase">
        <link:definition>306 - Disclosure - OTHER ACCOUNTS PAYABLE (Tables)</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:labelLink</link:usedOn>
        <link:usedOn>link:referenceLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.pluristem.com/role/PropertyAndEquipmentNet" id="psti-paen1" xmlns:link="http://www.xbrl.org/2003/linkbase">
        <link:definition>105 - Disclosure - PROPERTY AND EQUIPMENT, NET</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:labelLink</link:usedOn>
        <link:usedOn>link:referenceLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.pluristem.com/role/PropertyAndEquipmentNetDetails" id="psti-paend1" xmlns:link="http://www.xbrl.org/2003/linkbase">
        <link:definition>40501 - Disclosure - PROPERTY AND EQUIPMENT, NET (Details)</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:labelLink</link:usedOn>
        <link:usedOn>link:referenceLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.pluristem.com/role/PropertyAndEquipmentNetTables" id="psti-paent1" xmlns:link="http://www.xbrl.org/2003/linkbase">
        <link:definition>305 - Disclosure - PROPERTY AND EQUIPMENT, NET (Tables)</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:labelLink</link:usedOn>
        <link:usedOn>link:referenceLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.pluristem.com/role/SignificantAccountingPolicies" id="psti-sap1" xmlns:link="http://www.xbrl.org/2003/linkbase">
        <link:definition>102 - Disclosure - SIGNIFICANT ACCOUNTING POLICIES</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:labelLink</link:usedOn>
        <link:usedOn>link:referenceLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.pluristem.com/role/SignificantAccountingPoliciesComprehensiveIncomeDetails" id="psti-sapcid" xmlns:link="http://www.xbrl.org/2003/linkbase">
        <link:definition>40203 - Disclosure - SIGNIFICANT ACCOUNTING POLICIES (Comprehensive Income) (Details)</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:labelLink</link:usedOn>
        <link:usedOn>link:referenceLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.pluristem.com/role/SignificantAccountingPoliciesNarrativeDetails" id="psti-sapnd1" xmlns:link="http://www.xbrl.org/2003/linkbase">
        <link:definition>40201 - Disclosure - SIGNIFICANT ACCOUNTING POLICIES (Narrative) (Details)</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:labelLink</link:usedOn>
        <link:usedOn>link:referenceLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.pluristem.com/role/SignificantAccountingPoliciesPolicies" id="psti-sapp1" xmlns:link="http://www.xbrl.org/2003/linkbase">
        <link:definition>202 - Disclosure - SIGNIFICANT ACCOUNTING POLICIES (Policies)</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:labelLink</link:usedOn>
        <link:usedOn>link:referenceLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.pluristem.com/role/SignificantAccountingPoliciesScheduleOfPropertyAndEquipmentDepreciationRateDetails" id="psti-sapsopaedrd1" xmlns:link="http://www.xbrl.org/2003/linkbase">
        <link:definition>40202 - Disclosure - SIGNIFICANT ACCOUNTING POLICIES (Schedule of Property and Equipment Depreciation Rate) (Details)</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:labelLink</link:usedOn>
        <link:usedOn>link:referenceLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.pluristem.com/role/SignificantAccountingPoliciesTables" id="psti-sapt1" xmlns:link="http://www.xbrl.org/2003/linkbase">
        <link:definition>302 - Disclosure - SIGNIFICANT ACCOUNTING POLICIES (Tables)</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:labelLink</link:usedOn>
        <link:usedOn>link:referenceLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.pluristem.com/role/StockholdersEquity" id="psti-se12" xmlns:link="http://www.xbrl.org/2003/linkbase">
        <link:definition>108 - Disclosure - STOCKHOLDERS' EQUITY</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:labelLink</link:usedOn>
        <link:usedOn>link:referenceLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.pluristem.com/role/SubsequentEvents" id="psti-se123" xmlns:link="http://www.xbrl.org/2003/linkbase">
        <link:definition>111 - Disclosure - SUBSEQUENT EVENTS</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:labelLink</link:usedOn>
        <link:usedOn>link:referenceLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.pluristem.com/role/SubsequentEventsDetails" id="psti-sed1" xmlns:link="http://www.xbrl.org/2003/linkbase">
        <link:definition>41101 - Disclosure - SUBSEQUENT EVENTS (Details)</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:labelLink</link:usedOn>
        <link:usedOn>link:referenceLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.pluristem.com/role/StockholdersEquityNarrativeDetails" id="psti-send1" xmlns:link="http://www.xbrl.org/2003/linkbase">
        <link:definition>40801 - Disclosure - STOCKHOLDERS' EQUITY (Narrative) (Details)</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:labelLink</link:usedOn>
        <link:usedOn>link:referenceLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.pluristem.com/role/StockholdersEquityScheduleOfCompensationExpenseDetails" id="psti-sesoced1" xmlns:link="http://www.xbrl.org/2003/linkbase">
        <link:definition>40806 - Disclosure - STOCKHOLDERS' EQUITY (Schedule of Compensation Expense) (Details)</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:labelLink</link:usedOn>
        <link:usedOn>link:referenceLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.pluristem.com/role/StockholdersEquitySummaryOfOptionActivityDetails" id="psti-sesooad1" xmlns:link="http://www.xbrl.org/2003/linkbase">
        <link:definition>40802 - Disclosure - STOCKHOLDERS' EQUITY (Summary of Option Activity) (Details)</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:labelLink</link:usedOn>
        <link:usedOn>link:referenceLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.pluristem.com/role/StockholdersEquitySummaryOfOptionAndWarrantActivityToNonemployeesDetails" id="psti-sesooawatnd1" xmlns:link="http://www.xbrl.org/2003/linkbase">
        <link:definition>40803 - Disclosure - STOCKHOLDERS' EQUITY (Summary of Option and Warrant Activity to Non-employees) (Details)</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:labelLink</link:usedOn>
        <link:usedOn>link:referenceLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.pluristem.com/role/StockholdersEquitySummaryOfRsuActivityToConsultantsDetails" id="psti-sesoratcd1" xmlns:link="http://www.xbrl.org/2003/linkbase">
        <link:definition>40805 - Disclosure - STOCKHOLDERS' EQUITY (Summary of RSU Activity to Consultants) (Details)</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:labelLink</link:usedOn>
        <link:usedOn>link:referenceLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.pluristem.com/role/StockholdersEquitySummaryOfRsuActivityToEmployeesAndDirectorsDetails" id="psti-sesorateadd1" xmlns:link="http://www.xbrl.org/2003/linkbase">
        <link:definition>40804 - Disclosure - STOCKHOLDERS' EQUITY (Summary of RSU Activity to Employees and Directors) (Details)</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:labelLink</link:usedOn>
        <link:usedOn>link:referenceLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.pluristem.com/role/StockholdersEquitySummaryOfWarrantsAndOptionsDetails" id="psti-sesowaod" xmlns:link="http://www.xbrl.org/2003/linkbase">
        <link:definition>40807 - Disclosure - STOCKHOLDERS' EQUITY (Summary of Warrants and Options) (Details)</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:labelLink</link:usedOn>
        <link:usedOn>link:referenceLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.pluristem.com/role/StockholdersEquityTables" id="psti-set1" xmlns:link="http://www.xbrl.org/2003/linkbase">
        <link:definition>308 - Disclosure - STOCKHOLDERS' EQUITY (Tables)</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:labelLink</link:usedOn>
        <link:usedOn>link:referenceLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.pluristem.com/role/StatementsOfChangesInEquity" id="psti-socie1" xmlns:link="http://www.xbrl.org/2003/linkbase">
        <link:definition>006 - Statement - STATEMENTS OF CHANGES IN EQUITY</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:labelLink</link:usedOn>
        <link:usedOn>link:referenceLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.pluristem.com/role/StatementsOfChangesInEquityParenthetical" id="psti-sociep1" xmlns:link="http://www.xbrl.org/2003/linkbase">
        <link:definition>007 - Statement - STATEMENTS OF CHANGES IN EQUITY (Parenthetical)</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:labelLink</link:usedOn>
        <link:usedOn>link:referenceLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.pluristem.com/role/TaxesOnIncome" id="psti-toi1" xmlns:link="http://www.xbrl.org/2003/linkbase">
        <link:definition>110 - Disclosure - TAXES ON INCOME</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:labelLink</link:usedOn>
        <link:usedOn>link:referenceLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.pluristem.com/role/TaxesOnIncomeNarrativeDetails" id="psti-toind1" xmlns:link="http://www.xbrl.org/2003/linkbase">
        <link:definition>41001 - Disclosure - TAXES ON INCOME (Narrative) (Details)</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:labelLink</link:usedOn>
        <link:usedOn>link:referenceLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.pluristem.com/role/TaxesOnIncomeQualifyingPercentagesOfValueOfProductiveAssetsDetails" id="psti-toiqpovopad1" xmlns:link="http://www.xbrl.org/2003/linkbase">
        <link:definition>41002 - Disclosure - TAXES ON INCOME (Qualifying Percentages of Value of Productive Assets) (Details)</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:labelLink</link:usedOn>
        <link:usedOn>link:referenceLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.pluristem.com/role/TaxesOnIncomeScheduleOfSignificantComponentsOfDeferredTaxAssetsDetails" id="psti-toisoscodtad1" xmlns:link="http://www.xbrl.org/2003/linkbase">
        <link:definition>41003 - Disclosure - TAXES ON INCOME (Schedule of Significant Components of Deferred Tax Assets) (Details)</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:labelLink</link:usedOn>
        <link:usedOn>link:referenceLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.pluristem.com/role/TaxesOnIncomeTables" id="psti-toit1" xmlns:link="http://www.xbrl.org/2003/linkbase">
        <link:definition>310 - Disclosure - TAXES ON INCOME (Tables)</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:labelLink</link:usedOn>
        <link:usedOn>link:referenceLink</link:usedOn>
      </link:roleType>
    </xsd:appinfo>
  </xsd:annotation>
  <xsd:import namespace="http://www.xbrl.org/2009/role/negated" schemaLocation="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd" />
  <xsd:import namespace="http://www.xbrl.org/2003/instance" schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd" />
  <xsd:import namespace="http://xbrl.sec.gov/dei/2014-01-31" schemaLocation="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd" />
  <xsd:import namespace="http://xbrl.org/2005/xbrldt" schemaLocation="http://www.xbrl.org/2005/xbrldt-2005.xsd" />
  <xsd:import namespace="http://www.xbrl.org/dtr/type/non-numeric" schemaLocation="http://www.xbrl.org/dtr/type/nonNumeric-2009-12-16.xsd" />
  <xsd:import namespace="http://www.xbrl.org/dtr/type/numeric" schemaLocation="http://www.xbrl.org/dtr/type/numeric-2009-12-16.xsd" />
  <xsd:import namespace="http://fasb.org/us-gaap/2014-01-31" schemaLocation="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd" />
  <xsd:import namespace="http://fasb.org/us-types/2014-01-31" schemaLocation="http://xbrl.fasb.org/us-gaap/2014/elts/us-types-2014-01-31.xsd" />
  <xsd:element name="AdvancePaymentForDeveplomentCosts" id="psti_AdvancePaymentForDeveplomentCosts" nillable="true" xbrli:balance="debit" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" />
  <xsd:element name="AggregateGrantsReceived" id="psti_AggregateGrantsReceived" nillable="true" xbrli:balance="debit" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" />
  <xsd:element name="AggregateIntrinsicValueAbstract" id="psti_AggregateIntrinsicValueAbstract" nillable="true" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType" />
  <xsd:element name="AmortizationOfDiscountAndPremiumAndChangesInAccruedInterestFromMarketableSecurities" id="psti_AmortizationOfDiscountAndPremiumAndChangesInAccruedInterestFromMarketableSecurities" nillable="true" xbrli:balance="debit" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" />
  <xsd:element name="AvailableForSaleMarketableSecuritiesNumber" id="psti_AvailableForSaleMarketableSecuritiesNumber" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:sharesItemType" />
  <xsd:element name="AvailableForSaleSecuritiesMaturesAfterFiveYearsThroughTenYearsMember" id="psti_AvailableForSaleSecuritiesMaturesAfterFiveYearsThroughTenYearsMember" nillable="true" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType" />
  <xsd:element name="AvailableForSaleSecuritiesMaturesAfterOneYearThroughFiveYearsMember" id="psti_AvailableForSaleSecuritiesMaturesAfterOneYearThroughFiveYearsMember" nillable="true" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType" />
  <xsd:element name="AvailableForSaleSecuritiesMaturesWithinOneYearMember" id="psti_AvailableForSaleSecuritiesMaturesWithinOneYearMember" nillable="true" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType" />
  <xsd:element name="BeneficiaryEnterpriseProgramAxis" id="psti_BeneficiaryEnterpriseProgramAxis" nillable="true" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrldt:dimensionItem" type="xbrli:stringItemType" />
  <xsd:element name="BeneficiaryEnterpriseProgramDomain" id="psti_BeneficiaryEnterpriseProgramDomain" nillable="true" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType" />
  <xsd:element name="BenefitedPeriodMaximumYearsOfEligibility" id="psti_BenefitedPeriodMaximumYearsOfEligibility" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:durationItemType" />
  <xsd:element name="BenefitedPeriodMaximumYearsOfEligibilityForCompaniesInDevelopmentArea" id="psti_BenefitedPeriodMaximumYearsOfEligibilityForCompaniesInDevelopmentArea" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:durationItemType" />
  <xsd:element name="BiopharmaxMember" id="psti_BiopharmaxMember" nillable="true" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType" />
  <xsd:element name="BusinessCombinationContingentConsiderationReceivableUponCertainRegulatoryMilestones" id="psti_BusinessCombinationContingentConsiderationReceivableUponCertainRegulatoryMilestones" nillable="true" xbrli:balance="debit" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" />
  <xsd:element name="CarryforwardLossesForTaxPurposesAbstract" id="psti_CarryforwardLossesForTaxPurposesAbstract" nillable="true" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType" />
  <xsd:element name="CommonStockAggregateOfferingPriceAuthorized" id="psti_CommonStockAggregateOfferingPriceAuthorized" nillable="true" xbrli:balance="credit" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" />
  <xsd:element name="ConsultantRestrictedStockUnitsMember" id="psti_ConsultantRestrictedStockUnitsMember" nillable="true" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType" />
  <xsd:element name="ConsultantsMember" id="psti_ConsultantsMember" nillable="true" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType" />
  <xsd:element name="ConsultantWarrantsMember" id="psti_ConsultantWarrantsMember" nillable="true" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType" />
  <xsd:element name="DocumentAndEntityInformationAbstract" id="psti_DocumentAndEntityInformationAbstract" nillable="true" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType" />
  <xsd:element name="DocumentAndEntityInformationTable" id="psti_DocumentAndEntityInformationTable" nillable="true" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrldt:hypercubeItem" type="xbrli:stringItemType" />
  <xsd:element name="EmployeesMember" id="psti_EmployeesMember" nillable="true" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType" />
  <xsd:element name="EquityOptionsAndWarrantsMember" id="psti_EquityOptionsAndWarrantsMember" nillable="true" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType" />
  <xsd:element name="ExercisePriceRangeFiveMember" id="psti_ExercisePriceRangeFiveMember" nillable="true" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType" />
  <xsd:element name="ExercisePriceRangeFourMember" id="psti_ExercisePriceRangeFourMember" nillable="true" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType" />
  <xsd:element name="ExercisePriceRangeOneMember" id="psti_ExercisePriceRangeOneMember" nillable="true" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType" />
  <xsd:element name="ExercisePriceRangeSevenMember" id="psti_ExercisePriceRangeSevenMember" nillable="true" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType" />
  <xsd:element name="ExercisePriceRangeSixMember" id="psti_ExercisePriceRangeSixMember" nillable="true" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType" />
  <xsd:element name="ExercisePriceRangeThreeMember" id="psti_ExercisePriceRangeThreeMember" nillable="true" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType" />
  <xsd:element name="ExercisePriceRangeTwelveMember" id="psti_ExercisePriceRangeTwelveMember" nillable="true" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType" />
  <xsd:element name="ExercisePriceRangeTwoMember" id="psti_ExercisePriceRangeTwoMember" nillable="true" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType" />
  <xsd:element name="GeneralAbstract" id="psti_GeneralAbstract" nillable="true" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType" />
  <xsd:element name="GovernmentAndThirdPartyGrantsReceived" id="psti_GovernmentAndThirdPartyGrantsReceived" nillable="true" xbrli:balance="credit" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" />
  <xsd:element name="GovernmentDebtSecuritiesMember" id="psti_GovernmentDebtSecuritiesMember" nillable="true" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType" />
  <xsd:element name="IncomeTaxLineItems" id="psti_IncomeTaxLineItems" nillable="true" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType" />
  <xsd:element name="IncomeTaxTable" id="psti_IncomeTaxTable" nillable="true" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrldt:hypercubeItem" type="xbrli:stringItemType" />
  <xsd:element name="IndustrialEnterprisesTaxBenefitConditionsMaximumPercentageOfTotalSales" id="psti_IndustrialEnterprisesTaxBenefitConditionsMaximumPercentageOfTotalSales" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="num:percentItemType" />
  <xsd:element name="IndustrialEnterprisesTaxBenefitConditionsMinimumPercentageOfTotalRevenuesGeneratedFromAspecificMarket" id="psti_IndustrialEnterprisesTaxBenefitConditionsMinimumPercentageOfTotalRevenuesGeneratedFromAspecificMarket" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="num:percentItemType" />
  <xsd:element name="IndustrialEnterprisesTaxBenefitConditionsMinimumPercentageOfTotalRevenuesGivenMarketMinimumPopulation" id="psti_IndustrialEnterprisesTaxBenefitConditionsMinimumPercentageOfTotalRevenuesGivenMarketMinimumPopulation" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:integerItemType" />
  <xsd:element name="InterestOnShortTermBankCreditAndBankExpenses" id="psti_InterestOnShortTermBankCreditAndBankExpenses" nillable="true" xbrli:balance="debit" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" />
  <xsd:element name="InvestorWarrantsMember" id="psti_InvestorWarrantsMember" nillable="true" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType" />
  <xsd:element name="LawForEconomicEfficiencyAmendedLegislationImplementingEconomicPlanForTwoThousandNineAndTenTaxRate" id="psti_LawForEconomicEfficiencyAmendedLegislationImplementingEconomicPlanForTwoThousandNineAndTenTaxRate" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="num:percentItemType" />
  <xsd:element name="LeaseholdImprovementsAnnualRateOfDepreciationDescription" id="psti_LeaseholdImprovementsAnnualRateOfDepreciationDescription" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType" />
  <xsd:element name="LeaseholdImprovementsOfNewFacilityConstructionMember" id="psti_LeaseholdImprovementsOfNewFacilityConstructionMember" nillable="true" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType" />
  <xsd:element name="LinkageDifferencesAndInterestOnShortAndLongTermRestrictedLeaseDeposit" id="psti_LinkageDifferencesAndInterestOnShortAndLongTermRestrictedLeaseDeposit" nillable="true" xbrli:balance="debit" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" />
  <xsd:element name="LongTermPurchaseCommitmentFutureMinimumPaymentDue" id="psti_LongTermPurchaseCommitmentFutureMinimumPaymentDue" nillable="true" xbrli:balance="credit" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" />
  <xsd:element name="LongTermPurchaseCommitmentFutureMinimumPaymentDueCurrent" id="psti_LongTermPurchaseCommitmentFutureMinimumPaymentDueCurrent" nillable="true" xbrli:balance="credit" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" />
  <xsd:element name="LongTermPurchaseCommitmentFutureMinimumPaymentDueInThreeYears" id="psti_LongTermPurchaseCommitmentFutureMinimumPaymentDueInThreeYears" nillable="true" xbrli:balance="credit" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" />
  <xsd:element name="LongTermPurchaseCommitmentToSuppliersAndContractorMember" id="psti_LongTermPurchaseCommitmentToSuppliersAndContractorMember" nillable="true" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType" />
  <xsd:element name="LongTermRestrictedDepositPolicyTextBlock" id="psti_LongTermRestrictedDepositPolicyTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:textBlockItemType" />
  <xsd:element name="NationalPriorityZoneBcorporateBenefitedPeriodPeriodOfTime" id="psti_NationalPriorityZoneBcorporateBenefitedPeriodPeriodOfTime" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:durationItemType" />
  <xsd:element name="NationalPriorityZoneBCorporateBenefitedPeriodTaxRate" id="psti_NationalPriorityZoneBCorporateBenefitedPeriodTaxRate" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="num:percentItemType" />
  <xsd:element name="NationalPriorityZoneBCorporateTaxExemptionPeriod" id="psti_NationalPriorityZoneBCorporateTaxExemptionPeriod" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:durationItemType" />
  <xsd:element name="OperatingLeasedAssetsNumberOfUnits" id="psti_OperatingLeasedAssetsNumberOfUnits" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:decimalItemType" />
  <xsd:element name="OperatingLeasedAssetsParticipationFromLessor" id="psti_OperatingLeasedAssetsParticipationFromLessor" nillable="true" xbrli:balance="credit" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" />
  <xsd:element name="OptionsExercisePriceRangeEightMember" id="psti_OptionsExercisePriceRangeEightMember" nillable="true" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType" />
  <xsd:element name="OptionsExercisePriceRangeElevenMember" id="psti_OptionsExercisePriceRangeElevenMember" nillable="true" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType" />
  <xsd:element name="OptionsExercisePriceRangeFiveMember" id="psti_OptionsExercisePriceRangeFiveMember" nillable="true" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType" />
  <xsd:element name="OptionsExercisePriceRangeFourMember" id="psti_OptionsExercisePriceRangeFourMember" nillable="true" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType" />
  <xsd:element name="OptionsExercisePriceRangeNineMember" id="psti_OptionsExercisePriceRangeNineMember" nillable="true" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType" />
  <xsd:element name="OptionsExercisePriceRangeOneMember" id="psti_OptionsExercisePriceRangeOneMember" nillable="true" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType" />
  <xsd:element name="OptionsExercisePriceRangeSevenMember" id="psti_OptionsExercisePriceRangeSevenMember" nillable="true" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType" />
  <xsd:element name="OptionsExercisePriceRangeSixMember" id="psti_OptionsExercisePriceRangeSixMember" nillable="true" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType" />
  <xsd:element name="OptionsExercisePriceRangeTenMember" id="psti_OptionsExercisePriceRangeTenMember" nillable="true" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType" />
  <xsd:element name="OptionsExercisePriceRangeThreeMember" id="psti_OptionsExercisePriceRangeThreeMember" nillable="true" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType" />
  <xsd:element name="OptionsExercisePriceRangeTwoMember" id="psti_OptionsExercisePriceRangeTwoMember" nillable="true" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType" />
  <xsd:element name="OtherAccountsPayableAbstract" id="psti_OtherAccountsPayableAbstract" nillable="true" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType" />
  <xsd:element name="OtherAccountsPayablePayrollInstitutions" id="psti_OtherAccountsPayablePayrollInstitutions" nillable="true" xbrli:balance="credit" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" />
  <xsd:element name="PercentageOfQualifiedExpenditures" id="psti_PercentageOfQualifiedExpenditures" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="num:percentItemType" />
  <xsd:element name="ProductiveAssetsPercentageTierAxis" id="psti_ProductiveAssetsPercentageTierAxis" nillable="true" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrldt:dimensionItem" type="xbrli:stringItemType" />
  <xsd:element name="ProductiveAssetsPercentageTierDomain" id="psti_ProductiveAssetsPercentageTierDomain" nillable="true" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType" />
  <xsd:element name="PropertyPlantAndEquipmentAnnualRateOfDepreciation" id="psti_PropertyPlantAndEquipmentAnnualRateOfDepreciation" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="num:percentItemType" />
  <xsd:element name="PropertyPlantAndEquipmentEstimatedUsefulLivesRateTableTextBlock" id="psti_PropertyPlantAndEquipmentEstimatedUsefulLivesRateTableTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:textBlockItemType" />
  <xsd:element name="ProportionThatRequiredInvestmentBearsToValueOfProductiveAsset" id="psti_ProportionThatRequiredInvestmentBearsToValueOfProductiveAsset" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="num:percentItemType" />
  <xsd:element name="QualifyingPercentageOfValueOfProductiveAssetsTableTextBlock" id="psti_QualifyingPercentageOfValueOfProductiveAssetsTableTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:textBlockItemType" />
  <xsd:element name="ReclassFromResearchAndDevelopmentExpenseToCostOfRevenues" id="psti_ReclassFromResearchAndDevelopmentExpenseToCostOfRevenues" nillable="true" xbrli:balance="debit" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" />
  <xsd:element name="RemainingDeferredRevenueRecognitionPeriodForIntangibleAsset" id="psti_RemainingDeferredRevenueRecognitionPeriodForIntangibleAsset" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:durationItemType" />
  <xsd:element name="ResearchAndDevelopmentExpensesAndGrantsPolicyTextBlock" id="psti_ResearchAndDevelopmentExpensesAndGrantsPolicyTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:textBlockItemType" />
  <xsd:element name="ResearchAndDevelopmentExpensesNet" id="psti_ResearchAndDevelopmentExpensesNet" nillable="true" xbrli:balance="debit" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" />
  <xsd:element name="ResearchAndDevelopmentMilestoneRevenueReceivable" id="psti_ResearchAndDevelopmentMilestoneRevenueReceivable" nillable="true" xbrli:balance="credit" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" />
  <xsd:element name="RoyaltiesAmountPaidAndAccrued" id="psti_RoyaltiesAmountPaidAndAccrued" nillable="true" xbrli:balance="credit" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" />
  <xsd:element name="RoyaltyPayable" id="psti_RoyaltyPayable" nillable="true" xbrli:balance="credit" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" />
  <xsd:element name="RoyaltyRatePayableOnGrantsReceived" id="psti_RoyaltyRatePayableOnGrantsReceived" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="num:percentItemType" />
  <xsd:element name="RoyaltyRateSales" id="psti_RoyaltyRateSales" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="num:percentItemType" />
  <xsd:element name="SeverancePayPolicyTextBlock" id="psti_SeverancePayPolicyTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:textBlockItemType" />
  <xsd:element name="ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsExpectedToVest" id="psti_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsExpectedToVest" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:sharesItemType" />
  <xsd:element name="SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsForfeituresRate" id="psti_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsForfeituresRate" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="num:percentItemType" />
  <xsd:element name="SharebasedCompensationArrangementWarrantsExercised" id="psti_SharebasedCompensationArrangementWarrantsExercised" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:sharesItemType" />
  <xsd:element name="SharebasedGoodsAndNonemployeesServicesTransactionWarrantsAndOptionsExercised" id="psti_SharebasedGoodsAndNonemployeesServicesTransactionWarrantsAndOptionsExercised" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:sharesItemType" />
  <xsd:element name="SharebasedGoodsAndNonemployeesServicesTransactionWarrantsAndOptionsGranted" id="psti_SharebasedGoodsAndNonemployeesServicesTransactionWarrantsAndOptionsGranted" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:sharesItemType" />
  <xsd:element name="SharebasedGoodsAndNonemployeesServicesTransactionWarrantsAndOptionsNumber" id="psti_SharebasedGoodsAndNonemployeesServicesTransactionWarrantsAndOptionsNumber" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:sharesItemType" />
  <xsd:element name="SharebasedGoodsAndNonemployeesServicesTransactionWarrantsAndOptionsNumberExercisable" id="psti_SharebasedGoodsAndNonemployeesServicesTransactionWarrantsAndOptionsNumberExercisable" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:sharesItemType" />
  <xsd:element name="SharebasedGoodsAndNonemployeesServicesTransactionWarrantsAndOptionsNumberVestedAndExpectedToVest" id="psti_SharebasedGoodsAndNonemployeesServicesTransactionWarrantsAndOptionsNumberVestedAndExpectedToVest" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:sharesItemType" />
  <xsd:element name="ShortTermBankDepositPolicyTextBlock" id="psti_ShortTermBankDepositPolicyTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:textBlockItemType" />
  <xsd:element name="StockholdersEquityNoteLineItems" id="psti_StockholdersEquityNoteLineItems" nillable="true" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType" />
  <xsd:element name="StockholdersEquityNoteTable" id="psti_StockholdersEquityNoteTable" nillable="true" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrldt:hypercubeItem" type="xbrli:stringItemType" />
  <xsd:element name="StockIssuedDuringPeriodSharesStockOptionsAndWarrantsExercised" id="psti_StockIssuedDuringPeriodSharesStockOptionsAndWarrantsExercised" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:sharesItemType" />
  <xsd:element name="StockIssuedDuringPeriodSharesStockWarrantsExercised" id="psti_StockIssuedDuringPeriodSharesStockWarrantsExercised" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:sharesItemType" />
  <xsd:element name="StockIssuedDuringPeriodValueStockOptionsAndWarrantsExercised" id="psti_StockIssuedDuringPeriodValueStockOptionsAndWarrantsExercised" nillable="true" xbrli:balance="credit" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" />
  <xsd:element name="StockIssuedDuringPeriodValueStockWarrantsExercised" id="psti_StockIssuedDuringPeriodValueStockWarrantsExercised" nillable="true" xbrli:balance="credit" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" />
  <xsd:element name="TaxAmendmentLawAmendedTaxRatePreferredEnterprisesDevelopmentAreaYearsFiveAndThereafter" id="psti_TaxAmendmentLawAmendedTaxRatePreferredEnterprisesDevelopmentAreaYearsFiveAndThereafter" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="num:percentItemType" />
  <xsd:element name="TaxAmendmentLawAmendedTaxRatePreferredEnterprisesDevelopmentAreaYearsOneAndTwo" id="psti_TaxAmendmentLawAmendedTaxRatePreferredEnterprisesDevelopmentAreaYearsOneAndTwo" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="num:percentItemType" />
  <xsd:element name="TaxAmendmentLawAmendedTaxRatePreferredEnterprisesDevelopmentAreaYearsThreeAndFour" id="psti_TaxAmendmentLawAmendedTaxRatePreferredEnterprisesDevelopmentAreaYearsThreeAndFour" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="num:percentItemType" />
  <xsd:element name="TaxAmendmentLawAmendedTaxRatePreferredEnterprisesYearsFiveAndThereafter" id="psti_TaxAmendmentLawAmendedTaxRatePreferredEnterprisesYearsFiveAndThereafter" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="num:percentItemType" />
  <xsd:element name="TaxAmendmentLawAmendedTaxRatePreferredEnterprisesYearsOneAndTwo" id="psti_TaxAmendmentLawAmendedTaxRatePreferredEnterprisesYearsOneAndTwo" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="num:percentItemType" />
  <xsd:element name="TaxAmendmentLawAmendedTaxRatePreferredEnterprisesYearsThreeAndFour" id="psti_TaxAmendmentLawAmendedTaxRatePreferredEnterprisesYearsThreeAndFour" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="num:percentItemType" />
  <xsd:element name="TaxAmendmentLawMinimumQualifyingInvestmentAmount" id="psti_TaxAmendmentLawMinimumQualifyingInvestmentAmount" nillable="true" xbrli:balance="credit" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" />
  <xsd:element name="TaxBenefitAcceleratedDepreciationRate" id="psti_TaxBenefitAcceleratedDepreciationRate" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="num:percentItemType" />
  <xsd:element name="TaxRateBenefitsToCompanyAbstract" id="psti_TaxRateBenefitsToCompanyAbstract" nillable="true" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType" />
  <xsd:element name="TaxRatesApplicableToCompanyAbstract" id="psti_TaxRatesApplicableToCompanyAbstract" nillable="true" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType" />
  <xsd:element name="TierOneMember" id="psti_TierOneMember" nillable="true" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType" />
  <xsd:element name="TierThreeMember" id="psti_TierThreeMember" nillable="true" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType" />
  <xsd:element name="TierTwoMember" id="psti_TierTwoMember" nillable="true" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType" />
  <xsd:element name="TwoThousandSevenProgramMember" id="psti_TwoThousandSevenProgramMember" nillable="true" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType" />
  <xsd:element name="TwoThousandTwelveProgramMember" id="psti_TwoThousandTwelveProgramMember" nillable="true" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType" />
  <xsd:element name="UnderwritersOptionMember" id="psti_UnderwritersOptionMember" nillable="true" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType" />
  <xsd:element name="UnderwriterWarrantsMember" id="psti_UnderwriterWarrantsMember" nillable="true" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType" />
  <xsd:element name="ValueOfProductiveAssetsBeforeExpansion" id="psti_ValueOfProductiveAssetsBeforeExpansion" nillable="true" xbrli:balance="debit" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" />
  <xsd:element name="WarrantAwardsMember" id="psti_WarrantAwardsMember" nillable="true" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType" />
  <xsd:element name="WarrantsAndOptionsAggregateIntrinsicValue" id="psti_WarrantsAndOptionsAggregateIntrinsicValue" nillable="true" xbrli:balance="debit" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" />
  <xsd:element name="WarrantsAndOptionsAggregateIntrinsicValueExercisable" id="psti_WarrantsAndOptionsAggregateIntrinsicValueExercisable" nillable="true" xbrli:balance="debit" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" />
  <xsd:element name="WarrantsAndOptionsAggregateIntrinsicValuePriceAbstract" id="psti_WarrantsAndOptionsAggregateIntrinsicValuePriceAbstract" nillable="true" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType" />
  <xsd:element name="WarrantsAndOptionsAggregateIntrinsicValueVestedAndExpectedToVest" id="psti_WarrantsAndOptionsAggregateIntrinsicValueVestedAndExpectedToVest" nillable="true" xbrli:balance="debit" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" />
  <xsd:element name="WarrantsAndOptionsExercisedWeightedAverageExercisePrice" id="psti_WarrantsAndOptionsExercisedWeightedAverageExercisePrice" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="num:perShareItemType" />
  <xsd:element name="WarrantsAndOptionsGrantedWeightedAverageExercisePrice" id="psti_WarrantsAndOptionsGrantedWeightedAverageExercisePrice" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="num:perShareItemType" />
  <xsd:element name="WarrantsAndOptionsNumberAbstract" id="psti_WarrantsAndOptionsNumberAbstract" nillable="true" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType" />
  <xsd:element name="WarrantsAndOptionsWeightedAverageExercisePrice" id="psti_WarrantsAndOptionsWeightedAverageExercisePrice" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="num:perShareItemType" />
  <xsd:element name="WarrantsAndOptionsWeightedAverageExercisePriceAbstract" id="psti_WarrantsAndOptionsWeightedAverageExercisePriceAbstract" nillable="true" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType" />
  <xsd:element name="WarrantsAndOptionsWeightedAverageExercisePriceExcercisable" id="psti_WarrantsAndOptionsWeightedAverageExercisePriceExcercisable" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="num:perShareItemType" />
  <xsd:element name="WarrantsAndOptionsWeightedAverageExercisePriceVestedAndExpectedToVest" id="psti_WarrantsAndOptionsWeightedAverageExercisePriceVestedAndExpectedToVest" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="num:perShareItemType" />
  <xsd:element name="WarrantsAndOptionsWeightedAverageRemainingContractualTerm" id="psti_WarrantsAndOptionsWeightedAverageRemainingContractualTerm" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:durationItemType" />
  <xsd:element name="WarrantsAndOptionsWeightedAverageRemainingContractualTermExercisable" id="psti_WarrantsAndOptionsWeightedAverageRemainingContractualTermExercisable" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:durationItemType" />
  <xsd:element name="WarrantsAndOptionsWeightedAverageRemainingContractualTermsAbstract" id="psti_WarrantsAndOptionsWeightedAverageRemainingContractualTermsAbstract" nillable="true" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType" />
  <xsd:element name="WarrantsAndOptionsWeightedAverageRemainingContractualTermVestedAndExpectedToVest" id="psti_WarrantsAndOptionsWeightedAverageRemainingContractualTermVestedAndExpectedToVest" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:durationItemType" />
  <xsd:element name="WeightedAverageRemainingContractualTermsAbstract" id="psti_WeightedAverageRemainingContractualTermsAbstract" nillable="true" abstract="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType" />
  <xsd:element name="WithholdingTaxRateOnDividendsFromRetainedTaxExemptProfits" id="psti_WithholdingTaxRateOnDividendsFromRetainedTaxExemptProfits" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="num:percentItemType" />
</xsd:schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.CAL
<SEQUENCE>26
<FILENAME>psti-20140630_cal.xml
<DESCRIPTION>TAXONOMY EXTENSION CALCULATION LINKBASE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" standalone="no"?>
<!--Created by Z-K Global Ltd. ("ZKG")-->
<!--produced on 2014-09-10 @ 8:21 AM-->
<link:linkbase xmlns:psti="http://www.pluristem.com/20140630" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" xmlns:link="http://www.xbrl.org/2003/linkbase">
  <link:roleRef roleURI="http://www.pluristem.com/role/SignificantAccountingPolicies" xlink:href="psti-20140630.xsd#psti-sap1" xlink:type="simple" />
  <link:roleRef roleURI="http://www.pluristem.com/role/CommitmentsAndContingencies" xlink:href="psti-20140630.xsd#psti-cac1" xlink:type="simple" />
  <link:roleRef roleURI="http://www.pluristem.com/role/CommitmentsAndContingenciesOtherDetails" xlink:href="psti-20140630.xsd#psti-cacod" xlink:type="simple" />
  <link:roleRef roleURI="http://www.pluristem.com/role/ConsolidatedBalanceSheets" xlink:href="psti-20140630.xsd#psti-cbs1" xlink:type="simple" />
  <link:roleRef roleURI="http://www.pluristem.com/role/ConsolidatedBalanceSheetsParenthetical" xlink:href="psti-20140630.xsd#psti-cbsp1" xlink:type="simple" />
  <link:roleRef roleURI="http://www.pluristem.com/role/ConsolidatedStatementsOfCashFlows" xlink:href="psti-20140630.xsd#psti-csocf1" xlink:type="simple" />
  <link:roleRef roleURI="http://www.pluristem.com/role/ConsolidatedStatementsOfComprehensiveLoss" xlink:href="psti-20140630.xsd#psti-csocl1" xlink:type="simple" />
  <link:roleRef roleURI="http://www.pluristem.com/role/ConsolidatedStatementsOfOperations" xlink:href="psti-20140630.xsd#psti-csoo1" xlink:type="simple" />
  <link:roleRef roleURI="http://www.pluristem.com/role/StatementsOfChangesInEquity" xlink:href="psti-20140630.xsd#psti-socie1" xlink:type="simple" />
  <link:roleRef roleURI="http://www.pluristem.com/role/StatementsOfChangesInEquityParenthetical" xlink:href="psti-20140630.xsd#psti-sociep1" xlink:type="simple" />
  <link:roleRef roleURI="http://www.pluristem.com/role/FairValueOfFinancialInstruments" xlink:href="psti-20140630.xsd#psti-fvofi12" xlink:type="simple" />
  <link:roleRef roleURI="http://www.pluristem.com/role/FairValueOfFinancialInstrumentsScheduleOfFairValueOfFinancialInstrumentsDetails" xlink:href="psti-20140630.xsd#psti-fvofisofvofid1" xlink:type="simple" />
  <link:roleRef roleURI="http://www.pluristem.com/role/FairValueOfFinancialInstrumentsScheduleOfFairValueOfHedgingInstrumentsDetails" xlink:href="psti-20140630.xsd#psti-fvofisofvohid" xlink:type="simple" />
  <link:roleRef roleURI="http://www.pluristem.com/role/FairValueOfFinancialInstrumentsTables" xlink:href="psti-20140630.xsd#psti-fvofit1" xlink:type="simple" />
  <link:roleRef roleURI="http://www.pluristem.com/role/General" xlink:href="psti-20140630.xsd#psti-g1" xlink:type="simple" />
  <link:roleRef roleURI="http://www.pluristem.com/role/GeneralDetails" xlink:href="psti-20140630.xsd#psti-gd" xlink:type="simple" />
  <link:roleRef roleURI="http://www.pluristem.com/role/MarketableSecurities" xlink:href="psti-20140630.xsd#psti-ms" xlink:type="simple" />
  <link:roleRef roleURI="http://www.pluristem.com/role/MarketableSecuritiesScheduleOfAvailableforsaleMarketableSecuritiesDetails" xlink:href="psti-20140630.xsd#psti-mssoamsd1" xlink:type="simple" />
  <link:roleRef roleURI="http://www.pluristem.com/role/MarketableSecuritiesScheduleOfInvestmentsInUnrealizedLossDetails" xlink:href="psti-20140630.xsd#psti-mssoiiuld" xlink:type="simple" />
  <link:roleRef roleURI="http://www.pluristem.com/role/MarketableSecuritiesTables" xlink:href="psti-20140630.xsd#psti-mst1" xlink:type="simple" />
  <link:roleRef roleURI="http://www.pluristem.com/role/SubsequentEvents" xlink:href="psti-20140630.xsd#psti-se123" xlink:type="simple" />
  <link:roleRef roleURI="http://www.pluristem.com/role/StockholdersEquity" xlink:href="psti-20140630.xsd#psti-se12" xlink:type="simple" />
  <link:roleRef roleURI="http://www.pluristem.com/role/SubsequentEventsDetails" xlink:href="psti-20140630.xsd#psti-sed1" xlink:type="simple" />
  <link:roleRef roleURI="http://www.pluristem.com/role/StockholdersEquityNarrativeDetails" xlink:href="psti-20140630.xsd#psti-send1" xlink:type="simple" />
  <link:roleRef roleURI="http://www.pluristem.com/role/StockholdersEquityScheduleOfCompensationExpenseDetails" xlink:href="psti-20140630.xsd#psti-sesoced1" xlink:type="simple" />
  <link:roleRef roleURI="http://www.pluristem.com/role/StockholdersEquitySummaryOfOptionActivityDetails" xlink:href="psti-20140630.xsd#psti-sesooad1" xlink:type="simple" />
  <link:roleRef roleURI="http://www.pluristem.com/role/StockholdersEquitySummaryOfOptionAndWarrantActivityToNonemployeesDetails" xlink:href="psti-20140630.xsd#psti-sesooawatnd1" xlink:type="simple" />
  <link:roleRef roleURI="http://www.pluristem.com/role/StockholdersEquitySummaryOfRsuActivityToConsultantsDetails" xlink:href="psti-20140630.xsd#psti-sesoratcd1" xlink:type="simple" />
  <link:roleRef roleURI="http://www.pluristem.com/role/StockholdersEquitySummaryOfRsuActivityToEmployeesAndDirectorsDetails" xlink:href="psti-20140630.xsd#psti-sesorateadd1" xlink:type="simple" />
  <link:roleRef roleURI="http://www.pluristem.com/role/StockholdersEquityTables" xlink:href="psti-20140630.xsd#psti-set1" xlink:type="simple" />
  <link:roleRef roleURI="http://www.pluristem.com/role/PropertyAndEquipmentNet" xlink:href="psti-20140630.xsd#psti-paen1" xlink:type="simple" />
  <link:roleRef roleURI="http://www.pluristem.com/role/PropertyAndEquipmentNetTables" xlink:href="psti-20140630.xsd#psti-paent1" xlink:type="simple" />
  <link:roleRef roleURI="http://www.pluristem.com/role/PropertyAndEquipmentNetDetails" xlink:href="psti-20140630.xsd#psti-paend1" xlink:type="simple" />
  <link:roleRef roleURI="http://www.pluristem.com/role/OtherAccountsPayable" xlink:href="psti-20140630.xsd#psti-oap1" xlink:type="simple" />
  <link:roleRef roleURI="http://www.pluristem.com/role/FinancialIncomeNet" xlink:href="psti-20140630.xsd#psti-fin" xlink:type="simple" />
  <link:roleRef roleURI="http://www.pluristem.com/role/TaxesOnIncome" xlink:href="psti-20140630.xsd#psti-toi1" xlink:type="simple" />
  <link:roleRef roleURI="http://www.pluristem.com/role/CommitmentsAndContingenciesTables" xlink:href="psti-20140630.xsd#psti-cact1" xlink:type="simple" />
  <link:roleRef roleURI="http://www.pluristem.com/role/FinancialIncomeNetTables" xlink:href="psti-20140630.xsd#psti-fint" xlink:type="simple" />
  <link:roleRef roleURI="http://www.pluristem.com/role/TaxesOnIncomeTables" xlink:href="psti-20140630.xsd#psti-toit1" xlink:type="simple" />
  <link:roleRef roleURI="http://www.pluristem.com/role/OtherAccountsPayableTables" xlink:href="psti-20140630.xsd#psti-oapt1" xlink:type="simple" />
  <link:roleRef roleURI="http://www.pluristem.com/role/OtherAccountsPayableDetails" xlink:href="psti-20140630.xsd#psti-oapd1" xlink:type="simple" />
  <link:roleRef roleURI="http://www.pluristem.com/role/CommitmentsAndContingenciesOperatingLeaseDetails" xlink:href="psti-20140630.xsd#psti-cacold1" xlink:type="simple" />
  <link:roleRef roleURI="http://www.pluristem.com/role/CommitmentsAndContingenciesCommitmentToSuppliersAndContractorDetails" xlink:href="psti-20140630.xsd#psti-cacctsacd1" xlink:type="simple" />
  <link:roleRef roleURI="http://www.pluristem.com/role/FinancialIncomeNetDetails" xlink:href="psti-20140630.xsd#psti-find" xlink:type="simple" />
  <link:roleRef roleURI="http://www.pluristem.com/role/TaxesOnIncomeNarrativeDetails" xlink:href="psti-20140630.xsd#psti-toind1" xlink:type="simple" />
  <link:roleRef roleURI="http://www.pluristem.com/role/TaxesOnIncomeQualifyingPercentagesOfValueOfProductiveAssetsDetails" xlink:href="psti-20140630.xsd#psti-toiqpovopad1" xlink:type="simple" />
  <link:roleRef roleURI="http://www.pluristem.com/role/TaxesOnIncomeScheduleOfSignificantComponentsOfDeferredTaxAssetsDetails" xlink:href="psti-20140630.xsd#psti-toisoscodtad1" xlink:type="simple" />
  <link:roleRef roleURI="http://www.pluristem.com/role/SignificantAccountingPoliciesPolicies" xlink:href="psti-20140630.xsd#psti-sapp1" xlink:type="simple" />
  <link:roleRef roleURI="http://www.pluristem.com/role/SignificantAccountingPoliciesTables" xlink:href="psti-20140630.xsd#psti-sapt1" xlink:type="simple" />
  <link:roleRef roleURI="http://www.pluristem.com/role/DocumentAndEntityInformation" xlink:href="psti-20140630.xsd#psti-daei1" xlink:type="simple" />
  <link:roleRef roleURI="http://www.pluristem.com/role/SignificantAccountingPoliciesNarrativeDetails" xlink:href="psti-20140630.xsd#psti-sapnd1" xlink:type="simple" />
  <link:roleRef roleURI="http://www.pluristem.com/role/SignificantAccountingPoliciesScheduleOfPropertyAndEquipmentDepreciationRateDetails" xlink:href="psti-20140630.xsd#psti-sapsopaedrd1" xlink:type="simple" />
  <link:roleRef roleURI="http://www.pluristem.com/role/StockholdersEquitySummaryOfWarrantsAndOptionsDetails" xlink:href="psti-20140630.xsd#psti-sesowaod" xlink:type="simple" />
  <link:roleRef roleURI="http://www.pluristem.com/role/SignificantAccountingPoliciesComprehensiveIncomeDetails" xlink:href="psti-20140630.xsd#psti-sapcid" xlink:type="simple" />
  <link:calculationLink xlink:title="002 - Statement - CONSOLIDATED BALANCE SHEETS" xlink:role="http://www.pluristem.com/role/ConsolidatedBalanceSheets" xlink:type="extended">
    <link:loc xlink:label="loc_Assets.5987.14.6" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_Assets" xlink:type="locator" />
    <link:loc xlink:label="loc_AssetsCurrent.6017.14.6" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_AssetsCurrent" xlink:type="locator" />
    <link:calculationArc xlink:from="loc_Assets.5987.14.6" xlink:to="loc_AssetsCurrent.6017.14.6" order="1.00000" weight="1.00" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:type="arc" />
    <link:loc xlink:label="loc_AssetsNoncurrent.6012.14.6" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_AssetsNoncurrent" xlink:type="locator" />
    <link:calculationArc xlink:from="loc_Assets.5987.14.6" xlink:to="loc_AssetsNoncurrent.6012.14.6" order="2.00000" weight="1.00" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:type="arc" />
    <link:loc xlink:label="loc_PropertyPlantAndEquipmentNet.15032.14.6" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet" xlink:type="locator" />
    <link:calculationArc xlink:from="loc_AssetsNoncurrent.6012.14.6" xlink:to="loc_PropertyPlantAndEquipmentNet.15032.14.6" order="4.00000" weight="1.00" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:type="arc" />
    <link:loc xlink:label="loc_OtherAssetsNoncurrent.13645.14.6" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_OtherAssetsNoncurrent" xlink:type="locator" />
    <link:calculationArc xlink:from="loc_AssetsNoncurrent.6012.14.6" xlink:to="loc_OtherAssetsNoncurrent.13645.14.6" order="3.00000" weight="1.00" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:type="arc" />
    <link:loc xlink:label="loc_DefinedBenefitPlanAssetsForPlanBenefitsNoncurrent.8166.14.6" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_DefinedBenefitPlanAssetsForPlanBenefitsNoncurrent" xlink:type="locator" />
    <link:calculationArc xlink:from="loc_AssetsNoncurrent.6012.14.6" xlink:to="loc_DefinedBenefitPlanAssetsForPlanBenefitsNoncurrent.8166.14.6" order="2.00000" weight="1.00" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:type="arc" />
    <link:loc xlink:label="loc_LongTermInvestments.12613.14.6" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_LongTermInvestments" xlink:type="locator" />
    <link:calculationArc xlink:from="loc_AssetsNoncurrent.6012.14.6" xlink:to="loc_LongTermInvestments.12613.14.6" order="1.00000" weight="1.00" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:type="arc" />
    <link:loc xlink:label="loc_CashAndCashEquivalentsAtCarryingValue.6761.14.6" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:type="locator" />
    <link:calculationArc xlink:from="loc_AssetsCurrent.6017.14.6" xlink:to="loc_CashAndCashEquivalentsAtCarryingValue.6761.14.6" order="1.00000" weight="1.00" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:type="arc" />
    <link:loc xlink:label="loc_MarketableSecuritiesCurrent.12849.14.6" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_MarketableSecuritiesCurrent" xlink:type="locator" />
    <link:calculationArc xlink:from="loc_AssetsCurrent.6017.14.6" xlink:to="loc_MarketableSecuritiesCurrent.12849.14.6" order="6.00000" weight="1.00" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:type="arc" />
    <link:loc xlink:label="loc_ShortTermInvestments.16790.14.6" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ShortTermInvestments" xlink:type="locator" />
    <link:calculationArc xlink:from="loc_AssetsCurrent.6017.14.6" xlink:to="loc_ShortTermInvestments.16790.14.6" order="5.00000" weight="1.00" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:type="arc" />
    <link:loc xlink:label="loc_OtherAssetsCurrent.13702.14.6" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_OtherAssetsCurrent" xlink:type="locator" />
    <link:calculationArc xlink:from="loc_AssetsCurrent.6017.14.6" xlink:to="loc_OtherAssetsCurrent.13702.14.6" order="3.00000" weight="1.00" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:type="arc" />
    <link:loc xlink:label="loc_RestrictedCashAndCashEquivalentsAtCarryingValue.15718.14.6" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_RestrictedCashAndCashEquivalentsAtCarryingValue" xlink:type="locator" />
    <link:calculationArc xlink:from="loc_AssetsCurrent.6017.14.6" xlink:to="loc_RestrictedCashAndCashEquivalentsAtCarryingValue.15718.14.6" order="4.00000" weight="1.00" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:type="arc" />
    <link:loc xlink:label="loc_AccountsReceivableNetCurrent.5600.14.6" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_AccountsReceivableNetCurrent" xlink:type="locator" />
    <link:calculationArc xlink:from="loc_AssetsCurrent.6017.14.6" xlink:to="loc_AccountsReceivableNetCurrent.5600.14.6" order="2.00000" weight="1.00" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:type="arc" />
    <link:loc xlink:label="loc_LiabilitiesCurrent.12001.14.6" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_LiabilitiesCurrent" xlink:type="locator" />
    <link:loc xlink:label="loc_AccountsPayableCurrent.5620.14.6" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_AccountsPayableCurrent" xlink:type="locator" />
    <link:calculationArc xlink:from="loc_LiabilitiesCurrent.12001.14.6" xlink:to="loc_AccountsPayableCurrent.5620.14.6" order="1.00000" weight="1.00" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:type="arc" />
    <link:loc xlink:label="loc_AccruedLiabilitiesCurrent.5698.14.6" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_AccruedLiabilitiesCurrent" xlink:type="locator" />
    <link:calculationArc xlink:from="loc_LiabilitiesCurrent.12001.14.6" xlink:to="loc_AccruedLiabilitiesCurrent.5698.14.6" order="2.00000" weight="1.00" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:type="arc" />
    <link:loc xlink:label="loc_AccountsPayableOtherCurrent.5626.14.6" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_AccountsPayableOtherCurrent" xlink:type="locator" />
    <link:calculationArc xlink:from="loc_LiabilitiesCurrent.12001.14.6" xlink:to="loc_AccountsPayableOtherCurrent.5626.14.6" order="3.00000" weight="1.00" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:type="arc" />
    <link:loc xlink:label="loc_DeferredRevenueCurrent.7829.14.6" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_DeferredRevenueCurrent" xlink:type="locator" />
    <link:calculationArc xlink:from="loc_LiabilitiesCurrent.12001.14.6" xlink:to="loc_DeferredRevenueCurrent.7829.14.6" order="2.50000" weight="1.00" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:type="arc" />
    <link:loc xlink:label="loc_CustomerAdvancesCurrent.7446.14.6" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_CustomerAdvancesCurrent" xlink:type="locator" />
    <link:calculationArc xlink:from="loc_LiabilitiesCurrent.12001.14.6" xlink:to="loc_CustomerAdvancesCurrent.7446.14.6" order="2.75000" weight="1.00" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:type="arc" />
    <link:loc xlink:label="loc_LiabilitiesAndStockholdersEquity.12012.14.6" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquity" xlink:type="locator" />
    <link:calculationArc xlink:from="loc_LiabilitiesAndStockholdersEquity.12012.14.6" xlink:to="loc_LiabilitiesCurrent.12001.14.6" order="1.00000" weight="1.00" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:type="arc" />
    <link:loc xlink:label="loc_LiabilitiesNoncurrent.12040.14.6" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_LiabilitiesNoncurrent" xlink:type="locator" />
    <link:calculationArc xlink:from="loc_LiabilitiesAndStockholdersEquity.12012.14.6" xlink:to="loc_LiabilitiesNoncurrent.12040.14.6" order="3.00000" weight="1.00" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:type="arc" />
    <link:loc xlink:label="loc_StockholdersEquity.17019.14.6" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_StockholdersEquity" xlink:type="locator" />
    <link:calculationArc xlink:from="loc_LiabilitiesAndStockholdersEquity.12012.14.6" xlink:to="loc_StockholdersEquity.17019.14.6" order="4.00000" weight="1.00" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:type="arc" />
    <link:loc xlink:label="loc_CommitmentsAndContingencies.7037.14.6" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_CommitmentsAndContingencies" xlink:type="locator" />
    <link:calculationArc xlink:from="loc_LiabilitiesAndStockholdersEquity.12012.14.6" xlink:to="loc_CommitmentsAndContingencies.7037.14.6" order="2.00000" weight="1.00" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:type="arc" />
    <link:loc xlink:label="loc_DeferredRevenueNoncurrent.7842.14.6" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_DeferredRevenueNoncurrent" xlink:type="locator" />
    <link:calculationArc xlink:from="loc_LiabilitiesNoncurrent.12040.14.6" xlink:to="loc_DeferredRevenueNoncurrent.7842.14.6" order="1.00000" weight="1.00" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:type="arc" />
    <link:loc xlink:label="loc_OtherLiabilitiesNoncurrent.13846.14.6" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_OtherLiabilitiesNoncurrent" xlink:type="locator" />
    <link:calculationArc xlink:from="loc_LiabilitiesNoncurrent.12040.14.6" xlink:to="loc_OtherLiabilitiesNoncurrent.13846.14.6" order="3.00000" weight="1.00" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:type="arc" />
    <link:loc xlink:label="loc_PostemploymentBenefitsLiabilityNoncurrent.14433.14.6" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_PostemploymentBenefitsLiabilityNoncurrent" xlink:type="locator" />
    <link:calculationArc xlink:from="loc_LiabilitiesNoncurrent.12040.14.6" xlink:to="loc_PostemploymentBenefitsLiabilityNoncurrent.14433.14.6" order="2.00000" weight="1.00" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:type="arc" />
    <link:loc xlink:label="loc_CommonStockValue.7048.14.6" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_CommonStockValue" xlink:type="locator" />
    <link:calculationArc xlink:from="loc_StockholdersEquity.17019.14.6" xlink:to="loc_CommonStockValue.7048.14.6" order="1.00000" weight="1.00" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:type="arc" />
    <link:loc xlink:label="loc_AdditionalPaidInCapital.5750.14.6" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_AdditionalPaidInCapital" xlink:type="locator" />
    <link:calculationArc xlink:from="loc_StockholdersEquity.17019.14.6" xlink:to="loc_AdditionalPaidInCapital.5750.14.6" order="3.00000" weight="1.00" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:type="arc" />
    <link:loc xlink:label="loc_RetainedEarningsAccumulatedDeficit.15840.14.6" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_RetainedEarningsAccumulatedDeficit" xlink:type="locator" />
    <link:calculationArc xlink:from="loc_StockholdersEquity.17019.14.6" xlink:to="loc_RetainedEarningsAccumulatedDeficit.15840.14.6" order="2.00000" weight="1.00" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:type="arc" />
    <link:loc xlink:label="loc_AccumulatedOtherComprehensiveIncomeLossNetOfTax.5715.14.6" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:type="locator" />
    <link:calculationArc xlink:from="loc_StockholdersEquity.17019.14.6" xlink:to="loc_AccumulatedOtherComprehensiveIncomeLossNetOfTax.5715.14.6" order="4.00000" weight="1.00" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:type="arc" />
  </link:calculationLink>
  <link:calculationLink xlink:title="008 - Statement - CONSOLIDATED STATEMENTS OF CASH FLOWS" xlink:role="http://www.pluristem.com/role/ConsolidatedStatementsOfCashFlows" xlink:type="extended">
    <link:loc xlink:label="loc_CashAndCashEquivalentsPeriodIncreaseDecrease.6751.14.6" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease" xlink:type="locator" />
    <link:loc xlink:label="loc_NetCashProvidedByUsedInFinancingActivitiesContinuingOperations.13107.14.6" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperations" xlink:type="locator" />
    <link:calculationArc xlink:from="loc_CashAndCashEquivalentsPeriodIncreaseDecrease.6751.14.6" xlink:to="loc_NetCashProvidedByUsedInFinancingActivitiesContinuingOperations.13107.14.6" order="1.00000" weight="1.00" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:type="arc" />
    <link:loc xlink:label="loc_NetCashProvidedByUsedInInvestingActivitiesContinuingOperations.13117.14.6" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperations" xlink:type="locator" />
    <link:calculationArc xlink:from="loc_CashAndCashEquivalentsPeriodIncreaseDecrease.6751.14.6" xlink:to="loc_NetCashProvidedByUsedInInvestingActivitiesContinuingOperations.13117.14.6" order="2.00000" weight="1.00" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:type="arc" />
    <link:loc xlink:label="loc_NetCashProvidedByUsedInOperatingActivitiesContinuingOperations.13087.14.6" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperations" xlink:type="locator" />
    <link:calculationArc xlink:from="loc_CashAndCashEquivalentsPeriodIncreaseDecrease.6751.14.6" xlink:to="loc_NetCashProvidedByUsedInOperatingActivitiesContinuingOperations.13087.14.6" order="3.00000" weight="1.00" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:type="arc" />
    <link:loc xlink:label="loc_NetIncomeLoss.13072.14.6" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_NetIncomeLoss" xlink:type="locator" />
    <link:calculationArc xlink:from="loc_NetCashProvidedByUsedInOperatingActivitiesContinuingOperations.13087.14.6" xlink:to="loc_NetIncomeLoss.13072.14.6" order="1.00000" weight="1.00" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:type="arc" />
    <link:loc xlink:label="loc_Depreciation.8242.14.6" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_Depreciation" xlink:type="locator" />
    <link:calculationArc xlink:from="loc_NetCashProvidedByUsedInOperatingActivitiesContinuingOperations.13087.14.6" xlink:to="loc_Depreciation.8242.14.6" order="8.00000" weight="1.00" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:type="arc" />
    <link:loc xlink:label="loc_IncreaseDecreaseInOtherReceivables.11257.14.6" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_IncreaseDecreaseInOtherReceivables" xlink:type="locator" />
    <link:calculationArc xlink:from="loc_NetCashProvidedByUsedInOperatingActivitiesContinuingOperations.13087.14.6" xlink:to="loc_IncreaseDecreaseInOtherReceivables.11257.14.6" order="9.00000" weight="-1.00" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:type="arc" />
    <link:loc xlink:label="loc_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets.11312.14.6" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:type="locator" />
    <link:calculationArc xlink:from="loc_NetCashProvidedByUsedInOperatingActivitiesContinuingOperations.13087.14.6" xlink:to="loc_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets.11312.14.6" order="10.00000" weight="-1.00" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:type="arc" />
    <link:loc xlink:label="loc_IncreaseDecreaseInAccountsPayable.11150.14.6" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsPayable" xlink:type="locator" />
    <link:calculationArc xlink:from="loc_NetCashProvidedByUsedInOperatingActivitiesContinuingOperations.13087.14.6" xlink:to="loc_IncreaseDecreaseInAccountsPayable.11150.14.6" order="11.00000" weight="1.00" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:type="arc" />
    <link:loc xlink:label="loc_IncreaseDecreaseInDeferredRevenue.11220.14.6" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_IncreaseDecreaseInDeferredRevenue" xlink:type="locator" />
    <link:calculationArc xlink:from="loc_NetCashProvidedByUsedInOperatingActivitiesContinuingOperations.13087.14.6" xlink:to="loc_IncreaseDecreaseInDeferredRevenue.11220.14.6" order="12.00000" weight="1.00" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:type="arc" />
    <link:loc xlink:label="loc_IncreaseDecreaseInCustomerAdvances.11211.14.6" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_IncreaseDecreaseInCustomerAdvances" xlink:type="locator" />
    <link:calculationArc xlink:from="loc_NetCashProvidedByUsedInOperatingActivitiesContinuingOperations.13087.14.6" xlink:to="loc_IncreaseDecreaseInCustomerAdvances.11211.14.6" order="13.00000" weight="1.00" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:type="arc" />
    <link:loc xlink:label="loc_LinkageDifferencesAndInterestOnShortAndLongTermRestrictedLeaseDeposit.25541.14.6" xlink:href="psti-20140630.xsd#psti_LinkageDifferencesAndInterestOnShortAndLongTermRestrictedLeaseDeposit" xlink:type="locator" />
    <link:calculationArc xlink:from="loc_NetCashProvidedByUsedInOperatingActivitiesContinuingOperations.13087.14.6" xlink:to="loc_LinkageDifferencesAndInterestOnShortAndLongTermRestrictedLeaseDeposit.25541.14.6" order="14.00000" weight="1.00" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:type="arc" />
    <link:loc xlink:label="loc_AmortizationOfDiscountAndPremiumAndChangesInAccruedInterestFromMarketableSecurities.25526.14.6" xlink:href="psti-20140630.xsd#psti_AmortizationOfDiscountAndPremiumAndChangesInAccruedInterestFromMarketableSecurities" xlink:type="locator" />
    <link:calculationArc xlink:from="loc_NetCashProvidedByUsedInOperatingActivitiesContinuingOperations.13087.14.6" xlink:to="loc_AmortizationOfDiscountAndPremiumAndChangesInAccruedInterestFromMarketableSecurities.25526.14.6" order="15.00000" weight="1.00" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:type="arc" />
    <link:loc xlink:label="loc_MarketableSecuritiesRealizedGainLoss.12843.14.6" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_MarketableSecuritiesRealizedGainLoss" xlink:type="locator" />
    <link:calculationArc xlink:from="loc_NetCashProvidedByUsedInOperatingActivitiesContinuingOperations.13087.14.6" xlink:to="loc_MarketableSecuritiesRealizedGainLoss.12843.14.6" order="16.00000" weight="-1.00" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:type="arc" />
    <link:loc xlink:label="loc_IncreaseDecreaseInPensionAndPostretirementObligations.11356.14.6" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_IncreaseDecreaseInPensionAndPostretirementObligations" xlink:type="locator" />
    <link:calculationArc xlink:from="loc_NetCashProvidedByUsedInOperatingActivitiesContinuingOperations.13087.14.6" xlink:to="loc_IncreaseDecreaseInPensionAndPostretirementObligations.11356.14.6" order="17.00000" weight="1.00" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:type="arc" />
    <link:loc xlink:label="loc_ShareBasedCompensation.16630.14.6" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ShareBasedCompensation" xlink:type="locator" />
    <link:calculationArc xlink:from="loc_NetCashProvidedByUsedInOperatingActivitiesContinuingOperations.13087.14.6" xlink:to="loc_ShareBasedCompensation.16630.14.6" order="4.00000" weight="1.00" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:type="arc" />
    <link:loc xlink:label="loc_IssuanceOfStockAndWarrantsForServicesOrClaims.11880.14.6" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_IssuanceOfStockAndWarrantsForServicesOrClaims" xlink:type="locator" />
    <link:calculationArc xlink:from="loc_NetCashProvidedByUsedInOperatingActivitiesContinuingOperations.13087.14.6" xlink:to="loc_IssuanceOfStockAndWarrantsForServicesOrClaims.11880.14.6" order="5.00000" weight="1.00" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:type="arc" />
    <link:loc xlink:label="loc_GainLossOnSaleOfPropertyPlantEquipment.10522.14.6" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_GainLossOnSaleOfPropertyPlantEquipment" xlink:type="locator" />
    <link:calculationArc xlink:from="loc_NetCashProvidedByUsedInOperatingActivitiesContinuingOperations.13087.14.6" xlink:to="loc_GainLossOnSaleOfPropertyPlantEquipment.10522.14.6" order="6.00000" weight="-1.00" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:type="arc" />
    <link:loc xlink:label="loc_IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities.11250.14.6" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities" xlink:type="locator" />
    <link:calculationArc xlink:from="loc_NetCashProvidedByUsedInOperatingActivitiesContinuingOperations.13087.14.6" xlink:to="loc_IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities.11250.14.6" order="7.00000" weight="1.00" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:type="arc" />
    <link:loc xlink:label="loc_IncreaseDecreaseInAccruedInterestReceivableNet.11204.14.6" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_IncreaseDecreaseInAccruedInterestReceivableNet" xlink:type="locator" />
    <link:calculationArc xlink:from="loc_NetCashProvidedByUsedInOperatingActivitiesContinuingOperations.13087.14.6" xlink:to="loc_IncreaseDecreaseInAccruedInterestReceivableNet.11204.14.6" order="3.00000" weight="-1.00" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:type="arc" />
    <link:loc xlink:label="loc_IncreaseDecreaseInAccountsReceivable.11117.14.6" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:type="locator" />
    <link:calculationArc xlink:from="loc_NetCashProvidedByUsedInOperatingActivitiesContinuingOperations.13087.14.6" xlink:to="loc_IncreaseDecreaseInAccountsReceivable.11117.14.6" order="2.00000" weight="-1.00" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:type="arc" />
    <link:loc xlink:label="loc_ProceedsFromIssuanceOfCommonStock.14855.14.6" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ProceedsFromIssuanceOfCommonStock" xlink:type="locator" />
    <link:calculationArc xlink:from="loc_NetCashProvidedByUsedInFinancingActivitiesContinuingOperations.13107.14.6" xlink:to="loc_ProceedsFromIssuanceOfCommonStock.14855.14.6" order="1.00000" weight="1.00" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:type="arc" />
    <link:loc xlink:label="loc_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions.14931.14.6" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions" xlink:type="locator" />
    <link:calculationArc xlink:from="loc_NetCashProvidedByUsedInFinancingActivitiesContinuingOperations.13107.14.6" xlink:to="loc_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions.14931.14.6" order="2.00000" weight="1.00" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:type="arc" />
    <link:loc xlink:label="loc_PaymentsToAcquirePropertyPlantAndEquipment.14193.14.6" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:type="locator" />
    <link:calculationArc xlink:from="loc_NetCashProvidedByUsedInInvestingActivitiesContinuingOperations.13117.14.6" xlink:to="loc_PaymentsToAcquirePropertyPlantAndEquipment.14193.14.6" order="1.00000" weight="-1.00" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:type="arc" />
    <link:loc xlink:label="loc_ProceedsFromSaleOfAvailableForSaleSecurities.14910.14.6" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ProceedsFromSaleOfAvailableForSaleSecurities" xlink:type="locator" />
    <link:calculationArc xlink:from="loc_NetCashProvidedByUsedInInvestingActivitiesContinuingOperations.13117.14.6" xlink:to="loc_ProceedsFromSaleOfAvailableForSaleSecurities.14910.14.6" order="7.00000" weight="1.00" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:type="arc" />
    <link:loc xlink:label="loc_PaymentsForProceedsFromShortTermInvestments.14085.14.6" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_PaymentsForProceedsFromShortTermInvestments" xlink:type="locator" />
    <link:calculationArc xlink:from="loc_NetCashProvidedByUsedInInvestingActivitiesContinuingOperations.13117.14.6" xlink:to="loc_PaymentsForProceedsFromShortTermInvestments.14085.14.6" order="2.00000" weight="-1.00" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:type="arc" />
    <link:loc xlink:label="loc_PaymentsForProceedsFromLongtermInvestments.14128.14.6" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_PaymentsForProceedsFromLongtermInvestments" xlink:type="locator" />
    <link:calculationArc xlink:from="loc_NetCashProvidedByUsedInInvestingActivitiesContinuingOperations.13117.14.6" xlink:to="loc_PaymentsForProceedsFromLongtermInvestments.14128.14.6" order="3.00000" weight="-1.00" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:type="arc" />
    <link:loc xlink:label="loc_IncreaseDecreaseInRestrictedCashAndInvestments.11152.14.6" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_IncreaseDecreaseInRestrictedCashAndInvestments" xlink:type="locator" />
    <link:calculationArc xlink:from="loc_NetCashProvidedByUsedInInvestingActivitiesContinuingOperations.13117.14.6" xlink:to="loc_IncreaseDecreaseInRestrictedCashAndInvestments.11152.14.6" order="4.00000" weight="-1.00" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:type="arc" />
    <link:loc xlink:label="loc_ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities.14840.14.6" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities" xlink:type="locator" />
    <link:calculationArc xlink:from="loc_NetCashProvidedByUsedInInvestingActivitiesContinuingOperations.13117.14.6" xlink:to="loc_ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities.14840.14.6" order="5.00000" weight="1.00" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:type="arc" />
    <link:loc xlink:label="loc_PaymentsToAcquireAvailableForSaleSecurities.14179.14.6" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_PaymentsToAcquireAvailableForSaleSecurities" xlink:type="locator" />
    <link:calculationArc xlink:from="loc_NetCashProvidedByUsedInInvestingActivitiesContinuingOperations.13117.14.6" xlink:to="loc_PaymentsToAcquireAvailableForSaleSecurities.14179.14.6" order="6.00000" weight="-1.00" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:type="arc" />
  </link:calculationLink>
  <link:calculationLink xlink:title="005 - Statement - CONSOLIDATED STATEMENTS OF COMPREHENSIVE LOSS" xlink:role="http://www.pluristem.com/role/ConsolidatedStatementsOfComprehensiveLoss" xlink:type="extended">
    <link:loc xlink:label="loc_ComprehensiveIncomeNetOfTax.7101.14.6" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ComprehensiveIncomeNetOfTax" xlink:type="locator" />
    <link:loc xlink:label="loc_NetIncomeLoss.13072.14.6" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_NetIncomeLoss" xlink:type="locator" />
    <link:calculationArc xlink:from="loc_ComprehensiveIncomeNetOfTax.7101.14.6" xlink:to="loc_NetIncomeLoss.13072.14.6" order="4.00000" weight="1.00" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:type="arc" />
    <link:loc xlink:label="loc_OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodNetOfTax.13806.14.6" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodNetOfTax" xlink:type="locator" />
    <link:calculationArc xlink:from="loc_ComprehensiveIncomeNetOfTax.7101.14.6" xlink:to="loc_OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodNetOfTax.13806.14.6" order="1.00000" weight="1.00" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:type="arc" />
    <link:loc xlink:label="loc_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax.13804.14.6" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax" xlink:type="locator" />
    <link:calculationArc xlink:from="loc_ComprehensiveIncomeNetOfTax.7101.14.6" xlink:to="loc_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax.13804.14.6" order="2.00000" weight="1.00" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:type="arc" />
    <link:loc xlink:label="loc_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax.13575.14.6" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax" xlink:type="locator" />
    <link:calculationArc xlink:from="loc_ComprehensiveIncomeNetOfTax.7101.14.6" xlink:to="loc_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax.13575.14.6" order="3.00000" weight="-1.00" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:type="arc" />
  </link:calculationLink>
  <link:calculationLink xlink:title="004 - Statement - CONSOLIDATED STATEMENTS OF OPERATIONS" xlink:role="http://www.pluristem.com/role/ConsolidatedStatementsOfOperations" xlink:type="extended">
    <link:loc xlink:label="loc_GrossProfit.10657.14.6" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_GrossProfit" xlink:type="locator" />
    <link:loc xlink:label="loc_Revenues.15934.14.6" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_Revenues" xlink:type="locator" />
    <link:calculationArc xlink:from="loc_GrossProfit.10657.14.6" xlink:to="loc_Revenues.15934.14.6" order="1.00000" weight="1.00" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:type="arc" />
    <link:loc xlink:label="loc_CostOfRevenue.7342.14.6" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_CostOfRevenue" xlink:type="locator" />
    <link:calculationArc xlink:from="loc_GrossProfit.10657.14.6" xlink:to="loc_CostOfRevenue.7342.14.6" order="2.00000" weight="-1.00" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:type="arc" />
    <link:loc xlink:label="loc_NetIncomeLoss.13072.14.6" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_NetIncomeLoss" xlink:type="locator" />
    <link:loc xlink:label="loc_OperatingIncomeLoss.13445.14.6" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_OperatingIncomeLoss" xlink:type="locator" />
    <link:calculationArc xlink:from="loc_NetIncomeLoss.13072.14.6" xlink:to="loc_OperatingIncomeLoss.13445.14.6" order="1.00000" weight="1.00" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:type="arc" />
    <link:loc xlink:label="loc_NonoperatingIncomeExpense.13243.14.6" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_NonoperatingIncomeExpense" xlink:type="locator" />
    <link:calculationArc xlink:from="loc_NetIncomeLoss.13072.14.6" xlink:to="loc_NonoperatingIncomeExpense.13243.14.6" order="2.00000" weight="1.00" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:type="arc" />
    <link:calculationArc xlink:from="loc_OperatingIncomeLoss.13445.14.6" xlink:to="loc_GrossProfit.10657.14.6" order="1.00000" weight="1.00" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:type="arc" />
    <link:loc xlink:label="loc_ResearchAndDevelopmentExpensesNet.25542.14.6" xlink:href="psti-20140630.xsd#psti_ResearchAndDevelopmentExpensesNet" xlink:type="locator" />
    <link:calculationArc xlink:from="loc_OperatingIncomeLoss.13445.14.6" xlink:to="loc_ResearchAndDevelopmentExpensesNet.25542.14.6" order="2.00000" weight="-1.00" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:type="arc" />
    <link:loc xlink:label="loc_GeneralAndAdministrativeExpense.10581.14.6" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_GeneralAndAdministrativeExpense" xlink:type="locator" />
    <link:calculationArc xlink:from="loc_OperatingIncomeLoss.13445.14.6" xlink:to="loc_GeneralAndAdministrativeExpense.10581.14.6" order="3.00000" weight="-1.00" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:type="arc" />
    <link:loc xlink:label="loc_ResearchAndDevelopmentExpense.15670.14.6" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ResearchAndDevelopmentExpense" xlink:type="locator" />
    <link:calculationArc xlink:from="loc_ResearchAndDevelopmentExpensesNet.25542.14.6" xlink:to="loc_ResearchAndDevelopmentExpense.15670.14.6" order="1.00000" weight="1.00" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:type="arc" />
    <link:loc xlink:label="loc_GovernmentAndThirdPartyGrantsReceived.25539.14.6" xlink:href="psti-20140630.xsd#psti_GovernmentAndThirdPartyGrantsReceived" xlink:type="locator" />
    <link:calculationArc xlink:from="loc_ResearchAndDevelopmentExpensesNet.25542.14.6" xlink:to="loc_GovernmentAndThirdPartyGrantsReceived.25539.14.6" order="2.00000" weight="-1.00" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:type="arc" />
  </link:calculationLink>
  <link:calculationLink xlink:title="40401 - Disclosure - FAIR VALUE OF FINANCIAL INSTRUMENTS (Schedule of Fair Value of Financial Instruments) (Details)" xlink:role="http://www.pluristem.com/role/FairValueOfFinancialInstrumentsScheduleOfFairValueOfFinancialInstrumentsDetails" xlink:type="extended">
    <link:loc xlink:label="loc_FairValueNetAssetLiability.9433.14.6" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_FairValueNetAssetLiability" xlink:type="locator" />
    <link:loc xlink:label="loc_MarketableSecuritiesCurrent.12849.14.6" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_MarketableSecuritiesCurrent" xlink:type="locator" />
    <link:calculationArc xlink:from="loc_FairValueNetAssetLiability.9433.14.6" xlink:to="loc_MarketableSecuritiesCurrent.12849.14.6" order="1.00000" weight="1.00" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:type="arc" />
    <link:loc xlink:label="loc_DerivativeAssetsLiabilitiesAtFairValueNet.8291.14.6" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_DerivativeAssetsLiabilitiesAtFairValueNet" xlink:type="locator" />
    <link:calculationArc xlink:from="loc_FairValueNetAssetLiability.9433.14.6" xlink:to="loc_DerivativeAssetsLiabilitiesAtFairValueNet.8291.14.6" order="2.00000" weight="1.00" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:type="arc" />
  </link:calculationLink>
  <link:calculationLink xlink:title="40301 - Disclosure - MARKETABLE SECURITIES (Schedule of Available-for-sale Marketable Securities) (Details)" xlink:role="http://www.pluristem.com/role/MarketableSecuritiesScheduleOfAvailableforsaleMarketableSecuritiesDetails" xlink:type="extended">
    <link:loc xlink:label="loc_AvailableForSaleSecuritiesAmortizedCost.6142.14.6" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_AvailableForSaleSecuritiesAmortizedCost" xlink:type="locator" />
    <link:loc xlink:label="loc_AvailableForSaleSecurities.6116.14.6" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_AvailableForSaleSecurities" xlink:type="locator" />
    <link:calculationArc xlink:from="loc_AvailableForSaleSecuritiesAmortizedCost.6142.14.6" xlink:to="loc_AvailableForSaleSecurities.6116.14.6" order="1.00000" weight="1.00" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:type="arc" />
    <link:loc xlink:label="loc_AvailableForSaleEquitySecuritiesAccumulatedGrossUnrealizedGainBeforeTax.6136.14.6" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_AvailableForSaleEquitySecuritiesAccumulatedGrossUnrealizedGainBeforeTax" xlink:type="locator" />
    <link:calculationArc xlink:from="loc_AvailableForSaleSecuritiesAmortizedCost.6142.14.6" xlink:to="loc_AvailableForSaleEquitySecuritiesAccumulatedGrossUnrealizedGainBeforeTax.6136.14.6" order="2.00000" weight="-1.00" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:type="arc" />
    <link:loc xlink:label="loc_AvailableForSaleEquitySecuritiesAccumulatedGrossUnrealizedLossBeforeTax.6100.14.6" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_AvailableForSaleEquitySecuritiesAccumulatedGrossUnrealizedLossBeforeTax" xlink:type="locator" />
    <link:calculationArc xlink:from="loc_AvailableForSaleSecuritiesAmortizedCost.6142.14.6" xlink:to="loc_AvailableForSaleEquitySecuritiesAccumulatedGrossUnrealizedLossBeforeTax.6100.14.6" order="3.00000" weight="1.00" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:type="arc" />
  </link:calculationLink>
  <link:calculationLink xlink:title="40501 - Disclosure - PROPERTY AND EQUIPMENT, NET (Details)" xlink:role="http://www.pluristem.com/role/PropertyAndEquipmentNetDetails" xlink:type="extended">
    <link:loc xlink:label="loc_PropertyPlantAndEquipmentNet.15032.14.6" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet" xlink:type="locator" />
    <link:loc xlink:label="loc_PropertyPlantAndEquipmentGross.15025.14.6" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_PropertyPlantAndEquipmentGross" xlink:type="locator" />
    <link:calculationArc xlink:from="loc_PropertyPlantAndEquipmentNet.15032.14.6" xlink:to="loc_PropertyPlantAndEquipmentGross.15025.14.6" order="1.00000" weight="1.00" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:type="arc" />
    <link:loc xlink:label="loc_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment.5714.14.6" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:type="locator" />
    <link:calculationArc xlink:from="loc_PropertyPlantAndEquipmentNet.15032.14.6" xlink:to="loc_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment.5714.14.6" order="2.00000" weight="-1.00" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:type="arc" />
  </link:calculationLink>
  <link:calculationLink xlink:title="40601 - Disclosure - OTHER ACCOUNTS PAYABLE (Details)" xlink:role="http://www.pluristem.com/role/OtherAccountsPayableDetails" xlink:type="extended">
    <link:loc xlink:label="loc_AccountsPayableOtherCurrent.5626.14.6" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_AccountsPayableOtherCurrent" xlink:type="locator" />
    <link:loc xlink:label="loc_EmployeeRelatedLiabilitiesCurrent.9111.14.6" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_EmployeeRelatedLiabilitiesCurrent" xlink:type="locator" />
    <link:calculationArc xlink:from="loc_AccountsPayableOtherCurrent.5626.14.6" xlink:to="loc_EmployeeRelatedLiabilitiesCurrent.9111.14.6" order="1.00000" weight="1.00" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:type="arc" />
    <link:loc xlink:label="loc_OtherAccountsPayablePayrollInstitutions.25582.14.6" xlink:href="psti-20140630.xsd#psti_OtherAccountsPayablePayrollInstitutions" xlink:type="locator" />
    <link:calculationArc xlink:from="loc_AccountsPayableOtherCurrent.5626.14.6" xlink:to="loc_OtherAccountsPayablePayrollInstitutions.25582.14.6" order="5.00000" weight="1.00" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:type="arc" />
    <link:loc xlink:label="loc_AccruedVacationCurrent.5671.14.6" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_AccruedVacationCurrent" xlink:type="locator" />
    <link:calculationArc xlink:from="loc_AccountsPayableOtherCurrent.5626.14.6" xlink:to="loc_AccruedVacationCurrent.5671.14.6" order="6.00000" weight="1.00" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:type="arc" />
    <link:loc xlink:label="loc_DerivativeLiabilitiesCurrent.8339.14.6" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_DerivativeLiabilitiesCurrent" xlink:type="locator" />
    <link:calculationArc xlink:from="loc_AccountsPayableOtherCurrent.5626.14.6" xlink:to="loc_DerivativeLiabilitiesCurrent.8339.14.6" order="3.00000" weight="1.00" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:type="arc" />
    <link:loc xlink:label="loc_DeferredRentCreditCurrent.7843.14.6" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_DeferredRentCreditCurrent" xlink:type="locator" />
    <link:calculationArc xlink:from="loc_AccountsPayableOtherCurrent.5626.14.6" xlink:to="loc_DeferredRentCreditCurrent.7843.14.6" order="4.00000" weight="1.00" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:type="arc" />
    <link:loc xlink:label="loc_OtherAccruedLiabilitiesCurrent.13951.14.6" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_OtherAccruedLiabilitiesCurrent" xlink:type="locator" />
    <link:calculationArc xlink:from="loc_AccountsPayableOtherCurrent.5626.14.6" xlink:to="loc_OtherAccruedLiabilitiesCurrent.13951.14.6" order="2.00000" weight="1.00" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:type="arc" />
  </link:calculationLink>
  <link:calculationLink xlink:title="40701 - Disclosure - COMMITMENTS AND CONTINGENCIES (Operating Lease) (Details)" xlink:role="http://www.pluristem.com/role/CommitmentsAndContingenciesOperatingLeaseDetails" xlink:type="extended">
    <link:loc xlink:label="loc_OperatingLeasesFutureMinimumPaymentsDue.13467.14.6" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_OperatingLeasesFutureMinimumPaymentsDue" xlink:type="locator" />
    <link:loc xlink:label="loc_OperatingLeasesFutureMinimumPaymentsDueInTwoYears.13442.14.6" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_OperatingLeasesFutureMinimumPaymentsDueInTwoYears" xlink:type="locator" />
    <link:calculationArc xlink:from="loc_OperatingLeasesFutureMinimumPaymentsDue.13467.14.6" xlink:to="loc_OperatingLeasesFutureMinimumPaymentsDueInTwoYears.13442.14.6" order="1.00000" weight="1.00" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:type="arc" />
    <link:loc xlink:label="loc_OperatingLeasesFutureMinimumPaymentsDueInThreeYears.13435.14.6" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_OperatingLeasesFutureMinimumPaymentsDueInThreeYears" xlink:type="locator" />
    <link:calculationArc xlink:from="loc_OperatingLeasesFutureMinimumPaymentsDue.13467.14.6" xlink:to="loc_OperatingLeasesFutureMinimumPaymentsDueInThreeYears.13435.14.6" order="4.00000" weight="1.00" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:type="arc" />
    <link:loc xlink:label="loc_OperatingLeasesFutureMinimumPaymentsDueInFourYears.13426.14.6" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_OperatingLeasesFutureMinimumPaymentsDueInFourYears" xlink:type="locator" />
    <link:calculationArc xlink:from="loc_OperatingLeasesFutureMinimumPaymentsDue.13467.14.6" xlink:to="loc_OperatingLeasesFutureMinimumPaymentsDueInFourYears.13426.14.6" order="5.00000" weight="1.00" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:type="arc" />
    <link:loc xlink:label="loc_OperatingLeasesFutureMinimumPaymentsDueCurrent.13462.14.6" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_OperatingLeasesFutureMinimumPaymentsDueCurrent" xlink:type="locator" />
    <link:calculationArc xlink:from="loc_OperatingLeasesFutureMinimumPaymentsDue.13467.14.6" xlink:to="loc_OperatingLeasesFutureMinimumPaymentsDueCurrent.13462.14.6" order="2.00000" weight="1.00" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:type="arc" />
    <link:loc xlink:label="loc_OperatingLeasesFutureMinimumPaymentsDueInFiveYears.13419.14.6" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_OperatingLeasesFutureMinimumPaymentsDueInFiveYears" xlink:type="locator" />
    <link:calculationArc xlink:from="loc_OperatingLeasesFutureMinimumPaymentsDue.13467.14.6" xlink:to="loc_OperatingLeasesFutureMinimumPaymentsDueInFiveYears.13419.14.6" order="3.00000" weight="1.00" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:type="arc" />
  </link:calculationLink>
  <link:calculationLink xlink:title="40702 - Disclosure - COMMITMENTS AND CONTINGENCIES (Commitment to Suppliers and Contractor) (Details)" xlink:role="http://www.pluristem.com/role/CommitmentsAndContingenciesCommitmentToSuppliersAndContractorDetails" xlink:type="extended">
    <link:loc xlink:label="loc_LongTermPurchaseCommitmentFutureMinimumPaymentDue.25593.14.6" xlink:href="psti-20140630.xsd#psti_LongTermPurchaseCommitmentFutureMinimumPaymentDue" xlink:type="locator" />
    <link:loc xlink:label="loc_LongTermPurchaseCommitmentFutureMinimumPaymentDueCurrent.25591.14.6" xlink:href="psti-20140630.xsd#psti_LongTermPurchaseCommitmentFutureMinimumPaymentDueCurrent" xlink:type="locator" />
    <link:calculationArc xlink:from="loc_LongTermPurchaseCommitmentFutureMinimumPaymentDue.25593.14.6" xlink:to="loc_LongTermPurchaseCommitmentFutureMinimumPaymentDueCurrent.25591.14.6" order="1.00000" weight="1.00" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:type="arc" />
    <link:loc xlink:label="loc_LongTermPurchaseCommitmentFutureMinimumPaymentDueInThreeYears.25592.14.6" xlink:href="psti-20140630.xsd#psti_LongTermPurchaseCommitmentFutureMinimumPaymentDueInThreeYears" xlink:type="locator" />
    <link:calculationArc xlink:from="loc_LongTermPurchaseCommitmentFutureMinimumPaymentDue.25593.14.6" xlink:to="loc_LongTermPurchaseCommitmentFutureMinimumPaymentDueInThreeYears.25592.14.6" order="2.00000" weight="1.00" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:type="arc" />
  </link:calculationLink>
  <link:calculationLink xlink:title="40901 - Disclosure - FINANCIAL INCOME, NET (Details)" xlink:role="http://www.pluristem.com/role/FinancialIncomeNetDetails" xlink:type="extended">
    <link:loc xlink:label="loc_NonoperatingIncomeExpense.13243.14.6" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_NonoperatingIncomeExpense" xlink:type="locator" />
    <link:loc xlink:label="loc_ForeignCurrencyTransactionGainLossBeforeTax.10306.14.6" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ForeignCurrencyTransactionGainLossBeforeTax" xlink:type="locator" />
    <link:calculationArc xlink:from="loc_NonoperatingIncomeExpense.13243.14.6" xlink:to="loc_ForeignCurrencyTransactionGainLossBeforeTax.10306.14.6" order="1.00000" weight="1.00" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:type="arc" />
    <link:loc xlink:label="loc_InterestOnShortTermBankCreditAndBankExpenses.25596.14.6" xlink:href="psti-20140630.xsd#psti_InterestOnShortTermBankCreditAndBankExpenses" xlink:type="locator" />
    <link:calculationArc xlink:from="loc_NonoperatingIncomeExpense.13243.14.6" xlink:to="loc_InterestOnShortTermBankCreditAndBankExpenses.25596.14.6" order="2.00000" weight="-1.00" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:type="arc" />
    <link:loc xlink:label="loc_InterestIncomeDepositsWithFinancialInstitutions.11592.14.6" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_InterestIncomeDepositsWithFinancialInstitutions" xlink:type="locator" />
    <link:calculationArc xlink:from="loc_NonoperatingIncomeExpense.13243.14.6" xlink:to="loc_InterestIncomeDepositsWithFinancialInstitutions.11592.14.6" order="3.00000" weight="1.00" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:type="arc" />
    <link:loc xlink:label="loc_MarketableSecuritiesGainLoss.12850.14.6" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_MarketableSecuritiesGainLoss" xlink:type="locator" />
    <link:calculationArc xlink:from="loc_NonoperatingIncomeExpense.13243.14.6" xlink:to="loc_MarketableSecuritiesGainLoss.12850.14.6" order="4.00000" weight="1.00" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:type="arc" />
    <link:loc xlink:label="loc_DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet.8305.14.6" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet" xlink:type="locator" />
    <link:calculationArc xlink:from="loc_NonoperatingIncomeExpense.13243.14.6" xlink:to="loc_DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet.8305.14.6" order="5.00000" weight="1.00" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:type="arc" />
  </link:calculationLink>
  <link:calculationLink xlink:title="41003 - Disclosure - TAXES ON INCOME (Schedule of Significant Components of Deferred Tax Assets) (Details)" xlink:role="http://www.pluristem.com/role/TaxesOnIncomeScheduleOfSignificantComponentsOfDeferredTaxAssetsDetails" xlink:type="extended">
    <link:loc xlink:label="loc_DeferredTaxAssetsGross.7847.14.6" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_DeferredTaxAssetsGross" xlink:type="locator" />
    <link:loc xlink:label="loc_DeferredTaxAssetsOperatingLossCarryforwardsDomestic.7855.14.6" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsDomestic" xlink:type="locator" />
    <link:calculationArc xlink:from="loc_DeferredTaxAssetsGross.7847.14.6" xlink:to="loc_DeferredTaxAssetsOperatingLossCarryforwardsDomestic.7855.14.6" order="1.00000" weight="1.00" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:type="arc" />
    <link:loc xlink:label="loc_DeferredTaxAssetsOperatingLossCarryforwardsForeign.7872.14.6" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsForeign" xlink:type="locator" />
    <link:calculationArc xlink:from="loc_DeferredTaxAssetsGross.7847.14.6" xlink:to="loc_DeferredTaxAssetsOperatingLossCarryforwardsForeign.7872.14.6" order="2.00000" weight="1.00" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:type="arc" />
    <link:loc xlink:label="loc_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals.7863.14.6" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals" xlink:type="locator" />
    <link:calculationArc xlink:from="loc_DeferredTaxAssetsGross.7847.14.6" xlink:to="loc_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals.7863.14.6" order="3.00000" weight="1.00" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:type="arc" />
    <link:loc xlink:label="loc_DeferredTaxAssetsNet.7866.14.6" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_DeferredTaxAssetsNet" xlink:type="locator" />
    <link:calculationArc xlink:from="loc_DeferredTaxAssetsNet.7866.14.6" xlink:to="loc_DeferredTaxAssetsGross.7847.14.6" order="1.00000" weight="1.00" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:type="arc" />
    <link:loc xlink:label="loc_DeferredTaxAssetsValuationAllowance.7902.14.6" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_DeferredTaxAssetsValuationAllowance" xlink:type="locator" />
    <link:calculationArc xlink:from="loc_DeferredTaxAssetsNet.7866.14.6" xlink:to="loc_DeferredTaxAssetsValuationAllowance.7902.14.6" order="2.00000" weight="-1.00" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:type="arc" />
  </link:calculationLink>
  <link:calculationLink xlink:title="40203 - Disclosure - SIGNIFICANT ACCOUNTING POLICIES (Comprehensive Income) (Details)" xlink:role="http://www.pluristem.com/role/SignificantAccountingPoliciesComprehensiveIncomeDetails" xlink:type="extended">
    <link:loc xlink:label="loc_OtherComprehensiveIncomeLossNetOfTax.13526.14.6" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTax" xlink:type="locator" />
    <link:loc xlink:label="loc_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax.13608.14.6" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" xlink:type="locator" />
    <link:calculationArc xlink:from="loc_OtherComprehensiveIncomeLossNetOfTax.13526.14.6" xlink:to="loc_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax.13608.14.6" order="1.00000" weight="1.00" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:type="arc" />
    <link:loc xlink:label="loc_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax.15390.14.6" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" xlink:type="locator" />
    <link:calculationArc xlink:from="loc_OtherComprehensiveIncomeLossNetOfTax.13526.14.6" xlink:to="loc_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax.15390.14.6" order="2.00000" weight="-1.00" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:type="arc" />
  </link:calculationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.DEF
<SEQUENCE>27
<FILENAME>psti-20140630_def.xml
<DESCRIPTION>TAXONOMY EXTENSION DEFINITION LINKBASE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" standalone="no"?>
<!--Created by Z-K Global Ltd. ("ZKG")-->
<!--produced on 2014-09-10 @ 8:21 AM-->
<link:linkbase xmlns:psti="http://www.pluristem.com/20140630" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" xmlns:link="http://www.xbrl.org/2003/linkbase">
  <link:roleRef roleURI="http://www.pluristem.com/role/SignificantAccountingPolicies" xlink:href="psti-20140630.xsd#psti-sap1" xlink:type="simple" />
  <link:roleRef roleURI="http://www.pluristem.com/role/CommitmentsAndContingencies" xlink:href="psti-20140630.xsd#psti-cac1" xlink:type="simple" />
  <link:roleRef roleURI="http://www.pluristem.com/role/CommitmentsAndContingenciesOtherDetails" xlink:href="psti-20140630.xsd#psti-cacod" xlink:type="simple" />
  <link:roleRef roleURI="http://www.pluristem.com/role/ConsolidatedBalanceSheets" xlink:href="psti-20140630.xsd#psti-cbs1" xlink:type="simple" />
  <link:roleRef roleURI="http://www.pluristem.com/role/ConsolidatedBalanceSheetsParenthetical" xlink:href="psti-20140630.xsd#psti-cbsp1" xlink:type="simple" />
  <link:roleRef roleURI="http://www.pluristem.com/role/ConsolidatedStatementsOfCashFlows" xlink:href="psti-20140630.xsd#psti-csocf1" xlink:type="simple" />
  <link:roleRef roleURI="http://www.pluristem.com/role/ConsolidatedStatementsOfComprehensiveLoss" xlink:href="psti-20140630.xsd#psti-csocl1" xlink:type="simple" />
  <link:roleRef roleURI="http://www.pluristem.com/role/ConsolidatedStatementsOfOperations" xlink:href="psti-20140630.xsd#psti-csoo1" xlink:type="simple" />
  <link:roleRef roleURI="http://www.pluristem.com/role/StatementsOfChangesInEquity" xlink:href="psti-20140630.xsd#psti-socie1" xlink:type="simple" />
  <link:roleRef roleURI="http://www.pluristem.com/role/StatementsOfChangesInEquityParenthetical" xlink:href="psti-20140630.xsd#psti-sociep1" xlink:type="simple" />
  <link:roleRef roleURI="http://www.pluristem.com/role/FairValueOfFinancialInstruments" xlink:href="psti-20140630.xsd#psti-fvofi12" xlink:type="simple" />
  <link:roleRef roleURI="http://www.pluristem.com/role/FairValueOfFinancialInstrumentsScheduleOfFairValueOfFinancialInstrumentsDetails" xlink:href="psti-20140630.xsd#psti-fvofisofvofid1" xlink:type="simple" />
  <link:roleRef roleURI="http://www.pluristem.com/role/FairValueOfFinancialInstrumentsScheduleOfFairValueOfHedgingInstrumentsDetails" xlink:href="psti-20140630.xsd#psti-fvofisofvohid" xlink:type="simple" />
  <link:roleRef roleURI="http://www.pluristem.com/role/FairValueOfFinancialInstrumentsTables" xlink:href="psti-20140630.xsd#psti-fvofit1" xlink:type="simple" />
  <link:roleRef roleURI="http://www.pluristem.com/role/General" xlink:href="psti-20140630.xsd#psti-g1" xlink:type="simple" />
  <link:roleRef roleURI="http://www.pluristem.com/role/GeneralDetails" xlink:href="psti-20140630.xsd#psti-gd" xlink:type="simple" />
  <link:roleRef roleURI="http://www.pluristem.com/role/MarketableSecurities" xlink:href="psti-20140630.xsd#psti-ms" xlink:type="simple" />
  <link:roleRef roleURI="http://www.pluristem.com/role/MarketableSecuritiesScheduleOfAvailableforsaleMarketableSecuritiesDetails" xlink:href="psti-20140630.xsd#psti-mssoamsd1" xlink:type="simple" />
  <link:roleRef roleURI="http://www.pluristem.com/role/MarketableSecuritiesScheduleOfInvestmentsInUnrealizedLossDetails" xlink:href="psti-20140630.xsd#psti-mssoiiuld" xlink:type="simple" />
  <link:roleRef roleURI="http://www.pluristem.com/role/MarketableSecuritiesTables" xlink:href="psti-20140630.xsd#psti-mst1" xlink:type="simple" />
  <link:roleRef roleURI="http://www.pluristem.com/role/SubsequentEvents" xlink:href="psti-20140630.xsd#psti-se123" xlink:type="simple" />
  <link:roleRef roleURI="http://www.pluristem.com/role/StockholdersEquity" xlink:href="psti-20140630.xsd#psti-se12" xlink:type="simple" />
  <link:roleRef roleURI="http://www.pluristem.com/role/SubsequentEventsDetails" xlink:href="psti-20140630.xsd#psti-sed1" xlink:type="simple" />
  <link:roleRef roleURI="http://www.pluristem.com/role/StockholdersEquityNarrativeDetails" xlink:href="psti-20140630.xsd#psti-send1" xlink:type="simple" />
  <link:roleRef roleURI="http://www.pluristem.com/role/StockholdersEquityScheduleOfCompensationExpenseDetails" xlink:href="psti-20140630.xsd#psti-sesoced1" xlink:type="simple" />
  <link:roleRef roleURI="http://www.pluristem.com/role/StockholdersEquitySummaryOfOptionActivityDetails" xlink:href="psti-20140630.xsd#psti-sesooad1" xlink:type="simple" />
  <link:roleRef roleURI="http://www.pluristem.com/role/StockholdersEquitySummaryOfOptionAndWarrantActivityToNonemployeesDetails" xlink:href="psti-20140630.xsd#psti-sesooawatnd1" xlink:type="simple" />
  <link:roleRef roleURI="http://www.pluristem.com/role/StockholdersEquitySummaryOfRsuActivityToConsultantsDetails" xlink:href="psti-20140630.xsd#psti-sesoratcd1" xlink:type="simple" />
  <link:roleRef roleURI="http://www.pluristem.com/role/StockholdersEquitySummaryOfRsuActivityToEmployeesAndDirectorsDetails" xlink:href="psti-20140630.xsd#psti-sesorateadd1" xlink:type="simple" />
  <link:roleRef roleURI="http://www.pluristem.com/role/StockholdersEquityTables" xlink:href="psti-20140630.xsd#psti-set1" xlink:type="simple" />
  <link:roleRef roleURI="http://www.pluristem.com/role/PropertyAndEquipmentNet" xlink:href="psti-20140630.xsd#psti-paen1" xlink:type="simple" />
  <link:roleRef roleURI="http://www.pluristem.com/role/PropertyAndEquipmentNetTables" xlink:href="psti-20140630.xsd#psti-paent1" xlink:type="simple" />
  <link:roleRef roleURI="http://www.pluristem.com/role/PropertyAndEquipmentNetDetails" xlink:href="psti-20140630.xsd#psti-paend1" xlink:type="simple" />
  <link:roleRef roleURI="http://www.pluristem.com/role/OtherAccountsPayable" xlink:href="psti-20140630.xsd#psti-oap1" xlink:type="simple" />
  <link:roleRef roleURI="http://www.pluristem.com/role/FinancialIncomeNet" xlink:href="psti-20140630.xsd#psti-fin" xlink:type="simple" />
  <link:roleRef roleURI="http://www.pluristem.com/role/TaxesOnIncome" xlink:href="psti-20140630.xsd#psti-toi1" xlink:type="simple" />
  <link:roleRef roleURI="http://www.pluristem.com/role/CommitmentsAndContingenciesTables" xlink:href="psti-20140630.xsd#psti-cact1" xlink:type="simple" />
  <link:roleRef roleURI="http://www.pluristem.com/role/FinancialIncomeNetTables" xlink:href="psti-20140630.xsd#psti-fint" xlink:type="simple" />
  <link:roleRef roleURI="http://www.pluristem.com/role/TaxesOnIncomeTables" xlink:href="psti-20140630.xsd#psti-toit1" xlink:type="simple" />
  <link:roleRef roleURI="http://www.pluristem.com/role/OtherAccountsPayableTables" xlink:href="psti-20140630.xsd#psti-oapt1" xlink:type="simple" />
  <link:roleRef roleURI="http://www.pluristem.com/role/OtherAccountsPayableDetails" xlink:href="psti-20140630.xsd#psti-oapd1" xlink:type="simple" />
  <link:roleRef roleURI="http://www.pluristem.com/role/CommitmentsAndContingenciesOperatingLeaseDetails" xlink:href="psti-20140630.xsd#psti-cacold1" xlink:type="simple" />
  <link:roleRef roleURI="http://www.pluristem.com/role/CommitmentsAndContingenciesCommitmentToSuppliersAndContractorDetails" xlink:href="psti-20140630.xsd#psti-cacctsacd1" xlink:type="simple" />
  <link:roleRef roleURI="http://www.pluristem.com/role/FinancialIncomeNetDetails" xlink:href="psti-20140630.xsd#psti-find" xlink:type="simple" />
  <link:roleRef roleURI="http://www.pluristem.com/role/TaxesOnIncomeNarrativeDetails" xlink:href="psti-20140630.xsd#psti-toind1" xlink:type="simple" />
  <link:roleRef roleURI="http://www.pluristem.com/role/TaxesOnIncomeQualifyingPercentagesOfValueOfProductiveAssetsDetails" xlink:href="psti-20140630.xsd#psti-toiqpovopad1" xlink:type="simple" />
  <link:roleRef roleURI="http://www.pluristem.com/role/TaxesOnIncomeScheduleOfSignificantComponentsOfDeferredTaxAssetsDetails" xlink:href="psti-20140630.xsd#psti-toisoscodtad1" xlink:type="simple" />
  <link:roleRef roleURI="http://www.pluristem.com/role/SignificantAccountingPoliciesPolicies" xlink:href="psti-20140630.xsd#psti-sapp1" xlink:type="simple" />
  <link:roleRef roleURI="http://www.pluristem.com/role/SignificantAccountingPoliciesTables" xlink:href="psti-20140630.xsd#psti-sapt1" xlink:type="simple" />
  <link:roleRef roleURI="http://www.pluristem.com/role/DocumentAndEntityInformation" xlink:href="psti-20140630.xsd#psti-daei1" xlink:type="simple" />
  <link:roleRef roleURI="http://www.pluristem.com/role/SignificantAccountingPoliciesNarrativeDetails" xlink:href="psti-20140630.xsd#psti-sapnd1" xlink:type="simple" />
  <link:roleRef roleURI="http://www.pluristem.com/role/SignificantAccountingPoliciesScheduleOfPropertyAndEquipmentDepreciationRateDetails" xlink:href="psti-20140630.xsd#psti-sapsopaedrd1" xlink:type="simple" />
  <link:roleRef roleURI="http://www.pluristem.com/role/StockholdersEquitySummaryOfWarrantsAndOptionsDetails" xlink:href="psti-20140630.xsd#psti-sesowaod" xlink:type="simple" />
  <link:roleRef roleURI="http://www.pluristem.com/role/SignificantAccountingPoliciesComprehensiveIncomeDetails" xlink:href="psti-20140630.xsd#psti-sapcid" xlink:type="simple" />
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/all" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#all" xlink:type="simple" />
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/notAll" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#notAll" xlink:type="simple" />
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#hypercube-dimension" xlink:type="simple" />
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-domain" xlink:type="simple" />
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/domain-member" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#domain-member" xlink:type="simple" />
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-default" xlink:type="simple" />
  <link:definitionLink xlink:title="40703 - Disclosure - COMMITMENTS AND CONTINGENCIES (Other) (Details)" xlink:role="http://www.pluristem.com/role/CommitmentsAndContingenciesOtherDetails" xlink:type="extended">
    <link:loc xlink:label="loc_OtherCommitmentsTable.3714.5.6" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_OtherCommitmentsTable" xlink:type="locator" />
    <link:loc xlink:label="loc_RangeAxis.4349.5.6" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_RangeAxis" xlink:type="locator" />
    <link:definitionArc xlink:from="loc_OtherCommitmentsTable.3714.5.6" xlink:to="loc_RangeAxis.4349.5.6" order="1.00000" priority="0" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:type="arc" />
    <link:loc xlink:label="loc_OtherCommitmentsLineItems.3716.7.6" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_OtherCommitmentsLineItems" xlink:type="locator" />
    <link:loc xlink:label="loc_IncreaseDecreaseInSecurityDeposits.11316.7.6" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_IncreaseDecreaseInSecurityDeposits" xlink:type="locator" />
    <link:definitionArc xlink:from="loc_OtherCommitmentsLineItems.3716.7.6" xlink:to="loc_IncreaseDecreaseInSecurityDeposits.11316.7.6" order="1.00000" priority="0" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:type="arc" />
    <link:loc xlink:label="loc_RoyaltyRatePayableOnGrantsReceived.25545.7.6" xlink:href="psti-20140630.xsd#psti_RoyaltyRatePayableOnGrantsReceived" xlink:type="locator" />
    <link:definitionArc xlink:from="loc_OtherCommitmentsLineItems.3716.7.6" xlink:to="loc_RoyaltyRatePayableOnGrantsReceived.25545.7.6" order="4.00000" priority="0" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:type="arc" />
    <link:loc xlink:label="loc_RoyaltyRateSales.25546.7.6" xlink:href="psti-20140630.xsd#psti_RoyaltyRateSales" xlink:type="locator" />
    <link:definitionArc xlink:from="loc_OtherCommitmentsLineItems.3716.7.6" xlink:to="loc_RoyaltyRateSales.25546.7.6" order="3.00000" priority="0" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:type="arc" />
    <link:loc xlink:label="loc_RoyaltyGuaranteesCommitmentsAmount.15952.7.6" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_RoyaltyGuaranteesCommitmentsAmount" xlink:type="locator" />
    <link:definitionArc xlink:from="loc_OtherCommitmentsLineItems.3716.7.6" xlink:to="loc_RoyaltyGuaranteesCommitmentsAmount.15952.7.6" order="6.00000" priority="0" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:type="arc" />
    <link:loc xlink:label="loc_OtherCommitmentsLineItems.3716.9.6" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_OtherCommitmentsLineItems" xlink:type="locator" />
    <link:loc xlink:label="loc_OtherCommitmentsTable.3714.9.6" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_OtherCommitmentsTable" xlink:type="locator" />
    <link:definitionArc xlink:from="loc_OtherCommitmentsLineItems.3716.9.6" xlink:to="loc_OtherCommitmentsTable.3714.9.6" order="7.00000" xbrldt:closed="true" xbrldt:contextElement="segment" priority="0" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:type="arc" />
    <link:loc xlink:label="loc_RoyaltiesAmountPaidAndAccrued.25544.7.6" xlink:href="psti-20140630.xsd#psti_RoyaltiesAmountPaidAndAccrued" xlink:type="locator" />
    <link:definitionArc xlink:from="loc_OtherCommitmentsLineItems.3716.7.6" xlink:to="loc_RoyaltiesAmountPaidAndAccrued.25544.7.6" order="5.00000" priority="0" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:type="arc" />
    <link:loc xlink:label="loc_AggregateGrantsReceived.25524.7.6" xlink:href="psti-20140630.xsd#psti_AggregateGrantsReceived" xlink:type="locator" />
    <link:definitionArc xlink:from="loc_OtherCommitmentsLineItems.3716.7.6" xlink:to="loc_AggregateGrantsReceived.25524.7.6" order="2.50000" priority="0" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:type="arc" />
    <link:loc xlink:label="loc_PercentageOfQualifiedExpenditures.25580.7.6" xlink:href="psti-20140630.xsd#psti_PercentageOfQualifiedExpenditures" xlink:type="locator" />
    <link:definitionArc xlink:from="loc_OtherCommitmentsLineItems.3716.7.6" xlink:to="loc_PercentageOfQualifiedExpenditures.25580.7.6" order="2.75000" priority="0" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:type="arc" />
    <link:loc xlink:label="loc_RangeAxis.4349.6.6" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_RangeAxis" xlink:type="locator" />
    <link:loc xlink:label="loc_RangeMember.4350.6.6" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_RangeMember" xlink:type="locator" />
    <link:definitionArc xlink:from="loc_RangeAxis.4349.6.6" xlink:to="loc_RangeMember.4350.6.6" order="1.00000" priority="0" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:type="arc" />
    <link:loc xlink:label="loc_RangeAxis.4349.8.6" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_RangeAxis" xlink:type="locator" />
    <link:loc xlink:label="loc_RangeMember.4350.8.6" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_RangeMember" xlink:type="locator" />
    <link:definitionArc xlink:from="loc_RangeAxis.4349.8.6" xlink:to="loc_RangeMember.4350.8.6" order="2.00000" priority="0" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:type="arc" />
    <link:loc xlink:label="loc_RangeMember.4350.7.6" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_RangeMember" xlink:type="locator" />
    <link:loc xlink:label="loc_MinimumMember.3370.7.6" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_MinimumMember" xlink:type="locator" />
    <link:definitionArc xlink:from="loc_RangeMember.4350.7.6" xlink:to="loc_MinimumMember.3370.7.6" order="1.00000" priority="0" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:type="arc" />
    <link:loc xlink:label="loc_MaximumMember.3361.7.6" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_MaximumMember" xlink:type="locator" />
    <link:definitionArc xlink:from="loc_RangeMember.4350.7.6" xlink:to="loc_MaximumMember.3361.7.6" order="2.00000" priority="0" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:type="arc" />
  </link:definitionLink>
  <link:definitionLink xlink:title="006 - Statement - STATEMENTS OF CHANGES IN EQUITY" xlink:role="http://www.pluristem.com/role/StatementsOfChangesInEquity" xlink:type="extended">
    <link:loc xlink:label="loc_EquityComponentDomain.1898.7.6" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_EquityComponentDomain" xlink:type="locator" />
    <link:loc xlink:label="loc_CommonStockMember.1115.7.6" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_CommonStockMember" xlink:type="locator" />
    <link:definitionArc xlink:from="loc_EquityComponentDomain.1898.7.6" xlink:to="loc_CommonStockMember.1115.7.6" order="1.00000" priority="0" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:type="arc" />
    <link:loc xlink:label="loc_AdditionalPaidInCapitalMember.499.7.6" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_AdditionalPaidInCapitalMember" xlink:type="locator" />
    <link:definitionArc xlink:from="loc_EquityComponentDomain.1898.7.6" xlink:to="loc_AdditionalPaidInCapitalMember.499.7.6" order="2.00000" priority="0" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:type="arc" />
    <link:loc xlink:label="loc_AccumulatedOtherComprehensiveIncomeMember.478.7.6" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:type="locator" />
    <link:definitionArc xlink:from="loc_EquityComponentDomain.1898.7.6" xlink:to="loc_AccumulatedOtherComprehensiveIncomeMember.478.7.6" order="3.00000" priority="0" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:type="arc" />
    <link:loc xlink:label="loc_RetainedEarningsMember.4619.7.6" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_RetainedEarningsMember" xlink:type="locator" />
    <link:definitionArc xlink:from="loc_EquityComponentDomain.1898.7.6" xlink:to="loc_RetainedEarningsMember.4619.7.6" order="4.00000" priority="0" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:type="arc" />
    <link:loc xlink:label="loc_StatementTable.5107.5.6" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_StatementTable" xlink:type="locator" />
    <link:loc xlink:label="loc_StatementEquityComponentsAxis.5114.5.6" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_StatementEquityComponentsAxis" xlink:type="locator" />
    <link:definitionArc xlink:from="loc_StatementTable.5107.5.6" xlink:to="loc_StatementEquityComponentsAxis.5114.5.6" order="1.00000" priority="0" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:type="arc" />
    <link:loc xlink:label="loc_StatementLineItems.5108.9.6" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_StatementLineItems" xlink:type="locator" />
    <link:loc xlink:label="loc_StatementTable.5107.9.6" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_StatementTable" xlink:type="locator" />
    <link:definitionArc xlink:from="loc_StatementLineItems.5108.9.6" xlink:to="loc_StatementTable.5107.9.6" order="1.00000" xbrldt:closed="true" xbrldt:contextElement="segment" priority="0" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:type="arc" />
    <link:loc xlink:label="loc_StatementLineItems.5108.7.6" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_StatementLineItems" xlink:type="locator" />
    <link:loc xlink:label="loc_StockholdersEquity.17019.7.6" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_StockholdersEquity" xlink:type="locator" />
    <link:definitionArc xlink:from="loc_StatementLineItems.5108.7.6" xlink:to="loc_StockholdersEquity.17019.7.6" order="2.00000" priority="0" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:type="arc" />
    <link:loc xlink:label="loc_CommonStockSharesOutstanding.7078.7.6" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_CommonStockSharesOutstanding" xlink:type="locator" />
    <link:definitionArc xlink:from="loc_StatementLineItems.5108.7.6" xlink:to="loc_CommonStockSharesOutstanding.7078.7.6" order="3.00000" priority="0" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:type="arc" />
    <link:loc xlink:label="loc_NetIncomeLoss.13072.7.6" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_NetIncomeLoss" xlink:type="locator" />
    <link:definitionArc xlink:from="loc_StatementLineItems.5108.7.6" xlink:to="loc_NetIncomeLoss.13072.7.6" order="17.00000" priority="0" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:type="arc" />
    <link:loc xlink:label="loc_StockIssuedDuringPeriodValueNewIssues.17003.7.6" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueNewIssues" xlink:type="locator" />
    <link:definitionArc xlink:from="loc_StatementLineItems.5108.7.6" xlink:to="loc_StockIssuedDuringPeriodValueNewIssues.17003.7.6" order="7.50000" priority="0" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:type="arc" />
    <link:loc xlink:label="loc_StockIssuedDuringPeriodSharesNewIssues.16990.7.6" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:type="locator" />
    <link:definitionArc xlink:from="loc_StatementLineItems.5108.7.6" xlink:to="loc_StockIssuedDuringPeriodSharesNewIssues.16990.7.6" order="7.75000" priority="0" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:type="arc" />
    <link:loc xlink:label="loc_StockIssuedDuringPeriodValueStockWarrantsExercised.25558.7.6" xlink:href="psti-20140630.xsd#psti_StockIssuedDuringPeriodValueStockWarrantsExercised" xlink:type="locator" />
    <link:definitionArc xlink:from="loc_StatementLineItems.5108.7.6" xlink:to="loc_StockIssuedDuringPeriodValueStockWarrantsExercised.25558.7.6" order="12.50000" priority="0" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:type="arc" />
    <link:loc xlink:label="loc_StockIssuedDuringPeriodSharesStockWarrantsExercised.25556.7.6" xlink:href="psti-20140630.xsd#psti_StockIssuedDuringPeriodSharesStockWarrantsExercised" xlink:type="locator" />
    <link:definitionArc xlink:from="loc_StatementLineItems.5108.7.6" xlink:to="loc_StockIssuedDuringPeriodSharesStockWarrantsExercised.25556.7.6" order="12.60000" priority="0" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:type="arc" />
    <link:loc xlink:label="loc_StockIssuedDuringPeriodValueShareBasedCompensation.16998.7.6" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation" xlink:type="locator" />
    <link:definitionArc xlink:from="loc_StatementLineItems.5108.7.6" xlink:to="loc_StockIssuedDuringPeriodValueShareBasedCompensation.16998.7.6" order="16.12500" priority="0" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:type="arc" />
    <link:loc xlink:label="loc_StockIssuedDuringPeriodSharesShareBasedCompensation.16979.7.6" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation" xlink:type="locator" />
    <link:definitionArc xlink:from="loc_StatementLineItems.5108.7.6" xlink:to="loc_StockIssuedDuringPeriodSharesShareBasedCompensation.16979.7.6" order="16.25000" priority="0" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:type="arc" />
    <link:loc xlink:label="loc_StockIssuedDuringPeriodValuePurchaseOfAssets.17002.7.6" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_StockIssuedDuringPeriodValuePurchaseOfAssets" xlink:type="locator" />
    <link:definitionArc xlink:from="loc_StatementLineItems.5108.7.6" xlink:to="loc_StockIssuedDuringPeriodValuePurchaseOfAssets.17002.7.6" order="17.43750" priority="0" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:type="arc" />
    <link:loc xlink:label="loc_StockIssuedDuringPeriodSharesPurchaseOfAssets.16992.7.6" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesPurchaseOfAssets" xlink:type="locator" />
    <link:definitionArc xlink:from="loc_StatementLineItems.5108.7.6" xlink:to="loc_StockIssuedDuringPeriodSharesPurchaseOfAssets.16992.7.6" order="17.53125" priority="0" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:type="arc" />
    <link:loc xlink:label="loc_OtherComprehensiveIncomeLossNetOfTax.13526.7.6" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTax" xlink:type="locator" />
    <link:definitionArc xlink:from="loc_StatementLineItems.5108.7.6" xlink:to="loc_OtherComprehensiveIncomeLossNetOfTax.13526.7.6" order="18.00000" priority="0" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:type="arc" />
    <link:loc xlink:label="loc_StockIssuedDuringPeriodValueStockOptionsAndWarrantsExercised.25557.7.6" xlink:href="psti-20140630.xsd#psti_StockIssuedDuringPeriodValueStockOptionsAndWarrantsExercised" xlink:type="locator" />
    <link:definitionArc xlink:from="loc_StatementLineItems.5108.7.6" xlink:to="loc_StockIssuedDuringPeriodValueStockOptionsAndWarrantsExercised.25557.7.6" order="12.00000" priority="0" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:type="arc" />
    <link:loc xlink:label="loc_StockIssuedDuringPeriodSharesStockOptionsAndWarrantsExercised.25555.7.6" xlink:href="psti-20140630.xsd#psti_StockIssuedDuringPeriodSharesStockOptionsAndWarrantsExercised" xlink:type="locator" />
    <link:definitionArc xlink:from="loc_StatementLineItems.5108.7.6" xlink:to="loc_StockIssuedDuringPeriodSharesStockOptionsAndWarrantsExercised.25555.7.6" order="12.25000" priority="0" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:type="arc" />
    <link:loc xlink:label="loc_StockIssuedDuringPeriodValueIssuedForServices.16963.7.6" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueIssuedForServices" xlink:type="locator" />
    <link:definitionArc xlink:from="loc_StatementLineItems.5108.7.6" xlink:to="loc_StockIssuedDuringPeriodValueIssuedForServices.16963.7.6" order="17.20313" priority="0" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:type="arc" />
    <link:loc xlink:label="loc_StockIssuedDuringPeriodSharesIssuedForServices.16939.7.6" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesIssuedForServices" xlink:type="locator" />
    <link:definitionArc xlink:from="loc_StatementLineItems.5108.7.6" xlink:to="loc_StockIssuedDuringPeriodSharesIssuedForServices.16939.7.6" order="17.32031" priority="0" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:type="arc" />
    <link:loc xlink:label="loc_StatementEquityComponentsAxis.5114.6.6" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_StatementEquityComponentsAxis" xlink:type="locator" />
    <link:loc xlink:label="loc_EquityComponentDomain.1898.6.6" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_EquityComponentDomain" xlink:type="locator" />
    <link:definitionArc xlink:from="loc_StatementEquityComponentsAxis.5114.6.6" xlink:to="loc_EquityComponentDomain.1898.6.6" order="1.00000" priority="0" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:type="arc" />
    <link:loc xlink:label="loc_StatementEquityComponentsAxis.5114.8.6" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_StatementEquityComponentsAxis" xlink:type="locator" />
    <link:loc xlink:label="loc_EquityComponentDomain.1898.8.6" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_EquityComponentDomain" xlink:type="locator" />
    <link:definitionArc xlink:from="loc_StatementEquityComponentsAxis.5114.8.6" xlink:to="loc_EquityComponentDomain.1898.8.6" order="2.00000" priority="0" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:type="arc" />
  </link:definitionLink>
  <link:definitionLink xlink:title="40401 - Disclosure - FAIR VALUE OF FINANCIAL INSTRUMENTS (Schedule of Fair Value of Financial Instruments) (Details)" xlink:role="http://www.pluristem.com/role/FairValueOfFinancialInstrumentsScheduleOfFairValueOfFinancialInstrumentsDetails" xlink:type="extended">
    <link:loc xlink:label="loc_FairValueByMeasurementFrequencyAxis.2040.6.6" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_FairValueByMeasurementFrequencyAxis" xlink:type="locator" />
    <link:loc xlink:label="loc_FairValueMeasurementFrequencyDomain.2062.6.6" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_FairValueMeasurementFrequencyDomain" xlink:type="locator" />
    <link:definitionArc xlink:from="loc_FairValueByMeasurementFrequencyAxis.2040.6.6" xlink:to="loc_FairValueMeasurementFrequencyDomain.2062.6.6" order="1.00000" priority="0" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:type="arc" />
    <link:loc xlink:label="loc_FairValueByMeasurementFrequencyAxis.2040.8.6" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_FairValueByMeasurementFrequencyAxis" xlink:type="locator" />
    <link:loc xlink:label="loc_FairValueMeasurementFrequencyDomain.2062.8.6" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_FairValueMeasurementFrequencyDomain" xlink:type="locator" />
    <link:definitionArc xlink:from="loc_FairValueByMeasurementFrequencyAxis.2040.8.6" xlink:to="loc_FairValueMeasurementFrequencyDomain.2062.8.6" order="2.00000" priority="0" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:type="arc" />
    <link:loc xlink:label="loc_FairValueByFairValueHierarchyLevelAxis.2043.8.6" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:type="locator" />
    <link:loc xlink:label="loc_FairValueMeasurementsFairValueHierarchyDomain.2075.8.6" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:type="locator" />
    <link:definitionArc xlink:from="loc_FairValueByFairValueHierarchyLevelAxis.2043.8.6" xlink:to="loc_FairValueMeasurementsFairValueHierarchyDomain.2075.8.6" order="1.00000" priority="0" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:type="arc" />
    <link:loc xlink:label="loc_FairValueByFairValueHierarchyLevelAxis.2043.6.6" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:type="locator" />
    <link:loc xlink:label="loc_FairValueMeasurementsFairValueHierarchyDomain.2075.6.6" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:type="locator" />
    <link:definitionArc xlink:from="loc_FairValueByFairValueHierarchyLevelAxis.2043.6.6" xlink:to="loc_FairValueMeasurementsFairValueHierarchyDomain.2075.6.6" order="2.00000" priority="0" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:type="arc" />
    <link:loc xlink:label="loc_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable.2046.5.6" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:type="locator" />
    <link:loc xlink:label="loc_FairValueByFairValueHierarchyLevelAxis.2043.5.6" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:type="locator" />
    <link:definitionArc xlink:from="loc_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable.2046.5.6" xlink:to="loc_FairValueByFairValueHierarchyLevelAxis.2043.5.6" order="1.00000" priority="0" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:type="arc" />
    <link:loc xlink:label="loc_FairValueByMeasurementFrequencyAxis.2040.5.6" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_FairValueByMeasurementFrequencyAxis" xlink:type="locator" />
    <link:definitionArc xlink:from="loc_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable.2046.5.6" xlink:to="loc_FairValueByMeasurementFrequencyAxis.2040.5.6" order="1.50000" priority="0" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:type="arc" />
    <link:loc xlink:label="loc_FairValueMeasurementFrequencyDomain.2062.7.6" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_FairValueMeasurementFrequencyDomain" xlink:type="locator" />
    <link:loc xlink:label="loc_FairValueMeasurementsRecurringMember.2032.7.6" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_FairValueMeasurementsRecurringMember" xlink:type="locator" />
    <link:definitionArc xlink:from="loc_FairValueMeasurementFrequencyDomain.2062.7.6" xlink:to="loc_FairValueMeasurementsRecurringMember.2032.7.6" order="1.00000" priority="0" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:type="arc" />
    <link:loc xlink:label="loc_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems.2066.9.6" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:type="locator" />
    <link:loc xlink:label="loc_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable.2046.9.6" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:type="locator" />
    <link:definitionArc xlink:from="loc_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems.2066.9.6" xlink:to="loc_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable.2046.9.6" order="1.00000" xbrldt:closed="true" xbrldt:contextElement="segment" priority="0" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:type="arc" />
    <link:loc xlink:label="loc_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems.2066.7.6" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:type="locator" />
    <link:loc xlink:label="loc_MarketableSecuritiesCurrent.12849.7.6" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_MarketableSecuritiesCurrent" xlink:type="locator" />
    <link:definitionArc xlink:from="loc_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems.2066.7.6" xlink:to="loc_MarketableSecuritiesCurrent.12849.7.6" order="2.00000" priority="0" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:type="arc" />
    <link:loc xlink:label="loc_DerivativeAssetsLiabilitiesAtFairValueNet.8291.7.6" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_DerivativeAssetsLiabilitiesAtFairValueNet" xlink:type="locator" />
    <link:definitionArc xlink:from="loc_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems.2066.7.6" xlink:to="loc_DerivativeAssetsLiabilitiesAtFairValueNet.8291.7.6" order="3.00000" priority="0" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:type="arc" />
    <link:loc xlink:label="loc_FairValueNetAssetLiability.9433.7.6" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_FairValueNetAssetLiability" xlink:type="locator" />
    <link:definitionArc xlink:from="loc_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems.2066.7.6" xlink:to="loc_FairValueNetAssetLiability.9433.7.6" order="4.00000" priority="0" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:type="arc" />
    <link:loc xlink:label="loc_FairValueMeasurementsFairValueHierarchyDomain.2075.7.6" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:type="locator" />
    <link:loc xlink:label="loc_FairValueInputsLevel1Member.2136.7.6" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_FairValueInputsLevel1Member" xlink:type="locator" />
    <link:definitionArc xlink:from="loc_FairValueMeasurementsFairValueHierarchyDomain.2075.7.6" xlink:to="loc_FairValueInputsLevel1Member.2136.7.6" order="1.00000" priority="0" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:type="arc" />
    <link:loc xlink:label="loc_FairValueInputsLevel2Member.2135.7.6" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_FairValueInputsLevel2Member" xlink:type="locator" />
    <link:definitionArc xlink:from="loc_FairValueMeasurementsFairValueHierarchyDomain.2075.7.6" xlink:to="loc_FairValueInputsLevel2Member.2135.7.6" order="2.00000" priority="0" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:type="arc" />
    <link:loc xlink:label="loc_FairValueInputsLevel3Member.2137.7.6" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_FairValueInputsLevel3Member" xlink:type="locator" />
    <link:definitionArc xlink:from="loc_FairValueMeasurementsFairValueHierarchyDomain.2075.7.6" xlink:to="loc_FairValueInputsLevel3Member.2137.7.6" order="3.00000" priority="0" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:type="arc" />
  </link:definitionLink>
  <link:definitionLink xlink:title="40402 - Disclosure - FAIR VALUE OF FINANCIAL INSTRUMENTS (Schedule of the Fair Value of Hedging Instruments) (Details)" xlink:role="http://www.pluristem.com/role/FairValueOfFinancialInstrumentsScheduleOfFairValueOfHedgingInstrumentsDetails" xlink:type="extended">
    <link:loc xlink:label="loc_BalanceSheetLocationAxis.736.8.6" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_BalanceSheetLocationAxis" xlink:type="locator" />
    <link:loc xlink:label="loc_BalanceSheetLocationDomain.738.8.6" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_BalanceSheetLocationDomain" xlink:type="locator" />
    <link:definitionArc xlink:from="loc_BalanceSheetLocationAxis.736.8.6" xlink:to="loc_BalanceSheetLocationDomain.738.8.6" order="1.00000" priority="0" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:type="arc" />
    <link:loc xlink:label="loc_BalanceSheetLocationAxis.736.6.6" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_BalanceSheetLocationAxis" xlink:type="locator" />
    <link:loc xlink:label="loc_BalanceSheetLocationDomain.738.6.6" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_BalanceSheetLocationDomain" xlink:type="locator" />
    <link:definitionArc xlink:from="loc_BalanceSheetLocationAxis.736.6.6" xlink:to="loc_BalanceSheetLocationDomain.738.6.6" order="2.00000" priority="0" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:type="arc" />
    <link:loc xlink:label="loc_BalanceSheetLocationDomain.738.7.6" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_BalanceSheetLocationDomain" xlink:type="locator" />
    <link:loc xlink:label="loc_OtherCurrentAssetsMember.3743.7.6" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_OtherCurrentAssetsMember" xlink:type="locator" />
    <link:definitionArc xlink:from="loc_BalanceSheetLocationDomain.738.7.6" xlink:to="loc_OtherCurrentAssetsMember.3743.7.6" order="1.00000" priority="0" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:type="arc" />
    <link:loc xlink:label="loc_OtherCurrentLiabilitiesMember.3728.7.6" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_OtherCurrentLiabilitiesMember" xlink:type="locator" />
    <link:definitionArc xlink:from="loc_BalanceSheetLocationDomain.738.7.6" xlink:to="loc_OtherCurrentLiabilitiesMember.3728.7.6" order="2.00000" priority="0" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:type="arc" />
    <link:loc xlink:label="loc_DerivativeInstrumentsGainLossByHedgingRelationshipAxis.1619.8.6" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis" xlink:type="locator" />
    <link:loc xlink:label="loc_HedgingRelationshipDomain.2545.8.6" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_HedgingRelationshipDomain" xlink:type="locator" />
    <link:definitionArc xlink:from="loc_DerivativeInstrumentsGainLossByHedgingRelationshipAxis.1619.8.6" xlink:to="loc_HedgingRelationshipDomain.2545.8.6" order="1.00000" priority="0" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:type="arc" />
    <link:loc xlink:label="loc_DerivativeInstrumentsGainLossByHedgingRelationshipAxis.1619.6.6" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis" xlink:type="locator" />
    <link:loc xlink:label="loc_HedgingRelationshipDomain.2545.6.6" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_HedgingRelationshipDomain" xlink:type="locator" />
    <link:definitionArc xlink:from="loc_DerivativeInstrumentsGainLossByHedgingRelationshipAxis.1619.6.6" xlink:to="loc_HedgingRelationshipDomain.2545.6.6" order="2.00000" priority="0" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:type="arc" />
    <link:loc xlink:label="loc_DerivativesFairValueLineItems.1635.9.6" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_DerivativesFairValueLineItems" xlink:type="locator" />
    <link:loc xlink:label="loc_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable.2157.9.6" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable" xlink:type="locator" />
    <link:definitionArc xlink:from="loc_DerivativesFairValueLineItems.1635.9.6" xlink:to="loc_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable.2157.9.6" order="1.00000" xbrldt:closed="true" xbrldt:contextElement="segment" priority="0" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:type="arc" />
    <link:loc xlink:label="loc_DerivativesFairValueLineItems.1635.7.6" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_DerivativesFairValueLineItems" xlink:type="locator" />
    <link:loc xlink:label="loc_DerivativeAssetsLiabilitiesAtFairValueNet.8291.7.6" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_DerivativeAssetsLiabilitiesAtFairValueNet" xlink:type="locator" />
    <link:definitionArc xlink:from="loc_DerivativesFairValueLineItems.1635.7.6" xlink:to="loc_DerivativeAssetsLiabilitiesAtFairValueNet.8291.7.6" order="3.00000" priority="0" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:type="arc" />
    <link:loc xlink:label="loc_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable.2157.5.6" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable" xlink:type="locator" />
    <link:loc xlink:label="loc_HedgingDesignationAxis.2543.5.6" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_HedgingDesignationAxis" xlink:type="locator" />
    <link:definitionArc xlink:from="loc_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable.2157.5.6" xlink:to="loc_HedgingDesignationAxis.2543.5.6" order="1.00000" priority="0" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:type="arc" />
    <link:loc xlink:label="loc_BalanceSheetLocationAxis.736.5.6" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_BalanceSheetLocationAxis" xlink:type="locator" />
    <link:definitionArc xlink:from="loc_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable.2157.5.6" xlink:to="loc_BalanceSheetLocationAxis.736.5.6" order="2.00000" priority="0" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:type="arc" />
    <link:loc xlink:label="loc_DerivativeInstrumentsGainLossByHedgingRelationshipAxis.1619.5.6" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis" xlink:type="locator" />
    <link:definitionArc xlink:from="loc_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable.2157.5.6" xlink:to="loc_DerivativeInstrumentsGainLossByHedgingRelationshipAxis.1619.5.6" order="2.50000" priority="0" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:type="arc" />
    <link:loc xlink:label="loc_HedgingDesignationAxis.2543.8.6" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_HedgingDesignationAxis" xlink:type="locator" />
    <link:loc xlink:label="loc_HedgingDesignationDomain.2544.8.6" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_HedgingDesignationDomain" xlink:type="locator" />
    <link:definitionArc xlink:from="loc_HedgingDesignationAxis.2543.8.6" xlink:to="loc_HedgingDesignationDomain.2544.8.6" order="1.00000" priority="0" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:type="arc" />
    <link:loc xlink:label="loc_HedgingDesignationAxis.2543.6.6" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_HedgingDesignationAxis" xlink:type="locator" />
    <link:loc xlink:label="loc_HedgingDesignationDomain.2544.6.6" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_HedgingDesignationDomain" xlink:type="locator" />
    <link:definitionArc xlink:from="loc_HedgingDesignationAxis.2543.6.6" xlink:to="loc_HedgingDesignationDomain.2544.6.6" order="2.00000" priority="0" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:type="arc" />
    <link:loc xlink:label="loc_HedgingDesignationDomain.2544.7.6" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_HedgingDesignationDomain" xlink:type="locator" />
    <link:loc xlink:label="loc_DesignatedAsHedgingInstrumentMember.1352.7.6" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_DesignatedAsHedgingInstrumentMember" xlink:type="locator" />
    <link:definitionArc xlink:from="loc_HedgingDesignationDomain.2544.7.6" xlink:to="loc_DesignatedAsHedgingInstrumentMember.1352.7.6" order="1.00000" priority="0" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:type="arc" />
    <link:loc xlink:label="loc_NondesignatedMember.3619.7.6" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_NondesignatedMember" xlink:type="locator" />
    <link:definitionArc xlink:from="loc_HedgingDesignationDomain.2544.7.6" xlink:to="loc_NondesignatedMember.3619.7.6" order="2.00000" priority="0" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:type="arc" />
    <link:loc xlink:label="loc_HedgingRelationshipDomain.2545.7.6" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_HedgingRelationshipDomain" xlink:type="locator" />
    <link:loc xlink:label="loc_CashFlowHedgingMember.979.7.6" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_CashFlowHedgingMember" xlink:type="locator" />
    <link:definitionArc xlink:from="loc_HedgingRelationshipDomain.2545.7.6" xlink:to="loc_CashFlowHedgingMember.979.7.6" order="1.00000" priority="0" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:type="arc" />
    <link:loc xlink:label="loc_FairValueHedgingMember.2158.7.6" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_FairValueHedgingMember" xlink:type="locator" />
    <link:definitionArc xlink:from="loc_HedgingRelationshipDomain.2545.7.6" xlink:to="loc_FairValueHedgingMember.2158.7.6" order="2.00000" priority="0" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:type="arc" />
  </link:definitionLink>
  <link:definitionLink xlink:title="40301 - Disclosure - MARKETABLE SECURITIES (Schedule of Available-for-sale Marketable Securities) (Details)" xlink:role="http://www.pluristem.com/role/MarketableSecuritiesScheduleOfAvailableforsaleMarketableSecuritiesDetails" xlink:type="extended">
    <link:loc xlink:label="loc_MajorTypesOfDebtAndEquitySecuritiesAxis.3302.8.6" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_MajorTypesOfDebtAndEquitySecuritiesAxis" xlink:type="locator" />
    <link:loc xlink:label="loc_MajorTypesOfDebtAndEquitySecuritiesDomain.3304.8.6" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_MajorTypesOfDebtAndEquitySecuritiesDomain" xlink:type="locator" />
    <link:definitionArc xlink:from="loc_MajorTypesOfDebtAndEquitySecuritiesAxis.3302.8.6" xlink:to="loc_MajorTypesOfDebtAndEquitySecuritiesDomain.3304.8.6" order="1.00000" priority="0" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:type="arc" />
    <link:loc xlink:label="loc_MajorTypesOfDebtAndEquitySecuritiesAxis.3302.6.6" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_MajorTypesOfDebtAndEquitySecuritiesAxis" xlink:type="locator" />
    <link:loc xlink:label="loc_MajorTypesOfDebtAndEquitySecuritiesDomain.3304.6.6" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_MajorTypesOfDebtAndEquitySecuritiesDomain" xlink:type="locator" />
    <link:definitionArc xlink:from="loc_MajorTypesOfDebtAndEquitySecuritiesAxis.3302.6.6" xlink:to="loc_MajorTypesOfDebtAndEquitySecuritiesDomain.3304.6.6" order="2.00000" priority="0" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:type="arc" />
    <link:loc xlink:label="loc_MajorTypesOfDebtAndEquitySecuritiesDomain.3304.7.6" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_MajorTypesOfDebtAndEquitySecuritiesDomain" xlink:type="locator" />
    <link:loc xlink:label="loc_GovernmentDebtSecuritiesMember.25540.7.6" xlink:href="psti-20140630.xsd#psti_GovernmentDebtSecuritiesMember" xlink:type="locator" />
    <link:definitionArc xlink:from="loc_MajorTypesOfDebtAndEquitySecuritiesDomain.3304.7.6" xlink:to="loc_GovernmentDebtSecuritiesMember.25540.7.6" order="2.00000" priority="0" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:type="arc" />
    <link:loc xlink:label="loc_CorporateDebtSecuritiesMember.1263.7.6" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_CorporateDebtSecuritiesMember" xlink:type="locator" />
    <link:definitionArc xlink:from="loc_MajorTypesOfDebtAndEquitySecuritiesDomain.3304.7.6" xlink:to="loc_CorporateDebtSecuritiesMember.1263.7.6" order="3.00000" priority="0" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:type="arc" />
    <link:loc xlink:label="loc_EquitySecuritiesMember.1910.7.6" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_EquitySecuritiesMember" xlink:type="locator" />
    <link:definitionArc xlink:from="loc_MajorTypesOfDebtAndEquitySecuritiesDomain.3304.7.6" xlink:to="loc_EquitySecuritiesMember.1910.7.6" order="1.75000" priority="0" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:type="arc" />
    <link:loc xlink:label="loc_RangeAxis.4349.8.6" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_RangeAxis" xlink:type="locator" />
    <link:loc xlink:label="loc_RangeMember.4350.8.6" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_RangeMember" xlink:type="locator" />
    <link:definitionArc xlink:from="loc_RangeAxis.4349.8.6" xlink:to="loc_RangeMember.4350.8.6" order="1.00000" priority="0" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:type="arc" />
    <link:loc xlink:label="loc_RangeAxis.4349.6.6" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_RangeAxis" xlink:type="locator" />
    <link:loc xlink:label="loc_RangeMember.4350.6.6" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_RangeMember" xlink:type="locator" />
    <link:definitionArc xlink:from="loc_RangeAxis.4349.6.6" xlink:to="loc_RangeMember.4350.6.6" order="2.00000" priority="0" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:type="arc" />
    <link:loc xlink:label="loc_RangeMember.4350.7.6" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_RangeMember" xlink:type="locator" />
    <link:loc xlink:label="loc_AvailableForSaleSecuritiesMaturesWithinOneYearMember.25532.7.6" xlink:href="psti-20140630.xsd#psti_AvailableForSaleSecuritiesMaturesWithinOneYearMember" xlink:type="locator" />
    <link:definitionArc xlink:from="loc_RangeMember.4350.7.6" xlink:to="loc_AvailableForSaleSecuritiesMaturesWithinOneYearMember.25532.7.6" order="1.00000" priority="0" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:type="arc" />
    <link:loc xlink:label="loc_AvailableForSaleSecuritiesMaturesAfterOneYearThroughFiveYearsMember.25531.7.6" xlink:href="psti-20140630.xsd#psti_AvailableForSaleSecuritiesMaturesAfterOneYearThroughFiveYearsMember" xlink:type="locator" />
    <link:definitionArc xlink:from="loc_RangeMember.4350.7.6" xlink:to="loc_AvailableForSaleSecuritiesMaturesAfterOneYearThroughFiveYearsMember.25531.7.6" order="2.00000" priority="0" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:type="arc" />
    <link:loc xlink:label="loc_AvailableForSaleSecuritiesMaturesAfterFiveYearsThroughTenYearsMember.25530.7.6" xlink:href="psti-20140630.xsd#psti_AvailableForSaleSecuritiesMaturesAfterFiveYearsThroughTenYearsMember" xlink:type="locator" />
    <link:definitionArc xlink:from="loc_RangeMember.4350.7.6" xlink:to="loc_AvailableForSaleSecuritiesMaturesAfterFiveYearsThroughTenYearsMember.25530.7.6" order="3.00000" priority="0" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:type="arc" />
    <link:loc xlink:label="loc_ScheduleOfAvailableForSaleSecuritiesTable.4729.5.6" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ScheduleOfAvailableForSaleSecuritiesTable" xlink:type="locator" />
    <link:loc xlink:label="loc_MajorTypesOfDebtAndEquitySecuritiesAxis.3302.5.6" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_MajorTypesOfDebtAndEquitySecuritiesAxis" xlink:type="locator" />
    <link:definitionArc xlink:from="loc_ScheduleOfAvailableForSaleSecuritiesTable.4729.5.6" xlink:to="loc_MajorTypesOfDebtAndEquitySecuritiesAxis.3302.5.6" order="1.50000" priority="0" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:type="arc" />
    <link:loc xlink:label="loc_RangeAxis.4349.5.6" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_RangeAxis" xlink:type="locator" />
    <link:definitionArc xlink:from="loc_ScheduleOfAvailableForSaleSecuritiesTable.4729.5.6" xlink:to="loc_RangeAxis.4349.5.6" order="1.87500" priority="0" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:type="arc" />
    <link:loc xlink:label="loc_ScheduleOfAvailableForSaleSecuritiesLineItems.4769.9.6" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems" xlink:type="locator" />
    <link:loc xlink:label="loc_ScheduleOfAvailableForSaleSecuritiesTable.4729.9.6" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ScheduleOfAvailableForSaleSecuritiesTable" xlink:type="locator" />
    <link:definitionArc xlink:from="loc_ScheduleOfAvailableForSaleSecuritiesLineItems.4769.9.6" xlink:to="loc_ScheduleOfAvailableForSaleSecuritiesTable.4729.9.6" order="1.00000" xbrldt:closed="true" xbrldt:contextElement="segment" priority="0" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:type="arc" />
    <link:loc xlink:label="loc_ScheduleOfAvailableForSaleSecuritiesLineItems.4769.7.6" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems" xlink:type="locator" />
    <link:loc xlink:label="loc_AvailableForSaleSecuritiesAmortizedCost.6142.7.6" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_AvailableForSaleSecuritiesAmortizedCost" xlink:type="locator" />
    <link:definitionArc xlink:from="loc_ScheduleOfAvailableForSaleSecuritiesLineItems.4769.7.6" xlink:to="loc_AvailableForSaleSecuritiesAmortizedCost.6142.7.6" order="2.00000" priority="0" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:type="arc" />
    <link:loc xlink:label="loc_AvailableForSaleSecurities.6116.7.6" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_AvailableForSaleSecurities" xlink:type="locator" />
    <link:definitionArc xlink:from="loc_ScheduleOfAvailableForSaleSecuritiesLineItems.4769.7.6" xlink:to="loc_AvailableForSaleSecurities.6116.7.6" order="5.00000" priority="0" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:type="arc" />
    <link:loc xlink:label="loc_AvailableForSaleEquitySecuritiesAccumulatedGrossUnrealizedGainBeforeTax.6136.7.6" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_AvailableForSaleEquitySecuritiesAccumulatedGrossUnrealizedGainBeforeTax" xlink:type="locator" />
    <link:definitionArc xlink:from="loc_ScheduleOfAvailableForSaleSecuritiesLineItems.4769.7.6" xlink:to="loc_AvailableForSaleEquitySecuritiesAccumulatedGrossUnrealizedGainBeforeTax.6136.7.6" order="3.00000" priority="0" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:type="arc" />
    <link:loc xlink:label="loc_AvailableForSaleEquitySecuritiesAccumulatedGrossUnrealizedLossBeforeTax.6100.7.6" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_AvailableForSaleEquitySecuritiesAccumulatedGrossUnrealizedLossBeforeTax" xlink:type="locator" />
    <link:definitionArc xlink:from="loc_ScheduleOfAvailableForSaleSecuritiesLineItems.4769.7.6" xlink:to="loc_AvailableForSaleEquitySecuritiesAccumulatedGrossUnrealizedLossBeforeTax.6100.7.6" order="3.75000" priority="0" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:type="arc" />
  </link:definitionLink>
  <link:definitionLink xlink:title="41101 - Disclosure - SUBSEQUENT EVENTS (Details)" xlink:role="http://www.pluristem.com/role/SubsequentEventsDetails" xlink:type="extended">
    <link:loc xlink:label="loc_SubsequentEventTable.5159.5.6" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_SubsequentEventTable" xlink:type="locator" />
    <link:loc xlink:label="loc_SubsequentEventTypeAxis.5163.5.6" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_SubsequentEventTypeAxis" xlink:type="locator" />
    <link:definitionArc xlink:from="loc_SubsequentEventTable.5159.5.6" xlink:to="loc_SubsequentEventTypeAxis.5163.5.6" order="1.00000" priority="0" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:type="arc" />
    <link:loc xlink:label="loc_SubsequentEventLineItems.5160.9.6" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_SubsequentEventLineItems" xlink:type="locator" />
    <link:loc xlink:label="loc_SubsequentEventTable.5159.9.6" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_SubsequentEventTable" xlink:type="locator" />
    <link:definitionArc xlink:from="loc_SubsequentEventLineItems.5160.9.6" xlink:to="loc_SubsequentEventTable.5159.9.6" order="1.00000" xbrldt:closed="true" xbrldt:contextElement="segment" priority="0" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:type="arc" />
    <link:loc xlink:label="loc_SubsequentEventLineItems.5160.7.6" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_SubsequentEventLineItems" xlink:type="locator" />
    <link:loc xlink:label="loc_GrantsReceivableCurrent.10654.7.6" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_GrantsReceivableCurrent" xlink:type="locator" />
    <link:definitionArc xlink:from="loc_SubsequentEventLineItems.5160.7.6" xlink:to="loc_GrantsReceivableCurrent.10654.7.6" order="2.00000" priority="0" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:type="arc" />
    <link:loc xlink:label="loc_SubsequentEventTypeDomain.5162.7.6" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_SubsequentEventTypeDomain" xlink:type="locator" />
    <link:loc xlink:label="loc_SubsequentEventMember.5161.7.6" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_SubsequentEventMember" xlink:type="locator" />
    <link:definitionArc xlink:from="loc_SubsequentEventTypeDomain.5162.7.6" xlink:to="loc_SubsequentEventMember.5161.7.6" order="1.00000" priority="0" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:type="arc" />
    <link:loc xlink:label="loc_SubsequentEventTypeAxis.5163.8.6" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_SubsequentEventTypeAxis" xlink:type="locator" />
    <link:loc xlink:label="loc_SubsequentEventTypeDomain.5162.8.6" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_SubsequentEventTypeDomain" xlink:type="locator" />
    <link:definitionArc xlink:from="loc_SubsequentEventTypeAxis.5163.8.6" xlink:to="loc_SubsequentEventTypeDomain.5162.8.6" order="1.00000" priority="0" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:type="arc" />
    <link:loc xlink:label="loc_SubsequentEventTypeAxis.5163.6.6" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_SubsequentEventTypeAxis" xlink:type="locator" />
    <link:loc xlink:label="loc_SubsequentEventTypeDomain.5162.6.6" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_SubsequentEventTypeDomain" xlink:type="locator" />
    <link:definitionArc xlink:from="loc_SubsequentEventTypeAxis.5163.6.6" xlink:to="loc_SubsequentEventTypeDomain.5162.6.6" order="2.00000" priority="0" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:type="arc" />
  </link:definitionLink>
  <link:definitionLink xlink:title="40801 - Disclosure - STOCKHOLDERS' EQUITY (Narrative) (Details)" xlink:role="http://www.pluristem.com/role/StockholdersEquityNarrativeDetails" xlink:type="extended">
    <link:loc xlink:label="loc_AwardTypeAxis.367.8.6" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_AwardTypeAxis" xlink:type="locator" />
    <link:loc xlink:label="loc_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain.5034.8.6" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:type="locator" />
    <link:definitionArc xlink:from="loc_AwardTypeAxis.367.8.6" xlink:to="loc_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain.5034.8.6" order="1.00000" priority="0" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:type="arc" />
    <link:loc xlink:label="loc_AwardTypeAxis.367.6.6" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_AwardTypeAxis" xlink:type="locator" />
    <link:loc xlink:label="loc_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain.5034.6.6" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:type="locator" />
    <link:definitionArc xlink:from="loc_AwardTypeAxis.367.6.6" xlink:to="loc_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain.5034.6.6" order="2.00000" priority="0" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:type="arc" />
    <link:loc xlink:label="loc_ClassOfStockLineItems.1047.7.6" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ClassOfStockLineItems" xlink:type="locator" />
    <link:loc xlink:label="loc_CommonStockSharesAuthorized.7058.7.6" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_CommonStockSharesAuthorized" xlink:type="locator" />
    <link:definitionArc xlink:from="loc_ClassOfStockLineItems.1047.7.6" xlink:to="loc_CommonStockSharesAuthorized.7058.7.6" order="1.00000" priority="0" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:type="arc" />
    <link:loc xlink:label="loc_CommonStockParOrStatedValuePerShare.7045.7.6" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_CommonStockParOrStatedValuePerShare" xlink:type="locator" />
    <link:definitionArc xlink:from="loc_ClassOfStockLineItems.1047.7.6" xlink:to="loc_CommonStockParOrStatedValuePerShare.7045.7.6" order="2.00000" priority="0" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:type="arc" />
    <link:loc xlink:label="loc_PreferredStockSharesAuthorized.14532.7.6" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_PreferredStockSharesAuthorized" xlink:type="locator" />
    <link:definitionArc xlink:from="loc_ClassOfStockLineItems.1047.7.6" xlink:to="loc_PreferredStockSharesAuthorized.14532.7.6" order="3.00000" priority="0" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:type="arc" />
    <link:loc xlink:label="loc_PreferredStockParOrStatedValuePerShare.14499.7.6" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_PreferredStockParOrStatedValuePerShare" xlink:type="locator" />
    <link:definitionArc xlink:from="loc_ClassOfStockLineItems.1047.7.6" xlink:to="loc_PreferredStockParOrStatedValuePerShare.14499.7.6" order="4.00000" priority="0" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:type="arc" />
    <link:loc xlink:label="loc_ClassOfStockLineItems.1047.9.6" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ClassOfStockLineItems" xlink:type="locator" />
    <link:loc xlink:label="loc_ScheduleOfStockByClassTable.4849.9.6" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ScheduleOfStockByClassTable" xlink:type="locator" />
    <link:definitionArc xlink:from="loc_ClassOfStockLineItems.1047.9.6" xlink:to="loc_ScheduleOfStockByClassTable.4849.9.6" order="5.00000" xbrldt:closed="true" xbrldt:contextElement="segment" priority="0" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:type="arc" />
    <link:loc xlink:label="loc_AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts.5793.7.6" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts" xlink:type="locator" />
    <link:definitionArc xlink:from="loc_ClassOfStockLineItems.1047.7.6" xlink:to="loc_AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts.5793.7.6" order="7.00000" priority="0" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:type="arc" />
    <link:loc xlink:label="loc_ConversionOfStockSharesConverted1.7256.7.6" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ConversionOfStockSharesConverted1" xlink:type="locator" />
    <link:definitionArc xlink:from="loc_ClassOfStockLineItems.1047.7.6" xlink:to="loc_ConversionOfStockSharesConverted1.7256.7.6" order="8.00000" priority="0" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:type="arc" />
    <link:loc xlink:label="loc_ConversionOfStockSharesIssued1.7251.7.6" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ConversionOfStockSharesIssued1" xlink:type="locator" />
    <link:definitionArc xlink:from="loc_ClassOfStockLineItems.1047.7.6" xlink:to="loc_ConversionOfStockSharesIssued1.7251.7.6" order="9.00000" priority="0" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:type="arc" />
    <link:loc xlink:label="loc_StockIssuedDuringPeriodSharesOther.16964.7.6" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesOther" xlink:type="locator" />
    <link:definitionArc xlink:from="loc_ClassOfStockLineItems.1047.7.6" xlink:to="loc_StockIssuedDuringPeriodSharesOther.16964.7.6" order="10.00000" priority="0" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:type="arc" />
    <link:loc xlink:label="loc_StockIssuedDuringPeriodSharesStockOptionsExercised.16983.7.6" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:type="locator" />
    <link:definitionArc xlink:from="loc_ClassOfStockLineItems.1047.7.6" xlink:to="loc_StockIssuedDuringPeriodSharesStockOptionsExercised.16983.7.6" order="12.00000" priority="0" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:type="arc" />
    <link:loc xlink:label="loc_SharebasedGoodsAndNonemployeesServicesTransactionWarrantsAndOptionsExercised.25548.7.6" xlink:href="psti-20140630.xsd#psti_SharebasedGoodsAndNonemployeesServicesTransactionWarrantsAndOptionsExercised" xlink:type="locator" />
    <link:definitionArc xlink:from="loc_ClassOfStockLineItems.1047.7.6" xlink:to="loc_SharebasedGoodsAndNonemployeesServicesTransactionWarrantsAndOptionsExercised.25548.7.6" order="13.00000" priority="0" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:type="arc" />
    <link:loc xlink:label="loc_CommonStockAggregateOfferingPriceAuthorized.25533.7.6" xlink:href="psti-20140630.xsd#psti_CommonStockAggregateOfferingPriceAuthorized" xlink:type="locator" />
    <link:definitionArc xlink:from="loc_ClassOfStockLineItems.1047.7.6" xlink:to="loc_CommonStockAggregateOfferingPriceAuthorized.25533.7.6" order="14.00000" priority="0" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:type="arc" />
    <link:loc xlink:label="loc_ProceedsFromWarrantExercises.14695.7.6" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ProceedsFromWarrantExercises" xlink:type="locator" />
    <link:definitionArc xlink:from="loc_ClassOfStockLineItems.1047.7.6" xlink:to="loc_ProceedsFromWarrantExercises.14695.7.6" order="10.50000" priority="0" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:type="arc" />
    <link:loc xlink:label="loc_SharebasedCompensationArrangementWarrantsExercised.25813.7.6" xlink:href="psti-20140630.xsd#psti_SharebasedCompensationArrangementWarrantsExercised" xlink:type="locator" />
    <link:definitionArc xlink:from="loc_ClassOfStockLineItems.1047.7.6" xlink:to="loc_SharebasedCompensationArrangementWarrantsExercised.25813.7.6" order="15.00000" priority="0" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:type="arc" />
    <link:loc xlink:label="loc_StockIssuedDuringPeriodSharesPurchaseOfAssets.16992.7.6" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesPurchaseOfAssets" xlink:type="locator" />
    <link:definitionArc xlink:from="loc_ClassOfStockLineItems.1047.7.6" xlink:to="loc_StockIssuedDuringPeriodSharesPurchaseOfAssets.16992.7.6" order="16.00000" priority="0" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:type="arc" />
    <link:loc xlink:label="loc_AvailableForSaleMarketableSecuritiesNumber.25527.7.6" xlink:href="psti-20140630.xsd#psti_AvailableForSaleMarketableSecuritiesNumber" xlink:type="locator" />
    <link:definitionArc xlink:from="loc_ClassOfStockLineItems.1047.7.6" xlink:to="loc_AvailableForSaleMarketableSecuritiesNumber.25527.7.6" order="17.00000" priority="0" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:type="arc" />
    <link:loc xlink:label="loc_StockIssuedDuringPeriodValuePurchaseOfAssets.17002.7.6" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_StockIssuedDuringPeriodValuePurchaseOfAssets" xlink:type="locator" />
    <link:definitionArc xlink:from="loc_ClassOfStockLineItems.1047.7.6" xlink:to="loc_StockIssuedDuringPeriodValuePurchaseOfAssets.17002.7.6" order="18.00000" priority="0" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:type="arc" />
    <link:loc xlink:label="loc_StockIssuedDuringPeriodSharesNewIssues.16990.7.6" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:type="locator" />
    <link:definitionArc xlink:from="loc_ClassOfStockLineItems.1047.7.6" xlink:to="loc_StockIssuedDuringPeriodSharesNewIssues.16990.7.6" order="19.00000" priority="0" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:type="arc" />
    <link:loc xlink:label="loc_SharesIssuedPricePerShare.16778.7.6" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_SharesIssuedPricePerShare" xlink:type="locator" />
    <link:definitionArc xlink:from="loc_ClassOfStockLineItems.1047.7.6" xlink:to="loc_SharesIssuedPricePerShare.16778.7.6" order="20.00000" priority="0" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:type="arc" />
    <link:loc xlink:label="loc_ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight.6954.7.6" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight" xlink:type="locator" />
    <link:definitionArc xlink:from="loc_ClassOfStockLineItems.1047.7.6" xlink:to="loc_ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight.6954.7.6" order="21.00000" priority="0" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:type="arc" />
    <link:loc xlink:label="loc_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1.6952.7.6" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" xlink:type="locator" />
    <link:definitionArc xlink:from="loc_ClassOfStockLineItems.1047.7.6" xlink:to="loc_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1.6952.7.6" order="22.00000" priority="0" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:type="arc" />
    <link:loc xlink:label="loc_StockIssuedDuringPeriodValueNewIssues.17003.7.6" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueNewIssues" xlink:type="locator" />
    <link:definitionArc xlink:from="loc_ClassOfStockLineItems.1047.7.6" xlink:to="loc_StockIssuedDuringPeriodValueNewIssues.17003.7.6" order="19.50000" priority="0" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:type="arc" />
    <link:loc xlink:label="loc_ClassOfWarrantOrRightOutstanding.6947.7.6" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ClassOfWarrantOrRightOutstanding" xlink:type="locator" />
    <link:definitionArc xlink:from="loc_ClassOfStockLineItems.1047.7.6" xlink:to="loc_ClassOfWarrantOrRightOutstanding.6947.7.6" order="22.50000" priority="0" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:type="arc" />
    <link:loc xlink:label="loc_StockIssuedDuringPeriodSharesIssuedForServices.16939.7.6" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesIssuedForServices" xlink:type="locator" />
    <link:definitionArc xlink:from="loc_ClassOfStockLineItems.1047.7.6" xlink:to="loc_StockIssuedDuringPeriodSharesIssuedForServices.16939.7.6" order="16.50000" priority="0" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:type="arc" />
    <link:loc xlink:label="loc_ProceedsFromIssuanceOfCommonStock.14855.7.6" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ProceedsFromIssuanceOfCommonStock" xlink:type="locator" />
    <link:definitionArc xlink:from="loc_ClassOfStockLineItems.1047.7.6" xlink:to="loc_ProceedsFromIssuanceOfCommonStock.14855.7.6" order="24.00000" priority="0" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:type="arc" />
    <link:loc xlink:label="loc_ClassOfWarrantOrRightAxis.1048.6.6" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ClassOfWarrantOrRightAxis" xlink:type="locator" />
    <link:loc xlink:label="loc_ClassOfWarrantOrRightDomain.1049.6.6" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ClassOfWarrantOrRightDomain" xlink:type="locator" />
    <link:definitionArc xlink:from="loc_ClassOfWarrantOrRightAxis.1048.6.6" xlink:to="loc_ClassOfWarrantOrRightDomain.1049.6.6" order="1.00000" priority="0" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:type="arc" />
    <link:loc xlink:label="loc_ClassOfWarrantOrRightAxis.1048.8.6" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ClassOfWarrantOrRightAxis" xlink:type="locator" />
    <link:loc xlink:label="loc_ClassOfWarrantOrRightDomain.1049.8.6" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ClassOfWarrantOrRightDomain" xlink:type="locator" />
    <link:definitionArc xlink:from="loc_ClassOfWarrantOrRightAxis.1048.8.6" xlink:to="loc_ClassOfWarrantOrRightDomain.1049.8.6" order="2.00000" priority="0" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:type="arc" />
    <link:loc xlink:label="loc_ClassOfWarrantOrRightDomain.1049.7.6" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ClassOfWarrantOrRightDomain" xlink:type="locator" />
    <link:loc xlink:label="loc_InvestorWarrantsMember.25814.7.6" xlink:href="psti-20140630.xsd#psti_InvestorWarrantsMember" xlink:type="locator" />
    <link:definitionArc xlink:from="loc_ClassOfWarrantOrRightDomain.1049.7.6" xlink:to="loc_InvestorWarrantsMember.25814.7.6" order="1.00000" priority="0" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:type="arc" />
    <link:loc xlink:label="loc_UnderwritersOptionMember.25815.7.6" xlink:href="psti-20140630.xsd#psti_UnderwritersOptionMember" xlink:type="locator" />
    <link:definitionArc xlink:from="loc_ClassOfWarrantOrRightDomain.1049.7.6" xlink:to="loc_UnderwritersOptionMember.25815.7.6" order="2.00000" priority="0" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:type="arc" />
    <link:loc xlink:label="loc_UnderwriterWarrantsMember.25744.7.6" xlink:href="psti-20140630.xsd#psti_UnderwriterWarrantsMember" xlink:type="locator" />
    <link:definitionArc xlink:from="loc_ClassOfWarrantOrRightDomain.1049.7.6" xlink:to="loc_UnderwriterWarrantsMember.25744.7.6" order="3.00000" priority="0" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:type="arc" />
    <link:loc xlink:label="loc_ConsultantWarrantsMember.25816.7.6" xlink:href="psti-20140630.xsd#psti_ConsultantWarrantsMember" xlink:type="locator" />
    <link:definitionArc xlink:from="loc_ClassOfWarrantOrRightDomain.1049.7.6" xlink:to="loc_ConsultantWarrantsMember.25816.7.6" order="4.00000" priority="0" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:type="arc" />
    <link:loc xlink:label="loc_ScheduleOfStockByClassTable.4849.5.6" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ScheduleOfStockByClassTable" xlink:type="locator" />
    <link:loc xlink:label="loc_StatementClassOfStockAxis.5117.5.6" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_StatementClassOfStockAxis" xlink:type="locator" />
    <link:definitionArc xlink:from="loc_ScheduleOfStockByClassTable.4849.5.6" xlink:to="loc_StatementClassOfStockAxis.5117.5.6" order="1.00000" priority="0" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:type="arc" />
    <link:loc xlink:label="loc_ClassOfWarrantOrRightAxis.1048.5.6" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ClassOfWarrantOrRightAxis" xlink:type="locator" />
    <link:definitionArc xlink:from="loc_ScheduleOfStockByClassTable.4849.5.6" xlink:to="loc_ClassOfWarrantOrRightAxis.1048.5.6" order="1.50000" priority="0" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:type="arc" />
    <link:loc xlink:label="loc_ShareBasedGoodsAndNonemployeeServicesTransactionBySupplierAxis.5039.5.6" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ShareBasedGoodsAndNonemployeeServicesTransactionBySupplierAxis" xlink:type="locator" />
    <link:definitionArc xlink:from="loc_ScheduleOfStockByClassTable.4849.5.6" xlink:to="loc_ShareBasedGoodsAndNonemployeeServicesTransactionBySupplierAxis.5039.5.6" order="1.75000" priority="0" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:type="arc" />
    <link:loc xlink:label="loc_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable.4860.5.6" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:type="locator" />
    <link:loc xlink:label="loc_AwardTypeAxis.367.5.6" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_AwardTypeAxis" xlink:type="locator" />
    <link:definitionArc xlink:from="loc_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable.4860.5.6" xlink:to="loc_AwardTypeAxis.367.5.6" order="1.00000" priority="0" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:type="arc" />
    <link:loc xlink:label="loc_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems.5018.9.6" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:type="locator" />
    <link:loc xlink:label="loc_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable.4860.9.6" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:type="locator" />
    <link:definitionArc xlink:from="loc_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems.5018.9.6" xlink:to="loc_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable.4860.9.6" order="1.00000" xbrldt:closed="true" xbrldt:contextElement="segment" priority="0" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:type="arc" />
    <link:loc xlink:label="loc_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems.5018.7.6" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:type="locator" />
    <link:loc xlink:label="loc_StockIssuedDuringPeriodSharesStockOptionsAndWarrantsExercised.25555.7.6" xlink:href="psti-20140630.xsd#psti_StockIssuedDuringPeriodSharesStockOptionsAndWarrantsExercised" xlink:type="locator" />
    <link:definitionArc xlink:from="loc_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems.5018.7.6" xlink:to="loc_StockIssuedDuringPeriodSharesStockOptionsAndWarrantsExercised.25555.7.6" order="2.00000" priority="0" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:type="arc" />
    <link:loc xlink:label="loc_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized.16705.7.6" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" xlink:type="locator" />
    <link:definitionArc xlink:from="loc_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems.5018.7.6" xlink:to="loc_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized.16705.7.6" order="3.00000" priority="0" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:type="arc" />
    <link:loc xlink:label="loc_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant.16701.7.6" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" xlink:type="locator" />
    <link:definitionArc xlink:from="loc_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems.5018.7.6" xlink:to="loc_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant.16701.7.6" order="4.00000" priority="0" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:type="arc" />
    <link:loc xlink:label="loc_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain.5034.7.6" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:type="locator" />
    <link:loc xlink:label="loc_EmployeeStockOptionMember.1835.7.6" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_EmployeeStockOptionMember" xlink:type="locator" />
    <link:definitionArc xlink:from="loc_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain.5034.7.6" xlink:to="loc_EmployeeStockOptionMember.1835.7.6" order="1.00000" priority="0" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:type="arc" />
    <link:loc xlink:label="loc_WarrantAwardsMember.25559.7.6" xlink:href="psti-20140630.xsd#psti_WarrantAwardsMember" xlink:type="locator" />
    <link:definitionArc xlink:from="loc_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain.5034.7.6" xlink:to="loc_WarrantAwardsMember.25559.7.6" order="2.00000" priority="0" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:type="arc" />
    <link:loc xlink:label="loc_ShareBasedGoodsAndNonemployeeServicesTransactionSupplierDomain.5036.7.6" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ShareBasedGoodsAndNonemployeeServicesTransactionSupplierDomain" xlink:type="locator" />
    <link:loc xlink:label="loc_BiopharmaxMember.25817.7.6" xlink:href="psti-20140630.xsd#psti_BiopharmaxMember" xlink:type="locator" />
    <link:definitionArc xlink:from="loc_ShareBasedGoodsAndNonemployeeServicesTransactionSupplierDomain.5036.7.6" xlink:to="loc_BiopharmaxMember.25817.7.6" order="1.00000" priority="0" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:type="arc" />
    <link:loc xlink:label="loc_ShareBasedGoodsAndNonemployeeServicesTransactionBySupplierAxis.5039.6.6" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ShareBasedGoodsAndNonemployeeServicesTransactionBySupplierAxis" xlink:type="locator" />
    <link:loc xlink:label="loc_ShareBasedGoodsAndNonemployeeServicesTransactionSupplierDomain.5036.6.6" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ShareBasedGoodsAndNonemployeeServicesTransactionSupplierDomain" xlink:type="locator" />
    <link:definitionArc xlink:from="loc_ShareBasedGoodsAndNonemployeeServicesTransactionBySupplierAxis.5039.6.6" xlink:to="loc_ShareBasedGoodsAndNonemployeeServicesTransactionSupplierDomain.5036.6.6" order="1.00000" priority="0" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:type="arc" />
    <link:loc xlink:label="loc_ShareBasedGoodsAndNonemployeeServicesTransactionBySupplierAxis.5039.8.6" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ShareBasedGoodsAndNonemployeeServicesTransactionBySupplierAxis" xlink:type="locator" />
    <link:loc xlink:label="loc_ShareBasedGoodsAndNonemployeeServicesTransactionSupplierDomain.5036.8.6" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ShareBasedGoodsAndNonemployeeServicesTransactionSupplierDomain" xlink:type="locator" />
    <link:definitionArc xlink:from="loc_ShareBasedGoodsAndNonemployeeServicesTransactionBySupplierAxis.5039.8.6" xlink:to="loc_ShareBasedGoodsAndNonemployeeServicesTransactionSupplierDomain.5036.8.6" order="2.00000" priority="0" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:type="arc" />
    <link:loc xlink:label="loc_StatementClassOfStockAxis.5117.6.6" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_StatementClassOfStockAxis" xlink:type="locator" />
    <link:loc xlink:label="loc_ClassOfStockDomain.1053.6.6" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ClassOfStockDomain" xlink:type="locator" />
    <link:definitionArc xlink:from="loc_StatementClassOfStockAxis.5117.6.6" xlink:to="loc_ClassOfStockDomain.1053.6.6" order="1.00000" priority="0" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:type="arc" />
    <link:loc xlink:label="loc_StatementClassOfStockAxis.5117.8.6" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_StatementClassOfStockAxis" xlink:type="locator" />
    <link:loc xlink:label="loc_ClassOfStockDomain.1053.8.6" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ClassOfStockDomain" xlink:type="locator" />
    <link:definitionArc xlink:from="loc_StatementClassOfStockAxis.5117.8.6" xlink:to="loc_ClassOfStockDomain.1053.8.6" order="2.00000" priority="0" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:type="arc" />
  </link:definitionLink>
  <link:definitionLink xlink:title="40806 - Disclosure - STOCKHOLDERS' EQUITY (Schedule of Compensation Expense) (Details)" xlink:role="http://www.pluristem.com/role/StockholdersEquityScheduleOfCompensationExpenseDetails" xlink:type="extended">
    <link:loc xlink:label="loc_AwardTypeAxis.367.8.6" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_AwardTypeAxis" xlink:type="locator" />
    <link:loc xlink:label="loc_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain.5034.8.6" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:type="locator" />
    <link:definitionArc xlink:from="loc_AwardTypeAxis.367.8.6" xlink:to="loc_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain.5034.8.6" order="1.00000" priority="0" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:type="arc" />
    <link:loc xlink:label="loc_AwardTypeAxis.367.6.6" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_AwardTypeAxis" xlink:type="locator" />
    <link:loc xlink:label="loc_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain.5034.6.6" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:type="locator" />
    <link:definitionArc xlink:from="loc_AwardTypeAxis.367.6.6" xlink:to="loc_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain.5034.6.6" order="2.00000" priority="0" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:type="arc" />
    <link:loc xlink:label="loc_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems.1848.9.6" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems" xlink:type="locator" />
    <link:loc xlink:label="loc_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable.4779.9.6" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable" xlink:type="locator" />
    <link:definitionArc xlink:from="loc_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems.1848.9.6" xlink:to="loc_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable.4779.9.6" order="1.00000" xbrldt:closed="true" xbrldt:contextElement="segment" priority="0" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:type="arc" />
    <link:loc xlink:label="loc_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems.1848.7.6" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems" xlink:type="locator" />
    <link:loc xlink:label="loc_AllocatedShareBasedCompensationExpense.5851.7.6" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_AllocatedShareBasedCompensationExpense" xlink:type="locator" />
    <link:definitionArc xlink:from="loc_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems.1848.7.6" xlink:to="loc_AllocatedShareBasedCompensationExpense.5851.7.6" order="2.00000" priority="0" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:type="arc" />
    <link:loc xlink:label="loc_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized.9125.7.6" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized" xlink:type="locator" />
    <link:definitionArc xlink:from="loc_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems.1848.7.6" xlink:to="loc_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized.9125.7.6" order="3.00000" priority="0" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:type="arc" />
    <link:loc xlink:label="loc_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1.9127.7.6" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:type="locator" />
    <link:definitionArc xlink:from="loc_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems.1848.7.6" xlink:to="loc_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1.9127.7.6" order="4.00000" priority="0" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:type="arc" />
    <link:loc xlink:label="loc_IncomeStatementLocationAxis.2652.8.6" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_IncomeStatementLocationAxis" xlink:type="locator" />
    <link:loc xlink:label="loc_IncomeStatementLocationDomain.2668.8.6" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_IncomeStatementLocationDomain" xlink:type="locator" />
    <link:definitionArc xlink:from="loc_IncomeStatementLocationAxis.2652.8.6" xlink:to="loc_IncomeStatementLocationDomain.2668.8.6" order="1.00000" priority="0" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:type="arc" />
    <link:loc xlink:label="loc_IncomeStatementLocationAxis.2652.6.6" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_IncomeStatementLocationAxis" xlink:type="locator" />
    <link:loc xlink:label="loc_IncomeStatementLocationDomain.2668.6.6" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_IncomeStatementLocationDomain" xlink:type="locator" />
    <link:definitionArc xlink:from="loc_IncomeStatementLocationAxis.2652.6.6" xlink:to="loc_IncomeStatementLocationDomain.2668.6.6" order="2.00000" priority="0" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:type="arc" />
    <link:loc xlink:label="loc_IncomeStatementLocationDomain.2668.7.6" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_IncomeStatementLocationDomain" xlink:type="locator" />
    <link:loc xlink:label="loc_ResearchAndDevelopmentExpenseMember.4543.7.6" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ResearchAndDevelopmentExpenseMember" xlink:type="locator" />
    <link:definitionArc xlink:from="loc_IncomeStatementLocationDomain.2668.7.6" xlink:to="loc_ResearchAndDevelopmentExpenseMember.4543.7.6" order="1.00000" priority="0" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:type="arc" />
    <link:loc xlink:label="loc_GeneralAndAdministrativeExpenseMember.2476.7.6" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_GeneralAndAdministrativeExpenseMember" xlink:type="locator" />
    <link:definitionArc xlink:from="loc_IncomeStatementLocationDomain.2668.7.6" xlink:to="loc_GeneralAndAdministrativeExpenseMember.2476.7.6" order="2.00000" priority="0" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:type="arc" />
    <link:loc xlink:label="loc_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable.4779.5.6" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable" xlink:type="locator" />
    <link:loc xlink:label="loc_IncomeStatementLocationAxis.2652.5.6" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_IncomeStatementLocationAxis" xlink:type="locator" />
    <link:definitionArc xlink:from="loc_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable.4779.5.6" xlink:to="loc_IncomeStatementLocationAxis.2652.5.6" order="1.00000" priority="0" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:type="arc" />
    <link:loc xlink:label="loc_AwardTypeAxis.367.5.6" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_AwardTypeAxis" xlink:type="locator" />
    <link:definitionArc xlink:from="loc_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable.4779.5.6" xlink:to="loc_AwardTypeAxis.367.5.6" order="1.50000" priority="0" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:type="arc" />
    <link:loc xlink:label="loc_ShareBasedGoodsAndNonemployeeServicesTransactionBySupplierAxis.5039.5.6" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ShareBasedGoodsAndNonemployeeServicesTransactionBySupplierAxis" xlink:type="locator" />
    <link:definitionArc xlink:from="loc_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable.4779.5.6" xlink:to="loc_ShareBasedGoodsAndNonemployeeServicesTransactionBySupplierAxis.5039.5.6" order="1.75000" priority="0" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:type="arc" />
    <link:loc xlink:label="loc_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain.5034.7.6" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:type="locator" />
    <link:loc xlink:label="loc_EquityOptionsAndWarrantsMember.25537.7.6" xlink:href="psti-20140630.xsd#psti_EquityOptionsAndWarrantsMember" xlink:type="locator" />
    <link:definitionArc xlink:from="loc_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain.5034.7.6" xlink:to="loc_EquityOptionsAndWarrantsMember.25537.7.6" order="1.00000" priority="0" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:type="arc" />
    <link:loc xlink:label="loc_RestrictedStockUnitsRSUMember.4568.7.6" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_RestrictedStockUnitsRSUMember" xlink:type="locator" />
    <link:definitionArc xlink:from="loc_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain.5034.7.6" xlink:to="loc_RestrictedStockUnitsRSUMember.4568.7.6" order="2.00000" priority="0" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:type="arc" />
    <link:loc xlink:label="loc_ShareBasedGoodsAndNonemployeeServicesTransactionSupplierDomain.5036.7.6" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ShareBasedGoodsAndNonemployeeServicesTransactionSupplierDomain" xlink:type="locator" />
    <link:loc xlink:label="loc_ConsultantsMember.25535.7.6" xlink:href="psti-20140630.xsd#psti_ConsultantsMember" xlink:type="locator" />
    <link:definitionArc xlink:from="loc_ShareBasedGoodsAndNonemployeeServicesTransactionSupplierDomain.5036.7.6" xlink:to="loc_ConsultantsMember.25535.7.6" order="1.00000" priority="0" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:type="arc" />
    <link:loc xlink:label="loc_ShareBasedGoodsAndNonemployeeServicesTransactionBySupplierAxis.5039.8.6" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ShareBasedGoodsAndNonemployeeServicesTransactionBySupplierAxis" xlink:type="locator" />
    <link:loc xlink:label="loc_ShareBasedGoodsAndNonemployeeServicesTransactionSupplierDomain.5036.8.6" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ShareBasedGoodsAndNonemployeeServicesTransactionSupplierDomain" xlink:type="locator" />
    <link:definitionArc xlink:from="loc_ShareBasedGoodsAndNonemployeeServicesTransactionBySupplierAxis.5039.8.6" xlink:to="loc_ShareBasedGoodsAndNonemployeeServicesTransactionSupplierDomain.5036.8.6" order="1.00000" priority="0" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:type="arc" />
    <link:loc xlink:label="loc_ShareBasedGoodsAndNonemployeeServicesTransactionBySupplierAxis.5039.6.6" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ShareBasedGoodsAndNonemployeeServicesTransactionBySupplierAxis" xlink:type="locator" />
    <link:loc xlink:label="loc_ShareBasedGoodsAndNonemployeeServicesTransactionSupplierDomain.5036.6.6" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ShareBasedGoodsAndNonemployeeServicesTransactionSupplierDomain" xlink:type="locator" />
    <link:definitionArc xlink:from="loc_ShareBasedGoodsAndNonemployeeServicesTransactionBySupplierAxis.5039.6.6" xlink:to="loc_ShareBasedGoodsAndNonemployeeServicesTransactionSupplierDomain.5036.6.6" order="2.00000" priority="0" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:type="arc" />
  </link:definitionLink>
  <link:definitionLink xlink:title="40805 - Disclosure - STOCKHOLDERS' EQUITY (Summary of RSU Activity to Consultants) (Details)" xlink:role="http://www.pluristem.com/role/StockholdersEquitySummaryOfRsuActivityToConsultantsDetails" xlink:type="extended">
    <link:loc xlink:label="loc_ScheduleOfShareBasedGoodsAndNonemployeeServicesTransactionTable.4869.5.6" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ScheduleOfShareBasedGoodsAndNonemployeeServicesTransactionTable" xlink:type="locator" />
    <link:loc xlink:label="loc_ShareBasedGoodsAndNonemployeeServicesTransactionBySupplierAxis.5039.5.6" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ShareBasedGoodsAndNonemployeeServicesTransactionBySupplierAxis" xlink:type="locator" />
    <link:definitionArc xlink:from="loc_ScheduleOfShareBasedGoodsAndNonemployeeServicesTransactionTable.4869.5.6" xlink:to="loc_ShareBasedGoodsAndNonemployeeServicesTransactionBySupplierAxis.5039.5.6" order="1.00000" priority="0" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:type="arc" />
    <link:loc xlink:label="loc_ShareBasedGoodsAndNonemployeeServicesTransactionSupplierDomain.5036.7.6" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ShareBasedGoodsAndNonemployeeServicesTransactionSupplierDomain" xlink:type="locator" />
    <link:loc xlink:label="loc_ConsultantsMember.25535.7.6" xlink:href="psti-20140630.xsd#psti_ConsultantsMember" xlink:type="locator" />
    <link:definitionArc xlink:from="loc_ShareBasedGoodsAndNonemployeeServicesTransactionSupplierDomain.5036.7.6" xlink:to="loc_ConsultantsMember.25535.7.6" order="1.00000" priority="0" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:type="arc" />
    <link:loc xlink:label="loc_ShareBasedGoodsAndNonemployeeServicesTransactionLineItems.5038.9.6" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ShareBasedGoodsAndNonemployeeServicesTransactionLineItems" xlink:type="locator" />
    <link:loc xlink:label="loc_ScheduleOfShareBasedGoodsAndNonemployeeServicesTransactionTable.4869.9.6" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ScheduleOfShareBasedGoodsAndNonemployeeServicesTransactionTable" xlink:type="locator" />
    <link:definitionArc xlink:from="loc_ShareBasedGoodsAndNonemployeeServicesTransactionLineItems.5038.9.6" xlink:to="loc_ScheduleOfShareBasedGoodsAndNonemployeeServicesTransactionTable.4869.9.6" order="1.00000" xbrldt:closed="true" xbrldt:contextElement="segment" priority="0" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:type="arc" />
    <link:loc xlink:label="loc_ShareBasedGoodsAndNonemployeeServicesTransactionLineItems.5038.7.6" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ShareBasedGoodsAndNonemployeeServicesTransactionLineItems" xlink:type="locator" />
    <link:loc xlink:label="loc_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber.16626.7.6" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:type="locator" />
    <link:definitionArc xlink:from="loc_ShareBasedGoodsAndNonemployeeServicesTransactionLineItems.5038.7.6" xlink:to="loc_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber.16626.7.6" order="2.00000" priority="0" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:type="arc" />
    <link:loc xlink:label="loc_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod.16617.7.6" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:type="locator" />
    <link:definitionArc xlink:from="loc_ShareBasedGoodsAndNonemployeeServicesTransactionLineItems.5038.7.6" xlink:to="loc_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod.16617.7.6" order="3.00000" priority="0" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:type="arc" />
    <link:loc xlink:label="loc_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod.16661.7.6" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" xlink:type="locator" />
    <link:definitionArc xlink:from="loc_ShareBasedGoodsAndNonemployeeServicesTransactionLineItems.5038.7.6" xlink:to="loc_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod.16661.7.6" order="4.00000" priority="0" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:type="arc" />
    <link:loc xlink:label="loc_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod.16633.7.6" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" xlink:type="locator" />
    <link:definitionArc xlink:from="loc_ShareBasedGoodsAndNonemployeeServicesTransactionLineItems.5038.7.6" xlink:to="loc_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod.16633.7.6" order="5.00000" priority="0" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:type="arc" />
    <link:loc xlink:label="loc_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsExpectedToVest.25547.7.6" xlink:href="psti-20140630.xsd#psti_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsExpectedToVest" xlink:type="locator" />
    <link:definitionArc xlink:from="loc_ShareBasedGoodsAndNonemployeeServicesTransactionLineItems.5038.7.6" xlink:to="loc_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsExpectedToVest.25547.7.6" order="6.00000" priority="0" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:type="arc" />
    <link:loc xlink:label="loc_ShareBasedGoodsAndNonemployeeServicesTransactionBySupplierAxis.5039.8.6" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ShareBasedGoodsAndNonemployeeServicesTransactionBySupplierAxis" xlink:type="locator" />
    <link:loc xlink:label="loc_ShareBasedGoodsAndNonemployeeServicesTransactionSupplierDomain.5036.8.6" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ShareBasedGoodsAndNonemployeeServicesTransactionSupplierDomain" xlink:type="locator" />
    <link:definitionArc xlink:from="loc_ShareBasedGoodsAndNonemployeeServicesTransactionBySupplierAxis.5039.8.6" xlink:to="loc_ShareBasedGoodsAndNonemployeeServicesTransactionSupplierDomain.5036.8.6" order="1.00000" priority="0" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:type="arc" />
    <link:loc xlink:label="loc_ShareBasedGoodsAndNonemployeeServicesTransactionBySupplierAxis.5039.6.6" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ShareBasedGoodsAndNonemployeeServicesTransactionBySupplierAxis" xlink:type="locator" />
    <link:loc xlink:label="loc_ShareBasedGoodsAndNonemployeeServicesTransactionSupplierDomain.5036.6.6" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ShareBasedGoodsAndNonemployeeServicesTransactionSupplierDomain" xlink:type="locator" />
    <link:definitionArc xlink:from="loc_ShareBasedGoodsAndNonemployeeServicesTransactionBySupplierAxis.5039.6.6" xlink:to="loc_ShareBasedGoodsAndNonemployeeServicesTransactionSupplierDomain.5036.6.6" order="2.00000" priority="0" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:type="arc" />
  </link:definitionLink>
  <link:definitionLink xlink:title="40804 - Disclosure - STOCKHOLDERS' EQUITY (Summary of RSU Activity to Employees and Directors) (Details)" xlink:role="http://www.pluristem.com/role/StockholdersEquitySummaryOfRsuActivityToEmployeesAndDirectorsDetails" xlink:type="extended">
    <link:loc xlink:label="loc_AwardTypeAxis.367.8.6" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_AwardTypeAxis" xlink:type="locator" />
    <link:loc xlink:label="loc_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain.5034.8.6" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:type="locator" />
    <link:definitionArc xlink:from="loc_AwardTypeAxis.367.8.6" xlink:to="loc_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain.5034.8.6" order="1.00000" priority="0" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:type="arc" />
    <link:loc xlink:label="loc_AwardTypeAxis.367.6.6" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_AwardTypeAxis" xlink:type="locator" />
    <link:loc xlink:label="loc_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain.5034.6.6" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:type="locator" />
    <link:definitionArc xlink:from="loc_AwardTypeAxis.367.6.6" xlink:to="loc_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain.5034.6.6" order="2.00000" priority="0" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:type="arc" />
    <link:loc xlink:label="loc_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable.4860.5.6" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:type="locator" />
    <link:loc xlink:label="loc_AwardTypeAxis.367.5.6" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_AwardTypeAxis" xlink:type="locator" />
    <link:definitionArc xlink:from="loc_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable.4860.5.6" xlink:to="loc_AwardTypeAxis.367.5.6" order="1.25000" priority="0" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:type="arc" />
    <link:loc xlink:label="loc_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems.5018.9.6" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:type="locator" />
    <link:loc xlink:label="loc_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable.4860.9.6" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:type="locator" />
    <link:definitionArc xlink:from="loc_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems.5018.9.6" xlink:to="loc_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable.4860.9.6" order="1.00000" xbrldt:closed="true" xbrldt:contextElement="segment" priority="0" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:type="arc" />
    <link:loc xlink:label="loc_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems.5018.7.6" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:type="locator" />
    <link:loc xlink:label="loc_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber.16626.7.6" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:type="locator" />
    <link:definitionArc xlink:from="loc_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems.5018.7.6" xlink:to="loc_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber.16626.7.6" order="2.00000" priority="0" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:type="arc" />
    <link:loc xlink:label="loc_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod.16617.7.6" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:type="locator" />
    <link:definitionArc xlink:from="loc_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems.5018.7.6" xlink:to="loc_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod.16617.7.6" order="3.00000" priority="0" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:type="arc" />
    <link:loc xlink:label="loc_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod.16661.7.6" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" xlink:type="locator" />
    <link:definitionArc xlink:from="loc_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems.5018.7.6" xlink:to="loc_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod.16661.7.6" order="4.00000" priority="0" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:type="arc" />
    <link:loc xlink:label="loc_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod.16633.7.6" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" xlink:type="locator" />
    <link:definitionArc xlink:from="loc_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems.5018.7.6" xlink:to="loc_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod.16633.7.6" order="5.00000" priority="0" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:type="arc" />
    <link:loc xlink:label="loc_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsExpectedToVest.25547.7.6" xlink:href="psti-20140630.xsd#psti_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsExpectedToVest" xlink:type="locator" />
    <link:definitionArc xlink:from="loc_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems.5018.7.6" xlink:to="loc_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsExpectedToVest.25547.7.6" order="7.00000" priority="0" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:type="arc" />
    <link:loc xlink:label="loc_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain.5034.7.6" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:type="locator" />
    <link:loc xlink:label="loc_RestrictedStockUnitsRSUMember.4568.7.6" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_RestrictedStockUnitsRSUMember" xlink:type="locator" />
    <link:definitionArc xlink:from="loc_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain.5034.7.6" xlink:to="loc_RestrictedStockUnitsRSUMember.4568.7.6" order="4.00000" priority="0" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:type="arc" />
  </link:definitionLink>
  <link:definitionLink xlink:title="308 - Disclosure - STOCKHOLDERS' EQUITY (Tables)" xlink:role="http://www.pluristem.com/role/StockholdersEquityTables" xlink:type="extended">
    <link:loc xlink:label="loc_AwardTypeAxis.367.8.6" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_AwardTypeAxis" xlink:type="locator" />
    <link:loc xlink:label="loc_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain.5034.8.6" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:type="locator" />
    <link:definitionArc xlink:from="loc_AwardTypeAxis.367.8.6" xlink:to="loc_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain.5034.8.6" order="1.00000" priority="0" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:type="arc" />
    <link:loc xlink:label="loc_AwardTypeAxis.367.6.6" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_AwardTypeAxis" xlink:type="locator" />
    <link:loc xlink:label="loc_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain.5034.6.6" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:type="locator" />
    <link:definitionArc xlink:from="loc_AwardTypeAxis.367.6.6" xlink:to="loc_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain.5034.6.6" order="2.00000" priority="0" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:type="arc" />
    <link:loc xlink:label="loc_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain.5034.7.6" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:type="locator" />
    <link:loc xlink:label="loc_ConsultantRestrictedStockUnitsMember.25534.7.6" xlink:href="psti-20140630.xsd#psti_ConsultantRestrictedStockUnitsMember" xlink:type="locator" />
    <link:definitionArc xlink:from="loc_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain.5034.7.6" xlink:to="loc_ConsultantRestrictedStockUnitsMember.25534.7.6" order="2.00000" priority="0" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:type="arc" />
    <link:loc xlink:label="loc_RestrictedStockUnitsRSUMember.4568.7.6" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_RestrictedStockUnitsRSUMember" xlink:type="locator" />
    <link:definitionArc xlink:from="loc_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain.5034.7.6" xlink:to="loc_RestrictedStockUnitsRSUMember.4568.7.6" order="1.50000" priority="0" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:type="arc" />
    <link:loc xlink:label="loc_EquityOptionsAndWarrantsMember.25537.7.6" xlink:href="psti-20140630.xsd#psti_EquityOptionsAndWarrantsMember" xlink:type="locator" />
    <link:definitionArc xlink:from="loc_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain.5034.7.6" xlink:to="loc_EquityOptionsAndWarrantsMember.25537.7.6" order="0.20000" priority="0" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:type="arc" />
    <link:loc xlink:label="loc_StockholdersEquityNoteLineItems.25553.9.6" xlink:href="psti-20140630.xsd#psti_StockholdersEquityNoteLineItems" xlink:type="locator" />
    <link:loc xlink:label="loc_StockholdersEquityNoteTable.25554.9.6" xlink:href="psti-20140630.xsd#psti_StockholdersEquityNoteTable" xlink:type="locator" />
    <link:definitionArc xlink:from="loc_StockholdersEquityNoteLineItems.25553.9.6" xlink:to="loc_StockholdersEquityNoteTable.25554.9.6" order="1.00000" xbrldt:closed="true" xbrldt:contextElement="segment" priority="0" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:type="arc" />
    <link:loc xlink:label="loc_StockholdersEquityNoteLineItems.25553.7.6" xlink:href="psti-20140630.xsd#psti_StockholdersEquityNoteLineItems" xlink:type="locator" />
    <link:loc xlink:label="loc_ScheduleOfNonvestedRestrictedStockUnitsActivityTableTextBlock.16168.7.6" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ScheduleOfNonvestedRestrictedStockUnitsActivityTableTextBlock" xlink:type="locator" />
    <link:definitionArc xlink:from="loc_StockholdersEquityNoteLineItems.25553.7.6" xlink:to="loc_ScheduleOfNonvestedRestrictedStockUnitsActivityTableTextBlock.16168.7.6" order="4.00000" priority="0" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:type="arc" />
    <link:loc xlink:label="loc_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock.16254.7.6" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock" xlink:type="locator" />
    <link:definitionArc xlink:from="loc_StockholdersEquityNoteLineItems.25553.7.6" xlink:to="loc_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock.16254.7.6" order="7.00000" priority="0" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:type="arc" />
    <link:loc xlink:label="loc_StockholdersEquityNoteTable.25554.5.6" xlink:href="psti-20140630.xsd#psti_StockholdersEquityNoteTable" xlink:type="locator" />
    <link:loc xlink:label="loc_AwardTypeAxis.367.5.6" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_AwardTypeAxis" xlink:type="locator" />
    <link:definitionArc xlink:from="loc_StockholdersEquityNoteTable.25554.5.6" xlink:to="loc_AwardTypeAxis.367.5.6" order="1.00000" priority="0" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:type="arc" />
  </link:definitionLink>
  <link:definitionLink xlink:title="40501 - Disclosure - PROPERTY AND EQUIPMENT, NET (Details)" xlink:role="http://www.pluristem.com/role/PropertyAndEquipmentNetDetails" xlink:type="extended">
    <link:loc xlink:label="loc_PropertyPlantAndEquipmentTypeDomain.4257.7.6" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:type="locator" />
    <link:loc xlink:label="loc_OtherMachineryAndEquipmentMember.3840.7.6" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_OtherMachineryAndEquipmentMember" xlink:type="locator" />
    <link:definitionArc xlink:from="loc_PropertyPlantAndEquipmentTypeDomain.4257.7.6" xlink:to="loc_OtherMachineryAndEquipmentMember.3840.7.6" order="1.00000" priority="0" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:type="arc" />
    <link:loc xlink:label="loc_ComputerEquipmentMember.1163.7.6" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ComputerEquipmentMember" xlink:type="locator" />
    <link:definitionArc xlink:from="loc_PropertyPlantAndEquipmentTypeDomain.4257.7.6" xlink:to="loc_ComputerEquipmentMember.1163.7.6" order="2.00000" priority="0" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:type="arc" />
    <link:loc xlink:label="loc_OfficeEquipmentMember.3650.7.6" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_OfficeEquipmentMember" xlink:type="locator" />
    <link:definitionArc xlink:from="loc_PropertyPlantAndEquipmentTypeDomain.4257.7.6" xlink:to="loc_OfficeEquipmentMember.3650.7.6" order="3.00000" priority="0" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:type="arc" />
    <link:loc xlink:label="loc_LeaseholdImprovementsMember.3017.7.6" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_LeaseholdImprovementsMember" xlink:type="locator" />
    <link:definitionArc xlink:from="loc_PropertyPlantAndEquipmentTypeDomain.4257.7.6" xlink:to="loc_LeaseholdImprovementsMember.3017.7.6" order="4.00000" priority="0" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:type="arc" />
    <link:loc xlink:label="loc_VehiclesMember.5488.7.6" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_VehiclesMember" xlink:type="locator" />
    <link:definitionArc xlink:from="loc_PropertyPlantAndEquipmentTypeDomain.4257.7.6" xlink:to="loc_VehiclesMember.5488.7.6" order="7.00000" priority="0" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:type="arc" />
    <link:loc xlink:label="loc_LeaseholdImprovementsOfNewFacilityConstructionMember.25578.7.6" xlink:href="psti-20140630.xsd#psti_LeaseholdImprovementsOfNewFacilityConstructionMember" xlink:type="locator" />
    <link:definitionArc xlink:from="loc_PropertyPlantAndEquipmentTypeDomain.4257.7.6" xlink:to="loc_LeaseholdImprovementsOfNewFacilityConstructionMember.25578.7.6" order="6.00000" priority="0" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:type="arc" />
    <link:loc xlink:label="loc_PropertyPlantAndEquipmentByTypeAxis.4261.8.6" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:type="locator" />
    <link:loc xlink:label="loc_PropertyPlantAndEquipmentTypeDomain.4257.8.6" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:type="locator" />
    <link:definitionArc xlink:from="loc_PropertyPlantAndEquipmentByTypeAxis.4261.8.6" xlink:to="loc_PropertyPlantAndEquipmentTypeDomain.4257.8.6" order="1.00000" priority="0" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:type="arc" />
    <link:loc xlink:label="loc_PropertyPlantAndEquipmentByTypeAxis.4261.6.6" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:type="locator" />
    <link:loc xlink:label="loc_PropertyPlantAndEquipmentTypeDomain.4257.6.6" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:type="locator" />
    <link:definitionArc xlink:from="loc_PropertyPlantAndEquipmentByTypeAxis.4261.6.6" xlink:to="loc_PropertyPlantAndEquipmentTypeDomain.4257.6.6" order="2.00000" priority="0" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:type="arc" />
    <link:loc xlink:label="loc_PropertyPlantAndEquipmentLineItems.4267.9.6" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_PropertyPlantAndEquipmentLineItems" xlink:type="locator" />
    <link:loc xlink:label="loc_ScheduleOfPropertyPlantAndEquipmentTable.4834.9.6" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:type="locator" />
    <link:definitionArc xlink:from="loc_PropertyPlantAndEquipmentLineItems.4267.9.6" xlink:to="loc_ScheduleOfPropertyPlantAndEquipmentTable.4834.9.6" order="1.00000" xbrldt:closed="true" xbrldt:contextElement="segment" priority="0" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:type="arc" />
    <link:loc xlink:label="loc_PropertyPlantAndEquipmentLineItems.4267.7.6" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_PropertyPlantAndEquipmentLineItems" xlink:type="locator" />
    <link:loc xlink:label="loc_PropertyPlantAndEquipmentGross.15025.7.6" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_PropertyPlantAndEquipmentGross" xlink:type="locator" />
    <link:definitionArc xlink:from="loc_PropertyPlantAndEquipmentLineItems.4267.7.6" xlink:to="loc_PropertyPlantAndEquipmentGross.15025.7.6" order="2.00000" priority="0" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:type="arc" />
    <link:loc xlink:label="loc_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment.5714.7.6" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:type="locator" />
    <link:definitionArc xlink:from="loc_PropertyPlantAndEquipmentLineItems.4267.7.6" xlink:to="loc_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment.5714.7.6" order="3.00000" priority="0" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:type="arc" />
    <link:loc xlink:label="loc_PropertyPlantAndEquipmentNet.15032.7.6" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet" xlink:type="locator" />
    <link:definitionArc xlink:from="loc_PropertyPlantAndEquipmentLineItems.4267.7.6" xlink:to="loc_PropertyPlantAndEquipmentNet.15032.7.6" order="4.00000" priority="0" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:type="arc" />
    <link:loc xlink:label="loc_Depreciation.8242.7.6" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_Depreciation" xlink:type="locator" />
    <link:definitionArc xlink:from="loc_PropertyPlantAndEquipmentLineItems.4267.7.6" xlink:to="loc_Depreciation.8242.7.6" order="5.00000" priority="0" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:type="arc" />
    <link:loc xlink:label="loc_ScheduleOfPropertyPlantAndEquipmentTable.4834.5.6" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:type="locator" />
    <link:loc xlink:label="loc_PropertyPlantAndEquipmentByTypeAxis.4261.5.6" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:type="locator" />
    <link:definitionArc xlink:from="loc_ScheduleOfPropertyPlantAndEquipmentTable.4834.5.6" xlink:to="loc_PropertyPlantAndEquipmentByTypeAxis.4261.5.6" order="1.00000" priority="0" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:type="arc" />
  </link:definitionLink>
  <link:definitionLink xlink:title="307 - Disclosure - COMMITMENTS AND CONTINGENCIES (Tables)" xlink:role="http://www.pluristem.com/role/CommitmentsAndContingenciesTables" xlink:type="extended">
    <link:loc xlink:label="loc_LongTermPurchaseCommitmentLineItems.3235.9.6" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_LongTermPurchaseCommitmentLineItems" xlink:type="locator" />
    <link:loc xlink:label="loc_LongTermPurchaseCommitmentTable.3238.9.6" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_LongTermPurchaseCommitmentTable" xlink:type="locator" />
    <link:definitionArc xlink:from="loc_LongTermPurchaseCommitmentLineItems.3235.9.6" xlink:to="loc_LongTermPurchaseCommitmentTable.3238.9.6" order="1.00000" xbrldt:closed="true" xbrldt:contextElement="segment" priority="0" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:type="arc" />
    <link:loc xlink:label="loc_LongTermPurchaseCommitmentLineItems.3235.7.6" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_LongTermPurchaseCommitmentLineItems" xlink:type="locator" />
    <link:loc xlink:label="loc_ScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesTableTextBlock.16187.7.6" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesTableTextBlock" xlink:type="locator" />
    <link:definitionArc xlink:from="loc_LongTermPurchaseCommitmentLineItems.3235.7.6" xlink:to="loc_ScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesTableTextBlock.16187.7.6" order="2.00000" priority="0" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:type="arc" />
    <link:loc xlink:label="loc_UnrecordedUnconditionalPurchaseObligationsDisclosureTextBlock.17555.7.6" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_UnrecordedUnconditionalPurchaseObligationsDisclosureTextBlock" xlink:type="locator" />
    <link:definitionArc xlink:from="loc_LongTermPurchaseCommitmentLineItems.3235.7.6" xlink:to="loc_UnrecordedUnconditionalPurchaseObligationsDisclosureTextBlock.17555.7.6" order="4.00000" priority="0" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:type="arc" />
    <link:loc xlink:label="loc_LongTermPurchaseCommitmentTable.3238.5.6" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_LongTermPurchaseCommitmentTable" xlink:type="locator" />
    <link:loc xlink:label="loc_PropertyPlantAndEquipmentByTypeAxis.4261.5.6" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:type="locator" />
    <link:definitionArc xlink:from="loc_LongTermPurchaseCommitmentTable.3238.5.6" xlink:to="loc_PropertyPlantAndEquipmentByTypeAxis.4261.5.6" order="1.50000" priority="0" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:type="arc" />
    <link:loc xlink:label="loc_PropertyPlantAndEquipmentTypeDomain.4257.7.6" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:type="locator" />
    <link:loc xlink:label="loc_LandAndBuildingMember.3008.7.6" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_LandAndBuildingMember" xlink:type="locator" />
    <link:definitionArc xlink:from="loc_PropertyPlantAndEquipmentTypeDomain.4257.7.6" xlink:to="loc_LandAndBuildingMember.3008.7.6" order="1.00000" priority="0" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:type="arc" />
    <link:loc xlink:label="loc_AutomobilesMember.395.7.6" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_AutomobilesMember" xlink:type="locator" />
    <link:definitionArc xlink:from="loc_PropertyPlantAndEquipmentTypeDomain.4257.7.6" xlink:to="loc_AutomobilesMember.395.7.6" order="2.00000" priority="0" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:type="arc" />
    <link:loc xlink:label="loc_PropertyPlantAndEquipmentByTypeAxis.4261.6.6" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:type="locator" />
    <link:loc xlink:label="loc_PropertyPlantAndEquipmentTypeDomain.4257.6.6" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:type="locator" />
    <link:definitionArc xlink:from="loc_PropertyPlantAndEquipmentByTypeAxis.4261.6.6" xlink:to="loc_PropertyPlantAndEquipmentTypeDomain.4257.6.6" order="1.00000" priority="0" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:type="arc" />
    <link:loc xlink:label="loc_PropertyPlantAndEquipmentByTypeAxis.4261.8.6" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:type="locator" />
    <link:loc xlink:label="loc_PropertyPlantAndEquipmentTypeDomain.4257.8.6" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:type="locator" />
    <link:definitionArc xlink:from="loc_PropertyPlantAndEquipmentByTypeAxis.4261.8.6" xlink:to="loc_PropertyPlantAndEquipmentTypeDomain.4257.8.6" order="2.00000" priority="0" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:type="arc" />
  </link:definitionLink>
  <link:definitionLink xlink:title="40701 - Disclosure - COMMITMENTS AND CONTINGENCIES (Operating Lease) (Details)" xlink:role="http://www.pluristem.com/role/CommitmentsAndContingenciesOperatingLeaseDetails" xlink:type="extended">
    <link:loc xlink:label="loc_GuaranteeObligationsByNatureAxis.2502.8.6" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_GuaranteeObligationsByNatureAxis" xlink:type="locator" />
    <link:loc xlink:label="loc_GuaranteeObligationsNatureDomain.2504.8.6" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_GuaranteeObligationsNatureDomain" xlink:type="locator" />
    <link:definitionArc xlink:from="loc_GuaranteeObligationsByNatureAxis.2502.8.6" xlink:to="loc_GuaranteeObligationsNatureDomain.2504.8.6" order="1.00000" priority="0" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:type="arc" />
    <link:loc xlink:label="loc_GuaranteeObligationsByNatureAxis.2502.6.6" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_GuaranteeObligationsByNatureAxis" xlink:type="locator" />
    <link:loc xlink:label="loc_GuaranteeObligationsNatureDomain.2504.6.6" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_GuaranteeObligationsNatureDomain" xlink:type="locator" />
    <link:definitionArc xlink:from="loc_GuaranteeObligationsByNatureAxis.2502.6.6" xlink:to="loc_GuaranteeObligationsNatureDomain.2504.6.6" order="2.00000" priority="0" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:type="arc" />
    <link:loc xlink:label="loc_GuaranteeObligationsNatureDomain.2504.7.6" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_GuaranteeObligationsNatureDomain" xlink:type="locator" />
    <link:loc xlink:label="loc_PropertyLeaseGuaranteeMember.4264.7.6" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_PropertyLeaseGuaranteeMember" xlink:type="locator" />
    <link:definitionArc xlink:from="loc_GuaranteeObligationsNatureDomain.2504.7.6" xlink:to="loc_PropertyLeaseGuaranteeMember.4264.7.6" order="1.00000" priority="0" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:type="arc" />
    <link:loc xlink:label="loc_OperatingLeasedAssetsLineItems.3696.9.6" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_OperatingLeasedAssetsLineItems" xlink:type="locator" />
    <link:loc xlink:label="loc_ScheduleOfOperatingLeasedAssetsTable.4775.9.6" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ScheduleOfOperatingLeasedAssetsTable" xlink:type="locator" />
    <link:definitionArc xlink:from="loc_OperatingLeasedAssetsLineItems.3696.9.6" xlink:to="loc_ScheduleOfOperatingLeasedAssetsTable.4775.9.6" order="1.00000" xbrldt:closed="true" xbrldt:contextElement="segment" priority="0" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:type="arc" />
    <link:loc xlink:label="loc_OperatingLeasedAssetsLineItems.3696.7.6" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_OperatingLeasedAssetsLineItems" xlink:type="locator" />
    <link:loc xlink:label="loc_OperatingLeasesRentExpenseNet.13438.7.6" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_OperatingLeasesRentExpenseNet" xlink:type="locator" />
    <link:definitionArc xlink:from="loc_OperatingLeasedAssetsLineItems.3696.7.6" xlink:to="loc_OperatingLeasesRentExpenseNet.13438.7.6" order="7.00000" priority="0" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:type="arc" />
    <link:loc xlink:label="loc_OperatingLeasesFutureMinimumPaymentsDueInTwoYears.13442.7.6" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_OperatingLeasesFutureMinimumPaymentsDueInTwoYears" xlink:type="locator" />
    <link:definitionArc xlink:from="loc_OperatingLeasedAssetsLineItems.3696.7.6" xlink:to="loc_OperatingLeasesFutureMinimumPaymentsDueInTwoYears.13442.7.6" order="8.00000" priority="0" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:type="arc" />
    <link:loc xlink:label="loc_OperatingLeasesFutureMinimumPaymentsDueInThreeYears.13435.7.6" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_OperatingLeasesFutureMinimumPaymentsDueInThreeYears" xlink:type="locator" />
    <link:definitionArc xlink:from="loc_OperatingLeasedAssetsLineItems.3696.7.6" xlink:to="loc_OperatingLeasesFutureMinimumPaymentsDueInThreeYears.13435.7.6" order="9.00000" priority="0" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:type="arc" />
    <link:loc xlink:label="loc_OperatingLeasesFutureMinimumPaymentsDueInFourYears.13426.7.6" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_OperatingLeasesFutureMinimumPaymentsDueInFourYears" xlink:type="locator" />
    <link:definitionArc xlink:from="loc_OperatingLeasedAssetsLineItems.3696.7.6" xlink:to="loc_OperatingLeasesFutureMinimumPaymentsDueInFourYears.13426.7.6" order="10.00000" priority="0" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:type="arc" />
    <link:loc xlink:label="loc_OperatingLeasesFutureMinimumPaymentsDue.13467.7.6" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_OperatingLeasesFutureMinimumPaymentsDue" xlink:type="locator" />
    <link:definitionArc xlink:from="loc_OperatingLeasedAssetsLineItems.3696.7.6" xlink:to="loc_OperatingLeasesFutureMinimumPaymentsDue.13467.7.6" order="11.00000" priority="0" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:type="arc" />
    <link:loc xlink:label="loc_OperatingLeasedAssetsNumberOfUnits.25588.7.6" xlink:href="psti-20140630.xsd#psti_OperatingLeasedAssetsNumberOfUnits" xlink:type="locator" />
    <link:definitionArc xlink:from="loc_OperatingLeasedAssetsLineItems.3696.7.6" xlink:to="loc_OperatingLeasedAssetsNumberOfUnits.25588.7.6" order="0.50000" priority="0" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:type="arc" />
    <link:loc xlink:label="loc_OperatingLeasesFutureMinimumPaymentsDueCurrent.13462.7.6" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_OperatingLeasesFutureMinimumPaymentsDueCurrent" xlink:type="locator" />
    <link:definitionArc xlink:from="loc_OperatingLeasedAssetsLineItems.3696.7.6" xlink:to="loc_OperatingLeasesFutureMinimumPaymentsDueCurrent.13462.7.6" order="6.50000" priority="0" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:type="arc" />
    <link:loc xlink:label="loc_OperatingLeasesFutureMinimumPaymentsDueInFiveYears.13419.7.6" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_OperatingLeasesFutureMinimumPaymentsDueInFiveYears" xlink:type="locator" />
    <link:definitionArc xlink:from="loc_OperatingLeasedAssetsLineItems.3696.7.6" xlink:to="loc_OperatingLeasesFutureMinimumPaymentsDueInFiveYears.13419.7.6" order="9.50000" priority="0" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:type="arc" />
    <link:loc xlink:label="loc_OperatingLeasedAssetsParticipationFromLessor.26037.7.6" xlink:href="psti-20140630.xsd#psti_OperatingLeasedAssetsParticipationFromLessor" xlink:type="locator" />
    <link:definitionArc xlink:from="loc_OperatingLeasedAssetsLineItems.3696.7.6" xlink:to="loc_OperatingLeasedAssetsParticipationFromLessor.26037.7.6" order="1.50000" priority="0" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:type="arc" />
    <link:loc xlink:label="loc_PledgedAssetsNotSeparatelyReportedOtherFinancialInstruments.14323.7.6" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_PledgedAssetsNotSeparatelyReportedOtherFinancialInstruments" xlink:type="locator" />
    <link:definitionArc xlink:from="loc_OperatingLeasedAssetsLineItems.3696.7.6" xlink:to="loc_PledgedAssetsNotSeparatelyReportedOtherFinancialInstruments.14323.7.6" order="5.50000" priority="0" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:type="arc" />
    <link:loc xlink:label="loc_GuaranteeObligationsCurrentCarryingValue.10671.7.6" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_GuaranteeObligationsCurrentCarryingValue" xlink:type="locator" />
    <link:definitionArc xlink:from="loc_OperatingLeasedAssetsLineItems.3696.7.6" xlink:to="loc_GuaranteeObligationsCurrentCarryingValue.10671.7.6" order="3.50000" priority="0" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:type="arc" />
    <link:loc xlink:label="loc_PropertyPlantAndEquipmentTypeDomain.4257.7.6" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:type="locator" />
    <link:loc xlink:label="loc_AutomobilesMember.395.7.6" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_AutomobilesMember" xlink:type="locator" />
    <link:definitionArc xlink:from="loc_PropertyPlantAndEquipmentTypeDomain.4257.7.6" xlink:to="loc_AutomobilesMember.395.7.6" order="2.00000" priority="0" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:type="arc" />
    <link:loc xlink:label="loc_LandAndBuildingMember.3008.7.6" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_LandAndBuildingMember" xlink:type="locator" />
    <link:definitionArc xlink:from="loc_PropertyPlantAndEquipmentTypeDomain.4257.7.6" xlink:to="loc_LandAndBuildingMember.3008.7.6" order="1.50000" priority="0" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:type="arc" />
    <link:loc xlink:label="loc_PropertyPlantAndEquipmentByTypeAxis.4261.8.6" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:type="locator" />
    <link:loc xlink:label="loc_PropertyPlantAndEquipmentTypeDomain.4257.8.6" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:type="locator" />
    <link:definitionArc xlink:from="loc_PropertyPlantAndEquipmentByTypeAxis.4261.8.6" xlink:to="loc_PropertyPlantAndEquipmentTypeDomain.4257.8.6" order="1.00000" priority="0" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:type="arc" />
    <link:loc xlink:label="loc_PropertyPlantAndEquipmentByTypeAxis.4261.6.6" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:type="locator" />
    <link:loc xlink:label="loc_PropertyPlantAndEquipmentTypeDomain.4257.6.6" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:type="locator" />
    <link:definitionArc xlink:from="loc_PropertyPlantAndEquipmentByTypeAxis.4261.6.6" xlink:to="loc_PropertyPlantAndEquipmentTypeDomain.4257.6.6" order="2.00000" priority="0" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:type="arc" />
    <link:loc xlink:label="loc_RangeAxis.4349.8.6" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_RangeAxis" xlink:type="locator" />
    <link:loc xlink:label="loc_RangeMember.4350.8.6" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_RangeMember" xlink:type="locator" />
    <link:definitionArc xlink:from="loc_RangeAxis.4349.8.6" xlink:to="loc_RangeMember.4350.8.6" order="1.00000" priority="0" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:type="arc" />
    <link:loc xlink:label="loc_RangeAxis.4349.6.6" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_RangeAxis" xlink:type="locator" />
    <link:loc xlink:label="loc_RangeMember.4350.6.6" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_RangeMember" xlink:type="locator" />
    <link:definitionArc xlink:from="loc_RangeAxis.4349.6.6" xlink:to="loc_RangeMember.4350.6.6" order="2.00000" priority="0" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:type="arc" />
    <link:loc xlink:label="loc_RangeMember.4350.7.6" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_RangeMember" xlink:type="locator" />
    <link:loc xlink:label="loc_MaximumMember.3361.7.6" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_MaximumMember" xlink:type="locator" />
    <link:definitionArc xlink:from="loc_RangeMember.4350.7.6" xlink:to="loc_MaximumMember.3361.7.6" order="2.00000" priority="0" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:type="arc" />
    <link:loc xlink:label="loc_MinimumMember.3370.7.6" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_MinimumMember" xlink:type="locator" />
    <link:definitionArc xlink:from="loc_RangeMember.4350.7.6" xlink:to="loc_MinimumMember.3370.7.6" order="1.00000" priority="0" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:type="arc" />
    <link:loc xlink:label="loc_ScheduleOfOperatingLeasedAssetsTable.4775.5.6" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ScheduleOfOperatingLeasedAssetsTable" xlink:type="locator" />
    <link:loc xlink:label="loc_PropertyPlantAndEquipmentByTypeAxis.4261.5.6" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:type="locator" />
    <link:definitionArc xlink:from="loc_ScheduleOfOperatingLeasedAssetsTable.4775.5.6" xlink:to="loc_PropertyPlantAndEquipmentByTypeAxis.4261.5.6" order="1.00000" priority="0" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:type="arc" />
    <link:loc xlink:label="loc_GuaranteeObligationsByNatureAxis.2502.5.6" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_GuaranteeObligationsByNatureAxis" xlink:type="locator" />
    <link:definitionArc xlink:from="loc_ScheduleOfOperatingLeasedAssetsTable.4775.5.6" xlink:to="loc_GuaranteeObligationsByNatureAxis.2502.5.6" order="2.50000" priority="0" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:type="arc" />
    <link:loc xlink:label="loc_RangeAxis.4349.5.6" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_RangeAxis" xlink:type="locator" />
    <link:definitionArc xlink:from="loc_ScheduleOfOperatingLeasedAssetsTable.4775.5.6" xlink:to="loc_RangeAxis.4349.5.6" order="2.75000" priority="0" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:type="arc" />
  </link:definitionLink>
  <link:definitionLink xlink:title="40702 - Disclosure - COMMITMENTS AND CONTINGENCIES (Commitment to Suppliers and Contractor) (Details)" xlink:role="http://www.pluristem.com/role/CommitmentsAndContingenciesCommitmentToSuppliersAndContractorDetails" xlink:type="extended">
    <link:loc xlink:label="loc_LongTermPurchaseCommitmentLineItems.3235.9.6" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_LongTermPurchaseCommitmentLineItems" xlink:type="locator" />
    <link:loc xlink:label="loc_LongTermPurchaseCommitmentTable.3238.9.6" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_LongTermPurchaseCommitmentTable" xlink:type="locator" />
    <link:definitionArc xlink:from="loc_LongTermPurchaseCommitmentLineItems.3235.9.6" xlink:to="loc_LongTermPurchaseCommitmentTable.3238.9.6" order="1.00000" xbrldt:closed="true" xbrldt:contextElement="segment" priority="0" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:type="arc" />
    <link:loc xlink:label="loc_LongTermPurchaseCommitmentLineItems.3235.7.6" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_LongTermPurchaseCommitmentLineItems" xlink:type="locator" />
    <link:loc xlink:label="loc_LongTermPurchaseCommitmentFutureMinimumPaymentDueCurrent.25591.7.6" xlink:href="psti-20140630.xsd#psti_LongTermPurchaseCommitmentFutureMinimumPaymentDueCurrent" xlink:type="locator" />
    <link:definitionArc xlink:from="loc_LongTermPurchaseCommitmentLineItems.3235.7.6" xlink:to="loc_LongTermPurchaseCommitmentFutureMinimumPaymentDueCurrent.25591.7.6" order="2.00000" priority="0" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:type="arc" />
    <link:loc xlink:label="loc_LongTermPurchaseCommitmentFutureMinimumPaymentDueInThreeYears.25592.7.6" xlink:href="psti-20140630.xsd#psti_LongTermPurchaseCommitmentFutureMinimumPaymentDueInThreeYears" xlink:type="locator" />
    <link:definitionArc xlink:from="loc_LongTermPurchaseCommitmentLineItems.3235.7.6" xlink:to="loc_LongTermPurchaseCommitmentFutureMinimumPaymentDueInThreeYears.25592.7.6" order="3.00000" priority="0" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:type="arc" />
    <link:loc xlink:label="loc_LongTermPurchaseCommitmentFutureMinimumPaymentDue.25593.7.6" xlink:href="psti-20140630.xsd#psti_LongTermPurchaseCommitmentFutureMinimumPaymentDue" xlink:type="locator" />
    <link:definitionArc xlink:from="loc_LongTermPurchaseCommitmentLineItems.3235.7.6" xlink:to="loc_LongTermPurchaseCommitmentFutureMinimumPaymentDue.25593.7.6" order="4.00000" priority="0" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:type="arc" />
    <link:loc xlink:label="loc_GrantsReceivable.10656.7.6" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_GrantsReceivable" xlink:type="locator" />
    <link:definitionArc xlink:from="loc_LongTermPurchaseCommitmentLineItems.3235.7.6" xlink:to="loc_GrantsReceivable.10656.7.6" order="5.00000" priority="0" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:type="arc" />
    <link:loc xlink:label="loc_RoyaltyPayable.25594.7.6" xlink:href="psti-20140630.xsd#psti_RoyaltyPayable" xlink:type="locator" />
    <link:definitionArc xlink:from="loc_LongTermPurchaseCommitmentLineItems.3235.7.6" xlink:to="loc_RoyaltyPayable.25594.7.6" order="6.00000" priority="0" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:type="arc" />
    <link:loc xlink:label="loc_LongTermPurchaseCommitmentCategoryOfItemPurchasedDomain.3237.7.6" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_LongTermPurchaseCommitmentCategoryOfItemPurchasedDomain" xlink:type="locator" />
    <link:loc xlink:label="loc_LongTermPurchaseCommitmentToSuppliersAndContractorMember.25595.7.6" xlink:href="psti-20140630.xsd#psti_LongTermPurchaseCommitmentToSuppliersAndContractorMember" xlink:type="locator" />
    <link:definitionArc xlink:from="loc_LongTermPurchaseCommitmentCategoryOfItemPurchasedDomain.3237.7.6" xlink:to="loc_LongTermPurchaseCommitmentToSuppliersAndContractorMember.25595.7.6" order="1.00000" priority="0" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:type="arc" />
    <link:loc xlink:label="loc_LongTermPurchaseCommitmentTable.3238.5.6" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_LongTermPurchaseCommitmentTable" xlink:type="locator" />
    <link:loc xlink:label="loc_LongTermPurchaseCommitmentByCategoryOfItemPurchasedAxis.3241.5.6" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_LongTermPurchaseCommitmentByCategoryOfItemPurchasedAxis" xlink:type="locator" />
    <link:definitionArc xlink:from="loc_LongTermPurchaseCommitmentTable.3238.5.6" xlink:to="loc_LongTermPurchaseCommitmentByCategoryOfItemPurchasedAxis.3241.5.6" order="1.00000" priority="0" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:type="arc" />
    <link:loc xlink:label="loc_LongTermPurchaseCommitmentByCategoryOfItemPurchasedAxis.3241.6.6" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_LongTermPurchaseCommitmentByCategoryOfItemPurchasedAxis" xlink:type="locator" />
    <link:loc xlink:label="loc_LongTermPurchaseCommitmentCategoryOfItemPurchasedDomain.3237.6.6" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_LongTermPurchaseCommitmentCategoryOfItemPurchasedDomain" xlink:type="locator" />
    <link:definitionArc xlink:from="loc_LongTermPurchaseCommitmentByCategoryOfItemPurchasedAxis.3241.6.6" xlink:to="loc_LongTermPurchaseCommitmentCategoryOfItemPurchasedDomain.3237.6.6" order="1.00000" priority="0" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:type="arc" />
    <link:loc xlink:label="loc_LongTermPurchaseCommitmentByCategoryOfItemPurchasedAxis.3241.8.6" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_LongTermPurchaseCommitmentByCategoryOfItemPurchasedAxis" xlink:type="locator" />
    <link:loc xlink:label="loc_LongTermPurchaseCommitmentCategoryOfItemPurchasedDomain.3237.8.6" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_LongTermPurchaseCommitmentCategoryOfItemPurchasedDomain" xlink:type="locator" />
    <link:definitionArc xlink:from="loc_LongTermPurchaseCommitmentByCategoryOfItemPurchasedAxis.3241.8.6" xlink:to="loc_LongTermPurchaseCommitmentCategoryOfItemPurchasedDomain.3237.8.6" order="2.00000" priority="0" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:type="arc" />
  </link:definitionLink>
  <link:definitionLink xlink:title="41001 - Disclosure - TAXES ON INCOME (Narrative) (Details)" xlink:role="http://www.pluristem.com/role/TaxesOnIncomeNarrativeDetails" xlink:type="extended">
    <link:loc xlink:label="loc_EntityDomain.99.7.6" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_EntityDomain" xlink:type="locator" />
    <link:loc xlink:label="loc_ParentCompanyMember.3915.7.6" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ParentCompanyMember" xlink:type="locator" />
    <link:definitionArc xlink:from="loc_EntityDomain.99.7.6" xlink:to="loc_ParentCompanyMember.3915.7.6" order="1.00000" priority="0" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:type="arc" />
    <link:loc xlink:label="loc_SubsidiariesMember.5165.7.6" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_SubsidiariesMember" xlink:type="locator" />
    <link:definitionArc xlink:from="loc_EntityDomain.99.7.6" xlink:to="loc_SubsidiariesMember.5165.7.6" order="2.00000" priority="0" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:type="arc" />
    <link:loc xlink:label="loc_LegalEntityAxis.136.8.6" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_LegalEntityAxis" xlink:type="locator" />
    <link:loc xlink:label="loc_EntityDomain.99.8.6" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_EntityDomain" xlink:type="locator" />
    <link:definitionArc xlink:from="loc_LegalEntityAxis.136.8.6" xlink:to="loc_EntityDomain.99.8.6" order="1.00000" priority="0" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:type="arc" />
    <link:loc xlink:label="loc_LegalEntityAxis.136.6.6" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_LegalEntityAxis" xlink:type="locator" />
    <link:loc xlink:label="loc_EntityDomain.99.6.6" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_EntityDomain" xlink:type="locator" />
    <link:definitionArc xlink:from="loc_LegalEntityAxis.136.6.6" xlink:to="loc_EntityDomain.99.6.6" order="2.00000" priority="0" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:type="arc" />
    <link:loc xlink:label="loc_IncomeTaxAuthorityDomain.2635.7.6" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_IncomeTaxAuthorityDomain" xlink:type="locator" />
    <link:loc xlink:label="loc_DomesticCountryMember.1737.7.6" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_DomesticCountryMember" xlink:type="locator" />
    <link:definitionArc xlink:from="loc_IncomeTaxAuthorityDomain.2635.7.6" xlink:to="loc_DomesticCountryMember.1737.7.6" order="2.00000" priority="0" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:type="arc" />
    <link:loc xlink:label="loc_InternalRevenueServiceIRSMember.2877.7.6" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_InternalRevenueServiceIRSMember" xlink:type="locator" />
    <link:definitionArc xlink:from="loc_IncomeTaxAuthorityDomain.2635.7.6" xlink:to="loc_InternalRevenueServiceIRSMember.2877.7.6" order="3.00000" priority="0" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:type="arc" />
    <link:loc xlink:label="loc_IsraelTaxAuthorityMember.2580.7.6" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_IsraelTaxAuthorityMember" xlink:type="locator" />
    <link:definitionArc xlink:from="loc_IncomeTaxAuthorityDomain.2635.7.6" xlink:to="loc_IsraelTaxAuthorityMember.2580.7.6" order="1.50000" priority="0" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:type="arc" />
    <link:loc xlink:label="loc_IncomeTaxAuthorityAxis.2667.8.6" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_IncomeTaxAuthorityAxis" xlink:type="locator" />
    <link:loc xlink:label="loc_IncomeTaxAuthorityDomain.2635.8.6" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_IncomeTaxAuthorityDomain" xlink:type="locator" />
    <link:definitionArc xlink:from="loc_IncomeTaxAuthorityAxis.2667.8.6" xlink:to="loc_IncomeTaxAuthorityDomain.2635.8.6" order="1.00000" priority="0" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:type="arc" />
    <link:loc xlink:label="loc_IncomeTaxAuthorityAxis.2667.6.6" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_IncomeTaxAuthorityAxis" xlink:type="locator" />
    <link:loc xlink:label="loc_IncomeTaxAuthorityDomain.2635.6.6" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_IncomeTaxAuthorityDomain" xlink:type="locator" />
    <link:definitionArc xlink:from="loc_IncomeTaxAuthorityAxis.2667.6.6" xlink:to="loc_IncomeTaxAuthorityDomain.2635.6.6" order="2.00000" priority="0" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:type="arc" />
    <link:loc xlink:label="loc_PropertyPlantAndEquipmentTypeDomain.4257.7.6" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:type="locator" />
    <link:loc xlink:label="loc_BuildingMember.772.7.6" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_BuildingMember" xlink:type="locator" />
    <link:definitionArc xlink:from="loc_PropertyPlantAndEquipmentTypeDomain.4257.7.6" xlink:to="loc_BuildingMember.772.7.6" order="1.00000" priority="0" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:type="arc" />
    <link:loc xlink:label="loc_PropertyPlantAndEquipmentByTypeAxis.4261.8.6" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:type="locator" />
    <link:loc xlink:label="loc_PropertyPlantAndEquipmentTypeDomain.4257.8.6" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:type="locator" />
    <link:definitionArc xlink:from="loc_PropertyPlantAndEquipmentByTypeAxis.4261.8.6" xlink:to="loc_PropertyPlantAndEquipmentTypeDomain.4257.8.6" order="1.00000" priority="0" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:type="arc" />
    <link:loc xlink:label="loc_PropertyPlantAndEquipmentByTypeAxis.4261.6.6" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:type="locator" />
    <link:loc xlink:label="loc_PropertyPlantAndEquipmentTypeDomain.4257.6.6" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:type="locator" />
    <link:definitionArc xlink:from="loc_PropertyPlantAndEquipmentByTypeAxis.4261.6.6" xlink:to="loc_PropertyPlantAndEquipmentTypeDomain.4257.6.6" order="2.00000" priority="0" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:type="arc" />
    <link:loc xlink:label="loc_RangeAxis.4349.8.6" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_RangeAxis" xlink:type="locator" />
    <link:loc xlink:label="loc_RangeMember.4350.8.6" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_RangeMember" xlink:type="locator" />
    <link:definitionArc xlink:from="loc_RangeAxis.4349.8.6" xlink:to="loc_RangeMember.4350.8.6" order="1.00000" priority="0" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:type="arc" />
    <link:loc xlink:label="loc_RangeAxis.4349.6.6" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_RangeAxis" xlink:type="locator" />
    <link:loc xlink:label="loc_RangeMember.4350.6.6" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_RangeMember" xlink:type="locator" />
    <link:definitionArc xlink:from="loc_RangeAxis.4349.6.6" xlink:to="loc_RangeMember.4350.6.6" order="2.00000" priority="0" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:type="arc" />
    <link:loc xlink:label="loc_RangeMember.4350.7.6" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_RangeMember" xlink:type="locator" />
    <link:loc xlink:label="loc_MinimumMember.3370.7.6" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_MinimumMember" xlink:type="locator" />
    <link:definitionArc xlink:from="loc_RangeMember.4350.7.6" xlink:to="loc_MinimumMember.3370.7.6" order="1.00000" priority="0" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:type="arc" />
    <link:loc xlink:label="loc_MaximumMember.3361.7.6" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_MaximumMember" xlink:type="locator" />
    <link:definitionArc xlink:from="loc_RangeMember.4350.7.6" xlink:to="loc_MaximumMember.3361.7.6" order="2.00000" priority="0" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:type="arc" />
    <link:loc xlink:label="loc_TaxPeriodAxis.5240.6.6" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_TaxPeriodAxis" xlink:type="locator" />
    <link:loc xlink:label="loc_TaxPeriodDomain.5241.6.6" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_TaxPeriodDomain" xlink:type="locator" />
    <link:definitionArc xlink:from="loc_TaxPeriodAxis.5240.6.6" xlink:to="loc_TaxPeriodDomain.5241.6.6" order="1.00000" priority="0" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:type="arc" />
    <link:loc xlink:label="loc_TaxPeriodAxis.5240.8.6" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_TaxPeriodAxis" xlink:type="locator" />
    <link:loc xlink:label="loc_TaxPeriodDomain.5241.8.6" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_TaxPeriodDomain" xlink:type="locator" />
    <link:definitionArc xlink:from="loc_TaxPeriodAxis.5240.8.6" xlink:to="loc_TaxPeriodDomain.5241.8.6" order="2.00000" priority="0" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:type="arc" />
    <link:loc xlink:label="loc_TaxPeriodDomain.5241.7.6" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_TaxPeriodDomain" xlink:type="locator" />
    <link:loc xlink:label="loc_EarliestTaxYearMember.1754.7.6" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_EarliestTaxYearMember" xlink:type="locator" />
    <link:definitionArc xlink:from="loc_TaxPeriodDomain.5241.7.6" xlink:to="loc_EarliestTaxYearMember.1754.7.6" order="1.00000" priority="0" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:type="arc" />
    <link:loc xlink:label="loc_LatestTaxYearMember.2979.7.6" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_LatestTaxYearMember" xlink:type="locator" />
    <link:definitionArc xlink:from="loc_TaxPeriodDomain.5241.7.6" xlink:to="loc_LatestTaxYearMember.2979.7.6" order="2.00000" priority="0" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:type="arc" />
    <link:loc xlink:label="loc_IncomeTaxTable.25599.5.6" xlink:href="psti-20140630.xsd#psti_IncomeTaxTable" xlink:type="locator" />
    <link:loc xlink:label="loc_LegalEntityAxis.136.5.6" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_LegalEntityAxis" xlink:type="locator" />
    <link:definitionArc xlink:from="loc_IncomeTaxTable.25599.5.6" xlink:to="loc_LegalEntityAxis.136.5.6" order="1.00000" priority="0" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:type="arc" />
    <link:loc xlink:label="loc_IncomeTaxAuthorityAxis.2667.5.6" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_IncomeTaxAuthorityAxis" xlink:type="locator" />
    <link:definitionArc xlink:from="loc_IncomeTaxTable.25599.5.6" xlink:to="loc_IncomeTaxAuthorityAxis.2667.5.6" order="1.50000" priority="0" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:type="arc" />
    <link:loc xlink:label="loc_RangeAxis.4349.5.6" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_RangeAxis" xlink:type="locator" />
    <link:definitionArc xlink:from="loc_IncomeTaxTable.25599.5.6" xlink:to="loc_RangeAxis.4349.5.6" order="1.88000" priority="0" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:type="arc" />
    <link:loc xlink:label="loc_PropertyPlantAndEquipmentByTypeAxis.4261.5.6" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:type="locator" />
    <link:definitionArc xlink:from="loc_IncomeTaxTable.25599.5.6" xlink:to="loc_PropertyPlantAndEquipmentByTypeAxis.4261.5.6" order="1.94000" priority="0" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:type="arc" />
    <link:loc xlink:label="loc_BeneficiaryEnterpriseProgramAxis.25600.5.6" xlink:href="psti-20140630.xsd#psti_BeneficiaryEnterpriseProgramAxis" xlink:type="locator" />
    <link:definitionArc xlink:from="loc_IncomeTaxTable.25599.5.6" xlink:to="loc_BeneficiaryEnterpriseProgramAxis.25600.5.6" order="1.97000" priority="0" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:type="arc" />
    <link:loc xlink:label="loc_TaxPeriodAxis.5240.5.6" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_TaxPeriodAxis" xlink:type="locator" />
    <link:definitionArc xlink:from="loc_IncomeTaxTable.25599.5.6" xlink:to="loc_TaxPeriodAxis.5240.5.6" order="1.98500" priority="0" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:type="arc" />
    <link:loc xlink:label="loc_BeneficiaryEnterpriseProgramAxis.25600.8.6" xlink:href="psti-20140630.xsd#psti_BeneficiaryEnterpriseProgramAxis" xlink:type="locator" />
    <link:loc xlink:label="loc_BeneficiaryEnterpriseProgramDomain.25601.8.6" xlink:href="psti-20140630.xsd#psti_BeneficiaryEnterpriseProgramDomain" xlink:type="locator" />
    <link:definitionArc xlink:from="loc_BeneficiaryEnterpriseProgramAxis.25600.8.6" xlink:to="loc_BeneficiaryEnterpriseProgramDomain.25601.8.6" order="1.00000" priority="0" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:type="arc" />
    <link:loc xlink:label="loc_BeneficiaryEnterpriseProgramAxis.25600.6.6" xlink:href="psti-20140630.xsd#psti_BeneficiaryEnterpriseProgramAxis" xlink:type="locator" />
    <link:loc xlink:label="loc_BeneficiaryEnterpriseProgramDomain.25601.6.6" xlink:href="psti-20140630.xsd#psti_BeneficiaryEnterpriseProgramDomain" xlink:type="locator" />
    <link:definitionArc xlink:from="loc_BeneficiaryEnterpriseProgramAxis.25600.6.6" xlink:to="loc_BeneficiaryEnterpriseProgramDomain.25601.6.6" order="2.00000" priority="0" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:type="arc" />
    <link:loc xlink:label="loc_BeneficiaryEnterpriseProgramDomain.25601.7.6" xlink:href="psti-20140630.xsd#psti_BeneficiaryEnterpriseProgramDomain" xlink:type="locator" />
    <link:loc xlink:label="loc_TwoThousandSevenProgramMember.25602.7.6" xlink:href="psti-20140630.xsd#psti_TwoThousandSevenProgramMember" xlink:type="locator" />
    <link:definitionArc xlink:from="loc_BeneficiaryEnterpriseProgramDomain.25601.7.6" xlink:to="loc_TwoThousandSevenProgramMember.25602.7.6" order="1.00000" priority="0" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:type="arc" />
    <link:loc xlink:label="loc_TwoThousandTwelveProgramMember.25603.7.6" xlink:href="psti-20140630.xsd#psti_TwoThousandTwelveProgramMember" xlink:type="locator" />
    <link:definitionArc xlink:from="loc_BeneficiaryEnterpriseProgramDomain.25601.7.6" xlink:to="loc_TwoThousandTwelveProgramMember.25603.7.6" order="2.00000" priority="0" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:type="arc" />
    <link:loc xlink:label="loc_CarryforwardLossesForTaxPurposesAbstract.25604.7.6" xlink:href="psti-20140630.xsd#psti_CarryforwardLossesForTaxPurposesAbstract" xlink:type="locator" />
    <link:loc xlink:label="loc_OperatingLossCarryforwards.13469.7.6" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_OperatingLossCarryforwards" xlink:type="locator" />
    <link:definitionArc xlink:from="loc_CarryforwardLossesForTaxPurposesAbstract.25604.7.6" xlink:to="loc_OperatingLossCarryforwards.13469.7.6" order="1.00000" priority="0" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:type="arc" />
    <link:loc xlink:label="loc_OperatingLossCarryforwardsExpirationDate.13455.7.6" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_OperatingLossCarryforwardsExpirationDate" xlink:type="locator" />
    <link:definitionArc xlink:from="loc_CarryforwardLossesForTaxPurposesAbstract.25604.7.6" xlink:to="loc_OperatingLossCarryforwardsExpirationDate.13455.7.6" order="2.00000" priority="0" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:type="arc" />
    <link:loc xlink:label="loc_IncomeTaxLineItems.25605.9.6" xlink:href="psti-20140630.xsd#psti_IncomeTaxLineItems" xlink:type="locator" />
    <link:loc xlink:label="loc_IncomeTaxTable.25599.9.6" xlink:href="psti-20140630.xsd#psti_IncomeTaxTable" xlink:type="locator" />
    <link:definitionArc xlink:from="loc_IncomeTaxLineItems.25605.9.6" xlink:to="loc_IncomeTaxTable.25599.9.6" order="1.00000" xbrldt:closed="true" xbrldt:contextElement="segment" priority="0" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:type="arc" />
    <link:loc xlink:label="loc_IncomeTaxLineItems.25605.7.6" xlink:href="psti-20140630.xsd#psti_IncomeTaxLineItems" xlink:type="locator" />
    <link:loc xlink:label="loc_TaxRatesApplicableToCompanyAbstract.25606.7.6" xlink:href="psti-20140630.xsd#psti_TaxRatesApplicableToCompanyAbstract" xlink:type="locator" />
    <link:definitionArc xlink:from="loc_IncomeTaxLineItems.25605.7.6" xlink:to="loc_TaxRatesApplicableToCompanyAbstract.25606.7.6" order="2.00000" priority="0" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:type="arc" />
    <link:loc xlink:label="loc_TaxRateBenefitsToCompanyAbstract.25607.7.6" xlink:href="psti-20140630.xsd#psti_TaxRateBenefitsToCompanyAbstract" xlink:type="locator" />
    <link:definitionArc xlink:from="loc_IncomeTaxLineItems.25605.7.6" xlink:to="loc_TaxRateBenefitsToCompanyAbstract.25607.7.6" order="3.00000" priority="0" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:type="arc" />
    <link:definitionArc xlink:from="loc_IncomeTaxLineItems.25605.7.6" xlink:to="loc_CarryforwardLossesForTaxPurposesAbstract.25604.7.6" order="4.00000" priority="0" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:type="arc" />
    <link:loc xlink:label="loc_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate.9055.7.6" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" xlink:type="locator" />
    <link:definitionArc xlink:from="loc_TaxRatesApplicableToCompanyAbstract.25606.7.6" xlink:to="loc_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate.9055.7.6" order="1.00000" priority="0" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:type="arc" />
    <link:loc xlink:label="loc_EffectiveIncomeTaxRateContinuingOperations.9032.7.6" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:type="locator" />
    <link:definitionArc xlink:from="loc_TaxRatesApplicableToCompanyAbstract.25606.7.6" xlink:to="loc_EffectiveIncomeTaxRateContinuingOperations.9032.7.6" order="2.00000" priority="0" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:type="arc" />
    <link:loc xlink:label="loc_LawForEconomicEfficiencyAmendedLegislationImplementingEconomicPlanForTwoThousandNineAndTenTaxRate.25625.7.6" xlink:href="psti-20140630.xsd#psti_LawForEconomicEfficiencyAmendedLegislationImplementingEconomicPlanForTwoThousandNineAndTenTaxRate" xlink:type="locator" />
    <link:definitionArc xlink:from="loc_TaxRatesApplicableToCompanyAbstract.25606.7.6" xlink:to="loc_LawForEconomicEfficiencyAmendedLegislationImplementingEconomicPlanForTwoThousandNineAndTenTaxRate.25625.7.6" order="3.00000" priority="0" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:type="arc" />
    <link:loc xlink:label="loc_NationalPriorityZoneBCorporateTaxExemptionPeriod.25608.7.6" xlink:href="psti-20140630.xsd#psti_NationalPriorityZoneBCorporateTaxExemptionPeriod" xlink:type="locator" />
    <link:definitionArc xlink:from="loc_TaxRateBenefitsToCompanyAbstract.25607.7.6" xlink:to="loc_NationalPriorityZoneBCorporateTaxExemptionPeriod.25608.7.6" order="1.00000" priority="0" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:type="arc" />
    <link:loc xlink:label="loc_NationalPriorityZoneBCorporateBenefitedPeriodTaxRate.25609.7.6" xlink:href="psti-20140630.xsd#psti_NationalPriorityZoneBCorporateBenefitedPeriodTaxRate" xlink:type="locator" />
    <link:definitionArc xlink:from="loc_TaxRateBenefitsToCompanyAbstract.25607.7.6" xlink:to="loc_NationalPriorityZoneBCorporateBenefitedPeriodTaxRate.25609.7.6" order="2.00000" priority="0" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:type="arc" />
    <link:loc xlink:label="loc_NationalPriorityZoneBcorporateBenefitedPeriodPeriodOfTime.25610.7.6" xlink:href="psti-20140630.xsd#psti_NationalPriorityZoneBcorporateBenefitedPeriodPeriodOfTime" xlink:type="locator" />
    <link:definitionArc xlink:from="loc_TaxRateBenefitsToCompanyAbstract.25607.7.6" xlink:to="loc_NationalPriorityZoneBcorporateBenefitedPeriodPeriodOfTime.25610.7.6" order="3.00000" priority="0" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:type="arc" />
    <link:loc xlink:label="loc_BenefitedPeriodMaximumYearsOfEligibility.25611.7.6" xlink:href="psti-20140630.xsd#psti_BenefitedPeriodMaximumYearsOfEligibility" xlink:type="locator" />
    <link:definitionArc xlink:from="loc_TaxRateBenefitsToCompanyAbstract.25607.7.6" xlink:to="loc_BenefitedPeriodMaximumYearsOfEligibility.25611.7.6" order="4.00000" priority="0" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:type="arc" />
    <link:loc xlink:label="loc_WithholdingTaxRateOnDividendsFromRetainedTaxExemptProfits.25612.7.6" xlink:href="psti-20140630.xsd#psti_WithholdingTaxRateOnDividendsFromRetainedTaxExemptProfits" xlink:type="locator" />
    <link:definitionArc xlink:from="loc_TaxRateBenefitsToCompanyAbstract.25607.7.6" xlink:to="loc_WithholdingTaxRateOnDividendsFromRetainedTaxExemptProfits.25612.7.6" order="6.00000" priority="0" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:type="arc" />
    <link:loc xlink:label="loc_BenefitedPeriodMaximumYearsOfEligibilityForCompaniesInDevelopmentArea.25613.7.6" xlink:href="psti-20140630.xsd#psti_BenefitedPeriodMaximumYearsOfEligibilityForCompaniesInDevelopmentArea" xlink:type="locator" />
    <link:definitionArc xlink:from="loc_TaxRateBenefitsToCompanyAbstract.25607.7.6" xlink:to="loc_BenefitedPeriodMaximumYearsOfEligibilityForCompaniesInDevelopmentArea.25613.7.6" order="5.00000" priority="0" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:type="arc" />
    <link:loc xlink:label="loc_IndustrialEnterprisesTaxBenefitConditionsMaximumPercentageOfTotalSales.25614.7.6" xlink:href="psti-20140630.xsd#psti_IndustrialEnterprisesTaxBenefitConditionsMaximumPercentageOfTotalSales" xlink:type="locator" />
    <link:definitionArc xlink:from="loc_TaxRateBenefitsToCompanyAbstract.25607.7.6" xlink:to="loc_IndustrialEnterprisesTaxBenefitConditionsMaximumPercentageOfTotalSales.25614.7.6" order="7.00000" priority="0" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:type="arc" />
    <link:loc xlink:label="loc_IndustrialEnterprisesTaxBenefitConditionsMinimumPercentageOfTotalRevenuesGeneratedFromAspecificMarket.25615.7.6" xlink:href="psti-20140630.xsd#psti_IndustrialEnterprisesTaxBenefitConditionsMinimumPercentageOfTotalRevenuesGeneratedFromAspecificMarket" xlink:type="locator" />
    <link:definitionArc xlink:from="loc_TaxRateBenefitsToCompanyAbstract.25607.7.6" xlink:to="loc_IndustrialEnterprisesTaxBenefitConditionsMinimumPercentageOfTotalRevenuesGeneratedFromAspecificMarket.25615.7.6" order="8.00000" priority="0" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:type="arc" />
    <link:loc xlink:label="loc_IndustrialEnterprisesTaxBenefitConditionsMinimumPercentageOfTotalRevenuesGivenMarketMinimumPopulation.25616.7.6" xlink:href="psti-20140630.xsd#psti_IndustrialEnterprisesTaxBenefitConditionsMinimumPercentageOfTotalRevenuesGivenMarketMinimumPopulation" xlink:type="locator" />
    <link:definitionArc xlink:from="loc_TaxRateBenefitsToCompanyAbstract.25607.7.6" xlink:to="loc_IndustrialEnterprisesTaxBenefitConditionsMinimumPercentageOfTotalRevenuesGivenMarketMinimumPopulation.25616.7.6" order="9.00000" priority="0" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:type="arc" />
    <link:loc xlink:label="loc_TaxBenefitAcceleratedDepreciationRate.25617.7.6" xlink:href="psti-20140630.xsd#psti_TaxBenefitAcceleratedDepreciationRate" xlink:type="locator" />
    <link:definitionArc xlink:from="loc_TaxRateBenefitsToCompanyAbstract.25607.7.6" xlink:to="loc_TaxBenefitAcceleratedDepreciationRate.25617.7.6" order="10.00000" priority="0" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:type="arc" />
    <link:loc xlink:label="loc_TaxAmendmentLawAmendedTaxRatePreferredEnterprisesYearsOneAndTwo.25618.7.6" xlink:href="psti-20140630.xsd#psti_TaxAmendmentLawAmendedTaxRatePreferredEnterprisesYearsOneAndTwo" xlink:type="locator" />
    <link:definitionArc xlink:from="loc_TaxRateBenefitsToCompanyAbstract.25607.7.6" xlink:to="loc_TaxAmendmentLawAmendedTaxRatePreferredEnterprisesYearsOneAndTwo.25618.7.6" order="11.00000" priority="0" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:type="arc" />
    <link:loc xlink:label="loc_TaxAmendmentLawAmendedTaxRatePreferredEnterprisesDevelopmentAreaYearsOneAndTwo.25620.7.6" xlink:href="psti-20140630.xsd#psti_TaxAmendmentLawAmendedTaxRatePreferredEnterprisesDevelopmentAreaYearsOneAndTwo" xlink:type="locator" />
    <link:definitionArc xlink:from="loc_TaxRateBenefitsToCompanyAbstract.25607.7.6" xlink:to="loc_TaxAmendmentLawAmendedTaxRatePreferredEnterprisesDevelopmentAreaYearsOneAndTwo.25620.7.6" order="13.00000" priority="0" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:type="arc" />
    <link:loc xlink:label="loc_TaxAmendmentLawAmendedTaxRatePreferredEnterprisesYearsThreeAndFour.25619.7.6" xlink:href="psti-20140630.xsd#psti_TaxAmendmentLawAmendedTaxRatePreferredEnterprisesYearsThreeAndFour" xlink:type="locator" />
    <link:definitionArc xlink:from="loc_TaxRateBenefitsToCompanyAbstract.25607.7.6" xlink:to="loc_TaxAmendmentLawAmendedTaxRatePreferredEnterprisesYearsThreeAndFour.25619.7.6" order="14.00000" priority="0" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:type="arc" />
    <link:loc xlink:label="loc_TaxAmendmentLawAmendedTaxRatePreferredEnterprisesDevelopmentAreaYearsThreeAndFour.25621.7.6" xlink:href="psti-20140630.xsd#psti_TaxAmendmentLawAmendedTaxRatePreferredEnterprisesDevelopmentAreaYearsThreeAndFour" xlink:type="locator" />
    <link:definitionArc xlink:from="loc_TaxRateBenefitsToCompanyAbstract.25607.7.6" xlink:to="loc_TaxAmendmentLawAmendedTaxRatePreferredEnterprisesDevelopmentAreaYearsThreeAndFour.25621.7.6" order="15.00000" priority="0" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:type="arc" />
    <link:loc xlink:label="loc_TaxAmendmentLawAmendedTaxRatePreferredEnterprisesYearsFiveAndThereafter.25622.7.6" xlink:href="psti-20140630.xsd#psti_TaxAmendmentLawAmendedTaxRatePreferredEnterprisesYearsFiveAndThereafter" xlink:type="locator" />
    <link:definitionArc xlink:from="loc_TaxRateBenefitsToCompanyAbstract.25607.7.6" xlink:to="loc_TaxAmendmentLawAmendedTaxRatePreferredEnterprisesYearsFiveAndThereafter.25622.7.6" order="16.00000" priority="0" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:type="arc" />
    <link:loc xlink:label="loc_TaxAmendmentLawAmendedTaxRatePreferredEnterprisesDevelopmentAreaYearsFiveAndThereafter.25623.7.6" xlink:href="psti-20140630.xsd#psti_TaxAmendmentLawAmendedTaxRatePreferredEnterprisesDevelopmentAreaYearsFiveAndThereafter" xlink:type="locator" />
    <link:definitionArc xlink:from="loc_TaxRateBenefitsToCompanyAbstract.25607.7.6" xlink:to="loc_TaxAmendmentLawAmendedTaxRatePreferredEnterprisesDevelopmentAreaYearsFiveAndThereafter.25623.7.6" order="17.00000" priority="0" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:type="arc" />
    <link:loc xlink:label="loc_TaxAmendmentLawMinimumQualifyingInvestmentAmount.25624.7.6" xlink:href="psti-20140630.xsd#psti_TaxAmendmentLawMinimumQualifyingInvestmentAmount" xlink:type="locator" />
    <link:definitionArc xlink:from="loc_TaxRateBenefitsToCompanyAbstract.25607.7.6" xlink:to="loc_TaxAmendmentLawMinimumQualifyingInvestmentAmount.25624.7.6" order="12.00000" priority="0" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:type="arc" />
  </link:definitionLink>
  <link:definitionLink xlink:title="41002 - Disclosure - TAXES ON INCOME (Qualifying Percentages of Value of Productive Assets) (Details)" xlink:role="http://www.pluristem.com/role/TaxesOnIncomeQualifyingPercentagesOfValueOfProductiveAssetsDetails" xlink:type="extended">
    <link:loc xlink:label="loc_RangeAxis.4349.8.6" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_RangeAxis" xlink:type="locator" />
    <link:loc xlink:label="loc_RangeMember.4350.8.6" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_RangeMember" xlink:type="locator" />
    <link:definitionArc xlink:from="loc_RangeAxis.4349.8.6" xlink:to="loc_RangeMember.4350.8.6" order="1.00000" priority="0" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:type="arc" />
    <link:loc xlink:label="loc_RangeAxis.4349.6.6" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_RangeAxis" xlink:type="locator" />
    <link:loc xlink:label="loc_RangeMember.4350.6.6" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_RangeMember" xlink:type="locator" />
    <link:definitionArc xlink:from="loc_RangeAxis.4349.6.6" xlink:to="loc_RangeMember.4350.6.6" order="2.00000" priority="0" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:type="arc" />
    <link:loc xlink:label="loc_RangeMember.4350.7.6" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_RangeMember" xlink:type="locator" />
    <link:loc xlink:label="loc_MinimumMember.3370.7.6" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_MinimumMember" xlink:type="locator" />
    <link:definitionArc xlink:from="loc_RangeMember.4350.7.6" xlink:to="loc_MinimumMember.3370.7.6" order="1.00000" priority="0" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:type="arc" />
    <link:loc xlink:label="loc_MaximumMember.3361.7.6" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_MaximumMember" xlink:type="locator" />
    <link:definitionArc xlink:from="loc_RangeMember.4350.7.6" xlink:to="loc_MaximumMember.3361.7.6" order="2.00000" priority="0" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:type="arc" />
    <link:loc xlink:label="loc_StatementTable.5107.5.6" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_StatementTable" xlink:type="locator" />
    <link:loc xlink:label="loc_RangeAxis.4349.5.6" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_RangeAxis" xlink:type="locator" />
    <link:definitionArc xlink:from="loc_StatementTable.5107.5.6" xlink:to="loc_RangeAxis.4349.5.6" order="1.00000" priority="0" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:type="arc" />
    <link:loc xlink:label="loc_ProductiveAssetsPercentageTierAxis.25626.5.6" xlink:href="psti-20140630.xsd#psti_ProductiveAssetsPercentageTierAxis" xlink:type="locator" />
    <link:definitionArc xlink:from="loc_StatementTable.5107.5.6" xlink:to="loc_ProductiveAssetsPercentageTierAxis.25626.5.6" order="2.00000" priority="0" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:type="arc" />
    <link:loc xlink:label="loc_StatementLineItems.5108.9.6" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_StatementLineItems" xlink:type="locator" />
    <link:loc xlink:label="loc_StatementTable.5107.9.6" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_StatementTable" xlink:type="locator" />
    <link:definitionArc xlink:from="loc_StatementLineItems.5108.9.6" xlink:to="loc_StatementTable.5107.9.6" order="1.00000" xbrldt:closed="true" xbrldt:contextElement="segment" priority="0" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:type="arc" />
    <link:loc xlink:label="loc_StatementLineItems.5108.7.6" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_StatementLineItems" xlink:type="locator" />
    <link:loc xlink:label="loc_ValueOfProductiveAssetsBeforeExpansion.25627.7.6" xlink:href="psti-20140630.xsd#psti_ValueOfProductiveAssetsBeforeExpansion" xlink:type="locator" />
    <link:definitionArc xlink:from="loc_StatementLineItems.5108.7.6" xlink:to="loc_ValueOfProductiveAssetsBeforeExpansion.25627.7.6" order="2.00000" priority="0" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:type="arc" />
    <link:loc xlink:label="loc_ProportionThatRequiredInvestmentBearsToValueOfProductiveAsset.25628.7.6" xlink:href="psti-20140630.xsd#psti_ProportionThatRequiredInvestmentBearsToValueOfProductiveAsset" xlink:type="locator" />
    <link:definitionArc xlink:from="loc_StatementLineItems.5108.7.6" xlink:to="loc_ProportionThatRequiredInvestmentBearsToValueOfProductiveAsset.25628.7.6" order="3.00000" priority="0" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:type="arc" />
    <link:loc xlink:label="loc_ProductiveAssetsPercentageTierAxis.25626.8.6" xlink:href="psti-20140630.xsd#psti_ProductiveAssetsPercentageTierAxis" xlink:type="locator" />
    <link:loc xlink:label="loc_ProductiveAssetsPercentageTierDomain.25629.8.6" xlink:href="psti-20140630.xsd#psti_ProductiveAssetsPercentageTierDomain" xlink:type="locator" />
    <link:definitionArc xlink:from="loc_ProductiveAssetsPercentageTierAxis.25626.8.6" xlink:to="loc_ProductiveAssetsPercentageTierDomain.25629.8.6" order="1.00000" priority="0" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:type="arc" />
    <link:loc xlink:label="loc_ProductiveAssetsPercentageTierAxis.25626.6.6" xlink:href="psti-20140630.xsd#psti_ProductiveAssetsPercentageTierAxis" xlink:type="locator" />
    <link:loc xlink:label="loc_ProductiveAssetsPercentageTierDomain.25629.6.6" xlink:href="psti-20140630.xsd#psti_ProductiveAssetsPercentageTierDomain" xlink:type="locator" />
    <link:definitionArc xlink:from="loc_ProductiveAssetsPercentageTierAxis.25626.6.6" xlink:to="loc_ProductiveAssetsPercentageTierDomain.25629.6.6" order="2.00000" priority="0" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:type="arc" />
    <link:loc xlink:label="loc_ProductiveAssetsPercentageTierDomain.25629.7.6" xlink:href="psti-20140630.xsd#psti_ProductiveAssetsPercentageTierDomain" xlink:type="locator" />
    <link:loc xlink:label="loc_TierOneMember.25630.7.6" xlink:href="psti-20140630.xsd#psti_TierOneMember" xlink:type="locator" />
    <link:definitionArc xlink:from="loc_ProductiveAssetsPercentageTierDomain.25629.7.6" xlink:to="loc_TierOneMember.25630.7.6" order="1.00000" priority="0" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:type="arc" />
    <link:loc xlink:label="loc_TierTwoMember.25631.7.6" xlink:href="psti-20140630.xsd#psti_TierTwoMember" xlink:type="locator" />
    <link:definitionArc xlink:from="loc_ProductiveAssetsPercentageTierDomain.25629.7.6" xlink:to="loc_TierTwoMember.25631.7.6" order="2.00000" priority="0" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:type="arc" />
    <link:loc xlink:label="loc_TierThreeMember.25632.7.6" xlink:href="psti-20140630.xsd#psti_TierThreeMember" xlink:type="locator" />
    <link:definitionArc xlink:from="loc_ProductiveAssetsPercentageTierDomain.25629.7.6" xlink:to="loc_TierThreeMember.25632.7.6" order="3.00000" priority="0" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:type="arc" />
  </link:definitionLink>
  <link:definitionLink xlink:title="001 - Document - Document and Entity Information" xlink:role="http://www.pluristem.com/role/DocumentAndEntityInformation" xlink:type="extended">
    <link:loc xlink:label="loc_StatementLineItems.5108.9.6" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_StatementLineItems" xlink:type="locator" />
    <link:loc xlink:label="loc_DocumentAndEntityInformationTable.25640.9.6" xlink:href="psti-20140630.xsd#psti_DocumentAndEntityInformationTable" xlink:type="locator" />
    <link:definitionArc xlink:from="loc_StatementLineItems.5108.9.6" xlink:to="loc_DocumentAndEntityInformationTable.25640.9.6" order="1.00000" xbrldt:closed="true" xbrldt:contextElement="segment" priority="0" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:type="arc" />
    <link:loc xlink:label="loc_StatementLineItems.5108.7.6" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_StatementLineItems" xlink:type="locator" />
    <link:loc xlink:label="loc_DocumentType.210.7.6" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_DocumentType" xlink:type="locator" />
    <link:definitionArc xlink:from="loc_StatementLineItems.5108.7.6" xlink:to="loc_DocumentType.210.7.6" order="2.00000" priority="0" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:type="arc" />
    <link:loc xlink:label="loc_AmendmentFlag.144.7.6" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_AmendmentFlag" xlink:type="locator" />
    <link:definitionArc xlink:from="loc_StatementLineItems.5108.7.6" xlink:to="loc_AmendmentFlag.144.7.6" order="3.00000" priority="0" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:type="arc" />
    <link:loc xlink:label="loc_DocumentPeriodEndDate.161.7.6" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_DocumentPeriodEndDate" xlink:type="locator" />
    <link:definitionArc xlink:from="loc_StatementLineItems.5108.7.6" xlink:to="loc_DocumentPeriodEndDate.161.7.6" order="4.00000" priority="0" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:type="arc" />
    <link:loc xlink:label="loc_EntityRegistrantName.185.7.6" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_EntityRegistrantName" xlink:type="locator" />
    <link:definitionArc xlink:from="loc_StatementLineItems.5108.7.6" xlink:to="loc_EntityRegistrantName.185.7.6" order="5.00000" priority="0" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:type="arc" />
    <link:loc xlink:label="loc_EntityCentralIndexKey.186.7.6" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_EntityCentralIndexKey" xlink:type="locator" />
    <link:definitionArc xlink:from="loc_StatementLineItems.5108.7.6" xlink:to="loc_EntityCentralIndexKey.186.7.6" order="6.00000" priority="0" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:type="arc" />
    <link:loc xlink:label="loc_CurrentFiscalYearEndDate.155.7.6" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_CurrentFiscalYearEndDate" xlink:type="locator" />
    <link:definitionArc xlink:from="loc_StatementLineItems.5108.7.6" xlink:to="loc_CurrentFiscalYearEndDate.155.7.6" order="7.00000" priority="0" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:type="arc" />
    <link:loc xlink:label="loc_DocumentFiscalYearFocus.205.7.6" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_DocumentFiscalYearFocus" xlink:type="locator" />
    <link:definitionArc xlink:from="loc_StatementLineItems.5108.7.6" xlink:to="loc_DocumentFiscalYearFocus.205.7.6" order="8.00000" priority="0" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:type="arc" />
    <link:loc xlink:label="loc_DocumentFiscalPeriodFocus.206.7.6" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_DocumentFiscalPeriodFocus" xlink:type="locator" />
    <link:definitionArc xlink:from="loc_StatementLineItems.5108.7.6" xlink:to="loc_DocumentFiscalPeriodFocus.206.7.6" order="9.00000" priority="0" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:type="arc" />
    <link:loc xlink:label="loc_EntityFilerCategory.183.7.6" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_EntityFilerCategory" xlink:type="locator" />
    <link:definitionArc xlink:from="loc_StatementLineItems.5108.7.6" xlink:to="loc_EntityFilerCategory.183.7.6" order="10.00000" priority="0" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:type="arc" />
    <link:loc xlink:label="loc_EntityCommonStockSharesOutstanding.190.7.6" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_EntityCommonStockSharesOutstanding" xlink:type="locator" />
    <link:definitionArc xlink:from="loc_StatementLineItems.5108.7.6" xlink:to="loc_EntityCommonStockSharesOutstanding.190.7.6" order="10.50000" priority="0" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:type="arc" />
    <link:loc xlink:label="loc_EntityPublicFloat.184.7.6" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_EntityPublicFloat" xlink:type="locator" />
    <link:definitionArc xlink:from="loc_StatementLineItems.5108.7.6" xlink:to="loc_EntityPublicFloat.184.7.6" order="11.00000" priority="0" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:type="arc" />
    <link:loc xlink:label="loc_EntityVoluntaryFilers.181.7.6" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_EntityVoluntaryFilers" xlink:type="locator" />
    <link:definitionArc xlink:from="loc_StatementLineItems.5108.7.6" xlink:to="loc_EntityVoluntaryFilers.181.7.6" order="12.00000" priority="0" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:type="arc" />
    <link:loc xlink:label="loc_EntityWellKnownSeasonedIssuer.180.7.6" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_EntityWellKnownSeasonedIssuer" xlink:type="locator" />
    <link:definitionArc xlink:from="loc_StatementLineItems.5108.7.6" xlink:to="loc_EntityWellKnownSeasonedIssuer.180.7.6" order="13.00000" priority="0" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:type="arc" />
    <link:loc xlink:label="loc_EntityCurrentReportingStatus.182.7.6" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_EntityCurrentReportingStatus" xlink:type="locator" />
    <link:definitionArc xlink:from="loc_StatementLineItems.5108.7.6" xlink:to="loc_EntityCurrentReportingStatus.182.7.6" order="14.00000" priority="0" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:type="arc" />
    <link:loc xlink:label="loc_StatementClassOfStockAxis.5117.8.6" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_StatementClassOfStockAxis" xlink:type="locator" />
    <link:loc xlink:label="loc_ClassOfStockDomain.1053.8.6" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ClassOfStockDomain" xlink:type="locator" />
    <link:definitionArc xlink:from="loc_StatementClassOfStockAxis.5117.8.6" xlink:to="loc_ClassOfStockDomain.1053.8.6" order="1.00000" priority="0" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:type="arc" />
    <link:loc xlink:label="loc_StatementClassOfStockAxis.5117.6.6" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_StatementClassOfStockAxis" xlink:type="locator" />
    <link:loc xlink:label="loc_ClassOfStockDomain.1053.6.6" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ClassOfStockDomain" xlink:type="locator" />
    <link:definitionArc xlink:from="loc_StatementClassOfStockAxis.5117.6.6" xlink:to="loc_ClassOfStockDomain.1053.6.6" order="2.00000" priority="0" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:type="arc" />
    <link:loc xlink:label="loc_DocumentAndEntityInformationTable.25640.5.6" xlink:href="psti-20140630.xsd#psti_DocumentAndEntityInformationTable" xlink:type="locator" />
    <link:loc xlink:label="loc_StatementClassOfStockAxis.5117.5.6" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_StatementClassOfStockAxis" xlink:type="locator" />
    <link:definitionArc xlink:from="loc_DocumentAndEntityInformationTable.25640.5.6" xlink:to="loc_StatementClassOfStockAxis.5117.5.6" order="1.00000" priority="0" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:type="arc" />
  </link:definitionLink>
  <link:definitionLink xlink:title="40201 - Disclosure - SIGNIFICANT ACCOUNTING POLICIES (Narrative) (Details)" xlink:role="http://www.pluristem.com/role/SignificantAccountingPoliciesNarrativeDetails" xlink:type="extended">
    <link:loc xlink:label="loc_AwardTypeAxis.367.8.6" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_AwardTypeAxis" xlink:type="locator" />
    <link:loc xlink:label="loc_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain.5034.8.6" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:type="locator" />
    <link:definitionArc xlink:from="loc_AwardTypeAxis.367.8.6" xlink:to="loc_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain.5034.8.6" order="1.00000" priority="0" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:type="arc" />
    <link:loc xlink:label="loc_AwardTypeAxis.367.6.6" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_AwardTypeAxis" xlink:type="locator" />
    <link:loc xlink:label="loc_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain.5034.6.6" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:type="locator" />
    <link:definitionArc xlink:from="loc_AwardTypeAxis.367.6.6" xlink:to="loc_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain.5034.6.6" order="2.00000" priority="0" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:type="arc" />
    <link:loc xlink:label="loc_CurrencyAxis.1333.6.6" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_CurrencyAxis" xlink:type="locator" />
    <link:loc xlink:label="loc_AllCurrenciesDomain.17940.6.6" xlink:href="http://xbrl.sec.gov/currency/2014/currency-2014-01-31.xsd#currency_AllCurrenciesDomain" xlink:type="locator" />
    <link:definitionArc xlink:from="loc_CurrencyAxis.1333.6.6" xlink:to="loc_AllCurrenciesDomain.17940.6.6" order="1.00000" priority="0" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:type="arc" />
    <link:loc xlink:label="loc_CurrencyAxis.1333.8.6" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_CurrencyAxis" xlink:type="locator" />
    <link:loc xlink:label="loc_AllCurrenciesDomain.17940.8.6" xlink:href="http://xbrl.sec.gov/currency/2014/currency-2014-01-31.xsd#currency_AllCurrenciesDomain" xlink:type="locator" />
    <link:definitionArc xlink:from="loc_CurrencyAxis.1333.8.6" xlink:to="loc_AllCurrenciesDomain.17940.8.6" order="2.00000" priority="0" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:type="arc" />
    <link:loc xlink:label="loc_DeferredRevenueArrangementByTypeTable.1456.5.6" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_DeferredRevenueArrangementByTypeTable" xlink:type="locator" />
    <link:loc xlink:label="loc_FiniteLivedIntangibleAssetsByMajorClassAxis.2313.5.6" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:type="locator" />
    <link:definitionArc xlink:from="loc_DeferredRevenueArrangementByTypeTable.1456.5.6" xlink:to="loc_FiniteLivedIntangibleAssetsByMajorClassAxis.2313.5.6" order="1.00000" priority="0" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:type="arc" />
    <link:loc xlink:label="loc_DeferredRevenueArrangementTypeAxis.1469.5.6" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_DeferredRevenueArrangementTypeAxis" xlink:type="locator" />
    <link:definitionArc xlink:from="loc_DeferredRevenueArrangementByTypeTable.1456.5.6" xlink:to="loc_DeferredRevenueArrangementTypeAxis.1469.5.6" order="2.00000" priority="0" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:type="arc" />
    <link:loc xlink:label="loc_DeferredRevenueArrangementLineItems.1463.9.6" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_DeferredRevenueArrangementLineItems" xlink:type="locator" />
    <link:loc xlink:label="loc_DeferredRevenueArrangementByTypeTable.1456.9.6" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_DeferredRevenueArrangementByTypeTable" xlink:type="locator" />
    <link:definitionArc xlink:from="loc_DeferredRevenueArrangementLineItems.1463.9.6" xlink:to="loc_DeferredRevenueArrangementByTypeTable.1456.9.6" order="1.00000" xbrldt:closed="true" xbrldt:contextElement="segment" priority="0" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:type="arc" />
    <link:loc xlink:label="loc_DeferredRevenueArrangementLineItems.1463.7.6" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_DeferredRevenueArrangementLineItems" xlink:type="locator" />
    <link:loc xlink:label="loc_DeferredRevenueAdditions.7805.7.6" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_DeferredRevenueAdditions" xlink:type="locator" />
    <link:definitionArc xlink:from="loc_DeferredRevenueArrangementLineItems.1463.7.6" xlink:to="loc_DeferredRevenueAdditions.7805.7.6" order="2.00000" priority="0" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:type="arc" />
    <link:loc xlink:label="loc_BusinessCombinationContingentConsiderationReceivableUponCertainRegulatoryMilestones.25648.7.6" xlink:href="psti-20140630.xsd#psti_BusinessCombinationContingentConsiderationReceivableUponCertainRegulatoryMilestones" xlink:type="locator" />
    <link:definitionArc xlink:from="loc_DeferredRevenueArrangementLineItems.1463.7.6" xlink:to="loc_BusinessCombinationContingentConsiderationReceivableUponCertainRegulatoryMilestones.25648.7.6" order="3.00000" priority="0" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:type="arc" />
    <link:loc xlink:label="loc_RemainingDeferredRevenueRecognitionPeriodForIntangibleAsset.25653.7.6" xlink:href="psti-20140630.xsd#psti_RemainingDeferredRevenueRecognitionPeriodForIntangibleAsset" xlink:type="locator" />
    <link:definitionArc xlink:from="loc_DeferredRevenueArrangementLineItems.1463.7.6" xlink:to="loc_RemainingDeferredRevenueRecognitionPeriodForIntangibleAsset.25653.7.6" order="4.00000" priority="0" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:type="arc" />
    <link:loc xlink:label="loc_ResearchAndDevelopmentArrangementWithFederalGovernmentCustomerFundingToOffsetCostsIncurred.15675.7.6" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ResearchAndDevelopmentArrangementWithFederalGovernmentCustomerFundingToOffsetCostsIncurred" xlink:type="locator" />
    <link:definitionArc xlink:from="loc_DeferredRevenueArrangementLineItems.1463.7.6" xlink:to="loc_ResearchAndDevelopmentArrangementWithFederalGovernmentCustomerFundingToOffsetCostsIncurred.15675.7.6" order="6.00000" priority="0" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:type="arc" />
    <link:loc xlink:label="loc_AdvancePaymentForDeveplomentCosts.25651.7.6" xlink:href="psti-20140630.xsd#psti_AdvancePaymentForDeveplomentCosts" xlink:type="locator" />
    <link:definitionArc xlink:from="loc_DeferredRevenueArrangementLineItems.1463.7.6" xlink:to="loc_AdvancePaymentForDeveplomentCosts.25651.7.6" order="5.00000" priority="0" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:type="arc" />
    <link:loc xlink:label="loc_ReclassFromResearchAndDevelopmentExpenseToCostOfRevenues.25652.7.6" xlink:href="psti-20140630.xsd#psti_ReclassFromResearchAndDevelopmentExpenseToCostOfRevenues" xlink:type="locator" />
    <link:definitionArc xlink:from="loc_DeferredRevenueArrangementLineItems.1463.7.6" xlink:to="loc_ReclassFromResearchAndDevelopmentExpenseToCostOfRevenues.25652.7.6" order="7.00000" priority="0" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:type="arc" />
    <link:loc xlink:label="loc_DeferredRevenueArrangementTypeAxis.1469.6.6" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_DeferredRevenueArrangementTypeAxis" xlink:type="locator" />
    <link:loc xlink:label="loc_DeferredRevenueArrangementTypeDomain.1454.6.6" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_DeferredRevenueArrangementTypeDomain" xlink:type="locator" />
    <link:definitionArc xlink:from="loc_DeferredRevenueArrangementTypeAxis.1469.6.6" xlink:to="loc_DeferredRevenueArrangementTypeDomain.1454.6.6" order="1.00000" priority="0" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:type="arc" />
    <link:loc xlink:label="loc_DeferredRevenueArrangementTypeAxis.1469.8.6" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_DeferredRevenueArrangementTypeAxis" xlink:type="locator" />
    <link:loc xlink:label="loc_DeferredRevenueArrangementTypeDomain.1454.8.6" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_DeferredRevenueArrangementTypeDomain" xlink:type="locator" />
    <link:definitionArc xlink:from="loc_DeferredRevenueArrangementTypeAxis.1469.8.6" xlink:to="loc_DeferredRevenueArrangementTypeDomain.1454.8.6" order="2.00000" priority="0" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:type="arc" />
    <link:loc xlink:label="loc_DerivativeInstrumentRiskAxis.1594.8.6" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_DerivativeInstrumentRiskAxis" xlink:type="locator" />
    <link:loc xlink:label="loc_DerivativeContractTypeDomain.1632.8.6" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_DerivativeContractTypeDomain" xlink:type="locator" />
    <link:definitionArc xlink:from="loc_DerivativeInstrumentRiskAxis.1594.8.6" xlink:to="loc_DerivativeContractTypeDomain.1632.8.6" order="1.00000" priority="0" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:type="arc" />
    <link:loc xlink:label="loc_DerivativeInstrumentRiskAxis.1594.6.6" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_DerivativeInstrumentRiskAxis" xlink:type="locator" />
    <link:loc xlink:label="loc_DerivativeContractTypeDomain.1632.6.6" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_DerivativeContractTypeDomain" xlink:type="locator" />
    <link:definitionArc xlink:from="loc_DerivativeInstrumentRiskAxis.1594.6.6" xlink:to="loc_DerivativeContractTypeDomain.1632.6.6" order="2.00000" priority="0" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:type="arc" />
    <link:loc xlink:label="loc_DerivativeInstrumentsGainLossByHedgingRelationshipAxis.1619.6.6" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis" xlink:type="locator" />
    <link:loc xlink:label="loc_HedgingRelationshipDomain.2545.6.6" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_HedgingRelationshipDomain" xlink:type="locator" />
    <link:definitionArc xlink:from="loc_DerivativeInstrumentsGainLossByHedgingRelationshipAxis.1619.6.6" xlink:to="loc_HedgingRelationshipDomain.2545.6.6" order="1.00000" priority="0" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:type="arc" />
    <link:loc xlink:label="loc_DerivativeInstrumentsGainLossByHedgingRelationshipAxis.1619.8.6" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis" xlink:type="locator" />
    <link:loc xlink:label="loc_HedgingRelationshipDomain.2545.8.6" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_HedgingRelationshipDomain" xlink:type="locator" />
    <link:definitionArc xlink:from="loc_DerivativeInstrumentsGainLossByHedgingRelationshipAxis.1619.8.6" xlink:to="loc_HedgingRelationshipDomain.2545.8.6" order="2.00000" priority="0" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:type="arc" />
    <link:loc xlink:label="loc_DerivativeContractTypeDomain.1632.7.6" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_DerivativeContractTypeDomain" xlink:type="locator" />
    <link:loc xlink:label="loc_ForeignExchangeForwardMember.2365.7.6" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ForeignExchangeForwardMember" xlink:type="locator" />
    <link:definitionArc xlink:from="loc_DerivativeContractTypeDomain.1632.7.6" xlink:to="loc_ForeignExchangeForwardMember.2365.7.6" order="1.00000" priority="0" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:type="arc" />
    <link:loc xlink:label="loc_ForeignExchangeOptionMember.2351.7.6" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ForeignExchangeOptionMember" xlink:type="locator" />
    <link:definitionArc xlink:from="loc_DerivativeContractTypeDomain.1632.7.6" xlink:to="loc_ForeignExchangeOptionMember.2351.7.6" order="2.00000" priority="0" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:type="arc" />
    <link:loc xlink:label="loc_FiniteLivedIntangibleAssetsMajorClassNameDomain.2311.7.6" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:type="locator" />
    <link:loc xlink:label="loc_LicensingAgreementsMember.3087.7.6" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_LicensingAgreementsMember" xlink:type="locator" />
    <link:definitionArc xlink:from="loc_FiniteLivedIntangibleAssetsMajorClassNameDomain.2311.7.6" xlink:to="loc_LicensingAgreementsMember.3087.7.6" order="1.00000" priority="0" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:type="arc" />
    <link:loc xlink:label="loc_FiniteLivedIntangibleAssetsByMajorClassAxis.2313.8.6" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:type="locator" />
    <link:loc xlink:label="loc_FiniteLivedIntangibleAssetsMajorClassNameDomain.2311.8.6" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:type="locator" />
    <link:definitionArc xlink:from="loc_FiniteLivedIntangibleAssetsByMajorClassAxis.2313.8.6" xlink:to="loc_FiniteLivedIntangibleAssetsMajorClassNameDomain.2311.8.6" order="1.00000" priority="0" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:type="arc" />
    <link:loc xlink:label="loc_FiniteLivedIntangibleAssetsByMajorClassAxis.2313.6.6" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:type="locator" />
    <link:loc xlink:label="loc_FiniteLivedIntangibleAssetsMajorClassNameDomain.2311.6.6" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:type="locator" />
    <link:definitionArc xlink:from="loc_FiniteLivedIntangibleAssetsByMajorClassAxis.2313.6.6" xlink:to="loc_FiniteLivedIntangibleAssetsMajorClassNameDomain.2311.6.6" order="2.00000" priority="0" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:type="arc" />
    <link:loc xlink:label="loc_HedgingRelationshipDomain.2545.7.6" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_HedgingRelationshipDomain" xlink:type="locator" />
    <link:loc xlink:label="loc_DesignatedAsHedgingInstrumentMember.1352.7.6" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_DesignatedAsHedgingInstrumentMember" xlink:type="locator" />
    <link:definitionArc xlink:from="loc_HedgingRelationshipDomain.2545.7.6" xlink:to="loc_DesignatedAsHedgingInstrumentMember.1352.7.6" order="1.00000" priority="0" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:type="arc" />
    <link:loc xlink:label="loc_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable.4860.5.6" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:type="locator" />
    <link:loc xlink:label="loc_DerivativeInstrumentRiskAxis.1594.5.6" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_DerivativeInstrumentRiskAxis" xlink:type="locator" />
    <link:definitionArc xlink:from="loc_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable.4860.5.6" xlink:to="loc_DerivativeInstrumentRiskAxis.1594.5.6" order="1.50000" priority="0" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:type="arc" />
    <link:loc xlink:label="loc_AwardTypeAxis.367.5.6" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_AwardTypeAxis" xlink:type="locator" />
    <link:definitionArc xlink:from="loc_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable.4860.5.6" xlink:to="loc_AwardTypeAxis.367.5.6" order="1.25000" priority="0" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:type="arc" />
    <link:loc xlink:label="loc_TitleOfIndividualAxis.5277.5.6" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_TitleOfIndividualAxis" xlink:type="locator" />
    <link:definitionArc xlink:from="loc_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable.4860.5.6" xlink:to="loc_TitleOfIndividualAxis.5277.5.6" order="1.37500" priority="0" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:type="arc" />
    <link:loc xlink:label="loc_DerivativeInstrumentsGainLossByHedgingRelationshipAxis.1619.5.6" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis" xlink:type="locator" />
    <link:definitionArc xlink:from="loc_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable.4860.5.6" xlink:to="loc_DerivativeInstrumentsGainLossByHedgingRelationshipAxis.1619.5.6" order="1.75000" priority="0" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:type="arc" />
    <link:loc xlink:label="loc_CurrencyAxis.1333.5.6" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_CurrencyAxis" xlink:type="locator" />
    <link:definitionArc xlink:from="loc_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable.4860.5.6" xlink:to="loc_CurrencyAxis.1333.5.6" order="1.87500" priority="0" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:type="arc" />
    <link:loc xlink:label="loc_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems.5018.9.6" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:type="locator" />
    <link:loc xlink:label="loc_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable.4860.9.6" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:type="locator" />
    <link:definitionArc xlink:from="loc_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems.5018.9.6" xlink:to="loc_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable.4860.9.6" order="1.00000" xbrldt:closed="true" xbrldt:contextElement="segment" priority="0" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:type="arc" />
    <link:loc xlink:label="loc_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems.5018.7.6" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:type="locator" />
    <link:loc xlink:label="loc_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsForfeituresRate.25643.7.6" xlink:href="psti-20140630.xsd#psti_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsForfeituresRate" xlink:type="locator" />
    <link:definitionArc xlink:from="loc_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems.5018.7.6" xlink:to="loc_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsForfeituresRate.25643.7.6" order="2.00000" priority="0" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:type="arc" />
    <link:loc xlink:label="loc_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue.16620.7.6" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:type="locator" />
    <link:definitionArc xlink:from="loc_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems.5018.7.6" xlink:to="loc_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue.16620.7.6" order="3.00000" priority="0" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:type="arc" />
    <link:loc xlink:label="loc_PostemploymentBenefitsPeriodExpense.14432.7.6" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_PostemploymentBenefitsPeriodExpense" xlink:type="locator" />
    <link:definitionArc xlink:from="loc_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems.5018.7.6" xlink:to="loc_PostemploymentBenefitsPeriodExpense.14432.7.6" order="4.00000" priority="0" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:type="arc" />
    <link:loc xlink:label="loc_DerivativeNotionalAmount.278.7.6" xlink:href="http://xbrl.sec.gov/invest/2013/invest-2013-01-31.xsd#invest_DerivativeNotionalAmount" xlink:type="locator" />
    <link:definitionArc xlink:from="loc_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems.5018.7.6" xlink:to="loc_DerivativeNotionalAmount.278.7.6" order="7.00000" priority="0" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:type="arc" />
    <link:loc xlink:label="loc_AccumulatedOtherComprehensiveIncomeLossCumulativeChangesInNetGainLossFromCashFlowHedgesEffectNetOfTax.5728.7.6" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossCumulativeChangesInNetGainLossFromCashFlowHedgesEffectNetOfTax" xlink:type="locator" />
    <link:definitionArc xlink:from="loc_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems.5018.7.6" xlink:to="loc_AccumulatedOtherComprehensiveIncomeLossCumulativeChangesInNetGainLossFromCashFlowHedgesEffectNetOfTax.5728.7.6" order="8.00000" priority="0" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:type="arc" />
    <link:loc xlink:label="loc_DerivativeInstrumentsGainLossRecognizedInOtherComprehensiveIncomeEffectivePortionNet.8447.7.6" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_DerivativeInstrumentsGainLossRecognizedInOtherComprehensiveIncomeEffectivePortionNet" xlink:type="locator" />
    <link:definitionArc xlink:from="loc_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems.5018.7.6" xlink:to="loc_DerivativeInstrumentsGainLossRecognizedInOtherComprehensiveIncomeEffectivePortionNet.8447.7.6" order="9.00000" priority="0" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:type="arc" />
    <link:loc xlink:label="loc_GainLossOnDerivativeInstrumentsNetPretax.10456.7.6" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_GainLossOnDerivativeInstrumentsNetPretax" xlink:type="locator" />
    <link:definitionArc xlink:from="loc_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems.5018.7.6" xlink:to="loc_GainLossOnDerivativeInstrumentsNetPretax.10456.7.6" order="10.00000" priority="0" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:type="arc" />
    <link:loc xlink:label="loc_CashFlowHedgesDerivativeInstrumentsAtFairValueNet.6791.7.6" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_CashFlowHedgesDerivativeInstrumentsAtFairValueNet" xlink:type="locator" />
    <link:definitionArc xlink:from="loc_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems.5018.7.6" xlink:to="loc_CashFlowHedgesDerivativeInstrumentsAtFairValueNet.6791.7.6" order="12.00000" priority="0" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:type="arc" />
    <link:loc xlink:label="loc_FairValueHedgesAtFairValueNet.9623.7.6" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_FairValueHedgesAtFairValueNet" xlink:type="locator" />
    <link:definitionArc xlink:from="loc_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems.5018.7.6" xlink:to="loc_FairValueHedgesAtFairValueNet.9623.7.6" order="13.00000" priority="0" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:type="arc" />
    <link:loc xlink:label="loc_TitleOfIndividualAxis.5277.6.6" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_TitleOfIndividualAxis" xlink:type="locator" />
    <link:loc xlink:label="loc_TitleOfIndividualWithRelationshipToEntityDomain.5279.6.6" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_TitleOfIndividualWithRelationshipToEntityDomain" xlink:type="locator" />
    <link:definitionArc xlink:from="loc_TitleOfIndividualAxis.5277.6.6" xlink:to="loc_TitleOfIndividualWithRelationshipToEntityDomain.5279.6.6" order="1.00000" priority="0" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:type="arc" />
    <link:loc xlink:label="loc_TitleOfIndividualAxis.5277.8.6" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_TitleOfIndividualAxis" xlink:type="locator" />
    <link:loc xlink:label="loc_TitleOfIndividualWithRelationshipToEntityDomain.5279.8.6" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_TitleOfIndividualWithRelationshipToEntityDomain" xlink:type="locator" />
    <link:definitionArc xlink:from="loc_TitleOfIndividualAxis.5277.8.6" xlink:to="loc_TitleOfIndividualWithRelationshipToEntityDomain.5279.8.6" order="2.00000" priority="0" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:type="arc" />
    <link:loc xlink:label="loc_TitleOfIndividualWithRelationshipToEntityDomain.5279.7.6" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_TitleOfIndividualWithRelationshipToEntityDomain" xlink:type="locator" />
    <link:loc xlink:label="loc_EmployeesMember.25661.7.6" xlink:href="psti-20140630.xsd#psti_EmployeesMember" xlink:type="locator" />
    <link:definitionArc xlink:from="loc_TitleOfIndividualWithRelationshipToEntityDomain.5279.7.6" xlink:to="loc_EmployeesMember.25661.7.6" order="1.00000" priority="0" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:type="arc" />
    <link:loc xlink:label="loc_ManagementMember.3316.7.6" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ManagementMember" xlink:type="locator" />
    <link:definitionArc xlink:from="loc_TitleOfIndividualWithRelationshipToEntityDomain.5279.7.6" xlink:to="loc_ManagementMember.3316.7.6" order="2.00000" priority="0" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:type="arc" />
    <link:loc xlink:label="loc_AllCurrenciesDomain.17940.7.6" xlink:href="http://xbrl.sec.gov/currency/2014/currency-2014-01-31.xsd#currency_AllCurrenciesDomain" xlink:type="locator" />
    <link:loc xlink:label="loc_ILS.17830.7.6" xlink:href="http://xbrl.sec.gov/currency/2014/currency-2014-01-31.xsd#currency_ILS" xlink:type="locator" />
    <link:definitionArc xlink:from="loc_AllCurrenciesDomain.17940.7.6" xlink:to="loc_ILS.17830.7.6" order="1.00000" priority="0" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:type="arc" />
    <link:loc xlink:label="loc_KRW.17845.7.6" xlink:href="http://xbrl.sec.gov/currency/2014/currency-2014-01-31.xsd#currency_KRW" xlink:type="locator" />
    <link:definitionArc xlink:from="loc_AllCurrenciesDomain.17940.7.6" xlink:to="loc_KRW.17845.7.6" order="2.00000" priority="0" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:type="arc" />
  </link:definitionLink>
  <link:definitionLink xlink:title="40202 - Disclosure - SIGNIFICANT ACCOUNTING POLICIES (Schedule of Property and Equipment Depreciation Rate) (Details)" xlink:role="http://www.pluristem.com/role/SignificantAccountingPoliciesScheduleOfPropertyAndEquipmentDepreciationRateDetails" xlink:type="extended">
    <link:loc xlink:label="loc_PropertyPlantAndEquipmentTypeDomain.4257.7.6" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:type="locator" />
    <link:loc xlink:label="loc_OtherMachineryAndEquipmentMember.3840.7.6" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_OtherMachineryAndEquipmentMember" xlink:type="locator" />
    <link:definitionArc xlink:from="loc_PropertyPlantAndEquipmentTypeDomain.4257.7.6" xlink:to="loc_OtherMachineryAndEquipmentMember.3840.7.6" order="1.00000" priority="0" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:type="arc" />
    <link:loc xlink:label="loc_ComputerEquipmentMember.1163.7.6" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ComputerEquipmentMember" xlink:type="locator" />
    <link:definitionArc xlink:from="loc_PropertyPlantAndEquipmentTypeDomain.4257.7.6" xlink:to="loc_ComputerEquipmentMember.1163.7.6" order="2.00000" priority="0" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:type="arc" />
    <link:loc xlink:label="loc_OfficeEquipmentMember.3650.7.6" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_OfficeEquipmentMember" xlink:type="locator" />
    <link:definitionArc xlink:from="loc_PropertyPlantAndEquipmentTypeDomain.4257.7.6" xlink:to="loc_OfficeEquipmentMember.3650.7.6" order="3.00000" priority="0" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:type="arc" />
    <link:loc xlink:label="loc_LeaseholdImprovementsMember.3017.7.6" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_LeaseholdImprovementsMember" xlink:type="locator" />
    <link:definitionArc xlink:from="loc_PropertyPlantAndEquipmentTypeDomain.4257.7.6" xlink:to="loc_LeaseholdImprovementsMember.3017.7.6" order="4.00000" priority="0" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:type="arc" />
    <link:loc xlink:label="loc_VehiclesMember.5488.7.6" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_VehiclesMember" xlink:type="locator" />
    <link:definitionArc xlink:from="loc_PropertyPlantAndEquipmentTypeDomain.4257.7.6" xlink:to="loc_VehiclesMember.5488.7.6" order="5.00000" priority="0" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:type="arc" />
    <link:loc xlink:label="loc_LeaseholdImprovementsOfNewFacilityConstructionMember.25578.7.6" xlink:href="psti-20140630.xsd#psti_LeaseholdImprovementsOfNewFacilityConstructionMember" xlink:type="locator" />
    <link:definitionArc xlink:from="loc_PropertyPlantAndEquipmentTypeDomain.4257.7.6" xlink:to="loc_LeaseholdImprovementsOfNewFacilityConstructionMember.25578.7.6" order="6.00000" priority="0" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:type="arc" />
    <link:loc xlink:label="loc_PropertyPlantAndEquipmentByTypeAxis.4261.8.6" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:type="locator" />
    <link:loc xlink:label="loc_PropertyPlantAndEquipmentTypeDomain.4257.8.6" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:type="locator" />
    <link:definitionArc xlink:from="loc_PropertyPlantAndEquipmentByTypeAxis.4261.8.6" xlink:to="loc_PropertyPlantAndEquipmentTypeDomain.4257.8.6" order="1.00000" priority="0" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:type="arc" />
    <link:loc xlink:label="loc_PropertyPlantAndEquipmentByTypeAxis.4261.6.6" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:type="locator" />
    <link:loc xlink:label="loc_PropertyPlantAndEquipmentTypeDomain.4257.6.6" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:type="locator" />
    <link:definitionArc xlink:from="loc_PropertyPlantAndEquipmentByTypeAxis.4261.6.6" xlink:to="loc_PropertyPlantAndEquipmentTypeDomain.4257.6.6" order="2.00000" priority="0" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:type="arc" />
    <link:loc xlink:label="loc_PropertyPlantAndEquipmentLineItems.4267.9.6" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_PropertyPlantAndEquipmentLineItems" xlink:type="locator" />
    <link:loc xlink:label="loc_ScheduleOfPropertyPlantAndEquipmentTable.4834.9.6" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:type="locator" />
    <link:definitionArc xlink:from="loc_PropertyPlantAndEquipmentLineItems.4267.9.6" xlink:to="loc_ScheduleOfPropertyPlantAndEquipmentTable.4834.9.6" order="1.00000" xbrldt:closed="true" xbrldt:contextElement="segment" priority="0" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:type="arc" />
    <link:loc xlink:label="loc_PropertyPlantAndEquipmentLineItems.4267.7.6" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_PropertyPlantAndEquipmentLineItems" xlink:type="locator" />
    <link:loc xlink:label="loc_PropertyPlantAndEquipmentAnnualRateOfDepreciation.25659.7.6" xlink:href="psti-20140630.xsd#psti_PropertyPlantAndEquipmentAnnualRateOfDepreciation" xlink:type="locator" />
    <link:definitionArc xlink:from="loc_PropertyPlantAndEquipmentLineItems.4267.7.6" xlink:to="loc_PropertyPlantAndEquipmentAnnualRateOfDepreciation.25659.7.6" order="2.00000" priority="0" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:type="arc" />
    <link:loc xlink:label="loc_LeaseholdImprovementsAnnualRateOfDepreciationDescription.25660.7.6" xlink:href="psti-20140630.xsd#psti_LeaseholdImprovementsAnnualRateOfDepreciationDescription" xlink:type="locator" />
    <link:definitionArc xlink:from="loc_PropertyPlantAndEquipmentLineItems.4267.7.6" xlink:to="loc_LeaseholdImprovementsAnnualRateOfDepreciationDescription.25660.7.6" order="3.00000" priority="0" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:type="arc" />
    <link:loc xlink:label="loc_RangeAxis.4349.8.6" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_RangeAxis" xlink:type="locator" />
    <link:loc xlink:label="loc_RangeMember.4350.8.6" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_RangeMember" xlink:type="locator" />
    <link:definitionArc xlink:from="loc_RangeAxis.4349.8.6" xlink:to="loc_RangeMember.4350.8.6" order="1.00000" priority="0" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:type="arc" />
    <link:loc xlink:label="loc_RangeAxis.4349.6.6" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_RangeAxis" xlink:type="locator" />
    <link:loc xlink:label="loc_RangeMember.4350.6.6" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_RangeMember" xlink:type="locator" />
    <link:definitionArc xlink:from="loc_RangeAxis.4349.6.6" xlink:to="loc_RangeMember.4350.6.6" order="2.00000" priority="0" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:type="arc" />
    <link:loc xlink:label="loc_RangeMember.4350.7.6" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_RangeMember" xlink:type="locator" />
    <link:loc xlink:label="loc_MinimumMember.3370.7.6" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_MinimumMember" xlink:type="locator" />
    <link:definitionArc xlink:from="loc_RangeMember.4350.7.6" xlink:to="loc_MinimumMember.3370.7.6" order="1.00000" priority="0" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:type="arc" />
    <link:loc xlink:label="loc_MaximumMember.3361.7.6" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_MaximumMember" xlink:type="locator" />
    <link:definitionArc xlink:from="loc_RangeMember.4350.7.6" xlink:to="loc_MaximumMember.3361.7.6" order="2.00000" priority="0" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:type="arc" />
    <link:loc xlink:label="loc_ScheduleOfPropertyPlantAndEquipmentTable.4834.5.6" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:type="locator" />
    <link:loc xlink:label="loc_PropertyPlantAndEquipmentByTypeAxis.4261.5.6" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:type="locator" />
    <link:definitionArc xlink:from="loc_ScheduleOfPropertyPlantAndEquipmentTable.4834.5.6" xlink:to="loc_PropertyPlantAndEquipmentByTypeAxis.4261.5.6" order="1.00000" priority="0" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:type="arc" />
    <link:loc xlink:label="loc_RangeAxis.4349.5.6" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_RangeAxis" xlink:type="locator" />
    <link:definitionArc xlink:from="loc_ScheduleOfPropertyPlantAndEquipmentTable.4834.5.6" xlink:to="loc_RangeAxis.4349.5.6" order="1.50000" priority="0" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:type="arc" />
  </link:definitionLink>
  <link:definitionLink xlink:title="40807 - Disclosure - STOCKHOLDERS' EQUITY (Summary of Warrants and Options) (Details)" xlink:role="http://www.pluristem.com/role/StockholdersEquitySummaryOfWarrantsAndOptionsDetails" xlink:type="extended">
    <link:loc xlink:label="loc_AwardTypeAxis.367.6.6" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_AwardTypeAxis" xlink:type="locator" />
    <link:loc xlink:label="loc_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain.5034.6.6" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:type="locator" />
    <link:definitionArc xlink:from="loc_AwardTypeAxis.367.6.6" xlink:to="loc_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain.5034.6.6" order="1.00000" priority="0" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:type="arc" />
    <link:loc xlink:label="loc_AwardTypeAxis.367.8.6" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_AwardTypeAxis" xlink:type="locator" />
    <link:loc xlink:label="loc_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain.5034.8.6" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:type="locator" />
    <link:definitionArc xlink:from="loc_AwardTypeAxis.367.8.6" xlink:to="loc_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain.5034.8.6" order="2.00000" priority="0" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:type="arc" />
    <link:loc xlink:label="loc_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis.5031.6.6" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis" xlink:type="locator" />
    <link:loc xlink:label="loc_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain.5032.6.6" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain" xlink:type="locator" />
    <link:definitionArc xlink:from="loc_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis.5031.6.6" xlink:to="loc_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain.5032.6.6" order="1.00000" priority="0" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:type="arc" />
    <link:loc xlink:label="loc_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis.5031.8.6" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis" xlink:type="locator" />
    <link:loc xlink:label="loc_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain.5032.8.6" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain" xlink:type="locator" />
    <link:definitionArc xlink:from="loc_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis.5031.8.6" xlink:to="loc_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain.5032.8.6" order="2.00000" priority="0" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:type="arc" />
    <link:loc xlink:label="loc_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain.5032.7.6" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain" xlink:type="locator" />
    <link:loc xlink:label="loc_OptionsExercisePriceRangeOneMember.25733.7.6" xlink:href="psti-20140630.xsd#psti_OptionsExercisePriceRangeOneMember" xlink:type="locator" />
    <link:definitionArc xlink:from="loc_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain.5032.7.6" xlink:to="loc_OptionsExercisePriceRangeOneMember.25733.7.6" order="1.00000" priority="0" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:type="arc" />
    <link:loc xlink:label="loc_OptionsExercisePriceRangeTwoMember.25734.7.6" xlink:href="psti-20140630.xsd#psti_OptionsExercisePriceRangeTwoMember" xlink:type="locator" />
    <link:definitionArc xlink:from="loc_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain.5032.7.6" xlink:to="loc_OptionsExercisePriceRangeTwoMember.25734.7.6" order="2.00000" priority="0" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:type="arc" />
    <link:loc xlink:label="loc_OptionsExercisePriceRangeThreeMember.25735.7.6" xlink:href="psti-20140630.xsd#psti_OptionsExercisePriceRangeThreeMember" xlink:type="locator" />
    <link:definitionArc xlink:from="loc_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain.5032.7.6" xlink:to="loc_OptionsExercisePriceRangeThreeMember.25735.7.6" order="3.00000" priority="0" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:type="arc" />
    <link:loc xlink:label="loc_ExercisePriceRangeOneMember.25746.7.6" xlink:href="psti-20140630.xsd#psti_ExercisePriceRangeOneMember" xlink:type="locator" />
    <link:definitionArc xlink:from="loc_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain.5032.7.6" xlink:to="loc_ExercisePriceRangeOneMember.25746.7.6" order="4.00000" priority="0" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:type="arc" />
    <link:loc xlink:label="loc_ExercisePriceRangeTwoMember.25747.7.6" xlink:href="psti-20140630.xsd#psti_ExercisePriceRangeTwoMember" xlink:type="locator" />
    <link:definitionArc xlink:from="loc_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain.5032.7.6" xlink:to="loc_ExercisePriceRangeTwoMember.25747.7.6" order="5.00000" priority="0" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:type="arc" />
    <link:loc xlink:label="loc_ExercisePriceRangeThreeMember.25748.7.6" xlink:href="psti-20140630.xsd#psti_ExercisePriceRangeThreeMember" xlink:type="locator" />
    <link:definitionArc xlink:from="loc_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain.5032.7.6" xlink:to="loc_ExercisePriceRangeThreeMember.25748.7.6" order="6.00000" priority="0" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:type="arc" />
    <link:loc xlink:label="loc_ExercisePriceRangeFiveMember.25750.7.6" xlink:href="psti-20140630.xsd#psti_ExercisePriceRangeFiveMember" xlink:type="locator" />
    <link:definitionArc xlink:from="loc_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain.5032.7.6" xlink:to="loc_ExercisePriceRangeFiveMember.25750.7.6" order="7.00000" priority="0" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:type="arc" />
    <link:loc xlink:label="loc_ExercisePriceRangeSixMember.25751.7.6" xlink:href="psti-20140630.xsd#psti_ExercisePriceRangeSixMember" xlink:type="locator" />
    <link:definitionArc xlink:from="loc_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain.5032.7.6" xlink:to="loc_ExercisePriceRangeSixMember.25751.7.6" order="15.10000" priority="0" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:type="arc" />
    <link:loc xlink:label="loc_ExercisePriceRangeFourMember.25749.7.6" xlink:href="psti-20140630.xsd#psti_ExercisePriceRangeFourMember" xlink:type="locator" />
    <link:definitionArc xlink:from="loc_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain.5032.7.6" xlink:to="loc_ExercisePriceRangeFourMember.25749.7.6" order="9.00000" priority="0" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:type="arc" />
    <link:loc xlink:label="loc_ExercisePriceRangeSevenMember.25752.7.6" xlink:href="psti-20140630.xsd#psti_ExercisePriceRangeSevenMember" xlink:type="locator" />
    <link:definitionArc xlink:from="loc_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain.5032.7.6" xlink:to="loc_ExercisePriceRangeSevenMember.25752.7.6" order="15.20000" priority="0" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:type="arc" />
    <link:loc xlink:label="loc_OptionsExercisePriceRangeFourMember.25736.7.6" xlink:href="psti-20140630.xsd#psti_OptionsExercisePriceRangeFourMember" xlink:type="locator" />
    <link:definitionArc xlink:from="loc_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain.5032.7.6" xlink:to="loc_OptionsExercisePriceRangeFourMember.25736.7.6" order="10.00000" priority="0" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:type="arc" />
    <link:loc xlink:label="loc_OptionsExercisePriceRangeFiveMember.25737.7.6" xlink:href="psti-20140630.xsd#psti_OptionsExercisePriceRangeFiveMember" xlink:type="locator" />
    <link:definitionArc xlink:from="loc_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain.5032.7.6" xlink:to="loc_OptionsExercisePriceRangeFiveMember.25737.7.6" order="11.00000" priority="0" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:type="arc" />
    <link:loc xlink:label="loc_OptionsExercisePriceRangeSixMember.25738.7.6" xlink:href="psti-20140630.xsd#psti_OptionsExercisePriceRangeSixMember" xlink:type="locator" />
    <link:definitionArc xlink:from="loc_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain.5032.7.6" xlink:to="loc_OptionsExercisePriceRangeSixMember.25738.7.6" order="12.00000" priority="0" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:type="arc" />
    <link:loc xlink:label="loc_ExercisePriceRangeTwelveMember.25745.7.6" xlink:href="psti-20140630.xsd#psti_ExercisePriceRangeTwelveMember" xlink:type="locator" />
    <link:definitionArc xlink:from="loc_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain.5032.7.6" xlink:to="loc_ExercisePriceRangeTwelveMember.25745.7.6" order="14.00000" priority="0" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:type="arc" />
    <link:loc xlink:label="loc_OptionsExercisePriceRangeSevenMember.25739.7.6" xlink:href="psti-20140630.xsd#psti_OptionsExercisePriceRangeSevenMember" xlink:type="locator" />
    <link:definitionArc xlink:from="loc_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain.5032.7.6" xlink:to="loc_OptionsExercisePriceRangeSevenMember.25739.7.6" order="15.00000" priority="0" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:type="arc" />
    <link:loc xlink:label="loc_OptionsExercisePriceRangeEightMember.25740.7.6" xlink:href="psti-20140630.xsd#psti_OptionsExercisePriceRangeEightMember" xlink:type="locator" />
    <link:definitionArc xlink:from="loc_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain.5032.7.6" xlink:to="loc_OptionsExercisePriceRangeEightMember.25740.7.6" order="16.00000" priority="0" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:type="arc" />
    <link:loc xlink:label="loc_OptionsExercisePriceRangeNineMember.25741.7.6" xlink:href="psti-20140630.xsd#psti_OptionsExercisePriceRangeNineMember" xlink:type="locator" />
    <link:definitionArc xlink:from="loc_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain.5032.7.6" xlink:to="loc_OptionsExercisePriceRangeNineMember.25741.7.6" order="17.00000" priority="0" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:type="arc" />
    <link:loc xlink:label="loc_OptionsExercisePriceRangeTenMember.25742.7.6" xlink:href="psti-20140630.xsd#psti_OptionsExercisePriceRangeTenMember" xlink:type="locator" />
    <link:definitionArc xlink:from="loc_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain.5032.7.6" xlink:to="loc_OptionsExercisePriceRangeTenMember.25742.7.6" order="18.00000" priority="0" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:type="arc" />
    <link:loc xlink:label="loc_OptionsExercisePriceRangeElevenMember.25743.7.6" xlink:href="psti-20140630.xsd#psti_OptionsExercisePriceRangeElevenMember" xlink:type="locator" />
    <link:definitionArc xlink:from="loc_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain.5032.7.6" xlink:to="loc_OptionsExercisePriceRangeElevenMember.25743.7.6" order="20.00000" priority="0" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:type="arc" />
    <link:loc xlink:label="loc_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain.5034.7.6" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:type="locator" />
    <link:loc xlink:label="loc_WarrantMember.5496.7.6" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_WarrantMember" xlink:type="locator" />
    <link:definitionArc xlink:from="loc_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain.5034.7.6" xlink:to="loc_WarrantMember.5496.7.6" order="1.00000" priority="0" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:type="arc" />
    <link:loc xlink:label="loc_EmployeeStockOptionMember.1835.7.6" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_EmployeeStockOptionMember" xlink:type="locator" />
    <link:definitionArc xlink:from="loc_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain.5034.7.6" xlink:to="loc_EmployeeStockOptionMember.1835.7.6" order="2.00000" priority="0" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:type="arc" />
    <link:loc xlink:label="loc_StockholdersEquityNoteLineItems.25553.9.6" xlink:href="psti-20140630.xsd#psti_StockholdersEquityNoteLineItems" xlink:type="locator" />
    <link:loc xlink:label="loc_StockholdersEquityNoteTable.25554.9.6" xlink:href="psti-20140630.xsd#psti_StockholdersEquityNoteTable" xlink:type="locator" />
    <link:definitionArc xlink:from="loc_StockholdersEquityNoteLineItems.25553.9.6" xlink:to="loc_StockholdersEquityNoteTable.25554.9.6" order="1.00000" xbrldt:closed="true" xbrldt:contextElement="segment" priority="0" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:type="arc" />
    <link:loc xlink:label="loc_StockholdersEquityNoteLineItems.25553.7.6" xlink:href="psti-20140630.xsd#psti_StockholdersEquityNoteLineItems" xlink:type="locator" />
    <link:loc xlink:label="loc_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice.16713.7.6" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:type="locator" />
    <link:definitionArc xlink:from="loc_StockholdersEquityNoteLineItems.25553.7.6" xlink:to="loc_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice.16713.7.6" order="6.00000" priority="0" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:type="arc" />
    <link:loc xlink:label="loc_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber.16626.7.6" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:type="locator" />
    <link:definitionArc xlink:from="loc_StockholdersEquityNoteLineItems.25553.7.6" xlink:to="loc_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber.16626.7.6" order="11.00000" priority="0" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:type="arc" />
    <link:loc xlink:label="loc_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2.15996.7.6" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:type="locator" />
    <link:definitionArc xlink:from="loc_StockholdersEquityNoteLineItems.25553.7.6" xlink:to="loc_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2.15996.7.6" order="8.50000" priority="0" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:type="arc" />
    <link:loc xlink:label="loc_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit.16758.7.6" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit" xlink:type="locator" />
    <link:definitionArc xlink:from="loc_StockholdersEquityNoteLineItems.25553.7.6" xlink:to="loc_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit.16758.7.6" order="5.50000" priority="0" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:type="arc" />
    <link:loc xlink:label="loc_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit.16750.7.6" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit" xlink:type="locator" />
    <link:definitionArc xlink:from="loc_StockholdersEquityNoteLineItems.25553.7.6" xlink:to="loc_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit.16750.7.6" order="5.75000" priority="0" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:type="arc" />
    <link:loc xlink:label="loc_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions.16742.7.6" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions" xlink:type="locator" />
    <link:definitionArc xlink:from="loc_StockholdersEquityNoteLineItems.25553.7.6" xlink:to="loc_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions.16742.7.6" order="6.50000" priority="0" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:type="arc" />
    <link:loc xlink:label="loc_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions.16744.7.6" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions" xlink:type="locator" />
    <link:definitionArc xlink:from="loc_StockholdersEquityNoteLineItems.25553.7.6" xlink:to="loc_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions.16744.7.6" order="6.75000" priority="0" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:type="arc" />
    <link:loc xlink:label="loc_StockholdersEquityNoteTable.25554.5.6" xlink:href="psti-20140630.xsd#psti_StockholdersEquityNoteTable" xlink:type="locator" />
    <link:loc xlink:label="loc_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis.5031.5.6" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis" xlink:type="locator" />
    <link:definitionArc xlink:from="loc_StockholdersEquityNoteTable.25554.5.6" xlink:to="loc_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis.5031.5.6" order="1.00000" priority="0" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:type="arc" />
    <link:loc xlink:label="loc_AwardTypeAxis.367.5.6" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_AwardTypeAxis" xlink:type="locator" />
    <link:definitionArc xlink:from="loc_StockholdersEquityNoteTable.25554.5.6" xlink:to="loc_AwardTypeAxis.367.5.6" order="1.50000" priority="0" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:type="arc" />
  </link:definitionLink>
  <link:definitionLink xlink:title="40203 - Disclosure - SIGNIFICANT ACCOUNTING POLICIES (Comprehensive Income) (Details)" xlink:role="http://www.pluristem.com/role/SignificantAccountingPoliciesComprehensiveIncomeDetails" xlink:type="extended">
    <link:loc xlink:label="loc_AccumulatedOtherComprehensiveIncomeLossLineItems.486.7.6" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems" xlink:type="locator" />
    <link:loc xlink:label="loc_AccumulatedOtherComprehensiveIncomeLossNetOfTax.5715.7.6" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:type="locator" />
    <link:definitionArc xlink:from="loc_AccumulatedOtherComprehensiveIncomeLossLineItems.486.7.6" xlink:to="loc_AccumulatedOtherComprehensiveIncomeLossNetOfTax.5715.7.6" order="1.00000" priority="0" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:type="arc" />
    <link:loc xlink:label="loc_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax.13608.7.6" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" xlink:type="locator" />
    <link:definitionArc xlink:from="loc_AccumulatedOtherComprehensiveIncomeLossLineItems.486.7.6" xlink:to="loc_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax.13608.7.6" order="2.00000" priority="0" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:type="arc" />
    <link:loc xlink:label="loc_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax.15390.7.6" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" xlink:type="locator" />
    <link:definitionArc xlink:from="loc_AccumulatedOtherComprehensiveIncomeLossLineItems.486.7.6" xlink:to="loc_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax.15390.7.6" order="3.00000" priority="0" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:type="arc" />
    <link:loc xlink:label="loc_OtherComprehensiveIncomeLossNetOfTax.13526.7.6" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTax" xlink:type="locator" />
    <link:definitionArc xlink:from="loc_AccumulatedOtherComprehensiveIncomeLossLineItems.486.7.6" xlink:to="loc_OtherComprehensiveIncomeLossNetOfTax.13526.7.6" order="4.00000" priority="0" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:type="arc" />
    <link:loc xlink:label="loc_AccumulatedOtherComprehensiveIncomeLossLineItems.486.9.6" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems" xlink:type="locator" />
    <link:loc xlink:label="loc_AccumulatedOtherComprehensiveIncomeLossTable.487.9.6" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossTable" xlink:type="locator" />
    <link:definitionArc xlink:from="loc_AccumulatedOtherComprehensiveIncomeLossLineItems.486.9.6" xlink:to="loc_AccumulatedOtherComprehensiveIncomeLossTable.487.9.6" order="9.00000" xbrldt:closed="true" xbrldt:contextElement="segment" priority="0" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:type="arc" />
    <link:loc xlink:label="loc_AccumulatedOtherComprehensiveIncomeLossTable.487.5.6" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossTable" xlink:type="locator" />
    <link:loc xlink:label="loc_StatementEquityComponentsAxis.5114.5.6" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_StatementEquityComponentsAxis" xlink:type="locator" />
    <link:definitionArc xlink:from="loc_AccumulatedOtherComprehensiveIncomeLossTable.487.5.6" xlink:to="loc_StatementEquityComponentsAxis.5114.5.6" order="1.00000" priority="0" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:type="arc" />
    <link:loc xlink:label="loc_EquityComponentDomain.1898.7.6" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_EquityComponentDomain" xlink:type="locator" />
    <link:loc xlink:label="loc_AccumulatedNetUnrealizedInvestmentGainLossMember.477.7.6" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_AccumulatedNetUnrealizedInvestmentGainLossMember" xlink:type="locator" />
    <link:definitionArc xlink:from="loc_EquityComponentDomain.1898.7.6" xlink:to="loc_AccumulatedNetUnrealizedInvestmentGainLossMember.477.7.6" order="1.00000" priority="0" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:type="arc" />
    <link:loc xlink:label="loc_AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember.484.7.6" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember" xlink:type="locator" />
    <link:definitionArc xlink:from="loc_EquityComponentDomain.1898.7.6" xlink:to="loc_AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember.484.7.6" order="2.00000" priority="0" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:type="arc" />
    <link:loc xlink:label="loc_StatementEquityComponentsAxis.5114.6.6" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_StatementEquityComponentsAxis" xlink:type="locator" />
    <link:loc xlink:label="loc_EquityComponentDomain.1898.6.6" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_EquityComponentDomain" xlink:type="locator" />
    <link:definitionArc xlink:from="loc_StatementEquityComponentsAxis.5114.6.6" xlink:to="loc_EquityComponentDomain.1898.6.6" order="1.00000" priority="0" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:type="arc" />
    <link:loc xlink:label="loc_StatementEquityComponentsAxis.5114.8.6" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_StatementEquityComponentsAxis" xlink:type="locator" />
    <link:loc xlink:label="loc_EquityComponentDomain.1898.8.6" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_EquityComponentDomain" xlink:type="locator" />
    <link:definitionArc xlink:from="loc_StatementEquityComponentsAxis.5114.8.6" xlink:to="loc_EquityComponentDomain.1898.8.6" order="2.00000" priority="0" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:type="arc" />
  </link:definitionLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>28
<FILENAME>psti-20140630_lab.xml
<DESCRIPTION>TAXONOMY EXTENSION LABEL LINKBASE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" standalone="no"?>
<!--Created by Z-K Global Ltd. ("ZKG")-->
<!--produced on 2014-09-10 @ 8:21 AM-->
<link:linkbase xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" xmlns:link="http://www.xbrl.org/2003/linkbase">
  <link:roleRef roleURI="http://fasb.org/us-gaap/role/label/axisDefault" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-roles-2014-01-31.xsd#axisDefault" xlink:type="simple" />
  <link:roleRef roleURI="http://fasb.org/us-gaap/role/label/changeLabel2012" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-roles-2014-01-31.xsd#changeLabel2012" xlink:type="simple" />
  <link:roleRef roleURI="http://fasb.org/us-gaap/role/label/fragmentDocumentation" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-roles-2014-01-31.xsd#fragmentDocumentation" xlink:type="simple" />
  <link:roleRef roleURI="http://fasb.org/us-gaap/role/label/fragmentLabel" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-roles-2014-01-31.xsd#fragmentLabel" xlink:type="simple" />
  <link:roleRef roleURI="http://fasb.org/us-gaap/role/label/changeLabel2013" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-roles-2014-01-31.xsd#changeLabel2013" xlink:type="simple" />
  <link:roleRef roleURI="http://fasb.org/us-gaap/role/label/changeLabel2014" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-roles-2014-01-31.xsd#changeLabel2014" xlink:type="simple" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/deprecatedLabel" xlink:href="http://www.xbrl.org/lrr/role/deprecated-2009-12-16.xsd#deprecatedLabel" xlink:type="simple" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/deprecatedDateLabel" xlink:href="http://www.xbrl.org/lrr/role/deprecated-2009-12-16.xsd#deprecatedDateLabel" xlink:type="simple" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedLabel" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel" xlink:type="simple" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodEndLabel" xlink:type="simple" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodStartLabel" xlink:type="simple" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTotalLabel" xlink:type="simple" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedNetLabel" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedNetLabel" xlink:type="simple" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTerseLabel" xlink:type="simple" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/netLabel" xlink:href="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd#netLabel" xlink:type="simple" />
  <link:labelLink xlink:role="http://www.xbrl.org/2003/role/link" xlink:type="extended">
    <link:loc xlink:label="loc_AccountingPoliciesAbstract.425.11.6" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_AccountingPoliciesAbstract" xlink:type="locator" />
    <link:labelArc xlink:from="loc_AccountingPoliciesAbstract.425.11.6" xlink:to="lab_AccountingPoliciesAbstract.287275.254334.250774.255803" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_AccountingPoliciesAbstract.287275.254334.250774.255803" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US" id="lab_AccountingPoliciesAbstract.287275.254334.250774.255803">SIGNIFICANT ACCOUNTING POLICIES [Abstract]</link:label>
    <link:loc xlink:label="loc_SignificantAccountingPoliciesTextBlock.16839.11.7" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_SignificantAccountingPoliciesTextBlock" xlink:type="locator" />
    <link:labelArc xlink:from="loc_SignificantAccountingPoliciesTextBlock.16839.11.7" xlink:to="lab_SignificantAccountingPoliciesTextBlock.223329.256454.255804" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_SignificantAccountingPoliciesTextBlock.223329.256454.255804" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US" id="lab_SignificantAccountingPoliciesTextBlock.223329.256454.255804">SIGNIFICANT ACCOUNTING POLICIES</link:label>
    <link:loc xlink:label="loc_SignificantAccountingPoliciesTextBlock.16839.11.6" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_SignificantAccountingPoliciesTextBlock" xlink:type="locator" />
    <link:labelArc xlink:from="loc_SignificantAccountingPoliciesTextBlock.16839.11.6" xlink:to="lab_SignificantAccountingPoliciesTextBlock.287276.253940.250775.255805" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_SignificantAccountingPoliciesTextBlock.287276.253940.250775.255805" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US" id="lab_SignificantAccountingPoliciesTextBlock.287276.253940.250775.255805">SIGNIFICANT ACCOUNTING POLICIES</link:label>
    <link:loc xlink:label="loc_CommitmentsAndContingenciesDisclosureAbstract.1107.11.6" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:type="locator" />
    <link:labelArc xlink:from="loc_CommitmentsAndContingenciesDisclosureAbstract.1107.11.6" xlink:to="lab_CommitmentsAndContingenciesDisclosureAbstract.333749.253998.250339.255425" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_CommitmentsAndContingenciesDisclosureAbstract.333749.253998.250339.255425" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US" id="lab_CommitmentsAndContingenciesDisclosureAbstract.333749.253998.250339.255425">COMMITMENTS AND CONTINGENCIES [Abstract]</link:label>
    <link:loc xlink:label="loc_CommitmentsAndContingenciesDisclosureTextBlock.7041.11.6" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:type="locator" />
    <link:labelArc xlink:from="loc_CommitmentsAndContingenciesDisclosureTextBlock.7041.11.6" xlink:to="lab_CommitmentsAndContingenciesDisclosureTextBlock.1479.253999.250340.255426" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_CommitmentsAndContingenciesDisclosureTextBlock.1479.253999.250340.255426" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US" id="lab_CommitmentsAndContingenciesDisclosureTextBlock.1479.253999.250340.255426">Commitments and Contingencies Disclosure [Text Block]</link:label>
    <link:loc xlink:label="loc_CommitmentsAndContingenciesDisclosureTextBlock.7041.11.7" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:type="locator" />
    <link:labelArc xlink:from="loc_CommitmentsAndContingenciesDisclosureTextBlock.7041.11.7" xlink:to="lab_CommitmentsAndContingenciesDisclosureTextBlock.333751.254000.250341.255427" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_CommitmentsAndContingenciesDisclosureTextBlock.333751.254000.250341.255427" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US" id="lab_CommitmentsAndContingenciesDisclosureTextBlock.333751.254000.250341.255427">COMMITMENTS AND CONTINGENCIES</link:label>
    <link:loc xlink:label="loc_AggregateGrantsReceived.25524.11.12" xlink:href="psti-20140630.xsd#psti_AggregateGrantsReceived" xlink:type="locator" />
    <link:labelArc xlink:from="loc_AggregateGrantsReceived.25524.11.12" xlink:to="AggregateGrantsReceived.358815.255429" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="AggregateGrantsReceived.358815.255429" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US" id="AggregateGrantsReceived.358815.255429">Aggregate revenue received from grants as of the balance sheet date.</link:label>
    <link:loc xlink:label="loc_AggregateGrantsReceived.25524.11.7" xlink:href="psti-20140630.xsd#psti_AggregateGrantsReceived" xlink:type="locator" />
    <link:labelArc xlink:from="loc_AggregateGrantsReceived.25524.11.7" xlink:to="AggregateGrantsReceived.358816.255428" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="AggregateGrantsReceived.358816.255428" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US" id="AggregateGrantsReceived.358816.255428">Grants received</link:label>
    <link:loc xlink:label="loc_AggregateGrantsReceived.25524.11.6" xlink:href="psti-20140630.xsd#psti_AggregateGrantsReceived" xlink:type="locator" />
    <link:labelArc xlink:from="loc_AggregateGrantsReceived.25524.11.6" xlink:to="lab_AggregateGrantsReceived.358814.255430" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_AggregateGrantsReceived.358814.255430" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US" id="lab_AggregateGrantsReceived.358814.255430">Aggregate Grants Received</link:label>
    <link:loc xlink:label="loc_IncreaseDecreaseInSecurityDeposits.11316.11.6" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_IncreaseDecreaseInSecurityDeposits" xlink:type="locator" />
    <link:labelArc xlink:from="loc_IncreaseDecreaseInSecurityDeposits.11316.11.6" xlink:to="lab_IncreaseDecreaseInSecurityDeposits.16511.254084.250342.255431" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_IncreaseDecreaseInSecurityDeposits.16511.254084.250342.255431" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US" id="lab_IncreaseDecreaseInSecurityDeposits.16511.254084.250342.255431">Increase (Decrease) in Security Deposits</link:label>
    <link:loc xlink:label="loc_IncreaseDecreaseInSecurityDeposits.11316.11.7" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_IncreaseDecreaseInSecurityDeposits" xlink:type="locator" />
    <link:labelArc xlink:from="loc_IncreaseDecreaseInSecurityDeposits.11316.11.7" xlink:to="lab_IncreaseDecreaseInSecurityDeposits.1922150.254085.250343.255432" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_IncreaseDecreaseInSecurityDeposits.1922150.254085.250343.255432" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US" id="lab_IncreaseDecreaseInSecurityDeposits.1922150.254085.250343.255432">Security deposits increase</link:label>
    <link:loc xlink:label="loc_MaximumMember.3361.11.6" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_MaximumMember" xlink:type="locator" />
    <link:labelArc xlink:from="loc_MaximumMember.3361.11.6" xlink:to="lab_MaximumMember.11852.255433" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_MaximumMember.11852.255433" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US" id="lab_MaximumMember.11852.255433">Maximum [Member]</link:label>
    <link:loc xlink:label="loc_MinimumMember.3370.11.6" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_MinimumMember" xlink:type="locator" />
    <link:labelArc xlink:from="loc_MinimumMember.3370.11.6" xlink:to="lab_MinimumMember.11901.255434" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_MinimumMember.11901.255434" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US" id="lab_MinimumMember.11901.255434">Minimum [Member]</link:label>
    <link:loc xlink:label="loc_OtherCommitmentsLineItems.3716.11.6" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_OtherCommitmentsLineItems" xlink:type="locator" />
    <link:labelArc xlink:from="loc_OtherCommitmentsLineItems.3716.11.6" xlink:to="lab_OtherCommitmentsLineItems.12973.255435" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_OtherCommitmentsLineItems.12973.255435" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US" id="lab_OtherCommitmentsLineItems.12973.255435">Other Commitments [Line Items]</link:label>
    <link:loc xlink:label="loc_OtherCommitmentsTable.3714.11.6" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_OtherCommitmentsTable" xlink:type="locator" />
    <link:labelArc xlink:from="loc_OtherCommitmentsTable.3714.11.6" xlink:to="lab_OtherCommitmentsTable.12969.255436" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_OtherCommitmentsTable.12969.255436" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US" id="lab_OtherCommitmentsTable.12969.255436">Other Commitments [Table]</link:label>
    <link:loc xlink:label="loc_PercentageOfQualifiedExpenditures.25580.11.6" xlink:href="psti-20140630.xsd#psti_PercentageOfQualifiedExpenditures" xlink:type="locator" />
    <link:labelArc xlink:from="loc_PercentageOfQualifiedExpenditures.25580.11.6" xlink:to="lab_PercentageOfQualifiedExpenditures.256079" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_PercentageOfQualifiedExpenditures.256079" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US" id="lab_PercentageOfQualifiedExpenditures.256079">Percentage Of Qualified Expenditures</link:label>
    <link:loc xlink:label="loc_PercentageOfQualifiedExpenditures.25580.11.12" xlink:href="psti-20140630.xsd#psti_PercentageOfQualifiedExpenditures" xlink:type="locator" />
    <link:labelArc xlink:from="loc_PercentageOfQualifiedExpenditures.25580.11.12" xlink:to="lab_PercentageOfQualifiedExpenditures12.256080" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_PercentageOfQualifiedExpenditures12.256080" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US" id="lab_PercentageOfQualifiedExpenditures12.256080">Percentage Of Qualified Expenditures.</link:label>
    <link:loc xlink:label="loc_RangeAxis.4349.11.6" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_RangeAxis" xlink:type="locator" />
    <link:labelArc xlink:from="loc_RangeAxis.4349.11.6" xlink:to="lab_RangeAxis.15783.255437" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_RangeAxis.15783.255437" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US" id="lab_RangeAxis.15783.255437">Range [Axis]</link:label>
    <link:loc xlink:label="loc_RangeMember.4350.11.6" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_RangeMember" xlink:type="locator" />
    <link:labelArc xlink:from="loc_RangeMember.4350.11.6" xlink:to="lab_RangeMember.15784.255438" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_RangeMember.15784.255438" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US" id="lab_RangeMember.15784.255438">Range [Domain]</link:label>
    <link:loc xlink:label="loc_RoyaltiesAmountPaidAndAccrued.25544.11.6" xlink:href="psti-20140630.xsd#psti_RoyaltiesAmountPaidAndAccrued" xlink:type="locator" />
    <link:labelArc xlink:from="loc_RoyaltiesAmountPaidAndAccrued.25544.11.6" xlink:to="lab_RoyaltiesAmountPaidAndAccrued.327147.255439" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_RoyaltiesAmountPaidAndAccrued.327147.255439" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US" id="lab_RoyaltiesAmountPaidAndAccrued.327147.255439">Royalties Amount Paid And Accrued</link:label>
    <link:loc xlink:label="loc_RoyaltiesAmountPaidAndAccrued.25544.11.7" xlink:href="psti-20140630.xsd#psti_RoyaltiesAmountPaidAndAccrued" xlink:type="locator" />
    <link:labelArc xlink:from="loc_RoyaltiesAmountPaidAndAccrued.25544.11.7" xlink:to="lab_RoyaltiesAmountPaidAndAccrued.327148.255440" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_RoyaltiesAmountPaidAndAccrued.327148.255440" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US" id="lab_RoyaltiesAmountPaidAndAccrued.327148.255440">Accrued and paid royalties</link:label>
    <link:loc xlink:label="loc_RoyaltiesAmountPaidAndAccrued.25544.11.12" xlink:href="psti-20140630.xsd#psti_RoyaltiesAmountPaidAndAccrued" xlink:type="locator" />
    <link:labelArc xlink:from="loc_RoyaltiesAmountPaidAndAccrued.25544.11.12" xlink:to="lab_RoyaltiesAmountPaidAndAccrued.327149.255441" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_RoyaltiesAmountPaidAndAccrued.327149.255441" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US" id="lab_RoyaltiesAmountPaidAndAccrued.327149.255441">Amount of royalty paid or accrued.</link:label>
    <link:loc xlink:label="loc_RoyaltyGuaranteesCommitmentsAmount.15952.11.6" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_RoyaltyGuaranteesCommitmentsAmount" xlink:type="locator" />
    <link:labelArc xlink:from="loc_RoyaltyGuaranteesCommitmentsAmount.15952.11.6" xlink:to="lab_RoyaltyGuaranteesCommitmentsAmount.16962.255442" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_RoyaltyGuaranteesCommitmentsAmount.16962.255442" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US" id="lab_RoyaltyGuaranteesCommitmentsAmount.16962.255442">Royalty Guarantees, Commitments, Amount</link:label>
    <link:loc xlink:label="loc_RoyaltyRatePayableOnGrantsReceived.25545.11.6" xlink:href="psti-20140630.xsd#psti_RoyaltyRatePayableOnGrantsReceived" xlink:type="locator" />
    <link:labelArc xlink:from="loc_RoyaltyRatePayableOnGrantsReceived.25545.11.6" xlink:to="lab_RoyaltyRatePayableOnGrantsReceived.325369.255443" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_RoyaltyRatePayableOnGrantsReceived.325369.255443" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US" id="lab_RoyaltyRatePayableOnGrantsReceived.325369.255443">Royalty Rate Payable On Grants Received</link:label>
    <link:loc xlink:label="loc_RoyaltyRatePayableOnGrantsReceived.25545.11.12" xlink:href="psti-20140630.xsd#psti_RoyaltyRatePayableOnGrantsReceived" xlink:type="locator" />
    <link:labelArc xlink:from="loc_RoyaltyRatePayableOnGrantsReceived.25545.11.12" xlink:to="lab_RoyaltyRatePayableOnGrantsReceived.325370.255445" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_RoyaltyRatePayableOnGrantsReceived.325370.255445" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US" id="lab_RoyaltyRatePayableOnGrantsReceived.325370.255445">Maximum royalty payable based on a percentage of grants received.</link:label>
    <link:loc xlink:label="loc_RoyaltyRatePayableOnGrantsReceived.25545.11.7" xlink:href="psti-20140630.xsd#psti_RoyaltyRatePayableOnGrantsReceived" xlink:type="locator" />
    <link:labelArc xlink:from="loc_RoyaltyRatePayableOnGrantsReceived.25545.11.7" xlink:to="lab_RoyaltyRatePayableOnGrantsReceived.325371.255444" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_RoyaltyRatePayableOnGrantsReceived.325371.255444" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US" id="lab_RoyaltyRatePayableOnGrantsReceived.325371.255444">Royalty payable based on grants received</link:label>
    <link:loc xlink:label="loc_RoyaltyRateSales.25546.11.12" xlink:href="psti-20140630.xsd#psti_RoyaltyRateSales" xlink:type="locator" />
    <link:labelArc xlink:from="loc_RoyaltyRateSales.25546.11.12" xlink:to="lab_RoyaltyRatePayableOnSaleOfProducts.325367.255446" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_RoyaltyRatePayableOnSaleOfProducts.325367.255446" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US" id="lab_RoyaltyRatePayableOnSaleOfProducts.325367.255446">Royalty rate payable calculated as a percentage of the sale of products and other related revenues generated from such projects.</link:label>
    <link:loc xlink:label="loc_RoyaltyRateSales.25546.11.6" xlink:href="psti-20140630.xsd#psti_RoyaltyRateSales" xlink:type="locator" />
    <link:labelArc xlink:from="loc_RoyaltyRateSales.25546.11.6" xlink:to="lab_RoyaltyRateSales.325366.255447" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_RoyaltyRateSales.325366.255447" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US" id="lab_RoyaltyRateSales.325366.255447">Royalty Rate Sales</link:label>
    <link:loc xlink:label="loc_PercentageOfQualifiedExpenditures.25580.11.7" xlink:href="psti-20140630.xsd#psti_PercentageOfQualifiedExpenditures" xlink:type="locator" />
    <link:labelArc xlink:from="loc_PercentageOfQualifiedExpenditures.25580.11.7" xlink:to="lab_StringOne.257483" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_StringOne.257483" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US" id="lab_StringOne.257483">Percentage of qualified expenditures eligible for grant</link:label>
    <link:loc xlink:label="loc_RoyaltyRateSales.25546.11.7" xlink:href="psti-20140630.xsd#psti_RoyaltyRateSales" xlink:type="locator" />
    <link:labelArc xlink:from="loc_RoyaltyRateSales.25546.11.7" xlink:to="RoyaltyRateSales.325368.255448" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="RoyaltyRateSales.325368.255448" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US" id="RoyaltyRateSales.325368.255448">Royalty rate</link:label>
    <link:loc xlink:label="loc_RoyaltyGuaranteesCommitmentsAmount.15952.11.7" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_RoyaltyGuaranteesCommitmentsAmount" xlink:type="locator" />
    <link:labelArc xlink:from="loc_RoyaltyGuaranteesCommitmentsAmount.15952.11.7" xlink:to="us-gaap_RoyaltyGuaranteesCommitmentsAmount_lbl.433140.325372.255449" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="us-gaap_RoyaltyGuaranteesCommitmentsAmount_lbl.433140.325372.255449" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US" id="us-gaap_RoyaltyGuaranteesCommitmentsAmount_lbl.433140.325372.255449">Contingent liability amount</link:label>
    <link:loc xlink:label="loc_AccountsPayableCurrent.5620.11.6" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_AccountsPayableCurrent" xlink:type="locator" />
    <link:labelArc xlink:from="loc_AccountsPayableCurrent.5620.11.6" xlink:to="lab_AccountsPayableCurrent.12484.253648.250261.255511" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_AccountsPayableCurrent.12484.253648.250261.255511" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US" id="lab_AccountsPayableCurrent.12484.253648.250261.255511">Accounts Payable, Current</link:label>
    <link:loc xlink:label="loc_AccountsPayableCurrent.5620.11.7" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_AccountsPayableCurrent" xlink:type="locator" />
    <link:labelArc xlink:from="loc_AccountsPayableCurrent.5620.11.7" xlink:to="lab_AccountsPayableCurrent7.286696.253649.250262.255512" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_AccountsPayableCurrent7.286696.253649.250262.255512" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US" id="lab_AccountsPayableCurrent7.286696.253649.250262.255512">Trade payables</link:label>
    <link:loc xlink:label="loc_AccountsPayableOtherCurrent.5626.11.6" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_AccountsPayableOtherCurrent" xlink:type="locator" />
    <link:labelArc xlink:from="loc_AccountsPayableOtherCurrent.5626.11.6" xlink:to="lab_AccountsPayableOtherCurrent.15954.253650.250263.255513" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_AccountsPayableOtherCurrent.15954.253650.250263.255513" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US" id="lab_AccountsPayableOtherCurrent.15954.253650.250263.255513">Accounts Payable, Other, Current</link:label>
    <link:loc xlink:label="loc_AccountsPayableOtherCurrent.5626.11.7" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_AccountsPayableOtherCurrent" xlink:type="locator" />
    <link:labelArc xlink:from="loc_AccountsPayableOtherCurrent.5626.11.7" xlink:to="lab_AccountsPayableOtherCurrent.286699.253651.250264.255514" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_AccountsPayableOtherCurrent.286699.253651.250264.255514" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US" id="lab_AccountsPayableOtherCurrent.286699.253651.250264.255514">Other accounts payable</link:label>
    <link:loc xlink:label="loc_AccountsReceivableNetCurrent.5600.11.6" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_AccountsReceivableNetCurrent" xlink:type="locator" />
    <link:labelArc xlink:from="loc_AccountsReceivableNetCurrent.5600.11.6" xlink:to="lab_AccountsReceivableNetCurrent.423" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_AccountsReceivableNetCurrent.423" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US" id="lab_AccountsReceivableNetCurrent.423">Accounts Receivable, Net, Current</link:label>
    <link:loc xlink:label="loc_AccountsReceivableNetCurrent.5600.11.7" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_AccountsReceivableNetCurrent" xlink:type="locator" />
    <link:labelArc xlink:from="loc_AccountsReceivableNetCurrent.5600.11.7" xlink:to="lab_AccountsReceivableNetCurrent7.223175.183100.256310" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_AccountsReceivableNetCurrent7.223175.183100.256310" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US" id="lab_AccountsReceivableNetCurrent7.223175.183100.256310">Account receivable from OCS</link:label>
    <link:loc xlink:label="loc_AccruedLiabilitiesCurrent.5698.11.6" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_AccruedLiabilitiesCurrent" xlink:type="locator" />
    <link:labelArc xlink:from="loc_AccruedLiabilitiesCurrent.5698.11.6" xlink:to="lab_AccruedLiabilitiesCurrent.12488.253652.250265.255515" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_AccruedLiabilitiesCurrent.12488.253652.250265.255515" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US" id="lab_AccruedLiabilitiesCurrent.12488.253652.250265.255515">Accrued Liabilities, Current</link:label>
    <link:loc xlink:label="loc_AccruedLiabilitiesCurrent.5698.11.7" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_AccruedLiabilitiesCurrent" xlink:type="locator" />
    <link:labelArc xlink:from="loc_AccruedLiabilitiesCurrent.5698.11.7" xlink:to="lab_AccruedLiabilitiesCurrent7.286698.253653.250266.255516" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_AccruedLiabilitiesCurrent7.286698.253653.250266.255516" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US" id="lab_AccruedLiabilitiesCurrent7.286698.253653.250266.255516">Accrued expenses</link:label>
    <link:loc xlink:label="loc_AccumulatedOtherComprehensiveIncomeLossNetOfTax.5715.11.6" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:type="locator" />
    <link:labelArc xlink:from="loc_AccumulatedOtherComprehensiveIncomeLossNetOfTax.5715.11.6" xlink:to="lab_AccumulatedOtherComprehensiveIncomeLossNetOfTax.345.253654.250267.255517" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_AccumulatedOtherComprehensiveIncomeLossNetOfTax.345.253654.250267.255517" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US" id="lab_AccumulatedOtherComprehensiveIncomeLossNetOfTax.345.253654.250267.255517">Accumulated Other Comprehensive Income (Loss), Net of Tax</link:label>
    <link:loc xlink:label="loc_AccumulatedOtherComprehensiveIncomeLossNetOfTax.5715.11.7" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:type="locator" />
    <link:labelArc xlink:from="loc_AccumulatedOtherComprehensiveIncomeLossNetOfTax.5715.11.7" xlink:to="lab_AccumulatedOtherComprehensiveIncomeLossNetOfTax7.333710.253655.250268.255518" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_AccumulatedOtherComprehensiveIncomeLossNetOfTax7.333710.253655.250268.255518" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US" id="lab_AccumulatedOtherComprehensiveIncomeLossNetOfTax7.333710.253655.250268.255518">Other comprehensive income</link:label>
    <link:loc xlink:label="loc_AdditionalPaidInCapital.5750.11.6" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_AdditionalPaidInCapital" xlink:type="locator" />
    <link:labelArc xlink:from="loc_AdditionalPaidInCapital.5750.11.6" xlink:to="lab_AdditionalPaidInCapital.400.253656.250269.255519" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_AdditionalPaidInCapital.400.253656.250269.255519" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US" id="lab_AdditionalPaidInCapital.400.253656.250269.255519">Additional Paid in Capital</link:label>
    <link:loc xlink:label="loc_AdditionalPaidInCapital.5750.11.7" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_AdditionalPaidInCapital" xlink:type="locator" />
    <link:labelArc xlink:from="loc_AdditionalPaidInCapital.5750.11.7" xlink:to="lab_AdditionalPaidInCapital7.286706.253657.250270.255520" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_AdditionalPaidInCapital7.286706.253657.250270.255520" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US" id="lab_AdditionalPaidInCapital7.286706.253657.250270.255520">Additional paid-in capital</link:label>
    <link:loc xlink:label="loc_Assets.5987.11.9" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_Assets" xlink:type="locator" />
    <link:labelArc xlink:from="loc_Assets.5987.11.9" xlink:to="lab_Assets.286693.253659.250271.255521" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_Assets.286693.253659.250271.255521" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US" id="lab_Assets.286693.253659.250271.255521">Total assets</link:label>
    <link:loc xlink:label="loc_Assets.5987.11.6" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_Assets" xlink:type="locator" />
    <link:labelArc xlink:from="loc_Assets.5987.11.6" xlink:to="lab_Assets.8758.253658.250272.255522" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_Assets.8758.253658.250272.255522" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US" id="lab_Assets.8758.253658.250272.255522">Assets</link:label>
    <link:loc xlink:label="loc_AssetsAbstract.631.11.7" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_AssetsAbstract" xlink:type="locator" />
    <link:labelArc xlink:from="loc_AssetsAbstract.631.11.7" xlink:to="lab_AssetsAbstract.286679.253661.250273.255523" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_AssetsAbstract.286679.253661.250273.255523" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US" id="lab_AssetsAbstract.286679.253661.250273.255523">ASSETS</link:label>
    <link:loc xlink:label="loc_AssetsAbstract.631.11.6" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_AssetsAbstract" xlink:type="locator" />
    <link:labelArc xlink:from="loc_AssetsAbstract.631.11.6" xlink:to="lab_AssetsAbstract.9477.253660.250274.255524" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_AssetsAbstract.9477.253660.250274.255524" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US" id="lab_AssetsAbstract.9477.253660.250274.255524">Assets [Abstract]</link:label>
    <link:loc xlink:label="loc_AssetsCurrent.6017.11.9" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_AssetsCurrent" xlink:type="locator" />
    <link:labelArc xlink:from="loc_AssetsCurrent.6017.11.9" xlink:to="lab_AssetsCurrent.286686.253663.250275.255525" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_AssetsCurrent.286686.253663.250275.255525" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US" id="lab_AssetsCurrent.286686.253663.250275.255525">Total current assets</link:label>
    <link:loc xlink:label="loc_AssetsCurrent.6017.11.6" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_AssetsCurrent" xlink:type="locator" />
    <link:labelArc xlink:from="loc_AssetsCurrent.6017.11.6" xlink:to="lab_AssetsCurrent.8038.253662.250276.255526" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_AssetsCurrent.8038.253662.250276.255526" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US" id="lab_AssetsCurrent.8038.253662.250276.255526">Assets, Current</link:label>
    <link:loc xlink:label="loc_AssetsCurrentAbstract.628.11.7" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_AssetsCurrentAbstract" xlink:type="locator" />
    <link:labelArc xlink:from="loc_AssetsCurrentAbstract.628.11.7" xlink:to="lab_AssetsCurrentAbstract.286680.253665.250277.255527" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_AssetsCurrentAbstract.286680.253665.250277.255527" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US" id="lab_AssetsCurrentAbstract.286680.253665.250277.255527">CURRENT ASSETS:</link:label>
    <link:loc xlink:label="loc_AssetsCurrentAbstract.628.11.6" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_AssetsCurrentAbstract" xlink:type="locator" />
    <link:labelArc xlink:from="loc_AssetsCurrentAbstract.628.11.6" xlink:to="lab_AssetsCurrentAbstract.8037.253664.250278.255528" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_AssetsCurrentAbstract.8037.253664.250278.255528" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US" id="lab_AssetsCurrentAbstract.8037.253664.250278.255528">Assets, Current [Abstract]</link:label>
    <link:loc xlink:label="loc_AssetsNoncurrent.6012.11.9" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_AssetsNoncurrent" xlink:type="locator" />
    <link:labelArc xlink:from="loc_AssetsNoncurrent.6012.11.9" xlink:to="lab_AssetsNoncurrent.286692.253667.250279.255529" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_AssetsNoncurrent.286692.253667.250279.255529" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US" id="lab_AssetsNoncurrent.286692.253667.250279.255529">Total long-term assets</link:label>
    <link:loc xlink:label="loc_AssetsNoncurrent.6012.11.6" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_AssetsNoncurrent" xlink:type="locator" />
    <link:labelArc xlink:from="loc_AssetsNoncurrent.6012.11.6" xlink:to="lab_AssetsNoncurrent.5105.253666.250280.255530" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_AssetsNoncurrent.5105.253666.250280.255530" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US" id="lab_AssetsNoncurrent.5105.253666.250280.255530">Assets, Noncurrent</link:label>
    <link:loc xlink:label="loc_AssetsNoncurrentAbstract.641.11.7" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_AssetsNoncurrentAbstract" xlink:type="locator" />
    <link:labelArc xlink:from="loc_AssetsNoncurrentAbstract.641.11.7" xlink:to="lab_AssetsNoncurrentAbstract.286688.253669.250281.255531" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_AssetsNoncurrentAbstract.286688.253669.250281.255531" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US" id="lab_AssetsNoncurrentAbstract.286688.253669.250281.255531">LONG-TERM ASSETS:</link:label>
    <link:loc xlink:label="loc_AssetsNoncurrentAbstract.641.11.6" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_AssetsNoncurrentAbstract" xlink:type="locator" />
    <link:labelArc xlink:from="loc_AssetsNoncurrentAbstract.641.11.6" xlink:to="lab_AssetsNoncurrentAbstract.5104.253668.250282.255532" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_AssetsNoncurrentAbstract.5104.253668.250282.255532" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US" id="lab_AssetsNoncurrentAbstract.5104.253668.250282.255532">Assets, Noncurrent [Abstract]</link:label>
    <link:loc xlink:label="loc_CashAndCashEquivalentsAtCarryingValue.6761.11.6" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:type="locator" />
    <link:labelArc xlink:from="loc_CashAndCashEquivalentsAtCarryingValue.6761.11.6" xlink:to="lab_CashAndCashEquivalentsAtCarryingValue.1158.253670.250283.255533" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_CashAndCashEquivalentsAtCarryingValue.1158.253670.250283.255533" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US" id="lab_CashAndCashEquivalentsAtCarryingValue.1158.253670.250283.255533">Cash and Cash Equivalents, at Carrying Value</link:label>
    <link:loc xlink:label="loc_CashAndCashEquivalentsAtCarryingValue.6761.11.7" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:type="locator" />
    <link:labelArc xlink:from="loc_CashAndCashEquivalentsAtCarryingValue.6761.11.7" xlink:to="lab_CashAndCashEquivalentsAtCarryingValue.286681.253671.250284.255534" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_CashAndCashEquivalentsAtCarryingValue.286681.253671.250284.255534" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US" id="lab_CashAndCashEquivalentsAtCarryingValue.286681.253671.250284.255534">Cash and cash equivalents</link:label>
    <link:loc xlink:label="loc_CommitmentsAndContingencies.7037.11.6" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_CommitmentsAndContingencies" xlink:type="locator" />
    <link:labelArc xlink:from="loc_CommitmentsAndContingencies.7037.11.6" xlink:to="lab_CommitmentsAndContingencies.11903.253672.250285.255535" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_CommitmentsAndContingencies.11903.253672.250285.255535" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US" id="lab_CommitmentsAndContingencies.11903.253672.250285.255535">Commitments and Contingencies</link:label>
    <link:loc xlink:label="loc_CommitmentsAndContingencies.7037.11.7" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_CommitmentsAndContingencies" xlink:type="locator" />
    <link:labelArc xlink:from="loc_CommitmentsAndContingencies.7037.11.7" xlink:to="lab_COMMITMENTSANDCONTINGENCIESNote.8.333709.253673.250286.255536" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_COMMITMENTSANDCONTINGENCIESNote.8.333709.253673.250286.255536" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US" id="lab_COMMITMENTSANDCONTINGENCIESNote.8.333709.253673.250286.255536">COMMITMENTS AND CONTINGENCIES</link:label>
    <link:loc xlink:label="loc_CommonStockValue.7048.11.6" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_CommonStockValue" xlink:type="locator" />
    <link:labelArc xlink:from="loc_CommonStockValue.7048.11.6" xlink:to="lab_CommonStockValue.1498.253674.250287.255537" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_CommonStockValue.1498.253674.250287.255537" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US" id="lab_CommonStockValue.1498.253674.250287.255537">Common Stock, Value, Issued</link:label>
    <link:loc xlink:label="loc_CommonStockValue.7048.11.7" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_CommonStockValue" xlink:type="locator" />
    <link:labelArc xlink:from="loc_CommonStockValue.7048.11.7" xlink:to="lab_CommonStockValue7.286705.253675.250288.255538" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_CommonStockValue7.286705.253675.250288.255538" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US" id="lab_CommonStockValue7.286705.253675.250288.255538">Share capital: Common stock $0.00001 par value: Authorized: 200,000,000 shares Issued and outstanding: 68,601,452 shares as of June 30, 2014, 59,196,617 shares as of June 30, 2013;</link:label>
    <link:loc xlink:label="loc_CustomerAdvancesCurrent.7446.11.6" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_CustomerAdvancesCurrent" xlink:type="locator" />
    <link:labelArc xlink:from="loc_CustomerAdvancesCurrent.7446.11.6" xlink:to="lab_CustomerAdvancesCurrent.1834.253676.250289.255539" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_CustomerAdvancesCurrent.1834.253676.250289.255539" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US" id="lab_CustomerAdvancesCurrent.1834.253676.250289.255539">Customer Advances, Current</link:label>
    <link:loc xlink:label="loc_CustomerAdvancesCurrent.7446.11.7" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_CustomerAdvancesCurrent" xlink:type="locator" />
    <link:labelArc xlink:from="loc_CustomerAdvancesCurrent.7446.11.7" xlink:to="lab_CustomerAdvancesCurrent.333706.253677.250290.255540" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_CustomerAdvancesCurrent.333706.253677.250290.255540" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US" id="lab_CustomerAdvancesCurrent.333706.253677.250290.255540">Advance payment from United Therapeutics</link:label>
    <link:loc xlink:label="loc_DeferredRevenueCurrent.7829.11.6" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_DeferredRevenueCurrent" xlink:type="locator" />
    <link:labelArc xlink:from="loc_DeferredRevenueCurrent.7829.11.6" xlink:to="lab_DeferredRevenueCurrent.2193.253678.250291.255541" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_DeferredRevenueCurrent.2193.253678.250291.255541" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US" id="lab_DeferredRevenueCurrent.2193.253678.250291.255541">Deferred Revenue, Current</link:label>
    <link:loc xlink:label="loc_DeferredRevenueCurrent.7829.11.7" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_DeferredRevenueCurrent" xlink:type="locator" />
    <link:labelArc xlink:from="loc_DeferredRevenueCurrent.7829.11.7" xlink:to="lab_DeferredRevenueCurrent7.333704.253679.250292.255542" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_DeferredRevenueCurrent7.333704.253679.250292.255542" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US" id="lab_DeferredRevenueCurrent7.333704.253679.250292.255542">Deferred revenues</link:label>
    <link:loc xlink:label="loc_DeferredRevenueNoncurrent.7842.11.6" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_DeferredRevenueNoncurrent" xlink:type="locator" />
    <link:labelArc xlink:from="loc_DeferredRevenueNoncurrent.7842.11.6" xlink:to="lab_DeferredRevenueNoncurrent.2195.253680.250293.255543" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_DeferredRevenueNoncurrent.2195.253680.250293.255543" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US" id="lab_DeferredRevenueNoncurrent.2195.253680.250293.255543">Deferred Revenue, Noncurrent</link:label>
    <link:loc xlink:label="loc_DeferredRevenueNoncurrent.7842.11.7" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_DeferredRevenueNoncurrent" xlink:type="locator" />
    <link:labelArc xlink:from="loc_DeferredRevenueNoncurrent.7842.11.7" xlink:to="lab_DeferredRevenueNoncurrent.333707.253681.250294.255544" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_DeferredRevenueNoncurrent.333707.253681.250294.255544" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US" id="lab_DeferredRevenueNoncurrent.333707.253681.250294.255544">Deferred revenues</link:label>
    <link:loc xlink:label="loc_DefinedBenefitPlanAssetsForPlanBenefitsNoncurrent.8166.11.6" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_DefinedBenefitPlanAssetsForPlanBenefitsNoncurrent" xlink:type="locator" />
    <link:labelArc xlink:from="loc_DefinedBenefitPlanAssetsForPlanBenefitsNoncurrent.8166.11.6" xlink:to="lab_DefinedBenefitPlanAssetsForPlanBenefitsNoncurrent.16045.253682.250295.255545" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_DefinedBenefitPlanAssetsForPlanBenefitsNoncurrent.16045.253682.250295.255545" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US" id="lab_DefinedBenefitPlanAssetsForPlanBenefitsNoncurrent.16045.253682.250295.255545">Defined Benefit Plan, Assets for Plan Benefits, Noncurrent</link:label>
    <link:loc xlink:label="loc_DefinedBenefitPlanAssetsForPlanBenefitsNoncurrent.8166.11.7" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_DefinedBenefitPlanAssetsForPlanBenefitsNoncurrent" xlink:type="locator" />
    <link:labelArc xlink:from="loc_DefinedBenefitPlanAssetsForPlanBenefitsNoncurrent.8166.11.7" xlink:to="lab_DefinedBenefitPlanAssetsForPlanBenefitsNoncurrent.1872208.327163.255546" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_DefinedBenefitPlanAssetsForPlanBenefitsNoncurrent.1872208.327163.255546" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US" id="lab_DefinedBenefitPlanAssetsForPlanBenefitsNoncurrent.1872208.327163.255546">Severance pay fund</link:label>
    <link:loc xlink:label="loc_EquityAbstract.1881.11.7" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_EquityAbstract" xlink:type="locator" />
    <link:labelArc xlink:from="loc_EquityAbstract.1881.11.7" xlink:to="lab_EquityAbstract.286704.253687.250299.255547" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_EquityAbstract.286704.253687.250299.255547" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US" id="lab_EquityAbstract.286704.253687.250299.255547">STOCKHOLDERS' EQUITY</link:label>
    <link:loc xlink:label="loc_EquityAbstract.1881.11.6" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_EquityAbstract" xlink:type="locator" />
    <link:labelArc xlink:from="loc_EquityAbstract.1881.11.6" xlink:to="lab_EquityAbstract.9804.253686.250300.255548" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_EquityAbstract.9804.253686.250300.255548" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US" id="lab_EquityAbstract.9804.253686.250300.255548">Equity [Abstract]</link:label>
    <link:loc xlink:label="loc_LiabilitiesAndStockholdersEquity.12012.11.9" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquity" xlink:type="locator" />
    <link:labelArc xlink:from="loc_LiabilitiesAndStockholdersEquity.12012.11.9" xlink:to="lab_LiabilitiesAndStockholdersEquity.286709.253689.250301.255549" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_LiabilitiesAndStockholdersEquity.286709.253689.250301.255549" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US" id="lab_LiabilitiesAndStockholdersEquity.286709.253689.250301.255549">Total liabilities and stockholders' equity</link:label>
    <link:loc xlink:label="loc_LiabilitiesAndStockholdersEquity.12012.11.6" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquity" xlink:type="locator" />
    <link:labelArc xlink:from="loc_LiabilitiesAndStockholdersEquity.12012.11.6" xlink:to="lab_LiabilitiesAndStockholdersEquity.4242.253688.250302.255550" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_LiabilitiesAndStockholdersEquity.4242.253688.250302.255550" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US" id="lab_LiabilitiesAndStockholdersEquity.4242.253688.250302.255550">Liabilities and Equity</link:label>
    <link:loc xlink:label="loc_LiabilitiesAndStockholdersEquityAbstract.3052.11.7" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:type="locator" />
    <link:labelArc xlink:from="loc_LiabilitiesAndStockholdersEquityAbstract.3052.11.7" xlink:to="lab_LiabilitiesAndStockholdersEquityAbstract.286697.253691.250303.255551" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_LiabilitiesAndStockholdersEquityAbstract.286697.253691.250303.255551" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US" id="lab_LiabilitiesAndStockholdersEquityAbstract.286697.253691.250303.255551">LIABILITIES AND STOCKHOLDERS' EQUITY</link:label>
    <link:loc xlink:label="loc_LiabilitiesAndStockholdersEquityAbstract.3052.11.6" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:type="locator" />
    <link:labelArc xlink:from="loc_LiabilitiesAndStockholdersEquityAbstract.3052.11.6" xlink:to="lab_LiabilitiesAndStockholdersEquityAbstract.4241.253690.250304.255552" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_LiabilitiesAndStockholdersEquityAbstract.4241.253690.250304.255552" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US" id="lab_LiabilitiesAndStockholdersEquityAbstract.4241.253690.250304.255552">Liabilities and Equity [Abstract]</link:label>
    <link:loc xlink:label="loc_LiabilitiesCurrent.12001.11.6" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_LiabilitiesCurrent" xlink:type="locator" />
    <link:labelArc xlink:from="loc_LiabilitiesCurrent.12001.11.6" xlink:to="lab_LiabilitiesCurrent.1824.253692.250305.255553" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_LiabilitiesCurrent.1824.253692.250305.255553" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US" id="lab_LiabilitiesCurrent.1824.253692.250305.255553">Liabilities, Current</link:label>
    <link:loc xlink:label="loc_LiabilitiesCurrent.12001.11.9" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_LiabilitiesCurrent" xlink:type="locator" />
    <link:labelArc xlink:from="loc_LiabilitiesCurrent.12001.11.9" xlink:to="lab_LiabilitiesCurrent.286700.253693.250306.255554" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_LiabilitiesCurrent.286700.253693.250306.255554" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US" id="lab_LiabilitiesCurrent.286700.253693.250306.255554">Total current liabilities</link:label>
    <link:loc xlink:label="loc_LiabilitiesCurrentAbstract.3044.11.7" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_LiabilitiesCurrentAbstract" xlink:type="locator" />
    <link:labelArc xlink:from="loc_LiabilitiesCurrentAbstract.3044.11.7" xlink:to="lab_LiabilitiesCurrentAbstract.107687.253695.250307.255555" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_LiabilitiesCurrentAbstract.107687.253695.250307.255555" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US" id="lab_LiabilitiesCurrentAbstract.107687.253695.250307.255555">CURRENT LIABILITIES</link:label>
    <link:loc xlink:label="loc_LiabilitiesCurrentAbstract.3044.11.6" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_LiabilitiesCurrentAbstract" xlink:type="locator" />
    <link:labelArc xlink:from="loc_LiabilitiesCurrentAbstract.3044.11.6" xlink:to="lab_LiabilitiesCurrentAbstract.1823.253694.250308.255556" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_LiabilitiesCurrentAbstract.1823.253694.250308.255556" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US" id="lab_LiabilitiesCurrentAbstract.1823.253694.250308.255556">Liabilities, Current [Abstract]</link:label>
    <link:loc xlink:label="loc_LiabilitiesNoncurrent.12040.11.9" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_LiabilitiesNoncurrent" xlink:type="locator" />
    <link:labelArc xlink:from="loc_LiabilitiesNoncurrent.12040.11.9" xlink:to="lab_LiabilitiesNoncurrent.286703.253697.250309.255557" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_LiabilitiesNoncurrent.286703.253697.250309.255557" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US" id="lab_LiabilitiesNoncurrent.286703.253697.250309.255557">Total long-term liabilities</link:label>
    <link:loc xlink:label="loc_LiabilitiesNoncurrent.12040.11.6" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_LiabilitiesNoncurrent" xlink:type="locator" />
    <link:labelArc xlink:from="loc_LiabilitiesNoncurrent.12040.11.6" xlink:to="lab_LiabilitiesNoncurrent.5110.253696.250310.255558" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_LiabilitiesNoncurrent.5110.253696.250310.255558" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US" id="lab_LiabilitiesNoncurrent.5110.253696.250310.255558">Liabilities, Noncurrent</link:label>
    <link:loc xlink:label="loc_LiabilitiesNoncurrentAbstract.3048.11.7" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_LiabilitiesNoncurrentAbstract" xlink:type="locator" />
    <link:labelArc xlink:from="loc_LiabilitiesNoncurrentAbstract.3048.11.7" xlink:to="lab_LiabilitiesNoncurrentAbstract.286701.253699.250311.255559" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_LiabilitiesNoncurrentAbstract.286701.253699.250311.255559" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US" id="lab_LiabilitiesNoncurrentAbstract.286701.253699.250311.255559">LONG-TERM LIABILITIES</link:label>
    <link:loc xlink:label="loc_LiabilitiesNoncurrentAbstract.3048.11.6" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_LiabilitiesNoncurrentAbstract" xlink:type="locator" />
    <link:labelArc xlink:from="loc_LiabilitiesNoncurrentAbstract.3048.11.6" xlink:to="lab_LiabilitiesNoncurrentAbstract.5109.253698.250312.255560" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_LiabilitiesNoncurrentAbstract.5109.253698.250312.255560" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US" id="lab_LiabilitiesNoncurrentAbstract.5109.253698.250312.255560">Liabilities, Noncurrent [Abstract]</link:label>
    <link:loc xlink:label="loc_LongTermInvestments.12613.11.6" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_LongTermInvestments" xlink:type="locator" />
    <link:labelArc xlink:from="loc_LongTermInvestments.12613.11.6" xlink:to="lab_LongTermInvestments.11412.255561" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_LongTermInvestments.11412.255561" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US" id="lab_LongTermInvestments.11412.255561">Long-term Investments</link:label>
    <link:loc xlink:label="loc_LongTermInvestments.12613.11.7" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_LongTermInvestments" xlink:type="locator" />
    <link:labelArc xlink:from="loc_LongTermInvestments.12613.11.7" xlink:to="lab_LongTermInvestments.134115.358787.255562" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_LongTermInvestments.134115.358787.255562" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US" id="lab_LongTermInvestments.134115.358787.255562">Long-term deposits and restricted deposits</link:label>
    <link:loc xlink:label="loc_MarketableSecuritiesCurrent.12849.11.7" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_MarketableSecuritiesCurrent" xlink:type="locator" />
    <link:labelArc xlink:from="loc_MarketableSecuritiesCurrent.12849.11.7" xlink:to="lab_MarketableSecuritiesCurrent.333699.253701.250548.255563" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_MarketableSecuritiesCurrent.333699.253701.250548.255563" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US" id="lab_MarketableSecuritiesCurrent.333699.253701.250548.255563">Marketable securities</link:label>
    <link:loc xlink:label="loc_MarketableSecuritiesCurrent.12849.11.6" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_MarketableSecuritiesCurrent" xlink:type="locator" />
    <link:labelArc xlink:from="loc_MarketableSecuritiesCurrent.12849.11.6" xlink:to="lab_MarketableSecuritiesCurrent.4731.253700.250549.255564" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_MarketableSecuritiesCurrent.4731.253700.250549.255564" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US" id="lab_MarketableSecuritiesCurrent.4731.253700.250549.255564">Marketable Securities, Current</link:label>
    <link:loc xlink:label="loc_OtherAssetsCurrent.13702.11.6" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_OtherAssetsCurrent" xlink:type="locator" />
    <link:labelArc xlink:from="loc_OtherAssetsCurrent.13702.11.6" xlink:to="lab_OtherAssetsCurrent.13299.255565" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_OtherAssetsCurrent.13299.255565" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US" id="lab_OtherAssetsCurrent.13299.255565">Other Assets, Current</link:label>
    <link:loc xlink:label="loc_OtherAssetsCurrent.13702.11.7" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_OtherAssetsCurrent" xlink:type="locator" />
    <link:labelArc xlink:from="loc_OtherAssetsCurrent.13702.11.7" xlink:to="lab_OtherAssetsCurrent.223285.183150.255566" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_OtherAssetsCurrent.223285.183150.255566" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US" id="lab_OtherAssetsCurrent.223285.183150.255566">Other current assets</link:label>
    <link:loc xlink:label="loc_OtherAssetsNoncurrent.13645.11.6" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_OtherAssetsNoncurrent" xlink:type="locator" />
    <link:labelArc xlink:from="loc_OtherAssetsNoncurrent.13645.11.6" xlink:to="lab_OtherAssetsNoncurrent.10355.253704.250313.255567" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_OtherAssetsNoncurrent.10355.253704.250313.255567" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US" id="lab_OtherAssetsNoncurrent.10355.253704.250313.255567">Other Assets, Noncurrent</link:label>
    <link:loc xlink:label="loc_OtherAssetsNoncurrent.13645.11.7" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_OtherAssetsNoncurrent" xlink:type="locator" />
    <link:labelArc xlink:from="loc_OtherAssetsNoncurrent.13645.11.7" xlink:to="lab_OtherAssetsNoncurrent7.1840923.253705.250314.255568" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_OtherAssetsNoncurrent7.1840923.253705.250314.255568" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US" id="lab_OtherAssetsNoncurrent7.1840923.253705.250314.255568">Other long term assets</link:label>
    <link:loc xlink:label="loc_OtherLiabilitiesNoncurrent.13846.11.6" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_OtherLiabilitiesNoncurrent" xlink:type="locator" />
    <link:labelArc xlink:from="loc_OtherLiabilitiesNoncurrent.13846.11.6" xlink:to="lab_OtherLiabilitiesNoncurrent.12946.250315.255569" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_OtherLiabilitiesNoncurrent.12946.250315.255569" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US" id="lab_OtherLiabilitiesNoncurrent.12946.250315.255569">Other Liabilities, Noncurrent</link:label>
    <link:loc xlink:label="loc_OtherLiabilitiesNoncurrent.13846.11.7" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_OtherLiabilitiesNoncurrent" xlink:type="locator" />
    <link:labelArc xlink:from="loc_OtherLiabilitiesNoncurrent.13846.11.7" xlink:to="lab_OtherLiabilitiesNoncurrent.489053.250316.255570" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_OtherLiabilitiesNoncurrent.489053.250316.255570" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US" id="lab_OtherLiabilitiesNoncurrent.489053.250316.255570">Other long-term liabilities</link:label>
    <link:loc xlink:label="loc_PostemploymentBenefitsLiabilityNoncurrent.14433.11.7" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_PostemploymentBenefitsLiabilityNoncurrent" xlink:type="locator" />
    <link:labelArc xlink:from="loc_PostemploymentBenefitsLiabilityNoncurrent.14433.11.7" xlink:to="lab_PostemploymentBenefitsLiabilityNoncurrent.1872220.190675.255571" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_PostemploymentBenefitsLiabilityNoncurrent.1872220.190675.255571" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US" id="lab_PostemploymentBenefitsLiabilityNoncurrent.1872220.190675.255571">Accrued severance pay</link:label>
    <link:loc xlink:label="loc_PostemploymentBenefitsLiabilityNoncurrent.14433.11.6" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_PostemploymentBenefitsLiabilityNoncurrent" xlink:type="locator" />
    <link:labelArc xlink:from="loc_PostemploymentBenefitsLiabilityNoncurrent.14433.11.6" xlink:to="lab_PostemploymentBenefitsLiabilityNoncurrent.2021.253709.250320.255572" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_PostemploymentBenefitsLiabilityNoncurrent.2021.253709.250320.255572" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US" id="lab_PostemploymentBenefitsLiabilityNoncurrent.2021.253709.250320.255572">Postemployment Benefits Liability, Noncurrent</link:label>
    <link:loc xlink:label="loc_PropertyPlantAndEquipmentNet.15032.11.7" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet" xlink:type="locator" />
    <link:labelArc xlink:from="loc_PropertyPlantAndEquipmentNet.15032.11.7" xlink:to="lab_PropertyPlantAndEquipmentNet.286691.253714.250322.255573" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_PropertyPlantAndEquipmentNet.286691.253714.250322.255573" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US" id="lab_PropertyPlantAndEquipmentNet.286691.253714.250322.255573">Property and equipment, net</link:label>
    <link:loc xlink:label="loc_PropertyPlantAndEquipmentNet.15032.11.6" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet" xlink:type="locator" />
    <link:labelArc xlink:from="loc_PropertyPlantAndEquipmentNet.15032.11.6" xlink:to="lab_PropertyPlantAndEquipmentNet.6369.253713.250323.255574" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_PropertyPlantAndEquipmentNet.6369.253713.250323.255574" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US" id="lab_PropertyPlantAndEquipmentNet.6369.253713.250323.255574">Property, Plant and Equipment, Net</link:label>
    <link:loc xlink:label="loc_RestrictedCashAndCashEquivalentsAtCarryingValue.15718.11.6" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_RestrictedCashAndCashEquivalentsAtCarryingValue" xlink:type="locator" />
    <link:labelArc xlink:from="loc_RestrictedCashAndCashEquivalentsAtCarryingValue.15718.11.6" xlink:to="lab_RestrictedCashAndCashEquivalentsAtCarryingValue.16592.255575" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_RestrictedCashAndCashEquivalentsAtCarryingValue.16592.255575" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US" id="lab_RestrictedCashAndCashEquivalentsAtCarryingValue.16592.255575">Restricted Cash and Cash Equivalents, Current</link:label>
    <link:loc xlink:label="loc_RestrictedCashAndCashEquivalentsAtCarryingValue.15718.11.7" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_RestrictedCashAndCashEquivalentsAtCarryingValue" xlink:type="locator" />
    <link:labelArc xlink:from="loc_RestrictedCashAndCashEquivalentsAtCarryingValue.15718.11.7" xlink:to="lab_RestrictedCashAndCashEquivalentsAtCarryingValue.512318.250974.255576" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_RestrictedCashAndCashEquivalentsAtCarryingValue.512318.250974.255576" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US" id="lab_RestrictedCashAndCashEquivalentsAtCarryingValue.512318.250974.255576">Restricted cash and restricted short-term deposits</link:label>
    <link:loc xlink:label="loc_RetainedEarningsAccumulatedDeficit.15840.11.6" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_RetainedEarningsAccumulatedDeficit" xlink:type="locator" />
    <link:labelArc xlink:from="loc_RetainedEarningsAccumulatedDeficit.15840.11.6" xlink:to="lab_RetainedEarningsAccumulatedDeficit.7073.253717.250555.255577" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_RetainedEarningsAccumulatedDeficit.7073.253717.250555.255577" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US" id="lab_RetainedEarningsAccumulatedDeficit.7073.253717.250555.255577">Retained Earnings (Accumulated Deficit)</link:label>
    <link:loc xlink:label="loc_RetainedEarningsAccumulatedDeficit.15840.11.7" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_RetainedEarningsAccumulatedDeficit" xlink:type="locator" />
    <link:labelArc xlink:from="loc_RetainedEarningsAccumulatedDeficit.15840.11.7" xlink:to="lab_RetainedEarningsAccumulatedDeficit7.288027.253718.250556.255578" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_RetainedEarningsAccumulatedDeficit7.288027.253718.250556.255578" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US" id="lab_RetainedEarningsAccumulatedDeficit7.288027.253718.250556.255578">Accumulated deficit</link:label>
    <link:loc xlink:label="loc_ShortTermInvestments.16790.11.7" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ShortTermInvestments" xlink:type="locator" />
    <link:labelArc xlink:from="loc_ShortTermInvestments.16790.11.7" xlink:to="lab_ShortTermInvestments.334612.253720.250326.255579" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_ShortTermInvestments.334612.253720.250326.255579" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US" id="lab_ShortTermInvestments.334612.253720.250326.255579">Short-term bank deposits</link:label>
    <link:loc xlink:label="loc_ShortTermInvestments.16790.11.6" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ShortTermInvestments" xlink:type="locator" />
    <link:labelArc xlink:from="loc_ShortTermInvestments.16790.11.6" xlink:to="lab_ShortTermInvestments.7720.253719.250327.255580" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_ShortTermInvestments.7720.253719.250327.255580" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US" id="lab_ShortTermInvestments.7720.253719.250327.255580">Short-term Investments</link:label>
    <link:loc xlink:label="loc_StatementOfFinancialPositionAbstract.5115.11.6" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_StatementOfFinancialPositionAbstract" xlink:type="locator" />
    <link:labelArc xlink:from="loc_StatementOfFinancialPositionAbstract.5115.11.6" xlink:to="lab_StatementOfFinancialPositionAbstract.286678.253721.250328.255581" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_StatementOfFinancialPositionAbstract.286678.253721.250328.255581" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US" id="lab_StatementOfFinancialPositionAbstract.286678.253721.250328.255581">CONSOLIDATED BALANCE SHEETS [Abstract]</link:label>
    <link:loc xlink:label="loc_StockholdersEquity.17019.11.9" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_StockholdersEquity" xlink:type="locator" />
    <link:labelArc xlink:from="loc_StockholdersEquity.17019.11.9" xlink:to="lab_StockholdersEquity.286708.253723.250329.255582" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_StockholdersEquity.286708.253723.250329.255582" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US" id="lab_StockholdersEquity.286708.253723.250329.255582">Total stockholders' equity</link:label>
    <link:loc xlink:label="loc_StockholdersEquity.17019.11.6" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_StockholdersEquity" xlink:type="locator" />
    <link:labelArc xlink:from="loc_StockholdersEquity.17019.11.6" xlink:to="lab_StockholdersEquity.287265.253722.250330.255583" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_StockholdersEquity.287265.253722.250330.255583" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US" id="lab_StockholdersEquity.287265.253722.250330.255583">Stockholders Equity</link:label>
    <link:loc xlink:label="loc_CommonStockParOrStatedValuePerShare.7045.11.6" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_CommonStockParOrStatedValuePerShare" xlink:type="locator" />
    <link:labelArc xlink:from="loc_CommonStockParOrStatedValuePerShare.7045.11.6" xlink:to="lab_CommonStockParOrStatedValuePerShare.10677.253724.250331.255584" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_CommonStockParOrStatedValuePerShare.10677.253724.250331.255584" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US" id="lab_CommonStockParOrStatedValuePerShare.10677.253724.250331.255584">Common Stock, Par or Stated Value Per Share</link:label>
    <link:loc xlink:label="loc_CommonStockParOrStatedValuePerShare.7045.11.7" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_CommonStockParOrStatedValuePerShare" xlink:type="locator" />
    <link:labelArc xlink:from="loc_CommonStockParOrStatedValuePerShare.7045.11.7" xlink:to="lab_CommonStockParOrStatedValuePerShare.286710.253725.250332.255585" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_CommonStockParOrStatedValuePerShare.286710.253725.250332.255585" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US" id="lab_CommonStockParOrStatedValuePerShare.286710.253725.250332.255585">Common stock, par value per share</link:label>
    <link:loc xlink:label="loc_CommonStockSharesAuthorized.7058.11.6" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_CommonStockSharesAuthorized" xlink:type="locator" />
    <link:labelArc xlink:from="loc_CommonStockSharesAuthorized.7058.11.6" xlink:to="lab_CommonStockSharesAuthorized.1491.253726.250333.255586" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_CommonStockSharesAuthorized.1491.253726.250333.255586" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US" id="lab_CommonStockSharesAuthorized.1491.253726.250333.255586">Common Stock, Shares Authorized</link:label>
    <link:loc xlink:label="loc_CommonStockSharesAuthorized.7058.11.7" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_CommonStockSharesAuthorized" xlink:type="locator" />
    <link:labelArc xlink:from="loc_CommonStockSharesAuthorized.7058.11.7" xlink:to="lab_CommonStockSharesAuthorized.286711.253727.250334.255587" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_CommonStockSharesAuthorized.286711.253727.250334.255587" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US" id="lab_CommonStockSharesAuthorized.286711.253727.250334.255587">Common stock, shares authorized</link:label>
    <link:loc xlink:label="loc_CommonStockSharesIssued.7050.11.6" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_CommonStockSharesIssued" xlink:type="locator" />
    <link:labelArc xlink:from="loc_CommonStockSharesIssued.7050.11.6" xlink:to="lab_CommonStockSharesIssued.10338.253728.250335.255588" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_CommonStockSharesIssued.10338.253728.250335.255588" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US" id="lab_CommonStockSharesIssued.10338.253728.250335.255588">Common Stock, Shares, Issued</link:label>
    <link:loc xlink:label="loc_CommonStockSharesIssued.7050.11.7" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_CommonStockSharesIssued" xlink:type="locator" />
    <link:labelArc xlink:from="loc_CommonStockSharesIssued.7050.11.7" xlink:to="lab_CommonStockSharesIssued.286712.253729.250336.255589" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_CommonStockSharesIssued.286712.253729.250336.255589" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US" id="lab_CommonStockSharesIssued.286712.253729.250336.255589">Common stock, shares issued</link:label>
    <link:loc xlink:label="loc_CommonStockSharesOutstanding.7078.11.7" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_CommonStockSharesOutstanding" xlink:type="locator" />
    <link:labelArc xlink:from="loc_CommonStockSharesOutstanding.7078.11.7" xlink:to="lab_CommonStockSharesOutstanding.286713.253731.250337.255590" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_CommonStockSharesOutstanding.286713.253731.250337.255590" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US" id="lab_CommonStockSharesOutstanding.286713.253731.250337.255590">Common stock, shares outstanding</link:label>
    <link:loc xlink:label="loc_CommonStockSharesOutstanding.7078.11.6" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_CommonStockSharesOutstanding" xlink:type="locator" />
    <link:labelArc xlink:from="loc_CommonStockSharesOutstanding.7078.11.6" xlink:to="lab_CommonStockSharesOutstanding.286852.253730.250338.255591" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_CommonStockSharesOutstanding.286852.253730.250338.255591" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US" id="lab_CommonStockSharesOutstanding.286852.253730.250338.255591">Balance, shares</link:label>
    <link:loc xlink:label="loc_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract.517.11.6" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:type="locator" />
    <link:labelArc xlink:from="loc_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract.517.11.6" xlink:to="lab_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract.15733.253764.250346.255592" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract.15733.253764.250346.255592" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US" id="lab_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract.15733.253764.250346.255592">Adjustments to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities [Abstract]</link:label>
    <link:loc xlink:label="loc_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract.517.11.7" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:type="locator" />
    <link:labelArc xlink:from="loc_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract.517.11.7" xlink:to="lab_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract.287300.253765.250347.255593" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract.287300.253765.250347.255593" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US" id="lab_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract.287300.253765.250347.255593">Adjustments to reconcile net loss to net cash used in operating activities:</link:label>
    <link:loc xlink:label="loc_AmortizationOfDiscountAndPremiumAndChangesInAccruedInterestFromMarketableSecurities.25526.11.12" xlink:href="psti-20140630.xsd#psti_AmortizationOfDiscountAndPremiumAndChangesInAccruedInterestFromMarketableSecurities" xlink:type="locator" />
    <link:labelArc xlink:from="loc_AmortizationOfDiscountAndPremiumAndChangesInAccruedInterestFromMarketableSecurities.25526.11.12" xlink:to="lab_AmortizationOfDiscountAndChangesInAccruedInterestFromMarketableSecurities18.333246.253766.250348.255594" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_AmortizationOfDiscountAndChangesInAccruedInterestFromMarketableSecurities18.333246.253766.250348.255594" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US" id="lab_AmortizationOfDiscountAndChangesInAccruedInterestFromMarketableSecurities18.333246.253766.250348.255594">Amortization of discount and premium and changes in accrued interest from marketable securities.</link:label>
    <link:loc xlink:label="loc_AmortizationOfDiscountAndPremiumAndChangesInAccruedInterestFromMarketableSecurities.25526.11.7" xlink:href="psti-20140630.xsd#psti_AmortizationOfDiscountAndPremiumAndChangesInAccruedInterestFromMarketableSecurities" xlink:type="locator" />
    <link:labelArc xlink:from="loc_AmortizationOfDiscountAndPremiumAndChangesInAccruedInterestFromMarketableSecurities.25526.11.7" xlink:to="lab_AmortizationOfDiscountAndChangesInAccruedInterestFromMarketableSecurities7.333247.253767.250349.255595" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_AmortizationOfDiscountAndChangesInAccruedInterestFromMarketableSecurities7.333247.253767.250349.255595" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US" id="lab_AmortizationOfDiscountAndChangesInAccruedInterestFromMarketableSecurities7.333247.253767.250349.255595">Accretion of discount, amortization of premium and changes in accrued interest of marketable securities</link:label>
    <link:loc xlink:label="loc_AmortizationOfDiscountAndPremiumAndChangesInAccruedInterestFromMarketableSecurities.25526.11.6" xlink:href="psti-20140630.xsd#psti_AmortizationOfDiscountAndPremiumAndChangesInAccruedInterestFromMarketableSecurities" xlink:type="locator" />
    <link:labelArc xlink:from="loc_AmortizationOfDiscountAndPremiumAndChangesInAccruedInterestFromMarketableSecurities.25526.11.6" xlink:to="lab_AmortizationOfDiscountAndPremiumAndChangesInAccruedInterestFromMarketableSecurities.333245.253768.250350.255596" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_AmortizationOfDiscountAndPremiumAndChangesInAccruedInterestFromMarketableSecurities.333245.253768.250350.255596" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US" id="lab_AmortizationOfDiscountAndPremiumAndChangesInAccruedInterestFromMarketableSecurities.333245.253768.250350.255596">Amortization Of Discount And Premium And Changes In Accrued Interest From Marketable Securities</link:label>
    <link:loc xlink:label="loc_CapitalExpendituresIncurredButNotYetPaid.6608.11.7" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_CapitalExpendituresIncurredButNotYetPaid" xlink:type="locator" />
    <link:labelArc xlink:from="loc_CapitalExpendituresIncurredButNotYetPaid.6608.11.7" xlink:to="lab_CapitalExpendituresIncurredButNotYetPaid.134513.358864.255598" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_CapitalExpendituresIncurredButNotYetPaid.134513.358864.255598" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US" id="lab_CapitalExpendituresIncurredButNotYetPaid.134513.358864.255598">Purchase of property and equipment on credit</link:label>
    <link:loc xlink:label="loc_CapitalExpendituresIncurredButNotYetPaid.6608.11.6" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_CapitalExpendituresIncurredButNotYetPaid" xlink:type="locator" />
    <link:labelArc xlink:from="loc_CapitalExpendituresIncurredButNotYetPaid.6608.11.6" xlink:to="lab_CapitalExpendituresIncurredButNotYetPaid.2057.255597" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_CapitalExpendituresIncurredButNotYetPaid.2057.255597" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US" id="lab_CapitalExpendituresIncurredButNotYetPaid.2057.255597">Capital Expenditures Incurred but Not yet Paid</link:label>
    <link:loc xlink:label="loc_CashAndCashEquivalentsAtCarryingValue.6761.11.10" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:type="locator" />
    <link:labelArc xlink:from="loc_CashAndCashEquivalentsAtCarryingValue.6761.11.10" xlink:to="lab_CashAndCashEquivalentsAtCarryingValue.286815.253771.250351.255599" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_CashAndCashEquivalentsAtCarryingValue.286815.253771.250351.255599" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xml:lang="en-US" id="lab_CashAndCashEquivalentsAtCarryingValue.286815.253771.250351.255599">Cash and cash equivalents at the beginning of the period</link:label>
    <link:loc xlink:label="loc_CashAndCashEquivalentsAtCarryingValue.6761.11.11" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:type="locator" />
    <link:labelArc xlink:from="loc_CashAndCashEquivalentsAtCarryingValue.6761.11.11" xlink:to="lab_CashAndCashEquivalentsAtCarryingValue.286816.253772.250352.255600" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_CashAndCashEquivalentsAtCarryingValue.286816.253772.250352.255600" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xml:lang="en-US" id="lab_CashAndCashEquivalentsAtCarryingValue.286816.253772.250352.255600">Cash and cash equivalents at the end of the period</link:label>
    <link:loc xlink:label="loc_CashAndCashEquivalentsPeriodIncreaseDecrease.6751.11.9" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease" xlink:type="locator" />
    <link:labelArc xlink:from="loc_CashAndCashEquivalentsPeriodIncreaseDecrease.6751.11.9" xlink:to="lab_CashAndCashEquivalentsPeriodIncreaseDecrease.286814.253774.250353.255601" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_CashAndCashEquivalentsPeriodIncreaseDecrease.286814.253774.250353.255601" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US" id="lab_CashAndCashEquivalentsPeriodIncreaseDecrease.286814.253774.250353.255601">Decrease in cash and cash equivalents</link:label>
    <link:loc xlink:label="loc_CashAndCashEquivalentsPeriodIncreaseDecrease.6751.11.6" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease" xlink:type="locator" />
    <link:labelArc xlink:from="loc_CashAndCashEquivalentsPeriodIncreaseDecrease.6751.11.6" xlink:to="lab_CashAndCashEquivalentsPeriodIncreaseDecrease.4962.253773.250354.255602" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_CashAndCashEquivalentsPeriodIncreaseDecrease.4962.253773.250354.255602" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US" id="lab_CashAndCashEquivalentsPeriodIncreaseDecrease.4962.253773.250354.255602">Cash and Cash Equivalents, Period Increase (Decrease)</link:label>
    <link:loc xlink:label="loc_Depreciation.8242.11.7" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_Depreciation" xlink:type="locator" />
    <link:labelArc xlink:from="loc_Depreciation.8242.11.7" xlink:to="lab_Depreciation.286738.253786.250361.255603" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_Depreciation.286738.253786.250361.255603" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US" id="lab_Depreciation.286738.253786.250361.255603">Depreciation</link:label>
    <link:loc xlink:label="loc_Depreciation.8242.11.6" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_Depreciation" xlink:type="locator" />
    <link:labelArc xlink:from="loc_Depreciation.8242.11.6" xlink:to="lab_Depreciation.437.253785.250362.255604" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_Depreciation.437.253785.250362.255604" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US" id="lab_Depreciation.437.253785.250362.255604">Depreciation</link:label>
    <link:loc xlink:label="loc_GainLossOnSaleOfPropertyPlantEquipment.10522.11.53" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_GainLossOnSaleOfPropertyPlantEquipment" xlink:type="locator" />
    <link:labelArc xlink:from="loc_GainLossOnSaleOfPropertyPlantEquipment.10522.11.53" xlink:to="lab_GainLossOnSaleOfPropertyPlantEquipment.286739.253791.250363.255605" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_GainLossOnSaleOfPropertyPlantEquipment.286739.253791.250363.255605" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xml:lang="en-US" id="lab_GainLossOnSaleOfPropertyPlantEquipment.286739.253791.250363.255605">Loss on property and equipment</link:label>
    <link:loc xlink:label="loc_GainLossOnSaleOfPropertyPlantEquipment.10522.11.6" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_GainLossOnSaleOfPropertyPlantEquipment" xlink:type="locator" />
    <link:labelArc xlink:from="loc_GainLossOnSaleOfPropertyPlantEquipment.10522.11.6" xlink:to="lab_GainLossOnSaleOfPropertyPlantEquipment.3366.253790.250364.255606" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_GainLossOnSaleOfPropertyPlantEquipment.3366.253790.250364.255606" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US" id="lab_GainLossOnSaleOfPropertyPlantEquipment.3366.253790.250364.255606">Gain (Loss) on Sale of Property Plant Equipment</link:label>
    <link:loc xlink:label="loc_IncomeTaxesPaid.11047.11.7" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_IncomeTaxesPaid" xlink:type="locator" />
    <link:labelArc xlink:from="loc_IncomeTaxesPaid.11047.11.7" xlink:to="lab_IncomeTaxesPaid.286818.253795.250365.255607" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_IncomeTaxesPaid.286818.253795.250365.255607" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US" id="lab_IncomeTaxesPaid.286818.253795.250365.255607">Taxes paid due to non-deductible expenses</link:label>
    <link:loc xlink:label="loc_IncomeTaxesPaid.11047.11.6" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_IncomeTaxesPaid" xlink:type="locator" />
    <link:labelArc xlink:from="loc_IncomeTaxesPaid.11047.11.6" xlink:to="lab_IncomeTaxesPaid.7963.253794.250366.255608" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_IncomeTaxesPaid.7963.253794.250366.255608" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US" id="lab_IncomeTaxesPaid.7963.253794.250366.255608">Income Taxes Paid</link:label>
    <link:loc xlink:label="loc_IncreaseDecreaseInAccountsPayable.11150.11.6" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsPayable" xlink:type="locator" />
    <link:labelArc xlink:from="loc_IncreaseDecreaseInAccountsPayable.11150.11.6" xlink:to="lab_IncreaseDecreaseInAccountsPayable.1389.253796.250367.255609" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_IncreaseDecreaseInAccountsPayable.1389.253796.250367.255609" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US" id="lab_IncreaseDecreaseInAccountsPayable.1389.253796.250367.255609">Increase (Decrease) in Accounts Payable</link:label>
    <link:loc xlink:label="loc_IncreaseDecreaseInAccountsPayable.11150.11.7" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsPayable" xlink:type="locator" />
    <link:labelArc xlink:from="loc_IncreaseDecreaseInAccountsPayable.11150.11.7" xlink:to="lab_IncreaseDecreaseInAccountsPayable7.286759.253797.250368.255610" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_IncreaseDecreaseInAccountsPayable7.286759.253797.250368.255610" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US" id="lab_IncreaseDecreaseInAccountsPayable7.286759.253797.250368.255610">Increase (decrease) in trade payables</link:label>
    <link:loc xlink:label="loc_IncreaseDecreaseInAccountsReceivable.11117.11.6" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:type="locator" />
    <link:labelArc xlink:from="loc_IncreaseDecreaseInAccountsReceivable.11117.11.6" xlink:to="lab_IncreaseDecreaseInAccountsReceivable.9059" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_IncreaseDecreaseInAccountsReceivable.9059" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US" id="lab_IncreaseDecreaseInAccountsReceivable.9059">Increase (Decrease) in Accounts Receivable</link:label>
    <link:loc xlink:label="loc_IncreaseDecreaseInAccountsReceivable.11117.11.53" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:type="locator" />
    <link:labelArc xlink:from="loc_IncreaseDecreaseInAccountsReceivable.11117.11.53" xlink:to="lab_IncreaseDecreaseInAccountsReceivable.223198.183042.259740" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_IncreaseDecreaseInAccountsReceivable.223198.183042.259740" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xml:lang="en-US" id="lab_IncreaseDecreaseInAccountsReceivable.223198.183042.259740">Decrease (increase) in other accounts receivable</link:label>
    <link:loc xlink:label="loc_IncreaseDecreaseInAccruedInterestReceivableNet.11204.11.6" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_IncreaseDecreaseInAccruedInterestReceivableNet" xlink:type="locator" />
    <link:labelArc xlink:from="loc_IncreaseDecreaseInAccruedInterestReceivableNet.11204.11.6" xlink:to="lab_IncreaseDecreaseInAccruedInterestReceivableNet.9180" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_IncreaseDecreaseInAccruedInterestReceivableNet.9180" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US" id="lab_IncreaseDecreaseInAccruedInterestReceivableNet.9180">Increase (Decrease) in Accrued Interest Receivable, Net</link:label>
    <link:loc xlink:label="loc_IncreaseDecreaseInCustomerAdvances.11211.11.6" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_IncreaseDecreaseInCustomerAdvances" xlink:type="locator" />
    <link:labelArc xlink:from="loc_IncreaseDecreaseInCustomerAdvances.11211.11.6" xlink:to="lab_IncreaseDecreaseInCustomerAdvances.16453.253802.250371.255611" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_IncreaseDecreaseInCustomerAdvances.16453.253802.250371.255611" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US" id="lab_IncreaseDecreaseInCustomerAdvances.16453.253802.250371.255611">Increase (Decrease) in Customer Advances</link:label>
    <link:loc xlink:label="loc_IncreaseDecreaseInCustomerAdvances.11211.11.7" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_IncreaseDecreaseInCustomerAdvances" xlink:type="locator" />
    <link:labelArc xlink:from="loc_IncreaseDecreaseInCustomerAdvances.11211.11.7" xlink:to="lab_IncreaseDecreaseInCustomerAdvances.333740.253803.250372.255612" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_IncreaseDecreaseInCustomerAdvances.333740.253803.250372.255612" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US" id="lab_IncreaseDecreaseInCustomerAdvances.333740.253803.250372.255612">Increase (decrease) in advance payment from United Therapeutics</link:label>
    <link:loc xlink:label="loc_IncreaseDecreaseInDeferredRevenue.11220.11.6" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_IncreaseDecreaseInDeferredRevenue" xlink:type="locator" />
    <link:labelArc xlink:from="loc_IncreaseDecreaseInDeferredRevenue.11220.11.6" xlink:to="lab_IncreaseDecreaseInDeferredRevenue.17095.253804.250373.255613" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_IncreaseDecreaseInDeferredRevenue.17095.253804.250373.255613" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US" id="lab_IncreaseDecreaseInDeferredRevenue.17095.253804.250373.255613">Increase (Decrease) in Deferred Revenue</link:label>
    <link:loc xlink:label="loc_IncreaseDecreaseInDeferredRevenue.11220.11.7" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_IncreaseDecreaseInDeferredRevenue" xlink:type="locator" />
    <link:labelArc xlink:from="loc_IncreaseDecreaseInDeferredRevenue.11220.11.7" xlink:to="lab_IncreaseDecreaseInDeferredRevenue.333739.253805.250374.255614" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_IncreaseDecreaseInDeferredRevenue.333739.253805.250374.255614" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US" id="lab_IncreaseDecreaseInDeferredRevenue.333739.253805.250374.255614">Increase (decrease) in deferred revenues</link:label>
    <link:loc xlink:label="loc_IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities.11250.11.7" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities" xlink:type="locator" />
    <link:labelArc xlink:from="loc_IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities.11250.11.7" xlink:to="lab_IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities.1887944.358784.255616" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities.1887944.358784.255616" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US" id="lab_IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities.1887944.358784.255616">Increase in other accounts payable and accrued expenses</link:label>
    <link:loc xlink:label="loc_IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities.11250.11.6" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities" xlink:type="locator" />
    <link:labelArc xlink:from="loc_IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities.11250.11.6" xlink:to="lab_IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities.9279.255615" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities.9279.255615" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US" id="lab_IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities.9279.255615">Increase (Decrease) in Other Accounts Payable and Accrued Liabilities</link:label>
    <link:loc xlink:label="loc_IncreaseDecreaseInOtherReceivables.11257.11.6" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_IncreaseDecreaseInOtherReceivables" xlink:type="locator" />
    <link:labelArc xlink:from="loc_IncreaseDecreaseInOtherReceivables.11257.11.6" xlink:to="lab_IncreaseDecreaseInOtherReceivables.16486.253808.250375.255617" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_IncreaseDecreaseInOtherReceivables.16486.253808.250375.255617" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US" id="lab_IncreaseDecreaseInOtherReceivables.16486.253808.250375.255617">Increase (Decrease) in Other Receivables</link:label>
    <link:loc xlink:label="loc_IncreaseDecreaseInOtherReceivables.11257.11.53" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_IncreaseDecreaseInOtherReceivables" xlink:type="locator" />
    <link:labelArc xlink:from="loc_IncreaseDecreaseInOtherReceivables.11257.11.53" xlink:to="lab_IncreaseDecreaseInOtherReceivables.333788.253809.250376.255618" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_IncreaseDecreaseInOtherReceivables.333788.253809.250376.255618" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xml:lang="en-US" id="lab_IncreaseDecreaseInOtherReceivables.333788.253809.250376.255618">Increase in OCS receivables</link:label>
    <link:loc xlink:label="loc_IncreaseDecreaseInPensionAndPostretirementObligations.11356.11.6" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_IncreaseDecreaseInPensionAndPostretirementObligations" xlink:type="locator" />
    <link:labelArc xlink:from="loc_IncreaseDecreaseInPensionAndPostretirementObligations.11356.11.6" xlink:to="lab_IncreaseDecreaseInPensionAndPostretirementObligations.11801.253810.250377.255619" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_IncreaseDecreaseInPensionAndPostretirementObligations.11801.253810.250377.255619" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US" id="lab_IncreaseDecreaseInPensionAndPostretirementObligations.11801.253810.250377.255619">Increase (Decrease) in Pension and Postretirement Obligations</link:label>
    <link:loc xlink:label="loc_IncreaseDecreaseInPensionAndPostretirementObligations.11356.11.7" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_IncreaseDecreaseInPensionAndPostretirementObligations" xlink:type="locator" />
    <link:labelArc xlink:from="loc_IncreaseDecreaseInPensionAndPostretirementObligations.11356.11.7" xlink:to="lab_IncreaseDecreaseInPensionAndPostretirementObligations.286777.253811.250378.255620" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_IncreaseDecreaseInPensionAndPostretirementObligations.286777.253811.250378.255620" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US" id="lab_IncreaseDecreaseInPensionAndPostretirementObligations.286777.253811.250378.255620">Accrued severance pay, net</link:label>
    <link:loc xlink:label="loc_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets.11312.11.6" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:type="locator" />
    <link:labelArc xlink:from="loc_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets.11312.11.6" xlink:to="lab_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets.1379.253812.250379.255621" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets.1379.253812.250379.255621" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US" id="lab_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets.1379.253812.250379.255621">Increase (Decrease) in Prepaid Expense and Other Assets</link:label>
    <link:loc xlink:label="loc_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets.11312.11.53" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:type="locator" />
    <link:labelArc xlink:from="loc_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets.11312.11.53" xlink:to="lab_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets7.286758.253813.250380.255622" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets7.286758.253813.250380.255622" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xml:lang="en-US" id="lab_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets7.286758.253813.250380.255622">Decrease (increase) in prepaid expenses</link:label>
    <link:loc xlink:label="loc_IncreaseDecreaseInRestrictedCashAndInvestments.11152.11.6" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_IncreaseDecreaseInRestrictedCashAndInvestments" xlink:type="locator" />
    <link:labelArc xlink:from="loc_IncreaseDecreaseInRestrictedCashAndInvestments.11152.11.6" xlink:to="lab_IncreaseDecreaseInRestrictedCashAndInvestments.9148.255623" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_IncreaseDecreaseInRestrictedCashAndInvestments.9148.255623" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US" id="lab_IncreaseDecreaseInRestrictedCashAndInvestments.9148.255623">Increase (Decrease) in Restricted Cash and Investments</link:label>
    <link:loc xlink:label="loc_IssuanceOfStockAndWarrantsForServicesOrClaims.11880.11.7" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_IssuanceOfStockAndWarrantsForServicesOrClaims" xlink:type="locator" />
    <link:labelArc xlink:from="loc_IssuanceOfStockAndWarrantsForServicesOrClaims.11880.11.7" xlink:to="lab_IssuanceOfStockAndWarrantsForServicesOrClaims.288031.253825.250391.255624" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_IssuanceOfStockAndWarrantsForServicesOrClaims.288031.253825.250391.255624" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US" id="lab_IssuanceOfStockAndWarrantsForServicesOrClaims.288031.253825.250391.255624">Stock compensation to investor relations consultants</link:label>
    <link:loc xlink:label="loc_IssuanceOfStockAndWarrantsForServicesOrClaims.11880.11.6" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_IssuanceOfStockAndWarrantsForServicesOrClaims" xlink:type="locator" />
    <link:labelArc xlink:from="loc_IssuanceOfStockAndWarrantsForServicesOrClaims.11880.11.6" xlink:to="lab_IssuanceOfStockAndWarrantsForServicesOrClaims.448.253824.250392.255625" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_IssuanceOfStockAndWarrantsForServicesOrClaims.448.253824.250392.255625" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US" id="lab_IssuanceOfStockAndWarrantsForServicesOrClaims.448.253824.250392.255625">Issuance of Stock and Warrants for Services or Claims</link:label>
    <link:loc xlink:label="loc_LinkageDifferencesAndInterestOnShortAndLongTermRestrictedLeaseDeposit.25541.11.6" xlink:href="psti-20140630.xsd#psti_LinkageDifferencesAndInterestOnShortAndLongTermRestrictedLeaseDeposit" xlink:type="locator" />
    <link:labelArc xlink:from="loc_LinkageDifferencesAndInterestOnShortAndLongTermRestrictedLeaseDeposit.25541.11.6" xlink:to="lab_LinkageDifferencesAndInterestOnShortAndLongTermRestrictedLeaseDeposit.1921824.253832.250393.255626" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_LinkageDifferencesAndInterestOnShortAndLongTermRestrictedLeaseDeposit.1921824.253832.250393.255626" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US" id="lab_LinkageDifferencesAndInterestOnShortAndLongTermRestrictedLeaseDeposit.1921824.253832.250393.255626">Linkage Differences And Interest On Short And Long Term Restricted Lease Deposit</link:label>
    <link:loc xlink:label="loc_LinkageDifferencesAndInterestOnShortAndLongTermRestrictedLeaseDeposit.25541.11.12" xlink:href="psti-20140630.xsd#psti_LinkageDifferencesAndInterestOnShortAndLongTermRestrictedLeaseDeposit" xlink:type="locator" />
    <link:labelArc xlink:from="loc_LinkageDifferencesAndInterestOnShortAndLongTermRestrictedLeaseDeposit.25541.11.12" xlink:to="lab_LinkageDifferencesAndInterestOnShortAndLongTermRestrictedLeaseDeposit.1921825.253834.250394.255627" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_LinkageDifferencesAndInterestOnShortAndLongTermRestrictedLeaseDeposit.1921825.253834.250394.255627" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US" id="lab_LinkageDifferencesAndInterestOnShortAndLongTermRestrictedLeaseDeposit.1921825.253834.250394.255627">Linkage differences and interest on short and long term restricted lease deposit.</link:label>
    <link:loc xlink:label="loc_LinkageDifferencesAndInterestOnShortAndLongTermRestrictedLeaseDeposit.25541.11.7" xlink:href="psti-20140630.xsd#psti_LinkageDifferencesAndInterestOnShortAndLongTermRestrictedLeaseDeposit" xlink:type="locator" />
    <link:labelArc xlink:from="loc_LinkageDifferencesAndInterestOnShortAndLongTermRestrictedLeaseDeposit.25541.11.7" xlink:to="lab_LinkageDifferencesAndInterestOnShortAndLongTermRestrictedLeaseDeposit.1921826.253833.250395.255628" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_LinkageDifferencesAndInterestOnShortAndLongTermRestrictedLeaseDeposit.1921826.253833.250395.255628" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US" id="lab_LinkageDifferencesAndInterestOnShortAndLongTermRestrictedLeaseDeposit.1921826.253833.250395.255628">Linkage differences and interest on short and long-term restricted lease deposit</link:label>
    <link:loc xlink:label="loc_MarketableSecuritiesRealizedGainLoss.12843.11.53" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_MarketableSecuritiesRealizedGainLoss" xlink:type="locator" />
    <link:labelArc xlink:from="loc_MarketableSecuritiesRealizedGainLoss.12843.11.53" xlink:to="lab_MarketableSecuritiesRealizedGainLoss.286774.253842.250399.255629" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_MarketableSecuritiesRealizedGainLoss.286774.253842.250399.255629" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xml:lang="en-US" id="lab_MarketableSecuritiesRealizedGainLoss.286774.253842.250399.255629">Gain from sale of investments of available-for-sale marketable securities</link:label>
    <link:loc xlink:label="loc_MarketableSecuritiesRealizedGainLoss.12843.11.6" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_MarketableSecuritiesRealizedGainLoss" xlink:type="locator" />
    <link:labelArc xlink:from="loc_MarketableSecuritiesRealizedGainLoss.12843.11.6" xlink:to="lab_MarketableSecuritiesRealizedGainLoss.8832.253841.250400.255630" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_MarketableSecuritiesRealizedGainLoss.8832.253841.250400.255630" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US" id="lab_MarketableSecuritiesRealizedGainLoss.8832.253841.250400.255630">Marketable Securities, Realized Gain (Loss)</link:label>
    <link:loc xlink:label="loc_NetCashProvidedByUsedInFinancingActivitiesAbstract.3490.11.6" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:type="locator" />
    <link:labelArc xlink:from="loc_NetCashProvidedByUsedInFinancingActivitiesAbstract.3490.11.6" xlink:to="lab_NetCashProvidedByUsedInFinancingActivitiesAbstract.16836.253849.250405.255631" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_NetCashProvidedByUsedInFinancingActivitiesAbstract.16836.253849.250405.255631" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US" id="lab_NetCashProvidedByUsedInFinancingActivitiesAbstract.16836.253849.250405.255631">Net Cash Provided by (Used in) Financing Activities [Abstract]</link:label>
    <link:loc xlink:label="loc_NetCashProvidedByUsedInFinancingActivitiesAbstract.3490.11.7" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:type="locator" />
    <link:labelArc xlink:from="loc_NetCashProvidedByUsedInFinancingActivitiesAbstract.3490.11.7" xlink:to="lab_NetCashProvidedByUsedInFinancingActivitiesAbstract.286797.253850.250406.255632" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_NetCashProvidedByUsedInFinancingActivitiesAbstract.286797.253850.250406.255632" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US" id="lab_NetCashProvidedByUsedInFinancingActivitiesAbstract.286797.253850.250406.255632">CASH FLOWS FROM FINANCING ACTIVITIES:</link:label>
    <link:loc xlink:label="loc_NetCashProvidedByUsedInFinancingActivitiesContinuingOperations.13107.11.6" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperations" xlink:type="locator" />
    <link:labelArc xlink:from="loc_NetCashProvidedByUsedInFinancingActivitiesContinuingOperations.13107.11.6" xlink:to="lab_NetCashProvidedByUsedInFinancingActivitiesContinuingOperations.12278.255633" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_NetCashProvidedByUsedInFinancingActivitiesContinuingOperations.12278.255633" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US" id="lab_NetCashProvidedByUsedInFinancingActivitiesContinuingOperations.12278.255633">Net Cash Provided by (Used in) Financing Activities, Continuing Operations</link:label>
    <link:loc xlink:label="loc_NetCashProvidedByUsedInFinancingActivitiesContinuingOperations.13107.11.9" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperations" xlink:type="locator" />
    <link:labelArc xlink:from="loc_NetCashProvidedByUsedInFinancingActivitiesContinuingOperations.13107.11.9" xlink:to="lab_NetCashProvidedByUsedInFinancingActivitiesContinuingOperations.310997.255634" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_NetCashProvidedByUsedInFinancingActivitiesContinuingOperations.310997.255634" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US" id="lab_NetCashProvidedByUsedInFinancingActivitiesContinuingOperations.310997.255634">Net cash provided by financing activities</link:label>
    <link:loc xlink:label="loc_NetCashProvidedByUsedInInvestingActivitiesAbstract.3511.11.6" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:type="locator" />
    <link:labelArc xlink:from="loc_NetCashProvidedByUsedInInvestingActivitiesAbstract.3511.11.6" xlink:to="lab_NetCashProvidedByUsedInInvestingActivitiesAbstract.16837.253853.250409.255635" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_NetCashProvidedByUsedInInvestingActivitiesAbstract.16837.253853.250409.255635" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US" id="lab_NetCashProvidedByUsedInInvestingActivitiesAbstract.16837.253853.250409.255635">Net Cash Provided by (Used in) Investing Activities [Abstract]</link:label>
    <link:loc xlink:label="loc_NetCashProvidedByUsedInInvestingActivitiesAbstract.3511.11.7" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:type="locator" />
    <link:labelArc xlink:from="loc_NetCashProvidedByUsedInInvestingActivitiesAbstract.3511.11.7" xlink:to="lab_NetCashProvidedByUsedInInvestingActivitiesAbstract.286779.253854.250410.255636" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_NetCashProvidedByUsedInInvestingActivitiesAbstract.286779.253854.250410.255636" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US" id="lab_NetCashProvidedByUsedInInvestingActivitiesAbstract.286779.253854.250410.255636">CASH FLOWS FROM INVESTING ACTIVITIES:</link:label>
    <link:loc xlink:label="loc_NetCashProvidedByUsedInInvestingActivitiesContinuingOperations.13117.11.6" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperations" xlink:type="locator" />
    <link:labelArc xlink:from="loc_NetCashProvidedByUsedInInvestingActivitiesContinuingOperations.13117.11.6" xlink:to="lab_NetCashProvidedByUsedInInvestingActivitiesContinuingOperations.12298.255637" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_NetCashProvidedByUsedInInvestingActivitiesContinuingOperations.12298.255637" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US" id="lab_NetCashProvidedByUsedInInvestingActivitiesContinuingOperations.12298.255637">Net Cash Provided by (Used in) Investing Activities, Continuing Operations</link:label>
    <link:loc xlink:label="loc_NetCashProvidedByUsedInInvestingActivitiesContinuingOperations.13117.11.9" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperations" xlink:type="locator" />
    <link:labelArc xlink:from="loc_NetCashProvidedByUsedInInvestingActivitiesContinuingOperations.13117.11.9" xlink:to="lab_NetCashProvidedByUsedInInvestingActivitiesContinuingOperations.310996.255638" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_NetCashProvidedByUsedInInvestingActivitiesContinuingOperations.310996.255638" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US" id="lab_NetCashProvidedByUsedInInvestingActivitiesContinuingOperations.310996.255638">Net cash provided by (used in) investing activities</link:label>
    <link:loc xlink:label="loc_NetCashProvidedByUsedInOperatingActivitiesAbstract.3512.11.6" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:type="locator" />
    <link:labelArc xlink:from="loc_NetCashProvidedByUsedInOperatingActivitiesAbstract.3512.11.6" xlink:to="lab_NetCashProvidedByUsedInOperatingActivitiesAbstract.16838.253857.250413.255639" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_NetCashProvidedByUsedInOperatingActivitiesAbstract.16838.253857.250413.255639" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US" id="lab_NetCashProvidedByUsedInOperatingActivitiesAbstract.16838.253857.250413.255639">Net Cash Provided by (Used in) Operating Activities [Abstract]</link:label>
    <link:loc xlink:label="loc_NetCashProvidedByUsedInOperatingActivitiesAbstract.3512.11.7" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:type="locator" />
    <link:labelArc xlink:from="loc_NetCashProvidedByUsedInOperatingActivitiesAbstract.3512.11.7" xlink:to="lab_NetCashProvidedByUsedInOperatingActivitiesAbstract.286735.253858.250414.255640" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_NetCashProvidedByUsedInOperatingActivitiesAbstract.286735.253858.250414.255640" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US" id="lab_NetCashProvidedByUsedInOperatingActivitiesAbstract.286735.253858.250414.255640">CASH FLOWS FROM OPERATING ACTIVITIES:</link:label>
    <link:loc xlink:label="loc_NetCashProvidedByUsedInOperatingActivitiesContinuingOperations.13087.11.6" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperations" xlink:type="locator" />
    <link:labelArc xlink:from="loc_NetCashProvidedByUsedInOperatingActivitiesContinuingOperations.13087.11.6" xlink:to="lab_NetCashProvidedByUsedInOperatingActivitiesContinuingOperations.12234.255641" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_NetCashProvidedByUsedInOperatingActivitiesContinuingOperations.12234.255641" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US" id="lab_NetCashProvidedByUsedInOperatingActivitiesContinuingOperations.12234.255641">Net Cash Provided by (Used in) Operating Activities, Continuing Operations</link:label>
    <link:loc xlink:label="loc_NetCashProvidedByUsedInOperatingActivitiesContinuingOperations.13087.11.9" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperations" xlink:type="locator" />
    <link:labelArc xlink:from="loc_NetCashProvidedByUsedInOperatingActivitiesContinuingOperations.13087.11.9" xlink:to="lab_NetCashProvidedByUsedInOperatingActivitiesContinuingOperations.310995.255642" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_NetCashProvidedByUsedInOperatingActivitiesContinuingOperations.310995.255642" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US" id="lab_NetCashProvidedByUsedInOperatingActivitiesContinuingOperations.310995.255642">Net cash used in operating activities</link:label>
    <link:loc xlink:label="loc_NetIncomeLoss.13072.11.6" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_NetIncomeLoss" xlink:type="locator" />
    <link:labelArc xlink:from="loc_NetIncomeLoss.13072.11.6" xlink:to="lab_NetIncomeLoss.287266.253859.250553.255643" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_NetIncomeLoss.287266.253859.250553.255643" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US" id="lab_NetIncomeLoss.287266.253859.250553.255643">Net loss for the period</link:label>
    <link:loc xlink:label="loc_NetIncomeLoss.13072.11.7" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_NetIncomeLoss" xlink:type="locator" />
    <link:labelArc xlink:from="loc_NetIncomeLoss.13072.11.7" xlink:to="lab_NetIncomeLoss7.286736.253860.250554.255644" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_NetIncomeLoss7.286736.253860.250554.255644" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US" id="lab_NetIncomeLoss7.286736.253860.250554.255644">Net loss</link:label>
    <link:loc xlink:label="loc_NoncashOrPartNoncashAcquisitionInvestmentsAcquired1.13179.11.7" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_NoncashOrPartNoncashAcquisitionInvestmentsAcquired1" xlink:type="locator" />
    <link:labelArc xlink:from="loc_NoncashOrPartNoncashAcquisitionInvestmentsAcquired1.13179.11.7" xlink:to="lab_NoncashOrPartNoncashAcquisitionInvestmentsAcquired1.110207.310986.495466.323086.255646" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_NoncashOrPartNoncashAcquisitionInvestmentsAcquired1.110207.310986.495466.323086.255646" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US" id="lab_NoncashOrPartNoncashAcquisitionInvestmentsAcquired1.110207.310986.495466.323086.255646">Issuance of common stock under CHA Agreement (Note 1d)</link:label>
    <link:loc xlink:label="loc_NoncashOrPartNoncashAcquisitionInvestmentsAcquired1.13179.11.6" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_NoncashOrPartNoncashAcquisitionInvestmentsAcquired1" xlink:type="locator" />
    <link:labelArc xlink:from="loc_NoncashOrPartNoncashAcquisitionInvestmentsAcquired1.13179.11.6" xlink:to="lab_NoncashOrPartNoncashAcquisitionInvestmentsAcquired1.12414.255645" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_NoncashOrPartNoncashAcquisitionInvestmentsAcquired1.12414.255645" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US" id="lab_NoncashOrPartNoncashAcquisitionInvestmentsAcquired1.12414.255645">Noncash or Part Noncash Acquisition, Investments Acquired</link:label>
    <link:loc xlink:label="loc_OtherNoncashInvestingAndFinancingItemsAbstract.3827.11.6" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_OtherNoncashInvestingAndFinancingItemsAbstract" xlink:type="locator" />
    <link:labelArc xlink:from="loc_OtherNoncashInvestingAndFinancingItemsAbstract.3827.11.6" xlink:to="lab_OtherNoncashInvestingAndFinancingItemsAbstract.10120.253861.250415.255647" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_OtherNoncashInvestingAndFinancingItemsAbstract.10120.253861.250415.255647" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US" id="lab_OtherNoncashInvestingAndFinancingItemsAbstract.10120.253861.250415.255647">Other Noncash Investing and Financing Items [Abstract]</link:label>
    <link:loc xlink:label="loc_OtherNoncashInvestingAndFinancingItemsAbstract.3827.11.7" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_OtherNoncashInvestingAndFinancingItemsAbstract" xlink:type="locator" />
    <link:labelArc xlink:from="loc_OtherNoncashInvestingAndFinancingItemsAbstract.3827.11.7" xlink:to="lab_OtherNoncashInvestingAndFinancingItemsAbstract.286820.253862.250416.255648" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_OtherNoncashInvestingAndFinancingItemsAbstract.286820.253862.250416.255648" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US" id="lab_OtherNoncashInvestingAndFinancingItemsAbstract.286820.253862.250416.255648">Supplemental disclosure of non-cash activities:</link:label>
    <link:loc xlink:label="loc_OtherSignificantNoncashTransactionValueOfConsiderationGiven1.13662.11.6" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_OtherSignificantNoncashTransactionValueOfConsiderationGiven1" xlink:type="locator" />
    <link:labelArc xlink:from="loc_OtherSignificantNoncashTransactionValueOfConsiderationGiven1.13662.11.6" xlink:to="lab_OtherSignificantNoncashTransactionValueOfConsiderationGiven1.13171" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_OtherSignificantNoncashTransactionValueOfConsiderationGiven1.13171" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US" id="lab_OtherSignificantNoncashTransactionValueOfConsiderationGiven1.13171">Other Significant Noncash Transaction, Value of Consideration Given</link:label>
    <link:loc xlink:label="loc_OtherSignificantNoncashTransactionValueOfConsiderationGiven1.13662.11.7" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_OtherSignificantNoncashTransactionValueOfConsiderationGiven1" xlink:type="locator" />
    <link:labelArc xlink:from="loc_OtherSignificantNoncashTransactionValueOfConsiderationGiven1.13662.11.7" xlink:to="lab_OtherSignificantNoncashTransactionValueOfConsiderationGiven1.465728.199697.256316" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_OtherSignificantNoncashTransactionValueOfConsiderationGiven1.465728.199697.256316" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US" id="lab_OtherSignificantNoncashTransactionValueOfConsiderationGiven1.465728.199697.256316">Other receivables resulting from issuance of shares</link:label>
    <link:loc xlink:label="loc_PaymentsForProceedsFromLongtermInvestments.14128.11.6" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_PaymentsForProceedsFromLongtermInvestments" xlink:type="locator" />
    <link:labelArc xlink:from="loc_PaymentsForProceedsFromLongtermInvestments.14128.11.6" xlink:to="lab_PaymentsForProceedsFromLongtermInvestments.14015.255649" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_PaymentsForProceedsFromLongtermInvestments.14015.255649" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US" id="lab_PaymentsForProceedsFromLongtermInvestments.14015.255649">Payments for (Proceeds from) Long-term Investments</link:label>
    <link:loc xlink:label="loc_PaymentsForProceedsFromShortTermInvestments.14085.11.6" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_PaymentsForProceedsFromShortTermInvestments" xlink:type="locator" />
    <link:labelArc xlink:from="loc_PaymentsForProceedsFromShortTermInvestments.14085.11.6" xlink:to="lab_PaymentsForProceedsFromShortTermInvestments.13949.255650" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_PaymentsForProceedsFromShortTermInvestments.13949.255650" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US" id="lab_PaymentsForProceedsFromShortTermInvestments.13949.255650">Payments for (Proceeds from) Short-term Investments</link:label>
    <link:loc xlink:label="loc_PaymentsForProceedsFromShortTermInvestments.14085.11.53" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_PaymentsForProceedsFromShortTermInvestments" xlink:type="locator" />
    <link:labelArc xlink:from="loc_PaymentsForProceedsFromShortTermInvestments.14085.11.53" xlink:to="lab_PaymentsForProceedsFromShortTermInvestments46.1835464.413067.358859.255651" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_PaymentsForProceedsFromShortTermInvestments46.1835464.413067.358859.255651" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xml:lang="en-US" id="lab_PaymentsForProceedsFromShortTermInvestments46.1835464.413067.358859.255651">Repayment of (Investment in) short-term deposits</link:label>
    <link:loc xlink:label="loc_PaymentsToAcquireAvailableForSaleSecurities.14179.11.6" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_PaymentsToAcquireAvailableForSaleSecurities" xlink:type="locator" />
    <link:labelArc xlink:from="loc_PaymentsToAcquireAvailableForSaleSecurities.14179.11.6" xlink:to="lab_PaymentsToAcquireAvailableForSaleSecurities.14093.255652" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_PaymentsToAcquireAvailableForSaleSecurities.14093.255652" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US" id="lab_PaymentsToAcquireAvailableForSaleSecurities.14093.255652">Payments to Acquire Available-for-sale Securities</link:label>
    <link:loc xlink:label="loc_PaymentsToAcquireAvailableForSaleSecurities.14179.11.53" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_PaymentsToAcquireAvailableForSaleSecurities" xlink:type="locator" />
    <link:labelArc xlink:from="loc_PaymentsToAcquireAvailableForSaleSecurities.14179.11.53" xlink:to="lab_PaymentsToAcquireAvailableForSaleSecurities7.1887952.358863.255653" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_PaymentsToAcquireAvailableForSaleSecurities7.1887952.358863.255653" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xml:lang="en-US" id="lab_PaymentsToAcquireAvailableForSaleSecurities7.1887952.358863.255653">Investment in available-for-sale marketable securities</link:label>
    <link:loc xlink:label="loc_PaymentsToAcquirePropertyPlantAndEquipment.14193.11.6" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:type="locator" />
    <link:labelArc xlink:from="loc_PaymentsToAcquirePropertyPlantAndEquipment.14193.11.6" xlink:to="lab_PaymentsToAcquirePropertyPlantAndEquipment.6526.253882.250432.255654" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_PaymentsToAcquirePropertyPlantAndEquipment.6526.253882.250432.255654" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US" id="lab_PaymentsToAcquirePropertyPlantAndEquipment.6526.253882.250432.255654">Payments to Acquire Property, Plant, and Equipment</link:label>
    <link:loc xlink:label="loc_PaymentsToAcquirePropertyPlantAndEquipment.14193.11.53" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:type="locator" />
    <link:labelArc xlink:from="loc_PaymentsToAcquirePropertyPlantAndEquipment.14193.11.53" xlink:to="lab_PaymentsToAcquirePropertyPlantAndEquipment7.286782.253883.250433.255655" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_PaymentsToAcquirePropertyPlantAndEquipment7.286782.253883.250433.255655" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xml:lang="en-US" id="lab_PaymentsToAcquirePropertyPlantAndEquipment7.286782.253883.250433.255655">Purchase of property and equipment</link:label>
    <link:loc xlink:label="loc_ProceedsFromIssuanceOfCommonStock.14855.11.6" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ProceedsFromIssuanceOfCommonStock" xlink:type="locator" />
    <link:labelArc xlink:from="loc_ProceedsFromIssuanceOfCommonStock.14855.11.6" xlink:to="lab_ProceedsFromIssuanceOfCommonStock.6186.253886.250436.255656" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_ProceedsFromIssuanceOfCommonStock.6186.253886.250436.255656" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US" id="lab_ProceedsFromIssuanceOfCommonStock.6186.253886.250436.255656">Proceeds from Issuance of Common Stock</link:label>
    <link:loc xlink:label="loc_ProceedsFromIssuanceOfCommonStock.14855.11.7" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ProceedsFromIssuanceOfCommonStock" xlink:type="locator" />
    <link:labelArc xlink:from="loc_ProceedsFromIssuanceOfCommonStock.14855.11.7" xlink:to="lab_ProceedsFromIssuanceOfCommonStock7.286798.253887.250437.255657" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_ProceedsFromIssuanceOfCommonStock7.286798.253887.250437.255657" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US" id="lab_ProceedsFromIssuanceOfCommonStock7.286798.253887.250437.255657">Issuance of common stock and warrants, net of issuance costs</link:label>
    <link:loc xlink:label="loc_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions.14931.11.6" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions" xlink:type="locator" />
    <link:labelArc xlink:from="loc_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions.14931.11.6" xlink:to="lab_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions.12564.253890.250440.255658" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions.12564.253890.250440.255658" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US" id="lab_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions.12564.253890.250440.255658">Proceeds from Issuance of Shares under Incentive and Share-based Compensation Plans, Including Stock Options</link:label>
    <link:loc xlink:label="loc_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions.14931.11.7" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions" xlink:type="locator" />
    <link:labelArc xlink:from="loc_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions.14931.11.7" xlink:to="lab_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions7.286799.253891.250441.255659" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions7.286799.253891.250441.255659" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US" id="lab_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions7.286799.253891.250441.255659">Exercise of warrants and options</link:label>
    <link:loc xlink:label="loc_ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities.14840.11.6" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities" xlink:type="locator" />
    <link:labelArc xlink:from="loc_ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities.14840.11.6" xlink:to="lab_ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities.6221.253892.250442.255660" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities.6221.253892.250442.255660" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US" id="lab_ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities.6221.253892.250442.255660">Proceeds from Maturities, Prepayments and Calls of Available-for-sale Securities</link:label>
    <link:loc xlink:label="loc_ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities.14840.11.7" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities" xlink:type="locator" />
    <link:labelArc xlink:from="loc_ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities.14840.11.7" xlink:to="lab_ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities7.286794.253893.250443.255661" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities7.286794.253893.250443.255661" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US" id="lab_ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities7.286794.253893.250443.255661">Proceeds from redemption of available-for-sale marketable securities</link:label>
    <link:loc xlink:label="loc_ProceedsFromSaleOfAvailableForSaleSecurities.14910.11.6" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ProceedsFromSaleOfAvailableForSaleSecurities" xlink:type="locator" />
    <link:labelArc xlink:from="loc_ProceedsFromSaleOfAvailableForSaleSecurities.14910.11.6" xlink:to="lab_ProceedsFromSaleOfAvailableForSaleSecurities.15218.255662" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_ProceedsFromSaleOfAvailableForSaleSecurities.15218.255662" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US" id="lab_ProceedsFromSaleOfAvailableForSaleSecurities.15218.255662">Proceeds from Sale of Available-for-sale Securities</link:label>
    <link:loc xlink:label="loc_ProceedsFromSaleOfAvailableForSaleSecurities.14910.11.7" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ProceedsFromSaleOfAvailableForSaleSecurities" xlink:type="locator" />
    <link:labelArc xlink:from="loc_ProceedsFromSaleOfAvailableForSaleSecurities.14910.11.7" xlink:to="lab_ProceedsFromSaleOfAvailableForSaleSecurities.165879.256237.255663" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_ProceedsFromSaleOfAvailableForSaleSecurities.165879.256237.255663" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US" id="lab_ProceedsFromSaleOfAvailableForSaleSecurities.165879.256237.255663">Proceeds from sale of available-for-sale marketable securities</link:label>
    <link:loc xlink:label="loc_ShareBasedCompensation.16630.11.6" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ShareBasedCompensation" xlink:type="locator" />
    <link:labelArc xlink:from="loc_ShareBasedCompensation.16630.11.6" xlink:to="lab_ShareBasedCompensation.18138.255664" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_ShareBasedCompensation.18138.255664" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US" id="lab_ShareBasedCompensation.18138.255664">Share-based Compensation</link:label>
    <link:loc xlink:label="loc_ShareBasedCompensation.16630.11.7" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ShareBasedCompensation" xlink:type="locator" />
    <link:labelArc xlink:from="loc_ShareBasedCompensation.16630.11.7" xlink:to="lab_ShareBasedCompensation7.223227.358780.255665" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_ShareBasedCompensation7.223227.358780.255665" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US" id="lab_ShareBasedCompensation7.223227.358780.255665">Stock-based compensation to employees, directors and non-employee consultants</link:label>
    <link:loc xlink:label="loc_StatementOfCashFlowsAbstract.5113.11.6" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_StatementOfCashFlowsAbstract" xlink:type="locator" />
    <link:labelArc xlink:from="loc_StatementOfCashFlowsAbstract.5113.11.6" xlink:to="lab_StatementOfCashFlowsAbstract.286734.253929.250468.255666" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_StatementOfCashFlowsAbstract.286734.253929.250468.255666" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US" id="lab_StatementOfCashFlowsAbstract.286734.253929.250468.255666">CONSOLIDATED STATEMENTS OF CASH FLOWS [Abstract]</link:label>
    <link:loc xlink:label="loc_StockIssued1.16975.11.6" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_StockIssued1" xlink:type="locator" />
    <link:labelArc xlink:from="loc_StockIssued1.16975.11.6" xlink:to="lab_StockIssued1.18667.255667" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_StockIssued1.18667.255667" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US" id="lab_StockIssued1.18667.255667">Stock Issued</link:label>
    <link:loc xlink:label="loc_StockIssued1.16975.11.7" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_StockIssued1" xlink:type="locator" />
    <link:labelArc xlink:from="loc_StockIssued1.16975.11.7" xlink:to="lab_StockIssued1.1891955.414305.483236.358865.255668" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_StockIssued1.1891955.414305.483236.358865.255668" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US" id="lab_StockIssued1.1891955.414305.483236.358865.255668">Issuance of shares in consideration of new facility construction</link:label>
    <link:loc xlink:label="loc_SupplementalCashFlowInformationAbstract.5196.11.7" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_SupplementalCashFlowInformationAbstract" xlink:type="locator" />
    <link:labelArc xlink:from="loc_SupplementalCashFlowInformationAbstract.5196.11.7" xlink:to="lab_SupplementalCashFlowInformationAbstract.286817.253934.250472.255669" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_SupplementalCashFlowInformationAbstract.286817.253934.250472.255669" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US" id="lab_SupplementalCashFlowInformationAbstract.286817.253934.250472.255669">Supplemental disclosure of cash flow activities:</link:label>
    <link:loc xlink:label="loc_SupplementalCashFlowInformationAbstract.5196.11.6" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_SupplementalCashFlowInformationAbstract" xlink:type="locator" />
    <link:labelArc xlink:from="loc_SupplementalCashFlowInformationAbstract.5196.11.6" xlink:to="lab_SupplementalCashFlowInformationAbstract.7887.253933.250473.255670" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_SupplementalCashFlowInformationAbstract.7887.253933.250473.255670" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US" id="lab_SupplementalCashFlowInformationAbstract.7887.253933.250473.255670">Supplemental Cash Flow Information [Abstract]</link:label>
    <link:loc xlink:label="loc_PaymentsForProceedsFromLongtermInvestments.14128.11.53" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_PaymentsForProceedsFromLongtermInvestments" xlink:type="locator" />
    <link:labelArc xlink:from="loc_PaymentsForProceedsFromLongtermInvestments.14128.11.53" xlink:to="PaymentsForProceedsFromLongtermInvestments.358860.255671" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="PaymentsForProceedsFromLongtermInvestments.358860.255671" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xml:lang="en-US" id="PaymentsForProceedsFromLongtermInvestments.358860.255671">Investment in long-term deposits</link:label>
    <link:loc xlink:label="loc_IncreaseDecreaseInRestrictedCashAndInvestments.11152.11.53" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_IncreaseDecreaseInRestrictedCashAndInvestments" xlink:type="locator" />
    <link:labelArc xlink:from="loc_IncreaseDecreaseInRestrictedCashAndInvestments.11152.11.53" xlink:to="Restricteddeposit.224946.358862.255672" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="Restricteddeposit.224946.358862.255672" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xml:lang="en-US" id="Restricteddeposit.224946.358862.255672">Repayment of long-term restricted deposit</link:label>
    <link:loc xlink:label="loc_IncreaseDecreaseInAccruedInterestReceivableNet.11204.11.53" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_IncreaseDecreaseInAccruedInterestReceivableNet" xlink:type="locator" />
    <link:labelArc xlink:from="loc_IncreaseDecreaseInAccruedInterestReceivableNet.11204.11.53" xlink:to="us-gaap_IncreaseDecreaseInAccruedInterestReceivableNet_lbl.304321.362263.256315" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="us-gaap_IncreaseDecreaseInAccruedInterestReceivableNet_lbl.304321.362263.256315" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xml:lang="en-US" id="us-gaap_IncreaseDecreaseInAccruedInterestReceivableNet_lbl.304321.362263.256315">Increase in interest receivable on short-term deposits</link:label>
    <link:loc xlink:label="loc_ComprehensiveIncomeNetOfTax.7101.11.6" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ComprehensiveIncomeNetOfTax" xlink:type="locator" />
    <link:labelArc xlink:from="loc_ComprehensiveIncomeNetOfTax.7101.11.6" xlink:to="lab_ComprehensiveIncomeNetOfTax.1524.254005.250477.255673" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_ComprehensiveIncomeNetOfTax.1524.254005.250477.255673" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US" id="lab_ComprehensiveIncomeNetOfTax.1524.254005.250477.255673">Comprehensive Income (Loss), Net of Tax, Attributable to Parent</link:label>
    <link:loc xlink:label="loc_ComprehensiveIncomeNetOfTax.7101.11.9" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ComprehensiveIncomeNetOfTax" xlink:type="locator" />
    <link:labelArc xlink:from="loc_ComprehensiveIncomeNetOfTax.7101.11.9" xlink:to="lab_ComprehensiveIncomeNetOfTax.1921808.254006.250478.255674" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_ComprehensiveIncomeNetOfTax.1921808.254006.250478.255674" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US" id="lab_ComprehensiveIncomeNetOfTax.1921808.254006.250478.255674">Total comprehensive loss</link:label>
    <link:loc xlink:label="loc_OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParentAbstract.3871.11.6" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParentAbstract" xlink:type="locator" />
    <link:labelArc xlink:from="loc_OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParentAbstract.3871.11.6" xlink:to="lab_OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParentAbstract.16228.254009.250479.255675" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParentAbstract.16228.254009.250479.255675" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US" id="lab_OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParentAbstract.16228.254009.250479.255675">Other Comprehensive Income (Loss), Available-for-sale Securities Adjustment, Net of Tax, Portion Attributable to Parent [Abstract]</link:label>
    <link:loc xlink:label="loc_OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParentAbstract.3871.11.7" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParentAbstract" xlink:type="locator" />
    <link:labelArc xlink:from="loc_OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParentAbstract.3871.11.7" xlink:to="lab_OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParentAbstract.1921807.254010.250480.255676" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParentAbstract.1921807.254010.250480.255676" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US" id="lab_OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParentAbstract.1921807.254010.250480.255676">Other comprehensive income (loss), net:</link:label>
    <link:loc xlink:label="loc_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax.13575.11.6" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax" xlink:type="locator" />
    <link:labelArc xlink:from="loc_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax.13575.11.6" xlink:to="lab_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax.13150.255679" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax.13150.255679" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US" id="lab_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax.13150.255679">Other Comprehensive Income (Loss), Reclassification Adjustment from AOCI for Sale of Securities, Net of Tax</link:label>
    <link:loc xlink:label="loc_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax.13575.11.53" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax" xlink:type="locator" />
    <link:labelArc xlink:from="loc_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax.13575.11.53" xlink:to="lab_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax.256263.255680" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax.256263.255680" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xml:lang="en-US" id="lab_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax.256263.255680">Reclassification adjustment of available-for-sale marketable securities losses realized in net loss, net</link:label>
    <link:loc xlink:label="loc_OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodNetOfTax.13806.11.6" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodNetOfTax" xlink:type="locator" />
    <link:labelArc xlink:from="loc_OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodNetOfTax.13806.11.6" xlink:to="lab_OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodNetOfTax.13386.255681" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodNetOfTax.13386.255681" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US" id="lab_OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodNetOfTax.13386.255681">Other Comprehensive Income (Loss), Unrealized Gain (Loss) on Derivatives Arising During Period, Net of Tax</link:label>
    <link:loc xlink:label="loc_OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodNetOfTax.13806.11.7" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodNetOfTax" xlink:type="locator" />
    <link:labelArc xlink:from="loc_OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodNetOfTax.13806.11.7" xlink:to="lab_OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodNetOfTax.353149.250975.255682" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodNetOfTax.353149.250975.255682" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US" id="lab_OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodNetOfTax.353149.250975.255682">Unrealized gains on derivative instruments</link:label>
    <link:loc xlink:label="loc_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax.13804.11.6" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax" xlink:type="locator" />
    <link:labelArc xlink:from="loc_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax.13804.11.6" xlink:to="lab_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax.12884.250483.255683" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax.12884.250483.255683" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US" id="lab_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax.12884.250483.255683">Other Comprehensive Income (Loss), Unrealized Holding Gain (Loss) on Securities Arising During Period, Net of Tax</link:label>
    <link:loc xlink:label="loc_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax.13804.11.7" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax" xlink:type="locator" />
    <link:labelArc xlink:from="loc_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax.13804.11.7" xlink:to="lab_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax.510923.250484.255684" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax.510923.250484.255684" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US" id="lab_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax.510923.250484.255684">Unrealized gain (loss) on available-for-sale marketable securities, net</link:label>
    <link:loc xlink:label="loc_StatementOfIncomeAndComprehensiveIncomeAbstract.5111.11.6" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract" xlink:type="locator" />
    <link:labelArc xlink:from="loc_StatementOfIncomeAndComprehensiveIncomeAbstract.5111.11.6" xlink:to="lab_StatementOfIncomeAndComprehensiveIncomeAbstract.1921809.254011.250485.255685" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_StatementOfIncomeAndComprehensiveIncomeAbstract.1921809.254011.250485.255685" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US" id="lab_StatementOfIncomeAndComprehensiveIncomeAbstract.1921809.254011.250485.255685">CONSOLIDATED STATEMENTS OF COMPREHENSIVE LOSS [Abstract]</link:label>
    <link:loc xlink:label="loc_CostOfRevenue.7342.11.6" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_CostOfRevenue" xlink:type="locator" />
    <link:labelArc xlink:from="loc_CostOfRevenue.7342.11.6" xlink:to="lab_CostOfRevenue.1751.253732.250486.255686" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_CostOfRevenue.1751.253732.250486.255686" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US" id="lab_CostOfRevenue.1751.253732.250486.255686">Cost of Revenue</link:label>
    <link:loc xlink:label="loc_CostOfRevenue.7342.11.53" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_CostOfRevenue" xlink:type="locator" />
    <link:labelArc xlink:from="loc_CostOfRevenue.7342.11.53" xlink:to="lab_CostOfRevenue46.1921806.253733.250487.255687" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_CostOfRevenue46.1921806.253733.250487.255687" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xml:lang="en-US" id="lab_CostOfRevenue46.1921806.253733.250487.255687">Cost of revenues</link:label>
    <link:loc xlink:label="loc_EarningsPerShareAbstract.1792.11.6" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_EarningsPerShareAbstract" xlink:type="locator" />
    <link:labelArc xlink:from="loc_EarningsPerShareAbstract.1792.11.6" xlink:to="lab_EarningsPerShareAbstract.10391.253734.250488.255688" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_EarningsPerShareAbstract.10391.253734.250488.255688" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US" id="lab_EarningsPerShareAbstract.10391.253734.250488.255688">Earnings Per Share [Abstract]</link:label>
    <link:loc xlink:label="loc_EarningsPerShareAbstract.1792.11.7" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_EarningsPerShareAbstract" xlink:type="locator" />
    <link:labelArc xlink:from="loc_EarningsPerShareAbstract.1792.11.7" xlink:to="lab_EarningsPerShareAbstract.286731.253735.250489.255689" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_EarningsPerShareAbstract.286731.253735.250489.255689" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US" id="lab_EarningsPerShareAbstract.286731.253735.250489.255689">Loss per share:</link:label>
    <link:loc xlink:label="loc_EarningsPerShareBasicAndDiluted.8996.11.6" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_EarningsPerShareBasicAndDiluted" xlink:type="locator" />
    <link:labelArc xlink:from="loc_EarningsPerShareBasicAndDiluted.8996.11.6" xlink:to="lab_EarningsPerShareBasicAndDiluted.12855.253736.250490.255690" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_EarningsPerShareBasicAndDiluted.12855.253736.250490.255690" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US" id="lab_EarningsPerShareBasicAndDiluted.12855.253736.250490.255690">Earnings Per Share, Basic and Diluted</link:label>
    <link:loc xlink:label="loc_EarningsPerShareBasicAndDiluted.8996.11.7" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_EarningsPerShareBasicAndDiluted" xlink:type="locator" />
    <link:labelArc xlink:from="loc_EarningsPerShareBasicAndDiluted.8996.11.7" xlink:to="lab_EarningsPerShareBasicAndDiluted7.286732.253737.250491.255691" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_EarningsPerShareBasicAndDiluted7.286732.253737.250491.255691" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US" id="lab_EarningsPerShareBasicAndDiluted7.286732.253737.250491.255691">Basic and diluted net loss per share</link:label>
    <link:loc xlink:label="loc_GeneralAndAdministrativeExpense.10581.11.6" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_GeneralAndAdministrativeExpense" xlink:type="locator" />
    <link:labelArc xlink:from="loc_GeneralAndAdministrativeExpense.10581.11.6" xlink:to="lab_GeneralAndAdministrativeExpense.3393.253741.250495.255692" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_GeneralAndAdministrativeExpense.3393.253741.250495.255692" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US" id="lab_GeneralAndAdministrativeExpense.3393.253741.250495.255692">General and Administrative Expense</link:label>
    <link:loc xlink:label="loc_GeneralAndAdministrativeExpense.10581.11.53" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_GeneralAndAdministrativeExpense" xlink:type="locator" />
    <link:labelArc xlink:from="loc_GeneralAndAdministrativeExpense.10581.11.53" xlink:to="lab_GeneralAndAdministrativeExpense46.333718.253742.250496.255693" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_GeneralAndAdministrativeExpense46.333718.253742.250496.255693" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xml:lang="en-US" id="lab_GeneralAndAdministrativeExpense46.333718.253742.250496.255693">General and administrative expenses</link:label>
    <link:loc xlink:label="loc_GovernmentAndThirdPartyGrantsReceived.25539.11.6" xlink:href="psti-20140630.xsd#psti_GovernmentAndThirdPartyGrantsReceived" xlink:type="locator" />
    <link:labelArc xlink:from="loc_GovernmentAndThirdPartyGrantsReceived.25539.11.6" xlink:to="lab_GovernmentAndThirdPartyGrantsReceived.250503.255694" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_GovernmentAndThirdPartyGrantsReceived.250503.255694" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US" id="lab_GovernmentAndThirdPartyGrantsReceived.250503.255694">Government And Third Party Grants Received</link:label>
    <link:loc xlink:label="loc_GovernmentAndThirdPartyGrantsReceived.25539.11.12" xlink:href="psti-20140630.xsd#psti_GovernmentAndThirdPartyGrantsReceived" xlink:type="locator" />
    <link:labelArc xlink:from="loc_GovernmentAndThirdPartyGrantsReceived.25539.11.12" xlink:to="lab_GovernmentAndThirdPartyGrantsReceived.250504.255696" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_GovernmentAndThirdPartyGrantsReceived.250504.255696" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US" id="lab_GovernmentAndThirdPartyGrantsReceived.250504.255696">Grants received from the government and third parties for research and development programs.</link:label>
    <link:loc xlink:label="loc_GovernmentAndThirdPartyGrantsReceived.25539.11.7" xlink:href="psti-20140630.xsd#psti_GovernmentAndThirdPartyGrantsReceived" xlink:type="locator" />
    <link:labelArc xlink:from="loc_GovernmentAndThirdPartyGrantsReceived.25539.11.7" xlink:to="lab_GovernmentAndThirdPartyGrantsReceived.250505.255695" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_GovernmentAndThirdPartyGrantsReceived.250505.255695" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US" id="lab_GovernmentAndThirdPartyGrantsReceived.250505.255695">Less participation by the Office of the Chief Scientist and other parties</link:label>
    <link:loc xlink:label="loc_GrossProfit.10657.11.9" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_GrossProfit" xlink:type="locator" />
    <link:labelArc xlink:from="loc_GrossProfit.10657.11.9" xlink:to="lab_GrossProfit.1921805.253744.250497.255697" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_GrossProfit.1921805.253744.250497.255697" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US" id="lab_GrossProfit.1921805.253744.250497.255697">Gross profit</link:label>
    <link:loc xlink:label="loc_GrossProfit.10657.11.6" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_GrossProfit" xlink:type="locator" />
    <link:labelArc xlink:from="loc_GrossProfit.10657.11.6" xlink:to="lab_GrossProfit.3430.253743.250498.255698" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_GrossProfit.3430.253743.250498.255698" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US" id="lab_GrossProfit.3430.253743.250498.255698">Gross Profit</link:label>
    <link:loc xlink:label="loc_IncomeStatementAbstract.2649.11.6" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_IncomeStatementAbstract" xlink:type="locator" />
    <link:labelArc xlink:from="loc_IncomeStatementAbstract.2649.11.6" xlink:to="lab_IncomeStatementAbstract.286714.253745.250499.255699" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_IncomeStatementAbstract.286714.253745.250499.255699" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US" id="lab_IncomeStatementAbstract.286714.253745.250499.255699">CONSOLIDATED STATEMENTS OF OPERATIONS [Abstract]</link:label>
    <link:loc xlink:label="loc_NetIncomeLoss.13072.11.9" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_NetIncomeLoss" xlink:type="locator" />
    <link:labelArc xlink:from="loc_NetIncomeLoss.13072.11.9" xlink:to="lab_NetIncomeLoss.286730.253746.250500.255700" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_NetIncomeLoss.286730.253746.250500.255700" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US" id="lab_NetIncomeLoss.286730.253746.250500.255700">Net loss</link:label>
    <link:loc xlink:label="loc_NonoperatingIncomeExpense.13243.11.6" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_NonoperatingIncomeExpense" xlink:type="locator" />
    <link:labelArc xlink:from="loc_NonoperatingIncomeExpense.13243.11.6" xlink:to="lab_NonoperatingIncomeExpense.12540.255701" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_NonoperatingIncomeExpense.12540.255701" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US" id="lab_NonoperatingIncomeExpense.12540.255701">Nonoperating Income (Expense)</link:label>
    <link:loc xlink:label="loc_NonoperatingIncomeExpense.13243.11.7" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_NonoperatingIncomeExpense" xlink:type="locator" />
    <link:labelArc xlink:from="loc_NonoperatingIncomeExpense.13243.11.7" xlink:to="lab_NonoperatingIncomeExpense.134175.327164.255702" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_NonoperatingIncomeExpense.134175.327164.255702" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US" id="lab_NonoperatingIncomeExpense.134175.327164.255702">Financial income, net</link:label>
    <link:loc xlink:label="loc_OperatingIncomeLoss.13445.11.9" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_OperatingIncomeLoss" xlink:type="locator" />
    <link:labelArc xlink:from="loc_OperatingIncomeLoss.13445.11.9" xlink:to="lab_OperatingIncomeLoss.286726.253748.250501.255703" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_OperatingIncomeLoss.286726.253748.250501.255703" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US" id="lab_OperatingIncomeLoss.286726.253748.250501.255703">Operating loss</link:label>
    <link:loc xlink:label="loc_OperatingIncomeLoss.13445.11.6" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_OperatingIncomeLoss" xlink:type="locator" />
    <link:labelArc xlink:from="loc_OperatingIncomeLoss.13445.11.6" xlink:to="lab_OperatingIncomeLoss.5320.253747.250502.255704" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_OperatingIncomeLoss.5320.253747.250502.255704" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US" id="lab_OperatingIncomeLoss.5320.253747.250502.255704">Operating Income (Loss)</link:label>
    <link:loc xlink:label="loc_ResearchAndDevelopmentExpense.15670.11.53" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ResearchAndDevelopmentExpense" xlink:type="locator" />
    <link:labelArc xlink:from="loc_ResearchAndDevelopmentExpense.15670.11.53" xlink:to="lab_ResearchAndDevelopmentExpense.333714.253753.250506.255705" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_ResearchAndDevelopmentExpense.333714.253753.250506.255705" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xml:lang="en-US" id="lab_ResearchAndDevelopmentExpense.333714.253753.250506.255705">Research and development expenses</link:label>
    <link:loc xlink:label="loc_ResearchAndDevelopmentExpense.15670.11.6" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ResearchAndDevelopmentExpense" xlink:type="locator" />
    <link:labelArc xlink:from="loc_ResearchAndDevelopmentExpense.15670.11.6" xlink:to="lab_ResearchAndDevelopmentExpense.8474.253752.250507.255706" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_ResearchAndDevelopmentExpense.8474.253752.250507.255706" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US" id="lab_ResearchAndDevelopmentExpense.8474.253752.250507.255706">Research and Development Expense</link:label>
    <link:loc xlink:label="loc_ResearchAndDevelopmentExpensesNet.25542.11.12" xlink:href="psti-20140630.xsd#psti_ResearchAndDevelopmentExpensesNet" xlink:type="locator" />
    <link:labelArc xlink:from="loc_ResearchAndDevelopmentExpensesNet.25542.11.12" xlink:to="lab_ResearchAndDevelopmentExpensesGross.286717.253754.250508.255707" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_ResearchAndDevelopmentExpensesGross.286717.253754.250508.255707" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US" id="lab_ResearchAndDevelopmentExpensesGross.286717.253754.250508.255707">Research and development expenses, net.</link:label>
    <link:loc xlink:label="loc_ResearchAndDevelopmentExpensesNet.25542.11.6" xlink:href="psti-20140630.xsd#psti_ResearchAndDevelopmentExpensesNet" xlink:type="locator" />
    <link:labelArc xlink:from="loc_ResearchAndDevelopmentExpensesNet.25542.11.6" xlink:to="lab_ResearchAndDevelopmentExpensesNet.286716.253755.250509.255708" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_ResearchAndDevelopmentExpensesNet.286716.253755.250509.255708" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US" id="lab_ResearchAndDevelopmentExpensesNet.286716.253755.250509.255708">Research And Development Expenses Net</link:label>
    <link:loc xlink:label="loc_ResearchAndDevelopmentExpensesNet.25542.11.56" xlink:href="psti-20140630.xsd#psti_ResearchAndDevelopmentExpensesNet" xlink:type="locator" />
    <link:labelArc xlink:from="loc_ResearchAndDevelopmentExpensesNet.25542.11.56" xlink:to="lab_ResearchAndDevelopmentExpensesNet49.333717.253756.250510.255709" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_ResearchAndDevelopmentExpensesNet49.333717.253756.250510.255709" xlink:role="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:type="resource" xml:lang="en-US" id="lab_ResearchAndDevelopmentExpensesNet49.333717.253756.250510.255709">Research and development expenses, net</link:label>
    <link:loc xlink:label="loc_Revenues.15934.11.7" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_Revenues" xlink:type="locator" />
    <link:labelArc xlink:from="loc_Revenues.15934.11.7" xlink:to="lab_Revenues.333713.253758.250511.255710" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_Revenues.333713.253758.250511.255710" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US" id="lab_Revenues.333713.253758.250511.255710">Revenues</link:label>
    <link:loc xlink:label="loc_Revenues.15934.11.6" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_Revenues" xlink:type="locator" />
    <link:labelArc xlink:from="loc_Revenues.15934.11.6" xlink:to="lab_Revenues.5322.253757.250512.255711" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_Revenues.5322.253757.250512.255711" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US" id="lab_Revenues.5322.253757.250512.255711">Revenues</link:label>
    <link:loc xlink:label="loc_WeightedAverageNumberOfShareOutstandingBasicAndDiluted.17738.11.6" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted" xlink:type="locator" />
    <link:labelArc xlink:from="loc_WeightedAverageNumberOfShareOutstandingBasicAndDiluted.17738.11.6" xlink:to="lab_WeightedAverageNumberOfShareOutstandingBasicAndDiluted.19243.250513.255712" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_WeightedAverageNumberOfShareOutstandingBasicAndDiluted.19243.250513.255712" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US" id="lab_WeightedAverageNumberOfShareOutstandingBasicAndDiluted.19243.250513.255712">Weighted Average Number of Shares Outstanding, Basic and Diluted</link:label>
    <link:loc xlink:label="loc_WeightedAverageNumberOfShareOutstandingBasicAndDiluted.17738.11.7" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted" xlink:type="locator" />
    <link:labelArc xlink:from="loc_WeightedAverageNumberOfShareOutstandingBasicAndDiluted.17738.11.7" xlink:to="lab_WeightedAverageNumberOfShareOutstandingBasicAndDiluted.317116.250514.255713" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_WeightedAverageNumberOfShareOutstandingBasicAndDiluted.317116.250514.255713" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US" id="lab_WeightedAverageNumberOfShareOutstandingBasicAndDiluted.317116.250514.255713">Weighted average number of shares used in computing basic and diluted net loss per share</link:label>
    <link:loc xlink:label="loc_AccumulatedOtherComprehensiveIncomeMember.478.11.7" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:type="locator" />
    <link:labelArc xlink:from="loc_AccumulatedOtherComprehensiveIncomeMember.478.11.7" xlink:to="lab_AccumulatedOtherComprehensiveIncomeMembe.504946.250776.255714" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_AccumulatedOtherComprehensiveIncomeMembe.504946.250776.255714" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US" id="lab_AccumulatedOtherComprehensiveIncomeMembe.504946.250776.255714">Accumulated Other Comprehensive Income (Loss) [Member]</link:label>
    <link:loc xlink:label="loc_AccumulatedOtherComprehensiveIncomeMember.478.11.6" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:type="locator" />
    <link:labelArc xlink:from="loc_AccumulatedOtherComprehensiveIncomeMember.478.11.6" xlink:to="lab_AccumulatedOtherComprehensiveIncomeMember.333737.253943.250777.255715" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_AccumulatedOtherComprehensiveIncomeMember.333737.253943.250777.255715" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US" id="lab_AccumulatedOtherComprehensiveIncomeMember.333737.253943.250777.255715">Accumulated Other Comprehensive Gain [Member]</link:label>
    <link:loc xlink:label="loc_AdditionalPaidInCapitalMember.499.11.6" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_AdditionalPaidInCapitalMember" xlink:type="locator" />
    <link:labelArc xlink:from="loc_AdditionalPaidInCapitalMember.499.11.6" xlink:to="lab_AdditionalPaidInCapitalMember.11419.253944.250778.255716" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_AdditionalPaidInCapitalMember.11419.253944.250778.255716" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US" id="lab_AdditionalPaidInCapitalMember.11419.253944.250778.255716">Additional Paid-in Capital [Member]</link:label>
    <link:loc xlink:label="loc_CommonStockMember.1115.11.6" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_CommonStockMember" xlink:type="locator" />
    <link:labelArc xlink:from="loc_CommonStockMember.1115.11.6" xlink:to="lab_CommonStockMember.8433.253945.250779.255719" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_CommonStockMember.8433.253945.250779.255719" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US" id="lab_CommonStockMember.8433.253945.250779.255719">Common Stock [Member]</link:label>
    <link:loc xlink:label="loc_CommonStockSharesOutstanding.7078.11.10" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_CommonStockSharesOutstanding" xlink:type="locator" />
    <link:labelArc xlink:from="loc_CommonStockSharesOutstanding.7078.11.10" xlink:to="lab_CommonStockSharesOutstanding.287267.253947.250780.255720" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_CommonStockSharesOutstanding.287267.253947.250780.255720" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xml:lang="en-US" id="lab_CommonStockSharesOutstanding.287267.253947.250780.255720">Balance, shares</link:label>
    <link:loc xlink:label="loc_CommonStockSharesOutstanding.7078.11.11" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_CommonStockSharesOutstanding" xlink:type="locator" />
    <link:labelArc xlink:from="loc_CommonStockSharesOutstanding.7078.11.11" xlink:to="lab_CommonStockSharesOutstanding.287270.253946.250781.255721" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_CommonStockSharesOutstanding.287270.253946.250781.255721" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xml:lang="en-US" id="lab_CommonStockSharesOutstanding.287270.253946.250781.255721">Balance, shares</link:label>
    <link:loc xlink:label="loc_NetIncomeLoss.13072.11.8" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_NetIncomeLoss" xlink:type="locator" />
    <link:labelArc xlink:from="loc_NetIncomeLoss.13072.11.8" xlink:to="lab_NetIncomeLoss.493231.250813.255723" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_NetIncomeLoss.493231.250813.255723" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US" id="lab_NetIncomeLoss.493231.250813.255723">Net loss</link:label>
    <link:loc xlink:label="loc_OtherComprehensiveIncomeLossNetOfTax.13526.11.7" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTax" xlink:type="locator" />
    <link:labelArc xlink:from="loc_OtherComprehensiveIncomeLossNetOfTax.13526.11.7" xlink:to="lab_OtherComprehensiveIncomeLossNetOfTax.510899.250815.255724" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_OtherComprehensiveIncomeLossNetOfTax.510899.250815.255724" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US" id="lab_OtherComprehensiveIncomeLossNetOfTax.510899.250815.255724">Other comprehensive income (loss), net</link:label>
    <link:loc xlink:label="loc_RetainedEarningsMember.4619.11.6" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_RetainedEarningsMember" xlink:type="locator" />
    <link:labelArc xlink:from="loc_RetainedEarningsMember.4619.11.6" xlink:to="lab_RetainedEarningsMember.333738.253979.250816.255725" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_RetainedEarningsMember.333738.253979.250816.255725" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US" id="lab_RetainedEarningsMember.333738.253979.250816.255725">Accumulated Deficit [Member]</link:label>
    <link:loc xlink:label="loc_StatementOfStockholdersEquityAbstract.5110.11.6" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_StatementOfStockholdersEquityAbstract" xlink:type="locator" />
    <link:labelArc xlink:from="loc_StatementOfStockholdersEquityAbstract.5110.11.6" xlink:to="lab_StatementOfStockholdersEquityAbstract.286844.253982.250819.255728" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_StatementOfStockholdersEquityAbstract.286844.253982.250819.255728" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US" id="lab_StatementOfStockholdersEquityAbstract.286844.253982.250819.255728">STATEMENTS OF CHANGES IN EQUITY [Abstract]</link:label>
    <link:loc xlink:label="loc_StatementTable.5107.11.6" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_StatementTable" xlink:type="locator" />
    <link:labelArc xlink:from="loc_StatementTable.5107.11.6" xlink:to="lab_StatementTable.9237.253983.250820.255729" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_StatementTable.9237.253983.250820.255729" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US" id="lab_StatementTable.9237.253983.250820.255729">Statement [Table]</link:label>
    <link:loc xlink:label="loc_StockholdersEquity.17019.11.10" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_StockholdersEquity" xlink:type="locator" />
    <link:labelArc xlink:from="loc_StockholdersEquity.17019.11.10" xlink:to="lab_StockholdersEquity.287268.253990.250827.255730" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_StockholdersEquity.287268.253990.250827.255730" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xml:lang="en-US" id="lab_StockholdersEquity.287268.253990.250827.255730">Balance</link:label>
    <link:loc xlink:label="loc_StockholdersEquity.17019.11.11" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_StockholdersEquity" xlink:type="locator" />
    <link:labelArc xlink:from="loc_StockholdersEquity.17019.11.11" xlink:to="lab_StockholdersEquity.287269.253991.250828.255731" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_StockholdersEquity.287269.253991.250828.255731" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xml:lang="en-US" id="lab_StockholdersEquity.287269.253991.250828.255731">Balance</link:label>
    <link:loc xlink:label="loc_StockIssuedDuringPeriodSharesPurchaseOfAssets.16992.11.7" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesPurchaseOfAssets" xlink:type="locator" />
    <link:labelArc xlink:from="loc_StockIssuedDuringPeriodSharesPurchaseOfAssets.16992.11.7" xlink:to="lab_StockIssuedDuringPeriodSharesPurchaseOfAssets.1891841.414254.483163.358686.255735" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_StockIssuedDuringPeriodSharesPurchaseOfAssets.1891841.414254.483163.358686.255735" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US" id="lab_StockIssuedDuringPeriodSharesPurchaseOfAssets.1891841.414254.483163.358686.255735">Issuance of common stock under CHA Agreement (Note 1d), shares</link:label>
    <link:loc xlink:label="loc_StockIssuedDuringPeriodSharesShareBasedCompensation.16979.11.6" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation" xlink:type="locator" />
    <link:labelArc xlink:from="loc_StockIssuedDuringPeriodSharesShareBasedCompensation.16979.11.6" xlink:to="lab_StockIssuedDuringPeriodSharesShareBasedCompensation.18673.255736" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_StockIssuedDuringPeriodSharesShareBasedCompensation.18673.255736" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US" id="lab_StockIssuedDuringPeriodSharesShareBasedCompensation.18673.255736">Stock Issued During Period, Shares, Share-based Compensation, Net of Forfeitures</link:label>
    <link:loc xlink:label="loc_StockIssuedDuringPeriodSharesShareBasedCompensation.16979.11.7" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation" xlink:type="locator" />
    <link:labelArc xlink:from="loc_StockIssuedDuringPeriodSharesShareBasedCompensation.16979.11.7" xlink:to="lab_StockIssuedDuringPeriodSharesShareBasedCompensation.1891856.414256.483165.323075.255737" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_StockIssuedDuringPeriodSharesShareBasedCompensation.1891856.414256.483165.323075.255737" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US" id="lab_StockIssuedDuringPeriodSharesShareBasedCompensation.1891856.414256.483165.323075.255737">Stock based compensation to employees, directors and non-employee consultants, shares</link:label>
    <link:loc xlink:label="loc_StockIssuedDuringPeriodSharesStockWarrantsExercised.25556.11.6" xlink:href="psti-20140630.xsd#psti_StockIssuedDuringPeriodSharesStockWarrantsExercised" xlink:type="locator" />
    <link:labelArc xlink:from="loc_StockIssuedDuringPeriodSharesStockWarrantsExercised.25556.11.6" xlink:to="lab_StockIssuedDuringPeriodSharesStockWarrantsExercised.250786.255739" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_StockIssuedDuringPeriodSharesStockWarrantsExercised.250786.255739" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US" id="lab_StockIssuedDuringPeriodSharesStockWarrantsExercised.250786.255739">Stock Issued During Period Shares Stock Warrants Exercised</link:label>
    <link:loc xlink:label="loc_StockIssuedDuringPeriodValueIssuedForServices.16963.11.6" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueIssuedForServices" xlink:type="locator" />
    <link:labelArc xlink:from="loc_StockIssuedDuringPeriodValueIssuedForServices.16963.11.6" xlink:to="lab_StockIssuedDuringPeriodValueIssuedForServices.18392" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_StockIssuedDuringPeriodValueIssuedForServices.18392" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US" id="lab_StockIssuedDuringPeriodValueIssuedForServices.18392">Stock Issued During Period, Value, Issued for Services</link:label>
    <link:loc xlink:label="loc_StockIssuedDuringPeriodValueIssuedForServices.16963.11.7" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueIssuedForServices" xlink:type="locator" />
    <link:labelArc xlink:from="loc_StockIssuedDuringPeriodValueIssuedForServices.16963.11.7" xlink:to="lab_StockIssuedDuringPeriodValueIssuedForServices.168306.357825.256311" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_StockIssuedDuringPeriodValueIssuedForServices.168306.357825.256311" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US" id="lab_StockIssuedDuringPeriodValueIssuedForServices.168306.357825.256311">Stock based compensation to contractor</link:label>
    <link:loc xlink:label="loc_StockIssuedDuringPeriodValueShareBasedCompensation.16998.11.6" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation" xlink:type="locator" />
    <link:labelArc xlink:from="loc_StockIssuedDuringPeriodValueShareBasedCompensation.16998.11.6" xlink:to="lab_StockIssuedDuringPeriodValueShareBasedCompensation.18699.255744" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_StockIssuedDuringPeriodValueShareBasedCompensation.18699.255744" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US" id="lab_StockIssuedDuringPeriodValueShareBasedCompensation.18699.255744">Stock Issued During Period, Value, Share-based Compensation, Net of Forfeitures</link:label>
    <link:loc xlink:label="loc_StockIssuedDuringPeriodValueShareBasedCompensation.16998.11.7" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation" xlink:type="locator" />
    <link:labelArc xlink:from="loc_StockIssuedDuringPeriodValueShareBasedCompensation.16998.11.7" xlink:to="lab_StockIssuedDuringPeriodValueShareBasedCompensation.1892017.414260.483177.323074.255745" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_StockIssuedDuringPeriodValueShareBasedCompensation.1892017.414260.483177.323074.255745" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US" id="lab_StockIssuedDuringPeriodValueShareBasedCompensation.1892017.414260.483177.323074.255745">Stock based compensation to employees, directors and non-employee consultants</link:label>
    <link:loc xlink:label="loc_StockIssuedDuringPeriodValueStockOptionsAndWarrantsExercised.25557.11.6" xlink:href="psti-20140630.xsd#psti_StockIssuedDuringPeriodValueStockOptionsAndWarrantsExercised" xlink:type="locator" />
    <link:labelArc xlink:from="loc_StockIssuedDuringPeriodValueStockOptionsAndWarrantsExercised.25557.11.6" xlink:to="lab_StockIssuedDuringPeriodValueStockOptionsAndWarrantsExercised.360236.255746" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_StockIssuedDuringPeriodValueStockOptionsAndWarrantsExercised.360236.255746" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US" id="lab_StockIssuedDuringPeriodValueStockOptionsAndWarrantsExercised.360236.255746">Stock Issued During Period Value Stock Options And Warrants Exercised</link:label>
    <link:loc xlink:label="loc_StockIssuedDuringPeriodValueStockWarrantsExercised.25558.11.6" xlink:href="psti-20140630.xsd#psti_StockIssuedDuringPeriodValueStockWarrantsExercised" xlink:type="locator" />
    <link:labelArc xlink:from="loc_StockIssuedDuringPeriodValueStockWarrantsExercised.25558.11.6" xlink:to="lab_StockIssuedDuringPeriodValueStockWarrantsExercised.250783.255747" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_StockIssuedDuringPeriodValueStockWarrantsExercised.250783.255747" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US" id="lab_StockIssuedDuringPeriodValueStockWarrantsExercised.250783.255747">Stock Issued During Period Value Stock Warrants Exercised</link:label>
    <link:loc xlink:label="loc_StockIssuedDuringPeriodSharesStockOptionsAndWarrantsExercised.25555.11.7" xlink:href="psti-20140630.xsd#psti_StockIssuedDuringPeriodSharesStockOptionsAndWarrantsExercised" xlink:type="locator" />
    <link:labelArc xlink:from="loc_StockIssuedDuringPeriodSharesStockOptionsAndWarrantsExercised.25555.11.7" xlink:to="StockIssuedDuringPeriodSharesStockOptionsAndWarrantsExercised.360241.255748" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="StockIssuedDuringPeriodSharesStockOptionsAndWarrantsExercised.360241.255748" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US" id="StockIssuedDuringPeriodSharesStockOptionsAndWarrantsExercised.360241.255748">Exercise of options and warrants by employees and consultants, shares</link:label>
    <link:loc xlink:label="loc_StockIssuedDuringPeriodSharesStockWarrantsExercised.25556.11.12" xlink:href="psti-20140630.xsd#psti_StockIssuedDuringPeriodSharesStockWarrantsExercised" xlink:type="locator" />
    <link:labelArc xlink:from="loc_StockIssuedDuringPeriodSharesStockWarrantsExercised.25556.11.12" xlink:to="StockIssuedDuringPeriodSharesStockWarrantsExercised.250787.255751" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="StockIssuedDuringPeriodSharesStockWarrantsExercised.250787.255751" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US" id="StockIssuedDuringPeriodSharesStockWarrantsExercised.250787.255751">Number of shares of stock issued as a result of the exercise of stock warrants.</link:label>
    <link:loc xlink:label="loc_StockIssuedDuringPeriodSharesStockWarrantsExercised.25556.11.7" xlink:href="psti-20140630.xsd#psti_StockIssuedDuringPeriodSharesStockWarrantsExercised" xlink:type="locator" />
    <link:labelArc xlink:from="loc_StockIssuedDuringPeriodSharesStockWarrantsExercised.25556.11.7" xlink:to="StockIssuedDuringPeriodSharesStockWarrantsExercised.250788.255750" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="StockIssuedDuringPeriodSharesStockWarrantsExercised.250788.255750" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US" id="StockIssuedDuringPeriodSharesStockWarrantsExercised.250788.255750">Exercise of warrants by investors and finders, shares</link:label>
    <link:loc xlink:label="loc_StockIssuedDuringPeriodValueStockOptionsAndWarrantsExercised.25557.11.7" xlink:href="psti-20140630.xsd#psti_StockIssuedDuringPeriodValueStockOptionsAndWarrantsExercised" xlink:type="locator" />
    <link:labelArc xlink:from="loc_StockIssuedDuringPeriodValueStockOptionsAndWarrantsExercised.25557.11.7" xlink:to="StockIssuedDuringPeriodValueStockOptionsAndWarrantsExercised.360237.255752" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="StockIssuedDuringPeriodValueStockOptionsAndWarrantsExercised.360237.255752" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US" id="StockIssuedDuringPeriodValueStockOptionsAndWarrantsExercised.360237.255752">Exercise of options and warrants by employees and consultants</link:label>
    <link:loc xlink:label="loc_StockIssuedDuringPeriodValueStockOptionsAndWarrantsExercised.25557.11.12" xlink:href="psti-20140630.xsd#psti_StockIssuedDuringPeriodValueStockOptionsAndWarrantsExercised" xlink:type="locator" />
    <link:labelArc xlink:from="loc_StockIssuedDuringPeriodValueStockOptionsAndWarrantsExercised.25557.11.12" xlink:to="StockIssuedDuringPeriodValueStockOptionsAndWarrantsExercised.360238.255753" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="StockIssuedDuringPeriodValueStockOptionsAndWarrantsExercised.360238.255753" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US" id="StockIssuedDuringPeriodValueStockOptionsAndWarrantsExercised.360238.255753">Value of stock issued as a result of the exercise of stock options and warrants.</link:label>
    <link:loc xlink:label="loc_StockIssuedDuringPeriodValueStockWarrantsExercised.25558.11.12" xlink:href="psti-20140630.xsd#psti_StockIssuedDuringPeriodValueStockWarrantsExercised" xlink:type="locator" />
    <link:labelArc xlink:from="loc_StockIssuedDuringPeriodValueStockWarrantsExercised.25558.11.12" xlink:to="StockIssuedDuringPeriodValueStockWarrantsExercised.250784.255755" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="StockIssuedDuringPeriodValueStockWarrantsExercised.250784.255755" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US" id="StockIssuedDuringPeriodValueStockWarrantsExercised.250784.255755">Value of stock issued as a result of the exercise of stock warrants.</link:label>
    <link:loc xlink:label="loc_StockIssuedDuringPeriodValueStockWarrantsExercised.25558.11.7" xlink:href="psti-20140630.xsd#psti_StockIssuedDuringPeriodValueStockWarrantsExercised" xlink:type="locator" />
    <link:labelArc xlink:from="loc_StockIssuedDuringPeriodValueStockWarrantsExercised.25558.11.7" xlink:to="StockIssuedDuringPeriodValueStockWarrantsExercised.250785.255754" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="StockIssuedDuringPeriodValueStockWarrantsExercised.250785.255754" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US" id="StockIssuedDuringPeriodValueStockWarrantsExercised.250785.255754">Exercise of warrants by investors and finders</link:label>
    <link:loc xlink:label="loc_FairValueDisclosuresAbstract.2070.11.6" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_FairValueDisclosuresAbstract" xlink:type="locator" />
    <link:labelArc xlink:from="loc_FairValueDisclosuresAbstract.2070.11.6" xlink:to="lab_FairValueDisclosuresAbstract.333747.254077.250550.255472" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_FairValueDisclosuresAbstract.333747.254077.250550.255472" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US" id="lab_FairValueDisclosuresAbstract.333747.254077.250550.255472">FAIR VALUE OF FINANCIAL INSTRUMENTS [Abstract]</link:label>
    <link:loc xlink:label="loc_FairValueDisclosuresTextBlock.9611.11.7" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_FairValueDisclosuresTextBlock" xlink:type="locator" />
    <link:labelArc xlink:from="loc_FairValueDisclosuresTextBlock.9611.11.7" xlink:to="lab_FairValueDisclosuresTextBlock.333748.253997.250551.255473" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_FairValueDisclosuresTextBlock.333748.253997.250551.255473" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US" id="lab_FairValueDisclosuresTextBlock.333748.253997.250551.255473">FAIR VALUE OF FINANCIAL INSTRUMENTS</link:label>
    <link:loc xlink:label="loc_FairValueDisclosuresTextBlock.9611.11.6" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_FairValueDisclosuresTextBlock" xlink:type="locator" />
    <link:labelArc xlink:from="loc_FairValueDisclosuresTextBlock.9611.11.6" xlink:to="lab_FairValueDisclosuresTextBlock.9831.253996.250552.255474" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_FairValueDisclosuresTextBlock.9831.253996.250552.255474" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US" id="lab_FairValueDisclosuresTextBlock.9831.253996.250552.255474">Fair Value Disclosures [Text Block]</link:label>
    <link:loc xlink:label="loc_FairValueInputsLevel3Member.2137.11.7" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_FairValueInputsLevel3Member" xlink:type="locator" />
    <link:labelArc xlink:from="loc_FairValueInputsLevel3Member.2137.11.7" xlink:to="FairValueDisclosureLevel3.1858307.414461.482991.183520.211400" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="FairValueDisclosureLevel3.1858307.414461.482991.183520.211400" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US" id="FairValueDisclosureLevel3.1858307.414461.482991.183520.211400">Level 3 [Member]</link:label>
    <link:loc xlink:label="loc_FairValueInputsLevel1Member.2136.11.7" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_FairValueInputsLevel1Member" xlink:type="locator" />
    <link:labelArc xlink:from="loc_FairValueInputsLevel1Member.2136.11.7" xlink:to="FairValueInputsLevel1Member.1858305.414462.482992.183521.255475" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="FairValueInputsLevel1Member.1858305.414462.482992.183521.255475" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US" id="FairValueInputsLevel1Member.1858305.414462.482992.183521.255475">Level 1 [Member]</link:label>
    <link:loc xlink:label="loc_FairValueInputsLevel2Member.2135.11.7" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_FairValueInputsLevel2Member" xlink:type="locator" />
    <link:labelArc xlink:from="loc_FairValueInputsLevel2Member.2135.11.7" xlink:to="FairValueInputsLevel2Member.1858306.414463.482993.183522.255476" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="FairValueInputsLevel2Member.1858306.414463.482993.183522.255476" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US" id="FairValueInputsLevel2Member.1858306.414463.482993.183522.255476">Level 2 [Member]</link:label>
    <link:loc xlink:label="loc_DerivativeAssetsLiabilitiesAtFairValueNet.8291.11.6" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_DerivativeAssetsLiabilitiesAtFairValueNet" xlink:type="locator" />
    <link:labelArc xlink:from="loc_DerivativeAssetsLiabilitiesAtFairValueNet.8291.11.6" xlink:to="lab_DerivativeAssetsLiabilitiesAtFairValueNet.4753" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_DerivativeAssetsLiabilitiesAtFairValueNet.4753" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US" id="lab_DerivativeAssetsLiabilitiesAtFairValueNet.4753">Derivative Assets (Liabilities), at Fair Value, Net</link:label>
    <link:loc xlink:label="loc_DerivativeAssetsLiabilitiesAtFairValueNet.8291.11.8" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_DerivativeAssetsLiabilitiesAtFairValueNet" xlink:type="locator" />
    <link:labelArc xlink:from="loc_DerivativeAssetsLiabilitiesAtFairValueNet.8291.11.8" xlink:to="lab_DerivativeAssetsLiabilitiesAtFairValueNet8.256447" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_DerivativeAssetsLiabilitiesAtFairValueNet8.256447" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US" id="lab_DerivativeAssetsLiabilitiesAtFairValueNet8.256447">Foreign currency derivative instruments</link:label>
    <link:loc xlink:label="loc_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems.2066.11.6" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:type="locator" />
    <link:labelArc xlink:from="loc_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems.2066.11.6" xlink:to="lab_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems.14646.254074.250539.255479" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems.14646.254074.250539.255479" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US" id="lab_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems.14646.254074.250539.255479">Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</link:label>
    <link:loc xlink:label="loc_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable.2046.11.6" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:type="locator" />
    <link:labelArc xlink:from="loc_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable.2046.11.6" xlink:to="lab_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable.14611.254075.250540.255480" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable.14611.254075.250540.255480" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US" id="lab_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable.14611.254075.250540.255480">Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Table]</link:label>
    <link:loc xlink:label="loc_FairValueByFairValueHierarchyLevelAxis.2043.11.6" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:type="locator" />
    <link:labelArc xlink:from="loc_FairValueByFairValueHierarchyLevelAxis.2043.11.6" xlink:to="lab_FairValueByFairValueHierarchyLevelAxis.13589.254076.250541.255481" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_FairValueByFairValueHierarchyLevelAxis.13589.254076.250541.255481" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US" id="lab_FairValueByFairValueHierarchyLevelAxis.13589.254076.250541.255481">Fair Value, Hierarchy [Axis]</link:label>
    <link:loc xlink:label="loc_FairValueByMeasurementFrequencyAxis.2040.11.6" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_FairValueByMeasurementFrequencyAxis" xlink:type="locator" />
    <link:labelArc xlink:from="loc_FairValueByMeasurementFrequencyAxis.2040.11.6" xlink:to="lab_FairValueByMeasurementFrequencyAxis.6536" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_FairValueByMeasurementFrequencyAxis.6536" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US" id="lab_FairValueByMeasurementFrequencyAxis.6536">Measurement Frequency [Axis]</link:label>
    <link:loc xlink:label="loc_FairValueInputsLevel1Member.2136.11.6" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_FairValueInputsLevel1Member" xlink:type="locator" />
    <link:labelArc xlink:from="loc_FairValueInputsLevel1Member.2136.11.6" xlink:to="lab_FairValueInputsLevel1Member.9722.254078.250542.255482" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_FairValueInputsLevel1Member.9722.254078.250542.255482" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US" id="lab_FairValueInputsLevel1Member.9722.254078.250542.255482">Fair Value, Inputs, Level 1 [Member]</link:label>
    <link:loc xlink:label="loc_FairValueInputsLevel2Member.2135.11.6" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_FairValueInputsLevel2Member" xlink:type="locator" />
    <link:labelArc xlink:from="loc_FairValueInputsLevel2Member.2135.11.6" xlink:to="lab_FairValueInputsLevel2Member.9723.254079.250543.255483" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_FairValueInputsLevel2Member.9723.254079.250543.255483" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US" id="lab_FairValueInputsLevel2Member.9723.254079.250543.255483">Fair Value, Inputs, Level 2 [Member]</link:label>
    <link:loc xlink:label="loc_FairValueInputsLevel3Member.2137.11.6" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_FairValueInputsLevel3Member" xlink:type="locator" />
    <link:labelArc xlink:from="loc_FairValueInputsLevel3Member.2137.11.6" xlink:to="lab_FairValueInputsLevel3Member.6912" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_FairValueInputsLevel3Member.6912" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US" id="lab_FairValueInputsLevel3Member.6912">Fair Value, Inputs, Level 3 [Member]</link:label>
    <link:loc xlink:label="loc_FairValueMeasurementFrequencyDomain.2062.11.6" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_FairValueMeasurementFrequencyDomain" xlink:type="locator" />
    <link:labelArc xlink:from="loc_FairValueMeasurementFrequencyDomain.2062.11.6" xlink:to="lab_FairValueMeasurementFrequencyDomain.6613" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_FairValueMeasurementFrequencyDomain.6613" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US" id="lab_FairValueMeasurementFrequencyDomain.6613">Fair Value, Measurement Frequency [Domain]</link:label>
    <link:loc xlink:label="loc_FairValueMeasurementsFairValueHierarchyDomain.2075.11.6" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:type="locator" />
    <link:labelArc xlink:from="loc_FairValueMeasurementsFairValueHierarchyDomain.2075.11.6" xlink:to="lab_FairValueMeasurementsFairValueHierarchyDomain.14432.254081.250545.255484" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_FairValueMeasurementsFairValueHierarchyDomain.14432.254081.250545.255484" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US" id="lab_FairValueMeasurementsFairValueHierarchyDomain.14432.254081.250545.255484">Fair Value, Measurements, Fair Value Hierarchy [Domain]</link:label>
    <link:loc xlink:label="loc_FairValueMeasurementsRecurringMember.2032.11.6" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_FairValueMeasurementsRecurringMember" xlink:type="locator" />
    <link:labelArc xlink:from="loc_FairValueMeasurementsRecurringMember.2032.11.6" xlink:to="lab_FairValueMeasurementsRecurringMember.6500" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_FairValueMeasurementsRecurringMember.6500" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US" id="lab_FairValueMeasurementsRecurringMember.6500">Fair Value, Measurements, Recurring [Member]</link:label>
    <link:loc xlink:label="loc_FairValueNetAssetLiability.9433.11.6" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_FairValueNetAssetLiability" xlink:type="locator" />
    <link:labelArc xlink:from="loc_FairValueNetAssetLiability.9433.11.6" xlink:to="lab_FairValueNetAssetLiability.6474" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_FairValueNetAssetLiability.6474" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US" id="lab_FairValueNetAssetLiability.6474">Fair Value, Net Asset (Liability)</link:label>
    <link:loc xlink:label="loc_FairValueNetAssetLiability.9433.11.9" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_FairValueNetAssetLiability" xlink:type="locator" />
    <link:labelArc xlink:from="loc_FairValueNetAssetLiability.9433.11.9" xlink:to="lab_FairValueNetAssetLiability.256446" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_FairValueNetAssetLiability.256446" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US" id="lab_FairValueNetAssetLiability.256446">Total</link:label>
    <link:loc xlink:label="loc_CashFlowHedgingMember.979.11.7" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_CashFlowHedgingMember" xlink:type="locator" />
    <link:labelArc xlink:from="loc_CashFlowHedgingMember.979.11.7" xlink:to="CashFlowHedgingMember.360248.255807" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="CashFlowHedgingMember.360248.255807" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US" id="CashFlowHedgingMember.360248.255807">Cash flow [Member]</link:label>
    <link:loc xlink:label="loc_BalanceSheetLocationAxis.736.11.6" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_BalanceSheetLocationAxis" xlink:type="locator" />
    <link:labelArc xlink:from="loc_BalanceSheetLocationAxis.736.11.6" xlink:to="lab_BalanceSheetLocationAxis.1447.256001" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_BalanceSheetLocationAxis.1447.256001" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US" id="lab_BalanceSheetLocationAxis.1447.256001">Balance Sheet Location [Axis]</link:label>
    <link:loc xlink:label="loc_BalanceSheetLocationDomain.738.11.6" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_BalanceSheetLocationDomain" xlink:type="locator" />
    <link:labelArc xlink:from="loc_BalanceSheetLocationDomain.738.11.6" xlink:to="lab_BalanceSheetLocationDomain.1449.256002" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_BalanceSheetLocationDomain.1449.256002" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US" id="lab_BalanceSheetLocationDomain.1449.256002">Balance Sheet Location [Domain]</link:label>
    <link:loc xlink:label="loc_CashFlowHedgingMember.979.11.6" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_CashFlowHedgingMember" xlink:type="locator" />
    <link:labelArc xlink:from="loc_CashFlowHedgingMember.979.11.6" xlink:to="lab_CashFlowHedgingMember.2412.255810" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_CashFlowHedgingMember.2412.255810" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US" id="lab_CashFlowHedgingMember.2412.255810">Cash Flow Hedging [Member]</link:label>
    <link:loc xlink:label="loc_DerivativeAssetsLiabilitiesAtFairValueNet.8291.11.7" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_DerivativeAssetsLiabilitiesAtFairValueNet" xlink:type="locator" />
    <link:labelArc xlink:from="loc_DerivativeAssetsLiabilitiesAtFairValueNet.8291.11.7" xlink:to="lab_DerivativeAssetsLiabilitiesAtFairValueNet.1898120.227193.256418" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_DerivativeAssetsLiabilitiesAtFairValueNet.1898120.227193.256418" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US" id="lab_DerivativeAssetsLiabilitiesAtFairValueNet.1898120.227193.256418">Derivative fair value asset (liability)</link:label>
    <link:loc xlink:label="loc_DerivativeInstrumentsGainLossByHedgingRelationshipAxis.1619.11.6" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis" xlink:type="locator" />
    <link:labelArc xlink:from="loc_DerivativeInstrumentsGainLossByHedgingRelationshipAxis.1619.11.6" xlink:to="lab_DerivativeInstrumentsGainLossByHedgingRelationshipAxis.4914.255815" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_DerivativeInstrumentsGainLossByHedgingRelationshipAxis.4914.255815" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US" id="lab_DerivativeInstrumentsGainLossByHedgingRelationshipAxis.4914.255815">Hedging Relationship [Axis]</link:label>
    <link:loc xlink:label="loc_DerivativesFairValueLineItems.1635.11.7" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_DerivativesFairValueLineItems" xlink:type="locator" />
    <link:labelArc xlink:from="loc_DerivativesFairValueLineItems.1635.11.7" xlink:to="lab_DerivativesFairValueLineItems.257473" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_DerivativesFairValueLineItems.257473" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US" id="lab_DerivativesFairValueLineItems.257473">Derivatives Fair Value Line Items</link:label>
    <link:loc xlink:label="loc_DerivativesFairValueLineItems.1635.11.6" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_DerivativesFairValueLineItems" xlink:type="locator" />
    <link:labelArc xlink:from="loc_DerivativesFairValueLineItems.1635.11.6" xlink:to="lab_DerivativesFairValueLineItems.4976.256003" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_DerivativesFairValueLineItems.4976.256003" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US" id="lab_DerivativesFairValueLineItems.4976.256003">Derivatives, Fair Value [Line Items]</link:label>
    <link:loc xlink:label="loc_DesignatedAsHedgingInstrumentMember.1352.11.6" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_DesignatedAsHedgingInstrumentMember" xlink:type="locator" />
    <link:labelArc xlink:from="loc_DesignatedAsHedgingInstrumentMember.1352.11.6" xlink:to="lab_DesignatedAsHedgingInstrumentMember.3581.255820" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_DesignatedAsHedgingInstrumentMember.3581.255820" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US" id="lab_DesignatedAsHedgingInstrumentMember.3581.255820">Designated as Hedging Instrument [Member]</link:label>
    <link:loc xlink:label="loc_DesignatedAsHedgingInstrumentMember.1352.11.8" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_DesignatedAsHedgingInstrumentMember" xlink:type="locator" />
    <link:labelArc xlink:from="loc_DesignatedAsHedgingInstrumentMember.1352.11.8" xlink:to="lab_DesignatedAsHedgingInstrumentMember8.217134.363278.256004" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_DesignatedAsHedgingInstrumentMember8.217134.363278.256004" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US" id="lab_DesignatedAsHedgingInstrumentMember8.217134.363278.256004">Derivatives designated as hedge instruments [Member]</link:label>
    <link:loc xlink:label="loc_FairValueHedgingMember.2158.11.7" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_FairValueHedgingMember" xlink:type="locator" />
    <link:labelArc xlink:from="loc_FairValueHedgingMember.2158.11.7" xlink:to="lab_FairValueHedgingMember.360249.255822" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_FairValueHedgingMember.360249.255822" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US" id="lab_FairValueHedgingMember.360249.255822">Fair value [Member]</link:label>
    <link:loc xlink:label="loc_FairValueHedgingMember.2158.11.6" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_FairValueHedgingMember" xlink:type="locator" />
    <link:labelArc xlink:from="loc_FairValueHedgingMember.2158.11.6" xlink:to="lab_FairValueHedgingMember.7101.255821" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_FairValueHedgingMember.7101.255821" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US" id="lab_FairValueHedgingMember.7101.255821">Fair Value Hedging [Member]</link:label>
    <link:loc xlink:label="loc_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable.2157.11.6" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable" xlink:type="locator" />
    <link:labelArc xlink:from="loc_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable.2157.11.6" xlink:to="lab_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable.7100.256005" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable.7100.256005" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US" id="lab_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable.7100.256005">Fair Values Derivatives, Balance Sheet Location, by Derivative Contract Type [Table]</link:label>
    <link:loc xlink:label="loc_HedgingDesignationAxis.2543.11.6" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_HedgingDesignationAxis" xlink:type="locator" />
    <link:labelArc xlink:from="loc_HedgingDesignationAxis.2543.11.6" xlink:to="lab_HedgingDesignationAxis.8480.255825" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_HedgingDesignationAxis.8480.255825" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US" id="lab_HedgingDesignationAxis.8480.255825">Hedging Designation [Axis]</link:label>
    <link:loc xlink:label="loc_HedgingDesignationDomain.2544.11.6" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_HedgingDesignationDomain" xlink:type="locator" />
    <link:labelArc xlink:from="loc_HedgingDesignationDomain.2544.11.6" xlink:to="lab_HedgingDesignationDomain.8485.255826" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_HedgingDesignationDomain.8485.255826" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US" id="lab_HedgingDesignationDomain.8485.255826">Hedging Designation [Domain]</link:label>
    <link:loc xlink:label="loc_HedgingRelationshipDomain.2545.11.6" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_HedgingRelationshipDomain" xlink:type="locator" />
    <link:labelArc xlink:from="loc_HedgingRelationshipDomain.2545.11.6" xlink:to="lab_HedgingRelationshipDomain.8488.255827" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_HedgingRelationshipDomain.8488.255827" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US" id="lab_HedgingRelationshipDomain.8488.255827">Hedging Relationship [Domain]</link:label>
    <link:loc xlink:label="loc_NondesignatedMember.3619.11.6" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_NondesignatedMember" xlink:type="locator" />
    <link:labelArc xlink:from="loc_NondesignatedMember.3619.11.6" xlink:to="lab_NondesignatedMember.12686.256011" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_NondesignatedMember.12686.256011" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US" id="lab_NondesignatedMember.12686.256011">Not Designated as Hedging Instrument [Member]</link:label>
    <link:loc xlink:label="loc_NondesignatedMember.3619.11.8" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_NondesignatedMember" xlink:type="locator" />
    <link:labelArc xlink:from="loc_NondesignatedMember.3619.11.8" xlink:to="lab_NondesignatedMember.363279.256012" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_NondesignatedMember.363279.256012" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US" id="lab_NondesignatedMember.363279.256012">Derivatives not designated as hedge instruments [Member]</link:label>
    <link:loc xlink:label="loc_OtherCurrentAssetsMember.3743.11.6" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_OtherCurrentAssetsMember" xlink:type="locator" />
    <link:labelArc xlink:from="loc_OtherCurrentAssetsMember.3743.11.6" xlink:to="lab_OtherCurrentAssetsMember.13194.256013" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_OtherCurrentAssetsMember.13194.256013" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US" id="lab_OtherCurrentAssetsMember.13194.256013">Other Current Assets [Member]</link:label>
    <link:loc xlink:label="loc_OtherCurrentAssetsMember.3743.11.7" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_OtherCurrentAssetsMember" xlink:type="locator" />
    <link:labelArc xlink:from="loc_OtherCurrentAssetsMember.3743.11.7" xlink:to="lab_OtherCurrentAssetsMember.347699.358836.256014" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_OtherCurrentAssetsMember.347699.358836.256014" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US" id="lab_OtherCurrentAssetsMember.347699.358836.256014">Other current assets [Member]</link:label>
    <link:loc xlink:label="loc_OtherCurrentLiabilitiesMember.3728.11.6" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_OtherCurrentLiabilitiesMember" xlink:type="locator" />
    <link:labelArc xlink:from="loc_OtherCurrentLiabilitiesMember.3728.11.6" xlink:to="lab_OtherCurrentLiabilitiesMember.13001.256015" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_OtherCurrentLiabilitiesMember.13001.256015" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US" id="lab_OtherCurrentLiabilitiesMember.13001.256015">Other Current Liabilities [Member]</link:label>
    <link:loc xlink:label="loc_OtherCurrentLiabilitiesMember.3728.11.7" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_OtherCurrentLiabilitiesMember" xlink:type="locator" />
    <link:labelArc xlink:from="loc_OtherCurrentLiabilitiesMember.3728.11.7" xlink:to="lab_OtherCurrentLiabilitiesMember.360242.256016" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_OtherCurrentLiabilitiesMember.360242.256016" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US" id="lab_OtherCurrentLiabilitiesMember.360242.256016">Other current liabilities [Member]</link:label>
    <link:loc xlink:label="loc_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTableTextBlock.9404.11.6" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTableTextBlock" xlink:type="locator" />
    <link:labelArc xlink:from="loc_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTableTextBlock.9404.11.6" xlink:to="lab_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTableTextBlock.14649.254070.250684.255487" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTableTextBlock.14649.254070.250684.255487" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US" id="lab_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTableTextBlock.14649.254070.250684.255487">Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Table Text Block]</link:label>
    <link:loc xlink:label="loc_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTableTextBlock.9404.11.7" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTableTextBlock" xlink:type="locator" />
    <link:labelArc xlink:from="loc_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTableTextBlock.9404.11.7" xlink:to="lab_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTableTextBlock7.1921871.254071.250685.255488" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTableTextBlock7.1921871.254071.250685.255488" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US" id="lab_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTableTextBlock7.1921871.254071.250685.255488">Schedule of Fair Value of Financial Instruments</link:label>
    <link:loc xlink:label="loc_ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock.16347.11.6" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock" xlink:type="locator" />
    <link:labelArc xlink:from="loc_ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock.16347.11.6" xlink:to="lab_ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock.17571.255489" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock.17571.255489" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US" id="lab_ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock.17571.255489">Schedule of Derivative Instruments in Statement of Financial Position, Fair Value [Table Text Block]</link:label>
    <link:loc xlink:label="loc_ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock.16347.11.7" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock" xlink:type="locator" />
    <link:labelArc xlink:from="loc_ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock.16347.11.7" xlink:to="lab_ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock.332036.358866.255490" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock.332036.358866.255490" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US" id="lab_ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock.332036.358866.255490">Schedule of Derivative Hedging Activity and Balance Sheet Location</link:label>
    <link:loc xlink:label="loc_GeneralAbstract.25538.11.6" xlink:href="psti-20140630.xsd#psti_GeneralAbstract" xlink:type="locator" />
    <link:labelArc xlink:from="loc_GeneralAbstract.25538.11.6" xlink:to="lab_GeneralAbstract.287271.254012.250557.255491" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_GeneralAbstract.287271.254012.250557.255491" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US" id="lab_GeneralAbstract.287271.254012.250557.255491">GENERAL [Abstract]</link:label>
    <link:loc xlink:label="loc_GeneralAbstract.25538.11.12" xlink:href="psti-20140630.xsd#psti_GeneralAbstract" xlink:type="locator" />
    <link:labelArc xlink:from="loc_GeneralAbstract.25538.11.12" xlink:to="lab_GeneralDisclosureAbstrac.287272.254013.250558.255492" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_GeneralDisclosureAbstrac.287272.254013.250558.255492" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US" id="lab_GeneralDisclosureAbstrac.287272.254013.250558.255492">General Disclosure Abstract</link:label>
    <link:loc xlink:label="loc_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock.13494.11.7" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock" xlink:type="locator" />
    <link:labelArc xlink:from="loc_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock.13494.11.7" xlink:to="lab_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock.288109.253939.250559.255493" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock.288109.253939.250559.255493" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US" id="lab_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock.288109.253939.250559.255493">GENERAL</link:label>
    <link:loc xlink:label="loc_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock.13494.11.6" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock" xlink:type="locator" />
    <link:labelArc xlink:from="loc_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock.13494.11.6" xlink:to="lab_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock.5332.253938.250560.255494" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock.5332.253938.250560.255494" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US" id="lab_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock.5332.253938.250560.255494">Organization, Consolidation and Presentation of Financial Statements Disclosure [Text Block]</link:label>
    <link:loc xlink:label="loc_AvailableForSaleMarketableSecuritiesNumber.25527.11.12" xlink:href="psti-20140630.xsd#psti_AvailableForSaleMarketableSecuritiesNumber" xlink:type="locator" />
    <link:labelArc xlink:from="loc_AvailableForSaleMarketableSecuritiesNumber.25527.11.12" xlink:to="AvailableForSaleMarketableSecuritiesNumber.358872.255496" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="AvailableForSaleMarketableSecuritiesNumber.358872.255496" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US" id="AvailableForSaleMarketableSecuritiesNumber.358872.255496">Number of equity financial securities classified as available-for-sale.</link:label>
    <link:loc xlink:label="loc_AvailableForSaleMarketableSecuritiesNumber.25527.11.7" xlink:href="psti-20140630.xsd#psti_AvailableForSaleMarketableSecuritiesNumber" xlink:type="locator" />
    <link:labelArc xlink:from="loc_AvailableForSaleMarketableSecuritiesNumber.25527.11.7" xlink:to="AvailableForSaleMarketableSecuritiesNumber.358873.255495" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="AvailableForSaleMarketableSecuritiesNumber.358873.255495" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US" id="AvailableForSaleMarketableSecuritiesNumber.358873.255495">CHA shares classified as marketable securities</link:label>
    <link:loc xlink:label="loc_AvailableForSaleMarketableSecuritiesNumber.25527.11.6" xlink:href="psti-20140630.xsd#psti_AvailableForSaleMarketableSecuritiesNumber" xlink:type="locator" />
    <link:labelArc xlink:from="loc_AvailableForSaleMarketableSecuritiesNumber.25527.11.6" xlink:to="lab_AvailableForSaleMarketableSecuritiesNumber.358871.255497" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_AvailableForSaleMarketableSecuritiesNumber.358871.255497" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US" id="lab_AvailableForSaleMarketableSecuritiesNumber.358871.255497">Available For Sale Marketable Securities Number</link:label>
    <link:loc xlink:label="loc_LicensesRevenue.12148.11.6" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_LicensesRevenue" xlink:type="locator" />
    <link:labelArc xlink:from="loc_LicensesRevenue.12148.11.6" xlink:to="lab_LicensesRevenue.10742.255498" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_LicensesRevenue.10742.255498" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US" id="lab_LicensesRevenue.10742.255498">Licenses Revenue</link:label>
    <link:loc xlink:label="loc_LicensesRevenue.12148.11.7" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_LicensesRevenue" xlink:type="locator" />
    <link:labelArc xlink:from="loc_LicensesRevenue.12148.11.7" xlink:to="lab_LicensesRevenue.1877017.358874.255499" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_LicensesRevenue.1877017.358874.255499" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US" id="lab_LicensesRevenue.1877017.358874.255499">Upfront payment received</link:label>
    <link:loc xlink:label="loc_ProceedsFromCustomers.14773.11.6" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ProceedsFromCustomers" xlink:type="locator" />
    <link:labelArc xlink:from="loc_ProceedsFromCustomers.14773.11.6" xlink:to="lab_ProceedsFromCustomers.15028.255500" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_ProceedsFromCustomers.15028.255500" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US" id="lab_ProceedsFromCustomers.15028.255500">Proceeds from Customers</link:label>
    <link:loc xlink:label="loc_ProceedsFromCustomers.14773.11.7" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ProceedsFromCustomers" xlink:type="locator" />
    <link:labelArc xlink:from="loc_ProceedsFromCustomers.14773.11.7" xlink:to="lab_ProceedsFromCustomers.360253.255501" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_ProceedsFromCustomers.360253.255501" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US" id="lab_ProceedsFromCustomers.360253.255501">Advance payment on the development</link:label>
    <link:loc xlink:label="loc_ReimbursementRevenue.15504.11.6" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ReimbursementRevenue" xlink:type="locator" />
    <link:labelArc xlink:from="loc_ReimbursementRevenue.15504.11.6" xlink:to="lab_ReimbursementRevenue.16253.255502" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_ReimbursementRevenue.16253.255502" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US" id="lab_ReimbursementRevenue.16253.255502">Reimbursement Revenue</link:label>
    <link:loc xlink:label="loc_ReimbursementRevenue.15504.11.7" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ReimbursementRevenue" xlink:type="locator" />
    <link:labelArc xlink:from="loc_ReimbursementRevenue.15504.11.7" xlink:to="lab_ReimbursementRevenue.245355.498358.358879.255503" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_ReimbursementRevenue.245355.498358.358879.255503" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US" id="lab_ReimbursementRevenue.245355.498358.358879.255503">Reimbursement revenue receivable</link:label>
    <link:loc xlink:label="loc_ResearchAndDevelopmentMilestoneRevenueReceivable.25543.11.6" xlink:href="psti-20140630.xsd#psti_ResearchAndDevelopmentMilestoneRevenueReceivable" xlink:type="locator" />
    <link:labelArc xlink:from="loc_ResearchAndDevelopmentMilestoneRevenueReceivable.25543.11.6" xlink:to="lab_ResearchAndDevelopmentMilestoneRevenueReceivable.358876.255504" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_ResearchAndDevelopmentMilestoneRevenueReceivable.358876.255504" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US" id="lab_ResearchAndDevelopmentMilestoneRevenueReceivable.358876.255504">Research And Development Milestone Revenue Receivable</link:label>
    <link:loc xlink:label="loc_RevenueFromGrants.15863.11.6" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_RevenueFromGrants" xlink:type="locator" />
    <link:labelArc xlink:from="loc_RevenueFromGrants.15863.11.6" xlink:to="lab_RevenueFromGrants.16837.255505" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_RevenueFromGrants.16837.255505" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US" id="lab_RevenueFromGrants.16837.255505">Revenue from Grants</link:label>
    <link:loc xlink:label="loc_RevenueFromGrants.15863.11.7" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_RevenueFromGrants" xlink:type="locator" />
    <link:labelArc xlink:from="loc_RevenueFromGrants.15863.11.7" xlink:to="lab_RevenueFromGrants7.413793.358875.255506" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_RevenueFromGrants7.413793.358875.255506" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US" id="lab_RevenueFromGrants7.413793.358875.255506">Nonrefundable payments received</link:label>
    <link:loc xlink:label="loc_StockIssuedDuringPeriodSharesPurchaseOfAssets.16992.11.6" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesPurchaseOfAssets" xlink:type="locator" />
    <link:labelArc xlink:from="loc_StockIssuedDuringPeriodSharesPurchaseOfAssets.16992.11.6" xlink:to="lab_StockIssuedDuringPeriodSharesPurchaseOfAssets.18690.255734" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_StockIssuedDuringPeriodSharesPurchaseOfAssets.18690.255734" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US" id="lab_StockIssuedDuringPeriodSharesPurchaseOfAssets.18690.255734">Stock Issued During Period, Shares, Purchase of Assets</link:label>
    <link:loc xlink:label="loc_StockIssuedDuringPeriodValuePurchaseOfAssets.17002.11.6" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_StockIssuedDuringPeriodValuePurchaseOfAssets" xlink:type="locator" />
    <link:labelArc xlink:from="loc_StockIssuedDuringPeriodValuePurchaseOfAssets.17002.11.6" xlink:to="lab_StockIssuedDuringPeriodValuePurchaseOfAssets.18705.255742" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_StockIssuedDuringPeriodValuePurchaseOfAssets.18705.255742" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US" id="lab_StockIssuedDuringPeriodValuePurchaseOfAssets.18705.255742">Stock Issued During Period, Value, Purchase of Assets</link:label>
    <link:loc xlink:label="loc_StockIssuedDuringPeriodValuePurchaseOfAssets.17002.11.8" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_StockIssuedDuringPeriodValuePurchaseOfAssets" xlink:type="locator" />
    <link:labelArc xlink:from="loc_StockIssuedDuringPeriodValuePurchaseOfAssets.17002.11.8" xlink:to="lab_StockIssuedDuringPeriodValuePurchaseOfAssets.331887.496463.358870.255507" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_StockIssuedDuringPeriodValuePurchaseOfAssets.331887.496463.358870.255507" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US" id="lab_StockIssuedDuringPeriodValuePurchaseOfAssets.331887.496463.358870.255507">Total consideration reflected under the CHA agreement</link:label>
    <link:loc xlink:label="loc_ResearchAndDevelopmentMilestoneRevenueReceivable.25543.11.12" xlink:href="psti-20140630.xsd#psti_ResearchAndDevelopmentMilestoneRevenueReceivable" xlink:type="locator" />
    <link:labelArc xlink:from="loc_ResearchAndDevelopmentMilestoneRevenueReceivable.25543.11.12" xlink:to="ResearchAndDevelopmentMilestoneRevenueReceivable.358877.255509" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="ResearchAndDevelopmentMilestoneRevenueReceivable.358877.255509" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US" id="ResearchAndDevelopmentMilestoneRevenueReceivable.358877.255509">Maximum revenue receivable as milestone payments for licensing agreements.</link:label>
    <link:loc xlink:label="loc_ResearchAndDevelopmentMilestoneRevenueReceivable.25543.11.7" xlink:href="psti-20140630.xsd#psti_ResearchAndDevelopmentMilestoneRevenueReceivable" xlink:type="locator" />
    <link:labelArc xlink:from="loc_ResearchAndDevelopmentMilestoneRevenueReceivable.25543.11.7" xlink:to="ResearchAndDevelopmentMilestoneRevenueReceivable.358878.255508" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="ResearchAndDevelopmentMilestoneRevenueReceivable.358878.255508" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US" id="ResearchAndDevelopmentMilestoneRevenueReceivable.358878.255508">Milestone revenue receivable</link:label>
    <link:loc xlink:label="loc_StockIssuedDuringPeriodSharesPurchaseOfAssets.16992.11.8" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesPurchaseOfAssets" xlink:type="locator" />
    <link:labelArc xlink:from="loc_StockIssuedDuringPeriodSharesPurchaseOfAssets.16992.11.8" xlink:to="StockIssuedDuringPeriodSharesPurchaseOfAssets.331567.496467.358869.255510" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="StockIssuedDuringPeriodSharesPurchaseOfAssets.331567.496467.358869.255510" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US" id="StockIssuedDuringPeriodSharesPurchaseOfAssets.331567.496467.358869.255510">Issuance of common stock under CHA agreement</link:label>
    <link:loc xlink:label="loc_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock.11879.11.7" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock" xlink:type="locator" />
    <link:labelArc xlink:from="loc_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock.11879.11.7" xlink:to="lab_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock.333746.253995.250608.255758" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock.333746.253995.250608.255758" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US" id="lab_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock.333746.253995.250608.255758">MARKETABLE SECURITIES</link:label>
    <link:loc xlink:label="loc_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock.11879.11.6" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock" xlink:type="locator" />
    <link:labelArc xlink:from="loc_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock.11879.11.6" xlink:to="lab_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock.4088.253994.250609.255759" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock.4088.253994.250609.255759" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US" id="lab_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock.4088.253994.250609.255759">Investments in Debt and Marketable Equity Securities (and Certain Trading Assets) Disclosure [Text Block]</link:label>
    <link:loc xlink:label="loc_MarketableSecuritiesAbstract.3334.11.6" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_MarketableSecuritiesAbstract" xlink:type="locator" />
    <link:labelArc xlink:from="loc_MarketableSecuritiesAbstract.3334.11.6" xlink:to="lab_MarketableSecuritiesAbstract.1921829.254063.250610.255760" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_MarketableSecuritiesAbstract.1921829.254063.250610.255760" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US" id="lab_MarketableSecuritiesAbstract.1921829.254063.250610.255760">MARKETABLE SECURITIES [Abstract]</link:label>
    <link:loc xlink:label="loc_GovernmentDebtSecuritiesMember.25540.11.7" xlink:href="psti-20140630.xsd#psti_GovernmentDebtSecuritiesMember" xlink:type="locator" />
    <link:labelArc xlink:from="loc_GovernmentDebtSecuritiesMember.25540.11.7" xlink:to="GovernmentDebtSecuritiesMember.358839.255762" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="GovernmentDebtSecuritiesMember.358839.255762" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US" id="GovernmentDebtSecuritiesMember.358839.255762">Government Debentures [Member]</link:label>
    <link:loc xlink:label="loc_AvailableForSaleEquitySecuritiesAccumulatedGrossUnrealizedGainBeforeTax.6136.11.6" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_AvailableForSaleEquitySecuritiesAccumulatedGrossUnrealizedGainBeforeTax" xlink:type="locator" />
    <link:labelArc xlink:from="loc_AvailableForSaleEquitySecuritiesAccumulatedGrossUnrealizedGainBeforeTax.6136.11.6" xlink:to="lab_AvailableForSaleEquitySecuritiesAccumulatedGrossUnrealizedGainBeforeTax.1342" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_AvailableForSaleEquitySecuritiesAccumulatedGrossUnrealizedGainBeforeTax.1342" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US" id="lab_AvailableForSaleEquitySecuritiesAccumulatedGrossUnrealizedGainBeforeTax.1342">Available-for-sale Equity Securities, Accumulated Gross Unrealized Gain, before Tax</link:label>
    <link:loc xlink:label="loc_AvailableForSaleEquitySecuritiesAccumulatedGrossUnrealizedGainBeforeTax.6136.11.7" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_AvailableForSaleEquitySecuritiesAccumulatedGrossUnrealizedGainBeforeTax" xlink:type="locator" />
    <link:labelArc xlink:from="loc_AvailableForSaleEquitySecuritiesAccumulatedGrossUnrealizedGainBeforeTax.6136.11.7" xlink:to="lab_AvailableForSaleEquitySecuritiesAccumulatedGrossUnrealizedGainBeforeTax.256440" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_AvailableForSaleEquitySecuritiesAccumulatedGrossUnrealizedGainBeforeTax.256440" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US" id="lab_AvailableForSaleEquitySecuritiesAccumulatedGrossUnrealizedGainBeforeTax.256440">Gross unrealized gain</link:label>
    <link:loc xlink:label="loc_AvailableForSaleEquitySecuritiesAccumulatedGrossUnrealizedLossBeforeTax.6100.11.6" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_AvailableForSaleEquitySecuritiesAccumulatedGrossUnrealizedLossBeforeTax" xlink:type="locator" />
    <link:labelArc xlink:from="loc_AvailableForSaleEquitySecuritiesAccumulatedGrossUnrealizedLossBeforeTax.6100.11.6" xlink:to="lab_AvailableForSaleEquitySecuritiesAccumulatedGrossUnrealizedLossBeforeTax.1281" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_AvailableForSaleEquitySecuritiesAccumulatedGrossUnrealizedLossBeforeTax.1281" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US" id="lab_AvailableForSaleEquitySecuritiesAccumulatedGrossUnrealizedLossBeforeTax.1281">Available-for-sale Equity Securities, Accumulated Gross Unrealized Loss, before Tax</link:label>
    <link:loc xlink:label="loc_AvailableForSaleEquitySecuritiesAccumulatedGrossUnrealizedLossBeforeTax.6100.11.53" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_AvailableForSaleEquitySecuritiesAccumulatedGrossUnrealizedLossBeforeTax" xlink:type="locator" />
    <link:labelArc xlink:from="loc_AvailableForSaleEquitySecuritiesAccumulatedGrossUnrealizedLossBeforeTax.6100.11.53" xlink:to="lab_AvailableForSaleEquitySecuritiesAccumulatedGrossUnrealizedLossBeforeTax.256441" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_AvailableForSaleEquitySecuritiesAccumulatedGrossUnrealizedLossBeforeTax.256441" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xml:lang="en-US" id="lab_AvailableForSaleEquitySecuritiesAccumulatedGrossUnrealizedLossBeforeTax.256441">Gross unrealized loss</link:label>
    <link:loc xlink:label="loc_AvailableForSaleSecurities.6116.11.6" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_AvailableForSaleSecurities" xlink:type="locator" />
    <link:labelArc xlink:from="loc_AvailableForSaleSecurities.6116.11.6" xlink:to="lab_AvailableForSaleSecurities.1289.255763" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_AvailableForSaleSecurities.1289.255763" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US" id="lab_AvailableForSaleSecurities.1289.255763">Available-for-sale Securities</link:label>
    <link:loc xlink:label="loc_AvailableForSaleSecurities.6116.11.7" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_AvailableForSaleSecurities" xlink:type="locator" />
    <link:labelArc xlink:from="loc_AvailableForSaleSecurities.6116.11.7" xlink:to="lab_AvailableForSaleSecurities.253004.255764" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_AvailableForSaleSecurities.253004.255764" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US" id="lab_AvailableForSaleSecurities.253004.255764">Fair value</link:label>
    <link:loc xlink:label="loc_AvailableForSaleSecuritiesAmortizedCost.6142.11.6" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_AvailableForSaleSecuritiesAmortizedCost" xlink:type="locator" />
    <link:labelArc xlink:from="loc_AvailableForSaleSecuritiesAmortizedCost.6142.11.6" xlink:to="lab_AvailableForSaleSecuritiesAmortizedCost.1336.255765" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_AvailableForSaleSecuritiesAmortizedCost.1336.255765" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US" id="lab_AvailableForSaleSecuritiesAmortizedCost.1336.255765">Available-for-sale Securities, Amortized Cost Basis</link:label>
    <link:loc xlink:label="loc_AvailableForSaleSecuritiesAmortizedCost.6142.11.9" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_AvailableForSaleSecuritiesAmortizedCost" xlink:type="locator" />
    <link:labelArc xlink:from="loc_AvailableForSaleSecuritiesAmortizedCost.6142.11.9" xlink:to="lab_AvailableForSaleSecuritiesAmortizedCost.358793.255766" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_AvailableForSaleSecuritiesAmortizedCost.358793.255766" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US" id="lab_AvailableForSaleSecuritiesAmortizedCost.358793.255766">Amortized cost</link:label>
    <link:loc xlink:label="loc_AvailableForSaleSecuritiesMaturesAfterFiveYearsThroughTenYearsMember.25530.11.6" xlink:href="psti-20140630.xsd#psti_AvailableForSaleSecuritiesMaturesAfterFiveYearsThroughTenYearsMember" xlink:type="locator" />
    <link:labelArc xlink:from="loc_AvailableForSaleSecuritiesMaturesAfterFiveYearsThroughTenYearsMember.25530.11.6" xlink:to="lab_AvailableForSaleSecuritiesMaturesAfterFiveYearsThroughTenYearsMember.252998.255772" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_AvailableForSaleSecuritiesMaturesAfterFiveYearsThroughTenYearsMember.252998.255772" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US" id="lab_AvailableForSaleSecuritiesMaturesAfterFiveYearsThroughTenYearsMember.252998.255772">Available For Sale Securities Matures After Five Years Through Ten Years [Member]</link:label>
    <link:loc xlink:label="loc_AvailableForSaleSecuritiesMaturesAfterFiveYearsThroughTenYearsMember.25530.11.12" xlink:href="psti-20140630.xsd#psti_AvailableForSaleSecuritiesMaturesAfterFiveYearsThroughTenYearsMember" xlink:type="locator" />
    <link:labelArc xlink:from="loc_AvailableForSaleSecuritiesMaturesAfterFiveYearsThroughTenYearsMember.25530.11.12" xlink:to="lab_AvailableForSaleSecuritiesMaturesAfterFiveYearsThroughTenYearsMember.252999.255774" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_AvailableForSaleSecuritiesMaturesAfterFiveYearsThroughTenYearsMember.252999.255774" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US" id="lab_AvailableForSaleSecuritiesMaturesAfterFiveYearsThroughTenYearsMember.252999.255774">Available-for-sale securities with maturities after five years and within ten years.</link:label>
    <link:loc xlink:label="loc_AvailableForSaleSecuritiesMaturesAfterFiveYearsThroughTenYearsMember.25530.11.7" xlink:href="psti-20140630.xsd#psti_AvailableForSaleSecuritiesMaturesAfterFiveYearsThroughTenYearsMember" xlink:type="locator" />
    <link:labelArc xlink:from="loc_AvailableForSaleSecuritiesMaturesAfterFiveYearsThroughTenYearsMember.25530.11.7" xlink:to="lab_AvailableForSaleSecuritiesMaturesAfterFiveYearsThroughTenYearsMember.253000.255773" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_AvailableForSaleSecuritiesMaturesAfterFiveYearsThroughTenYearsMember.253000.255773" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US" id="lab_AvailableForSaleSecuritiesMaturesAfterFiveYearsThroughTenYearsMember.253000.255773">After Five Years through Ten Years [Member]</link:label>
    <link:loc xlink:label="loc_AvailableForSaleSecuritiesMaturesAfterOneYearThroughFiveYearsMember.25531.11.6" xlink:href="psti-20140630.xsd#psti_AvailableForSaleSecuritiesMaturesAfterOneYearThroughFiveYearsMember" xlink:type="locator" />
    <link:labelArc xlink:from="loc_AvailableForSaleSecuritiesMaturesAfterOneYearThroughFiveYearsMember.25531.11.6" xlink:to="lab_AvailableForSaleSecuritiesMaturesAfterOneYearThroughFiveYearsMember.252995.255775" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_AvailableForSaleSecuritiesMaturesAfterOneYearThroughFiveYearsMember.252995.255775" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US" id="lab_AvailableForSaleSecuritiesMaturesAfterOneYearThroughFiveYearsMember.252995.255775">Available For Sale Securities Matures After One Year Through Five Years [Member]</link:label>
    <link:loc xlink:label="loc_AvailableForSaleSecuritiesMaturesAfterOneYearThroughFiveYearsMember.25531.11.12" xlink:href="psti-20140630.xsd#psti_AvailableForSaleSecuritiesMaturesAfterOneYearThroughFiveYearsMember" xlink:type="locator" />
    <link:labelArc xlink:from="loc_AvailableForSaleSecuritiesMaturesAfterOneYearThroughFiveYearsMember.25531.11.12" xlink:to="lab_AvailableForSaleSecuritiesMaturesAfterOneYearThroughFiveYearsMember.252996.255777" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_AvailableForSaleSecuritiesMaturesAfterOneYearThroughFiveYearsMember.252996.255777" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US" id="lab_AvailableForSaleSecuritiesMaturesAfterOneYearThroughFiveYearsMember.252996.255777">Available-for sale securities with maturities between one and five years.</link:label>
    <link:loc xlink:label="loc_AvailableForSaleSecuritiesMaturesAfterOneYearThroughFiveYearsMember.25531.11.7" xlink:href="psti-20140630.xsd#psti_AvailableForSaleSecuritiesMaturesAfterOneYearThroughFiveYearsMember" xlink:type="locator" />
    <link:labelArc xlink:from="loc_AvailableForSaleSecuritiesMaturesAfterOneYearThroughFiveYearsMember.25531.11.7" xlink:to="lab_AvailableForSaleSecuritiesMaturesAfterOneYearThroughFiveYearsMember.252997.255776" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_AvailableForSaleSecuritiesMaturesAfterOneYearThroughFiveYearsMember.252997.255776" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US" id="lab_AvailableForSaleSecuritiesMaturesAfterOneYearThroughFiveYearsMember.252997.255776">One to Five Years [Member]</link:label>
    <link:loc xlink:label="loc_AvailableForSaleSecuritiesMaturesWithinOneYearMember.25532.11.6" xlink:href="psti-20140630.xsd#psti_AvailableForSaleSecuritiesMaturesWithinOneYearMember" xlink:type="locator" />
    <link:labelArc xlink:from="loc_AvailableForSaleSecuritiesMaturesWithinOneYearMember.25532.11.6" xlink:to="lab_AvailableForSaleSecuritiesMaturesWithinOneYearMember.252991.255778" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_AvailableForSaleSecuritiesMaturesWithinOneYearMember.252991.255778" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US" id="lab_AvailableForSaleSecuritiesMaturesWithinOneYearMember.252991.255778">Available For Sale Securities Matures Within One Year [Member]</link:label>
    <link:loc xlink:label="loc_AvailableForSaleSecuritiesMaturesWithinOneYearMember.25532.11.12" xlink:href="psti-20140630.xsd#psti_AvailableForSaleSecuritiesMaturesWithinOneYearMember" xlink:type="locator" />
    <link:labelArc xlink:from="loc_AvailableForSaleSecuritiesMaturesWithinOneYearMember.25532.11.12" xlink:to="lab_AvailableForSaleSecuritiesMaturesWithinOneYearMember.252993.255780" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_AvailableForSaleSecuritiesMaturesWithinOneYearMember.252993.255780" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US" id="lab_AvailableForSaleSecuritiesMaturesWithinOneYearMember.252993.255780">Available-for-sale securities with maturites within the nex year.</link:label>
    <link:loc xlink:label="loc_AvailableForSaleSecuritiesMaturesWithinOneYearMember.25532.11.7" xlink:href="psti-20140630.xsd#psti_AvailableForSaleSecuritiesMaturesWithinOneYearMember" xlink:type="locator" />
    <link:labelArc xlink:from="loc_AvailableForSaleSecuritiesMaturesWithinOneYearMember.25532.11.7" xlink:to="lab_AvailableForSaleSecuritiesMaturesWithinOneYearMember.252994.255779" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_AvailableForSaleSecuritiesMaturesWithinOneYearMember.252994.255779" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US" id="lab_AvailableForSaleSecuritiesMaturesWithinOneYearMember.252994.255779">Within One Year [Member]</link:label>
    <link:loc xlink:label="loc_CorporateDebtSecuritiesMember.1263.11.6" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_CorporateDebtSecuritiesMember" xlink:type="locator" />
    <link:labelArc xlink:from="loc_CorporateDebtSecuritiesMember.1263.11.6" xlink:to="lab_CorporateDebtSecuritiesMember.1640.254058.250599.255781" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_CorporateDebtSecuritiesMember.1640.254058.250599.255781" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US" id="lab_CorporateDebtSecuritiesMember.1640.254058.250599.255781">Corporate Debt Securities [Member]</link:label>
    <link:loc xlink:label="loc_CorporateDebtSecuritiesMember.1263.11.7" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_CorporateDebtSecuritiesMember" xlink:type="locator" />
    <link:labelArc xlink:from="loc_CorporateDebtSecuritiesMember.1263.11.7" xlink:to="lab_CorporateDebtSecuritiesMember.1900069.358840.255782" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_CorporateDebtSecuritiesMember.1900069.358840.255782" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US" id="lab_CorporateDebtSecuritiesMember.1900069.358840.255782">Corporate Debentures [Member]</link:label>
    <link:loc xlink:label="loc_EquitySecuritiesMember.1910.11.6" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_EquitySecuritiesMember" xlink:type="locator" />
    <link:labelArc xlink:from="loc_EquitySecuritiesMember.1910.11.6" xlink:to="lab_EquitySecuritiesMember.6167" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_EquitySecuritiesMember.6167" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US" id="lab_EquitySecuritiesMember.6167">Equity Securities [Member]</link:label>
    <link:loc xlink:label="loc_EquitySecuritiesMember.1910.11.7" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_EquitySecuritiesMember" xlink:type="locator" />
    <link:labelArc xlink:from="loc_EquitySecuritiesMember.1910.11.7" xlink:to="lab_EquitySecuritiesMember7.202648.256442" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_EquitySecuritiesMember7.202648.256442" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US" id="lab_EquitySecuritiesMember7.202648.256442">Stock and Index Linked Notes [Member]</link:label>
    <link:loc xlink:label="loc_GovernmentDebtSecuritiesMember.25540.11.12" xlink:href="psti-20140630.xsd#psti_GovernmentDebtSecuritiesMember" xlink:type="locator" />
    <link:labelArc xlink:from="loc_GovernmentDebtSecuritiesMember.25540.11.12" xlink:to="lab_GovernmentDebenturesMember.1921836.254061.250601.255785" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_GovernmentDebenturesMember.1921836.254061.250601.255785" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US" id="lab_GovernmentDebenturesMember.1921836.254061.250601.255785">Debt securities issued by a national, local, or municipal government.</link:label>
    <link:loc xlink:label="loc_GovernmentDebtSecuritiesMember.25540.11.6" xlink:href="psti-20140630.xsd#psti_GovernmentDebtSecuritiesMember" xlink:type="locator" />
    <link:labelArc xlink:from="loc_GovernmentDebtSecuritiesMember.25540.11.6" xlink:to="lab_GovernmentDebtSecuritiesMember.250600.255786" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_GovernmentDebtSecuritiesMember.250600.255786" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US" id="lab_GovernmentDebtSecuritiesMember.250600.255786">Government Debt Securities [Member]</link:label>
    <link:loc xlink:label="loc_MajorTypesOfDebtAndEquitySecuritiesAxis.3302.11.6" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_MajorTypesOfDebtAndEquitySecuritiesAxis" xlink:type="locator" />
    <link:labelArc xlink:from="loc_MajorTypesOfDebtAndEquitySecuritiesAxis.3302.11.6" xlink:to="lab_MajorTypesOfDebtAndEquitySecuritiesAxis.11217.250602.255787" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_MajorTypesOfDebtAndEquitySecuritiesAxis.11217.250602.255787" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US" id="lab_MajorTypesOfDebtAndEquitySecuritiesAxis.11217.250602.255787">Major Types of Debt and Equity Securities [Axis]</link:label>
    <link:loc xlink:label="loc_MajorTypesOfDebtAndEquitySecuritiesDomain.3304.11.6" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_MajorTypesOfDebtAndEquitySecuritiesDomain" xlink:type="locator" />
    <link:labelArc xlink:from="loc_MajorTypesOfDebtAndEquitySecuritiesDomain.3304.11.6" xlink:to="lab_MajorTypesOfDebtAndEquitySecuritiesDomain.14470.254062.250603.255788" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_MajorTypesOfDebtAndEquitySecuritiesDomain.14470.254062.250603.255788" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US" id="lab_MajorTypesOfDebtAndEquitySecuritiesDomain.14470.254062.250603.255788">Major Types of Debt and Equity Securities [Domain]</link:label>
    <link:loc xlink:label="loc_ScheduleOfAvailableForSaleSecuritiesLineItems.4769.11.6" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems" xlink:type="locator" />
    <link:labelArc xlink:from="loc_ScheduleOfAvailableForSaleSecuritiesLineItems.4769.11.6" xlink:to="lab_ScheduleOfAvailableForSaleSecuritiesLineItems.10586.254064.250604.255789" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_ScheduleOfAvailableForSaleSecuritiesLineItems.10586.254064.250604.255789" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US" id="lab_ScheduleOfAvailableForSaleSecuritiesLineItems.10586.254064.250604.255789">Schedule of Available-for-sale Securities [Line Items]</link:label>
    <link:loc xlink:label="loc_ScheduleOfAvailableForSaleSecuritiesTable.4729.11.6" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ScheduleOfAvailableForSaleSecuritiesTable" xlink:type="locator" />
    <link:labelArc xlink:from="loc_ScheduleOfAvailableForSaleSecuritiesTable.4729.11.6" xlink:to="lab_ScheduleOfAvailableForSaleSecuritiesTable.8554.254066.250605.255790" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_ScheduleOfAvailableForSaleSecuritiesTable.8554.254066.250605.255790" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US" id="lab_ScheduleOfAvailableForSaleSecuritiesTable.8554.254066.250605.255790">Schedule of Available-for-sale Securities [Table]</link:label>
    <link:loc xlink:label="loc_AvailableForSaleSecuritiesContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss.6105.11.6" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_AvailableForSaleSecuritiesContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss" xlink:type="locator" />
    <link:labelArc xlink:from="loc_AvailableForSaleSecuritiesContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss.6105.11.6" xlink:to="lab_AvailableForSaleSecuritiesContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss.1290" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_AvailableForSaleSecuritiesContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss.1290" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US" id="lab_AvailableForSaleSecuritiesContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss.1290">Available-for-sale Securities, Continuous Unrealized Loss Position, 12 Months or Longer, Accumulated Loss</link:label>
    <link:loc xlink:label="loc_AvailableForSaleSecuritiesContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss.6105.11.53" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_AvailableForSaleSecuritiesContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss" xlink:type="locator" />
    <link:labelArc xlink:from="loc_AvailableForSaleSecuritiesContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss.6105.11.53" xlink:to="lab_AvailableForSaleSecuritiesContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss.256445" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_AvailableForSaleSecuritiesContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss.256445" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xml:lang="en-US" id="lab_AvailableForSaleSecuritiesContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss.256445">12 months or greater, gross unrealized loss</link:label>
    <link:loc xlink:label="loc_AvailableForSaleSecuritiesContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss.6107.11.6" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_AvailableForSaleSecuritiesContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss" xlink:type="locator" />
    <link:labelArc xlink:from="loc_AvailableForSaleSecuritiesContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss.6107.11.6" xlink:to="lab_AvailableForSaleSecuritiesContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss.1294" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_AvailableForSaleSecuritiesContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss.1294" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US" id="lab_AvailableForSaleSecuritiesContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss.1294">Available-for-sale Securities, Continuous Unrealized Loss Position, Less than 12 Months, Accumulated Loss</link:label>
    <link:loc xlink:label="loc_AvailableForSaleSecuritiesContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss.6107.11.53" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_AvailableForSaleSecuritiesContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss" xlink:type="locator" />
    <link:labelArc xlink:from="loc_AvailableForSaleSecuritiesContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss.6107.11.53" xlink:to="lab_AvailableForSaleSecuritiesContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss.256444" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_AvailableForSaleSecuritiesContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss.256444" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xml:lang="en-US" id="lab_AvailableForSaleSecuritiesContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss.256444">Less than 12 months, gross unrealized loss</link:label>
    <link:loc xlink:label="loc_AvailableForSaleSecuritiesContinuousUnrealizedLossPositionLessThanTwelveMonthsFairValue.6088.11.6" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_AvailableForSaleSecuritiesContinuousUnrealizedLossPositionLessThanTwelveMonthsFairValue" xlink:type="locator" />
    <link:labelArc xlink:from="loc_AvailableForSaleSecuritiesContinuousUnrealizedLossPositionLessThanTwelveMonthsFairValue.6088.11.6" xlink:to="lab_AvailableForSaleSecuritiesContinuousUnrealizedLossPositionLessThanTwelveMonthsFairValue.1249.255795" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_AvailableForSaleSecuritiesContinuousUnrealizedLossPositionLessThanTwelveMonthsFairValue.1249.255795" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US" id="lab_AvailableForSaleSecuritiesContinuousUnrealizedLossPositionLessThanTwelveMonthsFairValue.1249.255795">Available-for-sale Securities, Continuous Unrealized Loss Position, Less than Twelve Months, Fair Value</link:label>
    <link:loc xlink:label="loc_AvailableForSaleSecuritiesContinuousUnrealizedLossPositionLessThanTwelveMonthsFairValue.6088.11.8" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_AvailableForSaleSecuritiesContinuousUnrealizedLossPositionLessThanTwelveMonthsFairValue" xlink:type="locator" />
    <link:labelArc xlink:from="loc_AvailableForSaleSecuritiesContinuousUnrealizedLossPositionLessThanTwelveMonthsFairValue.6088.11.8" xlink:to="lab_AvailableForSaleSecuritiesContinuousUnrealizedLossPositionLessThanTwelveMonthsFairValue8.250969.255796" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_AvailableForSaleSecuritiesContinuousUnrealizedLossPositionLessThanTwelveMonthsFairValue8.250969.255796" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US" id="lab_AvailableForSaleSecuritiesContinuousUnrealizedLossPositionLessThanTwelveMonthsFairValue8.250969.255796">Less than 12 months, fair value</link:label>
    <link:loc xlink:label="loc_AvailableForSaleSecuritiesContinuousUnrealizedLossPositionTwelveMonthsOrLongerFairValue.6114.11.6" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_AvailableForSaleSecuritiesContinuousUnrealizedLossPositionTwelveMonthsOrLongerFairValue" xlink:type="locator" />
    <link:labelArc xlink:from="loc_AvailableForSaleSecuritiesContinuousUnrealizedLossPositionTwelveMonthsOrLongerFairValue.6114.11.6" xlink:to="lab_AvailableForSaleSecuritiesContinuousUnrealizedLossPositionTwelveMonthsOrLongerFairValue.1285.255797" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_AvailableForSaleSecuritiesContinuousUnrealizedLossPositionTwelveMonthsOrLongerFairValue.1285.255797" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US" id="lab_AvailableForSaleSecuritiesContinuousUnrealizedLossPositionTwelveMonthsOrLongerFairValue.1285.255797">Available-for-sale Securities, Continuous Unrealized Loss Position, Twelve Months or Longer, Fair Value</link:label>
    <link:loc xlink:label="loc_AvailableForSaleSecuritiesContinuousUnrealizedLossPositionTwelveMonthsOrLongerFairValue.6114.11.8" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_AvailableForSaleSecuritiesContinuousUnrealizedLossPositionTwelveMonthsOrLongerFairValue" xlink:type="locator" />
    <link:labelArc xlink:from="loc_AvailableForSaleSecuritiesContinuousUnrealizedLossPositionTwelveMonthsOrLongerFairValue.6114.11.8" xlink:to="lab_AvailableForSaleSecuritiesContinuousUnrealizedLossPositionTwelveMonthsOrLongerFairValue.250966.255798" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_AvailableForSaleSecuritiesContinuousUnrealizedLossPositionTwelveMonthsOrLongerFairValue.250966.255798" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US" id="lab_AvailableForSaleSecuritiesContinuousUnrealizedLossPositionTwelveMonthsOrLongerFairValue.250966.255798">12 months or greater, fair value</link:label>
    <link:loc xlink:label="loc_InterestReceivable.11654.11.6" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_InterestReceivable" xlink:type="locator" />
    <link:labelArc xlink:from="loc_InterestReceivable.11654.11.6" xlink:to="lab_InterestReceivable.9866" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_InterestReceivable.9866" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US" id="lab_InterestReceivable.9866">Interest Receivable</link:label>
    <link:loc xlink:label="loc_InterestReceivable.11654.11.7" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_InterestReceivable" xlink:type="locator" />
    <link:labelArc xlink:from="loc_InterestReceivable.11654.11.7" xlink:to="lab_InterestReceivable7.257481" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_InterestReceivable7.257481" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US" id="lab_InterestReceivable7.257481">Interest receivable</link:label>
    <link:loc xlink:label="loc_AvailableForSaleSecuritiesContinuousUnrealizedLossPositionFairValueTableTextBlock.6144.11.6" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_AvailableForSaleSecuritiesContinuousUnrealizedLossPositionFairValueTableTextBlock" xlink:type="locator" />
    <link:labelArc xlink:from="loc_AvailableForSaleSecuritiesContinuousUnrealizedLossPositionFairValueTableTextBlock.6144.11.6" xlink:to="lab_AvailableForSaleSecuritiesContinuousUnrealizedLossPositionFairValueTableTextBlock.1322.250686.255799" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_AvailableForSaleSecuritiesContinuousUnrealizedLossPositionFairValueTableTextBlock.1322.250686.255799" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US" id="lab_AvailableForSaleSecuritiesContinuousUnrealizedLossPositionFairValueTableTextBlock.1322.250686.255799">Available-for-sale Securities, Continuous Unrealized Loss Position, Fair Value [Table Text Block]</link:label>
    <link:loc xlink:label="loc_AvailableForSaleSecuritiesContinuousUnrealizedLossPositionFairValueTableTextBlock.6144.11.7" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_AvailableForSaleSecuritiesContinuousUnrealizedLossPositionFairValueTableTextBlock" xlink:type="locator" />
    <link:labelArc xlink:from="loc_AvailableForSaleSecuritiesContinuousUnrealizedLossPositionFairValueTableTextBlock.6144.11.7" xlink:to="lab_AvailableForSaleSecuritiesContinuousUnrealizedLossPositionFairValueTableTextBlock.317180.250687.255800" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_AvailableForSaleSecuritiesContinuousUnrealizedLossPositionFairValueTableTextBlock.317180.250687.255800" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US" id="lab_AvailableForSaleSecuritiesContinuousUnrealizedLossPositionFairValueTableTextBlock.317180.250687.255800">Schedule of Investments in Continuous Unrealized Loss Position</link:label>
    <link:loc xlink:label="loc_AvailableForSaleSecuritiesTextBlock.6091.11.6" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_AvailableForSaleSecuritiesTextBlock" xlink:type="locator" />
    <link:labelArc xlink:from="loc_AvailableForSaleSecuritiesTextBlock.6091.11.6" xlink:to="lab_AvailableForSaleSecuritiesTextBlock.14216.254018.250688.255801" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_AvailableForSaleSecuritiesTextBlock.14216.254018.250688.255801" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US" id="lab_AvailableForSaleSecuritiesTextBlock.14216.254018.250688.255801">Available-for-sale Securities [Table Text Block]</link:label>
    <link:loc xlink:label="loc_AvailableForSaleSecuritiesTextBlock.6091.11.7" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_AvailableForSaleSecuritiesTextBlock" xlink:type="locator" />
    <link:labelArc xlink:from="loc_AvailableForSaleSecuritiesTextBlock.6091.11.7" xlink:to="lab_AvailableForSaleSecuritiesTextBlock7.1921830.254019.250689.255802" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_AvailableForSaleSecuritiesTextBlock7.1921830.254019.250689.255802" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US" id="lab_AvailableForSaleSecuritiesTextBlock7.1921830.254019.250689.255802">Schedule of Available-for-sale Marketable Securities</link:label>
    <link:loc xlink:label="loc_SubsequentEventsAbstract.5158.11.6" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_SubsequentEventsAbstract" xlink:type="locator" />
    <link:labelArc xlink:from="loc_SubsequentEventsAbstract.5158.11.6" xlink:to="lab_SubsequentEventsAbstract.250976.255998" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_SubsequentEventsAbstract.250976.255998" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US" id="lab_SubsequentEventsAbstract.250976.255998">SUBSEQUENT EVENTS [Abstract]</link:label>
    <link:loc xlink:label="loc_SubsequentEventsTextBlock.17048.11.6" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_SubsequentEventsTextBlock" xlink:type="locator" />
    <link:labelArc xlink:from="loc_SubsequentEventsTextBlock.17048.11.6" xlink:to="lab_SubsequentEventsTextBlock.18785.255999" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_SubsequentEventsTextBlock.18785.255999" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US" id="lab_SubsequentEventsTextBlock.18785.255999">Subsequent Events [Text Block]</link:label>
    <link:loc xlink:label="loc_SubsequentEventsTextBlock.17048.11.7" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_SubsequentEventsTextBlock" xlink:type="locator" />
    <link:labelArc xlink:from="loc_SubsequentEventsTextBlock.17048.11.7" xlink:to="lab_SubsequentEventsTextBlock.223409.250977.256000" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_SubsequentEventsTextBlock.223409.250977.256000" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US" id="lab_SubsequentEventsTextBlock.223409.250977.256000">SUBSEQUENT EVENTS</link:label>
    <link:loc xlink:label="loc_StockholdersEquityNoteAbstract.5143.11.6" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_StockholdersEquityNoteAbstract" xlink:type="locator" />
    <link:labelArc xlink:from="loc_StockholdersEquityNoteAbstract.5143.11.6" xlink:to="lab_StockholdersEquityNoteAbstract.1840931.254173.250833.255838" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_StockholdersEquityNoteAbstract.1840931.254173.250833.255838" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US" id="lab_StockholdersEquityNoteAbstract.1840931.254173.250833.255838">STOCKHOLDERS' EQUITY [Abstract]</link:label>
    <link:loc xlink:label="loc_StockholdersEquityNoteDisclosureTextBlock.17027.11.7" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:type="locator" />
    <link:labelArc xlink:from="loc_StockholdersEquityNoteDisclosureTextBlock.17027.11.7" xlink:to="lab_StockholdersEquityNoteDisclosureTextBlock.288111.253942.250834.255839" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_StockholdersEquityNoteDisclosureTextBlock.288111.253942.250834.255839" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US" id="lab_StockholdersEquityNoteDisclosureTextBlock.288111.253942.250834.255839">STOCKHOLDERS' EQUITY</link:label>
    <link:loc xlink:label="loc_StockholdersEquityNoteDisclosureTextBlock.17027.11.6" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:type="locator" />
    <link:labelArc xlink:from="loc_StockholdersEquityNoteDisclosureTextBlock.17027.11.6" xlink:to="lab_StockholdersEquityNoteDisclosureTextBlock.7816.253941.250835.255840" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_StockholdersEquityNoteDisclosureTextBlock.7816.253941.250835.255840" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US" id="lab_StockholdersEquityNoteDisclosureTextBlock.7816.253941.250835.255840">Stockholders' Equity Note Disclosure [Text Block]</link:label>
    <link:loc xlink:label="loc_GrantsReceivableCurrent.10654.11.7" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_GrantsReceivableCurrent" xlink:type="locator" />
    <link:labelArc xlink:from="loc_GrantsReceivableCurrent.10654.11.7" xlink:to="lab_GrantsReceivableCurrent.1915391.410168.223909.256041" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_GrantsReceivableCurrent.1915391.410168.223909.256041" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US" id="lab_GrantsReceivableCurrent.1915391.410168.223909.256041">Government of Israel - OCS receivable</link:label>
    <link:loc xlink:label="loc_GrantsReceivableCurrent.10654.11.6" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_GrantsReceivableCurrent" xlink:type="locator" />
    <link:labelArc xlink:from="loc_GrantsReceivableCurrent.10654.11.6" xlink:to="lab_GrantsReceivableCurrent.8331.256040" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_GrantsReceivableCurrent.8331.256040" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US" id="lab_GrantsReceivableCurrent.8331.256040">Grants Receivable, Current</link:label>
    <link:loc xlink:label="loc_SubsequentEventLineItems.5160.11.6" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_SubsequentEventLineItems" xlink:type="locator" />
    <link:labelArc xlink:from="loc_SubsequentEventLineItems.5160.11.6" xlink:to="lab_SubsequentEventLineItems.18792.256042" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_SubsequentEventLineItems.18792.256042" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US" id="lab_SubsequentEventLineItems.18792.256042">Subsequent Event [Line Items]</link:label>
    <link:loc xlink:label="loc_SubsequentEventMember.5161.11.6" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_SubsequentEventMember" xlink:type="locator" />
    <link:labelArc xlink:from="loc_SubsequentEventMember.5161.11.6" xlink:to="lab_SubsequentEventMember.18803.256043" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_SubsequentEventMember.18803.256043" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US" id="lab_SubsequentEventMember.18803.256043">Subsequent Event [Member]</link:label>
    <link:loc xlink:label="loc_SubsequentEventTable.5159.11.6" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_SubsequentEventTable" xlink:type="locator" />
    <link:labelArc xlink:from="loc_SubsequentEventTable.5159.11.6" xlink:to="lab_SubsequentEventTable.18790.256044" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_SubsequentEventTable.18790.256044" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US" id="lab_SubsequentEventTable.18790.256044">Subsequent Event [Table]</link:label>
    <link:loc xlink:label="loc_SubsequentEventTypeAxis.5163.11.6" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_SubsequentEventTypeAxis" xlink:type="locator" />
    <link:labelArc xlink:from="loc_SubsequentEventTypeAxis.5163.11.6" xlink:to="lab_SubsequentEventTypeAxis.18809.256045" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_SubsequentEventTypeAxis.18809.256045" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US" id="lab_SubsequentEventTypeAxis.18809.256045">Subsequent Event Type [Axis]</link:label>
    <link:loc xlink:label="loc_SubsequentEventTypeDomain.5162.11.6" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_SubsequentEventTypeDomain" xlink:type="locator" />
    <link:labelArc xlink:from="loc_SubsequentEventTypeDomain.5162.11.6" xlink:to="lab_SubsequentEventTypeDomain.18805.256046" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_SubsequentEventTypeDomain.18805.256046" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US" id="lab_SubsequentEventTypeDomain.18805.256046">Subsequent Event Type [Domain]</link:label>
    <link:loc xlink:label="loc_CommonStockAggregateOfferingPriceAuthorized.25533.11.7" xlink:href="psti-20140630.xsd#psti_CommonStockAggregateOfferingPriceAuthorized" xlink:type="locator" />
    <link:labelArc xlink:from="loc_CommonStockAggregateOfferingPriceAuthorized.25533.11.7" xlink:to="CommonStockAggregateOfferingPriceAuthorized.358855.255841" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="CommonStockAggregateOfferingPriceAuthorized.358855.255841" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US" id="CommonStockAggregateOfferingPriceAuthorized.358855.255841">Aggregate offering price authorized</link:label>
    <link:loc xlink:label="loc_CommonStockAggregateOfferingPriceAuthorized.25533.11.12" xlink:href="psti-20140630.xsd#psti_CommonStockAggregateOfferingPriceAuthorized" xlink:type="locator" />
    <link:labelArc xlink:from="loc_CommonStockAggregateOfferingPriceAuthorized.25533.11.12" xlink:to="CommonStockAggregateOfferingPriceAuthorized.358856.255842" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="CommonStockAggregateOfferingPriceAuthorized.358856.255842" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US" id="CommonStockAggregateOfferingPriceAuthorized.358856.255842">The maximum aggregate offering price of common shares permitted to be issued.</link:label>
    <link:loc xlink:label="loc_AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts.5793.11.7" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts" xlink:type="locator" />
    <link:labelArc xlink:from="loc_AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts.5793.11.7" xlink:to="lab_AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts.1892954.358853.255757" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts.1892954.358853.255757" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US" id="lab_AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts.1892954.358853.255757">Issuance of common stock and warrants, issuance costs</link:label>
    <link:loc xlink:label="loc_AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts.5793.11.6" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts" xlink:type="locator" />
    <link:labelArc xlink:from="loc_AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts.5793.11.6" xlink:to="lab_AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts.741.255756" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts.741.255756" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US" id="lab_AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts.741.255756">Adjustments to Additional Paid in Capital, Stock Issued, Issuance Costs</link:label>
    <link:loc xlink:label="loc_BiopharmaxMember.25817.11.6" xlink:href="psti-20140630.xsd#psti_BiopharmaxMember" xlink:type="locator" />
    <link:labelArc xlink:from="loc_BiopharmaxMember.25817.11.6" xlink:to="lab_BiopharmaxMember.257508" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_BiopharmaxMember.257508" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US" id="lab_BiopharmaxMember.257508">Biopharmax [Member]</link:label>
    <link:loc xlink:label="loc_BiopharmaxMember.25817.11.12" xlink:href="psti-20140630.xsd#psti_BiopharmaxMember" xlink:type="locator" />
    <link:labelArc xlink:from="loc_BiopharmaxMember.25817.11.12" xlink:to="lab_BiopharmaxMember12.257509" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_BiopharmaxMember12.257509" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US" id="lab_BiopharmaxMember12.257509">Biopharmax [Member]</link:label>
    <link:loc xlink:label="loc_ClassOfStockLineItems.1047.11.6" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ClassOfStockLineItems" xlink:type="locator" />
    <link:labelArc xlink:from="loc_ClassOfStockLineItems.1047.11.6" xlink:to="lab_ClassOfStockLineItems.2659" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_ClassOfStockLineItems.2659" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US" id="lab_ClassOfStockLineItems.2659">Class of Stock [Line Items]</link:label>
    <link:loc xlink:label="loc_ClassOfWarrantOrRightAxis.1048.11.6" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ClassOfWarrantOrRightAxis" xlink:type="locator" />
    <link:labelArc xlink:from="loc_ClassOfWarrantOrRightAxis.1048.11.6" xlink:to="lab_ClassOfWarrantOrRightAxis.2660" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_ClassOfWarrantOrRightAxis.2660" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US" id="lab_ClassOfWarrantOrRightAxis.2660">Class of Warrant or Right [Axis]</link:label>
    <link:loc xlink:label="loc_ClassOfWarrantOrRightDomain.1049.11.6" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ClassOfWarrantOrRightDomain" xlink:type="locator" />
    <link:labelArc xlink:from="loc_ClassOfWarrantOrRightDomain.1049.11.6" xlink:to="lab_ClassOfWarrantOrRightDomain.2662" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_ClassOfWarrantOrRightDomain.2662" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US" id="lab_ClassOfWarrantOrRightDomain.2662">Class of Warrant or Right [Domain]</link:label>
    <link:loc xlink:label="loc_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1.6952.11.6" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" xlink:type="locator" />
    <link:labelArc xlink:from="loc_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1.6952.11.6" xlink:to="lab_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1.2666" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1.2666" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US" id="lab_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1.2666">Class of Warrant or Right, Exercise Price of Warrants or Rights</link:label>
    <link:loc xlink:label="loc_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1.6952.11.7" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" xlink:type="locator" />
    <link:labelArc xlink:from="loc_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1.6952.11.7" xlink:to="lab_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1.257492" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1.257492" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US" id="lab_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1.257492">Warrant exercise price</link:label>
    <link:loc xlink:label="loc_ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight.6954.11.6" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight" xlink:type="locator" />
    <link:labelArc xlink:from="loc_ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight.6954.11.6" xlink:to="lab_ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight.2668" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight.2668" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US" id="lab_ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight.2668">Class of Warrant or Right, Number of Securities Called by Each Warrant or Right</link:label>
    <link:loc xlink:label="loc_ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight.6954.11.7" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight" xlink:type="locator" />
    <link:labelArc xlink:from="loc_ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight.6954.11.7" xlink:to="lab_ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight.189201.257491" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight.189201.257491" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US" id="lab_ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight.189201.257491">Shares covered by each warrant</link:label>
    <link:loc xlink:label="loc_ClassOfWarrantOrRightOutstanding.6947.11.6" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ClassOfWarrantOrRightOutstanding" xlink:type="locator" />
    <link:labelArc xlink:from="loc_ClassOfWarrantOrRightOutstanding.6947.11.6" xlink:to="lab_ClassOfWarrantOrRightOutstanding.2655" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_ClassOfWarrantOrRightOutstanding.2655" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US" id="lab_ClassOfWarrantOrRightOutstanding.2655">Class of Warrant or Right, Outstanding</link:label>
    <link:loc xlink:label="loc_ClassOfWarrantOrRightOutstanding.6947.11.7" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ClassOfWarrantOrRightOutstanding" xlink:type="locator" />
    <link:labelArc xlink:from="loc_ClassOfWarrantOrRightOutstanding.6947.11.7" xlink:to="lab_ClassOfWarrantOrRightOutstanding.1900525.190222.257128" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_ClassOfWarrantOrRightOutstanding.1900525.190222.257128" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US" id="lab_ClassOfWarrantOrRightOutstanding.1900525.190222.257128">Warrants for common stock</link:label>
    <link:loc xlink:label="loc_CommonStockAggregateOfferingPriceAuthorized.25533.11.6" xlink:href="psti-20140630.xsd#psti_CommonStockAggregateOfferingPriceAuthorized" xlink:type="locator" />
    <link:labelArc xlink:from="loc_CommonStockAggregateOfferingPriceAuthorized.25533.11.6" xlink:to="lab_CommonStockAggregateOfferingPriceAuthorized.358854.255844" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_CommonStockAggregateOfferingPriceAuthorized.358854.255844" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US" id="lab_CommonStockAggregateOfferingPriceAuthorized.358854.255844">Common Stock Aggregate Offering Price Authorized</link:label>
    <link:loc xlink:label="loc_ConsultantWarrantsMember.25816.11.6" xlink:href="psti-20140630.xsd#psti_ConsultantWarrantsMember" xlink:type="locator" />
    <link:labelArc xlink:from="loc_ConsultantWarrantsMember.25816.11.6" xlink:to="lab_ConsultantWarrantsMember.257506" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_ConsultantWarrantsMember.257506" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US" id="lab_ConsultantWarrantsMember.257506">Consultant Warrants [Member]</link:label>
    <link:loc xlink:label="loc_ConsultantWarrantsMember.25816.11.12" xlink:href="psti-20140630.xsd#psti_ConsultantWarrantsMember" xlink:type="locator" />
    <link:labelArc xlink:from="loc_ConsultantWarrantsMember.25816.11.12" xlink:to="lab_ConsultantWarrantsMember12.257507" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_ConsultantWarrantsMember12.257507" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US" id="lab_ConsultantWarrantsMember12.257507">Consultant Warrants [Member]</link:label>
    <link:loc xlink:label="loc_ConversionOfStockSharesConverted1.7256.11.7" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ConversionOfStockSharesConverted1" xlink:type="locator" />
    <link:labelArc xlink:from="loc_ConversionOfStockSharesConverted1.7256.11.7" xlink:to="lab_ConversionOfStockSharesConverted1.275901.360257.255846" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_ConversionOfStockSharesConverted1.275901.360257.255846" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US" id="lab_ConversionOfStockSharesConverted1.275901.360257.255846">Warrants exercised via cashless exercise</link:label>
    <link:loc xlink:label="loc_ConversionOfStockSharesConverted1.7256.11.6" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ConversionOfStockSharesConverted1" xlink:type="locator" />
    <link:labelArc xlink:from="loc_ConversionOfStockSharesConverted1.7256.11.6" xlink:to="lab_ConversionOfStockSharesConverted1.3201.255845" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_ConversionOfStockSharesConverted1.3201.255845" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US" id="lab_ConversionOfStockSharesConverted1.3201.255845">Conversion of Stock, Shares Converted</link:label>
    <link:loc xlink:label="loc_ConversionOfStockSharesIssued1.7251.11.7" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ConversionOfStockSharesIssued1" xlink:type="locator" />
    <link:labelArc xlink:from="loc_ConversionOfStockSharesIssued1.7251.11.7" xlink:to="lab_ConversionOfStockSharesIssued1.1870139.310643.360258.255848" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_ConversionOfStockSharesIssued1.1870139.310643.360258.255848" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US" id="lab_ConversionOfStockSharesIssued1.1870139.310643.360258.255848">Warrants exercised via cashless exercise, shares issued</link:label>
    <link:loc xlink:label="loc_ConversionOfStockSharesIssued1.7251.11.6" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ConversionOfStockSharesIssued1" xlink:type="locator" />
    <link:labelArc xlink:from="loc_ConversionOfStockSharesIssued1.7251.11.6" xlink:to="lab_ConversionOfStockSharesIssued1.3187.255847" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_ConversionOfStockSharesIssued1.3187.255847" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US" id="lab_ConversionOfStockSharesIssued1.3187.255847">Conversion of Stock, Shares Issued</link:label>
    <link:loc xlink:label="loc_EmployeeStockOptionMember.1835.11.7" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_EmployeeStockOptionMember" xlink:type="locator" />
    <link:labelArc xlink:from="loc_EmployeeStockOptionMember.1835.11.7" xlink:to="lab_EmployeeStockOptionMember.327665.255850" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_EmployeeStockOptionMember.327665.255850" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US" id="lab_EmployeeStockOptionMember.327665.255850">Options [Member]</link:label>
    <link:loc xlink:label="loc_EmployeeStockOptionMember.1835.11.6" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_EmployeeStockOptionMember" xlink:type="locator" />
    <link:labelArc xlink:from="loc_EmployeeStockOptionMember.1835.11.6" xlink:to="lab_EmployeeStockOptionMember.5884.255849" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_EmployeeStockOptionMember.5884.255849" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US" id="lab_EmployeeStockOptionMember.5884.255849">Employee Stock Option [Member]</link:label>
    <link:loc xlink:label="loc_InvestorWarrantsMember.25814.11.12" xlink:href="psti-20140630.xsd#psti_InvestorWarrantsMember" xlink:type="locator" />
    <link:labelArc xlink:from="loc_InvestorWarrantsMember.25814.11.12" xlink:to="lab_InvestorMember12.257499" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_InvestorMember12.257499" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US" id="lab_InvestorMember12.257499">Investor [Member]</link:label>
    <link:loc xlink:label="loc_InvestorWarrantsMember.25814.11.6" xlink:href="psti-20140630.xsd#psti_InvestorWarrantsMember" xlink:type="locator" />
    <link:labelArc xlink:from="loc_InvestorWarrantsMember.25814.11.6" xlink:to="lab_InvestorWarrantsMember.257496" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_InvestorWarrantsMember.257496" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US" id="lab_InvestorWarrantsMember.257496">Investor Warrants [Member]</link:label>
    <link:loc xlink:label="loc_PreferredStockParOrStatedValuePerShare.14499.11.6" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_PreferredStockParOrStatedValuePerShare" xlink:type="locator" />
    <link:labelArc xlink:from="loc_PreferredStockParOrStatedValuePerShare.14499.11.6" xlink:to="lab_PreferredStockParOrStatedValuePerShare.14492" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_PreferredStockParOrStatedValuePerShare.14492" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US" id="lab_PreferredStockParOrStatedValuePerShare.14492">Preferred Stock, Par or Stated Value Per Share</link:label>
    <link:loc xlink:label="loc_PreferredStockParOrStatedValuePerShare.14499.11.7" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_PreferredStockParOrStatedValuePerShare" xlink:type="locator" />
    <link:labelArc xlink:from="loc_PreferredStockParOrStatedValuePerShare.14499.11.7" xlink:to="lab_PreferredStockParOrStatedValuePerShare.1891798.414538.482966.357317.257485" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_PreferredStockParOrStatedValuePerShare.1891798.414538.482966.357317.257485" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US" id="lab_PreferredStockParOrStatedValuePerShare.1891798.414538.482966.357317.257485">Preferred stock,, par value per share</link:label>
    <link:loc xlink:label="loc_PreferredStockSharesAuthorized.14532.11.6" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_PreferredStockSharesAuthorized" xlink:type="locator" />
    <link:labelArc xlink:from="loc_PreferredStockSharesAuthorized.14532.11.6" xlink:to="lab_PreferredStockSharesAuthorized.14543" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_PreferredStockSharesAuthorized.14543" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US" id="lab_PreferredStockSharesAuthorized.14543">Preferred Stock, Shares Authorized</link:label>
    <link:loc xlink:label="loc_PreferredStockSharesAuthorized.14532.11.7" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_PreferredStockSharesAuthorized" xlink:type="locator" />
    <link:labelArc xlink:from="loc_PreferredStockSharesAuthorized.14532.11.7" xlink:to="lab_PreferredStockSharesAuthorized.223298.182722.257484" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_PreferredStockSharesAuthorized.223298.182722.257484" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US" id="lab_PreferredStockSharesAuthorized.223298.182722.257484">Preferred stock, shares authorized</link:label>
    <link:loc xlink:label="loc_ProceedsFromIssuanceOfCommonStock.14855.11.8" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ProceedsFromIssuanceOfCommonStock" xlink:type="locator" />
    <link:labelArc xlink:from="loc_ProceedsFromIssuanceOfCommonStock.14855.11.8" xlink:to="lab_ProceedsFromIssuanceOfCommonStock8.1889789.248765.544335.188020.259800" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_ProceedsFromIssuanceOfCommonStock8.1889789.248765.544335.188020.259800" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US" id="lab_ProceedsFromIssuanceOfCommonStock8.1889789.248765.544335.188020.259800">Proceeds from issuance of stock</link:label>
    <link:loc xlink:label="loc_ProceedsFromWarrantExercises.14695.11.6" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ProceedsFromWarrantExercises" xlink:type="locator" />
    <link:labelArc xlink:from="loc_ProceedsFromWarrantExercises.14695.11.6" xlink:to="lab_ProceedsFromWarrantExercises.14819" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_ProceedsFromWarrantExercises.14819" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US" id="lab_ProceedsFromWarrantExercises.14819">Proceeds from Warrant Exercises</link:label>
    <link:loc xlink:label="loc_ProceedsFromWarrantExercises.14695.11.7" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ProceedsFromWarrantExercises" xlink:type="locator" />
    <link:labelArc xlink:from="loc_ProceedsFromWarrantExercises.14695.11.7" xlink:to="lab_ProceedsFromWarrantExercises.1845323.516782.184441.257486" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_ProceedsFromWarrantExercises.1845323.516782.184441.257486" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US" id="lab_ProceedsFromWarrantExercises.1845323.516782.184441.257486">Aggregate cash consideration received</link:label>
    <link:loc xlink:label="loc_ScheduleOfStockByClassTable.4849.11.6" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ScheduleOfStockByClassTable" xlink:type="locator" />
    <link:labelArc xlink:from="loc_ScheduleOfStockByClassTable.4849.11.6" xlink:to="lab_ScheduleOfStockByClassTable.17402" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_ScheduleOfStockByClassTable.17402" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US" id="lab_ScheduleOfStockByClassTable.17402">Schedule of Stock by Class [Table]</link:label>
    <link:loc xlink:label="loc_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized.16705.11.6" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" xlink:type="locator" />
    <link:labelArc xlink:from="loc_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized.16705.11.6" xlink:to="lab_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized.17996" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized.17996" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US" id="lab_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized.17996">Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Authorized</link:label>
    <link:loc xlink:label="loc_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant.16701.11.6" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" xlink:type="locator" />
    <link:labelArc xlink:from="loc_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant.16701.11.6" xlink:to="lab_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant.17992" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant.17992" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US" id="lab_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant.17992">Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Available for Grant</link:label>
    <link:loc xlink:label="loc_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant.16701.11.7" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" xlink:type="locator" />
    <link:labelArc xlink:from="loc_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant.16701.11.7" xlink:to="lab_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant7.1915652.410357.223653.257495" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant7.1915652.410357.223653.257495" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US" id="lab_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant7.1915652.410357.223653.257495">Options available for future grant</link:label>
    <link:loc xlink:label="loc_SharebasedCompensationArrangementWarrantsExercised.25813.11.6" xlink:href="psti-20140630.xsd#psti_SharebasedCompensationArrangementWarrantsExercised" xlink:type="locator" />
    <link:labelArc xlink:from="loc_SharebasedCompensationArrangementWarrantsExercised.25813.11.6" xlink:to="lab_SharebasedCompensationArrangementWarrantsExercised.257487" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_SharebasedCompensationArrangementWarrantsExercised.257487" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US" id="lab_SharebasedCompensationArrangementWarrantsExercised.257487">Sharebased Compensation Arrangement, Warrants Exercised.</link:label>
    <link:loc xlink:label="loc_SharebasedCompensationArrangementWarrantsExercised.25813.11.12" xlink:href="psti-20140630.xsd#psti_SharebasedCompensationArrangementWarrantsExercised" xlink:type="locator" />
    <link:labelArc xlink:from="loc_SharebasedCompensationArrangementWarrantsExercised.25813.11.12" xlink:to="lab_SharebasedCompensationArrangementWarrantsExercised12.257489" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_SharebasedCompensationArrangementWarrantsExercised12.257489" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US" id="lab_SharebasedCompensationArrangementWarrantsExercised12.257489">Number of warrants exercised during the period.</link:label>
    <link:loc xlink:label="loc_SharebasedCompensationArrangementWarrantsExercised.25813.11.7" xlink:href="psti-20140630.xsd#psti_SharebasedCompensationArrangementWarrantsExercised" xlink:type="locator" />
    <link:labelArc xlink:from="loc_SharebasedCompensationArrangementWarrantsExercised.25813.11.7" xlink:to="lab_SharebasedCompensationArrangementWarrantsExercised7.257488" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_SharebasedCompensationArrangementWarrantsExercised7.257488" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US" id="lab_SharebasedCompensationArrangementWarrantsExercised7.257488">Number of warrants exercised</link:label>
    <link:loc xlink:label="loc_ShareBasedGoodsAndNonemployeeServicesTransactionBySupplierAxis.5039.11.6" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ShareBasedGoodsAndNonemployeeServicesTransactionBySupplierAxis" xlink:type="locator" />
    <link:labelArc xlink:from="loc_ShareBasedGoodsAndNonemployeeServicesTransactionBySupplierAxis.5039.11.6" xlink:to="lab_ShareBasedGoodsAndNonemployeeServicesTransactionBySupplierAxis.7685.254155.250906.256037" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_ShareBasedGoodsAndNonemployeeServicesTransactionBySupplierAxis.7685.254155.250906.256037" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US" id="lab_ShareBasedGoodsAndNonemployeeServicesTransactionBySupplierAxis.7685.254155.250906.256037">Share-based Goods and Nonemployee Services Transaction, by Supplier [Axis]</link:label>
    <link:loc xlink:label="loc_ShareBasedGoodsAndNonemployeeServicesTransactionSupplierDomain.5036.11.6" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ShareBasedGoodsAndNonemployeeServicesTransactionSupplierDomain" xlink:type="locator" />
    <link:labelArc xlink:from="loc_ShareBasedGoodsAndNonemployeeServicesTransactionSupplierDomain.5036.11.6" xlink:to="lab_ShareBasedGoodsAndNonemployeeServicesTransactionSupplierDomain.14535.254156.250910.256038" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_ShareBasedGoodsAndNonemployeeServicesTransactionSupplierDomain.14535.254156.250910.256038" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US" id="lab_ShareBasedGoodsAndNonemployeeServicesTransactionSupplierDomain.14535.254156.250910.256038">Share-based Goods and Nonemployee Services Transaction, Supplier [Domain]</link:label>
    <link:loc xlink:label="loc_SharebasedGoodsAndNonemployeesServicesTransactionWarrantsAndOptionsExercised.25548.11.6" xlink:href="psti-20140630.xsd#psti_SharebasedGoodsAndNonemployeesServicesTransactionWarrantsAndOptionsExercised" xlink:type="locator" />
    <link:labelArc xlink:from="loc_SharebasedGoodsAndNonemployeesServicesTransactionWarrantsAndOptionsExercised.25548.11.6" xlink:to="lab_SharebasedGoodsAndNonemployeesServicesTransactionWarrantsAndOptionsExercised.1921983.254157.250623.255855" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_SharebasedGoodsAndNonemployeesServicesTransactionWarrantsAndOptionsExercised.1921983.254157.250623.255855" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US" id="lab_SharebasedGoodsAndNonemployeesServicesTransactionWarrantsAndOptionsExercised.1921983.254157.250623.255855">Sharebased Goods And Nonemployees Services Transaction Warrants And Options Exercised</link:label>
    <link:loc xlink:label="loc_SharebasedGoodsAndNonemployeesServicesTransactionWarrantsAndOptionsExercised.25548.11.12" xlink:href="psti-20140630.xsd#psti_SharebasedGoodsAndNonemployeesServicesTransactionWarrantsAndOptionsExercised" xlink:type="locator" />
    <link:labelArc xlink:from="loc_SharebasedGoodsAndNonemployeesServicesTransactionWarrantsAndOptionsExercised.25548.11.12" xlink:to="lab_SharebasedGoodsAndNonemployeesServicesTransactionWarrantsAndOptionsExercised.1921984.254159.250624.255856" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_SharebasedGoodsAndNonemployeesServicesTransactionWarrantsAndOptionsExercised.1921984.254159.250624.255856" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US" id="lab_SharebasedGoodsAndNonemployeesServicesTransactionWarrantsAndOptionsExercised.1921984.254159.250624.255856">Sharebased goods and nonemployees services transaction warrants and options exercised.</link:label>
    <link:loc xlink:label="loc_SharebasedGoodsAndNonemployeesServicesTransactionWarrantsAndOptionsExercised.25548.11.7" xlink:href="psti-20140630.xsd#psti_SharebasedGoodsAndNonemployeesServicesTransactionWarrantsAndOptionsExercised" xlink:type="locator" />
    <link:labelArc xlink:from="loc_SharebasedGoodsAndNonemployeesServicesTransactionWarrantsAndOptionsExercised.25548.11.7" xlink:to="lab_SharebasedGoodsAndNonemployeesServicesTransactionWarrantsAndOptionsExercised.363404.255854" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_SharebasedGoodsAndNonemployeesServicesTransactionWarrantsAndOptionsExercised.363404.255854" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US" id="lab_SharebasedGoodsAndNonemployeesServicesTransactionWarrantsAndOptionsExercised.363404.255854">Options and warrants exercised</link:label>
    <link:loc xlink:label="loc_SharesIssuedPricePerShare.16778.11.6" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_SharesIssuedPricePerShare" xlink:type="locator" />
    <link:labelArc xlink:from="loc_SharesIssuedPricePerShare.16778.11.6" xlink:to="lab_SharesIssuedPricePerShare.18098" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_SharesIssuedPricePerShare.18098" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US" id="lab_SharesIssuedPricePerShare.18098">Shares Issued, Price Per Share</link:label>
    <link:loc xlink:label="loc_SharesIssuedPricePerShare.16778.11.7" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_SharesIssuedPricePerShare" xlink:type="locator" />
    <link:labelArc xlink:from="loc_SharesIssuedPricePerShare.16778.11.7" xlink:to="lab_SharesIssuedPricePerShare.355411.257490" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_SharesIssuedPricePerShare.355411.257490" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US" id="lab_SharesIssuedPricePerShare.355411.257490">Offering price per unit</link:label>
    <link:loc xlink:label="loc_StockIssuedDuringPeriodSharesIssuedForServices.16939.11.6" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesIssuedForServices" xlink:type="locator" />
    <link:labelArc xlink:from="loc_StockIssuedDuringPeriodSharesIssuedForServices.16939.11.6" xlink:to="lab_StockIssuedDuringPeriodSharesIssuedForServices.18360" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_StockIssuedDuringPeriodSharesIssuedForServices.18360" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US" id="lab_StockIssuedDuringPeriodSharesIssuedForServices.18360">Stock Issued During Period, Shares, Issued for Services</link:label>
    <link:loc xlink:label="loc_StockIssuedDuringPeriodSharesIssuedForServices.16939.11.7" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesIssuedForServices" xlink:type="locator" />
    <link:labelArc xlink:from="loc_StockIssuedDuringPeriodSharesIssuedForServices.16939.11.7" xlink:to="lab_StockIssuedDuringPeriodSharesIssuedForServices.537649.357836.256312" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_StockIssuedDuringPeriodSharesIssuedForServices.537649.357836.256312" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US" id="lab_StockIssuedDuringPeriodSharesIssuedForServices.537649.357836.256312">Stock based compensation to contractor, shares</link:label>
    <link:loc xlink:label="loc_StockIssuedDuringPeriodSharesNewIssues.16990.11.6" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:type="locator" />
    <link:labelArc xlink:from="loc_StockIssuedDuringPeriodSharesNewIssues.16990.11.6" xlink:to="lab_StockIssuedDuringPeriodSharesNewIssues.11686.254327.250918.255732" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_StockIssuedDuringPeriodSharesNewIssues.11686.254327.250918.255732" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US" id="lab_StockIssuedDuringPeriodSharesNewIssues.11686.254327.250918.255732">Stock Issued During Period, Shares, New Issues</link:label>
    <link:loc xlink:label="loc_StockIssuedDuringPeriodSharesNewIssues.16990.11.7" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:type="locator" />
    <link:labelArc xlink:from="loc_StockIssuedDuringPeriodSharesNewIssues.16990.11.7" xlink:to="lab_StockIssuedDuringPeriodSharesNewIssues.1891838.414400.483155.358684.255733" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_StockIssuedDuringPeriodSharesNewIssues.1891838.414400.483155.358684.255733" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US" id="lab_StockIssuedDuringPeriodSharesNewIssues.1891838.414400.483155.358684.255733">Issuance of common stock and warrants, net of issuance costs, shares</link:label>
    <link:loc xlink:label="loc_StockIssuedDuringPeriodSharesOther.16964.11.6" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesOther" xlink:type="locator" />
    <link:labelArc xlink:from="loc_StockIssuedDuringPeriodSharesOther.16964.11.6" xlink:to="lab_StockIssuedDuringPeriodSharesOther.18652.255858" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_StockIssuedDuringPeriodSharesOther.18652.255858" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US" id="lab_StockIssuedDuringPeriodSharesOther.18652.255858">Stock Issued During Period, Shares, Other</link:label>
    <link:loc xlink:label="loc_StockIssuedDuringPeriodSharesOther.16964.11.7" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesOther" xlink:type="locator" />
    <link:labelArc xlink:from="loc_StockIssuedDuringPeriodSharesOther.16964.11.7" xlink:to="lab_StockIssuedDuringPeriodSharesOther.537695.360259.255859" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_StockIssuedDuringPeriodSharesOther.537695.360259.255859" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US" id="lab_StockIssuedDuringPeriodSharesOther.537695.360259.255859">Warrants exercised for cash</link:label>
    <link:loc xlink:label="loc_StockIssuedDuringPeriodSharesStockOptionsAndWarrantsExercised.25555.11.6" xlink:href="psti-20140630.xsd#psti_StockIssuedDuringPeriodSharesStockOptionsAndWarrantsExercised" xlink:type="locator" />
    <link:labelArc xlink:from="loc_StockIssuedDuringPeriodSharesStockOptionsAndWarrantsExercised.25555.11.6" xlink:to="lab_StockIssuedDuringPeriodSharesStockOptionsAndWarrantsExercised.360239.255738" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_StockIssuedDuringPeriodSharesStockOptionsAndWarrantsExercised.360239.255738" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US" id="lab_StockIssuedDuringPeriodSharesStockOptionsAndWarrantsExercised.360239.255738">Stock Issued During Period Shares Stock Options And Warrants Exercised</link:label>
    <link:loc xlink:label="loc_StockIssuedDuringPeriodSharesStockOptionsExercised.16983.11.6" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:type="locator" />
    <link:labelArc xlink:from="loc_StockIssuedDuringPeriodSharesStockOptionsExercised.16983.11.6" xlink:to="lab_StockIssuedDuringPeriodSharesStockOptionsExercised.11705.254133.250829.255860" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_StockIssuedDuringPeriodSharesStockOptionsExercised.11705.254133.250829.255860" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US" id="lab_StockIssuedDuringPeriodSharesStockOptionsExercised.11705.254133.250829.255860">Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period</link:label>
    <link:loc xlink:label="loc_StockIssuedDuringPeriodSharesStockOptionsExercised.16983.11.7" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:type="locator" />
    <link:labelArc xlink:from="loc_StockIssuedDuringPeriodSharesStockOptionsExercised.16983.11.7" xlink:to="lab_StockIssuedDuringPeriodSharesStockOptionsExercised.333733.254134.250830.255861" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_StockIssuedDuringPeriodSharesStockOptionsExercised.333733.254134.250830.255861" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US" id="lab_StockIssuedDuringPeriodSharesStockOptionsExercised.333733.254134.250830.255861">Options exercised</link:label>
    <link:loc xlink:label="loc_StockIssuedDuringPeriodValueNewIssues.17003.11.6" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueNewIssues" xlink:type="locator" />
    <link:labelArc xlink:from="loc_StockIssuedDuringPeriodValueNewIssues.17003.11.6" xlink:to="lab_StockIssuedDuringPeriodValueNewIssues.11668.254329.250920.255740" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_StockIssuedDuringPeriodValueNewIssues.11668.254329.250920.255740" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US" id="lab_StockIssuedDuringPeriodValueNewIssues.11668.254329.250920.255740">Stock Issued During Period, Value, New Issues</link:label>
    <link:loc xlink:label="loc_StockIssuedDuringPeriodValueNewIssues.17003.11.7" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueNewIssues" xlink:type="locator" />
    <link:labelArc xlink:from="loc_StockIssuedDuringPeriodValueNewIssues.17003.11.7" xlink:to="lab_StockIssuedDuringPeriodValueNewIssues.1891839.414405.483167.358683.255741" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_StockIssuedDuringPeriodValueNewIssues.1891839.414405.483167.358683.255741" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US" id="lab_StockIssuedDuringPeriodValueNewIssues.1891839.414405.483167.358683.255741">Issuance of common stock and warrants, net of issuance costs</link:label>
    <link:loc xlink:label="loc_StockIssuedDuringPeriodValuePurchaseOfAssets.17002.11.7" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_StockIssuedDuringPeriodValuePurchaseOfAssets" xlink:type="locator" />
    <link:labelArc xlink:from="loc_StockIssuedDuringPeriodValuePurchaseOfAssets.17002.11.7" xlink:to="lab_StockIssuedDuringPeriodValuePurchaseOfAssets.1891842.414258.483175.358685.255743" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_StockIssuedDuringPeriodValuePurchaseOfAssets.1891842.414258.483175.358685.255743" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US" id="lab_StockIssuedDuringPeriodValuePurchaseOfAssets.1891842.414258.483175.358685.255743">Issuance of common stock under CHA Agreement (Note 1d)</link:label>
    <link:loc xlink:label="loc_UnderwritersOptionMember.25815.11.6" xlink:href="psti-20140630.xsd#psti_UnderwritersOptionMember" xlink:type="locator" />
    <link:labelArc xlink:from="loc_UnderwritersOptionMember.25815.11.6" xlink:to="lab_UnderwritersOptionMember.257497" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_UnderwritersOptionMember.257497" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US" id="lab_UnderwritersOptionMember.257497">Underwriters Option [Member]</link:label>
    <link:loc xlink:label="loc_UnderwritersOptionMember.25815.11.12" xlink:href="psti-20140630.xsd#psti_UnderwritersOptionMember" xlink:type="locator" />
    <link:labelArc xlink:from="loc_UnderwritersOptionMember.25815.11.12" xlink:to="lab_UnderwritersOptionMember12.257498" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_UnderwritersOptionMember12.257498" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US" id="lab_UnderwritersOptionMember12.257498">Underwriters Option [Member]</link:label>
    <link:loc xlink:label="loc_UnderwriterWarrantsMember.25744.11.6" xlink:href="psti-20140630.xsd#psti_UnderwriterWarrantsMember" xlink:type="locator" />
    <link:labelArc xlink:from="loc_UnderwriterWarrantsMember.25744.11.6" xlink:to="lab_UnderwriterWarrantsMember.257077" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_UnderwriterWarrantsMember.257077" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US" id="lab_UnderwriterWarrantsMember.257077">Underwriter Warrants [Member]</link:label>
    <link:loc xlink:label="loc_WarrantAwardsMember.25559.11.6" xlink:href="psti-20140630.xsd#psti_WarrantAwardsMember" xlink:type="locator" />
    <link:labelArc xlink:from="loc_WarrantAwardsMember.25559.11.6" xlink:to="lab_WarrantAwardsMember.363405.255862" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_WarrantAwardsMember.363405.255862" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US" id="lab_WarrantAwardsMember.363405.255862">Warrant Awards [Member]</link:label>
    <link:loc xlink:label="loc_StockIssuedDuringPeriodSharesStockOptionsAndWarrantsExercised.25555.11.12" xlink:href="psti-20140630.xsd#psti_StockIssuedDuringPeriodSharesStockOptionsAndWarrantsExercised" xlink:type="locator" />
    <link:labelArc xlink:from="loc_StockIssuedDuringPeriodSharesStockOptionsAndWarrantsExercised.25555.11.12" xlink:to="StockIssuedDuringPeriodSharesStockOptionsAndWarrantsExercised.360240.255749" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="StockIssuedDuringPeriodSharesStockOptionsAndWarrantsExercised.360240.255749" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US" id="StockIssuedDuringPeriodSharesStockOptionsAndWarrantsExercised.360240.255749">Number of share options and warrants exercised during the current period.</link:label>
    <link:loc xlink:label="loc_StockIssuedDuringPeriodSharesStockOptionsAndWarrantsExercised.25555.11.8" xlink:href="psti-20140630.xsd#psti_StockIssuedDuringPeriodSharesStockOptionsAndWarrantsExercised" xlink:type="locator" />
    <link:labelArc xlink:from="loc_StockIssuedDuringPeriodSharesStockOptionsAndWarrantsExercised.25555.11.8" xlink:to="StockIssuedDuringPeriodSharesStockOptionsAndWarrantsExercised.363408.255863" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="StockIssuedDuringPeriodSharesStockOptionsAndWarrantsExercised.363408.255863" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US" id="StockIssuedDuringPeriodSharesStockOptionsAndWarrantsExercised.363408.255863">Shares issued for stock-based awards</link:label>
    <link:loc xlink:label="loc_UnderwriterWarrantsMember.25744.11.12" xlink:href="psti-20140630.xsd#psti_UnderwriterWarrantsMember" xlink:type="locator" />
    <link:labelArc xlink:from="loc_UnderwriterWarrantsMember.25744.11.12" xlink:to="UnderwriterWarrantsMember.257119" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="UnderwriterWarrantsMember.257119" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US" id="UnderwriterWarrantsMember.257119">Underwriter Warrants [Member]</link:label>
    <link:loc xlink:label="loc_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized.16705.11.7" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" xlink:type="locator" />
    <link:labelArc xlink:from="loc_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized.16705.11.7" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized_lbl.270952.257494" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized_lbl.270952.257494" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US" id="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized_lbl.270952.257494">Options authorized</link:label>
    <link:loc xlink:label="loc_WarrantAwardsMember.25559.11.12" xlink:href="psti-20140630.xsd#psti_WarrantAwardsMember" xlink:type="locator" />
    <link:labelArc xlink:from="loc_WarrantAwardsMember.25559.11.12" xlink:to="WarrantAwardsMember.363406.255865" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="WarrantAwardsMember.363406.255865" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US" id="WarrantAwardsMember.363406.255865">Award that gives the holder the right to purchase shares of stock in accordance with the terms of the instrument, usually upon payment of a specified amount.</link:label>
    <link:loc xlink:label="loc_WarrantAwardsMember.25559.11.7" xlink:href="psti-20140630.xsd#psti_WarrantAwardsMember" xlink:type="locator" />
    <link:labelArc xlink:from="loc_WarrantAwardsMember.25559.11.7" xlink:to="WarrantAwardsMember.363407.255864" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="WarrantAwardsMember.363407.255864" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US" id="WarrantAwardsMember.363407.255864">Warrants [Member]</link:label>
    <link:loc xlink:label="loc_ConsultantsMember.25535.11.12" xlink:href="psti-20140630.xsd#psti_ConsultantsMember" xlink:type="locator" />
    <link:labelArc xlink:from="loc_ConsultantsMember.25535.11.12" xlink:to="ConsultantsMember.358852.256017" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="ConsultantsMember.358852.256017" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US" id="ConsultantsMember.358852.256017">Non-employee consultants providing a serivce to the company.</link:label>
    <link:loc xlink:label="loc_EquityOptionsAndWarrantsMember.25537.11.12" xlink:href="psti-20140630.xsd#psti_EquityOptionsAndWarrantsMember" xlink:type="locator" />
    <link:labelArc xlink:from="loc_EquityOptionsAndWarrantsMember.25537.11.12" xlink:to="EquityOptionsAndWarrantsMember.250619.256019" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="EquityOptionsAndWarrantsMember.250619.256019" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US" id="EquityOptionsAndWarrantsMember.250619.256019">Options and warrants issued as equity award compensation.</link:label>
    <link:loc xlink:label="loc_EquityOptionsAndWarrantsMember.25537.11.7" xlink:href="psti-20140630.xsd#psti_EquityOptionsAndWarrantsMember" xlink:type="locator" />
    <link:labelArc xlink:from="loc_EquityOptionsAndWarrantsMember.25537.11.7" xlink:to="EquityOptionsAndWarrantsMember.327670.256018" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="EquityOptionsAndWarrantsMember.327670.256018" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US" id="EquityOptionsAndWarrantsMember.327670.256018">Options and warrants [Member]</link:label>
    <link:loc xlink:label="loc_GeneralAndAdministrativeExpenseMember.2476.11.7" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_GeneralAndAdministrativeExpenseMember" xlink:type="locator" />
    <link:labelArc xlink:from="loc_GeneralAndAdministrativeExpenseMember.2476.11.7" xlink:to="GeneralAndAdministrativeExpenseMember.222398.256020" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="GeneralAndAdministrativeExpenseMember.222398.256020" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US" id="GeneralAndAdministrativeExpenseMember.222398.256020">General and administrative expenses [Member]</link:label>
    <link:loc xlink:label="loc_AllocatedShareBasedCompensationExpense.5851.11.7" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_AllocatedShareBasedCompensationExpense" xlink:type="locator" />
    <link:labelArc xlink:from="loc_AllocatedShareBasedCompensationExpense.5851.11.7" xlink:to="lab_AllocatedShareBasedCompensationExpense.1921946.254145.250611.256021" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_AllocatedShareBasedCompensationExpense.1921946.254145.250611.256021" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US" id="lab_AllocatedShareBasedCompensationExpense.1921946.254145.250611.256021">Compensation expenses</link:label>
    <link:loc xlink:label="loc_AllocatedShareBasedCompensationExpense.5851.11.6" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_AllocatedShareBasedCompensationExpense" xlink:type="locator" />
    <link:labelArc xlink:from="loc_AllocatedShareBasedCompensationExpense.5851.11.6" xlink:to="lab_AllocatedShareBasedCompensationExpense.2840.254144.250612.256022" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_AllocatedShareBasedCompensationExpense.2840.254144.250612.256022" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US" id="lab_AllocatedShareBasedCompensationExpense.2840.254144.250612.256022">Allocated Share-based Compensation Expense</link:label>
    <link:loc xlink:label="loc_ConsultantsMember.25535.11.6" xlink:href="psti-20140630.xsd#psti_ConsultantsMember" xlink:type="locator" />
    <link:labelArc xlink:from="loc_ConsultantsMember.25535.11.6" xlink:to="lab_ConsultantsMember.358851.256023" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_ConsultantsMember.358851.256023" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US" id="lab_ConsultantsMember.358851.256023">Consultants [Member]</link:label>
    <link:loc xlink:label="loc_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems.1848.11.6" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems" xlink:type="locator" />
    <link:labelArc xlink:from="loc_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems.1848.11.6" xlink:to="lab_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems.5883.256024" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems.5883.256024" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US" id="lab_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems.5883.256024">Employee Service Share-based Compensation, Allocation of Recognized Period Costs [Line Items]</link:label>
    <link:loc xlink:label="loc_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized.9125.11.7" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized" xlink:type="locator" />
    <link:labelArc xlink:from="loc_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized.9125.11.7" xlink:to="lab_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized.1929623.516864.184538.256026" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized.1929623.516864.184538.256026" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US" id="lab_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized.1929623.516864.184538.256026">Unrecognized compensation expense</link:label>
    <link:loc xlink:label="loc_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized.9125.11.6" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized" xlink:type="locator" />
    <link:labelArc xlink:from="loc_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized.9125.11.6" xlink:to="lab_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized.5908.256025" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized.5908.256025" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US" id="lab_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized.5908.256025">Employee Service Share-based Compensation, Nonvested Awards, Compensation Cost Not yet Recognized</link:label>
    <link:loc xlink:label="loc_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1.9127.11.7" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:type="locator" />
    <link:labelArc xlink:from="loc_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1.9127.11.7" xlink:to="lab_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1.522154.358868.256028" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1.522154.358868.256028" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US" id="lab_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1.522154.358868.256028">Unrecognized compensation expense, recognition period</link:label>
    <link:loc xlink:label="loc_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1.9127.11.6" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:type="locator" />
    <link:labelArc xlink:from="loc_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1.9127.11.6" xlink:to="lab_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1.5912.256027" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1.5912.256027" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US" id="lab_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1.5912.256027">Employee Service Share-based Compensation, Nonvested Awards, Compensation Cost Not yet Recognized, Period for Recognition</link:label>
    <link:loc xlink:label="loc_EquityOptionsAndWarrantsMember.25537.11.6" xlink:href="psti-20140630.xsd#psti_EquityOptionsAndWarrantsMember" xlink:type="locator" />
    <link:labelArc xlink:from="loc_EquityOptionsAndWarrantsMember.25537.11.6" xlink:to="lab_EquityOptionsAndWarrantsMember.250618.256029" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_EquityOptionsAndWarrantsMember.250618.256029" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US" id="lab_EquityOptionsAndWarrantsMember.250618.256029">Equity Options And Warrants [Member]</link:label>
    <link:loc xlink:label="loc_GeneralAndAdministrativeExpenseMember.2476.11.6" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_GeneralAndAdministrativeExpenseMember" xlink:type="locator" />
    <link:labelArc xlink:from="loc_GeneralAndAdministrativeExpenseMember.2476.11.6" xlink:to="lab_GeneralAndAdministrativeExpenseMember.3392.254150.250617.256030" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_GeneralAndAdministrativeExpenseMember.3392.254150.250617.256030" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US" id="lab_GeneralAndAdministrativeExpenseMember.3392.254150.250617.256030">General and Administrative Expense [Member]</link:label>
    <link:loc xlink:label="loc_IncomeStatementLocationAxis.2652.11.6" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_IncomeStatementLocationAxis" xlink:type="locator" />
    <link:labelArc xlink:from="loc_IncomeStatementLocationAxis.2652.11.6" xlink:to="lab_IncomeStatementLocationAxis.8839.256031" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_IncomeStatementLocationAxis.8839.256031" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US" id="lab_IncomeStatementLocationAxis.8839.256031">Income Statement Location [Axis]</link:label>
    <link:loc xlink:label="loc_IncomeStatementLocationDomain.2668.11.6" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_IncomeStatementLocationDomain" xlink:type="locator" />
    <link:labelArc xlink:from="loc_IncomeStatementLocationDomain.2668.11.6" xlink:to="lab_IncomeStatementLocationDomain.8906.256032" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_IncomeStatementLocationDomain.8906.256032" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US" id="lab_IncomeStatementLocationDomain.8906.256032">Income Statement Location [Domain]</link:label>
    <link:loc xlink:label="loc_ResearchAndDevelopmentExpenseMember.4543.11.6" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ResearchAndDevelopmentExpenseMember" xlink:type="locator" />
    <link:labelArc xlink:from="loc_ResearchAndDevelopmentExpenseMember.4543.11.6" xlink:to="lab_ResearchAndDevelopmentExpenseMember.14651.254153.250620.256033" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_ResearchAndDevelopmentExpenseMember.14651.254153.250620.256033" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US" id="lab_ResearchAndDevelopmentExpenseMember.14651.254153.250620.256033">Research and Development Expense [Member]</link:label>
    <link:loc xlink:label="loc_RestrictedStockUnitsRSUMember.4568.11.6" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_RestrictedStockUnitsRSUMember" xlink:type="locator" />
    <link:labelArc xlink:from="loc_RestrictedStockUnitsRSUMember.4568.11.6" xlink:to="lab_RestrictedStockUnitsRSUMember.14603.254227.250946.256034" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_RestrictedStockUnitsRSUMember.14603.254227.250946.256034" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US" id="lab_RestrictedStockUnitsRSUMember.14603.254227.250946.256034">Restricted Stock Units (RSUs) [Member]</link:label>
    <link:loc xlink:label="loc_RestrictedStockUnitsRSUMember.4568.11.7" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_RestrictedStockUnitsRSUMember" xlink:type="locator" />
    <link:labelArc xlink:from="loc_RestrictedStockUnitsRSUMember.4568.11.7" xlink:to="lab_RestrictedStockUnitsRSUMember7.1922044.254228.250947.256035" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_RestrictedStockUnitsRSUMember7.1922044.254228.250947.256035" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US" id="lab_RestrictedStockUnitsRSUMember7.1922044.254228.250947.256035">Restricted stock units [Member]</link:label>
    <link:loc xlink:label="loc_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable.4779.11.6" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable" xlink:type="locator" />
    <link:labelArc xlink:from="loc_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable.4779.11.6" xlink:to="lab_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable.17390.256036" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable.17390.256036" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US" id="lab_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable.17390.256036">Schedule of Employee Service Share-based Compensation, Allocation of Recognized Period Costs [Table]</link:label>
    <link:loc xlink:label="loc_ResearchAndDevelopmentExpenseMember.4543.11.7" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ResearchAndDevelopmentExpenseMember" xlink:type="locator" />
    <link:labelArc xlink:from="loc_ResearchAndDevelopmentExpenseMember.4543.11.7" xlink:to="ResearchAndDevelopmentExpenseMember.1915684.410448.358867.256039" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="ResearchAndDevelopmentExpenseMember.1915684.410448.358867.256039" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US" id="ResearchAndDevelopmentExpenseMember.1915684.410448.358867.256039">Research and development expenses [Member]</link:label>
    <link:loc xlink:label="loc_AggregateIntrinsicValueAbstract.25525.11.6" xlink:href="psti-20140630.xsd#psti_AggregateIntrinsicValueAbstract" xlink:type="locator" />
    <link:labelArc xlink:from="loc_AggregateIntrinsicValueAbstract.25525.11.6" xlink:to="lab_AggregateIntrinsicValueAbstract.1921921.254086.250713.255926" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_AggregateIntrinsicValueAbstract.1921921.254086.250713.255926" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US" id="lab_AggregateIntrinsicValueAbstract.1921921.254086.250713.255926">Aggregate Intrinsic Value [Abstract]</link:label>
    <link:loc xlink:label="loc_AggregateIntrinsicValueAbstract.25525.11.12" xlink:href="psti-20140630.xsd#psti_AggregateIntrinsicValueAbstract" xlink:type="locator" />
    <link:labelArc xlink:from="loc_AggregateIntrinsicValueAbstract.25525.11.12" xlink:to="lab_AggregateIntrinsicValueAbstract.1921922.254088.250714.255927" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_AggregateIntrinsicValueAbstract.1921922.254088.250714.255927" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US" id="lab_AggregateIntrinsicValueAbstract.1921922.254088.250714.255927">Aggregate Intrinsic Value [Abstract].</link:label>
    <link:loc xlink:label="loc_AggregateIntrinsicValueAbstract.25525.11.7" xlink:href="psti-20140630.xsd#psti_AggregateIntrinsicValueAbstract" xlink:type="locator" />
    <link:labelArc xlink:from="loc_AggregateIntrinsicValueAbstract.25525.11.7" xlink:to="lab_AggregateIntrinsicValueAbstract.1921923.254087.250715.255928" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_AggregateIntrinsicValueAbstract.1921923.254087.250715.255928" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US" id="lab_AggregateIntrinsicValueAbstract.1921923.254087.250715.255928">Aggregate intrinsic value price</link:label>
    <link:loc xlink:label="loc_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract.5025.11.6" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract" xlink:type="locator" />
    <link:labelArc xlink:from="loc_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract.5025.11.6" xlink:to="lab_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract.11891.254097.250723.255929" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract.11891.254097.250723.255929" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US" id="lab_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract.11891.254097.250723.255929">Share-based Compensation Arrangement by Share-based Payment Award, Options, Additional Disclosures [Abstract]</link:label>
    <link:loc xlink:label="loc_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract.5025.11.7" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract" xlink:type="locator" />
    <link:labelArc xlink:from="loc_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract.5025.11.7" xlink:to="lab_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract7.131400.254098.250724.255930" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract7.131400.254098.250724.255930" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US" id="lab_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract7.131400.254098.250724.255930">Weighted average exercise price</link:label>
    <link:loc xlink:label="loc_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1.15973.11.6" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1" xlink:type="locator" />
    <link:labelArc xlink:from="loc_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1.15973.11.6" xlink:to="lab_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1.15113.254099.250725.255931" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1.15113.254099.250725.255931" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US" id="lab_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1.15113.254099.250725.255931">Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Intrinsic Value</link:label>
    <link:loc xlink:label="loc_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1.15973.11.7" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1" xlink:type="locator" />
    <link:labelArc xlink:from="loc_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1.15973.11.7" xlink:to="lab_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1.1921944.254100.250726.255932" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1.1921944.254100.250726.255932" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US" id="lab_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1.1921944.254100.250726.255932">Options exercisable at the end of the period</link:label>
    <link:loc xlink:label="loc_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber.16696.11.11" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" xlink:type="locator" />
    <link:labelArc xlink:from="loc_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber.16696.11.11" xlink:to="lab_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber.520244.358843.255933" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber.520244.358843.255933" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xml:lang="en-US" id="lab_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber.520244.358843.255933">Options exercisable at the end of the period</link:label>
    <link:loc xlink:label="loc_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber.16696.11.6" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" xlink:type="locator" />
    <link:labelArc xlink:from="loc_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber.16696.11.6" xlink:to="lab_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber.7655.254101.250727.255934" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber.7655.254101.250727.255934" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US" id="lab_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber.7655.254101.250727.255934">Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Number</link:label>
    <link:loc xlink:label="loc_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice.16680.11.11" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" xlink:type="locator" />
    <link:labelArc xlink:from="loc_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice.16680.11.11" xlink:to="lab_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice.520245.358845.255935" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice.520245.358845.255935" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xml:lang="en-US" id="lab_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice.520245.358845.255935">Options exercisable at the end of the period</link:label>
    <link:loc xlink:label="loc_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice.16680.11.6" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" xlink:type="locator" />
    <link:labelArc xlink:from="loc_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice.16680.11.6" xlink:to="lab_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice.7653.254103.250729.255936" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice.7653.254103.250729.255936" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US" id="lab_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice.7653.254103.250729.255936">Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Exercise Price</link:label>
    <link:loc xlink:label="loc_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1.15994.11.6" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1" xlink:type="locator" />
    <link:labelArc xlink:from="loc_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1.15994.11.6" xlink:to="lab_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1.16365.250731.255937" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1.16365.250731.255937" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US" id="lab_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1.16365.250731.255937">Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Remaining Contractual Term</link:label>
    <link:loc xlink:label="loc_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1.15994.11.7" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1" xlink:type="locator" />
    <link:labelArc xlink:from="loc_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1.15994.11.7" xlink:to="lab_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1.254515.250732.255938" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1.254515.250732.255938" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US" id="lab_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1.254515.250732.255938">Options exercisable at the end of the period</link:label>
    <link:loc xlink:label="loc_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice.16710.11.6" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice" xlink:type="locator" />
    <link:labelArc xlink:from="loc_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice.16710.11.6" xlink:to="lab_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice.11600.254109.250733.255939" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice.11600.254109.250733.255939" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US" id="lab_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice.11600.254109.250733.255939">Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures and Expirations in Period, Weighted Average Exercise Price</link:label>
    <link:loc xlink:label="loc_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice.16710.11.7" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice" xlink:type="locator" />
    <link:labelArc xlink:from="loc_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice.16710.11.7" xlink:to="lab_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice.1921935.254110.250734.255940" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice.1921935.254110.250734.255940" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US" id="lab_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice.1921935.254110.250734.255940">Options forfeited</link:label>
    <link:loc xlink:label="loc_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod.16694.11.53" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" xlink:type="locator" />
    <link:labelArc xlink:from="loc_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod.16694.11.53" xlink:to="lab_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod.1869410.310075.323098.255941" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod.1869410.310075.323098.255941" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xml:lang="en-US" id="lab_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod.1869410.310075.323098.255941">Options forfeited</link:label>
    <link:loc xlink:label="loc_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod.16694.11.6" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" xlink:type="locator" />
    <link:labelArc xlink:from="loc_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod.16694.11.6" xlink:to="lab_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod.7637.254111.250735.255942" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod.7637.254111.250735.255942" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US" id="lab_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod.7637.254111.250735.255942">Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period</link:label>
    <link:loc xlink:label="loc_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue.16730.11.7" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" xlink:type="locator" />
    <link:labelArc xlink:from="loc_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue.16730.11.7" xlink:to="lab_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue.1921941.254114.250737.255943" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue.1921941.254114.250737.255943" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US" id="lab_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue.1921941.254114.250737.255943">Options outstanding at end of the period</link:label>
    <link:loc xlink:label="loc_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue.16730.11.6" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" xlink:type="locator" />
    <link:labelArc xlink:from="loc_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue.16730.11.6" xlink:to="lab_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue.7642.254113.250738.255944" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue.7642.254113.250738.255944" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US" id="lab_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue.7642.254113.250738.255944">Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Intrinsic Value</link:label>
    <link:loc xlink:label="loc_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber.16721.11.10" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:type="locator" />
    <link:labelArc xlink:from="loc_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber.16721.11.10" xlink:to="lab_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber.1921930.254117.250739.255945" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber.1921930.254117.250739.255945" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xml:lang="en-US" id="lab_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber.1921930.254117.250739.255945">Options outstanding at beginning of period</link:label>
    <link:loc xlink:label="loc_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber.16721.11.11" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:type="locator" />
    <link:labelArc xlink:from="loc_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber.16721.11.11" xlink:to="lab_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber.1921932.254116.250740.255946" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber.1921932.254116.250740.255946" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xml:lang="en-US" id="lab_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber.1921932.254116.250740.255946">Options outstanding at end of the period</link:label>
    <link:loc xlink:label="loc_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber.16721.11.6" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:type="locator" />
    <link:labelArc xlink:from="loc_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber.16721.11.6" xlink:to="lab_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber.7651.254115.250741.255947" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber.7651.254115.250741.255947" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US" id="lab_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber.7651.254115.250741.255947">Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number</link:label>
    <link:loc xlink:label="loc_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward.5033.11.6" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:type="locator" />
    <link:labelArc xlink:from="loc_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward.5033.11.6" xlink:to="lab_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward.11886.254118.250742.255948" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward.11886.254118.250742.255948" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US" id="lab_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward.11886.254118.250742.255948">Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding [Roll Forward]</link:label>
    <link:loc xlink:label="loc_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward.5033.11.7" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:type="locator" />
    <link:labelArc xlink:from="loc_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward.5033.11.7" xlink:to="lab_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward.1921929.254119.250743.255949" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward.1921929.254119.250743.255949" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US" id="lab_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward.1921929.254119.250743.255949">Number</link:label>
    <link:loc xlink:label="loc_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice.16713.11.10" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:type="locator" />
    <link:labelArc xlink:from="loc_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice.16713.11.10" xlink:to="lab_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice.1921942.254122.250744.255950" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice.1921942.254122.250744.255950" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xml:lang="en-US" id="lab_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice.1921942.254122.250744.255950">Options outstanding at beginning of period</link:label>
    <link:loc xlink:label="loc_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice.16713.11.11" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:type="locator" />
    <link:labelArc xlink:from="loc_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice.16713.11.11" xlink:to="lab_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice.1921943.254121.250745.255951" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice.1921943.254121.250745.255951" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xml:lang="en-US" id="lab_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice.1921943.254121.250745.255951">Options outstanding at end of the period</link:label>
    <link:loc xlink:label="loc_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice.16713.11.6" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:type="locator" />
    <link:labelArc xlink:from="loc_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice.16713.11.6" xlink:to="lab_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice.7646.254120.250746.255952" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice.7646.254120.250746.255952" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US" id="lab_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice.7646.254120.250746.255952">Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price</link:label>
    <link:loc xlink:label="loc_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2.15996.11.6" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:type="locator" />
    <link:labelArc xlink:from="loc_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2.15996.11.6" xlink:to="lab_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2.16368.250747.255953" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2.16368.250747.255953" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US" id="lab_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2.16368.250747.255953">Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Remaining Contractual Term</link:label>
    <link:loc xlink:label="loc_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2.15996.11.7" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:type="locator" />
    <link:labelArc xlink:from="loc_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2.15996.11.7" xlink:to="lab_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2.254521.250748.255954" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2.254521.250748.255954" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US" id="lab_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2.254521.250748.255954">Weighted Average Remaining Contractual Terms (in years)</link:label>
    <link:loc xlink:label="loc_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue.16715.11.6" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue" xlink:type="locator" />
    <link:labelArc xlink:from="loc_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue.16715.11.6" xlink:to="lab_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue.11913.254125.250749.255955" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue.11913.254125.250749.255955" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US" id="lab_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue.11913.254125.250749.255955">Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Exercisable, Aggregate Intrinsic Value</link:label>
    <link:loc xlink:label="loc_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue.16715.11.7" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue" xlink:type="locator" />
    <link:labelArc xlink:from="loc_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue.16715.11.7" xlink:to="lab_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue7.1921945.254126.250750.255956" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue7.1921945.254126.250750.255956" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US" id="lab_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue7.1921945.254126.250750.255956">Options vested</link:label>
    <link:loc xlink:label="loc_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1.15995.11.6" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1" xlink:type="locator" />
    <link:labelArc xlink:from="loc_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1.15995.11.6" xlink:to="lab_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1.16366.250751.255957" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1.16366.250751.255957" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US" id="lab_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1.16366.250751.255957">Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Exercisable, Weighted Average Remaining Contractual Term</link:label>
    <link:loc xlink:label="loc_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1.15995.11.7" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1" xlink:type="locator" />
    <link:labelArc xlink:from="loc_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1.15995.11.7" xlink:to="lab_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1.254519.250752.255958" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1.254519.250752.255958" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US" id="lab_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1.254519.250752.255958">Options vested</link:label>
    <link:loc xlink:label="loc_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber.16729.11.6" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber" xlink:type="locator" />
    <link:labelArc xlink:from="loc_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber.16729.11.6" xlink:to="lab_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber.11918.254129.250753.255959" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber.11918.254129.250753.255959" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US" id="lab_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber.11918.254129.250753.255959">Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Number</link:label>
    <link:loc xlink:label="loc_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice.16734.11.6" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice" xlink:type="locator" />
    <link:labelArc xlink:from="loc_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice.16734.11.6" xlink:to="lab_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice.11911.254131.250755.255960" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice.11911.254131.250755.255960" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US" id="lab_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice.11911.254131.250755.255960">Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Weighted Average Exercise Price</link:label>
    <link:loc xlink:label="loc_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice.16734.11.11" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice" xlink:type="locator" />
    <link:labelArc xlink:from="loc_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice.16734.11.11" xlink:to="lab_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice.229464.498046.358846.255961" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice.229464.498046.358846.255961" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xml:lang="en-US" id="lab_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice.229464.498046.358846.255961">Options vested</link:label>
    <link:loc xlink:label="loc_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice.16675.11.6" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:type="locator" />
    <link:labelArc xlink:from="loc_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice.16675.11.6" xlink:to="lab_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice.17487.250758.255962" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice.17487.250758.255962" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US" id="lab_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice.17487.250758.255962">Share-based Compensation Arrangements by Share-based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price</link:label>
    <link:loc xlink:label="loc_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice.16675.11.7" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:type="locator" />
    <link:labelArc xlink:from="loc_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice.16675.11.7" xlink:to="lab_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice.254520.250759.255963" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice.254520.250759.255963" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US" id="lab_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice.254520.250759.255963">Options exercised</link:label>
    <link:loc xlink:label="loc_StockIssuedDuringPeriodSharesStockOptionsExercised.16983.11.53" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:type="locator" />
    <link:labelArc xlink:from="loc_StockIssuedDuringPeriodSharesStockOptionsExercised.16983.11.53" xlink:to="lab_StockIssuedDuringPeriodSharesStockOptionsExercised42.256758.250760.255964" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_StockIssuedDuringPeriodSharesStockOptionsExercised42.256758.250760.255964" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xml:lang="en-US" id="lab_StockIssuedDuringPeriodSharesStockOptionsExercised42.256758.250760.255964">Options exercised</link:label>
    <link:loc xlink:label="loc_WeightedAverageRemainingContractualTermsAbstract.25575.11.6" xlink:href="psti-20140630.xsd#psti_WeightedAverageRemainingContractualTermsAbstract" xlink:type="locator" />
    <link:labelArc xlink:from="loc_WeightedAverageRemainingContractualTermsAbstract.25575.11.6" xlink:to="lab_WeightedAverageRemainingContractualTermsAbstract.1921924.254141.250767.255965" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_WeightedAverageRemainingContractualTermsAbstract.1921924.254141.250767.255965" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US" id="lab_WeightedAverageRemainingContractualTermsAbstract.1921924.254141.250767.255965">Weighted Average Remaining Contractual Terms [Abstract]</link:label>
    <link:loc xlink:label="loc_WeightedAverageRemainingContractualTermsAbstract.25575.11.12" xlink:href="psti-20140630.xsd#psti_WeightedAverageRemainingContractualTermsAbstract" xlink:type="locator" />
    <link:labelArc xlink:from="loc_WeightedAverageRemainingContractualTermsAbstract.25575.11.12" xlink:to="lab_WeightedAverageRemainingContractualTermsAbstract.1921925.254143.250768.255966" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_WeightedAverageRemainingContractualTermsAbstract.1921925.254143.250768.255966" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US" id="lab_WeightedAverageRemainingContractualTermsAbstract.1921925.254143.250768.255966">Weighted Average Remaining Contractual Terms [Abstract].</link:label>
    <link:loc xlink:label="loc_WeightedAverageRemainingContractualTermsAbstract.25575.11.7" xlink:href="psti-20140630.xsd#psti_WeightedAverageRemainingContractualTermsAbstract" xlink:type="locator" />
    <link:labelArc xlink:from="loc_WeightedAverageRemainingContractualTermsAbstract.25575.11.7" xlink:to="lab_WeightedAverageRemainingContractualTermsAbstract.1921926.254142.250769.255967" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_WeightedAverageRemainingContractualTermsAbstract.1921926.254142.250769.255967" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US" id="lab_WeightedAverageRemainingContractualTermsAbstract.1921926.254142.250769.255967">Weighted average remaining contractual term</link:label>
    <link:loc xlink:label="loc_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber.16729.11.11" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber" xlink:type="locator" />
    <link:labelArc xlink:from="loc_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber.16729.11.11" xlink:to="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber.229466.498072.358844.255968" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber.229466.498072.358844.255968" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xml:lang="en-US" id="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber.229466.498072.358844.255968">Options vested</link:label>
    <link:loc xlink:label="loc_SharebasedGoodsAndNonemployeesServicesTransactionWarrantsAndOptionsExercised.25548.11.53" xlink:href="psti-20140630.xsd#psti_SharebasedGoodsAndNonemployeesServicesTransactionWarrantsAndOptionsExercised" xlink:type="locator" />
    <link:labelArc xlink:from="loc_SharebasedGoodsAndNonemployeesServicesTransactionWarrantsAndOptionsExercised.25548.11.53" xlink:to="lab_SharebasedGoodsAndNonemployeesServicesTransactionWarrantsAndOptionsExercised.257130.250622.255866" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_SharebasedGoodsAndNonemployeesServicesTransactionWarrantsAndOptionsExercised.257130.250622.255866" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xml:lang="en-US" id="lab_SharebasedGoodsAndNonemployeesServicesTransactionWarrantsAndOptionsExercised.257130.250622.255866">Options and warrants exercised</link:label>
    <link:loc xlink:label="loc_SharebasedGoodsAndNonemployeesServicesTransactionWarrantsAndOptionsGranted.25549.11.6" xlink:href="psti-20140630.xsd#psti_SharebasedGoodsAndNonemployeesServicesTransactionWarrantsAndOptionsGranted" xlink:type="locator" />
    <link:labelArc xlink:from="loc_SharebasedGoodsAndNonemployeesServicesTransactionWarrantsAndOptionsGranted.25549.11.6" xlink:to="lab_SharebasedGoodsAndNonemployeesServicesTransactionWarrantsAndOptionsGranted.1921980.254160.250625.255867" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_SharebasedGoodsAndNonemployeesServicesTransactionWarrantsAndOptionsGranted.1921980.254160.250625.255867" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US" id="lab_SharebasedGoodsAndNonemployeesServicesTransactionWarrantsAndOptionsGranted.1921980.254160.250625.255867">Sharebased Goods And Nonemployees Services Transaction Warrants And Options Granted</link:label>
    <link:loc xlink:label="loc_SharebasedGoodsAndNonemployeesServicesTransactionWarrantsAndOptionsGranted.25549.11.12" xlink:href="psti-20140630.xsd#psti_SharebasedGoodsAndNonemployeesServicesTransactionWarrantsAndOptionsGranted" xlink:type="locator" />
    <link:labelArc xlink:from="loc_SharebasedGoodsAndNonemployeesServicesTransactionWarrantsAndOptionsGranted.25549.11.12" xlink:to="lab_SharebasedGoodsAndNonemployeesServicesTransactionWarrantsAndOptionsGranted.1921981.254162.250626.255868" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_SharebasedGoodsAndNonemployeesServicesTransactionWarrantsAndOptionsGranted.1921981.254162.250626.255868" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US" id="lab_SharebasedGoodsAndNonemployeesServicesTransactionWarrantsAndOptionsGranted.1921981.254162.250626.255868">Sharebased goods and nonemployees services transaction warrants and options granted.</link:label>
    <link:loc xlink:label="loc_SharebasedGoodsAndNonemployeesServicesTransactionWarrantsAndOptionsGranted.25549.11.7" xlink:href="psti-20140630.xsd#psti_SharebasedGoodsAndNonemployeesServicesTransactionWarrantsAndOptionsGranted" xlink:type="locator" />
    <link:labelArc xlink:from="loc_SharebasedGoodsAndNonemployeesServicesTransactionWarrantsAndOptionsGranted.25549.11.7" xlink:to="lab_SharebasedGoodsAndNonemployeesServicesTransactionWarrantsAndOptionsGranted.1921982.254161.250627.255869" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_SharebasedGoodsAndNonemployeesServicesTransactionWarrantsAndOptionsGranted.1921982.254161.250627.255869" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US" id="lab_SharebasedGoodsAndNonemployeesServicesTransactionWarrantsAndOptionsGranted.1921982.254161.250627.255869">Options granted</link:label>
    <link:loc xlink:label="loc_SharebasedGoodsAndNonemployeesServicesTransactionWarrantsAndOptionsNumber.25550.11.6" xlink:href="psti-20140630.xsd#psti_SharebasedGoodsAndNonemployeesServicesTransactionWarrantsAndOptionsNumber" xlink:type="locator" />
    <link:labelArc xlink:from="loc_SharebasedGoodsAndNonemployeesServicesTransactionWarrantsAndOptionsNumber.25550.11.6" xlink:to="lab_SharebasedGoodsAndNonemployeesServicesTransactionWarrantsAndOptionsNumber.1921975.254163.250628.255870" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_SharebasedGoodsAndNonemployeesServicesTransactionWarrantsAndOptionsNumber.1921975.254163.250628.255870" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US" id="lab_SharebasedGoodsAndNonemployeesServicesTransactionWarrantsAndOptionsNumber.1921975.254163.250628.255870">Sharebased Goods And Nonemployees Services Transaction Warrants And Options Number</link:label>
    <link:loc xlink:label="loc_SharebasedGoodsAndNonemployeesServicesTransactionWarrantsAndOptionsNumber.25550.11.12" xlink:href="psti-20140630.xsd#psti_SharebasedGoodsAndNonemployeesServicesTransactionWarrantsAndOptionsNumber" xlink:type="locator" />
    <link:labelArc xlink:from="loc_SharebasedGoodsAndNonemployeesServicesTransactionWarrantsAndOptionsNumber.25550.11.12" xlink:to="lab_SharebasedGoodsAndNonemployeesServicesTransactionWarrantsAndOptionsNumber.1921976.254165.250629.255871" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_SharebasedGoodsAndNonemployeesServicesTransactionWarrantsAndOptionsNumber.1921976.254165.250629.255871" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US" id="lab_SharebasedGoodsAndNonemployeesServicesTransactionWarrantsAndOptionsNumber.1921976.254165.250629.255871">Sharebased goods and nonemployees services transaction warrants and options number.</link:label>
    <link:loc xlink:label="loc_SharebasedGoodsAndNonemployeesServicesTransactionWarrantsAndOptionsNumber.25550.11.10" xlink:href="psti-20140630.xsd#psti_SharebasedGoodsAndNonemployeesServicesTransactionWarrantsAndOptionsNumber" xlink:type="locator" />
    <link:labelArc xlink:from="loc_SharebasedGoodsAndNonemployeesServicesTransactionWarrantsAndOptionsNumber.25550.11.10" xlink:to="lab_SharebasedGoodsAndNonemployeesServicesTransactionWarrantsAndOptionsNumber.1921978.254164.250630.255872" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_SharebasedGoodsAndNonemployeesServicesTransactionWarrantsAndOptionsNumber.1921978.254164.250630.255872" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xml:lang="en-US" id="lab_SharebasedGoodsAndNonemployeesServicesTransactionWarrantsAndOptionsNumber.1921978.254164.250630.255872">Options and warrants outstanding at beginning of period</link:label>
    <link:loc xlink:label="loc_SharebasedGoodsAndNonemployeesServicesTransactionWarrantsAndOptionsNumber.25550.11.11" xlink:href="psti-20140630.xsd#psti_SharebasedGoodsAndNonemployeesServicesTransactionWarrantsAndOptionsNumber" xlink:type="locator" />
    <link:labelArc xlink:from="loc_SharebasedGoodsAndNonemployeesServicesTransactionWarrantsAndOptionsNumber.25550.11.11" xlink:to="lab_SharebasedGoodsAndNonemployeesServicesTransactionWarrantsAndOptionsNumber.1921979.254166.250631.255873" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_SharebasedGoodsAndNonemployeesServicesTransactionWarrantsAndOptionsNumber.1921979.254166.250631.255873" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xml:lang="en-US" id="lab_SharebasedGoodsAndNonemployeesServicesTransactionWarrantsAndOptionsNumber.1921979.254166.250631.255873">Options and warrants outstanding at end of the period</link:label>
    <link:loc xlink:label="loc_SharebasedGoodsAndNonemployeesServicesTransactionWarrantsAndOptionsNumberExercisable.25551.11.6" xlink:href="psti-20140630.xsd#psti_SharebasedGoodsAndNonemployeesServicesTransactionWarrantsAndOptionsNumberExercisable" xlink:type="locator" />
    <link:labelArc xlink:from="loc_SharebasedGoodsAndNonemployeesServicesTransactionWarrantsAndOptionsNumberExercisable.25551.11.6" xlink:to="lab_SharebasedGoodsAndNonemployeesServicesTransactionWarrantsAndOptionsNumberExercisable.1921986.254167.250632.255874" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_SharebasedGoodsAndNonemployeesServicesTransactionWarrantsAndOptionsNumberExercisable.1921986.254167.250632.255874" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US" id="lab_SharebasedGoodsAndNonemployeesServicesTransactionWarrantsAndOptionsNumberExercisable.1921986.254167.250632.255874">Sharebased Goods And Nonemployees Services Transaction Warrants And Options Number Exercisable</link:label>
    <link:loc xlink:label="loc_SharebasedGoodsAndNonemployeesServicesTransactionWarrantsAndOptionsNumberExercisable.25551.11.12" xlink:href="psti-20140630.xsd#psti_SharebasedGoodsAndNonemployeesServicesTransactionWarrantsAndOptionsNumberExercisable" xlink:type="locator" />
    <link:labelArc xlink:from="loc_SharebasedGoodsAndNonemployeesServicesTransactionWarrantsAndOptionsNumberExercisable.25551.11.12" xlink:to="lab_SharebasedGoodsAndNonemployeesServicesTransactionWarrantsAndOptionsNumberExercisable.1921987.254169.250633.255875" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_SharebasedGoodsAndNonemployeesServicesTransactionWarrantsAndOptionsNumberExercisable.1921987.254169.250633.255875" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US" id="lab_SharebasedGoodsAndNonemployeesServicesTransactionWarrantsAndOptionsNumberExercisable.1921987.254169.250633.255875">Sharebased goods and nonemployees services transaction warrants and options number exercisable.</link:label>
    <link:loc xlink:label="loc_SharebasedGoodsAndNonemployeesServicesTransactionWarrantsAndOptionsNumberVestedAndExpectedToVest.25552.11.6" xlink:href="psti-20140630.xsd#psti_SharebasedGoodsAndNonemployeesServicesTransactionWarrantsAndOptionsNumberVestedAndExpectedToVest" xlink:type="locator" />
    <link:labelArc xlink:from="loc_SharebasedGoodsAndNonemployeesServicesTransactionWarrantsAndOptionsNumberVestedAndExpectedToVest.25552.11.6" xlink:to="lab_SharebasedGoodsAndNonemployeesServicesTransactionWarrantsAndOptionsNumberVestedAndExpectedToVest.1921989.254170.250635.255876" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_SharebasedGoodsAndNonemployeesServicesTransactionWarrantsAndOptionsNumberVestedAndExpectedToVest.1921989.254170.250635.255876" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US" id="lab_SharebasedGoodsAndNonemployeesServicesTransactionWarrantsAndOptionsNumberVestedAndExpectedToVest.1921989.254170.250635.255876">Sharebased Goods And Nonemployees Services Transaction Warrants And Options Number Vested And Expected To Vest</link:label>
    <link:loc xlink:label="loc_SharebasedGoodsAndNonemployeesServicesTransactionWarrantsAndOptionsNumberVestedAndExpectedToVest.25552.11.12" xlink:href="psti-20140630.xsd#psti_SharebasedGoodsAndNonemployeesServicesTransactionWarrantsAndOptionsNumberVestedAndExpectedToVest" xlink:type="locator" />
    <link:labelArc xlink:from="loc_SharebasedGoodsAndNonemployeesServicesTransactionWarrantsAndOptionsNumberVestedAndExpectedToVest.25552.11.12" xlink:to="lab_SharebasedGoodsAndNonemployeesServicesTransactionWarrantsAndOptionsNumberVestedAndExpectedToVest.1921990.254172.250636.255877" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_SharebasedGoodsAndNonemployeesServicesTransactionWarrantsAndOptionsNumberVestedAndExpectedToVest.1921990.254172.250636.255877" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US" id="lab_SharebasedGoodsAndNonemployeesServicesTransactionWarrantsAndOptionsNumberVestedAndExpectedToVest.1921990.254172.250636.255877">Sharebased goods and nonemployees services transaction warrants and options number vested and expected to vest.</link:label>
    <link:loc xlink:label="loc_WarrantsAndOptionsAggregateIntrinsicValue.25560.11.6" xlink:href="psti-20140630.xsd#psti_WarrantsAndOptionsAggregateIntrinsicValue" xlink:type="locator" />
    <link:labelArc xlink:from="loc_WarrantsAndOptionsAggregateIntrinsicValue.25560.11.6" xlink:to="lab_WarrantsAndOptionsAggregateIntrinsicValue.1922028.254178.250638.255878" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_WarrantsAndOptionsAggregateIntrinsicValue.1922028.254178.250638.255878" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US" id="lab_WarrantsAndOptionsAggregateIntrinsicValue.1922028.254178.250638.255878">Warrants And Options Aggregate Intrinsic Value</link:label>
    <link:loc xlink:label="loc_WarrantsAndOptionsAggregateIntrinsicValue.25560.11.12" xlink:href="psti-20140630.xsd#psti_WarrantsAndOptionsAggregateIntrinsicValue" xlink:type="locator" />
    <link:labelArc xlink:from="loc_WarrantsAndOptionsAggregateIntrinsicValue.25560.11.12" xlink:to="lab_WarrantsAndOptionsAggregateIntrinsicValue.1922029.254180.250639.255879" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_WarrantsAndOptionsAggregateIntrinsicValue.1922029.254180.250639.255879" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US" id="lab_WarrantsAndOptionsAggregateIntrinsicValue.1922029.254180.250639.255879">Warrants and options aggregate intrinsic value.</link:label>
    <link:loc xlink:label="loc_WarrantsAndOptionsAggregateIntrinsicValue.25560.11.7" xlink:href="psti-20140630.xsd#psti_WarrantsAndOptionsAggregateIntrinsicValue" xlink:type="locator" />
    <link:labelArc xlink:from="loc_WarrantsAndOptionsAggregateIntrinsicValue.25560.11.7" xlink:to="lab_WarrantsAndOptionsAggregateIntrinsicValue.1922030.254179.250640.255880" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_WarrantsAndOptionsAggregateIntrinsicValue.1922030.254179.250640.255880" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US" id="lab_WarrantsAndOptionsAggregateIntrinsicValue.1922030.254179.250640.255880">Options and warrants outstanding at end of the period</link:label>
    <link:loc xlink:label="loc_WarrantsAndOptionsAggregateIntrinsicValueExercisable.25561.11.6" xlink:href="psti-20140630.xsd#psti_WarrantsAndOptionsAggregateIntrinsicValueExercisable" xlink:type="locator" />
    <link:labelArc xlink:from="loc_WarrantsAndOptionsAggregateIntrinsicValueExercisable.25561.11.6" xlink:to="lab_WarrantsAndOptionsAggregateIntrinsicValueExercisable.1922031.254181.250641.255881" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_WarrantsAndOptionsAggregateIntrinsicValueExercisable.1922031.254181.250641.255881" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US" id="lab_WarrantsAndOptionsAggregateIntrinsicValueExercisable.1922031.254181.250641.255881">Warrants And Options Aggregate Intrinsic Value Exercisable</link:label>
    <link:loc xlink:label="loc_WarrantsAndOptionsAggregateIntrinsicValueExercisable.25561.11.12" xlink:href="psti-20140630.xsd#psti_WarrantsAndOptionsAggregateIntrinsicValueExercisable" xlink:type="locator" />
    <link:labelArc xlink:from="loc_WarrantsAndOptionsAggregateIntrinsicValueExercisable.25561.11.12" xlink:to="lab_WarrantsAndOptionsAggregateIntrinsicValueExercisable.1922032.254183.250642.255882" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_WarrantsAndOptionsAggregateIntrinsicValueExercisable.1922032.254183.250642.255882" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US" id="lab_WarrantsAndOptionsAggregateIntrinsicValueExercisable.1922032.254183.250642.255882">Warrants and options aggregate intrinsic value exercisable.</link:label>
    <link:loc xlink:label="loc_WarrantsAndOptionsAggregateIntrinsicValueExercisable.25561.11.7" xlink:href="psti-20140630.xsd#psti_WarrantsAndOptionsAggregateIntrinsicValueExercisable" xlink:type="locator" />
    <link:labelArc xlink:from="loc_WarrantsAndOptionsAggregateIntrinsicValueExercisable.25561.11.7" xlink:to="lab_WarrantsAndOptionsAggregateIntrinsicValueExercisable.1922033.254182.250643.255883" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_WarrantsAndOptionsAggregateIntrinsicValueExercisable.1922033.254182.250643.255883" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US" id="lab_WarrantsAndOptionsAggregateIntrinsicValueExercisable.1922033.254182.250643.255883">Options and warrants exercisable at the end of the period</link:label>
    <link:loc xlink:label="loc_WarrantsAndOptionsAggregateIntrinsicValuePriceAbstract.25562.11.6" xlink:href="psti-20140630.xsd#psti_WarrantsAndOptionsAggregateIntrinsicValuePriceAbstract" xlink:type="locator" />
    <link:labelArc xlink:from="loc_WarrantsAndOptionsAggregateIntrinsicValuePriceAbstract.25562.11.6" xlink:to="lab_WarrantsAndOptionsAggregateIntrinsicValuePriceAbstract.1921966.254184.250644.255884" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_WarrantsAndOptionsAggregateIntrinsicValuePriceAbstract.1921966.254184.250644.255884" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US" id="lab_WarrantsAndOptionsAggregateIntrinsicValuePriceAbstract.1921966.254184.250644.255884">Warrants And Options Aggregate Intrinsic Value Price [Abstract]</link:label>
    <link:loc xlink:label="loc_WarrantsAndOptionsAggregateIntrinsicValuePriceAbstract.25562.11.12" xlink:href="psti-20140630.xsd#psti_WarrantsAndOptionsAggregateIntrinsicValuePriceAbstract" xlink:type="locator" />
    <link:labelArc xlink:from="loc_WarrantsAndOptionsAggregateIntrinsicValuePriceAbstract.25562.11.12" xlink:to="lab_WarrantsAndOptionsAggregateIntrinsicValuePriceAbstract.1921967.254186.250645.255885" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_WarrantsAndOptionsAggregateIntrinsicValuePriceAbstract.1921967.254186.250645.255885" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US" id="lab_WarrantsAndOptionsAggregateIntrinsicValuePriceAbstract.1921967.254186.250645.255885">Warrants And Options Aggregate Intrinsic Value Price [Abstract].</link:label>
    <link:loc xlink:label="loc_WarrantsAndOptionsAggregateIntrinsicValuePriceAbstract.25562.11.7" xlink:href="psti-20140630.xsd#psti_WarrantsAndOptionsAggregateIntrinsicValuePriceAbstract" xlink:type="locator" />
    <link:labelArc xlink:from="loc_WarrantsAndOptionsAggregateIntrinsicValuePriceAbstract.25562.11.7" xlink:to="lab_WarrantsAndOptionsAggregateIntrinsicValuePriceAbstract.1921968.254185.250646.255886" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_WarrantsAndOptionsAggregateIntrinsicValuePriceAbstract.1921968.254185.250646.255886" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US" id="lab_WarrantsAndOptionsAggregateIntrinsicValuePriceAbstract.1921968.254185.250646.255886">Aggregate intrinsic value price</link:label>
    <link:loc xlink:label="loc_WarrantsAndOptionsAggregateIntrinsicValueVestedAndExpectedToVest.25563.11.6" xlink:href="psti-20140630.xsd#psti_WarrantsAndOptionsAggregateIntrinsicValueVestedAndExpectedToVest" xlink:type="locator" />
    <link:labelArc xlink:from="loc_WarrantsAndOptionsAggregateIntrinsicValueVestedAndExpectedToVest.25563.11.6" xlink:to="lab_WarrantsAndOptionsAggregateIntrinsicValueVestedAndExpectedToVest.1922034.254187.250647.255887" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_WarrantsAndOptionsAggregateIntrinsicValueVestedAndExpectedToVest.1922034.254187.250647.255887" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US" id="lab_WarrantsAndOptionsAggregateIntrinsicValueVestedAndExpectedToVest.1922034.254187.250647.255887">Warrants And Options Aggregate Intrinsic Value Vested And Expected To Vest</link:label>
    <link:loc xlink:label="loc_WarrantsAndOptionsAggregateIntrinsicValueVestedAndExpectedToVest.25563.11.12" xlink:href="psti-20140630.xsd#psti_WarrantsAndOptionsAggregateIntrinsicValueVestedAndExpectedToVest" xlink:type="locator" />
    <link:labelArc xlink:from="loc_WarrantsAndOptionsAggregateIntrinsicValueVestedAndExpectedToVest.25563.11.12" xlink:to="lab_WarrantsAndOptionsAggregateIntrinsicValueVestedAndExpectedToVest.1922035.254189.250648.255888" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_WarrantsAndOptionsAggregateIntrinsicValueVestedAndExpectedToVest.1922035.254189.250648.255888" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US" id="lab_WarrantsAndOptionsAggregateIntrinsicValueVestedAndExpectedToVest.1922035.254189.250648.255888">Warrants and options aggregate intrinsic value vested and expected to vest.</link:label>
    <link:loc xlink:label="loc_WarrantsAndOptionsAggregateIntrinsicValueVestedAndExpectedToVest.25563.11.7" xlink:href="psti-20140630.xsd#psti_WarrantsAndOptionsAggregateIntrinsicValueVestedAndExpectedToVest" xlink:type="locator" />
    <link:labelArc xlink:from="loc_WarrantsAndOptionsAggregateIntrinsicValueVestedAndExpectedToVest.25563.11.7" xlink:to="lab_WarrantsAndOptionsAggregateIntrinsicValueVestedAndExpectedToVest.1922036.254188.250649.255889" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_WarrantsAndOptionsAggregateIntrinsicValueVestedAndExpectedToVest.1922036.254188.250649.255889" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US" id="lab_WarrantsAndOptionsAggregateIntrinsicValueVestedAndExpectedToVest.1922036.254188.250649.255889">Options and warrants vested and expected to vest</link:label>
    <link:loc xlink:label="loc_WarrantsAndOptionsExercisedWeightedAverageExercisePrice.25564.11.12" xlink:href="psti-20140630.xsd#psti_WarrantsAndOptionsExercisedWeightedAverageExercisePrice" xlink:type="locator" />
    <link:labelArc xlink:from="loc_WarrantsAndOptionsExercisedWeightedAverageExercisePrice.25564.11.12" xlink:to="lab_WarrantsAndOptionsExercisedWeightedAverageExercisePrice.1922004.254192.250651.255891" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_WarrantsAndOptionsExercisedWeightedAverageExercisePrice.1922004.254192.250651.255891" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US" id="lab_WarrantsAndOptionsExercisedWeightedAverageExercisePrice.1922004.254192.250651.255891">Warrants and options exercised weighted average exercise price.</link:label>
    <link:loc xlink:label="loc_WarrantsAndOptionsExercisedWeightedAverageExercisePrice.25564.11.7" xlink:href="psti-20140630.xsd#psti_WarrantsAndOptionsExercisedWeightedAverageExercisePrice" xlink:type="locator" />
    <link:labelArc xlink:from="loc_WarrantsAndOptionsExercisedWeightedAverageExercisePrice.25564.11.7" xlink:to="lab_WarrantsAndOptionsExercisedWeightedAverageExercisePrice.1922005.254191.250652.255892" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_WarrantsAndOptionsExercisedWeightedAverageExercisePrice.1922005.254191.250652.255892" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US" id="lab_WarrantsAndOptionsExercisedWeightedAverageExercisePrice.1922005.254191.250652.255892">Options and warrants exercised</link:label>
    <link:loc xlink:label="loc_WarrantsAndOptionsExercisedWeightedAverageExercisePrice.25564.11.6" xlink:href="psti-20140630.xsd#psti_WarrantsAndOptionsExercisedWeightedAverageExercisePrice" xlink:type="locator" />
    <link:labelArc xlink:from="loc_WarrantsAndOptionsExercisedWeightedAverageExercisePrice.25564.11.6" xlink:to="lab_WarrantsAndOptionsExercisedWeightedAverageExercisePrice.250650.255890" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_WarrantsAndOptionsExercisedWeightedAverageExercisePrice.250650.255890" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US" id="lab_WarrantsAndOptionsExercisedWeightedAverageExercisePrice.250650.255890">Warrants And Options Exercised Weighted Average Exercise Price</link:label>
    <link:loc xlink:label="loc_WarrantsAndOptionsGrantedWeightedAverageExercisePrice.25565.11.12" xlink:href="psti-20140630.xsd#psti_WarrantsAndOptionsGrantedWeightedAverageExercisePrice" xlink:type="locator" />
    <link:labelArc xlink:from="loc_WarrantsAndOptionsGrantedWeightedAverageExercisePrice.25565.11.12" xlink:to="lab_WarrantsAndOptionsGrantedWeightedAverageExercisePrice.1922001.254195.250654.255894" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_WarrantsAndOptionsGrantedWeightedAverageExercisePrice.1922001.254195.250654.255894" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US" id="lab_WarrantsAndOptionsGrantedWeightedAverageExercisePrice.1922001.254195.250654.255894">Warrants and options granted weighted average exercise price.</link:label>
    <link:loc xlink:label="loc_WarrantsAndOptionsGrantedWeightedAverageExercisePrice.25565.11.7" xlink:href="psti-20140630.xsd#psti_WarrantsAndOptionsGrantedWeightedAverageExercisePrice" xlink:type="locator" />
    <link:labelArc xlink:from="loc_WarrantsAndOptionsGrantedWeightedAverageExercisePrice.25565.11.7" xlink:to="lab_WarrantsAndOptionsGrantedWeightedAverageExercisePrice.1922002.254194.250655.255895" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_WarrantsAndOptionsGrantedWeightedAverageExercisePrice.1922002.254194.250655.255895" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US" id="lab_WarrantsAndOptionsGrantedWeightedAverageExercisePrice.1922002.254194.250655.255895">Options granted</link:label>
    <link:loc xlink:label="loc_WarrantsAndOptionsGrantedWeightedAverageExercisePrice.25565.11.6" xlink:href="psti-20140630.xsd#psti_WarrantsAndOptionsGrantedWeightedAverageExercisePrice" xlink:type="locator" />
    <link:labelArc xlink:from="loc_WarrantsAndOptionsGrantedWeightedAverageExercisePrice.25565.11.6" xlink:to="lab_WarrantsAndOptionsGrantedWeightedAverageExercisePrice.250653.255893" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_WarrantsAndOptionsGrantedWeightedAverageExercisePrice.250653.255893" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US" id="lab_WarrantsAndOptionsGrantedWeightedAverageExercisePrice.250653.255893">Warrants And Options Granted Weighted Average Exercise Price</link:label>
    <link:loc xlink:label="loc_WarrantsAndOptionsNumberAbstract.25566.11.6" xlink:href="psti-20140630.xsd#psti_WarrantsAndOptionsNumberAbstract" xlink:type="locator" />
    <link:labelArc xlink:from="loc_WarrantsAndOptionsNumberAbstract.25566.11.6" xlink:to="lab_WarrantsAndOptionsNumberAbstract.1921957.254196.250656.255896" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_WarrantsAndOptionsNumberAbstract.1921957.254196.250656.255896" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US" id="lab_WarrantsAndOptionsNumberAbstract.1921957.254196.250656.255896">Warrants And Options Number [Abstract]</link:label>
    <link:loc xlink:label="loc_WarrantsAndOptionsNumberAbstract.25566.11.12" xlink:href="psti-20140630.xsd#psti_WarrantsAndOptionsNumberAbstract" xlink:type="locator" />
    <link:labelArc xlink:from="loc_WarrantsAndOptionsNumberAbstract.25566.11.12" xlink:to="lab_WarrantsAndOptionsNumberAbstract.1921958.254198.250657.255897" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_WarrantsAndOptionsNumberAbstract.1921958.254198.250657.255897" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US" id="lab_WarrantsAndOptionsNumberAbstract.1921958.254198.250657.255897">Warrants And Options Number [Abstract].</link:label>
    <link:loc xlink:label="loc_WarrantsAndOptionsNumberAbstract.25566.11.7" xlink:href="psti-20140630.xsd#psti_WarrantsAndOptionsNumberAbstract" xlink:type="locator" />
    <link:labelArc xlink:from="loc_WarrantsAndOptionsNumberAbstract.25566.11.7" xlink:to="lab_WarrantsAndOptionsNumberAbstract.1921959.254197.250658.255898" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_WarrantsAndOptionsNumberAbstract.1921959.254197.250658.255898" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US" id="lab_WarrantsAndOptionsNumberAbstract.1921959.254197.250658.255898">Number</link:label>
    <link:loc xlink:label="loc_WarrantsAndOptionsWeightedAverageExercisePrice.25567.11.6" xlink:href="psti-20140630.xsd#psti_WarrantsAndOptionsWeightedAverageExercisePrice" xlink:type="locator" />
    <link:labelArc xlink:from="loc_WarrantsAndOptionsWeightedAverageExercisePrice.25567.11.6" xlink:to="lab_WarrantsAndOptionsWeightedAverageExercisePrice.1921995.254199.250659.255899" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_WarrantsAndOptionsWeightedAverageExercisePrice.1921995.254199.250659.255899" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US" id="lab_WarrantsAndOptionsWeightedAverageExercisePrice.1921995.254199.250659.255899">Warrants And Options Weighted Average Exercise Price</link:label>
    <link:loc xlink:label="loc_WarrantsAndOptionsWeightedAverageExercisePrice.25567.11.12" xlink:href="psti-20140630.xsd#psti_WarrantsAndOptionsWeightedAverageExercisePrice" xlink:type="locator" />
    <link:labelArc xlink:from="loc_WarrantsAndOptionsWeightedAverageExercisePrice.25567.11.12" xlink:to="lab_WarrantsAndOptionsWeightedAverageExercisePrice.1921996.254201.250660.255900" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_WarrantsAndOptionsWeightedAverageExercisePrice.1921996.254201.250660.255900" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US" id="lab_WarrantsAndOptionsWeightedAverageExercisePrice.1921996.254201.250660.255900">Warrants and options weighted average exercise price.</link:label>
    <link:loc xlink:label="loc_WarrantsAndOptionsWeightedAverageExercisePrice.25567.11.10" xlink:href="psti-20140630.xsd#psti_WarrantsAndOptionsWeightedAverageExercisePrice" xlink:type="locator" />
    <link:labelArc xlink:from="loc_WarrantsAndOptionsWeightedAverageExercisePrice.25567.11.10" xlink:to="lab_WarrantsAndOptionsWeightedAverageExercisePrice.1921998.254200.250661.255901" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_WarrantsAndOptionsWeightedAverageExercisePrice.1921998.254200.250661.255901" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xml:lang="en-US" id="lab_WarrantsAndOptionsWeightedAverageExercisePrice.1921998.254200.250661.255901">Options and warrants outstanding at beginning of period</link:label>
    <link:loc xlink:label="loc_WarrantsAndOptionsWeightedAverageExercisePrice.25567.11.11" xlink:href="psti-20140630.xsd#psti_WarrantsAndOptionsWeightedAverageExercisePrice" xlink:type="locator" />
    <link:labelArc xlink:from="loc_WarrantsAndOptionsWeightedAverageExercisePrice.25567.11.11" xlink:to="lab_WarrantsAndOptionsWeightedAverageExercisePrice.1921999.254202.250662.255902" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_WarrantsAndOptionsWeightedAverageExercisePrice.1921999.254202.250662.255902" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xml:lang="en-US" id="lab_WarrantsAndOptionsWeightedAverageExercisePrice.1921999.254202.250662.255902">Options and warrants outstanding at end of the period</link:label>
    <link:loc xlink:label="loc_WarrantsAndOptionsWeightedAverageExercisePriceAbstract.25568.11.6" xlink:href="psti-20140630.xsd#psti_WarrantsAndOptionsWeightedAverageExercisePriceAbstract" xlink:type="locator" />
    <link:labelArc xlink:from="loc_WarrantsAndOptionsWeightedAverageExercisePriceAbstract.25568.11.6" xlink:to="lab_WarrantsAndOptionsWeightedAverageExercisePriceAbstract.1921960.254203.250663.255903" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_WarrantsAndOptionsWeightedAverageExercisePriceAbstract.1921960.254203.250663.255903" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US" id="lab_WarrantsAndOptionsWeightedAverageExercisePriceAbstract.1921960.254203.250663.255903">Warrants And Options Weighted Average Exercise Price [Abstract]</link:label>
    <link:loc xlink:label="loc_WarrantsAndOptionsWeightedAverageExercisePriceAbstract.25568.11.12" xlink:href="psti-20140630.xsd#psti_WarrantsAndOptionsWeightedAverageExercisePriceAbstract" xlink:type="locator" />
    <link:labelArc xlink:from="loc_WarrantsAndOptionsWeightedAverageExercisePriceAbstract.25568.11.12" xlink:to="lab_WarrantsAndOptionsWeightedAverageExercisePriceAbstract.1921961.254205.250664.255904" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_WarrantsAndOptionsWeightedAverageExercisePriceAbstract.1921961.254205.250664.255904" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US" id="lab_WarrantsAndOptionsWeightedAverageExercisePriceAbstract.1921961.254205.250664.255904">Warrants and options weighted average exercise price [Abstract].</link:label>
    <link:loc xlink:label="loc_WarrantsAndOptionsWeightedAverageExercisePriceAbstract.25568.11.7" xlink:href="psti-20140630.xsd#psti_WarrantsAndOptionsWeightedAverageExercisePriceAbstract" xlink:type="locator" />
    <link:labelArc xlink:from="loc_WarrantsAndOptionsWeightedAverageExercisePriceAbstract.25568.11.7" xlink:to="lab_WarrantsAndOptionsWeightedAverageExercisePriceAbstract.1921962.254204.250665.255905" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_WarrantsAndOptionsWeightedAverageExercisePriceAbstract.1921962.254204.250665.255905" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US" id="lab_WarrantsAndOptionsWeightedAverageExercisePriceAbstract.1921962.254204.250665.255905">Weighted average exercise price</link:label>
    <link:loc xlink:label="loc_WarrantsAndOptionsWeightedAverageExercisePriceExcercisable.25569.11.6" xlink:href="psti-20140630.xsd#psti_WarrantsAndOptionsWeightedAverageExercisePriceExcercisable" xlink:type="locator" />
    <link:labelArc xlink:from="loc_WarrantsAndOptionsWeightedAverageExercisePriceExcercisable.25569.11.6" xlink:to="lab_WarrantsAndOptionsWeightedAverageExercisePriceExcercisable.1922006.254206.250666.255906" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_WarrantsAndOptionsWeightedAverageExercisePriceExcercisable.1922006.254206.250666.255906" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US" id="lab_WarrantsAndOptionsWeightedAverageExercisePriceExcercisable.1922006.254206.250666.255906">Warrants And Options Weighted Average Exercise Price Excercisable</link:label>
    <link:loc xlink:label="loc_WarrantsAndOptionsWeightedAverageExercisePriceExcercisable.25569.11.12" xlink:href="psti-20140630.xsd#psti_WarrantsAndOptionsWeightedAverageExercisePriceExcercisable" xlink:type="locator" />
    <link:labelArc xlink:from="loc_WarrantsAndOptionsWeightedAverageExercisePriceExcercisable.25569.11.12" xlink:to="lab_WarrantsAndOptionsWeightedAverageExercisePriceExcercisable.1922007.254208.250667.255907" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_WarrantsAndOptionsWeightedAverageExercisePriceExcercisable.1922007.254208.250667.255907" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US" id="lab_WarrantsAndOptionsWeightedAverageExercisePriceExcercisable.1922007.254208.250667.255907">Warrants and options weighted average exercise price excercisable.</link:label>
    <link:loc xlink:label="loc_WarrantsAndOptionsWeightedAverageExercisePriceVestedAndExpectedToVest.25570.11.6" xlink:href="psti-20140630.xsd#psti_WarrantsAndOptionsWeightedAverageExercisePriceVestedAndExpectedToVest" xlink:type="locator" />
    <link:labelArc xlink:from="loc_WarrantsAndOptionsWeightedAverageExercisePriceVestedAndExpectedToVest.25570.11.6" xlink:to="lab_WarrantsAndOptionsWeightedAverageExercisePriceVestedAndExpectedToVest.1922009.254209.250669.255908" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_WarrantsAndOptionsWeightedAverageExercisePriceVestedAndExpectedToVest.1922009.254209.250669.255908" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US" id="lab_WarrantsAndOptionsWeightedAverageExercisePriceVestedAndExpectedToVest.1922009.254209.250669.255908">Warrants And Options Weighted Average Exercise Price Vested And Expected To Vest</link:label>
    <link:loc xlink:label="loc_WarrantsAndOptionsWeightedAverageExercisePriceVestedAndExpectedToVest.25570.11.12" xlink:href="psti-20140630.xsd#psti_WarrantsAndOptionsWeightedAverageExercisePriceVestedAndExpectedToVest" xlink:type="locator" />
    <link:labelArc xlink:from="loc_WarrantsAndOptionsWeightedAverageExercisePriceVestedAndExpectedToVest.25570.11.12" xlink:to="lab_WarrantsAndOptionsWeightedAverageExercisePriceVestedAndExpectedToVest.1922010.254211.250670.255909" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_WarrantsAndOptionsWeightedAverageExercisePriceVestedAndExpectedToVest.1922010.254211.250670.255909" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US" id="lab_WarrantsAndOptionsWeightedAverageExercisePriceVestedAndExpectedToVest.1922010.254211.250670.255909">Warrants and options weighted average exercise price vested and expected to vest.</link:label>
    <link:loc xlink:label="loc_WarrantsAndOptionsWeightedAverageRemainingContractualTerm.25571.11.12" xlink:href="psti-20140630.xsd#psti_WarrantsAndOptionsWeightedAverageRemainingContractualTerm" xlink:type="locator" />
    <link:labelArc xlink:from="loc_WarrantsAndOptionsWeightedAverageRemainingContractualTerm.25571.11.12" xlink:to="lab_WarrantsAndOptionsWeightedAverageRemainingContractualTerm.1922016.254214.250673.255910" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_WarrantsAndOptionsWeightedAverageRemainingContractualTerm.1922016.254214.250673.255910" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US" id="lab_WarrantsAndOptionsWeightedAverageRemainingContractualTerm.1922016.254214.250673.255910">Warrants and pptions weighted average remaining contractual term.</link:label>
    <link:loc xlink:label="loc_WarrantsAndOptionsWeightedAverageRemainingContractualTerm.25571.11.7" xlink:href="psti-20140630.xsd#psti_WarrantsAndOptionsWeightedAverageRemainingContractualTerm" xlink:type="locator" />
    <link:labelArc xlink:from="loc_WarrantsAndOptionsWeightedAverageRemainingContractualTerm.25571.11.7" xlink:to="lab_WarrantsAndOptionsWeightedAverageRemainingContractualTerm.1922017.254213.250674.255911" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_WarrantsAndOptionsWeightedAverageRemainingContractualTerm.1922017.254213.250674.255911" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US" id="lab_WarrantsAndOptionsWeightedAverageRemainingContractualTerm.1922017.254213.250674.255911">Options and warrants outstanding at end of the period</link:label>
    <link:loc xlink:label="loc_WarrantsAndOptionsWeightedAverageRemainingContractualTerm.25571.11.6" xlink:href="psti-20140630.xsd#psti_WarrantsAndOptionsWeightedAverageRemainingContractualTerm" xlink:type="locator" />
    <link:labelArc xlink:from="loc_WarrantsAndOptionsWeightedAverageRemainingContractualTerm.25571.11.6" xlink:to="lab_WarrantsAndOptionsWeightedAverageRemainingContractualTerm.254212.250672.255912" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_WarrantsAndOptionsWeightedAverageRemainingContractualTerm.254212.250672.255912" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US" id="lab_WarrantsAndOptionsWeightedAverageRemainingContractualTerm.254212.250672.255912">Warrants And Options Weighted Average Remaining Contractual Term</link:label>
    <link:loc xlink:label="loc_WarrantsAndOptionsWeightedAverageRemainingContractualTermExercisable.25572.11.12" xlink:href="psti-20140630.xsd#psti_WarrantsAndOptionsWeightedAverageRemainingContractualTermExercisable" xlink:type="locator" />
    <link:labelArc xlink:from="loc_WarrantsAndOptionsWeightedAverageRemainingContractualTermExercisable.25572.11.12" xlink:to="lab_WarrantsAndOptionsWeightedAverageRemainingContractualTermExercisable.1922020.254217.250676.255913" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_WarrantsAndOptionsWeightedAverageRemainingContractualTermExercisable.1922020.254217.250676.255913" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US" id="lab_WarrantsAndOptionsWeightedAverageRemainingContractualTermExercisable.1922020.254217.250676.255913">Warrants and options weighted average remaining contractual term exercisable.</link:label>
    <link:loc xlink:label="loc_WarrantsAndOptionsWeightedAverageRemainingContractualTermExercisable.25572.11.7" xlink:href="psti-20140630.xsd#psti_WarrantsAndOptionsWeightedAverageRemainingContractualTermExercisable" xlink:type="locator" />
    <link:labelArc xlink:from="loc_WarrantsAndOptionsWeightedAverageRemainingContractualTermExercisable.25572.11.7" xlink:to="lab_WarrantsAndOptionsWeightedAverageRemainingContractualTermExercisable.1922021.254216.250677.255914" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_WarrantsAndOptionsWeightedAverageRemainingContractualTermExercisable.1922021.254216.250677.255914" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US" id="lab_WarrantsAndOptionsWeightedAverageRemainingContractualTermExercisable.1922021.254216.250677.255914">Options and warrants exercisable at the end of the period</link:label>
    <link:loc xlink:label="loc_WarrantsAndOptionsWeightedAverageRemainingContractualTermExercisable.25572.11.6" xlink:href="psti-20140630.xsd#psti_WarrantsAndOptionsWeightedAverageRemainingContractualTermExercisable" xlink:type="locator" />
    <link:labelArc xlink:from="loc_WarrantsAndOptionsWeightedAverageRemainingContractualTermExercisable.25572.11.6" xlink:to="lab_WarrantsAndOptionsWeightedAverageRemainingContractualTermExercisable.254215.250675.255915" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_WarrantsAndOptionsWeightedAverageRemainingContractualTermExercisable.254215.250675.255915" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US" id="lab_WarrantsAndOptionsWeightedAverageRemainingContractualTermExercisable.254215.250675.255915">Warrants And Options Weighted Average Remaining Contractual Term Exercisable</link:label>
    <link:loc xlink:label="loc_WarrantsAndOptionsWeightedAverageRemainingContractualTermsAbstract.25573.11.6" xlink:href="psti-20140630.xsd#psti_WarrantsAndOptionsWeightedAverageRemainingContractualTermsAbstract" xlink:type="locator" />
    <link:labelArc xlink:from="loc_WarrantsAndOptionsWeightedAverageRemainingContractualTermsAbstract.25573.11.6" xlink:to="lab_WarrantsAndOptionsWeightedAverageRemainingContractualTermsAbstract.1921963.254218.250678.255916" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_WarrantsAndOptionsWeightedAverageRemainingContractualTermsAbstract.1921963.254218.250678.255916" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US" id="lab_WarrantsAndOptionsWeightedAverageRemainingContractualTermsAbstract.1921963.254218.250678.255916">Warrants And Options Weighted Average Remaining Contractual Terms Abstract</link:label>
    <link:loc xlink:label="loc_WarrantsAndOptionsWeightedAverageRemainingContractualTermsAbstract.25573.11.12" xlink:href="psti-20140630.xsd#psti_WarrantsAndOptionsWeightedAverageRemainingContractualTermsAbstract" xlink:type="locator" />
    <link:labelArc xlink:from="loc_WarrantsAndOptionsWeightedAverageRemainingContractualTermsAbstract.25573.11.12" xlink:to="lab_WarrantsAndOptionsWeightedAverageRemainingContractualTermsAbstract.1921964.254220.250679.255917" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_WarrantsAndOptionsWeightedAverageRemainingContractualTermsAbstract.1921964.254220.250679.255917" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US" id="lab_WarrantsAndOptionsWeightedAverageRemainingContractualTermsAbstract.1921964.254220.250679.255917">Warrants And Options Weighted Average Remaining Contractual Terms [Abstract].</link:label>
    <link:loc xlink:label="loc_WarrantsAndOptionsWeightedAverageRemainingContractualTermsAbstract.25573.11.7" xlink:href="psti-20140630.xsd#psti_WarrantsAndOptionsWeightedAverageRemainingContractualTermsAbstract" xlink:type="locator" />
    <link:labelArc xlink:from="loc_WarrantsAndOptionsWeightedAverageRemainingContractualTermsAbstract.25573.11.7" xlink:to="lab_WarrantsAndOptionsWeightedAverageRemainingContractualTermsAbstract.1921965.254219.250680.255918" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_WarrantsAndOptionsWeightedAverageRemainingContractualTermsAbstract.1921965.254219.250680.255918" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US" id="lab_WarrantsAndOptionsWeightedAverageRemainingContractualTermsAbstract.1921965.254219.250680.255918">Weighted average remaining contractual term</link:label>
    <link:loc xlink:label="loc_WarrantsAndOptionsWeightedAverageRemainingContractualTermVestedAndExpectedToVest.25574.11.12" xlink:href="psti-20140630.xsd#psti_WarrantsAndOptionsWeightedAverageRemainingContractualTermVestedAndExpectedToVest" xlink:type="locator" />
    <link:labelArc xlink:from="loc_WarrantsAndOptionsWeightedAverageRemainingContractualTermVestedAndExpectedToVest.25574.11.12" xlink:to="lab_WarrantsAndOptionsWeightedAverageRemainingContractualTermVestedAndExpectedToVest.1922023.254223.250682.255919" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_WarrantsAndOptionsWeightedAverageRemainingContractualTermVestedAndExpectedToVest.1922023.254223.250682.255919" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US" id="lab_WarrantsAndOptionsWeightedAverageRemainingContractualTermVestedAndExpectedToVest.1922023.254223.250682.255919">Warrants and options weighted average remaining contractual term vested and expected to vest.</link:label>
    <link:loc xlink:label="loc_WarrantsAndOptionsWeightedAverageRemainingContractualTermVestedAndExpectedToVest.25574.11.7" xlink:href="psti-20140630.xsd#psti_WarrantsAndOptionsWeightedAverageRemainingContractualTermVestedAndExpectedToVest" xlink:type="locator" />
    <link:labelArc xlink:from="loc_WarrantsAndOptionsWeightedAverageRemainingContractualTermVestedAndExpectedToVest.25574.11.7" xlink:to="lab_WarrantsAndOptionsWeightedAverageRemainingContractualTermVestedAndExpectedToVest.1922024.254222.250683.255920" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_WarrantsAndOptionsWeightedAverageRemainingContractualTermVestedAndExpectedToVest.1922024.254222.250683.255920" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US" id="lab_WarrantsAndOptionsWeightedAverageRemainingContractualTermVestedAndExpectedToVest.1922024.254222.250683.255920">Options and warrants vested and expected to vest</link:label>
    <link:loc xlink:label="loc_WarrantsAndOptionsWeightedAverageRemainingContractualTermVestedAndExpectedToVest.25574.11.6" xlink:href="psti-20140630.xsd#psti_WarrantsAndOptionsWeightedAverageRemainingContractualTermVestedAndExpectedToVest" xlink:type="locator" />
    <link:labelArc xlink:from="loc_WarrantsAndOptionsWeightedAverageRemainingContractualTermVestedAndExpectedToVest.25574.11.6" xlink:to="lab_WarrantsAndOptionsWeightedAverageRemainingContractualTermVestedAndExpectedToVest.254221.250681.255921" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_WarrantsAndOptionsWeightedAverageRemainingContractualTermVestedAndExpectedToVest.254221.250681.255921" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US" id="lab_WarrantsAndOptionsWeightedAverageRemainingContractualTermVestedAndExpectedToVest.254221.250681.255921">Warrants And Options Weighted Average Remaining Contractual Term Vested And Expected To Vest</link:label>
    <link:loc xlink:label="loc_SharebasedGoodsAndNonemployeesServicesTransactionWarrantsAndOptionsNumberExercisable.25551.11.11" xlink:href="psti-20140630.xsd#psti_SharebasedGoodsAndNonemployeesServicesTransactionWarrantsAndOptionsNumberExercisable" xlink:type="locator" />
    <link:labelArc xlink:from="loc_SharebasedGoodsAndNonemployeesServicesTransactionWarrantsAndOptionsNumberExercisable.25551.11.11" xlink:to="SharebasedGoodsAndNonemployeesServicesTransactionWarrantsAndOptionsNumberExercisable.358848.255922" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="SharebasedGoodsAndNonemployeesServicesTransactionWarrantsAndOptionsNumberExercisable.358848.255922" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xml:lang="en-US" id="SharebasedGoodsAndNonemployeesServicesTransactionWarrantsAndOptionsNumberExercisable.358848.255922">Options and warrants exercisable at the end of the period</link:label>
    <link:loc xlink:label="loc_SharebasedGoodsAndNonemployeesServicesTransactionWarrantsAndOptionsNumberVestedAndExpectedToVest.25552.11.11" xlink:href="psti-20140630.xsd#psti_SharebasedGoodsAndNonemployeesServicesTransactionWarrantsAndOptionsNumberVestedAndExpectedToVest" xlink:type="locator" />
    <link:labelArc xlink:from="loc_SharebasedGoodsAndNonemployeesServicesTransactionWarrantsAndOptionsNumberVestedAndExpectedToVest.25552.11.11" xlink:to="SharebasedGoodsAndNonemployeesServicesTransactionWarrantsAndOptionsNumberVestedAndExpectedToVest.358849.255923" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="SharebasedGoodsAndNonemployeesServicesTransactionWarrantsAndOptionsNumberVestedAndExpectedToVest.358849.255923" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xml:lang="en-US" id="SharebasedGoodsAndNonemployeesServicesTransactionWarrantsAndOptionsNumberVestedAndExpectedToVest.358849.255923">Options and warrants vested and expected to vest</link:label>
    <link:loc xlink:label="loc_WarrantsAndOptionsWeightedAverageExercisePriceExcercisable.25569.11.11" xlink:href="psti-20140630.xsd#psti_WarrantsAndOptionsWeightedAverageExercisePriceExcercisable" xlink:type="locator" />
    <link:labelArc xlink:from="loc_WarrantsAndOptionsWeightedAverageExercisePriceExcercisable.25569.11.11" xlink:to="WarrantsAndOptionsWeightedAverageExercisePriceExcercisable.358847.255924" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="WarrantsAndOptionsWeightedAverageExercisePriceExcercisable.358847.255924" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xml:lang="en-US" id="WarrantsAndOptionsWeightedAverageExercisePriceExcercisable.358847.255924">Options and warrants exercisable at the end of the period</link:label>
    <link:loc xlink:label="loc_WarrantsAndOptionsWeightedAverageExercisePriceVestedAndExpectedToVest.25570.11.11" xlink:href="psti-20140630.xsd#psti_WarrantsAndOptionsWeightedAverageExercisePriceVestedAndExpectedToVest" xlink:type="locator" />
    <link:labelArc xlink:from="loc_WarrantsAndOptionsWeightedAverageExercisePriceVestedAndExpectedToVest.25570.11.11" xlink:to="WarrantsAndOptionsWeightedAverageExercisePriceVestedAndExpectedToVest.358850.255925" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="WarrantsAndOptionsWeightedAverageExercisePriceVestedAndExpectedToVest.358850.255925" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xml:lang="en-US" id="WarrantsAndOptionsWeightedAverageExercisePriceVestedAndExpectedToVest.358850.255925">Options and warrants vested and expected to vest</link:label>
    <link:loc xlink:label="loc_ScheduleOfShareBasedGoodsAndNonemployeeServicesTransactionTable.4869.11.6" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ScheduleOfShareBasedGoodsAndNonemployeeServicesTransactionTable" xlink:type="locator" />
    <link:labelArc xlink:from="loc_ScheduleOfShareBasedGoodsAndNonemployeeServicesTransactionTable.4869.11.6" xlink:to="lab_ScheduleOfShareBasedGoodsAndNonemployeeServicesTransactionTable.17634.255969" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_ScheduleOfShareBasedGoodsAndNonemployeeServicesTransactionTable.17634.255969" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US" id="lab_ScheduleOfShareBasedGoodsAndNonemployeeServicesTransactionTable.17634.255969">Schedule of Share-based Goods and Nonemployee Services Transaction [Table]</link:label>
    <link:loc xlink:label="loc_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsExpectedToVest.25547.11.6" xlink:href="psti-20140630.xsd#psti_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsExpectedToVest" xlink:type="locator" />
    <link:labelArc xlink:from="loc_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsExpectedToVest.25547.11.6" xlink:to="lab_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsExpectedToVest.1922041.254235.250701.255970" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsExpectedToVest.1922041.254235.250701.255970" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US" id="lab_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsExpectedToVest.1922041.254235.250701.255970">Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Expected To Vest</link:label>
    <link:loc xlink:label="loc_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsExpectedToVest.25547.11.12" xlink:href="psti-20140630.xsd#psti_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsExpectedToVest" xlink:type="locator" />
    <link:labelArc xlink:from="loc_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsExpectedToVest.25547.11.12" xlink:to="lab_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsExpectedToVest.1922042.254237.250702.255971" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsExpectedToVest.1922042.254237.250702.255971" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US" id="lab_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsExpectedToVest.1922042.254237.250702.255971">Share based compensation arrangement by share based payment award equity instruments other than options expected to vest.</link:label>
    <link:loc xlink:label="loc_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsExpectedToVest.25547.11.7" xlink:href="psti-20140630.xsd#psti_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsExpectedToVest" xlink:type="locator" />
    <link:labelArc xlink:from="loc_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsExpectedToVest.25547.11.7" xlink:to="lab_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsExpectedToVest.1922043.254236.250703.255972" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsExpectedToVest.1922043.254236.250703.255972" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US" id="lab_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsExpectedToVest.1922043.254236.250703.255972">Expected to vest</link:label>
    <link:loc xlink:label="loc_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod.16661.11.6" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" xlink:type="locator" />
    <link:labelArc xlink:from="loc_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod.16661.11.6" xlink:to="lab_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod.7585.254229.250704.255973" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod.7585.254229.250704.255973" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US" id="lab_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod.7585.254229.250704.255973">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Forfeited in Period</link:label>
    <link:loc xlink:label="loc_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod.16661.11.53" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" xlink:type="locator" />
    <link:labelArc xlink:from="loc_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod.16661.11.53" xlink:to="lab_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod42.134172.250705.255974" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod42.134172.250705.255974" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xml:lang="en-US" id="lab_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod42.134172.250705.255974">Forfeited</link:label>
    <link:loc xlink:label="loc_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod.16617.11.6" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:type="locator" />
    <link:labelArc xlink:from="loc_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod.16617.11.6" xlink:to="lab_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod.7587.254238.250706.255975" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod.7587.254238.250706.255975" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US" id="lab_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod.7587.254238.250706.255975">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period</link:label>
    <link:loc xlink:label="loc_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber.16626.11.10" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:type="locator" />
    <link:labelArc xlink:from="loc_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber.16626.11.10" xlink:to="lab_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber.1922045.254240.250707.255976" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber.1922045.254240.250707.255976" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xml:lang="en-US" id="lab_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber.1922045.254240.250707.255976">Unvested at the beginning of period</link:label>
    <link:loc xlink:label="loc_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber.16626.11.11" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:type="locator" />
    <link:labelArc xlink:from="loc_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber.16626.11.11" xlink:to="lab_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber.1922047.254241.250708.255977" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber.1922047.254241.250708.255977" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xml:lang="en-US" id="lab_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber.1922047.254241.250708.255977">Unvested at the end of the period</link:label>
    <link:loc xlink:label="loc_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber.16626.11.6" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:type="locator" />
    <link:labelArc xlink:from="loc_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber.16626.11.6" xlink:to="lab_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber.7593.254239.250709.255978" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber.7593.254239.250709.255978" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US" id="lab_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber.7593.254239.250709.255978">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number</link:label>
    <link:loc xlink:label="loc_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod.16633.11.6" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" xlink:type="locator" />
    <link:labelArc xlink:from="loc_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod.16633.11.6" xlink:to="lab_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod.7598.254242.250710.255979" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod.7598.254242.250710.255979" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US" id="lab_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod.7598.254242.250710.255979">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period</link:label>
    <link:loc xlink:label="loc_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod.16633.11.53" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" xlink:type="locator" />
    <link:labelArc xlink:from="loc_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod.16633.11.53" xlink:to="lab_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod42.134171.250711.255980" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod42.134171.250711.255980" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xml:lang="en-US" id="lab_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod42.134171.250711.255980">Vested</link:label>
    <link:loc xlink:label="loc_ShareBasedGoodsAndNonemployeeServicesTransactionLineItems.5038.11.6" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ShareBasedGoodsAndNonemployeeServicesTransactionLineItems" xlink:type="locator" />
    <link:labelArc xlink:from="loc_ShareBasedGoodsAndNonemployeeServicesTransactionLineItems.5038.11.6" xlink:to="lab_ShareBasedGoodsAndNonemployeeServicesTransactionLineItems.18305.255981" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_ShareBasedGoodsAndNonemployeeServicesTransactionLineItems.18305.255981" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US" id="lab_ShareBasedGoodsAndNonemployeeServicesTransactionLineItems.18305.255981">Share-based Goods and Nonemployee Services Transaction [Line Items]</link:label>
    <link:loc xlink:label="loc_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod.16617.11.7" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:type="locator" />
    <link:labelArc xlink:from="loc_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod.16617.11.7" xlink:to="ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod.1858164.254246.250712.255982" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod.1858164.254246.250712.255982" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US" id="ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod.1858164.254246.250712.255982">Granted</link:label>
    <link:loc xlink:label="loc_ConsultantRestrictedStockUnitsMember.25534.11.6" xlink:href="psti-20140630.xsd#psti_ConsultantRestrictedStockUnitsMember" xlink:type="locator" />
    <link:labelArc xlink:from="loc_ConsultantRestrictedStockUnitsMember.25534.11.6" xlink:to="lab_ConsultantRestrictedStockUnitsMember.250699.255983" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_ConsultantRestrictedStockUnitsMember.250699.255983" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US" id="lab_ConsultantRestrictedStockUnitsMember.250699.255983">Consultant Restricted Stock Units [Member]</link:label>
    <link:loc xlink:label="loc_ConsultantRestrictedStockUnitsMember.25534.11.12" xlink:href="psti-20140630.xsd#psti_ConsultantRestrictedStockUnitsMember" xlink:type="locator" />
    <link:labelArc xlink:from="loc_ConsultantRestrictedStockUnitsMember.25534.11.12" xlink:to="lab_ConsultantRestrictedStockUnitsMember.250700.255985" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_ConsultantRestrictedStockUnitsMember.250700.255985" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US" id="lab_ConsultantRestrictedStockUnitsMember.250700.255985">Share instrument which is convertible to stock or an equivalent amount of cash, after a specified period of time or when specified performance conditions are met, issued to consultants.</link:label>
    <link:loc xlink:label="loc_ConsultantRestrictedStockUnitsMember.25534.11.7" xlink:href="psti-20140630.xsd#psti_ConsultantRestrictedStockUnitsMember" xlink:type="locator" />
    <link:labelArc xlink:from="loc_ConsultantRestrictedStockUnitsMember.25534.11.7" xlink:to="lab_ConsultantRestrictedStockUnitsMember.327664.255984" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_ConsultantRestrictedStockUnitsMember.327664.255984" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US" id="lab_ConsultantRestrictedStockUnitsMember.327664.255984">Consultant restricted stock units [Member]</link:label>
    <link:loc xlink:label="loc_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock.16254.11.6" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock" xlink:type="locator" />
    <link:labelArc xlink:from="loc_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock.16254.11.6" xlink:to="lab_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock.14110.254378.250925.255986" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock.14110.254378.250925.255986" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US" id="lab_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock.14110.254378.250925.255986">Schedule of Employee Service Share-based Compensation, Allocation of Recognized Period Costs [Table Text Block]</link:label>
    <link:loc xlink:label="loc_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock.16254.11.7" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock" xlink:type="locator" />
    <link:labelArc xlink:from="loc_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock.16254.11.7" xlink:to="lab_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock7.1922196.254379.250926.255987" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock7.1922196.254379.250926.255987" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US" id="lab_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock7.1922196.254379.250926.255987">Schedule of Stock-based Compensation Expenses</link:label>
    <link:loc xlink:label="loc_ScheduleOfNonvestedRestrictedStockUnitsActivityTableTextBlock.16168.11.6" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ScheduleOfNonvestedRestrictedStockUnitsActivityTableTextBlock" xlink:type="locator" />
    <link:labelArc xlink:from="loc_ScheduleOfNonvestedRestrictedStockUnitsActivityTableTextBlock.16168.11.6" xlink:to="lab_ScheduleOfNonvestedRestrictedStockUnitsActivityTableTextBlock.13776.254380.250927.255988" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_ScheduleOfNonvestedRestrictedStockUnitsActivityTableTextBlock.13776.254380.250927.255988" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US" id="lab_ScheduleOfNonvestedRestrictedStockUnitsActivityTableTextBlock.13776.254380.250927.255988">Schedule of Nonvested Restricted Stock Units Activity [Table Text Block]</link:label>
    <link:loc xlink:label="loc_ScheduleOfNonvestedRestrictedStockUnitsActivityTableTextBlock.16168.11.7" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ScheduleOfNonvestedRestrictedStockUnitsActivityTableTextBlock" xlink:type="locator" />
    <link:labelArc xlink:from="loc_ScheduleOfNonvestedRestrictedStockUnitsActivityTableTextBlock.16168.11.7" xlink:to="lab_ScheduleOfNonvestedRestrictedStockUnitsActivityTableTextBlock.1922194.254381.250928.255989" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_ScheduleOfNonvestedRestrictedStockUnitsActivityTableTextBlock.1922194.254381.250928.255989" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US" id="lab_ScheduleOfNonvestedRestrictedStockUnitsActivityTableTextBlock.1922194.254381.250928.255989">Schedule of Unvested Restricted Stock Units</link:label>
    <link:loc xlink:label="loc_ScheduleOfShareBasedCompensationActivityTableTextBlock.16175.11.7" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationActivityTableTextBlock" xlink:type="locator" />
    <link:labelArc xlink:from="loc_ScheduleOfShareBasedCompensationActivityTableTextBlock.16175.11.7" xlink:to="lab_ScheduleOfShareBasedCompensationActivityTableTextBlock.135278.327666.255991" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_ScheduleOfShareBasedCompensationActivityTableTextBlock.135278.327666.255991" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US" id="lab_ScheduleOfShareBasedCompensationActivityTableTextBlock.135278.327666.255991">Schedule of Stock Option and Warrant Activity</link:label>
    <link:loc xlink:label="loc_ScheduleOfShareBasedCompensationActivityTableTextBlock.16175.11.6" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationActivityTableTextBlock" xlink:type="locator" />
    <link:labelArc xlink:from="loc_ScheduleOfShareBasedCompensationActivityTableTextBlock.16175.11.6" xlink:to="lab_ScheduleOfShareBasedCompensationActivityTableTextBlock.17289.255990" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_ScheduleOfShareBasedCompensationActivityTableTextBlock.17289.255990" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US" id="lab_ScheduleOfShareBasedCompensationActivityTableTextBlock.17289.255990">Schedule of Share-based Compensation, Activity [Table Text Block]</link:label>
    <link:loc xlink:label="loc_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTextBlock.16376.11.6" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTextBlock" xlink:type="locator" />
    <link:labelArc xlink:from="loc_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTextBlock.16376.11.6" xlink:to="lab_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTextBlock.17446" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTextBlock.17446" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US" id="lab_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTextBlock.17446">Schedule of Share-based Compensation, Shares Authorized under Stock Option Plans, by Exercise Price Range [Table Text Block]</link:label>
    <link:loc xlink:label="loc_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTextBlock.16376.11.7" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTextBlock" xlink:type="locator" />
    <link:labelArc xlink:from="loc_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTextBlock.16376.11.7" xlink:to="lab_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTextBlock.135270.193639.257134" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTextBlock.135270.193639.257134" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US" id="lab_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTextBlock.135270.193639.257134">Summary of Options and Warrants Outstanding</link:label>
    <link:loc xlink:label="loc_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock.16116.11.6" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" xlink:type="locator" />
    <link:labelArc xlink:from="loc_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock.16116.11.6" xlink:to="lab_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock.13789.254384.250931.255992" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock.13789.254384.250931.255992" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US" id="lab_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock.13789.254384.250931.255992">Schedule of Share-based Compensation, Stock Options, Activity [Table Text Block]</link:label>
    <link:loc xlink:label="loc_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock.16116.11.7" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" xlink:type="locator" />
    <link:labelArc xlink:from="loc_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock.16116.11.7" xlink:to="lab_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock7.1922192.254385.250932.255993" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock7.1922192.254385.250932.255993" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US" id="lab_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock7.1922192.254385.250932.255993">Schedule of Stock Option Activity</link:label>
    <link:loc xlink:label="loc_PropertyPlantAndEquipmentAbstract.4255.11.6" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_PropertyPlantAndEquipmentAbstract" xlink:type="locator" />
    <link:labelArc xlink:from="loc_PropertyPlantAndEquipmentAbstract.4255.11.6" xlink:to="lab_PropertyPlantAndEquipmentAbstract.1872142.190087.256050" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_PropertyPlantAndEquipmentAbstract.1872142.190087.256050" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US" id="lab_PropertyPlantAndEquipmentAbstract.1872142.190087.256050">PROPERTY AND EQUIPMENT, NET [Abstract]</link:label>
    <link:loc xlink:label="loc_PropertyPlantAndEquipmentDisclosureTextBlock.15050.11.6" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock" xlink:type="locator" />
    <link:labelArc xlink:from="loc_PropertyPlantAndEquipmentDisclosureTextBlock.15050.11.6" xlink:to="lab_PropertyPlantAndEquipmentDisclosureTextBlock.15353" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_PropertyPlantAndEquipmentDisclosureTextBlock.15353" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US" id="lab_PropertyPlantAndEquipmentDisclosureTextBlock.15353">Property, Plant and Equipment Disclosure [Text Block]</link:label>
    <link:loc xlink:label="loc_PropertyPlantAndEquipmentDisclosureTextBlock.15050.11.7" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock" xlink:type="locator" />
    <link:labelArc xlink:from="loc_PropertyPlantAndEquipmentDisclosureTextBlock.15050.11.7" xlink:to="lab_PropertyPlantAndEquipmentDisclosureTextBlock.107895.191210.256051" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_PropertyPlantAndEquipmentDisclosureTextBlock.107895.191210.256051" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US" id="lab_PropertyPlantAndEquipmentDisclosureTextBlock.107895.191210.256051">PROPERTY AND EQUIPMENT, NET</link:label>
    <link:loc xlink:label="loc_PropertyPlantAndEquipmentTextBlock.15042.11.6" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_PropertyPlantAndEquipmentTextBlock" xlink:type="locator" />
    <link:labelArc xlink:from="loc_PropertyPlantAndEquipmentTextBlock.15042.11.6" xlink:to="lab_PropertyPlantAndEquipmentTextBlock.15338" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_PropertyPlantAndEquipmentTextBlock.15338" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US" id="lab_PropertyPlantAndEquipmentTextBlock.15338">Property, Plant and Equipment [Table Text Block]</link:label>
    <link:loc xlink:label="loc_PropertyPlantAndEquipmentTextBlock.15042.11.7" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_PropertyPlantAndEquipmentTextBlock" xlink:type="locator" />
    <link:labelArc xlink:from="loc_PropertyPlantAndEquipmentTextBlock.15042.11.7" xlink:to="lab_PropertyPlantAndEquipmentTextBlock7.1872749.190073.256053" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_PropertyPlantAndEquipmentTextBlock7.1872749.190073.256053" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US" id="lab_PropertyPlantAndEquipmentTextBlock7.1872749.190073.256053">Schedule of Property and Equipment, Net</link:label>
    <link:loc xlink:label="loc_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment.5714.11.6" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:type="locator" />
    <link:labelArc xlink:from="loc_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment.5714.11.6" xlink:to="lab_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment.596" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment.596" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US" id="lab_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment.596">Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment</link:label>
    <link:loc xlink:label="loc_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment.5714.11.7" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:type="locator" />
    <link:labelArc xlink:from="loc_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment.5714.11.7" xlink:to="lab_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment.1872147.190075.256065" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment.1872147.190075.256065" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US" id="lab_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment.1872147.190075.256065">Property and equipment, accumulated depreciation</link:label>
    <link:loc xlink:label="loc_ComputerEquipmentMember.1163.11.6" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ComputerEquipmentMember" xlink:type="locator" />
    <link:labelArc xlink:from="loc_ComputerEquipmentMember.1163.11.6" xlink:to="lab_ComputerEquipmentMember.2973" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_ComputerEquipmentMember.2973" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US" id="lab_ComputerEquipmentMember.2973">Computer Equipment [Member]</link:label>
    <link:loc xlink:label="loc_ComputerEquipmentMember.1163.11.7" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ComputerEquipmentMember" xlink:type="locator" />
    <link:labelArc xlink:from="loc_ComputerEquipmentMember.1163.11.7" xlink:to="lab_ComputerEquipmentMember.1872143.190077.256059" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_ComputerEquipmentMember.1872143.190077.256059" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US" id="lab_ComputerEquipmentMember.1872143.190077.256059">Computers and Peripheral Equipment [Member]</link:label>
    <link:loc xlink:label="loc_LeaseholdImprovementsMember.3017.11.6" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_LeaseholdImprovementsMember" xlink:type="locator" />
    <link:labelArc xlink:from="loc_LeaseholdImprovementsMember.3017.11.6" xlink:to="lab_LeaseholdImprovementsMember.10388" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_LeaseholdImprovementsMember.10388" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US" id="lab_LeaseholdImprovementsMember.10388">Leasehold Improvements [Member]</link:label>
    <link:loc xlink:label="loc_LeaseholdImprovementsOfNewFacilityConstructionMember.25578.11.6" xlink:href="psti-20140630.xsd#psti_LeaseholdImprovementsOfNewFacilityConstructionMember" xlink:type="locator" />
    <link:labelArc xlink:from="loc_LeaseholdImprovementsOfNewFacilityConstructionMember.25578.11.6" xlink:to="lab_LeaseholdImprovementsOfNewFacilityConstructionMember.1907099.190081.256054" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_LeaseholdImprovementsOfNewFacilityConstructionMember.1907099.190081.256054" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US" id="lab_LeaseholdImprovementsOfNewFacilityConstructionMember.1907099.190081.256054">Leasehold Improvements Of New Facility Construction [Member]</link:label>
    <link:loc xlink:label="loc_LeaseholdImprovementsOfNewFacilityConstructionMember.25578.11.12" xlink:href="psti-20140630.xsd#psti_LeaseholdImprovementsOfNewFacilityConstructionMember" xlink:type="locator" />
    <link:labelArc xlink:from="loc_LeaseholdImprovementsOfNewFacilityConstructionMember.25578.11.12" xlink:to="lab_LeaseholdImprovementsOfNewFacilityConstructionMember.1907100.190083.256055" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_LeaseholdImprovementsOfNewFacilityConstructionMember.1907100.190083.256055" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US" id="lab_LeaseholdImprovementsOfNewFacilityConstructionMember.1907100.190083.256055">Leasehold Improvements of New Facility Construction [Member]</link:label>
    <link:loc xlink:label="loc_LeaseholdImprovementsOfNewFacilityConstructionMember.25578.11.7" xlink:href="psti-20140630.xsd#psti_LeaseholdImprovementsOfNewFacilityConstructionMember" xlink:type="locator" />
    <link:labelArc xlink:from="loc_LeaseholdImprovementsOfNewFacilityConstructionMember.25578.11.7" xlink:to="lab_LeaseholdImprovementsOfNewFacilityConstructionMember.1907102.190082.256056" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_LeaseholdImprovementsOfNewFacilityConstructionMember.1907102.190082.256056" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US" id="lab_LeaseholdImprovementsOfNewFacilityConstructionMember.1907102.190082.256056">Leasehold Improvements of New Facility Construction [Member]</link:label>
    <link:loc xlink:label="loc_OfficeEquipmentMember.3650.11.6" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_OfficeEquipmentMember" xlink:type="locator" />
    <link:labelArc xlink:from="loc_OfficeEquipmentMember.3650.11.6" xlink:to="lab_OfficeEquipmentMember.12687" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_OfficeEquipmentMember.12687" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US" id="lab_OfficeEquipmentMember.12687">Office Equipment [Member]</link:label>
    <link:loc xlink:label="loc_OfficeEquipmentMember.3650.11.7" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_OfficeEquipmentMember" xlink:type="locator" />
    <link:labelArc xlink:from="loc_OfficeEquipmentMember.3650.11.7" xlink:to="lab_OfficeEquipmentMember.1865992.190085.256060" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_OfficeEquipmentMember.1865992.190085.256060" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US" id="lab_OfficeEquipmentMember.1865992.190085.256060">Office Furniture and Equipment [Member]</link:label>
    <link:loc xlink:label="loc_OtherMachineryAndEquipmentMember.3840.11.6" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_OtherMachineryAndEquipmentMember" xlink:type="locator" />
    <link:labelArc xlink:from="loc_OtherMachineryAndEquipmentMember.3840.11.6" xlink:to="lab_OtherMachineryAndEquipmentMember.13477" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_OtherMachineryAndEquipmentMember.13477" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US" id="lab_OtherMachineryAndEquipmentMember.13477">Other Machinery and Equipment [Member]</link:label>
    <link:loc xlink:label="loc_PropertyPlantAndEquipmentGross.15025.11.6" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_PropertyPlantAndEquipmentGross" xlink:type="locator" />
    <link:labelArc xlink:from="loc_PropertyPlantAndEquipmentGross.15025.11.6" xlink:to="lab_PropertyPlantAndEquipmentGross.15306" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_PropertyPlantAndEquipmentGross.15306" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US" id="lab_PropertyPlantAndEquipmentGross.15306">Property, Plant and Equipment, Gross</link:label>
    <link:loc xlink:label="loc_PropertyPlantAndEquipmentGross.15025.11.7" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_PropertyPlantAndEquipmentGross" xlink:type="locator" />
    <link:labelArc xlink:from="loc_PropertyPlantAndEquipmentGross.15025.11.7" xlink:to="lab_PropertyPlantAndEquipmentGross7.1872146.190089.256064" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_PropertyPlantAndEquipmentGross7.1872146.190089.256064" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US" id="lab_PropertyPlantAndEquipmentGross7.1872146.190089.256064">Property and equipment, cost</link:label>
    <link:loc xlink:label="loc_PropertyPlantAndEquipmentLineItems.4267.11.6" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_PropertyPlantAndEquipmentLineItems" xlink:type="locator" />
    <link:labelArc xlink:from="loc_PropertyPlantAndEquipmentLineItems.4267.11.6" xlink:to="lab_PropertyPlantAndEquipmentLineItems.10707.190090.256068" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_PropertyPlantAndEquipmentLineItems.10707.190090.256068" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US" id="lab_PropertyPlantAndEquipmentLineItems.10707.190090.256068">Property, Plant and Equipment [Line Items]</link:label>
    <link:loc xlink:label="loc_PropertyPlantAndEquipmentNet.15032.11.9" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet" xlink:type="locator" />
    <link:labelArc xlink:from="loc_PropertyPlantAndEquipmentNet.15032.11.9" xlink:to="lab_PropertyPlantAndEquipmentNet.1872148.190092.256066" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_PropertyPlantAndEquipmentNet.1872148.190092.256066" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US" id="lab_PropertyPlantAndEquipmentNet.1872148.190092.256066">Property and equipment, net</link:label>
    <link:loc xlink:label="loc_ScheduleOfPropertyPlantAndEquipmentTable.4834.11.6" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:type="locator" />
    <link:labelArc xlink:from="loc_ScheduleOfPropertyPlantAndEquipmentTable.4834.11.6" xlink:to="lab_ScheduleOfPropertyPlantAndEquipmentTable.10657.190093.256057" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_ScheduleOfPropertyPlantAndEquipmentTable.10657.190093.256057" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US" id="lab_ScheduleOfPropertyPlantAndEquipmentTable.10657.190093.256057">Schedule of Property, Plant and Equipment [Table]</link:label>
    <link:loc xlink:label="loc_VehiclesMember.5488.11.6" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_VehiclesMember" xlink:type="locator" />
    <link:labelArc xlink:from="loc_VehiclesMember.5488.11.6" xlink:to="lab_VehiclesMember.19594" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_VehiclesMember.19594" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US" id="lab_VehiclesMember.19594">Vehicles [Member]</link:label>
    <link:loc xlink:label="loc_LeaseholdImprovementsMember.3017.11.7" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_LeaseholdImprovementsMember" xlink:type="locator" />
    <link:labelArc xlink:from="loc_LeaseholdImprovementsMember.3017.11.7" xlink:to="LeaseholdImprovementsMember.1872144.190095.256061" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="LeaseholdImprovementsMember.1872144.190095.256061" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US" id="LeaseholdImprovementsMember.1872144.190095.256061">Leasehold Improvements [Member]</link:label>
    <link:loc xlink:label="loc_OtherMachineryAndEquipmentMember.3840.11.7" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_OtherMachineryAndEquipmentMember" xlink:type="locator" />
    <link:labelArc xlink:from="loc_OtherMachineryAndEquipmentMember.3840.11.7" xlink:to="OtherMachineryAndEquipmentMember.1863244.190096.256058" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="OtherMachineryAndEquipmentMember.1863244.190096.256058" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US" id="OtherMachineryAndEquipmentMember.1863244.190096.256058">Laboratory equipment [Member]</link:label>
    <link:loc xlink:label="loc_VehiclesMember.5488.11.7" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_VehiclesMember" xlink:type="locator" />
    <link:labelArc xlink:from="loc_VehiclesMember.5488.11.7" xlink:to="VehiclesMember.1872145.190097.256062" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="VehiclesMember.1872145.190097.256062" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US" id="VehiclesMember.1872145.190097.256062">Vehicles [Member]</link:label>
    <link:loc xlink:label="loc_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock.5589.11.6" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock" xlink:type="locator" />
    <link:labelArc xlink:from="loc_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock.5589.11.6" xlink:to="lab_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock.405" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock.405" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US" id="lab_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock.405">Accounts Payable and Accrued Liabilities Disclosure [Text Block]</link:label>
    <link:loc xlink:label="loc_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock.5589.11.7" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock" xlink:type="locator" />
    <link:labelArc xlink:from="loc_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock.5589.11.7" xlink:to="lab_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock.1872689.191212.256073" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock.1872689.191212.256073" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US" id="lab_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock.1872689.191212.256073">OTHER ACCOUNTS PAYABLE</link:label>
    <link:loc xlink:label="loc_OtherAccountsPayableAbstract.25579.11.6" xlink:href="psti-20140630.xsd#psti_OtherAccountsPayableAbstract" xlink:type="locator" />
    <link:labelArc xlink:from="loc_OtherAccountsPayableAbstract.25579.11.6" xlink:to="lab_OtherAccountsPayableAbstract.1872132.191213.256072" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_OtherAccountsPayableAbstract.1872132.191213.256072" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US" id="lab_OtherAccountsPayableAbstract.1872132.191213.256072">OTHER ACCOUNTS PAYABLE [Abstract]</link:label>
    <link:loc xlink:label="loc_OtherAccountsPayableAbstract.25579.11.12" xlink:href="psti-20140630.xsd#psti_OtherAccountsPayableAbstract" xlink:type="locator" />
    <link:labelArc xlink:from="loc_OtherAccountsPayableAbstract.25579.11.12" xlink:to="lab_OtherAccountsPayableAbstract.1872133.191214.256071" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_OtherAccountsPayableAbstract.1872133.191214.256071" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US" id="lab_OtherAccountsPayableAbstract.1872133.191214.256071">Other Accounts Payable [Abstract].</link:label>
    <link:loc xlink:label="loc_OtherIncomeAndExpensesAbstract.3781.11.6" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_OtherIncomeAndExpensesAbstract" xlink:type="locator" />
    <link:labelArc xlink:from="loc_OtherIncomeAndExpensesAbstract.3781.11.6" xlink:to="lab_OtherIncomeAndExpensesAbstract.1872710.191215.256075" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_OtherIncomeAndExpensesAbstract.1872710.191215.256075" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US" id="lab_OtherIncomeAndExpensesAbstract.1872710.191215.256075">FINANCIAL INCOME, NET [Abstract]</link:label>
    <link:loc xlink:label="loc_OtherIncomeAndOtherExpenseDisclosureTextBlock.13798.11.6" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_OtherIncomeAndOtherExpenseDisclosureTextBlock" xlink:type="locator" />
    <link:labelArc xlink:from="loc_OtherIncomeAndOtherExpenseDisclosureTextBlock.13798.11.6" xlink:to="lab_OtherIncomeAndOtherExpenseDisclosureTextBlock.13391" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_OtherIncomeAndOtherExpenseDisclosureTextBlock.13391" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US" id="lab_OtherIncomeAndOtherExpenseDisclosureTextBlock.13391">Other Income and Other Expense Disclosure [Text Block]</link:label>
    <link:loc xlink:label="loc_OtherIncomeAndOtherExpenseDisclosureTextBlock.13798.11.7" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_OtherIncomeAndOtherExpenseDisclosureTextBlock" xlink:type="locator" />
    <link:labelArc xlink:from="loc_OtherIncomeAndOtherExpenseDisclosureTextBlock.13798.11.7" xlink:to="lab_OtherIncomeAndOtherExpenseDisclosureTextBlock7.1872714.191217.256076" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_OtherIncomeAndOtherExpenseDisclosureTextBlock7.1872714.191217.256076" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US" id="lab_OtherIncomeAndOtherExpenseDisclosureTextBlock7.1872714.191217.256076">FINANCIAL INCOME, NET</link:label>
    <link:loc xlink:label="loc_IncomeTaxDisclosureAbstract.2654.11.6" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_IncomeTaxDisclosureAbstract" xlink:type="locator" />
    <link:labelArc xlink:from="loc_IncomeTaxDisclosureAbstract.2654.11.6" xlink:to="lab_IncomeTaxDisclosureAbstract.1871890.190538.256077" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_IncomeTaxDisclosureAbstract.1871890.190538.256077" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US" id="lab_IncomeTaxDisclosureAbstract.1871890.190538.256077">TAXES ON INCOME [Abstract]</link:label>
    <link:loc xlink:label="loc_IncomeTaxDisclosureTextBlock.11033.11.6" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_IncomeTaxDisclosureTextBlock" xlink:type="locator" />
    <link:labelArc xlink:from="loc_IncomeTaxDisclosureTextBlock.11033.11.6" xlink:to="lab_IncomeTaxDisclosureTextBlock.8938" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_IncomeTaxDisclosureTextBlock.8938" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US" id="lab_IncomeTaxDisclosureTextBlock.8938">Income Tax Disclosure [Text Block]</link:label>
    <link:loc xlink:label="loc_IncomeTaxDisclosureTextBlock.11033.11.7" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_IncomeTaxDisclosureTextBlock" xlink:type="locator" />
    <link:labelArc xlink:from="loc_IncomeTaxDisclosureTextBlock.11033.11.7" xlink:to="lab_IncomeTaxDisclosureTextBlock.1872720.191219.256078" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_IncomeTaxDisclosureTextBlock.1872720.191219.256078" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US" id="lab_IncomeTaxDisclosureTextBlock.1872720.191219.256078">TAXES ON INCOME</link:label>
    <link:loc xlink:label="loc_ScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesTableTextBlock.16187.11.6" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesTableTextBlock" xlink:type="locator" />
    <link:labelArc xlink:from="loc_ScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesTableTextBlock.16187.11.6" xlink:to="lab_ScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesTableTextBlock.17143" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_ScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesTableTextBlock.17143" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US" id="lab_ScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesTableTextBlock.17143">Schedule of Future Minimum Rental Payments for Operating Leases [Table Text Block]</link:label>
    <link:loc xlink:label="loc_ScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesTableTextBlock.16187.11.7" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesTableTextBlock" xlink:type="locator" />
    <link:labelArc xlink:from="loc_ScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesTableTextBlock.16187.11.7" xlink:to="lab_ScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesTableTextBlock.1872769.190121.256082" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_ScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesTableTextBlock.1872769.190121.256082" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US" id="lab_ScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesTableTextBlock.1872769.190121.256082">Schedule of Future Minimum Rental Commitments</link:label>
    <link:loc xlink:label="loc_UnrecordedUnconditionalPurchaseObligationsDisclosureTextBlock.17555.11.6" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_UnrecordedUnconditionalPurchaseObligationsDisclosureTextBlock" xlink:type="locator" />
    <link:labelArc xlink:from="loc_UnrecordedUnconditionalPurchaseObligationsDisclosureTextBlock.17555.11.6" xlink:to="lab_UnrecordedUnconditionalPurchaseObligationsDisclosureTextBlock.19339" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_UnrecordedUnconditionalPurchaseObligationsDisclosureTextBlock.19339" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US" id="lab_UnrecordedUnconditionalPurchaseObligationsDisclosureTextBlock.19339">Unrecorded Unconditional Purchase Obligations Disclosure [Table Text Block]</link:label>
    <link:loc xlink:label="loc_UnrecordedUnconditionalPurchaseObligationsDisclosureTextBlock.17555.11.7" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_UnrecordedUnconditionalPurchaseObligationsDisclosureTextBlock" xlink:type="locator" />
    <link:labelArc xlink:from="loc_UnrecordedUnconditionalPurchaseObligationsDisclosureTextBlock.17555.11.7" xlink:to="lab_UnrecordedUnconditionalPurchaseObligationsDisclosureTextBlock.1907103.190123.256084" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_UnrecordedUnconditionalPurchaseObligationsDisclosureTextBlock.1907103.190123.256084" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US" id="lab_UnrecordedUnconditionalPurchaseObligationsDisclosureTextBlock.1907103.190123.256084">Commitment to Suppliers and Contractor</link:label>
    <link:loc xlink:label="loc_ScheduleOfOtherNonoperatingIncomeExpenseTableTextBlock.16124.11.6" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ScheduleOfOtherNonoperatingIncomeExpenseTableTextBlock" xlink:type="locator" />
    <link:labelArc xlink:from="loc_ScheduleOfOtherNonoperatingIncomeExpenseTableTextBlock.16124.11.6" xlink:to="lab_ScheduleOfOtherNonoperatingIncomeExpenseTableTextBlock.17067" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_ScheduleOfOtherNonoperatingIncomeExpenseTableTextBlock.17067" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US" id="lab_ScheduleOfOtherNonoperatingIncomeExpenseTableTextBlock.17067">Schedule of Other Nonoperating Income (Expense) [Table Text Block]</link:label>
    <link:loc xlink:label="loc_ScheduleOfOtherNonoperatingIncomeExpenseTableTextBlock.16124.11.7" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ScheduleOfOtherNonoperatingIncomeExpenseTableTextBlock" xlink:type="locator" />
    <link:labelArc xlink:from="loc_ScheduleOfOtherNonoperatingIncomeExpenseTableTextBlock.16124.11.7" xlink:to="lab_ScheduleOfOtherNonoperatingIncomeExpenseTableTextBlock7.1872800.190490.256089" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_ScheduleOfOtherNonoperatingIncomeExpenseTableTextBlock7.1872800.190490.256089" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US" id="lab_ScheduleOfOtherNonoperatingIncomeExpenseTableTextBlock7.1872800.190490.256089">Schedule of Financial Expenses (Income), Net</link:label>
    <link:loc xlink:label="loc_QualifyingPercentageOfValueOfProductiveAssetsTableTextBlock.25581.11.6" xlink:href="psti-20140630.xsd#psti_QualifyingPercentageOfValueOfProductiveAssetsTableTextBlock" xlink:type="locator" />
    <link:labelArc xlink:from="loc_QualifyingPercentageOfValueOfProductiveAssetsTableTextBlock.25581.11.6" xlink:to="lab_QualifyingPercentageOfValueOfProductiveAssetsTableTextBlock.1907303.190521.256090" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_QualifyingPercentageOfValueOfProductiveAssetsTableTextBlock.1907303.190521.256090" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US" id="lab_QualifyingPercentageOfValueOfProductiveAssetsTableTextBlock.1907303.190521.256090">Qualifying Percentage Of Value Of Productive Assets [Table Text Block]</link:label>
    <link:loc xlink:label="loc_QualifyingPercentageOfValueOfProductiveAssetsTableTextBlock.25581.11.12" xlink:href="psti-20140630.xsd#psti_QualifyingPercentageOfValueOfProductiveAssetsTableTextBlock" xlink:type="locator" />
    <link:labelArc xlink:from="loc_QualifyingPercentageOfValueOfProductiveAssetsTableTextBlock.25581.11.12" xlink:to="lab_QualifyingPercentageOfValueOfProductiveAssetsTableTextBlock.1907304.190523.256091" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_QualifyingPercentageOfValueOfProductiveAssetsTableTextBlock.1907304.190523.256091" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US" id="lab_QualifyingPercentageOfValueOfProductiveAssetsTableTextBlock.1907304.190523.256091">Qualifying Percentage Of Value Of Productive Assets [Table Text Block]</link:label>
    <link:loc xlink:label="loc_QualifyingPercentageOfValueOfProductiveAssetsTableTextBlock.25581.11.7" xlink:href="psti-20140630.xsd#psti_QualifyingPercentageOfValueOfProductiveAssetsTableTextBlock" xlink:type="locator" />
    <link:labelArc xlink:from="loc_QualifyingPercentageOfValueOfProductiveAssetsTableTextBlock.25581.11.7" xlink:to="lab_QualifyingPercentageOfValueOfProductiveAssetsTableTextBlock.1907306.190522.256092" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_QualifyingPercentageOfValueOfProductiveAssetsTableTextBlock.1907306.190522.256092" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US" id="lab_QualifyingPercentageOfValueOfProductiveAssetsTableTextBlock.1907306.190522.256092">Qualifying Percentage of Value of Productive Assets</link:label>
    <link:loc xlink:label="loc_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock.16163.11.6" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" xlink:type="locator" />
    <link:labelArc xlink:from="loc_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock.16163.11.6" xlink:to="lab_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock.17110" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock.17110" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US" id="lab_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock.17110">Schedule of Deferred Tax Assets and Liabilities [Table Text Block]</link:label>
    <link:loc xlink:label="loc_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock.16163.11.7" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" xlink:type="locator" />
    <link:labelArc xlink:from="loc_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock.16163.11.7" xlink:to="lab_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock7.1872801.190525.256093" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock7.1872801.190525.256093" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US" id="lab_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock7.1872801.190525.256093">Schedule of Deferred Tax Assets</link:label>
    <link:loc xlink:label="loc_ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock.16214.11.6" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock" xlink:type="locator" />
    <link:labelArc xlink:from="loc_ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock.16214.11.6" xlink:to="lab_ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock.17182" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock.17182" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US" id="lab_ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock.17182">Schedule of Accounts Payable and Accrued Liabilities [Table Text Block]</link:label>
    <link:loc xlink:label="loc_ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock.16214.11.7" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock" xlink:type="locator" />
    <link:labelArc xlink:from="loc_ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock.16214.11.7" xlink:to="lab_ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock7.1872753.190099.256096" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock7.1872753.190099.256096" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US" id="lab_ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock7.1872753.190099.256096">Schedule of Other Accounts Payable</link:label>
    <link:loc xlink:label="loc_AccountsPayableOtherCurrent.5626.11.9" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_AccountsPayableOtherCurrent" xlink:type="locator" />
    <link:labelArc xlink:from="loc_AccountsPayableOtherCurrent.5626.11.9" xlink:to="lab_AccountsPayableOtherCurrent.1872141.190101.256111" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_AccountsPayableOtherCurrent.1872141.190101.256111" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US" id="lab_AccountsPayableOtherCurrent.1872141.190101.256111">Other accounts payable, total</link:label>
    <link:loc xlink:label="loc_OtherAccountsPayablePayrollInstitutions.25582.11.7" xlink:href="psti-20140630.xsd#psti_OtherAccountsPayablePayrollInstitutions" xlink:type="locator" />
    <link:labelArc xlink:from="loc_OtherAccountsPayablePayrollInstitutions.25582.11.7" xlink:to="lab_AccountsPayablePayrollInstitutions.1872137.190102.256099" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_AccountsPayablePayrollInstitutions.1872137.190102.256099" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US" id="lab_AccountsPayablePayrollInstitutions.1872137.190102.256099">Payroll institutions</link:label>
    <link:loc xlink:label="loc_AccruedVacationCurrent.5671.11.6" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_AccruedVacationCurrent" xlink:type="locator" />
    <link:labelArc xlink:from="loc_AccruedVacationCurrent.5671.11.6" xlink:to="lab_AccruedVacationCurrent.544" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_AccruedVacationCurrent.544" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US" id="lab_AccruedVacationCurrent.544">Accrued Vacation, Current</link:label>
    <link:loc xlink:label="loc_AccruedVacationCurrent.5671.11.7" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_AccruedVacationCurrent" xlink:type="locator" />
    <link:labelArc xlink:from="loc_AccruedVacationCurrent.5671.11.7" xlink:to="lab_AccruedVacationCurrent.1872138.190104.256109" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_AccruedVacationCurrent.1872138.190104.256109" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US" id="lab_AccruedVacationCurrent.1872138.190104.256109">Accrued vacation</link:label>
    <link:loc xlink:label="loc_DeferredRentCreditCurrent.7843.11.6" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_DeferredRentCreditCurrent" xlink:type="locator" />
    <link:labelArc xlink:from="loc_DeferredRentCreditCurrent.7843.11.6" xlink:to="lab_DeferredRentCreditCurrent.4122" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_DeferredRentCreditCurrent.4122" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US" id="lab_DeferredRentCreditCurrent.4122">Deferred Rent Credit, Current</link:label>
    <link:loc xlink:label="loc_DeferredRentCreditCurrent.7843.11.7" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_DeferredRentCreditCurrent" xlink:type="locator" />
    <link:labelArc xlink:from="loc_DeferredRentCreditCurrent.7843.11.7" xlink:to="lab_DeferredRentCreditCurrent7.1872425.480924.197994.256449" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_DeferredRentCreditCurrent7.1872425.480924.197994.256449" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US" id="lab_DeferredRentCreditCurrent7.1872425.480924.197994.256449">Advanced payment from lessor</link:label>
    <link:loc xlink:label="loc_DerivativeLiabilitiesCurrent.8339.11.6" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_DerivativeLiabilitiesCurrent" xlink:type="locator" />
    <link:labelArc xlink:from="loc_DerivativeLiabilitiesCurrent.8339.11.6" xlink:to="lab_DerivativeLiabilitiesCurrent.4835" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_DerivativeLiabilitiesCurrent.4835" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US" id="lab_DerivativeLiabilitiesCurrent.4835">Derivative Liability, Current</link:label>
    <link:loc xlink:label="loc_DerivativeLiabilitiesCurrent.8339.11.7" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_DerivativeLiabilitiesCurrent" xlink:type="locator" />
    <link:labelArc xlink:from="loc_DerivativeLiabilitiesCurrent.8339.11.7" xlink:to="lab_DerivativeLiabilitiesCurrent.1860696.265036.541365.188298.256450" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_DerivativeLiabilitiesCurrent.1860696.265036.541365.188298.256450" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US" id="lab_DerivativeLiabilitiesCurrent.1860696.265036.541365.188298.256450">Derivatives designated as a fair value hedge instruments</link:label>
    <link:loc xlink:label="loc_EmployeeRelatedLiabilitiesCurrent.9111.11.6" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_EmployeeRelatedLiabilitiesCurrent" xlink:type="locator" />
    <link:labelArc xlink:from="loc_EmployeeRelatedLiabilitiesCurrent.9111.11.6" xlink:to="lab_EmployeeRelatedLiabilitiesCurrent.5921" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_EmployeeRelatedLiabilitiesCurrent.5921" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US" id="lab_EmployeeRelatedLiabilitiesCurrent.5921">Employee-related Liabilities, Current</link:label>
    <link:loc xlink:label="loc_EmployeeRelatedLiabilitiesCurrent.9111.11.7" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_EmployeeRelatedLiabilitiesCurrent" xlink:type="locator" />
    <link:labelArc xlink:from="loc_EmployeeRelatedLiabilitiesCurrent.9111.11.7" xlink:to="lab_EmployeeRelatedLiabilitiesCurrent7.1872134.190106.256108" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_EmployeeRelatedLiabilitiesCurrent7.1872134.190106.256108" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US" id="lab_EmployeeRelatedLiabilitiesCurrent7.1872134.190106.256108">Accrued payroll</link:label>
    <link:loc xlink:label="loc_OtherAccountsPayablePayrollInstitutions.25582.11.6" xlink:href="psti-20140630.xsd#psti_OtherAccountsPayablePayrollInstitutions" xlink:type="locator" />
    <link:labelArc xlink:from="loc_OtherAccountsPayablePayrollInstitutions.25582.11.6" xlink:to="lab_OtherAccountsPayablePayrollInstitutions.1872135.190112.256100" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_OtherAccountsPayablePayrollInstitutions.1872135.190112.256100" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US" id="lab_OtherAccountsPayablePayrollInstitutions.1872135.190112.256100">Other Accounts Payable Payroll Institutions</link:label>
    <link:loc xlink:label="loc_OtherAccountsPayablePayrollInstitutions.25582.11.12" xlink:href="psti-20140630.xsd#psti_OtherAccountsPayablePayrollInstitutions" xlink:type="locator" />
    <link:labelArc xlink:from="loc_OtherAccountsPayablePayrollInstitutions.25582.11.12" xlink:to="lab_OtherAccountsPayablePayrollInstitutions.1872136.190113.256101" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_OtherAccountsPayablePayrollInstitutions.1872136.190113.256101" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US" id="lab_OtherAccountsPayablePayrollInstitutions.1872136.190113.256101">Other accounts payable related to payroll institutions.</link:label>
    <link:loc xlink:label="loc_OtherAccruedLiabilitiesCurrent.13951.11.6" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_OtherAccruedLiabilitiesCurrent" xlink:type="locator" />
    <link:labelArc xlink:from="loc_OtherAccruedLiabilitiesCurrent.13951.11.6" xlink:to="lab_OtherAccruedLiabilitiesCurrent.13639" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_OtherAccruedLiabilitiesCurrent.13639" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US" id="lab_OtherAccruedLiabilitiesCurrent.13639">Other Accrued Liabilities, Current</link:label>
    <link:loc xlink:label="loc_OtherAccruedLiabilitiesCurrent.13951.11.7" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_OtherAccruedLiabilitiesCurrent" xlink:type="locator" />
    <link:labelArc xlink:from="loc_OtherAccruedLiabilitiesCurrent.13951.11.7" xlink:to="lab_OtherAccruedLiabilitiesCurrent.207980.193847.259757" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_OtherAccruedLiabilitiesCurrent.207980.193847.259757" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US" id="lab_OtherAccruedLiabilitiesCurrent.207980.193847.259757">Other payables</link:label>
    <link:loc xlink:label="loc_AutomobilesMember.395.11.6" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_AutomobilesMember" xlink:type="locator" />
    <link:labelArc xlink:from="loc_AutomobilesMember.395.11.6" xlink:to="lab_AutomobilesMember.16065.190127.256085" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_AutomobilesMember.16065.190127.256085" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US" id="lab_AutomobilesMember.16065.190127.256085">Automobiles [Member]</link:label>
    <link:loc xlink:label="loc_AutomobilesMember.395.11.7" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_AutomobilesMember" xlink:type="locator" />
    <link:labelArc xlink:from="loc_AutomobilesMember.395.11.7" xlink:to="lab_AutomobilesMember.1872107.190128.256144" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_AutomobilesMember.1872107.190128.256144" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US" id="lab_AutomobilesMember.1872107.190128.256144">Cars [Member]</link:label>
    <link:loc xlink:label="loc_GuaranteeObligationsByNatureAxis.2502.11.6" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_GuaranteeObligationsByNatureAxis" xlink:type="locator" />
    <link:labelArc xlink:from="loc_GuaranteeObligationsByNatureAxis.2502.11.6" xlink:to="lab_GuaranteeObligationsByNatureAxis.2436.190131.256147" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_GuaranteeObligationsByNatureAxis.2436.190131.256147" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US" id="lab_GuaranteeObligationsByNatureAxis.2436.190131.256147">Guarantor Obligations by Nature [Axis]</link:label>
    <link:loc xlink:label="loc_GuaranteeObligationsCurrentCarryingValue.10671.11.6" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_GuaranteeObligationsCurrentCarryingValue" xlink:type="locator" />
    <link:labelArc xlink:from="loc_GuaranteeObligationsCurrentCarryingValue.10671.11.6" xlink:to="lab_GuaranteeObligationsCurrentCarryingValue.8334" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_GuaranteeObligationsCurrentCarryingValue.8334" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US" id="lab_GuaranteeObligationsCurrentCarryingValue.8334">Guarantor Obligations, Current Carrying Value</link:label>
    <link:loc xlink:label="loc_GuaranteeObligationsCurrentCarryingValue.10671.11.7" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_GuaranteeObligationsCurrentCarryingValue" xlink:type="locator" />
    <link:labelArc xlink:from="loc_GuaranteeObligationsCurrentCarryingValue.10671.11.7" xlink:to="lab_GuaranteeObligationsCurrentCarryingValue.1872121.190133.256134" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_GuaranteeObligationsCurrentCarryingValue.1872121.190133.256134" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US" id="lab_GuaranteeObligationsCurrentCarryingValue.1872121.190133.256134">Lessor favored bank guarantee</link:label>
    <link:loc xlink:label="loc_GuaranteeObligationsNatureDomain.2504.11.6" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_GuaranteeObligationsNatureDomain" xlink:type="locator" />
    <link:labelArc xlink:from="loc_GuaranteeObligationsNatureDomain.2504.11.6" xlink:to="lab_GuaranteeObligationsNatureDomain.14445.190134.256132" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_GuaranteeObligationsNatureDomain.14445.190134.256132" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US" id="lab_GuaranteeObligationsNatureDomain.14445.190134.256132">Guarantor Obligations, Nature [Domain]</link:label>
    <link:loc xlink:label="loc_LandAndBuildingMember.3008.11.6" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_LandAndBuildingMember" xlink:type="locator" />
    <link:labelArc xlink:from="loc_LandAndBuildingMember.3008.11.6" xlink:to="lab_LandAndBuildingMember.256346" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_LandAndBuildingMember.256346" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US" id="lab_LandAndBuildingMember.256346">Leased Facilities [Member]</link:label>
    <link:loc xlink:label="loc_OperatingLeasedAssetsLineItems.3696.11.6" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_OperatingLeasedAssetsLineItems" xlink:type="locator" />
    <link:labelArc xlink:from="loc_OperatingLeasedAssetsLineItems.3696.11.6" xlink:to="lab_OperatingLeasedAssetsLineItems.15098.190144.256146" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_OperatingLeasedAssetsLineItems.15098.190144.256146" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US" id="lab_OperatingLeasedAssetsLineItems.15098.190144.256146">Operating Leased Assets [Line Items]</link:label>
    <link:loc xlink:label="loc_OperatingLeasedAssetsNumberOfUnits.25588.11.6" xlink:href="psti-20140630.xsd#psti_OperatingLeasedAssetsNumberOfUnits" xlink:type="locator" />
    <link:labelArc xlink:from="loc_OperatingLeasedAssetsNumberOfUnits.25588.11.6" xlink:to="lab_OperatingLeasedAssetsNumberOfUnits.1875080.190145.256120" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_OperatingLeasedAssetsNumberOfUnits.1875080.190145.256120" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US" id="lab_OperatingLeasedAssetsNumberOfUnits.1875080.190145.256120">Operating Leased Assets Number Of Units</link:label>
    <link:loc xlink:label="loc_OperatingLeasedAssetsNumberOfUnits.25588.11.12" xlink:href="psti-20140630.xsd#psti_OperatingLeasedAssetsNumberOfUnits" xlink:type="locator" />
    <link:labelArc xlink:from="loc_OperatingLeasedAssetsNumberOfUnits.25588.11.12" xlink:to="lab_OperatingLeasedAssetsNumberOfUnits.1875084.190147.256121" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_OperatingLeasedAssetsNumberOfUnits.1875084.190147.256121" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US" id="lab_OperatingLeasedAssetsNumberOfUnits.1875084.190147.256121">The number of units (items of property) under operating lease arrangements.</link:label>
    <link:loc xlink:label="loc_OperatingLeasedAssetsNumberOfUnits.25588.11.7" xlink:href="psti-20140630.xsd#psti_OperatingLeasedAssetsNumberOfUnits" xlink:type="locator" />
    <link:labelArc xlink:from="loc_OperatingLeasedAssetsNumberOfUnits.25588.11.7" xlink:to="lab_OperatingLeasedAssetsNumberOfUnits.1875085.190146.256122" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_OperatingLeasedAssetsNumberOfUnits.1875085.190146.256122" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US" id="lab_OperatingLeasedAssetsNumberOfUnits.1875085.190146.256122">Number of vehicles leased under operating lease agreements</link:label>
    <link:loc xlink:label="loc_OperatingLeasedAssetsParticipationFromLessor.26037.11.6" xlink:href="psti-20140630.xsd#psti_OperatingLeasedAssetsParticipationFromLessor" xlink:type="locator" />
    <link:labelArc xlink:from="loc_OperatingLeasedAssetsParticipationFromLessor.26037.11.6" xlink:to="lab_OperatingLeasedAssetsParticipationFromLessor.259758" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_OperatingLeasedAssetsParticipationFromLessor.259758" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US" id="lab_OperatingLeasedAssetsParticipationFromLessor.259758">Operating Leased Assets Participation From Lessor</link:label>
    <link:loc xlink:label="loc_OperatingLeasedAssetsParticipationFromLessor.26037.11.12" xlink:href="psti-20140630.xsd#psti_OperatingLeasedAssetsParticipationFromLessor" xlink:type="locator" />
    <link:labelArc xlink:from="loc_OperatingLeasedAssetsParticipationFromLessor.26037.11.12" xlink:to="lab_OperatingLeasedAssetsParticipationFromLessor12.259759" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_OperatingLeasedAssetsParticipationFromLessor12.259759" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US" id="lab_OperatingLeasedAssetsParticipationFromLessor12.259759">Operating Leased Assets, Participation From Lessor.</link:label>
    <link:loc xlink:label="loc_OperatingLeasedAssetsParticipationFromLessor.26037.11.7" xlink:href="psti-20140630.xsd#psti_OperatingLeasedAssetsParticipationFromLessor" xlink:type="locator" />
    <link:labelArc xlink:from="loc_OperatingLeasedAssetsParticipationFromLessor.26037.11.7" xlink:to="lab_OperatingLeasedAssetsParticipationFromLessor7.259760" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_OperatingLeasedAssetsParticipationFromLessor7.259760" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US" id="lab_OperatingLeasedAssetsParticipationFromLessor7.259760">Participation from lessor</link:label>
    <link:loc xlink:label="loc_OperatingLeasesFutureMinimumPaymentsDue.13467.11.6" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_OperatingLeasesFutureMinimumPaymentsDue" xlink:type="locator" />
    <link:labelArc xlink:from="loc_OperatingLeasesFutureMinimumPaymentsDue.13467.11.6" xlink:to="lab_OperatingLeasesFutureMinimumPaymentsDue.12844" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_OperatingLeasesFutureMinimumPaymentsDue.12844" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US" id="lab_OperatingLeasesFutureMinimumPaymentsDue.12844">Operating Leases, Future Minimum Payments Due</link:label>
    <link:loc xlink:label="loc_OperatingLeasesFutureMinimumPaymentsDue.13467.11.9" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_OperatingLeasesFutureMinimumPaymentsDue" xlink:type="locator" />
    <link:labelArc xlink:from="loc_OperatingLeasesFutureMinimumPaymentsDue.13467.11.9" xlink:to="lab_OperatingLeasesFutureMinimumPaymentsDue.1872125.190149.256138" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_OperatingLeasesFutureMinimumPaymentsDue.1872125.190149.256138" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US" id="lab_OperatingLeasesFutureMinimumPaymentsDue.1872125.190149.256138">Total</link:label>
    <link:loc xlink:label="loc_OperatingLeasesFutureMinimumPaymentsDueCurrent.13462.11.6" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_OperatingLeasesFutureMinimumPaymentsDueCurrent" xlink:type="locator" />
    <link:labelArc xlink:from="loc_OperatingLeasesFutureMinimumPaymentsDueCurrent.13462.11.6" xlink:to="lab_OperatingLeasesFutureMinimumPaymentsDueCurrent.12836" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_OperatingLeasesFutureMinimumPaymentsDueCurrent.12836" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US" id="lab_OperatingLeasesFutureMinimumPaymentsDueCurrent.12836">Operating Leases, Future Minimum Payments Due, Next Twelve Months</link:label>
    <link:loc xlink:label="loc_OperatingLeasesFutureMinimumPaymentsDueCurrent.13462.11.7" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_OperatingLeasesFutureMinimumPaymentsDueCurrent" xlink:type="locator" />
    <link:labelArc xlink:from="loc_OperatingLeasesFutureMinimumPaymentsDueCurrent.13462.11.7" xlink:to="lab_OperatingLeasesFutureMinimumPaymentsDueCurrent.1904169.190151.256142" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_OperatingLeasesFutureMinimumPaymentsDueCurrent.1904169.190151.256142" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US" id="lab_OperatingLeasesFutureMinimumPaymentsDueCurrent.1904169.190151.256142">Year ended June 30, 2015</link:label>
    <link:loc xlink:label="loc_OperatingLeasesFutureMinimumPaymentsDueInFiveYears.13419.11.6" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_OperatingLeasesFutureMinimumPaymentsDueInFiveYears" xlink:type="locator" />
    <link:labelArc xlink:from="loc_OperatingLeasesFutureMinimumPaymentsDueInFiveYears.13419.11.6" xlink:to="lab_OperatingLeasesFutureMinimumPaymentsDueInFiveYears.12763" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_OperatingLeasesFutureMinimumPaymentsDueInFiveYears.12763" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US" id="lab_OperatingLeasesFutureMinimumPaymentsDueInFiveYears.12763">Operating Leases, Future Minimum Payments, Due in Five Years</link:label>
    <link:loc xlink:label="loc_OperatingLeasesFutureMinimumPaymentsDueInFiveYears.13419.11.7" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_OperatingLeasesFutureMinimumPaymentsDueInFiveYears" xlink:type="locator" />
    <link:labelArc xlink:from="loc_OperatingLeasesFutureMinimumPaymentsDueInFiveYears.13419.11.7" xlink:to="lab_OperatingLeasesFutureMinimumPaymentsDueInFiveYears.1904162.190153.256141" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_OperatingLeasesFutureMinimumPaymentsDueInFiveYears.1904162.190153.256141" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US" id="lab_OperatingLeasesFutureMinimumPaymentsDueInFiveYears.1904162.190153.256141">Year ended June 30, 2019</link:label>
    <link:loc xlink:label="loc_OperatingLeasesFutureMinimumPaymentsDueInFourYears.13426.11.6" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_OperatingLeasesFutureMinimumPaymentsDueInFourYears" xlink:type="locator" />
    <link:labelArc xlink:from="loc_OperatingLeasesFutureMinimumPaymentsDueInFourYears.13426.11.6" xlink:to="lab_OperatingLeasesFutureMinimumPaymentsDueInFourYears.12774" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_OperatingLeasesFutureMinimumPaymentsDueInFourYears.12774" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US" id="lab_OperatingLeasesFutureMinimumPaymentsDueInFourYears.12774">Operating Leases, Future Minimum Payments, Due in Four Years</link:label>
    <link:loc xlink:label="loc_OperatingLeasesFutureMinimumPaymentsDueInFourYears.13426.11.7" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_OperatingLeasesFutureMinimumPaymentsDueInFourYears" xlink:type="locator" />
    <link:labelArc xlink:from="loc_OperatingLeasesFutureMinimumPaymentsDueInFourYears.13426.11.7" xlink:to="lab_OperatingLeasesFutureMinimumPaymentsDueInFourYears.1872127.190155.256140" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_OperatingLeasesFutureMinimumPaymentsDueInFourYears.1872127.190155.256140" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US" id="lab_OperatingLeasesFutureMinimumPaymentsDueInFourYears.1872127.190155.256140">Year ended June 30, 2018</link:label>
    <link:loc xlink:label="loc_OperatingLeasesFutureMinimumPaymentsDueInThreeYears.13435.11.6" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_OperatingLeasesFutureMinimumPaymentsDueInThreeYears" xlink:type="locator" />
    <link:labelArc xlink:from="loc_OperatingLeasesFutureMinimumPaymentsDueInThreeYears.13435.11.6" xlink:to="lab_OperatingLeasesFutureMinimumPaymentsDueInThreeYears.12789" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_OperatingLeasesFutureMinimumPaymentsDueInThreeYears.12789" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US" id="lab_OperatingLeasesFutureMinimumPaymentsDueInThreeYears.12789">Operating Leases, Future Minimum Payments, Due in Three Years</link:label>
    <link:loc xlink:label="loc_OperatingLeasesFutureMinimumPaymentsDueInThreeYears.13435.11.7" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_OperatingLeasesFutureMinimumPaymentsDueInThreeYears" xlink:type="locator" />
    <link:labelArc xlink:from="loc_OperatingLeasesFutureMinimumPaymentsDueInThreeYears.13435.11.7" xlink:to="lab_OperatingLeasesFutureMinimumPaymentsDueInThreeYears.1872123.190157.256137" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_OperatingLeasesFutureMinimumPaymentsDueInThreeYears.1872123.190157.256137" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US" id="lab_OperatingLeasesFutureMinimumPaymentsDueInThreeYears.1872123.190157.256137">Year ended June 30, 2017</link:label>
    <link:loc xlink:label="loc_OperatingLeasesFutureMinimumPaymentsDueInTwoYears.13442.11.6" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_OperatingLeasesFutureMinimumPaymentsDueInTwoYears" xlink:type="locator" />
    <link:labelArc xlink:from="loc_OperatingLeasesFutureMinimumPaymentsDueInTwoYears.13442.11.6" xlink:to="lab_OperatingLeasesFutureMinimumPaymentsDueInTwoYears.12802" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_OperatingLeasesFutureMinimumPaymentsDueInTwoYears.12802" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US" id="lab_OperatingLeasesFutureMinimumPaymentsDueInTwoYears.12802">Operating Leases, Future Minimum Payments, Due in Two Years</link:label>
    <link:loc xlink:label="loc_OperatingLeasesFutureMinimumPaymentsDueInTwoYears.13442.11.7" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_OperatingLeasesFutureMinimumPaymentsDueInTwoYears" xlink:type="locator" />
    <link:labelArc xlink:from="loc_OperatingLeasesFutureMinimumPaymentsDueInTwoYears.13442.11.7" xlink:to="lab_OperatingLeasesFutureMinimumPaymentsDueInTwoYears.1872122.190159.256136" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_OperatingLeasesFutureMinimumPaymentsDueInTwoYears.1872122.190159.256136" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US" id="lab_OperatingLeasesFutureMinimumPaymentsDueInTwoYears.1872122.190159.256136">Year ended June 30, 2016</link:label>
    <link:loc xlink:label="loc_OperatingLeasesRentExpenseNet.13438.11.6" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_OperatingLeasesRentExpenseNet" xlink:type="locator" />
    <link:labelArc xlink:from="loc_OperatingLeasesRentExpenseNet.13438.11.6" xlink:to="lab_OperatingLeasesRentExpenseNet.12794" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_OperatingLeasesRentExpenseNet.12794" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US" id="lab_OperatingLeasesRentExpenseNet.12794">Operating Leases, Rent Expense, Net</link:label>
    <link:loc xlink:label="loc_OperatingLeasesRentExpenseNet.13438.11.7" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_OperatingLeasesRentExpenseNet" xlink:type="locator" />
    <link:labelArc xlink:from="loc_OperatingLeasesRentExpenseNet.13438.11.7" xlink:to="lab_OperatingLeasesRentExpenseNet.1872109.190164.256135" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_OperatingLeasesRentExpenseNet.1872109.190164.256135" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US" id="lab_OperatingLeasesRentExpenseNet.1872109.190164.256135">Lease expenses</link:label>
    <link:loc xlink:label="loc_PledgedAssetsNotSeparatelyReportedOtherFinancialInstruments.14323.11.6" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_PledgedAssetsNotSeparatelyReportedOtherFinancialInstruments" xlink:type="locator" />
    <link:labelArc xlink:from="loc_PledgedAssetsNotSeparatelyReportedOtherFinancialInstruments.14323.11.6" xlink:to="lab_PledgedAssetsNotSeparatelyReportedOtherFinancialInstruments.14236" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_PledgedAssetsNotSeparatelyReportedOtherFinancialInstruments.14236" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US" id="lab_PledgedAssetsNotSeparatelyReportedOtherFinancialInstruments.14236">Pledged Assets, Not Separately Reported, Other</link:label>
    <link:loc xlink:label="loc_PledgedAssetsNotSeparatelyReportedOtherFinancialInstruments.14323.11.7" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_PledgedAssetsNotSeparatelyReportedOtherFinancialInstruments" xlink:type="locator" />
    <link:labelArc xlink:from="loc_PledgedAssetsNotSeparatelyReportedOtherFinancialInstruments.14323.11.7" xlink:to="lab_PledgedAssetsNotSeparatelyReportedOtherFinancialInstruments.259805" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_PledgedAssetsNotSeparatelyReportedOtherFinancialInstruments.259805" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US" id="lab_PledgedAssetsNotSeparatelyReportedOtherFinancialInstruments.259805">Pledged cash and deposits</link:label>
    <link:loc xlink:label="loc_PropertyLeaseGuaranteeMember.4264.11.6" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_PropertyLeaseGuaranteeMember" xlink:type="locator" />
    <link:labelArc xlink:from="loc_PropertyLeaseGuaranteeMember.4264.11.6" xlink:to="lab_PropertyLeaseGuaranteeMember.11186.190167.256133" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_PropertyLeaseGuaranteeMember.11186.190167.256133" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US" id="lab_PropertyLeaseGuaranteeMember.11186.190167.256133">Property Lease Guarantee [Member]</link:label>
    <link:loc xlink:label="loc_PropertyPlantAndEquipmentByTypeAxis.4261.11.6" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:type="locator" />
    <link:labelArc xlink:from="loc_PropertyPlantAndEquipmentByTypeAxis.4261.11.6" xlink:to="lab_PropertyPlantAndEquipmentByTypeAxis.10706.190168.256067" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_PropertyPlantAndEquipmentByTypeAxis.10706.190168.256067" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US" id="lab_PropertyPlantAndEquipmentByTypeAxis.10706.190168.256067">Property, Plant and Equipment by Type [Axis]</link:label>
    <link:loc xlink:label="loc_PropertyPlantAndEquipmentTypeDomain.4257.11.6" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:type="locator" />
    <link:labelArc xlink:from="loc_PropertyPlantAndEquipmentTypeDomain.4257.11.6" xlink:to="lab_PropertyPlantAndEquipmentTypeDomain.14500.190169.256063" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_PropertyPlantAndEquipmentTypeDomain.14500.190169.256063" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US" id="lab_PropertyPlantAndEquipmentTypeDomain.14500.190169.256063">Property, Plant and Equipment, Type [Domain]</link:label>
    <link:loc xlink:label="loc_ScheduleOfOperatingLeasedAssetsTable.4775.11.6" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ScheduleOfOperatingLeasedAssetsTable" xlink:type="locator" />
    <link:labelArc xlink:from="loc_ScheduleOfOperatingLeasedAssetsTable.4775.11.6" xlink:to="lab_ScheduleOfOperatingLeasedAssetsTable.15094.190172.256131" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_ScheduleOfOperatingLeasedAssetsTable.15094.190172.256131" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US" id="lab_ScheduleOfOperatingLeasedAssetsTable.15094.190172.256131">Schedule of Operating Leased Assets [Table]</link:label>
    <link:loc xlink:label="loc_GrantsReceivable.10656.11.7" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_GrantsReceivable" xlink:type="locator" />
    <link:labelArc xlink:from="loc_GrantsReceivable.10656.11.7" xlink:to="GrantsReceivable.1872131.191345.256166" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="GrantsReceivable.1872131.191345.256166" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US" id="GrantsReceivable.1872131.191345.256166">Grants received</link:label>
    <link:loc xlink:label="loc_GrantsReceivable.10656.11.6" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_GrantsReceivable" xlink:type="locator" />
    <link:labelArc xlink:from="loc_GrantsReceivable.10656.11.6" xlink:to="lab_GrantsReceivable.8309" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_GrantsReceivable.8309" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US" id="lab_GrantsReceivable.8309">Grants Receivable</link:label>
    <link:loc xlink:label="loc_LongTermPurchaseCommitmentByCategoryOfItemPurchasedAxis.3241.11.6" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_LongTermPurchaseCommitmentByCategoryOfItemPurchasedAxis" xlink:type="locator" />
    <link:labelArc xlink:from="loc_LongTermPurchaseCommitmentByCategoryOfItemPurchasedAxis.3241.11.6" xlink:to="lab_LongTermPurchaseCommitmentByCategoryOfItemPurchasedAxis.10103.190114.256086" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_LongTermPurchaseCommitmentByCategoryOfItemPurchasedAxis.10103.190114.256086" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US" id="lab_LongTermPurchaseCommitmentByCategoryOfItemPurchasedAxis.10103.190114.256086">Long-term Purchase Commitment by Category of Item Purchased [Axis]</link:label>
    <link:loc xlink:label="loc_LongTermPurchaseCommitmentCategoryOfItemPurchasedDomain.3237.11.6" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_LongTermPurchaseCommitmentCategoryOfItemPurchasedDomain" xlink:type="locator" />
    <link:labelArc xlink:from="loc_LongTermPurchaseCommitmentCategoryOfItemPurchasedDomain.3237.11.6" xlink:to="lab_LongTermPurchaseCommitmentCategoryOfItemPurchasedDomain.14468.190115.256088" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_LongTermPurchaseCommitmentCategoryOfItemPurchasedDomain.14468.190115.256088" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US" id="lab_LongTermPurchaseCommitmentCategoryOfItemPurchasedDomain.14468.190115.256088">Long-term Purchase Commitment, Category of Item Purchased [Domain]</link:label>
    <link:loc xlink:label="loc_LongTermPurchaseCommitmentFutureMinimumPaymentDue.25593.11.6" xlink:href="psti-20140630.xsd#psti_LongTermPurchaseCommitmentFutureMinimumPaymentDue" xlink:type="locator" />
    <link:labelArc xlink:from="loc_LongTermPurchaseCommitmentFutureMinimumPaymentDue.25593.11.6" xlink:to="lab_LongTermPurchaseCommitmentFutureMinimumPaymentDue.1904224.191347.256154" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_LongTermPurchaseCommitmentFutureMinimumPaymentDue.1904224.191347.256154" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US" id="lab_LongTermPurchaseCommitmentFutureMinimumPaymentDue.1904224.191347.256154">Long Term Purchase Commitment Future Minimum Payment Due</link:label>
    <link:loc xlink:label="loc_LongTermPurchaseCommitmentFutureMinimumPaymentDue.25593.11.12" xlink:href="psti-20140630.xsd#psti_LongTermPurchaseCommitmentFutureMinimumPaymentDue" xlink:type="locator" />
    <link:labelArc xlink:from="loc_LongTermPurchaseCommitmentFutureMinimumPaymentDue.25593.11.12" xlink:to="lab_LongTermPurchaseCommitmentFutureMinimumPaymentDue.1904225.191349.256155" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_LongTermPurchaseCommitmentFutureMinimumPaymentDue.1904225.191349.256155" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US" id="lab_LongTermPurchaseCommitmentFutureMinimumPaymentDue.1904225.191349.256155">Long term purchase commitment future minimum payment due, total.</link:label>
    <link:loc xlink:label="loc_LongTermPurchaseCommitmentFutureMinimumPaymentDue.25593.11.9" xlink:href="psti-20140630.xsd#psti_LongTermPurchaseCommitmentFutureMinimumPaymentDue" xlink:type="locator" />
    <link:labelArc xlink:from="loc_LongTermPurchaseCommitmentFutureMinimumPaymentDue.25593.11.9" xlink:to="lab_LongTermPurchaseCommitmentFutureMinimumPaymentDue.1904226.191348.256156" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_LongTermPurchaseCommitmentFutureMinimumPaymentDue.1904226.191348.256156" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US" id="lab_LongTermPurchaseCommitmentFutureMinimumPaymentDue.1904226.191348.256156">Total</link:label>
    <link:loc xlink:label="loc_LongTermPurchaseCommitmentFutureMinimumPaymentDueCurrent.25591.11.6" xlink:href="psti-20140630.xsd#psti_LongTermPurchaseCommitmentFutureMinimumPaymentDueCurrent" xlink:type="locator" />
    <link:labelArc xlink:from="loc_LongTermPurchaseCommitmentFutureMinimumPaymentDueCurrent.25591.11.6" xlink:to="lab_LongTermPurchaseCommitmentFutureMinimumPaymentDueCurrent.1904219.191350.256148" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_LongTermPurchaseCommitmentFutureMinimumPaymentDueCurrent.1904219.191350.256148" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US" id="lab_LongTermPurchaseCommitmentFutureMinimumPaymentDueCurrent.1904219.191350.256148">Long Term Purchase Commitment Future Minimum Payment Due Current</link:label>
    <link:loc xlink:label="loc_LongTermPurchaseCommitmentFutureMinimumPaymentDueCurrent.25591.11.12" xlink:href="psti-20140630.xsd#psti_LongTermPurchaseCommitmentFutureMinimumPaymentDueCurrent" xlink:type="locator" />
    <link:labelArc xlink:from="loc_LongTermPurchaseCommitmentFutureMinimumPaymentDueCurrent.25591.11.12" xlink:to="lab_LongTermPurchaseCommitmentFutureMinimumPaymentDueCurrent.1904220.191352.256149" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_LongTermPurchaseCommitmentFutureMinimumPaymentDueCurrent.1904220.191352.256149" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US" id="lab_LongTermPurchaseCommitmentFutureMinimumPaymentDueCurrent.1904220.191352.256149">Long term purchase commitment future minimum payment due current.</link:label>
    <link:loc xlink:label="loc_LongTermPurchaseCommitmentFutureMinimumPaymentDueCurrent.25591.11.7" xlink:href="psti-20140630.xsd#psti_LongTermPurchaseCommitmentFutureMinimumPaymentDueCurrent" xlink:type="locator" />
    <link:labelArc xlink:from="loc_LongTermPurchaseCommitmentFutureMinimumPaymentDueCurrent.25591.11.7" xlink:to="lab_LongTermPurchaseCommitmentFutureMinimumPaymentDueCurrent.1904221.191351.256150" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_LongTermPurchaseCommitmentFutureMinimumPaymentDueCurrent.1904221.191351.256150" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US" id="lab_LongTermPurchaseCommitmentFutureMinimumPaymentDueCurrent.1904221.191351.256150">Year ending June 30, 2014</link:label>
    <link:loc xlink:label="loc_LongTermPurchaseCommitmentFutureMinimumPaymentDueInThreeYears.25592.11.6" xlink:href="psti-20140630.xsd#psti_LongTermPurchaseCommitmentFutureMinimumPaymentDueInThreeYears" xlink:type="locator" />
    <link:labelArc xlink:from="loc_LongTermPurchaseCommitmentFutureMinimumPaymentDueInThreeYears.25592.11.6" xlink:to="lab_LongTermPurchaseCommitmentFutureMinimumPaymentDueInThreeYears.1904164.191353.256151" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_LongTermPurchaseCommitmentFutureMinimumPaymentDueInThreeYears.1904164.191353.256151" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US" id="lab_LongTermPurchaseCommitmentFutureMinimumPaymentDueInThreeYears.1904164.191353.256151">Long Term Purchase Commitment Future Minimum Payment Due In Three Years</link:label>
    <link:loc xlink:label="loc_LongTermPurchaseCommitmentFutureMinimumPaymentDueInThreeYears.25592.11.7" xlink:href="psti-20140630.xsd#psti_LongTermPurchaseCommitmentFutureMinimumPaymentDueInThreeYears" xlink:type="locator" />
    <link:labelArc xlink:from="loc_LongTermPurchaseCommitmentFutureMinimumPaymentDueInThreeYears.25592.11.7" xlink:to="lab_LongTermPurchaseCommitmentFutureMinimumPaymentDueInThreeYears.1904222.191354.256152" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_LongTermPurchaseCommitmentFutureMinimumPaymentDueInThreeYears.1904222.191354.256152" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US" id="lab_LongTermPurchaseCommitmentFutureMinimumPaymentDueInThreeYears.1904222.191354.256152">Year ending June 30, 2015</link:label>
    <link:loc xlink:label="loc_LongTermPurchaseCommitmentFutureMinimumPaymentDueInThreeYears.25592.11.12" xlink:href="psti-20140630.xsd#psti_LongTermPurchaseCommitmentFutureMinimumPaymentDueInThreeYears" xlink:type="locator" />
    <link:labelArc xlink:from="loc_LongTermPurchaseCommitmentFutureMinimumPaymentDueInThreeYears.25592.11.12" xlink:to="lab_LongTermPurchaseCommitmentFutureMinimumPaymentDueInThreeYears.1904223.191355.256153" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_LongTermPurchaseCommitmentFutureMinimumPaymentDueInThreeYears.1904223.191355.256153" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US" id="lab_LongTermPurchaseCommitmentFutureMinimumPaymentDueInThreeYears.1904223.191355.256153">Long term purchase commitment future minimum payment due in three years.</link:label>
    <link:loc xlink:label="loc_LongTermPurchaseCommitmentLineItems.3235.11.6" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_LongTermPurchaseCommitmentLineItems" xlink:type="locator" />
    <link:labelArc xlink:from="loc_LongTermPurchaseCommitmentLineItems.3235.11.6" xlink:to="lab_LongTermPurchaseCommitmentLineItems.10104.190116.256087" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_LongTermPurchaseCommitmentLineItems.10104.190116.256087" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US" id="lab_LongTermPurchaseCommitmentLineItems.10104.190116.256087">Long-term Purchase Commitment [Line Items]</link:label>
    <link:loc xlink:label="loc_LongTermPurchaseCommitmentTable.3238.11.6" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_LongTermPurchaseCommitmentTable" xlink:type="locator" />
    <link:labelArc xlink:from="loc_LongTermPurchaseCommitmentTable.3238.11.6" xlink:to="lab_LongTermPurchaseCommitmentTable.10102.190117.256081" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_LongTermPurchaseCommitmentTable.10102.190117.256081" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US" id="lab_LongTermPurchaseCommitmentTable.10102.190117.256081">Long-term Purchase Commitment [Table]</link:label>
    <link:loc xlink:label="loc_LongTermPurchaseCommitmentToSuppliersAndContractorMember.25595.11.6" xlink:href="psti-20140630.xsd#psti_LongTermPurchaseCommitmentToSuppliersAndContractorMember" xlink:type="locator" />
    <link:labelArc xlink:from="loc_LongTermPurchaseCommitmentToSuppliersAndContractorMember.25595.11.6" xlink:to="lab_LongTermPurchaseCommitmentToSuppliersAndContractorMember.1904215.191356.256160" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_LongTermPurchaseCommitmentToSuppliersAndContractorMember.1904215.191356.256160" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US" id="lab_LongTermPurchaseCommitmentToSuppliersAndContractorMember.1904215.191356.256160">Long Term Purchase Commitment To Suppliers And Contractor [Member]</link:label>
    <link:loc xlink:label="loc_LongTermPurchaseCommitmentToSuppliersAndContractorMember.25595.11.12" xlink:href="psti-20140630.xsd#psti_LongTermPurchaseCommitmentToSuppliersAndContractorMember" xlink:type="locator" />
    <link:labelArc xlink:from="loc_LongTermPurchaseCommitmentToSuppliersAndContractorMember.25595.11.12" xlink:to="lab_LongTermPurchaseCommitmentToSuppliersAndContractorMember.1904216.191358.256161" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_LongTermPurchaseCommitmentToSuppliersAndContractorMember.1904216.191358.256161" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US" id="lab_LongTermPurchaseCommitmentToSuppliersAndContractorMember.1904216.191358.256161">Long Term Purchase Commitment To Suppliers And Contractor [Member].</link:label>
    <link:loc xlink:label="loc_LongTermPurchaseCommitmentToSuppliersAndContractorMember.25595.11.7" xlink:href="psti-20140630.xsd#psti_LongTermPurchaseCommitmentToSuppliersAndContractorMember" xlink:type="locator" />
    <link:labelArc xlink:from="loc_LongTermPurchaseCommitmentToSuppliersAndContractorMember.25595.11.7" xlink:to="lab_LongTermPurchaseCommitmentToSuppliersAndContractorMember.1904217.191357.256162" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_LongTermPurchaseCommitmentToSuppliersAndContractorMember.1904217.191357.256162" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US" id="lab_LongTermPurchaseCommitmentToSuppliersAndContractorMember.1904217.191357.256162">Suppliers and Contractor [Member]</link:label>
    <link:loc xlink:label="loc_RoyaltyPayable.25594.11.6" xlink:href="psti-20140630.xsd#psti_RoyaltyPayable" xlink:type="locator" />
    <link:labelArc xlink:from="loc_RoyaltyPayable.25594.11.6" xlink:to="lab_RoyaltyPayable.1904228.191359.256157" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_RoyaltyPayable.1904228.191359.256157" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US" id="lab_RoyaltyPayable.1904228.191359.256157">Royalty Payable</link:label>
    <link:loc xlink:label="loc_RoyaltyPayable.25594.11.12" xlink:href="psti-20140630.xsd#psti_RoyaltyPayable" xlink:type="locator" />
    <link:labelArc xlink:from="loc_RoyaltyPayable.25594.11.12" xlink:to="lab_RoyaltyPayable.1904229.191361.256158" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_RoyaltyPayable.1904229.191361.256158" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US" id="lab_RoyaltyPayable.1904229.191361.256158">Royalty payable.</link:label>
    <link:loc xlink:label="loc_RoyaltyPayable.25594.11.7" xlink:href="psti-20140630.xsd#psti_RoyaltyPayable" xlink:type="locator" />
    <link:labelArc xlink:from="loc_RoyaltyPayable.25594.11.7" xlink:to="lab_RoyaltyPayable.1904230.191360.256159" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_RoyaltyPayable.1904230.191360.256159" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US" id="lab_RoyaltyPayable.1904230.191360.256159">Royalty liabilities</link:label>
    <link:loc xlink:label="loc_DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet.8305.11.7" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet" xlink:type="locator" />
    <link:labelArc xlink:from="loc_DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet.8305.11.7" xlink:to="lab_DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet.358789.255817" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet.358789.255817" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US" id="lab_DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet.358789.255817">Gain (loss) from derivatives</link:label>
    <link:loc xlink:label="loc_DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet.8305.11.6" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet" xlink:type="locator" />
    <link:labelArc xlink:from="loc_DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet.8305.11.6" xlink:to="lab_DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet.4767.255816" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet.4767.255816" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US" id="lab_DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet.4767.255816">Derivative Instruments Not Designated as Hedging Instruments, Gain (Loss), Net</link:label>
    <link:loc xlink:label="loc_ForeignCurrencyTransactionGainLossBeforeTax.10306.11.6" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ForeignCurrencyTransactionGainLossBeforeTax" xlink:type="locator" />
    <link:labelArc xlink:from="loc_ForeignCurrencyTransactionGainLossBeforeTax.10306.11.6" xlink:to="lab_ForeignCurrencyTransactionGainLossBeforeTax.7777" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_ForeignCurrencyTransactionGainLossBeforeTax.7777" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US" id="lab_ForeignCurrencyTransactionGainLossBeforeTax.7777">Foreign Currency Transaction Gain (Loss), before Tax</link:label>
    <link:loc xlink:label="loc_ForeignCurrencyTransactionGainLossBeforeTax.10306.11.7" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ForeignCurrencyTransactionGainLossBeforeTax" xlink:type="locator" />
    <link:labelArc xlink:from="loc_ForeignCurrencyTransactionGainLossBeforeTax.10306.11.7" xlink:to="lab_ForeignCurrencyTransactionGainLossBeforeTax.1912782.413750.315434.257501" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_ForeignCurrencyTransactionGainLossBeforeTax.1912782.413750.315434.257501" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US" id="lab_ForeignCurrencyTransactionGainLossBeforeTax.1912782.413750.315434.257501">Foreign currency translation differences, net</link:label>
    <link:loc xlink:label="loc_InterestIncomeDepositsWithFinancialInstitutions.11592.11.6" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_InterestIncomeDepositsWithFinancialInstitutions" xlink:type="locator" />
    <link:labelArc xlink:from="loc_InterestIncomeDepositsWithFinancialInstitutions.11592.11.6" xlink:to="lab_InterestIncomeDepositsWithFinancialInstitutions.9772" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_InterestIncomeDepositsWithFinancialInstitutions.9772" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US" id="lab_InterestIncomeDepositsWithFinancialInstitutions.9772">Interest Income, Deposits with Financial Institutions</link:label>
    <link:loc xlink:label="loc_InterestIncomeDepositsWithFinancialInstitutions.11592.11.7" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_InterestIncomeDepositsWithFinancialInstitutions" xlink:type="locator" />
    <link:labelArc xlink:from="loc_InterestIncomeDepositsWithFinancialInstitutions.11592.11.7" xlink:to="lab_InterestIncomeDepositsWithFinancialInstitutions.201509.261887.257503" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_InterestIncomeDepositsWithFinancialInstitutions.201509.261887.257503" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US" id="lab_InterestIncomeDepositsWithFinancialInstitutions.201509.261887.257503">Interest income on deposits</link:label>
    <link:loc xlink:label="loc_InterestOnShortTermBankCreditAndBankExpenses.25596.11.6" xlink:href="psti-20140630.xsd#psti_InterestOnShortTermBankCreditAndBankExpenses" xlink:type="locator" />
    <link:labelArc xlink:from="loc_InterestOnShortTermBankCreditAndBankExpenses.25596.11.6" xlink:to="lab_InterestOnShortTermBankCreditAndBankExpenses.1874518.190512.256167" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_InterestOnShortTermBankCreditAndBankExpenses.1874518.190512.256167" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US" id="lab_InterestOnShortTermBankCreditAndBankExpenses.1874518.190512.256167">Interest On Short Term Bank Credit And Bank Expenses</link:label>
    <link:loc xlink:label="loc_InterestOnShortTermBankCreditAndBankExpenses.25596.11.12" xlink:href="psti-20140630.xsd#psti_InterestOnShortTermBankCreditAndBankExpenses" xlink:type="locator" />
    <link:labelArc xlink:from="loc_InterestOnShortTermBankCreditAndBankExpenses.25596.11.12" xlink:to="lab_InterestOnShortTermBankCreditAndBankExpenses.1874522.190514.256168" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_InterestOnShortTermBankCreditAndBankExpenses.1874522.190514.256168" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US" id="lab_InterestOnShortTermBankCreditAndBankExpenses.1874522.190514.256168">Interest on short-term bank credit and bank expenses.</link:label>
    <link:loc xlink:label="loc_InterestOnShortTermBankCreditAndBankExpenses.25596.11.53" xlink:href="psti-20140630.xsd#psti_InterestOnShortTermBankCreditAndBankExpenses" xlink:type="locator" />
    <link:labelArc xlink:from="loc_InterestOnShortTermBankCreditAndBankExpenses.25596.11.53" xlink:to="lab_InterestOnShortTermBankCreditAndBankExpenses53.257502" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_InterestOnShortTermBankCreditAndBankExpenses53.257502" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xml:lang="en-US" id="lab_InterestOnShortTermBankCreditAndBankExpenses53.257502">Bank commissions</link:label>
    <link:loc xlink:label="loc_MarketableSecuritiesGainLoss.12850.11.6" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_MarketableSecuritiesGainLoss" xlink:type="locator" />
    <link:labelArc xlink:from="loc_MarketableSecuritiesGainLoss.12850.11.6" xlink:to="lab_MarketableSecuritiesGainLoss.11764" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_MarketableSecuritiesGainLoss.11764" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US" id="lab_MarketableSecuritiesGainLoss.11764">Marketable Securities, Gain (Loss)</link:label>
    <link:loc xlink:label="loc_MarketableSecuritiesGainLoss.12850.11.7" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_MarketableSecuritiesGainLoss" xlink:type="locator" />
    <link:labelArc xlink:from="loc_MarketableSecuritiesGainLoss.12850.11.7" xlink:to="lab_MarketableSecuritiesGainLoss.1847947.481955.202202.257504" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_MarketableSecuritiesGainLoss.1847947.481955.202202.257504" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US" id="lab_MarketableSecuritiesGainLoss.1847947.481955.202202.257504">Gain (Loss) related to marketable securities</link:label>
    <link:loc xlink:label="loc_NonoperatingIncomeExpense.13243.11.9" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_NonoperatingIncomeExpense" xlink:type="locator" />
    <link:labelArc xlink:from="loc_NonoperatingIncomeExpense.13243.11.9" xlink:to="lab_NonoperatingIncomeExpense.257505" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_NonoperatingIncomeExpense.257505" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US" id="lab_NonoperatingIncomeExpense.257505">Financial income, net</link:label>
    <link:loc xlink:label="loc_DomesticCountryMember.1737.11.7" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_DomesticCountryMember" xlink:type="locator" />
    <link:labelArc xlink:from="loc_DomesticCountryMember.1737.11.7" xlink:to="DomesticCountryMember.1871950.190539.256272" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="DomesticCountryMember.1871950.190539.256272" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US" id="DomesticCountryMember.1871950.190539.256272">United States Tax Authority [Member]</link:label>
    <link:loc xlink:label="loc_BeneficiaryEnterpriseProgramAxis.25600.11.6" xlink:href="psti-20140630.xsd#psti_BeneficiaryEnterpriseProgramAxis" xlink:type="locator" />
    <link:labelArc xlink:from="loc_BeneficiaryEnterpriseProgramAxis.25600.11.6" xlink:to="lab_BeneficiaryEnterpriseProgramAxis.227520.256210" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_BeneficiaryEnterpriseProgramAxis.227520.256210" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US" id="lab_BeneficiaryEnterpriseProgramAxis.227520.256210">Beneficiary Enterprise Program [Axis]</link:label>
    <link:loc xlink:label="loc_BeneficiaryEnterpriseProgramDomain.25601.11.6" xlink:href="psti-20140630.xsd#psti_BeneficiaryEnterpriseProgramDomain" xlink:type="locator" />
    <link:labelArc xlink:from="loc_BeneficiaryEnterpriseProgramDomain.25601.11.6" xlink:to="lab_BeneficiaryEnterpriseProgramDomain.227521.256185" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_BeneficiaryEnterpriseProgramDomain.227521.256185" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US" id="lab_BeneficiaryEnterpriseProgramDomain.227521.256185">Beneficiary Enterprise Program [Domain]</link:label>
    <link:loc xlink:label="loc_BenefitedPeriodMaximumYearsOfEligibility.25611.11.6" xlink:href="psti-20140630.xsd#psti_BenefitedPeriodMaximumYearsOfEligibility" xlink:type="locator" />
    <link:labelArc xlink:from="loc_BenefitedPeriodMaximumYearsOfEligibility.25611.11.6" xlink:to="lab_BenefitedPeriodMaximumYearsOfEligibility.1871980.190540.256223" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_BenefitedPeriodMaximumYearsOfEligibility.1871980.190540.256223" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US" id="lab_BenefitedPeriodMaximumYearsOfEligibility.1871980.190540.256223">Benefited Period Maximum Years Of Eligibility</link:label>
    <link:loc xlink:label="loc_BenefitedPeriodMaximumYearsOfEligibility.25611.11.12" xlink:href="psti-20140630.xsd#psti_BenefitedPeriodMaximumYearsOfEligibility" xlink:type="locator" />
    <link:labelArc xlink:from="loc_BenefitedPeriodMaximumYearsOfEligibility.25611.11.12" xlink:to="lab_BenefitedPeriodMaximumYearsOfEligibility.1871981.190542.256224" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_BenefitedPeriodMaximumYearsOfEligibility.1871981.190542.256224" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US" id="lab_BenefitedPeriodMaximumYearsOfEligibility.1871981.190542.256224">The limitation of the benefit period from the election year.</link:label>
    <link:loc xlink:label="loc_BenefitedPeriodMaximumYearsOfEligibility.25611.11.7" xlink:href="psti-20140630.xsd#psti_BenefitedPeriodMaximumYearsOfEligibility" xlink:type="locator" />
    <link:labelArc xlink:from="loc_BenefitedPeriodMaximumYearsOfEligibility.25611.11.7" xlink:to="lab_BenefitedPeriodMaximumYearsOfEligibility.1871982.190541.256225" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_BenefitedPeriodMaximumYearsOfEligibility.1871982.190541.256225" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US" id="lab_BenefitedPeriodMaximumYearsOfEligibility.1871982.190541.256225">The limitation of benefit period from year of election</link:label>
    <link:loc xlink:label="loc_BenefitedPeriodMaximumYearsOfEligibilityForCompaniesInDevelopmentArea.25613.11.6" xlink:href="psti-20140630.xsd#psti_BenefitedPeriodMaximumYearsOfEligibilityForCompaniesInDevelopmentArea" xlink:type="locator" />
    <link:labelArc xlink:from="loc_BenefitedPeriodMaximumYearsOfEligibilityForCompaniesInDevelopmentArea.25613.11.6" xlink:to="lab_BenefitedPeriodMaximumYearsOfEligibilityForCompaniesInDevelopmentArea.1907398.190543.256229" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_BenefitedPeriodMaximumYearsOfEligibilityForCompaniesInDevelopmentArea.1907398.190543.256229" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US" id="lab_BenefitedPeriodMaximumYearsOfEligibilityForCompaniesInDevelopmentArea.1907398.190543.256229">Benefited Period Maximum Years Of Eligibility For Companies In Development Area</link:label>
    <link:loc xlink:label="loc_BenefitedPeriodMaximumYearsOfEligibilityForCompaniesInDevelopmentArea.25613.11.12" xlink:href="psti-20140630.xsd#psti_BenefitedPeriodMaximumYearsOfEligibilityForCompaniesInDevelopmentArea" xlink:type="locator" />
    <link:labelArc xlink:from="loc_BenefitedPeriodMaximumYearsOfEligibilityForCompaniesInDevelopmentArea.25613.11.12" xlink:to="lab_BenefitedPeriodMaximumYearsOfEligibilityForCompaniesInDevelopmentArea.1907401.190545.256230" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_BenefitedPeriodMaximumYearsOfEligibilityForCompaniesInDevelopmentArea.1907401.190545.256230" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US" id="lab_BenefitedPeriodMaximumYearsOfEligibilityForCompaniesInDevelopmentArea.1907401.190545.256230">The limitation of the benefit period from the election year for development companies.</link:label>
    <link:loc xlink:label="loc_BenefitedPeriodMaximumYearsOfEligibilityForCompaniesInDevelopmentArea.25613.11.7" xlink:href="psti-20140630.xsd#psti_BenefitedPeriodMaximumYearsOfEligibilityForCompaniesInDevelopmentArea" xlink:type="locator" />
    <link:labelArc xlink:from="loc_BenefitedPeriodMaximumYearsOfEligibilityForCompaniesInDevelopmentArea.25613.11.7" xlink:to="lab_BenefitedPeriodMaximumYearsOfEligibilityForCompaniesInDevelopmentArea.1907402.190544.256231" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_BenefitedPeriodMaximumYearsOfEligibilityForCompaniesInDevelopmentArea.1907402.190544.256231" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US" id="lab_BenefitedPeriodMaximumYearsOfEligibilityForCompaniesInDevelopmentArea.1907402.190544.256231">The limitation of benefit period from year of election for companies in development area A</link:label>
    <link:loc xlink:label="loc_BuildingMember.772.11.6" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_BuildingMember" xlink:type="locator" />
    <link:labelArc xlink:from="loc_BuildingMember.772.11.6" xlink:to="lab_BuildingMember.891.190546.256275" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_BuildingMember.891.190546.256275" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US" id="lab_BuildingMember.891.190546.256275">Building [Member]</link:label>
    <link:loc xlink:label="loc_CarryforwardLossesForTaxPurposesAbstract.25604.11.6" xlink:href="psti-20140630.xsd#psti_CarryforwardLossesForTaxPurposesAbstract" xlink:type="locator" />
    <link:labelArc xlink:from="loc_CarryforwardLossesForTaxPurposesAbstract.25604.11.6" xlink:to="lab_CarryforwardLossesForTaxPurposesAbstract.1872005.190547.256203" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_CarryforwardLossesForTaxPurposesAbstract.1872005.190547.256203" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US" id="lab_CarryforwardLossesForTaxPurposesAbstract.1872005.190547.256203">Carryforward Losses For Tax Purposes [Abstract]</link:label>
    <link:loc xlink:label="loc_CarryforwardLossesForTaxPurposesAbstract.25604.11.12" xlink:href="psti-20140630.xsd#psti_CarryforwardLossesForTaxPurposesAbstract" xlink:type="locator" />
    <link:labelArc xlink:from="loc_CarryforwardLossesForTaxPurposesAbstract.25604.11.12" xlink:to="lab_CarryforwardLossesForTaxPurposesAbstract.1872006.190549.256204" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_CarryforwardLossesForTaxPurposesAbstract.1872006.190549.256204" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US" id="lab_CarryforwardLossesForTaxPurposesAbstract.1872006.190549.256204">Carryforward Losses For Tax Purposes [Abstract].</link:label>
    <link:loc xlink:label="loc_CarryforwardLossesForTaxPurposesAbstract.25604.11.7" xlink:href="psti-20140630.xsd#psti_CarryforwardLossesForTaxPurposesAbstract" xlink:type="locator" />
    <link:labelArc xlink:from="loc_CarryforwardLossesForTaxPurposesAbstract.25604.11.7" xlink:to="lab_CarryforwardLossesForTaxPurposesAbstract.1872007.190548.256205" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_CarryforwardLossesForTaxPurposesAbstract.1872007.190548.256205" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US" id="lab_CarryforwardLossesForTaxPurposesAbstract.1872007.190548.256205">Carryforward Losses:</link:label>
    <link:loc xlink:label="loc_DomesticCountryMember.1737.11.6" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_DomesticCountryMember" xlink:type="locator" />
    <link:labelArc xlink:from="loc_DomesticCountryMember.1737.11.6" xlink:to="lab_DomesticCountryMember.5628" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_DomesticCountryMember.5628" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US" id="lab_DomesticCountryMember.5628">Domestic Tax Authority [Member]</link:label>
    <link:loc xlink:label="loc_EarliestTaxYearMember.1754.11.6" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_EarliestTaxYearMember" xlink:type="locator" />
    <link:labelArc xlink:from="loc_EarliestTaxYearMember.1754.11.6" xlink:to="lab_EarliestTaxYearMember.5690" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_EarliestTaxYearMember.5690" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US" id="lab_EarliestTaxYearMember.5690">Earliest Tax Year [Member]</link:label>
    <link:loc xlink:label="loc_EffectiveIncomeTaxRateContinuingOperations.9032.11.6" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:type="locator" />
    <link:labelArc xlink:from="loc_EffectiveIncomeTaxRateContinuingOperations.9032.11.6" xlink:to="lab_EffectiveIncomeTaxRateContinuingOperations.5801" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_EffectiveIncomeTaxRateContinuingOperations.5801" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US" id="lab_EffectiveIncomeTaxRateContinuingOperations.5801">Effective Income Tax Rate Reconciliation, Percent</link:label>
    <link:loc xlink:label="loc_EffectiveIncomeTaxRateContinuingOperations.9032.11.7" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:type="locator" />
    <link:labelArc xlink:from="loc_EffectiveIncomeTaxRateContinuingOperations.9032.11.7" xlink:to="lab_EffectiveIncomeTaxRateContinuingOperations.1872034.190552.256280" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_EffectiveIncomeTaxRateContinuingOperations.1872034.190552.256280" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US" id="lab_EffectiveIncomeTaxRateContinuingOperations.1872034.190552.256280">Effective income tax rate</link:label>
    <link:loc xlink:label="loc_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate.9055.11.6" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" xlink:type="locator" />
    <link:labelArc xlink:from="loc_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate.9055.11.6" xlink:to="lab_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate.5831" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate.5831" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US" id="lab_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate.5831">Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent</link:label>
    <link:loc xlink:label="loc_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate.9055.11.7" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" xlink:type="locator" />
    <link:labelArc xlink:from="loc_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate.9055.11.7" xlink:to="lab_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate7.1871899.190554.256279" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate7.1871899.190554.256279" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US" id="lab_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate7.1871899.190554.256279">Statutory tax rate</link:label>
    <link:loc xlink:label="loc_EntityDomain.99.11.6" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_EntityDomain" xlink:type="locator" />
    <link:labelArc xlink:from="loc_EntityDomain.99.11.6" xlink:to="lab_EntityDomain.40.190130.256130" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_EntityDomain.40.190130.256130" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US" id="lab_EntityDomain.40.190130.256130">Entity [Domain]</link:label>
    <link:loc xlink:label="loc_IncomeTaxAuthorityAxis.2667.11.6" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_IncomeTaxAuthorityAxis" xlink:type="locator" />
    <link:labelArc xlink:from="loc_IncomeTaxAuthorityAxis.2667.11.6" xlink:to="lab_IncomeTaxAuthorityAxis.14929.190557.256278" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_IncomeTaxAuthorityAxis.14929.190557.256278" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US" id="lab_IncomeTaxAuthorityAxis.14929.190557.256278">Income Tax Authority [Axis]</link:label>
    <link:loc xlink:label="loc_IncomeTaxAuthorityDomain.2635.11.6" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_IncomeTaxAuthorityDomain" xlink:type="locator" />
    <link:labelArc xlink:from="loc_IncomeTaxAuthorityDomain.2635.11.6" xlink:to="lab_IncomeTaxAuthorityDomain.14451.190558.256274" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_IncomeTaxAuthorityDomain.14451.190558.256274" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US" id="lab_IncomeTaxAuthorityDomain.14451.190558.256274">Income Tax Authority [Domain]</link:label>
    <link:loc xlink:label="loc_IncomeTaxLineItems.25605.11.6" xlink:href="psti-20140630.xsd#psti_IncomeTaxLineItems" xlink:type="locator" />
    <link:labelArc xlink:from="loc_IncomeTaxLineItems.25605.11.6" xlink:to="lab_IncomeTaxLineItems.1871895.190559.256208" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_IncomeTaxLineItems.1871895.190559.256208" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US" id="lab_IncomeTaxLineItems.1871895.190559.256208">Income Tax [Line Items]</link:label>
    <link:loc xlink:label="loc_IncomeTaxLineItems.25605.11.12" xlink:href="psti-20140630.xsd#psti_IncomeTaxLineItems" xlink:type="locator" />
    <link:labelArc xlink:from="loc_IncomeTaxLineItems.25605.11.12" xlink:to="lab_IncomeTaxLineItems.1871896.190560.256209" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_IncomeTaxLineItems.1871896.190560.256209" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US" id="lab_IncomeTaxLineItems.1871896.190560.256209">Income Tax [Line Items]</link:label>
    <link:loc xlink:label="loc_IncomeTaxTable.25599.11.6" xlink:href="psti-20140630.xsd#psti_IncomeTaxTable" xlink:type="locator" />
    <link:labelArc xlink:from="loc_IncomeTaxTable.25599.11.6" xlink:to="lab_IncomeTaxTable.1871891.190561.256182" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_IncomeTaxTable.1871891.190561.256182" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US" id="lab_IncomeTaxTable.1871891.190561.256182">Income Tax [Table]</link:label>
    <link:loc xlink:label="loc_IncomeTaxTable.25599.11.12" xlink:href="psti-20140630.xsd#psti_IncomeTaxTable" xlink:type="locator" />
    <link:labelArc xlink:from="loc_IncomeTaxTable.25599.11.12" xlink:to="lab_IncomeTaxTable.1871892.190562.256183" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_IncomeTaxTable.1871892.190562.256183" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US" id="lab_IncomeTaxTable.1871892.190562.256183">Income Tax [Table]</link:label>
    <link:loc xlink:label="loc_IndustrialEnterprisesTaxBenefitConditionsMaximumPercentageOfTotalSales.25614.11.6" xlink:href="psti-20140630.xsd#psti_IndustrialEnterprisesTaxBenefitConditionsMaximumPercentageOfTotalSales" xlink:type="locator" />
    <link:labelArc xlink:from="loc_IndustrialEnterprisesTaxBenefitConditionsMaximumPercentageOfTotalSales.25614.11.6" xlink:to="lab_IndustrialEnterprisesTaxBenefitConditionsMaximumPercentageOfTotalSales.1907405.190563.256232" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_IndustrialEnterprisesTaxBenefitConditionsMaximumPercentageOfTotalSales.1907405.190563.256232" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US" id="lab_IndustrialEnterprisesTaxBenefitConditionsMaximumPercentageOfTotalSales.1907405.190563.256232">Industrial Enterprises Tax Benefit Conditions Maximum Percentage Of Total Sales</link:label>
    <link:loc xlink:label="loc_IndustrialEnterprisesTaxBenefitConditionsMaximumPercentageOfTotalSales.25614.11.12" xlink:href="psti-20140630.xsd#psti_IndustrialEnterprisesTaxBenefitConditionsMaximumPercentageOfTotalSales" xlink:type="locator" />
    <link:labelArc xlink:from="loc_IndustrialEnterprisesTaxBenefitConditionsMaximumPercentageOfTotalSales.25614.11.12" xlink:to="lab_IndustrialEnterprisesTaxBenefitConditionsMaximumPercentageOfTotalSales.1907407.190565.256233" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_IndustrialEnterprisesTaxBenefitConditionsMaximumPercentageOfTotalSales.1907407.190565.256233" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US" id="lab_IndustrialEnterprisesTaxBenefitConditionsMaximumPercentageOfTotalSales.1907407.190565.256233">The maximum percentage of total sales that industrial sales can be annually in order to receive the tax benefit.</link:label>
    <link:loc xlink:label="loc_IndustrialEnterprisesTaxBenefitConditionsMaximumPercentageOfTotalSales.25614.11.7" xlink:href="psti-20140630.xsd#psti_IndustrialEnterprisesTaxBenefitConditionsMaximumPercentageOfTotalSales" xlink:type="locator" />
    <link:labelArc xlink:from="loc_IndustrialEnterprisesTaxBenefitConditionsMaximumPercentageOfTotalSales.25614.11.7" xlink:to="lab_IndustrialEnterprisesTaxBenefitConditionsMaximumPercentageOfTotalSales.1907408.190564.256234" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_IndustrialEnterprisesTaxBenefitConditionsMaximumPercentageOfTotalSales.1907408.190564.256234" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US" id="lab_IndustrialEnterprisesTaxBenefitConditionsMaximumPercentageOfTotalSales.1907408.190564.256234">Industrial enterprises conditions, maximum percentage of total sales</link:label>
    <link:loc xlink:label="loc_IndustrialEnterprisesTaxBenefitConditionsMinimumPercentageOfTotalRevenuesGeneratedFromAspecificMarket.25615.11.6" xlink:href="psti-20140630.xsd#psti_IndustrialEnterprisesTaxBenefitConditionsMinimumPercentageOfTotalRevenuesGeneratedFromAspecificMarket" xlink:type="locator" />
    <link:labelArc xlink:from="loc_IndustrialEnterprisesTaxBenefitConditionsMinimumPercentageOfTotalRevenuesGeneratedFromAspecificMarket.25615.11.6" xlink:to="lab_IndustrialEnterprisesTaxBenefitConditionsMinimumPercentageOfTotalRevenuesGeneratedFromAspecificMarket.1907409.190566.256235" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_IndustrialEnterprisesTaxBenefitConditionsMinimumPercentageOfTotalRevenuesGeneratedFromAspecificMarket.1907409.190566.256235" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US" id="lab_IndustrialEnterprisesTaxBenefitConditionsMinimumPercentageOfTotalRevenuesGeneratedFromAspecificMarket.1907409.190566.256235">Industrial Enterprises Tax Benefit Conditions Minimum Percentage Of Total Revenues Generated From Aspecific Market</link:label>
    <link:loc xlink:label="loc_IndustrialEnterprisesTaxBenefitConditionsMinimumPercentageOfTotalRevenuesGeneratedFromAspecificMarket.25615.11.12" xlink:href="psti-20140630.xsd#psti_IndustrialEnterprisesTaxBenefitConditionsMinimumPercentageOfTotalRevenuesGeneratedFromAspecificMarket" xlink:type="locator" />
    <link:labelArc xlink:from="loc_IndustrialEnterprisesTaxBenefitConditionsMinimumPercentageOfTotalRevenuesGeneratedFromAspecificMarket.25615.11.12" xlink:to="lab_IndustrialEnterprisesTaxBenefitConditionsMinimumPercentageOfTotalRevenuesGeneratedFromAspecificMarket.1907411.190568.256236" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_IndustrialEnterprisesTaxBenefitConditionsMinimumPercentageOfTotalRevenuesGeneratedFromAspecificMarket.1907411.190568.256236" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US" id="lab_IndustrialEnterprisesTaxBenefitConditionsMinimumPercentageOfTotalRevenuesGeneratedFromAspecificMarket.1907411.190568.256236">The minimum percentage of total revenues that must be generated from a specific market.</link:label>
    <link:loc xlink:label="loc_IndustrialEnterprisesTaxBenefitConditionsMinimumPercentageOfTotalRevenuesGeneratedFromAspecificMarket.25615.11.7" xlink:href="psti-20140630.xsd#psti_IndustrialEnterprisesTaxBenefitConditionsMinimumPercentageOfTotalRevenuesGeneratedFromAspecificMarket" xlink:type="locator" />
    <link:labelArc xlink:from="loc_IndustrialEnterprisesTaxBenefitConditionsMinimumPercentageOfTotalRevenuesGeneratedFromAspecificMarket.25615.11.7" xlink:to="lab_IndustrialEnterprisesTaxBenefitConditionsMinimumPercentageOfTotalRevenuesGeneratedFromAspecificMarket.1907412.190567.256237" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_IndustrialEnterprisesTaxBenefitConditionsMinimumPercentageOfTotalRevenuesGeneratedFromAspecificMarket.1907412.190567.256237" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US" id="lab_IndustrialEnterprisesTaxBenefitConditionsMinimumPercentageOfTotalRevenuesGeneratedFromAspecificMarket.1907412.190567.256237">Industrial enterprises conditions, minimum percentage of total revenues from given market</link:label>
    <link:loc xlink:label="loc_IndustrialEnterprisesTaxBenefitConditionsMinimumPercentageOfTotalRevenuesGivenMarketMinimumPopulation.25616.11.6" xlink:href="psti-20140630.xsd#psti_IndustrialEnterprisesTaxBenefitConditionsMinimumPercentageOfTotalRevenuesGivenMarketMinimumPopulation" xlink:type="locator" />
    <link:labelArc xlink:from="loc_IndustrialEnterprisesTaxBenefitConditionsMinimumPercentageOfTotalRevenuesGivenMarketMinimumPopulation.25616.11.6" xlink:to="lab_IndustrialEnterprisesTaxBenefitConditionsMinimumPercentageOfTotalRevenuesGivenMarketMinimumPopulation.1907414.190569.256238" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_IndustrialEnterprisesTaxBenefitConditionsMinimumPercentageOfTotalRevenuesGivenMarketMinimumPopulation.1907414.190569.256238" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US" id="lab_IndustrialEnterprisesTaxBenefitConditionsMinimumPercentageOfTotalRevenuesGivenMarketMinimumPopulation.1907414.190569.256238">Industrial Enterprises Tax Benefit Conditions Minimum Percentage Of Total Revenues Given Market Minimum Population</link:label>
    <link:loc xlink:label="loc_IndustrialEnterprisesTaxBenefitConditionsMinimumPercentageOfTotalRevenuesGivenMarketMinimumPopulation.25616.11.12" xlink:href="psti-20140630.xsd#psti_IndustrialEnterprisesTaxBenefitConditionsMinimumPercentageOfTotalRevenuesGivenMarketMinimumPopulation" xlink:type="locator" />
    <link:labelArc xlink:from="loc_IndustrialEnterprisesTaxBenefitConditionsMinimumPercentageOfTotalRevenuesGivenMarketMinimumPopulation.25616.11.12" xlink:to="lab_IndustrialEnterprisesTaxBenefitConditionsMinimumPercentageOfTotalRevenuesGivenMarketMinimumPopulation.1907415.190571.256239" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_IndustrialEnterprisesTaxBenefitConditionsMinimumPercentageOfTotalRevenuesGivenMarketMinimumPopulation.1907415.190571.256239" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US" id="lab_IndustrialEnterprisesTaxBenefitConditionsMinimumPercentageOfTotalRevenuesGivenMarketMinimumPopulation.1907415.190571.256239">The minimum population amount of the given market for which the minimum percentage of total revenues condition is based.</link:label>
    <link:loc xlink:label="loc_IndustrialEnterprisesTaxBenefitConditionsMinimumPercentageOfTotalRevenuesGivenMarketMinimumPopulation.25616.11.7" xlink:href="psti-20140630.xsd#psti_IndustrialEnterprisesTaxBenefitConditionsMinimumPercentageOfTotalRevenuesGivenMarketMinimumPopulation" xlink:type="locator" />
    <link:labelArc xlink:from="loc_IndustrialEnterprisesTaxBenefitConditionsMinimumPercentageOfTotalRevenuesGivenMarketMinimumPopulation.25616.11.7" xlink:to="lab_IndustrialEnterprisesTaxBenefitConditionsMinimumPercentageOfTotalRevenuesGivenMarketMinimumPopulation.1907416.190570.256240" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_IndustrialEnterprisesTaxBenefitConditionsMinimumPercentageOfTotalRevenuesGivenMarketMinimumPopulation.1907416.190570.256240" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US" id="lab_IndustrialEnterprisesTaxBenefitConditionsMinimumPercentageOfTotalRevenuesGivenMarketMinimumPopulation.1907416.190570.256240">Industrial enterprises conditions, minimum population of given market</link:label>
    <link:loc xlink:label="loc_InternalRevenueServiceIRSMember.2877.11.6" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_InternalRevenueServiceIRSMember" xlink:type="locator" />
    <link:labelArc xlink:from="loc_InternalRevenueServiceIRSMember.2877.11.6" xlink:to="lab_InternalRevenueServiceIRSMember.9927" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_InternalRevenueServiceIRSMember.9927" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US" id="lab_InternalRevenueServiceIRSMember.9927">Internal Revenue Service (IRS) [Member]</link:label>
    <link:loc xlink:label="loc_InternalRevenueServiceIRSMember.2877.11.7" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_InternalRevenueServiceIRSMember" xlink:type="locator" />
    <link:labelArc xlink:from="loc_InternalRevenueServiceIRSMember.2877.11.7" xlink:to="lab_InternalRevenueServiceIRSMember.1872301.190573.256273" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_InternalRevenueServiceIRSMember.1872301.190573.256273" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US" id="lab_InternalRevenueServiceIRSMember.1872301.190573.256273">Internal Revenue Service (IRS) [Member]</link:label>
    <link:loc xlink:label="loc_IsraelTaxAuthorityMember.2580.11.6" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_IsraelTaxAuthorityMember" xlink:type="locator" />
    <link:labelArc xlink:from="loc_IsraelTaxAuthorityMember.2580.11.6" xlink:to="lab_IsraelTaxAuthorityMember.8606" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_IsraelTaxAuthorityMember.8606" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US" id="lab_IsraelTaxAuthorityMember.8606">Israel Tax Authority [Member]</link:label>
    <link:loc xlink:label="loc_IsraelTaxAuthorityMember.2580.11.7" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_IsraelTaxAuthorityMember" xlink:type="locator" />
    <link:labelArc xlink:from="loc_IsraelTaxAuthorityMember.2580.11.7" xlink:to="lab_IsraelTaxAuthorityMember.257472" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_IsraelTaxAuthorityMember.257472" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US" id="lab_IsraelTaxAuthorityMember.257472">Israel Tax Authority [Member]</link:label>
    <link:loc xlink:label="loc_LatestTaxYearMember.2979.11.6" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_LatestTaxYearMember" xlink:type="locator" />
    <link:labelArc xlink:from="loc_LatestTaxYearMember.2979.11.6" xlink:to="lab_LatestTaxYearMember.10285" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_LatestTaxYearMember.10285" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US" id="lab_LatestTaxYearMember.10285">Latest Tax Year [Member]</link:label>
    <link:loc xlink:label="loc_LawForEconomicEfficiencyAmendedLegislationImplementingEconomicPlanForTwoThousandNineAndTenTaxRate.25625.11.6" xlink:href="psti-20140630.xsd#psti_LawForEconomicEfficiencyAmendedLegislationImplementingEconomicPlanForTwoThousandNineAndTenTaxRate" xlink:type="locator" />
    <link:labelArc xlink:from="loc_LawForEconomicEfficiencyAmendedLegislationImplementingEconomicPlanForTwoThousandNineAndTenTaxRate.25625.11.6" xlink:to="lab_LawForEconomicEfficiencyAmendedLegislationImplementingEconomicPlanForTwoThousandNineAndTenTaxRate.1871904.190574.256268" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_LawForEconomicEfficiencyAmendedLegislationImplementingEconomicPlanForTwoThousandNineAndTenTaxRate.1871904.190574.256268" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US" id="lab_LawForEconomicEfficiencyAmendedLegislationImplementingEconomicPlanForTwoThousandNineAndTenTaxRate.1871904.190574.256268">Law For Economic Efficiency Amended Legislation Implementing Economic Plan For Two Thousand Nine And Ten Tax Rate</link:label>
    <link:loc xlink:label="loc_LawForEconomicEfficiencyAmendedLegislationImplementingEconomicPlanForTwoThousandNineAndTenTaxRate.25625.11.12" xlink:href="psti-20140630.xsd#psti_LawForEconomicEfficiencyAmendedLegislationImplementingEconomicPlanForTwoThousandNineAndTenTaxRate" xlink:type="locator" />
    <link:labelArc xlink:from="loc_LawForEconomicEfficiencyAmendedLegislationImplementingEconomicPlanForTwoThousandNineAndTenTaxRate.25625.11.12" xlink:to="lab_LawForEconomicEfficiencyAmendedLegislationImplementingEconomicPlanForTwoThousandNineAndTenTaxRate.1871906.190576.256269" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_LawForEconomicEfficiencyAmendedLegislationImplementingEconomicPlanForTwoThousandNineAndTenTaxRate.1871906.190576.256269" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US" id="lab_LawForEconomicEfficiencyAmendedLegislationImplementingEconomicPlanForTwoThousandNineAndTenTaxRate.1871906.190576.256269">The amended tax rate for corporate and real capital gains tax as provided within the amended legislation.</link:label>
    <link:loc xlink:label="loc_LawForEconomicEfficiencyAmendedLegislationImplementingEconomicPlanForTwoThousandNineAndTenTaxRate.25625.11.7" xlink:href="psti-20140630.xsd#psti_LawForEconomicEfficiencyAmendedLegislationImplementingEconomicPlanForTwoThousandNineAndTenTaxRate" xlink:type="locator" />
    <link:labelArc xlink:from="loc_LawForEconomicEfficiencyAmendedLegislationImplementingEconomicPlanForTwoThousandNineAndTenTaxRate.25625.11.7" xlink:to="lab_LawForEconomicEfficiencyAmendedLegislationImplementingEconomicPlanForTwoThousandNineAndTenTaxRate.1871907.190575.256270" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_LawForEconomicEfficiencyAmendedLegislationImplementingEconomicPlanForTwoThousandNineAndTenTaxRate.1871907.190575.256270" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US" id="lab_LawForEconomicEfficiencyAmendedLegislationImplementingEconomicPlanForTwoThousandNineAndTenTaxRate.1871907.190575.256270">Corporate and real capital gains tax rate</link:label>
    <link:loc xlink:label="loc_LegalEntityAxis.136.11.6" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_LegalEntityAxis" xlink:type="locator" />
    <link:labelArc xlink:from="loc_LegalEntityAxis.136.11.6" xlink:to="lab_LegalEntityAxis.135.190142.256145" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_LegalEntityAxis.135.190142.256145" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US" id="lab_LegalEntityAxis.135.190142.256145">Legal Entity [Axis]</link:label>
    <link:loc xlink:label="loc_NationalPriorityZoneBcorporateBenefitedPeriodPeriodOfTime.25610.11.6" xlink:href="psti-20140630.xsd#psti_NationalPriorityZoneBcorporateBenefitedPeriodPeriodOfTime" xlink:type="locator" />
    <link:labelArc xlink:from="loc_NationalPriorityZoneBcorporateBenefitedPeriodPeriodOfTime.25610.11.6" xlink:to="lab_NationalPriorityZoneBcorporateBenefitedPeriodPeriodOfTime.1871975.190577.256220" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_NationalPriorityZoneBcorporateBenefitedPeriodPeriodOfTime.1871975.190577.256220" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US" id="lab_NationalPriorityZoneBcorporateBenefitedPeriodPeriodOfTime.1871975.190577.256220">National Priority Zone Bcorporate Benefited Period Period Of Time</link:label>
    <link:loc xlink:label="loc_NationalPriorityZoneBcorporateBenefitedPeriodPeriodOfTime.25610.11.12" xlink:href="psti-20140630.xsd#psti_NationalPriorityZoneBcorporateBenefitedPeriodPeriodOfTime" xlink:type="locator" />
    <link:labelArc xlink:from="loc_NationalPriorityZoneBcorporateBenefitedPeriodPeriodOfTime.25610.11.12" xlink:to="lab_NationalPriorityZoneBcorporateBenefitedPeriodPeriodOfTime.1871976.190579.256221" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_NationalPriorityZoneBcorporateBenefitedPeriodPeriodOfTime.1871976.190579.256221" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US" id="lab_NationalPriorityZoneBcorporateBenefitedPeriodPeriodOfTime.1871976.190579.256221">The amount of time that the benefited period tax rate is received by the entity.</link:label>
    <link:loc xlink:label="loc_NationalPriorityZoneBcorporateBenefitedPeriodPeriodOfTime.25610.11.7" xlink:href="psti-20140630.xsd#psti_NationalPriorityZoneBcorporateBenefitedPeriodPeriodOfTime" xlink:type="locator" />
    <link:labelArc xlink:from="loc_NationalPriorityZoneBcorporateBenefitedPeriodPeriodOfTime.25610.11.7" xlink:to="lab_NationalPriorityZoneBcorporateBenefitedPeriodPeriodOfTime.1871978.190578.256222" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_NationalPriorityZoneBcorporateBenefitedPeriodPeriodOfTime.1871978.190578.256222" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US" id="lab_NationalPriorityZoneBcorporateBenefitedPeriodPeriodOfTime.1871978.190578.256222">The period of time for use of the benefited period tax rate</link:label>
    <link:loc xlink:label="loc_NationalPriorityZoneBCorporateBenefitedPeriodTaxRate.25609.11.6" xlink:href="psti-20140630.xsd#psti_NationalPriorityZoneBCorporateBenefitedPeriodTaxRate" xlink:type="locator" />
    <link:labelArc xlink:from="loc_NationalPriorityZoneBCorporateBenefitedPeriodTaxRate.25609.11.6" xlink:to="lab_NationalPriorityZoneBCorporateBenefitedPeriodTaxRate.1871968.190580.256217" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_NationalPriorityZoneBCorporateBenefitedPeriodTaxRate.1871968.190580.256217" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US" id="lab_NationalPriorityZoneBCorporateBenefitedPeriodTaxRate.1871968.190580.256217">National Priority Zone B Corporate Benefited Period Tax Rate</link:label>
    <link:loc xlink:label="loc_NationalPriorityZoneBCorporateBenefitedPeriodTaxRate.25609.11.12" xlink:href="psti-20140630.xsd#psti_NationalPriorityZoneBCorporateBenefitedPeriodTaxRate" xlink:type="locator" />
    <link:labelArc xlink:from="loc_NationalPriorityZoneBCorporateBenefitedPeriodTaxRate.25609.11.12" xlink:to="lab_NationalPriorityZoneBCorporateBenefitedPeriodTaxRate.1871970.190582.256218" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_NationalPriorityZoneBCorporateBenefitedPeriodTaxRate.1871970.190582.256218" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US" id="lab_NationalPriorityZoneBCorporateBenefitedPeriodTaxRate.1871970.190582.256218">The benefited period tax rate the entity receives.</link:label>
    <link:loc xlink:label="loc_NationalPriorityZoneBCorporateBenefitedPeriodTaxRate.25609.11.7" xlink:href="psti-20140630.xsd#psti_NationalPriorityZoneBCorporateBenefitedPeriodTaxRate" xlink:type="locator" />
    <link:labelArc xlink:from="loc_NationalPriorityZoneBCorporateBenefitedPeriodTaxRate.25609.11.7" xlink:to="lab_NationalPriorityZoneBCorporateBenefitedPeriodTaxRate.1871974.190581.256219" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_NationalPriorityZoneBCorporateBenefitedPeriodTaxRate.1871974.190581.256219" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US" id="lab_NationalPriorityZoneBCorporateBenefitedPeriodTaxRate.1871974.190581.256219">The benefited period tax rate</link:label>
    <link:loc xlink:label="loc_NationalPriorityZoneBCorporateTaxExemptionPeriod.25608.11.6" xlink:href="psti-20140630.xsd#psti_NationalPriorityZoneBCorporateTaxExemptionPeriod" xlink:type="locator" />
    <link:labelArc xlink:from="loc_NationalPriorityZoneBCorporateTaxExemptionPeriod.25608.11.6" xlink:to="lab_NationalPriorityZoneBCorporateTaxExemptionPeriod.1871959.190583.256214" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_NationalPriorityZoneBCorporateTaxExemptionPeriod.1871959.190583.256214" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US" id="lab_NationalPriorityZoneBCorporateTaxExemptionPeriod.1871959.190583.256214">National Priority Zone B Corporate Tax Exemption Period</link:label>
    <link:loc xlink:label="loc_NationalPriorityZoneBCorporateTaxExemptionPeriod.25608.11.12" xlink:href="psti-20140630.xsd#psti_NationalPriorityZoneBCorporateTaxExemptionPeriod" xlink:type="locator" />
    <link:labelArc xlink:from="loc_NationalPriorityZoneBCorporateTaxExemptionPeriod.25608.11.12" xlink:to="lab_NationalPriorityZoneBCorporateTaxExemptionPeriod.1871966.190585.256215" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_NationalPriorityZoneBCorporateTaxExemptionPeriod.1871966.190585.256215" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US" id="lab_NationalPriorityZoneBCorporateTaxExemptionPeriod.1871966.190585.256215">The period of time that corporate tax exemption is received by the entity due it's location within the National Priority Zone "B".</link:label>
    <link:loc xlink:label="loc_NationalPriorityZoneBCorporateTaxExemptionPeriod.25608.11.7" xlink:href="psti-20140630.xsd#psti_NationalPriorityZoneBCorporateTaxExemptionPeriod" xlink:type="locator" />
    <link:labelArc xlink:from="loc_NationalPriorityZoneBCorporateTaxExemptionPeriod.25608.11.7" xlink:to="lab_NationalPriorityZoneBCorporateTaxExemptionPeriod.1871967.190584.256216" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_NationalPriorityZoneBCorporateTaxExemptionPeriod.1871967.190584.256216" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US" id="lab_NationalPriorityZoneBCorporateTaxExemptionPeriod.1871967.190584.256216">Period of corporate tax exemption</link:label>
    <link:loc xlink:label="loc_OperatingLossCarryforwards.13469.11.6" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_OperatingLossCarryforwards" xlink:type="locator" />
    <link:labelArc xlink:from="loc_OperatingLossCarryforwards.13469.11.6" xlink:to="lab_OperatingLossCarryforwards.12847" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_OperatingLossCarryforwards.12847" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US" id="lab_OperatingLossCarryforwards.12847">Operating Loss Carryforwards</link:label>
    <link:loc xlink:label="loc_OperatingLossCarryforwards.13469.11.7" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_OperatingLossCarryforwards" xlink:type="locator" />
    <link:labelArc xlink:from="loc_OperatingLossCarryforwards.13469.11.7" xlink:to="lab_OperatingLossCarryforwards.130703.190587.256276" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_OperatingLossCarryforwards.130703.190587.256276" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US" id="lab_OperatingLossCarryforwards.130703.190587.256276">Net operating loss carryforwards</link:label>
    <link:loc xlink:label="loc_OperatingLossCarryforwardsExpirationDate.13455.11.6" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_OperatingLossCarryforwardsExpirationDate" xlink:type="locator" />
    <link:labelArc xlink:from="loc_OperatingLossCarryforwardsExpirationDate.13455.11.6" xlink:to="lab_OperatingLossCarryforwardsExpirationDate.12822" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_OperatingLossCarryforwardsExpirationDate.12822" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US" id="lab_OperatingLossCarryforwardsExpirationDate.12822">Operating Loss Carryforwards, Expiration Date</link:label>
    <link:loc xlink:label="loc_OperatingLossCarryforwardsExpirationDate.13455.11.7" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_OperatingLossCarryforwardsExpirationDate" xlink:type="locator" />
    <link:labelArc xlink:from="loc_OperatingLossCarryforwardsExpirationDate.13455.11.7" xlink:to="lab_OperatingLossCarryforwardsExpirationDate.227204.256277" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_OperatingLossCarryforwardsExpirationDate.227204.256277" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US" id="lab_OperatingLossCarryforwardsExpirationDate.227204.256277">Net federal operating loss carry forward expiration date</link:label>
    <link:loc xlink:label="loc_ParentCompanyMember.3915.11.6" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ParentCompanyMember" xlink:type="locator" />
    <link:labelArc xlink:from="loc_ParentCompanyMember.3915.11.6" xlink:to="lab_ParentCompanyMember.13706" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_ParentCompanyMember.13706" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US" id="lab_ParentCompanyMember.13706">Parent Company [Member]</link:label>
    <link:loc xlink:label="loc_ParentCompanyMember.3915.11.7" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ParentCompanyMember" xlink:type="locator" />
    <link:labelArc xlink:from="loc_ParentCompanyMember.3915.11.7" xlink:to="lab_ParentCompanyMember.1871893.190166.256129" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_ParentCompanyMember.1871893.190166.256129" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US" id="lab_ParentCompanyMember.1871893.190166.256129">Pluristem Therapeutics Inc. [Member]</link:label>
    <link:loc xlink:label="loc_SubsidiariesMember.5165.11.6" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_SubsidiariesMember" xlink:type="locator" />
    <link:labelArc xlink:from="loc_SubsidiariesMember.5165.11.6" xlink:to="lab_SubsidiariesMember.18553" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_SubsidiariesMember.18553" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US" id="lab_SubsidiariesMember.18553">Subsidiaries [Member]</link:label>
    <link:loc xlink:label="loc_TaxAmendmentLawAmendedTaxRatePreferredEnterprisesDevelopmentAreaYearsFiveAndThereafter.25623.11.6" xlink:href="psti-20140630.xsd#psti_TaxAmendmentLawAmendedTaxRatePreferredEnterprisesDevelopmentAreaYearsFiveAndThereafter" xlink:type="locator" />
    <link:labelArc xlink:from="loc_TaxAmendmentLawAmendedTaxRatePreferredEnterprisesDevelopmentAreaYearsFiveAndThereafter.25623.11.6" xlink:to="lab_TaxAmendmentLawAmendedTaxRatePreferredEnterprisesDevelopmentAreaYearsFiveAndThereafter.1907476.190589.256259" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_TaxAmendmentLawAmendedTaxRatePreferredEnterprisesDevelopmentAreaYearsFiveAndThereafter.1907476.190589.256259" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US" id="lab_TaxAmendmentLawAmendedTaxRatePreferredEnterprisesDevelopmentAreaYearsFiveAndThereafter.1907476.190589.256259">Tax Amendment Law Amended Tax Rate Preferred Enterprises Development Area Years Five And Thereafter</link:label>
    <link:loc xlink:label="loc_TaxAmendmentLawAmendedTaxRatePreferredEnterprisesDevelopmentAreaYearsFiveAndThereafter.25623.11.12" xlink:href="psti-20140630.xsd#psti_TaxAmendmentLawAmendedTaxRatePreferredEnterprisesDevelopmentAreaYearsFiveAndThereafter" xlink:type="locator" />
    <link:labelArc xlink:from="loc_TaxAmendmentLawAmendedTaxRatePreferredEnterprisesDevelopmentAreaYearsFiveAndThereafter.25623.11.12" xlink:to="lab_TaxAmendmentLawAmendedTaxRatePreferredEnterprisesDevelopmentAreaYearsFiveAndThereafter.1907477.190591.256260" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_TaxAmendmentLawAmendedTaxRatePreferredEnterprisesDevelopmentAreaYearsFiveAndThereafter.1907477.190591.256260" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US" id="lab_TaxAmendmentLawAmendedTaxRatePreferredEnterprisesDevelopmentAreaYearsFiveAndThereafter.1907477.190591.256260">The tax rate applied in the fifth and forth-going years following the enactment of the amended tax law for companies in development areas.</link:label>
    <link:loc xlink:label="loc_TaxAmendmentLawAmendedTaxRatePreferredEnterprisesDevelopmentAreaYearsFiveAndThereafter.25623.11.7" xlink:href="psti-20140630.xsd#psti_TaxAmendmentLawAmendedTaxRatePreferredEnterprisesDevelopmentAreaYearsFiveAndThereafter" xlink:type="locator" />
    <link:labelArc xlink:from="loc_TaxAmendmentLawAmendedTaxRatePreferredEnterprisesDevelopmentAreaYearsFiveAndThereafter.25623.11.7" xlink:to="lab_TaxAmendmentLawAmendedTaxRatePreferredEnterprisesDevelopmentAreaYearsFiveAndThereafter.1907478.190590.256261" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_TaxAmendmentLawAmendedTaxRatePreferredEnterprisesDevelopmentAreaYearsFiveAndThereafter.1907478.190590.256261" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US" id="lab_TaxAmendmentLawAmendedTaxRatePreferredEnterprisesDevelopmentAreaYearsFiveAndThereafter.1907478.190590.256261">Encouragement Law Amendment, tax rate in 2015 and thereafter, development area</link:label>
    <link:loc xlink:label="loc_TaxAmendmentLawAmendedTaxRatePreferredEnterprisesDevelopmentAreaYearsOneAndTwo.25620.11.6" xlink:href="psti-20140630.xsd#psti_TaxAmendmentLawAmendedTaxRatePreferredEnterprisesDevelopmentAreaYearsOneAndTwo" xlink:type="locator" />
    <link:labelArc xlink:from="loc_TaxAmendmentLawAmendedTaxRatePreferredEnterprisesDevelopmentAreaYearsOneAndTwo.25620.11.6" xlink:to="lab_TaxAmendmentLawAmendedTaxRatePreferredEnterprisesDevelopmentAreaYearsOneAndTwo.1907447.190592.256250" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_TaxAmendmentLawAmendedTaxRatePreferredEnterprisesDevelopmentAreaYearsOneAndTwo.1907447.190592.256250" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US" id="lab_TaxAmendmentLawAmendedTaxRatePreferredEnterprisesDevelopmentAreaYearsOneAndTwo.1907447.190592.256250">Tax Amendment Law Amended Tax Rate Preferred Enterprises Development Area Years One And Two</link:label>
    <link:loc xlink:label="loc_TaxAmendmentLawAmendedTaxRatePreferredEnterprisesDevelopmentAreaYearsOneAndTwo.25620.11.12" xlink:href="psti-20140630.xsd#psti_TaxAmendmentLawAmendedTaxRatePreferredEnterprisesDevelopmentAreaYearsOneAndTwo" xlink:type="locator" />
    <link:labelArc xlink:from="loc_TaxAmendmentLawAmendedTaxRatePreferredEnterprisesDevelopmentAreaYearsOneAndTwo.25620.11.12" xlink:to="lab_TaxAmendmentLawAmendedTaxRatePreferredEnterprisesDevelopmentAreaYearsOneAndTwo.1907448.190594.256251" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_TaxAmendmentLawAmendedTaxRatePreferredEnterprisesDevelopmentAreaYearsOneAndTwo.1907448.190594.256251" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US" id="lab_TaxAmendmentLawAmendedTaxRatePreferredEnterprisesDevelopmentAreaYearsOneAndTwo.1907448.190594.256251">The tax rate applied in the first and second years following the enactment of the amended tax law for companies in development areas.</link:label>
    <link:loc xlink:label="loc_TaxAmendmentLawAmendedTaxRatePreferredEnterprisesDevelopmentAreaYearsOneAndTwo.25620.11.7" xlink:href="psti-20140630.xsd#psti_TaxAmendmentLawAmendedTaxRatePreferredEnterprisesDevelopmentAreaYearsOneAndTwo" xlink:type="locator" />
    <link:labelArc xlink:from="loc_TaxAmendmentLawAmendedTaxRatePreferredEnterprisesDevelopmentAreaYearsOneAndTwo.25620.11.7" xlink:to="lab_TaxAmendmentLawAmendedTaxRatePreferredEnterprisesDevelopmentAreaYearsOneAndTwo.1907449.190593.256252" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_TaxAmendmentLawAmendedTaxRatePreferredEnterprisesDevelopmentAreaYearsOneAndTwo.1907449.190593.256252" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US" id="lab_TaxAmendmentLawAmendedTaxRatePreferredEnterprisesDevelopmentAreaYearsOneAndTwo.1907449.190593.256252">Encouragement Law Amendment, tax rate in 2011 and 2012, development area</link:label>
    <link:loc xlink:label="loc_TaxAmendmentLawAmendedTaxRatePreferredEnterprisesDevelopmentAreaYearsThreeAndFour.25621.11.6" xlink:href="psti-20140630.xsd#psti_TaxAmendmentLawAmendedTaxRatePreferredEnterprisesDevelopmentAreaYearsThreeAndFour" xlink:type="locator" />
    <link:labelArc xlink:from="loc_TaxAmendmentLawAmendedTaxRatePreferredEnterprisesDevelopmentAreaYearsThreeAndFour.25621.11.6" xlink:to="lab_TaxAmendmentLawAmendedTaxRatePreferredEnterprisesDevelopmentAreaYearsThreeAndFour.1907450.190595.256253" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_TaxAmendmentLawAmendedTaxRatePreferredEnterprisesDevelopmentAreaYearsThreeAndFour.1907450.190595.256253" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US" id="lab_TaxAmendmentLawAmendedTaxRatePreferredEnterprisesDevelopmentAreaYearsThreeAndFour.1907450.190595.256253">Tax Amendment Law Amended Tax Rate Preferred Enterprises Development Area Years Three And Four</link:label>
    <link:loc xlink:label="loc_TaxAmendmentLawAmendedTaxRatePreferredEnterprisesDevelopmentAreaYearsThreeAndFour.25621.11.12" xlink:href="psti-20140630.xsd#psti_TaxAmendmentLawAmendedTaxRatePreferredEnterprisesDevelopmentAreaYearsThreeAndFour" xlink:type="locator" />
    <link:labelArc xlink:from="loc_TaxAmendmentLawAmendedTaxRatePreferredEnterprisesDevelopmentAreaYearsThreeAndFour.25621.11.12" xlink:to="lab_TaxAmendmentLawAmendedTaxRatePreferredEnterprisesDevelopmentAreaYearsThreeAndFour.1907451.190597.256254" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_TaxAmendmentLawAmendedTaxRatePreferredEnterprisesDevelopmentAreaYearsThreeAndFour.1907451.190597.256254" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US" id="lab_TaxAmendmentLawAmendedTaxRatePreferredEnterprisesDevelopmentAreaYearsThreeAndFour.1907451.190597.256254">The tax rate applied in the third and fourth years following the enactment of the amended tax law for companies in development areas.</link:label>
    <link:loc xlink:label="loc_TaxAmendmentLawAmendedTaxRatePreferredEnterprisesDevelopmentAreaYearsThreeAndFour.25621.11.7" xlink:href="psti-20140630.xsd#psti_TaxAmendmentLawAmendedTaxRatePreferredEnterprisesDevelopmentAreaYearsThreeAndFour" xlink:type="locator" />
    <link:labelArc xlink:from="loc_TaxAmendmentLawAmendedTaxRatePreferredEnterprisesDevelopmentAreaYearsThreeAndFour.25621.11.7" xlink:to="lab_TaxAmendmentLawAmendedTaxRatePreferredEnterprisesDevelopmentAreaYearsThreeAndFour.1907452.190596.256255" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_TaxAmendmentLawAmendedTaxRatePreferredEnterprisesDevelopmentAreaYearsThreeAndFour.1907452.190596.256255" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US" id="lab_TaxAmendmentLawAmendedTaxRatePreferredEnterprisesDevelopmentAreaYearsThreeAndFour.1907452.190596.256255">Encouragement Law Amendment, tax rate in 2013 and 2014, development area</link:label>
    <link:loc xlink:label="loc_TaxAmendmentLawAmendedTaxRatePreferredEnterprisesYearsFiveAndThereafter.25622.11.6" xlink:href="psti-20140630.xsd#psti_TaxAmendmentLawAmendedTaxRatePreferredEnterprisesYearsFiveAndThereafter" xlink:type="locator" />
    <link:labelArc xlink:from="loc_TaxAmendmentLawAmendedTaxRatePreferredEnterprisesYearsFiveAndThereafter.25622.11.6" xlink:to="lab_TaxAmendmentLawAmendedTaxRatePreferredEnterprisesYearsFiveAndThereafter.1907454.190598.256256" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_TaxAmendmentLawAmendedTaxRatePreferredEnterprisesYearsFiveAndThereafter.1907454.190598.256256" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US" id="lab_TaxAmendmentLawAmendedTaxRatePreferredEnterprisesYearsFiveAndThereafter.1907454.190598.256256">Tax Amendment Law Amended Tax Rate Preferred Enterprises Years Five And Thereafter</link:label>
    <link:loc xlink:label="loc_TaxAmendmentLawAmendedTaxRatePreferredEnterprisesYearsFiveAndThereafter.25622.11.12" xlink:href="psti-20140630.xsd#psti_TaxAmendmentLawAmendedTaxRatePreferredEnterprisesYearsFiveAndThereafter" xlink:type="locator" />
    <link:labelArc xlink:from="loc_TaxAmendmentLawAmendedTaxRatePreferredEnterprisesYearsFiveAndThereafter.25622.11.12" xlink:to="lab_TaxAmendmentLawAmendedTaxRatePreferredEnterprisesYearsFiveAndThereafter.1907456.190600.256257" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_TaxAmendmentLawAmendedTaxRatePreferredEnterprisesYearsFiveAndThereafter.1907456.190600.256257" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US" id="lab_TaxAmendmentLawAmendedTaxRatePreferredEnterprisesYearsFiveAndThereafter.1907456.190600.256257">The tax rate applied in the fifth and forth-going years following the enactment of the amended tax law.</link:label>
    <link:loc xlink:label="loc_TaxAmendmentLawAmendedTaxRatePreferredEnterprisesYearsFiveAndThereafter.25622.11.7" xlink:href="psti-20140630.xsd#psti_TaxAmendmentLawAmendedTaxRatePreferredEnterprisesYearsFiveAndThereafter" xlink:type="locator" />
    <link:labelArc xlink:from="loc_TaxAmendmentLawAmendedTaxRatePreferredEnterprisesYearsFiveAndThereafter.25622.11.7" xlink:to="lab_TaxAmendmentLawAmendedTaxRatePreferredEnterprisesYearsFiveAndThereafter.1907457.190599.256258" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_TaxAmendmentLawAmendedTaxRatePreferredEnterprisesYearsFiveAndThereafter.1907457.190599.256258" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US" id="lab_TaxAmendmentLawAmendedTaxRatePreferredEnterprisesYearsFiveAndThereafter.1907457.190599.256258">Encouragement Law Amendment, tax rate in 2015 and thereafter</link:label>
    <link:loc xlink:label="loc_TaxAmendmentLawAmendedTaxRatePreferredEnterprisesYearsOneAndTwo.25618.11.6" xlink:href="psti-20140630.xsd#psti_TaxAmendmentLawAmendedTaxRatePreferredEnterprisesYearsOneAndTwo" xlink:type="locator" />
    <link:labelArc xlink:from="loc_TaxAmendmentLawAmendedTaxRatePreferredEnterprisesYearsOneAndTwo.25618.11.6" xlink:to="lab_TaxAmendmentLawAmendedTaxRatePreferredEnterprisesYearsOneAndTwo.1907436.190601.256244" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_TaxAmendmentLawAmendedTaxRatePreferredEnterprisesYearsOneAndTwo.1907436.190601.256244" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US" id="lab_TaxAmendmentLawAmendedTaxRatePreferredEnterprisesYearsOneAndTwo.1907436.190601.256244">Tax Amendment Law Amended Tax Rate Preferred Enterprises Years One And Two</link:label>
    <link:loc xlink:label="loc_TaxAmendmentLawAmendedTaxRatePreferredEnterprisesYearsOneAndTwo.25618.11.12" xlink:href="psti-20140630.xsd#psti_TaxAmendmentLawAmendedTaxRatePreferredEnterprisesYearsOneAndTwo" xlink:type="locator" />
    <link:labelArc xlink:from="loc_TaxAmendmentLawAmendedTaxRatePreferredEnterprisesYearsOneAndTwo.25618.11.12" xlink:to="lab_TaxAmendmentLawAmendedTaxRatePreferredEnterprisesYearsOneAndTwo.1907440.190603.256245" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_TaxAmendmentLawAmendedTaxRatePreferredEnterprisesYearsOneAndTwo.1907440.190603.256245" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US" id="lab_TaxAmendmentLawAmendedTaxRatePreferredEnterprisesYearsOneAndTwo.1907440.190603.256245">The tax rate applied in the first and second years following the enactment of the amended tax law.</link:label>
    <link:loc xlink:label="loc_TaxAmendmentLawAmendedTaxRatePreferredEnterprisesYearsOneAndTwo.25618.11.7" xlink:href="psti-20140630.xsd#psti_TaxAmendmentLawAmendedTaxRatePreferredEnterprisesYearsOneAndTwo" xlink:type="locator" />
    <link:labelArc xlink:from="loc_TaxAmendmentLawAmendedTaxRatePreferredEnterprisesYearsOneAndTwo.25618.11.7" xlink:to="lab_TaxAmendmentLawAmendedTaxRatePreferredEnterprisesYearsOneAndTwo.1907442.190602.256246" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_TaxAmendmentLawAmendedTaxRatePreferredEnterprisesYearsOneAndTwo.1907442.190602.256246" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US" id="lab_TaxAmendmentLawAmendedTaxRatePreferredEnterprisesYearsOneAndTwo.1907442.190602.256246">Encouragement Law Amendment, tax rate in 2011 and 2012</link:label>
    <link:loc xlink:label="loc_TaxAmendmentLawAmendedTaxRatePreferredEnterprisesYearsThreeAndFour.25619.11.6" xlink:href="psti-20140630.xsd#psti_TaxAmendmentLawAmendedTaxRatePreferredEnterprisesYearsThreeAndFour" xlink:type="locator" />
    <link:labelArc xlink:from="loc_TaxAmendmentLawAmendedTaxRatePreferredEnterprisesYearsThreeAndFour.25619.11.6" xlink:to="lab_TaxAmendmentLawAmendedTaxRatePreferredEnterprisesYearsThreeAndFour.1907444.190604.256247" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_TaxAmendmentLawAmendedTaxRatePreferredEnterprisesYearsThreeAndFour.1907444.190604.256247" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US" id="lab_TaxAmendmentLawAmendedTaxRatePreferredEnterprisesYearsThreeAndFour.1907444.190604.256247">Tax Amendment Law Amended Tax Rate Preferred Enterprises Years Three And Four</link:label>
    <link:loc xlink:label="loc_TaxAmendmentLawAmendedTaxRatePreferredEnterprisesYearsThreeAndFour.25619.11.12" xlink:href="psti-20140630.xsd#psti_TaxAmendmentLawAmendedTaxRatePreferredEnterprisesYearsThreeAndFour" xlink:type="locator" />
    <link:labelArc xlink:from="loc_TaxAmendmentLawAmendedTaxRatePreferredEnterprisesYearsThreeAndFour.25619.11.12" xlink:to="lab_TaxAmendmentLawAmendedTaxRatePreferredEnterprisesYearsThreeAndFour.1907445.190606.256248" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_TaxAmendmentLawAmendedTaxRatePreferredEnterprisesYearsThreeAndFour.1907445.190606.256248" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US" id="lab_TaxAmendmentLawAmendedTaxRatePreferredEnterprisesYearsThreeAndFour.1907445.190606.256248">The tax rate applied in the third and fourth years following the enactment of the amended tax law.</link:label>
    <link:loc xlink:label="loc_TaxAmendmentLawAmendedTaxRatePreferredEnterprisesYearsThreeAndFour.25619.11.7" xlink:href="psti-20140630.xsd#psti_TaxAmendmentLawAmendedTaxRatePreferredEnterprisesYearsThreeAndFour" xlink:type="locator" />
    <link:labelArc xlink:from="loc_TaxAmendmentLawAmendedTaxRatePreferredEnterprisesYearsThreeAndFour.25619.11.7" xlink:to="lab_TaxAmendmentLawAmendedTaxRatePreferredEnterprisesYearsThreeAndFour.1907446.190605.256249" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_TaxAmendmentLawAmendedTaxRatePreferredEnterprisesYearsThreeAndFour.1907446.190605.256249" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US" id="lab_TaxAmendmentLawAmendedTaxRatePreferredEnterprisesYearsThreeAndFour.1907446.190605.256249">Encouragement Law Amendment, tax rate in 2013 and 2014</link:label>
    <link:loc xlink:label="loc_TaxAmendmentLawMinimumQualifyingInvestmentAmount.25624.11.6" xlink:href="psti-20140630.xsd#psti_TaxAmendmentLawMinimumQualifyingInvestmentAmount" xlink:type="locator" />
    <link:labelArc xlink:from="loc_TaxAmendmentLawMinimumQualifyingInvestmentAmount.25624.11.6" xlink:to="lab_TaxAmendmentLawMinimumQualifyingInvestmentAmount.1907481.190607.256262" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_TaxAmendmentLawMinimumQualifyingInvestmentAmount.1907481.190607.256262" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US" id="lab_TaxAmendmentLawMinimumQualifyingInvestmentAmount.1907481.190607.256262">Tax Amendment Law Minimum Qualifying Investment Amount</link:label>
    <link:loc xlink:label="loc_TaxAmendmentLawMinimumQualifyingInvestmentAmount.25624.11.12" xlink:href="psti-20140630.xsd#psti_TaxAmendmentLawMinimumQualifyingInvestmentAmount" xlink:type="locator" />
    <link:labelArc xlink:from="loc_TaxAmendmentLawMinimumQualifyingInvestmentAmount.25624.11.12" xlink:to="lab_TaxAmendmentLawMinimumQualifyingInvestmentAmount.1907510.190609.256263" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_TaxAmendmentLawMinimumQualifyingInvestmentAmount.1907510.190609.256263" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US" id="lab_TaxAmendmentLawMinimumQualifyingInvestmentAmount.1907510.190609.256263">The minimum amount that can be invested in the acquisition of productive assets per the Tax Amendment.</link:label>
    <link:loc xlink:label="loc_TaxAmendmentLawMinimumQualifyingInvestmentAmount.25624.11.7" xlink:href="psti-20140630.xsd#psti_TaxAmendmentLawMinimumQualifyingInvestmentAmount" xlink:type="locator" />
    <link:labelArc xlink:from="loc_TaxAmendmentLawMinimumQualifyingInvestmentAmount.25624.11.7" xlink:to="lab_TaxAmendmentLawMinimumQualifyingInvestmentAmount.1907511.190608.256264" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_TaxAmendmentLawMinimumQualifyingInvestmentAmount.1907511.190608.256264" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US" id="lab_TaxAmendmentLawMinimumQualifyingInvestmentAmount.1907511.190608.256264">Minimum qualifying investment amount</link:label>
    <link:loc xlink:label="loc_TaxBenefitAcceleratedDepreciationRate.25617.11.6" xlink:href="psti-20140630.xsd#psti_TaxBenefitAcceleratedDepreciationRate" xlink:type="locator" />
    <link:labelArc xlink:from="loc_TaxBenefitAcceleratedDepreciationRate.25617.11.6" xlink:to="lab_TaxBenefitAcceleratedDepreciationRate.1907417.190610.256241" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_TaxBenefitAcceleratedDepreciationRate.1907417.190610.256241" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US" id="lab_TaxBenefitAcceleratedDepreciationRate.1907417.190610.256241">Tax Benefit Accelerated Depreciation Rate</link:label>
    <link:loc xlink:label="loc_TaxBenefitAcceleratedDepreciationRate.25617.11.12" xlink:href="psti-20140630.xsd#psti_TaxBenefitAcceleratedDepreciationRate" xlink:type="locator" />
    <link:labelArc xlink:from="loc_TaxBenefitAcceleratedDepreciationRate.25617.11.12" xlink:to="lab_TaxBenefitAcceleratedDepreciationRate.1907418.190612.256242" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_TaxBenefitAcceleratedDepreciationRate.1907418.190612.256242" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US" id="lab_TaxBenefitAcceleratedDepreciationRate.1907418.190612.256242">The rate at which can be used to depreciate the fixed asset for tax benefit purposes.</link:label>
    <link:loc xlink:label="loc_TaxBenefitAcceleratedDepreciationRate.25617.11.7" xlink:href="psti-20140630.xsd#psti_TaxBenefitAcceleratedDepreciationRate" xlink:type="locator" />
    <link:labelArc xlink:from="loc_TaxBenefitAcceleratedDepreciationRate.25617.11.7" xlink:to="lab_TaxBenefitAcceleratedDepreciationRate.1907419.190611.256243" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_TaxBenefitAcceleratedDepreciationRate.1907419.190611.256243" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US" id="lab_TaxBenefitAcceleratedDepreciationRate.1907419.190611.256243">Accelerated depreciation rate</link:label>
    <link:loc xlink:label="loc_TaxPeriodAxis.5240.11.6" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_TaxPeriodAxis" xlink:type="locator" />
    <link:labelArc xlink:from="loc_TaxPeriodAxis.5240.11.6" xlink:to="lab_TaxPeriodAxis.18754" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_TaxPeriodAxis.18754" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US" id="lab_TaxPeriodAxis.18754">Tax Period [Axis]</link:label>
    <link:loc xlink:label="loc_TaxPeriodDomain.5241.11.6" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_TaxPeriodDomain" xlink:type="locator" />
    <link:labelArc xlink:from="loc_TaxPeriodDomain.5241.11.6" xlink:to="lab_TaxPeriodDomain.18755" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_TaxPeriodDomain.18755" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US" id="lab_TaxPeriodDomain.18755">Tax Period [Domain]</link:label>
    <link:loc xlink:label="loc_TaxRateBenefitsToCompanyAbstract.25607.11.6" xlink:href="psti-20140630.xsd#psti_TaxRateBenefitsToCompanyAbstract" xlink:type="locator" />
    <link:labelArc xlink:from="loc_TaxRateBenefitsToCompanyAbstract.25607.11.6" xlink:to="lab_TaxRateBenefitsToCompanyAbstract.1872002.190613.256200" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_TaxRateBenefitsToCompanyAbstract.1872002.190613.256200" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US" id="lab_TaxRateBenefitsToCompanyAbstract.1872002.190613.256200">Tax Rate Benefits To Company [Abstract]</link:label>
    <link:loc xlink:label="loc_TaxRateBenefitsToCompanyAbstract.25607.11.7" xlink:href="psti-20140630.xsd#psti_TaxRateBenefitsToCompanyAbstract" xlink:type="locator" />
    <link:labelArc xlink:from="loc_TaxRateBenefitsToCompanyAbstract.25607.11.7" xlink:to="lab_TaxRateBenefitsToCompanyAbstract.1872003.190614.256201" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_TaxRateBenefitsToCompanyAbstract.1872003.190614.256201" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US" id="lab_TaxRateBenefitsToCompanyAbstract.1872003.190614.256201">Tax Benefits:</link:label>
    <link:loc xlink:label="loc_TaxRatesApplicableToCompanyAbstract.25606.11.6" xlink:href="psti-20140630.xsd#psti_TaxRatesApplicableToCompanyAbstract" xlink:type="locator" />
    <link:labelArc xlink:from="loc_TaxRatesApplicableToCompanyAbstract.25606.11.6" xlink:to="lab_TaxRatesApplicableToCompanyAbstract.1871999.190615.256197" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_TaxRatesApplicableToCompanyAbstract.1871999.190615.256197" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US" id="lab_TaxRatesApplicableToCompanyAbstract.1871999.190615.256197">Tax Rates Applicable To Company [Abstract]</link:label>
    <link:loc xlink:label="loc_TaxRatesApplicableToCompanyAbstract.25606.11.12" xlink:href="psti-20140630.xsd#psti_TaxRatesApplicableToCompanyAbstract" xlink:type="locator" />
    <link:labelArc xlink:from="loc_TaxRatesApplicableToCompanyAbstract.25606.11.12" xlink:to="lab_TaxRatesApplicableToCompanyAbstract.1872000.190616.256198" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_TaxRatesApplicableToCompanyAbstract.1872000.190616.256198" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US" id="lab_TaxRatesApplicableToCompanyAbstract.1872000.190616.256198">Tax Rates Applicable To The Company [Abstract].</link:label>
    <link:loc xlink:label="loc_TaxRatesApplicableToCompanyAbstract.25606.11.7" xlink:href="psti-20140630.xsd#psti_TaxRatesApplicableToCompanyAbstract" xlink:type="locator" />
    <link:labelArc xlink:from="loc_TaxRatesApplicableToCompanyAbstract.25606.11.7" xlink:to="lab_TaxRatesApplicableToCompanyAbstract.1872001.190617.256199" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_TaxRatesApplicableToCompanyAbstract.1872001.190617.256199" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US" id="lab_TaxRatesApplicableToCompanyAbstract.1872001.190617.256199">Applicable Tax Rates:</link:label>
    <link:loc xlink:label="loc_TwoThousandSevenProgramMember.25602.11.6" xlink:href="psti-20140630.xsd#psti_TwoThousandSevenProgramMember" xlink:type="locator" />
    <link:labelArc xlink:from="loc_TwoThousandSevenProgramMember.25602.11.6" xlink:to="lab_TwoThousandSevenProgramMember.227534.256187" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_TwoThousandSevenProgramMember.227534.256187" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US" id="lab_TwoThousandSevenProgramMember.227534.256187">Two Thousand Seven Program [Member]</link:label>
    <link:loc xlink:label="loc_TwoThousandTwelveProgramMember.25603.11.6" xlink:href="psti-20140630.xsd#psti_TwoThousandTwelveProgramMember" xlink:type="locator" />
    <link:labelArc xlink:from="loc_TwoThousandTwelveProgramMember.25603.11.6" xlink:to="lab_TwoThousandTwelveProgramMember.227535.256190" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_TwoThousandTwelveProgramMember.227535.256190" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US" id="lab_TwoThousandTwelveProgramMember.227535.256190">Two Thousand Twelve Program [Member]</link:label>
    <link:loc xlink:label="loc_WithholdingTaxRateOnDividendsFromRetainedTaxExemptProfits.25612.11.6" xlink:href="psti-20140630.xsd#psti_WithholdingTaxRateOnDividendsFromRetainedTaxExemptProfits" xlink:type="locator" />
    <link:labelArc xlink:from="loc_WithholdingTaxRateOnDividendsFromRetainedTaxExemptProfits.25612.11.6" xlink:to="lab_WithholdingTaxRateOnDividendsFromRetainedTaxExemptProfits.1871991.190618.256226" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_WithholdingTaxRateOnDividendsFromRetainedTaxExemptProfits.1871991.190618.256226" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US" id="lab_WithholdingTaxRateOnDividendsFromRetainedTaxExemptProfits.1871991.190618.256226">Withholding Tax Rate On Dividends From Retained Tax Exempt Profits</link:label>
    <link:loc xlink:label="loc_WithholdingTaxRateOnDividendsFromRetainedTaxExemptProfits.25612.11.12" xlink:href="psti-20140630.xsd#psti_WithholdingTaxRateOnDividendsFromRetainedTaxExemptProfits" xlink:type="locator" />
    <link:labelArc xlink:from="loc_WithholdingTaxRateOnDividendsFromRetainedTaxExemptProfits.25612.11.12" xlink:to="lab_WithholdingTaxRateOnDividendsFromRetainedTaxExemptProfits.1871992.190619.256227" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_WithholdingTaxRateOnDividendsFromRetainedTaxExemptProfits.1871992.190619.256227" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US" id="lab_WithholdingTaxRateOnDividendsFromRetainedTaxExemptProfits.1871992.190619.256227">Withholding Tax Rate On Dividends From Retained Tax Exempt Profits</link:label>
    <link:loc xlink:label="loc_SubsidiariesMember.5165.11.7" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_SubsidiariesMember" xlink:type="locator" />
    <link:labelArc xlink:from="loc_SubsidiariesMember.5165.11.7" xlink:to="SubsidiariesMember.1871894.190176.256143" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="SubsidiariesMember.1871894.190176.256143" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US" id="SubsidiariesMember.1871894.190176.256143">Pluristem Ltd. [Member]</link:label>
    <link:loc xlink:label="loc_TaxRateBenefitsToCompanyAbstract.25607.11.12" xlink:href="psti-20140630.xsd#psti_TaxRateBenefitsToCompanyAbstract" xlink:type="locator" />
    <link:labelArc xlink:from="loc_TaxRateBenefitsToCompanyAbstract.25607.11.12" xlink:to="TaxRateBenefitsToCompanyAbstract.1907790.190621.256202" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="TaxRateBenefitsToCompanyAbstract.1907790.190621.256202" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US" id="TaxRateBenefitsToCompanyAbstract.1907790.190621.256202">Tax Rate Benefits To Company [Abstract]</link:label>
    <link:loc xlink:label="loc_WithholdingTaxRateOnDividendsFromRetainedTaxExemptProfits.25612.11.7" xlink:href="psti-20140630.xsd#psti_WithholdingTaxRateOnDividendsFromRetainedTaxExemptProfits" xlink:type="locator" />
    <link:labelArc xlink:from="loc_WithholdingTaxRateOnDividendsFromRetainedTaxExemptProfits.25612.11.7" xlink:to="Thecorporatetaxrateappliedtodividendsdistributedfromretainedtax-exemptprofits..1871998.190622.256228" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="Thecorporatetaxrateappliedtodividendsdistributedfromretainedtax-exemptprofits..1871998.190622.256228" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US" id="Thecorporatetaxrateappliedtodividendsdistributedfromretainedtax-exemptprofits..1871998.190622.256228">Withholding tax rate on divdidends from retained tax-exempt profits</link:label>
    <link:loc xlink:label="loc_TwoThousandSevenProgramMember.25602.11.12" xlink:href="psti-20140630.xsd#psti_TwoThousandSevenProgramMember" xlink:type="locator" />
    <link:labelArc xlink:from="loc_TwoThousandSevenProgramMember.25602.11.12" xlink:to="TwoThousandSevenProgramMember.227536.256189" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="TwoThousandSevenProgramMember.227536.256189" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US" id="TwoThousandSevenProgramMember.227536.256189">The Subsidiary's expansion program of its plant was granted the status of a "Beneficiary Enterprise" under the "Alternative Track" (the "2007 Program").</link:label>
    <link:loc xlink:label="loc_TwoThousandSevenProgramMember.25602.11.7" xlink:href="psti-20140630.xsd#psti_TwoThousandSevenProgramMember" xlink:type="locator" />
    <link:labelArc xlink:from="loc_TwoThousandSevenProgramMember.25602.11.7" xlink:to="TwoThousandSevenProgramMember.227537.256188" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="TwoThousandSevenProgramMember.227537.256188" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US" id="TwoThousandSevenProgramMember.227537.256188">2007 Program [Member}</link:label>
    <link:loc xlink:label="loc_TwoThousandTwelveProgramMember.25603.11.12" xlink:href="psti-20140630.xsd#psti_TwoThousandTwelveProgramMember" xlink:type="locator" />
    <link:labelArc xlink:from="loc_TwoThousandTwelveProgramMember.25603.11.12" xlink:to="TwoThousandTwelveProgramMember.227538.256191" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="TwoThousandTwelveProgramMember.227538.256191" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US" id="TwoThousandTwelveProgramMember.227538.256191">The Subsidiary has informed the Israeli Tax Authority that it has chosen the year 2012 as an election year to the expansion of its Beneficiary Enterprise program (the "2012 Program").</link:label>
    <link:loc xlink:label="loc_ProductiveAssetsPercentageTierAxis.25626.11.6" xlink:href="psti-20140630.xsd#psti_ProductiveAssetsPercentageTierAxis" xlink:type="locator" />
    <link:labelArc xlink:from="loc_ProductiveAssetsPercentageTierAxis.25626.11.6" xlink:to="lab_ProductiveAssetsPercentageTierAxis.1907588.191362.256281" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_ProductiveAssetsPercentageTierAxis.1907588.191362.256281" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US" id="lab_ProductiveAssetsPercentageTierAxis.1907588.191362.256281">Productive Assets Percentage Tier [Axis]</link:label>
    <link:loc xlink:label="loc_ProductiveAssetsPercentageTierAxis.25626.11.12" xlink:href="psti-20140630.xsd#psti_ProductiveAssetsPercentageTierAxis" xlink:type="locator" />
    <link:labelArc xlink:from="loc_ProductiveAssetsPercentageTierAxis.25626.11.12" xlink:to="lab_ProductiveAssetsPercentageTierAxis.1907590.191363.256282" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_ProductiveAssetsPercentageTierAxis.1907590.191363.256282" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US" id="lab_ProductiveAssetsPercentageTierAxis.1907590.191363.256282">Productive Assets Percentage Tier [Axis]</link:label>
    <link:loc xlink:label="loc_ProductiveAssetsPercentageTierDomain.25629.11.6" xlink:href="psti-20140630.xsd#psti_ProductiveAssetsPercentageTierDomain" xlink:type="locator" />
    <link:labelArc xlink:from="loc_ProductiveAssetsPercentageTierDomain.25629.11.6" xlink:to="lab_ProductiveAssetsPercentageTierDomain.1907591.191364.256291" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_ProductiveAssetsPercentageTierDomain.1907591.191364.256291" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US" id="lab_ProductiveAssetsPercentageTierDomain.1907591.191364.256291">Productive Assets Percentage Tier [Domain]</link:label>
    <link:loc xlink:label="loc_ProductiveAssetsPercentageTierDomain.25629.11.12" xlink:href="psti-20140630.xsd#psti_ProductiveAssetsPercentageTierDomain" xlink:type="locator" />
    <link:labelArc xlink:from="loc_ProductiveAssetsPercentageTierDomain.25629.11.12" xlink:to="lab_ProductiveAssetsPercentageTierDomain.1907601.191365.256292" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_ProductiveAssetsPercentageTierDomain.1907601.191365.256292" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US" id="lab_ProductiveAssetsPercentageTierDomain.1907601.191365.256292">Productive Assets Percentage Tier [Domain]</link:label>
    <link:loc xlink:label="loc_ProportionThatRequiredInvestmentBearsToValueOfProductiveAsset.25628.11.6" xlink:href="psti-20140630.xsd#psti_ProportionThatRequiredInvestmentBearsToValueOfProductiveAsset" xlink:type="locator" />
    <link:labelArc xlink:from="loc_ProportionThatRequiredInvestmentBearsToValueOfProductiveAsset.25628.11.6" xlink:to="lab_ProportionThatRequiredInvestmentBearsToValueOfProductiveAsset.1907565.191366.256286" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_ProportionThatRequiredInvestmentBearsToValueOfProductiveAsset.1907565.191366.256286" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US" id="lab_ProportionThatRequiredInvestmentBearsToValueOfProductiveAsset.1907565.191366.256286">Proportion That Required Investment Bears To Value Of Productive Asset</link:label>
    <link:loc xlink:label="loc_ProportionThatRequiredInvestmentBearsToValueOfProductiveAsset.25628.11.12" xlink:href="psti-20140630.xsd#psti_ProportionThatRequiredInvestmentBearsToValueOfProductiveAsset" xlink:type="locator" />
    <link:labelArc xlink:from="loc_ProportionThatRequiredInvestmentBearsToValueOfProductiveAsset.25628.11.12" xlink:to="lab_ProportionThatRequiredInvestmentBearsToValueOfProductiveAsset.1907568.191368.256287" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_ProportionThatRequiredInvestmentBearsToValueOfProductiveAsset.1907568.191368.256287" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US" id="lab_ProportionThatRequiredInvestmentBearsToValueOfProductiveAsset.1907568.191368.256287">The qualifying percentage of the value of the asset that can be used in lieu of the qualifying investment amount for tax beneficiary status.</link:label>
    <link:loc xlink:label="loc_ProportionThatRequiredInvestmentBearsToValueOfProductiveAsset.25628.11.7" xlink:href="psti-20140630.xsd#psti_ProportionThatRequiredInvestmentBearsToValueOfProductiveAsset" xlink:type="locator" />
    <link:labelArc xlink:from="loc_ProportionThatRequiredInvestmentBearsToValueOfProductiveAsset.25628.11.7" xlink:to="lab_ProportionThatRequiredInvestmentBearsToValueOfProductiveAsset.1907569.191367.256288" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_ProportionThatRequiredInvestmentBearsToValueOfProductiveAsset.1907569.191367.256288" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US" id="lab_ProportionThatRequiredInvestmentBearsToValueOfProductiveAsset.1907569.191367.256288">The new proportion that the required investment bears to the value of productive assets</link:label>
    <link:loc xlink:label="loc_TierOneMember.25630.11.6" xlink:href="psti-20140630.xsd#psti_TierOneMember" xlink:type="locator" />
    <link:labelArc xlink:from="loc_TierOneMember.25630.11.6" xlink:to="lab_TierOneMember.1907602.191369.256295" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_TierOneMember.1907602.191369.256295" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US" id="lab_TierOneMember.1907602.191369.256295">Tier One [Member]</link:label>
    <link:loc xlink:label="loc_TierOneMember.25630.11.12" xlink:href="psti-20140630.xsd#psti_TierOneMember" xlink:type="locator" />
    <link:labelArc xlink:from="loc_TierOneMember.25630.11.12" xlink:to="lab_TierOneMember.1907605.191370.256296" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_TierOneMember.1907605.191370.256296" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US" id="lab_TierOneMember.1907605.191370.256296">Tier One [Member]</link:label>
    <link:loc xlink:label="loc_TierThreeMember.25632.11.6" xlink:href="psti-20140630.xsd#psti_TierThreeMember" xlink:type="locator" />
    <link:labelArc xlink:from="loc_TierThreeMember.25632.11.6" xlink:to="lab_TierThreeMember.1907610.191371.256299" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_TierThreeMember.1907610.191371.256299" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US" id="lab_TierThreeMember.1907610.191371.256299">Tier Three [Member]</link:label>
    <link:loc xlink:label="loc_TierThreeMember.25632.11.12" xlink:href="psti-20140630.xsd#psti_TierThreeMember" xlink:type="locator" />
    <link:labelArc xlink:from="loc_TierThreeMember.25632.11.12" xlink:to="lab_TierThreeMember.1907612.191372.256300" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_TierThreeMember.1907612.191372.256300" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US" id="lab_TierThreeMember.1907612.191372.256300">Tier Three [Member]</link:label>
    <link:loc xlink:label="loc_TierTwoMember.25631.11.6" xlink:href="psti-20140630.xsd#psti_TierTwoMember" xlink:type="locator" />
    <link:labelArc xlink:from="loc_TierTwoMember.25631.11.6" xlink:to="lab_TierTwoMember.1907607.191373.256297" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_TierTwoMember.1907607.191373.256297" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US" id="lab_TierTwoMember.1907607.191373.256297">Tier Two [Member]</link:label>
    <link:loc xlink:label="loc_TierTwoMember.25631.11.12" xlink:href="psti-20140630.xsd#psti_TierTwoMember" xlink:type="locator" />
    <link:labelArc xlink:from="loc_TierTwoMember.25631.11.12" xlink:to="lab_TierTwoMember.1907609.191374.256298" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_TierTwoMember.1907609.191374.256298" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US" id="lab_TierTwoMember.1907609.191374.256298">Tier Two [Member]</link:label>
    <link:loc xlink:label="loc_ValueOfProductiveAssetsBeforeExpansion.25627.11.6" xlink:href="psti-20140630.xsd#psti_ValueOfProductiveAssetsBeforeExpansion" xlink:type="locator" />
    <link:labelArc xlink:from="loc_ValueOfProductiveAssetsBeforeExpansion.25627.11.6" xlink:to="lab_ValueOfProductiveAssetsBeforeExpansion.1907557.191375.256283" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_ValueOfProductiveAssetsBeforeExpansion.1907557.191375.256283" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US" id="lab_ValueOfProductiveAssetsBeforeExpansion.1907557.191375.256283">Value Of Productive Assets Before Expansion</link:label>
    <link:loc xlink:label="loc_ValueOfProductiveAssetsBeforeExpansion.25627.11.12" xlink:href="psti-20140630.xsd#psti_ValueOfProductiveAssetsBeforeExpansion" xlink:type="locator" />
    <link:labelArc xlink:from="loc_ValueOfProductiveAssetsBeforeExpansion.25627.11.12" xlink:to="lab_ValueOfProductiveAssetsBeforeExpansion.1907563.191377.256284" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_ValueOfProductiveAssetsBeforeExpansion.1907563.191377.256284" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US" id="lab_ValueOfProductiveAssetsBeforeExpansion.1907563.191377.256284">The value of the productive assets before expansion.</link:label>
    <link:loc xlink:label="loc_ValueOfProductiveAssetsBeforeExpansion.25627.11.7" xlink:href="psti-20140630.xsd#psti_ValueOfProductiveAssetsBeforeExpansion" xlink:type="locator" />
    <link:labelArc xlink:from="loc_ValueOfProductiveAssetsBeforeExpansion.25627.11.7" xlink:to="lab_ValueOfProductiveAssetsBeforeExpansion.1907564.191376.256285" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_ValueOfProductiveAssetsBeforeExpansion.1907564.191376.256285" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US" id="lab_ValueOfProductiveAssetsBeforeExpansion.1907564.191376.256285">Value of productive assets before expansion</link:label>
    <link:loc xlink:label="loc_DeferredTaxAssetsGross.7847.11.6" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_DeferredTaxAssetsGross" xlink:type="locator" />
    <link:labelArc xlink:from="loc_DeferredTaxAssetsGross.7847.11.6" xlink:to="lab_DeferredTaxAssetsGross.4127" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_DeferredTaxAssetsGross.4127" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US" id="lab_DeferredTaxAssetsGross.4127">Deferred Tax Assets, Gross</link:label>
    <link:loc xlink:label="loc_DeferredTaxAssetsGross.7847.11.9" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_DeferredTaxAssetsGross" xlink:type="locator" />
    <link:labelArc xlink:from="loc_DeferredTaxAssetsGross.7847.11.9" xlink:to="lab_DeferredTaxAssetsGross.1872039.190527.256304" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_DeferredTaxAssetsGross.1872039.190527.256304" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US" id="lab_DeferredTaxAssetsGross.1872039.190527.256304">Total deferred tax assets before valuation allowance</link:label>
    <link:loc xlink:label="loc_DeferredTaxAssetsNet.7866.11.6" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_DeferredTaxAssetsNet" xlink:type="locator" />
    <link:labelArc xlink:from="loc_DeferredTaxAssetsNet.7866.11.6" xlink:to="lab_DeferredTaxAssetsNet.4155" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_DeferredTaxAssetsNet.4155" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US" id="lab_DeferredTaxAssetsNet.4155">Deferred Tax Assets, Net of Valuation Allowance</link:label>
    <link:loc xlink:label="loc_DeferredTaxAssetsNet.7866.11.9" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_DeferredTaxAssetsNet" xlink:type="locator" />
    <link:labelArc xlink:from="loc_DeferredTaxAssetsNet.7866.11.9" xlink:to="lab_DeferredTaxAssetsNet.1872044.190529.256306" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_DeferredTaxAssetsNet.1872044.190529.256306" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US" id="lab_DeferredTaxAssetsNet.1872044.190529.256306">Net deferred tax asset</link:label>
    <link:loc xlink:label="loc_DeferredTaxAssetsOperatingLossCarryforwardsDomestic.7855.11.6" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsDomestic" xlink:type="locator" />
    <link:labelArc xlink:from="loc_DeferredTaxAssetsOperatingLossCarryforwardsDomestic.7855.11.6" xlink:to="lab_DeferredTaxAssetsOperatingLossCarryforwardsDomestic.4139" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_DeferredTaxAssetsOperatingLossCarryforwardsDomestic.4139" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US" id="lab_DeferredTaxAssetsOperatingLossCarryforwardsDomestic.4139">Deferred Tax Assets, Operating Loss Carryforwards, Domestic</link:label>
    <link:loc xlink:label="loc_DeferredTaxAssetsOperatingLossCarryforwardsDomestic.7855.11.7" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsDomestic" xlink:type="locator" />
    <link:labelArc xlink:from="loc_DeferredTaxAssetsOperatingLossCarryforwardsDomestic.7855.11.7" xlink:to="lab_DeferredTaxAssetsOperatingLossCarryforwardsDomestic.1872035.190531.256301" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_DeferredTaxAssetsOperatingLossCarryforwardsDomestic.1872035.190531.256301" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US" id="lab_DeferredTaxAssetsOperatingLossCarryforwardsDomestic.1872035.190531.256301">U.S. net operating loss carryforward</link:label>
    <link:loc xlink:label="loc_DeferredTaxAssetsOperatingLossCarryforwardsForeign.7872.11.6" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsForeign" xlink:type="locator" />
    <link:labelArc xlink:from="loc_DeferredTaxAssetsOperatingLossCarryforwardsForeign.7872.11.6" xlink:to="lab_DeferredTaxAssetsOperatingLossCarryforwardsForeign.4166" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_DeferredTaxAssetsOperatingLossCarryforwardsForeign.4166" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US" id="lab_DeferredTaxAssetsOperatingLossCarryforwardsForeign.4166">Deferred Tax Assets, Operating Loss Carryforwards, Foreign</link:label>
    <link:loc xlink:label="loc_DeferredTaxAssetsOperatingLossCarryforwardsForeign.7872.11.7" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsForeign" xlink:type="locator" />
    <link:labelArc xlink:from="loc_DeferredTaxAssetsOperatingLossCarryforwardsForeign.7872.11.7" xlink:to="lab_DeferredTaxAssetsOperatingLossCarryforwardsForeign.1872036.190533.256302" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_DeferredTaxAssetsOperatingLossCarryforwardsForeign.1872036.190533.256302" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US" id="lab_DeferredTaxAssetsOperatingLossCarryforwardsForeign.1872036.190533.256302">Israeli net operating loss carryforward</link:label>
    <link:loc xlink:label="loc_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals.7863.11.6" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals" xlink:type="locator" />
    <link:labelArc xlink:from="loc_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals.7863.11.6" xlink:to="lab_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals.4148" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals.4148" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US" id="lab_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals.4148">Deferred Tax Assets, Tax Deferred Expense, Reserves and Accruals</link:label>
    <link:loc xlink:label="loc_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals.7863.11.7" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals" xlink:type="locator" />
    <link:labelArc xlink:from="loc_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals.7863.11.7" xlink:to="lab_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals.1872038.190535.256303" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals.1872038.190535.256303" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US" id="lab_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals.1872038.190535.256303">Allowances and reserves</link:label>
    <link:loc xlink:label="loc_DeferredTaxAssetsValuationAllowance.7902.11.6" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_DeferredTaxAssetsValuationAllowance" xlink:type="locator" />
    <link:labelArc xlink:from="loc_DeferredTaxAssetsValuationAllowance.7902.11.6" xlink:to="lab_DeferredTaxAssetsValuationAllowance.4204" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_DeferredTaxAssetsValuationAllowance.4204" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US" id="lab_DeferredTaxAssetsValuationAllowance.4204">Deferred Tax Assets, Valuation Allowance</link:label>
    <link:loc xlink:label="loc_DeferredTaxAssetsValuationAllowance.7902.11.53" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_DeferredTaxAssetsValuationAllowance" xlink:type="locator" />
    <link:labelArc xlink:from="loc_DeferredTaxAssetsValuationAllowance.7902.11.53" xlink:to="lab_DeferredTaxAssetsValuationAllowance46.1872045.190537.256305" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_DeferredTaxAssetsValuationAllowance46.1872045.190537.256305" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xml:lang="en-US" id="lab_DeferredTaxAssetsValuationAllowance46.1872045.190537.256305">Valuation allowance</link:label>
    <link:loc xlink:label="loc_CashAndCashEquivalentsPolicyTextBlock.6740.11.6" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_CashAndCashEquivalentsPolicyTextBlock" xlink:type="locator" />
    <link:labelArc xlink:from="loc_CashAndCashEquivalentsPolicyTextBlock.6740.11.6" xlink:to="lab_CashAndCashEquivalentsPolicyTextBlock.2310" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_CashAndCashEquivalentsPolicyTextBlock.2310" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US" id="lab_CashAndCashEquivalentsPolicyTextBlock.2310">Cash and Cash Equivalents, Policy [Policy Text Block]</link:label>
    <link:loc xlink:label="loc_CashAndCashEquivalentsPolicyTextBlock.6740.11.7" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_CashAndCashEquivalentsPolicyTextBlock" xlink:type="locator" />
    <link:labelArc xlink:from="loc_CashAndCashEquivalentsPolicyTextBlock.6740.11.7" xlink:to="lab_CashAndCashEquivalentsPolicyTextBlock.1872399.189959.256333" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_CashAndCashEquivalentsPolicyTextBlock.1872399.189959.256333" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US" id="lab_CashAndCashEquivalentsPolicyTextBlock.1872399.189959.256333">Cash and cash equivalents</link:label>
    <link:loc xlink:label="loc_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy.6775.11.6" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy" xlink:type="locator" />
    <link:labelArc xlink:from="loc_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy.6775.11.6" xlink:to="lab_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy.2381" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy.2381" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US" id="lab_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy.2381">Cash and Cash Equivalents, Restricted Cash and Cash Equivalents, Policy [Policy Text Block]</link:label>
    <link:loc xlink:label="loc_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy.6775.11.7" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy" xlink:type="locator" />
    <link:labelArc xlink:from="loc_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy.6775.11.7" xlink:to="lab_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy.1905554.413150.227540.256341" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy.1905554.413150.227540.256341" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US" id="lab_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy.1905554.413150.227540.256341">Restricted cash and short-term deposits</link:label>
    <link:loc xlink:label="loc_ComprehensiveIncomePolicyPolicyTextBlock.7103.11.6" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ComprehensiveIncomePolicyPolicyTextBlock" xlink:type="locator" />
    <link:labelArc xlink:from="loc_ComprehensiveIncomePolicyPolicyTextBlock.7103.11.6" xlink:to="lab_ComprehensiveIncomePolicyPolicyTextBlock.2961" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_ComprehensiveIncomePolicyPolicyTextBlock.2961" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US" id="lab_ComprehensiveIncomePolicyPolicyTextBlock.2961">Comprehensive Income, Policy [Policy Text Block]</link:label>
    <link:loc xlink:label="loc_ComprehensiveIncomePolicyPolicyTextBlock.7103.11.7" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ComprehensiveIncomePolicyPolicyTextBlock" xlink:type="locator" />
    <link:labelArc xlink:from="loc_ComprehensiveIncomePolicyPolicyTextBlock.7103.11.7" xlink:to="lab_ComprehensiveIncomePolicyPolicyTextBlock.413794.192765.259756" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_ComprehensiveIncomePolicyPolicyTextBlock.413794.192765.259756" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US" id="lab_ComprehensiveIncomePolicyPolicyTextBlock.413794.192765.259756">Comprehensive income</link:label>
    <link:loc xlink:label="loc_ConcentrationRiskCreditRisk.7122.11.6" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ConcentrationRiskCreditRisk" xlink:type="locator" />
    <link:labelArc xlink:from="loc_ConcentrationRiskCreditRisk.7122.11.6" xlink:to="lab_ConcentrationRiskCreditRisk.2991" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_ConcentrationRiskCreditRisk.2991" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US" id="lab_ConcentrationRiskCreditRisk.2991">Concentration Risk, Credit Risk, Policy [Policy Text Block]</link:label>
    <link:loc xlink:label="loc_ConcentrationRiskCreditRisk.7122.11.7" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ConcentrationRiskCreditRisk" xlink:type="locator" />
    <link:labelArc xlink:from="loc_ConcentrationRiskCreditRisk.7122.11.7" xlink:to="lab_ConcentrationRiskCreditRisk.158451.463858.318518.361627.256345" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_ConcentrationRiskCreditRisk.158451.463858.318518.361627.256345" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US" id="lab_ConcentrationRiskCreditRisk.158451.463858.318518.361627.256345">Concentration of credit risk</link:label>
    <link:loc xlink:label="loc_ConsolidationPolicyTextBlock.7154.11.6" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ConsolidationPolicyTextBlock" xlink:type="locator" />
    <link:labelArc xlink:from="loc_ConsolidationPolicyTextBlock.7154.11.6" xlink:to="lab_ConsolidationPolicyTextBlock.3017.255830" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_ConsolidationPolicyTextBlock.3017.255830" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US" id="lab_ConsolidationPolicyTextBlock.3017.255830">Consolidation, Policy [Policy Text Block]</link:label>
    <link:loc xlink:label="loc_ConsolidationPolicyTextBlock.7154.11.7" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ConsolidationPolicyTextBlock" xlink:type="locator" />
    <link:labelArc xlink:from="loc_ConsolidationPolicyTextBlock.7154.11.7" xlink:to="lab_ConsolidationPolicyTextBlock7.1891980.414337.483296.325363.255831" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_ConsolidationPolicyTextBlock7.1891980.414337.483296.325363.255831" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US" id="lab_ConsolidationPolicyTextBlock7.1891980.414337.483296.325363.255831">Principles of consolidation</link:label>
    <link:loc xlink:label="loc_DerivativesPolicyTextBlock.8455.11.6" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_DerivativesPolicyTextBlock" xlink:type="locator" />
    <link:labelArc xlink:from="loc_DerivativesPolicyTextBlock.8455.11.6" xlink:to="lab_DerivativesPolicyTextBlock.13899.254342.250692.255832" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_DerivativesPolicyTextBlock.13899.254342.250692.255832" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US" id="lab_DerivativesPolicyTextBlock.13899.254342.250692.255832">Derivatives, Policy [Policy Text Block]</link:label>
    <link:loc xlink:label="loc_DerivativesPolicyTextBlock.8455.11.7" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_DerivativesPolicyTextBlock" xlink:type="locator" />
    <link:labelArc xlink:from="loc_DerivativesPolicyTextBlock.8455.11.7" xlink:to="lab_DerivativesPolicyTextBlock.1922182.254343.250693.255833" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_DerivativesPolicyTextBlock.1922182.254343.250693.255833" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US" id="lab_DerivativesPolicyTextBlock.1922182.254343.250693.255833">Derivative financial instruments</link:label>
    <link:loc xlink:label="loc_EarningsPerSharePolicyTextBlock.9000.11.6" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_EarningsPerSharePolicyTextBlock" xlink:type="locator" />
    <link:labelArc xlink:from="loc_EarningsPerSharePolicyTextBlock.9000.11.6" xlink:to="lab_EarningsPerSharePolicyTextBlock.5749" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_EarningsPerSharePolicyTextBlock.5749" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US" id="lab_EarningsPerSharePolicyTextBlock.5749">Earnings Per Share, Policy [Policy Text Block]</link:label>
    <link:loc xlink:label="loc_EarningsPerSharePolicyTextBlock.9000.11.7" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_EarningsPerSharePolicyTextBlock" xlink:type="locator" />
    <link:labelArc xlink:from="loc_EarningsPerSharePolicyTextBlock.9000.11.7" xlink:to="lab_EarningsPerSharePolicyTextBlock.1872458.189968.256337" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_EarningsPerSharePolicyTextBlock.1872458.189968.256337" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US" id="lab_EarningsPerSharePolicyTextBlock.1872458.189968.256337">Loss per share</link:label>
    <link:loc xlink:label="loc_FairValueOfFinancialInstrumentsPolicy.9621.11.6" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_FairValueOfFinancialInstrumentsPolicy" xlink:type="locator" />
    <link:labelArc xlink:from="loc_FairValueOfFinancialInstrumentsPolicy.9621.11.6" xlink:to="lab_FairValueOfFinancialInstrumentsPolicy.13921.254346.250694.255834" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_FairValueOfFinancialInstrumentsPolicy.13921.254346.250694.255834" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US" id="lab_FairValueOfFinancialInstrumentsPolicy.13921.254346.250694.255834">Fair Value of Financial Instruments, Policy [Policy Text Block]</link:label>
    <link:loc xlink:label="loc_FairValueOfFinancialInstrumentsPolicy.9621.11.7" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_FairValueOfFinancialInstrumentsPolicy" xlink:type="locator" />
    <link:labelArc xlink:from="loc_FairValueOfFinancialInstrumentsPolicy.9621.11.7" xlink:to="lab_FairValueOfFinancialInstrumentsPolicy7.1922181.254347.250695.255835" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_FairValueOfFinancialInstrumentsPolicy7.1922181.254347.250695.255835" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US" id="lab_FairValueOfFinancialInstrumentsPolicy7.1922181.254347.250695.255835">Fair value of financial instruments</link:label>
    <link:loc xlink:label="loc_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock.10297.11.6" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock" xlink:type="locator" />
    <link:labelArc xlink:from="loc_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock.10297.11.6" xlink:to="lab_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock.7759" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock.7759" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US" id="lab_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock.7759">Foreign Currency Transactions and Translations Policy [Policy Text Block]</link:label>
    <link:loc xlink:label="loc_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock.10297.11.7" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock" xlink:type="locator" />
    <link:labelArc xlink:from="loc_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock.10297.11.7" xlink:to="lab_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock.158453.463866.318526.361635.256317" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock.158453.463866.318526.361635.256317" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US" id="lab_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock.158453.463866.318526.361635.256317">Functional currency of the Subsidiary</link:label>
    <link:loc xlink:label="loc_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock.10902.11.6" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock" xlink:type="locator" />
    <link:labelArc xlink:from="loc_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock.10902.11.6" xlink:to="lab_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock.8709" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock.8709" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US" id="lab_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock.8709">Impairment or Disposal of Long-Lived Assets, Policy [Policy Text Block]</link:label>
    <link:loc xlink:label="loc_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock.10902.11.7" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock" xlink:type="locator" />
    <link:labelArc xlink:from="loc_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock.10902.11.7" xlink:to="lab_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock.1872413.189974.256335" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock.1872413.189974.256335" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US" id="lab_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock.1872413.189974.256335">Impairment of long-lived assets</link:label>
    <link:loc xlink:label="loc_IncomeTaxPolicyTextBlock.11082.11.6" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_IncomeTaxPolicyTextBlock" xlink:type="locator" />
    <link:labelArc xlink:from="loc_IncomeTaxPolicyTextBlock.11082.11.6" xlink:to="lab_IncomeTaxPolicyTextBlock.9011" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_IncomeTaxPolicyTextBlock.9011" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US" id="lab_IncomeTaxPolicyTextBlock.9011">Income Tax, Policy [Policy Text Block]</link:label>
    <link:loc xlink:label="loc_IncomeTaxPolicyTextBlock.11082.11.7" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_IncomeTaxPolicyTextBlock" xlink:type="locator" />
    <link:labelArc xlink:from="loc_IncomeTaxPolicyTextBlock.11082.11.7" xlink:to="lab_IncomeTaxPolicyTextBlock.1872460.189976.256338" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_IncomeTaxPolicyTextBlock.1872460.189976.256338" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US" id="lab_IncomeTaxPolicyTextBlock.1872460.189976.256338">Income taxes</link:label>
    <link:loc xlink:label="loc_LongTermRestrictedDepositPolicyTextBlock.25635.11.6" xlink:href="psti-20140630.xsd#psti_LongTermRestrictedDepositPolicyTextBlock" xlink:type="locator" />
    <link:labelArc xlink:from="loc_LongTermRestrictedDepositPolicyTextBlock.25635.11.6" xlink:to="lab_LongTermRestrictedDepositPolicyTextBlock.1872406.189977.256321" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_LongTermRestrictedDepositPolicyTextBlock.1872406.189977.256321" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US" id="lab_LongTermRestrictedDepositPolicyTextBlock.1872406.189977.256321">Long Term Restricted Deposit [Policy Text Block]</link:label>
    <link:loc xlink:label="loc_LongTermRestrictedDepositPolicyTextBlock.25635.11.12" xlink:href="psti-20140630.xsd#psti_LongTermRestrictedDepositPolicyTextBlock" xlink:type="locator" />
    <link:labelArc xlink:from="loc_LongTermRestrictedDepositPolicyTextBlock.25635.11.12" xlink:to="lab_LongTermRestrictedDepositPolicyTextBlock.1872408.189979.256322" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_LongTermRestrictedDepositPolicyTextBlock.1872408.189979.256322" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US" id="lab_LongTermRestrictedDepositPolicyTextBlock.1872408.189979.256322">The policy disclosure regarding long-term restricted deposits for the entity.</link:label>
    <link:loc xlink:label="loc_LongTermRestrictedDepositPolicyTextBlock.25635.11.7" xlink:href="psti-20140630.xsd#psti_LongTermRestrictedDepositPolicyTextBlock" xlink:type="locator" />
    <link:labelArc xlink:from="loc_LongTermRestrictedDepositPolicyTextBlock.25635.11.7" xlink:to="lab_LongTermRestrictedDepositPolicyTextBlock.1872409.189978.256323" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_LongTermRestrictedDepositPolicyTextBlock.1872409.189978.256323" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US" id="lab_LongTermRestrictedDepositPolicyTextBlock.1872409.189978.256323">Long-term restricted deposit</link:label>
    <link:loc xlink:label="loc_MarketableSecuritiesPolicy.12841.11.6" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_MarketableSecuritiesPolicy" xlink:type="locator" />
    <link:labelArc xlink:from="loc_MarketableSecuritiesPolicy.12841.11.6" xlink:to="lab_MarketableSecuritiesPolicy.11744" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_MarketableSecuritiesPolicy.11744" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US" id="lab_MarketableSecuritiesPolicy.11744">Marketable Securities, Policy [Policy Text Block]</link:label>
    <link:loc xlink:label="loc_MarketableSecuritiesPolicy.12841.11.7" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_MarketableSecuritiesPolicy" xlink:type="locator" />
    <link:labelArc xlink:from="loc_MarketableSecuritiesPolicy.12841.11.7" xlink:to="lab_MarketableSecuritiesPolicy.1901270.189981.256339" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_MarketableSecuritiesPolicy.1901270.189981.256339" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US" id="lab_MarketableSecuritiesPolicy.1901270.189981.256339">Marketable Securities</link:label>
    <link:loc xlink:label="loc_NewAccountingPronouncementsPolicyPolicyTextBlock.13168.11.6" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:type="locator" />
    <link:labelArc xlink:from="loc_NewAccountingPronouncementsPolicyPolicyTextBlock.13168.11.6" xlink:to="lab_NewAccountingPronouncementsPolicyPolicyTextBlock.12347" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_NewAccountingPronouncementsPolicyPolicyTextBlock.12347" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US" id="lab_NewAccountingPronouncementsPolicyPolicyTextBlock.12347">New Accounting Pronouncements, Policy [Policy Text Block]</link:label>
    <link:loc xlink:label="loc_NewAccountingPronouncementsPolicyPolicyTextBlock.13168.11.7" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:type="locator" />
    <link:labelArc xlink:from="loc_NewAccountingPronouncementsPolicyPolicyTextBlock.13168.11.7" xlink:to="lab_NewAccountingPronouncementsPolicyPolicyTextBlock.223732.182803.259755" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_NewAccountingPronouncementsPolicyPolicyTextBlock.223732.182803.259755" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US" id="lab_NewAccountingPronouncementsPolicyPolicyTextBlock.223732.182803.259755">Recent Accounting Pronouncement</link:label>
    <link:loc xlink:label="loc_PropertyPlantAndEquipmentPolicyTextBlock.15020.11.6" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_PropertyPlantAndEquipmentPolicyTextBlock" xlink:type="locator" />
    <link:labelArc xlink:from="loc_PropertyPlantAndEquipmentPolicyTextBlock.15020.11.6" xlink:to="lab_PropertyPlantAndEquipmentPolicyTextBlock.15294" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_PropertyPlantAndEquipmentPolicyTextBlock.15294" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US" id="lab_PropertyPlantAndEquipmentPolicyTextBlock.15294">Property, Plant and Equipment, Policy [Policy Text Block]</link:label>
    <link:loc xlink:label="loc_PropertyPlantAndEquipmentPolicyTextBlock.15020.11.7" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_PropertyPlantAndEquipmentPolicyTextBlock" xlink:type="locator" />
    <link:labelArc xlink:from="loc_PropertyPlantAndEquipmentPolicyTextBlock.15020.11.7" xlink:to="lab_PropertyPlantAndEquipmentPolicyTextBlock.1872411.189983.256334" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_PropertyPlantAndEquipmentPolicyTextBlock.1872411.189983.256334" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US" id="lab_PropertyPlantAndEquipmentPolicyTextBlock.1872411.189983.256334">Property and Equipment</link:label>
    <link:loc xlink:label="loc_ResearchAndDevelopmentExpensesAndGrantsPolicyTextBlock.25636.11.6" xlink:href="psti-20140630.xsd#psti_ResearchAndDevelopmentExpensesAndGrantsPolicyTextBlock" xlink:type="locator" />
    <link:labelArc xlink:from="loc_ResearchAndDevelopmentExpensesAndGrantsPolicyTextBlock.25636.11.6" xlink:to="lab_ResearchAndDevelopmentExpensesAndGrantsPolicyTextBlock.1872452.189984.256324" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_ResearchAndDevelopmentExpensesAndGrantsPolicyTextBlock.1872452.189984.256324" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US" id="lab_ResearchAndDevelopmentExpensesAndGrantsPolicyTextBlock.1872452.189984.256324">Research And Development Expenses And Grants Policy Text Block</link:label>
    <link:loc xlink:label="loc_ResearchAndDevelopmentExpensesAndGrantsPolicyTextBlock.25636.11.12" xlink:href="psti-20140630.xsd#psti_ResearchAndDevelopmentExpensesAndGrantsPolicyTextBlock" xlink:type="locator" />
    <link:labelArc xlink:from="loc_ResearchAndDevelopmentExpensesAndGrantsPolicyTextBlock.25636.11.12" xlink:to="lab_ResearchAndDevelopmentExpensesAndGrantsPolicyTextBlock.1872453.189986.256325" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_ResearchAndDevelopmentExpensesAndGrantsPolicyTextBlock.1872453.189986.256325" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US" id="lab_ResearchAndDevelopmentExpensesAndGrantsPolicyTextBlock.1872453.189986.256325">Disclosure of accounting policy for research and development expenses and grants.</link:label>
    <link:loc xlink:label="loc_ResearchAndDevelopmentExpensesAndGrantsPolicyTextBlock.25636.11.7" xlink:href="psti-20140630.xsd#psti_ResearchAndDevelopmentExpensesAndGrantsPolicyTextBlock" xlink:type="locator" />
    <link:labelArc xlink:from="loc_ResearchAndDevelopmentExpensesAndGrantsPolicyTextBlock.25636.11.7" xlink:to="lab_ResearchAndDevelopmentExpensesAndGrantsPolicyTextBlock.1872454.189985.256326" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_ResearchAndDevelopmentExpensesAndGrantsPolicyTextBlock.1872454.189985.256326" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US" id="lab_ResearchAndDevelopmentExpensesAndGrantsPolicyTextBlock.1872454.189985.256326">Research and Development expenses and grants</link:label>
    <link:loc xlink:label="loc_RevenueRecognitionPolicyTextBlock.15864.11.6" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_RevenueRecognitionPolicyTextBlock" xlink:type="locator" />
    <link:labelArc xlink:from="loc_RevenueRecognitionPolicyTextBlock.15864.11.6" xlink:to="lab_RevenueRecognitionPolicyTextBlock.16664" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_RevenueRecognitionPolicyTextBlock.16664" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US" id="lab_RevenueRecognitionPolicyTextBlock.16664">Revenue Recognition, Policy [Policy Text Block]</link:label>
    <link:loc xlink:label="loc_RevenueRecognitionPolicyTextBlock.15864.11.7" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_RevenueRecognitionPolicyTextBlock" xlink:type="locator" />
    <link:labelArc xlink:from="loc_RevenueRecognitionPolicyTextBlock.15864.11.7" xlink:to="lab_RevenueRecognitionPolicyTextBlock.1901271.189988.256340" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_RevenueRecognitionPolicyTextBlock.1901271.189988.256340" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US" id="lab_RevenueRecognitionPolicyTextBlock.1901271.189988.256340">Revenue Recognition from the license Agreement with United Therapeutics</link:label>
    <link:loc xlink:label="loc_SeverancePayPolicyTextBlock.25638.11.6" xlink:href="psti-20140630.xsd#psti_SeverancePayPolicyTextBlock" xlink:type="locator" />
    <link:labelArc xlink:from="loc_SeverancePayPolicyTextBlock.25638.11.6" xlink:to="lab_SeverancePayPolicyTextBlock.1872472.189989.256330" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_SeverancePayPolicyTextBlock.1872472.189989.256330" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US" id="lab_SeverancePayPolicyTextBlock.1872472.189989.256330">Severance Pay Policy Text Block</link:label>
    <link:loc xlink:label="loc_SeverancePayPolicyTextBlock.25638.11.12" xlink:href="psti-20140630.xsd#psti_SeverancePayPolicyTextBlock" xlink:type="locator" />
    <link:labelArc xlink:from="loc_SeverancePayPolicyTextBlock.25638.11.12" xlink:to="lab_SeverancePayPolicyTextBlock.1872474.189991.256331" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_SeverancePayPolicyTextBlock.1872474.189991.256331" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US" id="lab_SeverancePayPolicyTextBlock.1872474.189991.256331">Disclosure of accounting policy related to severance pay.</link:label>
    <link:loc xlink:label="loc_SeverancePayPolicyTextBlock.25638.11.7" xlink:href="psti-20140630.xsd#psti_SeverancePayPolicyTextBlock" xlink:type="locator" />
    <link:labelArc xlink:from="loc_SeverancePayPolicyTextBlock.25638.11.7" xlink:to="lab_SeverancePayPolicyTextBlock.1872475.189990.256332" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_SeverancePayPolicyTextBlock.1872475.189990.256332" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US" id="lab_SeverancePayPolicyTextBlock.1872475.189990.256332">Severance pay</link:label>
    <link:loc xlink:label="loc_ShareBasedCompensationOptionAndIncentivePlansPolicy.16716.11.6" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy" xlink:type="locator" />
    <link:labelArc xlink:from="loc_ShareBasedCompensationOptionAndIncentivePlansPolicy.16716.11.6" xlink:to="lab_ShareBasedCompensationOptionAndIncentivePlansPolicy.18012" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_ShareBasedCompensationOptionAndIncentivePlansPolicy.18012" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US" id="lab_ShareBasedCompensationOptionAndIncentivePlansPolicy.18012">Share-based Compensation, Option and Incentive Plans Policy [Policy Text Block]</link:label>
    <link:loc xlink:label="loc_ShareBasedCompensationOptionAndIncentivePlansPolicy.16716.11.7" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy" xlink:type="locator" />
    <link:labelArc xlink:from="loc_ShareBasedCompensationOptionAndIncentivePlansPolicy.16716.11.7" xlink:to="lab_ShareBasedCompensationOptionAndIncentivePlansPolicy.1872415.189993.256336" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_ShareBasedCompensationOptionAndIncentivePlansPolicy.1872415.189993.256336" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US" id="lab_ShareBasedCompensationOptionAndIncentivePlansPolicy.1872415.189993.256336">Accounting for stock-based compensation</link:label>
    <link:loc xlink:label="loc_ShortTermBankDepositPolicyTextBlock.25634.11.6" xlink:href="psti-20140630.xsd#psti_ShortTermBankDepositPolicyTextBlock" xlink:type="locator" />
    <link:labelArc xlink:from="loc_ShortTermBankDepositPolicyTextBlock.25634.11.6" xlink:to="lab_ShortTermBankDepositPolicyTextBlock.1872338.189994.256318" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_ShortTermBankDepositPolicyTextBlock.1872338.189994.256318" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US" id="lab_ShortTermBankDepositPolicyTextBlock.1872338.189994.256318">Short Term Bank Deposit [Policy Text Block]</link:label>
    <link:loc xlink:label="loc_ShortTermBankDepositPolicyTextBlock.25634.11.7" xlink:href="psti-20140630.xsd#psti_ShortTermBankDepositPolicyTextBlock" xlink:type="locator" />
    <link:labelArc xlink:from="loc_ShortTermBankDepositPolicyTextBlock.25634.11.7" xlink:to="lab_ShortTermBankDepositPolicyTextBlock.1872401.189995.256319" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_ShortTermBankDepositPolicyTextBlock.1872401.189995.256319" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US" id="lab_ShortTermBankDepositPolicyTextBlock.1872401.189995.256319">Short-term bank deposit</link:label>
    <link:loc xlink:label="loc_ShortTermBankDepositPolicyTextBlock.25634.11.12" xlink:href="psti-20140630.xsd#psti_ShortTermBankDepositPolicyTextBlock" xlink:type="locator" />
    <link:labelArc xlink:from="loc_ShortTermBankDepositPolicyTextBlock.25634.11.12" xlink:to="lab_ShortTermBankDepositPolicyTextBlock.1872404.189996.256320" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_ShortTermBankDepositPolicyTextBlock.1872404.189996.256320" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US" id="lab_ShortTermBankDepositPolicyTextBlock.1872404.189996.256320">The policy disclosure regarding short-term bank deposits for the entity.</link:label>
    <link:loc xlink:label="loc_UseOfEstimates.17598.11.6" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_UseOfEstimates" xlink:type="locator" />
    <link:labelArc xlink:from="loc_UseOfEstimates.17598.11.6" xlink:to="lab_UseOfEstimates.19676.255836" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_UseOfEstimates.19676.255836" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US" id="lab_UseOfEstimates.19676.255836">Use of Estimates, Policy [Policy Text Block]</link:label>
    <link:loc xlink:label="loc_UseOfEstimates.17598.11.7" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_UseOfEstimates" xlink:type="locator" />
    <link:labelArc xlink:from="loc_UseOfEstimates.17598.11.7" xlink:to="lab_UseOfEstimates.223416.325364.255837" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_UseOfEstimates.223416.325364.255837" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US" id="lab_UseOfEstimates.223416.325364.255837">Use of estimates</link:label>
    <link:loc xlink:label="loc_PropertyPlantAndEquipmentEstimatedUsefulLivesRateTableTextBlock.25639.11.6" xlink:href="psti-20140630.xsd#psti_PropertyPlantAndEquipmentEstimatedUsefulLivesRateTableTextBlock" xlink:type="locator" />
    <link:labelArc xlink:from="loc_PropertyPlantAndEquipmentEstimatedUsefulLivesRateTableTextBlock.25639.11.6" xlink:to="lab_PropertyPlantAndEquipmentEstimatedUsefulLivesRateTableTextBlock.1872735.189999.256342" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_PropertyPlantAndEquipmentEstimatedUsefulLivesRateTableTextBlock.1872735.189999.256342" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US" id="lab_PropertyPlantAndEquipmentEstimatedUsefulLivesRateTableTextBlock.1872735.189999.256342">Property Plant And Equipment Estimated Useful Lives Rate Table Text Block</link:label>
    <link:loc xlink:label="loc_PropertyPlantAndEquipmentEstimatedUsefulLivesRateTableTextBlock.25639.11.12" xlink:href="psti-20140630.xsd#psti_PropertyPlantAndEquipmentEstimatedUsefulLivesRateTableTextBlock" xlink:type="locator" />
    <link:labelArc xlink:from="loc_PropertyPlantAndEquipmentEstimatedUsefulLivesRateTableTextBlock.25639.11.12" xlink:to="lab_PropertyPlantAndEquipmentEstimatedUsefulLivesRateTableTextBlock.1872736.190001.256343" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_PropertyPlantAndEquipmentEstimatedUsefulLivesRateTableTextBlock.1872736.190001.256343" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US" id="lab_PropertyPlantAndEquipmentEstimatedUsefulLivesRateTableTextBlock.1872736.190001.256343">Property Plant And Equipment Estimated Useful Lives Rate [Table Text Block]</link:label>
    <link:loc xlink:label="loc_PropertyPlantAndEquipmentEstimatedUsefulLivesRateTableTextBlock.25639.11.7" xlink:href="psti-20140630.xsd#psti_PropertyPlantAndEquipmentEstimatedUsefulLivesRateTableTextBlock" xlink:type="locator" />
    <link:labelArc xlink:from="loc_PropertyPlantAndEquipmentEstimatedUsefulLivesRateTableTextBlock.25639.11.7" xlink:to="lab_PropertyPlantAndEquipmentEstimatedUsefulLivesRateTableTextBlock.1872737.190000.256344" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_PropertyPlantAndEquipmentEstimatedUsefulLivesRateTableTextBlock.1872737.190000.256344" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US" id="lab_PropertyPlantAndEquipmentEstimatedUsefulLivesRateTableTextBlock.1872737.190000.256344">Schedule of Property and Equipment, Estimated Useful Lives, Annual Rate</link:label>
    <link:loc xlink:label="loc_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock.16190.11.6" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock" xlink:type="locator" />
    <link:labelArc xlink:from="loc_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock.16190.11.6" xlink:to="lab_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock.17150" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock.17150" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US" id="lab_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock.17150">Schedule of Accumulated Other Comprehensive Income (Loss) [Table Text Block]</link:label>
    <link:loc xlink:label="loc_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock.16190.11.7" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock" xlink:type="locator" />
    <link:labelArc xlink:from="loc_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock.16190.11.7" xlink:to="lab_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock.1866932.270932.315450.260220" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock.1866932.270932.315450.260220" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US" id="lab_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock.1866932.270932.315450.260220">Schedule of Comprehensive Income</link:label>
    <link:loc xlink:label="loc_AmendmentFlag.144.11.6" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_AmendmentFlag" xlink:type="locator" />
    <link:labelArc xlink:from="loc_AmendmentFlag.144.11.6" xlink:to="lab_AmendmentFlag.8.253626.250516.255451" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_AmendmentFlag.8.253626.250516.255451" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US" id="lab_AmendmentFlag.8.253626.250516.255451">Amendment Flag</link:label>
    <link:loc xlink:label="loc_ClassOfStockDomain.1053.11.6" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ClassOfStockDomain" xlink:type="locator" />
    <link:labelArc xlink:from="loc_ClassOfStockDomain.1053.11.6" xlink:to="lab_ClassOfStockDomain.14390.189901.256357" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_ClassOfStockDomain.14390.189901.256357" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US" id="lab_ClassOfStockDomain.14390.189901.256357">Class of Stock [Domain]</link:label>
    <link:loc xlink:label="loc_CurrentFiscalYearEndDate.155.11.6" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_CurrentFiscalYearEndDate" xlink:type="locator" />
    <link:labelArc xlink:from="loc_CurrentFiscalYearEndDate.155.11.6" xlink:to="lab_CurrentFiscalYearEndDate.20.253628.250518.255453" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_CurrentFiscalYearEndDate.20.253628.250518.255453" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US" id="lab_CurrentFiscalYearEndDate.20.253628.250518.255453">Current Fiscal Year End Date</link:label>
    <link:loc xlink:label="loc_DocumentAndEntityInformationAbstract.25536.11.6" xlink:href="psti-20140630.xsd#psti_DocumentAndEntityInformationAbstract" xlink:type="locator" />
    <link:labelArc xlink:from="loc_DocumentAndEntityInformationAbstract.25536.11.6" xlink:to="lab_DocumentAndEntityInformationAbstract.286676.253630.250519.255454" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_DocumentAndEntityInformationAbstract.286676.253630.250519.255454" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US" id="lab_DocumentAndEntityInformationAbstract.286676.253630.250519.255454">Document and Entity Information [Abstract]</link:label>
    <link:loc xlink:label="loc_DocumentAndEntityInformationAbstract.25536.11.12" xlink:href="psti-20140630.xsd#psti_DocumentAndEntityInformationAbstract" xlink:type="locator" />
    <link:labelArc xlink:from="loc_DocumentAndEntityInformationAbstract.25536.11.12" xlink:to="lab_DocumentAndEntityInformationAbstract.286677.253631.250520.255455" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_DocumentAndEntityInformationAbstract.286677.253631.250520.255455" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US" id="lab_DocumentAndEntityInformationAbstract.286677.253631.250520.255455">Document And Entity Information Abstract</link:label>
    <link:loc xlink:label="loc_DocumentAndEntityInformationTable.25640.11.6" xlink:href="psti-20140630.xsd#psti_DocumentAndEntityInformationTable" xlink:type="locator" />
    <link:labelArc xlink:from="loc_DocumentAndEntityInformationTable.25640.11.6" xlink:to="lab_DocumentAndEntityInformationTable.1872630.189906.256349" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_DocumentAndEntityInformationTable.1872630.189906.256349" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US" id="lab_DocumentAndEntityInformationTable.1872630.189906.256349">Document And Entity Information [Table]</link:label>
    <link:loc xlink:label="loc_DocumentFiscalPeriodFocus.206.11.6" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_DocumentFiscalPeriodFocus" xlink:type="locator" />
    <link:labelArc xlink:from="loc_DocumentFiscalPeriodFocus.206.11.6" xlink:to="lab_DocumentFiscalPeriodFocus.123.253632.250522.255457" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_DocumentFiscalPeriodFocus.123.253632.250522.255457" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US" id="lab_DocumentFiscalPeriodFocus.123.253632.250522.255457">Document Fiscal Period Focus</link:label>
    <link:loc xlink:label="loc_DocumentFiscalYearFocus.205.11.6" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_DocumentFiscalYearFocus" xlink:type="locator" />
    <link:labelArc xlink:from="loc_DocumentFiscalYearFocus.205.11.6" xlink:to="lab_DocumentFiscalYearFocus.122.253634.250524.255459" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_DocumentFiscalYearFocus.122.253634.250524.255459" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US" id="lab_DocumentFiscalYearFocus.122.253634.250524.255459">Document Fiscal Year Focus</link:label>
    <link:loc xlink:label="loc_DocumentPeriodEndDate.161.11.6" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_DocumentPeriodEndDate" xlink:type="locator" />
    <link:labelArc xlink:from="loc_DocumentPeriodEndDate.161.11.6" xlink:to="lab_DocumentPeriodEndDate.30.253636.250526.255461" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_DocumentPeriodEndDate.30.253636.250526.255461" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US" id="lab_DocumentPeriodEndDate.30.253636.250526.255461">Document Period End Date</link:label>
    <link:loc xlink:label="loc_DocumentType.210.11.6" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_DocumentType" xlink:type="locator" />
    <link:labelArc xlink:from="loc_DocumentType.210.11.6" xlink:to="lab_DocumentType.32.253638.250528.255463" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_DocumentType.32.253638.250528.255463" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US" id="lab_DocumentType.32.253638.250528.255463">Document Type</link:label>
    <link:loc xlink:label="loc_EntityCentralIndexKey.186.11.6" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_EntityCentralIndexKey" xlink:type="locator" />
    <link:labelArc xlink:from="loc_EntityCentralIndexKey.186.11.6" xlink:to="lab_EntityCentralIndexKey.101.253640.250529.255464" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_EntityCentralIndexKey.101.253640.250529.255464" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US" id="lab_EntityCentralIndexKey.101.253640.250529.255464">Entity Central Index Key</link:label>
    <link:loc xlink:label="loc_EntityCommonStockSharesOutstanding.190.11.6" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_EntityCommonStockSharesOutstanding" xlink:type="locator" />
    <link:labelArc xlink:from="loc_EntityCommonStockSharesOutstanding.190.11.6" xlink:to="lab_EntityCommonStockSharesOutstanding.105.253642.250531.255466" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_EntityCommonStockSharesOutstanding.105.253642.250531.255466" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US" id="lab_EntityCommonStockSharesOutstanding.105.253642.250531.255466">Entity Common Stock, Shares Outstanding</link:label>
    <link:loc xlink:label="loc_EntityCurrentReportingStatus.182.11.6" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_EntityCurrentReportingStatus" xlink:type="locator" />
    <link:labelArc xlink:from="loc_EntityCurrentReportingStatus.182.11.6" xlink:to="lab_EntityCurrentReportingStatus.97.189913.256356" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_EntityCurrentReportingStatus.97.189913.256356" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US" id="lab_EntityCurrentReportingStatus.97.189913.256356">Entity Current Reporting Status</link:label>
    <link:loc xlink:label="loc_EntityFilerCategory.183.11.6" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_EntityFilerCategory" xlink:type="locator" />
    <link:labelArc xlink:from="loc_EntityFilerCategory.183.11.6" xlink:to="lab_EntityFilerCategory.98.253644.250534.255469" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_EntityFilerCategory.98.253644.250534.255469" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US" id="lab_EntityFilerCategory.98.253644.250534.255469">Entity Filer Category</link:label>
    <link:loc xlink:label="loc_EntityPublicFloat.184.11.6" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_EntityPublicFloat" xlink:type="locator" />
    <link:labelArc xlink:from="loc_EntityPublicFloat.184.11.6" xlink:to="lab_EntityPublicFloat.99.189915.256353" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_EntityPublicFloat.99.189915.256353" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US" id="lab_EntityPublicFloat.99.189915.256353">Entity Public Float</link:label>
    <link:loc xlink:label="loc_EntityRegistrantName.185.11.6" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_EntityRegistrantName" xlink:type="locator" />
    <link:labelArc xlink:from="loc_EntityRegistrantName.185.11.6" xlink:to="lab_EntityRegistrantName.100.253646.250535.255470" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_EntityRegistrantName.100.253646.250535.255470" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US" id="lab_EntityRegistrantName.100.253646.250535.255470">Entity Registrant Name</link:label>
    <link:loc xlink:label="loc_EntityVoluntaryFilers.181.11.6" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_EntityVoluntaryFilers" xlink:type="locator" />
    <link:labelArc xlink:from="loc_EntityVoluntaryFilers.181.11.6" xlink:to="lab_EntityVoluntaryFilers.96.189917.256354" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_EntityVoluntaryFilers.96.189917.256354" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US" id="lab_EntityVoluntaryFilers.96.189917.256354">Entity Voluntary Filers</link:label>
    <link:loc xlink:label="loc_EntityWellKnownSeasonedIssuer.180.11.6" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_EntityWellKnownSeasonedIssuer" xlink:type="locator" />
    <link:labelArc xlink:from="loc_EntityWellKnownSeasonedIssuer.180.11.6" xlink:to="lab_EntityWellKnownSeasonedIssuer.95.189918.256355" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_EntityWellKnownSeasonedIssuer.95.189918.256355" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US" id="lab_EntityWellKnownSeasonedIssuer.95.189918.256355">Entity Well-known Seasoned Issuer</link:label>
    <link:loc xlink:label="loc_StatementClassOfStockAxis.5117.11.6" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_StatementClassOfStockAxis" xlink:type="locator" />
    <link:labelArc xlink:from="loc_StatementClassOfStockAxis.5117.11.6" xlink:to="lab_StatementClassOfStockAxis.10602.189919.256358" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_StatementClassOfStockAxis.10602.189919.256358" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US" id="lab_StatementClassOfStockAxis.10602.189919.256358">Class of Stock [Axis]</link:label>
    <link:loc xlink:label="loc_StatementLineItems.5108.11.6" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_StatementLineItems" xlink:type="locator" />
    <link:labelArc xlink:from="loc_StatementLineItems.5108.11.6" xlink:to="lab_StatementLineItems.9478.253981.250818.255727" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_StatementLineItems.9478.253981.250818.255727" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US" id="lab_StatementLineItems.9478.253981.250818.255727">Statement [Line Items]</link:label>
    <link:loc xlink:label="loc_AccumulatedOtherComprehensiveIncomeLossCumulativeChangesInNetGainLossFromCashFlowHedgesEffectNetOfTax.5728.11.7" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossCumulativeChangesInNetGainLossFromCashFlowHedgesEffectNetOfTax" xlink:type="locator" />
    <link:labelArc xlink:from="loc_AccumulatedOtherComprehensiveIncomeLossCumulativeChangesInNetGainLossFromCashFlowHedgesEffectNetOfTax.5728.11.7" xlink:to="lab_AccumulatedOtherComprehensiveIncomeLossCumulativeChangesInNetGainLossFromCashFlowHedgesEffectNetOfTax.256435" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_AccumulatedOtherComprehensiveIncomeLossCumulativeChangesInNetGainLossFromCashFlowHedgesEffectNetOfTax.256435" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US" id="lab_AccumulatedOtherComprehensiveIncomeLossCumulativeChangesInNetGainLossFromCashFlowHedgesEffectNetOfTax.256435">Net unrealized gain on the effective portion</link:label>
    <link:loc xlink:label="loc_AccumulatedOtherComprehensiveIncomeLossCumulativeChangesInNetGainLossFromCashFlowHedgesEffectNetOfTax.5728.11.6" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossCumulativeChangesInNetGainLossFromCashFlowHedgesEffectNetOfTax" xlink:type="locator" />
    <link:labelArc xlink:from="loc_AccumulatedOtherComprehensiveIncomeLossCumulativeChangesInNetGainLossFromCashFlowHedgesEffectNetOfTax.5728.11.6" xlink:to="lab_AccumulatedOtherComprehensiveIncomeLossCumulativeChangesInNetGainLossFromCashFlowHedgesEffectNetOfTax.599.255809" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_AccumulatedOtherComprehensiveIncomeLossCumulativeChangesInNetGainLossFromCashFlowHedgesEffectNetOfTax.599.255809" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US" id="lab_AccumulatedOtherComprehensiveIncomeLossCumulativeChangesInNetGainLossFromCashFlowHedgesEffectNetOfTax.599.255809">Accumulated Other Comprehensive Income (Loss), Cumulative Changes in Net Gain (Loss) from Cash Flow Hedges, Effect Net of Tax</link:label>
    <link:loc xlink:label="loc_AdvancePaymentForDeveplomentCosts.25651.11.6" xlink:href="psti-20140630.xsd#psti_AdvancePaymentForDeveplomentCosts" xlink:type="locator" />
    <link:labelArc xlink:from="loc_AdvancePaymentForDeveplomentCosts.25651.11.6" xlink:to="lab_AdvancePaymentForDeveplomentCosts.1899443.189925.256385" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_AdvancePaymentForDeveplomentCosts.1899443.189925.256385" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US" id="lab_AdvancePaymentForDeveplomentCosts.1899443.189925.256385">Advance Payment For Deveploment Costs</link:label>
    <link:loc xlink:label="loc_AdvancePaymentForDeveplomentCosts.25651.11.12" xlink:href="psti-20140630.xsd#psti_AdvancePaymentForDeveplomentCosts" xlink:type="locator" />
    <link:labelArc xlink:from="loc_AdvancePaymentForDeveplomentCosts.25651.11.12" xlink:to="lab_AdvancePaymentForDeveplomentCosts.1899444.189927.256386" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_AdvancePaymentForDeveplomentCosts.1899444.189927.256386" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US" id="lab_AdvancePaymentForDeveplomentCosts.1899444.189927.256386">The advance payment for any development costs.</link:label>
    <link:loc xlink:label="loc_AdvancePaymentForDeveplomentCosts.25651.11.7" xlink:href="psti-20140630.xsd#psti_AdvancePaymentForDeveplomentCosts" xlink:type="locator" />
    <link:labelArc xlink:from="loc_AdvancePaymentForDeveplomentCosts.25651.11.7" xlink:to="lab_AdvancePaymentForDeveplomentCosts.1899445.189926.256387" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_AdvancePaymentForDeveplomentCosts.1899445.189926.256387" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US" id="lab_AdvancePaymentForDeveplomentCosts.1899445.189926.256387">Advance payment for development costs</link:label>
    <link:loc xlink:label="loc_AllCurrenciesDomain.17940.11.6" xlink:href="http://xbrl.sec.gov/currency/2014/currency-2014-01-31.xsd#currency_AllCurrenciesDomain" xlink:type="locator" />
    <link:labelArc xlink:from="loc_AllCurrenciesDomain.17940.11.6" xlink:to="lab_AllCurrenciesDomain.43204" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_AllCurrenciesDomain.43204" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US" id="lab_AllCurrenciesDomain.43204">All Currencies [Domain]</link:label>
    <link:loc xlink:label="loc_AwardTypeAxis.367.11.6" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_AwardTypeAxis" xlink:type="locator" />
    <link:labelArc xlink:from="loc_AwardTypeAxis.367.11.6" xlink:to="lab_AwardTypeAxis.250.250698.255843" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_AwardTypeAxis.250.250698.255843" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US" id="lab_AwardTypeAxis.250.250698.255843">Award Type [Axis]</link:label>
    <link:loc xlink:label="loc_BusinessCombinationContingentConsiderationReceivableUponCertainRegulatoryMilestones.25648.11.6" xlink:href="psti-20140630.xsd#psti_BusinessCombinationContingentConsiderationReceivableUponCertainRegulatoryMilestones" xlink:type="locator" />
    <link:labelArc xlink:from="loc_BusinessCombinationContingentConsiderationReceivableUponCertainRegulatoryMilestones.25648.11.6" xlink:to="lab_BusinessCombinationContingentConsiderationReceivableUponCertainRegulatoryMilestones.1899448.189932.256376" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_BusinessCombinationContingentConsiderationReceivableUponCertainRegulatoryMilestones.1899448.189932.256376" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US" id="lab_BusinessCombinationContingentConsiderationReceivableUponCertainRegulatoryMilestones.1899448.189932.256376">Business Combination Contingent Consideration Receivable Upon Certain Regulatory Milestones</link:label>
    <link:loc xlink:label="loc_BusinessCombinationContingentConsiderationReceivableUponCertainRegulatoryMilestones.25648.11.12" xlink:href="psti-20140630.xsd#psti_BusinessCombinationContingentConsiderationReceivableUponCertainRegulatoryMilestones" xlink:type="locator" />
    <link:labelArc xlink:from="loc_BusinessCombinationContingentConsiderationReceivableUponCertainRegulatoryMilestones.25648.11.12" xlink:to="lab_BusinessCombinationContingentConsiderationReceivableUponCertainRegulatoryMilestones.1899460.189934.256377" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_BusinessCombinationContingentConsiderationReceivableUponCertainRegulatoryMilestones.1899460.189934.256377" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US" id="lab_BusinessCombinationContingentConsiderationReceivableUponCertainRegulatoryMilestones.1899460.189934.256377">Business combination contingent consideration receivable upon certain regulatory milestones.</link:label>
    <link:loc xlink:label="loc_BusinessCombinationContingentConsiderationReceivableUponCertainRegulatoryMilestones.25648.11.7" xlink:href="psti-20140630.xsd#psti_BusinessCombinationContingentConsiderationReceivableUponCertainRegulatoryMilestones" xlink:type="locator" />
    <link:labelArc xlink:from="loc_BusinessCombinationContingentConsiderationReceivableUponCertainRegulatoryMilestones.25648.11.7" xlink:to="lab_BusinessCombinationContingentConsiderationReceivableUponCertainRegulatoryMilestones.1899462.189933.256378" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_BusinessCombinationContingentConsiderationReceivableUponCertainRegulatoryMilestones.1899462.189933.256378" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US" id="lab_BusinessCombinationContingentConsiderationReceivableUponCertainRegulatoryMilestones.1899462.189933.256378">Contingent consideration receivable if certain regulatory milestones are reached</link:label>
    <link:loc xlink:label="loc_CashFlowHedgesDerivativeInstrumentsAtFairValueNet.6791.11.6" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_CashFlowHedgesDerivativeInstrumentsAtFairValueNet" xlink:type="locator" />
    <link:labelArc xlink:from="loc_CashFlowHedgesDerivativeInstrumentsAtFairValueNet.6791.11.6" xlink:to="lab_CashFlowHedgesDerivativeInstrumentsAtFairValueNet.2405" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_CashFlowHedgesDerivativeInstrumentsAtFairValueNet.2405" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US" id="lab_CashFlowHedgesDerivativeInstrumentsAtFairValueNet.2405">Cash Flow Hedges Derivative Instruments at Fair Value, Net</link:label>
    <link:loc xlink:label="loc_CashFlowHedgesDerivativeInstrumentsAtFairValueNet.6791.11.7" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_CashFlowHedgesDerivativeInstrumentsAtFairValueNet" xlink:type="locator" />
    <link:labelArc xlink:from="loc_CashFlowHedgesDerivativeInstrumentsAtFairValueNet.6791.11.7" xlink:to="lab_CashFlowHedgesDerivativeInstrumentsAtFairValueNet.259801" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_CashFlowHedgesDerivativeInstrumentsAtFairValueNet.259801" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US" id="lab_CashFlowHedgesDerivativeInstrumentsAtFairValueNet.259801">Fair value of cash flow hedge derivatives</link:label>
    <link:loc xlink:label="loc_CurrencyAxis.1333.11.6" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_CurrencyAxis" xlink:type="locator" />
    <link:labelArc xlink:from="loc_CurrencyAxis.1333.11.6" xlink:to="lab_CurrencyAxis.3512" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_CurrencyAxis.3512" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US" id="lab_CurrencyAxis.3512">Currency [Axis]</link:label>
    <link:loc xlink:label="loc_DeferredRevenueAdditions.7805.11.6" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_DeferredRevenueAdditions" xlink:type="locator" />
    <link:labelArc xlink:from="loc_DeferredRevenueAdditions.7805.11.6" xlink:to="lab_DeferredRevenueAdditions.4058" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_DeferredRevenueAdditions.4058" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US" id="lab_DeferredRevenueAdditions.4058">Deferred Revenue, Additions</link:label>
    <link:loc xlink:label="loc_DeferredRevenueAdditions.7805.11.7" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_DeferredRevenueAdditions" xlink:type="locator" />
    <link:labelArc xlink:from="loc_DeferredRevenueAdditions.7805.11.7" xlink:to="lab_DeferredRevenueAdditions.256429" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_DeferredRevenueAdditions.256429" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US" id="lab_DeferredRevenueAdditions.256429">Deferred revenue</link:label>
    <link:loc xlink:label="loc_DeferredRevenueArrangementByTypeTable.1456.11.6" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_DeferredRevenueArrangementByTypeTable" xlink:type="locator" />
    <link:labelArc xlink:from="loc_DeferredRevenueArrangementByTypeTable.1456.11.6" xlink:to="lab_DeferredRevenueArrangementByTypeTable.4055" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_DeferredRevenueArrangementByTypeTable.4055" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US" id="lab_DeferredRevenueArrangementByTypeTable.4055">Deferred Revenue Arrangement, by Type [Table]</link:label>
    <link:loc xlink:label="loc_DeferredRevenueArrangementLineItems.1463.11.6" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_DeferredRevenueArrangementLineItems" xlink:type="locator" />
    <link:labelArc xlink:from="loc_DeferredRevenueArrangementLineItems.1463.11.6" xlink:to="lab_DeferredRevenueArrangementLineItems.4103" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_DeferredRevenueArrangementLineItems.4103" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US" id="lab_DeferredRevenueArrangementLineItems.4103">Deferred Revenue Arrangement [Line Items]</link:label>
    <link:loc xlink:label="loc_DeferredRevenueArrangementTypeAxis.1469.11.6" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_DeferredRevenueArrangementTypeAxis" xlink:type="locator" />
    <link:labelArc xlink:from="loc_DeferredRevenueArrangementTypeAxis.1469.11.6" xlink:to="lab_DeferredRevenueArrangementTypeAxis.4124" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_DeferredRevenueArrangementTypeAxis.4124" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US" id="lab_DeferredRevenueArrangementTypeAxis.4124">Deferred Revenue Arrangement Type [Axis]</link:label>
    <link:loc xlink:label="loc_DeferredRevenueArrangementTypeDomain.1454.11.6" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_DeferredRevenueArrangementTypeDomain" xlink:type="locator" />
    <link:labelArc xlink:from="loc_DeferredRevenueArrangementTypeDomain.1454.11.6" xlink:to="lab_DeferredRevenueArrangementTypeDomain.4049" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_DeferredRevenueArrangementTypeDomain.4049" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US" id="lab_DeferredRevenueArrangementTypeDomain.4049">Deferred Revenue [Domain]</link:label>
    <link:loc xlink:label="loc_DerivativeContractTypeDomain.1632.11.6" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_DerivativeContractTypeDomain" xlink:type="locator" />
    <link:labelArc xlink:from="loc_DerivativeContractTypeDomain.1632.11.6" xlink:to="lab_DerivativeContractTypeDomain.4905.255811" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_DerivativeContractTypeDomain.4905.255811" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US" id="lab_DerivativeContractTypeDomain.4905.255811">Derivative Contract [Domain]</link:label>
    <link:loc xlink:label="loc_DerivativeInstrumentRiskAxis.1594.11.6" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_DerivativeInstrumentRiskAxis" xlink:type="locator" />
    <link:labelArc xlink:from="loc_DerivativeInstrumentRiskAxis.1594.11.6" xlink:to="lab_DerivativeInstrumentRiskAxis.4771.255812" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_DerivativeInstrumentRiskAxis.4771.255812" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US" id="lab_DerivativeInstrumentRiskAxis.4771.255812">Derivative Instrument [Axis]</link:label>
    <link:loc xlink:label="loc_DerivativeInstrumentsGainLossRecognizedInOtherComprehensiveIncomeEffectivePortionNet.8447.11.6" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_DerivativeInstrumentsGainLossRecognizedInOtherComprehensiveIncomeEffectivePortionNet" xlink:type="locator" />
    <link:labelArc xlink:from="loc_DerivativeInstrumentsGainLossRecognizedInOtherComprehensiveIncomeEffectivePortionNet.8447.11.6" xlink:to="lab_DerivativeInstrumentsGainLossRecognizedInOtherComprehensiveIncomeEffectivePortionNet.4988" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_DerivativeInstrumentsGainLossRecognizedInOtherComprehensiveIncomeEffectivePortionNet.4988" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US" id="lab_DerivativeInstrumentsGainLossRecognizedInOtherComprehensiveIncomeEffectivePortionNet.4988">Derivative Instruments, Gain (Loss) Recognized in Other Comprehensive Income (Loss), Effective Portion, Net</link:label>
    <link:loc xlink:label="loc_DerivativeInstrumentsGainLossRecognizedInOtherComprehensiveIncomeEffectivePortionNet.8447.11.7" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_DerivativeInstrumentsGainLossRecognizedInOtherComprehensiveIncomeEffectivePortionNet" xlink:type="locator" />
    <link:labelArc xlink:from="loc_DerivativeInstrumentsGainLossRecognizedInOtherComprehensiveIncomeEffectivePortionNet.8447.11.7" xlink:to="lab_DerivativeInstrumentsGainLossRecognizedInOtherComprehensiveIncomeEffectivePortionNet.256436" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_DerivativeInstrumentsGainLossRecognizedInOtherComprehensiveIncomeEffectivePortionNet.256436" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US" id="lab_DerivativeInstrumentsGainLossRecognizedInOtherComprehensiveIncomeEffectivePortionNet.256436">Net gain, resulting in the cash flow hedge transactions</link:label>
    <link:loc xlink:label="loc_DerivativeNotionalAmount.278.11.6" xlink:href="http://xbrl.sec.gov/invest/2013/invest-2013-01-31.xsd#invest_DerivativeNotionalAmount" xlink:type="locator" />
    <link:labelArc xlink:from="loc_DerivativeNotionalAmount.278.11.6" xlink:to="lab_DerivativeNotionalAmount.142.255818" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_DerivativeNotionalAmount.142.255818" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US" id="lab_DerivativeNotionalAmount.142.255818">Derivative, Notional Amount</link:label>
    <link:loc xlink:label="loc_DerivativeNotionalAmount.278.11.7" xlink:href="http://xbrl.sec.gov/invest/2013/invest-2013-01-31.xsd#invest_DerivativeNotionalAmount" xlink:type="locator" />
    <link:labelArc xlink:from="loc_DerivativeNotionalAmount.278.11.7" xlink:to="lab_DerivativeNotionalAmount.196466.360254.255819" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_DerivativeNotionalAmount.196466.360254.255819" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US" id="lab_DerivativeNotionalAmount.196466.360254.255819">Notional amount</link:label>
    <link:loc xlink:label="loc_EmployeesMember.25661.11.6" xlink:href="psti-20140630.xsd#psti_EmployeesMember" xlink:type="locator" />
    <link:labelArc xlink:from="loc_EmployeesMember.25661.11.6" xlink:to="lab_EmployeesMember.256432" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_EmployeesMember.256432" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US" id="lab_EmployeesMember.256432">Employees [Member]</link:label>
    <link:loc xlink:label="loc_EmployeesMember.25661.11.12" xlink:href="psti-20140630.xsd#psti_EmployeesMember" xlink:type="locator" />
    <link:labelArc xlink:from="loc_EmployeesMember.25661.11.12" xlink:to="lab_EmployeesMember12.256433" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_EmployeesMember12.256433" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US" id="lab_EmployeesMember12.256433">Employees [Member]</link:label>
    <link:loc xlink:label="loc_FairValueHedgesAtFairValueNet.9623.11.6" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_FairValueHedgesAtFairValueNet" xlink:type="locator" />
    <link:labelArc xlink:from="loc_FairValueHedgesAtFairValueNet.9623.11.6" xlink:to="lab_FairValueHedgesAtFairValueNet.6749" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_FairValueHedgesAtFairValueNet.6749" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US" id="lab_FairValueHedgesAtFairValueNet.6749">Fair Value Hedges, Net</link:label>
    <link:loc xlink:label="loc_FairValueHedgesAtFairValueNet.9623.11.7" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_FairValueHedgesAtFairValueNet" xlink:type="locator" />
    <link:labelArc xlink:from="loc_FairValueHedgesAtFairValueNet.9623.11.7" xlink:to="lab_FairValueHedgesAtFairValueNet.259802" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_FairValueHedgesAtFairValueNet.259802" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US" id="lab_FairValueHedgesAtFairValueNet.259802">Fair value of fair value hedge derivatives</link:label>
    <link:loc xlink:label="loc_FiniteLivedIntangibleAssetsByMajorClassAxis.2313.11.6" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:type="locator" />
    <link:labelArc xlink:from="loc_FiniteLivedIntangibleAssetsByMajorClassAxis.2313.11.6" xlink:to="lab_FiniteLivedIntangibleAssetsByMajorClassAxis.7635.256422" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_FiniteLivedIntangibleAssetsByMajorClassAxis.7635.256422" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US" id="lab_FiniteLivedIntangibleAssetsByMajorClassAxis.7635.256422">Finite-Lived Intangible Assets by Major Class [Axis]</link:label>
    <link:loc xlink:label="loc_FiniteLivedIntangibleAssetsMajorClassNameDomain.2311.11.6" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:type="locator" />
    <link:labelArc xlink:from="loc_FiniteLivedIntangibleAssetsMajorClassNameDomain.2311.11.6" xlink:to="lab_FiniteLivedIntangibleAssetsMajorClassNameDomain.14438.189937.256416" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_FiniteLivedIntangibleAssetsMajorClassNameDomain.14438.189937.256416" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US" id="lab_FiniteLivedIntangibleAssetsMajorClassNameDomain.14438.189937.256416">Finite-Lived Intangible Assets, Major Class Name [Domain]</link:label>
    <link:loc xlink:label="loc_ForeignExchangeForwardMember.2365.11.7" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ForeignExchangeForwardMember" xlink:type="locator" />
    <link:labelArc xlink:from="loc_ForeignExchangeForwardMember.2365.11.7" xlink:to="lab_ForeignExchangeForwardMember.1872496.360247.255824" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_ForeignExchangeForwardMember.1872496.360247.255824" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US" id="lab_ForeignExchangeForwardMember.1872496.360247.255824">Forward contracts [Member]</link:label>
    <link:loc xlink:label="loc_ForeignExchangeForwardMember.2365.11.6" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ForeignExchangeForwardMember" xlink:type="locator" />
    <link:labelArc xlink:from="loc_ForeignExchangeForwardMember.2365.11.6" xlink:to="lab_ForeignExchangeForwardMember.7793.255823" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_ForeignExchangeForwardMember.7793.255823" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US" id="lab_ForeignExchangeForwardMember.7793.255823">Foreign Exchange Forward [Member]</link:label>
    <link:loc xlink:label="loc_ForeignExchangeOptionMember.2351.11.6" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ForeignExchangeOptionMember" xlink:type="locator" />
    <link:labelArc xlink:from="loc_ForeignExchangeOptionMember.2351.11.6" xlink:to="lab_ForeignExchangeOptionMember.7741" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_ForeignExchangeOptionMember.7741" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US" id="lab_ForeignExchangeOptionMember.7741">Foreign Exchange Option [Member]</link:label>
    <link:loc xlink:label="loc_ForeignExchangeOptionMember.2351.11.7" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ForeignExchangeOptionMember" xlink:type="locator" />
    <link:labelArc xlink:from="loc_ForeignExchangeOptionMember.2351.11.7" xlink:to="lab_ForeignExchangeOptionMember.1872497.190015.256414" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_ForeignExchangeOptionMember.1872497.190015.256414" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US" id="lab_ForeignExchangeOptionMember.1872497.190015.256414">Option [Member]</link:label>
    <link:loc xlink:label="loc_GainLossOnDerivativeInstrumentsNetPretax.10456.11.6" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_GainLossOnDerivativeInstrumentsNetPretax" xlink:type="locator" />
    <link:labelArc xlink:from="loc_GainLossOnDerivativeInstrumentsNetPretax.10456.11.6" xlink:to="lab_GainLossOnDerivativeInstrumentsNetPretax.7996" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_GainLossOnDerivativeInstrumentsNetPretax.7996" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US" id="lab_GainLossOnDerivativeInstrumentsNetPretax.7996">Gain (Loss) on Derivative Instruments, Net, Pretax</link:label>
    <link:loc xlink:label="loc_ILS.17830.11.6" xlink:href="http://xbrl.sec.gov/currency/2014/currency-2014-01-31.xsd#currency_ILS" xlink:type="locator" />
    <link:labelArc xlink:from="loc_ILS.17830.11.6" xlink:to="lab_ILS.256438" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_ILS.256438" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US" id="lab_ILS.256438">Israel, New Shekels [Member]</link:label>
    <link:loc xlink:label="loc_KRW.17845.11.6" xlink:href="http://xbrl.sec.gov/currency/2014/currency-2014-01-31.xsd#currency_KRW" xlink:type="locator" />
    <link:labelArc xlink:from="loc_KRW.17845.11.6" xlink:to="lab_KRW.256437" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_KRW.256437" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US" id="lab_KRW.256437">Korean Won [Member]</link:label>
    <link:loc xlink:label="loc_LicensingAgreementsMember.3087.11.6" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_LicensingAgreementsMember" xlink:type="locator" />
    <link:labelArc xlink:from="loc_LicensingAgreementsMember.3087.11.6" xlink:to="lab_LicensingAgreementsMember.4295.189941.256415" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_LicensingAgreementsMember.4295.189941.256415" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US" id="lab_LicensingAgreementsMember.4295.189941.256415">Licensing Agreements [Member]</link:label>
    <link:loc xlink:label="loc_ManagementMember.3316.11.6" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ManagementMember" xlink:type="locator" />
    <link:labelArc xlink:from="loc_ManagementMember.3316.11.6" xlink:to="lab_ManagementMember.11689" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_ManagementMember.11689" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US" id="lab_ManagementMember.11689">Management [Member]</link:label>
    <link:loc xlink:label="loc_PostemploymentBenefitsPeriodExpense.14432.11.6" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_PostemploymentBenefitsPeriodExpense" xlink:type="locator" />
    <link:labelArc xlink:from="loc_PostemploymentBenefitsPeriodExpense.14432.11.6" xlink:to="lab_PostemploymentBenefitsPeriodExpense.14398" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_PostemploymentBenefitsPeriodExpense.14398" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US" id="lab_PostemploymentBenefitsPeriodExpense.14398">Postemployment Benefits, Period Expense</link:label>
    <link:loc xlink:label="loc_PostemploymentBenefitsPeriodExpense.14432.11.7" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_PostemploymentBenefitsPeriodExpense" xlink:type="locator" />
    <link:labelArc xlink:from="loc_PostemploymentBenefitsPeriodExpense.14432.11.7" xlink:to="lab_PostemploymentBenefitsPeriodExpense.219557.240323.256434" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_PostemploymentBenefitsPeriodExpense.219557.240323.256434" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US" id="lab_PostemploymentBenefitsPeriodExpense.219557.240323.256434">Severance expenses</link:label>
    <link:loc xlink:label="loc_ReclassFromResearchAndDevelopmentExpenseToCostOfRevenues.25652.11.6" xlink:href="psti-20140630.xsd#psti_ReclassFromResearchAndDevelopmentExpenseToCostOfRevenues" xlink:type="locator" />
    <link:labelArc xlink:from="loc_ReclassFromResearchAndDevelopmentExpenseToCostOfRevenues.25652.11.6" xlink:to="lab_ReclassFromResearchAndDevelopmentExpenseToCostOfRevenues.256388" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_ReclassFromResearchAndDevelopmentExpenseToCostOfRevenues.256388" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US" id="lab_ReclassFromResearchAndDevelopmentExpenseToCostOfRevenues.256388">Reclass From Research And Development Expense To Cost Of Revenues</link:label>
    <link:loc xlink:label="loc_RemainingDeferredRevenueRecognitionPeriodForIntangibleAsset.25653.11.6" xlink:href="psti-20140630.xsd#psti_RemainingDeferredRevenueRecognitionPeriodForIntangibleAsset" xlink:type="locator" />
    <link:labelArc xlink:from="loc_RemainingDeferredRevenueRecognitionPeriodForIntangibleAsset.25653.11.6" xlink:to="lab_RemainingDeferredRevenueRecognitionPeriodForIntangibleAsset.229818.256391" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_RemainingDeferredRevenueRecognitionPeriodForIntangibleAsset.229818.256391" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US" id="lab_RemainingDeferredRevenueRecognitionPeriodForIntangibleAsset.229818.256391">Remaining Deferred Revenue Recognition Period For Intangible Asset</link:label>
    <link:loc xlink:label="loc_RemainingDeferredRevenueRecognitionPeriodForIntangibleAsset.25653.11.12" xlink:href="psti-20140630.xsd#psti_RemainingDeferredRevenueRecognitionPeriodForIntangibleAsset" xlink:type="locator" />
    <link:labelArc xlink:from="loc_RemainingDeferredRevenueRecognitionPeriodForIntangibleAsset.25653.11.12" xlink:to="lab_RemainingDeferredRevenueRecognitionPeriodForIntangibleAsset12.229819.256392" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_RemainingDeferredRevenueRecognitionPeriodForIntangibleAsset12.229819.256392" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US" id="lab_RemainingDeferredRevenueRecognitionPeriodForIntangibleAsset12.229819.256392">Remaining Deferred Revenue Recognition Period from the license agreeement with united therapeutics.</link:label>
    <link:loc xlink:label="loc_RemainingDeferredRevenueRecognitionPeriodForIntangibleAsset.25653.11.7" xlink:href="psti-20140630.xsd#psti_RemainingDeferredRevenueRecognitionPeriodForIntangibleAsset" xlink:type="locator" />
    <link:labelArc xlink:from="loc_RemainingDeferredRevenueRecognitionPeriodForIntangibleAsset.25653.11.7" xlink:to="lab_RemainingDeferredRevenueRecognitionPeriodForIntangibleAsset7.229820.256393" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_RemainingDeferredRevenueRecognitionPeriodForIntangibleAsset7.229820.256393" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US" id="lab_RemainingDeferredRevenueRecognitionPeriodForIntangibleAsset7.229820.256393">Remaining revenue recognition period</link:label>
    <link:loc xlink:label="loc_ResearchAndDevelopmentArrangementWithFederalGovernmentCustomerFundingToOffsetCostsIncurred.15675.11.6" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ResearchAndDevelopmentArrangementWithFederalGovernmentCustomerFundingToOffsetCostsIncurred" xlink:type="locator" />
    <link:labelArc xlink:from="loc_ResearchAndDevelopmentArrangementWithFederalGovernmentCustomerFundingToOffsetCostsIncurred.15675.11.6" xlink:to="lab_ResearchAndDevelopmentArrangementWithFederalGovernmentCustomerFundingToOffsetCostsIncurred.16356" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_ResearchAndDevelopmentArrangementWithFederalGovernmentCustomerFundingToOffsetCostsIncurred.16356" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US" id="lab_ResearchAndDevelopmentArrangementWithFederalGovernmentCustomerFundingToOffsetCostsIncurred.16356">Research and Development Arrangement with Federal Government, Customer Funding to Offset Costs Incurred</link:label>
    <link:loc xlink:label="loc_ResearchAndDevelopmentArrangementWithFederalGovernmentCustomerFundingToOffsetCostsIncurred.15675.11.7" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ResearchAndDevelopmentArrangementWithFederalGovernmentCustomerFundingToOffsetCostsIncurred" xlink:type="locator" />
    <link:labelArc xlink:from="loc_ResearchAndDevelopmentArrangementWithFederalGovernmentCustomerFundingToOffsetCostsIncurred.15675.11.7" xlink:to="lab_ResearchAndDevelopmentArrangementWithFederalGovernmentCustomerFundingToOffsetCostsIncurred7.207941.292081.256431" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_ResearchAndDevelopmentArrangementWithFederalGovernmentCustomerFundingToOffsetCostsIncurred7.207941.292081.256431" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US" id="lab_ResearchAndDevelopmentArrangementWithFederalGovernmentCustomerFundingToOffsetCostsIncurred7.207941.292081.256431">Consideration received in funding arrangement</link:label>
    <link:loc xlink:label="loc_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable.4860.11.6" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:type="locator" />
    <link:labelArc xlink:from="loc_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable.4860.11.6" xlink:to="lab_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable.7669.254234.250721.255851" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable.7669.254234.250721.255851" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US" id="lab_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable.7669.254234.250721.255851">Schedule of Share-based Compensation Arrangements by Share-based Payment Award [Table]</link:label>
    <link:loc xlink:label="loc_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue.16620.11.6" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:type="locator" />
    <link:labelArc xlink:from="loc_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue.16620.11.6" xlink:to="lab_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue.17882" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue.17882" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US" id="lab_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue.17882">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period, Weighted Average Grant Date Fair Value</link:label>
    <link:loc xlink:label="loc_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems.5018.11.6" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:type="locator" />
    <link:labelArc xlink:from="loc_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems.5018.11.6" xlink:to="lab_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems.7668.254244.250722.255852" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems.7668.254244.250722.255852" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US" id="lab_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems.7668.254244.250722.255852">Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</link:label>
    <link:loc xlink:label="loc_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsForfeituresRate.25643.11.6" xlink:href="psti-20140630.xsd#psti_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsForfeituresRate" xlink:type="locator" />
    <link:labelArc xlink:from="loc_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsForfeituresRate.25643.11.6" xlink:to="lab_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsForfeituresRate.1872164.190029.256364" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsForfeituresRate.1872164.190029.256364" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US" id="lab_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsForfeituresRate.1872164.190029.256364">Sharebased Compensation Arrangement By Sharebased Payment Award Options Forfeitures Rate</link:label>
    <link:loc xlink:label="loc_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsForfeituresRate.25643.11.12" xlink:href="psti-20140630.xsd#psti_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsForfeituresRate" xlink:type="locator" />
    <link:labelArc xlink:from="loc_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsForfeituresRate.25643.11.12" xlink:to="lab_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsForfeituresRate.1872165.190031.256365" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsForfeituresRate.1872165.190031.256365" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US" id="lab_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsForfeituresRate.1872165.190031.256365">The forfeiture rate of options and shares granted to employees, directors and officers.</link:label>
    <link:loc xlink:label="loc_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsForfeituresRate.25643.11.7" xlink:href="psti-20140630.xsd#psti_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsForfeituresRate" xlink:type="locator" />
    <link:labelArc xlink:from="loc_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsForfeituresRate.25643.11.7" xlink:to="lab_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsForfeituresRate.1872166.190030.256366" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsForfeituresRate.1872166.190030.256366" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US" id="lab_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsForfeituresRate.1872166.190030.256366">Forfeiture rate</link:label>
    <link:loc xlink:label="loc_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain.5034.11.6" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:type="locator" />
    <link:labelArc xlink:from="loc_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain.5034.11.6" xlink:to="lab_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain.14534.254245.250757.255853" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain.14534.254245.250757.255853" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US" id="lab_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain.14534.254245.250757.255853">Share-based Compensation Arrangements by Share-based Payment Award, Award Type and Plan Name [Domain]</link:label>
    <link:loc xlink:label="loc_TitleOfIndividualAxis.5277.11.6" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_TitleOfIndividualAxis" xlink:type="locator" />
    <link:labelArc xlink:from="loc_TitleOfIndividualAxis.5277.11.6" xlink:to="lab_TitleOfIndividualAxis.18945" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_TitleOfIndividualAxis.18945" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US" id="lab_TitleOfIndividualAxis.18945">Title of Individual [Axis]</link:label>
    <link:loc xlink:label="loc_TitleOfIndividualWithRelationshipToEntityDomain.5279.11.6" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_TitleOfIndividualWithRelationshipToEntityDomain" xlink:type="locator" />
    <link:labelArc xlink:from="loc_TitleOfIndividualWithRelationshipToEntityDomain.5279.11.6" xlink:to="lab_TitleOfIndividualWithRelationshipToEntityDomain.18947" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_TitleOfIndividualWithRelationshipToEntityDomain.18947" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US" id="lab_TitleOfIndividualWithRelationshipToEntityDomain.18947">Relationship to Entity [Domain]</link:label>
    <link:loc xlink:label="loc_ReclassFromResearchAndDevelopmentExpenseToCostOfRevenues.25652.11.12" xlink:href="psti-20140630.xsd#psti_ReclassFromResearchAndDevelopmentExpenseToCostOfRevenues" xlink:type="locator" />
    <link:labelArc xlink:from="loc_ReclassFromResearchAndDevelopmentExpenseToCostOfRevenues.25652.11.12" xlink:to="ReclassFromResearchAndDevelopmentExpenseToCostOfRevenues.227489.256390" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="ReclassFromResearchAndDevelopmentExpenseToCostOfRevenues.227489.256390" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US" id="ReclassFromResearchAndDevelopmentExpenseToCostOfRevenues.227489.256390">The amount that was deducted from the adavance payment according to ASC 730-20.</link:label>
    <link:loc xlink:label="loc_ReclassFromResearchAndDevelopmentExpenseToCostOfRevenues.25652.11.7" xlink:href="psti-20140630.xsd#psti_ReclassFromResearchAndDevelopmentExpenseToCostOfRevenues" xlink:type="locator" />
    <link:labelArc xlink:from="loc_ReclassFromResearchAndDevelopmentExpenseToCostOfRevenues.25652.11.7" xlink:to="ReclassFromResearchAndDevelopmentExpenseToCostOfRevenues.227490.256389" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="ReclassFromResearchAndDevelopmentExpenseToCostOfRevenues.227490.256389" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US" id="ReclassFromResearchAndDevelopmentExpenseToCostOfRevenues.227490.256389">Total deduction from advanced payment</link:label>
    <link:loc xlink:label="loc_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue.16620.11.7" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:type="locator" />
    <link:labelArc xlink:from="loc_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue.16620.11.7" xlink:to="ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue.1858175.190042.256417" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue.1858175.190042.256417" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US" id="ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue.1858175.190042.256417">Granted, weighted-average grant date fair value</link:label>
    <link:loc xlink:label="loc_GainLossOnDerivativeInstrumentsNetPretax.10456.11.7" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_GainLossOnDerivativeInstrumentsNetPretax" xlink:type="locator" />
    <link:labelArc xlink:from="loc_GainLossOnDerivativeInstrumentsNetPretax.10456.11.7" xlink:to="us-gaap_GainLossOnDerivativeInstrumentsNetPretax_lbl.463392.318078.361139.256439" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="us-gaap_GainLossOnDerivativeInstrumentsNetPretax_lbl.463392.318078.361139.256439" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US" id="us-gaap_GainLossOnDerivativeInstrumentsNetPretax_lbl.463392.318078.361139.256439">Gains (losses) on other derivatives</link:label>
    <link:loc xlink:label="loc_LeaseholdImprovementsAnnualRateOfDepreciationDescription.25660.11.6" xlink:href="psti-20140630.xsd#psti_LeaseholdImprovementsAnnualRateOfDepreciationDescription" xlink:type="locator" />
    <link:labelArc xlink:from="loc_LeaseholdImprovementsAnnualRateOfDepreciationDescription.25660.11.6" xlink:to="lab_LeaseholdImprovementsAnnualRateOfDepreciationDescription.1872179.190043.256426" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_LeaseholdImprovementsAnnualRateOfDepreciationDescription.1872179.190043.256426" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US" id="lab_LeaseholdImprovementsAnnualRateOfDepreciationDescription.1872179.190043.256426">Leasehold Improvements Annual Rate Of Depreciation Description</link:label>
    <link:loc xlink:label="loc_LeaseholdImprovementsAnnualRateOfDepreciationDescription.25660.11.12" xlink:href="psti-20140630.xsd#psti_LeaseholdImprovementsAnnualRateOfDepreciationDescription" xlink:type="locator" />
    <link:labelArc xlink:from="loc_LeaseholdImprovementsAnnualRateOfDepreciationDescription.25660.11.12" xlink:to="lab_LeaseholdImprovementsAnnualRateOfDepreciationDescription.1872180.190045.256427" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_LeaseholdImprovementsAnnualRateOfDepreciationDescription.1872180.190045.256427" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US" id="lab_LeaseholdImprovementsAnnualRateOfDepreciationDescription.1872180.190045.256427">The depreciation description for leasehold improvements.</link:label>
    <link:loc xlink:label="loc_LeaseholdImprovementsAnnualRateOfDepreciationDescription.25660.11.7" xlink:href="psti-20140630.xsd#psti_LeaseholdImprovementsAnnualRateOfDepreciationDescription" xlink:type="locator" />
    <link:labelArc xlink:from="loc_LeaseholdImprovementsAnnualRateOfDepreciationDescription.25660.11.7" xlink:to="lab_LeaseholdImprovementsAnnualRateOfDepreciationDescription.1872181.190044.256428" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_LeaseholdImprovementsAnnualRateOfDepreciationDescription.1872181.190044.256428" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US" id="lab_LeaseholdImprovementsAnnualRateOfDepreciationDescription.1872181.190044.256428">Depreciation, leasehold</link:label>
    <link:loc xlink:label="loc_PropertyPlantAndEquipmentAnnualRateOfDepreciation.25659.11.6" xlink:href="psti-20140630.xsd#psti_PropertyPlantAndEquipmentAnnualRateOfDepreciation" xlink:type="locator" />
    <link:labelArc xlink:from="loc_PropertyPlantAndEquipmentAnnualRateOfDepreciation.25659.11.6" xlink:to="lab_PropertyPlantAndEquipmentAnnualRateOfDepreciation.1872176.190047.256423" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_PropertyPlantAndEquipmentAnnualRateOfDepreciation.1872176.190047.256423" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US" id="lab_PropertyPlantAndEquipmentAnnualRateOfDepreciation.1872176.190047.256423">Property Plant And Equipment Annual Rate Of Depreciation</link:label>
    <link:loc xlink:label="loc_PropertyPlantAndEquipmentAnnualRateOfDepreciation.25659.11.12" xlink:href="psti-20140630.xsd#psti_PropertyPlantAndEquipmentAnnualRateOfDepreciation" xlink:type="locator" />
    <link:labelArc xlink:from="loc_PropertyPlantAndEquipmentAnnualRateOfDepreciation.25659.11.12" xlink:to="lab_PropertyPlantAndEquipmentAnnualRateOfDepreciation.1872177.190049.256424" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_PropertyPlantAndEquipmentAnnualRateOfDepreciation.1872177.190049.256424" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US" id="lab_PropertyPlantAndEquipmentAnnualRateOfDepreciation.1872177.190049.256424">The depreciation rate applied annually using the straight-line method.</link:label>
    <link:loc xlink:label="loc_PropertyPlantAndEquipmentAnnualRateOfDepreciation.25659.11.7" xlink:href="psti-20140630.xsd#psti_PropertyPlantAndEquipmentAnnualRateOfDepreciation" xlink:type="locator" />
    <link:labelArc xlink:from="loc_PropertyPlantAndEquipmentAnnualRateOfDepreciation.25659.11.7" xlink:to="lab_PropertyPlantAndEquipmentAnnualRateOfDepreciation.1872178.190048.256425" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_PropertyPlantAndEquipmentAnnualRateOfDepreciation.1872178.190048.256425" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US" id="lab_PropertyPlantAndEquipmentAnnualRateOfDepreciation.1872178.190048.256425">Depreciation rate</link:label>
    <link:loc xlink:label="loc_ExercisePriceRangeFiveMember.25750.11.6" xlink:href="psti-20140630.xsd#psti_ExercisePriceRangeFiveMember" xlink:type="locator" />
    <link:labelArc xlink:from="loc_ExercisePriceRangeFiveMember.25750.11.6" xlink:to="lab_ExercisePriceRangeFiveMember.1901193.190232.257093" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_ExercisePriceRangeFiveMember.1901193.190232.257093" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US" id="lab_ExercisePriceRangeFiveMember.1901193.190232.257093">Exercise Price Range Five [Member]</link:label>
    <link:loc xlink:label="loc_ExercisePriceRangeFiveMember.25750.11.12" xlink:href="psti-20140630.xsd#psti_ExercisePriceRangeFiveMember" xlink:type="locator" />
    <link:labelArc xlink:from="loc_ExercisePriceRangeFiveMember.25750.11.12" xlink:to="lab_ExercisePriceRangeFiveMember.1901195.190234.257094" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_ExercisePriceRangeFiveMember.1901195.190234.257094" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US" id="lab_ExercisePriceRangeFiveMember.1901195.190234.257094">Exercise Price Range Five [Member].</link:label>
    <link:loc xlink:label="loc_ExercisePriceRangeFiveMember.25750.11.7" xlink:href="psti-20140630.xsd#psti_ExercisePriceRangeFiveMember" xlink:type="locator" />
    <link:labelArc xlink:from="loc_ExercisePriceRangeFiveMember.25750.11.7" xlink:to="lab_ExercisePriceRangeFiveMember.1901196.190233.257095" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_ExercisePriceRangeFiveMember.1901196.190233.257095" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US" id="lab_ExercisePriceRangeFiveMember.1901196.190233.257095">$1.80 [Member]</link:label>
    <link:loc xlink:label="loc_ExercisePriceRangeFourMember.25749.11.6" xlink:href="psti-20140630.xsd#psti_ExercisePriceRangeFourMember" xlink:type="locator" />
    <link:labelArc xlink:from="loc_ExercisePriceRangeFourMember.25749.11.6" xlink:to="lab_ExercisePriceRangeFourMember.1901189.190235.257090" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_ExercisePriceRangeFourMember.1901189.190235.257090" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US" id="lab_ExercisePriceRangeFourMember.1901189.190235.257090">Exercise Price Range Four [Member]</link:label>
    <link:loc xlink:label="loc_ExercisePriceRangeFourMember.25749.11.12" xlink:href="psti-20140630.xsd#psti_ExercisePriceRangeFourMember" xlink:type="locator" />
    <link:labelArc xlink:from="loc_ExercisePriceRangeFourMember.25749.11.12" xlink:to="lab_ExercisePriceRangeFourMember.1901191.190237.257091" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_ExercisePriceRangeFourMember.1901191.190237.257091" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US" id="lab_ExercisePriceRangeFourMember.1901191.190237.257091">Exercise Price Range Four [Member].</link:label>
    <link:loc xlink:label="loc_ExercisePriceRangeFourMember.25749.11.7" xlink:href="psti-20140630.xsd#psti_ExercisePriceRangeFourMember" xlink:type="locator" />
    <link:labelArc xlink:from="loc_ExercisePriceRangeFourMember.25749.11.7" xlink:to="lab_ExercisePriceRangeFourMember.1901192.190236.257092" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_ExercisePriceRangeFourMember.1901192.190236.257092" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US" id="lab_ExercisePriceRangeFourMember.1901192.190236.257092">$1.90 [Member]</link:label>
    <link:loc xlink:label="loc_ExercisePriceRangeOneMember.25746.11.6" xlink:href="psti-20140630.xsd#psti_ExercisePriceRangeOneMember" xlink:type="locator" />
    <link:labelArc xlink:from="loc_ExercisePriceRangeOneMember.25746.11.6" xlink:to="lab_ExercisePriceRangeOneMember.1901180.190238.257081" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_ExercisePriceRangeOneMember.1901180.190238.257081" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US" id="lab_ExercisePriceRangeOneMember.1901180.190238.257081">Exercise Price Range One [Member]</link:label>
    <link:loc xlink:label="loc_ExercisePriceRangeOneMember.25746.11.12" xlink:href="psti-20140630.xsd#psti_ExercisePriceRangeOneMember" xlink:type="locator" />
    <link:labelArc xlink:from="loc_ExercisePriceRangeOneMember.25746.11.12" xlink:to="lab_ExercisePriceRangeOneMember.1901181.190240.257082" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_ExercisePriceRangeOneMember.1901181.190240.257082" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US" id="lab_ExercisePriceRangeOneMember.1901181.190240.257082">Exercise Price Range One [Member].</link:label>
    <link:loc xlink:label="loc_ExercisePriceRangeOneMember.25746.11.7" xlink:href="psti-20140630.xsd#psti_ExercisePriceRangeOneMember" xlink:type="locator" />
    <link:labelArc xlink:from="loc_ExercisePriceRangeOneMember.25746.11.7" xlink:to="lab_ExercisePriceRangeOneMember.1901184.190239.257083" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_ExercisePriceRangeOneMember.1901184.190239.257083" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US" id="lab_ExercisePriceRangeOneMember.1901184.190239.257083">$1.40 [Member]</link:label>
    <link:loc xlink:label="loc_ExercisePriceRangeSevenMember.25752.11.6" xlink:href="psti-20140630.xsd#psti_ExercisePriceRangeSevenMember" xlink:type="locator" />
    <link:labelArc xlink:from="loc_ExercisePriceRangeSevenMember.25752.11.6" xlink:to="lab_ExercisePriceRangeSevenMember.1901206.190241.257099" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_ExercisePriceRangeSevenMember.1901206.190241.257099" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US" id="lab_ExercisePriceRangeSevenMember.1901206.190241.257099">Exercise Price Range Seven [Member]</link:label>
    <link:loc xlink:label="loc_ExercisePriceRangeSevenMember.25752.11.12" xlink:href="psti-20140630.xsd#psti_ExercisePriceRangeSevenMember" xlink:type="locator" />
    <link:labelArc xlink:from="loc_ExercisePriceRangeSevenMember.25752.11.12" xlink:to="lab_ExercisePriceRangeSevenMember.1901208.190243.257100" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_ExercisePriceRangeSevenMember.1901208.190243.257100" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US" id="lab_ExercisePriceRangeSevenMember.1901208.190243.257100">Exercise Price Range Seven [Member].</link:label>
    <link:loc xlink:label="loc_ExercisePriceRangeSevenMember.25752.11.7" xlink:href="psti-20140630.xsd#psti_ExercisePriceRangeSevenMember" xlink:type="locator" />
    <link:labelArc xlink:from="loc_ExercisePriceRangeSevenMember.25752.11.7" xlink:to="lab_ExercisePriceRangeSevenMember.1901210.190242.257101" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_ExercisePriceRangeSevenMember.1901210.190242.257101" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US" id="lab_ExercisePriceRangeSevenMember.1901210.190242.257101">$5.00 [Member]</link:label>
    <link:loc xlink:label="loc_ExercisePriceRangeSixMember.25751.11.6" xlink:href="psti-20140630.xsd#psti_ExercisePriceRangeSixMember" xlink:type="locator" />
    <link:labelArc xlink:from="loc_ExercisePriceRangeSixMember.25751.11.6" xlink:to="lab_ExercisePriceRangeSixMember.1901199.190244.257096" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_ExercisePriceRangeSixMember.1901199.190244.257096" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US" id="lab_ExercisePriceRangeSixMember.1901199.190244.257096">Exercise Price Range Six [Member]</link:label>
    <link:loc xlink:label="loc_ExercisePriceRangeSixMember.25751.11.12" xlink:href="psti-20140630.xsd#psti_ExercisePriceRangeSixMember" xlink:type="locator" />
    <link:labelArc xlink:from="loc_ExercisePriceRangeSixMember.25751.11.12" xlink:to="lab_ExercisePriceRangeSixMember.1901203.190246.257097" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_ExercisePriceRangeSixMember.1901203.190246.257097" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US" id="lab_ExercisePriceRangeSixMember.1901203.190246.257097">Exercise Price Range Six [Member].</link:label>
    <link:loc xlink:label="loc_ExercisePriceRangeSixMember.25751.11.7" xlink:href="psti-20140630.xsd#psti_ExercisePriceRangeSixMember" xlink:type="locator" />
    <link:labelArc xlink:from="loc_ExercisePriceRangeSixMember.25751.11.7" xlink:to="lab_ExercisePriceRangeSixMember.1901204.190245.257098" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_ExercisePriceRangeSixMember.1901204.190245.257098" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US" id="lab_ExercisePriceRangeSixMember.1901204.190245.257098">$4.20 [Member]</link:label>
    <link:loc xlink:label="loc_ExercisePriceRangeThreeMember.25748.11.6" xlink:href="psti-20140630.xsd#psti_ExercisePriceRangeThreeMember" xlink:type="locator" />
    <link:labelArc xlink:from="loc_ExercisePriceRangeThreeMember.25748.11.6" xlink:to="lab_ExercisePriceRangeThreeMember.1901186.190247.257087" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_ExercisePriceRangeThreeMember.1901186.190247.257087" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US" id="lab_ExercisePriceRangeThreeMember.1901186.190247.257087">Exercise Price Range Three [Member]</link:label>
    <link:loc xlink:label="loc_ExercisePriceRangeThreeMember.25748.11.12" xlink:href="psti-20140630.xsd#psti_ExercisePriceRangeThreeMember" xlink:type="locator" />
    <link:labelArc xlink:from="loc_ExercisePriceRangeThreeMember.25748.11.12" xlink:to="lab_ExercisePriceRangeThreeMember.1901187.190249.257088" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_ExercisePriceRangeThreeMember.1901187.190249.257088" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US" id="lab_ExercisePriceRangeThreeMember.1901187.190249.257088">Exercise Price Range Three [Member].</link:label>
    <link:loc xlink:label="loc_ExercisePriceRangeThreeMember.25748.11.7" xlink:href="psti-20140630.xsd#psti_ExercisePriceRangeThreeMember" xlink:type="locator" />
    <link:labelArc xlink:from="loc_ExercisePriceRangeThreeMember.25748.11.7" xlink:to="lab_ExercisePriceRangeThreeMember.1901188.190248.257089" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_ExercisePriceRangeThreeMember.1901188.190248.257089" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US" id="lab_ExercisePriceRangeThreeMember.1901188.190248.257089">$1.60 [Member]</link:label>
    <link:loc xlink:label="loc_ExercisePriceRangeTwelveMember.25745.11.6" xlink:href="psti-20140630.xsd#psti_ExercisePriceRangeTwelveMember" xlink:type="locator" />
    <link:labelArc xlink:from="loc_ExercisePriceRangeTwelveMember.25745.11.6" xlink:to="lab_ExercisePriceRangeTwelveMember.257079" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_ExercisePriceRangeTwelveMember.257079" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US" id="lab_ExercisePriceRangeTwelveMember.257079">Exercise Price Range Twelve [Member]</link:label>
    <link:loc xlink:label="loc_ExercisePriceRangeTwoMember.25747.11.6" xlink:href="psti-20140630.xsd#psti_ExercisePriceRangeTwoMember" xlink:type="locator" />
    <link:labelArc xlink:from="loc_ExercisePriceRangeTwoMember.25747.11.6" xlink:to="lab_ExercisePriceRangeTwoMember.1901182.190250.257084" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_ExercisePriceRangeTwoMember.1901182.190250.257084" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US" id="lab_ExercisePriceRangeTwoMember.1901182.190250.257084">Exercise Price Range Two [Member]</link:label>
    <link:loc xlink:label="loc_ExercisePriceRangeTwoMember.25747.11.12" xlink:href="psti-20140630.xsd#psti_ExercisePriceRangeTwoMember" xlink:type="locator" />
    <link:labelArc xlink:from="loc_ExercisePriceRangeTwoMember.25747.11.12" xlink:to="lab_ExercisePriceRangeTwoMember.1901183.190252.257085" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_ExercisePriceRangeTwoMember.1901183.190252.257085" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US" id="lab_ExercisePriceRangeTwoMember.1901183.190252.257085">Exercise Price Range Two [Member].</link:label>
    <link:loc xlink:label="loc_ExercisePriceRangeTwoMember.25747.11.7" xlink:href="psti-20140630.xsd#psti_ExercisePriceRangeTwoMember" xlink:type="locator" />
    <link:labelArc xlink:from="loc_ExercisePriceRangeTwoMember.25747.11.7" xlink:to="lab_ExercisePriceRangeTwoMember.1901185.190251.257086" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_ExercisePriceRangeTwoMember.1901185.190251.257086" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US" id="lab_ExercisePriceRangeTwoMember.1901185.190251.257086">$1.50 [Member]</link:label>
    <link:loc xlink:label="loc_OptionsExercisePriceRangeEightMember.25740.11.6" xlink:href="psti-20140630.xsd#psti_OptionsExercisePriceRangeEightMember" xlink:type="locator" />
    <link:labelArc xlink:from="loc_OptionsExercisePriceRangeEightMember.25740.11.6" xlink:to="lab_OptionsExercisePriceRangeEightMember.1901256.190253.257065" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_OptionsExercisePriceRangeEightMember.1901256.190253.257065" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US" id="lab_OptionsExercisePriceRangeEightMember.1901256.190253.257065">Options Exercise Price Range Eight [Member]</link:label>
    <link:loc xlink:label="loc_OptionsExercisePriceRangeEightMember.25740.11.12" xlink:href="psti-20140630.xsd#psti_OptionsExercisePriceRangeEightMember" xlink:type="locator" />
    <link:labelArc xlink:from="loc_OptionsExercisePriceRangeEightMember.25740.11.12" xlink:to="lab_OptionsExercisePriceRangeEightMember.1901257.190255.257066" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_OptionsExercisePriceRangeEightMember.1901257.190255.257066" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US" id="lab_OptionsExercisePriceRangeEightMember.1901257.190255.257066">Options Exercise Price Range Eight [Member].</link:label>
    <link:loc xlink:label="loc_OptionsExercisePriceRangeEightMember.25740.11.7" xlink:href="psti-20140630.xsd#psti_OptionsExercisePriceRangeEightMember" xlink:type="locator" />
    <link:labelArc xlink:from="loc_OptionsExercisePriceRangeEightMember.25740.11.7" xlink:to="lab_OptionsExercisePriceRangeEightMember.1901258.190254.257067" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_OptionsExercisePriceRangeEightMember.1901258.190254.257067" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US" id="lab_OptionsExercisePriceRangeEightMember.1901258.190254.257067">$4.38 to $4.40 [Member]</link:label>
    <link:loc xlink:label="loc_OptionsExercisePriceRangeElevenMember.25743.11.6" xlink:href="psti-20140630.xsd#psti_OptionsExercisePriceRangeElevenMember" xlink:type="locator" />
    <link:labelArc xlink:from="loc_OptionsExercisePriceRangeElevenMember.25743.11.6" xlink:to="lab_OptionsExercisePriceRangeElevenMember.1901265.190256.257074" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_OptionsExercisePriceRangeElevenMember.1901265.190256.257074" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US" id="lab_OptionsExercisePriceRangeElevenMember.1901265.190256.257074">Options Exercise Price Range Eleven [Member]</link:label>
    <link:loc xlink:label="loc_OptionsExercisePriceRangeElevenMember.25743.11.12" xlink:href="psti-20140630.xsd#psti_OptionsExercisePriceRangeElevenMember" xlink:type="locator" />
    <link:labelArc xlink:from="loc_OptionsExercisePriceRangeElevenMember.25743.11.12" xlink:to="lab_OptionsExercisePriceRangeElevenMember.1901266.190258.257075" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_OptionsExercisePriceRangeElevenMember.1901266.190258.257075" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US" id="lab_OptionsExercisePriceRangeElevenMember.1901266.190258.257075">Options Exercise Price Range Eleven [Member].</link:label>
    <link:loc xlink:label="loc_OptionsExercisePriceRangeElevenMember.25743.11.7" xlink:href="psti-20140630.xsd#psti_OptionsExercisePriceRangeElevenMember" xlink:type="locator" />
    <link:labelArc xlink:from="loc_OptionsExercisePriceRangeElevenMember.25743.11.7" xlink:to="lab_OptionsExercisePriceRangeElevenMember.1901267.190257.257076" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_OptionsExercisePriceRangeElevenMember.1901267.190257.257076" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US" id="lab_OptionsExercisePriceRangeElevenMember.1901267.190257.257076">$20.00 [Member]</link:label>
    <link:loc xlink:label="loc_OptionsExercisePriceRangeFiveMember.25737.11.6" xlink:href="psti-20140630.xsd#psti_OptionsExercisePriceRangeFiveMember" xlink:type="locator" />
    <link:labelArc xlink:from="loc_OptionsExercisePriceRangeFiveMember.25737.11.6" xlink:to="lab_OptionsExercisePriceRangeFiveMember.1901247.190259.257056" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_OptionsExercisePriceRangeFiveMember.1901247.190259.257056" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US" id="lab_OptionsExercisePriceRangeFiveMember.1901247.190259.257056">Options Exercise Price Range Five [Member]</link:label>
    <link:loc xlink:label="loc_OptionsExercisePriceRangeFiveMember.25737.11.12" xlink:href="psti-20140630.xsd#psti_OptionsExercisePriceRangeFiveMember" xlink:type="locator" />
    <link:labelArc xlink:from="loc_OptionsExercisePriceRangeFiveMember.25737.11.12" xlink:to="lab_OptionsExercisePriceRangeFiveMember.1901248.190261.257057" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_OptionsExercisePriceRangeFiveMember.1901248.190261.257057" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US" id="lab_OptionsExercisePriceRangeFiveMember.1901248.190261.257057">Options Exercise Price Range Five [Member].</link:label>
    <link:loc xlink:label="loc_OptionsExercisePriceRangeFiveMember.25737.11.7" xlink:href="psti-20140630.xsd#psti_OptionsExercisePriceRangeFiveMember" xlink:type="locator" />
    <link:labelArc xlink:from="loc_OptionsExercisePriceRangeFiveMember.25737.11.7" xlink:to="lab_OptionsExercisePriceRangeFiveMember.1901249.190260.257058" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_OptionsExercisePriceRangeFiveMember.1901249.190260.257058" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US" id="lab_OptionsExercisePriceRangeFiveMember.1901249.190260.257058">$3.50 [Member]</link:label>
    <link:loc xlink:label="loc_OptionsExercisePriceRangeFourMember.25736.11.6" xlink:href="psti-20140630.xsd#psti_OptionsExercisePriceRangeFourMember" xlink:type="locator" />
    <link:labelArc xlink:from="loc_OptionsExercisePriceRangeFourMember.25736.11.6" xlink:to="lab_OptionsExercisePriceRangeFourMember.1901244.190262.257053" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_OptionsExercisePriceRangeFourMember.1901244.190262.257053" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US" id="lab_OptionsExercisePriceRangeFourMember.1901244.190262.257053">Options Exercise Price Range Four [Member]</link:label>
    <link:loc xlink:label="loc_OptionsExercisePriceRangeFourMember.25736.11.12" xlink:href="psti-20140630.xsd#psti_OptionsExercisePriceRangeFourMember" xlink:type="locator" />
    <link:labelArc xlink:from="loc_OptionsExercisePriceRangeFourMember.25736.11.12" xlink:to="lab_OptionsExercisePriceRangeFourMember.1901245.190264.257054" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_OptionsExercisePriceRangeFourMember.1901245.190264.257054" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US" id="lab_OptionsExercisePriceRangeFourMember.1901245.190264.257054">Options Exercise Price Range Four [Member].</link:label>
    <link:loc xlink:label="loc_OptionsExercisePriceRangeFourMember.25736.11.7" xlink:href="psti-20140630.xsd#psti_OptionsExercisePriceRangeFourMember" xlink:type="locator" />
    <link:labelArc xlink:from="loc_OptionsExercisePriceRangeFourMember.25736.11.7" xlink:to="lab_OptionsExercisePriceRangeFourMember.1901246.190263.257055" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_OptionsExercisePriceRangeFourMember.1901246.190263.257055" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US" id="lab_OptionsExercisePriceRangeFourMember.1901246.190263.257055">$2.97 [Member]</link:label>
    <link:loc xlink:label="loc_OptionsExercisePriceRangeNineMember.25741.11.6" xlink:href="psti-20140630.xsd#psti_OptionsExercisePriceRangeNineMember" xlink:type="locator" />
    <link:labelArc xlink:from="loc_OptionsExercisePriceRangeNineMember.25741.11.6" xlink:to="lab_OptionsExercisePriceRangeNineMember.1901259.190265.257068" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_OptionsExercisePriceRangeNineMember.1901259.190265.257068" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US" id="lab_OptionsExercisePriceRangeNineMember.1901259.190265.257068">Options Exercise Price Range Nine [Member]</link:label>
    <link:loc xlink:label="loc_OptionsExercisePriceRangeNineMember.25741.11.12" xlink:href="psti-20140630.xsd#psti_OptionsExercisePriceRangeNineMember" xlink:type="locator" />
    <link:labelArc xlink:from="loc_OptionsExercisePriceRangeNineMember.25741.11.12" xlink:to="lab_OptionsExercisePriceRangeNineMember.1901260.190267.257069" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_OptionsExercisePriceRangeNineMember.1901260.190267.257069" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US" id="lab_OptionsExercisePriceRangeNineMember.1901260.190267.257069">Options Exercise Price Range Nine [Member].</link:label>
    <link:loc xlink:label="loc_OptionsExercisePriceRangeNineMember.25741.11.7" xlink:href="psti-20140630.xsd#psti_OptionsExercisePriceRangeNineMember" xlink:type="locator" />
    <link:labelArc xlink:from="loc_OptionsExercisePriceRangeNineMember.25741.11.7" xlink:to="lab_OptionsExercisePriceRangeNineMember.1901261.190266.257070" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_OptionsExercisePriceRangeNineMember.1901261.190266.257070" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US" id="lab_OptionsExercisePriceRangeNineMember.1901261.190266.257070">$6.80 [Member]</link:label>
    <link:loc xlink:label="loc_OptionsExercisePriceRangeOneMember.25733.11.6" xlink:href="psti-20140630.xsd#psti_OptionsExercisePriceRangeOneMember" xlink:type="locator" />
    <link:labelArc xlink:from="loc_OptionsExercisePriceRangeOneMember.25733.11.6" xlink:to="lab_OptionsExercisePriceRangeOneMember.1901235.190268.257044" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_OptionsExercisePriceRangeOneMember.1901235.190268.257044" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US" id="lab_OptionsExercisePriceRangeOneMember.1901235.190268.257044">Options Exercise Price Range One [Member]</link:label>
    <link:loc xlink:label="loc_OptionsExercisePriceRangeOneMember.25733.11.12" xlink:href="psti-20140630.xsd#psti_OptionsExercisePriceRangeOneMember" xlink:type="locator" />
    <link:labelArc xlink:from="loc_OptionsExercisePriceRangeOneMember.25733.11.12" xlink:to="lab_OptionsExercisePriceRangeOneMember.1901236.190270.257045" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_OptionsExercisePriceRangeOneMember.1901236.190270.257045" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US" id="lab_OptionsExercisePriceRangeOneMember.1901236.190270.257045">Options Exercise Price Range One [Member].</link:label>
    <link:loc xlink:label="loc_OptionsExercisePriceRangeOneMember.25733.11.7" xlink:href="psti-20140630.xsd#psti_OptionsExercisePriceRangeOneMember" xlink:type="locator" />
    <link:labelArc xlink:from="loc_OptionsExercisePriceRangeOneMember.25733.11.7" xlink:to="lab_OptionsExercisePriceRangeOneMember.1901237.190269.257046" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_OptionsExercisePriceRangeOneMember.1901237.190269.257046" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US" id="lab_OptionsExercisePriceRangeOneMember.1901237.190269.257046">$0.00 [Member]</link:label>
    <link:loc xlink:label="loc_OptionsExercisePriceRangeSevenMember.25739.11.6" xlink:href="psti-20140630.xsd#psti_OptionsExercisePriceRangeSevenMember" xlink:type="locator" />
    <link:labelArc xlink:from="loc_OptionsExercisePriceRangeSevenMember.25739.11.6" xlink:to="lab_OptionsExercisePriceRangeSevenMember.1901253.190271.257062" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_OptionsExercisePriceRangeSevenMember.1901253.190271.257062" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US" id="lab_OptionsExercisePriceRangeSevenMember.1901253.190271.257062">Options Exercise Price Range Seven [Member]</link:label>
    <link:loc xlink:label="loc_OptionsExercisePriceRangeSevenMember.25739.11.12" xlink:href="psti-20140630.xsd#psti_OptionsExercisePriceRangeSevenMember" xlink:type="locator" />
    <link:labelArc xlink:from="loc_OptionsExercisePriceRangeSevenMember.25739.11.12" xlink:to="lab_OptionsExercisePriceRangeSevenMember.1901254.190273.257063" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_OptionsExercisePriceRangeSevenMember.1901254.190273.257063" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US" id="lab_OptionsExercisePriceRangeSevenMember.1901254.190273.257063">Options Exercise Price Range Seven [Member].</link:label>
    <link:loc xlink:label="loc_OptionsExercisePriceRangeSevenMember.25739.11.7" xlink:href="psti-20140630.xsd#psti_OptionsExercisePriceRangeSevenMember" xlink:type="locator" />
    <link:labelArc xlink:from="loc_OptionsExercisePriceRangeSevenMember.25739.11.7" xlink:to="lab_OptionsExercisePriceRangeSevenMember.1901255.190272.257064" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_OptionsExercisePriceRangeSevenMember.1901255.190272.257064" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US" id="lab_OptionsExercisePriceRangeSevenMember.1901255.190272.257064">$4.00 [Member]</link:label>
    <link:loc xlink:label="loc_OptionsExercisePriceRangeSixMember.25738.11.6" xlink:href="psti-20140630.xsd#psti_OptionsExercisePriceRangeSixMember" xlink:type="locator" />
    <link:labelArc xlink:from="loc_OptionsExercisePriceRangeSixMember.25738.11.6" xlink:to="lab_OptionsExercisePriceRangeSixMember.1901250.190274.257059" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_OptionsExercisePriceRangeSixMember.1901250.190274.257059" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US" id="lab_OptionsExercisePriceRangeSixMember.1901250.190274.257059">Options Exercise Price Range Six [Member]</link:label>
    <link:loc xlink:label="loc_OptionsExercisePriceRangeSixMember.25738.11.12" xlink:href="psti-20140630.xsd#psti_OptionsExercisePriceRangeSixMember" xlink:type="locator" />
    <link:labelArc xlink:from="loc_OptionsExercisePriceRangeSixMember.25738.11.12" xlink:to="lab_OptionsExercisePriceRangeSixMember.1901251.190276.257060" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_OptionsExercisePriceRangeSixMember.1901251.190276.257060" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US" id="lab_OptionsExercisePriceRangeSixMember.1901251.190276.257060">Options Exercise Price Range Six [Member].</link:label>
    <link:loc xlink:label="loc_OptionsExercisePriceRangeSixMember.25738.11.7" xlink:href="psti-20140630.xsd#psti_OptionsExercisePriceRangeSixMember" xlink:type="locator" />
    <link:labelArc xlink:from="loc_OptionsExercisePriceRangeSixMember.25738.11.7" xlink:to="lab_OptionsExercisePriceRangeSixMember.1901252.190275.257061" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_OptionsExercisePriceRangeSixMember.1901252.190275.257061" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US" id="lab_OptionsExercisePriceRangeSixMember.1901252.190275.257061">$3.72 [Member]</link:label>
    <link:loc xlink:label="loc_OptionsExercisePriceRangeTenMember.25742.11.6" xlink:href="psti-20140630.xsd#psti_OptionsExercisePriceRangeTenMember" xlink:type="locator" />
    <link:labelArc xlink:from="loc_OptionsExercisePriceRangeTenMember.25742.11.6" xlink:to="lab_OptionsExercisePriceRangeTenMember.1901262.190277.257071" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_OptionsExercisePriceRangeTenMember.1901262.190277.257071" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US" id="lab_OptionsExercisePriceRangeTenMember.1901262.190277.257071">Options Exercise Price Range Ten [Member]</link:label>
    <link:loc xlink:label="loc_OptionsExercisePriceRangeTenMember.25742.11.12" xlink:href="psti-20140630.xsd#psti_OptionsExercisePriceRangeTenMember" xlink:type="locator" />
    <link:labelArc xlink:from="loc_OptionsExercisePriceRangeTenMember.25742.11.12" xlink:to="lab_OptionsExercisePriceRangeTenMember.1901263.190279.257072" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_OptionsExercisePriceRangeTenMember.1901263.190279.257072" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US" id="lab_OptionsExercisePriceRangeTenMember.1901263.190279.257072">Options Exercise Price Range Ten [Member].</link:label>
    <link:loc xlink:label="loc_OptionsExercisePriceRangeTenMember.25742.11.7" xlink:href="psti-20140630.xsd#psti_OptionsExercisePriceRangeTenMember" xlink:type="locator" />
    <link:labelArc xlink:from="loc_OptionsExercisePriceRangeTenMember.25742.11.7" xlink:to="lab_OptionsExercisePriceRangeTenMember.1901264.190278.257073" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_OptionsExercisePriceRangeTenMember.1901264.190278.257073" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US" id="lab_OptionsExercisePriceRangeTenMember.1901264.190278.257073">$8.20 [Member]</link:label>
    <link:loc xlink:label="loc_OptionsExercisePriceRangeThreeMember.25735.11.6" xlink:href="psti-20140630.xsd#psti_OptionsExercisePriceRangeThreeMember" xlink:type="locator" />
    <link:labelArc xlink:from="loc_OptionsExercisePriceRangeThreeMember.25735.11.6" xlink:to="lab_OptionsExercisePriceRangeThreeMember.1901241.190280.257050" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_OptionsExercisePriceRangeThreeMember.1901241.190280.257050" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US" id="lab_OptionsExercisePriceRangeThreeMember.1901241.190280.257050">Options Exercise Price Range Three [Member]</link:label>
    <link:loc xlink:label="loc_OptionsExercisePriceRangeThreeMember.25735.11.12" xlink:href="psti-20140630.xsd#psti_OptionsExercisePriceRangeThreeMember" xlink:type="locator" />
    <link:labelArc xlink:from="loc_OptionsExercisePriceRangeThreeMember.25735.11.12" xlink:to="lab_OptionsExercisePriceRangeThreeMember.1901242.190282.257051" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_OptionsExercisePriceRangeThreeMember.1901242.190282.257051" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US" id="lab_OptionsExercisePriceRangeThreeMember.1901242.190282.257051">Options Exercise Price Range Three [Member].</link:label>
    <link:loc xlink:label="loc_OptionsExercisePriceRangeThreeMember.25735.11.7" xlink:href="psti-20140630.xsd#psti_OptionsExercisePriceRangeThreeMember" xlink:type="locator" />
    <link:labelArc xlink:from="loc_OptionsExercisePriceRangeThreeMember.25735.11.7" xlink:to="lab_OptionsExercisePriceRangeThreeMember.1901243.190281.257052" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_OptionsExercisePriceRangeThreeMember.1901243.190281.257052" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US" id="lab_OptionsExercisePriceRangeThreeMember.1901243.190281.257052">$1.04 [Member]</link:label>
    <link:loc xlink:label="loc_OptionsExercisePriceRangeTwoMember.25734.11.6" xlink:href="psti-20140630.xsd#psti_OptionsExercisePriceRangeTwoMember" xlink:type="locator" />
    <link:labelArc xlink:from="loc_OptionsExercisePriceRangeTwoMember.25734.11.6" xlink:to="lab_OptionsExercisePriceRangeTwoMember.1901238.190283.257047" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_OptionsExercisePriceRangeTwoMember.1901238.190283.257047" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US" id="lab_OptionsExercisePriceRangeTwoMember.1901238.190283.257047">Options Exercise Price Range Two [Member]</link:label>
    <link:loc xlink:label="loc_OptionsExercisePriceRangeTwoMember.25734.11.12" xlink:href="psti-20140630.xsd#psti_OptionsExercisePriceRangeTwoMember" xlink:type="locator" />
    <link:labelArc xlink:from="loc_OptionsExercisePriceRangeTwoMember.25734.11.12" xlink:to="lab_OptionsExercisePriceRangeTwoMember.1901239.190285.257048" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_OptionsExercisePriceRangeTwoMember.1901239.190285.257048" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US" id="lab_OptionsExercisePriceRangeTwoMember.1901239.190285.257048">Options Exercise Price Range Two [Member].</link:label>
    <link:loc xlink:label="loc_OptionsExercisePriceRangeTwoMember.25734.11.7" xlink:href="psti-20140630.xsd#psti_OptionsExercisePriceRangeTwoMember" xlink:type="locator" />
    <link:labelArc xlink:from="loc_OptionsExercisePriceRangeTwoMember.25734.11.7" xlink:to="lab_OptionsExercisePriceRangeTwoMember.1901240.190284.257049" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_OptionsExercisePriceRangeTwoMember.1901240.190284.257049" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US" id="lab_OptionsExercisePriceRangeTwoMember.1901240.190284.257049">$0.62 [Member]</link:label>
    <link:loc xlink:label="loc_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice.16713.11.7" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:type="locator" />
    <link:labelArc xlink:from="loc_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice.16713.11.7" xlink:to="lab_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice.1900579.190287.257129" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice.1900579.190287.257129" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US" id="lab_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice.1900579.190287.257129">Exercise Price per Share</link:label>
    <link:loc xlink:label="loc_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis.5031.11.6" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis" xlink:type="locator" />
    <link:labelArc xlink:from="loc_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis.5031.11.6" xlink:to="lab_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis.7616.190288.257133" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis.7616.190288.257133" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US" id="lab_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis.7616.190288.257133">Share-based Compensation, Shares Authorized under Stock Option Plans, by Exercise Price Range [Axis]</link:label>
    <link:loc xlink:label="loc_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain.5032.11.6" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain" xlink:type="locator" />
    <link:labelArc xlink:from="loc_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain.5032.11.6" xlink:to="lab_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain.13507.190289.257126" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain.13507.190289.257126" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US" id="lab_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain.13507.190289.257126">Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range [Domain]</link:label>
    <link:loc xlink:label="loc_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit.16758.11.6" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit" xlink:type="locator" />
    <link:labelArc xlink:from="loc_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit.16758.11.6" xlink:to="lab_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit.18072" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit.18072" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US" id="lab_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit.18072">Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range, Lower Range Limit</link:label>
    <link:loc xlink:label="loc_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit.16758.11.7" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit" xlink:type="locator" />
    <link:labelArc xlink:from="loc_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit.16758.11.7" xlink:to="lab_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit7.208448.194458.257468" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit7.208448.194458.257468" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US" id="lab_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit7.208448.194458.257468">Exercise Price per Share, minimum</link:label>
    <link:loc xlink:label="loc_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions.16744.11.6" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions" xlink:type="locator" />
    <link:labelArc xlink:from="loc_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions.16744.11.6" xlink:to="lab_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions.18054" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions.18054" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US" id="lab_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions.18054">Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range, Number of Exercisable Options</link:label>
    <link:loc xlink:label="loc_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions.16744.11.7" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions" xlink:type="locator" />
    <link:labelArc xlink:from="loc_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions.16744.11.7" xlink:to="lab_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions.208441.194460.257471" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions.208441.194460.257471" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US" id="lab_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions.208441.194460.257471">Options and Warrants Exercisable</link:label>
    <link:loc xlink:label="loc_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions.16742.11.6" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions" xlink:type="locator" />
    <link:labelArc xlink:from="loc_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions.16742.11.6" xlink:to="lab_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions.18050" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions.18050" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US" id="lab_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions.18050">Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range, Number of Outstanding Options</link:label>
    <link:loc xlink:label="loc_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions.16742.11.7" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions" xlink:type="locator" />
    <link:labelArc xlink:from="loc_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions.16742.11.7" xlink:to="lab_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions.208438.194462.257470" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions.208438.194462.257470" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US" id="lab_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions.208438.194462.257470">Options and Warrants for Common Stock</link:label>
    <link:loc xlink:label="loc_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit.16750.11.6" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit" xlink:type="locator" />
    <link:labelArc xlink:from="loc_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit.16750.11.6" xlink:to="lab_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit.18064" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit.18064" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US" id="lab_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit.18064">Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range, Upper Range Limit</link:label>
    <link:loc xlink:label="loc_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit.16750.11.7" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit" xlink:type="locator" />
    <link:labelArc xlink:from="loc_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit.16750.11.7" xlink:to="lab_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit.208449.194468.257469" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit.208449.194468.257469" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US" id="lab_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit.208449.194468.257469">Exercise Price per Share, maximum</link:label>
    <link:loc xlink:label="loc_StockholdersEquityNoteLineItems.25553.11.6" xlink:href="psti-20140630.xsd#psti_StockholdersEquityNoteLineItems" xlink:type="locator" />
    <link:labelArc xlink:from="loc_StockholdersEquityNoteLineItems.25553.11.6" xlink:to="lab_StockholdersEquityNoteLineItems.1921953.254174.250914.255994" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_StockholdersEquityNoteLineItems.1921953.254174.250914.255994" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US" id="lab_StockholdersEquityNoteLineItems.1921953.254174.250914.255994">Stockholders Equity Note [Line Items]</link:label>
    <link:loc xlink:label="loc_StockholdersEquityNoteLineItems.25553.11.12" xlink:href="psti-20140630.xsd#psti_StockholdersEquityNoteLineItems" xlink:type="locator" />
    <link:labelArc xlink:from="loc_StockholdersEquityNoteLineItems.25553.11.12" xlink:to="lab_StockholdersEquityNoteLineItems.1921954.254175.250915.255995" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_StockholdersEquityNoteLineItems.1921954.254175.250915.255995" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US" id="lab_StockholdersEquityNoteLineItems.1921954.254175.250915.255995">Stockholders' Equity Note [Line Items].</link:label>
    <link:loc xlink:label="loc_StockholdersEquityNoteTable.25554.11.6" xlink:href="psti-20140630.xsd#psti_StockholdersEquityNoteTable" xlink:type="locator" />
    <link:labelArc xlink:from="loc_StockholdersEquityNoteTable.25554.11.6" xlink:to="lab_StockholdersEquityNoteTable.1921949.254176.250916.255996" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_StockholdersEquityNoteTable.1921949.254176.250916.255996" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US" id="lab_StockholdersEquityNoteTable.1921949.254176.250916.255996">Stockholders Equity Note [Table]</link:label>
    <link:loc xlink:label="loc_StockholdersEquityNoteTable.25554.11.12" xlink:href="psti-20140630.xsd#psti_StockholdersEquityNoteTable" xlink:type="locator" />
    <link:labelArc xlink:from="loc_StockholdersEquityNoteTable.25554.11.12" xlink:to="lab_StockholdersEquityNoteTable.1921950.254177.250917.255997" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_StockholdersEquityNoteTable.1921950.254177.250917.255997" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US" id="lab_StockholdersEquityNoteTable.1921950.254177.250917.255997">Stockholders' Equity Note [Table].</link:label>
    <link:loc xlink:label="loc_ExercisePriceRangeTwelveMember.25745.11.7" xlink:href="psti-20140630.xsd#psti_ExercisePriceRangeTwelveMember" xlink:type="locator" />
    <link:labelArc xlink:from="loc_ExercisePriceRangeTwelveMember.25745.11.7" xlink:to="lab_StringOneMember.257467" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_StringOneMember.257467" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US" id="lab_StringOneMember.257467">$3.80 [Member]</link:label>
    <link:loc xlink:label="loc_WarrantMember.5496.11.6" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_WarrantMember" xlink:type="locator" />
    <link:labelArc xlink:from="loc_WarrantMember.5496.11.6" xlink:to="lab_WarrantMember.19605" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_WarrantMember.19605" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US" id="lab_WarrantMember.19605">Warrant [Member]</link:label>
    <link:loc xlink:label="loc_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber.16626.11.7" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:type="locator" />
    <link:labelArc xlink:from="loc_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber.16626.11.7" xlink:to="ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber.1900590.190293.257132" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber.1900590.190293.257132" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US" id="ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber.1900590.190293.257132">Restricted stock not included in summary of options and warrants</link:label>
    <link:loc xlink:label="loc_AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember.484.11.6" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember" xlink:type="locator" />
    <link:labelArc xlink:from="loc_AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember.484.11.6" xlink:to="lab_AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember.259754" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember.259754" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US" id="lab_AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember.259754">Unrealized Gains on Cash Flow Hedges [Member]</link:label>
    <link:loc xlink:label="loc_AccumulatedNetUnrealizedInvestmentGainLossMember.477.11.6" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_AccumulatedNetUnrealizedInvestmentGainLossMember" xlink:type="locator" />
    <link:labelArc xlink:from="loc_AccumulatedNetUnrealizedInvestmentGainLossMember.477.11.6" xlink:to="lab_AccumulatedNetUnrealizedInvestmentGainLossMember.315453.259750" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_AccumulatedNetUnrealizedInvestmentGainLossMember.315453.259750" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US" id="lab_AccumulatedNetUnrealizedInvestmentGainLossMember.315453.259750">Unrealized Gains on Marketable Securities [Member]</link:label>
    <link:loc xlink:label="loc_AccumulatedOtherComprehensiveIncomeLossLineItems.486.11.6" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems" xlink:type="locator" />
    <link:labelArc xlink:from="loc_AccumulatedOtherComprehensiveIncomeLossLineItems.486.11.6" xlink:to="lab_AccumulatedOtherComprehensiveIncomeLossLineItems.625.259749" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_AccumulatedOtherComprehensiveIncomeLossLineItems.625.259749" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US" id="lab_AccumulatedOtherComprehensiveIncomeLossLineItems.625.259749">Accumulated Other Comprehensive Income (Loss) [Line Items]</link:label>
    <link:loc xlink:label="loc_AccumulatedOtherComprehensiveIncomeLossNetOfTax.5715.11.10" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:type="locator" />
    <link:labelArc xlink:from="loc_AccumulatedOtherComprehensiveIncomeLossNetOfTax.5715.11.10" xlink:to="lab_AccumulatedOtherComprehensiveIncomeLossNetOfTax.315457.259742" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_AccumulatedOtherComprehensiveIncomeLossNetOfTax.315457.259742" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xml:lang="en-US" id="lab_AccumulatedOtherComprehensiveIncomeLossNetOfTax.315457.259742">Beginning balance</link:label>
    <link:loc xlink:label="loc_AccumulatedOtherComprehensiveIncomeLossNetOfTax.5715.11.11" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:type="locator" />
    <link:labelArc xlink:from="loc_AccumulatedOtherComprehensiveIncomeLossNetOfTax.5715.11.11" xlink:to="lab_AccumulatedOtherComprehensiveIncomeLossNetOfTax.315461.259745" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_AccumulatedOtherComprehensiveIncomeLossNetOfTax.315461.259745" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xml:lang="en-US" id="lab_AccumulatedOtherComprehensiveIncomeLossNetOfTax.315461.259745">Ending balance</link:label>
    <link:loc xlink:label="loc_AccumulatedOtherComprehensiveIncomeLossTable.487.11.6" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossTable" xlink:type="locator" />
    <link:labelArc xlink:from="loc_AccumulatedOtherComprehensiveIncomeLossTable.487.11.6" xlink:to="lab_AccumulatedOtherComprehensiveIncomeLossTable.626.259753" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_AccumulatedOtherComprehensiveIncomeLossTable.626.259753" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US" id="lab_AccumulatedOtherComprehensiveIncomeLossTable.626.259753">Accumulated Other Comprehensive Income (Loss) [Table]</link:label>
    <link:loc xlink:label="loc_EquityComponentDomain.1898.11.6" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_EquityComponentDomain" xlink:type="locator" />
    <link:labelArc xlink:from="loc_EquityComponentDomain.1898.11.6" xlink:to="lab_EquityComponentDomain.14420.253948.250782.255722" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_EquityComponentDomain.14420.253948.250782.255722" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US" id="lab_EquityComponentDomain.14420.253948.250782.255722">Equity Component [Domain]</link:label>
    <link:loc xlink:label="loc_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax.13608.11.6" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" xlink:type="locator" />
    <link:labelArc xlink:from="loc_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax.13608.11.6" xlink:to="lab_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax.13074" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax.13074" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US" id="lab_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax.13074">Other Comprehensive Income (Loss), before Reclassifications, Net of Tax</link:label>
    <link:loc xlink:label="loc_OtherComprehensiveIncomeLossNetOfTax.13526.11.6" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTax" xlink:type="locator" />
    <link:labelArc xlink:from="loc_OtherComprehensiveIncomeLossNetOfTax.13526.11.6" xlink:to="lab_OtherComprehensiveIncomeLossNetOfTax.12468.250814.255678" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_OtherComprehensiveIncomeLossNetOfTax.12468.250814.255678" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US" id="lab_OtherComprehensiveIncomeLossNetOfTax.12468.250814.255678">Other Comprehensive Income (Loss), Net of Tax</link:label>
    <link:loc xlink:label="loc_OtherComprehensiveIncomeLossNetOfTax.13526.11.9" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTax" xlink:type="locator" />
    <link:labelArc xlink:from="loc_OtherComprehensiveIncomeLossNetOfTax.13526.11.9" xlink:to="lab_OtherComprehensiveIncomeLossNetOfTax.256449.255677" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_OtherComprehensiveIncomeLossNetOfTax.256449.255677" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US" id="lab_OtherComprehensiveIncomeLossNetOfTax.256449.255677">Net current-period other comprehensive income</link:label>
    <link:loc xlink:label="loc_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax.15390.11.6" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" xlink:type="locator" />
    <link:labelArc xlink:from="loc_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax.15390.11.6" xlink:to="lab_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax.15917" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax.15917" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US" id="lab_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax.15917">Reclassification from Accumulated Other Comprehensive Income, Current Period, Net of Tax</link:label>
    <link:loc xlink:label="loc_StatementEquityComponentsAxis.5114.11.6" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_StatementEquityComponentsAxis" xlink:type="locator" />
    <link:labelArc xlink:from="loc_StatementEquityComponentsAxis.5114.11.6" xlink:to="lab_StatementEquityComponentsAxis.11418.253980.250817.255726" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="lab_StatementEquityComponentsAxis.11418.253980.250817.255726" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US" id="lab_StatementEquityComponentsAxis.11418.253980.250817.255726">Statement, Equity Components [Axis]</link:label>
    <link:loc xlink:label="loc_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax.13608.11.7" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" xlink:type="locator" />
    <link:labelArc xlink:from="loc_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax.13608.11.7" xlink:to="OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax.315458.259743" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax.315458.259743" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US" id="OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax.315458.259743">Other comprehensive income before reclassifications</link:label>
    <link:loc xlink:label="loc_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax.15390.11.53" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" xlink:type="locator" />
    <link:labelArc xlink:from="loc_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax.15390.11.53" xlink:to="ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax.315459.259744" order="1" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:type="arc" />
    <link:label xlink:label="ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax.315459.259744" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xml:lang="en-US" id="ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax.315459.259744">Amounts reclassified from accumulated other comprehensive loss</link:label>
  </link:labelLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>29
<FILENAME>psti-20140630_pre.xml
<DESCRIPTION>AXONOMY EXTENSION PRESENTATION LINKBASE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" standalone="no"?>
<!--Created by Z-K Global Ltd. ("ZKG")-->
<!--produced on 2014-09-10 @ 8:21 AM-->
<link:linkbase xmlns:psti="http://www.pluristem.com/20140630" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" xmlns:link="http://www.xbrl.org/2003/linkbase">
  <link:roleRef roleURI="http://www.pluristem.com/role/SignificantAccountingPolicies" xlink:href="psti-20140630.xsd#psti-sap1" xlink:type="simple" />
  <link:roleRef roleURI="http://www.pluristem.com/role/CommitmentsAndContingencies" xlink:href="psti-20140630.xsd#psti-cac1" xlink:type="simple" />
  <link:roleRef roleURI="http://www.pluristem.com/role/CommitmentsAndContingenciesOtherDetails" xlink:href="psti-20140630.xsd#psti-cacod" xlink:type="simple" />
  <link:roleRef roleURI="http://www.pluristem.com/role/ConsolidatedBalanceSheets" xlink:href="psti-20140630.xsd#psti-cbs1" xlink:type="simple" />
  <link:roleRef roleURI="http://www.pluristem.com/role/ConsolidatedBalanceSheetsParenthetical" xlink:href="psti-20140630.xsd#psti-cbsp1" xlink:type="simple" />
  <link:roleRef roleURI="http://www.pluristem.com/role/ConsolidatedStatementsOfCashFlows" xlink:href="psti-20140630.xsd#psti-csocf1" xlink:type="simple" />
  <link:roleRef roleURI="http://www.pluristem.com/role/ConsolidatedStatementsOfComprehensiveLoss" xlink:href="psti-20140630.xsd#psti-csocl1" xlink:type="simple" />
  <link:roleRef roleURI="http://www.pluristem.com/role/ConsolidatedStatementsOfOperations" xlink:href="psti-20140630.xsd#psti-csoo1" xlink:type="simple" />
  <link:roleRef roleURI="http://www.pluristem.com/role/StatementsOfChangesInEquity" xlink:href="psti-20140630.xsd#psti-socie1" xlink:type="simple" />
  <link:roleRef roleURI="http://www.pluristem.com/role/StatementsOfChangesInEquityParenthetical" xlink:href="psti-20140630.xsd#psti-sociep1" xlink:type="simple" />
  <link:roleRef roleURI="http://www.pluristem.com/role/FairValueOfFinancialInstruments" xlink:href="psti-20140630.xsd#psti-fvofi12" xlink:type="simple" />
  <link:roleRef roleURI="http://www.pluristem.com/role/FairValueOfFinancialInstrumentsScheduleOfFairValueOfFinancialInstrumentsDetails" xlink:href="psti-20140630.xsd#psti-fvofisofvofid1" xlink:type="simple" />
  <link:roleRef roleURI="http://www.pluristem.com/role/FairValueOfFinancialInstrumentsScheduleOfFairValueOfHedgingInstrumentsDetails" xlink:href="psti-20140630.xsd#psti-fvofisofvohid" xlink:type="simple" />
  <link:roleRef roleURI="http://www.pluristem.com/role/FairValueOfFinancialInstrumentsTables" xlink:href="psti-20140630.xsd#psti-fvofit1" xlink:type="simple" />
  <link:roleRef roleURI="http://www.pluristem.com/role/General" xlink:href="psti-20140630.xsd#psti-g1" xlink:type="simple" />
  <link:roleRef roleURI="http://www.pluristem.com/role/GeneralDetails" xlink:href="psti-20140630.xsd#psti-gd" xlink:type="simple" />
  <link:roleRef roleURI="http://www.pluristem.com/role/MarketableSecurities" xlink:href="psti-20140630.xsd#psti-ms" xlink:type="simple" />
  <link:roleRef roleURI="http://www.pluristem.com/role/MarketableSecuritiesScheduleOfAvailableforsaleMarketableSecuritiesDetails" xlink:href="psti-20140630.xsd#psti-mssoamsd1" xlink:type="simple" />
  <link:roleRef roleURI="http://www.pluristem.com/role/MarketableSecuritiesScheduleOfInvestmentsInUnrealizedLossDetails" xlink:href="psti-20140630.xsd#psti-mssoiiuld" xlink:type="simple" />
  <link:roleRef roleURI="http://www.pluristem.com/role/MarketableSecuritiesTables" xlink:href="psti-20140630.xsd#psti-mst1" xlink:type="simple" />
  <link:roleRef roleURI="http://www.pluristem.com/role/SubsequentEvents" xlink:href="psti-20140630.xsd#psti-se123" xlink:type="simple" />
  <link:roleRef roleURI="http://www.pluristem.com/role/StockholdersEquity" xlink:href="psti-20140630.xsd#psti-se12" xlink:type="simple" />
  <link:roleRef roleURI="http://www.pluristem.com/role/SubsequentEventsDetails" xlink:href="psti-20140630.xsd#psti-sed1" xlink:type="simple" />
  <link:roleRef roleURI="http://www.pluristem.com/role/StockholdersEquityNarrativeDetails" xlink:href="psti-20140630.xsd#psti-send1" xlink:type="simple" />
  <link:roleRef roleURI="http://www.pluristem.com/role/StockholdersEquityScheduleOfCompensationExpenseDetails" xlink:href="psti-20140630.xsd#psti-sesoced1" xlink:type="simple" />
  <link:roleRef roleURI="http://www.pluristem.com/role/StockholdersEquitySummaryOfOptionActivityDetails" xlink:href="psti-20140630.xsd#psti-sesooad1" xlink:type="simple" />
  <link:roleRef roleURI="http://www.pluristem.com/role/StockholdersEquitySummaryOfOptionAndWarrantActivityToNonemployeesDetails" xlink:href="psti-20140630.xsd#psti-sesooawatnd1" xlink:type="simple" />
  <link:roleRef roleURI="http://www.pluristem.com/role/StockholdersEquitySummaryOfRsuActivityToConsultantsDetails" xlink:href="psti-20140630.xsd#psti-sesoratcd1" xlink:type="simple" />
  <link:roleRef roleURI="http://www.pluristem.com/role/StockholdersEquitySummaryOfRsuActivityToEmployeesAndDirectorsDetails" xlink:href="psti-20140630.xsd#psti-sesorateadd1" xlink:type="simple" />
  <link:roleRef roleURI="http://www.pluristem.com/role/StockholdersEquityTables" xlink:href="psti-20140630.xsd#psti-set1" xlink:type="simple" />
  <link:roleRef roleURI="http://www.pluristem.com/role/PropertyAndEquipmentNet" xlink:href="psti-20140630.xsd#psti-paen1" xlink:type="simple" />
  <link:roleRef roleURI="http://www.pluristem.com/role/PropertyAndEquipmentNetTables" xlink:href="psti-20140630.xsd#psti-paent1" xlink:type="simple" />
  <link:roleRef roleURI="http://www.pluristem.com/role/PropertyAndEquipmentNetDetails" xlink:href="psti-20140630.xsd#psti-paend1" xlink:type="simple" />
  <link:roleRef roleURI="http://www.pluristem.com/role/OtherAccountsPayable" xlink:href="psti-20140630.xsd#psti-oap1" xlink:type="simple" />
  <link:roleRef roleURI="http://www.pluristem.com/role/FinancialIncomeNet" xlink:href="psti-20140630.xsd#psti-fin" xlink:type="simple" />
  <link:roleRef roleURI="http://www.pluristem.com/role/TaxesOnIncome" xlink:href="psti-20140630.xsd#psti-toi1" xlink:type="simple" />
  <link:roleRef roleURI="http://www.pluristem.com/role/CommitmentsAndContingenciesTables" xlink:href="psti-20140630.xsd#psti-cact1" xlink:type="simple" />
  <link:roleRef roleURI="http://www.pluristem.com/role/FinancialIncomeNetTables" xlink:href="psti-20140630.xsd#psti-fint" xlink:type="simple" />
  <link:roleRef roleURI="http://www.pluristem.com/role/TaxesOnIncomeTables" xlink:href="psti-20140630.xsd#psti-toit1" xlink:type="simple" />
  <link:roleRef roleURI="http://www.pluristem.com/role/OtherAccountsPayableTables" xlink:href="psti-20140630.xsd#psti-oapt1" xlink:type="simple" />
  <link:roleRef roleURI="http://www.pluristem.com/role/OtherAccountsPayableDetails" xlink:href="psti-20140630.xsd#psti-oapd1" xlink:type="simple" />
  <link:roleRef roleURI="http://www.pluristem.com/role/CommitmentsAndContingenciesOperatingLeaseDetails" xlink:href="psti-20140630.xsd#psti-cacold1" xlink:type="simple" />
  <link:roleRef roleURI="http://www.pluristem.com/role/CommitmentsAndContingenciesCommitmentToSuppliersAndContractorDetails" xlink:href="psti-20140630.xsd#psti-cacctsacd1" xlink:type="simple" />
  <link:roleRef roleURI="http://www.pluristem.com/role/FinancialIncomeNetDetails" xlink:href="psti-20140630.xsd#psti-find" xlink:type="simple" />
  <link:roleRef roleURI="http://www.pluristem.com/role/TaxesOnIncomeNarrativeDetails" xlink:href="psti-20140630.xsd#psti-toind1" xlink:type="simple" />
  <link:roleRef roleURI="http://www.pluristem.com/role/TaxesOnIncomeQualifyingPercentagesOfValueOfProductiveAssetsDetails" xlink:href="psti-20140630.xsd#psti-toiqpovopad1" xlink:type="simple" />
  <link:roleRef roleURI="http://www.pluristem.com/role/TaxesOnIncomeScheduleOfSignificantComponentsOfDeferredTaxAssetsDetails" xlink:href="psti-20140630.xsd#psti-toisoscodtad1" xlink:type="simple" />
  <link:roleRef roleURI="http://www.pluristem.com/role/SignificantAccountingPoliciesPolicies" xlink:href="psti-20140630.xsd#psti-sapp1" xlink:type="simple" />
  <link:roleRef roleURI="http://www.pluristem.com/role/SignificantAccountingPoliciesTables" xlink:href="psti-20140630.xsd#psti-sapt1" xlink:type="simple" />
  <link:roleRef roleURI="http://www.pluristem.com/role/DocumentAndEntityInformation" xlink:href="psti-20140630.xsd#psti-daei1" xlink:type="simple" />
  <link:roleRef roleURI="http://www.pluristem.com/role/SignificantAccountingPoliciesNarrativeDetails" xlink:href="psti-20140630.xsd#psti-sapnd1" xlink:type="simple" />
  <link:roleRef roleURI="http://www.pluristem.com/role/SignificantAccountingPoliciesScheduleOfPropertyAndEquipmentDepreciationRateDetails" xlink:href="psti-20140630.xsd#psti-sapsopaedrd1" xlink:type="simple" />
  <link:roleRef roleURI="http://www.pluristem.com/role/StockholdersEquitySummaryOfWarrantsAndOptionsDetails" xlink:href="psti-20140630.xsd#psti-sesowaod" xlink:type="simple" />
  <link:roleRef roleURI="http://www.pluristem.com/role/SignificantAccountingPoliciesComprehensiveIncomeDetails" xlink:href="psti-20140630.xsd#psti-sapcid" xlink:type="simple" />
  <link:presentationLink xlink:title="102 - Disclosure - SIGNIFICANT ACCOUNTING POLICIES" xlink:role="http://www.pluristem.com/role/SignificantAccountingPolicies" xlink:type="extended">
    <link:loc xlink:label="loc_AccountingPoliciesAbstract.425.12.7" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_AccountingPoliciesAbstract" xlink:type="locator" />
    <link:loc xlink:label="loc_SignificantAccountingPoliciesTextBlock.16839.12.7" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_SignificantAccountingPoliciesTextBlock" xlink:type="locator" />
    <link:presentationArc xlink:from="loc_AccountingPoliciesAbstract.425.12.7" xlink:to="loc_SignificantAccountingPoliciesTextBlock.16839.12.7" order="1.00000" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </link:presentationLink>
  <link:presentationLink xlink:title="107 - Disclosure - COMMITMENTS AND CONTINGENCIES" xlink:role="http://www.pluristem.com/role/CommitmentsAndContingencies" xlink:type="extended">
    <link:loc xlink:label="loc_CommitmentsAndContingenciesDisclosureAbstract.1107.12.7" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:type="locator" />
    <link:loc xlink:label="loc_CommitmentsAndContingenciesDisclosureTextBlock.7041.12.7" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:type="locator" />
    <link:presentationArc xlink:from="loc_CommitmentsAndContingenciesDisclosureAbstract.1107.12.7" xlink:to="loc_CommitmentsAndContingenciesDisclosureTextBlock.7041.12.7" order="1.00000" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </link:presentationLink>
  <link:presentationLink xlink:title="40703 - Disclosure - COMMITMENTS AND CONTINGENCIES (Other) (Details)" xlink:role="http://www.pluristem.com/role/CommitmentsAndContingenciesOtherDetails" xlink:type="extended">
    <link:loc xlink:label="loc_CommitmentsAndContingenciesDisclosureAbstract.1107.12.6" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:type="locator" />
    <link:loc xlink:label="loc_OtherCommitmentsTable.3714.12.6" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_OtherCommitmentsTable" xlink:type="locator" />
    <link:presentationArc xlink:from="loc_CommitmentsAndContingenciesDisclosureAbstract.1107.12.6" xlink:to="loc_OtherCommitmentsTable.3714.12.6" order="1.00000" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" />
    <link:loc xlink:label="loc_RangeAxis.4349.12.6" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_RangeAxis" xlink:type="locator" />
    <link:presentationArc xlink:from="loc_OtherCommitmentsTable.3714.12.6" xlink:to="loc_RangeAxis.4349.12.6" order="1.00000" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" />
    <link:loc xlink:label="loc_OtherCommitmentsLineItems.3716.12.6" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_OtherCommitmentsLineItems" xlink:type="locator" />
    <link:presentationArc xlink:from="loc_OtherCommitmentsTable.3714.12.6" xlink:to="loc_OtherCommitmentsLineItems.3716.12.6" order="2.00000" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" />
    <link:loc xlink:label="loc_OtherCommitmentsLineItems.3716.12.7" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_OtherCommitmentsLineItems" xlink:type="locator" />
    <link:loc xlink:label="loc_IncreaseDecreaseInSecurityDeposits.11316.12.7" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_IncreaseDecreaseInSecurityDeposits" xlink:type="locator" />
    <link:presentationArc xlink:from="loc_OtherCommitmentsLineItems.3716.12.7" xlink:to="loc_IncreaseDecreaseInSecurityDeposits.11316.12.7" order="1.00000" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:label="loc_RoyaltyRateSales.25546.12.7" xlink:href="psti-20140630.xsd#psti_RoyaltyRateSales" xlink:type="locator" />
    <link:presentationArc xlink:from="loc_OtherCommitmentsLineItems.3716.12.7" xlink:to="loc_RoyaltyRateSales.25546.12.7" order="3.00000" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:label="loc_RoyaltyRatePayableOnGrantsReceived.25545.12.7" xlink:href="psti-20140630.xsd#psti_RoyaltyRatePayableOnGrantsReceived" xlink:type="locator" />
    <link:presentationArc xlink:from="loc_OtherCommitmentsLineItems.3716.12.7" xlink:to="loc_RoyaltyRatePayableOnGrantsReceived.25545.12.7" order="4.00000" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:label="loc_RoyaltyGuaranteesCommitmentsAmount.15952.12.7" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_RoyaltyGuaranteesCommitmentsAmount" xlink:type="locator" />
    <link:presentationArc xlink:from="loc_OtherCommitmentsLineItems.3716.12.7" xlink:to="loc_RoyaltyGuaranteesCommitmentsAmount.15952.12.7" order="6.00000" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:label="loc_RoyaltiesAmountPaidAndAccrued.25544.12.7" xlink:href="psti-20140630.xsd#psti_RoyaltiesAmountPaidAndAccrued" xlink:type="locator" />
    <link:presentationArc xlink:from="loc_OtherCommitmentsLineItems.3716.12.7" xlink:to="loc_RoyaltiesAmountPaidAndAccrued.25544.12.7" order="5.00000" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:label="loc_AggregateGrantsReceived.25524.12.7" xlink:href="psti-20140630.xsd#psti_AggregateGrantsReceived" xlink:type="locator" />
    <link:presentationArc xlink:from="loc_OtherCommitmentsLineItems.3716.12.7" xlink:to="loc_AggregateGrantsReceived.25524.12.7" order="2.50000" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:label="loc_PercentageOfQualifiedExpenditures.25580.12.7" xlink:href="psti-20140630.xsd#psti_PercentageOfQualifiedExpenditures" xlink:type="locator" />
    <link:presentationArc xlink:from="loc_OtherCommitmentsLineItems.3716.12.7" xlink:to="loc_PercentageOfQualifiedExpenditures.25580.12.7" order="2.75000" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:label="loc_RangeMember.4350.12.6" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_RangeMember" xlink:type="locator" />
    <link:presentationArc xlink:from="loc_RangeAxis.4349.12.6" xlink:to="loc_RangeMember.4350.12.6" order="1.00000" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" />
    <link:loc xlink:label="loc_MinimumMember.3370.12.6" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_MinimumMember" xlink:type="locator" />
    <link:presentationArc xlink:from="loc_RangeMember.4350.12.6" xlink:to="loc_MinimumMember.3370.12.6" order="1.00000" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" />
    <link:loc xlink:label="loc_MaximumMember.3361.12.6" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_MaximumMember" xlink:type="locator" />
    <link:presentationArc xlink:from="loc_RangeMember.4350.12.6" xlink:to="loc_MaximumMember.3361.12.6" order="2.00000" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" />
  </link:presentationLink>
  <link:presentationLink xlink:title="002 - Statement - CONSOLIDATED BALANCE SHEETS" xlink:role="http://www.pluristem.com/role/ConsolidatedBalanceSheets" xlink:type="extended">
    <link:loc xlink:label="loc_AssetsCurrentAbstract.628.12.7" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_AssetsCurrentAbstract" xlink:type="locator" />
    <link:loc xlink:label="loc_CashAndCashEquivalentsAtCarryingValue.6761.12.7" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:type="locator" />
    <link:presentationArc xlink:from="loc_AssetsCurrentAbstract.628.12.7" xlink:to="loc_CashAndCashEquivalentsAtCarryingValue.6761.12.7" order="1.00000" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:label="loc_AssetsCurrentAbstract.628.12.9" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_AssetsCurrentAbstract" xlink:type="locator" />
    <link:loc xlink:label="loc_AssetsCurrent.6017.12.9" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_AssetsCurrent" xlink:type="locator" />
    <link:presentationArc xlink:from="loc_AssetsCurrentAbstract.628.12.9" xlink:to="loc_AssetsCurrent.6017.12.9" order="6.00000" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
    <link:loc xlink:label="loc_MarketableSecuritiesCurrent.12849.12.7" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_MarketableSecuritiesCurrent" xlink:type="locator" />
    <link:presentationArc xlink:from="loc_AssetsCurrentAbstract.628.12.7" xlink:to="loc_MarketableSecuritiesCurrent.12849.12.7" order="2.50000" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:label="loc_ShortTermInvestments.16790.12.7" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ShortTermInvestments" xlink:type="locator" />
    <link:presentationArc xlink:from="loc_AssetsCurrentAbstract.628.12.7" xlink:to="loc_ShortTermInvestments.16790.12.7" order="2.25000" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:label="loc_RestrictedCashAndCashEquivalentsAtCarryingValue.15718.12.7" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_RestrictedCashAndCashEquivalentsAtCarryingValue" xlink:type="locator" />
    <link:presentationArc xlink:from="loc_AssetsCurrentAbstract.628.12.7" xlink:to="loc_RestrictedCashAndCashEquivalentsAtCarryingValue.15718.12.7" order="2.37500" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:label="loc_OtherAssetsCurrent.13702.12.7" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_OtherAssetsCurrent" xlink:type="locator" />
    <link:presentationArc xlink:from="loc_AssetsCurrentAbstract.628.12.7" xlink:to="loc_OtherAssetsCurrent.13702.12.7" order="4.25000" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:label="loc_AccountsReceivableNetCurrent.5600.12.7" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_AccountsReceivableNetCurrent" xlink:type="locator" />
    <link:presentationArc xlink:from="loc_AssetsCurrentAbstract.628.12.7" xlink:to="loc_AccountsReceivableNetCurrent.5600.12.7" order="3.37500" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:label="loc_AssetsAbstract.631.12.7" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_AssetsAbstract" xlink:type="locator" />
    <link:presentationArc xlink:from="loc_AssetsAbstract.631.12.7" xlink:to="loc_AssetsCurrentAbstract.628.12.7" order="1.00000" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:label="loc_AssetsNoncurrentAbstract.641.12.7" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_AssetsNoncurrentAbstract" xlink:type="locator" />
    <link:presentationArc xlink:from="loc_AssetsAbstract.631.12.7" xlink:to="loc_AssetsNoncurrentAbstract.641.12.7" order="2.00000" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:label="loc_AssetsAbstract.631.12.9" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_AssetsAbstract" xlink:type="locator" />
    <link:loc xlink:label="loc_Assets.5987.12.9" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_Assets" xlink:type="locator" />
    <link:presentationArc xlink:from="loc_AssetsAbstract.631.12.9" xlink:to="loc_Assets.5987.12.9" order="3.00000" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
    <link:loc xlink:label="loc_PropertyPlantAndEquipmentNet.15032.12.7" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet" xlink:type="locator" />
    <link:presentationArc xlink:from="loc_AssetsNoncurrentAbstract.641.12.7" xlink:to="loc_PropertyPlantAndEquipmentNet.15032.12.7" order="3.00000" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:label="loc_AssetsNoncurrentAbstract.641.12.9" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_AssetsNoncurrentAbstract" xlink:type="locator" />
    <link:loc xlink:label="loc_AssetsNoncurrent.6012.12.9" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_AssetsNoncurrent" xlink:type="locator" />
    <link:presentationArc xlink:from="loc_AssetsNoncurrentAbstract.641.12.9" xlink:to="loc_AssetsNoncurrent.6012.12.9" order="4.00000" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
    <link:loc xlink:label="loc_OtherAssetsNoncurrent.13645.12.7" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_OtherAssetsNoncurrent" xlink:type="locator" />
    <link:presentationArc xlink:from="loc_AssetsNoncurrentAbstract.641.12.7" xlink:to="loc_OtherAssetsNoncurrent.13645.12.7" order="3.37500" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:label="loc_DefinedBenefitPlanAssetsForPlanBenefitsNoncurrent.8166.12.7" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_DefinedBenefitPlanAssetsForPlanBenefitsNoncurrent" xlink:type="locator" />
    <link:presentationArc xlink:from="loc_AssetsNoncurrentAbstract.641.12.7" xlink:to="loc_DefinedBenefitPlanAssetsForPlanBenefitsNoncurrent.8166.12.7" order="2.75000" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:label="loc_LongTermInvestments.12613.12.7" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_LongTermInvestments" xlink:type="locator" />
    <link:presentationArc xlink:from="loc_AssetsNoncurrentAbstract.641.12.7" xlink:to="loc_LongTermInvestments.12613.12.7" order="1.87500" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:label="loc_EquityAbstract.1881.12.7" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_EquityAbstract" xlink:type="locator" />
    <link:loc xlink:label="loc_CommonStockValue.7048.12.7" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_CommonStockValue" xlink:type="locator" />
    <link:presentationArc xlink:from="loc_EquityAbstract.1881.12.7" xlink:to="loc_CommonStockValue.7048.12.7" order="1.00000" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:label="loc_AdditionalPaidInCapital.5750.12.7" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_AdditionalPaidInCapital" xlink:type="locator" />
    <link:presentationArc xlink:from="loc_EquityAbstract.1881.12.7" xlink:to="loc_AdditionalPaidInCapital.5750.12.7" order="2.00000" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:label="loc_EquityAbstract.1881.12.9" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_EquityAbstract" xlink:type="locator" />
    <link:loc xlink:label="loc_StockholdersEquity.17019.12.9" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_StockholdersEquity" xlink:type="locator" />
    <link:presentationArc xlink:from="loc_EquityAbstract.1881.12.9" xlink:to="loc_StockholdersEquity.17019.12.9" order="4.00000" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
    <link:loc xlink:label="loc_RetainedEarningsAccumulatedDeficit.15840.12.7" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_RetainedEarningsAccumulatedDeficit" xlink:type="locator" />
    <link:presentationArc xlink:from="loc_EquityAbstract.1881.12.7" xlink:to="loc_RetainedEarningsAccumulatedDeficit.15840.12.7" order="3.50000" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:label="loc_AccumulatedOtherComprehensiveIncomeLossNetOfTax.5715.12.7" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:type="locator" />
    <link:presentationArc xlink:from="loc_EquityAbstract.1881.12.7" xlink:to="loc_AccumulatedOtherComprehensiveIncomeLossNetOfTax.5715.12.7" order="3.75000" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:label="loc_LiabilitiesCurrentAbstract.3044.12.7" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_LiabilitiesCurrentAbstract" xlink:type="locator" />
    <link:loc xlink:label="loc_AccountsPayableCurrent.5620.12.7" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_AccountsPayableCurrent" xlink:type="locator" />
    <link:presentationArc xlink:from="loc_LiabilitiesCurrentAbstract.3044.12.7" xlink:to="loc_AccountsPayableCurrent.5620.12.7" order="1.00000" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:label="loc_AccruedLiabilitiesCurrent.5698.12.7" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_AccruedLiabilitiesCurrent" xlink:type="locator" />
    <link:presentationArc xlink:from="loc_LiabilitiesCurrentAbstract.3044.12.7" xlink:to="loc_AccruedLiabilitiesCurrent.5698.12.7" order="2.00000" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:label="loc_AccountsPayableOtherCurrent.5626.12.7" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_AccountsPayableOtherCurrent" xlink:type="locator" />
    <link:presentationArc xlink:from="loc_LiabilitiesCurrentAbstract.3044.12.7" xlink:to="loc_AccountsPayableOtherCurrent.5626.12.7" order="3.00000" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:label="loc_LiabilitiesCurrentAbstract.3044.12.9" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_LiabilitiesCurrentAbstract" xlink:type="locator" />
    <link:loc xlink:label="loc_LiabilitiesCurrent.12001.12.9" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_LiabilitiesCurrent" xlink:type="locator" />
    <link:presentationArc xlink:from="loc_LiabilitiesCurrentAbstract.3044.12.9" xlink:to="loc_LiabilitiesCurrent.12001.12.9" order="4.00000" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
    <link:loc xlink:label="loc_DeferredRevenueCurrent.7829.12.7" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_DeferredRevenueCurrent" xlink:type="locator" />
    <link:presentationArc xlink:from="loc_LiabilitiesCurrentAbstract.3044.12.7" xlink:to="loc_DeferredRevenueCurrent.7829.12.7" order="2.50000" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:label="loc_CustomerAdvancesCurrent.7446.12.7" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_CustomerAdvancesCurrent" xlink:type="locator" />
    <link:presentationArc xlink:from="loc_LiabilitiesCurrentAbstract.3044.12.7" xlink:to="loc_CustomerAdvancesCurrent.7446.12.7" order="2.75000" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:label="loc_LiabilitiesNoncurrentAbstract.3048.12.9" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_LiabilitiesNoncurrentAbstract" xlink:type="locator" />
    <link:loc xlink:label="loc_LiabilitiesNoncurrent.12040.12.9" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_LiabilitiesNoncurrent" xlink:type="locator" />
    <link:presentationArc xlink:from="loc_LiabilitiesNoncurrentAbstract.3048.12.9" xlink:to="loc_LiabilitiesNoncurrent.12040.12.9" order="3.00000" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
    <link:loc xlink:label="loc_LiabilitiesNoncurrentAbstract.3048.12.7" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_LiabilitiesNoncurrentAbstract" xlink:type="locator" />
    <link:loc xlink:label="loc_PostemploymentBenefitsLiabilityNoncurrent.14433.12.7" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_PostemploymentBenefitsLiabilityNoncurrent" xlink:type="locator" />
    <link:presentationArc xlink:from="loc_LiabilitiesNoncurrentAbstract.3048.12.7" xlink:to="loc_PostemploymentBenefitsLiabilityNoncurrent.14433.12.7" order="2.00000" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:label="loc_DeferredRevenueNoncurrent.7842.12.7" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_DeferredRevenueNoncurrent" xlink:type="locator" />
    <link:presentationArc xlink:from="loc_LiabilitiesNoncurrentAbstract.3048.12.7" xlink:to="loc_DeferredRevenueNoncurrent.7842.12.7" order="1.00000" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:label="loc_OtherLiabilitiesNoncurrent.13846.12.7" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_OtherLiabilitiesNoncurrent" xlink:type="locator" />
    <link:presentationArc xlink:from="loc_LiabilitiesNoncurrentAbstract.3048.12.7" xlink:to="loc_OtherLiabilitiesNoncurrent.13846.12.7" order="2.50000" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:label="loc_LiabilitiesAndStockholdersEquityAbstract.3052.12.7" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:type="locator" />
    <link:presentationArc xlink:from="loc_LiabilitiesAndStockholdersEquityAbstract.3052.12.7" xlink:to="loc_LiabilitiesCurrentAbstract.3044.12.7" order="1.00000" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:from="loc_LiabilitiesAndStockholdersEquityAbstract.3052.12.7" xlink:to="loc_LiabilitiesNoncurrentAbstract.3048.12.7" order="2.00000" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:from="loc_LiabilitiesAndStockholdersEquityAbstract.3052.12.7" xlink:to="loc_EquityAbstract.1881.12.7" order="3.00000" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:label="loc_LiabilitiesAndStockholdersEquityAbstract.3052.12.9" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:type="locator" />
    <link:loc xlink:label="loc_LiabilitiesAndStockholdersEquity.12012.12.9" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquity" xlink:type="locator" />
    <link:presentationArc xlink:from="loc_LiabilitiesAndStockholdersEquityAbstract.3052.12.9" xlink:to="loc_LiabilitiesAndStockholdersEquity.12012.12.9" order="4.00000" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
    <link:loc xlink:label="loc_CommitmentsAndContingencies.7037.12.7" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_CommitmentsAndContingencies" xlink:type="locator" />
    <link:presentationArc xlink:from="loc_LiabilitiesAndStockholdersEquityAbstract.3052.12.7" xlink:to="loc_CommitmentsAndContingencies.7037.12.7" order="2.50000" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:label="loc_StatementOfFinancialPositionAbstract.5115.12.7" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_StatementOfFinancialPositionAbstract" xlink:type="locator" />
    <link:presentationArc xlink:from="loc_StatementOfFinancialPositionAbstract.5115.12.7" xlink:to="loc_AssetsAbstract.631.12.7" order="1.00000" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:from="loc_StatementOfFinancialPositionAbstract.5115.12.7" xlink:to="loc_LiabilitiesAndStockholdersEquityAbstract.3052.12.7" order="2.00000" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </link:presentationLink>
  <link:presentationLink xlink:title="003 - Statement - CONSOLIDATED BALANCE SHEETS (PARENTHETICAL)" xlink:role="http://www.pluristem.com/role/ConsolidatedBalanceSheetsParenthetical" xlink:type="extended">
    <link:loc xlink:label="loc_StatementOfFinancialPositionAbstract.5115.12.7" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_StatementOfFinancialPositionAbstract" xlink:type="locator" />
    <link:loc xlink:label="loc_CommonStockParOrStatedValuePerShare.7045.12.7" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_CommonStockParOrStatedValuePerShare" xlink:type="locator" />
    <link:presentationArc xlink:from="loc_StatementOfFinancialPositionAbstract.5115.12.7" xlink:to="loc_CommonStockParOrStatedValuePerShare.7045.12.7" order="1.00000" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:label="loc_CommonStockSharesAuthorized.7058.12.7" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_CommonStockSharesAuthorized" xlink:type="locator" />
    <link:presentationArc xlink:from="loc_StatementOfFinancialPositionAbstract.5115.12.7" xlink:to="loc_CommonStockSharesAuthorized.7058.12.7" order="2.00000" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:label="loc_CommonStockSharesIssued.7050.12.7" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_CommonStockSharesIssued" xlink:type="locator" />
    <link:presentationArc xlink:from="loc_StatementOfFinancialPositionAbstract.5115.12.7" xlink:to="loc_CommonStockSharesIssued.7050.12.7" order="3.00000" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:label="loc_CommonStockSharesOutstanding.7078.12.7" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_CommonStockSharesOutstanding" xlink:type="locator" />
    <link:presentationArc xlink:from="loc_StatementOfFinancialPositionAbstract.5115.12.7" xlink:to="loc_CommonStockSharesOutstanding.7078.12.7" order="4.00000" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </link:presentationLink>
  <link:presentationLink xlink:title="008 - Statement - CONSOLIDATED STATEMENTS OF CASH FLOWS" xlink:role="http://www.pluristem.com/role/ConsolidatedStatementsOfCashFlows" xlink:type="extended">
    <link:loc xlink:label="loc_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract.517.12.7" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:type="locator" />
    <link:loc xlink:label="loc_Depreciation.8242.12.7" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_Depreciation" xlink:type="locator" />
    <link:presentationArc xlink:from="loc_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract.517.12.7" xlink:to="loc_Depreciation.8242.12.7" order="1.00000" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:label="loc_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract.517.12.53" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:type="locator" />
    <link:loc xlink:label="loc_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets.11312.12.53" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:type="locator" />
    <link:presentationArc xlink:from="loc_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract.517.12.53" xlink:to="loc_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets.11312.12.53" order="12.00000" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
    <link:loc xlink:label="loc_IncreaseDecreaseInAccountsPayable.11150.12.7" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsPayable" xlink:type="locator" />
    <link:presentationArc xlink:from="loc_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract.517.12.7" xlink:to="loc_IncreaseDecreaseInAccountsPayable.11150.12.7" order="13.00000" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:label="loc_MarketableSecuritiesRealizedGainLoss.12843.12.53" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_MarketableSecuritiesRealizedGainLoss" xlink:type="locator" />
    <link:presentationArc xlink:from="loc_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract.517.12.53" xlink:to="loc_MarketableSecuritiesRealizedGainLoss.12843.12.53" order="5.27000" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
    <link:loc xlink:label="loc_IncreaseDecreaseInPensionAndPostretirementObligations.11356.12.7" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_IncreaseDecreaseInPensionAndPostretirementObligations" xlink:type="locator" />
    <link:presentationArc xlink:from="loc_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract.517.12.7" xlink:to="loc_IncreaseDecreaseInPensionAndPostretirementObligations.11356.12.7" order="28.00000" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:label="loc_AmortizationOfDiscountAndPremiumAndChangesInAccruedInterestFromMarketableSecurities.25526.12.7" xlink:href="psti-20140630.xsd#psti_AmortizationOfDiscountAndPremiumAndChangesInAccruedInterestFromMarketableSecurities" xlink:type="locator" />
    <link:presentationArc xlink:from="loc_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract.517.12.7" xlink:to="loc_AmortizationOfDiscountAndPremiumAndChangesInAccruedInterestFromMarketableSecurities.25526.12.7" order="5.26000" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:label="loc_IncreaseDecreaseInDeferredRevenue.11220.12.7" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_IncreaseDecreaseInDeferredRevenue" xlink:type="locator" />
    <link:presentationArc xlink:from="loc_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract.517.12.7" xlink:to="loc_IncreaseDecreaseInDeferredRevenue.11220.12.7" order="15.00000" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:label="loc_IncreaseDecreaseInCustomerAdvances.11211.12.7" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_IncreaseDecreaseInCustomerAdvances" xlink:type="locator" />
    <link:presentationArc xlink:from="loc_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract.517.12.7" xlink:to="loc_IncreaseDecreaseInCustomerAdvances.11211.12.7" order="16.00000" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:label="loc_IncreaseDecreaseInOtherReceivables.11257.12.53" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_IncreaseDecreaseInOtherReceivables" xlink:type="locator" />
    <link:presentationArc xlink:from="loc_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract.517.12.53" xlink:to="loc_IncreaseDecreaseInOtherReceivables.11257.12.53" order="11.00000" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
    <link:loc xlink:label="loc_LinkageDifferencesAndInterestOnShortAndLongTermRestrictedLeaseDeposit.25541.12.7" xlink:href="psti-20140630.xsd#psti_LinkageDifferencesAndInterestOnShortAndLongTermRestrictedLeaseDeposit" xlink:type="locator" />
    <link:presentationArc xlink:from="loc_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract.517.12.7" xlink:to="loc_LinkageDifferencesAndInterestOnShortAndLongTermRestrictedLeaseDeposit.25541.12.7" order="22.00000" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:label="loc_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract.517.12.9" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:type="locator" />
    <link:loc xlink:label="loc_NetCashProvidedByUsedInOperatingActivitiesContinuingOperations.13087.12.9" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperations" xlink:type="locator" />
    <link:presentationArc xlink:from="loc_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract.517.12.9" xlink:to="loc_NetCashProvidedByUsedInOperatingActivitiesContinuingOperations.13087.12.9" order="30.00000" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
    <link:loc xlink:label="loc_ShareBasedCompensation.16630.12.7" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ShareBasedCompensation" xlink:type="locator" />
    <link:presentationArc xlink:from="loc_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract.517.12.7" xlink:to="loc_ShareBasedCompensation.16630.12.7" order="9.50000" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:label="loc_IssuanceOfStockAndWarrantsForServicesOrClaims.11880.12.7" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_IssuanceOfStockAndWarrantsForServicesOrClaims" xlink:type="locator" />
    <link:presentationArc xlink:from="loc_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract.517.12.7" xlink:to="loc_IssuanceOfStockAndWarrantsForServicesOrClaims.11880.12.7" order="9.75000" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:label="loc_GainLossOnSaleOfPropertyPlantEquipment.10522.12.53" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_GainLossOnSaleOfPropertyPlantEquipment" xlink:type="locator" />
    <link:presentationArc xlink:from="loc_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract.517.12.53" xlink:to="loc_GainLossOnSaleOfPropertyPlantEquipment.10522.12.53" order="5.25000" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
    <link:loc xlink:label="loc_IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities.11250.12.7" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities" xlink:type="locator" />
    <link:presentationArc xlink:from="loc_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract.517.12.7" xlink:to="loc_IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities.11250.12.7" order="14.50000" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:label="loc_IncreaseDecreaseInAccruedInterestReceivableNet.11204.12.53" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_IncreaseDecreaseInAccruedInterestReceivableNet" xlink:type="locator" />
    <link:presentationArc xlink:from="loc_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract.517.12.53" xlink:to="loc_IncreaseDecreaseInAccruedInterestReceivableNet.11204.12.53" order="19.00000" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
    <link:loc xlink:label="loc_IncreaseDecreaseInAccountsReceivable.11117.12.53" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:type="locator" />
    <link:presentationArc xlink:from="loc_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract.517.12.53" xlink:to="loc_IncreaseDecreaseInAccountsReceivable.11117.12.53" order="11.50000" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
    <link:loc xlink:label="loc_NetCashProvidedByUsedInFinancingActivitiesAbstract.3490.12.7" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:type="locator" />
    <link:loc xlink:label="loc_ProceedsFromIssuanceOfCommonStock.14855.12.7" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ProceedsFromIssuanceOfCommonStock" xlink:type="locator" />
    <link:presentationArc xlink:from="loc_NetCashProvidedByUsedInFinancingActivitiesAbstract.3490.12.7" xlink:to="loc_ProceedsFromIssuanceOfCommonStock.14855.12.7" order="1.00000" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:label="loc_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions.14931.12.7" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions" xlink:type="locator" />
    <link:presentationArc xlink:from="loc_NetCashProvidedByUsedInFinancingActivitiesAbstract.3490.12.7" xlink:to="loc_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions.14931.12.7" order="2.00000" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:label="loc_NetCashProvidedByUsedInFinancingActivitiesAbstract.3490.12.9" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:type="locator" />
    <link:loc xlink:label="loc_NetCashProvidedByUsedInFinancingActivitiesContinuingOperations.13107.12.9" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperations" xlink:type="locator" />
    <link:presentationArc xlink:from="loc_NetCashProvidedByUsedInFinancingActivitiesAbstract.3490.12.9" xlink:to="loc_NetCashProvidedByUsedInFinancingActivitiesContinuingOperations.13107.12.9" order="12.00000" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
    <link:loc xlink:label="loc_NetCashProvidedByUsedInInvestingActivitiesAbstract.3511.12.53" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:type="locator" />
    <link:loc xlink:label="loc_PaymentsToAcquirePropertyPlantAndEquipment.14193.12.53" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:type="locator" />
    <link:presentationArc xlink:from="loc_NetCashProvidedByUsedInInvestingActivitiesAbstract.3511.12.53" xlink:to="loc_PaymentsToAcquirePropertyPlantAndEquipment.14193.12.53" order="2.00000" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
    <link:loc xlink:label="loc_NetCashProvidedByUsedInInvestingActivitiesAbstract.3511.12.7" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:type="locator" />
    <link:loc xlink:label="loc_ProceedsFromSaleOfAvailableForSaleSecurities.14910.12.7" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ProceedsFromSaleOfAvailableForSaleSecurities" xlink:type="locator" />
    <link:presentationArc xlink:from="loc_NetCashProvidedByUsedInInvestingActivitiesAbstract.3511.12.7" xlink:to="loc_ProceedsFromSaleOfAvailableForSaleSecurities.14910.12.7" order="9.50000" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:label="loc_NetCashProvidedByUsedInInvestingActivitiesAbstract.3511.12.9" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:type="locator" />
    <link:loc xlink:label="loc_NetCashProvidedByUsedInInvestingActivitiesContinuingOperations.13117.12.9" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperations" xlink:type="locator" />
    <link:presentationArc xlink:from="loc_NetCashProvidedByUsedInInvestingActivitiesAbstract.3511.12.9" xlink:to="loc_NetCashProvidedByUsedInInvestingActivitiesContinuingOperations.13117.12.9" order="14.00000" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
    <link:loc xlink:label="loc_PaymentsForProceedsFromShortTermInvestments.14085.12.53" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_PaymentsForProceedsFromShortTermInvestments" xlink:type="locator" />
    <link:presentationArc xlink:from="loc_NetCashProvidedByUsedInInvestingActivitiesAbstract.3511.12.53" xlink:to="loc_PaymentsForProceedsFromShortTermInvestments.14085.12.53" order="6.50000" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
    <link:loc xlink:label="loc_PaymentsForProceedsFromLongtermInvestments.14128.12.53" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_PaymentsForProceedsFromLongtermInvestments" xlink:type="locator" />
    <link:presentationArc xlink:from="loc_NetCashProvidedByUsedInInvestingActivitiesAbstract.3511.12.53" xlink:to="loc_PaymentsForProceedsFromLongtermInvestments.14128.12.53" order="8.34375" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
    <link:loc xlink:label="loc_IncreaseDecreaseInRestrictedCashAndInvestments.11152.12.53" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_IncreaseDecreaseInRestrictedCashAndInvestments" xlink:type="locator" />
    <link:presentationArc xlink:from="loc_NetCashProvidedByUsedInInvestingActivitiesAbstract.3511.12.53" xlink:to="loc_IncreaseDecreaseInRestrictedCashAndInvestments.11152.12.53" order="8.78125" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
    <link:loc xlink:label="loc_ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities.14840.12.7" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities" xlink:type="locator" />
    <link:presentationArc xlink:from="loc_NetCashProvidedByUsedInInvestingActivitiesAbstract.3511.12.7" xlink:to="loc_ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities.14840.12.7" order="10.75000" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:label="loc_PaymentsToAcquireAvailableForSaleSecurities.14179.12.53" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_PaymentsToAcquireAvailableForSaleSecurities" xlink:type="locator" />
    <link:presentationArc xlink:from="loc_NetCashProvidedByUsedInInvestingActivitiesAbstract.3511.12.53" xlink:to="loc_PaymentsToAcquireAvailableForSaleSecurities.14179.12.53" order="12.50000" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
    <link:loc xlink:label="loc_NetCashProvidedByUsedInOperatingActivitiesAbstract.3512.12.7" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:type="locator" />
    <link:loc xlink:label="loc_NetIncomeLoss.13072.12.7" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_NetIncomeLoss" xlink:type="locator" />
    <link:presentationArc xlink:from="loc_NetCashProvidedByUsedInOperatingActivitiesAbstract.3512.12.7" xlink:to="loc_NetIncomeLoss.13072.12.7" order="1.00000" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:from="loc_NetCashProvidedByUsedInOperatingActivitiesAbstract.3512.12.7" xlink:to="loc_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract.517.12.7" order="1.50000" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:label="loc_OtherNoncashInvestingAndFinancingItemsAbstract.3827.12.7" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_OtherNoncashInvestingAndFinancingItemsAbstract" xlink:type="locator" />
    <link:loc xlink:label="loc_NoncashOrPartNoncashAcquisitionInvestmentsAcquired1.13179.12.7" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_NoncashOrPartNoncashAcquisitionInvestmentsAcquired1" xlink:type="locator" />
    <link:presentationArc xlink:from="loc_OtherNoncashInvestingAndFinancingItemsAbstract.3827.12.7" xlink:to="loc_NoncashOrPartNoncashAcquisitionInvestmentsAcquired1.13179.12.7" order="6.00000" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:label="loc_CapitalExpendituresIncurredButNotYetPaid.6608.12.7" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_CapitalExpendituresIncurredButNotYetPaid" xlink:type="locator" />
    <link:presentationArc xlink:from="loc_OtherNoncashInvestingAndFinancingItemsAbstract.3827.12.7" xlink:to="loc_CapitalExpendituresIncurredButNotYetPaid.6608.12.7" order="1.00000" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:label="loc_StockIssued1.16975.12.7" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_StockIssued1" xlink:type="locator" />
    <link:presentationArc xlink:from="loc_OtherNoncashInvestingAndFinancingItemsAbstract.3827.12.7" xlink:to="loc_StockIssued1.16975.12.7" order="2.00000" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:label="loc_OtherSignificantNoncashTransactionValueOfConsiderationGiven1.13662.12.7" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_OtherSignificantNoncashTransactionValueOfConsiderationGiven1" xlink:type="locator" />
    <link:presentationArc xlink:from="loc_OtherNoncashInvestingAndFinancingItemsAbstract.3827.12.7" xlink:to="loc_OtherSignificantNoncashTransactionValueOfConsiderationGiven1.13662.12.7" order="3.00000" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:label="loc_StatementOfCashFlowsAbstract.5113.12.7" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_StatementOfCashFlowsAbstract" xlink:type="locator" />
    <link:presentationArc xlink:from="loc_StatementOfCashFlowsAbstract.5113.12.7" xlink:to="loc_NetCashProvidedByUsedInOperatingActivitiesAbstract.3512.12.7" order="1.00000" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:from="loc_StatementOfCashFlowsAbstract.5113.12.7" xlink:to="loc_NetCashProvidedByUsedInInvestingActivitiesAbstract.3511.12.7" order="2.00000" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:from="loc_StatementOfCashFlowsAbstract.5113.12.7" xlink:to="loc_NetCashProvidedByUsedInFinancingActivitiesAbstract.3490.12.7" order="3.00000" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:label="loc_StatementOfCashFlowsAbstract.5113.12.9" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_StatementOfCashFlowsAbstract" xlink:type="locator" />
    <link:loc xlink:label="loc_CashAndCashEquivalentsPeriodIncreaseDecrease.6751.12.9" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease" xlink:type="locator" />
    <link:presentationArc xlink:from="loc_StatementOfCashFlowsAbstract.5113.12.9" xlink:to="loc_CashAndCashEquivalentsPeriodIncreaseDecrease.6751.12.9" order="4.00000" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
    <link:loc xlink:label="loc_StatementOfCashFlowsAbstract.5113.12.10" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_StatementOfCashFlowsAbstract" xlink:type="locator" />
    <link:loc xlink:label="loc_CashAndCashEquivalentsAtCarryingValue.6761.12.10" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:type="locator" />
    <link:presentationArc xlink:from="loc_StatementOfCashFlowsAbstract.5113.12.10" xlink:to="loc_CashAndCashEquivalentsAtCarryingValue.6761.12.10" order="5.00000" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" />
    <link:loc xlink:label="loc_StatementOfCashFlowsAbstract.5113.12.11" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_StatementOfCashFlowsAbstract" xlink:type="locator" />
    <link:loc xlink:label="loc_CashAndCashEquivalentsAtCarryingValue.6761.12.11" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:type="locator" />
    <link:presentationArc xlink:from="loc_StatementOfCashFlowsAbstract.5113.12.11" xlink:to="loc_CashAndCashEquivalentsAtCarryingValue.6761.12.11" order="6.00000" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
    <link:loc xlink:label="loc_SupplementalCashFlowInformationAbstract.5196.12.7" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_SupplementalCashFlowInformationAbstract" xlink:type="locator" />
    <link:presentationArc xlink:from="loc_StatementOfCashFlowsAbstract.5113.12.7" xlink:to="loc_SupplementalCashFlowInformationAbstract.5196.12.7" order="7.00000" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:from="loc_StatementOfCashFlowsAbstract.5113.12.7" xlink:to="loc_OtherNoncashInvestingAndFinancingItemsAbstract.3827.12.7" order="8.00000" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:label="loc_IncomeTaxesPaid.11047.12.7" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_IncomeTaxesPaid" xlink:type="locator" />
    <link:presentationArc xlink:from="loc_SupplementalCashFlowInformationAbstract.5196.12.7" xlink:to="loc_IncomeTaxesPaid.11047.12.7" order="2.00000" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </link:presentationLink>
  <link:presentationLink xlink:title="005 - Statement - CONSOLIDATED STATEMENTS OF COMPREHENSIVE LOSS" xlink:role="http://www.pluristem.com/role/ConsolidatedStatementsOfComprehensiveLoss" xlink:type="extended">
    <link:loc xlink:label="loc_OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParentAbstract.3871.12.7" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParentAbstract" xlink:type="locator" />
    <link:loc xlink:label="loc_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax.13804.12.7" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax" xlink:type="locator" />
    <link:presentationArc xlink:from="loc_OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParentAbstract.3871.12.7" xlink:to="loc_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax.13804.12.7" order="2.12500" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:label="loc_OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParentAbstract.3871.12.53" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParentAbstract" xlink:type="locator" />
    <link:loc xlink:label="loc_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax.13575.12.53" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax" xlink:type="locator" />
    <link:presentationArc xlink:from="loc_OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParentAbstract.3871.12.53" xlink:to="loc_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax.13575.12.53" order="2.50000" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
    <link:loc xlink:label="loc_OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodNetOfTax.13806.12.7" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodNetOfTax" xlink:type="locator" />
    <link:presentationArc xlink:from="loc_OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParentAbstract.3871.12.7" xlink:to="loc_OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodNetOfTax.13806.12.7" order="2.03125" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:label="loc_StatementOfIncomeAndComprehensiveIncomeAbstract.5111.12.9" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract" xlink:type="locator" />
    <link:loc xlink:label="loc_ComprehensiveIncomeNetOfTax.7101.12.9" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ComprehensiveIncomeNetOfTax" xlink:type="locator" />
    <link:presentationArc xlink:from="loc_StatementOfIncomeAndComprehensiveIncomeAbstract.5111.12.9" xlink:to="loc_ComprehensiveIncomeNetOfTax.7101.12.9" order="3.00000" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
    <link:loc xlink:label="loc_StatementOfIncomeAndComprehensiveIncomeAbstract.5111.12.7" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract" xlink:type="locator" />
    <link:loc xlink:label="loc_NetIncomeLoss.13072.12.7" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_NetIncomeLoss" xlink:type="locator" />
    <link:presentationArc xlink:from="loc_StatementOfIncomeAndComprehensiveIncomeAbstract.5111.12.7" xlink:to="loc_NetIncomeLoss.13072.12.7" order="1.00000" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:from="loc_StatementOfIncomeAndComprehensiveIncomeAbstract.5111.12.7" xlink:to="loc_OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParentAbstract.3871.12.7" order="2.00000" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </link:presentationLink>
  <link:presentationLink xlink:title="004 - Statement - CONSOLIDATED STATEMENTS OF OPERATIONS" xlink:role="http://www.pluristem.com/role/ConsolidatedStatementsOfOperations" xlink:type="extended">
    <link:loc xlink:label="loc_EarningsPerShareAbstract.1792.12.7" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_EarningsPerShareAbstract" xlink:type="locator" />
    <link:loc xlink:label="loc_EarningsPerShareBasicAndDiluted.8996.12.7" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_EarningsPerShareBasicAndDiluted" xlink:type="locator" />
    <link:presentationArc xlink:from="loc_EarningsPerShareAbstract.1792.12.7" xlink:to="loc_EarningsPerShareBasicAndDiluted.8996.12.7" order="1.00000" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:label="loc_WeightedAverageNumberOfShareOutstandingBasicAndDiluted.17738.12.7" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted" xlink:type="locator" />
    <link:presentationArc xlink:from="loc_EarningsPerShareAbstract.1792.12.7" xlink:to="loc_WeightedAverageNumberOfShareOutstandingBasicAndDiluted.17738.12.7" order="2.00000" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:label="loc_IncomeStatementAbstract.2649.12.56" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_IncomeStatementAbstract" xlink:type="locator" />
    <link:loc xlink:label="loc_ResearchAndDevelopmentExpensesNet.25542.12.56" xlink:href="psti-20140630.xsd#psti_ResearchAndDevelopmentExpensesNet" xlink:type="locator" />
    <link:presentationArc xlink:from="loc_IncomeStatementAbstract.2649.12.56" xlink:to="loc_ResearchAndDevelopmentExpensesNet.25542.12.56" order="3.00000" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTotalLabel" />
    <link:loc xlink:label="loc_IncomeStatementAbstract.2649.12.7" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_IncomeStatementAbstract" xlink:type="locator" />
    <link:loc xlink:label="loc_GovernmentAndThirdPartyGrantsReceived.25539.12.7" xlink:href="psti-20140630.xsd#psti_GovernmentAndThirdPartyGrantsReceived" xlink:type="locator" />
    <link:presentationArc xlink:from="loc_IncomeStatementAbstract.2649.12.7" xlink:to="loc_GovernmentAndThirdPartyGrantsReceived.25539.12.7" order="2.00000" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:label="loc_IncomeStatementAbstract.2649.12.53" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_IncomeStatementAbstract" xlink:type="locator" />
    <link:loc xlink:label="loc_ResearchAndDevelopmentExpense.15670.12.53" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ResearchAndDevelopmentExpense" xlink:type="locator" />
    <link:presentationArc xlink:from="loc_IncomeStatementAbstract.2649.12.53" xlink:to="loc_ResearchAndDevelopmentExpense.15670.12.53" order="1.88000" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
    <link:loc xlink:label="loc_GeneralAndAdministrativeExpense.10581.12.53" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_GeneralAndAdministrativeExpense" xlink:type="locator" />
    <link:presentationArc xlink:from="loc_IncomeStatementAbstract.2649.12.53" xlink:to="loc_GeneralAndAdministrativeExpense.10581.12.53" order="4.00000" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
    <link:loc xlink:label="loc_IncomeStatementAbstract.2649.12.9" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_IncomeStatementAbstract" xlink:type="locator" />
    <link:loc xlink:label="loc_OperatingIncomeLoss.13445.12.9" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_OperatingIncomeLoss" xlink:type="locator" />
    <link:presentationArc xlink:from="loc_IncomeStatementAbstract.2649.12.9" xlink:to="loc_OperatingIncomeLoss.13445.12.9" order="6.00000" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
    <link:loc xlink:label="loc_NetIncomeLoss.13072.12.9" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_NetIncomeLoss" xlink:type="locator" />
    <link:presentationArc xlink:from="loc_IncomeStatementAbstract.2649.12.9" xlink:to="loc_NetIncomeLoss.13072.12.9" order="8.00000" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
    <link:presentationArc xlink:from="loc_IncomeStatementAbstract.2649.12.7" xlink:to="loc_EarningsPerShareAbstract.1792.12.7" order="9.00000" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:label="loc_Revenues.15934.12.7" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_Revenues" xlink:type="locator" />
    <link:presentationArc xlink:from="loc_IncomeStatementAbstract.2649.12.7" xlink:to="loc_Revenues.15934.12.7" order="1.75000" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:label="loc_CostOfRevenue.7342.12.53" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_CostOfRevenue" xlink:type="locator" />
    <link:presentationArc xlink:from="loc_IncomeStatementAbstract.2649.12.53" xlink:to="loc_CostOfRevenue.7342.12.53" order="1.81000" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
    <link:loc xlink:label="loc_GrossProfit.10657.12.9" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_GrossProfit" xlink:type="locator" />
    <link:presentationArc xlink:from="loc_IncomeStatementAbstract.2649.12.9" xlink:to="loc_GrossProfit.10657.12.9" order="1.84000" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
    <link:loc xlink:label="loc_NonoperatingIncomeExpense.13243.12.7" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_NonoperatingIncomeExpense" xlink:type="locator" />
    <link:presentationArc xlink:from="loc_IncomeStatementAbstract.2649.12.7" xlink:to="loc_NonoperatingIncomeExpense.13243.12.7" order="7.75000" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </link:presentationLink>
  <link:presentationLink xlink:title="006 - Statement - STATEMENTS OF CHANGES IN EQUITY" xlink:role="http://www.pluristem.com/role/StatementsOfChangesInEquity" xlink:type="extended">
    <link:loc xlink:label="loc_EquityComponentDomain.1898.12.6" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_EquityComponentDomain" xlink:type="locator" />
    <link:loc xlink:label="loc_CommonStockMember.1115.12.6" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_CommonStockMember" xlink:type="locator" />
    <link:presentationArc xlink:from="loc_EquityComponentDomain.1898.12.6" xlink:to="loc_CommonStockMember.1115.12.6" order="1.00000" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" />
    <link:loc xlink:label="loc_AdditionalPaidInCapitalMember.499.12.6" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_AdditionalPaidInCapitalMember" xlink:type="locator" />
    <link:presentationArc xlink:from="loc_EquityComponentDomain.1898.12.6" xlink:to="loc_AdditionalPaidInCapitalMember.499.12.6" order="2.00000" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" />
    <link:loc xlink:label="loc_EquityComponentDomain.1898.12.7" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_EquityComponentDomain" xlink:type="locator" />
    <link:loc xlink:label="loc_AccumulatedOtherComprehensiveIncomeMember.478.12.7" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:type="locator" />
    <link:presentationArc xlink:from="loc_EquityComponentDomain.1898.12.7" xlink:to="loc_AccumulatedOtherComprehensiveIncomeMember.478.12.7" order="3.00000" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:label="loc_RetainedEarningsMember.4619.12.6" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_RetainedEarningsMember" xlink:type="locator" />
    <link:presentationArc xlink:from="loc_EquityComponentDomain.1898.12.6" xlink:to="loc_RetainedEarningsMember.4619.12.6" order="4.00000" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" />
    <link:loc xlink:label="loc_StatementTable.5107.12.6" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_StatementTable" xlink:type="locator" />
    <link:loc xlink:label="loc_StatementEquityComponentsAxis.5114.12.6" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_StatementEquityComponentsAxis" xlink:type="locator" />
    <link:presentationArc xlink:from="loc_StatementTable.5107.12.6" xlink:to="loc_StatementEquityComponentsAxis.5114.12.6" order="1.00000" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" />
    <link:loc xlink:label="loc_StatementLineItems.5108.12.6" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_StatementLineItems" xlink:type="locator" />
    <link:presentationArc xlink:from="loc_StatementTable.5107.12.6" xlink:to="loc_StatementLineItems.5108.12.6" order="2.00000" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" />
    <link:loc xlink:label="loc_StatementLineItems.5108.12.10" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_StatementLineItems" xlink:type="locator" />
    <link:loc xlink:label="loc_StockholdersEquity.17019.12.10" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_StockholdersEquity" xlink:type="locator" />
    <link:presentationArc xlink:from="loc_StatementLineItems.5108.12.10" xlink:to="loc_StockholdersEquity.17019.12.10" order="1.00000" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" />
    <link:loc xlink:label="loc_StatementLineItems.5108.12.11" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_StatementLineItems" xlink:type="locator" />
    <link:loc xlink:label="loc_CommonStockSharesOutstanding.7078.12.11" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_CommonStockSharesOutstanding" xlink:type="locator" />
    <link:presentationArc xlink:from="loc_StatementLineItems.5108.12.11" xlink:to="loc_CommonStockSharesOutstanding.7078.12.11" order="21.00000" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
    <link:loc xlink:label="loc_StatementLineItems.5108.12.7" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_StatementLineItems" xlink:type="locator" />
    <link:loc xlink:label="loc_StockIssuedDuringPeriodValueStockWarrantsExercised.25558.12.7" xlink:href="psti-20140630.xsd#psti_StockIssuedDuringPeriodValueStockWarrantsExercised" xlink:type="locator" />
    <link:presentationArc xlink:from="loc_StatementLineItems.5108.12.7" xlink:to="loc_StockIssuedDuringPeriodValueStockWarrantsExercised.25558.12.7" order="12.37500" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:label="loc_StockIssuedDuringPeriodSharesStockWarrantsExercised.25556.12.7" xlink:href="psti-20140630.xsd#psti_StockIssuedDuringPeriodSharesStockWarrantsExercised" xlink:type="locator" />
    <link:presentationArc xlink:from="loc_StatementLineItems.5108.12.7" xlink:to="loc_StockIssuedDuringPeriodSharesStockWarrantsExercised.25556.12.7" order="12.60000" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:label="loc_StatementLineItems.5108.12.8" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_StatementLineItems" xlink:type="locator" />
    <link:loc xlink:label="loc_NetIncomeLoss.13072.12.8" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_NetIncomeLoss" xlink:type="locator" />
    <link:presentationArc xlink:from="loc_StatementLineItems.5108.12.8" xlink:to="loc_NetIncomeLoss.13072.12.8" order="19.00000" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <link:loc xlink:label="loc_StockholdersEquity.17019.12.11" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_StockholdersEquity" xlink:type="locator" />
    <link:presentationArc xlink:from="loc_StatementLineItems.5108.12.11" xlink:to="loc_StockholdersEquity.17019.12.11" order="20.00000" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
    <link:loc xlink:label="loc_CommonStockSharesOutstanding.7078.12.10" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_CommonStockSharesOutstanding" xlink:type="locator" />
    <link:presentationArc xlink:from="loc_StatementLineItems.5108.12.10" xlink:to="loc_CommonStockSharesOutstanding.7078.12.10" order="2.00000" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" />
    <link:loc xlink:label="loc_OtherComprehensiveIncomeLossNetOfTax.13526.12.7" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTax" xlink:type="locator" />
    <link:presentationArc xlink:from="loc_StatementLineItems.5108.12.7" xlink:to="loc_OtherComprehensiveIncomeLossNetOfTax.13526.12.7" order="18.00000" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:label="loc_StockIssuedDuringPeriodSharesShareBasedCompensation.16979.12.7" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation" xlink:type="locator" />
    <link:presentationArc xlink:from="loc_StatementLineItems.5108.12.7" xlink:to="loc_StockIssuedDuringPeriodSharesShareBasedCompensation.16979.12.7" order="16.25000" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:label="loc_StockIssuedDuringPeriodValueShareBasedCompensation.16998.12.7" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation" xlink:type="locator" />
    <link:presentationArc xlink:from="loc_StatementLineItems.5108.12.7" xlink:to="loc_StockIssuedDuringPeriodValueShareBasedCompensation.16998.12.7" order="16.12500" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:label="loc_StockIssuedDuringPeriodValueNewIssues.17003.12.7" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueNewIssues" xlink:type="locator" />
    <link:presentationArc xlink:from="loc_StatementLineItems.5108.12.7" xlink:to="loc_StockIssuedDuringPeriodValueNewIssues.17003.12.7" order="7.50000" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:label="loc_StockIssuedDuringPeriodSharesNewIssues.16990.12.7" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:type="locator" />
    <link:presentationArc xlink:from="loc_StatementLineItems.5108.12.7" xlink:to="loc_StockIssuedDuringPeriodSharesNewIssues.16990.12.7" order="7.75000" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:label="loc_StockIssuedDuringPeriodValuePurchaseOfAssets.17002.12.7" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_StockIssuedDuringPeriodValuePurchaseOfAssets" xlink:type="locator" />
    <link:presentationArc xlink:from="loc_StatementLineItems.5108.12.7" xlink:to="loc_StockIssuedDuringPeriodValuePurchaseOfAssets.17002.12.7" order="17.43750" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:label="loc_StockIssuedDuringPeriodSharesPurchaseOfAssets.16992.12.7" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesPurchaseOfAssets" xlink:type="locator" />
    <link:presentationArc xlink:from="loc_StatementLineItems.5108.12.7" xlink:to="loc_StockIssuedDuringPeriodSharesPurchaseOfAssets.16992.12.7" order="17.53125" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:label="loc_StockIssuedDuringPeriodValueStockOptionsAndWarrantsExercised.25557.12.7" xlink:href="psti-20140630.xsd#psti_StockIssuedDuringPeriodValueStockOptionsAndWarrantsExercised" xlink:type="locator" />
    <link:presentationArc xlink:from="loc_StatementLineItems.5108.12.7" xlink:to="loc_StockIssuedDuringPeriodValueStockOptionsAndWarrantsExercised.25557.12.7" order="12.00000" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:label="loc_StockIssuedDuringPeriodSharesStockOptionsAndWarrantsExercised.25555.12.7" xlink:href="psti-20140630.xsd#psti_StockIssuedDuringPeriodSharesStockOptionsAndWarrantsExercised" xlink:type="locator" />
    <link:presentationArc xlink:from="loc_StatementLineItems.5108.12.7" xlink:to="loc_StockIssuedDuringPeriodSharesStockOptionsAndWarrantsExercised.25555.12.7" order="12.25000" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:label="loc_StockIssuedDuringPeriodValueIssuedForServices.16963.12.7" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueIssuedForServices" xlink:type="locator" />
    <link:presentationArc xlink:from="loc_StatementLineItems.5108.12.7" xlink:to="loc_StockIssuedDuringPeriodValueIssuedForServices.16963.12.7" order="17.20313" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:label="loc_StockIssuedDuringPeriodSharesIssuedForServices.16939.12.7" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesIssuedForServices" xlink:type="locator" />
    <link:presentationArc xlink:from="loc_StatementLineItems.5108.12.7" xlink:to="loc_StockIssuedDuringPeriodSharesIssuedForServices.16939.12.7" order="17.32031" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:label="loc_StatementOfStockholdersEquityAbstract.5110.12.6" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_StatementOfStockholdersEquityAbstract" xlink:type="locator" />
    <link:presentationArc xlink:from="loc_StatementOfStockholdersEquityAbstract.5110.12.6" xlink:to="loc_StatementTable.5107.12.6" order="1.00000" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" />
    <link:presentationArc xlink:from="loc_StatementEquityComponentsAxis.5114.12.6" xlink:to="loc_EquityComponentDomain.1898.12.6" order="1.00000" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" />
  </link:presentationLink>
  <link:presentationLink xlink:title="007 - Statement - STATEMENTS OF CHANGES IN EQUITY (Parenthetical)" xlink:role="http://www.pluristem.com/role/StatementsOfChangesInEquityParenthetical" xlink:type="extended">
    <link:loc xlink:label="loc_StatementOfStockholdersEquityAbstract.5110.12.7" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_StatementOfStockholdersEquityAbstract" xlink:type="locator" />
    <link:loc xlink:label="loc_AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts.5793.12.7" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts" xlink:type="locator" />
    <link:presentationArc xlink:from="loc_StatementOfStockholdersEquityAbstract.5110.12.7" xlink:to="loc_AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts.5793.12.7" order="2.00000" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </link:presentationLink>
  <link:presentationLink xlink:title="104 - Disclosure - FAIR VALUE OF FINANCIAL INSTRUMENTS" xlink:role="http://www.pluristem.com/role/FairValueOfFinancialInstruments" xlink:type="extended">
    <link:loc xlink:label="loc_FairValueDisclosuresAbstract.2070.12.7" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_FairValueDisclosuresAbstract" xlink:type="locator" />
    <link:loc xlink:label="loc_FairValueDisclosuresTextBlock.9611.12.7" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_FairValueDisclosuresTextBlock" xlink:type="locator" />
    <link:presentationArc xlink:from="loc_FairValueDisclosuresAbstract.2070.12.7" xlink:to="loc_FairValueDisclosuresTextBlock.9611.12.7" order="1.00000" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </link:presentationLink>
  <link:presentationLink xlink:title="40401 - Disclosure - FAIR VALUE OF FINANCIAL INSTRUMENTS (Schedule of Fair Value of Financial Instruments) (Details)" xlink:role="http://www.pluristem.com/role/FairValueOfFinancialInstrumentsScheduleOfFairValueOfFinancialInstrumentsDetails" xlink:type="extended">
    <link:loc xlink:label="loc_FairValueByMeasurementFrequencyAxis.2040.12.6" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_FairValueByMeasurementFrequencyAxis" xlink:type="locator" />
    <link:loc xlink:label="loc_FairValueMeasurementFrequencyDomain.2062.12.6" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_FairValueMeasurementFrequencyDomain" xlink:type="locator" />
    <link:presentationArc xlink:from="loc_FairValueByMeasurementFrequencyAxis.2040.12.6" xlink:to="loc_FairValueMeasurementFrequencyDomain.2062.12.6" order="1.00000" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" />
    <link:loc xlink:label="loc_FairValueByFairValueHierarchyLevelAxis.2043.12.6" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:type="locator" />
    <link:loc xlink:label="loc_FairValueMeasurementsFairValueHierarchyDomain.2075.12.6" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:type="locator" />
    <link:presentationArc xlink:from="loc_FairValueByFairValueHierarchyLevelAxis.2043.12.6" xlink:to="loc_FairValueMeasurementsFairValueHierarchyDomain.2075.12.6" order="1.00000" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" />
    <link:loc xlink:label="loc_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable.2046.12.6" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:type="locator" />
    <link:presentationArc xlink:from="loc_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable.2046.12.6" xlink:to="loc_FairValueByFairValueHierarchyLevelAxis.2043.12.6" order="1.00000" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" />
    <link:loc xlink:label="loc_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems.2066.12.6" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:type="locator" />
    <link:presentationArc xlink:from="loc_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable.2046.12.6" xlink:to="loc_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems.2066.12.6" order="2.00000" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" />
    <link:presentationArc xlink:from="loc_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable.2046.12.6" xlink:to="loc_FairValueByMeasurementFrequencyAxis.2040.12.6" order="1.50000" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" />
    <link:loc xlink:label="loc_FairValueMeasurementsRecurringMember.2032.12.6" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_FairValueMeasurementsRecurringMember" xlink:type="locator" />
    <link:presentationArc xlink:from="loc_FairValueMeasurementFrequencyDomain.2062.12.6" xlink:to="loc_FairValueMeasurementsRecurringMember.2032.12.6" order="1.00000" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" />
    <link:loc xlink:label="loc_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems.2066.12.7" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:type="locator" />
    <link:loc xlink:label="loc_MarketableSecuritiesCurrent.12849.12.7" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_MarketableSecuritiesCurrent" xlink:type="locator" />
    <link:presentationArc xlink:from="loc_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems.2066.12.7" xlink:to="loc_MarketableSecuritiesCurrent.12849.12.7" order="2.00000" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:label="loc_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems.2066.12.8" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:type="locator" />
    <link:loc xlink:label="loc_DerivativeAssetsLiabilitiesAtFairValueNet.8291.12.8" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_DerivativeAssetsLiabilitiesAtFairValueNet" xlink:type="locator" />
    <link:presentationArc xlink:from="loc_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems.2066.12.8" xlink:to="loc_DerivativeAssetsLiabilitiesAtFairValueNet.8291.12.8" order="3.00000" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <link:loc xlink:label="loc_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems.2066.12.9" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:type="locator" />
    <link:loc xlink:label="loc_FairValueNetAssetLiability.9433.12.9" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_FairValueNetAssetLiability" xlink:type="locator" />
    <link:presentationArc xlink:from="loc_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems.2066.12.9" xlink:to="loc_FairValueNetAssetLiability.9433.12.9" order="5.00000" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
    <link:loc xlink:label="loc_FairValueDisclosuresAbstract.2070.12.6" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_FairValueDisclosuresAbstract" xlink:type="locator" />
    <link:presentationArc xlink:from="loc_FairValueDisclosuresAbstract.2070.12.6" xlink:to="loc_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable.2046.12.6" order="1.00000" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" />
    <link:loc xlink:label="loc_FairValueMeasurementsFairValueHierarchyDomain.2075.12.7" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:type="locator" />
    <link:loc xlink:label="loc_FairValueInputsLevel1Member.2136.12.7" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_FairValueInputsLevel1Member" xlink:type="locator" />
    <link:presentationArc xlink:from="loc_FairValueMeasurementsFairValueHierarchyDomain.2075.12.7" xlink:to="loc_FairValueInputsLevel1Member.2136.12.7" order="1.00000" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:label="loc_FairValueInputsLevel2Member.2135.12.7" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_FairValueInputsLevel2Member" xlink:type="locator" />
    <link:presentationArc xlink:from="loc_FairValueMeasurementsFairValueHierarchyDomain.2075.12.7" xlink:to="loc_FairValueInputsLevel2Member.2135.12.7" order="2.00000" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:label="loc_FairValueInputsLevel3Member.2137.12.7" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_FairValueInputsLevel3Member" xlink:type="locator" />
    <link:presentationArc xlink:from="loc_FairValueMeasurementsFairValueHierarchyDomain.2075.12.7" xlink:to="loc_FairValueInputsLevel3Member.2137.12.7" order="3.00000" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </link:presentationLink>
  <link:presentationLink xlink:title="40402 - Disclosure - FAIR VALUE OF FINANCIAL INSTRUMENTS (Schedule of the Fair Value of Hedging Instruments) (Details)" xlink:role="http://www.pluristem.com/role/FairValueOfFinancialInstrumentsScheduleOfFairValueOfHedgingInstrumentsDetails" xlink:type="extended">
    <link:loc xlink:label="loc_BalanceSheetLocationAxis.736.12.6" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_BalanceSheetLocationAxis" xlink:type="locator" />
    <link:loc xlink:label="loc_BalanceSheetLocationDomain.738.12.6" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_BalanceSheetLocationDomain" xlink:type="locator" />
    <link:presentationArc xlink:from="loc_BalanceSheetLocationAxis.736.12.6" xlink:to="loc_BalanceSheetLocationDomain.738.12.6" order="1.00000" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" />
    <link:loc xlink:label="loc_BalanceSheetLocationDomain.738.12.7" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_BalanceSheetLocationDomain" xlink:type="locator" />
    <link:loc xlink:label="loc_OtherCurrentAssetsMember.3743.12.7" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_OtherCurrentAssetsMember" xlink:type="locator" />
    <link:presentationArc xlink:from="loc_BalanceSheetLocationDomain.738.12.7" xlink:to="loc_OtherCurrentAssetsMember.3743.12.7" order="1.00000" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:label="loc_OtherCurrentLiabilitiesMember.3728.12.7" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_OtherCurrentLiabilitiesMember" xlink:type="locator" />
    <link:presentationArc xlink:from="loc_BalanceSheetLocationDomain.738.12.7" xlink:to="loc_OtherCurrentLiabilitiesMember.3728.12.7" order="2.00000" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:label="loc_DerivativeInstrumentsGainLossByHedgingRelationshipAxis.1619.12.6" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis" xlink:type="locator" />
    <link:loc xlink:label="loc_HedgingRelationshipDomain.2545.12.6" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_HedgingRelationshipDomain" xlink:type="locator" />
    <link:presentationArc xlink:from="loc_DerivativeInstrumentsGainLossByHedgingRelationshipAxis.1619.12.6" xlink:to="loc_HedgingRelationshipDomain.2545.12.6" order="1.00000" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" />
    <link:loc xlink:label="loc_DerivativesFairValueLineItems.1635.12.7" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_DerivativesFairValueLineItems" xlink:type="locator" />
    <link:loc xlink:label="loc_DerivativeAssetsLiabilitiesAtFairValueNet.8291.12.7" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_DerivativeAssetsLiabilitiesAtFairValueNet" xlink:type="locator" />
    <link:presentationArc xlink:from="loc_DerivativesFairValueLineItems.1635.12.7" xlink:to="loc_DerivativeAssetsLiabilitiesAtFairValueNet.8291.12.7" order="3.00000" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:label="loc_FairValueDisclosuresAbstract.2070.12.6" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_FairValueDisclosuresAbstract" xlink:type="locator" />
    <link:loc xlink:label="loc_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable.2157.12.6" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable" xlink:type="locator" />
    <link:presentationArc xlink:from="loc_FairValueDisclosuresAbstract.2070.12.6" xlink:to="loc_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable.2157.12.6" order="1.00000" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" />
    <link:loc xlink:label="loc_HedgingDesignationAxis.2543.12.6" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_HedgingDesignationAxis" xlink:type="locator" />
    <link:presentationArc xlink:from="loc_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable.2157.12.6" xlink:to="loc_HedgingDesignationAxis.2543.12.6" order="1.00000" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" />
    <link:presentationArc xlink:from="loc_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable.2157.12.6" xlink:to="loc_BalanceSheetLocationAxis.736.12.6" order="2.00000" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" />
    <link:loc xlink:label="loc_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable.2157.12.7" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable" xlink:type="locator" />
    <link:presentationArc xlink:from="loc_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable.2157.12.7" xlink:to="loc_DerivativesFairValueLineItems.1635.12.7" order="3.00000" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:from="loc_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable.2157.12.6" xlink:to="loc_DerivativeInstrumentsGainLossByHedgingRelationshipAxis.1619.12.6" order="2.50000" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" />
    <link:loc xlink:label="loc_HedgingDesignationDomain.2544.12.6" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_HedgingDesignationDomain" xlink:type="locator" />
    <link:presentationArc xlink:from="loc_HedgingDesignationAxis.2543.12.6" xlink:to="loc_HedgingDesignationDomain.2544.12.6" order="1.00000" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" />
    <link:loc xlink:label="loc_HedgingDesignationDomain.2544.12.8" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_HedgingDesignationDomain" xlink:type="locator" />
    <link:loc xlink:label="loc_DesignatedAsHedgingInstrumentMember.1352.12.8" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_DesignatedAsHedgingInstrumentMember" xlink:type="locator" />
    <link:presentationArc xlink:from="loc_HedgingDesignationDomain.2544.12.8" xlink:to="loc_DesignatedAsHedgingInstrumentMember.1352.12.8" order="1.00000" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <link:loc xlink:label="loc_NondesignatedMember.3619.12.8" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_NondesignatedMember" xlink:type="locator" />
    <link:presentationArc xlink:from="loc_HedgingDesignationDomain.2544.12.8" xlink:to="loc_NondesignatedMember.3619.12.8" order="2.00000" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <link:loc xlink:label="loc_HedgingRelationshipDomain.2545.12.7" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_HedgingRelationshipDomain" xlink:type="locator" />
    <link:loc xlink:label="loc_CashFlowHedgingMember.979.12.7" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_CashFlowHedgingMember" xlink:type="locator" />
    <link:presentationArc xlink:from="loc_HedgingRelationshipDomain.2545.12.7" xlink:to="loc_CashFlowHedgingMember.979.12.7" order="1.00000" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:label="loc_FairValueHedgingMember.2158.12.7" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_FairValueHedgingMember" xlink:type="locator" />
    <link:presentationArc xlink:from="loc_HedgingRelationshipDomain.2545.12.7" xlink:to="loc_FairValueHedgingMember.2158.12.7" order="2.00000" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </link:presentationLink>
  <link:presentationLink xlink:title="304 - Disclosure - FAIR VALUE OF FINANCIAL INSTRUMENTS (Tables)" xlink:role="http://www.pluristem.com/role/FairValueOfFinancialInstrumentsTables" xlink:type="extended">
    <link:loc xlink:label="loc_FairValueDisclosuresAbstract.2070.12.7" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_FairValueDisclosuresAbstract" xlink:type="locator" />
    <link:loc xlink:label="loc_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTableTextBlock.9404.12.7" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTableTextBlock" xlink:type="locator" />
    <link:presentationArc xlink:from="loc_FairValueDisclosuresAbstract.2070.12.7" xlink:to="loc_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTableTextBlock.9404.12.7" order="1.00000" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:label="loc_ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock.16347.12.7" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock" xlink:type="locator" />
    <link:presentationArc xlink:from="loc_FairValueDisclosuresAbstract.2070.12.7" xlink:to="loc_ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock.16347.12.7" order="3.00000" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </link:presentationLink>
  <link:presentationLink xlink:title="101 - Disclosure - GENERAL" xlink:role="http://www.pluristem.com/role/General" xlink:type="extended">
    <link:loc xlink:label="loc_GeneralAbstract.25538.12.7" xlink:href="psti-20140630.xsd#psti_GeneralAbstract" xlink:type="locator" />
    <link:loc xlink:label="loc_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock.13494.12.7" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock" xlink:type="locator" />
    <link:presentationArc xlink:from="loc_GeneralAbstract.25538.12.7" xlink:to="loc_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock.13494.12.7" order="2.00000" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </link:presentationLink>
  <link:presentationLink xlink:title="40101 - Disclosure - GENERAL (Details)" xlink:role="http://www.pluristem.com/role/GeneralDetails" xlink:type="extended">
    <link:loc xlink:label="loc_GeneralAbstract.25538.12.7" xlink:href="psti-20140630.xsd#psti_GeneralAbstract" xlink:type="locator" />
    <link:loc xlink:label="loc_RetainedEarningsAccumulatedDeficit.15840.12.7" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_RetainedEarningsAccumulatedDeficit" xlink:type="locator" />
    <link:presentationArc xlink:from="loc_GeneralAbstract.25538.12.7" xlink:to="loc_RetainedEarningsAccumulatedDeficit.15840.12.7" order="1.00000" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:label="loc_GeneralAbstract.25538.12.8" xlink:href="psti-20140630.xsd#psti_GeneralAbstract" xlink:type="locator" />
    <link:loc xlink:label="loc_StockIssuedDuringPeriodSharesPurchaseOfAssets.16992.12.8" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesPurchaseOfAssets" xlink:type="locator" />
    <link:presentationArc xlink:from="loc_GeneralAbstract.25538.12.8" xlink:to="loc_StockIssuedDuringPeriodSharesPurchaseOfAssets.16992.12.8" order="4.37500" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <link:loc xlink:label="loc_StockIssuedDuringPeriodValuePurchaseOfAssets.17002.12.8" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_StockIssuedDuringPeriodValuePurchaseOfAssets" xlink:type="locator" />
    <link:presentationArc xlink:from="loc_GeneralAbstract.25538.12.8" xlink:to="loc_StockIssuedDuringPeriodValuePurchaseOfAssets.17002.12.8" order="4.68750" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <link:loc xlink:label="loc_AvailableForSaleMarketableSecuritiesNumber.25527.12.7" xlink:href="psti-20140630.xsd#psti_AvailableForSaleMarketableSecuritiesNumber" xlink:type="locator" />
    <link:presentationArc xlink:from="loc_GeneralAbstract.25538.12.7" xlink:to="loc_AvailableForSaleMarketableSecuritiesNumber.25527.12.7" order="4.53125" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:label="loc_RevenueFromGrants.15863.12.7" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_RevenueFromGrants" xlink:type="locator" />
    <link:presentationArc xlink:from="loc_GeneralAbstract.25538.12.7" xlink:to="loc_RevenueFromGrants.15863.12.7" order="1.68750" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:label="loc_ResearchAndDevelopmentMilestoneRevenueReceivable.25543.12.7" xlink:href="psti-20140630.xsd#psti_ResearchAndDevelopmentMilestoneRevenueReceivable" xlink:type="locator" />
    <link:presentationArc xlink:from="loc_GeneralAbstract.25538.12.7" xlink:to="loc_ResearchAndDevelopmentMilestoneRevenueReceivable.25543.12.7" order="2.42188" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:label="loc_ReimbursementRevenue.15504.12.7" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ReimbursementRevenue" xlink:type="locator" />
    <link:presentationArc xlink:from="loc_GeneralAbstract.25538.12.7" xlink:to="loc_ReimbursementRevenue.15504.12.7" order="3.93750" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:label="loc_ProceedsFromCustomers.14773.12.7" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ProceedsFromCustomers" xlink:type="locator" />
    <link:presentationArc xlink:from="loc_GeneralAbstract.25538.12.7" xlink:to="loc_ProceedsFromCustomers.14773.12.7" order="2.13282" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:label="loc_NetIncomeLoss.13072.12.7" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_NetIncomeLoss" xlink:type="locator" />
    <link:presentationArc xlink:from="loc_GeneralAbstract.25538.12.7" xlink:to="loc_NetIncomeLoss.13072.12.7" order="1.31250" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:label="loc_LicensesRevenue.12148.12.7" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_LicensesRevenue" xlink:type="locator" />
    <link:presentationArc xlink:from="loc_GeneralAbstract.25538.12.7" xlink:to="loc_LicensesRevenue.12148.12.7" order="1.57813" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </link:presentationLink>
  <link:presentationLink xlink:title="103 - Disclosure - MARKETABLE SECURITIES" xlink:role="http://www.pluristem.com/role/MarketableSecurities" xlink:type="extended">
    <link:loc xlink:label="loc_MarketableSecuritiesAbstract.3334.12.7" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_MarketableSecuritiesAbstract" xlink:type="locator" />
    <link:loc xlink:label="loc_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock.11879.12.7" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock" xlink:type="locator" />
    <link:presentationArc xlink:from="loc_MarketableSecuritiesAbstract.3334.12.7" xlink:to="loc_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock.11879.12.7" order="1.00000" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </link:presentationLink>
  <link:presentationLink xlink:title="40301 - Disclosure - MARKETABLE SECURITIES (Schedule of Available-for-sale Marketable Securities) (Details)" xlink:role="http://www.pluristem.com/role/MarketableSecuritiesScheduleOfAvailableforsaleMarketableSecuritiesDetails" xlink:type="extended">
    <link:loc xlink:label="loc_MajorTypesOfDebtAndEquitySecuritiesAxis.3302.12.6" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_MajorTypesOfDebtAndEquitySecuritiesAxis" xlink:type="locator" />
    <link:loc xlink:label="loc_MajorTypesOfDebtAndEquitySecuritiesDomain.3304.12.6" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_MajorTypesOfDebtAndEquitySecuritiesDomain" xlink:type="locator" />
    <link:presentationArc xlink:from="loc_MajorTypesOfDebtAndEquitySecuritiesAxis.3302.12.6" xlink:to="loc_MajorTypesOfDebtAndEquitySecuritiesDomain.3304.12.6" order="1.00000" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" />
    <link:loc xlink:label="loc_MajorTypesOfDebtAndEquitySecuritiesDomain.3304.12.7" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_MajorTypesOfDebtAndEquitySecuritiesDomain" xlink:type="locator" />
    <link:loc xlink:label="loc_GovernmentDebtSecuritiesMember.25540.12.7" xlink:href="psti-20140630.xsd#psti_GovernmentDebtSecuritiesMember" xlink:type="locator" />
    <link:presentationArc xlink:from="loc_MajorTypesOfDebtAndEquitySecuritiesDomain.3304.12.7" xlink:to="loc_GovernmentDebtSecuritiesMember.25540.12.7" order="2.00000" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:label="loc_CorporateDebtSecuritiesMember.1263.12.7" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_CorporateDebtSecuritiesMember" xlink:type="locator" />
    <link:presentationArc xlink:from="loc_MajorTypesOfDebtAndEquitySecuritiesDomain.3304.12.7" xlink:to="loc_CorporateDebtSecuritiesMember.1263.12.7" order="3.00000" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:label="loc_EquitySecuritiesMember.1910.12.7" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_EquitySecuritiesMember" xlink:type="locator" />
    <link:presentationArc xlink:from="loc_MajorTypesOfDebtAndEquitySecuritiesDomain.3304.12.7" xlink:to="loc_EquitySecuritiesMember.1910.12.7" order="1.75000" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:label="loc_MarketableSecuritiesAbstract.3334.12.6" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_MarketableSecuritiesAbstract" xlink:type="locator" />
    <link:loc xlink:label="loc_ScheduleOfAvailableForSaleSecuritiesTable.4729.12.6" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ScheduleOfAvailableForSaleSecuritiesTable" xlink:type="locator" />
    <link:presentationArc xlink:from="loc_MarketableSecuritiesAbstract.3334.12.6" xlink:to="loc_ScheduleOfAvailableForSaleSecuritiesTable.4729.12.6" order="1.00000" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" />
    <link:loc xlink:label="loc_RangeAxis.4349.12.6" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_RangeAxis" xlink:type="locator" />
    <link:loc xlink:label="loc_RangeMember.4350.12.6" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_RangeMember" xlink:type="locator" />
    <link:presentationArc xlink:from="loc_RangeAxis.4349.12.6" xlink:to="loc_RangeMember.4350.12.6" order="1.00000" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" />
    <link:loc xlink:label="loc_RangeMember.4350.12.7" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_RangeMember" xlink:type="locator" />
    <link:loc xlink:label="loc_AvailableForSaleSecuritiesMaturesWithinOneYearMember.25532.12.7" xlink:href="psti-20140630.xsd#psti_AvailableForSaleSecuritiesMaturesWithinOneYearMember" xlink:type="locator" />
    <link:presentationArc xlink:from="loc_RangeMember.4350.12.7" xlink:to="loc_AvailableForSaleSecuritiesMaturesWithinOneYearMember.25532.12.7" order="1.00000" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:label="loc_AvailableForSaleSecuritiesMaturesAfterOneYearThroughFiveYearsMember.25531.12.7" xlink:href="psti-20140630.xsd#psti_AvailableForSaleSecuritiesMaturesAfterOneYearThroughFiveYearsMember" xlink:type="locator" />
    <link:presentationArc xlink:from="loc_RangeMember.4350.12.7" xlink:to="loc_AvailableForSaleSecuritiesMaturesAfterOneYearThroughFiveYearsMember.25531.12.7" order="2.00000" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:label="loc_AvailableForSaleSecuritiesMaturesAfterFiveYearsThroughTenYearsMember.25530.12.7" xlink:href="psti-20140630.xsd#psti_AvailableForSaleSecuritiesMaturesAfterFiveYearsThroughTenYearsMember" xlink:type="locator" />
    <link:presentationArc xlink:from="loc_RangeMember.4350.12.7" xlink:to="loc_AvailableForSaleSecuritiesMaturesAfterFiveYearsThroughTenYearsMember.25530.12.7" order="3.00000" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:label="loc_ScheduleOfAvailableForSaleSecuritiesLineItems.4769.12.6" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems" xlink:type="locator" />
    <link:presentationArc xlink:from="loc_ScheduleOfAvailableForSaleSecuritiesTable.4729.12.6" xlink:to="loc_ScheduleOfAvailableForSaleSecuritiesLineItems.4769.12.6" order="2.00000" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" />
    <link:presentationArc xlink:from="loc_ScheduleOfAvailableForSaleSecuritiesTable.4729.12.6" xlink:to="loc_MajorTypesOfDebtAndEquitySecuritiesAxis.3302.12.6" order="1.50000" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" />
    <link:presentationArc xlink:from="loc_ScheduleOfAvailableForSaleSecuritiesTable.4729.12.6" xlink:to="loc_RangeAxis.4349.12.6" order="1.87500" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" />
    <link:loc xlink:label="loc_ScheduleOfAvailableForSaleSecuritiesLineItems.4769.12.9" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems" xlink:type="locator" />
    <link:loc xlink:label="loc_AvailableForSaleSecuritiesAmortizedCost.6142.12.9" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_AvailableForSaleSecuritiesAmortizedCost" xlink:type="locator" />
    <link:presentationArc xlink:from="loc_ScheduleOfAvailableForSaleSecuritiesLineItems.4769.12.9" xlink:to="loc_AvailableForSaleSecuritiesAmortizedCost.6142.12.9" order="1.00000" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
    <link:loc xlink:label="loc_ScheduleOfAvailableForSaleSecuritiesLineItems.4769.12.7" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems" xlink:type="locator" />
    <link:loc xlink:label="loc_AvailableForSaleSecurities.6116.12.7" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_AvailableForSaleSecurities" xlink:type="locator" />
    <link:presentationArc xlink:from="loc_ScheduleOfAvailableForSaleSecuritiesLineItems.4769.12.7" xlink:to="loc_AvailableForSaleSecurities.6116.12.7" order="4.00000" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:label="loc_AvailableForSaleEquitySecuritiesAccumulatedGrossUnrealizedGainBeforeTax.6136.12.7" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_AvailableForSaleEquitySecuritiesAccumulatedGrossUnrealizedGainBeforeTax" xlink:type="locator" />
    <link:presentationArc xlink:from="loc_ScheduleOfAvailableForSaleSecuritiesLineItems.4769.12.7" xlink:to="loc_AvailableForSaleEquitySecuritiesAccumulatedGrossUnrealizedGainBeforeTax.6136.12.7" order="3.00000" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:label="loc_ScheduleOfAvailableForSaleSecuritiesLineItems.4769.12.53" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems" xlink:type="locator" />
    <link:loc xlink:label="loc_AvailableForSaleEquitySecuritiesAccumulatedGrossUnrealizedLossBeforeTax.6100.12.53" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_AvailableForSaleEquitySecuritiesAccumulatedGrossUnrealizedLossBeforeTax" xlink:type="locator" />
    <link:presentationArc xlink:from="loc_ScheduleOfAvailableForSaleSecuritiesLineItems.4769.12.53" xlink:to="loc_AvailableForSaleEquitySecuritiesAccumulatedGrossUnrealizedLossBeforeTax.6100.12.53" order="3.75000" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
  </link:presentationLink>
  <link:presentationLink xlink:title="40302 - Disclosure - MARKETABLE SECURITIES (Schedule of Investments in Unrealized Loss) (Details)" xlink:role="http://www.pluristem.com/role/MarketableSecuritiesScheduleOfInvestmentsInUnrealizedLossDetails" xlink:type="extended">
    <link:loc xlink:label="loc_MarketableSecuritiesAbstract.3334.12.8" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_MarketableSecuritiesAbstract" xlink:type="locator" />
    <link:loc xlink:label="loc_AvailableForSaleSecuritiesContinuousUnrealizedLossPositionLessThanTwelveMonthsFairValue.6088.12.8" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_AvailableForSaleSecuritiesContinuousUnrealizedLossPositionLessThanTwelveMonthsFairValue" xlink:type="locator" />
    <link:presentationArc xlink:from="loc_MarketableSecuritiesAbstract.3334.12.8" xlink:to="loc_AvailableForSaleSecuritiesContinuousUnrealizedLossPositionLessThanTwelveMonthsFairValue.6088.12.8" order="1.00000" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <link:loc xlink:label="loc_AvailableForSaleSecuritiesContinuousUnrealizedLossPositionTwelveMonthsOrLongerFairValue.6114.12.8" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_AvailableForSaleSecuritiesContinuousUnrealizedLossPositionTwelveMonthsOrLongerFairValue" xlink:type="locator" />
    <link:presentationArc xlink:from="loc_MarketableSecuritiesAbstract.3334.12.8" xlink:to="loc_AvailableForSaleSecuritiesContinuousUnrealizedLossPositionTwelveMonthsOrLongerFairValue.6114.12.8" order="2.00000" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <link:loc xlink:label="loc_MarketableSecuritiesAbstract.3334.12.7" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_MarketableSecuritiesAbstract" xlink:type="locator" />
    <link:loc xlink:label="loc_InterestReceivable.11654.12.7" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_InterestReceivable" xlink:type="locator" />
    <link:presentationArc xlink:from="loc_MarketableSecuritiesAbstract.3334.12.7" xlink:to="loc_InterestReceivable.11654.12.7" order="4.00000" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:label="loc_MarketableSecuritiesAbstract.3334.12.53" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_MarketableSecuritiesAbstract" xlink:type="locator" />
    <link:loc xlink:label="loc_AvailableForSaleSecuritiesContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss.6107.12.53" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_AvailableForSaleSecuritiesContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss" xlink:type="locator" />
    <link:presentationArc xlink:from="loc_MarketableSecuritiesAbstract.3334.12.53" xlink:to="loc_AvailableForSaleSecuritiesContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss.6107.12.53" order="1.75000" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
    <link:loc xlink:label="loc_AvailableForSaleSecuritiesContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss.6105.12.53" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_AvailableForSaleSecuritiesContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss" xlink:type="locator" />
    <link:presentationArc xlink:from="loc_MarketableSecuritiesAbstract.3334.12.53" xlink:to="loc_AvailableForSaleSecuritiesContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss.6105.12.53" order="3.50000" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
  </link:presentationLink>
  <link:presentationLink xlink:title="303 - Disclosure - MARKETABLE SECURITIES (Tables)" xlink:role="http://www.pluristem.com/role/MarketableSecuritiesTables" xlink:type="extended">
    <link:loc xlink:label="loc_MarketableSecuritiesAbstract.3334.12.7" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_MarketableSecuritiesAbstract" xlink:type="locator" />
    <link:loc xlink:label="loc_AvailableForSaleSecuritiesTextBlock.6091.12.7" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_AvailableForSaleSecuritiesTextBlock" xlink:type="locator" />
    <link:presentationArc xlink:from="loc_MarketableSecuritiesAbstract.3334.12.7" xlink:to="loc_AvailableForSaleSecuritiesTextBlock.6091.12.7" order="1.00000" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:label="loc_AvailableForSaleSecuritiesContinuousUnrealizedLossPositionFairValueTableTextBlock.6144.12.7" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_AvailableForSaleSecuritiesContinuousUnrealizedLossPositionFairValueTableTextBlock" xlink:type="locator" />
    <link:presentationArc xlink:from="loc_MarketableSecuritiesAbstract.3334.12.7" xlink:to="loc_AvailableForSaleSecuritiesContinuousUnrealizedLossPositionFairValueTableTextBlock.6144.12.7" order="2.00000" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </link:presentationLink>
  <link:presentationLink xlink:title="111 - Disclosure - SUBSEQUENT EVENTS" xlink:role="http://www.pluristem.com/role/SubsequentEvents" xlink:type="extended">
    <link:loc xlink:label="loc_SubsequentEventsAbstract.5158.12.7" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_SubsequentEventsAbstract" xlink:type="locator" />
    <link:loc xlink:label="loc_SubsequentEventsTextBlock.17048.12.7" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_SubsequentEventsTextBlock" xlink:type="locator" />
    <link:presentationArc xlink:from="loc_SubsequentEventsAbstract.5158.12.7" xlink:to="loc_SubsequentEventsTextBlock.17048.12.7" order="1.00000" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </link:presentationLink>
  <link:presentationLink xlink:title="108 - Disclosure - STOCKHOLDERS' EQUITY" xlink:role="http://www.pluristem.com/role/StockholdersEquity" xlink:type="extended">
    <link:loc xlink:label="loc_StockholdersEquityNoteAbstract.5143.12.7" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_StockholdersEquityNoteAbstract" xlink:type="locator" />
    <link:loc xlink:label="loc_StockholdersEquityNoteDisclosureTextBlock.17027.12.7" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:type="locator" />
    <link:presentationArc xlink:from="loc_StockholdersEquityNoteAbstract.5143.12.7" xlink:to="loc_StockholdersEquityNoteDisclosureTextBlock.17027.12.7" order="1.00000" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </link:presentationLink>
  <link:presentationLink xlink:title="41101 - Disclosure - SUBSEQUENT EVENTS (Details)" xlink:role="http://www.pluristem.com/role/SubsequentEventsDetails" xlink:type="extended">
    <link:loc xlink:label="loc_SubsequentEventsAbstract.5158.12.6" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_SubsequentEventsAbstract" xlink:type="locator" />
    <link:loc xlink:label="loc_SubsequentEventTable.5159.12.6" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_SubsequentEventTable" xlink:type="locator" />
    <link:presentationArc xlink:from="loc_SubsequentEventsAbstract.5158.12.6" xlink:to="loc_SubsequentEventTable.5159.12.6" order="1.00000" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" />
    <link:loc xlink:label="loc_SubsequentEventTypeAxis.5163.12.6" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_SubsequentEventTypeAxis" xlink:type="locator" />
    <link:presentationArc xlink:from="loc_SubsequentEventTable.5159.12.6" xlink:to="loc_SubsequentEventTypeAxis.5163.12.6" order="1.00000" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" />
    <link:loc xlink:label="loc_SubsequentEventLineItems.5160.12.6" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_SubsequentEventLineItems" xlink:type="locator" />
    <link:presentationArc xlink:from="loc_SubsequentEventTable.5159.12.6" xlink:to="loc_SubsequentEventLineItems.5160.12.6" order="2.00000" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" />
    <link:loc xlink:label="loc_SubsequentEventLineItems.5160.12.7" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_SubsequentEventLineItems" xlink:type="locator" />
    <link:loc xlink:label="loc_GrantsReceivableCurrent.10654.12.7" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_GrantsReceivableCurrent" xlink:type="locator" />
    <link:presentationArc xlink:from="loc_SubsequentEventLineItems.5160.12.7" xlink:to="loc_GrantsReceivableCurrent.10654.12.7" order="1.00000" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:label="loc_SubsequentEventTypeDomain.5162.12.6" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_SubsequentEventTypeDomain" xlink:type="locator" />
    <link:loc xlink:label="loc_SubsequentEventMember.5161.12.6" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_SubsequentEventMember" xlink:type="locator" />
    <link:presentationArc xlink:from="loc_SubsequentEventTypeDomain.5162.12.6" xlink:to="loc_SubsequentEventMember.5161.12.6" order="1.00000" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" />
    <link:presentationArc xlink:from="loc_SubsequentEventTypeAxis.5163.12.6" xlink:to="loc_SubsequentEventTypeDomain.5162.12.6" order="1.00000" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" />
  </link:presentationLink>
  <link:presentationLink xlink:title="40801 - Disclosure - STOCKHOLDERS' EQUITY (Narrative) (Details)" xlink:role="http://www.pluristem.com/role/StockholdersEquityNarrativeDetails" xlink:type="extended">
    <link:loc xlink:label="loc_AwardTypeAxis.367.12.6" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_AwardTypeAxis" xlink:type="locator" />
    <link:loc xlink:label="loc_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain.5034.12.6" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:type="locator" />
    <link:presentationArc xlink:from="loc_AwardTypeAxis.367.12.6" xlink:to="loc_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain.5034.12.6" order="1.00000" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" />
    <link:loc xlink:label="loc_ClassOfStockLineItems.1047.12.7" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ClassOfStockLineItems" xlink:type="locator" />
    <link:loc xlink:label="loc_CommonStockAggregateOfferingPriceAuthorized.25533.12.7" xlink:href="psti-20140630.xsd#psti_CommonStockAggregateOfferingPriceAuthorized" xlink:type="locator" />
    <link:presentationArc xlink:from="loc_ClassOfStockLineItems.1047.12.7" xlink:to="loc_CommonStockAggregateOfferingPriceAuthorized.25533.12.7" order="14.00000" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:label="loc_ConversionOfStockSharesConverted1.7256.12.7" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ConversionOfStockSharesConverted1" xlink:type="locator" />
    <link:presentationArc xlink:from="loc_ClassOfStockLineItems.1047.12.7" xlink:to="loc_ConversionOfStockSharesConverted1.7256.12.7" order="8.00000" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:label="loc_ConversionOfStockSharesIssued1.7251.12.7" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ConversionOfStockSharesIssued1" xlink:type="locator" />
    <link:presentationArc xlink:from="loc_ClassOfStockLineItems.1047.12.7" xlink:to="loc_ConversionOfStockSharesIssued1.7251.12.7" order="9.00000" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:label="loc_StockIssuedDuringPeriodSharesStockOptionsExercised.16983.12.7" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:type="locator" />
    <link:presentationArc xlink:from="loc_ClassOfStockLineItems.1047.12.7" xlink:to="loc_StockIssuedDuringPeriodSharesStockOptionsExercised.16983.12.7" order="12.00000" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:label="loc_StockIssuedDuringPeriodSharesOther.16964.12.7" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesOther" xlink:type="locator" />
    <link:presentationArc xlink:from="loc_ClassOfStockLineItems.1047.12.7" xlink:to="loc_StockIssuedDuringPeriodSharesOther.16964.12.7" order="10.00000" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:label="loc_SharebasedGoodsAndNonemployeesServicesTransactionWarrantsAndOptionsExercised.25548.12.7" xlink:href="psti-20140630.xsd#psti_SharebasedGoodsAndNonemployeesServicesTransactionWarrantsAndOptionsExercised" xlink:type="locator" />
    <link:presentationArc xlink:from="loc_ClassOfStockLineItems.1047.12.7" xlink:to="loc_SharebasedGoodsAndNonemployeesServicesTransactionWarrantsAndOptionsExercised.25548.12.7" order="13.00000" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:label="loc_AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts.5793.12.7" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts" xlink:type="locator" />
    <link:presentationArc xlink:from="loc_ClassOfStockLineItems.1047.12.7" xlink:to="loc_AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts.5793.12.7" order="7.00000" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:label="loc_CommonStockSharesAuthorized.7058.12.7" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_CommonStockSharesAuthorized" xlink:type="locator" />
    <link:presentationArc xlink:from="loc_ClassOfStockLineItems.1047.12.7" xlink:to="loc_CommonStockSharesAuthorized.7058.12.7" order="1.00000" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:label="loc_CommonStockParOrStatedValuePerShare.7045.12.7" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_CommonStockParOrStatedValuePerShare" xlink:type="locator" />
    <link:presentationArc xlink:from="loc_ClassOfStockLineItems.1047.12.7" xlink:to="loc_CommonStockParOrStatedValuePerShare.7045.12.7" order="2.00000" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:label="loc_PreferredStockSharesAuthorized.14532.12.7" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_PreferredStockSharesAuthorized" xlink:type="locator" />
    <link:presentationArc xlink:from="loc_ClassOfStockLineItems.1047.12.7" xlink:to="loc_PreferredStockSharesAuthorized.14532.12.7" order="3.00000" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:label="loc_PreferredStockParOrStatedValuePerShare.14499.12.7" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_PreferredStockParOrStatedValuePerShare" xlink:type="locator" />
    <link:presentationArc xlink:from="loc_ClassOfStockLineItems.1047.12.7" xlink:to="loc_PreferredStockParOrStatedValuePerShare.14499.12.7" order="4.00000" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:label="loc_ProceedsFromWarrantExercises.14695.12.7" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ProceedsFromWarrantExercises" xlink:type="locator" />
    <link:presentationArc xlink:from="loc_ClassOfStockLineItems.1047.12.7" xlink:to="loc_ProceedsFromWarrantExercises.14695.12.7" order="10.50000" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:label="loc_SharebasedCompensationArrangementWarrantsExercised.25813.12.7" xlink:href="psti-20140630.xsd#psti_SharebasedCompensationArrangementWarrantsExercised" xlink:type="locator" />
    <link:presentationArc xlink:from="loc_ClassOfStockLineItems.1047.12.7" xlink:to="loc_SharebasedCompensationArrangementWarrantsExercised.25813.12.7" order="15.00000" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:label="loc_ClassOfStockLineItems.1047.12.8" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ClassOfStockLineItems" xlink:type="locator" />
    <link:loc xlink:label="loc_StockIssuedDuringPeriodSharesPurchaseOfAssets.16992.12.8" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesPurchaseOfAssets" xlink:type="locator" />
    <link:presentationArc xlink:from="loc_ClassOfStockLineItems.1047.12.8" xlink:to="loc_StockIssuedDuringPeriodSharesPurchaseOfAssets.16992.12.8" order="16.00000" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <link:loc xlink:label="loc_AvailableForSaleMarketableSecuritiesNumber.25527.12.7" xlink:href="psti-20140630.xsd#psti_AvailableForSaleMarketableSecuritiesNumber" xlink:type="locator" />
    <link:presentationArc xlink:from="loc_ClassOfStockLineItems.1047.12.7" xlink:to="loc_AvailableForSaleMarketableSecuritiesNumber.25527.12.7" order="17.00000" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:label="loc_StockIssuedDuringPeriodValuePurchaseOfAssets.17002.12.7" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_StockIssuedDuringPeriodValuePurchaseOfAssets" xlink:type="locator" />
    <link:presentationArc xlink:from="loc_ClassOfStockLineItems.1047.12.7" xlink:to="loc_StockIssuedDuringPeriodValuePurchaseOfAssets.17002.12.7" order="18.00000" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:label="loc_StockIssuedDuringPeriodSharesNewIssues.16990.12.7" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:type="locator" />
    <link:presentationArc xlink:from="loc_ClassOfStockLineItems.1047.12.7" xlink:to="loc_StockIssuedDuringPeriodSharesNewIssues.16990.12.7" order="19.00000" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:label="loc_SharesIssuedPricePerShare.16778.12.7" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_SharesIssuedPricePerShare" xlink:type="locator" />
    <link:presentationArc xlink:from="loc_ClassOfStockLineItems.1047.12.7" xlink:to="loc_SharesIssuedPricePerShare.16778.12.7" order="20.00000" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:label="loc_ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight.6954.12.7" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight" xlink:type="locator" />
    <link:presentationArc xlink:from="loc_ClassOfStockLineItems.1047.12.7" xlink:to="loc_ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight.6954.12.7" order="21.00000" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:label="loc_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1.6952.12.7" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" xlink:type="locator" />
    <link:presentationArc xlink:from="loc_ClassOfStockLineItems.1047.12.7" xlink:to="loc_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1.6952.12.7" order="22.00000" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:label="loc_StockIssuedDuringPeriodValueNewIssues.17003.12.7" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueNewIssues" xlink:type="locator" />
    <link:presentationArc xlink:from="loc_ClassOfStockLineItems.1047.12.7" xlink:to="loc_StockIssuedDuringPeriodValueNewIssues.17003.12.7" order="19.50000" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:label="loc_ClassOfWarrantOrRightOutstanding.6947.12.7" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ClassOfWarrantOrRightOutstanding" xlink:type="locator" />
    <link:presentationArc xlink:from="loc_ClassOfStockLineItems.1047.12.7" xlink:to="loc_ClassOfWarrantOrRightOutstanding.6947.12.7" order="22.50000" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:label="loc_StockIssuedDuringPeriodSharesIssuedForServices.16939.12.7" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesIssuedForServices" xlink:type="locator" />
    <link:presentationArc xlink:from="loc_ClassOfStockLineItems.1047.12.7" xlink:to="loc_StockIssuedDuringPeriodSharesIssuedForServices.16939.12.7" order="16.50000" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:label="loc_ProceedsFromIssuanceOfCommonStock.14855.12.8" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ProceedsFromIssuanceOfCommonStock" xlink:type="locator" />
    <link:presentationArc xlink:from="loc_ClassOfStockLineItems.1047.12.8" xlink:to="loc_ProceedsFromIssuanceOfCommonStock.14855.12.8" order="24.00000" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <link:loc xlink:label="loc_ClassOfWarrantOrRightAxis.1048.12.6" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ClassOfWarrantOrRightAxis" xlink:type="locator" />
    <link:loc xlink:label="loc_ClassOfWarrantOrRightDomain.1049.12.6" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ClassOfWarrantOrRightDomain" xlink:type="locator" />
    <link:presentationArc xlink:from="loc_ClassOfWarrantOrRightAxis.1048.12.6" xlink:to="loc_ClassOfWarrantOrRightDomain.1049.12.6" order="1.00000" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" />
    <link:loc xlink:label="loc_InvestorWarrantsMember.25814.12.6" xlink:href="psti-20140630.xsd#psti_InvestorWarrantsMember" xlink:type="locator" />
    <link:presentationArc xlink:from="loc_ClassOfWarrantOrRightDomain.1049.12.6" xlink:to="loc_InvestorWarrantsMember.25814.12.6" order="1.00000" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" />
    <link:loc xlink:label="loc_UnderwritersOptionMember.25815.12.6" xlink:href="psti-20140630.xsd#psti_UnderwritersOptionMember" xlink:type="locator" />
    <link:presentationArc xlink:from="loc_ClassOfWarrantOrRightDomain.1049.12.6" xlink:to="loc_UnderwritersOptionMember.25815.12.6" order="2.00000" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" />
    <link:loc xlink:label="loc_UnderwriterWarrantsMember.25744.12.6" xlink:href="psti-20140630.xsd#psti_UnderwriterWarrantsMember" xlink:type="locator" />
    <link:presentationArc xlink:from="loc_ClassOfWarrantOrRightDomain.1049.12.6" xlink:to="loc_UnderwriterWarrantsMember.25744.12.6" order="3.00000" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" />
    <link:loc xlink:label="loc_ConsultantWarrantsMember.25816.12.6" xlink:href="psti-20140630.xsd#psti_ConsultantWarrantsMember" xlink:type="locator" />
    <link:presentationArc xlink:from="loc_ClassOfWarrantOrRightDomain.1049.12.6" xlink:to="loc_ConsultantWarrantsMember.25816.12.6" order="4.00000" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" />
    <link:loc xlink:label="loc_ScheduleOfStockByClassTable.4849.12.6" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ScheduleOfStockByClassTable" xlink:type="locator" />
    <link:loc xlink:label="loc_StatementClassOfStockAxis.5117.12.6" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_StatementClassOfStockAxis" xlink:type="locator" />
    <link:presentationArc xlink:from="loc_ScheduleOfStockByClassTable.4849.12.6" xlink:to="loc_StatementClassOfStockAxis.5117.12.6" order="1.00000" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" />
    <link:loc xlink:label="loc_ClassOfStockLineItems.1047.12.6" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ClassOfStockLineItems" xlink:type="locator" />
    <link:presentationArc xlink:from="loc_ScheduleOfStockByClassTable.4849.12.6" xlink:to="loc_ClassOfStockLineItems.1047.12.6" order="2.00000" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" />
    <link:presentationArc xlink:from="loc_ScheduleOfStockByClassTable.4849.12.6" xlink:to="loc_ClassOfWarrantOrRightAxis.1048.12.6" order="1.50000" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" />
    <link:loc xlink:label="loc_ShareBasedGoodsAndNonemployeeServicesTransactionBySupplierAxis.5039.12.6" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ShareBasedGoodsAndNonemployeeServicesTransactionBySupplierAxis" xlink:type="locator" />
    <link:presentationArc xlink:from="loc_ScheduleOfStockByClassTable.4849.12.6" xlink:to="loc_ShareBasedGoodsAndNonemployeeServicesTransactionBySupplierAxis.5039.12.6" order="1.75000" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" />
    <link:loc xlink:label="loc_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable.4860.12.6" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:type="locator" />
    <link:presentationArc xlink:from="loc_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable.4860.12.6" xlink:to="loc_AwardTypeAxis.367.12.6" order="1.00000" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" />
    <link:loc xlink:label="loc_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems.5018.12.6" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:type="locator" />
    <link:presentationArc xlink:from="loc_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable.4860.12.6" xlink:to="loc_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems.5018.12.6" order="2.00000" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" />
    <link:loc xlink:label="loc_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems.5018.12.8" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:type="locator" />
    <link:loc xlink:label="loc_StockIssuedDuringPeriodSharesStockOptionsAndWarrantsExercised.25555.12.8" xlink:href="psti-20140630.xsd#psti_StockIssuedDuringPeriodSharesStockOptionsAndWarrantsExercised" xlink:type="locator" />
    <link:presentationArc xlink:from="loc_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems.5018.12.8" xlink:to="loc_StockIssuedDuringPeriodSharesStockOptionsAndWarrantsExercised.25555.12.8" order="1.00000" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <link:loc xlink:label="loc_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems.5018.12.7" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:type="locator" />
    <link:loc xlink:label="loc_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized.16705.12.7" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" xlink:type="locator" />
    <link:presentationArc xlink:from="loc_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems.5018.12.7" xlink:to="loc_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized.16705.12.7" order="2.00000" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:label="loc_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant.16701.12.7" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" xlink:type="locator" />
    <link:presentationArc xlink:from="loc_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems.5018.12.7" xlink:to="loc_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant.16701.12.7" order="3.00000" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:label="loc_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain.5034.12.7" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:type="locator" />
    <link:loc xlink:label="loc_EmployeeStockOptionMember.1835.12.7" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_EmployeeStockOptionMember" xlink:type="locator" />
    <link:presentationArc xlink:from="loc_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain.5034.12.7" xlink:to="loc_EmployeeStockOptionMember.1835.12.7" order="1.00000" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:label="loc_WarrantAwardsMember.25559.12.7" xlink:href="psti-20140630.xsd#psti_WarrantAwardsMember" xlink:type="locator" />
    <link:presentationArc xlink:from="loc_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain.5034.12.7" xlink:to="loc_WarrantAwardsMember.25559.12.7" order="2.00000" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:label="loc_ShareBasedGoodsAndNonemployeeServicesTransactionSupplierDomain.5036.12.6" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ShareBasedGoodsAndNonemployeeServicesTransactionSupplierDomain" xlink:type="locator" />
    <link:loc xlink:label="loc_BiopharmaxMember.25817.12.6" xlink:href="psti-20140630.xsd#psti_BiopharmaxMember" xlink:type="locator" />
    <link:presentationArc xlink:from="loc_ShareBasedGoodsAndNonemployeeServicesTransactionSupplierDomain.5036.12.6" xlink:to="loc_BiopharmaxMember.25817.12.6" order="1.00000" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" />
    <link:presentationArc xlink:from="loc_ShareBasedGoodsAndNonemployeeServicesTransactionBySupplierAxis.5039.12.6" xlink:to="loc_ShareBasedGoodsAndNonemployeeServicesTransactionSupplierDomain.5036.12.6" order="1.00000" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" />
    <link:loc xlink:label="loc_ClassOfStockDomain.1053.12.6" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ClassOfStockDomain" xlink:type="locator" />
    <link:presentationArc xlink:from="loc_StatementClassOfStockAxis.5117.12.6" xlink:to="loc_ClassOfStockDomain.1053.12.6" order="1.00000" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" />
    <link:loc xlink:label="loc_StockholdersEquityNoteAbstract.5143.12.6" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_StockholdersEquityNoteAbstract" xlink:type="locator" />
    <link:presentationArc xlink:from="loc_StockholdersEquityNoteAbstract.5143.12.6" xlink:to="loc_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable.4860.12.6" order="7.62500" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" />
    <link:presentationArc xlink:from="loc_StockholdersEquityNoteAbstract.5143.12.6" xlink:to="loc_ScheduleOfStockByClassTable.4849.12.6" order="1.00000" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" />
  </link:presentationLink>
  <link:presentationLink xlink:title="40806 - Disclosure - STOCKHOLDERS' EQUITY (Schedule of Compensation Expense) (Details)" xlink:role="http://www.pluristem.com/role/StockholdersEquityScheduleOfCompensationExpenseDetails" xlink:type="extended">
    <link:loc xlink:label="loc_AwardTypeAxis.367.12.6" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_AwardTypeAxis" xlink:type="locator" />
    <link:loc xlink:label="loc_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain.5034.12.6" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:type="locator" />
    <link:presentationArc xlink:from="loc_AwardTypeAxis.367.12.6" xlink:to="loc_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain.5034.12.6" order="1.00000" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" />
    <link:loc xlink:label="loc_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems.1848.12.7" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems" xlink:type="locator" />
    <link:loc xlink:label="loc_AllocatedShareBasedCompensationExpense.5851.12.7" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_AllocatedShareBasedCompensationExpense" xlink:type="locator" />
    <link:presentationArc xlink:from="loc_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems.1848.12.7" xlink:to="loc_AllocatedShareBasedCompensationExpense.5851.12.7" order="1.00000" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:label="loc_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized.9125.12.7" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized" xlink:type="locator" />
    <link:presentationArc xlink:from="loc_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems.1848.12.7" xlink:to="loc_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized.9125.12.7" order="2.00000" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:label="loc_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1.9127.12.7" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:type="locator" />
    <link:presentationArc xlink:from="loc_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems.1848.12.7" xlink:to="loc_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1.9127.12.7" order="3.00000" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:label="loc_IncomeStatementLocationAxis.2652.12.6" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_IncomeStatementLocationAxis" xlink:type="locator" />
    <link:loc xlink:label="loc_IncomeStatementLocationDomain.2668.12.6" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_IncomeStatementLocationDomain" xlink:type="locator" />
    <link:presentationArc xlink:from="loc_IncomeStatementLocationAxis.2652.12.6" xlink:to="loc_IncomeStatementLocationDomain.2668.12.6" order="1.00000" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" />
    <link:loc xlink:label="loc_IncomeStatementLocationDomain.2668.12.7" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_IncomeStatementLocationDomain" xlink:type="locator" />
    <link:loc xlink:label="loc_ResearchAndDevelopmentExpenseMember.4543.12.7" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ResearchAndDevelopmentExpenseMember" xlink:type="locator" />
    <link:presentationArc xlink:from="loc_IncomeStatementLocationDomain.2668.12.7" xlink:to="loc_ResearchAndDevelopmentExpenseMember.4543.12.7" order="1.00000" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:label="loc_GeneralAndAdministrativeExpenseMember.2476.12.7" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_GeneralAndAdministrativeExpenseMember" xlink:type="locator" />
    <link:presentationArc xlink:from="loc_IncomeStatementLocationDomain.2668.12.7" xlink:to="loc_GeneralAndAdministrativeExpenseMember.2476.12.7" order="2.00000" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:label="loc_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable.4779.12.6" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable" xlink:type="locator" />
    <link:presentationArc xlink:from="loc_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable.4779.12.6" xlink:to="loc_IncomeStatementLocationAxis.2652.12.6" order="1.00000" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" />
    <link:loc xlink:label="loc_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems.1848.12.6" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems" xlink:type="locator" />
    <link:presentationArc xlink:from="loc_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable.4779.12.6" xlink:to="loc_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems.1848.12.6" order="2.00000" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" />
    <link:presentationArc xlink:from="loc_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable.4779.12.6" xlink:to="loc_AwardTypeAxis.367.12.6" order="1.50000" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" />
    <link:loc xlink:label="loc_ShareBasedGoodsAndNonemployeeServicesTransactionBySupplierAxis.5039.12.6" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ShareBasedGoodsAndNonemployeeServicesTransactionBySupplierAxis" xlink:type="locator" />
    <link:presentationArc xlink:from="loc_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable.4779.12.6" xlink:to="loc_ShareBasedGoodsAndNonemployeeServicesTransactionBySupplierAxis.5039.12.6" order="1.75000" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" />
    <link:loc xlink:label="loc_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain.5034.12.7" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:type="locator" />
    <link:loc xlink:label="loc_EquityOptionsAndWarrantsMember.25537.12.7" xlink:href="psti-20140630.xsd#psti_EquityOptionsAndWarrantsMember" xlink:type="locator" />
    <link:presentationArc xlink:from="loc_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain.5034.12.7" xlink:to="loc_EquityOptionsAndWarrantsMember.25537.12.7" order="1.00000" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:label="loc_RestrictedStockUnitsRSUMember.4568.12.7" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_RestrictedStockUnitsRSUMember" xlink:type="locator" />
    <link:presentationArc xlink:from="loc_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain.5034.12.7" xlink:to="loc_RestrictedStockUnitsRSUMember.4568.12.7" order="2.00000" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:label="loc_ShareBasedGoodsAndNonemployeeServicesTransactionSupplierDomain.5036.12.6" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ShareBasedGoodsAndNonemployeeServicesTransactionSupplierDomain" xlink:type="locator" />
    <link:loc xlink:label="loc_ConsultantsMember.25535.12.6" xlink:href="psti-20140630.xsd#psti_ConsultantsMember" xlink:type="locator" />
    <link:presentationArc xlink:from="loc_ShareBasedGoodsAndNonemployeeServicesTransactionSupplierDomain.5036.12.6" xlink:to="loc_ConsultantsMember.25535.12.6" order="1.00000" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" />
    <link:presentationArc xlink:from="loc_ShareBasedGoodsAndNonemployeeServicesTransactionBySupplierAxis.5039.12.6" xlink:to="loc_ShareBasedGoodsAndNonemployeeServicesTransactionSupplierDomain.5036.12.6" order="1.00000" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" />
    <link:loc xlink:label="loc_StockholdersEquityNoteAbstract.5143.12.6" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_StockholdersEquityNoteAbstract" xlink:type="locator" />
    <link:presentationArc xlink:from="loc_StockholdersEquityNoteAbstract.5143.12.6" xlink:to="loc_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable.4779.12.6" order="1.00000" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" />
  </link:presentationLink>
  <link:presentationLink xlink:title="40802 - Disclosure - STOCKHOLDERS' EQUITY (Summary of Option Activity) (Details)" xlink:role="http://www.pluristem.com/role/StockholdersEquitySummaryOfOptionActivityDetails" xlink:type="extended">
    <link:loc xlink:label="loc_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract.5025.12.7" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract" xlink:type="locator" />
    <link:loc xlink:label="loc_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice.16710.12.7" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice" xlink:type="locator" />
    <link:presentationArc xlink:from="loc_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract.5025.12.7" xlink:to="loc_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice.16710.12.7" order="3.00000" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:label="loc_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract.5025.12.11" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract" xlink:type="locator" />
    <link:loc xlink:label="loc_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice.16713.12.11" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:type="locator" />
    <link:presentationArc xlink:from="loc_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract.5025.12.11" xlink:to="loc_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice.16713.12.11" order="4.00000" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
    <link:loc xlink:label="loc_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice.16734.12.11" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice" xlink:type="locator" />
    <link:presentationArc xlink:from="loc_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract.5025.12.11" xlink:to="loc_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice.16734.12.11" order="6.00000" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
    <link:loc xlink:label="loc_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice.16680.12.11" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" xlink:type="locator" />
    <link:presentationArc xlink:from="loc_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract.5025.12.11" xlink:to="loc_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice.16680.12.11" order="5.00000" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
    <link:loc xlink:label="loc_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract.5025.12.10" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract" xlink:type="locator" />
    <link:loc xlink:label="loc_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice.16713.12.10" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:type="locator" />
    <link:presentationArc xlink:from="loc_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract.5025.12.10" xlink:to="loc_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice.16713.12.10" order="1.00000" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" />
    <link:loc xlink:label="loc_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice.16675.12.7" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:type="locator" />
    <link:presentationArc xlink:from="loc_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract.5025.12.7" xlink:to="loc_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice.16675.12.7" order="2.50000" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:label="loc_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward.5033.12.11" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:type="locator" />
    <link:loc xlink:label="loc_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber.16729.12.11" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber" xlink:type="locator" />
    <link:presentationArc xlink:from="loc_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward.5033.12.11" xlink:to="loc_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber.16729.12.11" order="6.00000" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
    <link:loc xlink:label="loc_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber.16696.12.11" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" xlink:type="locator" />
    <link:presentationArc xlink:from="loc_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward.5033.12.11" xlink:to="loc_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber.16696.12.11" order="5.00000" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
    <link:loc xlink:label="loc_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber.16721.12.11" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:type="locator" />
    <link:presentationArc xlink:from="loc_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward.5033.12.11" xlink:to="loc_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber.16721.12.11" order="3.87500" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
    <link:loc xlink:label="loc_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward.5033.12.53" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:type="locator" />
    <link:loc xlink:label="loc_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod.16694.12.53" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" xlink:type="locator" />
    <link:presentationArc xlink:from="loc_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward.5033.12.53" xlink:to="loc_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod.16694.12.53" order="3.75000" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
    <link:loc xlink:label="loc_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward.5033.12.10" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:type="locator" />
    <link:loc xlink:label="loc_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber.16721.12.10" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:type="locator" />
    <link:presentationArc xlink:from="loc_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward.5033.12.10" xlink:to="loc_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber.16721.12.10" order="1.00000" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" />
    <link:loc xlink:label="loc_StockIssuedDuringPeriodSharesStockOptionsExercised.16983.12.53" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:type="locator" />
    <link:presentationArc xlink:from="loc_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward.5033.12.53" xlink:to="loc_StockIssuedDuringPeriodSharesStockOptionsExercised.16983.12.53" order="2.25000" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
    <link:loc xlink:label="loc_StockholdersEquityNoteAbstract.5143.12.7" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_StockholdersEquityNoteAbstract" xlink:type="locator" />
    <link:loc xlink:label="loc_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward.5033.12.7" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:type="locator" />
    <link:presentationArc xlink:from="loc_StockholdersEquityNoteAbstract.5143.12.7" xlink:to="loc_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward.5033.12.7" order="3.00000" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:from="loc_StockholdersEquityNoteAbstract.5143.12.7" xlink:to="loc_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract.5025.12.7" order="4.00000" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:label="loc_AggregateIntrinsicValueAbstract.25525.12.7" xlink:href="psti-20140630.xsd#psti_AggregateIntrinsicValueAbstract" xlink:type="locator" />
    <link:presentationArc xlink:from="loc_StockholdersEquityNoteAbstract.5143.12.7" xlink:to="loc_AggregateIntrinsicValueAbstract.25525.12.7" order="6.00000" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:label="loc_WeightedAverageRemainingContractualTermsAbstract.25575.12.7" xlink:href="psti-20140630.xsd#psti_WeightedAverageRemainingContractualTermsAbstract" xlink:type="locator" />
    <link:presentationArc xlink:from="loc_StockholdersEquityNoteAbstract.5143.12.7" xlink:to="loc_WeightedAverageRemainingContractualTermsAbstract.25575.12.7" order="5.00000" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:label="loc_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue.16715.12.7" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue" xlink:type="locator" />
    <link:presentationArc xlink:from="loc_AggregateIntrinsicValueAbstract.25525.12.7" xlink:to="loc_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue.16715.12.7" order="3.00000" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:label="loc_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1.15973.12.7" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1" xlink:type="locator" />
    <link:presentationArc xlink:from="loc_AggregateIntrinsicValueAbstract.25525.12.7" xlink:to="loc_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1.15973.12.7" order="2.00000" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:label="loc_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue.16730.12.7" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" xlink:type="locator" />
    <link:presentationArc xlink:from="loc_AggregateIntrinsicValueAbstract.25525.12.7" xlink:to="loc_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue.16730.12.7" order="1.00000" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:label="loc_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1.15994.12.7" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1" xlink:type="locator" />
    <link:presentationArc xlink:from="loc_WeightedAverageRemainingContractualTermsAbstract.25575.12.7" xlink:to="loc_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1.15994.12.7" order="1.50000" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:label="loc_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1.15995.12.7" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1" xlink:type="locator" />
    <link:presentationArc xlink:from="loc_WeightedAverageRemainingContractualTermsAbstract.25575.12.7" xlink:to="loc_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1.15995.12.7" order="4.00000" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:label="loc_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2.15996.12.7" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:type="locator" />
    <link:presentationArc xlink:from="loc_WeightedAverageRemainingContractualTermsAbstract.25575.12.7" xlink:to="loc_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2.15996.12.7" order="1.25000" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </link:presentationLink>
  <link:presentationLink xlink:title="40803 - Disclosure - STOCKHOLDERS' EQUITY (Summary of Option and Warrant Activity to Non-employees) (Details)" xlink:role="http://www.pluristem.com/role/StockholdersEquitySummaryOfOptionAndWarrantActivityToNonemployeesDetails" xlink:type="extended">
    <link:loc xlink:label="loc_StockholdersEquityNoteAbstract.5143.12.7" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_StockholdersEquityNoteAbstract" xlink:type="locator" />
    <link:loc xlink:label="loc_WarrantsAndOptionsNumberAbstract.25566.12.7" xlink:href="psti-20140630.xsd#psti_WarrantsAndOptionsNumberAbstract" xlink:type="locator" />
    <link:presentationArc xlink:from="loc_StockholdersEquityNoteAbstract.5143.12.7" xlink:to="loc_WarrantsAndOptionsNumberAbstract.25566.12.7" order="3.00000" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:label="loc_WarrantsAndOptionsWeightedAverageExercisePriceAbstract.25568.12.7" xlink:href="psti-20140630.xsd#psti_WarrantsAndOptionsWeightedAverageExercisePriceAbstract" xlink:type="locator" />
    <link:presentationArc xlink:from="loc_StockholdersEquityNoteAbstract.5143.12.7" xlink:to="loc_WarrantsAndOptionsWeightedAverageExercisePriceAbstract.25568.12.7" order="4.00000" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:label="loc_WarrantsAndOptionsWeightedAverageRemainingContractualTermsAbstract.25573.12.7" xlink:href="psti-20140630.xsd#psti_WarrantsAndOptionsWeightedAverageRemainingContractualTermsAbstract" xlink:type="locator" />
    <link:presentationArc xlink:from="loc_StockholdersEquityNoteAbstract.5143.12.7" xlink:to="loc_WarrantsAndOptionsWeightedAverageRemainingContractualTermsAbstract.25573.12.7" order="5.00000" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:label="loc_WarrantsAndOptionsAggregateIntrinsicValuePriceAbstract.25562.12.7" xlink:href="psti-20140630.xsd#psti_WarrantsAndOptionsAggregateIntrinsicValuePriceAbstract" xlink:type="locator" />
    <link:presentationArc xlink:from="loc_StockholdersEquityNoteAbstract.5143.12.7" xlink:to="loc_WarrantsAndOptionsAggregateIntrinsicValuePriceAbstract.25562.12.7" order="6.00000" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:label="loc_WarrantsAndOptionsAggregateIntrinsicValue.25560.12.7" xlink:href="psti-20140630.xsd#psti_WarrantsAndOptionsAggregateIntrinsicValue" xlink:type="locator" />
    <link:presentationArc xlink:from="loc_WarrantsAndOptionsAggregateIntrinsicValuePriceAbstract.25562.12.7" xlink:to="loc_WarrantsAndOptionsAggregateIntrinsicValue.25560.12.7" order="1.00000" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:label="loc_WarrantsAndOptionsAggregateIntrinsicValueExercisable.25561.12.7" xlink:href="psti-20140630.xsd#psti_WarrantsAndOptionsAggregateIntrinsicValueExercisable" xlink:type="locator" />
    <link:presentationArc xlink:from="loc_WarrantsAndOptionsAggregateIntrinsicValuePriceAbstract.25562.12.7" xlink:to="loc_WarrantsAndOptionsAggregateIntrinsicValueExercisable.25561.12.7" order="2.00000" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:label="loc_WarrantsAndOptionsAggregateIntrinsicValueVestedAndExpectedToVest.25563.12.7" xlink:href="psti-20140630.xsd#psti_WarrantsAndOptionsAggregateIntrinsicValueVestedAndExpectedToVest" xlink:type="locator" />
    <link:presentationArc xlink:from="loc_WarrantsAndOptionsAggregateIntrinsicValuePriceAbstract.25562.12.7" xlink:to="loc_WarrantsAndOptionsAggregateIntrinsicValueVestedAndExpectedToVest.25563.12.7" order="3.00000" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:label="loc_WarrantsAndOptionsNumberAbstract.25566.12.10" xlink:href="psti-20140630.xsd#psti_WarrantsAndOptionsNumberAbstract" xlink:type="locator" />
    <link:loc xlink:label="loc_SharebasedGoodsAndNonemployeesServicesTransactionWarrantsAndOptionsNumber.25550.12.10" xlink:href="psti-20140630.xsd#psti_SharebasedGoodsAndNonemployeesServicesTransactionWarrantsAndOptionsNumber" xlink:type="locator" />
    <link:presentationArc xlink:from="loc_WarrantsAndOptionsNumberAbstract.25566.12.10" xlink:to="loc_SharebasedGoodsAndNonemployeesServicesTransactionWarrantsAndOptionsNumber.25550.12.10" order="1.00000" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" />
    <link:loc xlink:label="loc_SharebasedGoodsAndNonemployeesServicesTransactionWarrantsAndOptionsGranted.25549.12.7" xlink:href="psti-20140630.xsd#psti_SharebasedGoodsAndNonemployeesServicesTransactionWarrantsAndOptionsGranted" xlink:type="locator" />
    <link:presentationArc xlink:from="loc_WarrantsAndOptionsNumberAbstract.25566.12.7" xlink:to="loc_SharebasedGoodsAndNonemployeesServicesTransactionWarrantsAndOptionsGranted.25549.12.7" order="2.00000" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:label="loc_WarrantsAndOptionsNumberAbstract.25566.12.53" xlink:href="psti-20140630.xsd#psti_WarrantsAndOptionsNumberAbstract" xlink:type="locator" />
    <link:loc xlink:label="loc_SharebasedGoodsAndNonemployeesServicesTransactionWarrantsAndOptionsExercised.25548.12.53" xlink:href="psti-20140630.xsd#psti_SharebasedGoodsAndNonemployeesServicesTransactionWarrantsAndOptionsExercised" xlink:type="locator" />
    <link:presentationArc xlink:from="loc_WarrantsAndOptionsNumberAbstract.25566.12.53" xlink:to="loc_SharebasedGoodsAndNonemployeesServicesTransactionWarrantsAndOptionsExercised.25548.12.53" order="3.00000" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
    <link:loc xlink:label="loc_WarrantsAndOptionsNumberAbstract.25566.12.11" xlink:href="psti-20140630.xsd#psti_WarrantsAndOptionsNumberAbstract" xlink:type="locator" />
    <link:loc xlink:label="loc_SharebasedGoodsAndNonemployeesServicesTransactionWarrantsAndOptionsNumberExercisable.25551.12.11" xlink:href="psti-20140630.xsd#psti_SharebasedGoodsAndNonemployeesServicesTransactionWarrantsAndOptionsNumberExercisable" xlink:type="locator" />
    <link:presentationArc xlink:from="loc_WarrantsAndOptionsNumberAbstract.25566.12.11" xlink:to="loc_SharebasedGoodsAndNonemployeesServicesTransactionWarrantsAndOptionsNumberExercisable.25551.12.11" order="5.00000" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
    <link:loc xlink:label="loc_SharebasedGoodsAndNonemployeesServicesTransactionWarrantsAndOptionsNumberVestedAndExpectedToVest.25552.12.11" xlink:href="psti-20140630.xsd#psti_SharebasedGoodsAndNonemployeesServicesTransactionWarrantsAndOptionsNumberVestedAndExpectedToVest" xlink:type="locator" />
    <link:presentationArc xlink:from="loc_WarrantsAndOptionsNumberAbstract.25566.12.11" xlink:to="loc_SharebasedGoodsAndNonemployeesServicesTransactionWarrantsAndOptionsNumberVestedAndExpectedToVest.25552.12.11" order="6.00000" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
    <link:loc xlink:label="loc_SharebasedGoodsAndNonemployeesServicesTransactionWarrantsAndOptionsNumber.25550.12.11" xlink:href="psti-20140630.xsd#psti_SharebasedGoodsAndNonemployeesServicesTransactionWarrantsAndOptionsNumber" xlink:type="locator" />
    <link:presentationArc xlink:from="loc_WarrantsAndOptionsNumberAbstract.25566.12.11" xlink:to="loc_SharebasedGoodsAndNonemployeesServicesTransactionWarrantsAndOptionsNumber.25550.12.11" order="4.00000" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
    <link:loc xlink:label="loc_WarrantsAndOptionsWeightedAverageExercisePriceAbstract.25568.12.10" xlink:href="psti-20140630.xsd#psti_WarrantsAndOptionsWeightedAverageExercisePriceAbstract" xlink:type="locator" />
    <link:loc xlink:label="loc_WarrantsAndOptionsWeightedAverageExercisePrice.25567.12.10" xlink:href="psti-20140630.xsd#psti_WarrantsAndOptionsWeightedAverageExercisePrice" xlink:type="locator" />
    <link:presentationArc xlink:from="loc_WarrantsAndOptionsWeightedAverageExercisePriceAbstract.25568.12.10" xlink:to="loc_WarrantsAndOptionsWeightedAverageExercisePrice.25567.12.10" order="1.00000" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" />
    <link:loc xlink:label="loc_WarrantsAndOptionsGrantedWeightedAverageExercisePrice.25565.12.7" xlink:href="psti-20140630.xsd#psti_WarrantsAndOptionsGrantedWeightedAverageExercisePrice" xlink:type="locator" />
    <link:presentationArc xlink:from="loc_WarrantsAndOptionsWeightedAverageExercisePriceAbstract.25568.12.7" xlink:to="loc_WarrantsAndOptionsGrantedWeightedAverageExercisePrice.25565.12.7" order="2.00000" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:label="loc_WarrantsAndOptionsExercisedWeightedAverageExercisePrice.25564.12.7" xlink:href="psti-20140630.xsd#psti_WarrantsAndOptionsExercisedWeightedAverageExercisePrice" xlink:type="locator" />
    <link:presentationArc xlink:from="loc_WarrantsAndOptionsWeightedAverageExercisePriceAbstract.25568.12.7" xlink:to="loc_WarrantsAndOptionsExercisedWeightedAverageExercisePrice.25564.12.7" order="3.00000" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:label="loc_WarrantsAndOptionsWeightedAverageExercisePriceAbstract.25568.12.11" xlink:href="psti-20140630.xsd#psti_WarrantsAndOptionsWeightedAverageExercisePriceAbstract" xlink:type="locator" />
    <link:loc xlink:label="loc_WarrantsAndOptionsWeightedAverageExercisePriceExcercisable.25569.12.11" xlink:href="psti-20140630.xsd#psti_WarrantsAndOptionsWeightedAverageExercisePriceExcercisable" xlink:type="locator" />
    <link:presentationArc xlink:from="loc_WarrantsAndOptionsWeightedAverageExercisePriceAbstract.25568.12.11" xlink:to="loc_WarrantsAndOptionsWeightedAverageExercisePriceExcercisable.25569.12.11" order="5.00000" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
    <link:loc xlink:label="loc_WarrantsAndOptionsWeightedAverageExercisePriceVestedAndExpectedToVest.25570.12.11" xlink:href="psti-20140630.xsd#psti_WarrantsAndOptionsWeightedAverageExercisePriceVestedAndExpectedToVest" xlink:type="locator" />
    <link:presentationArc xlink:from="loc_WarrantsAndOptionsWeightedAverageExercisePriceAbstract.25568.12.11" xlink:to="loc_WarrantsAndOptionsWeightedAverageExercisePriceVestedAndExpectedToVest.25570.12.11" order="6.00000" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
    <link:loc xlink:label="loc_WarrantsAndOptionsWeightedAverageExercisePrice.25567.12.11" xlink:href="psti-20140630.xsd#psti_WarrantsAndOptionsWeightedAverageExercisePrice" xlink:type="locator" />
    <link:presentationArc xlink:from="loc_WarrantsAndOptionsWeightedAverageExercisePriceAbstract.25568.12.11" xlink:to="loc_WarrantsAndOptionsWeightedAverageExercisePrice.25567.12.11" order="4.00000" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
    <link:loc xlink:label="loc_WarrantsAndOptionsWeightedAverageRemainingContractualTerm.25571.12.7" xlink:href="psti-20140630.xsd#psti_WarrantsAndOptionsWeightedAverageRemainingContractualTerm" xlink:type="locator" />
    <link:presentationArc xlink:from="loc_WarrantsAndOptionsWeightedAverageRemainingContractualTermsAbstract.25573.12.7" xlink:to="loc_WarrantsAndOptionsWeightedAverageRemainingContractualTerm.25571.12.7" order="1.00000" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:label="loc_WarrantsAndOptionsWeightedAverageRemainingContractualTermExercisable.25572.12.7" xlink:href="psti-20140630.xsd#psti_WarrantsAndOptionsWeightedAverageRemainingContractualTermExercisable" xlink:type="locator" />
    <link:presentationArc xlink:from="loc_WarrantsAndOptionsWeightedAverageRemainingContractualTermsAbstract.25573.12.7" xlink:to="loc_WarrantsAndOptionsWeightedAverageRemainingContractualTermExercisable.25572.12.7" order="2.00000" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:label="loc_WarrantsAndOptionsWeightedAverageRemainingContractualTermVestedAndExpectedToVest.25574.12.7" xlink:href="psti-20140630.xsd#psti_WarrantsAndOptionsWeightedAverageRemainingContractualTermVestedAndExpectedToVest" xlink:type="locator" />
    <link:presentationArc xlink:from="loc_WarrantsAndOptionsWeightedAverageRemainingContractualTermsAbstract.25573.12.7" xlink:to="loc_WarrantsAndOptionsWeightedAverageRemainingContractualTermVestedAndExpectedToVest.25574.12.7" order="3.00000" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </link:presentationLink>
  <link:presentationLink xlink:title="40805 - Disclosure - STOCKHOLDERS' EQUITY (Summary of RSU Activity to Consultants) (Details)" xlink:role="http://www.pluristem.com/role/StockholdersEquitySummaryOfRsuActivityToConsultantsDetails" xlink:type="extended">
    <link:loc xlink:label="loc_ScheduleOfShareBasedGoodsAndNonemployeeServicesTransactionTable.4869.12.6" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ScheduleOfShareBasedGoodsAndNonemployeeServicesTransactionTable" xlink:type="locator" />
    <link:loc xlink:label="loc_ShareBasedGoodsAndNonemployeeServicesTransactionBySupplierAxis.5039.12.6" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ShareBasedGoodsAndNonemployeeServicesTransactionBySupplierAxis" xlink:type="locator" />
    <link:presentationArc xlink:from="loc_ScheduleOfShareBasedGoodsAndNonemployeeServicesTransactionTable.4869.12.6" xlink:to="loc_ShareBasedGoodsAndNonemployeeServicesTransactionBySupplierAxis.5039.12.6" order="1.00000" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" />
    <link:loc xlink:label="loc_ShareBasedGoodsAndNonemployeeServicesTransactionLineItems.5038.12.6" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ShareBasedGoodsAndNonemployeeServicesTransactionLineItems" xlink:type="locator" />
    <link:presentationArc xlink:from="loc_ScheduleOfShareBasedGoodsAndNonemployeeServicesTransactionTable.4869.12.6" xlink:to="loc_ShareBasedGoodsAndNonemployeeServicesTransactionLineItems.5038.12.6" order="2.00000" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" />
    <link:loc xlink:label="loc_ShareBasedGoodsAndNonemployeeServicesTransactionSupplierDomain.5036.12.6" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ShareBasedGoodsAndNonemployeeServicesTransactionSupplierDomain" xlink:type="locator" />
    <link:loc xlink:label="loc_ConsultantsMember.25535.12.6" xlink:href="psti-20140630.xsd#psti_ConsultantsMember" xlink:type="locator" />
    <link:presentationArc xlink:from="loc_ShareBasedGoodsAndNonemployeeServicesTransactionSupplierDomain.5036.12.6" xlink:to="loc_ConsultantsMember.25535.12.6" order="1.00000" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" />
    <link:loc xlink:label="loc_ShareBasedGoodsAndNonemployeeServicesTransactionLineItems.5038.12.10" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ShareBasedGoodsAndNonemployeeServicesTransactionLineItems" xlink:type="locator" />
    <link:loc xlink:label="loc_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber.16626.12.10" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:type="locator" />
    <link:presentationArc xlink:from="loc_ShareBasedGoodsAndNonemployeeServicesTransactionLineItems.5038.12.10" xlink:to="loc_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber.16626.12.10" order="1.00000" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" />
    <link:loc xlink:label="loc_ShareBasedGoodsAndNonemployeeServicesTransactionLineItems.5038.12.7" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ShareBasedGoodsAndNonemployeeServicesTransactionLineItems" xlink:type="locator" />
    <link:loc xlink:label="loc_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod.16617.12.7" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:type="locator" />
    <link:presentationArc xlink:from="loc_ShareBasedGoodsAndNonemployeeServicesTransactionLineItems.5038.12.7" xlink:to="loc_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod.16617.12.7" order="2.00000" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:label="loc_ShareBasedGoodsAndNonemployeeServicesTransactionLineItems.5038.12.53" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ShareBasedGoodsAndNonemployeeServicesTransactionLineItems" xlink:type="locator" />
    <link:loc xlink:label="loc_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod.16633.12.53" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" xlink:type="locator" />
    <link:presentationArc xlink:from="loc_ShareBasedGoodsAndNonemployeeServicesTransactionLineItems.5038.12.53" xlink:to="loc_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod.16633.12.53" order="4.00000" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
    <link:loc xlink:label="loc_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsExpectedToVest.25547.12.7" xlink:href="psti-20140630.xsd#psti_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsExpectedToVest" xlink:type="locator" />
    <link:presentationArc xlink:from="loc_ShareBasedGoodsAndNonemployeeServicesTransactionLineItems.5038.12.7" xlink:to="loc_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsExpectedToVest.25547.12.7" order="6.00000" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:label="loc_ShareBasedGoodsAndNonemployeeServicesTransactionLineItems.5038.12.11" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ShareBasedGoodsAndNonemployeeServicesTransactionLineItems" xlink:type="locator" />
    <link:loc xlink:label="loc_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber.16626.12.11" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:type="locator" />
    <link:presentationArc xlink:from="loc_ShareBasedGoodsAndNonemployeeServicesTransactionLineItems.5038.12.11" xlink:to="loc_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber.16626.12.11" order="5.00000" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
    <link:loc xlink:label="loc_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod.16661.12.53" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" xlink:type="locator" />
    <link:presentationArc xlink:from="loc_ShareBasedGoodsAndNonemployeeServicesTransactionLineItems.5038.12.53" xlink:to="loc_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod.16661.12.53" order="3.00000" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
    <link:presentationArc xlink:from="loc_ShareBasedGoodsAndNonemployeeServicesTransactionBySupplierAxis.5039.12.6" xlink:to="loc_ShareBasedGoodsAndNonemployeeServicesTransactionSupplierDomain.5036.12.6" order="1.00000" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" />
    <link:loc xlink:label="loc_StockholdersEquityNoteAbstract.5143.12.6" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_StockholdersEquityNoteAbstract" xlink:type="locator" />
    <link:presentationArc xlink:from="loc_StockholdersEquityNoteAbstract.5143.12.6" xlink:to="loc_ScheduleOfShareBasedGoodsAndNonemployeeServicesTransactionTable.4869.12.6" order="2.00000" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" />
  </link:presentationLink>
  <link:presentationLink xlink:title="40804 - Disclosure - STOCKHOLDERS' EQUITY (Summary of RSU Activity to Employees and Directors) (Details)" xlink:role="http://www.pluristem.com/role/StockholdersEquitySummaryOfRsuActivityToEmployeesAndDirectorsDetails" xlink:type="extended">
    <link:loc xlink:label="loc_AwardTypeAxis.367.12.6" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_AwardTypeAxis" xlink:type="locator" />
    <link:loc xlink:label="loc_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain.5034.12.6" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:type="locator" />
    <link:presentationArc xlink:from="loc_AwardTypeAxis.367.12.6" xlink:to="loc_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain.5034.12.6" order="1.00000" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" />
    <link:loc xlink:label="loc_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable.4860.12.6" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:type="locator" />
    <link:loc xlink:label="loc_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems.5018.12.6" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:type="locator" />
    <link:presentationArc xlink:from="loc_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable.4860.12.6" xlink:to="loc_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems.5018.12.6" order="2.00000" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" />
    <link:presentationArc xlink:from="loc_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable.4860.12.6" xlink:to="loc_AwardTypeAxis.367.12.6" order="1.25000" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" />
    <link:loc xlink:label="loc_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems.5018.12.10" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:type="locator" />
    <link:loc xlink:label="loc_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber.16626.12.10" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:type="locator" />
    <link:presentationArc xlink:from="loc_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems.5018.12.10" xlink:to="loc_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber.16626.12.10" order="1.00000" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" />
    <link:loc xlink:label="loc_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems.5018.12.7" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:type="locator" />
    <link:loc xlink:label="loc_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod.16617.12.7" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:type="locator" />
    <link:presentationArc xlink:from="loc_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems.5018.12.7" xlink:to="loc_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod.16617.12.7" order="2.00000" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:label="loc_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems.5018.12.53" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:type="locator" />
    <link:loc xlink:label="loc_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod.16661.12.53" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" xlink:type="locator" />
    <link:presentationArc xlink:from="loc_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems.5018.12.53" xlink:to="loc_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod.16661.12.53" order="3.00000" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
    <link:loc xlink:label="loc_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod.16633.12.53" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" xlink:type="locator" />
    <link:presentationArc xlink:from="loc_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems.5018.12.53" xlink:to="loc_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod.16633.12.53" order="4.00000" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
    <link:loc xlink:label="loc_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsExpectedToVest.25547.12.7" xlink:href="psti-20140630.xsd#psti_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsExpectedToVest" xlink:type="locator" />
    <link:presentationArc xlink:from="loc_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems.5018.12.7" xlink:to="loc_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsExpectedToVest.25547.12.7" order="6.00000" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:label="loc_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems.5018.12.11" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:type="locator" />
    <link:loc xlink:label="loc_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber.16626.12.11" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:type="locator" />
    <link:presentationArc xlink:from="loc_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems.5018.12.11" xlink:to="loc_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber.16626.12.11" order="5.00000" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
    <link:loc xlink:label="loc_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain.5034.12.7" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:type="locator" />
    <link:loc xlink:label="loc_RestrictedStockUnitsRSUMember.4568.12.7" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_RestrictedStockUnitsRSUMember" xlink:type="locator" />
    <link:presentationArc xlink:from="loc_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain.5034.12.7" xlink:to="loc_RestrictedStockUnitsRSUMember.4568.12.7" order="4.00000" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:label="loc_StockholdersEquityNoteAbstract.5143.12.6" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_StockholdersEquityNoteAbstract" xlink:type="locator" />
    <link:presentationArc xlink:from="loc_StockholdersEquityNoteAbstract.5143.12.6" xlink:to="loc_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable.4860.12.6" order="1.00000" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" />
  </link:presentationLink>
  <link:presentationLink xlink:title="308 - Disclosure - STOCKHOLDERS' EQUITY (Tables)" xlink:role="http://www.pluristem.com/role/StockholdersEquityTables" xlink:type="extended">
    <link:loc xlink:label="loc_AwardTypeAxis.367.12.6" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_AwardTypeAxis" xlink:type="locator" />
    <link:loc xlink:label="loc_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain.5034.12.6" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:type="locator" />
    <link:presentationArc xlink:from="loc_AwardTypeAxis.367.12.6" xlink:to="loc_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain.5034.12.6" order="1.00000" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" />
    <link:loc xlink:label="loc_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain.5034.12.7" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:type="locator" />
    <link:loc xlink:label="loc_ConsultantRestrictedStockUnitsMember.25534.12.7" xlink:href="psti-20140630.xsd#psti_ConsultantRestrictedStockUnitsMember" xlink:type="locator" />
    <link:presentationArc xlink:from="loc_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain.5034.12.7" xlink:to="loc_ConsultantRestrictedStockUnitsMember.25534.12.7" order="2.00000" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:label="loc_EquityOptionsAndWarrantsMember.25537.12.7" xlink:href="psti-20140630.xsd#psti_EquityOptionsAndWarrantsMember" xlink:type="locator" />
    <link:presentationArc xlink:from="loc_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain.5034.12.7" xlink:to="loc_EquityOptionsAndWarrantsMember.25537.12.7" order="0.20000" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:label="loc_RestrictedStockUnitsRSUMember.4568.12.7" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_RestrictedStockUnitsRSUMember" xlink:type="locator" />
    <link:presentationArc xlink:from="loc_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain.5034.12.7" xlink:to="loc_RestrictedStockUnitsRSUMember.4568.12.7" order="1.50000" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:label="loc_StockholdersEquityNoteAbstract.5143.12.6" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_StockholdersEquityNoteAbstract" xlink:type="locator" />
    <link:loc xlink:label="loc_StockholdersEquityNoteTable.25554.12.6" xlink:href="psti-20140630.xsd#psti_StockholdersEquityNoteTable" xlink:type="locator" />
    <link:presentationArc xlink:from="loc_StockholdersEquityNoteAbstract.5143.12.6" xlink:to="loc_StockholdersEquityNoteTable.25554.12.6" order="3.00000" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" />
    <link:loc xlink:label="loc_StockholdersEquityNoteAbstract.5143.12.7" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_StockholdersEquityNoteAbstract" xlink:type="locator" />
    <link:loc xlink:label="loc_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock.16116.12.7" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" xlink:type="locator" />
    <link:presentationArc xlink:from="loc_StockholdersEquityNoteAbstract.5143.12.7" xlink:to="loc_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock.16116.12.7" order="1.00000" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:label="loc_ScheduleOfShareBasedCompensationActivityTableTextBlock.16175.12.7" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationActivityTableTextBlock" xlink:type="locator" />
    <link:presentationArc xlink:from="loc_StockholdersEquityNoteAbstract.5143.12.7" xlink:to="loc_ScheduleOfShareBasedCompensationActivityTableTextBlock.16175.12.7" order="2.00000" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:label="loc_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTextBlock.16376.12.7" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTextBlock" xlink:type="locator" />
    <link:presentationArc xlink:from="loc_StockholdersEquityNoteAbstract.5143.12.7" xlink:to="loc_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTextBlock.16376.12.7" order="2.50000" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:label="loc_StockholdersEquityNoteLineItems.25553.12.7" xlink:href="psti-20140630.xsd#psti_StockholdersEquityNoteLineItems" xlink:type="locator" />
    <link:loc xlink:label="loc_ScheduleOfNonvestedRestrictedStockUnitsActivityTableTextBlock.16168.12.7" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ScheduleOfNonvestedRestrictedStockUnitsActivityTableTextBlock" xlink:type="locator" />
    <link:presentationArc xlink:from="loc_StockholdersEquityNoteLineItems.25553.12.7" xlink:to="loc_ScheduleOfNonvestedRestrictedStockUnitsActivityTableTextBlock.16168.12.7" order="7.00000" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:label="loc_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock.16254.12.7" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock" xlink:type="locator" />
    <link:presentationArc xlink:from="loc_StockholdersEquityNoteLineItems.25553.12.7" xlink:to="loc_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock.16254.12.7" order="8.00000" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:label="loc_StockholdersEquityNoteLineItems.25553.12.6" xlink:href="psti-20140630.xsd#psti_StockholdersEquityNoteLineItems" xlink:type="locator" />
    <link:presentationArc xlink:from="loc_StockholdersEquityNoteTable.25554.12.6" xlink:to="loc_StockholdersEquityNoteLineItems.25553.12.6" order="2.00000" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" />
    <link:presentationArc xlink:from="loc_StockholdersEquityNoteTable.25554.12.6" xlink:to="loc_AwardTypeAxis.367.12.6" order="1.00000" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" />
  </link:presentationLink>
  <link:presentationLink xlink:title="105 - Disclosure - PROPERTY AND EQUIPMENT, NET" xlink:role="http://www.pluristem.com/role/PropertyAndEquipmentNet" xlink:type="extended">
    <link:loc xlink:label="loc_PropertyPlantAndEquipmentAbstract.4255.12.7" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_PropertyPlantAndEquipmentAbstract" xlink:type="locator" />
    <link:loc xlink:label="loc_PropertyPlantAndEquipmentDisclosureTextBlock.15050.12.7" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock" xlink:type="locator" />
    <link:presentationArc xlink:from="loc_PropertyPlantAndEquipmentAbstract.4255.12.7" xlink:to="loc_PropertyPlantAndEquipmentDisclosureTextBlock.15050.12.7" order="1.00000" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </link:presentationLink>
  <link:presentationLink xlink:title="305 - Disclosure - PROPERTY AND EQUIPMENT, NET (Tables)" xlink:role="http://www.pluristem.com/role/PropertyAndEquipmentNetTables" xlink:type="extended">
    <link:loc xlink:label="loc_PropertyPlantAndEquipmentAbstract.4255.12.7" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_PropertyPlantAndEquipmentAbstract" xlink:type="locator" />
    <link:loc xlink:label="loc_PropertyPlantAndEquipmentTextBlock.15042.12.7" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_PropertyPlantAndEquipmentTextBlock" xlink:type="locator" />
    <link:presentationArc xlink:from="loc_PropertyPlantAndEquipmentAbstract.4255.12.7" xlink:to="loc_PropertyPlantAndEquipmentTextBlock.15042.12.7" order="1.00000" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </link:presentationLink>
  <link:presentationLink xlink:title="40501 - Disclosure - PROPERTY AND EQUIPMENT, NET (Details)" xlink:role="http://www.pluristem.com/role/PropertyAndEquipmentNetDetails" xlink:type="extended">
    <link:loc xlink:label="loc_PropertyPlantAndEquipmentAbstract.4255.12.6" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_PropertyPlantAndEquipmentAbstract" xlink:type="locator" />
    <link:loc xlink:label="loc_ScheduleOfPropertyPlantAndEquipmentTable.4834.12.6" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:type="locator" />
    <link:presentationArc xlink:from="loc_PropertyPlantAndEquipmentAbstract.4255.12.6" xlink:to="loc_ScheduleOfPropertyPlantAndEquipmentTable.4834.12.6" order="1.00000" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" />
    <link:loc xlink:label="loc_PropertyPlantAndEquipmentTypeDomain.4257.12.7" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:type="locator" />
    <link:loc xlink:label="loc_OtherMachineryAndEquipmentMember.3840.12.7" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_OtherMachineryAndEquipmentMember" xlink:type="locator" />
    <link:presentationArc xlink:from="loc_PropertyPlantAndEquipmentTypeDomain.4257.12.7" xlink:to="loc_OtherMachineryAndEquipmentMember.3840.12.7" order="1.00000" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:label="loc_ComputerEquipmentMember.1163.12.7" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ComputerEquipmentMember" xlink:type="locator" />
    <link:presentationArc xlink:from="loc_PropertyPlantAndEquipmentTypeDomain.4257.12.7" xlink:to="loc_ComputerEquipmentMember.1163.12.7" order="2.00000" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:label="loc_OfficeEquipmentMember.3650.12.7" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_OfficeEquipmentMember" xlink:type="locator" />
    <link:presentationArc xlink:from="loc_PropertyPlantAndEquipmentTypeDomain.4257.12.7" xlink:to="loc_OfficeEquipmentMember.3650.12.7" order="3.00000" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:label="loc_LeaseholdImprovementsMember.3017.12.7" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_LeaseholdImprovementsMember" xlink:type="locator" />
    <link:presentationArc xlink:from="loc_PropertyPlantAndEquipmentTypeDomain.4257.12.7" xlink:to="loc_LeaseholdImprovementsMember.3017.12.7" order="4.00000" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:label="loc_VehiclesMember.5488.12.7" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_VehiclesMember" xlink:type="locator" />
    <link:presentationArc xlink:from="loc_PropertyPlantAndEquipmentTypeDomain.4257.12.7" xlink:to="loc_VehiclesMember.5488.12.7" order="7.00000" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:label="loc_LeaseholdImprovementsOfNewFacilityConstructionMember.25578.12.7" xlink:href="psti-20140630.xsd#psti_LeaseholdImprovementsOfNewFacilityConstructionMember" xlink:type="locator" />
    <link:presentationArc xlink:from="loc_PropertyPlantAndEquipmentTypeDomain.4257.12.7" xlink:to="loc_LeaseholdImprovementsOfNewFacilityConstructionMember.25578.12.7" order="5.00000" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:label="loc_PropertyPlantAndEquipmentByTypeAxis.4261.12.6" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:type="locator" />
    <link:loc xlink:label="loc_PropertyPlantAndEquipmentTypeDomain.4257.12.6" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:type="locator" />
    <link:presentationArc xlink:from="loc_PropertyPlantAndEquipmentByTypeAxis.4261.12.6" xlink:to="loc_PropertyPlantAndEquipmentTypeDomain.4257.12.6" order="1.00000" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" />
    <link:loc xlink:label="loc_PropertyPlantAndEquipmentLineItems.4267.12.7" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_PropertyPlantAndEquipmentLineItems" xlink:type="locator" />
    <link:loc xlink:label="loc_PropertyPlantAndEquipmentGross.15025.12.7" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_PropertyPlantAndEquipmentGross" xlink:type="locator" />
    <link:presentationArc xlink:from="loc_PropertyPlantAndEquipmentLineItems.4267.12.7" xlink:to="loc_PropertyPlantAndEquipmentGross.15025.12.7" order="1.00000" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:label="loc_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment.5714.12.7" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:type="locator" />
    <link:presentationArc xlink:from="loc_PropertyPlantAndEquipmentLineItems.4267.12.7" xlink:to="loc_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment.5714.12.7" order="2.00000" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:label="loc_PropertyPlantAndEquipmentLineItems.4267.12.9" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_PropertyPlantAndEquipmentLineItems" xlink:type="locator" />
    <link:loc xlink:label="loc_PropertyPlantAndEquipmentNet.15032.12.9" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet" xlink:type="locator" />
    <link:presentationArc xlink:from="loc_PropertyPlantAndEquipmentLineItems.4267.12.9" xlink:to="loc_PropertyPlantAndEquipmentNet.15032.12.9" order="3.00000" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
    <link:loc xlink:label="loc_Depreciation.8242.12.7" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_Depreciation" xlink:type="locator" />
    <link:presentationArc xlink:from="loc_PropertyPlantAndEquipmentLineItems.4267.12.7" xlink:to="loc_Depreciation.8242.12.7" order="4.00000" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:from="loc_ScheduleOfPropertyPlantAndEquipmentTable.4834.12.6" xlink:to="loc_PropertyPlantAndEquipmentByTypeAxis.4261.12.6" order="1.00000" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" />
    <link:loc xlink:label="loc_PropertyPlantAndEquipmentLineItems.4267.12.6" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_PropertyPlantAndEquipmentLineItems" xlink:type="locator" />
    <link:presentationArc xlink:from="loc_ScheduleOfPropertyPlantAndEquipmentTable.4834.12.6" xlink:to="loc_PropertyPlantAndEquipmentLineItems.4267.12.6" order="2.00000" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" />
  </link:presentationLink>
  <link:presentationLink xlink:title="106 - Disclosure - OTHER ACCOUNTS PAYABLE" xlink:role="http://www.pluristem.com/role/OtherAccountsPayable" xlink:type="extended">
    <link:loc xlink:label="loc_OtherAccountsPayableAbstract.25579.12.7" xlink:href="psti-20140630.xsd#psti_OtherAccountsPayableAbstract" xlink:type="locator" />
    <link:loc xlink:label="loc_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock.5589.12.7" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock" xlink:type="locator" />
    <link:presentationArc xlink:from="loc_OtherAccountsPayableAbstract.25579.12.7" xlink:to="loc_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock.5589.12.7" order="1.00000" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </link:presentationLink>
  <link:presentationLink xlink:title="109 - Disclosure - FINANCIAL INCOME, NET" xlink:role="http://www.pluristem.com/role/FinancialIncomeNet" xlink:type="extended">
    <link:loc xlink:label="loc_OtherIncomeAndExpensesAbstract.3781.12.7" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_OtherIncomeAndExpensesAbstract" xlink:type="locator" />
    <link:loc xlink:label="loc_OtherIncomeAndOtherExpenseDisclosureTextBlock.13798.12.7" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_OtherIncomeAndOtherExpenseDisclosureTextBlock" xlink:type="locator" />
    <link:presentationArc xlink:from="loc_OtherIncomeAndExpensesAbstract.3781.12.7" xlink:to="loc_OtherIncomeAndOtherExpenseDisclosureTextBlock.13798.12.7" order="1.00000" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </link:presentationLink>
  <link:presentationLink xlink:title="110 - Disclosure - TAXES ON INCOME" xlink:role="http://www.pluristem.com/role/TaxesOnIncome" xlink:type="extended">
    <link:loc xlink:label="loc_IncomeTaxDisclosureAbstract.2654.12.7" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_IncomeTaxDisclosureAbstract" xlink:type="locator" />
    <link:loc xlink:label="loc_IncomeTaxDisclosureTextBlock.11033.12.7" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_IncomeTaxDisclosureTextBlock" xlink:type="locator" />
    <link:presentationArc xlink:from="loc_IncomeTaxDisclosureAbstract.2654.12.7" xlink:to="loc_IncomeTaxDisclosureTextBlock.11033.12.7" order="1.00000" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </link:presentationLink>
  <link:presentationLink xlink:title="307 - Disclosure - COMMITMENTS AND CONTINGENCIES (Tables)" xlink:role="http://www.pluristem.com/role/CommitmentsAndContingenciesTables" xlink:type="extended">
    <link:loc xlink:label="loc_CommitmentsAndContingenciesDisclosureAbstract.1107.12.6" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:type="locator" />
    <link:loc xlink:label="loc_LongTermPurchaseCommitmentTable.3238.12.6" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_LongTermPurchaseCommitmentTable" xlink:type="locator" />
    <link:presentationArc xlink:from="loc_CommitmentsAndContingenciesDisclosureAbstract.1107.12.6" xlink:to="loc_LongTermPurchaseCommitmentTable.3238.12.6" order="1.00000" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" />
    <link:loc xlink:label="loc_LongTermPurchaseCommitmentLineItems.3235.12.7" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_LongTermPurchaseCommitmentLineItems" xlink:type="locator" />
    <link:loc xlink:label="loc_ScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesTableTextBlock.16187.12.7" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesTableTextBlock" xlink:type="locator" />
    <link:presentationArc xlink:from="loc_LongTermPurchaseCommitmentLineItems.3235.12.7" xlink:to="loc_ScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesTableTextBlock.16187.12.7" order="1.00000" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:label="loc_UnrecordedUnconditionalPurchaseObligationsDisclosureTextBlock.17555.12.7" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_UnrecordedUnconditionalPurchaseObligationsDisclosureTextBlock" xlink:type="locator" />
    <link:presentationArc xlink:from="loc_LongTermPurchaseCommitmentLineItems.3235.12.7" xlink:to="loc_UnrecordedUnconditionalPurchaseObligationsDisclosureTextBlock.17555.12.7" order="3.00000" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:label="loc_LongTermPurchaseCommitmentLineItems.3235.12.6" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_LongTermPurchaseCommitmentLineItems" xlink:type="locator" />
    <link:presentationArc xlink:from="loc_LongTermPurchaseCommitmentTable.3238.12.6" xlink:to="loc_LongTermPurchaseCommitmentLineItems.3235.12.6" order="2.00000" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" />
    <link:loc xlink:label="loc_PropertyPlantAndEquipmentByTypeAxis.4261.12.6" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:type="locator" />
    <link:presentationArc xlink:from="loc_LongTermPurchaseCommitmentTable.3238.12.6" xlink:to="loc_PropertyPlantAndEquipmentByTypeAxis.4261.12.6" order="1.50000" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" />
    <link:loc xlink:label="loc_PropertyPlantAndEquipmentTypeDomain.4257.12.6" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:type="locator" />
    <link:loc xlink:label="loc_AutomobilesMember.395.12.6" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_AutomobilesMember" xlink:type="locator" />
    <link:presentationArc xlink:from="loc_PropertyPlantAndEquipmentTypeDomain.4257.12.6" xlink:to="loc_AutomobilesMember.395.12.6" order="2.00000" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" />
    <link:loc xlink:label="loc_LandAndBuildingMember.3008.12.6" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_LandAndBuildingMember" xlink:type="locator" />
    <link:presentationArc xlink:from="loc_PropertyPlantAndEquipmentTypeDomain.4257.12.6" xlink:to="loc_LandAndBuildingMember.3008.12.6" order="1.00000" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" />
    <link:presentationArc xlink:from="loc_PropertyPlantAndEquipmentByTypeAxis.4261.12.6" xlink:to="loc_PropertyPlantAndEquipmentTypeDomain.4257.12.6" order="1.00000" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" />
  </link:presentationLink>
  <link:presentationLink xlink:title="309 - Disclosure - FINANCIAL INCOME, NET (Tables)" xlink:role="http://www.pluristem.com/role/FinancialIncomeNetTables" xlink:type="extended">
    <link:loc xlink:label="loc_OtherIncomeAndExpensesAbstract.3781.12.7" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_OtherIncomeAndExpensesAbstract" xlink:type="locator" />
    <link:loc xlink:label="loc_ScheduleOfOtherNonoperatingIncomeExpenseTableTextBlock.16124.12.7" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ScheduleOfOtherNonoperatingIncomeExpenseTableTextBlock" xlink:type="locator" />
    <link:presentationArc xlink:from="loc_OtherIncomeAndExpensesAbstract.3781.12.7" xlink:to="loc_ScheduleOfOtherNonoperatingIncomeExpenseTableTextBlock.16124.12.7" order="1.00000" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </link:presentationLink>
  <link:presentationLink xlink:title="310 - Disclosure - TAXES ON INCOME (Tables)" xlink:role="http://www.pluristem.com/role/TaxesOnIncomeTables" xlink:type="extended">
    <link:loc xlink:label="loc_IncomeTaxDisclosureAbstract.2654.12.7" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_IncomeTaxDisclosureAbstract" xlink:type="locator" />
    <link:loc xlink:label="loc_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock.16163.12.7" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" xlink:type="locator" />
    <link:presentationArc xlink:from="loc_IncomeTaxDisclosureAbstract.2654.12.7" xlink:to="loc_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock.16163.12.7" order="2.00000" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:label="loc_QualifyingPercentageOfValueOfProductiveAssetsTableTextBlock.25581.12.7" xlink:href="psti-20140630.xsd#psti_QualifyingPercentageOfValueOfProductiveAssetsTableTextBlock" xlink:type="locator" />
    <link:presentationArc xlink:from="loc_IncomeTaxDisclosureAbstract.2654.12.7" xlink:to="loc_QualifyingPercentageOfValueOfProductiveAssetsTableTextBlock.25581.12.7" order="1.00000" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </link:presentationLink>
  <link:presentationLink xlink:title="306 - Disclosure - OTHER ACCOUNTS PAYABLE (Tables)" xlink:role="http://www.pluristem.com/role/OtherAccountsPayableTables" xlink:type="extended">
    <link:loc xlink:label="loc_OtherAccountsPayableAbstract.25579.12.7" xlink:href="psti-20140630.xsd#psti_OtherAccountsPayableAbstract" xlink:type="locator" />
    <link:loc xlink:label="loc_ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock.16214.12.7" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock" xlink:type="locator" />
    <link:presentationArc xlink:from="loc_OtherAccountsPayableAbstract.25579.12.7" xlink:to="loc_ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock.16214.12.7" order="1.00000" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </link:presentationLink>
  <link:presentationLink xlink:title="40601 - Disclosure - OTHER ACCOUNTS PAYABLE (Details)" xlink:role="http://www.pluristem.com/role/OtherAccountsPayableDetails" xlink:type="extended">
    <link:loc xlink:label="loc_OtherAccountsPayableAbstract.25579.12.7" xlink:href="psti-20140630.xsd#psti_OtherAccountsPayableAbstract" xlink:type="locator" />
    <link:loc xlink:label="loc_EmployeeRelatedLiabilitiesCurrent.9111.12.7" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_EmployeeRelatedLiabilitiesCurrent" xlink:type="locator" />
    <link:presentationArc xlink:from="loc_OtherAccountsPayableAbstract.25579.12.7" xlink:to="loc_EmployeeRelatedLiabilitiesCurrent.9111.12.7" order="1.00000" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:label="loc_OtherAccountsPayablePayrollInstitutions.25582.12.7" xlink:href="psti-20140630.xsd#psti_OtherAccountsPayablePayrollInstitutions" xlink:type="locator" />
    <link:presentationArc xlink:from="loc_OtherAccountsPayableAbstract.25579.12.7" xlink:to="loc_OtherAccountsPayablePayrollInstitutions.25582.12.7" order="2.00000" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:label="loc_AccruedVacationCurrent.5671.12.7" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_AccruedVacationCurrent" xlink:type="locator" />
    <link:presentationArc xlink:from="loc_OtherAccountsPayableAbstract.25579.12.7" xlink:to="loc_AccruedVacationCurrent.5671.12.7" order="3.00000" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:label="loc_OtherAccountsPayableAbstract.25579.12.9" xlink:href="psti-20140630.xsd#psti_OtherAccountsPayableAbstract" xlink:type="locator" />
    <link:loc xlink:label="loc_AccountsPayableOtherCurrent.5626.12.9" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_AccountsPayableOtherCurrent" xlink:type="locator" />
    <link:presentationArc xlink:from="loc_OtherAccountsPayableAbstract.25579.12.9" xlink:to="loc_AccountsPayableOtherCurrent.5626.12.9" order="6.00000" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
    <link:loc xlink:label="loc_DeferredRentCreditCurrent.7843.12.7" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_DeferredRentCreditCurrent" xlink:type="locator" />
    <link:presentationArc xlink:from="loc_OtherAccountsPayableAbstract.25579.12.7" xlink:to="loc_DeferredRentCreditCurrent.7843.12.7" order="4.00000" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:label="loc_DerivativeLiabilitiesCurrent.8339.12.7" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_DerivativeLiabilitiesCurrent" xlink:type="locator" />
    <link:presentationArc xlink:from="loc_OtherAccountsPayableAbstract.25579.12.7" xlink:to="loc_DerivativeLiabilitiesCurrent.8339.12.7" order="5.50000" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:label="loc_OtherAccruedLiabilitiesCurrent.13951.12.7" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_OtherAccruedLiabilitiesCurrent" xlink:type="locator" />
    <link:presentationArc xlink:from="loc_OtherAccountsPayableAbstract.25579.12.7" xlink:to="loc_OtherAccruedLiabilitiesCurrent.13951.12.7" order="5.75000" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </link:presentationLink>
  <link:presentationLink xlink:title="40701 - Disclosure - COMMITMENTS AND CONTINGENCIES (Operating Lease) (Details)" xlink:role="http://www.pluristem.com/role/CommitmentsAndContingenciesOperatingLeaseDetails" xlink:type="extended">
    <link:loc xlink:label="loc_CommitmentsAndContingenciesDisclosureAbstract.1107.12.6" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:type="locator" />
    <link:loc xlink:label="loc_ScheduleOfOperatingLeasedAssetsTable.4775.12.6" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ScheduleOfOperatingLeasedAssetsTable" xlink:type="locator" />
    <link:presentationArc xlink:from="loc_CommitmentsAndContingenciesDisclosureAbstract.1107.12.6" xlink:to="loc_ScheduleOfOperatingLeasedAssetsTable.4775.12.6" order="1.00000" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" />
    <link:loc xlink:label="loc_GuaranteeObligationsByNatureAxis.2502.12.6" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_GuaranteeObligationsByNatureAxis" xlink:type="locator" />
    <link:loc xlink:label="loc_GuaranteeObligationsNatureDomain.2504.12.6" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_GuaranteeObligationsNatureDomain" xlink:type="locator" />
    <link:presentationArc xlink:from="loc_GuaranteeObligationsByNatureAxis.2502.12.6" xlink:to="loc_GuaranteeObligationsNatureDomain.2504.12.6" order="1.00000" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" />
    <link:loc xlink:label="loc_PropertyLeaseGuaranteeMember.4264.12.6" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_PropertyLeaseGuaranteeMember" xlink:type="locator" />
    <link:presentationArc xlink:from="loc_GuaranteeObligationsNatureDomain.2504.12.6" xlink:to="loc_PropertyLeaseGuaranteeMember.4264.12.6" order="1.00000" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" />
    <link:loc xlink:label="loc_OperatingLeasedAssetsLineItems.3696.12.7" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_OperatingLeasedAssetsLineItems" xlink:type="locator" />
    <link:loc xlink:label="loc_OperatingLeasesRentExpenseNet.13438.12.7" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_OperatingLeasesRentExpenseNet" xlink:type="locator" />
    <link:presentationArc xlink:from="loc_OperatingLeasedAssetsLineItems.3696.12.7" xlink:to="loc_OperatingLeasesRentExpenseNet.13438.12.7" order="6.00000" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:label="loc_OperatingLeasesFutureMinimumPaymentsDueInTwoYears.13442.12.7" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_OperatingLeasesFutureMinimumPaymentsDueInTwoYears" xlink:type="locator" />
    <link:presentationArc xlink:from="loc_OperatingLeasedAssetsLineItems.3696.12.7" xlink:to="loc_OperatingLeasesFutureMinimumPaymentsDueInTwoYears.13442.12.7" order="7.00000" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:label="loc_OperatingLeasesFutureMinimumPaymentsDueInThreeYears.13435.12.7" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_OperatingLeasesFutureMinimumPaymentsDueInThreeYears" xlink:type="locator" />
    <link:presentationArc xlink:from="loc_OperatingLeasedAssetsLineItems.3696.12.7" xlink:to="loc_OperatingLeasesFutureMinimumPaymentsDueInThreeYears.13435.12.7" order="8.00000" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:label="loc_OperatingLeasedAssetsLineItems.3696.12.9" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_OperatingLeasedAssetsLineItems" xlink:type="locator" />
    <link:loc xlink:label="loc_OperatingLeasesFutureMinimumPaymentsDue.13467.12.9" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_OperatingLeasesFutureMinimumPaymentsDue" xlink:type="locator" />
    <link:presentationArc xlink:from="loc_OperatingLeasedAssetsLineItems.3696.12.9" xlink:to="loc_OperatingLeasesFutureMinimumPaymentsDue.13467.12.9" order="10.00000" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
    <link:loc xlink:label="loc_OperatingLeasesFutureMinimumPaymentsDueInFourYears.13426.12.7" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_OperatingLeasesFutureMinimumPaymentsDueInFourYears" xlink:type="locator" />
    <link:presentationArc xlink:from="loc_OperatingLeasedAssetsLineItems.3696.12.7" xlink:to="loc_OperatingLeasesFutureMinimumPaymentsDueInFourYears.13426.12.7" order="9.00000" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:label="loc_OperatingLeasedAssetsNumberOfUnits.25588.12.7" xlink:href="psti-20140630.xsd#psti_OperatingLeasedAssetsNumberOfUnits" xlink:type="locator" />
    <link:presentationArc xlink:from="loc_OperatingLeasedAssetsLineItems.3696.12.7" xlink:to="loc_OperatingLeasedAssetsNumberOfUnits.25588.12.7" order="0.50000" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:label="loc_OperatingLeasesFutureMinimumPaymentsDueInFiveYears.13419.12.7" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_OperatingLeasesFutureMinimumPaymentsDueInFiveYears" xlink:type="locator" />
    <link:presentationArc xlink:from="loc_OperatingLeasedAssetsLineItems.3696.12.7" xlink:to="loc_OperatingLeasesFutureMinimumPaymentsDueInFiveYears.13419.12.7" order="9.50000" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:label="loc_OperatingLeasesFutureMinimumPaymentsDueCurrent.13462.12.7" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_OperatingLeasesFutureMinimumPaymentsDueCurrent" xlink:type="locator" />
    <link:presentationArc xlink:from="loc_OperatingLeasedAssetsLineItems.3696.12.7" xlink:to="loc_OperatingLeasesFutureMinimumPaymentsDueCurrent.13462.12.7" order="6.50000" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:label="loc_OperatingLeasedAssetsParticipationFromLessor.26037.12.7" xlink:href="psti-20140630.xsd#psti_OperatingLeasedAssetsParticipationFromLessor" xlink:type="locator" />
    <link:presentationArc xlink:from="loc_OperatingLeasedAssetsLineItems.3696.12.7" xlink:to="loc_OperatingLeasedAssetsParticipationFromLessor.26037.12.7" order="1.50000" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:label="loc_PledgedAssetsNotSeparatelyReportedOtherFinancialInstruments.14323.12.7" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_PledgedAssetsNotSeparatelyReportedOtherFinancialInstruments" xlink:type="locator" />
    <link:presentationArc xlink:from="loc_OperatingLeasedAssetsLineItems.3696.12.7" xlink:to="loc_PledgedAssetsNotSeparatelyReportedOtherFinancialInstruments.14323.12.7" order="5.50000" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:label="loc_GuaranteeObligationsCurrentCarryingValue.10671.12.7" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_GuaranteeObligationsCurrentCarryingValue" xlink:type="locator" />
    <link:presentationArc xlink:from="loc_OperatingLeasedAssetsLineItems.3696.12.7" xlink:to="loc_GuaranteeObligationsCurrentCarryingValue.10671.12.7" order="3.50000" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:label="loc_PropertyPlantAndEquipmentTypeDomain.4257.12.7" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:type="locator" />
    <link:loc xlink:label="loc_AutomobilesMember.395.12.7" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_AutomobilesMember" xlink:type="locator" />
    <link:presentationArc xlink:from="loc_PropertyPlantAndEquipmentTypeDomain.4257.12.7" xlink:to="loc_AutomobilesMember.395.12.7" order="2.00000" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:label="loc_PropertyPlantAndEquipmentTypeDomain.4257.12.6" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:type="locator" />
    <link:loc xlink:label="loc_LandAndBuildingMember.3008.12.6" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_LandAndBuildingMember" xlink:type="locator" />
    <link:presentationArc xlink:from="loc_PropertyPlantAndEquipmentTypeDomain.4257.12.6" xlink:to="loc_LandAndBuildingMember.3008.12.6" order="1.50000" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" />
    <link:loc xlink:label="loc_PropertyPlantAndEquipmentByTypeAxis.4261.12.6" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:type="locator" />
    <link:presentationArc xlink:from="loc_PropertyPlantAndEquipmentByTypeAxis.4261.12.6" xlink:to="loc_PropertyPlantAndEquipmentTypeDomain.4257.12.6" order="1.00000" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" />
    <link:loc xlink:label="loc_RangeAxis.4349.12.6" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_RangeAxis" xlink:type="locator" />
    <link:loc xlink:label="loc_RangeMember.4350.12.6" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_RangeMember" xlink:type="locator" />
    <link:presentationArc xlink:from="loc_RangeAxis.4349.12.6" xlink:to="loc_RangeMember.4350.12.6" order="1.00000" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" />
    <link:loc xlink:label="loc_MaximumMember.3361.12.6" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_MaximumMember" xlink:type="locator" />
    <link:presentationArc xlink:from="loc_RangeMember.4350.12.6" xlink:to="loc_MaximumMember.3361.12.6" order="4.00000" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" />
    <link:loc xlink:label="loc_MinimumMember.3370.12.6" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_MinimumMember" xlink:type="locator" />
    <link:presentationArc xlink:from="loc_RangeMember.4350.12.6" xlink:to="loc_MinimumMember.3370.12.6" order="1.00000" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" />
    <link:presentationArc xlink:from="loc_ScheduleOfOperatingLeasedAssetsTable.4775.12.6" xlink:to="loc_PropertyPlantAndEquipmentByTypeAxis.4261.12.6" order="1.00000" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" />
    <link:loc xlink:label="loc_OperatingLeasedAssetsLineItems.3696.12.6" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_OperatingLeasedAssetsLineItems" xlink:type="locator" />
    <link:presentationArc xlink:from="loc_ScheduleOfOperatingLeasedAssetsTable.4775.12.6" xlink:to="loc_OperatingLeasedAssetsLineItems.3696.12.6" order="3.00000" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" />
    <link:presentationArc xlink:from="loc_ScheduleOfOperatingLeasedAssetsTable.4775.12.6" xlink:to="loc_GuaranteeObligationsByNatureAxis.2502.12.6" order="2.50000" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" />
    <link:presentationArc xlink:from="loc_ScheduleOfOperatingLeasedAssetsTable.4775.12.6" xlink:to="loc_RangeAxis.4349.12.6" order="2.75000" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" />
  </link:presentationLink>
  <link:presentationLink xlink:title="40702 - Disclosure - COMMITMENTS AND CONTINGENCIES (Commitment to Suppliers and Contractor) (Details)" xlink:role="http://www.pluristem.com/role/CommitmentsAndContingenciesCommitmentToSuppliersAndContractorDetails" xlink:type="extended">
    <link:loc xlink:label="loc_CommitmentsAndContingenciesDisclosureAbstract.1107.12.6" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:type="locator" />
    <link:loc xlink:label="loc_LongTermPurchaseCommitmentTable.3238.12.6" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_LongTermPurchaseCommitmentTable" xlink:type="locator" />
    <link:presentationArc xlink:from="loc_CommitmentsAndContingenciesDisclosureAbstract.1107.12.6" xlink:to="loc_LongTermPurchaseCommitmentTable.3238.12.6" order="1.00000" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" />
    <link:loc xlink:label="loc_LongTermPurchaseCommitmentLineItems.3235.12.7" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_LongTermPurchaseCommitmentLineItems" xlink:type="locator" />
    <link:loc xlink:label="loc_LongTermPurchaseCommitmentFutureMinimumPaymentDueCurrent.25591.12.7" xlink:href="psti-20140630.xsd#psti_LongTermPurchaseCommitmentFutureMinimumPaymentDueCurrent" xlink:type="locator" />
    <link:presentationArc xlink:from="loc_LongTermPurchaseCommitmentLineItems.3235.12.7" xlink:to="loc_LongTermPurchaseCommitmentFutureMinimumPaymentDueCurrent.25591.12.7" order="1.00000" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:label="loc_LongTermPurchaseCommitmentFutureMinimumPaymentDueInThreeYears.25592.12.7" xlink:href="psti-20140630.xsd#psti_LongTermPurchaseCommitmentFutureMinimumPaymentDueInThreeYears" xlink:type="locator" />
    <link:presentationArc xlink:from="loc_LongTermPurchaseCommitmentLineItems.3235.12.7" xlink:to="loc_LongTermPurchaseCommitmentFutureMinimumPaymentDueInThreeYears.25592.12.7" order="2.00000" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:label="loc_LongTermPurchaseCommitmentLineItems.3235.12.9" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_LongTermPurchaseCommitmentLineItems" xlink:type="locator" />
    <link:loc xlink:label="loc_LongTermPurchaseCommitmentFutureMinimumPaymentDue.25593.12.9" xlink:href="psti-20140630.xsd#psti_LongTermPurchaseCommitmentFutureMinimumPaymentDue" xlink:type="locator" />
    <link:presentationArc xlink:from="loc_LongTermPurchaseCommitmentLineItems.3235.12.9" xlink:to="loc_LongTermPurchaseCommitmentFutureMinimumPaymentDue.25593.12.9" order="3.00000" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
    <link:loc xlink:label="loc_GrantsReceivable.10656.12.7" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_GrantsReceivable" xlink:type="locator" />
    <link:presentationArc xlink:from="loc_LongTermPurchaseCommitmentLineItems.3235.12.7" xlink:to="loc_GrantsReceivable.10656.12.7" order="4.00000" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:label="loc_RoyaltyPayable.25594.12.7" xlink:href="psti-20140630.xsd#psti_RoyaltyPayable" xlink:type="locator" />
    <link:presentationArc xlink:from="loc_LongTermPurchaseCommitmentLineItems.3235.12.7" xlink:to="loc_RoyaltyPayable.25594.12.7" order="5.00000" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:label="loc_LongTermPurchaseCommitmentCategoryOfItemPurchasedDomain.3237.12.7" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_LongTermPurchaseCommitmentCategoryOfItemPurchasedDomain" xlink:type="locator" />
    <link:loc xlink:label="loc_LongTermPurchaseCommitmentToSuppliersAndContractorMember.25595.12.7" xlink:href="psti-20140630.xsd#psti_LongTermPurchaseCommitmentToSuppliersAndContractorMember" xlink:type="locator" />
    <link:presentationArc xlink:from="loc_LongTermPurchaseCommitmentCategoryOfItemPurchasedDomain.3237.12.7" xlink:to="loc_LongTermPurchaseCommitmentToSuppliersAndContractorMember.25595.12.7" order="1.00000" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:label="loc_LongTermPurchaseCommitmentByCategoryOfItemPurchasedAxis.3241.12.6" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_LongTermPurchaseCommitmentByCategoryOfItemPurchasedAxis" xlink:type="locator" />
    <link:presentationArc xlink:from="loc_LongTermPurchaseCommitmentTable.3238.12.6" xlink:to="loc_LongTermPurchaseCommitmentByCategoryOfItemPurchasedAxis.3241.12.6" order="1.00000" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" />
    <link:loc xlink:label="loc_LongTermPurchaseCommitmentLineItems.3235.12.6" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_LongTermPurchaseCommitmentLineItems" xlink:type="locator" />
    <link:presentationArc xlink:from="loc_LongTermPurchaseCommitmentTable.3238.12.6" xlink:to="loc_LongTermPurchaseCommitmentLineItems.3235.12.6" order="2.00000" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" />
    <link:loc xlink:label="loc_LongTermPurchaseCommitmentCategoryOfItemPurchasedDomain.3237.12.6" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_LongTermPurchaseCommitmentCategoryOfItemPurchasedDomain" xlink:type="locator" />
    <link:presentationArc xlink:from="loc_LongTermPurchaseCommitmentByCategoryOfItemPurchasedAxis.3241.12.6" xlink:to="loc_LongTermPurchaseCommitmentCategoryOfItemPurchasedDomain.3237.12.6" order="1.00000" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" />
  </link:presentationLink>
  <link:presentationLink xlink:title="40901 - Disclosure - FINANCIAL INCOME, NET (Details)" xlink:role="http://www.pluristem.com/role/FinancialIncomeNetDetails" xlink:type="extended">
    <link:loc xlink:label="loc_OtherIncomeAndExpensesAbstract.3781.12.53" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_OtherIncomeAndExpensesAbstract" xlink:type="locator" />
    <link:loc xlink:label="loc_InterestOnShortTermBankCreditAndBankExpenses.25596.12.53" xlink:href="psti-20140630.xsd#psti_InterestOnShortTermBankCreditAndBankExpenses" xlink:type="locator" />
    <link:presentationArc xlink:from="loc_OtherIncomeAndExpensesAbstract.3781.12.53" xlink:to="loc_InterestOnShortTermBankCreditAndBankExpenses.25596.12.53" order="2.00000" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
    <link:loc xlink:label="loc_OtherIncomeAndExpensesAbstract.3781.12.7" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_OtherIncomeAndExpensesAbstract" xlink:type="locator" />
    <link:loc xlink:label="loc_InterestIncomeDepositsWithFinancialInstitutions.11592.12.7" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_InterestIncomeDepositsWithFinancialInstitutions" xlink:type="locator" />
    <link:presentationArc xlink:from="loc_OtherIncomeAndExpensesAbstract.3781.12.7" xlink:to="loc_InterestIncomeDepositsWithFinancialInstitutions.11592.12.7" order="5.00000" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:label="loc_MarketableSecuritiesGainLoss.12850.12.7" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_MarketableSecuritiesGainLoss" xlink:type="locator" />
    <link:presentationArc xlink:from="loc_OtherIncomeAndExpensesAbstract.3781.12.7" xlink:to="loc_MarketableSecuritiesGainLoss.12850.12.7" order="10.00000" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:label="loc_DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet.8305.12.7" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet" xlink:type="locator" />
    <link:presentationArc xlink:from="loc_OtherIncomeAndExpensesAbstract.3781.12.7" xlink:to="loc_DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet.8305.12.7" order="14.25000" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:label="loc_ForeignCurrencyTransactionGainLossBeforeTax.10306.12.7" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ForeignCurrencyTransactionGainLossBeforeTax" xlink:type="locator" />
    <link:presentationArc xlink:from="loc_OtherIncomeAndExpensesAbstract.3781.12.7" xlink:to="loc_ForeignCurrencyTransactionGainLossBeforeTax.10306.12.7" order="1.50000" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:label="loc_OtherIncomeAndExpensesAbstract.3781.12.9" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_OtherIncomeAndExpensesAbstract" xlink:type="locator" />
    <link:loc xlink:label="loc_NonoperatingIncomeExpense.13243.12.9" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_NonoperatingIncomeExpense" xlink:type="locator" />
    <link:presentationArc xlink:from="loc_OtherIncomeAndExpensesAbstract.3781.12.9" xlink:to="loc_NonoperatingIncomeExpense.13243.12.9" order="16.00000" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
  </link:presentationLink>
  <link:presentationLink xlink:title="41001 - Disclosure - TAXES ON INCOME (Narrative) (Details)" xlink:role="http://www.pluristem.com/role/TaxesOnIncomeNarrativeDetails" xlink:type="extended">
    <link:loc xlink:label="loc_EntityDomain.99.12.7" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_EntityDomain" xlink:type="locator" />
    <link:loc xlink:label="loc_SubsidiariesMember.5165.12.7" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_SubsidiariesMember" xlink:type="locator" />
    <link:presentationArc xlink:from="loc_EntityDomain.99.12.7" xlink:to="loc_SubsidiariesMember.5165.12.7" order="2.00000" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:label="loc_ParentCompanyMember.3915.12.7" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ParentCompanyMember" xlink:type="locator" />
    <link:presentationArc xlink:from="loc_EntityDomain.99.12.7" xlink:to="loc_ParentCompanyMember.3915.12.7" order="1.00000" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:label="loc_LegalEntityAxis.136.12.6" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_LegalEntityAxis" xlink:type="locator" />
    <link:loc xlink:label="loc_EntityDomain.99.12.6" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_EntityDomain" xlink:type="locator" />
    <link:presentationArc xlink:from="loc_LegalEntityAxis.136.12.6" xlink:to="loc_EntityDomain.99.12.6" order="1.00000" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" />
    <link:loc xlink:label="loc_IncomeTaxAuthorityDomain.2635.12.7" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_IncomeTaxAuthorityDomain" xlink:type="locator" />
    <link:loc xlink:label="loc_DomesticCountryMember.1737.12.7" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_DomesticCountryMember" xlink:type="locator" />
    <link:presentationArc xlink:from="loc_IncomeTaxAuthorityDomain.2635.12.7" xlink:to="loc_DomesticCountryMember.1737.12.7" order="2.00000" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:label="loc_InternalRevenueServiceIRSMember.2877.12.7" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_InternalRevenueServiceIRSMember" xlink:type="locator" />
    <link:presentationArc xlink:from="loc_IncomeTaxAuthorityDomain.2635.12.7" xlink:to="loc_InternalRevenueServiceIRSMember.2877.12.7" order="3.00000" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:label="loc_IsraelTaxAuthorityMember.2580.12.7" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_IsraelTaxAuthorityMember" xlink:type="locator" />
    <link:presentationArc xlink:from="loc_IncomeTaxAuthorityDomain.2635.12.7" xlink:to="loc_IsraelTaxAuthorityMember.2580.12.7" order="1.50000" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:label="loc_IncomeTaxDisclosureAbstract.2654.12.6" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_IncomeTaxDisclosureAbstract" xlink:type="locator" />
    <link:loc xlink:label="loc_IncomeTaxTable.25599.12.6" xlink:href="psti-20140630.xsd#psti_IncomeTaxTable" xlink:type="locator" />
    <link:presentationArc xlink:from="loc_IncomeTaxDisclosureAbstract.2654.12.6" xlink:to="loc_IncomeTaxTable.25599.12.6" order="1.00000" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" />
    <link:loc xlink:label="loc_IncomeTaxAuthorityAxis.2667.12.6" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_IncomeTaxAuthorityAxis" xlink:type="locator" />
    <link:loc xlink:label="loc_IncomeTaxAuthorityDomain.2635.12.6" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_IncomeTaxAuthorityDomain" xlink:type="locator" />
    <link:presentationArc xlink:from="loc_IncomeTaxAuthorityAxis.2667.12.6" xlink:to="loc_IncomeTaxAuthorityDomain.2635.12.6" order="1.00000" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" />
    <link:loc xlink:label="loc_PropertyPlantAndEquipmentTypeDomain.4257.12.6" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:type="locator" />
    <link:loc xlink:label="loc_BuildingMember.772.12.6" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_BuildingMember" xlink:type="locator" />
    <link:presentationArc xlink:from="loc_PropertyPlantAndEquipmentTypeDomain.4257.12.6" xlink:to="loc_BuildingMember.772.12.6" order="1.00000" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" />
    <link:loc xlink:label="loc_PropertyPlantAndEquipmentByTypeAxis.4261.12.6" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:type="locator" />
    <link:presentationArc xlink:from="loc_PropertyPlantAndEquipmentByTypeAxis.4261.12.6" xlink:to="loc_PropertyPlantAndEquipmentTypeDomain.4257.12.6" order="1.00000" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" />
    <link:loc xlink:label="loc_RangeAxis.4349.12.6" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_RangeAxis" xlink:type="locator" />
    <link:loc xlink:label="loc_RangeMember.4350.12.6" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_RangeMember" xlink:type="locator" />
    <link:presentationArc xlink:from="loc_RangeAxis.4349.12.6" xlink:to="loc_RangeMember.4350.12.6" order="1.00000" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" />
    <link:loc xlink:label="loc_MinimumMember.3370.12.6" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_MinimumMember" xlink:type="locator" />
    <link:presentationArc xlink:from="loc_RangeMember.4350.12.6" xlink:to="loc_MinimumMember.3370.12.6" order="1.00000" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" />
    <link:loc xlink:label="loc_MaximumMember.3361.12.6" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_MaximumMember" xlink:type="locator" />
    <link:presentationArc xlink:from="loc_RangeMember.4350.12.6" xlink:to="loc_MaximumMember.3361.12.6" order="2.00000" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" />
    <link:loc xlink:label="loc_TaxPeriodAxis.5240.12.6" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_TaxPeriodAxis" xlink:type="locator" />
    <link:loc xlink:label="loc_TaxPeriodDomain.5241.12.6" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_TaxPeriodDomain" xlink:type="locator" />
    <link:presentationArc xlink:from="loc_TaxPeriodAxis.5240.12.6" xlink:to="loc_TaxPeriodDomain.5241.12.6" order="1.00000" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" />
    <link:loc xlink:label="loc_EarliestTaxYearMember.1754.12.6" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_EarliestTaxYearMember" xlink:type="locator" />
    <link:presentationArc xlink:from="loc_TaxPeriodDomain.5241.12.6" xlink:to="loc_EarliestTaxYearMember.1754.12.6" order="1.00000" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" />
    <link:loc xlink:label="loc_LatestTaxYearMember.2979.12.6" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_LatestTaxYearMember" xlink:type="locator" />
    <link:presentationArc xlink:from="loc_TaxPeriodDomain.5241.12.6" xlink:to="loc_LatestTaxYearMember.2979.12.6" order="2.00000" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" />
    <link:presentationArc xlink:from="loc_IncomeTaxTable.25599.12.6" xlink:to="loc_LegalEntityAxis.136.12.6" order="1.00000" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" />
    <link:loc xlink:label="loc_IncomeTaxLineItems.25605.12.6" xlink:href="psti-20140630.xsd#psti_IncomeTaxLineItems" xlink:type="locator" />
    <link:presentationArc xlink:from="loc_IncomeTaxTable.25599.12.6" xlink:to="loc_IncomeTaxLineItems.25605.12.6" order="2.00000" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" />
    <link:presentationArc xlink:from="loc_IncomeTaxTable.25599.12.6" xlink:to="loc_IncomeTaxAuthorityAxis.2667.12.6" order="1.50000" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" />
    <link:presentationArc xlink:from="loc_IncomeTaxTable.25599.12.6" xlink:to="loc_RangeAxis.4349.12.6" order="1.88000" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" />
    <link:presentationArc xlink:from="loc_IncomeTaxTable.25599.12.6" xlink:to="loc_PropertyPlantAndEquipmentByTypeAxis.4261.12.6" order="1.94000" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" />
    <link:loc xlink:label="loc_BeneficiaryEnterpriseProgramAxis.25600.12.6" xlink:href="psti-20140630.xsd#psti_BeneficiaryEnterpriseProgramAxis" xlink:type="locator" />
    <link:presentationArc xlink:from="loc_IncomeTaxTable.25599.12.6" xlink:to="loc_BeneficiaryEnterpriseProgramAxis.25600.12.6" order="1.97000" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" />
    <link:presentationArc xlink:from="loc_IncomeTaxTable.25599.12.6" xlink:to="loc_TaxPeriodAxis.5240.12.6" order="1.98500" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" />
    <link:loc xlink:label="loc_BeneficiaryEnterpriseProgramDomain.25601.12.6" xlink:href="psti-20140630.xsd#psti_BeneficiaryEnterpriseProgramDomain" xlink:type="locator" />
    <link:presentationArc xlink:from="loc_BeneficiaryEnterpriseProgramAxis.25600.12.6" xlink:to="loc_BeneficiaryEnterpriseProgramDomain.25601.12.6" order="1.00000" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" />
    <link:loc xlink:label="loc_BeneficiaryEnterpriseProgramDomain.25601.12.7" xlink:href="psti-20140630.xsd#psti_BeneficiaryEnterpriseProgramDomain" xlink:type="locator" />
    <link:loc xlink:label="loc_TwoThousandSevenProgramMember.25602.12.7" xlink:href="psti-20140630.xsd#psti_TwoThousandSevenProgramMember" xlink:type="locator" />
    <link:presentationArc xlink:from="loc_BeneficiaryEnterpriseProgramDomain.25601.12.7" xlink:to="loc_TwoThousandSevenProgramMember.25602.12.7" order="1.00000" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:label="loc_TwoThousandTwelveProgramMember.25603.12.6" xlink:href="psti-20140630.xsd#psti_TwoThousandTwelveProgramMember" xlink:type="locator" />
    <link:presentationArc xlink:from="loc_BeneficiaryEnterpriseProgramDomain.25601.12.6" xlink:to="loc_TwoThousandTwelveProgramMember.25603.12.6" order="2.00000" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" />
    <link:loc xlink:label="loc_CarryforwardLossesForTaxPurposesAbstract.25604.12.7" xlink:href="psti-20140630.xsd#psti_CarryforwardLossesForTaxPurposesAbstract" xlink:type="locator" />
    <link:loc xlink:label="loc_OperatingLossCarryforwards.13469.12.7" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_OperatingLossCarryforwards" xlink:type="locator" />
    <link:presentationArc xlink:from="loc_CarryforwardLossesForTaxPurposesAbstract.25604.12.7" xlink:to="loc_OperatingLossCarryforwards.13469.12.7" order="1.00000" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:label="loc_OperatingLossCarryforwardsExpirationDate.13455.12.7" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_OperatingLossCarryforwardsExpirationDate" xlink:type="locator" />
    <link:presentationArc xlink:from="loc_CarryforwardLossesForTaxPurposesAbstract.25604.12.7" xlink:to="loc_OperatingLossCarryforwardsExpirationDate.13455.12.7" order="3.00000" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:label="loc_IncomeTaxLineItems.25605.12.7" xlink:href="psti-20140630.xsd#psti_IncomeTaxLineItems" xlink:type="locator" />
    <link:loc xlink:label="loc_TaxRatesApplicableToCompanyAbstract.25606.12.7" xlink:href="psti-20140630.xsd#psti_TaxRatesApplicableToCompanyAbstract" xlink:type="locator" />
    <link:presentationArc xlink:from="loc_IncomeTaxLineItems.25605.12.7" xlink:to="loc_TaxRatesApplicableToCompanyAbstract.25606.12.7" order="1.00000" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:label="loc_TaxRateBenefitsToCompanyAbstract.25607.12.7" xlink:href="psti-20140630.xsd#psti_TaxRateBenefitsToCompanyAbstract" xlink:type="locator" />
    <link:presentationArc xlink:from="loc_IncomeTaxLineItems.25605.12.7" xlink:to="loc_TaxRateBenefitsToCompanyAbstract.25607.12.7" order="2.00000" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:from="loc_IncomeTaxLineItems.25605.12.7" xlink:to="loc_CarryforwardLossesForTaxPurposesAbstract.25604.12.7" order="3.00000" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:label="loc_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate.9055.12.7" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" xlink:type="locator" />
    <link:presentationArc xlink:from="loc_TaxRatesApplicableToCompanyAbstract.25606.12.7" xlink:to="loc_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate.9055.12.7" order="1.00000" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:label="loc_LawForEconomicEfficiencyAmendedLegislationImplementingEconomicPlanForTwoThousandNineAndTenTaxRate.25625.12.7" xlink:href="psti-20140630.xsd#psti_LawForEconomicEfficiencyAmendedLegislationImplementingEconomicPlanForTwoThousandNineAndTenTaxRate" xlink:type="locator" />
    <link:presentationArc xlink:from="loc_TaxRatesApplicableToCompanyAbstract.25606.12.7" xlink:to="loc_LawForEconomicEfficiencyAmendedLegislationImplementingEconomicPlanForTwoThousandNineAndTenTaxRate.25625.12.7" order="3.00000" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:label="loc_EffectiveIncomeTaxRateContinuingOperations.9032.12.7" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:type="locator" />
    <link:presentationArc xlink:from="loc_TaxRatesApplicableToCompanyAbstract.25606.12.7" xlink:to="loc_EffectiveIncomeTaxRateContinuingOperations.9032.12.7" order="2.00000" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:label="loc_NationalPriorityZoneBCorporateTaxExemptionPeriod.25608.12.7" xlink:href="psti-20140630.xsd#psti_NationalPriorityZoneBCorporateTaxExemptionPeriod" xlink:type="locator" />
    <link:presentationArc xlink:from="loc_TaxRateBenefitsToCompanyAbstract.25607.12.7" xlink:to="loc_NationalPriorityZoneBCorporateTaxExemptionPeriod.25608.12.7" order="2.00000" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:label="loc_NationalPriorityZoneBCorporateBenefitedPeriodTaxRate.25609.12.7" xlink:href="psti-20140630.xsd#psti_NationalPriorityZoneBCorporateBenefitedPeriodTaxRate" xlink:type="locator" />
    <link:presentationArc xlink:from="loc_TaxRateBenefitsToCompanyAbstract.25607.12.7" xlink:to="loc_NationalPriorityZoneBCorporateBenefitedPeriodTaxRate.25609.12.7" order="3.00000" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:label="loc_NationalPriorityZoneBcorporateBenefitedPeriodPeriodOfTime.25610.12.7" xlink:href="psti-20140630.xsd#psti_NationalPriorityZoneBcorporateBenefitedPeriodPeriodOfTime" xlink:type="locator" />
    <link:presentationArc xlink:from="loc_TaxRateBenefitsToCompanyAbstract.25607.12.7" xlink:to="loc_NationalPriorityZoneBcorporateBenefitedPeriodPeriodOfTime.25610.12.7" order="4.00000" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:label="loc_BenefitedPeriodMaximumYearsOfEligibility.25611.12.7" xlink:href="psti-20140630.xsd#psti_BenefitedPeriodMaximumYearsOfEligibility" xlink:type="locator" />
    <link:presentationArc xlink:from="loc_TaxRateBenefitsToCompanyAbstract.25607.12.7" xlink:to="loc_BenefitedPeriodMaximumYearsOfEligibility.25611.12.7" order="5.00000" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:label="loc_WithholdingTaxRateOnDividendsFromRetainedTaxExemptProfits.25612.12.7" xlink:href="psti-20140630.xsd#psti_WithholdingTaxRateOnDividendsFromRetainedTaxExemptProfits" xlink:type="locator" />
    <link:presentationArc xlink:from="loc_TaxRateBenefitsToCompanyAbstract.25607.12.7" xlink:to="loc_WithholdingTaxRateOnDividendsFromRetainedTaxExemptProfits.25612.12.7" order="7.00000" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:label="loc_BenefitedPeriodMaximumYearsOfEligibilityForCompaniesInDevelopmentArea.25613.12.7" xlink:href="psti-20140630.xsd#psti_BenefitedPeriodMaximumYearsOfEligibilityForCompaniesInDevelopmentArea" xlink:type="locator" />
    <link:presentationArc xlink:from="loc_TaxRateBenefitsToCompanyAbstract.25607.12.7" xlink:to="loc_BenefitedPeriodMaximumYearsOfEligibilityForCompaniesInDevelopmentArea.25613.12.7" order="5.50000" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:label="loc_IndustrialEnterprisesTaxBenefitConditionsMaximumPercentageOfTotalSales.25614.12.7" xlink:href="psti-20140630.xsd#psti_IndustrialEnterprisesTaxBenefitConditionsMaximumPercentageOfTotalSales" xlink:type="locator" />
    <link:presentationArc xlink:from="loc_TaxRateBenefitsToCompanyAbstract.25607.12.7" xlink:to="loc_IndustrialEnterprisesTaxBenefitConditionsMaximumPercentageOfTotalSales.25614.12.7" order="8.00000" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:label="loc_IndustrialEnterprisesTaxBenefitConditionsMinimumPercentageOfTotalRevenuesGeneratedFromAspecificMarket.25615.12.7" xlink:href="psti-20140630.xsd#psti_IndustrialEnterprisesTaxBenefitConditionsMinimumPercentageOfTotalRevenuesGeneratedFromAspecificMarket" xlink:type="locator" />
    <link:presentationArc xlink:from="loc_TaxRateBenefitsToCompanyAbstract.25607.12.7" xlink:to="loc_IndustrialEnterprisesTaxBenefitConditionsMinimumPercentageOfTotalRevenuesGeneratedFromAspecificMarket.25615.12.7" order="9.00000" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:label="loc_IndustrialEnterprisesTaxBenefitConditionsMinimumPercentageOfTotalRevenuesGivenMarketMinimumPopulation.25616.12.7" xlink:href="psti-20140630.xsd#psti_IndustrialEnterprisesTaxBenefitConditionsMinimumPercentageOfTotalRevenuesGivenMarketMinimumPopulation" xlink:type="locator" />
    <link:presentationArc xlink:from="loc_TaxRateBenefitsToCompanyAbstract.25607.12.7" xlink:to="loc_IndustrialEnterprisesTaxBenefitConditionsMinimumPercentageOfTotalRevenuesGivenMarketMinimumPopulation.25616.12.7" order="10.00000" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:label="loc_TaxBenefitAcceleratedDepreciationRate.25617.12.7" xlink:href="psti-20140630.xsd#psti_TaxBenefitAcceleratedDepreciationRate" xlink:type="locator" />
    <link:presentationArc xlink:from="loc_TaxRateBenefitsToCompanyAbstract.25607.12.7" xlink:to="loc_TaxBenefitAcceleratedDepreciationRate.25617.12.7" order="11.00000" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:label="loc_TaxAmendmentLawAmendedTaxRatePreferredEnterprisesYearsOneAndTwo.25618.12.7" xlink:href="psti-20140630.xsd#psti_TaxAmendmentLawAmendedTaxRatePreferredEnterprisesYearsOneAndTwo" xlink:type="locator" />
    <link:presentationArc xlink:from="loc_TaxRateBenefitsToCompanyAbstract.25607.12.7" xlink:to="loc_TaxAmendmentLawAmendedTaxRatePreferredEnterprisesYearsOneAndTwo.25618.12.7" order="12.00000" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:label="loc_TaxAmendmentLawAmendedTaxRatePreferredEnterprisesYearsThreeAndFour.25619.12.7" xlink:href="psti-20140630.xsd#psti_TaxAmendmentLawAmendedTaxRatePreferredEnterprisesYearsThreeAndFour" xlink:type="locator" />
    <link:presentationArc xlink:from="loc_TaxRateBenefitsToCompanyAbstract.25607.12.7" xlink:to="loc_TaxAmendmentLawAmendedTaxRatePreferredEnterprisesYearsThreeAndFour.25619.12.7" order="14.00000" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:label="loc_TaxAmendmentLawAmendedTaxRatePreferredEnterprisesDevelopmentAreaYearsOneAndTwo.25620.12.7" xlink:href="psti-20140630.xsd#psti_TaxAmendmentLawAmendedTaxRatePreferredEnterprisesDevelopmentAreaYearsOneAndTwo" xlink:type="locator" />
    <link:presentationArc xlink:from="loc_TaxRateBenefitsToCompanyAbstract.25607.12.7" xlink:to="loc_TaxAmendmentLawAmendedTaxRatePreferredEnterprisesDevelopmentAreaYearsOneAndTwo.25620.12.7" order="13.00000" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:label="loc_TaxAmendmentLawAmendedTaxRatePreferredEnterprisesDevelopmentAreaYearsThreeAndFour.25621.12.7" xlink:href="psti-20140630.xsd#psti_TaxAmendmentLawAmendedTaxRatePreferredEnterprisesDevelopmentAreaYearsThreeAndFour" xlink:type="locator" />
    <link:presentationArc xlink:from="loc_TaxRateBenefitsToCompanyAbstract.25607.12.7" xlink:to="loc_TaxAmendmentLawAmendedTaxRatePreferredEnterprisesDevelopmentAreaYearsThreeAndFour.25621.12.7" order="15.00000" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:label="loc_TaxAmendmentLawAmendedTaxRatePreferredEnterprisesYearsFiveAndThereafter.25622.12.7" xlink:href="psti-20140630.xsd#psti_TaxAmendmentLawAmendedTaxRatePreferredEnterprisesYearsFiveAndThereafter" xlink:type="locator" />
    <link:presentationArc xlink:from="loc_TaxRateBenefitsToCompanyAbstract.25607.12.7" xlink:to="loc_TaxAmendmentLawAmendedTaxRatePreferredEnterprisesYearsFiveAndThereafter.25622.12.7" order="16.00000" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:label="loc_TaxAmendmentLawAmendedTaxRatePreferredEnterprisesDevelopmentAreaYearsFiveAndThereafter.25623.12.7" xlink:href="psti-20140630.xsd#psti_TaxAmendmentLawAmendedTaxRatePreferredEnterprisesDevelopmentAreaYearsFiveAndThereafter" xlink:type="locator" />
    <link:presentationArc xlink:from="loc_TaxRateBenefitsToCompanyAbstract.25607.12.7" xlink:to="loc_TaxAmendmentLawAmendedTaxRatePreferredEnterprisesDevelopmentAreaYearsFiveAndThereafter.25623.12.7" order="17.00000" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:label="loc_TaxAmendmentLawMinimumQualifyingInvestmentAmount.25624.12.7" xlink:href="psti-20140630.xsd#psti_TaxAmendmentLawMinimumQualifyingInvestmentAmount" xlink:type="locator" />
    <link:presentationArc xlink:from="loc_TaxRateBenefitsToCompanyAbstract.25607.12.7" xlink:to="loc_TaxAmendmentLawMinimumQualifyingInvestmentAmount.25624.12.7" order="4.50000" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </link:presentationLink>
  <link:presentationLink xlink:title="41002 - Disclosure - TAXES ON INCOME (Qualifying Percentages of Value of Productive Assets) (Details)" xlink:role="http://www.pluristem.com/role/TaxesOnIncomeQualifyingPercentagesOfValueOfProductiveAssetsDetails" xlink:type="extended">
    <link:loc xlink:label="loc_IncomeTaxDisclosureAbstract.2654.12.6" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_IncomeTaxDisclosureAbstract" xlink:type="locator" />
    <link:loc xlink:label="loc_StatementTable.5107.12.6" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_StatementTable" xlink:type="locator" />
    <link:presentationArc xlink:from="loc_IncomeTaxDisclosureAbstract.2654.12.6" xlink:to="loc_StatementTable.5107.12.6" order="1.00000" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" />
    <link:loc xlink:label="loc_RangeAxis.4349.12.6" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_RangeAxis" xlink:type="locator" />
    <link:loc xlink:label="loc_RangeMember.4350.12.6" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_RangeMember" xlink:type="locator" />
    <link:presentationArc xlink:from="loc_RangeAxis.4349.12.6" xlink:to="loc_RangeMember.4350.12.6" order="1.00000" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" />
    <link:loc xlink:label="loc_MinimumMember.3370.12.6" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_MinimumMember" xlink:type="locator" />
    <link:presentationArc xlink:from="loc_RangeMember.4350.12.6" xlink:to="loc_MinimumMember.3370.12.6" order="1.00000" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" />
    <link:loc xlink:label="loc_MaximumMember.3361.12.6" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_MaximumMember" xlink:type="locator" />
    <link:presentationArc xlink:from="loc_RangeMember.4350.12.6" xlink:to="loc_MaximumMember.3361.12.6" order="2.00000" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" />
    <link:presentationArc xlink:from="loc_StatementTable.5107.12.6" xlink:to="loc_RangeAxis.4349.12.6" order="1.00000" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" />
    <link:loc xlink:label="loc_StatementLineItems.5108.12.6" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_StatementLineItems" xlink:type="locator" />
    <link:presentationArc xlink:from="loc_StatementTable.5107.12.6" xlink:to="loc_StatementLineItems.5108.12.6" order="3.00000" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" />
    <link:loc xlink:label="loc_ProductiveAssetsPercentageTierAxis.25626.12.6" xlink:href="psti-20140630.xsd#psti_ProductiveAssetsPercentageTierAxis" xlink:type="locator" />
    <link:presentationArc xlink:from="loc_StatementTable.5107.12.6" xlink:to="loc_ProductiveAssetsPercentageTierAxis.25626.12.6" order="2.00000" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" />
    <link:loc xlink:label="loc_StatementLineItems.5108.12.7" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_StatementLineItems" xlink:type="locator" />
    <link:loc xlink:label="loc_ValueOfProductiveAssetsBeforeExpansion.25627.12.7" xlink:href="psti-20140630.xsd#psti_ValueOfProductiveAssetsBeforeExpansion" xlink:type="locator" />
    <link:presentationArc xlink:from="loc_StatementLineItems.5108.12.7" xlink:to="loc_ValueOfProductiveAssetsBeforeExpansion.25627.12.7" order="1.00000" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:label="loc_ProportionThatRequiredInvestmentBearsToValueOfProductiveAsset.25628.12.7" xlink:href="psti-20140630.xsd#psti_ProportionThatRequiredInvestmentBearsToValueOfProductiveAsset" xlink:type="locator" />
    <link:presentationArc xlink:from="loc_StatementLineItems.5108.12.7" xlink:to="loc_ProportionThatRequiredInvestmentBearsToValueOfProductiveAsset.25628.12.7" order="2.00000" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:label="loc_ProductiveAssetsPercentageTierDomain.25629.12.6" xlink:href="psti-20140630.xsd#psti_ProductiveAssetsPercentageTierDomain" xlink:type="locator" />
    <link:presentationArc xlink:from="loc_ProductiveAssetsPercentageTierAxis.25626.12.6" xlink:to="loc_ProductiveAssetsPercentageTierDomain.25629.12.6" order="1.00000" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" />
    <link:loc xlink:label="loc_TierOneMember.25630.12.6" xlink:href="psti-20140630.xsd#psti_TierOneMember" xlink:type="locator" />
    <link:presentationArc xlink:from="loc_ProductiveAssetsPercentageTierDomain.25629.12.6" xlink:to="loc_TierOneMember.25630.12.6" order="1.00000" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" />
    <link:loc xlink:label="loc_TierTwoMember.25631.12.6" xlink:href="psti-20140630.xsd#psti_TierTwoMember" xlink:type="locator" />
    <link:presentationArc xlink:from="loc_ProductiveAssetsPercentageTierDomain.25629.12.6" xlink:to="loc_TierTwoMember.25631.12.6" order="2.00000" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" />
    <link:loc xlink:label="loc_TierThreeMember.25632.12.6" xlink:href="psti-20140630.xsd#psti_TierThreeMember" xlink:type="locator" />
    <link:presentationArc xlink:from="loc_ProductiveAssetsPercentageTierDomain.25629.12.6" xlink:to="loc_TierThreeMember.25632.12.6" order="3.00000" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" />
  </link:presentationLink>
  <link:presentationLink xlink:title="41003 - Disclosure - TAXES ON INCOME (Schedule of Significant Components of Deferred Tax Assets) (Details)" xlink:role="http://www.pluristem.com/role/TaxesOnIncomeScheduleOfSignificantComponentsOfDeferredTaxAssetsDetails" xlink:type="extended">
    <link:loc xlink:label="loc_IncomeTaxDisclosureAbstract.2654.12.7" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_IncomeTaxDisclosureAbstract" xlink:type="locator" />
    <link:loc xlink:label="loc_DeferredTaxAssetsOperatingLossCarryforwardsDomestic.7855.12.7" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsDomestic" xlink:type="locator" />
    <link:presentationArc xlink:from="loc_IncomeTaxDisclosureAbstract.2654.12.7" xlink:to="loc_DeferredTaxAssetsOperatingLossCarryforwardsDomestic.7855.12.7" order="1.00000" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:label="loc_DeferredTaxAssetsOperatingLossCarryforwardsForeign.7872.12.7" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsForeign" xlink:type="locator" />
    <link:presentationArc xlink:from="loc_IncomeTaxDisclosureAbstract.2654.12.7" xlink:to="loc_DeferredTaxAssetsOperatingLossCarryforwardsForeign.7872.12.7" order="2.00000" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:label="loc_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals.7863.12.7" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals" xlink:type="locator" />
    <link:presentationArc xlink:from="loc_IncomeTaxDisclosureAbstract.2654.12.7" xlink:to="loc_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals.7863.12.7" order="3.00000" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:label="loc_IncomeTaxDisclosureAbstract.2654.12.9" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_IncomeTaxDisclosureAbstract" xlink:type="locator" />
    <link:loc xlink:label="loc_DeferredTaxAssetsGross.7847.12.9" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_DeferredTaxAssetsGross" xlink:type="locator" />
    <link:presentationArc xlink:from="loc_IncomeTaxDisclosureAbstract.2654.12.9" xlink:to="loc_DeferredTaxAssetsGross.7847.12.9" order="4.00000" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
    <link:loc xlink:label="loc_IncomeTaxDisclosureAbstract.2654.12.53" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_IncomeTaxDisclosureAbstract" xlink:type="locator" />
    <link:loc xlink:label="loc_DeferredTaxAssetsValuationAllowance.7902.12.53" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_DeferredTaxAssetsValuationAllowance" xlink:type="locator" />
    <link:presentationArc xlink:from="loc_IncomeTaxDisclosureAbstract.2654.12.53" xlink:to="loc_DeferredTaxAssetsValuationAllowance.7902.12.53" order="5.00000" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
    <link:loc xlink:label="loc_DeferredTaxAssetsNet.7866.12.9" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_DeferredTaxAssetsNet" xlink:type="locator" />
    <link:presentationArc xlink:from="loc_IncomeTaxDisclosureAbstract.2654.12.9" xlink:to="loc_DeferredTaxAssetsNet.7866.12.9" order="6.00000" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
  </link:presentationLink>
  <link:presentationLink xlink:title="202 - Disclosure - SIGNIFICANT ACCOUNTING POLICIES (Policies)" xlink:role="http://www.pluristem.com/role/SignificantAccountingPoliciesPolicies" xlink:type="extended">
    <link:loc xlink:label="loc_AccountingPoliciesAbstract.425.12.7" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_AccountingPoliciesAbstract" xlink:type="locator" />
    <link:loc xlink:label="loc_UseOfEstimates.17598.12.7" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_UseOfEstimates" xlink:type="locator" />
    <link:presentationArc xlink:from="loc_AccountingPoliciesAbstract.425.12.7" xlink:to="loc_UseOfEstimates.17598.12.7" order="1.00000" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:label="loc_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock.10297.12.7" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock" xlink:type="locator" />
    <link:presentationArc xlink:from="loc_AccountingPoliciesAbstract.425.12.7" xlink:to="loc_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock.10297.12.7" order="2.00000" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:label="loc_ConsolidationPolicyTextBlock.7154.12.7" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ConsolidationPolicyTextBlock" xlink:type="locator" />
    <link:presentationArc xlink:from="loc_AccountingPoliciesAbstract.425.12.7" xlink:to="loc_ConsolidationPolicyTextBlock.7154.12.7" order="3.00000" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:label="loc_CashAndCashEquivalentsPolicyTextBlock.6740.12.7" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_CashAndCashEquivalentsPolicyTextBlock" xlink:type="locator" />
    <link:presentationArc xlink:from="loc_AccountingPoliciesAbstract.425.12.7" xlink:to="loc_CashAndCashEquivalentsPolicyTextBlock.6740.12.7" order="4.00000" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:label="loc_ShortTermBankDepositPolicyTextBlock.25634.12.7" xlink:href="psti-20140630.xsd#psti_ShortTermBankDepositPolicyTextBlock" xlink:type="locator" />
    <link:presentationArc xlink:from="loc_AccountingPoliciesAbstract.425.12.7" xlink:to="loc_ShortTermBankDepositPolicyTextBlock.25634.12.7" order="5.00000" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:label="loc_LongTermRestrictedDepositPolicyTextBlock.25635.12.7" xlink:href="psti-20140630.xsd#psti_LongTermRestrictedDepositPolicyTextBlock" xlink:type="locator" />
    <link:presentationArc xlink:from="loc_AccountingPoliciesAbstract.425.12.7" xlink:to="loc_LongTermRestrictedDepositPolicyTextBlock.25635.12.7" order="6.00000" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:label="loc_PropertyPlantAndEquipmentPolicyTextBlock.15020.12.7" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_PropertyPlantAndEquipmentPolicyTextBlock" xlink:type="locator" />
    <link:presentationArc xlink:from="loc_AccountingPoliciesAbstract.425.12.7" xlink:to="loc_PropertyPlantAndEquipmentPolicyTextBlock.15020.12.7" order="7.00000" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:label="loc_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock.10902.12.7" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock" xlink:type="locator" />
    <link:presentationArc xlink:from="loc_AccountingPoliciesAbstract.425.12.7" xlink:to="loc_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock.10902.12.7" order="8.00000" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:label="loc_ShareBasedCompensationOptionAndIncentivePlansPolicy.16716.12.7" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy" xlink:type="locator" />
    <link:presentationArc xlink:from="loc_AccountingPoliciesAbstract.425.12.7" xlink:to="loc_ShareBasedCompensationOptionAndIncentivePlansPolicy.16716.12.7" order="9.00000" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:label="loc_ResearchAndDevelopmentExpensesAndGrantsPolicyTextBlock.25636.12.7" xlink:href="psti-20140630.xsd#psti_ResearchAndDevelopmentExpensesAndGrantsPolicyTextBlock" xlink:type="locator" />
    <link:presentationArc xlink:from="loc_AccountingPoliciesAbstract.425.12.7" xlink:to="loc_ResearchAndDevelopmentExpensesAndGrantsPolicyTextBlock.25636.12.7" order="10.00000" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:label="loc_EarningsPerSharePolicyTextBlock.9000.12.7" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_EarningsPerSharePolicyTextBlock" xlink:type="locator" />
    <link:presentationArc xlink:from="loc_AccountingPoliciesAbstract.425.12.7" xlink:to="loc_EarningsPerSharePolicyTextBlock.9000.12.7" order="12.00000" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:label="loc_IncomeTaxPolicyTextBlock.11082.12.7" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_IncomeTaxPolicyTextBlock" xlink:type="locator" />
    <link:presentationArc xlink:from="loc_AccountingPoliciesAbstract.425.12.7" xlink:to="loc_IncomeTaxPolicyTextBlock.11082.12.7" order="13.00000" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:label="loc_SeverancePayPolicyTextBlock.25638.12.7" xlink:href="psti-20140630.xsd#psti_SeverancePayPolicyTextBlock" xlink:type="locator" />
    <link:presentationArc xlink:from="loc_AccountingPoliciesAbstract.425.12.7" xlink:to="loc_SeverancePayPolicyTextBlock.25638.12.7" order="15.00000" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:label="loc_FairValueOfFinancialInstrumentsPolicy.9621.12.7" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_FairValueOfFinancialInstrumentsPolicy" xlink:type="locator" />
    <link:presentationArc xlink:from="loc_AccountingPoliciesAbstract.425.12.7" xlink:to="loc_FairValueOfFinancialInstrumentsPolicy.9621.12.7" order="16.00000" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:label="loc_DerivativesPolicyTextBlock.8455.12.7" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_DerivativesPolicyTextBlock" xlink:type="locator" />
    <link:presentationArc xlink:from="loc_AccountingPoliciesAbstract.425.12.7" xlink:to="loc_DerivativesPolicyTextBlock.8455.12.7" order="17.00000" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:label="loc_MarketableSecuritiesPolicy.12841.12.7" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_MarketableSecuritiesPolicy" xlink:type="locator" />
    <link:presentationArc xlink:from="loc_AccountingPoliciesAbstract.425.12.7" xlink:to="loc_MarketableSecuritiesPolicy.12841.12.7" order="6.50000" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:label="loc_RevenueRecognitionPolicyTextBlock.15864.12.7" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_RevenueRecognitionPolicyTextBlock" xlink:type="locator" />
    <link:presentationArc xlink:from="loc_AccountingPoliciesAbstract.425.12.7" xlink:to="loc_RevenueRecognitionPolicyTextBlock.15864.12.7" order="6.75000" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:label="loc_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy.6775.12.7" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy" xlink:type="locator" />
    <link:presentationArc xlink:from="loc_AccountingPoliciesAbstract.425.12.7" xlink:to="loc_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy.6775.12.7" order="5.50000" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:label="loc_ConcentrationRiskCreditRisk.7122.12.7" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ConcentrationRiskCreditRisk" xlink:type="locator" />
    <link:presentationArc xlink:from="loc_AccountingPoliciesAbstract.425.12.7" xlink:to="loc_ConcentrationRiskCreditRisk.7122.12.7" order="14.50000" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:label="loc_ComprehensiveIncomePolicyPolicyTextBlock.7103.12.7" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ComprehensiveIncomePolicyPolicyTextBlock" xlink:type="locator" />
    <link:presentationArc xlink:from="loc_AccountingPoliciesAbstract.425.12.7" xlink:to="loc_ComprehensiveIncomePolicyPolicyTextBlock.7103.12.7" order="18.00000" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:label="loc_NewAccountingPronouncementsPolicyPolicyTextBlock.13168.12.7" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:type="locator" />
    <link:presentationArc xlink:from="loc_AccountingPoliciesAbstract.425.12.7" xlink:to="loc_NewAccountingPronouncementsPolicyPolicyTextBlock.13168.12.7" order="19.00000" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </link:presentationLink>
  <link:presentationLink xlink:title="302 - Disclosure - SIGNIFICANT ACCOUNTING POLICIES (Tables)" xlink:role="http://www.pluristem.com/role/SignificantAccountingPoliciesTables" xlink:type="extended">
    <link:loc xlink:label="loc_AccountingPoliciesAbstract.425.12.7" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_AccountingPoliciesAbstract" xlink:type="locator" />
    <link:loc xlink:label="loc_PropertyPlantAndEquipmentEstimatedUsefulLivesRateTableTextBlock.25639.12.7" xlink:href="psti-20140630.xsd#psti_PropertyPlantAndEquipmentEstimatedUsefulLivesRateTableTextBlock" xlink:type="locator" />
    <link:presentationArc xlink:from="loc_AccountingPoliciesAbstract.425.12.7" xlink:to="loc_PropertyPlantAndEquipmentEstimatedUsefulLivesRateTableTextBlock.25639.12.7" order="1.00000" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:label="loc_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock.16190.12.7" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock" xlink:type="locator" />
    <link:presentationArc xlink:from="loc_AccountingPoliciesAbstract.425.12.7" xlink:to="loc_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock.16190.12.7" order="2.00000" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </link:presentationLink>
  <link:presentationLink xlink:title="001 - Document - Document and Entity Information" xlink:role="http://www.pluristem.com/role/DocumentAndEntityInformation" xlink:type="extended">
    <link:loc xlink:label="loc_StatementLineItems.5108.12.6" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_StatementLineItems" xlink:type="locator" />
    <link:loc xlink:label="loc_DocumentType.210.12.6" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_DocumentType" xlink:type="locator" />
    <link:presentationArc xlink:from="loc_StatementLineItems.5108.12.6" xlink:to="loc_DocumentType.210.12.6" order="1.00000" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" />
    <link:loc xlink:label="loc_AmendmentFlag.144.12.6" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_AmendmentFlag" xlink:type="locator" />
    <link:presentationArc xlink:from="loc_StatementLineItems.5108.12.6" xlink:to="loc_AmendmentFlag.144.12.6" order="2.00000" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" />
    <link:loc xlink:label="loc_DocumentPeriodEndDate.161.12.6" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_DocumentPeriodEndDate" xlink:type="locator" />
    <link:presentationArc xlink:from="loc_StatementLineItems.5108.12.6" xlink:to="loc_DocumentPeriodEndDate.161.12.6" order="3.00000" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" />
    <link:loc xlink:label="loc_EntityRegistrantName.185.12.6" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_EntityRegistrantName" xlink:type="locator" />
    <link:presentationArc xlink:from="loc_StatementLineItems.5108.12.6" xlink:to="loc_EntityRegistrantName.185.12.6" order="4.00000" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" />
    <link:loc xlink:label="loc_EntityCentralIndexKey.186.12.6" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_EntityCentralIndexKey" xlink:type="locator" />
    <link:presentationArc xlink:from="loc_StatementLineItems.5108.12.6" xlink:to="loc_EntityCentralIndexKey.186.12.6" order="5.00000" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" />
    <link:loc xlink:label="loc_CurrentFiscalYearEndDate.155.12.6" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_CurrentFiscalYearEndDate" xlink:type="locator" />
    <link:presentationArc xlink:from="loc_StatementLineItems.5108.12.6" xlink:to="loc_CurrentFiscalYearEndDate.155.12.6" order="6.00000" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" />
    <link:loc xlink:label="loc_DocumentFiscalYearFocus.205.12.6" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_DocumentFiscalYearFocus" xlink:type="locator" />
    <link:presentationArc xlink:from="loc_StatementLineItems.5108.12.6" xlink:to="loc_DocumentFiscalYearFocus.205.12.6" order="7.00000" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" />
    <link:loc xlink:label="loc_DocumentFiscalPeriodFocus.206.12.6" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_DocumentFiscalPeriodFocus" xlink:type="locator" />
    <link:presentationArc xlink:from="loc_StatementLineItems.5108.12.6" xlink:to="loc_DocumentFiscalPeriodFocus.206.12.6" order="8.00000" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" />
    <link:loc xlink:label="loc_EntityFilerCategory.183.12.6" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_EntityFilerCategory" xlink:type="locator" />
    <link:presentationArc xlink:from="loc_StatementLineItems.5108.12.6" xlink:to="loc_EntityFilerCategory.183.12.6" order="9.00000" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" />
    <link:loc xlink:label="loc_EntityCommonStockSharesOutstanding.190.12.6" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_EntityCommonStockSharesOutstanding" xlink:type="locator" />
    <link:presentationArc xlink:from="loc_StatementLineItems.5108.12.6" xlink:to="loc_EntityCommonStockSharesOutstanding.190.12.6" order="10.00000" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" />
    <link:loc xlink:label="loc_EntityPublicFloat.184.12.6" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_EntityPublicFloat" xlink:type="locator" />
    <link:presentationArc xlink:from="loc_StatementLineItems.5108.12.6" xlink:to="loc_EntityPublicFloat.184.12.6" order="11.00000" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" />
    <link:loc xlink:label="loc_EntityVoluntaryFilers.181.12.6" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_EntityVoluntaryFilers" xlink:type="locator" />
    <link:presentationArc xlink:from="loc_StatementLineItems.5108.12.6" xlink:to="loc_EntityVoluntaryFilers.181.12.6" order="12.00000" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" />
    <link:loc xlink:label="loc_EntityWellKnownSeasonedIssuer.180.12.6" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_EntityWellKnownSeasonedIssuer" xlink:type="locator" />
    <link:presentationArc xlink:from="loc_StatementLineItems.5108.12.6" xlink:to="loc_EntityWellKnownSeasonedIssuer.180.12.6" order="13.00000" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" />
    <link:loc xlink:label="loc_EntityCurrentReportingStatus.182.12.6" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_EntityCurrentReportingStatus" xlink:type="locator" />
    <link:presentationArc xlink:from="loc_StatementLineItems.5108.12.6" xlink:to="loc_EntityCurrentReportingStatus.182.12.6" order="14.00000" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" />
    <link:loc xlink:label="loc_StatementClassOfStockAxis.5117.12.6" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_StatementClassOfStockAxis" xlink:type="locator" />
    <link:loc xlink:label="loc_ClassOfStockDomain.1053.12.6" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ClassOfStockDomain" xlink:type="locator" />
    <link:presentationArc xlink:from="loc_StatementClassOfStockAxis.5117.12.6" xlink:to="loc_ClassOfStockDomain.1053.12.6" order="1.00000" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" />
    <link:loc xlink:label="loc_DocumentAndEntityInformationAbstract.25536.12.6" xlink:href="psti-20140630.xsd#psti_DocumentAndEntityInformationAbstract" xlink:type="locator" />
    <link:loc xlink:label="loc_DocumentAndEntityInformationTable.25640.12.6" xlink:href="psti-20140630.xsd#psti_DocumentAndEntityInformationTable" xlink:type="locator" />
    <link:presentationArc xlink:from="loc_DocumentAndEntityInformationAbstract.25536.12.6" xlink:to="loc_DocumentAndEntityInformationTable.25640.12.6" order="1.00000" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" />
    <link:presentationArc xlink:from="loc_DocumentAndEntityInformationTable.25640.12.6" xlink:to="loc_StatementLineItems.5108.12.6" order="2.00000" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" />
    <link:presentationArc xlink:from="loc_DocumentAndEntityInformationTable.25640.12.6" xlink:to="loc_StatementClassOfStockAxis.5117.12.6" order="1.00000" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" />
  </link:presentationLink>
  <link:presentationLink xlink:title="40201 - Disclosure - SIGNIFICANT ACCOUNTING POLICIES (Narrative) (Details)" xlink:role="http://www.pluristem.com/role/SignificantAccountingPoliciesNarrativeDetails" xlink:type="extended">
    <link:loc xlink:label="loc_AwardTypeAxis.367.12.6" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_AwardTypeAxis" xlink:type="locator" />
    <link:loc xlink:label="loc_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain.5034.12.6" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:type="locator" />
    <link:presentationArc xlink:from="loc_AwardTypeAxis.367.12.6" xlink:to="loc_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain.5034.12.6" order="1.00000" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" />
    <link:loc xlink:label="loc_AccountingPoliciesAbstract.425.12.6" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_AccountingPoliciesAbstract" xlink:type="locator" />
    <link:loc xlink:label="loc_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable.4860.12.6" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:type="locator" />
    <link:presentationArc xlink:from="loc_AccountingPoliciesAbstract.425.12.6" xlink:to="loc_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable.4860.12.6" order="1.00000" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" />
    <link:loc xlink:label="loc_DeferredRevenueArrangementByTypeTable.1456.12.6" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_DeferredRevenueArrangementByTypeTable" xlink:type="locator" />
    <link:presentationArc xlink:from="loc_AccountingPoliciesAbstract.425.12.6" xlink:to="loc_DeferredRevenueArrangementByTypeTable.1456.12.6" order="3.00000" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" />
    <link:loc xlink:label="loc_CurrencyAxis.1333.12.6" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_CurrencyAxis" xlink:type="locator" />
    <link:loc xlink:label="loc_AllCurrenciesDomain.17940.12.6" xlink:href="http://xbrl.sec.gov/currency/2014/currency-2014-01-31.xsd#currency_AllCurrenciesDomain" xlink:type="locator" />
    <link:presentationArc xlink:from="loc_CurrencyAxis.1333.12.6" xlink:to="loc_AllCurrenciesDomain.17940.12.6" order="1.00000" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" />
    <link:loc xlink:label="loc_FiniteLivedIntangibleAssetsByMajorClassAxis.2313.12.6" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:type="locator" />
    <link:presentationArc xlink:from="loc_DeferredRevenueArrangementByTypeTable.1456.12.6" xlink:to="loc_FiniteLivedIntangibleAssetsByMajorClassAxis.2313.12.6" order="1.00000" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" />
    <link:loc xlink:label="loc_DeferredRevenueArrangementTypeAxis.1469.12.6" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_DeferredRevenueArrangementTypeAxis" xlink:type="locator" />
    <link:presentationArc xlink:from="loc_DeferredRevenueArrangementByTypeTable.1456.12.6" xlink:to="loc_DeferredRevenueArrangementTypeAxis.1469.12.6" order="2.00000" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" />
    <link:loc xlink:label="loc_DeferredRevenueArrangementLineItems.1463.12.6" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_DeferredRevenueArrangementLineItems" xlink:type="locator" />
    <link:presentationArc xlink:from="loc_DeferredRevenueArrangementByTypeTable.1456.12.6" xlink:to="loc_DeferredRevenueArrangementLineItems.1463.12.6" order="3.00000" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" />
    <link:loc xlink:label="loc_DeferredRevenueArrangementLineItems.1463.12.7" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_DeferredRevenueArrangementLineItems" xlink:type="locator" />
    <link:loc xlink:label="loc_BusinessCombinationContingentConsiderationReceivableUponCertainRegulatoryMilestones.25648.12.7" xlink:href="psti-20140630.xsd#psti_BusinessCombinationContingentConsiderationReceivableUponCertainRegulatoryMilestones" xlink:type="locator" />
    <link:presentationArc xlink:from="loc_DeferredRevenueArrangementLineItems.1463.12.7" xlink:to="loc_BusinessCombinationContingentConsiderationReceivableUponCertainRegulatoryMilestones.25648.12.7" order="2.00000" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:label="loc_AdvancePaymentForDeveplomentCosts.25651.12.7" xlink:href="psti-20140630.xsd#psti_AdvancePaymentForDeveplomentCosts" xlink:type="locator" />
    <link:presentationArc xlink:from="loc_DeferredRevenueArrangementLineItems.1463.12.7" xlink:to="loc_AdvancePaymentForDeveplomentCosts.25651.12.7" order="4.00000" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:label="loc_ReclassFromResearchAndDevelopmentExpenseToCostOfRevenues.25652.12.7" xlink:href="psti-20140630.xsd#psti_ReclassFromResearchAndDevelopmentExpenseToCostOfRevenues" xlink:type="locator" />
    <link:presentationArc xlink:from="loc_DeferredRevenueArrangementLineItems.1463.12.7" xlink:to="loc_ReclassFromResearchAndDevelopmentExpenseToCostOfRevenues.25652.12.7" order="7.00000" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:label="loc_RemainingDeferredRevenueRecognitionPeriodForIntangibleAsset.25653.12.7" xlink:href="psti-20140630.xsd#psti_RemainingDeferredRevenueRecognitionPeriodForIntangibleAsset" xlink:type="locator" />
    <link:presentationArc xlink:from="loc_DeferredRevenueArrangementLineItems.1463.12.7" xlink:to="loc_RemainingDeferredRevenueRecognitionPeriodForIntangibleAsset.25653.12.7" order="3.00000" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:label="loc_DeferredRevenueAdditions.7805.12.7" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_DeferredRevenueAdditions" xlink:type="locator" />
    <link:presentationArc xlink:from="loc_DeferredRevenueArrangementLineItems.1463.12.7" xlink:to="loc_DeferredRevenueAdditions.7805.12.7" order="1.00000" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:label="loc_ResearchAndDevelopmentArrangementWithFederalGovernmentCustomerFundingToOffsetCostsIncurred.15675.12.7" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ResearchAndDevelopmentArrangementWithFederalGovernmentCustomerFundingToOffsetCostsIncurred" xlink:type="locator" />
    <link:presentationArc xlink:from="loc_DeferredRevenueArrangementLineItems.1463.12.7" xlink:to="loc_ResearchAndDevelopmentArrangementWithFederalGovernmentCustomerFundingToOffsetCostsIncurred.15675.12.7" order="5.00000" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:label="loc_DeferredRevenueArrangementTypeDomain.1454.12.6" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_DeferredRevenueArrangementTypeDomain" xlink:type="locator" />
    <link:presentationArc xlink:from="loc_DeferredRevenueArrangementTypeAxis.1469.12.6" xlink:to="loc_DeferredRevenueArrangementTypeDomain.1454.12.6" order="1.00000" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" />
    <link:loc xlink:label="loc_DerivativeInstrumentRiskAxis.1594.12.6" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_DerivativeInstrumentRiskAxis" xlink:type="locator" />
    <link:loc xlink:label="loc_DerivativeContractTypeDomain.1632.12.6" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_DerivativeContractTypeDomain" xlink:type="locator" />
    <link:presentationArc xlink:from="loc_DerivativeInstrumentRiskAxis.1594.12.6" xlink:to="loc_DerivativeContractTypeDomain.1632.12.6" order="1.00000" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" />
    <link:loc xlink:label="loc_DerivativeInstrumentsGainLossByHedgingRelationshipAxis.1619.12.6" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis" xlink:type="locator" />
    <link:loc xlink:label="loc_HedgingRelationshipDomain.2545.12.6" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_HedgingRelationshipDomain" xlink:type="locator" />
    <link:presentationArc xlink:from="loc_DerivativeInstrumentsGainLossByHedgingRelationshipAxis.1619.12.6" xlink:to="loc_HedgingRelationshipDomain.2545.12.6" order="1.00000" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" />
    <link:loc xlink:label="loc_DerivativeContractTypeDomain.1632.12.7" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_DerivativeContractTypeDomain" xlink:type="locator" />
    <link:loc xlink:label="loc_ForeignExchangeForwardMember.2365.12.7" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ForeignExchangeForwardMember" xlink:type="locator" />
    <link:presentationArc xlink:from="loc_DerivativeContractTypeDomain.1632.12.7" xlink:to="loc_ForeignExchangeForwardMember.2365.12.7" order="1.00000" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:label="loc_ForeignExchangeOptionMember.2351.12.7" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ForeignExchangeOptionMember" xlink:type="locator" />
    <link:presentationArc xlink:from="loc_DerivativeContractTypeDomain.1632.12.7" xlink:to="loc_ForeignExchangeOptionMember.2351.12.7" order="2.00000" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:label="loc_FiniteLivedIntangibleAssetsMajorClassNameDomain.2311.12.6" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:type="locator" />
    <link:loc xlink:label="loc_LicensingAgreementsMember.3087.12.6" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_LicensingAgreementsMember" xlink:type="locator" />
    <link:presentationArc xlink:from="loc_FiniteLivedIntangibleAssetsMajorClassNameDomain.2311.12.6" xlink:to="loc_LicensingAgreementsMember.3087.12.6" order="1.00000" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" />
    <link:presentationArc xlink:from="loc_FiniteLivedIntangibleAssetsByMajorClassAxis.2313.12.6" xlink:to="loc_FiniteLivedIntangibleAssetsMajorClassNameDomain.2311.12.6" order="1.00000" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" />
    <link:loc xlink:label="loc_DesignatedAsHedgingInstrumentMember.1352.12.6" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_DesignatedAsHedgingInstrumentMember" xlink:type="locator" />
    <link:presentationArc xlink:from="loc_HedgingRelationshipDomain.2545.12.6" xlink:to="loc_DesignatedAsHedgingInstrumentMember.1352.12.6" order="1.00000" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" />
    <link:loc xlink:label="loc_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems.5018.12.6" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:type="locator" />
    <link:presentationArc xlink:from="loc_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable.4860.12.6" xlink:to="loc_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems.5018.12.6" order="2.00000" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" />
    <link:presentationArc xlink:from="loc_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable.4860.12.6" xlink:to="loc_DerivativeInstrumentRiskAxis.1594.12.6" order="1.50000" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" />
    <link:presentationArc xlink:from="loc_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable.4860.12.6" xlink:to="loc_AwardTypeAxis.367.12.6" order="1.25000" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" />
    <link:loc xlink:label="loc_TitleOfIndividualAxis.5277.12.6" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_TitleOfIndividualAxis" xlink:type="locator" />
    <link:presentationArc xlink:from="loc_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable.4860.12.6" xlink:to="loc_TitleOfIndividualAxis.5277.12.6" order="1.37500" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" />
    <link:presentationArc xlink:from="loc_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable.4860.12.6" xlink:to="loc_DerivativeInstrumentsGainLossByHedgingRelationshipAxis.1619.12.6" order="1.75000" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" />
    <link:presentationArc xlink:from="loc_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable.4860.12.6" xlink:to="loc_CurrencyAxis.1333.12.6" order="1.87500" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" />
    <link:loc xlink:label="loc_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems.5018.12.7" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:type="locator" />
    <link:loc xlink:label="loc_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsForfeituresRate.25643.12.7" xlink:href="psti-20140630.xsd#psti_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsForfeituresRate" xlink:type="locator" />
    <link:presentationArc xlink:from="loc_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems.5018.12.7" xlink:to="loc_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsForfeituresRate.25643.12.7" order="1.00000" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:label="loc_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue.16620.12.7" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:type="locator" />
    <link:presentationArc xlink:from="loc_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems.5018.12.7" xlink:to="loc_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue.16620.12.7" order="2.00000" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:label="loc_PostemploymentBenefitsPeriodExpense.14432.12.7" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_PostemploymentBenefitsPeriodExpense" xlink:type="locator" />
    <link:presentationArc xlink:from="loc_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems.5018.12.7" xlink:to="loc_PostemploymentBenefitsPeriodExpense.14432.12.7" order="4.00000" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:label="loc_DerivativeNotionalAmount.278.12.7" xlink:href="http://xbrl.sec.gov/invest/2013/invest-2013-01-31.xsd#invest_DerivativeNotionalAmount" xlink:type="locator" />
    <link:presentationArc xlink:from="loc_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems.5018.12.7" xlink:to="loc_DerivativeNotionalAmount.278.12.7" order="7.00000" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:label="loc_AccumulatedOtherComprehensiveIncomeLossCumulativeChangesInNetGainLossFromCashFlowHedgesEffectNetOfTax.5728.12.7" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossCumulativeChangesInNetGainLossFromCashFlowHedgesEffectNetOfTax" xlink:type="locator" />
    <link:presentationArc xlink:from="loc_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems.5018.12.7" xlink:to="loc_AccumulatedOtherComprehensiveIncomeLossCumulativeChangesInNetGainLossFromCashFlowHedgesEffectNetOfTax.5728.12.7" order="8.00000" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:label="loc_DerivativeInstrumentsGainLossRecognizedInOtherComprehensiveIncomeEffectivePortionNet.8447.12.7" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_DerivativeInstrumentsGainLossRecognizedInOtherComprehensiveIncomeEffectivePortionNet" xlink:type="locator" />
    <link:presentationArc xlink:from="loc_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems.5018.12.7" xlink:to="loc_DerivativeInstrumentsGainLossRecognizedInOtherComprehensiveIncomeEffectivePortionNet.8447.12.7" order="9.00000" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:label="loc_GainLossOnDerivativeInstrumentsNetPretax.10456.12.7" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_GainLossOnDerivativeInstrumentsNetPretax" xlink:type="locator" />
    <link:presentationArc xlink:from="loc_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems.5018.12.7" xlink:to="loc_GainLossOnDerivativeInstrumentsNetPretax.10456.12.7" order="10.00000" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:label="loc_CashFlowHedgesDerivativeInstrumentsAtFairValueNet.6791.12.7" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_CashFlowHedgesDerivativeInstrumentsAtFairValueNet" xlink:type="locator" />
    <link:presentationArc xlink:from="loc_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems.5018.12.7" xlink:to="loc_CashFlowHedgesDerivativeInstrumentsAtFairValueNet.6791.12.7" order="12.00000" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:label="loc_FairValueHedgesAtFairValueNet.9623.12.7" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_FairValueHedgesAtFairValueNet" xlink:type="locator" />
    <link:presentationArc xlink:from="loc_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems.5018.12.7" xlink:to="loc_FairValueHedgesAtFairValueNet.9623.12.7" order="13.00000" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:label="loc_TitleOfIndividualWithRelationshipToEntityDomain.5279.12.6" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_TitleOfIndividualWithRelationshipToEntityDomain" xlink:type="locator" />
    <link:presentationArc xlink:from="loc_TitleOfIndividualAxis.5277.12.6" xlink:to="loc_TitleOfIndividualWithRelationshipToEntityDomain.5279.12.6" order="1.00000" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" />
    <link:loc xlink:label="loc_EmployeesMember.25661.12.6" xlink:href="psti-20140630.xsd#psti_EmployeesMember" xlink:type="locator" />
    <link:presentationArc xlink:from="loc_TitleOfIndividualWithRelationshipToEntityDomain.5279.12.6" xlink:to="loc_EmployeesMember.25661.12.6" order="1.00000" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" />
    <link:loc xlink:label="loc_ManagementMember.3316.12.6" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ManagementMember" xlink:type="locator" />
    <link:presentationArc xlink:from="loc_TitleOfIndividualWithRelationshipToEntityDomain.5279.12.6" xlink:to="loc_ManagementMember.3316.12.6" order="2.00000" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" />
    <link:loc xlink:label="loc_ILS.17830.12.6" xlink:href="http://xbrl.sec.gov/currency/2014/currency-2014-01-31.xsd#currency_ILS" xlink:type="locator" />
    <link:presentationArc xlink:from="loc_AllCurrenciesDomain.17940.12.6" xlink:to="loc_ILS.17830.12.6" order="1.00000" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" />
    <link:loc xlink:label="loc_KRW.17845.12.6" xlink:href="http://xbrl.sec.gov/currency/2014/currency-2014-01-31.xsd#currency_KRW" xlink:type="locator" />
    <link:presentationArc xlink:from="loc_AllCurrenciesDomain.17940.12.6" xlink:to="loc_KRW.17845.12.6" order="2.00000" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" />
  </link:presentationLink>
  <link:presentationLink xlink:title="40202 - Disclosure - SIGNIFICANT ACCOUNTING POLICIES (Schedule of Property and Equipment Depreciation Rate) (Details)" xlink:role="http://www.pluristem.com/role/SignificantAccountingPoliciesScheduleOfPropertyAndEquipmentDepreciationRateDetails" xlink:type="extended">
    <link:loc xlink:label="loc_AccountingPoliciesAbstract.425.12.6" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_AccountingPoliciesAbstract" xlink:type="locator" />
    <link:loc xlink:label="loc_ScheduleOfPropertyPlantAndEquipmentTable.4834.12.6" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:type="locator" />
    <link:presentationArc xlink:from="loc_AccountingPoliciesAbstract.425.12.6" xlink:to="loc_ScheduleOfPropertyPlantAndEquipmentTable.4834.12.6" order="1.00000" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" />
    <link:loc xlink:label="loc_PropertyPlantAndEquipmentTypeDomain.4257.12.7" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:type="locator" />
    <link:loc xlink:label="loc_OtherMachineryAndEquipmentMember.3840.12.7" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_OtherMachineryAndEquipmentMember" xlink:type="locator" />
    <link:presentationArc xlink:from="loc_PropertyPlantAndEquipmentTypeDomain.4257.12.7" xlink:to="loc_OtherMachineryAndEquipmentMember.3840.12.7" order="1.00000" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:label="loc_ComputerEquipmentMember.1163.12.7" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ComputerEquipmentMember" xlink:type="locator" />
    <link:presentationArc xlink:from="loc_PropertyPlantAndEquipmentTypeDomain.4257.12.7" xlink:to="loc_ComputerEquipmentMember.1163.12.7" order="2.00000" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:label="loc_OfficeEquipmentMember.3650.12.7" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_OfficeEquipmentMember" xlink:type="locator" />
    <link:presentationArc xlink:from="loc_PropertyPlantAndEquipmentTypeDomain.4257.12.7" xlink:to="loc_OfficeEquipmentMember.3650.12.7" order="3.00000" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:label="loc_LeaseholdImprovementsMember.3017.12.7" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_LeaseholdImprovementsMember" xlink:type="locator" />
    <link:presentationArc xlink:from="loc_PropertyPlantAndEquipmentTypeDomain.4257.12.7" xlink:to="loc_LeaseholdImprovementsMember.3017.12.7" order="5.00000" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:label="loc_VehiclesMember.5488.12.7" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_VehiclesMember" xlink:type="locator" />
    <link:presentationArc xlink:from="loc_PropertyPlantAndEquipmentTypeDomain.4257.12.7" xlink:to="loc_VehiclesMember.5488.12.7" order="4.00000" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:label="loc_PropertyPlantAndEquipmentTypeDomain.4257.12.6" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:type="locator" />
    <link:loc xlink:label="loc_LeaseholdImprovementsOfNewFacilityConstructionMember.25578.12.6" xlink:href="psti-20140630.xsd#psti_LeaseholdImprovementsOfNewFacilityConstructionMember" xlink:type="locator" />
    <link:presentationArc xlink:from="loc_PropertyPlantAndEquipmentTypeDomain.4257.12.6" xlink:to="loc_LeaseholdImprovementsOfNewFacilityConstructionMember.25578.12.6" order="6.00000" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" />
    <link:loc xlink:label="loc_PropertyPlantAndEquipmentByTypeAxis.4261.12.6" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:type="locator" />
    <link:presentationArc xlink:from="loc_PropertyPlantAndEquipmentByTypeAxis.4261.12.6" xlink:to="loc_PropertyPlantAndEquipmentTypeDomain.4257.12.6" order="1.00000" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" />
    <link:loc xlink:label="loc_PropertyPlantAndEquipmentLineItems.4267.12.7" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_PropertyPlantAndEquipmentLineItems" xlink:type="locator" />
    <link:loc xlink:label="loc_PropertyPlantAndEquipmentAnnualRateOfDepreciation.25659.12.7" xlink:href="psti-20140630.xsd#psti_PropertyPlantAndEquipmentAnnualRateOfDepreciation" xlink:type="locator" />
    <link:presentationArc xlink:from="loc_PropertyPlantAndEquipmentLineItems.4267.12.7" xlink:to="loc_PropertyPlantAndEquipmentAnnualRateOfDepreciation.25659.12.7" order="1.00000" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:label="loc_LeaseholdImprovementsAnnualRateOfDepreciationDescription.25660.12.7" xlink:href="psti-20140630.xsd#psti_LeaseholdImprovementsAnnualRateOfDepreciationDescription" xlink:type="locator" />
    <link:presentationArc xlink:from="loc_PropertyPlantAndEquipmentLineItems.4267.12.7" xlink:to="loc_LeaseholdImprovementsAnnualRateOfDepreciationDescription.25660.12.7" order="2.00000" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:label="loc_RangeAxis.4349.12.6" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_RangeAxis" xlink:type="locator" />
    <link:loc xlink:label="loc_RangeMember.4350.12.6" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_RangeMember" xlink:type="locator" />
    <link:presentationArc xlink:from="loc_RangeAxis.4349.12.6" xlink:to="loc_RangeMember.4350.12.6" order="1.00000" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" />
    <link:loc xlink:label="loc_MinimumMember.3370.12.6" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_MinimumMember" xlink:type="locator" />
    <link:presentationArc xlink:from="loc_RangeMember.4350.12.6" xlink:to="loc_MinimumMember.3370.12.6" order="1.00000" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" />
    <link:loc xlink:label="loc_MaximumMember.3361.12.6" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_MaximumMember" xlink:type="locator" />
    <link:presentationArc xlink:from="loc_RangeMember.4350.12.6" xlink:to="loc_MaximumMember.3361.12.6" order="2.00000" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" />
    <link:presentationArc xlink:from="loc_ScheduleOfPropertyPlantAndEquipmentTable.4834.12.6" xlink:to="loc_PropertyPlantAndEquipmentByTypeAxis.4261.12.6" order="1.00000" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" />
    <link:loc xlink:label="loc_PropertyPlantAndEquipmentLineItems.4267.12.6" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_PropertyPlantAndEquipmentLineItems" xlink:type="locator" />
    <link:presentationArc xlink:from="loc_ScheduleOfPropertyPlantAndEquipmentTable.4834.12.6" xlink:to="loc_PropertyPlantAndEquipmentLineItems.4267.12.6" order="2.00000" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" />
    <link:presentationArc xlink:from="loc_ScheduleOfPropertyPlantAndEquipmentTable.4834.12.6" xlink:to="loc_RangeAxis.4349.12.6" order="1.50000" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" />
  </link:presentationLink>
  <link:presentationLink xlink:title="40807 - Disclosure - STOCKHOLDERS' EQUITY (Summary of Warrants and Options) (Details)" xlink:role="http://www.pluristem.com/role/StockholdersEquitySummaryOfWarrantsAndOptionsDetails" xlink:type="extended">
    <link:loc xlink:label="loc_AwardTypeAxis.367.12.6" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_AwardTypeAxis" xlink:type="locator" />
    <link:loc xlink:label="loc_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain.5034.12.6" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:type="locator" />
    <link:presentationArc xlink:from="loc_AwardTypeAxis.367.12.6" xlink:to="loc_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain.5034.12.6" order="1.00000" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" />
    <link:loc xlink:label="loc_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis.5031.12.6" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis" xlink:type="locator" />
    <link:loc xlink:label="loc_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain.5032.12.6" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain" xlink:type="locator" />
    <link:presentationArc xlink:from="loc_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis.5031.12.6" xlink:to="loc_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain.5032.12.6" order="1.00000" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" />
    <link:loc xlink:label="loc_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain.5032.12.7" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain" xlink:type="locator" />
    <link:loc xlink:label="loc_OptionsExercisePriceRangeOneMember.25733.12.7" xlink:href="psti-20140630.xsd#psti_OptionsExercisePriceRangeOneMember" xlink:type="locator" />
    <link:presentationArc xlink:from="loc_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain.5032.12.7" xlink:to="loc_OptionsExercisePriceRangeOneMember.25733.12.7" order="1.00000" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:label="loc_OptionsExercisePriceRangeTwoMember.25734.12.7" xlink:href="psti-20140630.xsd#psti_OptionsExercisePriceRangeTwoMember" xlink:type="locator" />
    <link:presentationArc xlink:from="loc_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain.5032.12.7" xlink:to="loc_OptionsExercisePriceRangeTwoMember.25734.12.7" order="2.00000" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:label="loc_OptionsExercisePriceRangeThreeMember.25735.12.7" xlink:href="psti-20140630.xsd#psti_OptionsExercisePriceRangeThreeMember" xlink:type="locator" />
    <link:presentationArc xlink:from="loc_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain.5032.12.7" xlink:to="loc_OptionsExercisePriceRangeThreeMember.25735.12.7" order="3.00000" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:label="loc_OptionsExercisePriceRangeFourMember.25736.12.7" xlink:href="psti-20140630.xsd#psti_OptionsExercisePriceRangeFourMember" xlink:type="locator" />
    <link:presentationArc xlink:from="loc_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain.5032.12.7" xlink:to="loc_OptionsExercisePriceRangeFourMember.25736.12.7" order="10.00000" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:label="loc_OptionsExercisePriceRangeFiveMember.25737.12.7" xlink:href="psti-20140630.xsd#psti_OptionsExercisePriceRangeFiveMember" xlink:type="locator" />
    <link:presentationArc xlink:from="loc_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain.5032.12.7" xlink:to="loc_OptionsExercisePriceRangeFiveMember.25737.12.7" order="11.00000" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:label="loc_OptionsExercisePriceRangeSixMember.25738.12.7" xlink:href="psti-20140630.xsd#psti_OptionsExercisePriceRangeSixMember" xlink:type="locator" />
    <link:presentationArc xlink:from="loc_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain.5032.12.7" xlink:to="loc_OptionsExercisePriceRangeSixMember.25738.12.7" order="12.00000" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:label="loc_OptionsExercisePriceRangeSevenMember.25739.12.7" xlink:href="psti-20140630.xsd#psti_OptionsExercisePriceRangeSevenMember" xlink:type="locator" />
    <link:presentationArc xlink:from="loc_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain.5032.12.7" xlink:to="loc_OptionsExercisePriceRangeSevenMember.25739.12.7" order="15.00000" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:label="loc_OptionsExercisePriceRangeEightMember.25740.12.7" xlink:href="psti-20140630.xsd#psti_OptionsExercisePriceRangeEightMember" xlink:type="locator" />
    <link:presentationArc xlink:from="loc_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain.5032.12.7" xlink:to="loc_OptionsExercisePriceRangeEightMember.25740.12.7" order="16.00000" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:label="loc_OptionsExercisePriceRangeNineMember.25741.12.7" xlink:href="psti-20140630.xsd#psti_OptionsExercisePriceRangeNineMember" xlink:type="locator" />
    <link:presentationArc xlink:from="loc_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain.5032.12.7" xlink:to="loc_OptionsExercisePriceRangeNineMember.25741.12.7" order="17.00000" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:label="loc_OptionsExercisePriceRangeTenMember.25742.12.7" xlink:href="psti-20140630.xsd#psti_OptionsExercisePriceRangeTenMember" xlink:type="locator" />
    <link:presentationArc xlink:from="loc_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain.5032.12.7" xlink:to="loc_OptionsExercisePriceRangeTenMember.25742.12.7" order="18.00000" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:label="loc_OptionsExercisePriceRangeElevenMember.25743.12.7" xlink:href="psti-20140630.xsd#psti_OptionsExercisePriceRangeElevenMember" xlink:type="locator" />
    <link:presentationArc xlink:from="loc_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain.5032.12.7" xlink:to="loc_OptionsExercisePriceRangeElevenMember.25743.12.7" order="20.00000" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:label="loc_ExercisePriceRangeOneMember.25746.12.7" xlink:href="psti-20140630.xsd#psti_ExercisePriceRangeOneMember" xlink:type="locator" />
    <link:presentationArc xlink:from="loc_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain.5032.12.7" xlink:to="loc_ExercisePriceRangeOneMember.25746.12.7" order="4.00000" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:label="loc_ExercisePriceRangeTwoMember.25747.12.7" xlink:href="psti-20140630.xsd#psti_ExercisePriceRangeTwoMember" xlink:type="locator" />
    <link:presentationArc xlink:from="loc_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain.5032.12.7" xlink:to="loc_ExercisePriceRangeTwoMember.25747.12.7" order="5.00000" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:label="loc_ExercisePriceRangeThreeMember.25748.12.7" xlink:href="psti-20140630.xsd#psti_ExercisePriceRangeThreeMember" xlink:type="locator" />
    <link:presentationArc xlink:from="loc_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain.5032.12.7" xlink:to="loc_ExercisePriceRangeThreeMember.25748.12.7" order="6.00000" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:label="loc_ExercisePriceRangeFourMember.25749.12.7" xlink:href="psti-20140630.xsd#psti_ExercisePriceRangeFourMember" xlink:type="locator" />
    <link:presentationArc xlink:from="loc_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain.5032.12.7" xlink:to="loc_ExercisePriceRangeFourMember.25749.12.7" order="9.00000" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:label="loc_ExercisePriceRangeFiveMember.25750.12.7" xlink:href="psti-20140630.xsd#psti_ExercisePriceRangeFiveMember" xlink:type="locator" />
    <link:presentationArc xlink:from="loc_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain.5032.12.7" xlink:to="loc_ExercisePriceRangeFiveMember.25750.12.7" order="7.00000" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:label="loc_ExercisePriceRangeSixMember.25751.12.7" xlink:href="psti-20140630.xsd#psti_ExercisePriceRangeSixMember" xlink:type="locator" />
    <link:presentationArc xlink:from="loc_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain.5032.12.7" xlink:to="loc_ExercisePriceRangeSixMember.25751.12.7" order="15.10000" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:label="loc_ExercisePriceRangeSevenMember.25752.12.7" xlink:href="psti-20140630.xsd#psti_ExercisePriceRangeSevenMember" xlink:type="locator" />
    <link:presentationArc xlink:from="loc_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain.5032.12.7" xlink:to="loc_ExercisePriceRangeSevenMember.25752.12.7" order="15.20000" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:label="loc_ExercisePriceRangeTwelveMember.25745.12.7" xlink:href="psti-20140630.xsd#psti_ExercisePriceRangeTwelveMember" xlink:type="locator" />
    <link:presentationArc xlink:from="loc_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain.5032.12.7" xlink:to="loc_ExercisePriceRangeTwelveMember.25745.12.7" order="14.00000" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:label="loc_WarrantMember.5496.12.6" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_WarrantMember" xlink:type="locator" />
    <link:presentationArc xlink:from="loc_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain.5034.12.6" xlink:to="loc_WarrantMember.5496.12.6" order="1.00000" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" />
    <link:loc xlink:label="loc_EmployeeStockOptionMember.1835.12.6" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_EmployeeStockOptionMember" xlink:type="locator" />
    <link:presentationArc xlink:from="loc_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain.5034.12.6" xlink:to="loc_EmployeeStockOptionMember.1835.12.6" order="2.00000" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" />
    <link:loc xlink:label="loc_StockholdersEquityNoteAbstract.5143.12.6" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_StockholdersEquityNoteAbstract" xlink:type="locator" />
    <link:loc xlink:label="loc_StockholdersEquityNoteTable.25554.12.6" xlink:href="psti-20140630.xsd#psti_StockholdersEquityNoteTable" xlink:type="locator" />
    <link:presentationArc xlink:from="loc_StockholdersEquityNoteAbstract.5143.12.6" xlink:to="loc_StockholdersEquityNoteTable.25554.12.6" order="1.00000" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" />
    <link:loc xlink:label="loc_StockholdersEquityNoteLineItems.25553.12.7" xlink:href="psti-20140630.xsd#psti_StockholdersEquityNoteLineItems" xlink:type="locator" />
    <link:loc xlink:label="loc_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice.16713.12.7" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:type="locator" />
    <link:presentationArc xlink:from="loc_StockholdersEquityNoteLineItems.25553.12.7" xlink:to="loc_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice.16713.12.7" order="5.00000" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:label="loc_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber.16626.12.7" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:type="locator" />
    <link:presentationArc xlink:from="loc_StockholdersEquityNoteLineItems.25553.12.7" xlink:to="loc_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber.16626.12.7" order="10.00000" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:label="loc_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2.15996.12.7" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:type="locator" />
    <link:presentationArc xlink:from="loc_StockholdersEquityNoteLineItems.25553.12.7" xlink:to="loc_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2.15996.12.7" order="8.50000" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:label="loc_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit.16758.12.7" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit" xlink:type="locator" />
    <link:presentationArc xlink:from="loc_StockholdersEquityNoteLineItems.25553.12.7" xlink:to="loc_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit.16758.12.7" order="5.50000" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:label="loc_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit.16750.12.7" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit" xlink:type="locator" />
    <link:presentationArc xlink:from="loc_StockholdersEquityNoteLineItems.25553.12.7" xlink:to="loc_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit.16750.12.7" order="5.75000" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:label="loc_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions.16742.12.7" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions" xlink:type="locator" />
    <link:presentationArc xlink:from="loc_StockholdersEquityNoteLineItems.25553.12.7" xlink:to="loc_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions.16742.12.7" order="6.50000" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:label="loc_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions.16744.12.7" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions" xlink:type="locator" />
    <link:presentationArc xlink:from="loc_StockholdersEquityNoteLineItems.25553.12.7" xlink:to="loc_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions.16744.12.7" order="6.75000" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:label="loc_StockholdersEquityNoteLineItems.25553.12.6" xlink:href="psti-20140630.xsd#psti_StockholdersEquityNoteLineItems" xlink:type="locator" />
    <link:presentationArc xlink:from="loc_StockholdersEquityNoteTable.25554.12.6" xlink:to="loc_StockholdersEquityNoteLineItems.25553.12.6" order="2.00000" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" />
    <link:presentationArc xlink:from="loc_StockholdersEquityNoteTable.25554.12.6" xlink:to="loc_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis.5031.12.6" order="1.00000" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" />
    <link:presentationArc xlink:from="loc_StockholdersEquityNoteTable.25554.12.6" xlink:to="loc_AwardTypeAxis.367.12.6" order="1.50000" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" />
  </link:presentationLink>
  <link:presentationLink xlink:title="40203 - Disclosure - SIGNIFICANT ACCOUNTING POLICIES (Comprehensive Income) (Details)" xlink:role="http://www.pluristem.com/role/SignificantAccountingPoliciesComprehensiveIncomeDetails" xlink:type="extended">
    <link:loc xlink:label="loc_AccountingPoliciesAbstract.425.12.6" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_AccountingPoliciesAbstract" xlink:type="locator" />
    <link:loc xlink:label="loc_AccumulatedOtherComprehensiveIncomeLossTable.487.12.6" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossTable" xlink:type="locator" />
    <link:presentationArc xlink:from="loc_AccountingPoliciesAbstract.425.12.6" xlink:to="loc_AccumulatedOtherComprehensiveIncomeLossTable.487.12.6" order="1.00000" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" />
    <link:loc xlink:label="loc_AccumulatedOtherComprehensiveIncomeLossLineItems.486.12.10" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems" xlink:type="locator" />
    <link:loc xlink:label="loc_AccumulatedOtherComprehensiveIncomeLossNetOfTax.5715.12.10" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:type="locator" />
    <link:presentationArc xlink:from="loc_AccumulatedOtherComprehensiveIncomeLossLineItems.486.12.10" xlink:to="loc_AccumulatedOtherComprehensiveIncomeLossNetOfTax.5715.12.10" order="1.00000" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" />
    <link:loc xlink:label="loc_AccumulatedOtherComprehensiveIncomeLossLineItems.486.12.7" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems" xlink:type="locator" />
    <link:loc xlink:label="loc_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax.13608.12.7" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" xlink:type="locator" />
    <link:presentationArc xlink:from="loc_AccumulatedOtherComprehensiveIncomeLossLineItems.486.12.7" xlink:to="loc_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax.13608.12.7" order="2.00000" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:label="loc_AccumulatedOtherComprehensiveIncomeLossLineItems.486.12.53" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems" xlink:type="locator" />
    <link:loc xlink:label="loc_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax.15390.12.53" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" xlink:type="locator" />
    <link:presentationArc xlink:from="loc_AccumulatedOtherComprehensiveIncomeLossLineItems.486.12.53" xlink:to="loc_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax.15390.12.53" order="3.00000" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
    <link:loc xlink:label="loc_AccumulatedOtherComprehensiveIncomeLossLineItems.486.12.9" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems" xlink:type="locator" />
    <link:loc xlink:label="loc_OtherComprehensiveIncomeLossNetOfTax.13526.12.9" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTax" xlink:type="locator" />
    <link:presentationArc xlink:from="loc_AccumulatedOtherComprehensiveIncomeLossLineItems.486.12.9" xlink:to="loc_OtherComprehensiveIncomeLossNetOfTax.13526.12.9" order="4.00000" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
    <link:loc xlink:label="loc_AccumulatedOtherComprehensiveIncomeLossLineItems.486.12.11" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems" xlink:type="locator" />
    <link:loc xlink:label="loc_AccumulatedOtherComprehensiveIncomeLossNetOfTax.5715.12.11" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:type="locator" />
    <link:presentationArc xlink:from="loc_AccumulatedOtherComprehensiveIncomeLossLineItems.486.12.11" xlink:to="loc_AccumulatedOtherComprehensiveIncomeLossNetOfTax.5715.12.11" order="5.00000" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
    <link:loc xlink:label="loc_StatementEquityComponentsAxis.5114.12.6" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_StatementEquityComponentsAxis" xlink:type="locator" />
    <link:presentationArc xlink:from="loc_AccumulatedOtherComprehensiveIncomeLossTable.487.12.6" xlink:to="loc_StatementEquityComponentsAxis.5114.12.6" order="1.00000" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" />
    <link:loc xlink:label="loc_AccumulatedOtherComprehensiveIncomeLossLineItems.486.12.6" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems" xlink:type="locator" />
    <link:presentationArc xlink:from="loc_AccumulatedOtherComprehensiveIncomeLossTable.487.12.6" xlink:to="loc_AccumulatedOtherComprehensiveIncomeLossLineItems.486.12.6" order="2.00000" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" />
    <link:loc xlink:label="loc_EquityComponentDomain.1898.12.6" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_EquityComponentDomain" xlink:type="locator" />
    <link:loc xlink:label="loc_AccumulatedNetUnrealizedInvestmentGainLossMember.477.12.6" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_AccumulatedNetUnrealizedInvestmentGainLossMember" xlink:type="locator" />
    <link:presentationArc xlink:from="loc_EquityComponentDomain.1898.12.6" xlink:to="loc_AccumulatedNetUnrealizedInvestmentGainLossMember.477.12.6" order="1.00000" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" />
    <link:loc xlink:label="loc_AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember.484.12.6" xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember" xlink:type="locator" />
    <link:presentationArc xlink:from="loc_EquityComponentDomain.1898.12.6" xlink:to="loc_AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember.484.12.6" order="2.00000" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" />
    <link:presentationArc xlink:from="loc_StatementEquityComponentsAxis.5114.12.6" xlink:to="loc_EquityComponentDomain.1898.12.6" order="1.00000" priority="0" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:type="arc" />
  </link:presentationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>30
<FILENAME>R39.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
  <head>
    <META http-equiv="Content-Type" content="text/html; charset=us-ascii">
    <link rel="StyleSheet" type="text/css" href="report.css"><script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script></head>
  <body><span style="display: none;">v2.4.0.8</span><table class="report" border="0" cellspacing="2" id="ID0ESBAG">
      <tr>
        <th class="tl" colspan="1" rowspan="2">
          <div style="width: 200px;"><strong>COMMITMENTS AND CONTINGENCIES (Operating Lease) (Details) (USD $)<br>In Thousands, unless otherwise specified</strong></div>
        </th>
        <th class="th" colspan="3">12 Months Ended</th>
      </tr>
      <tr>
        <th class="th">
          <div>Jun. 30, 2014</div>
        </th>
        <th class="th">
          <div>Jun. 30, 2013</div>
        </th>
        <th class="th">
          <div>Jun. 30, 2012</div>
        </th>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeasedAssetsLineItems', window );"><strong>Operating Leased Assets [Line Items]</strong></a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PledgedAssetsNotSeparatelyReportedOtherFinancialInstruments', window );">Pledged cash and deposits</a></td>
        <td class="nump">$ 4,805<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="rh">
        <td class="pl" style="border-bottom: 0px;" valign="top">
          <div class="a">Leased Facilities [Member]</div>
        </td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeasedAssetsLineItems', window );"><strong>Operating Leased Assets [Line Items]</strong></a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_psti_OperatingLeasedAssetsParticipationFromLessor', window );">Participation from lessor</a></td>
        <td class="nump">816<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GuaranteeObligationsCurrentCarryingValue', window );">Lessor favored bank guarantee</a></td>
        <td class="nump">388<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeasesRentExpenseNet', window );">Lease expenses</a></td>
        <td class="nump">720<span></span></td>
        <td class="nump">678<span></span></td>
        <td class="nump">382<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeasesFutureMinimumPaymentsDueCurrent', window );">Year ended June 30, 2015</a></td>
        <td class="nump">667<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeasesFutureMinimumPaymentsDueInTwoYears', window );">Year ended June 30, 2016</a></td>
        <td class="nump">497<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeasesFutureMinimumPaymentsDueInThreeYears', window );">Year ended June 30, 2017</a></td>
        <td class="nump">349<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="reu">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeasesFutureMinimumPaymentsDue', window );">Total</a></td>
        <td class="nump">1,513<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="rh">
        <td class="pl" style="border-bottom: 0px;" valign="top">
          <div class="a">Cars [Member]</div>
        </td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeasedAssetsLineItems', window );"><strong>Operating Leased Assets [Line Items]</strong></a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeasesRentExpenseNet', window );">Lease expenses</a></td>
        <td class="nump">244<span></span></td>
        <td class="nump">215<span></span></td>
        <td class="nump">176<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeasesFutureMinimumPaymentsDueCurrent', window );">Year ended June 30, 2015</a></td>
        <td class="nump">140<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeasesFutureMinimumPaymentsDueInTwoYears', window );">Year ended June 30, 2016</a></td>
        <td class="nump">85<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeasesFutureMinimumPaymentsDueInThreeYears', window );">Year ended June 30, 2017</a></td>
        <td class="nump">26<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="rou">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeasesFutureMinimumPaymentsDue', window );">Total</a></td>
        <td class="nump">$ 251<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
    </table>
    <div style="display: none;">
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_psti_OperatingLeasedAssetsParticipationFromLessor">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Operating Leased Assets, Participation From Lessor.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>psti_OperatingLeasedAssetsParticipationFromLessor</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>psti_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>credit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GuaranteeObligationsCurrentCarryingValue">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The current carrying amount of the liability for the freestanding or embedded guarantor's obligations under the guarantee or each group of similar guarantees.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 460<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 4<br><br> -Subparagraph (c)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6851643&amp;loc=d3e12069-110248<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_GuaranteeObligationsCurrentCarryingValue</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>credit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeasedAssetsLineItems">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div>
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_OperatingLeasedAssetsLineItems</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:stringItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeasesFutureMinimumPaymentsDue">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Amount of required minimum rental payments for leases having an initial or remaining non-cancelable letter-terms in excess of one year.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 840<br><br> -SubTopic 20<br><br> -Section 50<br><br> -Paragraph 2<br><br> -Subparagraph (a)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6453985&amp;loc=d3e41502-112717<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 840<br><br> -SubTopic 10<br><br> -Section 55<br><br> -Paragraph 40<br><br> -Subparagraph (Note 3)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6584154&amp;loc=d3e38371-112697<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_OperatingLeasesFutureMinimumPaymentsDue</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>credit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeasesFutureMinimumPaymentsDueCurrent">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Amount of required minimum rental payments for operating leases having an initial or remaining non-cancelable lease term in excess of one year due in the next fiscal year following the latest fiscal year. Excludes interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 840<br><br> -SubTopic 20<br><br> -Section 50<br><br> -Paragraph 2<br><br> -Subparagraph (a)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6453985&amp;loc=d3e41502-112717<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 840<br><br> -SubTopic 10<br><br> -Section 55<br><br> -Paragraph 40<br><br> -Subparagraph (Note 3)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6584154&amp;loc=d3e38371-112697<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_OperatingLeasesFutureMinimumPaymentsDueCurrent</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>credit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeasesFutureMinimumPaymentsDueInThreeYears">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Amount of required minimum rental payments for operating leases having an initial or remaining non-cancelable lease term in excess of one year due in the third fiscal year following the latest fiscal year. Excludes interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 840<br><br> -SubTopic 20<br><br> -Section 50<br><br> -Paragraph 2<br><br> -Subparagraph (a)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6453985&amp;loc=d3e41502-112717<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 840<br><br> -SubTopic 10<br><br> -Section 55<br><br> -Paragraph 40<br><br> -Subparagraph (Note 3)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6584154&amp;loc=d3e38371-112697<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_OperatingLeasesFutureMinimumPaymentsDueInThreeYears</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>credit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeasesFutureMinimumPaymentsDueInTwoYears">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Amount of required minimum rental payments for operating leases having an initial or remaining non-cancelable lease term in excess of one year due in the second fiscal year following the latest fiscal year. Excludes interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 840<br><br> -SubTopic 20<br><br> -Section 50<br><br> -Paragraph 2<br><br> -Subparagraph (a)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6453985&amp;loc=d3e41502-112717<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 840<br><br> -SubTopic 10<br><br> -Section 55<br><br> -Paragraph 40<br><br> -Subparagraph (Note 3)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6584154&amp;loc=d3e38371-112697<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_OperatingLeasesFutureMinimumPaymentsDueInTwoYears</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>credit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeasesRentExpenseNet">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Rental expense for the reporting period incurred under operating leases, including minimum and any contingent rent expense, net of related sublease income.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 840<br><br> -SubTopic 20<br><br> -Section 50<br><br> -Paragraph 1<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6453985&amp;loc=d3e41499-112717<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_OperatingLeasesRentExpenseNet</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>debit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PledgedAssetsNotSeparatelyReportedOtherFinancialInstruments">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The carrying amount, as of the date of the latest financial statement presented, of other assets which are owned but transferred to serve as collateral for the payment of the related debt obligation, primarily a secured borrowing or repurchase agreement, and for which the transferee is not permitted to sell or re-pledge them to an unrelated party.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 860<br><br> -SubTopic 30<br><br> -Section 50<br><br> -Paragraph 1A<br><br> -Subparagraph (b)(1)(i)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=34720971&amp;loc=SL6224234-111729<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_PledgedAssetsNotSeparatelyReportedOtherFinancialInstruments</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>debit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
    </div>
  </body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>31
<FILENAME>R48.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
  <head>
    <META http-equiv="Content-Type" content="text/html; charset=us-ascii">
    <link rel="StyleSheet" type="text/css" href="report.css"><script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script></head>
  <body><span style="display: none;">v2.4.0.8</span><table class="report" border="0" cellspacing="2" id="ID0EMOAC">
      <tr>
        <th class="tl" colspan="1" rowspan="2">
          <div style="width: 200px;"><strong>FINANCIAL INCOME, NET (Details) (USD $)<br>In Thousands, unless otherwise specified</strong></div>
        </th>
        <th class="th" colspan="3">12 Months Ended</th>
      </tr>
      <tr>
        <th class="th">
          <div>Jun. 30, 2014</div>
        </th>
        <th class="th">
          <div>Jun. 30, 2013</div>
        </th>
        <th class="th">
          <div>Jun. 30, 2012</div>
        </th>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherIncomeAndExpensesAbstract', window );"><strong>FINANCIAL INCOME, NET [Abstract]</strong></a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ForeignCurrencyTransactionGainLossBeforeTax', window );">Foreign currency translation differences, net</a></td>
        <td class="nump">$ 407<span></span></td>
        <td class="nump">$ 497<span></span></td>
        <td class="num">$ (98)<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_psti_InterestOnShortTermBankCreditAndBankExpenses', window );">Bank commissions</a></td>
        <td class="num">(36)<span></span></td>
        <td class="num">(29)<span></span></td>
        <td class="num">(12)<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InterestIncomeDepositsWithFinancialInstitutions', window );">Interest income on deposits</a></td>
        <td class="nump">246<span></span></td>
        <td class="nump">539<span></span></td>
        <td class="nump">575<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MarketableSecuritiesGainLoss', window );">Gain (Loss) related to marketable securities</a></td>
        <td class="nump">384<span></span></td>
        <td class="num">(79)<span></span></td>
        <td class="nump">89<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet', window );">Gain (loss) from derivatives</a></td>
        <td class="num">(83)<span></span></td>
        <td class="nump">140<span></span></td>
        <td class="num">(317)<span></span></td>
      </tr>
      <tr class="reu">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NonoperatingIncomeExpense', window );">Financial income, net</a></td>
        <td class="nump">$ 918<span></span></td>
        <td class="nump">$ 1,068<span></span></td>
        <td class="nump">$ 237<span></span></td>
      </tr>
    </table>
    <div style="display: none;">
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_psti_InterestOnShortTermBankCreditAndBankExpenses">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Interest on short-term bank credit and bank expenses.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>psti_InterestOnShortTermBankCreditAndBankExpenses</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>psti_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>debit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Amount of realized and unrealized gain (loss) of derivative instruments not designated or qualifying as hedging instruments.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 815<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 4C<br><br> -Subparagraph (e)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=35706170&amp;loc=SL5624171-113959<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>credit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ForeignCurrencyTransactionGainLossBeforeTax">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Amount before tax of foreign currency transaction realized and unrealized gain (loss) recognized in the income statement.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 830<br><br> -SubTopic 20<br><br> -Section 45<br><br> -Paragraph 1<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6450189&amp;loc=d3e30690-110894<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 830<br><br> -SubTopic 20<br><br> -Section 50<br><br> -Paragraph 1<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6450222&amp;loc=d3e30840-110895<br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 830<br><br> -SubTopic 20<br><br> -Section 45<br><br> -Paragraph 2<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6450189&amp;loc=d3e30700-110894<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_ForeignCurrencyTransactionGainLossBeforeTax</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>credit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestIncomeDepositsWithFinancialInstitutions">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Interest income derived from funds deposited with both domestic and foreign financial institutions including funds in money market and other accounts.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 942<br><br> -SubTopic 225<br><br> -Section S99<br><br> -Paragraph 1<br><br> -Subparagraph (SX 210.9-04.4)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6879574&amp;loc=d3e536633-122882<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher SEC<br><br> -Name Regulation S-X (SX)<br><br> -Number 210<br><br> -Section 04<br><br> -Paragraph 4<br><br> -Article 9<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_InterestIncomeDepositsWithFinancialInstitutions</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>credit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MarketableSecuritiesGainLoss">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>This item represents the net total realized and unrealized gain (loss) included in earnings for the period as a result of selling or holding marketable securities categorized as trading, available-for-sale, or held-to-maturity, including the unrealized holding gain (loss) of held-to-maturity securities transferred to the trading security category and the cumulative unrealized gain (loss) which was included in other comprehensive income (a separate component of shareholders' equity) for available-for-sale securities transferred to trading securities during the period. Additionally, this item would include any losses recognized for other than temporary impairments (OTTI) of the subject investments in debt and equity securities.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 225<br><br> -SubTopic 10<br><br> -Section S99<br><br> -Paragraph 2<br><br> -Subparagraph (SX 210.5-03.7(c))<br><br> -URI http://asc.fasb.org/extlink&amp;oid=26872669&amp;loc=d3e20235-122688<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 320<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 10<br><br> -Subparagraph (c)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=27724398&amp;loc=d3e27405-111563<br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher SEC<br><br> -Name Regulation S-X (SX)<br><br> -Number 210<br><br> -Section 03<br><br> -Paragraph 7<br><br> -Article 5<br><br><br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 320<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 9<br><br> -Subparagraph (a),(c)-(e)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=27724398&amp;loc=d3e27357-111563<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_MarketableSecuritiesGainLoss</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>credit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NonoperatingIncomeExpense">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 225<br><br> -SubTopic 10<br><br> -Section S99<br><br> -Paragraph 2<br><br> -Subparagraph (SX 210.5-03.7)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=26872669&amp;loc=d3e20235-122688<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher SEC<br><br> -Name Regulation S-X (SX)<br><br> -Number 210<br><br> -Section 03<br><br> -Paragraph 7<br><br> -Article 5<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_NonoperatingIncomeExpense</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>credit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherIncomeAndExpensesAbstract">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div>
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_OtherIncomeAndExpensesAbstract</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:stringItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
    </div>
  </body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EXCEL
<SEQUENCE>32
<FILENAME>Financial_Report.xlsx
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 Financial_Report.xlsx
M4$L#!!0`!@`(````(0!^-`H8$`(``,$>```3``@"6T-O;G1E;G1?5'EP97-=
M+GAM;""B!`(HH``"````````````````````````````````````````````
M````````````````````````````````````````````````````````````
M````````````````````````````````````````````````````````````
M````````````````````````````````````````````````````````````
M````````````````````````````````````````````````````````````
M````````````````````````````````````````````````````````````
M````````````````````````````````````````````````````````````
M````````````````````````````````````````````````````````````
M````````````````````````````````````````````````````````````
M````````````````````````````````````````````````````````````
M````````````````````````````````````````````````````````````
M``````````````````````````````````````#,V<UNVD`4!>!]I;Z#-=L*
M#_.3-*TP6?1GV49J^@!3^X(M[)G1S"2%M^_8)%$442)4I)X-".RY]^#%M^`L
MKK=#7]Q3B)VS%1/EG!5D:]=T=EVQG[=?9U>LB,G8QO3.4L5V%-GU\NV;Q>W.
M4RSR:1LKUJ;D/W(>ZY8&$TOGR>8K*Q<&D_+'L.;>U!NS)B[G\TM>.YO(IED:
M9[#EXC.MS%V?BB_;_/4^2:`^LN+3_L9Q5\6,]WU7FY23\GO;O-@R>]A0YI/3
M/;'M?'R78S!^<,-XY>\+'LY]SX\F=`T5-R:D;V;(,?BVY[]=V/QR;E,>'W(@
MI5NMNIH:5]\-^0F4T0<R36R)TM"7TWLYF,X^YCZR?[HY\NE-G#G(^/NFP2?F
MD"`Y%$@.#9+C`B3')4B.]R`YKD!R?`#)(>8H05!$%2BD"A13!0JJ`D55@<*J
M0'%5H,`J4&25*+)*%%DEBJP215:)(JM$D56BR"I19)4HLDH4616*K`I%5H4B
MJT*15:'(JE!D52BR*A19%8JL"D56C2*K1I%5H\BJ4635*+)J%%DUBJP:15:-
M(JM&D?7B?\F:<D%(?'K]=U.G,:\T5#'M>HIG_E=Y/_2US:T)U/Q((5>I9P_P
M?/:Q'+EHO`G.QURY!CK]*3QVJN/IF<^#**2.GEK50^WDT\9<UYZ^\$4]2F,A
MW%!S8#>?"NCE'P```/__`P!02P,$%``&``@````A`+55,"/U````3`(```L`
M"`)?<F5L<R\N<F5L<R"B!`(HH``"````````````````````````````````
M````````````````````````````````````````````````````````````
M````````````````````````````````````````````````````````````
M````````````````````````````````````````````````````````````
M````````````````````````````````````````````````````````````
M````````````````````````````````````````````````````````````
M````````````````````````````````````````````````````````````
M````````````````````````````````````````````````````````````
M````````````````````````````````````````````````````````````
M````````````````````````````````````````````````````````````
M````````````````````````````````````````````````````````````
M``````````````````````````````````````````````````",DL].PS`,
MQN](O$/D^^IN2`BAI;M,2+LA5![`).X?M8VC)$#W]H0#@DICV]'VY\\_6][N
MYFE4'QQB+T[#NBA!L3-B>]=J>*V?5@^@8B)G:13'&HX<85?=WFQ?>*24FV+7
M^ZBRBXL:NI3\(V(T'4\4"_'L<J61,%'*86C1DQFH9=R4Y3V&OQY0+3S5P6H(
M!WL'JC[Z//FRMS1-;W@OYGUBETZ,0)X3.\MVY4-F"ZG/VZB:0LM)@Q7SG-,1
MR?LB8P.>)MI<3_3_MCAQ(DN)T$C@\SS?BG-`Z^N!+I]HJ?B]SCSBIX3A363X
M8<'%#U1?````__\#`%!+`P04``8`"````"$`G_R)5CL"```,'@``&@`(`7AL
M+U]R96QS+W=O<FMB;V]K+GAM;"YR96QS(*($`2B@``$`````````````````
M````````````````````````````````````````````````````````````
M````````````````````````````````````````````````````````````
M````````````````````````````````````````````````````````````
M````````````````````````````````````````````````````````````
M````````````````````````````````````````````````````````````
M````````````````````````O)G-;MLP$(3O!?H.`N^UO+N4DQ21<PD*Y-JF
M#R#8]`]B2X+(M/7;ES`"N0:::0_"7`20@JCQ>O9;<G7_\.MX*'Z$(>Z[MG8R
MF[LBM*MNO6^WM?O^_.73K2MB:MIU<^C:4+M3B.YA^?'#_==P:%)^*.[V?2SR
M*FVLW2ZE_G-9QM4N')LXZ_K0YCN;;C@V*0^';=DWJY=F&TJ=SQ?E\.<:;GFU
M9O&TKMWPM!9SQ?.ISZ_^]^+=9K-?A<=N]7H,;?K+.\J?W?`2=R&DO&@S;$.J
MW3@5R_,=L5G6[,IWY.1X<.7<(CFZ(,O1!9)C=V0Y=H?DJ)#EJ"`YYLERS",Y
M7LERO$(Y-VPY-TA.E4E(3?1JCN2P@P-CPS8.](VP$2@0@<I&H$($"AN!`A&H
M;`0J1*"QG6S0RL;.<H-I[MD(]!"!OB(3V5>(R-6D&].X:X:P_I:&O/&.^7>^
M;4ZOIJ$:<FQ@:(1M'('&$3:2!2+9V$@VB&3/1K*'2*XF17),IT,^L5[RZ3Q&
MB42/!A+#-B[TK;!#(]`H.JE1QB[`Q2OCU%MC0&'M5G;M5EB[C8U@@P@V=NTV
M6*#\I+5[-,K[WO&PJ>39324/FTIL-5!,-6FU3+DQ&2Y_TWE8GJ^P1K+M`MTB
M;/`)!)^PP2<0?,HFC4+2&-TZT#O&SFV#R>W9O1N/>S?LHJFP:/I)T?<_50I"
MD*T&BF$;!_I&V,P1R!QE,T<A<Y3-'(7,,;9U#'K'L\]X?CSDE5??<)>_`0``
M__\#`%!+`P04``8`"````"$`YE9J+2\$``!]#P``#P```'AL+W=O<FMB;V]K
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M$+OT=%,>2F_?@\B/=_E7R=KW(M(H@=W^TO?`SU9TO=UN%Y\]B>!UE1T_)/D6
MZ.\=I-_9OTK1OKRC(YPZQ5F4!=D[-Z.#^T%,+<Q=-ZDR19:2VX#>)*:OY(FC
MRL"V''ML#@V7#?F#,3:L`>/.$V.N`Q(=U%"OT.!3`V0TR&1O]H>9."XE-&&6
MZW![Q.TI`Q4=5/2SN915!O8$5,CXPI5.5:5RXY-A/3*'FQ9G_\U-%U54D-E3
M@26=ER%/BQ[U0*97S:;4HXJF@6VBP2UJ^E)5>606FQEC^-$.]N.F^GW'?+3,
MD3DP+)<;@X$]MUS3>N13HF5@8C\ZV!"E7=69&+-OS#4>QL05&\QGIFLR3+J#
MG5!J@(X,<\:?C?&<Y22,3(L(-8TQ-<-Q9W.LI@O5*S5(IS.B:.:^<,,:[MLX
MS?'B%BNU$_N@U!"UW2<V.YKA$-LO>5F8`W9`:8!S,C'=`]9Y&M38W%-&%94M
MN<%2&NBT!]^>[/&0S9P#D2^00Y>63D&!4F,2':2)8!4'NCCI2@U%U_A!@V!;
M9']^,_XL3H)2H^\\33@*7:12N1)+2J*8J2YR2:NXLOD:N>2N]S.D\PY4$$_U
M2CQ+=2&?ZA5\YCEA0LBH>B&C#74AJNIUJ'),!UE5+V&UGDL/D3T<KKA&FY!M
M$$%RU?\CM^%^!%BM`?QW??*AR+P@1$+4D@-7`DNP%\!J:`,%%6#/CQ#!?A)"
M*[0:L^>%B/>3$'JBU9AM'B%GL1+^-A2@T\.9UFK,GM?!(>KA3&LU:L\?%K@<
M>CC6],^LXO5Y(6Q:#\=:JZW;CX^=G"2P2,.QIJ"24//1TT!CKZ13PYBV]L='
M$$>K-<2:@DI"YX70:AVQIJ`BY+BUTXQ;7I+0'_S?`C=-#S>67J>Z0<?9KM=>
M\L[C)3BM(]047)#/20<=TI%J"JX2*CF$5.LUJIL<.F6$,.I(-0679/1W6CD^
M,N@(-067Z!16XR;2D48**D*-F[V^8?52YVM,5_Z4`#VY%'8>D=9K2%=UCHN,
M\.%.`#H]U.GLB6[M=R8]HBV\<$'/COE+_O!UN'A\<K[_`P``__\#`%!+`P04
M``8`"````"$`RO,3N%T$```A#P``&````'AL+W=O<FMS:&5E=',O<VAE970T
M+GAM;)Q76X^K-A!^K]3_@'C?@`%SB4*.#J!MC]0C554OSX0X"5K`$2:;W7_?
M,4,`.\VEYR6[,)\_OKEXQEY]^:@KXYVUHN1-;)*%;1JL*?BV;/:Q^=>?KR^A
M:8@N;[9YQ1L6FY],F%_6/_^T.O/V31P8ZPQ@:$1L'KKNN+0L41Q8G8L%/[(&
M+#O>UGD'C^W>$L>6Y=M^45U9CFW[5IV7C8D,R_89#K[;E07+>'&J6=,A2<NJ
MO`/]XE`>Q86M+IZAJ_/V[71\*7A]!(I-697=9T]J&G6Q_+9O>)MO*O#[@WAY
M<>'N'Z[HZ[)HN>"[;@%T%@J]]CFR(@N8UJMM"1[(L!LMV\7F5[+,B&]:ZU4?
MH+]+=A:S_PUQX.=?VG+[6]DPB#;D269@P_F;A'[;RE>PV+I:_=IGX/?6V+)=
M?JJZ/_CY5U;N#QVDFX)'TK'E]C-CHH"(`LW"H9*IX!4(@%^C+F5I0$3RC_[O
MN=QVA]AT_04-;)<`W-@PT;V6DM(TBI/H>/T/@LA`A23.0.*!^L$.K^XOME!(
M[U>6=_EZU?*S`<4"GQ+'7)8>60+AQ2'\_.CB+0_!-4GR5;+T7"!>0%K>UX&W
MLMXADL4`21`2F,8((2HBO2!DV"1K-GMA@=Q1,WBK:W8AE?^=A(M$N4B32%4!
MR37$41'I-<+5(-DU)/!'%L4-]T?<D(MB$_K)&,8@&.G[L"4(@=\)HB+2AXCL
M'D)Q`FIFGHO[.9#@V(0(3<I"55J"$+^O(3>(5&LZM_JZ-9M;`W(CZK#/GA<L
MP9I@35*"$+<7_$+TFE:LCJVZDZG6::T28?__")9@57"H?31!"`IV?2W^Z=SJ
M4\W93+%&T_Y1!,,>?S["$JP)GN*`]8P0BA%VO,C5-2L`$D7VE'IL)"K`\<,;
MRN68UIKAX\8B%VD>:#TA00AZ0-U(DY?.S8X?N%J5S,TN=:;MKD0]^A'M<I&F
M7?MZ@I`A^B2BGN9<J@("Q]48,@40$3JE3W&`0`N?1_]^*^G1FO2KD2,98W/0
M'OJS1MS713J0#`#J>WJ]JP"?SK:+JEV.JEGE/-".@VW>!V<5B45/$#-(<X*0
M:OLXU1".X^B!5Q&$PC%C+"U5OAQ:S\O'$:?(UTHZ(8C!+A.1*>5#X-&,WA%[
M%E;<L,IRQ[U1\D1.J>=EXTQ39$_$0]01@^/GQ?$C?;RG_3=C\X(@A$Z]9-"N
M<!`OB*:Z5*,NY]7S\G&Z03,8AV>HA34AB`$!(T;S,'T,R>Y"5`_D`'O>`QQW
M2@*T#9?(PS1LV0B;O;VXZC8Z0!\&V17@5O3E+)MIER=?#[[^8.OB!)S[$&D;
M,X$+R-1V?)<2S[.U(DD5#*5>2%RJI4I>9"8>X'!)Z$_[#!.!-Q4\T=>LW;.4
M594P"GZ2MQ`"81S?X@TID3>D_HXS&N""<LSW['O>[LM&&!7;P5)[$4`P6KSB
MX$/'C_T!>L,[N)KT_Q[@*LK@J&XO`+SCO+L\R$O4>+E=_PL``/__`P!02P,$
M%``&``@````A`!*UQM9O!```)A(``!D```!X;"]W;W)K<VAE971S+W-H965T
M,SDN>&ULE)C?CZ)($,??+[G_@?"^0HOBCZB;%3)WF]PFE\O=[C-BJV2`-C2.
M,__]574!VJVVS(LS4%^*3U47532+K^]%[KSQ2F:B7+ILX+L.+U.QS<K]TOWO
MWY<O4]>1=5)NDUR4?.E^<.E^7?W^V^(LJE=YX+QVP$,IE^ZAKH]SSY/I@1>)
M'(@C+\&R$U61U'!8[3UYK'BR51<5N3?T_=`KDJQTR<.\ZN-#['99RF.1G@I>
MUN2DXGE2`[\\9$?9>BO2/NZ*I'H]';^DHCB"BTV69_6'<NHZ13K_OB]%E6QR
MB/N=C9*T]:T.;MP765H)*7;U`-QY!'H;\\R;>>!IM=AF$`&FW:GX;NE^8_-X
MZ+O>:J$2]#/C9WGUOR,/XOQ'E6W_RDH.V89UPA78"/&*TN];/`47>S=7OZ@5
M^+MRMGR7G/+Z'W'^DV?[0PW+/8:(,+#Y]B/F,H6,@IO!<(R>4I$#`/PZ18:E
M`1E)WM7?<[:M#TLW"`?CB1\PD#L;+NN7#%VZ3GJ2M2A^D8@UKLC)L'$R`OK&
M#J?L%WL$HN**DSI9+2IQ=J!8X%;RF&#IL3DX;`.BVW<A/HH00D,GW]"+\@7P
M$I;E;17.Q@OO#5*9-IHU:2:NTVF8KHA:!>8-W<97)SS@[:`A7!,Z@+6\OPHM
M(UZD,P8&P/I6,C00;Q6!(8EO)9.P\Z*%$>AAV/%1O'2AD73I"V<7ORI?:]+`
M;Z>9='=6BNBI(K8I-'JHENM%L-.C>.E":CJR<&:PK4D3JO(937VC?B(R6X*+
M;0H-'9ZU_N@HUM''4S/QI+&P14\5L4VAT8>?H4?QL[(AC8W^J2*V*31Z:`#]
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MJP%[*HFM$CT$G&;]0Z#9!_WLZO7`Z.1K?,^&=;J?OR:$IY+8ZD4/`4=:_Q!H
M`.JK8#3&-6NG)+XA#T?&(D6ZF1DO0+%F9H]>*AG.L_[8-/UT[)O.V8Y(Q&8C
M(ZI(W=&Z,+%5HF<=AUI_?!J!.OY-YVSG).)/C:Q&K+5>:L\8#;%5HM/C<.M/
M3Z-0IS<ZRYI=S\NA\5!$G=5"WSJX)]'H8>?\"7JE?M8W&Q&]U`_'1F5%C=GR
M3.-V_O%C3_BT7:=M;<&K/8]XGDLG%2?<BC/HV=U9^DRPAL\$:D_M=0;8I1^3
M/?^15/NLE$[.=W"I/YA`1ZEHGT\'M3BJ3>1&U+`_5_\>X'L,A^VJ/P#Q3HBZ
M/<`O"=T7GM7_````__\#`%!+`P04``8`"````"$`$IU)MO\"``#R"0``&0``
M`'AL+W=O<FMS:&5E=',O<VAE970T,"YX;6R<5MMNHS`0?5]I_P'YO8!S;:*0
MJE75W4J[TFJUEV<'3+`*&-E.T_[]CCT$`FE3LB])"&?.F3,SC%G=O!2Y]\R5
M%K*,"/5#XO$REHDHMQ'Y_>OAZIIXVK`R8;DL>41>N28WZ\^?5GNIGG3&N?&`
MH=01R8RIED&@XXP73/NRXB7<2:4JF(%+M0UTI3A+7%"1!Z,PG`4%$R5!AJ4:
MPB'35,3\7L:[@I<&213/F8'\=28J?6`KXB%T!5-/N^HJED4%%!N1"_/J2(E7
MQ,O';2D5V^3@^X5.6'S@=A<G](6(E=0R-3[0!9CHJ>=%L`B`:;U*!#BP9?<4
M3R-R2Y=W=$*"]<H5Z(_@>WWTV].9W']1(ODF2@[5AC[9#FRD?++0Q\3^!<'!
M2?2#Z\`/Y24\9;O<_)3[KUQL,P/MGH(C:VR9O-YS'4-%@<8?32U3+'-(`#Z]
M0MC1@(JP%_>]%XG)(C*>^=-Y.*8`]S9<FP=A*8D7[[21Q5\$T9H*248U"7S7
M)'3F3T;3^?4`E@`S<@;OF6'KE9)[#Z8&-'7%[`S2)3!;9V.HS]O.P)*-N;5!
M+A30&MKQO)Z'TU7P#"6,:\S=*88VB`#$FPQ`]?(,;%`W@W%+[Y*\.X6,WDY@
MW$W@O'4+C@@\V$?69PTO*B,&/EM,@^A8GURB;,$1`5<M:SAO>%$9,3/7$CJ!
MN6CN=W1AZ"XON0WJZU\W_*B/&$HQ@]!_1W_V/_HVJ*^_Z.DCYJ#?3D3'_;RK
M?K[?%MQ3I6%/%3%C5_7IN+G9$;5'P=%S=E[4@ONBK1DL-6(.K0[G[PSWXA)=
M"^[KMKRHBY@!PTUAC0RW[-`?/5@U:(AX;Z^=KS?%9=5YMFC;2#1>@P[#%?IA
MB^BTFMK-,[C7#MTO^J09HEH;E]D0XX"Y0-RB/ZPZ@H:(7[30X,0^';>VIK5S
M!!U5O:T-5AU/;3S4*K;EWYG:BE)[.4]A4X;^'):2PC,;+XRLW-&QD0;.6O<S
M@W<K#B<;;"SBI5*:PX5]*VC>UM;_````__\#`%!+`P04``8`"````"$`8*T?
MI^8)``!V1```&0```'AL+W=O<FMS:&5E=',O<VAE970T,2YX;6R<W-MNXDH6
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MYL=)'(''NOXN:/(D%O$[#SOW#H]'X#_[WE/UO'S?'/Y;?\35^N7UP`_WA#\B
M\<#F3[_\JEGQ/<K+#.R)J+2J-WP#^,_>=BVBP??(\N?Q_X_UT^'UOC]R!A/7
M&C'.>X]5<PC7HF2_MWIO#O7V_Q(Q54H6L541_K\JPB:#L3UQI[=4&:DJ?+VG
M*KS@E9O@J#OS_]6=;7;SXW!/.T,<!OE`;;[LRDU@[;[DOYSN/ANXS)J-W.MW
M)COM3?&+*C.R!M/)9.Q,;ZESVI]LW-:Q9P-[.F$3!Q_<H0S*,7?^\K!\N-O7
M'SW^9.8/KGE;BJ&!S47I4^)D/MH,_BZ"/'NBRI^BS+$83U?#GS<_'EPVN1O^
MX%E?*>-=,HYN%M+PH]368;KP3T*$7ZPZH`M"NB"B"V*Z(*$+4KH@HPMRNJ"0
M"_C/=M,=BSR\LFL^']Z0'Y'VL/"P=`X+'WA^,Q"<CH*X%SD*]"!(<KZ#7>;J
MNWC1-;8N_*X8$1)TB4OV1BC)^1ZC).H2LIZX*^BF)%U"UY->('2W9%>8_`I3
M7#`V>51EUWP*+2A\6-""<OE,<0J(T"(@IR>/)Q>X[8(%7>#3!0%=$,H%VF%D
M4STPT24STTU\A4FN,.D5)KM@;$O?GOR2^7RZ'@>?XI(9Z75*L]&.)A^`;SB:
M0M_W^=RO'7%<>ZROW).&;\*GT<4""A^*`(H0B@B*&(H$BA2*#(H<B@**TB2T
M2/"IQ@V1$/J^ST>/S\--(NM)8DJ$%)/C:9Q?`,A_>FK\*TP`UQ1"$4$10Y%`
MD4*109%#44!1FH26"CXQOB$50I-4D,'.D\24"BEFQU3P2U#]'PN^D9F&?Z,/
MX!:$4$10Q%`D4*109%#D4!10E":AI85/]VY(B]`D+38YN)XTIKA((0<1=GD,
M@44"*$(H(BAB*!(H4B@R*'(H"BA*D]`R(5I&YQ=^YHFCT#039#KO26/*A!37
M#R&P8@!%"$4$10Q%`D4*109%#D4!16D26D!F)""B,X`O0<6]]*`PFUP,>-*8
M@B*%(\\U,S+X^.>WVLZ,3'D#6#Z$(H(BAB*!(H4B@R*'HH"B-`DM$XRW(+11
MX[I0'.^FI\*U2=?!4\@4"TQ\3`),0DPB1=0L><+<F44>4:P19VK;C%P:)IH8
M6XX[)2+%6Y)ADF-2:)LR<O@96Y_QEQIP)N=`SXAH<IV?6:[,B.R-:9<NG9%#
M-&7Y\&+,""0^KA)@$F(2*:(F06-G-IF2P2K6R-BVV(RT11)-,&<ZIM?X*=Z2
M#),<DT+;%-NQZ;:6&A@Y,_<S1'I&1'_K/"/FV8?HG9.SBFN3_>0I9,R&K&,@
M/JX28!)B$BERRL;(OI`-N;F*\&PPYW-_'OM/B59EQ%]48.1R/\6;DF&28U)@
M4AJ)'A!^C&X)B.#D!#,B^\IC$AF._@(37Q$U[EL6B6'0EA`O@DPF9)(<MC>?
M=6CT@3;2UL!F#ID^Q=KMO#]#MB!I5W%Q"]+VYM]N089)CDF!26DD>B!$P^R&
M$4/VU_@3J&V$=<9-3[S>A<XFDJBGH';2.SX!?5PCP"3$),(DQB3!),4DPR3'
MI,"D-!(]'Z)U=D,^9*=-R\>(S-\\\<H[RH<D,A^.F!7I3V8?UP@P"3&),(DQ
M23!),<DPR3$I,"F-1,^':);=D`_96SO/ASLBIU:/F1IPQ^%A@8F/28!)B$FD
MB!K+QA=G'/(1*7)YQG%.+L\XX&[)\-;FF!28E$:B!T1TSLX#<N5EBVRXG0?%
MH9=Y'C-UY510))%[WA8GFNY0`JL$>$4A)A$F,28))BDF&28Y)@4FI9'H21$M
MM"\D17;>SI/"&+D<])BI/:>2`HF/JP28A(JHP>!2)"-<)<8DP23%),,DQZ3`
MI#02/2FBL?:%I,A^W'E2G&Y23$T[E11)U`'DEX\3B^3-9[!*@$F(281)C$F"
M28I)ADF.28%):21:4NRO-5:/=].O>QE]+Y&GD.FZ5Y%34L8T;3ZN$6`28A)A
M$F.28))BDF&28U)@4AJ)GI.O-5?M;G.5,=(W\!22(9@>9R#D:F:A$7LR<RSZ
M9CM?$4/:`DQ"3"),8DP23%),,DQR3`I,2B/1D\)/'U\X]]CB;F1$H>_F\Q0R
M'..%(J<1Q1G3,X\&1F-&WRL;X)6$F$28Q)@DF*289)CDF!28E$:BIX0?0RTE
MYD:\+;B>#I>.`)Y"\M5;<M@7ZD9#='Q,`DQ"3"),8DP23%),,DQR3`I,2B/1
MLW%;R]7NMES=$7DYTU/(</@7F/B8!)B$F$28Q)@DF*0M$3U[:S`B;WG(VML_
M^]FD6YEC4F!2&HD>C]LZKN(S*IVA@XP.GD+&>,"FK(^K!)B$F$28Q)@DF*2*
MR"&UDPVX1W*\B@*3TDCT;(@6X/F%+SBMR([A^06O2Y\"G@W;B@M,?$P"3$),
M(DQB3!),4DPR1=1D3+ZE6W^=(M<(?Q]"I_U8X/641J('1/0R;PB(;'WJ`2$O
MK7KBPWU\A)%/D@LSRH4&^(2S.R<%%0)5X7Q\HB_)AQ<,&:HC3&),$DQ23#),
M<DP*3$HCT<-QJ<$ZYJ,<&$5D8Y3_;%_S=;J7+K![NK`A\3$),`DQB3"),4DP
M23'),,DQ*3`IC41/BFA?WC",R&ZG/HR0)Z=GPY;H0A$UGO(7TAR7ON;CXS(!
M)B$F$28Q)@DF*289)CDF!2:ED6@1$6]9OB$B1TZO<,D[<#R%SD\#)$4+1=I3
M[L2:DF::CZL$F(281)C$F"28I)ADF.28%)B(KVD0LX'+QT@F1'X-@_PX_+;:
MOU2+:K-I>JOZ77S%@IA'M$OEUS\LV)Q_5)Q_>)8L3]F<?QZ\N]RSY][HPO*%
M/><?M.UZWY[SS]MVEP?VG'_LEB\?MBOFW_KPMGRIBN7^9;UK>IOJF6^R-1#?
M*+"7WQLA_SC4;\=/A#_6!_Y]#\=?7_GW>U3\D_/6@./GNCZ<_A`K:+\QY.$?
M````__\#`%!+`P04``8`"````"$`1-TFS<@#```6#P``&0```'AL+W=O<FMS
M:&5E=',O<VAE970T,BYX;6R<5UUOHSH4?%_I_@?$>P$3R)="5EM5W5UI5UJM
M]M[[3,!)K`)&V&W:?[_'/A1BDP_2ER2TXYDYML\8KSZ_EH7S0AO!>)6XQ`M<
MAU89SUFU2]Q__SS>S5U'R+3*TX)7-''?J'`_K__YM#KPYDGL*94.,%0B<?=2
MUDO?%]F>EJGP>$TK^,^6-V4JX;'9^:)N:)KK067AAT$P]<N452XR+)LQ''R[
M91E]X-ES22N))`TM4@G^Q9[5XIVMS,;0E6GS]%S?9;RL@6+#"B;?-*GKE-GR
M^Z[B3;HIH.Y7$J79.[=^&-"7+&NXX%OI`9V/1H<U+_R%#TSK5<Z@`C7M3D.W
MB?N%+._#R/77*SU!_S%Z$$>_';'GAZ\-RW^PBL)LPSJI%=AP_J2@WW/U)QCL
M#T8_ZA7XU3@YW:;/A?S-#]\HV^TE+'<,%:G"EOG;`Q49S"C0>&&LF#)>@`'X
M=$JFM@;,2/JJOP\LE_O$G4R]>!9,","=#17RD2E*U\F>A>3E_P@B+162A"T)
M?+<D83B6Q$=#NKZ'5*;K5<,/#FP:D!1UJK8@60*Q*FP"TW.Z,*A(C?FB!NFA
M@!:P&B_KV62Q\E]@!K,6<S_$D`[A@WCG`%1O=Z`&60[BCEZ;O!]"P@YA&)B8
M!BZ7KL")"WW=E1X1NW3$P&>'F9U6CDSE<9.O!B4N5->Q1^&DX\?:$1/KI2&+
M>$[B:8<P:H?==SSYEVM78%LYZGA1&3&H?$?B(`@Z@"$\O458@6WAOB`41DPK
M/"=!?&;.9Z;PN#E7@VP#\ZXP-("8=L[GTS!8]/O"*%T="C>WG!ID.^CYT0%B
M1CA8F`XNK[H"6\J3?E%1&3$CE`EDRW'QEZ4UVNRV661KMZ`1[48^%G:89)<;
M3E,G[D)W7.0%?4,:2T]4*!VM_97R,<),9;OA-.6[<N#-SRFK4!JOC!%F*ML=
M1Q"$-1/BQ?U^-(O^4,R14SEG]UP+0@L3;W:N>"OFQC6].N#MG1_V->+.;T%7
M'=R4=^1$X`UZK@5=5?Y0X!%,L^-S;A;U!WA;.X+&=-Z',H^<"KV!"009)J(S
M)SVQ@F_D/CB1@,-]@*!1-L*;0E"CKP5P"QHG;\7@Y1`*,?[,G=#W&>Z$%F3(
M=\>C$0:AE8#CED"/LN8@M,.@!4WQK2>(^KPR'8#+XR0<Z4"-LAW881`BJ#T'
MSSNP`O'*`IP(PD$8P.5'V3M;.]YL\,V_3G?T9]KL6"6<@F[A-3+P9I!U#=YK
M\$'R6K]?;[B$^XC^N8?[)X77_\`#\)9S^?Z@;D[=C7;]%P``__\#`%!+`P04
M``8`"````"$`3V9?:2$#``!6"0``&0```'AL+W=O<FMS:&5E=',O<VAE970S
M."YX;6R4EMN.VC`0AN\K]1TLWR\Y00*(L%JRVG:E5JJJ'JY-XA!KDSBRS;+[
M]AW;$(AI*=P`\?S^\\WX,"SNWYH:O5(A&6]3'(Q\C&B;\X*UFQ3__/%T-\5(
M*M(6I.8M3?$[E?A^^?'#8L?%BZPH50@<6IGB2JEN[GDRKVA#Y(AWM(5(R45#
M%#R*C2<[04EA)C6U%_I^[#6$M=@ZS,4U'KPL64X?>;YM:*NLB:`U4<`O*];)
M@UN37V/7$/&R[>YRWG1@L68U4^_&%*,FGS]O6B[(NH:\WX(QR0_>YN',OF&Y
MX)*7:@1VG@4]SWGFS3QP6BX*!AGHLB-!RQ0_!/,L\+&W7)@"_6)T)T]^(UGQ
MW2?!BB^LI5!M6">]`FO.7[3TN=!#,-D[F_UD5N";0`4MR;96W_GN,V6;2L%R
M3R`CG=B\>'^D,H>*@LTHG&BGG-<``)^H87IK0$7(F_G>L4)5*8[BT23QHP#D
M:$VE>F+:$J-\*Q5O?EM1L+>R)N'>)`+Z?1R&+D_V+(C)ZY$HLEP(OD.P6>!5
MLB-ZZP5S,-0)15"6OR<$F>@Y#WJ2F0IJ":OPNHQGT<)[A<KE>\W*:A*,>DTX
M5&3GBN@H\8"OAX3T;H?4DX:043`D6%E)8JJK$\M.!@8`4)E3@,O5T>(4PY'O
M,X^2F?-FJX'/7I,,%=DEQ8!M?`N;%J<8TNS?&TW=JEA-;-9U'(X=KM-H-#FN
M^H`)-O/U]=)BE^FX$<R.6UE-9)@BWXEF@^@)\8`IOH5)BUVF8ZZ6R6HL4YPX
MT>PT.O'COHH#)C@>U]=)BUTF9W565F.9ILZFR_X1'!#I3G7S?:`GN623/F-;
M+:O9DYVA':+'?1G[O<$`<#8$O'P4M=@%.RZ%!;,:"Q8X]<P.P?]S0=L95.XR
MF%$/R>*9\_+57F1/8AC-G(.J.YU.S\:#,#D>"ULQV\;L==]0L:$9K6N)<K[5
M+2J$P]2/VO:Y"N9P)T+;<L8S:*MFW.L#T-4ZLJ%?B=BP5J*:EF#ICQ(XBL+V
M1?N@>&<NX357T,_,SPK^OU"X;?T1B$O.U>%!=][^']'R#P```/__`P!02P,$
M%``&``@````A`+C]ZF9+!0``QQ<``!D```!X;"]W;W)K<VAE971S+W-H965T
M,S<N>&ULG%C;CJ,X$'U?:?\!\3X!`R$7)1D-6+T[TJZT6NWEF29.@CK@".A.
MS]]OF3($&];0_=(S21U7G^.J\G%[]_4]OUIOK*PR7NQMLG!MBQ4I/V;%>6__
M_=?3E[5M5752'),K+]C>_L$J^^OAYY]V=UZ^5!?&:@LR%-7>OM3U;>LX57IA
M>5(M^(T5$#GQ,D]J^%B>G>I6LN38+,JOCN>ZH9,G66%CAFTY)P<_G;*449Z^
MYJRH,4G)KDD-_*M+=JO:;'DZ)UV>E"^OMR\ISV^0XCF[9O6/)JEMY>GV^[G@
M9?)\!=WO)$C2-G?S89`^S]*25_Q4+R"=@T2'FC?.QH%,A]TQ`P5BVZV2G?;V
M-[*EWLIV#KMF@_[)V+WJ_=^J+OS^2YD=?\L*!KL-=1(5>.;\14"_'\57L-@9
MK'YJ*O!':1W9*7F]UG_R^Z\L.U]J*/<2%`EAV^,/RJH4=A32++RER)3R*Q"`
MGU:>B=:`'4G>FW_OV;&^[&T_7"Q7KD\`;CVSJG[*1$K;2E^KFN?_(HC(5)C$
MDTD"8"_C\)5YL8-$&ETTJ9/#KN1W"YH%?E5U2T3KD2TD;`7AK^\D_I]"D":2
M?!-9FEQ`OH*RO!W"]6KGO,%6IA(3(69E6QV&J(BX18A]$VEI[PL'^':D0:Y.
MVH=:CE>AY2@6J1Q]C4`TA'@:Q2'"UR!T"%F%719%AO\9&6+1WH8#I=O&,-!U
M(`9^=ABM&/$D@IH0B@KHFGXQS$40X+T-6]0Q"]?K;G>:JD>("9LV(L%FN53C
ML1KWB!:G&!]7KS"'D>LS%[T_W49BD:Y@HS*,$+-L%`1$[Y"X'_;\0%M-,3R#
M?ZCR-^^\`*N\@T"CC1"D3=RUYZOQ6(F3=?AH:QQ7C,\@#H=`?^/-Q`58)3[8
MT0@QDOG&U48R5L*NK^FB&/:Q7/ZCG91F$1;>.RC-G`58Y1QN7'4W(\2,[U:S
MG_$D@IH0"ON-RGY>JXM%4T<-8DPJ)A'4A%!4$#CDYQ>A06M5&!PV$H2M$[IZ
M/%;BX-3ZL,KX^`:HY(6;]3IH7@T(>J!Z8FHD(@E"$9X;Z/VOQ(GOZH,KXW-$
M"'?[N`CT1$7$X/0A"!HG@0,Q#:%&B%H/^$V?D")630T%09!1RB2$&K.H4H3E
M]:IB/IP(&J12#;WO(PG"0W'E:AX=*^%E[\Q$)^C"#Y]_W$!4ZL+M>M1G3@5Z
MI"IA,!6MD8K[:.!KYV\L[NU0253HK;4P[<+3$H3O?5P"NJ4B8:-?Y(C)4N5,
M3$*H,8M:#6&%'Y>"!@IF]+C5#>ZDI'79!^C1$E+*)(0:LZA2A#?VI$S,!#JI
M4HWA3+1VV_R!0[1BQ:0?7OK:[8IVX;$-4*D+0^Q1GSD3:*.JA,%,M%XK))#>
M'R:R`OVPWHV4M-%)!=Z'C+I!:T:]T3PLDB#3F3H-H4:(4@3O4W;=K)JR!PDR
M2D';-T"H,8LJ!7JBWT_F4?`$6JO&8!0D"&\<JV"I7:EC->Z'6A]2&1_7IY('
M3)_\O&'PQ"I=A$8BDB#Y9T.P>MS\<1ID'!TBU&]5M`M/C\.'_-D;\>=`.RLC
M"1K?0$D?\Q@@U)A%+<.G?%J\:DW>EB3(P#.>AE`C1)6B^?7$.(SX]'`<6A,6
MQ^IFT$?]:*A=I:C71J?;Z%/N#.^A,T8!0?CHHLU)+#-@4+]'B?=6D7^\?+CQ
M^)Z*[XXY*\\L9M=K9:7\5;R5$OC#N_L6WW$C>,=M'CV=+@#/J+?DS'Y/RG-6
M5-:5G6"INUA!AY7X$(L?:GYK7OF>>0T/J,U_+_!@SN`]T5T`^,1YW7X03[W=
M$_SA/P```/__`P!02P,$%``&``@````A`,MU?G96`P``70L``!D```!X;"]W
M;W)K<VAE971S+W-H965T,S8N>&ULE%9=;YLP%'V?M/^`_)X0("4?"JD:JFZ5
M-FF:]O'L@`E6`2/;:=I_OVL[(9AT3ON2!/O<DW//-==W=?M25]XSX8*R)D'!
M>((\TF0LI\TN0;]_/8SFR!,2-SFN6$,2]$H$NEU__K0Z,/XD2D*D!PR-2%`I
M9;OT?9&5I,9BS%K2P$[!>(TE//*=+UI.<*Z#ZLH/)Y/8KS%MD&%8\O=PL**@
M&;EGV;XFC30DG%18@GY1TE:<V.KL/70UYD_[=I2QN@6*+:VH?-6DR*NSY>.N
M81QO*\C[)9CB[,2M'R[H:YIQ)E@AQT#G&Z&7.2_\A0],ZU5.(0-EN\=)D:"[
M8)D&$?+7*VW0'TH.HO?;$R4[?.$T_T8;`FY#G50%MHP]*>ACKI8@V+^(?M`5
M^,&]G!1X7\F?[/"5T%TIH=PWD)%*;)F_WA.1@:-`,PYO%%/&*A``GUY-U=$`
M1_"+_C[07)8)BN+QS6P2!0#WMD3(!ZHHD9?MA63U7P,*CE2&)#R21*#^N`]+
M[F#?"-%YW6.)URO.#AX<%O@KT6)U]((E$*J$8K#E[80@$Q5SIX)T**`%5.%Y
M'<^#E?\,SF5'S,9@9LCK,*&-2"\1T1GB@[Y.)*0W%!E=%:F";)'14*.!S+2[
M*K&TMV`)`&?Z`MSN*'""X)7O,H_GY\2T@QN#@<\.,QNXXT)8VJ8?T:;`"8(T
MN_^-YY']SQN#B75=1_/I0'K:WUZ<8RU-<)C[?JE3-?WO:W(Z52IHJ&TZT&8P
M+M]<"$MC;&MTUU2!K]748%S:7`A+&[PV??_<VA1XZ-NY+N:\&4RD:QH.3$U/
MF[U#,>E\MW2I>^S#W4(%#?7==/Q&G\&XO',A+(T+6Z/;.P6^5E>#<6ES(2QM
M`72MOH%N<1H]=&Y8V2/(E'8TGR]L9]-N_WIU@S<N@^NOK8X:JHQM%9LCR&6B
M$V*[J-IT[QA><=$T=3@_O9XW:&J;P("<^EP06Q_0?$"?0@_]NZBR`9FF'`YV
MU<BC*,SN14\VTXRY]6O"=R0E526\C.W5I!)"3^A6S12U"9:;4%V*@_44IBN]
M[G<;,-RT>$>^8[ZCC?`J4@#E9#R#+LS->&0>)&OU7;QE$L8:_;.$,9;`I3L9
M`[A@3)X>U`#6#<;K?P```/__`P!02P,$%``&``@````A`'_YU9:O!```*!0`
M`!D```!X;"]W;W)K<VAE971S+W-H965T,S(N>&ULG%A=CYLZ$'VO=/\#XGW#
MUX8T49*J@/;>2JU45?>VSX0X"5K`$2:;W7]_QQX@V!##[DL2F./AG)GQ#/'Z
MRVN>&2^D9"DM-J8SLTV#%`G=I\5Q8_[W[]/#9]-@55SLXXP69&.^$69^V?[U
M:7VEY3,[$5(9X*%@&_-45>>59;'D1/*8S>B9%&`YT#*/*[@LCQ8[ER3>BT5Y
M9KFV[5MYG!8F>EB54WS0PR%-2$232TZ*"IV4)(LKX,].Z9DUWO)DBKL\+I\O
MYX>$YF=PL4NSM'H33DTC3U;?C@4MXUT&NE^=QSAI?(N+GOL\34K*Z*&:@3L+
MB?8U+ZVE!9ZVZWT*"GC8C9(<-N979Q6YKFEMUR)`OU-R99W?!CO1Z]]ENO^>
M%@2B#7GB&=A1^LRAW_;\%BRV>JN?1`9^EL:>'.)+5OVBUW](>CQ5D.XY*.+"
M5ONWB+`$(@IN9NZ<>TIH!@3@T\A37AH0D?A5?%_3?77:F)X_FR]LSP&XL2.L
M>DJY2]-(+JRB^1\$.;4K=.+63AZ!?6V'6_K%%A(1NJ*XBK?KDEX-*!9X%#O'
MO/2<%3AL!.'C6XGW%((T[N0K]R)\`7D&:7G9^G-G;;U`*),:$R!F81HM1D&$
M#8+'C;N-.C<LX-N2!KDJ:0]R.9R%AB-?)'/T%`)!'^+*(L(^PE,@41^R\%LO
MD@SO(S+XHHT)#:4-HS]7*`2(@<\6LV@9B,B&HXA(AY!40-5TDZ%/`@=O3`A1
MR\Q=+F5N`6)\44;N7+&&:-5HBW0(B3ELN2YS7OOC9<07R0H\6XT_8N9"@??H
MJL%'LTZ"#B%)\#\B@2]2)7A*$A#C"0D/BYZ$QGS+HR(RTB$D"=`1WI\%ODB5
M<-MEHL8#Q&`6W(5MRPI#-*-"[[-29E'7^N!XM\42=S[7.]U37_L<K')6HA8@
MIN:\[!4_FI%S;VM$C74H*1+MI4Q[6N'S13)]?ZY6#6(TE1V.(B(=0E+A0,OO
M1G^:#+%JK('6()V0<4BDA<A2^*2;7$@.SD5]%ZU!=VHE;,U#Q5)/7WS,<!!D
M^GSF=>A/S`1.RJZ,?BMU$-3T4OM1V<6U?9ADK0-=#$-D'8#Y@`Z^2MX9GJWN
M#`=!=QMJ:]?DHW$Q!)%U\!'X_GS@X)3SH395!T%UA_(72@,+:SM0;2>\`HFT
M$%D'GX,='?K^RE_$>WE0'A[4H*;#>HJ^L+9K^4^>S@X?@AW^$_<%CLYN'ORY
M4O>!<`WO*_?C'(Y#(BU$3@4?B.^7@F,4!E-;#?VW5:>9M3>0DK5P'!)I(;(4
M/B<[4D:J"J=J-QO]5U:G/WK]VRL#OG(/8!29D18B:^!3LJ-A8F7A;.UJ&>BX
MS0#F?^-<I8^%3F.]FZQ("Y%4N!^:X&+56+^M0=W]T<O(`$;-B!8B:U%&^+2,
MN/U1[ME*3PIJ4#W*U8RTUOL9T4)D%5`;W;K2[PTX:AGON#6H_C_78X\NNGGJ
MY4`'0?9X8(,'&SDICR0D6<:,A%[X88P#_V+:NWA0%,!!D3A5L5H#G-.<XR/Y
M$9?'M&!&1@ZPU)XMH-N7>-*#%Q4]BV.$':W@A$;\/,&)'($#"WL&X`.E57/!
MSY+:,[[M_P```/__`P!02P,$%``&``@````A`%@U/:B;"```ERP``!D```!X
M;"]W;W)K<VAE971S+W-H965T,S,N>&ULE%K;;N,V$'TOT'\P])[8U(6V@CA%
MI<6V!5J@*'IY5FPY%M:V#$G9[/Y]20YE<H8R);UDUYXCZG"&9PXM\?FG;^?3
MXFO9M%5]V0;L<14LRLNNWE>7MVWPS]^?'S;!HNV*R[XXU9=R&WPOV^"GEQ]_
M>/ZHFR_ML2R[A1CATFZ#8]==GY;+=G<LST7[6%_+BX@<ZN9<=.)C\[9LKTU9
M[-5%Y],R7*WX\EQ4EP!&>&JFC%$?#M6N_%3OWL_EI8-!FO)4=()_>ZRN;3_:
M>3=EN'/1?'F_/NSJ\U4,\5J=JNZ[&C18G'=/O[U=ZJ9X/8EY?V-QL>O'5A^<
MX<_5KJG;^M`]BN&60-2=<[I,EV*DE^=])68@T[YHRL,V^)D]Y7P=+%^>58+^
MK<J/UOK_HCW6'[\TU?[WZE**;(LZR0J\UO47"?UM+[\2%R^=JS^K"OS9+/;E
MH7@_=7_5'[^6U=NQ$^5.Q(SDQ)[VWS^5[4YD5`SS&"9RI%U]$@3$W\6YDDM#
M9*3XIO[]J/;=<1M$_#%9KR(FX(O7LNT^5W+(8+%[;[OZ_!^`F!X*!@GU()%@
MK^/B*__%2R"BYO6IZ(J7YZ;^6(C%(F[57@NY]-B3&%!.*+X[(3$3><W/\B)U
MJ4"WH@I?7WB2/"^_BLSM-"8#S#I8W#`A1N0N(C*0I>!W(RFF1TE&HG;#6>])
MRHLPR8AA!AE`U'I1$\NM+Q`!D9GY!.1%VT!(_Y8!GG#"`##B[PVSQHC<AT`<
M8\S1GQP)W@9BNK?[1HQR`PQ7]0W7JY!4.+?C+&*;.\43J\G.G9^7!&->/"$9
MR0"3`*^44UH0CE182.N63I0L/H>4!%-2F]NX:N5D@(&[/H0ICN8H&C&S#A$I
M(9;IF9)@2HK<-@-,GZF4F_O"<K?C+(IC$T>\I'M9/<)?00DFO+@I`B0+,+Y5
M[T,@;BGF)OO7>&N0%XTI$S`^CCX$XLA$KYJ>0(7&&72UJ4%06I;&$4EQC@#Q
MQBH!ID;ZO[^V#%JVW39<>6J07G7)ANI3QT$JH17&Q&0KGKSH&#1N3(Q*5(-Z
MC49$HSC,-D9,F)ALR-.)0?O&Q,S((`<&()TQEJ:FDX).$2!.+1?!U&99`',]
M@-,.D6F03P9>".9'K&":6.7^:E2M&N3EV1N#\3SC+)CG+'=@KCT,Z!5`4.)U
MLC*=5E?8C@M-F;6+F<VR"#;D$6;.>O$!"%01T060ZS&T6N\Y%YME$0J-.QQ/
MS(PUK]X"Y/;R@>Q-<CV$UO)=K1)W&.ENT-!'M`H@7<B-)45=2#O.URO3EU$A
M0V()TZ2@KB*)XZ199!KDDX(7@GD2?YC($WQ"5/"VO72WOB&`O#Q]$,Q3&L#D
MKAQ*-,ZC*UD-@B66QL0M=!36`5O')HYYB>G-X"71F)?KKR&`@!<C7I*CZ/H>
MJUE&$0X8A2-7#;*K:>TY0!LWC))T9`P8IXRXA%^T\G>SDS*2E$R#=,J8N;'F
M!6/TM;RW)0F)+4S4@FL/G!,&F1I:[%PMP9`^G7LA.('$)";R!!\8T6QO%D;8
M#D\?!/.<91HA^('=G0<T"R!=R<UF0WU6CP*`>!6:0F!JLXPC'#(.DI=,@^#.
M81*2MIWK.*S1,+JC7/G;9GH_46C:3ZC1:A#<^,'*"(@#A]GFCJ%%Q"C\JE5H
M2HRJ5H-TQEADW5I3`WOHB[DV*4?%C(@W3-.#NHI0Y*8JBD&F03[=>B&8IVSL
MEH=-Y"FO&OLQ&P'(R],'P3QGN4?DNH>K6PV"-9B:.NHZPQ`0C:R'*YC6+-^(
MAGR#W#C3($V+[`!0,#2-!I,BGC$BBP&O<)PV`I!=2\=I_1C,D+C%"$/H[G87
MYHDCW-X"I,^S%=V[1W8X2NXU%.(.$]7@N@2G3PBS"$!V!DGE<R\$YX]8Q42>
M8!F"B&>''`'(R],'03SC6<ZAT+C[N:K5H-[24OJD!\497QG+P\QF64<,31^O
M0%*^3(.T<(GCY2@:F]6+61'7\.LBEFB<+_<GK08!JP?3,:#+D>B]9,DV;9G$
M""V)IK3,A,'$8@#I,G+GZ1.*,QZ9ZW'"B"U((8R_2HI=>^"<=(Q,@WQ"\$(P
M3^(3TP0K9S)JLQKDY0GC#$,PSUG6$;O6,2#8"=:A!]+2L5[K87*S7",><@U'
ML[TM6"W1>(/62(^1SA*;?H.Y$><8D<B`8SB>&[N.X7CN#:-^W3*S5<3DB%V,
MD(/VCIN=T9_6K^L!+KD>(\FE&R,P1"XA'C%-&NHJTF0XK:X&#:][**X7@GD2
MQYC($YS#[[D)@+P\?1#,<Y:')*Z'N!+6()!GG!B7T#F$,2"<K(SS85YB>M--
M))%H4E_WI2R`](W-XM>T[*CUK@JS(@;BET8R8!R.;C5(W-ULLVA/N6&4;HVX
M,#=B&B/<H,G[99OT3B#OFSB[9!R^]Z,G(28Q40FN67!NU@JT%36T_YF4%X+S
M1_QB(D]H]R.*[3W!U)@TGSSQ03!/V>@G;Z\2L`6[S@.*!9!^2I&ZA<;Q];W>
M/,LXDB'C(&G)-`@T&]*'DCD*,^L]`\H8)Y[A5X9"TUY"5YX&`:\'X_+02W#T
MWD,?3BQBA!:T=+N0[L]:->0V@$(FC#X,RG%\9;U*PPF3+=I:8E(*X_MD+J\B
MB>.F68%D-<AN=Z3FN1>"><J>37C*AX$CF81.+]:TZ;CT)5G&`>3EZ8-@GK-L
M@[NVX4I6@V`!.J]^4'1][]TCG^48"DW*ZWBL!@$MY\T/BM[S"T[\8J28`S[A
M>*P:$ON$L_V\86!O;-8MKB0QB1%RT-1'-`L@.,3&G#<_XJRH5!6$URGE!>=`
MX;SDN6S>RKP\G=K%KGZ79SQ#<<3L]BV</\W84Q;*PYKD^UR<2U7?+V\!<2ST
M6KR5?Q3-6W5I%Z?R((9</:[%LFG@8"E\Z.JK.L7X6G?B0*CZ[U$<`"[%.<S5
MHP`?ZKKK/\BCJ[<CQ2__`P``__\#`%!+`P04``8`"````"$`DI!WHO,"```F
M"```&0```'AL+W=O<FMS:&5E=',O<VAE970S-"YX;6R455UOFS`4?9^T_V#Y
MO7PF)$$A54/5;=(F3=,^GATP8!4PLIVF_?>[MA,"9,W:ER3XGGLX]]R;Z_7M
M<U.C)RHDXVV"?<?#B+89SUE;)OC7SX>;)492D38G-6]I@E^HQ+>;CQ_6!RX>
M946I0L#0R@172G6QZ\JLH@V1#N]H"Y&"BX8H>!2E*SM!26Z2FMH-/"]R&\):
M;!EB\18.7A0LH_<\VS>T599$T)HHT"\KULD36Y.]A:XAXG'?W62\Z8!BQVJF
M7@PI1DT6?RE;+LBNAKJ?_1G)3MSFX8*^89G@DA?*`3K7"KVL>>6N7&#:K',&
M%6C;D:!%@N_\.%UB=[,V_OQF]"`'OY&L^.&38/E7UE(P&]JD&[#C_%%#O^3Z
M")+=B^P'TX#O`N6T(/M:_>"'SY25E8)NSZ$@75><O]Q3F8&A0.,$<\V4\1H$
MP"=JF)X,,(0\F^\#RU65X#!RY@LO]`&.=E2J!Z8I,<KV4O'FCP7Y1RI+$AQ)
M0E!_C,/1]637"C%UW1-%-FO!#PAF!5XE.Z(GSX^!4!<T>[4@J$3GW.DDDPIH
M"4UXVD0+;^T^@7/9$;.UF`5&/288(])+1'B&N*"O%PGE346&T+M_NWX2J9/&
M(D-_K&!K(0OCKBXL'1R,!(`S0P'77ZS!"89_?%\YM'?R9HN!SQZS&"/2:XB1
MMME[M&EP@J',_KW18NJ*Q42FK\OY))H.HW,_.!<V$@4C-#1,C]7_.Z:3IN+.
M_&;TMA83&G$W_M2T433TSLDC<=%8W/5N:O!45#CNU=9BK*A9-(FFP^AK$P[_
MD_?[I9.FTF83:19S\NMLB'$S'457?>K(+7UU#3;$=;<T>"IIWO/:%EJ,G:_5
M<AR$Y:T);#`X[Q2KR.YEN[\:*DJ:TKJ6*.-[O7,#&(K^U%X'6S^&/SGLX<EY
M"M>$.7?[`*SICI3T&Q$E:R6J:0&4GK.`D1)VT=L'Q3NS579<P8(V/RNXCRFL
M#\\!<,&Y.CWHJZ2_X3=_`0``__\#`%!+`P04``8`"````"$`S9PU(0@$``#O
M#P``&0```'AL+W=O<FMS:&5E=',O<VAE970S-2YX;6R<5U&/HS80?J_4_X!X
MWX`A@20*.5U8;7M23ZJJ]NZ9@)-8"QAA9[/[[SNV61:;Q.'V)0GXF_'G;V8\
MF<V7UZIT7G#+"*T3%\U\U\%U3@M2'Q/WOW^?'I:NPWA6%UE):YRX;YBY7[:_
M_[:YT/:9G3#F#GBH6>*>.&_6GL?R$ZXR-J,-KF'E0-LJX_#8'CW6M#@KI%%5
M>H'O1UZ5D=I5'M;M%!_T<"`Y?J3YN<(U5TY:7&8<^+,3:=B[MRJ?XJ[*VN=S
M\Y#3J@$7>U(2_B:=NDZ5K[\=:]IF^Q+._8KF6?[N6SZ,W%<D;RFC!SX#=YXB
M.C[SREMYX&F[*0B<0,CNM/B0N%_1.@U\U]MNI$`_"+ZPP6^'G>CECY84?Y$:
M@]H0)Q&!/:7/`OJM$*_`V!M9/\D(_-TZ!3YDYY+_0R]_8G(\<0CW`DXD#K8N
MWAXQRT%1<#,+%L)33DL@`)].141J@"+9J_R^D(*?$C>,9HO8#Q'`G3UF_(D(
MEZZ3GQFGU4\%0ITKY23HG(3`OEN'5W9C3Q&1YWK,>+;=M/3B0++`5JS)1.JA
M-3@4!XI`ENL'@I,(FZ_"2)H"FD$47K91'&V\%U`N[S`[A8E=I\<$.B(=(\(/
MB`?\>I)P/)-D>)>D,-))ADAGL%.06*HK#I8.7F@$0!F3P/QFV-]5$D:)"Z7?
M*Q#%L<%`8>"SQQB(U(;0.,YUCO8("G#BPG'[?4-CXYV"1#*\P6H5&>*EPW44
MSN<?ZQHMD,F4[G[LA)%!S]Q_IS"AY/>PG'^DCLS1=+B\"GO9-6[19[@)(YU;
M%"][_W+SG<+8PFI#:!RA@DS][J>>,+J7>@ICXVA#:!Q%>QM<(O;4$V!=OU'J
M*<A"I9Z_"'U=WG2X'H7H1N:M=%;B:KN?><+(8#?*/(49*A>9#*T033L$%]ET
M\21:YX=\8_-=![JMGP:X+2"ZTASN*RBM=(I1O-(CN.M`0PV-^R>U0G0)Q;4]
MR#\1Z?LU@M1E#[G4WX'C^[D#67DJ/]<A.D_`#'G:ZP0)M*[CJ%`ZC(KT:FXV
MN%1;C]&@D'1B1N^85BKH2A,9U4H'NGE-:^NW[FGQ%^L7A!MWCRLUHD!*N>5B
M:21H*K=,7+4>!\&-#H(^U4*DE1[::#FJ8EN+4#VN\S,E]3[51M"4/M*!KI/H
M>$[N)$A<[8-2OE,BJA%8_\9(CW#S#\O<D#JU8_12^51705/:2@>R,YW>6&`.
M^@4I)5I/R7'1="`K0SM&::GF*S6'5+@]XA27)7-R>A:S4P!]OW^KYKH=6L.?
M=9BGC/>IF/?$>Z]?@'&KR8[X>]8>2<V<$A_`I3^+H=Y;-;"I!TX;.1WL*8=!
M2_X\P6"-80SP9P`^4,K?'\0&_:B^_1\``/__`P!02P,$%``&``@````A`(51
M7DCG`P``.`\``!D```!X;"]W;W)K<VAE971S+W-H965T-#,N>&ULG%==;YM*
M$'VO=/\#XCW`\F%BR[AJ%*6MU$I75^V]SQC6-@JPB-W$R;_O[`X&[V)BKO/@
MV,F9,V=F9P[>]>>WJK1>:<L+5B<V<3S;HG7&\J+>)_;O7T]W][;%15KG:<EJ
MFMCOE-N?-W]]6A]9^\P/E`H+&&J>V`<AFI7K\NQ`JY0[K*$U_&?'VBH5\+'=
MN[QI:9JKH*IT?<];N%5:U#8RK-HY'&RW*S+ZR+*7BM8"25I:I@+T\T/1\!-;
ME<VAJ]+V^:6YRUC5`,6V*`OQKDAMJ\I6W_<U:]-M"76_D3#-3MSJPXB^*K*6
M<;83#M"Y*'1<\])=NL"T6><%5"#;;K5TE]A?R.K!#VUWLU8-^K>@1W[VWN('
M=OS:%OF/HJ;0;3@G>0);QIXE]'LN_P3![BCZ29W`WZV5TUWZ4HI_V/$;+?8'
M`<<=046RL%7^_DAY!AT%&L>/)%/&2A``KU95R-&`CJ1OZO>QR,4AL8.%$\5>
M0`!N;2D73X6DM*WLA0M6_8<@TE$AB=^1P.^.Q`^=T(_B^QDL+BI2!3ZF(MVL
M6W:T8&H@)V]2.8-D!<RRLG"R,BA)QGR102H4T!R.XW43A^':?8469AWF88PA
M/<*%Y+T"R&HJ"."$+O?VI$`&&0JBGEZ)?!A#_!ZA"0AT`1\GEN#$AL7N2P_)
MLN?%S(B!UQX3]P@M<ZAGELV_7KH,2FRHKF</`[-VQ$3J:`(219YW60"<]'GO
M/RY=@LW$BYX72T=,E]B;2KOX/VDEV$P[]!/3(@;3WBT6D_7&>N)Y#9=!I@#S
MR!&#`OP(['FBX?*)8*S;]1.708:`<.#'#B#F)(!,"EC>(D`&Z0+BT!PYQ)P$
M3'>`P&Z?M^#CF5-H?=_B4>T=:,;"D0MV=[W_*DJO?[QR'6BI=@Z,.80C&'X&
M=]0,@!CF=Z49:&GZZIL;J"@3>Z%T#%.BIY4.=3:&5]*BG^EIS0TD",+RB1,,
M"Z)GOLGRR"7/&S+@!G0@5!`Y9ZZL*S`\;YX'R*>]L0)PPH;Y=:"3`G_B@4<,
M^YNI8.R#XR54U(E]4C#9@YM\D*#)G3_[XG"HL3L%!,W9Q9N\D%PPP[-AZT0@
M2!,1#HNBS\--CDC&EGAA'A"DRQ@61Y/A&[8X;RA4E.Y,XZ'H0+J,B6[XAD%^
M[`P*;;IS8&Q%!]+2]Q"]!X8;SNS!)5<TS<%'$+IB$`Q3JPL`D>>^.%.`C-(/
M83P+/H("_$KFWT]TX"9[A*N/*>#"%"!HJ@-X]\&K09/NZ<^TW1<UMTJZ@^^9
MGA.#`;9X\\$/@C7J"_B6";BQJ+<'N*%2N!]X#H!WC(G3!WFWZN^\FS\```#_
M_P,`4$L#!!0`!@`(````(0"LT;J1[0(``#D(```9````>&PO=V]R:W-H965T
M<R]S:&5E=#0T+GAM;)156V^;,!A]G[3_8/F]W,(U"JG:5=TJ;=(T[?+L@`&K
M@)'M-.V_WV=,G(1>E+P`AN-SOG-L/J^NG[L6/5$A&>]S[#L>1K0O>,GZ.L=_
M?M]?I1A)1?J2M+RG.7ZA$E^O/W]:[;AXE`VE"@%#+W/<*#4L75<6#>V(=/A`
M>_A2<=$1!4-1NW(0E)3CI*YU`\^+W8ZP'AN&I3B'@U<5*^@=+[8=[94A$;0E
M"NJ7#1ODGJTKSJ'KB'C<#E<%[P:@V+"6J9>1%*.N6#[4/1=DTX+O9S\DQ9Y[
M'+RB[U@AN.25<H#.-86^]IRYF0M,ZU7)P(&.'0E:Y?C&7][Z'G;7JS&@OXSN
MY-$SD@W??16L_,YZ"FG#.ND5V'#^J*$/I7X%D]U7L^_'%?@I4$DKLFW5+[[[
M1EG=*%CN"!QI8\ORY8[*`A(%&B>(-%/!6R@`KJAC>FM`(N1YO.]8J9H<+V(G
M2KR%#W"TH5+=,TV)4;&5BG?_#,B?J`Q),)'`?2+Q8R<,HB0]@\4U%8T&[X@B
MZY7@.P2[!C3E0/0>])?`K)V%4).IPWI]SRIXU"0WFB7'"48P7<+Z/*V3,%VY
M3Y!I,6%N#0:N%N-;A`O5V)*@C..2W@YYKZS!6EF'KDNY-2^.98*W91:7R&AP
MCH';%A]EB>4UR@8#5XLY($X,AJ?*^\P_-JHGY1@ZBF6/_7G$!G-&!;#"YT>L
MP:?>P_#@S'@WF&A<>C^.O2B(;#HGWN-+E#5XKCSW;#"3<A#%6>B]K0R[\WS/
M&CQ7SBRO\6PP1ODJ#/UT80$GEO4I</2+?;S,&CP3C@[_B1$VF$G8#])%&KWC
M.;M$6H/GT@=+1MI@IK2C-`L7[_Q=T(XO<#VB3[63<)[W!-J+!X$7A+/$30<W
M#:ZCHJ9?:-M*5/"M[LX^;$_[UIX<-\'8^^T':-P#J>D/(FK62]32"J9Z3@);
M7)C6;P:*#V/[W'`%+7M\;."(IM"$/`?`%>=J/]"'BSWTU_\!``#__P,`4$L#
M!!0`!@`(````(0#J1HP`NP(``#T'```9````>&PO=V]R:W-H965T<R]S:&5E
M=#0U+GAM;)1576^;,!1]G[3_8/D]&$B`)`JIVE7=*FW2-.WCV3$&K&",;*=I
M__VN<4*^VBI]`6R.S[GG7OMZ<?,L&_3$M1&JS7$4A!CQEJE"M%6.__Q^&$TQ
M,I:V!6U4RW/\P@V^67[^M-@JO38UYQ8!0VMR7%O;S0DQK.:2FD!UO(4_I=*2
M6ACJBIA.<UKTBV1#XC!,B:2BQ9YAKJ_A4&4I&+]7;"-Y:SV)Y@VU$+^I16?V
M;))=0R>I7F^Z$5.R`XJ5:(1]Z4DQDFS^6+5*TU4#OI^C"65[[GYP02\%T\JH
MT@9`1WR@EYYG9$:`:;DH!#AP:4>:ESF^C>9W4TR6BSX_?P7?FJ-O9&JU_:I%
M\5VT')(-97(%6"FU=M#'PDW!8G*Q^J$OP$^-"E[236-_J>TW+JK:0K43,.1\
MS8N7>VX8)!1H@CAQ3$PU$``\D11N9T!"Z'/_WHK"UCD>IT&2A>,(X&C%C7T0
MCA(CMC%6R7\>%.VH/$F\(X'WCB1*@TF<9-,K6(B/J#=X3RU=+K3:(M@TH&DZ
MZK9@-`=FYVP,^?%Q#%[?L@H>'<FM8\EQAA$L-U">IV66A`OR!#EE.\R=Q\!S
MP$0#@D`T0T@0QG%(KR=YK^S`3MDEW85RYR>.9>+79<8?D7'@'`/W$'R6',+W
MRAX#SP/F=>7)J?(^Y^\;=8MR#`WEP)X<G/D(/.:*"&#779]B!S[U/IED@S.O
M[#''RNFA_B?533\B[<#GTM,S:8])^ETWG21I,OP_T87->;UE!S[3O2BWQWC=
M43H;1V\(NSO@Z(2]7V4'/A<>#X9\KCW&"T=)?'30O&'?QOPIEUQ7_`MO&H.8
MVK@6%4&BAMFA>][&?0,<?D#WZFC%?U!=B=:@AI>P-`PRJ+/V_<\/K.KZ'K)2
M%OI6_UG#-<7A)(8!@$NE['[@.NQP\2W_`P``__\#`%!+`P04``8`"````"$`
MRZ)+A,H-``#LB@``#0```'AL+W-T>6QE<RYX;6SL77MOX\81_[]`OP/!:XL$
MJ$T]*%MR+`<GG=D<<+T&.1<MT!0%35$V<WPH)'5GI^AW[PR?L^9K2:U('9(:
MS4F4./.;]^R06EY_^^38TB?3#RS/7<KC\Y$LF:[A;2SW82G__4X[F\M2$.KN
M1K<]UUS*SV8@?WOS^]]=!^&S;7YX-,U0`A)NL)0?PW!WI2B!\6@Z>G#N[4P7
M/MEZOJ.'\-9_4(*=;^J;`$]R;&4R&ETHCFZY<DSARC%XB#BZ_W&_.S,\9Z>'
MUKUE6^%S1$N6'./J[8/K^?J]#5"?QJINI+2C-P7RCF7X7N!MPW,@IWC;K668
M190+9:$`I9MK=^]H3AA(AK=WPZ4\R0Y)\2=O-TOY0I9BD=?>!D#\Z>>]%W[S
MA_B?5W]^]6KTGZ^_^=</YN;?/WY5_.S'KV4E94-H@@WJ:9Z/:LG"QS%E)9'@
MYGKKN420":@)M77UT?4^NQI^!LX`XN'7;JZ#7Z1/N@U'Q@C/\&S/ET*P,L@7
M'7%UQXR_L=9MZ]ZW\&M;W;'LY_CP!`]$CI%\S['`3'A0B3GTR^<>T:0RS1$&
M(],4CU"9'!!)QX/U,ND_E<C$\)HU\SI$?PRO2(IZN83Q*OI%08>'\,IL1?CX
M#_=+6=,@AXQ'(U0K-=B1F"W6(^#7&[.+66^23;6I=BE4,L87BW9#AE--I"H;
M&&JO+]_TID[QS*JD2])P7Q&``2=6BQ:$;DU\7VKXUX>?]%S0A%J,\8Z(,I/X
MH_#+\^.=Y9B!]-[\+/W@.;J+RJ6%+?IV>5T63WI/S2^>/.-=(LE'^@E`<99M
M9PWA=(8M$QRYN8;>-#1]5X,W4O+Z[GD'#9,+;31J7(F_U_#M!U]_'D^BMH'O
MA,"SK0VB>%A';5I2)M<7M]KZ-N)+D/&BJ""J:>O+(Q"]72W6XI&N%PO11"<:
M_`DF^GJ&?X*):O"_M3"=)HE2%04RHR>%%BZK1N>7B\5B/KZ8S^<+=3I6U4C)
M]XE'6^[&?#)QI25,344$,T"PF,X7%Q,`,E+G$:M>$4P!P.5L-I^-%Q,5_A]E
MY>,C$*W3F3RT50F"@:Q*$`QDU:BS5P1D_B128,@Q<*P2!`-9E2`8R*J7@C/P
MY>!6)0@&LBI!,)!5HWF4P%B%X>'`L4H0#&15@F`@JPIK/I,,O!C<J@3!0%8E
M"/JV:KJL6M_>:M%THMB9">N/$U[8Q+?G%:T:89UZ[_D;N,J37KH8J[!&C(_=
M7-OF-H05J6\]/.*_H;>#_]Y[80C71&ZN-Y;^X+FZ#2^5](STWYHSX:H17"!:
MRN&C97P$9LQ`(M9-S.)8'+*LI^)J0KU41Y?J;'(1+]@$L7;,C;5WBM)EO$O]
M$M2(NFT6G.C0S9@D[I`/QA2T0F(^SC,B4T>6YCP!?")U"<XS1,B8#XEY921G
M\,E(3N"4D9S!*R.$3EEPI9K<>'NX8/G2P)HV'XWB61POGWJ"!'B)QY2#(.<4
M]=EX2HE&&\]I*RODET)LK";X%W7')9(VG%&4L^&$$BD;SN"5D?6;U+H,\6QT
M@>FY!,D+?3-?[P8#&,4G$CPDPR?I"2\3Q!<*N+,=*VV!S0M)1/'AE8+H%J"U
M*XH=>/">4F?#I%Q#]3=,V_Z`]?B?VZP%@*G:S?73EMQF`/=^X'5XO(L!7\+H
M.GD9E_OX#0A?=1+<15!QDJ3O=O;S^[US;_I:=$-(Q"(ZJ@&?_-TJZE/R]Z]M
MZ\%US&@N*,=DOO>]T#3"Z(:5:*1?A6=:@6><$.+!<PA_M8(_Z(E;'X?PA[E3
MJ3U`+X/R!^?BYB_2'_#6G,2IP034J>OPB$0`TX44`1AA"`1X*U&B`W#/(1#`
MJBU%``Z:(P`X-5YQ2!R,238#'\A9`O]CL80<DTK)L#RBE%7I%_C72*DQZ?<@
M-9-\"XZ>JQG>U``XB&55BATJQ1"S0Z3E*H`W-2K0H.J**7GCJIP_F$)(T@4,
MN48@#=1I1)Q7DIP+/',`]1I9">Q#B%-@*AH:`L`9!`(QQ'B@^CNF&`:JP-0;
M!BK!%`)3@WN,"6H)ID(.A`'P#!(5>9\P9BI&CVH@$(;*D,0;)D.E2(IAJ!R9
MFV(R5(HD$(;*D-020Z5(BF&H'$E,,52*)!!`(X-D2&J)H5(DQ3!4CLQ-,1TJ
M11((0V5(8HGID5.D0L>F\1"5S$_'T$Q6ST+!0NGZ_Z6QGK:-D]1QU:H):*6G
MQ\NG>.D(QH@64V0MC;_>TM/AJ?3H^=8OL,K$7W$9,$TU?1E_]1=:!CWRV==W
M=^83K$7CZTY/VX,$;,"4\X?9NBSUR[R16[22;IR&O[`&.U%NM$HC")RH#(T!
M77%H#!A-"88O(#2$0VP;*5`E4W6AYI)Y+[QDZC>;2$2[+C495$P^$!H8&9//
M\3+'6#06FEE_V@>AM7VFJ;5U:A,.L*WS'--P5%EX9?X@37&[=F55;,R_1!>'
M<SO$$!C17&',&4%%0_2K"\H_BYHV$(2'R6DCBH.%*DC"W\%@MHSO<ZEKU7"B
MTJ/WG`JR;GXE.M).->HS[1P"L*J8XF4.MKU@\](JN;K25Z6?OIQDU8'3HFM/
MC=!HPNA6RZ(^,6UKB2H;T)9W:JR">Y.!5$B:DAM$Z`16D*-.7TX43\(7JO1X
M!+"_2CV>9`*H,#H<KEFHL;$CI+>ED2N$>2$WPEV#2EV+0A$<(W<4`+4:-_6)
M+KK]N-TTK$]X4:5K9<TC9#"!UCPR.EYKDD$?8\UZ>$?J!'A!5Z2O7@IL=Q=L
MZDW9UHF[4^W@DUQ&+\)M;_5.0@CU@J(4;!D3H/1#\3(=`NQT5[N`$8"WN*0O
M]>DJ)VF`^X4X28,4I^8D3'/4Y-.=HBZ].$='/:5^49%\&83PIFYQ<_J]HU!M
MX$V'=>KX<NU5J#V=/>8H.FK=,S).+`Q2FY#"Z.*:MU?&$+5)%S>>0`7B@\`F
M22Y`V?"OC4YH8\I8J&N:H2KBK(9HEW1B)GI2VTH7HIE3771Q%[QYM-1=3J=*
M52$4YCY-60^=IRRHBRKB+@5=?>;7-^-HU!17HUOPE?9]+E>"[+*8(/[=RQ*X
M^PBK?JK`UA.-[VI(HWEIYJZ\UE&,Q#HPW%%*DVN'0C,D7%Y'Y(J>HGK;AT\G
MI?-*4>4DC,.>_MJ\`>YO2B^]+Y772>B=F2W:'AZM=W+NW]HUKIOV6E4(4DLA
M)]Q'MPLDFU'4+>&Y:KM8>YW,4.&8*N-;P5<A$+:"+]3QIHZ_.CV(,EL;K\;J
M-N3ZH[*/`6!U4=5O"]A@&18,=\)N8Z<3&W14N4W!:ES9KT/_6QG7T'36^0VW
M<6A<=\K.1_9LH?B8YK!@P[KU3J5]NSKWL:<076PIUMMY>TKDFLX5B3/!8;&]
M1S'ZLKMEXSVZ3_<FF0QH\V_#:`+M?Q32$6B?MHYWV:^U-4FZQU!AJY11B:4X
M4*C+7YWJ03%B2IL^.O]H`9=G4=BQXZ!%HTL:JI0"'+6NZK)P*VL&A=>ZO6<]
M\C0',I7Z*\+]0KP`?)R[&G%Z0><TP&`YG31`ZSAU@+[A'AKP#-X3"'CAQ;'3
M%6BT;MD"NJ`@_JS'7$3).H?FWU153A8*6-B*R(7L0.\1;JRTCS_DEP,D&AE\
M3;FC4]/0%3"V_B7+@(9U4OORP>4%HH6H7WB>F!#@(Z66J!>"C37.&ECHA#KG
M!+)R;'"9@X%VRI]]KLNZ`:S*$B*R:G$ET93O,3>E7H@ON6I/>2!51GQ9!Q9M
M/`-;S9"-N]EMN[.-:21\JB?\!GCT1^E,>FU@RLCN7$9KW^\M&Y[^@Y=.<-,@
M`S8H\)Q5?##9Y:6.5C:+G6!#0FA!&+:E!13B9<L$-Y(BM,#F;6D!^YC6%*0E
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M&WM;QP=*I(1P1$0$PKTXN2@]FL9':0T/V\@(L?&`992'T.W3SM9=/?3\9PDW
M9,O(L4:?<9+[B^=E.F(I3.`M#Z#O3'UCN0\2Z"4IXHR"<">#-F2R6&#5@]LS
MMR$#9\=H6/_#M7D;,G!V3(9-JM@_\9!YZ^[VF8787(JEFX?$.\O]:&Y8SV&S
MQ`1`\E!Z;^Y#7\_\CPVI":=BWN,C6C(:;(J('Z*>/D\FZ3_?PQ-94B7B[5DD
M=K"'Y@'^MWU(U(AG$2+X8P@>(G=6"`_22JS)QC#"XB+AP2:)&8D7&863QC]T
MW\5H84+WA8]62)3O.0G=_^8I?UQ/I/=0AP>%10_RR=8#H*B-N=7W=GB7?;B4
M\]=_C1Y1!\Z4?.M[ZY,71B26<O[Z'3[[#Z(8KJU`NGD7P//DX%]I[UM+^;^W
MJ\O%FUMM<C8?K>9GZM2<G2UFJS=G,W6]>O-&6XPFH_7_0&6.[0973V-U*3^&
MX>Y*40+CT73TX-RQ#-\+O&UX;L`C!;WMUC),)=CYD%2"1],,'5N9C$8+9:$X
M>O0T+R!R%=CP+3\1-@'_(3^VE,F;&'[TP"^`#7L-I$(H`3[UZ`,RN?D_````
M__\#`%!+`P04``8`"````"$`;S36,X9I``!080$`%````'AL+W-H87)E9%-T
M<FEN9W,N>&ULS)WK<AS'E>>_;\2^0P6"LP(C``@74J1DB1,@")!8@R`,@/(Z
M)O9#H[L`M-7HAOO"BY]&SZ(GV]__G,RLK!M(R^.9C9!GP.JLS)/G?LNL'__]
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MMKA\<WB^?W;X_O+XX*(X/CUH@A,F/(`^\\$$NHS*3\4?R\_-<=]L;V_O[#Q]
M_NSY=O.G@]5\SNO%T7@Q9(J_E(-Y+_S?;&YN?[>YUYHC[3^?Y`C&6317^Z:+
MWLW7`Q:[)SCZ2W/.@(2C\:2<%P>@_68V;V-@?S@L&<#/(_;*7SW3',SN[F#K
MB^5L^,M&<7$[F)>+XMUJ:8*(9/:\=K:ZFHR'Q=%D-ECV#/EY-EE-EX/Y9U^_
MC9O36<^;?RXGD\U?IK./P%4.%BB#47&\6*SZ-Q&(>E[>S^9+H&8_@V4'.?Y2
MML`X>'=Z\>[D^-7^Y>&KXN7^R?[IP6%Q\>;P\/*B3]B/I\7E[6RU0$4L-E`E
MDW*Q*&;+VW+^<;PHB\5].1Q?CQ_6`GO-O1^\/S\_/+TL]B\N6/J'UL^#Q:WI
MI*'^*/^V&G\83&#DUGXN;D'!YK*<WQ57@^DOQ0B<+,;M<><E,CD>BC]L2ND[
M:!^?+:II^F9X.YC_4BX'5Q.V7`Y7\_%RW$8O?"@ER]3#$I`U^'H^NRO>'5PT
MM_A.&"R8R`1TL%B4;:@O9TND]N$Q)^].7V]>'IZ_[</ER6QZXQB*6S/,9KN/
MSYL@7I38K\%T6!;W@\_%]6K:TO1G<VS2'*,A?(I,]U*N&\6T;,F)[Q=;=U,8
MN1[:L48YR`^-ZOXM<M;)\?[+XY/CR^/#%NHOYX.1[4D$:K$4-)ROX)/R$^9V
MT?[]57E=0C3QSX=RNFH/V!]]B$@S4V,<\'XZ%O-=0O3!?;E:CH>MA1U#`V>A
MA7`N^)I$J?/$9#RX&D\Z>;%BC`=0$3>[R$G=7+(BG1/E@44=NHI^#PP]>/?V
M[?'E6[3`1;%_^JI`-5T>G[X^/#WH(-DWO_WZVZ]-N"XNWQW\\<V[DU>'YQ??
M%(=_>G]\V;(?IN.1^?LQHO1#$0S`0@:@>+2]A>G<W@'5\P(%LRI_*/972W3!
M^._EZ`?<E^T-?M?_BH7;"E/,(V/W664V?BB^>[[QW?;.QI.GNW'D`"5Y7>`*
ME<D5VBB>?K^Q\_UW&]_M/.L?MO>'YC[W1R,H/)NB"^X'X]'F>!HWU!HYQ)];
M3<P.CLKK\7#<(X?#V1V>XRT,/OY0%F,<T[:KXK0T5-W.)B-<V6],QI<M^QNH
M7O&B(>AKWGS0'IWMRT:\.<1!VC]YW&>?'IKB/_:OY(L-E_^WB:F<$38J!BA0
M9TZ:AU\([#!(W/)5P\<RZRTE6@<ES)QQ5VOJW(9?7&+*78C>'17OSG`I+X\9
MT(>MNC4O/PW+^Z4[0L5HL!S\7@._^_N`[*?/>8]R/9@1'B%8?<KW]7R&>W(_
MGUVW61\G``=XZ)[%B`4F,[-7O:K^1*X.R@%M/;X?2`2+J\\%AKMX=XUPE0)$
M_SJX'9?7Q<5PC/'#^7?U8/;=7FZ;B"]"TFE"7Y=3K,?$IA^,[L93"S26DN`^
M8_4.?@9PC.X$O#2)=#2>8JG&3.D:H'/5TW+9^?*)(3J*2\N%>SE8X#+++QB-
M)RO9/IP"FZA?QOY<CF]N-70@Q^.F+*:KNRM6`,U!+%8+?I7^0W]A1-G7U>]8
MIZ8RZA*$53H[/WQS>'IQ_/-A<?+NHE>2_K%)^CD].((="KE8%]$>&U5:^'T_
M)?*?R%`5-T3\6)LIWN\<K],8@B?+N<7V+:HWW@RKZ/W!A\%X(J=CDQ3`Y@*7
MN[CK<GL[^>2\'$YPR8@%ABXJ@]%?5XNEN4`0\&OG-A8A*DN[@]J1<SK7=>,C
MAJ@,6A>S-^C\9A]?0W%W<!Q^I\)LBI1!TWP8-+R%G<5_O"W%U"V+E%GYLV#E
M#]QMZ7\E,_?.1JR4H>'8['JQ+E%]_%6SX-S*:>@=^W(P,=]VL)1KD[(\.\T=
MAW$;46Z_-/[P4SD?*IR$4V;WTK0+TQT?!W.E4A;2N^7=_63VN80WI%6&#%E-
M2*"UPZ9_:K((<G-'^:0Y5./I!^+(V=RANAZ3I9FW1.X?>KD/`F<?]!TB+W;'
M>7-!6\XJW&R@;HD^$T#3V70S(NXAG/VG3OY[=@`]S5.;M7(W#X%6O=6WYM>I
MUR:U>_B\Y>9\@<];XQ4_F`#!Y]!0R:B%Q2)BZ<A6IN8D"?(7;?00KZ?%5/_,
M7'W8ZMGW7@]^XC1%0[Y;XWMA):F`@3]XLU_LW\S+TJS%^NEL618[H\?-57_?
M+!'(YFP]>WW2,RY.T]QK:_P7#<T9:4>RYR5NY6#2&]=\:9I^CZ(7374F&S_(
M70^Y-_L7;XJCDW=_[O>-JA%'Y^_>QKCD]'6Q?W!Y_+-E95H>S7[R%Q8%*@TM
M-L,YQ0>)YE]/];=E\*(GJ`24>[B$>>,/E@II3?VJQ"KBZ,JP-,EK?BQR2,S0
MD<MJCE;"!,(Q'OD<D597OF^C&-PI%?MWU\?\PG)WX]6=6ZK;P?0&JX4C0W+'
M<DOCZ;)4`DZ3='I8S65?X^)Y*M&\,ND&LSN2%TLT?*U[U9S8E.OFO\BHX'_@
MQF'5`9X4J$@:TJ(M94;EQX>N$XK87X_UULRBJ)03JR9H[J/G?>B@E$EO?)0@
M7!\%`&Q9+-$#&<+T4AO`D+0SND=B]\5F:9KZVN1M'LXO]KPW^)UIQS0=NTE\
M62%:<<%7I,=/QM-?%+&-QM>`3Z4SN&EIQCB-H:9*$&9IZ(FQ2DA&-^DKN5-6
MMI:H[(P'3K]&0S2G/V@HK./3GP\OE(Y\2&&=K4@FB+U-X+]&>U"R&7R.$='Z
M<1)A$/_X:[!<>X-(*:;)^S+XM?6JX1G2>]!-8G]8EJ-%7>?\7B53GXW<.1YI
MU*&_=\XZ*G[O+(E9T/X?QB,8C$!C/=@6J0(Y]THS5,;E2ZQS='Q*5>T+K-,9
M$,@\A^"GN4@GG`0;>(</0Y?T(M*=*E]?JJH=])7?Y/LHX75%D7LZU<JPOAY@
M.:F--Z'^XCQ4XQ^>X6)U?S\QKY`DE<PMD?UJ;A)GF[B>S#YFM&D9_LO!)Q21
MF8#1JC0'@H`(.J]P%E2>ZU/.#RRLD,H6KWBBM>Z758/T*H:.S'X3:[G[%M)>
M(A[Q+@PJ7\>=CVGYL;@>X""I:4._DN]A4VT'QR.@2J,KMZ+06>2SVE1R!"&F
M+]@$B:H,B>63GL=%ORMZ^N[RL-CY8;-G@L%6<\JS":75Q;*\JY7*:'X8;N%E
M%:?EA\%HP';GU+X-%1N$3?*MXB-$&/R\I6"Y8WTDVSM;Q0.3%BAPYOU(A6/R
MN:`(+QNSN@+58XKY&]FK)\O15K$N9E^[2`/6R,Y]O!V34QXW@/#`1L,G@X_F
MHNEO5>J->X\7\T$Y>1@TZ0-[*2U7$#E`O>`@X`X#O$&DO,]@^GFMF,V+M;3=
MM19ZKUI/+H$JO*T]#(JK\6R3.5.94G&JYB:[:!ESE_IKC=FD\6A":F\RF=V0
MFR;?2QO&1!#Q]F=YU)(SC`A0\;!8XMBEA"!UJN48X695]3>%9/%X>CT9W-'?
M1)N'N-HK7XLML4."4S1;D%O$*1:Y4P2@M%_P.R376GJQ@C;A.?AB1O@>38!$
M"2(@HRA0>J5^M42UU%;Z!H1D.;8X_PVAZHT5V9CRT<[.WL;SO2?,-Y^M;F[K
M-3]S=^!.U?G):U>Q#++V:/>[C>_W=A-Z/JL]!Y7(P%K=\$&:W9.0LW@I;0V8
MW#*P2P4'CAYEU#Z.E[>%`@CC1]7K41U5-\,&BQ.7B,"X;;."GA<5"/GGLAS>
M3F=0F4I_#-,#;@,'=M2W(5>2TF)]K6.$LZO_L/;84$4FX+=?7XYG_VMP=_^'
M5V/R'BS-VSS7B+0XR@#I,/5UXQE"`%Y@+8C#;-NB:V>Q)VCMSULH%>,!^47D
M(-CYW88]B.*04-N#3EL]%J(J3\F0&WF_1;MAZ\D%[%$6&&K+"Q<[UCBW_:P&
M"XP83`%\@T!6B:-;:B78XY*]*&@Q[2?./MV_>+7_)UJFK/*-0E3["NT[F!#;
MY.+SW=5L@K+`S6WKB7?3#*#OK1\/L#1O0$X%$+[`P!<7I]!!-Y,"UM#+<K*Y
M_V'\P?NMBL-/>,N@N@N(D\OS-A"C%JI.C"/+*E>T:%G>P&8IF]0T,.S,A&O'
M=X6-R';E`@`2C?_9%@72R<IJY"X,9<6"P18TUX-+3<PZV#T).OYE='LJ=)Z=
M_!]3GR;,0=<:DXO<RHY;M0<5(AT;(O;`96GBFH(]6TU@$[6DO:%A<KZ4+$.9
M];6S_3=KC[?447$)E9H;D-J6*RS+@KO7M8^/8[2\.Q3RH"**/L[FD]%'7@V:
M`U.E>EZE__.:J\0WWUGR:S)RP&01*XT-(^RVUX*]]._D>C5GMGFUHVB(KK'V
MLX_B5SE.E5L5PW=-7_'Z#\7Z6-JI6-TC\K1W94'<HV?6'F(>)C9E?W6#75+C
M*XP5'(,I^!$Z!\6CIS98#B1&'%DTN].<59AA[*Z-;4;U0;0R3/X!Z`!O=2_O
M]M'>LXVGM*NL[AF(M1W>VB:AOA)(6"TUA\BTWI%8(_,\!2YC5]2E#*;FT,ZS
M^<6I@VC+[7=9<2'>5F;I>3F^NUK-%YZ]97B`!4VFUAEIK```?V9XA;S1_2[&
MM5\*8`,W8_P+X>WUVS/29-,5[BXF6CM*CB^[.D7EWQ:T]M+@-Q!,'SI`BA!8
M)EW6'\)/V;`DPA#0L6L]"A+V!Y/$=6;.6:>2RQKWAG<VBOGL\P`G1WN@*0"<
MCS9E3O%Y1N,;JFQ()1:6GX*C=Y\E%"K9,+,VT2P!?8$XJ*FPDMN>#+.^7FK-
M5(Z1@*V8459O$$#X:*G9RRZU<%4.Z6<N2O([H`VC`^8BNYN!@..U$5,.R1DA
M.SJ>V)KJ2K)2_J"X)G11?\=RL0$I)!ZBJ0PP$6V,;_`J$32T%@ID7O*VC7'V
M'"*_@ZL4`1BW1PK?:)=32[+(U`,EWF=@K]".48Q(),^6D<L!.SFKF7%J*D;3
M,^'A'?'%:DJQ'*`!E*:0`#Q.;A?R1'\668[!H".)-K.54MG8`IOXF#2;?%7#
MRT:GVL4#,)QX"TJP'$FVG+,U>1(J^`4E9\@=J;]8('CTBL<A#,*)XK.Q.>4+
MV`3=30(DYZ1[`GN8)J@%]FM<F)%**PXM=2?H<L51Q<=]`M="<=-:UPI#S1_?
M!5..&RV-NY=':[`-:<@'#;G@SDRK,U[R,(-YKP$0;3L/-\SFPN:629`AF="/
M0ST'NX2E1N([IX<B*3ISZ[9YMO\JR3$R>@%;W!9_)"X9=&+MXXS'H]!CL?C!
M:%4S^P=J318@)VAE.LDMN!JX;!X+*W<D'43'@\D`P0O-&A[8<L8@SHR'`!..
M@L+0:TG_U'"R8<6['H\@V/_&MF2%'\!<ESW*`,L6O%+`)&9UW@>YV;3VO$&4
M:/^-RB.WDADV'4D9]__V:UV;(094?V1*I^[9\$`Q%GH8.>$76=::H<HC)Q,4
M?#?39LZ;2"':=`6U-`56\G.G,KX>S_$J$HLMEJL14CK#[Y<-85?05+D`Z;=H
M)6I4<JW,\$%Q9BGKXV-G5/&8<\5X*5U;XXHMHFYR`KZ<TBR#>\#\8*!C=C]X
MP"+1D];(.!?6?NOM:>14KHNC&>=F)!"OYBM.*PRNRXY]OI?+(MS[9C-?Q5<%
M1R(?&\!1CH:OSEDNE)JC,GTU\B;9,VB$(:-O\C9XK!97T^B>"_KKC%"`<US3
M*C>`E>:00?+@:R,2GB%.KES*Y,A&T*T>F*&L1?<*5H-1M).^9F*%#]JD&C8+
M)5[(A$$32*`=,0`(:33U,5F;HY1/AKLA%!DSAQP+>IGEMS/B(9".,2&A%]E%
M!9:0I5>#203!I"<OY\O$5\%D4T^+*P1U^8E#%=J%WK\C$P.Y/?MNEMQVI#-5
M[,[=Z@H]2E_RXJX<7W,XJTA9LBDRP%G>9@$H`)QY_&*IG0VYZT^WGV0Q-C!%
M!QY774*JN,R.8]3>!QYYV<)<!5'<%`^-=S^-26B5>`F/<(F?[#R17"D%I>*"
M;0^PA(0`.")WK_0%B#6I7O/@W<A_D<Z>K+F)"3UW/K*C#,+4*I_.1]9(8KIU
M_^*@V-O=+C:+M:J*LN"?K\HK^2F<<?/44+Z8-V7L814$NZ!-(;;Q`$H17*]`
M,\XFRBGS$*0SQHH]%[F[!V"BM?D[]E?#.;/H10)9F63S\W(/0QF:IB'6I$E3
MNC'&DIERR6""-$OIMMI&/!<0(WW+*SE'SDM/G)@DQJVY)R>G)YDYB_2,AXF)
M%%CH1W:(5H91!-F!)U/%6_@GMJ'L<5(?U_3"Z!5S8^`4_DQH"!&;G#DOC[.1
M.;&`^I21Y6CC#'SYS.+"%)$#%1P?Y3T3=CUFE1%-I1+8:G;L&1H&R)0[E(<:
M=HOL$\*X3TH*%;4-[WCN;3&S$&=!?4,.>$NU'4IB!.]G3[\KJP?69H7.&1B:
M?&,V!%L2Y,+4/SW$.)M8.0Y66,+TJN2Y#F5-,/8DH(06ZAB"U-]SCHWHL015
ML/^L>*-(!B8:DY_],!N:C,&OG\R\BC)U2$`&56Z3V2XWY</,HI3[V4</=31!
M$FIIJ18J+HY?GQX?<<!!A^$.#MZ]MT,PQ1F']+K.P7QA^)<J,;L_;'YAAJ:/
M?2EI0G)G$S,5I%Q3SS@A.IH?#EU`Q9B$1'&!::@I'FKHG>#M6PUD$0R78B?&
M<0I!&LS//HF,N%.4-BD/+)0ZWKK8*E[O[Y\I!4Q!D-.&BCY-DY,@QBRH"WS1
M0NY[M])H65/`K:83;<X!3E%GY_;8"VO!9D1*GUT2W.Q^!?1SI=G1YO(+(^O`
M=W>#7]!]$;"-XJ^KT8WA,AK6Q<IKY"$-YX4?'0\U%O6&'5,?5$SL0+@BW:3_
M)8EB/@LX^0,D(R.*[TP:P$O7V@@"1,"<QJ5Q$8J!!?PV&UU.*P_'E69W(FN5
M3J397!#4BD<B*1%WN=@J]MW?!244@&2>5\B\MXW$/(:\JP1?BZI'JZG%]2@J
M/QHY-(D7(%5AKHN/JU_1*2EO+\143I2@'I6NXGV#QGROE'"@QW=];>1_*3PZ
M!CG)';H+!U,R?+CNK</%REE!1H4LR]U;Y`V;A=F#D77<\4K&.U<E[(_C`$$"
MC?T=%>^T%()C!KB)&G73S51E*Z<?QF0QH]_AWE0=R`"BJ'5YN\)JM]>OEB>/
M^65R1.@<5C&!7!*X8D*-%??,0Z<@_]HO)H__.07"5BP#!J`*^>!+@1RV[L)Q
MAUV@@!=B_H#)+CTD_^>Y[B=8.\)RC&]PONP8+GST=D`4-%^L`2&FFXH*/=:V
MNW#(0NP1JH!6_1$0M/KYRH92;$_:SU7HEB>-2>V%`Z#$T`ZK>925`"55*M.5
M\0?L4<D6"I%3>K+3,<&#K@@Q&51'&;=$Y:S2HDPL?>EZ'%W1)2#5`$"K%D[0
M68E;R6Q#?J(64U>^[Z45?_V$*Q(RW#*E(D>\$C^)#F@.NB%'L^=-`MYRNP+7
M6W(0P$SK5:!V.1C6>"+%&XZ-&]:S+K9;HG<,SX1K,6@.K!SQNK+EX)+5H.6_
M6;,(>ML:/\STX]*3BS:7"P10_,4'@O*Z%0,28;C8BRMAQ5C8-K,#;0^@3;6>
M0^U-BKW,#[R[5>+D*GE>%&,=.)I313(3F@S,*Q*0!J?]E!PJ<2A6L8H_,.B6
M5<@0F*%LB[#!#]T;EK,W;?=CY7KPUUS/9.&0I-QJDG;R-K*6N7"-+MG`+E@$
M6?W8ZR:50@T*-0)/=`A*2QBN6T_.F;)Y*T"VR;A2$_$9?4!3G"&.-G[/GAO'
M$++CV%*A5OBF\DHZJ)7I&%<.-01VIN=O6ALY29V`V<(1H";X#PYV/NICG\0C
MC?T$E87!\R;.%*NT6>*?9H;F=FY;V.@,EYNOH:=B,!;]3H^=I*HR]I8!<48U
MQZOJENBS+$36FU\?5]<L?>5YN"UO'*A#S71#DCM[#$IE)%FK>;E)S]1DA0X*
M'1O4(K%YYO'"<9;5M11&W5I):=6!B]`PCX)>%A*J>B!B3.LP(4:U]:SO?81D
MR-DO>?KL[GJ`&C$]0>"L0%1V=U4_`6ER)]O,EH-[RIMK6*ET)-YC.9F=ZJA@
ML*I^U')-1-7<R>1IF\.J@=^R2(W3\"W^.R>&3@<S*["4A(J]-SU88]?`(PMK
M`90@.4A.X-I1"KT<:&M_]C20=+8I%5ZD7P%!M%WXW2S#@MP>=;AT,M.B)4L4
M1%<WOF'2V<=GS@[AJ`,+Q<&)TC:E]MA#532V'PKE98*6OE,3C%(<@A5HG;20
M#@W*B0:>"P7Y^=$+$CATHK'UD*_`BR3+XG;C:Z$D1Q6-446%'MRW2']940PV
M',YNIC""]E.,B8/&Y.D)5N&G.6TP9(`(("";LE551UIB]2AA"?`OG,HEDE`W
MK`AOE'$JLQG%EFP%U%V%?`;->X,IEWG<(2ADZQIR'A*<"R2.XM\*M8@/K!..
M"E!";"2&80.&:B9.>^W<:I[V$WA<Y7.#$,-G,3YEZI0,34$1RY&XDD2;?X&C
MYPFZ\I/%_"Q;!2^5AK"4D@55E6^C12M!JK#C\U5K$VI5;B\NIG<?&CMJBBGU
M)K\"A121]4N8]M1/EH2>H^$\M[K)=61[3XDPCM.^OI!@I5L@9@H&4U-4#2+E
M'"3A&2E9FYDC)^]"Z1=4=XB"U@>/?_M5\'GHSAKWR(.405`1WH+L6);4K5\U
M7YC8;,QN2I^YYHD?UBVS*V4%/YFW%[%,9`;;LP\("[&"[Z.0"E@"T.0D^(&L
M(2RJD>:E3L:_*%%N'JD>VL2,B360@*1J0GX+&4#Q(*[Z9R)SXKJXBJ)&F\15
M)+$:N2/MHHY>N?HNHN7(N2)@3&:N$EU`3:PN%!=K%;_D2ED<[WN-23)Q>Q[9
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MQ;R&9S0=;=JEE>Z1K<FP"(]>_"E1@B*`'=SW3:)5%:Y7;78NU-*UGR2-TF78
M:<7WJG"R+Z8#T_3HT9W@TF&[_RKH!8K)A3+[L2I`?F1HY<TF%BV+%Y*Y+O=U
M4-M`=&"NKA7`4H(!X&\H?EM*8%'./P`%9#!GS0@I9=/0`?7U(ZJD"_E%>ELN
MA.5`KJUA/2=1.P4N4@3+)\W%\4M`PAU9W6]:+Z-DN=:-&,4N[W&TMD5L6WX/
ME1UC8Z>JB8I[8N>A-K=87?V5BFED#'4A(GLQ/18;M;(*?]:-2!6[0\1;4G*!
MMO4T5,:AYJ$(]V&&2G6,O.'+ZA0M#C8<&'?P[MT_(#*@),]C:N4&-F-O9\3J
M-4DB#$%H!(5OTFE/V<*DK!`*^3[D%@;J,X%%<!#=GY.)J_%7:`"Q\BY_ZXI2
M=XM<CEBANN@H_-ZAQBZ6Y/EM.RMW#EZN:$V!W4AY7^R_I/"RLXT=Z-)P)$O%
M9:1!R=B*%3H@`I;G6T^M8&>:"!Q\^8A#3*Z3S^KFE<"C*HCB6N#<9@@T"1%%
M&MSG0B/5B1S9O2(=[&;FNTO3/WF*7[?MRM[.9!]$F>3R)TL;FT=8VYN9R_H&
M)L21UGI+=!(!;&<&A=4HNU:VS`4X-`:K[NLG2N43:K\9O3>,U[R1V!1)Q!,N
MVXJTMK3MP&X/2KV0)J0QORR;@9E`U.SXBM,YLG1<UYE-W4$9>"/SPJ6T/I/Y
MOH:7/N?$>=@YZHS`ZMD)5FMT1G.4*FM^2CO(/*0V<B1C>3!`J3;RD35T!\,6
M:="MFH)'(,8/XZU$Z:7D*/<I(>8XC#.:`H@=A((O<;2Y0<JOR%WO/,>2MM@A
MS?(;GHE/5>0XSV=XE6F#I!Y[&5<@15B=9]QZ5+YQEM"%Q(]V-IX]W6LIZ[^V
MGISEERVHV\0N8FNY0ODH14=^79N9&/G5EAL2`1$QV`RE@LRF;`_Y3SC2+WVP
M)'7ZEUP,.B2'X:9$Z*J-1FV[:=KVCM@659K4+5D$*R(KOT+O_@2=K"H<:^I=
MOXN4>HPB%ATKB^<+:)Y0*Y-"LO99E7]K;OC$FYK5H)^VVQPC>M`I%2X<DD:_
MER\\Z7\C7%;':0B</J6?96MZY_^YY#PCH7-SW1.*7*4U:.#ZJPM0JJ(UZE*(
MU&VZ6*F`&S&JW;R;$'>-$31EU5R#GI]%J'!;&1H*RS&,,UERN<5+O[2>'%>Q
M"3#8N7=1"W;IOF87F`.7XZJVAIN_1O`P+C\RA=1L%OOT"-_>=Y*\R.5J3)9'
M+[PG9E^S'J`I\DA!SXT14V>YQN%X#C/+6Y'3&/H8K8[C3*;\Z&>IG4P:T6C:
M(CDR=7HK-#:U&T*&+8NT[!]^;%@28RB1ZF(LQSGE'1J/6WR::JK(B'0EB.5X
M+LY)H&T'#)4X1'T8_%1:J,)]*:#1JB(ZO>UG0(P_'(:J%A_DTB'$40]=/0%B
M:0$\8@LKQ">V`:=,#.$S.OG/:`!/R;4V9U!;>X/Z**N\TL,;U/V9NB7!9+Z6
MN*NP@.KYSXZD)RV.EQ\:'#<QJ*6I.VYU:<K;9<7Y9L:8PHL@?1/T1<#/=I[#
M[Q*B>"O9YH7=:Y4_6L.7-,NT\UR-/+"9_O64X/GI=K$FP5A^WGQI]YN=N5.C
M^()&X^GF8;S[395Y&;>=YS"V55057,*64TOTT#$7]'0'332>%3S.C>[+@%NW
MH"`L+9)9J1;>MN:YD$DG6O);&38514K@[F8$'75+'I?MX@5#9IB#OB<=5X5A
MJS3]R\E@^,OFQ1#E6BXVWU)MEH#9#1D/+2G_-!&,5*Y=CH<"PXNAZ-.YRU3"
MD2HT$T`_4\!`!8]!N&FHR-*J;A!]U]ECD-6U8*VLB;G-)$^^FTY6BE4P!%4\
M`WFXNUU!NP7*X5*)9-LCBDT'7Y=FRA9]5$`*XI`JL4'#)WEL.QRAY:DN*8@4
M(T(2O^-5&M[#:G1+Y^%S/C00M57:E+%@Y'S^0<5!8L@V#;F>4(K;JB:VI6]F
M=EPDBY'-55>RA>YN/].KW+@83X<Y1BN\]HI8<`$0><HW^"Q.^L#1\9C]IC-4
M`,C<-B*CEB()NNH:38U+H0;+A7W&HY$"E+"@?VES5,A;YVT3VLB/EOE(5Q*V
MEI,"0I^O8L.9ES"DVG'<R6YA--$`*N&$.KWQVL+25Y4H880[TI2MH\''D,/B
M]7HKM.FN]A+0K_U0R1_H`GS),KK+1WVR$@IT%'%$^VUQ6ONIS\DV$\X>NL2Q
MM6MUU!LC*37K%(DJ1CP(=:*5M)+O'YQT_%1:OJL&N-VE@9J$],`CA6CX5E.9
M!,7]CIJ.[*1H\OCN4421=RN)-&\X]!6ZOJSN^>4<@"X"]5J[W;F^5;A)@)]E
M3.CO1<=U2K+G[QY:$YD/JEVH";P4L9530!'"LW\S(>Z[E2'BW)'_U`<+93TO
MD#87_;>K@>&N'WO<AB4)C?T^LPNG@],O@I)41CI2`!)0TTF.BC'EMBG$;3/A
M0ZRIV#YF:-&/-?6B"WGP25%3TD\IS2H\5-0*F_./G`0N,JR;O745_K%Y]W,U
M(),L;<!9,E)MY,Y5OZ82](_VMI[N;>C_/7%R/=K=>DHZ"SPH-B$VF+0/7MVU
MD'G>%TD'8X9F@,(&62LPJKV;Y6BB(5PD.X>+'8P1%4\>FZ-K)6/S<DTJ%?W&
M?&I>55*<$)(U35^O%P"'-_;>T@PKD^S]H6#;+ZIQ'F1I#M,+/`(229#.L%L$
M<F\1H6FW[FP%ORLE#(9,MR<W/'!#J@,'II'\$5Z.EQ-W[:V=WP$EJ>6^&GS(
M*$`41LSFQKT;M):%X6VSHR'AQ9N66('NW6!JFG82O7V"X<2JTF##F+&):A16
M?O<Y[%7=^R(5Y!P,\$,4&K%\0Z9:HE"IQR!);)I7JV--.L^ANHQH$03""AV2
M"C=&^8BZ/RJ675F5&CA`3+*TYK^[<:KZ^^VV![!9L4M,I,"LD1CQQG>OW;/A
M"*P4.G&FG7HV1>3'--*9)N,.^6*;-H40)S:SO01"RVU3004U[QV*+2F=M9X<
M>^?L4I>!-6EU66FJ>@@$,ZG=UE[J#7N>*,P/T]M=8Y8,A[*7LWM80$`.Y^,K
MQ$5,2@(DHBA^&(7SHI9H"@>"B#U318"58W0N&E5O!,<?14Q6H2HH>0DM9Z;\
M,L:K<OE1M\14]6IODS+Q97JM)LUN$A5#[&Q9*R'R[YKO4[FAY90>$=;6-);L
M,AFTJZ]JF6=<-;]!0%7&$'/E5T;"'\E[,,\/7<0)>3]TYN8?K(8+2@96@0P'
MMY5Q$SK('E\C;N!E06L+/H'\1W*LRHQ?^\V:&6;=S<$)JJ(+DE"T;YD'8BUG
M+7:R`/3)MEYA5+RD8@$F\<PM-M2B5"^@/@JO'IK3+4^`1Z7$4!4;6XACXJS$
M:'/[H):Q3./M&E/"+)'!1$5Q&#74\1WWSH;(Q"KJ:DTF):?,3FU-Z=B\G>).
M3>JAE^**XVLW<19]8T#P,G_%/>P]G/YIX>>^]>2`FWQ1YS!&T!*AK8%<TB]-
M@3S*NMQ01BM+,[(XEN*>$R0H!SP8KJV*-<9,?L$ZKE&UDO%RMI1^Q68PD??%
MVT32I7WW'>K.9W*9WO,3^VFIV*9VV^H9.(Z:,SXT$>CL]&LA2%KH;O!7@E,"
M\J#I#I*WVPN?K9"!:'JB!9S)K#<Y.27CB9'J&Q%:T]9'!TQ_L3IJO*'NM7]U
M1`<UX``T6-J>DHQ7BM1&NK@;*W*/"1A1!I2:D$I1C(C^ELKGH+[Q)I&%B-Z)
M@+!A>$TQ@TI/)#,X;,T-3$XBF-!0D2#0*IT(%K]6O*J/89`N$/.YBZ;@NI)>
M7#:.`=!904D.=^L^^#(A_5B1H>KEDF]+X\ZR1-MXKX'DC].36"R^^)D:+1V^
M)2ZJN4R,B"=;:`75*7C7DG8,(:.\(\`8_T%$2:BUH8`Q<PC5^DKY81S"/L\;
MB,?#96P0@\0&^\S<O/#$_`)'$-EF/C8)1GZ!KE,_N"4>K4BDKBYA"PH(F]":
M\^F653:5:_K&K'NV&?P,W08CY02>G-$)>JT'$<:Q/DCC/:>I]Y>H5!!;/KF&
MQP)XJ5KXD779F8JMO_T:OS?J06"$DWQ"/"U%VV&X'G"QF*DLQ,ZLEUALE@,I
M"Y=:(VV#[78G"Y13^H<C8QZ%*`NQ5;SA^"?[JT.BHW3!<"DF5]*#1"!6R30;
M5=9P6-A04T.&4%M'B'=>9S"WN.1OK2>UC_DU=:Y(6QW/41$D?,N+S_XI4-9V
M#%BRIHWB6=Y-Y2IC7%1KD<<M3@8?-PH^>[87;\],LX5?UV@Y_.W76EAII^G`
M+^I>3=,Z41ZT8DJ2<$N`72"I%O$@JI6?[.$@K_AP249D%Z&S7DQ60F.K.(PI
M9E.7LC,Q^-"I!SO9H^2J`Y.\4@OV:^N(7[DO"S&4K6.U>3EK'ST1QBO-4D>W
M(G2F%%]6N\58>QD],)%MVJ#"&":%Z`Q-=B"0"T6@Q@3C8I"DA*0.UPQ"]MK\
MFX!9-/M]'&Z>076T1J]962EX`17@-42V>$Z;#*!!)`6+DC3K;Y<L<&(<`>:L
M5)#+K';K-XCUD:IKWF",A(#1?/"16&0*8E(7"+B[IDG$5&3@I!F^&[=XBDI=
M3%QG>CQ9`U4%VNPHOCNF.1K;&Z;)Q&H:S@UNP2`0EZ2/X(U1U'(6QV9$<-T:
MT`7>="DJL0\&M(6Z%N(O>(TK(%6DU?>S4$M<SB5L5I1+'0GA.@%=)YQQVS0$
M_D"!.DS.U@S9)E_"5G:>1(EL27O-6T=F\+IPC3AM9O:WK5`LNB0:H0P".LSJ
M)Q51$2E<XI!/%B&08&154&TT;H7EHY!\672M4R?K.LI"6PA@&U&SAA1.B*:T
MU'U(B-#B0RDI>>)VDE00UAE)!E/ZOZ.7CA6Z;N#":\AW1'?SRJXU=(J:^P%$
M%:),V+TFK+R=A1@:P,?K2AI<:$/VE$E$D:MX':7(YX#JV'T_"&,O"X::N)M"
MU=-H;(%_`@Z\U\=J]5F:()N;#<6UD7^W@4E1!#KF9S_5B]-F\<0B*?DFSA(\
MKOPE7MPXA`TQ&0A?%2?I5TN8$W>KAO'HZ1Z_/-K;_=ZP]VCW&>V\N/3]V<%Y
M"Z*C6@&X[GWV?(KM$F@;%69S:3*LPL"=4ZE%+=Z<UQL?U.(7<5X6I<C1C^R!
M(Z<4KO4?6>"KL=XR'@)0$B[^/5KGKG!",]HM3`S<(,?9K[K),[97(=WC7$>D
M';IM%<,IN/(.C^K$80NO0E)DL5!U01HQ'9D#Q-_!1_+*09918B?HV8[OXM4/
MEN&;,LRB\.?6-F7D_%E?A2W>5N>[W92^HCR&U5J!SEC4YB7="9`Q`>*`X2P_
MX=M97EP,=<\;<BU"N!XZ-SQ#8A<A7%G#AK?I(B?J7]8L;G[A[]27AH%?7`.P
MKG8)CK>0P%B=B)V#72B:3J]'?17\2%-9^J8E%00R#PJSAK?<GE5QL(`/&`VE
MY(!ZLZ`&,-33U0U`W%4<D(,;JWHVO&/IXJ/-H+08H`M)0DR^W6QW!B?7DUO6
M5Z)NP;Q(RSL6:61+;D1"9F&>=F3'M#<)QL)Q0@I)>+9\QH-HPIL^@$)1N!W;
MDAB.IV1H*3B&#T_JD<R]^PV>N]/%V'*RQ(/&*8*HPF6C#CE_\>/RQ0G::U+L
M%)ONB?-,_YWQ?Q9_U_P_K>ULKWW[XD<NNG2E=E?R2$_F1UA3'W+);9(+KL3_
M6)QSZ=)4OUX/:*7^'&;0@V]MTF7QZ6[RP^(>`_O3FO'@_$.Y]J+XTXK0CA92
ME?>XW&(UC<?S["LXNOF`#*P3SA/^?KP#N^@<Z>Y;]MU?HW2FO=!NYG)FI^%S
M/I+G'3YWS-:_78S9/__C[XBBW?]N%!T[_5T9LKTI_>$YTH*#YK$D'!`I:YB0
M[S2[4N'?U%(T4$F:D^AR]3J.*USI53]("-G5\D4,M*0V9??/)E[I0M3>?S>B
MWD^SG0:IZ=]PT/(YU9<O+A&N2FXJV:14P*WBJ=\'&EAX9G<TW0TP.4BK67YI
M$NQ,&Q#9,\L_-4:N.H"VQ'27(-?\6CA[6=Z@*I0=C04*6:5L`QFKFW90(.EF
M$#C]Q@B:'$IN"^5ITD0M`]@N2+VJ#%JG<]`5WT<3"HY,EM7WY*XY<NYF+1:D
MR61J<])I7'A3K95]5)8&+K0&JD'JQO):NMU(N7O_0`N/(+Y=KC(,EZO4T9?\
M"O%(M88#0I<+]UAD1Y*4''^^@T^V5FW=A[[QH<D,[SR5&0[C*Y[)=1*PI=2-
M5:&JY9&Y*N>L)*%+I0EL2]F%@*[F%->="M]RV*I9!=FMZCBYH,KX97V\56Z1
MF:,ZX(M98/Q8W-$#(NX]?BZ#JU-;N!M*R-EIO'C4'Q:5!-0.@\D'T,P#NCX=
MVY[))$=Z.[ZW\>'^]%1Q77*/O+%JQPM^Z)*>:5B[!]BD$CO!(CN!TQ]FSLA0
M"UQ)^I"^3^^;T+??V0@1=XK^$UMZ74-OJ$>4!;F,NG)Z[/F&1^CV9:'P`*(Y
MEFSW_A&/ROF4W6>:P.VI&M\28_I71>\>Y%CUQ7]'I'%`(&FB3FA2PYJ@!]/N
MV8'37YP5F)%['?!*]:;FBAOJY3C&F>M4`14.TP3&Q[FC\T0=Q?&<B*9U#M:^
M,^3E2\)NUE:LPVWNG%J$`!ZYW/4.K5/=.8T:M*^F4"'0X2'B"$8E\;3"TP-G
M5U>64$Y;5?:`$UPXK_49-"`5K(2<1*4%EV];<9'D?[K9_#XD[QBH\_DQ>%`J
MPS#9V/D_M%Q=-9NG<Z#RTY'.[K\18X82-3_IOW^=3_BBKI`QJ9:.XL"VZ>Z&
M?>"A<5.-$53*,70J/TRDDJFVV$6IO9DL6>,%0:0""#-X_#WGG(1IFIC%2+'\
MJ-1M97`SJ@L^DY.;LLNW)6?$,4VGQQ>H^DMH&VU;,+A6>NK@3<L=F;63R':T
M`A+$%>OU)EDST,5N6$BJ60QJG0U!Y'KXQH+R2HN(*4VN0WY$/":U+!6$/-SC
M&^#7B^.R-.@#G"]]3EIN0;<>+V*$X?CJ+E@C8F!RE$-"*]";+.@F?^^DT&YB
M3P6_5IWO#Y)'CFTE8E%F&^OW7)IA!?I,9.MQ*KC`[2"3<&4N,PB9DH::@11N
M@YG>8-JYX+-&AL$UC)L4-&@FO:8*K;SITJ^ZD;*_"GD('6C+Q^1+I66$%1\8
M.1/^Q^_LU1(=U*[P(PY^0`4IM^MWLN/I*QIGTXT3A'H[,OGM@+3:;-Z03Y:P
M!*J<,1?4(($/TI&WD")CN_N4O8&9^/J(94&LGE!7\EF:QP:&VXQU`*MY(\]#
M`L*.\!0::,/X(!"/=O=<K#6GD=I;,EP5].CQ6((3IJPHX_F_!AY)OZAJI/A\
M/KLSHC1`R-,FBPT5ICQ)P^)B@3J6GCQW0-OD"%L/-%,2S[O*A>T'*6)E0`PN
MQ2>5M5+^TDN+[\(G#T*U<Z_N''&=MTF+)=0K95=)0=L+;.R^(RPS$W4D)\F3
M8?\?VZA\H[5`S`3"^M*#:#1"DT*&S**B1F(1#5*S0R&64624903$<W9-:+S>
M\C(3UW^I37IMH8)L02BB.=])LE1T\<BNIJNEBWH5LZYUX%Z?>,.6NWXF+K%&
MQTJ22--1VG94CX97=[]BN`KCI$3%\L6QW:';^N1.W8W6;=P+Z_HNUG6G]"F9
M%GT('E<=@_UAP`=7.+/\T#U(JH76*&9?TI@6?XZ7!T4M6G-WS'VO*=1*C>:.
M;W3R8TAK?(-E\=8ZX:-:SF2MDS,P:'CWY-"(H'7),7^A\>TZ\D@UF2@^+.B?
M@&H;!"?1@WIY_?GS[Q^W8A`Q9NZD5;&/04"<T49R1A1J6E;(,].,.M3V^G`B
M)1NXPKV%K[SSM)\_BW6Y`OS>[Q;AIKT#J%J074>30'YXDZ*!?2.2#?I!7DLG
M[#7N]=M\X+9\^+7J^I-TMC#0OX4&S4S]^IY>I4CDOS!$\*6K($BM/K3B:4.Z
MZR)3N>`M-M>%O!`\U9%2`JVU5)P%$<2+M::<G+/H.?:PRSUM$P>*NN'.8#^_
M:BJPBC6;6@"S^U\<*43?A3C%=:<^2I;:WA]@\M!*)`3T^S&U&J:7,-<?/=M&
M4>(\[9CJ67^T\^0I#W!YFE7,NF9>=G&<U&3SDL0?[9XE7M9__\*X-!1,ZE!>
M@H^HNX-PN<$>=D#J.`]%C/9]3:>SK6+7BGSU;1Y;RS<MW/7'*&EU@E=URU3'
M(WBK1[UFO-3[1AO@-_&`94;1$'/IW/`]E4_+EC5\TLHBZG82"ZTX-YTU4"QG
M*NLB@&&=.F-GM3@35"N4DA0QJ>G7.L&0R^RY?:_[%'4W4:J]T@AHY"QGBK)K
MA`&>IZW\DZ1]93KL2LSNTFV#+9<O_J(NT@ZWWODR%H^6+]ZGBT&;O]C6F@]Q
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MZW[XA(OC'G/)A`0YE<Y`0&I%3N8HK625+](>EI&AN<#R,'=CE;[;MYBA*>*-
M;U;<DH?N%RB8WJ'S.WPUB:V8:X#&\*HY;U9I)H.(ZT["][KYC9RS/0Q'O]AE
M<@"D,%QIMN!1S:=")>YSE9;36_$>%MJA:,Q$?\6<UU422L\CI8!;U2;HR[<%
MO<2KE^P^V?%=>EGD!+ZPX?K4=)0.U(8Q&(63UY9UHA=$-]W1.L[7Y'.;QJ]!
M1'C'YB1#-Y_I&(NB@W#3GX`0;^AFBZ&E"_6OM`0#<RR@HJ3^A7V_]Q]"5O7"
ME$B)`5LE<V_WS_]X>+G_\N2PN#@\>']^?'E\>-&4G,Y!7_H"S=X/FT7GB\W9
M.]-@LK8A4)&)]K/`E?*F708<.H-;6U>FX91H;<4V+>41TT7RKUH0<4&I^D)4
M-5VT],AK;H1M:<?*$C8GDR5J/NO2KT=$:,UQZC]I&:K]UN;XH)=U5:%.`I^J
M_BR?LM&1LGQQ86?]I"G:C?_-U==W6YA9WWF^W1SVNCI%RDVU"+2:I0#)[WPT
M0>($AIT5:[YZD(XJ_*-OKG_?G`O06L\>1)5K@8@IA,W+4]?JA!'NVK<XK>^T
M%]UM/7K:>O*L93C7OVL-^EW05\`F^#FNT0O^D]:J.RV<K>^UJ;[;,6JGA0PI
MN>H^+)V8DV(C^:LRT(VD)G<8@YLH5JSB=G?T7?'G[K'I71-T%";VIQ(W+]#$
MTW6JLJ`VHG";H3:[F#\AEZI5I4];]U/;*655MO/5JT.Q6MT2;J0-=%^V-I'N
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MN\SV>1-F=C&'9N1DA(YK.W+KF`<-Z<N(B%*#/S$+."HR[6T#G7%$O&P&KT>[
M;U)=F*/P%TY[F@2JEA0TC86:PCAJH-$Z;!4W[W_5-B*SQEI*Y27K]8JW1#MN
M\3?8:X?K$PM_346JY8"TQ>R),84<$GFB*`(SFP0YM#3;!9[F=",\N,Z/OG]N
MHQ]1QV9<,^]3.7A'^\?GQ<_[)^\/BW='Q='QZ?[IP?'^27%\>G%Y_O[MX>GE
M15,G?,4K7W+^GN#\?<4TS95#2V7WXY;&\=$MY734+/ET)S":BZP_?]):X25G
MP'1JX>+_L7?N.W%=^9Y_E1)R%")A-\7=&74DC+&;T[;A`.Y,3VO^*`-V4&Q`
M7.SVT3Q,GB5/-I_O[[=N>ZV]JXK8R8R4(YVCCHNUU_5WOUI;+RM2C3V__O)I
MMM9B+(E^:+&B9#8(CMK"?C)MD@N,W]V)W)DUY^?=3TMJIJ`30"L9<>I-!*.#
MA?&I%G&*Z*D'RN=0_W9PN'^P>WC\S]'VJZ>CW?]\O7<@Z%H:O=H]OL?069"U
M_OW#>RP4V7Z]@1WD^H9=__K+L?7]U1_K#[`/])8;'9RD-+$0NP5Q\?JD]<1/
MB[_EZ(W2$TVIU<?+U!3B?Y=75QWKUU;7C=")CIFLVF<M:Q)@IA**_>._[1Z.
M0F?2H]'!]C^E%=;;[1\UZ]$VOG_8_V$]/==\K1;/P7%>__D@!!()A&.:=STF
M3O%QXF:QYN^G%!M3^AEK6(J#&6[40>2RD;R&,;N-)IR-5RPH.M[(@#O[+U_N
M'1LI-MS9V;?6L+L0ZMVC65>[^?W#J=_7QS\&8F#=RM\VW[:'#^:4X.#`\L*%
MEBB3@XNJEE\W,9,"DP[AZ^+ML8^,[&;\6>#Y7O]I!@PW!6'^0(J&RVU:1?[_
MF%`V%UE$;,_&%UL!:3P_)H5P^#,A@U?5U\-;Q@W%IRW,][85>V0>'@E'WE@S
MM`4+C)W-<MGA_*GH+5(8<5I7G8"9K?&&&W3B*ISHM"VS[9>5XK'@!AYFA(U)
M]#48A<*!ZE+;=DE)DA+-[F;D6329`W*"8\E%288)\69A7[Q,@'+R4S.5D>(>
MA&+]CL315L(2O$1)*<VNJ$M$U7"X5,\J'*9SOTL(@3#@D+=3],,P4;`JQ>PI
M/_-L*TM/N2```8MH4"3ZDLD2JJ/X(YP44:B^&X$/"2L45#3):AC$#1UX.]=K
M6Y-`]%3(7#?$;%ZHGG*\+).P[PR]),9MRCGU8&,S2'.K6RM?FZ[K`0N<4L1X
ML'DKQ8K,P'?@'^EA!&$`96\G'Z5M.57P]W2=_,'JUE8CPU9SVVW?(,E;D"@:
M+]K7Z&.H,AW@8/BJ(_(&:L)F.M0D"MG.[B`7:X"NFVRV":]X[R2E)G=]<$+Z
MFX=H_3^`EVFPL+*&8^+!RGC=>?QX<^-KP\)VLMSSP@_6EK:6U_76)J:*?""H
M7%*8U8/SKC#+JYL8L6DBG@4,`;BFOWLJCF13LU;G+$1(?U3/U,]"4S_I@%IK
MB'YM5$(+444BG7L7ARP5#D(C=K:Z=W&*3\62XP^Q+*5Z^46U>Y6@V.(F%S49
M;I,PBFGEKT$&RE^5U?F@\92=PWMJMB8+TI=:Y06:*.T%=3R?V%$4$6$\087&
MN1V*MR83Z(30Z%@Q)J+1_LZ1D1$JE+RS3@PR:(1:?!S)*R"L+W\3Q[,35=!#
M&3<"BUU!%E5,!MWBC/XLZ3QI62F/?.D6AW23D5FQX/7EYPFAD6BTB:^2,:_X
M?_DAE/>NA:R7"`=T@JF[##>DVN+O5%#?DOSSG\N;+ESH?/619,+I&P&BM,(.
MJ5%O1T<4LL![Y4+#ZC=2=]>XG**I8MJF("M4V]6>B=]GQW8J,D#/3GZZ4,:F
M(L72:52\2VM!D<,30(RA'N/E_``>W*?N`"J*8\,4IH4TH?STTIG#&W73W;GF
M,'N^93[%+B)?E)@FYQ"&83U1\=5X\6:BZCV624FZG`DAX%)&>28;K4^!"DPA
M\6UMCU8JFUWN%Y4"@TLU`E@X>+0;W<0"6_3ZBF8'!?YX]=9.D=AHKAR]V'NR
M?R@LH.R(L5`>*12;2D3$$(D]7=UY[;13G5TG(36$QWVCFG*RD)YR9QS*4NNP
M&I[)^VI:C3*-8GL%^T[5'_0*+KCSC7ZUTYBL"5ZR'!<2TIF2!NO%;=*+]/`Q
M9R21@YO=F"E-'0RW=?DF]"E/7,,,,95PB&]YO+(N&)DR8]H(+T<@KX`8==$4
MGX[B1X.-F4'B0&`!7%%E-\<BI$%V(>%/7C%@FM&D:$\B?FAI>1,5\\*B[KQL
MB[]P!@CAUXV5.&2WL@`VMWATO+_S][_MOWBZ>WCTK5D`,`;\:_L-]!IH_]\U
M:WZU?[P[VOH>3U'?A_7H8Y&'Y`F<W.$C\(Q,T3W1!G-L<16*3#,GP,KRLJ(J
M+;+2HFC<.P9<(Z`J<9I\?T#HP?(C1BV/Y:[U:!L2A7[]91M0"U^9^=_1X",!
MG=`/FF__)!S6PP%THE9E"2%&6=*%3R!R+)LG+CIX"/S%'-\:`W&]8NNP$-M]
M)\JG7%LHKNZ^RK+_2"$R$%8O877CX;276'BI1<9,\!75:/-L_'*7H69.$/RL
M8(Z$6O")RH(1!B44*YN+<HHR-_H.5.3*@IPB\>C<=WUZOR5,_#9#N":1AG/Q
M`.4OZLZZ44X6*5'`JG"Z7,087SC`J5)?5$HG""5/+I7;RBL^M?QIM2[%1*L?
MO`91K%*2[,T-T`["%3?^]DR*6@]HC1O(8L7J@Z4"S%H80]A5[#6\R_+E_*;X
MQ!85F8>R(]5^/.<$,&K=&E>$X&,U>?A!%62L*%]A[7-V3JT`P9@5V@W7E!&G
MO3"#]E=(=!Z-W1X$)PCF?N_Y:,$RS1T^4X;%?]P!2XCE8XAR0?OX!<("-S9:
MRNQKRQM+FUNKY'](&02+S*T7JH%SVQ^1LA8DD4K[6$"0L3+A0#WG#QD=()2`
M1-!LYEEF'6]L+:VMK!6G*$%(]^%>#H,0YQOA4AZ-?OUE#PP-97I&J^OK2VN<
M8FA_$MZ2P.Q[8M<]6XH3Y8N=?TN"RL1G?#DC;8@X;K5(IA&Y/AZLKV],?Y25
MYE%6.X^RL;6RM((!9NC0O^U1UE!NQX\??X5'&2\!1TOCC>7!'<[]+'FJ/^!A
MU)'ML4EPVW?O4%S,)-O%A]4-XU#3;OZW(,3*QM+*U*L7/,U96KZ#W[+2=?$;
M7:O`[Y6E]?$F%NO-P:?Z;<`T7EK;>+RTOO45<!P-<6EME8TRV="]WP.>XE1_
M`#SA"M@@$^U>#[)A33T'#ZK7^"T`!MP^WER>@ML6*!%`+`H/D>;6TMTV6D*H
M4B#*GDK6F=;XYN[\_6E0VZCW_*F0`X,EFSY.XJ9/SB^OX&(4"AD1I(5>_>(6
M16AQ(?\N"X`6"/N(EK#QTGI74(2CU,0Z3Q(M447K%#&^E88$PU92D"$#1'*[
MYU3"3>K-I]YA=Z1(**]=_%Y_A/N=6-EX;?H#5JO)^\#(S'515C-TZWJ>(LAZ
M0'ES-`\5+,1FN%>7O0CZ<3>1E[2^7"(<>XIFNASV:9R]^SW\-E9*R3N*A^)R
M:ZUI&9:[ULT$:VYS_X*2A%?<C@H=CA]'4EH^I_6H0":OBP^X$>,31AQ%1YD^
M>@)((M\)K-C/5M(4K`P^#W7++%SO"?9263Y"4^$':R@+IBEH7!#B[*3ZMU\B
MKBF?5*%E1A,JZ#>5K;A]W8O&!E(D826MO/P(3U\_81G>Y'K<I'WH!HM$YP@0
M3>)*NH(WI$PC-I8]65`G7IIY+5SUJ@%E,,[RQ^8M\.<<%Z@E0[-5\S']&1%)
M#V76(KV#%*')B,:5IOR;)M,YMQO%Q*L["ER-EUS=7P#5=+CRZGP*R2"H=P-W
M&/7K?)@5N)F0N=VN:TM1'K7S$)?E(;]^]"RQ*2<(:T[H&1>,6ZZ]9J-;O/TR
M[MA%>&XJKB/)TJI><G3=H*\'Y!$>0AE#S`W(TS&R1P/2AT(S`EG2W0C,/.8Q
M>(6`TO0>`EE1/*B&F?4T&#4M]!TS"(WH$KP^IF-KP4C3[?73:BH']B;O1A".
M?B"Z8J?I!VG7O$U%UM;?RFY@>BU'":B4X\G#4B-7FT.%.8L8^D0@NRU>Z.4)
MHTSE-@-:O*DN2V!G*.NRX\'`5-/"*Z49O>4MHJ+*[=HD:8_\C2.'P/AD-.N.
M:0L96W2&QS4'DX34'GOIN#VG/@TYS*8Q7<T9U3[Q?2E]R!4$,/39)158CAZN
M0@T586]/&O7G'#//OO<)D^NM'BO+!G!F]*+D9"M`):C&>;=O125^!MSWHC9V
M)+MD9FM*F3A^F?]-/2ECUGR<H$\EM/UA01I9"G0#$^BK/9:`C&U@FM<1"FNE
M_@#?\<`[_ZNU6`^F:16S`>`0##BCQG;VT7UU*=/T(3MA34?!0HN6(=`E!=^`
M*C7VPZ]496&2`"'Y(B.:9R[BE.G!8Q?,HCBM'18W8BY>LP]S,EF.N^35#)U8
M.KRTL<BK2L[_C.P$XIAI6%RG(\38Y.U%-)#U%"F$0V@_<K;UAY;HKP'SHQ2%
MJ/$8969UA4([`_<C_,\WTY491*^N>'\O+`JQ>(!1?FE#3C&14_Z<%'[%81K]
M>3#F$OW6YCA85X*@4#*$GMG+HV`!S2TYRM=@>8T3'*I83:!*^JD#5<UE[AMO
MPYJ3**.`.-IR>#<W7'KW'=XPU<NM6\/ILH*^U@0='1>/87Q7]RA7",$&,DYB
MOPFI*50.";$`<-;UX",[X$=JJ<GL^3JYX?0CX0]Q^\V.IQS#/6_;G/CT!G0/
MAJHD!W38H3PHH>-9<6*J).8B[=Q7<7CG$0"YS\^K2%:#&;H_7Y1.3,:[0O*/
M$/1J@HN_&\*.LCR333!P)7G9@D^H>47T$P"@=@]PZ[D0_0#$%Y9J`7\"X8R,
MNNC`-]@N(("BL+*.D6R\&L63:F&)1=".K235Z/C#QRGP0VLUAPL@JJ6[MYX:
MTTT%.%P7ZD[*WNV`0DP'FBD3%ELJXA-#5TMQ4N:\/C7CGC$+:YDS1O.E:L0=
M]=&O4_!RH$&`D3U`A',)#A_5:$-[BOLI('#@H,6^=%4*E1`='HK^>'4G9:16
M9G^,#>ZV%0=!Q.5NL&&.#J1'S!Q^2&,5XE<@P3LAG5!JW[%QP$4NQR(@OJNG
MV4X,9T]%V/&#G(R\CDOOJO'1RXAF$"DGR0'OGCE7+Q2_C/+):3U@D80Z1.[Z
MY_A=0LUZP.(6*N=ZDX\0OZMV>@99"$1YKGV:1X(3BF3/_:V2%\Z:`^8+3EZD
M<!FVR&4`?R.#N3,7=YNKAV2PE<ZJMW8^$#1-EU=([V6_H>.B%*4@Q_AY31BQ
MTT3PLH^7IK;+.+\@G/[LH8HJ@$*^4=4KN(*^PRE<\@Q"K%%6+]R<70#)\!Q<
M"T.(Y','X5PUWA%`D9NJGQ,,Z5F2-@4%Z58_6I/L(U3TM-.34.6PTVVAE:0#
M=!177;@*!ZF@^%KBU9!$><72(1M".(4>)1(4*^<P602->I&"O\T@.3'@[.ST
MUU\Z;*'&IOT`A9VE*ARZ![8'VCG7*NE5Z]&+&QLR1]4_S[/5N5&V<]X2+>^+
M^YV)G!!(0M+/4H&]"=XE\6UMM+A`+C6)3OKR+#@HV%,)#Z;I@W:J]@X2#7.C
M/M"HK_J91[Y]Z9[$526U!`9GOD;0K2N_KX:<-Y/.'HP;C#L,#DU.-20$&XV;
M+H8X;S:%Q=W6)A^0O1MHF0L"%NW$IF?UORS>("%]=Q,F48CL#NE&#8UX;1E8
M>COG/G-@W7.+R&P8S[,HU=;/NHB6--YJ4F'^T<N^%I$?MU:7MM8;1*QW.A/I
M=BM$"`:FJ81I)G(TJH8K1W,\S=RH,@4-?OOJ<R'%[:=+%^!$YRF^N+:V>0_$
M*.A"`V;'P.3710:1NN8ZBF<H=G-_K%C$F[<Z;I*EOP)TE-N:&R*.LEJ1N+_.
M'SCV?+=]A@`%%&!QPB:7)Y3@(XK1-['B5:C/X*5/(.Y0T0[V-`O_&.,F_C(*
M?+-+#"BF=/O#;A0)"]G_=R_G--!ZPK=7K/Z&;A6_3_.+'Q3#=:1`EK1H49BP
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M$`.:ZZ^?8Z49+;Z@!(0T:':)B(>.Y]X<ET53BGC][>)FDS_KTRF?_3OS04C9
M.,5#_9'C\]#-#*VXM[C:5G,XWOZ?NT>C_5<D?.O9ZUFJ/\]ZZ_'R]P^K3^H9
MMQO0.R8>X_WD$^I[)UQ<')&WN9I<()PW*)S#!I!KKB=79S05/+DA_^/DD20G
M&GMSVW=FK;:"O.KTK46:U?-$%@U2?1M+S0]^_J294,?Q,%DKSM7L7')8D2PC
M>_P%N)H,)RH:@3S0G66$#8C8?J]8@*I'A2F#^O^!!:7H,5NL&XU?Q5(R`X<.
MS6&1$*F%K?]Q<XZ=YA>=C&4A2>U+22[#M?1]4Z@NWV_S4+U7HX/W+3)E'L67
MO:)`R*E"BM+5\*NL_JF$T"(^#_+_<&!_//O.[]?U+:VFVW*WV^KZ-W@7_AT[
MZEEM+!^-M*<4?W\;6LMSW.B6]`U#"$PC<NN<?RD9\42&9FA!'8+37(C\&)Y?
MHX>."1#M.W0@J+W%R;^-ND0*15;4S?6$[**,3D*1TE$J8.M>QLKZ-]JR0AW,
M#[9JO&YEXU'Z?:W=%],\H4FXM7-]G3Q%,6&K2=;:F5R=WW*?>ZD$28N>I&MC
MV##UW?U"]YE-J5[K%.6[Y<(6NLLS30SV*C"$:Y$_+`;KQP1#P225J_Q@I^0%
M0,87_*2D[>-LV!57P+QZ<[:`K8+.*RIHI*1)H_AZ3*8-(X!+_`:XKXI^Q<W>
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MXLH6GBQXR`7$,28$=0Y!`))Q5,4.D3NBR?1W3].Z.?]W,%B$4P50#=XA(QL#
MI$9)\>PMTM_Q\C</17;,3A(_9U+M$81[2Z9G6$DCM(/KY`FK%EUT4@S2R56@
MH=Z]A=GXUF3(7-7HIJV.;K#/LH1.>6"FIBA@__R":6C585/W@C-_@:(2\R<T
M,<#P?03(((",WS&1=@&#8VJE#-]L6'#=3VL2]$?H9-8,G;7@50)4'C@G\&A7
M"U[^I1^*IH*0>(@[BM[PE&!]'R!ER]?O!4A6#8\K-O_K'P-*9FW)H5CVN!=X
M?BQ<C'-N\Q^G]@]5D25_(4!`AZK[2_XQ%I)??VE6^WUL,0.F"_BR)[`1(B?T
MY3ZV88,DX`H5"6LHA)A/1F^[&,0W@7W_1)PT7T^&D"=P!0F)L3(:K!E##Q&_
MO-/U#:@18Z92P0AOG/=9\D@F(&($4$@);U[C+579!<'SL$@W)R?DX))&'V*$
M8&&2^<1L)+Z#[184"'GX,#FAJ*PJL8EC<R'G5P*52-^M`QX(I;[1DB6P%!H=
M-_)\?18J_SB7B@4O>O>?SF^D5RUG=#[$84*<C:%R..KFJY*&)[:1.&NISP%8
M(P'<.=C3&>O@#`']NSNB]O@*W2%@=_Q(Y"`$P2CGW$):1-]]Y40)G4Y-/X:X
M%&NID*!+(O-NFKLV:1T7C#)7`0/NF[?+T9IHV20>&SAJB87B'K$I*HB*0(Z%
M>+;D]M?8YGT?B4A73YZBE.Y48SGXSOT*WO"L4A`O/UWXGV))/XN>YOT_GI]]
MXB\<HETJ(7-ADCMF4[W[GV_[$@98:RCF1;.G\^<-^49RW;D`ZB'Z2O>4GKH>
MJO9N@BL:&K\'9VZ:T!8MJ;P/5D,O%E[54]CU:I&(Z?6`7W\I\/0-48V-/27`
M>CQ:/4$^:<#B>L#K*Y$3@\AQ:W2,OV.5M/_L\8*_5&U&#G(Q,,)8C:XBZ'W%
M$YN\!)XE+2(+NU1Z2+*N\K!_-EF/6<#+2HM$>/8)7.=QV\SG!9=T).80GS4Z
M.;M6'GPFA@8L12^"`-M_;@8G^N+6`)#I5$8\$-CT(^,8J88)="5HC4[&_\RW
M-HKE5IS*JP6M,9,"S@/DN^C=5>7%9N8"_S<P?U&;J`S!KH;>Q-B$_HX1[O:,
MDJS48[T^`\##/J8^J`:]OR.4O18Z0K5_*&QL3!=I"ZJ,`*>L2L/J-Y=O;W&`
M)$8CM4)^V8]G%W?<D,U",>^[4!:'<_47N`GQ2(J$@*4%_4:4([>TY5NEZ=^.
M%HU!7K&Q4.-&M/5O9P1Q!>Z^?2I6G;,-L$'E+1R66WCJM5<DV$0]#$J6V)51
MM>V:/VNYK(YA$>CHR-J<Y>@<N*KNR3#WM0A8G9P^6>;/C(1E,'W).A)J&0\I
M;#GOL9$&=.C0.;W@$S.IU1:TVC;)P#2[7C:)V5V@"`:4!G;V.JB<A`P)"T`$
M22-EDN1_JV,G9W]=N!*-N/YXMO"#BFVYY!V>()IE$)>OT52"T?@]%G0S_>E5
MN_J87DR_NK'(K!_Z9W`7D`5Z311U)6N(K$!G]"$+8*O09XH1146Z0!*^DO!(
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M?>X$L0?+B*A>%C`\8%)6B:Q8!7C)@KTF\YYN"%Z`0+2+`.1J7WJ")^/RDR+&
M(*32O(V*G6'DDL&(^@:JH1FQW9MHG*IQ-M[P:`ZP^B**#F8WU,7'44ORG*7-
MV.;289S0_YFE&VXLU#"[2<5%@\5`\JG\7>](6G/K7Y*H\UM&]V4IA-S^@/2J
M!RID\.(+DS*M0H"HB?''TYQ?V64LI-OADP@L+H=RI@=$`T?*ASY*$V_\>>(2
MO7M`?%9"$2SZC-1_ID^9"<#;FW-4FU0HD6-<3&#!^1?H(23HZ^H!5MJ*I8!6
MX9S/C]LJG)Q8&IS]:"%!A&M<9]-.ZJFO23OBV(1B>AW/DQ":$^MW:.W\*,KT
M4$ECY>R/-J'&[$:<Q0M7^;2.AT+Q\)9*2%OP@)\%XW^XD&7%TZU1W.N*RKK$
M'EA^'%9>CNR-U)B5TF+GH/;GYG#;%-ZG8/"MV$R\D:%G13N[5G!I.FX!6G&+
M03E"%-=>@A5"1\]`"H#X^7IOR[.UZ7)S%8I^&@C%72)Q!+M=>Y(3ZBN'56&7
MD%$O@=\+N840`%1B2LZE4I$493]'.S;8[9]4?L!8*`8)8\"T/BK-KXY\KI[D
MRQ#'#Z4O60Z]T_GRFOY#[Y\6*1S>A?`;8-C,G]QK*'=\V69=[D1O@E./\"+R
M;9B[*.!&(!!U?)0Q?*&!B5'Z@.OA<>/P$!H3_!6@5DJDI_H"Y0#>VQIAKP5]
M@:W8*VLJKR_[9V87JCF7*]U"C:C?H/+BIO%<GYD`X+X$O9Y',SCCA<V4GO9^
M2'M$9TG*D(M?G^=45TU5O(B2ISVSV?/G<)P4A9+R>R,]4)&'+46:$7P;X8WC
M0%/6,4LYBX,*(4D$#]+D(M99?@/Z8;6!2DD_TX:ZV*GBR%$<FH`3!K$.@'GG
M/?HZK!*X<W>HP[=B'#L0)H6TH0^[E!YQ!UK1+0!_H7;V=Y60Q2Z]&.4JKH?K
M%'Q_!XF#U?%<X+-:'YF_4!\U2Q8&C<B5PA<8Q]!^74P7274WMZ1R\,.E+0M@
M[)(L+;)PP!1>07(WF7EC^%!79H.C=RC>!`]2^VV(<P'B3,A3H0>3!ZQ6=?2<
M=<09-LC[HD:=4\?$K:98\+ORJ+8:&!3TZK=(I=3:HF3)TRB5'KCS"QNB;3.*
MLIG"UMH+>F03O^:*6>Z3&>`WV="WHTP"12;:Q>MDGA9Q6C$H2&*U79"=TRH/
M4?!,A-SMRI0O-M9B'+OWUL$^MWGHO</#<V=R2/6.CZ@F"OIIPM;PM;(XV:WI
M+U%UH'A$/(?V.>T@#7=]$N/5DMU3OO#>'05+](A*+MV8L+K`LN%+R1KJ6!`9
MC\UDE.O'1)3LE-.H5Y)L]-@"#O4,A4EXM.VF&0@M!`2IB6L8;]A(<]*S9_N#
M?*HM1A!G1X@8[I4KQ0A+#@JS7,,9W]\`_:4<L9?"$$<[!HVAVH/9(SZIJ@M`
MH/WID4-9Z_H@40/H:M[9[B$IQ=T"O1M.1A%6*>C#GK<C9W&OK)AJ[:SZK:[B
M>I@$CR6L7__7R3D9+Y!2<T*M<^FC4.._+M@OU\]`=3EK_[JP,WE__N;Z7./>
M3A#8B#+4SROZX>9$W_@/D)'+:_WXEZGZLCL_^[:R/',KQY36(=X`]#F\_$#A
MD6I+MO.P^@\WN33Y&'%8HFAI/!$:!]KQ$$[FO@N$95FDJ)G@X*0$[DA@XJ`;
M:LWEJ8OW=ON*D7O"\`6-4R"]F&(%Z?`/WET_@_U:H)C"N4(HEP%UWPFACLT3
MN"&VU6V.`?M"E(B=]S)13?*!RR3%6).#?KI4:\X.&4Y?B!0(>4-OCX9>/J5P
MC(-MQ-W;'W:(K/D,$.%>4^RW:E^[K05&C]N`9AAMWL5V2K;)G6=<%-GQ$'FK
M=6`Y"6^IQ2VR9.6+(%-P&GB!UK&8GK2RP#C8'R5BQ)7CB;(DQT65]9%65I8V
M5Y<1(Y%_BKXJS?P3`I==X$N6>+."$VO%ZR%\Q`BC>!6">ZKR2*Z:J'\QVB@;
M*\,%M&5:#[HQW=!$QFXM$JM<K"RO$`/)1"O+JVTH^6MZ+IS_E[->1%2[KO::
M>(Y0/*A`-?X3F0:-AYL-S;[+JE\A?%N@L."%(G2/"JZYOOGI_&I!5H6/W(>X
M31".+>='21F'[E3%>W%J=A@:B6S8&6[.H9F4PK(HHF(&!]-F%[9K:`WUFN(C
MFB$^G;?WJ&^\/>==OIH&B"L$XF".>Q:%BB\S]:@;`&9Q.`ZM#-,2>@/J#`*:
MLMS6B!!WJ2P\R3V`)F8Z1"@76*3?3D*6@``MWE9`8D$9$`I%EUV%JI'!_='<
MR],H&V0TZLDIZAV%T&#]ZXUXZ%V$@D[T'4`(B289!_--D8"6H%Q@IHNPB$&_
M/_LJA#_IH+$G@V0G'4BI.43]`VZ475$X$TB34%X?:,XXE=DK]%4^6!K\:'1T
M_NZ"<F5@L<1Z]GF!7)/`.M`CI'JNSQ41G2UN33*2=J0.&[5]X?:'=%?YDT8O
M&\#:#G&K26[DQ"T&3/UL6[N4DNP\'=R2`[,)XO+TS;[C!N12>%<0^..,]0[_
M,7O(X@J5BMH6R"I\1$NE>L)7`%6[I7I4'U\)]%.5@P44F<'@SHD^5"NGV7,L
MDXVY)[-#@//M#F3N%HD2`'HL"M#1<B>!I,OBU-YM48%H7F#3_+2?W85+N`R1
M(=@V16JZ?"D\7]#K<*&$<#)2%5!+^8<Y>65V]=:CIF.C(<`K;`6X?]\Y`OUR
MJM$0!Q'->'6*][@3CAA.\;\%7N7="%69LPX.H0K9K[]LKE&$_J?SDY]&:D6A
M8H%!:?"9[3+!UV:RO!`?8`N]!'7_"]N$UHG;`U4S=3!>(V7,0?Z*Q[+V*_PS
M?F^:*TK#V8VD8H.6#]B.*61G2AP-1Z[/"2\-3E2NH6?VSEQZZW(&'I#2[I))
M+D-`\RTU)JW1"`PMU<!!A/#?[3`:3Y/KN^O6Z#D;R*%*5K.!GB?J'IVN29,F
M_=E-&:IXFOX>[#)F*7(*>D%CR?>%^&[;PGK7P,>AC![JB)G8LY"-_\>RA9N-
M2?2ISGL!_"V&79!B&-P7WLFI=TQ#,O?:E+M4@]*<-#J2;0:DA.%9YI.V(VBX
M,Z2*YXC22P3M13D,V!,)C@(J>>W+S#Z625O..DV:;''YF^^DI>N'A@;<@.0J
MCO#0*VZ=P&I2>:-,'OHP4VCFV(+11>V;>BB5Y7-%>M:\SM'>\U=[S_9VME\=
MCT)WVKU7ST<'^R_VK#_JXL$ERCI8V(0-OR#4_R$FS@_`B;=.`=UP1`B4:^JK
M2[P^HQ&]LD<#4:C'S-S)L23D=A]'Z->G=]Y@[8`09B)H/>)_-T?\[V)YIT$0
M&WQ]@QGW_>@%^^#:MQV*#_E3LYUBVN[V]\R<4(\OR6`1KQO,@A`\H,UD!R?V
M>N3Z1KA(C*'@QN7(U`*C.$'4Q/!AY9+?PJBMW;4H(?I/R%_G3GF#NTS/BM[P
M?7-URUG*/16\=Z:%6/M!ZV#;P,O+[<._[QZK=_'H:'?G]>'>L;KH+L[Q-ML?
M)PCY/.%#H/:A+>FUC6W)H\%<_O)]LXW).,@.!ICSB[O+NYO1:ZB9\;'3T0MI
M:`>!HM;/]&QVP_:Y3O-L@L51LHQI,L^2T+F7WZ%>NCS(T_QR?PL-'K=E@U=6
MH5#^R83,$=C^D;5&?T'>M)A1/>.45MUS'6((71"IZJ7Z&TS/M<H^!/;:TE--
M-#CP/LWU`E/;+`^N8PT_3T?/<LOE?[VT%@9-/[1,K@YBWP'0^L.YYY+]ZP6.
MY=&><+3YLGRW4-GJ96B`>XC\``/+$S4B,PFZEQ\NWU`B_&8TM+6^!FV#)RYW
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MT)A6*9M[XT7<L6_,58W'S08(WG(AR$S+TL$LA$26O75:97`+,\7#5Z(Q"NL#
M0F;!"GK"\4^(#9!`I$!%)9&7#T![=3-:IMY.%"3*8R"RB7U9SXN80=,`E]5$
MZR,^V[DCN_R5Y3C8H&F15F=]*IE[[J4PL`^&RM</8V%0\TUJMZB>DD<D_3=P
M<H35E1D0)H*.U1"HY[)!CQ9=TOQ.H3XNHV;QLODD(6ZTZ98GG4:STX<!8!M(
M,Y'.6OG6`!,1843QF&#8`(PL@D36$$S(CCMH\*BYB(,BV?7\N7Y:@3$R%AA4
MHCR<7S;??+L5+/$;H>1J/6F-Z%++"BP'W6BH4'\4C6DQ^LK]FDXR3B,IJC]Z
M%KPIW(VB8@N&-?H_.'YOL%B:F@-J1KDR2Z2)N3'6#87B!9\D9/Y\ACMOB/>]
MHFO#I0SX;C:M]R0#7*5N"(9$ZK(F;*;85H+5M])/%`L4C65HU_JVJ^Z@%0'$
M-QQ9KH5Z"R:-&_2+%]5?3H'CKW:??\>:@2W]1PX^=(W=36:$-75.;"$J<\WQ
M=E.WAL&YO70MIBESKM;W\S)''PW-,).^EGR[7W$``*_@5\'0(Z6Z(,7UEEX0
M6P>]%N:FU/QT=0!H%+&']ANWH+YN,M!+FDT:_U1ZVMDE6V@HYLRM36BB<O<A
M[;8^FN1/S(+JP<6F8"LQ@*+8WX"6LF_-.D;/L.Y97_KZ6.&S.>[G'C/-.,X_
MSK#'3M-?3`DS$^D>1@VB9MT,L?_6J$O0S3ZC)9EN;!@\>'?EXRQ9J.Z99JZO
M^-MC&>UH4LTU1TN=V)O%H^'5D8T'017EW&(VQ`UN(&'*>$%\P4Z"'TBF*ZB%
M:(U"@EO+Y4R4T$-G(TZ0KV=+']N%)]&5X[Z)8NW#:=RTL'HX$X?\]!I5!N^[
M;X:="?%LSV1H$@^9HK@.&(-*2C&OU:>@%$,"_HQILP5I*O9[.%W%KVKP:@9)
M-JH'97I>_^5'`FG@8OO(\?\DW6GP\C4`8]\S&44U<)@%;[\5H!<#8RS3,>Z"
MZ9^Z9BI*M(=B]&],GU9\Y!7:=5X/@C+OII\K+/["9->G9UCKU=CG]YEH_NN9
MN:<ON+^=5`+QRXX[:Y[Y3SMKIB\X[!P87=E@"P(BP^L<>/Q"6A5V\0OEIJ*&
MHK/3%FY0?^D=[JE:!1;W(6B:7ER`VI6P>G+_AE?J'S_74JFN[;"^/I?EN:1Q
M1E^2725;=+)`/\]MYUEP=YA!QF2*%Z1_XI-3S:#12W=JXH>^($9'WF,Y%T0Q
MS.`1?WA"\AZ(/L52^D+%"$;C1.^@*N7R81V3#I:*E89$/)]NY>M.M_JUIKOW
M>TK0R-<AT:-5T>9YT:=942CGR^]2LZ/\00'\'JB"UA\`X7-C4,N?*<2E5"W1
MJ]_)C9==3O$)>7&7:&(,`M*6:G(5?S?IPMQ8\<?A_7[!PO%<`O"X4(1'UQ3C
MK].6OR!I[6N=O5YGJO=FE@4KJC^&IDF!4GFWME_.T-@RH@W';5+=ZHU.U8?J
MP7/J'?5G`SK$T!L-N:-F79L#9PI3P80KG8#X'W79KO<TPR6UC[4(@R.DTC8_
M!^>KOCB-!'D:33V@Y>([U!4S:H@F\U+R;3;BZ`&)2WCJK]R^:M8DE+:;RZ:!
MGA@J#/'MY",V"R(%)Q<_4V".7$K2:%I=6)K1H.70I-LSV=M3T7E%1JS7-SDP
MKBD//S"N:5I'9''&ZGJQ6<\&';Z>Y[$TKG3M365]9J0==@5@!`A5[D3W0VX,
MMV8F6<H>F@S=2:<PVVY]M,/+SY2-^2SKH.FRJ46;C1Y>'HWS^H[E!#]7DW.2
MV6PB:&.]`DJZ0!JQ/D56XI&VQG#UT%D6FKC9/A/+RQDVAWZ7Z'U,_,M3W4%T
M)'^4NMS7!WMR?GE%EY,/^*2&Z(\+P6!1<*`.0^-KL.,Z]F1WG^C@K,78V1.7
M'JV5^@BRM7@[V]D3[<BC([!T37$J,<)MXZ&NYCHB;DG=8+!S>1EJ`N[JC1Q4
M7Y"<CD+L#!CZZ1/4'Z5+)3OB^H2RX*=4:23?#;N$2!I8XS__UN_2OM4OMMUS
MS_*RZ&OY>L7<%M3H\TGEXQIP(UI?4]UX\HO'$S7W!SM%W(/'4,45%XZN3([J
M>A_F6<(Y)]V<V\+79$41POSUZ'#`=(\^^<`H#^8L/8;U0.0+I?4S4"774@]>
MSF=04@]/@0&#0)-&?`PA0Q[9[<WU>@EC/[TXJJ,74IS#'/0_M=Z)WK;X1@.W
M%9QSJ6M?KJX-5)BS1@&3MU@=ZPOY=C7XE\:N#H_&FSCU/C>T.0/;>>I!&S"I
MK_/MO'<BIA`A(@:1R"RE]&E"DM]??CXC[&ZV63.]&O,EP";,SE*$^2W99YE;
M/P]?0[B'&W(5>R\B7U@:N=X[<.85'!Z]3C"A,V=/BV[E*06F3G!1=$]_R-ZY
M;QW+X-L0,C.`1H_:C7;I@7/?>Y.9N'<W5OR>6$RSF[Y!]4N4?NKGEY=@MFX#
M>(C@,#HB/P!Z=*,"_]$K-U4^&CAD$54C&W@=M3,'U,47BUO"FPE+ZG'&8_X@
M)R'D(T.;L'3$('&D,]R^R'KJ>S^-_W7V:+);3PJ;+&)I:NAF/E7XHK[NF1_(
M.VHS3G-2KPXXI[\-!>#J50%C3,X$VNMM2V]U/%>"(2GU?>UNAX2C>\T\`YN^
M:-<SYN9<\V##<RONHFPX!.BB,"=&^R^^JGO./>-`]65]W=GGO*X!3,^L./`:
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M\_M`?9PY87K_NZ]7^Y^)31&D$B$<#X"N=2-%M'Z@;J3EUN_W%(%#G-7LA6)G
M'NQ?\YDI'[AQJ_X@:2WY$08(Q<:7`56\NK4(O./5_D?9JA[[?C<6!<M16F=E
MK7^=E2]DB@G&,GGI1\>!@/E97@'%SGC\:Z@ZA\ENJ#%H$RE_'Z/D=BY]HXCW
M0SS2;6[X;JK'E9-:>Z/ZCIJDQ1KD0OD"BZZ/G>(2BM2#,:KG<AWRY??L3?&:
MW9QCS&+YL\9DT=1^"(HCV0B'1]\-;F7.S^#*NZI'AD(^TAG-?1")5WT\;3V6
M#.D[@FQ,GU2I!*'^7(X=O.$*K:[GF7]O+_2\<^RL`:DR"J`L0B#U$R4\%"%(
MH=0Y>6*J&/V7FYO;'_ZO`````/__`P!02P,$%``&``@````A`)MGL&V*`@``
M]@8``!@```!X;"]W;W)K<VAE971S+W-H965T,RYX;6R4E5UOVC`4AN\G[3]8
MOB=.H$D+(E2%KENE39JF?5P;QR$6<1S9IK3_?L<V+1@V1',!<?*<U^\Y/G:F
MM\^R14]<&Z&Z$F=)BA'OF*I$MRKQKY\/@QN,C*5=15O5\1*_<(-O9Q\_3+=*
MKTW#N46@T)D2-];V$T(,:[BD)E$][^!-K;2D%H9Z14RO.:U\D&S),$T+(JGH
M<%"8Z$LT5%T+QN\5VTC>V2"B>4LM^#>-Z,VKFF27R$FJUYM^P)3L06(I6F%?
MO"A&DDT>5YW2=-E"WL_9%66OVGYP(B\%T\JHVB8@1X+1TYS'9$Q`:3:M!&3@
MRHXTKTM\ETT6!2:SJ:_/;\&WYN`>F49M/VM1?14=AV+#,KD%6"JU=NACY1Y!
M,#F)?O`+\%VCBM=TT]H?:ON%BU5C8;5S2,CE-:E>[KEA4%"028:Y4V*J!0/P
MBZ1PG0$%H<_^?RLJVY1X5"3Y=3K*`$=+;NR#<)(8L8VQ2OX)4+:3"B+#G<@(
MW._>PZ/SP208\7G=4TMG4ZVV"'H%IC(]=9V734#0)32"LOP[(<C$Q=RY(!\*
MM(%%>)H5-U/R!(5C.V1^B@QC8G%*C/8(`7MO'B&[]WMT026&?;?W.(X=S`,"
M6;\AUS&Q.$=$%D'DT.+Y\CFXQ*"]GS>-)YX'9.QK"\=)?&6?!GG,+R[G(]M7
M[['MX"/;66QC'I#<VX:3*5PQLSC/1/9@3UQ>50<?V=OWD^_;>4""O>*F2+.K
M_`A9'"+Y.!L71;9OBLA<\1YS#CXR-XKK,@_(67.'R'_,A:,K;/&>KO@WJE>B
M,ZCE-71;FEQ#@CH<7&%@5>^W\E)9.'#\;0/?%P[[/$T`KI6RKP-W-+Y]L69_
M`0``__\#`%!+`P04``8`"````"$`6U%GVA$&``#!&0``&````'AL+W=O<FMS
M:&5E=',O<VAE970R+GAM;)19WV^C.!!^/^G^!\1[`[:!0-1TM;#:NY5NI=/I
M?CQ30A+4$"*@V]W__L8>-[:'E@TO:<-\'G^>&7^#G?L/W]N3]ZWNAZ8[;WVV
M"GVO/E?=KCD?MOX_?W^^2WUO&,OSKCQUYWKK_Z@'_\/#K[_<OW3]TW"LZ]$#
M#^=AZQ_'\;()@J$ZUFTYK+I+?0;+ONO;<H2O_2$8+GU=[M2@]A3P,$R"MFS.
M/GK8]+?XZ/;[IJH_==5S6Y]'=-+7IW($_L.QN0ROWMKJ%G=MV3\]7^ZJKKV`
MB\?FU(P_E%/?:ZO-E\.YZ\O'$ZS[.XO*ZM6W^C)QWS95WPW=?ER!NP")3M><
M!5D`GA[N=PVL0(;=Z^O]UO_(-H58^\'#O0K0OTW],EC_>\.Q>_FM;W9_-.<:
MH@UYDAEX[+HG"?VRDX]@<#`9_5EEX,_>V]7[\ODT_M6]_%XWA^,(Z8YA17)A
MF]V/3_50043!S8K'TE/5G8``?'IM(TL#(E)^5W]?FMUXW/HB6<7K4#"`>X_U
M,'YNI$O?JYZ'L6O_0Q#3KM`)UTX$L-=V>#0_.$`B:EV?RK%\N.^[%P^*!:8:
M+J4L/;8!AW)!`L+R]H)@)7+,1SE(#07T`%GX]B#"^^`;!*[2D!PA:]^[0KB+
M**8(82`!T+MRA-4MYR@'$8[,99`C1)6+6E=A/7`(0&!L`O/!D>"M#SO^NG(A
MR,0(@<\K9.TBBCF$0RU:0DV"MSZL\CJOB-R)<X0D*JE1E!'FA6W.PM#0=DA!
M+=\>+PDFI&)""B&Q(L6R*":)+&R[8$#[.MZAE;BT;JMU.8C02Z[N5=GD"$%Z
M4<9(2`LT"]PGS`QVN,%.N3UD$DPXF4P@)X0@)YYE"0V9;6<BBHS=H24;ER4/
M\Y4OP8162D*%$$V+)[2\T(RAXFMC=3AE2SA),.%DJ@-#A1"<-`M)[16V-<[,
M6(<2`\F\/4X*[9**)OHI/6Y]C%3"LI0DN-!.$!#'86J(N]2(PL^GD*$J0QZN
M$F&5!L9+8^;D:Q;BTI.::U78;9N2H5+;2A:9YJ%I(D;ONY#N2NT"S1%_I_Z9
M%&*+WD^BA[+MT#)%K&F]2KMLFUEHYE7F0DT(/5BIA5V-;M06R3Z;ZGY$PI%K
M#)83"U-.>!<N@*7).T(F7X<61&RJ_I$I9!TQQ&!(B*`4:KK7>(GWMB=1_I]D
M<2KYD5FLYF1K/N.A(("".0#!A4FTF\E%PL^FRA\18<@U!C.YCL)I)FWM3U+Q
M7DMB4HUOKWW4;D<Y2+)RY5$FRZ@+85_,0MS(+>H#;-H(K-<$G53$8.1$E)!"
M++0/M/-4&.X.,;ZH&2BTVPQBV@PT1HL"H[RT^77O6KW$Y;6H$W#L!+:6T?>N
M7&.0EUB;W8=:]J[9I25UVBJSVSH`1W5WZ-$.H#%(C].-4CAF8;WJNO06=0`^
M[0`Q4=)<8W09B<PH@PX;^M#IY&NS+)?8HA[`IST@ICU`8W#BM<A,?6MBZ`/M
M<?9>SY1'63NA\VJKT.YY*28%GFO,G&[,0MRX+6H&?-H,IMO`UGJ>3@O-M@O.
M3:]PB2UJ!7S:"F+C&`5-8W0EA0G1XX+8K4[A$EO4"#@V`F=GDDK*-09W9IQ.
M>*$+-">ID4.7UJ(&P*<-(";SYAJ#\8KBD.S<PK5GW`B>0TQ>H-R^`12:-`#C
M&!.I,?8&2$Q4<'?.8UR"BSJ!F)X)Z'$RUQB;(,EY,0MQZ;W1$=8@*O-"(J8=
M(3'2J>.(&)OF-(ZS&)<H.%J0:(EV$TT/P+E`C-ZQ:SBYDQHM7`0<W$-3+"ZY
M1?U!3/M#0ON#QB"Y.\9$2J^/"A>2)EEH4N"R6]0D!!X!(#/78RE].\LU!MGQ
M+#9AT?L#?>BW`<OL\EK4'<2T.UCG(EUSMOHGG%DJJXG9@'@=61Y<:J0_W/:B
M!-?ADZHC6S/7&+SU>^O(X`#>.C+@C3G>++=U?ZB+^G0:O*I[EK?A'$ZSUZ=X
M4Y^S3<[EM39Y7L`-OGH>7`UP@7XI#_77LC\TY\$[U7MP&:ZD(O1X!8]?QNZB
M+GP?NQ&NSM6_1_BII(8;ZW`%X'W7C:]?Y"7_]<>7A_\!``#__P,`4$L#!!0`
M!@`(````(0#[8J5ME`8``*<;```3````>&PO=&AE;64O=&AE;64Q+GAM;.Q9
M3V_;-A2_#]AW('1O;2>V&P=UBMBQFZU-&\1NAQYIF9984Z)`TDE]&]KC@`'#
MNF&7`;OM,&PKT`*[=)\F6X>M`_H5]DA*LAC+2](&&];5AT0B?WS_W^,C=?7:
M@XBA0R(DY7';JUVN>HC$/A_3.&A[=X;]2QL>D@K'8\QX3-K>G$COVM;[[UW%
MFRHD$4&P/I:;N.V%2B6;E8KT81C+RSPA,<Q-N(BP@E<15,8"'P'=B%76JM5F
M)<(T]E",(R![>S*A/D%#3=+;RHCW&+S&2NH!GXF!)DV<%08[GM8T0LYEEPET
MB%G;`SYC?C0D#Y2'&)8*)MI>U?R\RM;5"MY,%S&U8FUA7=_\TG7I@O%TS?`4
MP2AG6NO76U=V<OH&P-0RKM?K=7NUG)X!8-\'3:TL19KU_D:MD]$L@.SC,NUN
MM5&MN_@"_?4EF5N=3J?12F6Q1`W(/M:7\!O59GU[S<$;D,4WEO#USG:WVW3P
M!F3QS25\_TJK67?Q!A0R&D^7T-JA_7Y*/8=,.-LMA6\`?*.:PA<HB(8\NC2+
M"8_5JEB+\'TN^@#00(85C9&:)V2"?8CB+HY&@F+-`&\27)BQ0[Y<&M*\D/0%
M353;^S#!D!$+>J^>?__J^5/TZOF3XX?/CA_^=/SHT?'#'RTM9^$NCH/BPI??
M?O;GUQ^C/YY^\_+Q%^5X6<3_^L,GO_S\>3D0,F@AT8LOG_SV[,F+KS[]_;O'
M)?!M@4=%^)!&1*);Y`@=\`AT,X9Q)2<C<;X5PQ!39P4.@78)Z9X*'>"M.69E
MN`YQC7=70/$H`UZ?W7=D'81BIF@)YQMAY`#W.&<=+DH-<$/S*EAX.(N#<N9B
M5L0=8'Q8QKN+8\>UO5D"53,+2L?VW9`X8NXS'"L<D)@HI.?XE)`2[>Y1ZMAU
MC_J"2SY1Z!Y%'4Q+33*D(R>0%HMV:01^F9?I#*YV;+-W%W4X*]-ZAQRZ2$@(
MS$J$'Q+FF/$ZGBD<E9$<XH@5#7X3J[!,R,%<^$5<3RKP=$`81[TQD;)LS6T!
M^A:<?@-#O2IU^QZ;1RY2*#HMHWD3<UY$[O!I-\114H8=T#@L8C^04PA1C/:Y
M*H/O<3=#]#OX`<<KW7V7$L?=IQ>".S1P1%H$B)Z9B1)?7B?<B=_!G$TP,54&
M2KI3J2,:_UW99A3JMN7PKFRWO6W8Q,J29_=$L5Z%^P^6Z!T\B_<)9,7R%O6N
M0K^KT-Y;7Z%7Y?+%U^5%*88JK1L2VVN;SCM:V7A/*&,#-6?DIC2]MX0-:-R'
M0;W.'#I)?A!+0GC4F0P,'%P@L%F#!%<?414.0IQ`WU[S-)%`IJ0#B1(NX;QH
MADMI:SST_LJ>-AOZ'&(KA\1JCX_M\+H>SHX;.1DC56#.M!FC=4W@K,S6KZ1$
M0;?785;30IV96\V(9HJBPRU769O8G,O!Y+EJ,)A;$SH;!/T06+D)QW[-&LX[
MF)&QMKOU4>86XX6+=)$,\9BD/M)Z+_NH9IR4Q<J2(EH/&PSZ['B*U0K<6IKL
M&W`[BY.*[.HKV&7>>Q,O91&\\!)0.YF.+"XF)XO14=MK-=8:'O)QTO8F<%2&
MQR@!KTO=3&(6P'V3KX0-^U.3V63YPINM3#$W"6IP^V'MOJ2P4P<2(=4.EJ$-
M#3.5A@"+-2<K_UH#S'I1"I14H[-)L;X!P?"O20%V=%U+)A/BJZ*S"R/:=O8U
M+:5\IH@8A.,C-&(S<8#!_3I409\QE7#C82J"?H'K.6UM,^46YS3IBI=B!F?'
M,4M"G)9;G:)9)ENX*4BY#.:M(![H5BJ[4>[\JIB4OR!5BF'\/U-%[R=P!;$^
MUA[PX7988*0SI>UQH4(.52@)J=\7T#B8V@'1`E>\,`U!!7?4YK\@A_J_S3E+
MPZ0UG"35`0V0H+`?J5`0L@]ER43?*<1JZ=YE2;*4D(FH@K@RL6*/R"%A0UT#
MFWIO]U`(H6ZJ25H&#.YD_+GO:0:-`MWD%//-J63YWFMSX)_N?&PR@U)N'38-
M36;_7,2\/5CLJG:]69[MO45%],2BS:IG60',"EM!*TW[UQ3AG%NMK5A+&J\U
M,N'`B\L:PV#>$"5PD83T']C_J/"9_>"A-]0A/X#:BN#[A28&80-1?<DV'D@7
M2#LX@L;)#MI@TJ2L:=/625LMVZPON-/-^9XPMI;L+/X^I['SYLQEY^3B11H[
MM;!C:SNVTM3@V9,I"D.3["!C'&.^E!4_9O'1?7#T#GPVF#$E33#!IRJ!H8<>
MF#R`Y+<<S=*MOP```/__`P!02P,$%``&``@````A`(56\=<1`P``S0@``!D`
M``!X;"]W;W)K<VAE971S+W-H965T-3`N>&ULE%9=;YLP%'V?M/]@^;U\AGR@
MD*I0=9NT2=.TCV<'3+`*&-E.T_[[7=L)`=)E[4L2?,\]/O?XXIOU[7-3HR<J
M).-M@GW'PXBV.2]8NTOPKY\/-TN,I")M06K>T@2_4(EO-Q\_K`]</,J*4H6`
MH94)KI3J8M>5>44;(AW>T18B)1<-4?`H=J[L!"6%26IJ-_"\N=L0UF++$(NW
M</"R9#F]Y_F^H:VR)(+61(%^6;%.GMB:_"UT#1&/^^XFYTT'%%M6,_5B2#%J
M\OC+KN6";&NH^]F?D?S$;1XNZ!N6"RYYJ1R@<ZW0RYI7[LH%ILVZ8%"!MAT)
M6B;XSH^S%78W:^//;T8/<O`;R8H?/@E6?&4M!;/AF/0!;#E_U-`OA5Z"9/<B
M^\$<P'>!"EJ2?:U^\,-GRG:5@M..H"!=5UR\W%.9@Z%`XP219LIY#0+@$S5,
M=P880I[-]X$5JDIP.'>BA1?Z`$=;*M4#TY08Y7NI>//'@OPCE24)CB0AJ#_&
M8>EZLFN%F+KNB2*;M>`'!+T"6\F.Z,[S8R#4!<W^61!4HG/N=)))!;2$0WC:
M+(/9VGT"Y_(C)K68!48])A@CLDM$>(:XH*\7">5-189P=J^[?A*ID\8B0W^L
M(+60A7%7%Y8-%D8"P)FA@.L;:W""X8WO*Y^MSH49!U.+@<\>LQAKRZXA1MIF
M[]&FP0F&,OM]HR@:[YQ:S-R<ZV(U#6>CL._-^^R1*NBAMSNFP5-59U[KF,5$
M1I4?+'VOW]?$LV%\&<W"/CR2-7^/+`V>RIH<4VHQH9$5A)-H-HSZT;FDD29X
M1X96Z5?P_]VMDZ;:EGW-UC*+L98%ON=-FC`;QOUHZ9T;8:1/SZ[!%7&]^35X
MJFLUT64Q5M?-:\)&@"O*5N]1IL$39?.)(ZG%#%_+^;3/KD*L;W9\V&NVH6)'
M,UK7$N5\KT=#`+W2K]JIE?HQW$4P+B;K&4PSL^[V`9@F'=G1;T3L6"M134N@
M])P%M+^P\\@^*-Z9RV_+%<P1\[."OPT4;CG/`7#)N3H]Z(G7_Q'9_`4``/__
M`P!02P,$%``&``@````A`%/6T_1H!```_A,``!D```!X;"]W;W)K<VAE971S
M+W-H965T-#DN>&ULE)C;CJ,X$(;O5]IW0-Q/B"%G)1E-L'IWI!UIM=K#-0$G
M00TXPJ33_?9;I@B#S4Q!;M(A?!3_7U6X:&\_O^>9\R9*E<IBY[+)U'5$$<LD
M+<X[]Y^_7SZM7$=549%$F2S$SOT0ROV\__67[5V6K^HB1.5`A$+MW$M573>>
MI^*+R",UD5=1P)F3+/.H@L/R[*EK*:*DOBC//'\Z77AYE!8N1MB48V+(TRF-
M!9?Q+1=%A4%*D445Z%>7]*H>T?)X3+@\*E]OUT^QS*\0XIAF:?51!W6=/-Y\
M/1>RC(X9^'YGLRA^Q*X/>N'S-"ZEDJ=J`N$\%-KWO/;6'D3:;Y,4'.BT.Z4X
M[=PO;,-]W_7VVSI!_Z;BKCK?'761]]_*-/DC+01D&^JD*W"4\E6C7Q/]$USL
M]:Y^J2OP9^DDXA3=LNHO>?]=I.=+!>6>@R-M;)-\<*%BR"B$F?AS'2F6&0B`
M3R=/=6M`1J+W^N\]3:K+S@T6D_ER&C#`G:-0U4NJ0[I.?%.5S/]#B#6A,(C?
M!)F!^N8\_$1?[*&0VA>/JFB_+>7=@6:!6ZEKI%N/;2#@PQ#>OK7X,X=@30?Y
MHJ/4L4"\@K*\[5<LV'IOD,JX80[(+%VG99A)A`]"YTV'Y9T?/-#;B@:[MN@`
M:OGC*CPTZHM,C8$EX-!'?$MBGP@LA/>1Y:*-8M@(3!NT?`WO7%A(VO2MV*R-
M6^?K@`Q\MLS2),)!@E.$H1ZZI5L$6KV&=RZDIE6V8G-3VP$9QA9U`TW-LR%Y
MEO_LK*$8'K'QBC5L*EXRJ]0'9*A\#Q*<(@SUBV?4:WBH6Y"AU`\2G"(,]?#<
MC\^]ALW<K]CW9PA['9FV6V"]M1IF".`$8$C7P[NS1-*-KF%3^K+WF")#)7Z0
MX!1AJ%\_HU[#0VV##*5^D.`48:AGL*R/3WY-F]GO-TX#?>^<P.Z<08)3A*E?
MC[#1S<-PX)G+I+6$'QJ(*L`PPDG$M*`'VG@+./Z@/3LK_<I\-`\,(=+"(,+)
M**8%N-,3%C1M=]':MH#0O)Y5LU4PL^<50P`^VT18E>0D8AK0\ZU3`_V:-OS&
MPW`J0B9;"2O?TGEH($)G.(QP$C&MZ('7L4(OI_KENK<B]=J)FJ'UM`B;.(1+
M3B*F!3WUQEO`&6E4@?7:"2%L)]]?!E:90G@KTHD@#5"(:4"/OHZ!D>V$`],P
MXMNOT`PA0F<XC'`2,:WH0=BQ,M!..#8'5B>$2`N#"&<48EK0T[!C860U<(::
MU;!?4!E",URE9FO?>HL*&X#PRDG$,.);PWJ<D?HJ:[GU[7\>&XC0&0XCG$1,
M*T_-;1_G-MU6#41:P#@$PLDHI@5HC>?;"G9/>L//M]NJ@9JV6@=3:SD+&X`T
M@C?Z,8)&<!L&MRMR49Y%*+),.;&\Z2T6!DW=_HK;/P?8_JGW2KSV!.R^7*.S
M^!:5Y[103B9.<.ETLH214>+^#1Y4\EIO#AQE!?LN]=<+[+,)V(:83@`^25D]
M#O0.4;MSM_\?``#__P,`4$L#!!0`!@`(````(0`:^SW</P,``-`)```9````
M>&PO=V]R:W-H965T<R]S:&5E=#0X+GAM;)1676^;,!1]G[3_@/R>`($$B$*J
M)JC;I$V:IGT\.V""5<#(=IKVW^\:)P0[6]J^)(%S[N'<#W.SNGMN:N>)<$%9
MFR)_ZB&'M#DK:+M/T:^?#Y,8.4+BML`U:TF*7HA`=^N/'U9'QA]%18AT0*$5
M*:JD[):N*_**-%A,64=:0$K&&RSADN]=T7&"BSZHJ=V9YRW<!M,6:84E?XL&
M*TN:DXSEAX:T4HMP4F,)_D5%.W%6:_*WR#68/QZZ2<Z:#B1VM*;RI1=%3I,O
MO^Q;QO&NAKR?_1#G9^W^XDJ^H3EG@I5R"G*N-GJ=<^(F+BBM5P6%#%39'4[*
M%-W[RRQ![GK5U^<W)4<Q^NV(BAT_<5I\I2V!8D.;5`-VC#TJZI="W8)@]RKZ
MH6_`=^X4I,2'6OY@Q\^$[BL)W9Y#0BJO9?&2$9%#04%F.ILKI9S58``^G8:J
MR8""X.?^^T@+6:4H6$SGD1?X0'=V1,@'JB21DQ^$9,T?3?)/4EID=A()P?T)
MAUNW@UUMI,\KPQ*O5YP='9@5>)3HL)H\?PF"YX3TXX<4_Y<AI*9$[I5*KP7F
M!73E:1W[_LI]@E+F)\Y&<R+D#!R+L3TS5-V4;#:ZX8+?P32D:YL.H)?_[L+9
MHPHR/0:6@<TU968FL;UF!!8ENZ9$BT'%2",PT[AM7Y%3!.^1H7QA%`^Z?;TV
MF@.?`R<R&=M7&=DMAN$>IN7]35!!*8(2#0[#V.Z"YBSZ,0H].P,#32PT&Z.3
MY%(?PSD<M;'SVW579-MQ8%9UHSE![W@27+K==V5KH+/$C,T,U+\,D^%X\1['
MBFP[GIM/W6B.=CP+;<=C=![8C@TTNB@;CN&<CVNLWBNO'U$59#NWO&TT1SL/
MXM#,:SM&)Y'M?(S&%]`PKC;UZ(5X>S@4V30<CUJH#Z7FG(8CMD9G.T;]T#/3
MR<;H)/`OTVY83MYC69$MRW:)-44?P,2_'"(]SF/4]Q86#-M7Z>O@66`[UIM5
M;Z"&\#W9DKH63LX.:FOZ<(*&NWJA;V"A]^O/'0!8J!W>DV^8[VDKG)J4$.I-
M(SA)7*]D?2%9U[_O=TS"*NU_5O#/B<!F\:9`+AF3YPNU](?_8NN_````__\#
M`%!+`P04``8`"````"$`AA.AJ%,-``"@5@``&0```'AL+W=O<FMS:&5E=',O
M<VAE970T-RYX;6R<G%UOVSH2AN\7V/]@^/XX^K(^@B0'M8ON'F`/L%CLQ[7K
M*(G1V`ILMVG__9*<D<P93JB1>Y$VU2OZ]9`O'THV=??[S_WK[$=[/.VZP_T\
M723S67O8=H^[P_/]_#___O);/9^=SIO#X^:U.[3W\U_M:?[[PU__<O?>';^=
M7MKV/#,M'$[W\Y?S^>WVYN:T?6GWF].B>VL/YLA3=]QOSN;7X_/-Z>W8;A[=
M2?O7FRQ)RIO]9G>80PNW1TT;W=/3;MM^[K;?]^WA#(T<V]?-V?@_O>S>3GUK
M^ZVFN?WF^.W[VV_;;O]FFOBZ>]V=?[E&Y[/]]O:/YT-WW'Q]->_[9UILMGW;
M[I>@^?UN>^Q.W=-Y89J[`:/A>VYNFAO3TL/=X\Z\`UOVV;%]NI]_2F_7:9[,
M;Q[N7(7^NVO?3]Z_9Z>7[OUOQ]WC/W:'UI3;=)3M@J]=]\U*_WBT_V5.O@G.
M_N*ZX)_'V6/[M/G^>OY7]_[W=O?\<C;]O31OR;ZSV\=?G]O3UI34-+/(EK:E
M;?=J#)B?L_W.C@U3DLU/]_?[[O'\<C_/R\6R2O+4R&=?V]/YR\XV.9]MOY_.
MW?Y_($JQ*6@DPT;,W]A(5BR*;%G54UK)L17S-[:2F@;C%F[@[;CJ?-Z<-P]W
MQ^Y]9L:<,7QZV]@1G-Z:!ONRP)L8"O51G4R!;".?;"OW\VH^,R4XF=[]\5"5
MY=W-#],A6]2L0&-^#IJ4*M:]PO:CL3=X-._.]RAW66_%BJT5VX76VPK^PW_=
MC+UNJ,@O$N+$5$COQ(KOYV8&&=[PLEG2EUZ!QOP<-!55K&,*XJV8XLV*[^?F
MC5]>MV2OO`)-X[HS7U0Y,^8?+A;)Y3!Q9<+A5\R.+Q/S#V+7]Z$]B;HK2EXY
MT"R=NS0KBSKW++B>7X-$+BXQ65*3\0%FQ=1<5=:T-BO07,Q5H3F0*,R95$VO
MH#V)FBPR%K<5:(B#XC+NH82"9GBKI(06E-X\$B^A%5-W5=D,[4)L04/<4<4Z
MIB#>FBG>K'@LM:")>8LIB+?4A,$OG"X@[BQ:P3`A*,)1F"SS(DL*5D/4R&^%
M&K6SL[J'4YC+Z03#4X*BN$%H2&/03N-Z@S#I$X-50JNSLEPU@T%^<0A(5$(+
M:)J9X,^JQ\9A"J*HOYB$^F,`48[$D"3"2`01='26ID72L+BO4Y#(;X7Z9$B)
M3S5VC1?,-<%`]&%B_.6"/S5,4D8391T%K%1\QG9-CXQ'-5=2!I:1.@()S)P[
MK!C"U8QK<L2?FBBIG=_U>08:D#P'*QK7Y/V\=(L&%O8U'M2,0`8490\#$WR'
M0E)`U$^):9($-M5HR1A:XAWLU!0IX;H&1;T]XX[;0X6BBAD#BJZ*[BQJ,US9
MH(B8J/C21A(-\S^9<3*+`6\D*IT"//S^KO@B>N6:CB<F*J$^S1OV?8YTN%6/
M$28#$:GD4"0@8%1"_3'"C/@+R5(%B<Y`!!<IR:(,.EF-%7L9[Q=/V<DA7L)0
MNZ;OYY":O*F786K4=,D8749J*%`EN%AQ3<;MJ:&2,:@HJPA0\*,BA%H@1\77
ML^[U/\H3'8P,+TJG`F8J?FF:@2@:FIB$^F2P&>EPH(-I/8+I+(80#'5,0OS9
MJWD_-W%_3DVG[S#4*()0FYNRO)/QN%Q?:NXJQN3AQ4L8:A1AJ`42HD#CDO%E
MI(0"5X),YR"*N`.!QIW1^!VL"TINSZ(='48:1<1$Q>X;KB71@"#:VY/XD@M\
MJ?@],!01A\.+0U2B$NJ/(6:DGX$)\2CG,7"@OYB$^IO$EEQB2U`_$/51#I*L
M!DM^%5C<66P4!G<24019*:HBS_@J`A7R**`EM/.ZMU0<Z6*@@(GB,%N':^X<
M1#%[H-#88S!19AE@X-L4LBP0HV(7VNM<$`UQ(H4L)F'%J6D_5Q6[Q;!"D5PF
MR$I40OTQLL0[N@"BF'X:.CJ\>D91U!^T(TNH/SN_JP=B`33P>SC$,HKZ++-5
MSQH/:[P9C>]--PH+>Q;MXY#**(*PU.9SM6"%B`J-S4DX*02<!%A&4<P>-*.Q
MQVBBK"+0P._I,,N%@(R:7^E+H@^R/(DKA<"5FM\)0Y%<)LRRFBT%8\M(EN$Z
M9"3+PL7*4!ST%Y/0+-OY79]EH('?PT*60=1GF:^Y"C@LEY=ZNXHHA4"4@,LH
M@K"DYH-V_@G6&A4*F\M).'%J.M6$7$91Q!XJ-/8837197@(-_)X.LXPB8J+F
M"QQ)-`Q7TM]+\VKZL>C4K)#UY9-B%X05BHC#X<4A*U$)]6>:F>#/JL?N@2U!
M%/47DU!_DZ"RE*#"U]@HZK/,UUQX6+9/O5U%E*5`E"#+*(*P5%E5)&Q&7Z-"
M8W,23I8"3@(NHRAF3TV3):.),LM`@Y$L"\BH^365>WW5+;#E)*XX-<\R6P2N
M4"3W(F99S98E8TN<RTX]FN78!0CZBTE(7LI)4'%J5K_@?C:*^BRS2Y@U'I;+
M2[U=1912($J0911!6(H\#;YW@P*-RTDT*:V:5Y!-=RL41=Q!*QIW1N.S1)?D
MTIY%78941A$Q4?-5F"0:P$A[FU%%Z52@2\WI4H*(.!U,0&*B$NJ3$2:>Z!+(
M8N:+R%4SBJ+^H!U90OU-0DLIH26H'X@@T=FB8<?7V(C&W%5@*06PA)$&$83&
M?#4Y^(`*6]&XG`25$F#@8R]<::,HXDZ-E)(A11D40(+O4HBTP(V:S4YK]_HJ
M.%<,+CJG[BPZ^50UH\@*17)G0J2C$A*9BH$F'FFG'H,TBJ+^`%2RA/JST[WZ
MXKD"./@]'5X\HP@BG2_8&FB-AS7>C,;WINQC>Q;MX_!&6`4BR$QC$\WOWZ!"
M8Y/19:2+!:H$"^X*1#%[,>[0'F904581H.#W=)CI2B!'$Q12$`V$I$X97I1.
M!<PT[/)I58%([DW,=$Q"?3+2C'0XP"..Z0I$47\Q"?4WB3&5Q!B&X16*^DP'
MWQ;"X[)_:NXJQ%0"8@),HPA2DYJOD01#46"0/!1KAI=X%SLUG7)"3*/H8W<H
M4-2P9E#1!<6=15V&D481,='P^V&2Z(,Z,KPHG0J8:?A]L1I$Q.E@`B(=E9!1
M69MF?-2,]+=5CV':-?G16@;]03OR6Z#^)C&FEAC#(XVB/M)\*8:'-=ZN`DPM
M`"9(-(HP,V6RY(E&@<8E@\M(#PM0"2A=@RCB3HV4FB%%F1-`0AS2KFDV#AM^
M5TP2#6&B(Y'!1>E4@$RPVZL&D=R9F)B8A/IDG!GI;R"#:3UR+5W'\('^8A+B
MKYE$&*>F<W>X\$81?'^;]S`>E(M+G5U%EP8N.<A8#/*,(DB,V=D9$!H%&I=V
M^E=?N#0`"]]=2&@41=Q!*QIW1N.[TZ6DL6?17@X)C2)BHN'WQB21G.=F$EF<
MFCJL^#V;%8J(P^'%(2=1"1V-C"[Q'#=`E7B.413U!^W($NIO$E<:B2N<S"@"
M,A<+OOK"PQIO5U&E$:@2)AE$D)5E4@I7T-B.QJ>=U?59!@:,9!E$47\@T?AC
M+%&F&5C@^Q32+`"CX6NQ1A`-@2*CT>R(F5)*D/,\\QMBO4JN%`0ZKF$>&6#B
MD4X3((OIK0B;>U7<([0D:YA'.]6KAV2:`!G\O@[YW*L`T/R^6']4Y<Z(?'>Z
M`6D^BC*GT=X.;XWU*HA.GJ5-P[^3L.XU*J^3`),FTK4+"\2J5\4]0DLJCPPR
MVGH")?Q>#Q.>)B%+ZF#A(ZDN7&!CDR%'ZS9D3\V_9V`J"RJY:GW68QKFE2%H
M+.N`E;&L@RKN,:9A'BT()F0=N.'W>ITP2)LZ@JJ'>,Z&L(D0".0WP0PR_HP5
M,01/S3^%-@9!U1LL+,$O?_CE0R_7V+URT[YNUS[9ME^D51;NE9ZR:W\:BI3[
M]@$S,#E]8%%/(K>%WAN=RK3CSGM_E`ISD[`_OPXV%*6"ZJ.YR>VYO\*M&5>,
M3'7""+DR.\^=2AZ#.#=%-316;E.]YW4D5K@'W\0VM@Z)[M3O/>K)Y#;H3_`8
M$DE8A^"N?XA^N0BF)CPNUYG5\#H6X59],CJ#:XP454CYTMPO&%:]?27U))JX
MH1\WZ_L.PSL&*:IB#O4<XEOZM4D/>20E/<1-G?#;!NF$7?XI@Y+6K02GRVSB
M^M4D'53R".S[/J:AHW3:7O\4=^F/)#VZEQ\]1C7,XS04"3O]A:2C"I)>+\Q:
MWO_#/E)9I_I-_^;KYG31I.Q^W*[OQTJX!$$5QLJN2GCP]=O^4[<#7S^%XH9]
MWZ$0?%3%',9@Q;J>72)I:QE>*@G!QV<`^%&JDV#*%U274#*WUUTLX39_OZYU
M$MQJ0)7O]N*C#U5X0771,*\,3R.(Q[W^8\&/0:?W&-,PCY80$\8G`,6OHQ1\
M4,&MABR,CYY*;KN^9T\[.`4JA83'9P%`C-*D"C\12*./"V"59$@:Z^T015+2
M016UJ"<1?QZ`LIK"@P&$J`L[_^LTZ'M!Q>,#SPF%)V'NV^-SNVY?7T^S;??=
M/@,T-0\(&OYW>$#II\P]870X8!X/^K9Y;O_<')]WA]/LM7TRIR8+^YVA(SQ@
M%'XY=V_N.9M?N[-Y,*C[YXMY$FQK'DZ9+(SXJ>O._2_VT9?#LV4?_@\``/__
M`P!02P,$%``&``@````A`([;24W#!0``<1P``!D```!X;"]W;W)K<VAE971S
M+W-H965T-#8N>&ULG%E=;^HX$'U?:?]#E/=+2$)(0:57EUC=O=)>:;7:C^<T
M&(A*"$K2C_OO=YPQQ&/H&/I""W,\.<<S]C'X_NM[M?->9=.6]7[AAZ.Q[\E]
M4:_*_6;A__/WXY<[WVN[?+_*=_5>+OR?LO6_/OSZR_U;W3RW6RD[#S+LVX6_
M[;K#/`C:8BNKO!W5![F'R+INJKR#M\TF:`^-S%?]H&H71./Q-*CR<N]CAGES
M38YZO2X+*>KBI9+[#I,T<I=WP+_=EH?VF*TJKDE7Y<WSR^%+45<'2/%4[LKN
M9Y_4]ZIB_GVSKYO\:0>ZW\-)7AQS]V_.TE=ET=1MO>Y&D"Y`HN>:9\$L@$P/
M]ZL2%*AI]QJY7OC?PKF(8S]XN.\GZ-]2OK7&_UZ[K=]^:\K5'^5>PFQ#G50%
MGNKZ64&_K]1',#@X&_W85^#/QEO)=?ZRZ_ZJWWZ7Y6;;0;D34*2$S5<_A6P+
MF%%(,XH2E:FH=T``7KVJ5*T!,Y*_]W_?RE6W7?CQ=)2DXS@$N/<DV^ZQ5"E]
MKWAIN[KZ#T&A3H5)(IUD`NQU'#[B!P=(I-<E\BY_N&_J-P^:!1[5'G+5>N$<
M$AX%X>-/$C]2"-)4DF\J2Y\+R+=0EM>'-(GO@U>8RD)CEHA)?>^$"2DB.R+4
MO*FTPO@@`+XGTB#7)AU#+2]7X<A1#:(<8XO`\AP2613/$;$%$>>0='K*0F3$
M5`9/7X$7/B0_35^:V/P1`Z\#YO3D?D8S)T)P",(>NL4NPN3#I7`L@AJT\&$[
M'!@F$\IQB1A.A1,A.`11`8Q-%7P-%-BN06*Q1\RT7P11>D>CF1E-8FN)"#,:
M14-U">/I+8P5F#).9O9\(X:;;R="<`C"'M:_.=]JOW%WC1KDZAK$<"J<",$A
MB`KEY\:NR7>-`M,:I(G=-8B)^ZX)A\+CHC6#T;"7X!YI!I,A2.C.;J&KP#;=
M(6__T"5B-%VKQ8\Q8XE3A.`0A'<(F[HYSZI;W!M]/\I6D%(.2PTB_9+8J_42
MB.81+(2*46YV==.$Z'WF?I_,SD0@B(B@_#*=AX$(%D(E*&\S)%RW>D-T1&A4
M9M/7((9GYH8(%D*EP)-,*?P2#A7:;BE[#6M0TB_B))E:!X.,Q*-H,J:E$B0^
MF29#G#)7WF84P<$<G=#LH]38)G`YAPA"YM%D8O59IN-,<00+H?R5RQG\KUS4
MZ(U4A\5SJ8[B4";",YG1:<XN@2A$L!`J1AF?)<;M9R':)1$S'<JMB\)Y:@_)
M=!ZBUY;"9:%2E/O=+@4]T[&X.6/54IP0$7(0*D69HB'%L4300DDUS@PZ1-`'
M#DVB9Q9-HN'0CY2S<D6#\Y5[*WHIX3ZUS@_+D#-</?U.B&"S$"G1!=MV+XI^
ME.N4IT%,QV=NB&`A5,I-IAV=F_;Y44^#<+,-P]2V"1W'3DOMPZ"PAD^'[Q"4
M.+3$[>T4J5&6S]D^MM0@M@:8AX$(-@N5`FD^(46-<K83@AB>6>2$"!9"I=SD
MW=$E[[9/'1J$[1*-K;6?T;"]K0D:-D93VA<L^XH%?<&RC79%EU._>]F632TL
M<T,$"Z%2/F78$;HH[W(:Q#83Y\;]A`@V"Y6B_-!P#-[E(G1/XA1V.RPUR)1@
MGTNR*S#BA%$_!<;#,8WRMUSZ.L>++KCUU/Y)0X-,'0,)=#PW1+`0*N53YAVA
MZ3JZRNG,F<[#J!4LA$A1WZ^O[ZH>;1G&65=I$#K>))Y9)]V,Q,,D&DY(N"1(
M/)[<#:6DS"VOOJZ?X@N>/;4W60UB9CAS0P0+H5(^Y=XQNB[?3QK$2G&[-YN%
M2H$GW=!/"NWL)P3A;ZSIT`VXL.'^1Z7XX!=8=3UDA(=61-)X\X,W))5L-C*3
MNUWK%?6+NM4)X:O]Z5.\<5K"C5-_/1.<`G#A<\@W\D?>;,I]Z^WD&H:.1RDX
M78-71OBFJP_]?<13W<%53__O%J[V)-Q\C$<`7M=U=WRC+J5.EX4/_P,``/__
M`P!02P,$%``&``@````A`$D<OT<E!```"A```!@```!X;"]W;W)K<VAE971S
M+W-H965T,2YX;6R4EUN/JS84A=\K]3\@OY^`R3T*.1J"ICU2*U5MS^FS`TZ"
M!C#%SF3FWW<;<[.=,LQ+$N#+\EK;-[S_^I9GSBNM>,J*`.&9AQQ:Q"Q)BTN`
MOO_]_&6#'"Y(D9",%31`[Y2CKX>??]K?6?7"KY0*!Q0*'J"K$.7.=7E\I3GA
M,U;2`IZ<6943`9?5Q>5E14E2_RG/7-_S5FY.T@(IA5TU18.=SVE,(Q;?<EH(
M)5+1C`CPSZ]IR5NU/)XBEY/JY59^B5E>@L0IS5+Q7HLB)X]WWRX%J\@I@]QO
M>$'B5KN^L.3S-*X89V<Q`SE7&;4S;]VM"TJ'?9)"`EEVIZ+G`#WA7817R#WL
MZP+]2.F=#WX[_,KNOU1I\EM:4*@V]),@I[]H1F-!$^@YY,@>.3'V(O_Z#6YY
MT`BO`=D(_[=MYLF7K;A=,\/?;9//=;?]43D)/9-;)OYD]U]I>KD*:&D)99#5
MV"7O$>4Q=`.T-?.74C5F&4C`IY.G<CQ!&<F;<I<FXAJ@^6JV7'MS#+ASHEP\
MIU(2.?&-"Y;_HR#<2"D1OQ&![[MZ[F\^+3)O1."[$<'^S-\L\7+U"2N+1@6^
M>Y6)>5Q5F[KL$1'DL*_8W8%!#^EY2>04PCL0;FNL*M)5_?^*#M66(D]2)4!K
M&!8!XM#SKP=O[[Y"W\8-$2H"/CL"Z\2Q)61'2M%H<,,%MYUEZ(JAY<?#H74F
M8>FL50W5C:$1WS!B$W.=B&QBT1&:5>CPZ58E'"#0[DJT[%3KBH2*@,^.6.G$
MT2;6.A&-$9IW&`W3O4M8][[1VPT5,?2^U8FC39C>QPC-.\SOZ=XEK'O'YNA5
MR*(>V0N\\8WG1_5\&,ZT/D9HUE>?L2YAP[HQK4*%#*UA<\#;B.E^C-#<PQ(P
MO?`2-MP;,RU4B.:^GVKUI#C:B.E^C-#<R]>-P6(XOK)(V'!OSE>%:.[-"6LC
MIOLQ0G.__8Q["1ONC89#A6CNC4E]M!%#)!HC-/<87BJF%[^F#?_&>A(VS#"`
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M[L3L)D].&`9A=[<["CZI,UKW``Y5);G0WTEU20ON9/0,?_5F:ZAQI8YEZD*P
MLCY0G)B`XU3]\PIG;@HO\]X,X#-CHKV0A\#N%'_X#P``__\#`%!+`P04``8`
M"````"$`G`+1G;D#``"O#@``&0```'AL+W=O<FMS:&5E=',O<VAE970S,2YX
M;6R<5U%OXC@0?E_I_D/D]Y(X0+I%A*J]JK<K[4JGT]WNLTD,6$WB*#:E_?<[
M]H"3F&[Q]061\,W,-]_8'_;R]J6NHF?>*2&;G-!)0B+>%+(4S38G__W[>/69
M1$JSIF25;'A.7KDBMZL_/BT/LGM2.\YU!!D:E9.=UNTBCE6QXS53$]GR!G[9
MR*YF&AZ[;:S:CK/2!M55G"9)%M=,-`0S++J0''*S$05_D,6^YHW&)!VOF`;^
M:B=:=<I6%R'I:M8][=NK0M8MI%B+2NA7FY1$=;'XNFUDQ]85]/U"9ZPXY;8/
M9^EK4712R8V>0+H8B9[W?!/?Q)!IM2P%=&!DCSJ^R<D=7=RG4Q*OEE:@'X(?
MU.![I';R\%<GRF^BX:`VS,E,8"WEDX%^+<TK"([/HA_M!/[NHI)OV+[2_\C#
M%RZV.PWCGD-'IK%%^?K`50&*0II).C>9"ED!`?B,:F&6!BC"7G*20F%1ZEU.
MIMED?IU,*<"C-5?Z49B4)"KV2LOZ)X*H)86Y++4'IMEJV<E#!/,&M&J963UT
M`8D-IRETAAD<R]^1!'8FR9W)DI-K$D&X`F6?5]GT9AD_@QK%$7./&/AT&.H0
M,;!QE(#&D-+;\IPJ&["I;.0R5.[QQ;!,^G:9Z;C,J?/WRYD@.P'71#9+7'YD
M@!CX=)AKAQ@U.OL(`Q.4$_`$ESV;]4(B`\0$,(!U$RZU`?N]]]IB9<10FME%
MD$QZ9J/.LW'=,.U-D%]_ZI3%^H@)Z!S6ZK#S,`8FZ)+VB`E@8&Q]L//>7W<&
M[/?N:X^8@?9S)\Y(_)MQX;#639!/8.;RH_B("6B=@L,,>P^C8*,NR7\$A9`P
MAA0\`(KV!>XRV'?^!(Z@?@33?GV.1D`]CPL4`+UMS*$?,@[!I@83'Q#]C?U0
MP`P%""1AHBY.`4$A)#P3?'\;4'2VL0)G4T!0/X4D<PMU/`7/_@(%>,L'^PK'
M*2`H1(`/>2$8;,`4@MV0>G9X80KH<1>F@*!^"K1?J>,I_"\CI&\Y8;_`C^HC
M*$3]#YDA1:>#*@,SZ/_JCB2"[3#U[/!]]2W:MV)_#QQ!E]5//1<,VP,VRN?P
MV>TR%.`("IA":HQM8,6!)$S4)2>RJ8/L$([^9R1FL(TO3,-$^4KX1U^;>DPB
MF_?'1MP.>&_`PWG-NRW_DU>5B@JY-W<""@<J]];=5^Y2>[AW/\!UH65;_IUU
M6]&HJ.(;"$TFU]!&AQ<.?-"RM4?_M=1P4;!?=W`QY'"`3B8`WDBI3P_F2N.N
MFJM?````__\#`%!+`P04``8`"````"$`%!(;K.4#```@#P``&0```'AL+W=O
M<FMS:&5E=',O<VAE970R.2YX;6R<EU^/HCH8A^\W.=^!<#]"14"-NEF$V=WD
MG.3DY/RY1JA*!BBA=9SY]ON6%QU;=HN>&Q5Y^-&G;Z'MZO-;55JOM.4%J]<V
MF;BV1>N,Y45]6-O__/W\-+<M+M(Z3TM6T[7]3KG]>?/;I]69M2_\2*FP(*'F
M:_LH1+-T')X=:97R"6MH#6?VK*U2`8?MP>%-2].\NZ@JG:GK!DZ5%K6-"<OV
MG@RVWQ<9C5EVJF@M,*2E92J@_?Q8-/R25F7WQ%5I^W)JGC)6-1"Q*\I"O'>A
MME5ER^^'FK7IK@3O-S)+LTMV=S"(KXJL99SMQ03B'&SHT'GA+!Q(VJSR`@QD
MMULMW:_M+V29$,]V-JNN@_XMZ)G?_+;XD9V_MD7^>U%3Z&VHDZS`CK$7B7[/
MY5]PL3.X^KFKP)^ME=-]>BK%7^S\C1:'HX!R^V`DQ9;Y>TQY!CT*,9.I+Y,R
M5D(#X-.J"CDTH$?2M^[[7.3BN+:]8.*'KD<`MW:4B^="1MI6=N*"5?\A1/HH
M#)GV(?#=AQ!_,IOZX?R1%*]/@?M>4B#0W`0'=;K>B5.1;E8M.ULPY*#!O$GE
M`"9+"+QT"TI<.^I7_00=)$.^R)0N"[J`0W%?-X'KKYQ7*$C6,]'/F$!EMLB$
MMG7-(2H17PA9(7GKY.8/!YRN8M`ENI@'H^;G];YXR(M4CU#7&"*!&ZJ-W`Z9
MJ4K$0\+3D&2(A!_=I:C"@+A5-2M*>&W#:^VCBT-7;5V$#'Q>&=UPE(A'B<1$
M*'ZS1_PDO+:A\ZYM#V::'B(F/22";B0_$>+-/2TC5HAYL'#U\IENHMC!4W=_
M]22LVLVUTD2(F.R0\-%N&BSTH1>K`"&^]A`D"D!FX>*C>Q2WX!$W":MN@3O7
M2H<,-CUT76W@;O&TP3T>)1(3H<C!:^K^PDE8EUMH<LB@G#^4P],FN5$B,1&*
MG%SWW,P+YG>*A#4YHI4F0@;E8.VCG=[B:9/<*)&8"$5N\8B<A'4Y;5:*D#&T
M?HL$ZGLA5%>M?3R:D)@(Q8[`-'=_[3I:]]->9E$/F01[!`T)%%@W',](C(CJ
M**?]F_$IURWCTSO!Q8(R.1!/K4340T97S.D'LWQ4A[:(&%(2XXU46[D6>-P6
M5Q"J[<>+NEL^100A0SNW/7*I+$P'KI82CZ<D1D2UA<;\#UMYE3Z.M7DK@AV&
MA(RVB.#<3]P9&;B.9LB-S*]O@ZZX4<&E>$7;`]W2LN16QDYR$T)@;K[^BQND
MK=P@=5N<ZPG8GS3I@?Z1MH>BYE9)]W"I.PEA=FYQAX,'@C7=HG;'!.Q,NI]'
MV(E26#Z[$X#WC(G+@=Q#7?>VFQ\```#__P,`4$L#!!0`!@`(````(0"QT?0>
M6PL```<U```9````>&PO=V]R:W-H965T<R]S:&5E=#$R+GAM;*R;V7(BN1*&
M[T_$>0>"^S$4FS%A>Z+-OB\&@[FC<=DFVK@<0"_S]I,J*4M2_@R-8^;&X(_,
M7R4IE5JJZOK/7]NWU(]PM]]$[S?IX"*;3H7OZ^AI\_YRDYY-&W^4TZG]8?7^
MM'J+WL.;]%_A/OWG[?__=_TSVGW;OX;A(44*[_N;].OA\%')9/;KUW"[VE]$
M'^$[_?(<[;:K`_V[>\GL/W;AZBEVVKYE<MEL*;-=;=[36J&R.T<C>G[>K,-:
MM/Z^#=\/6F07OJT.=/W[U\W'GM6VZW/DMJO=M^\??ZRC[0=)?-V\;0Y_Q:+I
MU'9=:;^\1[O5US>J]Z^@L%JS=OP/R&\WZUVTCYX/%R27T1>*=;[*7&5(Z?;Z
M:4,U4,V>VH7/-^DO0669"]*9V^NX@1XVX<^]\SVU?XU^-G>;I][F/:36IGY2
M/?`UBKXIT_:30N2<`>]&W`.C7>HI?%Y]?SM,HI^M<//R>J#N+E*-5,4J3W_5
MPOV:6I1D+G)%I;2.WN@"Z&]JNU&A02VR^G63SE'!FZ?#ZTTZ7[HH7F;S`9FG
MOH;[0V.C)-.I]??](=K.M5%<HT0D;T3HTX@$5V<[%XPS?;+S1;E8+)3*E^=?
M`5G&U:!/(U*\N`RR5_E/:)2,!GT:C<)%4,B6/M$0ET:"/I.Z?+8Q:63&5:'/
M1./3[4'-'XO0)XO8RISHR8`",'947Y)62*IPRI,B2'LZH92TWRE'CI[`AD_!
MB8!3KAP[@0V>\ZK)?1W8S@Z<,L^,^X#[6WU)6NO3G97C1E=?N+L^?S649G0/
MJ"__XFJX47.V4?,7A5SQLASGA!/]H49*'`/JB[F"G%,1=,WH=!1GM]KJL+J]
MWD4_4S1E4!7V'RLU`065''42YS4MD62Z?TITE.&4RA<E<Y.FWJ$<MJ?L_.,V
M7RQ>9WY01ET;FSNT"7R+*ENH]*ED:Q+4)6A(T)2@)4%;@HX$70EZ$O0E&$@P
ME&`DP5B"B03W$DPEF$GP(,%<@H4$CQ(L'9"A,$EBA1+.?Q$K2D;%"O?R'0,;
M/#D1&&S!+C4)ZA(T)&A*T)*@+4%'@JX$/0GZ$@PD&$HPDF`LP42">PFF$LPD
M>)!@+L%"@D<)E@[P`H,F%`B,/.78XXLCSAG*ZR9-TZ^3,TI^Q]]I&S7M)$:7
MODDU,4F"`T@=2`-($T@+2!M(!T@72`]('\@`R!#(",@8R`3(/9`ID!F0!R!S
M(`L@CT"6+O%BAKH48D8MJ#\Y\2@9FKO(,0D0G'F,T:DH2DR2*`)2!](`T@32
M`M(&T@'2!=(#T@<R`#($,@(R!C(!<@]D"F0&Y`'(',@"R".0I4N\**)^]Z+H
M=,91UG&P<"??::(V+T[XR`R3&+%;#4@=2`-($T@+2!M(!T@72`]('\@`R!#(
M",@8R`3(/9`ID!F0!R!S(`L@CT"6+O%B@U:SGX@-9>W'AB%VH5(%4@-2!](`
MT@32`M(&T@'2!=(#T@<R`#($,@(R!C(!<@]D"F0&Y`'(',@"R".0I4N\0*!M
MB1<(>H]S$8_ZU\WZVUU$@Y\6O4>21Y[V,GJ'HT3\^-`DGTL6LE5-BC9B:II<
M*ID?MX6@G,OZJY=Z8L"YI0&D":0%I`VD`Z0+I`>D#V2@22D^'HN;8JB)4\U1
MXJ6K69![OW%BP-6<`+D',@4R`_(`9`YD`>01R%(374TO>M0)+NR0Z>R.I@P5
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M8XRUD6FM4CX0!4V@H'LH:'I.03.OH,M`]LH#%#2'@A9)05S'Q\3&K:.HP]*5
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MKYL\;TL<8HDCUCI9XIBM=/6.I'96MH7=,[+5F[+,R<)F;*4+N\SE8%Q`S>98
MV()E3A;VR%8GVW+)\G'U_*&B#IIAJ'QZ51/H\VIO?&AT94=_U5@YJ(:HCJB!
MJ(FHA:B-J(.HBZB'J(]H@&B(:(1HC&B"Z![1%-$,T0.B.:(%HD=$2P_YL4/Y
M^63LG+=D4"IBR:"1NTM3=]+)ZI^W]S5KP2FZCJB!J&F0LW%K&>1L"MO6\1\V
MWAUKP1?01=1#U$<T0#0TZ,BV6=VSP7[X-_OF6%'TB2J$'J5QSF",59'6E'8A
M5!+9KL96]JBF;I"_PRZ(/4_#6G%[-@WRNDI?E]=5&OGR\KHZ*-]%^9Y!CGS?
M.CK5EE<_L%9\]4-/WA])ZF159N&<6C&[YQZG-Y;JQHP<1QIY2Y1\J>`OTZK&
ML>PMT,7\7S-&>3L;UAE1:]ONE^N8!EN9=8PHO,D_VXFW95`IGZRUVFQ52%"'
MD=I])P]"R$5$EZVL?(^1U>I;Y&J)[>&`K4Z6.&2K(U.M.C5U._DW_:G,Q1C4
MB+92'%-5];0/695L!6L&Y>U6JL[(.C886:NF004[8[<,<N3;!I6M8P=1%[5Z
MJ-4WR*G0@)&5'WI:_KA11XG<I*KEU7ESKJ2>"SQVQ.P<PZC'FV3K:B1&B]C7
M58WC;T:+D7)'2Z+.?=<P4C2FXB6^2)Q-_MEV;<L@;VAHW;*7A,7H[?!%7R6!
MTT7U'JKWV<H.E@$C?=5RTS?DGX_$OSI9<SOK-_&O#^*H5[G![@*-G'"I&N0$
M:(VM;`35&;GQ;[2L5=-8>?&OK1SY-FIU&%FM+FKU#'*T^NQHKVO`R&H-/2T_
M_M5QCMND<?Q31)Q_1*X>:Y4#02,Q$,3S(E7CZ`^$DIC$:\;*FS>T?,E6NF&L
M2M3:-IF7Q`ESD[4HY5FKK!B@+=9RIX^D0AQ*'=8ZF<R[;&6'8`_E^XQLA0:,
MO`K)V6GHR7L=JQZ;A(X-/KTMBV7\.<0@=PP9Y`1FC:UL%-89V5HV&%FKID'N
M&#+(D6^SH]7J,+):7=3JL95U[",:,+):0T_+;VKWL(CG$+>IS]K%Y/"`R"!O
M&.$!D;%R4GJ-'6WFJQMT^LRHP5;>`)'GETV6]ZQ@&!DKY[K:[&@G@PXC>ZE=
M1LZ8860=^P:=KM"`K4KQ#`ES#>LZ<XU^JT`_=[L-=R]A-7Q[VZ?6T7?UQ@`]
M_WM[G6#].D,[N*RH"9)2@_B%7G3X$F]W!+^C%R#BTTK)<_1BQ!&=NWR%'LXZ
MHE\@_:-"A0H]AX,.=\4*/8-QA)<J=$O^"`_HBFC_CK]4@WQ%[87Q%]KH5M3V
M$W^A;1OY'+NN-OVB]E/H0YLE4COV"ZTCR>?85=<N*W1O'+5&EQ6ZF8R\5J[4
MXY$NNJ-5KM"M5+3OE2MT'Q3YJ%P9'^/3<H7N0*+]HERAVX?$,TG!]!K*Q^HE
M[*]V+YOW?>HM?*:@R\:W"'?Z11;]S\'<R?X:'>@%%$K0M'*E%XY"NL>15;>[
MGZ/HP/^H`I)7F&[_!@``__\#`%!+`P04``8`"````"$`!X6**SH(``!Y(@``
M&0```'AL+W=O<FMS:&5E=',O<VAE970Q,RYX;6RLFFV/VD80Q]]7ZG=`O,^!
M'S`/.H@"MK&M5JJJM'WM`]^=%<#(]MTEW[ZSWAWO[@PE1](W(??SS-^[L[.S
M@\W]QZ_'P^"UJ)NR.BV'SMUX."A.NVI?GIZ6P[\^QQ]FPT'3YJ=]?JA.Q7+X
MK6B&'U>__G+_5M5?FN>B:`>@<&J6P^>V/2]&HV;W7!SSYJXZ%R>X\EC5Q[R%
M/^NG47.NBWS?.1T/(W<\#D;'O#P-I<*B?H]&]?A8[HJPVKT<BU,K1>KBD+<P
M_N:Y/#>H=MR]1^Z8UU]>SA]VU?$,$@_EH6R_=:+#P7&W2)].59T_'&#>7QT_
MWZ%V]P>3/Y:[NFJJQ_8.Y$9RH'S.\]%\!$JK^WT),Q!A']3%XW+XR5ED[F0X
M6MUW`?J[+-X:X_^#YKEZV];E_K?R5$"T89W$"CQ4U1=AFNX%`N<1\XZ[%?BC
M'NR+Q_SET/Y9O25%^?3<PG)/8$9B8HO]M[!H=A!1D+F3P]A5!Q@`_#LXEB(U
M("+YU^[SK=RWS\NA%]Q-IF//`?/!0]&T<2DDAX/=2]-6QW^DD2,&U8NX2@0^
M>Y&K#IYR@$_EX%R_@Z\<X%,YN'>./P[$(*\,#*YVLX-/Y1;<S283/YA-KSL&
MRG':.WYG@+"?NCO!YRT#G"LW^+QM@`YDBEPXD3)J42[&<"17O$N@,&_SU7U=
MO0U@5X)U<\[%'G<60@Y31\:S3Z;_RB58?Z'R2<@LAQ`H2),&-L#KR@OF]Z-7
M2-J=LEES&\>VV*"%2"LA&U(041!3L*4@H2"E(#/`",+2QP8R^?^(C9`1L<%9
MK1'H8+DD$&B!+B$%$04Q!5L*$@I2"C(#6(&`'<H"X4&R7*XOF!/":SF$O:!S
M8CJV)[J6-@[LZ-YH:IML>I,^&(Q$C,2,;!E)&$D9R4QBQ02&S&(B:NZ-&T?(
MP-X#QSX`?.<HHVM1ZDWZ*#$2,1(SLF4D821E)#.)%268EQ6EZQDCK+M@X"36
MBD`EUN&9TK+1&Z%;R$C$2,S(EI&$D921S"36W&'0-\Q=6-MS5T07C@TC(2,1
M(S$C6T821E)&,I-8$X6R;TU4GB%WXG1MG\O=EW4%BP=%]L+B>W!6R!-$B-CS
ME\1S^\*YD62B(Q)*,H7\,_*#5-.H-\+\B!G9,I(PDC*221+([LP\.D1GS8Y5
MZ*E41#Y7YRXB[P^/$+3#(\DDT.%1Q`B/)+.@.Y'=L>/;M37JK_>1D43.J%N8
M+5-->B]QSH.J9ZNF_754S4Q5*W6@Y>%QFNC4P4!=2!WH^C!WA(H='$D".-",
MO"#CW"@CKX]@*,E,DXB16!)/QWW+=!+FE3*2F3I63$0;9@7E^N0[<WOV"GF0
MGOWT78^<O1NTFNGY(S(=O3%QC-!JWJ55,)[-[`2(E8'?[0N91>BC;Y8@NGJS
M%*WDS>!+"6DK,^MF=B!%8V?NPN\$4O:!<!9CWJY%OP^9Y9GUQ?7H^8-6VC%$
MY/=:$2*1MJ^KZ9@%3=W+2"SM@B-*$&GA%)$4GG@3>S4RO-X)VP$2#=\-`9+]
MH14@B4BFD0*\<9257OP0D2Y6$:*93"N'A#E6UZVL8L()JFCA%)$4GGBD"F:6
ML!T@T?[=$"#5+>I$6#L2D0PB(]B@E78,$>F%CA0*?)E!_H04M!A]S!12]]?*
M"5IIY90HLPXT0Y\+.21Z/S-$/W3ZBV\`I(0K1%*+3'FCK`(]Y5`A7SZ>$-\C
M(T2BW7A=S<D.B?&R6:_D@`S=!*VT;HI(Z@9D2V=XF?<'HN'G4?N9!J%3),>`
M;$W)*<AR3UGI0R]46H'>0Q$B688=?SYA090ZYL&(3EHZ0:2E4T0H[3I$.E,6
M4MK>H*(IO99][VL@'-7;ZEVR5BB`6?5GJ#<E(]N@E9E^4@OR%HMVI*P\7?]B
MA:QB)AVME&-:*=?*+"T[/*)!-</SG1-0F),<DHC4+](1;!QEI>,7(M)5)E)(
MU2]W[)-S(D8?'<TM(JV<(-+*J:WL>..`GH%J@!?JE^A-;PB1;&4A(W%UUXY$
MI%"1TVN#5CH'0D1FIB@M>53YM&>+E8N5-KT+CBCAPBDB*>S.R`IFEK"=0Z)1
MO2%`LJ^U`J1:7;N+(HN_<925CFR(2*]TA$@V.\Z4+'2,U\T48L()6FGA%)$4
MGI/ER_`R3R#WMG:],[?WF$(D@6B=1BLC@1`9"80(BRFM6+$R,#,(?;1R@D@K
MIXA4>T8W;V8)6QGDTC[\AUJ$3H4$[F)[3EL$Y1CH4RA$I*<7(9+3(U\R8G75
M/-S00<LFB+1LBDC*TOV<6;IVT$1K:VZ[+F@_TR&XLEDV=Z9"Y)`C>VJ#5GI/
MA0J9/18BM^NQ?,<C&SQ&`Z/+XLH)6AE=%B*I['H^69T,#7B?Y=(&_N>CR'O\
M[B;+H=5G^6S[2C\K"R7RS;K(OVTK=5]5O/',)0D>*PLK.=G=$M2Y>K<4K=3=
MG%E`LB&S[F:GK.B96<K>_#3'%3)DHTLTUTFQ458&"CF*.(HYVG*4<)1RE%G(
MCH7HALU87.^\Q"M,.F>%X/0R&E#Z=@0=YWT_$G(4<11SM.4HX2CE2+S;[D;?
M#4*&0;ZKEJ\:CT7]5&R*PZ$9[*H7\1X::M#JOL?R)?G:7\![!.AA*)\LX!G[
M!1XLX)'T!>Z"$"S,I2L@!6/E5\+I`I[N7N"S!3PCY3R9+>`I)^?A?`%/##E/
MY@MX`L@Y_##@4_=\F\X9?C#0Y3KE+DS@@L[:6\";J@OZ/NAW$Q[U2O#B_YP_
M%;_G]5-Y:@:'XA$69-P]<JWE3P?D'ZUZ1OU0M?#*']8,7@[#3SP*^#X]%@^R
M'ZNJQ3_@SJ/^1R.K?P$``/__`P!02P,$%``&``@````A`/1+5A4`!@``!1<`
M`!D```!X;"]W;W)K<VAE971S+W-H965T,30N>&ULK)C;;JM&%(;O*_4=$/?;
M&`,V0;:W8AL,N)6J:K>])GALHQAC`3F]?=<<F8.;)FUN0ORQYH?Y9\W,8N;?
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MX0Z@1[ACT?YM@[H2'`69T82\1MF<X07@KU57.#7`D>*57%^J?7]:V%XP\B?!
M+'0AWGI`79]46-.VRJ>N;^J_:)2+WTJH3)@*7+G*=!3,QMYG1'PF`E<FXH["
M(/"GX>SC;P*1I#]P92+^YT5@<A`1N/[W-[EC(G#]])LX=)3(H&^*OEC.V^;%
M@ID$P]!="SPOW<B%'WRXZ=B(!/BG\8<APRKW6&9ASVP+1K:#I'U>>K-P[CQ#
MHI4L9F7&N&K$FD?@3,"R&QW$.DATL-5!JH-,![D.=A)PP"=A%F3C5YB%9;!9
MO)LK#@;W)IHS/((WV>@@UD&B@ZT.4AUD.LAUL).`XHSW-<Y@F84-LT1*HSO5
MBA6-<6%2BZ"9&K(6(<(N@\0&20RR-4AJD,P@N4%V,E%L@TY\14)A&9C`L$0)
M2\SIQX+>\TV$"-\,$ALD,<C6(*E!,H/D!MG)1/$->JKX=GMSXHL3CB;V\&ZM
M&)G*AH5C+8M$$&^V,4ALD,0@6X.D!LD,DAMD)Q/%#>C&)]S`T:H;C`P+TMH@
M&X/$!DD,LC5(:I#,(+E!=C)1N@X[CM)UNGV-\/[>GZKR<=7`C(#E_$:">+!-
MT<T+BZB.4.)-Q!*]IB08/-I0,H,<E2:=MF['(HCG4&*0K4%2@V0&R2F9DF*.
M=&-'"7UIQ21<FAM[/)13S*,?S95X]''#L*!J&"7!=#",$<DP2L(I*0\F8]=7
MYULL[@NO*)'ZN#544TI@&'#1`:J>JIJ)^UPU-\A.)HIS4&J9S@5#>G'K;J07
M%+L\O["*:A<EGI([H5X-L2!:9)-RZ%:SL;9LQ:(9-L2?:"XG[/8P4EO1@#N4
M?N0YF6A&JKU`\SV7GZ-XZL(GB6+J^^:1<-4]ACQ(^&'JA=K46_.H4.3DAJ,A
M*6..0I(_WEA32=A]?YAGVZ&),(RC03CCB`GKXY`KPJI!N/R4Y^N_&$2K5?I-
M2%:"%2[D(>.T_-)&:,VCI`3CR!>>Q1SA='Y>3F>:2L+O2PG%T2"<<C0(9QQ1
MX6`\52=NSN\38=4@7(5^PB!:M"H&4:1ED#95UBZ+DC-(-.1C'P]1V*!0*U<3
M=EM)($,WY2)R`HFH6[JYHJO:@\M-V1Z\*4ZF^'/]UCXH+50N*U2'@5LQI*52
MH([5FD<-#3<<#2,><T1'/#2MHH_WY%1B:!!.N<H@G'&$=S3Q_3G6UM.<1]U(
M*%QHZHZYTCK_H3("?Y)HZSQ#6IYIF;[F47*>42V?GHK@Q3]F43ZN6YZ7^NZ9
M\-OR0D5%O$$WY5&#;L81./V>>>R%Z.&1_%&,/SM,\_Y/>4$4M24?/X2L:'S>
MK5G4U!-KU88C96,P-D@>=4>,G'AW6J(D+$#)0_I\Z6$IEWGW81F/H@]S)S-M
M@\F5A]%Y3,_FZ#%-C=HC6J/SN;/*Y@F?N\&ZN)P+3`\%5],(:F2P1N.;602E
MXPT>1E!NF3P-(RB&3`Z'CO>D&-;T5_@P\D;\:A+!48&IL_(B^!@V^;T?W8,1
MYHV5'\%7X`T>1/`]!-P1;P2'D-?BB'XMVF-UZ:PS.H!98U*KM?08D_[H6;G[
MT/1P^@A^PJ$7'#<CF&-C7!,?FJ;G/_`#Q`'V\F\```#__P,`4$L#!!0`!@`(
M````(0`MLEL1_@<``(0B```9````>&PO=V]R:W-H965T<R]S:&5E=#$U+GAM
M;*Q:68_;1@Q^+]#_8.@]:^OPB=T-UI*F#=`"19&VSUI;7@NQ+4/29I-_7W(.
MS7"H>&VT+U'\#<GA-20UVON/WXZ'T=>R::OZ]!"$=Y-@5)XV];8ZO3P$?WT6
M'Q;!J.V*T[8XU*?R(?A>ML''QY]_NG^KFR_MOBR[$4@XM0_!ONO.J_&XW>S+
M8]'>U>?R!"N[NCD6'?QL7L;MN2F+K60Z'L;19#(;'XOJ%"@)J^8:&?5N5VW*
MK-Z\'LM3IX0TY:'H0/]V7YU;(^VXN4;<L6B^O)X_;.KC&40\5X>J^RZ%!J/C
M9O7IY50WQ?,![/X6)L7&R)8_F/ACM6GJMMYU=R!NK!3E-B_'RS%(>KS?5F`!
MNGW4E+N'X"E<B7@9C!_OI8/^KLJWUOG_J-W7;[\TU?:WZE2"MR%.&('GNOZ"
MI)^V"`'SF'$+&8$_FM&VW!6OA^[/^NW7LGK9=Q#N*5B$AJVVW[.RW8!'0<Q=
M-$5)F_H`"L"_HV.%J0$>*;[)YUNU[?8/03R[F\XG<0CDH^>R[42%(H/1YK7M
MZN,_BBC4HI202`N!IQ$"AEQ@B#4#/`W#[;LF6@@\M9#H;C&=)K/%'%2_L#NL
M2IOAJ1GGUS'.-",\-2.ZFN\T5DZ6,<N*KGB\;^JW$1P$<&-[+O!8A2L08H*E
M)/3A^U'T(&PHY`FE/`3S8`2!:2'EOCY.E_?CKY`E&TVRYB0AI4@-!:8$2LU\
M(/<!X0!C,*BW"L+^/UB%4M`JH]#:`-;,R+/!4!B6S`=R'Q`.0&R`3/1MB"&'
MAX^1"00R/0102OM`Q(LYU7&M:$)(TI[((TE[DMX.AN0,$2Y"3(&M?%-LFEZ=
M9"@%TA3RN]>;99FFN61;3]+;QI"<(<)%B&V@CFO;Y?`@L33![+W6"!R]WJAX
ML:`12WLBPY8Q)&>(<!&B,FQVO<I(3%76B#T7*4,RAN0,$2Y"](,ZXNHG:])L
M>H<U]+)[D9'JJA$X8[U[P[E_:#41%).>*%[8^D5TPRG%J9>7]4%BJH]&HKZF
MI!J1[8OLM*0[H1?B!;;,=YR`?'13C3B;:H18O)ST64?T"*'H7&^RI*;;&\C9
MWT#<ZA!+NN/@J\V6C-[&JCV$[L8:HI;;3D0MQ]+LZ'(YV+"-[W@#.4>%0QF'
M<@X)`E$UL>Y>KZ:NTFKTPCZ[#A6T=$])O/1/B:::Q7WN9AI:6`?G'!(:BF?(
M2#7'JGJ]YKH&NYHK:!G+F2.:A-,^A^4(D6*7@],0+QRE-02GWA[WB4U^R9A;
M1IQF9C.O0PJ]GJA9V)T]L$'=8)2NTJY1"H)PX-9@U,PW2A'$EB>3FX*=26]G
M;J"I%),LF05:RD!8L#([85%#H:R_W;[:?%G7X#@X00/G`0.A1T)=WJV2ZU!!
M-EJ>2JDF(-%2/(D:[S%=<TV5J*#'B:W4<F=AU@="@Y7>-PS&?,@$M.MS?99V
MW6"D;AVND0HBARGTTRL-%14)H8(22,]+>:FI5%3#:1C3Y!!&\D!8O=[EA]68
M/Q!6Z#I]7'E3"Q6TM,F7<BCC4,XA02!:++R&^(Z:O`V&&H*'=?#2\U]JJ?IA
MBT,YAP2!B.;131U44M-&9B"GCW`HXU#.(4$@JB;V1N=T7'9PI#NID_H&@G1P
M')S0!$TM5>]@#N4<$@2BFM_4J"/>J`WD.EA362CC5#F'!(&HFEZCQ@,X':ZC
MSH&+>,,V$.15[^APSARM&6&'GBI>V@Y)=<.N>'WP50^%%F-BN(XT9/V5<BCC
M4,XA02"J)C8M1TUT833%"G[CC07.T=Z8;"":OG[SM53&](Q#.8<$@:A17K]]
MY^#QQAIIR/4]@S).E7-($(BJB:W'\?T[:JI&15)$03"DN`GISYF1HG+G3`VY
M<R:'A(8&YLP(&]3UFJMV1C174#PW(YD]16K.E#O0.=-`8(X]?OX@D!NJA90<
M)MX<*O3ZP)P9W=0/);77550_A'#\8,[4/.Z08B#;ZG,#J8EDX7E&F&4^C^!M
MEAL5?QZY:LR40JA=&K+!\L=,0^"\%&C('3,-I-\MO#H@S#*?,F.OCTJ[_LN4
M*05Z-JKN2XX2GS(UHQM`#<TN9Z6A4ED93>T+LAJQC>"!H'JMV`_J=4-FS%NT
M@6SFI1S*.)1S2!"(U+C8:]&7:YRD]@*CFRX=,ED&]E1]$S&RY)<9Z>6<0X)`
M5/.;&C@FCM?^#.0T$0YE',HY)`A$U1QHX._/0)#!3%T-T1F(.5I3T1G(WJ]2
MW6[JP]!GF$ZLZ::&RGHUXU#.(4$@JB8V2*>;X1&+D^2*JT$HB4QE#1$W+KPN
ME!I&ZD;[XDWUNZG;PLL^TTE#UF>IH;)0QJ&<0X)`5$VO?THWJ@O6&V=)^)K*
M3-`06-(W_\1O_JEA=!M1SV@J0\ZI\/NMW%$R*JO4]UCU;>]8-B]E6AX.[6A3
MO^*W5ICJ'N][6'T(7L<)?`F6]92MS&!%%G>VLH`5N2U;69KOROY*%*WPK0@,
M8BN@`0S[0RM36)&O%XP'=`-S!GABV`=*^]!*#"ORXM*7!L(&984@"ZY<!V2%
MX`&XI1A:`0_`+<#`2C0!G>6DX.\?P==X>+$=X)FOUG"GS1?@UG6%UZP#*]%\
ME<,4S%?@F__3L#&@\0#]&B,VA*,?!_"G9/4$.<DW7D.`!^,+X971'?<.@;\!
M.!<OY>]%\U*=VM&AW$'>3N2M8Z/^BD#]Z/0MW7/=P==_Z+[PU1K^VJ.$J\$)
MO@CNZKHS/T"A<?_W(X__`@``__\#`%!+`P04``8`"````"$`XQ,FLAH:``!M
MA```&0```'AL+W=O<FMS:&5E=',O<VAE970Q,2YX;6RLG5ES&SFRA=]OQ/T/
M"KV/)9(2)3%L3Y2X[_OZII9E6]&6Z9#4[9Y_/PD63B60IZ9$=_1+6_TA<1)5
MF4`!*!)\_^^_GKZ=_/GP_/*X__[AM/3N_/3DX?O]_M/C]R\?3I>+UK^N3T]>
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MX_O#'5H]/OQ\"?X^>?FZ_]E^?OPT>/S^(+=;`N5"\-M^_[LS[7YR2"J?4>W6
M(023YY-/#Y_O_OCV.MO_[#P\?OGZ*O&^E$MR5U;[])_&P\N]W%*1>5>^=$KW
M^V_2`/GOR=.CRPVY)7=_'?[]^?CI]>N'TTKYW?7EY47U^DID?GMX>6T].LW3
MD_L_7E[W3^O4JN2U4I6R5Y%_H5)]=WEU7BF)TV-%*EY$_O4BY:MW5Z7SFXIK
M28'W"U]1_O45+]5Y03U1/5R[_.OKE:[>E:\O2Y=5U^R"FE5?\RJK>613I=\=
M7,J_O]34&U]/_D53+XZZ-R7)J#3`+K72V!U9,TL-^</7//(J2\@']\<O76<)
M2>#^P)6>!PE9$)02\L#]\6N7BDQP/><7+Q6I4)(_?NU2)7G2R&@6'9M_)>21
M^^/7+A695-)4.C*J9:22^^.7+K6,5')_^)K'7FH9N536C#BVP4B(LB;$<2.#
MZ_Z'V+@_T.`CT[",C"AK7(]M,,):UK`>V6"$M:QA+96/&@4K"*O[XY=RJ8*P
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M@I=0]!(*7T+Q2RB`21C!*%%EA/\G$M7)?#B51VHPR)K,O$UMW,PQ,[HRR9N9
MX)8TB#2)M(BTB72(=(GTB/2)#(@,B8R(C(E,B$R)S(C,B2R(+(FLB*R);(AL
MB>R()`DC#3-BF-39BN.:<&`3CFS"H97%_R'Y)+'$8Y3<DFK_1'([&9F$R#PU
M2UR>0GBCHNS.3'!G&D2:1%I$VD0Z1+I$>D3Z1`9$AD1&1,9$)D2F1&9$YD06
M1)9$5D361#9$MD1V1)*$T2VC.B..:\*!33BR"8<VB6(;9;?D8Y3=^?M1F`8[
MZT,2(_EN/9&U5)#6%3,B9T:HUB#2)-(BTB;2(=(ETB/2)S(@,B0R(C(F,B$R
M)3(C,B>R(+(DLB*R)K(ALB6R(Y(DC#30B&%29RN.:\*!33BR"8<VB6(;Y:PD
MVR_DK+..<]:3PU!_6(?5B32(-(FTB+2)=(ATB?2(](D,B`R)C(B,B4R(3(G,
MB,R)+(@LB:R(K(ELB&R)[(@D":-;1AS6A..:<&`3CFS"H4VBV$8)*OL$OY"@
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MG:<DN%T+7RM^?%W&MVR9&4%H161-9$-D2V1')$D8W3+R@;_2>6&"R`<(L0X0
M@AT@1#M`/MSIK8LRV[W[+4SMQ?['_TIM>?&%W#[(Q,GMT<7A@PWI5-<CZ3:X
M\0T@>?0$\XUJ'+"F6J%B"^@FTVI[='WX-,3!8P=6L;S9M>NJ%>1[0"K?9_D!
MK`KEAVH%^1&0RH]9?@*K2+YLWNQ,U0KR,R"]]W,@O?<+H$B^9.[]4JT@OP+2
MUJ\]"N[]!E:QO+GW6[6"_`Y(Y>4MB<M3V:#5V,I[DI1=%3I(ZFH&#_+ZQ%<-
M7"#)0A=9ED4N;`3DO4K6DLQ%EGJ'&,1]SKT$"E\,YCPVPKZ5OC.2[3N(WY92
M%/6M%$5]RZ-J5K'I*UXI:@%IKK2!U&,'2%8Z03^]COMI5ZW0U!Z0RO>!5'X`
M5"@_5"O(CX!4?@RD\A.@2+YL]O>G:@7Y&9#*SX%4?@&D=W7):`6D6FL@U=H`
M14TMF1N]52LT=0>D\M)K*"FDUV1941!)Z369&3Q(K_$L<)%EE%Z"O'C,Z@8N
M[.V67I.992ZR/#NXB'N->_\4]IJ_-0ESGS8RLS"/HL[DWW7I136\5?"$;C)J
M`>D=:@.I5@<HGJ7<V,[D&Z'/\1XJJGP?2.4'0)&\G3<.U0IW?P2D\F,@E9]X
M=)U^O,\MMZ:,9JBH6G,@U5H`Z34N&:V`5&L-I%H;H.BR2^:N;M4*E[T#4GGI
M.90!TG.R@(1I;>;CTG,R,WB0GN-9X")+'[T$Z3FI77!OI9LPRS+HH!=W$_<R
MJ:B;'#FA\^^DM'&W[N-VTG6JTAQ]!)3M?CNL=);>\.A:49-1RZ.*#J)MUNIP
MQ2ZC'FOU66O`%8>,1JPU9JT)5YPRFK'6G+467''):,5::];:<,4MHQUK20_P
MX=:H20](61!)27=FB'@02_E\"NLAYJ$>@AXR1#W5B]-=>GN4[F_,I9RY6:>D
MJ!)/\>R.IWOK+Q73CVD?UA8-H*CBN1D.FK"Z.2S@2]?7UV;^WO(6%SJU;:.2
M#A<=H$)O75BEWLJ7]J';8V=]U%%G`Z!"9T-8R49-,""8Q?9(/096Y\9JK%H8
M-"=`A8V8PLI?<:ER;2(PTP9`>HY*>LD+H$)O2UBEWB[.[?"W8F=KU%%G&Z!"
M9UM871]2IUPQ.;EC7])K*4^EU^9EN$U4Z<A9U2!09;,<E$=9:B;I&IC9>$IW
MS]1PU^7I=E1#LNS'3;XR:T;YU%K6!A&/QP/W8C!\_+TQ'OCWB.%C+D7N`YM!
M5ILFU-V'*=QXH!4;0#J7:0*YC9(_/]X8D1:*PT<>Z79@I;I=(*\;3QQ[*%79
M/I`V=P"DLD,@:8->^KD9KT:P4ODQD,I/@%1^"I2VNG1N4FN&<A6>`ZGP`DB%
MET"I<*5LYGPKE*OP&DB%-T`JO`5*A>VZ?X=BU94.2`&4#NB9*DMOR^P*[K7T
M-F\6N`BR*NA:[**-NOZV7)J!4;I1*!YW(UE^1MWH[RVVG(IYVJ;(/&W-\K;N
MOBAAG[8INM!51]-;7?B]\4NSGF^A/'RPDG`'5BK<!4J%+\VXVT.QZO8]"J8'
M`UBI[A!(9D)%_<M?J<J/67X"+96?`OEF<_\BX3D++Z"BPDL@")MPK5"N+5ZS
M\`96*KP%2H4K)D%W*%9=Z5\40>E?_L)46?J79]&]MB.#]*_LGH0A,;,3>9JQ
MURR]`J]MR/D[1?ZR;#M<4MSE9#)0V.6.7+@Y&=/G4E35F7R]E*+H\>51]-RS
MLX2FKUB]2*>S-Q<V:"U(ZXC5!M+!M@-4Z*T;>RM?7IO`]""CSOI`ZFP`5.AL
M""L9%+5WEHW'$:PD(=3*3G_&L-)&3(`*&S'U5O[^EDLW-V94FT%'+WD.I-X6
M0(7>EK&WB^NJZ8$KR*BS-9`ZVP`5.MO"RC],;2QW*%=?TMLI3Z6W'Y.H,@!D
M58-`V6R5`<";%<93!H!,+7CF'M409+\/Z<7-I9GWR',X:P--9]U+\'`ZZY[#
MY:K[GF[>R^;PK4'Z^EP>\6CPK?LBH`P-U2C!*V9Z5X>5AJ'AD3RTH=4$TD5-
MRZ-H'>L]JE8'%56K"Z1:/=;J>U15K0$JJM802+5&K#5FK0DJJM842+5FK#5G
MK04JJM822+56K+5FK0TJJM862+5VK"5]AVZ^])V4!9&4CN*9RDFO2%D02^D"
MK(>8AWKM'#U$/=6+'WON97B8X6\LV-)WYU%:I^BM!9NWTO[0<%]O=;-,G98W
M/<+P>WECAO\6ZF@6MH%4N0.DREV@=/2[,5.H'HI5MP^DN@,@U1T"Q9W:/#1&
ML"H<Y<:P4H\3(/4X]0CWJ,I/*']?]5KFD%'E!9`J+V/E4O7<7,8*=51Y#:3*
M&R!5W@*E=__"+!!W*%9=Z3Z4,-)]*&.D^V1VX7/&;(M+C\IN2F!FYPW2R3(U
M#+6R;<)>D70^"*5JQ5R2/%0RA_:AXKZ;'76YO[6X.ZC$$TV/WEC<P4K'FX9'
MX>(.J'R8:%[<V-5,"P:Z.&BS<@=6.DGO`J5S]'+5A*J'<A7NL_``5BH\!(J6
M'';7;@2KPOVS,7N<H*)ZG`*E-^FR5#5+U1D,]%KFK+R`E2HO@7#[K\RD904#
M55ZS\@96JKP%2F]_J6KZ^`[E*BQ?/4P_7Q$LKY-;V*FT?/TPM9,=@:"35<P8
M+M])]&:%(9`O*K+7+.L"KTB["Q^%\ZJ94LF7%S.'U!?=._#P\6?[XG&KOG+Z
M*CU\+'H4KOH\"E=]0(53]R:TTE7?U:7=$VQ!1@?0-I`.S!V@0F==6/EM*WLW
M>RA77WT@]34`*O0UA%7\]#2Y/H)5\=,35MJ("5!A(Z;>RH_E5]=V@3"#C%[Q
M'$B=+8`*G2UC9]7+*S,364%&G:V!U-D&J-#9%E9^R6>/+=BA7'U)7T]3.4A2
MZ>N>%7J3[I]5#;N_V767[N_-"L,IW3]3TT<Q6'%#D/L^HM4KNXTB(T+6!AH1
MW.M^.R(<M>1SQZ"8K1^/S)+/A+P.*PU#PZ-@8M\$TN=VRZ-@F=!FK0XJZA*F
M"Z1:/=;JL]8`%55K"*1:(]8:L]8$%55K"J1:,]::L]8"%55K":1:*]9:L]8&
M%55K"Z1:.]:2OI-F0+!&EKZ3LB"2TE$\4SGI%2D+8BE=@/40\U`/00^?SXAZ
MSI+/G=(397CQDN]@;B::3N&P<@LZ>MET]+JO&(PD#2!=&C2!HD<`/^"\1^TB
M;:V(\:$#I/)=H$+Y'JQ4O@^D@^X`2.6'0(7R(UBI_!A(Y2=`*C\%*I2?P4KE
MYT`JOP!2^2607Q1?FIG:"N4JO`92X0V0"F^!_'K/Z.Y0K+K2=WR$55CZ3I9G
M"+'TG<PNR#U:?F69]M9#)E/+/+3@0:]'#L3([`YODJ_-%$4>*-[@<$G1#HL[
MV2KJ;G:*>=2W5PXJIA<Z8>F%LGNI6^%E>KAX*QUK&EXK6NZE5OY=WHU9Q[10
M0Q<%;8^",:<#*YV<=X'\:L.LDGLH5MT^ZPY@I;I#(+GK>NUVU!C!2N7'+#^!
ME<I/@7RS2V:-.D.Y"L]9>`$K%5X"I<)7U^:&K%"NPFL6WL!*A;=`J;!]\;5#
ML>I*CZ/,D![G\T"5I<=EN1'<ZPOSJD(>8-[LK54=>\W2*_"*_/(9>75C[I3T
MN,P?3>%DN.0>)Z==2K*XKXMA37?\=\?<?K^=VJ4H6M^E*'K@>:NHC]KI:-/+
M5]-/&G'O\[HZ7+9]C<!5!R*%KKJP2EW9C^?VH*NN^D`Z,`\@4NAJ""O9MR[J
MHW1Q8_8X@5:AQRFL_,5QMR5?<_:U@$JAKR6LTD])E:XNS)BY@K+>RC60WLH-
M9`J=;6&57MB5<;6#KKJ2WNVO57U)[TY9M="9='AO%@7NPNZJ-.#AK4<L-Z0%
M#\4-0997<8_M.TL9!+SXX<KCQZXTZQ\>!)RB>02G*%K?E6SWKKOC)MV#.GP$
MI^@J'BS-F-KT%:]*Z2<0K\[MZ_"6MPA6#6WVUH%.H;<NK+RWFZJ9MO7869^=
M#2!3Z&P(*UGAZ.!P838C1^HQL+*[]F-NQ`3RA8V8P@I7?&,WNV;:`,P/Y^QM
M`9U";TM8I=Y*%?DR<?S)P15[6[.W#70*O6UAY7=%KTQN[=B7C!F4J#)F').I
M,F9XLSB>9MXDDX343/*U(*"R\.6&(-6+NXS,U'U#<)<O:.!"=\A;&LN`Q(/&
MI7[3'%.'-Y;,3L:,%![IHJ)>)M1@U&348M1FU&'49=1CU&<T8#1D-&(T9C1A
M-&4T8S1GM&"T9+1BM&:T8;1EM&,DW88"*=V&64[`I4.P74[(Y8Q&MLL)NCP0
M0[OX@>@^/Q!N;+Z1P^G'#:)7&BF2;^H%G=?.>^KN8&1)_N#[?`U&348M1FU&
M'49=1CU&?48#1D-&(T9C1A-&4T8S1G-&"T9+1BM&:T8;1EM&.T:2UA1(26MF
M.0&7M&:[G)!+6K-=3M`EK4.[.*W=>_9?2.OTM7R4UAZ%0S.AACNUVXWI:M5D
MU&+49M1AU&748]1G-&`T9#1B-&8T831E-&,T9[1@M&2T8K1FM&&T9;1C)#E,
M49,<9E;/83D1EXD)U\V)N<Q"V"Z.>I3#[ECW*(?_UA;A026>=7@4'G'C47!H
M2\,C^6YU.*Z;V7]3K3`5;C%J,^HPZC+J>535':J^1T%3!UHQ;*K9C1VJ%9HZ
M8C1F-&$T933S*&UJ'$CW6C$<C&P@CYL_NL/ZS?S1H^"I6O<H/'("2"8!P:K*
MO)AIJA5N3PM(#^1H>Q2<Q]&!521?,O)=M8)\#TA7P'T@W9\8`$7R%T9^J%:0
M'P%IZ\<>!:V?P"J2MZV?JA7D9T"'UL?Q=B_HBN)]U-Z^=$\*=XJB<*<H"K='
MP3/):P7G)+2`].:W@?3F=X#B0<"\3>BJ%>Y.#TCE^T`J/P#2I@X9C8!4:PRD
M6A.@PJ9.U0I-G0'E!-*]OBD*Y)$=-WT+%,XNY-`G%]SXX['V$Y!U;Q7L)C=R
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M.T4-1DU&+49M1AU&748]1GU&`T9#1B-&8T831E-&,T9S1@M&2T8K1FM&&T9;
M1CM&\OL*%,CD-H?E!#S)B;C\Q@+KY<1<?F6![>*HQSGL]FS#'';3YK+\V!1^
MX>_H'VN2(TIHO$Q1?*3RI1G$Z[ZB6*&7-Q@U&;48M1EU&'49]1CU&0T8#1F-
M&(T931A-&<T8S1DM&"T9K1BM&6T8;1GM&$G&9^%&("7CF>4$7#*>[7)"+C\K
MPG8Y09<?%@GMXHR7YT24\6^,VL[<+.T]TD\IUMV3W5DI:C!J,FHQ:C/J,.HR
MZC'J,QHP&C(:,1HSFC":,IHQFC-:,%HR6C%:,]HPVC+:,9(<ID!*#C/+";CD
M,-OEA%QRF.UR@BXY'-K%.>SV9,-1^XT<3K=PHYE'BLS0;#[=4)?WYBZMHZ&9
M4).M6HS:C-Q/_QKY+J,>HSZC`:,AHQ&C,:,)HRFC&:,YHP6C):,5HS6C#:,M
MHQTC26NZTY+6S'("+FG-=CDAE[1FNYR@'W[P6:.>IG7Z`\[I3T@^/3Q_>:@_
M?/OV<G*__\/].+.<"?CQ?8;3GXZ6K63Y[6C9ZY5'C2VJ7+J?E3[L6E!1U14=
M%JA4=.6*#@,X%5V[HL/6A2URKG(].4>Y?IR;7"_.2:Z/LJLB;Q=S+K7L*LD;
M&BZ2;;B:V\'A$MF-J[F]MKR2LI3DU9&-N)K;P^$Z[C>\\_BM^VWO/">W9=?D
M'*7;BA0<3NHP-SFYJ+D$9M^W4M`Y3!M-#=DNK;G-4*XBFVU2DN=>=DIK;D>-
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MY&S]FCO)F$ODB'W)K[Q6RYGA4I+7:CD`64KRU.3<_9H[Y9C]-&YJT[S'Z$(>
ML/*#"ES!Y9P[$9A+)!%K^4GE<BJ_J[N>[@[_937I_K7\KNQZLOOI`JXCIVA+
M2=ZMD8XO)0<_9]DH^?+Q_8^[+P_#N^<OC]]?3KX]?);IQOGA,V?/CU_<5DCZ
M/Z_^IR!^V[^^[I]DG2<_:?UP]^E!3H`^=ULEG_?[5_R/-.KLY_[Y]\.O8G_\
MKP````#__P,`4$L#!!0`!@`(````(0`N6LW_.2,```K4```9````>&PO=V]R
M:W-H965T<R]S:&5E=#$P+GAM;*R=6W/<MIJN[Z=J_H/+]V.+W3I7DJFXNWDF
M:VK7[+VO%5N)5;$MEZ0D:_W[>4$"Q.&!U&+6W.3P\`.)?E\</J!;Q`__^8^O
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M_L,^\V5#WL^M<&K4^YNGFY]^>+C_ZXV&"GW<Q^\W9N`IKLW=7'.>/5T:^'/M
M6VW2W.5G<YL?W\IE-=U']<H_?RJN-C^\_U,=Z:.-^9")B2-V+L(T=7/;?0H.
M*2A34*6@3D&3@C8%70KZ%`PI&`/P7M(N^JI1_&_H:VYC]'7*?'#`"Y[(O7,1
MKL@^!8<4E"FH4E"GH$E!FX(N!7T*AA2,`8C$5$>!F%OUW/S8Z]JF*?7C6XTD
M0=O<QBWOPQQC.L`2=!&'[):015"0`T@)4H'4(`U("]*!]"`#R!B22%M]=&AK
MYK65`X&YC<82%5R$Y$A@@UY2>PE9U`8Y@)0@%4@-TH"T(!U(#S*`C"&)U)8^
MD=HOMV`3/8GJQ/A@B>;C0.;3I,4N0:[8'N0`4H)4(#5(`]*"="`]R``RAB32
M4!]^A88F.M;0$C^H[D#V(`>0$J0"J4$:D!:D`^E!!I`Q))%@FIY7"&:B8\$L
MB4?2LZ31+4%+HP,Y@)0@%4@-TH"T(!U(#S*`C"&)--2'7Z&AB8XUM"1H="![
MD`-("5*!U"`-2`O2@?0@`\@8DD@PI>(K!#/1L6`SV2@E\"/=19KKV"!-;C[H
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M@S"CL6,$T+X`.A"51!513=00M40=44\T$(T1BLTTN<@*_6SJ$NHWHZ2'^@'5
M2FJCPAZJS>5G3#7S_8I*V?0@K%28,=@:`.T+H`-12501U40-44O4$?5$`]$8
MH=C4-"TR/?1\^TX[U\=Z*%.DPJ*PAUH4]M#-29$W<[,N(YK"XXS((3^V[HCV
M1`>BDJ@BJHD:HI:H(^J)!J(Q0I&9&Y/6O+XS3.&)?N8.Z1QZZ?O>W#]LP4W8
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MOJ;:;8#V1`>BDJ@BJHD:HI:H(^J)!J(Q0K%^:4IW9)QA'K>9D9F4@B;IM[%L
M%F"CXG'&9_-1I<RW8RM,G<+CU,2A2V\JT9[H0%02540U44/4$G5$/=%`-$8H
MUF]=:K>=\SA]_>6&BP\.J2,$IOJ-C]E4'^4*[HD.1"511503-40M44?4$PU$
M8X1B2==EIEMFIA:%XPS1GNA`5!)51#510]02=40]T4`T1BC6S^23KQ^GMS;]
M#)ODC))QQF_?V"9IH_0OWW`+OR:)*[4N2=TR274HF#R(]D0'HI*H(JJ)&J*6
MJ"/JB0:B,4*Q?FF2^NK]@"WS58>"%8=#T8JC>&8_8+LN.9W"DTG#9J*AF4![
M5]!''8A*HHJH)FJ(6J*.J"<:B,8(Q6:N2TZW3$XMBGMHX1>(MH?.!:/]@$WA
MUR5QI4PFMF+8F!.W:":S*%A&;H'V1`>BDJ@BJHD:HI:H(^J)!J(Q0K%^:7HW
M[:F?F2WUE3^1V3+S<TAR!F.M7SM:OVU!GXKM?4&7-QR(2J**J"9JB%JBCJ@G
M&HC&"$5JGZ[+6Z?P>`AR*&BM1'NB`U%)5!'51`U12]01]40#T1BA6+\T;_W;
MK?64*:U#<6M-E\X^RC7-/=&!J"2JB&JBAJ@EZHAZHH%HC%"L]KJ4]I0IK4-A
M:[51'NT9=2`JB2JBFJ@A:HDZHIYH(!HC%.MG4LUP;G*;K2M'UM,Y90TG+8?B
MMIJNJ7V4;ZOV7GZP/3"J)*J(:J*&J"7JB'JB@6B,4*SUNDS]E)FZ0[YA[HCV
M1`>BDJ@BJHD:HI:H(^J)!J(Q0K%^::;^\C;/*=-SA^(FZ3=PYLG>1_DF:>\5
M-DF@D@4KHIJH(6J).J*>:"`:(Q1+NFZ]<6I7$L&*UJ&P2=HHC_:,.A"51!51
M3=00M40=44\T$(T1BO5+UQM^LC_2.+GR.+5K"DT^02::;E>YJ'AOP.\@Q-53
M0X]&]R.5,N%)+F>1]W)W"K0G.A"51!513=00M40=44\T$(T1BO5+5QY']./R
MXG19.`2F;OQ6CAUQEB@_X@`=_+U<5$E4$=5$#5%+U!'U1`/1&*%(TK-URXLI
M/&Z2#OF]BQW1GNA`5!)51#510]02=40]T4`T1BC6[W]M>6&^4D]ZNT/JX7X(
MVOB]JKFU^BC7#O=$!Z*2J"*JB1JBEJ@CZHD&HC%"L=KKEA=G7%XX%+96&^71
MGE$'HI*H(JJ)&J*6J"/JB0:B,4*Q?NGRXN4!](RK"(?B)IGNQ_DHWR2YBF!4
M2501U40-44O4$?5$`]$8H5C2=:L(?56#7FZ1;W\[%^71GNA`5!)51#510]02
M=40]T4`T1BC6+UU%^)1MY9KWC`L,A^+6ZO>%[0"*I</>%W0-^$!4$E5$-5%#
MU!)U1#W10#1&*%9[W0+CC`L,AWS3W!'MB0Y$)5%%5!,U1"U11]03#41CA&+]
MT@7&D0&4RXHSB^(FF6YP^RC7_O9$!Z*2J"*JB1JBEJ@CZHD&HC%"L:128L6B
MZ,R$)QFH16&3!-J[@C[J0%02540U44/4$G5$/=%`-$8HUL^L3-(MP^VE>>?&
MVN]CSNPB)]A/<$AZ!BEHNL/MHWQSY8*)42511503-40M44?4$PU$8X0BN<_7
M+9BF\+BY.N0;XHYH3W0@*HDJHIJH(6J).J*>:"`:(Q3KERZ87AY!S[DJLBC^
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M#_DH\S:B;;+ZV;O+5^:7FG$%31(59A89PT,1;<X59`_G,TI$3'<+7)03\3+]
M\?G>161$3+.?(W5DAG,^HT3$1*6=C=+O8Z=7.B4)T-Y?3D6\6)<O3.%QOF"1
M^1UIX'*Z8LA'I?7T4:BGF6A?;_:%"4_J.2/5TR6!.QN55#V9JO<^"I5:-R]?
M<%ZV2/L/OE)S5(#VC#H0E40544W4$+5$'5%/-!"-$8IZ\$4Z+[_<.Z;PQ-1Y
M?HZ3K6TRR.ULP?CW=]MGYN>+=?/S%)Y4"I/QSD4%\S/1@:@DJHAJHH:H)>J(
M>J*!:(Q0;&IN?MX4YZ_XDUGS1[5IK[4HF)1=5#S@^$DYKDTZ`Q]I8IQI+RSR
MUNV(]D0'HI*H(JJ)&J*6J"/JB0:B,4*Q?NNR@`MF`1;%7?0TS51<E/JSGT5.
M?:X05VK=S'_!F=^AT%0;Y=&>40>BDJ@BJHD:HI:H(^J)!J(Q0K%^:59BTE+S
MM=;*+>T+IBL.2<S`QS2E\E%NVML3'8A*HHJH)FJ(6J*.J"<:B,8(15I?KDNP
MIO!X.G$HR!&(]D0'HI*H(JJ)&J*6J"/JB0:B,4*Q?B9M>WWB=SEG>>$O"QV*
MFV2:0?NHI4D2'8A*HHJH)FJ(6J*.J"<:B,8(Q9*N2ULOF;8Z%#9)&^71GE$'
MHI*H(JJ)&J*6J"/JB0:B,4*Q?NO2ULLY1XV:I$5QDTS73*Z@_QGAGNA`5!)5
M1#510]02=40]T4`T1BB6-$VZ__;7K)<V^0Z6^0[%:B=KSYV/\@.`O9<WX,"H
MDJ@BJHD:HI:H(^J)!J(Q0K'::8K^<E)\R;3<(=_;=T1[H@-12501U40-44O4
M$?5$`]$8H5B_=%'Q]ULKUQN7%L6M-=F4V/DHWUJ7@@X=&%42540U44/4$G5$
M/=%`-$8H5GO=$N222Q"'PM9JHSS:,^I`5!)51#510]02=40]T4`T1BC63RUI
M309EPI,,U**X2::[+)=+E&M_>Z(#44E4$=5$#5%+U!'U1`/1&*%8TG0!=60`
MY3KITB+?_G9$>Z(#44E4$=5$#5%+U!'U1`/1&*%(OZMT4>0'T)>5G`K&C=.B
M9'_!;^[-/Z)R4?'^PC.;1E?KUAQ3>%(INPSQFPD[%^71GNA`5!)51#510]02
M=40]T4`T1BBV-UU@&'OM;SZ.^,NUQI5%P0Z@0Q+9;S*<^2VEN#+KLO4K9NL.
M>>=V1'NB`U%)5!'51`U12]01]40#T1BA6+]<:EZ<R)4C5C(1O[(HM-*BV,IG
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M'7=AJD60)OEE6U*C=7E2<<)$:6&1P3;.,QD,)H/!9#"8#`:3P6`R&$P&@\E@
M,!D,)H/!9'#($CES:=.E3KD[.BP7)\R<%A;YF\V=_,HGJ9#)<]9T8)L7!;-#
M<6*9]U(=&$S^@LE?,/D+)G_!Y"^8_`63OV#R%TS^@LE?,/D;LD3.=;E4<<)D
MRK%DH/:+TGGINH2IL?E^?/[,<J<X69=/S?'I0&V3K,AG,/D,)I_!Y#.8?`:3
MSV#R&4P^@\EG,/D,)I_!Y'/($I]SZ=6%3@(]EET5)TRO%A9UXUR"=?[,$J@X
M69=AS?&IO4BHU(W!9"^8[`63O6"R%TSV@LE>,-D+)GO!9"^8[`63O2&+[9V.
MSPE'19,]O\I>=_!..#XZ%MKK6#0+G_LE4U(?DS*$]3F2"[@S>*):A&F''4-<
MG._1^X+LD&%EAE495F=8DV%MAG49UF?8D&%CS!(Y<VG6ZV9A=Q1/I*S-O")_
M+8O]?6:Q6TS'ZZSQUV8842W"K,/Y"R9_P>0OF/P%D[]@\A=,_H+)7S#Y"R9_
MP>0OF/P-6>)O+LMZ91KMCN6)I+4I561P+LTZ?V8!7.AK_G4=V*8842W"M,,9
M#":#P60PF`P&D\%@,AA,!H/)8#`9#":#P60PF`P.66+PRC3+'<\3R9G;M#K'
M>M@6C7\E?/[<>EC'4ZWSV:884<7"M,/Y#":?P>0SF'P&D\]@\AE,/H/)9S#Y
M#":?P>0SF'P.6>)S+LTJBM-7_&JX<*?W1-+:I&KC?UB_Q,4C]7/KX>FPGC4C
MM4TRHEI8%M7"LNGO$&(1II-KPD>^.AEQ9]Z$#W<L?+ACL03/+1E7GI=39`[,
M69A//'89IF/[D+3HW#XP'=P'II/[P'1T'YC.[@/3X7U@.KT/3,?W@>G\/C`=
MX!>RQ-Y<,O+*-F[6B.EVFF/A9.68:A&L%?V2,JF1F5G#!G<DVW3GX43-+)R=
M[2#FXKSI,AAQ,AA,!H/)8#`9#":#P60PF`P&D\%@,AA,!H<LD3.7C?R]OW4O
MW#DYD=0V$]$(XLV]\!L!3OTE;/DAQG*[Z<_HICBICSBI#R;UP:0^F-0'D_I@
M4A],ZH-)?3"I'[)$?9-%K&G,-NN(%`XS$2<GF!HSF.0$DYQ@DA-,<H))3C#)
M"28YP20GF.0$DYPA2^1,,Z]7?XE?N..`(F7M_E<T6%D6#587S^U\3"?BK/'7
M9AM1+<(,Q/D+)G_!Y"^8_`63OV#R%TS^@LE?,/D+)G_!Y"^8_`U9XF^:<1T;
M^VU&%<DYLW@#$X<^%_8L'C-R!N/6<TODZ72=-3YG$B][0H\23C<$*NNP<9[)
M9S#Y#":?P>0SF'P&D\]@\AE,/H/)9S#Y#":?0Q;[/)V9$\II^O'KMD#<<3NA
MY8Z%_=BQN!\_MT*>3IP)*W2DX4WQR0ZF8][+74&VS[!#AI495F58G6%-AK49
MUF58GV%#AHTQ2_S-996O^WO+PAY>H_6WZR8Z)=IFFI'!EL4&^Q5T4B.3(:TQ
MV&9442W"+,L.U.Z$'&^Z#$:<#`:3P6`R&$P&@\E@,!D,)H/!9#"8#`:3P2%+
MY#0I3RBGZ<#FK_6.]1N;*D6R6A:9.[-D='YNWV,ZH":LS;%:V`PCJD68=3AS
MP60NF,P%D[E@,A=,YH+)7#"9"R9SP60NF,P%D[DA2\S-95FO,=>F3I&LF13+
M'GZ3F/O<GL=TG,T:<VUZ$=4B3#F<N6`R%TSF@LE<,)D+)G/!9"Z8S`63N6`R
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MI#Z8U`>3^F!2'TSJ@TE],*D/)O7!I'[($O5-<K2F,=MD*E(X3+"<G&"2$TQR
M@DE.,,D))CG!)">8Y`23G&"2$TQR@DG.D"5RYA+*.>=8^7:/PAUD$BEM<\RX
M+?NM'"?^$N;:K<0'D_A@$A],XH-)?#")#R;QP20^F,0'D_A@$C]DB?@F%US3
MEFWN&"D<YI-.3C#)"28YP20GF.0$DYQ@DA-,<H))3C#)"28YP21GR!(Y378;
MRFD2+/O>SM6-><Z4HZT.>Y2+>1]Y,##[?2NG_EQ484%C!I/Z8%(?3.J#27TP
MJ0\F]<&D/IC4!Y/Z8%(_9(GZ)O,-U?]'<7KS\?K3/_>WCQ]OOTFQ$_-K9O>2
MRL*=XN)E^K"PX,]<,TR-V6;9/DYR@DE.,,D))CG!)">8Y`23G&"2$TQR@DG.
MD,5R3H>TA'+ZQ>#:MNS.>PF5MBQIRWZ+SK9E'^;;,MFA("LSK,JP.L.:#&LS
MK,NP/L.&#!MCEHAO5C6A^$?:LCOC)5(XLS)R<>'*B$QRHJSD!).<8)(33'*"
M24XPR0DF.<$D)YCD#%DB9[HR^A?:<F;1Y$Z(T=@4C,M^1]*U95LT3)A]4=>^
M)3[B)#Z8Q`>3^&`2'TSB@TE\,(D/)O'!)'[($O'-2F9-6[8KGZ@M6^;;[:YP
MA\AXML\PR8FRDA-,<H))3C#)"28YP20GF.0$DYQ@DC-DB9QF:1+*^2^T9;O*
MB91>5CYA6_8;L*XM+V&NW4I\,(D/)O'!)#Z8Q`>3^&`2'TSB@TE\,(D/)O%#
MEHAO%C*A^,?&9;OPB12VS.<.:LM@DA-,<H))3C#)"28YP20GF.0$DYQ@DA-,
M<H))SI`E<IJE22CGO]"6[2HG4GIFI@+!N.QWFUU;7L*"M@PF\<$D/IC$!Y/X
M8!(?3.*#27PPB0\F\<$D?L@2\<U")A3_6%NV"Y](8<NBM@RFM@PF.<$D)YCD
M!).<8)(33'*"24XPR0DF.<$D9\@2.<W*9(V<\THF6N#98VF2W5>_?>X:[%PT
MWGV]\K^K2RIF<OPU%;-K@LAGR_Q<JS$+3#Z#R6<P^0PFG\'D,YA\!I//8/(9
M3#Z#R6<P^1RR6,[I+)90SK\_9KEC74*E'8MRR2N_LVZ;@`_S8Q;9H2`K,ZS*
ML#K#F@QK,ZS+L#[#A@P;8Y:(;W+\4/PC8U;FO)O"L7#,(MMGXB2G76/XLI(3
M3'*"24XPR0DF.<$D)YCD!).<8)(S9(F<)FL/Y31M.3SOXU5GDQ3N))NH'<\+
M`OTZQS70G8L+F%2>X\RNFI^CKY(O&R3\$N9N)^'!)#R8A`>3\&`2'DS"@TEX
M,`D/)N%GII_*J,Z)\":_?TGXUQVT4KB3?"+EY[6#=LJ<5%(>3,K/S.R<!,HG
M6^-2?@ESMY/REGESI;QETZ>=1BDIOY1]X1$R8PESCY`9>(3,P"-DQE+6/T*O
M"OGA_9_2_*/=[),_2YA[A/RQ+/.7+=-Q/J$_Q\89NV2(?)A9[`.8?+!,4T[@
M0[*K*Q^6,/<)Y,/,M//AF'S`(^3#4O:%1\B')<S=3C[@$?(!CY`/*"O1P21Z
M>+^D4YB%PAK1[<(B$GUFL>A@$MVR6/1D^U&B+V%.$8D^LUAT/$*B+V5#T9.5
MM$1?PMPC)#H>(='Q"(F.LA(=3**']TM$-PN$4/2_.07,ZXPHF[6G.<5>S'$!
MDQ>6Q5-`LGTF+Y8P)Y2\F%GL!1XA+Y:RH1?)2E!>+&'N$?("CY`7>(2\0%EY
M`28OPOLE7IC5Q4M>O'96L*N4J&/,;*ON%XPR6%K8XZOT"T"G@/S)%-VF0ZS\
ML6'F*Y8_?]J<)?>663;@?+FW1JNED'N>S'K-\V364M1_HNU)DBG+/SQ5_BU%
MW5/EWVN>*DN7HME/*7_#YR7^IDO$:>EP_IIW[-@CN^+^-2\#S0_Z%DNW)TGJ
MI+G?AOE\0)8N19T`\L^RJ\F_[>E),@7)P#E"/_)RI60@[BX#<7>YM<1-NB5I
MAFS"O6734L8]3S;AWO+$,E?S]-0XF1+>/3'%+/723K=YG2EVE>@[RX?"'5T6
M]K/M2?)Q9<I<-.YGEOG%A4Q9XD*/Z8P-T]@2-(5D.I-9R]V<H#(+3Y592UQX
M.W:MY:GN=O)L*>J8/,,CY-D2%SXB^6`R;GE$&.8_6.SE=!X;O#3]X]4'+1;V
M3+>HI[ESWN*>ELQ0.U=4/WQUGWWOF'Z2Z-AA89MYI#R_2)*"<HD(>YJKA+][
MO<3YNS<+,X=':AQ.FEZ[7/?W[AP+:MX[%M1\6)BM^44Z"XQ+Q'3WQ!VS$$W=
MT4%;2DXF?]SLML8LN[8->Z`[_R[N@8G$,FLN&O5`R\ROOX)NE"PFY-]<5+]J
MFA2^VB8M0?[9FX=3G6.^KO+/WNG%!\I2&S8?Z9BQ%(^3I9;YQ\G2USQ.+MLP
M]_G2J5PNAP],7#:K7K@<G'?J;#ZRI++'\,7]<%Y1ZTTHKC/)1S!U.C"9!B:;
MP*H,DTV(DR=@ZEI@\@%,/H!)=##)'+)$9K-X#64^)N>\V(WEG%FTW;P]2;)B
M*6S#]*^@5_CT+JF8VO*JBIGXY,_EHM/Z[(XGF7RV9?VVM'P&D\]@\AE,/H/)
M9S#Y#":?P>0SF'P&D\\A2^0T2[?09Y,S_LT?^[J3"/V0\*%P3`F2-[=(ACRU
M@7D%J5>7N)XG]<&D/IC4!Y/Z8%(?3.J#27TPJ0\F]<&D/IC4#]FL_OO'S[>W
M3_N;IYN??OAZ^_#;[>[VRY?'-Q_O_S"_(RNTB@KXFX?;7W]\^T%?&EQ/WQQ(
MH:6,NW9^HFO:C,]>*\RU:0I'N8N-KFD8R)6[.#77IK&0Y<[,M<EH7#LS]]0/
M-G+W/-N::],>'LN9Y^G+\6PY\SQ]T9J]=FZN35,A[WEAKDW]%]=.33G]>C5W
MSU-33IO&V6N7YMK44GE/XY%^]98K=V8\TG9H]IKQ:-YFP#VWIBY:A>7*;<WS
M]#<YN6NGYIYS>H5[GAH?]#<`V7+&!^4HV6O&!R4FN6L;<TV_@,Q>,Y]!?WV?
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ME<F/L&:`S8^O9VJ)^='53%;YN<I,5?F9ZDQ:Y^>I4]U-?[N6^3QFP,V/MZ>Z
M6WZT/94+^;'63%WYF>M46N?GIJV>H\0B4[>M[J8_C,Y=T=WF17LZXIF))S_O
MG,J%>0LO+6,FI/Q\M%$-]):<3`TV:E7Y>6.CNNE-*IDR6]5`[^#(75$-\K/)
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MGV]O/MT^F``M0W^]OW]R_V,>\-?]P^_34O2G_Q$```#__P,`4$L#!!0`!@`(
M````(0`2*FED[P4``)P8```8````>&PO=V]R:W-H965T<R]S:&5E=#DN>&UL
MK%G;;MLX$'U?8/]!T'LM2_(=MHO$178+;('%8B_/BDS;0BW+D)3;W^\97B3>
MZMA!7YID.!P>GIDYI-CEY]?R&#RSNBFJTRJ,!\,P8*>\VA:G_2K\Y^^'3[,P
M:-KLM,V.U8FMPC?6A)_7O_ZR?*GJ[\V!L39`A%.S"@]M>UY$49,?6)DU@^K,
M3AC95769M?BSWD?-N6;9ED\JCU$R'$ZB,BM.H8BPJ*^)4>UV1<Z^5/E3R4ZM
M"%*S8]8"?W,HSHV*5N;7A"NS^OO3^5->E6>$>"R.1?O&@X9!F2^^[D]5G3T>
ML>_7>)3E*C;_PPE?%GE=-=6N'2!<)("Z>YY'\PB1ULMM@1T0[4'-=JOP+EYL
MTE$8K9><H'\+]M)HOP?-H7KYK2ZV?Q0G!K:1)\K`8U5])]>O6S)A<N3,?N`9
M^+,.MFR7/1W;OZJ7WUFQ/[1(]Q@[HHTMMF]?6).#4809)&.*E%='`,"_05E0
M:8"1[)7_?"FV[0&_S0;CZ3"-X1X\LJ9]*"AD&.1/35N5_TDG&4H$2600_)1!
MDL$H&4]G/,B%B:F<B)]R8CJY=O5([(03\R5KL_6RKEX"5!NP-N>,:C=>(+!B
M1,#H./H11>"&@MQ1E%4X#0/LOD%>G]?Q9+Z,GI&+7/K<>WQ,CXWRH!0"7H<1
M3/T$C!2%,%):"?2],O2@$PN0\K`!@:B?`(BBK$)H2T_:=&@BN!<^\4ASFIHN
MF\[%1HE)/P$E14%QH+Y[F$YNI=,EF)V+#1.1=9C^7E2%1LX<39=%:9GH^*:Q
MQ5'G9"^.:=<O3L[FXM+2%]5&MQA%C.;05^*--D2!7=XOS3*7E!9H7Y^/J5VX
MT@D-I3FE'2D&,#K<-`6XC(><33S2HE&@6XR5YN9*G()D.D!R+B]*\\Q%I07T
M:?L;=?OC_;V13B8)X\[)@!:#S^M9X-XF(F5*.GW9*%-,)G,U4CJ-<\[$B!\Z
M[U`1"XU$.W8-H$SZRM++W/KD!ULGE=/`7,Y%+#31`"!-6@DH+VXRM^[1SC%P
MOK.J%#E]V])D-H(MCK'T,IF8_8`)TJCKF9"*IF/214X4(4DW%2^_U9A,D"AI
MJU$1I#.Z>,C;P_6GKY0W'8DTH1>U#K&.Y`VI.H&;N15ZDS#&KC(J$]^WI$)Z
M>:BPQ/&=8G!%,?:IXLPZ3#?*"S71DS+KSPHS/21C6GK>P21%3T^!-,V[5MV`
M:,XW-YFK6=KXSFJN(L;"E!CM,+//A=[+EB2:J&^75^-D/IC>7HX\E*F.RH3]
M:\SW!Y(HD-[+04>"IB6#"^84=^^;>R6A2!8X:3+!V:>)FNCV2G*3@')O"X`4
M4*U7E)?;*PDIFD;%Y4KAWM9J0A)I/UHN^G-1YJ+S<G)AJ23E(AG">.,W0R*5
M46L993(ST9];$IJ<Z,D$Z=GUW$CUTP%(DYX)W63T;&)I)!$Q23_4,:Y^\N!(
MG$F%?;SU7DZ6;I+4Q)549=*ID%Z>H@1,G7BB8HJ/T]N+@@)9]2I-)A/]$2Z+
MHO-RF+A)6A-76I5)9T)ZN4RD/AW]T*G.(YE4*)-)A7VJ]UXV%:DEHY>U@WM;
M`*14:E0H+P\5EBYRH9BG'[GAI%(AM595)H.+N7WD]UX.%S?I:"KD4+_V*I/.
MA?3R<.$1S0\U")['[`91)I.)_EHC&J3WZI@0[V3B.:AD]9YMV/'8!'GU1&]@
M2.QZV9G%`]U]FN"%CG]I.",I1E*ZZS@C(_6J9X\DD\4&$N:9DTPQPK\>G#DS
MC'#I=T;F&.%7*WLD'0(!?QIT1NC%D7^@V2,)YN!"XL.&.3@]?2-@!R>W;P3L
MX"SVC8`=G'N^D3%&>,7;V&*L@T\LSYP8T<2WAC,'T43Y.B/(`J[KOFC@6GP<
M.'/`-2Z3GCGSQ3V^2-T!O.W>^2$CDL?_GKCTV:G.//:[T>).O!W;6$&)EU\0
MXF47='C9`!GBRM$M@+?A<[9GW[)Z7YR:X,AVZ)LAOP'4XG59_-%69^@H7HBK
M%J_"_-<#_A>`X15R2(?DKJI:]0>8B[K_5UC_#P``__\#`%!+`P04``8`"```
M`"$`+SZZ6D(#```)"@``&````'AL+W=O<FMS:&5E=',O<VAE970U+GAM;)Q6
M76^;,!1]G[3_@/R>\!E2HI"J">I6:9.F:1_/#IA@%3"RG:;]][O&@<3.EG9]
M(0&?>SCGWFM?EK?/3>T\$2XH:U/D3SWDD#9G!6UW*?KYXWYR@QPA<5O@FK4D
M12]$H-O5QP_+`^./HB)$.L#0BA154G8+UQ5Y11HLIJPC+:R4C#=8PBW?N:+C
M!!=]4%.[@>?%;H-IBS3#@K^%@Y4ES4G&\GU#6JE).*FQ!/VBHIT8V)K\+70-
MYH_[;I*SI@.*+:VI?.E)D=/DBX==RSC>UN#[V8]P/G#W-Q?T#<TY$ZR44Z!S
MM=!+SXF;N,"T6A84'*BT.YR4*;KS%UF"W-6RS\\O2@[B[+\C*G;XQ&GQA;8$
MD@UE4@78,O:HH`^%>@3![D7T?5^`;]PI2(GWM?S.#I\)W542JCT#0\K7HGC)
MB,@AH4`S#6:**6<U"("KTU#5&9`0_-S_'F@AJQ2%\70V]T(?X,Z6"'E/%25R
M\KV0K/FM0?Z12I,$1Y((U!_7X='U8%<+Z7UE6.+5DK.#`[T"KQ(=5IWG+X!P
M,*1?/UK\ET.PIDCN%$O/!>(%5.5IE?A+]PDRF1\A:PV9(V>$6(C-@%!I4ZS9
MV0,7Y(Z:P:VM.812_KT(@T059$H,+0'K2TA@FMA<(D(+DEU"YO'(8M@(WV-#
M!:4(CI,QC8FE8*TA<!TA\U%`G]C-JXCL&L(P`3US7HOK-5#@%$&&1F4WEK2U
MAL1]#TV".+'SNS$!OC^;F>8R`^!'\R0:`89RV'#GRE7GO]Y%*LA*?SC2]\E=
M:\BU]+^*R*XA#!/Q>TRH(+,,9SG2)C0D[,L06`XWP^*IC+%G)B&["C$<P(GP
M_V50098#JPW6&C+K'821=VH"O07TLC88^59P=KXZ\8-3DQK2U5"WSL[XU7-(
M!5G23^>#3KZ&:&V3^=G;M71C.;"",V/U5#E#>&(*O[YI%=@2?,J'%JPAPZ:-
M@HM-:P*\>6RK-@!^E`2G>FGE>B3KT=40OB,;4M?"R=E>C5L?RCP^U5\":_@2
MZ.>F.R[`).[PCGS%?$=;X=2DA%!O.H?=QO4LUS>2=?VDV#(),[C_6\$G%X&9
MY$T!7#(FAQOUM3!^Q*W^````__\#`%!+`P04``8`"````"$`,;ZH#3\)``"(
M,@``&````'AL+W=O<FMS:&5E=',O<VAE970V+GAM;)Q;76_CNA%]+]#_8/C=
ML2C)LF4DN;B2R/8"MT!1]./9<93$6-L*+.]F]]]WJ!DKY%`FY>S#.A$/CSB'
MP^&A(M__]O.PG_RH3^VN.3Y,Q5TTG=3';?.\.[X^3/_S;S5;32?M>7-\WNR;
M8_TP_56WT]\>__J7^X_F]*U]J^OS!!B.[</T[7Q^7\_G[?:M/FS:N^:]/D++
M2W,Z;,[PZ^EUWKZ?ZLUSU^FPG\=1E,T/F]UQB@SKTQB.YN5EMZVK9OO]4!_/
M2'*J]YLSC+]]V[VW%[;#=@S=87/Z]OU]MFT.[T#QM-OOSK\ZTNGDL%W_\7IL
M3ING/<3]4Z2;[86[^\6A/^RVIZ9M7LYW0#?'@;HQY_-\#DR/]\\[B$#+/CG5
M+P_3W\5:I>ET_GC?"?3?7?W1&C]/VK?FXV^GW?.?NV,-:L,\Z1EX:IIO&OK'
ML[X$G>=.;]7-P#]/D^?Z9?-]?_Y7\_'W>O?Z=H;I7D!$.K#U\Z^J;K>@*-#<
MQ0O-M&WV,`#X?W+8Z=0`138_N\^/W?/Y[6&:9'>+990(@$^>ZO:L=IIR.ME^
M;\_-X7\($D2%)#&1P">1B.A.I%%V`T="'/!)''%Z*T=*'/!Y"09^'!D$A-LI
M`9^7SK<KD1$)?%ZBR$,CF..4=#-<;<Z;Q_M3\S&!90.BM^\;O0C%&@@O4XL3
MT4_VM;F&2=8DOVN6C@NFL84$_?&8K^[G/R"GM@0I$+*<3GJ(B"(;4PYAA(VI
MAC"QC9%#F,3&J"%,VF/F($^O$:2<J=%PVE^DT&`F1=[3=FH5"%EVZ:WE*_F%
MBE^0_((R+EACA=0>/U8-?I@"E3$G"S98Q&3=I*9)&C.M2VR'_WN.C$UK95+D
M:;)DMY!A"F52S!91OOB<3BM\6(KCP]=@'G[&PD>,&=[21I2(6*!`<9HF8L4"
MK((D,HA0/H0E`=064P*]HA,H^?ZLU9VX%"S0`C%)%^B*Y71Y:?2DP06BRP/O
M+R^-U_LK+\22``K9[1+H3EP"7L00X\L&1&`V+-,5+W%5D$$&$<J'L'2`:GN[
M#KH3UX'-=H$83(7%@JV9\M)Z?2ZK"T3G@D,@+ZW7"9078HF@72C;X<+K07=B
M(@A6U@K$^)(!$9@,BSA9);PP!"ED$*%\"$L(,`E<B!36E+\PZ$Y<"+8E%XBA
M"IC'K&Z4V&SJY.P0?@899E!>B"6#@&)XNPY=+RX$VPL+`IFA<C$(@F*)/,JB
M.&%Z5F$:&88H+\161'NAFY>(0`=EN0?QN2VCU2$0AIMD2Z982>VF8DYR!#CD
M"`[EQ]AJ:&MUNQIHR&PU/OTDJ8$@,UHG/Q!"^;&(]#_;<%0BR"+#$.6%V(+`
M>+\@B.[%%PRK?X5`$&XD,Y&P4,N^_?I.4(W`R!ZC]QOW/JIO'[R/K88V8D9Z
M^,NG0-MFIL6*37E!&)SRF4B7.<N;DA!FWKBKQ#6('"-'\"C?:&PAM!\;+P2Z
M-U,((9AQ*/1#!<@9JA;+9>J4"P3XA3!)1)1D@KD72;>YEG7*&L8L6RS3SRFS
M)=!.;+P$Z-ML"3Z9J43XS%T'*05"4*4T2\%E+IPM)$@CB<;4D@U&>2&V$MJ/
M&4J,.W4(='&V(MQS$XB2(A41RYJ2`&8@//.K$(D<0:+\&%L/[<INUP.]G*T'
MR]Y"^`P?90A"4+(<GI8.;")!%AF^D?)";$&T0;M=$+1UEB`1R])"7+R?+NYB
MZ:3'I7FPMG>"57X*V3=?IU!^C*5%/.!`PT>2KA?;4".^6`ADK@4F5TD03`Z0
M:Y4Q1!4FD6&(\D)L/;[D/^,!_QGQQ4(@#!86`FLOJ=W4RZD=`0XY@D/Y,;8:
MD.VWKY18]V+9X9Q8"61&R^:^)`AE1Q:+9,$TJ\(L,@Q17H@M"(R7"Q(^N,:Z
M%Q>$;9,%@2@]ECD+M:1V4S`W/?!&USCD"`[EQ]AJ,/^I=]H1:K@^5`CFKHK8
MM9!.>B"$TF.YB)*4>?8JS"+#$.6%V()HOW?SSJ+_:N2D!S^]$HBB3?E)K*1V
M?WI8=M3AD",XE!]CJZ&-W^UJH%VT]EG!3B%%'/24Y0#$72]!&CE`PQ)1>2&V
M(E^RIO&0->7'5P+A02+AS[3+OOFZ;:A&8&2/T0;'N8WJFP=O8VNA79^1'?[#
M:XP>T<P*Y_!*&%PBLUB(!1.I)(1_D;ANE.>-',&C?*.QA6!V-"#$@`V-6=TK
M8@2A$G!FS+@1)8!?")-$I'#:85N2[%ET,L1\<U;6*&:K+(\^J[RE@#:<XU.A
M0[/=-.:[*8%(@5SD62;8NBU'8"K"F$(Q&AF&*"_$EN)+_C,9\)^"^W$"T0X2
MP6'=?IA7$L",E6=^%2*1(TB4'V/K\24'F@PY4):]!8%0#\C>+$H^\Q,/KV%(
M11!3-"=!<#0>B/*RV((`C;E6QCW=2'0OMF:<PRN!<`OACJSL6P=+.YY=>TQW
M_&5JRK[U.H/R8VPE!MRG7FC^^ID,N$_GZ$H@SXR5!*$"DZ1+5H.K,(<,0Y07
M8LOQ)>^9#'A/7N<+`E'ER#-664IJ-^5R"X?E/1T..8)#^3&V&E_RGLF0]V03
M6Q#(C):M^)(@5%I@WQ-<LRK,(L,0Y878@@Q8S_!9+1FRGLY>BR!:"BO^`+@D
M$E,P-SW\''($A_)C;#68^1QW<DU<$^J>7`ED1NND!_+0>DH6B<B84ZW"+#(,
M45Z(+0@SH2.WE2$SRLI^D5@^,DKY8:XD@*F8FQ\!$CF"1/DQEAXILZ3C].AZ
ML6TVYB=Y`E%Q&/JS:AF&5`0Q16-I)L,0Y878@GS)F*9#QI3E>D$@$F3I/-J@
M=C-4)S]&8&3@/LK/8:O!;*G?<Z2N'74.KX1!$69QECMFE!!^&5RKR:62(WB4
M;S2V$#`<TXX&A-!HOC[8,:1($82O><)37[Z`2@+XA3!)Q#+.^4O`TKI-G#NG
M5ZM])@2\,O4Y4EL#9D0#&@P8T-A9$@C";(`_BT0B7;"Z6L)K]EI,'Z8BC"F5
M4R60Q@/1+_3K.PU#4`I\81]?YS[4I]>ZK/?[=K)MONN7\?48^ZOX18%"K(M8
MOW;,KI=B70Y=K\2Z&KHNQ1K>2'9Y%'P1H;L^[V\`WP-XW[S6_]B<7G?'=K*O
M7V!HT=T2G.D)OTF`OYR;]^ZMZ:?F#-\`Z'Y\@V]\U/!Z='0'X)>F.5]^T=]5
MZ+]#\OA_````__\#`%!+`P04``8`"````"$`I0<HKG,"``#C!0``&````'AL
M+W=O<FMS:&5E=',O<VAE970W+GAM;)Q4R6[;,!"]%^@_$+Q'M.0M-BP'L0.W
M`5J@*+J<:6HD$1%%@:2WO^]0M)4J;H.T%TKDO'E\LW%Q=U05V8.Q4M<IC:,!
M)5`+G<FZ2.GW;YN;6TJLXW7&*UU#2D]@Z=WR_;O%09LG6P(X@@RU36GI7#-G
MS(H2%+>1;J!&2ZZ-X@ZWIF"V,<"SUDE5+!D,)DQQ6=/`,#=OX=!Y+@4\:+%3
M4+M`8J#B#O7;4C;VPJ;$6^@4-T^[YD9HU2#%5E;2G5I22I28/Q:U-GQ;8=S'
M>,3%A;O=7-$K*8RV.G<1TK$@]#KF&9LQ9%HN,HD1^+03`WE*[^/Y>D39<M'F
MYX>$@_WMG]A2'SX8F7V2-6"RL4R^`%NMGSST,?-'Z,RNO#=M`;X8DD'.=Y7[
MJ@\?01:EPVJ/,2`?USP[/8`5F%"DB9*Q9Q*Z0@&X$B5]9V!"^+']'F3FRI0.
M)]%X.AC&""=;L&XC/24E8F>=5C\#*#Y3!9+D3#)$]6<['KWNS(*0-JX'[OAR
M8?2!8*_@5;;AOO/B.1)>`@K7=R'^+4(,S9/<>Y:6"\5;K,I^&2>3!=MC*L49
MLPJ8*27/F#YB?4'X"J"\3B-&]U+C$$OWYZ1?)'FGOJ1AW+]O=0U)^HCU-6+X
M#.EIQ-S]NT;OE%)\&YY3DDS[$E8!@VN'>8%8OX;H:1S]CT;OE%),1'=_G-R^
MT!@PDU#XV;AOQ7GT#,&:3&:CSAS$A6$+3:G`%+"&JK)$Z)T?I!A)N],PXRN<
M\78B6&?`&6MX`9^Y*61M204YN@ZB*0Z5"5,:-DXW;4]LM</I:G]+?$P!>W@0
M(3C7VETVO@N[YWGY"P``__\#`%!+`P04``8`"````"$`,YCXHO,'``!U)```
M&````'AL+W=O<FMS:&5E=',O<VAE970X+GAM;)Q:VVZC2!!]7VG_P>+=,4US
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M)/_>_7XOM^U^[?#P(8A<SB1\\5(T[9=2N706F[>FK8[_`8AI5^#$TTY\R5[;
MY5?SBU=`I(M+Y&W^_%17[PO9+/)2S3E7K<<>I<,^(+C\$.*E"&5HRLEGY:7S
M)<DWLBS?GIF7/*V^R51N-"8%3.0L#`8CLAZA\J;<"NN+E>0[D);A4M)<UG*Z
M"CU'M0ASY`P32,<0#R.R,8(3B!A#HG#P@L+@]X2A%JT=.5!,&KD[^._RE@)&
M_APP$49D5Q%B#H&BD%UC%V.^"`J\=F2*!F8QH98").RZ:.F%"4UPA@&,!0$.
M3B``\Z/$'P"(N=QR-G/5^]?;2"VB^:=]!)BY_%]%B#D$BB+$4<SG7X%Q_AG-
M;PJ8`+9QXI+^SI#9Y7S(+>Q9,/-NM<]-:1!G.07LS,]S5F#*F5PU!0Q<-387
M[2AEO=$T74AVC.@AW>@:(D*<E8:32>G+(LUS5XLH=].-L%L!H_/MQ33?8(;0
M6$`6"V0U6PDQ3^YAKA91YB2Q*6"`VC+RS.4A[\CLF2$(C8*LIIZ(.9-3_>-)
M[U91[N3RJ09!VH,X('LX0W8O2HB<"63W$RMX'('2,*MMYMN%@>+9\Y%QDM94
M@X#YDB4):>9,`_JZ$+/`9L]2#\Q<"9G%_+;QR$#^<`3QL*.@XS5($V2^J3XT
M#K9[HQF#[*'9$IB_4K"/\P?=P_Q)[5/6BZ,:%TOFDO@R;/=H!06R2XD;TH,#
M4#IF!7"E=4#U$'&?E#YE`.IG34!:*\-V;HUOV+/:K@OG>Y=2K\3+8GYCZX#D
MX0C(MDS5:5O.)6`P%B=MU@$&`=GU`B\/3.%PYI6(?9P_2!_F3Z9YRFQ]7/+(
MU%ZW/K*'U"[T>@C0]^)+%5""]O$(0`9Q!&1SILS6RB7S28HS;>_'$XN)`X$`
M++AT.F9*VCX>`@@B#L$D2<\?6S67?!0!,C.ZBT3'K._!)4^,+.(N4@I'`KA^
M8F"@BS@`<P4=@"V>C/18IEWH76K-=[V)[<76%D?D/:*\\\.G0Q/%I8V1:A#0
M\FGC(^N2D7TOD-FD`W/^D-9Z$UKKDX&8:E#?S`GS"+&,(,*8WM`(C.!>=(F^
MK#GME^OW(YY:16Y(?#/7H%\T:.Z.Y#I$S$)P)8CV7NF>"<VE_9%Z`.HK$41D
MK&08X'.7=)C``.;'1ATQ>:*[MZF7-Z&_@;F"KH.MOY$_;B;;+@\6'KW[$OHR
M.@T>DX^.ID\/ZH&2W4U72C"AO?1(G'8NS=P;KMO%E@W6F=LLC>F+*)]Z#4YP
M">X28&]"@`,R'%,-@BG$/&+.D#FVCF8P.Y'9Z`8F?Y?V>A/:&Y`>3S4(\A<R
M1NP9LK.8S@&A[1!\?.GPX-VEO-TJH@'T=C75("`047.&S`%]A"B0F3$CZSC_
M$[I[PQR=T%WZ9"GU`-3WKSN^;<2(.."&I.X@Y")FX84MH!C;^_>V*=2MHD4P
M?0I32(,@"I;0`UJ&[/(&<WSSBQ'<C1(CG*@6G$CRC5&`-,LV'!X3RG/B,"IT
M%`":T[3NZFI@&3_$BYB%X%#NDF<.\BQ_FE`8E6<-T@5Q0Y\T388`W&<N*:G0
M`#M2ZQD7CD,)J74LG1<&KM"TH4;\`30T%)&]3#L!NR<[#I=2:#M,A=!Z((F)
MWZ7+?$J7R=$@U2`=@!=:-[9=LV4(P$/ND@H)#;@6PH=$F4^(LE55O0T`!-27
M?F!-14T=`,!LR>GS1:&OHAUP[EOW.SC_=XDRGQ#ET)Q9=!```@Z)ZY)=FFDG
MVLYC4C^![/*NV%(.',)=TLPGI#DD!X=4@X"B[R=4FI%]'*+`=CM$',%=VLSA
MCA8-U)`P3#7(GB&C.H"?&8B8]8)#N4NG^81.6X\`=3\!"'J>GH(R[0*L=!@+
M;#7['''W[U+G;A6Y5[/T'[AKT$R.L^L0,0O!H=PET3ZH+]*UD*A2JD&0:&_T
MF!>9XXCL*(',$3>B@>G?)<O^A"R'I-M3#;(K0<=OIC&P[>6C(B)]`MEY:`6)
MHY`7L47YMG.2KU81<0Y-GG0_`6@^BNL8H2^F=XT9'CB.NS1:OK(QBH/>F:4:
M!/\89JX_$CH-F`M4O1RBKG0!`Z'`VQ_PEL2QJ%^+K#@<FL6F>E-O=C#YG\WA
M6WCK))5OG72O:*P&@WSIXYR_%G_D]6MY:A:'8B>7N@^1U.(:7AN!#VUU[MY)
M>*E:^;I']^=>OMY3R+<?W`<)WE55VW]0+Z8,+PP]_P\``/__`P!02P,$%``&
M``@````A`)1(<0R%!0``'!D``!D```!X;"]W;W)K<VAE971S+W-H965T,S`N
M>&ULG%E=;ZLX$'U?:?\#XCV`(2%IE.3J@K>[5[HKK5;[\4R)DZ`&'`%M>O_]
MCK$A>*`FV3ZT2>;X,&<\]G'<S9>/_&R]L[+*>+&UB>/9%BM2OL^*X];^^Z_G
MV<JVJCHI]LF9%VQK_V"5_67W\T^;*R]?JQ-CM04,1;6U3W5]6;MNE9Y8GE0.
MO[`"(@=>YDD-;\NC6UU*ENR;0?G9]3TO=/,D*VS)L"[OX>"'0Y8RRM.WG!6U
M)"G9.:DA_^J47:J6+4_OH<N3\O7M,DMY?@&*E^R<U3\:4MO*T_6W8\'+Y.4,
MNC_(/$E;[N;-@#[/TI)7_%`[0.?*1(>:G]PG%YAVFWT&"D39K9(=MO97LJ;^
MRG9WFZ9`_V3L6O5>6]6)7W\ML_WWK&!0;9@G,0,OG+\*Z+>]^`@&NX/1S\T,
M_%%:>W9(WL[UG_SZ&\N.IQJF>P&*A+#U_@=E50H5!1K'7PBFE)\A`?AMY9EH
M#:A(\M'\O6;[^K2U@]!9++V``-QZ857]G`E*VTK?JIKG_TH04522Q%<D\%>1
MD-#Q5PNR"!]@"13+_,8"A.847"FGJ0Y-ZF2W*?G5@I:#A*M+(AJ8K(&P+8L4
MT17JLSI!@03)5\'2<$$)*IC<]UU(PHW[#A.2*DPD,4O;ZC!$1\0M0E1?T-+>
M!R[DVR4-<G'2`73$^%RV.8I!.,>EGD$TQ/@Z(AXB`@2A0\CR5@M-!\PDUC'_
MM"=;'6+0UH9]J:MC2%9ZEI'$P.\.@Y3&DPAJ0F@JH&VPBNG9$(.V-I2JRS`D
M3TB%Q#PU_10XBT`/QWIXCL*T'_:=Q;P;K24/Y>XG;VXA`49)^U['V_1L)#%A
MD_0BN#VUB<;]:.`CP;0?]9>+CEG+.'PD8P'&&:-E%TE,T&0\6R(]<3_J!V@L
M[4=G9/Y)RK#H^T46F\QTAXA!J,]]M-0BB3'U^22"FA!:X<51H+=5FEM%@''A
M48=&$K.0K>)YN/(R;!!'30@M]2<]=3$!TQN-&(0EH'Z.)$9*"):+@089-VDP
M(30-!';X^^O?H''VM_:4:U6!^NF%_FVOEDMV!(0V4VJ$Z"*$I?6:Z+ZE0*01
M:KNECY*(%$C.!9PN<3NI>%\LHJ!&B*Y#F-SC.J0UZCJP=Q$)DCK(<K#MJ[A1
MAZ08A^@Z`(-UA)-'"2)&X>9"FWFD0.-)J-:2/`8(-;+H4H3AH2F97N1$VB3L
M)#TC'DR)!!GRC!6/`4*-$%V*,,*>%/-6*X[Q>#8"U/V1`JG5L<*V':NX,7_Y
MG'&(GK^PQ5[^=ZYR::;:ZL"&&Y&^X_K(4>(N>IO-P1IO"<8@N@KAC(^KD'ZJ
MJ\"^35K3%5\5YJC=XBXZEF*S<J@1HJL0)OFX"FFMN@I4[8BT_BM4^,@:XRYJ
M4-$2C$%T%<(FD8H[%K<T5UT%RC,B)@=6^]0DA!I9-"D^\O'[#B/-*'0<''SM
M4:#Q%2JE3$.H$:)+06YNWJ?\$1<?[%,*I-R/#&U<`0P:J1&B"X#6P&TU?3+W
MQ2AD?P$^6RF0_"(T6ZV0/<8J;M0AGS,.T74`IJ]C8B($&N>/CGV1+T'C#U>]
M-`FA1A9=PO^R;_\>^U8@HY1)AZ=&%EW*0_8M;KX&LX%<*U(@`@8G-MNE`PNC
M_[/\988\)GY\"$5#/,>[=;6N$!G\1+^-&3LRO<@W^;+JMTD(-;+H$D;<?=I1
M?&G<X%N&XZ("&?NM/0#<>-"44R.++D78:,\<)V9#FJYNBNCA$5Q%BZ9L^PV=
M)F-S6%QDCX^6:<M+:GD-F[/RR&)V/E=6RM_$!32!#N\^E9?C$5R.-S?);A>`
MN^E+<F2_)^4Q*RKKS`XPU'.6L)A*>;LMW]3\TEQZOO`:;J6;ER?X+P2#ZU7/
M`?"!\[I](^[/N_]K[/X#``#__P,`4$L#!!0`!@`(````(0!V"FJZ7BP``&[Y
M```9````>&PO=V]R:W-H965T<R]S:&5E=#$V+GAM;*R=W9+;QK*E[R=BWD&A
M^]-JD"";[+!UPB()@L0/`<:9F>NVU+84EM2.[M[VWF\_JU"9J)]5(IN2?2')
M'[*R`*S,JLH"2/[TW__^\OG57_>/3Y\>OO[\.KNZ?OWJ_NO[AP^?OO[^\^O_
M\S_%?RU>OWIZOOOZX>[SP]?[GU__Y_[I]7^__=__ZZ>_'Q[_>/IX?__\"AZ^
M/OW\^N/S\Y^W;]X\O?]X_^7NZ>KAS_NO./+;P^.7NV?\[^/O;Y[^?+R_^S`T
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M2>;*;C_\9WW_]!ZW%&ZN)C/CZ?W#9YP`_GSUY9.)#=R2NW\/?__]Z</SQY]?
M3R=767X]A_6K7^^?GHM/QN/K5^__]?3\\.7_69M,/%D?$_$QQ<F+C_G5[.9Z
MFEW@)!<G^%N<Y%<WV?5R>H,3.=$YC@X7@+^EW61V-5G,LMEP"2=:SJ4E_M8>
M3_9T(_;X6WN:7BUFLWR^.'..R+;A'/&WM#Q]34NQQ]_:$_YYXE(RQ(V5$4II
MDQ>>7*;RF7](V_D8`J<ZA=ZV4T_X%][[3.4VL7KI":MPF5,NF[B`.W7*JF'F
M1)Q.7Q1GF8IH_O&R,WYC<VU(W?7=\]W;GQX?_GZ%`1$B/?UY9X;7[-:XTZ2U
M9SZF\;>R&.EKO/QBW/S\&E>"#'W"V//7VWGVTYN_,%J\%Y-W;!)9K-3"#`W&
MZSH&FQ@4,=C&H(S!+@;[&%0QJ&/0Q*"-P2$&70SZ&!P]\`;JC!(A%_X)B8P;
M(Y'>W7<*G&:34+*56FB3=0PV,2ABL(U!&8-=#/8QJ&)0QZ")01N#0PRZ&/0Q
M.'H@$`1CS#\AB''S\VODW)@S^764$N^LC1FB1J.;2*319%2)R(9(061+I"2R
M([(G4A&IB31$6B('(AV1GLC1)X%HN(7_A&C&#<9*3!6C(#32B<TIT4:3430B
M&R(%D2V1DLB.R)Y(1:0FTA!IB1R(=$1Z(D>?!*+A-@>BI9>2.@D9ZT$;O:GO
MA&!R'M7*K^-1;C329FLB&R(%D2V1DLB.R)Y(1:0FTA!IB1R(=$1Z(D>?!%K@
M)EZ@A;$.M1#B)J`5D361#9&"R)9(261'9$^D(E(3:8BT1`Y$.B(]D:-/@AN/
M555PX\T2#84%A+IPD68<A9H(">>@:33!C$9C?A#9$"F(;(F41'9$]D0J(C61
MADA+Y$"D(](3.?HDD`DW,9#I]%AEK$,MA'CY061-9$.D(+(E4A+9$=D3J8C4
M1!HB+9$#D8Y(3^3HD^#&HQZ]X,8;Z_#&"X%_;Y+(HR08C<8D(+(A4A#9$BF)
M[(CLB51$:B(-D9;(@4A'I"=R]$F@A:G^+Q!C,`_54)2/A<J*T9K1AE'!:,NH
M9+1CM&=4,:H9-8Q:1@=&':.>T3%`H1:FH*3:?G)C9H[3@U-F2U&L<C7:WRF"
MOF.69#?Q4DJMT'ZTRJ]G8RZ%YV?J*__\SIR4+<>"DQ+DQPJAM=E,,BGOK#:,
M"D9;1B6C':,]HXI1S:AAU#(Z,.H8]8R.`0JU,'63K\6P#W2S>$&L2,7EQXJ@
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M=8QZ1L<`!9$R@6*!%B92I@L\>#L7*T/+2!;C#"B,%;<.L:.*-@QB)7-C3WA^
M9L7I1_*96)$%JA?`$T%NNEDQ6C/:,"H8;1F5C':,]HPJ1C6CAE'+Z,"H8]0S
M.@8HU.*[5[837MDJ"F/%C1@2*ZF5;>8>[83G9]99%\2*79;Y5=!$D#<#,5HS
MVC`J&&T9E8QVC/:,*D8UHX91R^C`J&/4,SH&*-3"+#,OT$)6I7[>"L+<[@K@
M+"Z3S;LH9LA9C/7UFM&&4<%HRZADM&.T9U0QJADUC%I&!T8=HY[1,4"A/)<M
M[">\L%?DIXI8.;1FJPVC@M&64<EHQVC/J&)4,VH8M8P.C#I&/:-C@$(MXH7]
MF2F.5_,306&JQ&LT9Z5;46M&&T8%HRVCDM&.T9Y1Q:AFU#!J&1T8=8QZ1L<`
MA?*8XN*"D4QJ$7\D$^3R8C4AM&:T850PVC(J&>T8[1E5C&I&#:.6T8%1QZAG
M=`Q0J$5<UYQ)%2YG)EK.8-[PII5X1\TS<\GBFBK;).R*!-LF6)E@NP3;)UB5
M8'6"-0G6)M@AP;H$ZQ/L&+)`K^EEE=Y@'I84BKS<8;1FM&%4,-HR*AGM&.T9
M58QJ1@VCEM&!4<>H9W0,4*A%7.F=SIVIU'+>.*8(8Y>7.NZ1A%VR.RO-DC6C
M#:."T991R6C':,^H8E0S:ABUC`Z,.D8]HV.`0GDN*W2G7.@J\@I=1FM&&T8%
MHRVCDM&.T9Y1Q:AFU#!J&1T8=8QZ1L<`A5K$A>Z95.'J=BHH3)5X)\19N509
M&RK:L%7!:,NH9+1CM&=4,:H9-8Q:1@=&':.>T3%`H3R7U?E3KO,5^;,*E?YK
MMMHP*AAM&96,=HSVC"I&-:.&4<OHP*ACU#,Z!BC4PM3?+U\=3Z5<]V<502@>
MO5DE7I!IP[FK\QEM&!6,MHQ*1CM&>T85HYI1PZAE=&#4,>H9'0,4RG-9G3_E
M.E^1/ZN(E4-KMMHP*AAM&96,=HSVC"I&-:.&4<OHP*ACU#,Z!BC4XK(Z?\IU
MOB+,$6.J\)LC*:L\^\83WJDI1"_(7ZE;_?P5Y*)A-3C%.MZA-:,-HX+1EE')
M:,=HSZAB5#-J&+6,#HPZ1CVC8X#"`+FLNIUR=:LH7':X![:R0I>&WIZI:^B6
M'615L-664<EHQVC/J&)4,VH8M8P.C#I&/:-C@`)Y\LN*V<$\+&85N;Q8,5HS
MVC`J&&T9E8QVC/:,*D8UHX91R^C`J&/4,SH&*-0B+F:'!]RSX66(YX^?WO_Q
M[@$C)(P2*_<I/E0W),(O.=>X@E`;:"*L!,V<:FM!-U@SC@/Q9!D]F]@X*_55
M,-HR*AGM&.T958QJ1@VCEM&!4<>H9W04-+<?<?8_?I?'-:Y1[1OOWP\J_L_#
MGX.*%TC*=?'0J_D$M">IM0HDM6@1+D.CYY$;\04K)ZEM:"]WB*NM6'GN2]?0
M14P^<0^]AX8[9Z7N]X(\]Q6[KUU#W[U[3CJX;YR5NF_9_8'==ZZA[SZ*]]Y9
MJ?MCX#[,8%/H^@N/.(-5^T0&X[G6F,)2+WL+DMPB4[.,R9E/XJ<A8C6?CDJN
M74,]_XU:Y<,'<;/E;(%/H(]OM0QWM=!F+B:VVLPY+]7*/ZOI-06`G+NYP+_>
MYE?QBS9[=>,ZJ[BS6M#"]=\P:MG7@7UUW+!G=`Q\A4*;PMH7^HR@QCR:-BTR
MZUI/T+A"S*W5W-V9M2`T=(**KV"%-(GV,`MI:.:?L<>I]_*UI#GU6+H>_8:D
M\G@21N7KJT44G'O7OYYX)<B[O%K0PJWC&D8M^SJPKXX;]HR.@:]0Y7@?($[G
METW(O#V06Q1E<Y2#*[$*LMDVG/OB"PK%=Y61Y+/TZ,\$"?'%ETNQ4D_"C]-$
MBH\G8<3/LJM9-,GL]9)=)%?JVO56"UJX::UAU+*O`_OJN&'/Z!CX"M4W.P)^
MC@_JX^M"D#]F-:9C^07SN.PQ^..Z1=$P$!<WN;7R\F0MZ&98D`P:;Q1E=EQ?
MS"?7RTB&0FPP"&@2;MEYJ9["H8(RWI[5S63H#R_M4L9;`Z^SBCNK76=Z2HTB
M]9Q%GELQ\#P?V'.G;DY>1J]6<MNN\R@/CT%G88C$NQ\_'B*\09);%`T6D;`K
ML0H&"]L0XYO>V(U8(>B'/$V'B/3G,G7+SDOUA%'?FTTH1.04YM\,$>JLXLYJ
MUYE>2:-(/7.(D.<#>^[4S<G+Z-5*;ELB1/S.PA`Q.TG_["AB/$:+"8O"460:
MB;'*K54PBE@4C"*"3HXBUL9+ORT[+P7!^<D0D?XTUWD4H<XJ[JQVG;D0B3QS
MB)#G`WONG.<3E]&KU;='$;^S,$3B+;)XF:$SS9E%)F^=X>N\HA<)5XS6C#:,
M"D9;1B6C':,]HXI1S:AAU#(Z,.H8]8R.`0HTFB&(@S0^K<5@'N:H(H3!.&#F
MTZB:73DK#>,UHPVC@M&64<EHQVC/J&)4,VH8M8P.C#I&/:-C@$)YXJVS,_+P
M'ME,D%M9KQBM&6T8%8RVC$I&.T9[1A6CFE'#J&5T8-0QZAD=`Q1J8?:._!GO
MC!9VJ\E_8WTF"/L&8ZID-W%MG++*IV[_)CPILP=QP4G9+8O@I`3Y`4)H/2.T
M850PVC(J&>T8[1E5C&I&#:.6T8%1QZAG=`Q0J(79*?"U,//==&&^]3&UM>UM
MC.&S4?'21Y$K:%:*(,48/OG4E1#AR9C*U3^9,]%J"]T@,`2Y9?9J1FC-:,.H
M8+1E5#+:,=HSJAC5C!I&+:,#HXY1S^@8H%`+4R_Z6L0+H1?MM\QLU1E(9)&_
M6RY6WG;V6E#P`"2?1L/.QEGI#%TPVC(J&>T8[1E5C&I&#:.6T8%1QZAG=!24
M>`""6\BJ_;,/0(8NHN645%QNIV@E5H&DUNK,`Q!IZ#\`$>0]H=BR^](U]$8:
M>@#BK#1B]NR^8O>U:^B[CY:,C;-2]RV[/[#[SC7TW;L)=-A5ZIV5NC\&[L,,
M-D5.G,'F8PC!CMF9(=862D'^6A1N@4RC#>[5S%KY6R""T%!/?J-6]NG'-)O-
MX@<6A;;R=D"TE=NK+-7JY-;!3JWTX4>>7_O_1:/+7LU=UQ5W70OR'X4P:MG7
M@7UUW+!G=`Q\A9+'U>L9=;E*G5D4[5Y$NW`KL?)W+UQ#IZ[X6MH-)]SJZ,&6
MM/&W+MASZ3R[U.!=;[5:#)U%/>VYIXI[J@7YSSL8M>SKP+XZ;M@S.@:^`BDQ
MVG'V9I>^@#!X"0=K05'^1L\H5F+EYZ\BM^C>*$*R>ZN[:,>\T!XQ\8]6_+Q#
M?7E9K<B,6?I=Q:R\6EGELZMIM!V[=_UK:%;:QG56"_(?=S!JV=>!?77<L&=T
M#'R%XL<EM%E\X=N@S%=Q!*/WRY]WS+G,%A3E>G3W5F+EY[H@?Z=2D=URF\SP
MA?Y1#A9BXF<[^R[5T>F-2K6R&Y6SJRPZZSUW5G%GM;IQ!4NC2+=`E]'8U[+G
M`WONU,W)R^C52CJ+=Z".05]AA,2%_3\0(5S\SRT*QXH\$G8E5L%881OZCSO$
M2AYW3&99(D*D.S?A;MEWJ8Y.S_5J99])X/OEHZ7:7@SP.JT;%6S_WH74ZL8M
M6AI%^K1CZ:K98976LN>#(,]SIVY.7D:O5M+9)!I;CT%?8828W0]>_OW0&"(;
M*MXS4UR1V04(QY`\NM<KL0K&$-LP&$,$G1I#K$DPAECD^2ZENS,/.]3JVV,(
M=5;QA=3JQA]#Y$*^/8:0YP-[[ISG$]-?KU;?'$/\OL((,3LX<83X2XR7/>N8
M&S?1&D.0RYJ56CFT9K1A5##:,BH9[1CM&56,:D8-HY;1@5''J&=T#%"HD=F]
M\C4ZO:*?RV:7GZ&"_-57GD6USDH;NM%PS6C#J&"T950RVC':,ZH8U8P:1BVC
M`Z..4<_H&*!0'K.9=8$\=N_++Z<Q;@W9XU;5*T9K1AM&!:,MHY+1CM&>4<6H
M9M0P:AD=&'6,>D;'`(5:F/TE7XL7;V7C%2X:P02Y47VE5EA(C]5(GKLMFO!D
MS/Z'?S)G\M9NEP2!(<@/#$+K.:$-HX+1EE'):,=HSZAB5#-J&+6,#HPZ1CVC
M8X!"+>)=D>_:RI[S9HD@?RM;$';E=%6Y%A1N9>?1HG'CK+1AP6C+J&2T8[1G
M5#&J&36,6D$H7W&JP9TV*ZX@ZH<[_2.OZ0T>P\6%(/^N"_+ONB#L(YNWJR;7
M\8RW<0;C#1=D+VQ8RV_9<^D:BN=(RITS4,][]ERQY]HU%,]N<!G.IG$&ZKD-
M/(=BI#81+E_>W?#&@2`L^O4T5HK<J\)K1<YJH\A9%8+\%3U;E8J<KYTBYVO/
MOBJVJA4Y7XTBYZL-?(7WU52)+Q_:\4IF/+D("LKJ15PSJ9%;RJT5G2P9-VHE
M+\A%?@L][%9Z6T6NJU+1R:YV:F6[FD1;)7L][+JJ%+FN:D4GNVK42JXJVN]I
M]?#052B7J7]\N;YK]+^Q590_00L*2M]%O*X6(ZQ:-%76@O`I)D4;16X[LE#D
M%B!;0?A\IS8LU<KYVBG""8_+E&G\8U5[M7+N*W9?JY5SWR@R'W+[Z^TTVC=N
M]7!B;C`U(>GP0W.#\1C-#1:A)M9;M#+SKMFA<!&W%F0^;.#=HFA;:Z-6=@;Q
MOA-R&(L+]>N4W2IR797JY&17.[62R8KR2"[!=55Q5[4Z.=E5HU:VJ_BS1JWZ
M3>117(G&>?2RW0*SA1V+)LAM#:S4RJ$UHPVC@M&64<EHQVC/J&)4,VH8M8P.
MC#I&/:-C@,*Q[K)R](;+444H*\;4R',:U:2A&XG6KJ%FWH91P6C+J&2T8[1G
M5#&J&36,6D8'1AVCGM$Q0*$\<85ZNBB\X;)4D5N[K!BM&6T8%8RVC$I&.T9[
M1A6CFE'#J&5T8-0QZAD=`Q1J80KG>#JR;\J<444J;C?(O[L1Y$^YV4TT-:Y2
M5GGN7IP(3R^N6<^<%!>G-X+\4"&T9JL-HX+1EE'):,=HSZAB5#-J&+6,#HPZ
M1CVC8X`"+19Q57M:B\$\7)8H"D?5:)I?.2L=0M>,-HP*1EM&):,=HSVCBE'-
MJ&'4,CHPZACUC(X!"N6)Z]PS\G`]NQ#DI0JC-:,-HX+1EE'):,=HSZAB5#-J
M&+6,#HPZ1CVC8X!"+>+:.%XDONBM4;R#$:\1!?F;/H+\31]!9A'K5B_QNP$;
M9Z5Y5@A*;&GAO2Z>)R[?11G<1(."+2G]712Q\BJ\M2(7FQM%;O55"+*[**$B
MIG;PY[DSV6%+#;_.75@4[%;D>3R[J96;%M>*W")^(PC/NTSUF,WGUS/Z;+PV
MXQ)D$9<@9ZZ%2XW!`SVNCAZJK]3*W>"U(E\&ZQ[?YS-<RV0V7\:O1A32+*7+
M94MU\]9L5#8)BG2)-D96:N7K8GVAH<;_QEEYB3.+*N)"K=!^3"__1:XP\.+%
M[O<-!;P&7E@4[+ODLVB;:R56_L:+('_C19&_<LMGT;9KH5;ARSS?6+GA[<$P
MX8;K_I%]CL%C-';8%6>H_2S:B%Y)0V\W9"W(?S%'D>RLS19+_Y,[=K-#;.S+
M,J',\4+UQR^7U[(+BR+)XZI4K`+);4-LDKM0%R0?#IU-)M>3R%,AGA)INXS7
M@G%4OVP79'`32JK(9>6*T9K1AE'!:,NH9+1CM&=4,:H9-8Q:1@=&':.>T3%`
M04@N+UL0#N:1%K(@#-;K,Y?P0U*LM*$W33#:,"H8;1F5C':,]HPJ1C6CAE'+
MZ,"H8]0S.@8HE"=>(YZ>Q9>\&%3D)N,5HS6C#:."T991R6C':,^H8E0S:ABU
MC`Z,.D8]HV.`0BW.K6Y?M%Y?VI6LOV@4Y*_7!?GK=4'A>IT>C3LK'<0+1EM&
M):,=HSVCBE'-J&'4"O*>(!\$V3L1WOQX:?[#4^>25^^"`B&L52"$15C@R9/G
M:$;<B!L8.`UL&^]:MV+E>2Y=0_$<+5)VSD`][P5YGBOV7`M"\(CG:-G6.`/U
MW#(Z!"C4)RXWOG.NYS)D*:4#[N"XD*8'P&KDK=P5^>WH`Q$;L=(BB[[`MU`W
M3LRM(M=9J>AD9SNULJO'F_@QV5Z/N[XJ1:ZO6M')OAJQ&B]L'L52JVZX=%S&
MY5:LY<L&.J["!L=114E/@=7(7RE85WXQ(E;X2D,3T/ET&==?:N!6LUOV7*J5
M>VB[4V0]9[-)5"7NU<!YKMASK5;.<Z-(WC[.%]&^0*L&_$!XF2P0?Z10&CQ&
M*SE;+'HET$JL_`?"@LX\$%8K&^JSV3P:<`KU[&)]J\C%>JEN3L;Z3JUL9Y-)
MO+6P5\^NLTJ1ZZQ6-R<[:]3*=I;/X\J_5<^)Q$J6N][GU%Y8$-F"-EA"6(3Q
M68?OU9+0FM&&4<%HRZADM&.T9U0QJADUC%I&!T8=HY[1,4#A1&9*WI?O`2YM
MA1QH(0A_C1-6'K\\L-*&RU&Q-:,-HX+1EE'):,=HSZAB5#-J&+6,#HPZ1CVC
M8X`">?!)J(OTL?;A.#<RKR9*L'6";1*L2+!M@I4)MDNP?8)5"58G6)-@;8(=
M$JQ+L#[!CB&+Y+EL/R&[EMT#-PR_&YF_T9CQ[Z%K4]\LG[DY-3JQRRKIS/P^
M=[2)/+(@;L3.,<0-,<0-,<0-,<0-,<0-,<0-,<0-,<0-,<0-,<0-,<0-,<0-
M,<0-,<0-,<2-SR)YXN+Z]$9'=LUE],@P\7D#;_S`PC/3N1**B3NWZ(1BQ*`8
M,2A&#(H1@V+$H!@Q*$8,BA&#8L2@&#$H1@R*$8-BQ*"8SR+%L$RZ8*+,KHU]
M/!`+<\FS&NT<@SQD!WF(01YBD(<8Y"$&>8A!'F*0AQCD(09YB$$>8I"'&.0A
M!GF(01Z?1?*<*\A?5,1EUUR0*_.W291YNQE0S;8-=ZSH";-GIOD((6W3Q#/F
M[/I<=?JR1;3U$\>C+33#1T7T^%:;>H42+G9LJE>!$!6&BQD')'J]&!<K9EPP
M9-=QW7=N6+0EG+\<M3ZBJCO/>5B4ZL_52+@HR[S'[K@H8?91[@(KVVBO'Q=D
M31*/A+)K4Y7XR^OOVENP;F+Q;,$3BD?/.K5I*)YMZG\]^6@7SB;19@"N57J%
MAI[&[I9$61E7%S^\C9E=<P6B+'H&&.T`8:BU3?V'@,K\IX`C&Q\#QC4O;H-U
ME9(\BU?LL>0O3-C!3Z2Y,J_NS9BM$VR38$6";1.L3+!=@NT3K$JP.L&:!&L3
M[)!@78+U"78,61BJV84K^<$^ED=6]PB.,3GR>;15M\JTJ5<+)Q@4&]WI&`O%
MB$$Q8E",&!0C!L6(03%B4(P8%",&Q8A!,6)0C%B?8%#,MXL4,\MK?VP],UED
MLASW:R]E;O4%>?QE^_`X%PE%#/(0@SS$(`\QR$,,\A"#/,0@#S'(0PSR$(,\
MQ"`/,<A##/(0@SP^B^0Q:VE?GG@<?-F*+),E>:":9<&*3.R"%9FP<$5&SQ`S
M9^;EF>T"395!2&(0DAB$)`8AB4%(8A"2&(0D!B$M2ZT8,[-*IAO_(YOGV>`R
M'NSL8CP4P;)0!,N^_?Q0O?L/$)5YS_EP_\D[[G_L/9KUH<9HH4I"#<L\[U"#
MO$.-L>TWGB-Z%NH=VOC>HZ0P"WW2YN(M\0PK7JHNA04+0GIRJ"W]1QPCPWF/
M\Q8_.QS-Y+E#_,%!C'[VK+SO38)HPES^0C1A)_N#<F/3X>['+]E`1NH/,HZ-
M5!#(^)+^D&=C4U$[_$Y"".OW%PEKBII3PKYPM+.U$3K2LW^795(OH<H8U:''
MB*.5V]+!K&5;^@\21V8_I!E_$@4:2AOWN`\:RADXW]"0?$,P8=;WY"8JNB`8
M.8=@Y!R"D7.H$SJ/5E40Q_<=B6,*-!+GQT9$6_.%0EGFE5I83%@6IIME9QXI
M:E/\K,T0CO'=A%3BVY6PD(KZ@U0OZ0_JB9E\_-/[)NYA$03UJ#^H1_U!O9?T
M!T&#_B;QM[!!4;^_2%%3AI*BWS&.VG(VE%%8L"8DANPBAC4A,<A$##(1@TS$
MH`DQR$`,,A"##,1PSXGA-A/#FI`8UH3$L"8DAC6ASR+93-GLRW9NR6[+[%`>
M84CW<3C,Y_$[WEDVFNE("L6(03%B4(P8%",&Q8A!,6)0C!@4(P;%B$$Q8E",
M&!0C!L6(03%B4,QGH6*3>#?CC&*#?;125.8G%+-UQFR38$6";1.L3+!=@NT3
MK$JP.L&:!&L3[)!@78+U"78,622/*8\O2*B)E-/^^D(9@L!+J.@%EE7FS%Q"
M,8-B?L5N/R*08%",[*`8,2A&#(H1@V+$H!@Q*$8,BA&#8L2@&#$H1@R*^2Q2
MS%3,ER@F%7:@F##LI*L6T(<A4HHA%&*(I&((C1A")(90B2%D8@B=&$(HAE"*
M(:1B"*T80BR&4(LAY`I@I)<IM"_1RQ;FP90UL2PHE87A]\A40JAE[<RW!'B9
M&+]OZYEI4\AGF^+G?I1!/7'G0@?B);MP^_=#PD+.T4S=04UA[HPAIF7>54#+
ML:U_%=$GFJ'N:*9=0%S+O*N`MM0%I!W;^EVX=R&&JX#8HYEV`:W]+B*I3=WN
M2_U].U836_Z'$6"9^4YW3]EHKP(Y;,V\VXF@L,S;B4(&$T,$2!=!!(A=$`'4
M%G(3@]S"`KDM\\X/<E-;:$L,VEH6:DO^H"VUA9#$(*3O+Q+2U.FGA'SA(QCS
M2T?Q,WQAYLN5/26C2A=*VJ9>+0@E9?L`)SXV36RSJ)G=9LFNHOR'TN+'C?[(
M=>H/N3[VI^$/I<7.OAF?W^#S?-%,#^7)/Q*=_$-Y\@_ES_I'))!_9#GY1R20
M?T2",'MS\//5T=DC+GSO45R8+0(_+LXM9NV60IC)EGD/$2$V,8AM6?!,,B6V
MF.DO%$0C,<2V!O9)XS"N06SJ#V*/_7EB"Y-GUS<+^G4VB$W^(3;YA]CD'V*?
M]0^QR3_$)O\0F_Q#;&'RPQU7U]$D`K%][Y'89O?@$K'M;D,HMF5>%D-L8A#;
MLF#K-26VF&EF1Y<#L<4@R&SJ#V*/_7EBBYU\?GZ*54U4%$-L\@^QR3_$)O\0
M^ZQ_B$W^(3;YA]CD'V(+T\R.][L@MN\]$MOL.5PBMNQ1N(GQ73:Q+,QL8A#;
MLK.9+6::V=$4`;&M09C9U!_$'OOSQ!9F,_MF<I/'N_$0F_Q#;/(/L<D_Q#[K
M'V*3?XA-_B$V^8?8PC2SHY40M/:=1UJ;W8I+M);=C4!KR\+$)@:M+3N;V&*F
MB4VOS:B?(+&I/V@]]N=I+78R94_QEF+X8`)22S/G'E*3>TA-[B'U.?=0FMQ#
M:7(/I<D]E!:F:7T=Y0&D]KV'4D\OW'T:[*/=)V%!6C-;9\+.I;6:V<C-KZ+U
M1Z%^@K3F_DJU0W].:G5NTWIV/3>_01:++49>!Y4Z\RZR5N9UT(SL1`>M&GD=
M')1Y'73*O`[ZD=G;,[FZCE+AJ!;6>R2WV3;Q,_O["K"I[+[X"2\L2'AFB`+;
MUGRA^ZDUNIK9RZ1%FQP.'H1J$_?]HXB!L3<O!H19B::3;+E<4,)S!X@!:>@Z
M0`Q0!XB!\QT@!JR1=P6(`>H`,4`=(`:$V9LSO8HK#,2`[SV*`;,70S'P0\_J
ML.]"99PP\_,-H\[Y/`K65:9F;F!%B%AWP5-59>[>8R`0._])JC!\&%4%1Q!8
M.WP:4MEN9#?#LS^\'SS-)]=1(;@?K?P27;VY'A`%U`.B0-BI'A`&8N5Z0!A8
M%@X%EGGW!&$@S-T3""^,/_*93<W&#`E_^2.]P4\\!]A-GS#[B4%:RS#=JQ2;
MD;D;"FG%SDFV5>;U`6G)'Z05YOQ!2/*'=+;,\P<AR1^$)'^0C?Q!-O*'["5_
MD(W\03;?7Y2O9AO&E^U,36V64O&>BK`P&6^BB0_):)MZ@0?%+#L[:XN9'9(B
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M,QN[DZME],`'6HN%RSR,X]0AM!X[]+06.YO9YD=*HVD"6I-[:$WNH36YA];G
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MYQ_ZDW_H3_ZA_UG_"`!KX_E'`)!_!`#Y1P`(TR&1?M=;+9*9;C9J+I'<;NR$
MDEL69CHQ2&[9N<E=S6Q`SZ^B"(;8XL>%&,2F_B#VV)\GMMA).3Y'LL>/2[29
M<P^MR3VT)O?0^IQ[2"W-G'M(3>XA-;F'U,+LK9E>Q3^9AD'=]QYEM]F5N41J
MNXL32FV9-Q<ANXE!:LO.9K>8V=!=8"LI^"]ZB@'EK;V7)E">NH?R8_>>\L)L
MFF,?B%=U[![*DWLH3^ZA_#GW4-Z:>&</Y<D]E"?W4%Z83N[1!`CA?>>1\&:#
MQA?^^YZ2Y7:?)XP'R\+4)X9X$':FB%,SN<HH-:&_=8-="-45^E-WT'_L3NVP
MN!,FJZ_KF]0T3_X1`.0?`4#^$0!G_2,"R#\B@/PC`L@_(D"81L`B&A<1`K[W
M*`3,O@V%P`\]),/'S'C-9UFT+Q^5'!@QQ,S)B`BQ+/A>#66346Z$@+7SD@@A
M8%GPD$R9^\X$A("U,]_/-GQ"+L,:.#'7BS?W"`M!0#T@"(2Y'A`$U,.4>D`8
M4`\(`\N\D15A8)EW3Q`&PMP]@?"6)>=WLXGS#PMO]X7"<<"R\"77FVC\AO!B
MYI;,$%Z8*\0V(W,20'AK%^:^9>8;\331D?P*W2V"]`HQ/WH+R6@8Q4)/[=P3
M/:BOT'4#^16Z;J"_PK";:#,*$:!VKAN$@(7>8(H0$.;N#D)`F+L["`'+[-V)
M<M]L_E`(7/Z<%"]Q<\(+<Z<'D8E!9&(0F1A$)H;L)@:-B4%B8I"3&-0D!C&)
M04MBT(T89",&V8A!-F*0S6>1;&9?QI?MWUE^]_[VPW_6]T_O[[\BB*_Q,`8#
MV5#M_I+E=A\G3$MA^,L+^FBG%XJ-9II%4(P8%",&Q8A!,6)0C!@4(P;%B$$Q
M8E",&!0C!L6(03%B4(P8%",&Q7QF%7OS]/'^_GE]]WSW]J<O]X^_WZ_N/W]^
M>O7^X5]&)?,Y<X^_>KS_[>?7>'ET<HLWV8:Q8VRCQ_(%CB$TH`8?6YICPYQ#
MQ[(,Q_`%.*EVF>D/W[Z2/&;ZPZ=PD\=,?_B\9^K8Y!K'\"',Y#%S+OA86^+8
M$J>"GY%('<&)X*N'4T=P&OC6V\01S.;H"5-Z\IBY:GRM9O+8U!P;IJ+X3L[G
MMT<[$],1G.$\>88WLUOS:[J)GF[@#1_12AVYP9%A[(S[N<'UXE<D$VUFN-Q9
M\FIGN.7VTS*QMQDN=9:\TAG.>I8\ZWF.*QVFI]C;'&VPQ$N<VQ1M4-ZGCJ`-
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M<N'UJU\?GI\?O@S__'A_]^'^T1C@^&\/#\_Z/^CZS=\/CW\,I<?;_R\`````
M__\#`%!+`P04``8`"````"$`+)R^18@7```_B0``&0```'AL+W=O<FMS:&5E
M=',O<VAE970Q."YX;6RLG5MOW#J6A=\'F/]@^/W8I;J7D:01ET2*P@PP:'3/
M/#MV)3%BNP)7Y>2<?S^+(BER<S%ERT@_M$\^;K*X%[?(+>KV[A]_/3Z<_;E[
M/MSOG]Z?5Q>3\[/=T^W^[O[IR_OS?_]+_;$^/SL<;Y[N;A[V3[OWYW_O#N?_
M^/"?__'NY_[YV^'K;G<\0PM/A_?G7X_'[U>7EX?;K[O'F\/%_OON"26?]\^/
M-T?\\_G+Y>'[\^[FKJ_T^'`YG4R6EX\W]T_GKH6KY]>TL?_\^?YV5^]O?SSN
MGHZND>?=P\T1_3]\O?]^"*T]WKZFN<>;YV\_OO]QNW_\CB8^W3_<'__N&ST_
M>[R],E^>]L\WGQ[@]U_5_.8VM-W_@YI_O+]]WA_VGX\7:.[2=91]WEQN+M'2
MAW=W]_#`RG[VO/O\_OQC==55T_GYY8=WO4+_>[_[>4C^^^SP=?]3/]_?_=?]
MTPYR8Z#L$'S:[[]94W-G$2I?4FW5#\'_/)_=[3[?_'@X_G/_L]W=?_EZQ'@O
MX)+U[.KN[WIWN(6D:.9BNK`MW>X?T`'\_]GCO8T-2'+S5__WY_W=\>O[\^GJ
M8KI>5(LE[,\^[0Y'=6_;/#^[_7$X[A__SUE5OBW7RM2W@K^^E=GR8K&:S*H1
MC<Q\(_A;:.3$K\]]1?PM5'RE"W"V%P)_?2/5[**:3WH93OSXTM?#7U]O>K%>
M+.;+]0I-G:BX\A7Q-_S@YF0%'+-]#_$WN)F,U(E?0K-]1?P-O_0JURI$HPL.
M&Y8^.DXZ=^FBJP_6^N9X\^'=\_[G&:8`A,_A^XV=4*HKVVP(4]?K(7!_%;<(
M6-O*1]O,^W,HAH@\X&C[\\-\4[V[_!,'R*VWN6:;S&(;+.S18)NM<]#D0.5`
MYZ#-@<E!EX!+R#)H@X/F=VACF[':!*^N`XAB3:54VV`1JM0Y:'*@<J!ST.;`
MY*!+@!`"!_[O$,(V\_X<1TD2))GGU\ZFPHPQ&*TR<0:301TB#1%%1!-IB1@B
M74J$2.CR[Q#)-H.#$5/4(``?2M[HE$J#R:`2D8:((J*)M$0,D2XE0B7X)50J
M+X=A6K'6O1C!B6M/,*DG\LRR"!F,0K6:2$-$$=%$6B*&2)<2X3LZ/<)W:RU]
M]R3.)%LB-9&&B"*BB;1$#)$N)<)1K`,C'+76TE%/L!PE@SS/!MD;8?).C!:#
MD>B0S:K35>YTU%EKV2%/^G2Q7YFV1&HB#1%%1!-IB1@B74J$H\@DA*-V.9\N
M+A"2IUVV]:3+GO1)KG-Y('9YSY;NVA?*T5B61\/F&:*7I_O6F\O.!93T+B+;
MO6Q9J4.I[%]<682(E4T(7A\NO7G6/]L"4'*H!JN(:D8-(\5(,VH9&4:=0-)G
MN_:/\-FE"EBFPA1[77DDC]KU$`(NB(*5'(C-8"4[91?;$9WR:W/:J72Y]CT@
M5%>$&D:*D6;4,C*,.H&DSW;I'.&S7VE3GSW")#',C(O)9)#8RS!8A1&L;=9E
MHW8]#&K#2#'2C%I&AE$GD)3!KJ(C9/"+;BJ#1_&`V]JL2AZ6-:.&D6*D&;6,
M#*-.(.FS75!'^.S7W]1GC])C<#')YNIMY:W28W`QB5.F[-2XQ1Q37KZ2!)2L
MGHQJ1@TCQ4@S:AD91IU`TF>[OHX8"+\<IP/A4;I`#:BT?N*@ZW638Q(36]D_
MN]J.Z)]?G-/^>90>'(3JBE##2#'2C%I&AE$GD/!YFB<-,;49N5?1MR37ZX`P
M",F4F6><T6J8,ADUC!0CS:AE9!AU`DF%;-+Q^JB86O-,!H^2J`A6$=6,&D:*
MD6;4,C*,.H&DS^/2EBFG+0$E1VI$I50RE,HC]1<G'E.;68P8$Y^()$=JW\+[
M\XW;U[6[8EM&-:.&D6*D&;6,#*-.(#DF-HT8X;//.E*?'8+/Z>$8SR9<!H/=
M>QO`B3(UHX:18J09M8P,HTX@*<.X#,;NQ^>'HT?)PAFL(JH9-8P4(\VH9608
M=0))G\=E,%/.8`*:P/=D*HYG:G[L0Z(3HZ9.JH;YN2DP56"ZP-H",P7622;U
M&)<\33EY"BC.OUM&-:.&D6*D&;6,#*-.(.FSS632P__M"[7/B>(87T\]D@MU
M?I(9K4(@U(P:1HJ19M0R,HPZ@:1"-JU*%3J]_S'U65@J`R5FVV`5`Z5FU#!2
MC#2CEI%AU`DD?)[EZ=MIGWMSF9QXM)`30]PY<!-#M!J&GE'#2#'2C%I&AE$G
MD)3!9EBO'_J93\B2H0\HCO.64<VH8:08:48M(\.H$TCZG.=H;YX09IR^!20F
MA"K?[(A6,2I\6\EF!ULI1II1R\@PZ@22"HW+$F><)084\X(MHYI1PT@QTHQ:
M1H91)Y#T.<\2WQX5G$#./))1D>^#1*L8%4/%@!JV4HPTHY:18=0))!6RZ=^(
MN<)GB^E<X5$:%83J&:&&D6*D&;6,#*-.(.GSN`1RQ@ED0'+HX^:67R9\Q7CT
MU[%B''JR4FRE&;6,#*-.("G#N+QQQGEC0.G0>ZN(:K9J&"E&FE'+R##J!)(^
M8\1$N+]]0K`M9<F#1S(JXO::CXK!*H1`/2/4,%*,-*.6D6'4"205&I<WSCAO
M#"B&P)91S:AAI!AI1BTCPZ@32/@\S_-&&Q7+V46\A^O5]RCU3<FP"$B&1;[O
M%ZV&L&#4,%*,-*.6D6'4"20E&I=3SCFG#"@)"T8UHX:18J09M8P,HTX@Z7.>
M4YX^G9ASXAB0'/JXC>=FA&@5AYX31[92C#2CEI%AU`DD91B7.,XY<?1HD0Z]
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MU[&`DG6,4<VH8:08:48M(\.H$TCZG*]C]E"TPSSR<C;6Z7SF"$A&6;YN1*L8
M9;ZM>%K<L)5BI!FUC`RC3B"IS[CET^X+9Q-H0&E,>*N(:K9J&"E&FE'+R##J
M!)(^YRNQC0EW_^;8J.!%>N&1C(I\D8Y6,2J&B@$U;*48:48M(\.H$T@J-"X%
M6'`*$%`,@2VCFE'#2#'2C%I&AE$GD/39+O%I(FFC8K:VSXV-GBQL4]F2Y)$,
MBYC3NA,AF]K9BG%FJ!DUC!0CS:AE9!AU`DF)\KSFA>R!\Y>%1VE8$*K9JF&D
M&&E&+2/#J!-(^+S,,Z8W3Q9]2S(J`A)1,8LG$"XJHE68&6I&#2/%2#-J&1E&
MG4!2H7'Y&C+M_.`(*(D*1C6CAI%BI!FUC`RC3B#I<Y[NO3TJ.!-<>B2C(IZM
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M*(T*SG_8JF&D&&E&+2/#J!-(^CPN_UEQ_N-1-B'DNR?1*@Z]:PL5`VK82C'2
MC%I&AE$GD)1A7/YC+[+G$X)'Z=`3JD/%:-4P4HPTHY:18=0))'TNY3]OVSU9
M<484D)P1\MV3:!5BH&;4,%*,-*.6D6'4"20ERA.O%]8)SK96'L4!WS*J&36,
M%"/-J&5D&'4"29]M#I6N$R_X[%.N>!1?KQR2,\(\WR*)5G'HAXH!-6RE&&E&
M+2/#J!-(RC`N.USY5#"5P:-TZ`G5H6*T:A@I1II1R\@PZ@02/J_S[-"F"&^;
M$?JF9,H4$`8YY@CS?(\D6H48J!DUC!0CS:AE9!AU`DF)QF6.:\X<`XH#OF54
M,VH8*4::4<O(,.H$DC[_MLQQS9EC0#(JLG/0;;2*4<&9(ULI1II1R\@PZ@22
M"HW+'-><.0:41@5GCFS5,%*,-*.6D6'4"21]SC/'-Y]/K#FI#$A&17:ZOXU6
M,2I\6_%R3,-6BI%FU#(RC#J!I$+CDLHU)Y4!I5'!225;-8P4(\VH9608=0))
MGTM))5[0:-/0D5=JUYQ4!B3#(FY%N;W6:!7#PK>5A@4AQ14UHY:18=0))"4:
MEU2N.:D,*`T+RC-KMFH8*4::4<O(,.H$DCYCQ$8DE6MKGF4/'LFACUM[?N@'
MJSCTA)K0?(P&Q4@S:AD91IU`4H9Q2>6:D\J`TJ'GI)*M&D:*D6;4,C*,.H&$
MSYL\J3Q]/M&;RZ$/2`Y]ON48K8:A9]0P4HPTHY:18=0))&48ESC:1_RS(R"@
MN+6\950S:A@I1II1R\@PZ@22/N>)XPM#S]GAQB.HD9PSY/N*9:NX!24[-2Y7
MVW"N%E!R##*J&36,%"/-J&5D&'4"29]_6ZZVX5PM('EXYCL]T2H>GIRKL95B
MI!FUC`RC3B"IT+A<;<.Y6D!I5'"NQE8-(\5(,VH9&4:=0-+G8J[6OQ1Q9*JV
MX50M(!$5BWP3*%K%J*"\K&$KQ4@S:AD91IU`4J%QJ=J&4[6`TJC@5(VM&D:*
MD6;4,C*,.H&DSS9?2O?_WGQ>M[$M94NY1S(J\CV@4#'F9S6CAI%BI!FUC`RC
M3B"IT+@L;L-97$!I5'`6QU8-(\5(,VH9&4:=0,+G:C(NC7/V<O`')M]AL\@W
M>U*[85HHP:8$50GJ$FQ+T)1@E\%,FG&I737AW&Y@2404&%[7ZNM&.XA`#!H0
M@P3$H``Q"$`,_J<L<S_/\MX\8503S@`')J>,?"LH,4M"QC<7YQ&(10QB$8-8
MQ"`6,8A%#&*E+!-K7/9933C]#`SG&L'5;8$A5ES=Q`[N$X/[Q.`^,;A/#.X3
M@_LIR]PO):*CGPFK)IR%!H:7B22J.#O<01X85'',7@L>3BEFJVP.@E"#6:@*
MH8A!*&(0BAB$(@:A',-]NOB-3*@\'[4'5=7?G-8_.Q<>1WO]@W25G76SY3@P
M*9JSDZ(YADTM>]O5=%)E>V[0:[!(]'+,^==OT$`O:AUZ#75]Z]G1#?4&B]`Z
MU$M;S]0K9;9IF`7Y3I^05A/.:P.SYYQ#_.#K*?E;A'U5W'D:>HS0<\UA3STP
MZ$8,<>887H,1[*";8TE[T(WJ0BEB4"IM+U-J7(9;33C%'9A]A74B2;XW%^SP
M'H?@%B1Q[=FW7PQ59_D[F:&2-]NXA_PVBZQQ:.8L\#:`T#@T\[7B#T(SS_#G
MUS\(&;V9_T%(*`<8HCH+]X.9J#;+35/HE\+,9\7)Q>/*/F-KCU;[0NRAHXM%
MU@U,_,X.;XX)?D-4ST22X!AN`>YO1YVN\W=!04)?380=-0\)J7GH)9I?+^;9
M(0R]TM8SO?*$NI_LQCXI7-DG?6F"\\R^4#N1,=]!"G5E;+JZ>-E"D!:!Z)E]
M0!D3X2QK"")Z`Q&'CB6-0T1J'"**QO%!*XJYM'&I8?\B_S3F<@U?.>7U[61Y
MNV?)W+.MF.&U_?8<`7<,I'$76(Q/O+C?VZ6!QNWAU?W4'M[=[UEL#R_O3]O+
M9+%Y:R[+=-D_(O;"41F^"1!_Z;H*+`NGN-7H+D,$NV3$H8Y+H3'5Q7`*S$TS
M4YQF9(D(Q'+5Q,06JJ436V"Q>8CE?](U7RW6R7/&?4^A7=I\IIU-8W/MTE7T
M50_P5^'+!D)'GR%GLUN^:1CJBMG-MX?;TA,=77OV_N]XE"^SW29HZ<SL^Z4&
MLUFN";XBX<UBCQ&+_A?BKT+>XJ]FNQF0^(5?S52WV?,IU5][(+LL'&_5#S(A
M?!W#PP>!X4`FAE!U3(:J9S'FH*=C,C:I/8A'[4$\:@]*I>UELMA<^90LKPQ&
MEW)+53RSOSZ$!;XF*&=?*.7L9#`Z9M^),E0MY"^^JGW11V*610KT]+\0QP?!
M2+\*/5_SJY#8FYW\5:B>_FJFNLVQ3ZG^VF!TN;J4W;-X1$%B8@A&8O@:##&(
M1PSB$8-XQ*`4,<B2LDP6FU#GLKSI<?0J?'-"'*:V>:S!<C;+,BJ(-9B%HQEB
M$8-8Q"`6,8A%#&(1@UC$(%;*,K%LHIR*]=*ZZQ)KR!_<PL3E6<PLX#XQN$\,
M[A.#^\3@/C&X3PSN$X/[*<O<MWEOZO[;M\?"MS"$,BZMSF*%3D=#U3A[0ZRA
M:A`:8A&#6,0@%C&(10QB$8-8*<O$L@EN*M9+L>(28ADKGHE8(0;WB<%]8G"?
M&-PG!O>)P7UB<#]ETOW^&Q8CW`_?O$@#(C"(/"PUBV5VOKRMHED8_+K`F@)3
M!:8+K"TP4V#XW+#+WQ$7Z$NFB$U/QRCBTED1$.$K&6E`,(/[OFZT@_O$X#XQ
MN$\,[A.#^\3@?LHR]VWJ.,9]EVI*]ST#3",B.[E$1$2[)"080A2&4(4A9&$(
M71A"&(901L!,&ILKCI'&Y992&L_BK`@9B"$RB$$$8M"`&"0@!@6(00!B\#]E
MF?LV:4O=?_NRXC_5(95Q.:&=JI-9)-OM@%B#61(RQ"`6,8A%#&(1@UC$(!8Q
MB)4R)Y;["+G[KO/C[OG+;KM[>#B<W>Y_V`^,VXM:']X-W'W_')_KF]HOH/>7
M$;AL9LOZ_5LNFP]?3J>R:HDRY$A0B<M6MJS/@KEL;<OZ\.2RC2WK7X5&9=,)
MRC"MEGYOVG_AO=_4RNMMT"2N`9=J36R+N`A<++,M0LQBF543%\2*959-7"TJ
ME54+E+F0I%ZB&NYU*M3:8`APCT^I!,WA3IA2"88&=X"42C`PN$^B5()AP?T!
MA9(U6L-5DE()6L,-LJ42M(9[1DLE&`_<65DHV6`XW(4]4@>#@5OR"G76J(,G
M6THEJ(/G/THE&#X\]U`JP2BX*QEY#]88!=P57ZJ#4<"]XX62%>K@DERI!'5P
M]WBI!%KCV;U2";3&$VZE$FB-A[Y*)=`:CT852I;H`5XC42I!'3QL7RA906L\
M?UXJ@=9X2KM4`JWQ='*I!%KC&=Y"R0(]P)N0"B5+],!=><O'9XD>X#TYI3KH
M`=X/4RI!#]S^+[6&D<-5A4*=.7K@MH;R.G/TP&VK4PEZ@-?ZEEI##_#RVT+)
M`B5XG6"I!'W#B_0*)3.4N'WJO`<SC+;;XJ$2Q)N[)D<EB#>W648EB#>W"TPE
M&#F\WKO0MRGJX$68I1+4<2^_I-:@-;ZN4J@S@];X!DFI!%J[*[_4&A3%%RH*
M=>SB@7RU5((ZY95Q"JVQ.)?J0&N\6*54`JWQ_:A2";3&1Y8*)15Z@#V\4@EZ
M@%VN4@EZ4%YE*OS.+U9EC$)YW;7+;G'5_5A=?2Q&->0LJXF&2OVU`U/@'^=7
M'VT"5/`0KA<Y'"\J#^&+NMM%JM1^95TH^;"=SZ^V>#$O]\G>A'&%RUVE?J%L
M<=7?3L#U<-5L8>N5^HUZ2UNOU'?46]IZI;+KA16BU.+U`E+@A8O<C^L%8L/=
M'Y$?.0O(A+?QH<[E4'3X\.[[S9?=?]\\?[E_.IP][#XC^9STCT0]WW^Q>;O[
MQ]&_8OC3_GC</R(_/3_[NKNYV^'3AA/[5J+/^_TQ_,/^P,_]\[?#U]WN^.'_
M!0```/__`P!02P,$%``&``@````A`%=SY4L"!@``^18``!D```!X;"]W;W)K
M<VAE971S+W-H965T,C4N>&ULK%C;CN)&$'V/E'^P_+Z8QA@,`E9C;"<K;:0H
MVB3/'M.`-9A&MN?V]ZF^NB]>!I1Y&8;35=5UNJJKBEY]?:M/W@MNVHJ<USX:
MC7T/GTNRJ\Z'M?_WC_Q+['MM5YQWQ8F<\=I_QZW_=?/K+ZM7TCRU1XP[#RR<
MV[5_[+K+,@C:\HCKHAV1"S[#RIXT=='!U^80M)<&%SNF5)^"R7@\"^JB.OO<
MPK*YQ0;9[ZL2IZ1\KO&YXT8:?"HZ\+\]5I=66JO+6\S51?/T?/E2DOH")AZK
M4]6],Z.^5Y?+;X<S:8K'$_!^0].BE+;9%\=\794-:<F^&X&Y@#OJ<EX$BP`L
M;5:["AC08_<:O%_[#VB93R9^L%FQ`_JGPJ^M]K_7'LGK;TVU^UZ=,9PVQ(E&
MX)&0)RKZ;4<A4`X<[9Q%X,_&V^%]\7SJ_B*OO^/J<.P@W!$PHL26N_<4MR6<
M*)@932)JJ20G<`#^>G5%4P-.I'A;^Q/8N-IUQ[4?SD;1?!PB$/<><=OE%37I
M>^5SVY'Z7RZ$A"EN)!1&X%,80=%H$D<HFE$K5S2G0A,^Y?97Y<$:<Q<^A7P\
M0M/Q1]O,A!I\WN9@P(^)G7I:=,5FU9!7#U(9#J*]%/1BH"58D\?-*:H`_.S\
MX>"ID0=J9>W/?0^.MH6D>=E$<;0*7B#0I9!)7!ED2FRE!(TJ-9O:0&8#N08$
MP$C1@O!_`BUJA=*2#B42Z'E.+`Y20JJD-I#90*X!!@?(OD_@0*VPZZ"%9F8Z
MG7`9!$FKA.:FR%:)*&(.DCE(KB,&-]C*YA9"K1B^Y3++J-+:ATJOO(QBR\^$
MRUREHD04%0?)'"37$8,*7%V;"BU8=]X@:@7N('QHY&(S"(D0`E>4D,5_JT04
M.0?)'"37$8,<E`2;7!C3ROM!J*@>HR/=2`0"%U;Y'B[Z"F#L"H5$W_5Z5E!A
M<RN!]/=VZR"I@V0.DNN(X1\=-K2B>=T_*FSZQY$%W'OM*.Q"PH5FH2H^*4=B
MUGQ9?<P<).=(.*-:ALN+>URFPJ;+'%F$K+9/QL@J[EN^'L:]MP*!,^Q)CL=F
M0F=*C;:,V<Q*YIPO3_G$H)=W!+7B]@@P:9./@"`&=&<@9)7$K1`(^8S!NQ'=
M%.:)J2*9]5+4S'1A$Y#K;CP0[5Q:#O'&.YK#S>J.5?F4$#@VD!G(+1H$T79Y
M^X.JH:X9L[OV^TA9+FV%@!XJ`4WY$$2Y9A+B`0^G"S-PN5P?"`UM9S8Q&,$$
MKQ_DPGC=09+W1X,DAXP;A.SDVB(N98200U.]@H:V8B84IQ%+#A2AT&8O+`^$
ME78\FWW4AU72'P@K%%455]XW81=U=Z+8"D&"5'/MI9Q@*QF9(&FO)J',A7(#
M,@H);:TVPX];-]/ZJ'<+H:O-NY>1[J<NE+E0;D`F(]K]G)C=W<%I[^95LX]'
M%-LM7$KI&>A$35CJ"TW:JTG:F0OE!F1R'&CDDXC>RCOG%.1V=@E![U'I&BZ<
M@BH4M1;1*_:D'*G<D#))T0:M!>Z#2R7:N5XL]0[/2NH6.5#J0ID+Y09DNDF;
M\NUN\A8.H92'DB#1U?6<"1?VP""D](E!0/K(X$*Y-#]0S6@#OMUSWJX-ST6#
MG\LV:\\-2`CH6:%TM'1R:[12I)T7?C+;)9JO#\P.D[MF!R9MS@X"@CG@)[.#
M%.A#F$JHO]*9A'B7L7\NYW+9C<KD,T8'9L3BQ:>)4`7+KDM"1Q\=!*2/#A(2
MLZ)5!W*Y[$X.\*QD9!L;B?[/Y,`,6AQ%Y]:ODCLY"$5]<A#0#,I#7^2<K)12
M,4^-J/]]PZH+?3EC(Z065/X2QM]D:MP<\!:?3JU7DF?ZR@7%;[-2,'^"@\Z_
MI`T:ZH.S,H45EF/6R@.*E@^P^Y!.!#HL52V=!,U@A;GJK,QAA?V^LE;2>`F_
M2MQ=4@0+4&C<%7A0?!CV"[88D$\F\``YA,.A#)X)',G@B<"!P*#G.I3`>0P>
M!W!FE`/%&1X>+\4!_U$TA^K<>B>\AY"-V;37\*=+_J430^\CZ>#)$:(*#VWP
MQ(QATA[3'KPGI)-?P*%`/5IO_@,``/__`P!02P,$%``&``@````A`.Y@*#%A
M(@``(;<``!D```!X;"]W;W)K<VAE971S+W-H965T,C8N>&ULK)W9<MQ(LJ;O
MQVS>0<;[0^7*7*RD8V(BL>]V9N::)5$E6DFBC&1U=;_]>"#<X1'Q@YED27W1
M5'WP^`.`A\?B@01^^^]_?_OZYE^W#X]W]]_?7<PO9Q=O;K]_O/]T]_V/=Q?_
MYW_B_]I>O'E\NOG^Z>;K_??;=Q?_N7V\^._W__M__?;W_<.?CU]N;Y_>D,+W
MQW<77YZ>?NS?OGW\^.7VV\WCY?V/V^]TY//]P[>;)_K/AS_>/OYXN+WY-!3Z
M]O7M8C:[>OOMYN[[A578/[Q$X_[SY[N/M]']Q[^^W7Y_LB(/MU]OGNC\'[_<
M_7@4M6\?7R+W[>;AS[]^_-?'^V\_2.+WNZ]W3_\91"_>?/NXS_[X?O]P\_M7
MNNY_SU<W'T5[^`^0_W;W\>'^\?[STR7)O;4GBM>\>[M[2TKO?_MT1U=@;ON;
MA]O/[RX^S/?]?+:\>/O^M^$._=^[V[\?G7^_>?QR_W?R</>IO/M^2[>;'&5<
M\/O]_9_&-/MD$!5^"Z7CP07MPYM/MY]O_OKZU-__G=[>_?'EB?R]IDLR5[;_
M])_H]O$CW5*2N5RLC=+'^Z]T`O3_;[[=F;9!M^3FW^\NEE3QW:>G+_2OJ\OU
M9K:<D_F;WV\?G^([(WGQYN-?CT_WW_Z?-9JSE!59L0C]%9'+Q78]7U\9D1,%
MZ>A0._WE@O/-RTI><4GZ*R4O-_/9;KDY7>.&R]%?*3?3ZSUQJA0QPZG27RYX
MNJ(=V]-?ME_0/T]4,"??#S7,Z6:_[MSF"RE*_^"BF\O58KW9#FX\52LYWM8Z
MW0).%16WF_;VRA,6]\T=_RU>Y,"Y>-#\@VM=+E]65'PX5R?.3WK_K8V6(?BB
MFZ>;][\]W/_]AKHT<M'CCQO30<[W1DW"SMZN,1"?BT,*0*/RP<B\NZ`+H1![
MI-[C7^_7N]EO;_]%`?^1;:[19NY;',3"1+>1C4)P#$$<@B0$:0BR$.0A*$)0
MAJ`*01V")@1M"+H0]`YX2^X9?42Q\"M\9&2,C^3N7@M0IRT"AXB%%(E"<`Q!
M'((D!&D(LA#D(2A"4(:@"D$=@B8$;0BZ$/0.\!Q"/<RO<(B1>7=!03<&S6H6
MA,2UM9E3#S4:;0(GC2:CEX`<@<1`$B`ID`Q(#J0`4@*I@-1`&B`MD`Y([Q+/
M:70+?X73C`QUEC12C`Y9[T*OL=$IKXTFH]>`'('$0!(@*9`,2`ZD`%("J8#4
M0!H@+9`.2.\2SVMTGSVO34\'91@RUH-SY*9>,_&";+X-(F@TDF(1D".0&$@"
M)`62`<F!%$!*(!60&D@#I`72`>E=XOF"ICBO\(6Q]GW!1$>@`Y`(R!%(#"0!
MD@+)@.1`"B`ED`I(#:0!T@+I@/0N\6X\S:N\&V\G:9=FA?#TY>[CG]?WU!?1
M[&$B.)8T&;-3-"/B^\.2Y6*<$1PL6:N'(DLV%)]C=[?8!=.$XV@D\1,#28"D
M0#(@.9`"2`FD`E(#:8"T0#H@O257=BGKSM&H@P$7+=:7Y"&820\N^Y_['X/+
M7NX_4X/O/TM<_UGB^L^2+36MT7^K^<[O_XZCT>@_2^QU#LTG`>ET+.5(+X))
M?S8:B70.T@5(EV,I5SH89*O12*1KD&Y`NAU+N=)!@^Y&(Y'N76DO-FDM#(Z?
MKS4VQ=$3L4DY!0E.H^([UY*E&WBKQ=)WW,$:70UI&;MB&HO)F1_99C6LRN:[
M]9:R&;Y,S(6NQHX@`>%T%-;[MIR%WF8C<UW_>K^ZG`7GFT-%!5146K+5:ZJ`
MU*#3@$X+I3H@O:OC>=7D,#RWGG;?8.[[C]&2>@R-O,7*O_,'MKK26Q]IP=&%
M@J@1.EIK7RMFJQ6=^FBUG`56"=:8BKQ[JNA;L=H.SIU=;D/G:OURX@565C+:
M;L?&5B&J4:M!K18+=HAZ3\OWLEEQ8_9#@_=%`ZM)<P7!RRB(WB#L#FSEAJ\@
M'8&/@GSG!XO`6&IT._H)Y]M3=6I,1?Z,\[F@=?Y\?KD.QI!<3T"]#[65;+75
M.4>%J$:MAI%SYBT6[!#UGI;O?;.\!^]3TICBQ\RJI.=^^1!MTI=A2[`HZ`;"
M!0@7]+H!3CX,4XVA;S^RU69NN_+MU6*V"]P0LPUU`N*&!,534?*[BK`W%ZO%
M4!^E)B'B[3DZE15862DR>DJ5(%&>!\HU&SC*#2JW(G/R,CJQXMLV6P5QV'N5
M^4W$9!-^;1/A_(3=PC!)SNNY14%G$3CVP%9.`$2,5JO1UT=!=@2>3S<1KD_'
MG`3%4U%R)R`3@X+56ET]VT2@L@(K*[4R:;65(%'&)@+*#2JW(G/R,CJQXMLV
MT43<ROPF0LJ_N(D8Q6`R89'?BRR#>#V8+"$5]'H1BS8:>T>V.MV+V&).^"4H
MGHK2R?#+Q$IB'7L1J*S`RDJ1T2NI!(DR-A%0;E"Y%9F3E]&)U?.]B%N9WT1,
M1@5ZD5>O$4S.T;8+G=^MP[7XM5C1V8RSP&"R<%`;";<(T1%1C"A!E"+*$.6(
M"D0EH@I1C:A!U"+J$/4>\OUH$C2A'Y=;LQ\]E7IQEG=F=S`,:4;:G@]B17W-
MZ+K54H=&_V1,*L(]F3,K%&,>="J,=/@XF*U(8Z4H0G1$%"-*$*6(,D0YH@)1
MB:A"5"-J$+6(.D2]AWQ?F.R`ZXM_E*`SVZ^ABRQR4SQLY>9X&'E)NM4R6&H>
MU4J"/D:4($H198AR1`6B$E&%J$;4(&H1=8AZ1A,IN[E9_8=>^[4YNZ&*(.HX
MYZ`KH`-;>2[E7(6[G,.\'1>D[)ZZU!9T,W<HGVI!IZ>!W)U:B7S.R)$O4+[4
M@JY\F+]3*Y&O4;Y!^58+NO)A#D^M1+[WY+T(7M#@CVV!>D-O)7BZBQTT?&<S
M\J?VRR`E<V`K=VJO!>7DCV)E$WG+^7H=IM]B*:7M(9%2FDY+Q<J=(>#,7JPD
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MP`D`-[!6X=T[<$$OUFU!=P7.5KP"7ZSI46.(=EO*BW:+'.U4A$ZN7#.QLLOD
M]66X_9>S@5-9P<BIK!097;!4@F0!O@OZOAJ5&U1N1>;D971BQ94M@^E$[]7E
MMQ"S,O_%+<0N]KT68I'?5ZP"QQX6ULKK*RQRTWALM;*#[V(]GV@A7)T.N`EJ
MIR)$QJ?&`SX#FVM;7RZ">YNS#/5*VBO8,LZ%E%J96%6")(NWT]7LD-.N4;EA
MY"BW(G/R,CJQXLH60=_:>W7Y+60J0_.3?<B8K9&;<6WR!+3`\^<+J^!>']C*
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M&Y1OM:#;_02C0Z=6(M][\IY?EU/)+W=L>]%C,(.*WU4R6I.+G:XRF`(>V,JY
MAQ$CRFC+Z1\1Q2+ON%NL''<+4JT,42[(\2TCY[Q*L5*M"E'-R'4D:K58L$/4
M>UJ^U\+\59CTD'7OZ2YTB7DM1E>4*W#<%LRF#V*E.8B(D;<$@NS34:QXL_TR
M".Q8CFL'GF!=J5BI*S*QLAG2U6:U7`3#<BZE5+N04GH=I5BI=B56SVO74DJU
M&RFEVJU8J78GR-X0>K(N..M>#`9EOQ&8?,[+NV3J>,/I#"-GN7%`%#'REBX3
MGK7R2\DN!7UJS"KNB@3K2K4N"?Y,D,V.;NG7H)N@U>2H7:!V*4*:EZL$/:]=
MHW:#VJT(J78GB!.ME[-@&.@]9=^S)MWS"L_:[)`[V"XY8:2-[X`H8G0N9JW6
M4F(VN(Y85+3M)UA7*E;:]C.QXL>3Z=?:D'R04JI=2"F]M%*L5+L2J^>U:RFE
MVHV44NU6K%2[$R0QNPFZQUX,)F+69$Y>X5F;:/$\:Y$7LX`BX](PW3`1LVPE
M,1M<1\PJ7LQ"7:G6I3'+PC:N-HL-_+@Q1^V"D7-I)6I7@I[7KE&[0>U6A-R8
M]6[([#*8KO2>L!^R)GOP"L?:9(/G6(N<U->!0LYXT4$1(W,BX_@\X5A;<`S9
M(-,?BXHV_03K2L5*FWXF5CP4+NFU$,$.DA12Z4(*:5258J72E5@]*UU+(95N
MI)!*MV*ETIT@"=A9T-![,9@(6)-J>85?C7DP$;;(:=4'L\-C_*H7$C$Z-\C:
M@CS(KBZ#R4+,*E[`0EVIUJ4!R\(VJ-:S*[/?&WK6VCCB!5Y(B>*5H!/B-=LX
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MBI'3^@Z((D;G0C;(0(6#6\PRMHW:7[9C9:E6)C&2">+Y#`96CM(%2I>BHX%5
M"7I6ND;I!J5;T5'I3I"-V=7E/$C<])ZR[]C7):!H?A+.@ABY0R6BB-&YF/42
M4(O+7;#C$8N,MOT$*TO%2MM^)E8VKLRS6,$`DDLAE2ZDD(95*58J78G5L]*U
M%%+I1@JI="M6*MT)LA&[O-R"8_F&342L27"X<Z,SG;'-A[AS('I4:>B,]:P/
MB")&YR+6:M%4SKPS8'D9]#PQJW@!"]6G6I<&+`O;J-H9OX)CK8FC7>!UE*A=
M"7I>NV831[M![5:$W)#U;LCB<ATF*CQE/V1-RN<5GK49(L^S%GDA"RBBY]*,
M_\^%+%M)$]V$F0J1T6:4,'+J3\5*&W\F5C:NYC3(@F>Y;I4NI)#&58G2E5@]
M*UU+(95NI)!*MV*E9]T)LO=C<;FR;7)HF/1_P=WIQ7RHQW>S27>\PLTV.^*Y
MV2)OR`44T:]Z!S>?F26SE01PT%QC5G$"(6'D5)]J71K`+&R#;'XU6X.7K84C
M7:!TB=*5H&>E:[9PI!N4;D7'#5_O=E#X+G;N_X*[TWOU^%XV:9U7>-EF@3PO
M6^0$TV$%*&)T+IAM04J2#J]V"=="?%1C(L&:4JU)?<SG8\.-7O2*D0S2!4J7
M*%V)U;/2M132LVZDD!O)?`)N)#.22/9=O`,?NY?@^]CD55[A8YN&\7QLD1-*
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MUZY1NY%2JMT*4NU.D+A[&_1RO:?L^SM,9?WTUM`:LUV,@IQU,/D_B)5V:A$C
M]T<@@O2WY#$C+[CM2;A;0VRUVXTYX(P1):.'&=YB/E_!VZ5R*:>;-X4@3?F7
M@E2]0O4EJ-=23M4;1DXWV3)R[D,G2.]#S\C>!]_+85[KY[V,J:^U1?XCE.&;
M;PYBI2TZ$J0M^BA(;TO,R(MJ/HF9;AVF;#:?Z8W)1D;V8[="STKZO6(^FNF`
M68Q,JRA'IE54(_.K"#([]6BF533,G)ZQ%:1WI!.D=Z1G9.^([V^33W'GV&$O
M_K*MP+5-RU`LC7=MO0ONVC4;F7<%C5;!K.*@-C(SCA`=$<6($D0IH@Q1CJA`
M5"*J$-6(&D0MH@Y1[R'?C2:C@VZ<>+_NZ3GVVF:&W#7.>A<TS6LV.NU'*^2^
M*T>+B6N/B&)$":(4488H1U0@*A%5B&I$#:(648>H]Y#O1Y,?^15^M'D6FE9I
MJ*W#'R!?K]GJ9$".-N*U2(L).B**$26(4D09HAQ1@:A$5"&J$36(6D0=HMY#
MOB--5B-TY(O>AD4ONH$9,2/=E#Z(%4V?Q[YTM=*)DG\R9HWNGLR93L`NZ;TY
M.2,=9@YK0!&B(Z(848(H190ARA$5B$I$%:(:48.H1=0AZCWD^\*L]5U?A`/N
MRY9--F/@N8B3"#K5.)B?%M'BRGUU$B/_;5BK8!%\5"N)\!A1@BA%E"'*$16(
M2D05HIK1Q!NL"$W<Z9]YEFU0]!>KC.B7"G*G#HS<N\Z(7D5EDF2+V3R8&AW5
M0&1B1O1'4,+(44ZU("L'KLS40&1R1O1'4,'(42ZU("MKYS(\&5"I@<C4C.@/
M(:_97YW+%KQLGCG(!!ZP&03*`LEI'-B*4K6"(D%J=12D5C$C=WV(5JD@U<H$
MJ5:.6@5:E8)4JQ*D6K6GY=_7<%5^NFLW2ZX@W<+(RXYN@[3V08QT'1L)<B</
MF(`1*YM&G`>ZL1S6E7PB2*M*!9VL*A,KWG<(MOQS.:Q5%8*TJE+0R:HJL>*K
M"A+UM1S&U"@MW2;Z).=EIR_J_0>5(`KL`M?+A6Z#7N;`Y9Q\0<2(GF"24#D*
MTG5W+$A[C(21$V.I6*E6)LA=ZR[#SWCE8J7R!<J78J7RE2#S'1=Z/")83-9R
M>*([(O_B*/Q38X-1#'QB$9V%W-O#E46TR2`H8F2>6QAG<A-Q9`O2AJBY4HPC
MUM7&G6!5Z8NJRL2*!RN((ZBJP*I*$3EY5958V:K"+V_4HCL11]/K77RMU9GN
MT*Y2_;1%T(JN33+2>-:]E,#FH#;JU[&8H"-:Q8@21"FB#%&.J$!4(JH0U8@:
M1"VB#E'O(7_T^D7+7>K1C(MH13*&$*8MV.BT'W&UJ\74CV`5HU6"*$64(<H1
M%8A*1!6B&E&#J$74(>H]Y/MQ:K5KD@_P>:<S\3BN?5U'!GL4U_3>P/,!.=J(
MUR(M)NB(*$:4($H198AR1`6B$E&%J$;4(&H1=8AZ#_F.-(MZ=W5ZQE^<`]#A
M[/J*D1N+J_"C$@>U$E]$B(Z(8D0)HA11ABA'5"`J$56(:D0-HA91AZCWD.^>
M,'EPQCV8);ABI.N-`Z((T1%1C"A!E"+*$.6("D0EH@I1C:A!U"+J$/4>\GQ!
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MBM=#)>#R,)/#5I[+K19U[Z)U9"OJ,8<N:+U8S,)O+,9L,Q6VX5PP;-4O'`[&
M.:*V*-R*W+#5J46VVL@51HB.B&)$":(4488H1U0@*A%5B&I$#:(648>H]Y#?
M.[UNTKC!2:,@;TZ_#AX+.*B5NH>U=/@^HE6,*$&4(LH0Y8@*1"6B"E&-J$'4
M(NH0]1[RW+,-YY&G1_K!W!_I!>F\Z8`H0G1$%"-*$*6(,D0YH@)1B:A"5"-J
M$+6(.D2]AWQ?G)L!OR@]O[6S77=SEI$[IV?DSND9F;G'./BN8'-6K23.8D0)
MHA11ABA'5"`J$56(:D9VK3'L&C:,[)WP;WXX?1_&FY\97ND+#.%L@I'G"&OE
M.<*BY_=K6<;]MA`CYUH31HYRJ@7-D$P[P<%$)E,#\6Z.R@4JEXRH\;!R,+&I
MU$"4:T2-AWS_A$N2?S8?H,_;@%-XQ>&V>]B"Y'+NJDN06PZW3MA*%F+TRYI@
MQB<R.G].!.E</!5TLK),K.P,<Q-NU.1R7.LJ!&E=I:"3=55L-5[85="6:I'!
MY>66E''F_MI]R$$E&(N,<#!]A7U(+N<N.AFY"Q9!]MWW]#F1\.E],=`9;X+*
MJ5CIMF$FR"K/Z4>(?HO(Q4"5"U0NQ4J5*T'\OO[5-L@=U&*`6Y+;R47D3W5_
MN*`<*O'>EW=@Y,65+7AF2Y(+TB]Q38>S7L.+0D19VWHB2-MZ*C(GVWHF5K:R
MQ2),/^2BK)45@K2R4F1.5E:)E:UL=15F!VI1G@BLJ27Q<O;:C4D:6$P8T3`T
M3@36X>\!K]GHY(:6VDBG'R$Z(HH1)8A21!FB'%&!J$14(:H1-8A:1!VBWD/^
M6#>YU*>P>.6&UM8NRMV%$VY,LM%I/W*F0),9D183UQX1Q8@21"FB#%&.J$!4
M(JH0U8@:1"VB#E'O(=^/)JT`&:I_X$=.3U!))R"#9.HU?>YMF-JXO4LP`!S4
M1KP6(3HBBA$EB%)$&:(<48&H1%0AJA$UB%I$':+>0[XC7Y?$V&(20Y`;BZOP
M]2$'M5+W8!(#K6)$":(4488H1U0@*A%5B&I$#:(648>H]Y#GGMWKDAB#N3]Q
M%.0D,1!%B(Z(8D0)HA11ABA'5"`J$56(:D0-HA91AZCWD.^+7Y+$V&$2@Y&[
M=F;DK'`C1GX2`S8FU4KB+&8TL3&Y,\MQ[,5?.ZD:9()69Q?Z_N8";/AQ07=S
M@1$5E/,_"G+'"'C6,18KG#KNPO7UZ43@8!Y<#:^C::XPCE*XY<<%W;T#1LXS
MU$=!=LMONUI?!?G>F"TF=@YV9A%XRE\O2J,-*L$%&N'@U4JX'\8%/7?9@O3@
MB[J+D3\>!"O!F+5H-TAOZ;/[@/0CXHGK_IDEW*`8W`-32;#"7L%^&!?TG&P+
MNAM$;*4;1.%*)V:+*2=/K73<[^*\;'N(7L`[S)G<J,'M(;$BGXTM.YQ9J8WX
M.$)T1!0C2A"EB#)$.:("48FH0E0C:A"UB#I$O8?\X2)<ZISI=G@AHHOJZQTC
MFB>-SEE=!=F:@UJI>\:"@HYH%2-*$*6(,D0YH@)1B:A"5"-J$+6(.D2]AWSW
MF#6%VY>><0\O05SW,-*^[[`#%"$Z(HH1)8A21!FB'%&!J$14(:H1-8A:1!VB
MWD.^+\)%2)@!?]FXAFL3>M7$T*<[OR)CY,VLK)4_LX+M(2Y(5A)4,:($48HH
M0Y0C*A"5B"I$-:.)&9]YT8;?[']Z,\A*^F.I,'=**\R]\\(H8<2;*\$#&4?'
M8KSMPMPM(6&.>BI,U8-$?N98B'HNS%$OA#GJI3!5#_8_*L="U&MAD[XYM\!X
MV<A/[_:6H5^JO1;F3<AA*VBTTEXN&ID[1<#-H-&,$\GA;Y'BT4`3R<G(M#YR
MFCU[[TRA/O(<FW%]X5,3Y$8VT/K(C6,AN3/DQI?41[X<BW)+];<VR+%N?5[W
M9MZ$,A%TK]T5LC)AH/%"BT;\<8X`^T)2TMT8$N;N#(W,_NYK$\P$R8>V-CMK
MM>^Q%N9HDP_93G=PR&',K/8B_'05.0S$R6&6.>+D,!`G[_CBP1R)G.-J!\X)
MEX>_H$>TZT7W007Z7-$0E,[BZ2#,W2(2=F:/:#3CCC.\F^0J7K-J\Z=P8^:%
MFV6GZR/OL1G_HFP9]*3D/:B/O`?UD?=>4A\YU*L//L]&'G7KLQY]^_CE]O8I
MNGFZ>?_;M]N'/VX/MU^_/K[Y>/_7=XH-RH$Z^,W#[>=W%Q^VV_T'6HI1;S`6
ML$<HY[PW:=.I(SLZ,KQE*BRSF^U-_@C+?-A=[3^84\9#UW3(K"*FCFSHR#"[
MA(KHY&@ZA64^7&WV'^C10SQ"O^[9FQ^H3!TA-?IMQ-01NE1Z4A^/?-C0C:/=
M.CQR34?,0W-31TB-GM>:.+*E&T=/#TT<6:_VYO4\4T?6=&3J##ZLZ6;3YOU4
M&;K7]&Z1J2-TUO1RB8DC5U0/_=(.CWR8K_<?Z`OP>.2:CO0V^D//S<D+\RDO
M?%C06=/[I";4Z(CYMOC4$5*CSUI/':'KH8\JXY$/<SKI"7X]IQ.;X@L2FN++
M?3]UMA]6U-(G;SYY<I(;/TY50%<]=='1=K$_TM,T>&GT$-#>/.>#1^@AGKUY
M`@>/4%IU?Z0,Z=21W=Y,KB>.T"1N/\Q,\9B9=.Z'>24>,U/&_3`KQ&.TZ4PA
M,'6]UUMR,NW$89EH36=([^F8.')%)VBGF$$#I!=;[,V[*[`,O9AB;]X]@4?H
M-S%[\XN7B2/;^=X\GX9'KJ^,^Z:NA[Y>O2_H`\-8ACYBO3=?-L8C])7JO?G`
M,1ZACU7OF\DC],WJO?FV,9:ACU)3VYTZ<J`CYLO06(8^#[XW7X/&(_3][[WY
M*#0>H<^`[Y/)(_0U\+WY'C26H<]][\UGH?%(N2#_+*:.M'2DFSQ2+L@_BRG_
MM'2DFSQ2+A949BI66CK231ZAEFT:]L19MW2DFSQ2SNG<YI/G1D>ZR2/1?$M'
MIKJU:$[^F4_%0DI'LLDC)1VI)H^T=*2;/!)M]MUD+&ZI4YJX_G1+7=($+[<4
M.!.\I0N<XJ7IC*;LZ40'_G8,],?WO_VX^>.VNGGXX^[[XYNOMY]I]F.?E'FX
M^\/,;OFQF?L?M)BX>//[_=/3_;?AGU]N;S[=T@?L9Y>4-OY\?_\D_T'-\>W?
M]P]_#C.L]_]?`````/__`P!02P,$%``&``@````A`&6%NPKR!@``\AL``!D`
M``!X;"]W;W)K<VAE971S+W-H965T,C<N>&ULK)E=;Z,X%(;O5]K_$'$_"11"
M$I1TU'P02"!:K69WKRDA#6H2(J#3F7^_Q]C'!I]N-Y'FIC0/QZ_Q:Q]CF^G7
M'^=3[WM65GEQF1E6WS1ZV24M]OGE96;\]<W_,C9Z59U<]LFIN&0SXV=6&5\?
M?_]M^EZ4K]4QR^H>*%RJF7&LZZLW&%3I,3LG5;^X9A>X<RC*<U+#S_)E4%W+
M+-DWA<ZGP8-INH-SDE\,KN"5MV@4AT.>9LLB?3MGEYJ+E-DIJ>'YJV-^K5#M
MG-XB=T[*U[?KE[0X7T'B.3_E]<]&U.B=4R]\N11E\GR"=O^PG"1%[>8'D3_G
M:5E4Q:'N@]R`/RAM\V0P&8#2XW2?0PN8[;TR.\R,)\O;68XQ>)PV!OV=9^]5
MZ_]>=2S>UV6^C_)+!FY#/[$>>"Z*5Q8:[AF"P@-2VF]ZX(^RM\\.R=NI_K-X
M#[+\Y5A#=P^A1:QAWO[G,JM2<!1D^@]#II06)W@`^-L[YVQH@"/)C^;ZGN_K
MX\RPW?YP9-H6A/>>LZKV<R9I]-*WJB[.__`@2TAQD0<A`E<4&?9'ECFQ1[>+
M.$($KD+$ZH^'0\<=WR$"U37-@2L^R=VM<84&7.6#W.L(I%?S''"5&G<W9B)$
MX"I$G/L=L6!(\1YF8TOTWMV>6-C%[!^I<G>++!L?!OZ1;;(<T[UCM$$ZB1:U
MA\J-/33@X[])IV52)X_3LGCOP1P%([RZ)FS&LSQ6`R82'_8RM?XKLR"EF,H3
MDYD9(Z,'25/!=/#]T37-Z>`[I'`J8N8TQNI&+#""Y2N37>I@I0-?!VL=!#H(
M=;#1P58'D0YB'>Q:8`#62G]AW/P*?YD,\Q>=F2-0AC]H9F($%EGJ8*4#7P=K
M'00Z"'6PT<%6!Y$.8AWL6J!C)F3/KS"3R<P,F*/D8'5&XZY[<Q[#,D(&C;HA
M"QDB'29D18A/R)J0@)"0D`TA6T(B0F)"=FW2,1N:_BO,9C(PN<";21KIFEKB
MST709V[+$.DV(2M"?$+6A`2$A(1L"-D2$A$2$[)KDX[;X,\';O?9&J`^YNGK
MO`#[8)+Y8(%CPWS+9V$FTGB-'LTYL1_DQ+'@9*BFDB4G(W@TV4/.6)N\5S((
MI7U"UH0$A(2$;`C9$A(1$A.RX\3EZ\;V%`P+&FHMK/:$L]^*:^/L[38SP:[-
MG+1M%C%FRV>.QF[S>GPP+:<[GZSD?6DQ)[Q)30^OJ6P@B[&W+LC:7=E0WD?9
M#9'=<M(:%)$L)52UMTLL[Z/JKJW:&=JP*J#^PT)9[X`/AC8LCW!L,Y6NZ9RT
M32=DR<G0EN-_18@O2JF8-=$)2*F0D`W1V1*=B)2*"=FU=3I&LLUK>ZWVN6$L
MNFL8)W8WT;6I>"&"^*:I681]4,S6%W<K68R-%\?4WI6^N.W*?EC+`CB`@EOJ
M"66QIIZ)5L^&U+.5!;">Z)9Z8EFL/2EJ2;"3M:D@VQS*_.MT'NQF[N@\%MWM
M/$XF\+INS=):KB]XD#V6-B\%4=/02L:TA;2YR.=!#NR=9&WMEO')2"JAM0&I
M+90Q+2%'\W%S2VU;J82U1:2V6,:T:K,UDW;_4UNGU]@V\HYN:\*[_2;0!-:T
MTDIGK`9)8^5"1-FMM$/4G*(T42M$;%:$N=YQY5!K[OMXOY5FB)1P@$@)AXBX
M\-">=(4W>%\);Q$IX0B1$HX1">&1UNX=WF^$N\ZS'=7MLYW%-V"PSL3A,1=(
M2QG-LX6(:N<,HE;2(!HWSMMC/5_$?4@8K'ZMBB`*$"GA$!%,):WAH4]K2EY%
MD7S<*BVL,4*D:HP1\::,M:[>J:I`I-LC;%O6[A%^5J!>Y#>M4=E)BC:U":2E
MB+8C6XBH3HIP+5>U;B6BW*Z?6B-]U((UBW2=^+G&*#6F`I17-8:(N)]PJ*/G
M#G](NYT[`BGA"%64<(RHTY2))K\342#_<5.Z7<AV>Y]U(2Z&/U]:L/,LO0\Y
M<E4K%R*JA98"V:J5*T3JG>4+U$DF(A]@0:45(E):&ZJU%:CU7!$65%HQ(J6U
MZVAU?67[NL]\O2TUQ.Y0#8LY.X``IUVU.%T(U,D#'N7`I36<M9&R$@4=O@&9
M6%J"^2BLNG"-2#U1@"J?UA5B%)_W+=/5*MN@LJILBTA5%J',IY7%&"5V5K8V
M>[(/$<Q$GH&\W_B'!7X2>L[*EVR1G4Y5+RW>V$<#Z.C'J<3RB\93LXW6^)Q]
MZ6"SOLX?/#C'^H#;'IRY4/[D>$_PH/3&W/'@V(#RY="#7?`'W/5@*TEYX'JP
M%Z0\<CW8S5&^''FP6:(\&'FP^:$\&GFPF0$^D$[`%Y=K\I+%2?F27ZK>*3N`
MN6;SPBCY-QO^HQ9;\.>BAF\MX#^<0\.WM0R.@$VV3S\418T_6`7R:]WCOP``
M`/__`P!02P,$%``&``@````A`!7!\(=F"```+B,``!D```!X;"]W;W)K<VAE
M971S+W-H965T,C@N>&ULK%I;C]I*$GY?:?\#XCW@"S87#7,T8!O;VI56J[.[
MSQ[P#%8`(^S))/]^J]S5[DL1`D?)0Q@^5W^N_KJZJMKFZ8_OQ\/@6WEIJOJT
M'+HC9S@H3]MZ5YW>E\/__)E\F0T'35N<=L6A/I7+X8^R&?[Q_/>_/7W6EZ_-
MOBS;`3"<FN5PW[;GQ7C<;/?EL6A&];D\P96W^G(L6OAZ>1\WYTM9[+I!Q\/8
M<YQP?"RJTU`P+"[W<-1O;]6VC.KMQ[$\M8+D4AZ*%OQO]M6YD6S'[3UTQ^+R
M]>/\95L?ST#Q6AVJ]D='.AP<MXOL_51?BM<#S/N[.RFVDKO[PNB/U?92-_5;
M.P*ZL7"4SWD^GH^!Z?EI5\$,4/;!I7Q;#E_<1>[-A^/GITZ@_U;E9Z/]/6CV
M]>?F4NW^49U*4!O6"5?@M:Z_HFFV0P@&C]GHI%N!?UT&N_*M^#BT_ZX_T[)Z
MW[>PW`',"">VV/V(RF8+B@+-R`N0:5L?P`'X?W"L,#1`D>+[<NC!C:M=NU\.
M_7`43!W?!?/!:]FT2864P\'VHVGKX_^$D4M4@L0G$O@D$L\;S8)@$LZFP')C
MY(1&PN>5V]\8"+2=W_!)`]U@-'6=N?^+.X8T$#[E'>]S=4H#X?/!2<)>ZWR%
M3QHY41+?F..<QL'G8W-T(8RZ.^(?=\UR+,*BB[*H:(OGITO].8"M"PO?G`M,
M!.X"V61\";?[B/M9P$&D(<L+TBR'(!W$4@.[Y-MSZ'A/XV\0V5NR67$;U[18
M2PL,8Z2-;""V@<0&-C:0VD!F`[D&C$&67AO8,[]#&Z1!;>2L5A)08EE2K:6%
M'!+90&P#B0UL;""U@<P&<@TPA(!]_SN$0)KE$'9)'R23N37SE;!Q(5_T1E,K
M2GJ37AV&Q`Q)&+)A2,J0C"&YCA@B@<N_0R2D@<T(>:\7('1\4X(5&=U2J3?I
M56)(S)"$(1N&I`S)&)+KB*$2S,M0Z7H=DVD%K3LQY"16A.A!%+B!*<^Z-Y+#
M(H;$#$D8LF%(RI",(;F.&'.'DO3`W-':G+M`@DF?2=8,B1@2,R1AR(8A*4,R
MAN0Z8DP4ZL`#$T5K<Z(""<Q%#JU%IF%>KT9$B&..F_?C#!_!Z`$?T=KT42"6
MCW:JHF&:CX28/GK.=1^A,7C`1[0V?12(Y>.LOU=78]<T3/.1$,M'5:P-';%I
M>,#)SMSTDB"_7\BU--)\DI#EE"H?IE-8TGE;,\+>L=U7VZ^K&K(K&%U)/SZT
M+]34B,8`<K',(RM70*'HC[%'61/DZL[20`>4[+-XX*DL;CJ+9?>6LW_6YY\Y
M"TU\[ZVHWH:W!'5'#+':X&87)0J*#,CT#(N=[MD5N70/J#;J>@D(SQJ:$!,K
M!%VR4CU21)`+ZX[=I#-R?[;46&H>\)$JD^ZC@#S8FIJ/=DW!E@2VESCK47=*
M7!`!Z.-TY)C_IO&7GSF-->(!IZFDZ$X+R!+6SI'81J#3NK#$U0OKJ)F:BX_I
M7??QKQX-1)FP.AHK!%8N68&D_2+8V539R/T8<2CF4,*A#8=2#F4<R@W(%`SK
MCRV8%XQ`\$=/4U3)]/4FR`C20&44VMV]E5*(0;'+H(1#&PZE',HXE!N0J1!6
M/UVA7^03*I:Z#`*:J_2U=AD4<2CF4,*A#8=2#F4<R@W(G#-64WW.8AL]6HJH
M)NM2",A7=6?M"BC0M[N`IOJ^\J<J+75Q$]-`L))QDW!HPZ&40QF'<H)"\:C+
M.&+;W4.G#CRA@C2`=5J6OON+MH>,9H-!D*X40;I2!,W"+IE[CFNEJ%@9]"(1
M)";62;GAS*D:B&4"F*UMFRD#R9P;S$9`>=A<W`HHJ=GMS=716#J)MF4.+4*?
M@^$AGU6L:6"H^K6(H)F"8@XE!/EA'V0;SI7R@1F'<H/+E`<;'%V>7\A`_9"V
ML3R"L"_2=%!E4N1:,O-G_70B"4%^[0?ZCFKNQ6:35G/1-<P#BSDA@XE*<ALY
M1MTLE=#-FV72BF[F.E:+D!LW,Y5\K/OS>/<G(6SF>D&"P')A36:^6H-(0BHA
MQ02%DTXVUYNYEK")'*0'F'!*HTZEE:+.3.I9,+$V:"['=,RF2-@#ZN'VE]*[
M1YVD4F`E(>-16!#8/1&9&5$HR";JC!*3U03/-I"!?(LED=?UB!,L&G$JK11Q
M)B%![-I+F\OK5S(_]J&WA+LSC5$[JRLG("U!K;%-AJ*@01%!O@J#6$***Y&0
M'E*,*Y56BBN3D.+*)70EB*ZUVEZ(;W2NG5`!EH<^KV^N9>582<@*'/O83V;:
M^D824NU#+"&1/CS7L9_J)V1A)"OAE$:=2AY%G4E(4+O!3#N(=(DR-ZC-78<=
M[*W@N>M\#\<BUBH09&4L]0R)<K\PT])*1&2AFF$L(6A05?8+6=8B+A"MM_)M
M+3;$I=TQE?3JCIF$S#NJ)S>DZR_N:$J-[?4MJ>_<IZ)+UY].X($;-Z7:6VL.
M103Y:I:QA%0Q3`@RHI#1IW*@XLHDI+AR@\O4`IOI6UK<%W:B)3>D(,@,N]!J
MT]?P\`$5TX(@(F@"V5J+'BO&8FEEQI@5%XFD5PNRD9!*8ZGDNGG'3%K=O".^
M.>\FI*5$\29<O*,\EI?W<ET>#LU@6W_@6VXX9ST_];!\!1\N7H`),J!U!9XJ
M+/#`?NW*%*YT<<#&S.!*%P[6%7C5_](=MBQ\!3\!Z$JBC7OPTX!K]_87\!:)
M^_0R6;R(H+"))@MXH<('K((%O&RX@L.LKTUZ/5W@TTH^('+G"SRW7;GB.0L\
M^/`K<*I9X,&%7X'C`(RY=A]H[F%,=V7<SQ%^K7`NWLM_%I?WZM0,#N4;K+/3
MG8\OXO<.XDM+3T%?ZQ9^I]`]$-W#[U)*>`;KX'GQK:Y;^06<&O>_='G^/P``
M`/__`P!02P,$%``&``@````A`.(X,[MJ!P``M1X``!D```!X;"]W;W)K<VAE
M971S+W-H965T,3<N>&ULK)E=<Z)(%(;OMVK_@^7]J`@J4C%3\0-!P-K:FMV]
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M_J"TS=/^M`]*]W?['%K`;.^4V6'6?;"\K37N]N_O&H/^S;.WJO5_IWHNWM9E
MOH_S<P9N0S^Q'G@LBA<6&NX9@L)]4MIO>N"OLK//#NGKL?Z[>`NR_.FYANX>
M08M8P[S]]V56[<!1D.D-1TQI5QSA`>!OYY2SU`!'TF_-]2W?U\^SKCWL3:S!
MU)Z`RF-6U7[.)+N=W6M5%Z?_>)`EI+C(4(C`%45&-XLX0@2N0L3JN:.1,W9O
M>!)XYJ8Y<,4GZ8TF`]N"QG^T-6.A`5?Y(+=JP/!JG@.N4N/FQDR%"%R%B'.[
M(Q:D%.]AEENB]V[VQ,(N9O](E9M;9-GX,/"/;)/E#,8W](^%F<+^D<_RP1[J
M\_QOAM,RK=/[N[)XZ\`<!1E>75(VXUD>$\:!Q-->#JT?C2P84DSE@<G,NI-N
M!P9-!=/!UWMG,KGK?X4AO!,Q<QICZ1$+C&#CE<DN3;`R@6^"M0D"$X0FV)@@
M,D%L@L0$VQ;H@[727\B;W^$ODV'^HC-S!,KPH6$F1F"1I0E6)O!-L#9!8(+0
M!!L31":(39"88-L"FIDP>GZ'F4QFUH4YJI6LKN[>G,>P$2&#C'Q>R!#I,"$K
M0GQ"UH0$A(2$;`B)"(D)20C9MHEF-C3]=YC-9&!R@75(&DFG!A'TGMLR1+I-
MR(H0GY`U(0$A(2$;0B)"8D(20K9MHKD-_FAN7]_(X'3+HAM3T8RY(+!XMVR>
MZDF]D$%8;$G(BA"?D#4A`2$A(1M"(D)B0A)"MFVB>0B-O\%#%JU[*(B:91>$
M+`E9$>(3LB8D("0D9$-(1$A,2$+(MDTTPV"]U@SCBW^/;3SKYWSW,B\@F6!E
MNY*,-BSR?.EG(KJ/G-A#N5HM.!DI9Y><3&`\J'QU!WJ^KF00YJM/R)J0@)"0
MD`TA$2$Q(0DA6T[&_+#27O?909/LJ\8]=/9+<6F<_;C-3%"WF9.VS2)FT/*9
M(W?<[,F&`\LQ+);WI<6<\"8U/;RFLH$LQK9Z(&OKLJ&\C[(;(AMQTDJ*6)82
MJL:6)I'W477;5M52&PX/U'\XG9D=<"6U84^.N<U4=-,Y:9M.R)*3D2WS?T6(
M+TJIF#71"4BID)`-T8F(3DQ*)81LVSJ:D>P@I3GYOF--N&Z90+8^ULG>G]4#
MQW!^6N>[?X':!>V!.4F@/.LU.'8,C&V:C_>;MQ$\H1&IN@)$[]858I2H:VK4
MM<'[JJX(D:HK1O1N70E&L8R5ARK7&!);C((Y7D;9@Y$<CGI?LE-*>U;Z25_R
M0PWLW7"\S2V.IK!KE-4YKC'Z%R+*=F7!)2(U-:T0P1AN:1D3E"^B',@%&=5N
MH.A1_ERM&@.45S6&B-HUVHYAZ>9#-49*"\V)$:D:$T1:C;;AU_9G->J=R$Y'
M-W0B/TQIG<C1%"[24L=5.=-8NF"O/,P!*9`C^W6EHIHYVQG+S&M4?+RO1L0:
MD4JK`)$2#A'QH3:RC;WL!N\KX0B1$HX1*>$$D1">&.W>XOU&6'>>G95N<%X<
MK=3CS-F+(/#4&#Z&9PL1U4KF)2*56BM$;C/OV2X9.+PN&#B8H&M5!%&`2`F'
MB-HYZ[ADJI/R*HG(N(R4%M88(U(U)HAX4URCJ[?B-F^)WB,PA6H]\DL[6';*
M-Y9Y@8PA8KPD6(@H;<WB6F/5NI6(&NM^&HWT4>M'$[F8Y[A\J\8`Y56-(2+N
M)[QGU`?E1M6%O1(A4LD:HXH23A!I39D:\EO4^E%3]"Z$]>W=+L2M\D_6*B9C
M[#LX&JL98L%>0T!4"RT%LE4K5XC4\N4+I`TFHA5@0:45(E):&ZH5"=1ZKA@+
M*JT$D=+::EJZK^S4UYZL?FUH,!7#5H[&:NNZ@"\]+*J5E4N!',A7N<9<V;OQ
M@@X_GDPM8X#Y**RZ<(U()6KPH;I"C.+SOC48&Y5M4%E5%B%2E<4H\V[#$HP2
MYR[;F#W9M['&L=8BP[]U\9?SIZQ\RA;9\5AU=L4K^XX%'7U_)['\R/;0'+(-
M/F<?W]BL;_*A!Z]6KW#;@]>`E#\XW@,\*+TQ=SQXDW6%CSQX.W.%CSUX"4'Y
M<N+!F?H*=[U5D^1&`P+7@Y,EC8]=#\Z&E"^G'AR]*`^F'ARE*(^G'AR-@/=E
MQ?#1\)(^94E:/N7GJG/,#M`9@^8<6?+/COQ'+0[TCT4-GPNAO^!3"GP>SN`K
MQH"=^@]%4>,/5H'\X'S_/P```/__`P!02P,$%``&``@````A``M,V_F3!0``
MM10``!D```!X;"]W;W)K<VAE971S+W-H965T,C0N>&ULK%C;CNHV%'VOU'^(
M\GX((1="!!P-EY!`*U75:?N<"0:B(1@EF=O?G^UK8IN.AG9>)L/*\K*]O+>]
MX^GWM^ILO:"Z*?%E9KN#H6VA2X'WY>4XL__ZD7R+;*MI\\L^/^,+FMGOJ+&_
MSW_]9?J*ZZ?FA%!K@<*EF=FGMKW&CM,4)U3ES0!?T07>''!=Y2W\K(].<ZU1
MOJ>-JK,S&@Y#I\K+B\T4XOHS&OAP*`NTPL5SA2XM$ZG1.6]A_,VIO#9"K2H^
M(U?E]=/S]5N!JRM(/);GLGVGHK95%7%VO.`Z?SS#O-]</R^$-OUAR%=E4>,&
M']H!R#ELH.:<)\[$`:7Y=%_"#(CM5HT.,_O!C7>N9SOS*37H[Q*]-KW_K>:$
M7S=UN?^MO"!P&]:)K,`CQD^$FNT)!(T=HW5"5^"/VMJC0_Y\;O_$KRDJCZ<6
MECN`&9&)Q?OW%6H*<!1D!J.`*!7X#`.`OU95DM``1_(W^GPM]^UI9GO!P!\%
MX\@%OO6(FC8IB:9M%<]-BZM_&,OE6DQEQ%7@*53"03`>>O>(^%P$GES$'41!
MX(?1^/,C`2:=#SRYB'^_""0'%8'G?Q_)A(O`\^Z1.&R5Z**O\C:?3VO\:D$F
MP3(TUYSDI1N[\$,L-UL;&0#_MOZP\$3E@<C,[+%MP<HV$+0O\R#RILX+!%K!
M.0N3XZJ,I6"0J"*R*QU8ZT"B`QL=2'4@TX&M#NQZ@`,^2;,@&K_"+")#S!+3
M7`B@<V^D.2,8HLE*!]8ZD.C`1@=2'<AT8*L#NQZ@..-]C3-$9F9#EL@P\L83
MU8H%X[B0U)(T5BE+29%V&<C:0!(#V1A(:B"9@6P-9-='%-M@$E\14$0&$ABV
M*&E)$/FJ*0M.^L@W29&^&<C:0!(#V1A(:B"9@6P-9-='%-]@IC=\&Y!MO3V5
MQ=,"@Q&0Q3<.+0]V)[9G$1'JFICM@B'>2&;FDB%!EZLKAHQA:-)K;ZREZUJ2
MA'1B(!L#20TD,Y`M0T)ZAM-I[!C"!JV8%-XR"4Y1[M$/?*4>?=XP(J@:QI`@
M[`SC2,\PAD0A/15&0U>+R[5\+[UB2&^.&T,U90@L`SEK0%4[;#+Y7JAN#637
M1Q3GX!S[,+R$=3?""VH<$5]$1;6+(9X2.Y%^"'(2JZWH*7BKV7"HIO=:-B.&
M^"/-Y82_[E9J(QL(A]+/])/)9J0?+]!\W_;[43PEWP?]0N-C[PA;]8XA'NAW
M>1=I>;?DI$C&XTHV$[-<2PZ=P%"32-AKOTNPC6P@)%)#-),<*JJ[O^V+*JY`
M+7>'*X2MNL(0+:*T-5ER4B^B9#,QI;7DD`F$8TTBX:][X2,;"(G4$,TDAX@&
MPU`-V6U?5''%A:^6.VRA=-47#FGAHB7%4K!Z\2*@;@-;"RBB>TVDU2,)?]V/
MF*Z%-$=`G6XFH-NZ6T57M8?4I_U<(D7[*"3?8[=.O-Z61"I\+8(XI(50H"[5
M4K!Z,20@7R;;6D!D#WR91Z95K'NO%T9=D\XJSNJ$LX[5R_ZAMG-N!8O*JXZ1
MNE5WS`WN+!A<5OU"G27&NN"0%F=:H"\%JQ]G3,MGG[UDFU]SED\JE)>Y?DXF
MXG5O9S)U4\'J=#,!017:;9VF>7Q`[':@_]4#MPTWS/L_A015U!*6U<@0AL+;
M)6>%]+*#?P\R5JB<`L91*!I.J)$C;Z(%2L()2AQRY:ZS5,A\V%DF6*PS=Z37
M@ENE,Q:5[/*%?8=7J#ZB)3J?&ZO`S^1BA2A)E%WZK((8:D%P1L?#&.HG$T_#
M&*H;$X?+HP=:W6HZ"W*I=(._&,7PR6?J++P8/FI,_,&/'V"^YHN%'T,U#[@C
M>X9+HVM^1+_G];&\--89'6#N0YJ2-;MV8C]:7J<^XA9NBR!JX)("K@<1I,R0
M%+,'C%OQ@W0@+QSG/P$``/__`P!02P,$%``&``@````A`'5M/[&S"@``N3``
M`!D```!X;"]W;W)K<VAE971S+W-H965T,C(N>&ULK)M94R+-$H;O3\3Y#P3W
MG]`TM-BA?B'[O@F"W"&V2@S0!J#._/N3U5592R;#8,RY&?`AZ\VNK*R]Y_K?
MGYMUZC/:[5?Q]B;M7633J6B[C)]7V]>;]&1<^Z>83NT/B^WS8AUOHYOTKVB?
M_O?VO_^Y_HIW/_9O471(@<)V?Y-^.QS>PTQFOWR+-HO]1?P>;>&7EWBW61S@
MS]UK9O^^BQ;/2:'-.I/+9H/,9K':IJ5"N#M'(WYY62VC2KS\V$3;@Q391>O%
M`9Y__[9ZWZ/:9GF.W&:Q^_'Q_L\RWKR#Q--JO3K\2D33J<TR;+YNX]WB:0WU
M_NGE%TO43OY@\IO5<A?OXY?#!<AEY(/R.E]EKC*@='O]O((:B+"G=M'+3?K.
M"^?>53IS>YT$Z&$5?>VM[ZG]6_Q5WZV>.ZMM!-&&=A(M\!3'/X1I\UD@*)QA
MI6M)"PQVJ>?H9?&Q/HSBKT:T>GT[0',7H$:B8N'SKTJT7T)$0>8B5Q!*RW@-
M#P#_IC8KD1H0D<7/FW0.'*^>#V\W:3^X*%QF?0_,4T_1_E!;"<ET:OFQ/\2;
MJ33RE)04\94(?"H1J/*YA?.J,'QBX8MBH9`/BI?G/P%8)M6`3R52N+CTLE?^
M-S0"I0&?2B-_X>6SP3<"<:DDX%/7Y;O!A)Z95`4^M<:WXP'A3T3@$T5,94ZT
MI`<)F!047W04=!5.E80,DB6M5-+Q.U40L\<SZ9.W,N!44<P=SR3/>=7$MO9,
M8WN6SS/SWL/V%E]TM+[=6#D,NOB"S?7]I\GIO@Q?_N)I,*@Y$U3_(I\K7!:3
M,>%$>XB>DN2`^**>(&=5A!?-R.$H&=TJB\/B]GH7?Z5@RH`J[-\78@+RPAPT
M$HYK4D*/=+\;Z&"$$RIW0N8F#:T#8]@>1N?/6ZC&=>831M2ELBEQ&\^U**.%
M&#Z%;(6"*@4U"NH4-"AH4M"BH$U!AX(N!3T*^A0,*!A2,*+@GH(Q!1,*'BB8
M4C"CX)&"N04RD"8Z5V#`^7_DBI`1N8*M7$)@DB='$@,ML$B%@BH%-0KJ%#0H
M:%+0HJ!-08>"+@4]"OH4#"@84C"BX)Z",043"AXHF%(PH^"1@KD%G,2`"84E
MA@]C[/'%$8X9HM1-&J9?/6;XA<!M^)*T$=..-KIT3<K:1"<'(U5&:HS4&6DP
MTF2DQ4B;D0XC749ZC/09&3`R9&3$R#TC8T8FC#PP,F5DQL@C(W.;.#D#3<IR
M1BRHOSGQ"!F8NZ"@3I#"Y96;(B5E="J+M(G.(D:JC-08J3/28*3)2(N1-B,=
M1KJ,]!CI,S)@9,C(B)%[1L:,3!AY8&3*R(R11T;F-G&R"-K]2!9=B-W(X6VU
M_%&*(2U@/CLR$OFP3)&+%R&2Y!"V?4D2/Z?GJ+(D!3-K522Y%#*?MWFOF,NZ
M65?5!BA;8Z3.2(.1)B,M1MJ,=!CI,M*3)$AVODDH^I)8U1SH4K*:^4+!K>90
M&V`U1XS<,S)F9,+(`R-31F:,/#(RET16T\D>6._R[(%MN4J><?R>),_YF20$
MW4R2Q,XD2:P05R0IPH<>P_P"63U7M1&&N2:)U7IU22SIABYE2Y/AL:F-4+K%
MI-M,NJ-+6=(!Z0-=;832/2;=9](#7<J2I@$9:B.4'C'I>R8]UJ5L:1*0B39"
MZ0<F/672,UW*DJ8!>=1&*#VWI9WLA-T4STXX;J'I>61L@WTA#FY"Q4U)27P8
M4TVZT465LI$G6<E6[%BI+&GNJC0*\LF8F,L6?&)04RJ!'ECKS%/C'$]-Q]-5
MWB=;R19SU&:..MH1MD57VUBAR1+I'I/NZV(H--#2MA`)QE`:J6@%OD<<C9BC
M>^9H?(ZCB>/HTJ.M\L`<39FCF7:$=7S4-G8=21WFMK23W>)@G!\\F.P^:^86
M(FYR2^*#6Y/<`7FHLC(JZBRL2)*7QZTBWZN*P/K5"-%4J"DC,X'6F72#23>/
M20=DR]O2TK9_,O>VF;<.\]8]YHU6I*>]8>OVF?2`20_/D1XQZ7LF/6;2$RTM
MEAU7OKOF>&":4Z8Y8YJ/6M,.*<F-N2WM)"P<\?*$_9O%@A!TDU<29V3VZ!A;
M5D;6T"Q)WAG0:;&J,A(3P^?ML:%9Z5I#,_/4.,=3T_%4+!3)[-IBCMK,4><<
M1UUE!!/H[[MHCWGK,V^#<[P-E9$,X)'1FCFZ9X[&YSB:.(XN<SF:_,S1E#F:
MG>/H41F=C-_<]N;T!W%SP3O$M]<GB4S2#4PK%HIDJBRAE9WC=,UB;'`0JW!4
MY:C&49VC!D=-CEH<M3GJ<-3EJ,=1GZ,!1T..1AS=<S3F:,+1`T=3CF8</7(T
M=Y";7^(8^J]7")X\S(8#(DR*DD+VGDRAWV_F*\8"=:H<U3BJ*V1MTQH*6?NT
MIBGXFVUVRUC@`[0YZG#4Y:C'45^A(YMD3YSZLG;XFXDO471G/H6<-I&GS048
M@,SP'I#!L*(*6K&L*N3NI_-DM*@9*XQG72&GJ=1#F'.?IBEXXKE:Q@KEVUR^
MHY#U]%U3T)*G3]\S5BC?=^3=GB0.86D+YL0261R1X2G'Z6VDN#0FJQ6%G.6*
M'^3=I5I9616=%3E9$E10RO32*B)[Q/?IJJ:&5FI90YS7\6>SJ&DH%/AZ0&BB
M55ZC%B*QU\8;39^NFMMH9>0[B(Q6UR!;B\QP/;0ZZ;&/5HE'MY$A4$XC_Z$]
MA3GI@Q+!W@ESJBPN7L`J,!6L*.2;S5,5D2E80V2LZ@KES6:IH9`EWU2H:`JV
M.&ISK0[7ZBID5:B'R,CW'2TWI-`63DC%Y7@N$"_X'#M0M@Y=Q'T$C:Y$I+>0
M#5U9%?Q#;U%2=F_1ZMAV-27EJZY!!LXZ_FR:MJ&0TS6D;M$9A$GO;>%#)Z]?
M)>?(;:[>X>I=M#*=I8=(/C7=^/7QYR/Y+\[1[$'N#_DOC]U`#P-6$N^H0*-9
MZ5)6R$K0"EJ9#*HBLO-?:1FKNK)R\E]:6?)-KM5"9+3:7*NCD*75Q8+FN7J(
MC%;?T7+S7QS>8$A%Y)/\QWGCK`,:\<(.[0@2D8Y`+G[+JJ#;$0(RB5>4%>0X
MMF)5H<!4NH8(MO9F,`_(`7L=M:!-C%66=-`&:MG3AZX0/D0+M2!FEA8Y:FBC
ME>F"'2[?160JU$/D5(C.3GU'WFU8<<A!&];[_M9-GI4X?4@BIP])9"5FQ5-6
M)@NKB$PM:XB,55TAIP\Q^286-%HM1$:KS;4Z:&4*=CGJ(3):?4?+#;78/Y\*
M]7G=2.["G4A+Y'0C?E@DW@\5$[A)UXI"3I^15J=/D&JJ8-[I(/3<LH[RCA7O
M1NRYFEC03`8M1*9[MQ'9?49'`OM?5UF=KE`/K8+D3(S/-4K7FFODZ\'R!;I-
MM'N-RM%ZO4\MXP_QZF].W`5K+-]+;GJ%4$R0\&CD%WAC^2ZY8":\)-YD/F)?
MRH7P`@[7*?DAO&7!^5T^O$MF9*J?#^$^_8B]EPWO("3\EQ+\(C;J_)>RYX5B
MT\M_@1UM*/:9_!?8GT&98S6!K17$ZM@OL"L"M6._P((1RARK3Z40PI4W]S\H
MA'!'S'DE".&2E?-&$,(-*>>=((3K3<X'03@\QL=!"!>+W'X6A'`K"#RC&PI>
M'']?O$;=Q>YUM=VGUM$+9%<VN1O9R5?/Y1\'=4']%!_@E7%8S<,4#?]%((+[
MBZRXQ7Z)XP/^(1SH_W1P^S\```#__P,`4$L#!!0`!@`(````(0!J<SK',"0`
M`![5```9````>&PO=V]R:W-H965T<R]S:&5E=#$Y+GAM;*R=66\<N;:EWQOH
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M2>[QS'5ZPO!P_>NOJ\Z??="9OT#_^@M.?SF9G9Y?#+5]YDFZ[?`D_>LO/)Z]
M[$KUE.%*_7O09[OTU^E??]UEU/69FE9J`L,#*VE^8%VK6;A6_W%0;2OY/SXU
M-H0]7E3!=?<?_F'/N_%N;'M#4U[>/-U\?/]P__<;#1#ZI(\_;MQP4UVYNX5&
M/,HT->N?M6HU9W>7:W>;#V]EL1KLH_KB7Q]/SR[>O_M+W>>3CYDSIK(1BQ#A
M^HJ[[3('JQS4.6ART.:@R\$Z!YL<;'.PRT&?@'>2=M)7K>&?T-?=QND;E)D'
M$`6?96*&B'#),@>K'-0Y:'+0YJ#+P3H'FQQL<[#+09\`(Z8Z",0\5J<MC[BA
M;;JK/KS5(#*US>KRV(HU'V-<!YB"SFW(8@J9!`59@=0@#4@+TH&L038@6Y`=
M2)\2HZT^.K1UL]F!`X&[C<8273@)65V>62GG/N@YM:>026V0%4@-TH"T(!W(
M&F0#L@79@?0I,6I+'Z/V\RW810^B!C'F(YFIHT29S_,1P`?)\AB4>&$JI&G]
M@`JY:%LA3^((M0!9@JQ`:I`&I`7I0-8@&Y`MR`ZD3XD13'.=$6R8.$^&5&_/
M>.2NM.)Y,J2;P\2W\$2S2F)=')%,3=R"XA^8PMUMT'/S.=P'J5U/]8JU&JL^
MA83&N@19@=0@#4@+TH&L038@6Y`=2)\2H[:22J/V\SW715NO1Y+UW!,[0"Y\
MD.VYT0M3(9>U'E"C(=Q6*:"D\Q(MB59$-5%#U!)U1&NB#=&6:$?4&V3U<ZE;
MWG]F,RT9]B46;IF0N1M0TI4#LGWY<G+<5L:E/GEE7C$-N^5(WINU/S`]=.BJ
M\Q#U7'>.,5-_)EH1U40-44O4$:V)-D1;HAU1;Y`5WR5'J?C/]VVW<,OM'U'6
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M1`U12]01K8DV1%NB'5%OD!5?%AW0C68NW*;`'IFN/3O*=HD6(2KMVJDYME)Y
M*O=\FW2/SBOE4=*W0U1$2Z(544W4$+5$'=&::$.T)=H1]099_5PN]?*QT653
MN7X>:?";)L#9T:E-@A?APHMIFE\2K8AJHH:H)>J(UD0;HBW1CJ@WR$KJTKY4
MTM<.4CY]3-./V5&66\QG/NK906J*B8,4T"K>*4351`U12]01K8DV1%NB'5%O
MD!7?)8JI^'O&`Y]7)G.]^UHPSS]F1]GFZB)$V4$JFF,KE2>D>RHUY9W!B/G,
MH]A]%D1+HA513=00M40=T9IH0[0EVA'U!EG]#DLJ9TPJ`[*#5-SK&3?58E00
M?DFT(JJ)&J*6J"-:$VV(MD0[HMX@*ZG+5=-^\MI!RN>\Z2!U>A;W7<8MD)F/
M>G:0FF*B^$"K>*<051,U1"U11[0FVA!MB79$O4%6_#RAWC,>,)&>C<C-Z\FD
MF\F^"%%FD*KB4LI4RGW%9UK$\Y4:PFUZ%]#)-,<OB)9$*Z*:J"%JB3JB-=&&
M:$NT(^H-LOKEZ;'K42_:`CEFIAQ0LE`*2,'1\NHG6R#'>5K\RNX]W"=?*%59
MQCX/4<]U[Q@3.NZ2:$54$S5$+5%'M";:$&V)=D2]0;8EN(PX'5OW]"2?0"<Y
MR/&(;/>NXJ)XG*Y"E.W>T1Q;*9?P'5`IGQ^FE?(HKHH6QT!+HA513=00M40=
MT9IH0[0EVA'U!EG]\L32]:C9J?O^XL`O[X_'!#/=\0Q(\UW2M[/]B$6,BEW(
MWROFA2M&U40-44O4$:V)-D1;HAU1;Y!5^[",^9@9<T!I:_51$2T9M2*JB1JB
MEJ@C6A-MB+9$.Z+>(*M?GC&_OK4RF3[VR+;6?,4?HV)KG2X,:,6HFJ@A:HDZ
MHC71AFA+M"/J#;)JNSSU@+'5I[7IV.I1;)J+8Z`ET8JH)FJ(6J*.:$VT(=H2
M[8AZ@ZQ^>3[L6JO;8#YT9&6B?.R1Q$Q&UGPU'Z-"PUP2K8AJHH:H)>J(UD0;
MHBW1CJ@WR&A]<EB:/X3;-#^@I*T2+8E61#510]02=41KH@W1EFA'U!MD]<O3
M_.>3NQ/F]@'9)AFWCL;D+D9-39)H1503-40M44>T)MH0;8EV1+U!5M)_:+%R
MXG?RE1,E?3U;%,]#E%+7*0KB^SO%E>PR7A;\6!'51`U12]01K8DV1%NB'5%O
MD!4_7ZS$3&%/R^:RY:2X;,EWV4*47;9$FVSUW`KCY5/KB5^0)%-K0.EPQ64+
MHU9$-5%#U!)U1&NB#=&6:$?4&V3U<PN$`_3CVN1D6F+$_C*;Q4TD/UQ-4:%[
M+..%`:V(:J*&J"7JB-9$&Z(MT8ZH-\A*>MC:Y(1KDX#B\+(@6A*MB&JBAJ@E
MZHC61!NB+=&.J#?(ZO>/K4U.N#8)R$RNL[A+YELK%B++>&%LK8BJ&=40M40=
MT9IH0[0EVA'U!EFUW3+B@`'`A6?YGD=I:P5:G@"MB&JBAJ@EZHC61!NB+=&.
MJ#?(ZI>O3?;,BER"G)26(+-\,R]&A?:W)%H1U40-44O4$:V)-D1;HAU1;Y"1
M]/2P)<@0;IMD0$F3)%H2K8AJHH:H)>J(UD0;HBW1CJ@WR.J7+T%BRG;@@MFM
ML;/>'I"Z\Y0>SV9Q4WD<0&/4U%J)5D0U44/4$G5$:Z(-T99H1]0;9-7.5R?/
M#P"GTR(D*#,/*&VM7&`P:D54$S5$+5%'M";:$&V)=D2]05:_?(&Q1S\N*TX]
MLDTRWQV/44'X)=&*J"9JB%JBCFA-M"':$NV(>H.LI(<MBDZY*`HH;9(^*J(E
MHU9$-5%#U!)U1&NB#=&6:$?4&V3URQ=%;@`]OG`O$#ATR_'4KWN2!6=`MKGF
MV^,Q*C97K*%6C*J)&J*6J"-:$VV(MD0[HMX@*W>^8')RO^+W^*?32BJ=FK*]
MFWF(4G.>)K`L9A%CHOC^YK'YKQA5$S5$+5%'M";:$&V)=D2]05;\?+6U9_CE
MDNIT1/;+Z%F^A1ZBS*[.+`IO*^46"R]?E)RZ\"P#]"C9U0E1$2V)5D0U44/4
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M?KX[FW**D`G,/7*_MTM<SI<;Y2C4<[R][H5Z'C8OGW%>]FB\][@LCRBM>C95
M+V,4*I7/RZ_,U,ZF"3NM1YP_AMK.0U0Z&,6$P7\B?Z>8EBWC9<&R%5%-U!"U
M1!W1FFA#M"7:$?4&V>Z?3^I[6BYG\K,1V4SM&)+Z*).I'4=S3*7.#YO<AW`[
MN0>43.Y$2Z(544W4$+5$'=&::$.T)=H1]099_4J3^ZPZ>\%?1NNM>GG6&U`R
MHP=D1ZLXH]O:E*?O@U>]Y]/\G?3ODVPBG(>HY_IWC`F=>4FT(JJ)&J*6J"-:
M$VV(MD0[HMX@*_YA^<<Y\P^/;/\^R7.D$&7Z=V*.K=1A.<<Y<XZ`TO[MHR):
M,FI%5!,U1"U11[0FVA!MB79$O4%6OSP?<C.FVTP^<"?>O2@A6^(&9++-DSR9
MBU&Q`_E[)3\*9E1-U!"U1!W1FFA#M"7:$?4&6:T/2^W.F=H%%+.)!=&2:$54
M$S5$+5%'M";:$&V)=D2]05:_PU+.<Z:<`=DFF>?N,2HV27^OM$D"U;RP(6J)
M.J(UT89H2[0CZ@VRDKKT].7+H7.?S29+MH#2)NFC(EHR:D54$S5$+5%'M";:
M$&V)=D2]05:_PW+><^:\`=DFF:_68E1LDOY>:9,$JGEA0]02=41KH@W1EFA'
MU!MD)+W(,W8W([WJ#U6&.]ED/B"K=K;J7<2H26VB%5%-U!"U1!W1FFA#M"7:
M$?4&6;7S_/[Y1=L%<_J`8F]?$"V)5D0U44/4$G5$:Z(-T99H1]0;9/4KK4A>
MUUJG-4EH=/,+CVQKS;9#%C$J7+@D6A'51`U12]01K8DV1%NB'5%OD%7[L"7(
M!9<@`:6MU4=%M&34BJ@F:HA:HHYH3;0AVA+MB'J#K'Z'K98NN%H*R#;)?(LF
M1L4FZ>^53%>,JHD:HI:H(UH3;8BV1#NBWB`K:6D!]8HOAR^F!52Z)1'W0<8M
MQQ`E,:>]78CO[Y2V9Z!5O%.PJ"9JB%JBCFA-M"':$NV(>H.L^/F**N8*>^8Q
MKJTN1I1M3L1MQ7$_-T39S8EHDZW>80N6"RY8`HH[$0NB)=&*J"9JB%JBCFA-
MM"':$NV(>H.L?AIES.K$V>M_Y[+'7W=EEOIYE.P]7GAD]AY/XWZ4K<QAJ?X%
M4_V`4C-]5$1+1JV(:J*&J"7JB-9$&Z(MT8ZH-\CH=UG*ZZLCI3C/6SE<9ZT,
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M`:7=VT=%M&34BJ@F:HA:HHYH3;0AVA+MB'J#K'ZE1*PZ&W_CM<=@9F*7S,0"
MLOT[KFQL;0[+Q"Z9B044K5L0+8E61#510]02=41KH@W1EFA'U!MD]*N.2JG8
MQ>7P^_'GW1POM=G8Q)+Q>F+6T+B:RBKD$BE,'QHA#_P6LCIR-QISN6DPGIW%
MC'Y<14]ASXW92=`T:!>8CK?PSXSK;9UO`:8#+L!TP@68CK@`TQD78#KD`DRG
M7(#IF`LPG7.1LLR+P_*S(8//EEJ!91E:7"6/:^DIS(SAB5M9Q0[+T:HC)FD3
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MOF#R%TS^@LE?,/D+)G_!Y"^8_`63OV#R%TS^ILS*.9Q$E8Z&PX+Z11EW%4ZQ
M2D?&P-(.')@U^">+ZFHXH0HUT@!T:(X6CKK2I<FT$%=N/D<+8<_F:#$HYFAD
MJ['RF@32'(UQ32&N+;"NP-8%MBFP;8'M"JRW+&L=!^9HX30KTR)*NVAG^3*[
M\I>ZXP**;F45<_E&VDCV3.*ET[$"BSU^49$M"TP^I_G.T)#J`I//B)//8/(9
M3#Z#R6<P^0PFG\'D<\HR.4LY6E6=O.#7UXH*2Z'0->83F\4W7$_,C@(_67I7
M;I?\((-]AF):GF>F%I[Q#TVJX;"FM$V].),)QSR9A_NLQ3R\F,G\;+$Z'-V4
MUF=?&_>SN*E%.K/[U9`_$LHDJF1JX[A6;1Q,;1Q,;1Q,;1Q,;1Q,;1Q,;1Q,
M;1Q,;3QE61LO93(O;>.%5":<`V5F.A]GVWA<CV8U<M/R(0;[:=P8G$[MP6`P
M#6)@,AA,!H/)8#`9#":#P60PF`P&D\%@,AA,!J?,RCF<R)3*Z?KOZ]Y64(73
MG5*I`U,-X@QUGNWY+*9+A[];'!Q9%IC.J'2;8TH58IP.J033*95@.J823.=4
M@NF@2C"=5`FFHRK!=%8EF`ZK3%FFOMK\(8VY<.Q5%5@Z(Y-)3O<LL]26G&"2
M$TQR@DE.,,D))CG!)">8Y`23G&"2,V69G'GFE33F/?.`VPW+-\H"2P>KP%2)
MI#W_;-MD.,<I[UVO^"Z["@=":2).'AN7>T.7T6&P/EMY-BV/02'W4..8+@Q,
MC0-,C0-,C0-,C0-,C0-,C0-,C0-,C0-,C0-,C2-E6>/(T[5]+:*0HOFCH>S6
M*0YMKT*8*E-T*ZN8RZ[21K*O8CX;,\.L9V80`)//8/(93#Z#R6<P^0PFG\'D
M,YA\!I//8/(93#ZG+)/3Y8NIG&X0>-GF2S@DRBCKTT\S")12TO.?K<V'<Y+2
M"NWSUZ=CIA9IBN8SEG#^4O1<_B)._H+)7S#Y"R9_P>0OF/P%D[]@\A=,_H+)
MWY1E_I92TI?]T6L53DTRTOKTTQA<2DG/X_([JY%+KPXQV*=CIA9IBA8,!I/!
M8#(83`:#R6`P&0PF@\%D,)@,!I/!8#(83`:GS,HYG(*4RNDZL/NKQSW])IR>
ME,H:6&JN9VZJ2$;GN,65U<:E&VEM]M7"IR>F%I[%GKJHPHE+D2T+;%5@=8$U
M!=866%=@ZP+;%-BVP'8%UEN6R5E*T5YB;B$_"X<D&7/'N,S<GVV8#(<<'6*N
M3R^,N9Y%(V4NF,P%D[E@,A=,YH+)7#"9"R9SP60NF,P%D[E@,C=EF;EYBN5Z
M[OCW-OMZ32'9"L<E&7O'N,S>GVT&#4<`'6*OSRJ,O6FFX0?F<+10M%SV(D[V
M@LE>,-D+)GO!9"^8[`63O6"R%TSV@LG>E&7VOCZS"H<)&64+F56(TX"9C,T_
MVPL:#LU)_77M[37+JW#ZCCY[?.Q%7-7YY54(4R.<PN+0$AJ'3UWBMQEJ'&!J
M'&!J'&!J'&!J'&!J'&!J'&!J'&!J'&!J'&!J'"G+&D>>ENWK\3[%,BUB9'9Y
M=8'-(G_6CQT$$K>RBKE,(VTD^RKF,Q-3,<_BWT=IC`>3SV#R&4P^@\EG,/D,
M)I_!Y#.8?`:3SV#R&4P^I\S*.1Q>D\KI^MPK-PS#03BIU(&I*4Q];'81?[C@
M>UD,"QL6RXIL56!U@34%UA985V#K`ML4V+;`=@766Y:I?V`V&L[%,0H7LM$0
ME\YH9)(3UTI.,,D))CG!)">8Y`23G&"2$TQR@DG.E&5REK+15_V!<!4.P3%*
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MD65M.>[OA;8\A25M&4SB@TE\,(D/)O'!)#Z8Q`>3^&`2'TSB@TG\E&7BNRS_
MD+;L5P5&8<_,P`RFM@PF.<$D)YCD!).<8)(33'*"24XPR0DF.<$D9\HR.=VJ
M)I4S[HH</"Z/"R0[!7IFDXRXG1G:\A26M&4PB0\F\<$D/IC$!Y/X8!(?3.*#
M27PPB0\F\5.6B>]6,JGX_ZI.;CY=??[W\O;QT^UWS61'[B]KPKNCJW"PD&G+
M?C5DVC*8VC*8Y`23G&"2$TQR@DE.,,D))CG!)">8Y`23G"FS<@[G!J5ROKXM
MAR.(4J4#DY])CH$MEA@6VS+9JB*K"ZPIL+;`N@);%]BFP+8%MBNPWK),?+>0
M2<7?TY;#L4-&8;\82G.,$!?9LB*3G+A6<H))3C#)"28YP20GF.0$DYQ@DA-,
M<J8LD],M35(Y_QMMV:]RC-(CRW*,N%7MQV5_MI'"DK8\71J8Q`>3^&`2'TSB
M@TE\,(D/)O'!)#Z8Q`>3^"G+Q'<+F5S\UVS=AH.,E$M.0\9I_@.S>17"E,%/
M81Q7_.K*=`0P>0$F+\#D!9B\`),78/("3%Z`R0LP>0$F+U*6>>&6-:D7^\:5
M<1EDLA!_'E*V=1LW[D-K'R^U6[>7<8<WJYA;(!Q2,;^@B'U)QGN63MYD&O`0
M)Y_!Y#.8?`:3SV#R&4P^@\EG,/D,)I_!Y'/*,CE=RI_*^=\8\,;5@VT"GIG)
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MS"-DQA06'B$S\`B9@4?(C.G:^`B]FN']N[^D^2>_(I4_4UAXA/SQK/`'.<-1
M4*D_>\:9<'14ZH-GQ@>R9168:I/XD&T)KY*P\`GJP)2>!]8$ECRVG=BSC^B2
ML'"[=6#)(S:!)8_83BS^3<&NP/K`QOO93C&<:76(Z'Y58D0?65*U1>7/RDJ8
M1/=Q5I%L[U*B3V%!$8D^LD01B8['2O3IVM37+%V6Z%-8>(1$QR,D.AXAT7&M
M1`>3Z.G],M'=ZB(5_753@#_URZ0RGB6ZRXMQ,9,P>>&9G0*RO3=Y,84%H>3%
MR*P7>(2\F*Y-O<B6D?)B"@N/D!=XA+S`(^0%KI478/(BO5_FA5M=/.?%"V>%
MPKEHE6?NYV#)*(.E10B+?4K^C(L><^EQ/L3*'Q_F]@'_^C@[S>XMLWS`63I:
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M!V82RRP?9GK@R-PO%))NE"TFY)\/\S/=Y7'6$N2?O[F9ZO!`^?>2!\I2'S8>
M!UJP%(^3I7B<+'W)X^2R#PN?+Y_*Y7+ZP,QEM^K-^V"ZIQ!LWK>D&E?/;C<[
M\2)+*N2V#TLMH]=34&@F&FW!9"R8K`33.`HF*\'D&YBZ'YB\`I-78#(&3%:D
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M9:>N+I*Z=,]35Y=Q:X#7S5S9L'^9E5WK[S.D2[%L[LJ&/^`H/>_8U5,_^B^5
MG;AZC@NG['GZ^:VKYY@@LLS54S__+=[3M1?]EK58=N+*AJ\X>$_7EO2SP>)U
MKBWI5VTLN]9K`:2+_K:(9>Z=";I.7T@6R]SS]/.@8IG34W^G7"QS>NI/7$ME
MQTZS\5QM?+YC5Y=QUYUEKB[ZZRS>\UIO(]/GTT3',KU6RCU/KU,KEKGGZ157
MQ3+W^?1JH&*9^WSC2UA0SYEK+WKG2>FZF:N+7N#!LFN]]5:?06^]8]G<E>F%
M?*7K5.8^@UZE6KS.::;W<!;+W.?32QR+9>[SZ06`++N^5#7U6GR6Z"B)*W>R
M0JE$5=3K^5ER?7FJ#ZTW/K-(KZ[71<6J7ZKF>AUXZ1K56Z^6+I1<J`HZ>JI4
MHOZF$Y18<GVARNGH#I;,5>(._BF5J&XZ,Z94HKKI`!*67+O1O#SPNK%<62*O
MF;N1O#B07Y_/KJZ+GT='1NN:8B<YEP8ZAK?T''U2'1I;*M%XH^-02R720*=Z
MEDKT>71>9:'D5'4K#]QN;BU/K:>JM7YW4;J;:EV<<J]/SZZNRY.X2OKR5'RJ
M6NL;P<)SSN2"O@1BR?6)7"C68*Z2OCPMG.CSE`?^$WV>\K!_HEH7!_VYF[/+
M4[:;L<L3MINOR].UFZW+D[6;JXM3]?6Q-"A/CBKIQ^^7\^'S6!IH_4]%Y\?2
MH#C\SX^E07ER<W.^MGY*=Y,&XVX/:B`-RJF`RP3*B8#+`XJ?]'IV<G5=GB15
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MQS=?;W_3@OYH>"/MP]WO;G-E_#]/]S^TT'_[YM?[IZ?[;\-_?KF]^7S[X`*T
M;_G;_?U3^#_N`7_?/_PQ;!I\_/\"````__\#`%!+`P04``8`"````"$``VZ1
M0UP)```(*```&0```'AL+W=O<FMS:&5E=',O<VAE970R,"YX;6RLFEMOXDH2
MQ]]7VN^`>#^`;:Y6R%'P!1M?M%J=W7TFX"36`$;8F<Q\^U/M[G)?BC!DM"\A
M_+JZNOSO6W7CAS]_'`^][\6E+JO3LF\-1OU><=I5^_+TNNS_YZ_PCWF_5S?;
MTWY[J$[%LO^SJ/M_/O[S'P\?U>5;_58430\\G.IE_ZUISNYP6._>BN.V'E3G
MX@0E+]7EN&W@Z^5U6)\OQ7;?5CH>AO9H-!T>M^6ISSVXEWM\5"\OY:[PJ]W[
ML3@UW,FE.&P;B+]^*\\U>CON[G%WW%Z^O9__V%7',[AX+@]E\[-UVN\==V[\
M>JHNV^<#//</:[S=H>_V"W%_+'>7JJY>F@&X&_)`Z3,OAHLA>'I\V)?P!$SV
MWJ5X6?:?+#>WI_WAXT,KT'_+XJ-6_N_5;]7'^E+NT_)4@-K03ZP'GJOJ&S.-
M]PQ!Y2&I';8]\*]+;U^\;-\/S;^KCZ@H7]\:Z.X)/!%[,'?_TR_J'2@*;@;V
MA'G:50<(`/[VCB4;&J#(]L>R[T##Y;YY@_^F@\ELY%A@WGLNZB8LF<M^;_=>
M-]7Q?]S($JZXD[%P`I_H9&"-1U/FXD8U*&W;AD]1;7Y/M:FH!I^BFGU/M9FH
M!I^BFF4/YI/)>#J?W8X3YDH;)WR*FN.!/9]8DU\]X$)4A$]1<7I/I!:,@K9!
M"V3_8JR6C77A'U'7EAUZHS<L&`*\53D6IH.9-5HXO]#'POYG_W1M?CX`AGP,
MMD/:WS;;QX=+]=&#=0(>MSYOV:ICN<P7#F8>=3>\/QO=,*R9ER?F9MF'?H:!
M6\.4_/XXF5D/P^\PC7;"9D5M#`L/+=B<86Y]$P0F"$VP-D%D@M@$&Q,D)DA-
MD)D@5\`0I.WTA2'Q_]"7N6'ZHC(K!%)P6Y?;0PNLXIL@,$%H@K4)(A/$)MB8
M(#%!:H+,!+D"-#%AEA`Q'9BYUU=>')NLUK(/*TDW-JV%HXNUXC9L`G1&,]W$
MZTPZ00D)"`D)61,2$1(3LB$D(20E)",D5XFF+3PZT9;M:E]<")@;6$N@8B?D
M9&8,S94PNJ5V9]*I34A`2$C(FI"(D)B0#2$)(2DA&2&Y2C2U01^B]M09L%7_
M]F!F%5M]49>5(&W.TJZ:GB"P)'5]8-OS;CAK@<".K@5RNW5FK;<NB%R9/$)\
M0@)"0D+6A$2$Q(1L"$D(20G)",E5H@D&>YPF&-\PVYYKWLK=MU4%HH/T5X1T
M8&/DVR5SHNLHB-*+G-@PA)1>7'2]R#=(M9H6)CMLT'U=AOE7=?XL3$@A,4[F
M18^3$Y9ERJB<D1Z5)XRF;2(PMA:VL9;ZPJ`=-5K8D+9I85]140F/6>OA<6*#
M?R4\,\WHC%B>XAA;@2]*%^T90-W*68[XA>!:<STZ@0SUC-710RN4;SZ:Z/KZ
M:$'U8^GK5V+D:0LLU]URTGI8]@T)#9$\806;+]/0(@%ROU`,?K4.9LGR5P+D
MJ8`6($<.-*'T\5B7R&O;@9.5;D7B['R1.-E&J4Z@VR.19?+&4!0((D!M/8G4
MT*=ZZ+ZT(D&Q_40-ZG>S=;$OJ;-X,C/Z>,6R(?9,Z@ID3&1/VN!#^A0%%(44
MK2F**(HIVE"44)12E%&4:T@?N6Q;-<6W)P/`7\R16'9D#A:!U(5K,B.#NK.2
M:A,4H/MY-_!"BM84113%%&TH2BA**<HHRC6DJ\TV8%7M7\P_L5^K"YE`XTX&
MSR+(IRB@**1H35%$44S1AJ*$HI2BC*)<0[I^+#-0]?NM/,42^84J*T>.K<A*
MD"\JCJ%$+M(+8Z<+I!6.YY"B-44113%%&XH2BE**,HIR@1R'/;:N-$MF;BE]
M7ZIE\9P(9@1JL1)H+">R1Y$OT`2R$T5J8S$/I!6Z#Q')GEPC:I^RS3`C1#?=
MQ](*W6\02?<)(ND^1:2ZMT9&0IE)*W2?(VJW5[U#6`:G=L@OE@Z>\&G"<Z0)
M3Y!O"00?BO#&FAU(*PP]%&@B,X,U6LFNCA#==!]+*W2_H>X3M)+N4T1MGMMV
M=491KOG25+:_E@VWYGHV+)"J,D4^(ET&(Y$+I!7*$`JDJHQ64H8(D>[>2'-B
M:87N-]1]@E;2?8I(49FB7/.EJ\P2:74L_]8R;O-T7!WB`FGB<RL%^6BE+^-&
MPAI(*U0G%$@3G[B/9$5U!LF;BG98QM(*W6^H^P2M5/%%B_)R(D,KB7+-ERZ^
M>58QQ;]O9;?I&48@1TVM[85QN/?02FX)/B*UHF,NEP%:L8/\]T=[8C@.L;S]
MD:P5>8U(MA4ANME6C%:0AW:KH#,RCMP;M)(M)HADBRFBFRUF:/7)T^58WK:E
M=ZAYJ&,=:D_9SW37[FN4FP:;GN\$<M2YX8R,%,=#*SDL?41R#`:(%FV'.>.1
ML8N$PF`L[X?66$=ZCA!)SS&B.1\*1EJPH7X360.G6XI(^LT08<3F%4^N>=9[
M`;J7K&GW]0*K:6PB'&DSR1D9C^FQ6S2HZ,BQYB.2QX,`D3Z425<(7W"64`:\
ML2&MI2]4,4(D6XP1Z2V2R=.UB+X261%1BDBZSQ#I[HT'RM'JLP?2.P]\T<YC
M<^#NRT\VV\Q>Y,B82\8^XXF*CASQOD!CF4H%B&P^XJ<S8S,/T4"=2Z)]Z3E"
M*^DY1L3N<6%9-0;9!HNEWT0@)>(4K:3?#)&(>&:NYSD:T.LT>,^!=H<%KQ.(
M#L$=Z@N](\[(<JJLVD9@]L`P5$:\(:N'5K*B+]!8KV@D]P%:B?5\X1C]'J)G
MN7FL$<G&(G1SL[$8K?CE*NU#_O2.;"JA3:7HY&93&5KA<YG;,'M)I5V5E(V*
MOW3"?Z$_%I?7PBL.A[JWJ][9"R5PZ'Y\Z#!_VV4U=>''"E@%#/YDC=TG:(&6
MP,6>R^ZYKI5,H*35U/"VLJ`9N&V@=>"<Y[)\C);`<<]E:1DM@5.?RU(Q6@+'
M.GAYYUH)O-7SU!XE2600V!5/*QL<7>.."S^"TI:?0"ZX>:4%*U#KFEB0'+LL
M]:4UX&3ML@R8EL`!VUU?+8%SMLM.T;0.'`2AI#U`&(\.AQ>7'4VNU('86-Y,
M2^#FWO7A]IZ6K"S;75U5`"[3H<XU,>%&&TJNJ08W0"Z[1[G6SMQ=?1+;W/6N
MEL`EA\NN,*@W.(5#R35UX.0(_<.7S$XX>`_KO'TMLNWEM3S5O4/Q`M-JU/XL
M=N%O<O$OC?AY[+EJX`TL2#G@S1AXXZZ`EU)&;'%]J:H&OT!0P^X=OL>_`0``
M__\#`%!+`P04``8`"````"$`/,'):VX'``"X'0``&0```'AL+W=O<FMS:&5E
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MS?/1?`1,JX=]!2M@L@^:\K!T/KF+W'.=T>J!"_1W5;ZVVO^#]EB_;IMJ_UMU
M*4%M\!/SP&-=?V&FV9Y!,'ADC4ZX!_YH!OOR4#R?NC_KU[2LGHX=N'L"*V(+
M6^R_166[`T6!9NA-&-.N/L$$X._@7+'0`$6*K_SZ6NV[X]+QP^%D.O9=,!\\
MEFV75(S2&>R>VZX^_R.,^(IZ$D^2P%62>//AU!W/_>G[20))`E=)X@YGDTD0
MSNX@@<?QY<!5DDSNG@BD!N>`Z_=/9"Y)X'KO1$;"1=SC4=$5JX>F?AU`&H$3
MVFO!DM)=N!`IZ&OAF=[[_^5\\#IC^<1HEL[4&8!?6XC8E]5DYCZ,7B#*=M)F
M;=L0BPU:L)!BM!$%8@HD%-A2(*5`1H%<`T8@2Z\-A-[/T(;1,&UP56L$E%B>
M*=4&+7!(1(&8`@D%MA1(*9!1(-<`0PC_AA`^!,OM@H`QP48M'8CX/B;\Z=A<
MZ%K8N)"?O='4--GT)KT8%A);2&(A6PM)+22SD%Q'#$U@RC\C.!@-Y![4EEZ`
MR8R$PUH:O:52;]*K9"&QA206LK60U$(R"\EUQ%`)UG5#I2&KOMVQVGU9U[!L
MR+\;D>1#&1'%A9%PC7!M:X'X7I]3&X%,5)9%`IG"U'IE_2E1-NZ-D#JQD*V%
MI!:264@ND%#LM'I5"6])`ONC5.1S?>6*O%\>1FC*(Y!)J.21B":/0&8A+];>
MV`W,M(O[^[TR`A$KXH[96JQI/XIM`<#JFZQ9?Q]9<YW5"!W83-X,'13J1NA`
MFX&QPUA,<0020JW3XH+,<R.-_%[!2"`SA<06D@C$5[IO+9[4&I592*[S&)JP
M#EO?K=]>.[,VURX0'_C[M7L^J<D;:313:[\QS!^38;$TFO.`"L>SF>GZ1-P/
M>$*(\+$>E+[G09GQ(&@KY^:#<OU!AGK0-]VA'K,VU1.(KU<4SZ<]C#02?3%O
M8OIA&/-Q;\.R9#JF2LG;6ACU`Y`BM4BSWH9W7_Z$J**3&JJPKN\.6;BYJ8N$
M2%B14KM!*RVN$%)E*49H)L+()?(F\KX>1FI(KPY"BCA#2!!/?%+O<H/8%(CU
MA^_/.E>TD["EXW36$B*10V:P02LU,$(HZ+EB"84!%V@:3$CI2G",%CX(*>84
M(<6<$68_I(F%8SBS*1'K''6)Q&O$G?N\*_I/0SD!D=`B2][(@:%:<B2A0+Q4
MLCR,$6*-Q<MJ3A(DP=M:@;)Y4[12O!E"@C<DV9SC;;L3<%ES::GV(ZT`9R3)
M*3I8LM]9L2>MU/862:Y0Y5",D*CQ;C"?6"(*'GT+Q$&*.D5(46<((;7G$NI<
M6@AJ,_I8^VGI""_IM*=Z>[MD;R&DXDLH9$3X8@O?'\S2ND$K/?P$%\0M%H%8
M6OFJ_B42,HJ9&*B%<HH#%5>&D.+*#2Y3'M:*ZO+\CPS,G,20@$C](@W`AKW$
MP$!?59D((55E8@G)^N6-`[)/)#A&J;E%2#&G""GFS&1V_7%H^BG',3?J%^M"
M[Y!(-*W`A]Y=NP(BA8KL7ANT4GZ+$%+>C1$26U5`&[1$WC?"1CY>$:?(HH@S
MA`2Q-R,>S`UB,X982WJ'0**#-02232W$=Y]*GD^<OW&EE5(V0DAY.D:(M?DO
M*W=*')W@?3V$+.(4K11QAI`@GA/WY7C[1@"QIO,.?42/:N@CVUJ8IZ:/5:>E
ME?)SY/8#,1ACA+"8THJ52`,C@BSF%&GT".JMF/(A3=[<(#8CB#6@ND+?UR*(
M-M803G:V9F!9+8*P"M4N%+D24LN+$1()0OJ?1-XU-C>+-D4.19LA)&AI/N<&
MKR&:1WMS+MJ/=`B<T:SN$B*;',FI#5JIG(HDI/=8"'D\,P.7)GB"!EJ793.G
M:*5U60@)9L\/B'=R-+#[+(\V\#^NHMWC\X<L'://"FCZHI$6A1(*]/"U7Z[1
M2E:\\<PC`9Y("STX[:>ER//FTS*TDD]S9R&)!G;\Q/=ZK1**XR1QN'`NFZ=R
M4YY.[6!7/[.C(GAW6#WTL#C'6@<+^'((58O@T60!']1NX.$"/DO9>!HNX,.2
MC4?3!7RDL?%TNH"/+C8.YVJ?^"=%,I\UG+?Q2*2X!^=P-WC6_@*^&]_@#X"?
M$XUZ)C@WNQ9/Y>]%\U1=VL&I/(!88]ZZ-N+D3?SHY&?!Q[J#$S/0$XYJX(2T
MA!>;,?MV>*CK#G_`DT?]F>OJ7P```/__`P!02P,$%``&``@````A`,R?6\A1
M%P``IW```!D```!X;"]W;W)K<VAE971S+W-H965T,C$N>&ULK)U9<QPWLH7?
M;\3]#PR^C\A>V>RP-%'L?=_7-YJB)(9%44'2V[^?1`.G$I6G7*)G_&)3'Q(G
M4<C$5M5=_=.__WC\>O;;_?/+P].W]^>E=Y?G9_??[IX^/GS[_/Y\L^[^JW%^
M]O)Z^^WC[=>G;_?OS_^\?SG_]X?__[^??G]Z_N7ER_W]ZYDH?'MY?_[E]?5[
M\^+BY>[+_>/MR[NG[_??I.33T_/C[:O\\_GSQ<OWY_O;CZ=*CU\ORI>7]8O'
MVX=OYUZA^?P6C:=/GQ[N[MM/=[\^WG][]2+/]U]O7Z7]+U\>OK]`[?'N+7*/
MM\^__/K]7W=/C]]%XN>'KP^O?YY$S\\>[YJ#S]^>GF]__BK7_4>I>GL'[=,_
M2/[QX>[YZ>7IT^L[D;OP#>5KOKZXOA"E#S]]?)`K<-U^]GS_Z?UY4FHF_4KY
M_.+#3Z<>VC[<__X2_7WV\N7I]][SP\?QP[=[Z6X)E`O!ST]/OSC3P4>'I/(%
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M:QE)[OZ`KW?E1JU4^U&>5]"+[H]0]>_'0N8YGSWNCU2E4:M5ZPW7]C?.)A4D
MO_LCR-2T!XI5+OS\=IHNV[>OMQ]^>G[Z_4P6(0GVR_=;MZ25FA4)'R9*GZ'I
MU/E7,Z=,F4XE<3+OSR7795)\D?G^MP^UJ]I/%[_)%'T7;&[8II2U:,'"S<=.
MMFU!QX*N!3T+^A8,+!A:,+)@;,'$@JD%,POF%BPL6%JPLF!MP<:"K04["_86
M'"PX6I"DX45@DC28*:'@)12]A,*74/P2"F`21_!"TC;-71E._T3N.AF7N[B4
M&P!-YK))5%B@2MN"C@5="WH6]"T86#"T8&3!V(*)!5,+9A;,+5A8L+1@9<':
M@HT%6PMV%NPM.%APM"!)B*3!1*B2%ME0]!(*7T+Q2RB`21S!3*+*A/U/)*J3
M>7\NZU\ZR<IV-)N9-][&[792HZNL22LU09>TB72(=(GTB/2)#(@,B8R(C(E,
MB$R)S(C,B2R(+(FLB*R);(ALB>R([(D<B!R))`DC#3-BF'!8$XYKPH%-.+()
MAU9.:Z?DD\02CYGDEE3[)Y+;R<@F1/9#:>+6KNK9U+T)1D79G9J@9]I$.D2Z
M1'I$^D0&1(9$1D3&1"9$ID1F1.9$%D261%9$UD0V1+9$=D3V1`Y$CD22A)&&
M&3%,6FS%<4TXL`E'-N'0)IG89K);\C&3W?DW$+`-=M:G)$;#;SQI2//3M*Z4
MJMFT;J5&J-8FTB'2)=(CTB<R(#(D,B(R)C(A,B4R(S(GLB"R)+(BLB:R(;(E
MLB.R)W(@<B22)(PTT(AAPF%-.*X)!S;AR"8<VB03VTS.RDGZ;^2LL\[FK"<-
M?U_,G<-:1-I$.D2Z1'I$^D0&1(9$1D3&1"9$ID1F1.9$%D261%9$UD0V1+9$
M=D3V1`Y$CD22A-$-(PYKPG%-.+`)1S;AT":9V&825.X39!+4WW1XYVZ&O'YY
MN/OEYDDF2SF%YDRV%;FYX&\Y.)%LWGHB=UDP!%N>U/1LU_;DRLG\]J%::I0O
MLW-Q)S6`2)=(CTB?R(#(D,B(R)C(A,B4R(S(G,B"R-(3N9N$*UUY$G77.M3*
M+E_FQLXF-8+0ELB.R)[(@<B12)(PNF$4`G]UVJWZ=$'D(X181PC!CA"B':$0
M;M]UF<R6PUEA9J^?OO]59LNM4*2V4\FFMB?51AJKEB<R9-#I[4"D-Z*MAME!
M=U(C5.L&<IT*]3QIG)ZPG#JOG]:*I<VY<I`:07I(TB.2'J>U"J0GJ1&DIR0]
M(^EY6BN2+IM[CHO4"-++0+2O5X%H7Z_36I%TR?3U)C6"]#80[>N=)U%?[]-:
ML;3IZT-J!.DC22<):2<W:;T"\02YI=-F@N32EB<AE:*F)\BE3`K:'D]"?EU%
M\DBP4Y]G!I3<L\\,J)PE(1HXSCH[<#R)!XXG\<`)I)Z.@`Z1;B":%#W2Z:>U
MXLYM9->706J$R`U)>D32X[16@?0D-8+TE*1G)#U/:T7297-;:9$:07I)TBN2
M7E.M#9$MZ>Q(9Y_6BII8,AU[2(W0Q"-))PEI)S=IO0+QI)5:03UILSSR1B>*
M!(DCNR^=E6WW)D@F3<$$V<1#PCUTS8R)_VK[=%+)CI6`XL$24#Q:@'0][##J
M`D4#!DA[IP^4W5]<FR&C5NC\(9#*CX!4?@R4D;<[OHE:07X*I/(S()6?!]3P
M3_W=06G!:(F*JK4"4JTUD/;JAM$62+5V0*JU!\I<=LGTZD&M<-E'()671S\N
MV^3QB.K+PY_`,@YLOR8M-8,'>284JD8NTO2)7"!_HKZ5)T.^;LS2##KI95:.
MDGN,Q8\V]93QMKW82<:,$_^`K"X/$J(Q7<EF;2M4K.O^NAU00U&'43>@BDX&
M/=;J<\4!HR%KC5AKS!4GC*:L-6.M.5=<,%JRUHJUUEQQPVC+6CO6VG/%`Z,C
M:\D(".'6J,D(\"R*I*0[,T0\BJ4\!&4]Q#S60]!CAJA[O6RZN\=:<;H7[Y3<
MAV_,5BF@2G;W9N]5PDH'<!LH4_'2'JQA=7TZ>I<:C8;9BG>#154/'CU44F]]
MH$)O`UAY;^6:77*'[&R$.NIL#%3H;`(KV5U'$X(Y)D_58V1U::QFJH5)<PY4
MV(@%K,(5ERH-$X&E-@#2*U322UX#%7K;P,I[JUZ6S?2W96<[U%%G>Z!"9P=8
M-4ZI4ZZ8G#RR+QFU/L$KZDQ&;6"%WF0@IU6C0)7-Z4Z6,F\FZ1J9V7C*<$_5
MT.ORJ8<W-23-?G3RE3D&RD<CTC:(>'8^<`_L_L9\$)[OZ1I\4_+(?2HHRFK3
MA!:LM&(;2/<R'2!WC^.W#]=&I(OB>,D+WE6W#RO5'0`%W>P2/$2IRHZ`5'8,
MI+(3('=#$A]HJER:^6H**Y6?`:G\'$CE%T"^U:5+DUI+E*OP"DB%UT`JO`'R
MPI6RV?-M4:[".R`5W@.I\`'("]LC_1'%JBL#D`(H`S!-J70L1`E4T-<RVD+5
MR$645:E<FDK:>-DXIDUQV5>IF8E1AE$LGAU&DOV98?3?';:<BME$>F166W.H
M;;D/<DC%:!9K!U354T<'*-S5KIG3>Q?E\<)*PGU8J?``R`O7S+P[1+'JC@**
M&CR&E>I.@*3;B\:7;V.T'YBQ_!Q:*K\`"LWF\47"*Q9>0T6%-T`0-N':HEP[
M9,?">UBI\`'("U=,@AY1K+HROBB",K["A:FRK&:!9?K:S@PROM(^B4-B=B>R
MFK'7-+TBKSW(A9XB?VFVG2XI.^3<T]5XY;)#[HT'-_^05CY1@LGAQGVZ1$93
M="1K!511JS:07&F4G"8D'6A5_7;VNFJ#UH6.SE@](/76!RKT-LAZ*]<:)C!#
MR*BS$9`Z&P,5.IO`*K/ZE8W'*:PR=[;L]F<&*VW$'*BP$8M@5??]6RY=7YM9
M;0D=O>05D'I;`Q5ZVV2]51MU$^XM9-39#DB=[8$*G1U@%193&\LCRM67C':?
MNE&>RF@/K-";3`!IU2B?;;;*!!#,"N,I$T"JAF$EV]DW-039'T):O:Z9?8^L
MPVD;1#P[*;C'UW92*-?=MW?R'A-'SP1*KJ99>SVJ2UT=X16SO6N%BG4-0SL@
M6;1Q\1T@/6=T`XK6K1YK]5%1M09`JC5DK1%KC5%1M29`JC5EK1EKS5%1M19`
MJK5DK15KK5%1M39`JK5EK1UK[5%1M0Y`JG5D+1D[(=P:2!D[GD61E($2F,K)
MJ/`LBJ4,`=9#S&,]!#W:"TF&QWK9#)=3:2;#?W`#QYF;M/;H1P>V8*735KN4
M5M2T]@C3;^W:3/]=U-%.[0&I<A](=^,#(#_[79LMU!#%JCL"4MTQD.I.@+*#
MVBP:4UA)&'3H\ZI%?31'1?6X"`A]5.<5*LCHM:P@H]>R!E+E35:Y5+\TE[%%
M'57>`:GR'DB5#T"^]ZOF@'A$L>K*\*'.D.$3F"K+\$GMHJZMF/M",J+23HG,
M;`1DD*5JR$E99]@KDBX$H52OF$N2(9<ZI$7%/0ZWBTI)OE3E<NC-'T1R7]2S
M(]&C'QWN@I7.-^V@E3G<>:MJ^;31K%[;TTP7=?1PT`LHFGGZL-)-^@#([]'+
M=1.J(<I5>,3"8UBI\`0H<^2P=^VFL"J\?S9CCW-45(\+(-])M5+='%67,-!K
M6;'R&E:JO`%"]]O/I&]AH,H[5M[#2I4/0+[[2W4SQH\H5V$9BY0R,A9#@JBT
MC,7`LA$P<[B,Q6!6&`(9B^PUS;K(*](NI&KMLFZV5#(64X<T%MWC]**Q^,93
MGW\J+QM)3!LW)8\RISZ/HMUT.UAE%T]^B!&T_*GDJF;O"78AHQ-H#TB;U`<J
MW+D/8.7GZHKMS2'*U=<(2'V-@0I]36"573W-!GT*JQ^LGM2[<U0L;,0B6(6Y
M_*IA#PA+R.@5KX#TBM=`A<XV66=U^9I]]N[Q%C+J;`>DSO9`A<X.L`I'OI(9
M&$>4JR\9Z]2-,M8#*_0FPS^M&JVQ%7/7789_,"L,IPS_5`UC2I;B-S4$N1\B
M6K^R`TIFA+0-=D9P7UVG&>%-1[Y3S>S>."!SY#,A;\%*P]`.*-K8=X!TW>X&
M%!T3>JS51T4]P@R`5&O(6B/6&J.B:DV`5&O*6C/6FJ.B:BV`5&O)6BO66J.B
M:FV`5&O+6CO6VJ.B:AV`5.O(6O(]4)<[<J=/`YG<H*JJR7=!O5VT44H0\2B6
M\GU0UD/,H\R0[X2R'J+N]3)'OK+[)$"\YA4?^4[F)JW]9PFRJU;9#/16J!@O
M=T"Z@>\`998`6N!@I3W;`])9L0^D\@.@0ODAK%1^!*3R8R"5GP`5RD]AI?(S
M()6?`ZG\`JA0?@DKE5\!J?P:2.4W0.%07#,[M2W*57@'I,)[(!4^`(7SGM$]
MHEAU9>R$G%)A&3MIGJ5+0)15\2)CCU]M5/W!(@.SR&L73*]'1EC:NM.3Y(;9
MHLB7L(/!Z9*RP\T]+(^'FWVP\*;OG93](_=XAQG0#XY[L-*IJQU0?-P#\J>"
M:W..Z:)8#P4]UNW#2C?G`Z!PVC!A&J)8=4>L.X:5ZDZ`,B<-.VM,8:7R,Y:?
MPTKE%T"AV25S1EVB7(57++R&E0IO@+SP5<-TR!;E*KQCX3VL5/@`Y(7M@Z\C
MBE571ESX.(AFAHRX\,D.59;5*K!,7U?-HPI9P(*9K$5_?8]+UC3VFJ97Y!7Y
M50T]=6UZ2D9<ZH^V<-)2'G'R)JUP?P5GNK??;"D[1;,&>A2?[X)59L$+5G(S
M*.H4TW>=4+'N/VG$H\^+1!_GZ[&K/D0*70U@Y5W9C^<.H:LS\PA(I\@Q1`I=
M36`EA^_HVLT99`IY]3@#4H]S:!5Z7,`J7!P/6^K(%?M:0Z70UP96_E-2I:NJ
MF3.W4-8+VP'IA>TA4^CL`"M_85?&U1&ZZDI&=[A6]26C^RW9*`,^F&4"5S6!
MDP&?]F8<7[/6RX#GAG3AH?"J9=4-#4$?VV>6,@FD;:!)0`ZK__`DX!3-).!1
MYGQ7LJ?-EGM!F52,MOOM@*ZRDR7-"[[B5<E_`O'JTCX.[P:=Z-308V_]-WD;
MP"IXNZZ;4`[9V8B=C2%3>&D36,DDKI-#U=R,G*K'R,K>M9]Q(^:0+VS$`E:X
MXFM[LVNI#<`.=,7>UM`I]+:!E?=6JLC7@,V]'_:V8V][Z!1Z.\`JW)N^,KEU
M9%\R9U"BRIP1<K#0F\P9P2P;3[-ODCG#FTF^%@14Y@QN"%*]>,C(G!$:@EZN
MTL2%X9!W-)8M`D\:T:,9;!U^<&1V,J>90J^R9C]&>^,^1."LI,'I$*`S=&J#
M_&MK-:`.HRZC'J,^HP&C(:,1HS&C":,IHQFC.:,%HR6C%:,UHPVC+:,=HSVC
M`Z,C(QE:%$@96LQ:.2PGXC)"N&Y.S&4XL%TVZMFSJAR7,_G_@SQWYF9%]$B^
MS:=)7;%[HU8YM4(.MQEU&'49]1CU&0T8#1F-&(T931A-&<T8S1DM&"T9K1BM
M&6T8;1GM&.T9'1@=&4E:4R`EK9GE!%S6`K;+";F\`X_M<H(N>\'8+IO6LL_\
M.VGMS$U:!Z3WA%IE0FU&'49=1CU&?48#1D-&(T9C1A-&4T8S1G-&"T9+1BM&
M:T8;1EM&.T9[1@=&1T:2PQ1(R6%F.0&7'&:[G)!+#K-=3M`EAV.[;`Z[9]C_
M^VU$IV)2VZ/X!3;N;<=B%;V2I1V0O-LDGM?-":&C5IC7NXQZC/J,!HR&`=7U
M+M8HH*BI8ZT8-]7<L9VH%9HZ931C-&>T8+0,R#<U&TCWZ+$HD&_<8_HGF)D;
MPA[%WZ1W;Y^62$;?HVX#2::EV\Y*U6P\.VJ%[ND"Z=LX>@%%;^/HPRHC7S+R
M`[6"_!!(;T>.@/0>QA@H(V];/U$KR$^!M/6S@*+6SV&5D;>M7Z@5Y)=`I]9G
MXNW>XET8[S?=_S^I9`=N0'&X`XK##:0K5X=1%T@[OP>DG=\'RDX"YG'V0*W0
M.T,@E1\!J?P82)LZ830%4JT9D&K-@0J;NE`K-'4)E!-(]XCG?Q^X%?^D*!ZX
M`66?I]I/2;:"573'N9U;T=Y_ZL#*/XV35]!G;SMT4:ZW#WOLJP^K3(]:7P-8
MR;%#9Q?[U;<AK&3'IE;VOLZ(&S%&Q<)&3&`5'C_:CQA.4:X7/&-?<U@5^EK`
M*G/!]O.G2UC]U05G9PSW9"-.M.)3F*S<=DT/*/MHT,:]%:RBCRNT<RO:('=@
MY>_+UDKV:^[=8!#?EF1G[J=87,.SK;3.!K"2/8GFBOVRX5`]1E:<4=YC=,5C
MR&=F?-N(":S\#?B*N7$W5>^81V8!1:[F$"ETM8!5YGKM`[VE>LR_7I]0_I=J
M_$\O/-X_?[YOW7_]^G)V]_2K^Q6:J[K<5TZQ_XV<FYK\1LYI'K4%=2DX#1A3
M(+<VFHDT1Z[<E,@-#JDC=R#RBIR<G-CRBJY<T>GS,D905NRFF^RYDBS<3;<L
MYY14+IMNGN<26;.;;KKG$O=#0;D7Y'Y`Z/20TC3LINR:G*-T4Y&"TRL\3(VD
M*BY."YTIN)$">3$P-TIV5DVW;\HID4MTJRZ7R*:JZ19?+I&]5=.MP5PB6ZRF
M6W>Y1/903;?\<HF\YZ3I7FS")?+A0>DT]Y:2G#)Y`4E3OB>=5R8'#KG:TR)L
M.DCV]Q+JO)(;:=]-;OM:4M+*+9'M<--MB+AULM]MNGT1E\BVM^FV1UPBKZ=K
MRB<7<XNZ4B0OH<NIU+V6DKS`R@<>+UT'Y>KU1<^]B(@%Y?TO3?>^%RZ1-[DT
MW0M[N$3>QM-TK]_A$GFW3M.]3(=+Y$TY3?=J'"XY-IKNM4Y<(*\';,IG3'.+
M;J2HE=M!-])!\BZT'+D;UT'NE4\Y96W1<V]^XJ)U0]J=5[!M--W;KKC&KM%T
M[[SB@GVC*:]%S.'737DW7`Z7!KN78'')K-%TK_OB@KGD>YZ+N4QY>2[D#6$2
ML#RE9:.YS"U8-9KN]6#L>]AHNK>><<&HT73O/N."<:,I+\[,X3*KY+567I<F
MB9>G-&TTW2O16*I]U5SD+0]K63CDO:E<03)+$B6GH-5HYB>/Y$[^,)91[-X2
MQCYZC6;^0)5Q*B\IY0I]F<[S.D3&M(S1DXN+=.J37XG[?OOY?G+[_/GAV\O9
MU_M/LGY?GKXR].Q_9\[_XS6\Z?7GIU?Y?3@Y+\IO*\D/`M[+6^(NW>=?/CT]
MO>(?TJ2+]"<&/_Q'`````/__`P!02P,$%``&``@````A`-2O.;XR`0``0`(`
M`!$`"`%D;V-0<F]P<R]C;W)E+GAM;""B!`$HH``!````````````````````
M````````````````````````````````````````````````````````````
M````````````````````````````````````````````````````````````
M````````````````````````````````````````````````````````````
M````````````````````````````````````````````````````````````
M````````````````````````````````````````````````````````````
M`````````````````````)R104_#(!B&[R;^AX9[2^F699*6)6IV<HF),R[>
M$+YMQ$()H.W^O:SKZHR>/)+WY>'Y/LI%I^OD$YQ7C:D0R7*4@!&-5&97H>?U
M,IVCQ`=N)*\;`Q4Z@$<+=GU5"DM%X^#1-19<4."32#*>"ENA?0B68NS%'C3W
M66R8&&X;IWF(1[?#EHMWO@-<Y/D,:PA<\L#Q$9C:D8@&I!0CTGZXN@=(@:$&
M#29X3#*"O[L!G/9_7NB3BZ96X6#C3(/N)5N*4SBV.Z_&8MNV63OI-:(_P9O5
MPU,_:JK,<5<"$#ONI^8^K.(JMPKD[8%U;ZY.O-^7^'=62M';4>&`!Y!)?(^>
M[,[)R^3N?KU$K,C)-,UO4D+614[)C$[GKR4^MX;[;`3J0>#?Q#.`]=X__YQ]
M`0``__\#`%!+`P04``8`"````"$`YUE=C$P#``!T#```$``(`61O8U!R;W!S
M+V%P<"YX;6P@H@0!**```0``````````````````````````````````````
M````````````````````````````````````````````````````````````
M````````````````````````````````````````````````````````````
M````````````````````````````````````````````````````````````
M````````````````````````````````````````````````````````````
M````````````````````````````````````````````````````````````
M``"<5UU/VS`4?9^T_U#E'5(83!-*@[S4I=':I(M=-IXL+W5IM#2I;%/!?OUN
M"*4?NWC`6V+?<^_Q.=?M37!YORP[:Z5-45<][^2XZW54E=>SHKKM>5,^./KB
M=8R5U4R6=:5ZWH,RWF7X\4,PT?5*:5LHTX$4E>EY"VM7%[YO\H5:2G,,VQ7L
MS&N]E!9>]:U?S^=%KOIU?K=4E?5/N]W/OKJWJIJIV='J.:'79KQ8V_<FG=5Y
MP\]<\X<5$`X#LEJ512XMG#(<%[FN33VW'7J?JS+P=S<#8,=4?J<+^Q!V`W_W
M-6"Y+%4$B<.Y+(T*_.U",%2R$6TB"VW"8&TOUBJWM>Z8X@_(=NIU?DFC&CH]
M;RUU(2L+M)JP]N7QN5P9J\,?M?YM%DI9$_@0T"X^/N[&[CX79^$Y<(5@>-J/
M;!9;)K"QSY$7ME0FG4^DM@CE<VB%+>='%BWCEM#&10&](6AE02\15ZW;1;W+
M_/D,49JP=!3W":=]\96,2!)1P8:4<O;6>#$A_X<P#I7&-.%,I`.13NA;(5$Z
M1B'[B:,A2:XH$W$BZ/=IS-\!.4$Q>WH=U"2X9%<TH1D9H>E8?)7$@S@B"1<D
MBM)IPN/D2DS`DBC&M1F3[!OEY.L(?*+1-(MY3/'"`Q)GXIJ,IK31>A`G8&Y,
M1B`*X]D4Y3/)P)*,WPB2]!^5FS1>B83B"J9\2+,-<08-<-/P0C.#;^.8M\XW
MR4'(YJ@4*+U`G_$T^C9,1WV:L=;%&S3S[L&@"GV1+2<_H272!`1HXM!D;D/P
MGG!C3M$ZJ(N"RU]P_5&`VTR<V,MN-I70,KBC+F).8P5:!''650$SV!5_X+,K
M].ENBKZRLBAQY=WV?L)/Z+S79^_`G*,8O(T8_-W/[DKU#@C>2.[FPSO<C<%E
M<S0L.(0>YX6&=1GJ[EA<`3<&5P!K\T1J#2//6KW^9K"[Y5+J!U'/40&P*EL(
M?AHWYO6GV=;!_43K/#6GP`<2%/*L`'YST!\(5P<<_D)L76E0J,R'D,T=`UL$
M*W8A>^/=P4`W*JK?9KKB=5]:M9E8]Q<#MI!:S6"6V^QO%X(A#*NZ;))$"UG=
MJMDFYM^-9KZ^;C\BPI.SX^ZG+HRC.VN!O_U<"/\"``#__P,`4$L!`BT`%``&
M``@````A`'XT"A@0`@``P1X``!,``````````````````````%M#;VYT96YT
M7U1Y<&5S72YX;6Q02P$"+0`4``8`"````"$`M54P(_4```!,`@``"P``````
M``````````!)!```7W)E;',O+G)E;'-02P$"+0`4``8`"````"$`G_R)5CL"
M```,'@``&@````````````````!O!P``>&PO7W)E;',O=V]R:V)O;VLN>&UL
M+G)E;'-02P$"+0`4``8`"````"$`YE9J+2\$``!]#P``#P``````````````
M``#J"@``>&PO=V]R:V)O;VLN>&UL4$L!`BT`%``&``@````A`,KS$[A=!```
M(0\``!@`````````````````1@\``'AL+W=O<FMS:&5E=',O<VAE970T+GAM
M;%!+`0(M`!0`!@`(````(0`2M<;6;P0``"82```9`````````````````-D3
M``!X;"]W;W)K<VAE971S+W-H965T,SDN>&UL4$L!`BT`%``&``@````A`!*=
M2;;_`@``\@D``!D`````````````````?Q@``'AL+W=O<FMS:&5E=',O<VAE
M970T,"YX;6Q02P$"+0`4``8`"````"$`8*T?I^8)``!V1```&0``````````
M``````"U&P``>&PO=V]R:W-H965T<R]S:&5E=#0Q+GAM;%!+`0(M`!0`!@`(
M````(0!$W2;-R`,``!8/```9`````````````````-(E``!X;"]W;W)K<VAE
M971S+W-H965T-#(N>&UL4$L!`BT`%``&``@````A`$]F7VDA`P``5@D``!D`
M````````````````T2D``'AL+W=O<FMS:&5E=',O<VAE970S."YX;6Q02P$"
M+0`4``8`"````"$`N/WJ9DL%``#'%P``&0`````````````````I+0``>&PO
M=V]R:W-H965T<R]S:&5E=#,W+GAM;%!+`0(M`!0`!@`(````(0#+=7YV5@,`
M`%T+```9`````````````````*LR``!X;"]W;W)K<VAE971S+W-H965T,S8N
M>&UL4$L!`BT`%``&``@````A`'_YU9:O!```*!0``!D`````````````````
M.#8``'AL+W=O<FMS:&5E=',O<VAE970S,BYX;6Q02P$"+0`4``8`"````"$`
M6#4]J)L(``"7+```&0`````````````````>.P``>&PO=V]R:W-H965T<R]S
M:&5E=#,S+GAM;%!+`0(M`!0`!@`(````(0"2D'>B\P(``"8(```9````````
M`````````/!#``!X;"]W;W)K<VAE971S+W-H965T,S0N>&UL4$L!`BT`%``&
M``@````A`,V<-2$(!```[P\``!D`````````````````&D<``'AL+W=O<FMS
M:&5E=',O<VAE970S-2YX;6Q02P$"+0`4``8`"````"$`A5%>2.<#```X#P``
M&0````````````````!92P``>&PO=V]R:W-H965T<R]S:&5E=#0S+GAM;%!+
M`0(M`!0`!@`(````(0"LT;J1[0(``#D(```9`````````````````'=/``!X
M;"]W;W)K<VAE971S+W-H965T-#0N>&UL4$L!`BT`%``&``@````A`.I&C`"[
M`@``/0<``!D`````````````````FU(``'AL+W=O<FMS:&5E=',O<VAE970T
M-2YX;6Q02P$"+0`4``8`"````"$`RZ)+A,H-``#LB@``#0``````````````
M``"-50``>&PO<W1Y;&5S+GAM;%!+`0(M`!0`!@`(````(0!O--8SAFD``%!A
M`0`4`````````````````()C``!X;"]S:&%R9613=')I;F=S+GAM;%!+`0(M
M`!0`!@`(````(0";9[!MB@(``/8&```8`````````````````#K-``!X;"]W
M;W)K<VAE971S+W-H965T,RYX;6Q02P$"+0`4``8`"````"$`6U%GVA$&``#!
M&0``&`````````````````#ZSP``>&PO=V]R:W-H965T<R]S:&5E=#(N>&UL
M4$L!`BT`%``&``@````A`/MBI6V4!@``IQL``!,`````````````````0=8`
M`'AL+W1H96UE+W1H96UE,2YX;6Q02P$"+0`4``8`"````"$`A5;QUQ$#``#-
M"```&0`````````````````&W0``>&PO=V]R:W-H965T<R]S:&5E=#4P+GAM
M;%!+`0(M`!0`!@`(````(0!3UM/T:`0``/X3```9`````````````````$[@
M``!X;"]W;W)K<VAE971S+W-H965T-#DN>&UL4$L!`BT`%``&``@````A`!K[
M/=P_`P``T`D``!D`````````````````[>0``'AL+W=O<FMS:&5E=',O<VAE
M970T."YX;6Q02P$"+0`4``8`"````"$`AA.AJ%,-``"@5@``&0``````````
M``````!CZ```>&PO=V]R:W-H965T<R]S:&5E=#0W+GAM;%!+`0(M`!0`!@`(
M````(0".VTE-PP4``'$<```9`````````````````.WU``!X;"]W;W)K<VAE
M971S+W-H965T-#8N>&UL4$L!`BT`%``&``@````A`$D<OT<E!```"A```!@`
M````````````````Y_L``'AL+W=O<FMS:&5E=',O<VAE970Q+GAM;%!+`0(M
M`!0`!@`(````(0"<`M&=N0,``*\.```9`````````````````$(``0!X;"]W
M;W)K<VAE971S+W-H965T,S$N>&UL4$L!`BT`%``&``@````A`!02&ZSE`P``
M(`\``!D`````````````````,@0!`'AL+W=O<FMS:&5E=',O<VAE970R.2YX
M;6Q02P$"+0`4``8`"````"$`L='T'EL+```'-0``&0````````````````!.
M"`$`>&PO=V]R:W-H965T<R]S:&5E=#$R+GAM;%!+`0(M`!0`!@`(````(0`'
MA8HK.@@``'DB```9`````````````````.`3`0!X;"]W;W)K<VAE971S+W-H
M965T,3,N>&UL4$L!`BT`%``&``@````A`/1+5A4`!@``!1<``!D`````````
M````````41P!`'AL+W=O<FMS:&5E=',O<VAE970Q-"YX;6Q02P$"+0`4``8`
M"````"$`+;);$?X'``"$(@``&0````````````````"((@$`>&PO=V]R:W-H
M965T<R]S:&5E=#$U+GAM;%!+`0(M`!0`!@`(````(0#C$R:R&AH``&V$```9
M`````````````````+TJ`0!X;"]W;W)K<VAE971S+W-H965T,3$N>&UL4$L!
M`BT`%``&``@````A`"Y:S?\Y(P``"M0``!D`````````````````#D4!`'AL
M+W=O<FMS:&5E=',O<VAE970Q,"YX;6Q02P$"+0`4``8`"````"$`$BII9.\%
M``"<&```&`````````````````!^:`$`>&PO=V]R:W-H965T<R]S:&5E=#DN
M>&UL4$L!`BT`%``&``@````A`"\^NEI"`P``"0H``!@`````````````````
MHVX!`'AL+W=O<FMS:&5E=',O<VAE970U+GAM;%!+`0(M`!0`!@`(````(0`Q
MOJ@-/PD``(@R```8`````````````````!MR`0!X;"]W;W)K<VAE971S+W-H
M965T-BYX;6Q02P$"+0`4``8`"````"$`I0<HKG,"``#C!0``&```````````
M``````"0>P$`>&PO=V]R:W-H965T<R]S:&5E=#<N>&UL4$L!`BT`%``&``@`
M```A`#.8^*+S!P``=20``!@`````````````````.7X!`'AL+W=O<FMS:&5E
M=',O<VAE970X+GAM;%!+`0(M`!0`!@`(````(0"42'$,A04``!P9```9````
M`````````````&*&`0!X;"]W;W)K<VAE971S+W-H965T,S`N>&UL4$L!`BT`
M%``&``@````A`'8*:KI>+```;OD``!D`````````````````'HP!`'AL+W=O
M<FMS:&5E=',O<VAE970Q-BYX;6Q02P$"+0`4``8`"````"$`+)R^18@7```_
MB0``&0````````````````"SN`$`>&PO=V]R:W-H965T<R]S:&5E=#$X+GAM
M;%!+`0(M`!0`!@`(````(0!7<^5+`@8``/D6```9`````````````````'+0
M`0!X;"]W;W)K<VAE971S+W-H965T,C4N>&UL4$L!`BT`%``&``@````A`.Y@
M*#%A(@``(;<``!D`````````````````J]8!`'AL+W=O<FMS:&5E=',O<VAE
M970R-BYX;6Q02P$"+0`4``8`"````"$`986["O(&``#R&P``&0``````````
M``````!#^0$`>&PO=V]R:W-H965T<R]S:&5E=#(W+GAM;%!+`0(M`!0`!@`(
M````(0`5P?"'9@@``"XC```9`````````````````&P``@!X;"]W;W)K<VAE
M971S+W-H965T,C@N>&UL4$L!`BT`%``&``@````A`.(X,[MJ!P``M1X``!D`
M````````````````"0D"`'AL+W=O<FMS:&5E=',O<VAE970Q-RYX;6Q02P$"
M+0`4``8`"````"$`"TS;^9,%``"U%```&0````````````````"J$`(`>&PO
M=V]R:W-H965T<R]S:&5E=#(T+GAM;%!+`0(M`!0`!@`(````(0!U;3^QLPH`
M`+DP```9`````````````````'06`@!X;"]W;W)K<VAE971S+W-H965T,C(N
M>&UL4$L!`BT`%``&``@````A`&IS.L<P)```'M4``!D`````````````````
M7B$"`'AL+W=O<FMS:&5E=',O<VAE970Q.2YX;6Q02P$"+0`4``8`"````"$`
M`VZ10UP)```(*```&0````````````````#%10(`>&PO=V]R:W-H965T<R]S
M:&5E=#(P+GAM;%!+`0(M`!0`!@`(````(0`\P<EK;@<``+@=```9````````
M`````````%A/`@!X;"]W;W)K<VAE971S+W-H965T,C,N>&UL4$L!`BT`%``&
M``@````A`,R?6\A1%P``IW```!D`````````````````_58"`'AL+W=O<FMS
M:&5E=',O<VAE970R,2YX;6Q02P$"+0`4``8`"````"$`U*\YOC(!``!``@``
M$0````````````````"%;@(`9&]C4')O<',O8V]R92YX;6Q02P$"+0`4``8`
M"````"$`YUE=C$P#``!T#```$`````````````````#N<`(`9&]C4')O<',O
=87!P+GAM;%!+!08`````.P`[``\0``!P=0(`````
`
end

</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>33
<FILENAME>R46.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
  <head>
    <META http-equiv="Content-Type" content="text/html; charset=us-ascii">
    <link rel="StyleSheet" type="text/css" href="report.css"><script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script></head>
  <body><span style="display: none;">v2.4.0.8</span><table class="report" border="0" cellspacing="2" id="ID0EDYBG">
      <tr>
        <th class="tl" colspan="1" rowspan="2">
          <div style="width: 200px;"><strong>STOCKHOLDERS' EQUITY (Schedule of Compensation Expense) (Details) (USD $)<br>In Thousands, unless otherwise specified</strong></div>
        </th>
        <th class="th" colspan="3">12 Months Ended</th>
      </tr>
      <tr>
        <th class="th">
          <div>Jun. 30, 2014</div>
        </th>
        <th class="th">
          <div>Jun. 30, 2013</div>
        </th>
        <th class="th">
          <div>Jun. 30, 2012</div>
        </th>
      </tr>
      <tr class="rh">
        <td class="pl" style="border-bottom: 0px;" valign="top">
          <div class="a">Consultants [Member]</div>
        </td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems', window );"><strong>Employee Service Share-based Compensation, Allocation of Recognized Period Costs [Line Items]</strong></a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Compensation expenses</a></td>
        <td class="nump">$ 278<span></span></td>
        <td class="nump">$ 533<span></span></td>
        <td class="nump">$ 221<span></span></td>
      </tr>
      <tr class="rh">
        <td class="pl" style="border-bottom: 0px;" valign="top">
          <div class="a">Options and warrants [Member]</div>
        </td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems', window );"><strong>Employee Service Share-based Compensation, Allocation of Recognized Period Costs [Line Items]</strong></a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Compensation expenses</a></td>
        <td class="nump">11<span></span></td>
        <td class="nump">26<span></span></td>
        <td class="nump">56<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized', window );">Unrecognized compensation expense</a></td>
        <td class="nump">1<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1', window );">Unrecognized compensation expense, recognition period</a></td>
        <td class="text">3 months<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="rh">
        <td class="pl" style="border-bottom: 0px;" valign="top">
          <div class="a">Restricted stock units [Member]</div>
        </td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems', window );"><strong>Employee Service Share-based Compensation, Allocation of Recognized Period Costs [Line Items]</strong></a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Compensation expenses</a></td>
        <td class="nump">5,562<span></span></td>
        <td class="nump">2,240<span></span></td>
        <td class="nump">4,650<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized', window );">Unrecognized compensation expense</a></td>
        <td class="nump">2,447<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1', window );">Unrecognized compensation expense, recognition period</a></td>
        <td class="text">2 years<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="rh">
        <td class="pl" style="border-bottom: 0px;" valign="top">
          <div class="a">Research and development expenses [Member] | Options and warrants [Member]</div>
        </td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems', window );"><strong>Employee Service Share-based Compensation, Allocation of Recognized Period Costs [Line Items]</strong></a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Compensation expenses</a></td>
        <td class="nump">11<span></span></td>
        <td class="nump">26<span></span></td>
        <td class="nump">19<span></span></td>
      </tr>
      <tr class="rh">
        <td class="pl" style="border-bottom: 0px;" valign="top">
          <div class="a">Research and development expenses [Member] | Restricted stock units [Member]</div>
        </td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems', window );"><strong>Employee Service Share-based Compensation, Allocation of Recognized Period Costs [Line Items]</strong></a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Compensation expenses</a></td>
        <td class="nump">1,172<span></span></td>
        <td class="nump">711<span></span></td>
        <td class="nump">1,163<span></span></td>
      </tr>
      <tr class="rh">
        <td class="pl" style="border-bottom: 0px;" valign="top">
          <div class="a">Research and development expenses [Member] | Restricted stock units [Member] | Consultants [Member]</div>
        </td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems', window );"><strong>Employee Service Share-based Compensation, Allocation of Recognized Period Costs [Line Items]</strong></a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Compensation expenses</a></td>
        <td class="nump">201<span></span></td>
        <td class="nump">255<span></span></td>
        <td class="nump">201<span></span></td>
      </tr>
      <tr class="rh">
        <td class="pl" style="border-bottom: 0px;" valign="top">
          <div class="a">General and administrative expenses [Member] | Options and warrants [Member]</div>
        </td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems', window );"><strong>Employee Service Share-based Compensation, Allocation of Recognized Period Costs [Line Items]</strong></a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Compensation expenses</a></td>
        <td class="text">&nbsp;&nbsp;<span></span></td>
        <td class="text">&nbsp;&nbsp;<span></span></td>
        <td class="nump">37<span></span></td>
      </tr>
      <tr class="rh">
        <td class="pl" style="border-bottom: 0px;" valign="top">
          <div class="a">General and administrative expenses [Member] | Restricted stock units [Member]</div>
        </td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems', window );"><strong>Employee Service Share-based Compensation, Allocation of Recognized Period Costs [Line Items]</strong></a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Compensation expenses</a></td>
        <td class="nump">4,390<span></span></td>
        <td class="nump">1,529<span></span></td>
        <td class="nump">3,487<span></span></td>
      </tr>
      <tr class="rh">
        <td class="pl" style="border-bottom: 0px;" valign="top">
          <div class="a">General and administrative expenses [Member] | Restricted stock units [Member] | Consultants [Member]</div>
        </td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems', window );"><strong>Employee Service Share-based Compensation, Allocation of Recognized Period Costs [Line Items]</strong></a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Compensation expenses</a></td>
        <td class="nump">$ 77<span></span></td>
        <td class="nump">$ 278<span></span></td>
        <td class="nump">$ 20<span></span></td>
      </tr>
    </table>
    <div style="display: none;">
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AllocatedShareBasedCompensationExpense">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Represents the expense recognized during the period arising from equity-based compensation arrangements (for example, shares of stock, unit, stock options or other equity instruments) with employees, directors and certain consultants qualifying for treatment as employees.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 718<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 1<br><br> -Subparagraph (b)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6415400&amp;loc=d3e5047-113901<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 718<br><br> -SubTopic 10<br><br> -Section S99<br><br> -Paragraph 1<br><br> -Subparagraph (SAB TOPIC 14.F)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=27013229&amp;loc=d3e301413-122809<br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 718<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 2<br><br> -Subparagraph (h)(1)(i)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6415400&amp;loc=d3e5070-113901<br><br><br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher SEC<br><br> -Name Staff Accounting Bulletin (SAB)<br><br> -Number Topic 14<br><br> -Section F<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_AllocatedShareBasedCompensationExpense</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>debit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div>
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:stringItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Unrecognized cost of unvested share-based compensation awards.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 718<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 2<br><br> -Subparagraph (i)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6415400&amp;loc=d3e5070-113901<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>debit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Weighted average period over which unrecognized compensation is expected to be recognized for equity-based compensation plans, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 718<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 2<br><br> -Subparagraph (i)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6415400&amp;loc=d3e5070-113901<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:durationItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
    </div>
  </body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>34
<FILENAME>R33.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
  <head>
    <META http-equiv="Content-Type" content="text/html; charset=us-ascii">
    <link rel="StyleSheet" type="text/css" href="report.css"><script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script></head>
  <body><span style="display: none;">v2.4.0.8</span><table class="report" border="0" cellspacing="2" id="ID0EBLBI">
      <tr>
        <th class="tl" colspan="1" rowspan="1">
          <div style="width: 200px;"><strong>MARKETABLE SECURITIES (Schedule of Available-for-sale Marketable Securities) (Details) (USD $)<br>In Thousands, unless otherwise specified</strong></div>
        </th>
        <th class="th">
          <div>Jun. 30, 2014</div>
        </th>
        <th class="th">
          <div>Jun. 30, 2013</div>
        </th>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems', window );"><strong>Schedule of Available-for-sale Securities [Line Items]</strong></a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="rou">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesAmortizedCost', window );">Amortized cost</a></td>
        <td class="nump">$ 27,025<span></span></td>
        <td class="nump">$ 13,182<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleEquitySecuritiesAccumulatedGrossUnrealizedGainBeforeTax', window );">Gross unrealized gain</a></td>
        <td class="nump">2,965<span></span></td>
        <td class="nump">570<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleEquitySecuritiesAccumulatedGrossUnrealizedLossBeforeTax', window );">Gross unrealized loss</a></td>
        <td class="num">(29)<span></span></td>
        <td class="num">(311)<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecurities', window );">Fair value</a></td>
        <td class="nump">29,961<span></span></td>
        <td class="nump">13,441<span></span></td>
      </tr>
      <tr class="rh">
        <td class="pl" style="border-bottom: 0px;" valign="top">
          <div class="a">Within One Year [Member]</div>
        </td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems', window );"><strong>Schedule of Available-for-sale Securities [Line Items]</strong></a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="rou">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesAmortizedCost', window );">Amortized cost</a></td>
        <td class="nump">19,430<span></span></td>
        <td class="nump">4,860<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleEquitySecuritiesAccumulatedGrossUnrealizedGainBeforeTax', window );">Gross unrealized gain</a></td>
        <td class="nump">2,585<span></span></td>
        <td class="nump">285<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleEquitySecuritiesAccumulatedGrossUnrealizedLossBeforeTax', window );">Gross unrealized loss</a></td>
        <td class="num">(23)<span></span></td>
        <td class="num">(189)<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecurities', window );">Fair value</a></td>
        <td class="nump">21,992<span></span></td>
        <td class="nump">4,956<span></span></td>
      </tr>
      <tr class="rh">
        <td class="pl" style="border-bottom: 0px;" valign="top">
          <div class="a">One to Five Years [Member]</div>
        </td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems', window );"><strong>Schedule of Available-for-sale Securities [Line Items]</strong></a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="rou">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesAmortizedCost', window );">Amortized cost</a></td>
        <td class="nump">7,501<span></span></td>
        <td class="nump">6,578<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleEquitySecuritiesAccumulatedGrossUnrealizedGainBeforeTax', window );">Gross unrealized gain</a></td>
        <td class="nump">361<span></span></td>
        <td class="nump">211<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleEquitySecuritiesAccumulatedGrossUnrealizedLossBeforeTax', window );">Gross unrealized loss</a></td>
        <td class="num">(6)<span></span></td>
        <td class="num">(89)<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecurities', window );">Fair value</a></td>
        <td class="nump">7,856<span></span></td>
        <td class="nump">6,700<span></span></td>
      </tr>
      <tr class="rh">
        <td class="pl" style="border-bottom: 0px;" valign="top">
          <div class="a">After Five Years through Ten Years [Member]</div>
        </td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems', window );"><strong>Schedule of Available-for-sale Securities [Line Items]</strong></a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="rou">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesAmortizedCost', window );">Amortized cost</a></td>
        <td class="nump">94<span></span></td>
        <td class="nump">1,744<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleEquitySecuritiesAccumulatedGrossUnrealizedGainBeforeTax', window );">Gross unrealized gain</a></td>
        <td class="nump">19<span></span></td>
        <td class="nump">74<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleEquitySecuritiesAccumulatedGrossUnrealizedLossBeforeTax', window );">Gross unrealized loss</a></td>
        <td class="text">&nbsp;&nbsp;<span></span></td>
        <td class="num">(33)<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecurities', window );">Fair value</a></td>
        <td class="nump">113<span></span></td>
        <td class="nump">1,785<span></span></td>
      </tr>
      <tr class="rh">
        <td class="pl" style="border-bottom: 0px;" valign="top">
          <div class="a">Stock and Index Linked Notes [Member] | Within One Year [Member]</div>
        </td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems', window );"><strong>Schedule of Available-for-sale Securities [Line Items]</strong></a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="rou">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesAmortizedCost', window );">Amortized cost</a></td>
        <td class="nump">18,881<span></span></td>
        <td class="nump">4,023<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleEquitySecuritiesAccumulatedGrossUnrealizedGainBeforeTax', window );">Gross unrealized gain</a></td>
        <td class="nump">2,522<span></span></td>
        <td class="nump">234<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleEquitySecuritiesAccumulatedGrossUnrealizedLossBeforeTax', window );">Gross unrealized loss</a></td>
        <td class="num">(23)<span></span></td>
        <td class="num">(180)<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecurities', window );">Fair value</a></td>
        <td class="nump">21,380<span></span></td>
        <td class="nump">4,077<span></span></td>
      </tr>
      <tr class="rh">
        <td class="pl" style="border-bottom: 0px;" valign="top">
          <div class="a">Government Debentures [Member] | Within One Year [Member]</div>
        </td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems', window );"><strong>Schedule of Available-for-sale Securities [Line Items]</strong></a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="rou">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesAmortizedCost', window );">Amortized cost</a></td>
        <td class="nump">97<span></span></td>
        <td class="nump">329<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleEquitySecuritiesAccumulatedGrossUnrealizedGainBeforeTax', window );">Gross unrealized gain</a></td>
        <td class="nump">9<span></span></td>
        <td class="nump">21<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleEquitySecuritiesAccumulatedGrossUnrealizedLossBeforeTax', window );">Gross unrealized loss</a></td>
        <td class="text">&nbsp;&nbsp;<span></span></td>
        <td class="text">&nbsp;&nbsp;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecurities', window );">Fair value</a></td>
        <td class="nump">106<span></span></td>
        <td class="nump">350<span></span></td>
      </tr>
      <tr class="rh">
        <td class="pl" style="border-bottom: 0px;" valign="top">
          <div class="a">Government Debentures [Member] | One to Five Years [Member]</div>
        </td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems', window );"><strong>Schedule of Available-for-sale Securities [Line Items]</strong></a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="rou">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesAmortizedCost', window );">Amortized cost</a></td>
        <td class="nump">2,595<span></span></td>
        <td class="nump">1,602<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleEquitySecuritiesAccumulatedGrossUnrealizedGainBeforeTax', window );">Gross unrealized gain</a></td>
        <td class="nump">98<span></span></td>
        <td class="nump">49<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleEquitySecuritiesAccumulatedGrossUnrealizedLossBeforeTax', window );">Gross unrealized loss</a></td>
        <td class="num">(1)<span></span></td>
        <td class="num">(12)<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecurities', window );">Fair value</a></td>
        <td class="nump">2,692<span></span></td>
        <td class="nump">1,639<span></span></td>
      </tr>
      <tr class="rh">
        <td class="pl" style="border-bottom: 0px;" valign="top">
          <div class="a">Government Debentures [Member] | After Five Years through Ten Years [Member]</div>
        </td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems', window );"><strong>Schedule of Available-for-sale Securities [Line Items]</strong></a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="rou">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesAmortizedCost', window );">Amortized cost</a></td>
        <td class="text">&nbsp;&nbsp;<span></span></td>
        <td class="nump">955<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleEquitySecuritiesAccumulatedGrossUnrealizedGainBeforeTax', window );">Gross unrealized gain</a></td>
        <td class="text">&nbsp;&nbsp;<span></span></td>
        <td class="nump">45<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleEquitySecuritiesAccumulatedGrossUnrealizedLossBeforeTax', window );">Gross unrealized loss</a></td>
        <td class="text">&nbsp;&nbsp;<span></span></td>
        <td class="num">(14)<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecurities', window );">Fair value</a></td>
        <td class="text">&nbsp;&nbsp;<span></span></td>
        <td class="nump">986<span></span></td>
      </tr>
      <tr class="rh">
        <td class="pl" style="border-bottom: 0px;" valign="top">
          <div class="a">Corporate Debentures [Member] | Within One Year [Member]</div>
        </td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems', window );"><strong>Schedule of Available-for-sale Securities [Line Items]</strong></a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="rou">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesAmortizedCost', window );">Amortized cost</a></td>
        <td class="nump">452<span></span></td>
        <td class="nump">508<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleEquitySecuritiesAccumulatedGrossUnrealizedGainBeforeTax', window );">Gross unrealized gain</a></td>
        <td class="nump">54<span></span></td>
        <td class="nump">30<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleEquitySecuritiesAccumulatedGrossUnrealizedLossBeforeTax', window );">Gross unrealized loss</a></td>
        <td class="text">&nbsp;&nbsp;<span></span></td>
        <td class="num">(9)<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecurities', window );">Fair value</a></td>
        <td class="nump">506<span></span></td>
        <td class="nump">529<span></span></td>
      </tr>
      <tr class="rh">
        <td class="pl" style="border-bottom: 0px;" valign="top">
          <div class="a">Corporate Debentures [Member] | One to Five Years [Member]</div>
        </td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems', window );"><strong>Schedule of Available-for-sale Securities [Line Items]</strong></a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="rou">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesAmortizedCost', window );">Amortized cost</a></td>
        <td class="nump">4,906<span></span></td>
        <td class="nump">4,976<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleEquitySecuritiesAccumulatedGrossUnrealizedGainBeforeTax', window );">Gross unrealized gain</a></td>
        <td class="nump">263<span></span></td>
        <td class="nump">162<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleEquitySecuritiesAccumulatedGrossUnrealizedLossBeforeTax', window );">Gross unrealized loss</a></td>
        <td class="num">(5)<span></span></td>
        <td class="num">(77)<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecurities', window );">Fair value</a></td>
        <td class="nump">5,164<span></span></td>
        <td class="nump">5,061<span></span></td>
      </tr>
      <tr class="rh">
        <td class="pl" style="border-bottom: 0px;" valign="top">
          <div class="a">Corporate Debentures [Member] | After Five Years through Ten Years [Member]</div>
        </td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems', window );"><strong>Schedule of Available-for-sale Securities [Line Items]</strong></a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="rou">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesAmortizedCost', window );">Amortized cost</a></td>
        <td class="nump">94<span></span></td>
        <td class="nump">789<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleEquitySecuritiesAccumulatedGrossUnrealizedGainBeforeTax', window );">Gross unrealized gain</a></td>
        <td class="nump">19<span></span></td>
        <td class="nump">29<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleEquitySecuritiesAccumulatedGrossUnrealizedLossBeforeTax', window );">Gross unrealized loss</a></td>
        <td class="text">&nbsp;&nbsp;<span></span></td>
        <td class="num">(19)<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecurities', window );">Fair value</a></td>
        <td class="nump">$ 113<span></span></td>
        <td class="nump">$ 799<span></span></td>
      </tr>
    </table>
    <div style="display: none;">
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleEquitySecuritiesAccumulatedGrossUnrealizedGainBeforeTax">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Amount before tax of unrealized gain in accumulated other comprehensive income (AOCI) on investments in equity securities classified as available-for-sale.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 320<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 2<br><br> -Subparagraph (b)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=27724398&amp;loc=d3e27161-111563<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_AvailableForSaleEquitySecuritiesAccumulatedGrossUnrealizedGainBeforeTax</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>credit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleEquitySecuritiesAccumulatedGrossUnrealizedLossBeforeTax">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Amount before tax of unrealized loss in accumulated other comprehensive income (AOCI) on investments in equity securities classified as available-for-sale.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 320<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 2<br><br> -Subparagraph (c)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=27724398&amp;loc=d3e27161-111563<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_AvailableForSaleEquitySecuritiesAccumulatedGrossUnrealizedLossBeforeTax</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>debit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleSecurities">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Amount of investment in debt and equity securities categorized neither as held-to-maturity nor trading.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 320<br><br> -SubTopic 10<br><br> -Section 25<br><br> -Paragraph 1<br><br> -Subparagraph (b)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=28360136&amp;loc=d3e22054-111558<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 320<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 5<br><br> -Subparagraph (aa)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=27724398&amp;loc=d3e27232-111563<br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 320<br><br> -SubTopic 10<br><br> -Section 45<br><br> -Paragraph 1<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6871852&amp;loc=d3e26610-111562<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_AvailableForSaleSecurities</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>debit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleSecuritiesAmortizedCost">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>This item represents the cost of debt and equity securities, which are categorized neither as held-to-maturity nor trading, net of adjustments including accretion, amortization, collection of cash, previous other-than-temporary impairments recognized in earnings (less any cumulative-effect adjustments recognized, as defined), and fair value hedge accounting adjustments, if any.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 210<br><br> -SubTopic 10<br><br> -Section S99<br><br> -Paragraph 1<br><br> -Subparagraph (SX 210.5-02.2)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_AvailableForSaleSecuritiesAmortizedCost</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>debit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div>
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:stringItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
    </div>
  </body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>35
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
..report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

..report table.authRefData a {
	display: block;
	font-weight: bold;
}

..report table.authRefData p {
	margin-top: 0px;
}

..report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

..report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

..report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

..report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
..pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
..report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

..report hr {
	border: 1px solid #acf;
}

/* Top labels */
..report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

..report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

..report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	word-wrap: break-word;
}

..report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

..report td.pl div.a {
	width: 200px;
}

..report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
..report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
..report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
..report .re, .report .reu {
	background-color: #def;
}

..report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
..report .ro, .report .rou {
	background-color: white;
}

..report .rou td {
	border-bottom: 1px solid black;
}

..report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
..report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
..report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

..report .nump {
	padding-left: 2em;
}

..report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
..report .text {
	text-align: left;
	white-space: normal;
}

..report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

..report .text .more {
	display: none;
}

..report .text .note {
	font-style: italic;
	font-weight: bold;
}

..report .text .small {
	width: 10em;
}

..report sup {
	font-style: italic;
}

..report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>36
<FILENAME>0001178913-14-002913-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0001178913-14-002913-xbrl.zip
M4$L#!!0````(`.6!*T6(*P+X0C<!`.-2%P`1`!P`<'-T:2TR,#$T,#8S,"YX
M;6Q55`D``\T"$E3-`A)4=7@+``$$)0X```0Y`0``[%UMD^*VLOY^J^Y_\"'9
M4TG5P&#,ZVPFYS(#L^%FWN[`9K/GRREA"_!98Q/+S`SGU]]NR08#MC'&O"Z5
M2C)8LM3]J+O5:LFM7_[Q/C2D5VHSW3*O,W(NGY&HJ5J:;O:O,Y_;V7K[MM7*
M2,PAID8,RZ37&=/*_./7__ZO7_Z6S=[:E#A4D[H3Z9_9WZ5/AM4EAG3O:#GI
MI\P_?_^4^3F;=:N.;$L;JU#7,J5"7BYF\[6LG)?^1ZI>%62I_B`JOG=M0P*2
M3':E6F/3L2?7F8'CC*XN+[$HQZB:ZUNOEV[A);2D9/-R5I$SWFMCVP8.PMYS
M2R\%"?X7#=W\-GWI[>TMQU^T[#[4S2N76-PEC'K51\S1YZJ/C+&M,X<.<ZHU
MY.WGRTK>JXZ-Z1'-ZR9"K$Z;?Q\X0V.N_IO":\NU6NV2ETZK+E$^5Q5+O:H:
MU8-Q@8(`2'3SE3(G^`U1%C``8Y;M$S*:OM4CK,O)<0N"^F%6L2!7HN`1-=P7
MXN`(TB1)OR#S5TP=T"%YH3V)@W'E3$8@QDP?C@S$FS\;V+1WG<%!S7I#EWMG
M6D:Z%`T!0%?U(34U^->Y,TA?TK7KS-R37+5<R^5G_V0DU3(=^NZ\8-,]VQIF
M!5H5Y-ZQL@*(<A:Z6G@57OZU1PQ&?[E<ZGA&SRT79N=.9RHQOE)B-TVM`?K(
M20LK3)G*K"@2=(;U.2.Y8:GCX;3*,[5U2[N#9XS3'%J:,M%W7P6]H?V%$8P\
MA9$[+4N96"P-(G?:WS*Q@A._-`26;(%0OS0$]KE,;`>T<8Y&?)`R:7(^^_L\
M4=C)C):FZ>C.Y!:>V\1HF1I]_YU..%&!)2E3E\_G9;E4K51=X`+[7"+6&@XM
ML^U8ZK?V@-B4/8T=/DO#S.VG/*):KEJIA+-!6-;J9;VI.E]8K(WUQZ8N*C/>
M=D;2J*H/P7!=9UJ/=YE?R[5"I5J2"W-\15"TQ*0P*"]T9-D.E+<=XKC*%U4A
MY?'Y2MD<`X%]+I)^IQO4O@6)[UNV7Y3FGJ=,:%U5*;3.73+>CY_LN8X7J7T>
M=PU=O3,LXOAH]3V%T5=BR(J2E0LPL2_6GI.5S^V&7U#0<LC%0KY0S,_)B:_S
M16I?:!\\+9N8SB,94A_!\P4IH_M\__FEU>XT'Z3.;\V7^G/S<Z=UVY9:C[=^
MLN=)6*3\#\L`QY788C3\DKQ0DC+MCY:?QH6^%HG\0@WC=]-Z,]N4,'#YM19C
M8VK[B`VIL56B0_H4Q`MO]*H!4\TK<?17^F@YL*(A1GV(*P4QOX04@K`6<G*E
M"D3(BJ+D"DJYE)-+M2+\+$%)6:Z%6T9!.S207]E$F`)D%="`*GBO>;#_*QA)
MC]MB:6-N(YN(XE:6\_DUV$6O_*JNO:)?_TPFW`6R[`9]I2/#PE^W%G.$+JVL
ME:Z(1H^IQV0\^OV\]OLV[8.I_H1VA+U0E0(TFN`PN,P=E1ASN6\,8[,B%^5"
MR<=+,`U^#H8X-_Z'X&`^]1K@L.)PUDWMV:9#?3R$OVX'Q.Q3UC)AUK+'H,Y`
M+G@#SAV,P0.QOU&'=`W:IK!DUQV=NN.;?KL[E`A9J+F'8OJ\'.L(5/*K1Z`P
M-P+*5)#S:XU`J7@>@*`!D%</@#PW`(7I`,AK#4!E9_B_$MW`4K"U;6+0H.J/
MXV'7=6SB5T_1U"XOF_AB%5:#^:('4FRZ?+S?C)EN4L9@K=7530[P+=`(BQ4^
MVYA,UW"9`(^%[<;F/H^@$K4=HL/#_M@@#JP3'L!!9`YX6T+VMM#N#LVO4BGY
M9^0M,.,;@D_6*[5-G-U!C#L#W=:>B>U,`F;T6#5W"%-)J95G*,6B;IM\[VQN
M*)0KRB'QO2N3##Y[)3G?GD5^,ML#,.<=:@]OB/GMUJ::CDW@C^;[B)K,M2'K
MO+!+X^"3^75(W!T4NU.$VL%#L3-WI;`Q%/>4,#JP#*TU'-F@7*A:K&Z:8V*\
MP!(*'!\ZLJ%3/M,T*%-M?81_<EB2OLREOU`J5:JY8J$L)]>?@#9^[0RHQ!`"
M<)VLGN3`3PI\JQAV'#/:&QN2H?>H9-F\S.;Q&IP])<+8>`BUX,VA]ZJ!+.9<
MC)/RZ\=;-[^1/FWHO1[%O5X*[VL+8P=/[BVSCT/X`D]M'6GG?4/[%M-%""65
MEG:ZO)P):RJT'S*J.[.&627_/<&Z.Z]CBZ@N573K/%N&KDXZP-"-8:G?!'`Q
M*Z<<W/Z[X7S\6S;;>+KM?'UN2GB@0WK^?'/?NI4RV<O++\KMY66CTY#^_*WS
M<"\!M%('7#`@BX='+R^;CQDIX,Q'YT4<#I'Q9??/K.-[,Z<Y6D;*9O_>=SXB
M#9K^BG]*OK]=TMH..'YW-NFC$18O>+4DYDP,>IU!]K/$T/OFE:12'+#,M!I?
MHWH5[YX>.]EVZY_-*TG.CZ`&?W!7?VC=?[V2''T(;H!)WR1`D9B`+#4,-B(J
M/X64%[]'1-.\WV^ZY@RN,W(^_R$C=2T;%FKX?-:W+;URLH!$:^1[KGD$?6DU
M.K\!,=61DPGBK-%J/]_7@3;=-&"5&$VP6[K$WY=FZ]-OG2N@T-`^2@_UET^M
MQ^Q]\PX>\4KNDQ=1BS_J-/_L9%N/C>:C>"*(Z^>0O$O_6%TZFH^M';'@'^]_
MCT'5>A-!("I1EL_J]E2-0.&Y'K%(VB\=V_<WRLSL9Y!LDN'HH]EEHX]A-78K
M?*Z4N<*_'5F,IK_#Z7\$^E_$0"Z,N]MD.&Z;2M(2`4OT)A,;`-H92$/B>-%/
M<!B'EDW!:R2F9)E4FE!BH\<)#J4E,0R'@=,YXD$;LR\<2XGT;<K=2(E`*3B/
M#(=*DX@#]ILYTMM`5P<2&8&[^0[3DP/]#'F(#4=MC*L34S7&_%0%$3%(>")F
MIFBEC"O88&F;IC9O9Y<;=G]X$V;,.<LW)SYYN/`Y4ZLS1AV&2WM=U4?<G<:8
MZCUES!(!T75>X!,<^$F;KC8"FHCR(:JR;]&^#KU^7&`-8M=5'GJ&ZA,<*/B?
M;1E&RX0*SAA?%8O4F'6WNQ>GY'UN?DR*MLYO,0:_,_^[N!:_A>(F_#Y3&XTS
MN)=/O?^#9:3>TZG&E^FP:@>#(3A=66M;R[@1-.[G6,[\FL^57&Y74N7GTT;+
MYTR>#<)#=\V_QOI(A/&"5\^"[W7?$II>+>:%FBH*+*:*2K&64-_#&HK&1_;P
M69?Z`\`+_I,.7G,-A>)5X'B5C@VP<BDE`0MK*!JP?/F(`=M,PL(:.C$)D^6R
MLJ&S$M!$-$B*<F0@E8K533VZ@";V*4E-*$4G7_O,X]3W^BMEV%(''8GYN-"&
M;9S#1:>V+%]80N]OU>Q)ID1,3:*>6/+U+7.(;W%[`?@YN&R&E>MXB*<5Q/)Z
MIN72O*5@DDH,U:W8G?#]&3S,K/<'3A:9D(;4&5B:A)O$8N/'4X;9SL^K6*IC
M*>&+L`ND!W_VP$VWWOA2FNNPA$?5V55:\:$EX+NHB#$#;P%HAT7CHF-0'A5S
MO:(0S?=AT)ZSTV!I%?3")_U^@?<K@E>]6!35L4H/+%<BXN(%H[#YD&B4U^O-
MTTNC^9*]>>ITGAYP8`E8Z<+H76*6H8.!"N*@4/T0'=IUQ6/-L.@&8=P/*V)O
MD6SL<R#\2@B&L]M7+<,">_J#JE+:ZV7B")-GD^<%?\?CLJB!82-U3V#*X(>[
M9@8VZ>#MF_&L7,@IZS`OY[-RZ=1$]6V@._3T!/76&H[&#GY*A,X`N`7Z:$!M
MF%J_/[%5E%.3V9,UKT^]GJZ"/SBV31[(G/=DOQN)+9_M[+%([!]TH*L&C=[+
M#F%6+GW`U3\ZZ29&.?;-^/H.0;24?G?F:WI*4=)]QQ23B$:IO*%HI#[6V[`I
M$0=&EXU,VITOGTB=ZS/-0,)!@+U\W';[&"^?YXW&>%?G)#:,X?HBRF+[=:*;
M??^F[!]X1.2I]\QS6^'GR^+404`T>8/WSY'D-6>#U:'5.44N5#8/":*%^VLZ
MQ+@.<\?8TPI^F,C[,9J.MQLAQ<@K86Y\-"`@&L%Y(#WX3M>6+E>&2@.`V/.9
MSG)XF'+-6&#7<AQK./,R:EL)!R8]Z+D,<Y1L3<5G)CKK",G!\>2*?9?VQ($^
M[A"@K;#,H^;KI\=6&V9&::@;!AY$^CG1\F[_J[O-(N]'K6I(`6@93^YTY-+H
M#-R--QMC*[;K"1XK-S/9%5EC^*9GEQ)[>>5U3&PYUIR#<-2\+#DV:\0-5D8)
M:@=A%@_78!\J:.N$AUSRN'35[UN?'KWU<[)=UUW.3O$IG&,L6)$^C]`N@#,Q
M`UDNYH_7F3BT<8AOTN1"]*Y]_#CX6;8%:8M2+67G'Y7R9T'?@Z!7DLGYV8J'
M2_K#]&NULX#O7\!+\04\[3CT!M%?7PSZA:H&N-7X&=L+9;#P40=U4\,\DH8E
MHMHB^TC'PH223[T7*#''[A=.25_><F+)2LF7<RDIC7,8#8EN`M`-VJ,V+'G=
M.M"TU3=Y*-K+\VZW8!S,O@YH<^!=F!*_GW:ZX>K7\L,4F,14S6$3@2FF7!!)
MGH*2)"1[];QSL6P3SRD3=I,R87CH*1,\E>)GGWQ*Q;?&>5XL+.ASO4IEXCJ8
M$_*[E_<T/P>I?7=9&N8D50N0U.EW)B/_Y_;XW0?XO^J`V'V1HD%\3D(<D8\!
MZKO)&O![<\(S+>#5"EHZ>17.XGX6]W3%7=AB"?T6+LK]::I,E.46LPDU^$L6
M9BD0RD!Q5]^6>F-Q,0O/,X*)0.VP3J#\WU2%;E!W;.'?_4=\TH5]HF#P/_#@
M-S$G>'*`XOT(AIL%90QM"D(O\*HUK-HE3)]^DL63GGB:QGL'F@P=_X8^@12^
M%H$W.9NA9*H\F?[>%E3)_-'8OO#C=#6PHM8NL_O52L6"?ZVT@K1M,+N[/.V5
M@J+LF]E=I<*KR:5JFKQ.\U'/5HEN^NH(UL-?VE^&[G4I]2-C38B!YE=<)/),
M=`U:J7L9G!"&J!K;C7K,Q3RBR%AB:(*'%-V\-T]F0'+IU=5VE<D&,]G/\1A%
M5#"CF.^>+;+%'XJD%_Z4'LE8"6AB168099DG3E%"#GPY-I)RL-3$"@Z*JSEH
M@V;9[G4U0>&@B/)SS.<48SZ5HXCY_'7H,9^IWL#B8')>Y9Y7N?M;Y>)1Q_:X
MRW1-)_:$T_B#4OO()$,G7=W0G0E?N#*_Q"XD"('IA8UA%L=UIUC]ZCX)AZE!
MNB=O%P!N69%^PK5G9JDT\[,/G>E?>,^VYJU>A[A@A84PKCH9,8#8Z3=$PY%A
M32AF[!R#"R56L6[6$E/<[`,U,4DH7_V*ZFBE+W"MZS;2A2:1(#:@L#30\%I<
MJ3EM&!?A_N4U9AT=PGPV\`'F$H5H40)+99Z5=*X__.Z(2.Z)4NS5IE9OV5:%
MS!C^88N7>B3-KR/6-QSNQGB,+R;<&$:H\!'#0"`Q%^QLK$$&>V/#F&"DY%77
MQ)#S,8%G\[EC=9.-7>%%)T5W8^I=S)PCLKG"1#]_OAX&A_FJ0V<8@[$U-SYB
MBG.->,3;"61@3IS.@<RSB=^SB7<5`L070Y!>-F/^"5(/]02TS+`8WVWRY8@:
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MR'76O+T,U^9XG.6DN[&-WM*%^Q&+,$X^P\&W+S@JS*?X4-"E`V+T%J$2(X,[
M)/XV0`I,R_%2YTWW3'QVC_N+"YLN!F"`7@A0Q?.-S[:%?&T#0S/)L[`]GXF:
M4LZEHXL@CX@>L/MY,);A[``<EP,PLU_3,R4]]U(NL2K".1`/GZC"JBI@4S$<
MQ_^K<.W"78T+Z0UF2NG'D@(E/RJ%&B_YL5`I7>`&(29RT%^I,=G?=F!$/-(?
MU<3;5F]065&/`0^NI'7;QCMFL;.;R:R*>U%W_0TL':8-<":88-X><P/&T]!W
M!L1\XK>/L::;S:)C_4&9V&#:56=\[Z%8*E=S2KFRUG;%\DL1]]*V'N_P]N1"
M(5_PXL>[XG!Q!+NKN^PN=NDV?&?9/2I2YV/8>S90Z;7IWKQ7+LNY4J$2,B+Q
M;MY;;F-%9+_B'YGT6#JV`:@$@[?N9O5Y`!(/@!Q[`*(VT!,,0.D\`*X)4A2Y
MO*$%"F@B:K<W?\;>M3XQL8\R/F?L$QJ>F-A'V9WCP_X+L?EQBN8[M56=N6=!
MUG_-=5ZJ<C$GYXO539R7Y396>I=%!5XKQD5SB?C]`%8)9G9]9R,!8"C'Y=CB
M=RB`R;$!BW8.U@=,*96*LIPN7I\L2\,#IX^6.0WUM*G]JJN4\:,HA$<5O<:@
MYG21$XSDY@UNZX17"*KE<BF_+(2;LY$NW/R\67I@N\WM&&K?N<'T>$@7YT>Q
M\9X2S**U%$]CA@!;*!52A5;0?13(IG5U8YC(RJ54S</VD'4-S_2<]#8:WH4D
MRUN09!\+VX`>PWP4SSV'!5*WV,FQ&I<0=N:&Q[(=O";XAIC?@B\(=A%>6>]\
MJO<43_4>QY?<].!/]:+^B&O,NZ!!WO[N^51(*J="5E!]XT/</?!AV7I?Q_,&
M87?'.P.;NN<XF=0=.Y)!&5NX5G[AMGC&#S_P0PZST9[EH63\)CU!P](]\\Z`
MZO;FM\U++?<O/*,PY7CAA&(/&#=5/*8$+5G#`-U)M+^Z>H;PSSL._&XQ!M0W
M`'^>]$:W-#[S,5[H3F0P>87$%39IP;W?52[E2K)<3#YC!32Q:J8O*<7*=*+?
MA(=#0K,2",6Z`:X$:,J5<K5<.3DXY;AP1H6_$L!9*5;SNQ?.I!@>DEH7:OF"
M7*[&QNY@$-N?ZI8+LE*J'2%B^]+.4D&I*J5M`L;3S6UBX6(U$*:F[TR_,G4#
MUB3@U:2KM?P+Z_>A8;(KZ.4Z8&$(ZV_Y\L^'^[8ZH$.2U4WFX&FQC'1Y.+`%
MZVH,V)*J[HG`%JBP,6!+JK^G`1LH5;%6VW`J76XA,J>'/PJV`?&'`V(E"()U
M571-$"OEDT-1CHEBE,:NAV*U=FH@HCY7JNG.N<L-GI@1K`3QN.&,>_J@R<E`
MB]3>4P<-U;,L+YJH3?5SN<43@ZT2R.2F&GKZL,D)88O4T9.';7>I_$[1$UX)
M74J)`4_1_UV)72IY!O?A]28$['L**Z4'T<F&D%*$Z%3#1:DJVLY#0[5R=0W;
M="`6:0_A'Y"5=8SXH0"U^PA/J;2.GW`@.)UH$"==C3O!@$VZFG:"P9ET5>PD
M`S'I*ME)!EW25;.3#+"DJF@["J8<J^^XFX#)T7J,NXF)I.<G+G^G4>_W,5.:
M0UN8T,UDNLI;XJ#$KKW=FP@4Q?>U4&R:DG"]^'55DA>WC$6AF@"+X"^C8K\>
M]>73IHT<HNBL_FHIXHO@+U3O#_!US/;5]Z"GS[:NA@E5K'>W.%O]:T3M?_$C
M?PO):N2<4@L%+Q;5D9BYW_8F0"S&F_O`"VJ&"UL,FB/12@!3-#YI*EXH)*6<
M'"Y"!X1%6E\81V%1S!6+N\6B^:ZNFM'BOKXS>2G(B3#RTYH8K_5FN@0M';K6
M)9GZ%MJ;W@-]BSF"B>J,B='A7Z+%`3'L[;0OKE:^RO*#7&[$12F,KC206>UV
MKM_05O`J;0Q77$\T9G,;Z>N:C1ZJ!$:J[)AE^X2,KNJJRO,XNU>;U:>WM]V[
MEUGHE#5TIAH6&]MT_M/[A.^>/\=/_</DC;Y9=Z\\B4I@__C4:4KEJ^Q3Y[?F
MBU2_O7WZ_-AI2\_UK_6;^^;A?_?M;]!&Y=EILH-:Y8,_P4%`3H/G>J/1>OR4
MO7GJ=)X>KJ3"Z#TSS8/0M1S'&DY;JY1%:]A"S\)[A1+0'B\3.#8?DK8@">5R
M*H0'R'I*O-P\O32:+U-6N@8!0P<,2<PR="V4K4+A`YHPE`0H+$<GI0C2[^WE
MI%C.\A&F1_\[-JFDY"]69*N(&/9E:Q(E"))IO=ED=)T1_S]LP8@CY/M627].
MCE1LC'=]`1_)?7-W-CA^MO)^@U,X3H.#3MW9V)P%/)`MV2_@Q:,5<"5V%B7'
MEKI]X-BRKS,_J"JEO=Y<[JMU['3*2*T-2]1"PKO#?$0FMF48JPQ`A$J[)3-O
M_C"FITU3=ZUCUK#['W=#BH`YC)::H.7_V;O6WL9Q9/O]`O<_<+P[@[Z`'WK+
M2K8'Z,ZC)XMT$B2>U_VR4"PZUAU9\DIR'OOK+RG;B2W;M&3K04F%`:9C6Z2J
M#D\5R2)95"1EMS0E^^MCFQ>86"4FRJI<3R;NZC->QG:(:]ECW,U["GH=;FB'
M\TL*Z]=MI#4V/J0NWJX%J9YV#:2M,6GK.BQJ\@3FV1Q&5VY`5\2'U(5;M:;7
M=(@)I*TO:55!JR=IFS<O^F(]TR,RUO)>\OD5WC07N.=#I\2'U(7;=]^HIWD#
M9X&S5>-L$V='Y]BWG\F\Z)F\U,(!>=Y<7$!AHI%I^_.+(M`86T\XBN@M[E"'
M#HL/J8LW_KI:/Y"VOJ3MU).RR>=06>THX[DKNPW'V*>3*[H_>&\'==C>'5[]
M`'O;3OJEX6IH5;@?$1GK`CSN>2MG@QL8"4]:\=39ULY&TDP985<W%X(7:2]'
M[L+BSK2EMFR(#3)OH'NCZ2ZV)9VQ?:EV=$]Z2W#*.UV//+G,//Y\-O-]NI:V
MY73SXJ><TQ(IFAKE)6++=[P.&68UV<C9UI?U8W6()M\,159_S[=%)-)%L;19
ME21+E7)L()&XH>-4NL=#;#_39V]PN$VG;0_DW$Z2)F]5:ILHV6J5IRWI1R@5
M\X4QC;;_FF\C&>*&=]LN1E:ZY&E%@B(<H<QOB_V#6S2)_91ODVB;#-LBP_$J
MY-@2JJ`=HL)L,G/HZN0YGOJDONA9\K>#Z1]T-#'Q_-#^3_3]G>]-L1^^W3FF
M&]*,*O^>V=/)BM*95!:UG=Q7A*XB:6*J]MY2BIU75=GH`C)1H1HH*XE17J=D
M2I1%>9.9#4)9ZHJB)J?G\I92+)05><,/-PAD)3'(ZU1."7*47;:Q(!.O3.9E
M!WCES5))K@=K)LA*8I!C3CD=R)O3N09A3(@LB/H!1-XLQ22RHF\,]!N$LI(8
MY1B3TZ&L-7H,)W55I=]/3^4MI9CNHL$0*XDA7N=Q2H@;/7[+<6JOB'*3'42>
M83E9*=@OS&.RWH34/<9N8#_C*W?H3?"U%P1G\X?(=V=CTWW"P95[@\-OINW2
M7R]];W)F!N-+QWOYA>Z[#BY&(SP,R2.WHX'Y&H<]OS?-IX1ZG^`MRK+<E<C(
MK2NJ!IG"R"KY11.-9//#/56P6VY7N^6G]T&->DCSK`&=FUN1#'4G^9-(5P8<
M>?J"ZJ$A=15=9UQHN8,AFX78-)%WSF9Y!49)"LPZ5U("4TG"])4#"+-1*'O7
M7#)=-C1D7*.WBSU[4#KJXKQW0"QKD;;\SK2M*_?,G-JAZ<P5W_Y;OKV(J$N&
MT5]O\>UR9*%(GNN`BB(*QB&*T,SFT>FW@;>CQ,J5;O3_M&7/O"`,%MH>7D&A
M-QS&0D%'B,T5@L5=@J@92EX0.HXWI![O@=X5\]4,L$7='O%YT3R%7ASA!O.[
M1Y(]&K%#4E59[\J:WE54A0S2-54ZC&0[*V(2+A;@321W[K#H#&W2,N<@6"2-
M2UC$=+"PKLT\C"T&C["L&9&DZ-J*-D=>][RSWCQ&'3G;47IDDIE5-9$1=VMP
MN"DQH8C%<75.34E1M7X6W=&N>MB]47RS)1^PZ+O527T[^@&PZ)SVTF(J5)@7
MHA]$EO@F5CY@6;6A!)XED0VE<"R*;`@\PJ+O5N=@&TH!BZA*7`Y>5HWHR'[H
M$%ADI<]K1_31K1X\[]Y21<4G0P=/H%-"48$)$!.*9..U1%"H7$*QVLL<;!^;
M-3"!4#7N1V<'VT<Z*"0I?IZ!$RC$A%`DZD<203$_A,<?%-NG,M3VU:XJR$8F
M,YK5ZMA'"'CM6@[`*.7T)C%&JLHE1EMG.?LP2CG9J3B/MD]Y,K&U[=4Q9\M<
M#FBW3W\R,;7T$$EZGTN,MLZ%,C&U`S#BM5?[4."XB5&\CBH29KLFA\R-TJ"A
MREP&GA:SHR1H[)L>I>*&E$&?%`1XN<X<_9GO?@I=$>(;:**W[A<JQ[T16E\6
MM81"K9TB7OTFY_//HA$/%ZV^/*VD>1YS5H6^FD[2&\\=;@C[\67..WPD(;X#
M,/;^PT3.<R^/+,EB&I&?3=NA61@N/?_!=##=QQV^/6#R<)0`8&5+V3??"X)?
M71^;COT?\M&TW:]XY/GX??M9-G7--UD;HM`E'GT^-)"ZBJP8B1MX=V'V5$>*
M15*RT:<*@"MI`8\=Q3T,<%EI*MX14,H*9F(ZAC-*,X^"]9L*N)(:\'6&'PAX
M_)!-<P#?8+BP`EF2+<9,P@L[\<]F;PN7D&YP6#B*P[LQC'%8!0X?-@YAE$YQ
M8+<Y>&\0/.4PY$"\XU/EY@!.QMF2)A\^SMY9F#D+;.RH3TD+=VR4?1#<\;/I
MS8$[SNZ48^S=A=E[-.2FXAVG=\HA]F%XB_'M#\W!.\[OO<-!%K^3C@;CIPV:
M`W><WBE'WX?!'=\?V1RXX[U<FE'W1C%VW"\>E&X.R$IRD#>&VNE`;B[&\?XL
M%9'CQ9@C/:VQ$QDE.<:;/$Z#L13?CMP<C.,=5RH>QXO!$&,WC1-!O$GC-!#K
MC9V#YYI6*'[U17-@S7/7@,YU!(-F5,D*U;6Z2EL'SRJ`L:9-%>`N915<C.>E
M;@[>):V"9S6"JQS>)2V"BUE%Z"H'>$,7P0OE<#&+X&)6`^;J<UC*DL.[>\DF
M<3@MI`<N>]<84M9*=GJ2)EUIK3&@I:Q59Q7XJ:"3+6&I.JM@1>70+F6A.GX"
MLCEPL]:IC_7-#1T#E[`2G5E4OH+\+6HENL&1MX+6H<5^PVE<P#JTUE2$"UN%
M;CJ)XTN=!X4A]BR8UGK\4-`R<_Q(?I-XFN,R<U-!S7&16<YL7T\*5#^JVPK4
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MB?,)0G'Q8C5^-1L_(!075E;C]T3Q`T)AT6>>^XG"8M0*MR#D&<K6!8G;B7FN
M$6^QG^OLZHP(:[LS;Q;;_'KG!3:]4TR4OI,GQL&M?^VY3]A?V3)+']N#U)&U
MY\NI/1E-,M.B+DV1(\V3CG<Y:8E+T_9_,YT9'M#B`X+"5\<;_G5D"^RH=7&O
MY`[DDUQ)N5KXYY^<\/2'3N?\]FSPY]T%&H<3!]W]^O7ZZ@RU.KW>[_)9KW<^
M.$=__#+X?HW$KH`&ONG.)32=7N_BIH6V!(L'][U76I=("R_^[(0K);M6:+50
MI_/34WA*9;#L9_HG6OE[(=I#:/KAI6\^3;`;S@LLGT)!^.;@SZWSJX>[ZR]_
MGB#;=6P7GZ++VYM!Y_++]ZMK\N7`GN``W>`7=.]-3'?QZ\/5_UZ<(%&8DNJ^
M?[G_=G73N;ZX')R@U6_NK[[]LOQJ</''H'-U<WYQ,_^F%4DR&&,T\AS'>['=
M)Q32ID)3'P=$U@`]T5,$A.G+YD4.^4QD,5T+C4CSHF?:O@&IP$?AV*.W4+K/
M.`@G4>EP;(;H!?OT6U(D7@^:+HB"S`!Y(_3/F8N1++01;?#H%:O?R.WHJY"(
MZV#W*1S3(B%!9OZ:S;>/S6>,'C%VH[='))NS=?WE)[0I>K'66[;+$;C^9$ZF
MI^YC,#UEO8#ROD,P>7)/B%JC95GRT+PE%H]M-/@:/\*('R[AAT_Y00P*.TXP
M-8>D13^WA/GGJ6E9R\\OMA6./[?(+.3'E1?Z'W]:RQ???3D_O[KYUOEZ.QC<
M?C]!TO2U11N="/RY]>B%H3=I+:D^(@@?)/`IBO%_*X*T^G<)>Z%5GK31K[]?
MS"GPZ#E69@I\O;T_O[A_E__1,8D7)EJ@P'-L:T,70FK:SN0+K<5T*X_4\292
M:P.%=3T3&<0JJ8?$%K&_RTBN<1"Y"1>)$II$7=V&M21NZL5+OEQ??;M96-,&
M8*[WXIO3SZWYOWR3`=A<,3:_<QB1[O")]'7DV:;3N;?:K4`/4UV;E*IIDW02
M@J)92-,M$4A<61)'A[E9TPCN-8A-_<`6P18K:HO0H0")*T]BZ%!J9HOKTRST
M^$08ZOF?6W\;#C$>C5I;L(BK?6@4>0.M1711E7[,PSB2"[FFVW86?=D,/.]C
MT@YMQ1\YFJ6REQ/V8[S?(M:U_GLQHOCVTWBW+,9<EKXJ[I8FC6(Y6/VQS0O<
MXYM[GT2=#V"V<?=_@%"5(Y2BR>#,@'LE.3.)#V`2.;-=`^"7L1UB&/XF'?[*
M,/RMMM6J;5%BV"WT&<"^//L,6:A2IP&,XIY1,C@SH%Y)SLS@`Y?4X]]>M'?T
MX^/J<.Z'3N?"M=9W(V^.^18?LMC"OF,7>%9;U^D.PL'8?-\IG^TA@CVUYWR>
M(VFBBB.UJ$M3Y)F(/W&J'<[:8O""G6<\?]6[)6;4$EOKSM<D^FK2D[-'*5&'
M5LC1&E0RQ:Q2,ZQ6OCQ)E54S,.O.UQ@4+6F6N*.4J$,KY-DU9&4*F31"TK-[
M<!HOR6F\;2':C`[CQ0]^I=BAT$:FXT2GW\88G7F3J>F^13.[O\G&:8`FIO\7
M7IP>^TAS&AW#&SIF$-@C&UOTR)VY9$=GY/F=@/"CFV9+4*9J-N>TW+(Z2>!I
MGI]&\FP"%/QLYENH)?=_7-G8)RK5W-F7:B_3<;OBN`ZN`:_KR>LD:Y1UI74F
M9^F@_^'43M?,M*+[RM]3]A!-@K#"=EKN60E@.O=,K],)BDJK\63:+C@:<#3@
M:'C5H":.)O]C9N!H2M>EP8Z&KC54VD"?\S^4#19:NBX-ME"870/3F\%T&/1R
MH@;,KL'1@*/A68.:.!J878.CJ;.C@=EUS2R4PXQ+TNH&M?*YE?@4^L8^1-1!
M$S.<^73?HAV.;1=Y+D9OV/0WL_57Z5!=<O]6LJ!PP!*X`%PH6SC@`G`!N`!<
M`"X`%X`+7,`-7``N`!>:R@7ND@SF%/')-+SS$-+CR/3N1MNU\"LBL/^%+=*T
M(=X;\6=08_'+/)-/V<1H>,(D?2Z+V&_W^TW,O@UDY(^,4EMM9"),X")_7/PD
M,=)X<Y=*#NA5,7I)8EON"^#KRA<5R'BJM`66MP,N`A>+<XRR`DPL7U1@XNDG
MD=5!PQ`0^'5TKZLS[IZJLJ]KSD:[3,.NW[QG[+LTR2&R\"/Y)]I.UT$C^Q73
M4&R(R><0^6:X=U=G]5Q!6E/F0^K"O8914Y<!G*TQ9X&RY8L*E$U#V0Y0MGQ1
M@;*IEG(%#4A;OJA`VC2DE248''`@*I`VW>(=<+9\48&S,*`%RM:8LK):TPT2
MJ?<D)SJ<W\2(^9GG3ST:#S\Z8+X;:2:S./4P[*P=Z=?-JJ%5\4MX*F.[*H\9
M-<I)<`-6PI-6A5N)RMC1`T8"1L*C5CS-S\!&P$9XU*KXCH2UP@%6`E;"HU8E
M6$D?K`2L!*R$'5QDQ!;!2,!(>-2J^",0C,7Y8X7)Q<BVG8H`Y@/STP^B6/M2
M:M<_I#FOL6>UJ&0^5<^@FWP$2C3:"FL@5F6;`C)6C(Q26^VKP,7R104N0O89
MH%?.V6<,`S)M<2`JD/%4:?<U&`-R("IP\52"$2`/H@(3:?:9'(.O,`1L.K^4
MMJ'6]+QH4U)^1U^4=<F;.0JQ_W['&PK'OC=[&J.1_3S_)JCVM6^5/JF3VAGP
M)W;5?`[P&?@,?.8:8CZE!CX#GX'/I8L-?"X=8CZE!CX#GX'/I8L-?"X=8CZE
M!CX#GX'/I8M=-3Y#AGK(4-\,YU+&/EH#=E%P("K0-E62>L:I:>`L<)9'SGYB
M)**%+4)`Q`+[?`WVD_,@*M`VU?G#MB8`;3D0%6B;:N\FW)G`@:C`V71#58:C
MA;$J,+'(3E^NJ0.%Q/*06![2#]4@_9#2-B#7*=@)V,F^N)/&R),!5@)6PJ-6
MQ<^]&,NQD,:12XX`\[-)X]@6-;A]!.P$[&3O?$.'^0;8"=C)GMBA!A>^@96`
ME>R9;^@Z3#B`^AQH5<*$0]`8F_)JUT5`YOAZK)Q6+7V9WE8%AIU5V:2`BQ7C
MHLSR^,!$8&)Q`V]&#`?V6`&[CNUS^W5-&0I<K!@7M;:JPX$]#D0%+IY*(HS_
M.!`5F'CZ"7+&`[WR['1UH:8WM4#.^,)RQG^DB'_/&A]B%Y+&<R0U)*$J?WS%
M@7#`9[[!!CX#GX'/P&?@,Y]@`Y^!S\!GX#/PF4^P@<_`9^`S\!GXS"?8O/$9
MDL9#TOAF.)?"EQ8[]?080%F@+%`6*`N4!<H"98&R0-D&4-90X?HC#D0%TJ;*
M``2<Y4!4X&RZG/*,W&ZPW1V86%R7WZ_IP4C(*`\9Y2$Q40T2$QF0!A6,!(QD
M3WI'QO%),!(P$AZUXBDB"S8"-L*C5L5W)"+<2P)6`E:R)Z$4*UT%6`E8"8]:
M%9]>"(P$C`2,9-]24(Z9CR#E/%"?7^KK1I,ZB`/.8*0Q)TZ2T3?+$7"44XT[
MZX9U&V!^,YD/BS'`_&8R'U98@/B-)#XLFP#UFTK]MJ[`4!_(WTCRZ\!\8'XC
MF?])9HQX8-T"^%PQ/I-A3)]QDK!VSOSH\S%*A<_'1%_D>)G$P`M-)T(Y_6D8
MI4:^A^B"+&_VZ&#^G4]>LB;;*J.W!2F%^]EJ?%5R/\!_X/\J_]N&!O0'^C>4
M_I]86R6SGDQE8CPI)E/`Z`8R6C*(1V?<+@H>'?A?9_Z+<EOL2\!_X'\S^:_J
MC/M6@?Q`_CJ3_Y/,NE@=QO-`Z<I1FHQG%*5)X_G5]9%>2"^&_OBX&M3_H=.Y
M<*U+WWRB]T1T.DNYUR/_BP__Z,V"SI-I3D_>KYN^]/P'T\$/>#CS[=#&P0"_
MAE_IJL;/__U?"/UC6>#,G-JAZ5R\3K%KV5$2KBN7E/&Q]746WGCAGSB\,VT+
MV=;G5M*'NWW-Z`H?_[70D.!!!+C'H\^M$<&Q(PFBW!'TCB!V0H]^4CJ"UI&%
M>%%:>.;:\Y*_/IRWD(6']L1T@L^MCMSZ65)D01`^`$@J8B$HZ,)^%*0U%.0E
M"NM%]Z'0UR6.41#WHR"NH2"]HR"F04&7^YF@$(R_N!;]Y^+?,YNX%F*`P9?P
MS/3]-]M]^LUT9G@!08(GB1+2;OW-H..-UNB__O0^E17%B/,_@4QY*ZPD4/B#
MZ4H:A0U!T/E36$V@L/BNL)JJA:6^9/"GL99`XP\SUE(UL=S/2>$[[-N>17R`
MC\T`G^/YOPR]MQ<HL'OK**JH)`!CNZ"%8E)89]>1^_'>CE=(BNKY.K*L4)KD
M"8KGV,.W]U$D"XWU)[.UEI\7@^/SV[/!GW<7:!Q.''3WZ]?KJS/4ZO1ZO\MG
MO=[YX!S]\<O@^S4B***!;[H!&0-[KNGT>A<W+=0:A^'TI-=[>7GIOLA=SW_J
M#>Y[K[0ND19>_-D)5TIVK=!JH8^!^.HX?/'W0K2'T/3#]9$[BI>(1OX'S3\(
M?-AQ@JDY))[O<TN8?YZ:EK7\O)S\",+'K'F(:4+=%GKT?`O[]+'575K+Z5/H
M3;=MT?K]ZGSP"Y&MO]R'M&O7U-99XR"2_X;(?Y_'MJF-35)6=\\.J8)4H!3O
M1,">H/^;!:$]>IL+2,T%F:Z%AO0/_&$X3+F33AP9N]D2@;I%[%U(Q^:\6RRB
MNEPW=G"=+?\&49+$"HIE*IN6*VQ$ID]:;>SY88?`.4%C^VGLO"'')H_0!-W/
M.`@GT8/AV`RCITEG8MGD&>+@G[$?VK3=0V_.\Q<['*.)&2["$<@;D7(^QFA"
M>H,Q^>PC!P?DK2'Y'B.+)@8WA^1=9+;&MNB<0RJ).KDD/>@]`<RWAR&V6%4R
M.M9D%4!_NVDTJZ1?N(?BW5,)?6_.6Y8W>H11]GWO02KL='(?)C3W2K0;7O%Q
M%IYZA("Y]\0I??9:B\A:WCUW'E)3`A\K]<-'0_D?[;ALLZ@M_5C[S@+R%^F"
M`AH'IS=-^,19AO8SZ9>HKS&'U-G,N[HI*4M=@T6[H*$7A)M<SK0'2>;--SN6
M2\=[^05;3S@X?]?FRB5US2;SL,BE:?M12.0&A^^]2:I24112U/ND1Q!E6>Y*
MLJ9V1=50R$>5_**)1J(PYKXJV(']C>EL*AUBP#EF$-R.?C=]TNSAK7]/%Z<N
M7K$_M`-\1YH!O_\8+'X-Q#EXAY3L&J0CE=2^2-05E/[^.)G1$8VHD+"UV"I0
M_YIB_U_!F%!V%;*KF\O6SVIW#;)#)$\`V\UL\HC]V]''VM*9Z3C8^OIV80['
MZ\_NAC!-+;G!&<$8;.`H=&5U#XYIQ$^`Z>TL#$+BP,C`83=D*P^](Z(>ADB\
MV#Y$1!IQVTNN%0'STUE7#F+!9K%].BO242I[DXD]GR!1WTY$)(]@=TCG/I&V
MNW_?7#)Z#>P3UW;(*-&?X6-7D%XGCAN<D"H_;QF7$YW%WA_?KQ^&8SPQ.[9+
MM1N2=_:R5$])KU[B]:*\U3NW@Z'C!60X$0N&IBH"L[3,QYMYG[Z\N1U<(/VD
M<W;[_?O5X#OY\0%]N3E'9^2]5S??+F[.KBX>^(W'P5PXN^OM-J`WRYCX[ISE
M#L88C4A+."NA-HP>9H^!;=FF_[8(UD63G9E+&@)Y9%!I4H=%+("N=9E//L:1
M+VNCE[$]'"/\.K5)*<\EK>3;WBR(0G3D9UJU0_\,Z8OF#]ND$W`1<5EZ%UVY
MZ)^F.Z.OI1XM+HJ/AYB,XRU$?=Z\,AP$GH],Y'INQ\<C(F%$RZGY1B5:"K3X
M2"I8S-R"U=)3XFWLH3TUJ9^BPLQ_([J-B6=`]F3J>\]+#8G<YI1\\4JZ_Q`[
M;^CO?5'K1C`NWT(TLK`U&\Z#FN;_L_>FS8TCN;KP]Q-Q_P./IOJ&*T*21>VJ
M/MT1+MO5[7.J;-^R:WKZ_7*"(E,2IRE2P\7+_/H7R$QN$DGM%$GE+-V6Q`7(
M?(!$`DA@JN#2P0>+8(*)`P.M`-LN8YZEF;!G<)*\!;`(CXH\$JXS/`VWJ'`9
M$#E6#%R.)&=&8.\&CU.T%_J%?P_;XZK6U-3_C3M5N,*G"]BD0[A$$W!IA\Q+
MN'M>Q6J*>HB":GOE$H/D$5T+F^CU-9H39PG6[X5BOH?#ZU`1\4>R#J)($9X$
ML#H7(\<#8%+[<,JPA?*B`-.V@L9B`\4<)MG1MY^71&Y6QR%EC5FOP?)W"1U@
MWJZH<OMOSR0A^9U6'15-%X04E-@4XPASW=3GGB\::FBH\6E#1:.BG-'4R0QE
M2!4G"-W$,@SKU?F4ZOPI?_C.IV)[+U[$AMK`JLK)[.A%*WZLJY.>DDX\'(9!
M1IIWO+6$;&F#C+8;;7]L&T'P\D^BV!)A6VR4$@F$8XVA4NR>`VG$H4T)$PI`
M@!_;1:`T06V7.5<]NY9/900&%H[>[@)2U#,J!3J"DM\)DQ&CI=\?G)=T5GI!
M`_GL5T\^R]GX)W=1[H[.3)0W+IJ755BRE$(^6"?DYU5ALYP*HCC%.+D"Z73/
MJ87*`3J#99W)+I]>$>4SQ>GTK?2%7.]MTX#C;`ZGGS*S,=.76,RTQBR2ORY%
MD.:61\-RKB5]&+1;=>E#?S"D89\/G6%;FE@L:/!.%-M!SQY<ZCOVJ->[SH)L
M>`,FP=0Q(W)!5$R5,]XS`PS%<#<7+>?T.1ZMG&&(SW$\C+U)8\7\2YIZ"J8#
M$1J_FR@O,$$\WLH"10Z=,YB\80E&7^0&'"$W8%RXW(`(H&F$RY$<\D)LQ9#F
ME@MH?2$S707X;IL<H"\E!TB:9^-M3%O1H)P[LRUO.I.N%K9NL`R!:L;-BJ;(
MLD*E=6GB87F,DX1,"S=S"4._O)J+T.6N*G)3NTA$+D^]=:S*1J8<D<M]Y44$
M+JL6N)2[&:5.JRB<55[.1-RR.%3G+LE9#<"J*,CE#%L>0,1%U%)$+0^O/MI]
M$;3<)FA9*:VR3\RRHFJE0)N"XNF*WA;%M"NE+'9T#B=*74$]O+O&$=O=;AW^
M*?=8'%$>]*L?1Q21K"-$LM1"1;*N3`YS#&Q\Z-:'K1[^%=1U"@H#O2J.M#"P
M<(PFC=^7#Z"&U8'PAQE<AC[G:'F@NJ3:1--=B1[?PT=_CD5^G8J&L(0,'4&&
MCE">=`\9^D&#>0C\K\IKL"K<FJKEV0H[PXHR=6=J'E:K4@RLH`9KALI$[(;`
M<F`MV+%L>32$9>,"'U`+KH+'UC[2U2.\2POODA:V-;65.2\B.<=CS[C.Z!,=
M2WC9.H!.5^A=-(ZXH,>VJ1@KTA3/T)KX&*"+A2@Q#X.G7SQ</]%["+!-#VTC
M=U-:[0@O\18H^;W63_[U\.1_P@)'1>-OG='/#EM->>.`.L8P-8+'=&$"`CT2
M\!6\OHY1</*FSO`,<#"B_OEM>)=MO2L&/9<?G'AW%(.2#23@46[''Z'@>#ZG
M#T>J"3,P]0R%%2X+?XZ.N#0E)H;SC7>\ZT77UA`"`X&_7<]T,I&>5!TNT-EQ
M_LY/^&/W)SS'C%0Z,3)I]3QBO^@JQOJQ)I=_CE\!R*DS$_9NT_<H-P[5K3.@
MU9\*T-^Z(:&L^Q.A68:AV'A6^B^XA5Z&9^5MLL!V$M&SVI&YLL8PS>RP/Q`,
M7/*WA$S"(U2_*(N+_-":<:KK`7C\":#GMQ/9HW4,D#IE[!`\D>]?34>E#I9Q
M]%R_37CA4BE:Y,@_W<_YY`/PJAN&-`80>&/$'Y*OHZ[%@@I85U6R,1X/#P0Z
M^43);58U5?IZ!SL0E`I#5Q5>;94-7[CZ4<$"FA8>#)$#ZQORCD^9Z#:\8HQS
M@H57-1@SH(PHB&8L0:?!4]`^;$I?:.R>3YTT\8!@G(T`20$WM!H$)H(X."`3
MS\:/L&PJ8ZQ%\4Y1&,Q(15?-HB5^//.,FR7SWD7'0J`/QZY"U5J0`$)W#DM%
M,>`VN=UK9C\Q%#@45Z:Y5=6F&7/134FOTXSDI$0?DRC?$=$-X02:EF]+\)$K
M^HRN`/X[D?K6H(V2ZOIU-[C\A.*&6LR!56>,U(YA>3E<#<BMJD.M%J.RS"<7
M?GA4[`?[R<4)HH4.'XG]A-7+@@I4:ZX[;#>:C%*$<"W\1XX/P!KBCLGU`5O2
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MM,POS3N8&-9KD$,0Z3:DAVUJZ&V>:1.87'1^)3U+>5%T=K`2IY%&I^:*_1?A
M2CSH.;)5(LX>J4Y1,(;I@GFM*Z-![`#DGIF/_6Z1LHVWS-DL#N'9J8^I/'2Z
MT?..<BM[M<\I`9?92NN.HBZGR.V>E5N=K$LAC<4@?$=I3#I]7&QA_!$LG#M;
M:+G33%?X\I`+]D=H;)2'[-`J.E?%+/28T&-"CT7U6+`G*P_5,]K@5*@PH<**
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MFA>F,))V&RL5NJ.M*YK5GV&S^G9]U-FB4TSIF]4+^`OX[VB9"NP+[%<*^_51
M5IIAY>"_:>68W6LU;U2":KG*E8GG96R:MO===_ZZIDU#\"]>V"KU=U'+:M4H
M%[6L\JEEM3A%+:L$%E++6\7DAC;X8<UX;!"<3-)+5U\J?WQS('/YV@_NHQ2X
M9]._4BYKDX7AD&!=7Z\K%9E?=!,VZ=@4)UK>B9:46E@N-E&A);&"QAZ1$E2N
MA2H^Q+6S!&S\U<$>+`M;AU<LZ(.BS:WH'U@\ZP5;=;@.UKNR;+>!E:V"WA]U
MR;#,Z?)WV.K`UE5,8`J:A.`C-ZPP)41,B%AN(H9EV^;*/RT;B\3Q3C,)S4'2
MI(*U\`D%@U596Q8)VB:*U93#6O>FWT(G*M7P;DJ'-%;,OV@]NSO'5HC1E'[S
M:]_5><NAX+%SY1T;^X!4$S+'[D<+6,`T,J<]44R-]<JAIS[&6&)JKIM8<)7*
MOQ"[`HE=FB%7;;'SERHF&`ZMDNAX]L+PN,#IO+[&^D4$+YW$%DO=Y94:\9Z9
MXDCP"L7O3S7U=(T@0]AU+=+Q+5GX[X)BD-)UV(2-UFJD)24M"4:,V.&1*DZG
MZQ,'5\P5W<0.2)*C3`AH&JHG=-`C6D3O1*I."O$4XED0\<0*IRA&$7B"]6F[
M$\O0+=^,1$%`Z]&RX2>L83JV3`VD*^R@Z'_C8/U[)I:ZJ9$WB;?A,\&@72JC
MBFVSZ#V^#+/V>+0U%W8#HZ2Q)GG1@JVLX9]-5'PW$RXR1[)LK,RJ4KE'A<$T
M"8+`(UCAE4LL0)S5K06><,U5@AYBX5PE-A.#1=;0R0MA=/):JXKC6*"4<-VG
M)7!I*=@(L6@9A.0AHZ8EZ?`\W::CAH^A_661GZE)"[KR6K9(0%/ZW7J%=]IQ
M2E28+K\Q(SP/B/!L6H:7EZ-E/0'Y$,4&Q9V1I8&9+--\&-VTL^LLU<FUXBVC
MX7EZ87(=^/0+A+^LZKI[7]5Y6!_9$?I>[\1"ZH+PR+P$O#^K&A4=8:D4'^W5
MME1"..(9NF`;X&`K1+;*^NTXJ0'A%[`'(#\:L)3"IGR.S[&5!8%-@XH6O]ID
M%@I<%G9RQQ:],$>J[V*+='"G5_.<&@=LE1?<<A,3>T/#KIL21C?G,<DY]4*:
MNORMK*1T>V.9#Y-(%R?V-7`F^\MI]E5T86SWAF"TR*WN</>E->D9:_LO]N3!
MJ!5K,;:&W".-P2"9_FT;!^TR!OUANRUW"C`$\L9#D-59:)<AZ+;Z@V$!AH!+
M0O\`DK#\C+4HZ"WU6#K)"(P&R=2GR,$P!H)AH\.>L-L(=);[:!UB!%B#T$SV
M^24GU8-RMS_J#;MKN>>T'ISU$ZJ_+CQE-#H=YZ?3>G)_V&V?;LY/J.PZ?5`3
MIV+\E#JNW6_OCG7'?9A\)R_$#!I71K[)L:VC+"\IZ@@96]*<6Z/&]G*3[SUH
MSJOU8GOS<8:MES4G]I7V0G<ZU^Q,+:,^^;<#-KI.(KT[B-.>3,0AN#A43^L$
M+CJCSO9<W)`)@:^U[_`+<X)&^4C]];CS,1S%&$FEXE"L''%2]F6%BL^5ING,
M01#G)/YCCCH5K?\4ON(T9;*5/#W1GXX+L\X@;7*B-.S/PC%E?G\6[BU33><B
M_/7(*GBXI(-3Z3@4,\><E7:[OP\SS\K;E>,0U_G-QL!=E)/X3T>>$UC1VXE\
MQ*G8GXDCSH7<&[9Z^S.!M3\268`?RM!+?EN&"M]3?H7NAP6Q:2[-5YC-:\6V
MWR>6_:K8FG,#5I#CZFHRO^OO.ZZ4#4:]-?A<3^$IA^:(LCN06\EZ-(^A^6+9
M1)^:VXX,O^VXF)';0SG9`-N<PM,-S#'-[5ZW<]QQ@3_\[V[?%L1TR'?B$/N%
M.%>F=J6JM@?$)(_-1K<>>4GO)%M9V]%X^B$ZJL&P1N<<8HC^KA@>C9E>&8;U
M2I.J$L=C];J3FWRK)!V3U]-:AAOPBOW9/Q,3_G`?#<5D]X$JP0_\>V=U5[+=
M7<>=\U%+7AZ%[<@[U9@<$1NC563L-R8+FV`")^9U,W;#+_+TA8]6I#ND8RN2
M<W.%RZW.\HJ^*\EY><*[G67PI%-LZR_P_0MA</JJL\1D'=82]XNBVZB`2+A5
MV_!JJ@':<J??;+>Z'?A'IXU_<=*WWYRF/NHH^[IC#4EWOR&):Y)J#`E%22^1
MC\U@D7QOEG`TAMUE%;0AO;GB9(M!60'&]H,R6E9Q!1L2BI/!X;1)\J-*)3K=
M_89D!305&))VLS,`%@:@&4>#45/NR_"/3@_X@5WY1M#(O#\[@EML`>IFL[8]
M8K88J1*@ICVDO+1A2[8;;+(>D+T:K01H"XB<+.YV@<[FHU4"['`YZ"`?R,+&
MYDO:K=G^L^*C98L!2=$I6PQ(\2V7H_E-RF#)'L]!<N!YOPN+6/RFZ"8ZY[\'
M9U7O3-J1-*'@V>UD0E2\_]&R<7N].DJ'>S!UMLB#(0R6W.F`J=;I]YIR;]1E
MZA,5Z?:NFW7/R_0S#%/FX'`\;S!=]Y9[0QQ]2L\G73F_$VVJF],$$C+G9ING
MY.@P:PS3<+XC[04=T/S<>=WEN&5%!S0O9V.C(R^'](XTHA&='D][2[_@R&FB
MJ;;[*B6'9:H$V3$^_4Y2U8+TGT7-@M5CQZ+&9SXU/M?4!#E]C<]0;);J1'$E
M>NPB!EL>=\^WYL$QB$;@[DMUM!:0A\5T>+X/56RVHO**8-:"9=@[6!6&3+'B
MUD5-"R<\,LVUCUCO<J[8NO'.RG*9RI1(Y&UA.1Y6XK'P'31'BD6#U?=X2:*@
M>`!<)H7OX&7&V-HLC14'>_>:TM73M324>W4IJK;II7P9KP&E_*+:QZ9_O61C
MA4&;%Q**5/0,:@!)BF%(R2QBO2*BT^9V"MW086DC(UP*D2Y\+"]6(#DS`K:3
MXDH3V.NQFC^,9<XJ,H3,JC/%G(8U@L*KI0N]29IU:0IV"'L9K7ST$>LKI)"H
MD046=D)27F>$TJJ[M,(3+9J@!?8.':M_>0"7B4Z+*4D+T/GX9"48;5:(#0`P
MTQ?T^HEGXR/K/J?N^X*6,4JZH2E]`8K=F47+*B822TLF89FF1++>D2C_R9';
MXO68Y@#T\'[ZT^H]=0X<6B@"+PE@.29X)=Y!-%J02HF./_V^SDKE30SKU?\"
M&&.C1-B`F6@CAS6\8"*5`.T6RZU+JDE1F-(L1553=ZQZ7PI\YBA>['=8>72_
MQK0_,[14)TRQ8T7P5><20JNJ,2R86)R,^)4"_2E/E4FXCM9%BZHH6O.+JX8Q
M7C)Q4/*IW#(2V?-H,<78HX)7:ERGU*,:A2)MHMMS[*8YUUU?;&S+F\XDHM@F
M\,&NBA0Q@Y>DM^#D-=PB[]6Q2(ON+#T!+PC*O""E`8Z919+9/R"IRDU:@X!G
M6IZ1^&X66@`OF,EPD*,E8Y/&<FL&A"1N1772E*^AY_G/KT"0[L(;U)3*1]>H
M6;^@9L5EFS@Q:,3M`[K'H%/+3(DE<P5K%C*QCT@=+<>-4_]"R_Q&I7KB4:D/
M53MNXV`-?`]J!L/?M@4WH1ZA"QN\G+#<5EQG3<LO/P1/0]Y946%=>IJ1OX@!
MEM+]W=/'.`]SHN"JHR7H%)=56^+<X`I"*R520X*6-Z063+LE7:@&:`I<M5%E
M2`9Y(8;4YB]"WGU#P==O*:*UM*BA`%$E2LN5VP2O96]0J!ZQ3"Y&0)<W]]AP
M9*@96KW9&SM@;\&-])$1PNDD6G[6>3BLOMPJ\`2_F[#-_Z*_OLYTT+UX3>;T
MH-X/U8&O()?>7XL6@4>BZ[B0U^J2'M/+D6)4H-SQ.@<K0([I)A<&Q+1@7%0T
M:H$5L#1AGF/3H$Q<$MH+,,RF10M9T_*0X;H$CU;`%$=S+79-]%7!:_#A[$*?
M=>"'%A+=?+8W5I>2/I\3#2MM&F"S7P5%.Z7D6ITS14N03WC%PE!4$@HJE\#,
M>431NGNB+&`QX3?88"`5TH=V'62ASB0C+DC+%W:99*")YIDV`66$'+,9RA`0
M5@]\:=A8O=`/[4[X3/J@X+%8ACAE$'EI47SA.Y8,!R,$;E@:1]B9>`;;&*`Z
MHDIA:>:BM='JD<4D^$N9X^:"0R(^&-TA(WQU>OA0K)9HYK.$LY`Y4]0$`@/&
M!:2.WZ4;HI+Y&.#+2JD^F#%..W'$:#HM4LN*NX4T96U6ED8E<T6/+8;=SB!F
MH?#U-7W5&]O29:Y.B0(OUQBTE&C4<N_U.CJYSLJ>*[*>+WL-Z*+.O`3QZKG+
M:S*_@6[,Z3H%VTV&\A_-IR9O%)#C^OP;W<6S-@:T@#&3.2?ZW/BZA:])7:04
M7!_8JY$VMN>@JL.OCVQJON>`D>_+;,3NW\,4/@A,2VD+W]%BDR9A)D$P`W$'
MP/7O5Q*K("1=.`04J.422=8^8LEM27E1=`,7]0;`N.$H!DDHOO^^#.C_`4F`
MF_^PS+CZC$F:LB)KR:9QHEB!$>*^HI\(KPA?YW>\6!4<T-HTM!#VNF%@`_,B
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MM=%J=MLAMVLH/`++1\NERF*Y,SPIR\?*=LIDN7L@EI,R9-9<(])D1)K,J=)D
MUE3\/WV:#.81HB.;V9VBLT=Q.GN<7V=.NA!0FTK#I0!W(VC=&3&(2G0//U_0
M!2_(NT$K[I5@8WNT$3&L!F:LZ5%7+T;&V::*-K*9@TG+>I))EN=B3B:-NG-S
MD"CJC-J#3>G*,&)7\'L68?L/SV_P&>E_RZ["=3'6%>2-MB/1HOYS0_586HIO
M#&M\&0\8]HFE?/N!&`P8TDA_I!DB_J[`1J\1#!SZ(2DO_-E^K`IV>@ZB4SMI
M*Y(U*_:2">#'0=C)AV?E[3ML-Z[9!AF>\A#9MJ,UL/'EQ[)X%U[<!`*C(9+Y
MO#E]N0W#<:S@\@W#42SC/(<!3P[!5M=@]4NNW"]$PPP#,`A=S[7L]]C%&>.S
MU7.H+'0Z@(1NISO:79@2'I$ZB+"KP#+YZ\9Q*SX*/,"#Q-'95DS%`*</L+SI
M`&<I`#'`V2JB+^^M(E8>D3W`G;,9X$'BZ&RO(L0`9ZF(C08X6T44:H#G"\-Z
M)_`(&H)/.6"W]JKC'AWL+A6,64O.L7@\9A7Z7N<0/#X1^T57B>]6)1J&88CI
M4&3<6WR[>D5+Z#Y;KF)$?\<N,/>6^R=QOT<"*)&Q.?C36;6J7J\S:';Z@ZW0
MDW!7=F7"I-$].$/5F95NKS_<>E)6;\JN`[741J+LT_)(?2Q?+)M_A=?)QYVK
MQ%?R!FR98K59_[7E1_SZV/F6PWPE<G6.DY@MA9O,X<H3?GUL_UF,*0Q*S;`R
M-%=F=)G[QO,&'LSOA">7PP5`B>U_1&^Q\XRNR7@T\/"/%0'$[`"BC7[W7..'
MH\%/T9!*0A3E\>KFYN[^M\;GA^?GAV^?I/;BK19$7L:6ZUKSX&GMX4]!RE+F
M^;'L.-PFD9;@>-EJJ&47RN6#$)X0+SP0+Y\?OM_<?@]8&1L*""DP)-%&Y*EL
M=;H_H8PA$DP,K64'>I/RQHX7YUV-G*<%)V.I1&OB;!F3SQ]_]?7NM_M/DD$F
M;A8<)--ZM97%+S7V[V+#0T"]@E#O"*@GAE'%,E6PR=E;=N565';;Y13=KS2;
M5A9"*S!><8RW!<8%QBN.<6%\"8Q7'>/"5A$8KSK&A:TB,%YUC`M;)<U1)(VG
M,,66_4OM;ZI*R&22=$YD>01V/:>TSMUT8'1M3F2,MV0@?5NI3J&3[,J^,'X9
M0.&_A`&M8OC:]CT0MHVPX.L_Y$,*&^8T6D:,EG:KWNNTT@DZL2+8=X8%&,L$
MQE&]VY$%%D]/Z@X#7ARJ<X=M0T#V]*0*]?ESO]Z1A?HL`*D"BS\/ZK(P*XM`
MJEC*Q5*>ZO]XG>FN_ZCMG4+GZ!+YLEP),;E+Q>Z^MTQ8%52Y9#M;MU_(RL%5
MD913$9VXIXE*"!DI$E>YR\C%L-L^GCUQ%#'[*+`OL"_6![$^"!D1,B)D1,C(
MJ65DU!%"(H1$"(E82-:X#S/2IY;'H"L<B(PT6MYA1_=@MT(:"7B1-,L;&^2P
MPKMGH"Q76@^2H;61I)5)VPC\"_Q'\#^L]X8C`7\!__.$_Q9VIH"^@'Z5H+\F
MGTW`7\"_RO`?U-OM+3QQ`OX"_E6"_SD9/D?N!W3XFITII49O=$<U+'R<DU(U
M-.D*40"47[4Y_)+;@&UP8O;^X?E6ZGYJ2%^N[KY+?[_Z^N-6>O@B?;F[O[J_
MOKOZ*MW=/SU___'M]O[Y:16SA>D]YU,AZJ06)!IV`,(WA;`H'NF*.JFB[H6`
MNJB3*NJD"MFM4LT:47M,8+SJ&!>UQP3&JXYQ87P)C%<=X\)6$1BO.L:%K2(P
M7G6,"UM%U$G=,Z=?U$G-.UVA<%GX9<X^$&`L&1A%G=1B8;&<1RJ+E-$E(%OB
MR2^;^A1U4@46BX)%42>U6%@42_DY+^6B3JJHDYKW@1!1FD649A'EBX2,B#JI
MHDZJP+Y8'\3Z(&1$R(B0$2$C19<142=5"(D0$K&0K'4?BCJIHDZJJ!=SX@RM
MRA6-$?@7^!=U4@7\!?RWM#,%]`7TJP1]42=5P/^,X2_JI`KXGS'\S\GPV;1.
M:H9/*]';A/>,;>ER[=.J5&^R.RJ/XSK=E=F/'D3N'L.M2;\0)1K%D?L3([T=
M17J__$@7!^^/5*&Q$HI=[ATE1G5\B']6#,54B?0T(\25@$@%RX/OCO5STW.5
M*"V"]>XE6O!>*#D!\\K"_-"Z3D!>0+[@D!>:?:WY6HBZ4;X17.0<IYO@3*0C
M:<0!-A27:)+B2*KBS*2)8;U*,Z)-MSHRF:\]O6X\Y&9_._EZ<&?$YL=&71@*
M;%BT*\O%=7D7R*.=?Z)6-YV8,CNG,X%8`.)V&.+B4%VDL$IE0>IK2\I4`2@5
MRK*J,-RZT$9>YF)!9;-7:.J*:V>5<[';6DL4C^RR*:2B&V];N%0$&*H.!J'<
MBCW81<.S<,_M[9XS+7?)12<<<U5TS)53I^;OP\M(N"ZSIBSZRG^ZR-J!PVB[
M:!.!+Z$%"Z4%LPK`E!FEPCLGO'-"S8@-;&$4DE@V!9X%G@L]Q,6D6N"YJ`[&
MDW1.*)O7,>YQG&#JZ0NFGF[O?-PE"[F4CDE#5\:ZL5$'SMTRLXMJ3(MZECD5
MSL^JLE7QPOG%P44YT7QT>(B2K-6#NE#LI\ZTK)Q4"`>O</"*55HX$`JCD(1#
M3.#Y;/!<T&,V`MP%'>RB@;LL;2[*X.T]6IN+8IBLNU!>7'-6%"K=SW.:9\O1
M@]0ZW<)SN@;2Q0%Q.9?YM=-;HK6_<F5Y]U;T!;.$A9X_5E9LY:"_:47J_VPT
M;DWMBZU,,5S?:/ATQ\T^_N&_+CVG,564Q2>L-D6+3=WHCFI8CF<3YYF\N9_1
M<OWU__R')/W7RJ6_8VZ`<^4&7]P35](U&)>L*YK#0;LI#X;=7E/N=#K-=J</
M?_5&7?C8@U_Z\@B/&)@8E_].)K_4%*=A31I8L;C1ZC<Z+?J`UMI'>*;.[O_Q
M=%.3-*+J<\5P?JDU.K5?&\/AJ-5J);"?1'$*^_#+%1XG^,H3`=[CO*_\3.EN
MRYU^L]WJ`M&M3AO_:@$OK8TX3KTWB]5VJ]=I)?.Z0N'A&.UNR6@G8+2[*Z/]
MCBSGSB>=T-X>$YI\;Q:?PUX:=H\]GUOPN3*?V_,Y:+<[IYG/02*M;X[^R=2-
M7VJN[9%-IS?Y47&VW^:&Z7R"Q_]2F[GNXM/EY>OK:_.UT[3LZ66[U9(O__'M
MZY,Z(W.E@8E86`BS)ET>>')W9WIEKO-G^F'R13?A$ETQ[L)4M4?+T-4E_K.N
M;`[[HV8K_&^<WPFLXIS=0:,E-UPK-N/Q6^'F7_EJ?/-P_?SGXZTT<^>&]/CC
M\]>[:ZG6N+S\HW-]>7GS?"/]X_?G;U\EN=F2GFW%='2L;*H8EY>W]S4I87">
MOU^^X;-DO)G_V7`C=S8U5ZM)X<J_U&'"_QI(>W(5VXV;"LLNK-7LN(C7[?B-
M*$"C@RDVMFR-V/A]U!WHVVZNM4CR!/YQ=_/\.Q`S7+C9SKD=S57ZQ0X50)/=
M<W9SC6\N)Q:B\_U/SW'UR3LC\$N8$VI-I(DO1!NGAAZ@H\K6)T,Y`VECOF1Z
M)\A)OC#G>.9BMA_J1RFHSZ;_F=)_#_1_WWS+<DC,KA"P0F\J0)]G1%(5VWZ'
ML964N>4!(A&J+GQ_;<T7BOE."?];9_2SDPS@.GQ0#0]GAQ5&54R-_4'^Y>DP
M\NPB9V;9;@/F:$XO@)V2:^LJYDZ/%?,O,&,6%NABN!"TLD:DA?).$8376C2%
M6%%51E[T)_@2UE@MFE=<EY3%PK;>P"IR230K>TQ4Q7,(9P^^GA*3V(IAO#/B
M)$H<W.79]$'9RD6(IA#-HXLF%T%I3A3J7)!`0N!%+R`\5/;@;P"L_1?A<TI4
MCETJ'%IP5B$JKY+B1J7",^$RZ>KI6AJV6W6I%E;0EKZQM_*[X($1-T=-NJCQ
MFVH?F]&%3L=K)?*FN]("))S40=87<`<\!54$:A:F:.!/(.75\@S0`02N4@F0
MJDFN!8P8!CZ%5AZ0+!MD7J<_4)-M@MH@$/EW'`2XEJ(+9)E>HJAHUL%CW5="
M_#&"I]BNKNHPI*[3E*X<R?'463TZ&D@\O[HQ5AR@9AX.`B,8=`6G6".H,6#2
M48?AM1:EV)LO\.4.NSSAU9QGU$5`.@X2U;X1=B/<43H5?`'0-H'?P+QV=)Q:
MN`?IC[ZR[D^D!`@!2.C.#+$`E-B$-``8P0D5^%.QU=E[77J=Z?`0H,)"Z/R;
M.'2*='/A`:4>L@5$XE=X)^T@`&/BSBS-,JPI0@TQ2`<)*0K'\I-0GT)]GDY]
M)KJ=UQ?5_TI>B"')4B/N6/Y_GH6F"E5HCG3AF8J&;R/:1ZI]5*IDF:@S*04)
M!7VG@JG$JJ>@5$>,%*8;(E866$SX''@Z5=#X2U3S:&#+9`^O$"@A4,45J/:R
M0-VQ]869]B`,IO2OF(BQ/05\?M7=&8B8+Y=4;A0;K/BQ0^P7"AV4-VI6^,MG
ML'C6):+3-V@ZF!<N6`<HFJ;_J?DSFC5"K(18E52L.LMB]<.,R`6WX=+%0^QP
M!?1/O,.-GIKW]R0PK(X%^\%_>;I-V&X2;"G8Z,$&<*Z\Z7/8I5!$<V_.*N1Q
MLPH;LY4KO03Q>)V1Y`U,,[8%5\$"F\(6Z=^P)A$%=DSP.-R-1QB81_?+L&99
MIN]L<@C;@DD&BBWUL`7<'D8(]\U@R`KQ+,6/+)O`7%[3$_WJ^W.XW?Y-T<VO
MEN-\)J!RR+/RQJ)(FU]_V%A29J"TVQK$XZ2;4YGC<`Q:ZX>C'1N.,*[8VFHX
M1J48#GG]<,BQX6@'PR%O,QR-T?#8P^%<F1K]:%"?"A>U('MHS>"LN5L$9:MB
M%>P6B%V_*!\V$#L^?"!V)Q;2`[&>J3),\5(TZKL?YGKRQHZNZ8K]+JSAXN#^
M/*WA"!;#J*L--J/IH2%L$QZSI"6G:(0GB$"`O?FC^=24;BS#4&Q'NJAI["\,
MS]R9$DX:2D!=FEN.ZX.?1W3![EV5AI`":X'OI#&-F>)(8Q92T6CX@K\E9BQ'
M;H5!4*;,ASDFADY>HKY/=B\&7?#3PH85V'Y?$5`":Y<UUU78!;SHMF72A\&;
M6>`B3C0GE5!Z/*>>\/[P]9--E()/':.U*5VI*N`:1LQXQZ$TB8L7!<'I.=@#
MKN+/"'\L.GPCGJX(ZSBEN&.@&P>\!;8X?$298QE?1ILXHQ^,17<Z-$S'3`/)
MMPVD;XH+6'!J0*%AQ()@4R"';8D,,%2`%%S_*1'!F^GX`.L!/V/>.MJAK:-U
ME\P=3NO$(#1JSX-"C@NC[=\>P8D2SQ90K3E!UP-Y6Q#3H4%ZA\7I8=;A":?=
M!.UJ9L5M/=\4?###(G&1O=0]<1]M&%UF]VYZ<8Y;HL8@GO*\*8FYC$)N.Z%V
M1R[P*.2V`9*[O8,.PY-BD(?)HXTJPGU_!.WBWO[+TQ=,F<<&(>O2/,5AF#8"
M600>G?]E0<A(-MY3+@Z2;7R,$<A/"/8'`$LQ@V7D2D.')`@,%9U;M@XROK.O
MR1'RP_Z@'V<YF[0C\)J;GN_UNZ-3\YH7D/N]_G`/7FT`/8!]HG,Y#3_GB,W.
M,@LA%5N0FQN\^KW1(<C-#2&CWH;D>@K8PRXA#V/8PS*KF!G.[C7/(V;)@Y27
M#2^F1W\ZK=:PV6WWY61V4XX+)=R5B:+A$HHVI#`^"'>PR]5MU/8/]HWN+"Q'
M,1XF7RUS^A4S&.E9H42'[BXW"E_NJA-&'+#)YX#-7T4_8!,*%/H?#!"DAD&3
MB#?H628\NH6(9%3;H[OJ$5T!*7>LO>CD%;ZCR:,AJE.<@)T^.@']'4A=HGL0
MZN,+-B*U.DUM("_$EM"#S')0U9EB3EG2MJK;JC=G^S:'9L5ACD/H'ETZ%X0"
M%N2HSY5WVG25Y>U;\`Z$9%/Z[G]@F?EX"^/1M?#:&3&8XYKEE3M2X/D<OTL*
M+&S`N*T[ENG[81-H"%*9Z$.9']>%9^!)!MVA;EC"#R!-#.O5H3Y'ZK)D-(0>
M='AG^+"F=#<)\NG]6?%S[8.;V<P0K<Z2Y,-Y8C_C6$Q-FB.RQ%SDV`-\"EW7
MV0R2-Y40C3F@)[&SA%'";UCF"J[[=?QGAPXQ&H-UF*0HE=P!3!WX+$-YHA/M
MI,[774RB)6N,>I>?E;?P>,J2U95Q@;"NUJ]R>8:6-RC*=__P?`NO^M1XOOK'
M[9/T<"_=W5\_?+L5"_=1%N[VX$@I"'O8I5>GR#=(7^>5-\E07FE`"_04G6.^
M--$5S=2)<_334(D#A?>,;>DR]6G51&:N)F5>&3M[B(M<*'%Y-,!><5PR1P/9
M5A;$<W75D6"5;M)@N_(&)A,[EDHS&EPN7@?+5A>@/P?0MPL*^J^NMH+S.\=6
MB*$?'NK"_JFD_?.Y4-A&^P?WHHY#<P%.9.ID(O!`6YO8E"$P]I6;>-(?S:Y#
MMTI0"P%SJ`RJ%B(#+#DZ.H-8+0C5LA<6R[KZ69I9K^COJ0?N`?^.U;0V=&]H
MA,S#E\QLRYO.I':K-5J%UZ:ZY!"#(I1)KLKDNG#*A&9P)NRFN#/U4T-LI@Z/
MS&&STRU$UG4);,O2;*@J5H3E&,MXMW>89=Q-45P9LU.7%*#S1=$P]!$LXW4>
M>F!?$.EB85M3&Y9RL`@^,EN`!6CHKWBJ=8'OZ?1^JF/`@)=BHXG9[&J:^:UR
M.T+'*$Y0]H<1K)$%,6GYHB"EFU5QX]65V+59^W;5,C5/=5F!JK$'!@K0N[L5
M<8@YJ;(5(71U6?T`<8/_Z.KYZ(HQ*U!34%V>V?!)>>.U`=B)E4G@F@D\^>B[
M<;SQ/XE*H[X)^KC=^PFU)@O`AO'8?C/XOKN5:MS-&LTIFG>073",X6=BD@FN
M'C^H1PS'\ZOR2M,A;F$R/-L_Q@4#?*TL=!?6L[NP$N(>:TWGZ%O6HGH?@K-L
M_@9KFQ&O2_*H-Y(N\+Y:_`9X3.UC/>$@':WC8;!LBA?%UBV/^D&EL3_YFD=M
MIAI#@TKON\4%<P&F!ZE1VP3NF=*D3?H8O(L$5]!S9?H<[*\P[6*%-G96$:XW
ML2"C$;X=;GC1;3?,L%BY%4VS5:5='.?((87^Z?G/K_`-SKNN'DGJ@Z%G-8'!
MAL19]2WIW4?ZC(7ZP93^VS/>I0%=>UHK8H@^QL"_J,!JB.=&::86'L<$`Y2+
M]'</+)]I[6-X7-1?"G'BKCQWA@5#WYNK6H3=N?SB2`H<>5M@ZHJ%Q4]A:Z/,
M_6(Z"YK&]JI$))QO2#SJPU32-8,7+!NU*P.^-EGAVV=;4?^J<9;:K=9`>F2O
MQ&/12]Y7=68YK%S0.U%LB5ZML.0K@J=>D6#Z"]<.T<=EKC])T-QHD9?R6N4/
MCL)P%8^.4M+<+./$WYHB"G#;R@\;PTY9X8>U'UFMVG?I_\,*2[7/-987"5OD
MA6^41>>PSJ-M`#LR7[C^R>6);CNNY.AO],K`1<XUDK0@\!:6K)AB[7%MY5M]
M<NNG!EI^$UJ_E]^.AZ)-NJ1-8"'A;_(+LMD$3XNCX"R]]()MR.G:RXBE=:-H
M#P%^[CM2!/JCP%Z"!H11[S/K>]40,6$4YURY)"HUE@0+$X+*DJH%,XHIN4V/
MKYM+:H$#+]1N7*LEJZQ`]_FZ"9X:ZB8QI:GJ)!RG#54''=\'6G\A68=D*A#<
MQ`5%RM/4B/MJ'5F-3%!CPJT$F_P)19(+ZKY8AF&]^E7KB:FHKK\ANH(_-/KA
MWFI*_98/FMB.`=G;H;9G6G=#V'_4$44.^9?'<\ZO0)48DHR*KM6K1YP4K]26
MB>NG</<U(W.\6TE33=SB8@<3:!E&K8X9ZE@G!N4(VW1@+<:_");+QT*+WESZ
MEP>C.J')["&HT,B"Y1?]PS15.5;6,;S,ER9%A5]94C..,JA(="LC]'E&/,_0
MAW>K,Q@O#&2#:!'_T(.O`>8PL2BOF%Z/6T'+<_U*PJP0(Q4@9@%FTA_P3X4-
M2*!-#+P%RB8U5H&Y^[NG<,HZK5:]!?^78#K_8EO4Z#)S_7B7=*8#+YEZND80
M!($2B:8%*7QMPL8DV!(`R6$4!.L-4X?9[/!J-C/0(LSJWY9X&'L:(`"=-K9>
M<,.-;5A,__Q"V//%O[D6(034$OJ_03QJ/H^Q$PTK\]U$5;\$@:`$-#U$PC?Y
M;"C&,,V8/V&]FNPG':<=>TE@15'``S]D`TRLOJHT+KFC9*$DSM)FDT2[9B`B
M45MNMVG?;QP3!N+$)T/[K9^B\9R$2$EB1^#VXDUR+$/74IOK=D<_90=6DJ!T
MO..BJ\.<A:T`/B%T=A:/(O#$83^F-3_C-G^I^;J`Q8"V<P&5B2?A/ZZ+_D7#
ME3Y2VT5JYKZIM$49*+6H(0585<VRW;*C,3B(ZIM@I>8FQ&[$&ANC%5IJMKB1
MYVOX4O.R8MAL')V/K_192N7$:K&X"KNH@Q:?9FD\52W#LG^I_4U5"9E,DK)T
M5@^R[I:^DN?J=-`3NC]H0EIL9REW6^4U)HHV#YNK-+G]TQ9*+$3WZTQWB<!V
MTNGS)51+C?A7O98`^@F`/M@-YT*+IR/]&]O<*J8`>`$`WML<X+D>>BFR3Y-G
M<49<FS1B%LT["M-&E$AF@HN9";ZOW%W)"56DVC@2.&%1E_<:V[%BR'A.7)A.
M&PO!AZ$/ZB2-]@Q.2$\[1L0('?0L*J([K"<T1C,PJ8>&8#0/.[$K1B2+CL5%
MCDR8A,%6K#_$1_E]P0(?L;@%'7$6C(]G#VX\B6/+G:%/RP_NLBI6B6RS9O,X
MO3/+)0:MGV43C"(P.C+'S.]8Z2P'RH+V#4$>E;_/Q';1M(G#"S&LA1]9=*R)
M^XKA#7Z9GQL7?4J$`NRLC7W$5AY%F]*R9K,+8O.,!Q95]F._<"^M`B5=T"`.
MS?\*@?D[433?YQ\M$\M"<W<A"=^C)-R$)(AX\G*^[7+L+#5#+I8TY5?S"KYX
M)=@)9,L,N7I:W/'H"BA9/`/II7*ZU%B#2UQ,6^$#4N+52RGY,Q)/+(VHX.CX
M"WC&";^+:<F5)$W0(Y[M>`K//#A5`D1"=HV#-<V"OMF&PA-:5Q,W$0QAT@Y+
MVHKT>(3/IK.\WJ-2U#4J:/`"D$*6>S-3`,,8:UZ@KU#C9_(9<5/=-",]=59I
M0#4<.5!BQA6W313I"O:5<I>_:]-GLW5[:7#\)*'U>H9&RF':=9OP<RI#Z2)@
M>%,B&O2A'YO;DQ+5<#3A*DI+N[,#+5*#/E8L1,N2C@L%T(>K/RU5J>':KH\]
ME^?*X&"&J6X+6@B<-^U)6KD8=,:$"@RV%_:[<B\=CHJ?C*49W^S1ZS5\)`$S
MUON)2RFF_*'X8J+21<*9++G5P'-9=6F[C#BF,4#;T>5R!AJ+9H/Q`PKTP;V?
MI`MLJFR]8N$-MM9A/DR$5;C<!:%VWP405RTBQ$GRI!=IP5$<78UDL2'1[!"%
MGQVXLAG1G>@VDL,QLE_`.J-,Y&@A6S_'*NAV-K6M5Y?9U)A?0]<+`AL@M)TF
M8-P#!;X^G6*U?DD#.8#!5OV-`VW[1D\9X_/Q=N/=M_JB*7GU/(81B"*."OP"
MM_[)+Q[7915J;#)5V"F2Q.U5=GK6^4I.\F!16Y]VJ4;=0Y6FQHH$KUI/]4B?
M:I[#A1=&;&8_F7).W!R2NT)W71E/YHOJ?&6LH,*<A0F2%.MD"3(UT;&".>ZS
MF7>%GFH=ZY9+U)EI&=;T'8NLFXH9_<9O=7A(WTH=SZ]:P9F3X.P>?Z8-9O`+
M+IR+M.-IHG:FD,Y4Z2Q>S8QUTNDH!HFTRJ4'!KF#6071M?\B;G0)#)=%BV[B
M6:%]:0#&/#^TY5IXWIT]EME9:,+QVYJP(:BQI]:85WU"7?HHZ9)#%@K='=!>
M!#;5""H0;\WAJ<2V=3#=WH5`"H'<0B`[A1+(*Q=VS0H8A6TF+^X&`DK;@AA&
M**))TL@<VT&#CL`ID"'RB9).=SF*M+`6GA&LJHI/M=SV,YPK5F>W3-4?KE10
M,GR>-0*[0]C]XTQE[C#.<)^W5*,`PZ!PG^Y[V#3BAQ*I49H\INCJ&GLZ=5[1
MGNB)9^=BYZFB\>UHA-0%L0KJ',%R0'U?7?P#J0E>$JD:$?&U1_O6)+67+\\1
MK%Q$Y#K<@ON>'AX"]UL.11U/0G!6!8<ZJW&P8!`1VT%0D/5VTGCW',E;<&?P
MQ#,FL#3XL7C\*A8\U.F"DF/RADVF?`FCOO*Y9TP5'O6U"74UUH.H%JN[DGB6
M/5F<F]*]93:H9U"/QX2CWA_E75+Q5SQ%::`Q"^9M,#I+!7PFGAGL:^,=K?P+
MZSQ1@GGZ@!+BN/P<KF+ZE9;&H./`3H@X3N,J<$Z(ZQL/"OKMPSD.*2^YQS"?
M53APJC.@1+`8_+52!$MHFCCAMY,)8<=&_ELQ/80HMN5E;O7_P4*H8)%>^/Y]
M$!X0-IH>PRH*T"I,-AXEG">&-%C%LI4B2_P.19J`>F!+,IK1+'"*P:=WW^O/
M@LPQJX&>RWZ$1\!V%-Z_6F$M'CL8D_CMBI1T+[^U[C?R,]^9YQB%-3B5'O/Y
M8SD+!PUKW9D%)5>6XB),&]&-=+2"U`Y1$MK36+KQHR3\8+ET$;\IU(XB6+<<
M-5XIA<G"L"IKF`R(\R,+?J;<E>_VA"EXM/47W2#3),S0^:,XH=-MZ_"[3O/4
M>#H@MJ:D^7).&OA4OQP/+6S!\,_/0R9>'RWZ]ZH$<3S=3DHK#/A`.K,8$9!9
M:E3BCV6D8F/*!/+\R=4J@,VL.BSXQ7)1'T0F-9[(BF*FE5*P36:T]$X0S@<-
M,OK)3S6(.-NE*Y:2`\88R^,%%,A]>B7-\O1_:"9R1GT4&&M;8-EL(WR*35A=
MBIAN#2ML2M=4%[&A8\D7KP1K63B^R]]/,%@=LA/#,'K$($!(`KA2W"7K_6&)
MIO:>_L*K,`N&AOBI#DO&JI\B$U]&69]13`-GG51NB$KF8YC!CNQ7(GM5G+B1
M?PQ&(JF0F)VRG+E"4<94>2/(`,;VOR^Z!LJ6P=N$C8&O[_V+'.DB\NAH@@M-
M;F'08RDS&9(7>42[E3MUS=CP"VT=WPT<2@*">FD\@8P^*6FF8=%>F6QN/)Y:
MAQ5M<I8<@9JNT<A5:.H$>[F5PJ9T"S^S:'53*^F.H)@=ZZ1]#*6TN>`=UM&7
M&L3(-6:V=Y#,C[K96/[O*-&IU(&Z:6X>2>-4XK'"?(F\QC[JH%%>%5OSVYS[
M&:@+SUX`]C<OYR`.T+DTP0P4/!92C=:'B]K/?MK\3-%8I]8)T:B%:\)&CCOU
M0=?C;+`^]_[\L,0U=K8K,C]!$<#`<4C36M[T.2S=H+(^M-OU0:?5A''(?KX"
M2Q3S+P;)_.]^I95,O9:DN>IQ@PWWF9'"@L$KJ=]S@JX>9:KHIN,NGR-`IMLM
MGL!.;23,;F=%.]U70FB2>YL?]NED=X@XP^7OAZL;^K^#8"[%VRK."/-7PP1%
M;$$LF>G"'@ICTXH)YJ@A&?I<=[E;G?<<H*:,.E/,*<TVQQ*"MC/3%S5V`L2A
MU_J%&4UZC@G3LV@T&T1!8]G@HV&?%7N%%QB*S<X;19[`UN85*BC58`%Y1K`6
M4W@$_":RR@N0>>'0"-1D1T]]<Y.>TE54U9OS>$[*DH&;[0PMN$YA=8?U3K<5
M%"5ER-Q"=?B=M'P=@I<&WZF\)P?>LV3`<=,:MDV8F*0C`FFN;\GAL:X$U"$0
M<^/O9<(%:DTCBN*/6SZ#A"$)YH"E?E>6+<<<`4QQPE;0LMG>!;ZUB:E2'<86
M/^KXQ44<]1L3*':@E=5:I$WL=&4,FH[Z]Q#AV+?65-DA:%KP#FN7!H++@Z+^
MHVAR0XKAT92>@&OJ9>;[3\N,MLWEADXD_J#Y`^"WYN5!Y9.408U.W-+^((<-
MSJBWKN3IX]7-S=W];T$5QO;B+;7.Z:!?B#HA.U`N'X3P#7,&CE@*<XFM=ANV
MKZJ%2(`?^^6LC$G;0<"RO6[[FC[MJV5SLH`@F=:KK2Q^J;%_%Q$8Z>4+A=2>
M?'+VEEJY%97:=JFDMA$F8*.5+6160+S:$.\(B*<L2]F%^C(6H\T=T0<H[C;:
M``8)A?8:HY7M5+B;R.X,G,[\883]4&7V-A#98I@,)Y:B8XVW`,.Y@6'S@KY%
MT9ZX%.ZG/E-B`;&8T.[J=#7R6@R49H=2UT_"-BC'UW_(AQ0VS&FT\%*M@_JH
MUZNF``LLE@Z+<JM?32P>R!@OQ`J2'-$(%Q$_G?#LUI%M9:\85.<NYG*[/I1;
MU91S@=OJXG98[W4[U83MULU+=@EI%'[ANL)PLT)CZ>P,KD/LES7)CCL[DHNJ
M#+)]R-L;F.7@*G=ETNX,RN6>/DVX14A)D;C*WU3L9>P'*R<E!]PD%M8&+@!Q
MI;9ZMQ:AXI%=-K$4>!9XKA*>#Q+8.O:&;I-,@'7[N6=:>#0IP9@?]\!>R[P:
MAK_U$U[)8E"=_X9,KK=:[6I*O,!M=7$K]^K#5D4CN#OTFBV:8_(0Z]C?MU^F
MA+>E^*JB<-Z6BW5KX+X4'<5C\U'`7\#_(/!?MY26`_X'V]X5UF(M`'&EME&%
MST7@6>"Y4&27#<\'V)EU*[`SP_))J_[%'3=G60-2-NL4>)$TRQL;Y+"&W)XI
MS;G2NI$J:FR%CW+'MP7T!?3/%/J';H#5[?;WKSV42PNL7*LI\II_6!\Z7E;1
M887C-*Q<Y!E&4N2/%DWTF[W`&Y+BAJRN'!YG8$V9X)>$FHE8A8P6,T^LTU27
M'!T[Q,`52-D+D11IICO8RA!?NU*:#A_'^P)('MQHNXINNN_8W0$^F+0Z(]9,
MH@6=:*L*F\!(_IN^P2&)?,1JG)6\E-E1*MWYR%%4E16]HO6NW*!\'(YE.!DZ
M`X]".XN$[7^NGJY#B`ZZ+;_)@Z'8^@3OH56UV!LHIN`=*P]=J@NF6E,3YE9C
MW?I6RVF%E;QHO436'00A%.D:KOC/H0+@SN`7K";-6T<HCL>ZBDB*R]N'!(T_
M$IX>>];R$[#J&*L/9CG\;<I?!/NA8%%&HO(^!F/"OZ=,T=K[!)`I:C#NK/IL
MPCI`FA8@*H(:'-N@*P?K$S.)HHHWO:&EYA@\67W-L`J]WQFA9!WF,FJ/I)X=
M6#8XTJ;E._;044']!C5&:2O.&;$`QKH*PT?K]P'@3=#'%WS\/P8=IU772[MF
MJ]IW^\"SVRNC/;'1U*WKQ8/E@N4VZROA2Q&ORTP[E=O^]-*5ELS]":9]:NBR
M';0]B5<YE"ZPJRO,<J='.YPDO"8`P:J`21>MGSYB(Y5$*P/-"!?&KS%6'-JK
M;8[(40(MS`R0I+4?=3E;B)146PB[:P06TZJD_V>C<6MJ7VQEBEJ^T?"E.>[T
MX!_^Z])S&E-%67QB/0V>E;<;W5&!(U@EG@%=GQ$'O_Z?_Y"D_UJYDCB/B@Z+
MG?9+;>F[YK`_:K;"_]9HNRMXW'<R^:6&YED#1[K1&C1:<L.U\%.WT>HW.JWE
M6_%F#U8P>N>/IYL:C)NJSQ7#^:76Z-1^[0Y;K58"&XR0'2@?M-93WHY1WO$I
MC]^ZCG+YX)3+ZRF78Y2W`\KEK2CO[D#YHV7HZGN`J3@+2S\>%C^_<K&X>;A^
M_O/Q5IJY<T-Z_/'YZ]VU5&M<7O[1N;Z\O'F^D?[Q^_.WKQ(,A?1L*Z;#VV9>
M7M[>UZ3:S'47GRXO7U]?FZ^=IF5/+Y^_7[[ALV2\F?_9<"-W-C57JTFA""XI
M7?]K(.W)56PW+K/+JGFUVE;$D5N&!@\[-AP_7OVRY"7'.GP/\IU82.T!<1?9
M=&226KK&WOGCF0.7R]-^\!ZEP#N;_LW:RFS<FF1[<.[1C21],Q[=%R=OOJ4!
M5HSG*X!$%X\:=@T`F^K96NAJ=$^,-ICG!!:<7R#[';:S[LS2L/`\[*?&[\GU
MJB,EM0,RI;%B\,/$-GIA8/;G.NV=3"TV,+>2BG<G5>*F!;AQXZ:@/RB]DC=^
MQG?Q';@F>4ZLTU^TKQV[67GEN\!7'0S!,6W7P"Q1Y)<YB:)4XM.C&W>;O!`;
MNQ]'IXG;C>AG2#`MZ[CC-`D\S5'L]SI["C;=2QQ99AWK-G8WI;T`-.[=HM*+
MCT_8B`H%)114;@J*ZYFP_2X%/@H>S-[<THA!.X5IFHV=)M*\?3$GF=,,GNK[
M"K4D7V%,!8[?`W7F"WW8*3C1VQ=WS.F.WU&82C9M(<N/R8P)/C'N>TSQ!B;T
MR]Q%&O?=8"[9^BO;!=`A#KDA[-]WYA5?6!Z5=]9GB.T;LJ_*<0,JMWN#Y>U0
M-G%'XCB_C6NGTRL&QWEM>!O=]LJ6]S`<?X?%5G_9@.GPPCRQW>ULR'9(WE$Y
MSPWC[4[1.,\-Z_U-H;X5Y[9'--I/#-;B\$;,T4H=@]1;<I2`3G_]8*32F?NP
MY+<$($9*-"YY"4]GM,'*N/.X7(-M"S:4?:6]\*2(Q+%8OBQ'<6G(W74"LTS=
MT9C.31@:LCQ<MUKDQW5N08#>X-!3[3<(\-M-)O.\=%6>Z.X,1FM87B+N2!SG
M!^U^43C."];=]G"=_;,EQP\8[5W:'ER9&E\(OD9\A,ECL?'].4K"J-5>,T@;
M4UV@X<O/?.KUUNG.4HY?7D(ZZJW$SH\Z?*&5ECE*D<ORW*2/1NN,\67JCL9T
M;A(T*`[+>8&^W3DTSX_$Q&[=(!>/EN-B/AQ+#7T8&_J4MPU/'H8-[LPS!VB=
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M]WQW^U2:0YL''9/PW*SD'Y>M8T;RTGF]R#'J>2`\DA/(#3M2JQJ*X["<3,61
ME!=%-_"ZQL2R&XYB;'<P]J!L;G;^<OEI^1_QB>05;U#[(ZMH9[M5I()>6Y8;
M/0#A"<HDE^J<J6QUAM%6Y'+W&%6\#J%!6;)[FB#%-,6:9//*=B,2N*XLKM%F
M.U=8QRL7BO6G6G(:$]-V.:7T:H[G_OY-JSHXNQ:3+(*<'@\=`NF50/IOMN6L
MGB\O$P=87(D66UMM9U\F-J:*;@I%(Q2-4#1%Y:`BBL9(F@>A:(2BJ8BB^:+H
M=JD%E);4$!(J)+2J$BIVUP+IYX%T8?06A`VQNQ:*1BB:(G-0$44C=M="T519
MT8C==<4D=(<V@JM-&78KQ+PNI%\0;&W:@^)J)0]1:DAS!?O[.+0@KFY*EDFD
M=Z+8JTTERM2J='/]=F)"*]#F4V!!8$%@06!!8$%@06!!8$%@06!!8$%@06!!
M8.'0/I_7F>[ZCZJ"Q^>@[ITG[/5(>_;HID;>)!CVOX@&4^NN:="5*7E^ZQ?6
MKOW4P`AG_)"MZ->)![[^0SZDL&%.HV7`:)&']>%0KJ;H"S"6#(SM>J_=%E@\
M/:D"BS]?M#O%&)@D)'\4\"HYO-IRO3-L"5UW>E(%&'_NUEM9VDY@46`Q/\78
MZ0HDGIY4@<2?+^2L!5J8@`)?>Z^Z@T$U==WY)-H=U.WZF_5";!-K04H:&<._
M:#I=0YKH;[0-,BOY23NJ5\\+NZTH%X/JW+7&J*(J0V"VPI@5D#T]J0*RVT"V
M(2![>E(%9+<*Y;;Z`K2G)U6`=AO0=MK"."@`J0*TVP7O!&9/3ZK`K#!H!60K
M#-E.KZ()$EOG)&]T./\</>;7EKVPT!^^M\,\?:0SD550#9-=M6/[N%DYN,H_
MA-?+2%<M8D6-TQ2X$5)2)*YREY)>1D:/$!(A)$7DJDC[,R$C0D:*R%7^"TE6
MA$-(B9"2(G)U`BD9"BD14B*D)-NYF.%;%$(BA*2(7.5_!"(C.+\O,4<1LJ13
M$0+Y`OG;&U%9>2F56Q^V.:^Q)EIT8CR53Z#/^0B4/*IWLPRQ,LN4`&/)P-BN
M]X8]@<73DRJP**K/"'@=N?K,:"0J;16`5`'&G[OU85_8@`4@56#QY[:P`(M`
MJD`B5I\YHO-5F(#GCJ]N?=2KZ'G1<RGY3;\X59,W9>(2.^CQ)KDSV_*F,VFB
MO[!OG'*W?2OU29VME4'QR"Z;SA%X%G@6>"[T$!>3:H%G@6>!YY.3+?!\\B$N
M)M4"SP+/`L\G)UO@^>1#7$RJ!9X%G@6>3TYVV?`L*M2+"O7GH5Q.D4<[$ED4
M!2!5P':K(O49IZ8%9@5FBXC9BXQ"M")%2``QQS6_+_+)BT"J@.U6YP_K_9:`
M;0%(%;#=*G=3]$PH`*D"L]N9JAF*5MBJ`HEY+OJ=BBI045A>%)87Y8<J4'ZH
M6Q^)6J="3H2<K/,[]3/J9`@I$5)21*[RWWMEA&-%&<="8D0@_S!E'.MR7W0?
M$7(BY&3M?F,@]AM"3H2<K/$=]D7#-R$E0DK6[#<&`['A$-`O`%<GV'"T^AE)
M>95;(D3E^&I$3LM6OFQ0[[4RY*S,(B6P6#(L=K(TOD"B0&)^AG>&#T?D6`ET
M[;OF#JM:,E1@L618[-=[`W%@KP"D"BS^W):%_5<`4@42?[X0->,%O(ZYZ`Y:
M%>W4(FK&YU8S/BP1'U2-=XDIBL87B&I1A.KT]E4!B!-X+O9@"SP+/`L\"SP+
M/!=SL`6>!9X%G@6>!9Z+.=@"SP+/`L\"SP+/Q1SLHN%9%(T71>//0[GD'EIL
M5%-C",@*R`K("L@*R`K("L@*R`K(G@%D1SW1_J@`I`K0;E4!2&"V`*0*S&Y7
M4SZCMIM(=Q=(S&_)'U;T8*2H*"\JRHO"1!4H3#0295"%D`@A65/>,>/XI!`2
M(21%Y*I('EDA(T)&BLA5_@N)+/J2""D14K*FH%16N0HA)4)*BLA5_N6%A)`(
M(1%"LBX4=,3*1Z+DO(!^<:$_&)W3`K'#&8QMQ*D@Q>C/2Q$4J*9:X:1;Q&T$
M\L\3^2(8(Y!_GL@7$18!_+,$O@B;".B?*_3K@ZXP]07XSQ+\`X%\@?RS1/Y%
M)\/B$7$+@>>2X1G,F&'&2<+**?.]S\=T2WP^AGYQQ&82SY:K&'24MS\-TZV0
M[@%>),WRQ@8IOO(Y%JV;I<H,ZJWV%NHG4?C*I'X$_@7^H_BOC_H"_@+^9PK_
MBZQ4R4-OI@XB/%MLI@2BSQ#1[1%H](SNHD*C"_Q7&?]RIRX/VP+_`O_GB?_>
M(*/?J@"_`'^5P7_1R6JL+NQY`>G201KLF6[WG.SY:'SDTL7&T.''J%,_(RB1
M&!M8>O^Z1R7.[S/E]!XX_;YW`;#5V,6,2!/+,*Q7W9Q*E'-I81.'F*XC36W+
M<23/M`E,Y+^))AGP&6A13$V:*+J-$^S!YXEE2^[,<@@P\$(<=T[O=F>**[T2
M&[^%6Y:?(RTL1W=U"WYS)&LB_;=G$JG3JDOMEMREKXA^TZG3KUP@UR#FU)WA
M+8@!]IK5M\^4%R*-"3'IVR459EXW/<MSXB]?[>0=F9<]QG6SB7?)F]N@0L)%
M)I0U.A.[2$)-4HEA.`M%A1G]I=9BGQ>*IOF??3%L1<-MT0#A5I'R4XMN[M0F
MA!-SB>BOZE/5PGF&+_I%"IM&0:T2K!B8)B1?B4/5A"G);6D.XS-S=@RC;AB@
M/_RJ<SPP"#27#,T!AB58#J>PUL&UYP[G>-Z)6&%**Y/M<LKD%[12_XY6ZKE+
MH@!Q:4'\&V[#MMF*%HZ#I:V?D$4ABR651;&@"!"7'L1B0:F8+!:PXW.O7?Q>
M%U>KCN=U2"I#Z:\"A;;RBUR-&"W#7D;8JLP1*H&]PF/O0AX48V#V[_,E`%4$
M0'7[&:=NA3(3V#NJ,LO(9RV<,MOZ?*LP?Y/,WXXP?\LMM;VZW,Z06[%F"/0=
M<\WHM,JT:`A$%1Y1':',!/1.I,R.>$CWJ/;O0?.7X9ZQ+5UN_;38@!PH@WDY
M6S8KI_G:FB\4\UURWQ>ZJAC&.T\.=C`=>`;S;[PWL(DQ3"E1/5MW=>(TI3]F
MQ)0(9C4K+LV'GL63BC'1V8(O[09F+39<,L=>R38\'-ZFVWA1G=[DO]XF+SIY
MA1L5U;5L1W(\=8;YS@EYS)C>#`S"(R37DF#C`E>&2=;2#.ZBZ<QC8EBODFHY
MKC16'-UA+YSHIF*JNF)@IK/&\JKQR<B`XWC$IL]'DE2@?$HH"39QK3"OFM-,
MM<3?.J.?<:A\<AQB&'7,:WN=$;Q1TEUXKC2W;.!#_XO`^-(\3M-R\:=7W3"`
M4&#_7YYNPR`'CXB/*%PSP4?81+5>"(RC3W)P180:!=[FTI!/R'Q3^JPX\`UP
MB_<I8WB,/]CQF8!A40U/0UHP87PUJ1T3T8%JY471#12@!E#6<!3,P@X0PM+9
MD<E$%.!(FI:D`L<P"#3/_!6FC>?34_0@*<"D3H$8`*N)>S'$1IQF3=?HRW!X
MIB802V\/L89S:4\9[9;G.BX0@+"-$*S!'QS([T2Q)6+B$,1"'LUMY'IK0?VG
MY[CZY'V_//DB:9>$H!&=>'9((>R03E2BO]`L?@"N9[I,"CZ,AO3J#^T67.(L
MB.KJ+R`^JY/PGXW&K:E]L94I3G6CX:OC^/:<?_BO2\]I3!5E\>DN1-6=>4/&
M[I6I?5/LOPA=%6Y!'MWWIP`?\.,UL5U%-Y]M!;%S!;+@.C>ZHP)\/9L\PZA\
MQD'_]?_\AR3]E_^6K[HRU@W_$4\N7#"S#(W8#GN#I&N_U-9=U!P.VLU6^-\:
M/:4!+_Q.)K_4%*=A31HXO(U6O]%I+5^-UWNFSB[^\713DS2BZG/%<'ZI-3JU
M7P?=5KO3:K7"H5E'SW%8[&[`8B=@L;L-B_UA1^X?AL5KS[91HRPQQ;\^\DQU
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M\FD`3&=UD$CNFZ-_,G7CEYIK>V3324Y^5)SSM[EA.I_@\;_49JZ[^'1Y^?KZ
MVGSM-"U[>MENM>3+?WS[^J3.R%QIZ";NPU5X_^7!9WAWME<F_*1L_P8;SJ_H
M'DGCV[^@.>R/UAMCP-P@-,:"&8[?NM:J&7;7PMDGZZ`<#C8P-]LQ#L/)W,K<
M;`Q&)^)0WLB@CG#8#CB4M^%P>$@&'RU#5]]3V6,_'Q:@OW+'S\W#]?.?C[?2
MS)T;TN./SU_OKJ5:X_+RC\[UY>7-\XWTC]^?OWV58&RD9ULQ62D+Q;B\O+VO
M20FR^OS]\@V?)>/-_,^&&[FSJ;E:30J=3$M^./]K(.W)56PW[I7*JFK!TOCS
MKVLAC2U;(S9^'TT,\L,LKK5(R@KZX^[F^7<@9KAPL[-W=HS[['HP(MD3.5MU
M&L;#53FQD.#N902&8B.%<I-)\P'B6.7W4"/\]J4Z&@-35!4=T"Q\M11YP'#8
M/)RF2.0`R^;`C;:&JSK(ECN3KIZNI4Z[U:A%-_(-";W,U*G-':/A7->:,4(T
M`KI@#JAC`3#54!Q'G^BJXH>KDBFA]7T(BY+!10O/5F>*PR)F-FGP>!WAT36-
M.#!`])$.+RU$%/A^K!B4$V=&B"MI<$.<.)\:?*%A^$&:%(J<A#A14[I:C1VE
MW&\#]XIMZT1#[L(P7YT--+(;B5!-%5I!B==-LLG"LEUV9PVFR)M[!HUDTI@4
MK#_SA4UF!'3["T;2X#.1+O#.CS6<5'PVF&HNH1$D8-,/",)O3L1A'$3>),)<
MV3L+8;<S.%<Q_)X\A8!V1(>3@7E:-HM'+/FLK09H:U^"L"^;Z#KH;K?&8KWP
M!)A'`($F>8X?!,2($XH<F#4P_:'PT6@J51"^D/IWT&!K&IU,A)8BLW!Q(!WT
MD1F2`"]5-!Q$N)G&1]FC`HT`4)[KWIS5'`.PV\3_1=,=JM8PJC977'S@>U-Z
MH@'VR$/J\/N4Q:RI:`4!.HSW;DAE'<E<GHV4L1=BLN=J%02[<<Y7@]V8@8`%
MW<#P1_O%GXU(I@37W`F!_&0(LH2*`.I,$N!___2T*0O:CDEBO']I_8#U1D?%
M"638.A::\Y,^@,2H4/DI%/#@:&!_E=4ZQYPOB2N%[V*I%$&""*UW%RMRQ[(*
MEI-+EH8MN-\(JG(E*YWEU)/$9(VD?!0_T<0D"@PEC`=(MT5#X$X\5Z496!IR
MJ]'IU:7-#8ZZGW."Z%F3JL/5'3PK@@8VW0Y9*"P]"/2%)5TH'T/!<F=^2!^7
M8I;;$2C+2.H'$G@Q3KN1+=GP;&IL4$#X>+F`87G1@U256$:(A>8Y)ME@:DZ0
M5\-4.V."I:&P_!R\,C%'ASXX(U$'?UO*S?G8E+Z@EHP,%3Z$+3-@3&A),J(;
M_H`3C:&%#P`*:3@1NA.*`E6PM4FB<JTG&C#6@MB^O8>L.\#N7.?#FSSHD7FJ
MHSB`1HB0$[DP/C,K=*XUN<1RL`/5-RQI"5TE[%B*GV#3KF-^562F>.X6TWO<
MHB':P9)ITOT^Z]U'ONFWUD^V?&&./L]!>[#68;9,WE$YS\T7VNX7C/&\7*2=
M/?F^)^ZUXLP>^1+U^?V'0[0[DQO#YO0*$]I8[(*5W(7O'D(%C2.RWR-R%`^Y
MW6_'@P+[D5ZXD<Q-W#K]Y:21JHUD7O+;![,XYW%DQO=>X[CA(_*4[=&PL\E`
M;DAYX08ROZBB/!J,1I4>RKQD&VX9+*7"YC"4_/)]AG+#1^0HWH!*>2G9;S_:
M"S>4.0IX?SC<")6E'<K\!+P]Z!US).^H[R'8>\2^R5/ZVOW1JIT2DK(EW?E!
MO2W+O94)VIWNW'`E=P>C%?MZ9[IALF48B&9/EKLA`1EI9IN`)^&)1\@VVP1+
MN_&6!;"B\";OR%L6"`O"&V"H.QH=%I*K#SP1(G?B+`N0!>%,WHVS+#@6@S-$
MXV!X8#2N//!4:-R%LTPT%H,S>3?.,M%8",X0C7UY62ZVQM_J(_*U\3;D(1-I
MV_)P:'MO0QXR,;4E#UO:?J]7+!T0-A*PZS#A3Y5&4GE@B_TS./;-V=SN)I$4
M+9*B3Y44[14]*?H[P>F70H&28A(ETJ/SR#"X,Z5ORCO/,,`4D2]73Y]9]I$6
MG9HG+*FBV)HC_5A@RK!T;S4EIJU&TD7MZNF'_ZGVL2[5_&/EJ.(D=-C8"B8W
MT<3#:Z`(5+*-2=&1^R3'6\"71.-)T39_!,\SH8E3/#LG2-@.WO,]<M'%L[70
M5:G?ZGVLU7EN-,^$PKP(/[DI3#GSWT03ZG17HJIO@@EL"R!?Q[(Z4\O2:#L[
MA]@ONLJ>H/J,\+ZN/+N&9@/99&+0?"Z63L<RXE@R9RSOC%+T+I$WEOW%DJ[H
MEP;+NX%'DS>6F1QI+[M"3WPH=6!U,F$E57BU'=-3#)XQC?,)0ZWC(\9DJILT
M&T^9@"J6;D`HYV/X0^[1C)-^-/>.IHSJ\^!FG$Z:AT09CC^Z*=TJMO$N*9JU
MH&SS+*P%IO^Y+M'B28/P*Z]30"M4T;&!T5<Q!0\3UY=*4<%-JNOGR@6O@,_1
M4<"7N@X=?6Q?0C.9PG2J('/*.5B6S+;FP9)%8IFJXLP>[$=80_F'*Q60RY;A
M2.8?_=8FFLR,DNWORS.\V.K*2T;9]O2><*"67:Y[[@`SQNTP6Z1<QT;>>FQV
M]/(>:FPL/YS`M@6WH'9-A_@CD/QKCL(RDH?+HI),TX$8RRV>(+?Z.7.65\2A
MW1GLPMA#_)I@(YWP?:[AJL&P%R]FD$#0'ISD&,""_W2.R4E^(:U>:ZF6QN:<
M?"6*0YPOGNO9Y)MNZG-O_JB\4SU^PZL^;7@MK1,!`SIL=MM].9GOE-H2"7=E
MZHJ>G#)QV13F-`2CW@XCL')3IDKII4SW$?B/UMW8[I;\`-'O#W89C\22*SD-
MR_%!0HWJ?`?ESGR>V83\213;V69DHO?EAYI.=[3+`$6)/?$HY:!I^J<:HE=K
MEP'B=^4'HNYH)]43DGK"\3D^?(:](P[.=[B<F\[W)%$3QZ^@MNX:4&QB+&^)
MD$$[4P_':3PPPX-$:K>UJ;==C0?#TS$L;\IPENF][4(R;)^,881TIAQOA.CM
MUH1N]Z2`WHC=3#QOQZZ<J<2.#N>-V,U$\W9FXR!SR=^,7=AO7BNV_3ZQ[%<:
M$XKSNOPSJU4X'`R:;3#EMUJ/$N[*G,SVH).FCI>I.BASO6%K!^96[\JT18:=
M5)M_5^9@KG46EKK!H%XVJ_&+J7()YT<>]+K-7CNIV.8F.BKM0;^V6^UV`R#?
MD3?A.TYB_J/0'@U&!QF%^(-@%#K=`XV"/55,7A+F.HB,P8<K4WMD-1SHQX=)
M4-;E*8B4);1#8*-UX(>*O)F#9P[LE5RR00_-^X?G6TG^U/CM]O[V^]77XF9B
MY)]LQ+.*>++3*7*/#M09)GFXE<,G&JVG-S6KZ-'P;-T!U8+I!;:R()ZKJXYT
M9ZK-NJ3`,U\430%U8F-9%E83"%L38:T2]A5KHH1),;*,*1`MN9GU4%HN2)%>
M9Q;VUK)>3>RDY8T=7=,5^[T>N?6KJS6E"UHQZRFX`+-E6#:(OD2$9VI8&PG+
M'2FO05T@JC;QPYUC*\3()LVO,Q2^CE:IL<F$V+S&#6_!5>-Y&#7,*:D%STPH
MXE7J+"PA^P>6_7&A9'\IH4B1QKK5<*-BH08%.%^(82TPG\B:3/":AC,CQ@2+
M4%E38A)=I?,JL;O?,1=)\U1>.I06X;2)XOJ%E^:>X>H+K)WD8`X"W$SK+YD3
M0YG/%=>RW\/J7TX\\0G5AP-,*#IJCB!T[!?T8<WP6'(8K>K)O\?T,W8.,JS\
M9J&E15@9/^I[B[TIVD`N4BO3?\]T:I.I7^SI@RQWZK#=@.?:EC>=)73YTEE?
M&0U&V22\T!>,Q(=VOS[JM(-AVJG76MH$%[-'6EPC<5-IBSI_"P,LQMB$PM\L
M3XW0!+9(62^:0!E4S&3U2&/U&:F>X;EZEF30-CHT:XZH,],";,,2`#/-4RBC
M71A_F+126&P5N0Z72>FBEG`%6R_8#[6/%!C7OU^%\_19M^@'_/^-;CE(!CP)
MKL&K`T)8FB9-%IV"_<P2(1UO@2F%=`@0V8J-Q,)U7'BI\"GL6/![$S-9Z6)I
MF5-<-XD]C_<0#(8Y96CIVWDJ*/\4#+0O_6(Y%,MAUG*H%FHY?-(1YF%&+U6]
MK4%,+"*K@C-3;`9W6"7G%B^"#`O4"V%UY6!KJX4M1N^OGFZN_I]TK2QT5S%X
MB?.(U>J\SV&;"<;DT_/=\>W(XC3M3<K*[S5'6PKN@QF9N!%=,UMK)FX,ZS>;
M))K.;3B6/U7/Q&A<O0"[M`^B=.OGDR=,UM?G[]M5[MUMX(7F.;#F22CUF*_F
MH=V[Z4MX[S[I*EC>/QU;^G.0URS?5S&._F03?7-[_?#]ZOGN`8Q3*O=LQI,9
MXI9>,(,%8VN][J1[#:XWY;@=2!6`7\]8H:=K#(_6JS4X<`.[E'MKED<#3%=J
MAR=9S/Z^QW.([[)95=B/7__!E!>:H]R:I98M+KS$1O<X+85-+VJ,:6-O;H(F
M[S\?/0,6;/3O_/X.%JV+1C\UV1^O?J]];$;P&?SU')K\`6,2K[?,*QHG\4?K
M)+.6SB0R=*^6;6B@;\-!M/7I++)=CMGL2YPJT2;MZ:.U-!!8TAC'0`(>-^=P
MXMFT4G'`J4_@Q(*=_RNNG/'36@OEG2Y1O((R)^^3=*'C=D?R%K!3P)%C^2UT
M"SRHMUHM^$:GE9&OO"G`E0.1N_I8!7WT4'SHT8M-RVS89`*"25^V_%1:\Q_V
MUO1:17NA^Y?@E>;R"/\,U`%YWH+NY3N#>@]N\Q;T`)VBSBB3K-DU?#%%1P!Z
M*.8Z['9<"YN24'CSKMP^Y]$9Q,8&B1-!WPROMHD^'WNV$Y2FYK2`$8,LH(W)
M"4B==L+"T(ZD3^+RZ^`:H3LS.GZ_?7N40+%X6)B:%4N&O[#W+3U%=@_[QYET
M!4C3505I>TD@S:<$R[G3HWP``!//SL%X!4U(EKCGQ].0_Y]9?7-X<A1"*>CF
M]]3!A'E7#+^IBP)CKS5PGPYSK^E3G1Z34_V9IS?ZO5ZX><Z>3O?(ADX"]S`G
M,ZHO<",;'3_Z/M[]`JZ;*_84I^&%6X+)9>ZW,@E/OP(DBOZ8J,J<1`Y&6J%P
M^@L%#C=5<8$O!@_S&=P-CP<D*?0GP`YZ"M!S$6E-0#L;!/.-]>P7BDL=+;20
M.KW&XB="#4,9!Q$(*IL^#J<X%V;@W<"'V;X0+!2;@D:SZ&'*<.T(/)01HWYY
M!!*U)+]HKKQC\@'E4<%(AL\,27P411&\E/9?8(/FSBS/E50%5K[$%]V9S-U$
MQZV>N+C`1H:.V7L,L''Y]!VB5#7`*(.\T<'7K%>3DH2J5$4%:;".)B@M.N^8
M,(<-K#2./WYAZY8=*#D>78E.)5VN".VS!-0E.)]XDZ@DM;$Z!>>SI]W*XKS^
M_:KLYF:[SVKT1V-^&QB;B<;0L@D:&Q[?_H0OZ]1^P=@"B#Y=>6"08:T#C67#
MXYQT6RN@,6YI-1ZO;@)5`J!^`J&>2?]CP0*?B/%7/*&N\>9)SJ=5T_0:/=-(
MT%=8=J4[%A]1F*:]P]&9$TU'J;LV%,]_$.?Z+GPR6+$@3+YFP]N"-2\V-G7Z
M,<5*Y3;I$EMK1C#)%HH0%GGA&&,=?OL<[D@+'LOZO,4?[=N>=+8UM@KHT4?[
MJW]T4:;*-+Y&T6H&5$>:C$.L&^#2\@6@W>`7M.YB1E(T'$#5&YC7?K,//.5O
M8/$"K!B`CP#]NUW3LY(KKD1S8J+;8"@$,^BXGO;.RS7``,%,8N,7Q:$K="(R
M@Q8SBO1(+;F[.X8#Q".3!*R+`!=&)0%#>+K#7X>)"LH"MRZLZ<H]_$$]A+0U
M"*QK$5A'Q!I3\!T7,`!D?;$LC4[YC>U-I2=E0LY\;G\L^/Z)37!D/\1&&N:'
M%M"@V]!DQ5@/!#DTJV-B'*X'/$#&L!#L9.C*\"]/"3-(_FF!%$IH*05A7-@!
M+*S0JQ"[(L`6C2)&?0C^YCD,8,=I/^NY#^<ED$V^U4?W#;<'%0GS`5A.#H@8
MSAY<`+/A>"1I:QC%"=BA&BT\`JN!YZ)7`:\0PQ_4'D)O/=L"41>'P_(\YPO#
M'^Z$!5Z/A$:6[2U?OL@;43V:S`#WSSVZE$5:Q-'94Z(]X,)'\-I';72:4&=%
M&!=CU60BL3%F$46\1:@(Y#IN)7NM;N1.:JJQ-X65@2R7=86+UP:B/5JC!EK`
M%.XI42>]Z7,8'M`5Z$[IREVF'R+L`5EX/7^]CH8`S<%E*U0ML1LQZY49]'[5
MDEN[9C3#E1I;=*>3+NXML/DZ'WF*2FRA1`R`,>/P`DMHO43W8]1UYS#-&JU-
MQ.HIH49,VBI3SQ>MTA2\A]I;4>G%%(%E<S#!;FOR12.^W7=QG5Z"*G4;<$.?
M)C8P1-J$;=*IU@DWVE0$T'#US53>9Y/>H9N^5?L"]MB2.Q*QA4_UUS)_;^NK
MM0E01+&%9@;?C(19('06\7+6Q`T8L;5@^/REC9+/\J6PJR)G2J?."5^W1:UJ
MMJ?6"+-OPJ>#=C']%J34'\"YQ1Q,EWL`'(++,74RH,@Y%G6+.;SGZ5GKS%M$
M,<X-RQSC.P<8:6Q63">*#3.]9#5&3$T95S*(0AN_\OPLWN`0^QW2T+%)344Z
M.^P^;H%P2-#0<OCF*6ZML&VG#=BT5*I74$N]^R!-I@B&3)GZEO'J%NO%8L7$
MK%?F=*/FE:_04$,?K&K7H0\O+)VW0.:O5-4&DK_JRAA]T]C$(%I@(/,2?E@H
MY2Q$RM&BC:N++-7FRB;E\)QUXY1F%)`*&`T/^W6S&3U(S2C&@>,0-X&QZ-?'
MG:91JY<P3]'W[TYV=P.R-Q[T.-F]I7Y(6Y"--<B2*0]_.>Z8#]-(#PG8E_HC
M#GTG=>0SR;^.=G`-RPM]IBO$=^+;AWQK>T_<A\FS\A8RN=O]O([\8-_"W2M/
MR"X0TDI0?KLQ4+"1'';W'<F5)V370*OF.![L!.(:'"XUG\UE_#8>J)/*:+L_
MV'QL<AN$XHI77D-0UJY(!QZ)$O=0.O1(E+?CTA$41"G[,QU>-LK9S>GPDE'.
MWD_'L!Z6FP0=NC74TL*)MD.AEL[$IE*'[B*U7+XJ82=XTC%(:C]UZ'Y3RS5T
ME\L"G7H0DCM5[;M,K&N85$2]D-SO:M^%HI0CD=@U:]^EHHPCD=O>NY`KQ%K6
M#U(AO8CKPEK.#U11_:BKP;)SYDK#F!Y&B[X`%U</UW=?+/M),<C#)(R(;SQ>
M>ST]1\D:;.'4VHNGBDQ,;G*_7/-9S$OVO.2EE39W\N4P+3],F]`$0NTW13?Q
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MA7+Y((0G(/U`O'Q^^'YS^SU@96PHH-R`(8FF/:>RU8$)P:(%@`03*VIEE[]*
M$N^=>L=O+4BLO->2'#5&OB#]N5J-=$W9K`P,K"J6+%1(IO5J*XM?:NS?141)
MM!#7>8NP7RV.GDTIXE1M*M!QC/K2L5N=N=3Q:D5U0[M(JB&)^>0E%JTOH0J$
MY`C)V4%R.D)RA-E8'H`/FMW>1H9C%.-M@?$-#,5B&X-'%;YC$9<@0L6PJ4\,
M:@$&`08!!@&&`W,17]ND\11&V+)_J?U-50F93)+*PJ_ZEP^[3?!7SP-;3@?U
MG7^Q;`*T2^QDL?HNT2""P:JC:/ID0O!K[%!CDM7ZCAM+X\&WEP="?'8E_?5S
ML8W$X.L_Y$,*&^8T6D:,EFYK4$U5()!8-B2.!!(+0*I`XL\7HV$Q!B8)R1\W
MM7E>9[I+:AN@$"T4'X;QT/.1S)71!K'`!',EC`1^5LR_6&EPAY:2JYY)LJWX
M%(/J_"6UTR^1I`HD5AB)[9%`HD!B$9#(HQWE0.(V'IO*V"^T8#QQ7-HS?DY[
MV6AD83FZ*TR9@E"=N]BVNQFFC-C^"M`6$;2]3H;5(T`K0%M(T`YZU03M&7J"
M\!"1=(''B#Y*?@LDU\*^B'Z3!"<X7"1,JV)0G;O`=X;=:@J\`&UU07LQ$`XE
M@<0B('%841M_AV2A;<]0E=&8,J@QA6><DQH!:V%-C'7V5$'.H)S@P$EYE,DZ
MKO)?]H:=XZF^HZ3W)ZV%`OH"^EM#7^ZVMH+2R4^F5.20HI"2,DG)14?.R!,L
MQPIQ$$==`3!2!@"74^RV%HOBD5W"!:ELR!!X+M!@"SP+/`L\%]I=URUMR:,L
MRLNV)P)>),WRQ@8Y[/9ASV,FN=*ZD<X8R1GG4!(04E6'@`#_&8)?KK?Z`OX"
M_F<*_W8GP\M5.?!';;M+FK<5?HQ&&/^ST;@UM7B=XI6+_`]+-:DWK?V<4&CZ
MJZZ,=8-UXDCH#9_X\W';V_>&"0WN$^DX'#M'['??'R;T=-J4G2<`.6VG8KIX
MG>+,:/5L1<7R%7]7#(\\3*XMT]$U8M.2%K_I+\240X9W?,!JD?`].P#FTOCA
M=*-5Q@8D)QRMO"KXRPD=<W:D.CZ`C\H[:FGGBV4_VA9LTC4'6QQ]M<RI2^SY
MG?E"6.,CAP[7YI?GV0LD-C:;DYC;2)1,J(XY$KD)C-SN'1,63S/+=I\W'XVD
MZW,4D<:@VY8W&8\D.G,<D-P:U<BM-ORW!`.2E\``/#H'1LBS=:7^R]-M<O6B
MZ`9N&'C7O+"73&Q`-K@^1Y&16\->\H!L0&>.`Y*;R`Q[G6X9QB,OB1G*_>0E
M9O_Q`'E;$-M]?S3`N(/=\"U\NYC[&\#-+\]37'J#9#ML/96Y#49^;=`ZK5'A
M!R,W4ZR[Y#C8>3`,HDV)=N4XQ'7N+?>)+!38V1#C_3M9P*)$F-?HBVZ"6:LK
MQAT8N+8767AWO_^XCB(8H"5-LCNE2T-F.2Z9+PR+COAG8I*)[CJ^T^9]R;.T
M\=7''0ZYU8\[SC:F*R_FC^AE`\.T<SSF6;L^[E?-8#MV78ZKR(J)L9ZZ([*=
MVWK1:8^*Q'9N>XY!;T^V;3(A`'[MR;74OQX5^\%^<O%\.75_P8U/,\7FG&]T
MZ6$5V__"JO:_#CXWROG=_9?:KW`M_$>.\+X1?5GLTPN<*\^%#1JV\$Q@>_F2
M`[)+V716^,0=U-+JGTG1,H/AOO/:<UQK3FR^EB?]TAR.-I!8@.XPA"[]U)&7
M;UT+W56V$@A*Y^;.<3QTOJ&+=CZW3#H8*YPE7I7K'KC?[::RF4C=D5C.3Q5W
M@>EBL%RNCN6'XGO4'VXTU:.&/`P9A4^CY5M/--5,I?TP-1K.AH5,?\&(-OWZ
ML^(0#1LOPUI&8S*XY7'@,L/#?J_T'0\+_&%5S1W\#7DJDM'R'O"8C%5LEG+3
M?6TV36*6=IJEO*SF?J==A$GZIKC<F0D6W8*[=.`-UXIA.`^3=2[=0SPI1P4V
MZ*7;03O37_#!S4WO]):WO^<PN/E%PG-%+EZWU1BNNR%'(>_+2WDVV]"9ZY#D
M%R<?=M--@F(-26YQOV&Z0.T^(G\HMJV8[NT;L57=21B!Y0ORM`M;R^&L#+H.
MRV)>D]KKI>\$C\HA:*AV;RAWFW*K.\QF-$O')3TC>T.V'&/);4J3B=T6O-LR
M?%(,;\IP%I2W97@O1">'8Q,2\7W^-[[AL,OYK_S`P<W#]?.?C[?2S)T;TN./
MSU_OKJ5:X_+RC\[UY>7-\XWTC]^?OWV58!PEFB2KX^9&,2XO;^]K4H+3Z_G[
MY1L^2\:;^9\--W)G4W.UFA0>;HB>;>!_<]*>7,5VXZ<AMBHP]TP/<=R35^G[
M$3O09W6>O']XOI5ZGQJ/WQ\>;[\__RE=W=](M__OQ]WC-[BP+MW?/J^<[\C@
M;B/:HO7P_NDYKCYY3R-OZ?Q*"A71!X:GL-B9'5:#>(<3-0!>8F![6!6VS;_4
M6NSS0M$T_[-_8&@0:3`:;^B]0X&E0;_(QZ#7E(8Z`.$)@,^EDE(J6^UVM%%P
M_QA5)'<5\BCNT0U$[#0Y^F_/)%*G55\]JU6:8F>'!D:\G,$!I':EUJ@0X8*(
M<%*O[]*),-I*0GP%P*L,\(X`^$[E=K99E0J(BZP-RK7EN)_6P:+0%:NVD-EB
M6`QE+F0@P"#`L%:%;ESF-0\%>E!M^5496[;B6O:[1'Q'W>[*LZB5;0I4N";W
MNC3]>FN849:IS.(JL%@R+/;J@Y;H35.9Q0.SQCP7L_`54Y,6Q-87,V(K1I67
MDG)6O\U=T@<ML>84@%0!VNV:(XL^LQ59FAXF$UTETL2S3=WU;$)7*+$LG;N$
M]V6YFA(N0%M=T/8Z%>V&?(Y[IJ]$<<C,,C1)GR]LZX70-'NQ(!6#ZOSW2?5N
M+Z-_9IFE6\"VRK#M],_,D;>Z5SI4VE>1EZN_DYFN&L=J'7WJN1:]0/-ND)/A
M8"EBCDYI,\Z$6)1)++;IFU-ZL3A`6[A3+[''SF$+A_+9<A6#YK2)%5BHFD-T
MZ>K61SVQ"@O1*#Q7IQ"-MGQ.HE&*L."QU]HK5?7FGH'5-26-+&RBZK0,4KES
MR$OMSA*]FHOEK"T`<0+/Q1[LHN'Y+$.+9Y'+7TX5D'\[VGJKVZZF;`O85A>V
M<KW3ZE<3MJ78;8GS`4+.\Y#S;J=532D7H*TN:-O#BH+V''=+XH2`D/$D`W10
M4?-3@+:ZH!U5]%3+^6V9Q/$`(=@Q=TAW4-$SJ0*VU85MOZJNYPKD+HKC`2(#
MJZ@96!E'BBJ7?"6DHJ1<Y2X56:[RRHE%Z8_?Y7TV0$G)7Q1+LE`^APC4U>5.
MAC%?.?TC)*.D7)T@PZK3/2>#]0![WV[%UV:_]UD\EE@'FG8]OI<U8L473Z!>
MTBQO;)##RN>>=6]SI74S/V^K/FQGU(%)@$6YE8E`_+DC7JX/^QFA]LHA/KI\
M7M(N@^''#9LEQJA[IM3=D_16D+&EK=L[V+XS+Y+EX9XDWT2VPQ)Y6Q`3F[0J
M<\LS<;?L6M('N3YJM>OX[U:G0Y?M#]U.3YI8MN3.B/1.%-N1B*G!Y7Y+/-I8
MB_Z3W8#-6>N239P%45W]A1COS941^L]&X];4XHT_5RT"_B'6IG7C7JH;MFW]
MS;8<)[M1*[VD.1RTFYUAM]7LMOMR<H-6Q6E8DUA/5KBGE7179J/UUG"E^W`&
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M-/]ST%RR%?KB60_>FC2V;(W8>%DT"N#[7UQKD10`^./NYOEWMI//]N<GNIW6
M^PMV=>@G^PO^N;IQCSNG<F(AZM_XI^>X^N0](;X02$TFT0=P.VT=(N$T[^9)
MJB;0L^E?0<DFGL9\8;H9)H.8EZ38.'<T*T5Q06\[+`PF69/4C)5FW&&G.Y*J
M&"J_</Q.'7(.*%9T+S>0"6E.W)FE2=8+8>XZ`G3-Z>6>0R:>(1GZ"_`%[\1?
M%<<AKE-'>O#CQ#(,ZQ40`92;GF)(-MSI9)?]*ITT^50D.%:7O:BU/"5OV/HI
M*EY1B8I*FG]YMUOXR$^0BE!+Y*`]_.D8$>T]5KN?UH6DL]@H2B1ET]/*RV`J
M59;]/H6=EB?OU(PWY':SLPWS<JO!BW)6"*KI!QA+#=3#%7PI/6P[G:IAMK+J
M]3"5($J/V+[0LV5![*;'[I*8E7L_H1\-C73XI7URQK<W"+)1>G;J:[^2`5'6
M>_T]H7'PN3Z&3GE&-\+,LL%.\3T#F!NDND1;53*'?GG@EY@0B>48Q=YY2$="
M(0;;!G!:)O4G*([CS?,88YC8N3^S!@I',WN,=W'P'#JA:RGRL6%P9<.PB@BH
M)`14?,1%I2,L-Y&7'VPT2/6#[7B^\=2FV"D/4"7$4G)V^2VQU6Y'5]1^4<^T
ML-!'VKK@)[ZN,RD*?/#IT,"(&YD'D-H54TN(<$%$6&[%C>)2BC"NXT)\!<"K
M#/"U#M<S`GA)"OH>^SPN]LTL=Q^O+62V&!9#F8_H"3`(,.P14BA[,;_SZ!]5
MH%/9^=?EK+>&&:W&RRRN`HLEPV*O/FAEE,\I,Q9+8GT7-/6G/.);SD):N4OZ
MH"76G`*0*D"[U?+4J6C=_?/;UXA.3T+"DS9#<D6[Y@C05A>TO4ZWFJ`]QSV3
M:/8D9#NZ3ZIW>QDU0,LLW0*V589MIW]FCKS2-*,0S9Y$_?P-N<J_V5.&@Z6(
M.3JES3@38E$FL>AG.,LK)Q85Z*=X[!RVY7Y/F-,F5F"A:@Z@:N1N?=03J[`0
MC<)S=0K1:,OG)!JE"`L>>ZV]2JE,5^X<\E*[L[:6W.*17395(/`L\%PE/)]E
M:/$L<OG+J0).T*FTU<WHX5MFV1:PK2YLY7JGE=$AL,RP+<5N2YP/$'*>2XOY
M3JN:4BY`6UW0MH<5!>TY[I;$"0$AXTD&Z*"BYJ<`;75!.ZKHJ9;SVS*)XP%"
ML&/ND.Z@HF=2!6RK"]M^55W/%<A=%,<#1`9643.P,HX452[Y2DA%2;G*72JR
M7.65$XO2'[_+^VQ`6F==L20+Y7.(0%U=[F08\Y73/T(R2LK5"3*L.MUS,E@/
ML/?M5GQM]KMQQ6.)=:!IU^-[62-6?/$$ZB7-\L8&.:Q\[EGW-E=:-_/SMNK#
M=D8=F`18E%N9",2?.^+E^K"?$6JO'.)/U64RI;_D=Z(:BN/H$UVEV\4OP&/D
M*-R#.R,VYF_:9$9,1W\A=Z9JS<FU9]O8NI+8NJ7=$_=A\JR\T4Z4AWP@;3S9
M'0R:/5GN[MZX<O4)GJFSVW\\W=1@NZSJ<\5P?JDU.K5?!^U!J]4*1_20#)5N
M[(?=I9%[<_1/IF[\4G-MC^PP%2L/C$_%V]PPG4_PDE\2FH.V6RWY\A_?OCZI
M,S)7&KKIN(JI`A6791O7@_5A+0R2]?G8LQV:IO"=O!#3(WSD5G_(<03D%OM/
M=`Q6"5KFQ2&*K<Y`>=[`[X9%U>?MVP+&Q&<JXXH<N6MW1YWA$G<9E!V8S4%K
M/9OM&)L=G\WXK6LG<31J]4_'IKR>33G&9CM@4]Z*S79_V-N#3=?6L8_YM>+@
M#?@O7/O!,,+,H2OW6K'M=]V<_ETQ`MG<ZA[@IYT^%(K3L"8Q+,>O7L=]=R1W
MEYG?AKI3#$=W@^$(,=_=9C@Z\@KB]QD-5P$[5;M5;!.N<"(Z_X;`8J"[?`#6
M779<"#1DN3/L+*-@'4W'8_6(T]L`3=]J[\DI7;MP#?_-!EO?X8PM?=L<CC;0
MTZ#`AJ$"HY\Z\O*MZYCJK:ZU2\0D<@!6B34U:7OW1\O0U?=X9_NU5XG&]JO^
MT=7FJ1&W[/$[VX/9!1OOL65KQ,;OH_YB?Z?N6HLD5_$?=S?/OP,QP\4:S^^.
M#HI=7;_)CEZ]N<:?FQ,+T?G^I^>X^N2=$>C;XA'QD5`D)+#U)1`C:@5=36U"
M[6&8/W<F_8#KB"8]XQG-!?%<7<W.Z]K4HY'AOX]-0;<SV,#_SME<'Q[?AH[8
M3#S3F;B'F?B^20X=0G9?JF',Z6E9Q7R7;#9E_P8:;#Z+"]BX>*!()=>B$_AU
MXPD$K&&&`$@D[IC995=/UU*_U6NT>W6IE@"4NO3-,UQ]89#&K<$>?V6#QIJR
M9/3:*O8C(YLTH\NCG3)S\*"Q+5UN#:)33]YC9':B8TL4=09+I0$;:IOJ7MV1
M"*A!C^9JP,4:`04]!U4@O<X(;L(E,%/^Y<%;)SHPH<#_)(<L%!MNH"NP9$WH
M;'JF"YI7&BL./`@DV[\=L1%]X0P>44-GB0:L6/`>?#NI^3!2@2_8Y]M-BC\E
MG&,J1'_KC'YV<$UU=%#GU'$`=RDNLC'1W_#-=L""SQ\\%@!GP,3X3-)1V(@+
M),DF8/D`_7"'8>"O"QM/Z<$=RZ/9E.Y,:4I,/%!>9^S$2%TE(N'=NA.*FX8#
M'M``'Z>6I3G(I$/L%Z`"IL,.QI=H=="C<YV_8/7]_E"9EDL-$W@=2I*W0$WL
MT1.'$6X<(529&I'`0,$$F3!^#5C':%#5,ALVF7BF1L'G+VH+Y9VJ+)CH#[TZ
MV*5-Z0H,%69L^;_"1&/R%$+@0V=0!PN6SJWCC?])U$#-`FATPH[@X.-48J.I
M#N1,T3['.CMS':;.!<ERI/%[DOX5TQHG_$G'96A)3]%5"K_C`Q@N:YI%Y6>F
MH$98UF,4`E0WP+WS+11G$XO^P9((?QKO3'<L@<E;4)`%H)H0$@(*I5HC$V+;
M%)):5(6@X@%*;05C8!*:>:C?X`;KA>MG7[LLB#VQ[#E=EA?4Q0IJ7`<UQ;0H
MO"'P_/B_)ZSEL">83"@[7*-]]@R#P%_21>WIZG/M(TQD-WF9KS&U;Y,Y@)JJ
MVE6*@)9ALR>]$\6FPPIC\-\>\-1IU27<3@EXKVHM)=0VR9HBT$&ONF%(8Q+%
M#UT>$G0/6S'0?J!W)BN;>IJUU^VU8-?+#+[?4(5=^PN2"O("0+A:G5J4KB4&
M#,[`*[$#`C4!@?2%2S$<*[9Z*=H+SHP6K%(@<,O27J>:IDTU#34B?)AH1/-4
M5T?]I$P5C(+%E`1A_F$JI^CN,E6,WVA,RGV%YK^7J9I7Q8F2IU&#$17N.P'2
M0).\1[')E33H83?`)0:=J;V#X$,]KAJ>%EX[5@R*1&=&X(FHE]D`^'0TI4?%
M=KD*#SGP=21?A^.#@QI6M8!YJECK\&S%%Z.%H@<W^7.0+"I<3%#M^8O]8@':
M/F9**/XZU(S-*E7_="KP[AD)!9KNL'47&6`>?#JHB9.4(JD#%-,65=B1)T2B
M`.'BF"JW4>X9H1Q\<UPDZ%*X6-C6FSZ'088I_B#7![W.JASOF(FPUG&7Z`V,
MN3&='(-IG<$HR7F9[+-<IC*W6%A_+RKS"F4-5J(7B51:[XKAOO_F*>@<)L0!
ML,)&BF+ZBF&4TK_VLN.&)>1N:[#DJE]+49Q1S%?0/(,\3+B!YCPJ[ZAAKDP-
MOK$]HGW5E;%N@)00YQE_B?O`]WF`<(]GN\?#H^5Y><='@Y^B'O$#G&4Z=4[;
M*0]+)'C#<SEID,I6N_T3RA@B`7[L%S5_G86%TJQ7WY38,5V]"(<<C@>,34!^
M:I&,G](X@(Y9.9,A%$Y!%([<BBJ<=CD5#EH=0MD(@">R)4<!WBTMP#L;A]'/
MI?@FW[R@Y\2V#&.=`BA?H:@"G?W)_\AXNYM.39F/\`@DE@R)G5[&F<HR(_'\
M"F,^LI5"PK"'[GHTY%"]9:.<I1E.4!&IHO4%!6@K#-JJFD7GO(%Y4=2-JFT)
MJ:ZH5/<'%34Q!6BK"]J>Z+%6F85H):,,<Y`,XCB6+1:E8E"=NWP/,^K2E5F\
M!68%9LN&V7/<'=T06W^AY[@P5=:!ZVDZ+SV7,5%TFYW?D&9$FQ+JT;,]T>>F
M0%3G+_Q5E7X!VNJ"ME%-R):^`O]AVX32@]4+EG9]I#XW1=4#HI!X/J50,^("
M1<QY.TV"FQ"2(G%5I,6V<C)RBBYSQ8!=97MN%"@+JW"BW:YWLAH85TZ\!=S/
M&NYRO3TXIXY*1RY\O\\9V8SCNNN*8W^UG+4G=K=_ACBTNZ4WX,0%/H(*;AJO
M]X7E6%TRIV49+.HZ4*/SC@4R8.)Y@0LL/4$+>=`B#P:@`7BQ3$E5G)DT,:Q7
MZB''*A-:X%"/NLOI;9YI$R`<"W0D/4MY472#GFW&4B..`G_,%?LOPL\[$]6S
MJ6!DEG'9J&3+9I47JW0$N]\MTII<46,BE8=.-WHZ3(Y4FSVA*S'[+-B?1+$E
M8F*!G%C-EMW=BM4Q#80T%H/PXAY&/K`P_@@6SFV6OM/23%?X\I`+]D=H;)2'
M[-`J.E?%+/28T&-"CT7U6+`G*P_5-+U*J#"AP@J/U&<LQGVN0-TAVK?,[JZ]
M3-9MI4Z!FE7>DC'SF4QUTV0-!&B1V77X*5]J08&B*/D'!7LB([0`I`HD5C7-
M4^"P9#BLK$;<.N%8F#]^7G)B<'%,)I9-NTK$NCZ+TS4%H3K_RB/U;JNBM4<$
M;*L+V[:HK%$`4@5FMU2U[4$U82O\5#L9:JPQB!,QQXC&BG0H889@8JX8)G$)
MFZT85.>N2"X&67HDSWUPDA[Z**!X/E`4#K`"D"H@6V'M>8@C]TD6R?E96_?$
ME6C?2]-M\!ZVZ6GXZXPK<5"Y^*JE<,>[VO7^($/W5"Y]0<B)D)-#>_>$D`@A
M*2)7)UA,!JW6&<G)`2I?=(4IS$B[-;4MLN/21[,RZ@EXD33+&QND^`4*CD7K
MAEIGU,DH$+Z1Q)5)ZPCX"_CO:)D*[`OL5PK[]5%6FF'EX)]G<9KMR\&DU:>Y
M(1-BVT1[5MZN'(>XSI697N1FJ2[-5O>*>C1;VOA;UJ-I#S8X.[6F'HT_H7[Z
MIZN\$4PWF!A$=27`&@B+B]]*L(."KVAM&I?,%Y:MV.^2IL.W-H$M@B.-B?M*
MB$EO4A7;?L<-A,(3&.`NA0*&59@)(4,KRTQT$[89NF+`F^')+MZY\.R%A75H
M\`9\IO\HS\$<"+@K)#FXN"D]`=<T:Q54`KKM+9/P][MAZ1TJX'_KC'[&"O-\
M`/`Q/HDVP7+S$\LPK%?GTXJH;EW<!NX9V])ELG8H3GV;WB'KVV"AR%,KZ%,>
MXZ2_%JDA>KL=/=G9/X8+(H'G`Q_V]"O?[!Y].[G)<6A@'+0.CI#:@DEM#N>Q
MCR:U#:R8QR@N>:&JX\%"0+Q"$.\(B.\4C2E*OX_1!C!(B)HT1BO;J7`WL;I]
MV#B/L``+\18B6PR3H<S^)`$&`8:U^K.XW6@WJH^<J3Y_-)^:U.%D+8BM4#<0
MGF-A[J2)9;\J]FJ=LM*G91<HII![R&!0'_5ZU11@@<7285$^M];F6QKCA5A!
MDB,:X2)RY]@*,?3S6T?*F3:9?PN5=GTH9^1%EEG.!6ZKB]MAO=>M:%&+HW>-
M+<7"=87A9H7&TC'F;1.'V"^B;:PX&W"4-$5QS$Q(B9"2-:9B;XM,]M)+R0$W
MB86U@0M`7*FMWJU%J'ADETTL!9X%GJN$YX,$MHZ]H=LD$V#=?HXVIDA,,.9%
M=H$_CU;7!3.3;_V$5[(85.>_(9/KK59&9^<R2[S`;75Q*_?JPU9%([@'*"AP
M:L?D(=:QOV^_3`EO2_%51>&\+1?KUL!]*3J*QR:IFJF`OX#_]O!?MY26`_X'
MV]X5UF(M`'&EME&%ST7@6>"Y4&27#<^'*?56^IT9%BQ>]2_NN#D3)7O.L&1/
M1GG^RI7K$=`7T#]3Z.=6J6JK`E'I%:IL_45Q:6TKQ[4]I,6Y,Y]<Q27X]\/D
MBU\PZ-%B99J^*+J-?LJ,RE4'>*:H:+5J$YVX9M'@D#6+NH4RT'>M\]./'L?M
M'L.0I5_D4N='%`XYD'.YT+R(BE8,Z:)^R)'*6E5"L<N]HW@EC@_QSZR*O/0T
M(\25@$@:3=X=Z^>FY\I<("D``5K3-)5@C^2!RBDY`?.JP?S0NDY`7D"^X)`7
MFGVM^5J(AN>^$7S,J%8FD1OT'0K==%B:VP$V:(=S!6MW.#-I8EBOTHQH4^S"
M&;CQUL$N7WMZW7C(S?YV\O7`>I"RQJ3\",&N+!<WF%&@6$7^R?_==&+*''80
M:2<E$1C1RGV-M@P**%9O[LNF+"L*PZUKX.1E+A94-GN%IJZX=E8Y%SN18UDL
M=!>8.%&-^@S!()1;L0>[:'@6[KF]W7.FY2ZYZ(1CKHJ.N7+JU!-45*RFIBSZ
MRG^ZR-J!PVB[:!.!+Z$%"Z4%1Q75@L([)[QS0LV(#6QA%))8-@6>!9X+/<3%
MI%K@N:@.QHW2(L_=ZQCW.$XP]13+Z)+MG8^[9"&7TC%IA.>OCS$FQ36F1>&Z
M?`K7#8>CX[D@"EZTL3BX*">:CPZ/0]<"*<)AA=(>P!&*O4R*_9RD0CAXA8-7
MK-+"@5`8A20<8@+/9X/G@AZS$>`NZ&`7#=R'J4<LO+U(&FV;MJ.C,K.0:S%,
MUETH+ZXY*TK0[N<Y[>;8[N8@56RW\)RN@71Q0%S.97[M])9H[:]<P>6]%7W!
M+&&AYX^5%5LYZ.=8:_P`);W3:I#?SA>&]4[($[%?=)4\S12;?%8<HEU;\P4Q
M'5K6[<KP"[P]3+X3U9J:^K^)]@AT67"=XSIIU<@/_'1:7+S=ZW4&S4Y_L'MU
M\M5'E+M&>2ANQZ]$+K=:H?9FZ1DU:6S9&K'QLNCVT)=EUUHD[0S_N+MY_AUH
M&_(=T9+@Q;6(__9A9Y"]LTO4=<^4V7M@]GN*KDMH1\/>$T6J1-[P;WB430R:
MF^-:DK7`GQQ),8%*Q8:Y=1UIBO]BOP,X'<]PZ=>OQ"9PKXK#Q1)[+&PUZGS*
MW`=NJFDR-KI;G^%);LD3;%Z7YBJ%BMA;.RO)/<':GQ=VAZV?H@#=8)7*"A7W
MNT4V+<^PRF2G&ST+)[>R%451RTS^211;(B8HB'#@_.+I.[J+BA"U/C1:#EHW
M78ARP42Y$@5C14\/`?"J`URT\A``KS3`VP+@*397`9('"V*WE2^>6<Y04$FC
M/F7V<@MT"W0+=`MT"W27#]T%+/[H&VQ%3LS[3ARBV.J,1G0T\D(,:X$QMR#Z
MLVY'4#Z54J"LAMR3%F2YFM(O@%@R(+;[`HBG)U4`\6<YH\Q!F8&XM?OJ))5J
MRF`B_49,8BL&M9`4;:Z;NN/:-$5M8R/I9)YR<3;_0%R5:!=71.?\:4)-15UO
MSU.<1*D+(2-"1@HF(YW!&0G)84[T%CU`*PZCGFKS6KQ#2EG^OLH=4A+8%]C?
MT,4HL"^P7V7L]\X)^[D=3CWP"<_J'%/M]OK#_4ZIKCRAW(=4-_)CKS^H&?-C
MX]G1?8\RKCW@:1/'M745/SDN@L<S]?@13\+QPPZ!:KI-5->RMSGN*8YNBJ.;
MYWQ:0!S=++"#Z;3G9$XMI^*@:9453U6.*8F#I@+@E0:X.&@J`)[,EAP%>+>T
M`,\^:"IR^44NO\A<71O;J\N#C$JS9?;H"BR6#(L#<;"D"*0*)*)6[&=49BTS
M%D5*?^E3^HNJ,42V92[*J5OOC%KEVLZ+K&0A)R=8Q'OMC'-Y0DZ$G!21J_RS
M]^O=H4C@%PG\I5,%(I%STT3.>J^?X>2K7"ZG@+^`?S2'O][N;K%A$O`7\*\2
M_+OU?N^<X"\R^4^=R8_=HKK[-YSJBES^W7+Y-_5@'R"1?[=>3<5.WF?C*I+W
MB^&=.@#AA<O`$LG[!78N'1HM(AV^RJ)<E6QAD0XO`%YI@(MT>`'P2@-<]%T2
MR?\B^5^DN6X1&&F)A.L"D"J0^'.[UQ-(/#VI`HG5U8DB\5\D_HM$S3(G:@[.
M*4M3"(D0DIW6[\%02(F0$B$E:ZS<,Q(2D?!?$3T@4CZ/L0B6/N%3@%^`/WK:
MI9-1ND&`7X"_RN!OM\^I64O54OV_>*YGDV^ZJ<^]^7<@53$>E7>DV?EBV0\+
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M<A''+KZ"*%P<N],]IPJ/1PYDET^O/%NN8NRH6$1XY`S#(W*])Y]3=#"W`,D>
M\882!$-&O7UC(<M/J$8H))=J1ELXP+,"!G5I0F%PDL!!&8(`)RUX5$IO_B:S
ME14I$<[\4UM355G;R^',WU=>A"^_:KY\.:LP;Q6%L\K+F7#E%X?JW"5Y6-$#
M_-7RY!]`Q(4C7SCRCY"WW!=^_&W\^)72*ONX\2NJ5@JT*2B>KNAM<<:A4LJB
M;"[\>\M\(8Y+M.]!(?DGK"/_`\O(7ZFN_J*[[YFN^QV>0%WNW5Y_N%\'@I4G
M")?]LMX_A,O^>4:XVQR]H-S3[,WGBJW_&VAQX6>%3;-.T,%N2QY'Q`;="0@_
MMN.P@H:Z3537LMEC\,GO007SP/]*8P4E<."?^!1*_Z`-"M!B.;6>%35QJU83
M]]Z;CXF]NUUY<KOAT+#8VI=Q[&IO!9'[\FT?RNEUV-K2+Q[99=X]%*00MB_T
MI_!(;'J&\8=O8RHN-13'9*J;)EJHUD1:T!/=(M)1#*I/D$/8[[?JO;8(>`A]
M$92$97M.H1.*0?4)=$*[UZ^/1#:#T`H1K?#%LB=$%WJA,%3GKA<NNMVZ/,PX
M<9!GG"=)JWS<>_D_29GX,DC_W^D.8G?W4SE$2N1'Y*-(P,(8=NK#K$[N^Q)U
M%!?HQ@IFNT.,0L4DN2F(J:&#`O_<S$FQV]G(@LMI](1AA=3/J0].#D?U;J>]
M%8A.'D$Y;>JGT%-<3]V^+8C*8_*HL21EXA(['G,7JDJHJD.IJG:[WFIWSU15
M'35);(=\K.(EA[5[O4YWO^RPU4>(]+#E5:.8Z6&8";;R4R1G#)#@>(:KX+'N
M"N2)%?R@]YZND&&A>Z^<8^)85R2.G=Z6R"MQ[)3QGQ(T"CUJ%DEQU%XY-R[Y
M[4OD#N.[<9@A+/+>HQ@)(R50#7LGC)QZUH7X;RO^PVZ]US^SI+'M3K3FX"PM
M@6H0<6,1-SZ<UKGHC^H=.4/ME#MJ7+!83`G4BX@9BT!,3KI'[M7;60DK(@Q3
M@##,`TB^#<\+JIO>F:HU)QBR-1V2&7_9YE8>-VGM'G*)WER-8,M)'?'#@SKB
MB]T$_0P=\9V8(UYN'<,N.9HG?K7?723R)OSR*5;Q.8OPP<])G$J@XQCUI>.P
MVY0"5W=(8CZU%.&N.6-55`5"<H3D;"XY'2$YPFPL#\`'S6YONQ0.P'A;8'P#
M0['8QF"A'6^BVT4QQEN`08!!@.%LP5#`Y,1^">*`7RR;`.V2ZMDV,=5WB;JY
M#07]W)*F3R8$OR9.'4ARUYE2Y2M@4:`"V[F?D.JV*MIV6R"Q;$BL:@-X@<22
M(?%B-"S&P!PX'2K#0BE7K^_/BOD7Z]'J.&"B.-4S2<J9=Y2_I'8R>@453E(%
M$BN,Q/9((%$@L0A(E#,*\Q0.B0=HCEH^^^4.PU58^T:G29(2>EG(PG)T5Y@R
M!:$Z_TYFW0Q31FQ_!6B+"-I>)\/J$:`5H"TD:`=G=O*VPIZ@WQ3=E"Z^6H[S
M4;*)H?#"37/%_HOP@Q-$]6Q:$DJ85L6@.G>![PPSZO^56>`%:*L+VHN!<"@)
M)!8!B<.*VOB'*522F?A31F/*H,84GL*-#&3PET9L_45Q]9?U]E1!SJ"((B5[
M<)7_LG?,#CGYU"<1T!?0WP7Z<E;+N"*>3*G((44A)662DHN.G)$G6(X5XB".
MN@)@I`P`+J?8;2T6Q2.[A`M2V9`A\%R@P19X%G@6>"ZTNRZK+F5!3*H=*"_;
MGNA8A2CW/&92H**97&>,Y(QS*)4KF"G`+\`?]8;56WT!?P'_,X5_NY/AY:H<
M^',KEKQ-F>*T*LE/,\4FGQ6':-?6'.^C=1(VZE*YS:VB2G+\*B8#QR^&++=:
MH5)EE<5JTMBR-6+C9=$]B"]@KK5(VG[\<7?S_/LGVFF125A<&F*B'>5V,V?V
M,^7OGJ1WX$RN*7W%FV:^^Z7^$8J*^4ZI^UMG]+/CM]%\CZ946@N<3]8S\U6Q
M;=H4<ZE'I@X_.[Q'I[/:$',7B?<ALE&#RRC#X7*8%W!&@Y^BZ-A`;V=%NGKM
M(N]'S[`<8K<?JZ+=/48^3P+3!^YG&1;1#@?N$+W7BQ"//C1D#EI26\ASP>2Y
MF.5-MQ1GT9Y60+SB$/^#H"4'1NC5"^S9ID2Z?2.VJCM$>K1UE0CL"^R?#_:_
MD[FBT[;1US!R-FS4/,60GHD]=Z0+W93>P;QS/@J9$#)169FXFDYM,E5<@F4T
M;-UT=%7ZNV)X8CW(WK\4HAJNOPLZ,.H.6@WW(<G397FNX\(WJ'H55QJ3J6Y2
M/6Q--NR56;:TEO(DX^1_H%CNU7NMC&S],L=B2@+5`D4/\R^5V^R>XXGV`A,G
MJOD+,`@PG"+],[7KNS!E0U-VBD8L$29J):R5S4S4>DL8J)69\K(9J*VF`%^Q
MB!,VB0"#`$/!SR<E.J'/V6Z-N6`)C_NN-6-/%O`1E23VX"K_2A+]?K87MQS%
M),X`\`4RI0N'8KF958.[B&'.TL;S3T%X84TU@2R!+(&LX[BN-SK?)_8%R:D9
M!'[C)YLV2\S8[=CMJ4&UQ>'5"NT73GLFM]?.]JI7[ESN.4A'T3<7)X5\KREO
ML;L0>#\]X6(UR"O"VAQE=&P3HG'F&*K<4M#IR&<$]\-4FQ.[MG71'%J6`79M
MN%T3.S>Q5A]KYR:+G5OEI$,LUYD[M_8YK=?G@'>Q&AQLYY;19$B(QIECJ')+
M0:=]3H541;3MJ/NV%^*XT>)AX5]X&7E;$)57#,0KQ0Y.K-DB]B:6;;%LB]B;
MP+M8#43L38B&6`I$[&WC'=Q1NP%L4XY_NVX`]%OGRG-GEJW_FV@_3(W83RX\
MAVVJ'@W%=#Z_^Z4L:>6R[XHYW;)SP/ZO$5T&UN_!MRY@]T_/<?7)>]J^>ILM
M__HJ_S'JL-?`6O*R]OS/,\(+^&,Z+:^:3URLZF^[,TF)-@]0#(,&:P/?`'H`
M_#X!L:Q<!R^/E1E?[0ZPZ03LS6)&+X%-&@N$G12H&LZI(47$I;7IBI5>#S*)
MQ560I\Q"IKMKD]E,O&FS!@^%+T[YAR\*E[[W+!MCNY_C./4BO7LQTN,6(#WP
MA"8.\?H:G0DUJF,CN<,C%\26Z'H?>]KNB-K$1BR889B[A&PX-:47FN,KQF@L
M(5"28%-@]Z&Y94K4:"T;F(\'#[$"E'T%2`+\0=:!VS!Q4JP$0E+*+RG;-#E8
M0?P.[UOJDW"6\G,^I>%W-6TV39+P=7MVN\.B5PI;'NO3.^%/4$BE*VH6GA)\
MY0R.YE_\?="M=]IM`54!50%5`54!U0-5+!Y6%*>;YT.O,<R%L`G[.=-^[@G[
M66CZPFOZX6!8EP>B?Y*`JH"J@*J`ZL$Z?F1D9)<9I]NXRH4%723@EL^"[@L+
M6NCZPNMZN2/7VUG51014!50%5`54!52WLJ`'&64ZRHQ3X8$N)VS+9S\/A?TL
M-'WA-?V@/:AW6\(H$5`54!50%5`]E/W<J>CJ+SS0905N^2SH445EJ"3@$[I^
ML\323EUN9=3P%4@52!5(%4@52-TJ@T/XGX7U7"#8ELUZ[C;;PGH6FK[PFKY7
M;_5;V=6T!5@%6`58!5@%6+?K4M!L991L+S-.#]`/,ZDR3\$L[!TH+Q3@L\L+
M%;_(]I%(W;#=PC;M138L^U-<@3X#M)=ST2J<8'3J;7E4'PVWZ)DGI./TA`OI
M$-(AI$-(QVFEHYE5_J=R@K%W[\G$$1"5%BFUSY:K&$&S"3K<ARFE7TI1KJ:"
MVEK!%(.MRBFR4PI0@AZIIDR=CM%][8`$RK?/-6S5>YUNO=W*J&]21+DZWJP)
M4:L@HT+4BCAKPBPL+5?"+"S>_E:<1!%!]R2J2R2K919+@6>!9X'G0@]Q,:D6
M>!9X%G@^.=EEP_/682X1T<IJBBI:AR6,69D._K0R4P?++.DE`5\Y5Z[\RSNT
M9'&20D"U'%`5AWY./>D"JAL>')#%H1_A[B\4<,MG0?<KVGZO).`3NGZS?.;1
ML-X39HF`JH#JJ<>U#),NH+IIX9Q>-7$J2D^5$[9ELY_E9E9N9YDEJ"3@$YI^
M,Z-$>/5./><"J0*I`JD50FJW*8O6N\)^+A1PRV8_MYNC035EJ"3@$[I^,YP*
MJ^34<RZ0*I`JD%HAI'::PS.SGX7WN=BP+9OUW&GVA*87FK[PFGXDDDI//ND"
MJ@*J`JI5@FJ[V3NSQF'"_UQTX);/@AZ(_&>AZPNOZ^6>L$H$4@523SZL99AS
M@=0-[>?NF9T?%/[G8L.V?-;S4&AZH>D+K^GE?KTE(B4"J0*I`JD"J0?S/F>T
M7BLS3H7WN:S`+9O]W!7UZX2N+X&N[[9%10.!5('4DP]K&>9<('5#^[E349P*
M[W,Y85L^Z[DSE!K2!ZG;[%94E$J"0J'R-P.L/*BW1Q6-.0JH"J@*J`JHGB`(
MW19IT,*4+A1PRV9*]T4BA]#U9=#U_7I;A,<%4@52!5(%4@]E/W<J6H)+.*++
M"=NR6<_#9EMH>J'IBZ_I16F#4\^Y0*I`JD!JA9#:KFSL>1OO,R?O\>KFYN[^
MM\;GA^?GAV^?I/;B+97C@MC6.U!>*,!_?OA^<_L]H'ML*.I?2+WD6(:NK;SF
ME'9YGJ1N6"HU,_\Z`1/;C4?1)/H,X%[.5:MPDB&W!MEYM$(VRH<B(1M"-H1L
M"-DXZFYHF)&+4SG!V#S`D#("W:01^%GZ=O7]M[O[QM?;+\^?),H$_^;[W6^_
M^U_1V^[N;V[OV3=K=UJ4%DU_6=DKCPU+_6MK<-`O_KAE%(TM0]N&[AB[*YQ0
M:I\M5S$D:^'JENG0T0;:M]1/W5+K)Z!>TBQO;)!**:@TMC;2,,7@:R,Y+I,F
M.Z4()2B2BDK5"3G=UQ1(('U[ZZ`NR]UZ*RNMO(B"=;Q9$[)624Z+(FL=(6O"
M-*P$6\(T+-XF=[LXH-CF9FYS7Q7;5DS7D113VW//*WQRI>&JQ&JM]+Z[4PI0
MSK;IZ63J=(P6P08/N9+;]7YW6.^T,DHF%E'"\C/'A=!5@-$""MU`")TP%2O`
ME3`5B[$#OG25L4'"C]']V7\V&K>F]L56IG-BNHV&3W=\$\<__->EYS2FBK+X
M]*3.B.89Y&'R-%-L\EEQB'9MS1?$=!3<"-)OG2O/G5FV_F^B_3`U8C^YL)E]
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MMJ:8*@$%X,ZDJZ=K:2`/F]*5Y'CSN6*_2]:$WLZIH$+[M\[H9T=R$'><!G@0
M@QBES:=KBDX5H'<C^J@<23I<X,!##,-Z=3ZMB&_&5&WD%MIBZ)?44PH5T0>R
M12)4R2AM.RE,D$1B&,Y"475S^DNMQ3XO%$WS/_L+SR#B=(LZ"L69@$)9?MFF
M1BI;W?Y/J)01"?"CW"V2@S4*?!7T*;'3!.E/HM@2`3G7I/_V3")U6G4)EY+=
M':PGMV<.C92XDU^(<:$F9V\QEEM1,6Z74XKOO?F8V$)F!<0K"_$_"!IPL$Q=
MO1#8)1#)W]-)=%,GL"^P?S[8_T[FBF["?@-V?B;LMU774PSIF=AS1[J`G>,[
M6'7.1R$30B8J*Q-7TZE-IHI+I#N0`-UT=%7Z.W6@B/5@[R2EDN8C'33YB+MG
M)<MS'5<QT;LC*:XT)E/=I*K7FD@+8NN6M@YK98BWE#-*E/\!U_JH-ZS+O?YA
M1K)HT9R2@+5`A3M.T-DE*V8OP)<_<0G65#'$1(!!@*$28-CZ++FP7T/[E7`_
MF3!3*V&O;&0D7,B]["*1>5I02=KD8TGQ=\Z69ZLY%)9GH8@3QH8`@P"#..!9
M+H-T8MD3`H;[6H-49.:7D:O\C=VA7&_U,OJT[$O148)$219PU0%?(.NY<"B6
MY69OBX(D10A4EC8B?PK""VN>"60)9`EDB9JF14BN(%CAA1UIVBRU(GV<RR'H
MYUK`Z@2)&\-^NWPUWT2!MQR!=(PMQ4E!WVD.MJCO(/!^>L+%>I";:,A"-*HE
M&F(IR+1_6MV,I-7*`?X`@1NQ64O.)**5$V"SAKLTL6$3"[38L(E56JS28L,F
M\"[6`[%A$Z(AE@*Q81.QM=-OUUZ(LWN2776TC%B`Q89,K,)B%18;,H%WL1Z(
M#9D0#;$4B`W9=ANR4U3V7ULB?ZER?^)36#7^Q)\.6V%?\DR=W?GCZ:8F:435
MYXKA_%)K=&J_]H8]N=5J19A/I&AOA@:M]0RU8PQU?(;BMZYCJ#T8C7)A2%[/
MD!QCJ!TP)&_#4'?4'AR(H2OL5C@E*`R?W\-+'I5W_.KJ5;&UVW]Y@.8[TW%M
M#[]T'MP9L9]GBLD!_\4_(G=G/M*P:L8H'>5]%.'=7G_8[/0'NTO(ZA."2:`-
M"ISH/-S=?X&)Z,K#SKII.`K+><WM;[2994X3&W_9R695;O?ZH^Y:\3H\Q^<R
MJ>U>K]-K]EJ=T>[3FO2,=1,[!"STSF5:_3*\O`HO_?%&<<D71;=9Z=$\YWTM
M-4<T</YW0>S_I9"((J)=^[73[.6BO;<<"H&7C?!R-/LQ`R]=@9?RXN58YGDJ
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M9=-]R$$G8/GA.<Q#N]5K#0^A[M:PDC`;X_5O&2^_A<O8;7@4+F@_1'>"<C@?
M1WG\`6<D(0PFM[K]U3#841@YD'2LON<0=EO:4W.0AV&_W1J-#B`/:3P<;>"7
MO"1^?T;:CNO0TY'UKL.*2(;K<G"(U6,[WHZFQ99>&C08C/07Q/:"!U=OF[[W
ML,&,7Q\[?\K?Y,'-433=ICP=5A)Y0-O#Q<_4;M\6NDV?D.;%/+Q\[D7!*:)5
MM.;FX61X+_Z/!H;#[+32GWNLB4N+.,NMWN`H<W;@'1-_P4-8X2YN`1UD/E*?
M?@H[\1A\'&TR#F@FKCRUA&;B"@]E'?CN!@,?]Y1N-_"CWE#N]<LX\$=?_S=\
M5RGM\PUY.X?).Y2$94T>=KD4DW<4R>MU1WT:DFCW!MT^.K'EC:4P]=[-S.WF
M05)`Q:2NF=3!'I,ZV'Y2#Q*L$I.Z9E*'>TSJ</M)[8M)/?ZD]EJ[3VKLW@TG
M]2!Q%C&I:R1UM(>DCK:?U)&8U!PD5=Y#4N5M)[7;;(M)S6%2VWM,:GO;2>TU
MC^0P$Y,J#SL]?V(ZG>TF-?7>C2:U)28UETGM[C&IW>TGM7^(S',QJ6LFM;?'
MI/:V-Y1:AS@Y(B9US:1NZ5%*O7?#XT"C`\8"Q:2F3>J6'J74>S<]0RK6U!PF
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M6-X2`<X:8OQG'[#J\T%?>8HRSW#G-M-]4'XWF5[V7`#0G:G"N_07\F@HIO-H
M&;KZGC%'F?<=>`G\OX;[\W\V&C</U\]_/MY*,W=N2(\_/G^]NY9JC<O+/SK7
MEY<WSS?2/WY__O95`@-9>H8!=72D4#$N+V_O:U)"CZGG[Y=O^"P9;^9_-MS(
MG4W-U6I2H_%_I^[/2(.FO^"?4N1O3MJ3J]CN%Y@`G"]V@[1\AXLKJ^2X[P;Y
MI?;EX?ZY\73W_]U^DN36`JZ@7WRY^G;W]<]/DJO/B2.9Y%6"H5),&#YB&,Y"
M44&>?ZFUV.>%HFG^YU==<V>_U.16ZZ>:I!CZU/REAM-"[)HTMFR-V'A92(HM
MO?"K7&L1^5[SZ?OC[N;Y=Z!MN'!K46[\WV_NGAZ_7@&INFGH)EFB_YG2?P_T
M?T?Z^:\K[/YQ>_?;[\^?@$)#^UGZ=O7]M[O[QM?;+_`5O8A_\YU=1;]ZOOW'
M<^/N_N;VGGW#B#.:2-YE=+0O72W"5DXL(,0;=&`_2?_T'%>?O#,"KU35\D!*
MS*DTL6R@P%+_:E#[#"0C%*I,+BY=._(W@BG\N(3,%1;'!KQPPR%.8")MW/^O
M,E_\;(Z=Q<_;4+'E.,>(1D#N2_7SC$BHRA3S75+8Q#B9TP((H1?:&O:@`V%S
M9]+5T[4TD(=UJ1;5BJ`(X!%2]*N:=%'C%]<^2K`FTUM[K5ZCUY)JK*%6@ZI7
MB>M[1W(MZ1X>=CM?&-8[`9NQZ;]/L@G<`68D)5`Q=4*OAB4?EAR72"[P-E%T
M*M^P+[8F$F%O8%PMV!LD!9<41P+6\`8-[X1+IS;V=/(<A*EB2A95\8T%+"7X
MS=S2B-&,C9[_6B?AO70P^3,<]F@@@#T<K_YL*##83^K,,HC3^$9LU]KDE;$)
M(WR`*`[_UAG][$AT#4[F5C44Q]$G.ORB.'Q<_-]"NBBE#3HD$8;FQ)U9&B-E
MB<^$%])%!/9)E'7=@4E3K:E)6Y;!FV%HR1OB`^Z'59N^E4XKK#NP0!#[!<VC
M!5W>Z[`*N'0:^5!KR+C?-2!M-B*72(PR&-N9#E,"`ZL8]/6V3A#,"$A@&,9[
MP9[NX6VX7FMT%5Q^AT&M3,1<P%1<5E3+<>GD`)MT<)F\^&R%#Z:OGEI@*,&D
MSG3R0MC8S117FN$PX51H\"YL4HFSXZ@SHGFPAH:3!6@`BFQ*.9NBD%_\?>X9
MKKXP2(,!BQ.D+!:V!>]<734RM%:B+L%[QK9TN;4F/K4.O/%LNACI#N+AG2BV
M(Z$15L=_=NC48,=L'$1`PRO^P[3BTLP4CZ^B))AQ#123"AAS,@<VQDNW,T#*
M-QILJ;2CC1($NL>;\_$;$\-ZE4!O@!`9Y`6U+A4HQP7Y1"PS5P'=882Z$U:A
MA"GZ5*:!N%M=2)'B">P.4BWC)3N-/HBOAI1UO!F_JR<,((`R;51Q].=$<4#;
M@49`O4-`K8>Z'99<PTBX&\<][9E1@:B'XD#O,6%="Z5E:4[C0D?%S;\"52F(
M'NA-1]<(:^KS,Y-+^(G45PB77MGJ!G(-]*`6I#1*"[KK9IS&EWPAKJOB2K@_
M!8:--/P5*%Q7)5QS)&4R@8N8]6,RWR0NU:$CE<.C*7WV5R6^D$8LEL1UF4YK
MYKOA2FZP4=.5P=`'34PS@P$R^(E>A7I>(B8NJO_MF43JM*@RZ?K08QCLL8N1
M@)0;VG5Z82N\T%\9\.M56N*28$TF@$3^`7$-BS1=3V#LW-#6$*A<167<]%2V
M5E"H&C3B$GL.FG3)5E(-"RQ2,%W1J\"U17Q&ELUL1_K+M%Y-7Z<P-*)F83;C
M*W=-20KS344N2+*A`\!HS#9)-TJ0BP^=9J]3QW]UV2\?L+XN70-0</478B0@
MZ#\;C5M3BSMJ5C?=_,,ZMUVF"VP3WQO]-M*T]P<(FDUWD.S1]'$QC]YW]!-^
MM6"!8'_I<SVK">]A7I!/`M*F!:(ZPW7S<ABNCSB!?K?@2,2-NW<//Y?I[\JA
M>G%:Q*O5VB"B?7"&SW!&#UZZ.&5&.Z-A3\QH'C-Z\+K%:3,J1#2?"3UXS>*4
M"6V+"<UG0@]>KSAE0D=B%<UI1@]>K#C-+NJ)"<UC0@]?J#AM0ONM]>7$Q83N
M+Z$'+U*<,J'=MC!S<Y'0+9O3K7<JI$VH/&BOS[T4,[K_C!Z\Y'3:QJ7?%CHW
MCPD]>+EIL1,][80>O-1TJOMO(%;18\WH<3MLIZVB`(#VVA8K8D;WG]&#M]=.
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M[)AV9V(Y7];D@7&S^L.1VPF.NKWE1,U5&O8CO[L!^9V`_.XVY'?D;G>T+?GZ
MU-0GNJJ8;MB'A59IU8GS#)1]Q@*_C*&-+A7MC0Y>+7FO?D!77^]^N_\D&622
MVB'H_N'Y5FI_@G?^=G_WY>[ZZOY9NKJ^?OAQ_WQW_YOT^`"C?7?[=%[-=#89
MU`V*4F,);Q`1C?4/T4W%5'7%`(+A"Z8K9LH+D<:$F%C1?*'8K/#]<B>`'R#W
M\,N32WN83(E);,4P:,L7LJ!UI,,N2@M;A[<L#+CPHO:C^=24?KNZ>L0&.XN%
MH;.BUK1DON-B4Y&Q`G]MU>XCW]D53<*.WR1,*7J3L!\.B7;Z<:K5#:R:$,^F
M?P4?2;U,LL;M^`!-1>,SZS\!VII:^HC,1-VN4T4[L>PYMM.BBGQCU1TT,P/:
ME"GO_V3!I[](*`9UH$NCEH?#VDY$.^G0;E$*;:2C.&#4(+3&N$N1O`5MW(:$
M,0:4%T4WZ`6\7P&B"_]X9[U@%(WU+7"2W[WR:A4;7-$&(*P5U9SU)8,A`X.4
MK7"T*UK2H-%GP9#0M@HX**;E8IN0*]I;&9L8>(:+/=X\0Y,T'=YB2VA7PA.M
M*'W9*DWHB$+HB&(M@^.B+X-?/%-E&Q1)]6R;F.J[WX?DR1L[NJ8K]KO`?7%P
M/SK+M3&"Q;`MCDU>B.D1UEV,+8-T]0-U'VF[`RL#W;+<6(:!/6XN:AK[J_:Q
M25ND::Q%8EV:8S-%#GZ^D,!BL2H-(076@K`%VZ%-%.FF"Y<V?"E_2ZRC8^36
MR"(\)@8V9.3K*VT81N_%7E*L,16L/_;[BH`2,`6LN:Y*Q'S1;<ND#X,WO\YT
M=;9$-">5=;'T8*E=?7_X^LDF2L&GCM':I%UW;<2_\8Y#:1(7+PHZB,X5W705
M?T;X8[&AJH7=U?#=9I1U9F4$+>/@7LL?T;0&L4/LEU7[8MD$,"1=^X1_4US`
M`NWJ:AC19J'2%,AAUH%A.0YV\F2+?N3-='R`]8"?L6+0MSHS0F"PP<1P.*T3
MWJR36R*!_8&W1W`",`F-%+#-+#"+L+DJZU&*1I?#6F;"K&-S)Z%[BZ-[RV%S
MJ$6W.1[#/0G(1NC0TJO6D[N::*^VI;'>OPK@-3R-^"V1V?(&0'XT/!L]H'-\
MCJTLB.?JJ@,FAMJDBPRV!`R73[0]8([XKC3>Q!JOY@M-U)T+RS28-)0PNM^.
M28Y8*$H@.L5:*+2B+Q37BC-C?4OQ#W1?P?BC#`JL%P?KY[<AO5Y"(]T`.!@9
M;^"N4YKITYGQ+ADZ7(+[@3",'W6@:CI<`RK\A=BNCO,..QR*<[JAF2LNK":N
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MNL?6C_MHID[_7/5I9#&SPWD,U`W.I;TTOQX&V\%0=(CJ@>X#^0,CU-71>1]S
M("SK1=2(0C]53C]-BZZ?OEKF-!7AA])*%)H5WF&?GR,V$S9)&^30X`RLRB55
MR4-P8.T91'%@QSP%PY3&YQ*5Y5[F8W[`%@HW7X4[*[K"_48Q2F?\"8%/)41L
MC_,PYR)Y'F%<:&+9-/`3]0+J)E<E3#"#:4I+;.BT6XU:]#10`W;`8Y<:B+?_
M\C`3-)SK6BSA)$R$8<D:JJ$X#CUSXZ>9)E,23=J$BQ:>K<ZHUJ0V:8.@#J0Z
MT?%`2VK$@0$*$QPPKUJ![^/)$NBHC!/G4X,O-`R\37>=-(J<,*>T`:/:<!0#
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MI2=4`=&'U.'W*:&2045+CSC3-J6RCF0NST;*V`LQV7.U0J_FU`0TX9Q+.GRI
MVU15@9ZRI[`2@6J3%#P<BO9+D&L?J%!?<Z\JZ!0(CHEAO8909Y(`_\/\?V:U
MCPG3K0TTZF$K,`<%3+,F8NL'GCE#Q0EDV+KE@30IJFNQ%,&H4`$#+,O0"GE-
M9+4>,>N1/(.84W1S3X+S"Y&5/,SY1$7#U`S=HC`9P`S--Y>?L@AS,B/#%MP?
M.L63E4XX2O4E&B(7A?YH&!>6TTI%&&\P84?$-E2PGT&%Y#I^1J>.YZDQ?Y-;
M&G*KT>G5I<T-CGIXLD0QDR8M.LQ,W<&S(FA@T^VPTR]^LN>%\C$4K/#(!R[%
M;*\6*$N;`+-L])'`BW':C6S)AF=38X,"PL?+!0S+BXZJ)DB"#2PH"\USRZ5J
MS.1;2LPDG060?N?Y/0AAO)+N1@W]+V*\LUG%+^F#X9I7'6X>$W_0P@?JF(D[
ML6AT6+5>B/W^L2E]02T9&2H_@*SAYE5+DA$,*[,!)UH]<EB&"FDX$3R8046!
M*MC:<CR#*=?ZVH169-V1,#>)#V_RH$?FJ8[B`!HA0D[DPOC,K-"YUN02R\$.
M5-\`PD"@\.Q\'?_9H?.*)1P`!E9TIGBN---[W*))2CPHW'Y1^$CR\9'H1?>1
M?&?G1N#?5*_0A3)(_3=T%1/QI:O`/Q@]+A_-[,S5JW+&JBG%4N6G?]`WX7@*
ML[)P`K]N/(%I_I9^J]=HHPF4`)2Z],TS7$Q>;]P:[/%7MHV[>6HI9>]%DF9T
MH\";M''DK6B3]QB9G>C84O^01@Q8O6VJ>V&=][U*U`H('%>!\0[&P[\\>.O$
M=P<%)B,M8D/WP.'!9W8NV3)#VQ]SY2(O1..[1HM;`2L8-:`V><V'D0I\@4UA
M\^UV.,<QLYSM/]C6F1EX:(>_X9O#;;W/GTNW409,C,\D'86-N&"GD@P6ZT5S
MD1_N5DG@;8LP1P^V\8/A=;[/BI*Z2D3"N^.6E^*$-*!SQ;(TFHKH$/M%5[G[
MA).`AN>2/9@\5&@78S4?>!U*$LUJGWBN9\>F*KN6R!D*U9)&)-3A!-L,;]&`
M=<QTT60S&S:9>*9&P><O:@OEW;?@/_3JK58+MGW\^".8_?Q7W)"Y"@78A\Z@
MWFNU6(*K-_XG/7[/#7QUAH<&`X\FL?%T'Y`S1=>H!;N^.9CX($/H>AZ_)^E?
M,:U+^2`Z+D-+>LKQ]U]\`,-E3;.H_-#S(2MZC$*`\#W^?`O%N720DSH/XF#R
M%A1D`:@FA(2`0JG6R(38-C^)&U$AJ'B`4EO1IS.\W23<\X.;W9AV@=TE+26!
MXP%_ZY;&'2C^F5-`GF$MZ##PWQ/6\B=7F4RDL+28]-DS#`)_21>UIZO/M8\P
MD=WD99Y'46R"QU:IJEVE"&@9-GLTV.Q'/?[;`Y[P&"KNHP2\5[66$FJ;9$T1
MZ*#031+@ARX/";J'K1AH/]`[DY5-/<W:Z_9:C4Z+&7R_H0J[]A<DE873KE:G
MENZ)XPP8G(%76/Y\`K-WQ6<*@2!$:CA6;/52M!><&2U8I=!7N"3M=:IIVE33
M4"/"AXE&-$]EYR@4>J[;C2D)_W@URBGZZ4QZ`%UC4NXK-/^]3-6\*DZ4/(T:
MC*APWPF0YF'!G;AC*L-)EAC-B$='42^S`?#I:$J//`^:N9(Y!Q%/V>K@H(:-
M.HN=F>*+T4+1@YO\.4@6%2XFU,'*%WNL\Z;&3(D@?R;NDJ?JGTX%=\\&`DUW
MV#JMV>.`RE1GO%!#PB2E2.H`Q;1%%7;D"3>1)P2+8ZK<QCR[E%`.OL!'&DGY
M@2G^(-<'O<X!4B?/,#^M6*<=_UGTTXZ/-BH,'DS`,`O%=+5R=ZH)].HF8L8P
M27Q,LOV@JT3R)6FPB.\D@NP8#6-UJL[.I^.IG>`3KA.J8JC\PO$[7SW9WJ!!
M]P9SXL[`S`XV!WX=-LRM@-V((>$>*0AC*HY#:,TZ7L+&,@SKE69GFB:M\H;I
M2I^J)4V)EB2STZ+OP%*]N88ZAB!X$?&*2E14TOS+N]V?@N,%$S3$=B%N,['"
MQZ?(E?_6SP_?;VZ_-SX_/#\_?,.)5=2_I/;B3:*U%FJ)'+2'/V6O@$GV]_J@
MQAZKW4]KM$@F&Z><B*@0@F8>3U7+L$!A_TU5"9E,:IN`R5?Z<>#G/"_+$I@V
M4U\56)/8-I)LM.AG3-ZI&6_([69G&^;E5D/N50VJL']T2?6`BMLF#TNI46,`
MG6`+W#0:9PC;3J=JF*VL>GV83#!(-O%L4Z>!I9@E>S:([0L]6Q;$_IW,=-58
M<VHGA5FY]Q/V1T$CW<0..J=F?'N#(!NE9Z>^ON)A13P>@BEXML6"'CM!H]??
M$QH'G^MCZ!3T1=,"",2.>L[1S;NJ9`[]\L`O,:$U7>'EL7<>TI%0B,&.M`&@
MM?KS&&.:Q,YGEI[D;6:/\8$=/*(N0AE24/\J>@KJ79A/#5@V\+B[P0*-U(U9
M+3>E</J7R^F?7+!^!:2\D.&+3E[Y2<+H\9*4H\Q]C-_Z486ZA"TKW7C`JU:G
MY\T(NOUY1@<\.G)B5M5MU9MCQI-*O]#P0&6D>CV>\J5M7B(Q79/1+,V5=QK#
M'P>';%BZY'?_@V[@<1Z\A?'(SB;-B,%R`&A1"=V1@L+TXW<:<0?&;=UAIR13
M:`B#%'Y4G6<Z>J9_KM*O\C,QK%<GL%LX#6&#`QXM80]K2G<3=@H[,BM^MF5P
M<_Q`4&2>V,_11(8X<Y&S//`I/,66S2!Y`W-<<Q*."48)/_R9$Z$F"Z<FBY4$
M8!0]"2"2K4@/2&-U@`;+`E<CK8"KA?Q2I*M%*WJD34MJYI(\A&4OVLNY0?LV
M2]&O:M)%C5^,K35!%>*G7JO7Z+6D&CMWVZ!-H:7',%-;NH>'W<X7AO5.6+HB
M>T1X*)>5F.<';?T@>H)J9C4G.%=^+ISRJMB:XY]`H+6&X=*IC<LV*W&`-9=H
MD[8&'D?`;^:61HQX6EC00RWAO70P^3,<]NA8_83/&(%M/*DSRR!.XQL8#M8F
MKXQ-&.$#%+%G:+_I9&Z#NB3TV`,;%_^WD"Y*:8,.280AEK7`2%GB,^&%L:I]
M*P<N8&AY3EPT11K(<727^"<O>#IRD(`1IDD`XQ-"G=Y.VFQ$+@G/FLQTF!(8
M6`SMO.'3"8*95H,`S:3J"_9T9KT$9\V7WV$$QDMXY#XF*S1/D1:@,-G@,GGQ
MV0H?3%\]M13#B67^4H-O1O/982HPL1(/K./L..J,:!ZFJ@>3A;T1#6X_\<22
MV-F:N7^JBP&+$T1S`>&=.99.+)H.Y$;:!$Q4P`-+=D^PV'`0`0TT^QELMY@T
M,\7CJRAZ,@H4$SW>+1*D$W+D(VTO6:$,MM$RR`L_2!<IBD>5BD//<82Z$U:A
MA"E:37XJ\$#<K2ZD:[V)25MLOAK&?(3UA`$$4*:-*NU7ZF^)@AK3H6YGC<56
M[UZJWQI[9E0@ZJ$XT'OPN$TH+4MS&A<Z*F[^%:A*0?1B)^U^9G*)527J*X33
M%'>"1X/\'2FED1\KC+87\)=\(:ZKXAILTQ>PNOLK4+BNTL1#WKJ663^F-Q^S
MZ`1Y([:J.VR[1^'1E#[[J]*J!R9Q7:[S%H'I[X8KN<%&35<&0Q\T,<T,!LC@
M)WH5K:!)3%Q48PGT/O08!GL_!6<T4FYHLR;"K?!"?V5@E:J7:8E+@D5C]_P#
MXAH6:<4,2]?P(1*H7$5EW/14ME90J!HB331CMI)J8%MD,%VUV"'DY-)%_*E_
MF=:KZ>L4AL:P'N`KP:Q?U*[H@YM&+TBRH0/`:,PV23=*D(L/G6:O4\=_==DO
M']K-7I>N`2BX^@LQMBNTM\/Y#A'_R3?^,R]Z_"?U!%-X4`WW/-1ZKI:OI]Q>
MSO-K=O5]W6F]P/&`75N8=X`=>:2!"%I5+SAWF-$4-SB2*>`NX%Y`N'-/1E`G
M:HH>.=/'\IUC*\1@1BNM-D.%@3G8L)TVJQ._H!E<6OH)6/C]GW2?H-BQH%RT
M''/T!"L6S3%=W35X&4$,`S)"Z[ZQQBLL3,)JF[ZD,8\>GNSEWD;_Y*Y?#BN5
M3'Q,@NNFU((J3+1\3;0U#6M/;Z)]I>5<"=\Q5POL8E4JUZKT&92XRM2P;GBT
M!A@:748,HO1,+3NCL[1A7]E?ARXHW_V)?=CG<\OTHW&>2TL*X;+%=]FT3!AN
MM9F_,WI%/()'\V1H\6`2]R_0JYA[(=+4^HU7Q0A65O]<L!ZFTU"NB18R[!-+
M^1X35?&P)`6019?`I:+N&+5J!`-'PX'("W\V"Y\Y80L8L;")A6V/A<TJ^L)V
MQXHEN\I;U3K#B&6M7,M::KJ&'H%H:DY-MT6KU-,KG_%*6K0-%L%G:P&K)>IS
MU=;'/.<$%PC_V(#NYWFR3`":<&J3\7M8N0[>'.138@>1X`Y.IE^\R2][N>HH
MU_0)/(O0:\;$?<6U+JRPSAK*L/09]C:\T8DDGD9?JW-_8"P2&>8V$%-AJ1;P
M&%KF@MVLO#KQ&EDPD(3&H5A#![:PAE3BTZ,YIUA@UW:66O;P.OFX6V356OUR
MHJ\*#4;I$Y`E>)JCV%@]$)\">TJ2.++,*:3;D905UG^'2B^+K0H%)134Z104
MUS,(4)@PW9E1X*/@86L3S#FC[20TS<8&'DH\=],S_:*HB'F_,8C3#)ZJ&HK-
MLLQXAE+T[I@*'+\'ZLP7>NQL,O?FOI>(E]6%B^AA027V3I99%K:;F&/!.=YK
M8DSPB:N5[$)=%3AMA<M'6,;[6,:+HEO&UY:)\V\'>T_>L\36G;^J!7VQ$)5K
M(8HV/G-<V^/9WVC=+2SL,04_&>]AC>Z(Q>;2E+`0U\X2L%G"F(/!!UAS]`5]
M$%[B]Y.G?^#J`;-#:&@AH<-\G9T/6_HNK:UY<F,[(6)"Q$Z[&9TK_[1L?@`P
M.9TI52IX0EL@&*SQY+)(\":3W#F*7>HL`ZS`F%33QH]`!VP)S;_H]I=%%YO2
M;ZRC`Z_+[I#PL7BND9[CXWW!:*ELC<Q9TKX69H'"5?`Z:CSB-A3D7XA=@<3N
MK`\;<\%P:)5HQ[,7AL<%#D_]XK_7+R)XZ22V6.JN%\8E\+A(N)G3I*FG8Z\%
M$]-8@O`\/_:Z*OQA2T3\<:Z[+B%UWI:%%<O6L&U#I,$RH].-=#K$A@)T4^@H
M$\(+JQHZZ!$MHG<BW:*%>`KQ+(AXHF>!=8@-Y0#=F!/+T"W?C$1!H-%$&[M1
MNK#@6*8&TA7)E^'?T'@@[Q]I:N0-.X+\1?#\@[M\8(VUWG3J@0Q3APESR5(O
M(W5ZT-A?M-$ZNE.,H)LF%:Z@)REO9AOIQNYG&=M!;^.?PTKXN.:&/3["N4JN
M+#\&G4)>N.>9'UY7',?"ZL>$GW-;[@J/ED%('CL(LGP&WF]*X/MJM/`$?5/Z
MW7I%CVV<$A6FB_ML\7EXMLA66)N92#M2/D2Q0:%.IMC`3)9IKIANJHX_:%`*
M?]"_BNX/>D)Y\EMR5`OKY5Z'SW-W^N2-'3`387F(EN4)0I/T=%<4L4M%]J.-
M,MF.4H\@_!&N_ZJ\UF%P^QWI`K5_;>776J2U=OA7_"`UIIABWQP\J*D8BAT8
MM>$Y,W[86@]M[3`AB1WFP<-Q]'+6UT8),ECC37/8$:*@^@$+84828K$%VMPR
MW5GT0!(C*D@#HB?78N]#$T"AE@T+JL#6V9ID'A%*F[;\RUYLKSBNOM[]=K]-
M*8Q4\-&VZLQ(B)TI9,V2@@[K,.5T3HSW<#_'+"+3-TX68%&J?M0;2RS1%`#;
M4WB-AV@Y(2=R.:^@8&M!_016]HF;,ZL,Q.!4,7-&J/CRJ7@N$+2\!FQX_)YA
M*#P3G55"\[<3D3XKWL(_8).D'I.>R_V%*'::K;R:H"E!'(,&>R"Q$]@7^*<;
MZ+G=,9#,G!I)"TE\X3&45THJMC8(.X4YJ\*[RK"S=-84W3X.GE<P63VS%-&O
M\WTD'2YXS!SS26ST`:T,7<7$_&2GD+.JS;)6IO=8KQC7==B@RO44%1S"@ZT"
MJ'PBRX?O_:XO-Z%](NRHBMSUL;1BKC13EBUL.6SK8^X77+6;:':R31:&@NT(
MJ3<R^#V4@Z;T8T'+V(0/\RG!%6^I,EY"!2)_%5QOD=!Z>)'>F9$4:8>E?9N\
ME9V?:L9:[[$S2#:9*KR=']W3N[PX<IQI[G%0$OH!8TU`!;10W#'JZQR?LZ;T
MQ;/16JK'>KE&%`>-1LQ9FE\H^/##F,P48[(\5&QFT*D3?08M,.-*O/V4E=!+
ML>XWJXX<DS)@#%C+1EHT.))N'GEVO$Q-V(R74AI0'N:N8TO%K8Z."P-`&`";
MN!N"4^#1\AH.KZ]Q`YLKJE4[LN][7"J>2<O"?.AUNECVH#WB50\&O75%#RJQ
M#I;?>U>.;"Z[Z-Z[+['*(9.D#)IJ28#0]^72]\^K=9272QM%K,5$`-?YE@>?
ML%G"UE+1'\PQB21L85$?:@ZRI@[!<?;@=$;T)^J2(;%C"O5H^^1H[1[_C!YC
M#[Z>^KDLC#C6UR$,E5=L<1*B63[1]'</_,2-LQ*Q#2+'RSDHK%Z"#?)'3YQ&
MD[L4-RH5'CHUZ'F`(6UL3I>LO].?OK&WSH/<LAO=P<);2(E?*1ANJGUL1A<Z
MG1>-U5U6EPLM/GZP-:B$RK:E[&20Y1D:+P#/&MUC%0F"FU??=6K94M`Y'HO5
M3E`;1!R_>#H+]KV(+I#E2#W;8"O*@\A!>1CJ"+IRZ,ZN'AT-))Y?S<ODSL-!
M8`2#KN`4)YVYBE;.I)<GO)KSC+I(-R6_?G"4W0AWE$Z%U]!`6]POKDA//?.B
M^_XKZ_Y$+AT7P5,9I`'`\/F<P9]85^.]S@OJ`Q68=JC_FV<,Z.;"P_0%)SR.
M$1ZV8F?6+,.:\G0G-DCTW$@PEA5K="S49[G4)[YGI51KW&Q/XN8KUIB19*E!
MR0_:2/T_SV+U-74\IGCAF8J&;R/:1W8VE"I9)NK\^"AM$8%U,OE)0_3]1LY2
M!JU"HEDR6"':<?Q2.U'-@V[THS>6$@(E!.I(`M5>%J@[MKXPTQZ$P93^%1,Q
M'D9AB6H@8KY<4KE!!ZPUQBKM%#J^ARI8/H/%LRX1G;Z!%77%4R4V;=?#/C5_
M1K-&B)40JY**56=9K'Z8$;G@-ERZ>(@=KH#^B7>XD;U7L">!876LL'D,[B8Q
MH>J=G5UXT^?8QR-24&,5\O3,`QXP6KK22Q`/6H@B:0,3S__&!F]3V")ASK-?
MNPEWX[&^*Y']LF[2U*\@2X!NP20#Q99ZV`)N*R:$(@:2;PQDC9OR]#&0F]`+
M=9(`2+ZIC&7)G-FB[9C'H\"T'1%--5%4KF/]>GL.'NPFU!MT44MV.]8^HFD/
M6V3=X(K<Q#*`Y&U!'8KX%1X.!>(D6AO65-\SFFF%[^"'ZH@V1>T=^.&H'TSN
MU:7:S=*EO[-+`P>FW$,')O\S7'66LDS"!E*88IKF677\_4;RIC\I4R3NCF4L
M+]5AB30>76I==J$W2;,N317=C&27?<3U)85$C2SP&!.2`@L?I55G+:QH.HE&
M')@!FM:"8X6-6;`\#&4-79BT.E0PVNS8(0!@IB_H]1,_^X9SZKXOZ!*8=$-3
M^D(-4XL>(DXD-MCL)9+UCD3Y3XX%I*)S-P>@A_?3GU;OJ7/@!-F'`2Q9;1J\
M`SN7TA+%49,%OZ^''5/]+Z@+E_[-!LRD"<#!B35T&05H#VJ0%SB-IZAJZL[/
MX$R$#ZTQQ'Z'E4?WL^/\F?'+F8&M&>*KSB6$GB%D6#`5VLB&1T7]*4^528OW
MPHVJ*'K"C:N&,5XRP:V80N66=PRFSZ-'AU>:U3+T<9U2C\<ZL;:W;L]I-5+=
M]<7&MKSI#,Q4VP0^V%7Q\DK,[X*E6FT"]J_#AHZ6>V(G%B/OU5TR7VH,R+E.
MJ:7?3-S3KFN3M83`8$O[3*,1K&H<DND?BJ`S&0YR-+<R:2RW9D!(XE94)TWY
M&GJ>__P*!.DNO$%-V;A>HV;]@IH5EVU>+-2'QE*W1]QCT*EEIL22N8(G=)G8
M1Z2.%I_!J7^AB0!1J?9[2P:JG69K!OFHM-G$NVT9!D]G8)FF0=:<1DP+=J`*
MK[&!O`<'GF;D+]P$7MS?/7UL)L5YM92NU2$W*04I,?)W$6\=:C#_*W\1\NX;
M"KY^2Q&MI44-!8@J49[#BM?Z1?M1C\!FES<ZCYP*R%`SM%:)![OQ?WEP(WUD
MA'`ZB5P@L?"S/ZR^W"ISOVHRC0[S^LFZ&6D/GCD]\>8&OH)<>G\M6O((B:9]
M1FJTPF1$/\8#SG@=5G*VQG23"P."J<*6BD8ML`*6)LQS;!J4B4M">P&&V;1H
MV19Z&#I<E_ST%3#78M=$7Q6\AOJY7:;T&.M8)-!,5Z0)L[VQNL2C#D3#<^4&
M"U?S(^I2\LGTF:(ER"=&PC'9/114+H&9\XBB=?=$60B3?@!,']IUFLY`)6.I
M$=G2A5TF&6BB>28K_HE5.>@,90@(\^HL#1L['?^AW0F?21\4/!:+;J0,(C](
M[Z?:)K6^H\FS>'`1-P9AK?+XS$7[^=:3SDJR[`L.B?A@=(>\:_#*]%AIQ]?X
M+.$L9,X4-8'`@'$-FL0?9!"SP@$/9HS33APQFDY+,K"T]Y"FK,W*TJB(_GRY
M+->1Y*%]U^OHY#HK>Z[(>K[L-:"+.@_"Q[*EEM=D?@/=F(=A2,3=C^93DY?%
MRG%]_HWNXEG1+GJ^CLF<$WWN4E,>>$WJ(J7@^L!>3<^8T#T'51W^\3U3\ST'
MD]AQF8C=OX<I?!"8EM(6OJ,GLDQ^."R8@;@#X/KW*[_SQ85#\*":2R19^UBG
MB6`OBF[@HMX`&#<<Q2`):7[ORX#^'Y`$N/D/RXRKSYBD*2NREFP:)XI5[&Q7
M^#J_OMNJX(#6Y@>Y_,J.#&RZ$[X>_OX@R_56JQ4I;Q.V>UV_A%\,AZ./`JB[
M>7FC6YX5A9:`PPAN%9>=.J2@Y"?QTF`3>M&X#IL8K,K[.M,R5<-)%V@29/HR
M0*D^L!]W9Q)AJIL>=U!CE7FJR3OM5J,6%F-S&C=D[%(YN/V7A[+Y%.3BHBX.
M';J^URDV`NDL'*`MK+!18C8*0T0D*K!DH[#?H]Z[P`V-;=$C=DFD:BV/:U#L
MKH1$,-H1#493D5BNQ145'O+&75B$]^S&>IRPP79I6:[DY@S+#H>[IYQ="_YF
M!]8S/PRQD:6RV<8GH>G\Q8=!"Y9+V&W)])>+#W*W]U%T5:YRM'M-@93C1+L/
MG;MUG:#G8TIH)__YIY5'5"^II&A+5&I\.M'E2?7BQS0%>V\UI38]@A/'!VLO
M5&M*2;")G&$+3MDXTI(KFUHR6)Z2V$[@N:&G\W`/$6I?[E"%U8<L7!Z977(X
M1<\>C=^IWU33G4@E"]>JQ]X77X0B)V9X\4>';3/IRIGN+&8[4UQ(IPF;Y+BO
MA_8+3(G/T[:`,1_?\K,"8Y!5?DC>>24>#CS^PF)C"\5<UY71X*?H6I*P?#Q>
MW=S<W?_6^/SP_/SP[9/47KS5@B5G;+FN-0^>UN_^5-M(O67KYTTR'(/HX>H*
ML0OE<I$(__SP_>;V>T#WV%#4OY!ZR;$,74OEH0.C#]*%TVZBQ9"]VB<IV/4K
MY=:K`K.5TM3KGRGFX!H;(&.&XP7GL'Q0UIR#P?]J*XM?:NS?)\=`=-T6TE@,
MPG>41KD5E<9V"83Q1[!P[FRAY4XS7>'+0ZX5/<U='K)#J^A<%;/08T*/"3T6
MU6/!GJP\5,_"B+5084*%%1BISY:K&.<*U/@F2!I/8>HL^Y?:WU25D,DDR<>]
MS.ZN+NAU6ZE3H&:5MV3,?"93W339&1EZ_&0=?C(0P7\)_5'%D/]]_?S;2`6^
M_D,^I+!A3J-EQ&AI]T;IU)19W`422X;$AL#AZ4D5.*RN1DPS@%YGNDN$^9-L
M_CRD!Q?'K"MM>/Z#-<Y<NQ,LGSK85IR+077NFJ-3[[:ZU=0=`K;5A6V[(S![
M>E(%9K=4M>U!-6$K_%0[&6I7O`A][#@NS3U;=[`8D[B$S58,JG-7)!>#+#V2
MYSXX20]]%%`\'R@*!U@!2!60K;#VW-H#ME$0]!RMK7OB\J.:;L.OIY+J*5MG
M7.V6/U!4U9&=3;"];[P<7.7OM:CW!QFZIW+I"T).A)P<VKLGA$0(21&Y.L%B
M,FBUSDA.=O`Q+H]!5YC"C+1;5O1UP^RX]-&LC'H"7B3-\L8&.:PD[YE(DBNM
M&VJ=4:>_%4;*K74$_`7\=[1,!?8%]BN%_?HH*\VP<O`_0.48464I:Y`*467)
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MZ-1^[;?E=J?5:D686:%@=\*[&Q#>"0CO;D-X;]#M]X]&>&\#PN6`\-XVA'<[
MW7;[:(3W-R"\'1#>WX;PSF#0/1[A[:8LR[UF3Y:[(3EOCO[)U`VPS&R/;`3\
MA(?$>7J;&Z;S"1[\2VWFNHM/EY>OKZ_-UT[3LJ>7P)Y\^8]O7Y_4&9DK#2P_
MA_[$FG2YCPSLR%A<,(K'6&]7QN*"4SS&^KLR%A>LXC'6;G9'HR62-I"IU9NR
MU(0\:(]&PR,N*1OR$!>?+7GH=N76Z(BKRX8\Q"5E.QY&W<Z@=\1U9D,6XC*Q
MY32T.GWY>-,`XC`8[B`.*S=E\=`>]8['07=3#I:$83L.CLA`+X&6[9>0=?R<
M8`79<%Z6I&.K>6G(:+@?3S9`]'80CM6[LGF0.\-.]Y@"LB$;2Q*R)1O#_JAU
M/-NXMS$72W*Q)1>]UJAWO,U@?V,NEJ1B2R[ZL#4<[,G%O>62&]U1#=I(.-C"
MIS"7<G434)&^'4,7&0?>H-&2&ZX5DZ;XK7#SK]Q!<?-P_?SGXZTT<^>&]/CC
M\]>[:ZG6N+S\HW-]>7GS?"/]X_?G;U\EN=F2GM&AI;,F/I>7M_<U*4'_/7^_
M?,-GR7@S_[/A1NYL:JY6DT)GR)*'T_\:2'MR%=N->T\.[`?=RU6^24KUP_.M
M-/PD-:2GYX?K__G]X>O-[?>GL.[Z[?_[<??\YWFYFP]`=,3C%^D^J'CNS+)I
M-7?L@&QA>T44,MZ:A3H`0:EB<RG:8(HW]:'.9`4[FH==4#Z`A,!_9'0SLNN:
M2=T3K["-(7L*;4=(L.V@]&)1!R.-&3I!CY^H,]8R"5Y%PL=3UR\\;:ZX+GJ"
MF0,7K^&-R,?OC)M8*?WHNTU+6MBD0>8+]-;6:3]5U=:I1[..8_`"MU'O)K8W
MU>AUZ`H/J9PK[_A2[K2W3(,V59]XV%!@H>BLL2*VO<&N,X[#8FR4@J;T.R,K
M["`3&?]E[MDHV0J+TG$"X'O`FZ[1AO3XHG@K`3I)O)F+WUXJ^A+:CITSH.%I
M4>QN`V.&UWVVL,,94':CVW"[A61ZU.L[\?!M!IG2I@E!N?\S:_F<AT`"-"?$
MQDE9E4EY122QH7+\AGI$/E>%D_=V=8A-^Z`S2-7Y,PA8W_0#P`NFFC<[A-<`
MO%AGU!AV@HY.K*DJ#"7%&_Z;XVF5T56$):J+>RN=02;$8^RGQP0PKZ82FS<W
M/>^H^AXA=*50C8J^(*[_VS-HM%8&1-N6-YVQI@IH+(,J!<2[K#MCM]6O#X8=
MZ56QP83#T"MVVR)OQ%9I0/-%5Z0:UO<U8$6H!3]$FQ/S*!RBFC:Y08GO#^O=
M=C<B#;$%@X8KL;>,%:XH7.B:$?UX!TLF((@N8YU>K]X%;M+HI'UXL`PQEWV@
M+>PW&"7-?]`NI*$65*93&]83E_=BCH=L03D06)PUUAFZU^MG`T,DV%1.%8R+
MJPK:*ZJ@$U,%_6&[WI8/K0JZ[59='HT.J`KD.I!>E_NM_95!^*@<U$$;+*!1
M$S-IKKPIS%)]51MW^M1*RIJ!7>:@W:^W,Z<`R8;;Z3N7N#R-`C,V;&,J=-@1
M=)A:7!W66=%AW9@`M>L]>5`?M0:'-FCJW?ZHWAL>T*2IXT,[;?K0`R@R_U$Y
M*#*Y/NH/F]M-3+]W%,T&"G,TR-+>2D2WY:W:3N,Y$"KQ""HQ8;=^0I5XY:"W
M),QK!,EE[=117XP]W=#\!$A\_*H[8P*S:&#LA7I5/NO6`N1GKKQ)OX$(+Z2O
MKM:4+FKA]YBJZ\:2,*D'4:[W5MPZR_(7>3AO/CK1'15T`NW^C`:0V"*=F2PE
MN%]/*$NP(@>YS'Q+%)>NZ]^OI"M?PNK2HP$P=EPRIVLR_@A+E>JYO-GZW',]
MVO/<;YTK+3P;URLWS.<.'\$%J9T@2"PC.2),L/K%%V44=KG>DE$,H^L^T%3G
M;PJSR^DZO))?3A2X"&Y990J^5!8+VWK3YV`3P!K_06[5NW)7NG`()O6#G2!K
M'\7NX/S$=U(H\7TPI2>R</E9A)&_IXZN5AAF!R%38.6QYU2F=":9G@D3\VKC
M*0,3Q'1LZ"K@?D+H,@4",`S"%I@_X(!F<#&.Z-GJ3''PV('.C-`/W29<@\$*
MO(['*JAHX6<_%,(?BJ%!%A&,6Z.1Y3D>7#,U>@^WG%%J`PI:S4XO9>U-)[;G
M$\O"GM3X#\QRQS*"_44P%&.B*O/`6J=R8^%Q('BT/^0=2B=Y6^@V_7%E3@;Q
M8QQ`DZ08CB5-\;U<=P;S@8%&1>JT&IKR+O$S&U&^P4:!C^B\R30_@*1+T)$!
M<ZN/0.=4^@.::&C!=R$S[6[=]Z0MD<NBJ.&&!B[0;4[[\@;+)"X[LT(TQX]U
M^@/#@E*1T8^>JPE^]-^#4X5O]K%D\6@PW5U]Z'3K<JM?]WL>Q&Y$_0ZO"\:&
M1K'IR1Z-:)Y*T1HPB!^HW#@."Z>Q\*W*BO=2A/I8P0-*ID.2]YC!VU3%I.>7
M@N&BP6A<T"@W*=.1&*&G(\A&3E']TST*%['P_)0O/BR\+KU:GL&KW[WB<"P=
MIHK`!-_NP4/"#6ETNN`U0.\"8*KPC;J&ZHFJ%]T,`MI`$GU(0&/L(!B+E\-K
MX]?,<=N[,/0PT#U1`%.L:2P/E>)F.3ZQ5-#%UE:LYYNNY]-"K>=?+,.P7NDY
M0Q`N8DQ`AJ:8*<)L5OC?%PM6\:=&!Y9SE%:JB_R$D/`P(PC8@^I:W*J7XU)+
MH<,<:5';OXT'%U&92%<N+F\H9G>^L^E)`5D+-P)XEO7Y6_BY]I'G&9G1=<&W
MPT';8^J+0X]`UIE608+@DCE3H(XW_F<L]<5D7D+VJZ&#S<(:U4@.H?M\>!=?
MIV-TQ!G%I`>".X#Z:K9#G?H$<0/""""IBA=3%^B,F)%%+-#X@67!EM0/(^;I
M\]V!2RLE[JY@9NE@*E,@>.5X)Q[^M,`6F](D#7CB7/F+4`W/[EHFCCY\=2`*
MOC4IVOGN&^:<P6&DGAD"HZHQ7VZG58^<^U[R`<'6==2OMSIMY"^S4$52*8JT
M2A0I.*0GE$,_=6PWN[IAQ;RC?A?(1GL+=]2^**L63TSZ(`-8-P=09/IBX]_M
M#&(,KDVT*25"XCLM.0D3(+JLA<.RT'-C$-6=;@;S5;4A7Y=L?)!9H!8^[$5C
MEKN?[!8DF]$-*_7PS!>&]4XP04X+LB/QEDC(]U.YA_W@8[RR446]\D+M!;0Z
MT;S@F]*%`6LB75EA*]J3+A#1M4?XLO8Q<;?R(U`U>%&=/\:IKTY@QJRRMUR]
M8I4-,#MX8F.PD;92O`JP8,-";4>!4`_AL8R)Y,T6#`A[+ZOE@%LL%56J@988
M[MXL>T)T)(/O.:E'@`G\F-`&?$$2+M_NN9[-B4^HK[#I#N00LU[.NBS,0_'_
MMW>NO6TC61K^OL#^!ZTQ`W0#LLRK1&6G`SBQG?9N8F=LI[/S:4%+98O;%*DA
M*5_FUV\52=TEBJ0HLHI\.T##EJ525?%Y3YVZG;-EG':FH:%F,\\=JR.+P[OL
M2<Q'Q^D*H_$<-0)+5MN*WFWW9+6S_8O9D@QU_XSYB@HC9/<37_NN`D[$<F+I
MT\R($Q-8EFWE^9C?'UR+:%$@_?4=L18.-J,*9L*ZY!"[>P]%SYH3AL7CO36Q
M(E?$%J^#QGK;U%<MUMQX&_"6G3,S"IXT&\'8I&[O8UH:<\+EU&@==4SH8!@N
M"+$RO6$X$H8+.N?WGUL]V:`#7LN?CL>F][Y[XR;>UXE\0[:*^\(.6;"ZS>JU
MY*7MKQ\;$WVV),)N:87K8B(8\>4"URQ5"::VW_OKLGG=8E&S)!G0%9XB\&=,
MCU!`Q;?X.:5D$]C9+*W[5W8KFI%`_RAKQQ@WBG#N5AR1#2']8\<*V[X!D^/,
M!D63LIKL`#+FZN$<+&-96I:Q(J:*;\(9-C0+Q&N+^$_"'#@6X?>%>.8S:5W.
MCAE\9[M^8!_L-X?].S(VK3`$\BQ0-3NV\Q!NX?]"9XYLW]3_%9J`)FJKB?/Y
MYOLU58#E^-:@]4>X@(+Q(&G^DBI9V['SLLUF02(LL[K3@(55#$^]FL%2]'D6
M6"6,&[^/-1%2*HJ9"++TO#MRNZ\;;5E/2+LF<IH=06#E*#54Z01J'2DA[QG@
M*[]R6[PI/F0"&`!#+6#8Y<&^CJR`P']-]E_G-YO@IM;!7TGE)/PBAS<?^/"@
MMEF37P7EK\F>I]0QX'ER53DX&X`!,%3A>2:LG:9:4FZR0SJ_F9%_C5X,MR]Y
M>R:[,R!&J\IW=@VY+>F]XWE*1]DDVN8!UQUXCKQG[BB6Y8[>S\1$Y1N5PN[(
M5U%Q;MTSD`6R0-9QUJ'7>T##7"#Q<`4)XW>%-X[2':W8W<]B"'VK&T)KWQJZ
MTT>;U&J.L-RL"@YN&%VE+?4SN%A;Q2J2N6J"/GB?4E0*O=KI):S8@W<!><=X
M4)0T9$BC7M+`4)#H_TA:PJ'5V@%?P,8-)FO;3Q*%D1/H9"V,]8L)&P9H3-@P
M2F.4QH0-O&,\P(0-TL!0@`D;]M8JGZZQM&^Y#]G5Q\I@`,:$#*,P1F%,R,`[
MQ@-,R"`-#`68D&6;D.4,$[]2NPH"M(L95GX1SRP*".\^K>:[C:=W8>Z=H<5R
MWQ$6(OZ1!*^$.+L2^=JNSPY91MDZXD1YT9MMTP]:@6>&AS!9FMLXF5^TH1>&
MA-],Z]G>DA-TD>?%<D[I"Z=CUR&SK+G^KRV/3#SBDS#_+<M"&Z4<#=/W1$E0
M1^8+:P=AV4H'Q'I9%+TK0GT<X#Y*I>K3`E@J!WO]Y>VY<'W6`2M!KUD"0!;C
M/JK88&0ZS_0;'\TH+>R.O*>I<B?GSR>T:S6@<!FD63K94=/]F3U#6]F4["89
M;<:AZSV/Q\UN4G)K9JM73.?+Z;(=USF=6X&:)3@I7R(Q$7'FXN,D$DZN_P96
M:9R5(C,#[^=Z/4565*44R5?F^58\8L]2Q[H[N%Y*B[4OOTI.QD-'$OE2N)HS
M-C#J<-WRI2PZ#HE3D#BE>7JN111Q)$X!XC5''(E3P#[81^(4:`*:"-<OD#@%
MB5-*7\%%%A5^:UW^T1%9;^M)X:E%WC<7!%6.SGI4D$-%TP`?3Y7C-H898``,
MM8`!.50.<&6?F1.+#"KU\%;2N:C)^5-$M@2"@-ID!U7J`#Z^*@>?!#``ABH<
M5*1:*6@)-G4BP,HV?)!WY8!6E9]WI=M-7L5%WI4:HE&[O"L=%6E7A*(=R3%`
M%@<5!UE5SPP0&NH81S,0TA<10X[C:BFZDKRJ7KL8"DU0!^^3BTJ1USLRXJ75
MBW>,!D7%C^HW*9Q.$Z2!H2")=U5N$.[(OU+.;@Z2L6"L+F/F)F/F5CMU8+A.
MG+DI31JOF\`[1H/"9FZ(_%LO:6`H2.)=,1J$.W;;CCIOB[.R+![&_"?V-O(V
M(8,X8B![)V9P&+.Q]X9A&\,V]M[`.T8#[+U!&A@*L/>6>@:7,_[]U@D-^\RC
MUSK+7-I*6_?'70]?.#`&6HIY67LQ*6-3+X].MSPKG'Q%25*FCA6%:)^G'6@O
M91YA'UF*W;X9K1W9!>J376#>/$/M)2\[%)!J('[8T?>PY`+$\<TPGPU;'7!\
M6M2^O`)QO(KU_`*OQ",LM0Y['L-CI!K@`_A9+5:^5>UN,Q$G98K#D/ZZK(`4
M0U'2!82NQI-_@NB@)ZJVDN!`2C84O(8'34IPD',UDH<+*$734FAN`TB9,RG7
M(M`OLI$`\+H#K@)P`%YGP!4`OL/GXB"$)2=^6\)#C?^R2.;'AXLIYCY.YF5G
M_JHMVE(VZ`;=H!MT@V[QZ.8P?<[,8>/YU.@=\8GI#4;ACLZ0O!#;G8SI-&&^
M^[-O1B">2>'H[$+Y\><23B:(K'Z`*!B(2L*),(`($,NSB`FG=D4&\>"+-:6$
MMQ;!1?I"'.*9=N@AF<.QY5A^X)F!]4)2.TF5K90CQG5!K1)H%L?CXGPU6TV\
MCK?-E%/I0_LI-`*-0"/)=Q5Z#1)),6'">-^@S7?Y2"@[@*M(!:SWU>XF$M@'
M^RF7&,$^V*\S^WJ3V#_:#=14][X.O'ZZLE3)[A\>>EOM:AI,/7+P[;TGUZ/O
M:YDOQ#.?2?C$6+A7<S+QW#=K3(NTWUMJ:TP?RHB62+]Q+P+;'O)?5AZMW,G2
MT]7<\TNS)+ZCIHE+Y`NEEG5Q]N";LIMCQS'%<>@Z_F`3KC4#&3=G]:HFIZVY
MVW^!/#K3,;M#7M-KM[R9WX<1B2\ZLPQ'L9:GX['I6?^B=6'ALLU!8+U8@44B
M*SMUHBAMNV("+!GH'8\V+(:5_#Z_3MF:W:(,+V9Q'"]@5HO->PJE6L1NH;>E
M#8/GE2!<T!'S@L[-=/Q(O'V#&,>+M[6_HL.)[L6;[8NYFR/H`8&ZS/4Y.>8]
M$SW/9YA^S'S,.'G+(WFV'(=YJ'1.GRY]"XR*>(<QT^T1M;M=J:TK>K,L1N5.
M`L_VXDLTYX1-X*/6%=@$1>^V^UI"".\ZV@1X$8E6X<KUGH@%N\!-K4NW"[]H
M6ELV$O+QE+DKN\VJ_'KP\%_)/0@1U/]'E$LD]_*3&)+"N=-R#`GU,`RU;>@)
M'L:AE3K*$FAJ`\-;[ED13,SZ,@5RS"(GQ;$F.+K1;VNJD@FBRG=0JKT2"CL5
MVZG+M<1I+?,I(-[JGCM,%4Q54:9*4=J2HC745.%(Y]ZT#/E/#J5/TL#=B2$D
M7,`1HA*/$"'A0H-.%F4COVJ=(CU$G0U/+<XN(CT$`*\[X$@/`<"W-TM>!EP3
M%O#D]!`<'JH0(;P<(O!6>76[@M4\N9>PZ2#RHAU8%(S%'L)!\U!5D,BL8C?A
M5)G(+(IQ`$T$3ZFR0+R\6@R<52O%.&EMM9]P3(W'Z3QBB4(GE1Q42(BF#YU`
M)SRVJOR8NVW-0-A=A-T5SA0@_&+:\(MMO=NDD\7`'_@O1]YM*TDWAX$_\*\S
M_EJ[FW2MK7;X%W!8^Y`3UM'1WSU[VTGKBIP>"D^\B;\[R.]A423WAOP-7MTP
MS*3?LOS67Y2VIO40M!=!>X^UYC]L2-#>I=#;"-0K:*!>9DTW_I007EWPB+U;
MGDBE]V_T8D/X<KVJU,1#E%H-3@DCA._A:\-'OX`NP%&(H\;SY,?LB;GA5-Z"
M@ZQ&[4[(=%J7A04^0G<*8!H.#MU9]5.'_+/*W]#:>K=AX7LS;!Z7$\%/`-.`
M"'XXQ5*<U?FEVV^K<H+9$3M^'V=1L00P+XC>AY!8)=D>66\KV&/-MNS/>T"L
MM&:F@&A8RROQ=8F`Q<$*/")@U7H%'A&P&KLP#RES]7`0<H?5%S&E`'C=`4=,
M*0!>:\"38THU"W`.#T.($!<"$;0:%2N&&HUZ;G6"1-%(U&NZZ0X212.QKC81
MT;,0/0OG1(0\)S(+,MFD4"<0"422:_SN&5`)5`*5[/%R&R021,VJB1U`W)1C
M#(+"G^@#_(!_.62<FA#_'/`#_CK#KR@)RY>U@[^I(5QRG"=0E(Z^[5CS6CO"
MP$9AC>_#""[O[-[)J^EYX0EOMN+I3MAQ<1$.=1^]%H4^TV+#FFV-R4.B<#G!
MJ&7&`7K"QVO:=GBU:-MC;KG3P`_H"ZP8TV=O+RBZSL%-3(!@5X4J/=,?1AU;
MFHAF7B?8FBTW\29#6/F#HK%5<`N&A^-4/V=2.&O=1D)(9BS_FES50VC^XW/'
M/3)7\`/=VL7[#YQ=OA%O8/FD]=VS!F2S)W,4.2%>ZWYD>JNEY2<JC0?'F=M6
MND+X.7,J^CG3V!J&+L+<2+(0?)_=\=AU6O?LFJ!H,%=[O)H?-?(%,Q\CP#;@
M"QD'XJ$EG+1B)(!2A%?*3\(6J,BP=1Z'O;XC8],*0^E]IJ5YYB"8FG;K@7AC
M?X/X'-_WB^5$\;-_;:Y^.+SGH"M'.<&7U[5)>ZAO9MN38T8+$NZ-HR7RTE?`
MY4Y2QA215[L%@4_,(SKEYS;I:6U5:6(">PXJ!U2!*E"M(:I2QZ@II^GO[^QQ
MS"$V^,^)_G-2.$"1%20(?+#TJ3@U>D9;[FE`%:@"5:`*5`ORGZ5N/3G-LE0.
M#YHG<,7SH+OPH&'KN;?ULBJW$^\+`%6@"E2!*E#-Y$$G7;X5F5.L0(N)K7C^
MLP'_&9:>>TO?4WIMK:[A`H$J4`6J0+4"_UFMZ>B/%6A1P17/@^[75$."P`=;
MG^Y@J=J6I81H32`5I()4D`I2,YW@P/HSO&>.L!7->]8Z2>&115:0(/#!TJ<+
M=-J6NE);D@`K8`6LE?>L"(\=L*:+HMN1^O7DM(!<"$F913CQL'/4G"O@R\P7
M<HP0V%6F-M$[26-,[9*;-(!V,0<M[H2AMA6YW^X;&;(C0!W55QSJ@#J@#JBC
M6G5TDL+_U$X88N1*%C32XH,;F/8\V438W85G2JX:H*8;J,P&AH]FU<Z052F@
M+7:DGIJJKJ&'^@%;:I[]K*'4UE6MK4@)\4UXU-7QGAJD5L.&0FH\/C6XA<*V
M"FXA?_-;W$3!IONV6@ND59%E"9[!,WCFNHOYK#5X!L_@N?)JB\9SYFTN[&@E
M)45%ZK`M?2;2Q1\I\>B@R$H7!#XQ1Z[RPSM(,FY2`%4Q4,6EGZH?.E!->7%`
MQJ4?+/=S!:YX'G2WINGW!($/MC[=>>:^T=;AE@!5H%IUOXKPT(%JVL`Y>CTY
M1>@I,;$5S7^6.TEG.T56D"#PP=*G<TJPJE?U,P>I(!6DUHA4K2,C]2[\9Z[`
M%<U_5CK]7CTU)`A\L/7I.(574O4S!ZD@%:36B%2U8S3,?\;J,]_8BN8]JQT=
MEAZ6GGM+W\>ATLH?.E`%JD"U3J@J';UAB<.P_LP[N.)YT#V<?X:MY][6RSJ\
M$I`*4BOO5A&>.4A-Z3]K#;L_B/5GOK$5SWLV8.EAZ;FW]'*W+6&G!*2"5)`*
M4@M;?4Y(O28RIUA]%A5<T?QG#?'K8.L%L/6:@H@&(!6D5MZM(CQSD)K2?U9K
MRBE6G\7$5CSO635:IZV_M+2.5E,I"4(A3'XZ8.5>6^G7=,\1J`)5H`I4*]B$
M5G`,&JXT5^"*YDIW<9`#MEX$6]]M*]@>!ZD@%:2"U*+\9[6F(;BP$"TFMJ)Y
MST9'@:6'I>??TB.T0=7/'*2"5)!:(U*5VNX]9UE]CJOW_?SBXOKFR^FGVX>'
MVV\?6LKD;6>+.?&M<]2<*^`_W=Y=7-[-Z_UHFX,_6>U;OFM;PXVOJ=(O+[.J
M*4.E)IZ_WL)$MO[@3=$-P%W,48L[9<A2+_D<+;0A'D70!K0!;4`;1YT-&0EG
M<6HGC/0;##MZ0-O6`__9^G9^]^7ZYO3KY=7#AU;8B/B5N^LOO\]>"C]V?7-Q
M>1.]LG>F%=9E:+ULS)4?;7?P9V8XPA=^7D8U>G3M899ZKS1WHR5A;1_<P+1;
M[B2P7,</>YO6/:-]TH2V3[3VK:$[?;1)K0S4KF:ELC!\M"N5CD6R9%5*:(LA
MJ:FJ*FSIH:[`EJIG]P[:LJRUI:1CY3P*ZWA/#5JK94MYT9H*K<$UK$6SX!KR
M-\G-M@^(:6[B-/?5]#S3"?R6Z0P/G/-B34Z85@ELUH1?NZM20"7[IM5IJKJ&
M\N"#+UHE*^VN9K15*2%D(H\**\\=A^AJT%`.1=>#Z.`JUJ!5<!7YF`&?!>:C
M31:_+L_/$B:=J::,`7D+3L->^=#ZOZD?6$_ONV:-:U5/68N5/GH(^^B&]M'=
M#G.\4FG92%'KQ(GNR/);_G0\-KWWUM!ES\<-Z/,8V-,A:<GMKJ2UNX;2\H@?
M>-8@(`PH6NW6U+'HQ#@8F4'+]$CXJ1?Z'OIWTV^Y3ZW_FCJDI4KMEB+)6F>C
M/_[C]/32&5YYYO.8.,'IZ8RFU:EU_,O?SJ;^Z;-I3C[<L^\>4>M+//_RGU,K
M>+]Q`W)A^0/;]:<>>:#-_L2Z]>.__UNK];>5CUW[_I0,Y98U_.UD^86.T>UW
MI,6_D]:;;WUP+/NWD\";DI/6@")(R[TC3[^=/%%T3VF3U%.I=RK)IX'+?M-.
MI>ZI*JV7Q,IB_11^\L?]!2UY;#O^!UK^;R>C()A\.#M[?7WMO*H=UWL^4R1)
M/ON?;U_O!R,R-D\MQP],9T`K<):I-;VU&FRKOK)2?756_=6/;E9_2`;6V+3]
MWTY.U9./LB:Q_]:>3ER/;%66]U=97JFR,J^RG*7*:K>G9*_RQ=2SG.?OQ+/<
MX?V(XNY'KU^YWCWQ7JP!E<U:HU)\).QN69;UCBY3B62A+^GQ;2EQWB-^6)/B
M,3Q:!\G;FI.5CC0]LL#D^N:*HJWO1CM%S:OH*$4WY%Y'E]1^_I[:5@8_745'
MQ?!/*;IH_M9-XUZ,-=_1&8K>[TJJDK(SYK4\=B?TNT:J,:%_*AL+,.AO_?6/
M[ND$Z>2C(67AH;0N8`\SI2U)HB&'+>&4B1VCSS&&F[4.Z2O')N0V&!%O?V>$
M;PL?+#-\6D>6-",_&MO*V&L\-95^3$O9%6%]C]8-O>U-R`I$KFY@XU(W+1%'
M[@8Y=3?L&TJS=H.JZYHL'ZD7OD^]P<CTR>W3N>^3((6M6/]$I38TB\E8KWCY
MO52FQU%2SX3__T0_._SLCB?$\4VV'[Z_?[9_KD*69%57Y:Z>LL>V5[_"?JML
MV)9[=&*@I26-OWZK;"[9E[J2HJ:UZX=W'/OC;71:Y?*->`.+EI6BW[9]K&1C
M%LXET_;3MOJFZJ8_3'M*,LV[MW\BE)+6[Q\HQ<T2\BZZ[:]RV?TCI^R?),EE
MZY^D%3[^^J?L!<"C+$(?C9U\?9/7?(O4-U05/:-8;#8+%+)GY'P]DVB`ZM$S
MM"%=>=V4'@K-9HE"]HV<LV\2L:E)WZSY<)5L)_(W<O.P8UEDKZ1:0UY]YZXY
M_(';Y]6/T;GZHJ:^7%XNTOG]21QDG!=)74U++91LFPH'05'V!%'5:%=PUQ&,
MB#Q^62(@5?MEN9&HG>^>FXE<7E<B%)5[7;FIJ*%WGI>+O;Y5SO-W@HP9Y3C<
M1Q\ILFRF;?U`;3W,8GJF?!]+D]/K)==>8Y&]4SM_HZ!^J>&86TS/E#7JE*.B
M[!NH"1^KK24NN)=JN@I0="_5<V^G>,65/<+KABZG-DT'G%0XDO3*7FM1>OV^
ML-U5_MZ\UE=ZHG97+1W*(RBP=DM;1Y!=[3:HCZ"U&DY2CJ"V&BX9'D%O-=S:
M+UYQY4Q^!7<P]W92(0NS@KN5>SNID(,1A3N3/]@BRZ4?T.\(XA7[U9>*E<G'
M.`S"Q>WGAW]\OVR-@K'=^O[CT]?KSZV3T[.SG^KGL[.+AXO6__S^\.UKB_9-
MZ\$S'=]B-3?ML[/+FY/6%NOR<'?VQLJ2V8?C'T^#I4]VAL'PI+4(N;`6IF+V
M,JW:?6!ZP6J,AM;Z)\+(&[GB?]#N([;M3\P!?5;LZFCX^\0<#F>_SX*/2-)?
M3UIQ8)(!K0KQ3EJ/KC<D'GO;<AS,6?B2P)UL"X'Y\_KBX?<H:D9R5,JMH9+V
MQ^8X*"SE1FP.<S-LQFILEY*:L"4"2E1!*@\6ZH/,!))87>'BM=03\>3Z;_"1
M)D1/N8#NI/%A1%H3CTQ,+QK!*)E/ED,]*\NTZ9=30)D9HX;=87;[R?7&5O!.
M'T`P:CT3AWBF;;^WS,&`3,(H-H.!.W4"^IQHH18M9&+3BGGDGU/+HS_0NIG/
M88&MP*6__4D6,FC3>@U#FTE_9*%C33HHC:.;*HN(.1XQ?6J.&5J/;&!J32=L
MV`TK%C7`?#$M.WP#_4A`6\?H8C^\AP6,S2'IL%;[V[][XZL')BWSZ8D,HM+,
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M$,<=TS$E\0OW/;[U;]PL=/;7I7;OZK]8`&$7IC&TNM;O=M1NKZ/H/5UA\9'D
M:`JWTN%T)*(.Q7H/T+K0UY\L.A[Z;+V'K*P(^630>79?SCY?__?)1SJ;E67=
MZ!G2K.*+#Z\7ZY-PZ%OOT"&MQMO$M@96\(TPI=&QF+[/I^/_;R<S29Z_FM[P
MX7U"SM^L13"P\-/SRK%?9XM5W;/HCR<?YZ*.`N-'7_&WLZW?G*MJV^?IT87?
M\RGU)3SK7V3XPZ%^\=+]W^\VG=U^>I_=`O[N60-R9SK/V1LXH<[!A\UR[LD+
M<=*U=O;H5A_0[-451N)'.0F7*38>,)M[7U`_Y>,"SGG9\[^M?8A0`QI_)"9X
M\<7#I0_,7EWZZME+L38*DXL,N31/+M8;Q))'+!+$TCBQ7%DO!&K)H1:M#[4T
M3RWNU(-:\JC%@%H:IY:'D4<PN.222P]R:9Y<7EV()8]8NA!+X\1RZV!D22\6
MP^AH2G>^FR*J3+Y[+NVAX)W1%9P[0Y:#9<)*^_1^D'C^("-K8!,?1*4D:N/B
MA:!`W<^.&$39?)B%<QUVXB`W2N?#87S0[;MI#:^=S^;$"DP;9*4ER]!`UG:R
M!H/I>&K38H<W)/AB6LY7U_>O:)]>$-]Z=M@?;KV_3TW;>F)G9#Z;_NC*=E]_
M)\-GF+;T`*[?9@&`FP"&T?]9D1X9L2]^(=?.P!W#)4M/60^4I3!S/QR/4(-&
M9QC7#DOPQ[YJ9OH`6UK8-NX+@;:XQ#L24)K(\-+T'#IF@JG43.E=(UR`T71-
M[2A=7>DHNJ[J8?HV4?DZ?!GF;IZH-%P,^<'2E-[=_RA^628:;^>"^.H.PG69
M0RI.3&\P8H<@R0NQW7!>??G&5GQ2#NOY5I6^N.[0I]]Z0Y4\GMCN.R&S\+'A
MA2-SP-KUZ?U^.J&%$B_?`M)GUV%'Q$UJ*R#Q_!(7>.R`M@_1-N2PD(.B];H8
M\817Q9?HUA45Q?EP;#D6;08M\(5@S(/(ET6.,:^QZH8@%H(0?.F@8BF`I([:
MU[$)G;3P.0W<L?MH81\Z`U.&)D50J2H+2*5J?:"UB5:X7?/-'(PL.BB^+Q=<
M_$">[Y3/[-/?Z%`]GHXA@!P"H/^#`(07@/D&`6010%?'")!"`$]/UH#P2SW,
M?F[J8?:%I1ZV/AOURQ9>9-YA+,O%9LE$-A@;6)N,V,C=CJ[TA%_Z?+`"F]P^
M73MA;**I:1^`T"SL("A*2Y$DX>Y-$E-?36=(B_LTM6P6B0U@I01+,:AE4KIL
MJ[+?ZU-#I0F-5[3_]V"^Q7<*@_?<1%VS^+6.:=^QL%G3V<[Z]=U]\?X_K6\4
MYOL`_`/B![2<?Q`3H26RPR_W=`WP"PK_I4E[#OAGQU\WJ&\J2YHANE?QV39]
M__8IOKU^Z]VQ<*V''G>*2\,V:A:>-/"TRE-TX<CU0%-FFKITNH.9\R)Z17S&
M$PBE1TCO8=J\$ZBOQ/3)R+6'U^.)Y[Y$21)NGV[(ZY4YL.SP:ISC!]XT/$<,
MZM)3I_9PXV5FM<([EE$X'W98/=LXF'WZ@_LNO*JAX6?A!5<#3L(7K0?!79)*
ME0"0EFX-BDX2;K2)09L&L[7$SK:+/,`I)4ZR06W7+/"JCL"K\\6=I>"GQ[PZ
MS%40UH=78B-]1#[MJ-!.@[03N\N;Q5W:2.Z55T+(A0<)L5$(^LFG'R3'@WYH
M<3<68NGG$Q`2YD%`S(=CATR@H!P*4I%$#PI"AN-#%(3$>E`0DA[GUP\R[4$_
MR(-\@("0?0\"0FKD`P2$750("-F2#U&0!@5!04B@G%L_.(L`_2"G<C;]]`SZ
MLZQ2[2AJ5^_(>E^CO^I*1^[*PJ8#^3SU/.(,LH<?&,0?_'#]];Y(P5S0A_<2
M7E>X#B^TL9;=6?Z?N65^Y7K$>G8NWP:C:-;B,<M1O-*W5=R?92[\],Z2LEK.
M\QVQ0PO@CZQ)[B8MTK^>^W&YB^^$H-,*6NZJN'&:@!D;L:8!\3*&TP1:%"U9
M1_[-75"-J0/$?!W@E!*GI7\5@%2[KE9.I?ZI;,1='?W6[_2[ANA='3<L2U?'
MK3]B5QL+JL/?Z+2SWY,0TTB`F$;QT\O($WO$1^1IR4JJ,RL9\J3UD?-Z1Z*A
MX=!BDP[3_FY:PVOGLSFQ`M.NEJRL@X)Z]$%A-UD]`V1M)VLPF(ZG-IN*AAE7
M6)$>&;$O9O-@%M<`E*6EK"O#@.V*[Q*8ED.&EZ;G6,YSQ6.B2$QM9O1&"F.!
MDYP6$.@HW^Y%D\(]""]Q@<<.:)N[(&:"RF$1PPPCGL"J*"28&<:\VHL<8UYC
MU0U!+`0A^-)!Q5(`21VUK^-01-**YS1PQ^ZC95<:W%TPII#&DX\TGJ)A@S2>
M7*3Q%`T;I/'<0(B#-)Z"480TGLE,\9/&4RRPD'J+[]1;HM&$U%LK)/&0>DLT
MA)`$:8D?8=.^8/^P6#4T?&]!<#5@9Z%H/0CN7]0O"9)X("$)$DX(E$,;;F!R
M?@-3+)Q$OQ;(65?+*]<"Y?A:H-$7OJOE[#?FY./>F)-7J%;F5,NX,2?4C3DY
MNXB5HXMX-UFX,2?DC3G!*,.-.0%NS`G&%&[,U>J$,6[,0>+[)2[PV`%M<[?C
M):@<<&.N%JK`C3F(/(W(,>8U5MT0!&[,<7QC3BR2<&,NF2\^;LP)QA1NS/%Q
M8TXT;'!CCHL;<Z)A@QMS&PAQ<&-.,(IP8RZ9*7YNS(D%%KLQU\/)T1PK99\L
M=T*_<FQ6F2I:/-AP/9/?ZYFBT83KF2LD\7`]4S2$<#VS#A?2L%E=K!H:OI$E
MN!JPC56T'@3W+^IW/5,\D'`]$\=1RJ$-US,YOYXI%DZBWQGDI*M-_]1]BM./
M]D\EA?9N3\#>M1R?6>./BX;,"X__4F1'Q1BR:8BN];O1W$3OT7D)'4QED6W;
MX4>+8B_LF$=.F<6E?PUG(^&K_ODT&+F>]2\R_.$,B1=:TL@Q9!LZ_J?WRS?B
M#2R??/>H)Y!OISGR.3?*N:<3>Z=<J[T*^[)5*!-V&;`W#W:KY%TE/E"7@'KC
M4+^R7DI>DN*"=:T/UIO'NCOUFLBZ`=8;Q_K#R".--.P]P-X\V%_=)J+>!>J-
M0_W6:9Q5%WP?I63&:_#<#1RV3\+A#S*R!J5?.:R,!X1RY#J48W5<&!JXV!>(
M\88$7TS+^>KZ_I7GCB^(;ST[881&[^]3T[:>WBWG^;/ICZYL]_5W,GQNCEE!
M'$]1XGA6R$@/C*0P,3\<CU!C0N=#T74:]E4SL],45!"PE<^`K=41@3`\/(7A
MJ8P#!-'9,Y14%42G.B(,30(2"4B$;N<W<S"BPX;WOEQP4PCI:6JGIW8[_5Z_
M(S/70E;#X*6:*BHKGTP*R8#<CP@Y_(Y5-"^9>AZMS;GODV/<"[N@#_,EO+EU
M31^V-V4M]V=>[:=W-EFFWLP=L<.F^"-KDO]@_-($/'7XC"QMB0N>3?\/Z?K%
M$L*Y'Q>[Z)^FR5-ETF2J%-F*"Z?,`FF^<9WA'.C&T*L8(;T*I0NC2S+#7RV3
MNJ968*7U3CD=8JY,R_O#M*<$8XP@*NWJF"0DJO3IR1J0QLT,)+D'+))"T1'3
M)R/7'EZ/)Y[[$BYE-F9A`7$*]\!199S"RK!0V&57I2O^4G2T^?A@OL4'\(+W
MW"1<TU[S'-.^8_<:I[/@"==W]TUA0C<D,+'&A.^9Q%XNJC$PZ!J+E2Q%^9&4
M>:!M4:'X9OZ?Z[&1PK]]NB"/LR$D>+\G@ZD7SN;R'<C]0CT*SV'U8L4N2BM^
M.G7`J>'S%].RS4>;7+G>O6F3I6J:P=0C_D\K&%G.K4/^0<RFW(A:8UP&X_5F
M_/R)#O`QX@\CSYT^C]A=5_9K4Z8#:\A+0+X!R,\ACZ%_($[#F$?40&ZB!E:*
M`6+^"17SKU)6E`;G%L*<(8F,)F>=@J>=`90F9[6#?YJ:%)FZIXK$TAU(=-2A
M/PF-R_Q8P:?WQ0D#^ATL'<#[5Y8,X/`3"]?.9!KX86%J\1.RI19\(Z9/.66=
M<>61?TZ),\B_F#PO=ZE4_XY)PFO0SI/,CAF!]GRTRZ!=--IUT)Z7=@6T"T6[
MW)>Q9Y@2F/6"Q%I7;N+47S:H+9\%VM(1:&N>WFXIV%7Q%',:=.OAE=B-"9.[
M0KX*\AM$?KQ=M%G<I=V@\/\K`D"N"PB`C0#-I!_)+T`_+>[&:DS4T17\D1`#
M^#/OAZ67;R#_*I)D@/^&Y?Y:X1^),\!_H]*!K="/3!J@OUD9PE;P1W8-X-^L
MI&$K^&//"_@W+(_8"O\:^`?_34HMMD(_]GU!?Z.RC<WI%_S^1H78B\]`S]#T
MCJQ2ZZ>H7?J3WM>BT)@L2*:H1$2!+'.<=AW$'_SPWW<_BS1YVZ)>WEG^G_F/
MX[H>L9Z=R[?!*)JQ>4P$Q=OJ$L-U(@)F*$?Z,^2X+L?KK_>0(^18NAR5KHKS
M_BD#^KO>Q/4H+R*'DVGDL?\5R!$DK/:0(WC!&O.($M8,YAL>AT&6*?0(E9U$
M^G@RI9PT+<"^3)\:$GGN0F+L.N&Z8$-@6/I7`09<=Y1Z*BNGU$,V>JK8'14W
MY(@=-2.*F11=,Y"B(<G(_$%&UJ#*7*#JT86SS(/61]KH'7EAAT.++=R9]G?3
M&EX[G\V)%9AV4[@P-'"1(O7\;+WWRG/'BU7:6^_O4].VGMXMYWDYN69SS$K/
M`#[[\(GR_-$B/3)B7\PV$E@RD<8PT@,C*4S,#\<CU)C\B]!!Z(7X`?NJF=EI
M"BHL22A8V<;*'0DH"V1X:7H.'6T:0X3>-7!>*@+`#SQK0&U%N#+RP[$"_^[^
M1T,X4`T-:4KW)A/^9@Y&U$AX[\L%-X606;+T?J^/;-/59$PO\:C,\G0+>:8%
MDJ?*I,E4*;(5%TZ9!=)\XSK#.="-H5<Q0GH52A=&EV2&OUKFHV4?Z<!"B4/,
M(AHUQA@Q5-K5,4E(5.G3DS4@C9L92'(/6"2EJR>F3T:N/;P>3SSW)8HSWQ`X
MD),Z[7F_>B0OY>.T>:6,X[AYS1GG\K!YI<CCM'D3D.?NK'GIS",9L;#)B,MG
M!<F(X2QN)P/)B.%BI0(%R8CAF*0@!<F(D8RXPH25I=..9,1(1MP<VI&,&,F(
M&T([DA&G!P;)B(6C&Z&WFA6A!9!C+[3VD&.I#J&W&LE\PU<=$7IK+^F\A-XJ
M&PR$WN(X]%:Y,`@=4>JX':6<2OU3N=_I=_OA=I]!92-+FB&Z;#[;ID\=AY^F
MY]'^NO7N6-[E?`-QF##EE0Z]Q/,KSF$1/ZT2:=!`PRH-4=P.UXO+JL[1*IN%
MG@86=EN&AN$@\(A:0D?%KD<7,?D$BLFG'-_36N8"0=4$#*I6,B.(E,5]I*QR
MB<"J!M>K&N7"(+8/=M2.DN<=I<,'$\@'D\OE`CZ8@#Y8R8S`!^/>!RN7"/A@
M7/M@Y<(@L`]V>$=%K]`?_A]02P,$%`````@`Y8$K10KV%J-6%0``Z0T!`!4`
M'`!P<W1I+3(P,30P-C,P7V-A;"YX;6Q55`D``\T"$E3-`A)4=7@+``$$)0X`
M``0Y`0``W5W==^HXDG_?<^9_\&9>NL]9".8[??K.+)>07$XGP`32/3TO>Q1;
M)-XV%FV9Y&;^^BWY&["-92QC;3]T;L!Q5?VJ)%652J6?__Y]8RKOV*8&L;Y<
MJ<W6E8(MC>B&]?KEZGG9&"W'T^F50AUDZ<@D%OYR99&KO__M+__Q\W\V&F,;
M(P?KRLNG\J_&+\J]25Z0J3PX>E/YX>I?O]Q?_=AH^(]N;:+O-'B66$J[I78;
MK9N&VE+^6QG^U%:5T:/WH&E8?_S$_O>"*%:`-XO^M*6.\>7JS7&V/UU??WQ\
M-+?FSC:H@S=-C6RNV<M:_0XP[CW^_<4V=2?\`_9KD]BO\%RK=^U]&3[**.V]
M^J/C/JO>W-Q<N]^&CU(CZ4%XJ7K]S\>'I?:&-ZAA6`PH#<-?4>,GZG[X0#3D
MN.C&_CS.5><Z%#CU"?9;(WBLP3YJJ.U&1VU^IWK`XI$PR42N`&=%\9"VB8F?
M\%IA/Y^?IADHLR>NE\:K9:P-#5G.2-/(SG+`3!;$-#0#4V##?>>;C==?KIC2
M&H%J&)=_=3^A:*L&#SJ?6[`F:FRV)@!V79RM,=EL#&>#+8>.+'U,7+;`BO,R
MI2&M4J;FSANV;[&###,W@T07P*%%07<Z&\%?D<GL=OF&L9.3IQ<J`K04EA;(
M!B3?L`/&9^;E3XBI10PN'?B_J^#Y>HSHVYU)/G)B1XFVKI`YLMG:^`U;U'C'
M#X3F9]*LCLGY%MON/)F;.U(^<WNHO2$8L'1J3?[<&<YGONF-P/BNE"W^@>'R
M*&!HW"'#_A69.SQ?WQD6#%T#F5-8#^V=RWDNWM;O9&VH[:IY8ZNWOC/9M]D/
M\DS:KBR4N#_TRN%.%.D;UE]A%3I;H#>C_-7HA#PK]&+F7,Y=/IWR$;_'%DQ1
M^0;9JS#R/!I[+5]-C\C^`S@`92RQ!M\Z>9VL#:V$E\CN1^^`$_MR36R*3)ST
M-`^8&TH)VE`!0SE;CJGUCJGG2$ZM9PLB+M/X-];9.L[+OF'LS&I,@F.X;JB`
ML;K<O5#\YPY`F[SG7GTH5ML=`8LWT?YX(Z8.03:/*X$%K(.'L/`8$,4"3/\8
MG!FRF1_XCOEXLRIA+AJ5S*<&A]KU6"??V3\Y&08WK!I`E[O-!MF?S,-FS(XT
M`!<^YN66H(MP:^F_,8-@"0>/[Q69$0L#9?*)^29P3XH/Y%1D*X$D3W07,<_"
MGYWI(.[!1PD,"^V"G$\"S$$GMX:--0?6U0(R8*17(@7'$D2Q@"5H81,(:9U/
M@(LQM&4K^`P[N1C:(FQ5QA$'4(ROZJ#B,2[&F0"S<E-U?JZ3+M`G@RH7/T1$
MHC,6&,%G.*\UK0VK=%96Z#NF<\MC)!<7#C$JS;)RF+6&-`%6?:PMGB#6L!RQ
M2N-@!E0G`)^DL<7!%(RPBICBF8>`*P'34-9F@I<WM5X?,.+S0=FN@EDML]%7
M*[+<;;>F`<NU_Y"-F$?!*8#F4"3"*3H>NUR9,L,J/\S>&[R%HB08QB+6R#W&
M_K%#IK'^9/N"V-9`T>@5OES[F;V%NPG,^!Y1<+JXW$?@_L\M>2=;$8'(G@Q1
ME!?;\&0!'P0>;@[^%J^Q;6,=_JJ0')10C>B.D(@J:XN6=ZM6@`N3R1^/RRYD
M]K\EFIMN9HXH<.9\3JTUL3=NE)^++1UA`5Y.)FC%$B9H*R0*SF(T&E9)_OXM
MWD),:;A0/T&4R"D-A7D!ZW:U\;&?FF`KF)>NX(Z'/Y"`C?U,+>QM!GOS'2?4
M6I[='PV9VLYTM?D`OP?/&XX)?]!JM96&$NYJPK_'\]ER_C"]':TFM\K7T<-H
M-IXHRV^3R6H9T&*BG5W2X#&,OSL0+6+=*X4)6#:)YC]EHA=L?KF"#_['F]^;
MO9OAH*EVF_U]D.(U1FM$7]QJFQUMO"*T=0N3KK'IT."3AE?WI/IU.W_U/_9I
M[+-HLJHA8@>@YN!QO+/95G"SWU)%L^J3RL5QS!!&=L#\VB:;;'P=<D(V8L.`
M="O6V']7R@<V7M\<[X,K96L;Q(:A"K9VI>PHL$?<`1IMWR%;.[*H_8(I_XEK
MRH8[^^.&`<:V+S0\PZ&B&;&T2)*V8"U%U*I35+*$OJ[:<N@J6)T6)O(\@5A*
MJJGV6AUQBLLB79X2L\PP4&=N$'S==N70K1?>'Z*@=OK=GC"E)M*L5INGQ?;5
MV)%#C1"`&18L\=B"?SC,1CWA[HC-?O$_C\LZ5/M]81KF9J=:[9^%EEQS]P.Q
M7E?8WL2*)IIJNZ]VA.D^@6*UVCTELER.$BND90E!^,&6G'=DNGE$9PRA%LLJ
MN8FD9G_05X5I-!<+Y>DXU6\/%,P-B5P:3RH?"C!1V\/NC3!%9U"N4+UYY?>U
MVI=#J\LW8CM'TU)_<-,2ILXDDA7J\:3$O@)[<B@PYC*&UM@9M,3%/L<$*U3>
M"6GE\HZ?P/QL0W.PGF_I4'L#=2A,KYS<5*CT<W"2*^P--K2?L(9!.EAK((P/
M\.GU6^(FY2S*%:HZ+P"213L&>C',`X^AU1+G&A\3/"-KO5]D$2FC+=X:]VF6
M88>Y5'%HC>FBR^7"@SSV#NL)&/3Z-^)6EE2REU#H:0#DFEL.;-1UD&*&*BZ9
MED'XT@,U#02YW,.@>N4)OV-K%\X^@V%;7*B=3+-R?9X6/1RD/1E4.=Y1AVP@
M<M'?V5YWB,"@VQ4W0%.(5J[,',*'VAST)-!F3'H(1H[K3A@6`G>-3Y$O6<%Y
M10SSW-FV(9?'%!,FOB'7;G7%.;^)-.NCU!0<Y%I;DX0?M%1Q"VOMAND)!.3*
MFV24LC<'K8ZX.JL<+8TNI-^<D,@5[!SXA;&I:##LBEMQ4\F6K./,)2;%-T[&
M0*Y5UHW74G#H#`6ZR.F$+Z'9G##(M=(N""O]94>2V5P4U+`$4G[&9>QV.^+J
M/W+S<0G-%P-)KKF;+4C$<M<P;YMFT.J*RSD>4BM#J[F<QOCZFR:N7+/S2-<-
MC_X"&?K4&J.MX2"SV8-@75QV,9EHY6K,(;Q<\_$3.T1B87V";`L\0CK2M-V&
MH85U5G^H&:QL>"@PO#W-0.5*YL1$KGDW)HR7%S\^6,1Z5,VP,U^OT'>P;%5<
MC34G,]4/]^)@U2YB_OGZ$)X'^#W_V:]AUMFOY0I^/$YFJZ4ROU/&H^4WY>YA
M_EOA4V"935JY3X,EUXDL,"@!YG#-]H[@>S^;_4&OZB+59$Z*[]&S(@F@L+#)
MNP$(??U\IAA>[Y^.MU[][D#NL4*6"-C!9U$C5X@NU):X',EYS)4Q!9QG#L'<
M4"+(<CF`*8)[]9.Y!!=XTO$\YFIO745`ELL_21$\[)=R4O"6P"._YS%7>^LJ
M`K)<X0X('KEM3(Z!N#3Q'JTR=%_ZT(B90PHJ<JU,\684S6%;Z!9`1*G6JDV#
MQ%?L4`[%'LYL@`P+QZ*R8(!`;??$3?RG&:BU%7#BYQO'S:%Q-&2QCH6-M\C0
M@[TQO],OZ_<2'1@!B3L"RW**,269%7'C'*PG+6E-ZZ"V%*13!>:]3]*7S&"R
MT`ML0Q)GXUBX@ZUX-J4*/!1QDKYDII&%7F`:DL2PQ\(=%KTRZ51Q:<;3#$AF
M')GX!=8A20S*DNOH%=\::S!XS*2!!7-J.?`+=>:6>R`9/@D:1$3''?U6L5M"
M#:?9[O6Z20:4W`"N'**U-IKR80WLJCY[.-D[>QN0T/BW^YKY^M:@[E(+(H.7
MMC%V&Y8V"FXA\T\^!?#<@7J2&AHP.!+/#*58F0`6:FUSHB$/+%"2Y@-)\CSY
M%Q_=(\/RTDOM85=<75<>%FIM4MP8!C9RU&%$FI!JP?;3W4MC6.&;C1W#=O=^
MYR^F\1H`IG9ZX@H_"_%4:S,Z'^7`K@9RS#W+-V3CKR"I'K_CJ:GVV0(EKG=-
M$M%:&T8.G&I7NI(]GU"Z8S'!?.V6]D173[%&>4MLOQO@"L[ML8F,#;/PX5!@
M3,[#2ZW-I#BJ<O5+"I94"!!0O,>YVT`U[)[:5%N]MKA<<3XF:FTO!7!,ZXPF
MC=^2=.D,#)3CKA+NYDJ5F<#<G-7:ILI"W#<T21R9Q*1Y/'+<:X;$!&UUJ]U_
M2&5&,FO*C6M:C8LT,]5Q'RVV\R*P#"\/"_)92Q:&:55V-;410$S#6*<L#17Y
M>K%32B#6L">N\O\D?8'64;P..M9FGP,]N8JHDF5SPT;Z;($D,#3`E6.7@5EZ
M<C3)G#X*CYD['1!U`?$OV@%$;CKB]KV$\BZA18K0FESEQ.`DNL=(5F2D011B
MX]0;,D`\]4;@@>/<C`BTL^(U^J&=%<,S;0J48'7TXMG1.S),MNBS]`?:V["!
MP:&*"^YX6*FWY13%5*[P+1@@[):.N,2);<:[K:%`%RL_)_4VG(*(RN:1)XO)
MZA6<(RG5MKA>"?D9D=%L3N$I?:Q_U!Y]3U)5[559\YS%3*VMYPQ<T[;/:FI!
M\<'QB!Q_!78KNS_#?F'(-.F)!5MDDXA2>*RUO96O!;GVX8[BBDPIU8&XUHP<
MG-3;H@HB6K]MN7,[5_0X.E?,'Q=/DV^3V7+ZZT1YF"_+Z6`1;QMR7('&T\GB
MN`%)V'QDH`J\0B*#<*Y1D"B-U*=QN521^Z2M)$4W:=UPGBW[H%9Q;MUBVWA'
M+/5(1S!B8/ZZA9%CO7J'UD/,U,ZP);BU8ZD,7\R&!&,OUV[%:3"^$9/ELV,%
M*N&Z=PH2<?OJHMBNL5&6H`>YMAZR.H8]8<U$E!IK0_/TH/_OSHLE60`PFH^G
MOI,V7T<PQ3#I#01??"V"[]H99[F:J%_FZ%S'N9O?<9XO)D^CU10>*,-A3NN9
MP^$IW]N@7(BJUJQ;8ZLOL#=$C%)Q5]@_]0H^8>^F(V[="<B4,12S$8Z::28(
M)I>/,284AGMP+GG0$=A79H]4=4I*E5"R/91Z!Y3)7D)0JK;'>+<K<'T_IEA2
M(BL3^W`Q/B&P7'/#C%AD7R"_"0K(U!9XSC&5;I6JS"=\;;WV$RCD&YGA`8B4
MB58N<W["%,.S;'OK%E8#D[BE/+Y6F=OK'I!/FE133H2??&$9]LJG*3X9)5L!
M[[$%6)CL4(2^,2SPMVTW_1,.S%9O*"Y+?()Z];KF@:-^\5OQH0K>=G\@LFE_
M!NTRM%QD'LHUOO>`D6MNOB?OV+:8+"#9ZLVP]06RG<][]U2F=RH!ZPR73M+F
M:,K\G.NEE]8HO^3UF[7/R\5T6]V6JC04UF+$)'1G8_CE;C1]4GX=/3Q/6`;F
M;CH;S<;3T8,RG2U73\]>:N:'I?:&]9V)%;)6[I!A*^[U,^YO7M$Y,I6I!?/B
MSLV]_*C\<,NNOS#ICSR)'/9F]\7S=?C:V%L#)N#;[`=]VH6S/N'KP:#<]H/A
MI4G-&Y'72:73+1X9)G4"B:Y0'7;%E4!D4"YC*N!14E9;E"0PY)K2H^TYKU=F
M_()')PY3<]B^$>>VY6;C4MHOA%/MXLYSEX#.\1+P.'KZ9;(:?7V8*,O)^/EI
MNII.#B;]L.RGL29V@R+X-!I,2C2:"L[\20,SFNY#XD";D4YZ^MPY/[VNR6_/
MQ8XY4:?95P4F;G,R47PUR*C>ZJNJN,()L=5OA747=F#+!8M<J\*A3-XU53%H
MHENIW*S3?N''5S;6,-N<[*N=ZNRB().U-*(2`*]?`"+(Y%@")HY`2^`ED.4P
M*;G)I0)>NYM8SO5W>L?^SN*)%1JL?E=&LUME\H_GZ8*%N?^ES":K8NY+<'PU
M?G(5_,AS?9+44[%N:Y%>JR/.$\DB7=S]2'VK:YU,I+;09A$9Q,L8SYSZBIW:
MR(N*9"Y(_,K3Z`89^+>)70PM/=[[-OT0>&^@BJMF*8O+"UJ0"*#KYWN<NQ+T
MCU>"^>K;Y$D9C<?S9Y;G7(Q^=Z/@0HM`4ENQLZ/2_==Y)8A^PJK73VRJ7=J@
M2"-<?/J?N+?18_R$75.-Y5\"F6Y4@?<9G"1?BD_'H[%@_'(!(]<:D#0JX`>\
MW\W8&\[..X+6[O6&'!4!.5][,8T6$5NNLY9^W[M?D5?Q'"$R$#>"DVE>3,FG
M(4@[!EE/E48)\H09:-A)W!$N>^^@1K-R7CAJ%S*?4')P0Y+EC.&GX00B#41>
MJ9!*]H+JS0&$A`<JC_O8AEN<G1N!M])G$[_X2IP#D_]W>WV#XXAG/']\G*Z\
ML@Z6_AK/9ZOI['XR&[M[?F%AG.)>:%1P.X_UL#2<L..$VW+@%5L:X!X2\"],
M.B\^VG\;O=LY(.6C81F;W29H77#+KH'K=/OBSN[DY**$\OYL`E-K]4%^Q\CV
MBAG%90>Y^2FU9I-;UT>'!@K!*%G<E5M6,`P<2MNIX,1(?HYD,YMD*"7S(?)*
M>T=V=BBLP%04/T.2F4TRD')E`W(*&WE=W?[%EZ<2/=/*K"4)P-JYK27-+Q!X
MA\-"%9=[X&=(*HM)`[)V68OS@YTV9[`3A2F*0Y3E;KLU#6Q3!5FZPH(6&VF@
MV/)CH.BK%0FI^@]Y-,^-BX+[:1<[6WL#ZX@H)ID)L[-VKY?8MSSM)F!>`L6#
M'VY2P1S)1.*YW+@@G3)F@S+T%5YA7`9><@4[W"+O^>I,;HZMI[.(26\LJ<C5
MS@LY=SVY23@K%3L=!6O+Y(R2L=BY);_]T+ESOIQ-!)(/8!$;K,??4-,^5S:R
M**R+H*B@\5=4NZBV.@([_G%P4L;0YM%A,(2+@B77%!_<KS:WPI;]7Y'UA[=Q
M`[X3^R4X!^K.2QP7SO.\^U):+BQ__>JX<NG9P^46;PDU'/J;X;SMG?0,"RA4
M-7GQ+JL7/1<WES:.(J#5+@[D/LX:O]!>X`6I6:0OI?C<<,B5@XXJ+V*GNF<$
M7"0**QTKD1O1;UA_=9$*'P@$=T]P=EKB=C+.9N]2YE(JKK5+4)_I\*M`\M#A
M7XW^.5DJ\YGO[^^?B5T"9F['3\M16%]08C&TV#=!:8D"/I?B'38NF$6"%V`Z
MMSP%1R=B8Z0CRO-U0!?^RJ-Z;DQQ]$+O2,)@V!6WFYY,LW@P<?2^*'$*[QTC
MV_X$]_@#V3J]!9!AF=1`0(&WEA9@J(P)(Z\N#^NC"N(F5WC!(:P?;X&L`OM"
M\O-3<Q-)0*UV&2,^"X%_!)_Y*R_K3F2S)OG^9?+(9-CUQ1=5\O%4"TOA1D^N
M..5(7N8\@33B,E5)%(5H.E&25#T?V87DZP+K$>-A99KD@UV0W!S<M"I<"(X9
MJ(&6LU&I7PKJW+V!]G&HL)S>SZ9WT_%HM@H.%$YG]\IB_C`-=YNCJP,4SZ,O
M&!7$W'^_)II=>4%,P]]=/KRBX.PRVXRK#^*W&(BL`LO!PAD%MAEO][+GAS<\
MQ.7NM\3=HWH&9Z64J133?)X[,WAPE6O1.)3)O0,D.J*=!HJ_#W]X=4VO<R.R
M!VMYK-;`WH0A+]$2YG_!_O>"*(9/_@]02P,$%`````@`Y8$K1;:*L!>'00``
MI5`$`!4`'`!P<W1I+3(P,30P-C,P7V1E9BYX;6Q55`D``\T"$E3-`A)4=7@+
M``$$)0X```0Y`0``[%U==_*VEKZ?M>8_<'(NIKT(P7S3U7?.D(2DK":0!M(S
M/3>S%%N`SVML:IDD]->/Y$\"LI&-MA%OVXNW"3C6WL]^).V]M27]^(^/I55Y
MPRXQ'?O+A5:M752PK3N&:<^_7+Q,+ON3F^'PHD(\9!O(<FS\Y<)V+O[QW__Y
M'S_^[?+RQL7(PT;E=5/YU^7/E7O+>456Y<$SJI7O+O[U\_W%]Y>7X:,KUS'6
M.GW6L2OUFM:\K/4NM5KE?RK='^I:I?\8/&B9]M<?V#^OB.`*E<TF/ZR(9WZY
M6'C>ZH>KJ_?W]^K*6KLF\?"RJCO+*_:R6KM!!0\>_WAU+<.+_X#]6G7<.7VN
MUKH*OHP?92U]>O5[PW]6Z_5Z5_ZW\:/$Y#U(7ZI=_>_CPT1?X"6Z-&T&E([I
M7Q'S!^)_^.#HR//1W?KS;:D:5['"J4^PWRZCQR[91Y=:_;*A53^($8FXIPR_
MD0N*<Z42(.TZ%G[&LPK[_\OS,`-E]L35Q)S;YLS4D>WU==U9VQZER9-CF;J)
M"17#?^?"Q;,O%\QHEY%IF)1_]S\A:*5%#WJ;%643,9<KBP)V55RL&V>Y-+TE
MMCW2MXT;QQ>+LEA4*!WII0HU]A;8O<4>,BUA`1T#0$*;4-L9K`=?(XOQ=K+`
MV!.4Z95`@)8BTA-R*9(+[%'R6:+R@5`M$7#BT7]]`X]G-X@L[BSG71`[XNBS
M$H5SEBL7+[!-S#?\X!!Q(:WRA!ROL.N/D\+2.?*%^X3:`M$.2X;VX/>UZ6W$
MAC>']N]2Q<K?,7P9`;K&'3+=7Y&UQN/9G6G3KFLB:TCG0W?M2RXDV^S-F9E:
MO6S9V.QMK"WV;?:#>09M7Q?B^/\S2H>;J])/V)C36>AHA1:F_-GH@#Y3]&H)
M3N>^G)Y\Q.^Q38<HL4XV!VL^C\7F\LWTB-RO5`)JC`G6Z;>>J).U)*7(DO"^
M_T9Q8E_.')<@"_.>S@/FDA`'+0E`5\[68VB_81(XDD/[Q:81EV7^@0TVC^<5
MWS375CF4R-%=EP2@KT[6KP3_OJ:@#=Z$9Q^"M7H#8/)V]*\+QS)HD)W'E<``
M\^`N+'D(1#``]??!&2&7^8%O.)]L=BG");V2^=34H?8]UL$'^S&GP-0-*P?0
MR7JY1.Z&>=A,V+Y.P:4?YY7602>1UC;^R0C!$@Z!W%-GY-B8MNQL<+X!/-#B
M'7DE<272Y)FL$^%9^+.V/)2[\Q&'=@O]A)(/(LRI36Y-%^L>G5<+Z("148H6
M.:8@@@&FH"?7H2&MMZ%P,8%6;`8?84](H!7"=FD2Y0"*R54>5'G(Q20#H)6?
MJ@MSG>0);1A40O(X$(G.K<"(?H9%V30S;>FB3-$')F,[$$1("L\Q2\VRYJ"U
MCG0`5N];*T\0:]H>K-%R"$--!X`/KV_E$(KVL)*$RC,.4:D`AJ&LQ80@;VK/
M'S#*YX.R506K7&&3KZ;.9+U:62:=KL.'7,0\BIP*Z!Y!$$[1?M_-E2DS;?EA
M]J?.6RA*HMT88H[\)-@O:V29LPU;%\2N3@V-YO3+69C9>_(7@9G<?4*=KESN
M(Y7^]Y7SYJP@`I%/.B11WM:")POX:.#AY^!O\0R[+C;H7Q72@SA$=PP/)*+*
M6J+-NU0+X,)DRI?'90<9_6\=W4\W,T>42N9MAO;,<9=^E"\DEH$P@)>3"5JQ
MA`E:@43!68(FW8KG[]_B%8TI31_J9QHEYM2&T'$!&VZY\7&8FF`S6)"NR!T/
MOR.`A?U,*WQ:#`[&NYQ0ZR*K/\C5(ZG#'[<%CRM3J)=[99C+J_"9*V3MK*^D
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M4%?/(:9'JIK6@%/I</L`G$RW5L3+?+``,C9C.A+EZK.S09:W8>YZF"H;V_>^
M1_R,=4S]2Z-:;[6:K7T3\[U+@1>>Q&;Y]`QMUE3>9A-$HVU?<DXG/&PA_\]/
M;8\]'4+T&TJC?[]&C#YX.R-*^DL6JE6U5J]5AQH4#[=_2H,*PA*:N*VFB0]H
MWSN;"3S#WRI)"7$7]RA"]O8)>4CWD(*=B()!]/0#"VVP\>7"<]<X^9`&'S2R
M&%A^"3<-G?"<_2"5MWO9CWP#$HV*@F[VA$R#QDM]7:<:!+-:,^?<D/*N$XXK
M`MJ%]FRI.:3TYW,7S^ELM^]TU,7-D_*6DQA&0*/0)/5J2T63)*M;XUFPYF5B
MPR\$-$QO[08^2;<F;)R#[SN)F7)I&1NLTU+08#OY@+8*^8YT01]]3:FHK1JH
MJ(\<1`MQ*QW>3PF9/;T@`]S,Y'!!WG3/AS>0HD+QIBO`F^ZGP0:4-[S,=R[B
M;,L-%=+EM`=7V$=JHN5Z&8K;:'3`Q/W4DBP"I<`<42A-.[6S:X_HXY/4;0W,
M)MLME663%.T@.[:037Z\VM&0NDE?!5>Y:K5VY;(2;]=E/T_[TT&PPC6^J]S\
MU!_=#R:5X:@R^.5E./TMSY*6P.;DW,M8P9_'M4VW/D)5K=OK0G&-VV+Q@8NY
MLX[MUVB$5-(TC9-PEB/\7FL2.HN8":)NDZ6OVL-9WS#,H'46A@_M&[0R/61%
MPT2O!V6TS(9+-Z`@#"<?!K-MJ>OKY=IB9SA$0>5N45&D4`=L)!$6HGP;YX='
M\64+5BUAT]`?N;9ISTDD?5L#Z[7\)DLWY4'-U5[MBWV&(('=TFH=J%*/STT5
MG]'C]^P8BOA18DN#J[#);%D"\PX8(Z*<*`#G4,T2ZY+D&JG:7:@%I/WF)/!P
MRUK08LM:\!*`?8]MNVKNTNMLE[C2P`":N.1R<+?VO*IU:G"3;OI9%0!DY,RV
MV?JJ[1-O16:3!7(Q&:\]_]A,ZC94.S4X/SBKX7+-)PB!VK[N"'N!B\Y.V*EJ
MC5H'K!KG4U/EFBI5RVC8[ZAI'9]<0T+6V+A=N\$V0],Q_/V%(_SN?T/8H%%K
M@`Z2AT0XP;B9!Y6X?D7)Q?44=8(Q94N?=J\'MDXA)H,29L[`);:SDFOR6;3U
MOXLVV`T^:#ABDJ!`I,6925.J*O(WH(1!!0&(AFI%2V0RV9JAG7@Q<H$6E+"O
M*`2)@=MG9."`O4S%:T05VCXIS1^:`".OO/(HP09!O"(RM*M:O74V9`BIGJI=
M!S:6S2>0$G0012SA0_W<YO:GM:LOJ&[C67!\AN^9@D59>211@@$',4IBM&:#
M.G9G8OJ`V/MZT2&N;-OS15'"^(=12JS?:M"I0#7KIZUXLD3#"'OCV11]5+5&
MJPZ^F35+@G)MG1>3R,3=\TO"^-^%IZ$DI[?N^+<=>1%<1E-*].?<H"1._SG9
M?BND.:2G^';@H]I2POKY84G,?W9N7?#QG>-.L/MFZD$FJGV2/.R>*$JPX3!*
MR=Q>KS6TQIE8/V`Y5['&:>([->TO@%-"@`9C@'H$.%B;`K1=Z?CBG+P%T$"*
M%"^`%J2GD&DBIA[27_G]60)J`VV$*I^10(J<D)&<_5Z']%=BY]<QFT2:M69-
MVST*[:X_?*[\VG]X&;!](G?#47]T,^P_5(:CR?3Y)=A`\EUT@F;%F578?5D5
MWZ'P?XO.*ZYLW9E5\.@TH,O2<N]-B5]_O7G$B.'$7GOG^A?8Z!N?1'6*)=1`
M+=!^\5X>OYSWZI#S]5J[#JY<>OL21H`B)HS&@7P(*3]/"4,!-,BKP69HY=1@
M,V=6RX>0$G.<*)WC'W\RL4O_?K%YP&_8BN!HE,#H#!'DDIKLMQ0;K],JD]ZI
MDL@E>A[C9G%=!+ARQO"R6`_OE:C"^A)=%%58+^BOB`!7SE@OPW,)EB+[MO%@
MHE?3\B_Z#)4UQO8S.\:4Y;KH`R/'=J-?KQ$QP_/3*'1MJ,U;TJ24T'4$"`2-
MPO&C@V!GD4Z*O?XDBN8Y[(<3=B'A^7%4%*`0.01PC)DAOTY6/C,.!0A`RRFR
M0BAQIR(V?[BGNEYKE*K=K@`RB9_#B)G^0SI&:A_V(6,$2);9*&1@!^=*E51"
M#Y$S9"H,EJP]SK`4V^N5$NWRS>RL!C`!]/A_VE[^B-ROV&-T""]]8!=RT28P
M.^"\WFV"%4MD-*QF5^2>&"<$GMJ[Q&^Q:[ZAY`;,+:#Z7HSC"'O5;KT'=N"?
ML!1G0XXBN*J]#WU;:%^G2*5-M==L@%75I3=[-EP00D[M<YL*)!/+C)R.RL)F
M*SRT5VO:?5E^1XN"'JT![QCLMPL4#XJ;<8_/F=B<24"XI4,]T0&>OOOM*FW?
M?6S4]FMX.C02'3@;/N#LVS@#^^YC<W)OY-B:MOK1-6W>`N_4M?V$C3F=^$]4
MU1:V+K&F[1I9M&D\66#JE3!&,N*Q9'6'#N-`U0-I;1:?K'EO#/M`IP%6IIK>
MJH2>+FJ8J$^+0*!^/4.FUD#+^J73L40]RJ$CI_A`!`+E"PT.*`'D01QI1ZXF
MP7[?(#<5A+K1/0>=)ECDGM8H$!WYEOF\XSD3`;4#EFT%/B4I0BWJ8(3,;/GD
MQLS"0NT0)4D1;CET]_2M;!?^]29T]IZQY2-"%N;*'W$U=M0WD$M33*3BXQ+G
MA5'LPJXO!M(RM54)9)9DU(CI(@"I[]8=`PJ0MZ08TX&T5)7I'(]1!"#E/<8$
MDR0KDZP/:.U&"ZH2(K-E"6EPLM4`;\*^WB0/W#BVYR+=F]+F8B+<8F+.;?_9
ML/Y`:X$=8`\GMM2.(T*2O:0=I"6^F4H0`8S!E[*E=L0_WSI]/A/^"=;=@3H^
M=&7W:8;@+"=LZX5!878+;@,$OTF92T'PM-AQT=+A.X<=#YF93"`2')5B5HX&
MAQ$$]-.E\>"8\`6()H`QJ7(D.AK^F&,*[Z')&C!A<UM%YAM!%9*H'.PDH[1&
M)5!=T"3I4]Z>^NJGW[)TADT\E43#TI0HA8;IR;$L]97/C67K`!2P'F7"%+\A
M>!4V^F2O'B>Z`KO1`MLY*-`^"#]3C)7,YWE@47NI=>381JQ.M*@(>+4PI[U3
MF#!;;;774@^L'L".+@675[B*W""RN+.<]_#5H1D`KR7A-BB/?@(6B6]KS%9=
M[3$C*<+])#T-?\#J,OA-GL1T![4_^>AQ7#%Q8_^`S,?^\\^#:?_Z85"9#&Y>
MGH?3X6"G?+C_ADR+1<&7,\>])(A^FNP9K"2;!@M6$//V'R9EPW'CM&W6-._I
M8ZN'']&_'9?%_V0\N\6O7M\V@M-2DR9\M[;1J($=M2<H0_$16:"!L'=0-<%"
M8F$I)/3_HF9--L;F1TS]*#H7*D`1J6ID/YV:IR$[)S0O@ICRL7I.I<`."9!)
M`ZZB]\X;=FT6H[(&DO=&#DRKU>3<Z)MR/4SVR\KA:HI9(K:*ZWMRCRT[3'+<
ME>/20)6KAE:'N^4ELV4E;"R*C=IE#[M*1^+W-+`KMOE-*F'3@VC$_I.2%VL_
M(WN._6FTV6B"5:_'K12?#_Q7A.`V&RVPT\^WVI'`KW1X(_[P]5+?Z=[1#,C?
MA"`.I*A0Q.&XMWR]E'=@]\0&FC+RFH,K;)RJ87=PH>T$S2/RUBXF_S2]A6F/
M;?P;1F[BJO&.ITQQ38LT(8M?*6:(&':L]FKGA0]JUY]YV`V5FRY<9SU?W)EO
M_J];7GF#4]);U-2'6U3%\OFP43MB$5,V5B]4=XKM76W%XU$932I%!7%TU(YM
M.%GZ/;V#\KEFIPY6;B@L!6@Z,4FN`:DI,V=ZX'ZYPF;-D4S<P>L<CA+?\3*!
M[)S/B8>V)$_GV%9=%J2K:2L1S1_B73C-3KL'M8<OER3%AZB<ICZALK+V'QYG
MXOA*X0*X?3/;"PM`"'7K=#F])/WE_:7C>N8?V+AQB%=M:TVPRD=!&4[30W+Y
MM&F8G6L$0U70P$Y$36_V#"R]A4QHW-9Y&'?/[=3U]7)ML=+0>]<AY,5V,;(8
MA]FFG6M6982GZ(/J"W<VKB09E:7-\9BK'?86U]??%+:E;PTLH2M)QF^`8VF8
MQQP[U4KC4:6<FK9?RCEYN9X,?GD9C*:5P:_!*;!%ZC$GZU?B7ZWD#=YDG,VZ
M\[[`F6YI+;B$$*?!(P*KG;?1%_CQ<$MK@^VV3VE31F\4,48<&QU4_1QVRN]H
MD8PU5(T:6""<TJ@\'B:6*T<%:6&[J#G26+BC^+<3C&<"`Q5W2^?IO8N""_:P
M^<9,%5\E5&NWP$HL4QH%IRNO-/&P_FK'QYQ1/ZSJHBJ#94526Y4V8H:K:U0)
ML'.EN"T"S-KI)DD9-/=T5[O:(-/Q`"IE.\;G*M*/RE-#VAX#4;-D^(]["*A?
MNY>I-5!Y7-ED+$^-<LC(J0`404"%>L#C=GAV.6F!Z?CFYY_&#[>#Y\E_50:_
MO`RGOU6^&R'7]<\M*KAK<^(Y^M>%8U'`2)",B=]X;,*@_XY<([9GH]V!&BL_
M-71$WUH@%U\CPM9!EBMJY>`@%(J&/0^N-KK>),\\H0W[S&\[$<`VGBQDC]`R
M)F6M`;8)$T)@"3TZT^YQ-X8%6_WI:!\EH,%;^=X!-6F=2^_@37*P8*LP/V;O
MI[,0(>.9/SDEH;I6:X)=E,=ML7AOH69;.K;_-M].I+_V%A3C/[!1[=3@#N'(
M:%<"=\7,DFS\$\%`[0AV2X<GY([=B<>6IORS19ZPZZM%=8$[TD>@_5/:50`3
MM9-D3]16V'6QP:>IUN3N:I%CV^RV2S>K.!1J+^M_UB.5H5JSV0,K@Q.3X<0F
M%H%&[6O`,[0'6DR3["8D117^&Z\W_OO#.M5NLX3ZWKUV84F96;F;A<%NN=K9
M+@_VC7^OB>?[\%.G;QAF(,`3,HVA?8-6IH<L'X@A(6MLL'_9N=>L-)-46YT>
MV$D2QPA6^D@F"<6051U%AS?'?L,N"Z9"7()).?B8CMI:M5-O@94W'FS]!(ZG
M.!ZA9;MG9=F`K+X:8&N;V4VK8M-])$*#]M0TZ-98<[MV37M.G2G3,0)E_/M!
MJUJ[UP8KG#C<?NF6S0=)E`:HG:%]_2_'OG1D\(%=W20L8&KWNF"3=7YYU++_
M0<@B/BB:-_"U>&7)UWO',4C?-D:.C9<KR]E@JAUVWTP=DZF+;()T)N8_V:H:
M]5;HDWMJLV/..!G!E&WT,ILNGQ1`N$5T430GL94RZ\_G+I[3H'L\H[$XZQ8N
M57DKT<*.#>",&RELR/'F4R8*\V@=V5+1I,.3Z^@8&^2.HA*R,Z(DA:+9[H$E
M@[-:/D$N20R&9&*7?R2`U($\9:4M&H"VAYVN)MY!\S=PPD&Y"`:1@17=29CI
MACRM77U!%1_/@NLYF0?2@ZN-S2.*6OY:%E`1`=IJ$F!WRQGOY/G1.CJQI\Y9
M818\SRC]Q>6GQPKI'!E2T718"D&#M8L]?G9JM;([,E<25?KQ09@BZRN:,LL<
MGD;XW?\J&)?@=MD(R:"*Q3.@B6RM:C9M*P?H!PK)TF2[TP$KGDEM]C0>V2$`
MHLH*15-FH<:A[SAVG\WYP@LF'8I#/`W=(,O"QO5F@/3%YV>K-(8`2Y@>+5WY
MT;1$/"/JJ%IUQ5,U"C[\_A!_2<)OB<;4`YOQ"TFD!D5RX!;10M6D:X9GLS7-
M49>F[+S[9Q%4<0#2@4GF?R63,EP>C]<>\9!M4/4H9<$K@5,;5Z-7\]%(.K"2
M=LUT5(//6<`:K@(PA[4!=U)=+EE4Z=("4"7I&"4YL)TWCLIRQK.MI8*JUNRV
M2LFA<YL_:2+]("!1!U=T;80[5/D;7:CV7:B=/JFM%B_,Y+XRW$=#50&[^B.C
M77G$%#!/YMRSAT,YN^V.WT^4ICC0_LQ3\+),5<KB)6?[J!@.Y>QS.V87Z$$]
MRG1RCSVH96B_84(?CD+,^!Z$KL;)XZ2LJO!?`D6R%*@CFAW62.WM:R\VE>Z=
MRH-=$I3/;&G`\;%2;)+VFA-9140KM;>=;6FP1ZU.4[RSI+[G])9)UTOM[6,W
MCDWH<(Z2JH<M<G&*[5/KLOBO.9%A1+12>Z_7P6U"X-?2%-LJE9((09Y?6;,=
M*H;'WF@=,%726I5`RCSF27(<AU$XAY-)#[BO0-8\+KJ0;TT1%,[A>J#D7`U.
MB3*G0OEZ,UFO5I:)W8"ZM0;<6'24:*?JY;+P!+Q3&."^HN)'N$1PMFLES&G'
M25E\!MP_!@=(U_S''PEW`<D6CHOW^-"<PTQX$)(T1)(T>:NF=<&VO1\MWA$N
MGUS>P!\,4,+(<*"GR2<3Y\P!:<;X=@XPEX0[9)7>J3JQZ)Y&ZN7P-DVT>`N;
M:1M'CFE+H>YWS-;00S"JG>4KC&!<U;=W"%.[4P-;&I<NKN(DA+2.VCE.6:IO
M[3+QKTOP$8`[E1](ZC\'3;-LI7CF%^PPU%,1%>KD62Y\@RC5DLRK8>Y?ZS;`
M)I/45LOH;3(($?4_$?C47@0./2A?]V39I]7B%!>DN**<-YR;&0^`<"Z.I%@*
M-4J@)IB`G1)VG&C%1[5KTUG1II?H8VLA4WSO[NZ?2Z6S%"-%Q,U25.UQ1T;B
M'_QL>+"%%+".K`@D!3JRW/YS@"Y%EY]2(5>^R%4&@.`WE9Q??U,$$B7[6^;%
M+D="KG[Q[H'Z%:B!^J@JGJP"%O]-<2%9"^Q6M/WF9-!9V!@[!2M\K=4?[;/U
MA1JURB,?[$Z&4LF7OH&!K[420]^Q%]BUQ2ZPBY9B*\ZLLIT'J`P^V,_R[K5+
MUGRWFPE;^>NN.UFYE[_NNLN?PO_KKKL_2^_XZZZ[$GO'>=QU-_@<&Z7`8?D&
M,-DQ^<]8=^8V6W$.RB;\2RV2A42MVP0KH),LJXQJ.CDBA<5<G4X)5^Y(E%A"
M'X6FWW[)'8S%OIGR.Q"#0*_RGGH\"-O`!E^$T,NOMKIP%ZN(B:!JC^4=(IL7
M4[47485@&SG^CF\<^!9DZGC(VOZ>03=RO-^PEX!:[6EU^#H*V5*?$1'+L)S:
M!7M@"`1VN'/<\"/VG,9@`3M>K5Q5_F+Y81NK7?TWM'5GB>,$ZT,(LQ]1UMNM
M.E3"*:/=XFY*RDO#H+7>;H.=1939LH1>DL=,R>DJ8FBHG^`ZJ#U0WN=4)"U7
MG?)(RDE/B:*A?)Y)0)'_;^_:WA/7D?R_PMO.PWY9[B2/))WT\$T:,H0^9V??
MW"`2[S%VUC:YS%^_DF\8D&S)5MEEVB_G)'105?VJ="O5!6C++Z]6KD!+XA$J
M_.O4WGPC[\1RWMCHT;4D"I8;CH9@M8`EZ,/9K$!ML=6J88,[CO`[L8EK6%24
MZ69'D?)\ET+P3HZEZ0\G8$&N4AS4IFM5?'!?TP']A.#5%*KV[!8[BP#!4/8L
M(EMV`=(L<C;]$PR;4)'A`NIL5*'PO)H;;;TBI&&_F(SH]ZITU&9EELK*#&+2
MSLL<'%+3!O+93-F#-2U53QX:W/<6>@?S77/-'M!8,.)/"J^W?/Z9W+[@+MR9
ME)MF#K(P(K_6M"F<IY`<:M*FI[9\@9RS[]>0%".9Q)DI*NY5K,TJ`YG+2"#Y
M7;/*$+\EM6G3(!,."20H)UP%:=.UOHN5364:2:8R[7<[P_UBF4ST@-J94F#>
MJ:0=W^FD#@#Z$II"<HOMTMO'M%9.BE+9I"9>E4PY:TAJ8U91EK\(;]6M1;^G
MNTV/P<`YUA![[-N;8GM3_"UNBH^IVH>#"FI^*W*E(SFIQ#)888%OW?NFWHDC
M-I.L:M[%\+Z8)**2("/9/W3,Q:+E4\,S]LSVJ-(#E_;"?R7NZM6PHY>))!0[
M++1ZU1N/^Q7LO,!BU#_!==;`+:/$IKPGZ(8DJ`[LS>SPV9LAPJNKB-VLCZ7X
MS:Q:K$+<:4YPB#PX[I:8=)ZG01GC*U6N+LAO9MJ9BL2=R00'RA_!%I9&9``6
M]5Z5%+^978M5&!GUZ'<S:A:^SJ(^5@[#AKE!AO(1456Q]9M9J5@GD96.L5MI
M&\30!C&T00QM$$,S)QP22%!.N#:((3N(85@ZB"'.H?`ZAKVA8[GT+."XT`$-
M"566RQK3;.NUZHJX;NNUMO5:\V='6Z_U]YP=;;U6J==]/0W@F]O(6W(5:5SJ
ML6X-RZ8;]QN<]ZG>E1V%>UI'K`%`5_FFKPS5],V5#`HJJXP+#`_2UJ_X8B9Q
M&S!47\`0GN[9;>10&SFD_1FZ0>;=AA"U(427;N-M+%$;2W31!MX&%;5!10TR
MU]SHHDE#S;4MA=;6R<)6)ZN^@TV90(9!]UHNC"%PW94-2`@':8,,VB"#-LB@
M#3)H@PS:((/*@@S:(Z6>@B&\4U&JL`8'C]P:(N(AFW9D5(4)]\-&>X^HXQX!
M41M?1\?$MKZVMOK:W:L^1A6?W]?FCD\.#BPJR&AP'D4C<NYECU;BW,@=.`PM
M82P.2[*H+19'%<[DK"8GX.4$ST@!)>U4!K.[)``J"57@+>U)H@73UXJ"?DN_
M_-=5;]R#VR]+L5:9J?-\W[HPK=T)5VT/KA0$_1'<'02*;1PF!Z@+Y.\KN1O,
M66`YT`YZ87'N*KC*AJ[76UFU7)+DJ-L[?5UX6BZ>[I>K?W6F\V_!X\+3C_OY
MZC\[\_M5L;3')]>AXOA?].#-,`_Z<LZ)7S:A,1Z6W0'\]-A,5=&%8-@?@<7C
M2=`O/L."A^(?QOJ5+I?N$7+1G65P/>Q"299'7,-$+**\>#XJ8(.[?"S;Q?8^
M<4_Y[_7&8`%(`IHUJS0?"=R.N,5V2\\G9W8X'L'-41[%NB=F#@JXXV@?"3U9
MLK/!;/?F.N^A$RJ6H0L7UYU!MV9]RB&"^V+W!WDUUQ:)V1X-K\'N^,>D:M:=
M4&[<%Q^NR2VV<_+Q8*Q-B_+)7G!\=Q]4+SGX;R<<K0IN1$5(8)R("JC@+E4F
M1.;V*[EU#?OC'E1,C03]X@=Y:;57+9SB+:6@<6>H,#9N-83P1_E(8P$4!(/#
MG*L6KAYSYL3QJ"&$/BQ'*,[!D4N1F$"E[N>3U_%<)-99E`X_X#Q9ZO;@9S,!
M:=5B59Z[Y*6ANIC'3UG8JG8S:I@!PK&_NX[G7?5&W3ZGY12P7`'M"LV=<]Z6
MQP6W6VJZ7N]W>\OPR>8;>7/)V@S>R>C/%@E@LS?3G>/ZYK^#SX5B7XTF/;`W
M3%U,UFLR`%#C=I<))9@3G\V00;_RE8-21KING&""VV66MM^KZ_X03)%I0O4J
M3B`R\IQAI4,9>-4]#>?7<O=I(`EUW:=E*_`I*C-W[>'"=`'!"X/NY#1TX6[Q
MX\=LQ<(5GH/HA;O%?#6;?[^?W\WNGPME2-XYNYWI!_Y6BND=O:>8]@NQUR;Q
M2J9*/CKVRXJXNZ>]NWXU/'*@=%BN!OW!".KB*4&_^)P5#QX:,14,K!YB#FT-
M<[6(ZA)7OC0R%W.!EH8+ZH$5TM(/Z_;#WJ>KT`]J-[O];DE'-ZPH;8&5W5G0
M1=%@BT?PEN.=Q\E>PQ4.T\%BE=,F,R94$\RX+^X_;7H<92QN?MIT;F_,D)48
MN<4ORWP)#JO>8?]+B3D9C<!F4RG6:K8B;;#BOL!)[3%`IV4=N^]O?`U055W)
MT[_^1$9M5;<O.KSWT;`W=,S;O6EMZ&:5Q%1UP8*3N!3K#FO)00%W].YT[SL[
MYY=Y"+(:W(#MNF?$:E9=AO"X3U9M=$8;G:$:G0$<;`01G=&&SEV<->L*G0..
M-<H)G2N7KC8Y3U?+\?DF#H%.X!$HV+DOPPU\['$HF]3V?6^PRA0D?1>]_9H;
MS.<1F$)_U.U#&7P>\>)3F3=R.&YDI50LL)IY><0U3&)EM<4S6`$8_)&O<B@`
MG3WJ-MX*Q:K%>#F'*05@T,>YRLD"=+O3HN3,,U2P.25DXLI6_3&82%F$@6PV
M4UVG1Z8<0'"['H[/')NIYQ'?2[F_QS=CJ-?5;-(ZWM&X%*+8A\D$[#U<A@$-
MAJNHNO/W+REX+N;M6`8NJ`QK($L_>:)D3YBL#8#MD2!*<#`<@#F!,TE79-R\
MO'%91'#GKIZ(<?10'3]1?]N3F;WZ</Y%#-=CHL%%5RJS@\8`U)"+C.*ZZ49!
M=4\2X>"B80HPU`3#X*(7F<9-PTWCP=F[B6QP#335^6F`87"QBX]'W48;!I,(
M+N],D@GT)I!&*=9[DZYU8;/5Q38HL\F*.O`*F`A*7>0/B$5]><(F=9E1EMZ6
M-,6[O>NR%"]FD74?^R)>L.A?!;.DFDF3;8'N3.;[X<32NZE_5X_Y06\3`NR2
MTUX#["*"Y,EP?7-MO@4.S`<*WR/Q/,>]ZH^["L7Z58;&HEQY`'!W77BRR.8E
MV;X<_YF\&51,8GTMR9OC^F03E*M\,&W#7IN&E6H&>=4;#OI@A1Y+,%:?C6A"
M,\G;1&DRO+>+:)N[,USWBZ+VAV&QDVMW/`'KMBW+17W&4`2G)&<>I>8O.J:Y
MC8=M8CQL&XFN%(G>K&6EC0+%LV8BBP)%'$;6ANBW(?J74T!QR1K:A0(/AC=0
MJU1"I;AE!D/$@5"#41>456V[OAC>I+LC5R[\R^")9$#K`83A0+(*93B<A8@O
M5S,6G#3;4"U@%=7!9?:'\<F<N_&!>S`&\W<<4=)E/P*88PL228?[2A@YW!.N
M)V`F=$2I*IT(I,,=\2L?_PE>YZUD>&RY(W^CBSL44F*CZ[MI2!<"TKB6="%`
M=2N`D^PFB*MYG)RV@)2J=I@%U!Y/W$1-DU%32RZR!-R^8@+N(76VXSN=Y_W;
MFV42U^L8]J;#$FE=8TUUHS\O-U4YQTFH1G\4TBR;J]M6<&PK.+85'!M?P5$\
M."_^*!62UA^-;CC755';L8)DJK1VWLN8!G1P7W>5)3S*-F!B<F(Y=1F!YC2,
M2BU!A!/NO@;*8@:B<<*X=)E`T]2>Q@-WG<SO[(;E+<F:F._!UMWKCD=@Z36G
MU&K6:Y;PN/L>+)TOP_*_J,4%?#-SXY0Q$$R_XR_7K`.Q)+@[=HIEOC-\\N*X
M7XLMDSS^]TWT;$MQ@&NC7(PGD!N2X,)Y:,S*"XQ3WB^RR8":MIJ:)6Y.THCA
M=M-?9.5E\<"W7P)#"%Q?@_X0S&%?D"?029%=H;D\BDWPZ9>2$BAN`-)6]&^/
ME8-0?GLL.F'43")_(LFBB[ZL:RG(@,*VFC6+*@<!]2SB1,651[?YY61[W?-R
MLJOI?]\_=Q;SSFQ^M_AQW_G;W'#9Z]][T=*Q*^.3>`M[9M-/2#)8V;>G>YL*
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MN]<3,!7FT*Y#F?)PX'XEGWFN0:RTX(FK_AHL74!$M!9%Y@.`.VG\7.(PK'@\
M!O.>\$D6WQ2RE5:9$-H.(I(J.:PEN>+C/\)FR0SD"J_6#"L3HA(SY)R+)<1'
M?TJ^Z,(\)U5-)A.PVI.H:KJ(Q,;MF&MKN;2U7-I:+A=FSFTME[:62UO+)=?2
MVEHN^`RGK>52^X+3F%HN;=T0=->)MKX./IVLC,\G0CD*`[1&_2'8*GM$J?C$
M3H:)3FPCP&#=$UH:#"D;[MB4Q#*BCQ;E"`ATW(.T)VB6(>V)<U(5RX@B;E)=
M/T#;1A']\"--#-<RB>?3`5G&<?),/@)K<<REJ-/`!/`G`2DY$N,^F3P:_AGO
M_9L)6!\<#KT*=94M+>[S2O+`LTJR5#D5G`3IB\=?+CZ]>4%:F;EED*%NDN]G
M`KP2FQ")U(1$KZQ'0J"<OQ+OMGH4EBLS8,3';UR)358]&477Z-'K&JU&?H_B
ME[):+%CG\F:(5K^WQ*;(K$W#_;IGX7^41X]0,5]<8Q>5<AQWN]([:MYP%>I*
M1;*#IB9H-<6YV@'-.?6;M!Z-B20\:.=ZA%4[DM9VYDB`G$?*C,:Q4915CL^C
M`*O:_!KJ\,HL`^?RXG^MDT3BS`.*U]!TL%JUH7&<M&KRHG_=DQ9'ME:0)O7Q
M]\8/9_7J[#W#WCRSY(5HV"3J?=R5+X.8.1:PA8F`379(63EQN]=28JP^B/5.
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M`W]Z`B345^$DPD4KQ+B/VGQ9PY9&>WJ<C,Z5CNU1D09@*9SR;.`TCAS`<.^`
MC\8'717OJ7D[.W--!337)K'77]-=4!?PD;R8GA7(--N]A2=`*FC\]^S%E"VJ
M!W_(G*[+4WNS(G8\&RB:?87:X]#\U&U#E0*.9E?GVM[<"&D_15S]CV.3VSN'
M[LYT%K'9=?])=@%_X0-B`.JUM"FI#J_/,A3.D[%9E,$"]RZ3+5D$%=F$8J5L
MN,OQXA72-)\$8FWG8X)[3^%*MQ9(%_YWL5V9NT#$'B>%2T7M,G3PZ5X5'=P+
M^XD04<Y4T)5KL;VWS!?S%SU+^U^!1*IOC?G#UJK>(K+COG7^:?JOKTY0V"2"
M96%_,]_-#3VP>`\4LB6K+&V33;)+/;D.0RT04?Z)MC"=6O6M!1W<O9=D39H>
M3$/83.+-[&_DG5A.$$<Y=8D1B"O__JN%9B,6`FG4<+=(F]F;/87$#/(+HN=T
MCZ(7P4`OR9L`9"\"@J*RID(:+X3N;HYO6,^&1<))(?_2K(=HK6:B'[?(3B9-
MMY.HR^.IO%$=4^\[_0([,6W8(COUWLC:I'?I'X;[%PG@YI7_+VU&)7AJB)5I
M0CTRPNM+-T*3_C^4/OY3YVT?^F\"..2?^BKAZ4*,4!+UR`AO<!KA0?+I>DVL
M<%I](V\NG5.!*/&MOZ?T`ID_9JU&H"QU[-WJHM5BX+H-VJ\:'Y$;-\+GB>J*
MN"[9I`P^/`&&3ML/)Y!4WJ=9DEK=FM>%5&P32%V>RI*>G/K/!>_+>\7T$F^6
MQ4CC&!L04@=:L:FRHG;!9'UP]D$0<D_>@UZ>8+,,)1.OV#B0^N.TS(I3V?OR
M;ECM])ME.BIHQI:$U&=3;-H\T-,W6U%?"15_ZX<)#WV%5!P]5)ME-?G(Q;:"
MU`FL99[P`5#("@)AHEF6I(QK;%A('8(G`$07^G_N#<O<?IGVR\Q^)U[0)G:Z
M8_VH`M'D7<2JPV,R!B4L8C77%Q10MC-N/[<S[@&)SL$YY'6<;></P]H3]L.3
MZVSV09!>9^IYQ/=T--$]T$V176P#HHOM@61(L6RGW;;F=UOSN]!2VM;\;FM^
M%[:;MN9W6_.[K?E].36_67)*$#X>)G^.>EVP,HG'I$IN"XTJ%)@#LE2=0,0E
M-T]/MH?3[\HD;EPYI\^IBRJXC>4/6)U2U(0#G.S:U)4(_IAD1U+AK\^3U35/
M^\?RJ=,\G4&SK2LE7P+VV.:$8EY,0KX(#*#S@$X;%%SG;\G6<<G]YYL13,U@
M49"/R)`;%-`*.0<:=4%Q'W58`5?'9?17KX:_)/^W-UVR.3C+;H,W&H<O=B"F
M?`1&*5K5JED;++BS3:3W<=G:EYH.*068/10>ZW/\?H78U=F441EFN:/6N=3X
M76W2:,C6P41B='K8K=[H^)U`E:1&[Z93$$AA-].C1O[3'AUC8<?N%<K90"&,
M+?U=<$L2@9<\S(DDP>V78VRO/IP4VPIA/NGOHE``5Q+<)].`;18<E&)<(5+F
M^-LXE,"7IO8C8IG'YVZWQYZ>G?6>'8O3/QKVIG,?],OIS&QZ.]H=95'(O"/'
M0[&^$L%`G'&47X@;[.C)PB,N4S@>=J4++.:.5ZV#1TF\UNF#QQY9IY>K/J_Z
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M7!\\RKVF:RQW^#IT(Y2P_DPP"?W\22SK'[;S83\3PW-LLIEYWIZX5`JMJYZ`
M3!WZRI48>5&*:-D.KQA+$H06V2]!#P1F?#G]`10W*RZ56K:I''F1%XM(Y+VS
M#,];;(/]-NS$W.M-H!+VA%2+^^G3(T7OE+WN:``EP3DYG<:7JXSD0I\E-?XH
MJ1R!@;+^*K0^(`GJL#Y.!%6FU.C#I62?8F5S5_2\-!>9)]!I6X7F2;:Q%0#_
M+$<B`PPDR5.E*AYT^V'82;KBP?/L^WSV,+N;SE>=Z=W=XN=\-9M_[SPM'F=W
ML_OGSM_FALM:#+V3@F4-GLT7FU5L-6Q6?Y'5D&!%#1R+=:'QDL'+5C"8LIYK
M[`4Z4-M@#';0.")48OXQ!\2MX9$-*]5!E1[V^:)HV"^!*7JW7X>_>3*^`M-F
MM`\,V!O6G(<]6D5+Y:@[&((=L``8UC#K,_6>S&]8L/&?BLY1`CI&H)\=4`?`
MILP.SID+&&STI[;POKW^"C#J#09P9^P4H>)S8VI9T4!T_XS/R).;84Y)D]@;
MLHZ8"-F.?SME.?Z<1TV#769"GD0T90M:S:JKU:Z@/`?`=I7)-G*[XIP&<@2M
M9KTJLYM_BTKT1<7I4ROU[1=;C</;3F\XXE1)T&-Q4AP4-\4'IF+R2*\%FYGM
MTZ%-.ER4,?SUP_A?QPTN:F$RUJ`W@!)3@0\=%]A":HVMNAAF2&ZU!<T].=GT
MAF.PXBWYY&O7O1)"32@K(A;H\(A")1I`I9](T"^^NBGHNG+Q5)?OHE8M5F.^
M3?-1NIC,%FG0@%)=*K7]3=1_YVIRG1=PJ4^BF&B5%LZ+]<O'`G<2S>W>HT)Z
MWIVS^V7:@=<@[$S_PESI5!)S$W6G7Y(U,=_9C/WY1O^(N*Q!Y9*\L`Y*COOU
MP[2(YSMVV%5N*%\:!8"#FHT"&%/<Z4!+PH:@LIX@2$5U7D*\XY!8]^20RX0<
MR9=U+T&I9@/1A!'NQ*,E\0C]V]>IO3DJ/I_@Q'K@/A`V%:SOSCMQ[>#U;D\-
M?D?<AWT0TKER%MLM%?O.\7QO9@>NA\U5;S2>@.TT<'S7;G55*`1W2L]T\V[8
M:Q(YP.GT8DB\64X@*1,IF%_RY2YRQZM9YTKRXDZ6HXLC<WZ$S;%YEGS_R1X^
M"&N<X/F+;=SV,9!0OGI&43*U3^[RZ"#/\I)TD``]_&AR(140+79O#T=@3Y\R
M#(`:N%"%<NZQ,XC0/RS)0@'TW(3#FFL1KG)KYCQ?*4+4A.<LE]YC61#8S/9\
M-PCB6YI>&(#7&]T`ZEI,N(P)QZ.RBSOKOI36"RM?!2[..6$M)JN@IH.Q2H&!
M/X(J7WJP[;4>(P47IR8CY9X/I,!`'\C$$][[3H=[=#SO]NOO9/-";^%+$K:M
M]U[-MQ`6UH:V0NO-9ZFX77,&3$H,#D=04@JI`EET`:7&MBX#4`,.P,4QJ?`L
M4:.A`TF)U=`Y)P\9@)IT-A9M36!OIB7W:7Y@E^,2\\6^_UR_LDL+_95%$,>U
M70=C,,=\%F&MMBNAIB1B2PX,W/6>3X18!*PD,O"\X2`*3=-%HD\!%+B?]#.B
M"`\QA*DP__Z@!Z=B-5Z*KTJ/YIJMU?;+],4E8<9#W'FO>\WINZ-'/"%5#?9;
M5HVQ2<L@@WQ]4@V+!3HYZ0XEUC=[JQ>X\.PM;/2YJI:(HLY!$+\+2QD?H-LR
MWJE0O<!8I@+'4U`<0?2.LIR[(="&7^[R++@>>O3$:?AD,_6BX0^7YVBG[@UX
M$0RZ;HFY]#58L[RZ#AY=%5QPGV">UZ]DL[?(8EL\43<,EA]>CSFU1S0E0.OB
M4L>;ALCW#Y8A5/*))J>*#I@!G#^`9"*7S!/]A3&U90Z=9[P#*5V]TD'=6A9`
MDVBU/T*KU14K8+/8SNR-^6YN]H85%N?I3\#4RZ78"#7G897H>S`98=5WF;>`
M"A=Y30\\=5M,:;03DYK@74+.2P,`&8IR-8:ZU2]`)E'J-=YU(A<2$2*/AUJL
MW1Y<%[O2[!4_#6NV&RB$*KTVY,PT_<:4E%@"4,;%)#SKPAVJ]5^=DY@-_"N?
M]J]3VN'CH_?@N%MB^GN7>$O6E(=E@LHG26JFCFB*<EQ&@%#C?O(MC.G]_^V#
M*JO)D7'AO[)NO88=0?*=]53S9E$^ZI_$?'EE'KEWXAHO)/A'UBGJP3#=/PQK
MS[KBC?LYI?AKF,:ZQ6S`-,``4]H:<&>M/SFLX.V;Y01@W!*;ZB[H<\T:/H:9
M<ZP?)URLE@0#N(U.$4'<N>N'V_3<";F8[EC5XZO^).>,$I?2,^UWXOE,_X/H
M9Z;Y04KSX:="4KBUG0\0[F32Z7J]W[$J&V03K'$,()>\LGLL\Z"LG1UACI.[
M\(]8#%D0#T:7OCGQ8[<*2[:],[S7!\OY8`X6XMUOMV3MTS]9;%?&Y]5HT@<[
MTE8B`6XCK%J)R!LL9GD`H\HB_V9Q`"*L0KGIKT^L9XW#0+JZ'@[!@N<@&,9M
ML,`JPMU5,I9S87-AH*(\N<2G$Z[7907A@(Q.E@O<AE0$2^2M+8_78*Y84S^Y
M63##'T]NP.*6E;G!;2]EP$7>%S#A.I3M1(R;<1^LR&(F9=SV(`L:\MZ"&<_D
M0&&@Q4,*Y`1@);C2C[0KYS[H@Q1W9.A/P-)\%7G18.!RZA/&1$ACA3X7-@,(
MH,A^#'9<E6AUVC$G/:$X5OA370O)!K0]0]@!5^C[P.M)2)Q6U1^-Q_(5!$^^
M#6&.BDI(.MF*Y<(=;?W#L(WPA!0GN@UZ8!?*4V*(%)B!`^[G3'%W%RG?>T5M
M;+BLSQZ?*:O7`QA6Z>@:[$L*WMB(3@3"/?/_L?R3,9N7_U,0?3IZU>B?"%3[
MM"W;NK2OW+HT#KOJ.-O.D^N\$=?_ZACVIL,>JX/*IIUOY,TE:S-8'CLL<`.B
MR^DA_"OF@C6IC7E(L\`X*-L*-:;!.O+Y:4*I&@;#_@C,-R]!O_@:&7BW?QCK
M5],F[A&,\3YUG;?4%Y<LC[B&&5Y$>?&$5\`&]U+,?%9[G[BG_/=Z<&U/!#1K
M5FD^$K4OZ]G3=4O71')FA^,1W!SE4:Q[8N:@@#N^Z9$8'GEUK,UL]^8Z[R=E
M0'IP!5+$=&O6IQPBN,.4_B"OYMI*+NBCX358N,DQJ9IU)Y0;=P<#KLDMMG/R
M\6"L38ORR9H#^>Y^G:XZ-1KQ8LX$WJ0B)#!.1`54<#<<$2(3=L`+/,7#_ABL
MA(\$_>('>6FU5RV<UGK$15281,4J(82__I`T%D"/E#C,N6KAZC%GSANL&D+H
M:P@)Q7E,(B@H$A.HQ,E\\L5M^=Q==:ZS*!EQ,(3/#,UF`M*JQ:H\3^R4ANIB
M\C9E8:O:S:AA!@C'GMKVWK"8EW:Q3?MM@U98G.=HP5%;>?P*K9R7GU,&#MP.
M*NX-0B36-^*M7?,MEG#,<6*IW*TDR-2K=QW@X/9M+5D\9'AL&0S!PHH2*L57
MI&"(Z`(['(RZH*QJN]N+X4UZ#W+EPG^9.9$,Z%0/83B0K$(9#N<ZP9<+_;7A
MC&VH3L2*ZN`'0U$-[?:[)`)H`L;N$25=]B.`.0EQ$DB'^VWTA_%YQ#4O7%!7
M=-IG]3H12(?[$*EV"P2OP*KAPES.@0<DH2X'GFS!-45EYMZ6N#`!KC;:RJR=
M[,9`ZE4[[``KD2<RDOJWY>+HKKN3LSBZU>+N'W]?/'Z[7S[_1^?^GS]GJW]U
M_O:\W^T,]XO%SOUIN$'QEB!V+BKG4C1.SG?6?[$K)7&]L&1,1&>QC:E0)44T
MRD;"G5>\!3K\JA<#YN\CA8O#'1BP-\S24W7Y1]T!6'-2"(9UA,EFZ5VZTE$Y
ML-$GCIV#!.120#\Y@.1NS.3@N&6`P<:?C<8'(/C4F^[]5\KNO\GF)]V(W&!+
M"W<L)C!%YOZ3;N:F1YY<<TT.)PDJ/]CC-@"_NJ>J%#/GK!R,!ZPI-0"_.LZP
M%9A@]GS7I3'T>R$8U)5N+9<VV_&!U\39+KV[Z]+816_NV?)76KL6WF*YX$5W
M\_.!%S9)(FPG`_DRT_D#UCN]I%6>I'LH(83[N4$HR^K#2<DR+*_M9,!+T387
M(=P/&6)9J$[3MLM)DE;6]V'(B]$X'R7<(3`YR]204_U"5([D8E9P24QP9WCE
MK$B\XJS2BFWJ8BV)">Y<L-R%9RB?]'5)Z[(T+KC3OL[%>##?4U+P@H:DM7L8
MJO'*Y:."NW;\N13/YF=*"(7:7^*1&J]9+B;Q/6ETU6N&9A^<O9M:>^2S`[*&
M:KQN^:C@+C_.L5#R3NR4C7)</_+S]C!6X[4KP.4P=_L8]2N\T!T;ZT#^*B0Q
M8L-TK8@1\HKQ8FF.#A4#^3N2Q(@7HW$N1K'&F^;(/#IL#.1O3OD#7HJ^N0@A
M+^W/N^@3*VVWO$*/"OZ/PV`-4[,\,K&*D?JWQ/9Z?`@9R)^\989LF+I543H<
MU9JE]'O63S)EP_).$IDA+T7I`I1BI2/UB`G%F9M';GEY[XG$B)>B<CY&L<:1
M^LG$3VSI-6LH?^W.'_!2],U%*%8WTOZ#XO7*.MZE%+J72XUY*4H7X12'&R"]
MAL.%F5<:B55!3#\7OBAC*BEE>0/6J>*($MBDT:SX>-:(8,(=>16W4$DM&G'Q
MYVM>_(T>10NI-DWI,O#A#L8Z3Y6<.SYY3*KV]$>CT>"\_)I@.\P9K43X-W?@
M,+N6L<BI$*?$HJXJ;\IP)M'2<@)>3%TW.:!DCV%P=E>TQ65TB%KL?<\W[(UI
MO_Q)V+68;*;OQ#7H82I]O+KJC2<]L*X#%0E1V?3A+,0UZ`EW?$]A0$+84WUW
M@X8?JU?#CJ":._8[\2A`\WVXTXW'?;`C865B--)XR^@*^4M:(/"O?$Q^*4_H
M)6',T<_OZ/[H&FM_;U@KXN[Z5[W1#=SEI@:!:K?I^O076?<U0!45L,6YH#?G
MT?D@;OB3N3-]MD6-P+IL0')>N[E6H)$DYOOR[?+GV]L9"F"E_2`YOQB[S-!(
M8I>3T:7;97@46FQ3.TRTYS!`>*\]"$U4+,3%6*N<GI);V.4OJ#$@T;\PUU`:
MD(J?([0+<7&&FZVGQ'!QKKBY[LBS^HQ`_E;=\RJ[C@54V=2:2JD4F2X")6N8
M*A+0-Z%0Z7EM,R"K4:]I!Z!O@;074::TWQTHM_MF5N^25\;7.^G,[+6S`VGG
M?40G)%.Z4NEZO=_M+<,GF\!1R"'QZ'C>8;\<7H.YPU1Y*;Y72%*:$W^Q71F?
M5Z-)#^SA6Y$7#7.^K,Z39:`PBK@#(+*$N25;QR5+LK8,SPLF:NA4CV7L#<9=
M,$];"<80F8TF>'''4)R*\$!AE`#P;N^ZQ/:?"!5F<Y!Z-+B!:]BAD5-$5@:E
M`-PU=:36X=Y@!/<ZV[`]3!4PW)5W"J$"U$<3W6DN[KL`UAI5A8^ZI@`GS*P8
M?*>%$QH;=:8L/M3-7K?U")QXE``#/[SL,R*.'717#)PNO1Y<FZ`LRM5-!ZX>
M#Q&7<N@TP25U(D(4M=R[O@&[GG`I:EG6Z4[\TW:)83$_XBR(7V):^D['9SJ-
M>WM-P'K^JO*BP9[E],=9Q!7!PGT7/Y8KEH$=YK\1SWRQ@^GN_G-/I=U^L0`@
MPWM]L)R/OY/-"TEDO09["-/!7\W&4A94W!=QB24=JKE#Z0U/=5T'$J3XNI[W
M]J"BFB2_)D=^_#T?\L6&:D!0N44""5*C17*Z&N3)CZ(O@>A5+/J<_8?%W=)/
M_A]02P,$%`````@`Y8$K1>6(Q<$%]0``>D\.`!4`'`!P<W1I+3(P,30P-C,P
M7VQA8BYX;6Q55`D``\T"$E3-`A)4=7@+``$$)0X```0Y`0``W%U[<^,X<O\_
M5?D.B).JVZVR9;Y)379YT=K>.67]NI$GE=Q6ZHJ68)M9F=21U.SX/GT`-$E1
MXD,$2="8VZH=VQ(:Z`9^W6B@&\`/?_SZND9?<!3[8?#CB3I13A`.EN'*#YY_
M//F\.)LM+N;S$Q0G7K#RUF&`?SP)PI,_NO_\3S_\R]G9182]!*_0XQOZR]DO
MZ.,Z?/36Z#I93=!W)W_YY>/)]V=G:=%-%*ZV2U(V#)"FJ,:9,CU3%?0?R/F@
MJ6AV`P77?O#;!_K/HQ=C1'@+X@]?'Z/U*OGQY"5)-A_.S^F?DS!Z/M<4Q3R'
M+T^RHI0T+_G[[[]/?M=9674ZG9ZS;_.BL5]5D%2JGO_WS?5B^8)?O3,_H)(O
M,:&*_0\Q^_`Z7'H)ZZX">9$K_3R7H+8$_>LL*W9&/SI3M3-=G7R-5QF+)6&J
M&SDA'8<0=%T4KO$G_(3HS\^?YCGUDQ<_,LIM?/;L>9MS6N!\[3WB];GWU8\O
M\9.W7=-^9-6\1/AIO\-+%=`Q/,?K)*:?T-KB,QA6-97B7ROJ3=XV!$"Q_[I9
MDRX][\GX\L4+GO$U_9TTK0W*?$W=PPKP%'G/KSA(+L/EEOYDL!I4C,86Q`C#
M^DR($'LUBX22+A!*^A@"&`(%,+H+<&C#IB#!"F\BO*0323UV]DC7471(24WH
ME)I0U6(\U]0I@.=+\H\(ODOU#L9[@)^[='9*=LAQ56U#LWJ/(S]<704#\UQ=
MK1CF%XD7-=C&[NR7*QY:@(<P\=;#LEZN<FBF;_'`O7U8X>"]3)QP;D-RI)=+
M50[(=(?N3<I\MNU3-LM=D]_2DK3&!M\89D9P]PLUXZ\)#E9X!2YS7G>X3$NQ
M5GX\(1_\=;9<AML@(>N@^W#M+WT<SQ[C)/*6R<30S(FJ3JRNDRS]Y'".33]N
M:'9?DC5=A(11UDE[W32+,GF>HO"56YPD)"3>8Q.)YMB:;4XTT]!U@_Q0;)O^
M,!V%N#=AM,(164N>H`VQ3Y&?O/UX0I:5VYBP'6ZH`^KE`^Y%RR,CF98X7X9D
M&;9)SM9EO)`BE?UP,*@]1.+`7)F]",?A-F)KR-<UX8:NK'%P]GEQ@OQ5+[[<
MQ?SC[?SG^<7L]@'-+B[N/M\^S&\_HON[Z_G%_&J!?LVJ^=\?SG=]<1S\"_\Y
M\)_\I1<D9=8>B!;]1$K]-E$M1Y]2[-@B5*$=$_W4HK.@F9*TK$#3=%V;DG&S
M##,=/D-J3>DE5WMU26IFJ!8ZTX?#8XHC5EN$3!PR:DMI2FD[9M3F662P]*FA
M@,TS8>C,?PBE:1)/]%0S`(_#:L]%^/KJ)W1_)YX%JXN0,80#RLZE'R_78;R-
M<#X=JJIB"],A+E;ZJ5)/J3.%XJM&UW7;F+)!G3IT4'6=_F42#U!JO1I02M'J
M-1RK[L7=S<W\X>;J]F&!9K>7Z.*.J=G5;2_7KA6#.SM@*X;ZOOHVT-S55VXN
MC2O,A8:=CN^4C2\SIF1\K6]?X5H)*86^M>'4+=2$O&"%]NI"N\K0K[0ZQ.H;
M1_>$K*Z^`=TK+;8XZZ'6U53ITEE1%!AN%8;;_D?2OD8Q1UF*#<AP\ZS'IVZS
MY^>(;81^C(BW&W_"2^Q_P2O:E&90@!W&C#=QXC-]42Q=8=I"/ZFKI^>&7'OF
M*/SKBNNFXZ@F]-Y46E2WY+X]6%?U\>PC>&W'BIL70Q'^@H,M_0DE$1U#],RH
MD1>C\`DE+Q@]>FN:*(+B%XP3M"*4DX'1:DL,5KLU5BWH8N?;Q.J.>^&&M1T?
M+GR;HW-@S%D28ZX<L&CJ,;;W9^B*M+CCD$!X.*(5&P4;F8+P4R<0SH-EA+T8
M7V+X.0\6>+FEXW*)-V'L)S$9;9U`7M0R]#@#_9#<2<`,U&V(+5,%=\HQP)W2
M8(Q4J<'>4S+12M"//3<C1]]E%7R/_`!E=:"L$G&Z(F39*).NE-:';8BGFJ::
M"@R:"8.FPZ!IW[RV-,HVRDJP+Y=NKA^KM#Q1&JB*3U%NO*_^Z_;U!K\^XHBL
M."UQNYA[3?5#_Q&N,YSO%U-5QTSMCMS9%TULB[;F#6V[Z7?H5_B6<U/OQ@_V
MQLQ6Q"&MV%1/I#5SG2-MKYBJ3A78J='ESEYH8ELXTNK;=M/O.B+M+GG!46&O
M[=H/\#S!K_%$MP6ZQ[7-]D,@AS09&NM)5&UJIY.(W*',MB*(1FE+/EQ6#A5C
M([_2HHB5[8G?!^]QC>EH5VTUB,$N:W)8W-9(48=9*$XZV8)(KRYW)+`-^V-C
MM8*'*IRR8IP0O<>$E2#QGO'=TY^WWMI_\O'JZNL&!RL_V1)>(0>F_=;8T0K[
M@;$+OQDRV]!:BBUO5(%/"-$H;<V)NRN)[IY07A85"PN#;<N8ESRXW8^#M>II
M56-][<B]V<LCQAB1,4Z>6L&8,P;VB1XTG'WUXPEQE\7ERN;-]`-Q`[<95'=%
M5--V4K=*[NR#.I9%V\^:=EWV.?J5?L,YF3/*=!U&G%EQZ_)"0P,@JH[C/4QE
MRTO256E`1MZ(:C/3H^"JJN4,69?AJ^<'O-@*W[QU0@_JO-(<ZGO/7\V"U6RY
MC+80HS0XXJ>-E?5$%">?.<@:Z72-+'=LZ$BY_4,N.81#D8,9-R^,H#2BQ1$I
MCU("(8!MEV3R_H`MQ7Y:]*T#Y')[A5QRC!+3X>'(33]F&;0;"M@HHQ8"UY:K
MF??':WD5TZ);87O#D#N,SR7'6.L8'J;<U+Z&3RE8WP"Y882\E*`+=M\^;CV:
M%H-Q7,R/96T11V1J:N+\T:,,#(%Y3@'W<=],;$TM",\9<@?EN649Q\-HSU#J
M9;RA'<5I<1?U-'4^.BG`)R_!]]X;W8:]"\I9?$;5+0J-!KRIQD$0S<?Q`:*;
MB'7-U-/=:D/N(#V_,"-ANCU'.:@I"4IIT%W0+TV1!R)<;HD<J*YS4([VNPU'
MJ`RYXZ[\PHSKJG!PEN>K[+P50#B]#)+=K^FAS6YOEK@US_LYXMW<F58HXED^
MRH'[FH7D\?&`K`Y#[D08?F%&7%)RL)6;]!+6#[#=&=H+;PU1)\/J9L%9!8/A
MMI:=)IA2HKNG>W;3;A+#K`@;2H;<60;\PKRG=6[D+$=J1)V/#*Y+;[W<KME=
MR5Y<LL_T_%A,*J6_;])JV0Y*R+(:(@R4Z4FT&#WC`$?L(W86+=XN7RC=_V'*
MSE`:P.V8"U6`)J<;BK)A@'-1AN01MB.LC^A05[6_[SZS$L*R$=KY"_(D(Y3O
M_THB/WB^"S`I8QN.W&N[,K.CS/:E9HNI`\3D_2U/'<"%3D=X[3_[U'@^A1%,
M\T.9-FXO5:AIV\-4M6ZF^^ORAGB/L2T<9T<8V)N5Q>WF"CER)=-N[AY6VS/X
MU_7C>F+H.E$Q<.S3#4AY8\>#R"8<]4-PZ>;W=21H[7N/_IH>O_(Z;/NF]\G%
MJ:-\L8TB4NG$M#1QJ3?5;?93B+9R'%R4>UA>U0R6;*);+#ZJ:!9;SIJJW/&\
M#M*(=ECY67(SDFS[]Q2E5(-"6HB]?P=(E]S:ZO)DD>M8UM2"/I]"GVO0YW('
MZCK),XISW(4S]R'R5OGF`N?J[*!!.%RQPX.X<V0-#0\*[F:):A"^1T3='3`L
M[)PRZ7H=NE[NY5U7D48VWVWYJK#AC'084UZ)DC'L^;BX/V;9]XB8S9G":*@P
M&@:,AMQ1CLXRO8>%;\U=>J;-R[0@-??=4`]Q%4I_BY,=2!3QGGE5R\/@OIU,
MA\"OI#*T;\.TUS,_EA&OY6!GKG=%3A$IU-->-XZR4(/]3LBM-=E55#9]X$"U
MS8GJZ"J[3=,B/[]9+->),ZJAYF`L`WT:?V:Q/A:3N[O@O:P44DVOTQT8'\<[
M7$P=D5:ZNMG>0&\K30'E-21TG>_`'*G!'&G"'"EWRE$W@4:PX_Q<Y6G]!;+N
M9OT(,D39]/?!>94UKR9)U_SI$.@P!!8,@=SI&UU%&LNJ=V$NASR+2<8==EFV
MKY#QD5U?L8GP"ZG)_X+GP3)\Q==A'),)YN[IP?LZ,6U5Z*-R/,ST5HE^DA<4
MA:LBW3!A*`T82AN&4NY<D.&$'&'B&(93MU`3RN]MV=6%H#+T':WN>[:$H%D"
MI,YQ5%#4_"._"E;-53P5V>QJ?U6!<3=AW!T8=WES%X87=*QY;3B6T[VFY9X>
M^JP23J5;K7P827KF;AY<>!L_\=8$8@+O7ZAIM*<2M94D5Y8:`D-).]V"3I]"
MI\N;^]!-&.'S#R]'[HX"SL[[`4J)AL6TF`GC/3!=G@"J"9CK;"L0GC1MUO%P
M0,74)-]\ZB30.`:]"VM%D--3RV<$Y,M.((]CG,03<^JPEP:G0C#-VN@)X1H^
M<\3"]VQIIT.?0?@<#I.8FN39-RW8YT!C2'#0$8W'&7$?:/7(8R5[H4V,5S`\
MVLIS/GSOV&:ZC0")2)!=9VJ2)\4<95[XG'Z,`W?6&5SY(YN6+NX5O?VFAL!:
M+=O[D"N\#V]9\*:A94$$&6[O-66/:'*(,<[TVYXA=[987#WP!G@JAU>@Y1.)
MRAI#F!>;&K8-?0=9/39D-6B2YY&T%F(<P]B"D]1`=GX.&,BSH(6EJ**]OV'"
M+LU<[X.RF&OC@!MMP6X_/&EN2O[Z-8<4(WJ&;?A)'<0E%.WA*!Z.M$"K*1"?
M-48S*^8H.GA!%H1?;8A%2?Y4=&L9QC&9QQE)+6;7\'6QE=VLJ`F,7%>U."`\
M:X6H1.F>?^3`SIL%N\DV1'@D?URY@S0CNI\\?+D7GS]]NKI]0."-?A@0R.+M
MZPA`;C:W>6EB*5+?"@*5-@1%)'ZAMI,LHYK?%@P=FN&>'NPMZ=3==*L)=F)W
MK0V!WR;>][%;*,DVYC3HVW13&"(?$C\#SB_(B`YM2Y92GW8=!L]GQ-R_]O!J
M*\9=H.$5CMD:>ULH::H*Y(18$*MS((PA^Z/,'&*,8V5;\9(;V%WI?B#=S:^&
MZ`W5<J/#8K96E#KH[CMDZ<H"XB$.Q$,D?VRYFT`C>KZ<K+G7=[<?SQZN/MWT
M<7_K$3&*(1X'W$?M<DY`C`F<Q;0@#N-`'$;REY&[B#.VG6[!4X6][NP37WCQ
MRRQ8T1]7?]OZ7[PUNPDDN?"BZ,T/GO_+6V_QQ+(%OHK<BH5^P.\H9:8&[<A5
M-8U-VK#U#B\3F9(_M=Q;-M$*TI=!EU*R.Q+9+X4Z3I&7H*P:Q.H1J3Q"O"#I
ME*?D(+4C9S.X"B,(051X?LF4_/WH`:0;Q77JS^=.CY;T%[RKA5-I"A=.$8:R
M*Z66/HXG-MT$$C;/U#?<4T%X),K5HH&(/@4.F50VQ"0<")1)_F)U5Y&$SR#=
M^'*+;P2S^:-(.3SHQ<P/[PGZ\EQP=W,S?[BYNGU8S&XO+^YN'^:W'Z]N+^97
MB]LPP1.''3U0()G&AB"Q`_$XR5^_[BG9.'-`+Q[=`CDB]&BO`GYU"(-%$BY_
M@XG'5@QQX:3#UOH#OYGWHHG?*ZD:Z1E2&V(<#D3H)'_FE4>,,4QY2UY<*(M8
MX5-P[T_1/(ZY'T2L'7%A%GL$M)9M\T')]#0![!G;$%)V("@G^0NRG)*,8WNY
M>'(7+UZ$L^,9'U`*Y9B2HW]3)@KY3T4;+T)?:&4?T&R;O)!!^#M>?4"$WU,%
M_D<QK2=.40\/!6R3."&_D-GZ`[*<4TM13PU3RTIZ,3U!^Y_;`"-=.444HZ?(
MG)ZJ4^O44NWZ8OJ_<RK5EDCSBJ/9ZHM'QCQ/Q[&-RD<%!M*MZD9[JEA;27)-
MJR%0'1UV_.PT0@.A1,G?S>T@C?!9@ILE-R-!&4W'K*]C8!`S9;P'K,L32`T!
M<RHA[].&&/D40H^2OZ_;29YQ)I,.G+EI87HY(%VUP>53GP.?WJWP\((C;X.W
MB;_D7-A>XB=,&E]]@A=G<I`XVE28%:]NLQ_:V\J1@;VFO*:F1^!L"-I,(0PI
M^<.\_,*(MN#<'+D9!4I).MKO(S@08K[?`<\EXUU='JZ"2..0-D36IQ"'E/R]
MW4[RC&*\NW"V0W?VLE<O5!>R@FS'$)=.5MOLH-ANDJ8&WL4,/G4*BS`'`H=3
M"!Q*_O9N)WE&-MJMF*JPVUVST([#8@SK/1[(C]GP`@FS+9!>[4!<;PIQ/<D?
M)>THT7O8\9:\#6#)_0"O?L(!^26Y)YQ!,M#/843_2#\OYGTZJB5N0X6;G=Y*
MT5?Z@K)P5J5:2GI1G0.APBF$"B5_SWI804>80X;CUDUK0RD9HE6<HO0@-'TL
MD'Z0?=LC`;H[+D5-2=^&5E9-8;S#[]B:IC@37;/5]$40R9\P'DS&L::Y0;AU
M%V2^B[(=*/2T#3BC<#1M*7G+TV-5QQ&75;??5C_M.,9W!OV#<BP\!,M!)]W+
M@]UJR9\LYA%C%`!S,.0N'NXN?OG3W?7EU:?%']#5GS_/'_YG$)0*<;Y&0&G)
M;3HH-W6ROF01%5U)]YOE#A"W%T*TN].:$Q=*=L[S+UQJ/@M6+`[]$J[)",50
M\4351!Z&/=9\/_!V$"[#\U%29B\@)8J%"\F@I)O.<H=E^PG&89F[GZ;MQ6)V
MNG97!TMOB`NU_($E*2=OHC1%B%&715-*EO\HJ:$9<!*:Y;&0L8+M:U/N*&\?
ML43/#CUX<Z\/%.-*@"KD\Y:N"'S5O"T78C6C7M:V"K)W6G4*^X,L@$G&#99)
MIMQAXF$$',7I'X15]WH^^VE^/7^87T'&<__E`3?*WF6.>2>-XIYR\AJ('813
M2RS?A8PA[+>;<L>HAQ#OO:>@%CS63$5#+&5V#Y(IBKAU]M!/@;42H$('=FF,
M&JP268(`Z6K8\#;E#EGS"3(BKH]S4T1PQ[RBIC$7O>(6#MJF577A]D\[?7^#
M1?])_\+1(E/N$#2O*&.OG-LP=7"[:F'-W!?$A3G<,,98`0QZ*2"///70WFV:
M*C;L*9,A,&$(X#22*7>$N*M(8WOR/,SE5UX6?/C!P3Z2MS$:V%LX'X4(@0:I
MN"RWA70]'%XRY8Z]=A-H?&>D!5>53LD03G4QE*LIAC*&BS)4*D);,2H`OG^K
MHYW>"L#V!DBW0XS0E#OVVD&:L=V5EGR5[LX<PF>I0H1H$SX2L)LL]]X=D.FS
MCE.(+ZH07S3E#M=RRS*BO6[%T+ZI[IID5MEJ<0X7=R:]L6D!P*Z7JA'?^TD>
MZ784!`Y5"!R:WTS0EE>JL9UQ3OX*MW`.X9$W0&4\BSZF`K0S\,7+(R%N/H7`
MH`J!0>N;B<7RR?0N!K\%8W6&O[N;3ARB!^(/S8,O.(;;EX@38*FZ..276^R)
M]U8BY#"O*JT:61=+'C`]RKQPX![CP+W.7>Q"F0%!*<8?&1649>>CJK1NJ*HY
MT4W'3N\@LB2//K868AS7HBT[!<2N\":,_?1V/M)&$OE+>IU!]CD?C&^\Z#><
M>(]KO,#$3A^$.AQ#W`'PAI;[P9I/I`S>352ZGCIW.KAZBFG`CI0E=_2QLTRC
M@+\K=^Z.$,4YI0#8"W$MWA?V)5>CB<JP=16&0($A@)TJ2^[894>)1#LEW=@J
M8GU'US$<?Y>\X&C_'4"5M"DNY:K<8#^(MQ(@0W9EX>S<BR5W</(H[Z+1>HP!
MEQ5`O=Z*;!I-(1['F'`L^1<5A35-IS<OJXZNFK!M:LD=2&PMPRC^0UMN4JQF
MNQ!='B0K-%4,1.B688YA/(>*I[05HP*SQ?**;IHP74%X5H7D84ON."&_,",:
MV78<'5C=KC&5(S`0;7M'0G.3!=Z5MXFQ,)0IY!O`U;2DQR&-UY([0MA)GK$M
M<VO.4FS3X#?J_'`DJZ,F:JP[`N_8K6]X`(RW%6@/Z'6Q\ZF1!FHAT=>2.S;(
M*\HH)KL]/RFH!XF$MX&".-/]3MBN-N+51(8S54S(`E8A"]B6._+'+<MXQIN#
MJX+A[IFU=!_&"7[=K$-V5V]VR4K&REL1'X:ABPNTM.:C'_[[B)NI`T<=]((:
M39FH4P6NWB>#)W<@L;=LHZA+7R[=V7(9T7<*XN)50<(51X@7)*_BE'RD]G5H
MBI9NSD)ZCP8;"[;<@<Y!Y!/M30W!I+M?"<IJR9VNM^XNUWT4;G"4O-$[OY)9
ML*)G.#>TE5M,L$79$#<'-33=4WOXA,H5IHF,'2B'`5)ATT*#9`M;[@!I=Z'&
MF5NZLN=FE"Q)`&=DIRC`0E1`S&SRSBI0GC.:R"S=@GBU"@ZR!KMVMMS!TJXB
M"9\9NO&5X_Z477*:Y"?O4_C?\L+_4YY?T_)%9N+2B4O(Y>2FGY+T%SW3&^Z:
M+#-]!<"6.TS;3S#1.M2+.W='C1K>$N\4^.V,+"&>UK>A5"5_C+<F4]5TE:5J
M3VW8=+?E#C8/(^`H?MH@K!8U;IEI7"&_,WX)HV0_!917[1*/WFI\Y44!826>
M+9?;U^W:(Y73^XZ7/O5]'($G!(\ST%>Y.@BXTZ>CQ+9B0_!*92<W33/=Q)$[
M[MU/,/&35`_NW(P:9>3HNT(%**WA>W%Z(FA&DD=/*N:=8\3TE5='T6P8,P?&
M+`T7R!U1[RW;2+--/R[=HHJL@()/0Q9T*BJ=6[#LJ3B=J&JRGQ:T%"+#?65Q
M73<L=JQ(MS6X`4Y+NUGNL#J_,*,@FYLM=[%SBAZ]X+>.GE$S%(3X0F/CN>3O
M5!:WH8N)T4BWV>$`DB-W')U7%-$^#2<_11!W/HZX2(@YIW1W3S_[@1<L?6]]
M3U6!#$SAS*XJ+E^U#0<]$=Y)QASP;:CIICI[9I48&[@95X-S1X[<L?+^P@E7
MBKX<NA=WMXN[Z_GE[.'J$OTTNY[=7ERAQ9^NKAX6G8^65UT&;ROJ5-CU3T/?
M;=]*@)T*5+\VD/9XNIL.ASP<N>/;O*)P^"_=KWSB9"J][ZG_ZPU-(!!DZ\=#
M<84AK^AE6[,@:5Z#>VQU2!!PY(X_\XHBWDAS\>,6RW=Z;.$B?'T-`U;-O1?=
M16R66+%=TGL<+5Z\"$]L1>`IFQ8,](-V)PDSJ+<A5A7+AI6^!FD`.MP_Y,@=
M>>XKFFA5Z,F?"_2(57"*2!5D,!!4@E@MB%2#6#WB5$;(5HQ4*E/:IVE#3"=E
MN+;.UN`<B@Z!3T?N>'-OV4;9Q>G+9:8Z,:C.AJC.%Z8P&Z(P<2^%88W'LVU"
M5MS^W_&*P,@4EZ[1T/!@"G)<H@K%*!&I1II)IL$)%ATR:ARY(\0=)1IQYN!@
MZV#"`$JT(QT>\Z(GA_$QWS09E(B8"4H'`V[BU2$6[\@=S^TLT]C&GXN[`Z,?
M`_R]H>`_C^,M`$7<EGY-HP/#ODZ26LC_?WO__ALYCN2+H_\*<;#`F0'</JFW
M='X0X'KUU-WJ<ITJ]\S=V[CX0I4IVSJ35GJD3%?5`O=_OR1#RE1FZL&WF-6S
M6$R7;9&,(.,3#$8$@TT#!\]VXX>`@HT>A-%CNT.R(NP85_#3-/5J]RL$#=7*
MMAFU;D*VI]5YTX`JEB9$"-$5#T*$L=UA6"%^YE'C#)3UJ_!"A8C?[K;U-BM7
M1?E`TH$,FB^=D14+^RA/@Q+?;447`U*C/(B6>!!43.R.UXHS-8_LLY+7#X#-
MH;4&%)BQ9,RB8-JF.5F1.`"5Y$%^B`<QP\3ND*TX4\;M&U;*TE?9FMQ@;F6?
M3]YO5O]WU^0^W&T^YV22BW7^,=^^+Y>;I_S#IL:_)YG5GZK-2['*5Z]^_%[G
MJ_?E[7->95M,W,UR6[S`LYV'=(!(&TQT$"P'+R-3V*)2RV!.$'F@7D-PJ?M@
M7R1VAZ.-SX5N'6":H;0S(-INT'Y(<F</P:#H+V38OY(_TYM([=#HZP_T%S(Z
M*LJ_HCT!Z$"!<'Z(3D!I,6#_7#KIS%[6,I@;XZT.@A4A!"O\QN:S.[O`_&08
ML<^-LW6JFZJ];BJQ;EKC\<AOR;_IO:T=:"*TV2NB;#_>_^94/T^;:EO\=T;$
MZ/;^35$O-SMZ'_I3E3\5NR=RU>P1SQ$^GY=-'9GW)9[:O-Z^PP#LJSE-F')I
M;2W'/59`S_6VH&IE$6++CB@5\AL=-$@J%#.3LE<I0\/Q#N+$I*R]2_<\+&40
M`&K*VB=V)VL8FP-V!;+:+'<$D90F?AUBB*&T.Q#:W*-5,Q2]W?D,`DO_O82!
MB>+(FHI013,V(K*/GOI>/;BV2)]$_U8GPW.B7)M$('>0?A1".*UY-R"Q.XO%
MU!28,4;,,$.KQ.6G2N0*92?JA56CX$][]8E%ZB3\MSH9GI-)=2(Q&I5#R/@-
M(8[9U-)/[$X',CX7VGTPAADZ-E9N[U$[),(CH690^N]F6/2^1&WYRG9D1(9&
MO<_6<(8_LN=BFZW??G_.RU6QW9$@))3Q6[W:;3]NMO^5;S]EQ>HZ#!<:`X*,
M5$B&181YW8=(6'MP/#]P//*\7!Q"]DUB>0:('&=F0H92-*:?</>/69W##MY7
MN0]A0&(#8,5[4Y];L/3$$^T$T7F<D;4'=Q$TWB'+<P6%&-(>7Q2A*FU:H6XS
MU+9#7W=;A%NB'_D6D;:\,&$IVQ1&H4-]1`L](-%>?4R4S0,^6-J3"+$#)D8$
M*1(!7(M)+,_&DN>.'3E8QQ>;U9=M5FU%MQQ9:M-]73_JMLX/O:!LB[:/.?J:
M/Q0EJ3%#-B;R"Z!:*[:</P>V'`EL@:\Q@MN8-!<C"!>6IWS)<\>+K;?E2CNR
M!FB=1A;>P=1CZA/M"6^)58Z-R3<Y_!?+7.!HJV?`0XD.@+'R/`ZS@5[H&ONP
MQI"P0%\_P6ML>6J9,B8Y3D_B91.4D9NV7Q&?YW((@P:@IND49374>DY3'+WX
M20A)A1%4R0A\6%2[T[Y4L:C_Q*6$SL.^=EX)&CI#;6_H+VU_G-4WW^3/5;XL
MJ`_R.G9]?4]L=$>2P\LXS2T>CKXB>>3-9:$8@L:A`]-L=TX1.Q-&'&_,Y*3=
M+Q5(I!8-KUDBSS3TT5>^![''&-*?PL::M3LQA9$#W?J5C0P)&?PU*TJ2V'9;
M?L$*]_;^Z'V,_0,7U\XB<.E2!YX.^62C0DYRQ3EMI9JQ!ZHMX!V1!%PC86-(
MVIT^H8(]!CPD@(<R?R#5.\2TLP)24]*>1#_ZXR)Z4:1%R=L(HK.=@;$#SPO!
M!9+`5:"P,17M3A209T[W?B)-84IZ:.]+D'OGN!OB<-J_"P;/([T5PQ$D6M]E
MW_,:HIK.PM=WI>%D-#ED3)/>0N#T2^IX`.LR:7;V`*;;[A@@%Q]&C'8>BE+Z
M&7K&WZ'5+J>)]IOREU6^VBVW!<DOR4D\L.;-+AF4`RTZWXP(GVGQTR^C)(3K
M5PEXSJCVP--L=P((!Q>Z]3([*6ES90W$ES\B?>J5H1E>)!<+#_R#Y%7A!7<T
M%K.9'%]:AKG9ZTCU5%LO;LS)Q@T0P;+8'7^6XLN`Y`L3E_8X!8F'ONT!-5UH
M0X@NL\02A/29+N-M(WKF"IKU@F1SF@X:A([=@619UDP9.#)$=O"RZN)E6V4K
M^CH\Z8+?WAD@Z7.^S(N75J(TEDM@(4$79D:9G(9-IWFR""YU&SGC8KY-XY24
MR2WBT$"GW.MQF]HF^.<N4Z;VKNLY27SMQ-[")S[M)/(O=:^8Y,J0@U2<PD.J
MPU^*L@.8S?8QK\A]+X!-I1(VW0LF!_KHF^F.N_#-;AR#Q&A`$@_CHY`:[BAQ
M+']D2XB?63:8":)&MIKCBTR'M@(/QY]3]GI7;S=/>76S>B$ULFHB.XZ^;*%I
M`E0#A8'!87"<-PY]FMCEQ0M(KXP@EN_8G7HGR9EYP/"0-P2=M@_4=J(/*X:.
M\O-AA>$P?];8\SQL$\":0<Y6!$D'CMWI<[*LS728YR)RZ#"?06-RG*<7_&B-
MC]_+@KP/<X=MN.PYWVV+I324WN3W.;DA]3E_R<L=.06XKDFW\<GXJH$TS=XP
MCL[:1@L:?\*K".[\"-(0'+M3\N08,[_C<%`WM.&T7:"F#VT@,;3=S`42ALWF
MM"W1=9"L$R\@6!M!UH%C=Z:@)&<S;34\-`[M-*L6+!5T(KVEW!(?PXE'^Z9<
M-0>H#T7VM5A#M0DL:$8C,,R4J4:8S)0,8X^CUSB.$M\GA06BN)$(NY.P-'`[
M$T9EZ3[@]MQ_UP1[:-)C6\1)..%%7F8-V8R7!&,&.Y.]U\2-$A`+NW.0E?%H
MWOH4(W3($*6]G24R4+BV_L1.ETH0>W!+@A2:#-B>$J`%?^,,3L#LJ''HTWM`
MV%:"4E<1I!4ZUB=LRG`V$Z08R1L'4J<3?5@Q%>2=#RPL`=ZSUN1H$<>P:O"T
M4P39C([UZ:%2K,T6ZN4B\\A(O'W]I1/9E8;*)VQ.XA4DA04W]9:4&:URXI.\
M_;HN'NAE-2);7M!7EE,7>!AH4HTGL6D81AA;?_&"OH@9.W"%(X*L2>?2<HQD
MF36_:TE2/+21-=U2$_"X8]3IV2AD#3E?;(<L@\.%I3^2N4G%``L%W%:,('/3
MO;0$#FEN9W*XR-*=MD>S.G_)JS8*=T5>\)#&9963JTJMV_8MN&HPI7#LK.M\
M2R72T7>_5(PHY<@4FX@1:#)UZ$7@''>:U`4XP+N7EC,BR^P,NZD<Q8.[*72+
MFO[HKMKX7&B79O%JZN1H/V!93I@L/387(>#0XT#N1+P`J;BTW!4%_,YV%I6G
M?2@A^;E!L*JHQ><<;_G%$O/>%+5Z7[[DS>-<]$J4R9UUC!C5`.5D?!B7HQTE
MCM_829>6],+.EOG=D9FVH7WPT`':UV#K],$)JKK>$:OW]IZ^\8O)^4=683MX
M6[_;5%_RZJ58YO5M]7J=%4_T#!QKC.'ST"()*4FV]XCBZL?%W7C@0W`A8R.!
M?%K7\GP9=5R:.28JHS>E':#EYHGL6/`8RG:#44C@MJE0E:_AD(D_*>O=>IN9
M0J">7<UZ!)[O:5S]^#Z8+"YD%R:0FNM:'F%7Q*+VO4X-G6G;#RE2!/@C6US;
M%[K'N&M[P\N&H#\^T'W`/V</^9OB'ANY.4G<IALQW/:Y+;\\;BKRN-*'3?EP
MEU=/ARWW`VSFSYNZV!*"_;Y;.P/ODRD95`YUNOANT:BF?R=Q'9`++_;`/9!`
M'K!K=R*;"?9UH]@`#VDS!NH,0M\2V]^WNRT1'8C^E@R%R%A=TY>.AIKA9@4_
MX]O)/Q_ZS]]'5BD[<`W`:W8'R)!T[<[6,<$^._SE7D4VP,M>#:PZ:H!L]8>G
M24M44S5`?KLF:F!+U$!U4`-KJ@96S7"SZ@&V-X]_/C5P=BA6*3J0.N:!AS&!
MU#'7[B0D$^P;.48;8$1`!?PRJ@+X-$#?LZB?\VQ=_'>^:NNNXFTN]CU](1\6
M&N3P+LIEBV>F]C3(#O:>W]A[343/[O0E>>8,!6JD"84ZP/1N<=V4`"X.;F/R
M8_:2%6LRPB_XC/T+_4C!R^!\XJ?%KV4;QL[.S4S-8SA)X:6E62S^`@)NGMVY
M1K*LZ3[O2M*7]CYO?87:+E"G^C8?;C[F6Q+?^51M7HI5OGKUX_>:%+-Y5Y19
MN2S*AYOEMGBAH]U\Q9MAMMQ>>WZBSSG,3X\<I%3PW^)+H"\GC#VP6OP$UARL
M%L_N!"+%G.I&GUIR4]P=!$7;#M'7'^@OI$^\U_T5[;M%AW[1'VW/_U]C^-02
M/KT@?)X=&07Z(J9.`EF=P0+D`&Y(>'8G"ZEFU<A14#'1Z>N;+W]#[S[<_N,+
M>O?Y]C?T[OW'FX^OWW_\%=V\OGO_]_=W[]]^^=^ZX/AZ4VZ+<H=_=_N<5VUJ
MN.<L]%V?E"/.%$X9)X8?M/T=NVZ3A^W9G5^DE$][-M1I8D6VTRMTZ!<=.IX'
MRUJ>.?X9L'SV%K)DQ[C?)('[4)[=N4QJ&>78?,7?1%9*,L4T?0;YN8/I^SV2
MLWUG2B`+B8D#UF"@L>8I/SU:D,G%_P08Q_HBAZ+&V/+`V`*_GV=W:I-B3F?:
M7`7)G=I>]]UJ/*VRR*?)TZJ-^&0]K8[U11WS<.&)OJ&]\)W&A6AW1I-J5N<\
MK8H2?79:??_Q[V^_W.DXK?:0.&3(:7R=18XX4SAEG!A^T`X=C)+F8&1W$I)2
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MGHM-)7#V^I;'P36Q;`9B>H@_*M2#$?Q$[NK2>CV[$B\D>OVW&W3S4.50\?PO
M'S?;'#DKWEM0,I*KQS:Z*/">VUDBO;E[MY+E^632S&FWRF0I3)M&I/05Z0.U
M/W=ZN>H6A$1M1WS`H]5>F[X/P;MRM4\[?;_-GSI.Y]C5Y]CCHT4.;;)\MSCC
M[,=9."X\&QW"%5.G.4S:G6VBD$O=R%-':@IEQUO@'1)+2(V*PZ4(VI]PX$M0
M#K78JQ>`OS,CE;,??.Z(V_5V8;T;0\?N#!&5;!HQ1A42G'[9/3^OJ7F9K=&J
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M]^XH2EC:-J2AM;^T;2EN_DHK&T,]0^$'/`8(H\49[\XIBP/3X.FC1`MZ&%F>
M@$]_+U[BP[7-P.ZT1W&F9@+0-&7C"*+MYX"0GF*@=F/HO#0H1S=^>.W$7N"'
M_K7O>(LPNO:"&'(1\#K;?7Y3R28#T%24"U5(<OHY?X;>B('WET-+FIY8'Q#8
MU.`5A-_=I@E4W+1E2,FS(5FW+B.QAC1&]C@H48,^,99/P<?6RZ)Y?R&P.W-0
MG"E3.Q@W98<=;+MI@W'HYKS6[A?!`KM"TJ1W_[(30</[%T,W$5:2<90$+M6.
M8;.Z=F<CJF#/\'XE06IZM#-IJF9]1B?>79_S:OOC$V:+E,-_BW_[3#XA<I?H
MJVG-3HABI/$P/(BSX4ZPQH3TOQC"/1X\#!;8G5:IAD'C6Y@(E;W;6=O1%:)=
M7=%0^+XW_1`SM)U9A#&&S6RP%TBSC:&D>0QUJ;Q&C]J=X*6,Q[FV-4%ZTT]X
MH$?RT`D^@CTW?5"0Y8(@ZQP*#P\WOJ99G/3112QI<:#16S@UOB2B!-C;XVBR
M;>C$C7(,89T@)2&P.Z0EQ9?VK4F"N/3(*8BZ:<G0`3PCJ@T@6N+']@#D+!(\
MV19T60+U(V*H'^%!"=+`[GQ&6=:,Q'@EB1S.VR?[R;?FG=TK5.;4X;>/[BXW
M-;=OKY?2+S1&_#NY)/`>_Z+<%B\YW@KIKU_A/6[UNO/>-MDH:_S9>K<JR@?*
MWNUS<]'63SQ]%62UTJX#O/JF=1SXRL9U@Q#>KDK@P0`?2C`&=F=@SC<I\^S)
M!C@;V=!A].:&T7Y\JKGHGW[Y2DA`71KHD;0F=R(:,II7Q1M"K-1H!DV*/Y-&
M8S1E%(W;;,-05C:!6P3T`3$LY);GX<PX+3.:4$883-]^SZME`4?YUMJB"FPC
MJY!^R[:-4_M3U<9LR:.MK[/UNKZ]'XV1Q+Z^I^.4T*A.P:B<ICY%(MY_Z+H.
M2`UX77WPNH:69QWIYMVDH:.#@1-[YC#$%>H,0G4`'89H!I4!8K6RK]TV^3E4
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M)<N.C2R)!"Z>]G`8:T5+8-*#8>+24JU^V"@BN_.+Q)G2KN)%*4M?WW[\<OOA
M_9N;N[=OT)<[_)_?WGZ\^X)NWZ'.ZPJB-9XH%DGX@59Y"Y-(7[Y==RA9B1\E
M^B#BW<_B,&R,0[OS?T:HUB^D0T.#SD;P-Q42IL?.T"QAYS;%\80E3A($U[[C
M>PO\G]ASO1`NB,!E_-#N+!)^9LS8%KQD'26703$0<AEG>53IA]3GRK^A^VQ9
MK/$BT+]NJ]U2P*+N5`!K5?O[$I\NG^A(G9TX"?5)/AL1DJ`0Y70/%\8.2,4U
MASY9G7CP%&[4!++LSEE0PI\94"F@=*SV':VX=8\[%2]^QRMM>FP6&W%U;N@P
M=A!!)BY>2XCV1!#MB>R.[2O@3KOA)$WB,9CH6TRD$]3I1=C&%ZGU9+2XB!75
MK8YOLW'T0*T/\&Y87`12G"$&\,C>4Q,F[N3"]7I?S4JL$,C[<EGE69V_R>&_
M[\O/N/>J6&*N""9ORM61[#A.X.I#"Q\U<HB1YYR@YM"FF?]KU_43O['0P7*(
M[`TYLY)O`!&,I!P7QCF(?[5OWB)!%@@WRV6U(\^1X?YQYY_WM1@_YELL".["
M-PF$,6I4`X&7<P($,<K_G_77];5';KH[UU[HNK2P1.@Y]L8CE/-I`%JJ:4[;
MCL@.5#1M.\5*$;G<)ENBBL15JOPQ+^OB)8?7JC!1M_=WV??KR%GHNX,V,K`<
MT+@X:D\Z8XWPCD2.J/YB$8!Q#=[+R.Z,#$&.=)]HQ,A*CYHA:(?^0MY5^^L5
M^@BW.7$75^AFB_>GKSM(N]ANR#LRW`4$6"1(R\NPLV+B[$G7T:5*7"=>Q+!:
M<&D]@M!29'=>ACA3'/XS\:=:A<E+[\B@-.Q]P`G_@X*T('8/$?LLJ?M-51]E
M2=VL_N\.K/>6T$]X2R+.B0X2[S:`P\[;)I&^K<40$W*0G&VFCXK>&R#`P49-
M([00@XZ@_&9DK_5IR_3HWHPMX+$IP3^ZOX]F,*,#2<>60$/8@$4@]WB50=SJ
M>\'CWQIR8*:-:TBZL4<4(`X4#&BRVB*[TZ+LF"`C@4TK6&V4Y;&15S3*<@W*
MLLRW(J^!];!&M._G?+G.ZIJ^N$)IWS-%_.@WMZ_?-VGSM_<'S@\6JQ=HS/O2
M1K<>M:5C.J<TE8HQG:"1/[MS)$Q-P5PVF6(^6.RNT^$ZIA9<?B$CTK<KVKMF
MAU&[MIAUZDA/-.'/JX_."[;J&Y3<QFH*8\=VYY<8FP,#L0V3_*1G>B<[Z!V.
MJW;4_46?=,O6Q7_G*Q)&(87_R*^IG:1&+_U>M@/\FA4EF8S;\DU>%2\9J;%3
MWU1%790/;S!1Y<,G_/O-J@.@>*$OQTP]P7H4D=()G%)`4H-Y,11FC>U-QS'"
M^UPVD"H&6(R?PUB(#-;\GL1<.R.B9D@$8R(85+WMHP(B1AU)/Z..8?8/20SF
M!9Y#'XA;D*LA5%SM36LR.@>S>GE4<Y-VM,L#[K$F>F6U[Q!;*N32"$V)4ZU`
M_K99DZ)^!SXZ'JL)%/@SFBIB9.M6)LHFDUVEB`[IQC%<M(@;0]ON]!6S$S&_
M0:.0&T[KIAGYU,KI1MA,&SFRL)K)U/DY=92`V2,X9.`L$A<NL%"AQM)L=S*1
MX9FPQ`12R=.I(=2$L8@"8G7S"+AR.D43FBA>N>J+[76*7>C+5N(D1O;^N23G
M/64^F#J"N&8"<4VH&QTWYK#=>4!J&=5M:"BE=K1$R.UOGSZ__=O;CU_>__TM
M^G#[1;Q4R.M-C<G]G+_DY2Z_CCS?U9ATWAE*-J5VE.I#$FWW,R<*:!WER(,Z
MRJU+RNXT#V8>]">/LQ&2D@^);=I\JD(>]<0,M0OD>6CNZ#OR0#I5`2',9+,_
M0^)];'=!&SY&#`7)N(C:RVD%WW,Z>]YF58GMK!H;6K10VD&K1XD^'3HTJIST
MLO/2RO%PBX67-(JA.1I#EGQL=YD<(7YT:UP1HM*V$?$4P--%PK;!I%AH.>K/
M).)G)^W!%K2P6S/]<%<JAHSJV.XD+3&&C)Q[A4A+R0$8/6,QI_6@.!,O3X=\
ME=7%$AOL;XKU#F]`UW&BL0+-Q.!J17V2LR&)/VWHN.3E3KH6<`,J@8RVQ.Y4
M(!FV3*MX#MIZ-/T5HNUI:=6F!SV@,*+X9P'%Y#9PTA#>VZ"'(+Q&\"1J`F]R
M)78GJL@Q-LNVP$5B>L#""K[?)Z`=-@T^>/R:EWF5K3$%-ZNGHBS()D5"QF^_
MDW+'^%"\"&)]OLJ)T>7PP<]:"Y"IEIY'GZ'Q(A]<7`FXN!*[4RLDN-*]9XB3
MEC9-*2B.&Z.FM29`Z''@V(&(<R_/1%-2\,?S(OIX#%XE<*`EX$!+[,X,D.3,
MD!](CLHCE&3'*,FA!TY?T:^;E[PJ260`DW3W6%2K3UFU_?$K?:(3"M)@$P0/
M[R4]N\=SO2TH`A;D%00B_^0W;)U*0D"0[CT.&-LO@@4D4"1VAYR%^-&^'0@0
ME1X:(=P*T6:(MD/0$+4MM4JZXUZHJ!\(%Y!U",`G=L>=A/AAE_759DE3+'L>
MC5$K\WOBTD:PJ^;/<(MN^YBCAP,8B,K?4C`\XPY)_A6Y88<IRO',/<)A(G_)
MUYMG^OESM7FHLJ?Z6BM*H@L%R=E9FF/9&IO5[O0$(7Z,G)Q%*$L_Y.1H3.1^
M63S#Y:^O/RA";N_O"RB]3WYZ_5CD]^C+LB`OF=<`F@U->VQ`PXF&"A_)/U6;
M^X)$-L(@TE;BJS.2)!!&2=Z+>_<K&HH$5YX/09L$0I&)W8%>=B8X!%N\1A<S
M.2G]DFCH>]XZJ;VKJ\>EHU4@S^WQSE>>[RU@YB`PGD`(,;$[3LO(@7:;FXF,
M1@0_"8@@9(KM$\H.\;#0[SLB*JO(VS>HG&0R<](*Z6"#.(P<'V8:0H$)A`(3
MN\.N0OSH%F`1HL8R$F\_O?U\<_<>?R"<;?`QWQZNM%\[WB)RM1D"1V/)R?<4
MV:U8'W]'`Q>-V@C!#J.!O6AA=RR5@PLCY@`[/>G')OC#*96;<O-,WY<J'V"D
MO?_7<WU]+TL.CBLIK1SL["5WN`W)7(8)MCO6R<J";K7+2$?:_6Y_>ZSY]*_*
M!5A+-'\^`3YS.XRU\9THN/;<R`E]F'V[PY*\K!AQ-G`2E;XKRJQ<%MFZ*9\G
M4@_F>+QF[_7]0)O)T#.BG"2SL;"_]]?S-=GN7,AN]F/8[AR89+N#B-R\&#$E
M>*E*]PU$2GV/+;Z>6_Y&Y??\;GW/UX'G-L9:!'/KPMS:'03DY$2W2<%'3D=H
MCRZE\TGOYR8>0E*Q#M&0O=(G;]_I2_H8'5Q.I+GY:J5[O"%--H!#=>#!@H2P
M(':'-R2X,I3H(4YA^GDHIB>6XL$H.EI4^_R(.%/WX^UB/VJ6Q85EB6!9[(Z(
M"_.D>PL0)>P8`YVF8LF`HV20>I-D7+@8R9CW,=FC1N$>(IA)PFOJ^0=O:@23
M[\/DQS#Y=L?\I'DSE0<B2^CT+D#/IISI'1QRQ9;J9P\.^!0]M"7S#V<H>I4%
MSW\"\V]WJ%&2LUF5_B1Y!\&_Z5?]-:DPI4WL@TN3^X!?\/T$#-!&]4`\PFE\
MO':'+*5YXS;_[\3]-K+$,NX!O%B`F@+81$X\?671VF%D<3!([$':FT_H3,+U
MD@`\8@YXQ!R[`Y=L#!AQES.1DK9?R<J=IA.G'KGKT;+-)X'GPCV_`%Q:#KBT
M'+OCCBSDZS<4)FD0%+9_Y,7#(U;>-R]YE3WD'W=/7_/J]IY>U;S=;>LM5JA%
M^7!VISF*O%B;:(H1)2?(RB:B%7O1#A,7DM`"JE;PVMH=S53)IFX8*:0U;?M"
M36<(>J./^)#^:M3I4?I2OZQT:K%<+A&F9U:18(>>@Y5N8X9"5-RQ.V"KE$\C
M-I9*B@]PS1JXEGNXU@!7O$CTA9OEYNEY1Z-K7Y47'[A9+G=/NS4Y+0V5B?TM
M)W1=DY>I=>&6F0HYJ(HSVV*3M8=KDN,*V8)1!.$AQ^X`M"1G1O`G1V/::8XF
M"ZJC/T`4./.-N45,B[EJ*Y[.3%+V'LBQEE9C\1(P?:((0DZ.W>%N11SJ-D35
MD#D),?HB@2"R5JL"5O)35JS>EZ^SYV*;K5L!2_3=8!D=61)!7$SM43/:RG%\
M)X'U\6%](#+EV!T(%V=*.S9$*4L/+1%I^@L6_J:Q(`@PFIXVY9?M9OG/_?".
MOO2^L^'DI)V!^D-)X]-/8Y\6V\73',`T0]C)L3OHP<6';D'F(2:%CQ']6EY:
MP0/1.21=1PNP"0X><DV2>S:T,B%F8:I'H,^;N7'DALV>2MVH$;P0'[EVQS_$
MF6(7]6?ZYLB7;59MQ4X-PD2FKS+<X3*_:@[D.H3?^1F%W^$6_F@!2P!GMA@"
M5J[=81AQIGB%_VTI7+I>D$0YT1^XO1KKD'7]EV[C4VD^_LY//)<6DU[$C3/>
MM=OORD(^NX2^Y-77C?`=KVE2!&_8CKULWGWMWC7_D&Z7!#F!%61RZM6WH^:!
MLXCI;7V\*`$LBMV.3`FNC#@QQ>EK7H%<'GE4BL9IN897(`5RBK994>:KMBIR
MZWH('7T.E?XQ9=,^V/@XY(#T?D^]6[2$9Q(U\P\.9-=N-Z,(._IS1+AI.G(@
MOLGOBV6Q%3Q\=MY-HP;0XV:-5Z]^^Z\=7K?N:WCZKM`PD2`G]H)<]KSY-]+<
MC<.8.K>\)'9AQ<!/X-J=;*V`.]T8D2<Q/7G%[V\W'W]]^P6]_XC>_I_?W]_]
MEW#IG#UI=^1Y3K(EZ2M9=CR6(D@,T'TF^_!=XC91#?KL\B)V&S^`W?Y%=B:,
M2?(4)>G^2_0'_99;+D]Q<NU$"]CF]3@3ST>4E5`6#@YR>O8U]5K!%DJ?;L'3
M"S$XSVY_(2\K!KV$G*2U#A*%HJO%%6A4=,_\?D.3"O&R!,[Z+L3+/+N]?;RL
M&//Q<1(F(;COZWJ7K[HO@8-3\1.F\#&K\]O[F[K.M_6U$R8:G_+CHD6!M$NP
M?80#]G[BQ(E]Y]IW?#?PK_W8<T+OV@NP$0@')<_NLZ@&;HUX9M33G9+>"-I(
M5N<2`JHU#:CNRA5)COG;#;IYJ'*PAO[R<;/-D;/ZJYC7?93\]J6KG+X=GI<U
MO1I-1#;2Y^<1H$@C7IFG@`FU0[V18I&P_':GV\@SI_]`(4EA"KD+T`6"/A!T
M<M5<B6C^^\M7TA/J=G5%KBH3V+[;5/=YL=V9Q:/YG=,Z//+MHH,"@;5T$(*6
M#D%+D]*!WB("O[IG=]$,;3S/OZ-*4-\@&U"[[+1&VPW*GY[7FQ\Y`?>JJ/(E
M%MB:WIDH-^4O[1]QJ[+>K;?DY0H=VRWYXS^RBKZ,\?9[7BV+&AXQ"?K>_QVH
M5"`PA$Z\LO+$AM>AWA91:S_9[GF3YF[>'92%Q)$MM+U4"%^T':%]3TK0]/=L
MO<OAUW@?_I)7+\4RIR>M4%^5;"Y:M`".F>T)J`WU$WN6/Y0JQ,],<!HE:M0&
MI2VOVC^2-\':UD;`8]+&M`@\K';E8#^QMPCQ03^*76*0A)[EY2)4L#>GM<A#
MZ*AAB&>3QD$WE3IX#1]B$GW7^_@)T@<TY@E@0=OPJ1X>C(E\NW//I'F;<PMC
M(9!E.S/N46&20^.;G6U`Y-KVAL_F>"8B>C8/%_1L'D5P-H?"!OY%1B:D69Y]
M>Y0@7JTO12&@R=]NJ;S4-^6JW_'0EY'$YTQA&DLC:OFY9,+O5+=>N'`]..;[
M%QFH$&)SUNV5C]8QSPOMKW&\-#W2BJLZG3`CWK\^0U<4A*:AQ\(1,^`&O&D0
MD/(O,M#`P=SLX)JBD!52FF#4<;M.*?R`_8%VJ<%T1POX^"0XD^N3J%`?+C'Z
M]J:F*^51N^FIDMJT_0,Y!FZ:G8N8D]]:R'W]<;`YZ5_FC=,Q/BEQ68&ZXV<G
MA(-$D`L;V.O\5,`9.[K$GYR0)S/]>%HZD/R+[F4%;'89!A/"?\!((G_;/N8H
M[T`1OFU!R/DPA90LJMKD;,(7YX8VL+J0L1O8F]"O@#,+-J\I&H^VK.XV590O
M>;WWA]P7)*%3[1;%Z2"0@M+%N$%8P,5QWFYTJ+W1<)4LS@4W$6+E3,4Y\"=G
M*UX,`)FL1XX5;S2MO3535+(XHSTI0F\*;A$A:[(/LVHL2R;OG2HT6N20Y$3>
M@&4#@9_`WD"=/&-6H&R*2AELS8`G1=:E17#BLR0'EA-2T@-[TU+D&9O?:IPB
MD>^,QH>9=UE144K>%/5RO:E)ULJA+L="XP/,8R/+H8:/IS;\-=J*%/6A!33]
M100/006TX(,?V7NTDF-*=[A+F++TW<W[S^CO-Q]^?TL*PKQ[__'FX^OW-Q_0
M^X]?[C[_#I5B1(O"]%%UEW_?OL)__.=U$M(R`'J2K4:'5@^($:[&$'%H1M>H
M*1_1K)$#:V3O64>2*R-Y4.+TL2!#!QR,;0]&X<"T072:Q;2V)UX6>`J)/AR/
ME\5>TTF*ISFV!Q;"4M*P27?H-$5_D,:(MA;=$MZ7S[MM_8&\=>LUM?Y<Q^OS
M32M&P/G`BN2?A2,B_3V+`8VNG3B(O07-P/1#Y]J/75*2Q8F]@!3$<O#YR=X`
MCR17VC<#.?I2^BWR!,M+]LF(<Y`1?66%1P96+_6#'!U)?4\#6($`5L"%%7!A
M!9KMV%X'E#1?YB1?D,)&]AV%LN\>)*4O>TV?[+NZ9'^0HR'9=X]6((05\&`%
M/%B!9ANV-^-:FJ]99)^'PD;V74'9?Y-7Q4NV+5YRJ`/UH<B^%NMB6^#3^79/
MV\=\>XT'UV?],Y,AAPL);MM3`7L7OLU10!%6=)\!..E)#]\C:(#^TFGRURN4
M;='A>$#OZ^D&AY8W0:P%Q]E3(LQ=$(]&Z%M^AT"`&W:(2#TTPD]9^FY3Y<5#
MB9:[JLK+Y0^T.J"G*.MM10.'HM$$(..F7'4H^2W/R!EF=5M^SLFH1?F`/_BX
M*:OV1_*R-*:]S-]O\Z?ZVEV$?=6$%-M:*DA59)WIF;4S_Y6281P_I,\J^7#7
M<A%X"9@@=I<U,C<)QCQDNCE)NWMFL[&2>&-G.-2.AS8EVH](O^J.B>B@Z`\R
M+*+CBI[,)'B&^NWNPK=;MRAX*4#C;*G4*3`$%D#'`0&D;W7B?U`!C.UU()J;
M@$O0)9-<J-<C(L\K[%E]]6/_S[\5>867_/$'/3O??"_(+NKKJ\#&1H,B\'/R
M>8;L\?:.%\0)K#>$8N`VG!_;>V]*$7?&,"E,XA'@]DW1'Z2=.&H:B)+3P;LJ
M_]>.'!Y:43*0+31,@#*\L'/8`Y;!QF%@><EL=B8,BOXX)6GGSVC_=SD)'PD/
MZ97L.0)>PY+<TRB)J)O9)^\@4TT#3N?X0E+@^#@R)N-<9!VI=&AYA?1'NXP)
MOK%H%Y/@NX?U\&`]$E@/#];#;G>^($=S"/XT62."+QKJ8DF#,2;XQA)[F`2_
M;10FSN4I]V/BYQ#G(PI&)%<Z.:?/.GJS><J*DKB!7?T2/$R`(DGFX?!,HD<:
MAZ%S(=I[D@EC$CY%R9&D#UCF\+T">:_/#\5[N8@,&"TLI*C'``?78V@8[L;Q
M?0]LS]B!+3B`+?A"\IBEF9P#34*4#J$-[RZ='.B.VT<=]/:>V=:V6'AF]YI3
M"C0`;9+'47R=M@X#BQ.A.;F8!2&]I(Q`X!`\D#2Q/N9;&JMHHQ0_KA/?,Q`:
M.!M7D8PS\',FV>=MPHNYV#)$NS$I'B#@2'9)Y7CZT2%C[<=?E0ML\I,);,(A
ML#3MZ4+\[\/4LPOM=K/-UF+)9--TI'>D=S[Y?)W5C^_6FV]_RU</!S6N\SG(
MWA'EA)*-"2*._5_2<J&T_$R\L#?7D8EV#E$42X1GH2(E'Z%[_)7@-M^\%O[E
M,<=B3H0!SSD-+T4:(SY#@\K))C,KK;8<;(`/'>1J<;A8V!W$9V-`]T;/1$7[
M+#VBGZ'V.Z%(9=^`S7$Q\O2]RC0\K'JY'6!G3'(/!^8$)MUNQS4K"W-(;P\=
M@_(KY%08W4:U"*]I6^!,9/N_=GV'AG9CQV[O``/UN@5UF@0P!L@WJ/G(V!TX
M+?:KM==\S@K%L'?AQ$GLD$OJ;N0D'CU/./:^9*"$-^V&L@HJNW?G[HECXH5Z
MCS/P2:P%?1*'3M\?;A3]BO>+#YNZ?O6C0>GG?$TWD_JQ>`;#*73T[01B-*F"
MF-P\G..-JS\_<7Q0EO86)U#%GN[M2`&-:;M+=;\2.A$<B#E$DCX<KO:$&DL6
MC`ZM"C5,7)V#HZ^92YY*LCORS\:`X6UEA)3.WE%W0X\?]K>\=$BSYLUA)FD>
M4?5]S?R$)OWC(]HEB_01%^84]Q0I7;D^BJF+WU]\D]?%0YEM\]5-W6C_P_;1
M%OGP`GW!=`8"9,5<@,.#L$\W]@*:"1'$KMU'9FY>]`L^'T'IH0&IVMT:*X<V
MPJ=K=@G15#[#(@STE,R8;!Q?NT[D>/ZU%WHNO2*`]97=X7@)KMAQ(5E"0Y3"
M(_MG=02:1]S143D-V6R4$^^7TUN\7G%@7Z'/E)6/LX!^3Q`P`45EMYN?C0$C
MMCP3*9"5`LX?+:*J-VG*G*@.)TL=?Q\YBV9'M3N6RD*^;@N%@89N>5\Y)_]^
ML+JCOONB8:]^'#YXO2EI5?D[S-+>R=/N'/C;IEJ&$QBX/*2<;D5X,3"?9YA3
M/R86N@5L\';[2DU-@3'LZ^6CHS]J='2^[P]P7Y%G5CJQD79$1(84*T!R3B;4
M%@@T%ASI'U,.\*Q\M&`=^#[VXP5H=[N!QD*^;I`PT+`/*G0^$HHIG(_57C0*
M?-^@H*I(,6+G95A8FQ9XK@.8:[N3B=D8,"^P/53TBZQ08E%/V.VPTOK"!H/#
M*A%;%FY.Y+:G"9YQ2)MU[4T\YN#`D.1.D#$0PA62W8^;\N`\VA_.-69"]`PH
M)Z],'+22VO>QXX8QA%\<NT_+T\3KEL])"M*/FRUZ<^2-5.;"'UMH+2Y[HZ)Z
MYI+O_]AS(TB/M;Q$!@/UAESLTY0<N=)++,!ZW.FWV\>\>DT+7\,-I[JE)M)X
M"!L:54Z2V7EIQ7FPA>,YB0]+87<Z`2,'NG4P&QDI_0PUW[6%3S4)KI9(T$R"
M>Q8-&F[A1V&2D.AU[#4;H-WA4$Y.C,2'^&AJI'K92'6F2JJ/Z@XWXN#JBQR-
M#JU.OAFXZA/R\V:.MZ#!$+P&=KO+>-@PJ:<G:#E1UMW2U#IE6[O:GD6V1Q5X
M3S,2B79A)>QVKG'Q85QY3U%THKK7TC*NK'I\YX%7?Z'/R:R>7D6A4XWSI_S!
MAL-8Y.F0I@(Y"4,LPMB'&E5V.QH-SX2Q`*H1=C2]Y8#D7VE6CR&]V74_OPX:
MSNI3-E9T[22N$T?-RR,.2&M3*L_N^Z7F)\.(06*<K?3+\C%?[;`.V=QW+VN0
MGXHR*Y=%MNYXOCGO)+6=W][W7OQ[7W[99EM:>^[V?C_<ITU=$-G:ST5'M8;X
M5*W-P%%,K9QFT3]UK5Y1/E(41,UC*G8_:J>7<=V6BU;JC]1")Y&K,P`J2K0?
MXEA?M*,<7_^2-%6T`4*+H?+GT"5G-HKJD3S/77@A=:*&(17.Q.[[:V8FP(@M
M8H25(473!MUOEOA'O,#T`-2?;,JG1G[-R[S*UC=?:YJ12NCHK?[U7&\+"NY%
MZ"THM,EO3IO+X7*:EA979U_&D=N8=+22SR(((IA2NS-`N/C0O8/R$)/^^O;C
MV\\W']`?[>><V]?@6A\R"2P0O`,Q)Y+WIJB7ZPTY?C2-8+:@R+KCP6S%,%MV
M)W:(,<0NBZO-DBI(JIM$99*/NK1IA0[-4+NVG'&7ZB$KB_^FM+_>E/5F7:P@
M8[I<?<+DMWQU-/Y^%Z@/HW=,!<]/]+F#5),K&=[1/WG[D)#JH=PX=A;$:^DE
M'CPB%<!+UHGE.2U&)\),4,HD2^V^9HN:T).N\"=1$^=9$:J'"CSZK@H6)'AB
M,81GJA/+\X8,3H/VK`QSO*3=L:[0T6CT/-8=[]@#=!BR:Y/\(>S\N7G)BC7Q
M'[W;5%^R=?Y;5OTSWY)??"&^;^H>_[B#J^9!X$8<AC5[UW*PEV.!()JC!W+(
MCN#YT\3>I!!QADR8X\+4I?!;@HC\7SOBO+C?`Z/>-T7+=5;7Q7T!2=I9.]HO
M]YOJEQJ/=ZT?(M'%(R22`0@\DYK8FQ(HSI!V2U68M/3UWVY0_9A59Q!XVG?1
M@8E^$+`Y_FP&P9G=Q[LX$/=)[,X\$F=*MTTF3%FZ;XEP4T3:HD-C=&B-H#D?
M&#X4R[RL\_IS_I*7NQQ;$XZO+R?\9#0Y%$R3WHKZV9>+J'GW/;$[@V6<<-TB
M.SIZVOX5-7]6)'=:?(!FY.[,`W?V91Q%"R<"@$/"7V)W^@,C!T9\7FRTI+\_
MXZ4JM^@Y^T&S#JI\F1<O^8I//C]5FV6>K^IW>-E?[^KMY@D3?NWX4:3O%F/O
MF'*RRLI&*[$#WP<+EP82;']JE85\W5J3@8:T_0:1E4+[KY2*J!9%:EY$SY1J
M__?D'D;@P03;'=YFHM^(0F6A)+U9O=!\BE:=;DJT?<S1"BOA]>:9_(I/:C_G
MQ=/7'::9--VK<CR6/M=^WY!R,LO(1"NR_9^'^VFV.QC.0+UNG3I-0GKTB9A-
M.KZJ6O2I:=$\TZ:]G[M^X`7!-3;SL6T%]E4"$VUWH)>?&2-ZEINL$V&NH$EC
MR9)3/Z]<USF>Q,>;<O7FH+9_*]8YUOEEWE#T>=\[-:7[S-P!MQ=O_[("+LW-
M0?@YNZ++%,(RV1W.E&5-OT:7HB]MVR/<`>KT@/9=M'L`^BP,&]J>6$>_5EFY
M)49\'.H[_IV-)XN3:?(/0#C[-HR]"&;;WM`'"^GZ!7ET_+250GK2@R^4B:$F
MD\24&/88(R??1M>^XT6)!^@/8%+MC55S\6#(]&"C)J4W!.]WY8H&%9K#7BWH
M//NRW2S_^;ZN=_GJS8[<.?R4XV5:?:$!O4^8Y,>LSF_OX?XBQDN2Z'N6B8L6
M.5&797M_08:OGSA,:#I.Y-EMDLBPI5N+2]"6TK8(&B-HC:#Y%8(.KE#;!<GW
M@$Z4((K>GCDG+UHLC`.JEQ0M>&)E>@).`]W$T8)JQ<BWVRLCP=5,8&(@;11+
M34F,>:"DI?:J[5`Z*]?*U8WG.=C$N/:3T`\;>V,!]H;=.23JF&0'FE3Q5V4$
MIW>;;;9&>!;K`B\/Y.QB>5_G2U(F%EN'>46]_R0]*WNH\ES$_R_JOF',U;T4
M;]1QWJZ8/Z0Y9MJ;0R#+%CN"Q'-X)6E,?\N^%T^[IQXW+4U8W/NC]H>J^TV%
MUC29@59M:G%4<R;SBHL>6TKOI0`IDL=1$YFW-QE,EBWMS@9)`M.#VU8VVB%X
M"C=IX%GD?#@R\?CZP)9$$#:6!&1AA1#!<NQ-$E+(H0'C3AVU*>F%YG'@4]-R
M\_2$#;N:GK7`J),PZ-Z7+QBY3;F/-_G7+58!A_SDM_1RRR%)&?_Q=5YMLZ*\
MJ[(5J4Y&B>^]LNB0D*@N-[<NLN50;'`RVS.=MB$]SXO\D%X;3`):4FY!]7T4
MV+O/SC<A1L(!L["6_G;S^3_?WMV\^O`6?7G[^O?/[^_>O_UBFY+1XBO]LRJ9
M,Q^LMB']!7TR#(N=#V*7@-C9>R2>:SIT>WUGX"GMC$E*#9)1Z:7SSOTH&+A[
M3>HOY(MF<-2,WGB2_ZKF)GK?W:Y]'26L*O6ENHZ-+*<T^'AJ<3_:BA:==:$,
M=DCK%84.A-5">T\0DESI1J$X:?W;M'@MLPT^]I0$F@25!V*:=Q.(]V;![HL:
M[TU.LKDI)<(]T8B^Z`-Z*K0WCLC'A'8+E8N<]/`UT?OX/[M*^)F-T\NY9[O5
M<KE[VJW)8WF_5INZ_KVL\FQ=_#?^$6\BK_+[#=ZPLN_7H>.%VG2[(B+EP*)M
MIH:NI8L.X'B6!_#5,JI[7U%*[>%*^[Z0R;F==H4Z?2+:*3KTBDBW5^@K[1CA
MGN<%O!87U4\)^#/_DZH!W"#T?;OM1M6L&O$9*28Z!23O#DA^P)^90N\'_%-7
M)A<+"[?K(R+G0N_$3,FC]W@`QXWMOK:KEE%[M^L>:E5LUZ3;.;;K?C$.O'\C
MGGNJ5$.>;@A_#M"WK#+`/@'8E_D#Z=7TEMU+]OF6O<8_RR'X0`R6-,?<H?DP
MKEJ8C?$S!)Q.&ZQG&\^&W3>L65DPO;\-T-&W<QT^52[!1DZ!!B5X\JS6:>,&
MWF+AP\3;?0^)G8E9SE>#Y,##H"\DJUN5Y-X\;:HMT>BO-_46+[NO[]H0(Q&Z
M9'J"TVD!/^[`\;P0UL7NV]%"_,RGO(>)&M?D^/#1MD2D*;Q\JQ<ER9\&)8DH
M2KP@)E>-Z1+:?6M;D"..#8+<K%&]08S1EAX0L<1_586%WS(:9[NYQSO>N^(E
M_Z\\J^J[QVJS>WB\RTOZXR%PZO6YUQB+)XN,J0L74EQ/HX:K>S=)(+4NNJSX
ME@IVY]N9A&GN*]_<249J^D6T8T1Z1K0OU/2-<.?-;]2$MN6$6O"]C$O'\OF3
M=^HD!0ZKT:6>F<3990>SW'-Y&FCOLT8[KW9\*[:/Z(ET#C]G%-SW!-P_*)1)
M!B+YJ"C1%N.;_E+R*0\Y`1=[Y./28<WAW^#J'I_:(:TNNE1OGCB[,_M,A`E/
MSW;@K=$=^+:DM#:D[DGOB*RCVI8>'=($3GEYYH/I5.\N7%7!JW^I/AQA;NVP
MHWE(YC*C<<<4L7LCNH-J"S"LU(B^%!"+FM`,0@).PLCNJC(:N+7+@.8A_=A^
M1E/V\]=\^RW'NS`I#T!,YX,EK<5H9I1HE3;SI:!8T&)FD(T(9.-2W<3"W%ID
M+_/0G9(]=KLQL+/^@YZ3&]HZ\M@7JA3%8,\8FD''QA4SROJ[PPOFP(+9?>->
M!7NSF[33-#+:L-#1P8B=`U>J3%3+@"5@A`XN*T3:XLNZ<2#"GC5FYC2M''[9
MYL<"GC,J\^_4H%1M3XY*HR(#TC*,\9N(@^L*J4^1W;4<5+!GAQ$X36BJ9F]Z
MO:F>-U6VS7OO^3JNQD<V1H>6@PTG5RT\)IJ%_H+>UP](1'D1-#$HRR_+"/.D
MVXH3)2S=-X0B(QVS32<$M"04SPZ!LQUBHEFR6"S"A-[_]R%>$]N=^B+$CY$]
M0(2R8]F7*[1P>A-E/["C[R)F_YAR@L[*1ROA`]^'3FBWUWJ4;MW*>FSP]+RN
MDQ:)U**!9Y#(,YW;_WUT[2[<T(_AZI?=6I:1`R-ZE8V6YGD+$L)X7Z[PD?,#
M'B1?H8^;K;#\LE8O8O3HV%!HZ=Q+<]2RV8'V`NXZ,;TG@#EQH$`<>-QBN\/Z
MPCR9\L>($IA2"[GC=BG@.9>O/U"&R@PF_0H1Z<'_V53H:5<6R^(Y6Z.'_9"<
MCAA6T6*+%]@`@C,38K(A7H/&9K,[B,;'B&XC@XN:DZ)C"LZ!OV7_=U/=86+K
MV_NF:.;9;>WO!2GNK?%)+T8BY`1?F--#+4FV#AS'=2)8.!<6SFX;6XHOW?"0
M(2ZEC1%M3>K.[\NS]MCNI!/UT'FS><J*DHB4SI*KC&1HA\\0MQP`:KIP?#\"
M3UCHPJ(V(1:[X\AJ&+0`4M-4\F`+>N-$UY?E8[[:K<GS$H-Q`WQ\R=]O\Z?Z
MVH]"?574N4B10YDDU_MW\KBZ<19!W-C2385K"+C$=@>^U#&I&W'**$W;GNCC
MDV,WTM$?I$-$>]2`O#OR6RQ_[KRHHV3H1]P`MSQH@RYB?+J"E0UA92&_/+$[
MB4,)?S9@;(I('GC1OI3E1+W>E-NBW&UV)[6P/FWJ@JR]X_Z&OWBL;ZL/F_(A
MKSH5M,AGI%I:,$/I%$FR=:6)*)_-Z502V2$=UW(EH)MUW?I!,_U3]6$.@YQ6
MI43M.%?(<1$,1;R2,-AQ6<L/"NO>J0*)F5J6?QJ=,UWO4MV8-"QD=Y1"/_,,
MBD='34SEC*18>SSMM<<#[FE+U,>#SMJ94Z1_R.OZ[C';L]`C])&%9LL$V7.I
M$.[9E-<@4T/BO>]2"X>H8=U>LX6)?B5F"QD);?%0!P-F/K.%%22VF2T7KG-4
MFBU38](-[\^J=EKFK3=;&!E)C[3'4Z,]K+!:[K[EZY<<J">U;_].2M]>A^0Y
M2'MMEEZBY]8>C#.I3G7T#^BX/F34)S_KH8>#?_LMEVDF%)LO,.#>A*'UKO^N
MLMZU&KS$_]8\JF=2L^:AUWF2L)%;N]/C3$T!N_YYR:NO&_6W#I6RTV_&W"NO
MF#]%=)?8UF'4D7O'T9>(I(GHN30(YTS*:Y#Q`1TW;N*4=F<3&N'?7MN%G0DE
MMLN1Q=*-&IFW7=CP8IGM<L&:1Z'M,CX@W>B@=%IB=_ZEH1FPWG+AX68@;"1J
MN;PO<?.\WG[.EWGQ0O-M'"<,]%D=YP/*P9:)@19R/1\GL>5/C0S2K'M3'1HX
M;?^`#G]1)W1:+M":%+JSF[/G'Y.+#Y%O>4V.,;+914_BCNP(`0<1K`1%4%Q9
M[Q4SS2B\R[]O7^$._TE>/[+QK#9`[ERV$O/LR5M)0T,YG@NW(^)F4[4[;=[,
M!-A[0N/@0LD1[7`2:Y*&$1D3T4&-Y0]/P<3PRZ$_F9+A*#DG.I3G1$Z\`/FD
M17#CQ<^:+\PW!49,!T/,'-T_>%^^8(.$7/6N45&RZ!I5RJ0CX(ND[]4/W>I!
M.^!'.)R&<&?+\%T';FHY,2QE#$MIMR4NR]I\>SL3?>.[ML9-^%RJ#&^K,^"&
M8^O;-XZ:^BUPM=A)8/T26#^[:SXIX&[F#8N5SJF[<+]EU3_S+872H7/.BZ:[
MKW7^KQW>X=Z^D&WNYFN]K;+E]CIP`GTI5D.C2EXC9>9E?VMTJ`7QST;T#))8
M[F]G94'WAL%(1_KE]U=?WOZ?W]]^O$-O_X[_]POZH_V4]X[TR8B=C2E:^.:$
M5Y'&YV%G2'X[;>((PIR)Y:X05A9,R^\`'>GA.P0?8F-&U(QA6'(MULM\$GQF
MJ@RW<5W/7R2@/LCI+%Q8?MKF9<6($<))U+EZYI1H4MSR<;/&BU1#%1I2U[*S
M$?OZRKJ/CRTIVIQ\[<5[O)T3XR7P2-5$WXE(79]%[-'R/K%GN=4APY=V52Y!
M7/KE[O;U?_[M]L.;MY^__$^$H?#^[K_$391>2MX4]7*]J7=5?J0AW4B?PF>E
M0P=*V-@=1TQ?'VX<.PY91B_Q75A&'Y;1<HM'#8=FM@\EM/:"2CN2#&XR-B")
M<>_IZR.*J1\/KYP#*T?-7:PF?Q(<C?`WSU[$1V3:[>1_MM7]2#_HT)'$,>37
M*L.6X2$EX_6NJDCY96>A,W]G8%0YW+"SLB^I/-0B<?!:.->^LW#"F%C+";66
MPX5O=V1!C"$CNXD0:=UZRR0D5U<99OL7=/OZBW"FT*28:-D[YI'X\R+B`RVP
M%>S`I-NM]YGHUZW768A(X:-.2N45:KZ3\A-]V)>I#)Q0WYLY0Z,J=1*-\#+@
M(CJT<.(H<6&R[8Y8,7)@V,4Y0,:9AU.FC.GQB$T]?;S2^C(:>H=4*K)#7`S(
M:_M<1AS3RLUXCKU+$M9>\@U+:A\-/6(J]/C"R5!0GC1P`HU%=7M&5"J@`SP,
MR"=\353``N;6[JHN#-0;ELX>$GJ$4Z16[>E`F$#ZT`)6/1K=Z/V#JI7004Z&
MA+1M0'1`<S2PNWX(&P.F1;67BG-I)=\)O<?1,U[SC@%>:7V/UPP.JUQJA[@9
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MWF+;-TKT/?`N0YEDYKK2.=FGM,OTZL2)FP0^"`X\GQ587L%'`[M&0CP:"$_;
MC[H@WC^B_"VKJ)?]BB*8?K8DG<T`9#TWM"X;R.=WNF1ZC7QX83BP^P2EC$?=
M1RQ5A*:=CLA^>N@*D;[HW4GH[0K!^^?0X17:8_LU/VA?%9MGO)GCO7__4&_L
M]*7^#!BDI^WEX,)`38N!GD^C8&%WQN<@S;IE=&C@]/`'0=?_\(HQGFA,"=#Q
MV:1O4AP7IL7NS,<1JDV<,<9)D)>GU^NLKF_OJ8+[T'E*TM>7CM@[I.3IF8V+
M5A+[/W?#P&Y1'"-;MT8;&3NE?R.&+FR3XJ'W9I!_@'E\6WTN'AZWX/O7>3EN
M<%@E0LG"S8E@]C1QP]#N#*<IT@T)Z-#X!R%MOB!5"^DW0C&CWM%:3__"UQ>(
M'QE8@[0.<30JKTTC/.WV>A;9B)]%9KL4C$FM6*RH;\2WW_-J6=0Y]5GN_U@W
M?ZWQNB>!OCBH$$D:9)U_%D91,-D=7F"[/0(R;,V"'#;:AC%UA=H>T*?6`=]V
MLO^(\[PO)VI:W.P7![@SQ[K@Z@>1GUS@EL3,F!%GN12):0NYO`4:C70I@-3'
M'3G\X@/*H<):ME[GJU<_WF;+Q^-OB6#INS$A39X&J,G-SBCLN+K&"MANCZ$J
M%F?9__CI'-L+H3=ZK#\408,.T=<?B'1YUFHN()O;)R\1R&S[)U?7).JY:-2Z
MO1E46GB=;Y>5H#K]`ADD2W(O$0"<$P`WD6@%N+W=;>MM5JZ*\@$+GG[W\>#H
M&E`WRMLHJ+HMW3"P._V;D8-9]K8S,L:VKL['FB3;W(9C7K+9MHMN2R=9+`(W
M(/]U:3'TR'$OT,YC8&D^Y3]-7'NXJM$]AD(WZ<A`/BU;]H+=Z;3G*ITWP1.J
MQUA^&TV"*^VJ7YBT%)HV(<A#CGG;NO'HW0CGF)?U;HWQMVU!ULEW"'D`T-^/
MK+0S4W<0[<$F4;"PW#$]1;M^,1TG(#U\<'`@"^9G3"XM\TV&>23O/`]HJ$V;
MUF)WEC,#]:;R@J9)42N(^.A88SJ;+!`X4<*OM_D*VXUN$.JSC:>&EY9C7NXZ
MXCS1U(V"!!_%O7"!EP4V+.L5K!!+9JQC,>(.UG$;>UBAER)#RZQ^7),WN-M?
MZX*%'F>(+;#H,S`FFGK@G\*K8[E;A(\3`\8'!SGIX?-]AMX5:KR!^S9*9![2
MXZE(Z'O$9'QL+=(^R->$J+?MG#A:.%YR[3F+T/=`+<&C,[[E3A(9ON;<"Y@H
M9-X0KMKKEW#=4@M63&X.)K'"NBVT[3RG>=7,M_X4P,S&3!M"'RVCN\%[`?%^
M^_2\WOS(<]K3+5V3?>$K+]"V"PP.*R?4'-RT\CS<Q'.C,(2R!X'=J=O,/!C1
MZ:S4I/`WT?/L]%IKT<FS2>Z9)AYN$L1QXU>U^SX,(P>Z]2\;&6G[6>.BA@\%
MA1?>^-Q4/4XWG\,GV-^-G"2RDW9XEQY:=)U7ON4O0`W2;,KW-T1`VOY!DV2Q
MA3GF$*PS!3?8`$^4W?ZW"<IU*[3QX0\2)NE1_H0E**^J?$45XJ>LNJV^8#3D
M*_KN\:>\HG;IM>-CN=:V'[,1(2>YPHRVDLS1@=WY[7R,Z)9S+FK2_=?ML0DW
M(#E'T`31-@@W@N.47BAH.539"(6S\Q9K!W'B1$E\[3M^X.'_Q&X2AM=>$'E.
M1!59;+?/626;1DYM"@GN((UF+UU=H6<,M1<*L&<,L%H68.#PZ.22$&KTW7`<
M'UPEH!@8ZP=27T/+:[ZS,6!V#QF@XGSO:%QNHNE(K*MN8)^81YPG]H6SAJ[K
MN5CM.+$;0<*D']N=I"?$SPR:GHVR,Y7>AE1$:[Y^JC;+/%_5[[#DM.6X;N\[
MZ8-85$C162PJL1X,3(PO"P-^]@Y(F&A+%B=.HCBY=OTX"H/KP/<]XB2,XX5+
MG@-(8LM?+5;%(CM>7O+JZT8<,4K(3=M^$!&40^G(S;U(EG>7J.8@W][BK;%T
MA8D^'_C8T.IPP\!4'V1ZFL6.W<Y(%O+UVT&3-)S(;WMM9_^9#OG59`#-*[\]
MQL]8LY@831YY_B&*7?*C[\.]P-AN+Z@$5X8,(5'Z.C7P2;8)PM-5%W@=:"B@
M>2"2UR+ZLGS,5[MUWN0`O/I!;Q'!.S_8!-/X--3PP')@X.)H_Y;)2",G\A=V
M^T<9J->MR*=)2-M/#B7_OOY`<!U3[,DH<A9XE=7Y"MM$SWE94QS<$$0]Y"1$
M]NK'X9-/V0_RJYMO6;7:7X@^.R>&T4*?_:*<7DF<&)B^/;S4CQ4EED?CM/&L
M'<J:"(=B`K]\)<U0MVO4Z9OHA.YW3?^(#G!4743.%::*R9>L6!/=]6Y3T2=P
M*0@T/OFIB6P[5`G#9*K6*.=#8EFU?+?7S/JEZ)<!^O6HF78P>DG^5_[B)_HA
MHN7,^F?5-V=G95U#1M=.X@1AX%[[SL(C]\Y<+Z0/PD1^8G>P>:XI,7)*GXFY
M?79R=J1P[G?;796C!T&]\W6$CS8;J_5!K&AJ'$=Q#OX1%(!?EJ,C6/-V%OFQ
MW==,)+@RLOD+D98>F@YNZU>'Y,)#>W.`8<R?OB3$G.==\_?6I!G'=H=#I/AB
MAXU<_K8,D>G!JOUV?H=QM:/U;K:/-%FJV)C$#=NKPI<$FW[[D:NS)K'-[KN^
M,FR9L^/$"!S%B^CI[]?-9E7?E*N/FS)O+P#EU4NQS.L[/$2=+0E]V+C</3^O
MB[RB3Y$$"T]C($:*-E4'.37S<GY:$^HW"F-R7]!WZ/O3BV01TA?8O0NP^K0P
M;<XCI)CR(U\0[9L^I-KI';7=HT[_5]0]U`PA]-`/+T?M8,TK+EBP]15_D:/-
M+."GYD44\"?]D@311H1"*D+.`D3H`G9?/5S;!GEVTH4Q?P"\T!M)!TNCAZ.Z
MAZ76\L!?-EZ?KB$9]+Y<-VD:RX^MRFC6,@OGYK2"89S$=9+8`W$BYM\B=#VH
M%W`!'E@SLV#.+Z2;E:X?"=3#S;%ZJ'OUP\&S1#YOW;1O)<X#RE'"[7[Z.97%
MF,M*F7#Y(%P)"!>4:[#\J7:#LV#>'::;I:[6>-@;%657:]2MUMAVM,;><T`^
MWS1:(Y?V3:O$"Z_W[>?4&B,>.P7#>*'G+QIALOL&F4ZV#7O\E#-PB,YB,"OQ
M"3;EUFB5^<-MYS"*]#U;/3BN`E0RLG,$L?XV\2*Y@+/W&.U&+.81`MJWF^"+
MJ^8E`\%*$PRKJR__:!9A[=\/>MMX>`]QFC>S[+X!R<R#.4W-0$VZ?XV#/OM)
MBSGLRH(W$X9<.8#!WM!8YR<:YNP2\6Y3M?L#%H1$9]"%BQA)89=E?(\`SHYB
M+[0<#D(,:5?L(E2E<*,&_HR@'8*&;=F(J_:O)*.L;6X&0WKVA@O`T/DNPM=1
MX$6AGY!*-WB5B8?;<RQ/3E?!GYG=1P&E#>K`+;#L)J5M-^1ZYK;"1XQ-U=:M
M4`BVC_DW^B<J:\EBGHUJ3X1&<(TQR@2J3@=.&).E\STW@J`1K>H>>1<,*3;N
M9MVRF$ADVK]P3_"%9B29WZYF0A+?]M3I(,9+Y]%Z;/YB<>W''LF]\((XA,K%
MD6=W$3"5;,Z_6?$1G+:U9$AB6_>YSR.OUA4J\RWY8E\O9KFIR:^5[V2WVT=2
M;SQ,PKY*P0:P1PG0B+LA!IDPUS2.R8T1ZH6TW"O&R\NL.U,/04S[$&VG#P+F
MMQ_#$.#;=J`QL;^3`![C26"U++]/(,K3_!O*"'5]SQ_1=Z.S^E$A(CJ/(I"X
M3%^F?1#TE>H8BE[*#*81&`)\,F%FLE^RJEX"-L$%;RF\?,ZZW7`2.[(5M=?2
MNV^"0&+2^?TW3:CLY$V$)-=J%M.MER!#<!V;`&Z,=CIS2!$=DH/BD92U1>R"
M[KUD5SH_I];@E(E<%24GFO&N#H4-45$V<#<'8?.FIV40YC--^SOS/"_R(/O4
M\ZFH>`L0%>=GP_`HJ_,;LOQ$[U-\1+-Z^LFASQET_#019MWTEGE,@Q:(3;(Y
M@:K3]DX8QN`OIOF8":UJ'$3^1>Z%',S-M/VQ4SCJ)J'=*/?6#\F6R2UK1@BQ
M;DRG[:E'.`&/<$`]PF$$'F$/%O,B]R01+N?<C@3HE?+3JT/<)\SP(S98;^]O
MZCK?@D3J>R6$AQ1]^&-@F@6&Y]V0=?=)[2>?/"E.UCUJXC,!K/M%QLTDF)T=
ME$)D#V-S5^+%0Z__=H-N'JH<#GY_^;C9YLA9_94/E;^3KK[A]<>,'[T/2ZJ,
M</@^A_J1@P\'=2U41II$?F)W<85)VG6;;%,$I-T/Y)X)GEY:QIN&<TG>^0W`
MH3;M"[AVN\`9J&<7/[D;=].DZ!'$GD=E.1X6'NQ(F21.TM<CB>=M%M'%:,$!
MX@VJP7X*NN(G^]1PTYQZ:`_#!$'?O8`!R>OI0D[FV&AJI:WO:WJG+0"'E]V9
MCPS4ZY:W:1+:B#@X\D5%35&4F+4$P,6'PX^W>/FPJ]^XMNS-*5'*HPES027!
MG5I\-`%Q?Y6^_R9NMYKE<E=5Y!0F5M52C;3&?Q)4QBI!B95L#$K67J>(4A[9
M02G\KJ1*>ML+QL7A5AGU@33Q[8QNA\H-?OZCIV&+_WAG&FW@6/Q"Y#3A)O:0
M22I4FON'FG3*7\2R^G$.^Q\4._*Z:V/__UE_75^[T2()&F>&O95:C,Z!=A^]
M26X.-5P$7PX;/8`S[DYFO0+'.]+@B3:$C=W>DH<,E)O8DZ;)2.G?\.DCVZ*'
MXH64!,,'D<?-FL2&R#^KXN%Q2^X(/S?1I_9A^_91;I+[ERV7>"%HE.E;L7VD
M#3'`GNA7Y(>BK+?5#MZ]V-6[;+W^@7;/FQ(]-ZF%^+L,U<_YLK@OB$7VM-F5
M6\X3T*ADL94.,ROM$9.P1[!6]FIX!LJUZ^5I&E))D^LUUL2[]?;(KB.5?=E5
MZ5D/<J+%1!"1K/,/O2".Z3X3+AQ[W?B3=)M0H5-$I!\WY2_[<LW+P]=X+C<O
MQ8KX=C)2<+%XP=H1ZU'JZ,$V0U;^X-1O;_^UPTMS?NKMK'[$(8[CW<G))C^I
M1%`G6RU")X&)M_<TRL>$"1'FHJB_<&#C.,EJE-/.P&5R5$=$DS"S[=LVR'+$
M(<J>&^$#(\RYO0%]/B:T[_%<Y/3+L=C6_VM>YE6VQD/>K)Z*LL"V+!;YE_SM
M=R+]>2L(?A1J<Z`PD2`GYX)<$FEG;.JZ7A+3!7+M38L7XD6[[(M0E3:-*`2R
MHV8HAW:BB+A94^G*5_U^D(:JZR`.]#WXRT:#'"9$^6R3&AC;TWK>/JTWY/@!
M[,@.+*/=.>]*^-,.'E64ID<7)EL(:46.EEM7%B+G+!V(L;T;T\@[N9T`BP4'
M,]?N;"%YYG0G$TE3F.Y[.+I*?(2@IA=E?ABV/#=S;I@SH1YP)C0*QM[<`2;:
M=8OD%`%IYP-!L^;M\:M>`T$>$&S\K]O[S_ER\U"2R`QD)[PF-YH^%&7^?IL_
MD0L:O4]CJ='BBHF5/"3KGKD60JH'PB+D@039ZV#7SK=NZ.HD/GU[\E;>X'YS
MA0Y#D(#389"V5@T=!OU!!D)T)!WZX^.F?,EKO#%"L.)NL\W6W;\3(CYNMO^5
M;P\$7B>.JR\[0QO9!G2*FMGDTBY"0^*#14*>=@M(85F?Z+?`:T[J=K_%-=>4
M&#D5SL1<^GM9'93/LN=4:9O>F<^"^1GUCIA5(S1DD"P:L;,W6\;@#%AAZ4BS
MP6/S[`=K;OU<'9_!R5CXFRWZD6\[%I$E^@?LLG>;JOD5^<XA,.J+#5JNE'IY
ML513,<Z[=O753T?@ND[@T^-_V&#"WB"J-?-SV085!Z?3UM45J@Z]-->M+D+C
M7989]O-H/',&VX"<)ZUGW=YTO;FGY6)-NVG>]-M[5ZT+C-R-Z]"A)ZF++5!C
M0U+7.?`9DNF:G<C>'$5^1K2#BX>:%+[NKR9N(L5+RS9L78K7F>RS-?>\Q*4Q
MX6`!ZQ;1=?/L3?E2PIMNA,@2>)0-=MQ%&X@7Q,[[$MO8^9=MMJ4WWSXT(9:;
M[T5][9(':W0A9F1@.9QP<=2B8ZQ1''N08>W9G<_%S(-N:6<E)(4/T?Y+U'Z*
M_B`?JQ'E-YNGK"CQTH?ZPOFC0VL1YR&N)@2Z:18G]!8A7@6[<ZTXN)A)J'M(
M&1-K^)Q3L#_G=8[G[!%O'V_REWR]>2:]'N\=?N#KJ_3.0("<D`MQV(HZ2V/'
M#VFR$=Y;Z:L:H0N7#2Q_0%*6-=V@D*0O;=M3NZ;3@Z11@[O=5L629$"26\Z_
MX^-P_?G+[WM!TK@3C`XM#1(>KCKP&&F&5V=!WZAPF[=R_4:/V9U1)<Z4`4B(
M498>6C8/;M&VZ"^X=?U7K4C0$HN;'0EGD:[19A')^G`7-!<:KTX,J].<P.P.
MOTOQ922R)$-A%Q=M\?-"O/C2\C%?[=;Y[;V:O,:[[.LZO_:CJ*]8JZ+Z2SI(
ME@.@H5G</WZ@93@G\I+&%+$[B\\$^[JW10,\I.T8)#]8?6(Q'5'CR4W7)FS/
MR>UH0V8Z.B1.0)Z4]QV\.\20*=#L"_;&9^09T[XE2Y-X?'!;=0YNLG>3'QZJ
M_"';YN]+O.>7=;&DKZ?<?"7N[N66Q/9Z<UH'HI`3W4G>DN2F=7\_<J(EO<CJ
MTD/S(B8'A$7DT`>;$LOSS>48T[T'25&7[ENC?7-X@@[]T?:@2]@9BP+9(>WG
MKZ*PS;L+\Q[#O/LP[W9GS,@QQB[N<F^I2%'))/:<Y8.818FM?I`=8G]>/H)I
MVCV8]@BF/8!IMSLA5HXQ(_X&*1([(E_L1?Z%BCQ>BR7G]1[A8K-M/LUJ5<!R
MORGJY7I3[TCIV9:18*'QBH]6TB4=$&9G=>^(T#JL0]X$I#*9@$RZC?5A[V%G
MWDG1[K28B[-TL.Q&9W#T]<>15Z,A`%)'K]H$NRMTH`)UR!"V6LU`SZY*]C^+
M0CM_5E;GL-&UXV%C;0$R#I:E"Y:EY0F%<TZ+$0-I1@;3?^2D+#FI2/J25]E#
MOG]/2=B\^CK-R-<!1II79XAO]]A6Q`?9((GTY=3H(UR!(C(UH4=J2->@C@.&
M?I*`)(*A;WDRYTPS8L2B,LZ64G.J0\+5J4_$/MVESX[ZD^JN?A-*TZ"TH"7-
MBW#H=HJ%.@2AMCMO=[8Y,6<\S<#=OBQV?N@`95OZ*D%>KMKW6D2N1,O:@QV6
MX)&D:R<,$WH3R7%L/,J=$3SO\8UI_E0=VLX'"]R%Z\-5?!^<$)8G1IN:`G9]
M`JA[6Z[F.9`Q,G29*L1*[_;E:!#E;NSSL:(P"&#3<F#3BD#B[,XB-SH/MCNK
M>9C1=Z""H6?3/*UOZ@9<4^V;Q)^(8XH`*EY<A$DSQH8U:HIWKC5HKU$2Z`8:
MP`;:N!+LO@<P[\1<HJG$S^9E&%!LT++=K/J)M)A.$VR4`KR'>["'>["')R#)
M=N>16C`[%V2N";*HSXC;1_@:BMJ_YNC3K!&^DXGZG)/+^$7Y\'I3TL#E+EO?
MY=43]?8F_B6$_E@YLL:O+K$$&ASN[-2$7DA?E(H\!_!C=V:R-7-T00%%*48-
M*M,]8:A#&2*D79!BM3TN^2=0K#HCF<S48,LD<!HPN0`FN[/?[9FD2XMURK%K
M\<'[W::ZSXLM38$K5V^_/Q<5[:%^7\(5XHDS8N38>QR7XFW>0[KJ95%U=)>D
MRPDAL])90)J3UP3W?NY+`OHFS?:#OC;.E9JL'2KIG?`.G:@HFU(*.CP#\RL(
M*Z\J_%MO*[_K($D7R>SR()[J0&:7!SGQ_L]]%T+GM%W$70F-$[`WBN]A#-ZW
MGQ2RUC)#TT[H^3+P+%>,+<G6J+NQ.=2@Q0[#Q7@X+%R>LUA$P;7G>G!M!\O8
M!=R2,#H9#!HG`8U3TBOD,\6XN1FS6I/8?C*^`$6B\Q2['RT*O0@V*D@8\R!M
MPK^`RPKF9N*"SIL,[&@[1.X/C6;UT.UN6V_Q`;8H'X[O9I"#A6?O>6^0[GEU
M$L]TJM),(V/2VS50C)R6.,*2##FM_L]]W4%T2B[B?"7(W-[BV1S:DX#"S,$$
M!L18:0Y=K@)2;AH-CQF%/KSPY$`REM?8WS_W-0FA^;#=3!)A2JFQU"%`Q3UT
M-5.QOWH4N0[-WE]8KJMLN+K%-'\:E%,[&/4P0I#(@4I4'B2)^C_W?0?>J>"]
MX?!EFU7;V6TB%M:&;*&O^4-1TE0S;!'-;`V=0</*2U@7I%J47ZP:$KIF-X2*
MROX"A.[GOH#`.Q47<WF*DS'[#UFGL+#]<&6Y5M%YF#I<2VZ.])`CZ$,2MG\!
M&?FFYN&"#D^3S.@[-,UQU[Q#P.?->OUN4Y$_7@<+3W.I0>4T6Z."1N=1@QKJ
MCN<X,7TI`LLMU+GT(6'9OX`D=K.S<4$JB9$E78H)_4$(0`T%AJLS3^#*]MC7
MI>@GG4&O(_&E#QTD(,"0`-P4@_)_[GQQH?FXM'`7,V?IS*;.9,:N=Q'.8GMS
MIB7F6H,&FDYH;2(D]-4A+*B0T!K\W(G0:B;H,IW0X@Q?@FN:$7*V.ZQ_)O6F
MT[G-(,Q0<L6%;+FF>E3P<^=2JYF@2W2$B[-KOWN<#6ZVNZU^(LVFT[,U44C*
M!T>("[>0?*A+'OS<R=T*9N>"/%^"+.IST5M526QXHH9J6;BTVHKF&M9F.9JW
MX(V:)5!5\$:(FM`+&T\RI"('%Y!Z;L,<&5&C%C!J4)G:4DE,"M565A+[<RE6
MY97$1*@A5:/:`Q9D7`<7D%9OQ229BWO8P&[*H0=K])>B1#_RK*K_:O8,_O>\
M)AS2@A'Y$O_S;D-^U:FG-O#(.3TJVOLHN#!?\Y[352Z'JI.[!$U.XC0NJ2;=
M"E+!@Y\[X5_/A-E^OM?"M5(K%2ALZX91&M%V0W]]4@QW3^F\-YX4:`,K,VG^
MO,I9>4*.,$U1$S*`DD\N9-0'D%$?_-RW)K3-V44D]NCB?A]D>J$#F#W:3S/%
M5;A:LUUK!:/S.@*T+I@J_X!*(D,O;!`#5PZ""[A'8O'4V>ZFU<S_3':QM:Y=
M'>K$2H_OO_4_PX)9J/_I8P.0+QW`U8[@`N[NV#QW%^%-UCT+\D:W^I-$_[7=
MY-)<Q99=AI:8;,V^AAX2G(1>8\.GQ$9@X8I(\'-?!E(R/Q?JYN5BTISU.OM%
M[.GIFLK'].RM32S'G.WZE'-AS&G9B9=8$@=*''@0D0X@#3S\N6\]:9RUR]?(
MHJS/I*>M>KU'E9ZP\UK6OS6XCDM<DI2Y;N*'_K6?Q`L_O/:".&YRX,.?^VJ7
MSFF[F`M?&B=!K[.@GF"LI9/U?:TPFC&[3"DSFM6D[HEGUHJ*"8G\&`J(!I!3
M&5[X%3`#TS.[J:J?1R:;M.9\`CV?\?5(3?"=)_'KWWI3(,5++2$T&1VN3@:0
M1QE>P-6ON>?'CM0M`YR>/G#.;0=N-\M_OJ_K7;YZLZNP.0J$4+)K^L<36LGK
M8$GL:7RJD9LB2<6B9`;VVH&[-UK")H0M<1&%D(`76GX)21V7#$A5\C2B,HIE
M$<<8(:YOOM;T9S)N[]GIN=X6%$2+T%M0")'?</<OAQX%W+30X>X*BM?YU-GI
M@[,SA`NQH=TW4A1SJON8H)9<OHMT?[2=<E8T%9=+Q_VI8'9@1Q)GD"?NP^M$
M87.`L_MF@6).V7&VVBQWQ-BC!J$IO`V0+8JW:U.`BWXJO)V=%P57$XKF^%#8
M,&SL?;N3S!5S:N0,IY;F`]:R!FO5'FO+#M:V8AG51O/-+C7">9G9?<=12V/C
MT_A22.-+D0OQ):BA&MJ;SFS'Y!B)0%K!JJ*;@+]N-JL:D_)Q4^9/S^O-CQP?
MO//JI5CF]1UFJ,:Z$0_SCXQPMR5?GOE=,$%^W.=Y&K`95`ZNZGZ%GFDXOR*A
M9)S(H6__+4):8#F(+;?W#7!OREVEG9,]JDD&U[>FM;`769[<7\G/C7#W72[0
M!_%FY-D!/CP#"M'=#D+-V!@>]@P;V0A`-NP^9!B;`R/!=P.,I(>!$!T)X0Y0
M=RS4#H8ZHZ%V./IYJRR:$>?7#HQ>NI]9/9Q[]I2+%"02ARZ(5`@B9>_)P.@<
MF/(&FF*HJR<>J)X@ED'9U1-UJR>V'3VQMQW(YYM&3SPT(\ZO*-B\BS^SGABY
M1ZU(HN`1EM`!B8I`HB[@<J").3"7B6*`F_VAX6$F.Z!U5P1!L#!Z2%#F5=3$
MOT)L=U_HCB"H%'H@"#2H%$<7</?,P!1<P`&!A0^EYP/A.[EJ86'N=&"I7M!R
M-CB2)HB`A0%(4P+2=`$7F@Q,P06=#%CX47HP*&'`^37$XL^N(?J?\E0H3E`M
M(O2I.%'_,Q:G"[CT8V`*>(.'LL]QZF>I/YR@Y?5-Q3AP_NR*H/^^M$*1@>>E
MH>AA2*L28)&Y@$LL!J;`2!:!08:8U("*=RI5L-(IVT;AX,S@4>C08(EF&)\5
MY3JB.QSXGAHS-`+1@H!U9/E]&/.S<3'>!V:6-#@BNN5N;5(RIOT3%Z)E-'HM
MSJ4P`BE,0`H]D$*[[PW-,!L7Y\M@9DV#6Z--GZ*#SZ1O!E(^*<C<&0R<`7HL
M44/LLZ5<(PT-#4(+]G4$R3P>)/-$/WWVI<S,7(Q!),2>#N.H*>%WTRWA=P<E
M_&Q57J8-IPO77AH-JE$I3B`7,8(<(P]RC**?/K%49F8NSM`28E.'T?5RJ$2:
M=RJ1DE_SWF$]8W7H!3C,3LB1@,+<L>2M50GZ]]=5F?O`"^TN7(@'T+``YKG)
M*K`[1505B[HM#D5TIKTV@*(W,05$CK7`@K68Z2FIP+E28.3%C9'71-KM3IA4
MQ:*I?4X1O0?P='>>;`^>8@^>%]J9=O0P5DNP%CSG]1'X%LIK+`MPY_@0@([M
MSDA4Q:*17&)%Q)J(!#*3>N)M#CDB?2)C&`+5.%?<^#KQG.*EA9LB,62!^Q#D
MC>W.\=/`K35F'C/)G!:?>)1,3E15&X*6(%#"/#Q?8;B($4/2M@^QTMCN)#H-
MW%IG-#*3SFD_2D20Y(16L5EI"13%C<WS!?9@@<&CY4,8,;8[BTT#MW:9H,QT
MCU:[(,V)-4K,4%,6*2WIW*T>%W($9\5&,03$*<ZXH7C<(74OAY!"%$,6,I0J
MBF.[<\2T\&N-;<I!-*]U2KL6+P0K*;>JC52+("EAJ/8M-^39Q)`2[$/D.K8[
MH4H+O]89JQS$RV)3E\TZ(,&*K5:+L"ENN?:M-D2&8KC9!R^(Q;'=V41:^+7+
M>N6@/+T9/#$^\S]BQ$SA2())Z&FP5[6DVVC@EAN4(\D2^-`"E?+A;:S0AVH;
ML=W9,IHYM\:N%2*?=Q=5EHBG3M15F[V6(UO"%!Z7$"BZ$3?1,<C)B'^2]!@Q
MSJTSCX78X/7KSI"D-BGTBJUGRR$N;E&/"TCCY8"L*Q\21^*?))='C'.[K&PA
M'OK]Q2,@EL7POEKSQ!.`0>A+;<],XZB&K#!SPU!EZY*N\0*LM`1B`@%$R9-+
M2V-0P?!\6Z\"ZOMWW'W!<O3M].F5]D]P0I;>93F%6'1SO02`,FRE/`L.)E8"
M62P!A,Z32\MQ4,'P3!NG`M*5OB8@+9^B7JE+P!Z##XJU1[R`D*Z97%KZK!"'
MYGU*(F3V^X[V/:E]S?Z<Y*8,\*0L<CV5*3**:I@),C:,,I8.06="EF8"/OT`
MXN#)I24KR+,[G_4I37N_[=D4P=9N>7*)KJC=:3LD&6Q.]F6&9,T$,E,"B'XG
MEY:J(,_N3/:F-.%R9>@E!5'4N+0=8`R&)5M_>*4@[S*YM.Q8`?[,&Y7\1/:;
ME$T_N@U**!9PE.`2RL#HN#_5B)FD=A@<)TUI.D<`:58)I%D%D,Z17%KB#1=G
MY@'!0UX_%)IZ..I23(?$2/C`-(_4LQR#>F<?LI@2B*H$D!>17%I""Q=G\QUN
M>,AD%'_I$\N00(D>3N81?X8C1^_D0RF!!+*"`D@92"XMYX.+LYD.$CPTIB)/
MTYP/.6E+1S+&C<G#`2<GPQB8.L<Y2=)$#2"))H`H>W)I.1(2?)HWBL2)[=\C
M-)\2V(11V'RR#U<LIA7#&M+T%7<!X3CZ]&^0+"XMFB/!YWQFESC1_<YDW4YD
M1K%D>Q;I(A!V]L"1T"+&L(A0%XH^B(D7\=*2AR3X9$>8]%-%*NDV\QZ1L&RR
M/3IT$3`[>SY(:!D36$9(^J)O4^-EO+0<(`D^>6$F_!"02JKGJ?$U1N_1(3[6
M=133Y8@0Y$P,>"<7#Q>PQ%"_ACX2BY?XT@(X"OBUZZC&1K30D4VANYM/;K6<
MXNR`I.RI[F2Y'5ANR$:A3R[BY;ZTQ"$%_-IYRF,C7NBTI](7SR?!HAYZ^[')
MX,WG6&T75ALR4^B3R7BU+RV#2`&_,WG^Y2E/_S$.09VP>_M]>5RL+M%EJ79'
M,@F_"0[%('C4*22(-2XV"//3@E-X<2\MOT(1SW99KNR$BUFOW?[-8U6+#6L7
M6&5MV1X!B$``("N!EJ#"`G!I:2&*>+;3IF5G0,RNS;O]ZX3M2#F`2.KA'H%!
M36*9G6\Q5(_>IE\T?D((*=,7-[&L7%KFBWKV[=J9A7@0VZ0U%C:2`H&6[?L2
MT"^[J8_*C@/N20<"WE$3\/Z9TGS$V+=SJQ?B16S7UUG\Z(3%S_E35I"0[NM-
M2;T`NVQ]EU=/%`)RKTXPCJ09[SP,,F-\L%,0!CBX.>!"B2#LX%QXEI$@R]9@
M68S^8_P^#^&W:CM'RT/O:$NZ-XY711YI:^'*[Y>>6'HXL#D0)(P@$.%<>,:2
M(,MV>*?%B+<BN6):?!6=HZV%)_]Y>:1/O,R00Q-!#HUSX1E.G*S.?@[FHY?Q
MS+OO%'5Z1:1;0V!LS/K6?1O)O5O!/^A,&)U@6QJOW?[AC=CF4`17BR((8#@7
MGB,ES[WU)C$S*XRGVV'K6.GS;3(PT&PT6PI^=:;TN<A`>H\#P<L(PB#.A>=B
MR7-OMX'-S,=\S\/)B+MFT]M2D*LSR(^[QV(!N7L1Y`@Y%Y[-)<ZUM6;Z).G2
M%KO*IY`9F:J[J8J1U*LZO"/.!.LQCJ5!79^D_WD@*9"^$,4@*1>>(2;+N[4`
M9V1`&N:X83/0?"#7?4"W$.4*#^>GDD*+QKLN7`.-(&W!N?#4,EG>K3^8,S*B
M`.[Z[E-PB+_F0[F%@%=W(#\5E0!V!DA3BB$_P;GP3#-9WNT^C#-R<7XO8]C=
M9@C*8UE5<J_QR!$P$\XYID,:]J-)2BZ8ARY$3N,F;G/A^69J9\)Z$T"(+7D_
MO049:9,PTFPN7)A246=*C(M<8X-"+#B&Q"GW)\UU$YL)N\T,(9Z,/_>G"A6:
M/847IB/4>1&'A\+2`TG1,=2:<G_2S#J^&;#6H\C%AGSX0-F%ER^/695_S>I\
M]>MFLR)\?]R4^=/S>O,CS^LO>?52+//Z#E-;X_$QG><S!`5O3V)H@<-1?TP'
M$7*ZP]2T$`6B92POB&-X11KO1]9J#A.LLZL,B8IG!A@QE3N@C)61;31PY]`.
M6JR,.:9+J=88&I=*'_C&77MS#TU/PV5I$S:FYCZ5L!2)T%'(U+(Z&$?PENB1
M+BZDG+GV)@ZJ8]`())61:TT*(.>%;AT`O(B;[!*P'%._\!)OXMJ;_:>%5PO!
MRD:YYDWRR_(Q7^W6^>T]W?Q?#6S^/7O_'54R?MQ;W*V98CJ]]UG]E<[QKO[E
M(<N>_Q>![__*U]NZ_0T%]"\+YQ?/H9!N?BU+G*2!K7IF6J>=;,=.%'IPBS*T
M.Q:HEE'=+CBEU*9M;V0KI?W]0NUJ1'NDN.WTB=I.4:=7]`?ME[-X\8'VUYNG
MYQQW1OJZ(6KC(2?QSU<_#I]\RGZ07]U@M;)Z^Z\=EIWW9;VM:)RTOL460'7W
MF)6-`CK?J'R.MZ!,T:7@4#W/[.VU@RD2:,#(APLC'DTTCQ;@*8[L#@=:,D/:
M]9$5;*9T#$0'05U"4(<2].H'ZG[74(,H.0CH01V"$*4($9+V40@%X02CP&7,
MB?JWWIN:OID4'Y1-]B*0=TB]B>R.=5HR0Z9RKNQ@MU&`8+TMNPHPZRC`KS]0
MW?GNN5&`&56`.2C`HJ,`-U0!;HD";-.[)/.TS$.8+7_KWPIP8O9FTG^0>NB%
M(.Z0*139&[&U:(:,Y(?9P6OZ5LZYI(V)=YOJ/B\P8>_+3]1?=^V$Y'4\;9XH
M<YS8JLA8IER_+CNG(@IBN&KA)B"]X(2)[(T=6S1#EWN(Y6$S[7K@!@^Q7W\<
M>>J.#K%7PZ?8;><4>X7V9&%S#WT238,Q#>#`^[?2G&_.9]":^+3C>+Y#:\%A
MI$"!B<C>J+TMT\.@+Q/0EV7^D.$>;;/^F%E-]U_:HK]^I:'/+I"<O@"$[;KK
MF`U;%=?D9.M76B<DX.T=*LEZ,8@JE+6+[$UDL&5Z+M?(8^;1H(4'--EGWGW<
ME)`5`BF8!+)N2%WMB\M2D">,V*HA&>9;OXX\(X)Z<^`8Y"\`))`"&-E=$\J6
M*>+-$_NRS:JM;48>%\OI[V6;308)H%_SAZ*DU[\V]^(W.0QCSOFWCIMGON?2
M<6`(T+0%+,UP6RFRNR"6+5-D)!?6(H;/-)R*FVIF\79A9]Q+5V\&3[FG-$1!
MT@3C&B\V7)>*[*[]9<7\7.XYEYU)@P?=/5'XGY0L6[0D7)SH^J:\OK+"MBO)
M8S9LU9&3DZU?19Z0@,$1PT8//FL'[LI$EE^&L&!Z+E=!,O-H4#\VM5"L<P0.
M(?;2@KR7K1]-AG>/:6@C>G`,<B"5/_ZSWNE@G)N+#^RR\9G"9Z*JBNT^W(>B
MS-]O\Z?Z.EAXL0'+C),L5:I$>C;.-0-OET[L-2'[^%+N+LBQ:,Z$D:+SR`SA
MN?-)^D.T0VLN?@ZE`D2794Y<=M[%T74!<\/'0>PTSQ;XD!SNP,V8V-ZK`I;,
MCO9K`G;PF=*/>4V*UWB4W7J+6W[&!DE5D#L&7[:;Y3]_+XMM_5M.O6!X!(^C
M"BQ+GW*P%Z2ZW>89FR_"!-Q]L=TI["+LZ-Z^!6A*#VW0H1&BK1!MAOZ`AIP[
M,I^T,-XGMDW(S^_QLBY!M`"G36QW`I\(.^Q2+G=#5H"VYCKKX2XJ^O98+!]1
M49-'!%[R:EN06F#;#:HI`#85-ESI#=:7;$T^SYXV._R?S3U:9O7C%<KN\?:%
M,E0_Y\OBOB"77^FN00.LQ5-.>OCVF)?'']QOJJ<,KPX9=%7030<1NI[R[16F
MI=[!E;/EGL&:\SHLGQ2S766U#7MG5TB9FGMN%(9P-2:V.^%?A!WM5I<@8=U=
MICKL,@"RG<0N<RA;]/;XE#I@'JZI3.)_W=Y_SI>;A[+X;VP=4LB^WM3;^B[_
MOGV%O_DG/GM@@\]`;2_%=$N>[`Q.YWE!,.5C^@X-C?@>?5QRD;B-A\+R9-!9
M)D2[:VD.KHX*D;T]\3T=!<&Z8U^AP^BDX6'\)M:%*`5-B3)$*$&4%/N4EQXO
MU9]6>9V7K=`U9D23^IPD!,%.0+#AQD=L>:+G7'-BQ/J9B[OCFHK$<.H+\Y.*
M%66=UZ**:)_UU&?:W2RWQ0N6-*KVNNAP0HUQ+AG:5"D4-=-RKC2$^O6B"&2$
M/JN)900N,\26YTAJ8]J<Y:*8\B-([_L><L.U_2LT.Z3$6K-I<:EH'S$1A/JE
M>X(/`N2``$%J?VQYQI]&M@UO],H9.`+^[^.XER]H?F2.#$IO%!@`-0]1JM`L
M.1%C=<M9.O0"%Q]+J3L,;+G$\E05E7P:!JH\Q>=6=I/Q2A-8FA<.]ENQ66P:
M>V3`=FPRO2G`TF'DQA`(32S/#U7!GSDS69S(P8<#3MQSZDWA?IKI;^N;W?81
M"P0^M_]>8AFA:@&TPB<\$_6K'T</FWPF"2A=J?4BC9<8M3.@%^I:)IA5+:@8
M//+]2XDFZ)Z$N16,,DX8M1",APX#HAT9\=ALH(->D2LW[;B(#HSHR!>EP&8Y
M&_R9%!CWF4/%X,0*7N#CJA?2V[:1X]F=%C';G%AQEM'%7?IE]_2453^(QNL^
MN;9_,OUVMZVW^#=%^:!80QV('_&M.3.:4),$:M8P(A/$K$$8.O<B:J#[7NQ3
M/Y8']ZD2>W/@#7`^N[$C13ZKA=.Q9&J3QRX.D9_'*KD@G<!O54QVWH:J79"N
M`*0++D4D=J?MZV?>#CM!EHUA1ZB8\_-3M7G.J^T/8J!LR:NO_]H5S_1.SM=Z
M6V7+[;6/1]:VR4\.+X=7`>Y:-$XW=>+(=<B5YF2QH!5@PT5@M[]2F"?=NZHH
M8>FGS[>?WGZ^^R]T\_$->OM_?G__Z;>W'^^NT,>W=^B/MC'G+CA(S)NB7JXW
M]:[JJO,`TV$>'CVD:$(*&].3J.GOQ@OLWI5$V)D-*\,TI6V;*^KWVM(CY+X=
M.C3$%J2H[2@F0%JL1-M1<V;Y\76SP,<'O&<ECDO3J[$BM#MRK8`[([:;/)UC
MVY$B-!V)$]D/3>\\NI$SQN`D7HX4GV=WXB4[$[/M**>43.PCLNX''IDPNW',
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M@H6EQI=3RYXSBV#V5+@9:$`5A`<*H@E:V'T[C),3(_J:CZ:]0$.B%+G1_?R8
M5]E:6L`_Y%F=/V[6J_=/S]7FA18SW)?566A\]75D8#E!Y^*H%?:Q1L["L_RZ
M,P/UNO7Q-`GI_A/4_4:EW-[>?\R_O<N6Q1JO#JD"M:UVM-COH9Q7U%<\8*`(
MF<@8&F27GZM1J9[J#FN>:)&`XX=>)L4:R.XL795LSH(3,5J'`'5[CW!WJ.T/
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M-"AWAELG='!-.5Y#C$WF=[4-O87=5C<;`[J%FHF*\43&*T2_U2/09A,7#0HT
M>\(B;1@U\9L0]M($]E*[O:>"'!FQ5\1H&TQ66&YJSB2E00(^[!\C]-U07Y1L
M>GQ-.!CA;Q(*A[;.(EI`*DD"]PE"NP-IHBS-IO_'Z9I*;?\@^@+F(#T?\RU1
MGA[-]DZ,(@(/K0D+_4Q-PH`VHPHJAG4!=U9XH0;/"#L<>\%FFZT5[P7#A`UN
M!"5OAOKA"OQP[CRY)W+MQ[WO**JN%#%.A1P.Q'D]+_HPT8.S"(-&:37A%;L/
MN7*,Z=XEI*CKO=DQ=B6*<\OX>_Y8+-=YFQ,2^+&^9QR.QY)#PQ3=K<R??.<D
M06*WW=]/L&X9[1TU;7^K,8E-RQ%UUB2VH[/I:/X5W1Q]`'SCW[7W=K4`)]K/
MHOPTJ<UV8_8LZXD(V>$U/Y+W:3=O''INNRPA['+V'CY%V=$N^8*$I7BD347D
MX,?![A84_H$=6(NH&[`<CL3X=#NDNB2`R83L[]#>RH=LQ&L7428R9$V,F^62
M/,9<?\I^$..77*=:+JM=OOI09%])\DF1UWTE-8(@3G3>2!8A2DZLE<U$Y^JA
M4(?^PNXT22F^=-OA,L2E;6/4M(:;PM`>=3I04X1)5N!TW0N^/.CUW?H5ZI#H
MV)#T22H%@;O-\MN*BCDU$OU22W-Z>_>WMY_1S>O7M[]_O/N"/MW\U\VK#V\%
M#B*G=+7E#$F*;M]F-Y!X/-:7@B,%.Y5'63A#S:A904(`9%+!:Q;9:YJ)LF,D
M.X>/I@&Y%:Z$R28<C'=6YI;A\SLH##/LP0S[,,/V>H)$V6$78KD[)0*T-6EG
M9P;409BO!:3Y?;G</)']H7V1>4^%%\6.WFS*P;$5B#\'7T?B/]R.5K5R%K`J
MX*R+[#Y%B#%D1(_S4I6^>__QYN/K]S<?T/N/KV]_>RM7TOB8!OI30TBO4>1%
MB;Z($Q<M*I'!SW8_4J;[\2Q_2U2('[,X82.JV2.@%3U:PR^:AFH.U8)2I"^^
M8#5XSJ^H\/33%%,DE;>(/@2?9&1W&I`:!HT<DY60VK\W\6$*:+C+OA_&/5CL
M8:`O+VAD8#FX<''48F.L$9Y\)T[HC>K`BV'R[4[Y$>!&]Z;"3U)Z=_/_?OL%
MW7YLA%O8YNH9NJ,NG86GKUS;V-#*I7R,J1$Y/S2+$\LK=3-0/X,<GY"0-D80
M_D:-V<.VU%JLG+GE]\R&&6]&=DFW.<'!S8KH@@5Z@!TC]HD`8:?Z6C19^=V.
M7-S]K2B+I]W39^+H6G_*?M!,I'>;ZO8YK[)M43[07*7Z_$VW6-_%%B4TJLIS
M5CM-YUG04OUC6]7NT)I2/G7O.2J)/4J9ANY0TQ^"#E';([K?5&C?)X).%3YM
MJ42"-;]N^;,`?>2-2ZG^R4X0TB)O>"N@.T%L=X!1*]]&MF:='#!HA]>;IZ=B
M2P?A`_[O994OB62L?L?&1;DJ0`X^878?,8&W7]?%`XUI]><'1('&UR^E:),#
MNNII:0$NV6_B>7872%;"G^Z=6P61Z:$3=-0+:KM!G7Z.CYQR6[4BT=2R15\^
M8L^V9%EA(47H/%#HD(@2VWV92PN_1K9@'92GAXT5;3?HR^[Y>5VTQ=-?;TKJ
M^=Q4HL8V#3%\W)2;UBJ`$WX3=#@W&UT3-X)YB%)E3DM.Q+G]S-=AM`CMCAW(
M,6;N*"Q`W9%U"_'I;@=M]/HO31]_57C6%9,ZS8?;RX'?R/&5IT,(I,90'=EO
M:H[$=MNYBCDU?$150?/QH;0HLW)9D%=$F@0N]!?H\Z\"CSC^GUVV+NY_8+H^
MY9@E?,!]P$3_/5OOH"#!BI3E?<EOZCK?GIZ@W2#HS5,<R+J5&$H.>VIY;`$H
MTRLQ@#PP@(+&]Y#87155`[>Z=TKU)*>'+M&A3_)T`^V5_./0+X*.I;=0)=++
MF!A_V1`]3ZN7%P$?1``.*9;G4FK@EAVC<DGYZDF_7*RR/0!QV5`],V?E!2`$
M`8";<XG=,1@-W!HQ:]73/0#330O330],18^@;_+[O*KRU5WV'3JZ*;N7,L^/
M7AJ?,16D2M4A5'8JSD^AG#U&CF.WP2O)F3DWD`AY1P?*M@.:K]=LA,3EVBT)
MH,X/)"AYFAU!EP3"$5<05X^MM\$!E0P7OI)+R5I2PZIA9Y`2HJ?`*XI,EL(%
M9S+I.B;")/RDJ<*HDDDY!ZI(MY%S,9E%XNR9VS>%:3S"'W-1'74[J(Q(:MY&
M+Q.G(QLJ?[?-5;4`'@-/(#D\L?O:H!9^#6^MZBCO"9*>HERJ%!;M\O4.[]KE
M]CH(W5!;U?V1@>5PQ\710-FJHT90_H]:.LZ"^ML=QVYGJP`W'(@0+[C/3U=S
M<SUK9?P96EXA2H5\F1[\'\S4^GU9;XOMCB8%44>@R^[L9.Q63JC%:1^0\+[&
M4&`F@B5HO&!VA]_%F3*R`PB3ES:?HJ+S+;=B)SO,W[,EC7H<-&"DKWQ/_YC2
MZIR)CXZ<]W[OVYUN.4:V[G/'R-AI>UQH_WB%FC\KE49=!35-2V.?UNW['E`?
M`^II*2]G8;VFY6#$E'9E)VDOR"_-YWSRV[JRR#6;U_B_Q;8=+HI]?9&8P6'E
MI)B#FU:0AYOXCFNWZV>*=-WJ=6+\=.\F)1\@^$)0S4XOK!9-.YN8GNG;P29P
MH/;=X-J/%PG)6TVB)*'JP??M5KW"/!G1PJ+4I3>KEPS/SHJ<Z>B]"K+P:)W7
M->\]BC=Y5;QD)`C?\:>THA)[GKYR^6,CR\H^#T\'\1]IY<>>W84I&:C7KZNG
M2$@/G^Q]Z#^$U37#(FO2V+,*;H_>'FGEQ.$B)"_!A,'""_&YQ/'"`/\V=A-:
MC\H/[$[7D&?.D":7)+,#C1JM\KIX*+,M5O!9C3)TGQ45-KY)WM1COGK(J6NC
MV@E<57_[]+S>_,CSS_F:=-]#;.(X^IP<D\/+X4>`NQ9$TTV#Q+7;<\W*@NY]
M@)&.M/WNEPH^[(95!3<%=@'0LC-8(]YG>\1DT^;U=L^'LW\(9W^[:XR),V5D
M3Q`F;^]O>09/MN90C?C[(/.':IA>#1F.'=!WR1QXE<59V&T)27*F6^O+D3?T
M$D,;RWDO',OA%BF)MT;FQP/;"R3#ZQ+"NGBP+G;;.Y*<L0-"_;LD[&0.!/%1
M:S-M-^TN<13O%'FWY#RO9G^`\9)`\\,E@X.K`1`S8Z>P&6P86EY%BHT!4[O"
M*!4'Y7^:72EX#&!==7WO)\PLSOTO)`PW=!=1$I/J!%[LDR+\21387<M%B!\C
M5K\(90T`&MW.FZRRVVZ>-GB<_9N[6`KTI:F<CB:9$S!)_#X;X.Q+)UR$8$>Z
M\'!$;+>+GI$#[1DK3&2DG<]$'VD>6EL]&2N&!/,\3>5\/HDEMX"\-)=Z>!W;
M,ZA8>3"3G,)(3?HZJT2%\]==5F7E-N^6M'OUXV-&"L/>?"_(D6K1YQU1(ZQ3
MH\O)+C]OK2Q/M_2;$XH':<:^W6:"$#^Z%;`(46G3B-0M[Y1$_?H#03OT!VFI
M``.-G8*159&[^_2R_K6ST)GYRDJ&>E`P,CN&CMXN8L^S6]]S<C('(H;)Z<?"
M_JB(VB90:4(W)+08,[9"XLSX8>^"[.`N7%'QP+OULV!D@#4CII(DD>D'FC*&
M[K.7#<FB_)J5_T0/;9_RT('-Z<WF*2M*8G7HNU,^-;IZI(SS-@:0HY;8D/7A
M\.5!PK5G=T:P&$-S[""35`UM)*U)!4TYC:H/6;FZ*5>O=L5ZA='7'AX7"WW/
M'?<.*2?PC%RT4M[_.9YFS[?[AO0XX;JE=G3TE+YNLD+OLN6^UH#04??XN905
M%!/Y4)3Y^VW^5%][)#5-6VQG=&Q)9S@G7WM?^'@[)U@D<`/&!TUAN0B+L*,]
M[,-/4WKR'M=J7[N1M$.TH0K!_[@C$+J]_[TLMA`X[U/,0T'_R1XUB/04Q:-R
M?=P86X'!@H8?,&NT\)#C6I[U(LS4+#+.0MF@I$-C4L&4-M<G[*PI+A9)>T]B
M"^O\0WH=C;;A^;<\IT68*6/I+*(4IG>/.2I!Q#?W:$<^17\IB%XG/S]7I)+^
M]L=?\5]6Y),]2-9D((1/LYB<G.:\\V:W<,@98]T*BY!Q'NMG72$X#_F0=VKY
M151QILQ$_47)2S_N$?&2/Q9+$FY=PZXP@(.'*L\%;G[T4O@IJ[;%LGBFJN`=
M%C_P!UV[X<+K>VV8!PX#?6L`!CL7HQ`9[(8D:=B="2_$SRP&T@11@[;143M$
M&J(/`M==Q>1'QEZR"`:,-M1`/S19&R^2Y6F/8AS-:CU-DC>$BJMA6*@PD28%
M2L)8L@@6;`;40#>0PQ=>X"%ZDJ'Y#*<ITM)CL1<N?G#RD/31J]/M>]-O2/#,
M\\,^<TB'CW20"I70X&&U'Q4C/;BQY=ENG)R8M9.FR#G="_`F</*<>=L&O>'-
M?N`6$BW53>W$PUG94^8>:.2].?<E$'N\I-,$-V<<^X9X.50Y&M,[@1*H;",>
M[F+XH;X$4CYBC$!EF'%.Q.P[<F/ODD)OK`Q9LI\<4\6WK9`'2;]OT=VW?/V"
MO]B4VT<I=Q2[4.FYLG4!:)HXI4QWE"Q\)TRH(@R:O.)+<OF*,CC#*4:0U/2_
M\JQ">;G"Y_O_UZ[,D;>X0EAB`RW(>E^^*UYR,F1-A,S15^B-GR`C"!N?`$Z4
M'77F1J'=KRV),V7)WG5.&?O^=44V,%24B'2!:!_F`#;G]F4%P$2WL:/.J/IT
M07U"+K-_26%]&29MVLZFR1W:TA)=B,.<[07.-976R$*0*<2-3``_X@Z=N5'T
M4_CT>IBR9TL[H4QD2\-=Z-W2SN5KYBUM?H!);&F'SJB;"BXX!Y`IZ%]23$F&
M2<NVM`ERA[:T6!/B[C"L#D:4IZ^RAP!%AC`W.@7<H.OVYD;Q):4S<'%ES;YV
M1IK`QD;[T+JS]0G9O%N;%3@3W]RZO5%-ZH$FA81@S^["$0JYM&M[FZ1W:'^+
M=.'NVV8O<O[L`;,#/:8P-\P^/^+V?;GQXJ?P[9_S9,^N=DR8R)[V;:-W1SL3
MK9GWL[F1);&7[?NB.K-Q<S7I!#]%C'J:1\OVL7%JAW:Q4`IKY)VFM]^?\[+.
M/^8T-NOIN]4_.K92#$VR-8"7TW9NE%R4D["??L,[3"\1/;L)?>"N^9"D7_"6
MQ&5;<A,[Q`R2/*7Y3]O1<H,0GP^;<B%VUQ85XF<.C<Y$&92^0#E\QVD??5J3
M)Y*:3/*/F^V7_#G#%.3K'Y_SYTVUS5>TVNZ[HLS*99'1(NS-6TK7CN^Y^EXD
ME:!,#B5JIZ3%D%ROKN5VDP+N=.\D\B2F31?[^T2X%W3H!K7]7"':TPQ`U+(A
M7380SS8SF5[=((D7=N]M*M@SLM4I('0/R&56/Z*L7*$5;EIS5P/YU%13H!OI
MOCA:4V#*=T-]A?C&1I8$#Q=/>W",M7(<)X92NV'C`+4[<8^?&>U[$"]%:=L"
M3C9HWT:PNEG;W2=,WO:F7+W]UZYX)IAZ]>,.,T$+*F/AT%>^F($`-7+/Q>&I
M^(\U=A;1HEDF6EM]$=H=G!'FR108>`G;8^(*T:94\>\;DRK?I+E0C>]!DDB/
M36U,WPWTW6YE($`3/,8XG(1'I['C!PNHX14FL&*7L4EP\S0;/"8(&X?'50,.
MH6JM7Y:/^6JWSF_O>R^BWY'W>*[]*-*7=L-"@1Q`Q'AL$<+4FA1TA'I?$3SI
MZ-F=CRW.E&Z,"%.6MBU)*:F!>B'H#]J>]YD(8I_5G_-E7KS`\(LPT)?Z>3J<
MG/`S$$\D_?PS^AHCJ9?N>$WIQM!>AQ4K^=J/P8R$I/`=JNB'^4J50.HI+6](
M(,]KQY]^&GL+N],5!RC6K33[AVV%[/![SDKNF_+A+J^>/N'1'[$6?;UY>BJV
M8,Z_SK;YPZ;Z<7M/"A.W7ZRHA>^YOK[3IB!1<C*K;";V]>(%.W06S@(2UAP?
M7JJS5R<KYU,WBE02FY+.?L&;R!-J/T:'_LB)MNV1F"NDS_UW*Z%S[C#Q`Z0W
MYPW/[2UTJ1NLHT3I`BOG3$R#=;Q#Q_=#J/+N!"`7=I>]4<KG?&#E)W8<K%>C
M4!5[(V60^+Z$+U+&QPV"I"\P/U!RD'L`79!CYV<:;4-]D:NWKNN#B0U^]L#N
M/"QE/,Z',CY"*<+0W=!VV)\IS%^_34(.&4O<7@ZPSHO=BBYF`(L)N:6!W;%R
M93RR(TNN(*XJ@@%A=`][;A&V/"#L'A#VU"#LN4'8BI2RHE7H..OE2@AF\I,!
M[:PPHNB2AK"D\+QS<*D'.TX>.3QRXL4255$K4C:1>^RV2!81L#X_BBK`**GF
MII`[8?ATJXJYI,H.7K-@`??5+_7$)<:J=>;@.+W"5F'[U+%I).HR$BV!H@*3
M\6C!W04L.,3H?+M=]ZI9M=:`'*=;V(Y$RZ9?TZ!D>X3A4C%YENPLN=X0B6R*
M;@9VE]A1S:KVZ*\&HO<7.4DR0_<FIZ\99T>E$H@X]M4F4`4V=<4^5/,I#+OC
M4A.T.B!XQ9KJ@('=&4):^+7./F4@6MQ(?2]1MD>1&&O:&ZV#J_PN>28)+KU3
MCR4!;F4&=M<3T<*OG?LE`^6#FR9G*7%%TJGKV&@=#!4<('M6UX/5A>2YP.[<
M<RW\6GN49"!>_#Q9E&A+M\\?M'M5R/U0E#D)XI/L+(W5)!D(T`79$0ZG87EH
M3-*:(,G:"2%3PNY;4<(\S6>5CA,VD4/V!VE-\U'4Y8I!>CT6&WUE?28&UP6*
M`<ZF`='<.,#K`S66G`C6YU*/;R/\S`>$8:*F0"!RH6.$CLV7W?/SNL#F[$VY
M>KTIMU6VQ`+8W.<EAD[?EL%MT(V/HPT#O-PQH&.\2XC[0*Y"`&^^6_Y4K&I6
M9\24"+T3WHZ[#=IWBG"OZ-"MX/5U>6F5/EW9#4:>,Q73DD-20P!)#>'%;F-"
MK,Y_DA*B6P$JE9V?6.56UO5H-RHY'(Y,*Q[!BD/";'BIOD8Q5F=V,PH1G1X`
MEZG8!C]O?F3K[8]/V0]J"1,YZRM1-("BX]9RV)BDI)7XDP_!_1/#/#5IJ78[
M#-@8T&W`,5&1-E^AYC,UPL5H.9F0KG,KIW=>((,L;*+C=B?WL3%@RB)AHF8O
M9L_-9VKDC,T4,"%F9]MVW[1XD!,50IYB8'?:&AL#1K98)E+V(K8NLJ_%NM@6
MO/5MW^15\8)!\))WZ@=^W&S?Y'7Q4&9;4BKD;_GJH2@?.A_\FA7EATU=DZ*[
ML;?0][R--'ERDJ]A=EJLR'>-CS113#:U(';LM@V4\VH$@:JI3LF?T%_6^(]_
M143&T&H_PFRHU1*5^&E0>V:FRW?M1[1Z)98(N^\D*>94M^&OEMSTT!WJ?$X+
M6A]Z1%F-FCZ[7UTA`#KI^*\"CRN\VU0Y'@$R69<_[JJLK/%I&`M#2^ZK_!Y_
M<Y=]OW86WD)?K2(.2N00*\=R"TZ>7B+\?U;CCY\9W1#CIBAM6J"V">JT.0;)
M5]H2X:8&L*+%4K4;*V?F)U<O"7EIT[WV'2\*%M>>$_@>R0[$/]@=\%#'I!&#
M4QFY>^`M6^!M25]KZNQ`J^+^/B>_)@\!E;R[T_L2<YC7V_?E<O.4OVGJR?^C
MV#X>5:(OMCLR6(V%K_^R@QK4<5(CASQYUEOT\?:41)'=40PQAG3O6$)4I6TK
M!,VN4-L0?<,MT;XIZK8U!"(M6]=E@.AL"^/MB62L+_!I/'3B.`)5:7?ZLQH&
MC6Q=2D@](*^@W2"R60D]6-)V=%M^>=Q46Q*J?)65_WQ=Y:N"U`HG/S3OAD'"
M?=\9:L"SSM.W&J@(<G&*$Z9NG#CR`X?6=`L<N,=L^?L-*M@SM1%)T'@`QVV)
M:"^0PD*:(NB(9JO0G]\*O74G)F^,<4_;87,>,^5?-'@X-H#"I4YH=T15!7NF
MXJT*:#W@!^\J->D%\J"_$KPL`3\D^83^W+X5R1FR%9.\PZ6DBP;0@0T1`-$K
MPM@*N(QC#B='##!)`"9E_D`\RW)&&!]U*=TQZ"VRNN8_ROR65?_,MR1&_25?
M[BH:@F[=%>0U^V"A[?`_-K0<`CB9:@5^O)D3A7874F4A7[>EQ$!#>O@&'3XZ
MBKKH$&$M1^^Y1?CL4#W>+/:CQ(^N_=A)R*74A8O_'_3()4OV*%=&CL_B]*4=
MJ4=5OJ9QR>T&/1TP4N^[Y(/%QTVY:5_^@7-]LWE<.Y[K]U4?58.)P7'E`,'#
M3HN&X39T^NVNWCM-/(=LBY<+G20C/7A4B\;CRAV5>(.;82-Y^7JS*[?5CS;;
M/()'"/2DIO4-*9FXPL8%D<Z!3^,(ZPCZXEW@T7QGU^+``1</VO4P#S7I[V5!
M%.T7?)[-:Q*V1C>[[2.=6L$["Z_R,K\O,`JJ'V^)'8]7JLX_59N'*GNB#Z.0
M*[Q]MO3`<7&J/SE)%:"VU:G33=TH<&F*J^O8?;V5EQ7=QC,G/6GG>W1H@)H6
M0B_GC)'0/!I"1(.C%/-TC_I$>9!B%F%N&Y,YATL!L=T&`S\S<PIT+T63(BWT
MP@QTBA7^IQROV>JW[#NIKT,+]=S>OUT7#P5-OO]!J>`6[>E^50BX$/7'8L[0
M!=TN8]@N?5`TKMU!5EG6S$!`F+YTWQY!!ZCI`>HHHMM[U.E$-RP88T6VXN(\
M1L2Y.@ZLC@NK8[?/1)8U4[$A23K3N\<<K8NG`H8GKY)M\6^^0J_H&4!#KVN0
MW^?K'-)721TUSO`0O\"QW?6S%2YGSD7.I8(0GN_`4EV"[23.FA$WHR21/5#I
M@PE!!OE;"Q4]('FWJ5YOGIZSLLCK]^6;_"5?;YZ)%KFI\HS*(,<+?TH&-0,O
M7KYYL3?>/Q:(R$L@-\7W0##LOM*KE6];C#\1XODL0X2'0/LQ2#7NSBB(##,K
MS!4;EI>#<W&3=%IF_$5C+-'ZLZYW"<XX37S;9LR*,"%CZ:)[#/]5!_'+=G1-
M-C"C^*LUD"\']L*F-8O@-':?#X)C]Q4OK7Q;992+<"!HL5.T[Q%.:H=WH9_A
M\=`-)^QWQ9J\']!$U:)(WY6PXZ$D43M.]AY\QY_%2:-Z0X@76GYRG21>NY4[
M14':?B$86WV=5=4/+-/?LFI%,F7R&H/I+OO^:5<];_!/-U]K6G".!GHX*L6Q
M]BLGA!+4MP+*W`4^^./5#&#^:7T^U_)+4K*LZ19N2?K2;GL$'="S&,DY:/M`
M?[2]:`<&XT'+5F2<'Y<XUR>$]8%,$,NS'F59,W7HD:23%R*<)Q9^(6,[E-@*
MD;.C!>?R1+`\,2R/W;:/+&M&#@B21/;!XW^KS*[44T+,=';E>:FOWL_QG-I]
MK6^,;-VVSLC8:?LW)<F2;[-JC4^F6]P7.2COES+H,][5"&3OD'("R<A%*Y#]
MGP=A8K=?=HQLW0(Y,G;:_HT*)'WB4%`6[^^)UX04GB/)Z[BWS]DV)S7,BW*'
MSZRWD/Q.ZXLL/'U^#W8Z)*56@M^]*+/W$<26%YGBYD6[T',2E.X;-!5O*")(
M&_0Y)U-4K`OZ_14)%"ZQF:\=(%HN;%@,D#.;FZ,/:O5Y]+F[(("TIMCR'4&:
M.2-VMS29'6`U!6VV&%BX#>>+`_V$'&/S9OLNQPN>K<F5E!T6UQ]''U\3P@QO
M/5P$ZH"<Y`R-8Y&O\R"V/(ZFCLEYMC<!2CGVO6R+F@[1OL?31DIW1S'1-;AM
M7BBX&3=:KLXCFBX9)PFH?PB^1G9GQ>ED>\;-60D#Z0'B@OLUMA"V/YK[2:3[
MT6VWSI?7#YN7_[7*"P`E_L<I%O&OCGJ5!-0(?7M<=+_QZ:T2QX-W1RS/`YN@
M7/OV-#I\"G\6O(>V%]^]_PQN=8:A/D=L_YAR`LC*QZ&05._WCI^X#7@A7AK9
M[9KE84.WF'+0DG8,G8[C5N!R\/F@[27.T--W.AD:5;4,#_$R+,5-"\?W`TAY
M@4=*W<CNN#(?(^8E>82:`5F6T\8?BC)_O\V?H.H!QY/FYSTHDLDQBL[$\?`Q
MV$.0@A(T\?4+4:F33!@3PRE*NB+X!_D8T:\5"A]S159STM=7775@OB"]`]ZX
M<Q=V'Z/8F3"52\-,D6(QO-L_#=EWWIF2P#OY1RHG*3D3//@09@?VB>;MSMC>
MDDGL#!C3=V-4'`D9_5"1?/&J.(T"-J+:NE,#J?DAU/..[<ZI96/`N$H;HT:!
MI*UV];8JLO6A;$R->VNN9[S>E*N"!GN:"QJ-LS=[R&_O[TAUO"_9FI9##AV.
M#'(UH\H*MB;.#WA0,@!<<0%S*H1KK)[MFEHGX_HUO$;JTT/OG3I-4$JO&0`=
M1MA?33Z,0>XGTU$0'69>L#-O1S\?VONV/X5R`]FL87.)U?9M4R?CYK9;C5S0
M"XE/#9B?#V`F=Y$IF&O2&&T?,_((T%Y#P&^768F^YB@KRUVV7O\@]Q*I-)!Z
MQU6^S$DDE]Q<)E&;YIHC]P,.:L'!=A/@9U0+/:]U*10KJ&41-O=<;?>6ZF3<
M2+!5*PM=2R#O6`++?:]7TQI#%\R+LI>?S_E+7N[R^E?<@,2'5^\PD&[JYWQ9
MW!=+J.9.L<#E##9`E"DEH7;>^'6(S/@@IA`%"^$.LF?W-:99Y\6>8XAZYGA/
M*4!![RFEI0+MR4"$#K0G!`$E5FLRY>></XLJDSDE28NUT[AE(0KJA?_694/S
M8M\92SV3<`1K-%6?056UFHJ>PIXPH>34];!76[1D3(;V>@N>FM%VTE*"/]4'
ML3^+WI(XQLE+;N/CAT0DS_97:&><%\L.@>HY9#HCLJ@TJKL>"OQ3H[;FTEJ$
M!&"Y_73SO%O3W82BC^M!:@-$V:*U^.9-O=8:&Q]D%VZ!A9#OX]F>/C7CO%S.
MP9&?.2T'1ZJV@(Y#BSTE5FLRXP?'GT65Z3PX3HLU1&TCJ`#OV9Z+-^.\7-[!
MD9_)XX/C_FN4/9%R+VTYX:YQ1>N(?GLLEH_T3TP6VMZD0T6-OF9UOIKM9,D$
M4-,GRY]%L6D\64Z+-B3#1I`,Z]M]GVW6>;FPDR4_AUPGRX/.PWI+YA2)QRGW
M9'_)JY=BF;___*6I3^3&D<[[?*.#R^H03LX.X!]OF"2N[?X?%@;T'WD8J$C;
MK]JC!6J^0W_!7_Y5L`P6Z])KJ5%@A5#W[&CC#4G5&*]YIB&"S,C(]@PW(8X,
M[2(BM&D"0UUE^;I[)[&5E2#N>\-9$0H&1I44?V9>]G(_U"(.%Y8''\<IUZZ^
M1X=/X<]*"FA.+JH>-3V/@)XKYN$6D1]9?J=@BG8SRG:""I6R^B';GI7P=)-H
MJJZ*N)CV#"@GH4P<M,+9][&S<"U_.WR$:MU:<WCH%/XD6^'U0_;MW:9ZB^=I
M\U0LW]Z3]\7S<OGCYBDO5_GJ0_Y0U'`N?/_TO,Z)=Z\H']KO/V&B2<'N;YN[
MQ\VNSLK5QZ+,;\K575XVE8BH,<*1*JJ=(%EQ-S]?!_3H'IN^C;J`@$\$6<RA
MW5&^V>9$/_+G80SKE6_TA8FV*W08&S6#H\[HJ#O\H1$A`!ZJ^+9!+0V($($P
M%0B3L2\N:*W"8@SL_5MCG4^8:975N#XAN3FT.Y@WVYR8"N3-Q2`-XF6-BMHV
MY0V;]_ZJYPW]B6BA*L_6:)D]%R0X]Y`594V_SFHL*YN7@K3^5FP?BY)&]MH.
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M`,IT1'!MU+4[)JJ<5R.'*M544Y`V$&Q!2AP[>(7:Y.Q!J"K`X^L!RCO^A`5'
M;5B1,32@D)^K40!.=4=7-H25C2%)U;$[\5$EF[-8K&*T#AJKZ/6PM2H6S9&3
M2QD3U6*X,1JF3(L;+6!QX>$^Q^Y@KDHV9S5'Q6BFF]RPQ7DP,5O+LU9A:S*+
MI829:3'8V(Q+M@6%6'H,M\H<NZ.0*MF<SZ04(W@<:"HQA>EX^SU_HDL-E%')
MBU79BN?]Z\02$S=L..KIBJY5`&7*8DAB=^PN?ZF*Q7EM0V8Z6>Q"8@;N>VML
M0U.`4F(.VH,H7C-P:!U#\'C%$'ET[`Z8J6+1#O./F=X^_P9U0A[B`V1[RO?(
M&G0_HM4N1\7V?]:(2BKYMI/,,H#@__'J?R@U)<?$6H49:0](.<W'08&`[(`8
MTC`=NV\2J6+1`K.1F=CTTQZ<`Y#DP\_M,ZD35I0/'S9U_3JKJA_WF^I;5JU(
M@-X/]5T`&1Y8#D)<#+5@&6ODQK[=WL%IXG7;=9,4I/LO$/D$'7VC7F"U7*R;
M4V#/M/MHHT6T\$!M-._+VJW&N7DQHJ]YJ4H_YENTV8OYFHCY4H>8O_W^7%1T
M,WE#/0N>'^A[UY>5#%T0F&1V&A"G7;BQY9%67E;FT^Z]](SJ^BMT:(/><#NY
M^`7%\%8P+RHXMHF3+EPW<A=@9$:7:NV,LS3SIC%*'-T[[G,\Y_A$W+>'H*8;
M;.7OT;/B1L^GK,)G\]>;I^>L;.^2>TGO^REJ<-(SH!PDF#AHA;_O8\>++"^/
M,4*U;D4_/'0*?T+-WP3O>(^MGA8];53^SI1O[W32AU6I[>C`$RB.:W=\CH,+
M(RJ6G9[TTWI7%?4V?T)WCUBG/N>[;;&LT?MR>2THP5]V7^MB5615D=?-V($3
MZE.@Y^/)R2\+_:WX]GSKQ$%@=_&L8:)U*\_!D=/N7P3ECA2!(=?`2'S@0_:M
MN1+6!)<_88'+JRI?=2H[OLE?\O7FF7Q_4^49*<Q1ORM>Z(4PC(4\N]_20C*A
MZ[&'@/50(2?1QF:FA86F`6GES"8G/(:<\,#NC<'L1.B&KU%N4EJRJ1T.D4H7
M;46+-GT1[<<\JFW?&16186G)G1J1@:&>Q7YHNQ0,8TC\SZAASL/K6F41`DH)
MY""%=E_7,SL1ID+U1KFB`?U]ZF;V_+PNL$IIHO#WQ?WVD=[ZOM]4V\=?'C;$
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M"'=2$KB3$MB=4&1F`B[GN#+%"M<QQ:$Z!O_#M>*`<H?Q3[A[AQF`G''#9Y0N
M`18HB(GY4*HCCL:BHA7`U>H$[M=8'CLU-@<7<5YA8$3YD86.20\M9%1KM(?)
M@\M%J`]-QY<>D8.GM!+(,@_LOH5L;`XNZA##P-#H.6;[6%2K)D:SJ[://],Y
MIA]=!H\R%Z%M]!QH>N32!;F$.O:!W?>SC<W!Y1QK&+CA.MEX[<G&-WZR&0E1
MNAK/,U9$:YEY%U8'8S&[`&K4)%#Q,+`[5UXSY]:=4[C(%S^=S)53-B7YNLXA
M%P%[!6>.4?&A.8KA`F+U@=UWP#1S;NWY@HL-0YE?NL\-4[C0=%JX")T@?S(8
ME:@F1-^D+=M=LE,SYW:>`KAXD$J^,@'RHUB>PU&:4'*X.4`]QJL<F$^"6UZS
M+4!"L/^3>1#9.+;3CI\B6]9^-Y?_-"316NUUV^"KRCX_#4XO0"P@.&WY*V.:
M.+;;'I\B7W^6DA$3O$?D=9K>ML%;D:E]*BPN"`MDP?H_H[=MDF.+3>LIV@43
MA4S`]324Y'`\"R,_XAR@G>!8#K?GL17?!V&`;%3+2T3J8]I.VYJ!<EGSVFBN
MSHB`:S6R[<2T*E.[1TH"D!((F/H_H\N+A6F[#6X&#O1GU!BQN?O%7Z?9;2?@
M%1G?/8+3.%T@I=/_R0JN,#-ML0G.0+Y@4HL4@'\KRN)I]_1_=MFZN/^!E<;[
M\B6OJ<*XH4^X`G'"-O=D_TK!*<+-`!2GNZ*+&#NPB)`#&5[4_1EA%@W;RJ)T
M]EC&35?HT!<Z=(:@-U-X$C-XK074I#'+MHR!T_@=(=X77M15$V$69S)41>FE
M9NE3@Z7FJ6]X72<KT5>R19%N#I9JMOS7KJ@+6NX7FZ'/U6:U6VY)7E96U_FV
M)B_UT`^/$"MGFG*(KI`A:BT0IXQ,UD5OU"GDX847%7`59G$.`U*4V+3=S/YU
MV,R*PV:6B6UFS;N/-\MEOB;UN_/5F_RYRI<%53C$Q*7'F8C+(ISN5!HL0G1W
M$,+0GEH9#DU'"1U(3_.MK\4@SI<!*T^8.&K:-:U1ISGJMA=X/IM3D-A-.,L0
MT&NL,:]&#*O1A(^L/_.(\V70+!,FDMIBX![<HF^/Q?*QM<+P]*_0=H-6;4=Y
M$ZK_CG]/#2]ZG8XX%IJW>]'SKGK>U-SO8'-*'[.]91EJ^BPKYG5+8-V:M"CK
MCS7B?)FRH80I3+L;QJJ[850B&P8\9'CSO:BO`]?O*Z6GIH;^T5#2<C]&=4>\
M.Y\Y<63_Q>US>@V8,6>#4O.D>>#R#_)[_C+YT/K-YBDK2K)"?>5/%,L5#*9(
MLH8H/Y.MYD,R<=8G!?91;$R^CH8]DC#X"[^,$1W9:-'Z;M,\17+SM=Y6V9(Z
M%!9\Q[S1_J3EBI?:CJ2--\4SBA<)<J(<2'=<6%^.4X@E`[(J0E>Z3U1I6Z*[
MS>&-IK:U-@%GMD>M$/`^*Y1EUCV8=4@<6ECON!!BR93M*4)<UV=1_V\A6:YO
M2`;(,ONZSOL%).36UV-=*I%H3II/A'JT-7U9/&G,^P#2+*S/7Q3ERI#N%B!M
MK[YK=&BL4(.S21"[+\XBL>_UP[$L`UYM",HY\$Q<8GV*GRA7!GUP@B0.RC_Q
MS)UC@-^WQBY/7):,)1@8LF<85@)"8DX$*V%]UILH5R:M&@'ZTJ[4MU#@-7"^
M;>X>-[LZ*U=?\I>\_%1M'JKLJ7F`D,@*3[VDL<XD)9N3SKU,C[=SH\#SX9*6
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M=?YTX"591%$"_CD7\GT6]J8GBK)C0G,+TJ8GDJO`>&!SC%ZN<72DR>\>\^6F
M>MZ0=+9M]IW\I[DZOMVLVGY76.M4Q=?=-E\12JIF"/S]+SD=X[D9H]F'(>_4
MA;Q3U]YP@QGFM>\@1M@XLJ6V[07C38GP"*O&F"(=H[9G=.@:/8L84XS^4]9M
M:G9'[\D&->V0A)T_MC=6P<6#D:V(@R":#+\WOG[\SQKEW_'64Y/DWN?&9[:Y
M1V1?>L8#;=&WK$;XMR5)!2;)\34F<%>3;S+T/V`/6Y*>.H5S\!*5J^:^XO^X
M6>-?EQF]RWB'M[9__@_T%_H'S'G4NNG^QU]Y8WYLPL<8[9L=)!$G1B"R%%N\
MQ_#PH'^KX*`F[<IE>]KX_^D)?/`K\=DB'X-J?-`_'X-_WMXT.CXF#"OR:8I.
M-#EZS,AS7_>;ZJG1U._K*LO7!5P9WVT?Z<S#+?1B2S]?/F[J'"Z@D\I(M&0A
MPK_/2I2O\R6]\4'_L-U`J:3]5M%L$?WZ?[^1M(H>]RJJZ#_M;\+?T(OPGW(\
M?7AN'_*[(J_HC0)ZVY<]Y#+=HQRBA"AN';8,C>E=YY@8JHX7@J$:VPLR.:9T
MAT6$*4L/+1$T18>VB#06NM;"(SN,FX=-XGX>H&!=`.I'P0L`&?&QO2XK.:9,
MA1R$*9Q%[IM[/80$CMJV+'WJ%/U!JMEDO[W,1)?!@66`3'F+32I9MN;5]Z.T
ML4B^T#4S/BE2HO7-"S^OYN\L1;AHE@+*`":7K/O'V;)#^X_2J!,%SYN*L'.'
M#RB?\W_MBBI?'0K]O*(E(C=_S]:[_/;^A`/8G;BV!O'!I&&CE,\.G"3ZI2J/
M1+S)8D-MW=CN#"PM_!K8?I03G1XZ1:17U';;K=OX"@J9;Q#M&MW>HU,<SX)6
M]LWLPN':N_U)BT)S*(6D/,O3XK7P:W##5$X\==]U"M,]'[;1I@[Y"\5J6Y2<
M5B/JEI"DQ8N*$JV+?-=^-5;H[J24$3CM()K#[Y-3`0JVX,SE@__L^I8*<4I`
MG*"4K\6!(&W\:@\:Z:*<`K_,OQ$O>;MQ4UP3`%?MYMV![U>Z>3<N^+U2."L1
MRQFBPJ;Z;9D?PCQ>7UVFH8!4M[%D_&F"COU%FZ/OX'#BPLQ"XFMB>6T<%OIU
MVY\L1*3T$$>>E!3,M.Q?4-90IW;)ZKE0WC,K8&5'4$XSL?LHQ$2_*5.)A1@5
M(D9?B^BL+<_EU^/F\E(V3DM7S+I?TKEQP,$>07ZH[1>TV3@PH<6FR0`A@[>[
M%(L9AR[3+V?]^NQ\?D#/1RYH0LLOH[)Q8%*G39.C2."^;3HKW%?3<$S:VL8*
M9&V$CB-!VW\'NCZ"68&`H>VUAECH-Z+-)HAH1.O;1JU@\>@QK9(UH,-.9@4.
M4E$3D;/[R,M$OU']-4&,K(CU'X'K5_G]ILK?MGEC=#2.DIELO<K)I##EK:PR
M=D"]`4$#;0BHQ?9>%91G3+?BE*(N'0R$D*1&T@/:=Z$7"(Q*V$8DG*MMGC4)
M/5B3QC%F=^%L.<9,*7HI*JE?\BCF<.9B1%\!&OL\8,[``:^`L44(;(3&F<^?
M:VE\6)HFQFNW8U..,2->?"D2FYVB]U&V4SCPH>%-\Q`J>>V*]O=KM:GKZRCV
M^RPD-:43^L>4PP8K'RT4!K[W'<L+C(S2K=O:&1L\;?\(5SWHGZ\0_4"I1"8_
MB40FC!))BSEZM)AOX$;@Y[';3.%CA$/Y;K;96DSY<I&4WI&!T*J59Y*N<*QK
MB8$"3]%DY!'W#$^:I(Q_S+=8,L*^&T2:)/RC;&("&P^#TDV^]AW+'Q,9H=JX
MKMT/W:]I\9^)??#WO6C>:!!-,\I7KVA.*U[R-54-O@^J(0'58'<$EH>->93N
M,$$ID=YSA2LIN;?/Y/6PHGSX@)7]ZZRJ?F#M_2VK5O6;S5..3VU++!1!8$[G
M3A.D6.Y%9F`0%@R=^8YG=_18G"GC^IZ5LO[M8-\:D>;HJ/T5:GLP!S`M-?@N
M"F!GWAB1SL!B#:CZ]!Q0GW;?Q%/(I1$_C3IZT]^OOURCDMAE>S"N"1B7G4ZT
M(?`=/J@4#R46OZ@O+<DX`!MZC.%OD'\!^+5]^4YX838@*T\6[6Y'A(EL;DT'
MQI`U]]8V-[)D-K:V+]"@(6A0#S2HW7=LU3%IV[8V3F[:5O31N['A?[2_>_O]
M.2_K_'->Y]5+7M^4JYOELMIE:^),#?L>[]`$02::%,-0<!X&H<C6G^_X=J<V
M2?%E?+/C(*Y_PR/_WO^AZ>(*M9T@\N1(VXU1W)G9^NS'W?06R-8?J-P85&X`
M*M?N]"RUC,ZS%<J0G.[=[`##JFDI"<.]&W_?_764]#ZNI@ESYP0H!A@+AX-H
MZFGLNY<6%AUDPOC^-$1)_V:D/L0T(@N!]].+^X%%#GGWPR:4TGB=FNCUA853
M>?AB0$4"J"CSAVR;KQ3M#APTIG^730QXG=6/>-,A_WG[KUWQDJWS<EM_VJR+
MY8^[_/OV%?[HG]=AY/==E%:##282Y-`AR&4+#[;FKN?8?<&,APW=6P('+2GY
MB-HZ]!^=SZ\0-$!_-/\E+1%MRGF1@T]`M)Q"K(/!V1F#K3G15!YY##Y.D@`"
M[I[=1PHIOHR<(&0H/,!G2?Z1']JK@`@^N&RK8HEWOS$:L4Q%^M(>9"C3`2C1
M.1G'&6.OKF=Y76P%W,VS.?&0.+9G'?I!L^ULG")J<,.[&-@R;H^,O1*[/@A\
MDF'C!`OZZ(%/2X=X_D\,YW&N9]Q:5="?=H"^;(%>/VZJ[2^8WB>TRI\W-?=+
M6>31O"I_S,NZ>,G?E\O-4P[$G%H#D=/[SKPB[#)2(8E385[WF&3MP4U"RW'&
MQXGV+9*+G/3H<P3?*]SC>.5$SWYF)R;.]RG6'K!6B^C+M&Y$:V$G46!W-I(D
M9V;V&RD:3X!4T/:\8"E)R=6*N@T_%_4_7U?YJMB2?V&9<?6%?$8&EH4$!T<'
M%`PW<A/+7YN8)EZ__I^@(#WZ`I$_7"'XJ/E!G?:?7GY-"G]&@>Y1Z\.-G"#V
M`^?:#[TXB*\])PX<_)_0"9M+B+[=81Q9U@PI=BDB3_"RN4=+`$N%.^`&1(TQ
MM:(]G9L%^+RB4<4/CBP-"0Z>.I@8;N4M'#+[0>Q9'K9A9L*`TF>C)#WZ4JFJ
MGY8"7;I^3LGNT_:#K2(2`7"2>$$R_#PONO9C#Q_#KCTW@$?-\!I9;]_(<F=*
MYTO2F7ZJL!%?/*]S^KKTLMLA;Y)+5;S0%Z?/`D-X\]%YZ71H7-F,%G9^#GDL
M@VT<+TY(3,SW?%*\=!$F+JR![5G_0ASIS^@2(2OM-%.W*3`(BJ:TX=D$OR?]
M=W@]$M=U8A=6Q(,5:=2/W6%Y89Z,J'Y1ZCH80/=%F6'EGZU14=;;BM;`XPP'
MO,VJLB@?R&MV7QZS*C^E)5DL]&5N30PN!P-NSEHL3#4,(M_NF@%L#.A6\4Q4
MI.U7Y$%$1+]3I]A9)4"+=K="ML_T_%1#D@+D!S%-`8)7M[#E>='"/L"1$1TO
M1EM*[P@_8SS4I!&?S+_+BJJIW/BNW1W>'S:')NZ<A&Y?D7PUDL]$@IS\"W+9
MHH"MN>,EK@.;<`B;L`^;L-W7-N29T[TS2%.8DA[0OL3HOA/4Z47=-L(G;%HV
M$^L@=;:Q,#6/&M.V6=8(EC6`9;4[A*"$/R.;C@I*`6#[LM8*SAG-'?W7NZK*
M2[P'5EE99TNRI.3.(OUQ39U6YZ>AA9OH*^TK3)<DVA1.QQZ"PGU&46#WB4:6
M->T[FAQ]:=,>M1V@;@\T[Z_;A[J=35X*]6QW%PO*\WU1O$\2\_5HS#<,:<S7
M#6G,M[G+[=A]+M/+N)F=5"<+Z;M=N8050LL6]LT3$E]V7^MB19Z:YL/S^Z=G
MO&^3W?FV>E/4SYLZ6]_>?]B4#Q^*EWP%UT//95?G/7T1DN10K&@26@`+=1='
M"[LW5`FN=.^EXJ2EAZ9X[E';F*"*-/^%MM]7!5"UB<K)FY;]\])`=[9KBG5'
MO&F.1[UI\$2;9_FA4B6;1G9$A00?@?4>K0E`UQ2@(@^S0R+T7?;];'!G$6O<
MW0:&E003.S-[P`PU21:.W:DZ$Y1KWVU&AT_ASZ2:C,(-8W)Y]6P*,\GJN7(?
M;$(41;@`11&"HK"[JA\O*V:4-!]1K8QOL^^\5<"(XK_+JZ?#1<4W<"?Q[!)7
M0$X^S`^8LO8K)[H2U+>BS-P%G?I%"%,/.=NNW7I9EC7=BEN2OI2T1Z2#[GWZ
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M$*0KQ>W0H2$Z;JENPQ`7*BW;R*4@ZFS+X>[*=;W(<[&.=..%!X5C[`ZC*>+0
MR.:DAM;T<TYJ/0S"D`]IN.ES7FU_?,(4;V_*%:E3]TRZ.4]K6;CZ;H.QDB&'
M+`EF6T1Q=.$F=A],>%G1O2=QTI.VW^-MA[2@J9+[-NKV(GZAT;('V8J0LSV'
MO0N:&^"`00Y/MEE^O4:6-2.[C"21>U@=XXD/,^1)(CRMI/CIF_PE7V]H'\U[
M122!\M<JZRO9CTD(V4.%8J/(`4099RU<!#N$ZX,N+!XDUKAV@T<MH[HW(Z74
MIFUO"#=$G?[:Y_%J^@?H$IUM6&:QQQB,O$3PG0<JI989TMIBR*9P[3XGJ674
M5!!3*=7IFT,<<W./LL/YJ8ESDJ!EU2*5['ZK#E+S%JGD#P]T6,ZPIJSTL@4Y
M+Q&79S:DU+K[L.YPV\*UN^JP6D:-V)=*23[LC-G)SMB#-UZXO>3E+O^<+S</
M9=%7(,\)XE!?/<O)\64QQ\_>`5Z3;<,PM-V<9.1!OZ7(1DC:?(@Z7ZKS4G"(
M@Q;WA#W2WK.93+:EH<'F)`QI'+[==5V%>3*T18A1UP<11(2`YI+A'LB.@&X>
MJIQZNM&W8ON(?L??D4=?'_,J>\YWVV+)N5%\P8-6Y/7+3]FY!QX3UA>I'3"^
M1KJ2DW\^&EO)'VM%]^.H.:DV#[[9+?,"W.C6_?PDI?LF"+>1/>LSB07C@7Y>
MV3T_FD_/+1B329/+87=*O0`WI@[9_*1-GJ2K?$T>-4;;#:KW\OZ<\28",TD.
MV[%X7ND^LTFFYSR`.8<7P2PO-"S`C1$[A)^NCGK&XLHIK:1BWZNLSE?DH1UL
MJE`XWM*EP<?B]_2)AN(E)X&9?5):&#E]$0\U1KD`19)@4#(%>Y"(]!8O',O!
M(LZ5=G-&F+24-OWE*VF+NHVO$#2G;IQ]!S1BKZZ6D938:3D.7Q;RSK<G(4$@
MX>1&H3;A9+N=KPJY-+.=*:,W[22/D:A'O<6@:]"[[/3-"\--M27W9EYEY3]'
M+CWU^5R'S+;I+F5Q(T+S`2?3K>G+ZA[<KTL@).S8?;-=@BO].Y0H:2EM"K=^
M26-U]WVY1(CQM&*5V/=L#VRKX"_`PY<TE<_LOM(BP94A]2]*'\@^W$C\2F1?
MZ"XBE\RP.IVL$O0>)Q3SG#<^DB;;P')/JCA7QIQ2PB1.WERO^\$@>6G]]SJ_
MO7^+9?HIV^;UM1,%B;XK7L>#R2%DDO`6"Z<?)B$M)!/$EIOYHW3K-EC&!D_Q
M'XG_=/]G=>'@H475<M@U(8UG-LC)AZ[K^4[S0%[S5H#=-P.9Z#=B5[!0THIJ
MWGZFZ`Y%.^P*]W^_6Y-*@O5G_/,=N9![O$,G[*=&R>$T7:$0YG7R9@5CSV2_
MC+S&%P`12=]N7ZDFCG4K?3UD'VYFP'VGF^[]C/TFLD+0-Z*=(]([HMT+!YF5
M"33CF>#G0._Y64*-5(0D=V:Q@%BL;W>Q'TT<FSJ#Z"%?',9_G.)8U4U&7MEF
M<V+]'#AFO]_()1412`4$GBVO8*2)8R/&K1[:TR_+QWRU6U.;N/_"Y-4`E*\P
MX,M=MJ:0YG3`-8/>WM\LL5[;T1R;V^UC7I%X4)4_YF6-AX":KN0AP5->0LR%
MOF0#.>HDW7S*IV;O`93M.7("R[V!:CC4'OI10N81<CL=(=H3.NH*-=61_T)Z
M^ZOT]JM,1O5D+/P4\#T/5<GV'(=AXKG7;K0@__&<P`_P-A`N7-M]_%H9-Q/P
MTLG"D2+H@ST?N&_PGK\B^_Z[=?9P[?A3]\KJ?'G]L'GY7ZN\`(SB?YQ"$__J
MN%\YD(V3V`+F^"MR-<,+7?H(:^!0S[4?V)UIS<:`[MV*B8IT_Q4BG_%)W.MU
M5M>W]U](ZLZ;S5-6E-?.@EQZUF3?G8\G)XXL]+="V?>M[R50S+$Y6@=V^_M9
M6=`MF(QTI/0[HAOIE^@/^);3Y('G\[;OBGJ9K?\KSZJWY>H-UN+73M#W)(2(
M@AP:0E(X60G?2^A0`W<!V(\!^S%@WVZ_'3\SVJ66EZ*T:8&@"2)MT%MRQYS[
MV/VF<2(2[P'-#'A?WF^J)^I3O/E:;ZMLN27#\I0N8NE33H(%J6[EF:TY-K!H
M.-LCS-$%2&`!['9HR3.G6]ZE*4S;'L`K1?M`G4[0'VTWG"J=3ZX80SZVP>$\
M>,.^(!$LB$,7A*HGO"!V%P>29\Y42$::T@,N;OIQT?:B#A7T5$KL*K_/^2J`
M"-JA/C@,T<L"!6A+G.:$&VI20F*>;W?NKS!/<VX$8X1-RCEX,P65/QA5GW*\
MC*MW^'<UML.FKC&R&O2#8ZB1^&G23^7\O(7C>J!=7-`N+F@7NP^@(NR8DFX.
MF@Z"W5CVT`K19C+23$X(K4"H.IP.C*!2DH?)[I?CP_<.G52/Y+[3*?9ABB]#
M4;,S8U:&&2@ZDV!Z-I607T#`WD,13KT*Q2N]1_VKD=UQDD\E]_AK#X[\'GA3
M7?"FAG8[I3DY,26S;.0<!+;1M7)^E#M,Y;7K3&4B\$HIZ5:-</82>"J3]".O
M@3AXGUSP/H5V._?8&#`E@:-4'`2/?,8G;6#ROL:-JVS]OESEW_\S)]>A59FI
MO?W+R1\;R:T@#GQ-7?@>.;O1N02'D.6U''E9T2V<G/2DS?&J:8!H"X2;"$GL
MYNEI4]*@"[WO7]_NMO4V*\G5M>OI_"U.\1T93(DL\S!S(MBC31<!+`6<#JB7
M!R^%W??0I/@R)/)"Q.WEG[:&@.$5@@Y0IP<A.$`8YW/^O*E(N8HOVVQ+C.O8
M50N$WF&40("-@1/A[V^41-3+XT`=C^`BQ)V5$T,"SDC.7J2;*.*^`8(6(J+\
MKECGU6ML-C]L*K*M3Z5J\$GP4>\J!'><W&-Y/?XV@707'PZ^'AQ\0[O]"EQ\
MF)%5-F):2:5?H_9S$?G\M/NZ+I;OUIMLBY=;50+;6=\J9'.,U&/)['Z9P$/=
M#M3%L#P'@X5\,W(X2D,K?O`1HE^)"-_G_*$@@;=R^S%[(D$-52[8ONY5B.`$
MP<=2>/KQ`CPM/GA:O("".;([H9B3$S.RR4I.*Z:'[Q%I("*I?]^L=^4VJT`_
M$TM.E;^UMW\5LCI%\K&PGGZ=A(#Y"#!_":Z$:1;,B.<D':U<[C^$?5S(OOQ'
MOE[_9[GY5G[)LWI3YJOW=;W+*U*A4ZF`#HRC0E!963@6V*%6"=R@=^!]`<MS
M<'A9,2/`S/2T@DP:_/)/T@*U31"TX;PLA8]9])&';K[RS?>BO@X<#!]MEQB'
MAI63;@YN]A>7!ILXBW`!SPHX4!LBL+R<)!\GN@6;CYRS/'CR)>_%OW;$#T69
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MA#Y%2$@@?NYO"(BX0D`&_1J?$S`EG`IN]=*\44332#<5>0;W>;VA9Y1-O:V)
MD@WZG(P#=T<F.Y14%0+T[G$^V98<OWP?WNYV(<P06VX[B/*D'76"A*5-0]2T
M1+@IZK1%M+$V(6>\,VB/E)_?%F2=>:A=[H([.+8[GT.8)W8QE[L;*$H@+1B?
M-2+_W(@\J06?E3_0JO,D^9)VHDWNV:HJVB/VYZ=)Q@4`W[$+=]5BN]U`PCR9
M.>,)4K?7\%UQ/Q-U3DE?KR%;:EGD=5M9)$IZ+[WV!9^6T/@''*O:GTZ/5.WO
M^X:3E'PF^O>RWO.U[[D+NZ.C(U1K-T8&AT[QG]#A;X*E9FZ^9=6*7!.@KGPO
MU!<C.AI)4N9&B=[+VM%7;D#SST.:$!;$EI>`GJ1=N]Q-$)#2#^@%$Z'@SJM=
M790Y/KMNGKX6);5<7F_HRWI4!^/3)EX;^NO/^3(O7LBMZ]^?\4=YM<52_CE_
M(`?/3?7CMV*=U]M-F=,MUN=X=5X#"7)B;69.6GCH&`VV37A#CMY."KW(;O/<
MX"SHAJPY5M)V*-09"QT&0T>CH<-PB(R'F@'1841T&-(B-<)XHOYSZ9'S4[LV
MN0NA.H<'CU%&=I]X#,Z"*<^`.98."F7942C+@T)9'BF4ZJ!0=D2A+!N%4AT4
MRM-A2(LT"INOXL^E4,[\(?K$#K*4/+BN%-F=_F5P%HSX7,SQD[YFT!O%_;C6
M0!E]_#(CU:XYB[<>Q=K>Y!4><4OC=?6VHMJXOMF^RXKJ[]EZEW_,M]=AE$SE
MPDO4'^8E1TY5*.!^7QN6NRO77]@=\Q)E2??109"N]#2HBPY-4:<MRK:(M$:T
M^14)^9K"E)8,N8O!U-G>*K#001(O[*X2),Z4D9U/F+R48N:%_)9D2"P)V.X)
MV!Y)3VBU[XGST-PXC7]`]K;G:2Q^WQE)$@.C-!^7$V^^\@+'[F<Z>ZC5KNC/
MADS;7PFY<=_D]SENOOJ<O^3E+K]9K0HRI?5U%$]6`Q07JZ%1Y42,G9=]4:NA
M%GASM/MT,4&Y;C$<'SYM_XR:OU^A_1>*Q5.+>3"3>)YM]H,MR-G;M3N9<Y)V
M(UOW%!4'2:W@"SGQK"J20TDL@E<_2&2MJ53L!U/5U]3):B\):@67D<LA*>YO
MCA6'W4<_'C9,J]\16LYT,>I\?86^_FA"P$)EL0?)^+"_KN7XH3[SE($`7:(_
MPN&TX!\:^\["[D0&=B;F$_H32D9%7N)JX#`!^SP++`O)#-*N)BM'A+]I6=^W
M]1W7[BPQ9A[FD_1C0L8%73BU9WSX_>-IP52I+%V2KB+K48Q'-FEOL_P6MC_^
MP<[%O!+?)>5<YL7R)@]N/!)M(B_?=!>>O+^@3[B'1Y85:AZ>#L(\TLI/:/73
M(';L=B&S,Z%?E!DI23NQEO93:6$^^*0_%W53WB-(=&KJX9%5"3,+3^?"W-/*
MCR('9M]NOS([$^:$>8*2M#=P*&A^]`18VLNPG_/EYJ$D=^W?ET-7:M^V%^\_
MP;U[$I&)?5]?9KP.BM6#1_T<CH%.>C0_B6UWP6OC>@Y8JR&]7P_45T?WR0\C
MD-OF#-?4]\.A9CR!%`2MD-`4AOA3J96>\(>&T6CA%KNO-&CEVU#811\'M.0.
MJ;-SA3`ENS6M3E]`R9W3#`M2\;;&9K5(X+'EX.,&A.'F:;,K,1715+V<]F)G
M4;[D]9;`W6O^38#N=8`.OQT<2Q56)S@XA]M)`X>^?('-O$O9CT?H-[>S#A/1
MV2/Q/M9\AN`[M5(ZLBU=B)2.;`JG$YR$?AA>>^'"#7R8:MO=;UR<&%;<+#2E
M>^'-!(3W[=/S>O,CS^O?\J>O>47T>^\3C@.7+$Z:RXGA-"W[TLOG7_J>W>Z$
M(9)UZ\*!<=/][]$?\!=.!\'@8C'>]S,C.>?W[$X^=5R8$;OCO\-$LXN/W"VV
M00JD!6F?LPN9O2=)O$GHZLM<&!U:3B(YN6JE<[Q9&%D>S&(A7[?"8Z`A/5RC
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MY/H)N(_\B+J/+,\%%6''C(G&3UC:?$3KL9`L(^'S,HMDZ-E.YI7V\XUBK%44
M)1[,O=VN'78FM*M\5DK2YDO4?HI:V58BT;=T0?:+WUM\7HM`=P=6*L_C'`V(
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MAYN'*J?WZ]J\!6\1Z[L@,3BLG"QQ<-,*V'`3WVT>]_8=,&3L+D?!QXAN(>6B
M)MU_C0Z?"PKT;UF9P471=N4]1Y]1>#J:G/A.T]Y*[=F7CA/&=N=C#)&L6Q('
MQDT/OQ>4M$^;>IO3A"-:9R4O\_MB6W_"9MYF]?;[,Q;HG(8B]%T<9J!`3B#%
M6&R%E*VUE]AM`7)PH5N4V4E)CS]%[;?XI$&_1LWG&B5>B[_)+HD_<T"QM':=
M)`@B4F[7<STPY.SV0XDS9<0=)4Q>^B5_R2OZ^EL.WW&F)WW.ER1<3)[C_9S7
M.9[1QYMR]>;P>EPS_-V&/$%W>]_4IX"7`_MVA8'T9-%QY)"@D+L6'C)=>I9?
M_I7F3??F(4M@VG2`2`^H[0+A/E"GDW9C07<;^CHNNKUOZ[)PHXND7^`SP4DI
MF.:V(%EL`/F[3762%D)%L"\;<!!@PD/)8DPECP>82?3J)K$3TS5/[([R*>12
M/_14D9KNNT)G98\ZO;56'GFO^C37:084,E[#N6P8GE_OD>B6W&DA"Y_`PMN=
MFZN43W8LRETB4DDT)RJ)X-';Z6OJ]LI11IQ>X(KX5FP?T8ZD*J[()U7VG.^V
MQ9+WS2LE$LWVMM5EH_;L""?1:T3%PEV`6-B=ZJ6232/'/(4$=^#:%/DF[TCM
M4?I,N^'%6Y]%W:E:^`^,ZW<Y>;=J_>L&'SM+^C+YKMYNGO+JW:Y<86KN-K?W
M]YA>^F#Y^Y*&V%;73A!&^O(H]1$N"VZ#$WK`OKY!0R^P.]E"/_/ZS6S-'*3[
M4V]V<NKMEMFE6W@S##J,<X7:D5`S%-IN$`Q&C\HU:H>S3_=H<>;^F75/C]VA
M:U"\_2TB&FU-W$4,05?/]K.]Z<DP9,,89BM]W?-:)A39NV]T4'88G4_M?"$/
M:>[6^>W]E\>LRE]E=;XBA;OPB8:.UF&K?O7C\,VGC#KJ;TB2?O,L11Q.Y;")
M*QEE9,KI%(VSU6H0=4-$84C.MKY+WW->1"Y4=0WL5AI&^-=MPYA@(FT'(;?U
M:1>_?"5]H.Y`79.&WD;N?MB,AF[@IHW(4S&3[`UQ]_9?.RQUG11:6C+P[C$K
M(<N\_A5W030C'`?_D1</C]M\=4-B?0\Y_>.;;)OO"QE@VRYT->H?6_B4U%^V
ML-&S7'L%:`^-41S;[;.U;JZT*U;+&$Y9%.^HWKU"0-K1N\Q0.WF+J6MNE)%*
MRY1`8O0!B5>H)1(U5,(GB-#9>=;9D$+_L'^L*5@X4[549U#$']2\'*9C?J0U
MWZ%O;"[$U%SP&W,!JI,&/ZD:8V+<6IW$0KV\@I%X&8WV^76:LZ^GG#5*Z]VF
MNL^+[0Y/XF>LE.`\RY[0H7AX!<#7.A=':D#A2.0VIQ/Z]#:G"]'.T.Y<14,S
M8$0Q:&<C/?0QK"!>-0JB3S\THZ'.<(B,9XFN8$P[^7,HB_/T%#U"%E`A\QP0
M,KNO3!F:`5,I+6;82>\><W2__Q15Y-"PN4>;1AF0T%A-AJG1`SE5D$26#<K;
MRKQ7:%54^1)C`C[=W-\7R[SB37#1AA.VI)<_A\XX"U+ID;`0)`SR,T*[H^2&
M9L!(.,H,+^F[8UVAV*LPZ`4'5SAY'K=<?<+\=PH$!@M/WP.(.BC6['E0,H?,
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MI]U;HHC0]&ZSQ58>8(T<8BC8LA7%V:H%VL7GT6FY+&`-GS]='MV1QK&(OCB(
MG0BB#SX\\>?8:W1;/V_:=:3M,Y#^"M&H*_2MZ>&7K,E^HW$JM"*!K,/C9;J+
M5&O1DK86J3[2,;S$_C_KK^MK/_2\Q+WVG'@1Q==>Z#A>`I$J>^T;]8QJ1[%R
MDFD9[!K]98T[RZ$2]H;FJ`J_"O@AQQKD<;->O7]ZKC8OX`*^*<M=MB9AJ-O[
M-_ESE2\+JG_>Y/6R*J@(T)=X^Q+]!TX0HN/(84LA=_L2MZ)=TH`>\9D110IU
MTUR[P[.J6=7M$%-,;[KO#W4[1-`CS<TB!;FZG:).KZ9QR.A(NU0@GJ=<R2UW
MO(#E;MZ0M-<8UL&JJ20JQ7139]NJB[?5H0U)HT+K/62+SHB<7C5Y867SJETJ
M%,\RF227V8%E]F&9[:Y,J9I5([E)BHE.NY]?'3#'6?^XVCSGU?8'R2#8WI3T
MY`I7^`<(HV[=OFCK`+RX!Y##E0I^]J6/N?L"$P;2Q7QXJ-7R]Q&5\:C;K%1%
M:-IV1)-FMK38Z[ZO,:O2&*X83<C+`=:YT2BZF/`*FP\G<<M?UU7&HRDS417!
MY_8AS:?/GI_71;Y"&>UM_0,O$@V\XH_K;941_^4O:W(Y[RG?/FY6G-:BA'BR
MF8F7`[?S$OZ""QO#PL:PL'8GQ2GCT8@IJ(K:(QM0(!7][?>\6A9U_JDJEOEG
M$M5X5[SD[9ND011P^!;'^I+#`B>5K=B/-L/SZ#B)1_[K>B2@$BTL+V\JPHYN
MHTR`IK1M@V@C1%LATDSPS2(VZ6`TJN86XG-3B6&*`YAB'Z;8;JM(A!U3!I``
M;0S2S&G(L,D)F\TRMS2?62(,,QS"#'LPPW8;'2+L&+$O!`A+_\.YCA?J=#`F
M\2`./H?#:*POY4([1N6(T!Z:T<F,$YC,`";3WM1@479FL".F:!K0O+B95AD6
MMR.,"C&3'7$RQ8D#4QS!%-M=&5.$G1GMB"G:&*19WH[HD1-A.\*H-+/8$:<S
M[,(,AS##=I?\$F%G+CMBBC!B1R3J[(C;LF-5^GVO'C/+[+XKU2([1N.PQ!Y:
MP0:W@(F,Z43&EZ9])[DQ;T),D=2O<W$KG<(K;#^8E%X6Z^%T=F%'\Q<PNY>F
M;R>YF<]VF")M6HRE+8<>$1$U'$R*,8/9<#JY/NB(!";WTAS"D]S,9#1,T45L
M!E^=S4`>02X[OBB.=XE'.U,MLN-T#@MMMQV94'<!SASR5@8QPNR]/2#,CWGK
M89JH?L5+V^D596$;PK0LL]@1Y_,<PSQ3SZ2SN#1G&@,_\]D2T\2Q"+6T/=$K
M+*(6A6FA9K`JSJ;9@;,'O;F'I_G2#G<,_,QD64Q3EOY'<+U0:%L4WSL"X4A9
M%FU7RL5VA,81H=VW`L<..-S])M1I]QTI`6YFL"@F2!I0O<5WG<(K;DL8E%XF
M.^)H=MT%Y)WXC5_2[HM%`MS,:$-,D#8MQO+VP[F("%L/!L68Q7(XF5PX*?M-
MU-/N2SD"W,QE-4S0E?X'5LKJ;(8[+)-=YU3?@T#,`MOI3+7(CM,Y++3==N#@
M:8[*$-Z,+TWY,O!CWGJ8)JI?\=)V>D59V(8P+<LL=L3Y/$<PSXVW\M)T,`,_
M\]D2T\2Q"+6T/=$K+*(6A6FA9K`JSJ>Y<?LTL=!+<Q@S\#.393%-&8EUA`IM
MBV_YNIMXZP=2QD6G-^7".T[IB/2>-%Q$%R>O?1S,8$+TD#&@7^F7"H5TTUGW
MOIKR'!*ZT26>PS2.R>;F".V0#14TP?E+NXHQR<T<,CM.TI#\;G0*K[C!:U!Z
MF8S=D]D%7TX`E[7B2[M\,<G-C(;N!&G38BQOY)Z+B+"):U",6<S;D\F%2UH!
M!.KC2XM<3'(SEVD[01<Q;`-1P[8IBWH^ZEM2%Z`C$QP7DEGZE!-@0:I;269J
M3CV4`?AZ`KBM9?D3E#)LZ38P)&A+VZ=A>U4U;6]$^!F-#]ND_]P<X5@+\`H%
MX*"W_#E%&;9,&2@2-/+`@--FX1,H-N/%-AB<F3,<2P&NI``2!D*[HRHR;!DQ
M<"0().%!+R9/QN!_".<M#Q.P/DX[@X=K96V>M:HT.5&ZIP5^?9K,%38V)N06
M1':[4Z3XFL_NF29N0N.O)1*>.65)VO29"P0\QL_Y@C26*(00HDLU_AGXFM_\
MF2:2"PW*#*!>J9*U@.9"`X<-=+X>C3T*60_1I1X%&/B:V0J:IC#]#W<AGEH]
M./)Q(2&/(UK$T*4F.1^E>5+*3VKSD)0>.M.0!!%<J(Q/<S6;T3-)VKB2ERA6
MQR5!LN;.+&+/8>J<+0,<M$)P*0<7>L"=YFIV,V>21`[Y5V7B],F2I($SB_RS
M&S=GJP`70D*(;0=V)QI*<#6O83-)7_H?GH8XUG%9(X^CD`U#E[K$>XSF:?$^
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M.6R9TQ6`LU($'F#_0D^HDTS-;LE,4<@N^*KLF!XQDC1C9A!\=B/F=`$@ZAU"
MU-N_T#2#2:;F-6&FR$O_0T<.S4GA2H_C^266/C4)]SC5D^)]5@LR@%N6$82U
M0[MKTLNP-9LM,TW;N%*7*9;,)T:R%LU,TL]AU9RO!<3_HN8&VX4&7!G8FMVR
MF::1!P:JK)M>@9*T;V:"`;N-<[X4<+Z*(`H>7NAQEH&M>>V<:0+)K2D-EDZW
MS*;'45EQND==`CY"\;1X'U>N#,`9'#4A[@OUPD\R-9]],T'9A%H7+MW,(SS2
MEHUY>>>Q:DY6`#S`$7B`PPOUNT\R-;]%,T$AN^`KLV;.Q4C6EC$O^!QVS,D"
M0-VKJ(EZV_V`A#A3,]LP$^21S.#(5:W2[XXNR'&\537=HR;!'J-X4K#O3FZ5
M-9/<W"J[4,&>9&HV"V:*LG%%?J?>.],C/+(6S`SRSF'!G*Y`XR$##W!TH4[)
M2:9FMV"F*&07?%463(\825HP,P@^NP5SN@"-2ZRY2'^AWLA)IN:U8*;(2_\C
M%G_88GC4X[+D'D<):I8^=0GW*-73XGU2Z9L\#$DF.VXNDEWHT92!K?ELF4G:
M)I2ZQ%,8?&(D;=',(_T\5LW96H!E&3>WS2[5D)]F:W[+9I)&'A@HLV[Z!$K6
MOID'!APVSME2@)D9-S?I+]6ZGV9K9CMGDD!2C7CA*U?VW?K4GJ_"SE%32EN(
MXFGQ/BKY['I0)B*&J+9_H?4Y)IF:S[Z9H&Q"K0N_><`C/-*6C7EYY[%J3E8`
M[IK%X`'V+_1RWR13\ULT$Q2R"[XR:^9<C&1M&?."SV'''"^`#W'N&.+<_H6F
M%4PR-;,-,T$>R0P.1:--7QZS*G^5U?GJ]>;I.2]KBMB;JB(C$P2_^G'XY%/V
M@_SJYEM6K1IR;W?;>IN5JZ)\^$=."B+GJYN7O,H>\B-&KITP<OKRYIOII%-Y
MG]5?Z7SNZE\>LNSY?Q'4_*]\O:W;WU`<_;)P?O$<BJ3FUZ:XD$/D?%/=PMH8
M!<EB$42-<J81),>U6S?,/#-&%,R\/)X^7/2<5X@.IT)?T=_6-[OM(Q:K_\Y7
MOY=8TKYL-\M_`NV?\(34KWZ<Z]:;[T5]'2R\OH(4.E63%,$ZU)#B&1S7.'*#
M1:$#-\)B&JYP/+M#1*:F0/=IU!`?*>WQEZ]D(-0=Z0K418T.@Z$=&0W1X1",
MA^B`5^CKC_XSP!]D7"4V$A/GYWR_V3QE14D0TY?!,[O.&2)X-IW#/H,*=,[@
M8(X7+.!&7IS`CF;W+4AC<V"QUN%B1)':Z=<Y,.Z<6N?#YEM>P;^*IV)+S@A!
MWQT("_7/">D6*:+I2=6BDLZ&C6W/#C/!_D4IHGX>-.J@*T2';!02'=1&;630
M.?3GT4:,;B`UP^+S_B+V:9UXWX?'<'S+BQW.,1TS.GRT,C;HY;E"3T59/.V>
M9E0['W?$07Y[W_PE^[K.&]<6`8O?%Z6W4`,-<V&1,N*::BUZ:8R"V/;JVH9G
MXJ)LITEVM)I1,#K:W*/.^$W+VG+=9K]U]=/H-KTVUP@%=%=VZ*X,+Y7XEE^5
MFW=B+L\.XV5QGQ*3E2OTCXQ$^[9U5WE9H+0ZD<4NDB[$03[,A85*BVFJM2JM
M/@IBVZ_!&)Z)BS3(!MDQ9)!UQK?((!L#W.489!>OV\P89#T4D$W9`S<)/+#E
M6UX$?MZ)N5R#C)7%?H/L?E,1U?B$U1T=<D;-]?OS\YDC>7$9IM@)Z1;IJ.E)
MU:*8SH:-;:]L:(+]BS*O^GG0:E/1(2V)%0X"QW[CZ0*UD5XSZ718ZK!(8']L
M0DB7F":N=38NSR!BXFLL4)A]%P@4$K(>-VM,8?WV7SLL-!\W6TQ`F;_?YD_8
M%`N"@..!GHGN)*',3>L>C1,MG<1UDH#<`_4=6GQTD3CD/T&26+[K2S&F?3^7
MH2[MMD;0')'VZ`_2`Z)=\.8&LDH0XRU<.\3]_/XMV\3[,/$!3'P`$V_WZSQR
MC+'+N]P]7"DJC^3^?PX*/N=%W'Z2[D@@@PH21ZF%D:YT"/P0C>.R#JWH1/L)
M3'0($QW"1%N>AR[,U#PZG8&R$7U.6RM1Y2?"(J7&34DTJ_KNS'&P@#F.8(XC
MF&.[ZX6(,S6OVF:@<$QE@VQS:NN^R^SY^J7[OBI'^:?QWN0DG)O2@XQ7Q.-[
M]&9L:+L$]Y-LYJC9/S@IF2W\0&OC16]Z#/PDU.:N/AI*3N0FJ&X%[/@S)PD7
M=INVO?3JWLW[!DV;7YJNC`%J\WU9;RNJQ.O;[6->W3UF91/Y^;@I7_)ZFZ\@
M='3MA*$;VE<;@Y</'?Y-,]--H&9P?%(?(8$J+HD']Y[MO;\U^[QHWY7FYC#]
MC+_!9@?^#M4T1E-NMJ@HE^O="O^J*%&]>WK*JA\DR673"1Y_:X+'?'KM9HEM
MR]TZ(V3EVU^SHORPJ>MW&(AO\KIX*,D?;JO_L\O6Q?T/O%6_SNK'=^O-M[_E
MJX>\;C2L'^N[+:&"0#E=I&6*VOU<2>=ND$26WV%0RJ=N^T$EL>GO997C#TGD
ME?14HTV)2`-$6B!H(FB4'--Y&.@]531$";6TMU*(#WEF@#I-C$I0"K#>#T"&
MCCPG\*EW'R^OW;E;LJR9A1DW?;W(^BVK_IEOZ36<+_ERA]>C4`$ONI<3@Z#*
M'[%-4+SD[\OEYBDGQ!T\X'ZL[ZC)2XPR>(FQW@,OMHY"-Z`+;'GY2"F^#`*+
MF[BTTQC1UNBH.8+VZ"^DA[]*1"T9B<2:X?;^+OM^C<UC>&U@,2.\6FJ,H&N$
M=4YX[7NB&C2"M;;WE*F`,W:(/>>8]=67;59MQ7R8<I2FK_*'HBS)-86O&>Y_
MR7D%2UB6G#\OC!P5,`H=6$*[_:^2G/'"Z&VY,@>B`YWI6[CHHQ-!$#'S8R,G
MJ$E"C""GGV5.T$`GQ,E*[7:[RW,*\V2)27=&&*\Y)Y*T`)Y/TNVFQ(>VMJY>
MG.BK*=<[I&3,EXV+5OH'/O=]EX33O<0GR:V+B+ZN%$2NW<86/S.ZY9V;HK3)
M3]@W$2RT.(:N5_G]ILH_Y\MU5M?%?;',P+'?;DJ.%R[TR;P$97+(4#LE^U<E
MI'I=1';[NQ5PIQMB\B2FDQO*%?I*>T)G75TAW!F)8>'NU"&T0V#@ZG/&Z3_;
M"#+)`JY#<Q>N8"QBR$\/([M+\XDS-2>41BEC09`9G"1_!IPD0CAQ@]"G^;]X
MR>S.Y1-AAR.C8K/-UF+'>P'"4B+WRUU585ON%_`NH`U%R_((+07MB`\:I[L1
M">TRG+!>`S6?*#$'Z<+FJ+X;\2I)E8.:YDEK(:EXF,2Q&[(ZV-6]W6F@.3WM
M$Q'!0VS>BRO4=(V@;_$]\\L6#T4BSR?GSQH>MG$<C65AQX:6O;#!Q=4AF7VL
M&6[EQ/0L3A]2QU9-!&=QV^\@B3*E&U7"E*7[EE?HU`M2"[UQH^3$KR5_^;*=
M($<YQC(]TAAB#.$/>SWJ"CGDL%+%\G[5T=J<Z?JLU-8;4IUV98/Y>@AC_-M^
M%9DU@FFE8U"Q2D"L[/5VZF29`?4)H+[,'\AH_+C72'YZ\[39D2WX`'=LQE*[
M-NO8M7V'VC76.F<ZH?N+#_A?^)?MK_#_D.)/^#?_?U!+`P04````"`#E@2M%
M7<JP*?]@``!F:`8`%0`<`'!S=&DM,C`Q-#`V,S!?<')E+GAM;%54"0`#S0(2
M5,T"$E1U>`L``00E#@``!#D!``#L7=UWXCB6?]]S]G]@,R_=#R&8;_I,[2R5
MD!1G4L`$JGMG7O8HM@C:-C9MV532?_U*,OX`?R`9RS:NG8>NJ81"]_[NU=7]
MTM5?__:^U1M[:&%D&I]NE&;KI@$-U=20\?;IYMOR=KR\GTYO&M@&A@9TTX"?
M;@SSYF__^>__]M?_N+V]MR"PH=9X_6C\Z_;OC2?=?`5ZX]G6FHV?;O[U]Z>;
MGV]O#Q_=6:;FJ.2SIM%HMY3N;6MTJ[0:_]48_M)6&N.O[@=U9/S^"_W/*\"P
M06@S\"\[;*-/-QO;WOUR=_?]^_?F3G<LA&VX;:KF]HY^6:O?(82['W]_M73-
M]O\!_6O3M-[(YUJ]._>7_D?I2D=?_;W#/JN,1J,[]EO_HQC%?9!\J7+WWU^?
ME^H&;L$M,BA0*B3_"J-?,/OALZD"FZ$;^N=AJCIW/L.)GZ!_N_4^=DM_=*NT
M;SM*\QUK'HD19N(7N2$X-QHNTI:IPQ>X;M`_O[U,4U"FG[A;HC<#K9$*#'NL
MJJ9CV$1-%J:.5`0Q(8-]Y\:"ZT\W5&BWGF@HE7]A/\%@IW@?M#]V1)LPVNYT
M`MA==K+NS>T6V5MHV'AL:/<F(XMH,2]1*E`+)6IN;Z#U`&V`=&X"34T"A08F
MLM/H#OX,=*JWRPV$-B=-KU@&:`DD+8!%D-Q`FRB?SDN?%%4+"%S:Y+],P//U
M/<";1]W\SHD=-M5U@<29VYT%-]#`:`^?3<Q/I%X<D?,=M)B=Y*;.S)^X(]0V
M@&Q8/#4F?SC(_N`S;R;9WX62);XQ&(T2ML8C0-:O0'?@?/V(#+)U$="GY#RT
M'$8Y%VWKO;E&2KMHVNCIK3DZ_6WZ!T6,-N,%F^P/K7"X8UGZ`K4W<@I=S-`&
MY7\:G>%G!5YUSN.<T6GGC_@3-(B)XMMD;]*6%Y'86_YB^@JLWPD%1!A+J)+?
MVKQ.UA870DN@]^,]P8G^<FU:&.@P[M,B8&XQ-L$62]C*Z7Q,C3W$KB,Y-;X9
M).+2T9]0H^>X*/D(.7HQ*B&P7;=8PEY=.J\8_N$0T"9[[M,'0Z7=D7!XF^KO
M&U/72)`MXDI`">?@*2PB"H2A!-6/@C,#%O4#]U",-J,0XH)=27UJXE`SCW7R
M3O^O(,'$#2L&T*6SW0+K@WK8E-BQ2L`E/Q:EU@2E4&MHOU&%H`D'E^Z5.3,-
M2%8V/Z"8`7>Y^`[L@G3%X^0%.P'Q-/QQ=!L(;SYLDFVAEDCYQ,.<R.0!65"U
MR;F:@0<(M$*X$#B",)1P!"TLDX2T]@>!BQ*THR?X#-I<!.T`-`JC2``H2E=Q
M4(DH%Z5,@EJQ5-TAUXD7X(-"Q46/*2/1&0J,R,\@KS:MD9$[*2OP#O'<<`GA
MHL(V4:%95@&U5H$J0:NCTA()8I%ARQ6:`#%$=!+PB=M;`D21'58042)VB%`E
MP0RE%1/<O*GQ]@R!F`]*JPIZL<0&OUJ92V>WTQ$YK@\?L@#U*`094&T,9#A%
MT;TKE"E#1OYA]M'FS10ED6TLXXP\(NP?#M#1^H/6!:&E$D&#-_++]2&SMV!%
M8$KW&!.G2\A])-3_L3/WYDY&('+$0Q#EA0J>-.`C@0?+P3_`-;0LJ)%_E8D/
M;&+5U&PI$55:B5:T5"O!A4FE3\1EEV+]'TR5I9NI(THHLS^FQMJTMBS*YR)+
M`U""EY,*6K:$"=A)B8+3"`VV59R__P!W)*9$#.H7$B4*<H.)78":56Q\?$A-
MT!/,35<(Q\/?@83"?JH4CHK!KKT3A%KEJ?Z0-3"U_A259_(#[Q\@6R?_0FFU
M&[>-!X15W<2.!<E?EM.GV?1Q>C^>K1KC^_OYM]EJ.GMJ+.;/T_OI9.FM2!G,
MI4W%)1V^VR1NA)K;%.,1KYOJX5,Z>(7ZIQOR@_^)?M7X%3.OI=EM]YI*NSDX
M1C#<@+0&^)6UXCCX]@V`'>M:NH.ZC;V?W+I-4<JAJ><OAQ^G+'O,B4[;C$S+
MDT(J*^E&F&#RF7SJ]Z;2'W9&TACC(X*+R;"RC2V/X;5E;H5%9YN9(3(M8B)8
M#QW]WTUC9R'3(N;BTPWYBX,)^28S$D$)$5AJ1)^/F[8.G[C;L3+_K;I!IP4<
M\@FZU,$C>7:%G/A][,ML8LD@^Z2_9^]B-ZW`?AZ<[N?[^=>OT]77R6RU;(QG
M#^3O;$-/9J*[F:.[2W@OIWQGP(2O(PIA3]HV$"(E^Y;G6B;0ZT&KJY3+<KX6
MX$*!>U8A.XH_L''HM@:MCI!Y:/S$TC`_-WXZN"8_YV0PXCHO"S(>_2LV'@RV
MT%HL3FMV!DI7&F>Q2Y9H"OJGIN`L)B7N>`Z1OM`NPO$[PLUNISN2)D9_F5Q$
MQZF'GHAB>:RV6$XY)-843HEUPY3+?F&[S5^V#+%Q87`08_M:Q2C%L;I,C+&<
M3`W5<@L+[I]3X]#D]?$`=R9&-B8FLB.1I_,$2-'1%(EY>BH(S15[@.DGB?D!
M=/N#YNR60(>XV>[UNG'Z$)]1BOS[LL29RL=!>)T:"^]0[)P;3RRG^0)5B/90
M8S#$I;?.BS/A&RL@8!Y>#R+OUE3D3PZ@O,-P41:/MS33U51ZHUY;FD4_3T#)
M&L(+S4%#^O74$)HE93PO`-)(I#165<LY[)&NJ#U(^+)R!<W#X4'&O;K)>/SV
M9L$W8@JC%K`M(-V$KRE+KCQ<^9%#KUX2#?HMYFNW"P-!C;6F:\AV+->A&;;X
M97OV"\N2LABGOKP'O5K)FV4WOL+M*[2:W4ZO)3>'XRZ4B\134D]'F9LH;]7.
MW7Q%!MHZVP/9G<Y`GDB.ELI/*$G:Y(DED<.*"P:\'Y'=5^0))KQ4@8))XK#T
M--FEQ:,6ZQ3Q+\"SRM%L.7^>/HQ7DX?&Y_'S>'8_:2R_3"8KP;+RF>D7X@TB
MK!7PWK$H+'X!H=\>RNL-B5OQ@AHQP!M:$B%_T$:G/=!9X&/?`\NB'9VLB;/9
M'_0EEH9Y2,BG)X1+6G[A5Q2:NF;[4F$;78&2'WU=L]]2!L50+E]I1Z=*F\CJ
M]20N3!OH_,H9=Q/=8U]I#[ORFME25B[!6O'B4-=0>+DQ+7L%K6UH=D)3Z0]&
M<=%O3MV,,4N6(/FSG/LB;]<L&B;<6D@ESAS?4:WT!HH\QTR0FA(4Y1*\?!WJ
MT)1*?73(O?MW=&@J),:55PF)+EB")ISAVB^#U<Q@>'<\W1PQ/2MGT/8`Z/5;
M\HZ*M)5+D#\O$'X)O&:[WD4K@*DC+[H]7BI'62=2'QL*Q*A$O</5F6FHIZQ+
M[&]/6K1X@:<R7F)NL(0-+3'"SRLIT>R-AK*S$1)U,"'_$.;J>MJHQ!(/WH76
MA0[<R\.A*3;$=6YUY/F0:4OG*&P.$^J79WG!N!YMR/?0D;B],QXZ7&S0#&*[
M,/H+T=T$DQ7/\_4T!(H9KU``&&)<Z?1CVSYSCWP+%GE:_)O`?ETCGP>X1@;4
M/D.#_!^;FFL7AD?3HG\Y_#R,RE#IR^OT%R:G''VY"+6Z-B,]F\9;).W<[BL=
M:=H2LV(Y^G".=3^T'M;+>KBS4(*+DL.AO(CZ>*T+.AS,[=8TV$07-ZT]:'7E
M50%.5\M%/\_!'KZJGL1J;;,]FH9<NFE']]2X!SM$7*%F;]"3F,Z-7[1087,P
M7M=L3P)$4F*4O,Q0=*144QFTE)$TPI-GT,M0STA4=8;?N@96+W30!'$5)\`R
MD/&&QZKJ;!V==AQ2)U)%-!TR[,HS3><)*-1*">+AAUTUZTX)L>U=?CB=R$8?
M]YA!>[Y>@7=BQ!6IX\5$B"GV5,L.E*\[=8NS$'A%>KBARX>QTXJ]EI=3M)6X
M[@7YQ>,IRT')N2V_]GZ\9BY:+2*:T]I[,@2U==7=NY91T`CS(XD=\TG+EJD"
MYX&HJ_-^HO^NE0\V@;Q<8\K"53$&26#4M6K&`9F4V$C&T1:SFQ7Z5'2!3!2E
MQI%@[PSO=0WVO)GP+W`/#<<_R@?#MKQ;!_%KEF;`SD-0UPL']PZV231BC;4]
MO4CH*_Z@&SL)*:?T<ORBI8F?`X3:EK\"N&(J1YU#YEVVY<^S^2/V:ZDA=],S
MQ;&2MSKSR"?F*$L`X7J<,;'3C`\PV:F&/!5Z8=+[W_0)0UJB]:KTWF(?8?EV
MNQUY=6MN.@I4_&@+7R:PZAJEGO@U(>X'PZZ\SL[$9<O4#"XLZIJT8B%YPJ'0
M&4IT]9(7+E,7..&HJ],?XGQL:-$:9PA`B=,4>:G(6U$$64[.#L0%%C4P((5"
MF;YK:W`NRT<SN2AY/3Z^9/LE.^B[W'YEXI,&=!(O-IQ;OAS#G!;KGD>IKDG<
ME+=!FH-6IY17H"IR<'-"4U=GSY]`-U_[;P,OZ)!_"K@'7D^1V*G#0T$NNI*-
MU>,;5#'WDW\`G^XRY++LT2MV[2Z?#-GAGPS9^&DQ?IG,5E\FJ^G]^%GP/;&$
M29$+!M`&VD@][?<6&!M9(\MR[LX%`6QNL=4T=B=A`:WEAH!([R;(8X^#@`K8
M34&8:F!-SVD+XQF/'7M#./L3:H3]7B&7=4X7KI9VI,%RQ<>!F%9,,79<UN7U
MBB8L6D5MB,)1UZ1%A/6Y8V,;&!J)1@C_@P(-1&CE*NI$`C#7$[I+\!B':1[C
M<D7^<%^DG3\V[L?++XW'Y_EOF:>*^POA^9I.5WS4S>\73!?7_M<Y7"]>F2]0
M-8E^L%%MP46(E4F765CF'I'O_/SQ#4-M:LQWT`(T6!^K-MJ[X46@3?)2&C((
MSNZ%/D"B&V1'4<UH#MM2R[;!2KG8A4(D']1WXW&JJ[\I$]Q>I_[[*OH(YL*"
M.X`TKU&`O<N#X=C00H-6V,.8;7D89:.J\KLU`"OY#5)Q^+VM7>&H8>3N;8.]
M[:7Q[^XH/">7+`@2BL00XNSZE5>YR`$A!JFG6[6+0^)&[+]`H-.(_`D@@X+>
MI+/V._*L'`\-E5>PJ$T3A]9_I+$]J*B2Y6?`%O3Z,Q&3H=$F30O:R'*#QE<=
MO3$),O/>*_)%;@Z:*J^''(9.%'HO&S>LF_$;;TW+1G\REN?K!X39`4!Q(8`@
M9TL+Q!OZ;AEFIP.]WSHUR!H0VX]$F'$;G#W1*?!JN`02KD]%9<LAL*O]6NEO
M=&N?M#63;=R6.(7@[/K7IXIBD'IN8>V>58["<'HKCN*@R)N4=YZ`.NA6*JB>
M<EW!\V:7*A>+Z8.'.Q@./8FYI_,45%Z[>'(HZ;!Z^E7A7&C6<(/63,`;?$!K
ML@JD.XNX$)[+,#?8ZV+D)][(T^`1J6<7P!TM5U$7(O9UC017+I=%*Z]W,>U>
M>6/MQ1L53N15+TDO9YA]I7+T]#TGOK7<MEZ'_.SP2Q;2=EH2GR6YC+C*;_M(
MGWV.PO!Z/%K5W^]B;?BL@>$SL7(:'?D'#>R6(Y4^/3>D=4'&+EIY!8MY`O0L
M>`?%&=6M29^V0=%X8+YF?3#D]/P-6!8PV'#^);3VB)RR<^M>!VA+G;KA4&*,
M+T++]6E9=JA]Y:O9#!BO-$%<-Z`37(Z>0?+?0&HJK5Y;8N6;CXK*ZULT2LL"
M;Y"_K*JJY5<7<LO[QZ58LBNCXR59,%MD;I.;LLIK)4=F*IL8O)1"MW8G<ERW
M0+@.<?3J+,6DU2TR?95&3>75D2>5Q0^WIX.CZD83^;<!!7C0MA69;7L\--1%
MXU*A#=*GE;5U6?4L(;8_=//'`MOICN2=Q>+T9$\RD454"#5,"\M!<!"ZE=!4
MNL.>O%M^9]?/97/E(>'0.ZD"B-6U`3L>!?<*RS>#\$PL#"$.[:D;%9_;H"$`
M)A_3'7K9A4$WWQW29=V1Q/?<I=)^)?HJ0U)UO<9X@32*S+U+.1_XUTK(>RNM
MPHL0G,25O5-Y:PQ9L+Z"RP'9:@P)&+FO>";@W7-[3.0$".($7>"L@8]#@#!6
M_W"0!1/?;"=V61E)[&'GIT3F+A.3NG\@9D2Q^L=;S@$0#[Q%!D!R]E3(/7)3
MU.,]0#H-@&E)!!QUV1)O1Y$7]XF04O:V2G4SA7"L:U7S`G"+=):D;"K^M9(\
M&8E=/I<15_;&X_4:LV`=U#,J>\1E\QJ](Y]8HB,[19OU(H_`=UO#GGS/B8.4
MLE4MV742QO&@6?WJ&OFLOE,")+3_TXX@HK2'A6M6#"57HUAG43SHU9`$U9U!
MKTYZ%:W0!*W$%'?6=1Q"15%ZA4YF2*.F>OIU"9J^C@V&2KM6.A;>:E^!??#.
MV2B*#W]D,-!U?,:9E_D8>BXTEJV0J=%2/LA[OENK;@UZD71-*B#*8%1@UJNZ
M&L>1]N+%,<@EU\YYX^_J#P,L;PB9.#T7Q>A!:PF]H#"0RE>PELRM(22Y4`2=
M@$0-JO=%`BFYB=.71F7MT`7OD]&W@`@R@6TW-+_P-[7A-@3_L"UO_*,8+1=8
M'W>)N;4`EGWX"SN7W,&I(6?\<%II"DU5#>2]RIR!HEPLV:72]ZW8A8CZ*9KK
MM76QFG8/=L@&.INHIR'B:M.Q*NS9+>VS0X"R_PGM!4!:L]]O21Q#S$E%I50J
M"W0U.#+C+S?2KB=W8#?9-_W10.;##L%2E=*'1`RJ7QJ_X&1>HC<#K9$*#,^L
MKBQ@8((4X8B]]$#;/PU,'!JWJ/*$]M"@QK7?E^=27T):I90J-XSK.CL_-&#>
MGT<>'BPO[]'KM)5ST2$QUL3OXL>%+#4XH`J%E3._68,CH%!8.7NY?VBC)J7]
MXV*CEA!EL"(2_8.V#^Z!3B.M!23BTDZ+3\W^H">OST>$DN*,>*1M)2M@U_,0
MBN#P%!X4E=:U[X@Q,8:6]4'L'O/JB&3[BCS.N&@H;A,$3*;O@C20_.$(5=?_
M'=O*!!?+SGL7*+7=!5(XJ]HN4"[<!<H5)2O=73`Q!(J22V>WTQF*0/=0G!IK
MT]J"DS?%1O*FQ7,246(4F`&F@]8,*J\U1<<HV7,Y?G/4]4*:U'YG;N$*O$/,
M,MR*TNK*J[J=K);/KLIJ1D(]<XD07'&T?_ESA#V!YPCG7Q<ODR^3V7+ZZZ3Q
M/%_F\RRAN24T;NB[%ON8E@J!YPG9QC_Z.E?J?F\0T1=\U!L4U/AGD!@9HAX+
M^IH!42C;MM"KPQXF6)GN(]LABS&0=UVL(":R.X%)!'XSK,,#.5],G5ZM#TU+
M"V@E6D%^]4#^:KRY\;%'=%/I#-U)0(7B>BG9^94?RM#<HS-3ME!].TNGCEV7
MG:V4W9'3#WJUAH>JXPM4=8`QJ[HQ"GS2:%/R>'X_/?2%SM<!_2$E[0TDWI*2
M1OA5VIYH,V]!@O7-3V4[[K)V_IZWWH'9?B#V>0_HA)RS=EM>0)X_P5>Y%3(<
MPQ<),@AT.A6]_'-Q_>T@,$.+$V,H=2"O9"5(S`79V.B7^E(?*"V)1;GDA?-.
MH643IY^*Y4/H>LK2F:MP0CC*;K^1NRVN^RK(Q3+[_WL@>:)8@D?P0V<CN_S9
MR/EB\C)>3<D'\LA")LU$$4@_3H!E$/^+MGVPR9.^<)7!2)X)2EHUNP$]_<;/
M`".5;*`'I#L$M>9P)+%4=V;Q7&PLOZ`\,R``20VL:ZQ6_`;1VX;P.MZ3C?(&
M9\[V%5J'T:MSQ\8V,&A^\!0993#HR+N(DHVHDI0H!P2O^&S@*%#Z]MC'LMWO
MNC>W^_(*E9%5LUO.%Z(R!"S:_O$`]U`WV>!%=N,(LZP4>RJQ'<=1PKN49[\Q
M%UWFA]_394%.JQ]A':?>5F*!UCG\));9<]3>)Y,8)H-]EZ&M-LC2Z.7+CR?V
MHI;[D@(Q1T2NG3BF$A28ZTL+4>*(/1;G]X<UO[+&,!5H?IM*KS]HR>,F=?%B
MK'2DL"(`B.^V#H<55>VLQ9$G:!!_2Z</8&E;9""*&LV:^S"T>D.)9=4SRY>D
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M;W3V%[V=:7]D+_>R?TY[`TR#?/.#N07(:"K#$2O62"E8Q"YY40.9]\SG5TB+
M46Q4N#3J(\OE4X?C$T.H)2R9YQ)KMQSB&FL:<E>G-]BFQF&@W8&-[F@D37*I
M*Y<A15XH2DS8\S1:I#(MI[TB7PLR5E5GZ^C4V4OJE/)D,I#'%#<5!:AJ=(QP
M!HBJ7R[-&IS;!"NH>0D*C_&^(L]VQ:]9AM$ZSWV)B7:1=N(5;6%L]@X/M$J1
MVO%:V0V4_STGLL+C=X1IVV=7/@MQ2^?;*YP@D&#2*2<(U?9_?#9(\`#9#`?*
MLCQO.[I>.5*+9;?:GDT*[9*G?HG)*H%X$AQL3)T`C-T=TU0&+==(RZ+^=,5\
M-2U-"D?CD%.XOIJ^ULM&=<5`)7=`5PX*&XII6;T'A[I)FX/60"(;:4M+U^'H
MZ"U>(#SK>2W:+#9R*QDRN3>[\K*][E#V\&U6-C.-_>XW8+'^O,D[M%2$W0:]
M7AQS"0V)XBO(UN.TR?190`B>N.H,:C5G(P$7=ZNG`!-W6T5,.]*6J(IZ<,,0
MZ$>_XL8OZS7P*(C#JAN^A`X7*71+O+6:@OR97IYAH)C5;TK90^O5%#9=2=ZU
M)`>S\)@BXH^=X]ISPUJ5%W@&-XS/&94S*;I,KSPZ%IH7B*NY7I$IQ$R;<A0>
M6-0N?NQ.F(3"W1EA7+QCX@IZ/O/T;P_WCB$;9$"`8N"SAZODW3'+0%'%W.'S
MJ'GJU&^VKZ[I)GLLG8B+Q.*S.$%5429>S`)=JMF(RS1<9O`[^PVFSEU+Y@->
M'#142F/BD?&;_"H[AU#"\16"@NR75CDG5N6T)`V;*^X%S6Q*%HZE;HB%G:_'
M&$/;W3?R9N>(D%(5E3F/DW<(#9I=F@"NO>:XFR@*"=E+A:M./"U5T1T.I`+E
MZ=5M1NB9HLJ<L87'AA:?/H][,"-KC2EEK:KHBC@P05WAAXK+>2"*>UX[<P7J
M"I0G`S2!]OQ`8;C[8SK!'%I[I+H>8+^<$"I"2U64B0.IX-1JMSI*I_;*X^ZO
M6$QBAS,5X/-45GUXL`KTIT,5J$[ZXP_"C1;CPN-O6_+;:--(R%=9Q)B---Q&
M&G,KTQ?-C0!?N[L_,.+<18;2`;C\=NE`['9IXR=W0O,&VD@%^L\>91?>-CWZ
MTF-N!:Z>BBFZ[''N%^[J6`Z#*=IX92;<]@O9>_I?8*B0SDX@>CX8R7.A+J&L
M!"L7O8^6$[)74ZS/_ZJZPL:4/R"LZB9V+$C^\CB>OC1^'3]_FU!K\CB=C?^O
MO6_K;AS'U?TK>=NSUSH[V[(M7QZ=5%*=-:DXD[BZ3Y\WE4TGFK:EC"2G*OWK
M#ZF[+5(B)4*B&+]TURT"^>$#+P`(/%S?+>[Q>O*\>OH>+C,B*\BM97OAL7>Y
MC;N66KL[!ZOV$"JN]L*1?C<;?-8(=3B8PJT799+K+Q.TKZXP'E?X+_^ZG$\`
M^UF4BI9BZ&+*2NR;&Y+>/.B0;\#CP7A@U##ABW\\KU_1YK!#%^[V@B!]$4(=
M_BZQTXN<H?[WQ3^^D%>?.U_H`%%A_LD@\-^6_\-8=O/EXNKC&[((3E'C-?2?
M`W+6'^&A<HBQ!+L[<`Q`PN)!^W1\!AX.)D/XV;$'('<A$5%C83WA0ZGSFP(O
MH=-?_F8C#__\Z\<]*9&;@#%J@],E8Y!+:[\H*57=%*[BB]!09%-=2,%E;.<"
MKR>\CR)^"V=S;UL_[%W8L2B>ZF;I/)$N1L1SAO_!@^MXR6])2PH_\HI@Y";P
M?&DZ3+E<D@]:@6[<=-6?9YFG%V\K:G/M7FIA@#;Y)EL_RI0C4`EDON-6:M'M
MIP/6/4VDZ,0E;(:#4;NGY-,1R+4_D?M`Z<&A!*?/N([#^F%:6\>IB'VSO+]0
MV-LQ:P5YC45@1>"ISP#[`)5(5F9;*N%"8D"\`/;8[]R!R8&\'U;$Y+(&Z-$X
M<H-8!.D822^RV7!N@*'!/0R%K;'P2+L6MKTI6RC\?!L&=9`"YXH89YXCX4B2
M47Q<SL>C$?ST"W(5-K]"D7@^]&)[,Y6W-\&2\5R!+]B[1MTHI928'LBUO7!I
M[<D-1,@1"WO#D.;%+I_QG?-VP#LN\?X9R<71&+5P@RH*!KM7"ZBR8`3E^/0X
MK"U,CV$V_1;H7Q2L.CTH^&A_?<Q-?Y1-G_9X"8X>HW[0@X)/;ZXP,$DQP\9)
M,<$K.DF,^0UM7O`AI*.TF%BZQ*28*VM'$B*?7Q$^EA-.$^(2G_YT!!>M8@FM
M?]R@?3$VHND(KJ@V6ZR4U8);.<FZP`6#VD?EZBF`+/P--4F=2E0+*O+Z1G>=
M>(D>30%;A;&D@C&2H9WCBECE*.AZS,W/_>B2&P,PA"-TJ6@5N%"*AZX'V\P3
MG=O#OV+(2'VXJX]X?W]"NQ!-_]5^"]=[`[*G3+TQU5\6*1],SKOF&"Y]CRE6
MBC'(4FQB*5P@J;V39Y!D-YS,6VQ,`&_YI:+;C-$!SZZ-&)V@&NO'W/I]8=4U
M!E`^'S_'#MIYX.HC^P?7KA.*76%QZ8KX!?GVBQ/^V]BG;YAPC;C@QJU"/`54
M&6KO-<4)1(F))N#3![I,N41HP;Y.3APE$"I#`17AX_#5*)-6W-6:#NNR5WQ-
M;P'6XMFKXLBFP7E+`?P+:T'SRV"Z5"B91E\$)+N;PK4@94F58J:\!PCV;EF$
M0)G]LIX20?)+&RF1<2F//H4V"[\0'XL]BZ3A`F#*;.4`@"C*4EBV#@E!TQLO
MO'#&ZX/K;%(L$F]SO-K"-*4J"NR(`Q53[XVC75CGU1Y4D.-H,S<S=2;7EO]Z
MNW-_QI^.E0C9*84J42:!>;22=ERJF'YOEJVZ3L/CB>-3)US4D"ZS*\U7(]";
MY4M^AM.H5MVNBW^$=Q>IJ4K1%VNG(&E;QJMI?GNNT-5X,%;ZS>GQ>-MSAK.7
M#!#P==UJLF1#JNOBSLF5:4Q7@$?7#\LMII!GD!F3T1C.XR=YM!VR%1+W'OOV
MFI>T+-3#^WKS</.TN!?9];XB!WD-ZMK&/Y^QP#2I"8R,U@DG/]X@#=%[L1S[
M[Q"K:WSP<G?V)N*QLWG,X9BC6%;S-P,QQ[+1>`ZW'<D>KA3SKM9EFN(&B?8G
M/NZ.!VRKKI>`'^NT:0:]*F;^1.;AH,V-Y3GX).,OUNO#_K`C;I\O:&NO[>`2
MWYO&<*?IZ@&T;(J"B.AZN&,"-FN7H#7;>('X9]MO>%:MA8;MSC)G[OB2=,I3
MF<'"SMQZ[0/;I`Y<F\7&S*E&*27.9*9VCT5AXBS>\>9.[O.D68ZU0[3"3`^'
MR*UHFD.!MGC\7VYYVZLYY90#FK5*?$+OR#F@6XSDU[!C&]GT`;N2%>2U?NHI
MFV]ZR%'=TH6U["/R=!K?LKZ0U]#N6QCCMG?(#UP'Q:`\H36RWZ/D'=.D/L)C
M6+OH]UM7>H/II[?*\="8S73BA+W_<<`_0K"((<#&8`+ZTFDB6Z="Q:Q3Q^!<
MKX;*CYZ[1FCCDY7O^H!YO\<_?VF,IU.XQ9XJLV6%5\\[-7!C-)P-]='X`PKN
MG#6>+\FKQ),;3.%:9!_):EG#['FFVSDYLVEDR_?V&CD^\M/U:VB,X;(>3J2U
MK-VRN6;EM*>SGG6";1[$&9VZ>[\MGOYYLUI<W=]</-]<?W^Z6]W="'4BHUV%
M:CM^:1]+U3T:C>!.&662Z_OG[IQW%/?2NW.^H!\!/DQFDJ*.?#EYSN8:><3!
MNO*L#8FDAVX%:@3#F`'FJD$-6\HJ(,:19$5H11,]=G<WCR6-BK$DZN)R7`XJ
M]:S\S];U_L>W\)]F:KG(-%*S(A2-+%F&0"H<R_89;IVFL:QOUK]=CSQZ\4E&
M0LB[`MO(LXC1:`#7(H%S$/47.@X!<68BGB?<>Q;N84A:B6JJ-BMI7P,UM9_`
MB$\):#N7201Z#-!]1YY#=A0B(/MNDE%KFM3`,"LD6/JUMNC*4DU"6($Y]SBO
MHOSE@.N]N9X5("H"QA#0#5XJ6A6*<./3XV2Z4H*<`I;,?`[8;)TN4Q5*5".2
M[FDDR*X1%[CN*D`G(8C[+.7H'$=$,RG10^[Q=`A77HU[&.U=.`MGNUI0J7VV
M>[*<%Q2>:,>C,9QV4S$-$O?()^)E9CPRX6I!Y01)X5H)Q&DPBCZW'E#G9-`P
MT4)!A7!EN.2V+BL@SQ#^L(-7VUDZZ$]D>=GA=T2+E7#FNO#(D$<QEBI8"2_"
M"/38%=:,&HLM_F*,R^K5<P\OK[?V>_C;W#5I1"ME6)<IU2(5(HX@/KI>(_EP
M2I&)D5HAYQ0H`1^##)FJ,4D`(5TOG#PGS?NT5-5X.NGV8'XOM2=V@QN)R$F=
MBI\RQ>=:`*F&KUN9OM4MP$,]MZ<`S%I_.P"V;(#T9)2_;`CNN8N]ZP7VWVAS
M[?K!Y<08#\'FRCF(UA;'$A57[\1,W/IS_!?K/%D/4>`G^QT9#=:W`==TD"VW
M0],0.*3FT4G?@2AO#<TN,8430?8Z]*OG^OYWQT/6CJP7I'+G%4F[0"OK%X8*
ML'NEI$&JS#H)N)\O1WG$S9%&*S8_.\):NCEV#`9P8$@:98=FF>'2W"[9R*>&
MJ6QH=!X9IH->R,2D9Q466DYR9!7FLCTO;.<BP_F"``V22WB48'JLV.8IA!P!
M2)"'V3!19+:1D2+AMG-P#R>FD=1GND>^OWJUG-5/M'M'W_"_?LW*L5].!C-:
M$0;H\VBC0;<7H2X\;6]!#;VY!C9^!,\/7AZTI7?O.B_(RX%G&'#F##3H7G*8
M6PV]B4`)<UB_US;X<H`WX=R;;'P'-^&F4138Z0N7TMGKZH/@`@OF"J/JZ<@8
M1LM:[KH1OG+%UXII>Q<Z:>-NSZ:J;W0PRE`__;7DC@=$Y@2W9&^FX&>J2.:*
M<?>3S"+*2!T6[8=]NW=8C#A?6->J&4]3>\-"\;H=`4L"^.F+W<D`L)$PQP`Z
M/",*PM.;Z[NTY+NJA3`K$'Y<T'YBC.%,1?IPE62@!.A[<U4'*.UA%%[?/W^_
M>K[YU_>;A]7%S>^D48G(7O-\^.&C_QRPP)MW5*BX)[##G'XHI8@)V72');7!
MTZ>3+^8J0$P'@(5TF'+E1+ZXM9-F2W+AT..=HWF1G5G!$E?+ZW_^MKS_<O/T
M_%\7V";O5G\*&2,I0OOJ[C"F?A13K&^.A4\]N`'*J9U:P5%BF5^F[`:F2?TN
MM5C+=$"M1PLY/Z@Z.**:/*IH+(S6)S;HL4%IDU#87.O%E$]7TZ:AXLKU'";M
M'WJWC;*O\1P`GRY0)+:SQ18?)%1,7NVGGJ>CQS\<)L:;QF34FO9BH1`*9'"1
MI3S*]'NEO_LT[PG/`.XA-4MJ]QJD`J#,TY]Z*FSCIB*F0NH\HF+K64#S^N`1
M:"Z-`614ER$5@HDEFDE++G%@T./#F>A6$M>:P7#!5<MCBI5VGHE?I^)9&&W-
M0N+S70&U,-;4XOR5V1-K3)Y^O"DY$!31ZGSZS3-U9Y1+$L7O<?&/!\OSPK:<
M-?-P*1?8Y(M-KT^+GY:W254ZFDS!K/-(4H-UA72PNK)\\@)O_X8</^:M1]ZC
MALG(5Q_9OWFT/LB?A;*S`3B;QYWE/%C[E)<#P,)4$".6LJJ5ZSZU9F#`.U\(
MRHL?[BS?7VY#"\S.+L8`L#,Q561]@\%:V[M.^+7%RXL7I@`LM_@(0UI[>?8:
M+0[!*T;\;[0)BT<(]+,1^+04PG(J(RO,6&_F"2.URQR\=IUW_!-AX]@0EJ@=
M8/3'`=H8E].A"?<NL5)\-R01P"1FQNR3$"/J`A@B`)<_4BY;(4I0T(CY,->-
M#Z7=0\._7(;S\F]^(6]MXWV?M!"=`0?2A`;4!7$:PI;L.WW,YJA/IV7P2DKC
M3N83.`=7]0"4HTL1EH0>`^WH02;\@]P>OKKNAK0B>7`=M'_;N1\(VPWRWO%9
MS5_A"X=OK<D$_R"W7Q)8<C8%@R(5V04ZI\N4W0F'H+!+V*9=?83%YM^'^-GR
MREUL-G8TB4?+WMPYU]:;'5B[G&62_UK.&I%Z/_ZE.9W#;7)-1M8%]V0A&5-M
MJAO3<O?/:$W/W3>G`\!<P!+!'=_#RW#0-::3F_ZCY2V]YX`\PHCZJ2,O1`3#
M,#;;H`-K`!W3@@>7'J<Z5W2<C3].-Q!C3"^R+8<:Y<*[8(4`'+I6<#J&@&D;
MQG@\ARNVQS>([AG"!8^N3\'S79OC@WURFB?-FR=SN$VE3'0WK."$(KM&*_M<
ML^DUFA&H2ZY^^0O?S!"(]XA+Z/9*7`N'A!^F;HM%.8P@Y7<DAS)+'6:/!V_]
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MD!+J*9E;AWEN?&\'_<,.WV`"BOU/^-7#^DYWVN&:68>I94+-(,,CX-5'"$3<
MVGL&>((H$=PD_\,*P@R>_-$XKD5BP%6N8(J50DTA%66W0@XDU-YTRZ\WD,?:
M&NE(($JL1$"9C1ER^N67@)3#[;LPA(K14%[?41[?77T\'][>=C;R(EL=C`!7
MX$9CZW!IDX9IATV&Q+;FVA5V$B@ARU3*&J9L1LD&+4V58U1%4GLWK82#A4:V
M\9@#`[!@<N/Q]84_<C6AS!$`FG4P2=KML$X\SI4O!H)W.-J+!),:P&"]S&@B
M3(YE`5!!N*Y*)92]>6,L'/60B#]<1F)7IEA7=II15GB&.ID.X-[621^O:A9.
M3Q$%TY"N3\=EH99['!(6WP[!@ZOX!C7L3\/R4GWI^BH>M`YM-SR'*OQ+Q>\F
M<:%DYZ4XG&',1G![&5-L.]8JA12)_7)!V)LCIJ#]Q0?K$+<L$&::M.0\QBV%
M\HD>LJ`*"/U/&WR.V<0MF^%)BP9WX^P^'EO]1?7*=M^PZ+WU*Q<:I@6P&!9Q
M^O.2S4&.HA+BETY6&?>H;'2J8C9UXQ9LU)6!LC)NFV90F'"-SHKRY!@)?RX!
M+5Y;G+G:6N/LG0F4/]&X"ZJDUJ!%HX6(!Z3U+"=#4^VEL#EJ97'=SBU"1HN?
M"5^+GP22"W=[D2?0Q<TO\FMYG7\R[/-B8BGG;D#G;D!UE]!S-R`!'TITG&.`
ML0LU8)/V$4]H[;XXQ"$=A:S"VL>9I]"846N52_:\R!EL?2.-9:`-?0CQVG5I
MS@"[C/"-08HA@9,DS501QE57WQ07Y`]N^$X%12N1OW(#:Y?_>P([/O_\B8),
M(9=S8]B";U3VL/O%XU:TIZM7#@R\2(>WKA?_$?EW!D$4[LU^NW,Y&PF?GG4-
M*-XY^)J%4C_0?:RB\/@[G)APW99+!-<_9#$^&I^PAY,)7&YGJ6@I5B:DJNQ9
M*B<B:M\Y^*8!LAXW5RQU1D]8V7CVK_@B^`6]HYW[1KX>'U?CT,+8',-5#^(8
M`"1M6:I+B"N(CZZ'^J_(09ZUPR@L-GO;L8E7DK2\/@9B.)["=2SE&D*75!'&
M2-=C<.86E7,BBYW9TVD;3V0E#EGR*PE0,"LVZM/=7>UM&NHB`$*]+ER#BI$.
M4%_*O-E1#/+*EW7G-[Y]?N/;"H<^S>O@<[9SLVSG,%A>?!:6Y6N.!)I[E'^M
MASFL`O#H>KW$M^S`L]=!W$?NNV,'_M/S]_1^#>A7*17=0S9Q0ZGM[?.<&EW,
M$TVK9^57%8%J>H4/*)T<73Y=9>ZNY^SH<YYMIWFV0+>$SEDA(]=TR)EK>MCO
M+>^#I)I&)[B+!;:9=SQ;>5FFD8CE-A*0?+]I?FGM![#)276SL2,M9C#Y&?L&
M@+DZH$,'3("M&-:MZVV1'82#<38WO]YL+_R"?^=$YO8'(F79T&;QCCSK!1UU
M0"'OC@W`%F==SJV=8[A<OC=^9RZ=%+KFCK2C6,-0T:P47<ER?50JZ3E2%UW.
M:?1H><IPEK4^U5)UAX6:Q9:BMW")O7$V[2U'OT=)@^%:CX@?9^62/Q+`.?(,
MJ6E2S6;WJ2U-)C%B`U2_JW@'!AC#1FZU%8!.9@-U+8US&I_:I&JI.K8=\VP[
MM14Y4-%@M#E+*XFNACO\H/NS]*!',>%H.7H.+"]HH]+<\1*/>/TEDVF'?DNI
MD^F1*8E[S>#4GL;%-6O4*7%Q>G)WNUO7(W])HH']\.#D!MW=9EY]AXO*BY(E
M?CA7%U?>>2BQ!G$SM[V;.DW+YSLYUT4MA6XRGZAK((4!?TY+J-#;^2K-I:O<
M:F&H2_GSXL^CMS0*.YNV79"N3Y2GZ<H<*4Y[)8Z8N82!Y.X3+KIC=2&D#+D/
M:T<&)D"R!UUWZ>K1_D,9SM5C'JT>#GHAU;"463N4=XHJL7:4[5VJ`]BC,P>D
MXYBF-\U=Q+P=R;(V9,9D/H,\4@B/J`^TI6QW#9%/7:U#[78SOMQ\F"A#\Z<'
M7>S02J8M-]B@)3W?D)Y07*T&#1*%506?.QS6FPQ)P2C4XN7%"Q?3.R?`.X9O
MKW^W=H<,^:%I4A^.,-XE5GRN4T,5F6IO?/^BC:J.HZY/B+P@Q"O/M>N$(!RL
MW0IY>S\/"C4`S^IB)?C]3@G1"(S>N,I;#DLS8FVYP`/##L,L&G7?J-6>EQ2*
MBR_3P+%307UJ<(1A6\N/:G1_5,?CCM$S+@US/@4^B(,,7`6^PVM$_VH=C6\S
MQ>5@I.Y[6.:X5:`SN#YZXY#L;GGF/"R&J\0<N))8NS.28@$2+AX`*WPMI798
MDE%I8ZD^*0K!#7P54&*BNID6$`5T=;XUA9O]/H6%ZS#$%:XH?`<STLV&FBHU
MW9Z4#>(QC45&G:A1W3I1&/*+N-1G6C/J(G`O'ESG?Y)B;#Y8$:FTS&@B>N7F
MBL#YC8M+:1C_3.JR8NQBTXER+?(V.J$M=2S?=<7WNO55BTQ65V];$82R5V1'
MT-`*UG+S@$>*8NP0!D;7,U8E-'Q[/6UYK,L?Q:-B<@'3-4Y6A(GAY"N:W+`)
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M.YT=`V(8E=Q%IR(7*RE2M6`=%Z(ZW^YKG[4AF*8%I8XQ^M17=%8N;&A>C?*Q
M.`6U0Z@Z.=*-\XF/,.S-K;>M]/23*,.T45*QN$R-><="]O-<E#F!*CM:-+I!
M-Y.O,35Y$._Q_5O&^T]3^/WGT_/WHP>?&'/_L`N(@N0_]WSR#]D+SYRDQ@\\
MUZ]H<]BAY38K!T.)Q%`",:MPH1O/HNOH!.0%:+/!-<R6$!!WA17U]K:SD;?X
M9?ND!BL@*(W&)N>)CVS2%*L6-<6]PW,?`+_PDH7N\%(13G&F#+728>G%*BK:
M'9[B``B5F,T7EQP8R#PGRK#J>&SU%_'<+OD-)2D"(Y,R3\8!L_`!.327K*J$
MY>73U7T]A&YK`K$@5D`A6+@O.C#>.?@6<0@[ZRZ#5^2M7BTGR9-QG??P'I!U
M\!M2']=T7%E1="*=6&49`QO78&RFRMZXO!HV$J^K*.`ZHAJL%&$JR%'G,F.J
M7@56P6DHLDS(J]3:1(VZ^B2;ZP>ZLZ(&RT/D3<SS2LF^GH+S4&1]D-B,LI$B
MU0_/MMZALA+/HG=]3-LWRY+Z6QB7(D1O<2,LT4MO,EA:WPBAFY-KL!&RKV%J
M-7;OZXU:7D_W9JK4.<\2#M*X"?;Q`2,JG]2WDV)A*HI82)N'Q0IUJI\^P'%>
ME*VQJKAPW0@5.R:@N)^?KS8D3!BJ>3EI2:4OB^J7%_GL/$PI(Q=GW#@7YR9Y
M01R69_]B>_C\[WK0>3FI5*RW5&;3#)UP=5[AGPJ7D%&40`UB(4>2`,_;/FL/
MR@;@;!YWEO-@[5&VQ(U;B%#+&[&4!:5<]]Q[?D/`%=]3*(NG*`[I,CIH-9>M
MUC`[N`CG#YY&&^E'=<<'EH<DB5"-3^E4372^YRN$+&O%[+"[3;N6J5@R1T_]
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M8PX"`0]?^==ZR!,!>&*&#"Z'>C'D?+?K[&YG7)IZ<:GG=SN!.:W2#INTPRXK
M0,+^5+=W3\XI=AATED<^F(,B%/DJO`*AW&3[2IX0$;VM\+WU"G_AKTMC8A@3
MN(DW'F";S"]&ZN3BVYO44-%UO<HYQ81F2NN,U])CF/[1C0-'72\JE99(_M1?
M'()7/-V_T>:[@W'(F2<YH^'#W%&OF"=RRLO#.)IVN!(VGH#2U)6LGY3FG^*$
MG(6%R7&+=DP1.E'>2T@L2-6=!HUIMQOV@@5X;6PT-D`C*M-BT8R:XAI;R%3?
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M>\8P\:85S?@9`A)M!+3Q[,+%IG*<Z`F9:<<YBI;-O21OEA^MS@_B-==X_)DX
M!0'#`5<?@F,`]=D=ODGY9F%\'.0=+0IQFL1H-H8[LE9)AV5SF0(3/HO@T^.]
MJR+1<?]VP#]S.G7#F,"%\!E"NV<$!QJZ!@67VZV]1@4+F`!>:JDBNR=!)1+J
M%X2H1X%[9/F(N.#N]F^>^QXE[273'P!622H1W#T=.%'1]0W9[^C57N]0,F-S
M/(.+-A[+ZE[U[+GK&A&DDGVY?4`_;ZVUO<,S).G^@7<(JYEGJ=M3&BD8@94Z
M,KKG0F-D>O/H6Y`R3%2O/M+`S'@8E5-JUS^0#0#""UCD3+NS$[PAUC:.,C56
M.P*I*/74*7"?1E@Q$!WX!.Z;YQHQO_W5<WV?>&N''3CK0^&P+"[1726)B]CH
MZ@U8K->'_6%':F1]05C2V@Z1QK_>H1!R9[/8NUY@_QW^.1.Q2W-JP*7_R!IE
MYXR#@%M7_X0`SG-M5N4'%)!U9S1L?UJ%E!!X^YASK\BGN/3'(^,&UHZ?]/E5
MX7(V!`PVYR5UOBZRIJV!CX6_Y89H1++2:.@'>6W.XNW>OL16_0ZU3@6J\ZS0
MYNF1D]-LBN7JMYNGB\7U]?+[P^KYXG'QY^+J_D8D?2*,!^(SF7MP`O_1^BC&
MW`62)F@?2T/LQ"\TY_>8E7VK_JGC](/XL+E>>P>\Q-G6#^+1LI%/2]DSS1EM
M[-+.]G4&)<4*!566.\4WQ;'']\GFECP_M>3;NX?%P_7=XO[B[N%Z^>U&.,7Y
MUG8L!Y\?=G<._C/4)+LYY$3T&;*J_B*/+Y"?LF(TG1FP&11,V0WS0M+OAK^+
M/T[-T!U-YW`A'Z&QR+-R`8T>98O40NTS6[<Q.+7NU>+_WCQ?+!]BXQ:QZY7U
M"_E+)U)";9..?AQ_*QM6MLI/`)^ME0BN;\R4C^98:`Q&<&D\9:*EF*J0IA([
MY0;D$YOE:#`]-4MLB]_N5B0!^3G,1[Y>/JSN'K[>X(T8FVN=!P?7[GYO!V&<
M%"^8UZX3V,X+POLR\AL^.BCY,H4I6.=P%T2AH=2W\GO7>5DA;_]X\-:OEH\R
ML=&]<#0<P?5YK1`NQ=0;JC2-TO/CI+;C@SV1[$*/)P,7K.,8@(R\^]M#@!7[
MS7;L_6'_1!BRBTO#D;9,RS?D680)8?:%7WRB/P-LW2=CC%)LHQ87BDG[LJ#N
M\;Y92LKOCH?69'*;[_@(X6SL:!()ZLL?._LEU!'U-F],3<!W;HW&UCT)Y4';
MGTB/8.*=`+PM;_)R7=W")YGJK9V*4.<N[L^1-`>F[KIAK/:+6'VF+$)Z(.$0
MN'OWAYUE2H_F<`M505KKN<'%*B0E`*B]#MU;S@;/]NJ`OX#/?NFSA@'@;9(F
MLGL=5B*AS'WQG,DK,9`\X@P_U?*`%>-0#1U?.D:CL@MJ*.'!==SD*AI)BT45
M;Z3#-BK,B0RJT_B4!!Q[?+-OO`Y4!JIJK0!'$:N&QJ]7W"JCZY=8\UC`PO=1
MZ`#.I4Y0ZG("%I>O-ZKNHETR8-0U9?Q?!VMG;S_P`OB(O#6!_@7C]+NU.T2)
M=AOR5N\=16B=X#,T3>I>RLC0:B"J.^[(PN<S;QN\>8BU=@]:0IJ,$Z32:8G9
MBL:36%=8UH:`#X^:#*W+#$5ID'YB2\?<+U9P8]EZG>)M--TVK=RFOK4GA:Z?
M4/@,+D?#ZX-'"'$Y-PRX2VVE^"[-5@B;'INF,(7Q__"G=G<.YF5P"..&X8&$
M]CQ*@,V4SW:I_CHSU_4H'^]2OUM1O?N$_^9D"K<VT&5V_-*@`@5=P^-\@,T[
MW,A./A@*R10TG("]X"T1W")7"V]W.?&("3M1G["B+W>C;Y,\JVO\?SM()C^=
M`39'9(KM<MGBPD*#M[T,(GCVNT7\*)3SVVPT@GM*5R:Y6SKP(9(6S-*L+UD"
MV\FU.T'`&,U-X"@>4[@*QUT.6%)F3,V^,:.Y&V):=$-4O-U(4WLOPMS>_Z[G
MGRC)T#_.'6[JM/A\KSMRH=LC)#<YU_OE>#J%2ZKB&8%*[SQ$$>L\3Z54_U\/
MEF<Y`<HG0E]]/%@D7S],UQF:@R&8[JNDU^<U[<O1=^-,(CPON+8*5=*E\%E<
M=0F%1<!1F[Y)SEAH@>FTX@RZ\7`"I^(RR6#J+6?P:2)=%2AJJY:ZNMYG^?:3
M.5R7YW+9]5>EDY=.Y%8:IT:%9<5&XQ%@N8,RV7).WX(:2X_?W*CTQV4C>"\[
M1N#HN5SR4.[+`=TYJY_NG\CR?((*8$DVX?&HQ!]!]'2MI\Z/"F8.2G$!?-=;
M8T0]X14=05V['7/B"1)R:&EG9NF:Z!>PTBOG*-JTBD)TI0Y2R4ESH+XIB,5:
MN)>(6_?@I2O$L*V3*\^`^K'$TO&+>357GU825MB'`[G`+;??'3N(4B\$.I]4
M?U$A'E1..-;[0+OX#+<YV._9@<.`"^2)#T@A&@GCERXGGY-66;QK/.G\;BDU
M+`A+)QINJ:=":RK%4#Y:7F"O[;=0`;<8]GOD^ZYW.9P,1K0J22)[%./;"O%"
M`(0.2T7`=LC8H<U+NFV[P3/"H[$"M/MX0F^N%Z"H:&GN43)I5Q;:SZ4Q'@WA
MLI(:C*Q3BLE"5-=,%EIT)%Z'KRW/(R_+PM=DE\8`,E&7=QB=<JD65FDZKV;$
MT;OO.K,<#$R:>N?U<(IYZB4`Z/I"0>\23^<Z0>)U@OI5B4RWPG.?J@I2J<J?
M+.<EGN]H/`=3;"JF_BH3?B))D1F9`]BQ2EQ12B!.*,68F]K4^6;](FZ69)$;
M`:X+1Z+D*87%ID0MS!EV^!Z%1S&1_RL=]A3.5HY$M:@8U@R5L1C^IFXB6=U:
MMO'CO#2#\%="L@*LIOG!Z?!U;YN`B.14I]?)KD_;L)!0#QCIW-M_!B7O,=-0
M\#%3]H#D(G`OG@]O;SL;W]0O\+7L@CPG(>]&7$_^&Z=<X6HWE1K_HTCF^=W3
MN:O-B=&?N]KP*OQ>@ZXV[(_3@M:YF/70-.<"Q0;KRI%"Z49]0*0@I&NE(V%P
MCG*>"4("]8\:">LAD9A8Z1J/$($7)(U:K:4VU/F(OTB0L(#6;:*0$]X,D_Y4
MCA)+#O]*KI+^$UHC^ST\+!F#B0F7^GTJKONELA0`7:ON/+D?UB[XB*N/A$2G
ME85E&/_Q3W>OPI+9I*E%FBF0C=>U%:`7U_M8;@EJR=]OXJ@<QA`N:Z3FH$`N
MR`PG1.PO)Q2AW:*$=[MR.<"F(:AJCNLR/VJ?[Y9Q]<'`._0[CH9CN.!?S4$!
MTZ]V0T)N)/7QUIQ[4O:^)V73=;AE"C3?<NO30G"IK*8+-\*=KQC-8S[S8@$[
M1LNU.B&<8L\U*47TJQMRF2.0Z#50U[4[!Y\;D!\LG>=7UPL(*Z\LYZ^H/"O)
M;\2_2:2%YZ();8Z,XZ3(Q^4DY8NJ*+'(^C"H[S><1P;AH)>P>X!8?5+-F@PF
M>HX^_06]N;X=^'_8P>O1XYVTIKYAT+WILAJJ"8VF31,I7*::(*>K<^*;Y?V%
M-Q5\-'Q&:[P#D3JU7_%&?>_Z&(#A+$II`Z%.F>A.><*-28_*D-2M])U[!_C@
MXO.';[\X9`U>^+^AS4O8D#/]!PE&I,K:;#2`"WTW'EZG])(*;D+!,<DDTXF"
MMZZ',!Q1U'S]L?(LQ\>PXIDD2%RA+?XW*^O7I3$8#>#B(`(CZ917=1'3]1$Y
M)XXPA;>`#G_,5LB7!KZJTX+"<N;#E-LFXPMA8CXT$G[WH,IG(1[<V$5A#(HN
MBD(WZ`?+\\(-J6:NZ5%KZ/1C39T5-PZ>Q$?L-YI7U23RT?KRQ7W_WPVR(UKC
M7YRR&?_1T5?KV^'SX8=O;VS+L]-WP:8Q@3OQ%.5),;PRB-/Z]*535=]W4/,-
M="C[VMV_6<Y'^O+;@-,P16!K*JZ8K+;Q0_1B[2)\0F>W,:IZNL.[R)Q\N?XZ
M0]&>A.$)KX&5X84*)-,VH-3I=!X(J/"WQ?W(%X?@-1Q74B]_`IC=S9):GTKX
MYY$?V.MKTLS(2\S<F`(FF5!%2B$<OU+26W?5]'7=R4*O)Q[U$WI'S@$](^_=
M7J.[I^<D4V0VA6-`A?".N"``27]R2059X7L6VN5!2Q.'9G`N7Y;4KGC``8*N
MWI$4+<KKK>'$A&MT4R*X25`L_N@J32NE'9:80=[\3\LE(P^\V;K$G$7?SDC1
MX^;)!"Z=ABY3`H58RT=+LY!X+.=52X%_)1"H342]2Y>=5.J:3N$ZZ:E6JXPY
M]9[R\5RC+.]_.M<H.]<H.]<H.Y?"4E8QG[YXG**)_OBL^HCPB*)L=7,XAK.8
M(U'U%]WT,_&^9D(^1CH1)H5.%9`GA"J9I]JV?F-Y.QOY`9X`*;&0.HH!72)4
MD7*5Q6);&IFIFK7:2KNW@L+@A_,IW/&+(K!=A57,6)EEF]M'P?+<I1-FQAC5
MIF8ZP?OT'=W0G`QH+J4J]^2]U*>"W,A7S$`_JE7[S92IC"YMSF5E&8W+V4R3
M:=:M13L?*[BT7"$';>VU;7D?-R2DB4?G(SS#%\_:Q]5%)P/:B9BQT%1]K]UE
M1VAVF:*FFC"5><[.ICHS^\7)))J`]4:[\]1@I<1[30UCXF$J9<YJGU=$)L-7
MDD62`NG7Z9_NZM4]^):S>2;9'/%GTSC^9"!02;#T8^`D8X*;K@C<<]4U8S.'
MP.HGVKVC(@0C_H6E_&NMZ[NX`_#/5IDS.%5M85>XK>O]M+P->8>$_%O7(_O;
MP7MS\R\]R)0$BIOQ?K?^\I(5.,>?SXL+&_U.VFB4?"I8"B\;:*18Z[\4&EV7
M(O;T;WZ]V5Z(_!<K($^1QB9<GC#O,-1G30ELVB9AECA6^%;`FJXA5F3BB3@5
M%Z2LW)K<3E9N_";D2+&TE[:L';;ZDW+OE&5`YBY60O/4=06+<8B.*(%/!T&@
MW7;5]SK3--\,-<C_EPI>K<5>UY7Z9KM%ZZAD0PPA(=836KO.VM[9$>+!+<*S
MMW;/6`,'S.V/HW]\.1\`G@,D#%!6_*K&)I)&(>7"K.O*?6_]Q+9X@U%Q]_8:
M@X9OF*3DPV(?OJV^1R^VOPO!NMN_[1!Q;^,35_+OB>N;F')VNWS`R\$"7S*1
MDX"(5304*;H+/2`%N-DNZ)]K(8W:"1TP7O']@)3?F@]&<'7+^,>A`/7J@:;!
M@89*H0<K&O5C/)__YSKHZMK%IQ(,`@'GYA?:AS.+XB<AL#/^Q4ST^S()(G(8
M3ZN@-,'C<Y(DAAEM(D1R"_"`YM*K112Z#+7)PH&+KAL3%9@U`YCHO\OMRMZ'
MZ!BT)[,BK.$1I"1UA!'2M4W+R?SC?.JP2==R>[.S7^P?^`83?(1@"`=/J[_;
M-3MJS5_7JJJDINRK&SY8BR%=.E_L=WN#KPK^+8;[B=3&<M`FW9T?/9<@'J(C
M$+&N+:AKNLA!*.;/5#?^\!H3OE%&D-O(OW.^H'>T<\-LMH6'K!"ID?R5IE1H
MU[R2CURZ1FE7`&)SP'#:85)UG)G@8^1C!/'M<F.'=\H80PSHFBCM!>%=G10J
M?+9V*#)'@9"]'*E=LPP`NYAF,]V6,GZHXIZ.IU#%17K\K_@'R$%S0W:'A?^&
MUO;67D>UND,DA<*F+0RJ/R25A7S,X?F9PRPD;?S_"+CDG[IOA\AK'"(I$%MO
M95#Z<)@7>6UK^F>H+=9KM(LL^@O",M=18"UQ]1AB,?_JCW9-(O&9)R30+G)(
MWC21>%78U\WZ&<>N8FP?$\DY6XM.SE&DZJ<;@B3@2F\H3@'B2$,KH91VGO9Z
M((4M[#%,M^XAS&0V!/SNS27VDUA,S+(F()^=6R<7^:(]#@4\]7*E]XYS_%@F
M_-,N*"0%LU.S'0IX_Z4/0`L6,A%-B*A=0*'>AG&++SW$7%\11FX;1&^&AB(/
MXN2([1WI.-#K45>9#M8\.G8"P0B84?2.B.+8)KS4+B9V@EWLQ?G7P=K9VX^P
M`=0[\L,.U(L]J?$?HB(0F1#]OF)<$L,CS<+H7U!+1DNL865+K`S'B\RGZ%^X
MVXO?K=T!D5\\>N[F$*9E7BQ\'P6^C.Y9F=R<V.4V%+K<9B(CB4U;;.E5!)X\
M"`CSKJ/2&J8Q@*OS?"Q+[M,FD9+Q[#FK767B7"7W7"7W7"7W7"7W7"6WW?)3
M57LD7SFXKF=9OOW?IZ];\?1F\$>`>ZEE&7DU5#[=#M/T^=HB')UCL[/NRD9>
M4FUK2&O'R+B]57^Q5>4(3E"9Y4/4L&":W=8S+.K8&1>GJ!/ZS2]\U_;C#)"A
M0-H#WU?E,JX$_(1U-2:KZQ-I4N?3]<C(5Z]6\(3^<["QI,PG<A7&$5PZ8B%"
M`FD.C82USA)YT.CZ>+!\]<[JM@T%>LSQ?%,*%6KMK7S[%F7F:A\)R:"7#LH*
MYHT$JN$>_7`+JF'R*O7X,F>COA96/]W<N`6JOQ[]L"I:H,]&[5-<.&X2.,^-
MG-8_KDP/V8\KHPG&C#J__\@(4XPJPQ3/ZU>T.>S">,2S_>*0Q'S+"2Y(&,EU
M\-?#D,67>*^\6%F_),8J$N'+;4YT)GFY3>224%5K\0K8=NPRXQ4%>-C%$9/N
MY9?3&6`1J1H#:BWR46SHW@P]72\^`K#<XELA-ER,RA2NT([X>'I!*0IVNMZ&
M"J@05)-4E5]OR/'1$U:&A^^/"V>S6*^]@[7S,3(36KX/$*NXQJ00LX0QU+7N
M"@^<\_YNZ5\]O')@/8ZG8!.ARVR-Z_-*KA<PZ$\-&/*$4"Z7S5%_R4Q<@A%7
M=COWI^6LT>5T'C6=@)D6QPA:XWDV0R;1*_!1O]K-/**]@U[($\D&1X0'%)#-
M:]+>HO<@R9,N9\D[F7^L^1[DBA<6O*9^C&$QV?+Y[NO#W>W=]>)A=;&XOEY^
M?UC=/7R]>%S>WUW?W3Q?_./1W9'BJF*NB9P/`I^?2,8K2:*,OY3\O[;GH?C)
ME!5C:J5<.31GBZV_K'_WT7)[@^_#>U*1E/1XG</%<H^%2;%0`54D]EDR95W]
M`/$%]?J`!3CKCY5G.3Z&B-1*((\'R&^CZ@>1;7RLL#%<X1_\Z](8#.>T6+@<
M0M0>5U?<D0.DKLZ!:SQO/.U-B,`I`%,#T"5;)KDKKO"BH>ME_MKR7[%1D/^1
MQJKOUHX$`DZ!F$S'M%?8DFC!,X3.^"&*3W]NRF)$>7YUO6"%O/V5Y?SU!;VY
MOAV<PD#">0+OMS@^V97:16>K_D6Q9M\*UWDA,#PA4M-I'57A88$ATGZ"\[M=
MZ;_6O/MS9Q3/S*-VX"X<G\P!M5J'G'V"=QA=<:863+K6P[W;OUFV1V:_]+[8
M/K8=:[?<$K.ZM]_1)LX>*1R_Y]3FOY(\KC6&U!67&L.G:W'2YU<L_,KRT8:D
MK2!\L2.S6(9SP39WYY!T)`P1,<(8H$MC,J66:924^RX^HNY.-<W`T[5:*`GD
M8BGDH)\KWQ!'>8G/X*MG44[]9.\7*/]93TI77)&`B;:%.6\LS\%8DNS'T*1.
M09CCV8*M-Q7"N^*+`";:%E9,(U&%G=D8S``/-@RQG1U>>&#0M@+=,UXM/1))
M?K0^:*NCP"NEDD]U=H3@G)VV==UN\;D\?FAU:SL8"=O:W3D8M<,^\PQ>SNDU
M`R4%9'B&T%GP110?;<NR?4&>_6Z1\W3AE#0;@^:$L^1VQ0D^)+2M@Q85L2?/
MSY_1^H!GE*0WX-O5<#:&6RC8@KMB`B<4J2>U?\7.*BZ:86\#TA[[Q;%I(4?#
MG$W@(K"5\KN[;8H`D])C:FI%#WJP,8M!E`4C+R?3*=R>TF1D:H5NQ='4M9W8
MM1OZ^Z(^U$^V_]<U%F0'Y%>74X-:=%A:'@A+<(=I(#Q89&7[M>/"'G__%3E^
MVK,\,H1B2LP`[HT0[RBZ8XDX2@EEM(O$/*"?.0@]U\&_7*/<):^P@X^,"5S:
MJNAPNN)0(]@2,O4Q`M,T+7U4(RT]K/DE,2D]^MXY);TDV2')V=Y\]]'VL"/A
M:I\4S`ZA._85"C00:BA.N920&BCIFO:>U:3``!_VI,,?VBR#5^11MEORJOL$
M(V-BS.&B;0U'UYF;7B*H/4Z$;[KG#`8&V7/<=>B\SO_2<C87-U@GP<?%G;-U
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M<(O_Q+\<#F3IBB&ALYV)/=,.7W`(:RK:7Y,9R%K^F#(ZUA9]MAV^C.#>JF[M
M';ZIXWF_N!Y9PD=2-ZJCKW>T3;%FV.$3`_Z#A+O?N\YSX*[_"E.=_>4A\`/+
MV=@.OEC,95U<JX5U=<3@FW^7Z?_<NGP\_-C9Z]N=:P68A;)NNH5O=Z0I^NP2
MQ2CJ?HB&_KN[.V`LO&BE\/'P95UYJ=_O2$'L67;Y2();27^@W>Z?COO3>4:6
M[SIH<^?[!^3A:<A=!!ER.E):]:R[?-S`OXU%MY`G%/86<5X($`="05J-^08;
M&%5,5UM7U9RS#!\E-9?.^'IG^?YR&V["88<0TS!:Z)UZ*K:^MS__I;AO@#$P
MJPZZ#7*+"O+D4K!:(>GMOW3F:H<&RH)6N0[8YDB@$1S/-YM'E6A?CUK"#<W)
M6*#)3.4'I?"J)M"G%V&^62O#N2:HL)0IU'VQ^]-6*Q"4+5:=DZ%Q'Y;!,`K;
M"Z6*/5B>%SY1JMEGI31O+/UXTW8J"]+*@`230ZV-)G!;_I&D^LLOO>3$`L/A
MO$19CU<?V;]YM#Y";A/9V0"<#<F?(A&G>+LT!R.X1O<0(Y:3!E2J^_(:'_(`
M[WQY:)AA"6,L`!F6N5Y-M54:;0CCV02NX;JT8;:4*E<T&`B<U;:2I/AY_.HN
M-\.K#[(`1-,QQF95A*AY-?C2(71%"6%\U,Y/20HAA_N&,1H!7K)SDNJO?(O=
M+OX05E9R0Y[.J9<TFE]J'8\B&G?RN],Q)W].$R>%>.6PIVEI%9-5>R6YM1T[
M0&%-NCL,A?-B8\N(>UA_?+/^[7KA52/J83LRX)@G,!`Y]_-Z2VA:):,>;FJ3
M@8U)>FHUQA-:!V;H/47H'@.L>C&4E/%+"&H\<[+@R<"9/<<`U-8Y%2>UCQ,B
MDP%M)=A4Z=3971U\_!'?QU>`'[83$N+:#8^/Q&_F.KZ]0?$S<;1&]CM1_/<W
M_(^0%^"]^PF]D,<VKO?QS=XA/W#QMT*/G$#9+X`A`!M!B>(3$X#&M<>OE,H/
MPYOWN-Q:F-CF>J0:Y]O.#=VXKA^$*)BT&D(,=E5^L'NNB,U9UXX+V`[(&?`6
M8UI:C'7E$DR6VQCJ"!Q:]0YF7=IZ<KKGB12$=*W`_H3(71*OKR<0YVLLQ0FR
MWLD=),2'MG\S&51;E`HDDH.3KAV"3L'=;$),2'O8`7QC^U.IW?.%!P]=W^K3
M5]D<?G_8P>LM(B>YW5?W'7E.N&4?\'EMC[S;0Y@BO'*7VRVVGG`GOW-"/]SF
MTC`G@/7+X`;>/2%;4HJN+8[*_3&)1W9LPD6<>48`3#.V@X[/;56$275795*1
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ML5+XWUB5:==9'G24V<4;P%*=&\21*%.%K3)`,8X[/E[]2%G&A1^?WK*C8*QU
M8V1"7MPJ!R#%.@3.[]GE30@;M15=F57,2BK.7'_FP``LX=AX?%)H`ICNSOTT
M0D@3RF1F*8`LKX\FM=3VVR<HAQGK.4^*T;#UYC8<J]F*O+%;;N^<C?UN;P[6
M+GH^.)S"'=ZH(ONRYE3BE:I[1)H9?6Z3:.X52]%LOS.4<FBRWA^D&,TZ9AST
M<:G%=N_2CTML;'Y4R_YQ*CMRKOBWKK=%=G#PHF8#8?ZD0)J/9/%REG``NAR=
M%X'@UM7)65L?I#4&*6:0KOMAMX+5J^7$:$;]YN_B9*P_D/WR2BZ(I!WQ"PK_
MDI103=O/XEUA,@3L"Z'*//MA12H@=<0(7=W*CRXI2_&V<T,<KY"#MG;@QW75
MHVQ84OL>,)K&,0+E.2N*HJXIZ-F!_,&-QK_8D\?4E\-IU0DK>8QK.^_(#PA]
M1O&O"7%&.>)$?\J4I3Q9.$#2-<><L[G0=?2/2(`PC/7A-?L!!<G%CJ3ODR:L
MMSOW)[GB(?]FNT7K`/^3Y79E_;HTIT.X\WPK4U">PZTKLL,JW"VMF!071ORD
MX&\2RV+!'$&&?_M(*E2Z!-_+V7@\;2'[1=Z(E><[M)HZ+&,.2N\$HJ5#11"C
M\.BA`)NZ,8C?0H-PEG<8RO.P%IY=%E:'[4)]M'E0$5D$Z7V.F-QD.H?+FQ(>
MCO)T:P1PEQ7)85.QD@E'L)P@,)\,X4H9E(I6GD[<P'59#QV4.H7P'GEKE0]0
MK=R;L$IK4DAQ.(7+S!<<C!1Z<<:#F>%0?KS4SO*Y";U%""4)>T-S0NW1R`BM
MG/PXC&I$N9F6SB^9F]I:^68Y5K3*)7F4(P.NIN&I-+6T6(:%,KE,5"W>W3]?
M&M/9"*C^'_Z\%$WQE2U,U'$Z*;4-Z9]/?Y#15KZWJJD"_/D.5'`ZJ<ZM0$;E
M\Z%PY?,D%>7"W5X\>NX;\H*/J+_Y?PYV^);\X@O"@M=V*/:"Q+(ABJ1G*3')
M*$B-^V0,^2&0$32NI*YCI>@$.%*^.\BCEZ0*0=9-YQR%'$-O4N>9'R6U%V7V
M/++G5Q@-.-<QQP#JLSKTO'ZS,#X.\HZ6@N3\,AO#Y7=429?"XEH*3/@L@H^N
MV4;$I7'`/W,Z=<,`+#_)$-H](SC0T#7M9;G%IPI4L(")";A"T$1V3X)*)'2M
M4W:/+!^]NKO-W?[-<]]/GD\:<+M@B>#NZ<")BJ[%G7Y'K_9ZEWJNS/$,+I/D
M6%;WJF?/7==T-1&X0.Y`H`=BJBDOMP_HYZVUMG=A8^XPCK?.5U(PS2GM[2C#
M#UU'1NM,+[Z;;XI,;!"3GMWSHMKS8<1E/*2&&X!IG0T`E@1E$TUS=L48U-.K
M_7T:E<5`='"SOV_^BHGY[87C'*P=<>XMMWEW7UAF=\[_3DE8`"QY2U16R5TN
M2'2]W5.7=18B7Y"_]NRW!)P)[>(GLNEQR.F<-E(`TM4E\$027*(M8S2&2[I(
MQ=1?$,-/Q*>2\<B$Z]68$R2%NR40I\6)Z7-3>_?]9COV_K!/X^13.)4<B9*G
M%!:;TF0`U@P55XSUZVC8@&?>(U$M*H8UP\Z#T^*5#42CD96G(?HU0&W*"NSO
M[=[=Q$[R'6J="M0G,@?J+MMY):7FN2JSP;20J[):7O_SM^7]EYNGY_^ZN/G7
M][O5GQ?_>#[L]Y;W0?)3_K"\\-%WF)\2/P.OFXL2N.N_R.$9'RNCI^:QG.4V
MD8*5%,MHG&U2VKM=:H))7E*#G!+@-O(`^2<`(Y:3JU*J>^XR"0T!5WN7I,\^
M_%-_<0A>\5#_1IOOV-J\T&XCLR2SQ;#<_$+>VO;1HV>O4;9:XLG#'0\!!BS;
M6+D&4QQ*1AVXVJ,``Y9SBFF#AN46+TUKVAI\Y>1;+/@#3UEZNDMT*BE^>.F@
M-+PU'0G4]JK^8M<&QJ_V-!5&#"5=W>A,&%8_W1P,8PED2;^H$5GH*.GJ-6?#
M@!F1MQI:^Q)ANF3?U(DP#*1T3;QC`G'K'KP<#K1R$**,R3ZI$6$8.&E;YH$-
MA/V>-QQ:>H,P8=)/ZD08.DX)83[/">;9_I7#@9;:*<J7](L:T86.DK;E/-@X
MD-:E.20$4HIXOJD38QA()9S1+D^<B<0-*2J;(4%]<2;*F=PW->(,"ZF$,UTD
MUW;#F0<[[U\8TPI4B5(F^Z1&C&'@E!!&NVJI[!MC?K$=TWR8PC=K#3<E.DH)
M6[2K),I>:'?'N[-("P>NCVK$&296B?].N\MUA;=[+."%T2H8P(N+KF_C*AS;
MU`+#W+SHL=^?%Q==7\A6^J_'`FX5S5S\_-AT^("P978<.ZO'`CX4O;SYW,CH
M6@J\RBU-+;W!3XT>^^VYD=&U+4B%"]H4\(AHY:'GQ25SLQK:$^/X?F8*.#\T
M<\;S8Y/18Z@[/58_T2Z_=(X%TD[*OZ8#09CH)`S1[A8;O\Q(2]K,X:HY'XD"
M9(OL-Q4)79A0J9T8G!0;S]E+4L9N-H*KR\H4VT/-<T&HS`,Z>GIXX7'6@QN@
MM,:K:8Q'8%0HE]W@E0;UN]'COZ%IFK2G4:Q.S.Q/R>&K(/SIDP;.*:J]!-%G
M<9\^0R4S$6F;7?XYP#=ZK$4E#I<L#X$?6,[&=EY.FN<>'34NC<G4@"NGVM(L
M`.VBC!F-NR`WT)6N+FNXCM(/;MB+%FT>#M%^.9D,X;K8M3:/OG*_D;ZT39\.
ML?I1#></X:7D"9&#)?[S:]<)=_J#M5LA;X_OH^9\#FP([<Y(!9/H4(=I^]WV
MRT=TL#74=,C<NS^1%_W*WML!V5M-N/+!D$-7@>UM:"4]\9QIS0;P^]M;`4"X
M,OF00]>)UF5:26D]-<^T9@$8'0&7V]S6&&^6!$MJ5JV"#&?/0B>R<^HJS:HY
M+^?56,9_0WQM>2QIS_H5YGUQ%CKROD)7*>]U6^]YM=#$"R[F6*U'');3OMP/
M3I^H,H$8("A@2RHI$TF`08]5.TZ#\H_#P4BX52FAD(=>,8OL=W1QYZS=/4@K
MTB,YD9ASO]'\5`[[P\X*T"9TR%+0NG=]/REK"ECK4F`@4G:#&FU':X*ES+K6
MA`'9AC>>A9Y'8]`A#21$7#DE/:!@N5U9OR[-J6%V/N]D-+(LH*'F!0V#BF5O
M2K6](3RRS7-@>0'_,;DNQB"WO/:,J^SS5VCK>N@)K7>6[X?;=A3_2\AAC"8#
M.-=\@Y%U:G3TGL$2(-:U^EU=H,U1OTWO5.NWF'H<TJ\/'M'58[C(940Q1_,!
M'"HRQ]JI=6;PI)7^P=2@?NW!>62P#GHA4X4WV7F_+9;KR&2,S"'<9)4_<\Y%
MMC\J:/TI!N`&U@[>:`RCWU93^\[1Y;R5L*4,@<;W-Z-'F:G1_>W&$=B0\&4O
M"%.X(B\O@<5U2/)BY+HV#,`6*&6BVZ0/W?6714<X$=+3"=:E*U1L#6V%#0U@
M5"9T1G_)=LSN^-66,9O3^K%+>L5&$REEN\3+^'?'0]:.1.ONPJQK8L%?\?>)
M=I*VAM-6G/U<@Y'"<$X=4K@L"EAOUCH\L602Y'[Z!?GVBQ-:K_>O`Y[N]H,D
M'UO^Z^W._?D;VKR@=+(SN*U/Q@"[9TQC8)59$:O#X4*GI/1I:Q6ZG9L1.S`>
M_PWY#TGKQW_R_P%02P,$%`````@`Y8$K11*X/%C@%```L@<!`!$`'`!P<W1I
M+3(P,30P-C,P+GAS9%54"0`#S0(25,T"$E1U>`L``00E#@``!#D!``#M75&3
MVCBV?K]5^Q]\>=E,U1*:=)))4LGL==-TAQH:6*!G=N9E2FT+4,5(C&1W-_OK
M[SFR#08;,.`>1-8O26,?R>>3/ND<24?2YW\^3SWKD4K%!/]2J;^^J%B4.\)E
M?/RE<C^HVH-&JU6QE$^X2SS!Z9<*%Y5__O2W__G\O]5J0U+B4]=ZF%N_5W^V
M;CWQ0#RK[;NOK5>5WW^^K?Q0K4:B,RG<P`%9P:TW%_6WU8N/U?J%]7_6AT]O
MZI9]%PH^*_>3<B9T2BR?R#'U.V1*U8PX\-V)[\\^U6I/3T^O9UX@F?+I]+4C
MIC7,[N+]):KNT2GE_HV0TVLZ(H'G?ZG\&1"/C1AU*Q9@Y>K33/DL5VZA^/.#
M]%;E\<EK(<<@>G%98QP+QZ&Q/!><!]/L!*XO:_Y\1FL@5`4I*IF3_([K+](E
M/_*N%KY<?&)W_FMY*W<EP=-EG'6]]N^[]D"7>`4JP+)T%1#.A4]\X(1^%C^=
MS1@?B>@1//08__8)_WD@BO;IR'K63Z3PZ)8"P]<UAWA.X.E/M)<95*(<)I*.
MOE2PHJIQ=?P!*5X#FE@$87ZI*#:=>31^1J23^G8$M?[QX\>:EJH!$V=4^HRJ
M6JS[HISPP?;DL6A*<A7D,N=:(>7ETA'C;(_B@@3_Q<7ED0?JY2PID/TO+JF9
MI`JZS'U:(B3Y+@H,-1R"\A;^<=]O;3$*NJ@:8CIE/AH897.W(;@/5A*L)>A?
ML9@;%9-#G/J^JBT4BU5;-O>?ZA<_6E7KFBG'$RJ0%'XTNG=WK>%=LS,<6';G
M&GYWAJW.;;/3:#4'GVOK.:QG'BCJ=OE/^N^U?CA*'$EL2[C:(>5/M\ZW_"D7
M;3I_$B`OE5!#='.RZ&G,A9>CR/+54`R"V<QCX'5%0I(XOI#7U"?,6^.2XROB
MN(4RZNW%CQ=O]N*4]6JIO>4+:Z&_!6ZAM43P@_4J`O%#24,S:=CU)S2;:<(M
MFF27>Y),ZU9RR'P.@=4F^+--@0;99/**[[/J^](I5M/2>I;$,IY80_+@K3M3
M?J$\NMS3F[)>A3J5E#DM9;@2'G-QLNF*>#C=,IA0ZJ]0Y4$5RI0+[2,-H$CU
MG)(F2F?0;;>N[6'SVKJRVW:GT;0&7YO-8>ET&\F.'@$]P*?P&93X*E5F!7/E
M,C]7K%<]NP^]S=?FL-6PVV7/8@IW%O6GNJ,&49,;3SRM]#!*.*.">?-A&V\&
M0_@O-$S=&ZMA#[Y:-^WNKV5O8R1CQ!2`3RA7[)&VA5IGCE<P<][MP9SN7:_?
M_-KL#%J_-*UV=U`RR$0&1>,5>+M*'5$P<][F9TZWU^S;PQ8(E(PY(6.NA1-@
M9<%XJ0G#)7_>XB,AIQIM@BLNH:Q@KN@Q=_3UY)\X[Q>J8B5T*4ER0I+<,`ZN
M+R->B\,SVJ%^@AI08,4N2GQ<'T;?M#K@Y+;LMM7J@,%I_L/J-(<E(8PB1'JJ
M#LJMX&G?C^EYNDQJE+-QAI(D-0D'Q>87.P>7K_,HY]Z,(`AA\A?B!;0[2G!%
M^5([`BL\>10C5G]3K)UYFZ**W>I;O]CM^R8ZJ$GB#(;]>^VYEGPQER\8:^8&
M'K[=+IAAJY!?2NC_BEY=>IMAM783S7H5P['$R$)`ED:D?\68K`2H<@WJ?$GZ
ME;ICQL<Y*3IA!?M5;],Q&WLSU)_0-99&H$J.GAU'TVX:<J_HU=)#S&_IMYE`
MGUO*J5Q9]AH7')>8LIBWS4ZS;[?+:C]]M:=-T[A@>[2Y_DO[8003[HC\!O4`
M/?&`.O#67XU3GJIB>X-4L-^=W?^Y.;2OVDUKT&R`PL,R.MD\1BQ=7?L1VBR^
M'`FIB$>SI-/=RE0I0::JZ/'89;IWR>33JG^[@%`%#%4$82U16$L8I8M[#H1L
M\4>JPD#!%K_GDA*/_8>ZN+:>S4/&`J]@*W>9'G7EX&%"<XMQ:ZF[A<J7[#.7
M?:E1U505/:3*9RC+090)%-$[$FS'$0''<,(Y5DF"'((4&T=8OWB_3H[N\&NS
M;]F-1O<>A]8]^S<D2DD*PTB1-DC`C:*=HO=IIRB;'J6!,98H*0,#/"G:PN3L
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M@ND3/[O#4@(<<%<6WVWM3[CDRE6,)]S@%2.RDI`LQ%3V<&=`T]283Q4_U[@_
MW<IAGP&T\87S;2(\ETJ%K=R?)UE"B][$\2%%DF&W\?/7;ONZV1_\74\,#'\K
M"7%*0@0/BOX9`,#FX]JV'J3#9:%\J*==Z_NK`;"@"7U&\Y=R"X]A9,AP8&C!
MCDL](YPT18K2YS"#'BGCL6UL7ORRQ(<,JF38DW(\?@;,68ZD<&*.<J61-Y_Q
MSTPV*>$4W?<`H5(KYMF$2HZ4DOI:D<(ESXSE63"=$CG'0W80LNU`MP"/LQDF
M2/$,2X^3LAD6ZHD$"S6U8E5+;IT+M[C[*QH>')&'53<4'<'I=.:).<V*H0\Y
M]T3\%S"5Z162G+S#":`(QX*#>/8W0*DNL)2D-)Z4?14L>8A'CP6>3S8X]4J`
MOU3X:?,?TG$!.TG8']ROL"ZA>,FY\^)<,^XLH&.\9I+B10&;V4>)6SS_4KN8
M]^;?`H3N%Q<P2BX:S\7(AB'[0LNV@7M/I.@+$#ZDSQK?R;M86TVS2-^29*:2
M++W`0HM>7\DU=5XNJIC!C\1IP!/"QU2U>'IU13B,%GQ*Y_NU$UW7CO_]:G=N
MFP.KU2E76HQFR:;SZC5EBCZQ_L?].&.]6M&N[&E.R:$A>::JR\/HQ011?%'L
M^;_U^L6Z^1G:_P9:=#O108TE#4RAP98U&*!%T3-+]8OT(LP:-<KU%[,)\R]]
M,?(<XX6H=!`TF*+N*#IRK*?O:\;*LQ5XM1F#)F#5GS/Q*&9%SY;7+]*SY2EN
M+;6W$NKC$&IQMMT2@A5B*&EH(`V7*X")6#9<7!,\=)*N43U)74BUA8I**$>X
M_@MP,36#GN)B<EDP`<):HL`W,0X+@)2$-)>0J4$]L*O@4?U.MZH<T!=)B\^U
M]>OKHR>KU]SK2^X9-%GI6YQ,J9H19_/]V1]#ZG`ZQGM<*I:"3F!*VL+1&68G
M\Z1<257%?*KU-]7Z^]?P\?B*ZOT4N:PQKGR\]2R?$CH)_JK&Z5"-2U3CLIY?
M#9V?HL[KL7BLN935\'[PZD4=,MFH1V8:_*.Z3+RG!A&B=_J7Z^<N@C@!8G]W
M8.&[OJSA[><U+GB5!U,JF9-/@63*3ICP>"XL,SU,E2/T&!'UH',+5'5,R"PW
M&3(3UJCGJ_C)0=1(9HO@5$$*Z;RV:42]<#X%5?I2L=U';%\],L>'-WC%]R.=
M>0)_-81*AMG^D4.6,T^?;O>EXLL`6CLJS#X]A%<>?JFX]('Y\=,9U*5PL1.$
M%X&,K@I2P0-\RP_PUZT4P>Q+)11G8`\KEJ_%PR=3\%Q\(N<M>(/9;(,Y'DO=
MH=WJM8L^=2@XW6X2W":)0R&%79?_XHA:W)?P+>;H484-W\*;SK.0;9)<1TBB
M-ZN(CZXNA5\?YX$VA2;#_J._`,XU."&X:\3F;D_2*0NF>"=O/"UI.P[HZ`(T
M,+S*OY%BNOU4T3]>)'=C>1\?-PFM=;#AQ$SHW1^H3);0'HFR@1_;#M2$0'D?
M@&^IX!WQP6]5]@BJ[@9:\F^42#6<P'?'DR'E^N<=W8'\L.Q>O#V!2093^,D5
M4\)X8:74Y1I5!&H!\L!"VI';^971K\R?,![!VK]0,I,;5PI7E,,XRV'0NS2Q
MTYO!.)3VI!A+,K6?6;(?W2WZ`NA<_Y/+IG@T@M!P#K0PVW2_UF65$V@L;&A%
MP@"NI[]Y1Y[9-)CJ)M@=-3TV9@_,6UGV_2-_DMV=_D%V+4Y4(#QHC3C%13A#
M<X[^JB?T?F%;4G(`]AWY&5`P3,S`>$[)<ZJ+2K\RC[6!8IPJ/*_E@7']I8;0
M&X;U$`.:O1M=0!OZYZC\_0R$J/3A"WTZQKDE(>=WS`-_#?RDE1[K)7(WU?-K
M$"GG(R&?B-3G45,%W!V2YUX@9P)^90P4\B<Q;<0`-0I%HZ.?%J.=[FA$,7E/
M,H?:@3\1$L^W3N+=)]6.>G8D=4\R#ER&'?<IEI>CKVP&2/><^6GG+9^X<1U#
M(KAZ"Z1ST#\.G]P"8UW$.#3;+GO.Z%?RB9O6IVS3>KAZRO96A)'LRSC#$Y"4
M3O!`CW"&%X'C*4JFWAC'Q#`J+8I"7FYKRH"R0]`\9,]0L7J@`8:HC_-1.(9.
MX]HJ=@ZH1)`>36\7.P-4,,[/`2HA=0:8!C#:X3E0K<B=`RZ6'BMME3H#3,.)
MI'D8N")W#KB>J)>K%UP5/`MD(A<L82RFZ%Z_#`<P]<8T7^]6/%+)(P]N.&'2
M[1'ISS<N%N:4/WC,^-*3`TO]K^F#GYBK7F?@+D'C2!@'2#VW&==.<7("*.NE
M:51<Z+@^QEA_8>Z`HL7=`(6)MYPO5Z!X-,D*`UU7!W*I:)IU&1W;'0V%3SQ<
M0%FMMV(R+'JQ$IDY"[]5:+$PGHFBCXY50%78G?K4Q?5H6\VH@^&<X2KM0:5V
MU/>^ET)EZ+5J3+&HF$61BB]2J%N_]S++Z@Q4'E.9JUC#B(<N'TR$](=43J\(
M_];0%@ML'OZ(3A1:;:C[)#-UZCR\&U'(C9,)FP2,LX9M\G0C9-,17$R9TQSA
M,B;ESMP&&9>Z;3IF*J1<:SH+4T(7'\OWH")P!>!)#"<B4(2[';";Z/%0#I3'
M0W83A?(7?*OPY;7]^IHV)8KB[FH`(,$QTELD;:@1:-5ZZ2!Y!O$U58YDL[7N
MX_`L7FAI,;=1S]2\.^K0IQOBZ+51G,`&W1S\:JK)');<O`;%^#?HRZ_9*`KT
MQKG$M5X/GK0%'V/GMUQCT?BA<H5B21M=4'ZF]J2QWKU`.A-0&%?<F+YU]B;`
MJ)C8\H41I=?!2G^R?UI3U^CVAM(().YD/J8T%EE\-X72XGJV2@=E'%,RJ_F<
M7_$,Q2"8S3Q&)786&,&`7:)(SZ(?GH5Y_6ZJ`XSZ/GV0_'Q(G_TK3SC?,M#O
M3E*\6Q&B\^-/Y`#8T?D3KP<?E6`-?P>F7#E"SO2)4VOA2>&_,*!@R;WU?QR1
MQ^D#ES*5;VQ0/NU]'I;\Q`[E=J5!R^8SG6K_+]0[-]ZLI*>OXNY,AU?QL79>
MW'"#:1A(WAWI^),$P#S"+S-*=L'_GA+O4$`X$PQ#GYDN%9PQ:5.EA-P%;6,R
M8R>1H\7T]")%DXTG?LH:Y1,WSO)L5MO+7`_-*7\^.#/##G))GQ'&K""$7-+G
M@Q'G4_)C3$J?#\:LL(L\PN>#,#L((Y_X&:',",G((WP^"(?[U.+P'.LP.P0E
MG_@9H<P(V\@C;!Y"?T)E=$$;.*-S5"XCE&.[F&F+Z5G:PG]2>%Z++[ZF=N#+
M3&'JO%%RP3$\@8I15Z^Y@3ZX$3$!-H?LB4?(ZV=\+34>,JBGU1V)>83-W9.X
M7?O4KL1\XL9U,_'MG;C>YR>O)-VT"+8*>=^TIZ=OML9-^-(40RKN%1T%7ANJ
M4?7UQ`THFS6;>71.)DQR(@@\?$'PX83X?0H8))ZN@*OI*':E-]6+[//]U@KC
MB'Q.&[&2=:CAQC,--_+AJ%Q,X$*?.AY1"F>Z^E1!A3D3O'UAN:,VBA/!&T&4
MWQW%<3.),C@\"T//=.E3[$6A3N.#^"*-`:@8AX>?A;.Y-T*VH,KYF*'[M=8Z
MCLKE]+/$6ZL2EZO"*-O-"S^'9F!&J]BF>V>MGG?*FAH7D*WZ8EOUDK#1+NR=
MJ+<E-78"O2_FQ,-H:GN*PXT>82Z@BLX<2D+>+F?J2"14>QX-HE)XEB\,!X#>
M5*1KEV_<$I!'^,3>:$+%]0CK]*L3ZXH3ES(Z;6YS5[]5RH3^?(`'65WA*E_R
M,DX;PT;'6NYJOA2)0E1L/'\AW*_:TB%Q8:P<3DR`N\L7LTLSBD$-X.9"SY<L
MD[_LDR<^^TNC>-@-]&$=:`0'W)\1#><YUH()"L_YU(UI%YXXD#F>LG3W*8R,
MQ"\5K+H_-6Z%<-'G2UYO.:#RD3E4#4%M173`:?H*KNU%442VWT$A:0-7=!$M
M,OT."BAUMF*!>1K3_1Z))&H2:T[BRV3_O909&F"*HX#M;L"+?NKD99G88;0S
M&C27M!$>8^H*OX[P:=9NUIV2IJW&92N\OL]UJY2YFUZUVBVE8$A^'<AP7A:4
MT,U0Z9?IPV<R?8SC\CFYS=RI_G'@SP>RGHL_ON)S9F/L)-=.6$>5R3F5!-X.
MA'LA\5&;/$7[(J-8])Z,)NN;RVW%:\>+Z@TK&%^ISYR@\`3/64Z4UDM]X+3K
M986@ZH9[29]$T<65R/@[*"8=A`5X,,*UZ)):S?O,"JOXMO>=-+;B6M>9-Z="
MVX_I#2;:4[D,0EC&7H1K5)O!YTAJZGK0\I@/VW'@E3X3)1EOM#:-G%/^Y#7;
M7^Z04Q@K@>>;SS-B/W>+FC;BC#16-FYV=704S&Y\VZ6-@\CT71NI(.2UY\8%
M`J)^V2'BJ3=FZIX1^+WVW#R]EZ>KZ(TAT246:1S;Y4S&%9[[F`-8IJ!QR.[!
M49!/$K(`WTB/_U.8-HN8C&;CV4I;9(S#LR'<\HJ.A*3-9S`<:C6".6\"0^,3
MHPK12]WIFLM\:UR=I9<Y-MR/ET:6)XW9-;<;0?9BW&')S[TLPCM`TG[BH1F8
MYCKFQK%[M?'XK,Z&+(NIYE\I'EP`8#`&;4Q7MOMM+9J<.;Q4T)!>33D(>A29
M<3#P7.G-@QVN@^?J"-9%S6_R!U?FL;5XT*3&X96X3=U<59LO@_.N\.:SD\_\
MY\_DK(APB*$[*#_32V6QAR@^&RX@'D;/[%,2F_,X_2:C@Y7/ZQ\?DMT9%TO6
M=8)%9'9VW>DF3`7T+'MG;0"?CF#/^7.%^1.,8P/I:&6ARZ_9(W,I=Z--JWBM
MJ%X(#$_KZTDQ6CT%[X@\_KH]!Y]K"%XY$Z@C^/G_4$L!`AX#%`````@`Y8$K
M18@K`OA"-P$`XU(7`!$`&````````0```*2!`````'!S=&DM,C`Q-#`V,S`N
M>&UL550%``/-`A)4=7@+``$$)0X```0Y`0``4$L!`AX#%`````@`Y8$K10KV
M%J-6%0``Z0T!`!4`&````````0```*2!C3<!`'!S=&DM,C`Q-#`V,S!?8V%L
M+GAM;%54!0`#S0(25'5X"P`!!"4.```$.0$``%!+`0(>`Q0````(`.6!*T6V
MBK`7AT$``*50!``5`!@```````$```"D@3)-`0!P<W1I+3(P,30P-C,P7V1E
M9BYX;6Q55`4``\T"$E1U>`L``00E#@``!#D!``!02P$"'@,4````"`#E@2M%
MY8C%P07U``!Z3PX`%0`8```````!````I($(CP$`<'-T:2TR,#$T,#8S,%]L
M86(N>&UL550%``/-`A)4=7@+``$$)0X```0Y`0``4$L!`AX#%`````@`Y8$K
M15W*L"G_8```9F@&`!4`&````````0```*2!7(0"`'!S=&DM,C`Q-#`V,S!?
M<')E+GAM;%54!0`#S0(25'5X"P`!!"4.```$.0$``%!+`0(>`Q0````(`.6!
M*T42N#Q8X!0``+('`0`1`!@```````$```"D@:KE`@!P<W1I+3(P,30P-C,P
M+GAS9%54!0`#S0(25'5X"P`!!"4.```$.0$``%!+!08`````!@`&`!H"``#5
%^@(`````
`
end

</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>37
<FILENAME>R25.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
  <head>
    <META http-equiv="Content-Type" content="text/html; charset=us-ascii">
    <link rel="StyleSheet" type="text/css" href="report.css"><script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script></head>
  <body><span style="display: none;">v2.4.0.8</span><table class="report" border="0" cellspacing="2" id="ID0EEFAC">
      <tr>
        <th class="tl" colspan="1" rowspan="2">
          <div style="width: 200px;"><strong>COMMITMENTS AND CONTINGENCIES (Tables)<br></strong></div>
        </th>
        <th class="th" colspan="1">12 Months Ended</th>
      </tr>
      <tr>
        <th class="th">
          <div>Jun. 30, 2014</div>
        </th>
      </tr>
      <tr class="rh">
        <td class="pl" style="border-bottom: 0px;" valign="top">
          <div class="a">Leased Facilities [Member]</div>
        </td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermPurchaseCommitmentLineItems', window );"><strong>Long-term Purchase Commitment [Line Items]</strong></a></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesTableTextBlock', window );">Schedule of Future Minimum Rental Commitments</a></td>
        <td class="text"><!--DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd" --><div> <div><!--StartFragment--> <div style="text-align: center"> <table style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman" cellspacing="0" cellpadding="0" width="100%" border="0"> <tr valign="top"> <td> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-ALIGN: justify; TEXT-INDENT: 0pt"> As of June&nbsp;30, 2014 aggregate minimum lease commitments under non-cancelable operating lease agreements are as follows:</div> </td> </tr> </table> </div> <div style="DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> &nbsp;</div> <div style="MARGIN-LEFT: 18pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-ALIGN: left; TEXT-INDENT: 0pt"> <table style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman" cellspacing="0" cellpadding="0" width="50%"> <tr bgcolor="#cceeff"> <td valign="bottom" width="88%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 9pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: -9pt"> Year ending June 30,</div> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="10%" colspan="2"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> <tr bgcolor="white"> <td valign="bottom" width="88%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 9pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: -9pt"> 2015</div> </td> <td valign="bottom" width="1%" align="right"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%">$</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">667</td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> <tr bgcolor="#cceeff"> <td valign="bottom" width="88%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 9pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: -9pt"> 2016</div> </td> <td valign="bottom" width="1%" align="right"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">497</td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> <tr bgcolor="white"> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="88%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 9pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: -9pt"> 2017</div> </td> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%" align="right"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">349</td> <td style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> <tr bgcolor="#cceeff"> <td style="PADDING-BOTTOM: 4px" valign="bottom" width="88%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 9pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: -9pt"> Total</div> </td> <td style="PADDING-BOTTOM: 4px" valign="bottom" width="1%" align="right"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 4px double; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%">$</td> <td style="BORDER-BOTTOM: black 4px double; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">1,513</td> <td style="PADDING-BOTTOM: 4px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> </table> </div> <!--EndFragment--></div> </div><span></span></td>
      </tr>
      <tr class="rh">
        <td class="pl" style="border-bottom: 0px;" valign="top">
          <div class="a">Automobiles [Member]</div>
        </td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermPurchaseCommitmentLineItems', window );"><strong>Long-term Purchase Commitment [Line Items]</strong></a></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesTableTextBlock', window );">Schedule of Future Minimum Rental Commitments</a></td>
        <td class="text"><!--DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd" --><div> <div><!--StartFragment--> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> As of June&nbsp;30, 2014, future aggregate minimum lease commitments under non-cancelable operating lease agreements are as follows:</div> <div style="DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> &nbsp;</div> <div style="MARGIN-LEFT: 18pt; text-align: left"> <table style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman" cellspacing="0" cellpadding="0" width="50%"> <tr bgcolor="#cceeff"> <td valign="bottom" width="88%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"> Year ending June 30,</div> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="10%" colspan="2"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> <tr bgcolor="white"> <td valign="bottom" width="88%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"> 2015</div> </td> <td valign="bottom" width="1%" align="right"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%">$</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">140</td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> <tr bgcolor="#cceeff"> <td valign="bottom" width="88%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"> 2016</div> </td> <td valign="bottom" width="1%" align="right"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">85</td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> <tr bgcolor="white"> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="88%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"> 2017</div> </td> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%" align="right"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">26</td> <td style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> <tr bgcolor="#cceeff"> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="88%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"> Total</div> </td> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%" align="right"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%">$</td> <td style="BORDER-BOTTOM: black 2px solid; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">251</td> <td style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> </table> </div> <!--EndFragment--></div> </div><span></span></td>
      </tr>
    </table>
    <div style="display: none;">
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermPurchaseCommitmentLineItems">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div>
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_LongTermPurchaseCommitmentLineItems</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:stringItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesTableTextBlock">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Tabular disclosure of future minimum payments required in the aggregate and for each of the five succeeding fiscal years for operating leases having initial or remaining noncancelable lease terms in excess of one year and the total minimum rentals to be received in the future under noncancelable subleases as of the balance sheet date.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 840<br><br> -SubTopic 20<br><br> -Section 50<br><br> -Paragraph 2<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6453985&amp;loc=d3e41502-112717<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_ScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesTableTextBlock</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>nonnum:textBlockItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
    </div>
  </body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>38
<FILENAME>R50.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
  <head>
    <META http-equiv="Content-Type" content="text/html; charset=us-ascii">
    <link rel="StyleSheet" type="text/css" href="report.css"><script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script></head>
  <body><span style="display: none;">v2.4.0.8</span><table class="report" border="0" cellspacing="2" id="ID0E6IAC">
      <tr>
        <th class="tl" colspan="1" rowspan="1">
          <div style="width: 200px;"><strong>TAXES ON INCOME (Schedule of Significant Components of Deferred Tax Assets) (Details) (USD $)<br>In Thousands, unless otherwise specified</strong></div>
        </th>
        <th class="th">
          <div>Jun. 30, 2014</div>
        </th>
        <th class="th">
          <div>Jun. 30, 2013</div>
        </th>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureAbstract', window );"><strong>TAXES ON INCOME [Abstract]</strong></a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsDomestic', window );">U.S. net operating loss carryforward</a></td>
        <td class="nump">$ 7,955<span></span></td>
        <td class="nump">$ 7,106<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsForeign', window );">Israeli net operating loss carryforward</a></td>
        <td class="nump">12,810<span></span></td>
        <td class="nump">8,543<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals', window );">Allowances and reserves</a></td>
        <td class="nump">237<span></span></td>
        <td class="nump">156<span></span></td>
      </tr>
      <tr class="reu">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsGross', window );">Total deferred tax assets before valuation allowance</a></td>
        <td class="nump">21,002<span></span></td>
        <td class="nump">15,805<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsValuationAllowance', window );">Valuation allowance</a></td>
        <td class="num">(21,002)<span></span></td>
        <td class="num">(15,805)<span></span></td>
      </tr>
      <tr class="reu">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsNet', window );">Net deferred tax asset</a></td>
        <td class="text">&nbsp;&nbsp;<span></span></td>
        <td class="text">&nbsp;&nbsp;<span></span></td>
      </tr>
    </table>
    <div style="display: none;">
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsGross">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences and carryforwards.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 740<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 2<br><br> -Subparagraph (b)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6907707&amp;loc=d3e32537-109319<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Glossary Deferred Tax Asset<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6510090<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_DeferredTaxAssetsGross</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>debit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsNet">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Amount after allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences and carryforwards.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 740<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 2<br><br> -Subparagraph (b),(c)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6907707&amp;loc=d3e32537-109319<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_DeferredTaxAssetsNet</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>debit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsDomestic">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Amount before allocation of valuation allowances of deferred tax asset attributable to deductible domestic operating loss carryforwards. Excludes state and local operating loss carryforwards.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 740<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 6<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6907707&amp;loc=d3e32621-109319<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 740<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 8<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6907707&amp;loc=d3e32632-109319<br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 740<br><br> -SubTopic 10<br><br> -Section 25<br><br> -Paragraph 20<br><br> -Subparagraph (b)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=29652012&amp;loc=d3e28680-109314<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsDomestic</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>debit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsForeign">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Amount before allocation of valuation allowances of deferred tax asset attributable to deductible foreign operating loss carryforwards.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 740<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 6<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6907707&amp;loc=d3e32621-109319<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 740<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 8<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6907707&amp;loc=d3e32632-109319<br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 740<br><br> -SubTopic 10<br><br> -Section 25<br><br> -Paragraph 20<br><br> -Subparagraph (b)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=29652012&amp;loc=d3e28680-109314<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsForeign</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>debit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from reserves and accruals.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 740<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 6<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6907707&amp;loc=d3e32621-109319<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 740<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 8<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6907707&amp;loc=d3e32632-109319<br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 740<br><br> -SubTopic 10<br><br> -Section 25<br><br> -Paragraph 20<br><br> -Subparagraph (d)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=29652012&amp;loc=d3e28680-109314<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>debit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsValuationAllowance">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 740<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 2<br><br> -Subparagraph (c)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6907707&amp;loc=d3e32537-109319<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_DeferredTaxAssetsValuationAllowance</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>credit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureAbstract">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div>
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_IncomeTaxDisclosureAbstract</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:stringItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
    </div>
  </body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>39
<FILENAME>R42.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
  <head>
    <META http-equiv="Content-Type" content="text/html; charset=us-ascii">
    <link rel="StyleSheet" type="text/css" href="report.css"><script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script></head>
  <body><span style="display: none;">v2.4.0.8</span><table class="report" border="0" cellspacing="2" id="ID0EZKAE">
      <tr>
        <th class="tl" colspan="1" rowspan="2">
          <div style="width: 200px;"><strong>STOCKHOLDERS' EQUITY (Summary of Option Activity) (Details) (USD $)<br>In Thousands, except Share data, unless otherwise specified</strong></div>
        </th>
        <th class="th" colspan="1">12 Months Ended</th>
      </tr>
      <tr>
        <th class="th">
          <div>Jun. 30, 2014</div>
        </th>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward', window );"><strong>Number</strong></a></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber', window );">Options outstanding at beginning of period</a></td>
        <td class="nump">1,958,156<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised', window );">Options exercised</a></td>
        <td class="num">(15,000)<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod', window );">Options forfeited</a></td>
        <td class="num">(81,057)<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber', window );">Options outstanding at end of the period</a></td>
        <td class="nump">1,862,099<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber', window );">Options exercisable at the end of the period</a></td>
        <td class="nump">1,862,099<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber', window );">Options vested</a></td>
        <td class="nump">1,862,099<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract', window );"><strong>Weighted average exercise price</strong></a></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice', window );">Options outstanding at beginning of period</a></td>
        <td class="nump">$ 4.03<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice', window );">Options exercised</a></td>
        <td class="nump">$ 0.83<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice', window );">Options forfeited</a></td>
        <td class="nump">$ 11.59<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice', window );">Options outstanding at end of the period</a></td>
        <td class="nump">$ 3.73<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice', window );">Options exercisable at the end of the period</a></td>
        <td class="nump">$ 3.73<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice', window );">Options vested</a></td>
        <td class="nump">$ 3.73<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_psti_WeightedAverageRemainingContractualTermsAbstract', window );"><strong>Weighted average remaining contractual term</strong></a></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2', window );">Weighted Average Remaining Contractual Terms (in years)</a></td>
        <td class="text">3 years 1 month 17 days<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1', window );">Options exercisable at the end of the period</a></td>
        <td class="text">3 years 1 month 17 days<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1', window );">Options vested</a></td>
        <td class="text">3 years 1 month 17 days<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_psti_AggregateIntrinsicValueAbstract', window );"><strong>Aggregate intrinsic value price</strong></a></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue', window );">Options outstanding at end of the period</a></td>
        <td class="nump">$ 1,046<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1', window );">Options exercisable at the end of the period</a></td>
        <td class="nump">1,046<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue', window );">Options vested</a></td>
        <td class="nump">$ 1,046<span></span></td>
      </tr>
    </table>
    <div style="display: none;">
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_psti_AggregateIntrinsicValueAbstract">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div>
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>psti_AggregateIntrinsicValueAbstract</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>psti_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:stringItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_psti_WeightedAverageRemainingContractualTermsAbstract">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div>
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>psti_WeightedAverageRemainingContractualTermsAbstract</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>psti_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:stringItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div>
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:stringItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Amount of difference between fair value of the underlying shares reserved for issuance and exercise price of vested portions of options outstanding and currently exercisable.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 718<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 2<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6415400&amp;loc=d3e5070-113901<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>debit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The number of shares into which fully or partially vested stock options outstanding as of the balance sheet date can be currently converted under the option plan.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 718<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 2<br><br> -Subparagraph (c)(1)(iii)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6415400&amp;loc=d3e5070-113901<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:sharesItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The weighted-average price as of the balance sheet date at which grantees can acquire the shares reserved for issuance on vested portions of options outstanding and currently exercisable under the stock option plan.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 718<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 2<br><br> -Subparagraph (c)(1)(iii)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6415400&amp;loc=d3e5070-113901<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>num:perShareItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Weighted average remaining contractual term for vested portions of options outstanding and currently exercisable or convertible, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 718<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 2<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6415400&amp;loc=d3e5070-113901<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:durationItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Weighted average price of options that were either forfeited or expired.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 718<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 2<br><br> -Subparagraph (c)(1)(iv)(3)-(4)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6415400&amp;loc=d3e5070-113901<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>num:perShareItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The number of shares under options that were cancelled during the reporting period as a result of occurrence of a terminating event specified in contractual agreements pertaining to the stock option plan.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 718<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 2<br><br> -Subparagraph (c)(1)(iv)(3)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6415400&amp;loc=d3e5070-113901<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:sharesItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Amount by which the current fair value of the underlying stock exceeds the exercise price of options outstanding.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 718<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 2<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6415400&amp;loc=d3e5070-113901<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>debit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Number of options outstanding, including both vested and non-vested options.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 718<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 2<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6415400&amp;loc=d3e5070-113901<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 718<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 2<br><br> -Subparagraph (c)(1)(i)-(ii)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6415400&amp;loc=d3e5070-113901<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:sharesItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div>
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:stringItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Weighted average price at which grantees can acquire the shares reserved for issuance under the stock option plan.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 718<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 2<br><br> -Subparagraph (c)(1)(i)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6415400&amp;loc=d3e5070-113901<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>num:perShareItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Weighted average remaining contractual term for option awards outstanding, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 718<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 2<br><br> -Subparagraph (e)(1)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6415400&amp;loc=d3e5070-113901<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:durationItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Amount of difference between fair value of the underlying shares reserved for issuance and exercise price of fully vested and expected to vest options that are exercisable.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 718<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 2<br><br> -Subparagraph (e)(2)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6415400&amp;loc=d3e5070-113901<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>debit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Weighted average remaining contractual term for fully vested and expected to vest options that are exercisable or convertible, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 718<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 2<br><br> -Subparagraph (e)(2)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6415400&amp;loc=d3e5070-113901<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:durationItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>As of the balance sheet date, the number of shares into which fully vested and expected to vest stock options outstanding can be converted under the option plan.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 718<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 2<br><br> -Subparagraph (e)(1)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6415400&amp;loc=d3e5070-113901<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:sharesItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>As of the balance sheet date, the weighted-average exercise price for outstanding stock options that are fully vested or expected to vest.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 718<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 2<br><br> -Subparagraph (e)(1)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6415400&amp;loc=d3e5070-113901<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>num:perShareItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Weighted average price at which option holders acquired shares when converting their stock options into shares.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>num:perShareItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Number of share options (or share units) exercised during the current period.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher SEC<br><br> -Name Regulation S-X (SX)<br><br> -Number 210<br><br> -Section 04<br><br> -Article 3<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 505<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 2<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6928386&amp;loc=d3e21463-112644<br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 505<br><br> -SubTopic 10<br><br> -Section S99<br><br> -Paragraph 1<br><br> -Subparagraph (SX 210.3-04)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=27012166&amp;loc=d3e187085-122770<br><br><br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 210<br><br> -SubTopic 10<br><br> -Section S99<br><br> -Paragraph 1<br><br> -Subparagraph (SX 210.5-02.28,29)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br><br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 718<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 2<br><br> -Subparagraph (c)(1)(iv)(2)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6415400&amp;loc=d3e5070-113901<br><br><br><br>Reference 6: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher SEC<br><br> -Name Regulation S-X (SX)<br><br> -Number 210<br><br> -Section 02<br><br> -Paragraph 29, 30<br><br> -Article 5<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:sharesItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
    </div>
  </body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>40
<FILENAME>R37.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
  <head>
    <META http-equiv="Content-Type" content="text/html; charset=us-ascii">
    <link rel="StyleSheet" type="text/css" href="report.css"><script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script></head>
  <body><span style="display: none;">v2.4.0.8</span><table class="report" border="0" cellspacing="2" id="ID0EW1AG">
      <tr>
        <th class="tl" colspan="1" rowspan="2">
          <div style="width: 200px;"><strong>PROPERTY AND EQUIPMENT, NET (Details) (USD $)<br>In Thousands, unless otherwise specified</strong></div>
        </th>
        <th class="th" colspan="3">12 Months Ended</th>
      </tr>
      <tr>
        <th class="th">
          <div>Jun. 30, 2014</div>
        </th>
        <th class="th">
          <div>Jun. 30, 2013</div>
        </th>
        <th class="th">
          <div>Jun. 30, 2012</div>
        </th>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Property and equipment, cost</a></td>
        <td class="nump">$ 14,955<span></span></td>
        <td class="nump">$ 14,215<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment', window );">Property and equipment, accumulated depreciation</a></td>
        <td class="nump">4,132<span></span></td>
        <td class="nump">2,349<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="rou">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentNet', window );">Property and equipment, net</a></td>
        <td class="nump">10,823<span></span></td>
        <td class="nump">11,866<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Depreciation', window );">Depreciation</a></td>
        <td class="nump">1,902<span></span></td>
        <td class="nump">1,033<span></span></td>
        <td class="nump">435<span></span></td>
      </tr>
      <tr class="rh">
        <td class="pl" style="border-bottom: 0px;" valign="top">
          <div class="a">Laboratory equipment [Member]</div>
        </td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Property and equipment, cost</a></td>
        <td class="nump">6,088<span></span></td>
        <td class="nump">5,709<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment', window );">Property and equipment, accumulated depreciation</a></td>
        <td class="nump">2,042<span></span></td>
        <td class="nump">1,306<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="rh">
        <td class="pl" style="border-bottom: 0px;" valign="top">
          <div class="a">Computers and Peripheral Equipment [Member]</div>
        </td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Property and equipment, cost</a></td>
        <td class="nump">708<span></span></td>
        <td class="nump">535<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment', window );">Property and equipment, accumulated depreciation</a></td>
        <td class="nump">430<span></span></td>
        <td class="nump">280<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="rh">
        <td class="pl" style="border-bottom: 0px;" valign="top">
          <div class="a">Office Furniture and Equipment [Member]</div>
        </td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Property and equipment, cost</a></td>
        <td class="nump">611<span></span></td>
        <td class="nump">534<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment', window );">Property and equipment, accumulated depreciation</a></td>
        <td class="nump">176<span></span></td>
        <td class="nump">91<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="rh">
        <td class="pl" style="border-bottom: 0px;" valign="top">
          <div class="a">Leasehold Improvements [Member]</div>
        </td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Property and equipment, cost</a></td>
        <td class="nump">7,453<span></span></td>
        <td class="nump">7,369<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment', window );">Property and equipment, accumulated depreciation</a></td>
        <td class="nump">1,475<span></span></td>
        <td class="nump">642<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="rh">
        <td class="pl" style="border-bottom: 0px;" valign="top">
          <div class="a">Vehicles [Member]</div>
        </td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Property and equipment, cost</a></td>
        <td class="nump">95<span></span></td>
        <td class="nump">68<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment', window );">Property and equipment, accumulated depreciation</a></td>
        <td class="nump">$ 9<span></span></td>
        <td class="nump">$ 30<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
    </table>
    <div style="display: none;">
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Amount of accumulated depreciation, depletion and amortization for physical assets used in the normal conduct of business to produce goods and services.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 360<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 1<br><br> -Subparagraph (c)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 210<br><br> -SubTopic 10<br><br> -Section S99<br><br> -Paragraph 1<br><br> -Subparagraph (SX 210.5-02.14)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher SEC<br><br> -Name Regulation S-X (SX)<br><br> -Number 210<br><br> -Section 02<br><br> -Paragraph 14<br><br> -Article 5<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>credit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Depreciation">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 230<br><br> -SubTopic 10<br><br> -Section 45<br><br> -Paragraph 28<br><br> -Subparagraph (b)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=31042434&amp;loc=d3e3602-108585<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_Depreciation</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>debit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentGross">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Amount before accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 360<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 1<br><br> -Subparagraph (b)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 210<br><br> -SubTopic 10<br><br> -Section S99<br><br> -Paragraph 1<br><br> -Subparagraph (SX 210.5-02.13)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_PropertyPlantAndEquipmentGross</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>debit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentLineItems">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div>
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_PropertyPlantAndEquipmentLineItems</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:stringItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentNet">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 360<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 1<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 210<br><br> -SubTopic 10<br><br> -Section S99<br><br> -Paragraph 1<br><br> -Subparagraph (SX 210.5-02.13)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher SEC<br><br> -Name Regulation S-X (SX)<br><br> -Number 210<br><br> -Section 02<br><br> -Paragraph 13<br><br> -Subparagraph a<br><br> -Article 5<br><br><br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher SEC<br><br> -Name Regulation S-X (SX)<br><br> -Number 210<br><br> -Section 03<br><br> -Paragraph 8<br><br> -Article 7<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_PropertyPlantAndEquipmentNet</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>debit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
    </div>
  </body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>41
<FILENAME>R47.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
  <head>
    <META http-equiv="Content-Type" content="text/html; charset=us-ascii">
    <link rel="StyleSheet" type="text/css" href="report.css"><script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script></head>
  <body><span style="display: none;">v2.4.0.8</span><table class="report" border="0" cellspacing="2" id="ID0ETADK">
      <tr>
        <th class="tl" colspan="1" rowspan="2">
          <div style="width: 200px;"><strong>STOCKHOLDERS' EQUITY (Summary of Warrants and Options) (Details) (USD $)<br></strong></div>
        </th>
        <th class="th" colspan="1">12 Months Ended</th>
        <th class="th" colspan="1"></th>
      </tr>
      <tr>
        <th class="th">
          <div>Jun. 30, 2014</div>
        </th>
        <th class="th">
          <div>Jun. 30, 2013</div>
        </th>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_psti_StockholdersEquityNoteLineItems', window );"><strong>Stockholders Equity Note [Line Items]</strong></a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice', window );">Exercise Price per Share</a></td>
        <td class="nump">$ 3.73<span></span></td>
        <td class="nump">$ 4.03<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions', window );">Options and Warrants for Common Stock</a></td>
        <td class="nump">12,648,303<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions', window );">Options and Warrants Exercisable</a></td>
        <td class="nump">12,647,303<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2', window );">Weighted Average Remaining Contractual Terms (in years)</a></td>
        <td class="text">3 years 1 month 17 days<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="rh">
        <td class="pl" style="border-bottom: 0px;" valign="top">
          <div class="a">Warrant [Member]</div>
        </td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_psti_StockholdersEquityNoteLineItems', window );"><strong>Stockholders Equity Note [Line Items]</strong></a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions', window );">Options and Warrants for Common Stock</a></td>
        <td class="nump">10,534,204<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions', window );">Options and Warrants Exercisable</a></td>
        <td class="nump">10,534,204<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="rh">
        <td class="pl" style="border-bottom: 0px;" valign="top">
          <div class="a">Employee Stock Option [Member]</div>
        </td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_psti_StockholdersEquityNoteLineItems', window );"><strong>Stockholders Equity Note [Line Items]</strong></a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions', window );">Options and Warrants for Common Stock</a></td>
        <td class="nump">2,114,099<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions', window );">Options and Warrants Exercisable</a></td>
        <td class="nump">2,113,099<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="rh">
        <td class="pl" style="border-bottom: 0px;" valign="top">
          <div class="a">$0.00 [Member] | Employee Stock Option [Member]</div>
        </td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_psti_StockholdersEquityNoteLineItems', window );"><strong>Stockholders Equity Note [Line Items]</strong></a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice', window );">Exercise Price per Share</a></td>
        <td class="nump">$ 0.00<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions', window );">Options and Warrants for Common Stock</a></td>
        <td class="nump">101,000<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions', window );">Options and Warrants Exercisable</a></td>
        <td class="nump">100,000<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2', window );">Weighted Average Remaining Contractual Terms (in years)</a></td>
        <td class="text">5 years 2 months 9 days<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="rh">
        <td class="pl" style="border-bottom: 0px;" valign="top">
          <div class="a">$0.62 [Member] | Employee Stock Option [Member]</div>
        </td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_psti_StockholdersEquityNoteLineItems', window );"><strong>Stockholders Equity Note [Line Items]</strong></a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice', window );">Exercise Price per Share</a></td>
        <td class="nump">$ 0.62<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions', window );">Options and Warrants for Common Stock</a></td>
        <td class="nump">398,500<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions', window );">Options and Warrants Exercisable</a></td>
        <td class="nump">398,500<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2', window );">Weighted Average Remaining Contractual Terms (in years)</a></td>
        <td class="text">4 years 3 months<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="rh">
        <td class="pl" style="border-bottom: 0px;" valign="top">
          <div class="a">$1.04 [Member] | Employee Stock Option [Member]</div>
        </td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_psti_StockholdersEquityNoteLineItems', window );"><strong>Stockholders Equity Note [Line Items]</strong></a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice', window );">Exercise Price per Share</a></td>
        <td class="nump">$ 1.04<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions', window );">Options and Warrants for Common Stock</a></td>
        <td class="nump">30,000<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions', window );">Options and Warrants Exercisable</a></td>
        <td class="nump">30,000<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2', window );">Weighted Average Remaining Contractual Terms (in years)</a></td>
        <td class="text">4 years 1 month 28 days<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="rh">
        <td class="pl" style="border-bottom: 0px;" valign="top">
          <div class="a">$1.40 [Member] | Warrant [Member]</div>
        </td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_psti_StockholdersEquityNoteLineItems', window );"><strong>Stockholders Equity Note [Line Items]</strong></a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice', window );">Exercise Price per Share</a></td>
        <td class="nump">$ 1.40<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions', window );">Options and Warrants for Common Stock</a></td>
        <td class="nump">474,322<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions', window );">Options and Warrants Exercisable</a></td>
        <td class="nump">474,322<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2', window );">Weighted Average Remaining Contractual Terms (in years)</a></td>
        <td class="text">9 months 26 days<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="rh">
        <td class="pl" style="border-bottom: 0px;" valign="top">
          <div class="a">$1.50 [Member] | Warrant [Member]</div>
        </td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_psti_StockholdersEquityNoteLineItems', window );"><strong>Stockholders Equity Note [Line Items]</strong></a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice', window );">Exercise Price per Share</a></td>
        <td class="nump">$ 1.50<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions', window );">Options and Warrants for Common Stock</a></td>
        <td class="nump">878,174<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions', window );">Options and Warrants Exercisable</a></td>
        <td class="nump">878,174<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2', window );">Weighted Average Remaining Contractual Terms (in years)</a></td>
        <td class="text">22 days<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="rh">
        <td class="pl" style="border-bottom: 0px;" valign="top">
          <div class="a">$1.60 [Member] | Warrant [Member]</div>
        </td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_psti_StockholdersEquityNoteLineItems', window );"><strong>Stockholders Equity Note [Line Items]</strong></a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice', window );">Exercise Price per Share</a></td>
        <td class="nump">$ 1.60<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions', window );">Options and Warrants for Common Stock</a></td>
        <td class="nump">131,221<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions', window );">Options and Warrants Exercisable</a></td>
        <td class="nump">131,221<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2', window );">Weighted Average Remaining Contractual Terms (in years)</a></td>
        <td class="text">9 months 11 days<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="rh">
        <td class="pl" style="border-bottom: 0px;" valign="top">
          <div class="a">$1.80 [Member] | Warrant [Member]</div>
        </td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_psti_StockholdersEquityNoteLineItems', window );"><strong>Stockholders Equity Note [Line Items]</strong></a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice', window );">Exercise Price per Share</a></td>
        <td class="nump">$ 1.80<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions', window );">Options and Warrants for Common Stock</a></td>
        <td class="nump">727,401<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions', window );">Options and Warrants Exercisable</a></td>
        <td class="nump">727,401<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2', window );">Weighted Average Remaining Contractual Terms (in years)</a></td>
        <td class="text">3 months 18 days<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="rh">
        <td class="pl" style="border-bottom: 0px;" valign="top">
          <div class="a">$1.90 [Member] | Warrant [Member]</div>
        </td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_psti_StockholdersEquityNoteLineItems', window );"><strong>Stockholders Equity Note [Line Items]</strong></a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice', window );">Exercise Price per Share</a></td>
        <td class="nump">$ 1.90<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions', window );">Options and Warrants for Common Stock</a></td>
        <td class="nump">43,103<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions', window );">Options and Warrants Exercisable</a></td>
        <td class="nump">43,103<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2', window );">Weighted Average Remaining Contractual Terms (in years)</a></td>
        <td class="text">29 days<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="rh">
        <td class="pl" style="border-bottom: 0px;" valign="top">
          <div class="a">$2.97 [Member] | Employee Stock Option [Member]</div>
        </td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_psti_StockholdersEquityNoteLineItems', window );"><strong>Stockholders Equity Note [Line Items]</strong></a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice', window );">Exercise Price per Share</a></td>
        <td class="nump">$ 2.97<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions', window );">Options and Warrants for Common Stock</a></td>
        <td class="nump">20,000<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions', window );">Options and Warrants Exercisable</a></td>
        <td class="nump">20,000<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2', window );">Weighted Average Remaining Contractual Terms (in years)</a></td>
        <td class="text">3 years 10 months 10 days<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="rh">
        <td class="pl" style="border-bottom: 0px;" valign="top">
          <div class="a">$3.50 [Member] | Employee Stock Option [Member]</div>
        </td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_psti_StockholdersEquityNoteLineItems', window );"><strong>Stockholders Equity Note [Line Items]</strong></a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice', window );">Exercise Price per Share</a></td>
        <td class="nump">$ 3.50<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions', window );">Options and Warrants for Common Stock</a></td>
        <td class="nump">900,000<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions', window );">Options and Warrants Exercisable</a></td>
        <td class="nump">900,000<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2', window );">Weighted Average Remaining Contractual Terms (in years)</a></td>
        <td class="text">2 years 6 months 29 days<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="rh">
        <td class="pl" style="border-bottom: 0px;" valign="top">
          <div class="a">$3.72 [Member] | Employee Stock Option [Member]</div>
        </td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_psti_StockholdersEquityNoteLineItems', window );"><strong>Stockholders Equity Note [Line Items]</strong></a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice', window );">Exercise Price per Share</a></td>
        <td class="nump">$ 3.72<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions', window );">Options and Warrants for Common Stock</a></td>
        <td class="nump">15,000<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions', window );">Options and Warrants Exercisable</a></td>
        <td class="nump">15,000<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2', window );">Weighted Average Remaining Contractual Terms (in years)</a></td>
        <td class="text">2 years 5 months 27 days<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="rh">
        <td class="pl" style="border-bottom: 0px;" valign="top">
          <div class="a">$3.80 [Member] | Employee Stock Option [Member]</div>
        </td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_psti_StockholdersEquityNoteLineItems', window );"><strong>Stockholders Equity Note [Line Items]</strong></a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice', window );">Exercise Price per Share</a></td>
        <td class="nump">$ 3.80<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions', window );">Options and Warrants for Common Stock</a></td>
        <td class="nump">16,050<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions', window );">Options and Warrants Exercisable</a></td>
        <td class="nump">16,050<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2', window );">Weighted Average Remaining Contractual Terms (in years)</a></td>
        <td class="text">2 years 6 months 11 days<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="rh">
        <td class="pl" style="border-bottom: 0px;" valign="top">
          <div class="a">$4.00 [Member] | Employee Stock Option [Member]</div>
        </td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_psti_StockholdersEquityNoteLineItems', window );"><strong>Stockholders Equity Note [Line Items]</strong></a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice', window );">Exercise Price per Share</a></td>
        <td class="nump">$ 4.00<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions', window );">Options and Warrants for Common Stock</a></td>
        <td class="nump">42,500<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions', window );">Options and Warrants Exercisable</a></td>
        <td class="nump">42,500<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2', window );">Weighted Average Remaining Contractual Terms (in years)</a></td>
        <td class="text">2 years 3 months 18 days<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="rh">
        <td class="pl" style="border-bottom: 0px;" valign="top">
          <div class="a">$4.20 [Member] | Warrant [Member]</div>
        </td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_psti_StockholdersEquityNoteLineItems', window );"><strong>Stockholders Equity Note [Line Items]</strong></a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice', window );">Exercise Price per Share</a></td>
        <td class="nump">$ 4.20<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions', window );">Options and Warrants for Common Stock</a></td>
        <td class="nump">5,060,000<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions', window );">Options and Warrants Exercisable</a></td>
        <td class="nump">5,060,000<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2', window );">Weighted Average Remaining Contractual Terms (in years)</a></td>
        <td class="text">2 years 1 month 2 days<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="rh">
        <td class="pl" style="border-bottom: 0px;" valign="top">
          <div class="a">$5.00 [Member] | Warrant [Member]</div>
        </td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_psti_StockholdersEquityNoteLineItems', window );"><strong>Stockholders Equity Note [Line Items]</strong></a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice', window );">Exercise Price per Share</a></td>
        <td class="nump">$ 5.00<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions', window );">Options and Warrants for Common Stock</a></td>
        <td class="nump">3,219,983<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions', window );">Options and Warrants Exercisable</a></td>
        <td class="nump">3,219,983<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2', window );">Weighted Average Remaining Contractual Terms (in years)</a></td>
        <td class="text">3 years 2 months 19 days<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="rh">
        <td class="pl" style="border-bottom: 0px;" valign="top">
          <div class="a">$4.38 to $4.40 [Member] | Employee Stock Option [Member]</div>
        </td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_psti_StockholdersEquityNoteLineItems', window );"><strong>Stockholders Equity Note [Line Items]</strong></a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit', window );">Exercise Price per Share, minimum</a></td>
        <td class="nump">$ 4.38<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit', window );">Exercise Price per Share, maximum</a></td>
        <td class="nump">$ 4.40<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions', window );">Options and Warrants for Common Stock</a></td>
        <td class="nump">417,299<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions', window );">Options and Warrants Exercisable</a></td>
        <td class="nump">417,299<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2', window );">Weighted Average Remaining Contractual Terms (in years)</a></td>
        <td class="text">3 years 3 months 11 days<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="rh">
        <td class="pl" style="border-bottom: 0px;" valign="top">
          <div class="a">$6.80 [Member] | Employee Stock Option [Member]</div>
        </td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_psti_StockholdersEquityNoteLineItems', window );"><strong>Stockholders Equity Note [Line Items]</strong></a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice', window );">Exercise Price per Share</a></td>
        <td class="nump">$ 6.80<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions', window );">Options and Warrants for Common Stock</a></td>
        <td class="nump">36,250<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions', window );">Options and Warrants Exercisable</a></td>
        <td class="nump">36,250<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2', window );">Weighted Average Remaining Contractual Terms (in years)</a></td>
        <td class="text">3 years 4 months 13 days<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="rh">
        <td class="pl" style="border-bottom: 0px;" valign="top">
          <div class="a">$8.20 [Member] | Employee Stock Option [Member]</div>
        </td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_psti_StockholdersEquityNoteLineItems', window );"><strong>Stockholders Equity Note [Line Items]</strong></a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice', window );">Exercise Price per Share</a></td>
        <td class="nump">$ 8.20<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions', window );">Options and Warrants for Common Stock</a></td>
        <td class="nump">30,000<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions', window );">Options and Warrants Exercisable</a></td>
        <td class="nump">30,000<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2', window );">Weighted Average Remaining Contractual Terms (in years)</a></td>
        <td class="text">2 years 4 months 24 days<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="rh">
        <td class="pl" style="border-bottom: 0px;" valign="top">
          <div class="a">$20.00 [Member] | Employee Stock Option [Member]</div>
        </td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_psti_StockholdersEquityNoteLineItems', window );"><strong>Stockholders Equity Note [Line Items]</strong></a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice', window );">Exercise Price per Share</a></td>
        <td class="nump">$ 20.00<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions', window );">Options and Warrants for Common Stock</a></td>
        <td class="nump">107,500<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions', window );">Options and Warrants Exercisable</a></td>
        <td class="nump">107,500<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2', window );">Weighted Average Remaining Contractual Terms (in years)</a></td>
        <td class="text">2 years 10 months 17 days<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
    </table>
    <div style="display: none;">
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_psti_StockholdersEquityNoteLineItems">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div>
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>psti_StockholdersEquityNoteLineItems</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>psti_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:stringItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Weighted average price at which grantees can acquire the shares reserved for issuance under the stock option plan.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 718<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 2<br><br> -Subparagraph (c)(1)(i)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6415400&amp;loc=d3e5070-113901<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>num:perShareItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Weighted average remaining contractual term for option awards outstanding, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 718<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 2<br><br> -Subparagraph (e)(1)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6415400&amp;loc=d3e5070-113901<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:durationItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The floor of a customized range of exercise prices for purposes of disclosing shares potentially issuable under outstanding stock option awards on all stock option plans and other required information pertaining to awards in the customized range.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 718<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 2<br><br> -Subparagraph (g)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6415400&amp;loc=d3e5070-113901<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>num:perShareItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The number of shares reserved for issuance pertaining to the outstanding exercisable stock options as of the balance sheet date in the customized range of exercise prices for which the market and performance vesting condition has been satisfied.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 718<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 2<br><br> -Subparagraph (c)(iii)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6415400&amp;loc=d3e5070-113901<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:sharesItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The number of shares reserved for issuance pertaining to the outstanding stock options as of the balance sheet date for all option plans in the customized range of exercise prices.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 718<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 2<br><br> -Subparagraph (c)(1)(i)-(ii)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6415400&amp;loc=d3e5070-113901<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:sharesItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The ceiling of a customized range of exercise prices for purposes of disclosing shares potentially issuable under outstanding stock option awards on all stock option plans and other required information pertaining to awards in the customized range.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 718<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 2<br><br> -Subparagraph (g)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6415400&amp;loc=d3e5070-113901<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>num:perShareItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
    </div>
  </body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>42
<FILENAME>R9.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
  <head>
    <META http-equiv="Content-Type" content="text/html; charset=us-ascii">
    <link rel="StyleSheet" type="text/css" href="report.css"><script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script></head>
  <body><span style="display: none;">v2.4.0.8</span><table class="report" border="0" cellspacing="2" id="ID0EME">
      <tr>
        <th class="tl" colspan="1" rowspan="2">
          <div style="width: 200px;"><strong>GENERAL<br></strong></div>
        </th>
        <th class="th" colspan="1">12 Months Ended</th>
      </tr>
      <tr>
        <th class="th">
          <div>Jun. 30, 2014</div>
        </th>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_psti_GeneralAbstract', window );"><strong>GENERAL [Abstract]</strong></a></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock', window );">GENERAL</a></td>
        <td class="text"><!--DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd" --><div> <div><!--StartFragment--> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: left; TEXT-INDENT: 0pt"> NOTE 1:-GENERAL</div> <div style="DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> &nbsp;</div> <div> <table style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman" cellspacing="0" cellpadding="0" width="100%" align="center" border="0"> <tr valign="top"> <td style="WIDTH: 18pt"> <div style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt"> a.</div> </td> <td> <div style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; text-align: justify"> Pluristem Therapeutics Inc., a Nevada corporation, was incorporated on May 11, 2001. Pluristem Therapeutics Inc. has a wholly owned subsidiary, Pluristem Ltd. (the "Subsidiary"), which is incorporated under the laws of the State of Israel. Pluristem Therapeutics Inc. and the Subsidiary are referred to as the "Company" or "Pluristem".</div> </td> </tr> </table> </div> <div style="DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> &nbsp;</div> <div> <table style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman" cellspacing="0" cellpadding="0" width="100%" align="center" border="0"> <tr valign="top"> <td style="WIDTH: 18pt"> <div style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt"> b.</div> </td> <td> <div style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; text-align: justify"> The Company is a bio-therapeutics company developing off-the-shelf allogeneic cell therapy products for the treatment of multiple ischemic and inflammatory conditions. The Company has sustained operating losses and expects such losses to continue in the foreseeable future. The Company&#39;s accumulated losses aggregated to $113,834 through June 30, 2014 and incurred a net loss of $26,932 for the year ended June 30, 2014.</div> <div style="text-align: justify">&nbsp;</div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-ALIGN: justify; TEXT-INDENT: 0pt"> The Company plans to continue to finance its operations with sales of equity securities, entering into licensing technology agreements such as the United Therapeutics Corporation ("United Therapeutics" or "United") and CHA&nbsp;Bio&amp;Diostech ("CHA") agreements, and from grants to support its research and development activity. In the longer term, the Company plans to finance its operations from revenues from sales of products.</div> </td> </tr> </table> </div> <div style="DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> &nbsp;</div> <div> <table style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman" cellspacing="0" cellpadding="0" width="100%" align="center" border="0"> <tr valign="top"> <td style="WIDTH: 18pt"> <div style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt"> c.</div> </td> <td> <div style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; text-align: justify"> Since December 10, 2007, the Company&#39;s shares of common stock have been traded on the NASDAQ Capital Market under the symbol "PSTI".</div> </td> </tr> </table> </div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 5.9pt; text-align: justify; TEXT-INDENT: 0pt"> On December 19, 2010, the Company&#39;s shares began trading also on the Tel-Aviv Stock Exchange under the symbol "PLTR".</div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /> </div> <div> <table style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman" cellspacing="0" cellpadding="0" width="100%" align="center" border="0"> <tr valign="top"> <td style="WIDTH: 18pt"> <div style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt"> d.</div> </td> <td> <div style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; text-align: left"> License Agreements:</div> </td> </tr> </table> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 5.9pt; text-align: left; TEXT-INDENT: 0pt"> &nbsp;</div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 5.9pt; text-align: left; TEXT-DECORATION: underline; TEXT-INDENT: 0pt"> United Agreement</div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 5.9pt; text-align: justify; TEXT-INDENT: 0pt"> On June 19, 2011, the Company entered into an exclusive license agreement (the "United Agreement") with United Therapeutics for the use of the Company&#39;s PLX cells to develop and commercialize a cell-based product for the treatment of Pulmonary Hypertension ("PAH").&nbsp;&nbsp;The United Agreement provides that United Therapeutics will receive exclusive worldwide license rights for the development and commercialization of the Company&#39;s PLX cell-based product to treat PAH.&nbsp;&nbsp;The United Agreement further provides for the following consideration payable to the Company: (i) an upfront payment of $7,000 paid in August 2011, which includes a $5,000 non-refundable upfront payment and a $2,000 advance payment on the development; (ii) up to $37,500 upon reaching certain regulatory milestones with respect to the development of a product to treat PAH; (iii) reimbursement of up to $10,000 of certain of the Company&#39;s expenses if the Company establishes a GMP manufacturing facility in North America; (iv) reimbursement of certain costs in connection with the development of the product; and (v) following commercialization of the product, royalties at a mid-single digit percent and the purchase of commercial supplies of the developed product from the Company at a specified margin over the Company&#39;s cost.</div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 5.9pt; text-align: justify; TEXT-INDENT: 0pt"> The United Agreement became effective on August 2, 2011, and will continue until the later of a few events, including termination of all patents relating to the collaboration, upon certain government action or if the parties do not develop any product under the United Agreement.&nbsp;&nbsp;United may unilaterally terminate the United Agreement at any time and without cause.&nbsp;&nbsp;In such event, United Therapeutics shall pay the Company certain costs and expenses of winding down any non-cancellable commitments made by the Company prior to the date of termination and cease all development activities in connection with the United Agreement.</div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 5.9pt; text-align: justify; TEXT-DECORATION: underline; TEXT-INDENT: 0pt"> CHA Agreement</div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 5.9pt; text-align: justify; TEXT-INDENT: 0pt"> On June 26, 2013, Pluristem entered into an exclusive license and commercialization agreement (the "CHA Agreement") with CHA, for conducting clinical trials and commercialization of Pluristem&#39;s PLX-PAD product in South Korea in connection with two indications: the treatment of Critical Limb Ischemia, and Intermediate Claudication (the "Indications"). Under the terms of the CHA Agreement, CHA will receive exclusive rights in South Korea for conducting clinical trials with respect to the Indications, CHA will bear the costs of conducting the clinical trials for the agreed upon indications, and the Company&nbsp;will continue to retain nights to its proprietary manufacturing technology and cell-related intellectual property.</div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 5.9pt; text-align: justify; TEXT-INDENT: 0pt"> The first clinical study to be performed as part of the CHA Agreement will be a Phase II trial in Intermittent Claudication. This study was approved in November 2013 by South Korea&#39;s Ministry of Food and Drug Safety.</div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 5.9pt; text-align: justify; TEXT-INDENT: 0pt"> Upon the first regulatory approval for a PLX product in South Korea, for the specified indications, Pluristem and CHA will establish an equally owned joint venture. The purpose of the joint venture will be to commercialize PLX cell products in South Korea.</div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 5.9pt; text-align: justify; TEXT-INDENT: 0pt"> Pluristem will be able to use the data generated by CHA to pursue the development of PLX product candidates outside of South Korea.</div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 5.9pt; text-align: justify; TEXT-INDENT: 0pt"> In addition, and as contemplated by the CHA Agreement, in December 2013, Pluristem and CHA executed the mutual investment pursuant to which Pluristem issued 2,500,000 shares of its common stock in consideration for 1,011,504 shares of CHA, which reflects total consideration to each of Pluristem and CHA of approximately $10,414. The investment in CHA shares is presented as "Marketable Securities" and classified as available-for-sale in accordance with ASC 320 - "Investments - Debt and Equity Securities" (Note 3). The CHA Agreement contains customary termination provisions, including in the event the parties do not reach an agreement upon development plan for conducting the clinical trials. Upon termination of this CHA Agreement, the license granted thereunder will terminate and all rights included therein will revert to the Company, whereupon the Company will be free to enter into agreements with any other third parties for the granting of a license in or outside South Korea or to deal in any other manner with such rights as it shall see fit at its sole discretion.</div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 5.9pt; text-align: justify; TEXT-INDENT: 0pt"> Each party has agreed to hold the other party&#39;s shares for at least one year before selling any of such shares. The parties also agreed to give an irrevocable proxy to the other party&#39;s management with respect to the voting power of the shares issued.</div> <!--EndFragment--></div> </div><span></span></td>
      </tr>
    </table>
    <div style="display: none;">
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_psti_GeneralAbstract">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div>
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>psti_GeneralAbstract</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>psti_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:stringItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The entire disclosure for organization, consolidation and basis of presentation of financial statements disclosure.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 235<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 3<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6367646&amp;loc=d3e18780-107790<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 205<br><br> -SubTopic 10<br><br> -Section 45<br><br> -Paragraph 3<br><br> -URI http://asc.fasb.org/extlink&amp;oid=35735333&amp;loc=d3e288-107754<br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 810<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 1<br><br> -URI http://asc.fasb.org/extlink&amp;oid=18733093&amp;loc=d3e5614-111684<br><br><br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 915<br><br> -SubTopic 235<br><br> -Section 50<br><br> -Paragraph 1<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6472506&amp;loc=d3e38932-110933<br><br><br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 272<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 3<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6373374&amp;loc=d3e70478-108055<br><br><br><br>Reference 6: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 205<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 1<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6359566&amp;loc=d3e326-107755<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>nonnum:textBlockItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
    </div>
  </body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EXCEL
<SEQUENCE>43
<FILENAME>Financial_Report.xls
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 Financial_Report.xls
M[[N_34E-12U697)S:6]N.B`Q+C`-"E@M1&]C=6UE;G0M5'EP93H@5V]R:V)O
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M<B!E9&ET;W(@9&]E<VXG="!S=7!P;W)T(%=E8B!!<F-H:79E(&9I;&5S+B`@
M4&QE87-E(&1O=VYL;V%D(&$@8G)O=W-E<B!T:&%T('-U<'!O<G1S(%=E8B!!
M<F-H:79E+"!S=6-H(&%S($UI8W)O<V]F="!);G1E<FYE="!%>'!L;W)E<BX-
M"@T*+2TM+2TM/5].97AT4&%R=%\P8V%D-3EF9%\W,S)E7S0V93)?834S-%\P
M8SAA9#%A9CDP9&0-"D-O;G1E;G0M3&]C871I;VXZ(&9I;&4Z+R\O0SHO,&-A
M9#4Y9F1?-S,R95\T-F4R7V$U,S1?,&,X860Q868Y,&1D+U=O<FMB;V]K+FAT
M;6P-"D-O;G1E;G0M5')A;G-F97(M16YC;V1I;F<Z('%U;W1E9"UP<FEN=&%B
M;&4-"D-O;G1E;G0M5'EP93H@=&5X="]H=&UL.R!C:&%R<V5T/2)U<RUA<V-I
M:2(-"@T*/&AT;6P@>&UL;G,Z=CTS1")U<FXZ<V-H96UA<RUM:6-R;W-O9G0M
M8V]M.G9M;"(@>&UL;G,Z;STS1")U<FXZ<V-H96UA<RUM:6-R;W-O9G0M8V]M
M.F]F9FEC93IO9F9I8V4B('AM;&YS.G@],T0B=7)N.G-C:&5M87,M;6EC<F]S
M;V9T+6-O;3IO9F9I8V4Z97AC96PB('AM;&YS/3-$(FAT='`Z+R]W=W<N=S,N
M;W)G+U12+U)%0RUH=&UL-#`B/@T*/&AE860^#0H\;65T82!N86UE/3-$(D5X
M8V5L(%=O<FMB;V]K($9R86UE<V5T(CX-"@T*/&UE=&$@;F%M93TS1%!R;V=)
M9"!C;VYT96YT/3-$17AC96PN4VAE970^#0H\;&EN:R!R96P],T1&:6QE+4QI
M<W0@:')E9CTS1")7;W)K<VAE971S+V9I;&5L:7-T+GAM;"(^#0H-"CPA+2U;
M:68@9W1E(&US;R`Y73X\>&UL/@T*(#QX.D5X8V5L5V]R:V)O;VL^#0H@(#QX
M.D5X8V5L5V]R:W-H965T<SX-"B`@(#QX.D5X8V5L5V]R:W-H965T/@T*("`@
M(#QX.DYA;64^1&]C=6UE;G1?86YD7T5N=&ET>5]);F9O<FUA=&EO/"]X.DYA
M;64^#0H@("`@/'@Z5V]R:W-H965T4V]U<F-E($A2968],T0B5V]R:W-H965T
M<R]3:&5E=#`Q+FAT;6PB+SX-"B`@(#PO>#I%>&-E;%=O<FMS:&5E=#X-"B`@
M(#QX.D5X8V5L5V]R:W-H965T/@T*("`@(#QX.DYA;64^0T].4T],241!5$5$
M7T)!3$%.0T5?4TA%1513/"]X.DYA;64^#0H@("`@/'@Z5V]R:W-H965T4V]U
M<F-E($A2968],T0B5V]R:W-H965T<R]3:&5E=#`R+FAT;6PB+SX-"B`@(#PO
M>#I%>&-E;%=O<FMS:&5E=#X-"B`@(#QX.D5X8V5L5V]R:W-H965T/@T*("`@
M(#QX.DYA;64^0T].4T],241!5$5$7T)!3$%.0T5?4TA%15137U!!/"]X.DYA
M;64^#0H@("`@/'@Z5V]R:W-H965T4V]U<F-E($A2968],T0B5V]R:W-H965T
M<R]3:&5E=#`S+FAT;6PB+SX-"B`@(#PO>#I%>&-E;%=O<FMS:&5E=#X-"B`@
M(#QX.D5X8V5L5V]R:W-H965T/@T*("`@(#QX.DYA;64^0T].4T],241!5$5$
M7U-4051%345.5%-?3T9?3U!%/"]X.DYA;64^#0H@("`@/'@Z5V]R:W-H965T
M4V]U<F-E($A2968],T0B5V]R:W-H965T<R]3:&5E=#`T+FAT;6PB+SX-"B`@
M(#PO>#I%>&-E;%=O<FMS:&5E=#X-"B`@(#QX.D5X8V5L5V]R:W-H965T/@T*
M("`@(#QX.DYA;64^0T].4T],241!5$5$7U-4051%345.5%-?3T9?0T]-/"]X
M.DYA;64^#0H@("`@/'@Z5V]R:W-H965T4V]U<F-E($A2968],T0B5V]R:W-H
M965T<R]3:&5E=#`U+FAT;6PB+SX-"B`@(#PO>#I%>&-E;%=O<FMS:&5E=#X-
M"B`@(#QX.D5X8V5L5V]R:W-H965T/@T*("`@(#QX.DYA;64^4U1!5$5-14Y4
M4U]/1E]#2$%.1T537TE.7T5154E4/"]X.DYA;64^#0H@("`@/'@Z5V]R:W-H
M965T4V]U<F-E($A2968],T0B5V]R:W-H965T<R]3:&5E=#`V+FAT;6PB+SX-
M"B`@(#PO>#I%>&-E;%=O<FMS:&5E=#X-"B`@(#QX.D5X8V5L5V]R:W-H965T
M/@T*("`@(#QX.DYA;64^4U1!5$5-14Y44U]/1E]#2$%.1T537TE.7T5154E4
M,3PO>#I.86UE/@T*("`@(#QX.E=O<FMS:&5E=%-O=7)C92!(4F5F/3-$(E=O
M<FMS:&5E=',O4VAE970P-RYH=&UL(B\^#0H@("`\+W@Z17AC96Q7;W)K<VAE
M970^#0H@("`\>#I%>&-E;%=O<FMS:&5E=#X-"B`@("`\>#I.86UE/D-/3E-/
M3$E$051%1%]35$%414U%3E137T]&7T-!4SPO>#I.86UE/@T*("`@(#QX.E=O
M<FMS:&5E=%-O=7)C92!(4F5F/3-$(E=O<FMS:&5E=',O4VAE970P."YH=&UL
M(B\^#0H@("`\+W@Z17AC96Q7;W)K<VAE970^#0H@("`\>#I%>&-E;%=O<FMS
M:&5E=#X-"B`@("`\>#I.86UE/D=%3D5204P\+W@Z3F%M93X-"B`@("`\>#I7
M;W)K<VAE9713;W5R8V4@2%)E9CTS1")7;W)K<VAE971S+U-H965T,#DN:'1M
M;"(O/@T*("`@/"]X.D5X8V5L5V]R:W-H965T/@T*("`@/'@Z17AC96Q7;W)K
M<VAE970^#0H@("`@/'@Z3F%M93Y324=.249)0T%.5%]!0T-/54Y424Y'7U!/
M3$E#244\+W@Z3F%M93X-"B`@("`\>#I7;W)K<VAE9713;W5R8V4@2%)E9CTS
M1")7;W)K<VAE971S+U-H965T,3`N:'1M;"(O/@T*("`@/"]X.D5X8V5L5V]R
M:W-H965T/@T*("`@/'@Z17AC96Q7;W)K<VAE970^#0H@("`@/'@Z3F%M93Y-
M05)+151!0DQ%7U-%0U52251)15,\+W@Z3F%M93X-"B`@("`\>#I7;W)K<VAE
M9713;W5R8V4@2%)E9CTS1")7;W)K<VAE971S+U-H965T,3$N:'1M;"(O/@T*
M("`@/"]X.D5X8V5L5V]R:W-H965T/@T*("`@/'@Z17AC96Q7;W)K<VAE970^
M#0H@("`@/'@Z3F%M93Y&04E27U9!3%5%7T]&7T9)3D%.0TE!3%])3E-44E4\
M+W@Z3F%M93X-"B`@("`\>#I7;W)K<VAE9713;W5R8V4@2%)E9CTS1")7;W)K
M<VAE971S+U-H965T,3(N:'1M;"(O/@T*("`@/"]X.D5X8V5L5V]R:W-H965T
M/@T*("`@/'@Z17AC96Q7;W)K<VAE970^#0H@("`@/'@Z3F%M93Y04D]015)4
M65]!3D1?15%525!-14Y47TY%5#PO>#I.86UE/@T*("`@(#QX.E=O<FMS:&5E
M=%-O=7)C92!(4F5F/3-$(E=O<FMS:&5E=',O4VAE970Q,RYH=&UL(B\^#0H@
M("`\+W@Z17AC96Q7;W)K<VAE970^#0H@("`\>#I%>&-E;%=O<FMS:&5E=#X-
M"B`@("`\>#I.86UE/D]42$527T%#0T]53E137U!!64%"3$4\+W@Z3F%M93X-
M"B`@("`\>#I7;W)K<VAE9713;W5R8V4@2%)E9CTS1")7;W)K<VAE971S+U-H
M965T,30N:'1M;"(O/@T*("`@/"]X.D5X8V5L5V]R:W-H965T/@T*("`@/'@Z
M17AC96Q7;W)K<VAE970^#0H@("`@/'@Z3F%M93Y#3TU-251-14Y44U]!3D1?
M0T].5$E.1T5.0TE%4SPO>#I.86UE/@T*("`@(#QX.E=O<FMS:&5E=%-O=7)C
M92!(4F5F/3-$(E=O<FMS:&5E=',O4VAE970Q-2YH=&UL(B\^#0H@("`\+W@Z
M17AC96Q7;W)K<VAE970^#0H@("`\>#I%>&-E;%=O<FMS:&5E=#X-"B`@("`\
M>#I.86UE/E-43T-+2$],1$524U]%455)5%D\+W@Z3F%M93X-"B`@("`\>#I7
M;W)K<VAE9713;W5R8V4@2%)E9CTS1")7;W)K<VAE971S+U-H965T,38N:'1M
M;"(O/@T*("`@/"]X.D5X8V5L5V]R:W-H965T/@T*("`@/'@Z17AC96Q7;W)K
M<VAE970^#0H@("`@/'@Z3F%M93Y&24Y!3D-)04Q?24Y#3TU%7TY%5#PO>#I.
M86UE/@T*("`@(#QX.E=O<FMS:&5E=%-O=7)C92!(4F5F/3-$(E=O<FMS:&5E
M=',O4VAE970Q-RYH=&UL(B\^#0H@("`\+W@Z17AC96Q7;W)K<VAE970^#0H@
M("`\>#I%>&-E;%=O<FMS:&5E=#X-"B`@("`\>#I.86UE/E1!6$537T].7TE.
M0T]-13PO>#I.86UE/@T*("`@(#QX.E=O<FMS:&5E=%-O=7)C92!(4F5F/3-$
M(E=O<FMS:&5E=',O4VAE970Q."YH=&UL(B\^#0H@("`\+W@Z17AC96Q7;W)K
M<VAE970^#0H@("`\>#I%>&-E;%=O<FMS:&5E=#X-"B`@("`\>#I.86UE/E-)
M1TY)1DE#04Y47T%#0T]53E1)3D=?4$],24-)13$\+W@Z3F%M93X-"B`@("`\
M>#I7;W)K<VAE9713;W5R8V4@2%)E9CTS1")7;W)K<VAE971S+U-H965T,3DN
M:'1M;"(O/@T*("`@/"]X.D5X8V5L5V]R:W-H965T/@T*("`@/'@Z17AC96Q7
M;W)K<VAE970^#0H@("`@/'@Z3F%M93Y324=.249)0T%.5%]!0T-/54Y424Y'
M7U!/3$E#244R/"]X.DYA;64^#0H@("`@/'@Z5V]R:W-H965T4V]U<F-E($A2
M968],T0B5V]R:W-H965T<R]3:&5E=#(P+FAT;6PB+SX-"B`@(#PO>#I%>&-E
M;%=O<FMS:&5E=#X-"B`@(#QX.D5X8V5L5V]R:W-H965T/@T*("`@(#QX.DYA
M;64^34%22T5404),15]314-54DE424537U1A8FQE<SPO>#I.86UE/@T*("`@
M(#QX.E=O<FMS:&5E=%-O=7)C92!(4F5F/3-$(E=O<FMS:&5E=',O4VAE970R
M,2YH=&UL(B\^#0H@("`\+W@Z17AC96Q7;W)K<VAE970^#0H@("`\>#I%>&-E
M;%=O<FMS:&5E=#X-"B`@("`\>#I.86UE/D9!25)?5D%,545?3T9?1DE.04Y#
M24%,7TE.4U1253$\+W@Z3F%M93X-"B`@("`\>#I7;W)K<VAE9713;W5R8V4@
M2%)E9CTS1")7;W)K<VAE971S+U-H965T,C(N:'1M;"(O/@T*("`@/"]X.D5X
M8V5L5V]R:W-H965T/@T*("`@/'@Z17AC96Q7;W)K<VAE970^#0H@("`@/'@Z
M3F%M93Y04D]015)465]!3D1?15%525!-14Y47TY%5%]486(\+W@Z3F%M93X-
M"B`@("`\>#I7;W)K<VAE9713;W5R8V4@2%)E9CTS1")7;W)K<VAE971S+U-H
M965T,C,N:'1M;"(O/@T*("`@/"]X.D5X8V5L5V]R:W-H965T/@T*("`@/'@Z
M17AC96Q7;W)K<VAE970^#0H@("`@/'@Z3F%M93Y/5$A%4E]!0T-/54Y44U]0
M05E!0DQ%7U1A8FQE<SPO>#I.86UE/@T*("`@(#QX.E=O<FMS:&5E=%-O=7)C
M92!(4F5F/3-$(E=O<FMS:&5E=',O4VAE970R-"YH=&UL(B\^#0H@("`\+W@Z
M17AC96Q7;W)K<VAE970^#0H@("`\>#I%>&-E;%=O<FMS:&5E=#X-"B`@("`\
M>#I.86UE/D-/34U)5$U%3E137T%.1%]#3TY424Y'14Y#24537SPO>#I.86UE
M/@T*("`@(#QX.E=O<FMS:&5E=%-O=7)C92!(4F5F/3-$(E=O<FMS:&5E=',O
M4VAE970R-2YH=&UL(B\^#0H@("`\+W@Z17AC96Q7;W)K<VAE970^#0H@("`\
M>#I%>&-E;%=O<FMS:&5E=#X-"B`@("`\>#I.86UE/E-43T-+2$],1$524U]%
M455)5%E?5&%B;&5S/"]X.DYA;64^#0H@("`@/'@Z5V]R:W-H965T4V]U<F-E
M($A2968],T0B5V]R:W-H965T<R]3:&5E=#(V+FAT;6PB+SX-"B`@(#PO>#I%
M>&-E;%=O<FMS:&5E=#X-"B`@(#QX.D5X8V5L5V]R:W-H965T/@T*("`@(#QX
M.DYA;64^1DE.04Y#24%,7TE.0T]-15].151?5&%B;&5S/"]X.DYA;64^#0H@
M("`@/'@Z5V]R:W-H965T4V]U<F-E($A2968],T0B5V]R:W-H965T<R]3:&5E
M=#(W+FAT;6PB+SX-"B`@(#PO>#I%>&-E;%=O<FMS:&5E=#X-"B`@(#QX.D5X
M8V5L5V]R:W-H965T/@T*("`@(#QX.DYA;64^5$%815-?3TY?24Y#3TU%7U1A
M8FQE<SPO>#I.86UE/@T*("`@(#QX.E=O<FMS:&5E=%-O=7)C92!(4F5F/3-$
M(E=O<FMS:&5E=',O4VAE970R."YH=&UL(B\^#0H@("`\+W@Z17AC96Q7;W)K
M<VAE970^#0H@("`\>#I%>&-E;%=O<FMS:&5E=#X-"B`@("`\>#I.86UE/D=%
M3D5204Q?1&5T86EL<SPO>#I.86UE/@T*("`@(#QX.E=O<FMS:&5E=%-O=7)C
M92!(4F5F/3-$(E=O<FMS:&5E=',O4VAE970R.2YH=&UL(B\^#0H@("`\+W@Z
M17AC96Q7;W)K<VAE970^#0H@("`\>#I%>&-E;%=O<FMS:&5E=#X-"B`@("`\
M>#I.86UE/E-)1TY)1DE#04Y47T%#0T]53E1)3D=?4$],24-)13,\+W@Z3F%M
M93X-"B`@("`\>#I7;W)K<VAE9713;W5R8V4@2%)E9CTS1")7;W)K<VAE971S
M+U-H965T,S`N:'1M;"(O/@T*("`@/"]X.D5X8V5L5V]R:W-H965T/@T*("`@
M/'@Z17AC96Q7;W)K<VAE970^#0H@("`@/'@Z3F%M93Y324=.249)0T%.5%]!
M0T-/54Y424Y'7U!/3$E#244T/"]X.DYA;64^#0H@("`@/'@Z5V]R:W-H965T
M4V]U<F-E($A2968],T0B5V]R:W-H965T<R]3:&5E=#,Q+FAT;6PB+SX-"B`@
M(#PO>#I%>&-E;%=O<FMS:&5E=#X-"B`@(#QX.D5X8V5L5V]R:W-H965T/@T*
M("`@(#QX.DYA;64^4TE'3DE&24-!3E1?04-#3U5.5$E.1U]03TQ)0TE%-3PO
M>#I.86UE/@T*("`@(#QX.E=O<FMS:&5E=%-O=7)C92!(4F5F/3-$(E=O<FMS
M:&5E=',O4VAE970S,BYH=&UL(B\^#0H@("`\+W@Z17AC96Q7;W)K<VAE970^
M#0H@("`\>#I%>&-E;%=O<FMS:&5E=#X-"B`@("`\>#I.86UE/DU!4DM%5$%"
M3$5?4T5#55))5$E%4U]38VAE9'5L93PO>#I.86UE/@T*("`@(#QX.E=O<FMS
M:&5E=%-O=7)C92!(4F5F/3-$(E=O<FMS:&5E=',O4VAE970S,RYH=&UL(B\^
M#0H@("`\+W@Z17AC96Q7;W)K<VAE970^#0H@("`\>#I%>&-E;%=O<FMS:&5E
M=#X-"B`@("`\>#I.86UE/DU!4DM%5$%"3$5?4T5#55))5$E%4U]38VAE9'5L
M93$\+W@Z3F%M93X-"B`@("`\>#I7;W)K<VAE9713;W5R8V4@2%)E9CTS1")7
M;W)K<VAE971S+U-H965T,S0N:'1M;"(O/@T*("`@/"]X.D5X8V5L5V]R:W-H
M965T/@T*("`@/'@Z17AC96Q7;W)K<VAE970^#0H@("`@/'@Z3F%M93Y&04E2
M7U9!3%5%7T]&7T9)3D%.0TE!3%])3E-44E4R/"]X.DYA;64^#0H@("`@/'@Z
M5V]R:W-H965T4V]U<F-E($A2968],T0B5V]R:W-H965T<R]3:&5E=#,U+FAT
M;6PB+SX-"B`@(#PO>#I%>&-E;%=O<FMS:&5E=#X-"B`@(#QX.D5X8V5L5V]R
M:W-H965T/@T*("`@(#QX.DYA;64^1D%)4E]604Q515]/1E]&24Y!3D-)04Q?
M24Y35%)5,SPO>#I.86UE/@T*("`@(#QX.E=O<FMS:&5E=%-O=7)C92!(4F5F
M/3-$(E=O<FMS:&5E=',O4VAE970S-BYH=&UL(B\^#0H@("`\+W@Z17AC96Q7
M;W)K<VAE970^#0H@("`\>#I%>&-E;%=O<FMS:&5E=#X-"B`@("`\>#I.86UE
M/E!23U!%4E197T%.1%]%455)4$U%3E1?3D547T1E=#PO>#I.86UE/@T*("`@
M(#QX.E=O<FMS:&5E=%-O=7)C92!(4F5F/3-$(E=O<FMS:&5E=',O4VAE970S
M-RYH=&UL(B\^#0H@("`\+W@Z17AC96Q7;W)K<VAE970^#0H@("`\>#I%>&-E
M;%=O<FMS:&5E=#X-"B`@("`\>#I.86UE/D]42$527T%#0T]53E137U!!64%"
M3$5?1&5T86EL<SPO>#I.86UE/@T*("`@(#QX.E=O<FMS:&5E=%-O=7)C92!(
M4F5F/3-$(E=O<FMS:&5E=',O4VAE970S."YH=&UL(B\^#0H@("`\+W@Z17AC
M96Q7;W)K<VAE970^#0H@("`\>#I%>&-E;%=O<FMS:&5E=#X-"B`@("`\>#I.
M86UE/D-/34U)5$U%3E137T%.1%]#3TY424Y'14Y#24537S$\+W@Z3F%M93X-
M"B`@("`\>#I7;W)K<VAE9713;W5R8V4@2%)E9CTS1")7;W)K<VAE971S+U-H
M965T,SDN:'1M;"(O/@T*("`@/"]X.D5X8V5L5V]R:W-H965T/@T*("`@/'@Z
M17AC96Q7;W)K<VAE970^#0H@("`@/'@Z3F%M93Y#3TU-251-14Y44U]!3D1?
M0T].5$E.1T5.0TE%4U\R/"]X.DYA;64^#0H@("`@/'@Z5V]R:W-H965T4V]U
M<F-E($A2968],T0B5V]R:W-H965T<R]3:&5E=#0P+FAT;6PB+SX-"B`@(#PO
M>#I%>&-E;%=O<FMS:&5E=#X-"B`@(#QX.D5X8V5L5V]R:W-H965T/@T*("`@
M(#QX.DYA;64^4U1/0TM(3TQ$15)37T5154E465].87)R871I=F5?/"]X.DYA
M;64^#0H@("`@/'@Z5V]R:W-H965T4V]U<F-E($A2968],T0B5V]R:W-H965T
M<R]3:&5E=#0Q+FAT;6PB+SX-"B`@(#PO>#I%>&-E;%=O<FMS:&5E=#X-"B`@
M(#QX.D5X8V5L5V]R:W-H965T/@T*("`@(#QX.DYA;64^4U1/0TM(3TQ$15)3
M7T5154E465]3=6UM87)Y7V]F/"]X.DYA;64^#0H@("`@/'@Z5V]R:W-H965T
M4V]U<F-E($A2968],T0B5V]R:W-H965T<R]3:&5E=#0R+FAT;6PB+SX-"B`@
M(#PO>#I%>&-E;%=O<FMS:&5E=#X-"B`@(#QX.D5X8V5L5V]R:W-H965T/@T*
M("`@(#QX.DYA;64^4U1/0TM(3TQ$15)37T5154E465]3=6UM87)Y7V]F,3PO
M>#I.86UE/@T*("`@(#QX.E=O<FMS:&5E=%-O=7)C92!(4F5F/3-$(E=O<FMS
M:&5E=',O4VAE970T,RYH=&UL(B\^#0H@("`\+W@Z17AC96Q7;W)K<VAE970^
M#0H@("`\>#I%>&-E;%=O<FMS:&5E=#X-"B`@("`\>#I.86UE/E-43T-+2$],
M1$524U]%455)5%E?4W5M;6%R>5]O9C(\+W@Z3F%M93X-"B`@("`\>#I7;W)K
M<VAE9713;W5R8V4@2%)E9CTS1")7;W)K<VAE971S+U-H965T-#0N:'1M;"(O
M/@T*("`@/"]X.D5X8V5L5V]R:W-H965T/@T*("`@/'@Z17AC96Q7;W)K<VAE
M970^#0H@("`@/'@Z3F%M93Y35$]#2TA/3$1%4E-?15%525197U-U;6UA<GE?
M;V8S/"]X.DYA;64^#0H@("`@/'@Z5V]R:W-H965T4V]U<F-E($A2968],T0B
M5V]R:W-H965T<R]3:&5E=#0U+FAT;6PB+SX-"B`@(#PO>#I%>&-E;%=O<FMS
M:&5E=#X-"B`@(#QX.D5X8V5L5V]R:W-H965T/@T*("`@(#QX.DYA;64^4U1/
M0TM(3TQ$15)37T5154E465]38VAE9'5L95]O/"]X.DYA;64^#0H@("`@/'@Z
M5V]R:W-H965T4V]U<F-E($A2968],T0B5V]R:W-H965T<R]3:&5E=#0V+FAT
M;6PB+SX-"B`@(#PO>#I%>&-E;%=O<FMS:&5E=#X-"B`@(#QX.D5X8V5L5V]R
M:W-H965T/@T*("`@(#QX.DYA;64^4U1/0TM(3TQ$15)37T5154E465]3=6UM
M87)Y7V]F-#PO>#I.86UE/@T*("`@(#QX.E=O<FMS:&5E=%-O=7)C92!(4F5F
M/3-$(E=O<FMS:&5E=',O4VAE970T-RYH=&UL(B\^#0H@("`\+W@Z17AC96Q7
M;W)K<VAE970^#0H@("`\>#I%>&-E;%=O<FMS:&5E=#X-"B`@("`\>#I.86UE
M/D9)3D%.0TE!3%])3D-/345?3D547T1E=&%I;',\+W@Z3F%M93X-"B`@("`\
M>#I7;W)K<VAE9713;W5R8V4@2%)E9CTS1")7;W)K<VAE971S+U-H965T-#@N
M:'1M;"(O/@T*("`@/"]X.D5X8V5L5V]R:W-H965T/@T*("`@/'@Z17AC96Q7
M;W)K<VAE970^#0H@("`@/'@Z3F%M93Y405A%4U]/3E])3D-/345?3F%R<F%T
M:79E7T1E=&$\+W@Z3F%M93X-"B`@("`\>#I7;W)K<VAE9713;W5R8V4@2%)E
M9CTS1")7;W)K<VAE971S+U-H965T-#DN:'1M;"(O/@T*("`@/"]X.D5X8V5L
M5V]R:W-H965T/@T*("`@/'@Z17AC96Q7;W)K<VAE970^#0H@("`@/'@Z3F%M
M93Y405A%4U]/3E])3D-/345?4V-H961U;&5?;V9?4VD\+W@Z3F%M93X-"B`@
M("`\>#I7;W)K<VAE9713;W5R8V4@2%)E9CTS1")7;W)K<VAE971S+U-H965T
M-3`N:'1M;"(O/@T*("`@/"]X.D5X8V5L5V]R:W-H965T/@T*("`\+W@Z17AC
M96Q7;W)K<VAE971S/@T*("`\>#I3='EL97-H965T($A2968],T0B5V]R:W-H
M965T<R]R97!O<G0N8W-S(B\^#0H@(#QX.D%C=&EV95-H965T/C`\+W@Z06-T
M:79E4VAE970^#0H@(#QX.E!R;W1E8W13=')U8W1U<F4^1F%L<V4\+W@Z4')O
M=&5C=%-T<G5C='5R93X-"B`@/'@Z4')O=&5C=%=I;F1O=W,^1F%L<V4\+W@Z
M4')O=&5C=%=I;F1O=W,^#0H@/"]X.D5X8V5L5V]R:V)O;VL^#0H\+WAM;#X\
M(5ME;F1I9ETM+3X-"CPO:&5A9#X-"B`@/&)O9'D^#0H@("`\<#Y4:&ES('!A
M9V4@<VAO=6QD(&)E(&]P96YE9"!W:71H($UI8W)O<V]F="!%>&-E;"!84"!O
M<B!N97=E<BX\+W`^#0H@(#PO8F]D>3X-"CPO:'1M;#X-"@T*+2TM+2TM/5].
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M#0H-"CQH=&UL/@T*("`\:&5A9#X-"B`@("`\345402!H='1P+65Q=6EV/3-$
M0V]N=&5N="U4>7!E(&-O;G1E;G0],T0G=&5X="]H=&UL.R!C:&%R<V5T/75T
M9BTX)SX\<V-R:7!T('1Y<&4],T1T97AT+VIA=F%S8W)I<'0@<W)C/3-$4VAO
M=RYJ<SXO*B!$;R!.;W0@4F5M;W9E(%1H:7,@0V]M;65N="`J+SPO<V-R:7!T
M/CPO:&5A9#X-"B`@/&)O9'D^#0H@("`@/'1A8FQE(&-L87-S/3-$<F5P;W)T
M(&ED/3-$240P14A0044^#0H@("`@("`\='(^#0H@("`@("`@(#QT:"!C;&%S
M<STS1'1L(&-O;'-P86X],T0Q(')O=W-P86X],T0R/CQS=')O;F<^1&]C=6UE
M;G0@86YD($5N=&ET>2!);F9O<FUA=&EO;B`H55-$("0I/&)R/CPO<W1R;VYG
M/CPO=&@^#0H@("`@("`@(#QT:"!C;&%S<STS1'1H(&-O;'-P86X],T0Q/C$R
M($UO;G1H<R!%;F1E9#PO=&@^#0H@("`@("`@(#QT:"!C;&%S<STS1'1H(&-O
M;'-P86X],T0Q/CPO=&@^#0H@("`@("`@(#QT:"!C;&%S<STS1'1H(&-O;'-P
M86X],T0Q/CPO=&@^#0H@("`@("`\+W1R/@T*("`@("`@/'1R/@T*("`@("`@
M("`\=&@@8VQA<W,],T1T:#Y*=6XN(#,P+"`R,#$T/&)R/CPO=&@^#0H@("`@
M("`@(#QT:"!C;&%S<STS1'1H/E-E<"X@,#(L(#(P,30\8G(^/"]T:#X-"B`@
M("`@("`@/'1H(&-L87-S/3-$=&@^1&5C+B`S,2P@,C`Q,SQB<CX\+W1H/@T*
M("`@("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS1')E/@T*("`@("`@("`\
M=&0@8VQA<W,],T1P;"!V86QI9VX],T1T;W`^1&]C=6UE;G0@5'EP93PO=&0^
M#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)S$P+4L\<W!A;CX\+W-P86X^
M/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N
M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A
M;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS1')O/@T*
M("`@("`@("`\=&0@8VQA<W,],T1P;"!V86QI9VX],T1T;W`^06UE;F1M96YT
M($9L86<\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B=F86QS93QS
M<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\
M<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG
M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L
M87-S/3-$<F4^#0H@("`@("`@(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O
M<#Y$;V-U;65N="!097)I;V0@16YD($1A=&4\+W1D/@T*("`@("`@("`\=&0@
M8VQA<W,],T1T97AT/DIU;B`S,"P-"@D),C`Q-#QS<&%N/CPO<W!A;CX\+W1D
M/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T
M9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO
M=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$<F\^#0H@("`@
M("`@(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O<#Y%;G1I='D@4F5G:7-T
M<F%N="!.86UE/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG4$Q5
M4DE35$5-(%1(15)!4$555$E#4R!)3D,\<W!A;CX\+W-P86X^/"]T9#X-"B`@
M("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@
M("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*
M("`@("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS1')E/@T*("`@("`@("`\
M=&0@8VQA<W,],T1P;"!V86QI9VX],T1T;W`^16YT:71Y($-E;G1R86P@26YD
M97@@2V5Y/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG,#`P,3$U
M.#<X,#QS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T
M97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$
M=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@
M/'1R(&-L87-S/3-$<F\^#0H@("`@("`@(#QT9"!C;&%S<STS1'!L('9A;&EG
M;CTS1'1O<#Y#=7)R96YT($9I<V-A;"!996%R($5N9"!$871E/"]T9#X-"B`@
M("`@("`@/'1D(&-L87-S/3-$=&5X=#XG+2TP-BTS,#QS<&%N/CPO<W!A;CX\
M+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^
M/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N
M/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$<F4^#0H@
M("`@("`@(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O<#Y$;V-U;65N="!&
M:7-C86P@665A<B!&;V-U<SPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E
M>'0^)S(P,30\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S
M/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S
M<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@
M("`@(#QT<B!C;&%S<STS1')O/@T*("`@("`@("`\=&0@8VQA<W,],T1P;"!V
M86QI9VX],T1T;W`^1&]C=6UE;G0@1FES8V%L(%!E<FEO9"!&;V-U<SPO=&0^
M#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)T99/'-P86X^/"]S<&%N/CPO
M=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\
M+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^
M/"]T9#X-"B`@("`@(#PO='(^#0H@("`@("`\='(@8VQA<W,],T1R93X-"B`@
M("`@("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P/D5N=&ET>2!&:6QE
M<B!#871E9V]R>3PO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)T%C
M8V5L97)A=&5D($9I;&5R/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT
M9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\
M=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO
M='(^#0H@("`@("`\='(@8VQA<W,],T1R;SX-"B`@("`@("`@/'1D(&-L87-S
M/3-$<&P@=F%L:6=N/3-$=&]P/D5N=&ET>2!#;VUM;VX@4W1O8VLL(%-H87)E
M<R!/=71S=&%N9&EN9SPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^
M)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6UP
M/C8Y+#(W."PU,3(\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L
M87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*
M("`@("`@/'1R(&-L87-S/3-$<F4^#0H@("`@("`@(#QT9"!C;&%S<STS1'!L
M('9A;&EG;CTS1'1O<#Y%;G1I='D@4'5B;&EC($9L;V%T/"]T9#X-"B`@("`@
M("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@
M("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@
M("`@("`\=&0@8VQA<W,],T1N=6UP/B0@,C$T+#(P,BPT,#(\<W!A;CX\+W-P
M86X^/"]T9#X-"B`@("`@(#PO='(^#0H@("`@("`\='(@8VQA<W,],T1R;SX-
M"B`@("`@("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P/D5N=&ET>2!6
M;VQU;G1A<GD@1FEL97)S/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X
M=#XG3F\\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$
M=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS
M1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@("`@
M(#QT<B!C;&%S<STS1')E/@T*("`@("`@("`\=&0@8VQA<W,],T1P;"!V86QI
M9VX],T1T;W`^16YT:71Y(%=E;&PM:VYO=VX@4V5A<V]N960@27-S=65R/"]T
M9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG3F\\<W!A;CX\+W-P86X^
M/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N
M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A
M;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS1')O/@T*
M("`@("`@("`\=&0@8VQA<W,],T1P;"!V86QI9VX],T1T;W`^16YT:71Y($-U
M<G)E;G0@4F5P;W)T:6YG(%-T871U<SPO=&0^#0H@("`@("`@(#QT9"!C;&%S
M<STS1'1E>'0^)UEE<SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@
M8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D
M(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R
M/@T*("`@(#PO=&%B;&4^#0H@(#PO8F]D>3X-"CPO:'1M;#X-"@T*+2TM+2TM
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M:6DB#0H-"CQH=&UL/@T*("`\:&5A9#X-"B`@("`\345402!H='1P+65Q=6EV
M/3-$0V]N=&5N="U4>7!E(&-O;G1E;G0],T0G=&5X="]H=&UL.R!C:&%R<V5T
M/75T9BTX)SX\<V-R:7!T('1Y<&4],T1T97AT+VIA=F%S8W)I<'0@<W)C/3-$
M4VAO=RYJ<SXO*B!$;R!.;W0@4F5M;W9E(%1H:7,@0V]M;65N="`J+SPO<V-R
M:7!T/CPO:&5A9#X-"B`@/&)O9'D^#0H@("`@/'1A8FQE(&-L87-S/3-$<F5P
M;W)T(&ED/3-$240P14U304<^#0H@("`@("`\='(^#0H@("`@("`@(#QT:"!C
M;&%S<STS1'1L(&-O;'-P86X],T0Q(')O=W-P86X],T0Q/CQS=')O;F<^0T].
M4T],241!5$5$($)!3$%.0T4@4TA%1513("A54T0@)"D\8G(^26X@5&AO=7-A
M;F1S+"!U;FQE<W,@;W1H97)W:7-E('-P96-I9FEE9#PO<W1R;VYG/CPO=&@^
M#0H@("`@("`@(#QT:"!C;&%S<STS1'1H/DIU;BX@,S`L(#(P,30\8G(^/"]T
M:#X-"B`@("`@("`@/'1H(&-L87-S/3-$=&@^2G5N+B`S,"P@,C`Q,SQB<CX\
M+W1H/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS1')E/@T*("`@
M("`@("`\=&0@8VQA<W,],T1P;"!V86QI9VX],T1T;W`^/'-T<F]N9SY#55)2
M14Y4($%34T544SH\+W-T<F]N9SX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,]
M,T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S
M/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@
M("`@/'1R(&-L87-S/3-$<F\^#0H@("`@("`@(#QT9"!C;&%S<STS1'!L('9A
M;&EG;CTS1'1O<#Y#87-H(&%N9"!C87-H(&5Q=6EV86QE;G1S/"]T9#X-"B`@
M("`@("`@/'1D(&-L87-S/3-$;G5M<#XD(#0L-#DS/'-P86X^/"]S<&%N/CPO
M=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;7`^)"`Y+#`P-SQS<&%N/CPO
M<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS1')E
M/@T*("`@("`@("`\=&0@8VQA<W,],T1P;"!V86QI9VX],T1T;W`^4VAO<G0M
M=&5R;2!B86YK(&1E<&]S:71S/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$
M;G5M<#XQ.2PT-3$\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L
M87-S/3-$;G5M<#XS,2PT-#D\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO
M='(^#0H@("`@("`\='(@8VQA<W,],T1R;SX-"B`@("`@("`@/'1D(&-L87-S
M/3-$<&P@=F%L:6=N/3-$=&]P/E)E<W1R:6-T960@8V%S:"!A;F0@<F5S=')I
M8W1E9"!S:&]R="UT97)M(&1E<&]S:71S/"]T9#X-"B`@("`@("`@/'1D(&-L
M87-S/3-$;G5M<#XT+#DQ-#QS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\
M=&0@8VQA<W,],T1N=6UP/C,Q-CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@
M/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS1')E/@T*("`@("`@("`\=&0@8VQA
M<W,],T1P;"!V86QI9VX],T1T;W`^36%R:V5T86)L92!S96-U<FET:65S/"]T
M9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XR.2PY-C$\<W!A;CX\+W-P
M86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XQ,RPT-#$\<W!A
M;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO='(^#0H@("`@("`\='(@8VQA<W,]
M,T1R;SX-"B`@("`@("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P/D%C
M8V]U;G0@<F5C96EV86)L92!F<F]M($]#4SPO=&0^#0H@("`@("`@(#QT9"!C
M;&%S<STS1&YU;7`^,BPR-C,\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@
M/'1D(&-L87-S/3-$;G5M<#XR-S,\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@
M(#PO='(^#0H@("`@("`\='(@8VQA<W,],T1R93X-"B`@("`@("`@/'1D(&-L
M87-S/3-$<&P@=F%L:6=N/3-$=&]P/D]T:&5R(&-U<G)E;G0@87-S971S/"]T
M9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XY,#4\<W!A;CX\+W-P86X^
M/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XU.3D\<W!A;CX\+W-P
M86X^/"]T9#X-"B`@("`@(#PO='(^#0H@("`@("`\='(@8VQA<W,],T1R;W4^
M#0H@("`@("`@(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O<#Y4;W1A;"!C
M=7)R96YT(&%S<V5T<SPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;7`^
M-C$L.3@W/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS
M1&YU;7`^-34L,#@U/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*
M("`@("`@/'1R(&-L87-S/3-$<F4^#0H@("`@("`@(#QT9"!C;&%S<STS1'!L
M('9A;&EG;CTS1'1O<#X\<W1R;VYG/DQ/3D<M5$5232!!4U-%5%,Z/"]S=')O
M;F<^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S
M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO
M<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS1')O
M/@T*("`@("`@("`\=&0@8VQA<W,],T1P;"!V86QI9VX],T1T;W`^3&]N9RUT
M97)M(&1E<&]S:71S(&%N9"!R97-T<FEC=&5D(&1E<&]S:71S/"]T9#X-"B`@
M("`@("`@/'1D(&-L87-S/3-$;G5M<#XS,#0\<W!A;CX\+W-P86X^/"]T9#X-
M"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XT,C$\<W!A;CX\+W-P86X^/"]T
M9#X-"B`@("`@(#PO='(^#0H@("`@("`\='(@8VQA<W,],T1R93X-"B`@("`@
M("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P/E-E=F5R86YC92!P87D@
M9G5N9#PO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;7`^.3`Q/'-P86X^
M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;7`^.3`U/'-P
M86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S
M/3-$<F\^#0H@("`@("`@(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O<#Y0
M<F]P97)T>2!A;F0@97%U:7!M96YT+"!N970\+W1D/@T*("`@("`@("`\=&0@
M8VQA<W,],T1N=6UP/C$P+#@R,SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@
M("`\=&0@8VQA<W,],T1N=6UP/C$Q+#@V-CQS<&%N/CPO<W!A;CX\+W1D/@T*
M("`@("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS1')E/@T*("`@("`@("`\
M=&0@8VQA<W,],T1P;"!V86QI9VX],T1T;W`^3W1H97(@;&]N9R!T97)M(&%S
M<V5T<SPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;7`^.#QS<&%N/CPO
M<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6UP/C,Y/'-P86X^
M/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$
M<F]U/@T*("`@("`@("`\=&0@8VQA<W,],T1P;"!V86QI9VX],T1T;W`^5&]T
M86P@;&]N9RUT97)M(&%S<V5T<SPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS
M1&YU;7`^,3(L,#,V/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C
M;&%S<STS1&YU;7`^,3,L,C,Q/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\
M+W1R/@T*("`@("`@/'1R(&-L87-S/3-$<F5U/@T*("`@("`@("`\=&0@8VQA
M<W,],T1P;"!V86QI9VX],T1T;W`^5&]T86P@87-S971S/"]T9#X-"B`@("`@
M("`@/'1D(&-L87-S/3-$;G5M<#XW-"PP,C,\<W!A;CX\+W-P86X^/"]T9#X-
M"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XV."PS,38\<W!A;CX\+W-P86X^
M/"]T9#X-"B`@("`@(#PO='(^#0H@("`@("`\='(@8VQA<W,],T1R;SX-"B`@
M("`@("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P/CQS=')O;F<^0U52
M4D5.5"!,24%"24Q)5$E%4SPO<W1R;VYG/CPO=&0^#0H@("`@("`@(#QT9"!C
M;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@
M8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO='(^
M#0H@("`@("`\='(@8VQA<W,],T1R93X-"B`@("`@("`@/'1D(&-L87-S/3-$
M<&P@=F%L:6=N/3-$=&]P/E1R861E('!A>6%B;&5S/"]T9#X-"B`@("`@("`@
M/'1D(&-L87-S/3-$;G5M<#XS+#0V-3QS<&%N/CPO<W!A;CX\+W1D/@T*("`@
M("`@("`\=&0@8VQA<W,],T1N=6UP/C(L.#,W/'-P86X^/"]S<&%N/CPO=&0^
M#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$<F\^#0H@("`@("`@
M(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O<#Y!8V-R=65D(&5X<&5N<V5S
M/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XY,34\<W!A;CX\+W-P
M86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XQ+#`T,#QS<&%N
M/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS
M1')E/@T*("`@("`@("`\=&0@8VQA<W,],T1P;"!V86QI9VX],T1T;W`^1&5F
M97)R960@<F5V96YU97,\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6UP
M/C,W.3QS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N
M=6UP/C,W.3QS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@("`@
M(#QT<B!C;&%S<STS1')O/@T*("`@("`@("`\=&0@8VQA<W,],T1P;"!V86QI
M9VX],T1T;W`^061V86YC92!P87EM96YT(&9R;VT@56YI=&5D(%1H97)A<&5U
M=&EC<SPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;7`^,C0W/'-P86X^
M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;7`^,SDS/'-P
M86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S
M/3-$<F4^#0H@("`@("`@(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O<#Y/
M=&AE<B!A8V-O=6YT<R!P87EA8FQE/"]T9#X-"B`@("`@("`@/'1D(&-L87-S
M/3-$;G5M<#XR+#,Y,3QS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@
M8VQA<W,],T1N=6UP/C$L,C<R/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\
M+W1R/@T*("`@("`@/'1R(&-L87-S/3-$<F]U/@T*("`@("`@("`\=&0@8VQA
M<W,],T1P;"!V86QI9VX],T1T;W`^5&]T86P@8W5R<F5N="!L:6%B:6QI=&EE
M<SPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;7`^-RPS.3<\<W!A;CX\
M+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XU+#DR,3QS
M<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S
M<STS1')E/@T*("`@("`@("`\=&0@8VQA<W,],T1P;"!V86QI9VX],T1T;W`^
M/'-T<F]N9SY,3TY'+51%4DT@3$E!0DE,251)15,\+W-T<F]N9SX\+W1D/@T*
M("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-
M"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^
M#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$<F\^#0H@("`@("`@
M(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O<#Y$969E<G)E9"!R979E;G5E
M<SPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;7`^,BPX-#<\<W!A;CX\
M+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XS+#(R-CQS
M<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S
M<STS1')E/@T*("`@("`@("`\=&0@8VQA<W,],T1P;"!V86QI9VX],T1T;W`^
M06-C<G5E9"!S979E<F%N8V4@<&%Y/"]T9#X-"B`@("`@("`@/'1D(&-L87-S
M/3-$;G5M<#XQ+#`V.#QS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@
M8VQA<W,],T1N=6UP/C$L,#(S/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\
M+W1R/@T*("`@("`@/'1R(&-L87-S/3-$<F\^#0H@("`@("`@(#QT9"!C;&%S
M<STS1'!L('9A;&EG;CTS1'1O<#Y/=&AE<B!L;VYG+71E<FT@;&EA8FEL:71I
M97,\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6UP/C4X.#QS<&%N/CPO
M<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6UP/C8X,#QS<&%N
M/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS
M1')E=3X-"B`@("`@("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P/E1O
M=&%L(&QO;F<M=&5R;2!L:6%B:6QI=&EE<SPO=&0^#0H@("`@("`@(#QT9"!C
M;&%S<STS1&YU;7`^-"PU,#,\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@
M/'1D(&-L87-S/3-$;G5M<#XT+#DR.3QS<&%N/CPO<W!A;CX\+W1D/@T*("`@
M("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS1')O/@T*("`@("`@("`\=&0@
M8VQA<W,],T1P;"!V86QI9VX],T1T;W`^0T]-34E4345.5%,@04Y$($-/3E1)
M3D=%3D-)15,\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<F;F)S
M<#LF;F)S<#L\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S
M/3-$=&5X=#XG)FYB<W`[)FYB<W`[/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@
M("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$<F4^#0H@("`@("`@(#QT9"!C
M;&%S<STS1'!L('9A;&EG;CTS1'1O<#X\<W1R;VYG/E-43T-+2$],1$524R<@
M15%52519/"]S=')O;F<^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X
M=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E
M>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@("`@(#QT
M<B!C;&%S<STS1')O/@T*("`@("`@("`\=&0@8VQA<W,],T1P;"!V86QI9VX]
M,T1T;W`^4VAA<F4@8V%P:71A;#H@0V]M;6]N('-T;V-K("0P+C`P,#`Q('!A
M<B!V86QU93H@075T:&]R:7IE9#H@,C`P+#`P,"PP,#`@<VAA<F5S($ES<W5E
M9"!A;F0@;W5T<W1A;F1I;F<Z(#8X+#8P,2PT-3(@<VAA<F5S(&%S(&]F($IU
M;F4@,S`L(#(P,30L(#4Y+#$Y-BPV,3<@<VAA<F5S(&%S(&]F($IU;F4@,S`L
M(#(P,3,[/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG)FYB<W`[
M)FYB<W`[/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS
M1'1E>'0^)R9N8G-P.R9N8G-P.SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@
M/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS1')E/@T*("`@("`@("`\=&0@8VQA
M<W,],T1P;"!V86QI9VX],T1T;W`^061D:71I;VYA;"!P86ED+6EN(&-A<&ET
M86P\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6UP/C$W,BPY.3@\<W!A
M;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XQ-#0L
M,3`Y/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R
M(&-L87-S/3-$<F\^#0H@("`@("`@(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS
M1'1O<#Y!8V-U;75L871E9"!D969I8VET/"]T9#X-"B`@("`@("`@/'1D(&-L
M87-S/3-$;G5M/B@Q,3,L.#,T*3QS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@
M("`\=&0@8VQA<W,],T1N=6T^*#@V+#DP,BD\<W!A;CX\+W-P86X^/"]T9#X-
M"B`@("`@(#PO='(^#0H@("`@("`\='(@8VQA<W,],T1R93X-"B`@("`@("`@
M/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P/D]T:&5R(&-O;7!R96AE;G-I
M=F4@:6YC;VUE/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XR+#DU
M.3QS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6UP
M/C(U.3QS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@("`@(#QT
M<B!C;&%S<STS1')O=3X-"B`@("`@("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N
M/3-$=&]P/E1O=&%L('-T;V-K:&]L9&5R<R<@97%U:71Y/"]T9#X-"B`@("`@
M("`@/'1D(&-L87-S/3-$;G5M<#XV,BPQ,C,\<W!A;CX\+W-P86X^/"]T9#X-
M"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XU-RPT-C8\<W!A;CX\+W-P86X^
M/"]T9#X-"B`@("`@(#PO='(^#0H@("`@("`\='(@8VQA<W,],T1R974^#0H@
M("`@("`@(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O<#Y4;W1A;"!L:6%B
M:6QI=&EE<R!A;F0@<W1O8VMH;VQD97)S)R!E<75I='D\+W1D/@T*("`@("`@
M("`\=&0@8VQA<W,],T1N=6UP/B0@-S0L,#(S/'-P86X^/"]S<&%N/CPO=&0^
M#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;7`^)"`V."PS,38\<W!A;CX\+W-P
M86X^/"]T9#X-"B`@("`@(#PO='(^#0H@("`@/"]T86)L93X-"B`@/"]B;V1Y
M/@T*/"]H=&UL/@T*#0HM+2TM+2T]7TYE>'1087)T7S!C860U.69D7S<S,F5?
M-#9E,E]A-3,T7S!C.&%D,6%F.3!D9`T*0V]N=&5N="U,;V-A=&EO;CH@9FEL
M93HO+R]#.B\P8V%D-3EF9%\W,S)E7S0V93)?834S-%\P8SAA9#%A9CDP9&0O
M5V]R:W-H965T<R]3:&5E=#`S+FAT;6P-"D-O;G1E;G0M5')A;G-F97(M16YC
M;V1I;F<Z('%U;W1E9"UP<FEN=&%B;&4-"D-O;G1E;G0M5'EP93H@=&5X="]H
M=&UL.R!C:&%R<V5T/2)U<RUA<V-I:2(-"@T*/&AT;6P^#0H@(#QH96%D/@T*
M("`@(#Q-151!(&AT='`M97%U:78],T1#;VYT96YT+51Y<&4@8V]N=&5N=#TS
M1"=T97AT+VAT;6P[(&-H87)S970]=71F+3@G/CQS8W)I<'0@='EP93TS1'1E
M>'0O:F%V87-C<FEP="!S<F,],T13:&]W+FIS/B\J($1O($YO="!296UO=F4@
M5&AI<R!#;VUM96YT("HO/"]S8W)I<'0^/"]H96%D/@T*("`\8F]D>3X-"B`@
M("`\=&%B;&4@8VQA<W,],T1R97!O<G0@:60],T1)1#!%-D9!0SX-"B`@("`@
M(#QT<CX-"B`@("`@("`@/'1H(&-L87-S/3-$=&P@8V]L<W!A;CTS1#$@<F]W
M<W!A;CTS1#$^/'-T<F]N9SY#3TY33TQ)1$%4140@0D%,04Y#12!32$5%5%,@
M*%!!4D5.5$A%5$E#04PI("A54T0@)"D\8G(^/"]S=')O;F<^/"]T:#X-"B`@
M("`@("`@/'1H(&-L87-S/3-$=&@^2G5N+B`S,"P@,C`Q-#QB<CX\+W1H/@T*
M("`@("`@("`\=&@@8VQA<W,],T1T:#Y*=6XN(#,P+"`R,#$S/&)R/CPO=&@^
M#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$<F4^#0H@("`@("`@
M(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O<#X\<W1R;VYG/D-/3E-/3$E$
M051%1"!"04Q!3D-%(%-(14544R!;06)S=')A8W1=/"]S=')O;F<^/"]T9#X-
M"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^
M#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D
M/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS1')O/@T*("`@("`@
M("`\=&0@8VQA<W,],T1P;"!V86QI9VX],T1T;W`^0V]M;6]N('-T;V-K+"!P
M87(@=F%L=64@<&5R('-H87)E/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$
M;G5M<#XD(#`N,#`P,#$\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D
M(&-L87-S/3-$;G5M<#XD(#`N,#`P,#$\<W!A;CX\+W-P86X^/"]T9#X-"B`@
M("`@(#PO='(^#0H@("`@("`\='(@8VQA<W,],T1R93X-"B`@("`@("`@/'1D
M(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P/D-O;6UO;B!S=&]C:RP@<VAA<F5S
M(&%U=&AO<FEZ960\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6UP/C(P
M,"PP,#`L,#`P/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S
M<STS1&YU;7`^,C`P+#`P,"PP,#`\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@
M(#PO='(^#0H@("`@("`\='(@8VQA<W,],T1R;SX-"B`@("`@("`@/'1D(&-L
M87-S/3-$<&P@=F%L:6=N/3-$=&]P/D-O;6UO;B!S=&]C:RP@<VAA<F5S(&ES
M<W5E9#PO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;7`^-C@L-C`Q+#0U
M,CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6UP
M/C4Y+#$Y-BPV,3<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO='(^#0H@
M("`@("`\='(@8VQA<W,],T1R93X-"B`@("`@("`@/'1D(&-L87-S/3-$<&P@
M=F%L:6=N/3-$=&]P/D-O;6UO;B!S=&]C:RP@<VAA<F5S(&]U='-T86YD:6YG
M/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XV."PV,#$L-#4R/'-P
M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;7`^-3DL
M,3DV+#8Q-SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@("`\
M+W1A8FQE/@T*("`\+V)O9'D^#0H\+VAT;6P^#0H-"BTM+2TM+3U?3F5X=%!A
M<G1?,&-A9#4Y9F1?-S,R95\T-F4R7V$U,S1?,&,X860Q868Y,&1D#0I#;VYT
M96YT+4QO8V%T:6]N.B!F:6QE.B\O+T,Z+S!C860U.69D7S<S,F5?-#9E,E]A
M-3,T7S!C.&%D,6%F.3!D9"]7;W)K<VAE971S+U-H965T,#0N:'1M;`T*0V]N
M=&5N="U4<F%N<V9E<BU%;F-O9&EN9SH@<75O=&5D+7!R:6YT86)L90T*0V]N
M=&5N="U4>7!E.B!T97AT+VAT;6P[(&-H87)S970](G5S+6%S8VEI(@T*#0H\
M:'1M;#X-"B`@/&AE860^#0H@("`@/$U%5$$@:'1T<"UE<75I=CTS1$-O;G1E
M;G0M5'EP92!C;VYT96YT/3-$)W1E>'0O:'1M;#L@8VAA<G-E=#UU=&8M."<^
M/'-C<FEP="!T>7!E/3-$=&5X="]J879A<V-R:7!T('-R8STS1%-H;W<N:G,^
M+RH@1&\@3F]T(%)E;6]V92!4:&ES($-O;6UE;G0@*B\\+W-C<FEP=#X\+VAE
M860^#0H@(#QB;V1Y/@T*("`@(#QT86)L92!C;&%S<STS1')E<&]R="!I9#TS
M1$E$,$514T%%/@T*("`@("`@/'1R/@T*("`@("`@("`\=&@@8VQA<W,],T1T
M;"!C;VQS<&%N/3-$,2!R;W=S<&%N/3-$,CX\<W1R;VYG/D-/3E-/3$E$051%
M1"!35$%414U%3E13($]&($]015)!5$E/3E,@*%531"`D*3QB<CY);B!4:&]U
M<V%N9',L(&5X8V5P="!3:&%R92!D871A+"!U;FQE<W,@;W1H97)W:7-E('-P
M96-I9FEE9#PO<W1R;VYG/CPO=&@^#0H@("`@("`@(#QT:"!C;&%S<STS1'1H
M(&-O;'-P86X],T0S/C$R($UO;G1H<R!%;F1E9#PO=&@^#0H@("`@("`\+W1R
M/@T*("`@("`@/'1R/@T*("`@("`@("`\=&@@8VQA<W,],T1T:#Y*=6XN(#,P
M+"`R,#$T/&)R/CPO=&@^#0H@("`@("`@(#QT:"!C;&%S<STS1'1H/DIU;BX@
M,S`L(#(P,3,\8G(^/"]T:#X-"B`@("`@("`@/'1H(&-L87-S/3-$=&@^2G5N
M+B`S,"P@,C`Q,CQB<CX\+W1H/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<B!C
M;&%S<STS1')E/@T*("`@("`@("`\=&0@8VQA<W,],T1P;"!V86QI9VX],T1T
M;W`^/'-T<F]N9SY#3TY33TQ)1$%4140@4U1!5$5-14Y44R!/1B!/4$52051)
M3TY3(%M!8G-T<F%C=%T\+W-T<F]N9SX\+W1D/@T*("`@("`@("`\=&0@8VQA
M<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L
M87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C
M;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-
M"B`@("`@(#QT<B!C;&%S<STS1')O/@T*("`@("`@("`\=&0@8VQA<W,],T1P
M;"!V86QI9VX],T1T;W`^4F5V96YU97,\+W1D/@T*("`@("`@("`\=&0@8VQA
M<W,],T1N=6UP/B0@,S<Y/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT
M9"!C;&%S<STS1&YU;7`^)"`V-SD\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@
M("`@/'1D(&-L87-S/3-$;G5M<#XD(#<Q-CQS<&%N/CPO<W!A;CX\+W1D/@T*
M("`@("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS1')E/@T*("`@("`@("`\
M=&0@8VQA<W,],T1P;"!V86QI9VX],T1T;W`^0V]S="!O9B!R979E;G5E<SPO
M=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;3XH,3$I/'-P86X^/"]S<&%N
M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;3XH,C`I/'-P86X^/"]S
M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;3XH,C$I/'-P86X^
M/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$
M<F]U/@T*("`@("`@("`\=&0@8VQA<W,],T1P;"!V86QI9VX],T1T;W`^1W)O
M<W,@<')O9FET/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XS-C@\
M<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XV
M-3D\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M
M<#XV.34\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO='(^#0H@("`@("`\
M='(@8VQA<W,],T1R93X-"B`@("`@("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N
M/3-$=&]P/E)E<V5A<F-H(&%N9"!D979E;&]P;65N="!E>'!E;G-E<SPO=&0^
M#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;3XH,C0L.3,X*3QS<&%N/CPO<W!A
M;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6T^*#$Y+#DP-BD\<W!A
M;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M/B@Q,BPV
M.#4I/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R
M(&-L87-S/3-$<F\^#0H@("`@("`@(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS
M1'1O<#Y,97-S('!A<G1I8VEP871I;VX@8GD@=&AE($]F9FEC92!O9B!T:&4@
M0VAI968@4V-I96YT:7-T(&%N9"!O=&AE<B!P87)T:65S/"]T9#X-"B`@("`@
M("`@/'1D(&-L87-S/3-$;G5M<#XU+#,Y-CQS<&%N/CPO<W!A;CX\+W1D/@T*
M("`@("`@("`\=&0@8VQA<W,],T1N=6UP/C(L-C<S/'-P86X^/"]S<&%N/CPO
M=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;7`^,RPU,C<\<W!A;CX\+W-P
M86X^/"]T9#X-"B`@("`@(#PO='(^#0H@("`@("`\='(@8VQA<W,],T1R974^
M#0H@("`@("`@(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O<#Y297-E87)C
M:"!A;F0@9&5V96QO<&UE;G0@97AP96YS97,L(&YE=#PO=&0^#0H@("`@("`@
M(#QT9"!C;&%S<STS1&YU;3XH,3DL-30R*3QS<&%N/CPO<W!A;CX\+W1D/@T*
M("`@("`@("`\=&0@8VQA<W,],T1N=6T^*#$W+#(S,RD\<W!A;CX\+W-P86X^
M/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M/B@Y+#$U."D\<W!A;CX\
M+W-P86X^/"]T9#X-"B`@("`@(#PO='(^#0H@("`@("`\='(@8VQA<W,],T1R
M;SX-"B`@("`@("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P/D=E;F5R
M86P@86YD(&%D;6EN:7-T<F%T:79E(&5X<&5N<V5S/"]T9#X-"B`@("`@("`@
M/'1D(&-L87-S/3-$;G5M/B@X+#8W-BD\<W!A;CX\+W-P86X^/"]T9#X-"B`@
M("`@("`@/'1D(&-L87-S/3-$;G5M/B@U+#8T.2D\<W!A;CX\+W-P86X^/"]T
M9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M/B@V+#4V."D\<W!A;CX\+W-P
M86X^/"]T9#X-"B`@("`@(#PO='(^#0H@("`@("`\='(@8VQA<W,],T1R974^
M#0H@("`@("`@(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O<#Y/<&5R871I
M;F<@;&]S<SPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;3XH,C<L.#4P
M*3QS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6T^
M*#(R+#(R,RD\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S
M/3-$;G5M/B@Q-2PP,S$I/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R
M/@T*("`@("`@/'1R(&-L87-S/3-$<F\^#0H@("`@("`@(#QT9"!C;&%S<STS
M1'!L('9A;&EG;CTS1'1O<#Y&:6YA;F-I86P@:6YC;VUE+"!N970\+W1D/@T*
M("`@("`@("`\=&0@8VQA<W,],T1N=6UP/CDQ.#QS<&%N/CPO<W!A;CX\+W1D
M/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6UP/C$L,#8X/'-P86X^/"]S<&%N
M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;7`^,C,W/'-P86X^/"]S
M<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$<F5U
M/@T*("`@("`@("`\=&0@8VQA<W,],T1P;"!V86QI9VX],T1T;W`^3F5T(&QO
M<W,\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6T^)"`H,C8L.3,R*3QS
M<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6T^)"`H
M,C$L,34U*3QS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,]
M,T1N=6T^)"`H,30L-SDT*3QS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T
M<CX-"B`@("`@(#QT<B!C;&%S<STS1')O/@T*("`@("`@("`\=&0@8VQA<W,]
M,T1P;"!V86QI9VX],T1T;W`^/'-T<F]N9SY,;W-S('!E<B!S:&%R93H\+W-T
M<F]N9SX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\
M+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^
M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N
M/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS
M1')E/@T*("`@("`@("`\=&0@8VQA<W,],T1P;"!V86QI9VX],T1T;W`^0F%S
M:6,@86YD(&1I;'5T960@;F5T(&QO<W,@<&5R('-H87)E/"]T9#X-"B`@("`@
M("`@/'1D(&-L87-S/3-$;G5M/B0@*#`N-#(I/'-P86X^/"]S<&%N/CPO=&0^
M#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;3XD("@P+C,X*3QS<&%N/CPO<W!A
M;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6T^)"`H,"XS-"D\<W!A
M;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO='(^#0H@("`@("`\='(@8VQA<W,]
M,T1R;SX-"B`@("`@("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P/E=E
M:6=H=&5D(&%V97)A9V4@;G5M8F5R(&]F('-H87)E<R!U<V5D(&EN(&-O;7!U
M=&EN9R!B87-I8R!A;F0@9&EL=71E9"!N970@;&]S<R!P97(@<VAA<F4\+W1D
M/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6UP/C8S+#4Q-"PT,#4\<W!A;CX\
M+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XU-2PT.#$L
M,S4W/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU
M;7`^-#0L,#,Q+#@V-CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-
M"B`@("`\+W1A8FQE/@T*("`\+V)O9'D^#0H\+VAT;6P^#0H-"BTM+2TM+3U?
M3F5X=%!A<G1?,&-A9#4Y9F1?-S,R95\T-F4R7V$U,S1?,&,X860Q868Y,&1D
M#0I#;VYT96YT+4QO8V%T:6]N.B!F:6QE.B\O+T,Z+S!C860U.69D7S<S,F5?
M-#9E,E]A-3,T7S!C.&%D,6%F.3!D9"]7;W)K<VAE971S+U-H965T,#4N:'1M
M;`T*0V]N=&5N="U4<F%N<V9E<BU%;F-O9&EN9SH@<75O=&5D+7!R:6YT86)L
M90T*0V]N=&5N="U4>7!E.B!T97AT+VAT;6P[(&-H87)S970](G5S+6%S8VEI
M(@T*#0H\:'1M;#X-"B`@/&AE860^#0H@("`@/$U%5$$@:'1T<"UE<75I=CTS
M1$-O;G1E;G0M5'EP92!C;VYT96YT/3-$)W1E>'0O:'1M;#L@8VAA<G-E=#UU
M=&8M."<^/'-C<FEP="!T>7!E/3-$=&5X="]J879A<V-R:7!T('-R8STS1%-H
M;W<N:G,^+RH@1&\@3F]T(%)E;6]V92!4:&ES($-O;6UE;G0@*B\\+W-C<FEP
M=#X\+VAE860^#0H@(#QB;V1Y/@T*("`@(#QT86)L92!C;&%S<STS1')E<&]R
M="!I9#TS1$E$,$5+3T%#/@T*("`@("`@/'1R/@T*("`@("`@("`\=&@@8VQA
M<W,],T1T;"!C;VQS<&%N/3-$,2!R;W=S<&%N/3-$,CX\<W1R;VYG/D-/3E-/
M3$E$051%1"!35$%414U%3E13($]&($-/35!214A%3E-)5D4@3$]34R`H55-$
M("0I/&)R/DEN(%1H;W5S86YD<RP@=6YL97-S(&]T:&5R=VES92!S<&5C:69I
M960\+W-T<F]N9SX\+W1H/@T*("`@("`@("`\=&@@8VQA<W,],T1T:"!C;VQS
M<&%N/3-$,SXQ,B!-;VYT:',@16YD960\+W1H/@T*("`@("`@/"]T<CX-"B`@
M("`@(#QT<CX-"B`@("`@("`@/'1H(&-L87-S/3-$=&@^2G5N+B`S,"P@,C`Q
M-#QB<CX\+W1H/@T*("`@("`@("`\=&@@8VQA<W,],T1T:#Y*=6XN(#,P+"`R
M,#$S/&)R/CPO=&@^#0H@("`@("`@(#QT:"!C;&%S<STS1'1H/DIU;BX@,S`L
M(#(P,3(\8G(^/"]T:#X-"B`@("`@(#PO='(^#0H@("`@("`\='(@8VQA<W,]
M,T1R93X-"B`@("`@("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P/CQS
M=')O;F<^0T].4T],241!5$5$(%-4051%345.5%,@3T8@0T]-4%)%2$5.4TE6
M12!,3U-3(%M!8G-T<F%C=%T\+W-T<F]N9SX\+W1D/@T*("`@("`@("`\=&0@
M8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D
M(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT
M9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T
M<CX-"B`@("`@(#QT<B!C;&%S<STS1')O/@T*("`@("`@("`\=&0@8VQA<W,]
M,T1P;"!V86QI9VX],T1T;W`^3F5T(&QO<W,\+W1D/@T*("`@("`@("`\=&0@
M8VQA<W,],T1N=6T^)"`H,C8L.3,R*3QS<&%N/CPO<W!A;CX\+W1D/@T*("`@
M("`@("`\=&0@8VQA<W,],T1N=6T^)"`H,C$L,34U*3QS<&%N/CPO<W!A;CX\
M+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6T^)"`H,30L-SDT*3QS<&%N
M/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS
M1')E/@T*("`@("`@("`\=&0@8VQA<W,],T1P;"!V86QI9VX],T1T;W`^/'-T
M<F]N9SY/=&AE<B!C;VUP<F5H96YS:79E(&EN8V]M92`H;&]S<RDL(&YE=#H\
M+W-T<F]N9SX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A
M;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P
M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS
M<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S
M<STS1')O/@T*("`@("`@("`\=&0@8VQA<W,],T1P;"!V86QI9VX],T1T;W`^
M56YR96%L:7IE9"!G86EN<R!O;B!D97)I=F%T:79E(&EN<W1R=6UE;G1S/"]T
M9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XR,SQS<&%N/CPO<W!A;CX\
M+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<F;F)S<#LF;F)S<#L\
M<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG
M)FYB<W`[)FYB<W`[/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*
M("`@("`@/'1R(&-L87-S/3-$<F4^#0H@("`@("`@(#QT9"!C;&%S<STS1'!L
M('9A;&EG;CTS1'1O<#Y5;G)E86QI>F5D(&=A:6X@*&QO<W,I(&]N(&%V86EL
M86)L92UF;W(M<V%L92!M87)K971A8FQE('-E8W5R:71I97,L(&YE=#PO=&0^
M#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;7`^,RPT,#0\<W!A;CX\+W-P86X^
M/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XT,34\<W!A;CX\+W-P
M86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M/B@Q,C<I/'-P86X^
M/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$
M<F\^#0H@("`@("`@(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O<#Y296-L
M87-S:69I8V%T:6]N(&%D:G5S=&UE;G0@;V8@879A:6QA8FQE+69O<BUS86QE
M(&UA<FME=&%B;&4@<V5C=7)I=&EE<R!L;W-S97,@<F5A;&EZ960@:6X@;F5T
M(&QO<W,L(&YE=#PO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;3XH-S(W
M*3QS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6T^
M*#(V*3QS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N
M=6T^*#,I/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@
M/'1R(&-L87-S/3-$<F5U/@T*("`@("`@("`\=&0@8VQA<W,],T1P;"!V86QI
M9VX],T1T;W`^5&]T86P@8V]M<')E:&5N<VEV92!L;W-S/"]T9#X-"B`@("`@
M("`@/'1D(&-L87-S/3-$;G5M/B0@*#(T+#(S,BD\<W!A;CX\+W-P86X^/"]T
M9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M/B0@*#(P+#<V-BD\<W!A;CX\
M+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M/B0@*#$T+#DR
M-"D\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO='(^#0H@("`@/"]T86)L
M93X-"B`@/"]B;V1Y/@T*/"]H=&UL/@T*#0HM+2TM+2T]7TYE>'1087)T7S!C
M860U.69D7S<S,F5?-#9E,E]A-3,T7S!C.&%D,6%F.3!D9`T*0V]N=&5N="U,
M;V-A=&EO;CH@9FEL93HO+R]#.B\P8V%D-3EF9%\W,S)E7S0V93)?834S-%\P
M8SAA9#%A9CDP9&0O5V]R:W-H965T<R]3:&5E=#`V+FAT;6P-"D-O;G1E;G0M
M5')A;G-F97(M16YC;V1I;F<Z('%U;W1E9"UP<FEN=&%B;&4-"D-O;G1E;G0M
M5'EP93H@=&5X="]H=&UL.R!C:&%R<V5T/2)U<RUA<V-I:2(-"@T*/&AT;6P^
M#0H@(#QH96%D/@T*("`@(#Q-151!(&AT='`M97%U:78],T1#;VYT96YT+51Y
M<&4@8V]N=&5N=#TS1"=T97AT+VAT;6P[(&-H87)S970]=71F+3@G/CQS8W)I
M<'0@='EP93TS1'1E>'0O:F%V87-C<FEP="!S<F,],T13:&]W+FIS/B\J($1O
M($YO="!296UO=F4@5&AI<R!#;VUM96YT("HO/"]S8W)I<'0^/"]H96%D/@T*
M("`\8F]D>3X-"B`@("`\=&%B;&4@8VQA<W,],T1R97!O<G0@:60],T1)1#!%
M,E%$23X-"B`@("`@(#QT<CX-"B`@("`@("`@/'1H(&-L87-S/3-$=&P@8V]L
M<W!A;CTS1#$@<F]W<W!A;CTS1#$^/'-T<F]N9SY35$%414U%3E13($]&($-(
M04Y'15,@24X@15%52519("A54T0@)"D\8G(^26X@5&AO=7-A;F1S+"!E>&-E
M<'0@4VAA<F4@9&%T83PO<W1R;VYG/CPO=&@^#0H@("`@("`@(#QT:"!C;&%S
M<STS1'1H/E1O=&%L/&)R/CPO=&@^#0H@("`@("`@(#QT:"!C;&%S<STS1'1H
M/D-O;6UO;B!3=&]C:R!;365M8F5R73QB<CX\+W1H/@T*("`@("`@("`\=&@@
M8VQA<W,],T1T:#Y!9&1I=&EO;F%L(%!A:60M:6X@0V%P:71A;"!;365M8F5R
M73QB<CX\+W1H/@T*("`@("`@("`\=&@@8VQA<W,],T1T:#Y!8V-U;75L871E
M9"!/=&AE<B!#;VUP<F5H96YS:79E($EN8V]M92`H3&]S<RD@6TUE;6)E<ET\
M8G(^/"]T:#X-"B`@("`@("`@/'1H(&-L87-S/3-$=&@^06-C=6UU;&%T960@
M1&5F:6-I="!;365M8F5R73QB<CX\+W1H/@T*("`@("`@/"]T<CX-"B`@("`@
M(#QT<B!C;&%S<STS1')C/@T*("`@("`@("`\=&0@8VQA<W,],T1P;"!V86QI
M9VX],T1T;W`^0F%L86YC92!A="!*=6XN(#,P+"`R,#$Q/"]T9#X-"B`@("`@
M("`@/'1D(&-L87-S/3-$;G5M<#XD(#0S+#0R,CQS<&%N/CPO<W!A;CX\+W1D
M/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<F;F)S<#LF;F)S<#L\<W!A
M;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XD(#DT
M+#,W-3QS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T
M97AT/B<F;F)S<#LF;F)S<#L\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@
M/'1D(&-L87-S/3-$;G5M/B0@*#4P+#DU,RD\<W!A;CX\+W-P86X^/"]T9#X-
M"B`@("`@(#PO='(^#0H@("`@("`\='(@8VQA<W,],T1R8SX-"B`@("`@("`@
M/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P/D)A;&%N8V4L('-H87)E<R!A
M="!*=6XN(#,P+"`R,#$Q/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X
M=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU
M;7`^-#(L-#0S+#$X-3QS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@
M8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D
M(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT
M9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T
M<CX-"B`@("`@(#QT<B!C;&%S<STS1')E/@T*("`@("`@("`\=&0@8VQA<W,]
M,T1P;"!V86QI9VX],T1T;W`^17AE<F-I<V4@;V8@;W!T:6]N<R!A;F0@=V%R
M<F%N=',@8GD@96UP;&]Y965S(&%N9"!C;VYS=6QT86YT<SPO=&0^#0H@("`@
M("`@(#QT9"!C;&%S<STS1&YU;7`^.#D\<W!A;CX\+W-P86X^/"]T9#X-"B`@
M("`@("`@/'1D(&-L87-S/3-$=&5X=#XG)FYB<W`[)FYB<W`[/'-P86X^/"]S
M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;7`^.#D\<W!A;CX\
M+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG)FYB<W`[
M)FYB<W`[/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS
M1'1E>'0^)R9N8G-P.R9N8G-P.SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@
M/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS1')O/@T*("`@("`@("`\=&0@8VQA
M<W,],T1P;"!V86QI9VX],T1T;W`^17AE<F-I<V4@;V8@;W!T:6]N<R!A;F0@
M=V%R<F%N=',@8GD@96UP;&]Y965S(&%N9"!C;VYS=6QT86YT<RP@<VAA<F5S
M/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N
M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;7`^-S0L.#`P/'-P86X^
M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N
M/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A
M;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P
M86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S
M/3-$<F4^#0H@("`@("`@(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O<#Y%
M>&5R8VES92!O9B!W87)R86YT<R!B>2!I;G9E<W1O<G,@86YD(&9I;F1E<G,\
M+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6UP/C4U-CQS<&%N/CPO<W!A
M;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<F;F)S<#LF;F)S
M<#L\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M
M<#XU-38\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$
M=&5X=#XG)FYB<W`[)FYB<W`[/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@
M(#QT9"!C;&%S<STS1'1E>'0^)R9N8G-P.R9N8G-P.SQS<&%N/CPO<W!A;CX\
M+W1D/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS1')O/@T*("`@
M("`@("`\=&0@8VQA<W,],T1P;"!V86QI9VX],T1T;W`^17AE<F-I<V4@;V8@
M=V%R<F%N=',@8GD@:6YV97-T;W)S(&%N9"!F:6YD97)S+"!S:&%R97,\+W1D
M/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T
M9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XU,C,L.#,U/'-P86X^/"]S
M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO
M<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\
M+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^
M/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$
M<F4^#0H@("`@("`@(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O<#Y3=&]C
M:R!B87-E9"!C;VUP96YS871I;VX@=&\@96UP;&]Y965S+"!D:7)E8W1O<G,@
M86YD(&YO;BUE;7!L;WEE92!C;VYS=6QT86YT<SPO=&0^#0H@("`@("`@(#QT
M9"!C;&%S<STS1&YU;7`^-"PY,C<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@
M("`@/'1D(&-L87-S/3-$=&5X=#XG)FYB<W`[)FYB<W`[/'-P86X^/"]S<&%N
M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;7`^-"PY,C<\<W!A;CX\
M+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG)FYB<W`[
M)FYB<W`[/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS
M1'1E>'0^)R9N8G-P.R9N8G-P.SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@
M/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS1')O/@T*("`@("`@("`\=&0@8VQA
M<W,],T1P;"!V86QI9VX],T1T;W`^4W1O8VL@8F%S960@8V]M<&5N<V%T:6]N
M('1O(&5M<&QO>65E<RP@9&ER96-T;W)S(&%N9"!N;VXM96UP;&]Y964@8V]N
M<W5L=&%N=',L('-H87)E<SPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E
M>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N
M=6UP/C$Y+#`V,"PR,S$\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D
M(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT
M9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\
M=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO
M='(^#0H@("`@("`\='(@8VQA<W,],T1R93X-"B`@("`@("`@/'1D(&-L87-S
M/3-$<&P@=F%L:6=N/3-$=&]P/E-T;V-K(&)A<V5D(&-O;7!E;G-A=&EO;B!T
M;R!C;VYT<F%C=&]R/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XS
M+#8W,CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T
M97AT/B<F;F)S<#LF;F)S<#L\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@
M/'1D(&-L87-S/3-$;G5M<#XS+#8W,CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@
M("`@("`\=&0@8VQA<W,],T1T97AT/B<F;F)S<#LF;F)S<#L\<W!A;CX\+W-P
M86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG)FYB<W`[)FYB
M<W`[/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R
M(&-L87-S/3-$<F\^#0H@("`@("`@(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS
M1'1O<#Y3=&]C:R!B87-E9"!C;VUP96YS871I;VX@=&\@8V]N=')A8W1O<BP@
M<VAA<F5S/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^
M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;7`^,2PU,#`L
M,#`P/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E
M>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T
M97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$
M=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@
M/'1R(&-L87-S/3-$<F4^#0H@("`@("`@(#QT9"!C;&%S<STS1'!L('9A;&EG
M;CTS1'1O<#Y/=&AE<B!C;VUP<F5H96YS:79E(&EN8V]M92`H;&]S<RDL(&YE
M=#PO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;3XH,3,P*3QS<&%N/CPO
M<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<F;F)S<#LF
M;F)S<#L\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$
M=&5X=#XG)FYB<W`[)FYB<W`[/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@
M(#QT9"!C;&%S<STS1&YU;3XH,3,P*3QS<&%N/CPO<W!A;CX\+W1D/@T*("`@
M("`@("`\=&0@8VQA<W,],T1T97AT/B<F;F)S<#LF;F)S<#L\<W!A;CX\+W-P
M86X^/"]T9#X-"B`@("`@(#PO='(^#0H@("`@("`\='(@8VQA<W,],T1R;SX-
M"B`@("`@("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P/DYE="!L;W-S
M/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M/B@Q-"PW.30I/'-P86X^
M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)R9N8G-P
M.R9N8G-P.SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,]
M,T1T97AT/B<F;F)S<#LF;F)S<#L\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@
M("`@/'1D(&-L87-S/3-$=&5X=#XG)FYB<W`[)FYB<W`[/'-P86X^/"]S<&%N
M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;3XH,30L-SDT*3QS<&%N
M/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS
M1')C/@T*("`@("`@("`\=&0@8VQA<W,],T1P;"!V86QI9VX],T1T;W`^0F%L
M86YC92!A="!*=6XN(#,P+"`R,#$R/"]T9#X-"B`@("`@("`@/'1D(&-L87-S
M/3-$;G5M<#XS-RPW-#(\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D
M(&-L87-S/3-$=&5X=#XG)FYB<W`[)FYB<W`[/'-P86X^/"]S<&%N/CPO=&0^
M#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;7`^,3`S+#8Q.3QS<&%N/CPO<W!A
M;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6T^*#$S,"D\<W!A;CX\
M+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M/B@V-2PW-#<I
M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L
M87-S/3-$<F,^#0H@("`@("`@(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O
M<#Y"86QA;F-E+"!S:&%R97,@870@2G5N+B`S,"P@,C`Q,CPO=&0^#0H@("`@
M("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@
M("`@("`\=&0@8VQA<W,],T1N=6UP/C0V+#0T."PP-3$\<W!A;CX\+W-P86X^
M/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N
M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A
M;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P
M86X^/"]T9#X-"B`@("`@(#PO='(^#0H@("`@("`\='(@8VQA<W,],T1R93X-
M"B`@("`@("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P/DES<W5A;F-E
M(&]F(&-O;6UO;B!S=&]C:R!A;F0@=V%R<F%N=',L(&YE="!O9B!I<W-U86YC
M92!C;W-T<SPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;7`^,S0L,3`V
M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^
M)R9N8G-P.R9N8G-P.SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@
M8VQA<W,],T1N=6UP/C,T+#$P-CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@
M("`\=&0@8VQA<W,],T1T97AT/B<F;F)S<#LF;F)S<#L\<W!A;CX\+W-P86X^
M/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG)FYB<W`[)FYB<W`[
M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L
M87-S/3-$<F\^#0H@("`@("`@(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O
M<#Y)<W-U86YC92!O9B!C;VUM;VX@<W1O8VL@86YD('=A<G)A;G1S+"!N970@
M;V8@:7-S=6%N8V4@8V]S=',L('-H87)E<SPO=&0^#0H@("`@("`@(#QT9"!C
M;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@
M8VQA<W,],T1N=6UP/CDL,C`P+#`P,#QS<&%N/CPO<W!A;CX\+W1D/@T*("`@
M("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@
M("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@
M("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*
M("`@("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS1')E/@T*("`@("`@("`\
M=&0@8VQA<W,],T1P;"!V86QI9VX],T1T;W`^17AE<F-I<V4@;V8@;W!T:6]N
M<R!A;F0@=V%R<F%N=',@8GD@96UP;&]Y965S(&%N9"!C;VYS=6QT86YT<SPO
M=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;7`^,3<V/'-P86X^/"]S<&%N
M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)R9N8G-P.R9N8G-P
M.SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6UP
M/C$W-CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T
M97AT/B<F;F)S<#LF;F)S<#L\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@
M/'1D(&-L87-S/3-$=&5X=#XG)FYB<W`[)FYB<W`[/'-P86X^/"]S<&%N/CPO
M=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$<F\^#0H@("`@
M("`@(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O<#Y%>&5R8VES92!O9B!O
M<'1I;VYS(&%N9"!W87)R86YT<R!B>2!E;7!L;WEE97,@86YD(&-O;G-U;'1A
M;G1S+"!S:&%R97,\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\
M<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XQ
M-S8L.#8W/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS
M1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,]
M,T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S
M/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@
M("`@/'1R(&-L87-S/3-$<F4^#0H@("`@("`@(#QT9"!C;&%S<STS1'!L('9A
M;&EG;CTS1'1O<#Y%>&5R8VES92!O9B!W87)R86YT<R!B>2!I;G9E<W1O<G,@
M86YD(&9I;F1E<G,\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6UP/C(L
M,#`Y/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E
M>'0^)R9N8G-P.R9N8G-P.SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\
M=&0@8VQA<W,],T1N=6UP/C(L,#`Y/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@
M("`@(#QT9"!C;&%S<STS1'1E>'0^)R9N8G-P.R9N8G-P.SQS<&%N/CPO<W!A
M;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<F;F)S<#LF;F)S
M<#L\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO='(^#0H@("`@("`\='(@
M8VQA<W,],T1R;SX-"B`@("`@("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$
M=&]P/D5X97)C:7-E(&]F('=A<G)A;G1S(&)Y(&EN=F5S=&]R<R!A;F0@9FEN
M9&5R<RP@<VAA<F5S/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG
M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;7`^
M,2PV,C$L,S4Y/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S
M<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA
M<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L
M87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*
M("`@("`@/'1R(&-L87-S/3-$<F4^#0H@("`@("`@(#QT9"!C;&%S<STS1'!L
M('9A;&EG;CTS1'1O<#Y3=&]C:R!B87-E9"!C;VUP96YS871I;VX@=&\@96UP
M;&]Y965S+"!D:7)E8W1O<G,@86YD(&YO;BUE;7!L;WEE92!C;VYS=6QT86YT
M<SPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;7`^,BPW.3D\<W!A;CX\
M+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG)FYB<W`[
M)FYB<W`[/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS
M1&YU;7`^,BPW.3D\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L
M87-S/3-$=&5X=#XG)FYB<W`[)FYB<W`[/'-P86X^/"]S<&%N/CPO=&0^#0H@
M("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)R9N8G-P.R9N8G-P.SQS<&%N/CPO
M<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS1')O
M/@T*("`@("`@("`\=&0@8VQA<W,],T1P;"!V86QI9VX],T1T;W`^4W1O8VL@
M8F%S960@8V]M<&5N<V%T:6]N('1O(&5M<&QO>65E<RP@9&ER96-T;W)S(&%N
M9"!N;VXM96UP;&]Y964@8V]N<W5L=&%N=',L('-H87)E<SPO=&0^#0H@("`@
M("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@
M("`@("`\=&0@8VQA<W,],T1N=6UP/C$L-S4P+#,T,#QS<&%N/CPO<W!A;CX\
M+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^
M/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N
M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A
M;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS1')E/@T*
M("`@("`@("`\=&0@8VQA<W,],T1P;"!V86QI9VX],T1T;W`^4W1O8VL@8F%S
M960@8V]M<&5N<V%T:6]N('1O(&-O;G1R86-T;W(\+W1D/@T*("`@("`@("`\
M=&0@8VQA<W,],T1N=6UP/C$L-#`P/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@
M("`@(#QT9"!C;&%S<STS1'1E>'0^)R9N8G-P.R9N8G-P.SQS<&%N/CPO<W!A
M;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6UP/C$L-#`P/'-P86X^
M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)R9N8G-P
M.R9N8G-P.SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,]
M,T1T97AT/B<F;F)S<#LF;F)S<#L\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@
M(#PO='(^#0H@("`@("`\='(@8VQA<W,],T1R;SX-"B`@("`@("`@/'1D(&-L
M87-S/3-$<&P@=F%L:6=N/3-$=&]P/E-T;V-K(&)A<V5D(&-O;7!E;G-A=&EO
M;B!T;R!C;VYT<F%C=&]R+"!S:&%R97,\+W1D/@T*("`@("`@("`\=&0@8VQA
M<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L
M87-S/3-$=&5X=#XG)FYB<W`[)FYB<W`[/'-P86X^/"]S<&%N/CPO=&0^#0H@
M("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*
M("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-
M"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^
M#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$<F4^#0H@("`@("`@
M(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O<#Y/=&AE<B!C;VUP<F5H96YS
M:79E(&EN8V]M92`H;&]S<RDL(&YE=#PO=&0^#0H@("`@("`@(#QT9"!C;&%S
M<STS1&YU;7`^,S@Y/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C
M;&%S<STS1'1E>'0^)R9N8G-P.R9N8G-P.SQS<&%N/CPO<W!A;CX\+W1D/@T*
M("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<F;F)S<#LF;F)S<#L\<W!A;CX\
M+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XS.#D\<W!A
M;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG)FYB
M<W`[)FYB<W`[/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@
M("`@/'1R(&-L87-S/3-$<F\^#0H@("`@("`@(#QT9"!C;&%S<STS1'!L('9A
M;&EG;CTS1'1O<#Y.970@;&]S<SPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS
M1&YU;3XH,C$L,34U*3QS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@
M8VQA<W,],T1T97AT/B<F;F)S<#LF;F)S<#L\<W!A;CX\+W-P86X^/"]T9#X-
M"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG)FYB<W`[)FYB<W`[/'-P86X^
M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)R9N8G-P
M.R9N8G-P.SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,]
M,T1N=6T^*#(Q+#$U-2D\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO='(^
M#0H@("`@("`\='(@8VQA<W,],T1R8SX-"B`@("`@("`@/'1D(&-L87-S/3-$
M<&P@=F%L:6=N/3-$=&]P/D)A;&%N8V4@870@2G5N+B`S,"P@,C`Q,SPO=&0^
M#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;7`^-3<L-#8V/'-P86X^/"]S<&%N
M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)R9N8G-P.R9N8G-P
M.SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6UP
M/C$T-"PQ,#D\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S
M/3-$;G5M<#XR-3D\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L
M87-S/3-$;G5M/B@X-BPY,#(I/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\
M+W1R/@T*("`@("`@/'1R(&-L87-S/3-$<F,^#0H@("`@("`@(#QT9"!C;&%S
M<STS1'!L('9A;&EG;CTS1'1O<#Y"86QA;F-E+"!S:&%R97,@870@2G5N+B`S
M,"P@,C`Q,SPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;7`^-3DL,3DV
M+#8Q-SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N
M=6UP/C4Y+#$Y-BPV,3<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D
M(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT
M9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\
M=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO
M='(^#0H@("`@("`\='(@8VQA<W,],T1R93X-"B`@("`@("`@/'1D(&-L87-S
M/3-$<&P@=F%L:6=N/3-$=&]P/DES<W5A;F-E(&]F(&-O;6UO;B!S=&]C:R!A
M;F0@=V%R<F%N=',L(&YE="!O9B!I<W-U86YC92!C;W-T<SPO=&0^#0H@("`@
M("`@(#QT9"!C;&%S<STS1&YU;7`^,3`L-C0T/'-P86X^/"]S<&%N/CPO=&0^
M#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)R9N8G-P.R9N8G-P.SQS<&%N
M/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6UP/C$P+#8T
M-#QS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT
M/B<F;F)S<#LF;F)S<#L\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D
M(&-L87-S/3-$=&5X=#XG)FYB<W`[)FYB<W`[/'-P86X^/"]S<&%N/CPO=&0^
M#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$<F\^#0H@("`@("`@
M(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O<#Y)<W-U86YC92!O9B!C;VUM
M;VX@<W1O8VL@86YD('=A<G)A;G1S+"!N970@;V8@:7-S=6%N8V4@8V]S=',L
M('-H87)E<SPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;7`^,BPU.38L
M,#,R/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU
M;7`^,BPU.38L,#,R/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C
M;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@
M8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D
M(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R
M/@T*("`@("`@/'1R(&-L87-S/3-$<F4^#0H@("`@("`@(#QT9"!C;&%S<STS
M1'!L('9A;&EG;CTS1'1O<#Y%>&5R8VES92!O9B!O<'1I;VYS(&%N9"!W87)R
M86YT<R!B>2!E;7!L;WEE97,@86YD(&-O;G-U;'1A;G1S/"]T9#X-"B`@("`@
M("`@/'1D(&-L87-S/3-$;G5M<#XQ,CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@
M("`@("`\=&0@8VQA<W,],T1T97AT/B<F;F)S<#LF;F)S<#L\<W!A;CX\+W-P
M86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XQ,CQS<&%N/CPO
M<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<F;F)S<#LF
M;F)S<#L\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$
M=&5X=#XG)FYB<W`[)FYB<W`[/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\
M+W1R/@T*("`@("`@/'1R(&-L87-S/3-$<F\^#0H@("`@("`@(#QT9"!C;&%S
M<STS1'!L('9A;&EG;CTS1'1O<#Y%>&5R8VES92!O9B!O<'1I;VYS(&%N9"!W
M87)R86YT<R!B>2!E;7!L;WEE97,@86YD(&-O;G-U;'1A;G1S+"!S:&%R97,\
M+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^
M/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XU,RPT-S`\<W!A;CX\
M+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^
M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N
M/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A
M;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO='(^#0H@("`@("`\='(@8VQA<W,]
M,T1R93X-"B`@("`@("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P/D5X
M97)C:7-E(&]F('=A<G)A;G1S(&)Y(&EN=F5S=&]R<R!A;F0@9FEN9&5R<SPO
M=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;7`^,2PY-C@\<W!A;CX\+W-P
M86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG)FYB<W`[)FYB
M<W`[/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU
M;7`^,2PY-C@\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S
M/3-$=&5X=#XG)FYB<W`[)FYB<W`[/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@
M("`@(#QT9"!C;&%S<STS1'1E>'0^)R9N8G-P.R9N8G-P.SQS<&%N/CPO<W!A
M;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS1')O/@T*
M("`@("`@("`\=&0@8VQA<W,],T1P;"!V86QI9VX],T1T;W`^17AE<F-I<V4@
M;V8@=V%R<F%N=',@8GD@:6YV97-T;W)S(&%N9"!F:6YD97)S+"!S:&%R97,\
M+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^
M/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XR+#DP,BPQ-C@\<W!A
M;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P
M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS
M<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\
M<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO='(^#0H@("`@("`\='(@8VQA
M<W,],T1R93X-"B`@("`@("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P
M/E-T;V-K(&)A<V5D(&-O;7!E;G-A=&EO;B!T;R!E;7!L;WEE97,L(&1I<F5C
M=&]R<R!A;F0@;F]N+65M<&QO>65E(&-O;G-U;'1A;G1S/"]T9#X-"B`@("`@
M("`@/'1D(&-L87-S/3-$;G5M<#XU+#@U,3QS<&%N/CPO<W!A;CX\+W1D/@T*
M("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<F;F)S<#LF;F)S<#L\<W!A;CX\
M+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XU+#@U,3QS
M<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<F
M;F)S<#LF;F)S<#L\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L
M87-S/3-$=&5X=#XG)FYB<W`[)FYB<W`[/'-P86X^/"]S<&%N/CPO=&0^#0H@
M("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$<F\^#0H@("`@("`@(#QT
M9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O<#Y3=&]C:R!B87-E9"!C;VUP96YS
M871I;VX@=&\@96UP;&]Y965S+"!D:7)E8W1O<G,@86YD(&YO;BUE;7!L;WEE
M92!C;VYS=6QT86YT<RP@<VAA<F5S/"]T9#X-"B`@("`@("`@/'1D(&-L87-S
M/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S
M<STS1&YU;7`^,2PS-3,L,38U/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@
M(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@
M("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@
M("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@
M("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$<F4^#0H@("`@("`@(#QT9"!C
M;&%S<STS1'!L('9A;&EG;CTS1'1O<#Y)<W-U86YC92!O9B!C;VUM;VX@<W1O
M8VL@=6YD97(@0TA!($%G<F5E;65N="`H3F]T92`Q9"D\+W1D/@T*("`@("`@
M("`\=&0@8VQA<W,],T1N=6UP/C$P+#0Q-#QS<&%N/CPO<W!A;CX\+W1D/@T*
M("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<F;F)S<#LF;F)S<#L\<W!A;CX\
M+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XQ,"PT,30\
M<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG
M)FYB<W`[)FYB<W`[/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C
M;&%S<STS1'1E>'0^)R9N8G-P.R9N8G-P.SQS<&%N/CPO<W!A;CX\+W1D/@T*
M("`@("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS1')O/@T*("`@("`@("`\
M=&0@8VQA<W,],T1P;"!V86QI9VX],T1T;W`^27-S=6%N8V4@;V8@8V]M;6]N
M('-T;V-K('5N9&5R($-(02!!9W)E96UE;G0@*$YO=&4@,60I+"!S:&%R97,\
M+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6UP/C(L-3`P+#`P,#QS<&%N
M/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6UP/C(L-3`P
M+#`P,#QS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T
M97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$
M=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS
M1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@("`@
M(#QT<B!C;&%S<STS1')E/@T*("`@("`@("`\=&0@8VQA<W,],T1P;"!V86QI
M9VX],T1T;W`^3W1H97(@8V]M<')E:&5N<VEV92!I;F-O;64@*&QO<W,I+"!N
M970\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6UP/C(L-S`P/'-P86X^
M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)R9N8G-P
M.R9N8G-P.SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,]
M,T1T97AT/B<F;F)S<#LF;F)S<#L\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@
M("`@/'1D(&-L87-S/3-$;G5M<#XR+#<P,#QS<&%N/CPO<W!A;CX\+W1D/@T*
M("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<F;F)S<#LF;F)S<#L\<W!A;CX\
M+W-P86X^/"]T9#X-"B`@("`@(#PO='(^#0H@("`@("`\='(@8VQA<W,],T1R
M;SX-"B`@("`@("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P/DYE="!L
M;W-S/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M/B@R-BPY,S(I/'-P
M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)R9N
M8G-P.R9N8G-P.SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA
M<W,],T1T97AT/B<F;F)S<#LF;F)S<#L\<W!A;CX\+W-P86X^/"]T9#X-"B`@
M("`@("`@/'1D(&-L87-S/3-$=&5X=#XG)FYB<W`[)FYB<W`[/'-P86X^/"]S
M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;3XH,C8L.3,R*3QS
M<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S
M<STS1')C/@T*("`@("`@("`\=&0@8VQA<W,],T1P;"!V86QI9VX],T1T;W`^
M0F%L86YC92!A="!*=6XN(#,P+"`R,#$T/"]T9#X-"B`@("`@("`@/'1D(&-L
M87-S/3-$;G5M<#XD(#8R+#$R,SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@
M("`\=&0@8VQA<W,],T1T97AT/B<F;F)S<#LF;F)S<#L\<W!A;CX\+W-P86X^
M/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XD(#$W,BPY.3@\<W!A
M;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XD(#(L
M.34Y/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU
M;3XD("@Q,3,L.#,T*3QS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-
M"B`@("`@(#QT<B!C;&%S<STS1')C/@T*("`@("`@("`\=&0@8VQA<W,],T1P
M;"!V86QI9VX],T1T;W`^0F%L86YC92P@<VAA<F5S(&%T($IU;BX@,S`L(#(P
M,30\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6UP/C8X+#8P,2PT-3(\
M<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XV
M."PV,#$L-#4R/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S
M<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA
M<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L
M87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*
M("`@(#PO=&%B;&4^#0H@(#PO8F]D>3X-"CPO:'1M;#X-"@T*+2TM+2TM/5].
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M#0H-"CQH=&UL/@T*("`\:&5A9#X-"B`@("`\345402!H='1P+65Q=6EV/3-$
M0V]N=&5N="U4>7!E(&-O;G1E;G0],T0G=&5X="]H=&UL.R!C:&%R<V5T/75T
M9BTX)SX\<V-R:7!T('1Y<&4],T1T97AT+VIA=F%S8W)I<'0@<W)C/3-$4VAO
M=RYJ<SXO*B!$;R!.;W0@4F5M;W9E(%1H:7,@0V]M;65N="`J+SPO<V-R:7!T
M/CPO:&5A9#X-"B`@/&)O9'D^#0H@("`@/'1A8FQE(&-L87-S/3-$<F5P;W)T
M(&ED/3-$240P14=(/@T*("`@("`@/'1R/@T*("`@("`@("`\=&@@8VQA<W,]
M,T1T;"!C;VQS<&%N/3-$,2!R;W=S<&%N/3-$,CX\<W1R;VYG/E-4051%345.
M5%,@3T8@0TA!3D=%4R!)3B!%455)5%D@*%!A<F5N=&AE=&EC86PI("A54T0@
M)"D\8G(^26X@5&AO=7-A;F1S+"!U;FQE<W,@;W1H97)W:7-E('-P96-I9FEE
M9#PO<W1R;VYG/CPO=&@^#0H@("`@("`@(#QT:"!C;&%S<STS1'1H(&-O;'-P
M86X],T0R/C$R($UO;G1H<R!%;F1E9#PO=&@^#0H@("`@("`\+W1R/@T*("`@
M("`@/'1R/@T*("`@("`@("`\=&@@8VQA<W,],T1T:#Y*=6XN(#,P+"`R,#$T
M/&)R/CPO=&@^#0H@("`@("`@(#QT:"!C;&%S<STS1'1H/DIU;BX@,S`L(#(P
M,3,\8G(^/"]T:#X-"B`@("`@(#PO='(^#0H@("`@("`\='(@8VQA<W,],T1R
M93X-"B`@("`@("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P/CQS=')O
M;F<^4U1!5$5-14Y44R!/1B!#2$%.1T53($E.($5154E462!;06)S=')A8W1=
M/"]S=')O;F<^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P
M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS
M<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S
M<STS1')O/@T*("`@("`@("`\=&0@8VQA<W,],T1P;"!V86QI9VX],T1T;W`^
M27-S=6%N8V4@;V8@8V]M;6]N('-T;V-K(&%N9"!W87)R86YT<RP@:7-S=6%N
M8V4@8V]S=',\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6UP/B0@,3DU
M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;7`^
M)"`R+#8Y-#QS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@("`\
M+W1A8FQE/@T*("`\+V)O9'D^#0H\+VAT;6P^#0H-"BTM+2TM+3U?3F5X=%!A
M<G1?,&-A9#4Y9F1?-S,R95\T-F4R7V$U,S1?,&,X860Q868Y,&1D#0I#;VYT
M96YT+4QO8V%T:6]N.B!F:6QE.B\O+T,Z+S!C860U.69D7S<S,F5?-#9E,E]A
M-3,T7S!C.&%D,6%F.3!D9"]7;W)K<VAE971S+U-H965T,#@N:'1M;`T*0V]N
M=&5N="U4<F%N<V9E<BU%;F-O9&EN9SH@<75O=&5D+7!R:6YT86)L90T*0V]N
M=&5N="U4>7!E.B!T97AT+VAT;6P[(&-H87)S970](G5S+6%S8VEI(@T*#0H\
M:'1M;#X-"B`@/&AE860^#0H@("`@/$U%5$$@:'1T<"UE<75I=CTS1$-O;G1E
M;G0M5'EP92!C;VYT96YT/3-$)W1E>'0O:'1M;#L@8VAA<G-E=#UU=&8M."<^
M/'-C<FEP="!T>7!E/3-$=&5X="]J879A<V-R:7!T('-R8STS1%-H;W<N:G,^
M+RH@1&\@3F]T(%)E;6]V92!4:&ES($-O;6UE;G0@*B\\+W-C<FEP=#X\+VAE
M860^#0H@(#QB;V1Y/@T*("`@(#QT86)L92!C;&%S<STS1')E<&]R="!I9#TS
M1$E$,$595T)'/@T*("`@("`@/'1R/@T*("`@("`@("`\=&@@8VQA<W,],T1T
M;"!C;VQS<&%N/3-$,2!R;W=S<&%N/3-$,CX\<W1R;VYG/D-/3E-/3$E$051%
M1"!35$%414U%3E13($]&($-!4T@@1DQ/5U,@*%531"`D*3QB<CY);B!4:&]U
M<V%N9',L('5N;&5S<R!O=&AE<G=I<V4@<W!E8VEF:65D/"]S=')O;F<^/"]T
M:#X-"B`@("`@("`@/'1H(&-L87-S/3-$=&@@8V]L<W!A;CTS1#,^,3(@36]N
M=&AS($5N9&5D/"]T:#X-"B`@("`@(#PO='(^#0H@("`@("`\='(^#0H@("`@
M("`@(#QT:"!C;&%S<STS1'1H/DIU;BX@,S`L(#(P,30\8G(^/"]T:#X-"B`@
M("`@("`@/'1H(&-L87-S/3-$=&@^2G5N+B`S,"P@,C`Q,SQB<CX\+W1H/@T*
M("`@("`@("`\=&@@8VQA<W,],T1T:#Y*=6XN(#,P+"`R,#$R/&)R/CPO=&@^
M#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$<F4^#0H@("`@("`@
M(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O<#X\<W1R;VYG/D-!4T@@1DQ/
M5U,@1E)/32!/4$52051)3D<@04-4259)5$E%4SH\+W-T<F]N9SX\+W1D/@T*
M("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-
M"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^
M#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D
M/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS1')O/@T*("`@("`@
M("`\=&0@8VQA<W,],T1P;"!V86QI9VX],T1T;W`^3F5T(&QO<W,\+W1D/@T*
M("`@("`@("`\=&0@8VQA<W,],T1N=6T^)"`H,C8L.3,R*3QS<&%N/CPO<W!A
M;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6T^)"`H,C$L,34U*3QS
M<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6T^)"`H
M,30L-SDT*3QS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@("`@
M(#QT<B!C;&%S<STS1')E/@T*("`@("`@("`\=&0@8VQA<W,],T1P;"!V86QI
M9VX],T1T;W`^/'-T<F]N9SY!9&IU<W1M96YT<R!T;R!R96-O;F-I;&4@;F5T
M(&QO<W,@=&\@;F5T(&-A<V@@=7-E9"!I;B!O<&5R871I;F<@86-T:79I=&EE
M<SH\+W-T<F]N9SX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\
M<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG
M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^
M)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<B!C
M;&%S<STS1')O/@T*("`@("`@("`\=&0@8VQA<W,],T1P;"!V86QI9VX],T1T
M;W`^1&5P<F5C:6%T:6]N/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M
M<#XQ+#DP,CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,]
M,T1N=6UP/C$L,#,S/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C
M;&%S<STS1&YU;7`^-#,U/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R
M/@T*("`@("`@/'1R(&-L87-S/3-$<F4^#0H@("`@("`@(#QT9"!C;&%S<STS
M1'!L('9A;&EG;CTS1'1O<#Y,;W-S(&]N('!R;W!E<G1Y(&%N9"!E<75I<&UE
M;G0\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6UP/C@U/'-P86X^/"]S
M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)R9N8G-P.R9N
M8G-P.SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N
M=6UP/C$\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO='(^#0H@("`@("`\
M='(@8VQA<W,],T1R;SX-"B`@("`@("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N
M/3-$=&]P/D%C8W)E=&EO;B!O9B!D:7-C;W5N="P@86UO<G1I>F%T:6]N(&]F
M('!R96UI=6T@86YD(&-H86YG97,@:6X@86-C<G5E9"!I;G1E<F5S="!O9B!M
M87)K971A8FQE('-E8W5R:71I97,\+W1D/@T*("`@("`@("`\=&0@8VQA<W,]
M,T1N=6UP/C$L,C@R/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C
M;&%S<STS1&YU;7`^,34T/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT
M9"!C;&%S<STS1&YU;7`^,3<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO
M='(^#0H@("`@("`\='(@8VQA<W,],T1R93X-"B`@("`@("`@/'1D(&-L87-S
M/3-$<&P@=F%L:6=N/3-$=&]P/D=A:6X@9G)O;2!S86QE(&]F(&EN=F5S=&UE
M;G1S(&]F(&%V86EL86)L92UF;W(M<V%L92!M87)K971A8FQE('-E8W5R:71I
M97,\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6T^*#<R-RD\<W!A;CX\
M+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M/B@R-BD\<W!A
M;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M/B@S*3QS
M<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S
M<STS1')O/@T*("`@("`@("`\=&0@8VQA<W,],T1P;"!V86QI9VX],T1T;W`^
M4W1O8VLM8F%S960@8V]M<&5N<V%T:6]N('1O(&5M<&QO>65E<RP@9&ER96-T
M;W)S(&%N9"!N;VXM96UP;&]Y964@8V]N<W5L=&%N=',\+W1D/@T*("`@("`@
M("`\=&0@8VQA<W,],T1N=6UP/C4L.#4Q/'-P86X^/"]S<&%N/CPO=&0^#0H@
M("`@("`@(#QT9"!C;&%S<STS1&YU;7`^,BPW.3D\<W!A;CX\+W-P86X^/"]T
M9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XT+#DR-SQS<&%N/CPO<W!A
M;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS1')E/@T*
M("`@("`@("`\=&0@8VQA<W,],T1P;"!V86QI9VX],T1T;W`^26YC<F5A<V4@
M:6X@3T-3(')E8V5I=F%B;&5S/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$
M;G5M/B@Q+#DY,"D\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L
M87-S/3-$;G5M/B@W,"D\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D
M(&-L87-S/3-$;G5M/B@R,S`I/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\
M+W1R/@T*("`@("`@/'1R(&-L87-S/3-$<F\^#0H@("`@("`@(#QT9"!C;&%S
M<STS1'!L('9A;&EG;CTS1'1O<#Y$96-R96%S92`H:6YC<F5A<V4I(&EN(&]T
M:&5R(&%C8V]U;G1S(')E8V5I=F%B;&4\+W1D/@T*("`@("`@("`\=&0@8VQA
M<W,],T1N=6T^*#$T,RD\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D
M(&-L87-S/3-$;G5M/B@R,S,I/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@
M(#QT9"!C;&%S<STS1&YU;7`^-C0\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@
M(#PO='(^#0H@("`@("`\='(@8VQA<W,],T1R93X-"B`@("`@("`@/'1D(&-L
M87-S/3-$<&P@=F%L:6=N/3-$=&]P/D1E8W)E87-E("AI;F-R96%S92D@:6X@
M<')E<&%I9"!E>'!E;G-E<SPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU
M;3XH,3`X*3QS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,]
M,T1N=6T^*#(S-RD\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L
M87-S/3-$;G5M<#XR-CD\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO='(^
M#0H@("`@("`\='(@8VQA<W,],T1R;SX-"B`@("`@("`@/'1D(&-L87-S/3-$
M<&P@=F%L:6=N/3-$=&]P/DEN8W)E87-E("AD96-R96%S92D@:6X@=')A9&4@
M<&%Y86)L97,\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6UP/C$L,C4W
M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;7`^
M,2PS,S4\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$
M;G5M/B@T,C0I/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@
M("`@/'1R(&-L87-S/3-$<F4^#0H@("`@("`@(#QT9"!C;&%S<STS1'!L('9A
M;&EG;CTS1'1O<#Y);F-R96%S92!I;B!O=&AE<B!A8V-O=6YT<R!P87EA8FQE
M(&%N9"!A8V-R=65D(&5X<&5N<V5S/"]T9#X-"B`@("`@("`@/'1D(&-L87-S
M/3-$;G5M<#XY,#(\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L
M87-S/3-$;G5M<#XQ+#4U-CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\
M=&0@8VQA<W,],T1N=6UP/CDU.#QS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@
M/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS1')O/@T*("`@("`@("`\=&0@8VQA
M<W,],T1P;"!V86QI9VX],T1T;W`^26YC<F5A<V4@*&1E8W)E87-E*2!I;B!D
M969E<G)E9"!R979E;G5E<SPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU
M;3XH,S<Y*3QS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,]
M,T1N=6T^*#8W.2D\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L
M87-S/3-$;G5M<#XT+#(X-#QS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T
M<CX-"B`@("`@(#QT<B!C;&%S<STS1')E/@T*("`@("`@("`\=&0@8VQA<W,]
M,T1P;"!V86QI9VX],T1T;W`^26YC<F5A<V4@*&1E8W)E87-E*2!I;B!A9'9A
M;F-E('!A>6UE;G0@9G)O;2!5;FET960@5&AE<F%P975T:6-S/"]T9#X-"B`@
M("`@("`@/'1D(&-L87-S/3-$;G5M/B@Q-#8I/'-P86X^/"]S<&%N/CPO=&0^
M#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;3XH,2PQ.#,I/'-P86X^/"]S<&%N
M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;7`^,2PU-S8\<W!A;CX\
M+W-P86X^/"]T9#X-"B`@("`@(#PO='(^#0H@("`@("`\='(@8VQA<W,],T1R
M;SX-"B`@("`@("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P/DEN8W)E
M87-E(&EN(&EN=&5R97-T(')E8V5I=F%B;&4@;VX@<VAO<G0M=&5R;2!D97!O
M<VET<SPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;3XH,S8I/'-P86X^
M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;3XH,30P*3QS
M<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6T^*#,Y
M-2D\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO='(^#0H@("`@("`\='(@
M8VQA<W,],T1R93X-"B`@("`@("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$
M=&]P/DQI;FMA9V4@9&EF9F5R96YC97,@86YD(&EN=&5R97-T(&]N('-H;W)T
M(&%N9"!L;VYG+71E<FT@<F5S=')I8W1E9"!L96%S92!D97!O<VET/"]T9#X-
M"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XQ,CQS<&%N/CPO<W!A;CX\+W1D
M/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6T^*#,P*3QS<&%N/CPO<W!A;CX\
M+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6UP/C,U/'-P86X^/"]S<&%N
M/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$<F\^#0H@
M("`@("`@(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O<#Y!8V-R=65D('-E
M=F5R86YC92!P87DL(&YE=#PO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU
M;7`^-#D\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$
M;G5M/B@Q,2D\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S
M/3-$;G5M<#XU/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@
M("`@/'1R(&-L87-S/3-$<F5U/@T*("`@("`@("`\=&0@8VQA<W,],T1P;"!V
M86QI9VX],T1T;W`^3F5T(&-A<V@@=7-E9"!I;B!O<&5R871I;F<@86-T:79I
M=&EE<SPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;3XH,3DL,3(Q*3QS
M<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6T^*#$V
M+#@X-RD\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$
M;G5M/B@S+#(W-2D\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO='(^#0H@
M("`@("`\='(@8VQA<W,],T1R;SX-"B`@("`@("`@/'1D(&-L87-S/3-$<&P@
M=F%L:6=N/3-$=&]P/CQS=')O;F<^0T%32"!&3$]74R!&4D]-($E.5D535$E.
M1R!!0U1)5DE42453.CPO<W1R;VYG/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S
M<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA
M<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L
M87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*
M("`@("`@/'1R(&-L87-S/3-$<F4^#0H@("`@("`@(#QT9"!C;&%S<STS1'!L
M('9A;&EG;CTS1'1O<#Y0=7)C:&%S92!O9B!P<F]P97)T>2!A;F0@97%U:7!M
M96YT/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M/B@Q+#4W,RD\<W!A
M;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M/B@T+#,P
M.2D\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M
M/B@Q+#0X,"D\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO='(^#0H@("`@
M("`\='(@8VQA<W,],T1R;SX-"B`@("`@("`@/'1D(&-L87-S/3-$<&P@=F%L
M:6=N/3-$=&]P/E)E<&%Y;65N="!O9B`H26YV97-T;65N="!I;BD@<VAO<G0M
M=&5R;2!D97!O<VET<SPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;7`^
M-RPT,C$\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$
M;G5M/B@Q,"PR,#(I/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C
M;&%S<STS1&YU;3XH,C$L,#,Q*3QS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@
M/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS1')E/@T*("`@("`@("`\=&0@8VQA
M<W,],T1P;"!V86QI9VX],T1T;W`^26YV97-T;65N="!I;B!L;VYG+71E<FT@
M9&5P;W-I=',\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6T^*#,I/'-P
M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)R9N
M8G-P.R9N8G-P.SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA
M<W,],T1N=6T^*#$L,3(U*3QS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T
M<CX-"B`@("`@(#QT<B!C;&%S<STS1')O/@T*("`@("`@("`\=&0@8VQA<W,]
M,T1P;"!V86QI9VX],T1T;W`^4F5P87EM96YT(&]F(&QO;F<M=&5R;2!R97-T
M<FEC=&5D(&1E<&]S:70\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6UP
M/C$R,CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N
M=6UP/C@V.3QS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,]
M,T1N=6UP/C8\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO='(^#0H@("`@
M("`\='(@8VQA<W,],T1R93X-"B`@("`@("`@/'1D(&-L87-S/3-$<&P@=F%L
M:6=N/3-$=&]P/E!R;V-E961S(&9R;VT@<V%L92!O9B!A=F%I;&%B;&4M9F]R
M+7-A;&4@;6%R:V5T86)L92!S96-U<FET:65S/"]T9#X-"B`@("`@("`@/'1D
M(&-L87-S/3-$;G5M<#XV+#$Q,SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@
M("`\=&0@8VQA<W,],T1N=6UP/C$L.#0X/'-P86X^/"]S<&%N/CPO=&0^#0H@
M("`@("`@(#QT9"!C;&%S<STS1&YU;7`^.#@T/'-P86X^/"]S<&%N/CPO=&0^
M#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$<F\^#0H@("`@("`@
M(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O<#Y0<F]C965D<R!F<F]M(')E
M9&5M<'1I;VX@;V8@879A:6QA8FQE+69O<BUS86QE(&UA<FME=&%B;&4@<V5C
M=7)I=&EE<SPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;7`^-S4T/'-P
M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;7`^-3(Y
M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;7`^
M,3$T/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R
M(&-L87-S/3-$<F4^#0H@("`@("`@(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS
M1'1O<#Y);G9E<W1M96YT(&EN(&%V86EL86)L92UF;W(M<V%L92!M87)K971A
M8FQE('-E8W5R:71I97,\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6T^
M*#$P+#@U,2D\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S
M/3-$;G5M/B@X+#4S-"D\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D
M(&-L87-S/3-$;G5M/B@X+#$V-2D\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@
M(#PO='(^#0H@("`@("`\='(@8VQA<W,],T1R;W4^#0H@("`@("`@(#QT9"!C
M;&%S<STS1'!L('9A;&EG;CTS1'1O<#Y.970@8V%S:"!P<F]V:61E9"!B>2`H
M=7-E9"!I;BD@:6YV97-T:6YG(&%C=&EV:71I97,\+W1D/@T*("`@("`@("`\
M=&0@8VQA<W,],T1N=6UP/C$L.3@S/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@
M("`@(#QT9"!C;&%S<STS1&YU;3XH,3DL-SDY*3QS<&%N/CPO<W!A;CX\+W1D
M/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6T^*#,P+#<Y-RD\<W!A;CX\+W-P
M86X^/"]T9#X-"B`@("`@(#PO='(^#0H@("`@("`\='(@8VQA<W,],T1R93X-
M"B`@("`@("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P/CQS=')O;F<^
M0T%32"!&3$]74R!&4D]-($9)3D%.0TE.1R!!0U1)5DE42453.CPO<W1R;VYG
M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A
M;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P
M86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S
M<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$<F\^
M#0H@("`@("`@(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O<#Y)<W-U86YC
M92!O9B!C;VUM;VX@<W1O8VL@86YD('=A<G)A;G1S+"!N970@;V8@:7-S=6%N
M8V4@8V]S=',\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6UP/C$P+#8T
M-#QS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6UP
M/C,T+#$P-CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,]
M,T1T97AT/B<F;F)S<#LF;F)S<#L\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@
M(#PO='(^#0H@("`@("`\='(@8VQA<W,],T1R93X-"B`@("`@("`@/'1D(&-L
M87-S/3-$<&P@=F%L:6=N/3-$=&]P/D5X97)C:7-E(&]F('=A<G)A;G1S(&%N
M9"!O<'1I;VYS/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XQ+#DX
M,#QS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6UP
M/C(L,3DX/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS
M1&YU;7`^-C,R/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@
M("`@/'1R(&-L87-S/3-$<F]U/@T*("`@("`@("`\=&0@8VQA<W,],T1P;"!V
M86QI9VX],T1T;W`^3F5T(&-A<V@@<')O=FED960@8GD@9FEN86YC:6YG(&%C
M=&EV:71I97,\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6UP/C$R+#8R
M-#QS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6UP
M/C,V+#,P-#QS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,]
M,T1N=6UP/C8S,CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@
M("`@(#QT<B!C;&%S<STS1')E=3X-"B`@("`@("`@/'1D(&-L87-S/3-$<&P@
M=F%L:6=N/3-$=&]P/D1E8W)E87-E(&EN(&-A<V@@86YD(&-A<V@@97%U:79A
M;&5N=',\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6T^*#0L-3$T*3QS
M<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6T^*#,X
M,BD\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M
M/B@S,RPT-#`I/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@
M("`@/'1R(&-L87-S/3-$<F\^#0H@("`@("`@(#QT9"!C;&%S<STS1'!L('9A
M;&EG;CTS1'1O<#Y#87-H(&%N9"!C87-H(&5Q=6EV86QE;G1S(&%T('1H92!B
M96=I;FYI;F<@;V8@=&AE('!E<FEO9#PO=&0^#0H@("`@("`@(#QT9"!C;&%S
M<STS1&YU;7`^.2PP,#<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D
M(&-L87-S/3-$;G5M<#XY+#,X.3QS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@
M("`\=&0@8VQA<W,],T1N=6UP/C0R+#@R.3QS<&%N/CPO<W!A;CX\+W1D/@T*
M("`@("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS1')E/@T*("`@("`@("`\
M=&0@8VQA<W,],T1P;"!V86QI9VX],T1T;W`^0V%S:"!A;F0@8V%S:"!E<75I
M=F%L96YT<R!A="!T:&4@96YD(&]F('1H92!P97)I;V0\+W1D/@T*("`@("`@
M("`\=&0@8VQA<W,],T1N=6UP/C0L-#DS/'-P86X^/"]S<&%N/CPO=&0^#0H@
M("`@("`@(#QT9"!C;&%S<STS1&YU;7`^.2PP,#<\<W!A;CX\+W-P86X^/"]T
M9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XY+#,X.3QS<&%N/CPO<W!A
M;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS1')O/@T*
M("`@("`@("`\=&0@8VQA<W,],T1P;"!V86QI9VX],T1T;W`^/'-T<F]N9SY3
M=7!P;&5M96YT86P@9&ES8VQO<W5R92!O9B!C87-H(&9L;W<@86-T:79I=&EE
M<SH\+W-T<F]N9SX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\
M<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG
M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^
M)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<B!C
M;&%S<STS1')E/@T*("`@("`@("`\=&0@8VQA<W,],T1P;"!V86QI9VX],T1T
M;W`^5&%X97,@<&%I9"!D=64@=&\@;F]N+61E9'5C=&EB;&4@97AP96YS97,\
M+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6UP/C0X/'-P86X^/"]S<&%N
M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;7`^,3@\<W!A;CX\+W-P
M86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XQ-#QS<&%N/CPO
M<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS1')O
M/@T*("`@("`@("`\=&0@8VQA<W,],T1P;"!V86QI9VX],T1T;W`^/'-T<F]N
M9SY3=7!P;&5M96YT86P@9&ES8VQO<W5R92!O9B!N;VXM8V%S:"!A8W1I=FET
M:65S.CPO<W1R;VYG/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^
M)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT
M/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X
M=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R
M(&-L87-S/3-$<F4^#0H@("`@("`@(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS
M1'1O<#Y0=7)C:&%S92!O9B!P<F]P97)T>2!A;F0@97%U:7!M96YT(&]N(&-R
M961I=#PO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;7`^,C0S/'-P86X^
M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;7`^.#<R/'-P
M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;7`^-S,X
M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L
M87-S/3-$<F\^#0H@("`@("`@(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O
M<#Y)<W-U86YC92!O9B!S:&%R97,@:6X@8V]N<VED97)A=&EO;B!O9B!N97<@
M9F%C:6QI='D@8V]N<W1R=6-T:6]N/"]T9#X-"B`@("`@("`@/'1D(&-L87-S
M/3-$=&5X=#XG)FYB<W`[)FYB<W`[/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@
M("`@(#QT9"!C;&%S<STS1&YU;7`^,2PT,#`\<W!A;CX\+W-P86X^/"]T9#X-
M"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XS+#8W,CQS<&%N/CPO<W!A;CX\
M+W1D/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS1')E/@T*("`@
M("`@("`\=&0@8VQA<W,],T1P;"!V86QI9VX],T1T;W`^3W1H97(@<F5C96EV
M86)L97,@<F5S=6QT:6YG(&9R;VT@:7-S=6%N8V4@;V8@<VAA<F5S/"]T9#X-
M"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG)FYB<W`[)FYB<W`[/'-P86X^
M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)R9N8G-P
M.R9N8G-P.SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,]
M,T1N=6UP/C$S/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@
M("`@/'1R(&-L87-S/3-$<F\^#0H@("`@("`@(#QT9"!C;&%S<STS1'!L('9A
M;&EG;CTS1'1O<#Y)<W-U86YC92!O9B!C;VUM;VX@<W1O8VL@=6YD97(@0TA!
M($%G<F5E;65N="`H3F]T92`Q9"D\+W1D/@T*("`@("`@("`\=&0@8VQA<W,]
M,T1N=6UP/B0@,3`L-#$T/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT
M9"!C;&%S<STS1'1E>'0^)R9N8G-P.R9N8G-P.SQS<&%N/CPO<W!A;CX\+W1D
M/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<F;F)S<#LF;F)S<#L\<W!A
M;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO='(^#0H@("`@/"]T86)L93X-"B`@
M/"]B;V1Y/@T*/"]H=&UL/@T*#0HM+2TM+2T]7TYE>'1087)T7S!C860U.69D
M7S<S,F5?-#9E,E]A-3,T7S!C.&%D,6%F.3!D9`T*0V]N=&5N="U,;V-A=&EO
M;CH@9FEL93HO+R]#.B\P8V%D-3EF9%\W,S)E7S0V93)?834S-%\P8SAA9#%A
M9CDP9&0O5V]R:W-H965T<R]3:&5E=#`Y+FAT;6P-"D-O;G1E;G0M5')A;G-F
M97(M16YC;V1I;F<Z('%U;W1E9"UP<FEN=&%B;&4-"D-O;G1E;G0M5'EP93H@
M=&5X="]H=&UL.R!C:&%R<V5T/2)U<RUA<V-I:2(-"@T*/&AT;6P^#0H@(#QH
M96%D/@T*("`@(#Q-151!(&AT='`M97%U:78],T1#;VYT96YT+51Y<&4@8V]N
M=&5N=#TS1"=T97AT+VAT;6P[(&-H87)S970]=71F+3@G/CQS8W)I<'0@='EP
M93TS1'1E>'0O:F%V87-C<FEP="!S<F,],T13:&]W+FIS/B\J($1O($YO="!2
M96UO=F4@5&AI<R!#;VUM96YT("HO/"]S8W)I<'0^/"]H96%D/@T*("`\8F]D
M>3X-"B`@("`\=&%B;&4@8VQA<W,],T1R97!O<G0@:60],T1)1#!%344^#0H@
M("`@("`\='(^#0H@("`@("`@(#QT:"!C;&%S<STS1'1L(&-O;'-P86X],T0Q
M(')O=W-P86X],T0R/CQS=')O;F<^1T5.15)!3#QB<CX\+W-T<F]N9SX\+W1H
M/@T*("`@("`@("`\=&@@8VQA<W,],T1T:"!C;VQS<&%N/3-$,3XQ,B!-;VYT
M:',@16YD960\+W1H/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<CX-"B`@("`@
M("`@/'1H(&-L87-S/3-$=&@^2G5N+B`S,"P@,C`Q-#QB<CX\+W1H/@T*("`@
M("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS1')E/@T*("`@("`@("`\=&0@
M8VQA<W,],T1P;"!V86QI9VX],T1T;W`^/'-T<F]N9SY'14Y%4D%,(%M!8G-T
M<F%C=%T\+W-T<F]N9SX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT
M/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO='(^#0H@("`@("`\='(@
M8VQA<W,],T1R;SX-"B`@("`@("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$
M=&]P/D=%3D5204P\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\
M(2TM1$]#5%E012!H=&UL(%!50DQ)0R`B+2\O5S-#+R]$5$0@6$A434P@,2XP
M(%1R86YS:71I;VYA;"\O14XB(")H='1P.B\O=W=W+G<S+F]R9R]44B]X:'1M
M;#$O1%1$+WAH=&UL,2UT<F%N<VET:6]N86PN9'1D(B`M+3X\9&EV/B`\9&EV
M/CPA+2U3=&%R=$9R86=M96YT+2T^(#QD:78@<W1Y;&4],T0G1$E34$Q!63H@
M8FQO8VL[($9/3E0M1D%-24Q9.B!4:6UE<R!.97<@4F]M86X[($9/3E0M4TE:
M13H@,3!P=#L@1D].5"U714E'2%0Z(&)O;&0[($U!4D=)3BU,1494.B`P<'0[
M($U!4D=)3BU224=(5#H@,'!T.R!415A4+4%,24=..B!L969T.R!415A4+4E.
M1$5.5#H@,'!T)SX@3D]412`Q.BU'14Y%4D%,/"]D:78^(#QD:78@<W1Y;&4]
M,T0G1$E34$Q!63H@8FQO8VL[($U!4D=)3BU,1494.B`P<'0[($U!4D=)3BU2
M24=(5#H@,'!T.R!T97AT+6%L:6=N.B!J=7-T:69Y.R!415A4+4E.1$5.5#H@
M,'!T)SX@)FYB<W`[/"]D:78^(#QD:78^(#QT86)L92!S='EL93TS1"=&3TY4
M+5-)6D4Z(#$P<'0[($9/3E0M1D%-24Q9.B!T:6UE<R!N97<@<F]M86XG(&-E
M;&QS<&%C:6YG/3-$,"!C96QL<&%D9&EN9STS1#`@=VED=&@],T0Q,#`E(&%L
M:6=N/3-$8V5N=&5R(&)O<F1E<CTS1#`^(#QT<B!V86QI9VX],T1T;W`^(#QT
M9"!S='EL93TS1"=724142#H@,3AP="<^(#QD:78@<W1Y;&4],T0G1$E34$Q!
M63H@:6YL:6YE.R!&3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N.R!&3TY4
M+5-)6D4Z(#$P<'0[($U!4D=)3BU,1494.B`P<'0[($U!4D=)3BU224=(5#H@
M,'!T.R!415A4+4E.1$5.5#H@,'!T)SX@82X\+V1I=CX@/"]T9#X@/'1D/B`\
M9&EV('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ(%1I
M;65S($YE=R!2;VUA;CL@1D].5"U325I%.B`Q,'!T.R!T97AT+6%L:6=N.B!J
M=7-T:69Y)SX@4&QU<FES=&5M(%1H97)A<&5U=&EC<R!);F,N+"!A($YE=F%D
M82!C;W)P;W)A=&EO;BP@=V%S(&EN8V]R<&]R871E9"!O;B!-87D@,3$L(#(P
M,#$N(%!L=7)I<W1E;2!4:&5R87!E=71I8W,@26YC+B!H87,@82!W:&]L;'D@
M;W=N960@<W5B<VED:6%R>2P@4&QU<FES=&5M($QT9"X@*'1H92`B4W5B<VED
M:6%R>2(I+"!W:&EC:"!I<R!I;F-O<G!O<F%T960@=6YD97(@=&AE(&QA=W,@
M;V8@=&AE(%-T871E(&]F($ES<F%E;"X@4&QU<FES=&5M(%1H97)A<&5U=&EC
M<R!);F,N(&%N9"!T:&4@4W5B<VED:6%R>2!A<F4@<F5F97)R960@=&\@87,@
M=&AE(")#;VUP86YY(B!O<B`B4&QU<FES=&5M(BX\+V1I=CX@/"]T9#X@/"]T
M<CX@/"]T86)L93X@/"]D:78^(#QD:78@<W1Y;&4],T0G1$E34$Q!63H@8FQO
M8VL[($U!4D=)3BU,1494.B`P<'0[($U!4D=)3BU224=(5#H@,'!T.R!T97AT
M+6%L:6=N.B!J=7-T:69Y.R!415A4+4E.1$5.5#H@,'!T)SX@)FYB<W`[/"]D
M:78^(#QD:78^(#QT86)L92!S='EL93TS1"=&3TY4+5-)6D4Z(#$P<'0[($9/
M3E0M1D%-24Q9.B!T:6UE<R!N97<@<F]M86XG(&-E;&QS<&%C:6YG/3-$,"!C
M96QL<&%D9&EN9STS1#`@=VED=&@],T0Q,#`E(&%L:6=N/3-$8V5N=&5R(&)O
M<F1E<CTS1#`^(#QT<B!V86QI9VX],T1T;W`^(#QT9"!S='EL93TS1"=72414
M2#H@,3AP="<^(#QD:78@<W1Y;&4],T0G1$E34$Q!63H@:6YL:6YE.R!&3TY4
M+49!34E,63H@5&EM97,@3F5W(%)O;6%N.R!&3TY4+5-)6D4Z(#$P<'0[($U!
M4D=)3BU,1494.B`P<'0[($U!4D=)3BU224=(5#H@,'!T.R!415A4+4E.1$5.
M5#H@,'!T)SX@8BX\+V1I=CX@/"]T9#X@/'1D/B`\9&EV('-T>6QE/3-$)T1)
M4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ(%1I;65S($YE=R!2;VUA;CL@
M1D].5"U325I%.B`Q,'!T.R!T97AT+6%L:6=N.B!J=7-T:69Y)SX@5&AE($-O
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M('1O("0Q,3,L.#,T('1H<F]U9V@@2G5N92`S,"P@,C`Q-"!A;F0@:6YC=7)R
M960@82!N970@;&]S<R!O9B`D,C8L.3,R(&9O<B!T:&4@>65A<B!E;F1E9"!*
M=6YE(#,P+"`R,#$T+CPO9&EV/B`\9&EV('-T>6QE/3-$)W1E>'0M86QI9VXZ
M(&IU<W1I9GDG/B9N8G-P.SPO9&EV/B`\9&EV('-T>6QE/3-$)T1)4U!,05DZ
M(&)L;V-K.R!&3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N.R!&3TY4+5-)
M6D4Z(#$P<'0[($U!4D=)3BU,1494.B`P<'0[($U!4D=)3BU224=(5#H@,'!T
M.R!T97AT+6%L:6=N.B!J=7-T:69Y.R!415A4+4%,24=..B!J=7-T:69Y.R!4
M15A4+4E.1$5.5#H@,'!T)SX@5&AE($-O;7!A;GD@<&QA;G,@=&\@8V]N=&EN
M=64@=&\@9FEN86YC92!I=',@;W!E<F%T:6]N<R!W:71H('-A;&5S(&]F(&5Q
M=6ET>2!S96-U<FET:65S+"!E;G1E<FEN9R!I;G1O(&QI8V5N<VEN9R!T96-H
M;F]L;V=Y(&%G<F5E;65N=',@<W5C:"!A<R!T:&4@56YI=&5D(%1H97)A<&5U
M=&EC<R!#;W)P;W)A=&EO;B`H(E5N:71E9"!4:&5R87!E=71I8W,B(&]R(")5
M;FET960B*2!A;F0@0TA!)FYB<W`[0FEO)F%M<#M$:6]S=&5C:"`H(D-(02(I
M(&%G<F5E;65N=',L(&%N9"!F<F]M(&=R86YT<R!T;R!S=7!P;W)T(&ET<R!R
M97-E87)C:"!A;F0@9&5V96QO<&UE;G0@86-T:79I='DN($EN('1H92!L;VYG
M97(@=&5R;2P@=&AE($-O;7!A;GD@<&QA;G,@=&\@9FEN86YC92!I=',@;W!E
M<F%T:6]N<R!F<F]M(')E=F5N=65S(&9R;VT@<V%L97,@;V8@<')O9'5C=',N
M/"]D:78^(#PO=&0^(#PO='(^(#PO=&%B;&4^(#PO9&EV/B`\9&EV('-T>6QE
M/3-$)T1)4U!,05DZ(&)L;V-K.R!-05)'24XM3$5&5#H@,'!T.R!-05)'24XM
M4DE'2%0Z(#!P=#L@=&5X="UA;&EG;CH@:G5S=&EF>3L@5$585"U)3D1%3E0Z
M(#!P="<^("9N8G-P.SPO9&EV/B`\9&EV/B`\=&%B;&4@<W1Y;&4],T0G1D].
M5"U325I%.B`Q,'!T.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N)R!C
M96QL<W!A8VEN9STS1#`@8V5L;'!A9&1I;F<],T0P('=I9'1H/3-$,3`P)2!A
M;&EG;CTS1&-E;G1E<B!B;W)D97(],T0P/B`\='(@=F%L:6=N/3-$=&]P/B`\
M=&0@<W1Y;&4],T0G5TE$5$@Z(#$X<'0G/B`\9&EV('-T>6QE/3-$)T1)4U!,
M05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ(%1I;65S($YE=R!2;VUA;CL@1D].
M5"U325I%.B`Q,'!T.R!-05)'24XM3$5&5#H@,'!T.R!-05)'24XM4DE'2%0Z
M(#!P=#L@5$585"U)3D1%3E0Z(#!P="<^(&,N/"]D:78^(#PO=&0^(#QT9#X@
M/&1I=B!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!4
M:6UE<R!.97<@4F]M86X[($9/3E0M4TE:13H@,3!P=#L@=&5X="UA;&EG;CH@
M:G5S=&EF>2<^(%-I;F-E($1E8V5M8F5R(#$P+"`R,#`W+"!T:&4@0V]M<&%N
M>28C,SD[<R!S:&%R97,@;V8@8V]M;6]N('-T;V-K(&AA=F4@8F5E;B!T<F%D
M960@;VX@=&AE($Y!4T1!42!#87!I=&%L($UA<FME="!U;F1E<B!T:&4@<WEM
M8F]L(")04U1)(BX\+V1I=CX@/"]T9#X@/"]T<CX@/"]T86)L93X@/"]D:78^
M(#QD:78@<W1Y;&4],T0G1$E34$Q!63H@8FQO8VL[(%1%6%0M24Y$14Y4.B`P
M<'0G/CQB<B`O/B`\+V1I=CX@/&1I=B!S='EL93TS1"=$25-03$%9.B!B;&]C
M:SL@1D].5"U&04U)3%DZ(%1I;65S($YE=R!2;VUA;CL@1D].5"U325I%.B`Q
M,'!T.R!-05)'24XM3$5&5#H@,3AP=#L@34%21TE.+5))1TA4.B`U+CEP=#L@
M=&5X="UA;&EG;CH@:G5S=&EF>3L@5$585"U)3D1%3E0Z(#!P="<^($]N($1E
M8V5M8F5R(#$Y+"`R,#$P+"!T:&4@0V]M<&%N>28C,SD[<R!S:&%R97,@8F5G
M86X@=')A9&EN9R!A;'-O(&]N('1H92!496PM079I=B!3=&]C:R!%>&-H86YG
M92!U;F1E<B!T:&4@<WEM8F]L(")03%12(BX\+V1I=CX@/&1I=B!S='EL93TS
M1"=$25-03$%9.B!B;&]C:SL@5$585"U)3D1%3E0Z(#!P="<^/&)R("\^(#PO
M9&EV/B`\9&EV/B`\=&%B;&4@<W1Y;&4],T0G1D].5"U325I%.B`Q,'!T.R!&
M3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N)R!C96QL<W!A8VEN9STS1#`@
M8V5L;'!A9&1I;F<],T0P('=I9'1H/3-$,3`P)2!A;&EG;CTS1&-E;G1E<B!B
M;W)D97(],T0P/B`\='(@=F%L:6=N/3-$=&]P/B`\=&0@<W1Y;&4],T0G5TE$
M5$@Z(#$X<'0G/B`\9&EV('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].
M5"U&04U)3%DZ(%1I;65S($YE=R!2;VUA;CL@1D].5"U325I%.B`Q,'!T.R!-
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M(%1%6%0M24Y$14Y4.B`P<'0G/B`F;F)S<#L\+V1I=CX@/&1I=B!S='EL93TS
M1"=$25-03$%9.B!B;&]C:SL@1D].5"U&04U)3%DZ(%1I;65S($YE=R!2;VUA
M;CL@1D].5"U325I%.B`Q,'!T.R!-05)'24XM3$5&5#H@,3AP=#L@34%21TE.
M+5))1TA4.B`U+CEP=#L@=&5X="UA;&EG;CH@;&5F=#L@5$585"U$14-/4D%4
M24]..B!U;F1E<FQI;F4[(%1%6%0M24Y$14Y4.B`P<'0G/B!5;FET960@06=R
M965M96YT/"]D:78^(#QD:78@<W1Y;&4],T0G1$E34$Q!63H@8FQO8VL[($9/
M3E0M1D%-24Q9.B!4:6UE<R!.97<@4F]M86X[($9/3E0M4TE:13H@,3!P=#L@
M34%21TE.+4Q%1E0Z(#$X<'0[($U!4D=)3BU224=(5#H@-2XY<'0[('1E>'0M
M86QI9VXZ(&IU<W1I9GD[(%1%6%0M24Y$14Y4.B`P<'0G/B!/;B!*=6YE(#$Y
M+"`R,#$Q+"!T:&4@0V]M<&%N>2!E;G1E<F5D(&EN=&\@86X@97AC;'5S:79E
M(&QI8V5N<V4@86=R965M96YT("AT:&4@(E5N:71E9"!!9W)E96UE;G0B*2!W
M:71H(%5N:71E9"!4:&5R87!E=71I8W,@9F]R('1H92!U<V4@;V8@=&AE($-O
M;7!A;GDF(S,Y.W,@4$Q8(&-E;&QS('1O(&1E=F5L;W`@86YD(&-O;6UE<F-I
M86QI>F4@82!C96QL+6)A<V5D('!R;V1U8W0@9F]R('1H92!T<F5A=&UE;G0@
M;V8@4'5L;6]N87)Y($AY<&5R=&5N<VEO;B`H(E!!2"(I+B9N8G-P.R9N8G-P
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M('5P9G)O;G0@<&%Y;65N="!O9B`D-RPP,#`@<&%I9"!I;B!!=6=U<W0@,C`Q
M,2P@=VAI8V@@:6YC;'5D97,@82`D-2PP,#`@;F]N+7)E9G5N9&%B;&4@=7!F
M<F]N="!P87EM96YT(&%N9"!A("0R+#`P,"!A9'9A;F-E('!A>6UE;G0@;VX@
M=&AE(&1E=F5L;W!M96YT.R`H:6DI('5P('1O("0S-RPU,#`@=7!O;B!R96%C
M:&EN9R!C97)T86EN(')E9W5L871O<GD@;6EL97-T;VYE<R!W:71H(')E<W!E
M8W0@=&\@=&AE(&1E=F5L;W!M96YT(&]F(&$@<')O9'5C="!T;R!T<F5A="!0
M04@[("AI:6DI(')E:6UB=7)S96UE;G0@;V8@=7`@=&\@)#$P+#`P,"!O9B!C
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M25I%.B`Q,'!T.R!-05)'24XM3$5&5#H@,3AP=#L@34%21TE.+5))1TA4.B`U
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M4$Q!63H@8FQO8VL[(%1%6%0M24Y$14Y4.B`P<'0G/CQB<B`O/B`\+V1I=CX@
M/&1I=B!S='EL93TS1"=$25-03$%9.B!B;&]C:SL@1D].5"U&04U)3%DZ(%1I
M;65S($YE=R!2;VUA;CL@1D].5"U325I%.B`Q,'!T.R!-05)'24XM3$5&5#H@
M,3AP=#L@34%21TE.+5))1TA4.B`U+CEP=#L@=&5X="UA;&EG;CH@:G5S=&EF
M>3L@5$585"U$14-/4D%424]..B!U;F1E<FQI;F4[(%1%6%0M24Y$14Y4.B`P
M<'0G/B!#2$$@06=R965M96YT/"]D:78^(#QD:78@<W1Y;&4],T0G1$E34$Q!
M63H@8FQO8VL[($9/3E0M1D%-24Q9.B!4:6UE<R!.97<@4F]M86X[($9/3E0M
M4TE:13H@,3!P=#L@34%21TE.+4Q%1E0Z(#$X<'0[($U!4D=)3BU224=(5#H@
M-2XY<'0[('1E>'0M86QI9VXZ(&IU<W1I9GD[(%1%6%0M24Y$14Y4.B`P<'0G
M/B!/;B!*=6YE(#(V+"`R,#$S+"!0;'5R:7-T96T@96YT97)E9"!I;G1O(&%N
M(&5X8VQU<VEV92!L:6-E;G-E(&%N9"!C;VUM97)C:6%L:7IA=&EO;B!A9W)E
M96UE;G0@*'1H92`B0TA!($%G<F5E;65N="(I('=I=&@@0TA!+"!F;W(@8V]N
M9'5C=&EN9R!C;&EN:6-A;"!T<FEA;',@86YD(&-O;6UE<F-I86QI>F%T:6]N
M(&]F(%!L=7)I<W1E;28C,SD[<R!03%@M4$%$('!R;V1U8W0@:6X@4V]U=&@@
M2V]R96$@:6X@8V]N;F5C=&EO;B!W:71H('1W;R!I;F1I8V%T:6]N<SH@=&AE
M('1R96%T;65N="!O9B!#<FET:6-A;"!,:6UB($ES8VAE;6EA+"!A;F0@26YT
M97)M961I871E($-L875D:6-A=&EO;B`H=&AE("));F1I8V%T:6]N<R(I+B!5
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M96-T=6%L('!R;W!E<G1Y+CPO9&EV/B`\9&EV('-T>6QE/3-$)T1)4U!,05DZ
M(&)L;V-K.R!415A4+4E.1$5.5#H@,'!T)SX\8G(@+SX@/"]D:78^(#QD:78@
M<W1Y;&4],T0G1$E34$Q!63H@8FQO8VL[($9/3E0M1D%-24Q9.B!4:6UE<R!.
M97<@4F]M86X[($9/3E0M4TE:13H@,3!P=#L@34%21TE.+4Q%1E0Z(#$X<'0[
M($U!4D=)3BU224=(5#H@-2XY<'0[('1E>'0M86QI9VXZ(&IU<W1I9GD[(%1%
M6%0M24Y$14Y4.B`P<'0G/B!4:&4@9FER<W0@8VQI;FEC86P@<W1U9'D@=&\@
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M8VL[(%1%6%0M24Y$14Y4.B`P<'0G/CQB<B`O/B`\+V1I=CX@/&1I=B!S='EL
M93TS1"=$25-03$%9.B!B;&]C:SL@1D].5"U&04U)3%DZ(%1I;65S($YE=R!2
M;VUA;CL@1D].5"U325I%.B`Q,'!T.R!-05)'24XM3$5&5#H@,3AP=#L@34%2
M1TE.+5))1TA4.B`U+CEP=#L@=&5X="UA;&EG;CH@:G5S=&EF>3L@5$585"U)
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M3E0Z(#!P="<^/&)R("\^(#PO9&EV/B`\9&EV('-T>6QE/3-$)T1)4U!,05DZ
M(&)L;V-K.R!&3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N.R!&3TY4+5-)
M6D4Z(#$P<'0[($U!4D=)3BU,1494.B`Q.'!T.R!-05)'24XM4DE'2%0Z(#4N
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M(#!P="<^/&)R("\^(#PO9&EV/B`\9&EV('-T>6QE/3-$)T1)4U!,05DZ(&)L
M;V-K.R!&3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N.R!&3TY4+5-)6D4Z
M(#$P<'0[($U!4D=)3BU,1494.B`Q.'!T.R!-05)'24XM4DE'2%0Z(#4N.7!T
M.R!T97AT+6%L:6=N.B!J=7-T:69Y.R!415A4+4E.1$5.5#H@,'!T)SX@26X@
M861D:71I;VXL(&%N9"!A<R!C;VYT96UP;&%T960@8GD@=&AE($-(02!!9W)E
M96UE;G0L(&EN($1E8V5M8F5R(#(P,3,L(%!L=7)I<W1E;2!A;F0@0TA!(&5X
M96-U=&5D('1H92!M=71U86P@:6YV97-T;65N="!P=7)S=6%N="!T;R!W:&EC
M:"!0;'5R:7-T96T@:7-S=65D(#(L-3`P+#`P,"!S:&%R97,@;V8@:71S(&-O
M;6UO;B!S=&]C:R!I;B!C;VYS:61E<F%T:6]N(&9O<B`Q+#`Q,2PU,#0@<VAA
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M.B`P<'0G/CQB<B`O/B`\+V1I=CX@/&1I=B!S='EL93TS1"=$25-03$%9.B!B
M;&]C:SL@1D].5"U&04U)3%DZ(%1I;65S($YE=R!2;VUA;CL@1D].5"U325I%
M.B`Q,'!T.R!-05)'24XM3$5&5#H@,3AP=#L@34%21TE.+5))1TA4.B`U+CEP
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M("`@("`@/"]T<CX-"B`@("`\+W1A8FQE/@T*("`\+V)O9'D^#0H\+VAT;6P^
M#0H-"BTM+2TM+3U?3F5X=%!A<G1?,&-A9#4Y9F1?-S,R95\T-F4R7V$U,S1?
M,&,X860Q868Y,&1D#0I#;VYT96YT+4QO8V%T:6]N.B!F:6QE.B\O+T,Z+S!C
M860U.69D7S<S,F5?-#9E,E]A-3,T7S!C.&%D,6%F.3!D9"]7;W)K<VAE971S
M+U-H965T,3`N:'1M;`T*0V]N=&5N="U4<F%N<V9E<BU%;F-O9&EN9SH@<75O
M=&5D+7!R:6YT86)L90T*0V]N=&5N="U4>7!E.B!T97AT+VAT;6P[(&-H87)S
M970](G5S+6%S8VEI(@T*#0H\:'1M;#X-"B`@/&AE860^#0H@("`@/$U%5$$@
M:'1T<"UE<75I=CTS1$-O;G1E;G0M5'EP92!C;VYT96YT/3-$)W1E>'0O:'1M
M;#L@8VAA<G-E=#UU=&8M."<^/'-C<FEP="!T>7!E/3-$=&5X="]J879A<V-R
M:7!T('-R8STS1%-H;W<N:G,^+RH@1&\@3F]T(%)E;6]V92!4:&ES($-O;6UE
M;G0@*B\\+W-C<FEP=#X\+VAE860^#0H@(#QB;V1Y/@T*("`@(#QT86)L92!C
M;&%S<STS1')E<&]R="!I9#TS1$E$,$5-13X-"B`@("`@(#QT<CX-"B`@("`@
M("`@/'1H(&-L87-S/3-$=&P@8V]L<W!A;CTS1#$@<F]W<W!A;CTS1#(^/'-T
M<F]N9SY324=.249)0T%.5"!!0T-/54Y424Y'(%!/3$E#2453/&)R/CPO<W1R
M;VYG/CPO=&@^#0H@("`@("`@(#QT:"!C;&%S<STS1'1H(&-O;'-P86X],T0Q
M/C$R($UO;G1H<R!%;F1E9#PO=&@^#0H@("`@("`\+W1R/@T*("`@("`@/'1R
M/@T*("`@("`@("`\=&@@8VQA<W,],T1T:#Y*=6XN(#,P+"`R,#$T/&)R/CPO
M=&@^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$<F4^#0H@("`@
M("`@(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O<#X\<W1R;VYG/E-)1TY)
M1DE#04Y4($%#0T]53E1)3D<@4$],24-)15,@6T%B<W1R86-T73PO<W1R;VYG
M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A
M;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS1')O/@T*
M("`@("`@("`\=&0@8VQA<W,],T1P;"!V86QI9VX],T1T;W`^4TE'3DE&24-!
M3E0@04-#3U5.5$E.1R!03TQ)0TE%4SPO=&0^#0H@("`@("`@(#QT9"!C;&%S
M<STS1'1E>'0^)SPA+2U$3T-465!%(&AT;6P@4%5"3$E#("(M+R]7,T,O+T14
M1"!82%1-3"`Q+C`@5')A;G-I=&EO;F%L+R]%3B(@(FAT='`Z+R]W=W<N=S,N
M;W)G+U12+WAH=&UL,2]$5$0O>&AT;6PQ+71R86YS:71I;VYA;"YD=&0B("TM
M/CQD:78^(#QD:78^/"$M+5-T87)T1G)A9VUE;G0M+3X@/&1I=B!S='EL93TS
M1"=$25-03$%9.B!B;&]C:SL@1D].5"U&04U)3%DZ(%1I;65S($YE=R!2;VUA
M;CL@1D].5"U325I%.B`Q,'!T.R!&3TY4+5=%24=(5#H@8F]L9#L@34%21TE.
M+4Q%1E0Z(#!P=#L@34%21TE.+5))1TA4.B`P<'0[(%1%6%0M04Q)1TXZ(&QE
M9G0[(%1%6%0M24Y$14Y4.B`P<'0G/B!.3U1%(#(Z+5-)1TY)1DE#04Y4($%#
M0T]53E1)3D<@4$],24-)15,\+V1I=CX@/&1I=B!S='EL93TS1"=$25-03$%9
M.B!B;&]C:SL@34%21TE.+4Q%1E0Z(#!P=#L@34%21TE.+5))1TA4.B`P<'0[
M('1E>'0M86QI9VXZ(&IU<W1I9GD[(%1%6%0M24Y$14Y4.B`P<'0G/B`F;F)S
M<#L\+V1I=CX@/&1I=B!S='EL93TS1"=$25-03$%9.B!B;&]C:SL@1D].5"U&
M04U)3%DZ(%1I;65S($YE=R!2;VUA;CL@1D].5"U325I%.B`Q,'!T.R!-05)'
M24XM3$5&5#H@,'!T.R!-05)'24XM4DE'2%0Z(#!P=#L@5$585"U!3$E'3CH@
M:G5S=&EF>3L@5$585"U)3D1%3E0Z(#!P="<^(%1H92!C;VYS;VQI9&%T960@
M9FEN86YC:6%L('-T871E;65N=',@:&%V92!B965N('!R97!A<F5D(&EN(&%C
M8V]R9&%N8V4@=VET:"!5;FET960@4W1A=&5S(&=E;F5R86QL>2!A8V-E<'1E
M9"!A8V-O=6YT:6YG('!R:6YC:7!L97,@*")5+E,N($=!05`B*2!A<'!L:65D
M(&]N(&-O;G-I<W1E;G0@8F%S:7,N/"]D:78^(#QD:78@<W1Y;&4],T0G1$E3
M4$Q!63H@8FQO8VL[($U!4D=)3BU,1494.B`P<'0[($U!4D=)3BU224=(5#H@
M,'!T.R!T97AT+6%L:6=N.B!J=7-T:69Y.R!415A4+4E.1$5.5#H@,'!T)SX@
M)FYB<W`[/"]D:78^(#QD:78^(#QT86)L92!S='EL93TS1"=&3TY4+5-)6D4Z
M(#$P<'0[($9/3E0M1D%-24Q9.B!T:6UE<R!N97<@<F]M86XG(&-E;&QS<&%C
M:6YG/3-$,"!C96QL<&%D9&EN9STS1#`@=VED=&@],T0Q,#`E(&%L:6=N/3-$
M8V5N=&5R(&)O<F1E<CTS1#`^(#QT<B!V86QI9VX],T1T;W`^(#QT9"!S='EL
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M/B`\9&EV('-T>6QE/3-$)T1)4U!,05DZ(&)L;V-K.R!-05)'24XM3$5&5#H@
M,'!T.R!-05)'24XM4DE'2%0Z(#!P=#L@=&5X="UA;&EG;CH@:G5S=&EF>3L@
M5$585"U)3D1%3E0Z(#!P="<^("9N8G-P.SPO9&EV/B`\9&EV/B`\=&%B;&4@
M<W1Y;&4],T0G1D].5"U325I%.B`Q,'!T.R!&3TY4+49!34E,63H@=&EM97,@
M;F5W(')O;6%N)R!C96QL<W!A8VEN9STS1#`@8V5L;'!A9&1I;F<],T0P('=I
M9'1H/3-$,3`P)2!A;&EG;CTS1&-E;G1E<B!B;W)D97(],T0P/B`\='(@=F%L
M:6=N/3-$=&]P/B`\=&0@<W1Y;&4],T0G5TE$5$@Z(#$X<'0G/B`\9&EV('-T
M>6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ(%1I;65S($YE
M=R!2;VUA;CL@1$E34$Q!63H@:6YL:6YE)SX@)FYB<W`[/"]D:78^(#PO=&0^
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M(#PO='(^(#PO=&%B;&4^(#PO9&EV/B`\9&EV('-T>6QE/3-$)T1)4U!,05DZ
M(&)L;V-K.R!-05)'24XM3$5&5#H@,'!T.R!-05)'24XM4DE'2%0Z(#!P=#L@
M=&5X="UA;&EG;CH@:G5S=&EF>3L@5$585"U)3D1%3E0Z(#!P="<^("9N8G-P
M.SPO9&EV/B`\9&EV/B`\=&%B;&4@<W1Y;&4],T0G1D].5"U325I%.B`Q,'!T
M.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N)R!C96QL<W!A8VEN9STS
M1#`@8V5L;'!A9&1I;F<],T0P('=I9'1H/3-$,3`P)2!A;&EG;CTS1&-E;G1E
M<B!B;W)D97(],T0P/B`\='(@=F%L:6=N/3-$=&]P/B`\=&0@<W1Y;&4],T0G
M5TE$5$@Z(#$X<'0G/B`\9&EV('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@
M1D].5"U&04U)3%DZ(%1I;65S($YE=R!2;VUA;CL@1D].5"U325I%.B`Q,'!T
M.R!&3TY4+5=%24=(5#H@8F]L9#L@34%21TE.+4Q%1E0Z(#!P=#L@34%21TE.
M+5))1TA4.B`P<'0[(%1%6%0M24Y$14Y4.B`P<'0G/B!B+CPO9&EV/B`\+W1D
M/B`\=&0^(#QD:78@<W1Y;&4],T0G1$E34$Q!63H@:6YL:6YE.R!&3TY4+49!
M34E,63H@5&EM97,@3F5W(%)O;6%N.R!&3TY4+5-)6D4Z(#$P<'0[($9/3E0M
M5T5)1TA4.B!B;VQD.R!T97AT+6%L:6=N.B!J=7-T:69Y)SX@1G5N8W1I;VYA
M;"!C=7)R96YC>2!O9B!T:&4@4W5B<VED:6%R>3PO9&EV/B`\+W1D/B`\+W1R
M/B`\+W1A8FQE/B`\+V1I=CX@/&1I=B!S='EL93TS1"=$25-03$%9.B!B;&]C
M:SL@34%21TE.+4Q%1E0Z(#!P=#L@34%21TE.+5))1TA4.B`P<'0[('1E>'0M
M86QI9VXZ(&IU<W1I9GD[(%1%6%0M24Y$14Y4.B`P<'0G/B`F;F)S<#L\+V1I
M=CX@/&1I=CX@/'1A8FQE('-T>6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@1D].
M5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;B<@8V5L;'-P86-I;F<],T0P(&-E
M;&QP861D:6YG/3-$,"!W:61T:#TS1#$P,"4@86QI9VX],T1C96YT97(@8F]R
M9&5R/3-$,#X@/'1R('9A;&EG;CTS1'1O<#X@/'1D('-T>6QE/3-$)U=)1%1(
M.B`Q.7!T)SX@/&1I=B!S='EL93TS1"=&3TY4+5-)6D4Z(#$P<'0[($9/3E0M
M1D%-24Q9.B!4:6UE<R!.97<@4F]M86X[($1)4U!,05DZ(&EN;&EN92<^("9N
M8G-P.SPO9&EV/B`\+W1D/B`\=&0^(#QD:78@<W1Y;&4],T0G1$E34$Q!63H@
M:6YL:6YE.R!&3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N.R!&3TY4+5-)
M6D4Z(#$P<'0[('1E>'0M86QI9VXZ(&IU<W1I9GDG/B!4:&4@4W5B<VED:6%R
M>28C,SD[<R!R979E;G5E<R!A<F4@9V5N97)A=&5D(&%N9"!D971E<FUI;F5D
M(&EN(%4N4RX@1&]L;&%R<R`H(F1O;&QA<G,B*2X@26X@861D:71I;VXL(&UO
M<W0@;V8@=&AE(&9I;F%N8VEN9R!O9B!T:&4@4W5B<VED:6%R>28C,SD[<R!O
M<&5R871I;VYS(&AA<R!B965N(&UA9&4@:6X@9&]L;&%R<RX@5&AE($-O;7!A
M;GDF(S,Y.W,@;6%N86=E;65N="!B96QI979E<R!T:&%T('1H92!D;VQL87(@
M:7,@=&AE('!R:6UA<GD@8W5R<F5N8WD@;V8@=&AE(&5C;VYO;6EC(&5N=FER
M;VYM96YT(&EN('=H:6-H('1H92!3=6)S:61I87)Y(&]P97)A=&5S+B!4:'5S
M+"!M86YA9V5M96YT(&)E;&EE=F4@=&AA="!T:&4@9G5N8W1I;VYA;"!C=7)R
M96YC>2!O9B!T:&4@4W5B<VED:6%R>2!I<R!T:&4@9&]L;&%R+B!!8V-O<F1I
M;F=L>2P@;6]N971A<GD@86-C;W5N=',@;6%I;G1A:6YE9"!I;B!C=7)R96YC
M:65S(&]T:&5R('1H86X@=&AE(&1O;&QA<B!A<F4@<F5M96%S=7)E9"!I;G1O
M(&1O;&QA<G,@:6X@86-C;W)D86YC92!W:71H($%30R`X,S`L(")&;W)E:6=N
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M;&4^(#PO9&EV/B`\9&EV('-T>6QE/3-$)T1)4U!,05DZ(&)L;V-K.R!-05)'
M24XM3$5&5#H@,'!T.R!-05)'24XM4DE'2%0Z(#!P=#L@=&5X="UA;&EG;CH@
M:G5S=&EF>3L@5$585"U)3D1%3E0Z(#!P="<^("9N8G-P.SPO9&EV/B`\9&EV
M/B`\=&%B;&4@<W1Y;&4],T0G1D].5"U325I%.B`Q,'!T.R!&3TY4+49!34E,
M63H@=&EM97,@;F5W(')O;6%N)R!C96QL<W!A8VEN9STS1#`@8V5L;'!A9&1I
M;F<],T0P('=I9'1H/3-$,3`P)2!A;&EG;CTS1&-E;G1E<B!B;W)D97(],T0P
M/B`\='(@=F%L:6=N/3-$=&]P/B`\=&0@<W1Y;&4],T0G5TE$5$@Z(#$X<'0G
M/B`\9&EV('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ
M(%1I;65S($YE=R!2;VUA;CL@1D].5"U325I%.B`Q,'!T.R!&3TY4+5=%24=(
M5#H@8F]L9#L@34%21TE.+4Q%1E0Z(#!P=#L@34%21TE.+5))1TA4.B`P<'0[
M(%1%6%0M24Y$14Y4.B`P<'0G/B!C+CPO9&EV/B`\+W1D/B`\=&0^(#QD:78@
M<W1Y;&4],T0G1$E34$Q!63H@:6YL:6YE.R!&3TY4+49!34E,63H@5&EM97,@
M3F5W(%)O;6%N.R!&3TY4+5-)6D4Z(#$P<'0[($9/3E0M5T5)1TA4.B!B;VQD
M.R!T97AT+6%L:6=N.B!J=7-T:69Y)SX@4')I;F-I<&QE<R!O9B!C;VYS;VQI
M9&%T:6]N/"]D:78^(#PO=&0^(#PO='(^(#PO=&%B;&4^(#PO9&EV/B`\9&EV
M('-T>6QE/3-$)T1)4U!,05DZ(&)L;V-K.R!-05)'24XM3$5&5#H@,'!T.R!-
M05)'24XM4DE'2%0Z(#!P=#L@=&5X="UA;&EG;CH@:G5S=&EF>3L@5$585"U)
M3D1%3E0Z(#!P="<^("9N8G-P.SPO9&EV/B`\9&EV/B`\=&%B;&4@<W1Y;&4]
M,T0G1D].5"U325I%.B`Q,'!T.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O
M;6%N)R!C96QL<W!A8VEN9STS1#`@8V5L;'!A9&1I;F<],T0P('=I9'1H/3-$
M,3`P)2!A;&EG;CTS1&-E;G1E<B!B;W)D97(],T0P/B`\='(@=F%L:6=N/3-$
M=&]P/B`\=&0@<W1Y;&4],T0G5TE$5$@Z(#$X<'0G/B`\9&EV('-T>6QE/3-$
M)T9/3E0M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ(%1I;65S($YE=R!2;VUA
M;CL@1$E34$Q!63H@:6YL:6YE)SX@)FYB<W`[/"]D:78^(#PO=&0^(#QT9#X@
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M=7!O;B!C;VYS;VQI9&%T:6]N+CPO9&EV/B`\+W1D/B`\+W1R/B`\+W1A8FQE
M/B`\+V1I=CX@/&1I=B!S='EL93TS1"=$25-03$%9.B!B;&]C:SL@34%21TE.
M+4Q%1E0Z(#!P=#L@34%21TE.+5))1TA4.B`P<'0[('1E>'0M86QI9VXZ(&IU
M<W1I9GD[(%1%6%0M24Y$14Y4.B`P<'0G/B`F;F)S<#L\+V1I=CX@/&1I=CX@
M/'1A8FQE('-T>6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ
M('1I;65S(&YE=R!R;VUA;B<@8V5L;'-P86-I;F<],T0P(&-E;&QP861D:6YG
M/3-$,"!W:61T:#TS1#$P,"4@86QI9VX],T1C96YT97(@8F]R9&5R/3-$,#X@
M/'1R('9A;&EG;CTS1'1O<#X@/'1D('-T>6QE/3-$)U=)1%1(.B`Q.'!T)SX@
M/&1I=B!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!4
M:6UE<R!.97<@4F]M86X[($9/3E0M4TE:13H@,3!P=#L@1D].5"U714E'2%0Z
M(&)O;&0[($U!4D=)3BU,1494.B`P<'0[($U!4D=)3BU224=(5#H@,'!T.R!4
M15A4+4E.1$5.5#H@,'!T)SX@9"X\+V1I=CX@/"]T9#X@/'1D/B`\9&EV('-T
M>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ(%1I;65S($YE
M=R!2;VUA;CL@1D].5"U325I%.B`Q,'!T.R!&3TY4+5=%24=(5#H@8F]L9#L@
M=&5X="UA;&EG;CH@:G5S=&EF>2<^($-A<V@@86YD(&-A<V@@97%U:79A;&5N
M=',\+V1I=CX@/"]T9#X@/"]T<CX@/"]T86)L93X@/"]D:78^(#QD:78@<W1Y
M;&4],T0G1$E34$Q!63H@8FQO8VL[($U!4D=)3BU,1494.B`P<'0[($U!4D=)
M3BU224=(5#H@,'!T.R!T97AT+6%L:6=N.B!J=7-T:69Y.R!415A4+4E.1$5.
M5#H@,'!T)SX@)FYB<W`[/"]D:78^(#QD:78^(#QT86)L92!S='EL93TS1"=&
M3TY4+5-)6D4Z(#$P<'0[($9/3E0M1D%-24Q9.B!T:6UE<R!N97<@<F]M86XG
M(&-E;&QS<&%C:6YG/3-$,"!C96QL<&%D9&EN9STS1#`@=VED=&@],T0Q,#`E
M(&%L:6=N/3-$8V5N=&5R(&)O<F1E<CTS1#`^(#QT<B!V86QI9VX],T1T;W`^
M(#QT9"!S='EL93TS1"=724142#H@,3EP="<^(#QD:78@<W1Y;&4],T0G1D].
M5"U325I%.B`Q,'!T.R!&3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N.R!$
M25-03$%9.B!I;FQI;F4G/B`F;F)S<#L\+V1I=CX@/"]T9#X@/'1D/B`\9&EV
M('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ(%1I;65S
M($YE=R!2;VUA;CL@1D].5"U325I%.B`Q,'!T.R!T97AT+6%L:6=N.B!J=7-T
M:69Y)SX@0V%S:"!E<75I=F%L96YT<R!A<F4@<VAO<G0M=&5R;2!H:6=H;'D@
M;&EQ=6ED(&EN=F5S=&UE;G1S('1H870@87)E(')E861I;'D@8V]N=F5R=&EB
M;&4@=&\@8V%S:"!W:71H(&UA='5R:71I97,@;V8@=&AR964@;6]N=&AS(&]R
M(&QE<W,@870@=&AE(&1A=&4@86-Q=6ER960N/"]D:78^(#PO=&0^(#PO='(^
M(#PO=&%B;&4^(#PO9&EV/B`\9&EV('-T>6QE/3-$)T1)4U!,05DZ(&)L;V-K
M.R!-05)'24XM3$5&5#H@,'!T.R!-05)'24XM4DE'2%0Z(#!P=#L@=&5X="UA
M;&EG;CH@:G5S=&EF>3L@5$585"U)3D1%3E0Z(#!P="<^("9N8G-P.SPO9&EV
M/B`\9&EV('-T>6QE/3-$)W1E>'0M86QI9VXZ(&-E;G1E<B<^(#QT86)L92!S
M='EL93TS1"=&3TY4+5-)6D4Z(#$P<'0[($9/3E0M1D%-24Q9.B!T:6UE<R!N
M97<@<F]M86XG(&-E;&QS<&%C:6YG/3-$,"!C96QL<&%D9&EN9STS1#`@=VED
M=&@],T0Q,#`E(&)O<F1E<CTS1#`^(#QT<B!V86QI9VX],T1T;W`^(#QT9"!S
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M:&]R="UT97)M(&)A;FL@9&5P;W-I=#PO9&EV/B`\+W1D/B`\+W1R/B`\+W1A
M8FQE/B`\+V1I=CX@/&1I=B!S='EL93TS1"=$25-03$%9.B!B;&]C:SL@34%2
M1TE.+4Q%1E0Z(#!P=#L@34%21TE.+5))1TA4.B`P<'0[('1E>'0M86QI9VXZ
M(&IU<W1I9GD[(%1%6%0M24Y$14Y4.B`P<'0G/B`F;F)S<#L\+V1I=CX@/&1I
M=B!S='EL93TS1"=$25-03$%9.B!B;&]C:SL@1D].5"U&04U)3%DZ(%1I;65S
M($YE=R!2;VUA;CL@1D].5"U325I%.B`Q,'!T.R!-05)'24XM3$5&5#H@,3AP
M=#L@34%21TE.+5))1TA4.B`P<'0[('1E>'0M86QI9VXZ(&IU<W1I9GD[(%1%
M6%0M24Y$14Y4.B`P<'0G/B!"86YK(&1E<&]S:71S('=I=&@@;W)I9VEN86P@
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M/&)R("\^(#PO9&EV/B`\9&EV('-T>6QE/3-$)W1E>'0M86QI9VXZ(&-E;G1E
M<B<^(#QT86)L92!S='EL93TS1"=&3TY4+5-)6D4Z(#$P<'0[($9/3E0M1D%-
M24Q9.B!T:6UE<R!N97<@<F]M86XG(&-E;&QS<&%C:6YG/3-$,"!C96QL<&%D
M9&EN9STS1#`@=VED=&@],T0Q,#`E(&)O<F1E<CTS1#`^(#QT<B!V86QI9VX]
M,T1T;W`^(#QT9"!S='EL93TS1"=724142#H@,3AP="<^(#QD:78@<W1Y;&4]
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M+4E.1$5.5#H@,'!T)SX@)FYB<W`[/"]D:78^(#QD:78@<W1Y;&4],T0G1$E3
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M;G,@87)E('!R97-E;G1E9"!A="!C;W-T+CPO9&EV/B`\9&EV('-T>6QE/3-$
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M('-T>6QE/3-$)U=)1%1(.B`Q.'!T)SX@/&1I=B!S='EL93TS1"=$25-03$%9
M.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE<R!N97<@<F]M86X[($9/3E0M
M4TE:13H@,3!P=#L@1D].5"U714E'2%0Z(&)O;&0[($U!4D=)3BU,1494.B`P
M<'0[($U!4D=)3BU224=(5#H@,'!T.R!415A4+4E.1$5.5#H@,'!T)SX@9RX\
M+V1I=CX@/"]T9#X@/'1D/B`\9&EV('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN
M93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q
M,'!T.R!&3TY4+5=%24=(5#H@8F]L9#L@=&5X="UA;&EG;CH@:G5S=&EF>2<^
M($QO;F<M=&5R;2!R97-T<FEC=&5D(&1E<&]S:71S/"]D:78^(#PO=&0^(#PO
M='(^(#PO=&%B;&4^(#PO9&EV/B`\9&EV/B9N8G-P.SPO9&EV/B`\9&EV/B`\
M=&%B;&4@<W1Y;&4],T0G1D].5"U325I%.B`Q,'!T.R!&3TY4+49!34E,63H@
M=&EM97,@;F5W(')O;6%N)R!C96QL<W!A8VEN9STS1#`@8V5L;'!A9&1I;F<]
M,T0P('=I9'1H/3-$,3`P)2!A;&EG;CTS1&-E;G1E<B!B;W)D97(],T0P/B`\
M='(@=F%L:6=N/3-$=&]P/B`\=&0@<W1Y;&4],T0G5TE$5$@Z(#$X<'0G/B`\
M9&EV('-T>6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ(%1I
M;65S($YE=R!2;VUA;CL@1$E34$Q!63H@:6YL:6YE)SX@)FYB<W`[/"]D:78^
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M(#PO='(^(#PO=&%B;&4^(#PO9&EV/B`\9&EV/B9N8G-P.SPO9&EV/B`\9&EV
M('-T>6QE/3-$)W1E>'0M86QI9VXZ(&-E;G1E<B<^(#QT86)L92!S='EL93TS
M1"=&3TY4+5-)6D4Z(#$P<'0[($9/3E0M1D%-24Q9.B!T:6UE<R!N97<@<F]M
M86XG(&-E;&QS<&%C:6YG/3-$,"!C96QL<&%D9&EN9STS1#`@=VED=&@],T0Q
M,#`E(&)O<F1E<CTS1#`^(#QT<B!V86QI9VX],T1T;W`^(#QT9"!S='EL93TS
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M.B`P<'0[($U!4D=)3BU224=(5#H@,'!T.R!T97AT+6%L:6=N.B!J=7-T:69Y
M.R!415A4+4E.1$5.5#H@,'!T)SX@)FYB<W`[/"]D:78^(#QD:78@<W1Y;&4]
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M:71H($%30R`S,C`M(DEN=F5S=&UE;G1S("T@1&5B="!A;F0@17%U:71Y(%-E
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M(")A8V-U;75L871E9"!O=&AE<B!C;VUP<F5H96YS:79E(&EN8V]M92`H;&]S
M<RDB(&EN('1H92!S=&%T96UE;G0@;V8@8VAA;F=E<R!I;B!S=&]C:VAO;&1E
M<G,F(S,Y.R!E<75I='DN/"]D:78^(#QD:78@<W1Y;&4],T0G1$E34$Q!63H@
M8FQO8VL[($U!4D=)3BU,1494.B`T,S=P=#L@34%21TE.+5))1TA4.B`P<'0[
M('1E>'0M86QI9VXZ(&IU<W1I9GD[(%1%6%0M24Y$14Y4.B`P<'0G/B`F;F)S
M<#L\+V1I=CX@/&1I=B!S='EL93TS1"=$25-03$%9.B!B;&]C:SL@1D].5"U&
M04U)3%DZ(%1I;65S($YE=R!2;VUA;CL@1D].5"U325I%.B`Q,'!T.R!-05)'
M24XM3$5&5#H@,3AP=#L@34%21TE.+5))1TA4.B`P<'0[('1E>'0M86QI9VXZ
M(&IU<W1I9GD[(%1%6%0M24Y$14Y4.B`P<'0G/B!296%L:7IE9"!G86EN(&%N
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M('1H92`B1FEN86YC:6%L(&EN8V]M92P@;F5T(BX\+V1I=CX@/&1I=B!S='EL
M93TS1"=$25-03$%9.B!B;&]C:SL@34%21TE.+4Q%1E0Z(#0S-W!T.R!-05)'
M24XM4DE'2%0Z(#!P=#L@=&5X="UA;&EG;CH@:G5S=&EF>3L@5$585"U)3D1%
M3E0Z(#!P="<^("9N8G-P.SPO9&EV/B`\9&EV('-T>6QE/3-$)T1)4U!,05DZ
M(&)L;V-K.R!&3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N.R!&3TY4+5-)
M6D4Z(#$P<'0[($U!4D=)3BU,1494.B`Q.'!T.R!-05)'24XM4DE'2%0Z(#!P
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M<V5C=7)I=&EE<R!T;R!B92!S97!A<F%T960@:6YT;R`H82DF;F)S<#MT:&4@
M86UO=6YT(')E<')E<V5N=&EN9R!T:&4@8W)E9&ET(&QO<W,@86YD("AB*29N
M8G-P.W1H92!A;6]U;G0@<F5L871E9"!T;R!A;&P@;W1H97(@9F%C=&]R<R`H
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M;64@*&QO<W,I+CPO9&EV/B`\9&EV('-T>6QE/3-$)T1)4U!,05DZ(&)L;V-K
M.R!-05)'24XM3$5&5#H@-#,W<'0[($U!4D=)3BU224=(5#H@,'!T.R!T97AT
M+6%L:6=N.B!J=7-T:69Y.R!415A4+4E.1$5.5#H@,'!T)SX@)FYB<W`[/"]D
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M1E0Z(#!P=#L@34%21TE.+5))1TA4.B`P<'0[('1E>'0M86QI9VXZ(&IU<W1I
M9GD[(%1%6%0M24Y$14Y4.B`P<'0G/B`F;F)S<#L\+V1I=CX@/&1I=B!S='EL
M93TS1"=T97AT+6%L:6=N.B!C96YT97(G/B`\=&%B;&4@<W1Y;&4],T0G1D].
M5"U325I%.B`Q,'!T.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N)R!C
M96QL<W!A8VEN9STS1#`@8V5L;'!A9&1I;F<],T0P('=I9'1H/3-$,3`P)2!B
M;W)D97(],T0P/B`\='(@=F%L:6=N/3-$=&]P/B`\=&0@<W1Y;&4],T0G5TE$
M5$@Z(#$X<'0G/B`\9&EV('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].
M5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T.R!&
M3TY4+5=%24=(5#H@8F]L9#L@34%21TE.+4Q%1E0Z(#!P=#L@34%21TE.+5))
M1TA4.B`P<'0[(%1%6%0M24Y$14Y4.B`P<'0G/B!I+CPO9&EV/B`\+W1D/B`\
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M.B`T,S=P=#L@34%21TE.+5))1TA4.B`P<'0[('1E>'0M86QI9VXZ(&IU<W1I
M9GD[(%1%6%0M24Y$14Y4.B`P<'0G/B`F;F)S<#L\+V1I=CX@/&1I=B!S='EL
M93TS1"=$25-03$%9.B!B;&]C:SL@1D].5"U&04U)3%DZ(%1I;65S($YE=R!2
M;VUA;CL@1D].5"U325I%.B`Q,'!T.R!-05)'24XM3$5&5#H@,3AP=#L@34%2
M1TE.+5))1TA4.B`P<'0[('1E>'0M86QI9VXZ(&IU<W1I9GD[(%1%6%0M24Y$
M14Y4.B`P<'0G/B!4:&4@0V]M<&%N>2!R96-O9VYI>F5S(')E=F5N=64@<'5R
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M9&EV/B`\9&EV('-T>6QE/3-$)T1)4U!,05DZ(&)L;V-K.R!&3TY4+49!34E,
M63H@5&EM97,@3F5W(%)O;6%N.R!&3TY4+5-)6D4Z(#$P<'0[($U!4D=)3BU,
M1494.B`Q.'!T.R!-05)'24XM4DE'2%0Z(#!P=#L@=&5X="UA;&EG;CH@:G5S
M=&EF>3L@5$585"U)3D1%3E0Z(#!P="<^(%!U<G-U86YT('1O($%30R`V,#4M
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M="<^(#QB<B`O/B`\+V1I=CX@/&1I=B!S='EL93TS1"=$25-03$%9.B!B;&]C
M:SL@1D].5"U&04U)3%DZ(%1I;65S($YE=R!2;VUA;CL@1D].5"U325I%.B`Q
M,'!T.R!-05)'24XM3$5&5#H@,3AP=#L@34%21TE.+5))1TA4.B`P<'0[('1E
M>'0M86QI9VXZ(&IU<W1I9GD[(%1%6%0M24Y$14Y4.B`P<'0G/B!4:&4@0V]M
M<&%N>2!R96-E:79E9"!A;B!U<"UF<F]N="P@;F]N+7)E9G5N9&%B;&4@;&EC
M96YS92!P87EM96YT(&]F("0U+#`P,"X@061D:71I;VYA;"!P87EM96YT<R!T
M;W1A;&EN9R`D,S<L-3`P(&%R92!S=6)J96-T('1O('1H92!A8VAI979E;65N
M="!O9B!C97)T86EN(')E9W5L871O<GD@;6EL97-T;VYE<R!B>2!5;FET960@
M5&AE<F%P975T:6-S+CPO9&EV/B`\9&EV('-T>6QE/3-$)TU!4D=)3BU,1494
M.B`T,S=P=#L@1$E34$Q!63H@8FQO8VL[(%1%6%0M24Y$14Y4.B`P<'0G/B`\
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M+#`P,"!I<R!D969E<G)E9"!A;F0@<F5C;V=N:7IE9"!O;B!A('-T<F%I9VAT
M(&QI;F4@8F%S:7,@;W9E<B!T:&4@<F5L871E9"!P97)F;W)M86YC92!P97)I
M;V0@=VAI8V@@:7,@=&AE(&1E=F5L;W!M96YT('!E<FEO9"!I;B!A8V-O<F1A
M;F-E('=I=&@@4W1A9F8@06-C;W5N=&EN9R!"=6QL971I;B`H(E-!0B(I(#$P
M-"P@(E)E=F5N=64@4F5C;V=N:71I;VXB+B!4:&4@<F5M86EN:6YG('!E<F9O
M<FUA;F-E('!E<FEO9"!I<R`X+C4@>65A<G,@87,@;V8@2G5N92`S,"P@,C`Q
M-"X\+V1I=CX@/&1I=B!S='EL93TS1"=-05)'24XM3$5&5#H@-#,W<'0[($1)
M4U!,05DZ(&)L;V-K.R!415A4+4E.1$5.5#H@,'!T)SX@/&)R("\^(#PO9&EV
M/B`\9&EV('-T>6QE/3-$)T1)4U!,05DZ(&)L;V-K.R!&3TY4+49!34E,63H@
M5&EM97,@3F5W(%)O;6%N.R!&3TY4+5-)6D4Z(#$P<'0[($U!4D=)3BU,1494
M.B`Q.'!T.R!-05)'24XM4DE'2%0Z(#!P=#L@=&5X="UA;&EG;CH@:G5S=&EF
M>3L@5$585"U)3D1%3E0Z(#!P="<^(%1H92!A9&1I=&EO;F%L(')E9W5L871O
M<GD@;6EL97-T;VYE<R!P87EM96YT<R!W:6QL(&)E(')E8V]G;FEZ960@=7!O
M;B!T:&4@86-H:65V96UE;G0@;V8@9G5T=7)E<R!E=F5N=',@8GD@56YI=&5D
M(%1H97)A<&5U=&EC<RP@:6X@86-C;W)D86YC92!W:71H($%30R`T-3`M,S`M
M,C4L(")'86EN($-O;G1I;F=E;F-I97,B+B!!<R!O9B!*=6YE(#,P+"`R,#$T
M+"!N;R!R96=U;&%T;W)Y(&UI;&QS=&]N97,@=V5R92!A8VAI979E9"X\+V1I
M=CX@/&1I=B!S='EL93TS1"=-05)'24XM3$5&5#H@-#,W<'0[($1)4U!,05DZ
M(&)L;V-K.R!415A4+4E.1$5.5#H@,'!T)SX@/&)R("\^(#PO9&EV/B`\9&EV
M('-T>6QE/3-$)T1)4U!,05DZ(&)L;V-K.R!&3TY4+49!34E,63H@5&EM97,@
M3F5W(%)O;6%N.R!&3TY4+5-)6D4Z(#$P<'0[($U!4D=)3BU,1494.B`Q.'!T
M.R!-05)'24XM4DE'2%0Z(#!P=#L@=&5X="UA;&EG;CH@:G5S=&EF>3L@5$58
M5"U)3D1%3E0Z(#!P="<^(%1H92!#;VUP86YY(&%L<V\@<F5C96EV960@86X@
M861V86YC960@<&%Y;65N="!F;W(@=&AE(&1E=F5L;W!M96YT+"!O9B`D,BPP
M,#`@=&AA="!W:6QL(&)E(&1E9'5C=&EB;&4@86=A:6YS="!D979E;&]P;65N
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M($%30R`W,S`M,C`L(")297-E87)C:"!A;F0@1&5V96QO<&UE;G0@06=R965M
M96YT<R(N($%S(&]F($IU;F4@,S`L(#(P,30L('1H92!#;VUP86YY(&1E9'5C
M=&5D(&%N(&%M;W5N="!O9B!A<'!R;WAI;6%T96QY("0Q+#<U,RX\+V1I=CX@
M/&1I=B!S='EL93TS1"=$25-03$%9.B!B;&]C:SL@5$585"U)3D1%3E0Z(#!P
M="<^)FYB<W`[/"]D:78^(#QD:78^(#QT86)L92!S='EL93TS1"=&3TY4+5-)
M6D4Z(#$P<'0[($9/3E0M1D%-24Q9.B!T:6UE<R!N97<@<F]M86XG(&-E;&QS
M<&%C:6YG/3-$,"!C96QL<&%D9&EN9STS1#`@=VED=&@],T0Q,#`E(&%L:6=N
M/3-$8V5N=&5R(&)O<F1E<CTS1#`^(#QT<B!V86QI9VX],T1T;W`^(#QT9"!S
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M;&4^(#PO9&EV/B`\9&EV('-T>6QE/3-$)T1)4U!,05DZ(&)L;V-K.R!-05)'
M24XM3$5&5#H@,'!T.R!-05)'24XM4DE'2%0Z(#!P=#L@=&5X="UA;&EG;CH@
M:G5S=&EF>3L@5$585"U)3D1%3E0Z(#!P="<^("9N8G-P.SPO9&EV/B`\9&EV
M/B`\=&%B;&4@<W1Y;&4],T0G1D].5"U325I%.B`Q,'!T.R!&3TY4+49!34E,
M63H@=&EM97,@;F5W(')O;6%N)R!C96QL<W!A8VEN9STS1#`@8V5L;'!A9&1I
M;F<],T0P('=I9'1H/3-$,3`P)2!A;&EG;CTS1&-E;G1E<B!B;W)D97(],T0P
M/B`\='(@=F%L:6=N/3-$=&]P/B`\=&0@<W1Y;&4],T0G5TE$5$@Z(#$X<'0G
M/B`\9&EV('-T>6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ
M(%1I;65S($YE=R!2;VUA;CL@1$E34$Q!63H@:6YL:6YE)SX@)FYB<W`[/"]D
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M:78@<W1Y;&4],T0G1$E34$Q!63H@8FQO8VL[($U!4D=)3BU,1494.B`P<'0[
M($U!4D=)3BU224=(5#H@,'!T.R!T97AT+6%L:6=N.B!J=7-T:69Y.R!415A4
M+4E.1$5.5#H@,'!T)SX@)FYB<W`[/"]D:78^(#QD:78@<W1Y;&4],T0G34%2
M1TE.+4Q%1E0Z(#$X<'0[('1E>'0M86QI9VXZ(&QE9G0G/B`\=&%B;&4@<W1Y
M;&4],T0G1D].5"U325I%.B`Q,'!T.R!&3TY4+49!34E,63H@=&EM97,@;F5W
M(')O;6%N)R!C96QL<W!A8VEN9STS1#`@8V5L;'!A9&1I;F<],T0P('=I9'1H
M/3-$.#`E/B`\='(^(#QT9"!V86QI9VX],T1T;W`@=VED=&@],T0T-"4^/&9O
M;G0@<W1Y;&4],T0G1D].5"U325I%.B`Q,'!T.R!&3TY4+49!34E,63H@=&EM
M97,@;F5W(')O;6%N.R!$25-03$%9.B!I;FQI;F4G/B`F;F)S<#L\+V9O;G0^
M(#PO=&0^(#QT9"!S='EL93TS1"="3U)$15(M0D]45$]-.B!B;&%C:R`R<'@@
M<V]L:60G('9A;&EG;CTS1'1O<"!W:61T:#TS1#(X)3X@/&1I=B!S='EL93TS
M1"=$25-03$%9.B!B;&]C:SL@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA
M;CL@1D].5"U325I%.B`Q,'!T.R!-05)'24XM3$5&5#H@,'!T.R!-05)'24XM
M4DE'2%0Z(#!P=#L@5$585"U)3D1%3E0Z(#!P="<^("4\+V1I=CX@/"]T9#X@
M/'1D('9A;&EG;CTS1'1O<"!W:61T:#TS1#(X)3X\9F]N="!S='EL93TS1"=&
M3TY4+5-)6D4Z(#$P<'0[($9/3E0M1D%-24Q9.B!T:6UE<R!N97<@<F]M86X[
M($1)4U!,05DZ(&EN;&EN92<^("9N8G-P.SPO9F]N=#X@/"]T9#X@/"]T<CX@
M/'1R(&)G8V]L;W(],T0C8V-E969F/B`\=&0@=F%L:6=N/3-$=&]P('=I9'1H
M/3-$-#0E(&%L:6=N/3-$;&5F=#X@/&1I=B!S='EL93TS1"=$25-03$%9.B!B
M;&]C:SL@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%
M.B`Q,'!T.R!-05)'24XM3$5&5#H@,'!T.R!-05)'24XM4DE'2%0Z(#!P=#L@
M=&5X="UA;&EG;CH@;&5F=#L@5$585"U)3D1%3E0Z(#!P="<^($QA8F]R871O
M<GD@97%U:7!M96YT/"]D:78^(#PO=&0^(#QT9"!V86QI9VX],T1T;W`@=VED
M=&@],T0R."4@86QI9VX],T1L969T/B`\9&EV('-T>6QE/3-$)T1)4U!,05DZ
M(&)L;V-K.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!&3TY4+5-)
M6D4Z(#$P<'0[($U!4D=)3BU,1494.B`P<'0[($U!4D=)3BU224=(5#H@+3$R
M+C-P=#L@=&5X="UA;&EG;CH@;&5F=#L@5$585"U)3D1%3E0Z(#!P="<^(#$P
M+3$U/"]D:78^(#PO=&0^(#QT9"!V86QI9VX],T1T;W`@=VED=&@],T0R."4^
M/&9O;G0@<W1Y;&4],T0G1D].5"U325I%.B`Q,'!T.R!&3TY4+49!34E,63H@
M=&EM97,@;F5W(')O;6%N.R!$25-03$%9.B!I;FQI;F4G/B`F;F)S<#L\+V9O
M;G0^(#PO=&0^(#PO='(^(#QT<B!B9V-O;&]R/3-$=VAI=&4^(#QT9"!V86QI
M9VX],T1T;W`@=VED=&@],T0T-"4@86QI9VX],T1L969T/B`\9&EV('-T>6QE
M/3-$)T1)4U!,05DZ(&)L;V-K.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O
M;6%N.R!&3TY4+5-)6D4Z(#$P<'0[($U!4D=)3BU,1494.B`P<'0[($U!4D=)
M3BU224=(5#H@,'!T.R!T97AT+6%L:6=N.B!L969T.R!415A4+4E.1$5.5#H@
M,'!T)SX@0V]M<'5T97)S(&%N9"!P97)I<&AE<F%L(&5Q=6EP;65N=#PO9&EV
M/B`\+W1D/B`\=&0@=F%L:6=N/3-$=&]P('=I9'1H/3-$,C@E(&%L:6=N/3-$
M;&5F=#X@/&1I=B!S='EL93TS1"=$25-03$%9.B!B;&]C:SL@1D].5"U&04U)
M3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T.R!-05)'24XM
M3$5&5#H@,'!T.R!-05)'24XM4DE'2%0Z("TQ,BXS<'0[('1E>'0M86QI9VXZ
M(&QE9G0[(%1%6%0M24Y$14Y4.B`P<'0G/B`S,SPO9&EV/B`\+W1D/B`\=&0@
M=F%L:6=N/3-$=&]P('=I9'1H/3-$,C@E/CQF;VYT('-T>6QE/3-$)T9/3E0M
M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1$E3
M4$Q!63H@:6YL:6YE)SX@)FYB<W`[/"]F;VYT/B`\+W1D/B`\+W1R/B`\='(@
M8F=C;VQO<CTS1"-C8V5E9F8^(#QT9"!V86QI9VX],T1T;W`@=VED=&@],T0T
M-"4@86QI9VX],T1L969T/B`\9&EV('-T>6QE/3-$)T1)4U!,05DZ(&)L;V-K
M.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!&3TY4+5-)6D4Z(#$P
M<'0[($U!4D=)3BU,1494.B`P<'0[($U!4D=)3BU224=(5#H@,'!T.R!T97AT
M+6%L:6=N.B!L969T.R!415A4+4E.1$5.5#H@,'!T)SX@3V9F:6-E(&9U<FYI
M='5R92!A;F0@97%U:7!M96YT/"]D:78^(#PO=&0^(#QT9"!V86QI9VX],T1T
M;W`@=VED=&@],T0R."4@86QI9VX],T1L969T/B`\9&EV('-T>6QE/3-$)T1)
M4U!,05DZ(&)L;V-K.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!&
M3TY4+5-)6D4Z(#$P<'0[($U!4D=)3BU,1494.B`P<'0[($U!4D=)3BU224=(
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M34%21TE.+5))1TA4.B`P<'0[('1E>'0M86QI9VXZ(&QE9G0[(%1%6%0M24Y$
M14Y4.B`P<'0G/B!696AI8VQE<SPO9&EV/B`\+W1D/B`\=&0@=F%L:6=N/3-$
M=&]P('=I9'1H/3-$,34E(&-O;'-P86X],T0R(&%L:6=N/3-$;&5F=#X@/&1I
M=B!S='EL93TS1"=$25-03$%9.B!B;&]C:SL@1D].5"U&04U)3%DZ('1I;65S
M(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T.R!-05)'24XM3$5&5#H@,'!T
M.R!-05)'24XM4DE'2%0Z("TQ,BXS<'0[('1E>'0M86QI9VXZ(&QE9G0[(%1%
M6%0M24Y$14Y4.B`P<'0G/B`Q-3PO9&EV/B`\+W1D/B`\+W1R/B`\='(@8F=C
M;VQO<CTS1"-C8V5E9F8^(#QT9"!V86QI9VX],T1T;W`@=VED=&@],T0T-"4@
M86QI9VX],T1L969T/B`\9&EV('-T>6QE/3-$)T1)4U!,05DZ(&)L;V-K.R!&
M3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!&3TY4+5-)6D4Z(#$P<'0[
M($U!4D=)3BU,1494.B`P<'0[($U!4D=)3BU224=(5#H@,'!T.R!T97AT+6%L
M:6=N.B!L969T.R!415A4+4E.1$5.5#H@,'!T)SX@3&5A<V5H;VQD(&EM<')O
M=F5M96YT<SPO9&EV/B`\+W1D/B`\=&0@=F%L:6=N/3-$=&]P('=I9'1H/3-$
M-38E(&-O;'-P86X],T0R(&%L:6=N/3-$;&5F=#X@/&1I=B!S='EL93TS1"=$
M25-03$%9.B!B;&]C:SL@34%21TE.+4Q%1E0Z(#!P=#L@34%21TE.+5))1TA4
M.B`M,3(N,W!T.R!T97AT+6%L:6=N.B!L969T.R!415A4+4E.1$5.5#H@,'!T
M)SX@/&9O;G0@<W1Y;&4],T0G1D].5"U325I%.B`Q,'!T.R!&3TY4+49!34E,
M63H@=&EM97,@;F5W(')O;6%N.R!$25-03$%9.B!I;FQI;F4G/B!4:&4@<VAO
M<G1E<B!O9B!T:&4@97AP96-T960\+V9O;G0^(#QF;VYT('-T>6QE/3-$)T9/
M3E0M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@
M1$E34$Q!63H@:6YL:6YE)SX@=7-E9G5L(&QI9F4@;W(@=&AE/"]F;VYT/CPO
M9&EV/B`\9&EV('-T>6QE/3-$)T1)4U!,05DZ(&)L;V-K.R!-05)'24XM3$5&
M5#H@,'!T.R!-05)'24XM4DE'2%0Z("TQ,BXS<'0[('1E>'0M86QI9VXZ(&QE
M9G0[(%1%6%0M24Y$14Y4.B`P<'0G/B`\9F]N="!S='EL93TS1"=&3TY4+5-)
M6D4Z(#$P<'0[($9/3E0M1D%-24Q9.B!T:6UE<R!N97<@<F]M86X[($1)4U!,
M05DZ(&EN;&EN92<^(')E87-O;F%B;&4@87-S=6UE9#PO9F]N=#X@/&9O;G0@
M<W1Y;&4],T0G1D].5"U325I%.B`Q,'!T.R!&3TY4+49!34E,63H@=&EM97,@
M;F5W(')O;6%N.R!$25-03$%9.B!I;FQI;F4G/B!T97)M(&]F('1H92!L96%S
M92X\+V9O;G0^/"]D:78^(#PO=&0^(#PO='(^(#PO=&%B;&4^(#PO9&EV/B`\
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M;CTS1'1O<#X@/'1D('-T>6QE/3-$)U=)1%1(.B`Q.'!T)SX@/&1I=B!S='EL
M93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE<R!N97<@
M<F]M86X[($9/3E0M4TE:13H@,3!P=#L@1D].5"U714E'2%0Z(&)O;&0[($U!
M4D=)3BU,1494.B`P<'0[($U!4D=)3BU224=(5#H@,'!T.R!415A4+4E.1$5.
M5#H@,'!T)SX@:RX\+V1I=CX@/"]T9#X@/'1D/B`\9&EV('-T>6QE/3-$)T1)
M4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@
M1D].5"U325I%.B`Q,'!T.R!&3TY4+5=%24=(5#H@8F]L9#L@=&5X="UA;&EG
M;CH@:G5S=&EF>2<^($EM<&%I<FUE;G0@;V8@;&]N9RUL:79E9"!A<W-E=',\
M+V1I=CX@/"]T9#X@/"]T<CX@/"]T86)L93X@/"]D:78^(#QD:78@<W1Y;&4]
M,T0G1$E34$Q!63H@8FQO8VL[($U!4D=)3BU,1494.B`P<'0[($U!4D=)3BU2
M24=(5#H@,'!T.R!T97AT+6%L:6=N.B!J=7-T:69Y.R!415A4+4E.1$5.5#H@
M,'!T)SX@)FYB<W`[/"]D:78^(#QD:78^(#QT86)L92!S='EL93TS1"=&3TY4
M+5-)6D4Z(#$P<'0[($9/3E0M1D%-24Q9.B!T:6UE<R!N97<@<F]M86XG(&-E
M;&QS<&%C:6YG/3-$,"!C96QL<&%D9&EN9STS1#`@=VED=&@],T0Q,#`E(&%L
M:6=N/3-$8V5N=&5R(&)O<F1E<CTS1#`^(#QT<B!V86QI9VX],T1T;W`^(#QT
M9"!S='EL93TS1"=724142#H@,3AP="<^(#QD:78@<W1Y;&4],T0G1D].5"U3
M25I%.B`Q,'!T.R!&3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N.R!$25-0
M3$%9.B!I;FQI;F4G/B`F;F)S<#L\+V1I=CX@/"]T9#X@/'1D/B`\9&EV('-T
M>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ(%1I;65S($YE
M=R!2;VUA;CL@1D].5"U325I%.B`Q,'!T.R!T97AT+6%L:6=N.B!J=7-T:69Y
M)SX@5&AE($-O;7!A;GDF(S,Y.W,@;&]N9RUL:79E9"!A<W-E=',@87)E(')E
M=FEE=V5D(&9O<B!I;7!A:7)M96YT(&EN(&%C8V]R9&%N8V4@=VET:"!!4T,@
M,S8P+"`B4')O<&5R='DL(%!L86YT(&%N9"!%<75I<&UE;G0B+"!W:&5N979E
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M<W1Y;&4],T0G1$E34$Q!63H@8FQO8VL[($U!4D=)3BU,1494.B`P<'0[($U!
M4D=)3BU224=(5#H@,'!T.R!T97AT+6%L:6=N.B!J=7-T:69Y.R!415A4+4E.
M1$5.5#H@,'!T)SX@)FYB<W`[/"]D:78^(#QD:78^(#QT86)L92!S='EL93TS
M1"=&3TY4+5-)6D4Z(#$P<'0[($9/3E0M1D%-24Q9.B!T:6UE<R!N97<@<F]M
M86XG(&-E;&QS<&%C:6YG/3-$,"!C96QL<&%D9&EN9STS1#`@=VED=&@],T0Q
M,#`E(&%L:6=N/3-$8V5N=&5R(&)O<F1E<CTS1#`^(#QT<B!V86QI9VX],T1T
M;W`^(#QT9"!S='EL93TS1"=724142#H@,3AP="<^(#QD:78@<W1Y;&4],T0G
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M;&4],T0G1$E34$Q!63H@8FQO8VL[($U!4D=)3BU,1494.B`P<'0[($U!4D=)
M3BU224=(5#H@,'!T.R!T97AT+6%L:6=N.B!J=7-T:69Y.R!415A4+4E.1$5.
M5#H@,'!T)SX@)FYB<W`[/"]D:78^(#QD:78@<W1Y;&4],T0G1$E34$Q!63H@
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M=&]C:R!#;VUP96YS871I;VXB("@B05-#(#<Q."(I(&%N9"!!4T,@-3`U+34P
M(")%<75I='DM0F%S960@4&%Y;65N=',@=&\@3F]N+45M<&QO>65E<R(N($%3
M0R`W,3@@<F5Q=6ER97,@8V]M<&%N:65S('1O(&5S=&EM871E('1H92!F86ER
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M;B!T:&4@;75L=&EP;&4M;W!T:6]N(&%W87)D(&%P<')O86-H+CPO9&EV/B`\
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M<V-A;"!Y96%R<R`R,#$T+"`R,#$S(&%N9"`R,#$R('1H97)E('=E<F4@;F\@
M;W!T:6]N<R!G<F%N=',@=&\@96UP;&]Y965S(&]R(&1I<F5C=&]R<RX\+V1I
M=CX@/&1I=B!S='EL93TS1"=-05)'24XM3$5&5#H@-#,W<'0[($1)4U!,05DZ
M(&)L;V-K.R!415A4+4E.1$5.5#H@,'!T)SX@/&)R("\^(#PO9&EV/B`\9&EV
M('-T>6QE/3-$)T1)4U!,05DZ(&)L;V-K.R!&3TY4+49!34E,63H@5&EM97,@
M3F5W(%)O;6%N.R!&3TY4+5-)6D4Z(#$P<'0[($U!4D=)3BU,1494.B`Q.'!T
M.R!-05)'24XM4DE'2%0Z(#!P=#L@=&5X="UA;&EG;CH@:G5S=&EF>3L@5$58
M5"U)3D1%3E0Z(#!P="<^(%1H92!A<W-U;7!T:6]N<R!B96QO=R!A<F4@<F5L
M979A;G0@=&\@<F5S=')I8W1E9"!S:&%R97,@=6YI=',@9W)A;G1E9"!I;B`R
M,#$T+"`R,#$S(&%N9"`R,#$R.CPO9&EV/B`\9&EV('-T>6QE/3-$)T1)4U!,
M05DZ(&)L;V-K.R!&3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N.R!&3TY4
M+5-)6D4Z(#$P<'0[($U!4D=)3BU,1494.B`Q.'!T.R!-05)'24XM4DE'2%0Z
M(#!P=#L@=&5X="UA;&EG;CH@:G5S=&EF>3L@5$585"U)3D1%3E0Z(#!P="<^
M($EN(&%C8V]R9&%N8V4@=VET:"`\9F]N="!S='EL93TS1"=&3TY4+5-)6D4Z
M(#$P<'0[($1)4U!,05DZ(&EN;&EN92<^05-#(#<Q.#PO9F]N=#XL(')E<W1R
M:6-T960@<VAA<F5S(&]R(')E<W1R:6-T960@<VAA<F5S('5N:71S(&%R92!M
M96%S=7)E9"!A="!T:&5I<B!F86ER('9A;'5E+B!!;&P@<F5S=')I8W1E9"!S
M:&%R97,@86YD(')E<W1R:6-T960@<VAA<F5S('5N:71S('1O(&5M<&QO>65E
M<RP@9&ER96-T;W)S(&%N9"!N;VXM96UP;&]Y965S(&=R86YT960@:6X@,C`Q
M-#(P,3,@86YD(#(P,3(@=V5R92!G<F%N=&5D(&9O<B!N;R!C;VYS:61E<F%T
M:6]N.R!T:&5R969O<F4L('1H96ER(&9A:7(@=F%L=64@=V%S(&5Q=6%L('1O
M('1H92!S:&%R92!P<FEC92!A="!T:&4@9&%T92!O9B!G<F%N="X\+V1I=CX@
M/&1I=B!S='EL93TS1"=-05)'24XM3$5&5#H@-#,W<'0[($1)4U!,05DZ(&)L
M;V-K.R!415A4+4E.1$5.5#H@,'!T)SX@/&)R("\^(#PO9&EV/B`\9&EV('-T
M>6QE/3-$)T1)4U!,05DZ(&)L;V-K.R!&3TY4+49!34E,63H@5&EM97,@3F5W
M(%)O;6%N.R!&3TY4+5-)6D4Z(#$P<'0[($U!4D=)3BU,1494.B`Q.'!T.R!-
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M('EE87(@96YD960@2G5N92`S,"P@,C`Q-"!A;F0@,C`Q,R!A;F0@-24@9F]R
M('1H92!Y96%R(&5N9&5D($IU;F4@,S`L(#(P,3(L(&%N9"`P)2!F;W(@=&AE
M(&]P=&EO;G,@86YD('-H87)E<R!G<F%N=&5D('1O(&1I<F5C=&]R<R!A;F0@
M;V9F:6-E<G,@86YD(&-O;G-U;'1A;G1S(&]F('1H92!#;VUP86YY+CPO9&EV
M/B`\9&EV('-T>6QE/3-$)TU!4D=)3BU,1494.B`T,S=P=#L@1$E34$Q!63H@
M8FQO8VL[(%1%6%0M24Y$14Y4.B`P<'0G/B`\8G(@+SX@/"]D:78^(#QD:78@
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M92!O9B!S:&%R92!G<F%N=&5D(&1U<FEN9R!Y96%R<R`R,#$T+"`R,#$S(&%N
M9"`R,#$R('=A<R`D,RXU,RP@)#,N-#,@86YD("0R+C4T+"!R97-P96-T:79E
M;'DN/"]D:78^(#QD:78@<W1Y;&4],T0G1$E34$Q!63H@8FQO8VL[(%1%6%0M
M24Y$14Y4.B`P<'0G/B9N8G-P.SPO9&EV/B`\9&EV('-T>6QE/3-$)W1E>'0M
M86QI9VXZ(&-E;G1E<B<^(#QT86)L92!S='EL93TS1"=&3TY4+5-)6D4Z(#$P
M<'0[($9/3E0M1D%-24Q9.B!T:6UE<R!N97<@<F]M86XG(&-E;&QS<&%C:6YG
M/3-$,"!C96QL<&%D9&EN9STS1#`@=VED=&@],T0Q,#`E(&)O<F1E<CTS1#`^
M(#QT<B!V86QI9VX],T1T;W`^(#QT9"!S='EL93TS1"=724142#H@,3AP="<^
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M;G0@97AP96YS97,@86YD(&=R86YT<SPO9&EV/B`\+W1D/B`\+W1R/B`\+W1A
M8FQE/B`\+V1I=CX@/&1I=B!S='EL93TS1"=$25-03$%9.B!B;&]C:SL@34%2
M1TE.+4Q%1E0Z(#!P=#L@34%21TE.+5))1TA4.B`P<'0[('1E>'0M86QI9VXZ
M(&IU<W1I9GD[(%1%6%0M24Y$14Y4.B`P<'0G/B`F;F)S<#L\+V1I=CX@/&1I
M=CX@/'1A8FQE('-T>6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@1D].5"U&04U)
M3%DZ('1I;65S(&YE=R!R;VUA;B<@8V5L;'-P86-I;F<],T0P(&-E;&QP861D
M:6YG/3-$,"!W:61T:#TS1#$P,"4@86QI9VX],T1C96YT97(@8F]R9&5R/3-$
M,#X@/'1R('9A;&EG;CTS1'1O<#X@/'1D('-T>6QE/3-$)U=)1%1(.B`Q.7!T
M)SX@/&1I=B!S='EL93TS1"=&3TY4+5-)6D4Z(#$P<'0[($9/3E0M1D%-24Q9
M.B!4:6UE<R!.97<@4F]M86X[($1)4U!,05DZ(&EN;&EN92<^("9N8G-P.SPO
M9&EV/B`\+W1D/B`\=&0^(#QD:78@<W1Y;&4],T0G1$E34$Q!63H@:6YL:6YE
M.R!&3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N.R!&3TY4+5-)6D4Z(#$P
M<'0[('1E>'0M86QI9VXZ(&IU<W1I9GDG/B!297-E87)C:"!A;F0@9&5V96QO
M<&UE;G0@97AP96YS97,L(&YE="!O9B!P87)T:6-I<&%T:6]N<RP@87)E(&-H
M87)G960@=&\@=&AE('-T871E;65N="!O9B!O<&5R871I;VYS(&%S(&EN8W5R
M<F5D+CPO9&EV/B`\+W1D/B`\+W1R/B`\+W1A8FQE/B`\+V1I=CX@/&1I=B!S
M='EL93TS1"=$25-03$%9.B!B;&]C:SL@34%21TE.+4Q%1E0Z(#!P=#L@34%2
M1TE.+5))1TA4.B`P<'0[('1E>'0M86QI9VXZ(&IU<W1I9GD[(%1%6%0M24Y$
M14Y4.B`P<'0G/B`F;F)S<#L\+V1I=CX@/&1I=CX@/'1A8FQE('-T>6QE/3-$
M)T9/3E0M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA
M;B<@8V5L;'-P86-I;F<],T0P(&-E;&QP861D:6YG/3-$,"!W:61T:#TS1#$P
M,"4@86QI9VX],T1C96YT97(@8F]R9&5R/3-$,#X@/'1R('9A;&EG;CTS1'1O
M<#X@/'1D('-T>6QE/3-$)U=)1%1(.B`Q.7!T)SX@/&1I=B!S='EL93TS1"=&
M3TY4+5-)6D4Z(#$P<'0[($9/3E0M1D%-24Q9.B!4:6UE<R!.97<@4F]M86X[
M($1)4U!,05DZ(&EN;&EN92<^("9N8G-P.SPO9&EV/B`\+W1D/B`\=&0^(#QD
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M(&9R;VT@<F5S96%R8V@@86YD(&1E=F5L;W!M96YT(&-O<W1S+CPO9&EV/B`\
M+W1D/B`\+W1R/B`\+W1A8FQE/B`\+V1I=CX@/&1I=B!S='EL93TS1"=$25-0
M3$%9.B!B;&]C:SL@34%21TE.+4Q%1E0Z(#!P=#L@34%21TE.+5))1TA4.B`P
M<'0[('1E>'0M86QI9VXZ(&IU<W1I9GD[(%1%6%0M24Y$14Y4.B`P<'0G/B`F
M;F)S<#L\+V1I=CX@/&1I=B!S='EL93TS1"=T97AT+6%L:6=N.B!C96YT97(G
M/B`\=&%B;&4@<W1Y;&4],T0G1D].5"U325I%.B`Q,'!T.R!&3TY4+49!34E,
M63H@=&EM97,@;F5W(')O;6%N)R!C96QL<W!A8VEN9STS1#`@8V5L;'!A9&1I
M;F<],T0P('=I9'1H/3-$,3`P)2!B;W)D97(],T0P/B`\='(@=F%L:6=N/3-$
M=&]P/B`\=&0@<W1Y;&4],T0G5TE$5$@Z(#$X<'0G/B`\9&EV('-T>6QE/3-$
M)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA
M;CL@1D].5"U325I%.B`Q,'!T.R!&3TY4+5=%24=(5#H@8F]L9#L@34%21TE.
M+4Q%1E0Z(#!P=#L@34%21TE.+5))1TA4.B`P<'0[(%1%6%0M24Y$14Y4.B`P
M<'0G/B!N+CPO9&EV/B`\+W1D/B`\=&0^(#QD:78@<W1Y;&4],T0G1$E34$Q!
M63H@:6YL:6YE.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!&3TY4
M+5-)6D4Z(#$P<'0[($9/3E0M5T5)1TA4.B!B;VQD.R!T97AT+6%L:6=N.B!J
M=7-T:69Y)SX@3&]S<R!P97(@<VAA<F4\+V1I=CX@/"]T9#X@/"]T<CX@/"]T
M86)L93X@/"]D:78^(#QD:78@<W1Y;&4],T0G1$E34$Q!63H@8FQO8VL[($U!
M4D=)3BU,1494.B`P<'0[($U!4D=)3BU224=(5#H@,'!T.R!T97AT+6%L:6=N
M.B!J=7-T:69Y.R!415A4+4E.1$5.5#H@,'!T)SX@)FYB<W`[/"]D:78^(#QD
M:78^(#QT86)L92!S='EL93TS1"=&3TY4+5-)6D4Z(#$P<'0[($9/3E0M1D%-
M24Q9.B!T:6UE<R!N97<@<F]M86XG(&-E;&QS<&%C:6YG/3-$,"!C96QL<&%D
M9&EN9STS1#`@=VED=&@],T0Q,#`E(&%L:6=N/3-$8V5N=&5R(&)O<F1E<CTS
M1#`^(#QT<B!V86QI9VX],T1T;W`^(#QT9"!S='EL93TS1"=724142#H@,3EP
M="<^(#QD:78@<W1Y;&4],T0G1D].5"U325I%.B`Q,'!T.R!&3TY4+49!34E,
M63H@5&EM97,@3F5W(%)O;6%N.R!$25-03$%9.B!I;FQI;F4G/B`F;F)S<#L\
M+V1I=CX@/"]T9#X@/'1D/B`\9&EV('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN
M93L@1D].5"U&04U)3%DZ(%1I;65S($YE=R!2;VUA;CL@1D].5"U325I%.B`Q
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M(#PO='(^(#PO=&%B;&4^(#PO9&EV/B`\9&EV('-T>6QE/3-$)T1)4U!,05DZ
M(&)L;V-K.R!-05)'24XM3$5&5#H@,'!T.R!-05)'24XM4DE'2%0Z(#!P=#L@
M=&5X="UA;&EG;CH@:G5S=&EF>3L@5$585"U)3D1%3E0Z(#!P="<^("9N8G-P
M.SPO9&EV/B`\9&EV('-T>6QE/3-$)W1E>'0M86QI9VXZ(&-E;G1E<B<^(#QT
M86)L92!S='EL93TS1"=&3TY4+5-)6D4Z(#$P<'0[($9/3E0M1D%-24Q9.B!T
M:6UE<R!N97<@<F]M86XG(&-E;&QS<&%C:6YG/3-$,"!C96QL<&%D9&EN9STS
M1#`@=VED=&@],T0Q,#`E(&)O<F1E<CTS1#`^(#QT<B!V86QI9VX],T1T;W`^
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M1494.B`P<'0[($U!4D=)3BU224=(5#H@,'!T.R!T97AT+6%L:6=N.B!J=7-T
M:69Y.R!415A4+4E.1$5.5#H@,'!T)SX@)FYB<W`[/"]D:78^(#QD:78^(#QT
M86)L92!S='EL93TS1"=&3TY4+5-)6D4Z(#$P<'0[($9/3E0M1D%-24Q9.B!T
M:6UE<R!N97<@<F]M86XG(&-E;&QS<&%C:6YG/3-$,"!C96QL<&%D9&EN9STS
M1#`@=VED=&@],T0Q,#`E(&%L:6=N/3-$8V5N=&5R(&)O<F1E<CTS1#`^(#QT
M<B!V86QI9VX],T1T;W`^(#QT9"!S='EL93TS1"=724142#H@,3EP="<^(#QD
M:78@<W1Y;&4],T0G1D].5"U325I%.B`Q,'!T.R!&3TY4+49!34E,63H@5&EM
M97,@3F5W(%)O;6%N.R!$25-03$%9.B!I;FQI;F4G/B`F;F)S<#L\+V1I=CX@
M/"]T9#X@/'1D/B`\9&EV('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].
M5"U&04U)3%DZ(%1I;65S($YE=R!2;VUA;CL@1D].5"U325I%.B`Q,'!T.R!T
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M(&5S=&EM871E9"!R96%L:7IA8FQE('9A;'5E+CPO9&EV/B`\+W1D/B`\+W1R
M/B`\+W1A8FQE/B`\+V1I=CX@/&1I=B!S='EL93TS1"=$25-03$%9.B!B;&]C
M:SL@34%21TE.+4Q%1E0Z(#!P=#L@34%21TE.+5))1TA4.B`P<'0[('1E>'0M
M86QI9VXZ(&IU<W1I9GD[(%1%6%0M24Y$14Y4.B`P<'0G/B`F;F)S<#L\+V1I
M=CX@/&1I=CX@/'1A8FQE('-T>6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@1D].
M5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;B<@8V5L;'-P86-I;F<],T0P(&-E
M;&QP861D:6YG/3-$,"!W:61T:#TS1#$P,"4@86QI9VX],T1C96YT97(@8F]R
M9&5R/3-$,#X@/'1R('9A;&EG;CTS1'1O<#X@/'1D('-T>6QE/3-$)U=)1%1(
M.B`Q.7!T)SX@/&1I=B!S='EL93TS1"=&3TY4+5-)6D4Z(#$P<'0[($9/3E0M
M1D%-24Q9.B!4:6UE<R!.97<@4F]M86X[($1)4U!,05DZ(&EN;&EN92<^("9N
M8G-P.SPO9&EV/B`\+W1D/B`\=&0^(#QD:78@<W1Y;&4],T0G1$E34$Q!63H@
M:6YL:6YE.R!&3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N.R!&3TY4+5-)
M6D4Z(#$P<'0[('1E>'0M86QI9VXZ(&IU<W1I9GDG/B!!4T,@-S0P(&5S=&%B
M;&ES:&5S(&$@<VEN9VQE(&UO9&5L('1O(&%D9')E<W,@86-C;W5N=&EN9R!F
M;W(@=6YC97)T86EN('1A>"!P;W-I=&EO;G,N($%30R`W-#`@8VQA<FEF:65D
M('1H92!A8V-O=6YT:6YG(&9O<B!I;F-O;64@=&%X97,@8GD@<')E<V-R:6)I
M;F<@=&AE(&UI;FEM=6T@<F5C;V=N:71I;VX@=&AR97-H;VQD(&$@=&%X('!O
M<VET:6]N(&ES(')E<75I<F5D('1O(&UE970@8F5F;W)E(&)E:6YG(')E8V]G
M;FEZ960@:6X@=&AE(&9I;F%N8VEA;"!S=&%T96UE;G1S+CPO9&EV/B`\+W1D
M/B`\+W1R/B`\+W1A8FQE/B`\+V1I=CX@/&1I=B!S='EL93TS1"=$25-03$%9
M.B!B;&]C:SL@34%21TE.+4Q%1E0Z(#!P=#L@34%21TE.+5))1TA4.B`P<'0[
M('1E>'0M86QI9VXZ(&IU<W1I9GD[(%1%6%0M24Y$14Y4.B`P<'0G/B`F;F)S
M<#L\+V1I=CX@/&1I=B!S='EL93TS1"=T97AT+6%L:6=N.B!C96YT97(G/B`\
M=&%B;&4@<W1Y;&4],T0G1D].5"U325I%.B`Q,'!T.R!&3TY4+49!34E,63H@
M=&EM97,@;F5W(')O;6%N)R!C96QL<W!A8VEN9STS1#`@8V5L;'!A9&1I;F<]
M,T0P('=I9'1H/3-$,3`P)2!B;W)D97(],T0P/B`\='(@=F%L:6=N/3-$=&]P
M/B`\=&0@<W1Y;&4],T0G5TE$5$@Z(#$X<'0G/B`\9&EV('-T>6QE/3-$)T1)
M4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@
M1D].5"U325I%.B`Q,'!T.R!&3TY4+5=%24=(5#H@8F]L9#L@34%21TE.+4Q%
M1E0Z(#!P=#L@34%21TE.+5))1TA4.B`P<'0[(%1%6%0M24Y$14Y4.B`P<'0G
M/B!P+CPO9&EV/B`\+W1D/B`\=&0^(#QD:78@<W1Y;&4],T0G1$E34$Q!63H@
M:6YL:6YE.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!&3TY4+5-)
M6D4Z(#$P<'0[($9/3E0M5T5)1TA4.B!B;VQD.R!T97AT+6%L:6=N.B!J=7-T
M:69Y)SX@0V]N8V5N=')A=&EO;B!O9B!C<F5D:70@<FES:SPO9&EV/B`\+W1D
M/B`\+W1R/B`\+W1A8FQE/B`\+V1I=CX@/&1I=B!S='EL93TS1"=$25-03$%9
M.B!B;&]C:SL@34%21TE.+4Q%1E0Z(#!P=#L@34%21TE.+5))1TA4.B`P<'0[
M('1E>'0M86QI9VXZ(&IU<W1I9GD[(%1%6%0M24Y$14Y4.B`P<'0G/B`F;F)S
M<#L\+V1I=CX@/&1I=CX@/'1A8FQE('-T>6QE/3-$)T9/3E0M4TE:13H@,3!P
M=#L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;B<@8V5L;'-P86-I;F<]
M,T0P(&-E;&QP861D:6YG/3-$,"!W:61T:#TS1#$P,"4@86QI9VX],T1C96YT
M97(@8F]R9&5R/3-$,#X@/'1R('9A;&EG;CTS1'1O<#X@/'1D('-T>6QE/3-$
M)U=)1%1(.B`Q.7!T)SX@/&1I=B!S='EL93TS1"=&3TY4+5-)6D4Z(#$P<'0[
M($9/3E0M1D%-24Q9.B!4:6UE<R!.97<@4F]M86X[($1)4U!,05DZ(&EN;&EN
M92<^("9N8G-P.SPO9&EV/B`\+W1D/B`\=&0^(#QD:78@<W1Y;&4],T0G1$E3
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M:78^(#PO=&0^(#PO='(^(#PO=&%B;&4^(#PO9&EV/B`\9&EV('-T>6QE/3-$
M)T1)4U!,05DZ(&)L;V-K.R!-05)'24XM3$5&5#H@,'!T.R!-05)'24XM4DE'
M2%0Z(#!P=#L@=&5X="UA;&EG;CH@:G5S=&EF>3L@5$585"U)3D1%3E0Z(#!P
M="<^("9N8G-P.SPO9&EV/B`\9&EV/B`\=&%B;&4@<W1Y;&4],T0G1D].5"U3
M25I%.B`Q,'!T.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N)R!C96QL
M<W!A8VEN9STS1#`@8V5L;'!A9&1I;F<],T0P('=I9'1H/3-$,3`P)2!A;&EG
M;CTS1&-E;G1E<B!B;W)D97(],T0P/B`\='(@=F%L:6=N/3-$=&]P/B`\=&0@
M<W1Y;&4],T0G5TE$5$@Z(#$Y<'0G/B`\9&EV('-T>6QE/3-$)T9/3E0M4TE:
M13H@,3!P=#L@1D].5"U&04U)3%DZ(%1I;65S($YE=R!2;VUA;CL@1$E34$Q!
M63H@:6YL:6YE)SX@)FYB<W`[/"]D:78^(#PO=&0^(#QT9#X@/&1I=B!S='EL
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M;&4^(#PO9&EV/B`\9&EV('-T>6QE/3-$)T1)4U!,05DZ(&)L;V-K.R!-05)'
M24XM3$5&5#H@,'!T.R!-05)'24XM4DE'2%0Z(#!P=#L@=&5X="UA;&EG;CH@
M:G5S=&EF>3L@5$585"U)3D1%3E0Z(#!P="<^("9N8G-P.SPO9&EV/B`\9&EV
M/B`\=&%B;&4@<W1Y;&4],T0G1D].5"U325I%.B`Q,'!T.R!&3TY4+49!34E,
M63H@=&EM97,@;F5W(')O;6%N)R!C96QL<W!A8VEN9STS1#`@8V5L;'!A9&1I
M;F<],T0P('=I9'1H/3-$,3`P)2!A;&EG;CTS1&-E;G1E<B!B;W)D97(],T0P
M/B`\='(@=F%L:6=N/3-$=&]P/B`\=&0@<W1Y;&4],T0G5TE$5$@Z(#$X<'0G
M/B`\9&EV('-T>6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ
M(%1I;65S($YE=R!2;VUA;CL@1$E34$Q!63H@:6YL:6YE)SX@)FYB<W`[/"]D
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M/B`\+W1D/B`\+W1R/B`\+W1A8FQE/B`\+V1I=CX@/&1I=B!S='EL93TS1"=$
M25-03$%9.B!B;&]C:SL@34%21TE.+4Q%1E0Z(#!P=#L@34%21TE.+5))1TA4
M.B`P<'0[('1E>'0M86QI9VXZ(&IU<W1I9GD[(%1%6%0M24Y$14Y4.B`P<'0G
M/B`F;F)S<#L\+V1I=CX@/&1I=CX@/'1A8FQE('-T>6QE/3-$)T9/3E0M4TE:
M13H@,3!P=#L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;B<@8V5L;'-P
M86-I;F<],T0P(&-E;&QP861D:6YG/3-$,"!W:61T:#TS1#$P,"4@86QI9VX]
M,T1C96YT97(@8F]R9&5R/3-$,#X@/'1R('9A;&EG;CTS1'1O<#X@/'1D('-T
M>6QE/3-$)U=)1%1(.B`Q.'!T)SX@/&1I=B!S='EL93TS1"=&3TY4+5-)6D4Z
M(#$P<'0[($9/3E0M1D%-24Q9.B!4:6UE<R!.97<@4F]M86X[($1)4U!,05DZ
M(&EN;&EN92<^("9N8G-P.SPO9&EV/B`\+W1D/B`\=&0^(#QD:78@<W1Y;&4]
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M;V8@2G5N929N8G-P.S,P+"`R,#$T+"!T:&4@0V]M<&%N>2!B96QI979E<R!T
M:&4@;&]S<V5S(&%S<V]C:6%T960@=VET:"!I=',@:6YV97-T;65N=',@87)E
M('1E;7!O<F%R>2!A;F0@;F\@:6UP86ER;65N="!L;W-S('=A<R!R96-O9VYI
M>F5D(&1U<FEN9R`R,#$T+B!(;W=E=F5R+"!T:&4@0V]M<&%N>2!C86X@<')O
M=FED92!N;R!A<W-U<F%N8V4@=&AA="!I="!W:6QL(')E8V]V97(@9&5C;&EN
M97,@:6X@=&AE(&UA<FME="!V86QU92!O9B!I=',@:6YV97-T;65N=',N/"]D
M:78^(#PO=&0^(#PO='(^(#PO=&%B;&4^(#PO9&EV/B`\9&EV('-T>6QE/3-$
M)T1)4U!,05DZ(&)L;V-K.R!-05)'24XM3$5&5#H@,'!T.R!-05)'24XM4DE'
M2%0Z(#!P=#L@=&5X="UA;&EG;CH@:G5S=&EF>3L@5$585"U)3D1%3E0Z(#!P
M="<^("9N8G-P.SPO9&EV/B`\9&EV('-T>6QE/3-$)W1E>'0M86QI9VXZ(&-E
M;G1E<B<^(#QT86)L92!S='EL93TS1"=&3TY4+5-)6D4Z(#$P<'0[($9/3E0M
M1D%-24Q9.B!T:6UE<R!N97<@<F]M86XG(&-E;&QS<&%C:6YG/3-$,"!C96QL
M<&%D9&EN9STS1#`@=VED=&@],T0Q,#`E(&)O<F1E<CTS1#`^(#QT<B!V86QI
M9VX],T1T;W`^(#QT9"!S='EL93TS1"=724142#H@,3=P="<^(#QD:78@<W1Y
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M(#PO=&%B;&4^(#PO9&EV/B`\9&EV('-T>6QE/3-$)T1)4U!,05DZ(&)L;V-K
M.R!-05)'24XM3$5&5#H@,'!T.R!-05)'24XM4DE'2%0Z(#!P=#L@=&5X="UA
M;&EG;CH@:G5S=&EF>3L@5$585"U)3D1%3E0Z(#!P="<^("9N8G-P.SPO9&EV
M/B`\9&EV/B`\=&%B;&4@<W1Y;&4],T0G1D].5"U325I%.B`Q,'!T.R!&3TY4
M+49!34E,63H@=&EM97,@;F5W(')O;6%N)R!C96QL<W!A8VEN9STS1#`@8V5L
M;'!A9&1I;F<],T0P('=I9'1H/3-$,3`P)2!A;&EG;CTS1&-E;G1E<B!B;W)D
M97(],T0P/B`\='(@=F%L:6=N/3-$=&]P/B`\=&0@<W1Y;&4],T0G5TE$5$@Z
M(#$Y<'0G/B`\9&EV('-T>6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@1D].5"U&
M04U)3%DZ(%1I;65S($YE=R!2;VUA;CL@1$E34$Q!63H@:6YL:6YE)SX@)FYB
M<W`[/"]D:78^(#PO=&0^(#QT9#X@/&1I=B!S='EL93TS1"=$25-03$%9.B!I
M;FQI;F4[($9/3E0M1D%-24Q9.B!4:6UE<R!.97<@4F]M86X[($9/3E0M4TE:
M13H@,3!P=#L@=&5X="UA;&EG;CH@:G5S=&EF>2<^(%1H92!3=6)S:61I87)Y
M)B,S.3MS(&QI86)I;&ET>2!F;W(@<V5V97)A;F-E('!A>2!I<R!C86QC=6QA
M=&5D('!U<G-U86YT('1O($ES<F%E;&D@4V5V97)A;F-E(%!A>2!,87<L(#$Y
M-C,@*'1H92`B4V5V97)A;F-E(%!A>2!,87<B*29N8G-P.R9N8G-P.V)A<V5D
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M3%DZ(%1I;65S($YE=R!2;VUA;CL@1D].5"U325I%.B`Q,'!T.R!-05)'24XM
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M:78^(#PO=&0^(#PO='(^(#PO=&%B;&4^(#PO9&EV/B`\9&EV('-T>6QE/3-$
M)T1)4U!,05DZ(&)L;V-K.R!-05)'24XM3$5&5#H@,'!T.R!-05)'24XM4DE'
M2%0Z(#!P=#L@=&5X="UA;&EG;CH@:G5S=&EF>3L@5$585"U)3D1%3E0Z(#!P
M="<^("9N8G-P.SPO9&EV/B`\9&EV/B`\=&%B;&4@<W1Y;&4],T0G1D].5"U3
M25I%.B`Q,'!T.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N)R!C96QL
M<W!A8VEN9STS1#`@8V5L;'!A9&1I;F<],T0P('=I9'1H/3-$,3`P)2!A;&EG
M;CTS1&-E;G1E<B!B;W)D97(],T0P/B`\='(@=F%L:6=N/3-$=&]P/B`\=&0@
M<W1Y;&4],T0G5TE$5$@Z(#$Y<'0G/B`\9&EV('-T>6QE/3-$)T9/3E0M4TE:
M13H@,3!P=#L@1D].5"U&04U)3%DZ(%1I;65S($YE=R!2;VUA;CL@1$E34$Q!
M63H@:6YL:6YE)SX@)FYB<W`[/"]D:78^(#PO=&0^(#QT9#X@/&1I=B!S='EL
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M;&4],T0G1$E34$Q!63H@8FQO8VL[($U!4D=)3BU,1494.B`P<'0[($U!4D=)
M3BU224=(5#H@,'!T.R!T97AT+6%L:6=N.B!J=7-T:69Y.R!415A4+4E.1$5.
M5#H@,'!T)SX@)FYB<W`[/"]D:78^(#QD:78@<W1Y;&4],T0G1$E34$Q!63H@
M8FQO8VL[($9/3E0M1D%-24Q9.B!4:6UE<R!.97<@4F]M86X[($9/3E0M4TE:
M13H@,3!P=#L@34%21TE.+4Q%1E0Z(#$X<'0[($U!4D=)3BU224=(5#H@,'!T
M.R!T97AT+6%L:6=N.B!L969T.R!415A4+4E.1$5.5#H@,'!T)SX@4VEN8V4@
M3F]V96UB97(@,C`Q,2P@=&AE($-O;7!A;GDF(S,Y.W,@86=R965M96YT<R!W
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M($U!4D=)3BU,1494.B`P<'0[($U!4D=)3BU224=(5#H@,'!T.R!T97AT+6%L
M:6=N.B!J=7-T:69Y.R!415A4+4E.1$5.5#H@,'!T)SX@)FYB<W`[/"]D:78^
M(#QD:78^(#QT86)L92!S='EL93TS1"=&3TY4+5-)6D4Z(#$P<'0[($9/3E0M
M1D%-24Q9.B!T:6UE<R!N97<@<F]M86XG(&-E;&QS<&%C:6YG/3-$,"!C96QL
M<&%D9&EN9STS1#`@=VED=&@],T0Q,#`E(&%L:6=N/3-$8V5N=&5R(&)O<F1E
M<CTS1#`^(#QT<B!V86QI9VX],T1T;W`^(#QT9"!S='EL93TS1"=724142#H@
M,3EP="<^(#QD:78@<W1Y;&4],T0G1D].5"U325I%.B`Q,'!T.R!&3TY4+49!
M34E,63H@5&EM97,@3F5W(%)O;6%N.R!$25-03$%9.B!I;FQI;F4G/B`F;F)S
M<#L\+V1I=CX@/"]T9#X@/'1D/B`\9&EV('-T>6QE/3-$)T1)4U!,05DZ(&EN
M;&EN93L@1D].5"U&04U)3%DZ(%1I;65S($YE=R!2;VUA;CL@1D].5"U325I%
M.B`Q,'!T.R!T97AT+6%L:6=N.B!J=7-T:69Y)SX@4V5V97)A;F-E(&5X<&5N
M<V5S(&9O<B!T:&4@>65A<G,@96YD960@1&5C96UB97(@,S$L(#(P,30L(#(P
M,3,@86YD(#(P,3(L('=E<F4@)#4S-"P@)#,R.2!A;F0@)#(W-2P@<F5S<&5C
M=&EV96QY+CPO9&EV/B`\+W1D/B`\+W1R/B`\+W1A8FQE/B`\+V1I=CX@/&1I
M=B!S='EL93TS1"=$25-03$%9.B!B;&]C:SL@34%21TE.+4Q%1E0Z(#!P=#L@
M34%21TE.+5))1TA4.B`P<'0[('1E>'0M86QI9VXZ(&IU<W1I9GD[(%1%6%0M
M24Y$14Y4.B`P<'0G/B`F;F)S<#L\+V1I=CX@/&1I=B!S='EL93TS1"=T97AT
M+6%L:6=N.B!C96YT97(G/B`\=&%B;&4@<W1Y;&4],T0G1D].5"U325I%.B`Q
M,'!T.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N)R!C96QL<W!A8VEN
M9STS1#`@8V5L;'!A9&1I;F<],T0P('=I9'1H/3-$,3`P)2!B;W)D97(],T0P
M/B`\='(@=F%L:6=N/3-$=&]P/B`\=&0@<W1Y;&4],T0G5TE$5$@Z(#$X<'0G
M/B`\9&EV('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ
M('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T.R!&3TY4+5=%24=(
M5#H@8F]L9#L@34%21TE.+4Q%1E0Z(#!P=#L@34%21TE.+5))1TA4.B`P<'0[
M(%1%6%0M24Y$14Y4.B`P<'0G/B!R+CPO9&EV/B`\+W1D/B`\=&0^(#QD:78@
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M.B`P<'0[($U!4D=)3BU224=(5#H@,'!T.R!T97AT+6%L:6=N.B!J=7-T:69Y
M.R!415A4+4E.1$5.5#H@,'!T)SX@)FYB<W`[/"]D:78^(#QD:78^(#QT86)L
M92!S='EL93TS1"=&3TY4+5-)6D4Z(#$P<'0[($9/3E0M1D%-24Q9.B!T:6UE
M<R!N97<@<F]M86XG(&-E;&QS<&%C:6YG/3-$,"!C96QL<&%D9&EN9STS1#`@
M=VED=&@],T0Q,#`E(&%L:6=N/3-$8V5N=&5R(&)O<F1E<CTS1#`^(#QT<B!V
M86QI9VX],T1T;W`^(#QT9"!S='EL93TS1"=724142#H@,3EP="<^(#QD:78@
M<W1Y;&4],T0G1D].5"U325I%.B`Q,'!T.R!&3TY4+49!34E,63H@5&EM97,@
M3F5W(%)O;6%N.R!$25-03$%9.B!I;FQI;F4G/B`F;F)S<#L\+V1I=CX@/"]T
M9#X@/'1D/B`\9&EV('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&
M04U)3%DZ(%1I;65S($YE=R!2;VUA;CL@1D].5"U325I%.B`Q,'!T.R!T97AT
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M8VL[($U!4D=)3BU,1494.B`P<'0[($U!4D=)3BU224=(5#H@,'!T.R!T97AT
M+6%L:6=N.B!J=7-T:69Y.R!415A4+4E.1$5.5#H@,'!T)SX@)FYB<W`[/"]D
M:78^(#QD:78^(#QT86)L92!S='EL93TS1"=&3TY4+5-)6D4Z(#$P<'0[($9/
M3E0M1D%-24Q9.B!T:6UE<R!N97<@<F]M86XG(&-E;&QS<&%C:6YG/3-$,"!C
M96QL<&%D9&EN9STS1#`@=VED=&@],T0Q,#`E(&%L:6=N/3-$8V5N=&5R(&)O
M<F1E<CTS1#`^(#QT<B!V86QI9VX],T1T;W`^(#QT9"!S='EL93TS1"=72414
M2#H@,3EP="<^(#QD:78@<W1Y;&4],T0G1D].5"U325I%.B`Q,'!T.R!&3TY4
M+49!34E,63H@5&EM97,@3F5W(%)O;6%N.R!$25-03$%9.B!I;FQI;F4G/B`F
M;F)S<#L\+V1I=CX@/"]T9#X@/'1D/B`\9&EV('-T>6QE/3-$)T1)4U!,05DZ
M(&EN;&EN93L@1D].5"U&04U)3%DZ(%1I;65S($YE=R!2;VUA;CL@1D].5"U3
M25I%.B`Q,'!T.R!T97AT+6%L:6=N.B!J=7-T:69Y)SX@5&AE($-O;7!A;GD@
M;65A<W5R97,@:71S(&EN=F5S=&UE;G1S(&EN(&UA<FME=&%B;&4@<V5C=7)I
M=&EE<R!A;F0@9&5R:79A=&EV92!I;G-T<G5M96YT<R!A="!F86ER('9A;'5E
M('5N9&5R($%30R`X,C`L(")&86ER(%9A;'5E($UE87-U<F5M96YT<R!A;F0@
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M(#PO9&EV/B`\9&EV('-T>6QE/3-$)T1)4U!,05DZ(&)L;V-K.R!-05)'24XM
M3$5&5#H@,'!T.R!-05)'24XM4DE'2%0Z(#!P=#L@=&5X="UA;&EG;CH@:G5S
M=&EF>3L@5$585"U)3D1%3E0Z(#!P="<^("9N8G-P.SPO9&EV/B`\9&EV/B`\
M=&%B;&4@<W1Y;&4],T0G1D].5"U325I%.B`Q,'!T.R!&3TY4+49!34E,63H@
M=&EM97,@;F5W(')O;6%N)R!C96QL<W!A8VEN9STS1#`@8V5L;'!A9&1I;F<]
M,T0P('=I9'1H/3-$,3`P)2!A;&EG;CTS1&-E;G1E<B!B;W)D97(],T0P/B`\
M='(@=F%L:6=N/3-$=&]P/B`\=&0@<W1Y;&4],T0G5TE$5$@Z(#$Y<'0G/B`\
M9&EV('-T>6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ(%1I
M;65S($YE=R!2;VUA;CL@1$E34$Q!63H@:6YL:6YE)SX@)FYB<W`[/"]D:78^
M(#PO=&0^(#QT9#X@/&1I=B!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/
M3E0M1D%-24Q9.B!4:6UE<R!.97<@4F]M86X[($9/3E0M4TE:13H@,3!P=#L@
M=&5X="UA;&EG;CH@:G5S=&EF>2<^(#QF;VYT('-T>6QE/3-$)T9/3E0M5T5)
M1TA4.B!B;VQD.R!$25-03$%9.B!I;FQI;F4G/DQE=F5L(#$@+3PO9F]N=#X@
M475O=&5D('!R:6-E<R`H=6YA9&IU<W1E9"D@:6X@86-T:79E(&UA<FME=',@
M9F]R(&ED96YT:6-A;"!A<W-E=',@;W(@;&EA8FEL:71I97,@=&AA="!T:&4@
M0V]M<&%N>2!C86X@86-C97-S(&%T('1H92!M96%S=7)E;65N="!D871E.SPO
M9&EV/B`\+W1D/B`\+W1R/B`\+W1A8FQE/B`\+V1I=CX@/&1I=B!S='EL93TS
M1"=$25-03$%9.B!B;&]C:SL@34%21TE.+4Q%1E0Z(#!P=#L@34%21TE.+5))
M1TA4.B`P<'0[('1E>'0M86QI9VXZ(&IU<W1I9GD[(%1%6%0M24Y$14Y4.B`P
M<'0G/B`F;F)S<#L\+V1I=CX@/&1I=CX@/'1A8FQE('-T>6QE/3-$)T9/3E0M
M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;B<@8V5L
M;'-P86-I;F<],T0P(&-E;&QP861D:6YG/3-$,"!W:61T:#TS1#$P,"4@86QI
M9VX],T1C96YT97(@8F]R9&5R/3-$,#X@/'1R('9A;&EG;CTS1'1O<#X@/'1D
M('-T>6QE/3-$)U=)1%1(.B`Q.7!T)SX@/&1I=B!S='EL93TS1"=&3TY4+5-)
M6D4Z(#$P<'0[($9/3E0M1D%-24Q9.B!4:6UE<R!.97<@4F]M86X[($1)4U!,
M05DZ(&EN;&EN92<^("9N8G-P.SPO9&EV/B`\+W1D/B`\=&0^(#QD:78@<W1Y
M;&4],T0G1$E34$Q!63H@:6YL:6YE.R!&3TY4+49!34E,63H@5&EM97,@3F5W
M(%)O;6%N.R!&3TY4+5-)6D4Z(#$P<'0[('1E>'0M86QI9VXZ(&IU<W1I9GDG
M/B`\9F]N="!S='EL93TS1"=&3TY4+5=%24=(5#H@8F]L9#L@1$E34$Q!63H@
M:6YL:6YE)SY,979E;"`R("T\+V9O;G0^($EN<'5T<R!O=&AE<B!T:&%N('%U
M;W1E9"!P<FEC97,@:6YC;'5D960@=VET:&EN($QE=F5L(#$@=&AA="!A<F4@
M;V)S97)V86)L92!F;W(@=&AE(&%S<V5T(&]R(&QI86)I;&ET>2P@96ET:&5R
M(&1I<F5C=&QY(&]R(&EN9&ER96-T;'DN.R!A;F0\+V1I=CX@/"]T9#X@/"]T
M<CX@/"]T86)L93X@/"]D:78^(#QD:78@<W1Y;&4],T0G1$E34$Q!63H@8FQO
M8VL[($U!4D=)3BU,1494.B`P<'0[($U!4D=)3BU224=(5#H@,'!T.R!T97AT
M+6%L:6=N.B!J=7-T:69Y.R!415A4+4E.1$5.5#H@,'!T)SX@)FYB<W`[/"]D
M:78^(#QD:78^(#QT86)L92!S='EL93TS1"=&3TY4+5-)6D4Z(#$P<'0[($9/
M3E0M1D%-24Q9.B!T:6UE<R!N97<@<F]M86XG(&-E;&QS<&%C:6YG/3-$,"!C
M96QL<&%D9&EN9STS1#`@=VED=&@],T0Q,#`E(&%L:6=N/3-$8V5N=&5R(&)O
M<F1E<CTS1#`^(#QT<B!V86QI9VX],T1T;W`^(#QT9"!S='EL93TS1"=72414
M2#H@,3EP="<^(#QD:78@<W1Y;&4],T0G1D].5"U325I%.B`Q,'!T.R!&3TY4
M+49!34E,63H@5&EM97,@3F5W(%)O;6%N.R!$25-03$%9.B!I;FQI;F4G/B`F
M;F)S<#L\+V1I=CX@/"]T9#X@/'1D/B`\9&EV('-T>6QE/3-$)T1)4U!,05DZ
M(&EN;&EN93L@1D].5"U&04U)3%DZ(%1I;65S($YE=R!2;VUA;CL@1D].5"U3
M25I%.B`Q,'!T.R!T97AT+6%L:6=N.B!J=7-T:69Y)SX@/&9O;G0@<W1Y;&4]
M,T0G1D].5"U714E'2%0Z(&)O;&0[($1)4U!,05DZ(&EN;&EN92<^3&5V96P@
M,R`M/"]F;VYT/B!5;F]B<V5R=F%B;&4@:6YP=71S(&9O<B!T:&4@87-S970@
M;W(@;&EA8FEL:71Y+CPO9&EV/B`\+W1D/B`\+W1R/B`\+W1A8FQE/B`\+V1I
M=CX@/&1I=B!S='EL93TS1"=$25-03$%9.B!B;&]C:SL@34%21TE.+4Q%1E0Z
M(#!P=#L@34%21TE.+5))1TA4.B`P<'0[('1E>'0M86QI9VXZ(&IU<W1I9GD[
M(%1%6%0M24Y$14Y4.B`P<'0G/B`F;F)S<#L\+V1I=CX@/&1I=CX@/'1A8FQE
M('-T>6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ('1I;65S
M(&YE=R!R;VUA;B<@8V5L;'-P86-I;F<],T0P(&-E;&QP861D:6YG/3-$,"!W
M:61T:#TS1#$P,"4@86QI9VX],T1C96YT97(@8F]R9&5R/3-$,#X@/'1R('9A
M;&EG;CTS1'1O<#X@/'1D('-T>6QE/3-$)U=)1%1(.B`Q.7!T)SX@/&1I=B!S
M='EL93TS1"=&3TY4+5-)6D4Z(#$P<'0[($9/3E0M1D%-24Q9.B!4:6UE<R!.
M97<@4F]M86X[($1)4U!,05DZ(&EN;&EN92<^("9N8G-P.SPO9&EV/B`\+W1D
M/B`\=&0^(#QD:78@<W1Y;&4],T0G1$E34$Q!63H@:6YL:6YE.R!&3TY4+49!
M34E,63H@5&EM97,@3F5W(%)O;6%N.R!&3TY4+5-)6D4Z(#$P<'0[('1E>'0M
M86QI9VXZ(&IU<W1I9GDG/B!4:&4@9F%I<B!V86QU92!H:65R87)C:'D@86QS
M;R!R97%U:7)E<R!A;B!E;G1I='D@=&\@;6%X:6UI>F4@=&AE('5S92!O9B!O
M8G-E<G9A8FQE(&EN<'5T<R!A;F0@;6EN:6UI>F4@=&AE('5S92!O9B!U;F]B
M<V5R=F%B;&4@:6YP=71S('=H96X@;65A<W5R:6YG(&9A:7(@=F%L=64N(%1H
M92!#;VUP86YY(&-A=&5G;W)I>F5D(&5A8V@@;V8@:71S(&9A:7(@=F%L=64@
M;65A<W5R96UE;G1S(&EN(&]N92!O9B!T:&5S92!T:')E92!L979E;',@;V8@
M:&EE<F%R8VAY+CPO9&EV/B`\+W1D/B`\+W1R/B`\+W1A8FQE/B`\+V1I=CX@
M/&1I=B!S='EL93TS1"=$25-03$%9.B!B;&]C:SL@34%21TE.+4Q%1E0Z(#!P
M=#L@34%21TE.+5))1TA4.B`P<'0[('1E>'0M86QI9VXZ(&IU<W1I9GD[(%1%
M6%0M24Y$14Y4.B`P<'0G/B`F;F)S<#L\+V1I=CX@/&1I=B!S='EL93TS1"=T
M97AT+6%L:6=N.B!C96YT97(G/B`\=&%B;&4@<W1Y;&4],T0G1D].5"U325I%
M.B`Q,'!T.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N)R!C96QL<W!A
M8VEN9STS1#`@8V5L;'!A9&1I;F<],T0P('=I9'1H/3-$,3`P)2!B;W)D97(]
M,T0P/B`\='(@=F%L:6=N/3-$=&]P/B`\=&0@<W1Y;&4],T0G5TE$5$@Z(#$X
M<'0G/B`\9&EV('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)
M3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T.R!&3TY4+5=%
M24=(5#H@8F]L9#L@34%21TE.+4Q%1E0Z(#!P=#L@34%21TE.+5))1TA4.B`P
M<'0[(%1%6%0M24Y$14Y4.B`P<'0G/B!S+CPO9&EV/B`\+W1D/B`\=&0^(#QD
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M1E0Z(#!P=#L@34%21TE.+5))1TA4.B`P<'0[('1E>'0M86QI9VXZ(&IU<W1I
M9GD[(%1%6%0M24Y$14Y4.B`P<'0G/B`F;F)S<#L\+V1I=CX@/&1I=B!S='EL
M93TS1"=$25-03$%9.B!B;&]C:SL@1D].5"U&04U)3%DZ(%1I;65S($YE=R!2
M;VUA;CL@1D].5"U325I%.B`Q,'!T.R!-05)'24XM3$5&5#H@,3AP=#L@34%2
M1TE.+5))1TA4.B`P<'0[('1E>'0M86QI9VXZ(&IU<W1I9GD[(%1%6%0M24Y$
M14Y4.B`P<'0G/B!4:&4@0V]M<&%N>2!U<V5S(&9O<G=A<F0@8V]N=')A8W1S
M(&%N9"!O<'1I;VYS('-T<F%T96=I97,@*")D97)I=F%T:79E(&EN<W1R=6UE
M;G1S(BD@<')I;6%R:6QY('1O(&UA;F%G92!E>'!O<W5R92!T;R!F;W)E:6=N
M(&-U<G)E;F-Y+B!4:&4@0V]M<&%N>2!A8V-O=6YT<R!F;W(@9&5R:79A=&EV
M97,@86YD(&AE9&=I;F<@8F%S960@;VX@05-#(#@Q-2P@(D1E<FEV871I=F5S
M(&%N9"!(961G:6YG(B`H(D%30R`X,34B*2X@05-#(#@Q-2!R97%U:7)E<R!T
M:&4@0V]M<&%N>2!T;R!R96-O9VYI>F4@86QL(&1E<FEV871I=F4@:6YS=')U
M;65N=',@87,@96ET:&5R(&%S<V5T<R!O<B!L:6%B:6QI=&EE<R!O;B!T:&4@
M8F%L86YC92!S:&5E="!A="!F86ER('9A;'5E+B!4:&4@86-C;W5N=&EN9R!F
M;W(@8VAA;F=E<R!I;B!T:&4@9F%I<B!V86QU92`H:2YE+BP@9V%I;G,@;W(@
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M(#!P=#L@34%21TE.+5))1TA4.B`P<'0[('1E>'0M86QI9VXZ(&IU<W1I9GD[
M(%1%6%0M24Y$14Y4.B`P<'0G/B`F;F)S<#L\+V1I=CX@/&1I=B!S='EL93TS
M1"=$25-03$%9.B!B;&]C:SL@1D].5"U&04U)3%DZ(%1I;65S($YE=R!2;VUA
M;CL@1D].5"U325I%.B`Q,'!T.R!-05)'24XM3$5&5#H@,3AP=#L@34%21TE.
M+5))1TA4.B`P<'0[('1E>'0M86QI9VXZ(&IU<W1I9GD[(%1%6%0M24Y$14Y4
M.B`P<'0G/B!)9B!T:&4@9&5R:79A=&EV92!I;G-T<G5M96YT<R!M965T('1H
M92!D969I;FET:6]N(&]F(&$@:&5D9V4@86YD(&%R92!S;R!D97-I9VYA=&5D
M+"!D97!E;F1I;F<@;VX@=&AE(&YA='5R92!O9B!T:&4@:&5D9V4L(&-H86YG
M97,@:6X@=&AE(&9A:7(@=F%L=64@;V8@<W5C:"!D97)I=F%T:79E<R!W:6QL
M(&5I=&AE<B!B92!O9F9S970@86=A:6YS="!T:&4@8VAA;F=E(&EN(&9A:7(@
M=F%L=64@;V8@=&AE(&AE9&=E9"!A<W-E=',L(&QI86)I;&ET:65S+"!O<B!F
M:7)M(&-O;6UI=&UE;G1S('1H<F]U9V@@96%R;FEN9W,L(&]R(')E8V]G;FEZ
M960@:6X@;W1H97(@8V]M<')E:&5N<VEV92!I;F-O;64@=6YT:6P@=&AE(&AE
M9&=E9"!I=&5M(&ES(')E8V]G;FEZ960@:6X@=&AE('-T871E;65N="!O9B!O
M<&5R871I;VYS+CQF;VYT('-T>6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@1$E3
M4$Q!63H@:6YL:6YE)SXF;F)S<#L\+V9O;G0^(%1H92!I;F5F9F5C=&EV92!P
M;W)T:6]N(&]F(&$@9&5R:79A=&EV928C,SD[<R!C:&%N9V4@:6X@9F%I<B!V
M86QU92!I<R!R96-O9VYI>F5D(&EN('1H92!S=&%T96UE;G0@;V8@;W!E<F%T
M:6]N<RX\+V1I=CX@/&1I=B!S='EL93TS1"=$25-03$%9.B!B;&]C:SL@34%2
M1TE.+4Q%1E0Z(#!P=#L@34%21TE.+5))1TA4.B`P<'0[('1E>'0M86QI9VXZ
M(&IU<W1I9GD[(%1%6%0M24Y$14Y4.B`P<'0G/B`F;F)S<#L\+V1I=CX@/&1I
M=B!S='EL93TS1"=$25-03$%9.B!B;&]C:SL@1D].5"U&04U)3%DZ(%1I;65S
M($YE=R!2;VUA;CL@1D].5"U325I%.B`Q,'!T.R!-05)'24XM3$5&5#H@,3AP
M=#L@34%21TE.+5))1TA4.B`P<'0[('1E>'0M86QI9VXZ(&IU<W1I9GD[(%1%
M6%0M24Y$14Y4.B`P<'0G/B`\9F]N="!S='EL93TS1"=&3TY4+49!34E,63H@
M5&EM97,@3F5W(%)O;6%N.R!&3TY4+5-464Q%.B!I=&%L:6,[($1)4U!,05DZ
M(&EN;&EN92<^($-A<V@@1FQO=R!(961G97,\+V9O;G0^+B!4:&4@0V]M<&%N
M>2!E;G1E<F5D(&EN=&\@9F]R=V%R9"!C;VYT<F%C=',@=&\@:&5D9V4@86=A
M:6YS="!T:&4@<FES:R!O9B!O=F5R86QL(&-H86YG97,@:6X@9G5T=7)E(&-A
M<V@@9FQO=R!F<F]M('!A>6UE;G1S(&]F('!A>7)O;&P@86YD(')E;&%T960@
M97AP96YS97,@9&5N;VUI;F%T960@:6X@3F5W($ES<F%E;&D@4VAE:V5L<R`H
M3DE3*2X@5&AE($-O;7!A;GD@;65A<W5R960@=&AE(&9A:7(@=F%L=64@;V8@
M=&AE(&-O;G1R86-T<R!I;B!A8V-O<F1A;F-E('=I=&@@05-#(#@R,"`H8VQA
M<W-I9FEE9"!A<R!L979E;"`R*2X@5&AE(&=A:6X@;W(@;&]S<R!O;B!T:&4@
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M:69I960@:6YT;R`B1FEN86YC:6%L(&EN8V]M92P@;F5T(BP@:68@=&AE(&AE
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M=&5L>2X@07,@;V8@2G5N92`S,"P@,C`Q-"P@=&AE($-O;7!A;GD@:&%D(&9O
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M;G,@9'5R:6YG('1H92!Y96%R(&5N9&5D($IU;F4@,S`L(#(P,30L(')E<W5L
M=&EN9R!F<F]M('1H92!C87-H(&9L;W<@:&5D9V4@=')A;G-A8W1I;VYS+"9N
M8G-P.R9N8G-P.V%M;W5N=&5D('1O(&%P<')O>&EM871E;'D@)#0X+B!4:&4@
M9F]R=V%R9"!C;VYT<F%C=',@;VX@=&AE($-O;7!A;GDF(S,Y.W,@9G5T=7)E
M($Y)4R!P87ER;VQL(&%N9"!R96QA=&5D(&5X<&5N<V5S('=I;&P@<V5T=&QE
M(&)Y($1E8V5M8F5R(#(P,30N($]N($IU;F4@,S`L(#(P,3,L('1H92!#;VUP
M86YY(&1I9"!N;W0@:&%V92!C;VYT<F%C=',@9&5S:6=N871E9"!A;F0@<75A
M;&EF:65S(&%S(&-A<V@@9FQO=R!H961G92X\+V1I=CX@/&1I=B!S='EL93TS
M1"=-05)'24XM3$5&5#H@-#,W<'0[($1)4U!,05DZ(&)L;V-K.R!415A4+4E.
M1$5.5#H@,'!T)SX@/&)R("\^(#PO9&EV/B`\9&EV('-T>6QE/3-$)T1)4U!,
M05DZ(&)L;V-K.R!&3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N.R!&3TY4
M+5-)6D4Z(#$P<'0[($U!4D=)3BU,1494.B`Q.'!T.R!-05)'24XM4DE'2%0Z
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M;&]S<V5S(&]N('1H97-E(&-O;G1R86-T<R!A<F4@<F5C;V=N:7IE9"!I;B`B
M1FEN86YC:6%L(&EN8V]M92P@;F5T(BP@86QO;F<@=VET:"!T:&4@;V9F<V5T
M=&EN9R!L;W-S97,@86YD(&=A:6YS(&]F('1H92!R96QA=&5D(&AE9&=E9"!I
M=&5M<RX\+V1I=CX@/&1I=B!S='EL93TS1"=$25-03$%9.B!B;&]C:SL@34%2
M1TE.+4Q%1E0Z(#$X<'0[($U!4D=)3BU224=(5#H@,'!T.R!T97AT+6%L:6=N
M.B!J=7-T:69Y.R!415A4+4E.1$5.5#H@,'!T)SX@)FYB<W`[/"]D:78^(#QD
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M=')A8W0@:7,@)#$Q+#`P,"!A<R!O9B!*=6YE(#,P+"`R,#$T('=I=&@@9F%I
M<B!V86QU92!O9B!A<'!R;WAI;6%T96QY("0H.#@Y*2X\+V1I=CX@/&1I=B!S
M='EL93TS1"=$25-03$%9.B!B;&]C:SL@34%21TE.+4Q%1E0Z(#$X<'0[($U!
M4D=)3BU224=(5#H@,'!T.R!T97AT+6%L:6=N.B!J=7-T:69Y.R!415A4+4E.
M1$5.5#H@,'!T)SX@)FYB<W`[/"]D:78^(#QD:78@<W1Y;&4],T0G1$E34$Q!
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M8FQO8VL[(%1%6%0M24Y$14Y4.B`P<'0G/CQB<B`O/B`\+V1I=CX@/&1I=B!S
M='EL93TS1"=$25-03$%9.B!B;&]C:SL@1D].5"U&04U)3%DZ(%1I;65S($YE
M=R!2;VUA;CL@1D].5"U325I%.B`Q,'!T.R!-05)'24XM3$5&5#H@,3AP=#L@
M34%21TE.+5))1TA4.B`P<'0[('1E>'0M86QI9VXZ(&IU<W1I9GD[(%1%6%0M
M24Y$14Y4.B`P<'0G/B`\9F]N="!S='EL93TS1"=&3TY4+49!34E,63H@5&EM
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M:6YG('1H92!Y96%R(&5N9&5D($IU;F4@,S`L(#(P,30L(#(P,3,@86YD(#(P
M,3(@=V5R92`H)#<P*2P@)#(S,2!A;F0@*"0Q-#4I+"!R97-P96-T:79E;'DN
M/"]D:78^(#QD:78@<W1Y;&4],T0G1$E34$Q!63H@8FQO8VL[(%1%6%0M24Y$
M14Y4.B`P<'0G/B9N8G-P.SPO9&EV/B`\9&EV('-T>6QE/3-$)W1E>'0M86QI
M9VXZ(&-E;G1E<B<^(#QT86)L92!S='EL93TS1"=&3TY4+5-)6D4Z(#$P<'0[
M($9/3E0M1D%-24Q9.B!T:6UE<R!N97<@<F]M86XG(&-E;&QS<&%C:6YG/3-$
M,"!C96QL<&%D9&EN9STS1#`@=VED=&@],T0Q,#`E(&)O<F1E<CTS1#`^(#QT
M<B!V86QI9VX],T1T;W`^(#QT9"!S='EL93TS1"=724142#H@,3AP="<^(#QD
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M/CPO9&EV/B`\+W1D/B`\+W1R/B`\+W1A8FQE/B`\+V1I=CX@/&1I=B!S='EL
M93TS1"=$25-03$%9.B!B;&]C:SL@34%21TE.+4Q%1E0Z(#!P=#L@34%21TE.
M+5))1TA4.B`P<'0[('1E>'0M86QI9VXZ(&IU<W1I9GD[(%1%6%0M24Y$14Y4
M.B`P<'0G/B`F;F)S<#L\+V1I=CX@/&1I=B!S='EL93TS1"=$25-03$%9.B!B
M;&]C:SL@1D].5"U&04U)3%DZ(%1I;65S($YE=R!2;VUA;CL@1D].5"U325I%
M.B`Q,'!T.R!-05)'24XM3$5&5#H@,3AP=#L@34%21TE.+5))1TA4.B`P<'0[
M('1E>'0M86QI9VXZ(&IU<W1I9GD[(%1%6%0M24Y$14Y4.B`P<'0G/B!4:&4@
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M:65S+CPO9&EV/B`\9&EV('-T>6QE/3-$)T1)4U!,05DZ(&)L;V-K.R!415A4
M+4E.1$5.5#H@,'!T)SXF;F)S<#L\+V1I=CX@/&1I=B!S='EL93TS1"=T97AT
M+6%L:6=N.B!R:6=H="<^(#QT86)L92!S='EL93TS1"=&3TY4+5-)6D4Z(#$P
M<'0[($9/3E0M1D%-24Q9.B!T:6UE<R!N97<@<F]M86XG(&-E;&QS<&%C:6YG
M/3-$,"!C96QL<&%D9&EN9STS1#`@=VED=&@],T0Y-R4^(#QT<CX@/'1D('-T
M>6QE/3-$)U!!1$1)3D<M0D]45$]-.B`R<'@G('9A;&EG;CTS1&)O='1O;2!W
M:61T:#TS1#8T)3X\9F]N="!S='EL93TS1"=&3TY4+5-)6D4Z(#$P<'0[($9/
M3E0M1D%-24Q9.B!T:6UE<R!N97<@<F]M86X[($1)4U!,05DZ(&EN;&EN92<^
M("9N8G-P.SPO9F]N=#X@/"]T9#X@/'1D('-T>6QE/3-$)U!!1$1)3D<M0D]4
M5$]-.B`R<'@G('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E/CQF;VYT('-T
M>6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ('1I;65S(&YE
M=R!R;VUA;CL@1$E34$Q!63H@:6YL:6YE)SX@)FYB<W`[/"]F;VYT/B`\+W1D
M/B`\=&0@<W1Y;&4],T0G0D]21$52+4)/5%1/33H@8FQA8VL@,G!X('-O;&ED
M)R!V86QI9VX],T1B;W1T;VT@=VED=&@],T0S-"4@8V]L<W!A;CTS1#$P/B`\
M9&EV('-T>6QE/3-$)T1)4U!,05DZ(&)L;V-K.R!&3TY4+49!34E,63H@=&EM
M97,@;F5W(')O;6%N.R!&3TY4+5-)6D4Z(#$P<'0[($U!4D=)3BU,1494.B`P
M<'0[($U!4D=)3BU224=(5#H@,'!T.R!T97AT+6%L:6=N.B!C96YT97([(%1%
M6%0M24Y$14Y4.B`P<'0G/B!996%R(&5N9&5D($IU;F4@,S`L(#(P,30\+V1I
M=CX@/"]T9#X@/'1D('-T>6QE/3-$)U!!1$1)3D<M0D]45$]-.B`R<'@[(%1%
M6%0M04Q)1TXZ(&QE9G0G('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E(&YO
M=W)A<#TS1&YO=W)A<#X\9F]N="!S='EL93TS1"=&3TY4+5-)6D4Z(#$P<'0[
M($9/3E0M1D%-24Q9.B!T:6UE<R!N97<@<F]M86X[($1)4U!,05DZ(&EN;&EN
M92<^("9N8G-P.SPO9F]N=#X@/"]T9#X@/"]T<CX@/'1R/B`\=&0@<W1Y;&4]
M,T0G4$%$1$E.1RU"3U143TTZ(#)P>"<@=F%L:6=N/3-$8F]T=&]M('=I9'1H
M/3-$-C0E/CQF;VYT('-T>6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@1D].5"U&
M04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1$E34$Q!63H@:6YL:6YE)SX@)FYB
M<W`[/"]F;VYT/B`\+W1D/B`\=&0@<W1Y;&4],T0G4$%$1$E.1RU"3U143TTZ
M(#)P>"<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24^/&9O;G0@<W1Y;&4]
M,T0G1D].5"U325I%.B`Q,'!T.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O
M;6%N.R!$25-03$%9.B!I;FQI;F4G/B`F;F)S<#L\+V9O;G0^(#PO=&0^(#QT
M9"!S='EL93TS1"="3U)$15(M0D]45$]-.B!B;&%C:R`R<'@@<V]L:60G('9A
M;&EG;CTS1&)O='1O;2!W:61T:#TS1#$P)2!C;VQS<&%N/3-$,CX@/&1I=B!S
M='EL93TS1"=$25-03$%9.B!B;&]C:SL@1D].5"U&04U)3%DZ('1I;65S(&YE
M=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T.R!-05)'24XM3$5&5#H@,'!T.R!-
M05)'24XM4DE'2%0Z(#!P=#L@=&5X="UA;&EG;CH@8V5N=&5R.R!415A4+4E.
M1$5.5#H@,'!T)SX@56YR96%L:7IE9#PO9&EV/B`\9&EV('-T>6QE/3-$)T1)
M4U!,05DZ(&)L;V-K.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!&
M3TY4+5-)6D4Z(#$P<'0[($U!4D=)3BU,1494.B`P<'0[($U!4D=)3BU224=(
M5#H@,'!T.R!T97AT+6%L:6=N.B!C96YT97([(%1%6%0M24Y$14Y4.B`P<'0G
M/B!G86EN<SPO9&EV/B`\9&EV('-T>6QE/3-$)T1)4U!,05DZ(&)L;V-K.R!&
M3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!&3TY4+5-)6D4Z(#$P<'0[
M($U!4D=)3BU,1494.B`P<'0[($U!4D=)3BU224=(5#H@,'!T.R!T97AT+6%L
M:6=N.B!C96YT97([(%1%6%0M24Y$14Y4.B`P<'0G/B!O;B!M87)K971A8FQE
M/"]D:78^(#QD:78@<W1Y;&4],T0G1$E34$Q!63H@8FQO8VL[($9/3E0M1D%-
M24Q9.B!T:6UE<R!N97<@<F]M86X[($9/3E0M4TE:13H@,3!P=#L@34%21TE.
M+4Q%1E0Z(#!P=#L@34%21TE.+5))1TA4.B`P<'0[('1E>'0M86QI9VXZ(&-E
M;G1E<CL@5$585"U)3D1%3E0Z(#!P="<^('-E8W5R:71I97,\+V1I=CX@/"]T
M9#X@/'1D('-T>6QE/3-$)U!!1$1)3D<M0D]45$]-.B`R<'@[(%1%6%0M04Q)
M1TXZ(&QE9G0G('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E(&YO=W)A<#TS
M1&YO=W)A<#X\9F]N="!S='EL93TS1"=&3TY4+5-)6D4Z(#$P<'0[($9/3E0M
M1D%-24Q9.B!T:6UE<R!N97<@<F]M86X[($1)4U!,05DZ(&EN;&EN92<^("9N
M8G-P.SPO9F]N=#X@/"]T9#X@/'1D('-T>6QE/3-$)U!!1$1)3D<M0D]45$]-
M.B`R<'@G('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E/CQF;VYT('-T>6QE
M/3-$)T9/3E0M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R
M;VUA;CL@1$E34$Q!63H@:6YL:6YE)SX@)FYB<W`[/"]F;VYT/B`\+W1D/B`\
M=&0@<W1Y;&4],T0G0D]21$52+4)/5%1/33H@8FQA8VL@,G!X('-O;&ED)R!V
M86QI9VX],T1B;W1T;VT@=VED=&@],T0Q,"4@8V]L<W!A;CTS1#(^(#QD:78@
M<W1Y;&4],T0G1$E34$Q!63H@8FQO8VL[($9/3E0M1D%-24Q9.B!T:6UE<R!N
M97<@<F]M86X[($9/3E0M4TE:13H@,3!P=#L@34%21TE.+4Q%1E0Z(#!P=#L@
M34%21TE.+5))1TA4.B`P<'0[('1E>'0M86QI9VXZ(&-E;G1E<CL@5$585"U)
M3D1%3E0Z(#!P="<^(%5N<F5A;&EZ960\+V1I=CX@/&1I=B!S='EL93TS1"=$
M25-03$%9.B!B;&]C:SL@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@
M1D].5"U325I%.B`Q,'!T.R!-05)'24XM3$5&5#H@,'!T.R!-05)'24XM4DE'
M2%0Z(#!P=#L@=&5X="UA;&EG;CH@8V5N=&5R.R!415A4+4E.1$5.5#H@,'!T
M)SX@9V%I;G,\+V1I=CX@/&1I=B!S='EL93TS1"=$25-03$%9.B!B;&]C:SL@
M1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T
M.R!-05)'24XM3$5&5#H@,'!T.R!-05)'24XM4DE'2%0Z(#!P=#L@=&5X="UA
M;&EG;CH@8V5N=&5R.R!415A4+4E.1$5.5#H@,'!T)SX@;VX@8V%S:"!F;&]W
M/"]D:78^(#QD:78@<W1Y;&4],T0G1$E34$Q!63H@8FQO8VL[($9/3E0M1D%-
M24Q9.B!T:6UE<R!N97<@<F]M86X[($9/3E0M4TE:13H@,3!P=#L@34%21TE.
M+4Q%1E0Z(#!P=#L@34%21TE.+5))1TA4.B`P<'0[('1E>'0M86QI9VXZ(&-E
M;G1E<CL@5$585"U)3D1%3E0Z(#!P="<^(&AE9&=E<SPO9&EV/B`\+W1D/B`\
M=&0@<W1Y;&4],T0G4$%$1$E.1RU"3U143TTZ(#)P>#L@5$585"U!3$E'3CH@
M;&5F="<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@;F]W<F%P/3-$;F]W
M<F%P/CQF;VYT('-T>6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@1D].5"U&04U)
M3%DZ('1I;65S(&YE=R!R;VUA;CL@1$E34$Q!63H@:6YL:6YE)SX@)FYB<W`[
M/"]F;VYT/B`\+W1D/B`\=&0@<W1Y;&4],T0G4$%$1$E.1RU"3U143TTZ(#)P
M>"<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24^/&9O;G0@<W1Y;&4],T0G
M1D].5"U325I%.B`Q,'!T.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N
M.R!$25-03$%9.B!I;FQI;F4G/B`F;F)S<#L\+V9O;G0^(#PO=&0^(#QT9"!S
M='EL93TS1"="3U)$15(M0D]45$]-.B!B;&%C:R`R<'@@<V]L:60G('9A;&EG
M;CTS1&)O='1O;2!W:61T:#TS1#$P)2!C;VQS<&%N/3-$,CX@/&1I=B!S='EL
M93TS1"=$25-03$%9.B!B;&]C:SL@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R
M;VUA;CL@1D].5"U325I%.B`Q,'!T.R!-05)'24XM3$5&5#H@,'!T.R!-05)'
M24XM4DE'2%0Z(#!P=#L@=&5X="UA;&EG;CH@8V5N=&5R.R!415A4+4E.1$5.
M5#H@,'!T)SX@5&]T86P\+V1I=CX@/"]T9#X@/'1D('-T>6QE/3-$)U!!1$1)
M3D<M0D]45$]-.B`R<'@[(%1%6%0M04Q)1TXZ(&QE9G0G('9A;&EG;CTS1&)O
M='1O;2!W:61T:#TS1#$E(&YO=W)A<#TS1&YO=W)A<#X\9F]N="!S='EL93TS
M1"=&3TY4+5-)6D4Z(#$P<'0[($9/3E0M1D%-24Q9.B!T:6UE<R!N97<@<F]M
M86X[($1)4U!,05DZ(&EN;&EN92<^("9N8G-P.SPO9F]N=#X@/"]T9#X@/"]T
M<CX@/'1R(&)G8V]L;W(],T0C8V-E969F/B`\=&0@<W1Y;&4],T0G5$585"U!
M3$E'3CH@;&5F=#L@34%21TE.+4Q%1E0Z(#!P=#L@34%21TE.+5))1TA4.B`P
M<'0[(%1%6%0M24Y$14Y4.B`P<'0G('9A;&EG;CTS1&)O='1O;2!W:61T:#TS
M1#8T)3X@/&1I=B!S='EL93TS1"=$25-03$%9.B!B;&]C:SL@1D].5"U&04U)
M3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T.R!-05)'24XM
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M<W`[/"]F;VYT/B`\+W1D/B`\=&0@<W1Y;&4],T0G1$E34$Q!63H@:6YL:6YE
M.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!&3TY4+5-)6D4Z(#$P
M<'0[(%1%6%0M04Q)1TXZ(&QE9G0G('9A;&EG;CTS1&)O='1O;2!W:61T:#TS
M1#$E/B0\+W1D/B`\=&0@<W1Y;&4],T0G1$E34$Q!63H@:6YL:6YE.R!&3TY4
M+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!&3TY4+5-)6D4Z(#$P<'0[(%1%
M6%0M04Q)1TXZ(')I9VAT)R!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Y)3XR
M-3D\+W1D/B`\=&0@<W1Y;&4],T0G5$585"U!3$E'3CH@;&5F="<@=F%L:6=N
M/3-$8F]T=&]M('=I9'1H/3-$,24@;F]W<F%P/3-$;F]W<F%P/CQF;VYT('-T
M>6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ('1I;65S(&YE
M=R!R;VUA;CL@1$E34$Q!63H@:6YL:6YE)SX@)FYB<W`[/"]F;VYT/B`\+W1D
M/B`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@86QI9VX],T1R:6=H
M=#X\9F]N="!S='EL93TS1"=&3TY4+5-)6D4Z(#$P<'0[($9/3E0M1D%-24Q9
M.B!T:6UE<R!N97<@<F]M86X[($1)4U!,05DZ(&EN;&EN92<^("9N8G-P.SPO
M9F]N=#X@/"]T9#X@/'1D('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].
M5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T.R!4
M15A4+4%,24=..B!L969T)R!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)3XD
M/"]T9#X@/'1D('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)
M3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T.R!415A4+4%,
M24=..B!R:6=H="<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$.24^+3PO=&0^
M(#QT9"!S='EL93TS1"=415A4+4%,24=..B!L969T)R!V86QI9VX],T1B;W1T
M;VT@=VED=&@],T0Q)2!N;W=R87`],T1N;W=R87`^/&9O;G0@<W1Y;&4],T0G
M1D].5"U325I%.B`Q,'!T.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N
M.R!$25-03$%9.B!I;FQI;F4G/B`F;F)S<#L\+V9O;G0^(#PO=&0^(#QT9"!V
M86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)2!A;&EG;CTS1')I9VAT/CQF;VYT
M('-T>6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ('1I;65S
M(&YE=R!R;VUA;CL@1$E34$Q!63H@:6YL:6YE)SX@)FYB<W`[/"]F;VYT/B`\
M+W1D/B`\=&0@<W1Y;&4],T0G1$E34$Q!63H@:6YL:6YE.R!&3TY4+49!34E,
M63H@=&EM97,@;F5W(')O;6%N.R!&3TY4+5-)6D4Z(#$P<'0[(%1%6%0M04Q)
M1TXZ(&QE9G0G('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E/B0\+W1D/B`\
M=&0@<W1Y;&4],T0G1$E34$Q!63H@:6YL:6YE.R!&3TY4+49!34E,63H@=&EM
M97,@;F5W(')O;6%N.R!&3TY4+5-)6D4Z(#$P<'0[(%1%6%0M04Q)1TXZ(')I
M9VAT)R!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Y)3XR-3D\+W1D/B`\=&0@
M<W1Y;&4],T0G5$585"U!3$E'3CH@;&5F="<@=F%L:6=N/3-$8F]T=&]M('=I
M9'1H/3-$,24@;F]W<F%P/3-$;F]W<F%P/CQF;VYT('-T>6QE/3-$)T9/3E0M
M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1$E3
M4$Q!63H@:6YL:6YE)SX@)FYB<W`[/"]F;VYT/B`\+W1D/B`\+W1R/B`\='(@
M8F=C;VQO<CTS1'=H:71E/B`\=&0@<W1Y;&4],T0G5$585"U!3$E'3CH@;&5F
M=#L@34%21TE.+4Q%1E0Z(#!P=#L@34%21TE.+5))1TA4.B`P<'0[(%1%6%0M
M24Y$14Y4.B`P<'0G('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#8T)3X@/&1I
M=B!S='EL93TS1"=$25-03$%9.B!B;&]C:SL@1D].5"U&04U)3%DZ('1I;65S
M(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T.R!-05)'24XM3$5&5#H@,'!T
M.R!-05)'24XM4DE'2%0Z(#!P=#L@5$585"U!3$E'3CH@;&5F=#L@5$585"U)
M3D1%3E0Z(#!P="<^($]T:&5R(&-O;7!R96AE;G-I=F4@:6YC;VUE(&)E9F]R
M92!R96-L87-S:69I8V%T:6]N<SPO9&EV/B`\+W1D/B`\=&0@=F%L:6=N/3-$
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M)FYB<W`[/"]F;VYT/B`\+W1D/B`\=&0@<W1Y;&4],T0G1$E34$Q!63H@:6YL
M:6YE.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!&3TY4+5-)6D4Z
M(#$P<'0[(%1%6%0M04Q)1TXZ(')I9VAT)R!V86QI9VX],T1B;W1T;VT@=VED
M=&@],T0Y)3XS+#0P-#PO=&0^(#QT9"!S='EL93TS1"=415A4+4%,24=..B!L
M969T)R!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)2!N;W=R87`],T1N;W=R
M87`^/&9O;G0@<W1Y;&4],T0G1D].5"U325I%.B`Q,'!T.R!&3TY4+49!34E,
M63H@=&EM97,@;F5W(')O;6%N.R!$25-03$%9.B!I;FQI;F4G/B`F;F)S<#L\
M+V9O;G0^(#PO=&0^(#QT9"!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)2!A
M;&EG;CTS1')I9VAT/CQF;VYT('-T>6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@
M1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1$E34$Q!63H@:6YL:6YE
M)SX@)FYB<W`[/"]F;VYT/B`\+W1D/B`\=&0@<W1Y;&4],T0G5$585"U!3$E'
M3CH@;&5F="<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24^/&9O;G0@<W1Y
M;&4],T0G1D].5"U325I%.B`Q,'!T.R!&3TY4+49!34E,63H@=&EM97,@;F5W
M(')O;6%N.R!$25-03$%9.B!I;FQI;F4G/B`F;F)S<#L\+V9O;G0^(#PO=&0^
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M;&4],T0G1D].5"U325I%.B`Q,'!T.R!&3TY4+49!34E,63H@=&EM97,@;F5W
M(')O;6%N.R!$25-03$%9.B!I;FQI;F4G/B`F;F)S<#L\+V9O;G0^(#PO=&0^
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M25I%.B`Q,'!T.R!415A4+4%,24=..B!R:6=H="<@=F%L:6=N/3-$8F]T=&]M
M('=I9'1H/3-$.24^,RPT,C<\+W1D/B`\=&0@<W1Y;&4],T0G5$585"U!3$E'
M3CH@;&5F="<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@;F]W<F%P/3-$
M;F]W<F%P/CQF;VYT('-T>6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@1D].5"U&
M04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1$E34$Q!63H@:6YL:6YE)SX@)FYB
M<W`[/"]F;VYT/B`\+W1D/B`\+W1R/B`\='(@8F=C;VQO<CTS1"-C8V5E9F8^
M(#QT9"!S='EL93TS1"=415A4+4%,24=..B!L969T.R!-05)'24XM3$5&5#H@
M,'!T.R!-05)'24XM4DE'2%0Z(#!P=#L@5$585"U)3D1%3E0Z(#!P="<@=F%L
M:6=N/3-$8F]T=&]M('=I9'1H/3-$-C0E/B`\9&EV('-T>6QE/3-$)T1)4U!,
M05DZ(&)L;V-K.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!&3TY4
M+5-)6D4Z(#$P<'0[($U!4D=)3BU,1494.B`P<'0[($U!4D=)3BU224=(5#H@
M,'!T.R!415A4+4%,24=..B!L969T.R!415A4+4E.1$5.5#H@,'!T)SX@06UO
M=6YT<R!R96-L87-S:69I960@9G)O;2!A8V-U;75L871E9"!O=&AE<B!C;VUP
M<F5H96YS:79E(&QO<W,\+V1I=CX@/"]T9#X@/'1D('9A;&EG;CTS1&)O='1O
M;2!W:61T:#TS1#$E(&%L:6=N/3-$<FEG:'0^/&9O;G0@<W1Y;&4],T0G1D].
M5"U325I%.B`Q,'!T.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!$
M25-03$%9.B!I;FQI;F4G/B`F;F)S<#L\+V9O;G0^(#PO=&0^(#QT9"!S='EL
M93TS1"=415A4+4%,24=..B!L969T)R!V86QI9VX],T1B;W1T;VT@=VED=&@]
M,T0Q)3X\9F]N="!S='EL93TS1"=&3TY4+5-)6D4Z(#$P<'0[($9/3E0M1D%-
M24Q9.B!T:6UE<R!N97<@<F]M86X[($1)4U!,05DZ(&EN;&EN92<^("9N8G-P
M.SPO9F]N=#X@/"]T9#X@/'1D('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@
M1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T
M.R!415A4+4%,24=..B!R:6=H="<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$
M.24^*#<R-SPO=&0^(#QT9"!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/
M3E0M1D%-24Q9.B!T:6UE<R!N97<@<F]M86X[($9/3E0M4TE:13H@,3!P=#L@
M5$585"U!3$E'3CH@;&5F="<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@
M;F]W<F%P/3-$;F]W<F%P/BD\+W1D/B`\=&0@=F%L:6=N/3-$8F]T=&]M('=I
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M('1I;65S(&YE=R!R;VUA;CL@1$E34$Q!63H@:6YL:6YE)SX@)FYB<W`[/"]F
M;VYT/B`\+W1D/B`\=&0@<W1Y;&4],T0G1$E34$Q!63H@:6YL:6YE.R!&3TY4
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M/&9O;G0@<W1Y;&4],T0G1D].5"U325I%.B`Q,'!T.R!&3TY4+49!34E,63H@
M=&EM97,@;F5W(')O;6%N.R!$25-03$%9.B!I;FQI;F4G/B`F;F)S<#L\+V9O
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M;CL@1D].5"U325I%.B`Q,'!T.R!415A4+4%,24=..B!R:6=H="<@=F%L:6=N
M/3-$8F]T=&]M('=I9'1H/3-$.24^*#<R-SPO=&0^(#QT9"!S='EL93TS1"=$
M25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE<R!N97<@<F]M86X[
M($9/3E0M4TE:13H@,3!P=#L@5$585"U!3$E'3CH@;&5F="<@=F%L:6=N/3-$
M8F]T=&]M('=I9'1H/3-$,24@;F]W<F%P/3-$;F]W<F%P/BD\+W1D/B`\+W1R
M/B`\='(@8F=C;VQO<CTS1'=H:71E/B`\=&0@<W1Y;&4],T0G4$%$1$E.1RU"
M3U143TTZ(#)P>#L@5$585"U!3$E'3CH@;&5F=#L@34%21TE.+4Q%1E0Z(#!P
M=#L@34%21TE.+5))1TA4.B`P<'0[(%1%6%0M24Y$14Y4.B`P<'0G('9A;&EG
M;CTS1&)O='1O;2!W:61T:#TS1#8T)3X@/&1I=B!S='EL93TS1"=$25-03$%9
M.B!B;&]C:SL@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U3
M25I%.B`Q,'!T.R!-05)'24XM3$5&5#H@,'!T.R!-05)'24XM4DE'2%0Z(#!P
M=#L@5$585"U!3$E'3CH@;&5F=#L@5$585"U)3D1%3E0Z(#!P="<^($YE="!C
M=7)R96YT+7!E<FEO9"!O=&AE<B!C;VUP<F5H96YS:79E(&EN8V]M93PO9&EV
M/B`\+W1D/B`\=&0@<W1Y;&4],T0G4$%$1$E.1RU"3U143TTZ(#)P>"<@=F%L
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M,24^/&9O;G0@<W1Y;&4],T0G1D].5"U325I%.B`Q,'!T.R!&3TY4+49!34E,
M63H@=&EM97,@;F5W(')O;6%N.R!$25-03$%9.B!I;FQI;F4G/B`F;F)S<#L\
M+V9O;G0^(#PO=&0^(#QT9"!S='EL93TS1"="3U)$15(M0D]45$]-.B!B;&%C
M:R`R<'@@<V]L:60[($1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I
M;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T.R!415A4+4%,24=..B!R
M:6=H="<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$.24^,BPV-S<\+W1D/B`\
M=&0@<W1Y;&4],T0G4$%$1$E.1RU"3U143TTZ(#)P>#L@5$585"U!3$E'3CH@
M;&5F="<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@;F]W<F%P/3-$;F]W
M<F%P/CQF;VYT('-T>6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@1D].5"U&04U)
M3%DZ('1I;65S(&YE=R!R;VUA;CL@1$E34$Q!63H@:6YL:6YE)SX@)FYB<W`[
M/"]F;VYT/B`\+W1D/B`\=&0@<W1Y;&4],T0G4$%$1$E.1RU"3U143TTZ(#)P
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M9'1H/3-$,24^/&9O;G0@<W1Y;&4],T0G1D].5"U325I%.B`Q,'!T.R!&3TY4
M+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!$25-03$%9.B!I;FQI;F4G/B`F
M;F)S<#L\+V9O;G0^(#PO=&0^(#QT9"!S='EL93TS1"="3U)$15(M0D]45$]-
M.B!B;&%C:R`R<'@@<V]L:60[($1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)
M3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T.R!415A4+4%,
M24=..B!R:6=H="<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$.24^,C,\+W1D
M/B`\=&0@<W1Y;&4],T0G4$%$1$E.1RU"3U143TTZ(#)P>#L@5$585"U!3$E'
M3CH@;&5F="<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@;F]W<F%P/3-$
M;F]W<F%P/CQF;VYT('-T>6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@1D].5"U&
M04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1$E34$Q!63H@:6YL:6YE)SX@)FYB
M<W`[/"]F;VYT/B`\+W1D/B`\=&0@<W1Y;&4],T0G4$%$1$E.1RU"3U143TTZ
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M('=I9'1H/3-$,24^/&9O;G0@<W1Y;&4],T0G1D].5"U325I%.B`Q,'!T.R!&
M3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!$25-03$%9.B!I;FQI;F4G
M/B`F;F)S<#L\+V9O;G0^(#PO=&0^(#QT9"!S='EL93TS1"="3U)$15(M0D]4
M5$]-.B!B;&%C:R`R<'@@<V]L:60[($1)4U!,05DZ(&EN;&EN93L@1D].5"U&
M04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T.R!415A4
M+4%,24=..B!R:6=H="<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$.24^,BPW
M,#`\+W1D/B`\=&0@<W1Y;&4],T0G4$%$1$E.1RU"3U143TTZ(#)P>#L@5$58
M5"U!3$E'3CH@;&5F="<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@;F]W
M<F%P/3-$;F]W<F%P/CQF;VYT('-T>6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@
M1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1$E34$Q!63H@:6YL:6YE
M)SX@)FYB<W`[/"]F;VYT/B`\+W1D/B`\+W1R/B`\='(@8F=C;VQO<CTS1"-C
M8V5E9F8^(#QT9"!S='EL93TS1"=0041$24Y'+4)/5%1/33H@-'!X.R!415A4
M+4%,24=..B!L969T.R!-05)'24XM3$5&5#H@,'!T.R!-05)'24XM4DE'2%0Z
M(#!P=#L@5$585"U)3D1%3E0Z(#!P="<@=F%L:6=N/3-$8F]T=&]M('=I9'1H
M/3-$-C0E/B`\9&EV('-T>6QE/3-$)T1)4U!,05DZ(&)L;V-K.R!&3TY4+49!
M34E,63H@=&EM97,@;F5W(')O;6%N.R!&3TY4+5-)6D4Z(#$P<'0[($U!4D=)
M3BU,1494.B`P<'0[($U!4D=)3BU224=(5#H@,'!T.R!415A4+4%,24=..B!L
M969T.R!415A4+4E.1$5.5#H@,'!T)SX@16YD:6YG(&)A;&%N8V4\+V1I=CX@
M/"]T9#X@/'1D('-T>6QE/3-$)U!!1$1)3D<M0D]45$]-.B`T<'@G('9A;&EG
M;CTS1&)O='1O;2!W:61T:#TS1#$E(&%L:6=N/3-$<FEG:'0^/&9O;G0@<W1Y
M;&4],T0G1D].5"U325I%.B`Q,'!T.R!&3TY4+49!34E,63H@=&EM97,@;F5W
M(')O;6%N.R!$25-03$%9.B!I;FQI;F4G/B`F;F)S<#L\+V9O;G0^(#PO=&0^
M(#QT9"!S='EL93TS1"="3U)$15(M0D]45$]-.B!B;&%C:R`T<'@@9&]U8FQE
M.R!$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE<R!N97<@<F]M
M86X[($9/3E0M4TE:13H@,3!P=#L@5$585"U!3$E'3CH@;&5F="<@=F%L:6=N
M/3-$8F]T=&]M('=I9'1H/3-$,24^)#PO=&0^(#QT9"!S='EL93TS1"="3U)$
M15(M0D]45$]-.B!B;&%C:R`T<'@@9&]U8FQE.R!$25-03$%9.B!I;FQI;F4[
M($9/3E0M1D%-24Q9.B!T:6UE<R!N97<@<F]M86X[($9/3E0M4TE:13H@,3!P
M=#L@5$585"U!3$E'3CH@<FEG:'0G('9A;&EG;CTS1&)O='1O;2!W:61T:#TS
M1#DE/C(L.3,V/"]T9#X@/'1D('-T>6QE/3-$)U!!1$1)3D<M0D]45$]-.B`T
M<'@[(%1%6%0M04Q)1TXZ(&QE9G0G('9A;&EG;CTS1&)O='1O;2!W:61T:#TS
M1#$E(&YO=W)A<#TS1&YO=W)A<#X\9F]N="!S='EL93TS1"=&3TY4+5-)6D4Z
M(#$P<'0[($9/3E0M1D%-24Q9.B!T:6UE<R!N97<@<F]M86X[($1)4U!,05DZ
M(&EN;&EN92<^("9N8G-P.SPO9F]N=#X@/"]T9#X@/'1D('-T>6QE/3-$)U!!
M1$1)3D<M0D]45$]-.B`T<'@G('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E
M(&%L:6=N/3-$<FEG:'0^/&9O;G0@<W1Y;&4],T0G1D].5"U325I%.B`Q,'!T
M.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!$25-03$%9.B!I;FQI
M;F4G/B`F;F)S<#L\+V9O;G0^(#PO=&0^(#QT9"!S='EL93TS1"="3U)$15(M
M0D]45$]-.B!B;&%C:R`T<'@@9&]U8FQE.R!$25-03$%9.B!I;FQI;F4[($9/
M3E0M1D%-24Q9.B!T:6UE<R!N97<@<F]M86X[($9/3E0M4TE:13H@,3!P=#L@
M5$585"U!3$E'3CH@;&5F="<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24^
M)#PO=&0^(#QT9"!S='EL93TS1"="3U)$15(M0D]45$]-.B!B;&%C:R`T<'@@
M9&]U8FQE.R!$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE<R!N
M97<@<F]M86X[($9/3E0M4TE:13H@,3!P=#L@5$585"U!3$E'3CH@<FEG:'0G
M('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#DE/C(S/"]T9#X@/'1D('-T>6QE
M/3-$)U!!1$1)3D<M0D]45$]-.B`T<'@[(%1%6%0M04Q)1TXZ(&QE9G0G('9A
M;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E(&YO=W)A<#TS1&YO=W)A<#X\9F]N
M="!S='EL93TS1"=&3TY4+5-)6D4Z(#$P<'0[($9/3E0M1D%-24Q9.B!T:6UE
M<R!N97<@<F]M86X[($1)4U!,05DZ(&EN;&EN92<^("9N8G-P.SPO9F]N=#X@
M/"]T9#X@/'1D('-T>6QE/3-$)U!!1$1)3D<M0D]45$]-.B`T<'@G('9A;&EG
M;CTS1&)O='1O;2!W:61T:#TS1#$E(&%L:6=N/3-$<FEG:'0^/&9O;G0@<W1Y
M;&4],T0G1D].5"U325I%.B`Q,'!T.R!&3TY4+49!34E,63H@=&EM97,@;F5W
M(')O;6%N.R!$25-03$%9.B!I;FQI;F4G/B`F;F)S<#L\+V9O;G0^(#PO=&0^
M(#QT9"!S='EL93TS1"="3U)$15(M0D]45$]-.B!B;&%C:R`T<'@@9&]U8FQE
M.R!$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE<R!N97<@<F]M
M86X[($9/3E0M4TE:13H@,3!P=#L@5$585"U!3$E'3CH@;&5F="<@=F%L:6=N
M/3-$8F]T=&]M('=I9'1H/3-$,24^)#PO=&0^(#QT9"!S='EL93TS1"="3U)$
M15(M0D]45$]-.B!B;&%C:R`T<'@@9&]U8FQE.R!$25-03$%9.B!I;FQI;F4[
M($9/3E0M1D%-24Q9.B!T:6UE<R!N97<@<F]M86X[($9/3E0M4TE:13H@,3!P
M=#L@5$585"U!3$E'3CH@<FEG:'0G('9A;&EG;CTS1&)O='1O;2!W:61T:#TS
M1#DE/C(L.34Y/"]T9#X@/'1D('-T>6QE/3-$)U!!1$1)3D<M0D]45$]-.B`T
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M14Y4.B`P<'0G/B9N8G-P.SPO9&EV/B`\9&EV('-T>6QE/3-$)W1E>'0M86QI
M9VXZ(&-E;G1E<B<^(#QT86)L92!S='EL93TS1"=&3TY4+5-)6D4Z(#$P<'0[
M($9/3E0M1D%-24Q9.B!T:6UE<R!N97<@<F]M86XG(&-E;&QS<&%C:6YG/3-$
M,"!C96QL<&%D9&EN9STS1#`@=VED=&@],T0Q,#`E(&)O<F1E<CTS1#`^(#QT
M<B!V86QI9VX],T1T;W`^(#QT9"!S='EL93TS1"=724142#H@,3AP="<^(#QD
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M8V5M96YT/"]D:78^(#PO=&0^(#PO='(^(#PO=&%B;&4^(#PO9&EV/B`\9&EV
M('-T>6QE/3-$)T1)4U!,05DZ(&)L;V-K.R!-05)'24XM3$5&5#H@,'!T.R!-
M05)'24XM4DE'2%0Z(#!P=#L@=&5X="UA;&EG;CH@:G5S=&EF>3L@5$585"U)
M3D1%3E0Z(#!P="<^("9N8G-P.SPO9&EV/B`\9&EV('-T>6QE/3-$)T1)4U!,
M05DZ(&)L;V-K.R!&3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N.R!&3TY4
M+5-)6D4Z(#$P<'0[($U!4D=)3BU,1494.B`Q.'!T.R!-05)'24XM4DE'2%0Z
M(#!P=#L@=&5X="UA;&EG;CH@:G5S=&EF>3L@5$585"U)3D1%3E0Z(#!P="<^
M($EN($UA>2`R,#$T+"!T:&4@1D%30B!I<W-U960@06-C;W5N=&EN9R!3=&%N
M9&%R9',@57!D871E($YO+B`R,#$T+3`Y("@B05-5(#(P,30M,#DB*2P@(E)E
M=F5N=64@9G)O;2!#;VYT<F%C=',@=VET:"!#=7-T;VUE<G,B+B!!4U4@,C`Q
M-"TP.2!S=7!E<G-E9&5S('1H92!R979E;G5E(')E8V]G;FET:6]N(')E<75I
M<F5M96YT<R!I;B`B4F5V96YU92!296-O9VYI=&EO;B`H5&]P:6,@-C`U*2(L
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M+"`R,#$V+"!I;F-L=61I;F<@:6YT97)I;2!P97)I;V1S('=I=&AI;B!T:&%T
M(')E<&]R=&EN9R!P97)I;V0N($5A<FQY(&%D;W!T:6]N(&ES(&YO="!P97)M
M:71T960N(%1H92!#;VUP86YY(&ES(&-U<G)E;G1L>2!I;B!T:&4@<')O8V5S
M<R!O9B!E=F%L=6%T:6YG('1H92!I;7!A8W0@;V8@=&AE(&%D;W!T:6]N(&]F
M($%352`R,#$T+3`Y(&]N(&ET<R!C;VYS;VQI9&%T960@9FEN86YC:6%L('-T
M871E;65N=',N/"]D:78^(#PA+2U%;F1&<F%G;65N="TM/CPO9&EV/B`\+V1I
M=CX\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO='(^#0H@("`@/"]T86)L
M93X-"B`@/"]B;V1Y/@T*/"]H=&UL/@T*#0HM+2TM+2T]7TYE>'1087)T7S!C
M860U.69D7S<S,F5?-#9E,E]A-3,T7S!C.&%D,6%F.3!D9`T*0V]N=&5N="U,
M;V-A=&EO;CH@9FEL93HO+R]#.B\P8V%D-3EF9%\W,S)E7S0V93)?834S-%\P
M8SAA9#%A9CDP9&0O5V]R:W-H965T<R]3:&5E=#$Q+FAT;6P-"D-O;G1E;G0M
M5')A;G-F97(M16YC;V1I;F<Z('%U;W1E9"UP<FEN=&%B;&4-"D-O;G1E;G0M
M5'EP93H@=&5X="]H=&UL.R!C:&%R<V5T/2)U<RUA<V-I:2(-"@T*/&AT;6P^
M#0H@(#QH96%D/@T*("`@(#Q-151!(&AT='`M97%U:78],T1#;VYT96YT+51Y
M<&4@8V]N=&5N=#TS1"=T97AT+VAT;6P[(&-H87)S970]=71F+3@G/CQS8W)I
M<'0@='EP93TS1'1E>'0O:F%V87-C<FEP="!S<F,],T13:&]W+FIS/B\J($1O
M($YO="!296UO=F4@5&AI<R!#;VUM96YT("HO/"]S8W)I<'0^/"]H96%D/@T*
M("`\8F]D>3X-"B`@("`\=&%B;&4@8VQA<W,],T1R97!O<G0@:60],T1)1#!%
M344^#0H@("`@("`\='(^#0H@("`@("`@(#QT:"!C;&%S<STS1'1L(&-O;'-P
M86X],T0Q(')O=W-P86X],T0R/CQS=')O;F<^34%22T5404),12!314-54DE4
M2453/&)R/CPO<W1R;VYG/CPO=&@^#0H@("`@("`@(#QT:"!C;&%S<STS1'1H
M(&-O;'-P86X],T0Q/C$R($UO;G1H<R!%;F1E9#PO=&@^#0H@("`@("`\+W1R
M/@T*("`@("`@/'1R/@T*("`@("`@("`\=&@@8VQA<W,],T1T:#Y*=6XN(#,P
M+"`R,#$T/&)R/CPO=&@^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S
M/3-$<F4^#0H@("`@("`@(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O<#X\
M<W1R;VYG/DU!4DM%5$%"3$4@4T5#55))5$E%4R!;06)S=')A8W1=/"]S=')O
M;F<^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S
M<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$<F\^
M#0H@("`@("`@(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O<#Y-05)+151!
M0DQ%(%-%0U52251)15,\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT
M/B<\(2TM1$]#5%E012!H=&UL(%!50DQ)0R`B+2\O5S-#+R]$5$0@6$A434P@
M,2XP(%1R86YS:71I;VYA;"\O14XB(")H='1P.B\O=W=W+G<S+F]R9R]44B]X
M:'1M;#$O1%1$+WAH=&UL,2UT<F%N<VET:6]N86PN9'1D(B`M+3X\9&EV/B`\
M9&EV/CPA+2U3=&%R=$9R86=M96YT+2T^(#QD:78@<W1Y;&4],T0G1$E34$Q!
M63H@8FQO8VL[($9/3E0M1D%-24Q9.B!4:6UE<R!.97<@4F]M86X[($9/3E0M
M4TE:13H@,3!P=#L@1D].5"U714E'2%0Z(&)O;&0[($U!4D=)3BU,1494.B`P
M<'0[($U!4D=)3BU224=(5#H@,'!T.R!T97AT+6%L:6=N.B!L969T.R!415A4
M+4E.1$5.5#H@,'!T)SX@3D]412`S.BT@34%22T5404),12!314-54DE42453
M/"]D:78^(#QD:78@<W1Y;&4],T0G1$E34$Q!63H@8FQO8VL[(%1%6%0M24Y$
M14Y4.B`P<'0G/CQB<B`O/B`\+V1I=CX@/&1I=B!S='EL93TS1"=$25-03$%9
M.B!B;&]C:SL@1D].5"U&04U)3%DZ(%1I;65S($YE=R!2;VUA;CL@1D].5"U3
M25I%.B`Q,'!T.R!-05)'24XM3$5&5#H@,'!T.R!-05)'24XM4DE'2%0Z(#!P
M=#L@=&5X="UA;&EG;CH@;&5F=#L@5$585"U)3D1%3E0Z(#!P="<^($%S(&]F
M($IU;F4@,S`L(#(P,30L(&%L;"!O9B!T:&4@0V]M<&%N>28C,SD[<R!M87)K
M971A8FQE('-E8W5R:71I97,@=V5R92!C;&%S<VEF:65D(&%S(&%V86EL86)L
M92UF;W(M<V%L92X\+V1I=CX@/&1I=B!S='EL93TS1"=$25-03$%9.B!B;&]C
M:SL@34%21TE.+4Q%1E0Z(#!P=#L@34%21TE.+5))1TA4.B`P<'0[('1E>'0M
M86QI9VXZ(&QE9G0[(%1%6%0M24Y$14Y4.B`P<'0G/B`F;F)S<#L\+V1I=CX@
M/&1I=B!S='EL93TS1"=T97AT+6%L:6=N.B!L969T)SX@/'1A8FQE('-T>6QE
M/3-$)T9/3E0M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R
M;VUA;B<@8V5L;'-P86-I;F<],T0P(&-E;&QP861D:6YG/3-$,"!W:61T:#TS
M1#$P,"4^(#QT<CX@/'1D('-T>6QE/3-$)U!!1$1)3D<M0D]45$]-.B`R<'@G
M('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#(P)3X\9F]N="!S='EL93TS1"=&
M3TY4+5-)6D4Z(#$P<'0[($9/3E0M1D%-24Q9.B!T:6UE<R!N97<@<F]M86X[
M($1)4U!,05DZ(&EN;&EN92<^("9N8G-P.SPO9F]N=#X@/"]T9#X@/'1D('-T
M>6QE/3-$)U!!1$1)3D<M0D]45$]-.B`R<'@G('9A;&EG;CTS1&)O='1O;2!W
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M;VUA;CL@1D].5"U325I%.B`Q,'!T.R!&3TY4+5=%24=(5#H@8F]L9#L@34%2
M1TE.+4Q%1E0Z(#!P=#L@34%21TE.+5))1TA4.B`P<'0[('1E>'0M86QI9VXZ
M(&-E;G1E<CL@5$585"U)3D1%3E0Z(#!P="<^($IU;F4@,S`L(#(P,30\+V1I
M=CX@/"]T9#X@/'1D('-T>6QE/3-$)U!!1$1)3D<M0D]45$]-.B`R<'@[(%1%
M6%0M04Q)1TXZ(&QE9G0G('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E(&YO
M=W)A<#TS1&YO=W)A<#X\9F]N="!S='EL93TS1"=&3TY4+5-)6D4Z(#$P<'0[
M($9/3E0M1D%-24Q9.B!T:6UE<R!N97<@<F]M86X[($1)4U!,05DZ(&EN;&EN
M92<^("9N8G-P.SPO9F]N=#X@/"]T9#X@/'1D('-T>6QE/3-$)U!!1$1)3D<M
M0D]45$]-.B`R<'@G('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E/CQF;VYT
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M.B`Q,'!T.R!&3TY4+5=%24=(5#H@8F]L9#L@34%21TE.+4Q%1E0Z(#!P=#L@
M34%21TE.+5))1TA4.B`P<'0[('1E>'0M86QI9VXZ(&-E;G1E<CL@5$585"U)
M3D1%3E0Z(#!P="<^($IU;F4@,S`L,C`Q,SPO9&EV/B`\+W1D/B`\=&0@<W1Y
M;&4],T0G4$%$1$E.1RU"3U143TTZ(#)P>#L@5$585"U!3$E'3CH@;&5F="<@
M=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@;F]W<F%P/3-$;F]W<F%P/CQF
M;VYT('-T>6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ('1I
M;65S(&YE=R!R;VUA;CL@1$E34$Q!63H@:6YL:6YE)SX@)FYB<W`[/"]F;VYT
M/B`\+W1D/B`\+W1R/B`\='(^(#QT9"!S='EL93TS1"=0041$24Y'+4)/5%1/
M33H@,G!X)R!V86QI9VX],T1B;W1T;VT@=VED=&@],T0R,"4^/&9O;G0@<W1Y
M;&4],T0G1D].5"U325I%.B`Q,'!T.R!&3TY4+49!34E,63H@=&EM97,@;F5W
M(')O;6%N.R!$25-03$%9.B!I;FQI;F4G/B`F;F)S<#L\+V9O;G0^(#PO=&0^
M(#QT9"!S='EL93TS1"=0041$24Y'+4)/5%1/33H@,G!X)R!V86QI9VX],T1B
M;W1T;VT@=VED=&@],T0Q)3X\9F]N="!S='EL93TS1"=&3TY4+5-)6D4Z(#$P
M<'0[($9/3E0M1D%-24Q9.B!T:6UE<R!N97<@<F]M86X[($9/3E0M5T5)1TA4
M.B!B;VQD.R!$25-03$%9.B!I;FQI;F4G/B`F;F)S<#L\+V9O;G0^(#PO=&0^
M(#QT9"!S='EL93TS1"="3U)$15(M0D]45$]-.B!B;&%C:R`R<'@@<V]L:60G
M('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#@E(&-O;'-P86X],T0R/B`\9&EV
M('-T>6QE/3-$)T1)4U!,05DZ(&)L;V-K.R!&3TY4+49!34E,63H@=&EM97,@
M;F5W(')O;6%N.R!&3TY4+5-)6D4Z(#$P<'0[($9/3E0M5T5)1TA4.B!B;VQD
M.R!-05)'24XM3$5&5#H@,'!T.R!-05)'24XM4DE'2%0Z(#!P=#L@=&5X="UA
M;&EG;CH@8V5N=&5R.R!415A4+4E.1$5.5#H@,'!T)SX@06UO<G1I>F5D(&-O
M<W0\+V1I=CX@/"]T9#X@/'1D('-T>6QE/3-$)U!!1$1)3D<M0D]45$]-.B`R
M<'@[(%1%6%0M04Q)1TXZ(&QE9G0G('9A;&EG;CTS1&)O='1O;2!W:61T:#TS
M1#$E(&YO=W)A<#TS1&YO=W)A<#X\9F]N="!S='EL93TS1"=&3TY4+5-)6D4Z
M(#$P<'0[($9/3E0M1D%-24Q9.B!T:6UE<R!N97<@<F]M86X[($9/3E0M5T5)
M1TA4.B!B;VQD.R!$25-03$%9.B!I;FQI;F4G/B`F;F)S<#L\+V9O;G0^(#PO
M=&0^(#QT9"!S='EL93TS1"=0041$24Y'+4)/5%1/33H@,G!X)R!V86QI9VX]
M,T1B;W1T;VT@=VED=&@],T0Q)3X\9F]N="!S='EL93TS1"=&3TY4+5-)6D4Z
M(#$P<'0[($9/3E0M1D%-24Q9.B!T:6UE<R!N97<@<F]M86X[($9/3E0M5T5)
M1TA4.B!B;VQD.R!$25-03$%9.B!I;FQI;F4G/B`F;F)S<#L\+V9O;G0^(#PO
M=&0^(#QT9"!S='EL93TS1"="3U)$15(M0D]45$]-.B!B;&%C:R`R<'@@<V]L
M:60G('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#@E(&-O;'-P86X],T0R/B`\
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M('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T.R!&3TY4+5=%24=(
M5#H@8F]L9#L@34%21TE.+4Q%1E0Z(#!P=#L@34%21TE.+5))1TA4.B`P<'0[
M('1E>'0M86QI9VXZ(&-E;G1E<CL@5$585"U)3D1%3E0Z(#!P="<^('5N<F5A
M;&EZ960\+V1I=CX@/&1I=B!S='EL93TS1"=$25-03$%9.B!B;&]C:SL@1D].
M5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T.R!&
M3TY4+5=%24=(5#H@8F]L9#L@34%21TE.+4Q%1E0Z(#!P=#L@34%21TE.+5))
M1TA4.B`P<'0[('1E>'0M86QI9VXZ(&-E;G1E<CL@5$585"U)3D1%3E0Z(#!P
M="<^(&=A:6X\+V1I=CX@/"]T9#X@/'1D('-T>6QE/3-$)U!!1$1)3D<M0D]4
M5$]-.B`R<'@[(%1%6%0M04Q)1TXZ(&QE9G0G('9A;&EG;CTS1&)O='1O;2!W
M:61T:#TS1#$E(&YO=W)A<#TS1&YO=W)A<#X\9F]N="!S='EL93TS1"=&3TY4
M+5-)6D4Z(#$P<'0[($9/3E0M1D%-24Q9.B!T:6UE<R!N97<@<F]M86X[($9/
M3E0M5T5)1TA4.B!B;VQD.R!$25-03$%9.B!I;FQI;F4G/B`F;F)S<#L\+V9O
M;G0^(#PO=&0^(#QT9"!S='EL93TS1"=0041$24Y'+4)/5%1/33H@,G!X)R!V
M86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)3X\9F]N="!S='EL93TS1"=&3TY4
M+5-)6D4Z(#$P<'0[($9/3E0M1D%-24Q9.B!T:6UE<R!N97<@<F]M86X[($9/
M3E0M5T5)1TA4.B!B;VQD.R!$25-03$%9.B!I;FQI;F4G/B`F;F)S<#L\+V9O
M;G0^(#PO=&0^(#QT9"!S='EL93TS1"="3U)$15(M0D]45$]-.B!B;&%C:R`R
M<'@@<V]L:60G('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#@E(&-O;'-P86X]
M,T0R/B`\9&EV('-T>6QE/3-$)T1)4U!,05DZ(&)L;V-K.R!&3TY4+49!34E,
M63H@=&EM97,@;F5W(')O;6%N.R!&3TY4+5-)6D4Z(#$P<'0[($9/3E0M5T5)
M1TA4.B!B;VQD.R!-05)'24XM3$5&5#H@,'!T.R!-05)'24XM4DE'2%0Z(#!P
M=#L@=&5X="UA;&EG;CH@8V5N=&5R.R!415A4+4E.1$5.5#H@,'!T)SX@1W)O
M<W,\+V1I=CX@/&1I=B!S='EL93TS1"=$25-03$%9.B!B;&]C:SL@1D].5"U&
M04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T.R!&3TY4
M+5=%24=(5#H@8F]L9#L@34%21TE.+4Q%1E0Z(#!P=#L@34%21TE.+5))1TA4
M.B`P<'0[('1E>'0M86QI9VXZ(&-E;G1E<CL@5$585"U)3D1%3E0Z(#!P="<^
M('5N<F5A;&EZ960\+V1I=CX@/&1I=B!S='EL93TS1"=$25-03$%9.B!B;&]C
M:SL@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q
M,'!T.R!&3TY4+5=%24=(5#H@8F]L9#L@34%21TE.+4Q%1E0Z(#!P=#L@34%2
M1TE.+5))1TA4.B`P<'0[('1E>'0M86QI9VXZ(&-E;G1E<CL@5$585"U)3D1%
M3E0Z(#!P="<^(&QO<W,\+V1I=CX@/"]T9#X@/'1D('-T>6QE/3-$)U!!1$1)
M3D<M0D]45$]-.B`R<'@[(%1%6%0M04Q)1TXZ(&QE9G0G('9A;&EG;CTS1&)O
M='1O;2!W:61T:#TS1#$E(&YO=W)A<#TS1&YO=W)A<#X\9F]N="!S='EL93TS
M1"=&3TY4+5-)6D4Z(#$P<'0[($9/3E0M1D%-24Q9.B!T:6UE<R!N97<@<F]M
M86X[($9/3E0M5T5)1TA4.B!B;VQD.R!$25-03$%9.B!I;FQI;F4G/B`F;F)S
M<#L\+V9O;G0^(#PO=&0^(#QT9"!S='EL93TS1"=0041$24Y'+4)/5%1/33H@
M,G!X)R!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)3X\9F]N="!S='EL93TS
M1"=&3TY4+5-)6D4Z(#$P<'0[($9/3E0M1D%-24Q9.B!T:6UE<R!N97<@<F]M
M86X[($9/3E0M5T5)1TA4.B!B;VQD.R!$25-03$%9.B!I;FQI;F4G/B`F;F)S
M<#L\+V9O;G0^(#PO=&0^(#QT9"!S='EL93TS1"="3U)$15(M0D]45$]-.B!B
M;&%C:R`R<'@@<V]L:60G('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#@E(&-O
M;'-P86X],T0R/B`\9&EV('-T>6QE/3-$)T1)4U!,05DZ(&)L;V-K.R!&3TY4
M+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!&3TY4+5-)6D4Z(#$P<'0[($9/
M3E0M5T5)1TA4.B!B;VQD.R!-05)'24XM3$5&5#H@,'!T.R!-05)'24XM4DE'
M2%0Z(#!P=#L@=&5X="UA;&EG;CH@8V5N=&5R.R!415A4+4E.1$5.5#H@,'!T
M)SX@1F%I<CPO9&EV/B`\9&EV('-T>6QE/3-$)T1)4U!,05DZ(&)L;V-K.R!&
M3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!&3TY4+5-)6D4Z(#$P<'0[
M($9/3E0M5T5)1TA4.B!B;VQD.R!-05)'24XM3$5&5#H@,'!T.R!-05)'24XM
M4DE'2%0Z(#!P=#L@=&5X="UA;&EG;CH@8V5N=&5R.R!415A4+4E.1$5.5#H@
M,'!T)SX@=F%L=64\+V1I=CX@/"]T9#X@/'1D('-T>6QE/3-$)U!!1$1)3D<M
M0D]45$]-.B`R<'@[(%1%6%0M04Q)1TXZ(&QE9G0G('9A;&EG;CTS1&)O='1O
M;2!W:61T:#TS1#$E(&YO=W)A<#TS1&YO=W)A<#X\9F]N="!S='EL93TS1"=&
M3TY4+5-)6D4Z(#$P<'0[($9/3E0M1D%-24Q9.B!T:6UE<R!N97<@<F]M86X[
M($9/3E0M5T5)1TA4.B!B;VQD.R!$25-03$%9.B!I;FQI;F4G/B`F;F)S<#L\
M+V9O;G0^(#PO=&0^(#QT9"!S='EL93TS1"=0041$24Y'+4)/5%1/33H@,G!X
M)R!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)3X\9F]N="!S='EL93TS1"=&
M3TY4+5-)6D4Z(#$P<'0[($9/3E0M1D%-24Q9.B!T:6UE<R!N97<@<F]M86X[
M($9/3E0M5T5)1TA4.B!B;VQD.R!$25-03$%9.B!I;FQI;F4G/B`F;F)S<#L\
M+V9O;G0^(#PO=&0^(#QT9"!S='EL93TS1"="3U)$15(M0D]45$]-.B!B;&%C
M:R`R<'@@<V]L:60G('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#@E(&-O;'-P
M86X],T0R/B`\9&EV('-T>6QE/3-$)T1)4U!,05DZ(&)L;V-K.R!&3TY4+49!
M34E,63H@=&EM97,@;F5W(')O;6%N.R!&3TY4+5-)6D4Z(#$P<'0[($9/3E0M
M5T5)1TA4.B!B;VQD.R!-05)'24XM3$5&5#H@,'!T.R!-05)'24XM4DE'2%0Z
M(#!P=#L@=&5X="UA;&EG;CH@8V5N=&5R.R!415A4+4E.1$5.5#H@,'!T)SX@
M06UO<G1I>F5D(&-O<W0\+V1I=CX@/"]T9#X@/'1D('-T>6QE/3-$)U!!1$1)
M3D<M0D]45$]-.B`R<'@[(%1%6%0M04Q)1TXZ(&QE9G0G('9A;&EG;CTS1&)O
M='1O;2!W:61T:#TS1#$E(&YO=W)A<#TS1&YO=W)A<#X\9F]N="!S='EL93TS
M1"=&3TY4+5-)6D4Z(#$P<'0[($9/3E0M1D%-24Q9.B!T:6UE<R!N97<@<F]M
M86X[($9/3E0M5T5)1TA4.B!B;VQD.R!$25-03$%9.B!I;FQI;F4G/B`F;F)S
M<#L\+V9O;G0^(#PO=&0^(#QT9"!S='EL93TS1"=0041$24Y'+4)/5%1/33H@
M,G!X)R!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)3X\9F]N="!S='EL93TS
M1"=&3TY4+5-)6D4Z(#$P<'0[($9/3E0M1D%-24Q9.B!T:6UE<R!N97<@<F]M
M86X[($9/3E0M5T5)1TA4.B!B;VQD.R!$25-03$%9.B!I;FQI;F4G/B`F;F)S
M<#L\+V9O;G0^(#PO=&0^(#QT9"!S='EL93TS1"="3U)$15(M0D]45$]-.B!B
M;&%C:R`R<'@@<V]L:60G('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#@E(&-O
M;'-P86X],T0R/B`\9&EV('-T>6QE/3-$)T1)4U!,05DZ(&)L;V-K.R!&3TY4
M+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!&3TY4+5-)6D4Z(#$P<'0[($9/
M3E0M5T5)1TA4.B!B;VQD.R!-05)'24XM3$5&5#H@,'!T.R!-05)'24XM4DE'
M2%0Z(#!P=#L@=&5X="UA;&EG;CH@8V5N=&5R.R!415A4+4E.1$5.5#H@,'!T
M)SX@1W)O<W,\+V1I=CX@/&1I=B!S='EL93TS1"=$25-03$%9.B!B;&]C:SL@
M1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T
M.R!&3TY4+5=%24=(5#H@8F]L9#L@34%21TE.+4Q%1E0Z(#!P=#L@34%21TE.
M+5))1TA4.B`P<'0[('1E>'0M86QI9VXZ(&-E;G1E<CL@5$585"U)3D1%3E0Z
M(#!P="<^('5N<F5A;&EZ960\+V1I=CX@/&1I=B!S='EL93TS1"=$25-03$%9
M.B!B;&]C:SL@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U3
M25I%.B`Q,'!T.R!&3TY4+5=%24=(5#H@8F]L9#L@34%21TE.+4Q%1E0Z(#!P
M=#L@34%21TE.+5))1TA4.B`P<'0[('1E>'0M86QI9VXZ(&-E;G1E<CL@5$58
M5"U)3D1%3E0Z(#!P="<^(&=A:6X\+V1I=CX@/"]T9#X@/'1D('-T>6QE/3-$
M)U!!1$1)3D<M0D]45$]-.B`R<'@[(%1%6%0M04Q)1TXZ(&QE9G0G('9A;&EG
M;CTS1&)O='1O;2!W:61T:#TS1#$E(&YO=W)A<#TS1&YO=W)A<#X\9F]N="!S
M='EL93TS1"=&3TY4+5-)6D4Z(#$P<'0[($9/3E0M1D%-24Q9.B!T:6UE<R!N
M97<@<F]M86X[($9/3E0M5T5)1TA4.B!B;VQD.R!$25-03$%9.B!I;FQI;F4G
M/B`F;F)S<#L\+V9O;G0^(#PO=&0^(#QT9"!S='EL93TS1"=0041$24Y'+4)/
M5%1/33H@,G!X)R!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)3X\9F]N="!S
M='EL93TS1"=&3TY4+5-)6D4Z(#$P<'0[($9/3E0M1D%-24Q9.B!T:6UE<R!N
M97<@<F]M86X[($9/3E0M5T5)1TA4.B!B;VQD.R!$25-03$%9.B!I;FQI;F4G
M/B`F;F)S<#L\+V9O;G0^(#PO=&0^(#QT9"!S='EL93TS1"="3U)$15(M0D]4
M5$]-.B!B;&%C:R`R<'@@<V]L:60G('9A;&EG;CTS1&)O='1O;2!W:61T:#TS
M1#@E(&-O;'-P86X],T0R/B`\9&EV('-T>6QE/3-$)T1)4U!,05DZ(&)L;V-K
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M.B`Q,'!T.R!&3TY4+5=%24=(5#H@8F]L9#L@34%21TE.+4Q%1E0Z(#!P=#L@
M34%21TE.+5))1TA4.B`P<'0[('1E>'0M86QI9VXZ(&-E;G1E<CL@5$585"U)
M3D1%3E0Z(#!P="<^('5N<F5A;&EZ960\+V1I=CX@/&1I=B!S='EL93TS1"=$
M25-03$%9.B!B;&]C:SL@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@
M1D].5"U325I%.B`Q,'!T.R!&3TY4+5=%24=(5#H@8F]L9#L@34%21TE.+4Q%
M1E0Z(#!P=#L@34%21TE.+5))1TA4.B`P<'0[('1E>'0M86QI9VXZ(&-E;G1E
M<CL@5$585"U)3D1%3E0Z(#!P="<^(&QO<W,\+V1I=CX@/"]T9#X@/'1D('-T
M>6QE/3-$)U!!1$1)3D<M0D]45$]-.B`R<'@[(%1%6%0M04Q)1TXZ(&QE9G0G
M('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E(&YO=W)A<#TS1&YO=W)A<#X\
M9F]N="!S='EL93TS1"=&3TY4+5-)6D4Z(#$P<'0[($9/3E0M1D%-24Q9.B!T
M:6UE<R!N97<@<F]M86X[($9/3E0M5T5)1TA4.B!B;VQD.R!$25-03$%9.B!I
M;FQI;F4G/B`F;F)S<#L\+V9O;G0^(#PO=&0^(#QT9"!S='EL93TS1"=0041$
M24Y'+4)/5%1/33H@,G!X)R!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)3X\
M9F]N="!S='EL93TS1"=&3TY4+5-)6D4Z(#$P<'0[($9/3E0M1D%-24Q9.B!T
M:6UE<R!N97<@<F]M86X[($9/3E0M5T5)1TA4.B!B;VQD.R!$25-03$%9.B!I
M;FQI;F4G/B`F;F)S<#L\+V9O;G0^(#PO=&0^(#QT9"!S='EL93TS1"="3U)$
M15(M0D]45$]-.B!B;&%C:R`R<'@@<V]L:60G('9A;&EG;CTS1&)O='1O;2!W
M:61T:#TS1#@E(&-O;'-P86X],T0R/B`\9&EV('-T>6QE/3-$)T1)4U!,05DZ
M(&)L;V-K.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!&3TY4+5-)
M6D4Z(#$P<'0[($9/3E0M5T5)1TA4.B!B;VQD.R!-05)'24XM3$5&5#H@,'!T
M.R!-05)'24XM4DE'2%0Z(#!P=#L@=&5X="UA;&EG;CH@8V5N=&5R.R!415A4
M+4E.1$5.5#H@,'!T)SX@1F%I<CPO9&EV/B`\9&EV('-T>6QE/3-$)T1)4U!,
M05DZ(&)L;V-K.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!&3TY4
M+5-)6D4Z(#$P<'0[($9/3E0M5T5)1TA4.B!B;VQD.R!-05)'24XM3$5&5#H@
M,'!T.R!-05)'24XM4DE'2%0Z(#!P=#L@=&5X="UA;&EG;CH@8V5N=&5R.R!4
M15A4+4E.1$5.5#H@,'!T)SX@=F%L=64\+V1I=CX@/"]T9#X@/'1D('-T>6QE
M/3-$)U!!1$1)3D<M0D]45$]-.B`R<'@[(%1%6%0M04Q)1TXZ(&QE9G0G('9A
M;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E(&YO=W)A<#TS1&YO=W)A<#X\9F]N
M="!S='EL93TS1"=&3TY4+5-)6D4Z(#$P<'0[($9/3E0M1D%-24Q9.B!T:6UE
M<R!N97<@<F]M86X[($9/3E0M5T5)1TA4.B!B;VQD.R!$25-03$%9.B!I;FQI
M;F4G/B`F;F)S<#L\+V9O;G0^(#PO=&0^(#PO='(^(#QT<B!B9V-O;&]R/3-$
M(V-C965F9CX@/'1D('-T>6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0[($U!4D=)
M3BU,1494.B`P<'0[($U!4D=)3BU224=(5#H@,'!T.R!415A4+4E.1$5.5#H@
M,'!T)R!V86QI9VX],T1B;W1T;VT@=VED=&@],T0R,"4^(#QD:78@<W1Y;&4]
M,T0G1$E34$Q!63H@8FQO8VL[($9/3E0M1D%-24Q9.B!T:6UE<R!N97<@<F]M
M86X[($9/3E0M4TE:13H@,3!P=#L@1D].5"U714E'2%0Z(&)O;&0[($U!4D=)
M3BU,1494.B`P<'0[($U!4D=)3BU224=(5#H@,'!T.R!415A4+4%,24=..B!L
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M;CL@1$E34$Q!63H@:6YL:6YE)SX@)FYB<W`[/"]F;VYT/B`\+W1D/B`\=&0@
M<W1Y;&4],T0G5$585"U!3$E'3CH@;&5F="<@=F%L:6=N/3-$8F]T=&]M('=I
M9'1H/3-$,24@;F]W<F%P/3-$;F]W<F%P/CQF;VYT('-T>6QE/3-$)T9/3E0M
M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1$E3
M4$Q!63H@:6YL:6YE)SX@)FYB<W`[/"]F;VYT/B`\+W1D/B`\=&0@=F%L:6=N
M/3-$8F]T=&]M('=I9'1H/3-$,24^/&9O;G0@<W1Y;&4],T0G1D].5"U325I%
M.B`Q,'!T.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!$25-03$%9
M.B!I;FQI;F4G/B`F;F)S<#L\+V9O;G0^(#PO=&0^(#QT9"!V86QI9VX],T1B
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M:6YL:6YE)SX@)FYB<W`[/"]F;VYT/B`\+W1D/B`\=&0@=F%L:6=N/3-$8F]T
M=&]M('=I9'1H/3-$."4@8V]L<W!A;CTS1#(^/&9O;G0@<W1Y;&4],T0G1D].
M5"U325I%.B`Q,'!T.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!$
M25-03$%9.B!I;FQI;F4G/B`F;F)S<#L\+V9O;G0^(#PO=&0^(#QT9"!S='EL
M93TS1"=415A4+4%,24=..B!L969T)R!V86QI9VX],T1B;W1T;VT@=VED=&@]
M,T0Q)2!N;W=R87`],T1N;W=R87`^/&9O;G0@<W1Y;&4],T0G1D].5"U325I%
M.B`Q,'!T.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!$25-03$%9
M.B!I;FQI;F4G/B`F;F)S<#L\+V9O;G0^(#PO=&0^(#QT9"!V86QI9VX],T1B
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M4$Q!63H@:6YL:6YE)SX@)FYB<W`[/"]F;VYT/B`\+W1D/B`\=&0@<W1Y;&4]
M,T0G5$585"U!3$E'3CH@;&5F="<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$
M,24@;F]W<F%P/3-$;F]W<F%P/CQF;VYT('-T>6QE/3-$)T9/3E0M4TE:13H@
M,3!P=#L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1$E34$Q!63H@
M:6YL:6YE)SX@)FYB<W`[/"]F;VYT/B`\+W1D/B`\=&0@=F%L:6=N/3-$8F]T
M=&]M('=I9'1H/3-$,24^/&9O;G0@<W1Y;&4],T0G1D].5"U325I%.B`Q,'!T
M.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!$25-03$%9.B!I;FQI
M;F4G/B`F;F)S<#L\+V9O;G0^(#PO=&0^(#QT9"!V86QI9VX],T1B;W1T;VT@
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M)SX@)FYB<W`[/"]F;VYT/B`\+W1D/B`\=&0@=F%L:6=N/3-$8F]T=&]M('=I
M9'1H/3-$."4@8V]L<W!A;CTS1#(^/&9O;G0@<W1Y;&4],T0G1D].5"U325I%
M.B`Q,'!T.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!$25-03$%9
M.B!I;FQI;F4G/B`F;F)S<#L\+V9O;G0^(#PO=&0^(#QT9"!S='EL93TS1"=4
M15A4+4%,24=..B!L969T)R!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)2!N
M;W=R87`],T1N;W=R87`^/&9O;G0@<W1Y;&4],T0G1D].5"U325I%.B`Q,'!T
M.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!$25-03$%9.B!I;FQI
M;F4G/B`F;F)S<#L\+V9O;G0^(#PO=&0^(#QT9"!V86QI9VX],T1B;W1T;VT@
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M:6YL:6YE)SX@)FYB<W`[/"]F;VYT/B`\+W1D/B`\=&0@<W1Y;&4],T0G5$58
M5"U!3$E'3CH@;&5F="<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@;F]W
M<F%P/3-$;F]W<F%P/CQF;VYT('-T>6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@
M1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1$E34$Q!63H@:6YL:6YE
M)SX@)FYB<W`[/"]F;VYT/B`\+W1D/B`\=&0@=F%L:6=N/3-$8F]T=&]M('=I
M9'1H/3-$,24^/&9O;G0@<W1Y;&4],T0G1D].5"U325I%.B`Q,'!T.R!&3TY4
M+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!$25-03$%9.B!I;FQI;F4G/B`F
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M.B`P<'0[($U!4D=)3BU224=(5#H@,'!T.R!415A4+4E.1$5.5#H@,'!T)R!V
M86QI9VX],T1B;W1T;VT@=VED=&@],T0R,"4^(#QD:78@<W1Y;&4],T0G1$E3
M4$Q!63H@8FQO8VL[($9/3E0M1D%-24Q9.B!T:6UE<R!N97<@<F]M86X[($9/
M3E0M4TE:13H@,3!P=#L@34%21TE.+4Q%1E0Z(#!P=#L@34%21TE.+5))1TA4
M.B`P<'0[(%1%6%0M04Q)1TXZ(&QE9G0[(%1%6%0M24Y$14Y4.B`P<'0G/B!3
M=&]C:R!A;F0@:6YD97@@;&EN:V5D(&YO=&5S/"]D:78^(#PO=&0^(#QT9"!V
M86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)2!A;&EG;CTS1')I9VAT/CQF;VYT
M('-T>6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ('1I;65S
M(&YE=R!R;VUA;CL@1$E34$Q!63H@:6YL:6YE)SX@)FYB<W`[/"]F;VYT/B`\
M+W1D/B`\=&0@<W1Y;&4],T0G1$E34$Q!63H@:6YL:6YE.R!&3TY4+49!34E,
M63H@=&EM97,@;F5W(')O;6%N.R!&3TY4+5-)6D4Z(#$P<'0[(%1%6%0M04Q)
M1TXZ(&QE9G0G('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E/B0\+W1D/B`\
M=&0@<W1Y;&4],T0G1$E34$Q!63H@:6YL:6YE.R!&3TY4+49!34E,63H@=&EM
M97,@;F5W(')O;6%N.R!&3TY4+5-)6D4Z(#$P<'0[(%1%6%0M04Q)1TXZ(')I
M9VAT)R!V86QI9VX],T1B;W1T;VT@=VED=&@],T0W)3XQ."PX.#$\+W1D/B`\
M=&0@<W1Y;&4],T0G5$585"U!3$E'3CH@;&5F="<@=F%L:6=N/3-$8F]T=&]M
M('=I9'1H/3-$,24@;F]W<F%P/3-$;F]W<F%P/CQF;VYT('-T>6QE/3-$)T9/
M3E0M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@
M1$E34$Q!63H@:6YL:6YE)SX@)FYB<W`[/"]F;VYT/B`\+W1D/B`\=&0@=F%L
M:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@86QI9VX],T1R:6=H=#X\9F]N="!S
M='EL93TS1"=&3TY4+5-)6D4Z(#$P<'0[($9/3E0M1D%-24Q9.B!T:6UE<R!N
M97<@<F]M86X[($1)4U!,05DZ(&EN;&EN92<^("9N8G-P.SPO9F]N=#X@/"]T
M9#X@/'1D('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ
M('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T.R!415A4+4%,24=.
M.B!L969T)R!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)3XD/"]T9#X@/'1D
M('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S
M(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T.R!415A4+4%,24=..B!R:6=H
M="<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$-R4^,BPU,C(\+W1D/B`\=&0@
M<W1Y;&4],T0G5$585"U!3$E'3CH@;&5F="<@=F%L:6=N/3-$8F]T=&]M('=I
M9'1H/3-$,24@;F]W<F%P/3-$;F]W<F%P/CQF;VYT('-T>6QE/3-$)T9/3E0M
M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1$E3
M4$Q!63H@:6YL:6YE)SX@)FYB<W`[/"]F;VYT/B`\+W1D/B`\=&0@=F%L:6=N
M/3-$8F]T=&]M('=I9'1H/3-$,24@86QI9VX],T1R:6=H=#X\9F]N="!S='EL
M93TS1"=&3TY4+5-)6D4Z(#$P<'0[($9/3E0M1D%-24Q9.B!T:6UE<R!N97<@
M<F]M86X[($1)4U!,05DZ(&EN;&EN92<^("9N8G-P.SPO9F]N=#X@/"]T9#X@
M/'1D('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I
M;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T.R!415A4+4%,24=..B!L
M969T)R!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)3XD/"]T9#X@/'1D('-T
M>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE
M=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T.R!415A4+4%,24=..B!R:6=H="<@
M=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$-R4^*#(S/"]T9#X@/'1D('-T>6QE
M/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R
M;VUA;CL@1D].5"U325I%.B`Q,'!T.R!415A4+4%,24=..B!L969T)R!V86QI
M9VX],T1B;W1T;VT@=VED=&@],T0Q)2!N;W=R87`],T1N;W=R87`^*3PO=&0^
M(#QT9"!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)2!A;&EG;CTS1')I9VAT
M/CQF;VYT('-T>6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ
M('1I;65S(&YE=R!R;VUA;CL@1$E34$Q!63H@:6YL:6YE)SX@)FYB<W`[/"]F
M;VYT/B`\+W1D/B`\=&0@<W1Y;&4],T0G1$E34$Q!63H@:6YL:6YE.R!&3TY4
M+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!&3TY4+5-)6D4Z(#$P<'0[(%1%
M6%0M04Q)1TXZ(&QE9G0G('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E/B0\
M+W1D/B`\=&0@<W1Y;&4],T0G1$E34$Q!63H@:6YL:6YE.R!&3TY4+49!34E,
M63H@=&EM97,@;F5W(')O;6%N.R!&3TY4+5-)6D4Z(#$P<'0[(%1%6%0M04Q)
M1TXZ(')I9VAT)R!V86QI9VX],T1B;W1T;VT@=VED=&@],T0W)3XR,2PS.#`\
M+W1D/B`\=&0@<W1Y;&4],T0G5$585"U!3$E'3CH@;&5F="<@=F%L:6=N/3-$
M8F]T=&]M('=I9'1H/3-$,24@;F]W<F%P/3-$;F]W<F%P/CQF;VYT('-T>6QE
M/3-$)T9/3E0M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R
M;VUA;CL@1$E34$Q!63H@:6YL:6YE)SX@)FYB<W`[/"]F;VYT/B`\+W1D/B`\
M=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@86QI9VX],T1R:6=H=#X\
M9F]N="!S='EL93TS1"=&3TY4+5-)6D4Z(#$P<'0[($9/3E0M1D%-24Q9.B!T
M:6UE<R!N97<@<F]M86X[($1)4U!,05DZ(&EN;&EN92<^("9N8G-P.SPO9F]N
M=#X@/"]T9#X@/'1D('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&
M04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T.R!415A4
M+4%,24=..B!L969T)R!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)3XD/"]T
M9#X@/'1D('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ
M('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T.R!415A4+4%,24=.
M.B!R:6=H="<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$-R4^-"PP,C,\+W1D
M/B`\=&0@<W1Y;&4],T0G5$585"U!3$E'3CH@;&5F="<@=F%L:6=N/3-$8F]T
M=&]M('=I9'1H/3-$,24@;F]W<F%P/3-$;F]W<F%P/CQF;VYT('-T>6QE/3-$
M)T9/3E0M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA
M;CL@1$E34$Q!63H@:6YL:6YE)SX@)FYB<W`[/"]F;VYT/B`\+W1D/B`\=&0@
M=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@86QI9VX],T1R:6=H=#X\9F]N
M="!S='EL93TS1"=&3TY4+5-)6D4Z(#$P<'0[($9/3E0M1D%-24Q9.B!T:6UE
M<R!N97<@<F]M86X[($1)4U!,05DZ(&EN;&EN92<^("9N8G-P.SPO9F]N=#X@
M/"]T9#X@/'1D('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)
M3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T.R!415A4+4%,
M24=..B!L969T)R!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)3XD/"]T9#X@
M/'1D('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I
M;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T.R!415A4+4%,24=..B!R
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M;&4],T0G1D].5"U325I%.B`Q,'!T.R!&3TY4+49!34E,63H@=&EM97,@;F5W
M(')O;6%N.R!$25-03$%9.B!I;FQI;F4G/B`F;F)S<#L\+V9O;G0^(#PO=&0^
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M('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#<E/B@Q.#`\+W1D/B`\=&0@<W1Y
M;&4],T0G1$E34$Q!63H@:6YL:6YE.R!&3TY4+49!34E,63H@=&EM97,@;F5W
M(')O;6%N.R!&3TY4+5-)6D4Z(#$P<'0[(%1%6%0M04Q)1TXZ(&QE9G0G('9A
M;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E(&YO=W)A<#TS1&YO=W)A<#XI/"]T
M9#X@/'1D('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E(&%L:6=N/3-$<FEG
M:'0^/&9O;G0@<W1Y;&4],T0G1D].5"U325I%.B`Q,'!T.R!&3TY4+49!34E,
M63H@=&EM97,@;F5W(')O;6%N.R!$25-03$%9.B!I;FQI;F4G/B`F;F)S<#L\
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M/"]T<CX@/'1R(&)G8V]L;W(],T0C8V-E969F/B`\=&0@<W1Y;&4],T0G5$58
M5"U!3$E'3CH@;&5F=#L@34%21TE.+4Q%1E0Z(#!P=#L@34%21TE.+5))1TA4
M.B`P<'0[(%1%6%0M24Y$14Y4.B`P<'0G('9A;&EG;CTS1&)O='1O;2!W:61T
M:#TS1#(P)3X@/&1I=B!S='EL93TS1"=$25-03$%9.B!B;&]C:SL@1D].5"U&
M04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T.R!-05)'
M24XM3$5&5#H@,'!T.R!-05)'24XM4DE'2%0Z(#!P=#L@5$585"U!3$E'3CH@
M;&5F=#L@5$585"U)3D1%3E0Z(#!P="<^($=O=F5R;FUE;G0@9&5B96YT=7)E
M<R`M(&9I>&5D(&EN=&5R97-T(')A=&4\+V1I=CX@/"]T9#X@/'1D('9A;&EG
M;CTS1&)O='1O;2!W:61T:#TS1#$E(&%L:6=N/3-$<FEG:'0^/&9O;G0@<W1Y
M;&4],T0G1D].5"U325I%.B`Q,'!T.R!&3TY4+49!34E,63H@=&EM97,@;F5W
M(')O;6%N.R!$25-03$%9.B!I;FQI;F4G/B`F;F)S<#L\+V9O;G0^(#PO=&0^
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M25I%.B`Q,'!T.R!415A4+4%,24=..B!R:6=H="<@=F%L:6=N/3-$8F]T=&]M
M('=I9'1H/3-$-R4^.3<\+W1D/B`\=&0@<W1Y;&4],T0G5$585"U!3$E'3CH@
M;&5F="<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@;F]W<F%P/3-$;F]W
M<F%P/CQF;VYT('-T>6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@1D].5"U&04U)
M3%DZ('1I;65S(&YE=R!R;VUA;CL@1$E34$Q!63H@:6YL:6YE)SX@)FYB<W`[
M/"]F;VYT/B`\+W1D/B`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@
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M=R!R;VUA;CL@1$E34$Q!63H@:6YL:6YE)SX@)FYB<W`[/"]F;VYT/B`\+W1D
M/B`\=&0@<W1Y;&4],T0G1$E34$Q!63H@:6YL:6YE.R!&3TY4+49!34E,63H@
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M;&4],T0G1D].5"U325I%.B`Q,'!T.R!&3TY4+49!34E,63H@=&EM97,@;F5W
M(')O;6%N.R!$25-03$%9.B!I;FQI;F4G/B`F;F)S<#L\+V9O;G0^(#PO=&0^
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M25I%.B`Q,'!T.R!415A4+4%,24=..B!R:6=H="<@=F%L:6=N/3-$8F]T=&]M
M('=I9'1H/3-$-R4^+3PO=&0^(#QT9"!S='EL93TS1"=415A4+4%,24=..B!L
M969T)R!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)2!N;W=R87`],T1N;W=R
M87`^/&9O;G0@<W1Y;&4],T0G1D].5"U325I%.B`Q,'!T.R!&3TY4+49!34E,
M63H@=&EM97,@;F5W(')O;6%N.R!$25-03$%9.B!I;FQI;F4G/B`F;F)S<#L\
M+V9O;G0^(#PO=&0^(#QT9"!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)2!A
M;&EG;CTS1')I9VAT/CQF;VYT('-T>6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@
M1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1$E34$Q!63H@:6YL:6YE
M)SX@)FYB<W`[/"]F;VYT/B`\+W1D/B`\=&0@<W1Y;&4],T0G5$585"U!3$E'
M3CH@;&5F="<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24^/&9O;G0@<W1Y
M;&4],T0G1D].5"U325I%.B`Q,'!T.R!&3TY4+49!34E,63H@=&EM97,@;F5W
M(')O;6%N.R!$25-03$%9.B!I;FQI;F4G/B`F;F)S<#L\+V9O;G0^(#PO=&0^
M(#QT9"!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T
M:6UE<R!N97<@<F]M86X[($9/3E0M4TE:13H@,3!P=#L@5$585"U!3$E'3CH@
M<FEG:'0G('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#<E/C$P-CPO=&0^(#QT
M9"!S='EL93TS1"=415A4+4%,24=..B!L969T)R!V86QI9VX],T1B;W1T;VT@
M=VED=&@],T0Q)2!N;W=R87`],T1N;W=R87`^/&9O;G0@<W1Y;&4],T0G1D].
M5"U325I%.B`Q,'!T.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!$
M25-03$%9.B!I;FQI;F4G/B`F;F)S<#L\+V9O;G0^(#PO=&0^(#QT9"!V86QI
M9VX],T1B;W1T;VT@=VED=&@],T0Q)2!A;&EG;CTS1')I9VAT/CQF;VYT('-T
M>6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ('1I;65S(&YE
M=R!R;VUA;CL@1$E34$Q!63H@:6YL:6YE)SX@)FYB<W`[/"]F;VYT/B`\+W1D
M/B`\=&0@<W1Y;&4],T0G5$585"U!3$E'3CH@;&5F="<@=F%L:6=N/3-$8F]T
M=&]M('=I9'1H/3-$,24^/&9O;G0@<W1Y;&4],T0G1D].5"U325I%.B`Q,'!T
M.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!$25-03$%9.B!I;FQI
M;F4G/B`F;F)S<#L\+V9O;G0^(#PO=&0^(#QT9"!S='EL93TS1"=$25-03$%9
M.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE<R!N97<@<F]M86X[($9/3E0M
M4TE:13H@,3!P=#L@5$585"U!3$E'3CH@<FEG:'0G('9A;&EG;CTS1&)O='1O
M;2!W:61T:#TS1#<E/C,R.3PO=&0^(#QT9"!S='EL93TS1"=415A4+4%,24=.
M.B!L969T)R!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)2!N;W=R87`],T1N
M;W=R87`^/&9O;G0@<W1Y;&4],T0G1D].5"U325I%.B`Q,'!T.R!&3TY4+49!
M34E,63H@=&EM97,@;F5W(')O;6%N.R!$25-03$%9.B!I;FQI;F4G/B`F;F)S
M<#L\+V9O;G0^(#PO=&0^(#QT9"!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q
M)2!A;&EG;CTS1')I9VAT/CQF;VYT('-T>6QE/3-$)T9/3E0M4TE:13H@,3!P
M=#L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1$E34$Q!63H@:6YL
M:6YE)SX@)FYB<W`[/"]F;VYT/B`\+W1D/B`\=&0@<W1Y;&4],T0G5$585"U!
M3$E'3CH@;&5F="<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24^/&9O;G0@
M<W1Y;&4],T0G1D].5"U325I%.B`Q,'!T.R!&3TY4+49!34E,63H@=&EM97,@
M;F5W(')O;6%N.R!$25-03$%9.B!I;FQI;F4G/B`F;F)S<#L\+V9O;G0^(#PO
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M<W1Y;&4],T0G1D].5"U325I%.B`Q,'!T.R!&3TY4+49!34E,63H@=&EM97,@
M;F5W(')O;6%N.R!$25-03$%9.B!I;FQI;F4G/B`F;F)S<#L\+V9O;G0^(#PO
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M5"U325I%.B`Q,'!T.R!415A4+4%,24=..B!R:6=H="<@=F%L:6=N/3-$8F]T
M=&]M('=I9'1H/3-$-R4^+3PO=&0^(#QT9"!S='EL93TS1"=415A4+4%,24=.
M.B!L969T)R!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)2!N;W=R87`],T1N
M;W=R87`^/&9O;G0@<W1Y;&4],T0G1D].5"U325I%.B`Q,'!T.R!&3TY4+49!
M34E,63H@=&EM97,@;F5W(')O;6%N.R!$25-03$%9.B!I;FQI;F4G/B`F;F)S
M<#L\+V9O;G0^(#PO=&0^(#QT9"!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q
M)2!A;&EG;CTS1')I9VAT/CQF;VYT('-T>6QE/3-$)T9/3E0M4TE:13H@,3!P
M=#L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1$E34$Q!63H@:6YL
M:6YE)SX@)FYB<W`[/"]F;VYT/B`\+W1D/B`\=&0@<W1Y;&4],T0G5$585"U!
M3$E'3CH@;&5F="<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24^/&9O;G0@
M<W1Y;&4],T0G1D].5"U325I%.B`Q,'!T.R!&3TY4+49!34E,63H@=&EM97,@
M;F5W(')O;6%N.R!$25-03$%9.B!I;FQI;F4G/B`F;F)S<#L\+V9O;G0^(#PO
M=&0^(#QT9"!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9
M.B!T:6UE<R!N97<@<F]M86X[($9/3E0M4TE:13H@,3!P=#L@5$585"U!3$E'
M3CH@<FEG:'0G('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#<E/C,U,#PO=&0^
M(#QT9"!S='EL93TS1"=415A4+4%,24=..B!L969T)R!V86QI9VX],T1B;W1T
M;VT@=VED=&@],T0Q)2!N;W=R87`],T1N;W=R87`^/&9O;G0@<W1Y;&4],T0G
M1D].5"U325I%.B`Q,'!T.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N
M.R!$25-03$%9.B!I;FQI;F4G/B`F;F)S<#L\+V9O;G0^(#PO=&0^(#PO='(^
M(#QT<B!B9V-O;&]R/3-$=VAI=&4^(#QT9"!S='EL93TS1"=0041$24Y'+4)/
M5%1/33H@,G!X.R!415A4+4%,24=..B!L969T.R!-05)'24XM3$5&5#H@,'!T
M.R!-05)'24XM4DE'2%0Z(#!P=#L@5$585"U)3D1%3E0Z(#!P="<@=F%L:6=N
M/3-$8F]T=&]M('=I9'1H/3-$,C`E/B`\9&EV('-T>6QE/3-$)T1)4U!,05DZ
M(&)L;V-K.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!&3TY4+5-)
M6D4Z(#$P<'0[($U!4D=)3BU,1494.B`P<'0[($U!4D=)3BU224=(5#H@,'!T
M.R!415A4+4%,24=..B!L969T.R!415A4+4E.1$5.5#H@,'!T)SX@0V]R<&]R
M871E(&1E8F5N='5R97,@+2!F:7AE9"!I;G1E<F5S="!R871E/"]D:78^(#PO
M=&0^(#QT9"!S='EL93TS1"=0041$24Y'+4)/5%1/33H@,G!X)R!V86QI9VX]
M,T1B;W1T;VT@=VED=&@],T0Q)2!A;&EG;CTS1')I9VAT/CQF;VYT('-T>6QE
M/3-$)T9/3E0M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R
M;VUA;CL@1$E34$Q!63H@:6YL:6YE)SX@)FYB<W`[/"]F;VYT/B`\+W1D/B`\
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M)R!V86QI9VX],T1B;W1T;VT@=VED=&@],T0W)3XT-3(\+W1D/B`\=&0@<W1Y
M;&4],T0G4$%$1$E.1RU"3U143TTZ(#)P>#L@5$585"U!3$E'3CH@;&5F="<@
M=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@;F]W<F%P/3-$;F]W<F%P/CQF
M;VYT('-T>6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ('1I
M;65S(&YE=R!R;VUA;CL@1$E34$Q!63H@:6YL:6YE)SX@)FYB<W`[/"]F;VYT
M/B`\+W1D/B`\=&0@<W1Y;&4],T0G4$%$1$E.1RU"3U143TTZ(#)P>"<@=F%L
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M,24^/&9O;G0@<W1Y;&4],T0G1D].5"U325I%.B`Q,'!T.R!&3TY4+49!34E,
M63H@=&EM97,@;F5W(')O;6%N.R!$25-03$%9.B!I;FQI;F4G/B`F;F)S<#L\
M+V9O;G0^(#PO=&0^(#QT9"!S='EL93TS1"="3U)$15(M0D]45$]-.B!B;&%C
M:R`R<'@@<V]L:60[($1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I
M;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T.R!415A4+4%,24=..B!R
M:6=H="<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$-R4^-30\+W1D/B`\=&0@
M<W1Y;&4],T0G4$%$1$E.1RU"3U143TTZ(#)P>#L@5$585"U!3$E'3CH@;&5F
M="<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@;F]W<F%P/3-$;F]W<F%P
M/CQF;VYT('-T>6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ
M('1I;65S(&YE=R!R;VUA;CL@1$E34$Q!63H@:6YL:6YE)SX@)FYB<W`[/"]F
M;VYT/B`\+W1D/B`\=&0@<W1Y;&4],T0G4$%$1$E.1RU"3U143TTZ(#)P>"<@
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M/3-$,24^/&9O;G0@<W1Y;&4],T0G1D].5"U325I%.B`Q,'!T.R!&3TY4+49!
M34E,63H@=&EM97,@;F5W(')O;6%N.R!$25-03$%9.B!I;FQI;F4G/B`F;F)S
M<#L\+V9O;G0^(#PO=&0^(#QT9"!S='EL93TS1"="3U)$15(M0D]45$]-.B!B
M;&%C:R`R<'@@<V]L:60[($1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ
M('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T.R!415A4+4%,24=.
M.B!R:6=H="<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$-R4^+3PO=&0^(#QT
M9"!S='EL93TS1"=0041$24Y'+4)/5%1/33H@,G!X.R!415A4+4%,24=..B!L
M969T)R!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)2!N;W=R87`],T1N;W=R
M87`^/&9O;G0@<W1Y;&4],T0G1D].5"U325I%.B`Q,'!T.R!&3TY4+49!34E,
M63H@=&EM97,@;F5W(')O;6%N.R!$25-03$%9.B!I;FQI;F4G/B`F;F)S<#L\
M+V9O;G0^(#PO=&0^(#QT9"!S='EL93TS1"=0041$24Y'+4)/5%1/33H@,G!X
M)R!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)2!A;&EG;CTS1')I9VAT/CQF
M;VYT('-T>6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ('1I
M;65S(&YE=R!R;VUA;CL@1$E34$Q!63H@:6YL:6YE)SX@)FYB<W`[/"]F;VYT
M/B`\+W1D/B`\=&0@<W1Y;&4],T0G0D]21$52+4)/5%1/33H@8FQA8VL@,G!X
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M/B`\=&0@<W1Y;&4],T0G4$%$1$E.1RU"3U143TTZ(#)P>#L@5$585"U!3$E'
M3CH@;&5F="<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@;F]W<F%P/3-$
M;F]W<F%P/CQF;VYT('-T>6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@1D].5"U&
M04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1$E34$Q!63H@:6YL:6YE)SX@)FYB
M<W`[/"]F;VYT/B`\+W1D/B`\=&0@<W1Y;&4],T0G4$%$1$E.1RU"3U143TTZ
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M('=I9'1H/3-$,24^/&9O;G0@<W1Y;&4],T0G1D].5"U325I%.B`Q,'!T.R!&
M3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!$25-03$%9.B!I;FQI;F4G
M/B`F;F)S<#L\+V9O;G0^(#PO=&0^(#QT9"!S='EL93TS1"="3U)$15(M0D]4
M5$]-.B!B;&%C:R`R<'@@<V]L:60[($1)4U!,05DZ(&EN;&EN93L@1D].5"U&
M04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T.R!415A4
M+4%,24=..B!R:6=H="<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$-R4^-3`X
M/"]T9#X@/'1D('-T>6QE/3-$)U!!1$1)3D<M0D]45$]-.B`R<'@[(%1%6%0M
M04Q)1TXZ(&QE9G0G('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E(&YO=W)A
M<#TS1&YO=W)A<#X\9F]N="!S='EL93TS1"=&3TY4+5-)6D4Z(#$P<'0[($9/
M3E0M1D%-24Q9.B!T:6UE<R!N97<@<F]M86X[($1)4U!,05DZ(&EN;&EN92<^
M("9N8G-P.SPO9F]N=#X@/"]T9#X@/'1D('-T>6QE/3-$)U!!1$1)3D<M0D]4
M5$]-.B`R<'@G('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E(&%L:6=N/3-$
M<FEG:'0^/&9O;G0@<W1Y;&4],T0G1D].5"U325I%.B`Q,'!T.R!&3TY4+49!
M34E,63H@=&EM97,@;F5W(')O;6%N.R!$25-03$%9.B!I;FQI;F4G/B`F;F)S
M<#L\+V9O;G0^(#PO=&0^(#QT9"!S='EL93TS1"="3U)$15(M0D]45$]-.B!B
M;&%C:R`R<'@@<V]L:60[(%1%6%0M04Q)1TXZ(&QE9G0G('9A;&EG;CTS1&)O
M='1O;2!W:61T:#TS1#$E/CQF;VYT('-T>6QE/3-$)T9/3E0M4TE:13H@,3!P
M=#L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1$E34$Q!63H@:6YL
M:6YE)SX@)FYB<W`[/"]F;VYT/B`\+W1D/B`\=&0@<W1Y;&4],T0G0D]21$52
M+4)/5%1/33H@8FQA8VL@,G!X('-O;&ED.R!$25-03$%9.B!I;FQI;F4[($9/
M3E0M1D%-24Q9.B!T:6UE<R!N97<@<F]M86X[($9/3E0M4TE:13H@,3!P=#L@
M5$585"U!3$E'3CH@<FEG:'0G('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#<E
M/C,P/"]T9#X@/'1D('-T>6QE/3-$)U!!1$1)3D<M0D]45$]-.B`R<'@[(%1%
M6%0M04Q)1TXZ(&QE9G0G('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E(&YO
M=W)A<#TS1&YO=W)A<#X\9F]N="!S='EL93TS1"=&3TY4+5-)6D4Z(#$P<'0[
M($9/3E0M1D%-24Q9.B!T:6UE<R!N97<@<F]M86X[($1)4U!,05DZ(&EN;&EN
M92<^("9N8G-P.SPO9F]N=#X@/"]T9#X@/'1D('-T>6QE/3-$)U!!1$1)3D<M
M0D]45$]-.B`R<'@G('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E(&%L:6=N
M/3-$<FEG:'0^/&9O;G0@<W1Y;&4],T0G1D].5"U325I%.B`Q,'!T.R!&3TY4
M+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!$25-03$%9.B!I;FQI;F4G/B`F
M;F)S<#L\+V9O;G0^(#PO=&0^(#QT9"!S='EL93TS1"="3U)$15(M0D]45$]-
M.B!B;&%C:R`R<'@@<V]L:60[(%1%6%0M04Q)1TXZ(&QE9G0G('9A;&EG;CTS
M1&)O='1O;2!W:61T:#TS1#$E/CQF;VYT('-T>6QE/3-$)T9/3E0M4TE:13H@
M,3!P=#L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1$E34$Q!63H@
M:6YL:6YE)SX@)FYB<W`[/"]F;VYT/B`\+W1D/B`\=&0@<W1Y;&4],T0G0D]2
M1$52+4)/5%1/33H@8FQA8VL@,G!X('-O;&ED.R!$25-03$%9.B!I;FQI;F4[
M($9/3E0M1D%-24Q9.B!T:6UE<R!N97<@<F]M86X[($9/3E0M4TE:13H@,3!P
M=#L@5$585"U!3$E'3CH@<FEG:'0G('9A;&EG;CTS1&)O='1O;2!W:61T:#TS
M1#<E/B@Y/"]T9#X@/'1D('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].
M5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T.R!0
M041$24Y'+4)/5%1/33H@,G!X.R!415A4+4%,24=..B!L969T)R!V86QI9VX]
M,T1B;W1T;VT@=VED=&@],T0Q)2!N;W=R87`],T1N;W=R87`^*3PO=&0^(#QT
M9"!S='EL93TS1"=0041$24Y'+4)/5%1/33H@,G!X)R!V86QI9VX],T1B;W1T
M;VT@=VED=&@],T0Q)2!A;&EG;CTS1')I9VAT/CQF;VYT('-T>6QE/3-$)T9/
M3E0M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@
M1$E34$Q!63H@:6YL:6YE)SX@)FYB<W`[/"]F;VYT/B`\+W1D/B`\=&0@<W1Y
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M9VX],T1B;W1T;VT@=VED=&@],T0W)3XU,CD\+W1D/B`\=&0@<W1Y;&4],T0G
M4$%$1$E.1RU"3U143TTZ(#)P>#L@5$585"U!3$E'3CH@;&5F="<@=F%L:6=N
M/3-$8F]T=&]M('=I9'1H/3-$,24@;F]W<F%P/3-$;F]W<F%P/CQF;VYT('-T
M>6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ('1I;65S(&YE
M=R!R;VUA;CL@1$E34$Q!63H@:6YL:6YE)SX@)FYB<W`[/"]F;VYT/B`\+W1D
M/B`\+W1R/B`\='(@8F=C;VQO<CTS1"-C8V5E9F8^(#QT9"!V86QI9VX],T1B
M;W1T;VT@=VED=&@],T0R,"4^/&9O;G0@<W1Y;&4],T0G1D].5"U325I%.B`Q
M,'!T.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!$25-03$%9.B!I
M;FQI;F4G/B`F;F)S<#L\+V9O;G0^(#PO=&0^(#QT9"!V86QI9VX],T1B;W1T
M;VT@=VED=&@],T0Q)2!A;&EG;CTS1')I9VAT/CQF;VYT('-T>6QE/3-$)T9/
M3E0M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@
M1$E34$Q!63H@:6YL:6YE)SX@)FYB<W`[/"]F;VYT/B`\+W1D/B`\=&0@<W1Y
M;&4],T0G1$E34$Q!63H@:6YL:6YE.R!&3TY4+49!34E,63H@=&EM97,@;F5W
M(')O;6%N.R!&3TY4+5-)6D4Z(#$P<'0[(%1%6%0M04Q)1TXZ(&QE9G0G('9A
M;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E/B0\+W1D/B`\=&0@<W1Y;&4],T0G
M1$E34$Q!63H@:6YL:6YE.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N
M.R!&3TY4+5-)6D4Z(#$P<'0[(%1%6%0M04Q)1TXZ(')I9VAT)R!V86QI9VX]
M,T1B;W1T;VT@=VED=&@],T0W)3XQ.2PT,S`\+W1D/B`\=&0@<W1Y;&4],T0G
M5$585"U!3$E'3CH@;&5F="<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@
M;F]W<F%P/3-$;F]W<F%P/CQF;VYT('-T>6QE/3-$)T9/3E0M4TE:13H@,3!P
M=#L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1$E34$Q!63H@:6YL
M:6YE)SX@)FYB<W`[/"]F;VYT/B`\+W1D/B`\=&0@=F%L:6=N/3-$8F]T=&]M
M('=I9'1H/3-$,24@86QI9VX],T1R:6=H=#X\9F]N="!S='EL93TS1"=&3TY4
M+5-)6D4Z(#$P<'0[($9/3E0M1D%-24Q9.B!T:6UE<R!N97<@<F]M86X[($1)
M4U!,05DZ(&EN;&EN92<^("9N8G-P.SPO9F]N=#X@/"]T9#X@/'1D('-T>6QE
M/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R
M;VUA;CL@1D].5"U325I%.B`Q,'!T.R!415A4+4%,24=..B!L969T)R!V86QI
M9VX],T1B;W1T;VT@=VED=&@],T0Q)3XD/"]T9#X@/'1D('-T>6QE/3-$)T1)
M4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@
M1D].5"U325I%.B`Q,'!T.R!415A4+4%,24=..B!R:6=H="<@=F%L:6=N/3-$
M8F]T=&]M('=I9'1H/3-$-R4^,BPU.#4\+W1D/B`\=&0@<W1Y;&4],T0G5$58
M5"U!3$E'3CH@;&5F="<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@;F]W
M<F%P/3-$;F]W<F%P/CQF;VYT('-T>6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@
M1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1$E34$Q!63H@:6YL:6YE
M)SX@)FYB<W`[/"]F;VYT/B`\+W1D/B`\=&0@=F%L:6=N/3-$8F]T=&]M('=I
M9'1H/3-$,24@86QI9VX],T1R:6=H=#X\9F]N="!S='EL93TS1"=&3TY4+5-)
M6D4Z(#$P<'0[($9/3E0M1D%-24Q9.B!T:6UE<R!N97<@<F]M86X[($1)4U!,
M05DZ(&EN;&EN92<^("9N8G-P.SPO9F]N=#X@/"]T9#X@/'1D('-T>6QE/3-$
M)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA
M;CL@1D].5"U325I%.B`Q,'!T.R!415A4+4%,24=..B!L969T)R!V86QI9VX]
M,T1B;W1T;VT@=VED=&@],T0Q)3XD/"]T9#X@/'1D('-T>6QE/3-$)T1)4U!,
M05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].
M5"U325I%.B`Q,'!T.R!415A4+4%,24=..B!R:6=H="<@=F%L:6=N/3-$8F]T
M=&]M('=I9'1H/3-$-R4^*#(S/"]T9#X@/'1D('-T>6QE/3-$)T1)4U!,05DZ
M(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U3
M25I%.B`Q,'!T.R!415A4+4%,24=..B!L969T)R!V86QI9VX],T1B;W1T;VT@
M=VED=&@],T0Q)2!N;W=R87`],T1N;W=R87`^*3PO=&0^(#QT9"!V86QI9VX]
M,T1B;W1T;VT@=VED=&@],T0Q)2!A;&EG;CTS1')I9VAT/CQF;VYT('-T>6QE
M/3-$)T9/3E0M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R
M;VUA;CL@1$E34$Q!63H@:6YL:6YE)SX@)FYB<W`[/"]F;VYT/B`\+W1D/B`\
M=&0@<W1Y;&4],T0G1$E34$Q!63H@:6YL:6YE.R!&3TY4+49!34E,63H@=&EM
M97,@;F5W(')O;6%N.R!&3TY4+5-)6D4Z(#$P<'0[(%1%6%0M04Q)1TXZ(&QE
M9G0G('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E/B0\+W1D/B`\=&0@<W1Y
M;&4],T0G1$E34$Q!63H@:6YL:6YE.R!&3TY4+49!34E,63H@=&EM97,@;F5W
M(')O;6%N.R!&3TY4+5-)6D4Z(#$P<'0[(%1%6%0M04Q)1TXZ(')I9VAT)R!V
M86QI9VX],T1B;W1T;VT@=VED=&@],T0W)3XR,2PY.3(\+W1D/B`\=&0@<W1Y
M;&4],T0G5$585"U!3$E'3CH@;&5F="<@=F%L:6=N/3-$8F]T=&]M('=I9'1H
M/3-$,24@;F]W<F%P/3-$;F]W<F%P/CQF;VYT('-T>6QE/3-$)T9/3E0M4TE:
M13H@,3!P=#L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1$E34$Q!
M63H@:6YL:6YE)SX@)FYB<W`[/"]F;VYT/B`\+W1D/B`\=&0@=F%L:6=N/3-$
M8F]T=&]M('=I9'1H/3-$,24@86QI9VX],T1R:6=H=#X\9F]N="!S='EL93TS
M1"=&3TY4+5-)6D4Z(#$P<'0[($9/3E0M1D%-24Q9.B!T:6UE<R!N97<@<F]M
M86X[($1)4U!,05DZ(&EN;&EN92<^("9N8G-P.SPO9F]N=#X@/"]T9#X@/'1D
M('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S
M(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T.R!415A4+4%,24=..B!L969T
M)R!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)3XD/"]T9#X@/'1D('-T>6QE
M/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R
M;VUA;CL@1D].5"U325I%.B`Q,'!T.R!415A4+4%,24=..B!R:6=H="<@=F%L
M:6=N/3-$8F]T=&]M('=I9'1H/3-$-R4^-"PX-C`\+W1D/B`\=&0@<W1Y;&4]
M,T0G5$585"U!3$E'3CH@;&5F="<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$
M,24@;F]W<F%P/3-$;F]W<F%P/CQF;VYT('-T>6QE/3-$)T9/3E0M4TE:13H@
M,3!P=#L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1$E34$Q!63H@
M:6YL:6YE)SX@)FYB<W`[/"]F;VYT/B`\+W1D/B`\=&0@=F%L:6=N/3-$8F]T
M=&]M('=I9'1H/3-$,24@86QI9VX],T1R:6=H=#X\9F]N="!S='EL93TS1"=&
M3TY4+5-)6D4Z(#$P<'0[($9/3E0M1D%-24Q9.B!T:6UE<R!N97<@<F]M86X[
M($1)4U!,05DZ(&EN;&EN92<^("9N8G-P.SPO9F]N=#X@/"]T9#X@/'1D('-T
M>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE
M=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T.R!415A4+4%,24=..B!L969T)R!V
M86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)3XD/"]T9#X@/'1D('-T>6QE/3-$
M)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA
M;CL@1D].5"U325I%.B`Q,'!T.R!415A4+4%,24=..B!R:6=H="<@=F%L:6=N
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M25I%.B`Q,'!T.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!$25-0
M3$%9.B!I;FQI;F4G/B`F;F)S<#L\+V9O;G0^(#PO=&0^(#QT9"!S='EL93TS
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M='1O;2!W:61T:#TS1#<E/B@Q.#D\+W1D/B`\=&0@<W1Y;&4],T0G1$E34$Q!
M63H@:6YL:6YE.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!&3TY4
M+5-)6D4Z(#$P<'0[(%1%6%0M04Q)1TXZ(&QE9G0G('9A;&EG;CTS1&)O='1O
M;2!W:61T:#TS1#$E(&YO=W)A<#TS1&YO=W)A<#XI/"]T9#X@/'1D('9A;&EG
M;CTS1&)O='1O;2!W:61T:#TS1#$E(&%L:6=N/3-$<FEG:'0^/&9O;G0@<W1Y
M;&4],T0G1D].5"U325I%.B`Q,'!T.R!&3TY4+49!34E,63H@=&EM97,@;F5W
M(')O;6%N.R!$25-03$%9.B!I;FQI;F4G/B`F;F)S<#L\+V9O;G0^(#PO=&0^
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M($U!4D=)3BU,1494.B`P<'0[($U!4D=)3BU224=(5#H@,'!T.R!415A4+4E.
M1$5.5#H@,'!T)R!V86QI9VX],T1B;W1T;VT@=VED=&@],T0R,"4^(#QD:78@
M<W1Y;&4],T0G1$E34$Q!63H@8FQO8VL[($9/3E0M1D%-24Q9.B!T:6UE<R!N
M97<@<F]M86X[($9/3E0M4TE:13H@,3!P=#L@1D].5"U714E'2%0Z(&)O;&0[
M($U!4D=)3BU,1494.B`P<'0[($U!4D=)3BU224=(5#H@,'!T.R!415A4+4%,
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M4$Q!63H@:6YL:6YE)SX@)FYB<W`[/"]F;VYT/B`\+W1D/B`\=&0@<W1Y;&4]
M,T0G5$585"U!3$E'3CH@<FEG:'0G('9A;&EG;CTS1&)O='1O;2!W:61T:#TS
M1#<E/CQF;VYT('-T>6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@1D].5"U&04U)
M3%DZ('1I;65S(&YE=R!R;VUA;CL@1$E34$Q!63H@:6YL:6YE)SX@)FYB<W`[
M/"]F;VYT/B`\+W1D/B`\=&0@<W1Y;&4],T0G5$585"U!3$E'3CH@;&5F="<@
M=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@;F]W<F%P/3-$;F]W<F%P/CQF
M;VYT('-T>6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ('1I
M;65S(&YE=R!R;VUA;CL@1$E34$Q!63H@:6YL:6YE)SX@)FYB<W`[/"]F;VYT
M/B`\+W1D/B`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24^/&9O;G0@
M<W1Y;&4],T0G1D].5"U325I%.B`Q,'!T.R!&3TY4+49!34E,63H@=&EM97,@
M;F5W(')O;6%N.R!$25-03$%9.B!I;FQI;F4G/B`F;F)S<#L\+V9O;G0^(#PO
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M;CL@1$E34$Q!63H@:6YL:6YE)SX@)FYB<W`[/"]F;VYT/B`\+W1D/B`\=&0@
M<W1Y;&4],T0G5$585"U!3$E'3CH@;&5F="<@=F%L:6=N/3-$8F]T=&]M('=I
M9'1H/3-$,24^/&9O;G0@<W1Y;&4],T0G1D].5"U325I%.B`Q,'!T.R!&3TY4
M+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!$25-03$%9.B!I;FQI;F4G/B`F
M;F)S<#L\+V9O;G0^(#PO=&0^(#QT9"!S='EL93TS1"=415A4+4%,24=..B!R
M:6=H="<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$-R4^/&9O;G0@<W1Y;&4]
M,T0G1D].5"U325I%.B`Q,'!T.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O
M;6%N.R!$25-03$%9.B!I;FQI;F4G/B`F;F)S<#L\+V9O;G0^(#PO=&0^(#QT
M9"!S='EL93TS1"=415A4+4%,24=..B!L969T)R!V86QI9VX],T1B;W1T;VT@
M=VED=&@],T0Q)2!N;W=R87`],T1N;W=R87`^/&9O;G0@<W1Y;&4],T0G1D].
M5"U325I%.B`Q,'!T.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!$
M25-03$%9.B!I;FQI;F4G/B`F;F)S<#L\+V9O;G0^(#PO=&0^(#QT9"!V86QI
M9VX],T1B;W1T;VT@=VED=&@],T0Q)3X\9F]N="!S='EL93TS1"=&3TY4+5-)
M6D4Z(#$P<'0[($9/3E0M1D%-24Q9.B!T:6UE<R!N97<@<F]M86X[($1)4U!,
M05DZ(&EN;&EN92<^("9N8G-P.SPO9F]N=#X@/"]T9#X@/'1D('-T>6QE/3-$
M)U1%6%0M04Q)1TXZ(&QE9G0G('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E
M/CQF;VYT('-T>6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ
M('1I;65S(&YE=R!R;VUA;CL@1$E34$Q!63H@:6YL:6YE)SX@)FYB<W`[/"]F
M;VYT/B`\+W1D/B`\=&0@<W1Y;&4],T0G5$585"U!3$E'3CH@<FEG:'0G('9A
M;&EG;CTS1&)O='1O;2!W:61T:#TS1#<E/CQF;VYT('-T>6QE/3-$)T9/3E0M
M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1$E3
M4$Q!63H@:6YL:6YE)SX@)FYB<W`[/"]F;VYT/B`\+W1D/B`\=&0@<W1Y;&4]
M,T0G5$585"U!3$E'3CH@;&5F="<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$
M,24@;F]W<F%P/3-$;F]W<F%P/CQF;VYT('-T>6QE/3-$)T9/3E0M4TE:13H@
M,3!P=#L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1$E34$Q!63H@
M:6YL:6YE)SX@)FYB<W`[/"]F;VYT/B`\+W1D/B`\=&0@=F%L:6=N/3-$8F]T
M=&]M('=I9'1H/3-$,24^/&9O;G0@<W1Y;&4],T0G1D].5"U325I%.B`Q,'!T
M.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!$25-03$%9.B!I;FQI
M;F4G/B`F;F)S<#L\+V9O;G0^(#PO=&0^(#QT9"!S='EL93TS1"=415A4+4%,
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M<W`[/"]F;VYT/B`\+W1D/B`\=&0@<W1Y;&4],T0G5$585"U!3$E'3CH@;&5F
M="<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24^/&9O;G0@<W1Y;&4],T0G
M1D].5"U325I%.B`Q,'!T.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N
M.R!$25-03$%9.B!I;FQI;F4G/B`F;F)S<#L\+V9O;G0^(#PO=&0^(#QT9"!S
M='EL93TS1"=415A4+4%,24=..B!R:6=H="<@=F%L:6=N/3-$8F]T=&]M('=I
M9'1H/3-$-R4^/&9O;G0@<W1Y;&4],T0G1D].5"U325I%.B`Q,'!T.R!&3TY4
M+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!$25-03$%9.B!I;FQI;F4G/B`F
M;F)S<#L\+V9O;G0^(#PO=&0^(#QT9"!S='EL93TS1"=415A4+4%,24=..B!L
M969T)R!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)2!N;W=R87`],T1N;W=R
M87`^/&9O;G0@<W1Y;&4],T0G1D].5"U325I%.B`Q,'!T.R!&3TY4+49!34E,
M63H@=&EM97,@;F5W(')O;6%N.R!$25-03$%9.B!I;FQI;F4G/B`F;F)S<#L\
M+V9O;G0^(#PO=&0^(#QT9"!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)3X\
M9F]N="!S='EL93TS1"=&3TY4+5-)6D4Z(#$P<'0[($9/3E0M1D%-24Q9.B!T
M:6UE<R!N97<@<F]M86X[($1)4U!,05DZ(&EN;&EN92<^("9N8G-P.SPO9F]N
M=#X@/"]T9#X@/'1D('-T>6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G('9A;&EG
M;CTS1&)O='1O;2!W:61T:#TS1#$E/CQF;VYT('-T>6QE/3-$)T9/3E0M4TE:
M13H@,3!P=#L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1$E34$Q!
M63H@:6YL:6YE)SX@)FYB<W`[/"]F;VYT/B`\+W1D/B`\=&0@<W1Y;&4],T0G
M5$585"U!3$E'3CH@<FEG:'0G('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#<E
M/CQF;VYT('-T>6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ
M('1I;65S(&YE=R!R;VUA;CL@1$E34$Q!63H@:6YL:6YE)SX@)FYB<W`[/"]F
M;VYT/B`\+W1D/B`\=&0@<W1Y;&4],T0G5$585"U!3$E'3CH@;&5F="<@=F%L
M:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@;F]W<F%P/3-$;F]W<F%P/CQF;VYT
M('-T>6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ('1I;65S
M(&YE=R!R;VUA;CL@1$E34$Q!63H@:6YL:6YE)SX@)FYB<W`[/"]F;VYT/B`\
M+W1D/B`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24^/&9O;G0@<W1Y
M;&4],T0G1D].5"U325I%.B`Q,'!T.R!&3TY4+49!34E,63H@=&EM97,@;F5W
M(')O;6%N.R!$25-03$%9.B!I;FQI;F4G/B`F;F)S<#L\+V9O;G0^(#PO=&0^
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M<CX@/'1R(&)G8V]L;W(],T0C8V-E969F/B`\=&0@<W1Y;&4],T0G5$585"U!
M3$E'3CH@;&5F=#L@34%21TE.+4Q%1E0Z(#!P=#L@34%21TE.+5))1TA4.B`P
M<'0[(%1%6%0M24Y$14Y4.B`P<'0G('9A;&EG;CTS1&)O='1O;2!W:61T:#TS
M1#(P)3X@/&1I=B!S='EL93TS1"=$25-03$%9.B!B;&]C:SL@1D].5"U&04U)
M3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T.R!-05)'24XM
M3$5&5#H@,'!T.R!-05)'24XM4DE'2%0Z(#!P=#L@5$585"U!3$E'3CH@;&5F
M=#L@5$585"U)3D1%3E0Z(#!P="<^($=O=F5R;FUE;G0@9&5B96YT=7)E<R`M
M(&9I>&5D(&EN=&5R97-T(')A=&4\+V1I=CX@/"]T9#X@/'1D('9A;&EG;CTS
M1&)O='1O;2!W:61T:#TS1#$E(&%L:6=N/3-$<FEG:'0^/&9O;G0@<W1Y;&4]
M,T0G1D].5"U325I%.B`Q,'!T.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O
M;6%N.R!$25-03$%9.B!I;FQI;F4G/B`F;F)S<#L\+V9O;G0^(#PO=&0^(#QT
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M.B`Q,'!T.R!415A4+4%,24=..B!R:6=H="<@=F%L:6=N/3-$8F]T=&]M('=I
M9'1H/3-$-R4^,BPU.34\+W1D/B`\=&0@<W1Y;&4],T0G5$585"U!3$E'3CH@
M;&5F="<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@;F]W<F%P/3-$;F]W
M<F%P/CQF;VYT('-T>6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@1D].5"U&04U)
M3%DZ('1I;65S(&YE=R!R;VUA;CL@1$E34$Q!63H@:6YL:6YE)SX@)FYB<W`[
M/"]F;VYT/B`\+W1D/B`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@
M86QI9VX],T1R:6=H=#X\9F]N="!S='EL93TS1"=&3TY4+5-)6D4Z(#$P<'0[
M($9/3E0M1D%-24Q9.B!T:6UE<R!N97<@<F]M86X[($1)4U!,05DZ(&EN;&EN
M92<^("9N8G-P.SPO9F]N=#X@/"]T9#X@/'1D('-T>6QE/3-$)U1%6%0M04Q)
M1TXZ(&QE9G0G('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E/CQF;VYT('-T
M>6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ('1I;65S(&YE
M=R!R;VUA;CL@1$E34$Q!63H@:6YL:6YE)SX@)FYB<W`[/"]F;VYT/B`\+W1D
M/B`\=&0@<W1Y;&4],T0G1$E34$Q!63H@:6YL:6YE.R!&3TY4+49!34E,63H@
M=&EM97,@;F5W(')O;6%N.R!&3TY4+5-)6D4Z(#$P<'0[(%1%6%0M04Q)1TXZ
M(')I9VAT)R!V86QI9VX],T1B;W1T;VT@=VED=&@],T0W)3XY.#PO=&0^(#QT
M9"!S='EL93TS1"=415A4+4%,24=..B!L969T)R!V86QI9VX],T1B;W1T;VT@
M=VED=&@],T0Q)2!N;W=R87`],T1N;W=R87`^/&9O;G0@<W1Y;&4],T0G1D].
M5"U325I%.B`Q,'!T.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!$
M25-03$%9.B!I;FQI;F4G/B`F;F)S<#L\+V9O;G0^(#PO=&0^(#QT9"!V86QI
M9VX],T1B;W1T;VT@=VED=&@],T0Q)2!A;&EG;CTS1')I9VAT/CQF;VYT('-T
M>6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ('1I;65S(&YE
M=R!R;VUA;CL@1$E34$Q!63H@:6YL:6YE)SX@)FYB<W`[/"]F;VYT/B`\+W1D
M/B`\=&0@<W1Y;&4],T0G5$585"U!3$E'3CH@;&5F="<@=F%L:6=N/3-$8F]T
M=&]M('=I9'1H/3-$,24^/&9O;G0@<W1Y;&4],T0G1D].5"U325I%.B`Q,'!T
M.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!$25-03$%9.B!I;FQI
M;F4G/B`F;F)S<#L\+V9O;G0^(#PO=&0^(#QT9"!S='EL93TS1"=$25-03$%9
M.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE<R!N97<@<F]M86X[($9/3E0M
M4TE:13H@,3!P=#L@5$585"U!3$E'3CH@<FEG:'0G('9A;&EG;CTS1&)O='1O
M;2!W:61T:#TS1#<E/B@Q/"]T9#X@/'1D('-T>6QE/3-$)T1)4U!,05DZ(&EN
M;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%
M.B`Q,'!T.R!415A4+4%,24=..B!L969T)R!V86QI9VX],T1B;W1T;VT@=VED
M=&@],T0Q)2!N;W=R87`],T1N;W=R87`^*3PO=&0^(#QT9"!V86QI9VX],T1B
M;W1T;VT@=VED=&@],T0Q)2!A;&EG;CTS1')I9VAT/CQF;VYT('-T>6QE/3-$
M)T9/3E0M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA
M;CL@1$E34$Q!63H@:6YL:6YE)SX@)FYB<W`[/"]F;VYT/B`\+W1D/B`\=&0@
M<W1Y;&4],T0G5$585"U!3$E'3CH@;&5F="<@=F%L:6=N/3-$8F]T=&]M('=I
M9'1H/3-$,24^/&9O;G0@<W1Y;&4],T0G1D].5"U325I%.B`Q,'!T.R!&3TY4
M+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!$25-03$%9.B!I;FQI;F4G/B`F
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M:6=N/3-$<FEG:'0^/&9O;G0@<W1Y;&4],T0G1D].5"U325I%.B`Q,'!T.R!&
M3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!$25-03$%9.B!I;FQI;F4G
M/B`F;F)S<#L\+V9O;G0^(#PO=&0^(#QT9"!S='EL93TS1"=415A4+4%,24=.
M.B!L969T)R!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)3X\9F]N="!S='EL
M93TS1"=&3TY4+5-)6D4Z(#$P<'0[($9/3E0M1D%-24Q9.B!T:6UE<R!N97<@
M<F]M86X[($1)4U!,05DZ(&EN;&EN92<^("9N8G-P.SPO9F]N=#X@/"]T9#X@
M/'1D('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I
M;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T.R!415A4+4%,24=..B!R
M:6=H="<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$-R4^,2PV,#(\+W1D/B`\
M=&0@<W1Y;&4],T0G5$585"U!3$E'3CH@;&5F="<@=F%L:6=N/3-$8F]T=&]M
M('=I9'1H/3-$,24@;F]W<F%P/3-$;F]W<F%P/CQF;VYT('-T>6QE/3-$)T9/
M3E0M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@
M1$E34$Q!63H@:6YL:6YE)SX@)FYB<W`[/"]F;VYT/B`\+W1D/B`\=&0@=F%L
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M:6YE)SX@)FYB<W`[/"]F;VYT/B`\+W1D/B`\=&0@<W1Y;&4],T0G1$E34$Q!
M63H@:6YL:6YE.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!&3TY4
M+5-)6D4Z(#$P<'0[(%1%6%0M04Q)1TXZ(')I9VAT)R!V86QI9VX],T1B;W1T
M;VT@=VED=&@],T0W)3XT.3PO=&0^(#QT9"!S='EL93TS1"=415A4+4%,24=.
M.B!L969T)R!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)2!N;W=R87`],T1N
M;W=R87`^/&9O;G0@<W1Y;&4],T0G1D].5"U325I%.B`Q,'!T.R!&3TY4+49!
M34E,63H@=&EM97,@;F5W(')O;6%N.R!$25-03$%9.B!I;FQI;F4G/B`F;F)S
M<#L\+V9O;G0^(#PO=&0^(#QT9"!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q
M)2!A;&EG;CTS1')I9VAT/CQF;VYT('-T>6QE/3-$)T9/3E0M4TE:13H@,3!P
M=#L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1$E34$Q!63H@:6YL
M:6YE)SX@)FYB<W`[/"]F;VYT/B`\+W1D/B`\=&0@<W1Y;&4],T0G5$585"U!
M3$E'3CH@;&5F="<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24^/&9O;G0@
M<W1Y;&4],T0G1D].5"U325I%.B`Q,'!T.R!&3TY4+49!34E,63H@=&EM97,@
M;F5W(')O;6%N.R!$25-03$%9.B!I;FQI;F4G/B`F;F)S<#L\+V9O;G0^(#PO
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M<F%P/BD\+W1D/B`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@86QI
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M;VUA;CL@1$E34$Q!63H@:6YL:6YE)SX@)FYB<W`[/"]F;VYT/B`\+W1D/B`\
M=&0@<W1Y;&4],T0G1$E34$Q!63H@:6YL:6YE.R!&3TY4+49!34E,63H@=&EM
M97,@;F5W(')O;6%N.R!&3TY4+5-)6D4Z(#$P<'0[(%1%6%0M04Q)1TXZ(')I
M9VAT)R!V86QI9VX],T1B;W1T;VT@=VED=&@],T0W)3XQ+#8S.3PO=&0^(#QT
M9"!S='EL93TS1"=415A4+4%,24=..B!L969T)R!V86QI9VX],T1B;W1T;VT@
M=VED=&@],T0Q)2!N;W=R87`],T1N;W=R87`^/&9O;G0@<W1Y;&4],T0G1D].
M5"U325I%.B`Q,'!T.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!$
M25-03$%9.B!I;FQI;F4G/B`F;F)S<#L\+V9O;G0^(#PO=&0^(#PO='(^(#QT
M<B!B9V-O;&]R/3-$=VAI=&4^(#QT9"!S='EL93TS1"=0041$24Y'+4)/5%1/
M33H@,G!X.R!415A4+4%,24=..B!L969T.R!-05)'24XM3$5&5#H@,'!T.R!-
M05)'24XM4DE'2%0Z(#!P=#L@5$585"U)3D1%3E0Z(#!P="<@=F%L:6=N/3-$
M8F]T=&]M('=I9'1H/3-$,C`E/B`\9&EV('-T>6QE/3-$)T1)4U!,05DZ(&)L
M;V-K.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!&3TY4+5-)6D4Z
M(#$P<'0[($U!4D=)3BU,1494.B`P<'0[($U!4D=)3BU224=(5#H@,'!T.R!4
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M;CL@1$E34$Q!63H@:6YL:6YE)SX@)FYB<W`[/"]F;VYT/B`\+W1D/B`\=&0@
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M86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)2!N;W=R87`],T1N;W=R87`^/&9O
M;G0@<W1Y;&4],T0G1D].5"U325I%.B`Q,'!T.R!&3TY4+49!34E,63H@=&EM
M97,@;F5W(')O;6%N.R!$25-03$%9.B!I;FQI;F4G/B`F;F)S<#L\+V9O;G0^
M(#PO=&0^(#QT9"!S='EL93TS1"=0041$24Y'+4)/5%1/33H@,G!X)R!V86QI
M9VX],T1B;W1T;VT@=VED=&@],T0Q)2!A;&EG;CTS1')I9VAT/CQF;VYT('-T
M>6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ('1I;65S(&YE
M=R!R;VUA;CL@1$E34$Q!63H@:6YL:6YE)SX@)FYB<W`[/"]F;VYT/B`\+W1D
M/B`\=&0@<W1Y;&4],T0G0D]21$52+4)/5%1/33H@8FQA8VL@,G!X('-O;&ED
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M9VAT)R!V86QI9VX],T1B;W1T;VT@=VED=&@],T0W)3XR-C,\+W1D/B`\=&0@
M<W1Y;&4],T0G4$%$1$E.1RU"3U143TTZ(#)P>#L@5$585"U!3$E'3CH@;&5F
M="<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@;F]W<F%P/3-$;F]W<F%P
M/CQF;VYT('-T>6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ
M('1I;65S(&YE=R!R;VUA;CL@1$E34$Q!63H@:6YL:6YE)SX@)FYB<W`[/"]F
M;VYT/B`\+W1D/B`\=&0@<W1Y;&4],T0G4$%$1$E.1RU"3U143TTZ(#)P>"<@
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M/3-$,24^/&9O;G0@<W1Y;&4],T0G1D].5"U325I%.B`Q,'!T.R!&3TY4+49!
M34E,63H@=&EM97,@;F5W(')O;6%N.R!$25-03$%9.B!I;FQI;F4G/B`F;F)S
M<#L\+V9O;G0^(#PO=&0^(#QT9"!S='EL93TS1"="3U)$15(M0D]45$]-.B!B
M;&%C:R`R<'@@<V]L:60[($1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ
M('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T.R!415A4+4%,24=.
M.B!R:6=H="<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$-R4^*#4\+W1D/B`\
M=&0@<W1Y;&4],T0G1$E34$Q!63H@:6YL:6YE.R!&3TY4+49!34E,63H@=&EM
M97,@;F5W(')O;6%N.R!&3TY4+5-)6D4Z(#$P<'0[(%!!1$1)3D<M0D]45$]-
M.B`R<'@[(%1%6%0M04Q)1TXZ(&QE9G0G('9A;&EG;CTS1&)O='1O;2!W:61T
M:#TS1#$E(&YO=W)A<#TS1&YO=W)A<#XI/"]T9#X@/'1D('-T>6QE/3-$)U!!
M1$1)3D<M0D]45$]-.B`R<'@G('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E
M(&%L:6=N/3-$<FEG:'0^/&9O;G0@<W1Y;&4],T0G1D].5"U325I%.B`Q,'!T
M.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!$25-03$%9.B!I;FQI
M;F4G/B`F;F)S<#L\+V9O;G0^(#PO=&0^(#QT9"!S='EL93TS1"="3U)$15(M
M0D]45$]-.B!B;&%C:R`R<'@@<V]L:60[(%1%6%0M04Q)1TXZ(&QE9G0G('9A
M;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E/CQF;VYT('-T>6QE/3-$)T9/3E0M
M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1$E3
M4$Q!63H@:6YL:6YE)SX@)FYB<W`[/"]F;VYT/B`\+W1D/B`\=&0@<W1Y;&4]
M,T0G0D]21$52+4)/5%1/33H@8FQA8VL@,G!X('-O;&ED.R!$25-03$%9.B!I
M;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE<R!N97<@<F]M86X[($9/3E0M4TE:
M13H@,3!P=#L@5$585"U!3$E'3CH@<FEG:'0G('9A;&EG;CTS1&)O='1O;2!W
M:61T:#TS1#<E/C4L,38T/"]T9#X@/'1D('-T>6QE/3-$)U!!1$1)3D<M0D]4
M5$]-.B`R<'@[(%1%6%0M04Q)1TXZ(&QE9G0G('9A;&EG;CTS1&)O='1O;2!W
M:61T:#TS1#$E(&YO=W)A<#TS1&YO=W)A<#X\9F]N="!S='EL93TS1"=&3TY4
M+5-)6D4Z(#$P<'0[($9/3E0M1D%-24Q9.B!T:6UE<R!N97<@<F]M86X[($1)
M4U!,05DZ(&EN;&EN92<^("9N8G-P.SPO9F]N=#X@/"]T9#X@/'1D('-T>6QE
M/3-$)U!!1$1)3D<M0D]45$]-.B`R<'@G('9A;&EG;CTS1&)O='1O;2!W:61T
M:#TS1#$E(&%L:6=N/3-$<FEG:'0^/&9O;G0@<W1Y;&4],T0G1D].5"U325I%
M.B`Q,'!T.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!$25-03$%9
M.B!I;FQI;F4G/B`F;F)S<#L\+V9O;G0^(#PO=&0^(#QT9"!S='EL93TS1"="
M3U)$15(M0D]45$]-.B!B;&%C:R`R<'@@<V]L:60[(%1%6%0M04Q)1TXZ(&QE
M9G0G('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E/CQF;VYT('-T>6QE/3-$
M)T9/3E0M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA
M;CL@1$E34$Q!63H@:6YL:6YE)SX@)FYB<W`[/"]F;VYT/B`\+W1D/B`\=&0@
M<W1Y;&4],T0G0D]21$52+4)/5%1/33H@8FQA8VL@,G!X('-O;&ED.R!$25-0
M3$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE<R!N97<@<F]M86X[($9/
M3E0M4TE:13H@,3!P=#L@5$585"U!3$E'3CH@<FEG:'0G('9A;&EG;CTS1&)O
M='1O;2!W:61T:#TS1#<E/C0L.3<V/"]T9#X@/'1D('-T>6QE/3-$)U!!1$1)
M3D<M0D]45$]-.B`R<'@[(%1%6%0M04Q)1TXZ(&QE9G0G('9A;&EG;CTS1&)O
M='1O;2!W:61T:#TS1#$E(&YO=W)A<#TS1&YO=W)A<#X\9F]N="!S='EL93TS
M1"=&3TY4+5-)6D4Z(#$P<'0[($9/3E0M1D%-24Q9.B!T:6UE<R!N97<@<F]M
M86X[($1)4U!,05DZ(&EN;&EN92<^("9N8G-P.SPO9F]N=#X@/"]T9#X@/'1D
M('-T>6QE/3-$)U!!1$1)3D<M0D]45$]-.B`R<'@G('9A;&EG;CTS1&)O='1O
M;2!W:61T:#TS1#$E(&%L:6=N/3-$<FEG:'0^/&9O;G0@<W1Y;&4],T0G1D].
M5"U325I%.B`Q,'!T.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!$
M25-03$%9.B!I;FQI;F4G/B`F;F)S<#L\+V9O;G0^(#PO=&0^(#QT9"!S='EL
M93TS1"="3U)$15(M0D]45$]-.B!B;&%C:R`R<'@@<V]L:60[(%1%6%0M04Q)
M1TXZ(&QE9G0G('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E/CQF;VYT('-T
M>6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ('1I;65S(&YE
M=R!R;VUA;CL@1$E34$Q!63H@:6YL:6YE)SX@)FYB<W`[/"]F;VYT/B`\+W1D
M/B`\=&0@<W1Y;&4],T0G0D]21$52+4)/5%1/33H@8FQA8VL@,G!X('-O;&ED
M.R!$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE<R!N97<@<F]M
M86X[($9/3E0M4TE:13H@,3!P=#L@5$585"U!3$E'3CH@<FEG:'0G('9A;&EG
M;CTS1&)O='1O;2!W:61T:#TS1#<E/C$V,CPO=&0^(#QT9"!S='EL93TS1"=0
M041$24Y'+4)/5%1/33H@,G!X.R!415A4+4%,24=..B!L969T)R!V86QI9VX]
M,T1B;W1T;VT@=VED=&@],T0Q)2!N;W=R87`],T1N;W=R87`^/&9O;G0@<W1Y
M;&4],T0G1D].5"U325I%.B`Q,'!T.R!&3TY4+49!34E,63H@=&EM97,@;F5W
M(')O;6%N.R!$25-03$%9.B!I;FQI;F4G/B`F;F)S<#L\+V9O;G0^(#PO=&0^
M(#QT9"!S='EL93TS1"=0041$24Y'+4)/5%1/33H@,G!X)R!V86QI9VX],T1B
M;W1T;VT@=VED=&@],T0Q)2!A;&EG;CTS1')I9VAT/CQF;VYT('-T>6QE/3-$
M)T9/3E0M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA
M;CL@1$E34$Q!63H@:6YL:6YE)SX@)FYB<W`[/"]F;VYT/B`\+W1D/B`\=&0@
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M86QI9VX],T1B;W1T;VT@=VED=&@],T0W)3XH-S<\+W1D/B`\=&0@<W1Y;&4]
M,T0G1$E34$Q!63H@:6YL:6YE.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O
M;6%N.R!&3TY4+5-)6D4Z(#$P<'0[(%!!1$1)3D<M0D]45$]-.B`R<'@[(%1%
M6%0M04Q)1TXZ(&QE9G0G('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E(&YO
M=W)A<#TS1&YO=W)A<#XI/"]T9#X@/'1D('-T>6QE/3-$)U!!1$1)3D<M0D]4
M5$]-.B`R<'@G('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E(&%L:6=N/3-$
M<FEG:'0^/&9O;G0@<W1Y;&4],T0G1D].5"U325I%.B`Q,'!T.R!&3TY4+49!
M34E,63H@=&EM97,@;F5W(')O;6%N.R!$25-03$%9.B!I;FQI;F4G/B`F;F)S
M<#L\+V9O;G0^(#PO=&0^(#QT9"!S='EL93TS1"="3U)$15(M0D]45$]-.B!B
M;&%C:R`R<'@@<V]L:60[(%1%6%0M04Q)1TXZ(&QE9G0G('9A;&EG;CTS1&)O
M='1O;2!W:61T:#TS1#$E/CQF;VYT('-T>6QE/3-$)T9/3E0M4TE:13H@,3!P
M=#L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1$E34$Q!63H@:6YL
M:6YE)SX@)FYB<W`[/"]F;VYT/B`\+W1D/B`\=&0@<W1Y;&4],T0G0D]21$52
M+4)/5%1/33H@8FQA8VL@,G!X('-O;&ED.R!$25-03$%9.B!I;FQI;F4[($9/
M3E0M1D%-24Q9.B!T:6UE<R!N97<@<F]M86X[($9/3E0M4TE:13H@,3!P=#L@
M5$585"U!3$E'3CH@<FEG:'0G('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#<E
M/C4L,#8Q/"]T9#X@/'1D('-T>6QE/3-$)U!!1$1)3D<M0D]45$]-.B`R<'@[
M(%1%6%0M04Q)1TXZ(&QE9G0G('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E
M(&YO=W)A<#TS1&YO=W)A<#X\9F]N="!S='EL93TS1"=&3TY4+5-)6D4Z(#$P
M<'0[($9/3E0M1D%-24Q9.B!T:6UE<R!N97<@<F]M86X[($1)4U!,05DZ(&EN
M;&EN92<^("9N8G-P.SPO9F]N=#X@/"]T9#X@/"]T<CX@/'1R(&)G8V]L;W(]
M,T0C8V-E969F/B`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,C`E/CQF
M;VYT('-T>6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ('1I
M;65S(&YE=R!R;VUA;CL@1$E34$Q!63H@:6YL:6YE)SX@)FYB<W`[/"]F;VYT
M/B`\+W1D/B`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@86QI9VX]
M,T1R:6=H=#X\9F]N="!S='EL93TS1"=&3TY4+5-)6D4Z(#$P<'0[($9/3E0M
M1D%-24Q9.B!T:6UE<R!N97<@<F]M86X[($1)4U!,05DZ(&EN;&EN92<^("9N
M8G-P.SPO9F]N=#X@/"]T9#X@/'1D('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN
M93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q
M,'!T.R!415A4+4%,24=..B!L969T)R!V86QI9VX],T1B;W1T;VT@=VED=&@]
M,T0Q)3XD/"]T9#X@/'1D('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].
M5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T.R!4
M15A4+4%,24=..B!R:6=H="<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$-R4^
M-RPU,#$\+W1D/B`\=&0@<W1Y;&4],T0G5$585"U!3$E'3CH@;&5F="<@=F%L
M:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@;F]W<F%P/3-$;F]W<F%P/CQF;VYT
M('-T>6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ('1I;65S
M(&YE=R!R;VUA;CL@1$E34$Q!63H@:6YL:6YE)SX@)FYB<W`[/"]F;VYT/B`\
M+W1D/B`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@86QI9VX],T1R
M:6=H=#X\9F]N="!S='EL93TS1"=&3TY4+5-)6D4Z(#$P<'0[($9/3E0M1D%-
M24Q9.B!T:6UE<R!N97<@<F]M86X[($1)4U!,05DZ(&EN;&EN92<^("9N8G-P
M.SPO9F]N=#X@/"]T9#X@/'1D('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@
M1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T
M.R!415A4+4%,24=..B!L969T)R!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q
M)3XD/"]T9#X@/'1D('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&
M04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T.R!415A4
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M/&9O;G0@<W1Y;&4],T0G1D].5"U325I%.B`Q,'!T.R!&3TY4+49!34E,63H@
M=&EM97,@;F5W(')O;6%N.R!$25-03$%9.B!I;FQI;F4G/B`F;F)S<#L\+V9O
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M;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T.R!415A4+4%,24=..B!L
M969T)R!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)2!N;W=R87`],T1N;W=R
M87`^*3PO=&0^(#QT9"!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)2!A;&EG
M;CTS1')I9VAT/CQF;VYT('-T>6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@1D].
M5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1$E34$Q!63H@:6YL:6YE)SX@
M)FYB<W`[/"]F;VYT/B`\+W1D/B`\=&0@<W1Y;&4],T0G1$E34$Q!63H@:6YL
M:6YE.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!&3TY4+5-)6D4Z
M(#$P<'0[(%1%6%0M04Q)1TXZ(&QE9G0G('9A;&EG;CTS1&)O='1O;2!W:61T
M:#TS1#$E/B0\+W1D/B`\=&0@<W1Y;&4],T0G1$E34$Q!63H@:6YL:6YE.R!&
M3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!&3TY4+5-)6D4Z(#$P<'0[
M(%1%6%0M04Q)1TXZ(')I9VAT)R!V86QI9VX],T1B;W1T;VT@=VED=&@],T0W
M)3XW+#@U-CPO=&0^(#QT9"!S='EL93TS1"=415A4+4%,24=..B!L969T)R!V
M86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)2!N;W=R87`],T1N;W=R87`^/&9O
M;G0@<W1Y;&4],T0G1D].5"U325I%.B`Q,'!T.R!&3TY4+49!34E,63H@=&EM
M97,@;F5W(')O;6%N.R!$25-03$%9.B!I;FQI;F4G/B`F;F)S<#L\+V9O;G0^
M(#PO=&0^(#QT9"!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)2!A;&EG;CTS
M1')I9VAT/CQF;VYT('-T>6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@1D].5"U&
M04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1$E34$Q!63H@:6YL:6YE)SX@)FYB
M<W`[/"]F;VYT/B`\+W1D/B`\=&0@<W1Y;&4],T0G1$E34$Q!63H@:6YL:6YE
M.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!&3TY4+5-)6D4Z(#$P
M<'0[(%1%6%0M04Q)1TXZ(&QE9G0G('9A;&EG;CTS1&)O='1O;2!W:61T:#TS
M1#$E/B0\+W1D/B`\=&0@<W1Y;&4],T0G1$E34$Q!63H@:6YL:6YE.R!&3TY4
M+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!&3TY4+5-)6D4Z(#$P<'0[(%1%
M6%0M04Q)1TXZ(')I9VAT)R!V86QI9VX],T1B;W1T;VT@=VED=&@],T0W)3XV
M+#4W.#PO=&0^(#QT9"!S='EL93TS1"=415A4+4%,24=..B!L969T)R!V86QI
M9VX],T1B;W1T;VT@=VED=&@],T0Q)2!N;W=R87`],T1N;W=R87`^/&9O;G0@
M<W1Y;&4],T0G1D].5"U325I%.B`Q,'!T.R!&3TY4+49!34E,63H@=&EM97,@
M;F5W(')O;6%N.R!$25-03$%9.B!I;FQI;F4G/B`F;F)S<#L\+V9O;G0^(#PO
M=&0^(#QT9"!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)2!A;&EG;CTS1')I
M9VAT/CQF;VYT('-T>6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@1D].5"U&04U)
M3%DZ('1I;65S(&YE=R!R;VUA;CL@1$E34$Q!63H@:6YL:6YE)SX@)FYB<W`[
M/"]F;VYT/B`\+W1D/B`\=&0@<W1Y;&4],T0G1$E34$Q!63H@:6YL:6YE.R!&
M3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!&3TY4+5-)6D4Z(#$P<'0[
M(%1%6%0M04Q)1TXZ(&QE9G0G('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E
M/B0\+W1D/B`\=&0@<W1Y;&4],T0G1$E34$Q!63H@:6YL:6YE.R!&3TY4+49!
M34E,63H@=&EM97,@;F5W(')O;6%N.R!&3TY4+5-)6D4Z(#$P<'0[(%1%6%0M
M04Q)1TXZ(')I9VAT)R!V86QI9VX],T1B;W1T;VT@=VED=&@],T0W)3XR,3$\
M+W1D/B`\=&0@<W1Y;&4],T0G5$585"U!3$E'3CH@;&5F="<@=F%L:6=N/3-$
M8F]T=&]M('=I9'1H/3-$,24@;F]W<F%P/3-$;F]W<F%P/CQF;VYT('-T>6QE
M/3-$)T9/3E0M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R
M;VUA;CL@1$E34$Q!63H@:6YL:6YE)SX@)FYB<W`[/"]F;VYT/B`\+W1D/B`\
M=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@86QI9VX],T1R:6=H=#X\
M9F]N="!S='EL93TS1"=&3TY4+5-)6D4Z(#$P<'0[($9/3E0M1D%-24Q9.B!T
M:6UE<R!N97<@<F]M86X[($1)4U!,05DZ(&EN;&EN92<^("9N8G-P.SPO9F]N
M=#X@/"]T9#X@/'1D('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&
M04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T.R!415A4
M+4%,24=..B!L969T)R!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)3XD/"]T
M9#X@/'1D('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ
M('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T.R!415A4+4%,24=.
M.B!R:6=H="<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$-R4^*#@Y/"]T9#X@
M/'1D('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I
M;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T.R!415A4+4%,24=..B!L
M969T)R!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)2!N;W=R87`],T1N;W=R
M87`^*3PO=&0^(#QT9"!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)2!A;&EG
M;CTS1')I9VAT/CQF;VYT('-T>6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@1D].
M5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1$E34$Q!63H@:6YL:6YE)SX@
M)FYB<W`[/"]F;VYT/B`\+W1D/B`\=&0@<W1Y;&4],T0G1$E34$Q!63H@:6YL
M:6YE.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!&3TY4+5-)6D4Z
M(#$P<'0[(%1%6%0M04Q)1TXZ(&QE9G0G('9A;&EG;CTS1&)O='1O;2!W:61T
M:#TS1#$E/B0\+W1D/B`\=&0@<W1Y;&4],T0G1$E34$Q!63H@:6YL:6YE.R!&
M3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!&3TY4+5-)6D4Z(#$P<'0[
M(%1%6%0M04Q)1TXZ(')I9VAT)R!V86QI9VX],T1B;W1T;VT@=VED=&@],T0W
M)3XV+#<P,#PO=&0^(#QT9"!S='EL93TS1"=415A4+4%,24=..B!L969T)R!V
M86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)2!N;W=R87`],T1N;W=R87`^/&9O
M;G0@<W1Y;&4],T0G1D].5"U325I%.B`Q,'!T.R!&3TY4+49!34E,63H@=&EM
M97,@;F5W(')O;6%N.R!$25-03$%9.B!I;FQI;F4G/B`F;F)S<#L\+V9O;G0^
M(#PO=&0^(#PO='(^(#QT<B!B9V-O;&]R/3-$=VAI=&4^(#QT9"!S='EL93TS
M1"=415A4+4%,24=..B!L969T.R!-05)'24XM3$5&5#H@,'!T.R!-05)'24XM
M4DE'2%0Z(#!P=#L@5$585"U)3D1%3E0Z(#!P="<@=F%L:6=N/3-$8F]T=&]M
M('=I9'1H/3-$,C`E/B`\9&EV('-T>6QE/3-$)T1)4U!,05DZ(&)L;V-K.R!&
M3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!&3TY4+5-)6D4Z(#$P<'0[
M($9/3E0M5T5)1TA4.B!B;VQD.R!-05)'24XM3$5&5#H@,'!T.R!-05)'24XM
M4DE'2%0Z(#!P=#L@5$585"U!3$E'3CH@;&5F=#L@5$585"U)3D1%3E0Z(#!P
M="<^($%V86EL86)L92UF;W(M<V%L92`M(&UA='5R97,@869T97(@9FEV92!Y
M96%R<R!T:')O=6=H('1E;B!Y96%R<SH\+V1I=CX@/"]T9#X@/'1D('9A;&EG
M;CTS1&)O='1O;2!W:61T:#TS1#$E/CQF;VYT('-T>6QE/3-$)T9/3E0M4TE:
M13H@,3!P=#L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1$E34$Q!
M63H@:6YL:6YE)SX@)FYB<W`[/"]F;VYT/B`\+W1D/B`\=&0@<W1Y;&4],T0G
M5$585"U!3$E'3CH@;&5F="<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24^
M/&9O;G0@<W1Y;&4],T0G1D].5"U325I%.B`Q,'!T.R!&3TY4+49!34E,63H@
M=&EM97,@;F5W(')O;6%N.R!$25-03$%9.B!I;FQI;F4G/B`F;F)S<#L\+V9O
M;G0^(#PO=&0^(#QT9"!S='EL93TS1"=415A4+4%,24=..B!R:6=H="<@=F%L
M:6=N/3-$8F]T=&]M('=I9'1H/3-$-R4^/&9O;G0@<W1Y;&4],T0G1D].5"U3
M25I%.B`Q,'!T.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!$25-0
M3$%9.B!I;FQI;F4G/B`F;F)S<#L\+V9O;G0^(#PO=&0^(#QT9"!S='EL93TS
M1"=415A4+4%,24=..B!L969T)R!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q
M)2!N;W=R87`],T1N;W=R87`^/&9O;G0@<W1Y;&4],T0G1D].5"U325I%.B`Q
M,'!T.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!$25-03$%9.B!I
M;FQI;F4G/B`F;F)S<#L\+V9O;G0^(#PO=&0^(#QT9"!V86QI9VX],T1B;W1T
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M=R!R;VUA;CL@1$E34$Q!63H@:6YL:6YE)SX@)FYB<W`[/"]F;VYT/B`\+W1D
M/B`\=&0@<W1Y;&4],T0G5$585"U!3$E'3CH@<FEG:'0G('9A;&EG;CTS1&)O
M='1O;2!W:61T:#TS1#<E/CQF;VYT('-T>6QE/3-$)T9/3E0M4TE:13H@,3!P
M=#L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1$E34$Q!63H@:6YL
M:6YE)SX@)FYB<W`[/"]F;VYT/B`\+W1D/B`\=&0@<W1Y;&4],T0G5$585"U!
M3$E'3CH@;&5F="<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@;F]W<F%P
M/3-$;F]W<F%P/CQF;VYT('-T>6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@1D].
M5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1$E34$Q!63H@:6YL:6YE)SX@
M)FYB<W`[/"]F;VYT/B`\+W1D/B`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H
M/3-$,24^/&9O;G0@<W1Y;&4],T0G1D].5"U325I%.B`Q,'!T.R!&3TY4+49!
M34E,63H@=&EM97,@;F5W(')O;6%N.R!$25-03$%9.B!I;FQI;F4G/B`F;F)S
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M;65S(&YE=R!R;VUA;CL@1$E34$Q!63H@:6YL:6YE)SX@)FYB<W`[/"]F;VYT
M/B`\+W1D/B`\=&0@<W1Y;&4],T0G5$585"U!3$E'3CH@;&5F="<@=F%L:6=N
M/3-$8F]T=&]M('=I9'1H/3-$,24^/&9O;G0@<W1Y;&4],T0G1D].5"U325I%
M.B`Q,'!T.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!$25-03$%9
M.B!I;FQI;F4G/B`F;F)S<#L\+V9O;G0^(#PO=&0^(#QT9"!S='EL93TS1"=4
M15A4+4%,24=..B!R:6=H="<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$-R4^
M/&9O;G0@<W1Y;&4],T0G1D].5"U325I%.B`Q,'!T.R!&3TY4+49!34E,63H@
M=&EM97,@;F5W(')O;6%N.R!$25-03$%9.B!I;FQI;F4G/B`F;F)S<#L\+V9O
M;G0^(#PO=&0^(#QT9"!S='EL93TS1"=415A4+4%,24=..B!L969T)R!V86QI
M9VX],T1B;W1T;VT@=VED=&@],T0Q)2!N;W=R87`],T1N;W=R87`^/&9O;G0@
M<W1Y;&4],T0G1D].5"U325I%.B`Q,'!T.R!&3TY4+49!34E,63H@=&EM97,@
M;F5W(')O;6%N.R!$25-03$%9.B!I;FQI;F4G/B`F;F)S<#L\+V9O;G0^(#PO
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M)SX@)FYB<W`[/"]F;VYT/B`\+W1D/B`\=&0@<W1Y;&4],T0G5$585"U!3$E'
M3CH@<FEG:'0G('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#<E/CQF;VYT('-T
M>6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ('1I;65S(&YE
M=R!R;VUA;CL@1$E34$Q!63H@:6YL:6YE)SX@)FYB<W`[/"]F;VYT/B`\+W1D
M/B`\=&0@<W1Y;&4],T0G5$585"U!3$E'3CH@;&5F="<@=F%L:6=N/3-$8F]T
M=&]M('=I9'1H/3-$,24@;F]W<F%P/3-$;F]W<F%P/CQF;VYT('-T>6QE/3-$
M)T9/3E0M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA
M;CL@1$E34$Q!63H@:6YL:6YE)SX@)FYB<W`[/"]F;VYT/B`\+W1D/B`\=&0@
M=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24^/&9O;G0@<W1Y;&4],T0G1D].
M5"U325I%.B`Q,'!T.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!$
M25-03$%9.B!I;FQI;F4G/B`F;F)S<#L\+V9O;G0^(#PO=&0^(#QT9"!S='EL
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M:6YL:6YE)SX@)FYB<W`[/"]F;VYT/B`\+W1D/B`\=&0@<W1Y;&4],T0G5$58
M5"U!3$E'3CH@;&5F="<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24^/&9O
M;G0@<W1Y;&4],T0G1D].5"U325I%.B`Q,'!T.R!&3TY4+49!34E,63H@=&EM
M97,@;F5W(')O;6%N.R!$25-03$%9.B!I;FQI;F4G/B`F;F)S<#L\+V9O;G0^
M(#PO=&0^(#QT9"!S='EL93TS1"=415A4+4%,24=..B!R:6=H="<@=F%L:6=N
M/3-$8F]T=&]M('=I9'1H/3-$-R4^/&9O;G0@<W1Y;&4],T0G1D].5"U325I%
M.B`Q,'!T.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!$25-03$%9
M.B!I;FQI;F4G/B`F;F)S<#L\+V9O;G0^(#PO=&0^(#QT9"!S='EL93TS1"=4
M15A4+4%,24=..B!L969T)R!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)2!N
M;W=R87`],T1N;W=R87`^/&9O;G0@<W1Y;&4],T0G1D].5"U325I%.B`Q,'!T
M.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!$25-03$%9.B!I;FQI
M;F4G/B`F;F)S<#L\+V9O;G0^(#PO=&0^(#QT9"!V86QI9VX],T1B;W1T;VT@
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M;VUA;CL@1$E34$Q!63H@:6YL:6YE)SX@)FYB<W`[/"]F;VYT/B`\+W1D/B`\
M=&0@<W1Y;&4],T0G5$585"U!3$E'3CH@<FEG:'0G('9A;&EG;CTS1&)O='1O
M;2!W:61T:#TS1#<E/CQF;VYT('-T>6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@
M1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1$E34$Q!63H@:6YL:6YE
M)SX@)FYB<W`[/"]F;VYT/B`\+W1D/B`\=&0@<W1Y;&4],T0G5$585"U!3$E'
M3CH@;&5F="<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@;F]W<F%P/3-$
M;F]W<F%P/CQF;VYT('-T>6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@1D].5"U&
M04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1$E34$Q!63H@:6YL:6YE)SX@)FYB
M<W`[/"]F;VYT/B`\+W1D/B`\+W1R/B`\='(@8F=C;VQO<CTS1"-C8V5E9F8^
M(#QT9"!S='EL93TS1"=415A4+4%,24=..B!L969T.R!-05)'24XM3$5&5#H@
M,'!T.R!-05)'24XM4DE'2%0Z(#!P=#L@5$585"U)3D1%3E0Z(#!P="<@=F%L
M:6=N/3-$8F]T=&]M('=I9'1H/3-$,C`E/B`\9&EV('-T>6QE/3-$)T1)4U!,
M05DZ(&)L;V-K.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!&3TY4
M+5-)6D4Z(#$P<'0[($U!4D=)3BU,1494.B`P<'0[($U!4D=)3BU224=(5#H@
M,'!T.R!415A4+4%,24=..B!L969T.R!415A4+4E.1$5.5#H@,'!T)SX@1V]V
M97)N;65N="!D96)E;G1U<F5S("T@9FEX960@:6YT97)E<W0@<F%T93PO9&EV
M/B`\+W1D/B`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@86QI9VX]
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M;CL@1$E34$Q!63H@:6YL:6YE)SX@)FYB<W`[/"]F;VYT/B`\+W1D/B`\=&0@
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M1D].5"U325I%.B`Q,'!T.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N
M.R!$25-03$%9.B!I;FQI;F4G/B`F;F)S<#L\+V9O;G0^(#PO=&0^(#QT9"!S
M='EL93TS1"=415A4+4%,24=..B!L969T)R!V86QI9VX],T1B;W1T;VT@=VED
M=&@],T0Q)3X\9F]N="!S='EL93TS1"=&3TY4+5-)6D4Z(#$P<'0[($9/3E0M
M1D%-24Q9.B!T:6UE<R!N97<@<F]M86X[($1)4U!,05DZ(&EN;&EN92<^("9N
M8G-P.SPO9F]N=#X@/"]T9#X@/'1D('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN
M93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q
M,'!T.R!415A4+4%,24=..B!R:6=H="<@=F%L:6=N/3-$8F]T=&]M('=I9'1H
M/3-$-R4^+3PO=&0^(#QT9"!S='EL93TS1"=415A4+4%,24=..B!L969T)R!V
M86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)2!N;W=R87`],T1N;W=R87`^/&9O
M;G0@<W1Y;&4],T0G1D].5"U325I%.B`Q,'!T.R!&3TY4+49!34E,63H@=&EM
M97,@;F5W(')O;6%N.R!$25-03$%9.B!I;FQI;F4G/B`F;F)S<#L\+V9O;G0^
M(#PO=&0^(#QT9"!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)2!A;&EG;CTS
M1')I9VAT/CQF;VYT('-T>6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@1D].5"U&
M04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1$E34$Q!63H@:6YL:6YE)SX@)FYB
M<W`[/"]F;VYT/B`\+W1D/B`\=&0@<W1Y;&4],T0G5$585"U!3$E'3CH@;&5F
M="<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24^/&9O;G0@<W1Y;&4],T0G
M1D].5"U325I%.B`Q,'!T.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N
M.R!$25-03$%9.B!I;FQI;F4G/B`F;F)S<#L\+V9O;G0^(#PO=&0^(#QT9"!S
M='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE<R!N
M97<@<F]M86X[($9/3E0M4TE:13H@,3!P=#L@5$585"U!3$E'3CH@<FEG:'0G
M('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#<E/BT\+W1D/B`\=&0@<W1Y;&4]
M,T0G5$585"U!3$E'3CH@;&5F="<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$
M,24@;F]W<F%P/3-$;F]W<F%P/CQF;VYT('-T>6QE/3-$)T9/3E0M4TE:13H@
M,3!P=#L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1$E34$Q!63H@
M:6YL:6YE)SX@)FYB<W`[/"]F;VYT/B`\+W1D/B`\=&0@=F%L:6=N/3-$8F]T
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M<W`[/"]F;VYT/B`\+W1D/B`\=&0@<W1Y;&4],T0G1$E34$Q!63H@:6YL:6YE
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M<FEG:'0^/&9O;G0@<W1Y;&4],T0G1D].5"U325I%.B`Q,'!T.R!&3TY4+49!
M34E,63H@=&EM97,@;F5W(')O;6%N.R!$25-03$%9.B!I;FQI;F4G/B`F;F)S
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M=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T.R!415A4+4%,24=..B!R:6=H="<@
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M1D].5"U325I%.B`Q,'!T.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N
M.R!$25-03$%9.B!I;FQI;F4G/B`F;F)S<#L\+V9O;G0^(#PO=&0^(#QT9"!S
M='EL93TS1"=415A4+4%,24=..B!L969T)R!V86QI9VX],T1B;W1T;VT@=VED
M=&@],T0Q)3X\9F]N="!S='EL93TS1"=&3TY4+5-)6D4Z(#$P<'0[($9/3E0M
M1D%-24Q9.B!T:6UE<R!N97<@<F]M86X[($1)4U!,05DZ(&EN;&EN92<^("9N
M8G-P.SPO9F]N=#X@/"]T9#X@/'1D('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN
M93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q
M,'!T.R!415A4+4%,24=..B!R:6=H="<@=F%L:6=N/3-$8F]T=&]M('=I9'1H
M/3-$-R4^-#4\+W1D/B`\=&0@<W1Y;&4],T0G5$585"U!3$E'3CH@;&5F="<@
M=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@;F]W<F%P/3-$;F]W<F%P/CQF
M;VYT('-T>6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ('1I
M;65S(&YE=R!R;VUA;CL@1$E34$Q!63H@:6YL:6YE)SX@)FYB<W`[/"]F;VYT
M/B`\+W1D/B`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@86QI9VX]
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M;CL@1$E34$Q!63H@:6YL:6YE)SX@)FYB<W`[/"]F;VYT/B`\+W1D/B`\=&0@
M<W1Y;&4],T0G1$E34$Q!63H@:6YL:6YE.R!&3TY4+49!34E,63H@=&EM97,@
M;F5W(')O;6%N.R!&3TY4+5-)6D4Z(#$P<'0[(%1%6%0M04Q)1TXZ(')I9VAT
M)R!V86QI9VX],T1B;W1T;VT@=VED=&@],T0W)3XH,30\+W1D/B`\=&0@<W1Y
M;&4],T0G1$E34$Q!63H@:6YL:6YE.R!&3TY4+49!34E,63H@=&EM97,@;F5W
M(')O;6%N.R!&3TY4+5-)6D4Z(#$P<'0[(%1%6%0M04Q)1TXZ(&QE9G0G('9A
M;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E(&YO=W)A<#TS1&YO=W)A<#XI/"]T
M9#X@/'1D('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E(&%L:6=N/3-$<FEG
M:'0^/&9O;G0@<W1Y;&4],T0G1D].5"U325I%.B`Q,'!T.R!&3TY4+49!34E,
M63H@=&EM97,@;F5W(')O;6%N.R!$25-03$%9.B!I;FQI;F4G/B`F;F)S<#L\
M+V9O;G0^(#PO=&0^(#QT9"!S='EL93TS1"=415A4+4%,24=..B!L969T)R!V
M86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)3X\9F]N="!S='EL93TS1"=&3TY4
M+5-)6D4Z(#$P<'0[($9/3E0M1D%-24Q9.B!T:6UE<R!N97<@<F]M86X[($1)
M4U!,05DZ(&EN;&EN92<^("9N8G-P.SPO9F]N=#X@/"]T9#X@/'1D('-T>6QE
M/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R
M;VUA;CL@1D].5"U325I%.B`Q,'!T.R!415A4+4%,24=..B!R:6=H="<@=F%L
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M,T1W:&ET93X@/'1D('-T>6QE/3-$)U!!1$1)3D<M0D]45$]-.B`R<'@[(%1%
M6%0M04Q)1TXZ(&QE9G0[($U!4D=)3BU,1494.B`P<'0[($U!4D=)3BU224=(
M5#H@,'!T.R!415A4+4E.1$5.5#H@,'!T)R!V86QI9VX],T1B;W1T;VT@=VED
M=&@],T0R,"4^(#QD:78@<W1Y;&4],T0G1$E34$Q!63H@8FQO8VL[($9/3E0M
M1D%-24Q9.B!T:6UE<R!N97<@<F]M86X[($9/3E0M4TE:13H@,3!P=#L@34%2
M1TE.+4Q%1E0Z(#!P=#L@34%21TE.+5))1TA4.B`P<'0[(%1%6%0M04Q)1TXZ
M(&QE9G0[(%1%6%0M24Y$14Y4.B`P<'0G/B!#;W)P;W)A=&4@9&5B96YT=7)E
M<R`M(&9I>&5D(&EN=&5R97-T(')A=&4\+V1I=CX@/"]T9#X@/'1D('-T>6QE
M/3-$)U!!1$1)3D<M0D]45$]-.B`R<'@G('9A;&EG;CTS1&)O='1O;2!W:61T
M:#TS1#$E(&%L:6=N/3-$<FEG:'0^/&9O;G0@<W1Y;&4],T0G1D].5"U325I%
M.B`Q,'!T.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!$25-03$%9
M.B!I;FQI;F4G/B`F;F)S<#L\+V9O;G0^(#PO=&0^(#QT9"!S='EL93TS1"="
M3U)$15(M0D]45$]-.B!B;&%C:R`R<'@@<V]L:60[(%1%6%0M04Q)1TXZ(&QE
M9G0G('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E/CQF;VYT('-T>6QE/3-$
M)T9/3E0M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA
M;CL@1$E34$Q!63H@:6YL:6YE)SX@)FYB<W`[/"]F;VYT/B`\+W1D/B`\=&0@
M<W1Y;&4],T0G0D]21$52+4)/5%1/33H@8FQA8VL@,G!X('-O;&ED.R!$25-0
M3$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE<R!N97<@<F]M86X[($9/
M3E0M4TE:13H@,3!P=#L@5$585"U!3$E'3CH@<FEG:'0G('9A;&EG;CTS1&)O
M='1O;2!W:61T:#TS1#<E/CDT/"]T9#X@/'1D('-T>6QE/3-$)U!!1$1)3D<M
M0D]45$]-.B`R<'@[(%1%6%0M04Q)1TXZ(&QE9G0G('9A;&EG;CTS1&)O='1O
M;2!W:61T:#TS1#$E(&YO=W)A<#TS1&YO=W)A<#X\9F]N="!S='EL93TS1"=&
M3TY4+5-)6D4Z(#$P<'0[($9/3E0M1D%-24Q9.B!T:6UE<R!N97<@<F]M86X[
M($1)4U!,05DZ(&EN;&EN92<^("9N8G-P.SPO9F]N=#X@/"]T9#X@/'1D('-T
M>6QE/3-$)U!!1$1)3D<M0D]45$]-.B`R<'@G('9A;&EG;CTS1&)O='1O;2!W
M:61T:#TS1#$E(&%L:6=N/3-$<FEG:'0^/&9O;G0@<W1Y;&4],T0G1D].5"U3
M25I%.B`Q,'!T.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!$25-0
M3$%9.B!I;FQI;F4G/B`F;F)S<#L\+V9O;G0^(#PO=&0^(#QT9"!S='EL93TS
M1"="3U)$15(M0D]45$]-.B!B;&%C:R`R<'@@<V]L:60[(%1%6%0M04Q)1TXZ
M(&QE9G0G('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E/CQF;VYT('-T>6QE
M/3-$)T9/3E0M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R
M;VUA;CL@1$E34$Q!63H@:6YL:6YE)SX@)FYB<W`[/"]F;VYT/B`\+W1D/B`\
M=&0@<W1Y;&4],T0G0D]21$52+4)/5%1/33H@8FQA8VL@,G!X('-O;&ED.R!$
M25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE<R!N97<@<F]M86X[
M($9/3E0M4TE:13H@,3!P=#L@5$585"U!3$E'3CH@<FEG:'0G('9A;&EG;CTS
M1&)O='1O;2!W:61T:#TS1#<E/C$Y/"]T9#X@/'1D('-T>6QE/3-$)U!!1$1)
M3D<M0D]45$]-.B`R<'@[(%1%6%0M04Q)1TXZ(&QE9G0G('9A;&EG;CTS1&)O
M='1O;2!W:61T:#TS1#$E(&YO=W)A<#TS1&YO=W)A<#X\9F]N="!S='EL93TS
M1"=&3TY4+5-)6D4Z(#$P<'0[($9/3E0M1D%-24Q9.B!T:6UE<R!N97<@<F]M
M86X[($1)4U!,05DZ(&EN;&EN92<^("9N8G-P.SPO9F]N=#X@/"]T9#X@/'1D
M('-T>6QE/3-$)U!!1$1)3D<M0D]45$]-.B`R<'@G('9A;&EG;CTS1&)O='1O
M;2!W:61T:#TS1#$E(&%L:6=N/3-$<FEG:'0^/&9O;G0@<W1Y;&4],T0G1D].
M5"U325I%.B`Q,'!T.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!$
M25-03$%9.B!I;FQI;F4G/B`F;F)S<#L\+V9O;G0^(#PO=&0^(#QT9"!S='EL
M93TS1"="3U)$15(M0D]45$]-.B!B;&%C:R`R<'@@<V]L:60[(%1%6%0M04Q)
M1TXZ(&QE9G0G('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E/CQF;VYT('-T
M>6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ('1I;65S(&YE
M=R!R;VUA;CL@1$E34$Q!63H@:6YL:6YE)SX@)FYB<W`[/"]F;VYT/B`\+W1D
M/B`\=&0@<W1Y;&4],T0G0D]21$52+4)/5%1/33H@8FQA8VL@,G!X('-O;&ED
M.R!$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE<R!N97<@<F]M
M86X[($9/3E0M4TE:13H@,3!P=#L@5$585"U!3$E'3CH@<FEG:'0G('9A;&EG
M;CTS1&)O='1O;2!W:61T:#TS1#<E/BT\+W1D/B`\=&0@<W1Y;&4],T0G4$%$
M1$E.1RU"3U143TTZ(#)P>#L@5$585"U!3$E'3CH@;&5F="<@=F%L:6=N/3-$
M8F]T=&]M('=I9'1H/3-$,24@;F]W<F%P/3-$;F]W<F%P/CQF;VYT('-T>6QE
M/3-$)T9/3E0M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R
M;VUA;CL@1$E34$Q!63H@:6YL:6YE)SX@)FYB<W`[/"]F;VYT/B`\+W1D/B`\
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M<W1Y;&4],T0G1D].5"U325I%.B`Q,'!T.R!&3TY4+49!34E,63H@=&EM97,@
M;F5W(')O;6%N.R!$25-03$%9.B!I;FQI;F4G/B`F;F)S<#L\+V9O;G0^(#PO
M=&0^(#QT9"!S='EL93TS1"="3U)$15(M0D]45$]-.B!B;&%C:R`R<'@@<V]L
M:60[($1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R
M;VUA;CL@1D].5"U325I%.B`Q,'!T.R!415A4+4%,24=..B!R:6=H="<@=F%L
M:6=N/3-$8F]T=&]M('=I9'1H/3-$-R4^,3$S/"]T9#X@/'1D('-T>6QE/3-$
M)U!!1$1)3D<M0D]45$]-.B`R<'@[(%1%6%0M04Q)1TXZ(&QE9G0G('9A;&EG
M;CTS1&)O='1O;2!W:61T:#TS1#$E(&YO=W)A<#TS1&YO=W)A<#X\9F]N="!S
M='EL93TS1"=&3TY4+5-)6D4Z(#$P<'0[($9/3E0M1D%-24Q9.B!T:6UE<R!N
M97<@<F]M86X[($1)4U!,05DZ(&EN;&EN92<^("9N8G-P.SPO9F]N=#X@/"]T
M9#X@/'1D('-T>6QE/3-$)U!!1$1)3D<M0D]45$]-.B`R<'@G('9A;&EG;CTS
M1&)O='1O;2!W:61T:#TS1#$E(&%L:6=N/3-$<FEG:'0^/&9O;G0@<W1Y;&4]
M,T0G1D].5"U325I%.B`Q,'!T.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O
M;6%N.R!$25-03$%9.B!I;FQI;F4G/B`F;F)S<#L\+V9O;G0^(#PO=&0^(#QT
M9"!S='EL93TS1"="3U)$15(M0D]45$]-.B!B;&%C:R`R<'@@<V]L:60[(%1%
M6%0M04Q)1TXZ(&QE9G0G('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E/CQF
M;VYT('-T>6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ('1I
M;65S(&YE=R!R;VUA;CL@1$E34$Q!63H@:6YL:6YE)SX@)FYB<W`[/"]F;VYT
M/B`\+W1D/B`\=&0@<W1Y;&4],T0G0D]21$52+4)/5%1/33H@8FQA8VL@,G!X
M('-O;&ED.R!$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE<R!N
M97<@<F]M86X[($9/3E0M4TE:13H@,3!P=#L@5$585"U!3$E'3CH@<FEG:'0G
M('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#<E/C<X.3PO=&0^(#QT9"!S='EL
M93TS1"=0041$24Y'+4)/5%1/33H@,G!X.R!415A4+4%,24=..B!L969T)R!V
M86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)2!N;W=R87`],T1N;W=R87`^/&9O
M;G0@<W1Y;&4],T0G1D].5"U325I%.B`Q,'!T.R!&3TY4+49!34E,63H@=&EM
M97,@;F5W(')O;6%N.R!$25-03$%9.B!I;FQI;F4G/B`F;F)S<#L\+V9O;G0^
M(#PO=&0^(#QT9"!S='EL93TS1"=0041$24Y'+4)/5%1/33H@,G!X)R!V86QI
M9VX],T1B;W1T;VT@=VED=&@],T0Q)2!A;&EG;CTS1')I9VAT/CQF;VYT('-T
M>6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ('1I;65S(&YE
M=R!R;VUA;CL@1$E34$Q!63H@:6YL:6YE)SX@)FYB<W`[/"]F;VYT/B`\+W1D
M/B`\=&0@<W1Y;&4],T0G0D]21$52+4)/5%1/33H@8FQA8VL@,G!X('-O;&ED
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M)R!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)2!N;W=R87`],T1N;W=R87`^
M/&9O;G0@<W1Y;&4],T0G1D].5"U325I%.B`Q,'!T.R!&3TY4+49!34E,63H@
M=&EM97,@;F5W(')O;6%N.R!$25-03$%9.B!I;FQI;F4G/B`F;F)S<#L\+V9O
M;G0^(#PO=&0^(#QT9"!S='EL93TS1"=0041$24Y'+4)/5%1/33H@,G!X)R!V
M86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)2!A;&EG;CTS1')I9VAT/CQF;VYT
M('-T>6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ('1I;65S
M(&YE=R!R;VUA;CL@1$E34$Q!63H@:6YL:6YE)SX@)FYB<W`[/"]F;VYT/B`\
M+W1D/B`\=&0@<W1Y;&4],T0G0D]21$52+4)/5%1/33H@8FQA8VL@,G!X('-O
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M(')I9VAT)R!V86QI9VX],T1B;W1T;VT@=VED=&@],T0W)3XH,3D\+W1D/B`\
M=&0@<W1Y;&4],T0G1$E34$Q!63H@:6YL:6YE.R!&3TY4+49!34E,63H@=&EM
M97,@;F5W(')O;6%N.R!&3TY4+5-)6D4Z(#$P<'0[(%!!1$1)3D<M0D]45$]-
M.B`R<'@[(%1%6%0M04Q)1TXZ(&QE9G0G('9A;&EG;CTS1&)O='1O;2!W:61T
M:#TS1#$E(&YO=W)A<#TS1&YO=W)A<#XI/"]T9#X@/'1D('-T>6QE/3-$)U!!
M1$1)3D<M0D]45$]-.B`R<'@G('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E
M(&%L:6=N/3-$<FEG:'0^/&9O;G0@<W1Y;&4],T0G1D].5"U325I%.B`Q,'!T
M.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!$25-03$%9.B!I;FQI
M;F4G/B`F;F)S<#L\+V9O;G0^(#PO=&0^(#QT9"!S='EL93TS1"="3U)$15(M
M0D]45$]-.B!B;&%C:R`R<'@@<V]L:60[(%1%6%0M04Q)1TXZ(&QE9G0G('9A
M;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E/CQF;VYT('-T>6QE/3-$)T9/3E0M
M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1$E3
M4$Q!63H@:6YL:6YE)SX@)FYB<W`[/"]F;VYT/B`\+W1D/B`\=&0@<W1Y;&4]
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M=&@],T0Q)2!N;W=R87`],T1N;W=R87`^/&9O;G0@<W1Y;&4],T0G1D].5"U3
M25I%.B`Q,'!T.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!$25-0
M3$%9.B!I;FQI;F4G/B`F;F)S<#L\+V9O;G0^(#PO=&0^(#PO='(^(#QT<B!B
M9V-O;&]R/3-$(V-C965F9CX@/'1D('-T>6QE/3-$)U!!1$1)3D<M0D]45$]-
M.B`R<'@G('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#(P)3X\9F]N="!S='EL
M93TS1"=&3TY4+5-)6D4Z(#$P<'0[($9/3E0M1D%-24Q9.B!T:6UE<R!N97<@
M<F]M86X[($1)4U!,05DZ(&EN;&EN92<^("9N8G-P.SPO9F]N=#X@/"]T9#X@
M/'1D('-T>6QE/3-$)U!!1$1)3D<M0D]45$]-.B`R<'@G('9A;&EG;CTS1&)O
M='1O;2!W:61T:#TS1#$E(&%L:6=N/3-$<FEG:'0^/&9O;G0@<W1Y;&4],T0G
M1D].5"U325I%.B`Q,'!T.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N
M.R!$25-03$%9.B!I;FQI;F4G/B`F;F)S<#L\+V9O;G0^(#PO=&0^(#QT9"!S
M='EL93TS1"="3U)$15(M0D]45$]-.B!B;&%C:R`R<'@@<V]L:60[($1)4U!,
M05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].
M5"U325I%.B`Q,'!T.R!415A4+4%,24=..B!L969T)R!V86QI9VX],T1B;W1T
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M24=..B!L969T)R!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)2!N;W=R87`]
M,T1N;W=R87`^/&9O;G0@<W1Y;&4],T0G1D].5"U325I%.B`Q,'!T.R!&3TY4
M+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!$25-03$%9.B!I;FQI;F4G/B`F
M;F)S<#L\+V9O;G0^(#PO=&0^(#QT9"!S='EL93TS1"=0041$24Y'+4)/5%1/
M33H@,G!X)R!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)2!A;&EG;CTS1')I
M9VAT/CQF;VYT('-T>6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@1D].5"U&04U)
M3%DZ('1I;65S(&YE=R!R;VUA;CL@1$E34$Q!63H@:6YL:6YE)SX@)FYB<W`[
M/"]F;VYT/B`\+W1D/B`\=&0@<W1Y;&4],T0G0D]21$52+4)/5%1/33H@8FQA
M8VL@,G!X('-O;&ED.R!$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T
M:6UE<R!N97<@<F]M86X[($9/3E0M4TE:13H@,3!P=#L@5$585"U!3$E'3CH@
M;&5F="<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24^)#PO=&0^(#QT9"!S
M='EL93TS1"="3U)$15(M0D]45$]-.B!B;&%C:R`R<'@@<V]L:60[($1)4U!,
M05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].
M5"U325I%.B`Q,'!T.R!415A4+4%,24=..B!R:6=H="<@=F%L:6=N/3-$8F]T
M=&]M('=I9'1H/3-$-R4^,3D\+W1D/B`\=&0@<W1Y;&4],T0G4$%$1$E.1RU"
M3U143TTZ(#)P>#L@5$585"U!3$E'3CH@;&5F="<@=F%L:6=N/3-$8F]T=&]M
M('=I9'1H/3-$,24@;F]W<F%P/3-$;F]W<F%P/CQF;VYT('-T>6QE/3-$)T9/
M3E0M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@
M1$E34$Q!63H@:6YL:6YE)SX@)FYB<W`[/"]F;VYT/B`\+W1D/B`\=&0@<W1Y
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M:#TS1#$E/B0\+W1D/B`\=&0@<W1Y;&4],T0G0D]21$52+4)/5%1/33H@8FQA
M8VL@,G!X('-O;&ED.R!$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T
M:6UE<R!N97<@<F]M86X[($9/3E0M4TE:13H@,3!P=#L@5$585"U!3$E'3CH@
M<FEG:'0G('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#<E/BT\+W1D/B`\=&0@
M<W1Y;&4],T0G4$%$1$E.1RU"3U143TTZ(#)P>#L@5$585"U!3$E'3CH@;&5F
M="<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@;F]W<F%P/3-$;F]W<F%P
M/CQF;VYT('-T>6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ
M('1I;65S(&YE=R!R;VUA;CL@1$E34$Q!63H@:6YL:6YE)SX@)FYB<W`[/"]F
M;VYT/B`\+W1D/B`\=&0@<W1Y;&4],T0G4$%$1$E.1RU"3U143TTZ(#)P>"<@
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M;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E/B0\+W1D/B`\=&0@<W1Y;&4],T0G
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M,T0Q)2!N;W=R87`],T1N;W=R87`^/&9O;G0@<W1Y;&4],T0G1D].5"U325I%
M.B`Q,'!T.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!$25-03$%9
M.B!I;FQI;F4G/B`F;F)S<#L\+V9O;G0^(#PO=&0^(#QT9"!S='EL93TS1"=0
M041$24Y'+4)/5%1/33H@,G!X)R!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q
M)2!A;&EG;CTS1')I9VAT/CQF;VYT('-T>6QE/3-$)T9/3E0M4TE:13H@,3!P
M=#L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1$E34$Q!63H@:6YL
M:6YE)SX@)FYB<W`[/"]F;VYT/B`\+W1D/B`\=&0@<W1Y;&4],T0G0D]21$52
M+4)/5%1/33H@8FQA8VL@,G!X('-O;&ED.R!$25-03$%9.B!I;FQI;F4[($9/
M3E0M1D%-24Q9.B!T:6UE<R!N97<@<F]M86X[($9/3E0M4TE:13H@,3!P=#L@
M5$585"U!3$E'3CH@;&5F="<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24^
M)#PO=&0^(#QT9"!S='EL93TS1"="3U)$15(M0D]45$]-.B!B;&%C:R`R<'@@
M<V]L:60[($1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE
M=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T.R!415A4+4%,24=..B!R:6=H="<@
M=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$-R4^,2PW-#0\+W1D/B`\=&0@<W1Y
M;&4],T0G4$%$1$E.1RU"3U143TTZ(#)P>#L@5$585"U!3$E'3CH@;&5F="<@
M=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@;F]W<F%P/3-$;F]W<F%P/CQF
M;VYT('-T>6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ('1I
M;65S(&YE=R!R;VUA;CL@1$E34$Q!63H@:6YL:6YE)SX@)FYB<W`[/"]F;VYT
M/B`\+W1D/B`\=&0@<W1Y;&4],T0G4$%$1$E.1RU"3U143TTZ(#)P>"<@=F%L
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M;CTS1&)O='1O;2!W:61T:#TS1#$E/B0\+W1D/B`\=&0@<W1Y;&4],T0G0D]2
M1$52+4)/5%1/33H@8FQA8VL@,G!X('-O;&ED.R!$25-03$%9.B!I;FQI;F4[
M($9/3E0M1D%-24Q9.B!T:6UE<R!N97<@<F]M86X[($9/3E0M4TE:13H@,3!P
M=#L@5$585"U!3$E'3CH@<FEG:'0G('9A;&EG;CTS1&)O='1O;2!W:61T:#TS
M1#<E/C<T/"]T9#X@/'1D('-T>6QE/3-$)U!!1$1)3D<M0D]45$]-.B`R<'@[
M(%1%6%0M04Q)1TXZ(&QE9G0G('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E
M(&YO=W)A<#TS1&YO=W)A<#X\9F]N="!S='EL93TS1"=&3TY4+5-)6D4Z(#$P
M<'0[($9/3E0M1D%-24Q9.B!T:6UE<R!N97<@<F]M86X[($1)4U!,05DZ(&EN
M;&EN92<^("9N8G-P.SPO9F]N=#X@/"]T9#X@/'1D('-T>6QE/3-$)U!!1$1)
M3D<M0D]45$]-.B`R<'@G('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E(&%L
M:6=N/3-$<FEG:'0^/&9O;G0@<W1Y;&4],T0G1D].5"U325I%.B`Q,'!T.R!&
M3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!$25-03$%9.B!I;FQI;F4G
M/B`F;F)S<#L\+V9O;G0^(#PO=&0^(#QT9"!S='EL93TS1"="3U)$15(M0D]4
M5$]-.B!B;&%C:R`R<'@@<V]L:60[($1)4U!,05DZ(&EN;&EN93L@1D].5"U&
M04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T.R!415A4
M+4%,24=..B!L969T)R!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)3XD/"]T
M9#X@/'1D('-T>6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#)P>"!S;VQI
M9#L@1$E34$Q!63H@:6YL:6YE.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O
M;6%N.R!&3TY4+5-)6D4Z(#$P<'0[(%1%6%0M04Q)1TXZ(')I9VAT)R!V86QI
M9VX],T1B;W1T;VT@=VED=&@],T0W)3XH,S,\+W1D/B`\=&0@<W1Y;&4],T0G
M1$E34$Q!63H@:6YL:6YE.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N
M.R!&3TY4+5-)6D4Z(#$P<'0[(%!!1$1)3D<M0D]45$]-.B`R<'@[(%1%6%0M
M04Q)1TXZ(&QE9G0G('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E(&YO=W)A
M<#TS1&YO=W)A<#XI/"]T9#X@/'1D('-T>6QE/3-$)U!!1$1)3D<M0D]45$]-
M.B`R<'@G('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E(&%L:6=N/3-$<FEG
M:'0^/&9O;G0@<W1Y;&4],T0G1D].5"U325I%.B`Q,'!T.R!&3TY4+49!34E,
M63H@=&EM97,@;F5W(')O;6%N.R!$25-03$%9.B!I;FQI;F4G/B`F;F)S<#L\
M+V9O;G0^(#PO=&0^(#QT9"!S='EL93TS1"="3U)$15(M0D]45$]-.B!B;&%C
M:R`R<'@@<V]L:60[($1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I
M;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T.R!415A4+4%,24=..B!L
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M;VT@=VED=&@],T0Q)2!N;W=R87`],T1N;W=R87`^/&9O;G0@<W1Y;&4],T0G
M1D].5"U325I%.B`Q,'!T.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N
M.R!$25-03$%9.B!I;FQI;F4G/B`F;F)S<#L\+V9O;G0^(#PO=&0^(#PO='(^
M(#QT<B!B9V-O;&]R/3-$=VAI=&4^(#QT9"!S='EL93TS1"=0041$24Y'+4)/
M5%1/33H@-'!X.R!415A4+4%,24=..B!L969T.R!-05)'24XM3$5&5#H@,'!T
M.R!-05)'24XM4DE'2%0Z(#!P=#L@5$585"U)3D1%3E0Z(#!P="<@=F%L:6=N
M/3-$8F]T=&]M('=I9'1H/3-$,C`E/B`\9&EV('-T>6QE/3-$)T1)4U!,05DZ
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M:6YE)SX@)FYB<W`[/"]F;VYT/B`\+W1D/B`\=&0@<W1Y;&4],T0G0D]21$52
M+4)/5%1/33H@8FQA8VL@-'!X(&1O=6)L93L@1$E34$Q!63H@:6YL:6YE.R!&
M3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!&3TY4+5-)6D4Z(#$P<'0[
M(%1%6%0M04Q)1TXZ(&QE9G0G('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E
M/B0\+W1D/B`\=&0@<W1Y;&4],T0G0D]21$52+4)/5%1/33H@8FQA8VL@-'!X
M(&1O=6)L93L@1$E34$Q!63H@:6YL:6YE.R!&3TY4+49!34E,63H@=&EM97,@
M;F5W(')O;6%N.R!&3TY4+5-)6D4Z(#$P<'0[(%1%6%0M04Q)1TXZ(')I9VAT
M)R!V86QI9VX],T1B;W1T;VT@=VED=&@],T0W)3XR-RPP,C4\+W1D/B`\=&0@
M<W1Y;&4],T0G4$%$1$E.1RU"3U143TTZ(#1P>#L@5$585"U!3$E'3CH@;&5F
M="<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@;F]W<F%P/3-$;F]W<F%P
M/CQF;VYT('-T>6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ
M('1I;65S(&YE=R!R;VUA;CL@1$E34$Q!63H@:6YL:6YE)SX@)FYB<W`[/"]F
M;VYT/B`\+W1D/B`\=&0@<W1Y;&4],T0G4$%$1$E.1RU"3U143TTZ(#1P>"<@
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M=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T.R!415A4+4%,24=..B!L969T)R!V
M86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)3XD/"]T9#X@/'1D('-T>6QE/3-$
M)T)/4D1%4BU"3U143TTZ(&)L86-K(#1P>"!D;W5B;&4[($1)4U!,05DZ(&EN
M;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%
M.B`Q,'!T.R!415A4+4%,24=..B!R:6=H="<@=F%L:6=N/3-$8F]T=&]M('=I
M9'1H/3-$-R4^,BPY-C4\+W1D/B`\=&0@<W1Y;&4],T0G4$%$1$E.1RU"3U14
M3TTZ(#1P>#L@5$585"U!3$E'3CH@;&5F="<@=F%L:6=N/3-$8F]T=&]M('=I
M9'1H/3-$,24@;F]W<F%P/3-$;F]W<F%P/CQF;VYT('-T>6QE/3-$)T9/3E0M
M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1$E3
M4$Q!63H@:6YL:6YE)SX@)FYB<W`[/"]F;VYT/B`\+W1D/B`\=&0@<W1Y;&4]
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M93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q
M,'!T.R!415A4+4%,24=..B!L969T)R!V86QI9VX],T1B;W1T;VT@=VED=&@]
M,T0Q)3XD/"]T9#X@/'1D('-T>6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K
M(#1P>"!D;W5B;&4[($1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I
M;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T.R!415A4+4%,24=..B!R
M:6=H="<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$-R4^*#(Y/"]T9#X@/'1D
M('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S
M(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T.R!0041$24Y'+4)/5%1/33H@
M-'!X.R!415A4+4%,24=..B!L969T)R!V86QI9VX],T1B;W1T;VT@=VED=&@]
M,T0Q)2!N;W=R87`],T1N;W=R87`^*3PO=&0^(#QT9"!S='EL93TS1"=0041$
M24Y'+4)/5%1/33H@-'!X)R!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)2!A
M;&EG;CTS1')I9VAT/CQF;VYT('-T>6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@
M1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1$E34$Q!63H@:6YL:6YE
M)SX@)FYB<W`[/"]F;VYT/B`\+W1D/B`\=&0@<W1Y;&4],T0G0D]21$52+4)/
M5%1/33H@8FQA8VL@-'!X(&1O=6)L93L@1$E34$Q!63H@:6YL:6YE.R!&3TY4
M+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!&3TY4+5-)6D4Z(#$P<'0[(%1%
M6%0M04Q)1TXZ(&QE9G0G('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E/B0\
M+W1D/B`\=&0@<W1Y;&4],T0G0D]21$52+4)/5%1/33H@8FQA8VL@-'!X(&1O
M=6)L93L@1$E34$Q!63H@:6YL:6YE.R!&3TY4+49!34E,63H@=&EM97,@;F5W
M(')O;6%N.R!&3TY4+5-)6D4Z(#$P<'0[(%1%6%0M04Q)1TXZ(')I9VAT)R!V
M86QI9VX],T1B;W1T;VT@=VED=&@],T0W)3XR.2PY-C$\+W1D/B`\=&0@<W1Y
M;&4],T0G4$%$1$E.1RU"3U143TTZ(#1P>#L@5$585"U!3$E'3CH@;&5F="<@
M=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@;F]W<F%P/3-$;F]W<F%P/CQF
M;VYT('-T>6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ('1I
M;65S(&YE=R!R;VUA;CL@1$E34$Q!63H@:6YL:6YE)SX@)FYB<W`[/"]F;VYT
M/B`\+W1D/B`\=&0@<W1Y;&4],T0G4$%$1$E.1RU"3U143TTZ(#1P>"<@=F%L
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M;VUA;CL@1D].5"U325I%.B`Q,'!T.R!415A4+4%,24=..B!L969T)R!V86QI
M9VX],T1B;W1T;VT@=VED=&@],T0Q)3XD/"]T9#X@/'1D('-T>6QE/3-$)T)/
M4D1%4BU"3U143TTZ(&)L86-K(#1P>"!D;W5B;&4[($1)4U!,05DZ(&EN;&EN
M93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q
M,'!T.R!415A4+4%,24=..B!R:6=H="<@=F%L:6=N/3-$8F]T=&]M('=I9'1H
M/3-$-R4^,3,L,3@R/"]T9#X@/'1D('-T>6QE/3-$)U!!1$1)3D<M0D]45$]-
M.B`T<'@[(%1%6%0M04Q)1TXZ(&QE9G0G('9A;&EG;CTS1&)O='1O;2!W:61T
M:#TS1#$E(&YO=W)A<#TS1&YO=W)A<#X\9F]N="!S='EL93TS1"=&3TY4+5-)
M6D4Z(#$P<'0[($9/3E0M1D%-24Q9.B!T:6UE<R!N97<@<F]M86X[($1)4U!,
M05DZ(&EN;&EN92<^("9N8G-P.SPO9F]N=#X@/"]T9#X@/'1D('-T>6QE/3-$
M)U!!1$1)3D<M0D]45$]-.B`T<'@G('9A;&EG;CTS1&)O='1O;2!W:61T:#TS
M1#$E(&%L:6=N/3-$<FEG:'0^/&9O;G0@<W1Y;&4],T0G1D].5"U325I%.B`Q
M,'!T.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!$25-03$%9.B!I
M;FQI;F4G/B`F;F)S<#L\+V9O;G0^(#PO=&0^(#QT9"!S='EL93TS1"="3U)$
M15(M0D]45$]-.B!B;&%C:R`T<'@@9&]U8FQE.R!$25-03$%9.B!I;FQI;F4[
M($9/3E0M1D%-24Q9.B!T:6UE<R!N97<@<F]M86X[($9/3E0M4TE:13H@,3!P
M=#L@5$585"U!3$E'3CH@;&5F="<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$
M,24^)#PO=&0^(#QT9"!S='EL93TS1"="3U)$15(M0D]45$]-.B!B;&%C:R`T
M<'@@9&]U8FQE.R!$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE
M<R!N97<@<F]M86X[($9/3E0M4TE:13H@,3!P=#L@5$585"U!3$E'3CH@<FEG
M:'0G('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#<E/C4W,#PO=&0^(#QT9"!S
M='EL93TS1"=0041$24Y'+4)/5%1/33H@-'!X.R!415A4+4%,24=..B!L969T
M)R!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)2!N;W=R87`],T1N;W=R87`^
M/&9O;G0@<W1Y;&4],T0G1D].5"U325I%.B`Q,'!T.R!&3TY4+49!34E,63H@
M=&EM97,@;F5W(')O;6%N.R!$25-03$%9.B!I;FQI;F4G/B`F;F)S<#L\+V9O
M;G0^(#PO=&0^(#QT9"!S='EL93TS1"=0041$24Y'+4)/5%1/33H@-'!X)R!V
M86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)2!A;&EG;CTS1')I9VAT/CQF;VYT
M('-T>6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ('1I;65S
M(&YE=R!R;VUA;CL@1$E34$Q!63H@:6YL:6YE)SX@)FYB<W`[/"]F;VYT/B`\
M+W1D/B`\=&0@<W1Y;&4],T0G0D]21$52+4)/5%1/33H@8FQA8VL@-'!X(&1O
M=6)L93L@1$E34$Q!63H@:6YL:6YE.R!&3TY4+49!34E,63H@=&EM97,@;F5W
M(')O;6%N.R!&3TY4+5-)6D4Z(#$P<'0[(%1%6%0M04Q)1TXZ(&QE9G0G('9A
M;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E/B0\+W1D/B`\=&0@<W1Y;&4],T0G
M0D]21$52+4)/5%1/33H@8FQA8VL@-'!X(&1O=6)L93L@1$E34$Q!63H@:6YL
M:6YE.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!&3TY4+5-)6D4Z
M(#$P<'0[(%1%6%0M04Q)1TXZ(')I9VAT)R!V86QI9VX],T1B;W1T;VT@=VED
M=&@],T0W)3XH,S$Q/"]T9#X@/'1D('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN
M93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q
M,'!T.R!0041$24Y'+4)/5%1/33H@-'!X.R!415A4+4%,24=..B!L969T)R!V
M86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)2!N;W=R87`],T1N;W=R87`^*3PO
M=&0^(#QT9"!S='EL93TS1"=0041$24Y'+4)/5%1/33H@-'!X)R!V86QI9VX]
M,T1B;W1T;VT@=VED=&@],T0Q)2!A;&EG;CTS1')I9VAT/CQF;VYT('-T>6QE
M/3-$)T9/3E0M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R
M;VUA;CL@1$E34$Q!63H@:6YL:6YE)SX@)FYB<W`[/"]F;VYT/B`\+W1D/B`\
M=&0@<W1Y;&4],T0G0D]21$52+4)/5%1/33H@8FQA8VL@-'!X(&1O=6)L93L@
M1$E34$Q!63H@:6YL:6YE.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N
M.R!&3TY4+5-)6D4Z(#$P<'0[(%1%6%0M04Q)1TXZ(&QE9G0G('9A;&EG;CTS
M1&)O='1O;2!W:61T:#TS1#$E/B0\+W1D/B`\=&0@<W1Y;&4],T0G0D]21$52
M+4)/5%1/33H@8FQA8VL@-'!X(&1O=6)L93L@1$E34$Q!63H@:6YL:6YE.R!&
M3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!&3TY4+5-)6D4Z(#$P<'0[
M(%1%6%0M04Q)1TXZ(')I9VAT)R!V86QI9VX],T1B;W1T;VT@=VED=&@],T0W
M)3XQ,RPT-#$\+W1D/B`\=&0@<W1Y;&4],T0G4$%$1$E.1RU"3U143TTZ(#1P
M>#L@5$585"U!3$E'3CH@;&5F="<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$
M,24@;F]W<F%P/3-$;F]W<F%P/CQF;VYT('-T>6QE/3-$)T9/3E0M4TE:13H@
M,3!P=#L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1$E34$Q!63H@
M:6YL:6YE)SX@)FYB<W`[/"]F;VYT/B`\+W1D/B`\+W1R/B`\+W1A8FQE/B`\
M+V1I=CX@/&1I=B!S='EL93TS1"=$25-03$%9.B!B;&]C:SL@5$585"U)3D1%
M3E0Z(#!P="<^)FYB<W`[/"]D:78^(#QD:78@<W1Y;&4],T0G1$E34$Q!63H@
M:6YL:6YE.R!&3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N.R!&3TY4+5-)
M6D4Z(#$P<'0[($U!4D=)3BU,1494.B`P<'0[($U!4D=)3BU224=(5#H@,'!T
M.R!415A4+4E.1$5.5#H@,'!T)SX@5&AE(&9O;&QO=VEN9R!T86)L92!P<F5S
M96YT<R!G<F]S<R!U;G)E86QI>F5D(&QO<W-E<R!A;F0@9F%I<B!V86QU97,@
M9F]R('1H;W-E(&EN=F5S=&UE;G1S('1H870@=V5R92!I;B!A;B!U;G)E86QI
M>F5D(&QO<W,@<&]S:71I;VX@87,@;V8@2G5N92`S,"P@,C`Q-"!A;F0@2G5N
M92`S,"P@,C`Q,RP@86YD('1H92!L96YG=&@@;V8@=&EM92!T:&%T('1H;W-E
M(&EN=F5S=&UE;G1S(&AA=F4@8F5E;B!I;B!A(&-O;G1I;G5O=7,@;&]S<R!P
M;W-I=&EO;CH\+V1I=CX@/&1I=B!S='EL93TS1"=-05)'24XM3$5&5#H@,'!T
M.R!-05)'24XM4DE'2%0Z(#!P=#L@5$585"U)3D1%3E0Z(#!P="<^("9N8G-P
M.SPO9&EV/B`\9&EV('-T>6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0G/B`\=&%B
M;&4@<W1Y;&4],T0G1D].5"U325I%.B`Q,'!T.R!&3TY4+49!34E,63H@=&EM
M97,@;F5W(')O;6%N)R!C96QL<W!A8VEN9STS1#`@8V5L;'!A9&1I;F<],T0P
M('=I9'1H/3-$,3`P)3X@/'1R/B`\=&0@<W1Y;&4],T0G4$%$1$E.1RU"3U14
M3TTZ(#)P>"<@=F%L:6=N/3-$8F]T=&]M/CQF;VYT('-T>6QE/3-$)T9/3E0M
M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1$E3
M4$Q!63H@:6YL:6YE)SX@)FYB<W`[/"]F;VYT/B`\+W1D/B`\=&0@<W1Y;&4]
M,T0G4$%$1$E.1RU"3U143TTZ(#)P>"<@=F%L:6=N/3-$8F]T=&]M/CQF;VYT
M('-T>6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ('1I;65S
M(&YE=R!R;VUA;CL@1D].5"U714E'2%0Z(&)O;&0[($1)4U!,05DZ(&EN;&EN
M92<^("9N8G-P.SPO9F]N=#X@/"]T9#X@/'1D('-T>6QE/3-$)T)/4D1%4BU"
M3U143TTZ(&)L86-K(#)P>"!S;VQI9"<@=F%L:6=N/3-$8F]T=&]M(&-O;'-P
M86X],T0V/B`\9&EV('-T>6QE/3-$)T1)4U!,05DZ(&)L;V-K.R!&3TY4+49!
M34E,63H@=&EM97,@;F5W(')O;6%N.R!&3TY4+5-)6D4Z(#$P<'0[($9/3E0M
M5T5)1TA4.B!B;VQD.R!-05)'24XM3$5&5#H@,'!T.R!-05)'24XM4DE'2%0Z
M(#!P=#L@=&5X="UA;&EG;CH@8V5N=&5R.R!415A4+4E.1$5.5#H@,'!T)SX@
M3&5S<R!T:&%N(#$R(&UO;G1H<SPO9&EV/B`\+W1D/B`\=&0@<W1Y;&4],T0G
M4$%$1$E.1RU"3U143TTZ(#)P>#L@5$585"U!3$E'3CH@;&5F="<@=F%L:6=N
M/3-$8F]T=&]M(&YO=W)A<#TS1&YO=W)A<#X\9F]N="!S='EL93TS1"=&3TY4
M+5-)6D4Z(#$P<'0[($9/3E0M1D%-24Q9.B!T:6UE<R!N97<@<F]M86X[($9/
M3E0M5T5)1TA4.B!B;VQD.R!$25-03$%9.B!I;FQI;F4G/B`F;F)S<#L\+V9O
M;G0^(#PO=&0^(#QT9"!S='EL93TS1"=0041$24Y'+4)/5%1/33H@,G!X)R!V
M86QI9VX],T1B;W1T;VT^/&9O;G0@<W1Y;&4],T0G1D].5"U325I%.B`Q,'!T
M.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!&3TY4+5=%24=(5#H@
M8F]L9#L@1$E34$Q!63H@:6YL:6YE)SX@)FYB<W`[/"]F;VYT/B`\+W1D/B`\
M=&0@<W1Y;&4],T0G0D]21$52+4)/5%1/33H@8FQA8VL@,G!X('-O;&ED)R!V
M86QI9VX],T1B;W1T;VT@8V]L<W!A;CTS1#8^(#QD:78@<W1Y;&4],T0G1$E3
M4$Q!63H@8FQO8VL[($9/3E0M1D%-24Q9.B!T:6UE<R!N97<@<F]M86X[($9/
M3E0M4TE:13H@,3!P=#L@1D].5"U714E'2%0Z(&)O;&0[($U!4D=)3BU,1494
M.B`P<'0[($U!4D=)3BU224=(5#H@,'!T.R!T97AT+6%L:6=N.B!C96YT97([
M(%1%6%0M24Y$14Y4.B`P<'0G/B`Q,B!M;VYT:',@;W(@9W)E871E<CPO9&EV
M/B`\+W1D/B`\=&0@<W1Y;&4],T0G4$%$1$E.1RU"3U143TTZ(#)P>#L@5$58
M5"U!3$E'3CH@;&5F="<@=F%L:6=N/3-$8F]T=&]M(&YO=W)A<#TS1&YO=W)A
M<#X\9F]N="!S='EL93TS1"=&3TY4+5-)6D4Z(#$P<'0[($9/3E0M1D%-24Q9
M.B!T:6UE<R!N97<@<F]M86X[($9/3E0M5T5)1TA4.B!B;VQD.R!$25-03$%9
M.B!I;FQI;F4G/B`F;F)S<#L\+V9O;G0^(#PO=&0^(#PO='(^(#QT<CX@/'1D
M('-T>6QE/3-$)U!!1$1)3D<M0D]45$]-.B`R<'@G('9A;&EG;CTS1&)O='1O
M;3X\9F]N="!S='EL93TS1"=&3TY4+5-)6D4Z(#$P<'0[($9/3E0M1D%-24Q9
M.B!T:6UE<R!N97<@<F]M86X[($1)4U!,05DZ(&EN;&EN92<^("9N8G-P.SPO
M9F]N=#X@/"]T9#X@/'1D('-T>6QE/3-$)U!!1$1)3D<M0D]45$]-.B`R<'@G
M('9A;&EG;CTS1&)O='1O;3X\9F]N="!S='EL93TS1"=&3TY4+5-)6D4Z(#$P
M<'0[($9/3E0M1D%-24Q9.B!T:6UE<R!N97<@<F]M86X[($9/3E0M5T5)1TA4
M.B!B;VQD.R!$25-03$%9.B!I;FQI;F4G/B`F;F)S<#L\+V9O;G0^(#PO=&0^
M(#QT9"!S='EL93TS1"="3U)$15(M0D]45$]-.B!B;&%C:R`R<'@@<V]L:60G
M('9A;&EG;CTS1&)O='1O;2!C;VQS<&%N/3-$,CX@/&1I=B!S='EL93TS1"=$
M25-03$%9.B!B;&]C:SL@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@
M1D].5"U325I%.B`Q,'!T.R!&3TY4+5=%24=(5#H@8F]L9#L@34%21TE.+4Q%
M1E0Z(#!P=#L@34%21TE.+5))1TA4.B`P<'0[('1E>'0M86QI9VXZ(&-E;G1E
M<CL@5$585"U)3D1%3E0Z(#!P="<^($9A:7(@5F%L=64\+V1I=CX@/"]T9#X@
M/'1D('-T>6QE/3-$)U!!1$1)3D<M0D]45$]-.B`R<'@[(%1%6%0M04Q)1TXZ
M(&QE9G0G('9A;&EG;CTS1&)O='1O;2!N;W=R87`],T1N;W=R87`^/&9O;G0@
M<W1Y;&4],T0G1D].5"U325I%.B`Q,'!T.R!&3TY4+49!34E,63H@=&EM97,@
M;F5W(')O;6%N.R!&3TY4+5=%24=(5#H@8F]L9#L@1$E34$Q!63H@:6YL:6YE
M)SX@)FYB<W`[/"]F;VYT/B`\+W1D/B`\=&0@<W1Y;&4],T0G4$%$1$E.1RU"
M3U143TTZ(#)P>"<@=F%L:6=N/3-$8F]T=&]M/CQF;VYT('-T>6QE/3-$)T9/
M3E0M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@
M1D].5"U714E'2%0Z(&)O;&0[($1)4U!,05DZ(&EN;&EN92<^("9N8G-P.SPO
M9F]N=#X@/"]T9#X@/'1D('-T>6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K
M(#)P>"!S;VQI9"<@=F%L:6=N/3-$8F]T=&]M(&-O;'-P86X],T0R/B`\9&EV
M('-T>6QE/3-$)T1)4U!,05DZ(&)L;V-K.R!&3TY4+49!34E,63H@=&EM97,@
M;F5W(')O;6%N.R!&3TY4+5-)6D4Z(#$P<'0[($9/3E0M5T5)1TA4.B!B;VQD
M.R!-05)'24XM3$5&5#H@,'!T.R!-05)'24XM4DE'2%0Z(#!P=#L@=&5X="UA
M;&EG;CH@8V5N=&5R.R!415A4+4E.1$5.5#H@,'!T)SX@1W)O<W,\+V1I=CX@
M/&1I=B!S='EL93TS1"=$25-03$%9.B!B;&]C:SL@1D].5"U&04U)3%DZ('1I
M;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T.R!&3TY4+5=%24=(5#H@
M8F]L9#L@34%21TE.+4Q%1E0Z(#!P=#L@34%21TE.+5))1TA4.B`P<'0[('1E
M>'0M86QI9VXZ(&-E;G1E<CL@5$585"U)3D1%3E0Z(#!P="<^('5N<F5A;&EZ
M960@;&]S<SPO9&EV/B`\+W1D/B`\=&0@<W1Y;&4],T0G4$%$1$E.1RU"3U14
M3TTZ(#)P>#L@5$585"U!3$E'3CH@;&5F="<@=F%L:6=N/3-$8F]T=&]M(&YO
M=W)A<#TS1&YO=W)A<#X\9F]N="!S='EL93TS1"=&3TY4+5-)6D4Z(#$P<'0[
M($9/3E0M1D%-24Q9.B!T:6UE<R!N97<@<F]M86X[($9/3E0M5T5)1TA4.B!B
M;VQD.R!$25-03$%9.B!I;FQI;F4G/B`F;F)S<#L\+V9O;G0^(#PO=&0^(#QT
M9"!S='EL93TS1"=0041$24Y'+4)/5%1/33H@,G!X)R!V86QI9VX],T1B;W1T
M;VT^/&9O;G0@<W1Y;&4],T0G1D].5"U325I%.B`Q,'!T.R!&3TY4+49!34E,
M63H@=&EM97,@;F5W(')O;6%N.R!&3TY4+5=%24=(5#H@8F]L9#L@1$E34$Q!
M63H@:6YL:6YE)SX@)FYB<W`[/"]F;VYT/B`\+W1D/B`\=&0@<W1Y;&4],T0G
M0D]21$52+4)/5%1/33H@8FQA8VL@,G!X('-O;&ED)R!V86QI9VX],T1B;W1T
M;VT@8V]L<W!A;CTS1#(^(#QD:78@<W1Y;&4],T0G1$E34$Q!63H@8FQO8VL[
M($9/3E0M1D%-24Q9.B!T:6UE<R!N97<@<F]M86X[($9/3E0M4TE:13H@,3!P
M=#L@1D].5"U714E'2%0Z(&)O;&0[($U!4D=)3BU,1494.B`P<'0[($U!4D=)
M3BU224=(5#H@,'!T.R!T97AT+6%L:6=N.B!C96YT97([(%1%6%0M24Y$14Y4
M.B`P<'0G/B!&86ER(%9A;'5E/"]D:78^(#PO=&0^(#QT9"!S='EL93TS1"=0
M041$24Y'+4)/5%1/33H@,G!X.R!415A4+4%,24=..B!L969T)R!V86QI9VX]
M,T1B;W1T;VT@;F]W<F%P/3-$;F]W<F%P/CQF;VYT('-T>6QE/3-$)T9/3E0M
M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].
M5"U714E'2%0Z(&)O;&0[($1)4U!,05DZ(&EN;&EN92<^("9N8G-P.SPO9F]N
M=#X@/"]T9#X@/'1D('-T>6QE/3-$)U!!1$1)3D<M0D]45$]-.B`R<'@G('9A
M;&EG;CTS1&)O='1O;3X\9F]N="!S='EL93TS1"=&3TY4+5-)6D4Z(#$P<'0[
M($9/3E0M1D%-24Q9.B!T:6UE<R!N97<@<F]M86X[($9/3E0M5T5)1TA4.B!B
M;VQD.R!$25-03$%9.B!I;FQI;F4G/B`F;F)S<#L\+V9O;G0^(#PO=&0^(#QT
M9"!S='EL93TS1"="3U)$15(M0D]45$]-.B!B;&%C:R`R<'@@<V]L:60G('9A
M;&EG;CTS1&)O='1O;2!C;VQS<&%N/3-$,CX@/&1I=B!S='EL93TS1"=$25-0
M3$%9.B!B;&]C:SL@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].
M5"U325I%.B`Q,'!T.R!&3TY4+5=%24=(5#H@8F]L9#L@34%21TE.+4Q%1E0Z
M(#!P=#L@34%21TE.+5))1TA4.B`P<'0[('1E>'0M86QI9VXZ(&-E;G1E<CL@
M5$585"U)3D1%3E0Z(#!P="<^($=R;W-S/"]D:78^(#QD:78@<W1Y;&4],T0G
M1$E34$Q!63H@8FQO8VL[($9/3E0M1D%-24Q9.B!T:6UE<R!N97<@<F]M86X[
M($9/3E0M4TE:13H@,3!P=#L@1D].5"U714E'2%0Z(&)O;&0[($U!4D=)3BU,
M1494.B`P<'0[($U!4D=)3BU224=(5#H@,'!T.R!T97AT+6%L:6=N.B!C96YT
M97([(%1%6%0M24Y$14Y4.B`P<'0G/B!U;G)E86QI>F5D(&QO<W,\+V1I=CX@
M/"]T9#X@/'1D('-T>6QE/3-$)U!!1$1)3D<M0D]45$]-.B`R<'@[(%1%6%0M
M04Q)1TXZ(&QE9G0G('9A;&EG;CTS1&)O='1O;2!N;W=R87`],T1N;W=R87`^
M/&9O;G0@<W1Y;&4],T0G1D].5"U325I%.B`Q,'!T.R!&3TY4+49!34E,63H@
M=&EM97,@;F5W(')O;6%N.R!&3TY4+5=%24=(5#H@8F]L9#L@1$E34$Q!63H@
M:6YL:6YE)SX@)FYB<W`[/"]F;VYT/B`\+W1D/B`\+W1R/B`\='(@8F=C;VQO
M<CTS1"-C8V5E9F8^(#QT9"!S='EL93TS1"=415A4+4%,24=..B!L969T.R!-
M05)'24XM3$5&5#H@,'!T.R!-05)'24XM4DE'2%0Z(#!P=#L@5$585"U)3D1%
M3E0Z(#!P="<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$-3(E/B`\9&EV('-T
M>6QE/3-$)T1)4U!,05DZ(&)L;V-K.R!&3TY4+49!34E,63H@=&EM97,@;F5W
M(')O;6%N.R!&3TY4+5-)6D4Z(#$P<'0[($U!4D=)3BU,1494.B`P<'0[($U!
M4D=)3BU224=(5#H@,'!T.R!415A4+4%,24=..B!L969T.R!415A4+4E.1$5.
M5#H@,'!T)SX@07,@;V8@2G5N92`S,"P@,C`Q-#PO9&EV/B`\+W1D/B`\=&0@
M=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24^/&9O;G0@<W1Y;&4],T0G1D].
M5"U325I%.B`Q,'!T.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!$
M25-03$%9.B!I;FQI;F4G/B`F;F)S<#L\+V9O;G0^(#PO=&0^(#QT9"!S='EL
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M87`],T1N;W=R87`^/&9O;G0@<W1Y;&4],T0G1D].5"U325I%.B`Q,'!T.R!&
M3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!$25-03$%9.B!I;FQI;F4G
M/B`F;F)S<#L\+V9O;G0^(#PO=&0^(#QT9"!V86QI9VX],T1B;W1T;VT@=VED
M=&@],T0Q)3X\9F]N="!S='EL93TS1"=&3TY4+5-)6D4Z(#$P<'0[($9/3E0M
M1D%-24Q9.B!T:6UE<R!N97<@<F]M86X[($1)4U!,05DZ(&EN;&EN92<^("9N
M8G-P.SPO9F]N=#X@/"]T9#X@/'1D('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN
M93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q
M,'!T.R!415A4+4%,24=..B!L969T)R!V86QI9VX],T1B;W1T;VT@=VED=&@]
M,T0Q)3XD/"]T9#X@/'1D('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].
M5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T.R!4
M15A4+4%,24=..B!R:6=H="<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$.24^
M*#$W/"]T9#X@/'1D('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&
M04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T.R!415A4
M+4%,24=..B!L969T)R!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)2!N;W=R
M87`],T1N;W=R87`^*3PO=&0^(#QT9"!V86QI9VX],T1B;W1T;VT@=VED=&@]
M,T0Q)3X\9F]N="!S='EL93TS1"=&3TY4+5-)6D4Z(#$P<'0[($9/3E0M1D%-
M24Q9.B!T:6UE<R!N97<@<F]M86X[($1)4U!,05DZ(&EN;&EN92<^("9N8G-P
M.SPO9F]N=#X@/"]T9#X@/'1D('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@
M1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T
M.R!415A4+4%,24=..B!L969T)R!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q
M)3XD/"]T9#X@/'1D('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&
M04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T.R!415A4
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M;CL@1$E34$Q!63H@:6YL:6YE)SX@)FYB<W`[/"]F;VYT/B`\+W1D/B`\=&0@
M<W1Y;&4],T0G1$E34$Q!63H@:6YL:6YE.R!&3TY4+49!34E,63H@=&EM97,@
M;F5W(')O;6%N.R!&3TY4+5-)6D4Z(#$P<'0[(%1%6%0M04Q)1TXZ(&QE9G0G
M('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E/B0\+W1D/B`\=&0@<W1Y;&4]
M,T0G1$E34$Q!63H@:6YL:6YE.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O
M;6%N.R!&3TY4+5-)6D4Z(#$P<'0[(%1%6%0M04Q)1TXZ(')I9VAT)R!V86QI
M9VX],T1B;W1T;VT@=VED=&@],T0Y)3XH,3(\+W1D/B`\=&0@<W1Y;&4],T0G
M1$E34$Q!63H@:6YL:6YE.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N
M.R!&3TY4+5-)6D4Z(#$P<'0[(%1%6%0M04Q)1TXZ(&QE9G0G('9A;&EG;CTS
M1&)O='1O;2!W:61T:#TS1#$E(&YO=W)A<#TS1&YO=W)A<#XI/"]T9#X@/"]T
M<CX@/'1R(&)G8V]L;W(],T1W:&ET93X@/'1D('-T>6QE/3-$)U1%6%0M04Q)
M1TXZ(&QE9G0[($U!4D=)3BU,1494.B`P<'0[($U!4D=)3BU224=(5#H@,'!T
M.R!415A4+4E.1$5.5#H@,'!T)R!V86QI9VX],T1B;W1T;VT@=VED=&@],T0U
M,B4^(#QD:78@<W1Y;&4],T0G1$E34$Q!63H@8FQO8VL[($9/3E0M1D%-24Q9
M.B!T:6UE<R!N97<@<F]M86X[($9/3E0M4TE:13H@,3!P=#L@34%21TE.+4Q%
M1E0Z(#!P=#L@34%21TE.+5))1TA4.B`P<'0[(%1%6%0M04Q)1TXZ(&QE9G0[
M(%1%6%0M24Y$14Y4.B`P<'0G/B!!<R!O9B!*=6YE(#,P+"`R,#$S/"]D:78^
M(#PO=&0^(#QT9"!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)3X\9F]N="!S
M='EL93TS1"=&3TY4+5-)6D4Z(#$P<'0[($9/3E0M1D%-24Q9.B!T:6UE<R!N
M97<@<F]M86X[($1)4U!,05DZ(&EN;&EN92<^("9N8G-P.SPO9F]N=#X@/"]T
M9#X@/'1D('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ
M('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T.R!415A4+4%,24=.
M.B!L969T)R!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)3XD/"]T9#X@/'1D
M('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S
M(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T.R!415A4+4%,24=..B!R:6=H
M="<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$.24^-2PQ,C(\+W1D/B`\=&0@
M<W1Y;&4],T0G5$585"U!3$E'3CH@;&5F="<@=F%L:6=N/3-$8F]T=&]M('=I
M9'1H/3-$,24@;F]W<F%P/3-$;F]W<F%P/CQF;VYT('-T>6QE/3-$)T9/3E0M
M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1$E3
M4$Q!63H@:6YL:6YE)SX@)FYB<W`[/"]F;VYT/B`\+W1D/B`\=&0@=F%L:6=N
M/3-$8F]T=&]M('=I9'1H/3-$,24^/&9O;G0@<W1Y;&4],T0G1D].5"U325I%
M.B`Q,'!T.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!$25-03$%9
M.B!I;FQI;F4G/B`F;F)S<#L\+V9O;G0^(#PO=&0^(#QT9"!S='EL93TS1"=$
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M;2!W:61T:#TS1#DE/B@S,#(\+W1D/B`\=&0@<W1Y;&4],T0G1$E34$Q!63H@
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M:6YL:6YE)SX@)FYB<W`[/"]F;VYT/B`\+W1D/B`\=&0@<W1Y;&4],T0G1$E3
M4$Q!63H@:6YL:6YE.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!&
M3TY4+5-)6D4Z(#$P<'0[(%1%6%0M04Q)1TXZ(&QE9G0G('9A;&EG;CTS1&)O
M='1O;2!W:61T:#TS1#$E/B0\+W1D/B`\=&0@<W1Y;&4],T0G1$E34$Q!63H@
M:6YL:6YE.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!&3TY4+5-)
M6D4Z(#$P<'0[(%1%6%0M04Q)1TXZ(')I9VAT)R!V86QI9VX],T1B;W1T;VT@
M=VED=&@],T0Y)3XS,CPO=&0^(#QT9"!S='EL93TS1"=415A4+4%,24=..B!L
M969T)R!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)2!N;W=R87`],T1N;W=R
M87`^/&9O;G0@<W1Y;&4],T0G1D].5"U325I%.B`Q,'!T.R!&3TY4+49!34E,
M63H@=&EM97,@;F5W(')O;6%N.R!$25-03$%9.B!I;FQI;F4G/B`F;F)S<#L\
M+V9O;G0^(#PO=&0^(#QT9"!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)3X\
M9F]N="!S='EL93TS1"=&3TY4+5-)6D4Z(#$P<'0[($9/3E0M1D%-24Q9.B!T
M:6UE<R!N97<@<F]M86X[($1)4U!,05DZ(&EN;&EN92<^("9N8G-P.SPO9F]N
M=#X@/"]T9#X@/'1D('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&
M04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T.R!415A4
M+4%,24=..B!L969T)R!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)3XD/"]T
M9#X@/'1D('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ
M('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T.R!415A4+4%,24=.
M.B!R:6=H="<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$.24^*#D\+W1D/B`\
M=&0@<W1Y;&4],T0G1$E34$Q!63H@:6YL:6YE.R!&3TY4+49!34E,63H@=&EM
M97,@;F5W(')O;6%N.R!&3TY4+5-)6D4Z(#$P<'0[(%1%6%0M04Q)1TXZ(&QE
M9G0G('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E(&YO=W)A<#TS1&YO=W)A
M<#XI/"]T9#X@/"]T<CX@/"]T86)L93X@/"]D:78^(#QD:78@<W1Y;&4],T0G
M1$E34$Q!63H@8FQO8VL[(%1%6%0M24Y$14Y4.B`P<'0G/CQB<B`O/B`\+V1I
M=CX@/&1I=B!S='EL93TS1"=$25-03$%9.B!B;&]C:SL@1D].5"U&04U)3%DZ
M(%1I;65S($YE=R!2;VUA;CL@1D].5"U325I%.B`Q,'!T.R!-05)'24XM3$5&
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M960@2G5N92`S,"P@,C`Q-"X\+V1I=CX@/&1I=B!S='EL93TS1"=$25-03$%9
M.B!B;&]C:SL@34%21TE.+4Q%1E0Z(#!P=#L@34%21TE.+5))1TA4.B`P<'0[
M('1E>'0M86QI9VXZ(&IU<W1I9GD[(%1%6%0M24Y$14Y4.B`P<'0G/B`F;F)S
M<#L\+V1I=CX@/&1I=B!S='EL93TS1"=$25-03$%9.B!B;&]C:SL@1D].5"U&
M04U)3%DZ(%1I;65S($YE=R!2;VUA;CL@1D].5"U325I%.B`Q,'!T.R!-05)'
M24XM3$5&5#H@,'!T.R!-05)'24XM4DE'2%0Z(#!P=#L@=&5X="UA;&EG;CH@
M;&5F=#L@5$585"U)3D1%3E0Z(#!P="<^($%S(&]F($IU;F4@,S`L(#(P,30@
M86YD(#(P,3,L(&EN=&5R97-T(')E8V5I=F%B;&4@86UO=6YT960@=&\@)#DX
M(&%N9"`D,C`@<F5S<&5C=&EV96QY+CPO9&EV/B`\(2TM16YD1G)A9VUE;G0M
M+3X\+V1I=CX@/"]D:78^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R
M/@T*("`@(#PO=&%B;&4^#0H@(#PO8F]D>3X-"CPO:'1M;#X-"@T*+2TM+2TM
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M:6DB#0H-"CQH=&UL/@T*("`\:&5A9#X-"B`@("`\345402!H='1P+65Q=6EV
M/3-$0V]N=&5N="U4>7!E(&-O;G1E;G0],T0G=&5X="]H=&UL.R!C:&%R<V5T
M/75T9BTX)SX\<V-R:7!T('1Y<&4],T1T97AT+VIA=F%S8W)I<'0@<W)C/3-$
M4VAO=RYJ<SXO*B!$;R!.;W0@4F5M;W9E(%1H:7,@0V]M;65N="`J+SPO<V-R
M:7!T/CPO:&5A9#X-"B`@/&)O9'D^#0H@("`@/'1A8FQE(&-L87-S/3-$<F5P
M;W)T(&ED/3-$240P14U%/@T*("`@("`@/'1R/@T*("`@("`@("`\=&@@8VQA
M<W,],T1T;"!C;VQS<&%N/3-$,2!R;W=S<&%N/3-$,CX\<W1R;VYG/D9!25(@
M5D%,544@3T8@1DE.04Y#24%,($E.4U1254U%3E13/&)R/CPO<W1R;VYG/CPO
M=&@^#0H@("`@("`@(#QT:"!C;&%S<STS1'1H(&-O;'-P86X],T0Q/C$R($UO
M;G1H<R!%;F1E9#PO=&@^#0H@("`@("`\+W1R/@T*("`@("`@/'1R/@T*("`@
M("`@("`\=&@@8VQA<W,],T1T:#Y*=6XN(#,P+"`R,#$T/&)R/CPO=&@^#0H@
M("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$<F4^#0H@("`@("`@(#QT
M9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O<#X\<W1R;VYG/D9!25(@5D%,544@
M3T8@1DE.04Y#24%,($E.4U1254U%3E13(%M!8G-T<F%C=%T\+W-T<F]N9SX\
M+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^
M/"]T9#X-"B`@("`@(#PO='(^#0H@("`@("`\='(@8VQA<W,],T1R;SX-"B`@
M("`@("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P/D9!25(@5D%,544@
M3T8@1DE.04Y#24%,($E.4U1254U%3E13/"]T9#X-"B`@("`@("`@/'1D(&-L
M87-S/3-$=&5X=#XG/"$M+41/0U194$4@:'1M;"!054),24,@(BTO+U<S0R\O
M1%1$(%A(5$U,(#$N,"!4<F%N<VET:6]N86PO+T5.(B`B:'1T<#HO+W=W=RYW
M,RYO<F<O5%(O>&AT;6PQ+T141"]X:'1M;#$M=')A;G-I=&EO;F%L+F1T9"(@
M+2T^/&1I=CX@/&1I=CX\(2TM4W1A<G1&<F%G;65N="TM/B`\9F]N="!S='EL
M93TS1"=&3TY4+5-)6D4Z(#$P<'0[($9/3E0M1D%-24Q9.B!4:6UE<R!.97<@
M4F]M86X[($9/3E0M5T5)1TA4.B!B;VQD.R!$25-03$%9.B!I;FQI;F4G/B!.
M3U1%(#0Z+2!&04E2(%9!3%5%($]&($9)3D%.0TE!3"!)3E-44E5-14Y44SPO
M9F]N=#X@/&1I=B!S='EL93TS1"=$25-03$%9.B!B;&]C:SL@34%21TE.+4Q%
M1E0Z(#!P=#L@34%21TE.+5))1TA4.B`P<'0[('1E>'0M86QI9VXZ(&IU<W1I
M9GD[(%1%6%0M24Y$14Y4.B`P<'0G/B`F;F)S<#L\+V1I=CX@/&1I=B!S='EL
M93TS1"=T97AT+6%L:6=N.B!R:6=H="<^(#QT86)L92!S='EL93TS1"=&3TY4
M+5-)6D4Z(#$P<'0[($9/3E0M1D%-24Q9.B!T:6UE<R!N97<@<F]M86XG(&-E
M;&QS<&%C:6YG/3-$,"!C96QL<&%D9&EN9STS1#`@=VED=&@],T0Y-R4^(#QT
M<CX@/'1D('-T>6QE/3-$)U!!1$1)3D<M0D]45$]-.B`R<'@G('9A;&EG;CTS
M1&)O='1O;2!W:61T:#TS1#(X)3X\9F]N="!S='EL93TS1"=&3TY4+5-)6D4Z
M(#$P<'0[($9/3E0M1D%-24Q9.B!T:6UE<R!N97<@<F]M86X[($1)4U!,05DZ
M(&EN;&EN92<^("9N8G-P.SPO9F]N=#X@/"]T9#X@/'1D('-T>6QE/3-$)U!!
M1$1)3D<M0D]45$]-.B`R<'@G('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E
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M5"U325I%.B`Q,'!T.R!&3TY4+5=%24=(5#H@8F]L9#L@34%21TE.+4Q%1E0Z
M(#!P=#L@34%21TE.+5))1TA4.B`P<'0[('1E>'0M86QI9VXZ(&-E;G1E<CL@
M5$585"U)3D1%3E0Z(#!P="<^($IU;F4@,S`L(#(P,30\+V1I=CX@/"]T9#X@
M/'1D('-T>6QE/3-$)U!!1$1)3D<M0D]45$]-.B`R<'@[(%1%6%0M04Q)1TXZ
M(&QE9G0G('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E(&YO=W)A<#TS1&YO
M=W)A<#X\9F]N="!S='EL93TS1"=&3TY4+5-)6D4Z(#$P<'0[($9/3E0M1D%-
M24Q9.B!T:6UE<R!N97<@<F]M86X[($9/3E0M5T5)1TA4.B!B;VQD.R!$25-0
M3$%9.B!I;FQI;F4G/B`F;F)S<#L\+V9O;G0^(#PO=&0^(#QT9"!S='EL93TS
M1"=0041$24Y'+4)/5%1/33H@,G!X)R!V86QI9VX],T1B;W1T;VT@=VED=&@]
M,T0Q)3X\9F]N="!S='EL93TS1"=&3TY4+5-)6D4Z(#$P<'0[($9/3E0M1D%-
M24Q9.B!T:6UE<R!N97<@<F]M86X[($9/3E0M5T5)1TA4.B!B;VQD.R!$25-0
M3$%9.B!I;FQI;F4G/B`F;F)S<#L\+V9O;G0^(#PO=&0^(#QT9"!S='EL93TS
M1"="3U)$15(M0D]45$]-.B!B;&%C:R`R<'@@<V]L:60G('9A;&EG;CTS1&)O
M='1O;2!W:61T:#TS1#,T)2!C;VQS<&%N/3-$,3`^(#QD:78@<W1Y;&4],T0G
M1$E34$Q!63H@8FQO8VL[($9/3E0M1D%-24Q9.B!T:6UE<R!N97<@<F]M86X[
M($9/3E0M4TE:13H@,3!P=#L@1D].5"U714E'2%0Z(&)O;&0[($U!4D=)3BU,
M1494.B`P<'0[($U!4D=)3BU224=(5#H@,'!T.R!T97AT+6%L:6=N.B!C96YT
M97([(%1%6%0M24Y$14Y4.B`P<'0G/B!*=6YE(#,P+"`R,#$S/"]D:78^(#PO
M=&0^(#QT9"!S='EL93TS1"=0041$24Y'+4)/5%1/33H@,G!X.R!415A4+4%,
M24=..B!L969T)R!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)2!N;W=R87`]
M,T1N;W=R87`^/&9O;G0@<W1Y;&4],T0G1D].5"U325I%.B`Q,'!T.R!&3TY4
M+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!&3TY4+5=%24=(5#H@8F]L9#L@
M1$E34$Q!63H@:6YL:6YE)SX@)FYB<W`[/"]F;VYT/B`\+W1D/B`\+W1R/B`\
M='(^(#QT9"!S='EL93TS1"=0041$24Y'+4)/5%1/33H@,G!X)R!V86QI9VX]
M,T1B;W1T;VT@=VED=&@],T0R."4^/&9O;G0@<W1Y;&4],T0G1D].5"U325I%
M.B`Q,'!T.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!$25-03$%9
M.B!I;FQI;F4G/B`F;F)S<#L\+V9O;G0^(#PO=&0^(#QT9"!S='EL93TS1"=0
M041$24Y'+4)/5%1/33H@,G!X)R!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q
M)3X\9F]N="!S='EL93TS1"=&3TY4+5-)6D4Z(#$P<'0[($9/3E0M1D%-24Q9
M.B!T:6UE<R!N97<@<F]M86X[($9/3E0M5T5)1TA4.B!B;VQD.R!$25-03$%9
M.B!I;FQI;F4G/B`F;F)S<#L\+V9O;G0^(#PO=&0^(#QT9"!S='EL93TS1"="
M3U)$15(M0D]45$]-.B!B;&%C:R`R<'@@<V]L:60G('9A;&EG;CTS1&)O='1O
M;2!W:61T:#TS1#$P)2!C;VQS<&%N/3-$,CX@/&1I=B!S='EL93TS1"=$25-0
M3$%9.B!B;&]C:SL@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].
M5"U325I%.B`Q,'!T.R!&3TY4+5=%24=(5#H@8F]L9#L@34%21TE.+4Q%1E0Z
M(#!P=#L@34%21TE.+5))1TA4.B`P<'0[('1E>'0M86QI9VXZ(&-E;G1E<CL@
M5$585"U)3D1%3E0Z(#!P="<^($QE=F5L(#$\+V1I=CX@/"]T9#X@/'1D('-T
M>6QE/3-$)U!!1$1)3D<M0D]45$]-.B`R<'@[(%1%6%0M04Q)1TXZ(&QE9G0G
M('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E(&YO=W)A<#TS1&YO=W)A<#X\
M9F]N="!S='EL93TS1"=&3TY4+5-)6D4Z(#$P<'0[($9/3E0M1D%-24Q9.B!T
M:6UE<R!N97<@<F]M86X[($9/3E0M5T5)1TA4.B!B;VQD.R!$25-03$%9.B!I
M;FQI;F4G/B`F;F)S<#L\+V9O;G0^(#PO=&0^(#QT9"!S='EL93TS1"=0041$
M24Y'+4)/5%1/33H@,G!X)R!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)3X\
M9F]N="!S='EL93TS1"=&3TY4+5-)6D4Z(#$P<'0[($9/3E0M1D%-24Q9.B!T
M:6UE<R!N97<@<F]M86X[($9/3E0M5T5)1TA4.B!B;VQD.R!$25-03$%9.B!I
M;FQI;F4G/B`F;F)S<#L\+V9O;G0^(#PO=&0^(#QT9"!S='EL93TS1"="3U)$
M15(M0D]45$]-.B!B;&%C:R`R<'@@<V]L:60G('9A;&EG;CTS1&)O='1O;2!W
M:61T:#TS1#$P)2!C;VQS<&%N/3-$,CX@/&1I=B!S='EL93TS1"=$25-03$%9
M.B!B;&]C:SL@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U3
M25I%.B`Q,'!T.R!&3TY4+5=%24=(5#H@8F]L9#L@34%21TE.+4Q%1E0Z(#!P
M=#L@34%21TE.+5))1TA4.B`P<'0[('1E>'0M86QI9VXZ(&-E;G1E<CL@5$58
M5"U)3D1%3E0Z(#!P="<^($QE=F5L(#(\+V1I=CX@/"]T9#X@/'1D('-T>6QE
M/3-$)U!!1$1)3D<M0D]45$]-.B`R<'@[(%1%6%0M04Q)1TXZ(&QE9G0G('9A
M;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E(&YO=W)A<#TS1&YO=W)A<#X\9F]N
M="!S='EL93TS1"=&3TY4+5-)6D4Z(#$P<'0[($9/3E0M1D%-24Q9.B!T:6UE
M<R!N97<@<F]M86X[($9/3E0M5T5)1TA4.B!B;VQD.R!$25-03$%9.B!I;FQI
M;F4G/B`F;F)S<#L\+V9O;G0^(#PO=&0^(#QT9"!S='EL93TS1"=0041$24Y'
M+4)/5%1/33H@,G!X)R!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)3X\9F]N
M="!S='EL93TS1"=&3TY4+5-)6D4Z(#$P<'0[($9/3E0M1D%-24Q9.B!T:6UE
M<R!N97<@<F]M86X[($9/3E0M5T5)1TA4.B!B;VQD.R!$25-03$%9.B!I;FQI
M;F4G/B`F;F)S<#L\+V9O;G0^(#PO=&0^(#QT9"!S='EL93TS1"="3U)$15(M
M0D]45$]-.B!B;&%C:R`R<'@@<V]L:60G('9A;&EG;CTS1&)O='1O;2!W:61T
M:#TS1#$P)2!C;VQS<&%N/3-$,CX@/&1I=B!S='EL93TS1"=$25-03$%9.B!B
M;&]C:SL@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%
M.B`Q,'!T.R!&3TY4+5=%24=(5#H@8F]L9#L@34%21TE.+4Q%1E0Z(#!P=#L@
M34%21TE.+5))1TA4.B`P<'0[('1E>'0M86QI9VXZ(&-E;G1E<CL@5$585"U)
M3D1%3E0Z(#!P="<^($QE=F5L(#,\+V1I=CX@/"]T9#X@/'1D('-T>6QE/3-$
M)U!!1$1)3D<M0D]45$]-.B`R<'@[(%1%6%0M04Q)1TXZ(&QE9G0G('9A;&EG
M;CTS1&)O='1O;2!W:61T:#TS1#$E(&YO=W)A<#TS1&YO=W)A<#X\9F]N="!S
M='EL93TS1"=&3TY4+5-)6D4Z(#$P<'0[($9/3E0M1D%-24Q9.B!T:6UE<R!N
M97<@<F]M86X[($9/3E0M5T5)1TA4.B!B;VQD.R!$25-03$%9.B!I;FQI;F4G
M/B`F;F)S<#L\+V9O;G0^(#PO=&0^(#QT9"!S='EL93TS1"=0041$24Y'+4)/
M5%1/33H@,G!X)R!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)3X\9F]N="!S
M='EL93TS1"=&3TY4+5-)6D4Z(#$P<'0[($9/3E0M1D%-24Q9.B!T:6UE<R!N
M97<@<F]M86X[($9/3E0M5T5)1TA4.B!B;VQD.R!$25-03$%9.B!I;FQI;F4G
M/B`F;F)S<#L\+V9O;G0^(#PO=&0^(#QT9"!S='EL93TS1"="3U)$15(M0D]4
M5$]-.B!B;&%C:R`R<'@@<V]L:60G('9A;&EG;CTS1&)O='1O;2!W:61T:#TS
M1#$P)2!C;VQS<&%N/3-$,CX@/&1I=B!S='EL93TS1"=$25-03$%9.B!B;&]C
M:SL@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q
M,'!T.R!&3TY4+5=%24=(5#H@8F]L9#L@34%21TE.+4Q%1E0Z(#!P=#L@34%2
M1TE.+5))1TA4.B`P<'0[('1E>'0M86QI9VXZ(&-E;G1E<CL@5$585"U)3D1%
M3E0Z(#!P="<^($QE=F5L(#$\+V1I=CX@/"]T9#X@/'1D('-T>6QE/3-$)U!!
M1$1)3D<M0D]45$]-.B`R<'@[(%1%6%0M04Q)1TXZ(&QE9G0G('9A;&EG;CTS
M1&)O='1O;2!W:61T:#TS1#$E(&YO=W)A<#TS1&YO=W)A<#X\9F]N="!S='EL
M93TS1"=&3TY4+5-)6D4Z(#$P<'0[($9/3E0M1D%-24Q9.B!T:6UE<R!N97<@
M<F]M86X[($9/3E0M5T5)1TA4.B!B;VQD.R!$25-03$%9.B!I;FQI;F4G/B`F
M;F)S<#L\+V9O;G0^(#PO=&0^(#QT9"!S='EL93TS1"=0041$24Y'+4)/5%1/
M33H@,G!X)R!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)3X\9F]N="!S='EL
M93TS1"=&3TY4+5-)6D4Z(#$P<'0[($9/3E0M1D%-24Q9.B!T:6UE<R!N97<@
M<F]M86X[($9/3E0M5T5)1TA4.B!B;VQD.R!$25-03$%9.B!I;FQI;F4G/B`F
M;F)S<#L\+V9O;G0^(#PO=&0^(#QT9"!S='EL93TS1"="3U)$15(M0D]45$]-
M.B!B;&%C:R`R<'@@<V]L:60G('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$P
M)2!C;VQS<&%N/3-$,CX@/&1I=B!S='EL93TS1"=$25-03$%9.B!B;&]C:SL@
M1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T
M.R!&3TY4+5=%24=(5#H@8F]L9#L@34%21TE.+4Q%1E0Z(#!P=#L@34%21TE.
M+5))1TA4.B`P<'0[('1E>'0M86QI9VXZ(&-E;G1E<CL@5$585"U)3D1%3E0Z
M(#!P="<^($QE=F5L(#(\+V1I=CX@/"]T9#X@/'1D('-T>6QE/3-$)U!!1$1)
M3D<M0D]45$]-.B`R<'@[(%1%6%0M04Q)1TXZ(&QE9G0G('9A;&EG;CTS1&)O
M='1O;2!W:61T:#TS1#$E(&YO=W)A<#TS1&YO=W)A<#X\9F]N="!S='EL93TS
M1"=&3TY4+5-)6D4Z(#$P<'0[($9/3E0M1D%-24Q9.B!T:6UE<R!N97<@<F]M
M86X[($9/3E0M5T5)1TA4.B!B;VQD.R!$25-03$%9.B!I;FQI;F4G/B`F;F)S
M<#L\+V9O;G0^(#PO=&0^(#QT9"!S='EL93TS1"=0041$24Y'+4)/5%1/33H@
M,G!X)R!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)3X\9F]N="!S='EL93TS
M1"=&3TY4+5-)6D4Z(#$P<'0[($9/3E0M1D%-24Q9.B!T:6UE<R!N97<@<F]M
M86X[($9/3E0M5T5)1TA4.B!B;VQD.R!$25-03$%9.B!I;FQI;F4G/B`F;F)S
M<#L\+V9O;G0^(#PO=&0^(#QT9"!S='EL93TS1"="3U)$15(M0D]45$]-.B!B
M;&%C:R`R<'@@<V]L:60G('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$P)2!C
M;VQS<&%N/3-$,CX@/&1I=B!S='EL93TS1"=$25-03$%9.B!B;&]C:SL@1D].
M5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T.R!&
M3TY4+5=%24=(5#H@8F]L9#L@34%21TE.+4Q%1E0Z(#!P=#L@34%21TE.+5))
M1TA4.B`P<'0[('1E>'0M86QI9VXZ(&-E;G1E<CL@5$585"U)3D1%3E0Z(#!P
M="<^($QE=F5L(#,\+V1I=CX@/"]T9#X@/'1D('-T>6QE/3-$)U!!1$1)3D<M
M0D]45$]-.B`R<'@[(%1%6%0M04Q)1TXZ(&QE9G0G('9A;&EG;CTS1&)O='1O
M;2!W:61T:#TS1#$E(&YO=W)A<#TS1&YO=W)A<#X\9F]N="!S='EL93TS1"=&
M3TY4+5-)6D4Z(#$P<'0[($9/3E0M1D%-24Q9.B!T:6UE<R!N97<@<F]M86X[
M($9/3E0M5T5)1TA4.B!B;VQD.R!$25-03$%9.B!I;FQI;F4G/B`F;F)S<#L\
M+V9O;G0^(#PO=&0^(#PO='(^(#QT<B!B9V-O;&]R/3-$(V-C965F9CX@/'1D
M('-T>6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0[($U!4D=)3BU,1494.B`P<'0[
M($U!4D=)3BU224=(5#H@,'!T.R!415A4+4E.1$5.5#H@,'!T)R!V86QI9VX]
M,T1B;W1T;VT@=VED=&@],T0R."4^(#QD:78@<W1Y;&4],T0G1$E34$Q!63H@
M8FQO8VL[($9/3E0M1D%-24Q9.B!T:6UE<R!N97<@<F]M86X[($9/3E0M4TE:
M13H@,3!P=#L@34%21TE.+4Q%1E0Z(#!P=#L@34%21TE.+5))1TA4.B`P<'0[
M(%1%6%0M04Q)1TXZ(&QE9G0[(%1%6%0M24Y$14Y4.B`P<'0G/B!-87)K971A
M8FQE('-E8W5R:71I97,\+V1I=CX@/"]T9#X@/'1D('9A;&EG;CTS1&)O='1O
M;2!W:61T:#TS1#$E(&%L:6=N/3-$<FEG:'0^/&9O;G0@<W1Y;&4],T0G1D].
M5"U325I%.B`Q,'!T.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!$
M25-03$%9.B!I;FQI;F4G/B`F;F)S<#L\+V9O;G0^(#PO=&0^(#QT9"!S='EL
M93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE<R!N97<@
M<F]M86X[($9/3E0M4TE:13H@,3!P=#L@5$585"U!3$E'3CH@;&5F="<@=F%L
M:6=N/3-$8F]T=&]M('=I9'1H/3-$,24^)#PO=&0^(#QT9"!S='EL93TS1"=$
M25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE<R!N97<@<F]M86X[
M($9/3E0M4TE:13H@,3!P=#L@5$585"U!3$E'3CH@<FEG:'0G('9A;&EG;CTS
M1&)O='1O;2!W:61T:#TS1#DE/C(P+#4S,#PO=&0^(#QT9"!S='EL93TS1"=4
M15A4+4%,24=..B!L969T)R!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)2!N
M;W=R87`],T1N;W=R87`^/&9O;G0@<W1Y;&4],T0G1D].5"U325I%.B`Q,'!T
M.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!$25-03$%9.B!I;FQI
M;F4G/B`F;F)S<#L\+V9O;G0^(#PO=&0^(#QT9"!V86QI9VX],T1B;W1T;VT@
M=VED=&@],T0Q)2!A;&EG;CTS1')I9VAT/CQF;VYT('-T>6QE/3-$)T9/3E0M
M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1$E3
M4$Q!63H@:6YL:6YE)SX@)FYB<W`[/"]F;VYT/B`\+W1D/B`\=&0@<W1Y;&4]
M,T0G1$E34$Q!63H@:6YL:6YE.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O
M;6%N.R!&3TY4+5-)6D4Z(#$P<'0[(%1%6%0M04Q)1TXZ(&QE9G0G('9A;&EG
M;CTS1&)O='1O;2!W:61T:#TS1#$E/B0\+W1D/B`\=&0@<W1Y;&4],T0G1$E3
M4$Q!63H@:6YL:6YE.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!&
M3TY4+5-)6D4Z(#$P<'0[(%1%6%0M04Q)1TXZ(')I9VAT)R!V86QI9VX],T1B
M;W1T;VT@=VED=&@],T0Y)3XY+#0S,3PO=&0^(#QT9"!S='EL93TS1"=415A4
M+4%,24=..B!L969T)R!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)2!N;W=R
M87`],T1N;W=R87`^/&9O;G0@<W1Y;&4],T0G1D].5"U325I%.B`Q,'!T.R!&
M3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!$25-03$%9.B!I;FQI;F4G
M/B`F;F)S<#L\+V9O;G0^(#PO=&0^(#QT9"!V86QI9VX],T1B;W1T;VT@=VED
M=&@],T0Q)2!A;&EG;CTS1')I9VAT/CQF;VYT('-T>6QE/3-$)T9/3E0M4TE:
M13H@,3!P=#L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1$E34$Q!
M63H@:6YL:6YE)SX@)FYB<W`[/"]F;VYT/B`\+W1D/B`\=&0@<W1Y;&4],T0G
M5$585"U!3$E'3CH@;&5F="<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24^
M/&9O;G0@<W1Y;&4],T0G1D].5"U325I%.B`Q,'!T.R!&3TY4+49!34E,63H@
M=&EM97,@;F5W(')O;6%N.R!$25-03$%9.B!I;FQI;F4G/B`F;F)S<#L\+V9O
M;G0^(#PO=&0^(#QT9"!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M
M1D%-24Q9.B!T:6UE<R!N97<@<F]M86X[($9/3E0M4TE:13H@,3!P=#L@5$58
M5"U!3$E'3CH@<FEG:'0G('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#DE/BT\
M+W1D/B`\=&0@<W1Y;&4],T0G5$585"U!3$E'3CH@;&5F="<@=F%L:6=N/3-$
M8F]T=&]M('=I9'1H/3-$,24@;F]W<F%P/3-$;F]W<F%P/CQF;VYT('-T>6QE
M/3-$)T9/3E0M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R
M;VUA;CL@1$E34$Q!63H@:6YL:6YE)SX@)FYB<W`[/"]F;VYT/B`\+W1D/B`\
M=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@86QI9VX],T1R:6=H=#X\
M9F]N="!S='EL93TS1"=&3TY4+5-)6D4Z(#$P<'0[($9/3E0M1D%-24Q9.B!T
M:6UE<R!N97<@<F]M86X[($1)4U!,05DZ(&EN;&EN92<^("9N8G-P.SPO9F]N
M=#X@/"]T9#X@/'1D('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&
M04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T.R!415A4
M+4%,24=..B!L969T)R!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)3XD/"]T
M9#X@/'1D('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ
M('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T.R!415A4+4%,24=.
M.B!R:6=H="<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$.24^-BPS,3$\+W1D
M/B`\=&0@<W1Y;&4],T0G5$585"U!3$E'3CH@;&5F="<@=F%L:6=N/3-$8F]T
M=&]M('=I9'1H/3-$,24@;F]W<F%P/3-$;F]W<F%P/CQF;VYT('-T>6QE/3-$
M)T9/3E0M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA
M;CL@1$E34$Q!63H@:6YL:6YE)SX@)FYB<W`[/"]F;VYT/B`\+W1D/B`\=&0@
M=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@86QI9VX],T1R:6=H=#X\9F]N
M="!S='EL93TS1"=&3TY4+5-)6D4Z(#$P<'0[($9/3E0M1D%-24Q9.B!T:6UE
M<R!N97<@<F]M86X[($1)4U!,05DZ(&EN;&EN92<^("9N8G-P.SPO9F]N=#X@
M/"]T9#X@/'1D('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)
M3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T.R!415A4+4%,
M24=..B!L969T)R!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)3XD/"]T9#X@
M/'1D('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I
M;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T.R!415A4+4%,24=..B!R
M:6=H="<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$.24^-RPQ,S`\+W1D/B`\
M=&0@<W1Y;&4],T0G5$585"U!3$E'3CH@;&5F="<@=F%L:6=N/3-$8F]T=&]M
M('=I9'1H/3-$,24@;F]W<F%P/3-$;F]W<F%P/CQF;VYT('-T>6QE/3-$)T9/
M3E0M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@
M1$E34$Q!63H@:6YL:6YE)SX@)FYB<W`[/"]F;VYT/B`\+W1D/B`\=&0@=F%L
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M:6YE)SX@)FYB<W`[/"]F;VYT/B`\+W1D/B`\=&0@<W1Y;&4],T0G1$E34$Q!
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M('-T>6QE/3-$)U!!1$1)3D<M0D]45$]-.B`R<'@[(%1%6%0M04Q)1TXZ(&QE
M9G0[($U!4D=)3BU,1494.B`P<'0[($U!4D=)3BU224=(5#H@,'!T.R!415A4
M+4E.1$5.5#H@,'!T)R!V86QI9VX],T1B;W1T;VT@=VED=&@],T0R."4^(#QD
M:78@<W1Y;&4],T0G1$E34$Q!63H@8FQO8VL[($9/3E0M1D%-24Q9.B!T:6UE
M<R!N97<@<F]M86X[($9/3E0M4TE:13H@,3!P=#L@34%21TE.+4Q%1E0Z(#!P
M=#L@34%21TE.+5))1TA4.B`P<'0[(%1%6%0M04Q)1TXZ(&QE9G0[(%1%6%0M
M24Y$14Y4.B`P<'0G/B!&;W)E:6=N(&-U<G)E;F-Y(&1E<FEV871I=F4@:6YS
M=')U;65N=',\+V1I=CX@/"]T9#X@/'1D('-T>6QE/3-$)U!!1$1)3D<M0D]4
M5$]-.B`R<'@G('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E(&%L:6=N/3-$
M<FEG:'0^/&9O;G0@<W1Y;&4],T0G1D].5"U325I%.B`Q,'!T.R!&3TY4+49!
M34E,63H@=&EM97,@;F5W(')O;6%N.R!$25-03$%9.B!I;FQI;F4G/B`F;F)S
M<#L\+V9O;G0^(#PO=&0^(#QT9"!S='EL93TS1"="3U)$15(M0D]45$]-.B!B
M;&%C:R`R<'@@<V]L:60[(%1%6%0M04Q)1TXZ(&QE9G0G('9A;&EG;CTS1&)O
M='1O;2!W:61T:#TS1#$E/CQF;VYT('-T>6QE/3-$)T9/3E0M4TE:13H@,3!P
M=#L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1$E34$Q!63H@:6YL
M:6YE)SX@)FYB<W`[/"]F;VYT/B`\+W1D/B`\=&0@<W1Y;&4],T0G0D]21$52
M+4)/5%1/33H@8FQA8VL@,G!X('-O;&ED.R!$25-03$%9.B!I;FQI;F4[($9/
M3E0M1D%-24Q9.B!T:6UE<R!N97<@<F]M86X[($9/3E0M4TE:13H@,3!P=#L@
M5$585"U!3$E'3CH@<FEG:'0G('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#DE
M/BT\+W1D/B`\=&0@<W1Y;&4],T0G4$%$1$E.1RU"3U143TTZ(#)P>#L@5$58
M5"U!3$E'3CH@;&5F="<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@;F]W
M<F%P/3-$;F]W<F%P/CQF;VYT('-T>6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@
M1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1$E34$Q!63H@:6YL:6YE
M)SX@)FYB<W`[/"]F;VYT/B`\+W1D/B`\=&0@<W1Y;&4],T0G4$%$1$E.1RU"
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M8F]T=&]M('=I9'1H/3-$,24^/&9O;G0@<W1Y;&4],T0G1D].5"U325I%.B`Q
M,'!T.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!$25-03$%9.B!I
M;FQI;F4G/B`F;F)S<#L\+V9O;G0^(#PO=&0^(#QT9"!S='EL93TS1"="3U)$
M15(M0D]45$]-.B!B;&%C:R`R<'@@<V]L:60[($1)4U!,05DZ(&EN;&EN93L@
M1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T
M.R!415A4+4%,24=..B!R:6=H="<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$
M.24^*#@T,CPO=&0^(#QT9"!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/
M3E0M1D%-24Q9.B!T:6UE<R!N97<@<F]M86X[($9/3E0M4TE:13H@,3!P=#L@
M4$%$1$E.1RU"3U143TTZ(#)P>#L@5$585"U!3$E'3CH@;&5F="<@=F%L:6=N
M/3-$8F]T=&]M('=I9'1H/3-$,24@;F]W<F%P/3-$;F]W<F%P/BD\+W1D/B`\
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M<W1Y;&4],T0G1D].5"U325I%.B`Q,'!T.R!&3TY4+49!34E,63H@=&EM97,@
M;F5W(')O;6%N.R!$25-03$%9.B!I;FQI;F4G/B`F;F)S<#L\+V9O;G0^(#PO
M=&0^(#QT9"!S='EL93TS1"="3U)$15(M0D]45$]-.B!B;&%C:R`R<'@@<V]L
M:60[($1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R
M;VUA;CL@1D].5"U325I%.B`Q,'!T.R!415A4+4%,24=..B!R:6=H="<@=F%L
M:6=N/3-$8F]T=&]M('=I9'1H/3-$.24^+3PO=&0^(#QT9"!S='EL93TS1"=0
M041$24Y'+4)/5%1/33H@,G!X.R!415A4+4%,24=..B!L969T)R!V86QI9VX]
M,T1B;W1T;VT@=VED=&@],T0Q)2!N;W=R87`],T1N;W=R87`^/&9O;G0@<W1Y
M;&4],T0G1D].5"U325I%.B`Q,'!T.R!&3TY4+49!34E,63H@=&EM97,@;F5W
M(')O;6%N.R!$25-03$%9.B!I;FQI;F4G/B`F;F)S<#L\+V9O;G0^(#PO=&0^
M(#QT9"!S='EL93TS1"=0041$24Y'+4)/5%1/33H@,G!X)R!V86QI9VX],T1B
M;W1T;VT@=VED=&@],T0Q)2!A;&EG;CTS1')I9VAT/CQF;VYT('-T>6QE/3-$
M)T9/3E0M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA
M;CL@1$E34$Q!63H@:6YL:6YE)SX@)FYB<W`[/"]F;VYT/B`\+W1D/B`\=&0@
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M)U!!1$1)3D<M0D]45$]-.B`R<'@[(%1%6%0M04Q)1TXZ(&QE9G0G('9A;&EG
M;CTS1&)O='1O;2!W:61T:#TS1#$E(&YO=W)A<#TS1&YO=W)A<#X\9F]N="!S
M='EL93TS1"=&3TY4+5-)6D4Z(#$P<'0[($9/3E0M1D%-24Q9.B!T:6UE<R!N
M97<@<F]M86X[($1)4U!,05DZ(&EN;&EN92<^("9N8G-P.SPO9F]N=#X@/"]T
M9#X@/'1D('-T>6QE/3-$)U!!1$1)3D<M0D]45$]-.B`R<'@G('9A;&EG;CTS
M1&)O='1O;2!W:61T:#TS1#$E(&%L:6=N/3-$<FEG:'0^/&9O;G0@<W1Y;&4]
M,T0G1D].5"U325I%.B`Q,'!T.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O
M;6%N.R!$25-03$%9.B!I;FQI;F4G/B`F;F)S<#L\+V9O;G0^(#PO=&0^(#QT
M9"!S='EL93TS1"="3U)$15(M0D]45$]-.B!B;&%C:R`R<'@@<V]L:60[(%1%
M6%0M04Q)1TXZ(&QE9G0G('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E/CQF
M;VYT('-T>6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ('1I
M;65S(&YE=R!R;VUA;CL@1$E34$Q!63H@:6YL:6YE)SX@)FYB<W`[/"]F;VYT
M/B`\+W1D/B`\=&0@<W1Y;&4],T0G0D]21$52+4)/5%1/33H@8FQA8VL@,G!X
M('-O;&ED.R!$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE<R!N
M97<@<F]M86X[($9/3E0M4TE:13H@,3!P=#L@5$585"U!3$E'3CH@<FEG:'0G
M('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#DE/CDS/"]T9#X@/'1D('-T>6QE
M/3-$)U!!1$1)3D<M0D]45$]-.B`R<'@[(%1%6%0M04Q)1TXZ(&QE9G0G('9A
M;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E(&YO=W)A<#TS1&YO=W)A<#X\9F]N
M="!S='EL93TS1"=&3TY4+5-)6D4Z(#$P<'0[($9/3E0M1D%-24Q9.B!T:6UE
M<R!N97<@<F]M86X[($1)4U!,05DZ(&EN;&EN92<^("9N8G-P.SPO9F]N=#X@
M/"]T9#X@/'1D('-T>6QE/3-$)U!!1$1)3D<M0D]45$]-.B`R<'@G('9A;&EG
M;CTS1&)O='1O;2!W:61T:#TS1#$E(&%L:6=N/3-$<FEG:'0^/&9O;G0@<W1Y
M;&4],T0G1D].5"U325I%.B`Q,'!T.R!&3TY4+49!34E,63H@=&EM97,@;F5W
M(')O;6%N.R!$25-03$%9.B!I;FQI;F4G/B`F;F)S<#L\+V9O;G0^(#PO=&0^
M(#QT9"!S='EL93TS1"="3U)$15(M0D]45$]-.B!B;&%C:R`R<'@@<V]L:60[
M(%1%6%0M04Q)1TXZ(&QE9G0G('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E
M/CQF;VYT('-T>6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ
M('1I;65S(&YE=R!R;VUA;CL@1$E34$Q!63H@:6YL:6YE)SX@)FYB<W`[/"]F
M;VYT/B`\+W1D/B`\=&0@<W1Y;&4],T0G0D]21$52+4)/5%1/33H@8FQA8VL@
M,G!X('-O;&ED.R!$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE
M<R!N97<@<F]M86X[($9/3E0M4TE:13H@,3!P=#L@5$585"U!3$E'3CH@<FEG
M:'0G('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#DE/BT\+W1D/B`\=&0@<W1Y
M;&4],T0G4$%$1$E.1RU"3U143TTZ(#)P>#L@5$585"U!3$E'3CH@;&5F="<@
M=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@;F]W<F%P/3-$;F]W<F%P/CQF
M;VYT('-T>6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ('1I
M;65S(&YE=R!R;VUA;CL@1$E34$Q!63H@:6YL:6YE)SX@)FYB<W`[/"]F;VYT
M/B`\+W1D/B`\+W1R/B`\='(@8F=C;VQO<CTS1"-C8V5E9F8^(#QT9"!S='EL
M93TS1"=0041$24Y'+4)/5%1/33H@-'!X.R!415A4+4%,24=..B!L969T.R!-
M05)'24XM3$5&5#H@,'!T.R!-05)'24XM4DE'2%0Z(#!P=#L@5$585"U)3D1%
M3E0Z(#!P="<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,C@E/B`\9&EV('-T
M>6QE/3-$)T1)4U!,05DZ(&)L;V-K.R!&3TY4+49!34E,63H@=&EM97,@;F5W
M(')O;6%N.R!&3TY4+5-)6D4Z(#$P<'0[($U!4D=)3BU,1494.B`P<'0[($U!
M4D=)3BU224=(5#H@,'!T.R!415A4+4%,24=..B!L969T.R!415A4+4E.1$5.
M5#H@,'!T)SX@5&]T86P\+V1I=CX@/"]T9#X@/'1D('-T>6QE/3-$)U!!1$1)
M3D<M0D]45$]-.B`T<'@G('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E(&%L
M:6=N/3-$<FEG:'0^/&9O;G0@<W1Y;&4],T0G1D].5"U325I%.B`Q,'!T.R!&
M3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!$25-03$%9.B!I;FQI;F4G
M/B`F;F)S<#L\+V9O;G0^(#PO=&0^(#QT9"!S='EL93TS1"="3U)$15(M0D]4
M5$]-.B!B;&%C:R`T<'@@9&]U8FQE.R!$25-03$%9.B!I;FQI;F4[($9/3E0M
M1D%-24Q9.B!T:6UE<R!N97<@<F]M86X[($9/3E0M4TE:13H@,3!P=#L@5$58
M5"U!3$E'3CH@;&5F="<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24^)#PO
M=&0^(#QT9"!S='EL93TS1"="3U)$15(M0D]45$]-.B!B;&%C:R`T<'@@9&]U
M8FQE.R!$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE<R!N97<@
M<F]M86X[($9/3E0M4TE:13H@,3!P=#L@5$585"U!3$E'3CH@<FEG:'0G('9A
M;&EG;CTS1&)O='1O;2!W:61T:#TS1#DE/C(P+#4S,#PO=&0^(#QT9"!S='EL
M93TS1"=0041$24Y'+4)/5%1/33H@-'!X.R!415A4+4%,24=..B!L969T)R!V
M86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)2!N;W=R87`],T1N;W=R87`^/&9O
M;G0@<W1Y;&4],T0G1D].5"U325I%.B`Q,'!T.R!&3TY4+49!34E,63H@=&EM
M97,@;F5W(')O;6%N.R!$25-03$%9.B!I;FQI;F4G/B`F;F)S<#L\+V9O;G0^
M(#PO=&0^(#QT9"!S='EL93TS1"=0041$24Y'+4)/5%1/33H@-'!X)R!V86QI
M9VX],T1B;W1T;VT@=VED=&@],T0Q)2!A;&EG;CTS1')I9VAT/CQF;VYT('-T
M>6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ('1I;65S(&YE
M=R!R;VUA;CL@1$E34$Q!63H@:6YL:6YE)SX@)FYB<W`[/"]F;VYT/B`\+W1D
M/B`\=&0@<W1Y;&4],T0G0D]21$52+4)/5%1/33H@8FQA8VL@-'!X(&1O=6)L
M93L@1$E34$Q!63H@:6YL:6YE.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O
M;6%N.R!&3TY4+5-)6D4Z(#$P<'0[(%1%6%0M04Q)1TXZ(&QE9G0G('9A;&EG
M;CTS1&)O='1O;2!W:61T:#TS1#$E/B0\+W1D/B`\=&0@<W1Y;&4],T0G0D]2
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M,T0Q)2!N;W=R87`],T1N;W=R87`^/&9O;G0@<W1Y;&4],T0G1D].5"U325I%
M.B`Q,'!T.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!$25-03$%9
M.B!I;FQI;F4G/B`F;F)S<#L\+V9O;G0^(#PO=&0^(#QT9"!S='EL93TS1"=0
M041$24Y'+4)/5%1/33H@-'!X)R!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q
M)2!A;&EG;CTS1')I9VAT/CQF;VYT('-T>6QE/3-$)T9/3E0M4TE:13H@,3!P
M=#L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1$E34$Q!63H@:6YL
M:6YE)SX@)FYB<W`[/"]F;VYT/B`\+W1D/B`\=&0@<W1Y;&4],T0G0D]21$52
M+4)/5%1/33H@8FQA8VL@-'!X(&1O=6)L93L@1$E34$Q!63H@:6YL:6YE.R!&
M3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!&3TY4+5-)6D4Z(#$P<'0[
M(%1%6%0M04Q)1TXZ(&QE9G0G('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E
M/B0\+W1D/B`\=&0@<W1Y;&4],T0G0D]21$52+4)/5%1/33H@8FQA8VL@-'!X
M(&1O=6)L93L@1$E34$Q!63H@:6YL:6YE.R!&3TY4+49!34E,63H@=&EM97,@
M;F5W(')O;6%N.R!&3TY4+5-)6D4Z(#$P<'0[(%1%6%0M04Q)1TXZ(')I9VAT
M)R!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Y)3XM/"]T9#X@/'1D('-T>6QE
M/3-$)U!!1$1)3D<M0D]45$]-.B`T<'@[(%1%6%0M04Q)1TXZ(&QE9G0G('9A
M;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E(&YO=W)A<#TS1&YO=W)A<#X\9F]N
M="!S='EL93TS1"=&3TY4+5-)6D4Z(#$P<'0[($9/3E0M1D%-24Q9.B!T:6UE
M<R!N97<@<F]M86X[($1)4U!,05DZ(&EN;&EN92<^("9N8G-P.SPO9F]N=#X@
M/"]T9#X@/'1D('-T>6QE/3-$)U!!1$1)3D<M0D]45$]-.B`T<'@G('9A;&EG
M;CTS1&)O='1O;2!W:61T:#TS1#$E(&%L:6=N/3-$<FEG:'0^/&9O;G0@<W1Y
M;&4],T0G1D].5"U325I%.B`Q,'!T.R!&3TY4+49!34E,63H@=&EM97,@;F5W
M(')O;6%N.R!$25-03$%9.B!I;FQI;F4G/B`F;F)S<#L\+V9O;G0^(#PO=&0^
M(#QT9"!S='EL93TS1"="3U)$15(M0D]45$]-.B!B;&%C:R`T<'@@9&]U8FQE
M.R!$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE<R!N97<@<F]M
M86X[($9/3E0M4TE:13H@,3!P=#L@5$585"U!3$E'3CH@;&5F="<@=F%L:6=N
M/3-$8F]T=&]M('=I9'1H/3-$,24^)#PO=&0^(#QT9"!S='EL93TS1"="3U)$
M15(M0D]45$]-.B!B;&%C:R`T<'@@9&]U8FQE.R!$25-03$%9.B!I;FQI;F4[
M($9/3E0M1D%-24Q9.B!T:6UE<R!N97<@<F]M86X[($9/3E0M4TE:13H@,3!P
M=#L@5$585"U!3$E'3CH@<FEG:'0G('9A;&EG;CTS1&)O='1O;2!W:61T:#TS
M1#DE/C8L,S$Q/"]T9#X@/'1D('-T>6QE/3-$)U!!1$1)3D<M0D]45$]-.B`T
M<'@[(%1%6%0M04Q)1TXZ(&QE9G0G('9A;&EG;CTS1&)O='1O;2!W:61T:#TS
M1#$E(&YO=W)A<#TS1&YO=W)A<#X\9F]N="!S='EL93TS1"=&3TY4+5-)6D4Z
M(#$P<'0[($9/3E0M1D%-24Q9.B!T:6UE<R!N97<@<F]M86X[($1)4U!,05DZ
M(&EN;&EN92<^("9N8G-P.SPO9F]N=#X@/"]T9#X@/'1D('-T>6QE/3-$)U!!
M1$1)3D<M0D]45$]-.B`T<'@G('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E
M(&%L:6=N/3-$<FEG:'0^/&9O;G0@<W1Y;&4],T0G1D].5"U325I%.B`Q,'!T
M.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!$25-03$%9.B!I;FQI
M;F4G/B`F;F)S<#L\+V9O;G0^(#PO=&0^(#QT9"!S='EL93TS1"="3U)$15(M
M0D]45$]-.B!B;&%C:R`T<'@@9&]U8FQE.R!$25-03$%9.B!I;FQI;F4[($9/
M3E0M1D%-24Q9.B!T:6UE<R!N97<@<F]M86X[($9/3E0M4TE:13H@,3!P=#L@
M5$585"U!3$E'3CH@;&5F="<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24^
M)#PO=&0^(#QT9"!S='EL93TS1"="3U)$15(M0D]45$]-.B!B;&%C:R`T<'@@
M9&]U8FQE.R!$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE<R!N
M97<@<F]M86X[($9/3E0M4TE:13H@,3!P=#L@5$585"U!3$E'3CH@<FEG:'0G
M('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#DE/C<L,C(S/"]T9#X@/'1D('-T
M>6QE/3-$)U!!1$1)3D<M0D]45$]-.B`T<'@[(%1%6%0M04Q)1TXZ(&QE9G0G
M('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E(&YO=W)A<#TS1&YO=W)A<#X\
M9F]N="!S='EL93TS1"=&3TY4+5-)6D4Z(#$P<'0[($9/3E0M1D%-24Q9.B!T
M:6UE<R!N97<@<F]M86X[($1)4U!,05DZ(&EN;&EN92<^("9N8G-P.SPO9F]N
M=#X@/"]T9#X@/'1D('-T>6QE/3-$)U!!1$1)3D<M0D]45$]-.B`T<'@G('9A
M;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E(&%L:6=N/3-$<FEG:'0^/&9O;G0@
M<W1Y;&4],T0G1D].5"U325I%.B`Q,'!T.R!&3TY4+49!34E,63H@=&EM97,@
M;F5W(')O;6%N.R!$25-03$%9.B!I;FQI;F4G/B`F;F)S<#L\+V9O;G0^(#PO
M=&0^(#QT9"!S='EL93TS1"="3U)$15(M0D]45$]-.B!B;&%C:R`T<'@@9&]U
M8FQE.R!$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE<R!N97<@
M<F]M86X[($9/3E0M4TE:13H@,3!P=#L@5$585"U!3$E'3CH@;&5F="<@=F%L
M:6=N/3-$8F]T=&]M('=I9'1H/3-$,24^)#PO=&0^(#QT9"!S='EL93TS1"="
M3U)$15(M0D]45$]-.B!B;&%C:R`T<'@@9&]U8FQE.R!$25-03$%9.B!I;FQI
M;F4[($9/3E0M1D%-24Q9.B!T:6UE<R!N97<@<F]M86X[($9/3E0M4TE:13H@
M,3!P=#L@5$585"U!3$E'3CH@<FEG:'0G('9A;&EG;CTS1&)O='1O;2!W:61T
M:#TS1#DE/BT\+W1D/B`\=&0@<W1Y;&4],T0G4$%$1$E.1RU"3U143TTZ(#1P
M>#L@5$585"U!3$E'3CH@;&5F="<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$
M,24@;F]W<F%P/3-$;F]W<F%P/CQF;VYT('-T>6QE/3-$)T9/3E0M4TE:13H@
M,3!P=#L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1$E34$Q!63H@
M:6YL:6YE)SX@)FYB<W`[/"]F;VYT/B`\+W1D/B`\+W1R/B`\+W1A8FQE/B`\
M+V1I=CX@/&1I=B!S='EL93TS1"=$25-03$%9.B!B;&]C:SL@5$585"U)3D1%
M3E0Z(#!P="<^/&)R("\^(#PO9&EV/B`\9&EV('-T>6QE/3-$)W1E>'0M86QI
M9VXZ(')I9VAT)SX@/'1A8FQE('-T>6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@
M1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;B<@8V5L;'-P86-I;F<],T0P
M(&-E;&QP861D:6YG/3-$,"!W:61T:#TS1#DW)3X@/'1R/B`\=&0@<W1Y;&4]
M,T0G4$%$1$E.1RU"3U143TTZ(#)P>"<@=F%L:6=N/3-$8F]T=&]M('=I9'1H
M/3-$-#DE/CQF;VYT('-T>6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@1D].5"U&
M04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1$E34$Q!63H@:6YL:6YE)SX@)FYB
M<W`[/"]F;VYT/B`\+W1D/B`\=&0@<W1Y;&4],T0G0D]21$52+4)/5%1/33H@
M8FQA8VL@,G!X('-O;&ED)R!V86QI9VX],T1B;W1T;VT@=VED=&@],T0R-B4@
M8V]L<W!A;CTS1#0^(#QD:78@<W1Y;&4],T0G1$E34$Q!63H@8FQO8VL[($9/
M3E0M1D%-24Q9.B!T:6UE<R!N97<@<F]M86X[($9/3E0M4TE:13H@,3!P=#L@
M1D].5"U714E'2%0Z(&)O;&0[($U!4D=)3BU,1494.B`P<'0[($U!4D=)3BU2
M24=(5#H@,'!T.R!T97AT+6%L:6=N.B!C96YT97([(%1%6%0M24Y$14Y4.B`P
M<'0G/B!*=6YE(#,P+"`R,#$T/"]D:78^(#PO=&0^(#QT9"!S='EL93TS1"=0
M041$24Y'+4)/5%1/33H@,G!X.R!415A4+4%,24=..B!L969T)R!V86QI9VX]
M,T1B;W1T;VT@=VED=&@],T0Q)2!N;W=R87`],T1N;W=R87`^/&9O;G0@<W1Y
M;&4],T0G1D].5"U325I%.B`Q,'!T.R!&3TY4+49!34E,63H@=&EM97,@;F5W
M(')O;6%N.R!&3TY4+5=%24=(5#H@8F]L9#L@1$E34$Q!63H@:6YL:6YE)SX@
M)FYB<W`[/"]F;VYT/B`\+W1D/B`\=&0@<W1Y;&4],T0G4$%$1$E.1RU"3U14
M3TTZ(#)P>"<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24^/&9O;G0@<W1Y
M;&4],T0G1D].5"U325I%.B`Q,'!T.R!&3TY4+49!34E,63H@=&EM97,@;F5W
M(')O;6%N.R!&3TY4+5=%24=(5#H@8F]L9#L@1$E34$Q!63H@:6YL:6YE)SX@
M)FYB<W`[/"]F;VYT/B`\+W1D/B`\=&0@<W1Y;&4],T0G0D]21$52+4)/5%1/
M33H@8FQA8VL@,G!X('-O;&ED)R!V86QI9VX],T1B;W1T;VT@=VED=&@],T0R
M,B4@8V]L<W!A;CTS1#8^(#QD:78@<W1Y;&4],T0G1$E34$Q!63H@8FQO8VL[
M($9/3E0M1D%-24Q9.B!T:6UE<R!N97<@<F]M86X[($9/3E0M4TE:13H@,3!P
M=#L@1D].5"U714E'2%0Z(&)O;&0[($U!4D=)3BU,1494.B`P<'0[($U!4D=)
M3BU224=(5#H@,'!T.R!T97AT+6%L:6=N.B!C96YT97([(%1%6%0M24Y$14Y4
M.B`P<'0G/B!*=6YE(#,P+"`R,#$S/"]D:78^(#PO=&0^(#QT9"!S='EL93TS
M1"=0041$24Y'+4)/5%1/33H@,G!X.R!415A4+4%,24=..B!L969T)R!V86QI
M9VX],T1B;W1T;VT@=VED=&@],T0Q)2!N;W=R87`],T1N;W=R87`^/&9O;G0@
M<W1Y;&4],T0G1D].5"U325I%.B`Q,'!T.R!&3TY4+49!34E,63H@=&EM97,@
M;F5W(')O;6%N.R!&3TY4+5=%24=(5#H@8F]L9#L@1$E34$Q!63H@:6YL:6YE
M)SX@)FYB<W`[/"]F;VYT/B`\+W1D/B`\+W1R/B`\='(^(#QT9"!S='EL93TS
M1"=0041$24Y'+4)/5%1/33H@,G!X)R!V86QI9VX],T1B;W1T;VT@=VED=&@]
M,T0T.24^/&9O;G0@<W1Y;&4],T0G1D].5"U325I%.B`Q,'!T.R!&3TY4+49!
M34E,63H@=&EM97,@;F5W(')O;6%N.R!$25-03$%9.B!I;FQI;F4G/B`F;F)S
M<#L\+V9O;G0^(#PO=&0^(#QT9"!S='EL93TS1"="3U)$15(M0D]45$]-.B!B
M;&%C:R`R<'@@<V]L:60G('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$U)3X@
M/&1I=B!S='EL93TS1"=$25-03$%9.B!B;&]C:SL@1D].5"U&04U)3%DZ('1I
M;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T.R!&3TY4+5=%24=(5#H@
M8F]L9#L@34%21TE.+4Q%1E0Z(#!P=#L@34%21TE.+5))1TA4.B`P<'0[('1E
M>'0M86QI9VXZ(&-E;G1E<CL@5$585"U)3D1%3E0Z(#!P="<^($)A;&%N8V4@
M4VAE970@;&]C871I;VX\+V1I=CX@/"]T9#X@/'1D('-T>6QE/3-$)U!!1$1)
M3D<M0D]45$]-.B`R<'@G('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E/CQF
M;VYT('-T>6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ('1I
M;65S(&YE=R!R;VUA;CL@1D].5"U714E'2%0Z(&)O;&0[($1)4U!,05DZ(&EN
M;&EN92<^("9N8G-P.SPO9F]N=#X@/"]T9#X@/'1D('-T>6QE/3-$)T)/4D1%
M4BU"3U143TTZ(&)L86-K(#)P>"!S;VQI9"<@=F%L:6=N/3-$8F]T=&]M('=I
M9'1H/3-$,3`E(&-O;'-P86X],T0R/B`\9&EV('-T>6QE/3-$)T1)4U!,05DZ
M(&)L;V-K.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!&3TY4+5-)
M6D4Z(#$P<'0[($9/3E0M5T5)1TA4.B!B;VQD.R!-05)'24XM3$5&5#H@,'!T
M.R!-05)'24XM4DE'2%0Z(#!P=#L@=&5X="UA;&EG;CH@8V5N=&5R.R!415A4
M+4E.1$5.5#H@,'!T)SX@1F%I<B!686QU93PO9&EV/B`\+W1D/B`\=&0@<W1Y
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M3D<M0D]45$]-.B`R<'@G('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E/CQF
M;VYT('-T>6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ('1I
M;65S(&YE=R!R;VUA;CL@1D].5"U714E'2%0Z(&)O;&0[($1)4U!,05DZ(&EN
M;&EN92<^("9N8G-P.SPO9F]N=#X@/"]T9#X@/'1D('-T>6QE/3-$)T)/4D1%
M4BU"3U143TTZ(&)L86-K(#)P>"!S;VQI9"<@=F%L:6=N/3-$8F]T=&]M('=I
M9'1H/3-$,3`E(&-O;'-P86X],T0R/B`\9&EV('-T>6QE/3-$)T1)4U!,05DZ
M(&)L;V-K.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!&3TY4+5-)
M6D4Z(#$P<'0[($9/3E0M5T5)1TA4.B!B;VQD.R!-05)'24XM3$5&5#H@,'!T
M.R!-05)'24XM4DE'2%0Z(#!P=#L@=&5X="UA;&EG;CH@8V5N=&5R.R!415A4
M+4E.1$5.5#H@,'!T)SX@0F%L86YC92!3:&5E="!L;V-A=&EO;CPO9&EV/B`\
M+W1D/B`\=&0@<W1Y;&4],T0G4$%$1$E.1RU"3U143TTZ(#)P>#L@5$585"U!
M3$E'3CH@;&5F="<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@;F]W<F%P
M/3-$;F]W<F%P/CQF;VYT('-T>6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@1D].
M5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U714E'2%0Z(&)O;&0[
M($1)4U!,05DZ(&EN;&EN92<^("9N8G-P.SPO9F]N=#X@/"]T9#X@/'1D('-T
M>6QE/3-$)U!!1$1)3D<M0D]45$]-.B`R<'@G('9A;&EG;CTS1&)O='1O;2!W
M:61T:#TS1#$E/CQF;VYT('-T>6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@1D].
M5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U714E'2%0Z(&)O;&0[
M($1)4U!,05DZ(&EN;&EN92<^("9N8G-P.SPO9F]N=#X@/"]T9#X@/'1D('-T
M>6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#)P>"!S;VQI9"<@=F%L:6=N
M/3-$8F]T=&]M('=I9'1H/3-$,3`E(&-O;'-P86X],T0R/B`\9&EV('-T>6QE
M/3-$)T1)4U!,05DZ(&)L;V-K.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O
M;6%N.R!&3TY4+5-)6D4Z(#$P<'0[($9/3E0M5T5)1TA4.B!B;VQD.R!-05)'
M24XM3$5&5#H@,'!T.R!-05)'24XM4DE'2%0Z(#!P=#L@=&5X="UA;&EG;CH@
M8V5N=&5R.R!415A4+4E.1$5.5#H@,'!T)SX@1F%I<B!686QU93PO9&EV/B`\
M+W1D/B`\=&0@<W1Y;&4],T0G4$%$1$E.1RU"3U143TTZ(#)P>#L@5$585"U!
M3$E'3CH@;&5F="<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@;F]W<F%P
M/3-$;F]W<F%P/CQF;VYT('-T>6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@1D].
M5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U714E'2%0Z(&)O;&0[
M($1)4U!,05DZ(&EN;&EN92<^("9N8G-P.SPO9F]N=#X@/"]T9#X@/"]T<CX@
M/'1R(&)G8V]L;W(],T0C8V-E969F/B`\=&0@<W1Y;&4],T0G5$585"U!3$E'
M3CH@;&5F=#L@34%21TE.+4Q%1E0Z(#!P=#L@34%21TE.+5))1TA4.B`P<'0[
M(%1%6%0M24Y$14Y4.B`P<'0G('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#0Y
M)3X@/&1I=B!S='EL93TS1"=$25-03$%9.B!B;&]C:SL@1D].5"U&04U)3%DZ
M('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T.R!-05)'24XM3$5&
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M.B`Q+C9P=#L@=&5X="UA;&EG;CH@8V5N=&5R.R!415A4+4E.1$5.5#H@,'!T
M)SX@3W1H97(@8W5R<F5N="!A<W-E=',\+V1I=CX@/"]T9#X@/'1D('9A;&EG
M;CTS1&)O='1O;2!W:61T:#TS1#$E(&%L:6=N/3-$<FEG:'0^/&9O;G0@<W1Y
M;&4],T0G1D].5"U325I%.B`Q,'!T.R!&3TY4+49!34E,63H@=&EM97,@;F5W
M(')O;6%N.R!$25-03$%9.B!I;FQI;F4G/B`F;F)S<#L\+V9O;G0^(#PO=&0^
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M:6YE)SX@)FYB<W`[/"]F;VYT/B`\+W1D/B`\=&0@<W1Y;&4],T0G5$585"U!
M3$E'3CH@;&5F="<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24^/&9O;G0@
M<W1Y;&4],T0G1D].5"U325I%.B`Q,'!T.R!&3TY4+49!34E,63H@=&EM97,@
M;F5W(')O;6%N.R!$25-03$%9.B!I;FQI;F4G/B`F;F)S<#L\+V9O;G0^(#PO
M=&0^(#QT9"!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9
M.B!T:6UE<R!N97<@<F]M86X[($9/3E0M4TE:13H@,3!P=#L@5$585"U!3$E'
M3CH@<FEG:'0G('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#DE/BT\+W1D/B`\
M=&0@<W1Y;&4],T0G5$585"U!3$E'3CH@;&5F="<@=F%L:6=N/3-$8F]T=&]M
M('=I9'1H/3-$,24@;F]W<F%P/3-$;F]W<F%P/CQF;VYT('-T>6QE/3-$)T9/
M3E0M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@
M1$E34$Q!63H@:6YL:6YE)SX@)FYB<W`[/"]F;VYT/B`\+W1D/B`\=&0@=F%L
M:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@86QI9VX],T1L969T/CQF;VYT('-T
M>6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ('1I;65S(&YE
M=R!R;VUA;CL@1$E34$Q!63H@:6YL:6YE)SX@)FYB<W`[/"]F;VYT/B`\+W1D
M/B`\=&0@<W1Y;&4],T0G1$E34$Q!63H@:6YL:6YE.R!&3TY4+49!34E,63H@
M=&EM97,@;F5W(')O;6%N.R!&3TY4+5-)6D4Z(#$P<'0[(%1%6%0M04Q)1TXZ
M(&QE9G0G('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E/B0\+W1D/B`\=&0@
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M4D=)3BU,1494.B`P<'0[($U!4D=)3BU224=(5#H@,'!T.R!415A4+4E.1$5.
M5#H@,'!T)R!V86QI9VX],T1B;W1T;VT@=VED=&@],T0T.24^/&9O;G0@<W1Y
M;&4],T0G1D].5"U325I%.B`Q,'!T.R!&3TY4+49!34E,63H@=&EM97,@;F5W
M(')O;6%N.R!$25-03$%9.B!I;FQI;F4G/B`F;F)S<#L\+V9O;G0^(#PO=&0^
M(#QT9"!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q-24^/&9O;G0@<W1Y;&4]
M,T0G1D].5"U325I%.B`Q,'!T.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O
M;6%N.R!$25-03$%9.B!I;FQI;F4G/B`F;F)S<#L\+V9O;G0^(#PO=&0^(#QT
M9"!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)2!A;&EG;CTS1')I9VAT/CQF
M;VYT('-T>6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ('1I
M;65S(&YE=R!R;VUA;CL@1$E34$Q!63H@:6YL:6YE)SX@)FYB<W`[/"]F;VYT
M/B`\+W1D/B`\=&0@<W1Y;&4],T0G5$585"U!3$E'3CH@;&5F="<@=F%L:6=N
M/3-$8F]T=&]M('=I9'1H/3-$,24^/&9O;G0@<W1Y;&4],T0G1D].5"U325I%
M.B`Q,'!T.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!$25-03$%9
M.B!I;FQI;F4G/B`F;F)S<#L\+V9O;G0^(#PO=&0^(#QT9"!S='EL93TS1"=4
M15A4+4%,24=..B!R:6=H="<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$.24^
M/&9O;G0@<W1Y;&4],T0G1D].5"U325I%.B`Q,'!T.R!&3TY4+49!34E,63H@
M=&EM97,@;F5W(')O;6%N.R!$25-03$%9.B!I;FQI;F4G/B`F;F)S<#L\+V9O
M;G0^(#PO=&0^(#QT9"!S='EL93TS1"=415A4+4%,24=..B!L969T)R!V86QI
M9VX],T1B;W1T;VT@=VED=&@],T0Q)2!N;W=R87`],T1N;W=R87`^/&9O;G0@
M<W1Y;&4],T0G1D].5"U325I%.B`Q,'!T.R!&3TY4+49!34E,63H@=&EM97,@
M;F5W(')O;6%N.R!$25-03$%9.B!I;FQI;F4G/B`F;F)S<#L\+V9O;G0^(#PO
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M;VUA;CL@1$E34$Q!63H@:6YL:6YE)SX@)FYB<W`[/"]F;VYT/B`\+W1D/B`\
M=&0@<W1Y;&4],T0G5$585"U!3$E'3CH@;&5F="<@=F%L:6=N/3-$8F]T=&]M
M('=I9'1H/3-$,24^/&9O;G0@<W1Y;&4],T0G1D].5"U325I%.B`Q,'!T.R!&
M3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!$25-03$%9.B!I;FQI;F4G
M/B`F;F)S<#L\+V9O;G0^(#PO=&0^(#QT9"!S='EL93TS1"=415A4+4%,24=.
M.B!R:6=H="<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$.24^/&9O;G0@<W1Y
M;&4],T0G1D].5"U325I%.B`Q,'!T.R!&3TY4+49!34E,63H@=&EM97,@;F5W
M(')O;6%N.R!$25-03$%9.B!I;FQI;F4G/B`F;F)S<#L\+V9O;G0^(#PO=&0^
M(#QT9"!S='EL93TS1"=415A4+4%,24=..B!L969T)R!V86QI9VX],T1B;W1T
M;VT@=VED=&@],T0Q)2!N;W=R87`],T1N;W=R87`^/&9O;G0@<W1Y;&4],T0G
M1D].5"U325I%.B`Q,'!T.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N
M.R!$25-03$%9.B!I;FQI;F4G/B`F;F)S<#L\+V9O;G0^(#PO=&0^(#PO='(^
M(#QT<B!B9V-O;&]R/3-$(V-C965F9CX@/'1D('-T>6QE/3-$)U1%6%0M04Q)
M1TXZ(&QE9G0[($U!4D=)3BU,1494.B`P<'0[($U!4D=)3BU224=(5#H@,'!T
M.R!415A4+4E.1$5.5#H@,'!T)R!V86QI9VX],T1B;W1T;VT@=VED=&@],T0T
M.24^(#QD:78@<W1Y;&4],T0G1$E34$Q!63H@8FQO8VL[($9/3E0M1D%-24Q9
M.B!T:6UE<R!N97<@<F]M86X[($9/3E0M4TE:13H@,3!P=#L@34%21TE.+4Q%
M1E0Z(#!P=#L@34%21TE.+5))1TA4.B`P<'0[(%1%6%0M04Q)1TXZ(&QE9G0[
M(%1%6%0M24Y$14Y4.B`P<'0G/B!$97)I=F%T:79E<R!N;W0@9&5S:6=N871E
M9"!A<R!H961G92!I;G-T<G5M96YT<SPO9&EV/B`\+W1D/B`\=&0@=F%L:6=N
M/3-$8F]T=&]M('=I9'1H/3-$,34E/B`\9&EV('-T>6QE/3-$)T1)4U!,05DZ
M(&)L;V-K.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!&3TY4+5-)
M6D4Z(#$P<'0[($U!4D=)3BU,1494.B`P<'0[($U!4D=)3BU224=(5#H@,2XV
M<'0[('1E>'0M86QI9VXZ(&-E;G1E<CL@5$585"U)3D1%3E0Z(#!P="<^($]T
M:&5R(&-U<G)E;G0@87-S971S/"]D:78^(#PO=&0^(#QT9"!V86QI9VX],T1B
M;W1T;VT@=VED=&@],T0Q)2!A;&EG;CTS1')I9VAT/CQF;VYT('-T>6QE/3-$
M)T9/3E0M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA
M;CL@1$E34$Q!63H@:6YL:6YE)SX@)FYB<W`[/"]F;VYT/B`\+W1D/B`\=&0@
M<W1Y;&4],T0G5$585"U!3$E'3CH@;&5F="<@=F%L:6=N/3-$8F]T=&]M('=I
M9'1H/3-$,24^/&9O;G0@<W1Y;&4],T0G1D].5"U325I%.B`Q,'!T.R!&3TY4
M+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!$25-03$%9.B!I;FQI;F4G/B`F
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M(&YE=R!R;VUA;CL@1$E34$Q!63H@:6YL:6YE)SX@)FYB<W`[/"]F;VYT/B`\
M+W1D/B`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,3`E(&-O;'-P86X]
M,T0R/B`\9&EV('-T>6QE/3-$)T1)4U!,05DZ(&)L;V-K.R!&3TY4+49!34E,
M63H@=&EM97,@;F5W(')O;6%N.R!&3TY4+5-)6D4Z(#$P<'0[($U!4D=)3BU,
M1494.B`P<'0[($U!4D=)3BU224=(5#H@,'!T.R!T97AT+6%L:6=N.B!C96YT
M97([(%1%6%0M24Y$14Y4.B`P<'0G/B!/=&AE<B!C=7)R96YT(&%S<V5T<SPO
M9&EV/B`\+W1D/B`\=&0@<W1Y;&4],T0G5$585"U!3$E'3CH@;&5F="<@=F%L
M:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@;F]W<F%P/3-$;F]W<F%P/CQF;VYT
M('-T>6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ('1I;65S
M(&YE=R!R;VUA;CL@1$E34$Q!63H@:6YL:6YE)SX@)FYB<W`[/"]F;VYT/B`\
M+W1D/B`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24^/&9O;G0@<W1Y
M;&4],T0G1D].5"U325I%.B`Q,'!T.R!&3TY4+49!34E,63H@=&EM97,@;F5W
M(')O;6%N.R!$25-03$%9.B!I;FQI;F4G/B`F;F)S<#L\+V9O;G0^(#PO=&0^
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M25I%.B`Q,'!T.R!415A4+4%,24=..B!R:6=H="<@=F%L:6=N/3-$8F]T=&]M
M('=I9'1H/3-$.24^.3,\+W1D/B`\=&0@<W1Y;&4],T0G5$585"U!3$E'3CH@
M;&5F="<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@;F]W<F%P/3-$;F]W
M<F%P/CQF;VYT('-T>6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@1D].5"U&04U)
M3%DZ('1I;65S(&YE=R!R;VUA;CL@1$E34$Q!63H@:6YL:6YE)SX@)FYB<W`[
M/"]F;VYT/B`\+W1D/B`\+W1R/B`\='(@8F=C;VQO<CTS1'=H:71E/B`\=&0@
M<W1Y;&4],T0G5$585"U!3$E'3CH@;&5F=#L@34%21TE.+4Q%1E0Z(#!P=#L@
M34%21TE.+5))1TA4.B`P<'0[(%1%6%0M24Y$14Y4.B`P<'0G('9A;&EG;CTS
M1&)O='1O;2!W:61T:#TS1#0Y)3X\9F]N="!S='EL93TS1"=&3TY4+5-)6D4Z
M(#$P<'0[($9/3E0M1D%-24Q9.B!T:6UE<R!N97<@<F]M86X[($1)4U!,05DZ
M(&EN;&EN92<^("9N8G-P.SPO9F]N=#X@/"]T9#X@/'1D('9A;&EG;CTS1&)O
M='1O;2!W:61T:#TS1#$U)3X\9F]N="!S='EL93TS1"=&3TY4+5-)6D4Z(#$P
M<'0[($9/3E0M1D%-24Q9.B!T:6UE<R!N97<@<F]M86X[($1)4U!,05DZ(&EN
M;&EN92<^("9N8G-P.SPO9F]N=#X@/"]T9#X@/'1D('9A;&EG;CTS1&)O='1O
M;2!W:61T:#TS1#$E(&%L:6=N/3-$<FEG:'0^/&9O;G0@<W1Y;&4],T0G1D].
M5"U325I%.B`Q,'!T.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!$
M25-03$%9.B!I;FQI;F4G/B`F;F)S<#L\+V9O;G0^(#PO=&0^(#QT9"!S='EL
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M:6YL:6YE)SX@)FYB<W`[/"]F;VYT/B`\+W1D/B`\=&0@<W1Y;&4],T0G5$58
M5"U!3$E'3CH@;&5F="<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24^/&9O
M;G0@<W1Y;&4],T0G1D].5"U325I%.B`Q,'!T.R!&3TY4+49!34E,63H@=&EM
M97,@;F5W(')O;6%N.R!$25-03$%9.B!I;FQI;F4G/B`F;F)S<#L\+V9O;G0^
M(#PO=&0^(#QT9"!S='EL93TS1"=415A4+4%,24=..B!R:6=H="<@=F%L:6=N
M/3-$8F]T=&]M('=I9'1H/3-$.24^/&9O;G0@<W1Y;&4],T0G1D].5"U325I%
M.B`Q,'!T.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!$25-03$%9
M.B!I;FQI;F4G/B`F;F)S<#L\+V9O;G0^(#PO=&0^(#QT9"!S='EL93TS1"=4
M15A4+4%,24=..B!L969T)R!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)2!N
M;W=R87`],T1N;W=R87`^/&9O;G0@<W1Y;&4],T0G1D].5"U325I%.B`Q,'!T
M.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!$25-03$%9.B!I;FQI
M;F4G/B`F;F)S<#L\+V9O;G0^(#PO=&0^(#QT9"!V86QI9VX],T1B;W1T;VT@
M=VED=&@],T0Q)3X\9F]N="!S='EL93TS1"=&3TY4+5-)6D4Z(#$P<'0[($9/
M3E0M1D%-24Q9.B!T:6UE<R!N97<@<F]M86X[($1)4U!,05DZ(&EN;&EN92<^
M("9N8G-P.SPO9F]N=#X@/"]T9#X@/'1D('-T>6QE/3-$)U1%6%0M04Q)1TXZ
M(&QE9G0G('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E/CQF;VYT('-T>6QE
M/3-$)T9/3E0M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R
M;VUA;CL@1$E34$Q!63H@:6YL:6YE)SX@)FYB<W`[/"]F;VYT/B`\+W1D/B`\
M=&0@<W1Y;&4],T0G5$585"U!3$E'3CH@<FEG:'0G('9A;&EG;CTS1&)O='1O
M;2!W:61T:#TS1#DE/CQF;VYT('-T>6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@
M1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1$E34$Q!63H@:6YL:6YE
M)SX@)FYB<W`[/"]F;VYT/B`\+W1D/B`\=&0@<W1Y;&4],T0G5$585"U!3$E'
M3CH@;&5F="<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@;F]W<F%P/3-$
M;F]W<F%P/CQF;VYT('-T>6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@1D].5"U&
M04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1$E34$Q!63H@:6YL:6YE)SX@)FYB
M<W`[/"]F;VYT/B`\+W1D/B`\+W1R/B`\='(@8F=C;VQO<CTS1"-C8V5E9F8^
M(#QT9"!S='EL93TS1"=0041$24Y'+4)/5%1/33H@,G!X.R!415A4+4%,24=.
M.B!L969T.R!-05)'24XM3$5&5#H@,'!T.R!-05)'24XM4DE'2%0Z(#!P=#L@
M5$585"U)3D1%3E0Z(#!P="<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$-#DE
M/B`\9&EV('-T>6QE/3-$)T1)4U!,05DZ(&)L;V-K.R!&3TY4+49!34E,63H@
M=&EM97,@;F5W(')O;6%N.R!&3TY4+5-)6D4Z(#$P<'0[($U!4D=)3BU,1494
M.B`P<'0[($U!4D=)3BU224=(5#H@,'!T.R!415A4+4%,24=..B!L969T.R!4
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M34%21TE.+4Q%1E0Z(#!P=#L@34%21TE.+5))1TA4.B`Q+C9P=#L@=&5X="UA
M;&EG;CH@8V5N=&5R.R!415A4+4E.1$5.5#H@,'!T)SX@3W1H97(@8W5R<F5N
M="!L:6%B:6QI=&EE<SPO9&EV/B`\+W1D/B`\=&0@<W1Y;&4],T0G4$%$1$E.
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M.B`Q,'!T.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!$25-03$%9
M.B!I;FQI;F4G/B`F;F)S<#L\+V9O;G0^(#PO=&0^(#QT9"!S='EL93TS1"="
M3U)$15(M0D]45$]-.B!B;&%C:R`R<'@@<V]L:60[($1)4U!,05DZ(&EN;&EN
M93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q
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M/B`\=&0@<W1Y;&4],T0G4$%$1$E.1RU"3U143TTZ(#)P>"<@=F%L:6=N/3-$
M8F]T=&]M('=I9'1H/3-$,24^/&9O;G0@<W1Y;&4],T0G1D].5"U325I%.B`Q
M,'!T.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!$25-03$%9.B!I
M;FQI;F4G/B`F;F)S<#L\+V9O;G0^(#PO=&0^(#QT9"!S='EL93TS1"=415A4
M+4%,24=..B!L969T)R!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)3X\9F]N
M="!S='EL93TS1"=&3TY4+5-)6D4Z(#$P<'0[($9/3E0M1D%-24Q9.B!T:6UE
M<R!N97<@<F]M86X[($1)4U!,05DZ(&EN;&EN92<^("9N8G-P.SPO9F]N=#X@
M/"]T9#X@/'1D('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)
M3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T.R!0041$24Y'
M+4)/5%1/33H@,G!X.R!415A4+4%,24=..B!R:6=H="<@=F%L:6=N/3-$8F]T
M=&]M('=I9'1H/3-$.24^+3PO=&0^(#QT9"!S='EL93TS1"=0041$24Y'+4)/
M5%1/33H@,G!X.R!415A4+4%,24=..B!L969T)R!V86QI9VX],T1B;W1T;VT@
M=VED=&@],T0Q)2!N;W=R87`],T1N;W=R87`^/&9O;G0@<W1Y;&4],T0G1D].
M5"U325I%.B`Q,'!T.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!$
M25-03$%9.B!I;FQI;F4G/B`F;F)S<#L\+V9O;G0^(#PO=&0^(#QT9"!S='EL
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M8F]T=&]M('=I9'1H/3-$,24^/&9O;G0@<W1Y;&4],T0G1D].5"U325I%.B`Q
M,'!T.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!$25-03$%9.B!I
M;FQI;F4G/B`F;F)S<#L\+V9O;G0^(#PO=&0^(#QT9"!S='EL93TS1"="3U)$
M15(M0D]45$]-.B!B;&%C:R`R<'@@<V]L:60[($1)4U!,05DZ(&EN;&EN93L@
M1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T
M.R!415A4+4%,24=..B!R:6=H="<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$
M.24^+3PO=&0^(#QT9"!S='EL93TS1"=0041$24Y'+4)/5%1/33H@,G!X.R!4
M15A4+4%,24=..B!L969T)R!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)2!N
M;W=R87`],T1N;W=R87`^/&9O;G0@<W1Y;&4],T0G1D].5"U325I%.B`Q,'!T
M.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!$25-03$%9.B!I;FQI
M;F4G/B`F;F)S<#L\+V9O;G0^(#PO=&0^(#PO='(^(#QT<B!B9V-O;&]R/3-$
M=VAI=&4^(#QT9"!S='EL93TS1"=415A4+4%,24=..B!L969T.R!-05)'24XM
M3$5&5#H@,'!T.R!-05)'24XM4DE'2%0Z(#!P=#L@5$585"U)3D1%3E0Z(#!P
M="<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$-#DE/CQF;VYT('-T>6QE/3-$
M)T9/3E0M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA
M;CL@1$E34$Q!63H@:6YL:6YE)SX@)FYB<W`[/"]F;VYT/B`\+W1D/B`\=&0@
M=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,34E/CQF;VYT('-T>6QE/3-$)T9/
M3E0M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@
M1$E34$Q!63H@:6YL:6YE)SX@)FYB<W`[/"]F;VYT/B`\+W1D/B`\=&0@=F%L
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M:6YE)SX@)FYB<W`[/"]F;VYT/B`\+W1D/B`\=&0@<W1Y;&4],T0G5$585"U!
M3$E'3CH@<FEG:'0G('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#DE/CQF;VYT
M('-T>6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ('1I;65S
M(&YE=R!R;VUA;CL@1$E34$Q!63H@:6YL:6YE)SX@)FYB<W`[/"]F;VYT/B`\
M+W1D/B`\=&0@<W1Y;&4],T0G5$585"U!3$E'3CH@;&5F="<@=F%L:6=N/3-$
M8F]T=&]M('=I9'1H/3-$,24@;F]W<F%P/3-$;F]W<F%P/CQF;VYT('-T>6QE
M/3-$)T9/3E0M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R
M;VUA;CL@1$E34$Q!63H@:6YL:6YE)SX@)FYB<W`[/"]F;VYT/B`\+W1D/B`\
M=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24^/&9O;G0@<W1Y;&4],T0G
M1D].5"U325I%.B`Q,'!T.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N
M.R!$25-03$%9.B!I;FQI;F4G/B`F;F)S<#L\+V9O;G0^(#PO=&0^(#QT9"!S
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M)SX@)FYB<W`[/"]F;VYT/B`\+W1D/B`\=&0@<W1Y;&4],T0G5$585"U!3$E'
M3CH@<FEG:'0G('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#DE/CQF;VYT('-T
M>6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ('1I;65S(&YE
M=R!R;VUA;CL@1$E34$Q!63H@:6YL:6YE)SX@)FYB<W`[/"]F;VYT/B`\+W1D
M/B`\=&0@<W1Y;&4],T0G5$585"U!3$E'3CH@;&5F="<@=F%L:6=N/3-$8F]T
M=&]M('=I9'1H/3-$,24@;F]W<F%P/3-$;F]W<F%P/CQF;VYT('-T>6QE/3-$
M)T9/3E0M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA
M;CL@1$E34$Q!63H@:6YL:6YE)SX@)FYB<W`[/"]F;VYT/B`\+W1D/B`\+W1R
M/B`\='(@8F=C;VQO<CTS1"-C8V5E9F8^(#QT9"!S='EL93TS1"=0041$24Y'
M+4)/5%1/33H@-'!X.R!415A4+4%,24=..B!L969T.R!-05)'24XM3$5&5#H@
M,'!T.R!-05)'24XM4DE'2%0Z(#!P=#L@5$585"U)3D1%3E0Z(#!P="<@=F%L
M:6=N/3-$8F]T=&]M('=I9'1H/3-$-#DE/B`\9&EV('-T>6QE/3-$)T1)4U!,
M05DZ(&)L;V-K.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!&3TY4
M+5-)6D4Z(#$P<'0[($U!4D=)3BU,1494.B`P<'0[($U!4D=)3BU224=(5#H@
M,'!T.R!415A4+4%,24=..B!L969T.R!415A4+4E.1$5.5#H@,'!T)SX@5&]T
M86P\+V1I=CX@/"]T9#X@/'1D('-T>6QE/3-$)U!!1$1)3D<M0D]45$]-.B`T
M<'@G('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$U)3X\9F]N="!S='EL93TS
M1"=&3TY4+5-)6D4Z(#$P<'0[($9/3E0M1D%-24Q9.B!T:6UE<R!N97<@<F]M
M86X[($1)4U!,05DZ(&EN;&EN92<^("9N8G-P.SPO9F]N=#X@/"]T9#X@/'1D
M('-T>6QE/3-$)U!!1$1)3D<M0D]45$]-.B`T<'@G('9A;&EG;CTS1&)O='1O
M;2!W:61T:#TS1#$E(&%L:6=N/3-$<FEG:'0^/&9O;G0@<W1Y;&4],T0G1D].
M5"U325I%.B`Q,'!T.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!$
M25-03$%9.B!I;FQI;F4G/B`F;F)S<#L\+V9O;G0^(#PO=&0^(#QT9"!S='EL
M93TS1"="3U)$15(M0D]45$]-.B!B;&%C:R`T<'@@9&]U8FQE.R!$25-03$%9
M.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE<R!N97<@<F]M86X[($9/3E0M
M4TE:13H@,3!P=#L@5$585"U!3$E'3CH@;&5F="<@=F%L:6=N/3-$8F]T=&]M
M('=I9'1H/3-$,24^)#PO=&0^(#QT9"!S='EL93TS1"="3U)$15(M0D]45$]-
M.B!B;&%C:R`T<'@@9&]U8FQE.R!$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-
M24Q9.B!T:6UE<R!N97<@<F]M86X[($9/3E0M4TE:13H@,3!P=#L@5$585"U!
M3$E'3CH@<FEG:'0G('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#DE/B@X-#(\
M+W1D/B`\=&0@<W1Y;&4],T0G1$E34$Q!63H@:6YL:6YE.R!&3TY4+49!34E,
M63H@=&EM97,@;F5W(')O;6%N.R!&3TY4+5-)6D4Z(#$P<'0[(%!!1$1)3D<M
M0D]45$]-.B`T<'@[(%1%6%0M04Q)1TXZ(&QE9G0G('9A;&EG;CTS1&)O='1O
M;2!W:61T:#TS1#$E(&YO=W)A<#TS1&YO=W)A<#XI/"]T9#X@/'1D('-T>6QE
M/3-$)U!!1$1)3D<M0D]45$]-.B`T<'@G('9A;&EG;CTS1&)O='1O;2!W:61T
M:#TS1#$E/CQF;VYT('-T>6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@1D].5"U&
M04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1$E34$Q!63H@:6YL:6YE)SX@)FYB
M<W`[/"]F;VYT/B`\+W1D/B`\=&0@<W1Y;&4],T0G5$585"U!3$E'3CH@;&5F
M="<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24^/&9O;G0@<W1Y;&4],T0G
M1D].5"U325I%.B`Q,'!T.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N
M.R!$25-03$%9.B!I;FQI;F4G/B`F;F)S<#L\+V9O;G0^(#PO=&0^(#QT9"!S
M='EL93TS1"=0041$24Y'+4)/5%1/33H@-'!X.R!415A4+4%,24=..B!R:6=H
M="<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$.24^/&9O;G0@<W1Y;&4],T0G
M1D].5"U325I%.B`Q,'!T.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N
M.R!$25-03$%9.B!I;FQI;F4G/B`F;F)S<#L\+V9O;G0^(#PO=&0^(#QT9"!S
M='EL93TS1"=0041$24Y'+4)/5%1/33H@-'!X.R!415A4+4%,24=..B!L969T
M)R!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)2!N;W=R87`],T1N;W=R87`^
M/&9O;G0@<W1Y;&4],T0G1D].5"U325I%.B`Q,'!T.R!&3TY4+49!34E,63H@
M=&EM97,@;F5W(')O;6%N.R!$25-03$%9.B!I;FQI;F4G/B`F;F)S<#L\+V9O
M;G0^(#PO=&0^(#QT9"!S='EL93TS1"=0041$24Y'+4)/5%1/33H@-'!X)R!V
M86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)2!A;&EG;CTS1&QE9G0^/&9O;G0@
M<W1Y;&4],T0G1D].5"U325I%.B`Q,'!T.R!&3TY4+49!34E,63H@=&EM97,@
M;F5W(')O;6%N.R!$25-03$%9.B!I;FQI;F4G/B`F;F)S<#L\+V9O;G0^(#PO
M=&0^(#QT9"!S='EL93TS1"="3U)$15(M0D]45$]-.B!B;&%C:R`T<'@@9&]U
M8FQE.R!$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE<R!N97<@
M<F]M86X[($9/3E0M4TE:13H@,3!P=#L@5$585"U!3$E'3CH@;&5F="<@=F%L
M:6=N/3-$8F]T=&]M('=I9'1H/3-$,24^)#PO=&0^(#QT9"!S='EL93TS1"="
M3U)$15(M0D]45$]-.B!B;&%C:R`T<'@@9&]U8FQE.R!$25-03$%9.B!I;FQI
M;F4[($9/3E0M1D%-24Q9.B!T:6UE<R!N97<@<F]M86X[($9/3E0M4TE:13H@
M,3!P=#L@5$585"U!3$E'3CH@<FEG:'0G('9A;&EG;CTS1&)O='1O;2!W:61T
M:#TS1#DE/CDS/"]T9#X@/'1D('-T>6QE/3-$)U!!1$1)3D<M0D]45$]-.B`T
M<'@[(%1%6%0M04Q)1TXZ(&QE9G0G('9A;&EG;CTS1&)O='1O;2!W:61T:#TS
M1#$E(&YO=W)A<#TS1&YO=W)A<#X\9F]N="!S='EL93TS1"=&3TY4+5-)6D4Z
M(#$P<'0[($9/3E0M1D%-24Q9.B!T:6UE<R!N97<@<F]M86X[($1)4U!,05DZ
M(&EN;&EN92<^("9N8G-P.SPO9F]N=#X@/"]T9#X@/"]T<CX@/"]T86)L93X@
M/"]D:78^(#PA+2U%;F1&<F%G;65N="TM/CPO9&EV/B`\+V1I=CX\<W!A;CX\
M+W-P86X^/"]T9#X-"B`@("`@(#PO='(^#0H@("`@/"]T86)L93X-"B`@/"]B
M;V1Y/@T*/"]H=&UL/@T*#0HM+2TM+2T]7TYE>'1087)T7S!C860U.69D7S<S
M,F5?-#9E,E]A-3,T7S!C.&%D,6%F.3!D9`T*0V]N=&5N="U,;V-A=&EO;CH@
M9FEL93HO+R]#.B\P8V%D-3EF9%\W,S)E7S0V93)?834S-%\P8SAA9#%A9CDP
M9&0O5V]R:W-H965T<R]3:&5E=#$S+FAT;6P-"D-O;G1E;G0M5')A;G-F97(M
M16YC;V1I;F<Z('%U;W1E9"UP<FEN=&%B;&4-"D-O;G1E;G0M5'EP93H@=&5X
M="]H=&UL.R!C:&%R<V5T/2)U<RUA<V-I:2(-"@T*/&AT;6P^#0H@(#QH96%D
M/@T*("`@(#Q-151!(&AT='`M97%U:78],T1#;VYT96YT+51Y<&4@8V]N=&5N
M=#TS1"=T97AT+VAT;6P[(&-H87)S970]=71F+3@G/CQS8W)I<'0@='EP93TS
M1'1E>'0O:F%V87-C<FEP="!S<F,],T13:&]W+FIS/B\J($1O($YO="!296UO
M=F4@5&AI<R!#;VUM96YT("HO/"]S8W)I<'0^/"]H96%D/@T*("`\8F]D>3X-
M"B`@("`\=&%B;&4@8VQA<W,],T1R97!O<G0@:60],T1)1#!%344^#0H@("`@
M("`\='(^#0H@("`@("`@(#QT:"!C;&%S<STS1'1L(&-O;'-P86X],T0Q(')O
M=W-P86X],T0R/CQS=')O;F<^4%)/4$525%D@04Y$($5154E0345.5"P@3D54
M/&)R/CPO<W1R;VYG/CPO=&@^#0H@("`@("`@(#QT:"!C;&%S<STS1'1H(&-O
M;'-P86X],T0Q/C$R($UO;G1H<R!%;F1E9#PO=&@^#0H@("`@("`\+W1R/@T*
M("`@("`@/'1R/@T*("`@("`@("`\=&@@8VQA<W,],T1T:#Y*=6XN(#,P+"`R
M,#$T/&)R/CPO=&@^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$
M<F4^#0H@("`@("`@(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O<#X\<W1R
M;VYG/E!23U!%4E19($%.1"!%455)4$U%3E0L($Y%5"!;06)S=')A8W1=/"]S
M=')O;F<^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^
M/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$
M<F\^#0H@("`@("`@(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O<#Y04D]0
M15)462!!3D0@15%525!-14Y4+"!.150\+W1D/@T*("`@("`@("`\=&0@8VQA
M<W,],T1T97AT/B<\(2TM1$]#5%E012!H=&UL(%!50DQ)0R`B+2\O5S-#+R]$
M5$0@6$A434P@,2XP(%1R86YS:71I;VYA;"\O14XB(")H='1P.B\O=W=W+G<S
M+F]R9R]44B]X:'1M;#$O1%1$+WAH=&UL,2UT<F%N<VET:6]N86PN9'1D(B`M
M+3X\9&EV/B`\9&EV/CPA+2U3=&%R=$9R86=M96YT+2T^(#QD:78@<W1Y;&4]
M,T0G1$E34$Q!63H@8FQO8VL[($9/3E0M1D%-24Q9.B!4:6UE<R!.97<@4F]M
M86X[($9/3E0M4TE:13H@,3!P=#L@1D].5"U714E'2%0Z(&)O;&0[($U!4D=)
M3BU,1494.B`P<'0[($U!4D=)3BU224=(5#H@,'!T.R!415A4+4%,24=..B!L
M969T.R!415A4+4E.1$5.5#H@,'!T)SX@3D]412`U.BU04D]015)462!!3D0@
M15%525!-14Y4+"!.150\+V1I=CX@/&1I=B!S='EL93TS1"=$25-03$%9.B!B
M;&]C:SL@34%21TE.+4Q%1E0Z(#!P=#L@34%21TE.+5))1TA4.B`P<'0[('1E
M>'0M86QI9VXZ(&IU<W1I9GD[(%1%6%0M24Y$14Y4.B`P<'0G/B`F;F)S<#L\
M+V1I=CX@/&1I=B!S='EL93TS1"=T97AT+6%L:6=N.B!R:6=H="<^(#QT86)L
M92!S='EL93TS1"=&3TY4+5-)6D4Z(#$P<'0[($9/3E0M1D%-24Q9.B!T:6UE
M<R!N97<@<F]M86XG(&-E;&QS<&%C:6YG/3-$,"!C96QL<&%D9&EN9STS1#`@
M=VED=&@],T0Y-R4^(#QT<CX@/'1D('-T>6QE/3-$)U!!1$1)3D<M0D]45$]-
M.B`R<'@G('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#<V)3X\9F]N="!S='EL
M93TS1"=&3TY4+5-)6D4Z(#$P<'0[($9/3E0M1D%-24Q9.B!T:6UE<R!N97<@
M<F]M86X[($1)4U!,05DZ(&EN;&EN92<^("9N8G-P.SPO9F]N=#X@/"]T9#X@
M/'1D('-T>6QE/3-$)U!!1$1)3D<M0D]45$]-.B`R<'@G('9A;&EG;CTS1&)O
M='1O;2!W:61T:#TS1#$E/CQF;VYT('-T>6QE/3-$)T9/3E0M4TE:13H@,3!P
M=#L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U714E'2%0Z
M(&)O;&0[($1)4U!,05DZ(&EN;&EN92<^("9N8G-P.SPO9F]N=#X@/"]T9#X@
M/'1D('-T>6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#)P>"!S;VQI9"<@
M=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,C(E(&-O;'-P86X],T0V/B`\9&EV
M('-T>6QE/3-$)T1)4U!,05DZ(&)L;V-K.R!&3TY4+49!34E,63H@=&EM97,@
M;F5W(')O;6%N.R!&3TY4+5-)6D4Z(#$P<'0[($9/3E0M5T5)1TA4.B!B;VQD
M.R!-05)'24XM3$5&5#H@,'!T.R!-05)'24XM4DE'2%0Z(#!P=#L@=&5X="UA
M;&EG;CH@8V5N=&5R.R!415A4+4E.1$5.5#H@,'!T)SX@2G5N92`S,"P\+V1I
M=CX@/"]T9#X@/'1D('-T>6QE/3-$)U!!1$1)3D<M0D]45$]-.B`R<'@[(%1%
M6%0M04Q)1TXZ(&QE9G0G('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E(&YO
M=W)A<#TS1&YO=W)A<#X\9F]N="!S='EL93TS1"=&3TY4+5-)6D4Z(#$P<'0[
M($9/3E0M1D%-24Q9.B!T:6UE<R!N97<@<F]M86X[($9/3E0M5T5)1TA4.B!B
M;VQD.R!$25-03$%9.B!I;FQI;F4G/B`F;F)S<#L\+V9O;G0^(#PO=&0^(#PO
M='(^(#QT<CX@/'1D('-T>6QE/3-$)U!!1$1)3D<M0D]45$]-.B`R<'@G('9A
M;&EG;CTS1&)O='1O;2!W:61T:#TS1#<V)2!A;&EG;CTS1&QE9G0^/&9O;G0@
M<W1Y;&4],T0G1D].5"U325I%.B`Q,'!T.R!&3TY4+49!34E,63H@=&EM97,@
M;F5W(')O;6%N.R!$25-03$%9.B!I;FQI;F4G/B`F;F)S<#L\+V9O;G0^(#PO
M=&0^(#QT9"!S='EL93TS1"=0041$24Y'+4)/5%1/33H@,G!X)R!V86QI9VX]
M,T1B;W1T;VT@=VED=&@],T0Q)3X\9F]N="!S='EL93TS1"=&3TY4+5-)6D4Z
M(#$P<'0[($9/3E0M1D%-24Q9.B!T:6UE<R!N97<@<F]M86X[($9/3E0M5T5)
M1TA4.B!B;VQD.R!$25-03$%9.B!I;FQI;F4G/B`F;F)S<#L\+V9O;G0^(#PO
M=&0^(#QT9"!S='EL93TS1"="3U)$15(M0D]45$]-.B!B;&%C:R`R<'@@<V]L
M:60G('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$P)2!C;VQS<&%N/3-$,CX@
M/&1I=B!S='EL93TS1"=$25-03$%9.B!B;&]C:SL@1D].5"U&04U)3%DZ('1I
M;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T.R!&3TY4+5=%24=(5#H@
M8F]L9#L@34%21TE.+4Q%1E0Z(#!P=#L@34%21TE.+5))1TA4.B`P<'0[('1E
M>'0M86QI9VXZ(&-E;G1E<CL@5$585"U)3D1%3E0Z(#!P="<^(#(P,30\+V1I
M=CX@/"]T9#X@/'1D('-T>6QE/3-$)U!!1$1)3D<M0D]45$]-.B`R<'@[(%1%
M6%0M04Q)1TXZ(&QE9G0G('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E(&YO
M=W)A<#TS1&YO=W)A<#X\9F]N="!S='EL93TS1"=&3TY4+5-)6D4Z(#$P<'0[
M($9/3E0M1D%-24Q9.B!T:6UE<R!N97<@<F]M86X[($9/3E0M5T5)1TA4.B!B
M;VQD.R!$25-03$%9.B!I;FQI;F4G/B`F;F)S<#L\+V9O;G0^(#PO=&0^(#QT
M9"!S='EL93TS1"=0041$24Y'+4)/5%1/33H@,G!X)R!V86QI9VX],T1B;W1T
M;VT@=VED=&@],T0Q)3X\9F]N="!S='EL93TS1"=&3TY4+5-)6D4Z(#$P<'0[
M($9/3E0M1D%-24Q9.B!T:6UE<R!N97<@<F]M86X[($9/3E0M5T5)1TA4.B!B
M;VQD.R!$25-03$%9.B!I;FQI;F4G/B`F;F)S<#L\+V9O;G0^(#PO=&0^(#QT
M9"!S='EL93TS1"="3U)$15(M0D]45$]-.B!B;&%C:R`R<'@@<V]L:60G('9A
M;&EG;CTS1&)O='1O;2!W:61T:#TS1#$P)2!C;VQS<&%N/3-$,CX@/&1I=B!S
M='EL93TS1"=$25-03$%9.B!B;&]C:SL@1D].5"U&04U)3%DZ('1I;65S(&YE
M=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T.R!&3TY4+5=%24=(5#H@8F]L9#L@
M34%21TE.+4Q%1E0Z(#!P=#L@34%21TE.+5))1TA4.B`P<'0[('1E>'0M86QI
M9VXZ(&-E;G1E<CL@5$585"U)3D1%3E0Z(#!P="<^(#(P,3,\+V1I=CX@/"]T
M9#X@/'1D('-T>6QE/3-$)U!!1$1)3D<M0D]45$]-.B`R<'@[(%1%6%0M04Q)
M1TXZ(&QE9G0G('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E(&YO=W)A<#TS
M1&YO=W)A<#X\9F]N="!S='EL93TS1"=&3TY4+5-)6D4Z(#$P<'0[($9/3E0M
M1D%-24Q9.B!T:6UE<R!N97<@<F]M86X[($9/3E0M5T5)1TA4.B!B;VQD.R!$
M25-03$%9.B!I;FQI;F4G/B`F;F)S<#L\+V9O;G0^(#PO=&0^(#PO='(^(#QT
M<B!B9V-O;&]R/3-$(V-C965F9CX@/'1D('9A;&EG;CTS1&)O='1O;2!W:61T
M:#TS1#<V)2!A;&EG;CTS1&QE9G0^(#QD:78@<W1Y;&4],T0G1$E34$Q!63H@
M8FQO8VL[($9/3E0M1D%-24Q9.B!T:6UE<R!N97<@<F]M86X[($9/3E0M4TE:
M13H@,3!P=#L@1D].5"U714E'2%0Z(&)O;&0[($U!4D=)3BU,1494.B`P<'0[
M($U!4D=)3BU224=(5#H@,'!T.R!T97AT+6%L:6=N.B!L969T.R!415A4+4E.
M1$5.5#H@,'!T)SX@0V]S=#H\+V1I=CX@/"]T9#X@/'1D('9A;&EG;CTS1&)O
M='1O;2!W:61T:#TS1#$E/CQF;VYT('-T>6QE/3-$)T9/3E0M4TE:13H@,3!P
M=#L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1$E34$Q!63H@:6YL
M:6YE)SX@)FYB<W`[/"]F;VYT/B`\+W1D/B`\=&0@=F%L:6=N/3-$8F]T=&]M
M('=I9'1H/3-$,3`E(&-O;'-P86X],T0R/CQF;VYT('-T>6QE/3-$)T9/3E0M
M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1$E3
M4$Q!63H@:6YL:6YE)SX@)FYB<W`[/"]F;VYT/B`\+W1D/B`\=&0@<W1Y;&4]
M,T0G5$585"U!3$E'3CH@;&5F="<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$
M,24@;F]W<F%P/3-$;F]W<F%P/CQF;VYT('-T>6QE/3-$)T9/3E0M4TE:13H@
M,3!P=#L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1$E34$Q!63H@
M:6YL:6YE)SX@)FYB<W`[/"]F;VYT/B`\+W1D/B`\=&0@=F%L:6=N/3-$8F]T
M=&]M('=I9'1H/3-$,24^/&9O;G0@<W1Y;&4],T0G1D].5"U325I%.B`Q,'!T
M.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!$25-03$%9.B!I;FQI
M;F4G/B`F;F)S<#L\+V9O;G0^(#PO=&0^(#QT9"!V86QI9VX],T1B;W1T;VT@
M=VED=&@],T0Q,"4@8V]L<W!A;CTS1#(^/&9O;G0@<W1Y;&4],T0G1D].5"U3
M25I%.B`Q,'!T.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!$25-0
M3$%9.B!I;FQI;F4G/B`F;F)S<#L\+V9O;G0^(#PO=&0^(#QT9"!S='EL93TS
M1"=415A4+4%,24=..B!L969T)R!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q
M)2!N;W=R87`],T1N;W=R87`^/&9O;G0@<W1Y;&4],T0G1D].5"U325I%.B`Q
M,'!T.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!$25-03$%9.B!I
M;FQI;F4G/B`F;F)S<#L\+V9O;G0^(#PO=&0^(#PO='(^(#QT<B!B9V-O;&]R
M/3-$=VAI=&4^(#QT9"!V86QI9VX],T1B;W1T;VT@=VED=&@],T0W-B4@86QI
M9VX],T1L969T/B`\9&EV('-T>6QE/3-$)T1)4U!,05DZ(&)L;V-K.R!&3TY4
M+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!&3TY4+5-)6D4Z(#$P<'0[($U!
M4D=)3BU,1494.B`P<'0[($U!4D=)3BU224=(5#H@,'!T.R!T97AT+6%L:6=N
M.B!L969T.R!415A4+4E.1$5.5#H@,'!T)SX@3&%B;W)A=&]R>2!E<75I<&UE
M;G0\+V1I=CX@/"]T9#X@/'1D('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E
M(&%L:6=N/3-$<FEG:'0^/&9O;G0@<W1Y;&4],T0G1D].5"U325I%.B`Q,'!T
M.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!$25-03$%9.B!I;FQI
M;F4G/B`F;F)S<#L\+V9O;G0^(#PO=&0^(#QT9"!S='EL93TS1"=$25-03$%9
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M:6=N/3-$<FEG:'0^/&9O;G0@<W1Y;&4],T0G1D].5"U325I%.B`Q,'!T.R!&
M3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!$25-03$%9.B!I;FQI;F4G
M/B`F;F)S<#L\+V9O;G0^(#PO=&0^(#QT9"!S='EL93TS1"=$25-03$%9.B!I
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M1#DE/C4L-S`Y/"]T9#X@/'1D('-T>6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G
M('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E(&YO=W)A<#TS1&YO=W)A<#X\
M9F]N="!S='EL93TS1"=&3TY4+5-)6D4Z(#$P<'0[($9/3E0M1D%-24Q9.B!T
M:6UE<R!N97<@<F]M86X[($1)4U!,05DZ(&EN;&EN92<^("9N8G-P.SPO9F]N
M=#X@/"]T9#X@/"]T<CX@/'1R(&)G8V]L;W(],T0C8V-E969F/B`\=&0@=F%L
M:6=N/3-$8F]T=&]M('=I9'1H/3-$-S8E(&%L:6=N/3-$;&5F=#X@/&1I=B!S
M='EL93TS1"=$25-03$%9.B!B;&]C:SL@1D].5"U&04U)3%DZ('1I;65S(&YE
M=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T.R!-05)'24XM3$5&5#H@,'!T.R!-
M05)'24XM4DE'2%0Z(#!P=#L@=&5X="UA;&EG;CH@;&5F=#L@5$585"U)3D1%
M3E0Z(#!P="<^($-O;7!U=&5R<R!A;F0@<&5R:7!H97)A;"!E<75I<&UE;G0\
M+V1I=CX@/"]T9#X@/'1D('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E(&%L
M:6=N/3-$<FEG:'0^/&9O;G0@<W1Y;&4],T0G1D].5"U325I%.B`Q,'!T.R!&
M3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!$25-03$%9.B!I;FQI;F4G
M/B`F;F)S<#L\+V9O;G0^(#PO=&0^(#QT9"!S='EL93TS1"=415A4+4%,24=.
M.B!L969T)R!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)3X\9F]N="!S='EL
M93TS1"=&3TY4+5-)6D4Z(#$P<'0[($9/3E0M1D%-24Q9.B!T:6UE<R!N97<@
M<F]M86X[($1)4U!,05DZ(&EN;&EN92<^("9N8G-P.SPO9F]N=#X@/"]T9#X@
M/'1D('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I
M;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T.R!415A4+4%,24=..B!R
M:6=H="<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$.24^-S`X/"]T9#X@/'1D
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M;&4],T0G1D].5"U325I%.B`Q,'!T.R!&3TY4+49!34E,63H@=&EM97,@;F5W
M(')O;6%N.R!$25-03$%9.B!I;FQI;F4G/B`F;F)S<#L\+V9O;G0^(#PO=&0^
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M25I%.B`Q,'!T.R!415A4+4%,24=..B!R:6=H="<@=F%L:6=N/3-$8F]T=&]M
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M=#L@34%21TE.+5))1TA4.B`P<'0[('1E>'0M86QI9VXZ(&QE9G0[(%1%6%0M
M24Y$14Y4.B`P<'0G/B!/9F9I8V4@9G5R;FET=7)E(&%N9"!E<75I<&UE;G0\
M+V1I=CX@/"]T9#X@/'1D('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E(&%L
M:6=N/3-$<FEG:'0^/&9O;G0@<W1Y;&4],T0G1D].5"U325I%.B`Q,'!T.R!&
M3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!$25-03$%9.B!I;FQI;F4G
M/B`F;F)S<#L\+V9O;G0^(#PO=&0^(#QT9"!S='EL93TS1"=415A4+4%,24=.
M.B!L969T)R!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)3X\9F]N="!S='EL
M93TS1"=&3TY4+5-)6D4Z(#$P<'0[($9/3E0M1D%-24Q9.B!T:6UE<R!N97<@
M<F]M86X[($1)4U!,05DZ(&EN;&EN92<^("9N8G-P.SPO9F]N=#X@/"]T9#X@
M/'1D('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I
M;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T.R!415A4+4%,24=..B!R
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M;&4],T0G1D].5"U325I%.B`Q,'!T.R!&3TY4+49!34E,63H@=&EM97,@;F5W
M(')O;6%N.R!$25-03$%9.B!I;FQI;F4G/B`F;F)S<#L\+V9O;G0^(#PO=&0^
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M25I%.B`Q,'!T.R!415A4+4%,24=..B!R:6=H="<@=F%L:6=N/3-$8F]T=&]M
M('=I9'1H/3-$.24^-3,T/"]T9#X@/'1D('-T>6QE/3-$)U1%6%0M04Q)1TXZ
M(&QE9G0G('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E(&YO=W)A<#TS1&YO
M=W)A<#X\9F]N="!S='EL93TS1"=&3TY4+5-)6D4Z(#$P<'0[($9/3E0M1D%-
M24Q9.B!T:6UE<R!N97<@<F]M86X[($1)4U!,05DZ(&EN;&EN92<^("9N8G-P
M.SPO9F]N=#X@/"]T9#X@/"]T<CX@/'1R(&)G8V]L;W(],T0C8V-E969F/B`\
M=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$-S8E(&%L:6=N/3-$;&5F=#X@
M/&1I=B!S='EL93TS1"=$25-03$%9.B!B;&]C:SL@1D].5"U&04U)3%DZ('1I
M;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T.R!-05)'24XM3$5&5#H@
M,'!T.R!-05)'24XM4DE'2%0Z(#!P=#L@=&5X="UA;&EG;CH@;&5F=#L@5$58
M5"U)3D1%3E0Z(#!P="<^($QE87-E:&]L9"!I;7!R;W9E;65N=',\+V1I=CX@
M/"]T9#X@/'1D('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E(&%L:6=N/3-$
M<FEG:'0^/&9O;G0@<W1Y;&4],T0G1D].5"U325I%.B`Q,'!T.R!&3TY4+49!
M34E,63H@=&EM97,@;F5W(')O;6%N.R!$25-03$%9.B!I;FQI;F4G/B`F;F)S
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M=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T.R!415A4+4%,24=..B!R:6=H="<@
M=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$.24^-RPT-3,\+W1D/B`\=&0@<W1Y
M;&4],T0G5$585"U!3$E'3CH@;&5F="<@=F%L:6=N/3-$8F]T=&]M('=I9'1H
M/3-$,24@;F]W<F%P/3-$;F]W<F%P/CQF;VYT('-T>6QE/3-$)T9/3E0M4TE:
M13H@,3!P=#L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1$E34$Q!
M63H@:6YL:6YE)SX@)FYB<W`[/"]F;VYT/B`\+W1D/B`\=&0@=F%L:6=N/3-$
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M)FYB<W`[/"]F;VYT/B`\+W1D/B`\=&0@<W1Y;&4],T0G1$E34$Q!63H@:6YL
M:6YE.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!&3TY4+5-)6D4Z
M(#$P<'0[(%1%6%0M04Q)1TXZ(')I9VAT)R!V86QI9VX],T1B;W1T;VT@=VED
M=&@],T0Y)3XW+#,V.3PO=&0^(#QT9"!S='EL93TS1"=415A4+4%,24=..B!L
M969T)R!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)2!N;W=R87`],T1N;W=R
M87`^/&9O;G0@<W1Y;&4],T0G1D].5"U325I%.B`Q,'!T.R!&3TY4+49!34E,
M63H@=&EM97,@;F5W(')O;6%N.R!$25-03$%9.B!I;FQI;F4G/B`F;F)S<#L\
M+V9O;G0^(#PO=&0^(#PO='(^(#QT<B!B9V-O;&]R/3-$=VAI=&4^(#QT9"!S
M='EL93TS1"=0041$24Y'+4)/5%1/33H@,G!X)R!V86QI9VX],T1B;W1T;VT@
M=VED=&@],T0W-B4@86QI9VX],T1L969T/B`\9&EV('-T>6QE/3-$)T1)4U!,
M05DZ(&)L;V-K.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!&3TY4
M+5-)6D4Z(#$P<'0[($U!4D=)3BU,1494.B`P<'0[($U!4D=)3BU224=(5#H@
M,'!T.R!T97AT+6%L:6=N.B!L969T.R!415A4+4E.1$5.5#H@,'!T)SX@5F5H
M:6-L97,\+V1I=CX@/"]T9#X@/'1D('-T>6QE/3-$)U!!1$1)3D<M0D]45$]-
M.B`R<'@G('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E/CQF;VYT('-T>6QE
M/3-$)T9/3E0M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R
M;VUA;CL@1$E34$Q!63H@:6YL:6YE)SX@)FYB<W`[/"]F;VYT/B`\+W1D/B`\
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M86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)2!N;W=R87`],T1N;W=R87`^/&9O
M;G0@<W1Y;&4],T0G1D].5"U325I%.B`Q,'!T.R!&3TY4+49!34E,63H@=&EM
M97,@;F5W(')O;6%N.R!$25-03$%9.B!I;FQI;F4G/B`F;F)S<#L\+V9O;G0^
M(#PO=&0^(#QT9"!S='EL93TS1"=0041$24Y'+4)/5%1/33H@,G!X)R!V86QI
M9VX],T1B;W1T;VT@=VED=&@],T0Q)3X\9F]N="!S='EL93TS1"=&3TY4+5-)
M6D4Z(#$P<'0[($9/3E0M1D%-24Q9.B!T:6UE<R!N97<@<F]M86X[($1)4U!,
M05DZ(&EN;&EN92<^("9N8G-P.SPO9F]N=#X@/"]T9#X@/'1D('-T>6QE/3-$
M)T)/4D1%4BU"3U143TTZ(&)L86-K(#)P>"!S;VQI9#L@5$585"U!3$E'3CH@
M;&5F="<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24^/&9O;G0@<W1Y;&4]
M,T0G1D].5"U325I%.B`Q,'!T.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O
M;6%N.R!$25-03$%9.B!I;FQI;F4G/B`F;F)S<#L\+V9O;G0^(#PO=&0^(#QT
M9"!S='EL93TS1"="3U)$15(M0D]45$]-.B!B;&%C:R`R<'@@<V]L:60[($1)
M4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@
M1D].5"U325I%.B`Q,'!T.R!415A4+4%,24=..B!R:6=H="<@=F%L:6=N/3-$
M8F]T=&]M('=I9'1H/3-$.24^-C@\+W1D/B`\=&0@<W1Y;&4],T0G4$%$1$E.
M1RU"3U143TTZ(#)P>#L@5$585"U!3$E'3CH@;&5F="<@=F%L:6=N/3-$8F]T
M=&]M('=I9'1H/3-$,24@;F]W<F%P/3-$;F]W<F%P/CQF;VYT('-T>6QE/3-$
M)T9/3E0M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA
M;CL@1$E34$Q!63H@:6YL:6YE)SX@)FYB<W`[/"]F;VYT/B`\+W1D/B`\+W1R
M/B`\='(@8F=C;VQO<CTS1"-C8V5E9F8^(#QT9"!S='EL93TS1"=0041$24Y'
M+4)/5%1/33H@,G!X)R!V86QI9VX],T1B;W1T;VT@=VED=&@],T0W-B4@86QI
M9VX],T1L969T/B`\9&EV('-T>6QE/3-$)T1)4U!,05DZ(&)L;V-K.R!&3TY4
M+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!&3TY4+5-)6D4Z(#$P<'0[($9/
M3E0M5T5)1TA4.B!B;VQD.R!-05)'24XM3$5&5#H@,'!T.R!-05)'24XM4DE'
M2%0Z(#!P=#L@=&5X="UA;&EG;CH@;&5F=#L@5$585"U)3D1%3E0Z(#!P="<^
M("9N8G-P.U1O=&%L($-O<W0\+V1I=CX@/"]T9#X@/'1D('-T>6QE/3-$)U!!
M1$1)3D<M0D]45$]-.B`R<'@G('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E
M/CQF;VYT('-T>6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ
M('1I;65S(&YE=R!R;VUA;CL@1$E34$Q!63H@:6YL:6YE)SX@)FYB<W`[/"]F
M;VYT/B`\+W1D/B`\=&0@<W1Y;&4],T0G0D]21$52+4)/5%1/33H@8FQA8VL@
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M-34\+W1D/B`\=&0@<W1Y;&4],T0G4$%$1$E.1RU"3U143TTZ(#)P>#L@5$58
M5"U!3$E'3CH@;&5F="<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@;F]W
M<F%P/3-$;F]W<F%P/CQF;VYT('-T>6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@
M1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1$E34$Q!63H@:6YL:6YE
M)SX@)FYB<W`[/"]F;VYT/B`\+W1D/B`\=&0@<W1Y;&4],T0G4$%$1$E.1RU"
M3U143TTZ(#)P>"<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24^/&9O;G0@
M<W1Y;&4],T0G1D].5"U325I%.B`Q,'!T.R!&3TY4+49!34E,63H@=&EM97,@
M;F5W(')O;6%N.R!$25-03$%9.B!I;FQI;F4G/B`F;F)S<#L\+V9O;G0^(#PO
M=&0^(#QT9"!S='EL93TS1"="3U)$15(M0D]45$]-.B!B;&%C:R`R<'@@<V]L
M:60[(%1%6%0M04Q)1TXZ(&QE9G0G('9A;&EG;CTS1&)O='1O;2!W:61T:#TS
M1#$E/CQF;VYT('-T>6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@1D].5"U&04U)
M3%DZ('1I;65S(&YE=R!R;VUA;CL@1$E34$Q!63H@:6YL:6YE)SX@)FYB<W`[
M/"]F;VYT/B`\+W1D/B`\=&0@<W1Y;&4],T0G0D]21$52+4)/5%1/33H@8FQA
M8VL@,G!X('-O;&ED.R!$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T
M:6UE<R!N97<@<F]M86X[($9/3E0M4TE:13H@,3!P=#L@5$585"U!3$E'3CH@
M<FEG:'0G('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#DE/C$T+#(Q-3PO=&0^
M(#QT9"!S='EL93TS1"=0041$24Y'+4)/5%1/33H@,G!X.R!415A4+4%,24=.
M.B!L969T)R!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)2!N;W=R87`],T1N
M;W=R87`^/&9O;G0@<W1Y;&4],T0G1D].5"U325I%.B`Q,'!T.R!&3TY4+49!
M34E,63H@=&EM97,@;F5W(')O;6%N.R!$25-03$%9.B!I;FQI;F4G/B`F;F)S
M<#L\+V9O;G0^(#PO=&0^(#PO='(^(#QT<B!B9V-O;&]R/3-$=VAI=&4^(#QT
M9"!V86QI9VX],T1B;W1T;VT@=VED=&@],T0W-B4@86QI9VX],T1L969T/B`\
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M)SX@)FYB<W`[/"]F;VYT/B`\+W1D/B`\=&0@<W1Y;&4],T0G5$585"U!3$E'
M3CH@;&5F="<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24^/&9O;G0@<W1Y
M;&4],T0G1D].5"U325I%.B`Q,'!T.R!&3TY4+49!34E,63H@=&EM97,@;F5W
M(')O;6%N.R!$25-03$%9.B!I;FQI;F4G/B`F;F)S<#L\+V9O;G0^(#PO=&0^
M(#QT9"!S='EL93TS1"=415A4+4%,24=..B!R:6=H="<@=F%L:6=N/3-$8F]T
M=&]M('=I9'1H/3-$.24^/&9O;G0@<W1Y;&4],T0G1D].5"U325I%.B`Q,'!T
M.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!$25-03$%9.B!I;FQI
M;F4G/B`F;F)S<#L\+V9O;G0^(#PO=&0^(#QT9"!S='EL93TS1"=415A4+4%,
M24=..B!L969T)R!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)2!N;W=R87`]
M,T1N;W=R87`^/&9O;G0@<W1Y;&4],T0G1D].5"U325I%.B`Q,'!T.R!&3TY4
M+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!$25-03$%9.B!I;FQI;F4G/B`F
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M1$E34$Q!63H@:6YL:6YE)SX@)FYB<W`[/"]F;VYT/B`\+W1D/B`\=&0@<W1Y
M;&4],T0G5$585"U!3$E'3CH@<FEG:'0G('9A;&EG;CTS1&)O='1O;2!W:61T
M:#TS1#DE/CQF;VYT('-T>6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@1D].5"U&
M04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1$E34$Q!63H@:6YL:6YE)SX@)FYB
M<W`[/"]F;VYT/B`\+W1D/B`\=&0@<W1Y;&4],T0G5$585"U!3$E'3CH@;&5F
M="<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@;F]W<F%P/3-$;F]W<F%P
M/CQF;VYT('-T>6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ
M('1I;65S(&YE=R!R;VUA;CL@1$E34$Q!63H@:6YL:6YE)SX@)FYB<W`[/"]F
M;VYT/B`\+W1D/B`\+W1R/B`\='(@8F=C;VQO<CTS1"-C8V5E9F8^(#QT9"!V
M86QI9VX],T1B;W1T;VT@=VED=&@],T0W-B4@86QI9VX],T1L969T/B`\9&EV
M('-T>6QE/3-$)T1)4U!,05DZ(&)L;V-K.R!&3TY4+49!34E,63H@=&EM97,@
M;F5W(')O;6%N.R!&3TY4+5-)6D4Z(#$P<'0[($U!4D=)3BU,1494.B`P<'0[
M($U!4D=)3BU224=(5#H@,'!T.R!T97AT+6%L:6=N.B!L969T.R!415A4+4E.
M1$5.5#H@,'!T)SX@3&%B;W)A=&]R>2!E<75I<&UE;G0\+V1I=CX@/"]T9#X@
M/'1D('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E(&%L:6=N/3-$<FEG:'0^
M/&9O;G0@<W1Y;&4],T0G1D].5"U325I%.B`Q,'!T.R!&3TY4+49!34E,63H@
M=&EM97,@;F5W(')O;6%N.R!$25-03$%9.B!I;FQI;F4G/B`F;F)S<#L\+V9O
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M;CL@1D].5"U325I%.B`Q,'!T.R!415A4+4%,24=..B!R:6=H="<@=F%L:6=N
M/3-$8F]T=&]M('=I9'1H/3-$.24^,BPP-#(\+W1D/B`\=&0@<W1Y;&4],T0G
M5$585"U!3$E'3CH@;&5F="<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@
M;F]W<F%P/3-$;F]W<F%P/CQF;VYT('-T>6QE/3-$)T9/3E0M4TE:13H@,3!P
M=#L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1$E34$Q!63H@:6YL
M:6YE)SX@)FYB<W`[/"]F;VYT/B`\+W1D/B`\=&0@=F%L:6=N/3-$8F]T=&]M
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M3%DZ('1I;65S(&YE=R!R;VUA;CL@1$E34$Q!63H@:6YL:6YE)SX@)FYB<W`[
M/"]F;VYT/B`\+W1D/B`\=&0@<W1Y;&4],T0G1$E34$Q!63H@:6YL:6YE.R!&
M3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!&3TY4+5-)6D4Z(#$P<'0[
M(%1%6%0M04Q)1TXZ(')I9VAT)R!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Y
M)3XQ+#,P-CPO=&0^(#QT9"!S='EL93TS1"=415A4+4%,24=..B!L969T)R!V
M86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)2!N;W=R87`],T1N;W=R87`^/&9O
M;G0@<W1Y;&4],T0G1D].5"U325I%.B`Q,'!T.R!&3TY4+49!34E,63H@=&EM
M97,@;F5W(')O;6%N.R!$25-03$%9.B!I;FQI;F4G/B`F;F)S<#L\+V9O;G0^
M(#PO=&0^(#PO='(^(#QT<B!B9V-O;&]R/3-$=VAI=&4^(#QT9"!V86QI9VX]
M,T1B;W1T;VT@=VED=&@],T0W-B4@86QI9VX],T1L969T/B`\9&EV('-T>6QE
M/3-$)T1)4U!,05DZ(&)L;V-K.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O
M;6%N.R!&3TY4+5-)6D4Z(#$P<'0[($U!4D=)3BU,1494.B`P<'0[($U!4D=)
M3BU224=(5#H@,'!T.R!T97AT+6%L:6=N.B!L969T.R!415A4+4E.1$5.5#H@
M,'!T)SX@0V]M<'5T97)S(&%N9"!P97)I<&AE<F%L(&5Q=6EP;65N=#PO9&EV
M/B`\+W1D/B`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@86QI9VX]
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M;CL@1$E34$Q!63H@:6YL:6YE)SX@)FYB<W`[/"]F;VYT/B`\+W1D/B`\=&0@
M<W1Y;&4],T0G1$E34$Q!63H@:6YL:6YE.R!&3TY4+49!34E,63H@=&EM97,@
M;F5W(')O;6%N.R!&3TY4+5-)6D4Z(#$P<'0[(%1%6%0M04Q)1TXZ(')I9VAT
M)R!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Y)3XT,S`\+W1D/B`\=&0@<W1Y
M;&4],T0G5$585"U!3$E'3CH@;&5F="<@=F%L:6=N/3-$8F]T=&]M('=I9'1H
M/3-$,24@;F]W<F%P/3-$;F]W<F%P/CQF;VYT('-T>6QE/3-$)T9/3E0M4TE:
M13H@,3!P=#L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1$E34$Q!
M63H@:6YL:6YE)SX@)FYB<W`[/"]F;VYT/B`\+W1D/B`\=&0@=F%L:6=N/3-$
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M)FYB<W`[/"]F;VYT/B`\+W1D/B`\=&0@<W1Y;&4],T0G1$E34$Q!63H@:6YL
M:6YE.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!&3TY4+5-)6D4Z
M(#$P<'0[(%1%6%0M04Q)1TXZ(')I9VAT)R!V86QI9VX],T1B;W1T;VT@=VED
M=&@],T0Y)3XR.#`\+W1D/B`\=&0@<W1Y;&4],T0G5$585"U!3$E'3CH@;&5F
M="<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@;F]W<F%P/3-$;F]W<F%P
M/CQF;VYT('-T>6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ
M('1I;65S(&YE=R!R;VUA;CL@1$E34$Q!63H@:6YL:6YE)SX@)FYB<W`[/"]F
M;VYT/B`\+W1D/B`\+W1R/B`\='(@8F=C;VQO<CTS1"-C8V5E9F8^(#QT9"!V
M86QI9VX],T1B;W1T;VT@=VED=&@],T0W-B4@86QI9VX],T1L969T/B`\9&EV
M('-T>6QE/3-$)T1)4U!,05DZ(&)L;V-K.R!&3TY4+49!34E,63H@=&EM97,@
M;F5W(')O;6%N.R!&3TY4+5-)6D4Z(#$P<'0[($U!4D=)3BU,1494.B`P<'0[
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M)FYB<W`[/"]F;VYT/B`\+W1D/B`\=&0@<W1Y;&4],T0G5$585"U!3$E'3CH@
M;&5F="<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24^/&9O;G0@<W1Y;&4]
M,T0G1D].5"U325I%.B`Q,'!T.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O
M;6%N.R!$25-03$%9.B!I;FQI;F4G/B`F;F)S<#L\+V9O;G0^(#PO=&0^(#QT
M9"!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE
M<R!N97<@<F]M86X[($9/3E0M4TE:13H@,3!P=#L@5$585"U!3$E'3CH@<FEG
M:'0G('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#DE/C$W-CPO=&0^(#QT9"!S
M='EL93TS1"=415A4+4%,24=..B!L969T)R!V86QI9VX],T1B;W1T;VT@=VED
M=&@],T0Q)2!N;W=R87`],T1N;W=R87`^/&9O;G0@<W1Y;&4],T0G1D].5"U3
M25I%.B`Q,'!T.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!$25-0
M3$%9.B!I;FQI;F4G/B`F;F)S<#L\+V9O;G0^(#PO=&0^(#QT9"!V86QI9VX]
M,T1B;W1T;VT@=VED=&@],T0Q)2!A;&EG;CTS1')I9VAT/CQF;VYT('-T>6QE
M/3-$)T9/3E0M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R
M;VUA;CL@1$E34$Q!63H@:6YL:6YE)SX@)FYB<W`[/"]F;VYT/B`\+W1D/B`\
M=&0@<W1Y;&4],T0G5$585"U!3$E'3CH@;&5F="<@=F%L:6=N/3-$8F]T=&]M
M('=I9'1H/3-$,24^/&9O;G0@<W1Y;&4],T0G1D].5"U325I%.B`Q,'!T.R!&
M3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!$25-03$%9.B!I;FQI;F4G
M/B`F;F)S<#L\+V9O;G0^(#PO=&0^(#QT9"!S='EL93TS1"=$25-03$%9.B!I
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M34%21TE.+5))1TA4.B`P<'0[('1E>'0M86QI9VXZ(&QE9G0[(%1%6%0M24Y$
M14Y4.B`P<'0G/B!,96%S96AO;&0@:6UP<F]V96UE;G1S/"]D:78^(#PO=&0^
M(#QT9"!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)2!A;&EG;CTS1')I9VAT
M/CQF;VYT('-T>6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ
M('1I;65S(&YE=R!R;VUA;CL@1$E34$Q!63H@:6YL:6YE)SX@)FYB<W`[/"]F
M;VYT/B`\+W1D/B`\=&0@<W1Y;&4],T0G5$585"U!3$E'3CH@;&5F="<@=F%L
M:6=N/3-$8F]T=&]M('=I9'1H/3-$,24^/&9O;G0@<W1Y;&4],T0G1D].5"U3
M25I%.B`Q,'!T.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!$25-0
M3$%9.B!I;FQI;F4G/B`F;F)S<#L\+V9O;G0^(#PO=&0^(#QT9"!S='EL93TS
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M5"U325I%.B`Q,'!T.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!$
M25-03$%9.B!I;FQI;F4G/B`F;F)S<#L\+V9O;G0^(#PO=&0^(#QT9"!S='EL
M93TS1"=415A4+4%,24=..B!L969T)R!V86QI9VX],T1B;W1T;VT@=VED=&@]
M,T0Q)3X\9F]N="!S='EL93TS1"=&3TY4+5-)6D4Z(#$P<'0[($9/3E0M1D%-
M24Q9.B!T:6UE<R!N97<@<F]M86X[($1)4U!,05DZ(&EN;&EN92<^("9N8G-P
M.SPO9F]N=#X@/"]T9#X@/'1D('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@
M1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T
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M/"]T9#X@/"]T<CX@/'1R(&)G8V]L;W(],T0C8V-E969F/B`\=&0@<W1Y;&4]
M,T0G4$%$1$E.1RU"3U143TTZ(#)P>"<@=F%L:6=N/3-$8F]T=&]M('=I9'1H
M/3-$-S8E(&%L:6=N/3-$;&5F=#X@/&1I=B!S='EL93TS1"=$25-03$%9.B!B
M;&]C:SL@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%
M.B`Q,'!T.R!-05)'24XM3$5&5#H@,'!T.R!-05)'24XM4DE'2%0Z(#!P=#L@
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M<W1Y;&4],T0G1D].5"U325I%.B`Q,'!T.R!&3TY4+49!34E,63H@=&EM97,@
M;F5W(')O;6%N.R!$25-03$%9.B!I;FQI;F4G/B`F;F)S<#L\+V9O;G0^(#PO
M=&0^(#QT9"!S='EL93TS1"="3U)$15(M0D]45$]-.B!B;&%C:R`R<'@@<V]L
M:60[($1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R
M;VUA;CL@1D].5"U325I%.B`Q,'!T.R!415A4+4%,24=..B!R:6=H="<@=F%L
M:6=N/3-$8F]T=&]M('=I9'1H/3-$.24^.3PO=&0^(#QT9"!S='EL93TS1"=0
M041$24Y'+4)/5%1/33H@,G!X.R!415A4+4%,24=..B!L969T)R!V86QI9VX]
M,T1B;W1T;VT@=VED=&@],T0Q)2!N;W=R87`],T1N;W=R87`^/&9O;G0@<W1Y
M;&4],T0G1D].5"U325I%.B`Q,'!T.R!&3TY4+49!34E,63H@=&EM97,@;F5W
M(')O;6%N.R!$25-03$%9.B!I;FQI;F4G/B`F;F)S<#L\+V9O;G0^(#PO=&0^
M(#QT9"!S='EL93TS1"=0041$24Y'+4)/5%1/33H@,G!X)R!V86QI9VX],T1B
M;W1T;VT@=VED=&@],T0Q)3X\9F]N="!S='EL93TS1"=&3TY4+5-)6D4Z(#$P
M<'0[($9/3E0M1D%-24Q9.B!T:6UE<R!N97<@<F]M86X[($1)4U!,05DZ(&EN
M;&EN92<^("9N8G-P.SPO9F]N=#X@/"]T9#X@/'1D('-T>6QE/3-$)T)/4D1%
M4BU"3U143TTZ(&)L86-K(#)P>"!S;VQI9#L@5$585"U!3$E'3CH@;&5F="<@
M=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24^/&9O;G0@<W1Y;&4],T0G1D].
M5"U325I%.B`Q,'!T.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!$
M25-03$%9.B!I;FQI;F4G/B`F;F)S<#L\+V9O;G0^(#PO=&0^(#QT9"!S='EL
M93TS1"="3U)$15(M0D]45$]-.B!B;&%C:R`R<'@@<V]L:60[($1)4U!,05DZ
M(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U3
M25I%.B`Q,'!T.R!415A4+4%,24=..B!R:6=H="<@=F%L:6=N/3-$8F]T=&]M
M('=I9'1H/3-$.24^,S`\+W1D/B`\=&0@<W1Y;&4],T0G4$%$1$E.1RU"3U14
M3TTZ(#)P>#L@5$585"U!3$E'3CH@;&5F="<@=F%L:6=N/3-$8F]T=&]M('=I
M9'1H/3-$,24@;F]W<F%P/3-$;F]W<F%P/CQF;VYT('-T>6QE/3-$)T9/3E0M
M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1$E3
M4$Q!63H@:6YL:6YE)SX@)FYB<W`[/"]F;VYT/B`\+W1D/B`\+W1R/B`\='(@
M8F=C;VQO<CTS1'=H:71E/B`\=&0@<W1Y;&4],T0G4$%$1$E.1RU"3U143TTZ
M(#)P>"<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$-S8E(&%L:6=N/3-$;&5F
M=#X@/&1I=B!S='EL93TS1"=$25-03$%9.B!B;&]C:SL@1D].5"U&04U)3%DZ
M('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T.R!&3TY4+5=%24=(
M5#H@8F]L9#L@34%21TE.+4Q%1E0Z(#!P=#L@34%21TE.+5))1TA4.B`P<'0[
M('1E>'0M86QI9VXZ(&QE9G0[(%1%6%0M24Y$14Y4.B`P<'0G/B`F;F)S<#M4
M;W1A;"!A8V-U;75L871E9"!D97!R96-I871I;VX\+V1I=CX@/"]T9#X@/'1D
M('-T>6QE/3-$)U!!1$1)3D<M0D]45$]-.B`R<'@G('9A;&EG;CTS1&)O='1O
M;2!W:61T:#TS1#$E/CQF;VYT('-T>6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@
M1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1$E34$Q!63H@:6YL:6YE
M)SX@)FYB<W`[/"]F;VYT/B`\+W1D/B`\=&0@<W1Y;&4],T0G0D]21$52+4)/
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M=&@],T0Q)2!N;W=R87`],T1N;W=R87`^/&9O;G0@<W1Y;&4],T0G1D].5"U3
M25I%.B`Q,'!T.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!$25-0
M3$%9.B!I;FQI;F4G/B`F;F)S<#L\+V9O;G0^(#PO=&0^(#QT9"!S='EL93TS
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M=&]M('=I9'1H/3-$,24^/&9O;G0@<W1Y;&4],T0G1D].5"U325I%.B`Q,'!T
M.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!$25-03$%9.B!I;FQI
M;F4G/B`F;F)S<#L\+V9O;G0^(#PO=&0^(#QT9"!S='EL93TS1"="3U)$15(M
M0D]45$]-.B!B;&%C:R`R<'@@<V]L:60[($1)4U!,05DZ(&EN;&EN93L@1D].
M5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T.R!4
M15A4+4%,24=..B!R:6=H="<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$.24^
M,BPS-#D\+W1D/B`\=&0@<W1Y;&4],T0G4$%$1$E.1RU"3U143TTZ(#)P>#L@
M5$585"U!3$E'3CH@;&5F="<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@
M;F]W<F%P/3-$;F]W<F%P/CQF;VYT('-T>6QE/3-$)T9/3E0M4TE:13H@,3!P
M=#L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1$E34$Q!63H@:6YL
M:6YE)SX@)FYB<W`[/"]F;VYT/B`\+W1D/B`\+W1R/B`\='(@8F=C;VQO<CTS
M1"-C8V5E9F8^(#QT9"!S='EL93TS1"=0041$24Y'+4)/5%1/33H@-'!X)R!V
M86QI9VX],T1B;W1T;VT@=VED=&@],T0W-B4@86QI9VX],T1L969T/B`\9&EV
M('-T>6QE/3-$)T1)4U!,05DZ(&)L;V-K.R!&3TY4+49!34E,63H@=&EM97,@
M;F5W(')O;6%N.R!&3TY4+5-)6D4Z(#$P<'0[($9/3E0M5T5)1TA4.B!B;VQD
M.R!-05)'24XM3$5&5#H@,'!T.R!-05)'24XM4DE'2%0Z(#!P=#L@=&5X="UA
M;&EG;CH@;&5F=#L@5$585"U)3D1%3E0Z(#!P="<^(%!R;W!E<G1Y(&%N9"!E
M<75I<&UE;G0L(&YE=#PO9&EV/B`\+W1D/B`\=&0@<W1Y;&4],T0G4$%$1$E.
M1RU"3U143TTZ(#1P>"<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24^/&9O
M;G0@<W1Y;&4],T0G1D].5"U325I%.B`Q,'!T.R!&3TY4+49!34E,63H@=&EM
M97,@;F5W(')O;6%N.R!$25-03$%9.B!I;FQI;F4G/B`F;F)S<#L\+V9O;G0^
M(#PO=&0^(#QT9"!S='EL93TS1"="3U)$15(M0D]45$]-.B!B;&%C:R`T<'@@
M9&]U8FQE.R!$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE<R!N
M97<@<F]M86X[($9/3E0M4TE:13H@,3!P=#L@5$585"U!3$E'3CH@;&5F="<@
M=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24^)#PO=&0^(#QT9"!S='EL93TS
M1"="3U)$15(M0D]45$]-.B!B;&%C:R`T<'@@9&]U8FQE.R!$25-03$%9.B!I
M;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE<R!N97<@<F]M86X[($9/3E0M4TE:
M13H@,3!P=#L@5$585"U!3$E'3CH@<FEG:'0G('9A;&EG;CTS1&)O='1O;2!W
M:61T:#TS1#DE/C$P+#@R,SPO=&0^(#QT9"!S='EL93TS1"=0041$24Y'+4)/
M5%1/33H@-'!X.R!415A4+4%,24=..B!L969T)R!V86QI9VX],T1B;W1T;VT@
M=VED=&@],T0Q)2!N;W=R87`],T1N;W=R87`^/&9O;G0@<W1Y;&4],T0G1D].
M5"U325I%.B`Q,'!T.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!$
M25-03$%9.B!I;FQI;F4G/B`F;F)S<#L\+V9O;G0^(#PO=&0^(#QT9"!S='EL
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M3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T.R!415A4+4%,
M24=..B!L969T)R!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)3XD/"]T9#X@
M/'1D('-T>6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#1P>"!D;W5B;&4[
M($1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA
M;CL@1D].5"U325I%.B`Q,'!T.R!415A4+4%,24=..B!R:6=H="<@=F%L:6=N
M/3-$8F]T=&]M('=I9'1H/3-$.24^,3$L.#8V/"]T9#X@/'1D('-T>6QE/3-$
M)U!!1$1)3D<M0D]45$]-.B`T<'@[(%1%6%0M04Q)1TXZ(&QE9G0G('9A;&EG
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M<W`[/"]D:78^(#QD:78@<W1Y;&4],T0G1$E34$Q!63H@8FQO8VL[($9/3E0M
M1D%-24Q9.B!4:6UE<R!.97<@4F]M86X[($9/3E0M4TE:13H@,3!P=#L@34%2
M1TE.+4Q%1E0Z(#$X<'0[($U!4D=)3BU224=(5#H@,'!T.R!T97AT+6%L:6=N
M.B!L969T.R!415A4+4E.1$5.5#H@,'!T)SX@1&5P<F5C:6%T:6]N(&5X<&5N
M<V5S(&%M;W5N=&5D('1O("0Q+#DP,BP@)#$L,#,S(&%N9"`D-#,U(&9O<B!T
M:&4@>65A<G,@96YD960@2G5N92`S,"P@,C`Q-"P@,C`Q,R!A;F0@,C`Q,BP@
M<F5S<&5C=&EV96QY+CPO9&EV/B`\(2TM16YD1G)A9VUE;G0M+3X\+V1I=CX@
M/"]D:78^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@(#PO
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M=&UL/@T*("`\:&5A9#X-"B`@("`\345402!H='1P+65Q=6EV/3-$0V]N=&5N
M="U4>7!E(&-O;G1E;G0],T0G=&5X="]H=&UL.R!C:&%R<V5T/75T9BTX)SX\
M<V-R:7!T('1Y<&4],T1T97AT+VIA=F%S8W)I<'0@<W)C/3-$4VAO=RYJ<SXO
M*B!$;R!.;W0@4F5M;W9E(%1H:7,@0V]M;65N="`J+SPO<V-R:7!T/CPO:&5A
M9#X-"B`@/&)O9'D^#0H@("`@/'1A8FQE(&-L87-S/3-$<F5P;W)T(&ED/3-$
M240P14U%/@T*("`@("`@/'1R/@T*("`@("`@("`\=&@@8VQA<W,],T1T;"!C
M;VQS<&%N/3-$,2!R;W=S<&%N/3-$,CX\<W1R;VYG/D]42$52($%#0T]53E13
M(%!!64%"3$4\8G(^/"]S=')O;F<^/"]T:#X-"B`@("`@("`@/'1H(&-L87-S
M/3-$=&@@8V]L<W!A;CTS1#$^,3(@36]N=&AS($5N9&5D/"]T:#X-"B`@("`@
M(#PO='(^#0H@("`@("`\='(^#0H@("`@("`@(#QT:"!C;&%S<STS1'1H/DIU
M;BX@,S`L(#(P,30\8G(^/"]T:#X-"B`@("`@(#PO='(^#0H@("`@("`\='(@
M8VQA<W,],T1R93X-"B`@("`@("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$
M=&]P/CQS=')O;F<^3U1(15(@04-#3U5.5%,@4$%904),12!;06)S=')A8W1=
M/"]S=')O;F<^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P
M86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S
M/3-$<F\^#0H@("`@("`@(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O<#Y/
M5$A%4B!!0T-/54Y44R!005E!0DQ%/"]T9#X-"B`@("`@("`@/'1D(&-L87-S
M/3-$=&5X=#XG/"$M+41/0U194$4@:'1M;"!054),24,@(BTO+U<S0R\O1%1$
M(%A(5$U,(#$N,"!4<F%N<VET:6]N86PO+T5.(B`B:'1T<#HO+W=W=RYW,RYO
M<F<O5%(O>&AT;6PQ+T141"]X:'1M;#$M=')A;G-I=&EO;F%L+F1T9"(@+2T^
M/&1I=CX@/&1I=CX\(2TM4W1A<G1&<F%G;65N="TM/B`\9&EV('-T>6QE/3-$
M)T1)4U!,05DZ(&)L;V-K.R!&3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N
M.R!&3TY4+5-)6D4Z(#$P<'0[($9/3E0M5T5)1TA4.B!B;VQD.R!-05)'24XM
M3$5&5#H@,'!T.R!-05)'24XM4DE'2%0Z(#!P=#L@5$585"U!3$E'3CH@;&5F
M=#L@5$585"U)3D1%3E0Z(#!P="<^($Y/5$4@-CHM3U1(15(@04-#3U5.5%,@
M4$%904),13PO9&EV/B`\9&EV('-T>6QE/3-$)T1)4U!,05DZ(&)L;V-K.R!-
M05)'24XM3$5&5#H@,'!T.R!-05)'24XM4DE'2%0Z(#!P=#L@=&5X="UA;&EG
M;CH@:G5S=&EF>3L@5$585"U)3D1%3E0Z(#!P="<^("9N8G-P.SPO9&EV/B`\
M9&EV('-T>6QE/3-$)W1E>'0M86QI9VXZ(')I9VAT)SX@/'1A8FQE('-T>6QE
M/3-$)T9/3E0M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R
M;VUA;B<@8V5L;'-P86-I;F<],T0P(&-E;&QP861D:6YG/3-$,"!W:61T:#TS
M1#DW)3X@/'1R/B`\=&0@<W1Y;&4],T0G4$%$1$E.1RU"3U143TTZ(#)P>"<@
M=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$-S8E/CQF;VYT('-T>6QE/3-$)T9/
M3E0M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@
M1$E34$Q!63H@:6YL:6YE)SX@)FYB<W`[/"]F;VYT/B`\+W1D/B`\=&0@<W1Y
M;&4],T0G4$%$1$E.1RU"3U143TTZ(#)P>"<@=F%L:6=N/3-$8F]T=&]M('=I
M9'1H/3-$,24^/&9O;G0@<W1Y;&4],T0G1D].5"U325I%.B`Q,'!T.R!&3TY4
M+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!&3TY4+5=%24=(5#H@8F]L9#L@
M1$E34$Q!63H@:6YL:6YE)SX@)FYB<W`[/"]F;VYT/B`\+W1D/B`\=&0@<W1Y
M;&4],T0G0D]21$52+4)/5%1/33H@8FQA8VL@,G!X('-O;&ED)R!V86QI9VX]
M,T1B;W1T;VT@=VED=&@],T0R,B4@8V]L<W!A;CTS1#8^(#QD:78@<W1Y;&4]
M,T0G1$E34$Q!63H@8FQO8VL[($9/3E0M1D%-24Q9.B!T:6UE<R!N97<@<F]M
M86X[($9/3E0M4TE:13H@,3!P=#L@1D].5"U714E'2%0Z(&)O;&0[($U!4D=)
M3BU,1494.B`P<'0[($U!4D=)3BU224=(5#H@,'!T.R!T97AT+6%L:6=N.B!C
M96YT97([(%1%6%0M24Y$14Y4.B`P<'0G/B!*=6YE(#,P+#PO9&EV/B`\+W1D
M/B`\=&0@<W1Y;&4],T0G4$%$1$E.1RU"3U143TTZ(#)P>#L@5$585"U!3$E'
M3CH@;&5F="<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@;F]W<F%P/3-$
M;F]W<F%P/CQF;VYT('-T>6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@1D].5"U&
M04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U714E'2%0Z(&)O;&0[($1)
M4U!,05DZ(&EN;&EN92<^("9N8G-P.SPO9F]N=#X@/"]T9#X@/'1D('-T>6QE
M/3-$)U!!1$1)3D<M0D]45$]-.B`R<'@G('9A;&EG;CTS1&)O='1O;3X\9F]N
M="!S='EL93TS1"=&3TY4+5-)6D4Z(#$P<'0[($9/3E0M1D%-24Q9.B!T:6UE
M<R!N97<@<F]M86X[($1)4U!,05DZ(&EN;&EN92<^("9N8G-P.SPO9F]N=#X@
M/"]T9#X@/"]T<CX@/'1R/B`\=&0@<W1Y;&4],T0G4$%$1$E.1RU"3U143TTZ
M(#)P>"<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$-S8E(&%L:6=N/3-$;&5F
M=#X\9F]N="!S='EL93TS1"=&3TY4+5-)6D4Z(#$P<'0[($9/3E0M1D%-24Q9
M.B!T:6UE<R!N97<@<F]M86X[($1)4U!,05DZ(&EN;&EN92<^("9N8G-P.SPO
M9F]N=#X@/"]T9#X@/'1D('-T>6QE/3-$)U!!1$1)3D<M0D]45$]-.B`R<'@G
M('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E/CQF;VYT('-T>6QE/3-$)T9/
M3E0M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@
M1D].5"U714E'2%0Z(&)O;&0[($1)4U!,05DZ(&EN;&EN92<^("9N8G-P.SPO
M9F]N=#X@/"]T9#X@/'1D('-T>6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K
M(#)P>"!S;VQI9"<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,3`E(&-O;'-P
M86X],T0R/B`\9&EV('-T>6QE/3-$)T1)4U!,05DZ(&)L;V-K.R!&3TY4+49!
M34E,63H@=&EM97,@;F5W(')O;6%N.R!&3TY4+5-)6D4Z(#$P<'0[($9/3E0M
M5T5)1TA4.B!B;VQD.R!-05)'24XM3$5&5#H@,'!T.R!-05)'24XM4DE'2%0Z
M(#!P=#L@=&5X="UA;&EG;CH@8V5N=&5R.R!415A4+4E.1$5.5#H@,'!T)SX@
M,C`Q-#PO9&EV/B`\+W1D/B`\=&0@<W1Y;&4],T0G4$%$1$E.1RU"3U143TTZ
M(#)P>#L@5$585"U!3$E'3CH@;&5F="<@=F%L:6=N/3-$8F]T=&]M('=I9'1H
M/3-$,24@;F]W<F%P/3-$;F]W<F%P/CQF;VYT('-T>6QE/3-$)T9/3E0M4TE:
M13H@,3!P=#L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U7
M14E'2%0Z(&)O;&0[($1)4U!,05DZ(&EN;&EN92<^("9N8G-P.SPO9F]N=#X@
M/"]T9#X@/'1D('-T>6QE/3-$)U!!1$1)3D<M0D]45$]-.B`R<'@G('9A;&EG
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M/B`\9&EV('-T>6QE/3-$)T1)4U!,05DZ(&)L;V-K.R!&3TY4+49!34E,63H@
M=&EM97,@;F5W(')O;6%N.R!&3TY4+5-)6D4Z(#$P<'0[($9/3E0M5T5)1TA4
M.B!B;VQD.R!-05)'24XM3$5&5#H@,'!T.R!-05)'24XM4DE'2%0Z(#!P=#L@
M=&5X="UA;&EG;CH@8V5N=&5R.R!415A4+4E.1$5.5#H@,'!T)SX@,C`Q,SPO
M9&EV/B`\+W1D/B`\+W1R/B`\='(@8F=C;VQO<CTS1"-C8V5E9F8^(#QT9"!V
M86QI9VX],T1B;W1T;VT@=VED=&@],T0W-B4@86QI9VX],T1L969T/B`\9&EV
M('-T>6QE/3-$)T1)4U!,05DZ(&)L;V-K.R!&3TY4+49!34E,63H@=&EM97,@
M;F5W(')O;6%N.R!&3TY4+5-)6D4Z(#$P<'0[($U!4D=)3BU,1494.B`P<'0[
M($U!4D=)3BU224=(5#H@,'!T.R!T97AT+6%L:6=N.B!L969T.R!415A4+4E.
M1$5.5#H@,'!T)SX@06-C<G5E9"!P87ER;VQL/"]D:78^(#PO=&0^(#QT9"!V
M86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)2!A;&EG;CTS1')I9VAT/CQF;VYT
M('-T>6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ('1I;65S
M(&YE=R!R;VUA;CL@1$E34$Q!63H@:6YL:6YE)SX@)FYB<W`[/"]F;VYT/B`\
M+W1D/B`\=&0@<W1Y;&4],T0G1$E34$Q!63H@:6YL:6YE.R!&3TY4+49!34E,
M63H@=&EM97,@;F5W(')O;6%N.R!&3TY4+5-)6D4Z(#$P<'0[(%1%6%0M04Q)
M1TXZ(&QE9G0G('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E/B0\+W1D/B`\
M=&0@<W1Y;&4],T0G1$E34$Q!63H@:6YL:6YE.R!&3TY4+49!34E,63H@=&EM
M97,@;F5W(')O;6%N.R!&3TY4+5-)6D4Z(#$P<'0[(%1%6%0M04Q)1TXZ(')I
M9VAT)R!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Y)3XT,C0\+W1D/B`\=&0@
M<W1Y;&4],T0G5$585"U!3$E'3CH@;&5F="<@=F%L:6=N/3-$8F]T=&]M('=I
M9'1H/3-$,24@;F]W<F%P/3-$;F]W<F%P/CQF;VYT('-T>6QE/3-$)T9/3E0M
M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1$E3
M4$Q!63H@:6YL:6YE)SX@)FYB<W`[/"]F;VYT/B`\+W1D/B`\=&0@=F%L:6=N
M/3-$8F]T=&]M('=I9'1H/3-$,24@86QI9VX],T1R:6=H=#X\9F]N="!S='EL
M93TS1"=&3TY4+5-)6D4Z(#$P<'0[($9/3E0M1D%-24Q9.B!T:6UE<R!N97<@
M<F]M86X[($1)4U!,05DZ(&EN;&EN92<^("9N8G-P.SPO9F]N=#X@/"]T9#X@
M/'1D('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I
M;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T.R!415A4+4%,24=..B!L
M969T)R!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)3XD/"]T9#X@/'1D('-T
M>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE
M=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T.R!415A4+4%,24=..B!R:6=H="<@
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M34%21TE.+4Q%1E0Z(#!P=#L@34%21TE.+5))1TA4.B`P<'0[('1E>'0M86QI
M9VXZ(&QE9G0[(%1%6%0M24Y$14Y4.B`P<'0G/B!087ER;VQL(&EN<W1I='5T
M:6]N<SPO9&EV/B`\+W1D/B`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$
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M(&YE=R!R;VUA;CL@1$E34$Q!63H@:6YL:6YE)SX@)FYB<W`[/"]F;VYT/B`\
M+W1D/B`\=&0@<W1Y;&4],T0G1$E34$Q!63H@:6YL:6YE.R!&3TY4+49!34E,
M63H@=&EM97,@;F5W(')O;6%N.R!&3TY4+5-)6D4Z(#$P<'0[(%1%6%0M04Q)
M1TXZ(')I9VAT)R!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Y)3XS,#(\+W1D
M/B`\=&0@<W1Y;&4],T0G5$585"U!3$E'3CH@;&5F="<@=F%L:6=N/3-$8F]T
M=&]M('=I9'1H/3-$,24@;F]W<F%P/3-$;F]W<F%P/CQF;VYT('-T>6QE/3-$
M)T9/3E0M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA
M;CL@1$E34$Q!63H@:6YL:6YE)SX@)FYB<W`[/"]F;VYT/B`\+W1D/B`\=&0@
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M:6YL:6YE)SX@)FYB<W`[/"]F;VYT/B`\+W1D/B`\=&0@<W1Y;&4],T0G1$E3
M4$Q!63H@:6YL:6YE.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!&
M3TY4+5-)6D4Z(#$P<'0[(%1%6%0M04Q)1TXZ(')I9VAT)R!V86QI9VX],T1B
M;W1T;VT@=VED=&@],T0Y)3XS,C0\+W1D/B`\=&0@<W1Y;&4],T0G5$585"U!
M3$E'3CH@;&5F="<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@;F]W<F%P
M/3-$;F]W<F%P/CQF;VYT('-T>6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@1D].
M5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1$E34$Q!63H@:6YL:6YE)SX@
M)FYB<W`[/"]F;VYT/B`\+W1D/B`\+W1R/B`\='(@8F=C;VQO<CTS1"-C8V5E
M9F8^(#QT9"!V86QI9VX],T1B;W1T;VT@=VED=&@],T0W-B4@86QI9VX],T1L
M969T/B`\9&EV('-T>6QE/3-$)T1)4U!,05DZ(&)L;V-K.R!&3TY4+49!34E,
M63H@=&EM97,@;F5W(')O;6%N.R!&3TY4+5-)6D4Z(#$P<'0[($U!4D=)3BU,
M1494.B`P<'0[($U!4D=)3BU224=(5#H@,'!T.R!T97AT+6%L:6=N.B!L969T
M.R!415A4+4E.1$5.5#H@,'!T)SX@06-C<G5E9"!V86-A=&EO;CPO9&EV/B`\
M+W1D/B`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@86QI9VX],T1R
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M1$E34$Q!63H@:6YL:6YE)SX@)FYB<W`[/"]F;VYT/B`\+W1D/B`\=&0@<W1Y
M;&4],T0G1$E34$Q!63H@:6YL:6YE.R!&3TY4+49!34E,63H@=&EM97,@;F5W
M(')O;6%N.R!&3TY4+5-)6D4Z(#$P<'0[(%1%6%0M04Q)1TXZ(')I9VAT)R!V
M86QI9VX],T1B;W1T;VT@=VED=&@],T0Y)3XV-S,\+W1D/B`\=&0@<W1Y;&4]
M,T0G5$585"U!3$E'3CH@;&5F="<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$
M,24@;F]W<F%P/3-$;F]W<F%P/CQF;VYT('-T>6QE/3-$)T9/3E0M4TE:13H@
M,3!P=#L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1$E34$Q!63H@
M:6YL:6YE)SX@)FYB<W`[/"]F;VYT/B`\+W1D/B`\=&0@=F%L:6=N/3-$8F]T
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M<W`[/"]F;VYT/B`\+W1D/B`\=&0@<W1Y;&4],T0G1$E34$Q!63H@:6YL:6YE
M.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!&3TY4+5-)6D4Z(#$P
M<'0[(%1%6%0M04Q)1TXZ(')I9VAT)R!V86QI9VX],T1B;W1T;VT@=VED=&@]
M,T0Y)3XU,#8\+W1D/B`\=&0@<W1Y;&4],T0G5$585"U!3$E'3CH@;&5F="<@
M=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@;F]W<F%P/3-$;F]W<F%P/CQF
M;VYT('-T>6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ('1I
M;65S(&YE=R!R;VUA;CL@1$E34$Q!63H@:6YL:6YE)SX@)FYB<W`[/"]F;VYT
M/B`\+W1D/B`\+W1R/B`\='(@8F=C;VQO<CTS1'=H:71E/B`\=&0@=F%L:6=N
M/3-$8F]T=&]M('=I9'1H/3-$-S8E(&%L:6=N/3-$;&5F=#X@/&1I=B!S='EL
M93TS1"=$25-03$%9.B!B;&]C:SL@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R
M;VUA;CL@1D].5"U325I%.B`Q,'!T.R!-05)'24XM3$5&5#H@,'!T.R!-05)'
M24XM4DE'2%0Z(#!P=#L@=&5X="UA;&EG;CH@;&5F=#L@5$585"U)3D1%3E0Z
M(#!P="<^($%D=F%N8V5D('!A>6UE;G0@9G)O;2!L97-S;W(\+V1I=CX@/"]T
M9#X@/'1D('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E(&%L:6=N/3-$<FEG
M:'0^/&9O;G0@<W1Y;&4],T0G1D].5"U325I%.B`Q,'!T.R!&3TY4+49!34E,
M63H@=&EM97,@;F5W(')O;6%N.R!$25-03$%9.B!I;FQI;F4G/B`F;F)S<#L\
M+V9O;G0^(#PO=&0^(#QT9"!S='EL93TS1"=415A4+4%,24=..B!L969T)R!V
M86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)3X\9F]N="!S='EL93TS1"=&3TY4
M+5-)6D4Z(#$P<'0[($9/3E0M1D%-24Q9.B!T:6UE<R!N97<@<F]M86X[($1)
M4U!,05DZ(&EN;&EN92<^("9N8G-P.SPO9F]N=#X@/"]T9#X@/'1D('-T>6QE
M/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R
M;VUA;CL@1D].5"U325I%.B`Q,'!T.R!415A4+4%,24=..B!R:6=H="<@=F%L
M:6=N/3-$8F]T=&]M('=I9'1H/3-$.24^.#D\+W1D/B`\=&0@<W1Y;&4],T0G
M5$585"U!3$E'3CH@;&5F="<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@
M;F]W<F%P/3-$;F]W<F%P/CQF;VYT('-T>6QE/3-$)T9/3E0M4TE:13H@,3!P
M=#L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1$E34$Q!63H@:6YL
M:6YE)SX@)FYB<W`[/"]F;VYT/B`\+W1D/B`\=&0@=F%L:6=N/3-$8F]T=&]M
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M3%DZ('1I;65S(&YE=R!R;VUA;CL@1$E34$Q!63H@:6YL:6YE)SX@)FYB<W`[
M/"]F;VYT/B`\+W1D/B`\=&0@<W1Y;&4],T0G1$E34$Q!63H@:6YL:6YE.R!&
M3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!&3TY4+5-)6D4Z(#$P<'0[
M(%1%6%0M04Q)1TXZ(')I9VAT)R!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Y
M)3XX.3PO=&0^(#QT9"!S='EL93TS1"=415A4+4%,24=..B!L969T)R!V86QI
M9VX],T1B;W1T;VT@=VED=&@],T0Q)2!N;W=R87`],T1N;W=R87`^/&9O;G0@
M<W1Y;&4],T0G1D].5"U325I%.B`Q,'!T.R!&3TY4+49!34E,63H@=&EM97,@
M;F5W(')O;6%N.R!$25-03$%9.B!I;FQI;F4G/B`F;F)S<#L\+V9O;G0^(#PO
M=&0^(#PO='(^(#QT<B!B9V-O;&]R/3-$(V-C965F9CX@/'1D('9A;&EG;CTS
M1&)O='1O;2!W:61T:#TS1#<V)2!A;&EG;CTS1&QE9G0^(#QD:78@<W1Y;&4]
M,T0G1$E34$Q!63H@8FQO8VL[($9/3E0M1D%-24Q9.B!T:6UE<R!N97<@<F]M
M86X[($9/3E0M4TE:13H@,3!P=#L@34%21TE.+4Q%1E0Z(#!P=#L@34%21TE.
M+5))1TA4.B`P<'0[('1E>'0M86QI9VXZ(&QE9G0[(%1%6%0M24Y$14Y4.B`P
M<'0G/B!$97)I=F%T:79E<R!D97-I9VYA=&5D(&%S(&$@9F%I<B!V86QU92!H
M961G92!I;G-T<G5M96YT<SPO9&EV/B`\+W1D/B`\=&0@=F%L:6=N/3-$8F]T
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M<W`[/"]F;VYT/B`\+W1D/B`\=&0@<W1Y;&4],T0G1$E34$Q!63H@:6YL:6YE
M.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!&3TY4+5-)6D4Z(#$P
M<'0[(%1%6%0M04Q)1TXZ(')I9VAT)R!V86QI9VX],T1B;W1T;VT@=VED=&@]
M,T0Y)3XX.#D\+W1D/B`\=&0@<W1Y;&4],T0G5$585"U!3$E'3CH@;&5F="<@
M=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@;F]W<F%P/3-$;F]W<F%P/CQF
M;VYT('-T>6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ('1I
M;65S(&YE=R!R;VUA;CL@1$E34$Q!63H@:6YL:6YE)SX@)FYB<W`[/"]F;VYT
M/B`\+W1D/B`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@86QI9VX]
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M;CL@1$E34$Q!63H@:6YL:6YE)SX@)FYB<W`[/"]F;VYT/B`\+W1D/B`\=&0@
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M;W(],T1W:&ET93X@/'1D('-T>6QE/3-$)U!!1$1)3D<M0D]45$]-.B`R<'@G
M('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#<V)2!A;&EG;CTS1&QE9G0^(#QD
M:78@<W1Y;&4],T0G1$E34$Q!63H@8FQO8VL[($9/3E0M1D%-24Q9.B!T:6UE
M<R!N97<@<F]M86X[($9/3E0M4TE:13H@,3!P=#L@34%21TE.+4Q%1E0Z(#!P
M=#L@34%21TE.+5))1TA4.B`P<'0[('1E>'0M86QI9VXZ(&QE9G0[(%1%6%0M
M24Y$14Y4.B`P<'0G/B!/=&AE<B!P87EA8FQE<SPO9&EV/B`\+W1D/B`\=&0@
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M;&4],T0G1D].5"U325I%.B`Q,'!T.R!&3TY4+49!34E,63H@=&EM97,@;F5W
M(')O;6%N.R!$25-03$%9.B!I;FQI;F4G/B`F;F)S<#L\+V9O;G0^(#PO=&0^
M(#QT9"!S='EL93TS1"="3U)$15(M0D]45$]-.B!B;&%C:R`R<'@@<V]L:60[
M($1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA
M;CL@1D].5"U325I%.B`Q,'!T.R!415A4+4%,24=..B!R:6=H="<@=F%L:6=N
M/3-$8F]T=&]M('=I9'1H/3-$.24^,30\+W1D/B`\=&0@<W1Y;&4],T0G4$%$
M1$E.1RU"3U143TTZ(#)P>#L@5$585"U!3$E'3CH@;&5F="<@=F%L:6=N/3-$
M8F]T=&]M('=I9'1H/3-$,24@;F]W<F%P/3-$;F]W<F%P/CQF;VYT('-T>6QE
M/3-$)T9/3E0M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R
M;VUA;CL@1$E34$Q!63H@:6YL:6YE)SX@)FYB<W`[/"]F;VYT/B`\+W1D/B`\
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M<W1Y;&4],T0G1D].5"U325I%.B`Q,'!T.R!&3TY4+49!34E,63H@=&EM97,@
M;F5W(')O;6%N.R!$25-03$%9.B!I;FQI;F4G/B`F;F)S<#L\+V9O;G0^(#PO
M=&0^(#QT9"!S='EL93TS1"="3U)$15(M0D]45$]-.B!B;&%C:R`R<'@@<V]L
M:60[($1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R
M;VUA;CL@1D].5"U325I%.B`Q,'!T.R!415A4+4%,24=..B!R:6=H="<@=F%L
M:6=N/3-$8F]T=&]M('=I9'1H/3-$.24^+3PO=&0^(#QT9"!S='EL93TS1"=0
M041$24Y'+4)/5%1/33H@,G!X.R!415A4+4%,24=..B!L969T)R!V86QI9VX]
M,T1B;W1T;VT@=VED=&@],T0Q)2!N;W=R87`],T1N;W=R87`^/&9O;G0@<W1Y
M;&4],T0G1D].5"U325I%.B`Q,'!T.R!&3TY4+49!34E,63H@=&EM97,@;F5W
M(')O;6%N.R!$25-03$%9.B!I;FQI;F4G/B`F;F)S<#L\+V9O;G0^(#PO=&0^
M(#PO='(^(#QT<B!B9V-O;&]R/3-$(V-C965F9CX@/'1D('-T>6QE/3-$)U!!
M1$1)3D<M0D]45$]-.B`R<'@G('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#<V
M)2!A;&EG;CTS1&QE9G0^/&9O;G0@<W1Y;&4],T0G1D].5"U325I%.B`Q,'!T
M.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!$25-03$%9.B!I;FQI
M;F4G/B`F;F)S<#L\+V9O;G0^(#PO=&0^(#QT9"!S='EL93TS1"=0041$24Y'
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M;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E/B0\+W1D/B`\=&0@<W1Y;&4],T0G
M0D]21$52+4)/5%1/33H@8FQA8VL@,G!X('-O;&ED.R!$25-03$%9.B!I;FQI
M;F4[($9/3E0M1D%-24Q9.B!T:6UE<R!N97<@<F]M86X[($9/3E0M4TE:13H@
M,3!P=#L@5$585"U!3$E'3CH@<FEG:'0G('9A;&EG;CTS1&)O='1O;2!W:61T
M:#TS1#DE/C(L,SDQ/"]T9#X@/'1D('-T>6QE/3-$)U!!1$1)3D<M0D]45$]-
M.B`R<'@[(%1%6%0M04Q)1TXZ(&QE9G0G('9A;&EG;CTS1&)O='1O;2!W:61T
M:#TS1#$E(&YO=W)A<#TS1&YO=W)A<#X\9F]N="!S='EL93TS1"=&3TY4+5-)
M6D4Z(#$P<'0[($9/3E0M1D%-24Q9.B!T:6UE<R!N97<@<F]M86X[($1)4U!,
M05DZ(&EN;&EN92<^("9N8G-P.SPO9F]N=#X@/"]T9#X@/'1D('-T>6QE/3-$
M)U!!1$1)3D<M0D]45$]-.B`R<'@G('9A;&EG;CTS1&)O='1O;2!W:61T:#TS
M1#$E/CQF;VYT('-T>6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@1D].5"U&04U)
M3%DZ('1I;65S(&YE=R!R;VUA;CL@1$E34$Q!63H@:6YL:6YE)SX@)FYB<W`[
M/"]F;VYT/B`\+W1D/B`\=&0@<W1Y;&4],T0G0D]21$52+4)/5%1/33H@8FQA
M8VL@,G!X('-O;&ED.R!$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T
M:6UE<R!N97<@<F]M86X[($9/3E0M4TE:13H@,3!P=#L@5$585"U!3$E'3CH@
M;&5F="<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24^)#PO=&0^(#QT9"!S
M='EL93TS1"="3U)$15(M0D]45$]-.B!B;&%C:R`R<'@@<V]L:60[($1)4U!,
M05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].
M5"U325I%.B`Q,'!T.R!415A4+4%,24=..B!R:6=H="<@=F%L:6=N/3-$8F]T
M=&]M('=I9'1H/3-$.24^,2PR-S(\+W1D/B`\=&0@<W1Y;&4],T0G4$%$1$E.
M1RU"3U143TTZ(#)P>#L@5$585"U!3$E'3CH@;&5F="<@=F%L:6=N/3-$8F]T
M=&]M('=I9'1H/3-$,24@;F]W<F%P/3-$;F]W<F%P/CQF;VYT('-T>6QE/3-$
M)T9/3E0M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA
M;CL@1$E34$Q!63H@:6YL:6YE)SX@)FYB<W`[/"]F;VYT/B`\+W1D/B`\+W1R
M/B`\+W1A8FQE/B`\+V1I=CX@/"$M+45N9$9R86=M96YT+2T^/"]D:78^(#PO
M9&EV/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@("`\+W1A
M8FQE/@T*("`\+V)O9'D^#0H\+VAT;6P^#0H-"BTM+2TM+3U?3F5X=%!A<G1?
M,&-A9#4Y9F1?-S,R95\T-F4R7V$U,S1?,&,X860Q868Y,&1D#0I#;VYT96YT
M+4QO8V%T:6]N.B!F:6QE.B\O+T,Z+S!C860U.69D7S<S,F5?-#9E,E]A-3,T
M7S!C.&%D,6%F.3!D9"]7;W)K<VAE971S+U-H965T,34N:'1M;`T*0V]N=&5N
M="U4<F%N<V9E<BU%;F-O9&EN9SH@<75O=&5D+7!R:6YT86)L90T*0V]N=&5N
M="U4>7!E.B!T97AT+VAT;6P[(&-H87)S970](G5S+6%S8VEI(@T*#0H\:'1M
M;#X-"B`@/&AE860^#0H@("`@/$U%5$$@:'1T<"UE<75I=CTS1$-O;G1E;G0M
M5'EP92!C;VYT96YT/3-$)W1E>'0O:'1M;#L@8VAA<G-E=#UU=&8M."<^/'-C
M<FEP="!T>7!E/3-$=&5X="]J879A<V-R:7!T('-R8STS1%-H;W<N:G,^+RH@
M1&\@3F]T(%)E;6]V92!4:&ES($-O;6UE;G0@*B\\+W-C<FEP=#X\+VAE860^
M#0H@(#QB;V1Y/@T*("`@(#QT86)L92!C;&%S<STS1')E<&]R="!I9#TS1$E$
M,$5-13X-"B`@("`@(#QT<CX-"B`@("`@("`@/'1H(&-L87-S/3-$=&P@8V]L
M<W!A;CTS1#$@<F]W<W!A;CTS1#(^/'-T<F]N9SY#3TU-251-14Y44R!!3D0@
M0T].5$E.1T5.0TE%4SQB<CX\+W-T<F]N9SX\+W1H/@T*("`@("`@("`\=&@@
M8VQA<W,],T1T:"!C;VQS<&%N/3-$,3XQ,B!-;VYT:',@16YD960\+W1H/@T*
M("`@("`@/"]T<CX-"B`@("`@(#QT<CX-"B`@("`@("`@/'1H(&-L87-S/3-$
M=&@^2G5N+B`S,"P@,C`Q-#QB<CX\+W1H/@T*("`@("`@/"]T<CX-"B`@("`@
M(#QT<B!C;&%S<STS1')E/@T*("`@("`@("`\=&0@8VQA<W,],T1P;"!V86QI
M9VX],T1T;W`^/'-T<F]N9SY#3TU-251-14Y44R!!3D0@0T].5$E.1T5.0TE%
M4R!;06)S=')A8W1=/"]S=')O;F<^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S
M/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@
M("`@/'1R(&-L87-S/3-$<F\^#0H@("`@("`@(#QT9"!C;&%S<STS1'!L('9A
M;&EG;CTS1'1O<#Y#3TU-251-14Y44R!!3D0@0T].5$E.1T5.0TE%4SPO=&0^
M#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SPA+2U$3T-465!%(&AT;6P@
M4%5"3$E#("(M+R]7,T,O+T141"!82%1-3"`Q+C`@5')A;G-I=&EO;F%L+R]%
M3B(@(FAT='`Z+R]W=W<N=S,N;W)G+U12+WAH=&UL,2]$5$0O>&AT;6PQ+71R
M86YS:71I;VYA;"YD=&0B("TM/CQD:78^(#QD:78^/"$M+5-T87)T1G)A9VUE
M;G0M+3X@/&1I=B!S='EL93TS1"=$25-03$%9.B!B;&]C:SL@1D].5"U&04U)
M3%DZ(%1I;65S($YE=R!2;VUA;CL@1D].5"U325I%.B`Q,'!T.R!&3TY4+5=%
M24=(5#H@8F]L9#L@34%21TE.+4Q%1E0Z(#!P=#L@34%21TE.+5))1TA4.B`P
M<'0[(%1%6%0M04Q)1TXZ(&QE9G0[(%1%6%0M24Y$14Y4.B`P<'0G/B!.3U1%
M(#<Z+4-/34U)5$U%3E13($%.1"!#3TY424Y'14Y#2453/"]D:78^(#QD:78@
M<W1Y;&4],T0G1$E34$Q!63H@8FQO8VL[($U!4D=)3BU,1494.B`P<'0[($U!
M4D=)3BU224=(5#H@,'!T.R!T97AT+6%L:6=N.B!J=7-T:69Y.R!415A4+4E.
M1$5.5#H@,'!T)SX@)FYB<W`[/"]D:78^(#QD:78@<W1Y;&4],T0G=&5X="UA
M;&EG;CH@8V5N=&5R)SX@/'1A8FQE('-T>6QE/3-$)T9/3E0M4TE:13H@,3!P
M=#L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;B<@8V5L;'-P86-I;F<]
M,T0P(&-E;&QP861D:6YG/3-$,"!W:61T:#TS1#$P,"4@8F]R9&5R/3-$,#X@
M/'1R('9A;&EG;CTS1'1O<#X@/'1D('-T>6QE/3-$)U=)1%1(.B`Q.'!T)SX@
M/&1I=B!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T
M:6UE<R!N97<@<F]M86X[($9/3E0M4TE:13H@,3!P=#L@34%21TE.+4Q%1E0Z
M(#!P=#L@34%21TE.+5))1TA4.B`P<'0[(%1%6%0M24Y$14Y4.B`P<'0G/B!A
M+CPO9&EV/B`\+W1D/B`\=&0^(#QD:78@<W1Y;&4],T0G1$E34$Q!63H@:6YL
M:6YE.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!&3TY4+5-)6D4Z
M(#$P<'0[('1E>'0M86QI9VXZ(&IU<W1I9GDG/B!4:&4@9F%C:6QI=&EE<R!O
M9B!T:&4@4W5B<VED:6%R>2!A<F4@<F5N=&5D('5N9&5R(&]P97)A=&EN9R!L
M96%S92!A9W)E96UE;G1S+"!W:&EC:"!E>'!I<F4@;VX@=F%R:6]U<R!D871E
M<RP@=&AE(&QA=&5S="!O9B!W:&EC:"!I<R!I;B`R,#$W+B!);B!*86YU87)Y
M(#(P,3,@=&AE(%-U8G-I9&EA<GD@<F5C96EV960@9G)O;2!T:&4@;&5S<V]R
M(&$@;F]N+7)E9G5N9&%B;&4@<&%Y;65N="P@=VAI8V@@<&%Y;65N="!R97!R
M97-E;G1S('1H92!L97-S;W(@<&%R=&EC:7!A=&EO;B!I;B!T:&4@;&5A<V5H
M;VQD(&EM<')O=F5M96YT<RP@;V8@87!P<F]X:6UA=&5L>2`D.#$V+B!4:&4@
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M<W1Y;&4],T0G=&5X="UA;&EG;CH@:G5S=&EF>2<^)FYB<W`[/"]D:78^(#QD
M:78@<W1Y;&4],T0G=&5X="UA;&EG;CH@:G5S=&EF>2<^(#QD:78@<W1Y;&4]
M,T0G1$E34$Q!63H@8FQO8VL[($9/3E0M1D%-24Q9.B!4:6UE<R!.97<@4F]M
M86X[($9/3E0M4TE:13H@,3!P=#L@34%21TE.+4Q%1E0Z(#!P=#L@34%21TE.
M+5))1TA4.B`P<'0[(%1%6%0M04Q)1TXZ(&IU<W1I9GD[(%1%6%0M24Y$14Y4
M.B`P<'0G/B!4:&4@0V]M<&%N>2!R96-O9VYI>F5S(')E;G0@97AP96YS92P@
M;F5T(&]F(&QE<W-O<B!P87)T:6-I<&%T:6]N+"!U;F1E<B!S=6-H(&%R<F%N
M9V5M96YT<R!O;B!A('-T<F%I9VAT+6QI;F4@8F%S:7,@;W9E<B!T:&4@;&5A
M<V4@=&5R;2X\+V1I=CX@/&1I=B!S='EL93TS1"=415A4+4%,24=..B!J=7-T
M:69Y.R!-05)'24XM3$5&5#H@,'!T.R!$25-03$%9.B!B;&]C:SL@34%21TE.
M+5))1TA4.B`P<'0[(%1%6%0M24Y$14Y4.B`P<'0G/B`F;F)S<#L\+V1I=CX@
M/&1I=B!S='EL93TS1"=$25-03$%9.B!B;&]C:SL@1D].5"U&04U)3%DZ(%1I
M;65S($YE=R!2;VUA;CL@1D].5"U325I%.B`Q,'!T.R!-05)'24XM3$5&5#H@
M,'!T.R!-05)'24XM4DE'2%0Z(#!P=#L@5$585"U!3$E'3CH@:G5S=&EF>3L@
M5$585"U)3D1%3E0Z(#!P="<^($%S(&]F($IU;F4F;F)S<#LS,"P@,C`Q-"!A
M9V=R96=A=&4@;6EN:6UU;2!L96%S92!C;VUM:71M96YT<R!U;F1E<B!N;VXM
M8V%N8V5L86)L92!O<&5R871I;F<@;&5A<V4@86=R965M96YT<R!A<F4@87,@
M9F]L;&]W<SH\+V1I=CX@/"]D:78^(#PO=&0^(#PO='(^(#PO=&%B;&4^(#PO
M9&EV/B`\9&EV('-T>6QE/3-$)T1)4U!,05DZ(&)L;V-K.R!-05)'24XM3$5&
M5#H@,'!T.R!-05)'24XM4DE'2%0Z(#!P=#L@=&5X="UA;&EG;CH@:G5S=&EF
M>3L@5$585"U)3D1%3E0Z(#!P="<^("9N8G-P.SPO9&EV/B`\9&EV('-T>6QE
M/3-$)TU!4D=)3BU,1494.B`Q.'!T.R!-05)'24XM4DE'2%0Z(#!P=#L@=&5X
M="UA;&EG;CH@;&5F=#L@5$585"U!3$E'3CH@;&5F=#L@5$585"U)3D1%3E0Z
M(#!P="<^(#QT86)L92!S='EL93TS1"=&3TY4+5-)6D4Z(#$P<'0[($9/3E0M
M1D%-24Q9.B!T:6UE<R!N97<@<F]M86XG(&-E;&QS<&%C:6YG/3-$,"!C96QL
M<&%D9&EN9STS1#`@=VED=&@],T0U,"4^(#QT<B!B9V-O;&]R/3-$(V-C965F
M9CX@/'1D('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#@X)2!A;&EG;CTS1&QE
M9G0^(#QD:78@<W1Y;&4],T0G1$E34$Q!63H@8FQO8VL[($9/3E0M1D%-24Q9
M.B!T:6UE<R!N97<@<F]M86X[($9/3E0M4TE:13H@,3!P=#L@34%21TE.+4Q%
M1E0Z(#EP=#L@34%21TE.+5))1TA4.B`P<'0[('1E>'0M86QI9VXZ(&QE9G0[
M(%1%6%0M24Y$14Y4.B`M.7!T)SX@665A<B!E;F1I;F<@2G5N92`S,"P\+V1I
M=CX@/"]T9#X@/'1D('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E/CQF;VYT
M('-T>6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ('1I;65S
M(&YE=R!R;VUA;CL@1$E34$Q!63H@:6YL:6YE)SX@)FYB<W`[/"]F;VYT/B`\
M+W1D/B`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,3`E(&-O;'-P86X]
M,T0R/CQF;VYT('-T>6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@1D].5"U&04U)
M3%DZ('1I;65S(&YE=R!R;VUA;CL@1$E34$Q!63H@:6YL:6YE)SX@)FYB<W`[
M/"]F;VYT/B`\+W1D/B`\=&0@<W1Y;&4],T0G5$585"U!3$E'3CH@;&5F="<@
M=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@;F]W<F%P/3-$;F]W<F%P/CQF
M;VYT('-T>6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ('1I
M;65S(&YE=R!R;VUA;CL@1$E34$Q!63H@:6YL:6YE)SX@)FYB<W`[/"]F;VYT
M/B`\+W1D/B`\+W1R/B`\='(@8F=C;VQO<CTS1'=H:71E/B`\=&0@=F%L:6=N
M/3-$8F]T=&]M('=I9'1H/3-$.#@E(&%L:6=N/3-$;&5F=#X@/&1I=B!S='EL
M93TS1"=$25-03$%9.B!B;&]C:SL@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R
M;VUA;CL@1D].5"U325I%.B`Q,'!T.R!-05)'24XM3$5&5#H@.7!T.R!-05)'
M24XM4DE'2%0Z(#!P=#L@=&5X="UA;&EG;CH@;&5F=#L@5$585"U)3D1%3E0Z
M("TY<'0G/B`R,#$U/"]D:78^(#PO=&0^(#QT9"!V86QI9VX],T1B;W1T;VT@
M=VED=&@],T0Q)2!A;&EG;CTS1')I9VAT/CQF;VYT('-T>6QE/3-$)T9/3E0M
M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1$E3
M4$Q!63H@:6YL:6YE)SX@)FYB<W`[/"]F;VYT/B`\+W1D/B`\=&0@<W1Y;&4]
M,T0G1$E34$Q!63H@:6YL:6YE.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O
M;6%N.R!&3TY4+5-)6D4Z(#$P<'0[(%1%6%0M04Q)1TXZ(&QE9G0G('9A;&EG
M;CTS1&)O='1O;2!W:61T:#TS1#$E/B0\+W1D/B`\=&0@<W1Y;&4],T0G1$E3
M4$Q!63H@:6YL:6YE.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!&
M3TY4+5-)6D4Z(#$P<'0[(%1%6%0M04Q)1TXZ(')I9VAT)R!V86QI9VX],T1B
M;W1T;VT@=VED=&@],T0Y)3XV-C<\+W1D/B`\=&0@<W1Y;&4],T0G5$585"U!
M3$E'3CH@;&5F="<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@;F]W<F%P
M/3-$;F]W<F%P/CQF;VYT('-T>6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@1D].
M5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1$E34$Q!63H@:6YL:6YE)SX@
M)FYB<W`[/"]F;VYT/B`\+W1D/B`\+W1R/B`\='(@8F=C;VQO<CTS1"-C8V5E
M9F8^(#QT9"!V86QI9VX],T1B;W1T;VT@=VED=&@],T0X."4@86QI9VX],T1L
M969T/B`\9&EV('-T>6QE/3-$)T1)4U!,05DZ(&)L;V-K.R!&3TY4+49!34E,
M63H@=&EM97,@;F5W(')O;6%N.R!&3TY4+5-)6D4Z(#$P<'0[($U!4D=)3BU,
M1494.B`Y<'0[($U!4D=)3BU224=(5#H@,'!T.R!T97AT+6%L:6=N.B!L969T
M.R!415A4+4E.1$5.5#H@+3EP="<^(#(P,38\+V1I=CX@/"]T9#X@/'1D('9A
M;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E(&%L:6=N/3-$<FEG:'0^/&9O;G0@
M<W1Y;&4],T0G1D].5"U325I%.B`Q,'!T.R!&3TY4+49!34E,63H@=&EM97,@
M;F5W(')O;6%N.R!$25-03$%9.B!I;FQI;F4G/B`F;F)S<#L\+V9O;G0^(#PO
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M5"U325I%.B`Q,'!T.R!415A4+4%,24=..B!R:6=H="<@=F%L:6=N/3-$8F]T
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M/'1D('-T>6QE/3-$)U!!1$1)3D<M0D]45$]-.B`R<'@G('9A;&EG;CTS1&)O
M='1O;2!W:61T:#TS1#@X)2!A;&EG;CTS1&QE9G0^(#QD:78@<W1Y;&4],T0G
M1$E34$Q!63H@8FQO8VL[($9/3E0M1D%-24Q9.B!T:6UE<R!N97<@<F]M86X[
M($9/3E0M4TE:13H@,3!P=#L@34%21TE.+4Q%1E0Z(#EP=#L@34%21TE.+5))
M1TA4.B`P<'0[('1E>'0M86QI9VXZ(&QE9G0[(%1%6%0M24Y$14Y4.B`M.7!T
M)SX@,C`Q-SPO9&EV/B`\+W1D/B`\=&0@<W1Y;&4],T0G4$%$1$E.1RU"3U14
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M=&]M('=I9'1H/3-$,24^/&9O;G0@<W1Y;&4],T0G1D].5"U325I%.B`Q,'!T
M.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!$25-03$%9.B!I;FQI
M;F4G/B`F;F)S<#L\+V9O;G0^(#PO=&0^(#QT9"!S='EL93TS1"="3U)$15(M
M0D]45$]-.B!B;&%C:R`R<'@@<V]L:60[($1)4U!,05DZ(&EN;&EN93L@1D].
M5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T.R!4
M15A4+4%,24=..B!R:6=H="<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$.24^
M,S0Y/"]T9#X@/'1D('-T>6QE/3-$)U!!1$1)3D<M0D]45$]-.B`R<'@[(%1%
M6%0M04Q)1TXZ(&QE9G0G('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E(&YO
M=W)A<#TS1&YO=W)A<#X\9F]N="!S='EL93TS1"=&3TY4+5-)6D4Z(#$P<'0[
M($9/3E0M1D%-24Q9.B!T:6UE<R!N97<@<F]M86X[($1)4U!,05DZ(&EN;&EN
M92<^("9N8G-P.SPO9F]N=#X@/"]T9#X@/"]T<CX@/'1R(&)G8V]L;W(],T0C
M8V-E969F/B`\=&0@<W1Y;&4],T0G4$%$1$E.1RU"3U143TTZ(#1P>"<@=F%L
M:6=N/3-$8F]T=&]M('=I9'1H/3-$.#@E(&%L:6=N/3-$;&5F=#X@/&1I=B!S
M='EL93TS1"=$25-03$%9.B!B;&]C:SL@1D].5"U&04U)3%DZ('1I;65S(&YE
M=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T.R!-05)'24XM3$5&5#H@.7!T.R!-
M05)'24XM4DE'2%0Z(#!P=#L@=&5X="UA;&EG;CH@;&5F=#L@5$585"U)3D1%
M3E0Z("TY<'0G/B!4;W1A;#PO9&EV/B`\+W1D/B`\=&0@<W1Y;&4],T0G4$%$
M1$E.1RU"3U143TTZ(#1P>"<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@
M86QI9VX],T1R:6=H=#X\9F]N="!S='EL93TS1"=&3TY4+5-)6D4Z(#$P<'0[
M($9/3E0M1D%-24Q9.B!T:6UE<R!N97<@<F]M86X[($1)4U!,05DZ(&EN;&EN
M92<^("9N8G-P.SPO9F]N=#X@/"]T9#X@/'1D('-T>6QE/3-$)T)/4D1%4BU"
M3U143TTZ(&)L86-K(#1P>"!D;W5B;&4[($1)4U!,05DZ(&EN;&EN93L@1D].
M5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T.R!4
M15A4+4%,24=..B!L969T)R!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)3XD
M/"]T9#X@/'1D('-T>6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#1P>"!D
M;W5B;&4[($1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE
M=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T.R!415A4+4%,24=..B!R:6=H="<@
M=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$.24^,2PU,3,\+W1D/B`\=&0@<W1Y
M;&4],T0G4$%$1$E.1RU"3U143TTZ(#1P>#L@5$585"U!3$E'3CH@;&5F="<@
M=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@;F]W<F%P/3-$;F]W<F%P/CQF
M;VYT('-T>6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ('1I
M;65S(&YE=R!R;VUA;CL@1$E34$Q!63H@:6YL:6YE)SX@)FYB<W`[/"]F;VYT
M/B`\+W1D/B`\+W1R/B`\+W1A8FQE/B`\+V1I=CX@/&1I=B!S='EL93TS1"=$
M25-03$%9.B!B;&]C:SL@1D].5"U&04U)3%DZ(%1I;65S($YE=R!2;VUA;CL@
M1D].5"U325I%.B`Q,'!T.R!-05)'24XM3$5&5#H@,S9P=#L@34%21TE.+5))
M1TA4.B`P<'0[('1E>'0M86QI9VXZ(&QE9G0[(%1%6%0M24Y$14Y4.B`P<'0G
M/B`F;F)S<#L\+V1I=CX@/&1I=B!S='EL93TS1"=$25-03$%9.B!B;&]C:SL@
M1D].5"U&04U)3%DZ(%1I;65S($YE=R!2;VUA;CL@1D].5"U325I%.B`Q,'!T
M.R!-05)'24XM3$5&5#H@,3AP=#L@34%21TE.+5))1TA4.B`P<'0[('1E>'0M
M86QI9VXZ(&QE9G0[(%1%6%0M24Y$14Y4.B`P<'0G/B!,96%S92!E>'!E;G-E
M<R!A;6]U;G1E9"!T;R`D-S(P+"`D-C<X(&%N9"`D,S@R(&9O<B!T:&4@>65A
M<G,@96YD960@2G5N92`S,"P@,C`Q-"P@,C`Q,R!A;F0@,C`Q,BP@<F5S<&5C
M=&EV96QY+CPO9&EV/B`\9&EV('-T>6QE/3-$)T1)4U!,05DZ(&)L;V-K.R!-
M05)'24XM3$5&5#H@,'!T.R!-05)'24XM4DE'2%0Z(#!P=#L@=&5X="UA;&EG
M;CH@:G5S=&EF>3L@5$585"U)3D1%3E0Z(#!P="<^("9N8G-P.SPO9&EV/B`\
M9&EV('-T>6QE/3-$)T1)4U!,05DZ(&)L;V-K.R!&3TY4+49!34E,63H@5&EM
M97,@3F5W(%)O;6%N.R!&3TY4+5-)6D4Z(#$P<'0[($U!4D=)3BU,1494.B`Q
M.'!T.R!-05)'24XM4DE'2%0Z(#!P=#L@=&5X="UA;&EG;CH@:G5S=&EF>3L@
M5$585"U)3D1%3E0Z(#!P="<^(%1H92!3=6)S:61I87)Y(&AA<R!I<W-U960@
M82!B86YK(&=U87)A;G1E92!I;B!F879O<B!O9B!T:&4@;&5S<V]R<R!F;W(@
M)#,X."X\+V1I=CX@/&1I=B!S='EL93TS1"=$25-03$%9.B!B;&]C:SL@34%2
M1TE.+4Q%1E0Z(#!P=#L@34%21TE.+5))1TA4.B`P<'0[('1E>'0M86QI9VXZ
M(&IU<W1I9GD[(%1%6%0M24Y$14Y4.B`P<'0G/B`F;F)S<#L\+V1I=CX@/&1I
M=B!S='EL93TS1"=T97AT+6%L:6=N.B!C96YT97(G/B`\=&%B;&4@<W1Y;&4]
M,T0G1D].5"U325I%.B`Q,'!T.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O
M;6%N)R!C96QL<W!A8VEN9STS1#`@8V5L;'!A9&1I;F<],T0P('=I9'1H/3-$
M,3`P)2!B;W)D97(],T0P/B`\='(@=F%L:6=N/3-$=&]P/B`\=&0@<W1Y;&4]
M,T0G5TE$5$@Z(#$X<'0G/B`\9&EV('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN
M93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q
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M<F4@:6X@=F%R:6]U<R!D871E<R!D=7)I;F<@>65A<G,@,C`Q-"!T:')O=6=H
M($%P<FEL(#(P,3<N/"]D:78^(#PO=&0^(#PO='(^(#PO=&%B;&4^(#PO9&EV
M/B`\9&EV('-T>6QE/3-$)T1)4U!,05DZ(&)L;V-K.R!-05)'24XM3$5&5#H@
M,'!T.R!-05)'24XM4DE'2%0Z(#!P=#L@=&5X="UA;&EG;CH@:G5S=&EF>3L@
M5$585"U)3D1%3E0Z(#!P="<^("9N8G-P.SPO9&EV/B`\9&EV('-T>6QE/3-$
M)T1)4U!,05DZ(&)L;V-K.R!&3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N
M.R!&3TY4+5-)6D4Z(#$P<'0[($U!4D=)3BU,1494.B`Q.'!T.R!-05)'24XM
M4DE'2%0Z(#!P=#L@=&5X="UA;&EG;CH@:G5S=&EF>3L@5$585"U)3D1%3E0Z
M(#!P="<^($%S(&]F($IU;F4F;F)S<#LS,"P@,C`Q-"P@9G5T=7)E(&%G9W)E
M9V%T92!M:6YI;75M(&QE87-E(&-O;6UI=&UE;G1S('5N9&5R(&YO;BUC86YC
M96QA8FQE(&]P97)A=&EN9R!L96%S92!A9W)E96UE;G1S(&%R92!A<R!F;VQL
M;W=S.CPO9&EV/B`\9&EV('-T>6QE/3-$)T1)4U!,05DZ(&)L;V-K.R!-05)'
M24XM3$5&5#H@,'!T.R!-05)'24XM4DE'2%0Z(#!P=#L@=&5X="UA;&EG;CH@
M:G5S=&EF>3L@5$585"U)3D1%3E0Z(#!P="<^("9N8G-P.SPO9&EV/B`\9&EV
M('-T>6QE/3-$)TU!4D=)3BU,1494.B`Q.'!T.R!T97AT+6%L:6=N.B!L969T
M)SX@/'1A8FQE('-T>6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@1D].5"U&04U)
M3%DZ('1I;65S(&YE=R!R;VUA;B<@8V5L;'-P86-I;F<],T0P(&-E;&QP861D
M:6YG/3-$,"!W:61T:#TS1#4P)3X@/'1R(&)G8V]L;W(],T0C8V-E969F/B`\
M=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$.#@E(&%L:6=N/3-$;&5F=#X@
M/&1I=B!S='EL93TS1"=$25-03$%9.B!B;&]C:SL@1D].5"U&04U)3%DZ('1I
M;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T.R!-05)'24XM3$5&5#H@
M,'!T.R!-05)'24XM4DE'2%0Z(#!P=#L@=&5X="UA;&EG;CH@;&5F=#L@5$58
M5"U)3D1%3E0Z(#!P="<^(%EE87(@96YD:6YG($IU;F4@,S`L/"]D:78^(#PO
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M1TA4.B`P<'0[('1E>'0M86QI9VXZ(&QE9G0[(%1%6%0M24Y$14Y4.B`P<'0G
M/B`R,#$U/"]D:78^(#PO=&0^(#QT9"!V86QI9VX],T1B;W1T;VT@=VED=&@]
M,T0Q)2!A;&EG;CTS1')I9VAT/CQF;VYT('-T>6QE/3-$)T9/3E0M4TE:13H@
M,3!P=#L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1$E34$Q!63H@
M:6YL:6YE)SX@)FYB<W`[/"]F;VYT/B`\+W1D/B`\=&0@<W1Y;&4],T0G1$E3
M4$Q!63H@:6YL:6YE.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!&
M3TY4+5-)6D4Z(#$P<'0[(%1%6%0M04Q)1TXZ(&QE9G0G('9A;&EG;CTS1&)O
M='1O;2!W:61T:#TS1#$E/B0\+W1D/B`\=&0@<W1Y;&4],T0G1$E34$Q!63H@
M:6YL:6YE.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!&3TY4+5-)
M6D4Z(#$P<'0[(%1%6%0M04Q)1TXZ(')I9VAT)R!V86QI9VX],T1B;W1T;VT@
M=VED=&@],T0Y)3XQ-#`\+W1D/B`\=&0@<W1Y;&4],T0G5$585"U!3$E'3CH@
M;&5F="<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@;F]W<F%P/3-$;F]W
M<F%P/CQF;VYT('-T>6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@1D].5"U&04U)
M3%DZ('1I;65S(&YE=R!R;VUA;CL@1$E34$Q!63H@:6YL:6YE)SX@)FYB<W`[
M/"]F;VYT/B`\+W1D/B`\+W1R/B`\='(@8F=C;VQO<CTS1"-C8V5E9F8^(#QT
M9"!V86QI9VX],T1B;W1T;VT@=VED=&@],T0X."4@86QI9VX],T1L969T/B`\
M9&EV('-T>6QE/3-$)T1)4U!,05DZ(&)L;V-K.R!&3TY4+49!34E,63H@=&EM
M97,@;F5W(')O;6%N.R!&3TY4+5-)6D4Z(#$P<'0[($U!4D=)3BU,1494.B`P
M<'0[($U!4D=)3BU224=(5#H@,'!T.R!T97AT+6%L:6=N.B!L969T.R!415A4
M+4E.1$5.5#H@,'!T)SX@,C`Q-CPO9&EV/B`\+W1D/B`\=&0@=F%L:6=N/3-$
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M)FYB<W`[/"]F;VYT/B`\+W1D/B`\=&0@<W1Y;&4],T0G1$E34$Q!63H@:6YL
M:6YE.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!&3TY4+5-)6D4Z
M(#$P<'0[(%1%6%0M04Q)1TXZ(')I9VAT)R!V86QI9VX],T1B;W1T;VT@=VED
M=&@],T0Y)3XX-3PO=&0^(#QT9"!S='EL93TS1"=415A4+4%,24=..B!L969T
M)R!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)2!N;W=R87`],T1N;W=R87`^
M/&9O;G0@<W1Y;&4],T0G1D].5"U325I%.B`Q,'!T.R!&3TY4+49!34E,63H@
M=&EM97,@;F5W(')O;6%N.R!$25-03$%9.B!I;FQI;F4G/B`F;F)S<#L\+V9O
M;G0^(#PO=&0^(#PO='(^(#QT<B!B9V-O;&]R/3-$=VAI=&4^(#QT9"!S='EL
M93TS1"=0041$24Y'+4)/5%1/33H@,G!X)R!V86QI9VX],T1B;W1T;VT@=VED
M=&@],T0X."4@86QI9VX],T1L969T/B`\9&EV('-T>6QE/3-$)T1)4U!,05DZ
M(&)L;V-K.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!&3TY4+5-)
M6D4Z(#$P<'0[($U!4D=)3BU,1494.B`P<'0[($U!4D=)3BU224=(5#H@,'!T
M.R!T97AT+6%L:6=N.B!L969T.R!415A4+4E.1$5.5#H@,'!T)SX@,C`Q-SPO
M9&EV/B`\+W1D/B`\=&0@<W1Y;&4],T0G4$%$1$E.1RU"3U143TTZ(#)P>"<@
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M/3-$,24^/&9O;G0@<W1Y;&4],T0G1D].5"U325I%.B`Q,'!T.R!&3TY4+49!
M34E,63H@=&EM97,@;F5W(')O;6%N.R!$25-03$%9.B!I;FQI;F4G/B`F;F)S
M<#L\+V9O;G0^(#PO=&0^(#QT9"!S='EL93TS1"="3U)$15(M0D]45$]-.B!B
M;&%C:R`R<'@@<V]L:60[($1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ
M('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T.R!415A4+4%,24=.
M.B!R:6=H="<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$.24^,C8\+W1D/B`\
M=&0@<W1Y;&4],T0G4$%$1$E.1RU"3U143TTZ(#)P>#L@5$585"U!3$E'3CH@
M;&5F="<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@;F]W<F%P/3-$;F]W
M<F%P/CQF;VYT('-T>6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@1D].5"U&04U)
M3%DZ('1I;65S(&YE=R!R;VUA;CL@1$E34$Q!63H@:6YL:6YE)SX@)FYB<W`[
M/"]F;VYT/B`\+W1D/B`\+W1R/B`\='(@8F=C;VQO<CTS1"-C8V5E9F8^(#QT
M9"!S='EL93TS1"=0041$24Y'+4)/5%1/33H@,G!X)R!V86QI9VX],T1B;W1T
M;VT@=VED=&@],T0X."4@86QI9VX],T1L969T/B`\9&EV('-T>6QE/3-$)T1)
M4U!,05DZ(&)L;V-K.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!&
M3TY4+5-)6D4Z(#$P<'0[($U!4D=)3BU,1494.B`P<'0[($U!4D=)3BU224=(
M5#H@,'!T.R!T97AT+6%L:6=N.B!L969T.R!415A4+4E.1$5.5#H@,'!T)SX@
M5&]T86P\+V1I=CX@/"]T9#X@/'1D('-T>6QE/3-$)U!!1$1)3D<M0D]45$]-
M.B`R<'@G('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E(&%L:6=N/3-$<FEG
M:'0^/&9O;G0@<W1Y;&4],T0G1D].5"U325I%.B`Q,'!T.R!&3TY4+49!34E,
M63H@=&EM97,@;F5W(')O;6%N.R!$25-03$%9.B!I;FQI;F4G/B`F;F)S<#L\
M+V9O;G0^(#PO=&0^(#QT9"!S='EL93TS1"="3U)$15(M0D]45$]-.B!B;&%C
M:R`R<'@@<V]L:60[($1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I
M;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T.R!415A4+4%,24=..B!L
M969T)R!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)3XD/"]T9#X@/'1D('-T
M>6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#)P>"!S;VQI9#L@1$E34$Q!
M63H@:6YL:6YE.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!&3TY4
M+5-)6D4Z(#$P<'0[(%1%6%0M04Q)1TXZ(')I9VAT)R!V86QI9VX],T1B;W1T
M;VT@=VED=&@],T0Y)3XR-3$\+W1D/B`\=&0@<W1Y;&4],T0G4$%$1$E.1RU"
M3U143TTZ(#)P>#L@5$585"U!3$E'3CH@;&5F="<@=F%L:6=N/3-$8F]T=&]M
M('=I9'1H/3-$,24@;F]W<F%P/3-$;F]W<F%P/CQF;VYT('-T>6QE/3-$)T9/
M3E0M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@
M1$E34$Q!63H@:6YL:6YE)SX@)FYB<W`[/"]F;VYT/B`\+W1D/B`\+W1R/B`\
M+W1A8FQE/B`\+V1I=CX@/&1I=B!S='EL93TS1"=$25-03$%9.B!B;&]C:SL@
M5$585"U)3D1%3E0Z(#!P="<^)FYB<W`[/"]D:78^(#QD:78@<W1Y;&4],T0G
M1$E34$Q!63H@8FQO8VL[($9/3E0M1D%-24Q9.B!4:6UE<R!.97<@4F]M86X[
M($9/3E0M4TE:13H@,3!P=#L@34%21TE.+4Q%1E0Z(#$X<'0[($U!4D=)3BU2
M24=(5#H@,'!T.R!T97AT+6%L:6=N.B!L969T.R!415A4+4E.1$5.5#H@,'!T
M)SX@3&5A<V4@97AP96YS97,@86UO=6YT960@=&\@)#(T-"P@)#(Q-2!A;F0@
M)#$W-B!F;W(@=&AE('EE87)S(&5N9&5D($IU;F4@,S`L(#(P,30L(#(P,3,@
M86YD(#(P,3(L(')E<W!E8W1I=F5L>2X\+V1I=CX@/&1I=B!S='EL93TS1"=$
M25-03$%9.B!B;&]C:SL@34%21TE.+4Q%1E0Z(#!P=#L@34%21TE.+5))1TA4
M.B`P<'0[('1E>'0M86QI9VXZ(&IU<W1I9GD[(%1%6%0M24Y$14Y4.B`P<'0G
M/B`F;F)S<#L\+V1I=CX@/&1I=B!S='EL93TS1"=T97AT+6%L:6=N.B!C96YT
M97(G/B`\=&%B;&4@<W1Y;&4],T0G1D].5"U325I%.B`Q,'!T.R!&3TY4+49!
M34E,63H@=&EM97,@;F5W(')O;6%N)R!C96QL<W!A8VEN9STS1#`@8V5L;'!A
M9&1I;F<],T0P('=I9'1H/3-$,3`P)2!B;W)D97(],T0P/B`\='(@=F%L:6=N
M/3-$=&]P/B`\=&0@<W1Y;&4],T0G5TE$5$@Z(#$X<'0G/B`\9&EV('-T>6QE
M/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R
M;VUA;CL@1D].5"U325I%.B`Q,'!T.R!-05)'24XM3$5&5#H@,'!T.R!-05)'
M24XM4DE'2%0Z(#!P=#L@5$585"U)3D1%3E0Z(#!P="<^(&,N/"]D:78^(#PO
M=&0^(#QT9#X@/&1I=B!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M
M1D%-24Q9.B!T:6UE<R!N97<@<F]M86X[($9/3E0M4TE:13H@,3!P=#L@=&5X
M="UA;&EG;CH@:G5S=&EF>2<^($%N(&%M;W5N="!O9B`D-"PX,#4@;V8@8V%S
M:"!A;F0@9&5P;W-I=',@=V%S('!L961G960@8GD@=&AE(%-U8G-I9&EA<GD@
M=&\@<V5C=7)E('1H92!H961G:6YG('1R86YS86-T:6]N<RP@8W)E9&ET(&QI
M;F4@86YD($)A;FL@9W5A<F%N=&5E<RX\+V1I=CX@/"]T9#X@/"]T<CX@/"]T
M86)L93X@/"]D:78^(#QD:78@<W1Y;&4],T0G1$E34$Q!63H@8FQO8VL[($U!
M4D=)3BU,1494.B`P<'0[($U!4D=)3BU224=(5#H@,'!T.R!T97AT+6%L:6=N
M.B!J=7-T:69Y.R!415A4+4E.1$5.5#H@,'!T)SX@)FYB<W`[/"]D:78^(#QD
M:78@<W1Y;&4],T0G=&5X="UA;&EG;CH@8V5N=&5R)SX@/'1A8FQE('-T>6QE
M/3-$)T9/3E0M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R
M;VUA;B<@8V5L;'-P86-I;F<],T0P(&-E;&QP861D:6YG/3-$,"!W:61T:#TS
M1#$P,"4@8F]R9&5R/3-$,#X@/'1R('9A;&EG;CTS1'1O<#X@/'1D('-T>6QE
M/3-$)U=)1%1(.B`Q.'!T)SX@/&1I=B!S='EL93TS1"=$25-03$%9.B!I;FQI
M;F4[($9/3E0M1D%-24Q9.B!T:6UE<R!N97<@<F]M86X[($9/3E0M4TE:13H@
M,3!P=#L@34%21TE.+4Q%1E0Z(#!P=#L@34%21TE.+5))1TA4.B`P<'0[(%1%
M6%0M24Y$14Y4.B`P<'0G/B!D+CPO9&EV/B`\+W1D/B`\=&0^(#QD:78@<W1Y
M;&4],T0G1$E34$Q!63H@:6YL:6YE.R!&3TY4+49!34E,63H@=&EM97,@;F5W
M(')O;6%N.R!&3TY4+5-)6D4Z(#$P<'0[('1E>'0M86QI9VXZ(&IU<W1I9GDG
M/B!5;F1E<B!T:&4@3&%W(&9O<B!T:&4@16YC;W5R86=E;65N="!O9B!);F1U
M<W1R:6%L(%)E<V5A<F-H(&%N9"!$979E;&]P;65N="P@,3DX-"P@*'1H92`B
M4F5S96%R8V@@3&%W(BDL(')E<V5A<F-H(&%N9"!D979E;&]P;65N="!P<F]G
M<F%M<R!T:&%T(&UE970@<W!E8VEF:65D(&-R:71E<FEA(&%N9"!A<F4@87!P
M<F]V960@8GD@82!G;W9E<FYM96YT86P@8V]M;6ET=&5E(&]F('1H92!/0U,@
M87)E(&5L:6=I8FQE(&9O<B!G<F%N=',@;V8@=7`@=&\@-3`E(&]F('1H92!P
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M9B`S)2!T;R`T)2!O;B!S86QE<R!O9B!P<F]D=6-T<R!A;F0@<V5R=FEC97,@
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M('-U8FIE8W0@=&\@:6YT97)E<W0@870@82!R871E(&5Q=6%L('1O('1H92`Q
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M(#PO9&EV/B`\9&EV('-T>6QE/3-$)T1)4U!,05DZ(&)L;V-K.R!-05)'24XM
M3$5&5#H@,'!T.R!-05)'24XM4DE'2%0Z(#!P=#L@=&5X="UA;&EG;CH@:G5S
M=&EF>3L@5$585"U)3D1%3E0Z(#!P="<^("9N8G-P.SPO9&EV/B`\9&EV('-T
M>6QE/3-$)T1)4U!,05DZ(&)L;V-K.R!&3TY4+49!34E,63H@5&EM97,@3F5W
M(%)O;6%N.R!&3TY4+5-)6D4Z(#$P<'0[($U!4D=)3BU,1494.B`Q.'!T.R!-
M05)'24XM4DE'2%0Z(#!P=#L@=&5X="UA;&EG;CH@:G5S=&EF>3L@5$585"U)
M3D1%3E0Z(#!P="<^(%1H<F]U9V@@2G5N92`S,"P@,C`Q-"P@=&]T86P@9W)A
M;G1S(&]B=&%I;F5D(&%G9W)E9V%T960@=&\@87!P<F]X:6UA=&5L>2`D,30L
M,3(U+B!4:')O=6=H($IU;F4@,S`L(#(P,30L('1O=&%L(')O>6%L=&EE<R!P
M86ED(&%N9"!A8V-R=65D(&%M;W5N=&5D('1O("0U,RX@07,@;V8@2G5N92`S
M,"P@,C`Q-"P@=&AE($-O;7!A;GDF(S,Y.W,@8V]N=&EN9V5N="!L:6%B:6QI
M='D@:6X@<F5S<&5C="!T;R!R;WEA;'1I97,@=&\@=&AE($]#4R!A;6]U;G1E
M9"`D,30L,#<R+"!N;W0@:6YC;'5D92!,24)/4B!I;G1E<F5S="!A<R!D97-C
M<FEB960@86)O=F4N/"]D:78^(#PA+2U%;F1&<F%G;65N="TM/CPO9&EV/B`\
M+V1I=CX\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO='(^#0H@("`@/"]T
M86)L93X-"B`@/"]B;V1Y/@T*/"]H=&UL/@T*#0HM+2TM+2T]7TYE>'1087)T
M7S!C860U.69D7S<S,F5?-#9E,E]A-3,T7S!C.&%D,6%F.3!D9`T*0V]N=&5N
M="U,;V-A=&EO;CH@9FEL93HO+R]#.B\P8V%D-3EF9%\W,S)E7S0V93)?834S
M-%\P8SAA9#%A9CDP9&0O5V]R:W-H965T<R]3:&5E=#$V+FAT;6P-"D-O;G1E
M;G0M5')A;G-F97(M16YC;V1I;F<Z('%U;W1E9"UP<FEN=&%B;&4-"D-O;G1E
M;G0M5'EP93H@=&5X="]H=&UL.R!C:&%R<V5T/2)U<RUA<V-I:2(-"@T*/&AT
M;6P^#0H@(#QH96%D/@T*("`@(#Q-151!(&AT='`M97%U:78],T1#;VYT96YT
M+51Y<&4@8V]N=&5N=#TS1"=T97AT+VAT;6P[(&-H87)S970]=71F+3@G/CQS
M8W)I<'0@='EP93TS1'1E>'0O:F%V87-C<FEP="!S<F,],T13:&]W+FIS/B\J
M($1O($YO="!296UO=F4@5&AI<R!#;VUM96YT("HO/"]S8W)I<'0^/"]H96%D
M/@T*("`\8F]D>3X-"B`@("`\=&%B;&4@8VQA<W,],T1R97!O<G0@:60],T1)
M1#!%344^#0H@("`@("`\='(^#0H@("`@("`@(#QT:"!C;&%S<STS1'1L(&-O
M;'-P86X],T0Q(')O=W-P86X],T0R/CQS=')O;F<^4U1/0TM(3TQ$15)3)R!%
M455)5%D\8G(^/"]S=')O;F<^/"]T:#X-"B`@("`@("`@/'1H(&-L87-S/3-$
M=&@@8V]L<W!A;CTS1#$^,3(@36]N=&AS($5N9&5D/"]T:#X-"B`@("`@(#PO
M='(^#0H@("`@("`\='(^#0H@("`@("`@(#QT:"!C;&%S<STS1'1H/DIU;BX@
M,S`L(#(P,30\8G(^/"]T:#X-"B`@("`@(#PO='(^#0H@("`@("`\='(@8VQA
M<W,],T1R93X-"B`@("`@("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P
M/CQS=')O;F<^4U1/0TM(3TQ$15)3)R!%455)5%D@6T%B<W1R86-T73PO<W1R
M;VYG/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO
M<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS1')O
M/@T*("`@("`@("`\=&0@8VQA<W,],T1P;"!V86QI9VX],T1T;W`^4U1/0TM(
M3TQ$15)3)R!%455)5%D\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT
M/B<\(2TM1$]#5%E012!H=&UL(%!50DQ)0R`B+2\O5S-#+R]$5$0@6$A434P@
M,2XP(%1R86YS:71I;VYA;"\O14XB(")H='1P.B\O=W=W+G<S+F]R9R]44B]X
M:'1M;#$O1%1$+WAH=&UL,2UT<F%N<VET:6]N86PN9'1D(B`M+3X\9&EV/B`\
M9&EV/CPA+2U3=&%R=$9R86=M96YT+2T^(#QD:78@<W1Y;&4],T0G1$E34$Q!
M63H@8FQO8VL[($9/3E0M1D%-24Q9.B!4:6UE<R!.97<@4F]M86X[($9/3E0M
M4TE:13H@,3!P=#L@1D].5"U714E'2%0Z(&)O;&0[($U!4D=)3BU,1494.B`P
M<'0[($U!4D=)3BU224=(5#H@,'!T.R!415A4+4%,24=..B!L969T.R!415A4
M+4E.1$5.5#H@,'!T)SX@3D]412`X.B`M(%-43T-+2$],1$524R8C,SD[($51
M54E463PO9&EV/B`\9&EV('-T>6QE/3-$)T1)4U!,05DZ(&)L;V-K.R!-05)'
M24XM3$5&5#H@,'!T.R!-05)'24XM4DE'2%0Z(#!P=#L@=&5X="UA;&EG;CH@
M:G5S=&EF>3L@5$585"U)3D1%3E0Z(#!P="<^("9N8G-P.SPO9&EV/B`\9&EV
M('-T>6QE/3-$)T1)4U!,05DZ(&)L;V-K.R!&3TY4+49!34E,63H@5&EM97,@
M3F5W(%)O;6%N.R!&3TY4+5-)6D4Z(#$P<'0[($U!4D=)3BU,1494.B`P<'0[
M($U!4D=)3BU224=(5#H@,'!T.R!T97AT+6%L:6=N.B!J=7-T:69Y.R!415A4
M+4E.1$5.5#H@,'!T)SX@5&AE($-O;7!A;GDF(S,Y.W,@875T:&]R:7IE9"!C
M;VUM;VX@<W1O8VL@8V]N<VES=',@;V8@,C`P+#`P,"PP,#`@<VAA<F5S('=I
M=&@@82!P87(@=F%L=64@;V8@)#`N,#`P,#$@<&5R('-H87)E+B9N8G-P.R9N
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M1TA4.B`P<'0[('1E>'0M86QI9VXZ(&IU<W1I9GD[(%1%6%0M24Y$14Y4.B`P
M<'0G/B`F;F)S<#L\+V1I=CX@/&1I=B!S='EL93TS1"=$25-03$%9.B!B;&]C
M:SL@1D].5"U&04U)3%DZ(%1I;65S($YE=R!2;VUA;CL@1D].5"U325I%.B`Q
M,'!T.R!-05)'24XM3$5&5#H@,'!T.R!-05)'24XM4DE'2%0Z(#!P=#L@=&5X
M="UA;&EG;CH@:G5S=&EF>3L@5$585"U)3D1%3E0Z(#!P="<^(%1H92!#;VUP
M86YY)B,S.3MS(&%U=&AO<FEZ960@<')E9F5R<F5D('-T;V-K(&-O;G-I<W1S
M(&]F(#$P+#`P,"PP,#`@<VAA<F5S(&]F('!R969E<G)E9"!S=&]C:RP@<&%R
M('9A;'5E("0P+C`P,#`Q('!E<B!S:&%R92P@=VET:"!S97)I97,L(')I9VAT
M<RP@<')E9F5R96YC97,L('!R:79I;&5G97,@86YD(')E<W1R:6-T:6]N<R!A
M<R!M87D@8F4@9&5S:6=N871E9"!F<F]M('1I;64@=&\@=&EM92!B>2!T:&4@
M0V]M<&%N>28C,SD[<R!";V%R9"!O9B!$:7)E8W1O<G,N)FYB<W`[)FYB<W`[
M3F\@<VAA<F5S(&]F('!R969E<G)E9"!S=&]C:R!H879E(&)E96X@:7-S=65D
M+CPO9&EV/B`\9&EV('-T>6QE/3-$)T1)4U!,05DZ(&)L;V-K.R!415A4+4E.
M1$5.5#H@,'!T)SXF;F)S<#L\+V1I=CX@/&1I=B!S='EL93TS1"=$25-03$%9
M.B!B;&]C:SL@5$585"U)3D1%3E0Z(#!P="<^(#QT86)L92!S='EL93TS1"=&
M3TY4+5-)6D4Z(#$P<'0[($9/3E0M1D%-24Q9.B!T:6UE<R!N97<@<F]M86XG
M(&-E;&QS<&%C:6YG/3-$,"!C96QL<&%D9&EN9STS1#`@=VED=&@],T0Q,#`E
M(&)O<F1E<CTS1#`^(#QT<B!V86QI9VX],T1T;W`^(#QT9"!S='EL93TS1"=7
M24142#H@,3AP="<^(#QD:78@<W1Y;&4],T0G1$E34$Q!63H@:6YL:6YE.R!&
M3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!&3TY4+5-)6D4Z(#$P<'0[
M($U!4D=)3BU,1494.B`P<'0[($U!4D=)3BU224=(5#H@,'!T.R!415A4+4E.
M1$5.5#H@,'!T)SX@82X\+V1I=CX@/"]T9#X@/'1D/B`\9&EV('-T>6QE/3-$
M)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA
M;CL@1D].5"U325I%.B`Q,'!T.R!T97AT+6%L:6=N.B!J=7-T:69Y)SX@1G)O
M;2!*=6QY(#(P,3$@=&AR;W5G:"!*=6YE(#(P,3(L(&$@=&]T86P@;V8@-#`V
M+#<X,R!W87)R86YT<R!W97)E(&5X97)C:7-E9"!V:6$@(F-A<VAL97-S(B!E
M>&5R8VES92P@<F5S=6QT:6YG(&EN('1H92!I<W-U86YC92!O9B`Q-C@L-#(T
M('-H87)E<R!O9B!C;VUM;VX@<W1O8VL@=&\@:6YV97-T;W)S(&]F('1H92!#
M;VUP86YY+B`F;F)S<#M);B!A9&1I=&EO;B`S-34L-#$Q('=A<G)A;G1S('=E
M<F4@97AE<F-I<V5D(&9O<B!C87-H(&%N9"!R97-U;'1E9"!I;B!T:&4@:7-S
M=6%N8V4@;V8@,S4U+#0Q,2!S:&%R97,@;V8@8V]M;6]N('-T;V-K('1O(&EN
M=F5S=&]R<R!O9B!T:&4@0V]M<&%N>2X@5&AE(&%G9W)E9V%T92!C87-H(&-O
M;G-I9&5R871I;VX@<F5C96EV960@=V%S("0U-38N/"]D:78^(#PO=&0^(#PO
M='(^(#PO=&%B;&4^(#PO9&EV/B`\9&EV('-T>6QE/3-$)T1)4U!,05DZ(&)L
M;V-K.R!415A4+4E.1$5.5#H@,'!T)SXF;F)S<#L\+V1I=CX@/&1I=B!S='EL
M93TS1"=T97AT+6%L:6=N.B!C96YT97(G/B`\=&%B;&4@<W1Y;&4],T0G1D].
M5"U325I%.B`Q,'!T.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N)R!C
M96QL<W!A8VEN9STS1#`@8V5L;'!A9&1I;F<],T0P('=I9'1H/3-$,3`P)2!B
M;W)D97(],T0P/B`\='(@=F%L:6=N/3-$=&]P/B`\=&0@<W1Y;&4],T0G5TE$
M5$@Z(#$X<'0G/B`\9&EV('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].
M5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T.R!-
M05)'24XM3$5&5#H@,'!T.R!-05)'24XM4DE'2%0Z(#!P=#L@5$585"U)3D1%
M3E0Z(#!P="<^(&(N/"]D:78^(#PO=&0^(#QT9#X@/&1I=B!S='EL93TS1"=$
M25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE<R!N97<@<F]M86X[
M($9/3E0M4TE:13H@,3!P=#L@=&5X="UA;&EG;CH@:G5S=&EF>2<^($9R;VT@
M2G5L>2`R,#$R('1H<F]U9V@@2G5N92`R,#$S+"!A('1O=&%L(&]F(#8X,BPR
M,3,@=V%R<F%N=',@=V5R92!E>&5R8VES960@=FEA(")C87-H;&5S<R(@97AE
M<F-I<V4L(')E<W5L=&EN9R!I;B!T:&4@:7-S=6%N8V4@;V8@-#(P+#$Y.2!S
M:&%R97,@;V8@8V]M;6]N('-T;V-K('1O(&EN=F5S=&]R<R!O9B!T:&4@0V]M
M<&%N>2X@)FYB<W`[26X@861D:71I;VX@,2PR,#$L,38P('=A<G)A;G1S('=E
M<F4@97AE<F-I<V5D(&9O<B!C87-H(&%N9"!R97-U;'1E9"!I;B!T:&4@:7-S
M=6%N8V4@;V8@,2PR,#$L,38P('-H87)E<R!O9B!C;VUM;VX@<W1O8VL@=&\@
M:6YV97-T;W)S(&]F('1H92!#;VUP86YY+B!4:&4@86=G<F5G871E(&-A<V@@
M8V]N<VED97)A=&EO;B!R96-E:79E9"!W87,@)#(L,#`Y+B!);B!!=6=U<W0L
M(#(P,3(L(&$@=&]T86P@;V8@,S8L,#`P('=A<G)A;G1S('=E<F4@97AE<F-I
M<V5D('9I82!A(")C87-H;&5S<R(@97AE<F-I<V4L(')E<W5L=&EN9R!I;B!T
M:&4@:7-S=6%N8V4@;V8@,C8L,CDY('-H87)E<R!O9B!C;VUM;VX@<W1O8VL@
M=&\@8V]N<W5L=&%N=',@;V8@=&AE($-O;7!A;GDN/"]D:78^(#PO=&0^(#PO
M='(^(#PO=&%B;&4^(#PO9&EV/B`\9&EV('-T>6QE/3-$)T1)4U!,05DZ(&)L
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M1%1(.B`Q.'!T)SX@/&1I=B!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/
M3E0M1D%-24Q9.B!T:6UE<R!N97<@<F]M86X[($9/3E0M4TE:13H@,3!P=#L@
M34%21TE.+4Q%1E0Z(#!P=#L@34%21TE.+5))1TA4.B`P<'0[(%1%6%0M24Y$
M14Y4.B`P<'0G/B!C+CPO9&EV/B`\+W1D/B`\=&0^(#QD:78@<W1Y;&4],T0G
M1$E34$Q!63H@:6YL:6YE.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N
M.R!&3TY4+5-)6D4Z(#$P<'0[('1E>'0M86QI9VXZ(&IU<W1I9GDG/B!&<F]M
M($IU;'D@,C`Q,R!T:')O=6=H($IU;F4@,C`Q-"P@82!T;W1A;"!O9B`R+#4Q
M-RPY,#<@=V%R<F%N=',@=V5R92!E>&5R8VES960@=FEA(")C87-H;&5S<R(@
M97AE<F-I<V4L(')E<W5L=&EN9R!I;B!T:&4@:7-S=6%N8V4@;V8@,2PT-CDL
M-3@T('-H87)E<R!O9B!C;VUM;VX@<W1O8VL@=&\@:6YV97-T;W)S(&]F('1H
M92!#;VUP86YY+B`F;F)S<#M);B!A9&1I=&EO;BP@,2PT,S(L-3@T('=A<G)A
M;G1S('=E<F4@97AE<F-I<V5D(&9O<B!C87-H(&%N9"!R97-U;'1E9"!I;B!T
M:&4@:7-S=6%N8V4@;V8@,2PT,S(L-3@T('-H87)E<R!O9B!C;VUM;VX@<W1O
M8VL@=&\@:6YV97-T;W)S(&]F('1H92!#;VUP86YY+B!4:&4@86=G<F5G871E
M(&-A<V@@8V]N<VED97)A=&EO;B!R96-E:79E9"!W87,@)#$L.38X+B!&<F]M
M($IU;'D@,C`Q,R!T:')O=6=H($IU;F4@,C`Q-"P@82!T;W1A;"!O9B`V-2PP
M,#`@=V%R<F%N=',@=V5R92!E>&5R8VES960@=FEA(&$@(F-A<VAL97-S(B!E
M>&5R8VES92P@<F5S=6QT:6YG(&EN('1H92!I<W-U86YC92!O9B`S-BPY-S`@
M<VAA<F5S(&]F(&-O;6UO;B!S=&]C:R!T;R!A(&-O;G-U;'1A;G0@;V8@=&AE
M($-O;7!A;GDN/"]D:78^(#PO=&0^(#PO='(^(#PO=&%B;&4^(#PO9&EV/B`\
M9&EV('-T>6QE/3-$)T1)4U!,05DZ(&)L;V-K.R!-05)'24XM3$5&5#H@,'!T
M.R!-05)'24XM4DE'2%0Z(#!P=#L@=&5X="UA;&EG;CH@:G5S=&EF>3L@5$58
M5"U)3D1%3E0Z(#!P="<^("9N8G-P.SPO9&EV/B`\9&EV('-T>6QE/3-$)W1E
M>'0M86QI9VXZ(&-E;G1E<B<^(#QT86)L92!S='EL93TS1"=&3TY4+5-)6D4Z
M(#$P<'0[($9/3E0M1D%-24Q9.B!T:6UE<R!N97<@<F]M86XG(&-E;&QS<&%C
M:6YG/3-$,"!C96QL<&%D9&EN9STS1#`@=VED=&@],T0Q,#`E(&)O<F1E<CTS
M1#`^(#QT<B!V86QI9VX],T1T;W`^(#QT9"!S='EL93TS1"=724142#H@,3AP
M="<^(#QD:78@<W1Y;&4],T0G1$E34$Q!63H@:6YL:6YE.R!&3TY4+49!34E,
M63H@=&EM97,@;F5W(')O;6%N.R!&3TY4+5-)6D4Z(#$P<'0[($U!4D=)3BU,
M1494.B`P<'0[($U!4D=)3BU224=(5#H@,'!T.R!415A4+4E.1$5.5#H@,'!T
M)SX@9"X\+V1I=CX@/"]T9#X@/'1D/B`\9&EV('-T>6QE/3-$)T1)4U!,05DZ
M(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U3
M25I%.B`Q,'!T.R!T97AT+6%L:6=N.B!J=7-T:69Y)SX@07,@<&%R="!O9B!T
M:&4@86=R965M96YT(&9O<B!B=6EL9&EN9R!T:&4@;F5W($-O;7!A;GDF(S,Y
M.W,@9F%C:6QI='D@=VET:"!":6]P:&%R;6%X($=R;W5P($QT9"X@*")":6]P
M:&%R;6%X(BDL('1H92!#;VUP86YY(&ES<W5E9"`Q+#4P,"PP,#`@<VAA<F5S
M(&]F(&-O;6UO;B!S=&]C:R!T;R!":6]P:&%R;6%X(&1U<FEN9R!F:7-C86P@
M>65A<B`R,#$R+CPO9&EV/B`\+W1D/B`\+W1R/B`\+W1A8FQE/B`\+V1I=CX@
M/&1I=B!S='EL93TS1"=$25-03$%9.B!B;&]C:SL@5$585"U)3D1%3E0Z(#!P
M="<^)FYB<W`[/"]D:78^(#QD:78@<W1Y;&4],T0G=&5X="UA;&EG;CH@8V5N
M=&5R)SX@/'1A8FQE('-T>6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@1D].5"U&
M04U)3%DZ('1I;65S(&YE=R!R;VUA;B<@8V5L;'-P86-I;F<],T0P(&-E;&QP
M861D:6YG/3-$,"!W:61T:#TS1#$P,"4@8F]R9&5R/3-$,#X@/'1R('9A;&EG
M;CTS1'1O<#X@/'1D('-T>6QE/3-$)U=)1%1(.B`Q.'!T)SX@/&1I=B!S='EL
M93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE<R!N97<@
M<F]M86X[($9/3E0M4TE:13H@,3!P=#L@34%21TE.+4Q%1E0Z(#!P=#L@34%2
M1TE.+5))1TA4.B`P<'0[(%1%6%0M24Y$14Y4.B`P<'0G/B!E+CPO9&EV/B`\
M+W1D/B`\=&0^(#QD:78@<W1Y;&4],T0G1$E34$Q!63H@:6YL:6YE.R!&3TY4
M+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!&3TY4+5-)6D4Z(#$P<'0[('1E
M>'0M86QI9VXZ(&IU<W1I9GDG/B!);B!$96-E;6)E<B`R,#$S+"!A<R!P87)T
M(&]F('1H92!#2$$@06=R965M96YT+"!0;'5R:7-T96T@86YD($-(02!E>&5C
M=71E9"!T:&4@;75T=6%L(&EN=F5S=&UE;G0@<'5R<W5A;G0@=&\@=VAI8V@@
M4&QU<FES=&5M(&ES<W5E9"`R+#4P,"PP,#`@<VAA<F5S(&]F(&ET<R!C;VUM
M;VX@<W1O8VL@:6X@8V]N<VED97)A=&EO;B!F;W(@,2PP,3$L-3`T('-H87)E
M<R!O9B!#2$$L('=H:6-H(')E9FQE8W1S('1O=&%L(&-O;G-I9&5R871I;VX@
M=&\@96%C:"!O9B!0;'5R:7-T96T@86YD($-(02!O9B!A<'!R;WAI;6%T96QY
M("0Q,"PT,30@*'-E92!.;W1E(#%D*2X\+V1I=CX@/"]T9#X@/"]T<CX@/"]T
M86)L93X@/"]D:78^(#QD:78@<W1Y;&4],T0G1$E34$Q!63H@8FQO8VL[(%1%
M6%0M24Y$14Y4.B`P<'0G/CQB<B`O/B`\+V1I=CX@/&1I=B!S='EL93TS1"=T
M97AT+6%L:6=N.B!C96YT97(G/B`\=&%B;&4@<W1Y;&4],T0G1D].5"U325I%
M.B`Q,'!T.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N)R!C96QL<W!A
M8VEN9STS1#`@8V5L;'!A9&1I;F<],T0P('=I9'1H/3-$,3`P)2!B;W)D97(]
M,T0P/B`\='(@=F%L:6=N/3-$=&]P/B`\=&0@<W1Y;&4],T0G5TE$5$@Z(#$X
M<'0G/B`\9&EV('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)
M3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T.R!-05)'24XM
M3$5&5#H@,'!T.R!-05)'24XM4DE'2%0Z(#!P=#L@5$585"U)3D1%3E0Z(#!P
M="<^(&8N/"]D:78^(#PO=&0^(#QT9#X@/&1I=B!S='EL93TS1"=$25-03$%9
M.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE<R!N97<@<F]M86X[($9/3E0M
M4TE:13H@,3!P=#L@=&5X="UA;&EG;CH@:G5S=&EF>2<^($]N(%-E<'1E;6)E
M<B`Q.2P@,C`Q,BP@=&AE($-O;7!A;GD@8VQO<V5D(&$@9FER;2!C;VUM:71M
M96YT('5N9&5R=W)I='1E;B!P=6)L:6,@;V9F97)I;F<@;V8@."PP,#`L,#`P
M('5N:71S+"!A="!A('!U<F-H87-E('!R:6-E(&]F("0T+C`P('!E<B!U;FET
M+"!W:71H(&5A8V@@=6YI="!C;VYS:7-T:6YG(&]F(&]N92!S:&%R92!O9B!T
M:&4@0V]M<&%N>28C,SD[<R!C;VUM;VX@<W1O8VL@86YD(&]N92!W87)R86YT
M('1O('!U<F-H87-E(#`N,S4@<VAA<F5S(&]F(&-O;6UO;B!S=&]C:RP@870@
M82!P=7)C:&%S92!P<FEC92!O9B`D-2XP,"!P97(@<VAA<F4N(%1H92!W87)R
M86YT<R!S;VQD(&EN('1H92!O9F9E<FEN9R!B96-A;64@97AE<F-I<V%B;&4@
M;VX@36%R8V@@,3DL(#(P,3,@86YD(&5X<&ER92!O;B!397!T96UB97(@,3DL
M(#(P,3<N(%1H92!#;VUP86YY(&AA<R!A;'-O(&=R86YT960@=&AE('5N9&5R
M=W)I=&5R<R!A(#,P+61A>2!O<'1I;VX@=&\@<'5R8VAA<V4@=7`@=&\@,2PR
M,#`L,#`P('-H87)E<R!O9B!C;VUM;VX@<W1O8VL@86YD+V]R('=A<G)A;G1S
M('1O('!U<F-H87-E('5P('1O(#0R,"PP,#`@<VAA<F5S(&]F(&-O;6UO;B!S
M=&]C:RX@07,@;V8@4V5P=&5M8F5R(#(T+"`R,#$R('1H92!U;F1E<G=R:71E
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M3BU,1494.B`P<'0[($U!4D=)3BU224=(5#H@,'!T.R!T97AT+6%L:6=N.B!J
M=7-T:69Y.R!415A4+4E.1$5.5#H@,'!T)SX@)FYB<W`[/"]D:78^(#QD:78@
M<W1Y;&4],T0G=&5X="UA;&EG;CH@8V5N=&5R)SX@/'1A8FQE('-T>6QE/3-$
M)T9/3E0M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA
M;B<@8V5L;'-P86-I;F<],T0P(&-E;&QP861D:6YG/3-$,"!W:61T:#TS1#$P
M,"4@8F]R9&5R/3-$,#X@/'1R('9A;&EG;CTS1'1O<#X@/'1D('-T>6QE/3-$
M)U=)1%1(.B`Q.'!T)SX@/&1I=B!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[
M($9/3E0M1D%-24Q9.B!T:6UE<R!N97<@<F]M86X[($9/3E0M4TE:13H@,3!P
M=#L@34%21TE.+4Q%1E0Z(#!P=#L@34%21TE.+5))1TA4.B`P<'0[(%1%6%0M
M24Y$14Y4.B`P<'0G/B!G+CPO9&EV/B`\+W1D/B`\=&0^(#QD:78@<W1Y;&4]
M,T0G1$E34$Q!63H@:6YL:6YE.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O
M;6%N.R!&3TY4+5-)6D4Z(#$P<'0[('1E>'0M86QI9VXZ(&IU<W1I9GDG/B!&
M;VQL;W=I;F<@82!S:&5L9B!R96=I<W1R871I;VX@;VX@1F]R;2!3+3,@9FEL
M960@86YD(&1E8VQA<F5D(&5F9F5C=&EV92!I;B!/8W1O8F5R(#(P,3$L('1H
M92!#;VUP86YY(&5N=&5R960@:6X@1&5C96UB97(@,C`Q,B!I;G1O(&%N($%T
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M-2PP,#`@=&AR;W5G:"!T:&4@=6YD97)W<FET97(@87,@82!S86QE<R!A9V5N
M="X@5&AE($-O;7!A;GD@:7,@;F]T(&]B;&EG871E9"!T;R!M86ME(&%N>2!S
M86QE<R!O9B!C;VUM;VX@<W1O8VL@=6YD97(@=&AE($%432!!9W)E96UE;G0N
M/"]D:78^(#PO=&0^(#PO='(^(#PO=&%B;&4^(#PO9&EV/B`\9&EV('-T>6QE
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M9&5D($IU;F4@,S`L(#(P,30L('1H92!#;VUP86YY(&ES<W5E9"`R+#4Y-BPP
M,S(\9F]N="!S='EL93TS1"=&3TY4+5-)6D4Z(#$P<'0[($1)4U!,05DZ(&EN
M;&EN92<^)FYB<W`[/"]F;VYT/B!S:&%R97,@;V8@8V]M;6]N('-T;V-K(&9O
M<B!A9V=R96=A=&4@8V]N<VED97)A=&EO;B!O9B!A<'!R;WAI;6%T96QY("0@
M,3`L-C0T+"!N970@;V8@:7-S=6%N8V4@8V]S=',@;V8@)#$Y-2P@=6YD97(@
M=&AE($%432!!9W)E96UE;G0N/"]D:78^(#QD:78@<W1Y;&4],T0G34%21TE.
M+4Q%1E0Z(#0S-W!T.R!$25-03$%9.B!B;&]C:SL@5$585"U)3D1%3E0Z(#!P
M="<^(#QB<B`O/B`\+V1I=CX@/&1I=B!S='EL93TS1"=$25-03$%9.B!B;&]C
M:SL@1D].5"U&04U)3%DZ(%1I;65S($YE=R!2;VUA;CL@1D].5"U325I%.B`Q
M,'!T.R!-05)'24XM3$5&5#H@,3AP=#L@34%21TE.+5))1TA4.B`P<'0[('1E
M>'0M86QI9VXZ(&IU<W1I9GD[(%1%6%0M24Y$14Y4.B`P<'0G/B!/;B!397!T
M96UB97(@,3$L(#(P,30L('1H92!#;VUP86YY(&YO=&EF:65D('1H92!U;F1E
M<G=R:71E<B!O9B!T:&4@=&5R;6EN871I;VX@;V8@=&AE($%432!!9W)E96UE
M;G0N/"]D:78^(#QD:78@<W1Y;&4],T0G34%21TE.+4Q%1E0Z(#0S-W!T.R!$
M25-03$%9.B!B;&]C:SL@5$585"U)3D1%3E0Z(#!P="<^(#QB<B`O/B`\+V1I
M=CX@/&1I=B!S='EL93TS1"=$25-03$%9.B!B;&]C:SL@1D].5"U&04U)3%DZ
M(%1I;65S($YE=R!2;VUA;CL@1D].5"U325I%.B`Q,'!T.R!&3TY4+5=%24=(
M5#H@8F]L9#L@34%21TE.+4Q%1E0Z(#$X<'0[($U!4D=)3BU224=(5#H@,'!T
M.R!T97AT+6%L:6=N.B!J=7-T:69Y.R!415A4+4E.1$5.5#H@,'!T)SX@3W!T
M:6]N<RP@=V%R<F%N=',@86YD(')E<W1R:6-T960@<W1O8VL@=6YI=',@=&\@
M96UP;&]Y965S+"!D:7)E8W1O<G,@86YD(&-O;G-U;'1A;G1S.CPO9&EV/B`\
M9&EV('-T>6QE/3-$)TU!4D=)3BU,1494.B`T,S=P=#L@1$E34$Q!63H@8FQO
M8VL[(%1%6%0M24Y$14Y4.B`P<'0G/B`\8G(@+SX@/"]D:78^(#QD:78@<W1Y
M;&4],T0G1$E34$Q!63H@8FQO8VL[($9/3E0M1D%-24Q9.B!4:6UE<R!.97<@
M4F]M86X[($9/3E0M4TE:13H@,3!P=#L@34%21TE.+4Q%1E0Z(#$X<'0[($U!
M4D=)3BU224=(5#H@,'!T.R!T97AT+6%L:6=N.B!J=7-T:69Y.R!415A4+4E.
M1$5.5#H@,'!T)SX@5&AE($-O;7!A;GD@:&%S(&%P<')O=F5D(&EN8V5N=&EV
M92!O<'1I;VX@<&QA;B!F<F]M(#(P,#4@*'1H92`B4&QA;B(I+B9N8G-P.R9N
M8G-P.U5N9&5R('1H92!0;&%N+"!O<'1I;VYS+"!R97-T<FEC=&5D('-T;V-K
M(&%N9"!R97-T<FEC=&5D('-T;V-K('5N:71S("AT:&4@(D%W87)D<R(I(&UA
M>2!B92!G<F%N=&5D('1O('1H92!#;VUP86YY)B,S.3MS(&]F9FEC97)S+"!D
M:7)E8W1O<G,L(&5M<&QO>65E<R!A;F0@8V]N<W5L=&%N=',N)FYB<W`[)FYB
M<W`[06YY($%W87)D<R!T:&%T(&%R92!C86YC96QL960@;W(@9F]R9F5I=&5D
M(&)E9F]R92!E>'!I<F%T:6]N(&)E8V]M92!A=F%I;&%B;&4@9F]R(&9U='5R
M92!G<F%N=',N/"]D:78^(#QD:78@<W1Y;&4],T0G1$E34$Q!63H@8FQO8VL[
M($U!4D=)3BU,1494.B`Q.'!T.R!-05)'24XM4DE'2%0Z(#!P=#L@=&5X="UA
M;&EG;CH@:G5S=&EF>3L@5$585"U)3D1%3E0Z(#!P="<^("9N8G-P.SPO9&EV
M/B`\9&EV('-T>6QE/3-$)T1)4U!,05DZ(&)L;V-K.R!&3TY4+49!34E,63H@
M5&EM97,@3F5W(%)O;6%N.R!&3TY4+5-)6D4Z(#$P<'0[($U!4D=)3BU,1494
M.B`Q.'!T.R!-05)'24XM4DE'2%0Z(#!P=#L@=&5X="UA;&EG;CH@:G5S=&EF
M>3L@5$585"U)3D1%3E0Z(#!P="<^($%S(&]F($IU;F4@,S`L(#(P,30L('1H
M92!N=6UB97(@;V8@<VAA<F5S(&]F(&-O;6UO;B!S=&]C:R!A=71H;W)I>F5D
M(&9O<B!I<W-U86YC92!U;F1E<B!T:&4@4&QA;B!A;6]U;G1E9"!T;R`Q,RPR
M-38L-S$S+B!!<R!O9B!*=6YE(#,P+"`R,#$T+"`Q+#(P-2PP.#`@<VAA<F5S
M(&%R92!A=F%I;&%B;&4@9F]R(&9U='5R92!G<F%N="!U;F1E<B!T:&4@4&QA
M;BX\+V1I=CX@/&1I=B!S='EL93TS1"=$25-03$%9.B!B;&]C:SL@5$585"U)
M3D1%3E0Z(#!P="<^/&)R("\^(#PO9&EV/B`\9&EV('-T>6QE/3-$)T1)4U!,
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M:SL@34%21TE.+4Q%1E0Z(#!P=#L@34%21TE.+5))1TA4.B`P<'0[('1E>'0M
M86QI9VXZ(&IU<W1I9GD[(%1%6%0M24Y$14Y4.B`P<'0G/B`F;F)S<#L\+V1I
M=CX@/&1I=B!S='EL93TS1"=$25-03$%9.B!B;&]C:SL@34%21TE.+4Q%1E0Z
M(#!P=#L@34%21TE.+5))1TA4.B`P<'0[('1E>'0M86QI9VXZ(&-E;G1E<CL@
M5$585"U!3$E'3CH@;&5F=#L@5$585"U)3D1%3E0Z(#!P="<^(#QT86)L92!S
M='EL93TS1"=&3TY4+5-)6D4Z(#$P<'0[($9/3E0M1D%-24Q9.B!T:6UE<R!N
M97<@<F]M86XG(&-E;&QS<&%C:6YG/3-$,"!C96QL<&%D9&EN9STS1#`@=VED
M=&@],T0Q,#`E(&)O<F1E<CTS1#`^(#QT<B!V86QI9VX],T1T;W`^(#QT9"!S
M='EL93TS1"=724142#H@,3AP="<@86QI9VX],T1R:6=H=#X@/&1I=B!S='EL
M93TS1"=$25-03$%9.B!B;&]C:SL@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R
M;VUA;CL@1D].5"U325I%.B`Q,'!T.R!-05)'24XM3$5&5#H@,'!T.R!-05)'
M24XM4DE'2%0Z(#!P=#L@5$585"U!3$E'3CH@;&5F=#L@5$585"U)3D1%3E0Z
M(#!P="<^(&$N/"]D:78^(#PO=&0^(#QT9"!A;&EG;CTS1&QE9G0^(#QD:78@
M<W1Y;&4],T0G1$E34$Q!63H@8FQO8VL[($9/3E0M1D%-24Q9.B!T:6UE<R!N
M97<@<F]M86X[($9/3E0M4TE:13H@,3!P=#L@34%21TE.+4Q%1E0Z(#!P=#L@
M34%21TE.+5))1TA4.B`P<'0[(%1%6%0M04Q)1TXZ(&QE9G0[(%1%6%0M24Y$
M14Y4.B`P<'0G/B!/<'1I;VYS('1O(&5M<&QO>65E<R!A;F0@9&ER96-T;W)S
M.CPO9&EV/B`\+W1D/B`\+W1R/B`\+W1A8FQE/B`\+V1I=CX@/&1I=B!S='EL
M93TS1"=$25-03$%9.B!B;&]C:SL@34%21TE.+4Q%1E0Z(#!P=#L@34%21TE.
M+5))1TA4.B`P<'0[('1E>'0M86QI9VXZ(&IU<W1I9GD[(%1%6%0M24Y$14Y4
M.B`P<'0G/B`F;F)S<#L\+V1I=CX@/&1I=B!S='EL93TS1"=$25-03$%9.B!B
M;&]C:SL@1D].5"U&04U)3%DZ(%1I;65S($YE=R!2;VUA;CL@1D].5"U325I%
M.B`Q,'!T.R!-05)'24XM3$5&5#H@,3AP=#L@34%21TE.+5))1TA4.B`P<'0[
M('1E>'0M86QI9VXZ(&IU<W1I9GD[(%1%6%0M24Y$14Y4.B`P<'0G/B!4:&4@
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M92!0;&%N<R!I<R!A<R!F;VQL;W=S.CPO9&EV/B`\9&EV('-T>6QE/3-$)T1)
M4U!,05DZ(&)L;V-K.R!-05)'24XM3$5&5#H@,'!T.R!-05)'24XM4DE'2%0Z
M(#!P=#L@=&5X="UA;&EG;CH@:G5S=&EF>3L@5$585"U)3D1%3E0Z(#!P="<^
M("9N8G-P.SPO9&EV/B`\9&EV('-T>6QE/3-$)W1E>'0M86QI9VXZ(')I9VAT
M)SX@/'1A8FQE('-T>6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@1D].5"U&04U)
M3%DZ('1I;65S(&YE=R!R;VUA;B<@8V5L;'-P86-I;F<],T0P(&-E;&QP861D
M:6YG/3-$,"!W:61T:#TS1#DW)3X@/'1R/B`\=&0@<W1Y;&4],T0G4$%$1$E.
M1RU"3U143TTZ(#)P>"<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$-3(E/CQF
M;VYT('-T>6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ('1I
M;65S(&YE=R!R;VUA;CL@1$E34$Q!63H@:6YL:6YE)SX@)FYB<W`[/"]F;VYT
M/B`\+W1D/B`\=&0@<W1Y;&4],T0G4$%$1$E.1RU"3U143TTZ(#)P>"<@=F%L
M:6=N/3-$8F]T=&]M('=I9'1H/3-$,24^/&9O;G0@<W1Y;&4],T0G1D].5"U3
M25I%.B`Q,'!T.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!&3TY4
M+5=%24=(5#H@8F]L9#L@1$E34$Q!63H@:6YL:6YE)SX@)FYB<W`[/"]F;VYT
M/B`\+W1D/B`\=&0@<W1Y;&4],T0G0D]21$52+4)/5%1/33H@8FQA8VL@,G!X
M('-O;&ED)R!V86QI9VX],T1B;W1T;VT@=VED=&@],T0T-B4@8V]L<W!A;CTS
M1#$T/B`\9&EV('-T>6QE/3-$)T1)4U!,05DZ(&)L;V-K.R!&3TY4+49!34E,
M63H@=&EM97,@;F5W(')O;6%N.R!&3TY4+5-)6D4Z(#$P<'0[($9/3E0M5T5)
M1TA4.B!B;VQD.R!-05)'24XM3$5&5#H@,'!T.R!-05)'24XM4DE'2%0Z(#!P
M=#L@=&5X="UA;&EG;CH@8V5N=&5R.R!415A4+4E.1$5.5#H@,'!T)SX@665A
M<B!E;F1E9"!*=6YE(#,P+"`R,#$T/"]D:78^(#PO=&0^(#QT9"!S='EL93TS
M1"=0041$24Y'+4)/5%1/33H@,G!X.R!415A4+4%,24=..B!L969T)R!V86QI
M9VX],T1B;W1T;VT@=VED=&@],T0Q)2!N;W=R87`],T1N;W=R87`^/&9O;G0@
M<W1Y;&4],T0G1D].5"U325I%.B`Q,'!T.R!&3TY4+49!34E,63H@=&EM97,@
M;F5W(')O;6%N.R!&3TY4+5=%24=(5#H@8F]L9#L@1$E34$Q!63H@:6YL:6YE
M)SX@)FYB<W`[/"]F;VYT/B`\+W1D/B`\+W1R/B`\='(^(#QT9"!S='EL93TS
M1"=0041$24Y'+4)/5%1/33H@,G!X)R!V86QI9VX],T1B;W1T;VT@=VED=&@]
M,T0U,B4^/&9O;G0@<W1Y;&4],T0G1D].5"U325I%.B`Q,'!T.R!&3TY4+49!
M34E,63H@=&EM97,@;F5W(')O;6%N.R!$25-03$%9.B!I;FQI;F4G/B`F;F)S
M<#L\+V9O;G0^(#PO=&0^(#QT9"!S='EL93TS1"=0041$24Y'+4)/5%1/33H@
M,G!X)R!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)3X\9F]N="!S='EL93TS
M1"=&3TY4+5-)6D4Z(#$P<'0[($9/3E0M1D%-24Q9.B!T:6UE<R!N97<@<F]M
M86X[($9/3E0M5T5)1TA4.B!B;VQD.R!$25-03$%9.B!I;FQI;F4G/B`F;F)S
M<#L\+V9O;G0^(#PO=&0^(#QT9"!S='EL93TS1"="3U)$15(M0D]45$]-.B!B
M;&%C:R`R<'@@<V]L:60G('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$P)2!C
M;VQS<&%N/3-$,CX@/&1I=B!S='EL93TS1"=$25-03$%9.B!B;&]C:SL@1D].
M5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T.R!&
M3TY4+5=%24=(5#H@8F]L9#L@34%21TE.+4Q%1E0Z(#!P=#L@34%21TE.+5))
M1TA4.B`P<'0[('1E>'0M86QI9VXZ(&-E;G1E<CL@5$585"U)3D1%3E0Z(#!P
M="<^($YU;6)E<CPO9&EV/B`\+W1D/B`\=&0@<W1Y;&4],T0G4$%$1$E.1RU"
M3U143TTZ(#)P>#L@5$585"U!3$E'3CH@;&5F="<@=F%L:6=N/3-$8F]T=&]M
M('=I9'1H/3-$,24@;F]W<F%P/3-$;F]W<F%P/CQF;VYT('-T>6QE/3-$)T9/
M3E0M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@
M1D].5"U714E'2%0Z(&)O;&0[($1)4U!,05DZ(&EN;&EN92<^("9N8G-P.SPO
M9F]N=#X@/"]T9#X@/'1D('-T>6QE/3-$)U!!1$1)3D<M0D]45$]-.B`R<'@G
M('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E/CQF;VYT('-T>6QE/3-$)T9/
M3E0M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@
M1D].5"U714E'2%0Z(&)O;&0[($1)4U!,05DZ(&EN;&EN92<^("9N8G-P.SPO
M9F]N=#X@/"]T9#X@/'1D('-T>6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K
M(#)P>"!S;VQI9"<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,3`E(&-O;'-P
M86X],T0R/B`\9&EV('-T>6QE/3-$)T1)4U!,05DZ(&)L;V-K.R!&3TY4+49!
M34E,63H@=&EM97,@;F5W(')O;6%N.R!&3TY4+5-)6D4Z(#$P<'0[($9/3E0M
M5T5)1TA4.B!B;VQD.R!-05)'24XM3$5&5#H@,'!T.R!-05)'24XM4DE'2%0Z
M(#!P=#L@=&5X="UA;&EG;CH@8V5N=&5R.R!415A4+4E.1$5.5#H@,'!T)SX@
M5V5I9VAT960@079E<F%G92!%>&5R8VES92!0<FEC93PO9&EV/B`\+W1D/B`\
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M)U!!1$1)3D<M0D]45$]-.B`R<'@G('9A;&EG;CTS1&)O='1O;2!W:61T:#TS
M1#$E/CQF;VYT('-T>6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@1D].5"U&04U)
M3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U714E'2%0Z(&)O;&0[($1)4U!,
M05DZ(&EN;&EN92<^("9N8G-P.SPO9F]N=#X@/"]T9#X@/'1D('-T>6QE/3-$
M)T)/4D1%4BU"3U143TTZ(&)L86-K(#)P>"!S;VQI9"<@=F%L:6=N/3-$8F]T
M=&]M('=I9'1H/3-$,3`E(&-O;'-P86X],T0R/B`\9&EV('-T>6QE/3-$)T1)
M4U!,05DZ(&)L;V-K.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!&
M3TY4+5-)6D4Z(#$P<'0[($9/3E0M5T5)1TA4.B!B;VQD.R!-05)'24XM3$5&
M5#H@,'!T.R!-05)'24XM4DE'2%0Z(#!P=#L@=&5X="UA;&EG;CH@8V5N=&5R
M.R!415A4+4E.1$5.5#H@,'!T)SX@5V5I9VAT960@079E<F%G92!296UA:6YI
M;F<@0V]N=')A8W1U86P@5&5R;7,@*&EN('EE87)S*3PO9&EV/B`\+W1D/B`\
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M)U!!1$1)3D<M0D]45$]-.B`R<'@G('9A;&EG;CTS1&)O='1O;2!W:61T:#TS
M1#$E/CQF;VYT('-T>6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@1D].5"U&04U)
M3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U714E'2%0Z(&)O;&0[($1)4U!,
M05DZ(&EN;&EN92<^("9N8G-P.SPO9F]N=#X@/"]T9#X@/'1D('-T>6QE/3-$
M)T)/4D1%4BU"3U143TTZ(&)L86-K(#)P>"!S;VQI9"<@=F%L:6=N/3-$8F]T
M=&]M('=I9'1H/3-$,3`E(&-O;'-P86X],T0R/B`\9&EV('-T>6QE/3-$)T1)
M4U!,05DZ(&)L;V-K.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!&
M3TY4+5-)6D4Z(#$P<'0[($9/3E0M5T5)1TA4.B!B;VQD.R!-05)'24XM3$5&
M5#H@,'!T.R!-05)'24XM4DE'2%0Z(#!P=#L@=&5X="UA;&EG;CH@8V5N=&5R
M.R!415A4+4E.1$5.5#H@,'!T)SX@06=G<F5G871E($EN=')I;G-I8R!686QU
M92!0<FEC93PO9&EV/B`\+W1D/B`\=&0@<W1Y;&4],T0G4$%$1$E.1RU"3U14
M3TTZ(#)P>#L@5$585"U!3$E'3CH@;&5F="<@=F%L:6=N/3-$8F]T=&]M('=I
M9'1H/3-$,24@;F]W<F%P/3-$;F]W<F%P/CQF;VYT('-T>6QE/3-$)T9/3E0M
M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].
M5"U714E'2%0Z(&)O;&0[($1)4U!,05DZ(&EN;&EN92<^("9N8G-P.SPO9F]N
M=#X@/"]T9#X@/"]T<CX@/'1R(&)G8V]L;W(],T0C8V-E969F/B`\=&0@<W1Y
M;&4],T0G5$585"U!3$E'3CH@;&5F=#L@34%21TE.+4Q%1E0Z(#!P=#L@34%2
M1TE.+5))1TA4.B`P<'0[(%1%6%0M24Y$14Y4.B`P<'0G('9A;&EG;CTS1&)O
M='1O;2!W:61T:#TS1#4R)3X@/&1I=B!S='EL93TS1"=$25-03$%9.B!B;&]C
M:SL@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q
M,'!T.R!-05)'24XM3$5&5#H@,'!T.R!-05)'24XM4DE'2%0Z(#!P=#L@5$58
M5"U!3$E'3CH@;&5F=#L@5$585"U)3D1%3E0Z(#!P="<^($]P=&EO;G,@;W5T
M<W1A;F1I;F<@870@8F5G:6YN:6YG(&]F('!E<FEO9#PO9&EV/B`\+W1D/B`\
M=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24^/&9O;G0@<W1Y;&4],T0G
M1D].5"U325I%.B`Q,'!T.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N
M.R!$25-03$%9.B!I;FQI;F4G/B`F;F)S<#L\+V9O;G0^(#PO=&0^(#QT9"!S
M='EL93TS1"=415A4+4%,24=..B!L969T)R!V86QI9VX],T1B;W1T;VT@=VED
M=&@],T0Q)3X\9F]N="!S='EL93TS1"=&3TY4+5-)6D4Z(#$P<'0[($9/3E0M
M1D%-24Q9.B!T:6UE<R!N97<@<F]M86X[($1)4U!,05DZ(&EN;&EN92<^("9N
M8G-P.SPO9F]N=#X@/"]T9#X@/'1D('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN
M93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q
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M('1I;65S(&YE=R!R;VUA;CL@1$E34$Q!63H@:6YL:6YE)SX@)FYB<W`[/"]F
M;VYT/B`\+W1D/B`\=&0@<W1Y;&4],T0G1$E34$Q!63H@:6YL:6YE.R!&3TY4
M+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!&3TY4+5-)6D4Z(#$P<'0[(%1%
M6%0M04Q)1TXZ(&QE9G0G('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E/B0\
M+W1D/B`\=&0@<W1Y;&4],T0G1$E34$Q!63H@:6YL:6YE.R!&3TY4+49!34E,
M63H@=&EM97,@;F5W(')O;6%N.R!&3TY4+5-)6D4Z(#$P<'0[(%1%6%0M04Q)
M1TXZ(')I9VAT)R!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Y)3XT+C`S/"]T
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M1$E34$Q!63H@:6YL:6YE)SX@)FYB<W`[/"]F;VYT/B`\+W1D/B`\=&0@=F%L
M:6=N/3-$8F]T=&]M('=I9'1H/3-$,3`E(&-O;'-P86X],T0R/CQF;VYT('-T
M>6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ('1I;65S(&YE
M=R!R;VUA;CL@1$E34$Q!63H@:6YL:6YE)SX@)FYB<W`[/"]F;VYT/B`\+W1D
M/B`\=&0@<W1Y;&4],T0G5$585"U!3$E'3CH@;&5F="<@=F%L:6=N/3-$8F]T
M=&]M('=I9'1H/3-$,24@;F]W<F%P/3-$;F]W<F%P/CQF;VYT('-T>6QE/3-$
M)T9/3E0M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA
M;CL@1$E34$Q!63H@:6YL:6YE)SX@)FYB<W`[/"]F;VYT/B`\+W1D/B`\=&0@
M=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24^/&9O;G0@<W1Y;&4],T0G1D].
M5"U325I%.B`Q,'!T.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!$
M25-03$%9.B!I;FQI;F4G/B`F;F)S<#L\+V9O;G0^(#PO=&0^(#QT9"!V86QI
M9VX],T1B;W1T;VT@=VED=&@],T0Q,"4@8V]L<W!A;CTS1#(^/&9O;G0@<W1Y
M;&4],T0G1D].5"U325I%.B`Q,'!T.R!&3TY4+49!34E,63H@=&EM97,@;F5W
M(')O;6%N.R!$25-03$%9.B!I;FQI;F4G/B`F;F)S<#L\+V9O;G0^(#PO=&0^
M(#QT9"!S='EL93TS1"=415A4+4%,24=..B!L969T)R!V86QI9VX],T1B;W1T
M;VT@=VED=&@],T0Q)2!N;W=R87`],T1N;W=R87`^/&9O;G0@<W1Y;&4],T0G
M1D].5"U325I%.B`Q,'!T.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N
M.R!$25-03$%9.B!I;FQI;F4G/B`F;F)S<#L\+V9O;G0^(#PO=&0^(#PO='(^
M(#QT<B!B9V-O;&]R/3-$=VAI=&4^(#QT9"!S='EL93TS1"=415A4+4%,24=.
M.B!L969T.R!-05)'24XM3$5&5#H@,'!T.R!-05)'24XM4DE'2%0Z(#!P=#L@
M5$585"U)3D1%3E0Z(#!P="<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$-3(E
M/B`\9&EV('-T>6QE/3-$)T1)4U!,05DZ(&)L;V-K.R!&3TY4+49!34E,63H@
M=&EM97,@;F5W(')O;6%N.R!&3TY4+5-)6D4Z(#$P<'0[($U!4D=)3BU,1494
M.B`P<'0[($U!4D=)3BU224=(5#H@,'!T.R!415A4+4%,24=..B!L969T.R!4
M15A4+4E.1$5.5#H@,'!T)SX@3W!T:6]N<R!E>&5R8VES960\+V1I=CX@/"]T
M9#X@/'1D('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E/CQF;VYT('-T>6QE
M/3-$)T9/3E0M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R
M;VUA;CL@1$E34$Q!63H@:6YL:6YE)SX@)FYB<W`[/"]F;VYT/B`\+W1D/B`\
M=&0@<W1Y;&4],T0G5$585"U!3$E'3CH@;&5F="<@=F%L:6=N/3-$8F]T=&]M
M('=I9'1H/3-$,24^/&9O;G0@<W1Y;&4],T0G1D].5"U325I%.B`Q,'!T.R!&
M3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!$25-03$%9.B!I;FQI;F4G
M/B`F;F)S<#L\+V9O;G0^(#PO=&0^(#QT9"!S='EL93TS1"=$25-03$%9.B!I
M;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE<R!N97<@<F]M86X[($9/3E0M4TE:
M13H@,3!P=#L@5$585"U!3$E'3CH@<FEG:'0G('9A;&EG;CTS1&)O='1O;2!W
M:61T:#TS1#DE/B@Q-2PP,#`\+W1D/B`\=&0@<W1Y;&4],T0G1$E34$Q!63H@
M:6YL:6YE.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!&3TY4+5-)
M6D4Z(#$P<'0[(%1%6%0M04Q)1TXZ(&QE9G0G('9A;&EG;CTS1&)O='1O;2!W
M:61T:#TS1#$E(&YO=W)A<#TS1&YO=W)A<#XI/"]T9#X@/'1D('9A;&EG;CTS
M1&)O='1O;2!W:61T:#TS1#$E/CQF;VYT('-T>6QE/3-$)T9/3E0M4TE:13H@
M,3!P=#L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1$E34$Q!63H@
M:6YL:6YE)SX@)FYB<W`[/"]F;VYT/B`\+W1D/B`\=&0@<W1Y;&4],T0G1$E3
M4$Q!63H@:6YL:6YE.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!&
M3TY4+5-)6D4Z(#$P<'0[(%1%6%0M04Q)1TXZ(&QE9G0G('9A;&EG;CTS1&)O
M='1O;2!W:61T:#TS1#$E/B0\+W1D/B`\=&0@<W1Y;&4],T0G1$E34$Q!63H@
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M('1I;65S(&YE=R!R;VUA;CL@1$E34$Q!63H@:6YL:6YE)SX@)FYB<W`[/"]F
M;VYT/B`\+W1D/B`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,3`E(&-O
M;'-P86X],T0R/CQF;VYT('-T>6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@1D].
M5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1$E34$Q!63H@:6YL:6YE)SX@
M)FYB<W`[/"]F;VYT/B`\+W1D/B`\=&0@<W1Y;&4],T0G5$585"U!3$E'3CH@
M;&5F="<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@;F]W<F%P/3-$;F]W
M<F%P/CQF;VYT('-T>6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@1D].5"U&04U)
M3%DZ('1I;65S(&YE=R!R;VUA;CL@1$E34$Q!63H@:6YL:6YE)SX@)FYB<W`[
M/"]F;VYT/B`\+W1D/B`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24^
M/&9O;G0@<W1Y;&4],T0G1D].5"U325I%.B`Q,'!T.R!&3TY4+49!34E,63H@
M=&EM97,@;F5W(')O;6%N.R!$25-03$%9.B!I;FQI;F4G/B`F;F)S<#L\+V9O
M;G0^(#PO=&0^(#QT9"!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q,"4@8V]L
M<W!A;CTS1#(^/&9O;G0@<W1Y;&4],T0G1D].5"U325I%.B`Q,'!T.R!&3TY4
M+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!$25-03$%9.B!I;FQI;F4G/B`F
M;F)S<#L\+V9O;G0^(#PO=&0^(#QT9"!S='EL93TS1"=415A4+4%,24=..B!L
M969T)R!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)2!N;W=R87`],T1N;W=R
M87`^/&9O;G0@<W1Y;&4],T0G1D].5"U325I%.B`Q,'!T.R!&3TY4+49!34E,
M63H@=&EM97,@;F5W(')O;6%N.R!$25-03$%9.B!I;FQI;F4G/B`F;F)S<#L\
M+V9O;G0^(#PO=&0^(#PO='(^(#QT<B!B9V-O;&]R/3-$(V-C965F9CX@/'1D
M('-T>6QE/3-$)U!!1$1)3D<M0D]45$]-.B`R<'@[(%1%6%0M04Q)1TXZ(&QE
M9G0[($U!4D=)3BU,1494.B`P<'0[($U!4D=)3BU224=(5#H@,'!T.R!415A4
M+4E.1$5.5#H@,'!T)R!V86QI9VX],T1B;W1T;VT@=VED=&@],T0U,B4^(#QD
M:78@<W1Y;&4],T0G1$E34$Q!63H@8FQO8VL[($9/3E0M1D%-24Q9.B!T:6UE
M<R!N97<@<F]M86X[($9/3E0M4TE:13H@,3!P=#L@34%21TE.+4Q%1E0Z(#!P
M=#L@34%21TE.+5))1TA4.B`P<'0[(%1%6%0M04Q)1TXZ(&QE9G0[(%1%6%0M
M24Y$14Y4.B`P<'0G/B!/<'1I;VYS(&9O<F9E:71E9#PO9&EV/B`\+W1D/B`\
M=&0@<W1Y;&4],T0G4$%$1$E.1RU"3U143TTZ(#)P>"<@=F%L:6=N/3-$8F]T
M=&]M('=I9'1H/3-$,24^/&9O;G0@<W1Y;&4],T0G1D].5"U325I%.B`Q,'!T
M.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!$25-03$%9.B!I;FQI
M;F4G/B`F;F)S<#L\+V9O;G0^(#PO=&0^(#QT9"!S='EL93TS1"="3U)$15(M
M0D]45$]-.B!B;&%C:R`R<'@@<V]L:60[(%1%6%0M04Q)1TXZ(&QE9G0G('9A
M;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E/CQF;VYT('-T>6QE/3-$)T9/3E0M
M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1$E3
M4$Q!63H@:6YL:6YE)SX@)FYB<W`[/"]F;VYT/B`\+W1D/B`\=&0@<W1Y;&4]
M,T0G0D]21$52+4)/5%1/33H@8FQA8VL@,G!X('-O;&ED.R!$25-03$%9.B!I
M;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE<R!N97<@<F]M86X[($9/3E0M4TE:
M13H@,3!P=#L@5$585"U!3$E'3CH@<FEG:'0G('9A;&EG;CTS1&)O='1O;2!W
M:61T:#TS1#DE/B@X,2PP-3<\+W1D/B`\=&0@<W1Y;&4],T0G1$E34$Q!63H@
M:6YL:6YE.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!&3TY4+5-)
M6D4Z(#$P<'0[(%!!1$1)3D<M0D]45$]-.B`R<'@[(%1%6%0M04Q)1TXZ(&QE
M9G0G('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E(&YO=W)A<#TS1&YO=W)A
M<#XI/"]T9#X@/'1D('-T>6QE/3-$)U!!1$1)3D<M0D]45$]-.B`R<'@G('9A
M;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E/CQF;VYT('-T>6QE/3-$)T9/3E0M
M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1$E3
M4$Q!63H@:6YL:6YE)SX@)FYB<W`[/"]F;VYT/B`\+W1D/B`\=&0@<W1Y;&4]
M,T0G0D]21$52+4)/5%1/33H@8FQA8VL@,G!X('-O;&ED.R!$25-03$%9.B!I
M;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE<R!N97<@<F]M86X[($9/3E0M4TE:
M13H@,3!P=#L@5$585"U!3$E'3CH@;&5F="<@=F%L:6=N/3-$8F]T=&]M('=I
M9'1H/3-$,24^)#PO=&0^(#QT9"!S='EL93TS1"="3U)$15(M0D]45$]-.B!B
M;&%C:R`R<'@@<V]L:60[($1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ
M('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T.R!415A4+4%,24=.
M.B!R:6=H="<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$.24^,3$N-3D\+W1D
M/B`\=&0@<W1Y;&4],T0G4$%$1$E.1RU"3U143TTZ(#)P>#L@5$585"U!3$E'
M3CH@;&5F="<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@;F]W<F%P/3-$
M;F]W<F%P/CQF;VYT('-T>6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@1D].5"U&
M04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1$E34$Q!63H@:6YL:6YE)SX@)FYB
M<W`[/"]F;VYT/B`\+W1D/B`\=&0@<W1Y;&4],T0G4$%$1$E.1RU"3U143TTZ
M(#)P>"<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24^/&9O;G0@<W1Y;&4]
M,T0G1D].5"U325I%.B`Q,'!T.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O
M;6%N.R!$25-03$%9.B!I;FQI;F4G/B`F;F)S<#L\+V9O;G0^(#PO=&0^(#QT
M9"!S='EL93TS1"=0041$24Y'+4)/5%1/33H@,G!X)R!V86QI9VX],T1B;W1T
M;VT@=VED=&@],T0Q,"4@8V]L<W!A;CTS1#(^/&9O;G0@<W1Y;&4],T0G1D].
M5"U325I%.B`Q,'!T.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!$
M25-03$%9.B!I;FQI;F4G/B`F;F)S<#L\+V9O;G0^(#PO=&0^(#QT9"!S='EL
M93TS1"=0041$24Y'+4)/5%1/33H@,G!X.R!415A4+4%,24=..B!L969T)R!V
M86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)2!N;W=R87`],T1N;W=R87`^/&9O
M;G0@<W1Y;&4],T0G1D].5"U325I%.B`Q,'!T.R!&3TY4+49!34E,63H@=&EM
M97,@;F5W(')O;6%N.R!$25-03$%9.B!I;FQI;F4G/B`F;F)S<#L\+V9O;G0^
M(#PO=&0^(#QT9"!S='EL93TS1"=0041$24Y'+4)/5%1/33H@,G!X)R!V86QI
M9VX],T1B;W1T;VT@=VED=&@],T0Q)3X\9F]N="!S='EL93TS1"=&3TY4+5-)
M6D4Z(#$P<'0[($9/3E0M1D%-24Q9.B!T:6UE<R!N97<@<F]M86X[($1)4U!,
M05DZ(&EN;&EN92<^("9N8G-P.SPO9F]N=#X@/"]T9#X@/'1D('-T>6QE/3-$
M)U!!1$1)3D<M0D]45$]-.B`R<'@G('9A;&EG;CTS1&)O='1O;2!W:61T:#TS
M1#$P)2!C;VQS<&%N/3-$,CX\9F]N="!S='EL93TS1"=&3TY4+5-)6D4Z(#$P
M<'0[($9/3E0M1D%-24Q9.B!T:6UE<R!N97<@<F]M86X[($1)4U!,05DZ(&EN
M;&EN92<^("9N8G-P.SPO9F]N=#X@/"]T9#X@/'1D('-T>6QE/3-$)U!!1$1)
M3D<M0D]45$]-.B`R<'@[(%1%6%0M04Q)1TXZ(&QE9G0G('9A;&EG;CTS1&)O
M='1O;2!W:61T:#TS1#$E(&YO=W)A<#TS1&YO=W)A<#X\9F]N="!S='EL93TS
M1"=&3TY4+5-)6D4Z(#$P<'0[($9/3E0M1D%-24Q9.B!T:6UE<R!N97<@<F]M
M86X[($1)4U!,05DZ(&EN;&EN92<^("9N8G-P.SPO9F]N=#X@/"]T9#X@/"]T
M<CX@/'1R(&)G8V]L;W(],T1W:&ET93X@/'1D('-T>6QE/3-$)U!!1$1)3D<M
M0D]45$]-.B`T<'@[(%1%6%0M04Q)1TXZ(&QE9G0[($U!4D=)3BU,1494.B`P
M<'0[($U!4D=)3BU224=(5#H@,'!T.R!415A4+4E.1$5.5#H@,'!T)R!V86QI
M9VX],T1B;W1T;VT@=VED=&@],T0U,B4^(#QD:78@<W1Y;&4],T0G1$E34$Q!
M63H@8FQO8VL[($9/3E0M1D%-24Q9.B!T:6UE<R!N97<@<F]M86X[($9/3E0M
M4TE:13H@,3!P=#L@34%21TE.+4Q%1E0Z(#!P=#L@34%21TE.+5))1TA4.B`P
M<'0[(%1%6%0M04Q)1TXZ(&QE9G0[(%1%6%0M24Y$14Y4.B`P<'0G/B!/<'1I
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M;CL@1$E34$Q!63H@:6YL:6YE)SX@)FYB<W`[/"]F;VYT/B`\+W1D/B`\=&0@
M<W1Y;&4],T0G0D]21$52+4)/5%1/33H@8FQA8VL@-'!X(&1O=6)L93L@1$E3
M4$Q!63H@:6YL:6YE.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!&
M3TY4+5-)6D4Z(#$P<'0[(%1%6%0M04Q)1TXZ(')I9VAT)R!V86QI9VX],T1B
M;W1T;VT@=VED=&@],T0Y)3XQ+#@V,BPP.3D\+W1D/B`\=&0@<W1Y;&4],T0G
M4$%$1$E.1RU"3U143TTZ(#1P>#L@5$585"U!3$E'3CH@;&5F="<@=F%L:6=N
M/3-$8F]T=&]M('=I9'1H/3-$,24@;F]W<F%P/3-$;F]W<F%P/CQF;VYT('-T
M>6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ('1I;65S(&YE
M=R!R;VUA;CL@1$E34$Q!63H@:6YL:6YE)SX@)FYB<W`[/"]F;VYT/B`\+W1D
M/B`\=&0@<W1Y;&4],T0G4$%$1$E.1RU"3U143TTZ(#1P>"<@=F%L:6=N/3-$
M8F]T=&]M('=I9'1H/3-$,24^/&9O;G0@<W1Y;&4],T0G1D].5"U325I%.B`Q
M,'!T.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!$25-03$%9.B!I
M;FQI;F4G/B`F;F)S<#L\+V9O;G0^(#PO=&0^(#QT9"!S='EL93TS1"="3U)$
M15(M0D]45$]-.B!B;&%C:R`T<'@@9&]U8FQE.R!$25-03$%9.B!I;FQI;F4[
M($9/3E0M1D%-24Q9.B!T:6UE<R!N97<@<F]M86X[($9/3E0M4TE:13H@,3!P
M=#L@5$585"U!3$E'3CH@;&5F="<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$
M,24^)#PO=&0^(#QT9"!S='EL93TS1"="3U)$15(M0D]45$]-.B!B;&%C:R`T
M<'@@9&]U8FQE.R!$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE
M<R!N97<@<F]M86X[($9/3E0M4TE:13H@,3!P=#L@5$585"U!3$E'3CH@<FEG
M:'0G('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#DE/C,N-S,\+W1D/B`\=&0@
M<W1Y;&4],T0G4$%$1$E.1RU"3U143TTZ(#1P>#L@5$585"U!3$E'3CH@;&5F
M="<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@;F]W<F%P/3-$;F]W<F%P
M/CQF;VYT('-T>6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ
M('1I;65S(&YE=R!R;VUA;CL@1$E34$Q!63H@:6YL:6YE)SX@)FYB<W`[/"]F
M;VYT/B`\+W1D/B`\=&0@<W1Y;&4],T0G4$%$1$E.1RU"3U143TTZ(#1P>"<@
M=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24^/&9O;G0@<W1Y;&4],T0G1D].
M5"U325I%.B`Q,'!T.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!$
M25-03$%9.B!I;FQI;F4G/B`F;F)S<#L\+V9O;G0^(#PO=&0^(#QT9"!S='EL
M93TS1"="3U)$15(M0D]45$]-.B!B;&%C:R`T<'@@9&]U8FQE.R!415A4+4%,
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M;VUA;CL@1D].5"U325I%.B`Q,'!T.R!415A4+4%,24=..B!R:6=H="<@=F%L
M:6=N/3-$8F]T=&]M('=I9'1H/3-$.24^,RXQ,SPO=&0^(#QT9"!S='EL93TS
M1"=0041$24Y'+4)/5%1/33H@-'!X.R!415A4+4%,24=..B!L969T)R!V86QI
M9VX],T1B;W1T;VT@=VED=&@],T0Q)2!N;W=R87`],T1N;W=R87`^/&9O;G0@
M<W1Y;&4],T0G1D].5"U325I%.B`Q,'!T.R!&3TY4+49!34E,63H@=&EM97,@
M;F5W(')O;6%N.R!$25-03$%9.B!I;FQI;F4G/B`F;F)S<#L\+V9O;G0^(#PO
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M93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q
M,'!T.R!415A4+4%,24=..B!L969T)R!V86QI9VX],T1B;W1T;VT@=VED=&@]
M,T0Q)3XD/"]T9#X@/'1D('-T>6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K
M(#1P>"!D;W5B;&4[($1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I
M;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T.R!415A4+4%,24=..B!R
M:6=H="<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$.24^,2PP-#8\+W1D/B`\
M=&0@<W1Y;&4],T0G4$%$1$E.1RU"3U143TTZ(#1P>#L@5$585"U!3$E'3CH@
M;&5F="<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@;F]W<F%P/3-$;F]W
M<F%P/CQF;VYT('-T>6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@1D].5"U&04U)
M3%DZ('1I;65S(&YE=R!R;VUA;CL@1$E34$Q!63H@:6YL:6YE)SX@)FYB<W`[
M/"]F;VYT/B`\+W1D/B`\+W1R/B`\='(@8F=C;VQO<CTS1"-C8V5E9F8^(#QT
M9"!S='EL93TS1"=0041$24Y'+4)/5%1/33H@-'!X.R!415A4+4%,24=..B!L
M969T.R!-05)'24XM3$5&5#H@,'!T.R!-05)'24XM4DE'2%0Z(#!P=#L@5$58
M5"U)3D1%3E0Z(#!P="<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$-3(E/B`\
M9&EV('-T>6QE/3-$)T1)4U!,05DZ(&)L;V-K.R!&3TY4+49!34E,63H@=&EM
M97,@;F5W(')O;6%N.R!&3TY4+5-)6D4Z(#$P<'0[($U!4D=)3BU,1494.B`P
M<'0[($U!4D=)3BU224=(5#H@,'!T.R!415A4+4%,24=..B!L969T.R!415A4
M+4E.1$5.5#H@,'!T)SX@3W!T:6]N<R!E>&5R8VES86)L92!A="!T:&4@96YD
M(&]F('1H92!P97)I;V0\+V1I=CX@/"]T9#X@/'1D('-T>6QE/3-$)U!!1$1)
M3D<M0D]45$]-.B`T<'@G('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E/CQF
M;VYT('-T>6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ('1I
M;65S(&YE=R!R;VUA;CL@1$E34$Q!63H@:6YL:6YE)SX@)FYB<W`[/"]F;VYT
M/B`\+W1D/B`\=&0@<W1Y;&4],T0G0D]21$52+4)/5%1/33H@8FQA8VL@-'!X
M(&1O=6)L93L@5$585"U!3$E'3CH@;&5F="<@=F%L:6=N/3-$8F]T=&]M('=I
M9'1H/3-$,24^/&9O;G0@<W1Y;&4],T0G1D].5"U325I%.B`Q,'!T.R!&3TY4
M+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!$25-03$%9.B!I;FQI;F4G/B`F
M;F)S<#L\+V9O;G0^(#PO=&0^(#QT9"!S='EL93TS1"="3U)$15(M0D]45$]-
M.B!B;&%C:R`T<'@@9&]U8FQE.R!$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-
M24Q9.B!T:6UE<R!N97<@<F]M86X[($9/3E0M4TE:13H@,3!P=#L@5$585"U!
M3$E'3CH@<FEG:'0G('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#DE/C$L.#8R
M+#`Y.3PO=&0^(#QT9"!S='EL93TS1"=0041$24Y'+4)/5%1/33H@-'!X.R!4
M15A4+4%,24=..B!L969T)R!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)2!N
M;W=R87`],T1N;W=R87`^/&9O;G0@<W1Y;&4],T0G1D].5"U325I%.B`Q,'!T
M.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!$25-03$%9.B!I;FQI
M;F4G/B`F;F)S<#L\+V9O;G0^(#PO=&0^(#QT9"!S='EL93TS1"=0041$24Y'
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M=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T.R!415A4+4%,24=..B!L969T)R!V
M86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)3XD/"]T9#X@/'1D('-T>6QE/3-$
M)T)/4D1%4BU"3U143TTZ(&)L86-K(#1P>"!D;W5B;&4[($1)4U!,05DZ(&EN
M;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%
M.B`Q,'!T.R!415A4+4%,24=..B!R:6=H="<@=F%L:6=N/3-$8F]T=&]M('=I
M9'1H/3-$.24^,RXW,SPO=&0^(#QT9"!S='EL93TS1"=0041$24Y'+4)/5%1/
M33H@-'!X.R!415A4+4%,24=..B!L969T)R!V86QI9VX],T1B;W1T;VT@=VED
M=&@],T0Q)2!N;W=R87`],T1N;W=R87`^/&9O;G0@<W1Y;&4],T0G1D].5"U3
M25I%.B`Q,'!T.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!$25-0
M3$%9.B!I;FQI;F4G/B`F;F)S<#L\+V9O;G0^(#PO=&0^(#QT9"!S='EL93TS
M1"=0041$24Y'+4)/5%1/33H@-'!X)R!V86QI9VX],T1B;W1T;VT@=VED=&@]
M,T0Q)3X\9F]N="!S='EL93TS1"=&3TY4+5-)6D4Z(#$P<'0[($9/3E0M1D%-
M24Q9.B!T:6UE<R!N97<@<F]M86X[($1)4U!,05DZ(&EN;&EN92<^("9N8G-P
M.SPO9F]N=#X@/"]T9#X@/'1D('-T>6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L
M86-K(#1P>"!D;W5B;&4[(%1%6%0M04Q)1TXZ(&QE9G0G('9A;&EG;CTS1&)O
M='1O;2!W:61T:#TS1#$E/CQF;VYT('-T>6QE/3-$)T9/3E0M4TE:13H@,3!P
M=#L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1$E34$Q!63H@:6YL
M:6YE)SX@)FYB<W`[/"]F;VYT/B`\+W1D/B`\=&0@<W1Y;&4],T0G0D]21$52
M+4)/5%1/33H@8FQA8VL@-'!X(&1O=6)L93L@1$E34$Q!63H@:6YL:6YE.R!&
M3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!&3TY4+5-)6D4Z(#$P<'0[
M(%1%6%0M04Q)1TXZ(')I9VAT)R!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Y
M)3XS+C$S/"]T9#X@/'1D('-T>6QE/3-$)U!!1$1)3D<M0D]45$]-.B`T<'@[
M(%1%6%0M04Q)1TXZ(&QE9G0G('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E
M(&YO=W)A<#TS1&YO=W)A<#X\9F]N="!S='EL93TS1"=&3TY4+5-)6D4Z(#$P
M<'0[($9/3E0M1D%-24Q9.B!T:6UE<R!N97<@<F]M86X[($1)4U!,05DZ(&EN
M;&EN92<^("9N8G-P.SPO9F]N=#X@/"]T9#X@/'1D('-T>6QE/3-$)U!!1$1)
M3D<M0D]45$]-.B`T<'@G('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E/CQF
M;VYT('-T>6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ('1I
M;65S(&YE=R!R;VUA;CL@1$E34$Q!63H@:6YL:6YE)SX@)FYB<W`[/"]F;VYT
M/B`\+W1D/B`\=&0@<W1Y;&4],T0G0D]21$52+4)/5%1/33H@8FQA8VL@-'!X
M(&1O=6)L93L@1$E34$Q!63H@:6YL:6YE.R!&3TY4+49!34E,63H@=&EM97,@
M;F5W(')O;6%N.R!&3TY4+5-)6D4Z(#$P<'0[(%1%6%0M04Q)1TXZ(&QE9G0G
M('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E/B0\+W1D/B`\=&0@<W1Y;&4]
M,T0G0D]21$52+4)/5%1/33H@8FQA8VL@-'!X(&1O=6)L93L@1$E34$Q!63H@
M:6YL:6YE.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!&3TY4+5-)
M6D4Z(#$P<'0[(%1%6%0M04Q)1TXZ(')I9VAT)R!V86QI9VX],T1B;W1T;VT@
M=VED=&@],T0Y)3XQ+#`T-CPO=&0^(#QT9"!S='EL93TS1"=0041$24Y'+4)/
M5%1/33H@-'!X.R!415A4+4%,24=..B!L969T)R!V86QI9VX],T1B;W1T;VT@
M=VED=&@],T0Q)2!N;W=R87`],T1N;W=R87`^/&9O;G0@<W1Y;&4],T0G1D].
M5"U325I%.B`Q,'!T.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!$
M25-03$%9.B!I;FQI;F4G/B`F;F)S<#L\+V9O;G0^(#PO=&0^(#PO='(^(#QT
M<B!B9V-O;&]R/3-$=VAI=&4^(#QT9"!S='EL93TS1"=0041$24Y'+4)/5%1/
M33H@-'!X.R!415A4+4%,24=..B!L969T.R!-05)'24XM3$5&5#H@,'!T.R!-
M05)'24XM4DE'2%0Z(#!P=#L@5$585"U)3D1%3E0Z(#!P="<@=F%L:6=N/3-$
M8F]T=&]M('=I9'1H/3-$-3(E/B`\9&EV('-T>6QE/3-$)T1)4U!,05DZ(&)L
M;V-K.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!&3TY4+5-)6D4Z
M(#$P<'0[($U!4D=)3BU,1494.B`P<'0[($U!4D=)3BU224=(5#H@,'!T.R!4
M15A4+4%,24=..B!L969T.R!415A4+4E.1$5.5#H@,'!T)SX@3W!T:6]N<R!V
M97-T960\+V1I=CX@/"]T9#X@/'1D('-T>6QE/3-$)U!!1$1)3D<M0D]45$]-
M.B`T<'@G('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E/CQF;VYT('-T>6QE
M/3-$)T9/3E0M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R
M;VUA;CL@1$E34$Q!63H@:6YL:6YE)SX@)FYB<W`[/"]F;VYT/B`\+W1D/B`\
M=&0@<W1Y;&4],T0G0D]21$52+4)/5%1/33H@8FQA8VL@-'!X(&1O=6)L93L@
M5$585"U!3$E'3CH@;&5F="<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24^
M/&9O;G0@<W1Y;&4],T0G1D].5"U325I%.B`Q,'!T.R!&3TY4+49!34E,63H@
M=&EM97,@;F5W(')O;6%N.R!$25-03$%9.B!I;FQI;F4G/B`F;F)S<#L\+V9O
M;G0^(#PO=&0^(#QT9"!S='EL93TS1"="3U)$15(M0D]45$]-.B!B;&%C:R`T
M<'@@9&]U8FQE.R!$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE
M<R!N97<@<F]M86X[($9/3E0M4TE:13H@,3!P=#L@5$585"U!3$E'3CH@<FEG
M:'0G('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#DE/C$L.#8R+#`Y.3PO=&0^
M(#QT9"!S='EL93TS1"=0041$24Y'+4)/5%1/33H@-'!X.R!415A4+4%,24=.
M.B!L969T)R!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)2!N;W=R87`],T1N
M;W=R87`^/&9O;G0@<W1Y;&4],T0G1D].5"U325I%.B`Q,'!T.R!&3TY4+49!
M34E,63H@=&EM97,@;F5W(')O;6%N.R!$25-03$%9.B!I;FQI;F4G/B`F;F)S
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M1D].5"U325I%.B`Q,'!T.R!415A4+4%,24=..B!L969T)R!V86QI9VX],T1B
M;W1T;VT@=VED=&@],T0Q)3XD/"]T9#X@/'1D('-T>6QE/3-$)T)/4D1%4BU"
M3U143TTZ(&)L86-K(#1P>"!D;W5B;&4[($1)4U!,05DZ(&EN;&EN93L@1D].
M5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T.R!4
M15A4+4%,24=..B!R:6=H="<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$.24^
M,RXW,SPO=&0^(#QT9"!S='EL93TS1"=0041$24Y'+4)/5%1/33H@-'!X.R!4
M15A4+4%,24=..B!L969T)R!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)2!N
M;W=R87`],T1N;W=R87`^/&9O;G0@<W1Y;&4],T0G1D].5"U325I%.B`Q,'!T
M.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!$25-03$%9.B!I;FQI
M;F4G/B`F;F)S<#L\+V9O;G0^(#PO=&0^(#QT9"!S='EL93TS1"=0041$24Y'
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M<W`[/"]F;VYT/B`\+W1D/B`\=&0@<W1Y;&4],T0G0D]21$52+4)/5%1/33H@
M8FQA8VL@-'!X(&1O=6)L93L@1$E34$Q!63H@:6YL:6YE.R!&3TY4+49!34E,
M63H@=&EM97,@;F5W(')O;6%N.R!&3TY4+5-)6D4Z(#$P<'0[(%1%6%0M04Q)
M1TXZ(')I9VAT)R!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Y)3XS+C$S/"]T
M9#X@/'1D('-T>6QE/3-$)U!!1$1)3D<M0D]45$]-.B`T<'@[(%1%6%0M04Q)
M1TXZ(&QE9G0G('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E(&YO=W)A<#TS
M1&YO=W)A<#X\9F]N="!S='EL93TS1"=&3TY4+5-)6D4Z(#$P<'0[($9/3E0M
M1D%-24Q9.B!T:6UE<R!N97<@<F]M86X[($1)4U!,05DZ(&EN;&EN92<^("9N
M8G-P.SPO9F]N=#X@/"]T9#X@/'1D('-T>6QE/3-$)U!!1$1)3D<M0D]45$]-
M.B`T<'@G('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E/CQF;VYT('-T>6QE
M/3-$)T9/3E0M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R
M;VUA;CL@1$E34$Q!63H@:6YL:6YE)SX@)FYB<W`[/"]F;VYT/B`\+W1D/B`\
M=&0@<W1Y;&4],T0G0D]21$52+4)/5%1/33H@8FQA8VL@-'!X(&1O=6)L93L@
M1$E34$Q!63H@:6YL:6YE.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N
M.R!&3TY4+5-)6D4Z(#$P<'0[(%1%6%0M04Q)1TXZ(&QE9G0G('9A;&EG;CTS
M1&)O='1O;2!W:61T:#TS1#$E/B0\+W1D/B`\=&0@<W1Y;&4],T0G0D]21$52
M+4)/5%1/33H@8FQA8VL@-'!X(&1O=6)L93L@1$E34$Q!63H@:6YL:6YE.R!&
M3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!&3TY4+5-)6D4Z(#$P<'0[
M(%1%6%0M04Q)1TXZ(')I9VAT)R!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Y
M)3XQ+#`T-CPO=&0^(#QT9"!S='EL93TS1"=0041$24Y'+4)/5%1/33H@-'!X
M.R!415A4+4%,24=..B!L969T)R!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q
M)2!N;W=R87`],T1N;W=R87`^/&9O;G0@<W1Y;&4],T0G1D].5"U325I%.B`Q
M,'!T.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!$25-03$%9.B!I
M;FQI;F4G/B`F;F)S<#L\+V9O;G0^(#PO=&0^(#PO='(^(#PO=&%B;&4^(#PO
M9&EV/B`\9&EV('-T>6QE/3-$)T1)4U!,05DZ(&)L;V-K.R!&3TY4+49!34E,
M63H@5&EM97,@3F5W(%)O;6%N.R!&3TY4+5-)6D4Z(#$P<'0[($U!4D=)3BU,
M1494.B`Q.'!T.R!-05)'24XM4DE'2%0Z(#!P=#L@=&5X="UA;&EG;CH@:G5S
M=&EF>3L@5$585"U)3D1%3E0Z(#!P="<^("9N8G-P.SPO9&EV/B`\9&EV('-T
M>6QE/3-$)T1)4U!,05DZ(&)L;V-K.R!&3TY4+49!34E,63H@5&EM97,@3F5W
M(%)O;6%N.R!&3TY4+5-)6D4Z(#$P<'0[($U!4D=)3BU,1494.B`Q.'!T.R!-
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M:7(@;W!T:6]N<R!O;B!*=6YE(#,P+"`R,#$T+B!4:&ES(&%M;W5N="!C:&%N
M9V5S(&)A<V5D(&]N('1H92!F86ER(&UA<FME="!V86QU92!O9B!T:&4@0V]M
M<&%N>28C,SD[<R!C;VUM;VX@<W1O8VLN/"]D:78^(#QD:78@<W1Y;&4],T0G
M1$E34$Q!63H@8FQO8VL[($U!4D=)3BU,1494.B`P<'0[($U!4D=)3BU224=(
M5#H@,'!T.R!T97AT+6%L:6=N.B!J=7-T:69Y.R!415A4+4E.1$5.5#H@,'!T
M)SX@)FYB<W`[/"]D:78^(#QD:78@<W1Y;&4],T0G5$585"U!3$E'3CH@;&5F
M=#L@34%21TE.+4Q%1E0Z(#!P=#L@1$E34$Q!63H@8FQO8VL[($U!4D=)3BU2
M24=(5#H@,'!T.R!415A4+4E.1$5.5#H@,'!T)SX@/'1A8FQE('-T>6QE/3-$
M)T9/3E0M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA
M;B<@8V5L;'-P86-I;F<],T0P(&-E;&QP861D:6YG/3-$,"!W:61T:#TS1#$P
M,"4@8F]R9&5R/3-$,#X@/'1R('9A;&EG;CTS1'1O<#X@/'1D('-T>6QE/3-$
M)U=)1%1(.B`Q.'!T)R!A;&EG;CTS1')I9VAT/B`\9&EV('-T>6QE/3-$)T1)
M4U!,05DZ(&)L;V-K.R!&3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N.R!&
M3TY4+5-)6D4Z(#$P<'0[($U!4D=)3BU,1494.B`P<'0[($U!4D=)3BU224=(
M5#H@,'!T.R!415A4+4%,24=..B!L969T.R!415A4+4E.1$5.5#H@,'!T)SX@
M8BX\+V1I=CX@/"]T9#X@/'1D(&%L:6=N/3-$;&5F=#X@/&1I=B!S='EL93TS
M1"=$25-03$%9.B!B;&]C:SL@1D].5"U&04U)3%DZ(%1I;65S($YE=R!2;VUA
M;CL@1D].5"U325I%.B`Q,'!T.R!-05)'24XM3$5&5#H@,'!T.R!-05)'24XM
M4DE'2%0Z(#!P=#L@5$585"U!3$E'3CH@;&5F=#L@5$585"U)3D1%3E0Z(#!P
M="<^($]P=&EO;G,@86YD('=A<G)A;G1S('1O(&YO;BUE;7!L;WEE97,Z/"]D
M:78^(#PO=&0^(#PO='(^(#PO=&%B;&4^(#PO9&EV/B`\9&EV('-T>6QE/3-$
M)T1)4U!,05DZ(&)L;V-K.R!-05)'24XM3$5&5#H@,'!T.R!-05)'24XM4DE'
M2%0Z(#!P=#L@=&5X="UA;&EG;CH@:G5S=&EF>3L@5$585"U)3D1%3E0Z(#!P
M="<^("9N8G-P.SPO9&EV/B`\9&EV/B`\=&%B;&4@<W1Y;&4],T0G1D].5"U3
M25I%.B`Q,'!T.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N)R!C96QL
M<W!A8VEN9STS1#`@8V5L;'!A9&1I;F<],T0P('=I9'1H/3-$,3`P)2!A;&EG
M;CTS1&-E;G1E<B!B;W)D97(],T0P/B`\='(@=F%L:6=N/3-$=&]P/B`\=&0@
M<W1Y;&4],T0G5TE$5$@Z(#$X<'0G/B`\9&EV('-T>6QE/3-$)T9/3E0M4TE:
M13H@,3!P=#L@1D].5"U&04U)3%DZ(%1I;65S($YE=R!2;VUA;CL@1$E34$Q!
M63H@:6YL:6YE)SX@)FYB<W`[/"]D:78^(#PO=&0^(#QT9#X@/&1I=B!S='EL
M93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!4:6UE<R!.97<@
M4F]M86X[($9/3E0M4TE:13H@,3!P=#L@=&5X="UA;&EG;CH@;&5F="<^($$@
M<W5M;6%R>2!O9B!T:&4@0V]M<&%N>28C,SD[<R!A8W1I=FET>2!R96QA=&5D
M('1O(&]P=&EO;G,@86YD('=A<G)A;G1S('1O(&-O;G-U;'1A;G1S(&ES(&%S
M(&9O;&QO=W,Z/"]D:78^(#PO=&0^(#PO='(^(#PO=&%B;&4^(#PO9&EV/B`\
M9&EV/B9N8G-P.SPO9&EV/B`\9&EV('-T>6QE/3-$)W1E>'0M86QI9VXZ(')I
M9VAT)SX@/'1A8FQE('-T>6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@1D].5"U&
M04U)3%DZ('1I;65S(&YE=R!R;VUA;B<@8V5L;'-P86-I;F<],T0P(&-E;&QP
M861D:6YG/3-$,"!W:61T:#TS1#DW)3X@/'1R/B`\=&0@<W1Y;&4],T0G4$%$
M1$E.1RU"3U143TTZ(#)P>"<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$-3(E
M/CQF;VYT('-T>6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ
M('1I;65S(&YE=R!R;VUA;CL@1$E34$Q!63H@:6YL:6YE)SX@)FYB<W`[/"]F
M;VYT/B`\+W1D/B`\=&0@<W1Y;&4],T0G4$%$1$E.1RU"3U143TTZ(#)P>"<@
M=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24^/&9O;G0@<W1Y;&4],T0G1D].
M5"U325I%.B`Q,'!T.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!&
M3TY4+5=%24=(5#H@8F]L9#L@1$E34$Q!63H@:6YL:6YE)SX@)FYB<W`[/"]F
M;VYT/B`\+W1D/B`\=&0@<W1Y;&4],T0G0D]21$52+4)/5%1/33H@8FQA8VL@
M,G!X('-O;&ED)R!V86QI9VX],T1B;W1T;VT@=VED=&@],T0T-B4@8V]L<W!A
M;CTS1#$T/B`\9&EV('-T>6QE/3-$)T1)4U!,05DZ(&)L;V-K.R!&3TY4+49!
M34E,63H@=&EM97,@;F5W(')O;6%N.R!&3TY4+5-)6D4Z(#$P<'0[($9/3E0M
M5T5)1TA4.B!B;VQD.R!-05)'24XM3$5&5#H@,'!T.R!-05)'24XM4DE'2%0Z
M(#!P=#L@=&5X="UA;&EG;CH@8V5N=&5R.R!415A4+4E.1$5.5#H@,'!T)SX@
M665A<B!E;F1E9"9N8G-P.TIU;F4@,S`L(#(P,30\+V1I=CX@/"]T9#X@/'1D
M('-T>6QE/3-$)U!!1$1)3D<M0D]45$]-.B`R<'@[(%1%6%0M04Q)1TXZ(&QE
M9G0G('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E(&YO=W)A<#TS1&YO=W)A
M<#X\9F]N="!S='EL93TS1"=&3TY4+5-)6D4Z(#$P<'0[($9/3E0M1D%-24Q9
M.B!T:6UE<R!N97<@<F]M86X[($9/3E0M5T5)1TA4.B!B;VQD.R!$25-03$%9
M.B!I;FQI;F4G/B`F;F)S<#L\+V9O;G0^(#PO=&0^(#PO='(^(#QT<CX@/'1D
M('-T>6QE/3-$)U!!1$1)3D<M0D]45$]-.B`R<'@G('9A;&EG;CTS1&)O='1O
M;2!W:61T:#TS1#4R)3X\9F]N="!S='EL93TS1"=&3TY4+5-)6D4Z(#$P<'0[
M($9/3E0M1D%-24Q9.B!T:6UE<R!N97<@<F]M86X[($1)4U!,05DZ(&EN;&EN
M92<^("9N8G-P.SPO9F]N=#X@/"]T9#X@/'1D('-T>6QE/3-$)U!!1$1)3D<M
M0D]45$]-.B`R<'@G('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E/CQF;VYT
M('-T>6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ('1I;65S
M(&YE=R!R;VUA;CL@1D].5"U714E'2%0Z(&)O;&0[($1)4U!,05DZ(&EN;&EN
M92<^("9N8G-P.SPO9F]N=#X@/"]T9#X@/'1D('-T>6QE/3-$)T)/4D1%4BU"
M3U143TTZ(&)L86-K(#)P>"!S;VQI9"<@=F%L:6=N/3-$8F]T=&]M('=I9'1H
M/3-$,3`E(&-O;'-P86X],T0R/B`\9&EV('-T>6QE/3-$)T1)4U!,05DZ(&)L
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M,T1B;W1T;VT@=VED=&@],T0Q)2!N;W=R87`],T1N;W=R87`^/&9O;G0@<W1Y
M;&4],T0G1D].5"U325I%.B`Q,'!T.R!&3TY4+49!34E,63H@=&EM97,@;F5W
M(')O;6%N.R!&3TY4+5=%24=(5#H@8F]L9#L@1$E34$Q!63H@:6YL:6YE)SX@
M)FYB<W`[/"]F;VYT/B`\+W1D/B`\=&0@<W1Y;&4],T0G4$%$1$E.1RU"3U14
M3TTZ(#)P>"<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24^/&9O;G0@<W1Y
M;&4],T0G1D].5"U325I%.B`Q,'!T.R!&3TY4+49!34E,63H@=&EM97,@;F5W
M(')O;6%N.R!&3TY4+5=%24=(5#H@8F]L9#L@1$E34$Q!63H@:6YL:6YE)SX@
M)FYB<W`[/"]F;VYT/B`\+W1D/B`\=&0@<W1Y;&4],T0G0D]21$52+4)/5%1/
M33H@8FQA8VL@,G!X('-O;&ED)R!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q
M,"4@8V]L<W!A;CTS1#(^(#QD:78@<W1Y;&4],T0G1$E34$Q!63H@8FQO8VL[
M($9/3E0M1D%-24Q9.B!T:6UE<R!N97<@<F]M86X[($9/3E0M4TE:13H@,3!P
M=#L@1D].5"U714E'2%0Z(&)O;&0[($U!4D=)3BU,1494.B`P<'0[($U!4D=)
M3BU224=(5#H@,'!T.R!T97AT+6%L:6=N.B!C96YT97([(%1%6%0M24Y$14Y4
M.B`P<'0G/B!796EG:'1E9"!!=F5R86=E($5X97)C:7-E(%!R:6-E/"]D:78^
M(#PO=&0^(#QT9"!S='EL93TS1"=0041$24Y'+4)/5%1/33H@,G!X.R!415A4
M+4%,24=..B!L969T)R!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)2!N;W=R
M87`],T1N;W=R87`^/&9O;G0@<W1Y;&4],T0G1D].5"U325I%.B`Q,'!T.R!&
M3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!&3TY4+5=%24=(5#H@8F]L
M9#L@1$E34$Q!63H@:6YL:6YE)SX@)FYB<W`[/"]F;VYT/B`\+W1D/B`\=&0@
M<W1Y;&4],T0G4$%$1$E.1RU"3U143TTZ(#)P>"<@=F%L:6=N/3-$8F]T=&]M
M('=I9'1H/3-$,24^/&9O;G0@<W1Y;&4],T0G1D].5"U325I%.B`Q,'!T.R!&
M3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!&3TY4+5=%24=(5#H@8F]L
M9#L@1$E34$Q!63H@:6YL:6YE)SX@)FYB<W`[/"]F;VYT/B`\+W1D/B`\=&0@
M<W1Y;&4],T0G0D]21$52+4)/5%1/33H@8FQA8VL@,G!X('-O;&ED)R!V86QI
M9VX],T1B;W1T;VT@=VED=&@],T0Q,"4@8V]L<W!A;CTS1#(^(#QD:78@<W1Y
M;&4],T0G1$E34$Q!63H@8FQO8VL[($9/3E0M1D%-24Q9.B!T:6UE<R!N97<@
M<F]M86X[($9/3E0M4TE:13H@,3!P=#L@1D].5"U714E'2%0Z(&)O;&0[($U!
M4D=)3BU,1494.B`P<'0[($U!4D=)3BU224=(5#H@,'!T.R!T97AT+6%L:6=N
M.B!C96YT97([(%1%6%0M24Y$14Y4.B`P<'0G/B!796EG:'1E9"!!=F5R86=E
M(%)E;6%I;FEN9R!#;VYT<F%C='5A;"!497)M<R`H:6X@>65A<G,I/"]D:78^
M(#PO=&0^(#QT9"!S='EL93TS1"=0041$24Y'+4)/5%1/33H@,G!X.R!415A4
M+4%,24=..B!L969T)R!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)2!N;W=R
M87`],T1N;W=R87`^/&9O;G0@<W1Y;&4],T0G1D].5"U325I%.B`Q,'!T.R!&
M3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!&3TY4+5=%24=(5#H@8F]L
M9#L@1$E34$Q!63H@:6YL:6YE)SX@)FYB<W`[/"]F;VYT/B`\+W1D/B`\=&0@
M<W1Y;&4],T0G4$%$1$E.1RU"3U143TTZ(#)P>"<@=F%L:6=N/3-$8F]T=&]M
M('=I9'1H/3-$,24^/&9O;G0@<W1Y;&4],T0G1D].5"U325I%.B`Q,'!T.R!&
M3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!&3TY4+5=%24=(5#H@8F]L
M9#L@1$E34$Q!63H@:6YL:6YE)SX@)FYB<W`[/"]F;VYT/B`\+W1D/B`\=&0@
M<W1Y;&4],T0G0D]21$52+4)/5%1/33H@8FQA8VL@,G!X('-O;&ED)R!V86QI
M9VX],T1B;W1T;VT@=VED=&@],T0Q,"4@8V]L<W!A;CTS1#(^(#QD:78@<W1Y
M;&4],T0G1$E34$Q!63H@8FQO8VL[($9/3E0M1D%-24Q9.B!T:6UE<R!N97<@
M<F]M86X[($9/3E0M4TE:13H@,3!P=#L@1D].5"U714E'2%0Z(&)O;&0[($U!
M4D=)3BU,1494.B`P<'0[($U!4D=)3BU224=(5#H@,'!T.R!T97AT+6%L:6=N
M.B!C96YT97([(%1%6%0M24Y$14Y4.B`P<'0G/B!!9V=R96=A=&4@26YT<FEN
M<VEC(%9A;'5E(%!R:6-E/"]D:78^(#PO=&0^(#QT9"!S='EL93TS1"=0041$
M24Y'+4)/5%1/33H@,G!X.R!415A4+4%,24=..B!L969T)R!V86QI9VX],T1B
M;W1T;VT@=VED=&@],T0Q)2!N;W=R87`],T1N;W=R87`^/&9O;G0@<W1Y;&4]
M,T0G1D].5"U325I%.B`Q,'!T.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O
M;6%N.R!&3TY4+5=%24=(5#H@8F]L9#L@1$E34$Q!63H@:6YL:6YE)SX@)FYB
M<W`[/"]F;VYT/B`\+W1D/B`\+W1R/B`\='(@8F=C;VQO<CTS1"-C8V5E9F8^
M(#QT9"!S='EL93TS1"=415A4+4%,24=..B!L969T.R!-05)'24XM3$5&5#H@
M,'!T.R!-05)'24XM4DE'2%0Z(#!P=#L@5$585"U)3D1%3E0Z(#!P="<@=F%L
M:6=N/3-$8F]T=&]M('=I9'1H/3-$-3(E/B`\9&EV('-T>6QE/3-$)T1)4U!,
M05DZ(&)L;V-K.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!&3TY4
M+5-)6D4Z(#$P<'0[($U!4D=)3BU,1494.B`P<'0[($U!4D=)3BU224=(5#H@
M,'!T.R!415A4+4%,24=..B!L969T.R!415A4+4E.1$5.5#H@,'!T)SX@3W!T
M:6]N<R!A;F0@=V%R<F%N=',@;W5T<W1A;F1I;F<@870@8F5G:6YN:6YG(&]F
M('!E<FEO9#PO9&EV/B`\+W1D/B`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H
M/3-$,24^/&9O;G0@<W1Y;&4],T0G1D].5"U325I%.B`Q,'!T.R!&3TY4+49!
M34E,63H@=&EM97,@;F5W(')O;6%N.R!$25-03$%9.B!I;FQI;F4G/B`F;F)S
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M=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T.R!415A4+4%,24=..B!R:6=H="<@
M=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$.24^,S$U+#4P,#PO=&0^(#QT9"!S
M='EL93TS1"=415A4+4%,24=..B!L969T)R!V86QI9VX],T1B;W1T;VT@=VED
M=&@],T0Q)2!N;W=R87`],T1N;W=R87`^/&9O;G0@<W1Y;&4],T0G1D].5"U3
M25I%.B`Q,'!T.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!$25-0
M3$%9.B!I;FQI;F4G/B`F;F)S<#L\+V9O;G0^(#PO=&0^(#QT9"!V86QI9VX]
M,T1B;W1T;VT@=VED=&@],T0Q)3X\9F]N="!S='EL93TS1"=&3TY4+5-)6D4Z
M(#$P<'0[($9/3E0M1D%-24Q9.B!T:6UE<R!N97<@<F]M86X[($1)4U!,05DZ
M(&EN;&EN92<^("9N8G-P.SPO9F]N=#X@/"]T9#X@/'1D('-T>6QE/3-$)T1)
M4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@
M1D].5"U325I%.B`Q,'!T.R!415A4+4%,24=..B!L969T)R!V86QI9VX],T1B
M;W1T;VT@=VED=&@],T0Q)3XD/"]T9#X@/'1D('-T>6QE/3-$)T1)4U!,05DZ
M(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U3
M25I%.B`Q,'!T.R!415A4+4%,24=..B!R:6=H="<@=F%L:6=N/3-$8F]T=&]M
M('=I9'1H/3-$.24^-"XT-#PO=&0^(#QT9"!S='EL93TS1"=415A4+4%,24=.
M.B!L969T)R!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)2!N;W=R87`],T1N
M;W=R87`^/&9O;G0@<W1Y;&4],T0G1D].5"U325I%.B`Q,'!T.R!&3TY4+49!
M34E,63H@=&EM97,@;F5W(')O;6%N.R!$25-03$%9.B!I;FQI;F4G/B`F;F)S
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M('1I;65S(&YE=R!R;VUA;CL@1$E34$Q!63H@:6YL:6YE)SX@)FYB<W`[/"]F
M;VYT/B`\+W1D/B`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,3`E(&-O
M;'-P86X],T0R/CQF;VYT('-T>6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@1D].
M5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1$E34$Q!63H@:6YL:6YE)SX@
M)FYB<W`[/"]F;VYT/B`\+W1D/B`\=&0@<W1Y;&4],T0G5$585"U!3$E'3CH@
M;&5F="<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@;F]W<F%P/3-$;F]W
M<F%P/CQF;VYT('-T>6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@1D].5"U&04U)
M3%DZ('1I;65S(&YE=R!R;VUA;CL@1$E34$Q!63H@:6YL:6YE)SX@)FYB<W`[
M/"]F;VYT/B`\+W1D/B`\+W1R/B`\='(@8F=C;VQO<CTS1'=H:71E/B`\=&0@
M<W1Y;&4],T0G5$585"U!3$E'3CH@;&5F=#L@34%21TE.+4Q%1E0Z(#!P=#L@
M34%21TE.+5))1TA4.B`P<'0[(%1%6%0M24Y$14Y4.B`P<'0G('9A;&EG;CTS
M1&)O='1O;2!W:61T:#TS1#4R)3X@/&1I=B!S='EL93TS1"=$25-03$%9.B!B
M;&]C:SL@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%
M.B`Q,'!T.R!-05)'24XM3$5&5#H@,'!T.R!-05)'24XM4DE'2%0Z(#!P=#L@
M5$585"U!3$E'3CH@;&5F=#L@5$585"U)3D1%3E0Z(#!P="<^($]P=&EO;G,@
M9W)A;G1E9#PO9&EV/B`\+W1D/B`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H
M/3-$,24^/&9O;G0@<W1Y;&4],T0G1D].5"U325I%.B`Q,'!T.R!&3TY4+49!
M34E,63H@=&EM97,@;F5W(')O;6%N.R!$25-03$%9.B!I;FQI;F4G/B`F;F)S
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M=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T.R!415A4+4%,24=..B!R:6=H="<@
M=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$.24^,RPP,#`\+W1D/B`\=&0@<W1Y
M;&4],T0G5$585"U!3$E'3CH@;&5F="<@=F%L:6=N/3-$8F]T=&]M('=I9'1H
M/3-$,24@;F]W<F%P/3-$;F]W<F%P/CQF;VYT('-T>6QE/3-$)T9/3E0M4TE:
M13H@,3!P=#L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1$E34$Q!
M63H@:6YL:6YE)SX@)FYB<W`[/"]F;VYT/B`\+W1D/B`\=&0@=F%L:6=N/3-$
M8F]T=&]M('=I9'1H/3-$,24^/&9O;G0@<W1Y;&4],T0G1D].5"U325I%.B`Q
M,'!T.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!$25-03$%9.B!I
M;FQI;F4G/B`F;F)S<#L\+V9O;G0^(#PO=&0^(#QT9"!S='EL93TS1"=$25-0
M3$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE<R!N97<@<F]M86X[($9/
M3E0M4TE:13H@,3!P=#L@5$585"U!3$E'3CH@;&5F="<@=F%L:6=N/3-$8F]T
M=&]M('=I9'1H/3-$,24^)#PO=&0^(#QT9"!S='EL93TS1"=$25-03$%9.B!I
M;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE<R!N97<@<F]M86X[($9/3E0M4TE:
M13H@,3!P=#L@5$585"U!3$E'3CH@<FEG:'0G('9A;&EG;CTS1&)O='1O;2!W
M:61T:#TS1#DE/C`N,#`\+W1D/B`\=&0@<W1Y;&4],T0G5$585"U!3$E'3CH@
M;&5F="<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@;F]W<F%P/3-$;F]W
M<F%P/CQF;VYT('-T>6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@1D].5"U&04U)
M3%DZ('1I;65S(&YE=R!R;VUA;CL@1$E34$Q!63H@:6YL:6YE)SX@)FYB<W`[
M/"]F;VYT/B`\+W1D/B`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24^
M/&9O;G0@<W1Y;&4],T0G1D].5"U325I%.B`Q,'!T.R!&3TY4+49!34E,63H@
M=&EM97,@;F5W(')O;6%N.R!$25-03$%9.B!I;FQI;F4G/B`F;F)S<#L\+V9O
M;G0^(#PO=&0^(#QT9"!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q,"4@8V]L
M<W!A;CTS1#(^/&9O;G0@<W1Y;&4],T0G1D].5"U325I%.B`Q,'!T.R!&3TY4
M+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!$25-03$%9.B!I;FQI;F4G/B`F
M;F)S<#L\+V9O;G0^(#PO=&0^(#QT9"!S='EL93TS1"=415A4+4%,24=..B!L
M969T)R!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)2!N;W=R87`],T1N;W=R
M87`^/&9O;G0@<W1Y;&4],T0G1D].5"U325I%.B`Q,'!T.R!&3TY4+49!34E,
M63H@=&EM97,@;F5W(')O;6%N.R!$25-03$%9.B!I;FQI;F4G/B`F;F)S<#L\
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M9F]N=#X@/"]T9#X@/"]T<CX@/'1R(&)G8V]L;W(],T0C8V-E969F/B`\=&0@
M<W1Y;&4],T0G4$%$1$E.1RU"3U143TTZ(#)P>#L@5$585"U!3$E'3CH@;&5F
M=#L@34%21TE.+4Q%1E0Z(#!P=#L@34%21TE.+5))1TA4.B`P<'0[(%1%6%0M
M24Y$14Y4.B`P<'0G('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#4R)3X@/&1I
M=B!S='EL93TS1"=$25-03$%9.B!B;&]C:SL@1D].5"U&04U)3%DZ('1I;65S
M(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T.R!-05)'24XM3$5&5#H@,'!T
M.R!-05)'24XM4DE'2%0Z(#!P=#L@5$585"U!3$E'3CH@;&5F=#L@5$585"U)
M3D1%3E0Z(#!P="<^($]P=&EO;G,@86YD('=A<G)A;G1S(&5X97)C:7-E9#PO
M9&EV/B`\+W1D/B`\=&0@<W1Y;&4],T0G4$%$1$E.1RU"3U143TTZ(#)P>"<@
M=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24^/&9O;G0@<W1Y;&4],T0G1D].
M5"U325I%.B`Q,'!T.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!$
M25-03$%9.B!I;FQI;F4G/B`F;F)S<#L\+V9O;G0^(#PO=&0^(#QT9"!S='EL
M93TS1"="3U)$15(M0D]45$]-.B!B;&%C:R`R<'@@<V]L:60[(%1%6%0M04Q)
M1TXZ(&QE9G0G('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E/CQF;VYT('-T
M>6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ('1I;65S(&YE
M=R!R;VUA;CL@1$E34$Q!63H@:6YL:6YE)SX@)FYB<W`[/"]F;VYT/B`\+W1D
M/B`\=&0@<W1Y;&4],T0G0D]21$52+4)/5%1/33H@8FQA8VL@,G!X('-O;&ED
M.R!$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE<R!N97<@<F]M
M86X[($9/3E0M4TE:13H@,3!P=#L@5$585"U!3$E'3CH@<FEG:'0G('9A;&EG
M;CTS1&)O='1O;2!W:61T:#TS1#DE/B@V-BPU,#`\+W1D/B`\=&0@<W1Y;&4]
M,T0G1$E34$Q!63H@:6YL:6YE.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O
M;6%N.R!&3TY4+5-)6D4Z(#$P<'0[(%!!1$1)3D<M0D]45$]-.B`R<'@[(%1%
M6%0M04Q)1TXZ(&QE9G0G('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E(&YO
M=W)A<#TS1&YO=W)A<#XI/"]T9#X@/'1D('-T>6QE/3-$)U!!1$1)3D<M0D]4
M5$]-.B`R<'@G('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E/CQF;VYT('-T
M>6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ('1I;65S(&YE
M=R!R;VUA;CL@1$E34$Q!63H@:6YL:6YE)SX@)FYB<W`[/"]F;VYT/B`\+W1D
M/B`\=&0@<W1Y;&4],T0G0D]21$52+4)/5%1/33H@8FQA8VL@,G!X('-O;&ED
M.R!$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE<R!N97<@<F]M
M86X[($9/3E0M4TE:13H@,3!P=#L@5$585"U!3$E'3CH@;&5F="<@=F%L:6=N
M/3-$8F]T=&]M('=I9'1H/3-$,24^)#PO=&0^(#QT9"!S='EL93TS1"="3U)$
M15(M0D]45$]-.B!B;&%C:R`R<'@@<V]L:60[($1)4U!,05DZ(&EN;&EN93L@
M1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T
M.R!415A4+4%,24=..B!R:6=H="<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$
M.24^,2XS.3PO=&0^(#QT9"!S='EL93TS1"=0041$24Y'+4)/5%1/33H@,G!X
M.R!415A4+4%,24=..B!L969T)R!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q
M)2!N;W=R87`],T1N;W=R87`^/&9O;G0@<W1Y;&4],T0G1D].5"U325I%.B`Q
M,'!T.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!$25-03$%9.B!I
M;FQI;F4G/B`F;F)S<#L\+V9O;G0^(#PO=&0^(#QT9"!S='EL93TS1"=0041$
M24Y'+4)/5%1/33H@,G!X)R!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)3X\
M9F]N="!S='EL93TS1"=&3TY4+5-)6D4Z(#$P<'0[($9/3E0M1D%-24Q9.B!T
M:6UE<R!N97<@<F]M86X[($1)4U!,05DZ(&EN;&EN92<^("9N8G-P.SPO9F]N
M=#X@/"]T9#X@/'1D('-T>6QE/3-$)U!!1$1)3D<M0D]45$]-.B`R<'@G('9A
M;&EG;CTS1&)O='1O;2!W:61T:#TS1#$P)2!C;VQS<&%N/3-$,CX\9F]N="!S
M='EL93TS1"=&3TY4+5-)6D4Z(#$P<'0[($9/3E0M1D%-24Q9.B!T:6UE<R!N
M97<@<F]M86X[($1)4U!,05DZ(&EN;&EN92<^("9N8G-P.SPO9F]N=#X@/"]T
M9#X@/'1D('-T>6QE/3-$)U!!1$1)3D<M0D]45$]-.B`R<'@[(%1%6%0M04Q)
M1TXZ(&QE9G0G('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E(&YO=W)A<#TS
M1&YO=W)A<#X\9F]N="!S='EL93TS1"=&3TY4+5-)6D4Z(#$P<'0[($9/3E0M
M1D%-24Q9.B!T:6UE<R!N97<@<F]M86X[($1)4U!,05DZ(&EN;&EN92<^("9N
M8G-P.SPO9F]N=#X@/"]T9#X@/'1D('-T>6QE/3-$)U!!1$1)3D<M0D]45$]-
M.B`R<'@G('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E/CQF;VYT('-T>6QE
M/3-$)T9/3E0M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R
M;VUA;CL@1$E34$Q!63H@:6YL:6YE)SX@)FYB<W`[/"]F;VYT/B`\+W1D/B`\
M=&0@<W1Y;&4],T0G4$%$1$E.1RU"3U143TTZ(#)P>"<@=F%L:6=N/3-$8F]T
M=&]M('=I9'1H/3-$,3`E(&-O;'-P86X],T0R/CQF;VYT('-T>6QE/3-$)T9/
M3E0M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@
M1$E34$Q!63H@:6YL:6YE)SX@)FYB<W`[/"]F;VYT/B`\+W1D/B`\=&0@<W1Y
M;&4],T0G4$%$1$E.1RU"3U143TTZ(#)P>#L@5$585"U!3$E'3CH@;&5F="<@
M=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@;F]W<F%P/3-$;F]W<F%P/CQF
M;VYT('-T>6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ('1I
M;65S(&YE=R!R;VUA;CL@1$E34$Q!63H@:6YL:6YE)SX@)FYB<W`[/"]F;VYT
M/B`\+W1D/B`\+W1R/B`\='(@8F=C;VQO<CTS1'=H:71E/B`\=&0@<W1Y;&4]
M,T0G4$%$1$E.1RU"3U143TTZ(#1P>#L@5$585"U!3$E'3CH@;&5F=#L@34%2
M1TE.+4Q%1E0Z(#!P=#L@34%21TE.+5))1TA4.B`P<'0[(%1%6%0M24Y$14Y4
M.B`P<'0G('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#4R)3X@/&1I=B!S='EL
M93TS1"=$25-03$%9.B!B;&]C:SL@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R
M;VUA;CL@1D].5"U325I%.B`Q,'!T.R!-05)'24XM3$5&5#H@,'!T.R!-05)'
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M)FYB<W`[/"]F;VYT/B`\+W1D/B`\=&0@<W1Y;&4],T0G0D]21$52+4)/5%1/
M33H@8FQA8VL@-'!X(&1O=6)L93L@1$E34$Q!63H@:6YL:6YE.R!&3TY4+49!
M34E,63H@=&EM97,@;F5W(')O;6%N.R!&3TY4+5-)6D4Z(#$P<'0[(%1%6%0M
M04Q)1TXZ(')I9VAT)R!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Y)3XR-3(L
M,#`P/"]T9#X@/'1D('-T>6QE/3-$)U!!1$1)3D<M0D]45$]-.B`T<'@[(%1%
M6%0M04Q)1TXZ(&QE9G0G('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E(&YO
M=W)A<#TS1&YO=W)A<#X\9F]N="!S='EL93TS1"=&3TY4+5-)6D4Z(#$P<'0[
M($9/3E0M1D%-24Q9.B!T:6UE<R!N97<@<F]M86X[($1)4U!,05DZ(&EN;&EN
M92<^("9N8G-P.SPO9F]N=#X@/"]T9#X@/'1D('-T>6QE/3-$)U!!1$1)3D<M
M0D]45$]-.B`T<'@G('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E/CQF;VYT
M('-T>6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ('1I;65S
M(&YE=R!R;VUA;CL@1$E34$Q!63H@:6YL:6YE)SX@)FYB<W`[/"]F;VYT/B`\
M+W1D/B`\=&0@<W1Y;&4],T0G0D]21$52+4)/5%1/33H@8FQA8VL@-'!X(&1O
M=6)L93L@1$E34$Q!63H@:6YL:6YE.R!&3TY4+49!34E,63H@=&EM97,@;F5W
M(')O;6%N.R!&3TY4+5-)6D4Z(#$P<'0[(%1%6%0M04Q)1TXZ(&QE9G0G('9A
M;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E/B0\+W1D/B`\=&0@<W1Y;&4],T0G
M0D]21$52+4)/5%1/33H@8FQA8VL@-'!X(&1O=6)L93L@1$E34$Q!63H@:6YL
M:6YE.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!&3TY4+5-)6D4Z
M(#$P<'0[(%1%6%0M04Q)1TXZ(')I9VAT)R!V86QI9VX],T1B;W1T;VT@=VED
M=&@],T0Y)3XU+C$Y/"]T9#X@/'1D('-T>6QE/3-$)U!!1$1)3D<M0D]45$]-
M.B`T<'@[(%1%6%0M04Q)1TXZ(&QE9G0G('9A;&EG;CTS1&)O='1O;2!W:61T
M:#TS1#$E(&YO=W)A<#TS1&YO=W)A<#X\9F]N="!S='EL93TS1"=&3TY4+5-)
M6D4Z(#$P<'0[($9/3E0M1D%-24Q9.B!T:6UE<R!N97<@<F]M86X[($1)4U!,
M05DZ(&EN;&EN92<^("9N8G-P.SPO9F]N=#X@/"]T9#X@/'1D('-T>6QE/3-$
M)U!!1$1)3D<M0D]45$]-.B`T<'@G('9A;&EG;CTS1&)O='1O;2!W:61T:#TS
M1#$E/CQF;VYT('-T>6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@1D].5"U&04U)
M3%DZ('1I;65S(&YE=R!R;VUA;CL@1$E34$Q!63H@:6YL:6YE)SX@)FYB<W`[
M/"]F;VYT/B`\+W1D/B`\=&0@<W1Y;&4],T0G0D]21$52+4)/5%1/33H@8FQA
M8VL@-'!X(&1O=6)L93L@5$585"U!3$E'3CH@;&5F="<@=F%L:6=N/3-$8F]T
M=&]M('=I9'1H/3-$,24^/&9O;G0@<W1Y;&4],T0G1D].5"U325I%.B`Q,'!T
M.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!$25-03$%9.B!I;FQI
M;F4G/B`F;F)S<#L\+V9O;G0^(#PO=&0^(#QT9"!S='EL93TS1"="3U)$15(M
M0D]45$]-.B!B;&%C:R`T<'@@9&]U8FQE.R!$25-03$%9.B!I;FQI;F4[($9/
M3E0M1D%-24Q9.B!T:6UE<R!N97<@<F]M86X[($9/3E0M4TE:13H@,3!P=#L@
M5$585"U!3$E'3CH@<FEG:'0G('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#DE
M/C,N.38\+W1D/B`\=&0@<W1Y;&4],T0G4$%$1$E.1RU"3U143TTZ(#1P>#L@
M5$585"U!3$E'3CH@;&5F="<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@
M;F]W<F%P/3-$;F]W<F%P/CQF;VYT('-T>6QE/3-$)T9/3E0M4TE:13H@,3!P
M=#L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1$E34$Q!63H@:6YL
M:6YE)SX@)FYB<W`[/"]F;VYT/B`\+W1D/B`\=&0@<W1Y;&4],T0G4$%$1$E.
M1RU"3U143TTZ(#1P>"<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24^/&9O
M;G0@<W1Y;&4],T0G1D].5"U325I%.B`Q,'!T.R!&3TY4+49!34E,63H@=&EM
M97,@;F5W(')O;6%N.R!$25-03$%9.B!I;FQI;F4G/B`F;F)S<#L\+V9O;G0^
M(#PO=&0^(#QT9"!S='EL93TS1"="3U)$15(M0D]45$]-.B!B;&%C:R`T<'@@
M9&]U8FQE.R!$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE<R!N
M97<@<F]M86X[($9/3E0M4TE:13H@,3!P=#L@5$585"U!3$E'3CH@;&5F="<@
M=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24^)#PO=&0^(#QT9"!S='EL93TS
M1"="3U)$15(M0D]45$]-.B!B;&%C:R`T<'@@9&]U8FQE.R!$25-03$%9.B!I
M;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE<R!N97<@<F]M86X[($9/3E0M4TE:
M13H@,3!P=#L@5$585"U!3$E'3CH@<FEG:'0G('9A;&EG;CTS1&)O='1O;2!W
M:61T:#TS1#DE/C,S,3PO=&0^(#QT9"!S='EL93TS1"=0041$24Y'+4)/5%1/
M33H@-'!X.R!415A4+4%,24=..B!L969T)R!V86QI9VX],T1B;W1T;VT@=VED
M=&@],T0Q)2!N;W=R87`],T1N;W=R87`^/&9O;G0@<W1Y;&4],T0G1D].5"U3
M25I%.B`Q,'!T.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!$25-0
M3$%9.B!I;FQI;F4G/B`F;F)S<#L\+V9O;G0^(#PO=&0^(#PO='(^(#QT<B!B
M9V-O;&]R/3-$(V-C965F9CX@/'1D('-T>6QE/3-$)U!!1$1)3D<M0D]45$]-
M.B`T<'@[(%1%6%0M04Q)1TXZ(&QE9G0[($U!4D=)3BU,1494.B`P<'0[($U!
M4D=)3BU224=(5#H@,'!T.R!415A4+4E.1$5.5#H@,'!T)R!V86QI9VX],T1B
M;W1T;VT@=VED=&@],T0U,B4^(#QD:78@<W1Y;&4],T0G1$E34$Q!63H@8FQO
M8VL[($9/3E0M1D%-24Q9.B!T:6UE<R!N97<@<F]M86X[($9/3E0M4TE:13H@
M,3!P=#L@34%21TE.+4Q%1E0Z(#!P=#L@34%21TE.+5))1TA4.B`P<'0[(%1%
M6%0M04Q)1TXZ(&QE9G0[(%1%6%0M24Y$14Y4.B`P<'0G/B!/<'1I;VYS(&%N
M9"!W87)R86YT<R!E>&5R8VES86)L92!A="!T:&4@96YD(&]F('1H92!P97)I
M;V0\+V1I=CX@/"]T9#X@/'1D('-T>6QE/3-$)U!!1$1)3D<M0D]45$]-.B`T
M<'@G('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E/CQF;VYT('-T>6QE/3-$
M)T9/3E0M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA
M;CL@1$E34$Q!63H@:6YL:6YE)SX@)FYB<W`[/"]F;VYT/B`\+W1D/B`\=&0@
M<W1Y;&4],T0G0D]21$52+4)/5%1/33H@8FQA8VL@-'!X(&1O=6)L93L@5$58
M5"U!3$E'3CH@;&5F="<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24^/&9O
M;G0@<W1Y;&4],T0G1D].5"U325I%.B`Q,'!T.R!&3TY4+49!34E,63H@=&EM
M97,@;F5W(')O;6%N.R!$25-03$%9.B!I;FQI;F4G/B`F;F)S<#L\+V9O;G0^
M(#PO=&0^(#QT9"!S='EL93TS1"="3U)$15(M0D]45$]-.B!B;&%C:R`T<'@@
M9&]U8FQE.R!$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE<R!N
M97<@<F]M86X[($9/3E0M4TE:13H@,3!P=#L@5$585"U!3$E'3CH@<FEG:'0G
M('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#DE/C(U,2PP,#`\+W1D/B`\=&0@
M<W1Y;&4],T0G4$%$1$E.1RU"3U143TTZ(#1P>#L@5$585"U!3$E'3CH@;&5F
M="<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@;F]W<F%P/3-$;F]W<F%P
M/CQF;VYT('-T>6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ
M('1I;65S(&YE=R!R;VUA;CL@1$E34$Q!63H@:6YL:6YE)SX@)FYB<W`[/"]F
M;VYT/B`\+W1D/B`\=&0@<W1Y;&4],T0G4$%$1$E.1RU"3U143TTZ(#1P>"<@
M=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24^/&9O;G0@<W1Y;&4],T0G1D].
M5"U325I%.B`Q,'!T.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!$
M25-03$%9.B!I;FQI;F4G/B`F;F)S<#L\+V9O;G0^(#PO=&0^(#QT9"!S='EL
M93TS1"="3U)$15(M0D]45$]-.B!B;&%C:R`T<'@@9&]U8FQE.R!$25-03$%9
M.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE<R!N97<@<F]M86X[($9/3E0M
M4TE:13H@,3!P=#L@5$585"U!3$E'3CH@;&5F="<@=F%L:6=N/3-$8F]T=&]M
M('=I9'1H/3-$,24^)#PO=&0^(#QT9"!S='EL93TS1"="3U)$15(M0D]45$]-
M.B!B;&%C:R`T<'@@9&]U8FQE.R!$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-
M24Q9.B!T:6UE<R!N97<@<F]M86X[($9/3E0M4TE:13H@,3!P=#L@5$585"U!
M3$E'3CH@<FEG:'0G('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#DE/C4N,C$\
M+W1D/B`\=&0@<W1Y;&4],T0G4$%$1$E.1RU"3U143TTZ(#1P>#L@5$585"U!
M3$E'3CH@;&5F="<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@;F]W<F%P
M/3-$;F]W<F%P/CQF;VYT('-T>6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@1D].
M5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1$E34$Q!63H@:6YL:6YE)SX@
M)FYB<W`[/"]F;VYT/B`\+W1D/B`\=&0@<W1Y;&4],T0G4$%$1$E.1RU"3U14
M3TTZ(#1P>"<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24^/&9O;G0@<W1Y
M;&4],T0G1D].5"U325I%.B`Q,'!T.R!&3TY4+49!34E,63H@=&EM97,@;F5W
M(')O;6%N.R!$25-03$%9.B!I;FQI;F4G/B`F;F)S<#L\+V9O;G0^(#PO=&0^
M(#QT9"!S='EL93TS1"="3U)$15(M0D]45$]-.B!B;&%C:R`T<'@@9&]U8FQE
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M;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T.R!415A4+4%,24=..B!R
M:6=H="<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$.24^,RXY,SPO=&0^(#QT
M9"!S='EL93TS1"=0041$24Y'+4)/5%1/33H@-'!X.R!415A4+4%,24=..B!L
M969T)R!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)2!N;W=R87`],T1N;W=R
M87`^/&9O;G0@<W1Y;&4],T0G1D].5"U325I%.B`Q,'!T.R!&3TY4+49!34E,
M63H@=&EM97,@;F5W(')O;6%N.R!$25-03$%9.B!I;FQI;F4G/B`F;F)S<#L\
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M5"U325I%.B`Q,'!T.R!415A4+4%,24=..B!L969T)R!V86QI9VX],T1B;W1T
M;VT@=VED=&@],T0Q)3XD/"]T9#X@/'1D('-T>6QE/3-$)T)/4D1%4BU"3U14
M3TTZ(&)L86-K(#1P>"!D;W5B;&4[($1)4U!,05DZ(&EN;&EN93L@1D].5"U&
M04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T.R!415A4
M+4%,24=..B!R:6=H="<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$.24^,S(X
M/"]T9#X@/'1D('-T>6QE/3-$)U!!1$1)3D<M0D]45$]-.B`T<'@[(%1%6%0M
M04Q)1TXZ(&QE9G0G('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E(&YO=W)A
M<#TS1&YO=W)A<#X\9F]N="!S='EL93TS1"=&3TY4+5-)6D4Z(#$P<'0[($9/
M3E0M1D%-24Q9.B!T:6UE<R!N97<@<F]M86X[($1)4U!,05DZ(&EN;&EN92<^
M("9N8G-P.SPO9F]N=#X@/"]T9#X@/"]T<CX@/'1R(&)G8V]L;W(],T1W:&ET
M93X@/'1D('-T>6QE/3-$)U!!1$1)3D<M0D]45$]-.B`T<'@[(%1%6%0M04Q)
M1TXZ(&QE9G0[($U!4D=)3BU,1494.B`P<'0[($U!4D=)3BU224=(5#H@,'!T
M.R!415A4+4E.1$5.5#H@,'!T)R!V86QI9VX],T1B;W1T;VT@=VED=&@],T0U
M,B4^(#QD:78@<W1Y;&4],T0G1$E34$Q!63H@8FQO8VL[($9/3E0M1D%-24Q9
M.B!T:6UE<R!N97<@<F]M86X[($9/3E0M4TE:13H@,3!P=#L@34%21TE.+4Q%
M1E0Z(#!P=#L@34%21TE.+5))1TA4.B`P<'0[(%1%6%0M04Q)1TXZ(&QE9G0[
M(%1%6%0M24Y$14Y4.B`P<'0G/B!/<'1I;VYS(&%N9"!W87)R86YT<R!V97-T
M960F;F)S<#LF;F)S<#MA;F0@97AP96-T960@=&\@=F5S=#PO9&EV/B`\+W1D
M/B`\=&0@<W1Y;&4],T0G4$%$1$E.1RU"3U143TTZ(#1P>"<@=F%L:6=N/3-$
M8F]T=&]M('=I9'1H/3-$,24^/&9O;G0@<W1Y;&4],T0G1D].5"U325I%.B`Q
M,'!T.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!$25-03$%9.B!I
M;FQI;F4G/B`F;F)S<#L\+V9O;G0^(#PO=&0^(#QT9"!S='EL93TS1"="3U)$
M15(M0D]45$]-.B!B;&%C:R`T<'@@9&]U8FQE.R!415A4+4%,24=..B!L969T
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M5"U325I%.B`Q,'!T.R!415A4+4%,24=..B!R:6=H="<@=F%L:6=N/3-$8F]T
M=&]M('=I9'1H/3-$.24^,C4R+#`P,#PO=&0^(#QT9"!S='EL93TS1"=0041$
M24Y'+4)/5%1/33H@-'!X.R!415A4+4%,24=..B!L969T)R!V86QI9VX],T1B
M;W1T;VT@=VED=&@],T0Q)2!N;W=R87`],T1N;W=R87`^/&9O;G0@<W1Y;&4]
M,T0G1D].5"U325I%.B`Q,'!T.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O
M;6%N.R!$25-03$%9.B!I;FQI;F4G/B`F;F)S<#L\+V9O;G0^(#PO=&0^(#QT
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M5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T.R!4
M15A4+4%,24=..B!L969T)R!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)3XD
M/"]T9#X@/'1D('-T>6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#1P>"!D
M;W5B;&4[($1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE
M=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T.R!415A4+4%,24=..B!R:6=H="<@
M=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$.24^-2XQ.3PO=&0^(#QT9"!S='EL
M93TS1"=0041$24Y'+4)/5%1/33H@-'!X.R!415A4+4%,24=..B!L969T)R!V
M86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)2!N;W=R87`],T1N;W=R87`^/&9O
M;G0@<W1Y;&4],T0G1D].5"U325I%.B`Q,'!T.R!&3TY4+49!34E,63H@=&EM
M97,@;F5W(')O;6%N.R!$25-03$%9.B!I;FQI;F4G/B`F;F)S<#L\+V9O;G0^
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M;VUA;CL@1$E34$Q!63H@:6YL:6YE)SX@)FYB<W`[/"]F;VYT/B`\+W1D/B`\
M=&0@<W1Y;&4],T0G0D]21$52+4)/5%1/33H@8FQA8VL@-'!X(&1O=6)L93L@
M1$E34$Q!63H@:6YL:6YE.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N
M.R!&3TY4+5-)6D4Z(#$P<'0[(%1%6%0M04Q)1TXZ(')I9VAT)R!V86QI9VX]
M,T1B;W1T;VT@=VED=&@],T0Y)3XS+CDV/"]T9#X@/'1D('-T>6QE/3-$)U!!
M1$1)3D<M0D]45$]-.B`T<'@[(%1%6%0M04Q)1TXZ(&QE9G0G('9A;&EG;CTS
M1&)O='1O;2!W:61T:#TS1#$E(&YO=W)A<#TS1&YO=W)A<#X\9F]N="!S='EL
M93TS1"=&3TY4+5-)6D4Z(#$P<'0[($9/3E0M1D%-24Q9.B!T:6UE<R!N97<@
M<F]M86X[($1)4U!,05DZ(&EN;&EN92<^("9N8G-P.SPO9F]N=#X@/"]T9#X@
M/'1D('-T>6QE/3-$)U!!1$1)3D<M0D]45$]-.B`T<'@G('9A;&EG;CTS1&)O
M='1O;2!W:61T:#TS1#$E/CQF;VYT('-T>6QE/3-$)T9/3E0M4TE:13H@,3!P
M=#L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1$E34$Q!63H@:6YL
M:6YE)SX@)FYB<W`[/"]F;VYT/B`\+W1D/B`\=&0@<W1Y;&4],T0G0D]21$52
M+4)/5%1/33H@8FQA8VL@-'!X(&1O=6)L93L@1$E34$Q!63H@:6YL:6YE.R!&
M3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!&3TY4+5-)6D4Z(#$P<'0[
M(%1%6%0M04Q)1TXZ(&QE9G0G('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E
M/B0\+W1D/B`\=&0@<W1Y;&4],T0G0D]21$52+4)/5%1/33H@8FQA8VL@-'!X
M(&1O=6)L93L@1$E34$Q!63H@:6YL:6YE.R!&3TY4+49!34E,63H@=&EM97,@
M;F5W(')O;6%N.R!&3TY4+5-)6D4Z(#$P<'0[(%1%6%0M04Q)1TXZ(')I9VAT
M)R!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Y)3XS,S$\+W1D/B`\=&0@<W1Y
M;&4],T0G4$%$1$E.1RU"3U143TTZ(#1P>#L@5$585"U!3$E'3CH@;&5F="<@
M=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@;F]W<F%P/3-$;F]W<F%P/CQF
M;VYT('-T>6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ('1I
M;65S(&YE=R!R;VUA;CL@1$E34$Q!63H@:6YL:6YE)SX@)FYB<W`[/"]F;VYT
M/B`\+W1D/B`\+W1R/B`\+W1A8FQE/B`\+V1I=CX@/&1I=B!S='EL93TS1"=$
M25-03$%9.B!B;&]C:SL@5$585"U)3D1%3E0Z(#!P="<^/&)R("\^(#PO9&EV
M/B`\9&EV('-T>6QE/3-$)T1)4U!,05DZ(&)L;V-K.R!&3TY4+49!34E,63H@
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M1TE.+5))1TA4.B`P<'0[('1E>'0M86QI9VXZ(&IU<W1I9GD[(%1%6%0M24Y$
M14Y4.B`P<'0G/B`F;F)S<#L\+V1I=CX@/&1I=CX@/'1A8FQE('-T>6QE/3-$
M)T9/3E0M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA
M;B<@8V5L;'-P86-I;F<],T0P(&-E;&QP861D:6YG/3-$,"!W:61T:#TS1#$P
M,"4@86QI9VX],T1C96YT97(@8F]R9&5R/3-$,#X@/'1R('9A;&EG;CTS1'1O
M<#X@/'1D('-T>6QE/3-$)U=)1%1(.B`Q.'!T)SX@/&1I=B!S='EL93TS1"=&
M3TY4+5-)6D4Z(#$P<'0[($9/3E0M1D%-24Q9.B!4:6UE<R!.97<@4F]M86X[
M($1)4U!,05DZ(&EN;&EN92<^("9N8G-P.SPO9&EV/B`\+W1D/B`\=&0@=VED
M=&@],T0Q.#,W/B`\9&EV('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].
M5"U&04U)3%DZ(%1I;65S($YE=R!2;VUA;CL@1D].5"U325I%.B`Q,'!T.R!T
M97AT+6%L:6=N.B!J=7-T:69Y)SX@0V]M<&5N<V%T:6]N(&5X<&5N<V5S(')E
M;&%T960@=&\@;W!T:6]N<R!A;F0@=V%R<F%N=',@9W)A;G1E9"!T;R!C;VYS
M=6QT86YT<R!W97)E(')E8V]R9&5D(&%S(&9O;&QO=W,Z/"]D:78^(#PO=&0^
M(#PO='(^(#PO=&%B;&4^(#PO9&EV/B`\9&EV('-T>6QE/3-$)T1)4U!,05DZ
M(&)L;V-K.R!-05)'24XM3$5&5#H@,'!T.R!-05)'24XM4DE'2%0Z(#!P=#L@
M=&5X="UA;&EG;CH@:G5S=&EF>3L@5$585"U)3D1%3E0Z(#!P="<^("9N8G-P
M.SPO9&EV/B`\9&EV('-T>6QE/3-$)TU!4D=)3BU,1494.B`S-G!T.R!T97AT
M+6%L:6=N.B!L969T)SX@/'1A8FQE('-T>6QE/3-$)T9/3E0M4TE:13H@,3!P
M=#L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;B<@8V5L;'-P86-I;F<]
M,T0P(&-E;&QP861D:6YG/3-$,"!W:61T:#TS1#@P)3X@/'1R/B`\=&0@<W1Y
M;&4],T0G4$%$1$E.1RU"3U143TTZ(#)P>"<@=F%L:6=N/3-$8F]T=&]M('=I
M9'1H/3-$-C0E/CQF;VYT('-T>6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@1D].
M5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1$E34$Q!63H@:6YL:6YE)SX@
M)FYB<W`[/"]F;VYT/B`\+W1D/B`\=&0@<W1Y;&4],T0G4$%$1$E.1RU"3U14
M3TTZ(#)P>"<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24^/&9O;G0@<W1Y
M;&4],T0G1D].5"U325I%.B`Q,'!T.R!&3TY4+49!34E,63H@=&EM97,@;F5W
M(')O;6%N.R!&3TY4+5=%24=(5#H@8F]L9#L@1$E34$Q!63H@:6YL:6YE)SX@
M)FYB<W`[/"]F;VYT/B`\+W1D/B`\=&0@<W1Y;&4],T0G0D]21$52+4)/5%1/
M33H@8FQA8VL@,G!X('-O;&ED)R!V86QI9VX],T1B;W1T;VT@=VED=&@],T0S
M-"4@8V]L<W!A;CTS1#$P/B`\9&EV('-T>6QE/3-$)T1)4U!,05DZ(&)L;V-K
M.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!&3TY4+5-)6D4Z(#$P
M<'0[($9/3E0M5T5)1TA4.B!B;VQD.R!-05)'24XM3$5&5#H@,'!T.R!-05)'
M24XM4DE'2%0Z(#!P=#L@=&5X="UA;&EG;CH@8V5N=&5R.R!415A4+4E.1$5.
M5#H@,'!T)SX@665A<B!E;F1E9"9N8G-P.TIU;F4@,S`L/"]D:78^(#PO=&0^
M(#QT9"!S='EL93TS1"=0041$24Y'+4)/5%1/33H@,G!X.R!415A4+4%,24=.
M.B!L969T)R!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)2!N;W=R87`],T1N
M;W=R87`^/&9O;G0@<W1Y;&4],T0G1D].5"U325I%.B`Q,'!T.R!&3TY4+49!
M34E,63H@=&EM97,@;F5W(')O;6%N.R!&3TY4+5=%24=(5#H@8F]L9#L@1$E3
M4$Q!63H@:6YL:6YE)SX@)FYB<W`[/"]F;VYT/B`\+W1D/B`\+W1R/B`\='(^
M(#QT9"!S='EL93TS1"=0041$24Y'+4)/5%1/33H@,G!X)R!V86QI9VX],T1B
M;W1T;VT@=VED=&@],T0V-"4^/&9O;G0@<W1Y;&4],T0G1D].5"U325I%.B`Q
M,'!T.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!$25-03$%9.B!I
M;FQI;F4G/B`F;F)S<#L\+V9O;G0^(#PO=&0^(#QT9"!S='EL93TS1"=0041$
M24Y'+4)/5%1/33H@,G!X)R!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)3X\
M9F]N="!S='EL93TS1"=&3TY4+5-)6D4Z(#$P<'0[($9/3E0M1D%-24Q9.B!T
M:6UE<R!N97<@<F]M86X[($9/3E0M5T5)1TA4.B!B;VQD.R!$25-03$%9.B!I
M;FQI;F4G/B`F;F)S<#L\+V9O;G0^(#PO=&0^(#QT9"!S='EL93TS1"="3U)$
M15(M0D]45$]-.B!B;&%C:R`R<'@@<V]L:60G('9A;&EG;CTS1&)O='1O;2!W
M:61T:#TS1#$P)2!C;VQS<&%N/3-$,CX@/&1I=B!S='EL93TS1"=$25-03$%9
M.B!B;&]C:SL@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U3
M25I%.B`Q,'!T.R!&3TY4+5=%24=(5#H@8F]L9#L@34%21TE.+4Q%1E0Z(#!P
M=#L@34%21TE.+5))1TA4.B`P<'0[('1E>'0M86QI9VXZ(&-E;G1E<CL@5$58
M5"U)3D1%3E0Z(#!P="<^(#(P,30\+V1I=CX@/"]T9#X@/'1D('-T>6QE/3-$
M)U!!1$1)3D<M0D]45$]-.B`R<'@[(%1%6%0M04Q)1TXZ(&QE9G0G('9A;&EG
M;CTS1&)O='1O;2!W:61T:#TS1#$E(&YO=W)A<#TS1&YO=W)A<#X\9F]N="!S
M='EL93TS1"=&3TY4+5-)6D4Z(#$P<'0[($9/3E0M1D%-24Q9.B!T:6UE<R!N
M97<@<F]M86X[($9/3E0M5T5)1TA4.B!B;VQD.R!$25-03$%9.B!I;FQI;F4G
M/B`F;F)S<#L\+V9O;G0^(#PO=&0^(#QT9"!S='EL93TS1"=0041$24Y'+4)/
M5%1/33H@,G!X)R!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)3X\9F]N="!S
M='EL93TS1"=&3TY4+5-)6D4Z(#$P<'0[($9/3E0M1D%-24Q9.B!T:6UE<R!N
M97<@<F]M86X[($9/3E0M5T5)1TA4.B!B;VQD.R!$25-03$%9.B!I;FQI;F4G
M/B`F;F)S<#L\+V9O;G0^(#PO=&0^(#QT9"!S='EL93TS1"="3U)$15(M0D]4
M5$]-.B!B;&%C:R`R<'@@<V]L:60G('9A;&EG;CTS1&)O='1O;2!W:61T:#TS
M1#$P)2!C;VQS<&%N/3-$,CX@/&1I=B!S='EL93TS1"=$25-03$%9.B!B;&]C
M:SL@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q
M,'!T.R!&3TY4+5=%24=(5#H@8F]L9#L@34%21TE.+4Q%1E0Z(#!P=#L@34%2
M1TE.+5))1TA4.B`P<'0[('1E>'0M86QI9VXZ(&-E;G1E<CL@5$585"U)3D1%
M3E0Z(#!P="<^(#(P,3,\+V1I=CX@/"]T9#X@/'1D('-T>6QE/3-$)U!!1$1)
M3D<M0D]45$]-.B`R<'@[(%1%6%0M04Q)1TXZ(&QE9G0G('9A;&EG;CTS1&)O
M='1O;2!W:61T:#TS1#$E(&YO=W)A<#TS1&YO=W)A<#X\9F]N="!S='EL93TS
M1"=&3TY4+5-)6D4Z(#$P<'0[($9/3E0M1D%-24Q9.B!T:6UE<R!N97<@<F]M
M86X[($9/3E0M5T5)1TA4.B!B;VQD.R!$25-03$%9.B!I;FQI;F4G/B`F;F)S
M<#L\+V9O;G0^(#PO=&0^(#QT9"!S='EL93TS1"=0041$24Y'+4)/5%1/33H@
M,G!X)R!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)3X\9F]N="!S='EL93TS
M1"=&3TY4+5-)6D4Z(#$P<'0[($9/3E0M1D%-24Q9.B!T:6UE<R!N97<@<F]M
M86X[($9/3E0M5T5)1TA4.B!B;VQD.R!$25-03$%9.B!I;FQI;F4G/B`F;F)S
M<#L\+V9O;G0^(#PO=&0^(#QT9"!S='EL93TS1"="3U)$15(M0D]45$]-.B!B
M;&%C:R`R<'@@<V]L:60G('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$P)2!C
M;VQS<&%N/3-$,CX@/&1I=B!S='EL93TS1"=$25-03$%9.B!B;&]C:SL@1D].
M5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T.R!&
M3TY4+5=%24=(5#H@8F]L9#L@34%21TE.+4Q%1E0Z(#!P=#L@34%21TE.+5))
M1TA4.B`P<'0[('1E>'0M86QI9VXZ(&-E;G1E<CL@5$585"U)3D1%3E0Z(#!P
M="<^(#(P,3(\+V1I=CX@/"]T9#X@/'1D('-T>6QE/3-$)U!!1$1)3D<M0D]4
M5$]-.B`R<'@[(%1%6%0M04Q)1TXZ(&QE9G0G('9A;&EG;CTS1&)O='1O;2!W
M:61T:#TS1#$E(&YO=W)A<#TS1&YO=W)A<#X\9F]N="!S='EL93TS1"=&3TY4
M+5-)6D4Z(#$P<'0[($9/3E0M1D%-24Q9.B!T:6UE<R!N97<@<F]M86X[($9/
M3E0M5T5)1TA4.B!B;VQD.R!$25-03$%9.B!I;FQI;F4G/B`F;F)S<#L\+V9O
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M:6YE)SX@)FYB<W`[/"]F;VYT/B`\+W1D/B`\=&0@=F%L:6=N/3-$8F]T=&]M
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M3%DZ('1I;65S(&YE=R!R;VUA;CL@1$E34$Q!63H@:6YL:6YE)SX@)FYB<W`[
M/"]F;VYT/B`\+W1D/B`\=&0@<W1Y;&4],T0G5$585"U!3$E'3CH@<FEG:'0G
M('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#DE/CQF;VYT('-T>6QE/3-$)T9/
M3E0M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@
M1$E34$Q!63H@:6YL:6YE)SX@)FYB<W`[/"]F;VYT/B`\+W1D/B`\=&0@<W1Y
M;&4],T0G5$585"U!3$E'3CH@;&5F="<@=F%L:6=N/3-$8F]T=&]M('=I9'1H
M/3-$,24@;F]W<F%P/3-$;F]W<F%P/CQF;VYT('-T>6QE/3-$)T9/3E0M4TE:
M13H@,3!P=#L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1$E34$Q!
M63H@:6YL:6YE)SX@)FYB<W`[/"]F;VYT/B`\+W1D/B`\=&0@=F%L:6=N/3-$
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M)FYB<W`[/"]F;VYT/B`\+W1D/B`\=&0@<W1Y;&4],T0G5$585"U!3$E'3CH@
M<FEG:'0G('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#DE/CQF;VYT('-T>6QE
M/3-$)T9/3E0M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R
M;VUA;CL@1$E34$Q!63H@:6YL:6YE)SX@)FYB<W`[/"]F;VYT/B`\+W1D/B`\
M=&0@<W1Y;&4],T0G5$585"U!3$E'3CH@;&5F="<@=F%L:6=N/3-$8F]T=&]M
M('=I9'1H/3-$,24@;F]W<F%P/3-$;F]W<F%P/CQF;VYT('-T>6QE/3-$)T9/
M3E0M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@
M1$E34$Q!63H@:6YL:6YE)SX@)FYB<W`[/"]F;VYT/B`\+W1D/B`\=&0@=F%L
M:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@86QI9VX],T1R:6=H=#X\9F]N="!S
M='EL93TS1"=&3TY4+5-)6D4Z(#$P<'0[($9/3E0M1D%-24Q9.B!T:6UE<R!N
M97<@<F]M86X[($1)4U!,05DZ(&EN;&EN92<^("9N8G-P.SPO9F]N=#X@/"]T
M9#X@/'1D('-T>6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G('9A;&EG;CTS1&)O
M='1O;2!W:61T:#TS1#$E/CQF;VYT('-T>6QE/3-$)T9/3E0M4TE:13H@,3!P
M=#L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1$E34$Q!63H@:6YL
M:6YE)SX@)FYB<W`[/"]F;VYT/B`\+W1D/B`\=&0@<W1Y;&4],T0G5$585"U!
M3$E'3CH@<FEG:'0G('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#DE/CQF;VYT
M('-T>6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ('1I;65S
M(&YE=R!R;VUA;CL@1$E34$Q!63H@:6YL:6YE)SX@)FYB<W`[/"]F;VYT/B`\
M+W1D/B`\=&0@<W1Y;&4],T0G5$585"U!3$E'3CH@;&5F="<@=F%L:6=N/3-$
M8F]T=&]M('=I9'1H/3-$,24@;F]W<F%P/3-$;F]W<F%P/CQF;VYT('-T>6QE
M/3-$)T9/3E0M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R
M;VUA;CL@1$E34$Q!63H@:6YL:6YE)SX@)FYB<W`[/"]F;VYT/B`\+W1D/B`\
M+W1R/B`\='(@8F=C;VQO<CTS1"-C8V5E9F8^(#QT9"!S='EL93TS1"=415A4
M+4%,24=..B!L969T.R!-05)'24XM3$5&5#H@,'!T.R!-05)'24XM4DE'2%0Z
M(#!P=#L@5$585"U)3D1%3E0Z(#!P="<@=F%L:6=N/3-$8F]T=&]M('=I9'1H
M/3-$-C0E/B`\9&EV('-T>6QE/3-$)T1)4U!,05DZ(&)L;V-K.R!&3TY4+49!
M34E,63H@=&EM97,@;F5W(')O;6%N.R!&3TY4+5-)6D4Z(#$P<'0[($U!4D=)
M3BU,1494.B`P<'0[($U!4D=)3BU224=(5#H@,'!T.R!415A4+4%,24=..B!L
M969T.R!415A4+4E.1$5.5#H@,'!T)SX@4F5S96%R8V@@86YD(&1E=F5L;W!M
M96YT(&5X<&5N<V5S/"]D:78^(#PO=&0^(#QT9"!V86QI9VX],T1B;W1T;VT@
M=VED=&@],T0Q)2!A;&EG;CTS1')I9VAT/CQF;VYT('-T>6QE/3-$)T9/3E0M
M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1$E3
M4$Q!63H@:6YL:6YE)SX@)FYB<W`[/"]F;VYT/B`\+W1D/B`\=&0@<W1Y;&4]
M,T0G1$E34$Q!63H@:6YL:6YE.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O
M;6%N.R!&3TY4+5-)6D4Z(#$P<'0[(%1%6%0M04Q)1TXZ(&QE9G0G('9A;&EG
M;CTS1&)O='1O;2!W:61T:#TS1#$E/B0\+W1D/B`\=&0@<W1Y;&4],T0G1$E3
M4$Q!63H@:6YL:6YE.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!&
M3TY4+5-)6D4Z(#$P<'0[(%1%6%0M04Q)1TXZ(')I9VAT)R!V86QI9VX],T1B
M;W1T;VT@=VED=&@],T0Y)3XQ,3PO=&0^(#QT9"!S='EL93TS1"=415A4+4%,
M24=..B!L969T)R!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)2!N;W=R87`]
M,T1N;W=R87`^/&9O;G0@<W1Y;&4],T0G1D].5"U325I%.B`Q,'!T.R!&3TY4
M+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!$25-03$%9.B!I;FQI;F4G/B`F
M;F)S<#L\+V9O;G0^(#PO=&0^(#QT9"!V86QI9VX],T1B;W1T;VT@=VED=&@]
M,T0Q)2!A;&EG;CTS1')I9VAT/CQF;VYT('-T>6QE/3-$)T9/3E0M4TE:13H@
M,3!P=#L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1$E34$Q!63H@
M:6YL:6YE)SX@)FYB<W`[/"]F;VYT/B`\+W1D/B`\=&0@<W1Y;&4],T0G1$E3
M4$Q!63H@:6YL:6YE.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!&
M3TY4+5-)6D4Z(#$P<'0[(%1%6%0M04Q)1TXZ(&QE9G0G('9A;&EG;CTS1&)O
M='1O;2!W:61T:#TS1#$E/B0\+W1D/B`\=&0@<W1Y;&4],T0G1$E34$Q!63H@
M:6YL:6YE.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!&3TY4+5-)
M6D4Z(#$P<'0[(%1%6%0M04Q)1TXZ(')I9VAT)R!V86QI9VX],T1B;W1T;VT@
M=VED=&@],T0Y)3XR-CPO=&0^(#QT9"!S='EL93TS1"=415A4+4%,24=..B!L
M969T)R!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)2!N;W=R87`],T1N;W=R
M87`^/&9O;G0@<W1Y;&4],T0G1D].5"U325I%.B`Q,'!T.R!&3TY4+49!34E,
M63H@=&EM97,@;F5W(')O;6%N.R!$25-03$%9.B!I;FQI;F4G/B`F;F)S<#L\
M+V9O;G0^(#PO=&0^(#QT9"!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)2!A
M;&EG;CTS1')I9VAT/CQF;VYT('-T>6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@
M1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1$E34$Q!63H@:6YL:6YE
M)SX@)FYB<W`[/"]F;VYT/B`\+W1D/B`\=&0@<W1Y;&4],T0G1$E34$Q!63H@
M:6YL:6YE.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!&3TY4+5-)
M6D4Z(#$P<'0[(%1%6%0M04Q)1TXZ(&QE9G0G('9A;&EG;CTS1&)O='1O;2!W
M:61T:#TS1#$E/B0\+W1D/B`\=&0@<W1Y;&4],T0G1$E34$Q!63H@:6YL:6YE
M.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!&3TY4+5-)6D4Z(#$P
M<'0[(%1%6%0M04Q)1TXZ(')I9VAT)R!V86QI9VX],T1B;W1T;VT@=VED=&@]
M,T0Y)3XQ.3PO=&0^(#QT9"!S='EL93TS1"=415A4+4%,24=..B!L969T)R!V
M86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)2!N;W=R87`],T1N;W=R87`^/&9O
M;G0@<W1Y;&4],T0G1D].5"U325I%.B`Q,'!T.R!&3TY4+49!34E,63H@=&EM
M97,@;F5W(')O;6%N.R!$25-03$%9.B!I;FQI;F4G/B`F;F)S<#L\+V9O;G0^
M(#PO=&0^(#PO='(^(#QT<B!B9V-O;&]R/3-$=VAI=&4^(#QT9"!S='EL93TS
M1"=0041$24Y'+4)/5%1/33H@,G!X.R!415A4+4%,24=..B!L969T.R!-05)'
M24XM3$5&5#H@,'!T.R!-05)'24XM4DE'2%0Z(#!P=#L@5$585"U)3D1%3E0Z
M(#!P="<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$-C0E/B`\9&EV('-T>6QE
M/3-$)T1)4U!,05DZ(&)L;V-K.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O
M;6%N.R!&3TY4+5-)6D4Z(#$P<'0[($U!4D=)3BU,1494.B`P<'0[($U!4D=)
M3BU224=(5#H@,'!T.R!415A4+4%,24=..B!L969T.R!415A4+4E.1$5.5#H@
M,'!T)SX@1V5N97)A;"!A;F0@861M:6YI<W1R871I=F4@97AP96YS97,\+V1I
M=CX@/"]T9#X@/'1D('-T>6QE/3-$)U!!1$1)3D<M0D]45$]-.B`R<'@G('9A
M;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E/CQF;VYT('-T>6QE/3-$)T9/3E0M
M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1$E3
M4$Q!63H@:6YL:6YE)SX@)FYB<W`[/"]F;VYT/B`\+W1D/B`\=&0@<W1Y;&4]
M,T0G0D]21$52+4)/5%1/33H@8FQA8VL@,G!X('-O;&ED.R!415A4+4%,24=.
M.B!L969T)R!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)3X\9F]N="!S='EL
M93TS1"=&3TY4+5-)6D4Z(#$P<'0[($9/3E0M1D%-24Q9.B!T:6UE<R!N97<@
M<F]M86X[($1)4U!,05DZ(&EN;&EN92<^("9N8G-P.SPO9F]N=#X@/"]T9#X@
M/'1D('-T>6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#)P>"!S;VQI9#L@
M5$585"U!3$E'3CH@<FEG:'0G('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#DE
M/CQF;VYT('-T>6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ
M('1I;65S(&YE=R!R;VUA;CL@1$E34$Q!63H@:6YL:6YE)SX@)FYB<W`[/"]F
M;VYT/B`\+W1D/B`\=&0@<W1Y;&4],T0G4$%$1$E.1RU"3U143TTZ(#)P>#L@
M5$585"U!3$E'3CH@;&5F="<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@
M;F]W<F%P/3-$;F]W<F%P/CQF;VYT('-T>6QE/3-$)T9/3E0M4TE:13H@,3!P
M=#L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1$E34$Q!63H@:6YL
M:6YE)SX@)FYB<W`[/"]F;VYT/B`\+W1D/B`\=&0@<W1Y;&4],T0G4$%$1$E.
M1RU"3U143TTZ(#)P>"<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@86QI
M9VX],T1R:6=H=#X\9F]N="!S='EL93TS1"=&3TY4+5-)6D4Z(#$P<'0[($9/
M3E0M1D%-24Q9.B!T:6UE<R!N97<@<F]M86X[($1)4U!,05DZ(&EN;&EN92<^
M("9N8G-P.SPO9F]N=#X@/"]T9#X@/'1D('-T>6QE/3-$)T)/4D1%4BU"3U14
M3TTZ(&)L86-K(#)P>"!S;VQI9#L@5$585"U!3$E'3CH@;&5F="<@=F%L:6=N
M/3-$8F]T=&]M('=I9'1H/3-$,24^/&9O;G0@<W1Y;&4],T0G1D].5"U325I%
M.B`Q,'!T.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!$25-03$%9
M.B!I;FQI;F4G/B`F;F)S<#L\+V9O;G0^(#PO=&0^(#QT9"!S='EL93TS1"="
M3U)$15(M0D]45$]-.B!B;&%C:R`R<'@@<V]L:60[($1)4U!,05DZ(&EN;&EN
M93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q
M,'!T.R!415A4+4%,24=..B!R:6=H="<@=F%L:6=N/3-$8F]T=&]M('=I9'1H
M/3-$.24^+3PO=&0^(#QT9"!S='EL93TS1"=0041$24Y'+4)/5%1/33H@,G!X
M.R!415A4+4%,24=..B!L969T)R!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q
M)2!N;W=R87`],T1N;W=R87`^/&9O;G0@<W1Y;&4],T0G1D].5"U325I%.B`Q
M,'!T.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!$25-03$%9.B!I
M;FQI;F4G/B`F;F)S<#L\+V9O;G0^(#PO=&0^(#QT9"!S='EL93TS1"=0041$
M24Y'+4)/5%1/33H@,G!X)R!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)2!A
M;&EG;CTS1')I9VAT/CQF;VYT('-T>6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@
M1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1$E34$Q!63H@:6YL:6YE
M)SX@)FYB<W`[/"]F;VYT/B`\+W1D/B`\=&0@<W1Y;&4],T0G0D]21$52+4)/
M5%1/33H@8FQA8VL@,G!X('-O;&ED.R!415A4+4%,24=..B!L969T)R!V86QI
M9VX],T1B;W1T;VT@=VED=&@],T0Q)3X\9F]N="!S='EL93TS1"=&3TY4+5-)
M6D4Z(#$P<'0[($9/3E0M1D%-24Q9.B!T:6UE<R!N97<@<F]M86X[($1)4U!,
M05DZ(&EN;&EN92<^("9N8G-P.SPO9F]N=#X@/"]T9#X@/'1D('-T>6QE/3-$
M)T)/4D1%4BU"3U143TTZ(&)L86-K(#)P>"!S;VQI9#L@1$E34$Q!63H@:6YL
M:6YE.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!&3TY4+5-)6D4Z
M(#$P<'0[(%1%6%0M04Q)1TXZ(')I9VAT)R!V86QI9VX],T1B;W1T;VT@=VED
M=&@],T0Y)3XS-SPO=&0^(#QT9"!S='EL93TS1"=0041$24Y'+4)/5%1/33H@
M,G!X.R!415A4+4%,24=..B!L969T)R!V86QI9VX],T1B;W1T;VT@=VED=&@]
M,T0Q)2!N;W=R87`],T1N;W=R87`^/&9O;G0@<W1Y;&4],T0G1D].5"U325I%
M.B`Q,'!T.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!$25-03$%9
M.B!I;FQI;F4G/B`F;F)S<#L\+V9O;G0^(#PO=&0^(#PO='(^(#QT<B!B9V-O
M;&]R/3-$(V-C965F9CX@/'1D('-T>6QE/3-$)U!!1$1)3D<M0D]45$]-.B`T
M<'@G('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#8T)3X\9F]N="!S='EL93TS
M1"=&3TY4+5-)6D4Z(#$P<'0[($9/3E0M1D%-24Q9.B!T:6UE<R!N97<@<F]M
M86X[($1)4U!,05DZ(&EN;&EN92<^("9N8G-P.SPO9F]N=#X@/"]T9#X@/'1D
M('-T>6QE/3-$)U!!1$1)3D<M0D]45$]-.B`T<'@G('9A;&EG;CTS1&)O='1O
M;2!W:61T:#TS1#$E(&%L:6=N/3-$<FEG:'0^/&9O;G0@<W1Y;&4],T0G1D].
M5"U325I%.B`Q,'!T.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!$
M25-03$%9.B!I;FQI;F4G/B`F;F)S<#L\+V9O;G0^(#PO=&0^(#QT9"!S='EL
M93TS1"="3U)$15(M0D]45$]-.B!B;&%C:R`T<'@@9&]U8FQE.R!$25-03$%9
M.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE<R!N97<@<F]M86X[($9/3E0M
M4TE:13H@,3!P=#L@5$585"U!3$E'3CH@;&5F="<@=F%L:6=N/3-$8F]T=&]M
M('=I9'1H/3-$,24^)#PO=&0^(#QT9"!S='EL93TS1"="3U)$15(M0D]45$]-
M.B!B;&%C:R`T<'@@9&]U8FQE.R!$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-
M24Q9.B!T:6UE<R!N97<@<F]M86X[($9/3E0M4TE:13H@,3!P=#L@5$585"U!
M3$E'3CH@<FEG:'0G('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#DE/C$Q/"]T
M9#X@/'1D('-T>6QE/3-$)U!!1$1)3D<M0D]45$]-.B`T<'@[(%1%6%0M04Q)
M1TXZ(&QE9G0G('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E(&YO=W)A<#TS
M1&YO=W)A<#X\9F]N="!S='EL93TS1"=&3TY4+5-)6D4Z(#$P<'0[($9/3E0M
M1D%-24Q9.B!T:6UE<R!N97<@<F]M86X[($1)4U!,05DZ(&EN;&EN92<^("9N
M8G-P.SPO9F]N=#X@/"]T9#X@/'1D('-T>6QE/3-$)U!!1$1)3D<M0D]45$]-
M.B`T<'@G('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E(&%L:6=N/3-$<FEG
M:'0^/&9O;G0@<W1Y;&4],T0G1D].5"U325I%.B`Q,'!T.R!&3TY4+49!34E,
M63H@=&EM97,@;F5W(')O;6%N.R!$25-03$%9.B!I;FQI;F4G/B`F;F)S<#L\
M+V9O;G0^(#PO=&0^(#QT9"!S='EL93TS1"="3U)$15(M0D]45$]-.B!B;&%C
M:R`T<'@@9&]U8FQE.R!$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T
M:6UE<R!N97<@<F]M86X[($9/3E0M4TE:13H@,3!P=#L@5$585"U!3$E'3CH@
M;&5F="<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24^)#PO=&0^(#QT9"!S
M='EL93TS1"="3U)$15(M0D]45$]-.B!B;&%C:R`T<'@@9&]U8FQE.R!$25-0
M3$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE<R!N97<@<F]M86X[($9/
M3E0M4TE:13H@,3!P=#L@5$585"U!3$E'3CH@<FEG:'0G('9A;&EG;CTS1&)O
M='1O;2!W:61T:#TS1#DE/C(V/"]T9#X@/'1D('-T>6QE/3-$)U!!1$1)3D<M
M0D]45$]-.B`T<'@[(%1%6%0M04Q)1TXZ(&QE9G0G('9A;&EG;CTS1&)O='1O
M;2!W:61T:#TS1#$E(&YO=W)A<#TS1&YO=W)A<#X\9F]N="!S='EL93TS1"=&
M3TY4+5-)6D4Z(#$P<'0[($9/3E0M1D%-24Q9.B!T:6UE<R!N97<@<F]M86X[
M($1)4U!,05DZ(&EN;&EN92<^("9N8G-P.SPO9F]N=#X@/"]T9#X@/'1D('-T
M>6QE/3-$)U!!1$1)3D<M0D]45$]-.B`T<'@G('9A;&EG;CTS1&)O='1O;2!W
M:61T:#TS1#$E(&%L:6=N/3-$<FEG:'0^/&9O;G0@<W1Y;&4],T0G1D].5"U3
M25I%.B`Q,'!T.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!$25-0
M3$%9.B!I;FQI;F4G/B`F;F)S<#L\+V9O;G0^(#PO=&0^(#QT9"!S='EL93TS
M1"="3U)$15(M0D]45$]-.B!B;&%C:R`T<'@@9&]U8FQE.R!$25-03$%9.B!I
M;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE<R!N97<@<F]M86X[($9/3E0M4TE:
M13H@,3!P=#L@5$585"U!3$E'3CH@;&5F="<@=F%L:6=N/3-$8F]T=&]M('=I
M9'1H/3-$,24^)#PO=&0^(#QT9"!S='EL93TS1"="3U)$15(M0D]45$]-.B!B
M;&%C:R`T<'@@9&]U8FQE.R!$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9
M.B!T:6UE<R!N97<@<F]M86X[($9/3E0M4TE:13H@,3!P=#L@5$585"U!3$E'
M3CH@<FEG:'0G('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#DE/C4V/"]T9#X@
M/'1D('-T>6QE/3-$)U!!1$1)3D<M0D]45$]-.B`T<'@[(%1%6%0M04Q)1TXZ
M(&QE9G0G('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E(&YO=W)A<#TS1&YO
M=W)A<#X\9F]N="!S='EL93TS1"=&3TY4+5-)6D4Z(#$P<'0[($9/3E0M1D%-
M24Q9.B!T:6UE<R!N97<@<F]M86X[($1)4U!,05DZ(&EN;&EN92<^("9N8G-P
M.SPO9F]N=#X@/"]T9#X@/"]T<CX@/"]T86)L93X@/"]D:78^(#QD:78@<W1Y
M;&4],T0G1$E34$Q!63H@8FQO8VL[(%1%6%0M24Y$14Y4.B`P<'0G/B9N8G-P
M.SPO9&EV/B`\9&EV('-T>6QE/3-$)T1)4U!,05DZ(&)L;V-K.R!&3TY4+49!
M34E,63H@5&EM97,@3F5W(%)O;6%N.R!&3TY4+5-)6D4Z(#$P<'0[($U!4D=)
M3BU,1494.B`Q.'!T.R!-05)'24XM4DE'2%0Z(#!P=#L@=&5X="UA;&EG;CH@
M:G5S=&EF>3L@5$585"U)3D1%3E0Z(#!P="<^($9U='5R92!E>'!E;G-E<R!R
M96QA=&5D('1O(&]P=&EO;G,@86YD('=A<G)A;G1S(&=R86YT960@=&\@8V]N
M<W5L=&%N=',@9F]R(&%N(&%V97)A9V4@=&EM92!O9B!A<'!R;WAI;6%T96QY
M(#,@;6]N=&AS(&%R92`\9F]N="!S='EL93TS1"=&3TY4+5-)6D4Z(#$P<'0[
M($1)4U!,05DZ(&EN;&EN92<^)#PO9F]N=#XQ+CPO9&EV/B`\9&EV('-T>6QE
M/3-$)T1)4U!,05DZ(&)L;V-K.R!-05)'24XM3$5&5#H@,'!T.R!-05)'24XM
M4DE'2%0Z(#!P=#L@=&5X="UA;&EG;CH@:G5S=&EF>3L@5$585"U)3D1%3E0Z
M(#!P="<^("9N8G-P.SPO9&EV/B`\9&EV('-T>6QE/3-$)U1%6%0M04Q)1TXZ
M(&QE9G0[($U!4D=)3BU,1494.B`P<'0[($1)4U!,05DZ(&)L;V-K.R!-05)'
M24XM4DE'2%0Z(#!P=#L@5$585"U)3D1%3E0Z(#!P="<^(#QT86)L92!S='EL
M93TS1"=&3TY4+5-)6D4Z(#$P<'0[($9/3E0M1D%-24Q9.B!T:6UE<R!N97<@
M<F]M86XG(&-E;&QS<&%C:6YG/3-$,"!C96QL<&%D9&EN9STS1#`@=VED=&@]
M,T0Q,#`E(&)O<F1E<CTS1#`^(#QT<B!V86QI9VX],T1T;W`^(#QT9"!S='EL
M93TS1"=724142#H@,3AP="<@86QI9VX],T1R:6=H=#X@/&1I=B!S='EL93TS
M1"=$25-03$%9.B!B;&]C:SL@1D].5"U&04U)3%DZ(%1I;65S($YE=R!2;VUA
M;CL@1D].5"U325I%.B`Q,'!T.R!-05)'24XM3$5&5#H@,'!T.R!-05)'24XM
M4DE'2%0Z(#!P=#L@5$585"U!3$E'3CH@;&5F=#L@5$585"U)3D1%3E0Z(#!P
M="<^(&,N/"]D:78^(#PO=&0^(#QT9"!A;&EG;CTS1&QE9G0^(#QD:78@<W1Y
M;&4],T0G1$E34$Q!63H@8FQO8VL[($9/3E0M1D%-24Q9.B!4:6UE<R!.97<@
M4F]M86X[($9/3E0M4TE:13H@,3!P=#L@34%21TE.+4Q%1E0Z(#!P=#L@34%2
M1TE.+5))1TA4.B`P<'0[(%1%6%0M04Q)1TXZ(&QE9G0[(%1%6%0M24Y$14Y4
M.B`P<'0G/B!297-T<FEC=&5D('-T;V-K('5N:71S('1O(&5M<&QO>65E<R!A
M;F0@9&ER96-T;W)S.CPO9&EV/B`\+W1D/B`\+W1R/B`\+W1A8FQE/B`\+V1I
M=CX@/&1I=B!S='EL93TS1"=$25-03$%9.B!B;&]C:SL@34%21TE.+4Q%1E0Z
M(#!P=#L@34%21TE.+5))1TA4.B`P<'0[('1E>'0M86QI9VXZ(&IU<W1I9GD[
M(%1%6%0M24Y$14Y4.B`P<'0G/B`F;F)S<#L\+V1I=CX@/&1I=B!S='EL93TS
M1"=$25-03$%9.B!B;&]C:SL@1D].5"U&04U)3%DZ(%1I;65S($YE=R!2;VUA
M;CL@1D].5"U325I%.B`Q,'!T.R!-05)'24XM3$5&5#H@,3AP=#L@34%21TE.
M+5))1TA4.B`P<'0[('1E>'0M86QI9VXZ(&IU<W1I9GD[(%1%6%0M24Y$14Y4
M.B`P<'0G/B!4:&4@9F]L;&]W:6YG('1A8FQE('-U;6UA<FEZ97,@=&AE(&%C
M=&EV:71I97,@9F]R('5N=F5S=&5D(')E<W1R:6-T960@<W1O8VL@=6YI=',@
M9W)A;G1E9"!T;R!E;7!L;WEE97,@86YD(&1I<F5C=&]R<R!F;W(@=&AE('EE
M87(@96YD960@2G5N92`S,"P@,C`Q-#H\+V1I=CX@/&1I=B!S='EL93TS1"=$
M25-03$%9.B!B;&]C:SL@34%21TE.+4Q%1E0Z(#!P=#L@34%21TE.+5))1TA4
M.B`P<'0[('1E>'0M86QI9VXZ(&IU<W1I9GD[(%1%6%0M24Y$14Y4.B`P<'0G
M/B`F;F)S<#L\+V1I=CX@/&1I=B!S='EL93TS1"=T97AT+6%L:6=N.B!C96YT
M97(G/B`\=&%B;&4@<W1Y;&4],T0G1D].5"U325I%.B`Q,'!T.R!&3TY4+49!
M34E,63H@=&EM97,@;F5W(')O;6%N)R!C96QL<W!A8VEN9STS1#`@8V5L;'!A
M9&1I;F<],T0P('=I9'1H/3-$-C`E/B`\='(^(#QT9"!S='EL93TS1"=0041$
M24Y'+4)/5%1/33H@,G!X)R!V86QI9VX],T1B;W1T;VT@=VED=&@],T0X."4^
M/&9O;G0@<W1Y;&4],T0G1D].5"U325I%.B`Q,'!T.R!&3TY4+49!34E,63H@
M=&EM97,@;F5W(')O;6%N.R!$25-03$%9.B!I;FQI;F4G/B`F;F)S<#L\+V9O
M;G0^(#PO=&0^(#QT9"!S='EL93TS1"=0041$24Y'+4)/5%1/33H@,G!X)R!V
M86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)3X\9F]N="!S='EL93TS1"=&3TY4
M+5-)6D4Z(#$P<'0[($9/3E0M1D%-24Q9.B!T:6UE<R!N97<@<F]M86X[($9/
M3E0M5T5)1TA4.B!B;VQD.R!$25-03$%9.B!I;FQI;F4G/B`F;F)S<#L\+V9O
M;G0^(#PO=&0^(#QT9"!S='EL93TS1"="3U)$15(M0D]45$]-.B!B;&%C:R`R
M<'@@<V]L:60G('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$P)2!C;VQS<&%N
M/3-$,CX@/&1I=B!S='EL93TS1"=$25-03$%9.B!B;&]C:SL@1D].5"U&04U)
M3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T.R!&3TY4+5=%
M24=(5#H@8F]L9#L@34%21TE.+4Q%1E0Z(#!P=#L@34%21TE.+5))1TA4.B`P
M<'0[('1E>'0M86QI9VXZ(&-E;G1E<CL@5$585"U)3D1%3E0Z(#!P="<^($YU
M;6)E<CPO9&EV/B`\+W1D/B`\=&0@<W1Y;&4],T0G4$%$1$E.1RU"3U143TTZ
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M)U1%6%0M04Q)1TXZ(&QE9G0[($U!4D=)3BU,1494.B`P<'0[($U!4D=)3BU2
M24=(5#H@,'!T.R!415A4+4E.1$5.5#H@,'!T)R!V86QI9VX],T1B;W1T;VT@
M=VED=&@],T0X."4^/&9O;G0@<W1Y;&4],T0G1D].5"U325I%.B`Q,'!T.R!&
M3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!$25-03$%9.B!I;FQI;F4G
M/B`F;F)S<#L\+V9O;G0^(#PO=&0^(#QT9"!V86QI9VX],T1B;W1T;VT@=VED
M=&@],T0Q)2!A;&EG;CTS1')I9VAT/CQF;VYT('-T>6QE/3-$)T9/3E0M4TE:
M13H@,3!P=#L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1$E34$Q!
M63H@:6YL:6YE)SX@)FYB<W`[/"]F;VYT/B`\+W1D/B`\=&0@<W1Y;&4],T0G
M5$585"U!3$E'3CH@;&5F="<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24^
M/&9O;G0@<W1Y;&4],T0G1D].5"U325I%.B`Q,'!T.R!&3TY4+49!34E,63H@
M=&EM97,@;F5W(')O;6%N.R!$25-03$%9.B!I;FQI;F4G/B`F;F)S<#L\+V9O
M;G0^(#PO=&0^(#QT9"!S='EL93TS1"=415A4+4%,24=..B!R:6=H="<@=F%L
M:6=N/3-$8F]T=&]M('=I9'1H/3-$.24^/&9O;G0@<W1Y;&4],T0G1D].5"U3
M25I%.B`Q,'!T.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!$25-0
M3$%9.B!I;FQI;F4G/B`F;F)S<#L\+V9O;G0^(#PO=&0^(#QT9"!S='EL93TS
M1"=415A4+4%,24=..B!L969T)R!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q
M)2!N;W=R87`],T1N;W=R87`^/&9O;G0@<W1Y;&4],T0G1D].5"U325I%.B`Q
M,'!T.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!$25-03$%9.B!I
M;FQI;F4G/B`F;F)S<#L\+V9O;G0^(#PO=&0^(#PO='(^(#QT<B!B9V-O;&]R
M/3-$(V-C965F9CX@/'1D('-T>6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0[($U!
M4D=)3BU,1494.B`P<'0[($U!4D=)3BU224=(5#H@,'!T.R!415A4+4E.1$5.
M5#H@,'!T)R!V86QI9VX],T1B;W1T;VT@=VED=&@],T0X."4^(#QD:78@<W1Y
M;&4],T0G1$E34$Q!63H@8FQO8VL[($9/3E0M1D%-24Q9.B!T:6UE<R!N97<@
M<F]M86X[($9/3E0M4TE:13H@,3!P=#L@34%21TE.+4Q%1E0Z(#!P=#L@34%2
M1TE.+5))1TA4.B`P<'0[(%1%6%0M04Q)1TXZ(&QE9G0[(%1%6%0M24Y$14Y4
M.B`P<'0G/B!5;G9E<W1E9"!A="!T:&4@8F5G:6YN:6YG(&]F('!E<FEO9#PO
M9&EV/B`\+W1D/B`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@86QI
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M;VUA;CL@1$E34$Q!63H@:6YL:6YE)SX@)FYB<W`[/"]F;VYT/B`\+W1D/B`\
M=&0@<W1Y;&4],T0G1$E34$Q!63H@:6YL:6YE.R!&3TY4+49!34E,63H@=&EM
M97,@;F5W(')O;6%N.R!&3TY4+5-)6D4Z(#$P<'0[(%1%6%0M04Q)1TXZ(')I
M9VAT)R!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Y)3XQ+#8V,"PU,C4\+W1D
M/B`\=&0@<W1Y;&4],T0G5$585"U!3$E'3CH@;&5F="<@=F%L:6=N/3-$8F]T
M=&]M('=I9'1H/3-$,24@;F]W<F%P/3-$;F]W<F%P/CQF;VYT('-T>6QE/3-$
M)T9/3E0M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA
M;CL@1$E34$Q!63H@:6YL:6YE)SX@)FYB<W`[/"]F;VYT/B`\+W1D/B`\+W1R
M/B`\='(@8F=C;VQO<CTS1'=H:71E/B`\=&0@<W1Y;&4],T0G5$585"U!3$E'
M3CH@;&5F=#L@34%21TE.+4Q%1E0Z(#!P=#L@34%21TE.+5))1TA4.B`P<'0[
M(%1%6%0M24Y$14Y4.B`P<'0G('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#@X
M)3X@/&1I=B!S='EL93TS1"=$25-03$%9.B!B;&]C:SL@1D].5"U&04U)3%DZ
M('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T.R!-05)'24XM3$5&
M5#H@,'!T.R!-05)'24XM4DE'2%0Z(#!P=#L@5$585"U!3$E'3CH@;&5F=#L@
M5$585"U)3D1%3E0Z(#!P="<^($=R86YT960\+V1I=CX@/"]T9#X@/'1D('9A
M;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E(&%L:6=N/3-$<FEG:'0^/&9O;G0@
M<W1Y;&4],T0G1D].5"U325I%.B`Q,'!T.R!&3TY4+49!34E,63H@=&EM97,@
M;F5W(')O;6%N.R!$25-03$%9.B!I;FQI;F4G/B`F;F)S<#L\+V9O;G0^(#PO
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M5"U325I%.B`Q,'!T.R!415A4+4%,24=..B!R:6=H="<@=F%L:6=N/3-$8F]T
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M8V-E969F/B`\=&0@<W1Y;&4],T0G5$585"U!3$E'3CH@;&5F=#L@34%21TE.
M+4Q%1E0Z(#!P=#L@34%21TE.+5))1TA4.B`P<'0[(%1%6%0M24Y$14Y4.B`P
M<'0G('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#@X)3X@/&1I=B!S='EL93TS
M1"=$25-03$%9.B!B;&]C:SL@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA
M;CL@1D].5"U325I%.B`Q,'!T.R!-05)'24XM3$5&5#H@,'!T.R!-05)'24XM
M4DE'2%0Z(#!P=#L@5$585"U!3$E'3CH@;&5F=#L@5$585"U)3D1%3E0Z(#!P
M="<^($9O<F9E:71E9#PO9&EV/B`\+W1D/B`\=&0@=F%L:6=N/3-$8F]T=&]M
M('=I9'1H/3-$,24@86QI9VX],T1R:6=H=#X\9F]N="!S='EL93TS1"=&3TY4
M+5-)6D4Z(#$P<'0[($9/3E0M1D%-24Q9.B!T:6UE<R!N97<@<F]M86X[($1)
M4U!,05DZ(&EN;&EN92<^("9N8G-P.SPO9F]N=#X@/"]T9#X@/'1D('-T>6QE
M/3-$)U1%6%0M04Q)1TXZ(&QE9G0G('9A;&EG;CTS1&)O='1O;2!W:61T:#TS
M1#$E/CQF;VYT('-T>6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@1D].5"U&04U)
M3%DZ('1I;65S(&YE=R!R;VUA;CL@1$E34$Q!63H@:6YL:6YE)SX@)FYB<W`[
M/"]F;VYT/B`\+W1D/B`\=&0@<W1Y;&4],T0G1$E34$Q!63H@:6YL:6YE.R!&
M3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!&3TY4+5-)6D4Z(#$P<'0[
M(%1%6%0M04Q)1TXZ(')I9VAT)R!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Y
M)3XH-#0L,3@S/"]T9#X@/'1D('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@
M1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T
M.R!415A4+4%,24=..B!L969T)R!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q
M)2!N;W=R87`],T1N;W=R87`^*3PO=&0^(#PO='(^(#QT<B!B9V-O;&]R/3-$
M=VAI=&4^(#QT9"!S='EL93TS1"=0041$24Y'+4)/5%1/33H@,G!X.R!415A4
M+4%,24=..B!L969T.R!-05)'24XM3$5&5#H@,'!T.R!-05)'24XM4DE'2%0Z
M(#!P=#L@5$585"U)3D1%3E0Z(#!P="<@=F%L:6=N/3-$8F]T=&]M('=I9'1H
M/3-$.#@E/B`\9&EV('-T>6QE/3-$)T1)4U!,05DZ(&)L;V-K.R!&3TY4+49!
M34E,63H@=&EM97,@;F5W(')O;6%N.R!&3TY4+5-)6D4Z(#$P<'0[($U!4D=)
M3BU,1494.B`P<'0[($U!4D=)3BU224=(5#H@,'!T.R!415A4+4%,24=..B!L
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M25I%.B`Q,'!T.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!$25-0
M3$%9.B!I;FQI;F4G/B`F;F)S<#L\+V9O;G0^(#PO=&0^(#QT9"!S='EL93TS
M1"="3U)$15(M0D]45$]-.B!B;&%C:R`R<'@@<V]L:60[($1)4U!,05DZ(&EN
M;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%
M.B`Q,'!T.R!415A4+4%,24=..B!R:6=H="<@=F%L:6=N/3-$8F]T=&]M('=I
M9'1H/3-$.24^*#$L,C@S+#@U,#PO=&0^(#QT9"!S='EL93TS1"=$25-03$%9
M.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE<R!N97<@<F]M86X[($9/3E0M
M4TE:13H@,3!P=#L@4$%$1$E.1RU"3U143TTZ(#)P>#L@5$585"U!3$E'3CH@
M;&5F="<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@;F]W<F%P/3-$;F]W
M<F%P/BD\+W1D/B`\+W1R/B`\='(@8F=C;VQO<CTS1"-C8V5E9F8^(#QT9"!S
M='EL93TS1"=0041$24Y'+4)/5%1/33H@-'!X.R!415A4+4%,24=..B!L969T
M.R!-05)'24XM3$5&5#H@,'!T.R!-05)'24XM4DE'2%0Z(#!P=#L@5$585"U)
M3D1%3E0Z(#!P="<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$.#@E/B`\9&EV
M('-T>6QE/3-$)T1)4U!,05DZ(&)L;V-K.R!&3TY4+49!34E,63H@=&EM97,@
M;F5W(')O;6%N.R!&3TY4+5-)6D4Z(#$P<'0[($U!4D=)3BU,1494.B`P<'0[
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M(&YE=R!R;VUA;CL@1$E34$Q!63H@:6YL:6YE)SX@)FYB<W`[/"]F;VYT/B`\
M+W1D/B`\=&0@<W1Y;&4],T0G0D]21$52+4)/5%1/33H@8FQA8VL@-'!X(&1O
M=6)L93L@1$E34$Q!63H@:6YL:6YE.R!&3TY4+49!34E,63H@=&EM97,@;F5W
M(')O;6%N.R!&3TY4+5-)6D4Z(#$P<'0[(%1%6%0M04Q)1TXZ(')I9VAT)R!V
M86QI9VX],T1B;W1T;VT@=VED=&@],T0Y)3XQ+#4X.2PT,S(\+W1D/B`\=&0@
M<W1Y;&4],T0G4$%$1$E.1RU"3U143TTZ(#1P>#L@5$585"U!3$E'3CH@;&5F
M="<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@;F]W<F%P/3-$;F]W<F%P
M/CQF;VYT('-T>6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ
M('1I;65S(&YE=R!R;VUA;CL@1$E34$Q!63H@:6YL:6YE)SX@)FYB<W`[/"]F
M;VYT/B`\+W1D/B`\+W1R/B`\='(@8F=C;VQO<CTS1'=H:71E/B`\=&0@<W1Y
M;&4],T0G4$%$1$E.1RU"3U143TTZ(#1P>#L@5$585"U!3$E'3CH@;&5F=#L@
M34%21TE.+4Q%1E0Z(#!P=#L@34%21TE.+5))1TA4.B`P<'0[(%1%6%0M24Y$
M14Y4.B`P<'0G('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#@X)3X@/&1I=B!S
M='EL93TS1"=$25-03$%9.B!B;&]C:SL@1D].5"U&04U)3%DZ('1I;65S(&YE
M=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T.R!-05)'24XM3$5&5#H@,'!T.R!-
M05)'24XM4DE'2%0Z(#!P=#L@5$585"U!3$E'3CH@;&5F=#L@5$585"U)3D1%
M3E0Z(#!P="<^($5X<&5C=&5D('1O('9E<W0@869T97(@2G5N92`S,"P@,C`Q
M-#PO9&EV/B`\+W1D/B`\=&0@<W1Y;&4],T0G4$%$1$E.1RU"3U143TTZ(#1P
M>"<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24^/&9O;G0@<W1Y;&4],T0G
M1D].5"U325I%.B`Q,'!T.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N
M.R!$25-03$%9.B!I;FQI;F4G/B`F;F)S<#L\+V9O;G0^(#PO=&0^(#QT9"!S
M='EL93TS1"="3U)$15(M0D]45$]-.B!B;&%C:R`T<'@@9&]U8FQE.R!415A4
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M=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T.R!415A4+4%,24=..B!R:6=H="<@
M=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$.24^,2PU,C(L,#(T/"]T9#X@/'1D
M('-T>6QE/3-$)U!!1$1)3D<M0D]45$]-.B`T<'@[(%1%6%0M04Q)1TXZ(&QE
M9G0G('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E(&YO=W)A<#TS1&YO=W)A
M<#X\9F]N="!S='EL93TS1"=&3TY4+5-)6D4Z(#$P<'0[($9/3E0M1D%-24Q9
M.B!T:6UE<R!N97<@<F]M86X[($1)4U!,05DZ(&EN;&EN92<^("9N8G-P.SPO
M9F]N=#X@/"]T9#X@/"]T<CX@/"]T86)L93X@/"]D:78^(#QD:78@<W1Y;&4]
M,T0G1$E34$Q!63H@8FQO8VL[(%1%6%0M24Y$14Y4.B`P<'0G/B9N8G-P.SPO
M9&EV/B`\9&EV('-T>6QE/3-$)T1)4U!,05DZ(&)L;V-K.R!&3TY4+49!34E,
M63H@5&EM97,@3F5W(%)O;6%N.R!&3TY4+5-)6D4Z(#$P<'0[($U!4D=)3BU,
M1494.B`Q.'!T.R!-05)'24XM4DE'2%0Z(#!P=#L@=&5X="UA;&EG;CH@:G5S
M=&EF>3L@5$585"U)3D1%3E0Z(#!P="<^($-O;7!E;G-A=&EO;B!E>'!E;G-E
M<R!R96QA=&5D('1O(')E<W1R:6-T960@<W1O8VL@=6YI=',@9W)A;G1E9"!T
M;R!E;7!L;WEE97,@86YD(&1I<F5C=&]R<R!W97)E(')E8V]R9&5D(&%S(&9O
M;&QO=W,Z/"]D:78^(#QD:78@<W1Y;&4],T0G1$E34$Q!63H@8FQO8VL[($U!
M4D=)3BU,1494.B`P<'0[($U!4D=)3BU224=(5#H@,'!T.R!T97AT+6%L:6=N
M.B!J=7-T:69Y.R!415A4+4E.1$5.5#H@,'!T)SX@)FYB<W`[/"]D:78^(#QD
M:78@<W1Y;&4],T0G34%21TE.+4Q%1E0Z(#,V<'0[('1E>'0M86QI9VXZ(&QE
M9G0G/B`\=&%B;&4@<W1Y;&4],T0G1D].5"U325I%.B`Q,'!T.R!&3TY4+49!
M34E,63H@=&EM97,@;F5W(')O;6%N)R!C96QL<W!A8VEN9STS1#`@8V5L;'!A
M9&1I;F<],T0P('=I9'1H/3-$.#`E/B`\='(^(#QT9"!S='EL93TS1"=0041$
M24Y'+4)/5%1/33H@,G!X)R!V86QI9VX],T1B;W1T;VT@=VED=&@],T0V-"4^
M/&9O;G0@<W1Y;&4],T0G1D].5"U325I%.B`Q,'!T.R!&3TY4+49!34E,63H@
M=&EM97,@;F5W(')O;6%N.R!$25-03$%9.B!I;FQI;F4G/B`F;F)S<#L\+V9O
M;G0^(#PO=&0^(#QT9"!S='EL93TS1"=0041$24Y'+4)/5%1/33H@,G!X)R!V
M86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)3X\9F]N="!S='EL93TS1"=&3TY4
M+5-)6D4Z(#$P<'0[($9/3E0M1D%-24Q9.B!T:6UE<R!N97<@<F]M86X[($9/
M3E0M5T5)1TA4.B!B;VQD.R!$25-03$%9.B!I;FQI;F4G/B`F;F)S<#L\+V9O
M;G0^(#PO=&0^(#QT9"!S='EL93TS1"="3U)$15(M0D]45$]-.B!B;&%C:R`R
M<'@@<V]L:60G('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#,T)2!C;VQS<&%N
M/3-$,3`^(#QD:78@<W1Y;&4],T0G1$E34$Q!63H@8FQO8VL[($9/3E0M1D%-
M24Q9.B!T:6UE<R!N97<@<F]M86X[($9/3E0M4TE:13H@,3!P=#L@1D].5"U7
M14E'2%0Z(&)O;&0[($U!4D=)3BU,1494.B`P<'0[($U!4D=)3BU224=(5#H@
M,'!T.R!T97AT+6%L:6=N.B!C96YT97([(%1%6%0M24Y$14Y4.B`P<'0G/B!9
M96%R(&5N9&5D)FYB<W`[2G5N92`S,"P\+V1I=CX@/"]T9#X@/'1D('-T>6QE
M/3-$)U!!1$1)3D<M0D]45$]-.B`R<'@[(%1%6%0M04Q)1TXZ(&QE9G0G('9A
M;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E(&YO=W)A<#TS1&YO=W)A<#X\9F]N
M="!S='EL93TS1"=&3TY4+5-)6D4Z(#$P<'0[($9/3E0M1D%-24Q9.B!T:6UE
M<R!N97<@<F]M86X[($9/3E0M5T5)1TA4.B!B;VQD.R!$25-03$%9.B!I;FQI
M;F4G/B`F;F)S<#L\+V9O;G0^(#PO=&0^(#QT9"!S='EL93TS1"=0041$24Y'
M+4)/5%1/33H@,G!X)R!V86QI9VX],T1B;W1T;VT^/&9O;G0@<W1Y;&4],T0G
M1D].5"U325I%.B`Q,'!T.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N
M.R!$25-03$%9.B!I;FQI;F4G/B`F;F)S<#L\+V9O;G0^(#PO=&0^(#PO='(^
M(#QT<CX@/'1D('-T>6QE/3-$)U!!1$1)3D<M0D]45$]-.B`R<'@G('9A;&EG
M;CTS1&)O='1O;2!W:61T:#TS1#8T)3X\9F]N="!S='EL93TS1"=&3TY4+5-)
M6D4Z(#$P<'0[($9/3E0M1D%-24Q9.B!T:6UE<R!N97<@<F]M86X[($1)4U!,
M05DZ(&EN;&EN92<^("9N8G-P.SPO9F]N=#X@/"]T9#X@/'1D('-T>6QE/3-$
M)U!!1$1)3D<M0D]45$]-.B`R<'@G('9A;&EG;CTS1&)O='1O;2!W:61T:#TS
M1#$E/CQF;VYT('-T>6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@1D].5"U&04U)
M3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U714E'2%0Z(&)O;&0[($1)4U!,
M05DZ(&EN;&EN92<^("9N8G-P.SPO9F]N=#X@/"]T9#X@/'1D('-T>6QE/3-$
M)T)/4D1%4BU"3U143TTZ(&)L86-K(#)P>"!S;VQI9"<@=F%L:6=N/3-$8F]T
M=&]M('=I9'1H/3-$,3`E(&-O;'-P86X],T0R/B`\9&EV('-T>6QE/3-$)T1)
M4U!,05DZ(&)L;V-K.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!&
M3TY4+5-)6D4Z(#$P<'0[($9/3E0M5T5)1TA4.B!B;VQD.R!-05)'24XM3$5&
M5#H@,'!T.R!-05)'24XM4DE'2%0Z(#!P=#L@=&5X="UA;&EG;CH@8V5N=&5R
M.R!415A4+4E.1$5.5#H@,'!T)SX@,C`Q-#PO9&EV/B`\+W1D/B`\=&0@<W1Y
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M3D<M0D]45$]-.B`R<'@G('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E/CQF
M;VYT('-T>6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ('1I
M;65S(&YE=R!R;VUA;CL@1D].5"U714E'2%0Z(&)O;&0[($1)4U!,05DZ(&EN
M;&EN92<^("9N8G-P.SPO9F]N=#X@/"]T9#X@/'1D('-T>6QE/3-$)T)/4D1%
M4BU"3U143TTZ(&)L86-K(#)P>"!S;VQI9"<@=F%L:6=N/3-$8F]T=&]M('=I
M9'1H/3-$,3`E(&-O;'-P86X],T0R/B`\9&EV('-T>6QE/3-$)T1)4U!,05DZ
M(&)L;V-K.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!&3TY4+5-)
M6D4Z(#$P<'0[($9/3E0M5T5)1TA4.B!B;VQD.R!-05)'24XM3$5&5#H@,'!T
M.R!-05)'24XM4DE'2%0Z(#!P=#L@=&5X="UA;&EG;CH@8V5N=&5R.R!415A4
M+4E.1$5.5#H@,'!T)SX@,C`Q,SPO9&EV/B`\+W1D/B`\=&0@<W1Y;&4],T0G
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M5$]-.B`R<'@G('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E/CQF;VYT('-T
M>6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ('1I;65S(&YE
M=R!R;VUA;CL@1D].5"U714E'2%0Z(&)O;&0[($1)4U!,05DZ(&EN;&EN92<^
M("9N8G-P.SPO9F]N=#X@/"]T9#X@/'1D('-T>6QE/3-$)T)/4D1%4BU"3U14
M3TTZ(&)L86-K(#)P>"!S;VQI9"<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$
M,3$E(&-O;'-P86X],T0T/B`\9&EV('-T>6QE/3-$)T1)4U!,05DZ(&)L;V-K
M.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!&3TY4+5-)6D4Z(#$P
M<'0[($9/3E0M5T5)1TA4.B!B;VQD.R!-05)'24XM3$5&5#H@,'!T.R!-05)'
M24XM4DE'2%0Z(#!P=#L@=&5X="UA;&EG;CH@8V5N=&5R.R!415A4+4E.1$5.
M5#H@,'!T)SX@,C`Q,CPO9&EV/B`\+W1D/B`\+W1R/B`\='(@8F=C;VQO<CTS
M1"-C8V5E9F8^(#QT9"!S='EL93TS1"=415A4+4%,24=..B!L969T.R!-05)'
M24XM3$5&5#H@,'!T.R!-05)'24XM4DE'2%0Z(#!P=#L@5$585"U)3D1%3E0Z
M(#!P="<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$-C0E/B`\9&EV('-T>6QE
M/3-$)T1)4U!,05DZ(&)L;V-K.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O
M;6%N.R!&3TY4+5-)6D4Z(#$P<'0[($U!4D=)3BU,1494.B`P<'0[($U!4D=)
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M<W`[/"]F;VYT/B`\+W1D/B`\=&0@<W1Y;&4],T0G1$E34$Q!63H@:6YL:6YE
M.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!&3TY4+5-)6D4Z(#$P
M<'0[(%1%6%0M04Q)1TXZ(&QE9G0G('9A;&EG;CTS1&)O='1O;2!W:61T:#TS
M1#$E/B0\+W1D/B`\=&0@<W1Y;&4],T0G1$E34$Q!63H@:6YL:6YE.R!&3TY4
M+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!&3TY4+5-)6D4Z(#$P<'0[(%1%
M6%0M04Q)1TXZ(')I9VAT)R!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Y)3XQ
M+#$W,CPO=&0^(#QT9"!S='EL93TS1"=415A4+4%,24=..B!L969T)R!V86QI
M9VX],T1B;W1T;VT@=VED=&@],T0Q)2!N;W=R87`],T1N;W=R87`^/&9O;G0@
M<W1Y;&4],T0G1D].5"U325I%.B`Q,'!T.R!&3TY4+49!34E,63H@=&EM97,@
M;F5W(')O;6%N.R!$25-03$%9.B!I;FQI;F4G/B`F;F)S<#L\+V9O;G0^(#PO
M=&0^(#QT9"!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)2!A;&EG;CTS1')I
M9VAT/CQF;VYT('-T>6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@1D].5"U&04U)
M3%DZ('1I;65S(&YE=R!R;VUA;CL@1$E34$Q!63H@:6YL:6YE)SX@)FYB<W`[
M/"]F;VYT/B`\+W1D/B`\=&0@<W1Y;&4],T0G1$E34$Q!63H@:6YL:6YE.R!&
M3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!&3TY4+5-)6D4Z(#$P<'0[
M(%1%6%0M04Q)1TXZ(&QE9G0G('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E
M/B0\+W1D/B`\=&0@<W1Y;&4],T0G1$E34$Q!63H@:6YL:6YE.R!&3TY4+49!
M34E,63H@=&EM97,@;F5W(')O;6%N.R!&3TY4+5-)6D4Z(#$P<'0[(%1%6%0M
M04Q)1TXZ(')I9VAT)R!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Y)3XW,3$\
M+W1D/B`\=&0@<W1Y;&4],T0G5$585"U!3$E'3CH@;&5F="<@=F%L:6=N/3-$
M8F]T=&]M('=I9'1H/3-$,24@;F]W<F%P/3-$;F]W<F%P/CQF;VYT('-T>6QE
M/3-$)T9/3E0M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R
M;VUA;CL@1$E34$Q!63H@:6YL:6YE)SX@)FYB<W`[/"]F;VYT/B`\+W1D/B`\
M=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@86QI9VX],T1R:6=H=#X\
M9F]N="!S='EL93TS1"=&3TY4+5-)6D4Z(#$P<'0[($9/3E0M1D%-24Q9.B!T
M:6UE<R!N97<@<F]M86X[($1)4U!,05DZ(&EN;&EN92<^("9N8G-P.SPO9F]N
M=#X@/"]T9#X@/'1D('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&
M04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T.R!415A4
M+4%,24=..B!L969T)R!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)3XD/"]T
M9#X@/'1D('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ
M('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T.R!415A4+4%,24=.
M.B!R:6=H="<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$.24^,2PQ-C,\+W1D
M/B`\=&0@<W1Y;&4],T0G5$585"U!3$E'3CH@;&5F="<@=F%L:6=N/3-$8F]T
M=&]M('=I9'1H/3-$,24@;F]W<F%P/3-$;F]W<F%P/CQF;VYT('-T>6QE/3-$
M)T9/3E0M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA
M;CL@1$E34$Q!63H@:6YL:6YE)SX@)FYB<W`[/"]F;VYT/B`\+W1D/B`\+W1R
M/B`\='(@8F=C;VQO<CTS1'=H:71E/B`\=&0@<W1Y;&4],T0G4$%$1$E.1RU"
M3U143TTZ(#)P>#L@5$585"U!3$E'3CH@;&5F=#L@34%21TE.+4Q%1E0Z(#!P
M=#L@34%21TE.+5))1TA4.B`P<'0[(%1%6%0M24Y$14Y4.B`P<'0G('9A;&EG
M;CTS1&)O='1O;2!W:61T:#TS1#8T)3X@/&1I=B!S='EL93TS1"=$25-03$%9
M.B!B;&]C:SL@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U3
M25I%.B`Q,'!T.R!-05)'24XM3$5&5#H@,'!T.R!-05)'24XM4DE'2%0Z(#!P
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M1$E34$Q!63H@:6YL:6YE)SX@)FYB<W`[/"]F;VYT/B`\+W1D/B`\=&0@<W1Y
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M9VX],T1B;W1T;VT@=VED=&@],T0Q)2!N;W=R87`],T1N;W=R87`^/&9O;G0@
M<W1Y;&4],T0G1D].5"U325I%.B`Q,'!T.R!&3TY4+49!34E,63H@=&EM97,@
M;F5W(')O;6%N.R!$25-03$%9.B!I;FQI;F4G/B`F;F)S<#L\+V9O;G0^(#PO
M=&0^(#QT9"!S='EL93TS1"=0041$24Y'+4)/5%1/33H@,G!X)R!V86QI9VX]
M,T1B;W1T;VT@=VED=&@],T0Q)2!A;&EG;CTS1')I9VAT/CQF;VYT('-T>6QE
M/3-$)T9/3E0M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R
M;VUA;CL@1$E34$Q!63H@:6YL:6YE)SX@)FYB<W`[/"]F;VYT/B`\+W1D/B`\
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M)R!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)2!N;W=R87`],T1N;W=R87`^
M/&9O;G0@<W1Y;&4],T0G1D].5"U325I%.B`Q,'!T.R!&3TY4+49!34E,63H@
M=&EM97,@;F5W(')O;6%N.R!$25-03$%9.B!I;FQI;F4G/B`F;F)S<#L\+V9O
M;G0^(#PO=&0^(#QT9"!S='EL93TS1"=0041$24Y'+4)/5%1/33H@,G!X)R!V
M86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)2!A;&EG;CTS1')I9VAT/CQF;VYT
M('-T>6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ('1I;65S
M(&YE=R!R;VUA;CL@1$E34$Q!63H@:6YL:6YE)SX@)FYB<W`[/"]F;VYT/B`\
M+W1D/B`\=&0@<W1Y;&4],T0G0D]21$52+4)/5%1/33H@8FQA8VL@,G!X('-O
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M.B!L969T)R!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)2!N;W=R87`],T1N
M;W=R87`^/&9O;G0@<W1Y;&4],T0G1D].5"U325I%.B`Q,'!T.R!&3TY4+49!
M34E,63H@=&EM97,@;F5W(')O;6%N.R!$25-03$%9.B!I;FQI;F4G/B`F;F)S
M<#L\+V9O;G0^(#PO=&0^(#PO='(^(#QT<B!B9V-O;&]R/3-$(V-C965F9CX@
M/'1D('-T>6QE/3-$)U!!1$1)3D<M0D]45$]-.B`T<'@G('9A;&EG;CTS1&)O
M='1O;2!W:61T:#TS1#8T)3X\9F]N="!S='EL93TS1"=&3TY4+5-)6D4Z(#$P
M<'0[($9/3E0M1D%-24Q9.B!T:6UE<R!N97<@<F]M86X[($1)4U!,05DZ(&EN
M;&EN92<^("9N8G-P.SPO9F]N=#X@/"]T9#X@/'1D('-T>6QE/3-$)U!!1$1)
M3D<M0D]45$]-.B`T<'@G('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E(&%L
M:6=N/3-$<FEG:'0^/&9O;G0@<W1Y;&4],T0G1D].5"U325I%.B`Q,'!T.R!&
M3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!$25-03$%9.B!I;FQI;F4G
M/B`F;F)S<#L\+V9O;G0^(#PO=&0^(#QT9"!S='EL93TS1"="3U)$15(M0D]4
M5$]-.B!B;&%C:R`T<'@@9&]U8FQE.R!$25-03$%9.B!I;FQI;F4[($9/3E0M
M1D%-24Q9.B!T:6UE<R!N97<@<F]M86X[($9/3E0M4TE:13H@,3!P=#L@5$58
M5"U!3$E'3CH@;&5F="<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24^)#PO
M=&0^(#QT9"!S='EL93TS1"="3U)$15(M0D]45$]-.B!B;&%C:R`T<'@@9&]U
M8FQE.R!$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE<R!N97<@
M<F]M86X[($9/3E0M4TE:13H@,3!P=#L@5$585"U!3$E'3CH@<FEG:'0G('9A
M;&EG;CTS1&)O='1O;2!W:61T:#TS1#DE/C4L-38R/"]T9#X@/'1D('-T>6QE
M/3-$)U!!1$1)3D<M0D]45$]-.B`T<'@[(%1%6%0M04Q)1TXZ(&QE9G0G('9A
M;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E(&YO=W)A<#TS1&YO=W)A<#X\9F]N
M="!S='EL93TS1"=&3TY4+5-)6D4Z(#$P<'0[($9/3E0M1D%-24Q9.B!T:6UE
M<R!N97<@<F]M86X[($1)4U!,05DZ(&EN;&EN92<^("9N8G-P.SPO9F]N=#X@
M/"]T9#X@/'1D('-T>6QE/3-$)U!!1$1)3D<M0D]45$]-.B`T<'@G('9A;&EG
M;CTS1&)O='1O;2!W:61T:#TS1#$E(&%L:6=N/3-$<FEG:'0^/&9O;G0@<W1Y
M;&4],T0G1D].5"U325I%.B`Q,'!T.R!&3TY4+49!34E,63H@=&EM97,@;F5W
M(')O;6%N.R!$25-03$%9.B!I;FQI;F4G/B`F;F)S<#L\+V9O;G0^(#PO=&0^
M(#QT9"!S='EL93TS1"="3U)$15(M0D]45$]-.B!B;&%C:R`T<'@@9&]U8FQE
M.R!$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE<R!N97<@<F]M
M86X[($9/3E0M4TE:13H@,3!P=#L@5$585"U!3$E'3CH@;&5F="<@=F%L:6=N
M/3-$8F]T=&]M('=I9'1H/3-$,24^)#PO=&0^(#QT9"!S='EL93TS1"="3U)$
M15(M0D]45$]-.B!B;&%C:R`T<'@@9&]U8FQE.R!$25-03$%9.B!I;FQI;F4[
M($9/3E0M1D%-24Q9.B!T:6UE<R!N97<@<F]M86X[($9/3E0M4TE:13H@,3!P
M=#L@5$585"U!3$E'3CH@<FEG:'0G('9A;&EG;CTS1&)O='1O;2!W:61T:#TS
M1#DE/C(L,C0P/"]T9#X@/'1D('-T>6QE/3-$)U!!1$1)3D<M0D]45$]-.B`T
M<'@[(%1%6%0M04Q)1TXZ(&QE9G0G('9A;&EG;CTS1&)O='1O;2!W:61T:#TS
M1#$E(&YO=W)A<#TS1&YO=W)A<#X\9F]N="!S='EL93TS1"=&3TY4+5-)6D4Z
M(#$P<'0[($9/3E0M1D%-24Q9.B!T:6UE<R!N97<@<F]M86X[($1)4U!,05DZ
M(&EN;&EN92<^("9N8G-P.SPO9F]N=#X@/"]T9#X@/'1D('-T>6QE/3-$)U!!
M1$1)3D<M0D]45$]-.B`T<'@G('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E
M(&%L:6=N/3-$<FEG:'0^/&9O;G0@<W1Y;&4],T0G1D].5"U325I%.B`Q,'!T
M.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!$25-03$%9.B!I;FQI
M;F4G/B`F;F)S<#L\+V9O;G0^(#PO=&0^(#QT9"!S='EL93TS1"="3U)$15(M
M0D]45$]-.B!B;&%C:R`T<'@@9&]U8FQE.R!$25-03$%9.B!I;FQI;F4[($9/
M3E0M1D%-24Q9.B!T:6UE<R!N97<@<F]M86X[($9/3E0M4TE:13H@,3!P=#L@
M5$585"U!3$E'3CH@;&5F="<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24^
M)#PO=&0^(#QT9"!S='EL93TS1"="3U)$15(M0D]45$]-.B!B;&%C:R`T<'@@
M9&]U8FQE.R!$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE<R!N
M97<@<F]M86X[($9/3E0M4TE:13H@,3!P=#L@5$585"U!3$E'3CH@<FEG:'0G
M('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#DE/C0L-C4P/"]T9#X@/'1D('-T
M>6QE/3-$)U!!1$1)3D<M0D]45$]-.B`T<'@[(%1%6%0M04Q)1TXZ(&QE9G0G
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M)SX@)FYB<W`[/"]D:78^(#QD:78@<W1Y;&4],T0G1$E34$Q!63H@8FQO8VL[
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M/B`\9&EV('-T>6QE/3-$)T1)4U!,05DZ(&)L;V-K.R!-05)'24XM3$5&5#H@
M,'!T.R!-05)'24XM4DE'2%0Z(#!P=#L@=&5X="UA;&EG;CH@:G5S=&EF>3L@
M5$585"U)3D1%3E0Z(#!P="<^("9N8G-P.SPO9&EV/B`\9&EV('-T>6QE/3-$
M)U1%6%0M04Q)1TXZ(&QE9G0[($U!4D=)3BU,1494.B`P<'0[($1)4U!,05DZ
M(&)L;V-K.R!-05)'24XM4DE'2%0Z(#!P=#L@5$585"U)3D1%3E0Z(#!P="<^
M(#QT86)L92!S='EL93TS1"=&3TY4+5-)6D4Z(#$P<'0[($9/3E0M1D%-24Q9
M.B!T:6UE<R!N97<@<F]M86XG(&-E;&QS<&%C:6YG/3-$,"!C96QL<&%D9&EN
M9STS1#`@=VED=&@],T0Q,#`E(&)O<F1E<CTS1#`^(#QT<B!V86QI9VX],T1T
M;W`^(#QT9"!S='EL93TS1"=724142#H@,3AP="<@86QI9VX],T1R:6=H=#X@
M/&1I=B!S='EL93TS1"=$25-03$%9.B!B;&]C:SL@1D].5"U&04U)3%DZ(%1I
M;65S($YE=R!2;VUA;CL@1D].5"U325I%.B`Q,'!T.R!-05)'24XM3$5&5#H@
M,'!T.R!-05)'24XM4DE'2%0Z(#!P=#L@5$585"U!3$E'3CH@;&5F=#L@5$58
M5"U)3D1%3E0Z(#!P="<^(&0N/"]D:78^(#PO=&0^(#QT9"!A;&EG;CTS1&QE
M9G0^(#QD:78@<W1Y;&4],T0G1$E34$Q!63H@8FQO8VL[($9/3E0M1D%-24Q9
M.B!4:6UE<R!.97<@4F]M86X[($9/3E0M4TE:13H@,3!P=#L@34%21TE.+4Q%
M1E0Z(#!P=#L@34%21TE.+5))1TA4.B`P<'0[(%1%6%0M04Q)1TXZ(&QE9G0[
M(%1%6%0M24Y$14Y4.B`P<'0G/B!297-T<FEC=&5D('-T;V-K('5N:71S('1O
M(&-O;G-U;'1A;G1S.CPO9&EV/B`\+W1D/B`\+W1R/B`\+W1A8FQE/B`\+V1I
M=CX@/&1I=B!S='EL93TS1"=$25-03$%9.B!B;&]C:SL@34%21TE.+4Q%1E0Z
M(#!P=#L@34%21TE.+5))1TA4.B`P<'0[('1E>'0M86QI9VXZ(&IU<W1I9GD[
M(%1%6%0M24Y$14Y4.B`P<'0G/B`F;F)S<#L\+V1I=CX@/&1I=B!S='EL93TS
M1"=$25-03$%9.B!B;&]C:SL@1D].5"U&04U)3%DZ(%1I;65S($YE=R!2;VUA
M;CL@1D].5"U325I%.B`Q,'!T.R!-05)'24XM3$5&5#H@,3AP=#L@34%21TE.
M+5))1TA4.B`P<'0[('1E>'0M86QI9VXZ(&IU<W1I9GD[(%1%6%0M24Y$14Y4
M.B`P<'0G/B!4:&4@9F]L;&]W:6YG('1A8FQE('-U;6UA<FEZ97,@=&AE(&%C
M=&EV:71I97,@9F]R('5N=F5S=&5D(')E<W1R:6-T960@<W1O8VL@=6YI=',@
M86YD(')E<W1R:6-T960@<W1O8VL@9W)A;G1E9"!T;R!C;VYS=6QT86YT<R!F
M;W(@=&AE('EE87(@96YD960@2G5N92`S,"P@,C`Q-#H\+V1I=CX@/&1I=B!S
M='EL93TS1"=$25-03$%9.B!B;&]C:SL@34%21TE.+4Q%1E0Z(#!P=#L@34%2
M1TE.+5))1TA4.B`P<'0[('1E>'0M86QI9VXZ(&IU<W1I9GD[(%1%6%0M24Y$
M14Y4.B`P<'0G/B`F;F)S<#L\+V1I=CX@/&1I=B!S='EL93TS1"=-05)'24XM
M3$5&5#H@,3AP=#L@=&5X="UA;&EG;CH@;&5F="<^(#QT86)L92!S='EL93TS
M1"=&3TY4+5-)6D4Z(#$P<'0[($9/3E0M1D%-24Q9.B!T:6UE<R!N97<@<F]M
M86XG(&-E;&QS<&%C:6YG/3-$,"!C96QL<&%D9&EN9STS1#`@=VED=&@],T0U
M,"4^(#QT<CX@/'1D('-T>6QE/3-$)U!!1$1)3D<M0D]45$]-.B`R<'@G('9A
M;&EG;CTS1&)O='1O;2!W:61T:#TS1#@T)3X\9F]N="!S='EL93TS1"=&3TY4
M+5-)6D4Z(#$P<'0[($9/3E0M1D%-24Q9.B!T:6UE<R!N97<@<F]M86X[($1)
M4U!,05DZ(&EN;&EN92<^("9N8G-P.SPO9F]N=#X@/"]T9#X@/'1D('-T>6QE
M/3-$)U!!1$1)3D<M0D]45$]-.B`R<'@G('9A;&EG;CTS1&)O='1O;2!W:61T
M:#TS1#$E/CQF;VYT('-T>6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@1D].5"U&
M04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U714E'2%0Z(&)O;&0[($1)
M4U!,05DZ(&EN;&EN92<^("9N8G-P.SPO9F]N=#X@/"]T9#X@/'1D('-T>6QE
M/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#)P>"!S;VQI9"<@=F%L:6=N/3-$
M8F]T=&]M('=I9'1H/3-$,30E(&-O;'-P86X],T0R/B`\9&EV('-T>6QE/3-$
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M969T)R!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)2!N;W=R87`],T1N;W=R
M87`^/&9O;G0@<W1Y;&4],T0G1D].5"U325I%.B`Q,'!T.R!&3TY4+49!34E,
M63H@=&EM97,@;F5W(')O;6%N.R!&3TY4+5=%24=(5#H@8F]L9#L@1$E34$Q!
M63H@:6YL:6YE)SX@)FYB<W`[/"]F;VYT/B`\+W1D/B`\+W1R/B`\='(@8F=C
M;VQO<CTS1"-C8V5E9F8^(#QT9"!S='EL93TS1"=415A4+4%,24=..B!L969T
M.R!-05)'24XM3$5&5#H@,'!T.R!-05)'24XM4DE'2%0Z(#!P=#L@5$585"U)
M3D1%3E0Z(#!P="<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$.#0E/B`\9&EV
M('-T>6QE/3-$)T1)4U!,05DZ(&)L;V-K.R!&3TY4+49!34E,63H@=&EM97,@
M;F5W(')O;6%N.R!&3TY4+5-)6D4Z(#$P<'0[($U!4D=)3BU,1494.B`P<'0[
M($U!4D=)3BU224=(5#H@,'!T.R!415A4+4%,24=..B!L969T.R!415A4+4E.
M1$5.5#H@,'!T)SX@56YV97-T960@870@=&AE(&)E9VEN;FEN9R!O9B!P97)I
M;V0\+V1I=CX@/"]T9#X@/'1D('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E
M/CQF;VYT('-T>6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ
M('1I;65S(&YE=R!R;VUA;CL@1$E34$Q!63H@:6YL:6YE)SX@)FYB<W`[/"]F
M;VYT/B`\+W1D/B`\=&0@<W1Y;&4],T0G5$585"U!3$E'3CH@;&5F="<@=F%L
M:6=N/3-$8F]T=&]M('=I9'1H/3-$,24^/&9O;G0@<W1Y;&4],T0G1D].5"U3
M25I%.B`Q,'!T.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!$25-0
M3$%9.B!I;FQI;F4G/B`F;F)S<#L\+V9O;G0^(#PO=&0^(#QT9"!S='EL93TS
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M1494.B`P<'0[($U!4D=)3BU224=(5#H@,'!T.R!415A4+4E.1$5.5#H@,'!T
M)R!V86QI9VX],T1B;W1T;VT@=VED=&@],T0X-"4^(#QD:78@<W1Y;&4],T0G
M1$E34$Q!63H@8FQO8VL[($9/3E0M1D%-24Q9.B!T:6UE<R!N97<@<F]M86X[
M($9/3E0M4TE:13H@,3!P=#L@34%21TE.+4Q%1E0Z(#!P=#L@34%21TE.+5))
M1TA4.B`P<'0[(%1%6%0M04Q)1TXZ(&QE9G0[(%1%6%0M24Y$14Y4.B`P<'0G
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M;CL@1$E34$Q!63H@:6YL:6YE)SX@)FYB<W`[/"]F;VYT/B`\+W1D/B`\=&0@
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M(&)G8V]L;W(],T0C8V-E969F/B`\=&0@<W1Y;&4],T0G4$%$1$E.1RU"3U14
M3TTZ(#)P>#L@5$585"U!3$E'3CH@;&5F=#L@34%21TE.+4Q%1E0Z(#!P=#L@
M34%21TE.+5))1TA4.B`P<'0[(%1%6%0M24Y$14Y4.B`P<'0G('9A;&EG;CTS
M1&)O='1O;2!W:61T:#TS1#@T)3X@/&1I=B!S='EL93TS1"=$25-03$%9.B!B
M;&]C:SL@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%
M.B`Q,'!T.R!-05)'24XM3$5&5#H@,'!T.R!-05)'24XM4DE'2%0Z(#!P=#L@
M5$585"U!3$E'3CH@;&5F=#L@5$585"U)3D1%3E0Z(#!P="<^(%9E<W1E9#PO
M9&EV/B`\+W1D/B`\=&0@<W1Y;&4],T0G4$%$1$E.1RU"3U143TTZ(#)P>"<@
M=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24^/&9O;G0@<W1Y;&4],T0G1D].
M5"U325I%.B`Q,'!T.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!$
M25-03$%9.B!I;FQI;F4G/B`F;F)S<#L\+V9O;G0^(#PO=&0^(#QT9"!S='EL
M93TS1"="3U)$15(M0D]45$]-.B!B;&%C:R`R<'@@<V]L:60[(%1%6%0M04Q)
M1TXZ(&QE9G0G('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E/CQF;VYT('-T
M>6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ('1I;65S(&YE
M=R!R;VUA;CL@1$E34$Q!63H@:6YL:6YE)SX@)FYB<W`[/"]F;VYT/B`\+W1D
M/B`\=&0@<W1Y;&4],T0G0D]21$52+4)/5%1/33H@8FQA8VL@,G!X('-O;&ED
M.R!$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE<R!N97<@<F]M
M86X[($9/3E0M4TE:13H@,3!P=#L@5$585"U!3$E'3CH@<FEG:'0G('9A;&EG
M;CTS1&)O='1O;2!W:61T:#TS1#$S)3XH-CDL,S$U/"]T9#X@/'1D('-T>6QE
M/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R
M;VUA;CL@1D].5"U325I%.B`Q,'!T.R!0041$24Y'+4)/5%1/33H@,G!X.R!4
M15A4+4%,24=..B!L969T)R!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)2!N
M;W=R87`],T1N;W=R87`^*3PO=&0^(#PO='(^(#QT<B!B9V-O;&]R/3-$=VAI
M=&4^(#QT9"!S='EL93TS1"=0041$24Y'+4)/5%1/33H@-'!X.R!415A4+4%,
M24=..B!L969T.R!-05)'24XM3$5&5#H@,'!T.R!-05)'24XM4DE'2%0Z(#!P
M=#L@5$585"U)3D1%3E0Z(#!P="<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$
M.#0E/B`\9&EV('-T>6QE/3-$)T1)4U!,05DZ(&)L;V-K.R!&3TY4+49!34E,
M63H@=&EM97,@;F5W(')O;6%N.R!&3TY4+5-)6D4Z(#$P<'0[($U!4D=)3BU,
M1494.B`P<'0[($U!4D=)3BU224=(5#H@,'!T.R!415A4+4%,24=..B!L969T
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M3%DZ('1I;65S(&YE=R!R;VUA;CL@1$E34$Q!63H@:6YL:6YE)SX@)FYB<W`[
M/"]F;VYT/B`\+W1D/B`\=&0@<W1Y;&4],T0G0D]21$52+4)/5%1/33H@8FQA
M8VL@-'!X(&1O=6)L93L@1$E34$Q!63H@:6YL:6YE.R!&3TY4+49!34E,63H@
M=&EM97,@;F5W(')O;6%N.R!&3TY4+5-)6D4Z(#$P<'0[(%1%6%0M04Q)1TXZ
M(')I9VAT)R!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q,R4^,34L,C4P/"]T
M9#X@/'1D('-T>6QE/3-$)U!!1$1)3D<M0D]45$]-.B`T<'@[(%1%6%0M04Q)
M1TXZ(&QE9G0G('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E(&YO=W)A<#TS
M1&YO=W)A<#X\9F]N="!S='EL93TS1"=&3TY4+5-)6D4Z(#$P<'0[($9/3E0M
M1D%-24Q9.B!T:6UE<R!N97<@<F]M86X[($1)4U!,05DZ(&EN;&EN92<^("9N
M8G-P.SPO9F]N=#X@/"]T9#X@/"]T<CX@/"]T86)L93X@/"]D:78^(#QD:78@
M<W1Y;&4],T0G1$E34$Q!63H@8FQO8VL[(%1%6%0M24Y$14Y4.B`P<'0G/B9N
M8G-P.SPO9&EV/B`\9&EV('-T>6QE/3-$)T1)4U!,05DZ(&)L;V-K.R!&3TY4
M+49!34E,63H@5&EM97,@3F5W(%)O;6%N.R!&3TY4+5-)6D4Z(#$P<'0[($U!
M4D=)3BU,1494.B`Q.'!T.R!-05)'24XM4DE'2%0Z(#!P=#L@5$585"U!3$E'
M3CH@;&5F=#L@5$585"U)3D1%3E0Z(#!P="<^($-O;7!E;G-A=&EO;B!E>'!E
M;G-E<R!R96QA=&5D('1O(')E<W1R:6-T960@<W1O8VL@=6YI=',@9W)A;G1E
M9"!T;R!C;VYS=6QT86YT<R!W97)E(')E8V]R9&5D(&%S(&9O;&QO=W,Z/"]D
M:78^(#QD:78@<W1Y;&4],T0G1$E34$Q!63H@8FQO8VL[($U!4D=)3BU,1494
M.B`P<'0[($U!4D=)3BU224=(5#H@,'!T.R!T97AT+6%L:6=N.B!J=7-T:69Y
M.R!415A4+4E.1$5.5#H@,'!T)SX@)FYB<W`[/"]D:78^(#QD:78@<W1Y;&4]
M,T0G34%21TE.+4Q%1E0Z(#$X<'0[('1E>'0M86QI9VXZ(&QE9G0G/B`\=&%B
M;&4@<W1Y;&4],T0G1D].5"U325I%.B`Q,'!T.R!&3TY4+49!34E,63H@=&EM
M97,@;F5W(')O;6%N)R!C96QL<W!A8VEN9STS1#`@8V5L;'!A9&1I;F<],T0P
M('=I9'1H/3-$.#`E/B`\='(^(#QT9"!S='EL93TS1"=0041$24Y'+4)/5%1/
M33H@,G!X)R!V86QI9VX],T1B;W1T;VT@=VED=&@],T0V-"4^/&9O;G0@<W1Y
M;&4],T0G1D].5"U325I%.B`Q,'!T.R!&3TY4+49!34E,63H@=&EM97,@;F5W
M(')O;6%N.R!$25-03$%9.B!I;FQI;F4G/B`F;F)S<#L\+V9O;G0^(#PO=&0^
M(#QT9"!S='EL93TS1"=0041$24Y'+4)/5%1/33H@,G!X)R!V86QI9VX],T1B
M;W1T;VT@=VED=&@],T0Q)3X\9F]N="!S='EL93TS1"=&3TY4+5-)6D4Z(#$P
M<'0[($9/3E0M1D%-24Q9.B!T:6UE<R!N97<@<F]M86X[($9/3E0M5T5)1TA4
M.B!B;VQD.R!$25-03$%9.B!I;FQI;F4G/B`F;F)S<#L\+V9O;G0^(#PO=&0^
M(#QT9"!S='EL93TS1"="3U)$15(M0D]45$]-.B!B;&%C:R`R<'@@<V]L:60G
M('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#,T)2!C;VQS<&%N/3-$,3`^(#QD
M:78@<W1Y;&4],T0G1$E34$Q!63H@8FQO8VL[($9/3E0M1D%-24Q9.B!T:6UE
M<R!N97<@<F]M86X[($9/3E0M4TE:13H@,3!P=#L@1D].5"U714E'2%0Z(&)O
M;&0[($U!4D=)3BU,1494.B`P<'0[($U!4D=)3BU224=(5#H@,'!T.R!T97AT
M+6%L:6=N.B!C96YT97([(%1%6%0M24Y$14Y4.B`P<'0G/B!996%R(&5N9&5D
M)FYB<W`[2G5N92`S,"P\+V1I=CX@/"]T9#X@/'1D('-T>6QE/3-$)U!!1$1)
M3D<M0D]45$]-.B`R<'@[(%1%6%0M04Q)1TXZ(&QE9G0G('9A;&EG;CTS1&)O
M='1O;2!W:61T:#TS1#$E(&YO=W)A<#TS1&YO=W)A<#X\9F]N="!S='EL93TS
M1"=&3TY4+5-)6D4Z(#$P<'0[($9/3E0M1D%-24Q9.B!T:6UE<R!N97<@<F]M
M86X[($9/3E0M5T5)1TA4.B!B;VQD.R!$25-03$%9.B!I;FQI;F4G/B`F;F)S
M<#L\+V9O;G0^(#PO=&0^(#PO='(^(#QT<CX@/'1D('-T>6QE/3-$)U!!1$1)
M3D<M0D]45$]-.B`R<'@G('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#8T)3X\
M9F]N="!S='EL93TS1"=&3TY4+5-)6D4Z(#$P<'0[($9/3E0M1D%-24Q9.B!T
M:6UE<R!N97<@<F]M86X[($1)4U!,05DZ(&EN;&EN92<^("9N8G-P.SPO9F]N
M=#X@/"]T9#X@/'1D('-T>6QE/3-$)U!!1$1)3D<M0D]45$]-.B`R<'@G('9A
M;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E/CQF;VYT('-T>6QE/3-$)T9/3E0M
M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].
M5"U714E'2%0Z(&)O;&0[($1)4U!,05DZ(&EN;&EN92<^("9N8G-P.SPO9F]N
M=#X@/"]T9#X@/'1D('-T>6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#)P
M>"!S;VQI9"<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,3`E(&-O;'-P86X]
M,T0R/B`\9&EV('-T>6QE/3-$)T1)4U!,05DZ(&)L;V-K.R!&3TY4+49!34E,
M63H@=&EM97,@;F5W(')O;6%N.R!&3TY4+5-)6D4Z(#$P<'0[($9/3E0M5T5)
M1TA4.B!B;VQD.R!-05)'24XM3$5&5#H@,'!T.R!-05)'24XM4DE'2%0Z(#!P
M=#L@=&5X="UA;&EG;CH@8V5N=&5R.R!415A4+4E.1$5.5#H@,'!T)SX@,C`Q
M-#PO9&EV/B`\+W1D/B`\=&0@<W1Y;&4],T0G4$%$1$E.1RU"3U143TTZ(#)P
M>#L@5$585"U!3$E'3CH@;&5F="<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$
M,24@;F]W<F%P/3-$;F]W<F%P/CQF;VYT('-T>6QE/3-$)T9/3E0M4TE:13H@
M,3!P=#L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U714E'
M2%0Z(&)O;&0[($1)4U!,05DZ(&EN;&EN92<^("9N8G-P.SPO9F]N=#X@/"]T
M9#X@/'1D('-T>6QE/3-$)U!!1$1)3D<M0D]45$]-.B`R<'@G('9A;&EG;CTS
M1&)O='1O;2!W:61T:#TS1#$E/CQF;VYT('-T>6QE/3-$)T9/3E0M4TE:13H@
M,3!P=#L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U714E'
M2%0Z(&)O;&0[($1)4U!,05DZ(&EN;&EN92<^("9N8G-P.SPO9F]N=#X@/"]T
M9#X@/'1D('-T>6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#)P>"!S;VQI
M9"<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,3`E(&-O;'-P86X],T0R/B`\
M9&EV('-T>6QE/3-$)T1)4U!,05DZ(&)L;V-K.R!&3TY4+49!34E,63H@=&EM
M97,@;F5W(')O;6%N.R!&3TY4+5-)6D4Z(#$P<'0[($9/3E0M5T5)1TA4.B!B
M;VQD.R!-05)'24XM3$5&5#H@,'!T.R!-05)'24XM4DE'2%0Z(#!P=#L@=&5X
M="UA;&EG;CH@8V5N=&5R.R!415A4+4E.1$5.5#H@,'!T)SX@,C`Q,SPO9&EV
M/B`\+W1D/B`\=&0@<W1Y;&4],T0G4$%$1$E.1RU"3U143TTZ(#)P>#L@5$58
M5"U!3$E'3CH@;&5F="<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@;F]W
M<F%P/3-$;F]W<F%P/CQF;VYT('-T>6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@
M1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U714E'2%0Z(&)O
M;&0[($1)4U!,05DZ(&EN;&EN92<^("9N8G-P.SPO9F]N=#X@/"]T9#X@/'1D
M('-T>6QE/3-$)U!!1$1)3D<M0D]45$]-.B`R<'@G('9A;&EG;CTS1&)O='1O
M;2!W:61T:#TS1#$E/CQF;VYT('-T>6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@
M1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U714E'2%0Z(&)O
M;&0[($1)4U!,05DZ(&EN;&EN92<^("9N8G-P.SPO9F]N=#X@/"]T9#X@/'1D
M('-T>6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#)P>"!S;VQI9"<@=F%L
M:6=N/3-$8F]T=&]M('=I9'1H/3-$,3`E(&-O;'-P86X],T0R/B`\9&EV('-T
M>6QE/3-$)T1)4U!,05DZ(&)L;V-K.R!&3TY4+49!34E,63H@=&EM97,@;F5W
M(')O;6%N.R!&3TY4+5-)6D4Z(#$P<'0[($9/3E0M5T5)1TA4.B!B;VQD.R!-
M05)'24XM3$5&5#H@,'!T.R!-05)'24XM4DE'2%0Z(#!P=#L@=&5X="UA;&EG
M;CH@8V5N=&5R.R!415A4+4E.1$5.5#H@,'!T)SX@,C`Q,CPO9&EV/B`\+W1D
M/B`\=&0@<W1Y;&4],T0G4$%$1$E.1RU"3U143TTZ(#)P>#L@5$585"U!3$E'
M3CH@;&5F="<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@;F]W<F%P/3-$
M;F]W<F%P/CQF;VYT('-T>6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@1D].5"U&
M04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U714E'2%0Z(&)O;&0[($1)
M4U!,05DZ(&EN;&EN92<^("9N8G-P.SPO9F]N=#X@/"]T9#X@/"]T<CX@/'1R
M(&)G8V]L;W(],T0C8V-E969F/B`\=&0@<W1Y;&4],T0G5$585"U!3$E'3CH@
M;&5F=#L@34%21TE.+4Q%1E0Z(#!P=#L@34%21TE.+5))1TA4.B`P<'0[(%1%
M6%0M24Y$14Y4.B`P<'0G('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#8T)3X@
M/&1I=B!S='EL93TS1"=$25-03$%9.B!B;&]C:SL@1D].5"U&04U)3%DZ('1I
M;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T.R!-05)'24XM3$5&5#H@
M,'!T.R!-05)'24XM4DE'2%0Z(#!P=#L@5$585"U!3$E'3CH@;&5F=#L@5$58
M5"U)3D1%3E0Z(#!P="<^(%)E<V5A<F-H(&%N9"!D979E;&]P;65N="!E>'!E
M;G-E<SPO9&EV/B`\+W1D/B`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$
M,24@86QI9VX],T1R:6=H=#X\9F]N="!S='EL93TS1"=&3TY4+5-)6D4Z(#$P
M<'0[($9/3E0M1D%-24Q9.B!T:6UE<R!N97<@<F]M86X[($1)4U!,05DZ(&EN
M;&EN92<^("9N8G-P.SPO9F]N=#X@/"]T9#X@/'1D('-T>6QE/3-$)T1)4U!,
M05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].
M5"U325I%.B`Q,'!T.R!415A4+4%,24=..B!L969T)R!V86QI9VX],T1B;W1T
M;VT@=VED=&@],T0Q)3XD/"]T9#X@/'1D('-T>6QE/3-$)T1)4U!,05DZ(&EN
M;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%
M.B`Q,'!T.R!415A4+4%,24=..B!R:6=H="<@=F%L:6=N/3-$8F]T=&]M('=I
M9'1H/3-$.24^,C`Q/"]T9#X@/'1D('-T>6QE/3-$)U1%6%0M04Q)1TXZ(&QE
M9G0G('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E(&YO=W)A<#TS1&YO=W)A
M<#X\9F]N="!S='EL93TS1"=&3TY4+5-)6D4Z(#$P<'0[($9/3E0M1D%-24Q9
M.B!T:6UE<R!N97<@<F]M86X[($1)4U!,05DZ(&EN;&EN92<^("9N8G-P.SPO
M9F]N=#X@/"]T9#X@/'1D('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E(&%L
M:6=N/3-$<FEG:'0^/&9O;G0@<W1Y;&4],T0G1D].5"U325I%.B`Q,'!T.R!&
M3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!$25-03$%9.B!I;FQI;F4G
M/B`F;F)S<#L\+V9O;G0^(#PO=&0^(#QT9"!S='EL93TS1"=$25-03$%9.B!I
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M86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)2!N;W=R87`],T1N;W=R87`^/&9O
M;G0@<W1Y;&4],T0G1D].5"U325I%.B`Q,'!T.R!&3TY4+49!34E,63H@=&EM
M97,@;F5W(')O;6%N.R!$25-03$%9.B!I;FQI;F4G/B`F;F)S<#L\+V9O;G0^
M(#PO=&0^(#QT9"!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)2!A;&EG;CTS
M1')I9VAT/CQF;VYT('-T>6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@1D].5"U&
M04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1$E34$Q!63H@:6YL:6YE)SX@)FYB
M<W`[/"]F;VYT/B`\+W1D/B`\=&0@<W1Y;&4],T0G1$E34$Q!63H@:6YL:6YE
M.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!&3TY4+5-)6D4Z(#$P
M<'0[(%1%6%0M04Q)1TXZ(&QE9G0G('9A;&EG;CTS1&)O='1O;2!W:61T:#TS
M1#$E/B0\+W1D/B`\=&0@<W1Y;&4],T0G1$E34$Q!63H@:6YL:6YE.R!&3TY4
M+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!&3TY4+5-)6D4Z(#$P<'0[(%1%
M6%0M04Q)1TXZ(')I9VAT)R!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Y)3XR
M,#$\+W1D/B`\=&0@<W1Y;&4],T0G5$585"U!3$E'3CH@;&5F="<@=F%L:6=N
M/3-$8F]T=&]M('=I9'1H/3-$,24@;F]W<F%P/3-$;F]W<F%P/CQF;VYT('-T
M>6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ('1I;65S(&YE
M=R!R;VUA;CL@1$E34$Q!63H@:6YL:6YE)SX@)FYB<W`[/"]F;VYT/B`\+W1D
M/B`\+W1R/B`\='(@8F=C;VQO<CTS1'=H:71E/B`\=&0@<W1Y;&4],T0G4$%$
M1$E.1RU"3U143TTZ(#)P>#L@5$585"U!3$E'3CH@;&5F=#L@34%21TE.+4Q%
M1E0Z(#!P=#L@34%21TE.+5))1TA4.B`P<'0[(%1%6%0M24Y$14Y4.B`P<'0G
M('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#8T)3X@/&1I=B!S='EL93TS1"=$
M25-03$%9.B!B;&]C:SL@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@
M1D].5"U325I%.B`Q,'!T.R!-05)'24XM3$5&5#H@,'!T.R!-05)'24XM4DE'
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M;VUA;CL@1$E34$Q!63H@:6YL:6YE)SX@)FYB<W`[/"]F;VYT/B`\+W1D/B`\
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M86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)2!N;W=R87`],T1N;W=R87`^/&9O
M;G0@<W1Y;&4],T0G1D].5"U325I%.B`Q,'!T.R!&3TY4+49!34E,63H@=&EM
M97,@;F5W(')O;6%N.R!$25-03$%9.B!I;FQI;F4G/B`F;F)S<#L\+V9O;G0^
M(#PO=&0^(#QT9"!S='EL93TS1"=0041$24Y'+4)/5%1/33H@,G!X)R!V86QI
M9VX],T1B;W1T;VT@=VED=&@],T0Q)2!A;&EG;CTS1')I9VAT/CQF;VYT('-T
M>6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ('1I;65S(&YE
M=R!R;VUA;CL@1$E34$Q!63H@:6YL:6YE)SX@)FYB<W`[/"]F;VYT/B`\+W1D
M/B`\=&0@<W1Y;&4],T0G0D]21$52+4)/5%1/33H@8FQA8VL@,G!X('-O;&ED
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M9VAT)R!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Y)3XR-S@\+W1D/B`\=&0@
M<W1Y;&4],T0G4$%$1$E.1RU"3U143TTZ(#)P>#L@5$585"U!3$E'3CH@;&5F
M="<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@;F]W<F%P/3-$;F]W<F%P
M/CQF;VYT('-T>6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ
M('1I;65S(&YE=R!R;VUA;CL@1$E34$Q!63H@:6YL:6YE)SX@)FYB<W`[/"]F
M;VYT/B`\+W1D/B`\=&0@<W1Y;&4],T0G4$%$1$E.1RU"3U143TTZ(#)P>"<@
M=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@86QI9VX],T1R:6=H=#X\9F]N
M="!S='EL93TS1"=&3TY4+5-)6D4Z(#$P<'0[($9/3E0M1D%-24Q9.B!T:6UE
M<R!N97<@<F]M86X[($1)4U!,05DZ(&EN;&EN92<^("9N8G-P.SPO9F]N=#X@
M/"]T9#X@/'1D('-T>6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#)P>"!S
M;VQI9#L@5$585"U!3$E'3CH@;&5F="<@=F%L:6=N/3-$8F]T=&]M('=I9'1H
M/3-$,24^/&9O;G0@<W1Y;&4],T0G1D].5"U325I%.B`Q,'!T.R!&3TY4+49!
M34E,63H@=&EM97,@;F5W(')O;6%N.R!$25-03$%9.B!I;FQI;F4G/B`F;F)S
M<#L\+V9O;G0^(#PO=&0^(#QT9"!S='EL93TS1"="3U)$15(M0D]45$]-.B!B
M;&%C:R`R<'@@<V]L:60[($1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ
M('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T.R!415A4+4%,24=.
M.B!R:6=H="<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$.24^,C`\+W1D/B`\
M=&0@<W1Y;&4],T0G4$%$1$E.1RU"3U143TTZ(#)P>#L@5$585"U!3$E'3CH@
M;&5F="<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@;F]W<F%P/3-$;F]W
M<F%P/CQF;VYT('-T>6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@1D].5"U&04U)
M3%DZ('1I;65S(&YE=R!R;VUA;CL@1$E34$Q!63H@:6YL:6YE)SX@)FYB<W`[
M/"]F;VYT/B`\+W1D/B`\+W1R/B`\='(@8F=C;VQO<CTS1"-C8V5E9F8^(#QT
M9"!S='EL93TS1"=0041$24Y'+4)/5%1/33H@-'!X)R!V86QI9VX],T1B;W1T
M;VT@=VED=&@],T0V-"4^/&9O;G0@<W1Y;&4],T0G1D].5"U325I%.B`Q,'!T
M.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!$25-03$%9.B!I;FQI
M;F4G/B`F;F)S<#L\+V9O;G0^(#PO=&0^(#QT9"!S='EL93TS1"=0041$24Y'
M+4)/5%1/33H@-'!X)R!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)2!A;&EG
M;CTS1')I9VAT/CQF;VYT('-T>6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@1D].
M5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1$E34$Q!63H@:6YL:6YE)SX@
M)FYB<W`[/"]F;VYT/B`\+W1D/B`\=&0@<W1Y;&4],T0G0D]21$52+4)/5%1/
M33H@8FQA8VL@-'!X(&1O=6)L93L@1$E34$Q!63H@:6YL:6YE.R!&3TY4+49!
M34E,63H@=&EM97,@;F5W(')O;6%N.R!&3TY4+5-)6D4Z(#$P<'0[(%1%6%0M
M04Q)1TXZ(&QE9G0G('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E/B0\+W1D
M/B`\=&0@<W1Y;&4],T0G0D]21$52+4)/5%1/33H@8FQA8VL@-'!X(&1O=6)L
M93L@1$E34$Q!63H@:6YL:6YE.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O
M;6%N.R!&3TY4+5-)6D4Z(#$P<'0[(%1%6%0M04Q)1TXZ(')I9VAT)R!V86QI
M9VX],T1B;W1T;VT@=VED=&@],T0Y)3XR-S@\+W1D/B`\=&0@<W1Y;&4],T0G
M4$%$1$E.1RU"3U143TTZ(#1P>#L@5$585"U!3$E'3CH@;&5F="<@=F%L:6=N
M/3-$8F]T=&]M('=I9'1H/3-$,24@;F]W<F%P/3-$;F]W<F%P/CQF;VYT('-T
M>6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ('1I;65S(&YE
M=R!R;VUA;CL@1$E34$Q!63H@:6YL:6YE)SX@)FYB<W`[/"]F;VYT/B`\+W1D
M/B`\=&0@<W1Y;&4],T0G4$%$1$E.1RU"3U143TTZ(#1P>"<@=F%L:6=N/3-$
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M1D].5"U325I%.B`Q,'!T.R!415A4+4%,24=..B!L969T)R!V86QI9VX],T1B
M;W1T;VT@=VED=&@],T0Q)3XD/"]T9#X@/'1D('-T>6QE/3-$)T)/4D1%4BU"
M3U143TTZ(&)L86-K(#1P>"!D;W5B;&4[($1)4U!,05DZ(&EN;&EN93L@1D].
M5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T.R!4
M15A4+4%,24=..B!R:6=H="<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$.24^
M-3,S/"]T9#X@/'1D('-T>6QE/3-$)U!!1$1)3D<M0D]45$]-.B`T<'@[(%1%
M6%0M04Q)1TXZ(&QE9G0G('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E(&YO
M=W)A<#TS1&YO=W)A<#X\9F]N="!S='EL93TS1"=&3TY4+5-)6D4Z(#$P<'0[
M($9/3E0M1D%-24Q9.B!T:6UE<R!N97<@<F]M86X[($1)4U!,05DZ(&EN;&EN
M92<^("9N8G-P.SPO9F]N=#X@/"]T9#X@/'1D('-T>6QE/3-$)U!!1$1)3D<M
M0D]45$]-.B`T<'@G('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E(&%L:6=N
M/3-$<FEG:'0^/&9O;G0@<W1Y;&4],T0G1D].5"U325I%.B`Q,'!T.R!&3TY4
M+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!$25-03$%9.B!I;FQI;F4G/B`F
M;F)S<#L\+V9O;G0^(#PO=&0^(#QT9"!S='EL93TS1"="3U)$15(M0D]45$]-
M.B!B;&%C:R`T<'@@9&]U8FQE.R!$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-
M24Q9.B!T:6UE<R!N97<@<F]M86X[($9/3E0M4TE:13H@,3!P=#L@5$585"U!
M3$E'3CH@;&5F="<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24^)#PO=&0^
M(#QT9"!S='EL93TS1"="3U)$15(M0D]45$]-.B!B;&%C:R`T<'@@9&]U8FQE
M.R!$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE<R!N97<@<F]M
M86X[($9/3E0M4TE:13H@,3!P=#L@5$585"U!3$E'3CH@<FEG:'0G('9A;&EG
M;CTS1&)O='1O;2!W:61T:#TS1#DE/C(R,3PO=&0^(#QT9"!S='EL93TS1"=0
M041$24Y'+4)/5%1/33H@-'!X.R!415A4+4%,24=..B!L969T)R!V86QI9VX]
M,T1B;W1T;VT@=VED=&@],T0Q)2!N;W=R87`],T1N;W=R87`^/&9O;G0@<W1Y
M;&4],T0G1D].5"U325I%.B`Q,'!T.R!&3TY4+49!34E,63H@=&EM97,@;F5W
M(')O;6%N.R!$25-03$%9.B!I;FQI;F4G/B`F;F)S<#L\+V9O;G0^(#PO=&0^
M(#PO='(^(#PO=&%B;&4^(#PO9&EV/B`\9&EV('-T>6QE/3-$)T1)4U!,05DZ
M(&)L;V-K.R!-05)'24XM3$5&5#H@,'!T.R!-05)'24XM4DE'2%0Z(#!P=#L@
M=&5X="UA;&EG;CH@:G5S=&EF>3L@5$585"U)3D1%3E0Z(#!P="<^("9N8G-P
M.SPO9&EV/B`\9&EV('-T>6QE/3-$)T1)4U!,05DZ(&)L;V-K.R!&3TY4+49!
M34E,63H@5&EM97,@3F5W(%)O;6%N.R!&3TY4+5-)6D4Z(#$P<'0[($9/3E0M
M5T5)1TA4.B!B;VQD.R!-05)'24XM3$5&5#H@,'!T.R!-05)'24XM4DE'2%0Z
M(#(R+C5P=#L@=&5X="UA;&EG;CH@;&5F=#L@5$585"U)3D1%3E0Z(#$X<'0G
M/B!3=6UM87)Y(&]F('=A<G)A;G1S(&%N9"!O<'1I;VYS.CPO9&EV/B`\9&EV
M('-T>6QE/3-$)T1)4U!,05DZ(&)L;V-K.R!-05)'24XM3$5&5#H@,'!T.R!-
M05)'24XM4DE'2%0Z(#!P=#L@=&5X="UA;&EG;CH@:G5S=&EF>3L@5$585"U)
M3D1%3E0Z(#!P="<^("9N8G-P.SPO9&EV/B`\9&EV('-T>6QE/3-$)T1)4U!,
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M='-T86YD:6YG(&%S(&]F($IU;F4@,S`L(#(P,30Z/"]D:78^(#QD:78@<W1Y
M;&4],T0G1$E34$Q!63H@8FQO8VL[($U!4D=)3BU,1494.B`Q.'!T.R!-05)'
M24XM4DE'2%0Z(#!P=#L@=&5X="UA;&EG;CH@;&5F=#L@5$585"U)3D1%3E0Z
M(#!P="<^("9N8G-P.SPO9&EV/B`\+V1I=CX@/&1I=B!S='EL93TS1"=T97AT
M+6%L:6=N.B!L969T)SX@/'1A8FQE('-T>6QE/3-$)T9/3E0M4TE:13H@,3!P
M=#L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;B<@8V5L;'-P86-I;F<]
M,T0P(&-E;&QP861D:6YG/3-$,"!W:61T:#TS1#$P,"4^(#QT<CX@/'1D('-T
M>6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#)P>"!S;VQI9"<@=F%L:6=N
M/3-$8F]T=&]M/B`\9&EV('-T>6QE/3-$)TU!4D=)3BU,1494.B`P<'0[($1)
M4U!,05DZ(&)L;V-K.R!-05)'24XM4DE'2%0Z(#!P=#L@5$585"U)3D1%3E0Z
M(#!P="<^(#QD:78@<W1Y;&4],T0G1$E34$Q!63H@8FQO8VL[(%1%6%0M24Y$
M14Y4.B`P<'0G/B9N8G-P.SPO9&EV/B`\9&EV('-T>6QE/3-$)T1)4U!,05DZ
M(&)L;V-K.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!&3TY4+5-)
M6D4Z(#$P<'0[($9/3E0M5T5)1TA4.B!B;VQD.R!-05)'24XM3$5&5#H@,'!T
M.R!-05)'24XM4DE'2%0Z(#!P=#L@=&5X="UA;&EG;CH@8V5N=&5R.R!415A4
M+4E.1$5.5#H@,'!T)SX@5V%R<F%N=',@+R!/<'1I;VYS/"]D:78^(#PO9&EV
M/B`\+W1D/B`\=&0@<W1Y;&4],T0G4$%$1$E.1RU"3U143TTZ(#)P>"<@=F%L
M:6=N/3-$8F]T=&]M/CQF;VYT('-T>6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@
M1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1$E34$Q!63H@:6YL:6YE
M)SX@)FYB<W`[/"]F;VYT/B`\+W1D/B`\=&0@<W1Y;&4],T0G0D]21$52+4)/
M5%1/33H@8FQA8VL@,G!X('-O;&ED)R!V86QI9VX],T1B;W1T;VT@8V]L<W!A
M;CTS1#(^(#QD:78@<W1Y;&4],T0G1$E34$Q!63H@8FQO8VL[($9/3E0M1D%-
M24Q9.B!T:6UE<R!N97<@<F]M86X[($9/3E0M4TE:13H@,3!P=#L@34%21TE.
M+4Q%1E0Z(#!P=#L@34%21TE.+5))1TA4.B`P<'0[('1E>'0M86QI9VXZ(&-E
M;G1E<CL@5$585"U)3D1%3E0Z(#!P="<^(#QF;VYT('-T>6QE/3-$)T9/3E0M
M5T5)1TA4.B!B;VQD.R!$25-03$%9.B!I;FQI;F4G/D5X97)C:7-E(%!R:6-E
M/"]F;VYT/B`\9F]N="!S='EL93TS1"=&3TY4+5=%24=(5#H@8F]L9#L@1$E3
M4$Q!63H@:6YL:6YE)SYP97(@4VAA<F4\+V9O;G0^/"]D:78^(#PO=&0^(#QT
M9"!S='EL93TS1"=0041$24Y'+4)/5%1/33H@,G!X.R!415A4+4%,24=..B!L
M969T)R!V86QI9VX],T1B;W1T;VT@;F]W<F%P/3-$;F]W<F%P/CQF;VYT('-T
M>6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ('1I;65S(&YE
M=R!R;VUA;CL@1$E34$Q!63H@:6YL:6YE)SX@)FYB<W`[/"]F;VYT/B`\+W1D
M/B`\=&0@<W1Y;&4],T0G4$%$1$E.1RU"3U143TTZ(#)P>"<@=F%L:6=N/3-$
M8F]T=&]M/CQF;VYT('-T>6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@1D].5"U&
M04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U714E'2%0Z(&)O;&0[($1)
M4U!,05DZ(&EN;&EN92<^("9N8G-P.SPO9F]N=#X@/"]T9#X@/'1D('-T>6QE
M/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#)P>"!S;VQI9"<@=F%L:6=N/3-$
M8F]T=&]M(&-O;'-P86X],T0R/B`\9&EV('-T>6QE/3-$)T1)4U!,05DZ(&)L
M;V-K.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!&3TY4+5-)6D4Z
M(#$P<'0[($9/3E0M5T5)1TA4.B!B;VQD.R!-05)'24XM3$5&5#H@,'!T.R!-
M05)'24XM4DE'2%0Z(#!P=#L@=&5X="UA;&EG;CH@8V5N=&5R.R!415A4+4E.
M1$5.5#H@,'!T)SX@3W!T:6]N<R!A;F0@5V%R<F%N=',@9F]R($-O;6UO;B!3
M=&]C:SPO9&EV/B`\+W1D/B`\=&0@<W1Y;&4],T0G4$%$1$E.1RU"3U143TTZ
M(#)P>#L@5$585"U!3$E'3CH@;&5F="<@=F%L:6=N/3-$8F]T=&]M(&YO=W)A
M<#TS1&YO=W)A<#X\9F]N="!S='EL93TS1"=&3TY4+5-)6D4Z(#$P<'0[($9/
M3E0M1D%-24Q9.B!T:6UE<R!N97<@<F]M86X[($9/3E0M5T5)1TA4.B!B;VQD
M.R!$25-03$%9.B!I;FQI;F4G/B`F;F)S<#L\+V9O;G0^(#PO=&0^(#QT9"!S
M='EL93TS1"=0041$24Y'+4)/5%1/33H@,G!X)R!V86QI9VX],T1B;W1T;VT^
M/&9O;G0@<W1Y;&4],T0G1D].5"U325I%.B`Q,'!T.R!&3TY4+49!34E,63H@
M=&EM97,@;F5W(')O;6%N.R!$25-03$%9.B!I;FQI;F4G/B`F;F)S<#L\+V9O
M;G0^(#PO=&0^(#QT9"!S='EL93TS1"="3U)$15(M0D]45$]-.B!B;&%C:R`R
M<'@@<V]L:60G('9A;&EG;CTS1&)O='1O;2!C;VQS<&%N/3-$,CX@/&1I=B!S
M='EL93TS1"=$25-03$%9.B!B;&]C:SL@1D].5"U&04U)3%DZ('1I;65S(&YE
M=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T.R!-05)'24XM3$5&5#H@,'!T.R!-
M05)'24XM4DE'2%0Z(#!P=#L@=&5X="UA;&EG;CH@8V5N=&5R.R!415A4+4E.
M1$5.5#H@,'!T)SX@/&9O;G0@<W1Y;&4],T0G1D].5"U714E'2%0Z(&)O;&0[
M($1)4U!,05DZ(&EN;&EN92<^3W!T:6]N<R!A;F0@5V%R<F%N=',\+V9O;G0^
M(#QF;VYT('-T>6QE/3-$)T9/3E0M5T5)1TA4.B!B;VQD.R!$25-03$%9.B!I
M;FQI;F4G/D5X97)C:7-A8FQE/"]F;VYT/CPO9&EV/B`\+W1D/B`\=&0@<W1Y
M;&4],T0G4$%$1$E.1RU"3U143TTZ(#)P>#L@5$585"U!3$E'3CH@;&5F="<@
M=F%L:6=N/3-$8F]T=&]M(&YO=W)A<#TS1&YO=W)A<#X\9F]N="!S='EL93TS
M1"=&3TY4+5-)6D4Z(#$P<'0[($9/3E0M1D%-24Q9.B!T:6UE<R!N97<@<F]M
M86X[($1)4U!,05DZ(&EN;&EN92<^("9N8G-P.SPO9F]N=#X@/"]T9#X@/'1D
M('-T>6QE/3-$)U!!1$1)3D<M0D]45$]-.B`R<'@G('9A;&EG;CTS1&)O='1O
M;3X\9F]N="!S='EL93TS1"=&3TY4+5-)6D4Z(#$P<'0[($9/3E0M1D%-24Q9
M.B!T:6UE<R!N97<@<F]M86X[($1)4U!,05DZ(&EN;&EN92<^("9N8G-P.SPO
M9F]N=#X@/"]T9#X@/'1D('-T>6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K
M(#)P>"!S;VQI9"<@=F%L:6=N/3-$8F]T=&]M(&-O;'-P86X],T0R/B`\9&EV
M('-T>6QE/3-$)T1)4U!,05DZ(&)L;V-K.R!&3TY4+49!34E,63H@=&EM97,@
M;F5W(')O;6%N.R!&3TY4+5-)6D4Z(#$P<'0[($U!4D=)3BU,1494.B`P<'0[
M($U!4D=)3BU224=(5#H@,'!T.R!T97AT+6%L:6=N.B!C96YT97([(%1%6%0M
M24Y$14Y4.B`P<'0G/B`\9F]N="!S='EL93TS1"=&3TY4+5=%24=(5#H@8F]L
M9#L@1$E34$Q!63H@:6YL:6YE)SY796EG:'1E9"!!=F5R86=E(%)E;6%I;FEN
M9R!#;VYT<F%C='5A;"!497)M<SPO9F]N=#X\9F]N="!S='EL93TS1"=&3TY4
M+5=%24=(5#H@8F]L9#L@1$E34$Q!63H@:6YL:6YE)SXH:6X@>65A<G,I/"]F
M;VYT/CPO9&EV/B`\+W1D/B`\=&0@<W1Y;&4],T0G4$%$1$E.1RU"3U143TTZ
M(#)P>#L@5$585"U!3$E'3CH@;&5F="<@=F%L:6=N/3-$8F]T=&]M(&YO=W)A
M<#TS1&YO=W)A<#X\9F]N="!S='EL93TS1"=&3TY4+5-)6D4Z(#$P<'0[($9/
M3E0M1D%-24Q9.B!T:6UE<R!N97<@<F]M86X[($1)4U!,05DZ(&EN;&EN92<^
M("9N8G-P.SPO9F]N=#X@/"]T9#X@/"]T<CX@/'1R(&)G8V]L;W(],T0C8V-E
M969F/B`\=&0@<W1Y;&4],T0G5$585"U!3$E'3CH@;&5F=#L@34%21TE.+4Q%
M1E0Z(#!P=#L@34%21TE.+5))1TA4.B`P<'0[(%1%6%0M24Y$14Y4.B`P<'0G
M('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#4R)3X@/&1I=B!S='EL93TS1"=$
M25-03$%9.B!B;&]C:SL@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@
M1D].5"U325I%.B`Q,'!T.R!&3TY4+5=%24=(5#H@8F]L9#L@34%21TE.+4Q%
M1E0Z(#!P=#L@34%21TE.+5))1TA4.B`P<'0[(%1%6%0M04Q)1TXZ(&QE9G0[
M(%1%6%0M24Y$14Y4.B`P<'0G/B!787)R86YT<SH\+V1I=CX@/"]T9#X@/'1D
M('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E/CQF;VYT('-T>6QE/3-$)T9/
M3E0M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@
M1$E34$Q!63H@:6YL:6YE)SX@)FYB<W`[/"]F;VYT/B`\+W1D/B`\=&0@<W1Y
M;&4],T0G1$E34$Q!63H@:6YL:6YE.R!&3TY4+49!34E,63H@=&EM97,@;F5W
M(')O;6%N.R!&3TY4+5-)6D4Z(#$P<'0[(%1%6%0M04Q)1TXZ(&QE9G0G('9A
M;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E/B0\+W1D/B`\=&0@<W1Y;&4],T0G
M1$E34$Q!63H@:6YL:6YE.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N
M.R!&3TY4+5-)6D4Z(#$P<'0[(%1%6%0M04Q)1TXZ(')I9VAT)R!V86QI9VX]
M,T1B;W1T;VT@=VED=&@],T0Y)3XQ+C0P/"]T9#X@/'1D('-T>6QE/3-$)U1%
M6%0M04Q)1TXZ(&QE9G0G('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E(&YO
M=W)A<#TS1&YO=W)A<#X\9F]N="!S='EL93TS1"=&3TY4+5-)6D4Z(#$P<'0[
M($9/3E0M1D%-24Q9.B!T:6UE<R!N97<@<F]M86X[($1)4U!,05DZ(&EN;&EN
M92<^("9N8G-P.SPO9F]N=#X@/"]T9#X@/'1D('9A;&EG;CTS1&)O='1O;2!W
M:61T:#TS1#$E/CQF;VYT('-T>6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@1D].
M5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1$E34$Q!63H@:6YL:6YE)SX@
M)FYB<W`[/"]F;VYT/B`\+W1D/B`\=&0@<W1Y;&4],T0G5$585"U!3$E'3CH@
M;&5F="<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24^/&9O;G0@<W1Y;&4]
M,T0G1D].5"U325I%.B`Q,'!T.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O
M;6%N.R!$25-03$%9.B!I;FQI;F4G/B`F;F)S<#L\+V9O;G0^(#PO=&0^(#QT
M9"!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE
M<R!N97<@<F]M86X[($9/3E0M4TE:13H@,3!P=#L@5$585"U!3$E'3CH@<FEG
M:'0G('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#DE/C0W-"PS,C(\+W1D/B`\
M=&0@<W1Y;&4],T0G5$585"U!3$E'3CH@;&5F="<@=F%L:6=N/3-$8F]T=&]M
M('=I9'1H/3-$,24@;F]W<F%P/3-$;F]W<F%P/CQF;VYT('-T>6QE/3-$)T9/
M3E0M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@
M1$E34$Q!63H@:6YL:6YE)SX@)FYB<W`[/"]F;VYT/B`\+W1D/B`\=&0@=F%L
M:6=N/3-$8F]T=&]M('=I9'1H/3-$,24^/&9O;G0@<W1Y;&4],T0G1D].5"U3
M25I%.B`Q,'!T.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!$25-0
M3$%9.B!I;FQI;F4G/B`F;F)S<#L\+V9O;G0^(#PO=&0^(#QT9"!S='EL93TS
M1"=415A4+4%,24=..B!L969T)R!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q
M)3X\9F]N="!S='EL93TS1"=&3TY4+5-)6D4Z(#$P<'0[($9/3E0M1D%-24Q9
M.B!T:6UE<R!N97<@<F]M86X[($1)4U!,05DZ(&EN;&EN92<^("9N8G-P.SPO
M9F]N=#X@/"]T9#X@/'1D('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].
M5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T.R!4
M15A4+4%,24=..B!R:6=H="<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$.24^
M-#<T+#,R,CPO=&0^(#QT9"!S='EL93TS1"=415A4+4%,24=..B!L969T)R!V
M86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)2!N;W=R87`],T1N;W=R87`^/&9O
M;G0@<W1Y;&4],T0G1D].5"U325I%.B`Q,'!T.R!&3TY4+49!34E,63H@=&EM
M97,@;F5W(')O;6%N.R!$25-03$%9.B!I;FQI;F4G/B`F;F)S<#L\+V9O;G0^
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M:6YE)SX@)FYB<W`[/"]F;VYT/B`\+W1D/B`\=&0@<W1Y;&4],T0G1$E34$Q!
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M1$E34$Q!63H@:6YL:6YE)SX@)FYB<W`[/"]F;VYT/B`\+W1D/B`\=&0@<W1Y
M;&4],T0G1$E34$Q!63H@:6YL:6YE.R!&3TY4+49!34E,63H@=&EM97,@;F5W
M(')O;6%N.R!&3TY4+5-)6D4Z(#$P<'0[(%1%6%0M04Q)1TXZ(&QE9G0G('9A
M;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E/B0\+W1D/B`\=&0@<W1Y;&4],T0G
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M)FYB<W`[/"]F;VYT/B`\+W1D/B`\=&0@<W1Y;&4],T0G5$585"U!3$E'3CH@
M;&5F="<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24^/&9O;G0@<W1Y;&4]
M,T0G1D].5"U325I%.B`Q,'!T.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O
M;6%N.R!$25-03$%9.B!I;FQI;F4G/B`F;F)S<#L\+V9O;G0^(#PO=&0^(#QT
M9"!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE
M<R!N97<@<F]M86X[($9/3E0M4TE:13H@,3!P=#L@5$585"U!3$E'3CH@<FEG
M:'0G('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#DE/C@W."PQ-S0\+W1D/B`\
M=&0@<W1Y;&4],T0G5$585"U!3$E'3CH@;&5F="<@=F%L:6=N/3-$8F]T=&]M
M('=I9'1H/3-$,24@;F]W<F%P/3-$;F]W<F%P/CQF;VYT('-T>6QE/3-$)T9/
M3E0M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@
M1$E34$Q!63H@:6YL:6YE)SX@)FYB<W`[/"]F;VYT/B`\+W1D/B`\=&0@=F%L
M:6=N/3-$8F]T=&]M('=I9'1H/3-$,24^/&9O;G0@<W1Y;&4],T0G1D].5"U3
M25I%.B`Q,'!T.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!$25-0
M3$%9.B!I;FQI;F4G/B`F;F)S<#L\+V9O;G0^(#PO=&0^(#QT9"!S='EL93TS
M1"=415A4+4%,24=..B!L969T)R!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q
M)3X\9F]N="!S='EL93TS1"=&3TY4+5-)6D4Z(#$P<'0[($9/3E0M1D%-24Q9
M.B!T:6UE<R!N97<@<F]M86X[($1)4U!,05DZ(&EN;&EN92<^("9N8G-P.SPO
M9F]N=#X@/"]T9#X@/'1D('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].
M5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T.R!4
M15A4+4%,24=..B!R:6=H="<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$.24^
M.#<X+#$W-#PO=&0^(#QT9"!S='EL93TS1"=415A4+4%,24=..B!L969T)R!V
M86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)2!N;W=R87`],T1N;W=R87`^/&9O
M;G0@<W1Y;&4],T0G1D].5"U325I%.B`Q,'!T.R!&3TY4+49!34E,63H@=&EM
M97,@;F5W(')O;6%N.R!$25-03$%9.B!I;FQI;F4G/B`F;F)S<#L\+V9O;G0^
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M:6YE)SX@)FYB<W`[/"]F;VYT/B`\+W1D/B`\=&0@<W1Y;&4],T0G1$E34$Q!
M63H@:6YL:6YE.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!&3TY4
M+5-)6D4Z(#$P<'0[(%1%6%0M04Q)1TXZ(')I9VAT)R!V86QI9VX],T1B;W1T
M;VT@=VED=&@],T0Y)3XP+C`V/"]T9#X@/'1D('-T>6QE/3-$)U1%6%0M04Q)
M1TXZ(&QE9G0G('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E(&YO=W)A<#TS
M1&YO=W)A<#X\9F]N="!S='EL93TS1"=&3TY4+5-)6D4Z(#$P<'0[($9/3E0M
M1D%-24Q9.B!T:6UE<R!N97<@<F]M86X[($1)4U!,05DZ(&EN;&EN92<^("9N
M8G-P.SPO9F]N=#X@/"]T9#X@/"]T<CX@/'1R(&)G8V]L;W(],T0C8V-E969F
M/B`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$-3(E/CQF;VYT('-T>6QE
M/3-$)T9/3E0M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R
M;VUA;CL@1$E34$Q!63H@:6YL:6YE)SX@)FYB<W`[/"]F;VYT/B`\+W1D/B`\
M=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24^/&9O;G0@<W1Y;&4],T0G
M1D].5"U325I%.B`Q,'!T.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N
M.R!$25-03$%9.B!I;FQI;F4G/B`F;F)S<#L\+V9O;G0^(#PO=&0^(#QT9"!S
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M;CTS1&)O='1O;2!W:61T:#TS1#DE/C$N-C`\+W1D/B`\=&0@<W1Y;&4],T0G
M5$585"U!3$E'3CH@;&5F="<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@
M;F]W<F%P/3-$;F]W<F%P/CQF;VYT('-T>6QE/3-$)T9/3E0M4TE:13H@,3!P
M=#L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1$E34$Q!63H@:6YL
M:6YE)SX@)FYB<W`[/"]F;VYT/B`\+W1D/B`\=&0@=F%L:6=N/3-$8F]T=&]M
M('=I9'1H/3-$,24^/&9O;G0@<W1Y;&4],T0G1D].5"U325I%.B`Q,'!T.R!&
M3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!$25-03$%9.B!I;FQI;F4G
M/B`F;F)S<#L\+V9O;G0^(#PO=&0^(#QT9"!S='EL93TS1"=415A4+4%,24=.
M.B!L969T)R!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)3X\9F]N="!S='EL
M93TS1"=&3TY4+5-)6D4Z(#$P<'0[($9/3E0M1D%-24Q9.B!T:6UE<R!N97<@
M<F]M86X[($1)4U!,05DZ(&EN;&EN92<^("9N8G-P.SPO9F]N=#X@/"]T9#X@
M/'1D('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I
M;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T.R!415A4+4%,24=..B!R
M:6=H="<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$.24^,3,Q+#(R,3PO=&0^
M(#QT9"!S='EL93TS1"=415A4+4%,24=..B!L969T)R!V86QI9VX],T1B;W1T
M;VT@=VED=&@],T0Q)2!N;W=R87`],T1N;W=R87`^/&9O;G0@<W1Y;&4],T0G
M1D].5"U325I%.B`Q,'!T.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N
M.R!$25-03$%9.B!I;FQI;F4G/B`F;F)S<#L\+V9O;G0^(#PO=&0^(#QT9"!V
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M3%DZ('1I;65S(&YE=R!R;VUA;CL@1$E34$Q!63H@:6YL:6YE)SX@)FYB<W`[
M/"]F;VYT/B`\+W1D/B`\=&0@<W1Y;&4],T0G1$E34$Q!63H@:6YL:6YE.R!&
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M(&YE=R!R;VUA;CL@1$E34$Q!63H@:6YL:6YE)SX@)FYB<W`[/"]F;VYT/B`\
M+W1D/B`\=&0@<W1Y;&4],T0G5$585"U!3$E'3CH@;&5F="<@=F%L:6=N/3-$
M8F]T=&]M('=I9'1H/3-$,24^/&9O;G0@<W1Y;&4],T0G1D].5"U325I%.B`Q
M,'!T.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!$25-03$%9.B!I
M;FQI;F4G/B`F;F)S<#L\+V9O;G0^(#PO=&0^(#QT9"!S='EL93TS1"=$25-0
M3$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE<R!N97<@<F]M86X[($9/
M3E0M4TE:13H@,3!P=#L@5$585"U!3$E'3CH@<FEG:'0G('9A;&EG;CTS1&)O
M='1O;2!W:61T:#TS1#DE/C`N-S@\+W1D/B`\=&0@<W1Y;&4],T0G5$585"U!
M3$E'3CH@;&5F="<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@;F]W<F%P
M/3-$;F]W<F%P/CQF;VYT('-T>6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@1D].
M5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1$E34$Q!63H@:6YL:6YE)SX@
M)FYB<W`[/"]F;VYT/B`\+W1D/B`\+W1R/B`\='(@8F=C;VQO<CTS1'=H:71E
M/B`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$-3(E/CQF;VYT('-T>6QE
M/3-$)T9/3E0M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R
M;VUA;CL@1$E34$Q!63H@:6YL:6YE)SX@)FYB<W`[/"]F;VYT/B`\+W1D/B`\
M=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24^/&9O;G0@<W1Y;&4],T0G
M1D].5"U325I%.B`Q,'!T.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N
M.R!$25-03$%9.B!I;FQI;F4G/B`F;F)S<#L\+V9O;G0^(#PO=&0^(#QT9"!S
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M;CTS1&)O='1O;2!W:61T:#TS1#DE/C$N.#`\+W1D/B`\=&0@<W1Y;&4],T0G
M5$585"U!3$E'3CH@;&5F="<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@
M;F]W<F%P/3-$;F]W<F%P/CQF;VYT('-T>6QE/3-$)T9/3E0M4TE:13H@,3!P
M=#L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1$E34$Q!63H@:6YL
M:6YE)SX@)FYB<W`[/"]F;VYT/B`\+W1D/B`\=&0@=F%L:6=N/3-$8F]T=&]M
M('=I9'1H/3-$,24^/&9O;G0@<W1Y;&4],T0G1D].5"U325I%.B`Q,'!T.R!&
M3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!$25-03$%9.B!I;FQI;F4G
M/B`F;F)S<#L\+V9O;G0^(#PO=&0^(#QT9"!S='EL93TS1"=415A4+4%,24=.
M.B!L969T)R!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)3X\9F]N="!S='EL
M93TS1"=&3TY4+5-)6D4Z(#$P<'0[($9/3E0M1D%-24Q9.B!T:6UE<R!N97<@
M<F]M86X[($1)4U!,05DZ(&EN;&EN92<^("9N8G-P.SPO9F]N=#X@/"]T9#X@
M/'1D('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I
M;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T.R!415A4+4%,24=..B!R
M:6=H="<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$.24^-S(W+#0P,3PO=&0^
M(#QT9"!S='EL93TS1"=415A4+4%,24=..B!L969T)R!V86QI9VX],T1B;W1T
M;VT@=VED=&@],T0Q)2!N;W=R87`],T1N;W=R87`^/&9O;G0@<W1Y;&4],T0G
M1D].5"U325I%.B`Q,'!T.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N
M.R!$25-03$%9.B!I;FQI;F4G/B`F;F)S<#L\+V9O;G0^(#PO=&0^(#QT9"!V
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M3%DZ('1I;65S(&YE=R!R;VUA;CL@1$E34$Q!63H@:6YL:6YE)SX@)FYB<W`[
M/"]F;VYT/B`\+W1D/B`\=&0@<W1Y;&4],T0G1$E34$Q!63H@:6YL:6YE.R!&
M3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!&3TY4+5-)6D4Z(#$P<'0[
M(%1%6%0M04Q)1TXZ(')I9VAT)R!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Y
M)3XW,C<L-#`Q/"]T9#X@/'1D('-T>6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G
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M(&YE=R!R;VUA;CL@1$E34$Q!63H@:6YL:6YE)SX@)FYB<W`[/"]F;VYT/B`\
M+W1D/B`\=&0@<W1Y;&4],T0G5$585"U!3$E'3CH@;&5F="<@=F%L:6=N/3-$
M8F]T=&]M('=I9'1H/3-$,24^/&9O;G0@<W1Y;&4],T0G1D].5"U325I%.B`Q
M,'!T.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!$25-03$%9.B!I
M;FQI;F4G/B`F;F)S<#L\+V9O;G0^(#PO=&0^(#QT9"!S='EL93TS1"=$25-0
M3$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE<R!N97<@<F]M86X[($9/
M3E0M4TE:13H@,3!P=#L@5$585"U!3$E'3CH@<FEG:'0G('9A;&EG;CTS1&)O
M='1O;2!W:61T:#TS1#DE/C`N,S`\+W1D/B`\=&0@<W1Y;&4],T0G5$585"U!
M3$E'3CH@;&5F="<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@;F]W<F%P
M/3-$;F]W<F%P/CQF;VYT('-T>6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@1D].
M5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1$E34$Q!63H@:6YL:6YE)SX@
M)FYB<W`[/"]F;VYT/B`\+W1D/B`\+W1R/B`\='(@8F=C;VQO<CTS1"-C8V5E
M9F8^(#QT9"!V86QI9VX],T1B;W1T;VT@=VED=&@],T0U,B4^/&9O;G0@<W1Y
M;&4],T0G1D].5"U325I%.B`Q,'!T.R!&3TY4+49!34E,63H@=&EM97,@;F5W
M(')O;6%N.R!$25-03$%9.B!I;FQI;F4G/B`F;F)S<#L\+V9O;G0^(#PO=&0^
M(#QT9"!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)3X\9F]N="!S='EL93TS
M1"=&3TY4+5-)6D4Z(#$P<'0[($9/3E0M1D%-24Q9.B!T:6UE<R!N97<@<F]M
M86X[($1)4U!,05DZ(&EN;&EN92<^("9N8G-P.SPO9F]N=#X@/"]T9#X@/'1D
M('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S
M(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T.R!415A4+4%,24=..B!L969T
M)R!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)3XD/"]T9#X@/'1D('-T>6QE
M/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R
M;VUA;CL@1D].5"U325I%.B`Q,'!T.R!415A4+4%,24=..B!R:6=H="<@=F%L
M:6=N/3-$8F]T=&]M('=I9'1H/3-$.24^,2XY,#PO=&0^(#QT9"!S='EL93TS
M1"=415A4+4%,24=..B!L969T)R!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q
M)2!N;W=R87`],T1N;W=R87`^/&9O;G0@<W1Y;&4],T0G1D].5"U325I%.B`Q
M,'!T.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!$25-03$%9.B!I
M;FQI;F4G/B`F;F)S<#L\+V9O;G0^(#PO=&0^(#QT9"!V86QI9VX],T1B;W1T
M;VT@=VED=&@],T0Q)3X\9F]N="!S='EL93TS1"=&3TY4+5-)6D4Z(#$P<'0[
M($9/3E0M1D%-24Q9.B!T:6UE<R!N97<@<F]M86X[($1)4U!,05DZ(&EN;&EN
M92<^("9N8G-P.SPO9F]N=#X@/"]T9#X@/'1D('-T>6QE/3-$)U1%6%0M04Q)
M1TXZ(&QE9G0G('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E/CQF;VYT('-T
M>6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ('1I;65S(&YE
M=R!R;VUA;CL@1$E34$Q!63H@:6YL:6YE)SX@)FYB<W`[/"]F;VYT/B`\+W1D
M/B`\=&0@<W1Y;&4],T0G1$E34$Q!63H@:6YL:6YE.R!&3TY4+49!34E,63H@
M=&EM97,@;F5W(')O;6%N.R!&3TY4+5-)6D4Z(#$P<'0[(%1%6%0M04Q)1TXZ
M(')I9VAT)R!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Y)3XT,RPQ,#,\+W1D
M/B`\=&0@<W1Y;&4],T0G5$585"U!3$E'3CH@;&5F="<@=F%L:6=N/3-$8F]T
M=&]M('=I9'1H/3-$,24@;F]W<F%P/3-$;F]W<F%P/CQF;VYT('-T>6QE/3-$
M)T9/3E0M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA
M;CL@1$E34$Q!63H@:6YL:6YE)SX@)FYB<W`[/"]F;VYT/B`\+W1D/B`\=&0@
M=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24^/&9O;G0@<W1Y;&4],T0G1D].
M5"U325I%.B`Q,'!T.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!$
M25-03$%9.B!I;FQI;F4G/B`F;F)S<#L\+V9O;G0^(#PO=&0^(#QT9"!S='EL
M93TS1"=415A4+4%,24=..B!L969T)R!V86QI9VX],T1B;W1T;VT@=VED=&@]
M,T0Q)3X\9F]N="!S='EL93TS1"=&3TY4+5-)6D4Z(#$P<'0[($9/3E0M1D%-
M24Q9.B!T:6UE<R!N97<@<F]M86X[($1)4U!,05DZ(&EN;&EN92<^("9N8G-P
M.SPO9F]N=#X@/"]T9#X@/'1D('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@
M1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T
M.R!415A4+4%,24=..B!R:6=H="<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$
M.24^-#,L,3`S/"]T9#X@/'1D('-T>6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G
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M(&YE=R!R;VUA;CL@1$E34$Q!63H@:6YL:6YE)SX@)FYB<W`[/"]F;VYT/B`\
M+W1D/B`\=&0@<W1Y;&4],T0G5$585"U!3$E'3CH@;&5F="<@=F%L:6=N/3-$
M8F]T=&]M('=I9'1H/3-$,24^/&9O;G0@<W1Y;&4],T0G1D].5"U325I%.B`Q
M,'!T.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!$25-03$%9.B!I
M;FQI;F4G/B`F;F)S<#L\+V9O;G0^(#PO=&0^(#QT9"!S='EL93TS1"=$25-0
M3$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE<R!N97<@<F]M86X[($9/
M3E0M4TE:13H@,3!P=#L@5$585"U!3$E'3CH@<FEG:'0G('9A;&EG;CTS1&)O
M='1O;2!W:61T:#TS1#DE/C`N,#@\+W1D/B`\=&0@<W1Y;&4],T0G5$585"U!
M3$E'3CH@;&5F="<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@;F]W<F%P
M/3-$;F]W<F%P/CQF;VYT('-T>6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@1D].
M5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1$E34$Q!63H@:6YL:6YE)SX@
M)FYB<W`[/"]F;VYT/B`\+W1D/B`\+W1R/B`\='(@8F=C;VQO<CTS1'=H:71E
M/B`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$-3(E/CQF;VYT('-T>6QE
M/3-$)T9/3E0M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R
M;VUA;CL@1$E34$Q!63H@:6YL:6YE)SX@)FYB<W`[/"]F;VYT/B`\+W1D/B`\
M=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24^/&9O;G0@<W1Y;&4],T0G
M1D].5"U325I%.B`Q,'!T.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N
M.R!$25-03$%9.B!I;FQI;F4G/B`F;F)S<#L\+V9O;G0^(#PO=&0^(#QT9"!S
M='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE<R!N
M97<@<F]M86X[($9/3E0M4TE:13H@,3!P=#L@5$585"U!3$E'3CH@;&5F="<@
M=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24^)#PO=&0^(#QT9"!S='EL93TS
M1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE<R!N97<@<F]M
M86X[($9/3E0M4TE:13H@,3!P=#L@5$585"U!3$E'3CH@<FEG:'0G('9A;&EG
M;CTS1&)O='1O;2!W:61T:#TS1#DE/C0N,C`\+W1D/B`\=&0@<W1Y;&4],T0G
M5$585"U!3$E'3CH@;&5F="<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@
M;F]W<F%P/3-$;F]W<F%P/CQF;VYT('-T>6QE/3-$)T9/3E0M4TE:13H@,3!P
M=#L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1$E34$Q!63H@:6YL
M:6YE)SX@)FYB<W`[/"]F;VYT/B`\+W1D/B`\=&0@=F%L:6=N/3-$8F]T=&]M
M('=I9'1H/3-$,24^/&9O;G0@<W1Y;&4],T0G1D].5"U325I%.B`Q,'!T.R!&
M3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!$25-03$%9.B!I;FQI;F4G
M/B`F;F)S<#L\+V9O;G0^(#PO=&0^(#QT9"!S='EL93TS1"=415A4+4%,24=.
M.B!L969T)R!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)3X\9F]N="!S='EL
M93TS1"=&3TY4+5-)6D4Z(#$P<'0[($9/3E0M1D%-24Q9.B!T:6UE<R!N97<@
M<F]M86X[($1)4U!,05DZ(&EN;&EN92<^("9N8G-P.SPO9F]N=#X@/"]T9#X@
M/'1D('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I
M;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T.R!415A4+4%,24=..B!R
M:6=H="<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$.24^-2PP-C`L,#`P/"]T
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M1$E34$Q!63H@:6YL:6YE)SX@)FYB<W`[/"]F;VYT/B`\+W1D/B`\=&0@<W1Y
M;&4],T0G5$585"U!3$E'3CH@;&5F="<@=F%L:6=N/3-$8F]T=&]M('=I9'1H
M/3-$,24^/&9O;G0@<W1Y;&4],T0G1D].5"U325I%.B`Q,'!T.R!&3TY4+49!
M34E,63H@=&EM97,@;F5W(')O;6%N.R!$25-03$%9.B!I;FQI;F4G/B`F;F)S
M<#L\+V9O;G0^(#PO=&0^(#QT9"!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[
M($9/3E0M1D%-24Q9.B!T:6UE<R!N97<@<F]M86X[($9/3E0M4TE:13H@,3!P
M=#L@5$585"U!3$E'3CH@<FEG:'0G('9A;&EG;CTS1&)O='1O;2!W:61T:#TS
M1#DE/C4L,#8P+#`P,#PO=&0^(#QT9"!S='EL93TS1"=415A4+4%,24=..B!L
M969T)R!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)2!N;W=R87`],T1N;W=R
M87`^/&9O;G0@<W1Y;&4],T0G1D].5"U325I%.B`Q,'!T.R!&3TY4+49!34E,
M63H@=&EM97,@;F5W(')O;6%N.R!$25-03$%9.B!I;FQI;F4G/B`F;F)S<#L\
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M63H@:6YL:6YE)SX@)FYB<W`[/"]F;VYT/B`\+W1D/B`\=&0@<W1Y;&4],T0G
M1$E34$Q!63H@:6YL:6YE.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N
M.R!&3TY4+5-)6D4Z(#$P<'0[(%1%6%0M04Q)1TXZ(')I9VAT)R!V86QI9VX]
M,T1B;W1T;VT@=VED=&@],T0Y)3XR+C`Y/"]T9#X@/'1D('-T>6QE/3-$)U1%
M6%0M04Q)1TXZ(&QE9G0G('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E(&YO
M=W)A<#TS1&YO=W)A<#X\9F]N="!S='EL93TS1"=&3TY4+5-)6D4Z(#$P<'0[
M($9/3E0M1D%-24Q9.B!T:6UE<R!N97<@<F]M86X[($1)4U!,05DZ(&EN;&EN
M92<^("9N8G-P.SPO9F]N=#X@/"]T9#X@/"]T<CX@/'1R(&)G8V]L;W(],T0C
M8V-E969F/B`\=&0@<W1Y;&4],T0G4$%$1$E.1RU"3U143TTZ(#)P>"<@=F%L
M:6=N/3-$8F]T=&]M('=I9'1H/3-$-3(E/CQF;VYT('-T>6QE/3-$)T9/3E0M
M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1$E3
M4$Q!63H@:6YL:6YE)SX@)FYB<W`[/"]F;VYT/B`\+W1D/B`\=&0@<W1Y;&4]
M,T0G4$%$1$E.1RU"3U143TTZ(#)P>"<@=F%L:6=N/3-$8F]T=&]M('=I9'1H
M/3-$,24^/&9O;G0@<W1Y;&4],T0G1D].5"U325I%.B`Q,'!T.R!&3TY4+49!
M34E,63H@=&EM97,@;F5W(')O;6%N.R!$25-03$%9.B!I;FQI;F4G/B`F;F)S
M<#L\+V9O;G0^(#PO=&0^(#QT9"!S='EL93TS1"="3U)$15(M0D]45$]-.B!B
M;&%C:R`R<'@@<V]L:60[($1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ
M('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T.R!415A4+4%,24=.
M.B!L969T)R!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)3XD/"]T9#X@/'1D
M('-T>6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#)P>"!S;VQI9#L@1$E3
M4$Q!63H@:6YL:6YE.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!&
M3TY4+5-)6D4Z(#$P<'0[(%1%6%0M04Q)1TXZ(')I9VAT)R!V86QI9VX],T1B
M;W1T;VT@=VED=&@],T0Y)3XU+C`P/"]T9#X@/'1D('-T>6QE/3-$)U!!1$1)
M3D<M0D]45$]-.B`R<'@[(%1%6%0M04Q)1TXZ(&QE9G0G('9A;&EG;CTS1&)O
M='1O;2!W:61T:#TS1#$E(&YO=W)A<#TS1&YO=W)A<#X\9F]N="!S='EL93TS
M1"=&3TY4+5-)6D4Z(#$P<'0[($9/3E0M1D%-24Q9.B!T:6UE<R!N97<@<F]M
M86X[($1)4U!,05DZ(&EN;&EN92<^("9N8G-P.SPO9F]N=#X@/"]T9#X@/'1D
M('-T>6QE/3-$)U!!1$1)3D<M0D]45$]-.B`R<'@G('9A;&EG;CTS1&)O='1O
M;2!W:61T:#TS1#$E/CQF;VYT('-T>6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@
M1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1$E34$Q!63H@:6YL:6YE
M)SX@)FYB<W`[/"]F;VYT/B`\+W1D/B`\=&0@<W1Y;&4],T0G0D]21$52+4)/
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M=&@],T0Y)3XS+#(Q.2PY.#,\+W1D/B`\=&0@<W1Y;&4],T0G4$%$1$E.1RU"
M3U143TTZ(#)P>#L@5$585"U!3$E'3CH@;&5F="<@=F%L:6=N/3-$8F]T=&]M
M('=I9'1H/3-$,24@;F]W<F%P/3-$;F]W<F%P/CQF;VYT('-T>6QE/3-$)T9/
M3E0M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@
M1$E34$Q!63H@:6YL:6YE)SX@)FYB<W`[/"]F;VYT/B`\+W1D/B`\=&0@<W1Y
M;&4],T0G4$%$1$E.1RU"3U143TTZ(#)P>"<@=F%L:6=N/3-$8F]T=&]M('=I
M9'1H/3-$,24^/&9O;G0@<W1Y;&4],T0G1D].5"U325I%.B`Q,'!T.R!&3TY4
M+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!$25-03$%9.B!I;FQI;F4G/B`F
M;F)S<#L\+V9O;G0^(#PO=&0^(#QT9"!S='EL93TS1"="3U)$15(M0D]45$]-
M.B!B;&%C:R`R<'@@<V]L:60[(%1%6%0M04Q)1TXZ(&QE9G0G('9A;&EG;CTS
M1&)O='1O;2!W:61T:#TS1#$E/CQF;VYT('-T>6QE/3-$)T9/3E0M4TE:13H@
M,3!P=#L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1$E34$Q!63H@
M:6YL:6YE)SX@)FYB<W`[/"]F;VYT/B`\+W1D/B`\=&0@<W1Y;&4],T0G0D]2
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M=&@],T0Q)2!N;W=R87`],T1N;W=R87`^/&9O;G0@<W1Y;&4],T0G1D].5"U3
M25I%.B`Q,'!T.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!$25-0
M3$%9.B!I;FQI;F4G/B`F;F)S<#L\+V9O;G0^(#PO=&0^(#QT9"!S='EL93TS
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M=&]M('=I9'1H/3-$,24^/&9O;G0@<W1Y;&4],T0G1D].5"U325I%.B`Q,'!T
M.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!$25-03$%9.B!I;FQI
M;F4G/B`F;F)S<#L\+V9O;G0^(#PO=&0^(#QT9"!S='EL93TS1"="3U)$15(M
M0D]45$]-.B!B;&%C:R`R<'@@<V]L:60[($1)4U!,05DZ(&EN;&EN93L@1D].
M5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T.R!4
M15A4+4%,24=..B!R:6=H="<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$.24^
M,RXR,CPO=&0^(#QT9"!S='EL93TS1"=0041$24Y'+4)/5%1/33H@,G!X.R!4
M15A4+4%,24=..B!L969T)R!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)2!N
M;W=R87`],T1N;W=R87`^/&9O;G0@<W1Y;&4],T0G1D].5"U325I%.B`Q,'!T
M.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!$25-03$%9.B!I;FQI
M;F4G/B`F;F)S<#L\+V9O;G0^(#PO=&0^(#PO='(^(#QT<B!B9V-O;&]R/3-$
M=VAI=&4^(#QT9"!S='EL93TS1"=0041$24Y'+4)/5%1/33H@,G!X.R!415A4
M+4%,24=..B!L969T.R!-05)'24XM3$5&5#H@,'!T.R!-05)'24XM4DE'2%0Z
M(#!P=#L@5$585"U)3D1%3E0Z(#!P="<@=F%L:6=N/3-$8F]T=&]M('=I9'1H
M/3-$-3(E/B`\9&EV('-T>6QE/3-$)T1)4U!,05DZ(&)L;V-K.R!&3TY4+49!
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M/3-$,24^/&9O;G0@<W1Y;&4],T0G1D].5"U325I%.B`Q,'!T.R!&3TY4+49!
M34E,63H@=&EM97,@;F5W(')O;6%N.R!$25-03$%9.B!I;FQI;F4G/B`F;F)S
M<#L\+V9O;G0^(#PO=&0^(#QT9"!S='EL93TS1"="3U)$15(M0D]45$]-.B!B
M;&%C:R`R<'@@<V]L:60[(%1%6%0M04Q)1TXZ(')I9VAT)R!V86QI9VX],T1B
M;W1T;VT@=VED=&@],T0Y)3X\9F]N="!S='EL93TS1"=&3TY4+5-)6D4Z(#$P
M<'0[($9/3E0M1D%-24Q9.B!T:6UE<R!N97<@<F]M86X[($1)4U!,05DZ(&EN
M;&EN92<^("9N8G-P.SPO9F]N=#X@/"]T9#X@/'1D('-T>6QE/3-$)U!!1$1)
M3D<M0D]45$]-.B`R<'@[(%1%6%0M04Q)1TXZ(&QE9G0G('9A;&EG;CTS1&)O
M='1O;2!W:61T:#TS1#$E(&YO=W)A<#TS1&YO=W)A<#X\9F]N="!S='EL93TS
M1"=&3TY4+5-)6D4Z(#$P<'0[($9/3E0M1D%-24Q9.B!T:6UE<R!N97<@<F]M
M86X[($1)4U!,05DZ(&EN;&EN92<^("9N8G-P.SPO9F]N=#X@/"]T9#X@/'1D
M('-T>6QE/3-$)U!!1$1)3D<M0D]45$]-.B`R<'@G('9A;&EG;CTS1&)O='1O
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M;G0@<W1Y;&4],T0G1D].5"U325I%.B`Q,'!T.R!&3TY4+49!34E,63H@=&EM
M97,@;F5W(')O;6%N.R!&3TY4+5=%24=(5#H@8F]L9#L@1$E34$Q!63H@:6YL
M:6YE)SX@)FYB<W`[/"]F;VYT/B`\+W1D/B`\=&0@<W1Y;&4],T0G0D]21$52
M+4)/5%1/33H@8FQA8VL@,G!X('-O;&ED.R!$25-03$%9.B!I;FQI;F4[($9/
M3E0M1D%-24Q9.B!T:6UE<R!N97<@<F]M86X[($9/3E0M4TE:13H@,3!P=#L@
M1D].5"U714E'2%0Z(&)O;&0[(%1%6%0M04Q)1TXZ(')I9VAT)R!V86QI9VX]
M,T1B;W1T;VT@=VED=&@],T0Y)3XQ,"PU,S0L,C`T/"]T9#X@/'1D('-T>6QE
M/3-$)U!!1$1)3D<M0D]45$]-.B`R<'@[(%1%6%0M04Q)1TXZ(&QE9G0G('9A
M;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E(&YO=W)A<#TS1&YO=W)A<#X\9F]N
M="!S='EL93TS1"=&3TY4+5-)6D4Z(#$P<'0[($9/3E0M1D%-24Q9.B!T:6UE
M<R!N97<@<F]M86X[($9/3E0M5T5)1TA4.B!B;VQD.R!$25-03$%9.B!I;FQI
M;F4G/B`F;F)S<#L\+V9O;G0^(#PO=&0^(#QT9"!S='EL93TS1"=0041$24Y'
M+4)/5%1/33H@,G!X)R!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)3X\9F]N
M="!S='EL93TS1"=&3TY4+5-)6D4Z(#$P<'0[($9/3E0M1D%-24Q9.B!T:6UE
M<R!N97<@<F]M86X[($9/3E0M5T5)1TA4.B!B;VQD.R!$25-03$%9.B!I;FQI
M;F4G/B`F;F)S<#L\+V9O;G0^(#PO=&0^(#QT9"!S='EL93TS1"="3U)$15(M
M0D]45$]-.B!B;&%C:R`R<'@@<V]L:60[(%1%6%0M04Q)1TXZ(&QE9G0G('9A
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M.24^,3`L-3,T+#(P-#PO=&0^(#QT9"!S='EL93TS1"=0041$24Y'+4)/5%1/
M33H@,G!X.R!415A4+4%,24=..B!L969T)R!V86QI9VX],T1B;W1T;VT@=VED
M=&@],T0Q)2!N;W=R87`],T1N;W=R87`^/&9O;G0@<W1Y;&4],T0G1D].5"U3
M25I%.B`Q,'!T.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!&3TY4
M+5=%24=(5#H@8F]L9#L@1$E34$Q!63H@:6YL:6YE)SX@)FYB<W`[/"]F;VYT
M/B`\+W1D/B`\=&0@<W1Y;&4],T0G4$%$1$E.1RU"3U143TTZ(#)P>"<@=F%L
M:6=N/3-$8F]T=&]M('=I9'1H/3-$,24^/&9O;G0@<W1Y;&4],T0G1D].5"U3
M25I%.B`Q,'!T.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!$25-0
M3$%9.B!I;FQI;F4G/B`F;F)S<#L\+V9O;G0^(#PO=&0^(#QT9"!S='EL93TS
M1"="3U)$15(M0D]45$]-.B!B;&%C:R`R<'@@<V]L:60[(%1%6%0M04Q)1TXZ
M(&QE9G0G('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E/CQF;VYT('-T>6QE
M/3-$)T9/3E0M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R
M;VUA;CL@1$E34$Q!63H@:6YL:6YE)SX@)FYB<W`[/"]F;VYT/B`\+W1D/B`\
M=&0@<W1Y;&4],T0G0D]21$52+4)/5%1/33H@8FQA8VL@,G!X('-O;&ED.R!4
M15A4+4%,24=..B!R:6=H="<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$.24^
M/&9O;G0@<W1Y;&4],T0G1D].5"U325I%.B`Q,'!T.R!&3TY4+49!34E,63H@
M=&EM97,@;F5W(')O;6%N.R!$25-03$%9.B!I;FQI;F4G/B`F;F)S<#L\+V9O
M;G0^(#PO=&0^(#QT9"!S='EL93TS1"=0041$24Y'+4)/5%1/33H@,G!X.R!4
M15A4+4%,24=..B!L969T)R!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)2!N
M;W=R87`],T1N;W=R87`^/&9O;G0@<W1Y;&4],T0G1D].5"U325I%.B`Q,'!T
M.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!$25-03$%9.B!I;FQI
M;F4G/B`F;F)S<#L\+V9O;G0^(#PO=&0^(#PO='(^(#QT<B!B9V-O;&]R/3-$
M(V-C965F9CX@/'1D('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#4R)3X\9F]N
M="!S='EL93TS1"=&3TY4+5-)6D4Z(#$P<'0[($9/3E0M1D%-24Q9.B!T:6UE
M<R!N97<@<F]M86X[($1)4U!,05DZ(&EN;&EN92<^("9N8G-P.SPO9F]N=#X@
M/"]T9#X@/'1D('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E/CQF;VYT('-T
M>6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ('1I;65S(&YE
M=R!R;VUA;CL@1$E34$Q!63H@:6YL:6YE)SX@)FYB<W`[/"]F;VYT/B`\+W1D
M/B`\=&0@<W1Y;&4],T0G5$585"U!3$E'3CH@;&5F="<@=F%L:6=N/3-$8F]T
M=&]M('=I9'1H/3-$,24^/&9O;G0@<W1Y;&4],T0G1D].5"U325I%.B`Q,'!T
M.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!$25-03$%9.B!I;FQI
M;F4G/B`F;F)S<#L\+V9O;G0^(#PO=&0^(#QT9"!S='EL93TS1"=415A4+4%,
M24=..B!R:6=H="<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$.24^/&9O;G0@
M<W1Y;&4],T0G1D].5"U325I%.B`Q,'!T.R!&3TY4+49!34E,63H@=&EM97,@
M;F5W(')O;6%N.R!$25-03$%9.B!I;FQI;F4G/B`F;F)S<#L\+V9O;G0^(#PO
M=&0^(#QT9"!S='EL93TS1"=415A4+4%,24=..B!L969T)R!V86QI9VX],T1B
M;W1T;VT@=VED=&@],T0Q)2!N;W=R87`],T1N;W=R87`^/&9O;G0@<W1Y;&4]
M,T0G1D].5"U325I%.B`Q,'!T.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O
M;6%N.R!$25-03$%9.B!I;FQI;F4G/B`F;F)S<#L\+V9O;G0^(#PO=&0^(#QT
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M<W`[/"]F;VYT/B`\+W1D/B`\=&0@<W1Y;&4],T0G5$585"U!3$E'3CH@<FEG
M:'0G('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#DE/CQF;VYT('-T>6QE/3-$
M)T9/3E0M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA
M;CL@1$E34$Q!63H@:6YL:6YE)SX@)FYB<W`[/"]F;VYT/B`\+W1D/B`\=&0@
M<W1Y;&4],T0G5$585"U!3$E'3CH@;&5F="<@=F%L:6=N/3-$8F]T=&]M('=I
M9'1H/3-$,24@;F]W<F%P/3-$;F]W<F%P/CQF;VYT('-T>6QE/3-$)T9/3E0M
M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1$E3
M4$Q!63H@:6YL:6YE)SX@)FYB<W`[/"]F;VYT/B`\+W1D/B`\=&0@=F%L:6=N
M/3-$8F]T=&]M('=I9'1H/3-$,24^/&9O;G0@<W1Y;&4],T0G1D].5"U325I%
M.B`Q,'!T.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!$25-03$%9
M.B!I;FQI;F4G/B`F;F)S<#L\+V9O;G0^(#PO=&0^(#QT9"!S='EL93TS1"=4
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M)SX@)FYB<W`[/"]F;VYT/B`\+W1D/B`\=&0@<W1Y;&4],T0G5$585"U!3$E'
M3CH@;&5F="<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24^/&9O;G0@<W1Y
M;&4],T0G1D].5"U325I%.B`Q,'!T.R!&3TY4+49!34E,63H@=&EM97,@;F5W
M(')O;6%N.R!$25-03$%9.B!I;FQI;F4G/B`F;F)S<#L\+V9O;G0^(#PO=&0^
M(#QT9"!S='EL93TS1"=415A4+4%,24=..B!R:6=H="<@=F%L:6=N/3-$8F]T
M=&]M('=I9'1H/3-$.24^/&9O;G0@<W1Y;&4],T0G1D].5"U325I%.B`Q,'!T
M.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!$25-03$%9.B!I;FQI
M;F4G/B`F;F)S<#L\+V9O;G0^(#PO=&0^(#QT9"!S='EL93TS1"=415A4+4%,
M24=..B!L969T)R!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)2!N;W=R87`]
M,T1N;W=R87`^/&9O;G0@<W1Y;&4],T0G1D].5"U325I%.B`Q,'!T.R!&3TY4
M+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!$25-03$%9.B!I;FQI;F4G/B`F
M;F)S<#L\+V9O;G0^(#PO=&0^(#PO='(^(#QT<B!B9V-O;&]R/3-$=VAI=&4^
M(#QT9"!S='EL93TS1"=415A4+4%,24=..B!L969T.R!-05)'24XM3$5&5#H@
M,'!T.R!-05)'24XM4DE'2%0Z(#!P=#L@5$585"U)3D1%3E0Z(#!P="<@=F%L
M:6=N/3-$8F]T=&]M('=I9'1H/3-$-3(E/B`\9&EV('-T>6QE/3-$)T1)4U!,
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M;CL@1D].5"U325I%.B`Q,'!T.R!415A4+4%,24=..B!L969T)R!V86QI9VX]
M,T1B;W1T;VT@=VED=&@],T0Q)3XD/"]T9#X@/'1D('-T>6QE/3-$)T1)4U!,
M05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].
M5"U325I%.B`Q,'!T.R!415A4+4%,24=..B!R:6=H="<@=F%L:6=N/3-$8F]T
M=&]M('=I9'1H/3-$.24^,"XP,#PO=&0^(#QT9"!S='EL93TS1"=415A4+4%,
M24=..B!L969T)R!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)2!N;W=R87`]
M,T1N;W=R87`^/&9O;G0@<W1Y;&4],T0G1D].5"U325I%.B`Q,'!T.R!&3TY4
M+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!$25-03$%9.B!I;FQI;F4G/B`F
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M1$E34$Q!63H@:6YL:6YE)SX@)FYB<W`[/"]F;VYT/B`\+W1D/B`\=&0@<W1Y
M;&4],T0G1$E34$Q!63H@:6YL:6YE.R!&3TY4+49!34E,63H@=&EM97,@;F5W
M(')O;6%N.R!&3TY4+5-)6D4Z(#$P<'0[(%1%6%0M04Q)1TXZ(')I9VAT)R!V
M86QI9VX],T1B;W1T;VT@=VED=&@],T0Y)3XQ,#$L,#`P/"]T9#X@/'1D('-T
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M:6YL:6YE)SX@)FYB<W`[/"]F;VYT/B`\+W1D/B`\=&0@<W1Y;&4],T0G5$58
M5"U!3$E'3CH@;&5F="<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24^/&9O
M;G0@<W1Y;&4],T0G1D].5"U325I%.B`Q,'!T.R!&3TY4+49!34E,63H@=&EM
M97,@;F5W(')O;6%N.R!$25-03$%9.B!I;FQI;F4G/B`F;F)S<#L\+V9O;G0^
M(#PO=&0^(#QT9"!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-
M24Q9.B!T:6UE<R!N97<@<F]M86X[($9/3E0M4TE:13H@,3!P=#L@5$585"U!
M3$E'3CH@<FEG:'0G('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#DE/C$P,"PP
M,#`\+W1D/B`\=&0@<W1Y;&4],T0G5$585"U!3$E'3CH@;&5F="<@=F%L:6=N
M/3-$8F]T=&]M('=I9'1H/3-$,24@;F]W<F%P/3-$;F]W<F%P/CQF;VYT('-T
M>6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ('1I;65S(&YE
M=R!R;VUA;CL@1$E34$Q!63H@:6YL:6YE)SX@)FYB<W`[/"]F;VYT/B`\+W1D
M/B`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24^/&9O;G0@<W1Y;&4]
M,T0G1D].5"U325I%.B`Q,'!T.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O
M;6%N.R!$25-03$%9.B!I;FQI;F4G/B`F;F)S<#L\+V9O;G0^(#PO=&0^(#QT
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M.B`Q,'!T.R!415A4+4%,24=..B!R:6=H="<@=F%L:6=N/3-$8F]T=&]M('=I
M9'1H/3-$.24^-2XQ.3PO=&0^(#QT9"!S='EL93TS1"=415A4+4%,24=..B!L
M969T)R!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)2!N;W=R87`],T1N;W=R
M87`^/&9O;G0@<W1Y;&4],T0G1D].5"U325I%.B`Q,'!T.R!&3TY4+49!34E,
M63H@=&EM97,@;F5W(')O;6%N.R!$25-03$%9.B!I;FQI;F4G/B`F;F)S<#L\
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M4$Q!63H@:6YL:6YE)SX@)FYB<W`[/"]F;VYT/B`\+W1D/B`\=&0@<W1Y;&4]
M,T0G1$E34$Q!63H@:6YL:6YE.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O
M;6%N.R!&3TY4+5-)6D4Z(#$P<'0[(%1%6%0M04Q)1TXZ(&QE9G0G('9A;&EG
M;CTS1&)O='1O;2!W:61T:#TS1#$E/B0\+W1D/B`\=&0@<W1Y;&4],T0G1$E3
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M<W`[/"]F;VYT/B`\+W1D/B`\=&0@<W1Y;&4],T0G5$585"U!3$E'3CH@;&5F
M="<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24^/&9O;G0@<W1Y;&4],T0G
M1D].5"U325I%.B`Q,'!T.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N
M.R!$25-03$%9.B!I;FQI;F4G/B`F;F)S<#L\+V9O;G0^(#PO=&0^(#QT9"!S
M='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE<R!N
M97<@<F]M86X[($9/3E0M4TE:13H@,3!P=#L@5$585"U!3$E'3CH@<FEG:'0G
M('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#DE/C,Y."PU,#`\+W1D/B`\=&0@
M<W1Y;&4],T0G5$585"U!3$E'3CH@;&5F="<@=F%L:6=N/3-$8F]T=&]M('=I
M9'1H/3-$,24@;F]W<F%P/3-$;F]W<F%P/CQF;VYT('-T>6QE/3-$)T9/3E0M
M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1$E3
M4$Q!63H@:6YL:6YE)SX@)FYB<W`[/"]F;VYT/B`\+W1D/B`\=&0@=F%L:6=N
M/3-$8F]T=&]M('=I9'1H/3-$,24^/&9O;G0@<W1Y;&4],T0G1D].5"U325I%
M.B`Q,'!T.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!$25-03$%9
M.B!I;FQI;F4G/B`F;F)S<#L\+V9O;G0^(#PO=&0^(#QT9"!S='EL93TS1"=4
M15A4+4%,24=..B!L969T)R!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)3X\
M9F]N="!S='EL93TS1"=&3TY4+5-)6D4Z(#$P<'0[($9/3E0M1D%-24Q9.B!T
M:6UE<R!N97<@<F]M86X[($1)4U!,05DZ(&EN;&EN92<^("9N8G-P.SPO9F]N
M=#X@/"]T9#X@/'1D('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&
M04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T.R!415A4
M+4%,24=..B!R:6=H="<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$.24^,SDX
M+#4P,#PO=&0^(#QT9"!S='EL93TS1"=415A4+4%,24=..B!L969T)R!V86QI
M9VX],T1B;W1T;VT@=VED=&@],T0Q)2!N;W=R87`],T1N;W=R87`^/&9O;G0@
M<W1Y;&4],T0G1D].5"U325I%.B`Q,'!T.R!&3TY4+49!34E,63H@=&EM97,@
M;F5W(')O;6%N.R!$25-03$%9.B!I;FQI;F4G/B`F;F)S<#L\+V9O;G0^(#PO
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M)SX@)FYB<W`[/"]F;VYT/B`\+W1D/B`\=&0@<W1Y;&4],T0G1$E34$Q!63H@
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M4$Q!63H@:6YL:6YE)SX@)FYB<W`[/"]F;VYT/B`\+W1D/B`\=&0@<W1Y;&4]
M,T0G1$E34$Q!63H@:6YL:6YE.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O
M;6%N.R!&3TY4+5-)6D4Z(#$P<'0[(%1%6%0M04Q)1TXZ(&QE9G0G('9A;&EG
M;CTS1&)O='1O;2!W:61T:#TS1#$E/B0\+W1D/B`\=&0@<W1Y;&4],T0G1$E3
M4$Q!63H@:6YL:6YE.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!&
M3TY4+5-)6D4Z(#$P<'0[(%1%6%0M04Q)1TXZ(')I9VAT)R!V86QI9VX],T1B
M;W1T;VT@=VED=&@],T0Y)3XQ+C`T/"]T9#X@/'1D('-T>6QE/3-$)U1%6%0M
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M<W`[/"]F;VYT/B`\+W1D/B`\=&0@<W1Y;&4],T0G5$585"U!3$E'3CH@;&5F
M="<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24^/&9O;G0@<W1Y;&4],T0G
M1D].5"U325I%.B`Q,'!T.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N
M.R!$25-03$%9.B!I;FQI;F4G/B`F;F)S<#L\+V9O;G0^(#PO=&0^(#QT9"!S
M='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE<R!N
M97<@<F]M86X[($9/3E0M4TE:13H@,3!P=#L@5$585"U!3$E'3CH@<FEG:'0G
M('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#DE/C,P+#`P,#PO=&0^(#QT9"!S
M='EL93TS1"=415A4+4%,24=..B!L969T)R!V86QI9VX],T1B;W1T;VT@=VED
M=&@],T0Q)2!N;W=R87`],T1N;W=R87`^/&9O;G0@<W1Y;&4],T0G1D].5"U3
M25I%.B`Q,'!T.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!$25-0
M3$%9.B!I;FQI;F4G/B`F;F)S<#L\+V9O;G0^(#PO=&0^(#QT9"!V86QI9VX]
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M;65S(&YE=R!R;VUA;CL@1$E34$Q!63H@:6YL:6YE)SX@)FYB<W`[/"]F;VYT
M/B`\+W1D/B`\=&0@<W1Y;&4],T0G1$E34$Q!63H@:6YL:6YE.R!&3TY4+49!
M34E,63H@=&EM97,@;F5W(')O;6%N.R!&3TY4+5-)6D4Z(#$P<'0[(%1%6%0M
M04Q)1TXZ(')I9VAT)R!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Y)3XS,"PP
M,#`\+W1D/B`\=&0@<W1Y;&4],T0G5$585"U!3$E'3CH@;&5F="<@=F%L:6=N
M/3-$8F]T=&]M('=I9'1H/3-$,24@;F]W<F%P/3-$;F]W<F%P/CQF;VYT('-T
M>6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ('1I;65S(&YE
M=R!R;VUA;CL@1$E34$Q!63H@:6YL:6YE)SX@)FYB<W`[/"]F;VYT/B`\+W1D
M/B`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24^/&9O;G0@<W1Y;&4]
M,T0G1D].5"U325I%.B`Q,'!T.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O
M;6%N.R!$25-03$%9.B!I;FQI;F4G/B`F;F)S<#L\+V9O;G0^(#PO=&0^(#QT
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M.B`Q,'!T.R!415A4+4%,24=..B!R:6=H="<@=F%L:6=N/3-$8F]T=&]M('=I
M9'1H/3-$.24^-"XQ-CPO=&0^(#QT9"!S='EL93TS1"=415A4+4%,24=..B!L
M969T)R!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)2!N;W=R87`],T1N;W=R
M87`^/&9O;G0@<W1Y;&4],T0G1D].5"U325I%.B`Q,'!T.R!&3TY4+49!34E,
M63H@=&EM97,@;F5W(')O;6%N.R!$25-03$%9.B!I;FQI;F4G/B`F;F)S<#L\
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M4$Q!63H@:6YL:6YE)SX@)FYB<W`[/"]F;VYT/B`\+W1D/B`\=&0@<W1Y;&4]
M,T0G1$E34$Q!63H@:6YL:6YE.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O
M;6%N.R!&3TY4+5-)6D4Z(#$P<'0[(%1%6%0M04Q)1TXZ(&QE9G0G('9A;&EG
M;CTS1&)O='1O;2!W:61T:#TS1#$E/B0\+W1D/B`\=&0@<W1Y;&4],T0G1$E3
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M<W`[/"]F;VYT/B`\+W1D/B`\=&0@<W1Y;&4],T0G5$585"U!3$E'3CH@;&5F
M="<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24^/&9O;G0@<W1Y;&4],T0G
M1D].5"U325I%.B`Q,'!T.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N
M.R!$25-03$%9.B!I;FQI;F4G/B`F;F)S<#L\+V9O;G0^(#PO=&0^(#QT9"!S
M='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE<R!N
M97<@<F]M86X[($9/3E0M4TE:13H@,3!P=#L@5$585"U!3$E'3CH@<FEG:'0G
M('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#DE/C(P+#`P,#PO=&0^(#QT9"!S
M='EL93TS1"=415A4+4%,24=..B!L969T)R!V86QI9VX],T1B;W1T;VT@=VED
M=&@],T0Q)2!N;W=R87`],T1N;W=R87`^/&9O;G0@<W1Y;&4],T0G1D].5"U3
M25I%.B`Q,'!T.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!$25-0
M3$%9.B!I;FQI;F4G/B`F;F)S<#L\+V9O;G0^(#PO=&0^(#QT9"!V86QI9VX]
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M;65S(&YE=R!R;VUA;CL@1$E34$Q!63H@:6YL:6YE)SX@)FYB<W`[/"]F;VYT
M/B`\+W1D/B`\=&0@<W1Y;&4],T0G1$E34$Q!63H@:6YL:6YE.R!&3TY4+49!
M34E,63H@=&EM97,@;F5W(')O;6%N.R!&3TY4+5-)6D4Z(#$P<'0[(%1%6%0M
M04Q)1TXZ(')I9VAT)R!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Y)3XR,"PP
M,#`\+W1D/B`\=&0@<W1Y;&4],T0G5$585"U!3$E'3CH@;&5F="<@=F%L:6=N
M/3-$8F]T=&]M('=I9'1H/3-$,24@;F]W<F%P/3-$;F]W<F%P/CQF;VYT('-T
M>6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ('1I;65S(&YE
M=R!R;VUA;CL@1$E34$Q!63H@:6YL:6YE)SX@)FYB<W`[/"]F;VYT/B`\+W1D
M/B`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24^/&9O;G0@<W1Y;&4]
M,T0G1D].5"U325I%.B`Q,'!T.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O
M;6%N.R!$25-03$%9.B!I;FQI;F4G/B`F;F)S<#L\+V9O;G0^(#PO=&0^(#QT
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M.B`Q,'!T.R!415A4+4%,24=..B!R:6=H="<@=F%L:6=N/3-$8F]T=&]M('=I
M9'1H/3-$.24^,RXX-CPO=&0^(#QT9"!S='EL93TS1"=415A4+4%,24=..B!L
M969T)R!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)2!N;W=R87`],T1N;W=R
M87`^/&9O;G0@<W1Y;&4],T0G1D].5"U325I%.B`Q,'!T.R!&3TY4+49!34E,
M63H@=&EM97,@;F5W(')O;6%N.R!$25-03$%9.B!I;FQI;F4G/B`F;F)S<#L\
M+V9O;G0^(#PO=&0^(#PO='(^(#QT<B!B9V-O;&]R/3-$=VAI=&4^(#QT9"!V
M86QI9VX],T1B;W1T;VT@=VED=&@],T0U,B4^/&9O;G0@<W1Y;&4],T0G1D].
M5"U325I%.B`Q,'!T.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!$
M25-03$%9.B!I;FQI;F4G/B`F;F)S<#L\+V9O;G0^(#PO=&0^(#QT9"!V86QI
M9VX],T1B;W1T;VT@=VED=&@],T0Q)3X\9F]N="!S='EL93TS1"=&3TY4+5-)
M6D4Z(#$P<'0[($9/3E0M1D%-24Q9.B!T:6UE<R!N97<@<F]M86X[($1)4U!,
M05DZ(&EN;&EN92<^("9N8G-P.SPO9F]N=#X@/"]T9#X@/'1D('-T>6QE/3-$
M)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA
M;CL@1D].5"U325I%.B`Q,'!T.R!415A4+4%,24=..B!L969T)R!V86QI9VX]
M,T1B;W1T;VT@=VED=&@],T0Q)3XD/"]T9#X@/'1D('-T>6QE/3-$)T1)4U!,
M05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].
M5"U325I%.B`Q,'!T.R!415A4+4%,24=..B!R:6=H="<@=F%L:6=N/3-$8F]T
M=&]M('=I9'1H/3-$.24^,RXU,#PO=&0^(#QT9"!S='EL93TS1"=415A4+4%,
M24=..B!L969T)R!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)2!N;W=R87`]
M,T1N;W=R87`^/&9O;G0@<W1Y;&4],T0G1D].5"U325I%.B`Q,'!T.R!&3TY4
M+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!$25-03$%9.B!I;FQI;F4G/B`F
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M1$E34$Q!63H@:6YL:6YE)SX@)FYB<W`[/"]F;VYT/B`\+W1D/B`\=&0@<W1Y
M;&4],T0G1$E34$Q!63H@:6YL:6YE.R!&3TY4+49!34E,63H@=&EM97,@;F5W
M(')O;6%N.R!&3TY4+5-)6D4Z(#$P<'0[(%1%6%0M04Q)1TXZ(')I9VAT)R!V
M86QI9VX],T1B;W1T;VT@=VED=&@],T0Y)3XY,#`L,#`P/"]T9#X@/'1D('-T
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M:6YL:6YE)SX@)FYB<W`[/"]F;VYT/B`\+W1D/B`\=&0@<W1Y;&4],T0G5$58
M5"U!3$E'3CH@;&5F="<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24^/&9O
M;G0@<W1Y;&4],T0G1D].5"U325I%.B`Q,'!T.R!&3TY4+49!34E,63H@=&EM
M97,@;F5W(')O;6%N.R!$25-03$%9.B!I;FQI;F4G/B`F;F)S<#L\+V9O;G0^
M(#PO=&0^(#QT9"!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-
M24Q9.B!T:6UE<R!N97<@<F]M86X[($9/3E0M4TE:13H@,3!P=#L@5$585"U!
M3$E'3CH@<FEG:'0G('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#DE/CDP,"PP
M,#`\+W1D/B`\=&0@<W1Y;&4],T0G5$585"U!3$E'3CH@;&5F="<@=F%L:6=N
M/3-$8F]T=&]M('=I9'1H/3-$,24@;F]W<F%P/3-$;F]W<F%P/CQF;VYT('-T
M>6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ('1I;65S(&YE
M=R!R;VUA;CL@1$E34$Q!63H@:6YL:6YE)SX@)FYB<W`[/"]F;VYT/B`\+W1D
M/B`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24^/&9O;G0@<W1Y;&4]
M,T0G1D].5"U325I%.B`Q,'!T.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O
M;6%N.R!$25-03$%9.B!I;FQI;F4G/B`F;F)S<#L\+V9O;G0^(#PO=&0^(#QT
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M.B`Q,'!T.R!415A4+4%,24=..B!R:6=H="<@=F%L:6=N/3-$8F]T=&]M('=I
M9'1H/3-$.24^,BXU.#PO=&0^(#QT9"!S='EL93TS1"=415A4+4%,24=..B!L
M969T)R!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)2!N;W=R87`],T1N;W=R
M87`^/&9O;G0@<W1Y;&4],T0G1D].5"U325I%.B`Q,'!T.R!&3TY4+49!34E,
M63H@=&EM97,@;F5W(')O;6%N.R!$25-03$%9.B!I;FQI;F4G/B`F;F)S<#L\
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M4$Q!63H@:6YL:6YE)SX@)FYB<W`[/"]F;VYT/B`\+W1D/B`\=&0@<W1Y;&4]
M,T0G1$E34$Q!63H@:6YL:6YE.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O
M;6%N.R!&3TY4+5-)6D4Z(#$P<'0[(%1%6%0M04Q)1TXZ(&QE9G0G('9A;&EG
M;CTS1&)O='1O;2!W:61T:#TS1#$E/B0\+W1D/B`\=&0@<W1Y;&4],T0G1$E3
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M<W`[/"]F;VYT/B`\+W1D/B`\=&0@<W1Y;&4],T0G5$585"U!3$E'3CH@;&5F
M="<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24^/&9O;G0@<W1Y;&4],T0G
M1D].5"U325I%.B`Q,'!T.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N
M.R!$25-03$%9.B!I;FQI;F4G/B`F;F)S<#L\+V9O;G0^(#PO=&0^(#QT9"!S
M='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE<R!N
M97<@<F]M86X[($9/3E0M4TE:13H@,3!P=#L@5$585"U!3$E'3CH@<FEG:'0G
M('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#DE/C$U+#`P,#PO=&0^(#QT9"!S
M='EL93TS1"=415A4+4%,24=..B!L969T)R!V86QI9VX],T1B;W1T;VT@=VED
M=&@],T0Q)2!N;W=R87`],T1N;W=R87`^/&9O;G0@<W1Y;&4],T0G1D].5"U3
M25I%.B`Q,'!T.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!$25-0
M3$%9.B!I;FQI;F4G/B`F;F)S<#L\+V9O;G0^(#PO=&0^(#QT9"!V86QI9VX]
M,T1B;W1T;VT@=VED=&@],T0Q)3X\9F]N="!S='EL93TS1"=&3TY4+5-)6D4Z
M(#$P<'0[($9/3E0M1D%-24Q9.B!T:6UE<R!N97<@<F]M86X[($1)4U!,05DZ
M(&EN;&EN92<^("9N8G-P.SPO9F]N=#X@/"]T9#X@/'1D('-T>6QE/3-$)U1%
M6%0M04Q)1TXZ(&QE9G0G('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E/CQF
M;VYT('-T>6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ('1I
M;65S(&YE=R!R;VUA;CL@1$E34$Q!63H@:6YL:6YE)SX@)FYB<W`[/"]F;VYT
M/B`\+W1D/B`\=&0@<W1Y;&4],T0G1$E34$Q!63H@:6YL:6YE.R!&3TY4+49!
M34E,63H@=&EM97,@;F5W(')O;6%N.R!&3TY4+5-)6D4Z(#$P<'0[(%1%6%0M
M04Q)1TXZ(')I9VAT)R!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Y)3XQ-2PP
M,#`\+W1D/B`\=&0@<W1Y;&4],T0G5$585"U!3$E'3CH@;&5F="<@=F%L:6=N
M/3-$8F]T=&]M('=I9'1H/3-$,24@;F]W<F%P/3-$;F]W<F%P/CQF;VYT('-T
M>6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ('1I;65S(&YE
M=R!R;VUA;CL@1$E34$Q!63H@:6YL:6YE)SX@)FYB<W`[/"]F;VYT/B`\+W1D
M/B`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24^/&9O;G0@<W1Y;&4]
M,T0G1D].5"U325I%.B`Q,'!T.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O
M;6%N.R!$25-03$%9.B!I;FQI;F4G/B`F;F)S<#L\+V9O;G0^(#PO=&0^(#QT
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M.B`Q,'!T.R!415A4+4%,24=..B!R:6=H="<@=F%L:6=N/3-$8F]T=&]M('=I
M9'1H/3-$.24^,BXT.3PO=&0^(#QT9"!S='EL93TS1"=415A4+4%,24=..B!L
M969T)R!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)2!N;W=R87`],T1N;W=R
M87`^/&9O;G0@<W1Y;&4],T0G1D].5"U325I%.B`Q,'!T.R!&3TY4+49!34E,
M63H@=&EM97,@;F5W(')O;6%N.R!$25-03$%9.B!I;FQI;F4G/B`F;F)S<#L\
M+V9O;G0^(#PO=&0^(#PO='(^(#QT<B!B9V-O;&]R/3-$=VAI=&4^(#QT9"!V
M86QI9VX],T1B;W1T;VT@=VED=&@],T0U,B4^/&9O;G0@<W1Y;&4],T0G1D].
M5"U325I%.B`Q,'!T.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!$
M25-03$%9.B!I;FQI;F4G/B`F;F)S<#L\+V9O;G0^(#PO=&0^(#QT9"!V86QI
M9VX],T1B;W1T;VT@=VED=&@],T0Q)3X\9F]N="!S='EL93TS1"=&3TY4+5-)
M6D4Z(#$P<'0[($9/3E0M1D%-24Q9.B!T:6UE<R!N97<@<F]M86X[($1)4U!,
M05DZ(&EN;&EN92<^("9N8G-P.SPO9F]N=#X@/"]T9#X@/'1D('-T>6QE/3-$
M)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA
M;CL@1D].5"U325I%.B`Q,'!T.R!415A4+4%,24=..B!L969T)R!V86QI9VX]
M,T1B;W1T;VT@=VED=&@],T0Q)3XD/"]T9#X@/'1D('-T>6QE/3-$)T1)4U!,
M05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].
M5"U325I%.B`Q,'!T.R!415A4+4%,24=..B!R:6=H="<@=F%L:6=N/3-$8F]T
M=&]M('=I9'1H/3-$.24^,RXX,#PO=&0^(#QT9"!S='EL93TS1"=415A4+4%,
M24=..B!L969T)R!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)2!N;W=R87`]
M,T1N;W=R87`^/&9O;G0@<W1Y;&4],T0G1D].5"U325I%.B`Q,'!T.R!&3TY4
M+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!$25-03$%9.B!I;FQI;F4G/B`F
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M1$E34$Q!63H@:6YL:6YE)SX@)FYB<W`[/"]F;VYT/B`\+W1D/B`\=&0@<W1Y
M;&4],T0G1$E34$Q!63H@:6YL:6YE.R!&3TY4+49!34E,63H@=&EM97,@;F5W
M(')O;6%N.R!&3TY4+5-)6D4Z(#$P<'0[(%1%6%0M04Q)1TXZ(')I9VAT)R!V
M86QI9VX],T1B;W1T;VT@=VED=&@],T0Y)3XQ-BPP-3`\+W1D/B`\=&0@<W1Y
M;&4],T0G5$585"U!3$E'3CH@;&5F="<@=F%L:6=N/3-$8F]T=&]M('=I9'1H
M/3-$,24@;F]W<F%P/3-$;F]W<F%P/CQF;VYT('-T>6QE/3-$)T9/3E0M4TE:
M13H@,3!P=#L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1$E34$Q!
M63H@:6YL:6YE)SX@)FYB<W`[/"]F;VYT/B`\+W1D/B`\=&0@=F%L:6=N/3-$
M8F]T=&]M('=I9'1H/3-$,24^/&9O;G0@<W1Y;&4],T0G1D].5"U325I%.B`Q
M,'!T.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!$25-03$%9.B!I
M;FQI;F4G/B`F;F)S<#L\+V9O;G0^(#PO=&0^(#QT9"!S='EL93TS1"=415A4
M+4%,24=..B!L969T)R!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)3X\9F]N
M="!S='EL93TS1"=&3TY4+5-)6D4Z(#$P<'0[($9/3E0M1D%-24Q9.B!T:6UE
M<R!N97<@<F]M86X[($1)4U!,05DZ(&EN;&EN92<^("9N8G-P.SPO9F]N=#X@
M/"]T9#X@/'1D('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)
M3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T.R!415A4+4%,
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M;CL@1$E34$Q!63H@:6YL:6YE)SX@)FYB<W`[/"]F;VYT/B`\+W1D/B`\=&0@
M<W1Y;&4],T0G5$585"U!3$E'3CH@;&5F="<@=F%L:6=N/3-$8F]T=&]M('=I
M9'1H/3-$,24^/&9O;G0@<W1Y;&4],T0G1D].5"U325I%.B`Q,'!T.R!&3TY4
M+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!$25-03$%9.B!I;FQI;F4G/B`F
M;F)S<#L\+V9O;G0^(#PO=&0^(#QT9"!S='EL93TS1"=$25-03$%9.B!I;FQI
M;F4[($9/3E0M1D%-24Q9.B!T:6UE<R!N97<@<F]M86X[($9/3E0M4TE:13H@
M,3!P=#L@5$585"U!3$E'3CH@<FEG:'0G('9A;&EG;CTS1&)O='1O;2!W:61T
M:#TS1#DE/C(N-3,\+W1D/B`\=&0@<W1Y;&4],T0G5$585"U!3$E'3CH@;&5F
M="<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@;F]W<F%P/3-$;F]W<F%P
M/CQF;VYT('-T>6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ
M('1I;65S(&YE=R!R;VUA;CL@1$E34$Q!63H@:6YL:6YE)SX@)FYB<W`[/"]F
M;VYT/B`\+W1D/B`\+W1R/B`\='(@8F=C;VQO<CTS1"-C8V5E9F8^(#QT9"!V
M86QI9VX],T1B;W1T;VT@=VED=&@],T0U,B4^/&9O;G0@<W1Y;&4],T0G1D].
M5"U325I%.B`Q,'!T.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!$
M25-03$%9.B!I;FQI;F4G/B`F;F)S<#L\+V9O;G0^(#PO=&0^(#QT9"!V86QI
M9VX],T1B;W1T;VT@=VED=&@],T0Q)3X\9F]N="!S='EL93TS1"=&3TY4+5-)
M6D4Z(#$P<'0[($9/3E0M1D%-24Q9.B!T:6UE<R!N97<@<F]M86X[($1)4U!,
M05DZ(&EN;&EN92<^("9N8G-P.SPO9F]N=#X@/"]T9#X@/'1D('-T>6QE/3-$
M)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA
M;CL@1D].5"U325I%.B`Q,'!T.R!415A4+4%,24=..B!L969T)R!V86QI9VX]
M,T1B;W1T;VT@=VED=&@],T0Q)3XD/"]T9#X@/'1D('-T>6QE/3-$)T1)4U!,
M05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].
M5"U325I%.B`Q,'!T.R!415A4+4%,24=..B!R:6=H="<@=F%L:6=N/3-$8F]T
M=&]M('=I9'1H/3-$.24^-"XP,#PO=&0^(#QT9"!S='EL93TS1"=415A4+4%,
M24=..B!L969T)R!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)2!N;W=R87`]
M,T1N;W=R87`^/&9O;G0@<W1Y;&4],T0G1D].5"U325I%.B`Q,'!T.R!&3TY4
M+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!$25-03$%9.B!I;FQI;F4G/B`F
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M1$E34$Q!63H@:6YL:6YE)SX@)FYB<W`[/"]F;VYT/B`\+W1D/B`\=&0@<W1Y
M;&4],T0G1$E34$Q!63H@:6YL:6YE.R!&3TY4+49!34E,63H@=&EM97,@;F5W
M(')O;6%N.R!&3TY4+5-)6D4Z(#$P<'0[(%1%6%0M04Q)1TXZ(')I9VAT)R!V
M86QI9VX],T1B;W1T;VT@=VED=&@],T0Y)3XT,BPU,#`\+W1D/B`\=&0@<W1Y
M;&4],T0G5$585"U!3$E'3CH@;&5F="<@=F%L:6=N/3-$8F]T=&]M('=I9'1H
M/3-$,24@;F]W<F%P/3-$;F]W<F%P/CQF;VYT('-T>6QE/3-$)T9/3E0M4TE:
M13H@,3!P=#L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1$E34$Q!
M63H@:6YL:6YE)SX@)FYB<W`[/"]F;VYT/B`\+W1D/B`\=&0@=F%L:6=N/3-$
M8F]T=&]M('=I9'1H/3-$,24^/&9O;G0@<W1Y;&4],T0G1D].5"U325I%.B`Q
M,'!T.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!$25-03$%9.B!I
M;FQI;F4G/B`F;F)S<#L\+V9O;G0^(#PO=&0^(#QT9"!S='EL93TS1"=415A4
M+4%,24=..B!L969T)R!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)3X\9F]N
M="!S='EL93TS1"=&3TY4+5-)6D4Z(#$P<'0[($9/3E0M1D%-24Q9.B!T:6UE
M<R!N97<@<F]M86X[($1)4U!,05DZ(&EN;&EN92<^("9N8G-P.SPO9F]N=#X@
M/"]T9#X@/'1D('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)
M3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T.R!415A4+4%,
M24=..B!R:6=H="<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$.24^-#(L-3`P
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M;CL@1$E34$Q!63H@:6YL:6YE)SX@)FYB<W`[/"]F;VYT/B`\+W1D/B`\=&0@
M<W1Y;&4],T0G5$585"U!3$E'3CH@;&5F="<@=F%L:6=N/3-$8F]T=&]M('=I
M9'1H/3-$,24^/&9O;G0@<W1Y;&4],T0G1D].5"U325I%.B`Q,'!T.R!&3TY4
M+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!$25-03$%9.B!I;FQI;F4G/B`F
M;F)S<#L\+V9O;G0^(#PO=&0^(#QT9"!S='EL93TS1"=$25-03$%9.B!I;FQI
M;F4[($9/3E0M1D%-24Q9.B!T:6UE<R!N97<@<F]M86X[($9/3E0M4TE:13H@
M,3!P=#L@5$585"U!3$E'3CH@<FEG:'0G('9A;&EG;CTS1&)O='1O;2!W:61T
M:#TS1#DE/C(N,S`\+W1D/B`\=&0@<W1Y;&4],T0G5$585"U!3$E'3CH@;&5F
M="<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@;F]W<F%P/3-$;F]W<F%P
M/CQF;VYT('-T>6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ
M('1I;65S(&YE=R!R;VUA;CL@1$E34$Q!63H@:6YL:6YE)SX@)FYB<W`[/"]F
M;VYT/B`\+W1D/B`\+W1R/B`\='(@8F=C;VQO<CTS1'=H:71E/B`\=&0@=F%L
M:6=N/3-$8F]T=&]M('=I9'1H/3-$-3(E/CQF;VYT('-T>6QE/3-$)T9/3E0M
M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1$E3
M4$Q!63H@:6YL:6YE)SX@)FYB<W`[/"]F;VYT/B`\+W1D/B`\=&0@=F%L:6=N
M/3-$8F]T=&]M('=I9'1H/3-$,24^/&9O;G0@<W1Y;&4],T0G1D].5"U325I%
M.B`Q,'!T.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!$25-03$%9
M.B!I;FQI;F4G/B`F;F)S<#L\+V9O;G0^(#PO=&0^(#QT9"!S='EL93TS1"=$
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M;2!W:61T:#TS1#DE/C0N,S@@+2`D(#0N-#`\+W1D/B`\=&0@<W1Y;&4],T0G
M5$585"U!3$E'3CH@;&5F="<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@
M;F]W<F%P/3-$;F]W<F%P/CQF;VYT('-T>6QE/3-$)T9/3E0M4TE:13H@,3!P
M=#L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1$E34$Q!63H@:6YL
M:6YE)SX@)FYB<W`[/"]F;VYT/B`\+W1D/B`\=&0@=F%L:6=N/3-$8F]T=&]M
M('=I9'1H/3-$,24^/&9O;G0@<W1Y;&4],T0G1D].5"U325I%.B`Q,'!T.R!&
M3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!$25-03$%9.B!I;FQI;F4G
M/B`F;F)S<#L\+V9O;G0^(#PO=&0^(#QT9"!S='EL93TS1"=415A4+4%,24=.
M.B!L969T)R!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)3X\9F]N="!S='EL
M93TS1"=&3TY4+5-)6D4Z(#$P<'0[($9/3E0M1D%-24Q9.B!T:6UE<R!N97<@
M<F]M86X[($1)4U!,05DZ(&EN;&EN92<^("9N8G-P.SPO9F]N=#X@/"]T9#X@
M/'1D('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I
M;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T.R!415A4+4%,24=..B!R
M:6=H="<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$.24^-#$W+#(Y.3PO=&0^
M(#QT9"!S='EL93TS1"=415A4+4%,24=..B!L969T)R!V86QI9VX],T1B;W1T
M;VT@=VED=&@],T0Q)2!N;W=R87`],T1N;W=R87`^/&9O;G0@<W1Y;&4],T0G
M1D].5"U325I%.B`Q,'!T.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N
M.R!$25-03$%9.B!I;FQI;F4G/B`F;F)S<#L\+V9O;G0^(#PO=&0^(#QT9"!V
M86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)3X\9F]N="!S='EL93TS1"=&3TY4
M+5-)6D4Z(#$P<'0[($9/3E0M1D%-24Q9.B!T:6UE<R!N97<@<F]M86X[($1)
M4U!,05DZ(&EN;&EN92<^("9N8G-P.SPO9F]N=#X@/"]T9#X@/'1D('-T>6QE
M/3-$)U1%6%0M04Q)1TXZ(&QE9G0G('9A;&EG;CTS1&)O='1O;2!W:61T:#TS
M1#$E/CQF;VYT('-T>6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@1D].5"U&04U)
M3%DZ('1I;65S(&YE=R!R;VUA;CL@1$E34$Q!63H@:6YL:6YE)SX@)FYB<W`[
M/"]F;VYT/B`\+W1D/B`\=&0@<W1Y;&4],T0G1$E34$Q!63H@:6YL:6YE.R!&
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M(&YE=R!R;VUA;CL@1$E34$Q!63H@:6YL:6YE)SX@)FYB<W`[/"]F;VYT/B`\
M+W1D/B`\=&0@<W1Y;&4],T0G5$585"U!3$E'3CH@;&5F="<@=F%L:6=N/3-$
M8F]T=&]M('=I9'1H/3-$,24^/&9O;G0@<W1Y;&4],T0G1D].5"U325I%.B`Q
M,'!T.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!$25-03$%9.B!I
M;FQI;F4G/B`F;F)S<#L\+V9O;G0^(#PO=&0^(#QT9"!S='EL93TS1"=$25-0
M3$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE<R!N97<@<F]M86X[($9/
M3E0M4TE:13H@,3!P=#L@5$585"U!3$E'3CH@<FEG:'0G('9A;&EG;CTS1&)O
M='1O;2!W:61T:#TS1#DE/C,N,C@\+W1D/B`\=&0@<W1Y;&4],T0G5$585"U!
M3$E'3CH@;&5F="<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@;F]W<F%P
M/3-$;F]W<F%P/CQF;VYT('-T>6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@1D].
M5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1$E34$Q!63H@:6YL:6YE)SX@
M)FYB<W`[/"]F;VYT/B`\+W1D/B`\+W1R/B`\='(@8F=C;VQO<CTS1"-C8V5E
M9F8^(#QT9"!V86QI9VX],T1B;W1T;VT@=VED=&@],T0U,B4^/&9O;G0@<W1Y
M;&4],T0G1D].5"U325I%.B`Q,'!T.R!&3TY4+49!34E,63H@=&EM97,@;F5W
M(')O;6%N.R!$25-03$%9.B!I;FQI;F4G/B`F;F)S<#L\+V9O;G0^(#PO=&0^
M(#QT9"!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)3X\9F]N="!S='EL93TS
M1"=&3TY4+5-)6D4Z(#$P<'0[($9/3E0M1D%-24Q9.B!T:6UE<R!N97<@<F]M
M86X[($1)4U!,05DZ(&EN;&EN92<^("9N8G-P.SPO9F]N=#X@/"]T9#X@/'1D
M('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S
M(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T.R!415A4+4%,24=..B!L969T
M)R!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)3XD/"]T9#X@/'1D('-T>6QE
M/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R
M;VUA;CL@1D].5"U325I%.B`Q,'!T.R!415A4+4%,24=..B!R:6=H="<@=F%L
M:6=N/3-$8F]T=&]M('=I9'1H/3-$.24^-BXX,#PO=&0^(#QT9"!S='EL93TS
M1"=415A4+4%,24=..B!L969T)R!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q
M)2!N;W=R87`],T1N;W=R87`^/&9O;G0@<W1Y;&4],T0G1D].5"U325I%.B`Q
M,'!T.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!$25-03$%9.B!I
M;FQI;F4G/B`F;F)S<#L\+V9O;G0^(#PO=&0^(#QT9"!V86QI9VX],T1B;W1T
M;VT@=VED=&@],T0Q)3X\9F]N="!S='EL93TS1"=&3TY4+5-)6D4Z(#$P<'0[
M($9/3E0M1D%-24Q9.B!T:6UE<R!N97<@<F]M86X[($1)4U!,05DZ(&EN;&EN
M92<^("9N8G-P.SPO9F]N=#X@/"]T9#X@/'1D('-T>6QE/3-$)U1%6%0M04Q)
M1TXZ(&QE9G0G('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E/CQF;VYT('-T
M>6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ('1I;65S(&YE
M=R!R;VUA;CL@1$E34$Q!63H@:6YL:6YE)SX@)FYB<W`[/"]F;VYT/B`\+W1D
M/B`\=&0@<W1Y;&4],T0G1$E34$Q!63H@:6YL:6YE.R!&3TY4+49!34E,63H@
M=&EM97,@;F5W(')O;6%N.R!&3TY4+5-)6D4Z(#$P<'0[(%1%6%0M04Q)1TXZ
M(')I9VAT)R!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Y)3XS-BPR-3`\+W1D
M/B`\=&0@<W1Y;&4],T0G5$585"U!3$E'3CH@;&5F="<@=F%L:6=N/3-$8F]T
M=&]M('=I9'1H/3-$,24@;F]W<F%P/3-$;F]W<F%P/CQF;VYT('-T>6QE/3-$
M)T9/3E0M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA
M;CL@1$E34$Q!63H@:6YL:6YE)SX@)FYB<W`[/"]F;VYT/B`\+W1D/B`\=&0@
M=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24^/&9O;G0@<W1Y;&4],T0G1D].
M5"U325I%.B`Q,'!T.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!$
M25-03$%9.B!I;FQI;F4G/B`F;F)S<#L\+V9O;G0^(#PO=&0^(#QT9"!S='EL
M93TS1"=415A4+4%,24=..B!L969T)R!V86QI9VX],T1B;W1T;VT@=VED=&@]
M,T0Q)3X\9F]N="!S='EL93TS1"=&3TY4+5-)6D4Z(#$P<'0[($9/3E0M1D%-
M24Q9.B!T:6UE<R!N97<@<F]M86X[($1)4U!,05DZ(&EN;&EN92<^("9N8G-P
M.SPO9F]N=#X@/"]T9#X@/'1D('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@
M1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T
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M(&YE=R!R;VUA;CL@1$E34$Q!63H@:6YL:6YE)SX@)FYB<W`[/"]F;VYT/B`\
M+W1D/B`\=&0@<W1Y;&4],T0G5$585"U!3$E'3CH@;&5F="<@=F%L:6=N/3-$
M8F]T=&]M('=I9'1H/3-$,24^/&9O;G0@<W1Y;&4],T0G1D].5"U325I%.B`Q
M,'!T.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!$25-03$%9.B!I
M;FQI;F4G/B`F;F)S<#L\+V9O;G0^(#PO=&0^(#QT9"!S='EL93TS1"=$25-0
M3$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE<R!N97<@<F]M86X[($9/
M3E0M4TE:13H@,3!P=#L@5$585"U!3$E'3CH@<FEG:'0G('9A;&EG;CTS1&)O
M='1O;2!W:61T:#TS1#DE/C,N,S<\+W1D/B`\=&0@<W1Y;&4],T0G5$585"U!
M3$E'3CH@;&5F="<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@;F]W<F%P
M/3-$;F]W<F%P/CQF;VYT('-T>6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@1D].
M5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1$E34$Q!63H@:6YL:6YE)SX@
M)FYB<W`[/"]F;VYT/B`\+W1D/B`\+W1R/B`\='(@8F=C;VQO<CTS1'=H:71E
M/B`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$-3(E/CQF;VYT('-T>6QE
M/3-$)T9/3E0M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R
M;VUA;CL@1$E34$Q!63H@:6YL:6YE)SX@)FYB<W`[/"]F;VYT/B`\+W1D/B`\
M=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24^/&9O;G0@<W1Y;&4],T0G
M1D].5"U325I%.B`Q,'!T.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N
M.R!$25-03$%9.B!I;FQI;F4G/B`F;F)S<#L\+V9O;G0^(#PO=&0^(#QT9"!S
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M;CTS1&)O='1O;2!W:61T:#TS1#DE/C@N,C`\+W1D/B`\=&0@<W1Y;&4],T0G
M5$585"U!3$E'3CH@;&5F="<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@
M;F]W<F%P/3-$;F]W<F%P/CQF;VYT('-T>6QE/3-$)T9/3E0M4TE:13H@,3!P
M=#L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1$E34$Q!63H@:6YL
M:6YE)SX@)FYB<W`[/"]F;VYT/B`\+W1D/B`\=&0@=F%L:6=N/3-$8F]T=&]M
M('=I9'1H/3-$,24^/&9O;G0@<W1Y;&4],T0G1D].5"U325I%.B`Q,'!T.R!&
M3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!$25-03$%9.B!I;FQI;F4G
M/B`F;F)S<#L\+V9O;G0^(#PO=&0^(#QT9"!S='EL93TS1"=415A4+4%,24=.
M.B!L969T)R!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)3X\9F]N="!S='EL
M93TS1"=&3TY4+5-)6D4Z(#$P<'0[($9/3E0M1D%-24Q9.B!T:6UE<R!N97<@
M<F]M86X[($1)4U!,05DZ(&EN;&EN92<^("9N8G-P.SPO9F]N=#X@/"]T9#X@
M/'1D('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I
M;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T.R!415A4+4%,24=..B!R
M:6=H="<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$.24^,S`L,#`P/"]T9#X@
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M4$Q!63H@:6YL:6YE)SX@)FYB<W`[/"]F;VYT/B`\+W1D/B`\=&0@<W1Y;&4]
M,T0G5$585"U!3$E'3CH@;&5F="<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$
M,24^/&9O;G0@<W1Y;&4],T0G1D].5"U325I%.B`Q,'!T.R!&3TY4+49!34E,
M63H@=&EM97,@;F5W(')O;6%N.R!$25-03$%9.B!I;FQI;F4G/B`F;F)S<#L\
M+V9O;G0^(#PO=&0^(#QT9"!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/
M3E0M1D%-24Q9.B!T:6UE<R!N97<@<F]M86X[($9/3E0M4TE:13H@,3!P=#L@
M5$585"U!3$E'3CH@<FEG:'0G('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#DE
M/C,P+#`P,#PO=&0^(#QT9"!S='EL93TS1"=415A4+4%,24=..B!L969T)R!V
M86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)2!N;W=R87`],T1N;W=R87`^/&9O
M;G0@<W1Y;&4],T0G1D].5"U325I%.B`Q,'!T.R!&3TY4+49!34E,63H@=&EM
M97,@;F5W(')O;6%N.R!$25-03$%9.B!I;FQI;F4G/B`F;F)S<#L\+V9O;G0^
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M:6YE)SX@)FYB<W`[/"]F;VYT/B`\+W1D/B`\=&0@<W1Y;&4],T0G1$E34$Q!
M63H@:6YL:6YE.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!&3TY4
M+5-)6D4Z(#$P<'0[(%1%6%0M04Q)1TXZ(')I9VAT)R!V86QI9VX],T1B;W1T
M;VT@=VED=&@],T0Y)3XR+C0P/"]T9#X@/'1D('-T>6QE/3-$)U1%6%0M04Q)
M1TXZ(&QE9G0G('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E(&YO=W)A<#TS
M1&YO=W)A<#X\9F]N="!S='EL93TS1"=&3TY4+5-)6D4Z(#$P<'0[($9/3E0M
M1D%-24Q9.B!T:6UE<R!N97<@<F]M86X[($1)4U!,05DZ(&EN;&EN92<^("9N
M8G-P.SPO9F]N=#X@/"]T9#X@/"]T<CX@/'1R(&)G8V]L;W(],T0C8V-E969F
M/B`\=&0@<W1Y;&4],T0G4$%$1$E.1RU"3U143TTZ(#)P>"<@=F%L:6=N/3-$
M8F]T=&]M('=I9'1H/3-$-3(E/CQF;VYT('-T>6QE/3-$)T9/3E0M4TE:13H@
M,3!P=#L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1$E34$Q!63H@
M:6YL:6YE)SX@)FYB<W`[/"]F;VYT/B`\+W1D/B`\=&0@<W1Y;&4],T0G4$%$
M1$E.1RU"3U143TTZ(#)P>"<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24^
M/&9O;G0@<W1Y;&4],T0G1D].5"U325I%.B`Q,'!T.R!&3TY4+49!34E,63H@
M=&EM97,@;F5W(')O;6%N.R!$25-03$%9.B!I;FQI;F4G/B`F;F)S<#L\+V9O
M;G0^(#PO=&0^(#QT9"!S='EL93TS1"="3U)$15(M0D]45$]-.B!B;&%C:R`R
M<'@@<V]L:60[($1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S
M(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T.R!415A4+4%,24=..B!L969T
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M=VED=&@],T0Q)2!N;W=R87`],T1N;W=R87`^/&9O;G0@<W1Y;&4],T0G1D].
M5"U325I%.B`Q,'!T.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!$
M25-03$%9.B!I;FQI;F4G/B`F;F)S<#L\+V9O;G0^(#PO=&0^(#QT9"!S='EL
M93TS1"=0041$24Y'+4)/5%1/33H@,G!X)R!V86QI9VX],T1B;W1T;VT@=VED
M=&@],T0Q)3X\9F]N="!S='EL93TS1"=&3TY4+5-)6D4Z(#$P<'0[($9/3E0M
M1D%-24Q9.B!T:6UE<R!N97<@<F]M86X[($1)4U!,05DZ(&EN;&EN92<^("9N
M8G-P.SPO9F]N=#X@/"]T9#X@/'1D('-T>6QE/3-$)T)/4D1%4BU"3U143TTZ
M(&)L86-K(#)P>"!S;VQI9#L@5$585"U!3$E'3CH@;&5F="<@=F%L:6=N/3-$
M8F]T=&]M('=I9'1H/3-$,24^/&9O;G0@<W1Y;&4],T0G1D].5"U325I%.B`Q
M,'!T.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!$25-03$%9.B!I
M;FQI;F4G/B`F;F)S<#L\+V9O;G0^(#PO=&0^(#QT9"!S='EL93TS1"="3U)$
M15(M0D]45$]-.B!B;&%C:R`R<'@@<V]L:60[($1)4U!,05DZ(&EN;&EN93L@
M1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T
M.R!415A4+4%,24=..B!R:6=H="<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$
M.24^,3`W+#4P,#PO=&0^(#QT9"!S='EL93TS1"=0041$24Y'+4)/5%1/33H@
M,G!X.R!415A4+4%,24=..B!L969T)R!V86QI9VX],T1B;W1T;VT@=VED=&@]
M,T0Q)2!N;W=R87`],T1N;W=R87`^/&9O;G0@<W1Y;&4],T0G1D].5"U325I%
M.B`Q,'!T.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!$25-03$%9
M.B!I;FQI;F4G/B`F;F)S<#L\+V9O;G0^(#PO=&0^(#QT9"!S='EL93TS1"=0
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M('=I9'1H/3-$,24^/&9O;G0@<W1Y;&4],T0G1D].5"U325I%.B`Q,'!T.R!&
M3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!$25-03$%9.B!I;FQI;F4G
M/B`F;F)S<#L\+V9O;G0^(#PO=&0^(#QT9"!S='EL93TS1"="3U)$15(M0D]4
M5$]-.B!B;&%C:R`R<'@@<V]L:60[($1)4U!,05DZ(&EN;&EN93L@1D].5"U&
M04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T.R!415A4
M+4%,24=..B!R:6=H="<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$.24^,3`W
M+#4P,#PO=&0^(#QT9"!S='EL93TS1"=0041$24Y'+4)/5%1/33H@,G!X.R!4
M15A4+4%,24=..B!L969T)R!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)2!N
M;W=R87`],T1N;W=R87`^/&9O;G0@<W1Y;&4],T0G1D].5"U325I%.B`Q,'!T
M.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!$25-03$%9.B!I;FQI
M;F4G/B`F;F)S<#L\+V9O;G0^(#PO=&0^(#QT9"!S='EL93TS1"=0041$24Y'
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M/3-$,24^/&9O;G0@<W1Y;&4],T0G1D].5"U325I%.B`Q,'!T.R!&3TY4+49!
M34E,63H@=&EM97,@;F5W(')O;6%N.R!$25-03$%9.B!I;FQI;F4G/B`F;F)S
M<#L\+V9O;G0^(#PO=&0^(#QT9"!S='EL93TS1"="3U)$15(M0D]45$]-.B!B
M;&%C:R`R<'@@<V]L:60[($1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ
M('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T.R!415A4+4%,24=.
M.B!R:6=H="<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$.24^,BXX.#PO=&0^
M(#QT9"!S='EL93TS1"=0041$24Y'+4)/5%1/33H@,G!X.R!415A4+4%,24=.
M.B!L969T)R!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)2!N;W=R87`],T1N
M;W=R87`^/&9O;G0@<W1Y;&4],T0G1D].5"U325I%.B`Q,'!T.R!&3TY4+49!
M34E,63H@=&EM97,@;F5W(')O;6%N.R!$25-03$%9.B!I;FQI;F4G/B`F;F)S
M<#L\+V9O;G0^(#PO=&0^(#PO='(^(#QT<B!B9V-O;&]R/3-$=VAI=&4^(#QT
M9"!S='EL93TS1"=0041$24Y'+4)/5%1/33H@-'!X.R!415A4+4%,24=..B!L
M969T.R!-05)'24XM3$5&5#H@,'!T.R!-05)'24XM4DE'2%0Z(#!P=#L@5$58
M5"U)3D1%3E0Z(#!P="<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$-3(E/B`\
M9&EV('-T>6QE/3-$)T1)4U!,05DZ(&)L;V-K.R!&3TY4+49!34E,63H@=&EM
M97,@;F5W(')O;6%N.R!&3TY4+5-)6D4Z(#$P<'0[($9/3E0M5T5)1TA4.B!B
M;VQD.R!-05)'24XM3$5&5#H@,'!T.R!-05)'24XM4DE'2%0Z(#!P=#L@5$58
M5"U!3$E'3CH@;&5F=#L@5$585"U)3D1%3E0Z(#!P="<^(%1O=&%L(&]P=&EO
M;G,\+V1I=CX@/"]T9#X@/'1D('-T>6QE/3-$)U!!1$1)3D<M0D]45$]-.B`T
M<'@G('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E/CQF;VYT('-T>6QE/3-$
M)T9/3E0M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA
M;CL@1$E34$Q!63H@:6YL:6YE)SX@)FYB<W`[/"]F;VYT/B`\+W1D/B`\=&0@
M<W1Y;&4],T0G0D]21$52+4)/5%1/33H@8FQA8VL@-'!X(&1O=6)L93L@5$58
M5"U!3$E'3CH@;&5F="<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24^/&9O
M;G0@<W1Y;&4],T0G1D].5"U325I%.B`Q,'!T.R!&3TY4+49!34E,63H@=&EM
M97,@;F5W(')O;6%N.R!$25-03$%9.B!I;FQI;F4G/B`F;F)S<#L\+V9O;G0^
M(#PO=&0^(#QT9"!S='EL93TS1"="3U)$15(M0D]45$]-.B!B;&%C:R`T<'@@
M9&]U8FQE.R!415A4+4%,24=..B!R:6=H="<@=F%L:6=N/3-$8F]T=&]M('=I
M9'1H/3-$.24^/&9O;G0@<W1Y;&4],T0G1D].5"U325I%.B`Q,'!T.R!&3TY4
M+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!$25-03$%9.B!I;FQI;F4G/B`F
M;F)S<#L\+V9O;G0^(#PO=&0^(#QT9"!S='EL93TS1"=0041$24Y'+4)/5%1/
M33H@-'!X.R!415A4+4%,24=..B!L969T)R!V86QI9VX],T1B;W1T;VT@=VED
M=&@],T0Q)2!N;W=R87`],T1N;W=R87`^/&9O;G0@<W1Y;&4],T0G1D].5"U3
M25I%.B`Q,'!T.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!$25-0
M3$%9.B!I;FQI;F4G/B`F;F)S<#L\+V9O;G0^(#PO=&0^(#QT9"!S='EL93TS
M1"=0041$24Y'+4)/5%1/33H@-'!X)R!V86QI9VX],T1B;W1T;VT@=VED=&@]
M,T0Q)3X\9F]N="!S='EL93TS1"=&3TY4+5-)6D4Z(#$P<'0[($9/3E0M1D%-
M24Q9.B!T:6UE<R!N97<@<F]M86X[($9/3E0M5T5)1TA4.B!B;VQD.R!$25-0
M3$%9.B!I;FQI;F4G/B`F;F)S<#L\+V9O;G0^(#PO=&0^(#QT9"!S='EL93TS
M1"="3U)$15(M0D]45$]-.B!B;&%C:R`T<'@@9&]U8FQE.R!415A4+4%,24=.
M.B!L969T)R!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)3X\9F]N="!S='EL
M93TS1"=&3TY4+5-)6D4Z(#$P<'0[($9/3E0M1D%-24Q9.B!T:6UE<R!N97<@
M<F]M86X[($9/3E0M5T5)1TA4.B!B;VQD.R!$25-03$%9.B!I;FQI;F4G/B`F
M;F)S<#L\+V9O;G0^(#PO=&0^(#QT9"!S='EL93TS1"="3U)$15(M0D]45$]-
M.B!B;&%C:R`T<'@@9&]U8FQE.R!$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-
M24Q9.B!T:6UE<R!N97<@<F]M86X[($9/3E0M4TE:13H@,3!P=#L@1D].5"U7
M14E'2%0Z(&)O;&0[(%1%6%0M04Q)1TXZ(')I9VAT)R!V86QI9VX],T1B;W1T
M;VT@=VED=&@],T0Y)3XR+#$Q-"PP.3D\+W1D/B`\=&0@<W1Y;&4],T0G4$%$
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M.B`T<'@G('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E/CQF;VYT('-T>6QE
M/3-$)T9/3E0M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R
M;VUA;CL@1D].5"U714E'2%0Z(&)O;&0[($1)4U!,05DZ(&EN;&EN92<^("9N
M8G-P.SPO9F]N=#X@/"]T9#X@/'1D('-T>6QE/3-$)T)/4D1%4BU"3U143TTZ
M(&)L86-K(#1P>"!D;W5B;&4[(%1%6%0M04Q)1TXZ(&QE9G0G('9A;&EG;CTS
M1&)O='1O;2!W:61T:#TS1#$E/CQF;VYT('-T>6QE/3-$)T9/3E0M4TE:13H@
M,3!P=#L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U714E'
M2%0Z(&)O;&0[($1)4U!,05DZ(&EN;&EN92<^("9N8G-P.SPO9F]N=#X@/"]T
M9#X@/'1D('-T>6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#1P>"!D;W5B
M;&4[($1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R
M;VUA;CL@1D].5"U325I%.B`Q,'!T.R!&3TY4+5=%24=(5#H@8F]L9#L@5$58
M5"U!3$E'3CH@<FEG:'0G('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#DE/C(L
M,3$S+#`Y.3PO=&0^(#QT9"!S='EL93TS1"=0041$24Y'+4)/5%1/33H@-'!X
M.R!415A4+4%,24=..B!L969T)R!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q
M)2!N;W=R87`],T1N;W=R87`^/&9O;G0@<W1Y;&4],T0G1D].5"U325I%.B`Q
M,'!T.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!&3TY4+5=%24=(
M5#H@8F]L9#L@1$E34$Q!63H@:6YL:6YE)SX@)FYB<W`[/"]F;VYT/B`\+W1D
M/B`\=&0@<W1Y;&4],T0G4$%$1$E.1RU"3U143TTZ(#1P>"<@=F%L:6=N/3-$
M8F]T=&]M('=I9'1H/3-$,24^/&9O;G0@<W1Y;&4],T0G1D].5"U325I%.B`Q
M,'!T.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!$25-03$%9.B!I
M;FQI;F4G/B`F;F)S<#L\+V9O;G0^(#PO=&0^(#QT9"!S='EL93TS1"="3U)$
M15(M0D]45$]-.B!B;&%C:R`T<'@@9&]U8FQE.R!415A4+4%,24=..B!L969T
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M/"]T9#X@/'1D('-T>6QE/3-$)U!!1$1)3D<M0D]45$]-.B`T<'@[(%1%6%0M
M04Q)1TXZ(&QE9G0G('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E(&YO=W)A
M<#TS1&YO=W)A<#X\9F]N="!S='EL93TS1"=&3TY4+5-)6D4Z(#$P<'0[($9/
M3E0M1D%-24Q9.B!T:6UE<R!N97<@<F]M86X[($1)4U!,05DZ(&EN;&EN92<^
M("9N8G-P.SPO9F]N=#X@/"]T9#X@/"]T<CX@/'1R(&)G8V]L;W(],T0C8V-E
M969F/B`\=&0@<W1Y;&4],T0G4$%$1$E.1RU"3U143TTZ(#)P>#L@5$585"U!
M3$E'3CH@;&5F=#L@34%21TE.+4Q%1E0Z(#!P=#L@34%21TE.+5))1TA4.B`P
M<'0[(%1%6%0M24Y$14Y4.B`P<'0G('9A;&EG;CTS1&)O='1O;2!W:61T:#TS
M1#4R)3X@/&1I=B!S='EL93TS1"=$25-03$%9.B!B;&]C:SL@1D].5"U&04U)
M3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T.R!&3TY4+5=%
M24=(5#H@8F]L9#L@34%21TE.+4Q%1E0Z(#!P=#L@34%21TE.+5))1TA4.B`P
M<'0[(%1%6%0M04Q)1TXZ(&QE9G0[(%1%6%0M24Y$14Y4.B`P<'0G/B!4;W1A
M;"!W87)R86YT<R!A;F0@;W!T:6]N<SPO9&EV/B`\+W1D/B`\=&0@<W1Y;&4]
M,T0G4$%$1$E.1RU"3U143TTZ(#)P>"<@=F%L:6=N/3-$8F]T=&]M('=I9'1H
M/3-$,24^/&9O;G0@<W1Y;&4],T0G1D].5"U325I%.B`Q,'!T.R!&3TY4+49!
M34E,63H@=&EM97,@;F5W(')O;6%N.R!$25-03$%9.B!I;FQI;F4G/B`F;F)S
M<#L\+V9O;G0^(#PO=&0^(#QT9"!S='EL93TS1"="3U)$15(M0D]45$]-.B!B
M;&%C:R`R<'@@<V]L:60[(%1%6%0M04Q)1TXZ(&QE9G0G('9A;&EG;CTS1&)O
M='1O;2!W:61T:#TS1#$E/CQF;VYT('-T>6QE/3-$)T9/3E0M4TE:13H@,3!P
M=#L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1$E34$Q!63H@:6YL
M:6YE)SX@)FYB<W`[/"]F;VYT/B`\+W1D/B`\=&0@<W1Y;&4],T0G0D]21$52
M+4)/5%1/33H@8FQA8VL@,G!X('-O;&ED.R!415A4+4%,24=..B!R:6=H="<@
M=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$.24^/&9O;G0@<W1Y;&4],T0G1D].
M5"U325I%.B`Q,'!T.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!$
M25-03$%9.B!I;FQI;F4G/B`F;F)S<#L\+V9O;G0^(#PO=&0^(#QT9"!S='EL
M93TS1"=0041$24Y'+4)/5%1/33H@,G!X.R!415A4+4%,24=..B!L969T)R!V
M86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)2!N;W=R87`],T1N;W=R87`^/&9O
M;G0@<W1Y;&4],T0G1D].5"U325I%.B`Q,'!T.R!&3TY4+49!34E,63H@=&EM
M97,@;F5W(')O;6%N.R!$25-03$%9.B!I;FQI;F4G/B`F;F)S<#L\+V9O;G0^
M(#PO=&0^(#QT9"!S='EL93TS1"=0041$24Y'+4)/5%1/33H@,G!X)R!V86QI
M9VX],T1B;W1T;VT@=VED=&@],T0Q)3X\9F]N="!S='EL93TS1"=&3TY4+5-)
M6D4Z(#$P<'0[($9/3E0M1D%-24Q9.B!T:6UE<R!N97<@<F]M86X[($9/3E0M
M5T5)1TA4.B!B;VQD.R!$25-03$%9.B!I;FQI;F4G/B`F;F)S<#L\+V9O;G0^
M(#PO=&0^(#QT9"!S='EL93TS1"="3U)$15(M0D]45$]-.B!B;&%C:R`R<'@@
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M="<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$.24^)FYB<W`[,3(L-C0X+#,P
M,SPO=&0^(#QT9"!S='EL93TS1"=0041$24Y'+4)/5%1/33H@,G!X.R!415A4
M+4%,24=..B!L969T)R!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)2!N;W=R
M87`],T1N;W=R87`^/&9O;G0@<W1Y;&4],T0G1D].5"U325I%.B`Q,'!T.R!&
M3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!&3TY4+5=%24=(5#H@8F]L
M9#L@1$E34$Q!63H@:6YL:6YE)SX@)FYB<W`[/"]F;VYT/B`\+W1D/B`\=&0@
M<W1Y;&4],T0G4$%$1$E.1RU"3U143TTZ(#)P>"<@=F%L:6=N/3-$8F]T=&]M
M('=I9'1H/3-$,24^/&9O;G0@<W1Y;&4],T0G1D].5"U325I%.B`Q,'!T.R!&
M3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!&3TY4+5=%24=(5#H@8F]L
M9#L@1$E34$Q!63H@:6YL:6YE)SX@)FYB<W`[/"]F;VYT/B`\+W1D/B`\=&0@
M<W1Y;&4],T0G0D]21$52+4)/5%1/33H@8FQA8VL@,G!X('-O;&ED.R!415A4
M+4%,24=..B!L969T)R!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)3X\9F]N
M="!S='EL93TS1"=&3TY4+5-)6D4Z(#$P<'0[($9/3E0M1D%-24Q9.B!T:6UE
M<R!N97<@<F]M86X[($9/3E0M5T5)1TA4.B!B;VQD.R!$25-03$%9.B!I;FQI
M;F4G/B`F;F)S<#L\+V9O;G0^(#PO=&0^(#QT9"!S='EL93TS1"="3U)$15(M
M0D]45$]-.B!B;&%C:R`R<'@@<V]L:60[($1)4U!,05DZ(&EN;&EN93L@1D].
M5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T.R!&
M3TY4+5=%24=(5#H@8F]L9#L@5$585"U!3$E'3CH@<FEG:'0G('9A;&EG;CTS
M1&)O='1O;2!W:61T:#TS1#DE/B9N8G-P.S$R+#8T-RPS,#,\+W1D/B`\=&0@
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M1$1)3D<M0D]45$]-.B`R<'@G('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E
M/CQF;VYT('-T>6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ
M('1I;65S(&YE=R!R;VUA;CL@1$E34$Q!63H@:6YL:6YE)SX@)FYB<W`[/"]F
M;VYT/B`\+W1D/B`\=&0@<W1Y;&4],T0G0D]21$52+4)/5%1/33H@8FQA8VL@
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M63H@:6YL:6YE)SX@)FYB<W`[/"]F;VYT/B`\+W1D/B`\=&0@<W1Y;&4],T0G
M4$%$1$E.1RU"3U143TTZ(#)P>#L@5$585"U!3$E'3CH@;&5F="<@=F%L:6=N
M/3-$8F]T=&]M('=I9'1H/3-$,24@;F]W<F%P/3-$;F]W<F%P/CQF;VYT('-T
M>6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ('1I;65S(&YE
M=R!R;VUA;CL@1$E34$Q!63H@:6YL:6YE)SX@)FYB<W`[/"]F;VYT/B`\+W1D
M/B`\+W1R/B`\+W1A8FQE/B`\+V1I=CX@/&1I=B!S='EL93TS1"=$25-03$%9
M.B!B;&]C:SL@34%21TE.+4Q%1E0Z(#!P=#L@34%21TE.+5))1TA4.B`P<'0[
M('1E>'0M86QI9VXZ(&IU<W1I9GD[(%1%6%0M24Y$14Y4.B`P<'0G/B`F;F)S
M<#L\+V1I=CX@/&1I=B!S='EL93TS1"=$25-03$%9.B!B;&]C:SL@1D].5"U&
M04U)3%DZ(%1I;65S($YE=R!2;VUA;CL@1D].5"U325I%.B`Q,'!T.R!-05)'
M24XM3$5&5#H@,3AP=#L@34%21TE.+5))1TA4.B`P<'0[('1E>'0M86QI9VXZ
M(&QE9G0[(%1%6%0M24Y$14Y4.B`P<'0G/B!4:&ES('-U;6UA<GD@9&]E<R!N
M;W0@:6YC;'5D92`Q+#8P-"PV.#(@<F5S=')I8W1E9"!S=&]C:R!U;FET<R!T
M:&%T(&%R92!N;W0@=F5S=&5D(&%S(&]F($IU;F4@,S`L(#(P,30N/"]D:78^
M(#PA+2U%;F1&<F%G;65N="TM/CPO9&EV/B`\+V1I=CX\<W!A;CX\+W-P86X^
M/"]T9#X-"B`@("`@(#PO='(^#0H@("`@/"]T86)L93X-"B`@/"]B;V1Y/@T*
M/"]H=&UL/@T*#0HM+2TM+2T]7TYE>'1087)T7S!C860U.69D7S<S,F5?-#9E
M,E]A-3,T7S!C.&%D,6%F.3!D9`T*0V]N=&5N="U,;V-A=&EO;CH@9FEL93HO
M+R]#.B\P8V%D-3EF9%\W,S)E7S0V93)?834S-%\P8SAA9#%A9CDP9&0O5V]R
M:W-H965T<R]3:&5E=#$W+FAT;6P-"D-O;G1E;G0M5')A;G-F97(M16YC;V1I
M;F<Z('%U;W1E9"UP<FEN=&%B;&4-"D-O;G1E;G0M5'EP93H@=&5X="]H=&UL
M.R!C:&%R<V5T/2)U<RUA<V-I:2(-"@T*/&AT;6P^#0H@(#QH96%D/@T*("`@
M(#Q-151!(&AT='`M97%U:78],T1#;VYT96YT+51Y<&4@8V]N=&5N=#TS1"=T
M97AT+VAT;6P[(&-H87)S970]=71F+3@G/CQS8W)I<'0@='EP93TS1'1E>'0O
M:F%V87-C<FEP="!S<F,],T13:&]W+FIS/B\J($1O($YO="!296UO=F4@5&AI
M<R!#;VUM96YT("HO/"]S8W)I<'0^/"]H96%D/@T*("`\8F]D>3X-"B`@("`\
M=&%B;&4@8VQA<W,],T1R97!O<G0@:60],T1)1#!%344^#0H@("`@("`\='(^
M#0H@("`@("`@(#QT:"!C;&%S<STS1'1L(&-O;'-P86X],T0Q(')O=W-P86X]
M,T0R/CQS=')O;F<^1DE.04Y#24%,($E.0T]-12P@3D54/&)R/CPO<W1R;VYG
M/CPO=&@^#0H@("`@("`@(#QT:"!C;&%S<STS1'1H(&-O;'-P86X],T0Q/C$R
M($UO;G1H<R!%;F1E9#PO=&@^#0H@("`@("`\+W1R/@T*("`@("`@/'1R/@T*
M("`@("`@("`\=&@@8VQA<W,],T1T:#Y*=6XN(#,P+"`R,#$T/&)R/CPO=&@^
M#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$<F4^#0H@("`@("`@
M(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O<#X\<W1R;VYG/D9)3D%.0TE!
M3"!)3D-/344L($Y%5"!;06)S=')A8W1=/"]S=')O;F<^/"]T9#X-"B`@("`@
M("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@
M("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$<F\^#0H@("`@("`@(#QT9"!C
M;&%S<STS1'!L('9A;&EG;CTS1'1O<#Y&24Y!3D-)04P@24Y#3TU%+"!.150\
M+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\(2TM1$]#5%E012!H
M=&UL(%!50DQ)0R`B+2\O5S-#+R]$5$0@6$A434P@,2XP(%1R86YS:71I;VYA
M;"\O14XB(")H='1P.B\O=W=W+G<S+F]R9R]44B]X:'1M;#$O1%1$+WAH=&UL
M,2UT<F%N<VET:6]N86PN9'1D(B`M+3X\9&EV/B`\9&EV/CPA+2U3=&%R=$9R
M86=M96YT+2T^(#QD:78@<W1Y;&4],T0G1$E34$Q!63H@8FQO8VL[($9/3E0M
M1D%-24Q9.B!4:6UE<R!.97<@4F]M86X[($9/3E0M4TE:13H@,3!P=#L@1D].
M5"U714E'2%0Z(&)O;&0[($U!4D=)3BU,1494.B`P<'0[($U!4D=)3BU224=(
M5#H@,'!T.R!415A4+4%,24=..B!L969T.R!415A4+4E.1$5.5#H@,'!T)SX@
M3D]412`Y.BU&24Y!3D-)04P@24Y#3TU%+"!.150\+V1I=CX@/&1I=B!S='EL
M93TS1"=$25-03$%9.B!B;&]C:SL@34%21TE.+4Q%1E0Z(#!P=#L@34%21TE.
M+5))1TA4.B`P<'0[('1E>'0M86QI9VXZ(&IU<W1I9GD[(%1%6%0M24Y$14Y4
M.B`P<'0G/B`F;F)S<#L\+V1I=CX@/&1I=B!S='EL93TS1"=T97AT+6%L:6=N
M.B!L969T)SX@/'1A8FQE('-T>6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@1D].
M5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;B<@8V5L;'-P86-I;F<],T0P(&-E
M;&QP861D:6YG/3-$,"!W:61T:#TS1#@P)3X@/'1R/B`\=&0@<W1Y;&4],T0G
M4$%$1$E.1RU"3U143TTZ(#)P>"<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$
M-C0E/CQF;VYT('-T>6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@1D].5"U&04U)
M3%DZ('1I;65S(&YE=R!R;VUA;CL@1$E34$Q!63H@:6YL:6YE)SX@)FYB<W`[
M/"]F;VYT/B`\+W1D/B`\=&0@<W1Y;&4],T0G4$%$1$E.1RU"3U143TTZ(#)P
M>"<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24^/&9O;G0@<W1Y;&4],T0G
M1D].5"U325I%.B`Q,'!T.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N
M.R!&3TY4+5=%24=(5#H@8F]L9#L@1$E34$Q!63H@:6YL:6YE)SX@)FYB<W`[
M/"]F;VYT/B`\+W1D/B`\=&0@<W1Y;&4],T0G0D]21$52+4)/5%1/33H@8FQA
M8VL@,G!X('-O;&ED)R!V86QI9VX],T1B;W1T;VT@=VED=&@],T0S-"4@8V]L
M<W!A;CTS1#$P/B`\9&EV('-T>6QE/3-$)T1)4U!,05DZ(&)L;V-K.R!&3TY4
M+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!&3TY4+5-)6D4Z(#$P<'0[($9/
M3E0M5T5)1TA4.B!B;VQD.R!-05)'24XM3$5&5#H@,'!T.R!-05)'24XM4DE'
M2%0Z(#!P=#L@=&5X="UA;&EG;CH@8V5N=&5R.R!415A4+4E.1$5.5#H@+3EP
M="<^(%EE87(@96YD960@2G5N92`S,"P\+V1I=CX@/"]T9#X@/'1D('-T>6QE
M/3-$)U!!1$1)3D<M0D]45$]-.B`R<'@[(%1%6%0M04Q)1TXZ(&QE9G0G('9A
M;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E(&YO=W)A<#TS1&YO=W)A<#X\9F]N
M="!S='EL93TS1"=&3TY4+5-)6D4Z(#$P<'0[($9/3E0M1D%-24Q9.B!T:6UE
M<R!N97<@<F]M86X[($9/3E0M5T5)1TA4.B!B;VQD.R!$25-03$%9.B!I;FQI
M;F4G/B`F;F)S<#L\+V9O;G0^(#PO=&0^(#PO='(^(#QT<CX@/'1D('-T>6QE
M/3-$)U!!1$1)3D<M0D]45$]-.B`R<'@G('9A;&EG;CTS1&)O='1O;2!W:61T
M:#TS1#8T)3X\9F]N="!S='EL93TS1"=&3TY4+5-)6D4Z(#$P<'0[($9/3E0M
M1D%-24Q9.B!T:6UE<R!N97<@<F]M86X[($1)4U!,05DZ(&EN;&EN92<^("9N
M8G-P.SPO9F]N=#X@/"]T9#X@/'1D('-T>6QE/3-$)U!!1$1)3D<M0D]45$]-
M.B`R<'@G('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E(&%L:6=N/3-$<FEG
M:'0^/&9O;G0@<W1Y;&4],T0G1D].5"U325I%.B`Q,'!T.R!&3TY4+49!34E,
M63H@=&EM97,@;F5W(')O;6%N.R!&3TY4+5=%24=(5#H@8F]L9#L@1$E34$Q!
M63H@:6YL:6YE)SX@)FYB<W`[/"]F;VYT/B`\+W1D/B`\=&0@<W1Y;&4],T0G
M0D]21$52+4)/5%1/33H@8FQA8VL@,G!X('-O;&ED.R!415A4+4%,24=..B!C
M96YT97([($U!4D=)3BU,1494.B`P<'0[($U!4D=)3BU224=(5#H@,'!T.R!4
M15A4+4E.1$5.5#H@,'!T)R!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q,"4@
M8V]L<W!A;CTS1#(^(#QD:78@<W1Y;&4],T0G1$E34$Q!63H@8FQO8VL[($9/
M3E0M1D%-24Q9.B!T:6UE<R!N97<@<F]M86X[($9/3E0M4TE:13H@,3!P=#L@
M1D].5"U714E'2%0Z(&)O;&0[($U!4D=)3BU,1494.B`P<'0[($U!4D=)3BU2
M24=(5#H@,'!T.R!415A4+4%,24=..B!C96YT97([(%1%6%0M24Y$14Y4.B`P
M<'0G/B`R,#$T/"]D:78^(#PO=&0^(#QT9"!S='EL93TS1"=0041$24Y'+4)/
M5%1/33H@,G!X.R!415A4+4%,24=..B!L969T)R!V86QI9VX],T1B;W1T;VT@
M=VED=&@],T0Q)2!N;W=R87`],T1N;W=R87`^/&9O;G0@<W1Y;&4],T0G1D].
M5"U325I%.B`Q,'!T.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!&
M3TY4+5=%24=(5#H@8F]L9#L@1$E34$Q!63H@:6YL:6YE)SX@)FYB<W`[/"]F
M;VYT/B`\+W1D/B`\=&0@<W1Y;&4],T0G4$%$1$E.1RU"3U143TTZ(#)P>"<@
M=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@86QI9VX],T1R:6=H=#X\9F]N
M="!S='EL93TS1"=&3TY4+5-)6D4Z(#$P<'0[($9/3E0M1D%-24Q9.B!T:6UE
M<R!N97<@<F]M86X[($9/3E0M5T5)1TA4.B!B;VQD.R!$25-03$%9.B!I;FQI
M;F4G/B`F;F)S<#L\+V9O;G0^(#PO=&0^(#QT9"!S='EL93TS1"="3U)$15(M
M0D]45$]-.B!B;&%C:R`R<'@@<V]L:60[(%1%6%0M04Q)1TXZ(&-E;G1E<CL@
M34%21TE.+4Q%1E0Z(#!P=#L@34%21TE.+5))1TA4.B`P<'0[(%1%6%0M24Y$
M14Y4.B`P<'0G('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$P)2!C;VQS<&%N
M/3-$,CX@/&1I=B!S='EL93TS1"=$25-03$%9.B!B;&]C:SL@1D].5"U&04U)
M3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T.R!&3TY4+5=%
M24=(5#H@8F]L9#L@34%21TE.+4Q%1E0Z(#!P=#L@34%21TE.+5))1TA4.B`P
M<'0[(%1%6%0M04Q)1TXZ(&-E;G1E<CL@5$585"U)3D1%3E0Z(#!P="<^(#(P
M,3,\+V1I=CX@/"]T9#X@/'1D('-T>6QE/3-$)U!!1$1)3D<M0D]45$]-.B`R
M<'@[(%1%6%0M04Q)1TXZ(&QE9G0G('9A;&EG;CTS1&)O='1O;2!W:61T:#TS
M1#$E(&YO=W)A<#TS1&YO=W)A<#X\9F]N="!S='EL93TS1"=&3TY4+5-)6D4Z
M(#$P<'0[($9/3E0M1D%-24Q9.B!T:6UE<R!N97<@<F]M86X[($9/3E0M5T5)
M1TA4.B!B;VQD.R!$25-03$%9.B!I;FQI;F4G/B`F;F)S<#L\+V9O;G0^(#PO
M=&0^(#QT9"!S='EL93TS1"=0041$24Y'+4)/5%1/33H@,G!X)R!V86QI9VX]
M,T1B;W1T;VT@=VED=&@],T0Q)3X\9F]N="!S='EL93TS1"=&3TY4+5-)6D4Z
M(#$P<'0[($9/3E0M1D%-24Q9.B!T:6UE<R!N97<@<F]M86X[($9/3E0M5T5)
M1TA4.B!B;VQD.R!$25-03$%9.B!I;FQI;F4G/B`F;F)S<#L\+V9O;G0^(#PO
M=&0^(#QT9"!S='EL93TS1"="3U)$15(M0D]45$]-.B!B;&%C:R`R<'@@<V]L
M:60G('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$P)2!C;VQS<&%N/3-$,CX@
M/&1I=B!S='EL93TS1"=$25-03$%9.B!B;&]C:SL@1D].5"U&04U)3%DZ('1I
M;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T.R!&3TY4+5=%24=(5#H@
M8F]L9#L@34%21TE.+4Q%1E0Z(#!P=#L@34%21TE.+5))1TA4.B`W+C0U<'0[
M('1E>'0M86QI9VXZ(&-E;G1E<CL@5$585"U)3D1%3E0Z(#!P="<^(#(P,3(\
M+V1I=CX@/"]T9#X@/'1D('-T>6QE/3-$)U!!1$1)3D<M0D]45$]-.B`R<'@[
M(%1%6%0M04Q)1TXZ(&QE9G0G('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E
M(&YO=W)A<#TS1&YO=W)A<#X\9F]N="!S='EL93TS1"=&3TY4+5-)6D4Z(#$P
M<'0[($9/3E0M1D%-24Q9.B!T:6UE<R!N97<@<F]M86X[($9/3E0M5T5)1TA4
M.B!B;VQD.R!$25-03$%9.B!I;FQI;F4G/B`F;F)S<#L\+V9O;G0^(#PO=&0^
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M(&YE=R!R;VUA;CL@1$E34$Q!63H@:6YL:6YE)SX@)FYB<W`[/"]F;VYT/B`\
M+W1D/B`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,3`E(&-O;'-P86X]
M,T0R/CQF;VYT('-T>6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@1D].5"U&04U)
M3%DZ('1I;65S(&YE=R!R;VUA;CL@1$E34$Q!63H@:6YL:6YE)SX@)FYB<W`[
M/"]F;VYT/B`\+W1D/B`\=&0@<W1Y;&4],T0G5$585"U!3$E'3CH@;&5F="<@
M=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@;F]W<F%P/3-$;F]W<F%P/CQF
M;VYT('-T>6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ('1I
M;65S(&YE=R!R;VUA;CL@1$E34$Q!63H@:6YL:6YE)SX@)FYB<W`[/"]F;VYT
M/B`\+W1D/B`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24^/&9O;G0@
M<W1Y;&4],T0G1D].5"U325I%.B`Q,'!T.R!&3TY4+49!34E,63H@=&EM97,@
M;F5W(')O;6%N.R!$25-03$%9.B!I;FQI;F4G/B`F;F)S<#L\+V9O;G0^(#PO
M=&0^(#QT9"!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q,"4@8V]L<W!A;CTS
M1#(^/&9O;G0@<W1Y;&4],T0G1D].5"U325I%.B`Q,'!T.R!&3TY4+49!34E,
M63H@=&EM97,@;F5W(')O;6%N.R!$25-03$%9.B!I;FQI;F4G/B`F;F)S<#L\
M+V9O;G0^(#PO=&0^(#QT9"!S='EL93TS1"=415A4+4%,24=..B!L969T)R!V
M86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)2!N;W=R87`],T1N;W=R87`^/&9O
M;G0@<W1Y;&4],T0G1D].5"U325I%.B`Q,'!T.R!&3TY4+49!34E,63H@=&EM
M97,@;F5W(')O;6%N.R!$25-03$%9.B!I;FQI;F4G/B`F;F)S<#L\+V9O;G0^
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M/"]T9#X@/"]T<CX@/'1R(&)G8V]L;W(],T0C8V-E969F/B`\=&0@<W1Y;&4]
M,T0G5$585"U!3$E'3CH@;&5F=#L@34%21TE.+4Q%1E0Z(#!P=#L@34%21TE.
M+5))1TA4.B`P<'0[(%1%6%0M24Y$14Y4.B`P<'0G('9A;&EG;CTS1&)O='1O
M;2!W:61T:#TS1#8T)3X@/&1I=B!S='EL93TS1"=$25-03$%9.B!B;&]C:SL@
M1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T
M.R!-05)'24XM3$5&5#H@,'!T.R!-05)'24XM4DE'2%0Z(#!P=#L@5$585"U!
M3$E'3CH@;&5F=#L@5$585"U)3D1%3E0Z(#!P="<^($9O<F5I9VX@8W5R<F5N
M8WD@=')A;G-L871I;VX@9&EF9F5R96YC97,L(&YE=#PO9&EV/B`\+W1D/B`\
M=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@86QI9VX],T1R:6=H=#X\
M9F]N="!S='EL93TS1"=&3TY4+5-)6D4Z(#$P<'0[($9/3E0M1D%-24Q9.B!T
M:6UE<R!N97<@<F]M86X[($1)4U!,05DZ(&EN;&EN92<^("9N8G-P.SPO9F]N
M=#X@/"]T9#X@/'1D('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&
M04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T.R!415A4
M+4%,24=..B!L969T)R!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)3XD/"]T
M9#X@/'1D('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ
M('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T.R!415A4+4%,24=.
M.B!R:6=H="<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$.24^-#`W/"]T9#X@
M/'1D('-T>6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G('9A;&EG;CTS1&)O='1O
M;2!W:61T:#TS1#$E(&YO=W)A<#TS1&YO=W)A<#X\9F]N="!S='EL93TS1"=&
M3TY4+5-)6D4Z(#$P<'0[($9/3E0M1D%-24Q9.B!T:6UE<R!N97<@<F]M86X[
M($1)4U!,05DZ(&EN;&EN92<^("9N8G-P.SPO9F]N=#X@/"]T9#X@/'1D('9A
M;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E(&%L:6=N/3-$<FEG:'0^/&9O;G0@
M<W1Y;&4],T0G1D].5"U325I%.B`Q,'!T.R!&3TY4+49!34E,63H@=&EM97,@
M;F5W(')O;6%N.R!$25-03$%9.B!I;FQI;F4G/B`F;F)S<#L\+V9O;G0^(#PO
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M=&@],T0Q)2!N;W=R87`],T1N;W=R87`^/&9O;G0@<W1Y;&4],T0G1D].5"U3
M25I%.B`Q,'!T.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!$25-0
M3$%9.B!I;FQI;F4G/B`F;F)S<#L\+V9O;G0^(#PO=&0^(#QT9"!V86QI9VX]
M,T1B;W1T;VT@=VED=&@],T0Q)2!A;&EG;CTS1')I9VAT/CQF;VYT('-T>6QE
M/3-$)T9/3E0M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R
M;VUA;CL@1$E34$Q!63H@:6YL:6YE)SX@)FYB<W`[/"]F;VYT/B`\+W1D/B`\
M=&0@<W1Y;&4],T0G1$E34$Q!63H@:6YL:6YE.R!&3TY4+49!34E,63H@=&EM
M97,@;F5W(')O;6%N.R!&3TY4+5-)6D4Z(#$P<'0[(%1%6%0M04Q)1TXZ(&QE
M9G0G('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E/B0\+W1D/B`\=&0@<W1Y
M;&4],T0G1$E34$Q!63H@:6YL:6YE.R!&3TY4+49!34E,63H@=&EM97,@;F5W
M(')O;6%N.R!&3TY4+5-)6D4Z(#$P<'0[(%1%6%0M04Q)1TXZ(')I9VAT)R!V
M86QI9VX],T1B;W1T;VT@=VED=&@],T0Y)3XH.3@\+W1D/B`\=&0@<W1Y;&4]
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M.B`P<'0[('1E>'0M86QI9VXZ(&QE9G0[(%1%6%0M24Y$14Y4.B`M.7!T)SX@
M0F%N:R!C;VUM:7-S:6]N<SPO9&EV/B`\+W1D/B`\=&0@=F%L:6=N/3-$8F]T
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M<W`[/"]F;VYT/B`\+W1D/B`\=&0@<W1Y;&4],T0G1$E34$Q!63H@:6YL:6YE
M.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!&3TY4+5-)6D4Z(#$P
M<'0[(%1%6%0M04Q)1TXZ(')I9VAT)R!V86QI9VX],T1B;W1T;VT@=VED=&@]
M,T0Y)3XH,S8\+W1D/B`\=&0@<W1Y;&4],T0G1$E34$Q!63H@:6YL:6YE.R!&
M3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!&3TY4+5-)6D4Z(#$P<'0[
M(%1%6%0M04Q)1TXZ(&QE9G0G('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E
M(&YO=W)A<#TS1&YO=W)A<#XI/"]T9#X@/'1D('9A;&EG;CTS1&)O='1O;2!W
M:61T:#TS1#$E(&%L:6=N/3-$<FEG:'0^/&9O;G0@<W1Y;&4],T0G1D].5"U3
M25I%.B`Q,'!T.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!$25-0
M3$%9.B!I;FQI;F4G/B`F;F)S<#L\+V9O;G0^(#PO=&0^(#QT9"!S='EL93TS
M1"=415A4+4%,24=..B!L969T)R!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q
M)3X\9F]N="!S='EL93TS1"=&3TY4+5-)6D4Z(#$P<'0[($9/3E0M1D%-24Q9
M.B!T:6UE<R!N97<@<F]M86X[($1)4U!,05DZ(&EN;&EN92<^("9N8G-P.SPO
M9F]N=#X@/"]T9#X@/'1D('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].
M5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T.R!4
M15A4+4%,24=..B!R:6=H="<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$.24^
M*#(Y/"]T9#X@/'1D('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&
M04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T.R!415A4
M+4%,24=..B!L969T)R!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)2!N;W=R
M87`],T1N;W=R87`^*3PO=&0^(#QT9"!V86QI9VX],T1B;W1T;VT@=VED=&@]
M,T0Q)2!A;&EG;CTS1')I9VAT/CQF;VYT('-T>6QE/3-$)T9/3E0M4TE:13H@
M,3!P=#L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1$E34$Q!63H@
M:6YL:6YE)SX@)FYB<W`[/"]F;VYT/B`\+W1D/B`\=&0@<W1Y;&4],T0G5$58
M5"U!3$E'3CH@;&5F="<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24^/&9O
M;G0@<W1Y;&4],T0G1D].5"U325I%.B`Q,'!T.R!&3TY4+49!34E,63H@=&EM
M97,@;F5W(')O;6%N.R!$25-03$%9.B!I;FQI;F4G/B`F;F)S<#L\+V9O;G0^
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M;F]W<F%P/BD\+W1D/B`\+W1R/B`\='(@8F=C;VQO<CTS1"-C8V5E9F8^(#QT
M9"!V86QI9VX],T1B;W1T;VT@=VED=&@],T0V-"4@86QI9VX],T1L969T/B`\
M9&EV('-T>6QE/3-$)T1)4U!,05DZ(&)L;V-K.R!&3TY4+49!34E,63H@=&EM
M97,@;F5W(')O;6%N.R!&3TY4+5-)6D4Z(#$P<'0[($U!4D=)3BU,1494.B`Y
M<'0[($U!4D=)3BU224=(5#H@,'!T.R!T97AT+6%L:6=N.B!L969T.R!415A4
M+4E.1$5.5#H@+3EP="<^($EN=&5R97-T(&EN8V]M92!O;B!D97!O<VET<SPO
M9&EV/B`\+W1D/B`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@86QI
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M;VUA;CL@1$E34$Q!63H@:6YL:6YE)SX@)FYB<W`[/"]F;VYT/B`\+W1D/B`\
M=&0@<W1Y;&4],T0G1$E34$Q!63H@:6YL:6YE.R!&3TY4+49!34E,63H@=&EM
M97,@;F5W(')O;6%N.R!&3TY4+5-)6D4Z(#$P<'0[(%1%6%0M04Q)1TXZ(')I
M9VAT)R!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Y)3XR-#8\+W1D/B`\=&0@
M<W1Y;&4],T0G5$585"U!3$E'3CH@;&5F="<@=F%L:6=N/3-$8F]T=&]M('=I
M9'1H/3-$,24@;F]W<F%P/3-$;F]W<F%P/CQF;VYT('-T>6QE/3-$)T9/3E0M
M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1$E3
M4$Q!63H@:6YL:6YE)SX@)FYB<W`[/"]F;VYT/B`\+W1D/B`\=&0@=F%L:6=N
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M)SX@)FYB<W`[/"]F;VYT/B`\+W1D/B`\=&0@<W1Y;&4],T0G1$E34$Q!63H@
M:6YL:6YE.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!&3TY4+5-)
M6D4Z(#$P<'0[(%1%6%0M04Q)1TXZ(')I9VAT)R!V86QI9VX],T1B;W1T;VT@
M=VED=&@],T0Y)3XU,SD\+W1D/B`\=&0@<W1Y;&4],T0G5$585"U!3$E'3CH@
M;&5F="<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@;F]W<F%P/3-$;F]W
M<F%P/CQF;VYT('-T>6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@1D].5"U&04U)
M3%DZ('1I;65S(&YE=R!R;VUA;CL@1$E34$Q!63H@:6YL:6YE)SX@)FYB<W`[
M/"]F;VYT/B`\+W1D/B`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@
M86QI9VX],T1R:6=H=#X\9F]N="!S='EL93TS1"=&3TY4+5-)6D4Z(#$P<'0[
M($9/3E0M1D%-24Q9.B!T:6UE<R!N97<@<F]M86X[($1)4U!,05DZ(&EN;&EN
M92<^("9N8G-P.SPO9F]N=#X@/"]T9#X@/'1D('-T>6QE/3-$)U1%6%0M04Q)
M1TXZ(&QE9G0G('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E/CQF;VYT('-T
M>6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ('1I;65S(&YE
M=R!R;VUA;CL@1$E34$Q!63H@:6YL:6YE)SX@)FYB<W`[/"]F;VYT/B`\+W1D
M/B`\=&0@<W1Y;&4],T0G1$E34$Q!63H@:6YL:6YE.R!&3TY4+49!34E,63H@
M=&EM97,@;F5W(')O;6%N.R!&3TY4+5-)6D4Z(#$P<'0[(%1%6%0M04Q)1TXZ
M(')I9VAT)R!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Y)3XU-S4\+W1D/B`\
M=&0@<W1Y;&4],T0G5$585"U!3$E'3CH@;&5F="<@=F%L:6=N/3-$8F]T=&]M
M('=I9'1H/3-$,24@;F]W<F%P/3-$;F]W<F%P/CQF;VYT('-T>6QE/3-$)T9/
M3E0M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@
M1$E34$Q!63H@:6YL:6YE)SX@)FYB<W`[/"]F;VYT/B`\+W1D/B`\+W1R/B`\
M='(@8F=C;VQO<CTS1'=H:71E/B`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H
M/3-$-C0E(&%L:6=N/3-$;&5F=#X@/&1I=B!S='EL93TS1"=$25-03$%9.B!B
M;&]C:SL@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%
M.B`Q,'!T.R!-05)'24XM3$5&5#H@.7!T.R!-05)'24XM4DE'2%0Z(#!P=#L@
M=&5X="UA;&EG;CH@;&5F=#L@5$585"U)3D1%3E0Z("TY<'0G/B!'86EN("A,
M;W-S*2!R96QA=&5D('1O(&UA<FME=&%B;&4@<V5C=7)I=&EE<SPO9&EV/B`\
M+W1D/B`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@86QI9VX],T1R
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M1$E34$Q!63H@:6YL:6YE)SX@)FYB<W`[/"]F;VYT/B`\+W1D/B`\=&0@<W1Y
M;&4],T0G1$E34$Q!63H@:6YL:6YE.R!&3TY4+49!34E,63H@=&EM97,@;F5W
M(')O;6%N.R!&3TY4+5-)6D4Z(#$P<'0[(%1%6%0M04Q)1TXZ(')I9VAT)R!V
M86QI9VX],T1B;W1T;VT@=VED=&@],T0Y)3XS.#0\+W1D/B`\=&0@<W1Y;&4]
M,T0G5$585"U!3$E'3CH@;&5F="<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$
M,24@;F]W<F%P/3-$;F]W<F%P/CQF;VYT('-T>6QE/3-$)T9/3E0M4TE:13H@
M,3!P=#L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1$E34$Q!63H@
M:6YL:6YE)SX@)FYB<W`[/"]F;VYT/B`\+W1D/B`\=&0@=F%L:6=N/3-$8F]T
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M<W`[/"]F;VYT/B`\+W1D/B`\=&0@<W1Y;&4],T0G1$E34$Q!63H@:6YL:6YE
M.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!&3TY4+5-)6D4Z(#$P
M<'0[(%1%6%0M04Q)1TXZ(')I9VAT)R!V86QI9VX],T1B;W1T;VT@=VED=&@]
M,T0Y)3XH-SD\+W1D/B`\=&0@<W1Y;&4],T0G1$E34$Q!63H@:6YL:6YE.R!&
M3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!&3TY4+5-)6D4Z(#$P<'0[
M(%1%6%0M04Q)1TXZ(&QE9G0G('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E
M(&YO=W)A<#TS1&YO=W)A<#XI/"]T9#X@/'1D('9A;&EG;CTS1&)O='1O;2!W
M:61T:#TS1#$E(&%L:6=N/3-$<FEG:'0^/&9O;G0@<W1Y;&4],T0G1D].5"U3
M25I%.B`Q,'!T.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!$25-0
M3$%9.B!I;FQI;F4G/B`F;F)S<#L\+V9O;G0^(#PO=&0^(#QT9"!S='EL93TS
M1"=415A4+4%,24=..B!L969T)R!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q
M)3X\9F]N="!S='EL93TS1"=&3TY4+5-)6D4Z(#$P<'0[($9/3E0M1D%-24Q9
M.B!T:6UE<R!N97<@<F]M86X[($1)4U!,05DZ(&EN;&EN92<^("9N8G-P.SPO
M9F]N=#X@/"]T9#X@/'1D('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].
M5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T.R!4
M15A4+4%,24=..B!R:6=H="<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$.24^
M.#D\+W1D/B`\=&0@<W1Y;&4],T0G5$585"U!3$E'3CH@;&5F="<@=F%L:6=N
M/3-$8F]T=&]M('=I9'1H/3-$,24@;F]W<F%P/3-$;F]W<F%P/CQF;VYT('-T
M>6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ('1I;65S(&YE
M=R!R;VUA;CL@1$E34$Q!63H@:6YL:6YE)SX@)FYB<W`[/"]F;VYT/B`\+W1D
M/B`\+W1R/B`\='(@8F=C;VQO<CTS1"-C8V5E9F8^(#QT9"!S='EL93TS1"=0
M041$24Y'+4)/5%1/33H@,G!X)R!V86QI9VX],T1B;W1T;VT@=VED=&@],T0V
M-"4@86QI9VX],T1L969T/B`\9&EV('-T>6QE/3-$)T1)4U!,05DZ(&)L;V-K
M.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!&3TY4+5-)6D4Z(#$P
M<'0[($U!4D=)3BU,1494.B`Y<'0[($U!4D=)3BU224=(5#H@,'!T.R!T97AT
M+6%L:6=N.B!L969T.R!415A4+4E.1$5.5#H@+3EP="<^($=A:6X@*&QO<W,I
M(&9R;VTF;F)S<#LF;F)S<#MD97)I=F%T:79E<SPO9&EV/B`\+W1D/B`\=&0@
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M;&4],T0G1D].5"U325I%.B`Q,'!T.R!&3TY4+49!34E,63H@=&EM97,@;F5W
M(')O;6%N.R!$25-03$%9.B!I;FQI;F4G/B`F;F)S<#L\+V9O;G0^(#PO=&0^
M(#QT9"!S='EL93TS1"="3U)$15(M0D]45$]-.B!B;&%C:R`R<'@@<V]L:60[
M($1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA
M;CL@1D].5"U325I%.B`Q,'!T.R!415A4+4%,24=..B!R:6=H="<@=F%L:6=N
M/3-$8F]T=&]M('=I9'1H/3-$.24^*#@S/"]T9#X@/'1D('-T>6QE/3-$)T1)
M4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@
M1D].5"U325I%.B`Q,'!T.R!0041$24Y'+4)/5%1/33H@,G!X.R!415A4+4%,
M24=..B!L969T)R!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)2!N;W=R87`]
M,T1N;W=R87`^*3PO=&0^(#QT9"!S='EL93TS1"=0041$24Y'+4)/5%1/33H@
M,G!X)R!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)2!A;&EG;CTS1')I9VAT
M/CQF;VYT('-T>6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ
M('1I;65S(&YE=R!R;VUA;CL@1$E34$Q!63H@:6YL:6YE)SX@)FYB<W`[/"]F
M;VYT/B`\+W1D/B`\=&0@<W1Y;&4],T0G0D]21$52+4)/5%1/33H@8FQA8VL@
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M04Q)1TXZ(')I9VAT)R!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Y)3XQ-#`\
M+W1D/B`\=&0@<W1Y;&4],T0G4$%$1$E.1RU"3U143TTZ(#)P>#L@5$585"U!
M3$E'3CH@;&5F="<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@;F]W<F%P
M/3-$;F]W<F%P/CQF;VYT('-T>6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@1D].
M5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1$E34$Q!63H@:6YL:6YE)SX@
M)FYB<W`[/"]F;VYT/B`\+W1D/B`\=&0@<W1Y;&4],T0G4$%$1$E.1RU"3U14
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M=&]M('=I9'1H/3-$,24^/&9O;G0@<W1Y;&4],T0G1D].5"U325I%.B`Q,'!T
M.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!$25-03$%9.B!I;FQI
M;F4G/B`F;F)S<#L\+V9O;G0^(#PO=&0^(#QT9"!S='EL93TS1"="3U)$15(M
M0D]45$]-.B!B;&%C:R`R<'@@<V]L:60[($1)4U!,05DZ(&EN;&EN93L@1D].
M5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T.R!4
M15A4+4%,24=..B!R:6=H="<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$.24^
M*#,Q-SPO=&0^(#QT9"!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M
M1D%-24Q9.B!T:6UE<R!N97<@<F]M86X[($9/3E0M4TE:13H@,3!P=#L@4$%$
M1$E.1RU"3U143TTZ(#)P>#L@5$585"U!3$E'3CH@;&5F="<@=F%L:6=N/3-$
M8F]T=&]M('=I9'1H/3-$,24@;F]W<F%P/3-$;F]W<F%P/BD\+W1D/B`\+W1R
M/B`\='(@8F=C;VQO<CTS1'=H:71E/B`\=&0@=F%L:6=N/3-$8F]T=&]M('=I
M9'1H/3-$-C0E/CQF;VYT('-T>6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@1D].
M5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1$E34$Q!63H@:6YL:6YE)SX@
M)FYB<W`[/"]F;VYT/B`\+W1D/B`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H
M/3-$,24^/&9O;G0@<W1Y;&4],T0G1D].5"U325I%.B`Q,'!T.R!&3TY4+49!
M34E,63H@=&EM97,@;F5W(')O;6%N.R!$25-03$%9.B!I;FQI;F4G/B`F;F)S
M<#L\+V9O;G0^(#PO=&0^(#QT9"!S='EL93TS1"=415A4+4%,24=..B!L969T
M)R!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)3X\9F]N="!S='EL93TS1"=&
M3TY4+5-)6D4Z(#$P<'0[($9/3E0M1D%-24Q9.B!T:6UE<R!N97<@<F]M86X[
M($1)4U!,05DZ(&EN;&EN92<^("9N8G-P.SPO9F]N=#X@/"]T9#X@/'1D('-T
M>6QE/3-$)U1%6%0M04Q)1TXZ(')I9VAT)R!V86QI9VX],T1B;W1T;VT@=VED
M=&@],T0Y)3X\9F]N="!S='EL93TS1"=&3TY4+5-)6D4Z(#$P<'0[($9/3E0M
M1D%-24Q9.B!T:6UE<R!N97<@<F]M86X[($1)4U!,05DZ(&EN;&EN92<^("9N
M8G-P.SPO9F]N=#X@/"]T9#X@/'1D('-T>6QE/3-$)U1%6%0M04Q)1TXZ(&QE
M9G0G('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E(&YO=W)A<#TS1&YO=W)A
M<#X\9F]N="!S='EL93TS1"=&3TY4+5-)6D4Z(#$P<'0[($9/3E0M1D%-24Q9
M.B!T:6UE<R!N97<@<F]M86X[($1)4U!,05DZ(&EN;&EN92<^("9N8G-P.SPO
M9F]N=#X@/"]T9#X@/'1D('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E/CQF
M;VYT('-T>6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ('1I
M;65S(&YE=R!R;VUA;CL@1$E34$Q!63H@:6YL:6YE)SX@)FYB<W`[/"]F;VYT
M/B`\+W1D/B`\=&0@<W1Y;&4],T0G5$585"U!3$E'3CH@;&5F="<@=F%L:6=N
M/3-$8F]T=&]M('=I9'1H/3-$,24^/&9O;G0@<W1Y;&4],T0G1D].5"U325I%
M.B`Q,'!T.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!$25-03$%9
M.B!I;FQI;F4G/B`F;F)S<#L\+V9O;G0^(#PO=&0^(#QT9"!S='EL93TS1"=4
M15A4+4%,24=..B!R:6=H="<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$.24^
M/&9O;G0@<W1Y;&4],T0G1D].5"U325I%.B`Q,'!T.R!&3TY4+49!34E,63H@
M=&EM97,@;F5W(')O;6%N.R!$25-03$%9.B!I;FQI;F4G/B`F;F)S<#L\+V9O
M;G0^(#PO=&0^(#QT9"!S='EL93TS1"=415A4+4%,24=..B!L969T)R!V86QI
M9VX],T1B;W1T;VT@=VED=&@],T0Q)2!N;W=R87`],T1N;W=R87`^/&9O;G0@
M<W1Y;&4],T0G1D].5"U325I%.B`Q,'!T.R!&3TY4+49!34E,63H@=&EM97,@
M;F5W(')O;6%N.R!$25-03$%9.B!I;FQI;F4G/B`F;F)S<#L\+V9O;G0^(#PO
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M)SX@)FYB<W`[/"]F;VYT/B`\+W1D/B`\=&0@<W1Y;&4],T0G5$585"U!3$E'
M3CH@<FEG:'0G('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#DE/CQF;VYT('-T
M>6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ('1I;65S(&YE
M=R!R;VUA;CL@1$E34$Q!63H@:6YL:6YE)SX@)FYB<W`[/"]F;VYT/B`\+W1D
M/B`\=&0@<W1Y;&4],T0G5$585"U!3$E'3CH@;&5F="<@=F%L:6=N/3-$8F]T
M=&]M('=I9'1H/3-$,24@;F]W<F%P/3-$;F]W<F%P/CQF;VYT('-T>6QE/3-$
M)T9/3E0M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA
M;CL@1$E34$Q!63H@:6YL:6YE)SX@)FYB<W`[/"]F;VYT/B`\+W1D/B`\+W1R
M/B`\='(@8F=C;VQO<CTS1"-C8V5E9F8^(#QT9"!S='EL93TS1"=0041$24Y'
M+4)/5%1/33H@-'!X)R!V86QI9VX],T1B;W1T;VT@=VED=&@],T0V-"4^/&9O
M;G0@<W1Y;&4],T0G1D].5"U325I%.B`Q,'!T.R!&3TY4+49!34E,63H@=&EM
M97,@;F5W(')O;6%N.R!$25-03$%9.B!I;FQI;F4G/B`F;F)S<#L\+V9O;G0^
M(#PO=&0^(#QT9"!S='EL93TS1"=0041$24Y'+4)/5%1/33H@-'!X)R!V86QI
M9VX],T1B;W1T;VT@=VED=&@],T0Q)2!A;&EG;CTS1')I9VAT/CQF;VYT('-T
M>6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ('1I;65S(&YE
M=R!R;VUA;CL@1$E34$Q!63H@:6YL:6YE)SX@)FYB<W`[/"]F;VYT/B`\+W1D
M/B`\=&0@<W1Y;&4],T0G0D]21$52+4)/5%1/33H@8FQA8VL@-'!X(&1O=6)L
M93L@1$E34$Q!63H@:6YL:6YE.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O
M;6%N.R!&3TY4+5-)6D4Z(#$P<'0[(%1%6%0M04Q)1TXZ(&QE9G0G('9A;&EG
M;CTS1&)O='1O;2!W:61T:#TS1#$E/B0\+W1D/B`\=&0@<W1Y;&4],T0G0D]2
M1$52+4)/5%1/33H@8FQA8VL@-'!X(&1O=6)L93L@1$E34$Q!63H@:6YL:6YE
M.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!&3TY4+5-)6D4Z(#$P
M<'0[(%1%6%0M04Q)1TXZ(')I9VAT)R!V86QI9VX],T1B;W1T;VT@=VED=&@]
M,T0Y)3XY,3@\+W1D/B`\=&0@<W1Y;&4],T0G4$%$1$E.1RU"3U143TTZ(#1P
M>#L@5$585"U!3$E'3CH@;&5F="<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$
M,24@;F]W<F%P/3-$;F]W<F%P/CQF;VYT('-T>6QE/3-$)T9/3E0M4TE:13H@
M,3!P=#L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1$E34$Q!63H@
M:6YL:6YE)SX@)FYB<W`[/"]F;VYT/B`\+W1D/B`\=&0@<W1Y;&4],T0G4$%$
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M5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T.R!4
M15A4+4%,24=..B!L969T)R!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)3XD
M/"]T9#X@/'1D('-T>6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#1P>"!D
M;W5B;&4[($1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE
M=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T.R!415A4+4%,24=..B!R:6=H="<@
M=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$.24^,2PP-C@\+W1D/B`\=&0@<W1Y
M;&4],T0G4$%$1$E.1RU"3U143TTZ(#1P>#L@5$585"U!3$E'3CH@;&5F="<@
M=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@;F]W<F%P/3-$;F]W<F%P/CQF
M;VYT('-T>6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ('1I
M;65S(&YE=R!R;VUA;CL@1$E34$Q!63H@:6YL:6YE)SX@)FYB<W`[/"]F;VYT
M/B`\+W1D/B`\=&0@<W1Y;&4],T0G4$%$1$E.1RU"3U143TTZ(#1P>"<@=F%L
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M;VUA;CL@1D].5"U325I%.B`Q,'!T.R!415A4+4%,24=..B!L969T)R!V86QI
M9VX],T1B;W1T;VT@=VED=&@],T0Q)3XD/"]T9#X@/'1D('-T>6QE/3-$)T)/
M4D1%4BU"3U143TTZ(&)L86-K(#1P>"!D;W5B;&4[($1)4U!,05DZ(&EN;&EN
M93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q
M,'!T.R!415A4+4%,24=..B!R:6=H="<@=F%L:6=N/3-$8F]T=&]M('=I9'1H
M/3-$.24^,C,W/"]T9#X@/'1D('-T>6QE/3-$)U!!1$1)3D<M0D]45$]-.B`T
M<'@[(%1%6%0M04Q)1TXZ(&QE9G0G('9A;&EG;CTS1&)O='1O;2!W:61T:#TS
M1#$E(&YO=W)A<#TS1&YO=W)A<#X\9F]N="!S='EL93TS1"=&3TY4+5-)6D4Z
M(#$P<'0[($9/3E0M1D%-24Q9.B!T:6UE<R!N97<@<F]M86X[($1)4U!,05DZ
M(&EN;&EN92<^("9N8G-P.SPO9F]N=#X@/"]T9#X@/"]T<CX@/"]T86)L93X@
M/"]D:78^(#PA+2U%;F1&<F%G;65N="TM/CPO9&EV/B`\+V1I=CX\<W!A;CX\
M+W-P86X^/"]T9#X-"B`@("`@(#PO='(^#0H@("`@/"]T86)L93X-"B`@/"]B
M;V1Y/@T*/"]H=&UL/@T*#0HM+2TM+2T]7TYE>'1087)T7S!C860U.69D7S<S
M,F5?-#9E,E]A-3,T7S!C.&%D,6%F.3!D9`T*0V]N=&5N="U,;V-A=&EO;CH@
M9FEL93HO+R]#.B\P8V%D-3EF9%\W,S)E7S0V93)?834S-%\P8SAA9#%A9CDP
M9&0O5V]R:W-H965T<R]3:&5E=#$X+FAT;6P-"D-O;G1E;G0M5')A;G-F97(M
M16YC;V1I;F<Z('%U;W1E9"UP<FEN=&%B;&4-"D-O;G1E;G0M5'EP93H@=&5X
M="]H=&UL.R!C:&%R<V5T/2)U<RUA<V-I:2(-"@T*/&AT;6P^#0H@(#QH96%D
M/@T*("`@(#Q-151!(&AT='`M97%U:78],T1#;VYT96YT+51Y<&4@8V]N=&5N
M=#TS1"=T97AT+VAT;6P[(&-H87)S970]=71F+3@G/CQS8W)I<'0@='EP93TS
M1'1E>'0O:F%V87-C<FEP="!S<F,],T13:&]W+FIS/B\J($1O($YO="!296UO
M=F4@5&AI<R!#;VUM96YT("HO/"]S8W)I<'0^/"]H96%D/@T*("`\8F]D>3X-
M"B`@("`\=&%B;&4@8VQA<W,],T1R97!O<G0@:60],T1)1#!%344^#0H@("`@
M("`\='(^#0H@("`@("`@(#QT:"!C;&%S<STS1'1L(&-O;'-P86X],T0Q(')O
M=W-P86X],T0R/CQS=')O;F<^5$%815,@3TX@24Y#3TU%/&)R/CPO<W1R;VYG
M/CPO=&@^#0H@("`@("`@(#QT:"!C;&%S<STS1'1H(&-O;'-P86X],T0Q/C$R
M($UO;G1H<R!%;F1E9#PO=&@^#0H@("`@("`\+W1R/@T*("`@("`@/'1R/@T*
M("`@("`@("`\=&@@8VQA<W,],T1T:#Y*=6XN(#,P+"`R,#$T/&)R/CPO=&@^
M#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$<F4^#0H@("`@("`@
M(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O<#X\<W1R;VYG/E1!6$53($].
M($E.0T]-12!;06)S=')A8W1=/"]S=')O;F<^/"]T9#X-"B`@("`@("`@/'1D
M(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R
M/@T*("`@("`@/'1R(&-L87-S/3-$<F\^#0H@("`@("`@(#QT9"!C;&%S<STS
M1'!L('9A;&EG;CTS1'1O<#Y405A%4R!/3B!)3D-/344\+W1D/@T*("`@("`@
M("`\=&0@8VQA<W,],T1T97AT/B<\(2TM1$]#5%E012!H=&UL(%!50DQ)0R`B
M+2\O5S-#+R]$5$0@6$A434P@,2XP(%1R86YS:71I;VYA;"\O14XB(")H='1P
M.B\O=W=W+G<S+F]R9R]44B]X:'1M;#$O1%1$+WAH=&UL,2UT<F%N<VET:6]N
M86PN9'1D(B`M+3X\9&EV/B`\9&EV/CPA+2U3=&%R=$9R86=M96YT+2T^(#QD
M:78@<W1Y;&4],T0G1$E34$Q!63H@8FQO8VL[($9/3E0M1D%-24Q9.B!4:6UE
M<R!.97<@4F]M86X[($9/3E0M4TE:13H@,3!P=#L@1D].5"U714E'2%0Z(&)O
M;&0[($U!4D=)3BU,1494.B`P<'0[($U!4D=)3BU224=(5#H@,'!T.R!415A4
M+4%,24=..B!L969T.R!415A4+4E.1$5.5#H@,'!T)SX@3D]412`Q,#HM5$%8
M15,@3TX@24Y#3TU%/"]D:78^(#QD:78@<W1Y;&4],T0G1$E34$Q!63H@8FQO
M8VL[($U!4D=)3BU,1494.B`P<'0[($U!4D=)3BU224=(5#H@,'!T.R!T97AT
M+6%L:6=N.B!J=7-T:69Y.R!415A4+4E.1$5.5#H@,'!T)SX@)FYB<W`[/"]D
M:78^(#QD:78^(#QT86)L92!S='EL93TS1"=&3TY4+5-)6D4Z(#$P<'0[($9/
M3E0M1D%-24Q9.B!T:6UE<R!N97<@<F]M86XG(&-E;&QS<&%C:6YG/3-$,"!C
M96QL<&%D9&EN9STS1#`@=VED=&@],T0Q,#`E(&%L:6=N/3-$8V5N=&5R(&)O
M<F1E<CTS1#`^(#QT<B!V86QI9VX],T1T;W`^(#QT9"!S='EL93TS1"=72414
M2#H@,C=P="<^(#QD:78@<W1Y;&4],T0G1$E34$Q!63H@:6YL:6YE.R!&3TY4
M+49!34E,63H@5&EM97,@3F5W(%)O;6%N.R!&3TY4+5-)6D4Z(#$P<'0[($U!
M4D=)3BU,1494.B`P<'0[($U!4D=)3BU224=(5#H@,'!T.R!415A4+4E.1$5.
M5#H@,'!T)SX@02X\+V1I=CX@/"]T9#X@/'1D/B`\9&EV('-T>6QE/3-$)T1)
M4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ(%1I;65S($YE=R!2;VUA;CL@
M1D].5"U325I%.B`Q,'!T.R!T97AT+6%L:6=N.B!J=7-T:69Y)SX@5&%X(&QA
M=W,@87!P;&EC86)L92!T;R!T:&4@8V]M<&%N:65S.CPO9&EV/B`\+W1D/B`\
M+W1R/B`\+W1A8FQE/B`\+V1I=CX@/&1I=B!S='EL93TS1"=$25-03$%9.B!B
M;&]C:SL@5$585"U)3D1%3E0Z(#!P="<^/&)R("\^(#PO9&EV/B`\9&EV/B`\
M=&%B;&4@<W1Y;&4],T0G1D].5"U325I%.B`Q,'!T.R!&3TY4+49!34E,63H@
M=&EM97,@;F5W(')O;6%N)R!C96QL<W!A8VEN9STS1#`@8V5L;'!A9&1I;F<]
M,T0P('=I9'1H/3-$,3`P)2!A;&EG;CTS1&-E;G1E<B!B;W)D97(],T0P/B`\
M='(@=F%L:6=N/3-$=&]P/B`\=&0@<W1Y;&4],T0G5TE$5$@Z(#(W<'0G/B`\
M9&EV('-T>6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ(%1I
M;65S($YE=R!2;VUA;CL@1$E34$Q!63H@:6YL:6YE)SX@)FYB<W`[/"]D:78^
M(#PO=&0^(#QT9"!S='EL93TS1"=724142#H@,3AP="<^(#QD:78@<W1Y;&4]
M,T0G1$E34$Q!63H@:6YL:6YE.R!&3TY4+49!34E,63H@5&EM97,@3F5W(%)O
M;6%N.R!&3TY4+5-)6D4Z(#$P<'0[($U!4D=)3BU,1494.B`P<'0[($U!4D=)
M3BU224=(5#H@,'!T.R!415A4+4E.1$5.5#H@,'!T)SX@,2X\+V1I=CX@/"]T
M9#X@/'1D/B`\9&EV('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&
M04U)3%DZ(%1I;65S($YE=R!2;VUA;CL@1D].5"U325I%.B`Q,'!T.R!T97AT
M+6%L:6=N.B!J=7-T:69Y)SX@4&QU<FES=&5M(%1H97)A<&5U=&EC<R!);F,N
M(&ES('1A>&5D('5N9&5R(%4N4RX@=&%X(&QA=W,N/"]D:78^(#PO=&0^(#PO
M='(^(#PO=&%B;&4^(#PO9&EV/B`\9&EV/B`\=&%B;&4@<W1Y;&4],T0G1D].
M5"U325I%.B`Q,'!T.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N)R!C
M96QL<W!A8VEN9STS1#`@8V5L;'!A9&1I;F<],T0P('=I9'1H/3-$,3`P)2!A
M;&EG;CTS1&-E;G1E<B!B;W)D97(],T0P/B`\='(@=F%L:6=N/3-$=&]P/B`\
M=&0@<W1Y;&4],T0G5TE$5$@Z(#(W<'0G/B`\9&EV('-T>6QE/3-$)T9/3E0M
M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ(%1I;65S($YE=R!2;VUA;CL@1$E3
M4$Q!63H@:6YL:6YE)SX@)FYB<W`[/"]D:78^(#PO=&0^(#QT9"!S='EL93TS
M1"=724142#H@,3AP="<^(#QD:78@<W1Y;&4],T0G1$E34$Q!63H@:6YL:6YE
M.R!&3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N.R!&3TY4+5-)6D4Z(#$P
M<'0[($U!4D=)3BU,1494.B`P<'0[($U!4D=)3BU224=(5#H@,'!T.R!415A4
M+4E.1$5.5#H@,'!T)SX@,BX\+V1I=CX@/"]T9#X@/'1D/B`\9&EV('-T>6QE
M/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ(%1I;65S($YE=R!2
M;VUA;CL@1D].5"U325I%.B`Q,'!T.R!T97AT+6%L:6=N.B!J=7-T:69Y)SX@
M4&QU<FES=&5M($QT9"X@:7,@=&%X960@=6YD97(@27-R865L:2!T87@@;&%W
M<RX\+V1I=CX@/"]T9#X@/"]T<CX@/"]T86)L93X@/"]D:78^(#QD:78@<W1Y
M;&4],T0G1$E34$Q!63H@8FQO8VL[($U!4D=)3BU,1494.B`P<'0[($U!4D=)
M3BU224=(5#H@,'!T.R!T97AT+6%L:6=N.B!J=7-T:69Y.R!415A4+4E.1$5.
M5#H@,'!T)SX@)FYB<W`[/"]D:78^(#QD:78^(#QT86)L92!S='EL93TS1"=&
M3TY4+5-)6D4Z(#$P<'0[($9/3E0M1D%-24Q9.B!T:6UE<R!N97<@<F]M86XG
M(&-E;&QS<&%C:6YG/3-$,"!C96QL<&%D9&EN9STS1#`@=VED=&@],T0Q,#`E
M(&%L:6=N/3-$8V5N=&5R(&)O<F1E<CTS1#`^(#QT<B!V86QI9VX],T1T;W`^
M(#QT9"!S='EL93TS1"=724142#H@,C=P="<^(#QD:78@<W1Y;&4],T0G1$E3
M4$Q!63H@:6YL:6YE.R!&3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N.R!&
M3TY4+5-)6D4Z(#$P<'0[($U!4D=)3BU,1494.B`P<'0[($U!4D=)3BU224=(
M5#H@,'!T.R!415A4+4E.1$5.5#H@,'!T)SX@0BX\+V1I=CX@/"]T9#X@/'1D
M/B`\9&EV('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ
M(%1I;65S($YE=R!2;VUA;CL@1D].5"U325I%.B`Q,'!T.R!T97AT+6%L:6=N
M.B!J=7-T:69Y)SX@5&%X(&%S<V5S<VUE;G1S.CPO9&EV/B`\+W1D/B`\+W1R
M/B`\+W1A8FQE/B`\+V1I=CX@/&1I=B!S='EL93TS1"=$25-03$%9.B!B;&]C
M:SL@5$585"U)3D1%3E0Z(#!P="<^)FYB<W`[/"]D:78^(#QD:78@<W1Y;&4]
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M9&5E;65D(&9I;F%L('1H<F]U9V@@,C`P.2X\+V1I=CX@/&1I=B!S='EL93TS
M1"=$25-03$%9.B!B;&]C:SL@34%21TE.+4Q%1E0Z(#(W<'0[($U!4D=)3BU2
M24=(5#H@,'!T.R!T97AT+6%L:6=N.B!J=7-T:69Y.R!415A4+4E.1$5.5#H@
M,'!T)SX@)FYB<W`[/"]D:78^(#QD:78^(#QT86)L92!S='EL93TS1"=&3TY4
M+5-)6D4Z(#$P<'0[($9/3E0M1D%-24Q9.B!T:6UE<R!N97<@<F]M86XG(&-E
M;&QS<&%C:6YG/3-$,"!C96QL<&%D9&EN9STS1#`@=VED=&@],T0Q,#`E(&%L
M:6=N/3-$8V5N=&5R(&)O<F1E<CTS1#`^(#QT<B!V86QI9VX],T1T;W`^(#QT
M9"!S='EL93TS1"=724142#H@,C=P="<^(#QD:78@<W1Y;&4],T0G1$E34$Q!
M63H@:6YL:6YE.R!&3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N.R!&3TY4
M+5-)6D4Z(#$P<'0[($U!4D=)3BU,1494.B`P<'0[($U!4D=)3BU224=(5#H@
M,'!T.R!415A4+4E.1$5.5#H@,'!T)SX@0RX\+V1I=CX@/"]T9#X@/'1D/B`\
M9&EV('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ(%1I
M;65S($YE=R!2;VUA;CL@1D].5"U325I%.B`Q,'!T.R!T97AT+6%L:6=N.B!J
M=7-T:69Y)SX@5&%X(')A=&5S(&%P<&QI8V%B;&4@=&\@=&AE($-O;7!A;GDZ
M+3PO9&EV/B`\+W1D/B`\+W1R/B`\+W1A8FQE/B`\+V1I=CX@/&1I=B!S='EL
M93TS1"=$25-03$%9.B!B;&]C:SL@5$585"U)3D1%3E0Z(#!P="<^/&)R("\^
M(#PO9&EV/B`\9&EV/B`\=&%B;&4@<W1Y;&4],T0G1D].5"U325I%.B`Q,'!T
M.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N)R!C96QL<W!A8VEN9STS
M1#`@8V5L;'!A9&1I;F<],T0P('=I9'1H/3-$,3`P)2!A;&EG;CTS1&-E;G1E
M<B!B;W)D97(],T0P/B`\='(@=F%L:6=N/3-$=&]P/B`\=&0@<W1Y;&4],T0G
M5TE$5$@Z(#(X+C,T.7!T)SX@/&1I=B!S='EL93TS1"=&3TY4+5-)6D4Z(#$P
M<'0[($9/3E0M1D%-24Q9.B!4:6UE<R!.97<@4F]M86X[($1)4U!,05DZ(&EN
M;&EN92<^("9N8G-P.SPO9&EV/B`\+W1D/B`\=&0@<W1Y;&4],T0G5TE$5$@Z
M(#$X<'0G/B`\9&EV('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&
M04U)3%DZ(%1I;65S($YE=R!2;VUA;CL@1D].5"U325I%.B`Q,'!T.R!-05)'
M24XM3$5&5#H@,'!T.R!-05)'24XM4DE'2%0Z(#!P=#L@5$585"U)3D1%3E0Z
M(#!P="<^(#$N/"]D:78^(#PO=&0^(#QT9#X@/&1I=B!S='EL93TS1"=$25-0
M3$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!4:6UE<R!.97<@4F]M86X[($9/
M3E0M4TE:13H@,3!P=#L@=&5X="UA;&EG;CH@:G5S=&EF>2<^(%!L=7)I<W1E
M;2!4:&5R87!E=71I8W,@26YC+CH\+V1I=CX@/"]T9#X@/"]T<CX@/"]T86)L
M93X@/"]D:78^(#QD:78@<W1Y;&4],T0G1$E34$Q!63H@8FQO8VL[($U!4D=)
M3BU,1494.B`P<'0[($U!4D=)3BU224=(5#H@,'!T.R!T97AT+6%L:6=N.B!J
M=7-T:69Y.R!415A4+4E.1$5.5#H@,'!T)SX@)FYB<W`[/"]D:78^(#QD:78@
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M=&4@;V8@=7`@=&\@,S4E+"!E>&-L=61I;F<@<W1A=&4@=&%X(&%N9"!L;V-A
M;"!T87@@:68@86YY+"!W:&EC:"!R871E<R!D97!E;F0@;VX@=&AE('-T871E
M(&%N9"!C:71Y(&EN('=H:6-H(%!L=7)I<W1E;2!4:&5R87!E=71I8W,@26YC
M+B!C;VYD=6-T<R!I=',@8G5S:6YE<W,N/"]D:78^(#QD:78@<W1Y;&4],T0G
M1$E34$Q!63H@8FQO8VL[($U!4D=)3BU,1494.B`T-7!T.R!-05)'24XM4DE'
M2%0Z(#!P=#L@=&5X="UA;&EG;CH@:G5S=&EF>3L@5$585"U)3D1%3E0Z(#!P
M="<^("9N8G-P.SPO9&EV/B`\9&EV/B`\=&%B;&4@<W1Y;&4],T0G1D].5"U3
M25I%.B`Q,'!T.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N)R!C96QL
M<W!A8VEN9STS1#`@8V5L;'!A9&1I;F<],T0P('=I9'1H/3-$,3`P)2!A;&EG
M;CTS1&-E;G1E<B!B;W)D97(],T0P/B`\='(@=F%L:6=N/3-$=&]P/B`\=&0@
M<W1Y;&4],T0G5TE$5$@Z(#(X+C,T.7!T)SX@/&1I=B!S='EL93TS1"=&3TY4
M+5-)6D4Z(#$P<'0[($9/3E0M1D%-24Q9.B!4:6UE<R!.97<@4F]M86X[($1)
M4U!,05DZ(&EN;&EN92<^("9N8G-P.SPO9&EV/B`\+W1D/B`\=&0@<W1Y;&4]
M,T0G5TE$5$@Z(#$X<'0G/B`\9&EV('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN
M93L@1D].5"U&04U)3%DZ(%1I;65S($YE=R!2;VUA;CL@1D].5"U325I%.B`Q
M,'!T.R!-05)'24XM3$5&5#H@,'!T.R!-05)'24XM4DE'2%0Z(#!P=#L@5$58
M5"U)3D1%3E0Z(#!P="<^(#(N/"]D:78^(#PO=&0^(#QT9#X@/&1I=B!S='EL
M93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!4:6UE<R!.97<@
M4F]M86X[($9/3E0M4TE:13H@,3!P=#L@=&5X="UA;&EG;CH@:G5S=&EF>2<^
M(%1H92!3=6)S:61I87)Y.CPO9&EV/B`\+W1D/B`\+W1R/B`\+W1A8FQE/B`\
M+V1I=CX@/&1I=B!S='EL93TS1"=$25-03$%9.B!B;&]C:SL@1D].5"U&04U)
M3%DZ(%1I;65S($YE=R!2;VUA;CL@1D].5"U325I%.B`Q,'!T.R!-05)'24XM
M3$5&5#H@-#5P=#L@34%21TE.+5))1TA4.B`P<'0[('1E>'0M86QI9VXZ(&QE
M9G0[(%1%6%0M24Y$14Y4.B`P<'0G/B`F;F)S<#L\+V1I=CX@/&1I=B!S='EL
M93TS1"=$25-03$%9.B!B;&]C:SL@1D].5"U&04U)3%DZ(%1I;65S($YE=R!2
M;VUA;CL@1D].5"U325I%.B`Q,'!T.R!-05)'24XM3$5&5#H@-#5P=#L@34%2
M1TE.+5))1TA4.B`P<'0[('1E>'0M86QI9VXZ(&QE9G0[(%1%6%0M24Y$14Y4
M.B`P<'0G/B!487AA8FQE(&EN8V]M92!O9B!)<W)A96QI(&-O;7!A;FEE<R!I
M<R!S=6)J96-T('1O('1A>"!A="!T:&4@<F%T92!O9B`R-24@:6X@,C`Q,BP@
M,C`Q,R!A;F0@,C8N-24@:6X@,C`Q-"X\+V1I=CX@/&1I=B!S='EL93TS1"=$
M25-03$%9.B!B;&]C:SL@5$585"U)3D1%3E0Z(#!P="<^/&)R("\^(#PO9&EV
M/B`\9&EV('-T>6QE/3-$)T1)4U!,05DZ(&)L;V-K.R!&3TY4+49!34E,63H@
M5&EM97,@3F5W(%)O;6%N.R!&3TY4+5-)6D4Z(#$P<'0[($9/3E0M5T5)1TA4
M.B!B;VQD.R!-05)'24XM3$5&5#H@,C=P=#L@34%21TE.+5))1TA4.B`P<'0[
M('1E>'0M86QI9VXZ(&IU<W1I9GD[(%1%6%0M24Y$14Y4.B`P<'0G/B!487@@
M0F5N969I=',@56YD97(@=&AE($QA=R!F;W(@16YC;W5R86=E;65N="!O9B!#
M87!I=&%L($EN=F5S=&UE;G1S+CPO9&EV/B`\9&EV('-T>6QE/3-$)T1)4U!,
M05DZ(&)L;V-K.R!-05)'24XM3$5&5#H@-#,W<'0[($U!4D=)3BU224=(5#H@
M,'!T.R!T97AT+6%L:6=N.B!J=7-T:69Y.R!415A4+4E.1$5.5#H@,'!T)SX@
M)FYB<W`[/"]D:78^(#QD:78@<W1Y;&4],T0G1$E34$Q!63H@8FQO8VL[($9/
M3E0M1D%-24Q9.B!4:6UE<R!.97<@4F]M86X[($9/3E0M4TE:13H@,3!P=#L@
M34%21TE.+4Q%1E0Z(#(W<'0[($U!4D=)3BU224=(5#H@,'!T.R!T97AT+6%L
M:6=N.B!J=7-T:69Y.R!415A4+4E.1$5.5#H@,'!T)SX@06-C;W)D:6YG('1O
M('1H92!,87<@9F]R($5N8V]U<F%G96UE;G0@;V8@0V%P:71A;"!);G9E<W1M
M96YT<RP@,3DU.2`H=&AE(")%;F-O=7)A9V5M96YT($QA=R(I+"!T:&4@4W5B
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M5#H@,'!T)SX@)FYB<W`[/"]D:78^(#QD:78@<W1Y;&4],T0G1$E34$Q!63H@
M8FQO8VL[($9/3E0M1D%-24Q9.B!4:6UE<R!.97<@4F]M86X[($9/3E0M4TE:
M13H@,3!P=#L@1D].5"U35%E,13H@:71A;&EC.R!-05)'24XM3$5&5#H@,C=P
M=#L@34%21TE.+5))1TA4.B`P<'0[('1E>'0M86QI9VXZ(&IU<W1I9GD[(%1%
M6%0M24Y$14Y4.B`P<'0G/B!487@@8F5N969I=',@86YD(')E9'5C960@=&%X
M(')A=&5S.CPO9&EV/B`\9&EV('-T>6QE/3-$)T1)4U!,05DZ(&)L;V-K.R!-
M05)'24XM3$5&5#H@-#,W<'0[($U!4D=)3BU224=(5#H@,'!T.R!T97AT+6%L
M:6=N.B!J=7-T:69Y.R!415A4+4E.1$5.5#H@,'!T)SX@)FYB<W`[/"]D:78^
M(#QD:78@<W1Y;&4],T0G1$E34$Q!63H@8FQO8VL[($9/3E0M1D%-24Q9.B!4
M:6UE<R!.97<@4F]M86X[($9/3E0M4TE:13H@,3!P=#L@34%21TE.+4Q%1E0Z
M(#(W<'0[($U!4D=)3BU224=(5#H@,'!T.R!T97AT+6%L:6=N.B!J=7-T:69Y
M.R!415A4+4E.1$5.5#H@,'!T)SX@3VX@2G5L>2`W+"`R,#$P+"!T:&4@4W5B
M<VED:6%R>2!H87,@<F5C96EV960@82!L971T97(@;V8@87!P<F]V86P@*'1H
M92`B4G5L:6YG(BD@9G)O;2!T:&4@27-R865L:2!487@@075T:&]R:71Y+B!!
M8V-O<F1I;F<@=&\@=&AE(%)U;&EN9RP@=&AE(%-U8G-I9&EA<GDF(S,Y.W,@
M97AP86YS:6]N('!R;V=R86T@;V8@:71S('!L86YT('=A<R!G<F%N=&5D('1H
M92!S=&%T=7,@;V8@82`B0F5N969I8VEA<GD@16YT97)P<FES92(@=6YD97(@
M=&AE(")!;'1E<FYA=&EV92!4<F%C:R(@*'1H92`B,C`P-R!0<F]G<F%M(BDN
M(%1H92!3=6)S:61I87)Y(&-H;W-E('1H92!Y96%R(#(P,#<@87,@=&AE(&5L
M96-T:6]N('EE87(@;V8@=&AE(#(P,#<@4')O9W)A;2X\+V1I=CX@/&1I=B!S
M='EL93TS1"=-05)'24XM3$5&5#H@-#,W<'0[($1)4U!,05DZ(&)L;V-K.R!4
M15A4+4E.1$5.5#H@,'!T)SX@/&)R("\^(#PO9&EV/B`\9&EV('-T>6QE/3-$
M)T1)4U!,05DZ(&)L;V-K.R!&3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N
M.R!&3TY4+5-)6D4Z(#$P<'0[($U!4D=)3BU,1494.B`R-W!T.R!-05)'24XM
M4DE'2%0Z(#!P=#L@=&5X="UA;&EG;CH@:G5S=&EF>3L@5$585"U)3D1%3E0Z
M(#!P="<^(%5N9&5R('1H92`R,#`W(%!R;V=R86T@(D%L=&5R;F%T:79E(%1R
M86-K(BP@=&AE(%-U8G-I9&EA<GDL('=H:6-H('=A<R!L;V-A=&5D(&EN(&$@
M3F%T:6]N86P@4')I;W)I='D@6F]N92`B0B(@=VET:"!R97-P96-T('1O('1H
M92!Y96%R(#(P,#<L(&ES('1A>"!E>&5M<'0@:6X@=&AE(&9I<G-T('-I>"!Y
M96%R<R!O9B!T:&4@8F5N969I="!P97)I;V0@86YD('-U8FIE8W0@=&\@=&%X
M(&%T('1H92!R961U8V5D(')A=&4@;V8@,3`E+3(U)2!F;W(@82!P97)I;V0@
M;V8@;VYE('1O(&9O=7(@>65A<G,@9F]R('1H92!R96UA:6YI;F<@8F5N969I
M="!P97)I;V0@*&1E<&5N9&5N="!O;B!T:&4@;&5V96P@;V8@9F]R96EG;B!I
M;G9E<W1M96YT<RDN/"]D:78^(#QD:78@<W1Y;&4],T0G34%21TE.+4Q%1E0Z
M(#0S-W!T.R!$25-03$%9.B!B;&]C:SL@5$585"U)3D1%3E0Z(#!P="<^(#QB
M<B`O/B`\+V1I=CX@/&1I=B!S='EL93TS1"=$25-03$%9.B!B;&]C:SL@1D].
M5"U&04U)3%DZ(%1I;65S($YE=R!2;VUA;CL@1D].5"U325I%.B`Q,'!T.R!-
M05)'24XM3$5&5#H@,C=P=#L@34%21TE.+5))1TA4.B`P<'0[('1E>'0M86QI
M9VXZ(&IU<W1I9GD[(%1%6%0M24Y$14Y4.B`P<'0G/B!/;B!*=6YE(#8L(#(P
M,3,L('1H92!3=6)S:61I87)Y(&EN9F]R;65D('1H92!)<W)A96QI(%1A>"!!
M=71H;W)I='D@=&AA="!I="!H87,@8VAO<V5N('1H92!Y96%R(#(P,3(@87,@
M86X@96QE8W1I;VX@>65A<B!T;R!T:&4@97AP86YS:6]N(&]F(&ET<R!"96YE
M9FEC:6%R>2!%;G1E<G!R:7-E('!R;V=R86T@*'1H92`B,C`Q,B!0<F]G<F%M
M(BDN/"]D:78^(#QD:78@<W1Y;&4],T0G34%21TE.+4Q%1E0Z(#0S-W!T.R!$
M25-03$%9.B!B;&]C:SL@5$585"U)3D1%3E0Z(#!P="<^(#QB<B`O/B`\+V1I
M=CX@/&1I=B!S='EL93TS1"=$25-03$%9.B!B;&]C:SL@1D].5"U&04U)3%DZ
M(%1I;65S($YE=R!2;VUA;CL@1D].5"U325I%.B`Q,'!T.R!-05)'24XM3$5&
M5#H@,C=P=#L@34%21TE.+5))1TA4.B`P<'0[('1E>'0M86QI9VXZ(&IU<W1I
M9GD[(%1%6%0M24Y$14Y4.B`P<'0G/B!5;F1E<B!T:&4@,C`Q,B!0<F]G<F%M
M+"!T:&4@4W5B<VED:6%R>2P@=VAI8V@@=V%S(&QO8V%T960@:6X@=&AE(")/
M=&AE<B!.871I;VYA;"!0<FEO<FET>2!:;VYE(B!W:71H(')E<W!E8W0@=&\@
M=&AE('EE87(@,C`Q,BP@=V]U;&0@8F4@=&%X(&5X96UP="!I;B!T:&4@9FER
M<W0@='=O('EE87)S(&]F('1H92!B96YE9FET('!E<FEO9"!A;F0@<W5B:F5C
M="!T;R!T87@@870@=&AE(')E9'5C960@<F%T92!O9B`Q,"4M,C4E(&9O<B!A
M('!E<FEO9"!O9B!F:79E('1O(&5I9VAT('EE87)S(&9O<B!T:&4@<F5M86EN
M:6YG(&)E;F5F:70@<&5R:6]D("AD97!E;F1E;G0@;VX@=&AE(&QE=F5L(&]F
M(&9O<F5I9VX@:6YV97-T;65N=',I+CPO9&EV/B`\9&EV('-T>6QE/3-$)TU!
M4D=)3BU,1494.B`T,S=P=#L@1$E34$Q!63H@8FQO8VL[(%1%6%0M24Y$14Y4
M.B`P<'0G/B`\8G(@+SX@/"]D:78^(#QD:78@<W1Y;&4],T0G1$E34$Q!63H@
M8FQO8VL[($9/3E0M1D%-24Q9.B!4:6UE<R!.97<@4F]M86X[($9/3E0M4TE:
M13H@,3!P=#L@34%21TE.+4Q%1E0Z(#(W<'0[($U!4D=)3BU224=(5#H@,'!T
M.R!T97AT+6%L:6=N.B!J=7-T:69Y.R!415A4+4E.1$5.5#H@,'!T)SX@1F]L
M;&]W:6YG('1H92!E;F%C=&UE;G0@;V8@06UE;F1M96YT($YO+B`V,"!T;R!T
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M<W`[,S`P+#`P,"P@;&EN:V5D('1O('1H92!)<W)A96QI($-022!I;B!A8V-O
M<F1A;F-E('=I=&@@=&AE(&=U:61E;&EN97,@;V8@=&AE($ES<F%E;&D@=&%X
M(&%U=&AO<FET:65S+B!!<R!F;W(@<&QA;G0@97AP86YS:6]N+"!T:&4@;6EN
M:6UU;2!Q=6%L:69Y:6YG(&EN=F5S=&UE;G0@:7,@=&AE(&AI9VAE<B!O9B!.
M25,F;F)S<#LS,#`L,#`P+"!L:6YK960@=&\@=&AE($ES<F%E;&D@0U!)(&%S
M('-T871E9"!A8F]V92P@86YD(&%N(&%M;W5N="!E<75I=F%L96YT('1O('1H
M92`B<75A;&EF>6EN9R!P97)C96YT86=E(B!O9B!T:&4@=F%L=64@;V8@=&AE
M('!R;V1U8W1I=F4@87-S971S+B!0<F]D=6-T:79E(&%S<V5T<R!T:&%T(&%R
M92!U<V5D(&)Y('1H92!P;&%N="!B=70@;F]T(&]W;F5D(&)Y(&ET('=I;&P@
M86QS;R!B92!V:65W960@87,@<')O9'5C=&EV92!A<W-E=',N/"]D:78^(#QD
M:78@<W1Y;&4],T0G1$E34$Q!63H@8FQO8VL[(%1%6%0M24Y$14Y4.B`P<'0G
M/CQB<B`O/B`\+V1I=CX@/&1I=B!S='EL93TS1"=$25-03$%9.B!B;&]C:SL@
M1D].5"U&04U)3%DZ(%1I;65S($YE=R!2;VUA;CL@1D].5"U325I%.B`Q,'!T
M.R!-05)'24XM3$5&5#H@,C=P=#L@34%21TE.+5))1TA4.B`P<'0[('1E>'0M
M86QI9VXZ(&IU<W1I9GD[(%1%6%0M24Y$14Y4.B`P<'0G/B!4:&4@<75A;&EF
M>6EN9R!P97)C96YT86=E(&]F('1H92!V86QU92!O9B!T:&4@<')O9'5C=&EV
M92!A<W-E=',@:7,@87,@9F]L;&]W<SH\+V1I=CX@/&1I=B!S='EL93TS1"=$
M25-03$%9.B!B;&]C:SL@5$585"U)3D1%3E0Z(#!P="<^/&)R("\^(#PO9&EV
M/B`\9&EV('-T>6QE/3-$)TU!4D=)3BU,1494.B`R-W!T.R!T97AT+6%L:6=N
M.B!C96YT97(G/B`\=&%B;&4@<W1Y;&4],T0G1D].5"U325I%.B`Q,'!T.R!&
M3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N)R!C96QL<W!A8VEN9STS1#`@
M8V5L;'!A9&1I;F<],T0P('=I9'1H/3-$-C`E/B`\='(^(#QT9"!S='EL93TS
M1"="3U)$15(M0D]45$]-.B!B;&%C:R`R<'@@<V]L:60G('9A;&EG;CTS1&)O
M='1O;2!W:61T:#TS1#0Y)3X@/&1I=B!S='EL93TS1"=$25-03$%9.B!B;&]C
M:SL@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q
M,'!T.R!&3TY4+5=%24=(5#H@8F]L9#L@34%21TE.+4Q%1E0Z(#!P=#L@34%2
M1TE.+5))1TA4.B`P<'0[('1E>'0M86QI9VXZ(&-E;G1E<CL@5$585"U)3D1%
M3E0Z(#!P="<^(%1H92!V86QU92!O9B!P<F]D=6-T:79E/"]D:78^(#QD:78@
M<W1Y;&4],T0G1$E34$Q!63H@8FQO8VL[($9/3E0M1D%-24Q9.B!T:6UE<R!N
M97<@<F]M86X[($9/3E0M4TE:13H@,3!P=#L@1D].5"U714E'2%0Z(&)O;&0[
M($U!4D=)3BU,1494.B`P<'0[($U!4D=)3BU224=(5#H@,'!T.R!T97AT+6%L
M:6=N.B!C96YT97([(%1%6%0M24Y$14Y4.B`P<'0G/B!A<W-E=',@8F5F;W)E
M('1H92!E>'!A;G-I;VX\+V1I=CX@/&1I=B!S='EL93TS1"=$25-03$%9.B!B
M;&]C:SL@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%
M.B`Q,'!T.R!&3TY4+5=%24=(5#H@8F]L9#L@34%21TE.+4Q%1E0Z(#!P=#L@
M34%21TE.+5))1TA4.B`P<'0[('1E>'0M86QI9VXZ(&-E;G1E<CL@5$585"U)
M3D1%3E0Z(#!P="<^("A.25,@:6X@;6EL;&EO;G,I/"]D:78^(#PO=&0^(#QT
M9"!V86QI9VX],T1T;W`@=VED=&@],T0R)3X\9F]N="!S='EL93TS1"=&3TY4
M+5-)6D4Z(#$P<'0[($9/3E0M1D%-24Q9.B!T:6UE<R!N97<@<F]M86X[($1)
M4U!,05DZ(&EN;&EN92<^("9N8G-P.SPO9F]N=#X@/"]T9#X@/'1D('-T>6QE
M/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#)P>"!S;VQI9"<@=F%L:6=N/3-$
M=&]P('=I9'1H/3-$-#DE/B`\9&EV('-T>6QE/3-$)T1)4U!,05DZ(&)L;V-K
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M3BU,1494.B`P<'0[($U!4D=)3BU224=(5#H@,'!T.R!T97AT+6%L:6=N.B!C
M96YT97([(%1%6%0M24Y$14Y4.B`P<'0G/B!T:&%T('1H92!R97%U:7)E9#PO
M9&EV/B`\9&EV('-T>6QE/3-$)T1)4U!,05DZ(&)L;V-K.R!&3TY4+49!34E,
M63H@=&EM97,@;F5W(')O;6%N.R!&3TY4+5-)6D4Z(#$P<'0[($9/3E0M5T5)
M1TA4.B!B;VQD.R!-05)'24XM3$5&5#H@,'!T.R!-05)'24XM4DE'2%0Z(#!P
M=#L@=&5X="UA;&EG;CH@8V5N=&5R.R!415A4+4E.1$5.5#H@,'!T)SX@)FYB
M<W`[:6YV97-T;65N="!B96%R<SPO9&EV/B`\9&EV('-T>6QE/3-$)T1)4U!,
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M($U!4D=)3BU,1494.B`P<'0[($U!4D=)3BU224=(5#H@,'!T.R!T97AT+6%L
M:6=N.B!C96YT97([(%1%6%0M24Y$14Y4.B`P<'0G/B!P<F]D=6-T:79E(&%S
M<V5T<SPO9&EV/B`\+W1D/B`\+W1R/B`\='(^(#QT9"!V86QI9VX],T1T;W`@
M=VED=&@],T0T.24^/&9O;G0@<W1Y;&4],T0G1D].5"U325I%.B`Q,'!T.R!&
M3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!$25-03$%9.B!I;FQI;F4G
M/B`F;F)S<#L\+V9O;G0^(#PO=&0^(#QT9"!V86QI9VX],T1T;W`@=VED=&@]
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M=#X@/"]T9#X@/"]T<CX@/'1R(&)G8V]L;W(],T0C8V-E969F/B`\=&0@<W1Y
M;&4],T0G5$585"U!3$E'3CH@;&5F=#L@34%21TE.+4Q%1E0Z(#!P=#L@34%2
M1TE.+5))1TA4.B`P<'0[(%1%6%0M24Y$14Y4.B`P<'0G('9A;&EG;CTS1'1O
M<"!W:61T:#TS1#0Y)3X@/&1I=B!S='EL93TS1"=$25-03$%9.B!B;&]C:SL@
M1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T
M.R!-05)'24XM3$5&5#H@,'!T.R!-05)'24XM4DE'2%0Z(#!P=#L@5$585"U!
M3$E'3CH@;&5F=#L@5$585"U)3D1%3E0Z(#!P="<^(%5P('1O($Y)4R9N8G-P
M.S$T,#PO9&EV/B`\+W1D/B`\=&0@=F%L:6=N/3-$=&]P('=I9'1H/3-$,B4^
M/&9O;G0@<W1Y;&4],T0G1D].5"U325I%.B`Q,'!T.R!&3TY4+49!34E,63H@
M=&EM97,@;F5W(')O;6%N.R!$25-03$%9.B!I;FQI;F4G/B`F;F)S<#L\+V9O
M;G0^(#PO=&0^(#QT9"!V86QI9VX],T1T;W`@=VED=&@],T0T.24^(#QD:78@
M<W1Y;&4],T0G1$E34$Q!63H@8FQO8VL[($9/3E0M1D%-24Q9.B!T:6UE<R!N
M97<@<F]M86X[($9/3E0M4TE:13H@,3!P=#L@34%21TE.+4Q%1E0Z(#!P=#L@
M34%21TE.+5))1TA4.B`P<'0[('1E>'0M86QI9VXZ(&-E;G1E<CL@5$585"U)
M3D1%3E0Z(#!P="<^(#$R)3PO9&EV/B`\+W1D/B`\+W1R/B`\='(@8F=C;VQO
M<CTS1'=H:71E/B`\=&0@<W1Y;&4],T0G5$585"U!3$E'3CH@;&5F=#L@34%2
M1TE.+4Q%1E0Z(#!P=#L@34%21TE.+5))1TA4.B`P<'0[(%1%6%0M24Y$14Y4
M.B`P<'0G('9A;&EG;CTS1'1O<"!W:61T:#TS1#0Y)3X@/&1I=B!S='EL93TS
M1"=$25-03$%9.B!B;&]C:SL@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA
M;CL@1D].5"U325I%.B`Q,'!T.R!-05)'24XM3$5&5#H@,'!T.R!-05)'24XM
M4DE'2%0Z(#!P=#L@5$585"U!3$E'3CH@;&5F=#L@5$585"U)3D1%3E0Z(#!P
M="<^($Y)4R9N8G-P.S$T,"`M($Y)4R9N8G-P.S4P,#PO9&EV/B`\+W1D/B`\
M=&0@=F%L:6=N/3-$=&]P('=I9'1H/3-$,B4^/&9O;G0@<W1Y;&4],T0G1D].
M5"U325I%.B`Q,'!T.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!$
M25-03$%9.B!I;FQI;F4G/B`F;F)S<#L\+V9O;G0^(#PO=&0^(#QT9"!V86QI
M9VX],T1T;W`@=VED=&@],T0T.24^(#QD:78@<W1Y;&4],T0G1$E34$Q!63H@
M8FQO8VL[($9/3E0M1D%-24Q9.B!T:6UE<R!N97<@<F]M86X[($9/3E0M4TE:
M13H@,3!P=#L@34%21TE.+4Q%1E0Z(#!P=#L@34%21TE.+5))1TA4.B`P<'0[
M('1E>'0M86QI9VXZ(&-E;G1E<CL@5$585"U)3D1%3E0Z(#!P="<^(#<E/"]D
M:78^(#PO=&0^(#PO='(^(#QT<B!B9V-O;&]R/3-$(V-C965F9CX@/'1D('-T
M>6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0[($U!4D=)3BU,1494.B`P<'0[($U!
M4D=)3BU224=(5#H@,'!T.R!415A4+4E.1$5.5#H@,'!T)R!V86QI9VX],T1T
M;W`@=VED=&@],T0T.24^(#QD:78@<W1Y;&4],T0G1$E34$Q!63H@8FQO8VL[
M($9/3E0M1D%-24Q9.B!T:6UE<R!N97<@<F]M86X[($9/3E0M4TE:13H@,3!P
M=#L@34%21TE.+4Q%1E0Z(#!P=#L@34%21TE.+5))1TA4.B`P<'0[(%1%6%0M
M04Q)1TXZ(&QE9G0[(%1%6%0M24Y$14Y4.B`P<'0G/B!-;W)E('1H86X@3DE3
M)FYB<W`[-3`P/"]D:78^(#PO=&0^(#QT9"!V86QI9VX],T1T;W`@=VED=&@]
M,T0R)3X\9F]N="!S='EL93TS1"=&3TY4+5-)6D4Z(#$P<'0[($9/3E0M1D%-
M24Q9.B!T:6UE<R!N97<@<F]M86X[($1)4U!,05DZ(&EN;&EN92<^("9N8G-P
M.SPO9F]N=#X@/"]T9#X@/'1D('9A;&EG;CTS1'1O<"!W:61T:#TS1#0Y)3X@
M/&1I=B!S='EL93TS1"=$25-03$%9.B!B;&]C:SL@1D].5"U&04U)3%DZ('1I
M;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T.R!-05)'24XM3$5&5#H@
M,'!T.R!-05)'24XM4DE'2%0Z(#!P=#L@=&5X="UA;&EG;CH@8V5N=&5R.R!4
M15A4+4E.1$5.5#H@,'!T)SX@-24\+V1I=CX@/"]T9#X@/"]T<CX@/"]T86)L
M93X@/"]D:78^(#QD:78@<W1Y;&4],T0G1$E34$Q!63H@8FQO8VL[(%1%6%0M
M24Y$14Y4.B`P<'0G/CQB<B`O/B`\+V1I=CX@/&1I=B!S='EL93TS1"=$25-0
M3$%9.B!B;&]C:SL@1D].5"U&04U)3%DZ(%1I;65S($YE=R!2;VUA;CL@1D].
M5"U325I%.B`Q,'!T.R!-05)'24XM3$5&5#H@,C=P=#L@34%21TE.+5))1TA4
M.B`P<'0[('1E>'0M86QI9VXZ(&IU<W1I9GD[(%1%6%0M24Y$14Y4.B`P<'0G
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M,'!T)SX@/&)R("\^(#PO9&EV/B`\9&EV('-T>6QE/3-$)T1)4U!,05DZ(&)L
M;V-K.R!&3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N.R!&3TY4+5-)6D4Z
M(#$P<'0[($U!4D=)3BU,1494.B`R-W!T.R!-05)'24XM4DE'2%0Z(#!P=#L@
M=&5X="UA;&EG;CH@:G5S=&EF>3L@5$585"U)3D1%3E0Z(#!P="<^($%S('-T
M871E9"!A8F]V92P@=&AE(%-U8G-I9&EA<GDF(S,Y.W,@,C`P-R!0<F]G<F%M
M(&%N9"`R,#$R(%!R;V=R86T@=V5R92!G<F%N=&5D('1H92!S=&%T=7,@;V8@
M82`B0F5N969I8VEA<GD@16YT97)P<FES92(L(&EN(&%C8V]R9&%N8V4@=VET
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M)SX@/&)R("\^(#PO9&EV/B`\9&EV('-T>6QE/3-$)T1)4U!,05DZ(&)L;V-K
M.R!&3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N.R!&3TY4+5-)6D4Z(#$P
M<'0[($U!4D=)3BU,1494.B`R-W!T.R!-05)'24XM4DE'2%0Z(#!P=#L@=&5X
M="UA;&EG;CH@:G5S=&EF>3L@5$585"U)3D1%3E0Z(#!P="<^($EN(')E<W!E
M8W0@;V8@97AP86YS:6]N('!R;V=R86US('!U<G-U86YT('1O($%M96YD;65N
M="!.;RX@-C`@=&\@=&AE($5N8V]U<F%G96UE;G0\9F]N="!S='EL93TS1"=&
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M<B!T:&4@4W5B<VED:6%R>28C,SD[<R`R,#`W(%!R;V=R86T@=VEL;"!E>'!I
M<F4@:6X@,C`Q."`H,3(@>65A<G,@<VEN8V4@=&AE(&)E9VEN;FEN9R!O9B!T
M:&4@96QE8W1I;VX@>65A<BT@,C`P-RDN5&AE(&)E;F5F:70@<&5R:6]D(&9O
M<B!T:&4@4W5B<VED:6%R>28C,SD[<R`R,#$R(%!R;V=R86T@=V]U;&0@97AP
M:7)E(&EN(#(P,C,@*#$R('EE87)S('-I;F-E('1H92!B96=I;FYI;F<@;V8@
M=&AE(&5L96-T:6]N('EE87(@+2`R,#$R*2X\+V1I=CX@/&1I=B!S='EL93TS
M1"=-05)'24XM3$5&5#H@-#,W<'0[($1)4U!,05DZ(&)L;V-K.R!415A4+4E.
M1$5.5#H@,'!T)SX@/&)R("\^(#PO9&EV/B`\9&EV('-T>6QE/3-$)T1)4U!,
M05DZ(&)L;V-K.R!&3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N.R!&3TY4
M+5-)6D4Z(#$P<'0[($U!4D=)3BU,1494.B`R-W!T.R!-05)'24XM4DE'2%0Z
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M87@@870@=&AE(')A=&4@;V8@,3`M(#(U)2P@9&5P96YD96YT(&]N('1H92!L
M979E;"!O9B!F;W)E:6=N(&EN=F5S=&UE;G1S*2!A;F0@=&\@02!W:71H:&]L
M9&EN9R!T87@@<F%T92!O9B`Q-24@*&]R(&QO=V5R+"!U;F1E<B!A;B!A<'!L
M:6-A8FQE('1A>"!T<F5A='DI+CPO9&EV/B`\9&EV('-T>6QE/3-$)TU!4D=)
M3BU,1494.B`T,S=P=#L@1$E34$Q!63H@8FQO8VL[(%1%6%0M24Y$14Y4.B`P
M<'0G/B`\8G(@+SX@/"]D:78^(#QD:78@<W1Y;&4],T0G1$E34$Q!63H@8FQO
M8VL[($9/3E0M1D%-24Q9.B!4:6UE<R!.97<@4F]M86X[($9/3E0M4TE:13H@
M,3!P=#L@34%21TE.+4Q%1E0Z(#(W<'0[($U!4D=)3BU224=(5#H@,'!T.R!T
M97AT+6%L:6=N.B!J=7-T:69Y.R!415A4+4E.1$5.5#H@,'!T)SX@07,@9F]R
M($)E;F5F:6-I87)Y($5N=&5R<')I<V5S('!U<G-U86YT('1O($%M96YD;65N
M="!.;RX@-C`@=&\@=&AE($5N8V]U<F%G96UE;G0\9F]N="!S='EL93TS1"=&
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M5"U714E'2%0Z(&)O;&0[($1)4U!,05DZ(&EN;&EN92<^)FYB<W`[/"]F;VYT
M/B!,87<@<')E<V-R:6)E<R!V87)I;W5S(')E<75I<F5M96YT<R!R96=A<F1I
M;F<@:6YD=7-T<FEA;"!E;G1E<G!R:7-E<RX\+V1I=CX@/&1I=B!S='EL93TS
M1"=-05)'24XM3$5&5#H@-#,W<'0[($1)4U!,05DZ(&)L;V-K.R!415A4+4E.
M1$5.5#H@,'!T)SX@/&)R("\^(#PO9&EV/B`\9&EV('-T>6QE/3-$)T1)4U!,
M05DZ(&)L;V-K.R!&3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N.R!&3TY4
M+5-)6D4Z(#$P<'0[($U!4D=)3BU,1494.B`R-W!T.R!-05)'24XM4DE'2%0Z
M(#!P=#L@=&5X="UA;&EG;CH@:G5S=&EF>3L@5$585"U)3D1%3E0Z(#!P="<^
M($%S(&9O<B!I;F1U<W1R:6%L(&5N=&5R<')I<V5S+"!I;B!E86-H('1A>"!Y
M96%R(&1U<FEN9R!T:&4@8F5N969I="!P97)I;V0L(&]N92!O9B!T:&4@9F]L
M;&]W:6YG(&-O;F1I=&EO;G,@;75S="!B92!M970Z/"]D:78^(#QD:78@<W1Y
M;&4],T0G1$E34$Q!63H@8FQO8VL[(%1%6%0M24Y$14Y4.B`P<'0G/CQB<B`O
M/B`\+V1I=CX@/&1I=CX@/'1A8FQE('-T>6QE/3-$)T9/3E0M4TE:13H@,3!P
M=#L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;B<@8V5L;'-P86-I;F<]
M,T0P(&-E;&QP861D:6YG/3-$,"!W:61T:#TS1#$P,"4@86QI9VX],T1C96YT
M97(@8F]R9&5R/3-$,#X@/'1R('9A;&EG;CTS1'1O<#X@/'1D('-T>6QE/3-$
M)U=)1%1(.B`R-W!T)SX@/&1I=B!S='EL93TS1"=&3TY4+5-)6D4Z(#$P<'0[
M($9/3E0M1D%-24Q9.B!4:6UE<R!.97<@4F]M86X[($1)4U!,05DZ(&EN;&EN
M92<^("9N8G-P.SPO9&EV/B`\+W1D/B`\=&0@<W1Y;&4],T0G5TE$5$@Z(#$X
M<'0G/B`\9&EV('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)
M3%DZ(%1I;65S($YE=R!2;VUA;CL@1D].5"U325I%.B`Q,'!T.R!-05)'24XM
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M<')O=F%L(&]F('1H92!R96QE=F%N="!P<F]G<F%M+CPO9&EV/B`\+W1D/B`\
M+W1R/B`\+W1A8FQE/B`\+V1I=CX@/&1I=CX@/'1A8FQE('-T>6QE/3-$)T9/
M3E0M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;B<@
M8V5L;'-P86-I;F<],T0P(&-E;&QP861D:6YG/3-$,"!W:61T:#TS1#$P,"4@
M86QI9VX],T1C96YT97(@8F]R9&5R/3-$,#X@/'1R('9A;&EG;CTS1'1O<#X@
M/'1D('-T>6QE/3-$)U=)1%1(.B`R-W!T)SX@/&1I=B!S='EL93TS1"=&3TY4
M+5-)6D4Z(#$P<'0[($9/3E0M1D%-24Q9.B!4:6UE<R!.97<@4F]M86X[($1)
M4U!,05DZ(&EN;&EN92<^("9N8G-P.SPO9&EV/B`\+W1D/B`\=&0@<W1Y;&4]
M,T0G5TE$5$@Z(#$X<'0G/B`\9&EV('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN
M93L@1D].5"U&04U)3%DZ(%1I;65S($YE=R!2;VUA;CL@1D].5"U325I%.B`Q
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M='(^(#PO=&%B;&4^(#PO9&EV/B`\9&EV/B`\=&%B;&4@<W1Y;&4],T0G1D].
M5"U325I%.B`Q,'!T.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N)R!C
M96QL<W!A8VEN9STS1#`@8V5L;'!A9&1I;F<],T0P('=I9'1H/3-$,3`P)2!A
M;&EG;CTS1&-E;G1E<B!B;W)D97(],T0P/B`\='(@=F%L:6=N/3-$=&]P/B`\
M=&0@<W1Y;&4],T0G5TE$5$@Z(#(W<'0G/B`\9&EV('-T>6QE/3-$)T9/3E0M
M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ(%1I;65S($YE=R!2;VUA;CL@1$E3
M4$Q!63H@:6YL:6YE)SX@)FYB<W`[/"]D:78^(#PO=&0^(#QT9"!S='EL93TS
M1"=724142#H@,3AP="<^(#QD:78@<W1Y;&4],T0G1$E34$Q!63H@:6YL:6YE
M.R!&3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N.R!&3TY4+5-)6D4Z(#$P
M<'0[($U!4D=)3BU,1494.B`P<'0[($U!4D=)3BU224=(5#H@,'!T.R!415A4
M+4E.1$5.5#H@,'!T)SX@,RX\+V1I=CX@/"]T9#X@/'1D/B`\9&EV('-T>6QE
M/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ(%1I;65S($YE=R!2
M;VUA;CL@1D].5"U325I%.B`Q,'!T.R!T97AT+6%L:6=N.B!J=7-T:69Y)SX@
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M.B`P<'0[($U!4D=)3BU224=(5#H@,'!T.R!T97AT+6%L:6=N.B!J=7-T:69Y
M.R!415A4+4E.1$5.5#H@,'!T)SX@)FYB<W`[/"]D:78^(#QD:78@<W1Y;&4]
M,T0G1$E34$Q!63H@8FQO8VL[($9/3E0M1D%-24Q9.B!4:6UE<R!.97<@4F]M
M86X[($9/3E0M4TE:13H@,3!P=#L@1D].5"U35%E,13H@:71A;&EC.R!-05)'
M24XM3$5&5#H@,C=P=#L@34%21TE.+5))1TA4.B`P<'0[('1E>'0M86QI9VXZ
M(&IU<W1I9GD[(%1%6%0M24Y$14Y4.B`P<'0G/B!!8V-E;&5R871E9"!D97!R
M96-I871I;VXZ/"]D:78^(#QD:78@<W1Y;&4],T0G34%21TE.+4Q%1E0Z(#0S
M-W!T.R!$25-03$%9.B!B;&]C:SL@5$585"U)3D1%3E0Z(#!P="<^(#QB<B`O
M/B`\+V1I=CX@/&1I=B!S='EL93TS1"=$25-03$%9.B!B;&]C:SL@1D].5"U&
M04U)3%DZ(%1I;65S($YE=R!2;VUA;CL@1D].5"U325I%.B`Q,'!T.R!-05)'
M24XM3$5&5#H@,C=P=#L@34%21TE.+5))1TA4.B`P<'0[('1E>'0M86QI9VXZ
M(&IU<W1I9GD[(%1%6%0M24Y$14Y4.B`P<'0G/B!4:&4@4W5B<VED:6%R>2!I
M<R!E;&EG:6)L92!F;W(@9&5D=6-T:6]N(&]F(&%C8V5L97)A=&5D(&1E<')E
M8VEA=&EO;B!O;B!B=6EL9&EN9W,L(&UA8VAI;F5R>2!A;F0@97%U:7!M96YT
M('5S960@8GD@=&AE(&)E;F5F:6-I87)Y(&5N=&5R<')I<V4@870@82!R871E
M(&]F(#(P,"4@*&]R(#0P,"4@9F]R(&)U:6QD:6YG<RD@9G)O;2!T:&4@9FER
M<W0@>65A<B!O9B!T:&4@87-S970F(S,Y.W,@;W!E<F%T:6]N+CPO9&EV/B`\
M9&EV('-T>6QE/3-$)T1)4U!,05DZ(&)L;V-K.R!415A4+4E.1$5.5#H@,'!T
M)SX\8G(@+SX@/"]D:78^(#QD:78@<W1Y;&4],T0G1$E34$Q!63H@8FQO8VL[
M($9/3E0M1D%-24Q9.B!4:6UE<R!.97<@4F]M86X[($9/3E0M4TE:13H@,3!P
M=#L@1D].5"U35%E,13H@:71A;&EC.R!-05)'24XM3$5&5#H@,C=P=#L@34%2
M1TE.+5))1TA4.B`P<'0[('1E>'0M86QI9VXZ(&IU<W1I9GD[(%1%6%0M24Y$
M14Y4.B`P<'0G/B!#;VYD:71I;VYS(&9O<B!T:&4@96YT:71L96UE;G0@=&\@
M=&AE(&)E;F5F:71S.CPO9&EV/B`\9&EV('-T>6QE/3-$)TU!4D=)3BU,1494
M.B`T,S=P=#L@1$E34$Q!63H@8FQO8VL[(%1%6%0M24Y$14Y4.B`P<'0G/B`\
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M($1)4U!,05DZ(&EN;&EN92<^)FYB<W`[/"]F;VYT/B!,87<L(')E9W5L871I
M;VYS('!R;VUU;&=A=&5D('1H97)E=6YD97(L(&%N9"!T:&4@4G5L:6YG('=I
M=&@@<F5S<&5C="!T;R!T:&4@8F5N969I8VEA<GD@96YT97)P<FES92X@3F]N
M+6-O;7!L:6%N8V4@=VET:"!T:&4@8V]N9&ET:6]N<R!M87D@8V%N8V5L(&%L
M;"!O<B!P87)T(&]F('1H92!B96YE9FET<R!A;F0@<F5F=6YD(&]F('1H92!A
M;6]U;G0@;V8@=&AE(&)E;F5F:71S+"!I;F-L=61I;F<@:6YT97)E<W0N(%1H
M92!M86YA9V5M96YT(&)E;&EE=F5S('1H870@=&AE(%-U8G-I9&EA<GD@:7,@
M;65E=&EN9R!T:&4@869O<F5M96YT:6]N960@8V]N9&ET:6]N<RX\+V1I=CX@
M/&1I=B!S='EL93TS1"=-05)'24XM3$5&5#H@-#,W<'0[($1)4U!,05DZ(&)L
M;V-K.R!415A4+4E.1$5.5#H@,'!T)SX@/&)R("\^(#PO9&EV/B`\9&EV('-T
M>6QE/3-$)T1)4U!,05DZ(&)L;V-K.R!&3TY4+49!34E,63H@5&EM97,@3F5W
M(%)O;6%N.R!&3TY4+5-)6D4Z(#$P<'0[($9/3E0M4U193$4Z(&ET86QI8SL@
M34%21TE.+4Q%1E0Z(#(W<'0[($U!4D=)3BU224=(5#H@,'!T.R!T97AT+6%L
M:6=N.B!J=7-T:69Y.R!415A4+4E.1$5.5#H@,'!T)SX@06UE;F1M96YT('1O
M('1H929N8G-P.R9N8G-P.T5N8V]U<F%G96UE;G0@3&%W.CPO9&EV/B`\9&EV
M('-T>6QE/3-$)TU!4D=)3BU,1494.B`T,S=P=#L@1$E34$Q!63H@8FQO8VL[
M(%1%6%0M24Y$14Y4.B`P<'0G/B`\8G(@+SX@/"]D:78^(#QD:78@<W1Y;&4]
M,T0G1$E34$Q!63H@8FQO8VL[($9/3E0M1D%-24Q9.B!4:6UE<R!.97<@4F]M
M86X[($9/3E0M4TE:13H@,3!P=#L@34%21TE.+4Q%1E0Z(#(W<'0[($U!4D=)
M3BU224=(5#H@,'!T.R!T97AT+6%L:6=N.B!J=7-T:69Y.R!415A4+4E.1$5.
M5#H@,'!T)SX@169F96-T:79E($IA;G5A<GD@,C`Q,2P@=&AE($MN97-S970@
M*$ES<F%E;&D@<&%R;&EA;65N="D@96YA8W1E9"!A(')E9F]R;2!T;R!T:&4@
M16YC;W5R86=E;65N="!,87<N($%C8V]R9&EN9R!T;R!T:&4@<F5F;W)M(&$@
M9FQA="!R871E('1A>"!W;W5L9"!A<'!L>2!T;R!C;VUP86YI97,@96QI9VEB
M;&4@9F]R('1H92`B4')E9F5R<F5D($5N=&5R<')I<V4B('-T871U<RX@26X@
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M("AA(&-O;7!E=&ET:79E(&5N=&5R<')I<V4I+CPO9&EV/B`\9&EV('-T>6QE
M/3-$)TU!4D=)3BU,1494.B`T,S=P=#L@1$E34$Q!63H@8FQO8VL[(%1%6%0M
M24Y$14Y4.B`P<'0G/B`\8G(@+SX@/"]D:78^(#QD:78@<W1Y;&4],T0G1$E3
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M:6QE9V5D($5N=&5R<')I<V4@<W1A='5S+CPO9&EV/B`\9&EV('-T>6QE/3-$
M)TU!4D=)3BU,1494.B`T,S=P=#L@1$E34$Q!63H@8FQO8VL[(%1%6%0M24Y$
M14Y4.B`P<'0G/B`\8G(@+SX@/"]D:78^(#QD:78@<W1Y;&4],T0G1$E34$Q!
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M($IA;G5A<GD@,2P@,C`Q-"P@=&AE(')E9'5C960@=&%X(')A=&4@:7,@.24@
M:6X@=&AE($1E=F5L;W!M96YT($%R96$@02!R96=I;VYS(&%N9"`Q-B4@:6X@
M;W1H97(@<F5G:6]N<RX@4')E9F5R<F5D($5N=&5R<')I<V5S(&EN('!E<FEP
M:&5R86P@<F5G:6]N<R!A<F4@86QS;R!E;&EG:6)L92!F;W(@26YV97-T;65N
M="!#96YT97(@9W)A;G1S+"!A<R!W96QL(&%S('1H92!A<'!L:6-A8FQE(')E
M9'5C960@=&%X(')A=&5S+CPO9&EV/B`\9&EV('-T>6QE/3-$)TU!4D=)3BU,
M1494.B`T,S=P=#L@1$E34$Q!63H@8FQO8VL[(%1%6%0M24Y$14Y4.B`P<'0G
M/B`\8G(@+SX@/"]D:78^(#QD:78@<W1Y;&4],T0G5$585"U!3$E'3CH@:G5S
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M/&9O;G0@<W1Y;&4],T0G1D].5"U325I%.B`Q,'!T.R!&3TY4+49!34E,63H@
M5&EM97,@3F5W(%)O;6%N.R!$25-03$%9.B!I;FQI;F4G/B!S=6)J96-T('1O
M(#$U)2!W:71H:&]L9&EN9R!T87@@9F]R($ES<F%E;&DM<F5S:61E;G0@:6YD
M:79I9'5A;',@86YD(&YO;BU)<W)A96QI(')E<VED96YT<R`H<W5B:F5C="!T
M;R!A<'!L:6-A8FQE('1R96%T>2!R871E<RD@86YD(&5F9F5C=&EV92!*86YU
M87)Y(#$L(#(P,30L('-U8FIE8W0@=&\@,C`E('=I=&AH;VQD:6YG('1A>"!F
M;W(@27-R865L:2UR97-I9&5N="!I;F1I=FED=6%L<R!A;F0@;F]N+4ES<F%E
M;&D@<F5S:61E;G1S("AS=6)J96-T('1O(&%P<&QI8V%B;&4@=')E871Y(')A
M=&5S*2X\+V9O;G0^/"]D:78^(#QD:78@<W1Y;&4],T0G34%21TE.+4Q%1E0Z
M(#0S-W!T.R!$25-03$%9.B!B;&]C:SL@5$585"U)3D1%3E0Z(#!P="<^(#QB
M<B`O/B`\+V1I=CX@/&1I=B!S='EL93TS1"=$25-03$%9.B!B;&]C:SL@1D].
M5"U&04U)3%DZ(%1I;65S($YE=R!2;VUA;CL@1D].5"U325I%.B`Q,'!T.R!-
M05)'24XM3$5&5#H@,C=P=#L@34%21TE.+5))1TA4.B`P<'0[('1E>'0M86QI
M9VXZ(&IU<W1I9GD[(%1%6%0M24Y$14Y4.B`P<'0G/B!!(&1I<W1R:6)U=&EO
M;B!F<F]M(&$@4')E9F5R<F5D($5N=&5R<')I<V4@;W5T(&]F('1H92`B4')E
M9F5R<F5D($EN8V]M92(@=V]U;&0@8F4@97AE;7!T(&9R;VT@=VET:&AO;&1I
M;F<@=&%X(&9O<B!A;B!)<W)A96QI+7)E<VED96YT(&-O;7!A;GDN/"]D:78^
M(#QD:78@<W1Y;&4],T0G34%21TE.+4Q%1E0Z(#0S-W!T.R!$25-03$%9.B!B
M;&]C:SL@5$585"U)3D1%3E0Z(#!P="<^(#QB<B`O/B`\+V1I=CX@/&1I=B!S
M='EL93TS1"=$25-03$%9.B!B;&]C:SL@1D].5"U&04U)3%DZ(%1I;65S($YE
M=R!2;VUA;CL@1D].5"U325I%.B`Q,'!T.R!-05)'24XM3$5&5#H@,C=P=#L@
M34%21TE.+5))1TA4.B`P<'0[('1E>'0M86QI9VXZ(&IU<W1I9GD[(%1%6%0M
M24Y$14Y4.B`P<'0G/B!4:&4@4W5B<VED:6%R>2!D:60@;F]T(&%P<&QY('1H
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M(#PO9&EV/B`\9&EV('-T>6QE/3-$)W1E>'0M86QI9VXZ(&IU<W1I9GDG/B`\
M=&%B;&4@<W1Y;&4],T0G1D].5"U325I%.B`Q,'!T.R!&3TY4+49!34E,63H@
M=&EM97,@;F5W(')O;6%N)R!C96QL<W!A8VEN9STS1#`@8V5L;'!A9&1I;F<]
M,T0P('=I9'1H/3-$,3`P)2!B;W)D97(],T0P/B`\='(@=F%L:6=N/3-$=&]P
M/B`\=&0@<W1Y;&4],T0G5TE$5$@Z(#(W<'0G(&%L:6=N/3-$<FEG:'0^(#QD
M:78@<W1Y;&4],T0G1$E34$Q!63H@:6YL:6YE.R!&3TY4+49!34E,63H@5&EM
M97,@3F5W(%)O;6%N.R!&3TY4+5-)6D4Z(#$P<'0[('1E>'0M86QI9VXZ(&IU
M<W1I9GDG/B!$+B9N8G-P.SPO9&EV/B`\+W1D/B`\=&0@86QI9VX],T1L969T
M/B`\9&EV('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ
M(%1I;65S($YE=R!2;VUA;CL@1D].5"U325I%.B`Q,'!T.R!T97AT+6%L:6=N
M.B!J=7-T:69Y)SX@0V%R<GEF;W)W87)D(&QO<W-E<R!F;W(@=&%X('!U<G!O
M<V5S/"]D:78^(#PO=&0^(#PO='(^(#PO=&%B;&4^(#PO9&EV/B`\9&EV('-T
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M.S,P+"`R,#$T+"!T:&4@0V]M<&%N>2!H860@52Y3+B!F961E<F%L(&YE="!O
M<&5R871I;F<@;&]S<R!C87)R>69O<G=A<F0@9F]R(&EN8V]M92!T87@@<'5R
M<&]S97,@:6X@=&AE(&%M;W5N="!O9B!A<'!R;WAI;6%T96QY("0R,BPW,S`N
M($YE="!O<&5R871I;F<@;&]S<R!C87)R>69O<G=A<F0@87)I<VEN9R!I;B!T
M87AA8FQE('EE87)S/&9O;G0@<W1Y;&4],T0G1D].5"U325I%.B`Q,'!T.R!$
M25-03$%9.B!I;FQI;F4G/BP\+V9O;G0^(&-A;B!B92!C87)R:65D(&9O<G=A
M<F0@86YD(&]F9G-E="!A9V%I;G-T('1A>&%B;&4@:6YC;VUE(&9O<B`R,"!Y
M96%R<R!A;F0@97AP:7)I;F<@8F5T=V5E;B`R,#(R(&%N9"`R,#,T+CPO9&EV
M/B`\9&EV('-T>6QE/3-$)TU!4D=)3BU,1494.B`T,S=P=#L@1$E34$Q!63H@
M8FQO8VL[(%1%6%0M24Y$14Y4.B`P<'0G/B`\8G(@+SX@/"]D:78^(#QD:78@
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M86P@;&EM:71A=&EO;G,@9'5E('1O('1H92`B8VAA;F=E(&EN(&]W;F5R<VAI
M<"(@<')O=FES:6]N<R!O9B!T:&4@26YT97)N86P@4F5V96YU92!#;V1E(&]F
M(#$Y.#8@86YD('-I;6EL87(@<W1A=&4@<')O=FES:6]N<RX@5&AE(&%N;G5A
M;"!L:6UI=&%T:6]N(&UA>2!R97-U;'0@:6X@=&AE(&5X<&ER871I;VX@;V8@
M;F5T(&]P97)A=&EN9R!L;W-S97,@8F5F;W)E('5T:6QI>F%T:6]N+CPO9&EV
M/B`\9&EV('-T>6QE/3-$)TU!4D=)3BU,1494.B`T,S=P=#L@1$E34$Q!63H@
M8FQO8VL[(%1%6%0M24Y$14Y4.B`P<'0G/B`\8G(@+SX@/"]D:78^(#QD:78@
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M)FYB<W`[,S`L(#(P,30L(&EN('1H92!A;6]U;G0@;V8@87!P<F]X:6UA=&5L
M>2`D-#@L,S0P+"!W:&EC:"!M87D@8F4@8V%R<FEE9"!F;W)W87)D(&%N9"!O
M9F9S970@86=A:6YS="!T87AA8FQE(&)U<VEN97-S(&EN8V]M92!A;F0@8G5S
M:6YE<W,@8V%P:71A;"!G86EN(&EN('1H92!F=71U<F4@9F]R(&%N(&EN9&5F
M:6YI=&4@<&5R:6]D+CPO9&EV/B`\9&EV('-T>6QE/3-$)TU!4D=)3BU,1494
M.B`T,S=P=#L@1$E34$Q!63H@8FQO8VL[(%1%6%0M24Y$14Y4.B`P<'0G/B`\
M8G(@+SX@/"]D:78^(#QD:78@<W1Y;&4],T0G1$E34$Q!63H@8FQO8VL[($9/
M3E0M1D%-24Q9.B!4:6UE<R!.97<@4F]M86X[($9/3E0M4TE:13H@,3!P=#L@
M1D].5"U714E'2%0Z(&)O;&0[($U!4D=)3BU,1494.B`R-W!T.R!-05)'24XM
M4DE'2%0Z(#!P=#L@=&5X="UA;&EG;CH@:G5S=&EF>3L@5$585"U)3D1%3E0Z
M(#!P="<^($1E9F5R<F5D(&EN8V]M92!T87AE<SH\+V1I=CX@/&1I=B!S='EL
M93TS1"=-05)'24XM3$5&5#H@-#,W<'0[($1)4U!,05DZ(&)L;V-K.R!415A4
M+4E.1$5.5#H@,'!T)SX@/&)R("\^(#PO9&EV/B`\9&EV('-T>6QE/3-$)T1)
M4U!,05DZ(&)L;V-K.R!&3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N.R!&
M3TY4+5-)6D4Z(#$P<'0[($U!4D=)3BU,1494.B`R-W!T.R!-05)'24XM4DE'
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M87-S971S(&%R92!A<R!F;VQL;W=S.CPO9&EV/B`\9&EV('-T>6QE/3-$)T1)
M4U!,05DZ(&)L;V-K.R!415A4+4E.1$5.5#H@,'!T)SX\8G(@+SX@/"]D:78^
M(#QD:78@<W1Y;&4],T0G=&5X="UA;&EG;CH@<FEG:'0G/B`\=&%B;&4@<W1Y
M;&4],T0G1D].5"U325I%.B`Q,'!T.R!&3TY4+49!34E,63H@=&EM97,@;F5W
M(')O;6%N)R!C96QL<W!A8VEN9STS1#`@8V5L;'!A9&1I;F<],T0P('=I9'1H
M/3-$.34E/B`\='(^(#QT9"!S='EL93TS1"=0041$24Y'+4)/5%1/33H@,G!X
M)R!V86QI9VX],T1B;W1T;VT@=VED=&@],T0W-B4^/&9O;G0@<W1Y;&4],T0G
M1D].5"U325I%.B`Q,'!T.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N
M.R!$25-03$%9.B!I;FQI;F4G/B`F;F)S<#L\+V9O;G0^(#PO=&0^(#QT9"!S
M='EL93TS1"=0041$24Y'+4)/5%1/33H@,G!X)R!V86QI9VX],T1B;W1T;VT@
M=VED=&@],T0Q)3X\9F]N="!S='EL93TS1"=&3TY4+5-)6D4Z(#$P<'0[($9/
M3E0M1D%-24Q9.B!T:6UE<R!N97<@<F]M86X[($9/3E0M5T5)1TA4.B!B;VQD
M.R!$25-03$%9.B!I;FQI;F4G/B`F;F)S<#L\+V9O;G0^(#PO=&0^(#QT9"!S
M='EL93TS1"="3U)$15(M0D]45$]-.B!B;&%C:R`R<'@@<V]L:60G('9A;&EG
M;CTS1&)O='1O;2!W:61T:#TS1#(R)2!C;VQS<&%N/3-$-CX@/&1I=B!S='EL
M93TS1"=$25-03$%9.B!B;&]C:SL@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R
M;VUA;CL@1D].5"U325I%.B`Q,'!T.R!&3TY4+5=%24=(5#H@8F]L9#L@34%2
M1TE.+4Q%1E0Z(#!P=#L@34%21TE.+5))1TA4.B`P<'0[('1E>'0M86QI9VXZ
M(&-E;G1E<CL@5$585"U)3D1%3E0Z(#!P="<^($IU;F4@,S`L/"]D:78^(#PO
M=&0^(#QT9"!S='EL93TS1"=0041$24Y'+4)/5%1/33H@,G!X.R!415A4+4%,
M24=..B!L969T)R!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)2!N;W=R87`]
M,T1N;W=R87`^/&9O;G0@<W1Y;&4],T0G1D].5"U325I%.B`Q,'!T.R!&3TY4
M+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!&3TY4+5=%24=(5#H@8F]L9#L@
M1$E34$Q!63H@:6YL:6YE)SX@)FYB<W`[/"]F;VYT/B`\+W1D/B`\+W1R/B`\
M='(^(#QT9"!S='EL93TS1"=0041$24Y'+4)/5%1/33H@,G!X)R!V86QI9VX]
M,T1B;W1T;VT@=VED=&@],T0W-B4^/&9O;G0@<W1Y;&4],T0G1D].5"U325I%
M.B`Q,'!T.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!$25-03$%9
M.B!I;FQI;F4G/B`F;F)S<#L\+V9O;G0^(#PO=&0^(#QT9"!S='EL93TS1"=0
M041$24Y'+4)/5%1/33H@,G!X)R!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q
M)3X\9F]N="!S='EL93TS1"=&3TY4+5-)6D4Z(#$P<'0[($9/3E0M1D%-24Q9
M.B!T:6UE<R!N97<@<F]M86X[($9/3E0M5T5)1TA4.B!B;VQD.R!$25-03$%9
M.B!I;FQI;F4G/B`F;F)S<#L\+V9O;G0^(#PO=&0^(#QT9"!S='EL93TS1"="
M3U)$15(M0D]45$]-.B!B;&%C:R`R<'@@<V]L:60G('9A;&EG;CTS1&)O='1O
M;2!W:61T:#TS1#$P)2!C;VQS<&%N/3-$,CX@/&1I=B!S='EL93TS1"=$25-0
M3$%9.B!B;&]C:SL@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].
M5"U325I%.B`Q,'!T.R!&3TY4+5=%24=(5#H@8F]L9#L@34%21TE.+4Q%1E0Z
M(#!P=#L@34%21TE.+5))1TA4.B`P<'0[('1E>'0M86QI9VXZ(&-E;G1E<CL@
M5$585"U)3D1%3E0Z("TQ.'!T)SX@,C`Q-#PO9&EV/B`\+W1D/B`\=&0@<W1Y
M;&4],T0G4$%$1$E.1RU"3U143TTZ(#)P>#L@5$585"U!3$E'3CH@;&5F="<@
M=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@;F]W<F%P/3-$;F]W<F%P/CQF
M;VYT('-T>6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ('1I
M;65S(&YE=R!R;VUA;CL@1D].5"U714E'2%0Z(&)O;&0[($1)4U!,05DZ(&EN
M;&EN92<^("9N8G-P.SPO9F]N=#X@/"]T9#X@/'1D('-T>6QE/3-$)U!!1$1)
M3D<M0D]45$]-.B`R<'@G('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E/CQF
M;VYT('-T>6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ('1I
M;65S(&YE=R!R;VUA;CL@1D].5"U714E'2%0Z(&)O;&0[($1)4U!,05DZ(&EN
M;&EN92<^("9N8G-P.SPO9F]N=#X@/"]T9#X@/'1D('-T>6QE/3-$)T)/4D1%
M4BU"3U143TTZ(&)L86-K(#)P>"!S;VQI9"<@=F%L:6=N/3-$8F]T=&]M('=I
M9'1H/3-$,3`E(&-O;'-P86X],T0R/B`\9&EV('-T>6QE/3-$)T1)4U!,05DZ
M(&)L;V-K.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!&3TY4+5-)
M6D4Z(#$P<'0[($9/3E0M5T5)1TA4.B!B;VQD.R!-05)'24XM3$5&5#H@,'!T
M.R!-05)'24XM4DE'2%0Z(#!P=#L@=&5X="UA;&EG;CH@8V5N=&5R.R!415A4
M+4E.1$5.5#H@+3$X<'0G/B`R,#$S/"]D:78^(#PO=&0^(#QT9"!S='EL93TS
M1"=0041$24Y'+4)/5%1/33H@,G!X.R!415A4+4%,24=..B!L969T)R!V86QI
M9VX],T1B;W1T;VT@=VED=&@],T0Q)2!N;W=R87`],T1N;W=R87`^/&9O;G0@
M<W1Y;&4],T0G1D].5"U325I%.B`Q,'!T.R!&3TY4+49!34E,63H@=&EM97,@
M;F5W(')O;6%N.R!&3TY4+5=%24=(5#H@8F]L9#L@1$E34$Q!63H@:6YL:6YE
M)SX@)FYB<W`[/"]F;VYT/B`\+W1D/B`\+W1R/B`\='(@8F=C;VQO<CTS1"-C
M8V5E9F8^(#QT9"!V86QI9VX],T1B;W1T;VT@=VED=&@],T0W-B4@86QI9VX]
M,T1L969T/B`\9&EV('-T>6QE/3-$)T1)4U!,05DZ(&)L;V-K.R!&3TY4+49!
M34E,63H@=&EM97,@;F5W(')O;6%N.R!&3TY4+5-)6D4Z(#$P<'0[($U!4D=)
M3BU,1494.B`Y<'0[($U!4D=)3BU224=(5#H@,'!T.R!T97AT+6%L:6=N.B!L
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M;65S(&YE=R!R;VUA;CL@1$E34$Q!63H@:6YL:6YE)SX@)FYB<W`[/"]F;VYT
M/B`\+W1D/B`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,3`E(&-O;'-P
M86X],T0R/CQF;VYT('-T>6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@1D].5"U&
M04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1$E34$Q!63H@:6YL:6YE)SX@)FYB
M<W`[/"]F;VYT/B`\+W1D/B`\=&0@<W1Y;&4],T0G5$585"U!3$E'3CH@;&5F
M="<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@;F]W<F%P/3-$;F]W<F%P
M/CQF;VYT('-T>6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ
M('1I;65S(&YE=R!R;VUA;CL@1$E34$Q!63H@:6YL:6YE)SX@)FYB<W`[/"]F
M;VYT/B`\+W1D/B`\+W1R/B`\='(@8F=C;VQO<CTS1'=H:71E/B`\=&0@=F%L
M:6=N/3-$8F]T=&]M('=I9'1H/3-$-S8E(&%L:6=N/3-$;&5F=#X@/&1I=B!S
M='EL93TS1"=$25-03$%9.B!B;&]C:SL@1D].5"U&04U)3%DZ('1I;65S(&YE
M=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T.R!-05)'24XM3$5&5#H@,3AP=#L@
M34%21TE.+5))1TA4.B`P<'0[('1E>'0M86QI9VXZ(&QE9G0[(%1%6%0M24Y$
M14Y4.B`M.7!T)SX@52Y3+B!N970@;W!E<F%T:6YG(&QO<W,@8V%R<GEF;W)W
M87)D/"]D:78^(#PO=&0^(#QT9"!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q
M)2!A;&EG;CTS1')I9VAT/CQF;VYT('-T>6QE/3-$)T9/3E0M4TE:13H@,3!P
M=#L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1$E34$Q!63H@:6YL
M:6YE)SX@)FYB<W`[/"]F;VYT/B`\+W1D/B`\=&0@<W1Y;&4],T0G1$E34$Q!
M63H@:6YL:6YE.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!&3TY4
M+5-)6D4Z(#$P<'0[(%1%6%0M04Q)1TXZ(&QE9G0G('9A;&EG;CTS1&)O='1O
M;2!W:61T:#TS1#$E/B0\+W1D/B`\=&0@<W1Y;&4],T0G1$E34$Q!63H@:6YL
M:6YE.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!&3TY4+5-)6D4Z
M(#$P<'0[(%1%6%0M04Q)1TXZ(')I9VAT)R!V86QI9VX],T1B;W1T;VT@=VED
M=&@],T0Y)3XW+#DU-3PO=&0^(#QT9"!S='EL93TS1"=415A4+4%,24=..B!L
M969T)R!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)2!N;W=R87`],T1N;W=R
M87`^/&9O;G0@<W1Y;&4],T0G1D].5"U325I%.B`Q,'!T.R!&3TY4+49!34E,
M63H@=&EM97,@;F5W(')O;6%N.R!$25-03$%9.B!I;FQI;F4G/B`F;F)S<#L\
M+V9O;G0^(#PO=&0^(#QT9"!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)2!A
M;&EG;CTS1')I9VAT/CQF;VYT('-T>6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@
M1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1$E34$Q!63H@:6YL:6YE
M)SX@)FYB<W`[/"]F;VYT/B`\+W1D/B`\=&0@<W1Y;&4],T0G1$E34$Q!63H@
M:6YL:6YE.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!&3TY4+5-)
M6D4Z(#$P<'0[(%1%6%0M04Q)1TXZ(&QE9G0G('9A;&EG;CTS1&)O='1O;2!W
M:61T:#TS1#$E/B0\+W1D/B`\=&0@<W1Y;&4],T0G1$E34$Q!63H@:6YL:6YE
M.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!&3TY4+5-)6D4Z(#$P
M<'0[(%1%6%0M04Q)1TXZ(')I9VAT)R!V86QI9VX],T1B;W1T;VT@=VED=&@]
M,T0Y)3XW+#$P-CPO=&0^(#QT9"!S='EL93TS1"=415A4+4%,24=..B!L969T
M)R!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)2!N;W=R87`],T1N;W=R87`^
M/&9O;G0@<W1Y;&4],T0G1D].5"U325I%.B`Q,'!T.R!&3TY4+49!34E,63H@
M=&EM97,@;F5W(')O;6%N.R!$25-03$%9.B!I;FQI;F4G/B`F;F)S<#L\+V9O
M;G0^(#PO=&0^(#PO='(^(#QT<B!B9V-O;&]R/3-$(V-C965F9CX@/'1D('9A
M;&EG;CTS1&)O='1O;2!W:61T:#TS1#<V)3X@/&1I=B!S='EL93TS1"=$25-0
M3$%9.B!B;&]C:SL@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].
M5"U325I%.B`Q,'!T.R!-05)'24XM3$5&5#H@,3AP=#L@34%21TE.+5))1TA4
M.B`P<'0[('1E>'0M86QI9VXZ(&IU<W1I9GD[(%1%6%0M24Y$14Y4.B`M.7!T
M)SX@27-R865L:2!N970@;W!E<F%T:6YG(&QO<W,@8V%R<GEF;W)W87)D/"]D
M:78^(#PO=&0^(#QT9"!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)2!A;&EG
M;CTS1')I9VAT/CQF;VYT('-T>6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@1D].
M5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1$E34$Q!63H@:6YL:6YE)SX@
M)FYB<W`[/"]F;VYT/B`\+W1D/B`\=&0@<W1Y;&4],T0G5$585"U!3$E'3CH@
M;&5F="<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24^/&9O;G0@<W1Y;&4]
M,T0G1D].5"U325I%.B`Q,'!T.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O
M;6%N.R!$25-03$%9.B!I;FQI;F4G/B`F;F)S<#L\+V9O;G0^(#PO=&0^(#QT
M9"!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE
M<R!N97<@<F]M86X[($9/3E0M4TE:13H@,3!P=#L@5$585"U!3$E'3CH@<FEG
M:'0G('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#DE/C$R+#@Q,#PO=&0^(#QT
M9"!S='EL93TS1"=415A4+4%,24=..B!L969T)R!V86QI9VX],T1B;W1T;VT@
M=VED=&@],T0Q)2!N;W=R87`],T1N;W=R87`^/&9O;G0@<W1Y;&4],T0G1D].
M5"U325I%.B`Q,'!T.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!$
M25-03$%9.B!I;FQI;F4G/B`F;F)S<#L\+V9O;G0^(#PO=&0^(#QT9"!V86QI
M9VX],T1B;W1T;VT@=VED=&@],T0Q)2!A;&EG;CTS1')I9VAT/CQF;VYT('-T
M>6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ('1I;65S(&YE
M=R!R;VUA;CL@1$E34$Q!63H@:6YL:6YE)SX@)FYB<W`[/"]F;VYT/B`\+W1D
M/B`\=&0@<W1Y;&4],T0G5$585"U!3$E'3CH@;&5F="<@=F%L:6=N/3-$8F]T
M=&]M('=I9'1H/3-$,24^/&9O;G0@<W1Y;&4],T0G1D].5"U325I%.B`Q,'!T
M.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!$25-03$%9.B!I;FQI
M;F4G/B`F;F)S<#L\+V9O;G0^(#PO=&0^(#QT9"!S='EL93TS1"=$25-03$%9
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M/'1D('-T>6QE/3-$)U!!1$1)3D<M0D]45$]-.B`R<'@G('9A;&EG;CTS1&)O
M='1O;2!W:61T:#TS1#<V)3X@/&1I=B!S='EL93TS1"=$25-03$%9.B!B;&]C
M:SL@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q
M,'!T.R!-05)'24XM3$5&5#H@,3AP=#L@34%21TE.+5))1TA4.B`P<'0[('1E
M>'0M86QI9VXZ(&IU<W1I9GD[(%1%6%0M24Y$14Y4.B`M.7!T)SX@06QL;W=A
M;F-E<R!A;F0@<F5S97)V97,\+V1I=CX@/"]T9#X@/'1D('-T>6QE/3-$)U!!
M1$1)3D<M0D]45$]-.B`R<'@G('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E
M(&%L:6=N/3-$<FEG:'0^/&9O;G0@<W1Y;&4],T0G1D].5"U325I%.B`Q,'!T
M.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!$25-03$%9.B!I;FQI
M;F4G/B`F;F)S<#L\+V9O;G0^(#PO=&0^(#QT9"!S='EL93TS1"="3U)$15(M
M0D]45$]-.B!B;&%C:R`R<'@@<V]L:60[(%1%6%0M04Q)1TXZ(&QE9G0G('9A
M;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E/CQF;VYT('-T>6QE/3-$)T9/3E0M
M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1$E3
M4$Q!63H@:6YL:6YE)SX@)FYB<W`[/"]F;VYT/B`\+W1D/B`\=&0@<W1Y;&4]
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M=&@],T0Q)2!N;W=R87`],T1N;W=R87`^/&9O;G0@<W1Y;&4],T0G1D].5"U3
M25I%.B`Q,'!T.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!$25-0
M3$%9.B!I;FQI;F4G/B`F;F)S<#L\+V9O;G0^(#PO=&0^(#QT9"!S='EL93TS
M1"=0041$24Y'+4)/5%1/33H@,G!X)R!V86QI9VX],T1B;W1T;VT@=VED=&@]
M,T0Q)2!A;&EG;CTS1')I9VAT/CQF;VYT('-T>6QE/3-$)T9/3E0M4TE:13H@
M,3!P=#L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1$E34$Q!63H@
M:6YL:6YE)SX@)FYB<W`[/"]F;VYT/B`\+W1D/B`\=&0@<W1Y;&4],T0G0D]2
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M;VT@=VED=&@],T0Y)3XQ-38\+W1D/B`\=&0@<W1Y;&4],T0G4$%$1$E.1RU"
M3U143TTZ(#)P>#L@5$585"U!3$E'3CH@;&5F="<@=F%L:6=N/3-$8F]T=&]M
M('=I9'1H/3-$,24@;F]W<F%P/3-$;F]W<F%P/CQF;VYT('-T>6QE/3-$)T9/
M3E0M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@
M1$E34$Q!63H@:6YL:6YE)SX@)FYB<W`[/"]F;VYT/B`\+W1D/B`\+W1R/B`\
M='(@8F=C;VQO<CTS1"-C8V5E9F8^(#QT9"!V86QI9VX],T1B;W1T;VT@=VED
M=&@],T0W-B4^/&9O;G0@<W1Y;&4],T0G1D].5"U325I%.B`Q,'!T.R!&3TY4
M+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!$25-03$%9.B!I;FQI;F4G/B`F
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M1$E34$Q!63H@:6YL:6YE)SX@)FYB<W`[/"]F;VYT/B`\+W1D/B`\=&0@<W1Y
M;&4],T0G5$585"U!3$E'3CH@<FEG:'0G('9A;&EG;CTS1&)O='1O;2!W:61T
M:#TS1#DE/CQF;VYT('-T>6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@1D].5"U&
M04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1$E34$Q!63H@:6YL:6YE)SX@)FYB
M<W`[/"]F;VYT/B`\+W1D/B`\=&0@<W1Y;&4],T0G5$585"U!3$E'3CH@;&5F
M="<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@;F]W<F%P/3-$;F]W<F%P
M/CQF;VYT('-T>6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ
M('1I;65S(&YE=R!R;VUA;CL@1$E34$Q!63H@:6YL:6YE)SX@)FYB<W`[/"]F
M;VYT/B`\+W1D/B`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24^/&9O
M;G0@<W1Y;&4],T0G1D].5"U325I%.B`Q,'!T.R!&3TY4+49!34E,63H@=&EM
M97,@;F5W(')O;6%N.R!$25-03$%9.B!I;FQI;F4G/B`F;F)S<#L\+V9O;G0^
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M:SL@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q
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M)SX@)FYB<W`[/"]F;VYT/B`\+W1D/B`\=&0@<W1Y;&4],T0G5$585"U!3$E'
M3CH@;&5F="<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24^/&9O;G0@<W1Y
M;&4],T0G1D].5"U325I%.B`Q,'!T.R!&3TY4+49!34E,63H@=&EM97,@;F5W
M(')O;6%N.R!$25-03$%9.B!I;FQI;F4G/B`F;F)S<#L\+V9O;G0^(#PO=&0^
M(#QT9"!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T
M:6UE<R!N97<@<F]M86X[($9/3E0M4TE:13H@,3!P=#L@5$585"U!3$E'3CH@
M<FEG:'0G('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#DE/C(Q+#`P,CPO=&0^
M(#QT9"!S='EL93TS1"=415A4+4%,24=..B!L969T)R!V86QI9VX],T1B;W1T
M;VT@=VED=&@],T0Q)2!N;W=R87`],T1N;W=R87`^/&9O;G0@<W1Y;&4],T0G
M1D].5"U325I%.B`Q,'!T.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N
M.R!$25-03$%9.B!I;FQI;F4G/B`F;F)S<#L\+V9O;G0^(#PO=&0^(#QT9"!V
M86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)2!A;&EG;CTS1')I9VAT/CQF;VYT
M('-T>6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ('1I;65S
M(&YE=R!R;VUA;CL@1$E34$Q!63H@:6YL:6YE)SX@)FYB<W`[/"]F;VYT/B`\
M+W1D/B`\=&0@<W1Y;&4],T0G5$585"U!3$E'3CH@;&5F="<@=F%L:6=N/3-$
M8F]T=&]M('=I9'1H/3-$,24^/&9O;G0@<W1Y;&4],T0G1D].5"U325I%.B`Q
M,'!T.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!$25-03$%9.B!I
M;FQI;F4G/B`F;F)S<#L\+V9O;G0^(#PO=&0^(#QT9"!S='EL93TS1"=$25-0
M3$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE<R!N97<@<F]M86X[($9/
M3E0M4TE:13H@,3!P=#L@5$585"U!3$E'3CH@<FEG:'0G('9A;&EG;CTS1&)O
M='1O;2!W:61T:#TS1#DE/C$U+#@P-3PO=&0^(#QT9"!S='EL93TS1"=415A4
M+4%,24=..B!L969T)R!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)2!N;W=R
M87`],T1N;W=R87`^/&9O;G0@<W1Y;&4],T0G1D].5"U325I%.B`Q,'!T.R!&
M3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!$25-03$%9.B!I;FQI;F4G
M/B`F;F)S<#L\+V9O;G0^(#PO=&0^(#PO='(^(#QT<B!B9V-O;&]R/3-$(V-C
M965F9CX@/'1D('-T>6QE/3-$)U!!1$1)3D<M0D]45$]-.B`R<'@G('9A;&EG
M;CTS1&)O='1O;2!W:61T:#TS1#<V)3X@/&1I=B!S='EL93TS1"=$25-03$%9
M.B!B;&]C:SL@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U3
M25I%.B`Q,'!T.R!-05)'24XM3$5&5#H@.7!T.R!-05)'24XM4DE'2%0Z(#!P
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M:6YE)SX@)FYB<W`[/"]F;VYT/B`\+W1D/B`\=&0@<W1Y;&4],T0G0D]21$52
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M=VED=&@],T0Y)3XH,C$L,#`R/"]T9#X@/'1D('-T>6QE/3-$)T1)4U!,05DZ
M(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U3
M25I%.B`Q,'!T.R!0041$24Y'+4)/5%1/33H@,G!X.R!415A4+4%,24=..B!L
M969T)R!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)2!N;W=R87`],T1N;W=R
M87`^*3PO=&0^(#QT9"!S='EL93TS1"=0041$24Y'+4)/5%1/33H@,G!X)R!V
M86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)2!A;&EG;CTS1')I9VAT/CQF;VYT
M('-T>6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ('1I;65S
M(&YE=R!R;VUA;CL@1$E34$Q!63H@:6YL:6YE)SX@)FYB<W`[/"]F;VYT/B`\
M+W1D/B`\=&0@<W1Y;&4],T0G0D]21$52+4)/5%1/33H@8FQA8VL@,G!X('-O
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M(')I9VAT)R!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Y)3XH,34L.#`U/"]T
M9#X@/'1D('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ
M('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T.R!0041$24Y'+4)/
M5%1/33H@,G!X.R!415A4+4%,24=..B!L969T)R!V86QI9VX],T1B;W1T;VT@
M=VED=&@],T0Q)2!N;W=R87`],T1N;W=R87`^*3PO=&0^(#PO='(^(#QT<B!B
M9V-O;&]R/3-$=VAI=&4^(#QT9"!V86QI9VX],T1B;W1T;VT@=VED=&@],T0W
M-B4^/&9O;G0@<W1Y;&4],T0G1D].5"U325I%.B`Q,'!T.R!&3TY4+49!34E,
M63H@=&EM97,@;F5W(')O;6%N.R!$25-03$%9.B!I;FQI;F4G/B`F;F)S<#L\
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M63H@:6YL:6YE)SX@)FYB<W`[/"]F;VYT/B`\+W1D/B`\=&0@<W1Y;&4],T0G
M5$585"U!3$E'3CH@<FEG:'0G('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#DE
M/CQF;VYT('-T>6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ
M('1I;65S(&YE=R!R;VUA;CL@1$E34$Q!63H@:6YL:6YE)SX@)FYB<W`[/"]F
M;VYT/B`\+W1D/B`\=&0@<W1Y;&4],T0G5$585"U!3$E'3CH@;&5F="<@=F%L
M:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@;F]W<F%P/3-$;F]W<F%P/CQF;VYT
M('-T>6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ('1I;65S
M(&YE=R!R;VUA;CL@1$E34$Q!63H@:6YL:6YE)SX@)FYB<W`[/"]F;VYT/B`\
M+W1D/B`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24^/&9O;G0@<W1Y
M;&4],T0G1D].5"U325I%.B`Q,'!T.R!&3TY4+49!34E,63H@=&EM97,@;F5W
M(')O;6%N.R!$25-03$%9.B!I;FQI;F4G/B`F;F)S<#L\+V9O;G0^(#PO=&0^
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M<CX@/'1R(&)G8V]L;W(],T0C8V-E969F/B`\=&0@<W1Y;&4],T0G4$%$1$E.
M1RU"3U143TTZ(#1P>"<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$-S8E/B`\
M9&EV('-T>6QE/3-$)T1)4U!,05DZ(&)L;V-K.R!&3TY4+49!34E,63H@=&EM
M97,@;F5W(')O;6%N.R!&3TY4+5-)6D4Z(#$P<'0[($U!4D=)3BU,1494.B`Y
M<'0[($U!4D=)3BU224=(5#H@,'!T.R!T97AT+6%L:6=N.B!J=7-T:69Y.R!4
M15A4+4E.1$5.5#H@+3EP="<^($YE="!D969E<G)E9"!T87@@87-S970\+V1I
M=CX@/"]T9#X@/'1D('-T>6QE/3-$)U!!1$1)3D<M0D]45$]-.B`T<'@G('9A
M;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E(&%L:6=N/3-$<FEG:'0^/&9O;G0@
M<W1Y;&4],T0G1D].5"U325I%.B`Q,'!T.R!&3TY4+49!34E,63H@=&EM97,@
M;F5W(')O;6%N.R!$25-03$%9.B!I;FQI;F4G/B`F;F)S<#L\+V9O;G0^(#PO
M=&0^(#QT9"!S='EL93TS1"="3U)$15(M0D]45$]-.B!B;&%C:R`T<'@@9&]U
M8FQE.R!$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE<R!N97<@
M<F]M86X[($9/3E0M4TE:13H@,3!P=#L@5$585"U!3$E'3CH@;&5F="<@=F%L
M:6=N/3-$8F]T=&]M('=I9'1H/3-$,24^)#PO=&0^(#QT9"!S='EL93TS1"="
M3U)$15(M0D]45$]-.B!B;&%C:R`T<'@@9&]U8FQE.R!$25-03$%9.B!I;FQI
M;F4[($9/3E0M1D%-24Q9.B!T:6UE<R!N97<@<F]M86X[($9/3E0M4TE:13H@
M,3!P=#L@5$585"U!3$E'3CH@<FEG:'0G('9A;&EG;CTS1&)O='1O;2!W:61T
M:#TS1#DE/BT\+W1D/B`\=&0@<W1Y;&4],T0G4$%$1$E.1RU"3U143TTZ(#1P
M>#L@5$585"U!3$E'3CH@;&5F="<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$
M,24@;F]W<F%P/3-$;F]W<F%P/CQF;VYT('-T>6QE/3-$)T9/3E0M4TE:13H@
M,3!P=#L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1$E34$Q!63H@
M:6YL:6YE)SX@)FYB<W`[/"]F;VYT/B`\+W1D/B`\=&0@<W1Y;&4],T0G4$%$
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M5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T.R!4
M15A4+4%,24=..B!L969T)R!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)3XD
M/"]T9#X@/'1D('-T>6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#1P>"!D
M;W5B;&4[($1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE
M=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T.R!415A4+4%,24=..B!R:6=H="<@
M=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$.24^+3PO=&0^(#QT9"!S='EL93TS
M1"=0041$24Y'+4)/5%1/33H@-'!X.R!415A4+4%,24=..B!L969T)R!V86QI
M9VX],T1B;W1T;VT@=VED=&@],T0Q)2!N;W=R87`],T1N;W=R87`^/&9O;G0@
M<W1Y;&4],T0G1D].5"U325I%.B`Q,'!T.R!&3TY4+49!34E,63H@=&EM97,@
M;F5W(')O;6%N.R!$25-03$%9.B!I;FQI;F4G/B`F;F)S<#L\+V9O;G0^(#PO
M=&0^(#PO='(^(#PO=&%B;&4^(#PO9&EV/B`\9&EV('-T>6QE/3-$)T1)4U!,
M05DZ(&)L;V-K.R!-05)'24XM3$5&5#H@-#0V<'0[($U!4D=)3BU224=(5#H@
M,'!T.R!T97AT+6%L:6=N.B!J=7-T:69Y.R!415A4+4E.1$5.5#H@,'!T)SX@
M)FYB<W`[/"]D:78^(#QD:78@<W1Y;&4],T0G1$E34$Q!63H@8FQO8VL[($9/
M3E0M1D%-24Q9.B!4:6UE<R!.97<@4F]M86X[($9/3E0M4TE:13H@,3!P=#L@
M34%21TE.+4Q%1E0Z(#(W<'0[($U!4D=)3BU224=(5#H@,'!T.R!T97AT+6%L
M:6=N.B!J=7-T:69Y.R!415A4+4E.1$5.5#H@,'!T)SX@07,@;V8@2G5N929N
M8G-P.S,P+"`R,#$T(&%N9"`R,#$S+"!T:&4@0V]M<&%N>2!H87,@<')O=FED
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M9G5T=7)E+CPO9&EV/B`\9&EV('-T>6QE/3-$)TU!4D=)3BU,1494.B`T,S=P
M=#L@1$E34$Q!63H@8FQO8VL[(%1%6%0M24Y$14Y4.B`P<'0G/B`\8G(@+SX@
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M-W!T.R!$25-03$%9.B!B;&]C:SL@5$585"U)3D1%3E0Z(#!P="<^(#QB<B`O
M/B`\+V1I=CX@/&1I=B!S='EL93TS1"=$25-03$%9.B!B;&]C:SL@1D].5"U&
M04U)3%DZ(%1I;65S($YE=R!2;VUA;CL@1D].5"U325I%.B`Q,'!T.R!-05)'
M24XM3$5&5#H@,C=P=#L@34%21TE.+5))1TA4.B`P<'0[('1E>'0M86QI9VXZ
M(&IU<W1I9GD[(%1%6%0M24Y$14Y4.B`P<'0G/B!!<R!O9B!*=6YE)FYB<W`[
M,S`L(#(P,30@86YD(#(P,3,L('1H97)E('=E<F4@;F\@=6YR96-O9VYI>F5D
M('1A>"!B96YE9FET<R!T:&%T(&EF(')E8V]G;FEZ960@=V]U;&0@869F96-T
M('1H92!A;FYU86P@969F96-T:79E('1A>"!R871E+CPO9&EV/B`\9&EV('-T
M>6QE/3-$)T1)4U!,05DZ(&)L;V-K.R!415A4+4E.1$5.5#H@,'!T)SX\8G(@
M+SX@/"]D:78^(#QD:78@<W1Y;&4],T0G1$E34$Q!63H@8FQO8VL[($9/3E0M
M1D%-24Q9.B!4:6UE<R!.97<@4F]M86X[($9/3E0M4TE:13H@,3!P=#L@1D].
M5"U714E'2%0Z(&)O;&0[($U!4D=)3BU,1494.B`Q.'!T.R!-05)'24XM4DE'
M2%0Z(#!P=#L@5$585"U!3$E'3CH@;&5F=#L@5$585"U)3D1%3E0Z(#!P="<^
M(%)E8V]N8VEL:6%T:6]N(&]F('1H92!T:&5O<F5T:6-A;"!T87@@97AP96YS
M92`H8F5N969I="D@=&\@=&AE(&%C='5A;"!T87@@97AP96YS92`H8F5N969I
M="DZ/"]D:78^(#QD:78@<W1Y;&4],T0G1$E34$Q!63H@8FQO8VL[($9/3E0M
M1D%-24Q9.B!4:6UE<R!.97<@4F]M86X[($9/3E0M4TE:13H@,3!P=#L@34%2
M1TE.+4Q%1E0Z(#0U<'0[($U!4D=)3BU224=(5#H@,'!T.R!T97AT+6%L:6=N
M.B!J=7-T:69Y.R!415A4+4E.1$5.5#H@,'!T)SX@)FYB<W`[/"]D:78^(#QD
M:78@<W1Y;&4],T0G1$E34$Q!63H@8FQO8VL[($9/3E0M1D%-24Q9.B!4:6UE
M<R!.97<@4F]M86X[($9/3E0M4TE:13H@,3!P=#L@34%21TE.+4Q%1E0Z(#$X
M<'0[($U!4D=)3BU224=(5#H@,'!T.R!415A4+4%,24=..B!J=7-T:69Y.R!4
M15A4+4E.1$5.5#H@,'!T)SX@26X@,C`Q,BP@,C`Q,R!A;F0@,C`Q-"P@=&AE
M(&UA:6X@<F5C;VYC:6QI;F<@:71E;2!O9B!T:&4@<W1A='5T;W)Y('1A>"!R
M871E(&]F('1H92!#;VUP86YY("@R-24@=&\@,S4E(&EN(#(P,3(L(#(P,3,@
M86YD(#(P,30I('1O('1H92!E9F9E8W1I=F4@=&%X(')A=&4@*#`E*2!I<R!T
M87@@;&]S<R!C87)R>69O<G=A<F1S+"!S=&]C:RUB87-E9"!C;VUP96YS871I
M;VX@86YD(&]T:&5R(&1E9F5R<F5D('1A>"!A<W-E=',@9F]R('=H:6-H(&$@
M9G5L;"!V86QU871I;VX@86QL;W=A;F-E('=A<R!P<F]V:61E9"X\+V1I=CX@
M/"$M+45N9$9R86=M96YT+2T^/"]D:78^(#PO9&EV/CQS<&%N/CPO<W!A;CX\
M+W1D/@T*("`@("`@/"]T<CX-"B`@("`\+W1A8FQE/@T*("`\+V)O9'D^#0H\
M+VAT;6P^#0H-"BTM+2TM+3U?3F5X=%!A<G1?,&-A9#4Y9F1?-S,R95\T-F4R
M7V$U,S1?,&,X860Q868Y,&1D#0I#;VYT96YT+4QO8V%T:6]N.B!F:6QE.B\O
M+T,Z+S!C860U.69D7S<S,F5?-#9E,E]A-3,T7S!C.&%D,6%F.3!D9"]7;W)K
M<VAE971S+U-H965T,3DN:'1M;`T*0V]N=&5N="U4<F%N<V9E<BU%;F-O9&EN
M9SH@<75O=&5D+7!R:6YT86)L90T*0V]N=&5N="U4>7!E.B!T97AT+VAT;6P[
M(&-H87)S970](G5S+6%S8VEI(@T*#0H\:'1M;#X-"B`@/&AE860^#0H@("`@
M/$U%5$$@:'1T<"UE<75I=CTS1$-O;G1E;G0M5'EP92!C;VYT96YT/3-$)W1E
M>'0O:'1M;#L@8VAA<G-E=#UU=&8M."<^/'-C<FEP="!T>7!E/3-$=&5X="]J
M879A<V-R:7!T('-R8STS1%-H;W<N:G,^+RH@1&\@3F]T(%)E;6]V92!4:&ES
M($-O;6UE;G0@*B\\+W-C<FEP=#X\+VAE860^#0H@(#QB;V1Y/@T*("`@(#QT
M86)L92!C;&%S<STS1')E<&]R="!I9#TS1$E$,$4Q2D%%/@T*("`@("`@/'1R
M/@T*("`@("`@("`\=&@@8VQA<W,],T1T;"!C;VQS<&%N/3-$,2!R;W=S<&%N
M/3-$,CX\<W1R;VYG/E-)1TY)1DE#04Y4($%#0T]53E1)3D<@4$],24-)15,@
M*%!O;&EC:65S*3QB<CX\+W-T<F]N9SX\+W1H/@T*("`@("`@("`\=&@@8VQA
M<W,],T1T:"!C;VQS<&%N/3-$,3XQ,B!-;VYT:',@16YD960\+W1H/@T*("`@
M("`@/"]T<CX-"B`@("`@(#QT<CX-"B`@("`@("`@/'1H(&-L87-S/3-$=&@^
M2G5N+B`S,"P@,C`Q-#QB<CX\+W1H/@T*("`@("`@/"]T<CX-"B`@("`@(#QT
M<B!C;&%S<STS1')E/@T*("`@("`@("`\=&0@8VQA<W,],T1P;"!V86QI9VX]
M,T1T;W`^/'-T<F]N9SY324=.249)0T%.5"!!0T-/54Y424Y'(%!/3$E#2453
M(%M!8G-T<F%C=%T\+W-T<F]N9SX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,]
M,T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO='(^#0H@("`@
M("`\='(@8VQA<W,],T1R;SX-"B`@("`@("`@/'1D(&-L87-S/3-$<&P@=F%L
M:6=N/3-$=&]P/E5S92!O9B!E<W1I;6%T97,\+W1D/@T*("`@("`@("`\=&0@
M8VQA<W,],T1T97AT/B<\(2TM1$]#5%E012!H=&UL(%!50DQ)0R`B+2\O5S-#
M+R]$5$0@6$A434P@,2XP(%1R86YS:71I;VYA;"\O14XB(")H='1P.B\O=W=W
M+G<S+F]R9R]44B]X:'1M;#$O1%1$+WAH=&UL,2UT<F%N<VET:6]N86PN9'1D
M(B`M+3X\9&EV/B`\9&EV/CPA+2U3=&%R=$9R86=M96YT+2T^(#QD:78^(#QT
M86)L92!S='EL93TS1"=&3TY4+5-)6D4Z(#$P<'0[($9/3E0M1D%-24Q9.B!T
M:6UE<R!N97<@<F]M86XG(&-E;&QS<&%C:6YG/3-$,"!C96QL<&%D9&EN9STS
M1#`@=VED=&@],T0Q,#`E(&%L:6=N/3-$8V5N=&5R(&)O<F1E<CTS1#`^(#QT
M<B!V86QI9VX],T1T;W`^(#QT9"!S='EL93TS1"=724142#H@,3AP="<^(#QD
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M=&0^(#PO='(^(#PO=&%B;&4^(#PO9&EV/B`\9&EV('-T>6QE/3-$)T1)4U!,
M05DZ(&)L;V-K.R!-05)'24XM3$5&5#H@,'!T.R!-05)'24XM4DE'2%0Z(#!P
M=#L@=&5X="UA;&EG;CH@:G5S=&EF>3L@5$585"U)3D1%3E0Z(#!P="<^("9N
M8G-P.SPO9&EV/B`\9&EV/B`\=&%B;&4@<W1Y;&4],T0G1D].5"U325I%.B`Q
M,'!T.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N)R!C96QL<W!A8VEN
M9STS1#`@8V5L;'!A9&1I;F<],T0P('=I9'1H/3-$,3`P)2!A;&EG;CTS1&-E
M;G1E<B!B;W)D97(],T0P/B`\='(@=F%L:6=N/3-$=&]P/B`\=&0@<W1Y;&4]
M,T0G5TE$5$@Z(#$X<'0G/B`\9&EV('-T>6QE/3-$)T9/3E0M4TE:13H@,3!P
M=#L@1D].5"U&04U)3%DZ(%1I;65S($YE=R!2;VUA;CL@1$E34$Q!63H@:6YL
M:6YE)SX@)FYB<W`[/"]D:78^(#PO=&0^(#QT9#X@/&1I=B!S='EL93TS1"=$
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M/B`\(2TM16YD1G)A9VUE;G0M+3X\+V1I=CX@/"]D:78^/'-P86X^/"]S<&%N
M/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$<F4^#0H@
M("`@("`@(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O<#Y&=6YC=&EO;F%L
M(&-U<G)E;F-Y(&]F('1H92!3=6)S:61I87)Y/"]T9#X-"B`@("`@("`@/'1D
M(&-L87-S/3-$=&5X=#XG/"$M+41/0U194$4@:'1M;"!054),24,@(BTO+U<S
M0R\O1%1$(%A(5$U,(#$N,"!4<F%N<VET:6]N86PO+T5.(B`B:'1T<#HO+W=W
M=RYW,RYO<F<O5%(O>&AT;6PQ+T141"]X:'1M;#$M=')A;G-I=&EO;F%L+F1T
M9"(@+2T^/&1I=CX@/&1I=CX\(2TM4W1A<G1&<F%G;65N="TM/B`\9&EV/B`\
M=&%B;&4@<W1Y;&4],T0G1D].5"U325I%.B`Q,'!T.R!&3TY4+49!34E,63H@
M=&EM97,@;F5W(')O;6%N)R!C96QL<W!A8VEN9STS1#`@8V5L;'!A9&1I;F<]
M,T0P('=I9'1H/3-$,3`P)2!A;&EG;CTS1&-E;G1E<B!B;W)D97(],T0P/B`\
M='(@=F%L:6=N/3-$=&]P/B`\=&0@<W1Y;&4],T0G5TE$5$@Z(#$X<'0G/B`\
M9&EV('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ(%1I
M;65S($YE=R!2;VUA;CL@1D].5"U325I%.B`Q,'!T.R!&3TY4+5=%24=(5#H@
M8F]L9#L@34%21TE.+4Q%1E0Z(#!P=#L@34%21TE.+5))1TA4.B`P<'0[(%1%
M6%0M24Y$14Y4.B`P<'0G/B!B+CPO9&EV/B`\+W1D/B`\=&0^(#QD:78@<W1Y
M;&4],T0G1$E34$Q!63H@:6YL:6YE.R!&3TY4+49!34E,63H@5&EM97,@3F5W
M(%)O;6%N.R!&3TY4+5-)6D4Z(#$P<'0[($9/3E0M5T5)1TA4.B!B;VQD.R!T
M97AT+6%L:6=N.B!J=7-T:69Y)SX@1G5N8W1I;VYA;"!C=7)R96YC>2!O9B!T
M:&4@4W5B<VED:6%R>3PO9&EV/B`\+W1D/B`\+W1R/B`\+W1A8FQE/B`\+V1I
M=CX@/&1I=B!S='EL93TS1"=$25-03$%9.B!B;&]C:SL@34%21TE.+4Q%1E0Z
M(#!P=#L@34%21TE.+5))1TA4.B`P<'0[('1E>'0M86QI9VXZ(&IU<W1I9GD[
M(%1%6%0M24Y$14Y4.B`P<'0G/B`F;F)S<#L\+V1I=CX@/&1I=CX@/'1A8FQE
M('-T>6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ('1I;65S
M(&YE=R!R;VUA;B<@8V5L;'-P86-I;F<],T0P(&-E;&QP861D:6YG/3-$,"!W
M:61T:#TS1#$P,"4@86QI9VX],T1C96YT97(@8F]R9&5R/3-$,#X@/'1R('9A
M;&EG;CTS1'1O<#X@/'1D('-T>6QE/3-$)U=)1%1(.B`Q.7!T)SX@/&1I=B!S
M='EL93TS1"=&3TY4+5-)6D4Z(#$P<'0[($9/3E0M1D%-24Q9.B!4:6UE<R!.
M97<@4F]M86X[($1)4U!,05DZ(&EN;&EN92<^("9N8G-P.SPO9&EV/B`\+W1D
M/B`\=&0^(#QD:78@<W1Y;&4],T0G1$E34$Q!63H@:6YL:6YE.R!&3TY4+49!
M34E,63H@5&EM97,@3F5W(%)O;6%N.R!&3TY4+5-)6D4Z(#$P<'0[('1E>'0M
M86QI9VXZ(&IU<W1I9GDG/B!4:&4@4W5B<VED:6%R>28C,SD[<R!R979E;G5E
M<R!A<F4@9V5N97)A=&5D(&%N9"!D971E<FUI;F5D(&EN(%4N4RX@1&]L;&%R
M<R`H(F1O;&QA<G,B*2X@26X@861D:71I;VXL(&UO<W0@;V8@=&AE(&9I;F%N
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M;W)D86YC92!W:71H($%30R`X,S`L(")&;W)E:6=N($-U<G)E;F-Y($UA='1E
M<G,B+B!!;&P@=')A;G-A8W1I;VX@9V%I;G,@86YD(&QO<W-E<R!F<F]M('1H
M92!R96UE87-U<F5M96YT(&]F(&UO;F5T87)Y(&)A;&%N8V4@<VAE970@:71E
M;7,@87)E(')E9FQE8W1E9"!I;B!T:&4@<W1A=&5M96YT(&]F(&]P97)A=&EO
M;G,@87,@9FEN86YC:6%L(&EN8V]M92!O<B!E>'!E;G-E<RP@87,@87!P<F]P
M<FEA=&4N/"]D:78^(#PO=&0^(#PO='(^(#PO=&%B;&4^(#PO9&EV/B`\(2TM
M16YD1G)A9VUE;G0M+3X\+V1I=CX@/"]D:78^/'-P86X^/"]S<&%N/CPO=&0^
M#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$<F\^#0H@("`@("`@
M(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O<#Y0<FEN8VEP;&5S(&]F(&-O
M;G-O;&ED871I;VX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\
M(2TM1$]#5%E012!H=&UL(%!50DQ)0R`B+2\O5S-#+R]$5$0@6$A434P@,2XP
M(%1R86YS:71I;VYA;"\O14XB(")H='1P.B\O=W=W+G<S+F]R9R]44B]X:'1M
M;#$O1%1$+WAH=&UL,2UT<F%N<VET:6]N86PN9'1D(B`M+3X\9&EV/B`\9&EV
M/CPA+2U3=&%R=$9R86=M96YT+2T^(#QD:78^(#QT86)L92!S='EL93TS1"=&
M3TY4+5-)6D4Z(#$P<'0[($9/3E0M1D%-24Q9.B!T:6UE<R!N97<@<F]M86XG
M(&-E;&QS<&%C:6YG/3-$,"!C96QL<&%D9&EN9STS1#`@=VED=&@],T0Q,#`E
M(&%L:6=N/3-$8V5N=&5R(&)O<F1E<CTS1#`^(#QT<B!V86QI9VX],T1T;W`^
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M8FQO8VL[($U!4D=)3BU,1494.B`P<'0[($U!4D=)3BU224=(5#H@,'!T.R!T
M97AT+6%L:6=N.B!J=7-T:69Y.R!415A4+4E.1$5.5#H@,'!T)SX@)FYB<W`[
M/"]D:78^(#QD:78^(#QT86)L92!S='EL93TS1"=&3TY4+5-)6D4Z(#$P<'0[
M($9/3E0M1D%-24Q9.B!T:6UE<R!N97<@<F]M86XG(&-E;&QS<&%C:6YG/3-$
M,"!C96QL<&%D9&EN9STS1#`@=VED=&@],T0Q,#`E(&%L:6=N/3-$8V5N=&5R
M(&)O<F1E<CTS1#`^(#QT<B!V86QI9VX],T1T;W`^(#QT9"!S='EL93TS1"=7
M24142#H@,3AP="<^(#QD:78@<W1Y;&4],T0G1D].5"U325I%.B`Q,'!T.R!&
M3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N.R!$25-03$%9.B!I;FQI;F4G
M/B`F;F)S<#L\+V1I=CX@/"]T9#X@/'1D/B`\9&EV('-T>6QE/3-$)T1)4U!,
M05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ(%1I;65S($YE=R!2;VUA;CL@1D].
M5"U325I%.B`Q,'!T.R!T97AT+6%L:6=N.B!J=7-T:69Y)SX@5&AE(&-O;G-O
M;&ED871E9"!F:6YA;F-I86P@<W1A=&5M96YT<R!I;F-L=61E('1H92!A8V-O
M=6YT<R!O9B!0;'5R:7-T96T@5&AE<F%P975T:6-S($EN8RX@86YD(&ET<R!3
M=6)S:61I87)Y+B!);G1E<F-O;7!A;GD@=')A;G-A8W1I;VYS(&%N9"!B86QA
M;F-E<R!H879E(&)E96X@96QI;6EN871E9"!U<&]N(&-O;G-O;&ED871I;VXN
M/"]D:78^(#PO=&0^(#PO='(^(#PO=&%B;&4^(#PO9&EV/B`\(2TM16YD1G)A
M9VUE;G0M+3X\+V1I=CX@/"]D:78^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@
M("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$<F4^#0H@("`@("`@(#QT9"!C
M;&%S<STS1'!L('9A;&EG;CTS1'1O<#Y#87-H(&%N9"!C87-H(&5Q=6EV86QE
M;G1S/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/"$M+41/0U19
M4$4@:'1M;"!054),24,@(BTO+U<S0R\O1%1$(%A(5$U,(#$N,"!4<F%N<VET
M:6]N86PO+T5.(B`B:'1T<#HO+W=W=RYW,RYO<F<O5%(O>&AT;6PQ+T141"]X
M:'1M;#$M=')A;G-I=&EO;F%L+F1T9"(@+2T^/&1I=CX@/&1I=CX\(2TM4W1A
M<G1&<F%G;65N="TM/B`\9&EV/B`\=&%B;&4@<W1Y;&4],T0G1D].5"U325I%
M.B`Q,'!T.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N)R!C96QL<W!A
M8VEN9STS1#`@8V5L;'!A9&1I;F<],T0P('=I9'1H/3-$,3`P)2!A;&EG;CTS
M1&-E;G1E<B!B;W)D97(],T0P/B`\='(@=F%L:6=N/3-$=&]P/B`\=&0@<W1Y
M;&4],T0G5TE$5$@Z(#$X<'0G/B`\9&EV('-T>6QE/3-$)T1)4U!,05DZ(&EN
M;&EN93L@1D].5"U&04U)3%DZ(%1I;65S($YE=R!2;VUA;CL@1D].5"U325I%
M.B`Q,'!T.R!&3TY4+5=%24=(5#H@8F]L9#L@34%21TE.+4Q%1E0Z(#!P=#L@
M34%21TE.+5))1TA4.B`P<'0[(%1%6%0M24Y$14Y4.B`P<'0G/B!D+CPO9&EV
M/B`\+W1D/B`\=&0^(#QD:78@<W1Y;&4],T0G1$E34$Q!63H@:6YL:6YE.R!&
M3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N.R!&3TY4+5-)6D4Z(#$P<'0[
M($9/3E0M5T5)1TA4.B!B;VQD.R!T97AT+6%L:6=N.B!J=7-T:69Y)SX@0V%S
M:"!A;F0@8V%S:"!E<75I=F%L96YT<SPO9&EV/B`\+W1D/B`\+W1R/B`\+W1A
M8FQE/B`\+V1I=CX@/&1I=B!S='EL93TS1"=$25-03$%9.B!B;&]C:SL@34%2
M1TE.+4Q%1E0Z(#!P=#L@34%21TE.+5))1TA4.B`P<'0[('1E>'0M86QI9VXZ
M(&IU<W1I9GD[(%1%6%0M24Y$14Y4.B`P<'0G/B`F;F)S<#L\+V1I=CX@/&1I
M=CX@/'1A8FQE('-T>6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@1D].5"U&04U)
M3%DZ('1I;65S(&YE=R!R;VUA;B<@8V5L;'-P86-I;F<],T0P(&-E;&QP861D
M:6YG/3-$,"!W:61T:#TS1#$P,"4@86QI9VX],T1C96YT97(@8F]R9&5R/3-$
M,#X@/'1R('9A;&EG;CTS1'1O<#X@/'1D('-T>6QE/3-$)U=)1%1(.B`Q.7!T
M)SX@/&1I=B!S='EL93TS1"=&3TY4+5-)6D4Z(#$P<'0[($9/3E0M1D%-24Q9
M.B!4:6UE<R!.97<@4F]M86X[($1)4U!,05DZ(&EN;&EN92<^("9N8G-P.SPO
M9&EV/B`\+W1D/B`\=&0^(#QD:78@<W1Y;&4],T0G1$E34$Q!63H@:6YL:6YE
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M<F%G;65N="TM/CPO9&EV/B`\+V1I=CX\<W!A;CX\+W-P86X^/"]T9#X-"B`@
M("`@(#PO='(^#0H@("`@("`\='(@8VQA<W,],T1R;SX-"B`@("`@("`@/'1D
M(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P/E-H;W)T+71E<FT@8F%N:R!D97!O
M<VET/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/"$M+41/0U19
M4$4@:'1M;"!054),24,@(BTO+U<S0R\O1%1$(%A(5$U,(#$N,"!4<F%N<VET
M:6]N86PO+T5.(B`B:'1T<#HO+W=W=RYW,RYO<F<O5%(O>&AT;6PQ+T141"]X
M:'1M;#$M=')A;G-I=&EO;F%L+F1T9"(@+2T^/&1I=CX@/&1I=CX\(2TM4W1A
M<G1&<F%G;65N="TM/B`\9&EV('-T>6QE/3-$)W1E>'0M86QI9VXZ(&-E;G1E
M<B<^(#QT86)L92!S='EL93TS1"=&3TY4+5-)6D4Z(#$P<'0[($9/3E0M1D%-
M24Q9.B!T:6UE<R!N97<@<F]M86XG(&-E;&QS<&%C:6YG/3-$,"!C96QL<&%D
M9&EN9STS1#`@=VED=&@],T0Q,#`E(&)O<F1E<CTS1#`^(#QT<B!V86QI9VX]
M,T1T;W`^(#QT9"!S='EL93TS1"=724142#H@,3AP="<^(#QD:78@<W1Y;&4]
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M(&IU<W1I9GDG/B!3:&]R="UT97)M(&)A;FL@9&5P;W-I=#PO9&EV/B`\+W1D
M/B`\+W1R/B`\+W1A8FQE/B`\+V1I=CX@/&1I=B!S='EL93TS1"=$25-03$%9
M.B!B;&]C:SL@34%21TE.+4Q%1E0Z(#!P=#L@34%21TE.+5))1TA4.B`P<'0[
M('1E>'0M86QI9VXZ(&IU<W1I9GD[(%1%6%0M24Y$14Y4.B`P<'0G/B`F;F)S
M<#L\+V1I=CX@/&1I=B!S='EL93TS1"=$25-03$%9.B!B;&]C:SL@1D].5"U&
M04U)3%DZ(%1I;65S($YE=R!2;VUA;CL@1D].5"U325I%.B`Q,'!T.R!-05)'
M24XM3$5&5#H@,3AP=#L@34%21TE.+5))1TA4.B`P<'0[('1E>'0M86QI9VXZ
M(&IU<W1I9GD[(%1%6%0M24Y$14Y4.B`P<'0G/B!"86YK(&1E<&]S:71S('=I
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M/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS
M1')E/@T*("`@("`@("`\=&0@8VQA<W,],T1P;"!V86QI9VX],T1T;W`^4F5S
M=')I8W1E9"!C87-H(&%N9"!S:&]R="UT97)M(&1E<&]S:71S/"]T9#X-"B`@
M("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/"$M+41/0U194$4@:'1M;"!054),
M24,@(BTO+U<S0R\O1%1$(%A(5$U,(#$N,"!4<F%N<VET:6]N86PO+T5.(B`B
M:'1T<#HO+W=W=RYW,RYO<F<O5%(O>&AT;6PQ+T141"]X:'1M;#$M=')A;G-I
M=&EO;F%L+F1T9"(@+2T^/&1I=CX@/&1I=CX\(2TM4W1A<G1&<F%G;65N="TM
M/B`\9&EV('-T>6QE/3-$)W1E>'0M86QI9VXZ(&-E;G1E<B<^(#QT86)L92!S
M='EL93TS1"=&3TY4+5-)6D4Z(#$P<'0[($9/3E0M1D%-24Q9.B!T:6UE<R!N
M97<@<F]M86XG(&-E;&QS<&%C:6YG/3-$,"!C96QL<&%D9&EN9STS1#`@=VED
M=&@],T0Q,#`E(&)O<F1E<CTS1#`^(#QT<B!V86QI9VX],T1T;W`^(#QT9"!S
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M)SX@)FYB<W`[/"]D:78^(#QD:78@<W1Y;&4],T0G1$E34$Q!63H@8FQO8VL[
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M;G1E9"!A="!C;W-T+CPO9&EV/B`\(2TM16YD1G)A9VUE;G0M+3X\+V1I=CX@
M/"]D:78^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@
M/'1R(&-L87-S/3-$<F\^#0H@("`@("`@(#QT9"!C;&%S<STS1'!L('9A;&EG
M;CTS1'1O<#Y,;VYG+71E<FT@<F5S=')I8W1E9"!D97!O<VET/"]T9#X-"B`@
M("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/"$M+41/0U194$4@:'1M;"!054),
M24,@(BTO+U<S0R\O1%1$(%A(5$U,(#$N,"!4<F%N<VET:6]N86PO+T5.(B`B
M:'1T<#HO+W=W=RYW,RYO<F<O5%(O>&AT;6PQ+T141"]X:'1M;#$M=')A;G-I
M=&EO;F%L+F1T9"(@+2T^/&1I=CX@/&1I=CX\(2TM4W1A<G1&<F%G;65N="TM
M/B`\9&EV('-T>6QE/3-$)W1E>'0M86QI9VXZ(&-E;G1E<B<^(#QT86)L92!S
M='EL93TS1"=&3TY4+5-)6D4Z(#$P<'0[($9/3E0M1D%-24Q9.B!T:6UE<R!N
M97<@<F]M86XG(&-E;&QS<&%C:6YG/3-$,"!C96QL<&%D9&EN9STS1#`@=VED
M=&@],T0Q,#`E(&)O<F1E<CTS1#`^(#QT<B!V86QI9VX],T1T;W`^(#QT9"!S
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M;VYG+71E<FT@<F5S=')I8W1E9"!D97!O<VET<SPO9&EV/B`\+W1D/B`\+W1R
M/B`\+W1A8FQE/B`\+V1I=CX@/&1I=CXF;F)S<#L\+V1I=CX@/&1I=CX@/'1A
M8FQE('-T>6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ('1I
M;65S(&YE=R!R;VUA;B<@8V5L;'-P86-I;F<],T0P(&-E;&QP861D:6YG/3-$
M,"!W:61T:#TS1#$P,"4@86QI9VX],T1C96YT97(@8F]R9&5R/3-$,#X@/'1R
M('9A;&EG;CTS1'1O<#X@/'1D('-T>6QE/3-$)U=)1%1(.B`Q.'!T)SX@/&1I
M=B!S='EL93TS1"=&3TY4+5-)6D4Z(#$P<'0[($9/3E0M1D%-24Q9.B!4:6UE
M<R!.97<@4F]M86X[($1)4U!,05DZ(&EN;&EN92<^("9N8G-P.SPO9&EV/B`\
M+W1D/B`\=&0^(#QD:78@<W1Y;&4],T0G1$E34$Q!63H@:6YL:6YE.R!&3TY4
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M=65S(&EN8VQU9&EN9R!A8V-R=65D(&EN=&5R97-T+CPO9&EV/B`\+W1D/B`\
M+W1R/B`\+W1A8FQE/B`\+V1I=CX@/"$M+45N9$9R86=M96YT+2T^/"]D:78^
M(#PO9&EV/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@("`@
M(#QT<B!C;&%S<STS1')E/@T*("`@("`@("`\=&0@8VQA<W,],T1P;"!V86QI
M9VX],T1T;W`^36%R:V5T86)L92!396-U<FET:65S/"]T9#X-"B`@("`@("`@
M/'1D(&-L87-S/3-$=&5X=#XG/"$M+41/0U194$4@:'1M;"!054),24,@(BTO
M+U<S0R\O1%1$(%A(5$U,(#$N,"!4<F%N<VET:6]N86PO+T5.(B`B:'1T<#HO
M+W=W=RYW,RYO<F<O5%(O>&AT;6PQ+T141"]X:'1M;#$M=')A;G-I=&EO;F%L
M+F1T9"(@+2T^/&1I=CX@/&1I=CX\(2TM4W1A<G1&<F%G;65N="TM/B`\9&EV
M('-T>6QE/3-$)W1E>'0M86QI9VXZ(&-E;G1E<B<^(#QT86)L92!S='EL93TS
M1"=&3TY4+5-)6D4Z(#$P<'0[($9/3E0M1D%-24Q9.B!T:6UE<R!N97<@<F]M
M86XG(&-E;&QS<&%C:6YG/3-$,"!C96QL<&%D9&EN9STS1#`@=VED=&@],T0Q
M,#`E(&)O<F1E<CTS1#`^(#QT<B!V86QI9VX],T1T;W`^(#QT9"!S='EL93TS
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M.B`P<'0[($U!4D=)3BU224=(5#H@,'!T.R!T97AT+6%L:6=N.B!J=7-T:69Y
M.R!415A4+4E.1$5.5#H@,'!T)SX@)FYB<W`[/"]D:78^(#QD:78@<W1Y;&4]
M,T0G1$E34$Q!63H@8FQO8VL[($9/3E0M1D%-24Q9.B!4:6UE<R!.97<@4F]M
M86X[($9/3E0M4TE:13H@,3!P=#L@34%21TE.+4Q%1E0Z(#$X<'0[($U!4D=)
M3BU224=(5#H@,'!T.R!T97AT+6%L:6=N.B!J=7-T:69Y.R!415A4+4E.1$5.
M5#H@,'!T)SX@5&AE($-O;7!A;GD@86-C;W5N=',@9F]R(&ET<R!I;G9E<W1M
M96YT<R!I;B!M87)K971A8FQE('-E8W5R:71I97,@:6X@86-C;W)D86YC92!W
M:71H($%30R`S,C`M(DEN=F5S=&UE;G1S("T@1&5B="!A;F0@17%U:71Y(%-E
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M(")A8V-U;75L871E9"!O=&AE<B!C;VUP<F5H96YS:79E(&EN8V]M92`H;&]S
M<RDB(&EN('1H92!S=&%T96UE;G0@;V8@8VAA;F=E<R!I;B!S=&]C:VAO;&1E
M<G,F(S,Y.R!E<75I='DN/"]D:78^(#QD:78@<W1Y;&4],T0G1$E34$Q!63H@
M8FQO8VL[($U!4D=)3BU,1494.B`T,S=P=#L@34%21TE.+5))1TA4.B`P<'0[
M('1E>'0M86QI9VXZ(&IU<W1I9GD[(%1%6%0M24Y$14Y4.B`P<'0G/B`F;F)S
M<#L\+V1I=CX@/&1I=B!S='EL93TS1"=$25-03$%9.B!B;&]C:SL@1D].5"U&
M04U)3%DZ(%1I;65S($YE=R!2;VUA;CL@1D].5"U325I%.B`Q,'!T.R!-05)'
M24XM3$5&5#H@,3AP=#L@34%21TE.+5))1TA4.B`P<'0[('1E>'0M86QI9VXZ
M(&IU<W1I9GD[(%1%6%0M24Y$14Y4.B`P<'0G/B!296%L:7IE9"!G86EN(&%N
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M('1H92`B1FEN86YC:6%L(&EN8V]M92P@;F5T(BX\+V1I=CX@/&1I=B!S='EL
M93TS1"=$25-03$%9.B!B;&]C:SL@34%21TE.+4Q%1E0Z(#0S-W!T.R!-05)'
M24XM4DE'2%0Z(#!P=#L@=&5X="UA;&EG;CH@:G5S=&EF>3L@5$585"U)3D1%
M3E0Z(#!P="<^("9N8G-P.SPO9&EV/B`\9&EV('-T>6QE/3-$)T1)4U!,05DZ
M(&)L;V-K.R!&3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N.R!&3TY4+5-)
M6D4Z(#$P<'0[($U!4D=)3BU,1494.B`Q.'!T.R!-05)'24XM4DE'2%0Z(#!P
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M<V5C=7)I=&EE<R!T;R!B92!S97!A<F%T960@:6YT;R`H82DF;F)S<#MT:&4@
M86UO=6YT(')E<')E<V5N=&EN9R!T:&4@8W)E9&ET(&QO<W,@86YD("AB*29N
M8G-P.W1H92!A;6]U;G0@<F5L871E9"!T;R!A;&P@;W1H97(@9F%C=&]R<R`H
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M;64@*&QO<W,I+CPO9&EV/B`\9&EV('-T>6QE/3-$)T1)4U!,05DZ(&)L;V-K
M.R!-05)'24XM3$5&5#H@-#,W<'0[($U!4D=)3BU224=(5#H@,'!T.R!T97AT
M+6%L:6=N.B!J=7-T:69Y.R!415A4+4E.1$5.5#H@,'!T)SX@)FYB<W`[/"]D
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M<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS1')O
M/@T*("`@("`@("`\=&0@8VQA<W,],T1P;"!V86QI9VX],T1T;W`^4F5V96YU
M92!296-O9VYI=&EO;B!F<F]M('1H92!L:6-E;G-E($%G<F5E;65N="!W:71H
M(%5N:71E9"!4:&5R87!E=71I8W,\+W1D/@T*("`@("`@("`\=&0@8VQA<W,]
M,T1T97AT/B<\(2TM1$]#5%E012!H=&UL(%!50DQ)0R`B+2\O5S-#+R]$5$0@
M6$A434P@,2XP(%1R86YS:71I;VYA;"\O14XB(")H='1P.B\O=W=W+G<S+F]R
M9R]44B]X:'1M;#$O1%1$+WAH=&UL,2UT<F%N<VET:6]N86PN9'1D(B`M+3X\
M9&EV/B`\9&EV/CPA+2U3=&%R=$9R86=M96YT+2T^(#QD:78@<W1Y;&4],T0G
M=&5X="UA;&EG;CH@8V5N=&5R)SX@/'1A8FQE('-T>6QE/3-$)T9/3E0M4TE:
M13H@,3!P=#L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;B<@8V5L;'-P
M86-I;F<],T0P(&-E;&QP861D:6YG/3-$,"!W:61T:#TS1#$P,"4@8F]R9&5R
M/3-$,#X@/'1R('9A;&EG;CTS1'1O<#X@/'1D('-T>6QE/3-$)U=)1%1(.B`Q
M.'!T)SX@/&1I=B!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-
M24Q9.B!T:6UE<R!N97<@<F]M86X[($9/3E0M4TE:13H@,3!P=#L@1D].5"U7
M14E'2%0Z(&)O;&0[($U!4D=)3BU,1494.B`P<'0[($U!4D=)3BU224=(5#H@
M,'!T.R!415A4+4E.1$5.5#H@,'!T)SX@:2X\+V1I=CX@/"]T9#X@/'1D/B`\
M9&EV('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I
M;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T.R!&3TY4+5=%24=(5#H@
M8F]L9#L@=&5X="UA;&EG;CH@:G5S=&EF>2<^(%)E=F5N=64@4F5C;V=N:71I
M;VX@9G)O;2!T:&4@;&EC96YS92!!9W)E96UE;G0@=VET:"!5;FET960@5&AE
M<F%P975T:6-S/"]D:78^(#PO=&0^(#PO='(^(#PO=&%B;&4^(#PO9&EV/B`\
M9&EV('-T>6QE/3-$)T1)4U!,05DZ(&)L;V-K.R!-05)'24XM3$5&5#H@-#,W
M<'0[($U!4D=)3BU224=(5#H@,'!T.R!T97AT+6%L:6=N.B!J=7-T:69Y.R!4
M15A4+4E.1$5.5#H@,'!T)SX@)FYB<W`[/"]D:78^(#QD:78@<W1Y;&4],T0G
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M=71I8W,@:6X@86-C;W)D86YC92!W:71H($%30R`V,#4M,C4L(")2979E;G5E
M(%)E8V]G;FET:6]N+"!-=6QT:7!L92U%;&5M96YT($%R<F%N9V5M96YT<R(N
M/"]D:78^(#QD:78@<W1Y;&4],T0G34%21TE.+4Q%1E0Z(#0S-W!T.R!$25-0
M3$%9.B!B;&]C:SL@5$585"U)3D1%3E0Z(#!P="<^(#QB<B`O/B`\+V1I=CX@
M/&1I=B!S='EL93TS1"=$25-03$%9.B!B;&]C:SL@1D].5"U&04U)3%DZ(%1I
M;65S($YE=R!2;VUA;CL@1D].5"U325I%.B`Q,'!T.R!-05)'24XM3$5&5#H@
M,3AP=#L@34%21TE.+5))1TA4.B`P<'0[('1E>'0M86QI9VXZ(&IU<W1I9GD[
M(%1%6%0M24Y$14Y4.B`P<'0G/B!0=7)S=6%N="!T;R!!4T,@-C`U+3(U+"!E
M86-H(&1E;&EV97)A8FQE(&ES(&5V86QU871E9"!T;R!D971E<FUI;F4@=VAE
M=&AE<B!I="!Q=6%L:69I97,@87,@82!S97!A<F%T92!U;FET(&]F(&%C8V]U
M;G1I;F<@8F%S960@;VX@=VAE=&AE<B!T:&4@9&5L:79E<F%B;&4@:&%S(")S
M=&%N9"UA;&]N92!V86QU92(@=&\@=&AE(&-U<W1O;65R+B!4:&4@87)R86YG
M96UE;G0F(S,Y.W,@8V]N<VED97)A=&EO;B!T:&%T(&ES(&9I>&5D(&]R(&1E
M=&5R;6EN86)L92!I<R!T:&5N(&%L;&]C871E9"!T;R!E86-H('-E<&%R871E
M('5N:70@;V8@86-C;W5N=&EN9R!B87-E9"!O;B!T:&4@<F5L871I=F4@<V5L
M;&EN9R!P<FEC92!O9B!E86-H(&1E;&EV97)A8FQE+B!);B!G96YE<F%L+"!T
M:&4@8V]N<VED97)A=&EO;B!A;&QO8V%T960@=&\@96%C:"!U;FET(&]F(&%C
M8V]U;G1I;F<@:7,@<F5C;V=N:7IE9"!A<R!T:&4@<F5L871E9"!G;V]D<R!O
M<B!S97)V:6-E<R!A<F4@9&5L:79E<F5D+"!L:6UI=&5D('1O('1H92!C;VYS
M:61E<F%T:6]N('1H870@:7,@;F]T(&-O;G1I;F=E;G0@=7!O;B!F=71U<F4@
M9&5L:79E<F%B;&5S+CPO9&EV/B`\9&EV('-T>6QE/3-$)TU!4D=)3BU,1494
M.B`T,S=P=#L@1$E34$Q!63H@8FQO8VL[(%1%6%0M24Y$14Y4.B`P<'0G/B`\
M8G(@+SX@/"]D:78^(#QD:78@<W1Y;&4],T0G1$E34$Q!63H@8FQO8VL[($9/
M3E0M1D%-24Q9.B!4:6UE<R!.97<@4F]M86X[($9/3E0M4TE:13H@,3!P=#L@
M34%21TE.+4Q%1E0Z(#$X<'0[($U!4D=)3BU224=(5#H@,'!T.R!T97AT+6%L
M:6=N.B!J=7-T:69Y.R!415A4+4E.1$5.5#H@,'!T)SX@5&AE($-O;7!A;GD@
M<F5C96EV960@86X@=7`M9G)O;G0L(&YO;BUR969U;F1A8FQE(&QI8V5N<V4@
M<&%Y;65N="!O9B`D-2PP,#`N($%D9&ET:6]N86P@<&%Y;65N=',@=&]T86QI
M;F<@)#,W+#4P,"!A<F4@<W5B:F5C="!T;R!T:&4@86-H:65V96UE;G0@;V8@
M8V5R=&%I;B!R96=U;&%T;W)Y(&UI;&5S=&]N97,@8GD@56YI=&5D(%1H97)A
M<&5U=&EC<RX\+V1I=CX@/&1I=B!S='EL93TS1"=-05)'24XM3$5&5#H@-#,W
M<'0[($1)4U!,05DZ(&)L;V-K.R!415A4+4E.1$5.5#H@,'!T)SX@/&)R("\^
M(#PO9&EV/B`\9&EV('-T>6QE/3-$)T1)4U!,05DZ(&)L;V-K.R!&3TY4+49!
M34E,63H@5&EM97,@3F5W(%)O;6%N.R!&3TY4+5-)6D4Z(#$P<'0[($U!4D=)
M3BU,1494.B`Q.'!T.R!-05)'24XM4DE'2%0Z(#!P=#L@=&5X="UA;&EG;CH@
M:G5S=&EF>3L@5$585"U)3D1%3E0Z(#!P="<^(%-I;F-E('1H92!D96QI=F5R
M86)L97,@:6X@=&AE(%5N:71E9"!!9W)E96UE;G0@9&\@;F]T(&AA=F4@<W1A
M;F0M86QO;F4@=F%L=64L(&YO;F4@;V8@=&AE;2!Q=6%L:69I97,@87,@82!S
M97!A<F%T92!U;FET(&]F(&%C8V]U;G1I;F<N($%C8V]R9&EN9VQY+"!T:&4@
M;F]N+7)E9G5N9&%B;&4@=7!F<F]N="!L:6-E;G-E(&9E92!O9B`D-2PP,#`@
M:7,@9&5F97)R960@86YD(')E8V]G;FEZ960@;VX@82!S=')A:6=H="!L:6YE
M(&)A<VES(&]V97(@=&AE(')E;&%T960@<&5R9F]R;6%N8V4@<&5R:6]D('=H
M:6-H(&ES('1H92!D979E;&]P;65N="!P97)I;V0@:6X@86-C;W)D86YC92!W
M:71H(%-T869F($%C8V]U;G1I;F<@0G5L;&5T:6X@*")304(B*2`Q,#0L(")2
M979E;G5E(%)E8V]G;FET:6]N(BX@5&AE(')E;6%I;FEN9R!P97)F;W)M86YC
M92!P97)I;V0@:7,@."XU('EE87)S(&%S(&]F($IU;F4@,S`L(#(P,30N/"]D
M:78^(#QD:78@<W1Y;&4],T0G34%21TE.+4Q%1E0Z(#0S-W!T.R!$25-03$%9
M.B!B;&]C:SL@5$585"U)3D1%3E0Z(#!P="<^(#QB<B`O/B`\+V1I=CX@/&1I
M=B!S='EL93TS1"=$25-03$%9.B!B;&]C:SL@1D].5"U&04U)3%DZ(%1I;65S
M($YE=R!2;VUA;CL@1D].5"U325I%.B`Q,'!T.R!-05)'24XM3$5&5#H@,3AP
M=#L@34%21TE.+5))1TA4.B`P<'0[('1E>'0M86QI9VXZ(&IU<W1I9GD[(%1%
M6%0M24Y$14Y4.B`P<'0G/B!4:&4@861D:71I;VYA;"!R96=U;&%T;W)Y(&UI
M;&5S=&]N97,@<&%Y;65N=',@=VEL;"!B92!R96-O9VYI>F5D('5P;VX@=&AE
M(&%C:&EE=F5M96YT(&]F(&9U='5R97,@979E;G1S(&)Y(%5N:71E9"!4:&5R
M87!E=71I8W,L(&EN(&%C8V]R9&%N8V4@=VET:"!!4T,@-#4P+3,P+3(U+"`B
M1V%I;B!#;VYT:6YG96YC:65S(BX@07,@;V8@2G5N92`S,"P@,C`Q-"P@;F\@
M<F5G=6QA=&]R>2!M:6QL<W1O;F5S('=E<F4@86-H:65V960N/"]D:78^(#QD
M:78@<W1Y;&4],T0G34%21TE.+4Q%1E0Z(#0S-W!T.R!$25-03$%9.B!B;&]C
M:SL@5$585"U)3D1%3E0Z(#!P="<^(#QB<B`O/B`\+V1I=CX@/&1I=B!S='EL
M93TS1"=$25-03$%9.B!B;&]C:SL@1D].5"U&04U)3%DZ(%1I;65S($YE=R!2
M;VUA;CL@1D].5"U325I%.B`Q,'!T.R!-05)'24XM3$5&5#H@,3AP=#L@34%2
M1TE.+5))1TA4.B`P<'0[('1E>'0M86QI9VXZ(&IU<W1I9GD[(%1%6%0M24Y$
M14Y4.B`P<'0G/B!4:&4@0V]M<&%N>2!A;'-O(')E8V5I=F5D(&%N(&%D=F%N
M8V5D('!A>6UE;G0@9F]R('1H92!D979E;&]P;65N="P@;V8@)#(L,#`P('1H
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M-S,P+3(P+"`B4F5S96%R8V@@86YD($1E=F5L;W!M96YT($%G<F5E;65N=',B
M+B!!<R!O9B!*=6YE(#,P+"`R,#$T+"!T:&4@0V]M<&%N>2!D961U8W1E9"!A
M;B!A;6]U;G0@;V8@87!P<F]X:6UA=&5L>2`D,2PW-3,N/"]D:78^(#PA+2U%
M;F1&<F%G;65N="TM/CPO9&EV/B`\+V1I=CX\<W!A;CX\+W-P86X^/"]T9#X-
M"B`@("`@(#PO='(^#0H@("`@("`\='(@8VQA<W,],T1R93X-"B`@("`@("`@
M/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P/E!R;W!E<G1Y(&%N9"!%<75I
M<&UE;G0\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\(2TM1$]#
M5%E012!H=&UL(%!50DQ)0R`B+2\O5S-#+R]$5$0@6$A434P@,2XP(%1R86YS
M:71I;VYA;"\O14XB(")H='1P.B\O=W=W+G<S+F]R9R]44B]X:'1M;#$O1%1$
M+WAH=&UL,2UT<F%N<VET:6]N86PN9'1D(B`M+3X\9&EV/B`\9&EV/CPA+2U3
M=&%R=$9R86=M96YT+2T^(#QD:78^(#QT86)L92!S='EL93TS1"=&3TY4+5-)
M6D4Z(#$P<'0[($9/3E0M1D%-24Q9.B!T:6UE<R!N97<@<F]M86XG(&-E;&QS
M<&%C:6YG/3-$,"!C96QL<&%D9&EN9STS1#`@=VED=&@],T0Q,#`E(&%L:6=N
M/3-$8V5N=&5R(&)O<F1E<CTS1#`^(#QT<B!V86QI9VX],T1T;W`^(#QT9"!S
M='EL93TS1"=724142#H@,3AP="<^(#QD:78@<W1Y;&4],T0G1$E34$Q!63H@
M:6YL:6YE.R!&3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N.R!&3TY4+5-)
M6D4Z(#$P<'0[($9/3E0M5T5)1TA4.B!B;VQD.R!-05)'24XM3$5&5#H@,'!T
M.R!-05)'24XM4DE'2%0Z(#!P=#L@5$585"U)3D1%3E0Z(#!P="<^(&HN/"]D
M:78^(#PO=&0^(#QT9#X@/&1I=B!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[
M($9/3E0M1D%-24Q9.B!4:6UE<R!.97<@4F]M86X[($9/3E0M4TE:13H@,3!P
M=#L@1D].5"U714E'2%0Z(&)O;&0[('1E>'0M86QI9VXZ(&IU<W1I9GDG/B!0
M<F]P97)T>2!A;F0@17%U:7!M96YT/"]D:78^(#PO=&0^(#PO='(^(#PO=&%B
M;&4^(#PO9&EV/B`\9&EV('-T>6QE/3-$)T1)4U!,05DZ(&)L;V-K.R!-05)'
M24XM3$5&5#H@,'!T.R!-05)'24XM4DE'2%0Z(#!P=#L@=&5X="UA;&EG;CH@
M:G5S=&EF>3L@5$585"U)3D1%3E0Z(#!P="<^("9N8G-P.SPO9&EV/B`\9&EV
M/B`\=&%B;&4@<W1Y;&4],T0G1D].5"U325I%.B`Q,'!T.R!&3TY4+49!34E,
M63H@=&EM97,@;F5W(')O;6%N)R!C96QL<W!A8VEN9STS1#`@8V5L;'!A9&1I
M;F<],T0P('=I9'1H/3-$,3`P)2!A;&EG;CTS1&-E;G1E<B!B;W)D97(],T0P
M/B`\='(@=F%L:6=N/3-$=&]P/B`\=&0@<W1Y;&4],T0G5TE$5$@Z(#$X<'0G
M/B`\9&EV('-T>6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ
M(%1I;65S($YE=R!2;VUA;CL@1$E34$Q!63H@:6YL:6YE)SX@)FYB<W`[/"]D
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M:78@<W1Y;&4],T0G1$E34$Q!63H@8FQO8VL[($U!4D=)3BU,1494.B`P<'0[
M($U!4D=)3BU224=(5#H@,'!T.R!T97AT+6%L:6=N.B!J=7-T:69Y.R!415A4
M+4E.1$5.5#H@,'!T)SX@)FYB<W`[/"]D:78^(#QD:78@<W1Y;&4],T0G34%2
M1TE.+4Q%1E0Z(#$X<'0[('1E>'0M86QI9VXZ(&QE9G0G/B`\=&%B;&4@<W1Y
M;&4],T0G1D].5"U325I%.B`Q,'!T.R!&3TY4+49!34E,63H@=&EM97,@;F5W
M(')O;6%N)R!C96QL<W!A8VEN9STS1#`@8V5L;'!A9&1I;F<],T0P('=I9'1H
M/3-$.#`E/B`\='(^(#QT9"!V86QI9VX],T1T;W`@=VED=&@],T0T-"4^/&9O
M;G0@<W1Y;&4],T0G1D].5"U325I%.B`Q,'!T.R!&3TY4+49!34E,63H@=&EM
M97,@;F5W(')O;6%N.R!$25-03$%9.B!I;FQI;F4G/B`F;F)S<#L\+V9O;G0^
M(#PO=&0^(#QT9"!S='EL93TS1"="3U)$15(M0D]45$]-.B!B;&%C:R`R<'@@
M<V]L:60G('9A;&EG;CTS1'1O<"!W:61T:#TS1#(X)3X@/&1I=B!S='EL93TS
M1"=$25-03$%9.B!B;&]C:SL@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA
M;CL@1D].5"U325I%.B`Q,'!T.R!-05)'24XM3$5&5#H@,'!T.R!-05)'24XM
M4DE'2%0Z(#!P=#L@5$585"U)3D1%3E0Z(#!P="<^("4\+V1I=CX@/"]T9#X@
M/'1D('9A;&EG;CTS1'1O<"!W:61T:#TS1#(X)3X\9F]N="!S='EL93TS1"=&
M3TY4+5-)6D4Z(#$P<'0[($9/3E0M1D%-24Q9.B!T:6UE<R!N97<@<F]M86X[
M($1)4U!,05DZ(&EN;&EN92<^("9N8G-P.SPO9F]N=#X@/"]T9#X@/"]T<CX@
M/'1R(&)G8V]L;W(],T0C8V-E969F/B`\=&0@=F%L:6=N/3-$=&]P('=I9'1H
M/3-$-#0E(&%L:6=N/3-$;&5F=#X@/&1I=B!S='EL93TS1"=$25-03$%9.B!B
M;&]C:SL@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%
M.B`Q,'!T.R!-05)'24XM3$5&5#H@,'!T.R!-05)'24XM4DE'2%0Z(#!P=#L@
M=&5X="UA;&EG;CH@;&5F=#L@5$585"U)3D1%3E0Z(#!P="<^($QA8F]R871O
M<GD@97%U:7!M96YT/"]D:78^(#PO=&0^(#QT9"!V86QI9VX],T1T;W`@=VED
M=&@],T0R."4@86QI9VX],T1L969T/B`\9&EV('-T>6QE/3-$)T1)4U!,05DZ
M(&)L;V-K.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!&3TY4+5-)
M6D4Z(#$P<'0[($U!4D=)3BU,1494.B`P<'0[($U!4D=)3BU224=(5#H@+3$R
M+C-P=#L@=&5X="UA;&EG;CH@;&5F=#L@5$585"U)3D1%3E0Z(#!P="<^(#$P
M+3$U/"]D:78^(#PO=&0^(#QT9"!V86QI9VX],T1T;W`@=VED=&@],T0R."4^
M/&9O;G0@<W1Y;&4],T0G1D].5"U325I%.B`Q,'!T.R!&3TY4+49!34E,63H@
M=&EM97,@;F5W(')O;6%N.R!$25-03$%9.B!I;FQI;F4G/B`F;F)S<#L\+V9O
M;G0^(#PO=&0^(#PO='(^(#QT<B!B9V-O;&]R/3-$=VAI=&4^(#QT9"!V86QI
M9VX],T1T;W`@=VED=&@],T0T-"4@86QI9VX],T1L969T/B`\9&EV('-T>6QE
M/3-$)T1)4U!,05DZ(&)L;V-K.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O
M;6%N.R!&3TY4+5-)6D4Z(#$P<'0[($U!4D=)3BU,1494.B`P<'0[($U!4D=)
M3BU224=(5#H@,'!T.R!T97AT+6%L:6=N.B!L969T.R!415A4+4E.1$5.5#H@
M,'!T)SX@0V]M<'5T97)S(&%N9"!P97)I<&AE<F%L(&5Q=6EP;65N=#PO9&EV
M/B`\+W1D/B`\=&0@=F%L:6=N/3-$=&]P('=I9'1H/3-$,C@E(&%L:6=N/3-$
M;&5F=#X@/&1I=B!S='EL93TS1"=$25-03$%9.B!B;&]C:SL@1D].5"U&04U)
M3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T.R!-05)'24XM
M3$5&5#H@,'!T.R!-05)'24XM4DE'2%0Z("TQ,BXS<'0[('1E>'0M86QI9VXZ
M(&QE9G0[(%1%6%0M24Y$14Y4.B`P<'0G/B`S,SPO9&EV/B`\+W1D/B`\=&0@
M=F%L:6=N/3-$=&]P('=I9'1H/3-$,C@E/CQF;VYT('-T>6QE/3-$)T9/3E0M
M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1$E3
M4$Q!63H@:6YL:6YE)SX@)FYB<W`[/"]F;VYT/B`\+W1D/B`\+W1R/B`\='(@
M8F=C;VQO<CTS1"-C8V5E9F8^(#QT9"!V86QI9VX],T1T;W`@=VED=&@],T0T
M-"4@86QI9VX],T1L969T/B`\9&EV('-T>6QE/3-$)T1)4U!,05DZ(&)L;V-K
M.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!&3TY4+5-)6D4Z(#$P
M<'0[($U!4D=)3BU,1494.B`P<'0[($U!4D=)3BU224=(5#H@,'!T.R!T97AT
M+6%L:6=N.B!L969T.R!415A4+4E.1$5.5#H@,'!T)SX@3V9F:6-E(&9U<FYI
M='5R92!A;F0@97%U:7!M96YT/"]D:78^(#PO=&0^(#QT9"!V86QI9VX],T1T
M;W`@=VED=&@],T0R."4@86QI9VX],T1L969T/B`\9&EV('-T>6QE/3-$)T1)
M4U!,05DZ(&)L;V-K.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!&
M3TY4+5-)6D4Z(#$P<'0[($U!4D=)3BU,1494.B`P<'0[($U!4D=)3BU224=(
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M34%21TE.+5))1TA4.B`P<'0[('1E>'0M86QI9VXZ(&QE9G0[(%1%6%0M24Y$
M14Y4.B`P<'0G/B!696AI8VQE<SPO9&EV/B`\+W1D/B`\=&0@=F%L:6=N/3-$
M=&]P('=I9'1H/3-$,34E(&-O;'-P86X],T0R(&%L:6=N/3-$;&5F=#X@/&1I
M=B!S='EL93TS1"=$25-03$%9.B!B;&]C:SL@1D].5"U&04U)3%DZ('1I;65S
M(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T.R!-05)'24XM3$5&5#H@,'!T
M.R!-05)'24XM4DE'2%0Z("TQ,BXS<'0[('1E>'0M86QI9VXZ(&QE9G0[(%1%
M6%0M24Y$14Y4.B`P<'0G/B`Q-3PO9&EV/B`\+W1D/B`\+W1R/B`\='(@8F=C
M;VQO<CTS1"-C8V5E9F8^(#QT9"!V86QI9VX],T1T;W`@=VED=&@],T0T-"4@
M86QI9VX],T1L969T/B`\9&EV('-T>6QE/3-$)T1)4U!,05DZ(&)L;V-K.R!&
M3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!&3TY4+5-)6D4Z(#$P<'0[
M($U!4D=)3BU,1494.B`P<'0[($U!4D=)3BU224=(5#H@,'!T.R!T97AT+6%L
M:6=N.B!L969T.R!415A4+4E.1$5.5#H@,'!T)SX@3&5A<V5H;VQD(&EM<')O
M=F5M96YT<SPO9&EV/B`\+W1D/B`\=&0@=F%L:6=N/3-$=&]P('=I9'1H/3-$
M-38E(&-O;'-P86X],T0R(&%L:6=N/3-$;&5F=#X@/&1I=B!S='EL93TS1"=$
M25-03$%9.B!B;&]C:SL@34%21TE.+4Q%1E0Z(#!P=#L@34%21TE.+5))1TA4
M.B`M,3(N,W!T.R!T97AT+6%L:6=N.B!L969T.R!415A4+4E.1$5.5#H@,'!T
M)SX@/&9O;G0@<W1Y;&4],T0G1D].5"U325I%.B`Q,'!T.R!&3TY4+49!34E,
M63H@=&EM97,@;F5W(')O;6%N.R!$25-03$%9.B!I;FQI;F4G/B!4:&4@<VAO
M<G1E<B!O9B!T:&4@97AP96-T960\+V9O;G0^(#QF;VYT('-T>6QE/3-$)T9/
M3E0M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@
M1$E34$Q!63H@:6YL:6YE)SX@=7-E9G5L(&QI9F4@;W(@=&AE/"]F;VYT/CPO
M9&EV/B`\9&EV('-T>6QE/3-$)T1)4U!,05DZ(&)L;V-K.R!-05)'24XM3$5&
M5#H@,'!T.R!-05)'24XM4DE'2%0Z("TQ,BXS<'0[('1E>'0M86QI9VXZ(&QE
M9G0[(%1%6%0M24Y$14Y4.B`P<'0G/B`\9F]N="!S='EL93TS1"=&3TY4+5-)
M6D4Z(#$P<'0[($9/3E0M1D%-24Q9.B!T:6UE<R!N97<@<F]M86X[($1)4U!,
M05DZ(&EN;&EN92<^(')E87-O;F%B;&4@87-S=6UE9#PO9F]N=#X@/&9O;G0@
M<W1Y;&4],T0G1D].5"U325I%.B`Q,'!T.R!&3TY4+49!34E,63H@=&EM97,@
M;F5W(')O;6%N.R!$25-03$%9.B!I;FQI;F4G/B!T97)M(&]F('1H92!L96%S
M92X\+V9O;G0^/"]D:78^(#PO=&0^(#PO='(^(#PO=&%B;&4^(#PO9&EV/B`\
M(2TM16YD1G)A9VUE;G0M+3X\+V1I=CX@/"]D:78^/'-P86X^/"]S<&%N/CPO
M=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$<F\^#0H@("`@
M("`@(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O<#Y);7!A:7)M96YT(&]F
M(&QO;F<M;&EV960@87-S971S/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$
M=&5X=#XG/"$M+41/0U194$4@:'1M;"!054),24,@(BTO+U<S0R\O1%1$(%A(
M5$U,(#$N,"!4<F%N<VET:6]N86PO+T5.(B`B:'1T<#HO+W=W=RYW,RYO<F<O
M5%(O>&AT;6PQ+T141"]X:'1M;#$M=')A;G-I=&EO;F%L+F1T9"(@+2T^/&1I
M=CX@/&1I=CX\(2TM4W1A<G1&<F%G;65N="TM/B`\9&EV('-T>6QE/3-$)W1E
M>'0M86QI9VXZ(&-E;G1E<B<^(#QT86)L92!S='EL93TS1"=&3TY4+5-)6D4Z
M(#$P<'0[($9/3E0M1D%-24Q9.B!T:6UE<R!N97<@<F]M86XG(&-E;&QS<&%C
M:6YG/3-$,"!C96QL<&%D9&EN9STS1#`@=VED=&@],T0Q,#`E(&)O<F1E<CTS
M1#`^(#QT<B!V86QI9VX],T1T;W`^(#QT9"!S='EL93TS1"=724142#H@,3AP
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M/B`\9&EV('-T>6QE/3-$)T1)4U!,05DZ(&)L;V-K.R!-05)'24XM3$5&5#H@
M,'!T.R!-05)'24XM4DE'2%0Z(#!P=#L@=&5X="UA;&EG;CH@:G5S=&EF>3L@
M5$585"U)3D1%3E0Z(#!P="<^("9N8G-P.SPO9&EV/B`\9&EV/B`\=&%B;&4@
M<W1Y;&4],T0G1D].5"U325I%.B`Q,'!T.R!&3TY4+49!34E,63H@=&EM97,@
M;F5W(')O;6%N)R!C96QL<W!A8VEN9STS1#`@8V5L;'!A9&1I;F<],T0P('=I
M9'1H/3-$,3`P)2!A;&EG;CTS1&-E;G1E<B!B;W)D97(],T0P/B`\='(@=F%L
M:6=N/3-$=&]P/B`\=&0@<W1Y;&4],T0G5TE$5$@Z(#$X<'0G/B`\9&EV('-T
M>6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ(%1I;65S($YE
M=R!2;VUA;CL@1$E34$Q!63H@:6YL:6YE)SX@)FYB<W`[/"]D:78^(#PO=&0^
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M<FEN9R`R,#$T+"`R,#$S(&%N9"`R,#$R+"!N;R!I;7!A:7)M96YT(&QO<W-E
M<R!B965N(&ED96YT:69I960N/"]D:78^(#PO=&0^(#PO='(^(#PO=&%B;&4^
M(#PO9&EV/B`\(2TM16YD1G)A9VUE;G0M+3X\+V1I=CX@/"]D:78^/'-P86X^
M/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$
M<F4^#0H@("`@("`@(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O<#Y!8V-O
M=6YT:6YG(&9O<B!S=&]C:RUB87-E9"!C;VUP96YS871I;VX\+W1D/@T*("`@
M("`@("`\=&0@8VQA<W,],T1T97AT/B<\(2TM1$]#5%E012!H=&UL(%!50DQ)
M0R`B+2\O5S-#+R]$5$0@6$A434P@,2XP(%1R86YS:71I;VYA;"\O14XB(")H
M='1P.B\O=W=W+G<S+F]R9R]44B]X:'1M;#$O1%1$+WAH=&UL,2UT<F%N<VET
M:6]N86PN9'1D(B`M+3X\9&EV/B`\9&EV/CPA+2U3=&%R=$9R86=M96YT+2T^
M(#QD:78^(#QT86)L92!S='EL93TS1"=&3TY4+5-)6D4Z(#$P<'0[($9/3E0M
M1D%-24Q9.B!T:6UE<R!N97<@<F]M86XG(&-E;&QS<&%C:6YG/3-$,"!C96QL
M<&%D9&EN9STS1#`@=VED=&@],T0Q,#`E(&%L:6=N/3-$8V5N=&5R(&)O<F1E
M<CTS1#`^(#QT<B!V86QI9VX],T1T;W`^(#QT9"!S='EL93TS1"=724142#H@
M,3AP="<^(#QD:78@<W1Y;&4],T0G1$E34$Q!63H@:6YL:6YE.R!&3TY4+49!
M34E,63H@5&EM97,@3F5W(%)O;6%N.R!&3TY4+5-)6D4Z(#$P<'0[($9/3E0M
M5T5)1TA4.B!B;VQD.R!-05)'24XM3$5&5#H@,'!T.R!-05)'24XM4DE'2%0Z
M(#!P=#L@5$585"U)3D1%3E0Z(#!P="<^(&PN/"]D:78^(#PO=&0^(#QT9#X@
M/&1I=B!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!4
M:6UE<R!.97<@4F]M86X[($9/3E0M4TE:13H@,3!P=#L@1D].5"U714E'2%0Z
M(&)O;&0[('1E>'0M86QI9VXZ(&IU<W1I9GDG/B!!8V-O=6YT:6YG(&9O<B!S
M=&]C:RUB87-E9"!C;VUP96YS871I;VX\+V1I=CX@/"]T9#X@/"]T<CX@/"]T
M86)L93X@/"]D:78^(#QD:78@<W1Y;&4],T0G1$E34$Q!63H@8FQO8VL[($U!
M4D=)3BU,1494.B`P<'0[($U!4D=)3BU224=(5#H@,'!T.R!T97AT+6%L:6=N
M.B!J=7-T:69Y.R!415A4+4E.1$5.5#H@,'!T)SX@)FYB<W`[/"]D:78^(#QD
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M(#<Q."(I(&%N9"!!4T,@-3`U+34P(")%<75I='DM0F%S960@4&%Y;65N=',@
M=&\@3F]N+45M<&QO>65E<R(N($%30R`W,3@@<F5Q=6ER97,@8V]M<&%N:65S
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M87)D(&%P<')O86-H+CPO9&EV/B`\9&EV('-T>6QE/3-$)T1)4U!,05DZ(&)L
M;V-K.R!415A4+4E.1$5.5#H@,'!T)SX\8G(@+SX@/"]D:78^(#QD:78@<W1Y
M;&4],T0G1$E34$Q!63H@8FQO8VL[($9/3E0M1D%-24Q9.B!4:6UE<R!.97<@
M4F]M86X[($9/3E0M4TE:13H@,3!P=#L@34%21TE.+4Q%1E0Z(#$X<'0[($U!
M4D=)3BU224=(5#H@,'!T.R!T97AT+6%L:6=N.B!J=7-T:69Y.R!415A4+4E.
M1$5.5#H@,'!T)SX@1'5R:6YG(&9I<V-A;"!Y96%R<R`R,#$T+"`R,#$S(&%N
M9"`R,#$R('1H97)E('=E<F4@;F\@;W!T:6]N<R!G<F%N=',@=&\@96UP;&]Y
M965S(&]R(&1I<F5C=&]R<RX\+V1I=CX@/&1I=B!S='EL93TS1"=-05)'24XM
M3$5&5#H@-#,W<'0[($1)4U!,05DZ(&)L;V-K.R!415A4+4E.1$5.5#H@,'!T
M)SX@/&)R("\^(#PO9&EV/B`\9&EV('-T>6QE/3-$)T1)4U!,05DZ(&)L;V-K
M.R!&3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N.R!&3TY4+5-)6D4Z(#$P
M<'0[($U!4D=)3BU,1494.B`Q.'!T.R!-05)'24XM4DE'2%0Z(#!P=#L@=&5X
M="UA;&EG;CH@:G5S=&EF>3L@5$585"U)3D1%3E0Z(#!P="<^(%1H92!A<W-U
M;7!T:6]N<R!B96QO=R!A<F4@<F5L979A;G0@=&\@<F5S=')I8W1E9"!S:&%R
M97,@=6YI=',@9W)A;G1E9"!I;B`R,#$T+"`R,#$S(&%N9"`R,#$R.CPO9&EV
M/B`\9&EV('-T>6QE/3-$)T1)4U!,05DZ(&)L;V-K.R!&3TY4+49!34E,63H@
M5&EM97,@3F5W(%)O;6%N.R!&3TY4+5-)6D4Z(#$P<'0[($U!4D=)3BU,1494
M.B`Q.'!T.R!-05)'24XM4DE'2%0Z(#!P=#L@=&5X="UA;&EG;CH@:G5S=&EF
M>3L@5$585"U)3D1%3E0Z(#!P="<^($EN(&%C8V]R9&%N8V4@=VET:"`\9F]N
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M;&]Y965S(&=R86YT960@:6X@,C`Q-#(P,3,@86YD(#(P,3(@=V5R92!G<F%N
M=&5D(&9O<B!N;R!C;VYS:61E<F%T:6]N.R!T:&5R969O<F4L('1H96ER(&9A
M:7(@=F%L=64@=V%S(&5Q=6%L('1O('1H92!S:&%R92!P<FEC92!A="!T:&4@
M9&%T92!O9B!G<F%N="X\+V1I=CX@/&1I=B!S='EL93TS1"=-05)'24XM3$5&
M5#H@-#,W<'0[($1)4U!,05DZ(&)L;V-K.R!415A4+4E.1$5.5#H@,'!T)SX@
M/&)R("\^(#PO9&EV/B`\9&EV('-T>6QE/3-$)T1)4U!,05DZ(&)L;V-K.R!&
M3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N.R!&3TY4+5-)6D4Z(#$P<'0[
M($U!4D=)3BU,1494.B`Q.'!T.R!-05)'24XM4DE'2%0Z(#!P=#L@=&5X="UA
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M;R!E;7!L;WEE97,@:7,@-R4@9F]R('EE87(@96YD960@2G5N92`S,"P@,C`Q
M-"!A;F0@,C`Q,R!A;F0@-24@9F]R('1H92!Y96%R(&5N9&5D($IU;F4@,S`L
M(#(P,3(L(&%N9"`P)2!F;W(@=&AE(&]P=&EO;G,@86YD('-H87)E<R!G<F%N
M=&5D('1O(&1I<F5C=&]R<R!A;F0@;V9F:6-E<G,@86YD(&-O;G-U;'1A;G1S
M(&]F('1H92!#;VUP86YY+CPO9&EV/B`\9&EV('-T>6QE/3-$)TU!4D=)3BU,
M1494.B`T,S=P=#L@1$E34$Q!63H@8FQO8VL[(%1%6%0M24Y$14Y4.B`P<'0G
M/B`\8G(@+SX@/"]D:78^(#QD:78@<W1Y;&4],T0G1$E34$Q!63H@8FQO8VL[
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M9R!Y96%R<R`R,#$T+"`R,#$S(&%N9"`R,#$R('=A<R`D,RXU,RP@)#,N-#,@
M86YD("0R+C4T+"!R97-P96-T:79E;'DN/"]D:78^(#PA+2U%;F1&<F%G;65N
M="TM/CPO9&EV/B`\+V1I=CX\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO
M='(^#0H@("`@("`\='(@8VQA<W,],T1R;SX-"B`@("`@("`@/'1D(&-L87-S
M/3-$<&P@=F%L:6=N/3-$=&]P/E)E<V5A<F-H(&%N9"!$979E;&]P;65N="!E
M>'!E;G-E<R!A;F0@9W)A;G1S/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$
M=&5X=#XG/"$M+41/0U194$4@:'1M;"!054),24,@(BTO+U<S0R\O1%1$(%A(
M5$U,(#$N,"!4<F%N<VET:6]N86PO+T5.(B`B:'1T<#HO+W=W=RYW,RYO<F<O
M5%(O>&AT;6PQ+T141"]X:'1M;#$M=')A;G-I=&EO;F%L+F1T9"(@+2T^/&1I
M=CX@/&1I=CX\(2TM4W1A<G1&<F%G;65N="TM/B`\9&EV('-T>6QE/3-$)W1E
M>'0M86QI9VXZ(&-E;G1E<B<^(#QT86)L92!S='EL93TS1"=&3TY4+5-)6D4Z
M(#$P<'0[($9/3E0M1D%-24Q9.B!T:6UE<R!N97<@<F]M86XG(&-E;&QS<&%C
M:6YG/3-$,"!C96QL<&%D9&EN9STS1#`@=VED=&@],T0Q,#`E(&)O<F1E<CTS
M1#`^(#QT<B!V86QI9VX],T1T;W`^(#QT9"!S='EL93TS1"=724142#H@,3AP
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M<&UE;G0@97AP96YS97,@86YD(&=R86YT<SPO9&EV/B`\+W1D/B`\+W1R/B`\
M+W1A8FQE/B`\+V1I=CX@/&1I=B!S='EL93TS1"=$25-03$%9.B!B;&]C:SL@
M34%21TE.+4Q%1E0Z(#!P=#L@34%21TE.+5))1TA4.B`P<'0[('1E>'0M86QI
M9VXZ(&IU<W1I9GD[(%1%6%0M24Y$14Y4.B`P<'0G/B`F;F)S<#L\+V1I=CX@
M/&1I=CX@/'1A8FQE('-T>6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@1D].5"U&
M04U)3%DZ('1I;65S(&YE=R!R;VUA;B<@8V5L;'-P86-I;F<],T0P(&-E;&QP
M861D:6YG/3-$,"!W:61T:#TS1#$P,"4@86QI9VX],T1C96YT97(@8F]R9&5R
M/3-$,#X@/'1R('9A;&EG;CTS1'1O<#X@/'1D('-T>6QE/3-$)U=)1%1(.B`Q
M.7!T)SX@/&1I=B!S='EL93TS1"=&3TY4+5-)6D4Z(#$P<'0[($9/3E0M1D%-
M24Q9.B!4:6UE<R!.97<@4F]M86X[($1)4U!,05DZ(&EN;&EN92<^("9N8G-P
M.SPO9&EV/B`\+W1D/B`\=&0^(#QD:78@<W1Y;&4],T0G1$E34$Q!63H@:6YL
M:6YE.R!&3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N.R!&3TY4+5-)6D4Z
M(#$P<'0[('1E>'0M86QI9VXZ(&IU<W1I9GDG/B!297-E87)C:"!A;F0@9&5V
M96QO<&UE;G0@97AP96YS97,L(&YE="!O9B!P87)T:6-I<&%T:6]N<RP@87)E
M(&-H87)G960@=&\@=&AE('-T871E;65N="!O9B!O<&5R871I;VYS(&%S(&EN
M8W5R<F5D+CPO9&EV/B`\+W1D/B`\+W1R/B`\+W1A8FQE/B`\+V1I=CX@/&1I
M=B!S='EL93TS1"=$25-03$%9.B!B;&]C:SL@34%21TE.+4Q%1E0Z(#!P=#L@
M34%21TE.+5))1TA4.B`P<'0[('1E>'0M86QI9VXZ(&IU<W1I9GD[(%1%6%0M
M24Y$14Y4.B`P<'0G/B`F;F)S<#L\+V1I=CX@/&1I=CX@/'1A8FQE('-T>6QE
M/3-$)T9/3E0M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R
M;VUA;B<@8V5L;'-P86-I;F<],T0P(&-E;&QP861D:6YG/3-$,"!W:61T:#TS
M1#$P,"4@86QI9VX],T1C96YT97(@8F]R9&5R/3-$,#X@/'1R('9A;&EG;CTS
M1'1O<#X@/'1D('-T>6QE/3-$)U=)1%1(.B`Q.7!T)SX@/&1I=B!S='EL93TS
M1"=&3TY4+5-)6D4Z(#$P<'0[($9/3E0M1D%-24Q9.B!4:6UE<R!.97<@4F]M
M86X[($1)4U!,05DZ(&EN;&EN92<^("9N8G-P.SPO9&EV/B`\+W1D/B`\=&0^
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M/B`\+W1D/B`\+W1R/B`\+W1A8FQE/B`\+V1I=CX@/"$M+45N9$9R86=M96YT
M+2T^/"]D:78^(#PO9&EV/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T
M<CX-"B`@("`@(#QT<B!C;&%S<STS1')E/@T*("`@("`@("`\=&0@8VQA<W,]
M,T1P;"!V86QI9VX],T1T;W`^3&]S<R!P97(@<VAA<F4\+W1D/@T*("`@("`@
M("`\=&0@8VQA<W,],T1T97AT/B<\(2TM1$]#5%E012!H=&UL(%!50DQ)0R`B
M+2\O5S-#+R]$5$0@6$A434P@,2XP(%1R86YS:71I;VYA;"\O14XB(")H='1P
M.B\O=W=W+G<S+F]R9R]44B]X:'1M;#$O1%1$+WAH=&UL,2UT<F%N<VET:6]N
M86PN9'1D(B`M+3X\9&EV/B`\9&EV/CPA+2U3=&%R=$9R86=M96YT+2T^(#QD
M:78@<W1Y;&4],T0G=&5X="UA;&EG;CH@8V5N=&5R)SX@/'1A8FQE('-T>6QE
M/3-$)T9/3E0M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R
M;VUA;B<@8V5L;'-P86-I;F<],T0P(&-E;&QP861D:6YG/3-$,"!W:61T:#TS
M1#$P,"4@8F]R9&5R/3-$,#X@/'1R('9A;&EG;CTS1'1O<#X@/'1D('-T>6QE
M/3-$)U=)1%1(.B`Q.'!T)SX@/&1I=B!S='EL93TS1"=$25-03$%9.B!I;FQI
M;F4[($9/3E0M1D%-24Q9.B!T:6UE<R!N97<@<F]M86X[($9/3E0M4TE:13H@
M,3!P=#L@1D].5"U714E'2%0Z(&)O;&0[($U!4D=)3BU,1494.B`P<'0[($U!
M4D=)3BU224=(5#H@,'!T.R!415A4+4E.1$5.5#H@,'!T)SX@;BX\+V1I=CX@
M/"]T9#X@/'1D/B`\9&EV('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].
M5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T.R!&
M3TY4+5=%24=(5#H@8F]L9#L@=&5X="UA;&EG;CH@:G5S=&EF>2<^($QO<W,@
M<&5R('-H87)E/"]D:78^(#PO=&0^(#PO='(^(#PO=&%B;&4^(#PO9&EV/B`\
M9&EV('-T>6QE/3-$)T1)4U!,05DZ(&)L;V-K.R!-05)'24XM3$5&5#H@,'!T
M.R!-05)'24XM4DE'2%0Z(#!P=#L@=&5X="UA;&EG;CH@:G5S=&EF>3L@5$58
M5"U)3D1%3E0Z(#!P="<^("9N8G-P.SPO9&EV/B`\9&EV/B`\=&%B;&4@<W1Y
M;&4],T0G1D].5"U325I%.B`Q,'!T.R!&3TY4+49!34E,63H@=&EM97,@;F5W
M(')O;6%N)R!C96QL<W!A8VEN9STS1#`@8V5L;'!A9&1I;F<],T0P('=I9'1H
M/3-$,3`P)2!A;&EG;CTS1&-E;G1E<B!B;W)D97(],T0P/B`\='(@=F%L:6=N
M/3-$=&]P/B`\=&0@<W1Y;&4],T0G5TE$5$@Z(#$Y<'0G/B`\9&EV('-T>6QE
M/3-$)T9/3E0M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ(%1I;65S($YE=R!2
M;VUA;CL@1$E34$Q!63H@:6YL:6YE)SX@)FYB<W`[/"]D:78^(#PO=&0^(#QT
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M('!E<FEO9',@<')E<V5N=&5D+CPO9&EV/B`\+W1D/B`\+W1R/B`\+W1A8FQE
M/B`\+V1I=CX@/"$M+45N9$9R86=M96YT+2T^/"]D:78^(#PO9&EV/CQS<&%N
M/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS
M1')O/@T*("`@("`@("`\=&0@8VQA<W,],T1P;"!V86QI9VX],T1T;W`^26YC
M;VUE('1A>&5S/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/"$M
M+41/0U194$4@:'1M;"!054),24,@(BTO+U<S0R\O1%1$(%A(5$U,(#$N,"!4
M<F%N<VET:6]N86PO+T5.(B`B:'1T<#HO+W=W=RYW,RYO<F<O5%(O>&AT;6PQ
M+T141"]X:'1M;#$M=')A;G-I=&EO;F%L+F1T9"(@+2T^/&1I=CX@/&1I=CX\
M(2TM4W1A<G1&<F%G;65N="TM/B`\9&EV('-T>6QE/3-$)W1E>'0M86QI9VXZ
M(&-E;G1E<B<^(#QT86)L92!S='EL93TS1"=&3TY4+5-)6D4Z(#$P<'0[($9/
M3E0M1D%-24Q9.B!T:6UE<R!N97<@<F]M86XG(&-E;&QS<&%C:6YG/3-$,"!C
M96QL<&%D9&EN9STS1#`@=VED=&@],T0Q,#`E(&)O<F1E<CTS1#`^(#QT<B!V
M86QI9VX],T1T;W`^(#QT9"!S='EL93TS1"=724142#H@,3AP="<^(#QD:78@
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M8VL[($U!4D=)3BU,1494.B`P<'0[($U!4D=)3BU224=(5#H@,'!T.R!T97AT
M+6%L:6=N.B!J=7-T:69Y.R!415A4+4E.1$5.5#H@,'!T)SX@)FYB<W`[/"]D
M:78^(#QD:78^(#QT86)L92!S='EL93TS1"=&3TY4+5-)6D4Z(#$P<'0[($9/
M3E0M1D%-24Q9.B!T:6UE<R!N97<@<F]M86XG(&-E;&QS<&%C:6YG/3-$,"!C
M96QL<&%D9&EN9STS1#`@=VED=&@],T0Q,#`E(&%L:6=N/3-$8V5N=&5R(&)O
M<F1E<CTS1#`^(#QT<B!V86QI9VX],T1T;W`^(#QT9"!S='EL93TS1"=72414
M2#H@,3EP="<^(#QD:78@<W1Y;&4],T0G1D].5"U325I%.B`Q,'!T.R!&3TY4
M+49!34E,63H@5&EM97,@3F5W(%)O;6%N.R!$25-03$%9.B!I;FQI;F4G/B`F
M;F)S<#L\+V1I=CX@/"]T9#X@/'1D/B`\9&EV('-T>6QE/3-$)T1)4U!,05DZ
M(&EN;&EN93L@1D].5"U&04U)3%DZ(%1I;65S($YE=R!2;VUA;CL@1D].5"U3
M25I%.B`Q,'!T.R!T97AT+6%L:6=N.B!J=7-T:69Y)SX@5&AE($-O;7!A;GD@
M86-C;W5N=',@9F]R(&EN8V]M92!T87AE<R!I;B!A8V-O<F1A;F-E('=I=&@@
M05-#(#<T,"P@(DEN8V]M92!487AE<R(N(%1H:7,@5&]P:6,@<')E<V-R:6)E
M<R!T:&4@=7-E(&]F('1H92!L:6%B:6QI='D@;65T:&]D+"!W:&5R96)Y(&1E
M9F5R<F5D('1A>"!A<W-E=',@86YD(&QI86)I;&ET>2!A8V-O=6YT(&)A;&%N
M8V5S(&%R92!D971E<FUI;F5D(&)A<V5D(&]N(&1I9F9E<F5N8V5S(&)E='=E
M96X@9FEN86YC:6%L(')E<&]R=&EN9R!A;F0@=&%X(&)A<V5S(&]F(&%S<V5T
M<R!A;F0@;&EA8FEL:71I97,@86YD(&%R92!M96%S=7)E9"!U<VEN9R!T:&4@
M96YA8W1E9"!T87@@<F%T97,@86YD(&QA=W,@=&AA="!W:6QL(&)E(&EN(&5F
M9F5C="!W:&5N('1H92!D:69F97)E;F-E<R!A<F4@97AP96-T960@=&\@<F5V
M97)S92X@5&AE($-O;7!A;GD@<')O=FED97,@82!V86QU871I;VX@86QL;W=A
M;F-E+"!I9B!N96-E<W-A<GDL('1O(')E9'5C92!D969E<G)E9"!T87@@87-S
M971S('1O('1H96ER(&5S=&EM871E9"!R96%L:7IA8FQE('9A;'5E+CPO9&EV
M/B`\+W1D/B`\+W1R/B`\+W1A8FQE/B`\+V1I=CX@/&1I=B!S='EL93TS1"=$
M25-03$%9.B!B;&]C:SL@34%21TE.+4Q%1E0Z(#!P=#L@34%21TE.+5))1TA4
M.B`P<'0[('1E>'0M86QI9VXZ(&IU<W1I9GD[(%1%6%0M24Y$14Y4.B`P<'0G
M/B`F;F)S<#L\+V1I=CX@/&1I=CX@/'1A8FQE('-T>6QE/3-$)T9/3E0M4TE:
M13H@,3!P=#L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;B<@8V5L;'-P
M86-I;F<],T0P(&-E;&QP861D:6YG/3-$,"!W:61T:#TS1#$P,"4@86QI9VX]
M,T1C96YT97(@8F]R9&5R/3-$,#X@/'1R('9A;&EG;CTS1'1O<#X@/'1D('-T
M>6QE/3-$)U=)1%1(.B`Q.7!T)SX@/&1I=B!S='EL93TS1"=&3TY4+5-)6D4Z
M(#$P<'0[($9/3E0M1D%-24Q9.B!4:6UE<R!.97<@4F]M86X[($1)4U!,05DZ
M(&EN;&EN92<^("9N8G-P.SPO9&EV/B`\+W1D/B`\=&0^(#QD:78@<W1Y;&4]
M,T0G1$E34$Q!63H@:6YL:6YE.R!&3TY4+49!34E,63H@5&EM97,@3F5W(%)O
M;6%N.R!&3TY4+5-)6D4Z(#$P<'0[('1E>'0M86QI9VXZ(&IU<W1I9GDG/B!!
M4T,@-S0P(&5S=&%B;&ES:&5S(&$@<VEN9VQE(&UO9&5L('1O(&%D9')E<W,@
M86-C;W5N=&EN9R!F;W(@=6YC97)T86EN('1A>"!P;W-I=&EO;G,N($%30R`W
M-#`@8VQA<FEF:65D('1H92!A8V-O=6YT:6YG(&9O<B!I;F-O;64@=&%X97,@
M8GD@<')E<V-R:6)I;F<@=&AE(&UI;FEM=6T@<F5C;V=N:71I;VX@=&AR97-H
M;VQD(&$@=&%X('!O<VET:6]N(&ES(')E<75I<F5D('1O(&UE970@8F5F;W)E
M(&)E:6YG(')E8V]G;FEZ960@:6X@=&AE(&9I;F%N8VEA;"!S=&%T96UE;G1S
M+CPO9&EV/B`\+W1D/B`\+W1R/B`\+W1A8FQE/B`\+V1I=CX@/"$M+45N9$9R
M86=M96YT+2T^/"]D:78^(#PO9&EV/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@
M("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS1')E/@T*("`@("`@("`\=&0@
M8VQA<W,],T1P;"!V86QI9VX],T1T;W`^0V]N8V5N=')A=&EO;B!O9B!C<F5D
M:70@<FES:SPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SPA+2U$
M3T-465!%(&AT;6P@4%5"3$E#("(M+R]7,T,O+T141"!82%1-3"`Q+C`@5')A
M;G-I=&EO;F%L+R]%3B(@(FAT='`Z+R]W=W<N=S,N;W)G+U12+WAH=&UL,2]$
M5$0O>&AT;6PQ+71R86YS:71I;VYA;"YD=&0B("TM/CQD:78^(#QD:78^/"$M
M+5-T87)T1G)A9VUE;G0M+3X@/&1I=B!S='EL93TS1"=T97AT+6%L:6=N.B!C
M96YT97(G/B`\=&%B;&4@<W1Y;&4],T0G1D].5"U325I%.B`Q,'!T.R!&3TY4
M+49!34E,63H@=&EM97,@;F5W(')O;6%N)R!C96QL<W!A8VEN9STS1#`@8V5L
M;'!A9&1I;F<],T0P('=I9'1H/3-$,3`P)2!B;W)D97(],T0P/B`\='(@=F%L
M:6=N/3-$=&]P/B`\=&0@<W1Y;&4],T0G5TE$5$@Z(#$X<'0G/B`\9&EV('-T
M>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE
M=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T.R!&3TY4+5=%24=(5#H@8F]L9#L@
M34%21TE.+4Q%1E0Z(#!P=#L@34%21TE.+5))1TA4.B`P<'0[(%1%6%0M24Y$
M14Y4.B`P<'0G/B!P+CPO9&EV/B`\+W1D/B`\=&0^(#QD:78@<W1Y;&4],T0G
M1$E34$Q!63H@:6YL:6YE.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N
M.R!&3TY4+5-)6D4Z(#$P<'0[($9/3E0M5T5)1TA4.B!B;VQD.R!T97AT+6%L
M:6=N.B!J=7-T:69Y)SX@0V]N8V5N=')A=&EO;B!O9B!C<F5D:70@<FES:SPO
M9&EV/B`\+W1D/B`\+W1R/B`\+W1A8FQE/B`\+V1I=CX@/&1I=B!S='EL93TS
M1"=$25-03$%9.B!B;&]C:SL@34%21TE.+4Q%1E0Z(#!P=#L@34%21TE.+5))
M1TA4.B`P<'0[('1E>'0M86QI9VXZ(&IU<W1I9GD[(%1%6%0M24Y$14Y4.B`P
M<'0G/B`F;F)S<#L\+V1I=CX@/&1I=CX@/'1A8FQE('-T>6QE/3-$)T9/3E0M
M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;B<@8V5L
M;'-P86-I;F<],T0P(&-E;&QP861D:6YG/3-$,"!W:61T:#TS1#$P,"4@86QI
M9VX],T1C96YT97(@8F]R9&5R/3-$,#X@/'1R('9A;&EG;CTS1'1O<#X@/'1D
M('-T>6QE/3-$)U=)1%1(.B`Q.7!T)SX@/&1I=B!S='EL93TS1"=&3TY4+5-)
M6D4Z(#$P<'0[($9/3E0M1D%-24Q9.B!4:6UE<R!.97<@4F]M86X[($1)4U!,
M05DZ(&EN;&EN92<^("9N8G-P.SPO9&EV/B`\+W1D/B`\=&0^(#QD:78@<W1Y
M;&4],T0G1$E34$Q!63H@:6YL:6YE.R!&3TY4+49!34E,63H@5&EM97,@3F5W
M(%)O;6%N.R!&3TY4+5-)6D4Z(#$P<'0[('1E>'0M86QI9VXZ(&IU<W1I9GDG
M/B!&:6YA;F-I86P@:6YS=')U;65N=',@=&AA="!P;W1E;G1I86QL>2!S=6)J
M96-T('1H92!#;VUP86YY('1O(&-O;F-E;G1R871I;VYS(&]F(&-R961I="!R
M:7-K(&-O;G-I<W0@<')I;F-I<&%L;'D@;V8@8V%S:"!A;F0@8V%S:"!E<75I
M=F%L96YT<RP@<VAO<G0M=&5R;2!D97!O<VET<RP@;&]N9RUT97)M(&1E<&]S
M:71S+"!R97-T<FEC=&5D(&1E<&]S:71S(&%N9"!M87)K971A8FQE('-E8W5R
M:71I97,N/"]D:78^(#PO=&0^(#PO='(^(#PO=&%B;&4^(#PO9&EV/B`\9&EV
M('-T>6QE/3-$)T1)4U!,05DZ(&)L;V-K.R!-05)'24XM3$5&5#H@,'!T.R!-
M05)'24XM4DE'2%0Z(#!P=#L@=&5X="UA;&EG;CH@:G5S=&EF>3L@5$585"U)
M3D1%3E0Z(#!P="<^("9N8G-P.SPO9&EV/B`\9&EV/B`\=&%B;&4@<W1Y;&4]
M,T0G1D].5"U325I%.B`Q,'!T.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O
M;6%N)R!C96QL<W!A8VEN9STS1#`@8V5L;'!A9&1I;F<],T0P('=I9'1H/3-$
M,3`P)2!A;&EG;CTS1&-E;G1E<B!B;W)D97(],T0P/B`\='(@=F%L:6=N/3-$
M=&]P/B`\=&0@<W1Y;&4],T0G5TE$5$@Z(#$Y<'0G/B`\9&EV('-T>6QE/3-$
M)T9/3E0M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ(%1I;65S($YE=R!2;VUA
M;CL@1$E34$Q!63H@:6YL:6YE)SX@)FYB<W`[/"]D:78^(#PO=&0^(#QT9#X@
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M='(^(#PO=&%B;&4^(#PO9&EV/B`\9&EV('-T>6QE/3-$)T1)4U!,05DZ(&)L
M;V-K.R!-05)'24XM3$5&5#H@,'!T.R!-05)'24XM4DE'2%0Z(#!P=#L@=&5X
M="UA;&EG;CH@:G5S=&EF>3L@5$585"U)3D1%3E0Z(#!P="<^("9N8G-P.SPO
M9&EV/B`\9&EV/B`\=&%B;&4@<W1Y;&4],T0G1D].5"U325I%.B`Q,'!T.R!&
M3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N)R!C96QL<W!A8VEN9STS1#`@
M8V5L;'!A9&1I;F<],T0P('=I9'1H/3-$,3`P)2!A;&EG;CTS1&-E;G1E<B!B
M;W)D97(],T0P/B`\='(@=F%L:6=N/3-$=&]P/B`\=&0@<W1Y;&4],T0G5TE$
M5$@Z(#$X<'0G/B`\9&EV('-T>6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@1D].
M5"U&04U)3%DZ(%1I;65S($YE=R!2;VUA;CL@1$E34$Q!63H@:6YL:6YE)SX@
M)FYB<W`[/"]D:78^(#PO=&0^(#QT9#X@/&1I=B!S='EL93TS1"=$25-03$%9
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M;G1S+CPO9&EV/B`\+W1D/B`\+W1R/B`\+W1A8FQE/B`\+V1I=CX@/&1I=B!S
M='EL93TS1"=$25-03$%9.B!B;&]C:SL@34%21TE.+4Q%1E0Z(#!P=#L@34%2
M1TE.+5))1TA4.B`P<'0[('1E>'0M86QI9VXZ(&IU<W1I9GD[(%1%6%0M24Y$
M14Y4.B`P<'0G/B`F;F)S<#L\+V1I=CX@/&1I=CX@/'1A8FQE('-T>6QE/3-$
M)T9/3E0M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA
M;B<@8V5L;'-P86-I;F<],T0P(&-E;&QP861D:6YG/3-$,"!W:61T:#TS1#$P
M,"4@86QI9VX],T1C96YT97(@8F]R9&5R/3-$,#X@/'1R('9A;&EG;CTS1'1O
M<#X@/'1D('-T>6QE/3-$)U=)1%1(.B`Q.'!T)SX@/&1I=B!S='EL93TS1"=&
M3TY4+5-)6D4Z(#$P<'0[($9/3E0M1D%-24Q9.B!4:6UE<R!.97<@4F]M86X[
M($1)4U!,05DZ(&EN;&EN92<^("9N8G-P.SPO9&EV/B`\+W1D/B`\=&0^(#QD
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M;F=L>2P@87,@;V8@2G5N929N8G-P.S,P+"`R,#$T+"!T:&4@0V]M<&%N>2!B
M96QI979E<R!T:&4@;&]S<V5S(&%S<V]C:6%T960@=VET:"!I=',@:6YV97-T
M;65N=',@87)E('1E;7!O<F%R>2!A;F0@;F\@:6UP86ER;65N="!L;W-S('=A
M<R!R96-O9VYI>F5D(&1U<FEN9R`R,#$T+B!(;W=E=F5R+"!T:&4@0V]M<&%N
M>2!C86X@<')O=FED92!N;R!A<W-U<F%N8V4@=&AA="!I="!W:6QL(')E8V]V
M97(@9&5C;&EN97,@:6X@=&AE(&UA<FME="!V86QU92!O9B!I=',@:6YV97-T
M;65N=',N/"]D:78^(#PO=&0^(#PO='(^(#PO=&%B;&4^(#PO9&EV/B`\(2TM
M16YD1G)A9VUE;G0M+3X\+V1I=CX@/"]D:78^/'-P86X^/"]S<&%N/CPO=&0^
M#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$<F\^#0H@("`@("`@
M(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O<#Y3979E<F%N8V4@<&%Y/"]T
M9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/"$M+41/0U194$4@:'1M
M;"!054),24,@(BTO+U<S0R\O1%1$(%A(5$U,(#$N,"!4<F%N<VET:6]N86PO
M+T5.(B`B:'1T<#HO+W=W=RYW,RYO<F<O5%(O>&AT;6PQ+T141"]X:'1M;#$M
M=')A;G-I=&EO;F%L+F1T9"(@+2T^/&1I=CX@/&1I=CX\(2TM4W1A<G1&<F%G
M;65N="TM/B`\9&EV('-T>6QE/3-$)W1E>'0M86QI9VXZ(&-E;G1E<B<^(#QT
M86)L92!S='EL93TS1"=&3TY4+5-)6D4Z(#$P<'0[($9/3E0M1D%-24Q9.B!T
M:6UE<R!N97<@<F]M86XG(&-E;&QS<&%C:6YG/3-$,"!C96QL<&%D9&EN9STS
M1#`@=VED=&@],T0Q,#`E(&)O<F1E<CTS1#`^(#QT<B!V86QI9VX],T1T;W`^
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M(#PO9&EV/B`\9&EV('-T>6QE/3-$)T1)4U!,05DZ(&)L;V-K.R!-05)'24XM
M3$5&5#H@,'!T.R!-05)'24XM4DE'2%0Z(#!P=#L@=&5X="UA;&EG;CH@:G5S
M=&EF>3L@5$585"U)3D1%3E0Z(#!P="<^("9N8G-P.SPO9&EV/B`\9&EV/B`\
M=&%B;&4@<W1Y;&4],T0G1D].5"U325I%.B`Q,'!T.R!&3TY4+49!34E,63H@
M=&EM97,@;F5W(')O;6%N)R!C96QL<W!A8VEN9STS1#`@8V5L;'!A9&1I;F<]
M,T0P('=I9'1H/3-$,3`P)2!A;&EG;CTS1&-E;G1E<B!B;W)D97(],T0P/B`\
M='(@=F%L:6=N/3-$=&]P/B`\=&0@<W1Y;&4],T0G5TE$5$@Z(#$Y<'0G/B`\
M9&EV('-T>6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ(%1I
M;65S($YE=R!2;VUA;CL@1$E34$Q!63H@:6YL:6YE)SX@)FYB<W`[/"]D:78^
M(#PO=&0^(#QT9#X@/&1I=B!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/
M3E0M1D%-24Q9.B!4:6UE<R!.97<@4F]M86X[($9/3E0M4TE:13H@,3!P=#L@
M=&5X="UA;&EG;CH@:G5S=&EF>2<^(%1H92!3=6)S:61I87)Y)B,S.3MS(&QI
M86)I;&ET>2!F;W(@<V5V97)A;F-E('!A>2!I<R!C86QC=6QA=&5D('!U<G-U
M86YT('1O($ES<F%E;&D@4V5V97)A;F-E(%!A>2!,87<L(#$Y-C,@*'1H92`B
M4V5V97)A;F-E(%!A>2!,87<B*29N8G-P.R9N8G-P.V)A<V5D(&]N('1H92!M
M;W-T(')E8V5N="!S86QA<GD@;V8@=&AE(&5M<&QO>65E<R!M=6QT:7!L:65D
M(&)Y('1H92!N=6UB97(@;V8@>65A<G,@;V8@96UP;&]Y;65N="P@87,@;V8@
M=&AE(&)A;&%N8V4@<VAE970@9&%T92X@16UP;&]Y965S(&%R92!E;G1I=&QE
M9"!T;R!O;F4@;6]N=&@F(S,Y.W,@<V%L87)Y(&9O<B!E86-H('EE87(@;V8@
M96UP;&]Y;65N="!O<B!A('!O<G1I;VX@=&AE<F5O9BX\+V1I=CX@/&1I=B!S
M='EL93TS1"=T97AT+6%L:6=N.B!J=7-T:69Y)SXF;F)S<#L\+V1I=CX@/&1I
M=B!S='EL93TS1"=$25-03$%9.B!B;&]C:SL@1D].5"U&04U)3%DZ(%1I;65S
M($YE=R!2;VUA;CL@1D].5"U325I%.B`Q,'!T.R!-05)'24XM3$5&5#H@,'!T
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M(#PO='(^(#PO=&%B;&4^(#PO9&EV/B`\9&EV('-T>6QE/3-$)T1)4U!,05DZ
M(&)L;V-K.R!-05)'24XM3$5&5#H@,'!T.R!-05)'24XM4DE'2%0Z(#!P=#L@
M=&5X="UA;&EG;CH@:G5S=&EF>3L@5$585"U)3D1%3E0Z(#!P="<^("9N8G-P
M.SPO9&EV/B`\9&EV/B`\=&%B;&4@<W1Y;&4],T0G1D].5"U325I%.B`Q,'!T
M.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N)R!C96QL<W!A8VEN9STS
M1#`@8V5L;'!A9&1I;F<],T0P('=I9'1H/3-$,3`P)2!A;&EG;CTS1&-E;G1E
M<B!B;W)D97(],T0P/B`\='(@=F%L:6=N/3-$=&]P/B`\=&0@<W1Y;&4],T0G
M5TE$5$@Z(#$Y<'0G/B`\9&EV('-T>6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@
M1D].5"U&04U)3%DZ(%1I;65S($YE=R!2;VUA;CL@1$E34$Q!63H@:6YL:6YE
M)SX@)FYB<W`[/"]D:78^(#PO=&0^(#QT9#X@/&1I=B!S='EL93TS1"=$25-0
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M4$Q!63H@8FQO8VL[($U!4D=)3BU,1494.B`P<'0[($U!4D=)3BU224=(5#H@
M,'!T.R!T97AT+6%L:6=N.B!J=7-T:69Y.R!415A4+4E.1$5.5#H@,'!T)SX@
M)FYB<W`[/"]D:78^(#QD:78@<W1Y;&4],T0G1$E34$Q!63H@8FQO8VL[($9/
M3E0M1D%-24Q9.B!4:6UE<R!.97<@4F]M86X[($9/3E0M4TE:13H@,3!P=#L@
M34%21TE.+4Q%1E0Z(#$X<'0[($U!4D=)3BU224=(5#H@,'!T.R!T97AT+6%L
M:6=N.B!L969T.R!415A4+4E.1$5.5#H@,'!T)SX@4VEN8V4@3F]V96UB97(@
M,C`Q,2P@=&AE($-O;7!A;GDF(S,Y.W,@86=R965M96YT<R!W:71H(&YE=R!E
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M1494.B`P<'0[($U!4D=)3BU224=(5#H@,'!T.R!T97AT+6%L:6=N.B!J=7-T
M:69Y.R!415A4+4E.1$5.5#H@,'!T)SX@)FYB<W`[/"]D:78^(#QD:78^(#QT
M86)L92!S='EL93TS1"=&3TY4+5-)6D4Z(#$P<'0[($9/3E0M1D%-24Q9.B!T
M:6UE<R!N97<@<F]M86XG(&-E;&QS<&%C:6YG/3-$,"!C96QL<&%D9&EN9STS
M1#`@=VED=&@],T0Q,#`E(&%L:6=N/3-$8V5N=&5R(&)O<F1E<CTS1#`^(#QT
M<B!V86QI9VX],T1T;W`^(#QT9"!S='EL93TS1"=724142#H@,3EP="<^(#QD
M:78@<W1Y;&4],T0G1D].5"U325I%.B`Q,'!T.R!&3TY4+49!34E,63H@5&EM
M97,@3F5W(%)O;6%N.R!$25-03$%9.B!I;FQI;F4G/B`F;F)S<#L\+V1I=CX@
M/"]T9#X@/'1D/B`\9&EV('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].
M5"U&04U)3%DZ(%1I;65S($YE=R!2;VUA;CL@1D].5"U325I%.B`Q,'!T.R!T
M97AT+6%L:6=N.B!J=7-T:69Y)SX@4V5V97)A;F-E(&5X<&5N<V5S(&9O<B!T
M:&4@>65A<G,@96YD960@1&5C96UB97(@,S$L(#(P,30L(#(P,3,@86YD(#(P
M,3(L('=E<F4@)#4S-"P@)#,R.2!A;F0@)#(W-2P@<F5S<&5C=&EV96QY+CPO
M9&EV/B`\+W1D/B`\+W1R/B`\+W1A8FQE/B`\+V1I=CX@/"$M+45N9$9R86=M
M96YT+2T^/"]D:78^(#PO9&EV/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@
M/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS1')E/@T*("`@("`@("`\=&0@8VQA
M<W,],T1P;"!V86QI9VX],T1T;W`^1F%I<B!V86QU92!O9B!F:6YA;F-I86P@
M:6YS=')U;65N=',\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\
M(2TM1$]#5%E012!H=&UL(%!50DQ)0R`B+2\O5S-#+R]$5$0@6$A434P@,2XP
M(%1R86YS:71I;VYA;"\O14XB(")H='1P.B\O=W=W+G<S+F]R9R]44B]X:'1M
M;#$O1%1$+WAH=&UL,2UT<F%N<VET:6]N86PN9'1D(B`M+3X\9&EV/B`\9&EV
M/CPA+2U3=&%R=$9R86=M96YT+2T^(#QD:78@<W1Y;&4],T0G=&5X="UA;&EG
M;CH@8V5N=&5R)SX@/'1A8FQE('-T>6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@
M1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;B<@8V5L;'-P86-I;F<],T0P
M(&-E;&QP861D:6YG/3-$,"!W:61T:#TS1#$P,"4@8F]R9&5R/3-$,#X@/'1R
M('9A;&EG;CTS1'1O<#X@/'1D('-T>6QE/3-$)U=)1%1(.B`Q.'!T)SX@/&1I
M=B!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE
M<R!N97<@<F]M86X[($9/3E0M4TE:13H@,3!P=#L@1D].5"U714E'2%0Z(&)O
M;&0[($U!4D=)3BU,1494.B`P<'0[($U!4D=)3BU224=(5#H@,'!T.R!415A4
M+4E.1$5.5#H@,'!T)SX@<BX\+V1I=CX@/"]T9#X@/'1D/B`\9&EV('-T>6QE
M/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R
M;VUA;CL@1D].5"U325I%.B`Q,'!T.R!&3TY4+5=%24=(5#H@8F]L9#L@=&5X
M="UA;&EG;CH@:G5S=&EF>2<^($9A:7(@=F%L=64@;V8@9FEN86YC:6%L(&EN
M<W1R=6UE;G1S/"]D:78^(#PO=&0^(#PO='(^(#PO=&%B;&4^(#PO9&EV/B`\
M9&EV('-T>6QE/3-$)T1)4U!,05DZ(&)L;V-K.R!-05)'24XM3$5&5#H@,'!T
M.R!-05)'24XM4DE'2%0Z(#!P=#L@=&5X="UA;&EG;CH@:G5S=&EF>3L@5$58
M5"U)3D1%3E0Z(#!P="<^("9N8G-P.SPO9&EV/B`\9&EV/B`\=&%B;&4@<W1Y
M;&4],T0G1D].5"U325I%.B`Q,'!T.R!&3TY4+49!34E,63H@=&EM97,@;F5W
M(')O;6%N)R!C96QL<W!A8VEN9STS1#`@8V5L;'!A9&1I;F<],T0P('=I9'1H
M/3-$,3`P)2!A;&EG;CTS1&-E;G1E<B!B;W)D97(],T0P/B`\='(@=F%L:6=N
M/3-$=&]P/B`\=&0@<W1Y;&4],T0G5TE$5$@Z(#$Y<'0G/B`\9&EV('-T>6QE
M/3-$)T9/3E0M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ(%1I;65S($YE=R!2
M;VUA;CL@1$E34$Q!63H@:6YL:6YE)SX@)FYB<W`[/"]D:78^(#PO=&0^(#QT
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M=&%B;&4^(#PO9&EV/B`\9&EV('-T>6QE/3-$)T1)4U!,05DZ(&)L;V-K.R!-
M05)'24XM3$5&5#H@,'!T.R!-05)'24XM4DE'2%0Z(#!P=#L@=&5X="UA;&EG
M;CH@:G5S=&EF>3L@5$585"U)3D1%3E0Z(#!P="<^("9N8G-P.SPO9&EV/B`\
M9&EV/B`\=&%B;&4@<W1Y;&4],T0G1D].5"U325I%.B`Q,'!T.R!&3TY4+49!
M34E,63H@=&EM97,@;F5W(')O;6%N)R!C96QL<W!A8VEN9STS1#`@8V5L;'!A
M9&1I;F<],T0P('=I9'1H/3-$,3`P)2!A;&EG;CTS1&-E;G1E<B!B;W)D97(]
M,T0P/B`\='(@=F%L:6=N/3-$=&]P/B`\=&0@<W1Y;&4],T0G5TE$5$@Z(#$Y
M<'0G/B`\9&EV('-T>6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@1D].5"U&04U)
M3%DZ(%1I;65S($YE=R!2;VUA;CL@1$E34$Q!63H@:6YL:6YE)SX@)FYB<W`[
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M<B!!4T,@.#(P+"`B1F%I<B!686QU92!-96%S=7)E;65N=',@86YD($1I<V-L
M;W-U<F5S(B`H(D%30R`X,C`B*2X@1F%I<B!V86QU92!I<R!A;B!E>&ET('!R
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M9R!F86ER('9A;'5E.CPO9&EV/B`\+W1D/B`\+W1R/B`\+W1A8FQE/B`\+V1I
M=CX@/&1I=B!S='EL93TS1"=$25-03$%9.B!B;&]C:SL@34%21TE.+4Q%1E0Z
M(#!P=#L@34%21TE.+5))1TA4.B`P<'0[('1E>'0M86QI9VXZ(&IU<W1I9GD[
M(%1%6%0M24Y$14Y4.B`P<'0G/B`F;F)S<#L\+V1I=CX@/&1I=CX@/'1A8FQE
M('-T>6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ('1I;65S
M(&YE=R!R;VUA;B<@8V5L;'-P86-I;F<],T0P(&-E;&QP861D:6YG/3-$,"!W
M:61T:#TS1#$P,"4@86QI9VX],T1C96YT97(@8F]R9&5R/3-$,#X@/'1R('9A
M;&EG;CTS1'1O<#X@/'1D('-T>6QE/3-$)U=)1%1(.B`Q.7!T)SX@/&1I=B!S
M='EL93TS1"=&3TY4+5-)6D4Z(#$P<'0[($9/3E0M1D%-24Q9.B!4:6UE<R!.
M97<@4F]M86X[($1)4U!,05DZ(&EN;&EN92<^("9N8G-P.SPO9&EV/B`\+W1D
M/B`\=&0^(#QD:78@<W1Y;&4],T0G1$E34$Q!63H@:6YL:6YE.R!&3TY4+49!
M34E,63H@5&EM97,@3F5W(%)O;6%N.R!&3TY4+5-)6D4Z(#$P<'0[('1E>'0M
M86QI9VXZ(&IU<W1I9GDG/B`\9F]N="!S='EL93TS1"=&3TY4+5=%24=(5#H@
M8F]L9#L@1$E34$Q!63H@:6YL:6YE)SY,979E;"`Q("T\+V9O;G0^(%%U;W1E
M9"!P<FEC97,@*'5N861J=7-T960I(&EN(&%C=&EV92!M87)K971S(&9O<B!I
M9&5N=&EC86P@87-S971S(&]R(&QI86)I;&ET:65S('1H870@=&AE($-O;7!A
M;GD@8V%N(&%C8V5S<R!A="!T:&4@;65A<W5R96UE;G0@9&%T93L\+V1I=CX@
M/"]T9#X@/"]T<CX@/"]T86)L93X@/"]D:78^(#QD:78@<W1Y;&4],T0G1$E3
M4$Q!63H@8FQO8VL[($U!4D=)3BU,1494.B`P<'0[($U!4D=)3BU224=(5#H@
M,'!T.R!T97AT+6%L:6=N.B!J=7-T:69Y.R!415A4+4E.1$5.5#H@,'!T)SX@
M)FYB<W`[/"]D:78^(#QD:78^(#QT86)L92!S='EL93TS1"=&3TY4+5-)6D4Z
M(#$P<'0[($9/3E0M1D%-24Q9.B!T:6UE<R!N97<@<F]M86XG(&-E;&QS<&%C
M:6YG/3-$,"!C96QL<&%D9&EN9STS1#`@=VED=&@],T0Q,#`E(&%L:6=N/3-$
M8V5N=&5R(&)O<F1E<CTS1#`^(#QT<B!V86QI9VX],T1T;W`^(#QT9"!S='EL
M93TS1"=724142#H@,3EP="<^(#QD:78@<W1Y;&4],T0G1D].5"U325I%.B`Q
M,'!T.R!&3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N.R!$25-03$%9.B!I
M;FQI;F4G/B`F;F)S<#L\+V1I=CX@/"]T9#X@/'1D/B`\9&EV('-T>6QE/3-$
M)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ(%1I;65S($YE=R!2;VUA
M;CL@1D].5"U325I%.B`Q,'!T.R!T97AT+6%L:6=N.B!J=7-T:69Y)SX@/&9O
M;G0@<W1Y;&4],T0G1D].5"U714E'2%0Z(&)O;&0[($1)4U!,05DZ(&EN;&EN
M92<^3&5V96P@,B`M/"]F;VYT/B!);G!U=',@;W1H97(@=&AA;B!Q=6]T960@
M<')I8V5S(&EN8VQU9&5D('=I=&AI;B!,979E;"`Q('1H870@87)E(&]B<V5R
M=F%B;&4@9F]R('1H92!A<W-E="!O<B!L:6%B:6QI='DL(&5I=&AE<B!D:7)E
M8W1L>2!O<B!I;F1I<F5C=&QY+CL@86YD/"]D:78^(#PO=&0^(#PO='(^(#PO
M=&%B;&4^(#PO9&EV/B`\9&EV('-T>6QE/3-$)T1)4U!,05DZ(&)L;V-K.R!-
M05)'24XM3$5&5#H@,'!T.R!-05)'24XM4DE'2%0Z(#!P=#L@=&5X="UA;&EG
M;CH@:G5S=&EF>3L@5$585"U)3D1%3E0Z(#!P="<^("9N8G-P.SPO9&EV/B`\
M9&EV/B`\=&%B;&4@<W1Y;&4],T0G1D].5"U325I%.B`Q,'!T.R!&3TY4+49!
M34E,63H@=&EM97,@;F5W(')O;6%N)R!C96QL<W!A8VEN9STS1#`@8V5L;'!A
M9&1I;F<],T0P('=I9'1H/3-$,3`P)2!A;&EG;CTS1&-E;G1E<B!B;W)D97(]
M,T0P/B`\='(@=F%L:6=N/3-$=&]P/B`\=&0@<W1Y;&4],T0G5TE$5$@Z(#$Y
M<'0G/B`\9&EV('-T>6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@1D].5"U&04U)
M3%DZ(%1I;65S($YE=R!2;VUA;CL@1$E34$Q!63H@:6YL:6YE)SX@)FYB<W`[
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M:78@<W1Y;&4],T0G1$E34$Q!63H@8FQO8VL[($U!4D=)3BU,1494.B`P<'0[
M($U!4D=)3BU224=(5#H@,'!T.R!T97AT+6%L:6=N.B!J=7-T:69Y.R!415A4
M+4E.1$5.5#H@,'!T)SX@)FYB<W`[/"]D:78^(#QD:78^(#QT86)L92!S='EL
M93TS1"=&3TY4+5-)6D4Z(#$P<'0[($9/3E0M1D%-24Q9.B!T:6UE<R!N97<@
M<F]M86XG(&-E;&QS<&%C:6YG/3-$,"!C96QL<&%D9&EN9STS1#`@=VED=&@]
M,T0Q,#`E(&%L:6=N/3-$8V5N=&5R(&)O<F1E<CTS1#`^(#QT<B!V86QI9VX]
M,T1T;W`^(#QT9"!S='EL93TS1"=724142#H@,3EP="<^(#QD:78@<W1Y;&4]
M,T0G1D].5"U325I%.B`Q,'!T.R!&3TY4+49!34E,63H@5&EM97,@3F5W(%)O
M;6%N.R!$25-03$%9.B!I;FQI;F4G/B`F;F)S<#L\+V1I=CX@/"]T9#X@/'1D
M/B`\9&EV('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ
M(%1I;65S($YE=R!2;VUA;CL@1D].5"U325I%.B`Q,'!T.R!T97AT+6%L:6=N
M.B!J=7-T:69Y)SX@5&AE(&9A:7(@=F%L=64@:&EE<F%R8VAY(&%L<V\@<F5Q
M=6ER97,@86X@96YT:71Y('1O(&UA>&EM:7IE('1H92!U<V4@;V8@;V)S97)V
M86)L92!I;G!U=',@86YD(&UI;FEM:7IE('1H92!U<V4@;V8@=6YO8G-E<G9A
M8FQE(&EN<'5T<R!W:&5N(&UE87-U<FEN9R!F86ER('9A;'5E+B!4:&4@0V]M
M<&%N>2!C871E9V]R:7IE9"!E86-H(&]F(&ET<R!F86ER('9A;'5E(&UE87-U
M<F5M96YT<R!I;B!O;F4@;V8@=&AE<V4@=&AR964@;&5V96QS(&]F(&AI97)A
M<F-H>2X\+V1I=CX@/"]T9#X@/"]T<CX@/"]T86)L93X@/"]D:78^(#PA+2U%
M;F1&<F%G;65N="TM/CPO9&EV/B`\+V1I=CX\<W!A;CX\+W-P86X^/"]T9#X-
M"B`@("`@(#PO='(^#0H@("`@("`\='(@8VQA<W,],T1R;SX-"B`@("`@("`@
M/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P/D1E<FEV871I=F4@9FEN86YC
M:6%L(&EN<W1R=6UE;G1S/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X
M=#XG/"$M+41/0U194$4@:'1M;"!054),24,@(BTO+U<S0R\O1%1$(%A(5$U,
M(#$N,"!4<F%N<VET:6]N86PO+T5.(B`B:'1T<#HO+W=W=RYW,RYO<F<O5%(O
M>&AT;6PQ+T141"]X:'1M;#$M=')A;G-I=&EO;F%L+F1T9"(@+2T^/&1I=CX@
M/&1I=CX\(2TM4W1A<G1&<F%G;65N="TM/B`\9&EV('-T>6QE/3-$)W1E>'0M
M86QI9VXZ(&-E;G1E<B<^(#QT86)L92!S='EL93TS1"=&3TY4+5-)6D4Z(#$P
M<'0[($9/3E0M1D%-24Q9.B!T:6UE<R!N97<@<F]M86XG(&-E;&QS<&%C:6YG
M/3-$,"!C96QL<&%D9&EN9STS1#`@=VED=&@],T0Q,#`E(&)O<F1E<CTS1#`^
M(#QT<B!V86QI9VX],T1T;W`^(#QT9"!S='EL93TS1"=724142#H@,3AP="<^
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M;G-T<G5M96YT<SPO9&EV/B`\+W1D/B`\+W1R/B`\+W1A8FQE/B`\+V1I=CX@
M/&1I=B!S='EL93TS1"=$25-03$%9.B!B;&]C:SL@1D].5"U&04U)3%DZ(%1I
M;65S($YE=R!2;VUA;CL@1D].5"U325I%.B`Q,'!T.R!-05)'24XM3$5&5#H@
M,'!T.R!-05)'24XM4DE'2%0Z(#!P=#L@=&5X="UA;&EG;CH@:G5S=&EF>3L@
M5$585"U)3D1%3E0Z(#!P="<^("9N8G-P.SPO9&EV/B`\9&EV('-T>6QE/3-$
M)T1)4U!,05DZ(&)L;V-K.R!&3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N
M.R!&3TY4+5-)6D4Z(#$P<'0[($U!4D=)3BU,1494.B`Q.'!T.R!-05)'24XM
M4DE'2%0Z(#!P=#L@=&5X="UA;&EG;CH@:G5S=&EF>3L@5$585"U)3D1%3E0Z
M(#!P="<^(%1H92!#;VUP86YY('5S97,@9F]R=V%R9"!C;VYT<F%C=',@86YD
M(&]P=&EO;G,@<W1R871E9VEE<R`H(F1E<FEV871I=F4@:6YS=')U;65N=',B
M*2!P<FEM87)I;'D@=&\@;6%N86=E(&5X<&]S=7)E('1O(&9O<F5I9VX@8W5R
M<F5N8WDN(%1H92!#;VUP86YY(&%C8V]U;G1S(&9O<B!D97)I=F%T:79E<R!A
M;F0@:&5D9VEN9R!B87-E9"!O;B!!4T,@.#$U+"`B1&5R:79A=&EV97,@86YD
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M87)T(&]F(&$@:&5D9VEN9R!R96QA=&EO;G-H:7`@86YD(&9U<G1H97(L(&]N
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M970@:6YV97-T;65N="!I;B!A(&9O<F5I9VX@;W!E<F%T:6]N+CPO9&EV/B`\
M9&EV('-T>6QE/3-$)T1)4U!,05DZ(&)L;V-K.R!-05)'24XM3$5&5#H@,'!T
M.R!-05)'24XM4DE'2%0Z(#!P=#L@=&5X="UA;&EG;CH@:G5S=&EF>3L@5$58
M5"U)3D1%3E0Z(#!P="<^("9N8G-P.SPO9&EV/B`\9&EV('-T>6QE/3-$)T1)
M4U!,05DZ(&)L;V-K.R!&3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N.R!&
M3TY4+5-)6D4Z(#$P<'0[($U!4D=)3BU,1494.B`Q.'!T.R!-05)'24XM4DE'
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M=&EO;G,N/&9O;G0@<W1Y;&4],T0G1D].5"U325I%.B`Q,'!T.R!$25-03$%9
M.B!I;FQI;F4G/B9N8G-P.SPO9F]N=#X@5&AE(&EN969F96-T:79E('!O<G1I
M;VX@;V8@82!D97)I=F%T:79E)B,S.3MS(&-H86YG92!I;B!F86ER('9A;'5E
M(&ES(')E8V]G;FEZ960@:6X@=&AE('-T871E;65N="!O9B!O<&5R871I;VYS
M+CPO9&EV/B`\9&EV('-T>6QE/3-$)T1)4U!,05DZ(&)L;V-K.R!-05)'24XM
M3$5&5#H@,'!T.R!-05)'24XM4DE'2%0Z(#!P=#L@=&5X="UA;&EG;CH@:G5S
M=&EF>3L@5$585"U)3D1%3E0Z(#!P="<^("9N8G-P.SPO9&EV/B`\9&EV('-T
M>6QE/3-$)T1)4U!,05DZ(&)L;V-K.R!&3TY4+49!34E,63H@5&EM97,@3F5W
M(%)O;6%N.R!&3TY4+5-)6D4Z(#$P<'0[($U!4D=)3BU,1494.B`Q.'!T.R!-
M05)'24XM4DE'2%0Z(#!P=#L@=&5X="UA;&EG;CH@:G5S=&EF>3L@5$585"U)
M3D1%3E0Z(#!P="<^(#QF;VYT('-T>6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UE
M<R!.97<@4F]M86X[($9/3E0M4U193$4Z(&ET86QI8SL@1$E34$Q!63H@:6YL
M:6YE)SX@0V%S:"!&;&]W($AE9&=E<SPO9F]N=#XN(%1H92!#;VUP86YY(&5N
M=&5R960@:6YT;R!F;W)W87)D(&-O;G1R86-T<R!T;R!H961G92!A9V%I;G-T
M('1H92!R:7-K(&]F(&]V97)A;&P@8VAA;F=E<R!I;B!F=71U<F4@8V%S:"!F
M;&]W(&9R;VT@<&%Y;65N=',@;V8@<&%Y<F]L;"!A;F0@<F5L871E9"!E>'!E
M;G-E<R!D96YO;6EN871E9"!I;B!.97<@27-R865L:2!3:&5K96QS("A.25,I
M+B!4:&4@0V]M<&%N>2!M96%S=7)E9"!T:&4@9F%I<B!V86QU92!O9B!T:&4@
M8V]N=')A8W1S(&EN(&%C8V]R9&%N8V4@=VET:"!!4T,@.#(P("AC;&%S<VEF
M:65D(&%S(&QE=F5L(#(I+B!4:&4@9V%I;B!O<B!L;W-S(&]N('1H92!E9F9E
M8W1I=F4@<&]R=&EO;B!O9B!A(&-A<V@@9FQO=R!H961G92!I<R!I;FET:6%L
M;'D@<F5P;W)T960@87,@82!C;VUP;VYE;G0@;V8@86-C=6UU;&%T960@;W1H
M97(@8V]M<')E:&5N<VEV92!I;F-O;64@86YD('-U8G-E<75E;G1L>2!R96-L
M87-S:69I960@:6YT;R!O<&5R871I;F<@97AP96YS97,@:6X@=&AE('-A;64@
M<&5R:6]D(&]R('!E<FEO9',@:6X@=VAI8V@@=&AE('!A>7)O;&P@86YD(')E
M;&%T960@97AP96YS97,@87)E(')E8V]G;FEZ960L(&]R(')E8VQA<W-I9FEE
M9"!I;G1O(")&:6YA;F-I86P@:6YC;VUE+"!N970B+"!I9B!T:&4@:&5D9V5D
M('1R86YS86-T:6]N(&)E8V]M97,@<')O8F%B;&4@;V8@;F]T(&]C8W5R<FEN
M9RX@06YY(&=A:6X@;W(@;&]S<R!A9G1E<B!A(&AE9&=E(&ES(&YO(&QO;F=E
M<B!D97-I9VYA=&5D+"!B96-A=7-E(&ET(&ES(&YO(&QO;F=E<B!P<F]B86)L
M92!O9B!O8V-U<G)I;F<@;W(@:70@:7,@<F5L871E9"!T;R!A;B!I;F5F9F5C
M=&EV92!P;W)T:6]N(&]F(&$@8V%S:"!F;&]W(&AE9&=E(&ES(')E8V]G;FEZ
M960@:6X@=&AE('-T871E;65N="!O9B!O<&5R871I;VYS(&EM;65D:6%T96QY
M+B!!<R!O9B!*=6YE(#,P+"`R,#$T+"!T:&4@0V]M<&%N>2!H860@9F]R=V%R
M9"!C;VYT<F%C=',@:6X@<&QA8V4@=&\@:&5D9V4@9G5T=7)E('!A>7)O;&P@
M86YD(')E;&%T960@97AP96YS97,@:6X@3DE3(&]F(&%P<')O>&EM871E;'D@
M)#(L.#(P+"!W:71H(&9A:7(@=F%L=64@;V8@87!P<F]X:6UA=&5L>2`D,C0N
M(%1H92!N970@=6YR96%L:7IE9"!G86EN(&]N('1H92!E9F9E8W1I=F4@<&]R
M=&EO;B!O9B!T:&5S92!C87-H(&9L;W<@:&5D9V5S('=A<R`D,C,N(%1H92!N
M970@9V%I;B!R96%L:7IE9"!I;B!S=&%T96UE;G0@;V8@;W!E<F%T:6]N<R!D
M=7)I;F<@=&AE('EE87(@96YD960@2G5N92`S,"P@,C`Q-"P@<F5S=6QT:6YG
M(&9R;VT@=&AE(&-A<V@@9FQO=R!H961G92!T<F%N<V%C=&EO;G,L)FYB<W`[
M)FYB<W`[86UO=6YT960@=&\@87!P<F]X:6UA=&5L>2`D-#@N(%1H92!F;W)W
M87)D(&-O;G1R86-T<R!O;B!T:&4@0V]M<&%N>28C,SD[<R!F=71U<F4@3DE3
M('!A>7)O;&P@86YD(')E;&%T960@97AP96YS97,@=VEL;"!S971T;&4@8GD@
M1&5C96UB97(@,C`Q-"X@3VX@2G5N92`S,"P@,C`Q,RP@=&AE($-O;7!A;GD@
M9&ED(&YO="!H879E(&-O;G1R86-T<R!D97-I9VYA=&5D(&%N9"!Q=6%L:69I
M97,@87,@8V%S:"!F;&]W(&AE9&=E+CPO9&EV/B`\9&EV('-T>6QE/3-$)TU!
M4D=)3BU,1494.B`T,S=P=#L@1$E34$Q!63H@8FQO8VL[(%1%6%0M24Y$14Y4
M.B`P<'0G/B`\8G(@+SX@/"]D:78^(#QD:78@<W1Y;&4],T0G1$E34$Q!63H@
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M0R`X,C`@*&-L87-S:69I960@87,@;&5V96P@,BDN($=A:6YS(&%N9"!L;W-S
M97,@;VX@=&AE<V4@8V]N=')A8W1S(&%R92!R96-O9VYI>F5D(&EN(")&:6YA
M;F-I86P@:6YC;VUE+"!N970B+"!A;&]N9R!W:71H('1H92!O9F9S971T:6YG
M(&QO<W-E<R!A;F0@9V%I;G,@;V8@=&AE(')E;&%T960@:&5D9V5D(&ET96US
M+CPO9&EV/B`\9&EV('-T>6QE/3-$)T1)4U!,05DZ(&)L;V-K.R!-05)'24XM
M3$5&5#H@,3AP=#L@34%21TE.+5))1TA4.B`P<'0[('1E>'0M86QI9VXZ(&IU
M<W1I9GD[(%1%6%0M24Y$14Y4.B`P<'0G/B`F;F)S<#L\+V1I=CX@/&1I=B!S
M='EL93TS1"=$25-03$%9.B!B;&]C:SL@1D].5"U&04U)3%DZ(%1I;65S($YE
M=R!2;VUA;CL@1D].5"U325I%.B`Q,'!T.R!-05)'24XM3$5&5#H@,3AP=#L@
M34%21TE.+5))1TA4.B`P<'0[('1E>'0M86QI9VXZ(&IU<W1I9GD[(%1%6%0M
M24Y$14Y4.B`P<'0G/B!);B!C;VYN96-T:6]N('=I=&@@=&AE(&EN=F5S=&UE
M;G0@:6X@0TA!('-H87)E<R`H<V5E($YO=&4@,60I+"!A;B!A=F%I;&%B;&4M
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M="!I<R`D,3$L,#`P(&%S(&]F($IU;F4@,S`L(#(P,30@=VET:"!F86ER('9A
M;'5E(&]F(&%P<')O>&EM871E;'D@)"@X.#DI+CPO9&EV/B`\9&EV('-T>6QE
M/3-$)T1)4U!,05DZ(&)L;V-K.R!-05)'24XM3$5&5#H@,3AP=#L@34%21TE.
M+5))1TA4.B`P<'0[('1E>'0M86QI9VXZ(&IU<W1I9GD[(%1%6%0M24Y$14Y4
M.B`P<'0G/B`F;F)S<#L\+V1I=CX@/&1I=B!S='EL93TS1"=$25-03$%9.B!B
M;&]C:SL@1D].5"U&04U)3%DZ(%1I;65S($YE=R!2;VUA;CL@1D].5"U325I%
M.B`Q,'!T.R!-05)'24XM3$5&5#H@,3AP=#L@34%21TE.+5))1TA4.B`P<'0[
M('1E>'0M86QI9VXZ(&IU<W1I9GD[(%1%6%0M24Y$14Y4.B`P<'0G/B!4:&4@
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M<BUS86QE($-(02!S:&%R97,@8V]N=&EN=64@=&\@9F]L;&]W($%30R`S,C`M
M(DEN=F5S=&UE;G1S+41E8G0@86YD($5Q=6ET>2!396-U<FET:65S(BP@86-C
M;W5N=&EN9R!A;F0@87)E(')E9FQE8W1E9"!I;B!O=&AE<B!C;VUP<F5H96YS
M:79E(&EN8V]M92X\+V1I=CX@/&1I=B!S='EL93TS1"=$25-03$%9.B!B;&]C
M:SL@5$585"U)3D1%3E0Z(#!P="<^/&)R("\^(#PO9&EV/B`\9&EV('-T>6QE
M/3-$)T1)4U!,05DZ(&)L;V-K.R!&3TY4+49!34E,63H@5&EM97,@3F5W(%)O
M;6%N.R!&3TY4+5-)6D4Z(#$P<'0[($U!4D=)3BU,1494.B`Q.'!T.R!-05)'
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M('1H92!C;VYT<F%C=',@:6X@86-C;W)D86YC92!W:71H($%30R`X,C`@*&-L
M87-S:69I960@87,@;&5V96P@,BDN(%1H92!N970@9V%I;G,@*&QO<W-E<RD@
M<F5C;V=N:7IE9"!I;B`B1FEN86YC:6%L(&EN8V]M92P@;F5T(B!D=7)I;F<@
M=&AE('EE87(@96YD960@2G5N92`S,"P@,C`Q-"P@,C`Q,R!A;F0@,C`Q,B!W
M97)E("@D-S`I+"`D,C,Q(&%N9"`H)#$T-2DL(')E<W!E8W1I=F5L>2X\+V1I
M=CX@/"$M+45N9$9R86=M96YT+2T^/"]D:78^(#PO9&EV/CQS<&%N/CPO<W!A
M;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS1')E/@T*
M("`@("`@("`\=&0@8VQA<W,],T1P;"!V86QI9VX],T1T;W`^0V]M<')E:&5N
M<VEV92!I;F-O;64\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\
M(2TM1$]#5%E012!H=&UL(%!50DQ)0R`B+2\O5S-#+R]$5$0@6$A434P@,2XP
M(%1R86YS:71I;VYA;"\O14XB(")H='1P.B\O=W=W+G<S+F]R9R]44B]X:'1M
M;#$O1%1$+WAH=&UL,2UT<F%N<VET:6]N86PN9'1D(B`M+3X\9&EV/B`\9&EV
M/CPA+2U3=&%R=$9R86=M96YT+2T^(#QD:78@<W1Y;&4],T0G=&5X="UA;&EG
M;CH@8V5N=&5R)SX@/'1A8FQE('-T>6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@
M1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;B<@8V5L;'-P86-I;F<],T0P
M(&-E;&QP861D:6YG/3-$,"!W:61T:#TS1#$P,"4@8F]R9&5R/3-$,#X@/'1R
M('9A;&EG;CTS1'1O<#X@/'1D('-T>6QE/3-$)U=)1%1(.B`Q.'!T)SX@/&1I
M=B!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE
M<R!N97<@<F]M86X[($9/3E0M4TE:13H@,3!P=#L@1D].5"U714E'2%0Z(&)O
M;&0[($U!4D=)3BU,1494.B`P<'0[($U!4D=)3BU224=(5#H@,'!T.R!415A4
M+4E.1$5.5#H@,'!T)SX@="X\+V1I=CX@/"]T9#X@/'1D/B`\9&EV('-T>6QE
M/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R
M;VUA;CL@1D].5"U325I%.B`Q,'!T.R!T97AT+6%L:6=N.B!J=7-T:69Y)SX@
M/&9O;G0@<W1Y;&4],T0G1D].5"U714E'2%0Z(&)O;&0[($1)4U!,05DZ(&EN
M;&EN92<^0V]M<')E:&5N<VEV92!I;F-O;64\+V9O;G0^/&9O;G0@<W1Y;&4]
M,T0G1D].5"U325I%.B`Q,'!T.R!$25-03$%9.B!I;FQI;F4G/CH\+V9O;G0^
M/"]D:78^(#PO=&0^(#PO='(^(#PO=&%B;&4^(#PO9&EV/B`\9&EV('-T>6QE
M/3-$)T1)4U!,05DZ(&)L;V-K.R!-05)'24XM3$5&5#H@,'!T.R!-05)'24XM
M4DE'2%0Z(#!P=#L@=&5X="UA;&EG;CH@:G5S=&EF>3L@5$585"U)3D1%3E0Z
M(#!P="<^("9N8G-P.SPO9&EV/B`\9&EV('-T>6QE/3-$)T1)4U!,05DZ(&)L
M;V-K.R!&3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N.R!&3TY4+5-)6D4Z
M(#$P<'0[($U!4D=)3BU,1494.B`Q.'!T.R!-05)'24XM4DE'2%0Z(#!P=#L@
M=&5X="UA;&EG;CH@:G5S=&EF>3L@5$585"U)3D1%3E0Z(#!P="<^(%1H92!#
M;VUP86YY(&%C8V]U;G1S(&9O<B!C;VUP<F5H96YS:79E(&EN8V]M92`H;&]S
M<RD@:6X@86-C;W)D86YC92!W:71H($%30R!.;RX@,C(P+"`B0V]M<')E:&5N
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M24Y$14Y4.B`P<'0G/B9N8G-P.SPO9&EV/B`\9&EV('-T>6QE/3-$)W1E>'0M
M86QI9VXZ(')I9VAT)SX@/'1A8FQE('-T>6QE/3-$)T9/3E0M4TE:13H@,3!P
M=#L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;B<@8V5L;'-P86-I;F<]
M,T0P(&-E;&QP861D:6YG/3-$,"!W:61T:#TS1#DW)3X@/'1R/B`\=&0@<W1Y
M;&4],T0G4$%$1$E.1RU"3U143TTZ(#)P>"<@=F%L:6=N/3-$8F]T=&]M('=I
M9'1H/3-$-C0E/CQF;VYT('-T>6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@1D].
M5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1$E34$Q!63H@:6YL:6YE)SX@
M)FYB<W`[/"]F;VYT/B`\+W1D/B`\=&0@<W1Y;&4],T0G4$%$1$E.1RU"3U14
M3TTZ(#)P>"<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24^/&9O;G0@<W1Y
M;&4],T0G1D].5"U325I%.B`Q,'!T.R!&3TY4+49!34E,63H@=&EM97,@;F5W
M(')O;6%N.R!$25-03$%9.B!I;FQI;F4G/B`F;F)S<#L\+V9O;G0^(#PO=&0^
M(#QT9"!S='EL93TS1"="3U)$15(M0D]45$]-.B!B;&%C:R`R<'@@<V]L:60G
M('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#,T)2!C;VQS<&%N/3-$,3`^(#QD
M:78@<W1Y;&4],T0G1$E34$Q!63H@8FQO8VL[($9/3E0M1D%-24Q9.B!T:6UE
M<R!N97<@<F]M86X[($9/3E0M4TE:13H@,3!P=#L@34%21TE.+4Q%1E0Z(#!P
M=#L@34%21TE.+5))1TA4.B`P<'0[('1E>'0M86QI9VXZ(&-E;G1E<CL@5$58
M5"U)3D1%3E0Z(#!P="<^(%EE87(@96YD960@2G5N92`S,"P@,C`Q-#PO9&EV
M/B`\+W1D/B`\=&0@<W1Y;&4],T0G4$%$1$E.1RU"3U143TTZ(#)P>#L@5$58
M5"U!3$E'3CH@;&5F="<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@;F]W
M<F%P/3-$;F]W<F%P/CQF;VYT('-T>6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@
M1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1$E34$Q!63H@:6YL:6YE
M)SX@)FYB<W`[/"]F;VYT/B`\+W1D/B`\+W1R/B`\='(^(#QT9"!S='EL93TS
M1"=0041$24Y'+4)/5%1/33H@,G!X)R!V86QI9VX],T1B;W1T;VT@=VED=&@]
M,T0V-"4^/&9O;G0@<W1Y;&4],T0G1D].5"U325I%.B`Q,'!T.R!&3TY4+49!
M34E,63H@=&EM97,@;F5W(')O;6%N.R!$25-03$%9.B!I;FQI;F4G/B`F;F)S
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M:6=N/3-$8F]T=&]M('=I9'1H/3-$,3`E(&-O;'-P86X],T0R/B`\9&EV('-T
M>6QE/3-$)T1)4U!,05DZ(&)L;V-K.R!&3TY4+49!34E,63H@=&EM97,@;F5W
M(')O;6%N.R!&3TY4+5-)6D4Z(#$P<'0[($U!4D=)3BU,1494.B`P<'0[($U!
M4D=)3BU224=(5#H@,'!T.R!T97AT+6%L:6=N.B!C96YT97([(%1%6%0M24Y$
M14Y4.B`P<'0G/B!5;G)E86QI>F5D/"]D:78^(#QD:78@<W1Y;&4],T0G1$E3
M4$Q!63H@8FQO8VL[($9/3E0M1D%-24Q9.B!T:6UE<R!N97<@<F]M86X[($9/
M3E0M4TE:13H@,3!P=#L@34%21TE.+4Q%1E0Z(#!P=#L@34%21TE.+5))1TA4
M.B`P<'0[('1E>'0M86QI9VXZ(&-E;G1E<CL@5$585"U)3D1%3E0Z(#!P="<^
M(&=A:6YS/"]D:78^(#QD:78@<W1Y;&4],T0G1$E34$Q!63H@8FQO8VL[($9/
M3E0M1D%-24Q9.B!T:6UE<R!N97<@<F]M86X[($9/3E0M4TE:13H@,3!P=#L@
M34%21TE.+4Q%1E0Z(#!P=#L@34%21TE.+5))1TA4.B`P<'0[('1E>'0M86QI
M9VXZ(&-E;G1E<CL@5$585"U)3D1%3E0Z(#!P="<^(&]N(&UA<FME=&%B;&4\
M+V1I=CX@/&1I=B!S='EL93TS1"=$25-03$%9.B!B;&]C:SL@1D].5"U&04U)
M3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T.R!-05)'24XM
M3$5&5#H@,'!T.R!-05)'24XM4DE'2%0Z(#!P=#L@=&5X="UA;&EG;CH@8V5N
M=&5R.R!415A4+4E.1$5.5#H@,'!T)SX@<V5C=7)I=&EE<SPO9&EV/B`\+W1D
M/B`\=&0@<W1Y;&4],T0G4$%$1$E.1RU"3U143TTZ(#)P>#L@5$585"U!3$E'
M3CH@;&5F="<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@;F]W<F%P/3-$
M;F]W<F%P/CQF;VYT('-T>6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@1D].5"U&
M04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1$E34$Q!63H@:6YL:6YE)SX@)FYB
M<W`[/"]F;VYT/B`\+W1D/B`\=&0@<W1Y;&4],T0G4$%$1$E.1RU"3U143TTZ
M(#)P>"<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24^/&9O;G0@<W1Y;&4]
M,T0G1D].5"U325I%.B`Q,'!T.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O
M;6%N.R!$25-03$%9.B!I;FQI;F4G/B`F;F)S<#L\+V9O;G0^(#PO=&0^(#QT
M9"!S='EL93TS1"="3U)$15(M0D]45$]-.B!B;&%C:R`R<'@@<V]L:60G('9A
M;&EG;CTS1&)O='1O;2!W:61T:#TS1#$P)2!C;VQS<&%N/3-$,CX@/&1I=B!S
M='EL93TS1"=$25-03$%9.B!B;&]C:SL@1D].5"U&04U)3%DZ('1I;65S(&YE
M=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T.R!-05)'24XM3$5&5#H@,'!T.R!-
M05)'24XM4DE'2%0Z(#!P=#L@=&5X="UA;&EG;CH@8V5N=&5R.R!415A4+4E.
M1$5.5#H@,'!T)SX@56YR96%L:7IE9#PO9&EV/B`\9&EV('-T>6QE/3-$)T1)
M4U!,05DZ(&)L;V-K.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!&
M3TY4+5-)6D4Z(#$P<'0[($U!4D=)3BU,1494.B`P<'0[($U!4D=)3BU224=(
M5#H@,'!T.R!T97AT+6%L:6=N.B!C96YT97([(%1%6%0M24Y$14Y4.B`P<'0G
M/B!G86EN<SPO9&EV/B`\9&EV('-T>6QE/3-$)T1)4U!,05DZ(&)L;V-K.R!&
M3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!&3TY4+5-)6D4Z(#$P<'0[
M($U!4D=)3BU,1494.B`P<'0[($U!4D=)3BU224=(5#H@,'!T.R!T97AT+6%L
M:6=N.B!C96YT97([(%1%6%0M24Y$14Y4.B`P<'0G/B!O;B!C87-H(&9L;W<\
M+V1I=CX@/&1I=B!S='EL93TS1"=$25-03$%9.B!B;&]C:SL@1D].5"U&04U)
M3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T.R!-05)'24XM
M3$5&5#H@,'!T.R!-05)'24XM4DE'2%0Z(#!P=#L@=&5X="UA;&EG;CH@8V5N
M=&5R.R!415A4+4E.1$5.5#H@,'!T)SX@:&5D9V5S/"]D:78^(#PO=&0^(#QT
M9"!S='EL93TS1"=0041$24Y'+4)/5%1/33H@,G!X.R!415A4+4%,24=..B!L
M969T)R!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)2!N;W=R87`],T1N;W=R
M87`^/&9O;G0@<W1Y;&4],T0G1D].5"U325I%.B`Q,'!T.R!&3TY4+49!34E,
M63H@=&EM97,@;F5W(')O;6%N.R!$25-03$%9.B!I;FQI;F4G/B`F;F)S<#L\
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M/3-$8F]T=&]M('=I9'1H/3-$,3`E(&-O;'-P86X],T0R/B`\9&EV('-T>6QE
M/3-$)T1)4U!,05DZ(&)L;V-K.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O
M;6%N.R!&3TY4+5-)6D4Z(#$P<'0[($U!4D=)3BU,1494.B`P<'0[($U!4D=)
M3BU224=(5#H@,'!T.R!T97AT+6%L:6=N.B!C96YT97([(%1%6%0M24Y$14Y4
M.B`P<'0G/B!4;W1A;#PO9&EV/B`\+W1D/B`\=&0@<W1Y;&4],T0G4$%$1$E.
M1RU"3U143TTZ(#)P>#L@5$585"U!3$E'3CH@;&5F="<@=F%L:6=N/3-$8F]T
M=&]M('=I9'1H/3-$,24@;F]W<F%P/3-$;F]W<F%P/CQF;VYT('-T>6QE/3-$
M)T9/3E0M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA
M;CL@1$E34$Q!63H@:6YL:6YE)SX@)FYB<W`[/"]F;VYT/B`\+W1D/B`\+W1R
M/B`\='(@8F=C;VQO<CTS1"-C8V5E9F8^(#QT9"!S='EL93TS1"=415A4+4%,
M24=..B!L969T.R!-05)'24XM3$5&5#H@,'!T.R!-05)'24XM4DE'2%0Z(#!P
M=#L@5$585"U)3D1%3E0Z(#!P="<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$
M-C0E/B`\9&EV('-T>6QE/3-$)T1)4U!,05DZ(&)L;V-K.R!&3TY4+49!34E,
M63H@=&EM97,@;F5W(')O;6%N.R!&3TY4+5-)6D4Z(#$P<'0[($U!4D=)3BU,
M1494.B`P<'0[($U!4D=)3BU224=(5#H@,'!T.R!415A4+4%,24=..B!L969T
M.R!415A4+4E.1$5.5#H@,'!T)SX@0F5G:6YN:6YG(&)A;&%N8V4\+V1I=CX@
M/"]T9#X@/'1D('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E(&%L:6=N/3-$
M<FEG:'0^/&9O;G0@<W1Y;&4],T0G1D].5"U325I%.B`Q,'!T.R!&3TY4+49!
M34E,63H@=&EM97,@;F5W(')O;6%N.R!$25-03$%9.B!I;FQI;F4G/B`F;F)S
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M,T1B;W1T;VT@=VED=&@],T0Q)2!N;W=R87`],T1N;W=R87`^/&9O;G0@<W1Y
M;&4],T0G1D].5"U325I%.B`Q,'!T.R!&3TY4+49!34E,63H@=&EM97,@;F5W
M(')O;6%N.R!$25-03$%9.B!I;FQI;F4G/B`F;F)S<#L\+V9O;G0^(#PO=&0^
M(#QT9"!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)2!A;&EG;CTS1')I9VAT
M/CQF;VYT('-T>6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ
M('1I;65S(&YE=R!R;VUA;CL@1$E34$Q!63H@:6YL:6YE)SX@)FYB<W`[/"]F
M;VYT/B`\+W1D/B`\=&0@<W1Y;&4],T0G1$E34$Q!63H@:6YL:6YE.R!&3TY4
M+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!&3TY4+5-)6D4Z(#$P<'0[(%1%
M6%0M04Q)1TXZ(&QE9G0G('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E/B0\
M+W1D/B`\=&0@<W1Y;&4],T0G1$E34$Q!63H@:6YL:6YE.R!&3TY4+49!34E,
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M<W1Y;&4],T0G1D].5"U325I%.B`Q,'!T.R!&3TY4+49!34E,63H@=&EM97,@
M;F5W(')O;6%N.R!$25-03$%9.B!I;FQI;F4G/B`F;F)S<#L\+V9O;G0^(#PO
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M=&@],T0Q)2!N;W=R87`],T1N;W=R87`^/&9O;G0@<W1Y;&4],T0G1D].5"U3
M25I%.B`Q,'!T.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!$25-0
M3$%9.B!I;FQI;F4G/B`F;F)S<#L\+V9O;G0^(#PO=&0^(#PO='(^(#QT<B!B
M9V-O;&]R/3-$=VAI=&4^(#QT9"!S='EL93TS1"=415A4+4%,24=..B!L969T
M.R!-05)'24XM3$5&5#H@,'!T.R!-05)'24XM4DE'2%0Z(#!P=#L@5$585"U)
M3D1%3E0Z(#!P="<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$-C0E/B`\9&EV
M('-T>6QE/3-$)T1)4U!,05DZ(&)L;V-K.R!&3TY4+49!34E,63H@=&EM97,@
M;F5W(')O;6%N.R!&3TY4+5-)6D4Z(#$P<'0[($U!4D=)3BU,1494.B`P<'0[
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M;CL@1$E34$Q!63H@:6YL:6YE)SX@)FYB<W`[/"]F;VYT/B`\+W1D/B`\=&0@
M<W1Y;&4],T0G5$585"U!3$E'3CH@;&5F="<@=F%L:6=N/3-$8F]T=&]M('=I
M9'1H/3-$,24^/&9O;G0@<W1Y;&4],T0G1D].5"U325I%.B`Q,'!T.R!&3TY4
M+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!$25-03$%9.B!I;FQI;F4G/B`F
M;F)S<#L\+V9O;G0^(#PO=&0^(#QT9"!S='EL93TS1"=$25-03$%9.B!I;FQI
M;F4[($9/3E0M1D%-24Q9.B!T:6UE<R!N97<@<F]M86X[($9/3E0M4TE:13H@
M,3!P=#L@5$585"U!3$E'3CH@<FEG:'0G('9A;&EG;CTS1&)O='1O;2!W:61T
M:#TS1#DE/C,L-#`T/"]T9#X@/'1D('-T>6QE/3-$)U1%6%0M04Q)1TXZ(&QE
M9G0G('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E(&YO=W)A<#TS1&YO=W)A
M<#X\9F]N="!S='EL93TS1"=&3TY4+5-)6D4Z(#$P<'0[($9/3E0M1D%-24Q9
M.B!T:6UE<R!N97<@<F]M86X[($1)4U!,05DZ(&EN;&EN92<^("9N8G-P.SPO
M9F]N=#X@/"]T9#X@/'1D('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E(&%L
M:6=N/3-$<FEG:'0^/&9O;G0@<W1Y;&4],T0G1D].5"U325I%.B`Q,'!T.R!&
M3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!$25-03$%9.B!I;FQI;F4G
M/B`F;F)S<#L\+V9O;G0^(#PO=&0^(#QT9"!S='EL93TS1"=415A4+4%,24=.
M.B!L969T)R!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)3X\9F]N="!S='EL
M93TS1"=&3TY4+5-)6D4Z(#$P<'0[($9/3E0M1D%-24Q9.B!T:6UE<R!N97<@
M<F]M86X[($1)4U!,05DZ(&EN;&EN92<^("9N8G-P.SPO9F]N=#X@/"]T9#X@
M/'1D('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I
M;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T.R!415A4+4%,24=..B!R
M:6=H="<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$.24^,C,\+W1D/B`\=&0@
M<W1Y;&4],T0G5$585"U!3$E'3CH@;&5F="<@=F%L:6=N/3-$8F]T=&]M('=I
M9'1H/3-$,24@;F]W<F%P/3-$;F]W<F%P/CQF;VYT('-T>6QE/3-$)T9/3E0M
M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1$E3
M4$Q!63H@:6YL:6YE)SX@)FYB<W`[/"]F;VYT/B`\+W1D/B`\=&0@=F%L:6=N
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M)SX@)FYB<W`[/"]F;VYT/B`\+W1D/B`\=&0@<W1Y;&4],T0G1$E34$Q!63H@
M:6YL:6YE.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!&3TY4+5-)
M6D4Z(#$P<'0[(%1%6%0M04Q)1TXZ(')I9VAT)R!V86QI9VX],T1B;W1T;VT@
M=VED=&@],T0Y)3XS+#0R-SPO=&0^(#QT9"!S='EL93TS1"=415A4+4%,24=.
M.B!L969T)R!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)2!N;W=R87`],T1N
M;W=R87`^/&9O;G0@<W1Y;&4],T0G1D].5"U325I%.B`Q,'!T.R!&3TY4+49!
M34E,63H@=&EM97,@;F5W(')O;6%N.R!$25-03$%9.B!I;FQI;F4G/B`F;F)S
M<#L\+V9O;G0^(#PO=&0^(#PO='(^(#QT<B!B9V-O;&]R/3-$(V-C965F9CX@
M/'1D('-T>6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0[($U!4D=)3BU,1494.B`P
M<'0[($U!4D=)3BU224=(5#H@,'!T.R!415A4+4E.1$5.5#H@,'!T)R!V86QI
M9VX],T1B;W1T;VT@=VED=&@],T0V-"4^(#QD:78@<W1Y;&4],T0G1$E34$Q!
M63H@8FQO8VL[($9/3E0M1D%-24Q9.B!T:6UE<R!N97<@<F]M86X[($9/3E0M
M4TE:13H@,3!P=#L@34%21TE.+4Q%1E0Z(#!P=#L@34%21TE.+5))1TA4.B`P
M<'0[(%1%6%0M04Q)1TXZ(&QE9G0[(%1%6%0M24Y$14Y4.B`P<'0G/B!!;6]U
M;G1S(')E8VQA<W-I9FEE9"!F<F]M(&%C8W5M=6QA=&5D(&]T:&5R(&-O;7!R
M96AE;G-I=F4@;&]S<SPO9&EV/B`\+W1D/B`\=&0@=F%L:6=N/3-$8F]T=&]M
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M3%DZ('1I;65S(&YE=R!R;VUA;CL@1$E34$Q!63H@:6YL:6YE)SX@)FYB<W`[
M/"]F;VYT/B`\+W1D/B`\=&0@<W1Y;&4],T0G1$E34$Q!63H@:6YL:6YE.R!&
M3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!&3TY4+5-)6D4Z(#$P<'0[
M(%1%6%0M04Q)1TXZ(')I9VAT)R!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Y
M)3XH-S(W/"]T9#X@/'1D('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].
M5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T.R!4
M15A4+4%,24=..B!L969T)R!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)2!N
M;W=R87`],T1N;W=R87`^*3PO=&0^(#QT9"!V86QI9VX],T1B;W1T;VT@=VED
M=&@],T0Q)2!A;&EG;CTS1')I9VAT/CQF;VYT('-T>6QE/3-$)T9/3E0M4TE:
M13H@,3!P=#L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1$E34$Q!
M63H@:6YL:6YE)SX@)FYB<W`[/"]F;VYT/B`\+W1D/B`\=&0@<W1Y;&4],T0G
M5$585"U!3$E'3CH@;&5F="<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24^
M/&9O;G0@<W1Y;&4],T0G1D].5"U325I%.B`Q,'!T.R!&3TY4+49!34E,63H@
M=&EM97,@;F5W(')O;6%N.R!$25-03$%9.B!I;FQI;F4G/B`F;F)S<#L\+V9O
M;G0^(#PO=&0^(#QT9"!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M
M1D%-24Q9.B!T:6UE<R!N97<@<F]M86X[($9/3E0M4TE:13H@,3!P=#L@5$58
M5"U!3$E'3CH@<FEG:'0G('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#DE/BT\
M+W1D/B`\=&0@<W1Y;&4],T0G5$585"U!3$E'3CH@;&5F="<@=F%L:6=N/3-$
M8F]T=&]M('=I9'1H/3-$,24@;F]W<F%P/3-$;F]W<F%P/CQF;VYT('-T>6QE
M/3-$)T9/3E0M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R
M;VUA;CL@1$E34$Q!63H@:6YL:6YE)SX@)FYB<W`[/"]F;VYT/B`\+W1D/B`\
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M63H@:6YL:6YE)SX@)FYB<W`[/"]F;VYT/B`\+W1D/B`\=&0@<W1Y;&4],T0G
M1$E34$Q!63H@:6YL:6YE.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N
M.R!&3TY4+5-)6D4Z(#$P<'0[(%1%6%0M04Q)1TXZ(')I9VAT)R!V86QI9VX]
M,T1B;W1T;VT@=VED=&@],T0Y)3XH-S(W/"]T9#X@/'1D('-T>6QE/3-$)T1)
M4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@
M1D].5"U325I%.B`Q,'!T.R!415A4+4%,24=..B!L969T)R!V86QI9VX],T1B
M;W1T;VT@=VED=&@],T0Q)2!N;W=R87`],T1N;W=R87`^*3PO=&0^(#PO='(^
M(#QT<B!B9V-O;&]R/3-$=VAI=&4^(#QT9"!S='EL93TS1"=0041$24Y'+4)/
M5%1/33H@,G!X.R!415A4+4%,24=..B!L969T.R!-05)'24XM3$5&5#H@,'!T
M.R!-05)'24XM4DE'2%0Z(#!P=#L@5$585"U)3D1%3E0Z(#!P="<@=F%L:6=N
M/3-$8F]T=&]M('=I9'1H/3-$-C0E/B`\9&EV('-T>6QE/3-$)T1)4U!,05DZ
M(&)L;V-K.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!&3TY4+5-)
M6D4Z(#$P<'0[($U!4D=)3BU,1494.B`P<'0[($U!4D=)3BU224=(5#H@,'!T
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M=R!R;VUA;CL@1$E34$Q!63H@:6YL:6YE)SX@)FYB<W`[/"]F;VYT/B`\+W1D
M/B`\=&0@<W1Y;&4],T0G0D]21$52+4)/5%1/33H@8FQA8VL@,G!X('-O;&ED
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M969T)R!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)2!N;W=R87`],T1N;W=R
M87`^/&9O;G0@<W1Y;&4],T0G1D].5"U325I%.B`Q,'!T.R!&3TY4+49!34E,
M63H@=&EM97,@;F5W(')O;6%N.R!$25-03$%9.B!I;FQI;F4G/B`F;F)S<#L\
M+V9O;G0^(#PO=&0^(#QT9"!S='EL93TS1"=0041$24Y'+4)/5%1/33H@,G!X
M)R!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)2!A;&EG;CTS1')I9VAT/CQF
M;VYT('-T>6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ('1I
M;65S(&YE=R!R;VUA;CL@1$E34$Q!63H@:6YL:6YE)SX@)FYB<W`[/"]F;VYT
M/B`\+W1D/B`\=&0@<W1Y;&4],T0G0D]21$52+4)/5%1/33H@8FQA8VL@,G!X
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M.B!L969T)R!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)2!N;W=R87`],T1N
M;W=R87`^/&9O;G0@<W1Y;&4],T0G1D].5"U325I%.B`Q,'!T.R!&3TY4+49!
M34E,63H@=&EM97,@;F5W(')O;6%N.R!$25-03$%9.B!I;FQI;F4G/B`F;F)S
M<#L\+V9O;G0^(#PO=&0^(#QT9"!S='EL93TS1"=0041$24Y'+4)/5%1/33H@
M,G!X)R!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)2!A;&EG;CTS1')I9VAT
M/CQF;VYT('-T>6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ
M('1I;65S(&YE=R!R;VUA;CL@1$E34$Q!63H@:6YL:6YE)SX@)FYB<W`[/"]F
M;VYT/B`\+W1D/B`\=&0@<W1Y;&4],T0G0D]21$52+4)/5%1/33H@8FQA8VL@
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M87`],T1N;W=R87`^/&9O;G0@<W1Y;&4],T0G1D].5"U325I%.B`Q,'!T.R!&
M3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!$25-03$%9.B!I;FQI;F4G
M/B`F;F)S<#L\+V9O;G0^(#PO=&0^(#PO='(^(#QT<B!B9V-O;&]R/3-$(V-C
M965F9CX@/'1D('-T>6QE/3-$)U!!1$1)3D<M0D]45$]-.B`T<'@[(%1%6%0M
M04Q)1TXZ(&QE9G0[($U!4D=)3BU,1494.B`P<'0[($U!4D=)3BU224=(5#H@
M,'!T.R!415A4+4E.1$5.5#H@,'!T)R!V86QI9VX],T1B;W1T;VT@=VED=&@]
M,T0V-"4^(#QD:78@<W1Y;&4],T0G1$E34$Q!63H@8FQO8VL[($9/3E0M1D%-
M24Q9.B!T:6UE<R!N97<@<F]M86X[($9/3E0M4TE:13H@,3!P=#L@34%21TE.
M+4Q%1E0Z(#!P=#L@34%21TE.+5))1TA4.B`P<'0[(%1%6%0M04Q)1TXZ(&QE
M9G0[(%1%6%0M24Y$14Y4.B`P<'0G/B!%;F1I;F<@8F%L86YC93PO9&EV/B`\
M+W1D/B`\=&0@<W1Y;&4],T0G4$%$1$E.1RU"3U143TTZ(#1P>"<@=F%L:6=N
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M;CL@1D].5"U325I%.B`Q,'!T.R!415A4+4%,24=..B!L969T)R!V86QI9VX]
M,T1B;W1T;VT@=VED=&@],T0Q)3XD/"]T9#X@/'1D('-T>6QE/3-$)T)/4D1%
M4BU"3U143TTZ(&)L86-K(#1P>"!D;W5B;&4[($1)4U!,05DZ(&EN;&EN93L@
M1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T
M.R!415A4+4%,24=..B!R:6=H="<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$
M.24^,BPY,S8\+W1D/B`\=&0@<W1Y;&4],T0G4$%$1$E.1RU"3U143TTZ(#1P
M>#L@5$585"U!3$E'3CH@;&5F="<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$
M,24@;F]W<F%P/3-$;F]W<F%P/CQF;VYT('-T>6QE/3-$)T9/3E0M4TE:13H@
M,3!P=#L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1$E34$Q!63H@
M:6YL:6YE)SX@)FYB<W`[/"]F;VYT/B`\+W1D/B`\=&0@<W1Y;&4],T0G4$%$
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M5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T.R!4
M15A4+4%,24=..B!L969T)R!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)3XD
M/"]T9#X@/'1D('-T>6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#1P>"!D
M;W5B;&4[($1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE
M=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T.R!415A4+4%,24=..B!R:6=H="<@
M=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$.24^,C,\+W1D/B`\=&0@<W1Y;&4]
M,T0G4$%$1$E.1RU"3U143TTZ(#1P>#L@5$585"U!3$E'3CH@;&5F="<@=F%L
M:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@;F]W<F%P/3-$;F]W<F%P/CQF;VYT
M('-T>6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ('1I;65S
M(&YE=R!R;VUA;CL@1$E34$Q!63H@:6YL:6YE)SX@)FYB<W`[/"]F;VYT/B`\
M+W1D/B`\=&0@<W1Y;&4],T0G4$%$1$E.1RU"3U143TTZ(#1P>"<@=F%L:6=N
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M;CL@1D].5"U325I%.B`Q,'!T.R!415A4+4%,24=..B!L969T)R!V86QI9VX]
M,T1B;W1T;VT@=VED=&@],T0Q)3XD/"]T9#X@/'1D('-T>6QE/3-$)T)/4D1%
M4BU"3U143TTZ(&)L86-K(#1P>"!D;W5B;&4[($1)4U!,05DZ(&EN;&EN93L@
M1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T
M.R!415A4+4%,24=..B!R:6=H="<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$
M.24^,BPY-3D\+W1D/B`\=&0@<W1Y;&4],T0G4$%$1$E.1RU"3U143TTZ(#1P
M>#L@5$585"U!3$E'3CH@;&5F="<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$
M,24@;F]W<F%P/3-$;F]W<F%P/CQF;VYT('-T>6QE/3-$)T9/3E0M4TE:13H@
M,3!P=#L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1$E34$Q!63H@
M:6YL:6YE)SX@)FYB<W`[/"]F;VYT/B`\+W1D/B`\+W1R/B`\+W1A8FQE/B`\
M+V1I=CX@/"$M+45N9$9R86=M96YT+2T^/"]D:78^(#PO9&EV/CQS<&%N/CPO
M<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS1')O
M/@T*("`@("`@("`\=&0@8VQA<W,],T1P;"!V86QI9VX],T1T;W`^4F5C96YT
M($%C8V]U;G1I;F<@4')O;F]U;F-E;65N=#PO=&0^#0H@("`@("`@(#QT9"!C
M;&%S<STS1'1E>'0^)SPA+2U$3T-465!%(&AT;6P@4%5"3$E#("(M+R]7,T,O
M+T141"!82%1-3"`Q+C`@5')A;G-I=&EO;F%L+R]%3B(@(FAT='`Z+R]W=W<N
M=S,N;W)G+U12+WAH=&UL,2]$5$0O>&AT;6PQ+71R86YS:71I;VYA;"YD=&0B
M("TM/CQD:78^(#QD:78^/"$M+5-T87)T1G)A9VUE;G0M+3X@/&1I=B!S='EL
M93TS1"=T97AT+6%L:6=N.B!C96YT97(G/B`\=&%B;&4@<W1Y;&4],T0G1D].
M5"U325I%.B`Q,'!T.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N)R!C
M96QL<W!A8VEN9STS1#`@8V5L;'!A9&1I;F<],T0P('=I9'1H/3-$,3`P)2!B
M;W)D97(],T0P/B`\='(@=F%L:6=N/3-$=&]P/B`\=&0@<W1Y;&4],T0G5TE$
M5$@Z(#$X<'0G/B`\9&EV('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].
M5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T.R!&
M3TY4+5=%24=(5#H@8F]L9#L@34%21TE.+4Q%1E0Z(#!P=#L@34%21TE.+5))
M1TA4.B`P<'0[(%1%6%0M24Y$14Y4.B`P<'0G/B!U+CPO9&EV/B`\+W1D/B`\
M=&0^(#QD:78@<W1Y;&4],T0G1$E34$Q!63H@:6YL:6YE.R!&3TY4+49!34E,
M63H@=&EM97,@;F5W(')O;6%N.R!&3TY4+5-)6D4Z(#$P<'0[($9/3E0M5T5)
M1TA4.B!B;VQD.R!T97AT+6%L:6=N.B!J=7-T:69Y)SX@4F5C96YT($%C8V]U
M;G1I;F<@4')O;F]U;F-E;65N=#PO9&EV/B`\+W1D/B`\+W1R/B`\+W1A8FQE
M/B`\+V1I=CX@/&1I=B!S='EL93TS1"=$25-03$%9.B!B;&]C:SL@34%21TE.
M+4Q%1E0Z(#!P=#L@34%21TE.+5))1TA4.B`P<'0[('1E>'0M86QI9VXZ(&IU
M<W1I9GD[(%1%6%0M24Y$14Y4.B`P<'0G/B`F;F)S<#L\+V1I=CX@/&1I=B!S
M='EL93TS1"=$25-03$%9.B!B;&]C:SL@1D].5"U&04U)3%DZ(%1I;65S($YE
M=R!2;VUA;CL@1D].5"U325I%.B`Q,'!T.R!-05)'24XM3$5&5#H@,3AP=#L@
M34%21TE.+5))1TA4.B`P<'0[('1E>'0M86QI9VXZ(&IU<W1I9GD[(%1%6%0M
M24Y$14Y4.B`P<'0G/B!);B!-87D@,C`Q-"P@=&AE($9!4T(@:7-S=65D($%C
M8V]U;G1I;F<@4W1A;F1A<F1S(%5P9&%T92!.;RX@,C`Q-"TP.2`H(D%352`R
M,#$T+3`Y(BDL(")2979E;G5E(&9R;VT@0V]N=')A8W1S('=I=&@@0W5S=&]M
M97)S(BX@05-5(#(P,30M,#D@<W5P97)S961E<R!T:&4@<F5V96YU92!R96-O
M9VYI=&EO;B!R97%U:7)E;65N=',@:6X@(E)E=F5N=64@4F5C;V=N:71I;VX@
M*%1O<&EC(#8P-2DB+"!A;F0@<F5Q=6ER97,@96YT:71I97,@=&\@<F5C;V=N
M:7IE(')E=F5N=64@=VAE;B!I="!T<F%N<V9E<G,@<')O;6ES960@9V]O9',@
M;W(@<V5R=FEC97,@=&\@8W5S=&]M97)S(&EN(&%N(&%M;W5N="!T:&%T(')E
M9FQE8W1S('1H92!C;VYS:61E<F%T:6]N('1O('=H:6-H('1H92!E;G1I='D@
M97AP96-T<R!T;R!B92!E;G1I=&QE9"!T;R!I;B!E>&-H86YG92!F;W(@=&AO
M<V4@9V]O9',@;W(@<V5R=FEC97,N($%352`R,#$T+3`Y(&ES(&5F9F5C=&EV
M92!F;W(@86YN=6%L(')E<&]R=&EN9R!P97)I;V1S(&)E9VEN;FEN9R!A9G1E
M<B!$96-E;6)E<B`Q-2P@,C`Q-BP@:6YC;'5D:6YG(&EN=&5R:6T@<&5R:6]D
M<R!W:71H:6X@=&AA="!R97!O<G1I;F<@<&5R:6]D+B!%87)L>2!A9&]P=&EO
M;B!I<R!N;W0@<&5R;6ET=&5D+B!4:&4@0V]M<&%N>2!I<R!C=7)R96YT;'D@
M:6X@=&AE('!R;V-E<W,@;V8@979A;'5A=&EN9R!T:&4@:6UP86-T(&]F('1H
M92!A9&]P=&EO;B!O9B!!4U4@,C`Q-"TP.2!O;B!I=',@8V]N<V]L:61A=&5D
M(&9I;F%N8VEA;"!S=&%T96UE;G1S+CPO9&EV/B`\(2TM16YD1G)A9VUE;G0M
M+3X\+V1I=CX@/"]D:78^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R
M/@T*("`@(#PO=&%B;&4^#0H@(#PO8F]D>3X-"CPO:'1M;#X-"@T*+2TM+2TM
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M:6DB#0H-"CQH=&UL/@T*("`\:&5A9#X-"B`@("`\345402!H='1P+65Q=6EV
M/3-$0V]N=&5N="U4>7!E(&-O;G1E;G0],T0G=&5X="]H=&UL.R!C:&%R<V5T
M/75T9BTX)SX\<V-R:7!T('1Y<&4],T1T97AT+VIA=F%S8W)I<'0@<W)C/3-$
M4VAO=RYJ<SXO*B!$;R!.;W0@4F5M;W9E(%1H:7,@0V]M;65N="`J+SPO<V-R
M:7!T/CPO:&5A9#X-"B`@/&)O9'D^#0H@("`@/'1A8FQE(&-L87-S/3-$<F5P
M;W)T(&ED/3-$240P13)&/@T*("`@("`@/'1R/@T*("`@("`@("`\=&@@8VQA
M<W,],T1T;"!C;VQS<&%N/3-$,2!R;W=S<&%N/3-$,CX\<W1R;VYG/E-)1TY)
M1DE#04Y4($%#0T]53E1)3D<@4$],24-)15,@*%1A8FQE<RD\8G(^/"]S=')O
M;F<^/"]T:#X-"B`@("`@("`@/'1H(&-L87-S/3-$=&@@8V]L<W!A;CTS1#$^
M,3(@36]N=&AS($5N9&5D/"]T:#X-"B`@("`@(#PO='(^#0H@("`@("`\='(^
M#0H@("`@("`@(#QT:"!C;&%S<STS1'1H/DIU;BX@,S`L(#(P,30\8G(^/"]T
M:#X-"B`@("`@(#PO='(^#0H@("`@("`\='(@8VQA<W,],T1R93X-"B`@("`@
M("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P/CQS=')O;F<^4TE'3DE&
M24-!3E0@04-#3U5.5$E.1R!03TQ)0TE%4R!;06)S=')A8W1=/"]S=')O;F<^
M/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N
M/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$<F\^#0H@
M("`@("`@(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O<#Y38VAE9'5L92!O
M9B!0<F]P97)T>2!A;F0@17%U:7!M96YT+"!%<W1I;6%T960@57-E9G5L($QI
M=F5S+"!!;FYU86P@4F%T93PO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E
M>'0^)SPA+2U$3T-465!%(&AT;6P@4%5"3$E#("(M+R]7,T,O+T141"!82%1-
M3"`Q+C`@5')A;G-I=&EO;F%L+R]%3B(@(FAT='`Z+R]W=W<N=S,N;W)G+U12
M+WAH=&UL,2]$5$0O>&AT;6PQ+71R86YS:71I;VYA;"YD=&0B("TM/CQD:78^
M(#QD:78^/"$M+5-T87)T1G)A9VUE;G0M+3X@/&1I=CX@/'1A8FQE('-T>6QE
M/3-$)T9/3E0M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R
M;VUA;B<@8V5L;'-P86-I;F<],T0P(&-E;&QP861D:6YG/3-$,"!W:61T:#TS
M1#$P,"4@86QI9VX],T1C96YT97(@8F]R9&5R/3-$,#X@/'1R('9A;&EG;CTS
M1'1O<#X@/'1D('-T>6QE/3-$)U=)1%1(.B`Q.'!T)SXF;F)S<#L\+W1D/B`\
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M:78^(#PO=&0^(#PO='(^(#PO=&%B;&4^(#PO9&EV/B`\9&EV('-T>6QE/3-$
M)T1)4U!,05DZ(&)L;V-K.R!-05)'24XM3$5&5#H@,'!T.R!-05)'24XM4DE'
M2%0Z(#!P=#L@=&5X="UA;&EG;CH@:G5S=&EF>3L@5$585"U)3D1%3E0Z(#!P
M="<^("9N8G-P.SPO9&EV/B`\9&EV('-T>6QE/3-$)TU!4D=)3BU,1494.B`Q
M.'!T.R!T97AT+6%L:6=N.B!L969T)SX@/'1A8FQE('-T>6QE/3-$)T9/3E0M
M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;B<@8V5L
M;'-P86-I;F<],T0P(&-E;&QP861D:6YG/3-$,"!W:61T:#TS1#@P)3X@/'1R
M/B`\=&0@=F%L:6=N/3-$=&]P('=I9'1H/3-$-#0E/CQF;VYT('-T>6QE/3-$
M)T9/3E0M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA
M;CL@1$E34$Q!63H@:6YL:6YE)SX@)FYB<W`[/"]F;VYT/B`\+W1D/B`\=&0@
M<W1Y;&4],T0G0D]21$52+4)/5%1/33H@8FQA8VL@,G!X('-O;&ED)R!V86QI
M9VX],T1T;W`@=VED=&@],T0R."4^(#QD:78@<W1Y;&4],T0G1$E34$Q!63H@
M8FQO8VL[($9/3E0M1D%-24Q9.B!T:6UE<R!N97<@<F]M86X[($9/3E0M4TE:
M13H@,3!P=#L@34%21TE.+4Q%1E0Z(#!P=#L@34%21TE.+5))1TA4.B`P<'0[
M(%1%6%0M24Y$14Y4.B`P<'0G/B`E/"]D:78^(#PO=&0^(#QT9"!V86QI9VX]
M,T1T;W`@=VED=&@],T0R."4^/&9O;G0@<W1Y;&4],T0G1D].5"U325I%.B`Q
M,'!T.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!$25-03$%9.B!I
M;FQI;F4G/B`F;F)S<#L\+V9O;G0^(#PO=&0^(#PO='(^(#QT<B!B9V-O;&]R
M/3-$(V-C965F9CX@/'1D('9A;&EG;CTS1'1O<"!W:61T:#TS1#0T)2!A;&EG
M;CTS1&QE9G0^(#QD:78@<W1Y;&4],T0G1$E34$Q!63H@8FQO8VL[($9/3E0M
M1D%-24Q9.B!T:6UE<R!N97<@<F]M86X[($9/3E0M4TE:13H@,3!P=#L@34%2
M1TE.+4Q%1E0Z(#!P=#L@34%21TE.+5))1TA4.B`P<'0[('1E>'0M86QI9VXZ
M(&QE9G0[(%1%6%0M24Y$14Y4.B`P<'0G/B!,86)O<F%T;W)Y(&5Q=6EP;65N
M=#PO9&EV/B`\+W1D/B`\=&0@=F%L:6=N/3-$=&]P('=I9'1H/3-$,C@E(&%L
M:6=N/3-$;&5F=#X@/&1I=B!S='EL93TS1"=$25-03$%9.B!B;&]C:SL@1D].
M5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T.R!-
M05)'24XM3$5&5#H@,'!T.R!-05)'24XM4DE'2%0Z("TQ,BXS<'0[('1E>'0M
M86QI9VXZ(&QE9G0[(%1%6%0M24Y$14Y4.B`P<'0G/B`Q,"TQ-3PO9&EV/B`\
M+W1D/B`\=&0@=F%L:6=N/3-$=&]P('=I9'1H/3-$,C@E/CQF;VYT('-T>6QE
M/3-$)T9/3E0M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R
M;VUA;CL@1$E34$Q!63H@:6YL:6YE)SX@)FYB<W`[/"]F;VYT/B`\+W1D/B`\
M+W1R/B`\='(@8F=C;VQO<CTS1'=H:71E/B`\=&0@=F%L:6=N/3-$=&]P('=I
M9'1H/3-$-#0E(&%L:6=N/3-$;&5F=#X@/&1I=B!S='EL93TS1"=$25-03$%9
M.B!B;&]C:SL@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U3
M25I%.B`Q,'!T.R!-05)'24XM3$5&5#H@,'!T.R!-05)'24XM4DE'2%0Z(#!P
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M34%21TE.+5))1TA4.B`M,3(N,W!T.R!T97AT+6%L:6=N.B!L969T.R!415A4
M+4E.1$5.5#H@,'!T)SX@,S,\+V1I=CX@/"]T9#X@/'1D('9A;&EG;CTS1'1O
M<"!W:61T:#TS1#(X)3X\9F]N="!S='EL93TS1"=&3TY4+5-)6D4Z(#$P<'0[
M($9/3E0M1D%-24Q9.B!T:6UE<R!N97<@<F]M86X[($1)4U!,05DZ(&EN;&EN
M92<^("9N8G-P.SPO9F]N=#X@/"]T9#X@/"]T<CX@/'1R(&)G8V]L;W(],T0C
M8V-E969F/B`\=&0@=F%L:6=N/3-$=&]P('=I9'1H/3-$-#0E(&%L:6=N/3-$
M;&5F=#X@/&1I=B!S='EL93TS1"=$25-03$%9.B!B;&]C:SL@1D].5"U&04U)
M3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T.R!-05)'24XM
M3$5&5#H@,'!T.R!-05)'24XM4DE'2%0Z(#!P=#L@=&5X="UA;&EG;CH@;&5F
M=#L@5$585"U)3D1%3E0Z(#!P="<^($]F9FEC92!F=7)N:71U<F4@86YD(&5Q
M=6EP;65N=#PO9&EV/B`\+W1D/B`\=&0@=F%L:6=N/3-$=&]P('=I9'1H/3-$
M,C@E(&%L:6=N/3-$;&5F=#X@/&1I=B!S='EL93TS1"=$25-03$%9.B!B;&]C
M:SL@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q
M,'!T.R!-05)'24XM3$5&5#H@,'!T.R!-05)'24XM4DE'2%0Z("TQ,BXS<'0[
M('1E>'0M86QI9VXZ(&QE9G0[(%1%6%0M24Y$14Y4.B`P<'0G/B`V+3$U/"]D
M:78^(#PO=&0^(#QT9"!V86QI9VX],T1T;W`@=VED=&@],T0R."4^/&9O;G0@
M<W1Y;&4],T0G1D].5"U325I%.B`Q,'!T.R!&3TY4+49!34E,63H@=&EM97,@
M;F5W(')O;6%N.R!$25-03$%9.B!I;FQI;F4G/B`F;F)S<#L\+V9O;G0^(#PO
M=&0^(#PO='(^(#QT<B!B9V-O;&]R/3-$=VAI=&4^(#QT9"!V86QI9VX],T1T
M;W`@=VED=&@],T0T-"4@86QI9VX],T1L969T/B`\9&EV('-T>6QE/3-$)T1)
M4U!,05DZ(&)L;V-K.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!&
M3TY4+5-)6D4Z(#$P<'0[($U!4D=)3BU,1494.B`P<'0[($U!4D=)3BU224=(
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M1TA4.B`M,3(N,W!T.R!T97AT+6%L:6=N.B!L969T.R!415A4+4E.1$5.5#H@
M,'!T)SX@,34\+V1I=CX@/"]T9#X@/"]T<CX@/'1R(&)G8V]L;W(],T0C8V-E
M969F/B`\=&0@=F%L:6=N/3-$=&]P('=I9'1H/3-$-#0E(&%L:6=N/3-$;&5F
M=#X@/&1I=B!S='EL93TS1"=$25-03$%9.B!B;&]C:SL@1D].5"U&04U)3%DZ
M('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T.R!-05)'24XM3$5&
M5#H@,'!T.R!-05)'24XM4DE'2%0Z(#!P=#L@=&5X="UA;&EG;CH@;&5F=#L@
M5$585"U)3D1%3E0Z(#!P="<^($QE87-E:&]L9"!I;7!R;W9E;65N=',\+V1I
M=CX@/"]T9#X@/'1D('9A;&EG;CTS1'1O<"!W:61T:#TS1#4V)2!C;VQS<&%N
M/3-$,B!A;&EG;CTS1&QE9G0^(#QD:78@<W1Y;&4],T0G1$E34$Q!63H@8FQO
M8VL[($U!4D=)3BU,1494.B`P<'0[($U!4D=)3BU224=(5#H@+3$R+C-P=#L@
M=&5X="UA;&EG;CH@;&5F=#L@5$585"U)3D1%3E0Z(#!P="<^(#QF;VYT('-T
M>6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ('1I;65S(&YE
M=R!R;VUA;CL@1$E34$Q!63H@:6YL:6YE)SX@5&AE('-H;W)T97(@;V8@=&AE
M(&5X<&5C=&5D/"]F;VYT/B`\9F]N="!S='EL93TS1"=&3TY4+5-)6D4Z(#$P
M<'0[($9/3E0M1D%-24Q9.B!T:6UE<R!N97<@<F]M86X[($1)4U!,05DZ(&EN
M;&EN92<^('5S969U;"!L:69E(&]R('1H93PO9F]N=#X\+V1I=CX@/&1I=B!S
M='EL93TS1"=$25-03$%9.B!B;&]C:SL@34%21TE.+4Q%1E0Z(#!P=#L@34%2
M1TE.+5))1TA4.B`M,3(N,W!T.R!T97AT+6%L:6=N.B!L969T.R!415A4+4E.
M1$5.5#H@,'!T)SX@/&9O;G0@<W1Y;&4],T0G1D].5"U325I%.B`Q,'!T.R!&
M3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!$25-03$%9.B!I;FQI;F4G
M/B!R96%S;VYA8FQE(&%S<W5M960\+V9O;G0^(#QF;VYT('-T>6QE/3-$)T9/
M3E0M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@
M1$E34$Q!63H@:6YL:6YE)SX@=&5R;2!O9B!T:&4@;&5A<V4N/"]F;VYT/CPO
M9&EV/B`\+W1D/B`\+W1R/B`\+W1A8FQE/B`\+V1I=CX@/"$M+45N9$9R86=M
M96YT+2T^/"]D:78^(#PO9&EV/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@
M/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS1')E/@T*("`@("`@("`\=&0@8VQA
M<W,],T1P;"!V86QI9VX],T1T;W`^4V-H961U;&4@;V8@0V]M<')E:&5N<VEV
M92!);F-O;64\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\(2TM
M1$]#5%E012!H=&UL(%!50DQ)0R`B+2\O5S-#+R]$5$0@6$A434P@,2XP(%1R
M86YS:71I;VYA;"\O14XB(")H='1P.B\O=W=W+G<S+F]R9R]44B]X:'1M;#$O
M1%1$+WAH=&UL,2UT<F%N<VET:6]N86PN9'1D(B`M+3X\9&EV/B`\9&EV/CPA
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M93TS1"=$25-03$%9.B!B;&]C:SL@5$585"U)3D1%3E0Z(#!P="<^)FYB<W`[
M/"]D:78^(#QD:78@<W1Y;&4],T0G=&5X="UA;&EG;CH@<FEG:'0G/B`\=&%B
M;&4@<W1Y;&4],T0G1D].5"U325I%.B`Q,'!T.R!&3TY4+49!34E,63H@=&EM
M97,@;F5W(')O;6%N)R!C96QL<W!A8VEN9STS1#`@8V5L;'!A9&1I;F<],T0P
M('=I9'1H/3-$.3<E/B`\='(^(#QT9"!S='EL93TS1"=0041$24Y'+4)/5%1/
M33H@,G!X)R!V86QI9VX],T1B;W1T;VT@=VED=&@],T0V-"4^/&9O;G0@<W1Y
M;&4],T0G1D].5"U325I%.B`Q,'!T.R!&3TY4+49!34E,63H@=&EM97,@;F5W
M(')O;6%N.R!$25-03$%9.B!I;FQI;F4G/B`F;F)S<#L\+V9O;G0^(#PO=&0^
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M25I%.B`Q,'!T.R!-05)'24XM3$5&5#H@,'!T.R!-05)'24XM4DE'2%0Z(#!P
M=#L@=&5X="UA;&EG;CH@8V5N=&5R.R!415A4+4E.1$5.5#H@,'!T)SX@665A
M<B!E;F1E9"!*=6YE(#,P+"`R,#$T/"]D:78^(#PO=&0^(#QT9"!S='EL93TS
M1"=0041$24Y'+4)/5%1/33H@,G!X.R!415A4+4%,24=..B!L969T)R!V86QI
M9VX],T1B;W1T;VT@=VED=&@],T0Q)2!N;W=R87`],T1N;W=R87`^/&9O;G0@
M<W1Y;&4],T0G1D].5"U325I%.B`Q,'!T.R!&3TY4+49!34E,63H@=&EM97,@
M;F5W(')O;6%N.R!$25-03$%9.B!I;FQI;F4G/B`F;F)S<#L\+V9O;G0^(#PO
M=&0^(#PO='(^(#QT<CX@/'1D('-T>6QE/3-$)U!!1$1)3D<M0D]45$]-.B`R
M<'@G('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#8T)3X\9F]N="!S='EL93TS
M1"=&3TY4+5-)6D4Z(#$P<'0[($9/3E0M1D%-24Q9.B!T:6UE<R!N97<@<F]M
M86X[($1)4U!,05DZ(&EN;&EN92<^("9N8G-P.SPO9F]N=#X@/"]T9#X@/'1D
M('-T>6QE/3-$)U!!1$1)3D<M0D]45$]-.B`R<'@G('9A;&EG;CTS1&)O='1O
M;2!W:61T:#TS1#$E/CQF;VYT('-T>6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@
M1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1$E34$Q!63H@:6YL:6YE
M)SX@)FYB<W`[/"]F;VYT/B`\+W1D/B`\=&0@<W1Y;&4],T0G0D]21$52+4)/
M5%1/33H@8FQA8VL@,G!X('-O;&ED)R!V86QI9VX],T1B;W1T;VT@=VED=&@]
M,T0Q,"4@8V]L<W!A;CTS1#(^(#QD:78@<W1Y;&4],T0G1$E34$Q!63H@8FQO
M8VL[($9/3E0M1D%-24Q9.B!T:6UE<R!N97<@<F]M86X[($9/3E0M4TE:13H@
M,3!P=#L@34%21TE.+4Q%1E0Z(#!P=#L@34%21TE.+5))1TA4.B`P<'0[('1E
M>'0M86QI9VXZ(&-E;G1E<CL@5$585"U)3D1%3E0Z(#!P="<^(%5N<F5A;&EZ
M960\+V1I=CX@/&1I=B!S='EL93TS1"=$25-03$%9.B!B;&]C:SL@1D].5"U&
M04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T.R!-05)'
M24XM3$5&5#H@,'!T.R!-05)'24XM4DE'2%0Z(#!P=#L@=&5X="UA;&EG;CH@
M8V5N=&5R.R!415A4+4E.1$5.5#H@,'!T)SX@9V%I;G,\+V1I=CX@/&1I=B!S
M='EL93TS1"=$25-03$%9.B!B;&]C:SL@1D].5"U&04U)3%DZ('1I;65S(&YE
M=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T.R!-05)'24XM3$5&5#H@,'!T.R!-
M05)'24XM4DE'2%0Z(#!P=#L@=&5X="UA;&EG;CH@8V5N=&5R.R!415A4+4E.
M1$5.5#H@,'!T)SX@;VX@;6%R:V5T86)L93PO9&EV/B`\9&EV('-T>6QE/3-$
M)T1)4U!,05DZ(&)L;V-K.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N
M.R!&3TY4+5-)6D4Z(#$P<'0[($U!4D=)3BU,1494.B`P<'0[($U!4D=)3BU2
M24=(5#H@,'!T.R!T97AT+6%L:6=N.B!C96YT97([(%1%6%0M24Y$14Y4.B`P
M<'0G/B!S96-U<FET:65S/"]D:78^(#PO=&0^(#QT9"!S='EL93TS1"=0041$
M24Y'+4)/5%1/33H@,G!X.R!415A4+4%,24=..B!L969T)R!V86QI9VX],T1B
M;W1T;VT@=VED=&@],T0Q)2!N;W=R87`],T1N;W=R87`^/&9O;G0@<W1Y;&4]
M,T0G1D].5"U325I%.B`Q,'!T.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O
M;6%N.R!$25-03$%9.B!I;FQI;F4G/B`F;F)S<#L\+V9O;G0^(#PO=&0^(#QT
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M/3-$,3`E(&-O;'-P86X],T0R/B`\9&EV('-T>6QE/3-$)T1)4U!,05DZ(&)L
M;V-K.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!&3TY4+5-)6D4Z
M(#$P<'0[($U!4D=)3BU,1494.B`P<'0[($U!4D=)3BU224=(5#H@,'!T.R!T
M97AT+6%L:6=N.B!C96YT97([(%1%6%0M24Y$14Y4.B`P<'0G/B!5;G)E86QI
M>F5D/"]D:78^(#QD:78@<W1Y;&4],T0G1$E34$Q!63H@8FQO8VL[($9/3E0M
M1D%-24Q9.B!T:6UE<R!N97<@<F]M86X[($9/3E0M4TE:13H@,3!P=#L@34%2
M1TE.+4Q%1E0Z(#!P=#L@34%21TE.+5))1TA4.B`P<'0[('1E>'0M86QI9VXZ
M(&-E;G1E<CL@5$585"U)3D1%3E0Z(#!P="<^(&=A:6YS/"]D:78^(#QD:78@
M<W1Y;&4],T0G1$E34$Q!63H@8FQO8VL[($9/3E0M1D%-24Q9.B!T:6UE<R!N
M97<@<F]M86X[($9/3E0M4TE:13H@,3!P=#L@34%21TE.+4Q%1E0Z(#!P=#L@
M34%21TE.+5))1TA4.B`P<'0[('1E>'0M86QI9VXZ(&-E;G1E<CL@5$585"U)
M3D1%3E0Z(#!P="<^(&]N(&-A<V@@9FQO=SPO9&EV/B`\9&EV('-T>6QE/3-$
M)T1)4U!,05DZ(&)L;V-K.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N
M.R!&3TY4+5-)6D4Z(#$P<'0[($U!4D=)3BU,1494.B`P<'0[($U!4D=)3BU2
M24=(5#H@,'!T.R!T97AT+6%L:6=N.B!C96YT97([(%1%6%0M24Y$14Y4.B`P
M<'0G/B!H961G97,\+V1I=CX@/"]T9#X@/'1D('-T>6QE/3-$)U!!1$1)3D<M
M0D]45$]-.B`R<'@[(%1%6%0M04Q)1TXZ(&QE9G0G('9A;&EG;CTS1&)O='1O
M;2!W:61T:#TS1#$E(&YO=W)A<#TS1&YO=W)A<#X\9F]N="!S='EL93TS1"=&
M3TY4+5-)6D4Z(#$P<'0[($9/3E0M1D%-24Q9.B!T:6UE<R!N97<@<F]M86X[
M($1)4U!,05DZ(&EN;&EN92<^("9N8G-P.SPO9F]N=#X@/"]T9#X@/'1D('-T
M>6QE/3-$)U!!1$1)3D<M0D]45$]-.B`R<'@G('9A;&EG;CTS1&)O='1O;2!W
M:61T:#TS1#$E/CQF;VYT('-T>6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@1D].
M5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1$E34$Q!63H@:6YL:6YE)SX@
M)FYB<W`[/"]F;VYT/B`\+W1D/B`\=&0@<W1Y;&4],T0G0D]21$52+4)/5%1/
M33H@8FQA8VL@,G!X('-O;&ED)R!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q
M,"4@8V]L<W!A;CTS1#(^(#QD:78@<W1Y;&4],T0G1$E34$Q!63H@8FQO8VL[
M($9/3E0M1D%-24Q9.B!T:6UE<R!N97<@<F]M86X[($9/3E0M4TE:13H@,3!P
M=#L@34%21TE.+4Q%1E0Z(#!P=#L@34%21TE.+5))1TA4.B`P<'0[('1E>'0M
M86QI9VXZ(&-E;G1E<CL@5$585"U)3D1%3E0Z(#!P="<^(%1O=&%L/"]D:78^
M(#PO=&0^(#QT9"!S='EL93TS1"=0041$24Y'+4)/5%1/33H@,G!X.R!415A4
M+4%,24=..B!L969T)R!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)2!N;W=R
M87`],T1N;W=R87`^/&9O;G0@<W1Y;&4],T0G1D].5"U325I%.B`Q,'!T.R!&
M3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!$25-03$%9.B!I;FQI;F4G
M/B`F;F)S<#L\+V9O;G0^(#PO=&0^(#PO='(^(#QT<B!B9V-O;&]R/3-$(V-C
M965F9CX@/'1D('-T>6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0[($U!4D=)3BU,
M1494.B`P<'0[($U!4D=)3BU224=(5#H@,'!T.R!415A4+4E.1$5.5#H@,'!T
M)R!V86QI9VX],T1B;W1T;VT@=VED=&@],T0V-"4^(#QD:78@<W1Y;&4],T0G
M1$E34$Q!63H@8FQO8VL[($9/3E0M1D%-24Q9.B!T:6UE<R!N97<@<F]M86X[
M($9/3E0M4TE:13H@,3!P=#L@34%21TE.+4Q%1E0Z(#!P=#L@34%21TE.+5))
M1TA4.B`P<'0[(%1%6%0M04Q)1TXZ(&QE9G0[(%1%6%0M24Y$14Y4.B`P<'0G
M/B!"96=I;FYI;F<@8F%L86YC93PO9&EV/B`\+W1D/B`\=&0@=F%L:6=N/3-$
M8F]T=&]M('=I9'1H/3-$,24@86QI9VX],T1R:6=H=#X\9F]N="!S='EL93TS
M1"=&3TY4+5-)6D4Z(#$P<'0[($9/3E0M1D%-24Q9.B!T:6UE<R!N97<@<F]M
M86X[($1)4U!,05DZ(&EN;&EN92<^("9N8G-P.SPO9F]N=#X@/"]T9#X@/'1D
M('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S
M(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T.R!415A4+4%,24=..B!L969T
M)R!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)3XD/"]T9#X@/'1D('-T>6QE
M/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R
M;VUA;CL@1D].5"U325I%.B`Q,'!T.R!415A4+4%,24=..B!R:6=H="<@=F%L
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M5"U325I%.B`Q,'!T.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!$
M25-03$%9.B!I;FQI;F4G/B`F;F)S<#L\+V9O;G0^(#PO=&0^(#QT9"!S='EL
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M1&)O='1O;2!W:61T:#TS1#DE/BT\+W1D/B`\=&0@<W1Y;&4],T0G5$585"U!
M3$E'3CH@;&5F="<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@;F]W<F%P
M/3-$;F]W<F%P/CQF;VYT('-T>6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@1D].
M5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1$E34$Q!63H@:6YL:6YE)SX@
M)FYB<W`[/"]F;VYT/B`\+W1D/B`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H
M/3-$,24@86QI9VX],T1R:6=H=#X\9F]N="!S='EL93TS1"=&3TY4+5-)6D4Z
M(#$P<'0[($9/3E0M1D%-24Q9.B!T:6UE<R!N97<@<F]M86X[($1)4U!,05DZ
M(&EN;&EN92<^("9N8G-P.SPO9F]N=#X@/"]T9#X@/'1D('-T>6QE/3-$)T1)
M4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@
M1D].5"U325I%.B`Q,'!T.R!415A4+4%,24=..B!L969T)R!V86QI9VX],T1B
M;W1T;VT@=VED=&@],T0Q)3XD/"]T9#X@/'1D('-T>6QE/3-$)T1)4U!,05DZ
M(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U3
M25I%.B`Q,'!T.R!415A4+4%,24=..B!R:6=H="<@=F%L:6=N/3-$8F]T=&]M
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M('-T>6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0[($U!4D=)3BU,1494.B`P<'0[
M($U!4D=)3BU224=(5#H@,'!T.R!415A4+4E.1$5.5#H@,'!T)R!V86QI9VX]
M,T1B;W1T;VT@=VED=&@],T0V-"4^(#QD:78@<W1Y;&4],T0G1$E34$Q!63H@
M8FQO8VL[($9/3E0M1D%-24Q9.B!T:6UE<R!N97<@<F]M86X[($9/3E0M4TE:
M13H@,3!P=#L@34%21TE.+4Q%1E0Z(#!P=#L@34%21TE.+5))1TA4.B`P<'0[
M(%1%6%0M04Q)1TXZ(&QE9G0[(%1%6%0M24Y$14Y4.B`P<'0G/B!/=&AE<B!C
M;VUP<F5H96YS:79E(&EN8V]M92!B969O<F4@<F5C;&%S<VEF:6-A=&EO;G,\
M+V1I=CX@/"]T9#X@/'1D('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E(&%L
M:6=N/3-$<FEG:'0^/&9O;G0@<W1Y;&4],T0G1D].5"U325I%.B`Q,'!T.R!&
M3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!$25-03$%9.B!I;FQI;F4G
M/B`F;F)S<#L\+V9O;G0^(#PO=&0^(#QT9"!S='EL93TS1"=415A4+4%,24=.
M.B!L969T)R!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)3X\9F]N="!S='EL
M93TS1"=&3TY4+5-)6D4Z(#$P<'0[($9/3E0M1D%-24Q9.B!T:6UE<R!N97<@
M<F]M86X[($1)4U!,05DZ(&EN;&EN92<^("9N8G-P.SPO9F]N=#X@/"]T9#X@
M/'1D('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I
M;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T.R!415A4+4%,24=..B!R
M:6=H="<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$.24^,RPT,#0\+W1D/B`\
M=&0@<W1Y;&4],T0G5$585"U!3$E'3CH@;&5F="<@=F%L:6=N/3-$8F]T=&]M
M('=I9'1H/3-$,24@;F]W<F%P/3-$;F]W<F%P/CQF;VYT('-T>6QE/3-$)T9/
M3E0M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@
M1$E34$Q!63H@:6YL:6YE)SX@)FYB<W`[/"]F;VYT/B`\+W1D/B`\=&0@=F%L
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M:6YE)SX@)FYB<W`[/"]F;VYT/B`\+W1D/B`\=&0@<W1Y;&4],T0G1$E34$Q!
M63H@:6YL:6YE.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!&3TY4
M+5-)6D4Z(#$P<'0[(%1%6%0M04Q)1TXZ(')I9VAT)R!V86QI9VX],T1B;W1T
M;VT@=VED=&@],T0Y)3XR,SPO=&0^(#QT9"!S='EL93TS1"=415A4+4%,24=.
M.B!L969T)R!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)2!N;W=R87`],T1N
M;W=R87`^/&9O;G0@<W1Y;&4],T0G1D].5"U325I%.B`Q,'!T.R!&3TY4+49!
M34E,63H@=&EM97,@;F5W(')O;6%N.R!$25-03$%9.B!I;FQI;F4G/B`F;F)S
M<#L\+V9O;G0^(#PO=&0^(#QT9"!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q
M)2!A;&EG;CTS1')I9VAT/CQF;VYT('-T>6QE/3-$)T9/3E0M4TE:13H@,3!P
M=#L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1$E34$Q!63H@:6YL
M:6YE)SX@)FYB<W`[/"]F;VYT/B`\+W1D/B`\=&0@<W1Y;&4],T0G5$585"U!
M3$E'3CH@;&5F="<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24^/&9O;G0@
M<W1Y;&4],T0G1D].5"U325I%.B`Q,'!T.R!&3TY4+49!34E,63H@=&EM97,@
M;F5W(')O;6%N.R!$25-03$%9.B!I;FQI;F4G/B`F;F)S<#L\+V9O;G0^(#PO
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M<CX@/'1R(&)G8V]L;W(],T0C8V-E969F/B`\=&0@<W1Y;&4],T0G5$585"U!
M3$E'3CH@;&5F=#L@34%21TE.+4Q%1E0Z(#!P=#L@34%21TE.+5))1TA4.B`P
M<'0[(%1%6%0M24Y$14Y4.B`P<'0G('9A;&EG;CTS1&)O='1O;2!W:61T:#TS
M1#8T)3X@/&1I=B!S='EL93TS1"=$25-03$%9.B!B;&]C:SL@1D].5"U&04U)
M3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T.R!-05)'24XM
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M<W`[/"]F;VYT/B`\+W1D/B`\=&0@<W1Y;&4],T0G5$585"U!3$E'3CH@;&5F
M="<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24^/&9O;G0@<W1Y;&4],T0G
M1D].5"U325I%.B`Q,'!T.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N
M.R!$25-03$%9.B!I;FQI;F4G/B`F;F)S<#L\+V9O;G0^(#PO=&0^(#QT9"!S
M='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE<R!N
M97<@<F]M86X[($9/3E0M4TE:13H@,3!P=#L@5$585"U!3$E'3CH@<FEG:'0G
M('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#DE/B@W,C<\+W1D/B`\=&0@<W1Y
M;&4],T0G1$E34$Q!63H@:6YL:6YE.R!&3TY4+49!34E,63H@=&EM97,@;F5W
M(')O;6%N.R!&3TY4+5-)6D4Z(#$P<'0[(%1%6%0M04Q)1TXZ(&QE9G0G('9A
M;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E(&YO=W)A<#TS1&YO=W)A<#XI/"]T
M9#X@/'1D('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E(&%L:6=N/3-$<FEG
M:'0^/&9O;G0@<W1Y;&4],T0G1D].5"U325I%.B`Q,'!T.R!&3TY4+49!34E,
M63H@=&EM97,@;F5W(')O;6%N.R!$25-03$%9.B!I;FQI;F4G/B`F;F)S<#L\
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M;VUA;CL@1D].5"U325I%.B`Q,'!T.R!415A4+4%,24=..B!R:6=H="<@=F%L
M:6=N/3-$8F]T=&]M('=I9'1H/3-$.24^+3PO=&0^(#QT9"!S='EL93TS1"=4
M15A4+4%,24=..B!L969T)R!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)2!N
M;W=R87`],T1N;W=R87`^/&9O;G0@<W1Y;&4],T0G1D].5"U325I%.B`Q,'!T
M.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!$25-03$%9.B!I;FQI
M;F4G/B`F;F)S<#L\+V9O;G0^(#PO=&0^(#QT9"!V86QI9VX],T1B;W1T;VT@
M=VED=&@],T0Q)2!A;&EG;CTS1')I9VAT/CQF;VYT('-T>6QE/3-$)T9/3E0M
M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1$E3
M4$Q!63H@:6YL:6YE)SX@)FYB<W`[/"]F;VYT/B`\+W1D/B`\=&0@<W1Y;&4]
M,T0G5$585"U!3$E'3CH@;&5F="<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$
M,24^/&9O;G0@<W1Y;&4],T0G1D].5"U325I%.B`Q,'!T.R!&3TY4+49!34E,
M63H@=&EM97,@;F5W(')O;6%N.R!$25-03$%9.B!I;FQI;F4G/B`F;F)S<#L\
M+V9O;G0^(#PO=&0^(#QT9"!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/
M3E0M1D%-24Q9.B!T:6UE<R!N97<@<F]M86X[($9/3E0M4TE:13H@,3!P=#L@
M5$585"U!3$E'3CH@<FEG:'0G('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#DE
M/B@W,C<\+W1D/B`\=&0@<W1Y;&4],T0G1$E34$Q!63H@:6YL:6YE.R!&3TY4
M+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!&3TY4+5-)6D4Z(#$P<'0[(%1%
M6%0M04Q)1TXZ(&QE9G0G('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E(&YO
M=W)A<#TS1&YO=W)A<#XI/"]T9#X@/"]T<CX@/'1R(&)G8V]L;W(],T1W:&ET
M93X@/'1D('-T>6QE/3-$)U!!1$1)3D<M0D]45$]-.B`R<'@[(%1%6%0M04Q)
M1TXZ(&QE9G0[($U!4D=)3BU,1494.B`P<'0[($U!4D=)3BU224=(5#H@,'!T
M.R!415A4+4E.1$5.5#H@,'!T)R!V86QI9VX],T1B;W1T;VT@=VED=&@],T0V
M-"4^(#QD:78@<W1Y;&4],T0G1$E34$Q!63H@8FQO8VL[($9/3E0M1D%-24Q9
M.B!T:6UE<R!N97<@<F]M86X[($9/3E0M4TE:13H@,3!P=#L@34%21TE.+4Q%
M1E0Z(#!P=#L@34%21TE.+5))1TA4.B`P<'0[(%1%6%0M04Q)1TXZ(&QE9G0[
M(%1%6%0M24Y$14Y4.B`P<'0G/B!.970@8W5R<F5N="UP97)I;V0@;W1H97(@
M8V]M<')E:&5N<VEV92!I;F-O;64\+V1I=CX@/"]T9#X@/'1D('-T>6QE/3-$
M)U!!1$1)3D<M0D]45$]-.B`R<'@G('9A;&EG;CTS1&)O='1O;2!W:61T:#TS
M1#$E(&%L:6=N/3-$<FEG:'0^/&9O;G0@<W1Y;&4],T0G1D].5"U325I%.B`Q
M,'!T.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!$25-03$%9.B!I
M;FQI;F4G/B`F;F)S<#L\+V9O;G0^(#PO=&0^(#QT9"!S='EL93TS1"="3U)$
M15(M0D]45$]-.B!B;&%C:R`R<'@@<V]L:60[(%1%6%0M04Q)1TXZ(&QE9G0G
M('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E/CQF;VYT('-T>6QE/3-$)T9/
M3E0M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@
M1$E34$Q!63H@:6YL:6YE)SX@)FYB<W`[/"]F;VYT/B`\+W1D/B`\=&0@<W1Y
M;&4],T0G0D]21$52+4)/5%1/33H@8FQA8VL@,G!X('-O;&ED.R!$25-03$%9
M.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE<R!N97<@<F]M86X[($9/3E0M
M4TE:13H@,3!P=#L@5$585"U!3$E'3CH@<FEG:'0G('9A;&EG;CTS1&)O='1O
M;2!W:61T:#TS1#DE/C(L-C<W/"]T9#X@/'1D('-T>6QE/3-$)U!!1$1)3D<M
M0D]45$]-.B`R<'@[(%1%6%0M04Q)1TXZ(&QE9G0G('9A;&EG;CTS1&)O='1O
M;2!W:61T:#TS1#$E(&YO=W)A<#TS1&YO=W)A<#X\9F]N="!S='EL93TS1"=&
M3TY4+5-)6D4Z(#$P<'0[($9/3E0M1D%-24Q9.B!T:6UE<R!N97<@<F]M86X[
M($1)4U!,05DZ(&EN;&EN92<^("9N8G-P.SPO9F]N=#X@/"]T9#X@/'1D('-T
M>6QE/3-$)U!!1$1)3D<M0D]45$]-.B`R<'@G('9A;&EG;CTS1&)O='1O;2!W
M:61T:#TS1#$E(&%L:6=N/3-$<FEG:'0^/&9O;G0@<W1Y;&4],T0G1D].5"U3
M25I%.B`Q,'!T.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!$25-0
M3$%9.B!I;FQI;F4G/B`F;F)S<#L\+V9O;G0^(#PO=&0^(#QT9"!S='EL93TS
M1"="3U)$15(M0D]45$]-.B!B;&%C:R`R<'@@<V]L:60[(%1%6%0M04Q)1TXZ
M(&QE9G0G('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E/CQF;VYT('-T>6QE
M/3-$)T9/3E0M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R
M;VUA;CL@1$E34$Q!63H@:6YL:6YE)SX@)FYB<W`[/"]F;VYT/B`\+W1D/B`\
M=&0@<W1Y;&4],T0G0D]21$52+4)/5%1/33H@8FQA8VL@,G!X('-O;&ED.R!$
M25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE<R!N97<@<F]M86X[
M($9/3E0M4TE:13H@,3!P=#L@5$585"U!3$E'3CH@<FEG:'0G('9A;&EG;CTS
M1&)O='1O;2!W:61T:#TS1#DE/C(S/"]T9#X@/'1D('-T>6QE/3-$)U!!1$1)
M3D<M0D]45$]-.B`R<'@[(%1%6%0M04Q)1TXZ(&QE9G0G('9A;&EG;CTS1&)O
M='1O;2!W:61T:#TS1#$E(&YO=W)A<#TS1&YO=W)A<#X\9F]N="!S='EL93TS
M1"=&3TY4+5-)6D4Z(#$P<'0[($9/3E0M1D%-24Q9.B!T:6UE<R!N97<@<F]M
M86X[($1)4U!,05DZ(&EN;&EN92<^("9N8G-P.SPO9F]N=#X@/"]T9#X@/'1D
M('-T>6QE/3-$)U!!1$1)3D<M0D]45$]-.B`R<'@G('9A;&EG;CTS1&)O='1O
M;2!W:61T:#TS1#$E(&%L:6=N/3-$<FEG:'0^/&9O;G0@<W1Y;&4],T0G1D].
M5"U325I%.B`Q,'!T.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!$
M25-03$%9.B!I;FQI;F4G/B`F;F)S<#L\+V9O;G0^(#PO=&0^(#QT9"!S='EL
M93TS1"="3U)$15(M0D]45$]-.B!B;&%C:R`R<'@@<V]L:60[(%1%6%0M04Q)
M1TXZ(&QE9G0G('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E/CQF;VYT('-T
M>6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ('1I;65S(&YE
M=R!R;VUA;CL@1$E34$Q!63H@:6YL:6YE)SX@)FYB<W`[/"]F;VYT/B`\+W1D
M/B`\=&0@<W1Y;&4],T0G0D]21$52+4)/5%1/33H@8FQA8VL@,G!X('-O;&ED
M.R!$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE<R!N97<@<F]M
M86X[($9/3E0M4TE:13H@,3!P=#L@5$585"U!3$E'3CH@<FEG:'0G('9A;&EG
M;CTS1&)O='1O;2!W:61T:#TS1#DE/C(L-S`P/"]T9#X@/'1D('-T>6QE/3-$
M)U!!1$1)3D<M0D]45$]-.B`R<'@[(%1%6%0M04Q)1TXZ(&QE9G0G('9A;&EG
M;CTS1&)O='1O;2!W:61T:#TS1#$E(&YO=W)A<#TS1&YO=W)A<#X\9F]N="!S
M='EL93TS1"=&3TY4+5-)6D4Z(#$P<'0[($9/3E0M1D%-24Q9.B!T:6UE<R!N
M97<@<F]M86X[($1)4U!,05DZ(&EN;&EN92<^("9N8G-P.SPO9F]N=#X@/"]T
M9#X@/"]T<CX@/'1R(&)G8V]L;W(],T0C8V-E969F/B`\=&0@<W1Y;&4],T0G
M4$%$1$E.1RU"3U143TTZ(#1P>#L@5$585"U!3$E'3CH@;&5F=#L@34%21TE.
M+4Q%1E0Z(#!P=#L@34%21TE.+5))1TA4.B`P<'0[(%1%6%0M24Y$14Y4.B`P
M<'0G('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#8T)3X@/&1I=B!S='EL93TS
M1"=$25-03$%9.B!B;&]C:SL@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA
M;CL@1D].5"U325I%.B`Q,'!T.R!-05)'24XM3$5&5#H@,'!T.R!-05)'24XM
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M:6YE)SX@)FYB<W`[/"]F;VYT/B`\+W1D/B`\=&0@<W1Y;&4],T0G0D]21$52
M+4)/5%1/33H@8FQA8VL@-'!X(&1O=6)L93L@1$E34$Q!63H@:6YL:6YE.R!&
M3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!&3TY4+5-)6D4Z(#$P<'0[
M(%1%6%0M04Q)1TXZ(&QE9G0G('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E
M/B0\+W1D/B`\=&0@<W1Y;&4],T0G0D]21$52+4)/5%1/33H@8FQA8VL@-'!X
M(&1O=6)L93L@1$E34$Q!63H@:6YL:6YE.R!&3TY4+49!34E,63H@=&EM97,@
M;F5W(')O;6%N.R!&3TY4+5-)6D4Z(#$P<'0[(%1%6%0M04Q)1TXZ(')I9VAT
M)R!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Y)3XR+#DS-CPO=&0^(#QT9"!S
M='EL93TS1"=0041$24Y'+4)/5%1/33H@-'!X.R!415A4+4%,24=..B!L969T
M)R!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)2!N;W=R87`],T1N;W=R87`^
M/&9O;G0@<W1Y;&4],T0G1D].5"U325I%.B`Q,'!T.R!&3TY4+49!34E,63H@
M=&EM97,@;F5W(')O;6%N.R!$25-03$%9.B!I;FQI;F4G/B`F;F)S<#L\+V9O
M;G0^(#PO=&0^(#QT9"!S='EL93TS1"=0041$24Y'+4)/5%1/33H@-'!X)R!V
M86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)2!A;&EG;CTS1')I9VAT/CQF;VYT
M('-T>6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ('1I;65S
M(&YE=R!R;VUA;CL@1$E34$Q!63H@:6YL:6YE)SX@)FYB<W`[/"]F;VYT/B`\
M+W1D/B`\=&0@<W1Y;&4],T0G0D]21$52+4)/5%1/33H@8FQA8VL@-'!X(&1O
M=6)L93L@1$E34$Q!63H@:6YL:6YE.R!&3TY4+49!34E,63H@=&EM97,@;F5W
M(')O;6%N.R!&3TY4+5-)6D4Z(#$P<'0[(%1%6%0M04Q)1TXZ(&QE9G0G('9A
M;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E/B0\+W1D/B`\=&0@<W1Y;&4],T0G
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M,T0Q)2!N;W=R87`],T1N;W=R87`^/&9O;G0@<W1Y;&4],T0G1D].5"U325I%
M.B`Q,'!T.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!$25-03$%9
M.B!I;FQI;F4G/B`F;F)S<#L\+V9O;G0^(#PO=&0^(#QT9"!S='EL93TS1"=0
M041$24Y'+4)/5%1/33H@-'!X)R!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q
M)2!A;&EG;CTS1')I9VAT/CQF;VYT('-T>6QE/3-$)T9/3E0M4TE:13H@,3!P
M=#L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1$E34$Q!63H@:6YL
M:6YE)SX@)FYB<W`[/"]F;VYT/B`\+W1D/B`\=&0@<W1Y;&4],T0G0D]21$52
M+4)/5%1/33H@8FQA8VL@-'!X(&1O=6)L93L@1$E34$Q!63H@:6YL:6YE.R!&
M3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!&3TY4+5-)6D4Z(#$P<'0[
M(%1%6%0M04Q)1TXZ(&QE9G0G('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E
M/B0\+W1D/B`\=&0@<W1Y;&4],T0G0D]21$52+4)/5%1/33H@8FQA8VL@-'!X
M(&1O=6)L93L@1$E34$Q!63H@:6YL:6YE.R!&3TY4+49!34E,63H@=&EM97,@
M;F5W(')O;6%N.R!&3TY4+5-)6D4Z(#$P<'0[(%1%6%0M04Q)1TXZ(')I9VAT
M)R!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Y)3XR+#DU.3PO=&0^(#QT9"!S
M='EL93TS1"=0041$24Y'+4)/5%1/33H@-'!X.R!415A4+4%,24=..B!L969T
M)R!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)2!N;W=R87`],T1N;W=R87`^
M/&9O;G0@<W1Y;&4],T0G1D].5"U325I%.B`Q,'!T.R!&3TY4+49!34E,63H@
M=&EM97,@;F5W(')O;6%N.R!$25-03$%9.B!I;FQI;F4G/B`F;F)S<#L\+V9O
M;G0^(#PO=&0^(#PO='(^(#PO=&%B;&4^(#PO9&EV/B`\(2TM16YD1G)A9VUE
M;G0M+3X\+V1I=CX@/"]D:78^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\
M+W1R/@T*("`@(#PO=&%B;&4^#0H@(#PO8F]D>3X-"CPO:'1M;#X-"@T*+2TM
M+2TM/5].97AT4&%R=%\P8V%D-3EF9%\W,S)E7S0V93)?834S-%\P8SAA9#%A
M9CDP9&0-"D-O;G1E;G0M3&]C871I;VXZ(&9I;&4Z+R\O0SHO,&-A9#4Y9F1?
M-S,R95\T-F4R7V$U,S1?,&,X860Q868Y,&1D+U=O<FMS:&5E=',O4VAE970R
M,2YH=&UL#0I#;VYT96YT+51R86YS9F5R+45N8V]D:6YG.B!Q=6]T960M<')I
M;G1A8FQE#0I#;VYT96YT+51Y<&4Z('1E>'0O:'1M;#L@8VAA<G-E=#TB=7,M
M87-C:6DB#0H-"CQH=&UL/@T*("`\:&5A9#X-"B`@("`\345402!H='1P+65Q
M=6EV/3-$0V]N=&5N="U4>7!E(&-O;G1E;G0],T0G=&5X="]H=&UL.R!C:&%R
M<V5T/75T9BTX)SX\<V-R:7!T('1Y<&4],T1T97AT+VIA=F%S8W)I<'0@<W)C
M/3-$4VAO=RYJ<SXO*B!$;R!.;W0@4F5M;W9E(%1H:7,@0V]M;65N="`J+SPO
M<V-R:7!T/CPO:&5A9#X-"B`@/&)O9'D^#0H@("`@/'1A8FQE(&-L87-S/3-$
M<F5P;W)T(&ED/3-$240P13)&/@T*("`@("`@/'1R/@T*("`@("`@("`\=&@@
M8VQA<W,],T1T;"!C;VQS<&%N/3-$,2!R;W=S<&%N/3-$,CX\<W1R;VYG/DU!
M4DM%5$%"3$4@4T5#55))5$E%4R`H5&%B;&5S*3QB<CX\+W-T<F]N9SX\+W1H
M/@T*("`@("`@("`\=&@@8VQA<W,],T1T:"!C;VQS<&%N/3-$,3XQ,B!-;VYT
M:',@16YD960\+W1H/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<CX-"B`@("`@
M("`@/'1H(&-L87-S/3-$=&@^2G5N+B`S,"P@,C`Q-#QB<CX\+W1H/@T*("`@
M("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS1')E/@T*("`@("`@("`\=&0@
M8VQA<W,],T1P;"!V86QI9VX],T1T;W`^/'-T<F]N9SY-05)+151!0DQ%(%-%
M0U52251)15,@6T%B<W1R86-T73PO<W1R;VYG/CPO=&0^#0H@("`@("`@(#QT
M9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T
M<CX-"B`@("`@(#QT<B!C;&%S<STS1')O/@T*("`@("`@("`\=&0@8VQA<W,]
M,T1P;"!V86QI9VX],T1T;W`^4V-H961U;&4@;V8@079A:6QA8FQE+69O<BUS
M86QE($UA<FME=&%B;&4@4V5C=7)I=&EE<SPO=&0^#0H@("`@("`@(#QT9"!C
M;&%S<STS1'1E>'0^)SPA+2U$3T-465!%(&AT;6P@4%5"3$E#("(M+R]7,T,O
M+T141"!82%1-3"`Q+C`@5')A;G-I=&EO;F%L+R]%3B(@(FAT='`Z+R]W=W<N
M=S,N;W)G+U12+WAH=&UL,2]$5$0O>&AT;6PQ+71R86YS:71I;VYA;"YD=&0B
M("TM/CQD:78^(#QD:78^/"$M+5-T87)T1G)A9VUE;G0M+3X@/&1I=B!S='EL
M93TS1"=$25-03$%9.B!B;&]C:SL@1D].5"U&04U)3%DZ(%1I;65S($YE=R!2
M;VUA;CL@1D].5"U325I%.B`Q,'!T.R!-05)'24XM3$5&5#H@,'!T.R!-05)'
M24XM4DE'2%0Z(#!P=#L@=&5X="UA;&EG;CH@;&5F=#L@5$585"U)3D1%3E0Z
M(#!P="<^($%S(&]F($IU;F4@,S`L(#(P,30L(&%L;"!O9B!T:&4@0V]M<&%N
M>28C,SD[<R!M87)K971A8FQE('-E8W5R:71I97,@=V5R92!C;&%S<VEF:65D
M(&%S(&%V86EL86)L92UF;W(M<V%L92X\+V1I=CX@/&1I=B!S='EL93TS1"=$
M25-03$%9.B!B;&]C:SL@34%21TE.+4Q%1E0Z(#!P=#L@34%21TE.+5))1TA4
M.B`P<'0[('1E>'0M86QI9VXZ(&QE9G0[(%1%6%0M24Y$14Y4.B`P<'0G/B`F
M;F)S<#L\+V1I=CX@/&1I=B!S='EL93TS1"=T97AT+6%L:6=N.B!L969T)SX@
M/'1A8FQE('-T>6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ
M('1I;65S(&YE=R!R;VUA;B<@8V5L;'-P86-I;F<],T0P(&-E;&QP861D:6YG
M/3-$,"!W:61T:#TS1#$P,"4^(#QT<CX@/'1D('-T>6QE/3-$)U!!1$1)3D<M
M0D]45$]-.B`R<'@G('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#(P)3X\9F]N
M="!S='EL93TS1"=&3TY4+5-)6D4Z(#$P<'0[($9/3E0M1D%-24Q9.B!T:6UE
M<R!N97<@<F]M86X[($1)4U!,05DZ(&EN;&EN92<^("9N8G-P.SPO9F]N=#X@
M/"]T9#X@/'1D('-T>6QE/3-$)U!!1$1)3D<M0D]45$]-.B`R<'@G('9A;&EG
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M('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T.R!&3TY4+5=%24=(
M5#H@8F]L9#L@34%21TE.+4Q%1E0Z(#!P=#L@34%21TE.+5))1TA4.B`P<'0[
M('1E>'0M86QI9VXZ(&-E;G1E<CL@5$585"U)3D1%3E0Z(#!P="<^($IU;F4@
M,S`L(#(P,30\+V1I=CX@/"]T9#X@/'1D('-T>6QE/3-$)U!!1$1)3D<M0D]4
M5$]-.B`R<'@[(%1%6%0M04Q)1TXZ(&QE9G0G('9A;&EG;CTS1&)O='1O;2!W
M:61T:#TS1#$E(&YO=W)A<#TS1&YO=W)A<#X\9F]N="!S='EL93TS1"=&3TY4
M+5-)6D4Z(#$P<'0[($9/3E0M1D%-24Q9.B!T:6UE<R!N97<@<F]M86X[($1)
M4U!,05DZ(&EN;&EN92<^("9N8G-P.SPO9F]N=#X@/"]T9#X@/'1D('-T>6QE
M/3-$)U!!1$1)3D<M0D]45$]-.B`R<'@G('9A;&EG;CTS1&)O='1O;2!W:61T
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M;CL@1D].5"U325I%.B`Q,'!T.R!&3TY4+5=%24=(5#H@8F]L9#L@34%21TE.
M+4Q%1E0Z(#!P=#L@34%21TE.+5))1TA4.B`P<'0[('1E>'0M86QI9VXZ(&-E
M;G1E<CL@5$585"U)3D1%3E0Z(#!P="<^($IU;F4@,S`L,C`Q,SPO9&EV/B`\
M+W1D/B`\=&0@<W1Y;&4],T0G4$%$1$E.1RU"3U143TTZ(#)P>#L@5$585"U!
M3$E'3CH@;&5F="<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@;F]W<F%P
M/3-$;F]W<F%P/CQF;VYT('-T>6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@1D].
M5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1$E34$Q!63H@:6YL:6YE)SX@
M)FYB<W`[/"]F;VYT/B`\+W1D/B`\+W1R/B`\='(^(#QT9"!S='EL93TS1"=0
M041$24Y'+4)/5%1/33H@,G!X)R!V86QI9VX],T1B;W1T;VT@=VED=&@],T0R
M,"4^/&9O;G0@<W1Y;&4],T0G1D].5"U325I%.B`Q,'!T.R!&3TY4+49!34E,
M63H@=&EM97,@;F5W(')O;6%N.R!$25-03$%9.B!I;FQI;F4G/B`F;F)S<#L\
M+V9O;G0^(#PO=&0^(#QT9"!S='EL93TS1"=0041$24Y'+4)/5%1/33H@,G!X
M)R!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)3X\9F]N="!S='EL93TS1"=&
M3TY4+5-)6D4Z(#$P<'0[($9/3E0M1D%-24Q9.B!T:6UE<R!N97<@<F]M86X[
M($9/3E0M5T5)1TA4.B!B;VQD.R!$25-03$%9.B!I;FQI;F4G/B`F;F)S<#L\
M+V9O;G0^(#PO=&0^(#QT9"!S='EL93TS1"="3U)$15(M0D]45$]-.B!B;&%C
M:R`R<'@@<V]L:60G('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#@E(&-O;'-P
M86X],T0R/B`\9&EV('-T>6QE/3-$)T1)4U!,05DZ(&)L;V-K.R!&3TY4+49!
M34E,63H@=&EM97,@;F5W(')O;6%N.R!&3TY4+5-)6D4Z(#$P<'0[($9/3E0M
M5T5)1TA4.B!B;VQD.R!-05)'24XM3$5&5#H@,'!T.R!-05)'24XM4DE'2%0Z
M(#!P=#L@=&5X="UA;&EG;CH@8V5N=&5R.R!415A4+4E.1$5.5#H@,'!T)SX@
M06UO<G1I>F5D(&-O<W0\+V1I=CX@/"]T9#X@/'1D('-T>6QE/3-$)U!!1$1)
M3D<M0D]45$]-.B`R<'@[(%1%6%0M04Q)1TXZ(&QE9G0G('9A;&EG;CTS1&)O
M='1O;2!W:61T:#TS1#$E(&YO=W)A<#TS1&YO=W)A<#X\9F]N="!S='EL93TS
M1"=&3TY4+5-)6D4Z(#$P<'0[($9/3E0M1D%-24Q9.B!T:6UE<R!N97<@<F]M
M86X[($9/3E0M5T5)1TA4.B!B;VQD.R!$25-03$%9.B!I;FQI;F4G/B`F;F)S
M<#L\+V9O;G0^(#PO=&0^(#QT9"!S='EL93TS1"=0041$24Y'+4)/5%1/33H@
M,G!X)R!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)3X\9F]N="!S='EL93TS
M1"=&3TY4+5-)6D4Z(#$P<'0[($9/3E0M1D%-24Q9.B!T:6UE<R!N97<@<F]M
M86X[($9/3E0M5T5)1TA4.B!B;VQD.R!$25-03$%9.B!I;FQI;F4G/B`F;F)S
M<#L\+V9O;G0^(#PO=&0^(#QT9"!S='EL93TS1"="3U)$15(M0D]45$]-.B!B
M;&%C:R`R<'@@<V]L:60G('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#@E(&-O
M;'-P86X],T0R/B`\9&EV('-T>6QE/3-$)T1)4U!,05DZ(&)L;V-K.R!&3TY4
M+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!&3TY4+5-)6D4Z(#$P<'0[($9/
M3E0M5T5)1TA4.B!B;VQD.R!-05)'24XM3$5&5#H@,'!T.R!-05)'24XM4DE'
M2%0Z(#!P=#L@=&5X="UA;&EG;CH@8V5N=&5R.R!415A4+4E.1$5.5#H@,'!T
M)SX@1W)O<W,\+V1I=CX@/&1I=B!S='EL93TS1"=$25-03$%9.B!B;&]C:SL@
M1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T
M.R!&3TY4+5=%24=(5#H@8F]L9#L@34%21TE.+4Q%1E0Z(#!P=#L@34%21TE.
M+5))1TA4.B`P<'0[('1E>'0M86QI9VXZ(&-E;G1E<CL@5$585"U)3D1%3E0Z
M(#!P="<^('5N<F5A;&EZ960\+V1I=CX@/&1I=B!S='EL93TS1"=$25-03$%9
M.B!B;&]C:SL@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U3
M25I%.B`Q,'!T.R!&3TY4+5=%24=(5#H@8F]L9#L@34%21TE.+4Q%1E0Z(#!P
M=#L@34%21TE.+5))1TA4.B`P<'0[('1E>'0M86QI9VXZ(&-E;G1E<CL@5$58
M5"U)3D1%3E0Z(#!P="<^(&=A:6X\+V1I=CX@/"]T9#X@/'1D('-T>6QE/3-$
M)U!!1$1)3D<M0D]45$]-.B`R<'@[(%1%6%0M04Q)1TXZ(&QE9G0G('9A;&EG
M;CTS1&)O='1O;2!W:61T:#TS1#$E(&YO=W)A<#TS1&YO=W)A<#X\9F]N="!S
M='EL93TS1"=&3TY4+5-)6D4Z(#$P<'0[($9/3E0M1D%-24Q9.B!T:6UE<R!N
M97<@<F]M86X[($9/3E0M5T5)1TA4.B!B;VQD.R!$25-03$%9.B!I;FQI;F4G
M/B`F;F)S<#L\+V9O;G0^(#PO=&0^(#QT9"!S='EL93TS1"=0041$24Y'+4)/
M5%1/33H@,G!X)R!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)3X\9F]N="!S
M='EL93TS1"=&3TY4+5-)6D4Z(#$P<'0[($9/3E0M1D%-24Q9.B!T:6UE<R!N
M97<@<F]M86X[($9/3E0M5T5)1TA4.B!B;VQD.R!$25-03$%9.B!I;FQI;F4G
M/B`F;F)S<#L\+V9O;G0^(#PO=&0^(#QT9"!S='EL93TS1"="3U)$15(M0D]4
M5$]-.B!B;&%C:R`R<'@@<V]L:60G('9A;&EG;CTS1&)O='1O;2!W:61T:#TS
M1#@E(&-O;'-P86X],T0R/B`\9&EV('-T>6QE/3-$)T1)4U!,05DZ(&)L;V-K
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M.B`Q,'!T.R!&3TY4+5=%24=(5#H@8F]L9#L@34%21TE.+4Q%1E0Z(#!P=#L@
M34%21TE.+5))1TA4.B`P<'0[('1E>'0M86QI9VXZ(&-E;G1E<CL@5$585"U)
M3D1%3E0Z(#!P="<^('5N<F5A;&EZ960\+V1I=CX@/&1I=B!S='EL93TS1"=$
M25-03$%9.B!B;&]C:SL@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@
M1D].5"U325I%.B`Q,'!T.R!&3TY4+5=%24=(5#H@8F]L9#L@34%21TE.+4Q%
M1E0Z(#!P=#L@34%21TE.+5))1TA4.B`P<'0[('1E>'0M86QI9VXZ(&-E;G1E
M<CL@5$585"U)3D1%3E0Z(#!P="<^(&QO<W,\+V1I=CX@/"]T9#X@/'1D('-T
M>6QE/3-$)U!!1$1)3D<M0D]45$]-.B`R<'@[(%1%6%0M04Q)1TXZ(&QE9G0G
M('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E(&YO=W)A<#TS1&YO=W)A<#X\
M9F]N="!S='EL93TS1"=&3TY4+5-)6D4Z(#$P<'0[($9/3E0M1D%-24Q9.B!T
M:6UE<R!N97<@<F]M86X[($9/3E0M5T5)1TA4.B!B;VQD.R!$25-03$%9.B!I
M;FQI;F4G/B`F;F)S<#L\+V9O;G0^(#PO=&0^(#QT9"!S='EL93TS1"=0041$
M24Y'+4)/5%1/33H@,G!X)R!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)3X\
M9F]N="!S='EL93TS1"=&3TY4+5-)6D4Z(#$P<'0[($9/3E0M1D%-24Q9.B!T
M:6UE<R!N97<@<F]M86X[($9/3E0M5T5)1TA4.B!B;VQD.R!$25-03$%9.B!I
M;FQI;F4G/B`F;F)S<#L\+V9O;G0^(#PO=&0^(#QT9"!S='EL93TS1"="3U)$
M15(M0D]45$]-.B!B;&%C:R`R<'@@<V]L:60G('9A;&EG;CTS1&)O='1O;2!W
M:61T:#TS1#@E(&-O;'-P86X],T0R/B`\9&EV('-T>6QE/3-$)T1)4U!,05DZ
M(&)L;V-K.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!&3TY4+5-)
M6D4Z(#$P<'0[($9/3E0M5T5)1TA4.B!B;VQD.R!-05)'24XM3$5&5#H@,'!T
M.R!-05)'24XM4DE'2%0Z(#!P=#L@=&5X="UA;&EG;CH@8V5N=&5R.R!415A4
M+4E.1$5.5#H@,'!T)SX@1F%I<CPO9&EV/B`\9&EV('-T>6QE/3-$)T1)4U!,
M05DZ(&)L;V-K.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!&3TY4
M+5-)6D4Z(#$P<'0[($9/3E0M5T5)1TA4.B!B;VQD.R!-05)'24XM3$5&5#H@
M,'!T.R!-05)'24XM4DE'2%0Z(#!P=#L@=&5X="UA;&EG;CH@8V5N=&5R.R!4
M15A4+4E.1$5.5#H@,'!T)SX@=F%L=64\+V1I=CX@/"]T9#X@/'1D('-T>6QE
M/3-$)U!!1$1)3D<M0D]45$]-.B`R<'@[(%1%6%0M04Q)1TXZ(&QE9G0G('9A
M;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E(&YO=W)A<#TS1&YO=W)A<#X\9F]N
M="!S='EL93TS1"=&3TY4+5-)6D4Z(#$P<'0[($9/3E0M1D%-24Q9.B!T:6UE
M<R!N97<@<F]M86X[($9/3E0M5T5)1TA4.B!B;VQD.R!$25-03$%9.B!I;FQI
M;F4G/B`F;F)S<#L\+V9O;G0^(#PO=&0^(#QT9"!S='EL93TS1"=0041$24Y'
M+4)/5%1/33H@,G!X)R!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)3X\9F]N
M="!S='EL93TS1"=&3TY4+5-)6D4Z(#$P<'0[($9/3E0M1D%-24Q9.B!T:6UE
M<R!N97<@<F]M86X[($9/3E0M5T5)1TA4.B!B;VQD.R!$25-03$%9.B!I;FQI
M;F4G/B`F;F)S<#L\+V9O;G0^(#PO=&0^(#QT9"!S='EL93TS1"="3U)$15(M
M0D]45$]-.B!B;&%C:R`R<'@@<V]L:60G('9A;&EG;CTS1&)O='1O;2!W:61T
M:#TS1#@E(&-O;'-P86X],T0R/B`\9&EV('-T>6QE/3-$)T1)4U!,05DZ(&)L
M;V-K.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!&3TY4+5-)6D4Z
M(#$P<'0[($9/3E0M5T5)1TA4.B!B;VQD.R!-05)'24XM3$5&5#H@,'!T.R!-
M05)'24XM4DE'2%0Z(#!P=#L@=&5X="UA;&EG;CH@8V5N=&5R.R!415A4+4E.
M1$5.5#H@,'!T)SX@06UO<G1I>F5D(&-O<W0\+V1I=CX@/"]T9#X@/'1D('-T
M>6QE/3-$)U!!1$1)3D<M0D]45$]-.B`R<'@[(%1%6%0M04Q)1TXZ(&QE9G0G
M('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E(&YO=W)A<#TS1&YO=W)A<#X\
M9F]N="!S='EL93TS1"=&3TY4+5-)6D4Z(#$P<'0[($9/3E0M1D%-24Q9.B!T
M:6UE<R!N97<@<F]M86X[($9/3E0M5T5)1TA4.B!B;VQD.R!$25-03$%9.B!I
M;FQI;F4G/B`F;F)S<#L\+V9O;G0^(#PO=&0^(#QT9"!S='EL93TS1"=0041$
M24Y'+4)/5%1/33H@,G!X)R!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)3X\
M9F]N="!S='EL93TS1"=&3TY4+5-)6D4Z(#$P<'0[($9/3E0M1D%-24Q9.B!T
M:6UE<R!N97<@<F]M86X[($9/3E0M5T5)1TA4.B!B;VQD.R!$25-03$%9.B!I
M;FQI;F4G/B`F;F)S<#L\+V9O;G0^(#PO=&0^(#QT9"!S='EL93TS1"="3U)$
M15(M0D]45$]-.B!B;&%C:R`R<'@@<V]L:60G('9A;&EG;CTS1&)O='1O;2!W
M:61T:#TS1#@E(&-O;'-P86X],T0R/B`\9&EV('-T>6QE/3-$)T1)4U!,05DZ
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M5"U325I%.B`Q,'!T.R!&3TY4+5=%24=(5#H@8F]L9#L@34%21TE.+4Q%1E0Z
M(#!P=#L@34%21TE.+5))1TA4.B`P<'0[('1E>'0M86QI9VXZ(&-E;G1E<CL@
M5$585"U)3D1%3E0Z(#!P="<^('5N<F5A;&EZ960\+V1I=CX@/&1I=B!S='EL
M93TS1"=$25-03$%9.B!B;&]C:SL@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R
M;VUA;CL@1D].5"U325I%.B`Q,'!T.R!&3TY4+5=%24=(5#H@8F]L9#L@34%2
M1TE.+4Q%1E0Z(#!P=#L@34%21TE.+5))1TA4.B`P<'0[('1E>'0M86QI9VXZ
M(&-E;G1E<CL@5$585"U)3D1%3E0Z(#!P="<^(&=A:6X\+V1I=CX@/"]T9#X@
M/'1D('-T>6QE/3-$)U!!1$1)3D<M0D]45$]-.B`R<'@[(%1%6%0M04Q)1TXZ
M(&QE9G0G('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E(&YO=W)A<#TS1&YO
M=W)A<#X\9F]N="!S='EL93TS1"=&3TY4+5-)6D4Z(#$P<'0[($9/3E0M1D%-
M24Q9.B!T:6UE<R!N97<@<F]M86X[($9/3E0M5T5)1TA4.B!B;VQD.R!$25-0
M3$%9.B!I;FQI;F4G/B`F;F)S<#L\+V9O;G0^(#PO=&0^(#QT9"!S='EL93TS
M1"=0041$24Y'+4)/5%1/33H@,G!X)R!V86QI9VX],T1B;W1T;VT@=VED=&@]
M,T0Q)3X\9F]N="!S='EL93TS1"=&3TY4+5-)6D4Z(#$P<'0[($9/3E0M1D%-
M24Q9.B!T:6UE<R!N97<@<F]M86X[($9/3E0M5T5)1TA4.B!B;VQD.R!$25-0
M3$%9.B!I;FQI;F4G/B`F;F)S<#L\+V9O;G0^(#PO=&0^(#QT9"!S='EL93TS
M1"="3U)$15(M0D]45$]-.B!B;&%C:R`R<'@@<V]L:60G('9A;&EG;CTS1&)O
M='1O;2!W:61T:#TS1#@E(&-O;'-P86X],T0R/B`\9&EV('-T>6QE/3-$)T1)
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M;CL@1D].5"U325I%.B`Q,'!T.R!&3TY4+5=%24=(5#H@8F]L9#L@34%21TE.
M+4Q%1E0Z(#!P=#L@34%21TE.+5))1TA4.B`P<'0[('1E>'0M86QI9VXZ(&-E
M;G1E<CL@5$585"U)3D1%3E0Z(#!P="<^('5N<F5A;&EZ960\+V1I=CX@/&1I
M=B!S='EL93TS1"=$25-03$%9.B!B;&]C:SL@1D].5"U&04U)3%DZ('1I;65S
M(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T.R!&3TY4+5=%24=(5#H@8F]L
M9#L@34%21TE.+4Q%1E0Z(#!P=#L@34%21TE.+5))1TA4.B`P<'0[('1E>'0M
M86QI9VXZ(&-E;G1E<CL@5$585"U)3D1%3E0Z(#!P="<^(&QO<W,\+V1I=CX@
M/"]T9#X@/'1D('-T>6QE/3-$)U!!1$1)3D<M0D]45$]-.B`R<'@[(%1%6%0M
M04Q)1TXZ(&QE9G0G('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E(&YO=W)A
M<#TS1&YO=W)A<#X\9F]N="!S='EL93TS1"=&3TY4+5-)6D4Z(#$P<'0[($9/
M3E0M1D%-24Q9.B!T:6UE<R!N97<@<F]M86X[($9/3E0M5T5)1TA4.B!B;VQD
M.R!$25-03$%9.B!I;FQI;F4G/B`F;F)S<#L\+V9O;G0^(#PO=&0^(#QT9"!S
M='EL93TS1"=0041$24Y'+4)/5%1/33H@,G!X)R!V86QI9VX],T1B;W1T;VT@
M=VED=&@],T0Q)3X\9F]N="!S='EL93TS1"=&3TY4+5-)6D4Z(#$P<'0[($9/
M3E0M1D%-24Q9.B!T:6UE<R!N97<@<F]M86X[($9/3E0M5T5)1TA4.B!B;VQD
M.R!$25-03$%9.B!I;FQI;F4G/B`F;F)S<#L\+V9O;G0^(#PO=&0^(#QT9"!S
M='EL93TS1"="3U)$15(M0D]45$]-.B!B;&%C:R`R<'@@<V]L:60G('9A;&EG
M;CTS1&)O='1O;2!W:61T:#TS1#@E(&-O;'-P86X],T0R/B`\9&EV('-T>6QE
M/3-$)T1)4U!,05DZ(&)L;V-K.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O
M;6%N.R!&3TY4+5-)6D4Z(#$P<'0[($9/3E0M5T5)1TA4.B!B;VQD.R!-05)'
M24XM3$5&5#H@,'!T.R!-05)'24XM4DE'2%0Z(#!P=#L@=&5X="UA;&EG;CH@
M8V5N=&5R.R!415A4+4E.1$5.5#H@,'!T)SX@1F%I<CPO9&EV/B`\9&EV('-T
M>6QE/3-$)T1)4U!,05DZ(&)L;V-K.R!&3TY4+49!34E,63H@=&EM97,@;F5W
M(')O;6%N.R!&3TY4+5-)6D4Z(#$P<'0[($9/3E0M5T5)1TA4.B!B;VQD.R!-
M05)'24XM3$5&5#H@,'!T.R!-05)'24XM4DE'2%0Z(#!P=#L@=&5X="UA;&EG
M;CH@8V5N=&5R.R!415A4+4E.1$5.5#H@,'!T)SX@=F%L=64\+V1I=CX@/"]T
M9#X@/'1D('-T>6QE/3-$)U!!1$1)3D<M0D]45$]-.B`R<'@[(%1%6%0M04Q)
M1TXZ(&QE9G0G('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E(&YO=W)A<#TS
M1&YO=W)A<#X\9F]N="!S='EL93TS1"=&3TY4+5-)6D4Z(#$P<'0[($9/3E0M
M1D%-24Q9.B!T:6UE<R!N97<@<F]M86X[($9/3E0M5T5)1TA4.B!B;VQD.R!$
M25-03$%9.B!I;FQI;F4G/B`F;F)S<#L\+V9O;G0^(#PO=&0^(#PO='(^(#QT
M<B!B9V-O;&]R/3-$(V-C965F9CX@/'1D('-T>6QE/3-$)U1%6%0M04Q)1TXZ
M(&QE9G0[($U!4D=)3BU,1494.B`P<'0[($U!4D=)3BU224=(5#H@,'!T.R!4
M15A4+4E.1$5.5#H@,'!T)R!V86QI9VX],T1B;W1T;VT@=VED=&@],T0R,"4^
M(#QD:78@<W1Y;&4],T0G1$E34$Q!63H@8FQO8VL[($9/3E0M1D%-24Q9.B!T
M:6UE<R!N97<@<F]M86X[($9/3E0M4TE:13H@,3!P=#L@1D].5"U714E'2%0Z
M(&)O;&0[($U!4D=)3BU,1494.B`P<'0[($U!4D=)3BU224=(5#H@,'!T.R!4
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M;65S(&YE=R!R;VUA;CL@1$E34$Q!63H@:6YL:6YE)SX@)FYB<W`[/"]F;VYT
M/B`\+W1D/B`\=&0@<W1Y;&4],T0G5$585"U!3$E'3CH@;&5F="<@=F%L:6=N
M/3-$8F]T=&]M('=I9'1H/3-$,24@;F]W<F%P/3-$;F]W<F%P/CQF;VYT('-T
M>6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ('1I;65S(&YE
M=R!R;VUA;CL@1$E34$Q!63H@:6YL:6YE)SX@)FYB<W`[/"]F;VYT/B`\+W1D
M/B`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24^/&9O;G0@<W1Y;&4]
M,T0G1D].5"U325I%.B`Q,'!T.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O
M;6%N.R!$25-03$%9.B!I;FQI;F4G/B`F;F)S<#L\+V9O;G0^(#PO=&0^(#QT
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M;CL@1$E34$Q!63H@:6YL:6YE)SX@)FYB<W`[/"]F;VYT/B`\+W1D/B`\=&0@
M=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$."4@8V]L<W!A;CTS1#(^/&9O;G0@
M<W1Y;&4],T0G1D].5"U325I%.B`Q,'!T.R!&3TY4+49!34E,63H@=&EM97,@
M;F5W(')O;6%N.R!$25-03$%9.B!I;FQI;F4G/B`F;F)S<#L\+V9O;G0^(#PO
M=&0^(#QT9"!S='EL93TS1"=415A4+4%,24=..B!L969T)R!V86QI9VX],T1B
M;W1T;VT@=VED=&@],T0Q)2!N;W=R87`],T1N;W=R87`^/&9O;G0@<W1Y;&4]
M,T0G1D].5"U325I%.B`Q,'!T.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O
M;6%N.R!$25-03$%9.B!I;FQI;F4G/B`F;F)S<#L\+V9O;G0^(#PO=&0^(#QT
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M=R!R;VUA;CL@1$E34$Q!63H@:6YL:6YE)SX@)FYB<W`[/"]F;VYT/B`\+W1D
M/B`\=&0@<W1Y;&4],T0G5$585"U!3$E'3CH@;&5F="<@=F%L:6=N/3-$8F]T
M=&]M('=I9'1H/3-$,24@;F]W<F%P/3-$;F]W<F%P/CQF;VYT('-T>6QE/3-$
M)T9/3E0M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA
M;CL@1$E34$Q!63H@:6YL:6YE)SX@)FYB<W`[/"]F;VYT/B`\+W1D/B`\=&0@
M=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24^/&9O;G0@<W1Y;&4],T0G1D].
M5"U325I%.B`Q,'!T.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!$
M25-03$%9.B!I;FQI;F4G/B`F;F)S<#L\+V9O;G0^(#PO=&0^(#QT9"!V86QI
M9VX],T1B;W1T;VT@=VED=&@],T0X)2!C;VQS<&%N/3-$,CX\9F]N="!S='EL
M93TS1"=&3TY4+5-)6D4Z(#$P<'0[($9/3E0M1D%-24Q9.B!T:6UE<R!N97<@
M<F]M86X[($1)4U!,05DZ(&EN;&EN92<^("9N8G-P.SPO9F]N=#X@/"]T9#X@
M/'1D('-T>6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G('9A;&EG;CTS1&)O='1O
M;2!W:61T:#TS1#$E(&YO=W)A<#TS1&YO=W)A<#X\9F]N="!S='EL93TS1"=&
M3TY4+5-)6D4Z(#$P<'0[($9/3E0M1D%-24Q9.B!T:6UE<R!N97<@<F]M86X[
M($1)4U!,05DZ(&EN;&EN92<^("9N8G-P.SPO9F]N=#X@/"]T9#X@/'1D('9A
M;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E/CQF;VYT('-T>6QE/3-$)T9/3E0M
M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1$E3
M4$Q!63H@:6YL:6YE)SX@)FYB<W`[/"]F;VYT/B`\+W1D/B`\=&0@=F%L:6=N
M/3-$8F]T=&]M('=I9'1H/3-$."4@8V]L<W!A;CTS1#(^/&9O;G0@<W1Y;&4]
M,T0G1D].5"U325I%.B`Q,'!T.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O
M;6%N.R!$25-03$%9.B!I;FQI;F4G/B`F;F)S<#L\+V9O;G0^(#PO=&0^(#QT
M9"!S='EL93TS1"=415A4+4%,24=..B!L969T)R!V86QI9VX],T1B;W1T;VT@
M=VED=&@],T0Q)2!N;W=R87`],T1N;W=R87`^/&9O;G0@<W1Y;&4],T0G1D].
M5"U325I%.B`Q,'!T.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!$
M25-03$%9.B!I;FQI;F4G/B`F;F)S<#L\+V9O;G0^(#PO=&0^(#QT9"!V86QI
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M;CL@1$E34$Q!63H@:6YL:6YE)SX@)FYB<W`[/"]F;VYT/B`\+W1D/B`\=&0@
M<W1Y;&4],T0G5$585"U!3$E'3CH@;&5F="<@=F%L:6=N/3-$8F]T=&]M('=I
M9'1H/3-$,24@;F]W<F%P/3-$;F]W<F%P/CQF;VYT('-T>6QE/3-$)T9/3E0M
M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1$E3
M4$Q!63H@:6YL:6YE)SX@)FYB<W`[/"]F;VYT/B`\+W1D/B`\=&0@=F%L:6=N
M/3-$8F]T=&]M('=I9'1H/3-$,24^/&9O;G0@<W1Y;&4],T0G1D].5"U325I%
M.B`Q,'!T.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!$25-03$%9
M.B!I;FQI;F4G/B`F;F)S<#L\+V9O;G0^(#PO=&0^(#QT9"!V86QI9VX],T1B
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M($U!4D=)3BU,1494.B`P<'0[($U!4D=)3BU224=(5#H@,'!T.R!415A4+4E.
M1$5.5#H@,'!T)R!V86QI9VX],T1B;W1T;VT@=VED=&@],T0R,"4^(#QD:78@
M<W1Y;&4],T0G1$E34$Q!63H@8FQO8VL[($9/3E0M1D%-24Q9.B!T:6UE<R!N
M97<@<F]M86X[($9/3E0M4TE:13H@,3!P=#L@34%21TE.+4Q%1E0Z(#!P=#L@
M34%21TE.+5))1TA4.B`P<'0[(%1%6%0M04Q)1TXZ(&QE9G0[(%1%6%0M24Y$
M14Y4.B`P<'0G/B!3=&]C:R!A;F0@:6YD97@@;&EN:V5D(&YO=&5S/"]D:78^
M(#PO=&0^(#QT9"!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)2!A;&EG;CTS
M1')I9VAT/CQF;VYT('-T>6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@1D].5"U&
M04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1$E34$Q!63H@:6YL:6YE)SX@)FYB
M<W`[/"]F;VYT/B`\+W1D/B`\=&0@<W1Y;&4],T0G1$E34$Q!63H@:6YL:6YE
M.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!&3TY4+5-)6D4Z(#$P
M<'0[(%1%6%0M04Q)1TXZ(&QE9G0G('9A;&EG;CTS1&)O='1O;2!W:61T:#TS
M1#$E/B0\+W1D/B`\=&0@<W1Y;&4],T0G1$E34$Q!63H@:6YL:6YE.R!&3TY4
M+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!&3TY4+5-)6D4Z(#$P<'0[(%1%
M6%0M04Q)1TXZ(')I9VAT)R!V86QI9VX],T1B;W1T;VT@=VED=&@],T0W)3XQ
M."PX.#$\+W1D/B`\=&0@<W1Y;&4],T0G5$585"U!3$E'3CH@;&5F="<@=F%L
M:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@;F]W<F%P/3-$;F]W<F%P/CQF;VYT
M('-T>6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ('1I;65S
M(&YE=R!R;VUA;CL@1$E34$Q!63H@:6YL:6YE)SX@)FYB<W`[/"]F;VYT/B`\
M+W1D/B`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@86QI9VX],T1R
M:6=H=#X\9F]N="!S='EL93TS1"=&3TY4+5-)6D4Z(#$P<'0[($9/3E0M1D%-
M24Q9.B!T:6UE<R!N97<@<F]M86X[($1)4U!,05DZ(&EN;&EN92<^("9N8G-P
M.SPO9F]N=#X@/"]T9#X@/'1D('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@
M1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T
M.R!415A4+4%,24=..B!L969T)R!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q
M)3XD/"]T9#X@/'1D('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&
M04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T.R!415A4
M+4%,24=..B!R:6=H="<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$-R4^,BPU
M,C(\+W1D/B`\=&0@<W1Y;&4],T0G5$585"U!3$E'3CH@;&5F="<@=F%L:6=N
M/3-$8F]T=&]M('=I9'1H/3-$,24@;F]W<F%P/3-$;F]W<F%P/CQF;VYT('-T
M>6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ('1I;65S(&YE
M=R!R;VUA;CL@1$E34$Q!63H@:6YL:6YE)SX@)FYB<W`[/"]F;VYT/B`\+W1D
M/B`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@86QI9VX],T1R:6=H
M=#X\9F]N="!S='EL93TS1"=&3TY4+5-)6D4Z(#$P<'0[($9/3E0M1D%-24Q9
M.B!T:6UE<R!N97<@<F]M86X[($1)4U!,05DZ(&EN;&EN92<^("9N8G-P.SPO
M9F]N=#X@/"]T9#X@/'1D('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].
M5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T.R!4
M15A4+4%,24=..B!L969T)R!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)3XD
M/"]T9#X@/'1D('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)
M3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T.R!415A4+4%,
M24=..B!R:6=H="<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$-R4^*#(S/"]T
M9#X@/'1D('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ
M('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T.R!415A4+4%,24=.
M.B!L969T)R!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)2!N;W=R87`],T1N
M;W=R87`^*3PO=&0^(#QT9"!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)2!A
M;&EG;CTS1')I9VAT/CQF;VYT('-T>6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@
M1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1$E34$Q!63H@:6YL:6YE
M)SX@)FYB<W`[/"]F;VYT/B`\+W1D/B`\=&0@<W1Y;&4],T0G1$E34$Q!63H@
M:6YL:6YE.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!&3TY4+5-)
M6D4Z(#$P<'0[(%1%6%0M04Q)1TXZ(&QE9G0G('9A;&EG;CTS1&)O='1O;2!W
M:61T:#TS1#$E/B0\+W1D/B`\=&0@<W1Y;&4],T0G1$E34$Q!63H@:6YL:6YE
M.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!&3TY4+5-)6D4Z(#$P
M<'0[(%1%6%0M04Q)1TXZ(')I9VAT)R!V86QI9VX],T1B;W1T;VT@=VED=&@]
M,T0W)3XR,2PS.#`\+W1D/B`\=&0@<W1Y;&4],T0G5$585"U!3$E'3CH@;&5F
M="<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@;F]W<F%P/3-$;F]W<F%P
M/CQF;VYT('-T>6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ
M('1I;65S(&YE=R!R;VUA;CL@1$E34$Q!63H@:6YL:6YE)SX@)FYB<W`[/"]F
M;VYT/B`\+W1D/B`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@86QI
M9VX],T1R:6=H=#X\9F]N="!S='EL93TS1"=&3TY4+5-)6D4Z(#$P<'0[($9/
M3E0M1D%-24Q9.B!T:6UE<R!N97<@<F]M86X[($1)4U!,05DZ(&EN;&EN92<^
M("9N8G-P.SPO9F]N=#X@/"]T9#X@/'1D('-T>6QE/3-$)T1)4U!,05DZ(&EN
M;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%
M.B`Q,'!T.R!415A4+4%,24=..B!L969T)R!V86QI9VX],T1B;W1T;VT@=VED
M=&@],T0Q)3XD/"]T9#X@/'1D('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@
M1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T
M.R!415A4+4%,24=..B!R:6=H="<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$
M-R4^-"PP,C,\+W1D/B`\=&0@<W1Y;&4],T0G5$585"U!3$E'3CH@;&5F="<@
M=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@;F]W<F%P/3-$;F]W<F%P/CQF
M;VYT('-T>6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ('1I
M;65S(&YE=R!R;VUA;CL@1$E34$Q!63H@:6YL:6YE)SX@)FYB<W`[/"]F;VYT
M/B`\+W1D/B`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@86QI9VX]
M,T1R:6=H=#X\9F]N="!S='EL93TS1"=&3TY4+5-)6D4Z(#$P<'0[($9/3E0M
M1D%-24Q9.B!T:6UE<R!N97<@<F]M86X[($1)4U!,05DZ(&EN;&EN92<^("9N
M8G-P.SPO9F]N=#X@/"]T9#X@/'1D('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN
M93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q
M,'!T.R!415A4+4%,24=..B!L969T)R!V86QI9VX],T1B;W1T;VT@=VED=&@]
M,T0Q)3XD/"]T9#X@/'1D('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].
M5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T.R!4
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M:'0^/&9O;G0@<W1Y;&4],T0G1D].5"U325I%.B`Q,'!T.R!&3TY4+49!34E,
M63H@=&EM97,@;F5W(')O;6%N.R!$25-03$%9.B!I;FQI;F4G/B`F;F)S<#L\
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M3$E'3CH@<FEG:'0G('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#<E/B@Q.#`\
M+W1D/B`\=&0@<W1Y;&4],T0G1$E34$Q!63H@:6YL:6YE.R!&3TY4+49!34E,
M63H@=&EM97,@;F5W(')O;6%N.R!&3TY4+5-)6D4Z(#$P<'0[(%1%6%0M04Q)
M1TXZ(&QE9G0G('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E(&YO=W)A<#TS
M1&YO=W)A<#XI/"]T9#X@/'1D('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E
M(&%L:6=N/3-$<FEG:'0^/&9O;G0@<W1Y;&4],T0G1D].5"U325I%.B`Q,'!T
M.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!$25-03$%9.B!I;FQI
M;F4G/B`F;F)S<#L\+V9O;G0^(#PO=&0^(#QT9"!S='EL93TS1"=$25-03$%9
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M9F]N=#X@/"]T9#X@/"]T<CX@/'1R(&)G8V]L;W(],T0C8V-E969F/B`\=&0@
M<W1Y;&4],T0G5$585"U!3$E'3CH@;&5F=#L@34%21TE.+4Q%1E0Z(#!P=#L@
M34%21TE.+5))1TA4.B`P<'0[(%1%6%0M24Y$14Y4.B`P<'0G('9A;&EG;CTS
M1&)O='1O;2!W:61T:#TS1#(P)3X@/&1I=B!S='EL93TS1"=$25-03$%9.B!B
M;&]C:SL@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%
M.B`Q,'!T.R!-05)'24XM3$5&5#H@,'!T.R!-05)'24XM4DE'2%0Z(#!P=#L@
M5$585"U!3$E'3CH@;&5F=#L@5$585"U)3D1%3E0Z(#!P="<^($=O=F5R;FUE
M;G0@9&5B96YT=7)E<R`M(&9I>&5D(&EN=&5R97-T(')A=&4\+V1I=CX@/"]T
M9#X@/'1D('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E(&%L:6=N/3-$<FEG
M:'0^/&9O;G0@<W1Y;&4],T0G1D].5"U325I%.B`Q,'!T.R!&3TY4+49!34E,
M63H@=&EM97,@;F5W(')O;6%N.R!$25-03$%9.B!I;FQI;F4G/B`F;F)S<#L\
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M;VUA;CL@1D].5"U325I%.B`Q,'!T.R!415A4+4%,24=..B!R:6=H="<@=F%L
M:6=N/3-$8F]T=&]M('=I9'1H/3-$-R4^.3<\+W1D/B`\=&0@<W1Y;&4],T0G
M5$585"U!3$E'3CH@;&5F="<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@
M;F]W<F%P/3-$;F]W<F%P/CQF;VYT('-T>6QE/3-$)T9/3E0M4TE:13H@,3!P
M=#L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1$E34$Q!63H@:6YL
M:6YE)SX@)FYB<W`[/"]F;VYT/B`\+W1D/B`\=&0@=F%L:6=N/3-$8F]T=&]M
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M3%DZ('1I;65S(&YE=R!R;VUA;CL@1$E34$Q!63H@:6YL:6YE)SX@)FYB<W`[
M/"]F;VYT/B`\+W1D/B`\=&0@<W1Y;&4],T0G1$E34$Q!63H@:6YL:6YE.R!&
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M:'0^/&9O;G0@<W1Y;&4],T0G1D].5"U325I%.B`Q,'!T.R!&3TY4+49!34E,
M63H@=&EM97,@;F5W(')O;6%N.R!$25-03$%9.B!I;FQI;F4G/B`F;F)S<#L\
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M;VUA;CL@1D].5"U325I%.B`Q,'!T.R!415A4+4%,24=..B!R:6=H="<@=F%L
M:6=N/3-$8F]T=&]M('=I9'1H/3-$-R4^+3PO=&0^(#QT9"!S='EL93TS1"=4
M15A4+4%,24=..B!L969T)R!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)2!N
M;W=R87`],T1N;W=R87`^/&9O;G0@<W1Y;&4],T0G1D].5"U325I%.B`Q,'!T
M.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!$25-03$%9.B!I;FQI
M;F4G/B`F;F)S<#L\+V9O;G0^(#PO=&0^(#QT9"!V86QI9VX],T1B;W1T;VT@
M=VED=&@],T0Q)2!A;&EG;CTS1')I9VAT/CQF;VYT('-T>6QE/3-$)T9/3E0M
M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1$E3
M4$Q!63H@:6YL:6YE)SX@)FYB<W`[/"]F;VYT/B`\+W1D/B`\=&0@<W1Y;&4]
M,T0G5$585"U!3$E'3CH@;&5F="<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$
M,24^/&9O;G0@<W1Y;&4],T0G1D].5"U325I%.B`Q,'!T.R!&3TY4+49!34E,
M63H@=&EM97,@;F5W(')O;6%N.R!$25-03$%9.B!I;FQI;F4G/B`F;F)S<#L\
M+V9O;G0^(#PO=&0^(#QT9"!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/
M3E0M1D%-24Q9.B!T:6UE<R!N97<@<F]M86X[($9/3E0M4TE:13H@,3!P=#L@
M5$585"U!3$E'3CH@<FEG:'0G('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#<E
M/C$P-CPO=&0^(#QT9"!S='EL93TS1"=415A4+4%,24=..B!L969T)R!V86QI
M9VX],T1B;W1T;VT@=VED=&@],T0Q)2!N;W=R87`],T1N;W=R87`^/&9O;G0@
M<W1Y;&4],T0G1D].5"U325I%.B`Q,'!T.R!&3TY4+49!34E,63H@=&EM97,@
M;F5W(')O;6%N.R!$25-03$%9.B!I;FQI;F4G/B`F;F)S<#L\+V9O;G0^(#PO
M=&0^(#QT9"!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)2!A;&EG;CTS1')I
M9VAT/CQF;VYT('-T>6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@1D].5"U&04U)
M3%DZ('1I;65S(&YE=R!R;VUA;CL@1$E34$Q!63H@:6YL:6YE)SX@)FYB<W`[
M/"]F;VYT/B`\+W1D/B`\=&0@<W1Y;&4],T0G5$585"U!3$E'3CH@;&5F="<@
M=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24^/&9O;G0@<W1Y;&4],T0G1D].
M5"U325I%.B`Q,'!T.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!$
M25-03$%9.B!I;FQI;F4G/B`F;F)S<#L\+V9O;G0^(#PO=&0^(#QT9"!S='EL
M93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE<R!N97<@
M<F]M86X[($9/3E0M4TE:13H@,3!P=#L@5$585"U!3$E'3CH@<FEG:'0G('9A
M;&EG;CTS1&)O='1O;2!W:61T:#TS1#<E/C,R.3PO=&0^(#QT9"!S='EL93TS
M1"=415A4+4%,24=..B!L969T)R!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q
M)2!N;W=R87`],T1N;W=R87`^/&9O;G0@<W1Y;&4],T0G1D].5"U325I%.B`Q
M,'!T.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!$25-03$%9.B!I
M;FQI;F4G/B`F;F)S<#L\+V9O;G0^(#PO=&0^(#QT9"!V86QI9VX],T1B;W1T
M;VT@=VED=&@],T0Q)2!A;&EG;CTS1')I9VAT/CQF;VYT('-T>6QE/3-$)T9/
M3E0M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@
M1$E34$Q!63H@:6YL:6YE)SX@)FYB<W`[/"]F;VYT/B`\+W1D/B`\=&0@<W1Y
M;&4],T0G5$585"U!3$E'3CH@;&5F="<@=F%L:6=N/3-$8F]T=&]M('=I9'1H
M/3-$,24^/&9O;G0@<W1Y;&4],T0G1D].5"U325I%.B`Q,'!T.R!&3TY4+49!
M34E,63H@=&EM97,@;F5W(')O;6%N.R!$25-03$%9.B!I;FQI;F4G/B`F;F)S
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M<FEG:'0^/&9O;G0@<W1Y;&4],T0G1D].5"U325I%.B`Q,'!T.R!&3TY4+49!
M34E,63H@=&EM97,@;F5W(')O;6%N.R!$25-03$%9.B!I;FQI;F4G/B`F;F)S
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M=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T.R!415A4+4%,24=..B!R:6=H="<@
M=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$-R4^+3PO=&0^(#QT9"!S='EL93TS
M1"=415A4+4%,24=..B!L969T)R!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q
M)2!N;W=R87`],T1N;W=R87`^/&9O;G0@<W1Y;&4],T0G1D].5"U325I%.B`Q
M,'!T.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!$25-03$%9.B!I
M;FQI;F4G/B`F;F)S<#L\+V9O;G0^(#PO=&0^(#QT9"!V86QI9VX],T1B;W1T
M;VT@=VED=&@],T0Q)2!A;&EG;CTS1')I9VAT/CQF;VYT('-T>6QE/3-$)T9/
M3E0M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@
M1$E34$Q!63H@:6YL:6YE)SX@)FYB<W`[/"]F;VYT/B`\+W1D/B`\=&0@<W1Y
M;&4],T0G5$585"U!3$E'3CH@;&5F="<@=F%L:6=N/3-$8F]T=&]M('=I9'1H
M/3-$,24^/&9O;G0@<W1Y;&4],T0G1D].5"U325I%.B`Q,'!T.R!&3TY4+49!
M34E,63H@=&EM97,@;F5W(')O;6%N.R!$25-03$%9.B!I;FQI;F4G/B`F;F)S
M<#L\+V9O;G0^(#PO=&0^(#QT9"!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[
M($9/3E0M1D%-24Q9.B!T:6UE<R!N97<@<F]M86X[($9/3E0M4TE:13H@,3!P
M=#L@5$585"U!3$E'3CH@<FEG:'0G('9A;&EG;CTS1&)O='1O;2!W:61T:#TS
M1#<E/C,U,#PO=&0^(#QT9"!S='EL93TS1"=415A4+4%,24=..B!L969T)R!V
M86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)2!N;W=R87`],T1N;W=R87`^/&9O
M;G0@<W1Y;&4],T0G1D].5"U325I%.B`Q,'!T.R!&3TY4+49!34E,63H@=&EM
M97,@;F5W(')O;6%N.R!$25-03$%9.B!I;FQI;F4G/B`F;F)S<#L\+V9O;G0^
M(#PO=&0^(#PO='(^(#QT<B!B9V-O;&]R/3-$=VAI=&4^(#QT9"!S='EL93TS
M1"=0041$24Y'+4)/5%1/33H@,G!X.R!415A4+4%,24=..B!L969T.R!-05)'
M24XM3$5&5#H@,'!T.R!-05)'24XM4DE'2%0Z(#!P=#L@5$585"U)3D1%3E0Z
M(#!P="<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,C`E/B`\9&EV('-T>6QE
M/3-$)T1)4U!,05DZ(&)L;V-K.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O
M;6%N.R!&3TY4+5-)6D4Z(#$P<'0[($U!4D=)3BU,1494.B`P<'0[($U!4D=)
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M('1I;65S(&YE=R!R;VUA;CL@1$E34$Q!63H@:6YL:6YE)SX@)FYB<W`[/"]F
M;VYT/B`\+W1D/B`\=&0@<W1Y;&4],T0G0D]21$52+4)/5%1/33H@8FQA8VL@
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M+W1D/B`\=&0@<W1Y;&4],T0G4$%$1$E.1RU"3U143TTZ(#)P>#L@5$585"U!
M3$E'3CH@;&5F="<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@;F]W<F%P
M/3-$;F]W<F%P/CQF;VYT('-T>6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@1D].
M5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1$E34$Q!63H@:6YL:6YE)SX@
M)FYB<W`[/"]F;VYT/B`\+W1D/B`\=&0@<W1Y;&4],T0G4$%$1$E.1RU"3U14
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M=&]M('=I9'1H/3-$,24^/&9O;G0@<W1Y;&4],T0G1D].5"U325I%.B`Q,'!T
M.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!$25-03$%9.B!I;FQI
M;F4G/B`F;F)S<#L\+V9O;G0^(#PO=&0^(#QT9"!S='EL93TS1"="3U)$15(M
M0D]45$]-.B!B;&%C:R`R<'@@<V]L:60[($1)4U!,05DZ(&EN;&EN93L@1D].
M5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T.R!4
M15A4+4%,24=..B!R:6=H="<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$-R4^
M-30\+W1D/B`\=&0@<W1Y;&4],T0G4$%$1$E.1RU"3U143TTZ(#)P>#L@5$58
M5"U!3$E'3CH@;&5F="<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@;F]W
M<F%P/3-$;F]W<F%P/CQF;VYT('-T>6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@
M1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1$E34$Q!63H@:6YL:6YE
M)SX@)FYB<W`[/"]F;VYT/B`\+W1D/B`\=&0@<W1Y;&4],T0G4$%$1$E.1RU"
M3U143TTZ(#)P>"<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@86QI9VX]
M,T1R:6=H=#X\9F]N="!S='EL93TS1"=&3TY4+5-)6D4Z(#$P<'0[($9/3E0M
M1D%-24Q9.B!T:6UE<R!N97<@<F]M86X[($1)4U!,05DZ(&EN;&EN92<^("9N
M8G-P.SPO9F]N=#X@/"]T9#X@/'1D('-T>6QE/3-$)T)/4D1%4BU"3U143TTZ
M(&)L86-K(#)P>"!S;VQI9#L@5$585"U!3$E'3CH@;&5F="<@=F%L:6=N/3-$
M8F]T=&]M('=I9'1H/3-$,24^/&9O;G0@<W1Y;&4],T0G1D].5"U325I%.B`Q
M,'!T.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!$25-03$%9.B!I
M;FQI;F4G/B`F;F)S<#L\+V9O;G0^(#PO=&0^(#QT9"!S='EL93TS1"="3U)$
M15(M0D]45$]-.B!B;&%C:R`R<'@@<V]L:60[($1)4U!,05DZ(&EN;&EN93L@
M1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T
M.R!415A4+4%,24=..B!R:6=H="<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$
M-R4^+3PO=&0^(#QT9"!S='EL93TS1"=0041$24Y'+4)/5%1/33H@,G!X.R!4
M15A4+4%,24=..B!L969T)R!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)2!N
M;W=R87`],T1N;W=R87`^/&9O;G0@<W1Y;&4],T0G1D].5"U325I%.B`Q,'!T
M.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!$25-03$%9.B!I;FQI
M;F4G/B`F;F)S<#L\+V9O;G0^(#PO=&0^(#QT9"!S='EL93TS1"=0041$24Y'
M+4)/5%1/33H@,G!X)R!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)2!A;&EG
M;CTS1')I9VAT/CQF;VYT('-T>6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@1D].
M5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1$E34$Q!63H@:6YL:6YE)SX@
M)FYB<W`[/"]F;VYT/B`\+W1D/B`\=&0@<W1Y;&4],T0G0D]21$52+4)/5%1/
M33H@8FQA8VL@,G!X('-O;&ED.R!415A4+4%,24=..B!L969T)R!V86QI9VX]
M,T1B;W1T;VT@=VED=&@],T0Q)3X\9F]N="!S='EL93TS1"=&3TY4+5-)6D4Z
M(#$P<'0[($9/3E0M1D%-24Q9.B!T:6UE<R!N97<@<F]M86X[($1)4U!,05DZ
M(&EN;&EN92<^("9N8G-P.SPO9F]N=#X@/"]T9#X@/'1D('-T>6QE/3-$)T)/
M4D1%4BU"3U143TTZ(&)L86-K(#)P>"!S;VQI9#L@1$E34$Q!63H@:6YL:6YE
M.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!&3TY4+5-)6D4Z(#$P
M<'0[(%1%6%0M04Q)1TXZ(')I9VAT)R!V86QI9VX],T1B;W1T;VT@=VED=&@]
M,T0W)3XU,#8\+W1D/B`\=&0@<W1Y;&4],T0G4$%$1$E.1RU"3U143TTZ(#)P
M>#L@5$585"U!3$E'3CH@;&5F="<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$
M,24@;F]W<F%P/3-$;F]W<F%P/CQF;VYT('-T>6QE/3-$)T9/3E0M4TE:13H@
M,3!P=#L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1$E34$Q!63H@
M:6YL:6YE)SX@)FYB<W`[/"]F;VYT/B`\+W1D/B`\=&0@<W1Y;&4],T0G4$%$
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M25I%.B`Q,'!T.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!$25-0
M3$%9.B!I;FQI;F4G/B`F;F)S<#L\+V9O;G0^(#PO=&0^(#QT9"!S='EL93TS
M1"="3U)$15(M0D]45$]-.B!B;&%C:R`R<'@@<V]L:60[($1)4U!,05DZ(&EN
M;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%
M.B`Q,'!T.R!415A4+4%,24=..B!R:6=H="<@=F%L:6=N/3-$8F]T=&]M('=I
M9'1H/3-$-R4^-3`X/"]T9#X@/'1D('-T>6QE/3-$)U!!1$1)3D<M0D]45$]-
M.B`R<'@[(%1%6%0M04Q)1TXZ(&QE9G0G('9A;&EG;CTS1&)O='1O;2!W:61T
M:#TS1#$E(&YO=W)A<#TS1&YO=W)A<#X\9F]N="!S='EL93TS1"=&3TY4+5-)
M6D4Z(#$P<'0[($9/3E0M1D%-24Q9.B!T:6UE<R!N97<@<F]M86X[($1)4U!,
M05DZ(&EN;&EN92<^("9N8G-P.SPO9F]N=#X@/"]T9#X@/'1D('-T>6QE/3-$
M)U!!1$1)3D<M0D]45$]-.B`R<'@G('9A;&EG;CTS1&)O='1O;2!W:61T:#TS
M1#$E(&%L:6=N/3-$<FEG:'0^/&9O;G0@<W1Y;&4],T0G1D].5"U325I%.B`Q
M,'!T.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!$25-03$%9.B!I
M;FQI;F4G/B`F;F)S<#L\+V9O;G0^(#PO=&0^(#QT9"!S='EL93TS1"="3U)$
M15(M0D]45$]-.B!B;&%C:R`R<'@@<V]L:60[(%1%6%0M04Q)1TXZ(&QE9G0G
M('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E/CQF;VYT('-T>6QE/3-$)T9/
M3E0M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@
M1$E34$Q!63H@:6YL:6YE)SX@)FYB<W`[/"]F;VYT/B`\+W1D/B`\=&0@<W1Y
M;&4],T0G0D]21$52+4)/5%1/33H@8FQA8VL@,G!X('-O;&ED.R!$25-03$%9
M.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE<R!N97<@<F]M86X[($9/3E0M
M4TE:13H@,3!P=#L@5$585"U!3$E'3CH@<FEG:'0G('9A;&EG;CTS1&)O='1O
M;2!W:61T:#TS1#<E/C,P/"]T9#X@/'1D('-T>6QE/3-$)U!!1$1)3D<M0D]4
M5$]-.B`R<'@[(%1%6%0M04Q)1TXZ(&QE9G0G('9A;&EG;CTS1&)O='1O;2!W
M:61T:#TS1#$E(&YO=W)A<#TS1&YO=W)A<#X\9F]N="!S='EL93TS1"=&3TY4
M+5-)6D4Z(#$P<'0[($9/3E0M1D%-24Q9.B!T:6UE<R!N97<@<F]M86X[($1)
M4U!,05DZ(&EN;&EN92<^("9N8G-P.SPO9F]N=#X@/"]T9#X@/'1D('-T>6QE
M/3-$)U!!1$1)3D<M0D]45$]-.B`R<'@G('9A;&EG;CTS1&)O='1O;2!W:61T
M:#TS1#$E(&%L:6=N/3-$<FEG:'0^/&9O;G0@<W1Y;&4],T0G1D].5"U325I%
M.B`Q,'!T.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!$25-03$%9
M.B!I;FQI;F4G/B`F;F)S<#L\+V9O;G0^(#PO=&0^(#QT9"!S='EL93TS1"="
M3U)$15(M0D]45$]-.B!B;&%C:R`R<'@@<V]L:60[(%1%6%0M04Q)1TXZ(&QE
M9G0G('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E/CQF;VYT('-T>6QE/3-$
M)T9/3E0M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA
M;CL@1$E34$Q!63H@:6YL:6YE)SX@)FYB<W`[/"]F;VYT/B`\+W1D/B`\=&0@
M<W1Y;&4],T0G0D]21$52+4)/5%1/33H@8FQA8VL@,G!X('-O;&ED.R!$25-0
M3$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE<R!N97<@<F]M86X[($9/
M3E0M4TE:13H@,3!P=#L@5$585"U!3$E'3CH@<FEG:'0G('9A;&EG;CTS1&)O
M='1O;2!W:61T:#TS1#<E/B@Y/"]T9#X@/'1D('-T>6QE/3-$)T1)4U!,05DZ
M(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U3
M25I%.B`Q,'!T.R!0041$24Y'+4)/5%1/33H@,G!X.R!415A4+4%,24=..B!L
M969T)R!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)2!N;W=R87`],T1N;W=R
M87`^*3PO=&0^(#QT9"!S='EL93TS1"=0041$24Y'+4)/5%1/33H@,G!X)R!V
M86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)2!A;&EG;CTS1')I9VAT/CQF;VYT
M('-T>6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ('1I;65S
M(&YE=R!R;VUA;CL@1$E34$Q!63H@:6YL:6YE)SX@)FYB<W`[/"]F;VYT/B`\
M+W1D/B`\=&0@<W1Y;&4],T0G0D]21$52+4)/5%1/33H@8FQA8VL@,G!X('-O
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M(')I9VAT)R!V86QI9VX],T1B;W1T;VT@=VED=&@],T0W)3XU,CD\+W1D/B`\
M=&0@<W1Y;&4],T0G4$%$1$E.1RU"3U143TTZ(#)P>#L@5$585"U!3$E'3CH@
M;&5F="<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@;F]W<F%P/3-$;F]W
M<F%P/CQF;VYT('-T>6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@1D].5"U&04U)
M3%DZ('1I;65S(&YE=R!R;VUA;CL@1$E34$Q!63H@:6YL:6YE)SX@)FYB<W`[
M/"]F;VYT/B`\+W1D/B`\+W1R/B`\='(@8F=C;VQO<CTS1"-C8V5E9F8^(#QT
M9"!V86QI9VX],T1B;W1T;VT@=VED=&@],T0R,"4^/&9O;G0@<W1Y;&4],T0G
M1D].5"U325I%.B`Q,'!T.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N
M.R!$25-03$%9.B!I;FQI;F4G/B`F;F)S<#L\+V9O;G0^(#PO=&0^(#QT9"!V
M86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)2!A;&EG;CTS1')I9VAT/CQF;VYT
M('-T>6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ('1I;65S
M(&YE=R!R;VUA;CL@1$E34$Q!63H@:6YL:6YE)SX@)FYB<W`[/"]F;VYT/B`\
M+W1D/B`\=&0@<W1Y;&4],T0G1$E34$Q!63H@:6YL:6YE.R!&3TY4+49!34E,
M63H@=&EM97,@;F5W(')O;6%N.R!&3TY4+5-)6D4Z(#$P<'0[(%1%6%0M04Q)
M1TXZ(&QE9G0G('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E/B0\+W1D/B`\
M=&0@<W1Y;&4],T0G1$E34$Q!63H@:6YL:6YE.R!&3TY4+49!34E,63H@=&EM
M97,@;F5W(')O;6%N.R!&3TY4+5-)6D4Z(#$P<'0[(%1%6%0M04Q)1TXZ(')I
M9VAT)R!V86QI9VX],T1B;W1T;VT@=VED=&@],T0W)3XQ.2PT,S`\+W1D/B`\
M=&0@<W1Y;&4],T0G5$585"U!3$E'3CH@;&5F="<@=F%L:6=N/3-$8F]T=&]M
M('=I9'1H/3-$,24@;F]W<F%P/3-$;F]W<F%P/CQF;VYT('-T>6QE/3-$)T9/
M3E0M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@
M1$E34$Q!63H@:6YL:6YE)SX@)FYB<W`[/"]F;VYT/B`\+W1D/B`\=&0@=F%L
M:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@86QI9VX],T1R:6=H=#X\9F]N="!S
M='EL93TS1"=&3TY4+5-)6D4Z(#$P<'0[($9/3E0M1D%-24Q9.B!T:6UE<R!N
M97<@<F]M86X[($1)4U!,05DZ(&EN;&EN92<^("9N8G-P.SPO9F]N=#X@/"]T
M9#X@/'1D('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ
M('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T.R!415A4+4%,24=.
M.B!L969T)R!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)3XD/"]T9#X@/'1D
M('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S
M(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T.R!415A4+4%,24=..B!R:6=H
M="<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$-R4^,BPU.#4\+W1D/B`\=&0@
M<W1Y;&4],T0G5$585"U!3$E'3CH@;&5F="<@=F%L:6=N/3-$8F]T=&]M('=I
M9'1H/3-$,24@;F]W<F%P/3-$;F]W<F%P/CQF;VYT('-T>6QE/3-$)T9/3E0M
M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1$E3
M4$Q!63H@:6YL:6YE)SX@)FYB<W`[/"]F;VYT/B`\+W1D/B`\=&0@=F%L:6=N
M/3-$8F]T=&]M('=I9'1H/3-$,24@86QI9VX],T1R:6=H=#X\9F]N="!S='EL
M93TS1"=&3TY4+5-)6D4Z(#$P<'0[($9/3E0M1D%-24Q9.B!T:6UE<R!N97<@
M<F]M86X[($1)4U!,05DZ(&EN;&EN92<^("9N8G-P.SPO9F]N=#X@/"]T9#X@
M/'1D('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I
M;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T.R!415A4+4%,24=..B!L
M969T)R!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)3XD/"]T9#X@/'1D('-T
M>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE
M=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T.R!415A4+4%,24=..B!R:6=H="<@
M=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$-R4^*#(S/"]T9#X@/'1D('-T>6QE
M/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R
M;VUA;CL@1D].5"U325I%.B`Q,'!T.R!415A4+4%,24=..B!L969T)R!V86QI
M9VX],T1B;W1T;VT@=VED=&@],T0Q)2!N;W=R87`],T1N;W=R87`^*3PO=&0^
M(#QT9"!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)2!A;&EG;CTS1')I9VAT
M/CQF;VYT('-T>6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ
M('1I;65S(&YE=R!R;VUA;CL@1$E34$Q!63H@:6YL:6YE)SX@)FYB<W`[/"]F
M;VYT/B`\+W1D/B`\=&0@<W1Y;&4],T0G1$E34$Q!63H@:6YL:6YE.R!&3TY4
M+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!&3TY4+5-)6D4Z(#$P<'0[(%1%
M6%0M04Q)1TXZ(&QE9G0G('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E/B0\
M+W1D/B`\=&0@<W1Y;&4],T0G1$E34$Q!63H@:6YL:6YE.R!&3TY4+49!34E,
M63H@=&EM97,@;F5W(')O;6%N.R!&3TY4+5-)6D4Z(#$P<'0[(%1%6%0M04Q)
M1TXZ(')I9VAT)R!V86QI9VX],T1B;W1T;VT@=VED=&@],T0W)3XR,2PY.3(\
M+W1D/B`\=&0@<W1Y;&4],T0G5$585"U!3$E'3CH@;&5F="<@=F%L:6=N/3-$
M8F]T=&]M('=I9'1H/3-$,24@;F]W<F%P/3-$;F]W<F%P/CQF;VYT('-T>6QE
M/3-$)T9/3E0M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R
M;VUA;CL@1$E34$Q!63H@:6YL:6YE)SX@)FYB<W`[/"]F;VYT/B`\+W1D/B`\
M=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@86QI9VX],T1R:6=H=#X\
M9F]N="!S='EL93TS1"=&3TY4+5-)6D4Z(#$P<'0[($9/3E0M1D%-24Q9.B!T
M:6UE<R!N97<@<F]M86X[($1)4U!,05DZ(&EN;&EN92<^("9N8G-P.SPO9F]N
M=#X@/"]T9#X@/'1D('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&
M04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T.R!415A4
M+4%,24=..B!L969T)R!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)3XD/"]T
M9#X@/'1D('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ
M('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T.R!415A4+4%,24=.
M.B!R:6=H="<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$-R4^-"PX-C`\+W1D
M/B`\=&0@<W1Y;&4],T0G5$585"U!3$E'3CH@;&5F="<@=F%L:6=N/3-$8F]T
M=&]M('=I9'1H/3-$,24@;F]W<F%P/3-$;F]W<F%P/CQF;VYT('-T>6QE/3-$
M)T9/3E0M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA
M;CL@1$E34$Q!63H@:6YL:6YE)SX@)FYB<W`[/"]F;VYT/B`\+W1D/B`\=&0@
M=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@86QI9VX],T1R:6=H=#X\9F]N
M="!S='EL93TS1"=&3TY4+5-)6D4Z(#$P<'0[($9/3E0M1D%-24Q9.B!T:6UE
M<R!N97<@<F]M86X[($1)4U!,05DZ(&EN;&EN92<^("9N8G-P.SPO9F]N=#X@
M/"]T9#X@/'1D('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)
M3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T.R!415A4+4%,
M24=..B!L969T)R!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)3XD/"]T9#X@
M/'1D('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I
M;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T.R!415A4+4%,24=..B!R
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M;&4],T0G1D].5"U325I%.B`Q,'!T.R!&3TY4+49!34E,63H@=&EM97,@;F5W
M(')O;6%N.R!$25-03$%9.B!I;FQI;F4G/B`F;F)S<#L\+V9O;G0^(#PO=&0^
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M('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#<E/B@Q.#D\+W1D/B`\=&0@<W1Y
M;&4],T0G1$E34$Q!63H@:6YL:6YE.R!&3TY4+49!34E,63H@=&EM97,@;F5W
M(')O;6%N.R!&3TY4+5-)6D4Z(#$P<'0[(%1%6%0M04Q)1TXZ(&QE9G0G('9A
M;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E(&YO=W)A<#TS1&YO=W)A<#XI/"]T
M9#X@/'1D('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E(&%L:6=N/3-$<FEG
M:'0^/&9O;G0@<W1Y;&4],T0G1D].5"U325I%.B`Q,'!T.R!&3TY4+49!34E,
M63H@=&EM97,@;F5W(')O;6%N.R!$25-03$%9.B!I;FQI;F4G/B`F;F)S<#L\
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M04Q)1TXZ(&QE9G0[($U!4D=)3BU,1494.B`P<'0[($U!4D=)3BU224=(5#H@
M,'!T.R!415A4+4E.1$5.5#H@,'!T)R!V86QI9VX],T1B;W1T;VT@=VED=&@]
M,T0R,"4^(#QD:78@<W1Y;&4],T0G1$E34$Q!63H@8FQO8VL[($9/3E0M1D%-
M24Q9.B!T:6UE<R!N97<@<F]M86X[($9/3E0M4TE:13H@,3!P=#L@1D].5"U7
M14E'2%0Z(&)O;&0[($U!4D=)3BU,1494.B`P<'0[($U!4D=)3BU224=(5#H@
M,'!T.R!415A4+4%,24=..B!L969T.R!415A4+4E.1$5.5#H@,'!T)SX@079A
M:6QA8FQE+69O<BUS86QE("T@;6%T=7)E<R!A9G1E<B!O;F4@>65A<B!T:')O
M=6=H(&9I=F4@>65A<G,Z/"]D:78^(#PO=&0^(#QT9"!V86QI9VX],T1B;W1T
M;VT@=VED=&@],T0Q)3X\9F]N="!S='EL93TS1"=&3TY4+5-)6D4Z(#$P<'0[
M($9/3E0M1D%-24Q9.B!T:6UE<R!N97<@<F]M86X[($1)4U!,05DZ(&EN;&EN
M92<^("9N8G-P.SPO9F]N=#X@/"]T9#X@/'1D('-T>6QE/3-$)U1%6%0M04Q)
M1TXZ(&QE9G0G('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E/CQF;VYT('-T
M>6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ('1I;65S(&YE
M=R!R;VUA;CL@1$E34$Q!63H@:6YL:6YE)SX@)FYB<W`[/"]F;VYT/B`\+W1D
M/B`\=&0@<W1Y;&4],T0G5$585"U!3$E'3CH@<FEG:'0G('9A;&EG;CTS1&)O
M='1O;2!W:61T:#TS1#<E/CQF;VYT('-T>6QE/3-$)T9/3E0M4TE:13H@,3!P
M=#L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1$E34$Q!63H@:6YL
M:6YE)SX@)FYB<W`[/"]F;VYT/B`\+W1D/B`\=&0@<W1Y;&4],T0G5$585"U!
M3$E'3CH@;&5F="<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@;F]W<F%P
M/3-$;F]W<F%P/CQF;VYT('-T>6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@1D].
M5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1$E34$Q!63H@:6YL:6YE)SX@
M)FYB<W`[/"]F;VYT/B`\+W1D/B`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H
M/3-$,24^/&9O;G0@<W1Y;&4],T0G1D].5"U325I%.B`Q,'!T.R!&3TY4+49!
M34E,63H@=&EM97,@;F5W(')O;6%N.R!$25-03$%9.B!I;FQI;F4G/B`F;F)S
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M;65S(&YE=R!R;VUA;CL@1$E34$Q!63H@:6YL:6YE)SX@)FYB<W`[/"]F;VYT
M/B`\+W1D/B`\=&0@<W1Y;&4],T0G5$585"U!3$E'3CH@;&5F="<@=F%L:6=N
M/3-$8F]T=&]M('=I9'1H/3-$,24^/&9O;G0@<W1Y;&4],T0G1D].5"U325I%
M.B`Q,'!T.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!$25-03$%9
M.B!I;FQI;F4G/B`F;F)S<#L\+V9O;G0^(#PO=&0^(#QT9"!S='EL93TS1"=4
M15A4+4%,24=..B!R:6=H="<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$-R4^
M/&9O;G0@<W1Y;&4],T0G1D].5"U325I%.B`Q,'!T.R!&3TY4+49!34E,63H@
M=&EM97,@;F5W(')O;6%N.R!$25-03$%9.B!I;FQI;F4G/B`F;F)S<#L\+V9O
M;G0^(#PO=&0^(#QT9"!S='EL93TS1"=415A4+4%,24=..B!L969T)R!V86QI
M9VX],T1B;W1T;VT@=VED=&@],T0Q)2!N;W=R87`],T1N;W=R87`^/&9O;G0@
M<W1Y;&4],T0G1D].5"U325I%.B`Q,'!T.R!&3TY4+49!34E,63H@=&EM97,@
M;F5W(')O;6%N.R!$25-03$%9.B!I;FQI;F4G/B`F;F)S<#L\+V9O;G0^(#PO
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M)SX@)FYB<W`[/"]F;VYT/B`\+W1D/B`\=&0@<W1Y;&4],T0G5$585"U!3$E'
M3CH@<FEG:'0G('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#<E/CQF;VYT('-T
M>6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ('1I;65S(&YE
M=R!R;VUA;CL@1$E34$Q!63H@:6YL:6YE)SX@)FYB<W`[/"]F;VYT/B`\+W1D
M/B`\=&0@<W1Y;&4],T0G5$585"U!3$E'3CH@;&5F="<@=F%L:6=N/3-$8F]T
M=&]M('=I9'1H/3-$,24@;F]W<F%P/3-$;F]W<F%P/CQF;VYT('-T>6QE/3-$
M)T9/3E0M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA
M;CL@1$E34$Q!63H@:6YL:6YE)SX@)FYB<W`[/"]F;VYT/B`\+W1D/B`\=&0@
M=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24^/&9O;G0@<W1Y;&4],T0G1D].
M5"U325I%.B`Q,'!T.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!$
M25-03$%9.B!I;FQI;F4G/B`F;F)S<#L\+V9O;G0^(#PO=&0^(#QT9"!S='EL
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M:6YL:6YE)SX@)FYB<W`[/"]F;VYT/B`\+W1D/B`\=&0@<W1Y;&4],T0G5$58
M5"U!3$E'3CH@;&5F="<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24^/&9O
M;G0@<W1Y;&4],T0G1D].5"U325I%.B`Q,'!T.R!&3TY4+49!34E,63H@=&EM
M97,@;F5W(')O;6%N.R!$25-03$%9.B!I;FQI;F4G/B`F;F)S<#L\+V9O;G0^
M(#PO=&0^(#QT9"!S='EL93TS1"=415A4+4%,24=..B!R:6=H="<@=F%L:6=N
M/3-$8F]T=&]M('=I9'1H/3-$-R4^/&9O;G0@<W1Y;&4],T0G1D].5"U325I%
M.B`Q,'!T.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!$25-03$%9
M.B!I;FQI;F4G/B`F;F)S<#L\+V9O;G0^(#PO=&0^(#QT9"!S='EL93TS1"=4
M15A4+4%,24=..B!L969T)R!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)2!N
M;W=R87`],T1N;W=R87`^/&9O;G0@<W1Y;&4],T0G1D].5"U325I%.B`Q,'!T
M.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!$25-03$%9.B!I;FQI
M;F4G/B`F;F)S<#L\+V9O;G0^(#PO=&0^(#QT9"!V86QI9VX],T1B;W1T;VT@
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M;VUA;CL@1$E34$Q!63H@:6YL:6YE)SX@)FYB<W`[/"]F;VYT/B`\+W1D/B`\
M=&0@<W1Y;&4],T0G5$585"U!3$E'3CH@<FEG:'0G('9A;&EG;CTS1&)O='1O
M;2!W:61T:#TS1#<E/CQF;VYT('-T>6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@
M1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1$E34$Q!63H@:6YL:6YE
M)SX@)FYB<W`[/"]F;VYT/B`\+W1D/B`\=&0@<W1Y;&4],T0G5$585"U!3$E'
M3CH@;&5F="<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@;F]W<F%P/3-$
M;F]W<F%P/CQF;VYT('-T>6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@1D].5"U&
M04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1$E34$Q!63H@:6YL:6YE)SX@)FYB
M<W`[/"]F;VYT/B`\+W1D/B`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$
M,24^/&9O;G0@<W1Y;&4],T0G1D].5"U325I%.B`Q,'!T.R!&3TY4+49!34E,
M63H@=&EM97,@;F5W(')O;6%N.R!$25-03$%9.B!I;FQI;F4G/B`F;F)S<#L\
M+V9O;G0^(#PO=&0^(#QT9"!S='EL93TS1"=415A4+4%,24=..B!L969T)R!V
M86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)3X\9F]N="!S='EL93TS1"=&3TY4
M+5-)6D4Z(#$P<'0[($9/3E0M1D%-24Q9.B!T:6UE<R!N97<@<F]M86X[($1)
M4U!,05DZ(&EN;&EN92<^("9N8G-P.SPO9F]N=#X@/"]T9#X@/'1D('-T>6QE
M/3-$)U1%6%0M04Q)1TXZ(')I9VAT)R!V86QI9VX],T1B;W1T;VT@=VED=&@]
M,T0W)3X\9F]N="!S='EL93TS1"=&3TY4+5-)6D4Z(#$P<'0[($9/3E0M1D%-
M24Q9.B!T:6UE<R!N97<@<F]M86X[($1)4U!,05DZ(&EN;&EN92<^("9N8G-P
M.SPO9F]N=#X@/"]T9#X@/'1D('-T>6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G
M('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E(&YO=W)A<#TS1&YO=W)A<#X\
M9F]N="!S='EL93TS1"=&3TY4+5-)6D4Z(#$P<'0[($9/3E0M1D%-24Q9.B!T
M:6UE<R!N97<@<F]M86X[($1)4U!,05DZ(&EN;&EN92<^("9N8G-P.SPO9F]N
M=#X@/"]T9#X@/"]T<CX@/'1R(&)G8V]L;W(],T0C8V-E969F/B`\=&0@<W1Y
M;&4],T0G5$585"U!3$E'3CH@;&5F=#L@34%21TE.+4Q%1E0Z(#!P=#L@34%2
M1TE.+5))1TA4.B`P<'0[(%1%6%0M24Y$14Y4.B`P<'0G('9A;&EG;CTS1&)O
M='1O;2!W:61T:#TS1#(P)3X@/&1I=B!S='EL93TS1"=$25-03$%9.B!B;&]C
M:SL@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q
M,'!T.R!-05)'24XM3$5&5#H@,'!T.R!-05)'24XM4DE'2%0Z(#!P=#L@5$58
M5"U!3$E'3CH@;&5F=#L@5$585"U)3D1%3E0Z(#!P="<^($=O=F5R;FUE;G0@
M9&5B96YT=7)E<R`M(&9I>&5D(&EN=&5R97-T(')A=&4\+V1I=CX@/"]T9#X@
M/'1D('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E(&%L:6=N/3-$<FEG:'0^
M/&9O;G0@<W1Y;&4],T0G1D].5"U325I%.B`Q,'!T.R!&3TY4+49!34E,63H@
M=&EM97,@;F5W(')O;6%N.R!$25-03$%9.B!I;FQI;F4G/B`F;F)S<#L\+V9O
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M;CL@1D].5"U325I%.B`Q,'!T.R!415A4+4%,24=..B!R:6=H="<@=F%L:6=N
M/3-$8F]T=&]M('=I9'1H/3-$-R4^,BPU.34\+W1D/B`\=&0@<W1Y;&4],T0G
M5$585"U!3$E'3CH@;&5F="<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@
M;F]W<F%P/3-$;F]W<F%P/CQF;VYT('-T>6QE/3-$)T9/3E0M4TE:13H@,3!P
M=#L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1$E34$Q!63H@:6YL
M:6YE)SX@)FYB<W`[/"]F;VYT/B`\+W1D/B`\=&0@=F%L:6=N/3-$8F]T=&]M
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M3%DZ('1I;65S(&YE=R!R;VUA;CL@1$E34$Q!63H@:6YL:6YE)SX@)FYB<W`[
M/"]F;VYT/B`\+W1D/B`\=&0@<W1Y;&4],T0G1$E34$Q!63H@:6YL:6YE.R!&
M3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!&3TY4+5-)6D4Z(#$P<'0[
M(%1%6%0M04Q)1TXZ(')I9VAT)R!V86QI9VX],T1B;W1T;VT@=VED=&@],T0W
M)3XY.#PO=&0^(#QT9"!S='EL93TS1"=415A4+4%,24=..B!L969T)R!V86QI
M9VX],T1B;W1T;VT@=VED=&@],T0Q)2!N;W=R87`],T1N;W=R87`^/&9O;G0@
M<W1Y;&4],T0G1D].5"U325I%.B`Q,'!T.R!&3TY4+49!34E,63H@=&EM97,@
M;F5W(')O;6%N.R!$25-03$%9.B!I;FQI;F4G/B`F;F)S<#L\+V9O;G0^(#PO
M=&0^(#QT9"!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)2!A;&EG;CTS1')I
M9VAT/CQF;VYT('-T>6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@1D].5"U&04U)
M3%DZ('1I;65S(&YE=R!R;VUA;CL@1$E34$Q!63H@:6YL:6YE)SX@)FYB<W`[
M/"]F;VYT/B`\+W1D/B`\=&0@<W1Y;&4],T0G5$585"U!3$E'3CH@;&5F="<@
M=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24^/&9O;G0@<W1Y;&4],T0G1D].
M5"U325I%.B`Q,'!T.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!$
M25-03$%9.B!I;FQI;F4G/B`F;F)S<#L\+V9O;G0^(#PO=&0^(#QT9"!S='EL
M93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE<R!N97<@
M<F]M86X[($9/3E0M4TE:13H@,3!P=#L@5$585"U!3$E'3CH@<FEG:'0G('9A
M;&EG;CTS1&)O='1O;2!W:61T:#TS1#<E/B@Q/"]T9#X@/'1D('-T>6QE/3-$
M)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA
M;CL@1D].5"U325I%.B`Q,'!T.R!415A4+4%,24=..B!L969T)R!V86QI9VX]
M,T1B;W1T;VT@=VED=&@],T0Q)2!N;W=R87`],T1N;W=R87`^*3PO=&0^(#QT
M9"!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)2!A;&EG;CTS1')I9VAT/CQF
M;VYT('-T>6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ('1I
M;65S(&YE=R!R;VUA;CL@1$E34$Q!63H@:6YL:6YE)SX@)FYB<W`[/"]F;VYT
M/B`\+W1D/B`\=&0@<W1Y;&4],T0G5$585"U!3$E'3CH@;&5F="<@=F%L:6=N
M/3-$8F]T=&]M('=I9'1H/3-$,24^/&9O;G0@<W1Y;&4],T0G1D].5"U325I%
M.B`Q,'!T.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!$25-03$%9
M.B!I;FQI;F4G/B`F;F)S<#L\+V9O;G0^(#PO=&0^(#QT9"!S='EL93TS1"=$
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M25I%.B`Q,'!T.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!$25-0
M3$%9.B!I;FQI;F4G/B`F;F)S<#L\+V9O;G0^(#PO=&0^(#QT9"!S='EL93TS
M1"=415A4+4%,24=..B!L969T)R!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q
M)3X\9F]N="!S='EL93TS1"=&3TY4+5-)6D4Z(#$P<'0[($9/3E0M1D%-24Q9
M.B!T:6UE<R!N97<@<F]M86X[($1)4U!,05DZ(&EN;&EN92<^("9N8G-P.SPO
M9F]N=#X@/"]T9#X@/'1D('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].
M5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T.R!4
M15A4+4%,24=..B!R:6=H="<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$-R4^
M,2PV,#(\+W1D/B`\=&0@<W1Y;&4],T0G5$585"U!3$E'3CH@;&5F="<@=F%L
M:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@;F]W<F%P/3-$;F]W<F%P/CQF;VYT
M('-T>6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ('1I;65S
M(&YE=R!R;VUA;CL@1$E34$Q!63H@:6YL:6YE)SX@)FYB<W`[/"]F;VYT/B`\
M+W1D/B`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@86QI9VX],T1R
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M1$E34$Q!63H@:6YL:6YE)SX@)FYB<W`[/"]F;VYT/B`\+W1D/B`\=&0@<W1Y
M;&4],T0G1$E34$Q!63H@:6YL:6YE.R!&3TY4+49!34E,63H@=&EM97,@;F5W
M(')O;6%N.R!&3TY4+5-)6D4Z(#$P<'0[(%1%6%0M04Q)1TXZ(')I9VAT)R!V
M86QI9VX],T1B;W1T;VT@=VED=&@],T0W)3XT.3PO=&0^(#QT9"!S='EL93TS
M1"=415A4+4%,24=..B!L969T)R!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q
M)2!N;W=R87`],T1N;W=R87`^/&9O;G0@<W1Y;&4],T0G1D].5"U325I%.B`Q
M,'!T.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!$25-03$%9.B!I
M;FQI;F4G/B`F;F)S<#L\+V9O;G0^(#PO=&0^(#QT9"!V86QI9VX],T1B;W1T
M;VT@=VED=&@],T0Q)2!A;&EG;CTS1')I9VAT/CQF;VYT('-T>6QE/3-$)T9/
M3E0M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@
M1$E34$Q!63H@:6YL:6YE)SX@)FYB<W`[/"]F;VYT/B`\+W1D/B`\=&0@<W1Y
M;&4],T0G5$585"U!3$E'3CH@;&5F="<@=F%L:6=N/3-$8F]T=&]M('=I9'1H
M/3-$,24^/&9O;G0@<W1Y;&4],T0G1D].5"U325I%.B`Q,'!T.R!&3TY4+49!
M34E,63H@=&EM97,@;F5W(')O;6%N.R!$25-03$%9.B!I;FQI;F4G/B`F;F)S
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M;F]W<F%P/3-$;F]W<F%P/BD\+W1D/B`\=&0@=F%L:6=N/3-$8F]T=&]M('=I
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M('1I;65S(&YE=R!R;VUA;CL@1$E34$Q!63H@:6YL:6YE)SX@)FYB<W`[/"]F
M;VYT/B`\+W1D/B`\=&0@<W1Y;&4],T0G1$E34$Q!63H@:6YL:6YE.R!&3TY4
M+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!&3TY4+5-)6D4Z(#$P<'0[(%1%
M6%0M04Q)1TXZ(')I9VAT)R!V86QI9VX],T1B;W1T;VT@=VED=&@],T0W)3XQ
M+#8S.3PO=&0^(#QT9"!S='EL93TS1"=415A4+4%,24=..B!L969T)R!V86QI
M9VX],T1B;W1T;VT@=VED=&@],T0Q)2!N;W=R87`],T1N;W=R87`^/&9O;G0@
M<W1Y;&4],T0G1D].5"U325I%.B`Q,'!T.R!&3TY4+49!34E,63H@=&EM97,@
M;F5W(')O;6%N.R!$25-03$%9.B!I;FQI;F4G/B`F;F)S<#L\+V9O;G0^(#PO
M=&0^(#PO='(^(#QT<B!B9V-O;&]R/3-$=VAI=&4^(#QT9"!S='EL93TS1"=0
M041$24Y'+4)/5%1/33H@,G!X.R!415A4+4%,24=..B!L969T.R!-05)'24XM
M3$5&5#H@,'!T.R!-05)'24XM4DE'2%0Z(#!P=#L@5$585"U)3D1%3E0Z(#!P
M="<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,C`E/B`\9&EV('-T>6QE/3-$
M)T1)4U!,05DZ(&)L;V-K.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N
M.R!&3TY4+5-)6D4Z(#$P<'0[($U!4D=)3BU,1494.B`P<'0[($U!4D=)3BU2
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M;65S(&YE=R!R;VUA;CL@1$E34$Q!63H@:6YL:6YE)SX@)FYB<W`[/"]F;VYT
M/B`\+W1D/B`\=&0@<W1Y;&4],T0G0D]21$52+4)/5%1/33H@8FQA8VL@,G!X
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M24=..B!L969T)R!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)2!N;W=R87`]
M,T1N;W=R87`^/&9O;G0@<W1Y;&4],T0G1D].5"U325I%.B`Q,'!T.R!&3TY4
M+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!$25-03$%9.B!I;FQI;F4G/B`F
M;F)S<#L\+V9O;G0^(#PO=&0^(#QT9"!S='EL93TS1"=0041$24Y'+4)/5%1/
M33H@,G!X)R!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)2!A;&EG;CTS1')I
M9VAT/CQF;VYT('-T>6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@1D].5"U&04U)
M3%DZ('1I;65S(&YE=R!R;VUA;CL@1$E34$Q!63H@:6YL:6YE)SX@)FYB<W`[
M/"]F;VYT/B`\+W1D/B`\=&0@<W1Y;&4],T0G0D]21$52+4)/5%1/33H@8FQA
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M-C,\+W1D/B`\=&0@<W1Y;&4],T0G4$%$1$E.1RU"3U143TTZ(#)P>#L@5$58
M5"U!3$E'3CH@;&5F="<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@;F]W
M<F%P/3-$;F]W<F%P/CQF;VYT('-T>6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@
M1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1$E34$Q!63H@:6YL:6YE
M)SX@)FYB<W`[/"]F;VYT/B`\+W1D/B`\=&0@<W1Y;&4],T0G4$%$1$E.1RU"
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M8F]T=&]M('=I9'1H/3-$,24^/&9O;G0@<W1Y;&4],T0G1D].5"U325I%.B`Q
M,'!T.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!$25-03$%9.B!I
M;FQI;F4G/B`F;F)S<#L\+V9O;G0^(#PO=&0^(#QT9"!S='EL93TS1"="3U)$
M15(M0D]45$]-.B!B;&%C:R`R<'@@<V]L:60[($1)4U!,05DZ(&EN;&EN93L@
M1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T
M.R!415A4+4%,24=..B!R:6=H="<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$
M-R4^*#4\+W1D/B`\=&0@<W1Y;&4],T0G1$E34$Q!63H@:6YL:6YE.R!&3TY4
M+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!&3TY4+5-)6D4Z(#$P<'0[(%!!
M1$1)3D<M0D]45$]-.B`R<'@[(%1%6%0M04Q)1TXZ(&QE9G0G('9A;&EG;CTS
M1&)O='1O;2!W:61T:#TS1#$E(&YO=W)A<#TS1&YO=W)A<#XI/"]T9#X@/'1D
M('-T>6QE/3-$)U!!1$1)3D<M0D]45$]-.B`R<'@G('9A;&EG;CTS1&)O='1O
M;2!W:61T:#TS1#$E(&%L:6=N/3-$<FEG:'0^/&9O;G0@<W1Y;&4],T0G1D].
M5"U325I%.B`Q,'!T.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!$
M25-03$%9.B!I;FQI;F4G/B`F;F)S<#L\+V9O;G0^(#PO=&0^(#QT9"!S='EL
M93TS1"="3U)$15(M0D]45$]-.B!B;&%C:R`R<'@@<V]L:60[(%1%6%0M04Q)
M1TXZ(&QE9G0G('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E/CQF;VYT('-T
M>6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ('1I;65S(&YE
M=R!R;VUA;CL@1$E34$Q!63H@:6YL:6YE)SX@)FYB<W`[/"]F;VYT/B`\+W1D
M/B`\=&0@<W1Y;&4],T0G0D]21$52+4)/5%1/33H@8FQA8VL@,G!X('-O;&ED
M.R!$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE<R!N97<@<F]M
M86X[($9/3E0M4TE:13H@,3!P=#L@5$585"U!3$E'3CH@<FEG:'0G('9A;&EG
M;CTS1&)O='1O;2!W:61T:#TS1#<E/C4L,38T/"]T9#X@/'1D('-T>6QE/3-$
M)U!!1$1)3D<M0D]45$]-.B`R<'@[(%1%6%0M04Q)1TXZ(&QE9G0G('9A;&EG
M;CTS1&)O='1O;2!W:61T:#TS1#$E(&YO=W)A<#TS1&YO=W)A<#X\9F]N="!S
M='EL93TS1"=&3TY4+5-)6D4Z(#$P<'0[($9/3E0M1D%-24Q9.B!T:6UE<R!N
M97<@<F]M86X[($1)4U!,05DZ(&EN;&EN92<^("9N8G-P.SPO9F]N=#X@/"]T
M9#X@/'1D('-T>6QE/3-$)U!!1$1)3D<M0D]45$]-.B`R<'@G('9A;&EG;CTS
M1&)O='1O;2!W:61T:#TS1#$E(&%L:6=N/3-$<FEG:'0^/&9O;G0@<W1Y;&4]
M,T0G1D].5"U325I%.B`Q,'!T.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O
M;6%N.R!$25-03$%9.B!I;FQI;F4G/B`F;F)S<#L\+V9O;G0^(#PO=&0^(#QT
M9"!S='EL93TS1"="3U)$15(M0D]45$]-.B!B;&%C:R`R<'@@<V]L:60[(%1%
M6%0M04Q)1TXZ(&QE9G0G('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E/CQF
M;VYT('-T>6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ('1I
M;65S(&YE=R!R;VUA;CL@1$E34$Q!63H@:6YL:6YE)SX@)FYB<W`[/"]F;VYT
M/B`\+W1D/B`\=&0@<W1Y;&4],T0G0D]21$52+4)/5%1/33H@8FQA8VL@,G!X
M('-O;&ED.R!$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE<R!N
M97<@<F]M86X[($9/3E0M4TE:13H@,3!P=#L@5$585"U!3$E'3CH@<FEG:'0G
M('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#<E/C0L.3<V/"]T9#X@/'1D('-T
M>6QE/3-$)U!!1$1)3D<M0D]45$]-.B`R<'@[(%1%6%0M04Q)1TXZ(&QE9G0G
M('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E(&YO=W)A<#TS1&YO=W)A<#X\
M9F]N="!S='EL93TS1"=&3TY4+5-)6D4Z(#$P<'0[($9/3E0M1D%-24Q9.B!T
M:6UE<R!N97<@<F]M86X[($1)4U!,05DZ(&EN;&EN92<^("9N8G-P.SPO9F]N
M=#X@/"]T9#X@/'1D('-T>6QE/3-$)U!!1$1)3D<M0D]45$]-.B`R<'@G('9A
M;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E(&%L:6=N/3-$<FEG:'0^/&9O;G0@
M<W1Y;&4],T0G1D].5"U325I%.B`Q,'!T.R!&3TY4+49!34E,63H@=&EM97,@
M;F5W(')O;6%N.R!$25-03$%9.B!I;FQI;F4G/B`F;F)S<#L\+V9O;G0^(#PO
M=&0^(#QT9"!S='EL93TS1"="3U)$15(M0D]45$]-.B!B;&%C:R`R<'@@<V]L
M:60[(%1%6%0M04Q)1TXZ(&QE9G0G('9A;&EG;CTS1&)O='1O;2!W:61T:#TS
M1#$E/CQF;VYT('-T>6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@1D].5"U&04U)
M3%DZ('1I;65S(&YE=R!R;VUA;CL@1$E34$Q!63H@:6YL:6YE)SX@)FYB<W`[
M/"]F;VYT/B`\+W1D/B`\=&0@<W1Y;&4],T0G0D]21$52+4)/5%1/33H@8FQA
M8VL@,G!X('-O;&ED.R!$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T
M:6UE<R!N97<@<F]M86X[($9/3E0M4TE:13H@,3!P=#L@5$585"U!3$E'3CH@
M<FEG:'0G('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#<E/C$V,CPO=&0^(#QT
M9"!S='EL93TS1"=0041$24Y'+4)/5%1/33H@,G!X.R!415A4+4%,24=..B!L
M969T)R!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)2!N;W=R87`],T1N;W=R
M87`^/&9O;G0@<W1Y;&4],T0G1D].5"U325I%.B`Q,'!T.R!&3TY4+49!34E,
M63H@=&EM97,@;F5W(')O;6%N.R!$25-03$%9.B!I;FQI;F4G/B`F;F)S<#L\
M+V9O;G0^(#PO=&0^(#QT9"!S='EL93TS1"=0041$24Y'+4)/5%1/33H@,G!X
M)R!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)2!A;&EG;CTS1')I9VAT/CQF
M;VYT('-T>6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ('1I
M;65S(&YE=R!R;VUA;CL@1$E34$Q!63H@:6YL:6YE)SX@)FYB<W`[/"]F;VYT
M/B`\+W1D/B`\=&0@<W1Y;&4],T0G0D]21$52+4)/5%1/33H@8FQA8VL@,G!X
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M/B`\=&0@<W1Y;&4],T0G1$E34$Q!63H@:6YL:6YE.R!&3TY4+49!34E,63H@
M=&EM97,@;F5W(')O;6%N.R!&3TY4+5-)6D4Z(#$P<'0[(%!!1$1)3D<M0D]4
M5$]-.B`R<'@[(%1%6%0M04Q)1TXZ(&QE9G0G('9A;&EG;CTS1&)O='1O;2!W
M:61T:#TS1#$E(&YO=W)A<#TS1&YO=W)A<#XI/"]T9#X@/'1D('-T>6QE/3-$
M)U!!1$1)3D<M0D]45$]-.B`R<'@G('9A;&EG;CTS1&)O='1O;2!W:61T:#TS
M1#$E(&%L:6=N/3-$<FEG:'0^/&9O;G0@<W1Y;&4],T0G1D].5"U325I%.B`Q
M,'!T.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!$25-03$%9.B!I
M;FQI;F4G/B`F;F)S<#L\+V9O;G0^(#PO=&0^(#QT9"!S='EL93TS1"="3U)$
M15(M0D]45$]-.B!B;&%C:R`R<'@@<V]L:60[(%1%6%0M04Q)1TXZ(&QE9G0G
M('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E/CQF;VYT('-T>6QE/3-$)T9/
M3E0M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@
M1$E34$Q!63H@:6YL:6YE)SX@)FYB<W`[/"]F;VYT/B`\+W1D/B`\=&0@<W1Y
M;&4],T0G0D]21$52+4)/5%1/33H@8FQA8VL@,G!X('-O;&ED.R!$25-03$%9
M.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE<R!N97<@<F]M86X[($9/3E0M
M4TE:13H@,3!P=#L@5$585"U!3$E'3CH@<FEG:'0G('9A;&EG;CTS1&)O='1O
M;2!W:61T:#TS1#<E/C4L,#8Q/"]T9#X@/'1D('-T>6QE/3-$)U!!1$1)3D<M
M0D]45$]-.B`R<'@[(%1%6%0M04Q)1TXZ(&QE9G0G('9A;&EG;CTS1&)O='1O
M;2!W:61T:#TS1#$E(&YO=W)A<#TS1&YO=W)A<#X\9F]N="!S='EL93TS1"=&
M3TY4+5-)6D4Z(#$P<'0[($9/3E0M1D%-24Q9.B!T:6UE<R!N97<@<F]M86X[
M($1)4U!,05DZ(&EN;&EN92<^("9N8G-P.SPO9F]N=#X@/"]T9#X@/"]T<CX@
M/'1R(&)G8V]L;W(],T0C8V-E969F/B`\=&0@=F%L:6=N/3-$8F]T=&]M('=I
M9'1H/3-$,C`E/CQF;VYT('-T>6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@1D].
M5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1$E34$Q!63H@:6YL:6YE)SX@
M)FYB<W`[/"]F;VYT/B`\+W1D/B`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H
M/3-$,24@86QI9VX],T1R:6=H=#X\9F]N="!S='EL93TS1"=&3TY4+5-)6D4Z
M(#$P<'0[($9/3E0M1D%-24Q9.B!T:6UE<R!N97<@<F]M86X[($1)4U!,05DZ
M(&EN;&EN92<^("9N8G-P.SPO9F]N=#X@/"]T9#X@/'1D('-T>6QE/3-$)T1)
M4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@
M1D].5"U325I%.B`Q,'!T.R!415A4+4%,24=..B!L969T)R!V86QI9VX],T1B
M;W1T;VT@=VED=&@],T0Q)3XD/"]T9#X@/'1D('-T>6QE/3-$)T1)4U!,05DZ
M(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U3
M25I%.B`Q,'!T.R!415A4+4%,24=..B!R:6=H="<@=F%L:6=N/3-$8F]T=&]M
M('=I9'1H/3-$-R4^-RPU,#$\+W1D/B`\=&0@<W1Y;&4],T0G5$585"U!3$E'
M3CH@;&5F="<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@;F]W<F%P/3-$
M;F]W<F%P/CQF;VYT('-T>6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@1D].5"U&
M04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1$E34$Q!63H@:6YL:6YE)SX@)FYB
M<W`[/"]F;VYT/B`\+W1D/B`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$
M,24@86QI9VX],T1R:6=H=#X\9F]N="!S='EL93TS1"=&3TY4+5-)6D4Z(#$P
M<'0[($9/3E0M1D%-24Q9.B!T:6UE<R!N97<@<F]M86X[($1)4U!,05DZ(&EN
M;&EN92<^("9N8G-P.SPO9F]N=#X@/"]T9#X@/'1D('-T>6QE/3-$)T1)4U!,
M05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].
M5"U325I%.B`Q,'!T.R!415A4+4%,24=..B!L969T)R!V86QI9VX],T1B;W1T
M;VT@=VED=&@],T0Q)3XD/"]T9#X@/'1D('-T>6QE/3-$)T1)4U!,05DZ(&EN
M;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%
M.B`Q,'!T.R!415A4+4%,24=..B!R:6=H="<@=F%L:6=N/3-$8F]T=&]M('=I
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M:6=N/3-$<FEG:'0^/&9O;G0@<W1Y;&4],T0G1D].5"U325I%.B`Q,'!T.R!&
M3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!$25-03$%9.B!I;FQI;F4G
M/B`F;F)S<#L\+V9O;G0^(#PO=&0^(#QT9"!S='EL93TS1"=$25-03$%9.B!I
M;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE<R!N97<@<F]M86X[($9/3E0M4TE:
M13H@,3!P=#L@5$585"U!3$E'3CH@;&5F="<@=F%L:6=N/3-$8F]T=&]M('=I
M9'1H/3-$,24^)#PO=&0^(#QT9"!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[
M($9/3E0M1D%-24Q9.B!T:6UE<R!N97<@<F]M86X[($9/3E0M4TE:13H@,3!P
M=#L@5$585"U!3$E'3CH@<FEG:'0G('9A;&EG;CTS1&)O='1O;2!W:61T:#TS
M1#<E/B@V/"]T9#X@/'1D('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].
M5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T.R!4
M15A4+4%,24=..B!L969T)R!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)2!N
M;W=R87`],T1N;W=R87`^*3PO=&0^(#QT9"!V86QI9VX],T1B;W1T;VT@=VED
M=&@],T0Q)2!A;&EG;CTS1')I9VAT/CQF;VYT('-T>6QE/3-$)T9/3E0M4TE:
M13H@,3!P=#L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1$E34$Q!
M63H@:6YL:6YE)SX@)FYB<W`[/"]F;VYT/B`\+W1D/B`\=&0@<W1Y;&4],T0G
M1$E34$Q!63H@:6YL:6YE.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N
M.R!&3TY4+5-)6D4Z(#$P<'0[(%1%6%0M04Q)1TXZ(&QE9G0G('9A;&EG;CTS
M1&)O='1O;2!W:61T:#TS1#$E/B0\+W1D/B`\=&0@<W1Y;&4],T0G1$E34$Q!
M63H@:6YL:6YE.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!&3TY4
M+5-)6D4Z(#$P<'0[(%1%6%0M04Q)1TXZ(')I9VAT)R!V86QI9VX],T1B;W1T
M;VT@=VED=&@],T0W)3XW+#@U-CPO=&0^(#QT9"!S='EL93TS1"=415A4+4%,
M24=..B!L969T)R!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)2!N;W=R87`]
M,T1N;W=R87`^/&9O;G0@<W1Y;&4],T0G1D].5"U325I%.B`Q,'!T.R!&3TY4
M+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!$25-03$%9.B!I;FQI;F4G/B`F
M;F)S<#L\+V9O;G0^(#PO=&0^(#QT9"!V86QI9VX],T1B;W1T;VT@=VED=&@]
M,T0Q)2!A;&EG;CTS1')I9VAT/CQF;VYT('-T>6QE/3-$)T9/3E0M4TE:13H@
M,3!P=#L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1$E34$Q!63H@
M:6YL:6YE)SX@)FYB<W`[/"]F;VYT/B`\+W1D/B`\=&0@<W1Y;&4],T0G1$E3
M4$Q!63H@:6YL:6YE.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!&
M3TY4+5-)6D4Z(#$P<'0[(%1%6%0M04Q)1TXZ(&QE9G0G('9A;&EG;CTS1&)O
M='1O;2!W:61T:#TS1#$E/B0\+W1D/B`\=&0@<W1Y;&4],T0G1$E34$Q!63H@
M:6YL:6YE.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!&3TY4+5-)
M6D4Z(#$P<'0[(%1%6%0M04Q)1TXZ(')I9VAT)R!V86QI9VX],T1B;W1T;VT@
M=VED=&@],T0W)3XV+#4W.#PO=&0^(#QT9"!S='EL93TS1"=415A4+4%,24=.
M.B!L969T)R!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)2!N;W=R87`],T1N
M;W=R87`^/&9O;G0@<W1Y;&4],T0G1D].5"U325I%.B`Q,'!T.R!&3TY4+49!
M34E,63H@=&EM97,@;F5W(')O;6%N.R!$25-03$%9.B!I;FQI;F4G/B`F;F)S
M<#L\+V9O;G0^(#PO=&0^(#QT9"!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q
M)2!A;&EG;CTS1')I9VAT/CQF;VYT('-T>6QE/3-$)T9/3E0M4TE:13H@,3!P
M=#L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1$E34$Q!63H@:6YL
M:6YE)SX@)FYB<W`[/"]F;VYT/B`\+W1D/B`\=&0@<W1Y;&4],T0G1$E34$Q!
M63H@:6YL:6YE.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!&3TY4
M+5-)6D4Z(#$P<'0[(%1%6%0M04Q)1TXZ(&QE9G0G('9A;&EG;CTS1&)O='1O
M;2!W:61T:#TS1#$E/B0\+W1D/B`\=&0@<W1Y;&4],T0G1$E34$Q!63H@:6YL
M:6YE.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!&3TY4+5-)6D4Z
M(#$P<'0[(%1%6%0M04Q)1TXZ(')I9VAT)R!V86QI9VX],T1B;W1T;VT@=VED
M=&@],T0W)3XR,3$\+W1D/B`\=&0@<W1Y;&4],T0G5$585"U!3$E'3CH@;&5F
M="<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@;F]W<F%P/3-$;F]W<F%P
M/CQF;VYT('-T>6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ
M('1I;65S(&YE=R!R;VUA;CL@1$E34$Q!63H@:6YL:6YE)SX@)FYB<W`[/"]F
M;VYT/B`\+W1D/B`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@86QI
M9VX],T1R:6=H=#X\9F]N="!S='EL93TS1"=&3TY4+5-)6D4Z(#$P<'0[($9/
M3E0M1D%-24Q9.B!T:6UE<R!N97<@<F]M86X[($1)4U!,05DZ(&EN;&EN92<^
M("9N8G-P.SPO9F]N=#X@/"]T9#X@/'1D('-T>6QE/3-$)T1)4U!,05DZ(&EN
M;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%
M.B`Q,'!T.R!415A4+4%,24=..B!L969T)R!V86QI9VX],T1B;W1T;VT@=VED
M=&@],T0Q)3XD/"]T9#X@/'1D('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@
M1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T
M.R!415A4+4%,24=..B!R:6=H="<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$
M-R4^*#@Y/"]T9#X@/'1D('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].
M5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T.R!4
M15A4+4%,24=..B!L969T)R!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)2!N
M;W=R87`],T1N;W=R87`^*3PO=&0^(#QT9"!V86QI9VX],T1B;W1T;VT@=VED
M=&@],T0Q)2!A;&EG;CTS1')I9VAT/CQF;VYT('-T>6QE/3-$)T9/3E0M4TE:
M13H@,3!P=#L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1$E34$Q!
M63H@:6YL:6YE)SX@)FYB<W`[/"]F;VYT/B`\+W1D/B`\=&0@<W1Y;&4],T0G
M1$E34$Q!63H@:6YL:6YE.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N
M.R!&3TY4+5-)6D4Z(#$P<'0[(%1%6%0M04Q)1TXZ(&QE9G0G('9A;&EG;CTS
M1&)O='1O;2!W:61T:#TS1#$E/B0\+W1D/B`\=&0@<W1Y;&4],T0G1$E34$Q!
M63H@:6YL:6YE.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!&3TY4
M+5-)6D4Z(#$P<'0[(%1%6%0M04Q)1TXZ(')I9VAT)R!V86QI9VX],T1B;W1T
M;VT@=VED=&@],T0W)3XV+#<P,#PO=&0^(#QT9"!S='EL93TS1"=415A4+4%,
M24=..B!L969T)R!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)2!N;W=R87`]
M,T1N;W=R87`^/&9O;G0@<W1Y;&4],T0G1D].5"U325I%.B`Q,'!T.R!&3TY4
M+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!$25-03$%9.B!I;FQI;F4G/B`F
M;F)S<#L\+V9O;G0^(#PO=&0^(#PO='(^(#QT<B!B9V-O;&]R/3-$=VAI=&4^
M(#QT9"!S='EL93TS1"=415A4+4%,24=..B!L969T.R!-05)'24XM3$5&5#H@
M,'!T.R!-05)'24XM4DE'2%0Z(#!P=#L@5$585"U)3D1%3E0Z(#!P="<@=F%L
M:6=N/3-$8F]T=&]M('=I9'1H/3-$,C`E/B`\9&EV('-T>6QE/3-$)T1)4U!,
M05DZ(&)L;V-K.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!&3TY4
M+5-)6D4Z(#$P<'0[($9/3E0M5T5)1TA4.B!B;VQD.R!-05)'24XM3$5&5#H@
M,'!T.R!-05)'24XM4DE'2%0Z(#!P=#L@5$585"U!3$E'3CH@;&5F=#L@5$58
M5"U)3D1%3E0Z(#!P="<^($%V86EL86)L92UF;W(M<V%L92`M(&UA='5R97,@
M869T97(@9FEV92!Y96%R<R!T:')O=6=H('1E;B!Y96%R<SH\+V1I=CX@/"]T
M9#X@/'1D('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E/CQF;VYT('-T>6QE
M/3-$)T9/3E0M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R
M;VUA;CL@1$E34$Q!63H@:6YL:6YE)SX@)FYB<W`[/"]F;VYT/B`\+W1D/B`\
M=&0@<W1Y;&4],T0G5$585"U!3$E'3CH@;&5F="<@=F%L:6=N/3-$8F]T=&]M
M('=I9'1H/3-$,24^/&9O;G0@<W1Y;&4],T0G1D].5"U325I%.B`Q,'!T.R!&
M3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!$25-03$%9.B!I;FQI;F4G
M/B`F;F)S<#L\+V9O;G0^(#PO=&0^(#QT9"!S='EL93TS1"=415A4+4%,24=.
M.B!R:6=H="<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$-R4^/&9O;G0@<W1Y
M;&4],T0G1D].5"U325I%.B`Q,'!T.R!&3TY4+49!34E,63H@=&EM97,@;F5W
M(')O;6%N.R!$25-03$%9.B!I;FQI;F4G/B`F;F)S<#L\+V9O;G0^(#PO=&0^
M(#QT9"!S='EL93TS1"=415A4+4%,24=..B!L969T)R!V86QI9VX],T1B;W1T
M;VT@=VED=&@],T0Q)2!N;W=R87`],T1N;W=R87`^/&9O;G0@<W1Y;&4],T0G
M1D].5"U325I%.B`Q,'!T.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N
M.R!$25-03$%9.B!I;FQI;F4G/B`F;F)S<#L\+V9O;G0^(#PO=&0^(#QT9"!V
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M3%DZ('1I;65S(&YE=R!R;VUA;CL@1$E34$Q!63H@:6YL:6YE)SX@)FYB<W`[
M/"]F;VYT/B`\+W1D/B`\=&0@<W1Y;&4],T0G5$585"U!3$E'3CH@<FEG:'0G
M('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#<E/CQF;VYT('-T>6QE/3-$)T9/
M3E0M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@
M1$E34$Q!63H@:6YL:6YE)SX@)FYB<W`[/"]F;VYT/B`\+W1D/B`\=&0@<W1Y
M;&4],T0G5$585"U!3$E'3CH@;&5F="<@=F%L:6=N/3-$8F]T=&]M('=I9'1H
M/3-$,24@;F]W<F%P/3-$;F]W<F%P/CQF;VYT('-T>6QE/3-$)T9/3E0M4TE:
M13H@,3!P=#L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1$E34$Q!
M63H@:6YL:6YE)SX@)FYB<W`[/"]F;VYT/B`\+W1D/B`\=&0@=F%L:6=N/3-$
M8F]T=&]M('=I9'1H/3-$,24^/&9O;G0@<W1Y;&4],T0G1D].5"U325I%.B`Q
M,'!T.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!$25-03$%9.B!I
M;FQI;F4G/B`F;F)S<#L\+V9O;G0^(#PO=&0^(#QT9"!S='EL93TS1"=415A4
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M)FYB<W`[/"]F;VYT/B`\+W1D/B`\=&0@<W1Y;&4],T0G5$585"U!3$E'3CH@
M;&5F="<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24^/&9O;G0@<W1Y;&4]
M,T0G1D].5"U325I%.B`Q,'!T.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O
M;6%N.R!$25-03$%9.B!I;FQI;F4G/B`F;F)S<#L\+V9O;G0^(#PO=&0^(#QT
M9"!S='EL93TS1"=415A4+4%,24=..B!R:6=H="<@=F%L:6=N/3-$8F]T=&]M
M('=I9'1H/3-$-R4^/&9O;G0@<W1Y;&4],T0G1D].5"U325I%.B`Q,'!T.R!&
M3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!$25-03$%9.B!I;FQI;F4G
M/B`F;F)S<#L\+V9O;G0^(#PO=&0^(#QT9"!S='EL93TS1"=415A4+4%,24=.
M.B!L969T)R!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)2!N;W=R87`],T1N
M;W=R87`^/&9O;G0@<W1Y;&4],T0G1D].5"U325I%.B`Q,'!T.R!&3TY4+49!
M34E,63H@=&EM97,@;F5W(')O;6%N.R!$25-03$%9.B!I;FQI;F4G/B`F;F)S
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M4$Q!63H@:6YL:6YE)SX@)FYB<W`[/"]F;VYT/B`\+W1D/B`\=&0@<W1Y;&4]
M,T0G5$585"U!3$E'3CH@<FEG:'0G('9A;&EG;CTS1&)O='1O;2!W:61T:#TS
M1#<E/CQF;VYT('-T>6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@1D].5"U&04U)
M3%DZ('1I;65S(&YE=R!R;VUA;CL@1$E34$Q!63H@:6YL:6YE)SX@)FYB<W`[
M/"]F;VYT/B`\+W1D/B`\=&0@<W1Y;&4],T0G5$585"U!3$E'3CH@;&5F="<@
M=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@;F]W<F%P/3-$;F]W<F%P/CQF
M;VYT('-T>6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ('1I
M;65S(&YE=R!R;VUA;CL@1$E34$Q!63H@:6YL:6YE)SX@)FYB<W`[/"]F;VYT
M/B`\+W1D/B`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24^/&9O;G0@
M<W1Y;&4],T0G1D].5"U325I%.B`Q,'!T.R!&3TY4+49!34E,63H@=&EM97,@
M;F5W(')O;6%N.R!$25-03$%9.B!I;FQI;F4G/B`F;F)S<#L\+V9O;G0^(#PO
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M;CL@1$E34$Q!63H@:6YL:6YE)SX@)FYB<W`[/"]F;VYT/B`\+W1D/B`\=&0@
M<W1Y;&4],T0G5$585"U!3$E'3CH@;&5F="<@=F%L:6=N/3-$8F]T=&]M('=I
M9'1H/3-$,24^/&9O;G0@<W1Y;&4],T0G1D].5"U325I%.B`Q,'!T.R!&3TY4
M+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!$25-03$%9.B!I;FQI;F4G/B`F
M;F)S<#L\+V9O;G0^(#PO=&0^(#QT9"!S='EL93TS1"=415A4+4%,24=..B!R
M:6=H="<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$-R4^/&9O;G0@<W1Y;&4]
M,T0G1D].5"U325I%.B`Q,'!T.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O
M;6%N.R!$25-03$%9.B!I;FQI;F4G/B`F;F)S<#L\+V9O;G0^(#PO=&0^(#QT
M9"!S='EL93TS1"=415A4+4%,24=..B!L969T)R!V86QI9VX],T1B;W1T;VT@
M=VED=&@],T0Q)2!N;W=R87`],T1N;W=R87`^/&9O;G0@<W1Y;&4],T0G1D].
M5"U325I%.B`Q,'!T.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!$
M25-03$%9.B!I;FQI;F4G/B`F;F)S<#L\+V9O;G0^(#PO=&0^(#QT9"!V86QI
M9VX],T1B;W1T;VT@=VED=&@],T0Q)3X\9F]N="!S='EL93TS1"=&3TY4+5-)
M6D4Z(#$P<'0[($9/3E0M1D%-24Q9.B!T:6UE<R!N97<@<F]M86X[($1)4U!,
M05DZ(&EN;&EN92<^("9N8G-P.SPO9F]N=#X@/"]T9#X@/'1D('-T>6QE/3-$
M)U1%6%0M04Q)1TXZ(&QE9G0G('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E
M/CQF;VYT('-T>6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ
M('1I;65S(&YE=R!R;VUA;CL@1$E34$Q!63H@:6YL:6YE)SX@)FYB<W`[/"]F
M;VYT/B`\+W1D/B`\=&0@<W1Y;&4],T0G5$585"U!3$E'3CH@<FEG:'0G('9A
M;&EG;CTS1&)O='1O;2!W:61T:#TS1#<E/CQF;VYT('-T>6QE/3-$)T9/3E0M
M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1$E3
M4$Q!63H@:6YL:6YE)SX@)FYB<W`[/"]F;VYT/B`\+W1D/B`\=&0@<W1Y;&4]
M,T0G5$585"U!3$E'3CH@;&5F="<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$
M,24@;F]W<F%P/3-$;F]W<F%P/CQF;VYT('-T>6QE/3-$)T9/3E0M4TE:13H@
M,3!P=#L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1$E34$Q!63H@
M:6YL:6YE)SX@)FYB<W`[/"]F;VYT/B`\+W1D/B`\+W1R/B`\='(@8F=C;VQO
M<CTS1"-C8V5E9F8^(#QT9"!S='EL93TS1"=415A4+4%,24=..B!L969T.R!-
M05)'24XM3$5&5#H@,'!T.R!-05)'24XM4DE'2%0Z(#!P=#L@5$585"U)3D1%
M3E0Z(#!P="<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,C`E/B`\9&EV('-T
M>6QE/3-$)T1)4U!,05DZ(&)L;V-K.R!&3TY4+49!34E,63H@=&EM97,@;F5W
M(')O;6%N.R!&3TY4+5-)6D4Z(#$P<'0[($U!4D=)3BU,1494.B`P<'0[($U!
M4D=)3BU224=(5#H@,'!T.R!415A4+4%,24=..B!L969T.R!415A4+4E.1$5.
M5#H@,'!T)SX@1V]V97)N;65N="!D96)E;G1U<F5S("T@9FEX960@:6YT97)E
M<W0@<F%T93PO9&EV/B`\+W1D/B`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H
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M;65S(&YE=R!R;VUA;CL@1$E34$Q!63H@:6YL:6YE)SX@)FYB<W`[/"]F;VYT
M/B`\+W1D/B`\=&0@<W1Y;&4],T0G1$E34$Q!63H@:6YL:6YE.R!&3TY4+49!
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M;G0@<W1Y;&4],T0G1D].5"U325I%.B`Q,'!T.R!&3TY4+49!34E,63H@=&EM
M97,@;F5W(')O;6%N.R!$25-03$%9.B!I;FQI;F4G/B`F;F)S<#L\+V9O;G0^
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M1D].5"U325I%.B`Q,'!T.R!415A4+4%,24=..B!R:6=H="<@=F%L:6=N/3-$
M8F]T=&]M('=I9'1H/3-$-R4^+3PO=&0^(#QT9"!S='EL93TS1"=415A4+4%,
M24=..B!L969T)R!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)2!N;W=R87`]
M,T1N;W=R87`^/&9O;G0@<W1Y;&4],T0G1D].5"U325I%.B`Q,'!T.R!&3TY4
M+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!$25-03$%9.B!I;FQI;F4G/B`F
M;F)S<#L\+V9O;G0^(#PO=&0^(#QT9"!V86QI9VX],T1B;W1T;VT@=VED=&@]
M,T0Q)2!A;&EG;CTS1')I9VAT/CQF;VYT('-T>6QE/3-$)T9/3E0M4TE:13H@
M,3!P=#L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1$E34$Q!63H@
M:6YL:6YE)SX@)FYB<W`[/"]F;VYT/B`\+W1D/B`\=&0@<W1Y;&4],T0G5$58
M5"U!3$E'3CH@;&5F="<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24^/&9O
M;G0@<W1Y;&4],T0G1D].5"U325I%.B`Q,'!T.R!&3TY4+49!34E,63H@=&EM
M97,@;F5W(')O;6%N.R!$25-03$%9.B!I;FQI;F4G/B`F;F)S<#L\+V9O;G0^
M(#PO=&0^(#QT9"!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-
M24Q9.B!T:6UE<R!N97<@<F]M86X[($9/3E0M4TE:13H@,3!P=#L@5$585"U!
M3$E'3CH@<FEG:'0G('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#<E/BT\+W1D
M/B`\=&0@<W1Y;&4],T0G5$585"U!3$E'3CH@;&5F="<@=F%L:6=N/3-$8F]T
M=&]M('=I9'1H/3-$,24@;F]W<F%P/3-$;F]W<F%P/CQF;VYT('-T>6QE/3-$
M)T9/3E0M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA
M;CL@1$E34$Q!63H@:6YL:6YE)SX@)FYB<W`[/"]F;VYT/B`\+W1D/B`\=&0@
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M:6YL:6YE)SX@)FYB<W`[/"]F;VYT/B`\+W1D/B`\=&0@<W1Y;&4],T0G1$E3
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M1#$E(&%L:6=N/3-$<FEG:'0^/&9O;G0@<W1Y;&4],T0G1D].5"U325I%.B`Q
M,'!T.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!$25-03$%9.B!I
M;FQI;F4G/B`F;F)S<#L\+V9O;G0^(#PO=&0^(#QT9"!S='EL93TS1"=415A4
M+4%,24=..B!L969T)R!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)3X\9F]N
M="!S='EL93TS1"=&3TY4+5-)6D4Z(#$P<'0[($9/3E0M1D%-24Q9.B!T:6UE
M<R!N97<@<F]M86X[($1)4U!,05DZ(&EN;&EN92<^("9N8G-P.SPO9F]N=#X@
M/"]T9#X@/'1D('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)
M3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T.R!415A4+4%,
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M;G0@<W1Y;&4],T0G1D].5"U325I%.B`Q,'!T.R!&3TY4+49!34E,63H@=&EM
M97,@;F5W(')O;6%N.R!$25-03$%9.B!I;FQI;F4G/B`F;F)S<#L\+V9O;G0^
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M1D].5"U325I%.B`Q,'!T.R!415A4+4%,24=..B!R:6=H="<@=F%L:6=N/3-$
M8F]T=&]M('=I9'1H/3-$-R4^-#4\+W1D/B`\=&0@<W1Y;&4],T0G5$585"U!
M3$E'3CH@;&5F="<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@;F]W<F%P
M/3-$;F]W<F%P/CQF;VYT('-T>6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@1D].
M5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1$E34$Q!63H@:6YL:6YE)SX@
M)FYB<W`[/"]F;VYT/B`\+W1D/B`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H
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M;65S(&YE=R!R;VUA;CL@1$E34$Q!63H@:6YL:6YE)SX@)FYB<W`[/"]F;VYT
M/B`\+W1D/B`\=&0@<W1Y;&4],T0G1$E34$Q!63H@:6YL:6YE.R!&3TY4+49!
M34E,63H@=&EM97,@;F5W(')O;6%N.R!&3TY4+5-)6D4Z(#$P<'0[(%1%6%0M
M04Q)1TXZ(')I9VAT)R!V86QI9VX],T1B;W1T;VT@=VED=&@],T0W)3XH,30\
M+W1D/B`\=&0@<W1Y;&4],T0G1$E34$Q!63H@:6YL:6YE.R!&3TY4+49!34E,
M63H@=&EM97,@;F5W(')O;6%N.R!&3TY4+5-)6D4Z(#$P<'0[(%1%6%0M04Q)
M1TXZ(&QE9G0G('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E(&YO=W)A<#TS
M1&YO=W)A<#XI/"]T9#X@/'1D('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E
M(&%L:6=N/3-$<FEG:'0^/&9O;G0@<W1Y;&4],T0G1D].5"U325I%.B`Q,'!T
M.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!$25-03$%9.B!I;FQI
M;F4G/B`F;F)S<#L\+V9O;G0^(#PO=&0^(#QT9"!S='EL93TS1"=415A4+4%,
M24=..B!L969T)R!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)3X\9F]N="!S
M='EL93TS1"=&3TY4+5-)6D4Z(#$P<'0[($9/3E0M1D%-24Q9.B!T:6UE<R!N
M97<@<F]M86X[($1)4U!,05DZ(&EN;&EN92<^("9N8G-P.SPO9F]N=#X@/"]T
M9#X@/'1D('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ
M('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T.R!415A4+4%,24=.
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M5$]-.B`R<'@[(%1%6%0M04Q)1TXZ(&QE9G0[($U!4D=)3BU,1494.B`P<'0[
M($U!4D=)3BU224=(5#H@,'!T.R!415A4+4E.1$5.5#H@,'!T)R!V86QI9VX]
M,T1B;W1T;VT@=VED=&@],T0R,"4^(#QD:78@<W1Y;&4],T0G1$E34$Q!63H@
M8FQO8VL[($9/3E0M1D%-24Q9.B!T:6UE<R!N97<@<F]M86X[($9/3E0M4TE:
M13H@,3!P=#L@34%21TE.+4Q%1E0Z(#!P=#L@34%21TE.+5))1TA4.B`P<'0[
M(%1%6%0M04Q)1TXZ(&QE9G0[(%1%6%0M24Y$14Y4.B`P<'0G/B!#;W)P;W)A
M=&4@9&5B96YT=7)E<R`M(&9I>&5D(&EN=&5R97-T(')A=&4\+V1I=CX@/"]T
M9#X@/'1D('-T>6QE/3-$)U!!1$1)3D<M0D]45$]-.B`R<'@G('9A;&EG;CTS
M1&)O='1O;2!W:61T:#TS1#$E(&%L:6=N/3-$<FEG:'0^/&9O;G0@<W1Y;&4]
M,T0G1D].5"U325I%.B`Q,'!T.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O
M;6%N.R!$25-03$%9.B!I;FQI;F4G/B`F;F)S<#L\+V9O;G0^(#PO=&0^(#QT
M9"!S='EL93TS1"="3U)$15(M0D]45$]-.B!B;&%C:R`R<'@@<V]L:60[(%1%
M6%0M04Q)1TXZ(&QE9G0G('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E/CQF
M;VYT('-T>6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ('1I
M;65S(&YE=R!R;VUA;CL@1$E34$Q!63H@:6YL:6YE)SX@)FYB<W`[/"]F;VYT
M/B`\+W1D/B`\=&0@<W1Y;&4],T0G0D]21$52+4)/5%1/33H@8FQA8VL@,G!X
M('-O;&ED.R!$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE<R!N
M97<@<F]M86X[($9/3E0M4TE:13H@,3!P=#L@5$585"U!3$E'3CH@<FEG:'0G
M('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#<E/CDT/"]T9#X@/'1D('-T>6QE
M/3-$)U!!1$1)3D<M0D]45$]-.B`R<'@[(%1%6%0M04Q)1TXZ(&QE9G0G('9A
M;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E(&YO=W)A<#TS1&YO=W)A<#X\9F]N
M="!S='EL93TS1"=&3TY4+5-)6D4Z(#$P<'0[($9/3E0M1D%-24Q9.B!T:6UE
M<R!N97<@<F]M86X[($1)4U!,05DZ(&EN;&EN92<^("9N8G-P.SPO9F]N=#X@
M/"]T9#X@/'1D('-T>6QE/3-$)U!!1$1)3D<M0D]45$]-.B`R<'@G('9A;&EG
M;CTS1&)O='1O;2!W:61T:#TS1#$E(&%L:6=N/3-$<FEG:'0^/&9O;G0@<W1Y
M;&4],T0G1D].5"U325I%.B`Q,'!T.R!&3TY4+49!34E,63H@=&EM97,@;F5W
M(')O;6%N.R!$25-03$%9.B!I;FQI;F4G/B`F;F)S<#L\+V9O;G0^(#PO=&0^
M(#QT9"!S='EL93TS1"="3U)$15(M0D]45$]-.B!B;&%C:R`R<'@@<V]L:60[
M(%1%6%0M04Q)1TXZ(&QE9G0G('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E
M/CQF;VYT('-T>6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ
M('1I;65S(&YE=R!R;VUA;CL@1$E34$Q!63H@:6YL:6YE)SX@)FYB<W`[/"]F
M;VYT/B`\+W1D/B`\=&0@<W1Y;&4],T0G0D]21$52+4)/5%1/33H@8FQA8VL@
M,G!X('-O;&ED.R!$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE
M<R!N97<@<F]M86X[($9/3E0M4TE:13H@,3!P=#L@5$585"U!3$E'3CH@<FEG
M:'0G('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#<E/C$Y/"]T9#X@/'1D('-T
M>6QE/3-$)U!!1$1)3D<M0D]45$]-.B`R<'@[(%1%6%0M04Q)1TXZ(&QE9G0G
M('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E(&YO=W)A<#TS1&YO=W)A<#X\
M9F]N="!S='EL93TS1"=&3TY4+5-)6D4Z(#$P<'0[($9/3E0M1D%-24Q9.B!T
M:6UE<R!N97<@<F]M86X[($1)4U!,05DZ(&EN;&EN92<^("9N8G-P.SPO9F]N
M=#X@/"]T9#X@/'1D('-T>6QE/3-$)U!!1$1)3D<M0D]45$]-.B`R<'@G('9A
M;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E(&%L:6=N/3-$<FEG:'0^/&9O;G0@
M<W1Y;&4],T0G1D].5"U325I%.B`Q,'!T.R!&3TY4+49!34E,63H@=&EM97,@
M;F5W(')O;6%N.R!$25-03$%9.B!I;FQI;F4G/B`F;F)S<#L\+V9O;G0^(#PO
M=&0^(#QT9"!S='EL93TS1"="3U)$15(M0D]45$]-.B!B;&%C:R`R<'@@<V]L
M:60[(%1%6%0M04Q)1TXZ(&QE9G0G('9A;&EG;CTS1&)O='1O;2!W:61T:#TS
M1#$E/CQF;VYT('-T>6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@1D].5"U&04U)
M3%DZ('1I;65S(&YE=R!R;VUA;CL@1$E34$Q!63H@:6YL:6YE)SX@)FYB<W`[
M/"]F;VYT/B`\+W1D/B`\=&0@<W1Y;&4],T0G0D]21$52+4)/5%1/33H@8FQA
M8VL@,G!X('-O;&ED.R!$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T
M:6UE<R!N97<@<F]M86X[($9/3E0M4TE:13H@,3!P=#L@5$585"U!3$E'3CH@
M<FEG:'0G('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#<E/BT\+W1D/B`\=&0@
M<W1Y;&4],T0G4$%$1$E.1RU"3U143TTZ(#)P>#L@5$585"U!3$E'3CH@;&5F
M="<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@;F]W<F%P/3-$;F]W<F%P
M/CQF;VYT('-T>6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ
M('1I;65S(&YE=R!R;VUA;CL@1$E34$Q!63H@:6YL:6YE)SX@)FYB<W`[/"]F
M;VYT/B`\+W1D/B`\=&0@<W1Y;&4],T0G4$%$1$E.1RU"3U143TTZ(#)P>"<@
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M/3-$,24^/&9O;G0@<W1Y;&4],T0G1D].5"U325I%.B`Q,'!T.R!&3TY4+49!
M34E,63H@=&EM97,@;F5W(')O;6%N.R!$25-03$%9.B!I;FQI;F4G/B`F;F)S
M<#L\+V9O;G0^(#PO=&0^(#QT9"!S='EL93TS1"="3U)$15(M0D]45$]-.B!B
M;&%C:R`R<'@@<V]L:60[($1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ
M('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T.R!415A4+4%,24=.
M.B!R:6=H="<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$-R4^,3$S/"]T9#X@
M/'1D('-T>6QE/3-$)U!!1$1)3D<M0D]45$]-.B`R<'@[(%1%6%0M04Q)1TXZ
M(&QE9G0G('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E(&YO=W)A<#TS1&YO
M=W)A<#X\9F]N="!S='EL93TS1"=&3TY4+5-)6D4Z(#$P<'0[($9/3E0M1D%-
M24Q9.B!T:6UE<R!N97<@<F]M86X[($1)4U!,05DZ(&EN;&EN92<^("9N8G-P
M.SPO9F]N=#X@/"]T9#X@/'1D('-T>6QE/3-$)U!!1$1)3D<M0D]45$]-.B`R
M<'@G('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E(&%L:6=N/3-$<FEG:'0^
M/&9O;G0@<W1Y;&4],T0G1D].5"U325I%.B`Q,'!T.R!&3TY4+49!34E,63H@
M=&EM97,@;F5W(')O;6%N.R!$25-03$%9.B!I;FQI;F4G/B`F;F)S<#L\+V9O
M;G0^(#PO=&0^(#QT9"!S='EL93TS1"="3U)$15(M0D]45$]-.B!B;&%C:R`R
M<'@@<V]L:60[(%1%6%0M04Q)1TXZ(&QE9G0G('9A;&EG;CTS1&)O='1O;2!W
M:61T:#TS1#$E/CQF;VYT('-T>6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@1D].
M5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1$E34$Q!63H@:6YL:6YE)SX@
M)FYB<W`[/"]F;VYT/B`\+W1D/B`\=&0@<W1Y;&4],T0G0D]21$52+4)/5%1/
M33H@8FQA8VL@,G!X('-O;&ED.R!$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-
M24Q9.B!T:6UE<R!N97<@<F]M86X[($9/3E0M4TE:13H@,3!P=#L@5$585"U!
M3$E'3CH@<FEG:'0G('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#<E/C<X.3PO
M=&0^(#QT9"!S='EL93TS1"=0041$24Y'+4)/5%1/33H@,G!X.R!415A4+4%,
M24=..B!L969T)R!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)2!N;W=R87`]
M,T1N;W=R87`^/&9O;G0@<W1Y;&4],T0G1D].5"U325I%.B`Q,'!T.R!&3TY4
M+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!$25-03$%9.B!I;FQI;F4G/B`F
M;F)S<#L\+V9O;G0^(#PO=&0^(#QT9"!S='EL93TS1"=0041$24Y'+4)/5%1/
M33H@,G!X)R!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)2!A;&EG;CTS1')I
M9VAT/CQF;VYT('-T>6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@1D].5"U&04U)
M3%DZ('1I;65S(&YE=R!R;VUA;CL@1$E34$Q!63H@:6YL:6YE)SX@)FYB<W`[
M/"]F;VYT/B`\+W1D/B`\=&0@<W1Y;&4],T0G0D]21$52+4)/5%1/33H@8FQA
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M87`],T1N;W=R87`^/&9O;G0@<W1Y;&4],T0G1D].5"U325I%.B`Q,'!T.R!&
M3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!$25-03$%9.B!I;FQI;F4G
M/B`F;F)S<#L\+V9O;G0^(#PO=&0^(#QT9"!S='EL93TS1"=0041$24Y'+4)/
M5%1/33H@,G!X)R!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)2!A;&EG;CTS
M1')I9VAT/CQF;VYT('-T>6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@1D].5"U&
M04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1$E34$Q!63H@:6YL:6YE)SX@)FYB
M<W`[/"]F;VYT/B`\+W1D/B`\=&0@<W1Y;&4],T0G0D]21$52+4)/5%1/33H@
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M)3XH,3D\+W1D/B`\=&0@<W1Y;&4],T0G1$E34$Q!63H@:6YL:6YE.R!&3TY4
M+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!&3TY4+5-)6D4Z(#$P<'0[(%!!
M1$1)3D<M0D]45$]-.B`R<'@[(%1%6%0M04Q)1TXZ(&QE9G0G('9A;&EG;CTS
M1&)O='1O;2!W:61T:#TS1#$E(&YO=W)A<#TS1&YO=W)A<#XI/"]T9#X@/'1D
M('-T>6QE/3-$)U!!1$1)3D<M0D]45$]-.B`R<'@G('9A;&EG;CTS1&)O='1O
M;2!W:61T:#TS1#$E(&%L:6=N/3-$<FEG:'0^/&9O;G0@<W1Y;&4],T0G1D].
M5"U325I%.B`Q,'!T.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!$
M25-03$%9.B!I;FQI;F4G/B`F;F)S<#L\+V9O;G0^(#PO=&0^(#QT9"!S='EL
M93TS1"="3U)$15(M0D]45$]-.B!B;&%C:R`R<'@@<V]L:60[(%1%6%0M04Q)
M1TXZ(&QE9G0G('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E/CQF;VYT('-T
M>6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ('1I;65S(&YE
M=R!R;VUA;CL@1$E34$Q!63H@:6YL:6YE)SX@)FYB<W`[/"]F;VYT/B`\+W1D
M/B`\=&0@<W1Y;&4],T0G0D]21$52+4)/5%1/33H@8FQA8VL@,G!X('-O;&ED
M.R!$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE<R!N97<@<F]M
M86X[($9/3E0M4TE:13H@,3!P=#L@5$585"U!3$E'3CH@<FEG:'0G('9A;&EG
M;CTS1&)O='1O;2!W:61T:#TS1#<E/C<Y.3PO=&0^(#QT9"!S='EL93TS1"=0
M041$24Y'+4)/5%1/33H@,G!X.R!415A4+4%,24=..B!L969T)R!V86QI9VX]
M,T1B;W1T;VT@=VED=&@],T0Q)2!N;W=R87`],T1N;W=R87`^/&9O;G0@<W1Y
M;&4],T0G1D].5"U325I%.B`Q,'!T.R!&3TY4+49!34E,63H@=&EM97,@;F5W
M(')O;6%N.R!$25-03$%9.B!I;FQI;F4G/B`F;F)S<#L\+V9O;G0^(#PO=&0^
M(#PO='(^(#QT<B!B9V-O;&]R/3-$(V-C965F9CX@/'1D('-T>6QE/3-$)U!!
M1$1)3D<M0D]45$]-.B`R<'@G('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#(P
M)3X\9F]N="!S='EL93TS1"=&3TY4+5-)6D4Z(#$P<'0[($9/3E0M1D%-24Q9
M.B!T:6UE<R!N97<@<F]M86X[($1)4U!,05DZ(&EN;&EN92<^("9N8G-P.SPO
M9F]N=#X@/"]T9#X@/'1D('-T>6QE/3-$)U!!1$1)3D<M0D]45$]-.B`R<'@G
M('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E(&%L:6=N/3-$<FEG:'0^/&9O
M;G0@<W1Y;&4],T0G1D].5"U325I%.B`Q,'!T.R!&3TY4+49!34E,63H@=&EM
M97,@;F5W(')O;6%N.R!$25-03$%9.B!I;FQI;F4G/B`F;F)S<#L\+V9O;G0^
M(#PO=&0^(#QT9"!S='EL93TS1"="3U)$15(M0D]45$]-.B!B;&%C:R`R<'@@
M<V]L:60[($1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE
M=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T.R!415A4+4%,24=..B!L969T)R!V
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M,T0Q)2!N;W=R87`],T1N;W=R87`^/&9O;G0@<W1Y;&4],T0G1D].5"U325I%
M.B`Q,'!T.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!$25-03$%9
M.B!I;FQI;F4G/B`F;F)S<#L\+V9O;G0^(#PO=&0^(#QT9"!S='EL93TS1"=0
M041$24Y'+4)/5%1/33H@,G!X)R!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q
M)2!A;&EG;CTS1')I9VAT/CQF;VYT('-T>6QE/3-$)T9/3E0M4TE:13H@,3!P
M=#L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1$E34$Q!63H@:6YL
M:6YE)SX@)FYB<W`[/"]F;VYT/B`\+W1D/B`\=&0@<W1Y;&4],T0G0D]21$52
M+4)/5%1/33H@8FQA8VL@,G!X('-O;&ED.R!$25-03$%9.B!I;FQI;F4[($9/
M3E0M1D%-24Q9.B!T:6UE<R!N97<@<F]M86X[($9/3E0M4TE:13H@,3!P=#L@
M5$585"U!3$E'3CH@;&5F="<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24^
M)#PO=&0^(#QT9"!S='EL93TS1"="3U)$15(M0D]45$]-.B!B;&%C:R`R<'@@
M<V]L:60[($1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE
M=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T.R!415A4+4%,24=..B!R:6=H="<@
M=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$-R4^,3D\+W1D/B`\=&0@<W1Y;&4]
M,T0G4$%$1$E.1RU"3U143TTZ(#)P>#L@5$585"U!3$E'3CH@;&5F="<@=F%L
M:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@;F]W<F%P/3-$;F]W<F%P/CQF;VYT
M('-T>6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ('1I;65S
M(&YE=R!R;VUA;CL@1$E34$Q!63H@:6YL:6YE)SX@)FYB<W`[/"]F;VYT/B`\
M+W1D/B`\=&0@<W1Y;&4],T0G4$%$1$E.1RU"3U143TTZ(#)P>"<@=F%L:6=N
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M1&)O='1O;2!W:61T:#TS1#$E/B0\+W1D/B`\=&0@<W1Y;&4],T0G0D]21$52
M+4)/5%1/33H@8FQA8VL@,G!X('-O;&ED.R!$25-03$%9.B!I;FQI;F4[($9/
M3E0M1D%-24Q9.B!T:6UE<R!N97<@<F]M86X[($9/3E0M4TE:13H@,3!P=#L@
M5$585"U!3$E'3CH@<FEG:'0G('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#<E
M/BT\+W1D/B`\=&0@<W1Y;&4],T0G4$%$1$E.1RU"3U143TTZ(#)P>#L@5$58
M5"U!3$E'3CH@;&5F="<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@;F]W
M<F%P/3-$;F]W<F%P/CQF;VYT('-T>6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@
M1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1$E34$Q!63H@:6YL:6YE
M)SX@)FYB<W`[/"]F;VYT/B`\+W1D/B`\=&0@<W1Y;&4],T0G4$%$1$E.1RU"
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M1TXZ(&QE9G0G('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E/B0\+W1D/B`\
M=&0@<W1Y;&4],T0G0D]21$52+4)/5%1/33H@8FQA8VL@,G!X('-O;&ED.R!$
M25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE<R!N97<@<F]M86X[
M($9/3E0M4TE:13H@,3!P=#L@5$585"U!3$E'3CH@<FEG:'0G('9A;&EG;CTS
M1&)O='1O;2!W:61T:#TS1#<E/C$Q,SPO=&0^(#QT9"!S='EL93TS1"=0041$
M24Y'+4)/5%1/33H@,G!X.R!415A4+4%,24=..B!L969T)R!V86QI9VX],T1B
M;W1T;VT@=VED=&@],T0Q)2!N;W=R87`],T1N;W=R87`^/&9O;G0@<W1Y;&4]
M,T0G1D].5"U325I%.B`Q,'!T.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O
M;6%N.R!$25-03$%9.B!I;FQI;F4G/B`F;F)S<#L\+V9O;G0^(#PO=&0^(#QT
M9"!S='EL93TS1"=0041$24Y'+4)/5%1/33H@,G!X)R!V86QI9VX],T1B;W1T
M;VT@=VED=&@],T0Q)2!A;&EG;CTS1')I9VAT/CQF;VYT('-T>6QE/3-$)T9/
M3E0M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@
M1$E34$Q!63H@:6YL:6YE)SX@)FYB<W`[/"]F;VYT/B`\+W1D/B`\=&0@<W1Y
M;&4],T0G0D]21$52+4)/5%1/33H@8FQA8VL@,G!X('-O;&ED.R!$25-03$%9
M.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE<R!N97<@<F]M86X[($9/3E0M
M4TE:13H@,3!P=#L@5$585"U!3$E'3CH@;&5F="<@=F%L:6=N/3-$8F]T=&]M
M('=I9'1H/3-$,24^)#PO=&0^(#QT9"!S='EL93TS1"="3U)$15(M0D]45$]-
M.B!B;&%C:R`R<'@@<V]L:60[($1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)
M3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T.R!415A4+4%,
M24=..B!R:6=H="<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$-R4^,2PW-#0\
M+W1D/B`\=&0@<W1Y;&4],T0G4$%$1$E.1RU"3U143TTZ(#)P>#L@5$585"U!
M3$E'3CH@;&5F="<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@;F]W<F%P
M/3-$;F]W<F%P/CQF;VYT('-T>6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@1D].
M5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1$E34$Q!63H@:6YL:6YE)SX@
M)FYB<W`[/"]F;VYT/B`\+W1D/B`\=&0@<W1Y;&4],T0G4$%$1$E.1RU"3U14
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M(&QE9G0G('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E/B0\+W1D/B`\=&0@
M<W1Y;&4],T0G0D]21$52+4)/5%1/33H@8FQA8VL@,G!X('-O;&ED.R!$25-0
M3$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE<R!N97<@<F]M86X[($9/
M3E0M4TE:13H@,3!P=#L@5$585"U!3$E'3CH@<FEG:'0G('9A;&EG;CTS1&)O
M='1O;2!W:61T:#TS1#<E/C<T/"]T9#X@/'1D('-T>6QE/3-$)U!!1$1)3D<M
M0D]45$]-.B`R<'@[(%1%6%0M04Q)1TXZ(&QE9G0G('9A;&EG;CTS1&)O='1O
M;2!W:61T:#TS1#$E(&YO=W)A<#TS1&YO=W)A<#X\9F]N="!S='EL93TS1"=&
M3TY4+5-)6D4Z(#$P<'0[($9/3E0M1D%-24Q9.B!T:6UE<R!N97<@<F]M86X[
M($1)4U!,05DZ(&EN;&EN92<^("9N8G-P.SPO9F]N=#X@/"]T9#X@/'1D('-T
M>6QE/3-$)U!!1$1)3D<M0D]45$]-.B`R<'@G('9A;&EG;CTS1&)O='1O;2!W
M:61T:#TS1#$E(&%L:6=N/3-$<FEG:'0^/&9O;G0@<W1Y;&4],T0G1D].5"U3
M25I%.B`Q,'!T.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!$25-0
M3$%9.B!I;FQI;F4G/B`F;F)S<#L\+V9O;G0^(#PO=&0^(#QT9"!S='EL93TS
M1"="3U)$15(M0D]45$]-.B!B;&%C:R`R<'@@<V]L:60[($1)4U!,05DZ(&EN
M;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%
M.B`Q,'!T.R!415A4+4%,24=..B!L969T)R!V86QI9VX],T1B;W1T;VT@=VED
M=&@],T0Q)3XD/"]T9#X@/'1D('-T>6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L
M86-K(#)P>"!S;VQI9#L@1$E34$Q!63H@:6YL:6YE.R!&3TY4+49!34E,63H@
M=&EM97,@;F5W(')O;6%N.R!&3TY4+5-)6D4Z(#$P<'0[(%1%6%0M04Q)1TXZ
M(')I9VAT)R!V86QI9VX],T1B;W1T;VT@=VED=&@],T0W)3XH,S,\+W1D/B`\
M=&0@<W1Y;&4],T0G1$E34$Q!63H@:6YL:6YE.R!&3TY4+49!34E,63H@=&EM
M97,@;F5W(')O;6%N.R!&3TY4+5-)6D4Z(#$P<'0[(%!!1$1)3D<M0D]45$]-
M.B`R<'@[(%1%6%0M04Q)1TXZ(&QE9G0G('9A;&EG;CTS1&)O='1O;2!W:61T
M:#TS1#$E(&YO=W)A<#TS1&YO=W)A<#XI/"]T9#X@/'1D('-T>6QE/3-$)U!!
M1$1)3D<M0D]45$]-.B`R<'@G('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E
M(&%L:6=N/3-$<FEG:'0^/&9O;G0@<W1Y;&4],T0G1D].5"U325I%.B`Q,'!T
M.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!$25-03$%9.B!I;FQI
M;F4G/B`F;F)S<#L\+V9O;G0^(#PO=&0^(#QT9"!S='EL93TS1"="3U)$15(M
M0D]45$]-.B!B;&%C:R`R<'@@<V]L:60[($1)4U!,05DZ(&EN;&EN93L@1D].
M5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T.R!4
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M86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)2!N;W=R87`],T1N;W=R87`^/&9O
M;G0@<W1Y;&4],T0G1D].5"U325I%.B`Q,'!T.R!&3TY4+49!34E,63H@=&EM
M97,@;F5W(')O;6%N.R!$25-03$%9.B!I;FQI;F4G/B`F;F)S<#L\+V9O;G0^
M(#PO=&0^(#PO='(^(#QT<B!B9V-O;&]R/3-$=VAI=&4^(#QT9"!S='EL93TS
M1"=0041$24Y'+4)/5%1/33H@-'!X.R!415A4+4%,24=..B!L969T.R!-05)'
M24XM3$5&5#H@,'!T.R!-05)'24XM4DE'2%0Z(#!P=#L@5$585"U)3D1%3E0Z
M(#!P="<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,C`E/B`\9&EV('-T>6QE
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M1$E34$Q!63H@:6YL:6YE)SX@)FYB<W`[/"]F;VYT/B`\+W1D/B`\=&0@<W1Y
M;&4],T0G0D]21$52+4)/5%1/33H@8FQA8VL@-'!X(&1O=6)L93L@1$E34$Q!
M63H@:6YL:6YE.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!&3TY4
M+5-)6D4Z(#$P<'0[(%1%6%0M04Q)1TXZ(&QE9G0G('9A;&EG;CTS1&)O='1O
M;2!W:61T:#TS1#$E/B0\+W1D/B`\=&0@<W1Y;&4],T0G0D]21$52+4)/5%1/
M33H@8FQA8VL@-'!X(&1O=6)L93L@1$E34$Q!63H@:6YL:6YE.R!&3TY4+49!
M34E,63H@=&EM97,@;F5W(')O;6%N.R!&3TY4+5-)6D4Z(#$P<'0[(%1%6%0M
M04Q)1TXZ(')I9VAT)R!V86QI9VX],T1B;W1T;VT@=VED=&@],T0W)3XR-RPP
M,C4\+W1D/B`\=&0@<W1Y;&4],T0G4$%$1$E.1RU"3U143TTZ(#1P>#L@5$58
M5"U!3$E'3CH@;&5F="<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@;F]W
M<F%P/3-$;F]W<F%P/CQF;VYT('-T>6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@
M1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1$E34$Q!63H@:6YL:6YE
M)SX@)FYB<W`[/"]F;VYT/B`\+W1D/B`\=&0@<W1Y;&4],T0G4$%$1$E.1RU"
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M3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T.R!415A4+4%,
M24=..B!L969T)R!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)3XD/"]T9#X@
M/'1D('-T>6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#1P>"!D;W5B;&4[
M($1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA
M;CL@1D].5"U325I%.B`Q,'!T.R!415A4+4%,24=..B!R:6=H="<@=F%L:6=N
M/3-$8F]T=&]M('=I9'1H/3-$-R4^,BPY-C4\+W1D/B`\=&0@<W1Y;&4],T0G
M4$%$1$E.1RU"3U143TTZ(#1P>#L@5$585"U!3$E'3CH@;&5F="<@=F%L:6=N
M/3-$8F]T=&]M('=I9'1H/3-$,24@;F]W<F%P/3-$;F]W<F%P/CQF;VYT('-T
M>6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ('1I;65S(&YE
M=R!R;VUA;CL@1$E34$Q!63H@:6YL:6YE)SX@)FYB<W`[/"]F;VYT/B`\+W1D
M/B`\=&0@<W1Y;&4],T0G4$%$1$E.1RU"3U143TTZ(#1P>"<@=F%L:6=N/3-$
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M1D].5"U325I%.B`Q,'!T.R!415A4+4%,24=..B!L969T)R!V86QI9VX],T1B
M;W1T;VT@=VED=&@],T0Q)3XD/"]T9#X@/'1D('-T>6QE/3-$)T)/4D1%4BU"
M3U143TTZ(&)L86-K(#1P>"!D;W5B;&4[($1)4U!,05DZ(&EN;&EN93L@1D].
M5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T.R!4
M15A4+4%,24=..B!R:6=H="<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$-R4^
M*#(Y/"]T9#X@/'1D('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&
M04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T.R!0041$
M24Y'+4)/5%1/33H@-'!X.R!415A4+4%,24=..B!L969T)R!V86QI9VX],T1B
M;W1T;VT@=VED=&@],T0Q)2!N;W=R87`],T1N;W=R87`^*3PO=&0^(#QT9"!S
M='EL93TS1"=0041$24Y'+4)/5%1/33H@-'!X)R!V86QI9VX],T1B;W1T;VT@
M=VED=&@],T0Q)2!A;&EG;CTS1')I9VAT/CQF;VYT('-T>6QE/3-$)T9/3E0M
M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1$E3
M4$Q!63H@:6YL:6YE)SX@)FYB<W`[/"]F;VYT/B`\+W1D/B`\=&0@<W1Y;&4]
M,T0G0D]21$52+4)/5%1/33H@8FQA8VL@-'!X(&1O=6)L93L@1$E34$Q!63H@
M:6YL:6YE.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!&3TY4+5-)
M6D4Z(#$P<'0[(%1%6%0M04Q)1TXZ(&QE9G0G('9A;&EG;CTS1&)O='1O;2!W
M:61T:#TS1#$E/B0\+W1D/B`\=&0@<W1Y;&4],T0G0D]21$52+4)/5%1/33H@
M8FQA8VL@-'!X(&1O=6)L93L@1$E34$Q!63H@:6YL:6YE.R!&3TY4+49!34E,
M63H@=&EM97,@;F5W(')O;6%N.R!&3TY4+5-)6D4Z(#$P<'0[(%1%6%0M04Q)
M1TXZ(')I9VAT)R!V86QI9VX],T1B;W1T;VT@=VED=&@],T0W)3XR.2PY-C$\
M+W1D/B`\=&0@<W1Y;&4],T0G4$%$1$E.1RU"3U143TTZ(#1P>#L@5$585"U!
M3$E'3CH@;&5F="<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@;F]W<F%P
M/3-$;F]W<F%P/CQF;VYT('-T>6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@1D].
M5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1$E34$Q!63H@:6YL:6YE)SX@
M)FYB<W`[/"]F;VYT/B`\+W1D/B`\=&0@<W1Y;&4],T0G4$%$1$E.1RU"3U14
M3TTZ(#1P>"<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@86QI9VX],T1R
M:6=H=#X\9F]N="!S='EL93TS1"=&3TY4+5-)6D4Z(#$P<'0[($9/3E0M1D%-
M24Q9.B!T:6UE<R!N97<@<F]M86X[($1)4U!,05DZ(&EN;&EN92<^("9N8G-P
M.SPO9F]N=#X@/"]T9#X@/'1D('-T>6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L
M86-K(#1P>"!D;W5B;&4[($1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ
M('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T.R!415A4+4%,24=.
M.B!L969T)R!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)3XD/"]T9#X@/'1D
M('-T>6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#1P>"!D;W5B;&4[($1)
M4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@
M1D].5"U325I%.B`Q,'!T.R!415A4+4%,24=..B!R:6=H="<@=F%L:6=N/3-$
M8F]T=&]M('=I9'1H/3-$-R4^,3,L,3@R/"]T9#X@/'1D('-T>6QE/3-$)U!!
M1$1)3D<M0D]45$]-.B`T<'@[(%1%6%0M04Q)1TXZ(&QE9G0G('9A;&EG;CTS
M1&)O='1O;2!W:61T:#TS1#$E(&YO=W)A<#TS1&YO=W)A<#X\9F]N="!S='EL
M93TS1"=&3TY4+5-)6D4Z(#$P<'0[($9/3E0M1D%-24Q9.B!T:6UE<R!N97<@
M<F]M86X[($1)4U!,05DZ(&EN;&EN92<^("9N8G-P.SPO9F]N=#X@/"]T9#X@
M/'1D('-T>6QE/3-$)U!!1$1)3D<M0D]45$]-.B`T<'@G('9A;&EG;CTS1&)O
M='1O;2!W:61T:#TS1#$E(&%L:6=N/3-$<FEG:'0^/&9O;G0@<W1Y;&4],T0G
M1D].5"U325I%.B`Q,'!T.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N
M.R!$25-03$%9.B!I;FQI;F4G/B`F;F)S<#L\+V9O;G0^(#PO=&0^(#QT9"!S
M='EL93TS1"="3U)$15(M0D]45$]-.B!B;&%C:R`T<'@@9&]U8FQE.R!$25-0
M3$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE<R!N97<@<F]M86X[($9/
M3E0M4TE:13H@,3!P=#L@5$585"U!3$E'3CH@;&5F="<@=F%L:6=N/3-$8F]T
M=&]M('=I9'1H/3-$,24^)#PO=&0^(#QT9"!S='EL93TS1"="3U)$15(M0D]4
M5$]-.B!B;&%C:R`T<'@@9&]U8FQE.R!$25-03$%9.B!I;FQI;F4[($9/3E0M
M1D%-24Q9.B!T:6UE<R!N97<@<F]M86X[($9/3E0M4TE:13H@,3!P=#L@5$58
M5"U!3$E'3CH@<FEG:'0G('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#<E/C4W
M,#PO=&0^(#QT9"!S='EL93TS1"=0041$24Y'+4)/5%1/33H@-'!X.R!415A4
M+4%,24=..B!L969T)R!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)2!N;W=R
M87`],T1N;W=R87`^/&9O;G0@<W1Y;&4],T0G1D].5"U325I%.B`Q,'!T.R!&
M3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!$25-03$%9.B!I;FQI;F4G
M/B`F;F)S<#L\+V9O;G0^(#PO=&0^(#QT9"!S='EL93TS1"=0041$24Y'+4)/
M5%1/33H@-'!X)R!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)2!A;&EG;CTS
M1')I9VAT/CQF;VYT('-T>6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@1D].5"U&
M04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1$E34$Q!63H@:6YL:6YE)SX@)FYB
M<W`[/"]F;VYT/B`\+W1D/B`\=&0@<W1Y;&4],T0G0D]21$52+4)/5%1/33H@
M8FQA8VL@-'!X(&1O=6)L93L@1$E34$Q!63H@:6YL:6YE.R!&3TY4+49!34E,
M63H@=&EM97,@;F5W(')O;6%N.R!&3TY4+5-)6D4Z(#$P<'0[(%1%6%0M04Q)
M1TXZ(&QE9G0G('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E/B0\+W1D/B`\
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M1D].5"U325I%.B`Q,'!T.R!0041$24Y'+4)/5%1/33H@-'!X.R!415A4+4%,
M24=..B!L969T)R!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)2!N;W=R87`]
M,T1N;W=R87`^*3PO=&0^(#QT9"!S='EL93TS1"=0041$24Y'+4)/5%1/33H@
M-'!X)R!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)2!A;&EG;CTS1')I9VAT
M/CQF;VYT('-T>6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ
M('1I;65S(&YE=R!R;VUA;CL@1$E34$Q!63H@:6YL:6YE)SX@)FYB<W`[/"]F
M;VYT/B`\+W1D/B`\=&0@<W1Y;&4],T0G0D]21$52+4)/5%1/33H@8FQA8VL@
M-'!X(&1O=6)L93L@1$E34$Q!63H@:6YL:6YE.R!&3TY4+49!34E,63H@=&EM
M97,@;F5W(')O;6%N.R!&3TY4+5-)6D4Z(#$P<'0[(%1%6%0M04Q)1TXZ(&QE
M9G0G('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E/B0\+W1D/B`\=&0@<W1Y
M;&4],T0G0D]21$52+4)/5%1/33H@8FQA8VL@-'!X(&1O=6)L93L@1$E34$Q!
M63H@:6YL:6YE.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!&3TY4
M+5-)6D4Z(#$P<'0[(%1%6%0M04Q)1TXZ(')I9VAT)R!V86QI9VX],T1B;W1T
M;VT@=VED=&@],T0W)3XQ,RPT-#$\+W1D/B`\=&0@<W1Y;&4],T0G4$%$1$E.
M1RU"3U143TTZ(#1P>#L@5$585"U!3$E'3CH@;&5F="<@=F%L:6=N/3-$8F]T
M=&]M('=I9'1H/3-$,24@;F]W<F%P/3-$;F]W<F%P/CQF;VYT('-T>6QE/3-$
M)T9/3E0M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA
M;CL@1$E34$Q!63H@:6YL:6YE)SX@)FYB<W`[/"]F;VYT/B`\+W1D/B`\+W1R
M/B`\+W1A8FQE/B`\+V1I=CX@/"$M+45N9$9R86=M96YT+2T^/"]D:78^(#PO
M9&EV/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@("`@(#QT
M<B!C;&%S<STS1')E/@T*("`@("`@("`\=&0@8VQA<W,],T1P;"!V86QI9VX]
M,T1T;W`^4V-H961U;&4@;V8@26YV97-T;65N=',@:6X@0V]N=&EN=6]U<R!5
M;G)E86QI>F5D($QO<W,@4&]S:71I;VX\+W1D/@T*("`@("`@("`\=&0@8VQA
M<W,],T1T97AT/B<\(2TM1$]#5%E012!H=&UL(%!50DQ)0R`B+2\O5S-#+R]$
M5$0@6$A434P@,2XP(%1R86YS:71I;VYA;"\O14XB(")H='1P.B\O=W=W+G<S
M+F]R9R]44B]X:'1M;#$O1%1$+WAH=&UL,2UT<F%N<VET:6]N86PN9'1D(B`M
M+3X\9&EV/B`\9&EV/CPA+2U3=&%R=$9R86=M96YT+2T^(#QD:78@<W1Y;&4]
M,T0G1$E34$Q!63H@:6YL:6YE.R!&3TY4+49!34E,63H@5&EM97,@3F5W(%)O
M;6%N.R!&3TY4+5-)6D4Z(#$P<'0[($U!4D=)3BU,1494.B`P<'0[($U!4D=)
M3BU224=(5#H@,'!T.R!415A4+4E.1$5.5#H@,'!T)SX@5&AE(&9O;&QO=VEN
M9R!T86)L92!P<F5S96YT<R!G<F]S<R!U;G)E86QI>F5D(&QO<W-E<R!A;F0@
M9F%I<B!V86QU97,@9F]R('1H;W-E(&EN=F5S=&UE;G1S('1H870@=V5R92!I
M;B!A;B!U;G)E86QI>F5D(&QO<W,@<&]S:71I;VX@87,@;V8@2G5N92`S,"P@
M,C`Q-"!A;F0@2G5N92`S,"P@,C`Q,RP@86YD('1H92!L96YG=&@@;V8@=&EM
M92!T:&%T('1H;W-E(&EN=F5S=&UE;G1S(&AA=F4@8F5E;B!I;B!A(&-O;G1I
M;G5O=7,@;&]S<R!P;W-I=&EO;CH\+V1I=CX@/&1I=B!S='EL93TS1"=-05)'
M24XM3$5&5#H@,'!T.R!-05)'24XM4DE'2%0Z(#!P=#L@5$585"U)3D1%3E0Z
M(#!P="<^("9N8G-P.SPO9&EV/B`\9&EV('-T>6QE/3-$)W1E>'0M86QI9VXZ
M(&QE9G0G/B`\=&%B;&4@<W1Y;&4],T0G1D].5"U325I%.B`Q,'!T.R!&3TY4
M+49!34E,63H@=&EM97,@;F5W(')O;6%N)R!C96QL<W!A8VEN9STS1#`@8V5L
M;'!A9&1I;F<],T0P('=I9'1H/3-$,3`P)3X@/'1R/B`\=&0@<W1Y;&4],T0G
M4$%$1$E.1RU"3U143TTZ(#)P>"<@=F%L:6=N/3-$8F]T=&]M/CQF;VYT('-T
M>6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ('1I;65S(&YE
M=R!R;VUA;CL@1$E34$Q!63H@:6YL:6YE)SX@)FYB<W`[/"]F;VYT/B`\+W1D
M/B`\=&0@<W1Y;&4],T0G4$%$1$E.1RU"3U143TTZ(#)P>"<@=F%L:6=N/3-$
M8F]T=&]M/CQF;VYT('-T>6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@1D].5"U&
M04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U714E'2%0Z(&)O;&0[($1)
M4U!,05DZ(&EN;&EN92<^("9N8G-P.SPO9F]N=#X@/"]T9#X@/'1D('-T>6QE
M/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#)P>"!S;VQI9"<@=F%L:6=N/3-$
M8F]T=&]M(&-O;'-P86X],T0V/B`\9&EV('-T>6QE/3-$)T1)4U!,05DZ(&)L
M;V-K.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!&3TY4+5-)6D4Z
M(#$P<'0[($9/3E0M5T5)1TA4.B!B;VQD.R!-05)'24XM3$5&5#H@,'!T.R!-
M05)'24XM4DE'2%0Z(#!P=#L@=&5X="UA;&EG;CH@8V5N=&5R.R!415A4+4E.
M1$5.5#H@,'!T)SX@3&5S<R!T:&%N(#$R(&UO;G1H<SPO9&EV/B`\+W1D/B`\
M=&0@<W1Y;&4],T0G4$%$1$E.1RU"3U143TTZ(#)P>#L@5$585"U!3$E'3CH@
M;&5F="<@=F%L:6=N/3-$8F]T=&]M(&YO=W)A<#TS1&YO=W)A<#X\9F]N="!S
M='EL93TS1"=&3TY4+5-)6D4Z(#$P<'0[($9/3E0M1D%-24Q9.B!T:6UE<R!N
M97<@<F]M86X[($9/3E0M5T5)1TA4.B!B;VQD.R!$25-03$%9.B!I;FQI;F4G
M/B`F;F)S<#L\+V9O;G0^(#PO=&0^(#QT9"!S='EL93TS1"=0041$24Y'+4)/
M5%1/33H@,G!X)R!V86QI9VX],T1B;W1T;VT^/&9O;G0@<W1Y;&4],T0G1D].
M5"U325I%.B`Q,'!T.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!&
M3TY4+5=%24=(5#H@8F]L9#L@1$E34$Q!63H@:6YL:6YE)SX@)FYB<W`[/"]F
M;VYT/B`\+W1D/B`\=&0@<W1Y;&4],T0G0D]21$52+4)/5%1/33H@8FQA8VL@
M,G!X('-O;&ED)R!V86QI9VX],T1B;W1T;VT@8V]L<W!A;CTS1#8^(#QD:78@
M<W1Y;&4],T0G1$E34$Q!63H@8FQO8VL[($9/3E0M1D%-24Q9.B!T:6UE<R!N
M97<@<F]M86X[($9/3E0M4TE:13H@,3!P=#L@1D].5"U714E'2%0Z(&)O;&0[
M($U!4D=)3BU,1494.B`P<'0[($U!4D=)3BU224=(5#H@,'!T.R!T97AT+6%L
M:6=N.B!C96YT97([(%1%6%0M24Y$14Y4.B`P<'0G/B`Q,B!M;VYT:',@;W(@
M9W)E871E<CPO9&EV/B`\+W1D/B`\=&0@<W1Y;&4],T0G4$%$1$E.1RU"3U14
M3TTZ(#)P>#L@5$585"U!3$E'3CH@;&5F="<@=F%L:6=N/3-$8F]T=&]M(&YO
M=W)A<#TS1&YO=W)A<#X\9F]N="!S='EL93TS1"=&3TY4+5-)6D4Z(#$P<'0[
M($9/3E0M1D%-24Q9.B!T:6UE<R!N97<@<F]M86X[($9/3E0M5T5)1TA4.B!B
M;VQD.R!$25-03$%9.B!I;FQI;F4G/B`F;F)S<#L\+V9O;G0^(#PO=&0^(#PO
M='(^(#QT<CX@/'1D('-T>6QE/3-$)U!!1$1)3D<M0D]45$]-.B`R<'@G('9A
M;&EG;CTS1&)O='1O;3X\9F]N="!S='EL93TS1"=&3TY4+5-)6D4Z(#$P<'0[
M($9/3E0M1D%-24Q9.B!T:6UE<R!N97<@<F]M86X[($1)4U!,05DZ(&EN;&EN
M92<^("9N8G-P.SPO9F]N=#X@/"]T9#X@/'1D('-T>6QE/3-$)U!!1$1)3D<M
M0D]45$]-.B`R<'@G('9A;&EG;CTS1&)O='1O;3X\9F]N="!S='EL93TS1"=&
M3TY4+5-)6D4Z(#$P<'0[($9/3E0M1D%-24Q9.B!T:6UE<R!N97<@<F]M86X[
M($9/3E0M5T5)1TA4.B!B;VQD.R!$25-03$%9.B!I;FQI;F4G/B`F;F)S<#L\
M+V9O;G0^(#PO=&0^(#QT9"!S='EL93TS1"="3U)$15(M0D]45$]-.B!B;&%C
M:R`R<'@@<V]L:60G('9A;&EG;CTS1&)O='1O;2!C;VQS<&%N/3-$,CX@/&1I
M=B!S='EL93TS1"=$25-03$%9.B!B;&]C:SL@1D].5"U&04U)3%DZ('1I;65S
M(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T.R!&3TY4+5=%24=(5#H@8F]L
M9#L@34%21TE.+4Q%1E0Z(#!P=#L@34%21TE.+5))1TA4.B`P<'0[('1E>'0M
M86QI9VXZ(&-E;G1E<CL@5$585"U)3D1%3E0Z(#!P="<^($9A:7(@5F%L=64\
M+V1I=CX@/"]T9#X@/'1D('-T>6QE/3-$)U!!1$1)3D<M0D]45$]-.B`R<'@[
M(%1%6%0M04Q)1TXZ(&QE9G0G('9A;&EG;CTS1&)O='1O;2!N;W=R87`],T1N
M;W=R87`^/&9O;G0@<W1Y;&4],T0G1D].5"U325I%.B`Q,'!T.R!&3TY4+49!
M34E,63H@=&EM97,@;F5W(')O;6%N.R!&3TY4+5=%24=(5#H@8F]L9#L@1$E3
M4$Q!63H@:6YL:6YE)SX@)FYB<W`[/"]F;VYT/B`\+W1D/B`\=&0@<W1Y;&4]
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M86X],T0R/B`\9&EV('-T>6QE/3-$)T1)4U!,05DZ(&)L;V-K.R!&3TY4+49!
M34E,63H@=&EM97,@;F5W(')O;6%N.R!&3TY4+5-)6D4Z(#$P<'0[($9/3E0M
M5T5)1TA4.B!B;VQD.R!-05)'24XM3$5&5#H@,'!T.R!-05)'24XM4DE'2%0Z
M(#!P=#L@=&5X="UA;&EG;CH@8V5N=&5R.R!415A4+4E.1$5.5#H@,'!T)SX@
M1W)O<W,\+V1I=CX@/&1I=B!S='EL93TS1"=$25-03$%9.B!B;&]C:SL@1D].
M5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T.R!&
M3TY4+5=%24=(5#H@8F]L9#L@34%21TE.+4Q%1E0Z(#!P=#L@34%21TE.+5))
M1TA4.B`P<'0[('1E>'0M86QI9VXZ(&-E;G1E<CL@5$585"U)3D1%3E0Z(#!P
M="<^('5N<F5A;&EZ960@;&]S<SPO9&EV/B`\+W1D/B`\=&0@<W1Y;&4],T0G
M4$%$1$E.1RU"3U143TTZ(#)P>#L@5$585"U!3$E'3CH@;&5F="<@=F%L:6=N
M/3-$8F]T=&]M(&YO=W)A<#TS1&YO=W)A<#X\9F]N="!S='EL93TS1"=&3TY4
M+5-)6D4Z(#$P<'0[($9/3E0M1D%-24Q9.B!T:6UE<R!N97<@<F]M86X[($9/
M3E0M5T5)1TA4.B!B;VQD.R!$25-03$%9.B!I;FQI;F4G/B`F;F)S<#L\+V9O
M;G0^(#PO=&0^(#QT9"!S='EL93TS1"=0041$24Y'+4)/5%1/33H@,G!X)R!V
M86QI9VX],T1B;W1T;VT^/&9O;G0@<W1Y;&4],T0G1D].5"U325I%.B`Q,'!T
M.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!&3TY4+5=%24=(5#H@
M8F]L9#L@1$E34$Q!63H@:6YL:6YE)SX@)FYB<W`[/"]F;VYT/B`\+W1D/B`\
M=&0@<W1Y;&4],T0G0D]21$52+4)/5%1/33H@8FQA8VL@,G!X('-O;&ED)R!V
M86QI9VX],T1B;W1T;VT@8V]L<W!A;CTS1#(^(#QD:78@<W1Y;&4],T0G1$E3
M4$Q!63H@8FQO8VL[($9/3E0M1D%-24Q9.B!T:6UE<R!N97<@<F]M86X[($9/
M3E0M4TE:13H@,3!P=#L@1D].5"U714E'2%0Z(&)O;&0[($U!4D=)3BU,1494
M.B`P<'0[($U!4D=)3BU224=(5#H@,'!T.R!T97AT+6%L:6=N.B!C96YT97([
M(%1%6%0M24Y$14Y4.B`P<'0G/B!&86ER(%9A;'5E/"]D:78^(#PO=&0^(#QT
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M5$]-.B`R<'@G('9A;&EG;CTS1&)O='1O;3X\9F]N="!S='EL93TS1"=&3TY4
M+5-)6D4Z(#$P<'0[($9/3E0M1D%-24Q9.B!T:6UE<R!N97<@<F]M86X[($9/
M3E0M5T5)1TA4.B!B;VQD.R!$25-03$%9.B!I;FQI;F4G/B`F;F)S<#L\+V9O
M;G0^(#PO=&0^(#QT9"!S='EL93TS1"="3U)$15(M0D]45$]-.B!B;&%C:R`R
M<'@@<V]L:60G('9A;&EG;CTS1&)O='1O;2!C;VQS<&%N/3-$,CX@/&1I=B!S
M='EL93TS1"=$25-03$%9.B!B;&]C:SL@1D].5"U&04U)3%DZ('1I;65S(&YE
M=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T.R!&3TY4+5=%24=(5#H@8F]L9#L@
M34%21TE.+4Q%1E0Z(#!P=#L@34%21TE.+5))1TA4.B`P<'0[('1E>'0M86QI
M9VXZ(&-E;G1E<CL@5$585"U)3D1%3E0Z(#!P="<^($=R;W-S/"]D:78^(#QD
M:78@<W1Y;&4],T0G1$E34$Q!63H@8FQO8VL[($9/3E0M1D%-24Q9.B!T:6UE
M<R!N97<@<F]M86X[($9/3E0M4TE:13H@,3!P=#L@1D].5"U714E'2%0Z(&)O
M;&0[($U!4D=)3BU,1494.B`P<'0[($U!4D=)3BU224=(5#H@,'!T.R!T97AT
M+6%L:6=N.B!C96YT97([(%1%6%0M24Y$14Y4.B`P<'0G/B!U;G)E86QI>F5D
M(&QO<W,\+V1I=CX@/"]T9#X@/'1D('-T>6QE/3-$)U!!1$1)3D<M0D]45$]-
M.B`R<'@[(%1%6%0M04Q)1TXZ(&QE9G0G('9A;&EG;CTS1&)O='1O;2!N;W=R
M87`],T1N;W=R87`^/&9O;G0@<W1Y;&4],T0G1D].5"U325I%.B`Q,'!T.R!&
M3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!&3TY4+5=%24=(5#H@8F]L
M9#L@1$E34$Q!63H@:6YL:6YE)SX@)FYB<W`[/"]F;VYT/B`\+W1D/B`\+W1R
M/B`\='(@8F=C;VQO<CTS1"-C8V5E9F8^(#QT9"!S='EL93TS1"=415A4+4%,
M24=..B!L969T.R!-05)'24XM3$5&5#H@,'!T.R!-05)'24XM4DE'2%0Z(#!P
M=#L@5$585"U)3D1%3E0Z(#!P="<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$
M-3(E/B`\9&EV('-T>6QE/3-$)T1)4U!,05DZ(&)L;V-K.R!&3TY4+49!34E,
M63H@=&EM97,@;F5W(')O;6%N.R!&3TY4+5-)6D4Z(#$P<'0[($U!4D=)3BU,
M1494.B`P<'0[($U!4D=)3BU224=(5#H@,'!T.R!415A4+4%,24=..B!L969T
M.R!415A4+4E.1$5.5#H@,'!T)SX@07,@;V8@2G5N92`S,"P@,C`Q-#PO9&EV
M/B`\+W1D/B`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24^/&9O;G0@
M<W1Y;&4],T0G1D].5"U325I%.B`Q,'!T.R!&3TY4+49!34E,63H@=&EM97,@
M;F5W(')O;6%N.R!$25-03$%9.B!I;FQI;F4G/B`F;F)S<#L\+V9O;G0^(#PO
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M=&@],T0Q)2!N;W=R87`],T1N;W=R87`^/&9O;G0@<W1Y;&4],T0G1D].5"U3
M25I%.B`Q,'!T.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!$25-0
M3$%9.B!I;FQI;F4G/B`F;F)S<#L\+V9O;G0^(#PO=&0^(#QT9"!V86QI9VX]
M,T1B;W1T;VT@=VED=&@],T0Q)3X\9F]N="!S='EL93TS1"=&3TY4+5-)6D4Z
M(#$P<'0[($9/3E0M1D%-24Q9.B!T:6UE<R!N97<@<F]M86X[($1)4U!,05DZ
M(&EN;&EN92<^("9N8G-P.SPO9F]N=#X@/"]T9#X@/'1D('-T>6QE/3-$)T1)
M4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@
M1D].5"U325I%.B`Q,'!T.R!415A4+4%,24=..B!L969T)R!V86QI9VX],T1B
M;W1T;VT@=VED=&@],T0Q)3XD/"]T9#X@/'1D('-T>6QE/3-$)T1)4U!,05DZ
M(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U3
M25I%.B`Q,'!T.R!415A4+4%,24=..B!R:6=H="<@=F%L:6=N/3-$8F]T=&]M
M('=I9'1H/3-$.24^*#$W/"]T9#X@/'1D('-T>6QE/3-$)T1)4U!,05DZ(&EN
M;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%
M.B`Q,'!T.R!415A4+4%,24=..B!L969T)R!V86QI9VX],T1B;W1T;VT@=VED
M=&@],T0Q)2!N;W=R87`],T1N;W=R87`^*3PO=&0^(#QT9"!V86QI9VX],T1B
M;W1T;VT@=VED=&@],T0Q)3X\9F]N="!S='EL93TS1"=&3TY4+5-)6D4Z(#$P
M<'0[($9/3E0M1D%-24Q9.B!T:6UE<R!N97<@<F]M86X[($1)4U!,05DZ(&EN
M;&EN92<^("9N8G-P.SPO9F]N=#X@/"]T9#X@/'1D('-T>6QE/3-$)T1)4U!,
M05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].
M5"U325I%.B`Q,'!T.R!415A4+4%,24=..B!L969T)R!V86QI9VX],T1B;W1T
M;VT@=VED=&@],T0Q)3XD/"]T9#X@/'1D('-T>6QE/3-$)T1)4U!,05DZ(&EN
M;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%
M.B`Q,'!T.R!415A4+4%,24=..B!R:6=H="<@=F%L:6=N/3-$8F]T=&]M('=I
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M;65S(&YE=R!R;VUA;CL@1$E34$Q!63H@:6YL:6YE)SX@)FYB<W`[/"]F;VYT
M/B`\+W1D/B`\=&0@<W1Y;&4],T0G1$E34$Q!63H@:6YL:6YE.R!&3TY4+49!
M34E,63H@=&EM97,@;F5W(')O;6%N.R!&3TY4+5-)6D4Z(#$P<'0[(%1%6%0M
M04Q)1TXZ(&QE9G0G('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E/B0\+W1D
M/B`\=&0@<W1Y;&4],T0G1$E34$Q!63H@:6YL:6YE.R!&3TY4+49!34E,63H@
M=&EM97,@;F5W(')O;6%N.R!&3TY4+5-)6D4Z(#$P<'0[(%1%6%0M04Q)1TXZ
M(')I9VAT)R!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Y)3XH,3(\+W1D/B`\
M=&0@<W1Y;&4],T0G1$E34$Q!63H@:6YL:6YE.R!&3TY4+49!34E,63H@=&EM
M97,@;F5W(')O;6%N.R!&3TY4+5-)6D4Z(#$P<'0[(%1%6%0M04Q)1TXZ(&QE
M9G0G('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E(&YO=W)A<#TS1&YO=W)A
M<#XI/"]T9#X@/"]T<CX@/'1R(&)G8V]L;W(],T1W:&ET93X@/'1D('-T>6QE
M/3-$)U1%6%0M04Q)1TXZ(&QE9G0[($U!4D=)3BU,1494.B`P<'0[($U!4D=)
M3BU224=(5#H@,'!T.R!415A4+4E.1$5.5#H@,'!T)R!V86QI9VX],T1B;W1T
M;VT@=VED=&@],T0U,B4^(#QD:78@<W1Y;&4],T0G1$E34$Q!63H@8FQO8VL[
M($9/3E0M1D%-24Q9.B!T:6UE<R!N97<@<F]M86X[($9/3E0M4TE:13H@,3!P
M=#L@34%21TE.+4Q%1E0Z(#!P=#L@34%21TE.+5))1TA4.B`P<'0[(%1%6%0M
M04Q)1TXZ(&QE9G0[(%1%6%0M24Y$14Y4.B`P<'0G/B!!<R!O9B!*=6YE(#,P
M+"`R,#$S/"]D:78^(#PO=&0^(#QT9"!V86QI9VX],T1B;W1T;VT@=VED=&@]
M,T0Q)3X\9F]N="!S='EL93TS1"=&3TY4+5-)6D4Z(#$P<'0[($9/3E0M1D%-
M24Q9.B!T:6UE<R!N97<@<F]M86X[($1)4U!,05DZ(&EN;&EN92<^("9N8G-P
M.SPO9F]N=#X@/"]T9#X@/'1D('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@
M1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T
M.R!415A4+4%,24=..B!L969T)R!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q
M)3XD/"]T9#X@/'1D('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&
M04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T.R!415A4
M+4%,24=..B!R:6=H="<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$.24^-2PQ
M,C(\+W1D/B`\=&0@<W1Y;&4],T0G5$585"U!3$E'3CH@;&5F="<@=F%L:6=N
M/3-$8F]T=&]M('=I9'1H/3-$,24@;F]W<F%P/3-$;F]W<F%P/CQF;VYT('-T
M>6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ('1I;65S(&YE
M=R!R;VUA;CL@1$E34$Q!63H@:6YL:6YE)SX@)FYB<W`[/"]F;VYT/B`\+W1D
M/B`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24^/&9O;G0@<W1Y;&4]
M,T0G1D].5"U325I%.B`Q,'!T.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O
M;6%N.R!$25-03$%9.B!I;FQI;F4G/B`F;F)S<#L\+V9O;G0^(#PO=&0^(#QT
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M;&EG;CTS1&)O='1O;2!W:61T:#TS1#DE/B@S,#(\+W1D/B`\=&0@<W1Y;&4]
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M;CL@1$E34$Q!63H@:6YL:6YE)SX@)FYB<W`[/"]F;VYT/B`\+W1D/B`\=&0@
M<W1Y;&4],T0G1$E34$Q!63H@:6YL:6YE.R!&3TY4+49!34E,63H@=&EM97,@
M;F5W(')O;6%N.R!&3TY4+5-)6D4Z(#$P<'0[(%1%6%0M04Q)1TXZ(&QE9G0G
M('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E/B0\+W1D/B`\=&0@<W1Y;&4]
M,T0G1$E34$Q!63H@:6YL:6YE.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O
M;6%N.R!&3TY4+5-)6D4Z(#$P<'0[(%1%6%0M04Q)1TXZ(')I9VAT)R!V86QI
M9VX],T1B;W1T;VT@=VED=&@],T0Y)3XS,CPO=&0^(#QT9"!S='EL93TS1"=4
M15A4+4%,24=..B!L969T)R!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)2!N
M;W=R87`],T1N;W=R87`^/&9O;G0@<W1Y;&4],T0G1D].5"U325I%.B`Q,'!T
M.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!$25-03$%9.B!I;FQI
M;F4G/B`F;F)S<#L\+V9O;G0^(#PO=&0^(#QT9"!V86QI9VX],T1B;W1T;VT@
M=VED=&@],T0Q)3X\9F]N="!S='EL93TS1"=&3TY4+5-)6D4Z(#$P<'0[($9/
M3E0M1D%-24Q9.B!T:6UE<R!N97<@<F]M86X[($1)4U!,05DZ(&EN;&EN92<^
M("9N8G-P.SPO9F]N=#X@/"]T9#X@/'1D('-T>6QE/3-$)T1)4U!,05DZ(&EN
M;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%
M.B`Q,'!T.R!415A4+4%,24=..B!L969T)R!V86QI9VX],T1B;W1T;VT@=VED
M=&@],T0Q)3XD/"]T9#X@/'1D('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@
M1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T
M.R!415A4+4%,24=..B!R:6=H="<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$
M.24^*#D\+W1D/B`\=&0@<W1Y;&4],T0G1$E34$Q!63H@:6YL:6YE.R!&3TY4
M+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!&3TY4+5-)6D4Z(#$P<'0[(%1%
M6%0M04Q)1TXZ(&QE9G0G('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E(&YO
M=W)A<#TS1&YO=W)A<#XI/"]T9#X@/"]T<CX@/"]T86)L93X@/"]D:78^(#PA
M+2U%;F1&<F%G;65N="TM/CPO9&EV/B`\+V1I=CX\<W!A;CX\+W-P86X^/"]T
M9#X-"B`@("`@(#PO='(^#0H@("`@/"]T86)L93X-"B`@/"]B;V1Y/@T*/"]H
M=&UL/@T*#0HM+2TM+2T]7TYE>'1087)T7S!C860U.69D7S<S,F5?-#9E,E]A
M-3,T7S!C.&%D,6%F.3!D9`T*0V]N=&5N="U,;V-A=&EO;CH@9FEL93HO+R]#
M.B\P8V%D-3EF9%\W,S)E7S0V93)?834S-%\P8SAA9#%A9CDP9&0O5V]R:W-H
M965T<R]3:&5E=#(R+FAT;6P-"D-O;G1E;G0M5')A;G-F97(M16YC;V1I;F<Z
M('%U;W1E9"UP<FEN=&%B;&4-"D-O;G1E;G0M5'EP93H@=&5X="]H=&UL.R!C
M:&%R<V5T/2)U<RUA<V-I:2(-"@T*/&AT;6P^#0H@(#QH96%D/@T*("`@(#Q-
M151!(&AT='`M97%U:78],T1#;VYT96YT+51Y<&4@8V]N=&5N=#TS1"=T97AT
M+VAT;6P[(&-H87)S970]=71F+3@G/CQS8W)I<'0@='EP93TS1'1E>'0O:F%V
M87-C<FEP="!S<F,],T13:&]W+FIS/B\J($1O($YO="!296UO=F4@5&AI<R!#
M;VUM96YT("HO/"]S8W)I<'0^/"]H96%D/@T*("`\8F]D>3X-"B`@("`\=&%B
M;&4@8VQA<W,],T1R97!O<G0@:60],T1)1#!%,D8^#0H@("`@("`\='(^#0H@
M("`@("`@(#QT:"!C;&%S<STS1'1L(&-O;'-P86X],T0Q(')O=W-P86X],T0R
M/CQS=')O;F<^1D%)4B!604Q512!/1B!&24Y!3D-)04P@24Y35%)5345.5%,@
M*%1A8FQE<RD\8G(^/"]S=')O;F<^/"]T:#X-"B`@("`@("`@/'1H(&-L87-S
M/3-$=&@@8V]L<W!A;CTS1#$^,3(@36]N=&AS($5N9&5D/"]T:#X-"B`@("`@
M(#PO='(^#0H@("`@("`\='(^#0H@("`@("`@(#QT:"!C;&%S<STS1'1H/DIU
M;BX@,S`L(#(P,30\8G(^/"]T:#X-"B`@("`@(#PO='(^#0H@("`@("`\='(@
M8VQA<W,],T1R93X-"B`@("`@("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$
M=&]P/CQS=')O;F<^1D%)4B!604Q512!/1B!&24Y!3D-)04P@24Y35%)5345.
M5%,@6T%B<W1R86-T73PO<W1R;VYG/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S
M<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@
M("`@(#QT<B!C;&%S<STS1')O/@T*("`@("`@("`\=&0@8VQA<W,],T1P;"!V
M86QI9VX],T1T;W`^4V-H961U;&4@;V8@1F%I<B!686QU92!O9B!&:6YA;F-I
M86P@26YS=')U;65N=',\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT
M/B<\(2TM1$]#5%E012!H=&UL(%!50DQ)0R`B+2\O5S-#+R]$5$0@6$A434P@
M,2XP(%1R86YS:71I;VYA;"\O14XB(")H='1P.B\O=W=W+G<S+F]R9R]44B]X
M:'1M;#$O1%1$+WAH=&UL,2UT<F%N<VET:6]N86PN9'1D(B`M+3X\9&EV/B`\
M9&EV/CPA+2U3=&%R=$9R86=M96YT+2T^(#QD:78@<W1Y;&4],T0G=&5X="UA
M;&EG;CH@<FEG:'0G/B`\=&%B;&4@<W1Y;&4],T0G1D].5"U325I%.B`Q,'!T
M.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N)R!C96QL<W!A8VEN9STS
M1#`@8V5L;'!A9&1I;F<],T0P('=I9'1H/3-$.3<E/B`\='(^(#QT9"!S='EL
M93TS1"=0041$24Y'+4)/5%1/33H@,G!X)R!V86QI9VX],T1B;W1T;VT@=VED
M=&@],T0R."4^/&9O;G0@<W1Y;&4],T0G1D].5"U325I%.B`Q,'!T.R!&3TY4
M+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!$25-03$%9.B!I;FQI;F4G/B`F
M;F)S<#L\+V9O;G0^(#PO=&0^(#QT9"!S='EL93TS1"=0041$24Y'+4)/5%1/
M33H@,G!X)R!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)3X\9F]N="!S='EL
M93TS1"=&3TY4+5-)6D4Z(#$P<'0[($9/3E0M1D%-24Q9.B!T:6UE<R!N97<@
M<F]M86X[($9/3E0M5T5)1TA4.B!B;VQD.R!$25-03$%9.B!I;FQI;F4G/B`F
M;F)S<#L\+V9O;G0^(#PO=&0^(#QT9"!S='EL93TS1"="3U)$15(M0D]45$]-
M.B!B;&%C:R`R<'@@<V]L:60G('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#,T
M)2!C;VQS<&%N/3-$,3`^(#QD:78@<W1Y;&4],T0G1$E34$Q!63H@8FQO8VL[
M($9/3E0M1D%-24Q9.B!T:6UE<R!N97<@<F]M86X[($9/3E0M4TE:13H@,3!P
M=#L@1D].5"U714E'2%0Z(&)O;&0[($U!4D=)3BU,1494.B`P<'0[($U!4D=)
M3BU224=(5#H@,'!T.R!T97AT+6%L:6=N.B!C96YT97([(%1%6%0M24Y$14Y4
M.B`P<'0G/B!*=6YE(#,P+"`R,#$T/"]D:78^(#PO=&0^(#QT9"!S='EL93TS
M1"=0041$24Y'+4)/5%1/33H@,G!X.R!415A4+4%,24=..B!L969T)R!V86QI
M9VX],T1B;W1T;VT@=VED=&@],T0Q)2!N;W=R87`],T1N;W=R87`^/&9O;G0@
M<W1Y;&4],T0G1D].5"U325I%.B`Q,'!T.R!&3TY4+49!34E,63H@=&EM97,@
M;F5W(')O;6%N.R!&3TY4+5=%24=(5#H@8F]L9#L@1$E34$Q!63H@:6YL:6YE
M)SX@)FYB<W`[/"]F;VYT/B`\+W1D/B`\=&0@<W1Y;&4],T0G4$%$1$E.1RU"
M3U143TTZ(#)P>"<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24^/&9O;G0@
M<W1Y;&4],T0G1D].5"U325I%.B`Q,'!T.R!&3TY4+49!34E,63H@=&EM97,@
M;F5W(')O;6%N.R!&3TY4+5=%24=(5#H@8F]L9#L@1$E34$Q!63H@:6YL:6YE
M)SX@)FYB<W`[/"]F;VYT/B`\+W1D/B`\=&0@<W1Y;&4],T0G0D]21$52+4)/
M5%1/33H@8FQA8VL@,G!X('-O;&ED)R!V86QI9VX],T1B;W1T;VT@=VED=&@]
M,T0S-"4@8V]L<W!A;CTS1#$P/B`\9&EV('-T>6QE/3-$)T1)4U!,05DZ(&)L
M;V-K.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!&3TY4+5-)6D4Z
M(#$P<'0[($9/3E0M5T5)1TA4.B!B;VQD.R!-05)'24XM3$5&5#H@,'!T.R!-
M05)'24XM4DE'2%0Z(#!P=#L@=&5X="UA;&EG;CH@8V5N=&5R.R!415A4+4E.
M1$5.5#H@,'!T)SX@2G5N92`S,"P@,C`Q,SPO9&EV/B`\+W1D/B`\=&0@<W1Y
M;&4],T0G4$%$1$E.1RU"3U143TTZ(#)P>#L@5$585"U!3$E'3CH@;&5F="<@
M=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@;F]W<F%P/3-$;F]W<F%P/CQF
M;VYT('-T>6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ('1I
M;65S(&YE=R!R;VUA;CL@1D].5"U714E'2%0Z(&)O;&0[($1)4U!,05DZ(&EN
M;&EN92<^("9N8G-P.SPO9F]N=#X@/"]T9#X@/"]T<CX@/'1R/B`\=&0@<W1Y
M;&4],T0G4$%$1$E.1RU"3U143TTZ(#)P>"<@=F%L:6=N/3-$8F]T=&]M('=I
M9'1H/3-$,C@E/CQF;VYT('-T>6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@1D].
M5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1$E34$Q!63H@:6YL:6YE)SX@
M)FYB<W`[/"]F;VYT/B`\+W1D/B`\=&0@<W1Y;&4],T0G4$%$1$E.1RU"3U14
M3TTZ(#)P>"<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24^/&9O;G0@<W1Y
M;&4],T0G1D].5"U325I%.B`Q,'!T.R!&3TY4+49!34E,63H@=&EM97,@;F5W
M(')O;6%N.R!&3TY4+5=%24=(5#H@8F]L9#L@1$E34$Q!63H@:6YL:6YE)SX@
M)FYB<W`[/"]F;VYT/B`\+W1D/B`\=&0@<W1Y;&4],T0G0D]21$52+4)/5%1/
M33H@8FQA8VL@,G!X('-O;&ED)R!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q
M,"4@8V]L<W!A;CTS1#(^(#QD:78@<W1Y;&4],T0G1$E34$Q!63H@8FQO8VL[
M($9/3E0M1D%-24Q9.B!T:6UE<R!N97<@<F]M86X[($9/3E0M4TE:13H@,3!P
M=#L@1D].5"U714E'2%0Z(&)O;&0[($U!4D=)3BU,1494.B`P<'0[($U!4D=)
M3BU224=(5#H@,'!T.R!T97AT+6%L:6=N.B!C96YT97([(%1%6%0M24Y$14Y4
M.B`P<'0G/B!,979E;"`Q/"]D:78^(#PO=&0^(#QT9"!S='EL93TS1"=0041$
M24Y'+4)/5%1/33H@,G!X.R!415A4+4%,24=..B!L969T)R!V86QI9VX],T1B
M;W1T;VT@=VED=&@],T0Q)2!N;W=R87`],T1N;W=R87`^/&9O;G0@<W1Y;&4]
M,T0G1D].5"U325I%.B`Q,'!T.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O
M;6%N.R!&3TY4+5=%24=(5#H@8F]L9#L@1$E34$Q!63H@:6YL:6YE)SX@)FYB
M<W`[/"]F;VYT/B`\+W1D/B`\=&0@<W1Y;&4],T0G4$%$1$E.1RU"3U143TTZ
M(#)P>"<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24^/&9O;G0@<W1Y;&4]
M,T0G1D].5"U325I%.B`Q,'!T.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O
M;6%N.R!&3TY4+5=%24=(5#H@8F]L9#L@1$E34$Q!63H@:6YL:6YE)SX@)FYB
M<W`[/"]F;VYT/B`\+W1D/B`\=&0@<W1Y;&4],T0G0D]21$52+4)/5%1/33H@
M8FQA8VL@,G!X('-O;&ED)R!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q,"4@
M8V]L<W!A;CTS1#(^(#QD:78@<W1Y;&4],T0G1$E34$Q!63H@8FQO8VL[($9/
M3E0M1D%-24Q9.B!T:6UE<R!N97<@<F]M86X[($9/3E0M4TE:13H@,3!P=#L@
M1D].5"U714E'2%0Z(&)O;&0[($U!4D=)3BU,1494.B`P<'0[($U!4D=)3BU2
M24=(5#H@,'!T.R!T97AT+6%L:6=N.B!C96YT97([(%1%6%0M24Y$14Y4.B`P
M<'0G/B!,979E;"`R/"]D:78^(#PO=&0^(#QT9"!S='EL93TS1"=0041$24Y'
M+4)/5%1/33H@,G!X.R!415A4+4%,24=..B!L969T)R!V86QI9VX],T1B;W1T
M;VT@=VED=&@],T0Q)2!N;W=R87`],T1N;W=R87`^/&9O;G0@<W1Y;&4],T0G
M1D].5"U325I%.B`Q,'!T.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N
M.R!&3TY4+5=%24=(5#H@8F]L9#L@1$E34$Q!63H@:6YL:6YE)SX@)FYB<W`[
M/"]F;VYT/B`\+W1D/B`\=&0@<W1Y;&4],T0G4$%$1$E.1RU"3U143TTZ(#)P
M>"<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24^/&9O;G0@<W1Y;&4],T0G
M1D].5"U325I%.B`Q,'!T.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N
M.R!&3TY4+5=%24=(5#H@8F]L9#L@1$E34$Q!63H@:6YL:6YE)SX@)FYB<W`[
M/"]F;VYT/B`\+W1D/B`\=&0@<W1Y;&4],T0G0D]21$52+4)/5%1/33H@8FQA
M8VL@,G!X('-O;&ED)R!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q,"4@8V]L
M<W!A;CTS1#(^(#QD:78@<W1Y;&4],T0G1$E34$Q!63H@8FQO8VL[($9/3E0M
M1D%-24Q9.B!T:6UE<R!N97<@<F]M86X[($9/3E0M4TE:13H@,3!P=#L@1D].
M5"U714E'2%0Z(&)O;&0[($U!4D=)3BU,1494.B`P<'0[($U!4D=)3BU224=(
M5#H@,'!T.R!T97AT+6%L:6=N.B!C96YT97([(%1%6%0M24Y$14Y4.B`P<'0G
M/B!,979E;"`S/"]D:78^(#PO=&0^(#QT9"!S='EL93TS1"=0041$24Y'+4)/
M5%1/33H@,G!X.R!415A4+4%,24=..B!L969T)R!V86QI9VX],T1B;W1T;VT@
M=VED=&@],T0Q)2!N;W=R87`],T1N;W=R87`^/&9O;G0@<W1Y;&4],T0G1D].
M5"U325I%.B`Q,'!T.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!&
M3TY4+5=%24=(5#H@8F]L9#L@1$E34$Q!63H@:6YL:6YE)SX@)FYB<W`[/"]F
M;VYT/B`\+W1D/B`\=&0@<W1Y;&4],T0G4$%$1$E.1RU"3U143TTZ(#)P>"<@
M=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24^/&9O;G0@<W1Y;&4],T0G1D].
M5"U325I%.B`Q,'!T.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!&
M3TY4+5=%24=(5#H@8F]L9#L@1$E34$Q!63H@:6YL:6YE)SX@)FYB<W`[/"]F
M;VYT/B`\+W1D/B`\=&0@<W1Y;&4],T0G0D]21$52+4)/5%1/33H@8FQA8VL@
M,G!X('-O;&ED)R!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q,"4@8V]L<W!A
M;CTS1#(^(#QD:78@<W1Y;&4],T0G1$E34$Q!63H@8FQO8VL[($9/3E0M1D%-
M24Q9.B!T:6UE<R!N97<@<F]M86X[($9/3E0M4TE:13H@,3!P=#L@1D].5"U7
M14E'2%0Z(&)O;&0[($U!4D=)3BU,1494.B`P<'0[($U!4D=)3BU224=(5#H@
M,'!T.R!T97AT+6%L:6=N.B!C96YT97([(%1%6%0M24Y$14Y4.B`P<'0G/B!,
M979E;"`Q/"]D:78^(#PO=&0^(#QT9"!S='EL93TS1"=0041$24Y'+4)/5%1/
M33H@,G!X.R!415A4+4%,24=..B!L969T)R!V86QI9VX],T1B;W1T;VT@=VED
M=&@],T0Q)2!N;W=R87`],T1N;W=R87`^/&9O;G0@<W1Y;&4],T0G1D].5"U3
M25I%.B`Q,'!T.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!&3TY4
M+5=%24=(5#H@8F]L9#L@1$E34$Q!63H@:6YL:6YE)SX@)FYB<W`[/"]F;VYT
M/B`\+W1D/B`\=&0@<W1Y;&4],T0G4$%$1$E.1RU"3U143TTZ(#)P>"<@=F%L
M:6=N/3-$8F]T=&]M('=I9'1H/3-$,24^/&9O;G0@<W1Y;&4],T0G1D].5"U3
M25I%.B`Q,'!T.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!&3TY4
M+5=%24=(5#H@8F]L9#L@1$E34$Q!63H@:6YL:6YE)SX@)FYB<W`[/"]F;VYT
M/B`\+W1D/B`\=&0@<W1Y;&4],T0G0D]21$52+4)/5%1/33H@8FQA8VL@,G!X
M('-O;&ED)R!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q,"4@8V]L<W!A;CTS
M1#(^(#QD:78@<W1Y;&4],T0G1$E34$Q!63H@8FQO8VL[($9/3E0M1D%-24Q9
M.B!T:6UE<R!N97<@<F]M86X[($9/3E0M4TE:13H@,3!P=#L@1D].5"U714E'
M2%0Z(&)O;&0[($U!4D=)3BU,1494.B`P<'0[($U!4D=)3BU224=(5#H@,'!T
M.R!T97AT+6%L:6=N.B!C96YT97([(%1%6%0M24Y$14Y4.B`P<'0G/B!,979E
M;"`R/"]D:78^(#PO=&0^(#QT9"!S='EL93TS1"=0041$24Y'+4)/5%1/33H@
M,G!X.R!415A4+4%,24=..B!L969T)R!V86QI9VX],T1B;W1T;VT@=VED=&@]
M,T0Q)2!N;W=R87`],T1N;W=R87`^/&9O;G0@<W1Y;&4],T0G1D].5"U325I%
M.B`Q,'!T.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!&3TY4+5=%
M24=(5#H@8F]L9#L@1$E34$Q!63H@:6YL:6YE)SX@)FYB<W`[/"]F;VYT/B`\
M+W1D/B`\=&0@<W1Y;&4],T0G4$%$1$E.1RU"3U143TTZ(#)P>"<@=F%L:6=N
M/3-$8F]T=&]M('=I9'1H/3-$,24^/&9O;G0@<W1Y;&4],T0G1D].5"U325I%
M.B`Q,'!T.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!&3TY4+5=%
M24=(5#H@8F]L9#L@1$E34$Q!63H@:6YL:6YE)SX@)FYB<W`[/"]F;VYT/B`\
M+W1D/B`\=&0@<W1Y;&4],T0G0D]21$52+4)/5%1/33H@8FQA8VL@,G!X('-O
M;&ED)R!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q,"4@8V]L<W!A;CTS1#(^
M(#QD:78@<W1Y;&4],T0G1$E34$Q!63H@8FQO8VL[($9/3E0M1D%-24Q9.B!T
M:6UE<R!N97<@<F]M86X[($9/3E0M4TE:13H@,3!P=#L@1D].5"U714E'2%0Z
M(&)O;&0[($U!4D=)3BU,1494.B`P<'0[($U!4D=)3BU224=(5#H@,'!T.R!T
M97AT+6%L:6=N.B!C96YT97([(%1%6%0M24Y$14Y4.B`P<'0G/B!,979E;"`S
M/"]D:78^(#PO=&0^(#QT9"!S='EL93TS1"=0041$24Y'+4)/5%1/33H@,G!X
M.R!415A4+4%,24=..B!L969T)R!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q
M)2!N;W=R87`],T1N;W=R87`^/&9O;G0@<W1Y;&4],T0G1D].5"U325I%.B`Q
M,'!T.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!&3TY4+5=%24=(
M5#H@8F]L9#L@1$E34$Q!63H@:6YL:6YE)SX@)FYB<W`[/"]F;VYT/B`\+W1D
M/B`\+W1R/B`\='(@8F=C;VQO<CTS1"-C8V5E9F8^(#QT9"!S='EL93TS1"=4
M15A4+4%,24=..B!L969T.R!-05)'24XM3$5&5#H@,'!T.R!-05)'24XM4DE'
M2%0Z(#!P=#L@5$585"U)3D1%3E0Z(#!P="<@=F%L:6=N/3-$8F]T=&]M('=I
M9'1H/3-$,C@E/B`\9&EV('-T>6QE/3-$)T1)4U!,05DZ(&)L;V-K.R!&3TY4
M+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!&3TY4+5-)6D4Z(#$P<'0[($U!
M4D=)3BU,1494.B`P<'0[($U!4D=)3BU224=(5#H@,'!T.R!415A4+4%,24=.
M.B!L969T.R!415A4+4E.1$5.5#H@,'!T)SX@36%R:V5T86)L92!S96-U<FET
M:65S/"]D:78^(#PO=&0^(#QT9"!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q
M)2!A;&EG;CTS1')I9VAT/CQF;VYT('-T>6QE/3-$)T9/3E0M4TE:13H@,3!P
M=#L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1$E34$Q!63H@:6YL
M:6YE)SX@)FYB<W`[/"]F;VYT/B`\+W1D/B`\=&0@<W1Y;&4],T0G1$E34$Q!
M63H@:6YL:6YE.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!&3TY4
M+5-)6D4Z(#$P<'0[(%1%6%0M04Q)1TXZ(&QE9G0G('9A;&EG;CTS1&)O='1O
M;2!W:61T:#TS1#$E/B0\+W1D/B`\=&0@<W1Y;&4],T0G1$E34$Q!63H@:6YL
M:6YE.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!&3TY4+5-)6D4Z
M(#$P<'0[(%1%6%0M04Q)1TXZ(')I9VAT)R!V86QI9VX],T1B;W1T;VT@=VED
M=&@],T0Y)3XR,"PU,S`\+W1D/B`\=&0@<W1Y;&4],T0G5$585"U!3$E'3CH@
M;&5F="<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@;F]W<F%P/3-$;F]W
M<F%P/CQF;VYT('-T>6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@1D].5"U&04U)
M3%DZ('1I;65S(&YE=R!R;VUA;CL@1$E34$Q!63H@:6YL:6YE)SX@)FYB<W`[
M/"]F;VYT/B`\+W1D/B`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@
M86QI9VX],T1R:6=H=#X\9F]N="!S='EL93TS1"=&3TY4+5-)6D4Z(#$P<'0[
M($9/3E0M1D%-24Q9.B!T:6UE<R!N97<@<F]M86X[($1)4U!,05DZ(&EN;&EN
M92<^("9N8G-P.SPO9F]N=#X@/"]T9#X@/'1D('-T>6QE/3-$)T1)4U!,05DZ
M(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U3
M25I%.B`Q,'!T.R!415A4+4%,24=..B!L969T)R!V86QI9VX],T1B;W1T;VT@
M=VED=&@],T0Q)3XD/"]T9#X@/'1D('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN
M93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q
M,'!T.R!415A4+4%,24=..B!R:6=H="<@=F%L:6=N/3-$8F]T=&]M('=I9'1H
M/3-$.24^.2PT,S$\+W1D/B`\=&0@<W1Y;&4],T0G5$585"U!3$E'3CH@;&5F
M="<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@;F]W<F%P/3-$;F]W<F%P
M/CQF;VYT('-T>6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ
M('1I;65S(&YE=R!R;VUA;CL@1$E34$Q!63H@:6YL:6YE)SX@)FYB<W`[/"]F
M;VYT/B`\+W1D/B`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@86QI
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M;VUA;CL@1$E34$Q!63H@:6YL:6YE)SX@)FYB<W`[/"]F;VYT/B`\+W1D/B`\
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M,T0G1D].5"U325I%.B`Q,'!T.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O
M;6%N.R!$25-03$%9.B!I;FQI;F4G/B`F;F)S<#L\+V9O;G0^(#PO=&0^(#QT
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M1D].5"U325I%.B`Q,'!T.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N
M.R!$25-03$%9.B!I;FQI;F4G/B`F;F)S<#L\+V9O;G0^(#PO=&0^(#QT9"!S
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M5"U325I%.B`Q,'!T.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!$
M25-03$%9.B!I;FQI;F4G/B`F;F)S<#L\+V9O;G0^(#PO=&0^(#QT9"!S='EL
M93TS1"=415A4+4%,24=..B!L969T)R!V86QI9VX],T1B;W1T;VT@=VED=&@]
M,T0Q)3X\9F]N="!S='EL93TS1"=&3TY4+5-)6D4Z(#$P<'0[($9/3E0M1D%-
M24Q9.B!T:6UE<R!N97<@<F]M86X[($1)4U!,05DZ(&EN;&EN92<^("9N8G-P
M.SPO9F]N=#X@/"]T9#X@/'1D('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@
M1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T
M.R!415A4+4%,24=..B!R:6=H="<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$
M.24^+3PO=&0^(#QT9"!S='EL93TS1"=415A4+4%,24=..B!L969T)R!V86QI
M9VX],T1B;W1T;VT@=VED=&@],T0Q)2!N;W=R87`],T1N;W=R87`^/&9O;G0@
M<W1Y;&4],T0G1D].5"U325I%.B`Q,'!T.R!&3TY4+49!34E,63H@=&EM97,@
M;F5W(')O;6%N.R!$25-03$%9.B!I;FQI;F4G/B`F;F)S<#L\+V9O;G0^(#PO
M=&0^(#PO='(^(#QT<B!B9V-O;&]R/3-$=VAI=&4^(#QT9"!S='EL93TS1"=0
M041$24Y'+4)/5%1/33H@,G!X.R!415A4+4%,24=..B!L969T.R!-05)'24XM
M3$5&5#H@,'!T.R!-05)'24XM4DE'2%0Z(#!P=#L@5$585"U)3D1%3E0Z(#!P
M="<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,C@E/B`\9&EV('-T>6QE/3-$
M)T1)4U!,05DZ(&)L;V-K.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N
M.R!&3TY4+5-)6D4Z(#$P<'0[($U!4D=)3BU,1494.B`P<'0[($U!4D=)3BU2
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M(&YE=R!R;VUA;CL@1$E34$Q!63H@:6YL:6YE)SX@)FYB<W`[/"]F;VYT/B`\
M+W1D/B`\=&0@<W1Y;&4],T0G0D]21$52+4)/5%1/33H@8FQA8VL@,G!X('-O
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M('-T>6QE/3-$)U!!1$1)3D<M0D]45$]-.B`R<'@[(%1%6%0M04Q)1TXZ(&QE
M9G0G('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E(&YO=W)A<#TS1&YO=W)A
M<#X\9F]N="!S='EL93TS1"=&3TY4+5-)6D4Z(#$P<'0[($9/3E0M1D%-24Q9
M.B!T:6UE<R!N97<@<F]M86X[($1)4U!,05DZ(&EN;&EN92<^("9N8G-P.SPO
M9F]N=#X@/"]T9#X@/'1D('-T>6QE/3-$)U!!1$1)3D<M0D]45$]-.B`R<'@G
M('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E(&%L:6=N/3-$<FEG:'0^/&9O
M;G0@<W1Y;&4],T0G1D].5"U325I%.B`Q,'!T.R!&3TY4+49!34E,63H@=&EM
M97,@;F5W(')O;6%N.R!$25-03$%9.B!I;FQI;F4G/B`F;F)S<#L\+V9O;G0^
M(#PO=&0^(#QT9"!S='EL93TS1"="3U)$15(M0D]45$]-.B!B;&%C:R`R<'@@
M<V]L:60[(%1%6%0M04Q)1TXZ(&QE9G0G('9A;&EG;CTS1&)O='1O;2!W:61T
M:#TS1#$E/CQF;VYT('-T>6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@1D].5"U&
M04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1$E34$Q!63H@:6YL:6YE)SX@)FYB
M<W`[/"]F;VYT/B`\+W1D/B`\=&0@<W1Y;&4],T0G0D]21$52+4)/5%1/33H@
M8FQA8VL@,G!X('-O;&ED.R!$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9
M.B!T:6UE<R!N97<@<F]M86X[($9/3E0M4TE:13H@,3!P=#L@5$585"U!3$E'
M3CH@<FEG:'0G('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#DE/B@X-#(\+W1D
M/B`\=&0@<W1Y;&4],T0G1$E34$Q!63H@:6YL:6YE.R!&3TY4+49!34E,63H@
M=&EM97,@;F5W(')O;6%N.R!&3TY4+5-)6D4Z(#$P<'0[(%!!1$1)3D<M0D]4
M5$]-.B`R<'@[(%1%6%0M04Q)1TXZ(&QE9G0G('9A;&EG;CTS1&)O='1O;2!W
M:61T:#TS1#$E(&YO=W)A<#TS1&YO=W)A<#XI/"]T9#X@/'1D('-T>6QE/3-$
M)U!!1$1)3D<M0D]45$]-.B`R<'@G('9A;&EG;CTS1&)O='1O;2!W:61T:#TS
M1#$E(&%L:6=N/3-$<FEG:'0^/&9O;G0@<W1Y;&4],T0G1D].5"U325I%.B`Q
M,'!T.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!$25-03$%9.B!I
M;FQI;F4G/B`F;F)S<#L\+V9O;G0^(#PO=&0^(#QT9"!S='EL93TS1"="3U)$
M15(M0D]45$]-.B!B;&%C:R`R<'@@<V]L:60[(%1%6%0M04Q)1TXZ(&QE9G0G
M('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E/CQF;VYT('-T>6QE/3-$)T9/
M3E0M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@
M1$E34$Q!63H@:6YL:6YE)SX@)FYB<W`[/"]F;VYT/B`\+W1D/B`\=&0@<W1Y
M;&4],T0G0D]21$52+4)/5%1/33H@8FQA8VL@,G!X('-O;&ED.R!$25-03$%9
M.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE<R!N97<@<F]M86X[($9/3E0M
M4TE:13H@,3!P=#L@5$585"U!3$E'3CH@<FEG:'0G('9A;&EG;CTS1&)O='1O
M;2!W:61T:#TS1#DE/BT\+W1D/B`\=&0@<W1Y;&4],T0G4$%$1$E.1RU"3U14
M3TTZ(#)P>#L@5$585"U!3$E'3CH@;&5F="<@=F%L:6=N/3-$8F]T=&]M('=I
M9'1H/3-$,24@;F]W<F%P/3-$;F]W<F%P/CQF;VYT('-T>6QE/3-$)T9/3E0M
M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1$E3
M4$Q!63H@:6YL:6YE)SX@)FYB<W`[/"]F;VYT/B`\+W1D/B`\=&0@<W1Y;&4]
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M1D].5"U325I%.B`Q,'!T.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N
M.R!$25-03$%9.B!I;FQI;F4G/B`F;F)S<#L\+V9O;G0^(#PO=&0^(#QT9"!S
M='EL93TS1"="3U)$15(M0D]45$]-.B!B;&%C:R`R<'@@<V]L:60[($1)4U!,
M05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].
M5"U325I%.B`Q,'!T.R!415A4+4%,24=..B!R:6=H="<@=F%L:6=N/3-$8F]T
M=&]M('=I9'1H/3-$.24^+3PO=&0^(#QT9"!S='EL93TS1"=0041$24Y'+4)/
M5%1/33H@,G!X.R!415A4+4%,24=..B!L969T)R!V86QI9VX],T1B;W1T;VT@
M=VED=&@],T0Q)2!N;W=R87`],T1N;W=R87`^/&9O;G0@<W1Y;&4],T0G1D].
M5"U325I%.B`Q,'!T.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!$
M25-03$%9.B!I;FQI;F4G/B`F;F)S<#L\+V9O;G0^(#PO=&0^(#QT9"!S='EL
M93TS1"=0041$24Y'+4)/5%1/33H@,G!X)R!V86QI9VX],T1B;W1T;VT@=VED
M=&@],T0Q)2!A;&EG;CTS1')I9VAT/CQF;VYT('-T>6QE/3-$)T9/3E0M4TE:
M13H@,3!P=#L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1$E34$Q!
M63H@:6YL:6YE)SX@)FYB<W`[/"]F;VYT/B`\+W1D/B`\=&0@<W1Y;&4],T0G
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M;VT@=VED=&@],T0Q)2!N;W=R87`],T1N;W=R87`^/&9O;G0@<W1Y;&4],T0G
M1D].5"U325I%.B`Q,'!T.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N
M.R!$25-03$%9.B!I;FQI;F4G/B`F;F)S<#L\+V9O;G0^(#PO=&0^(#QT9"!S
M='EL93TS1"=0041$24Y'+4)/5%1/33H@,G!X)R!V86QI9VX],T1B;W1T;VT@
M=VED=&@],T0Q)2!A;&EG;CTS1')I9VAT/CQF;VYT('-T>6QE/3-$)T9/3E0M
M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1$E3
M4$Q!63H@:6YL:6YE)SX@)FYB<W`[/"]F;VYT/B`\+W1D/B`\=&0@<W1Y;&4]
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M3D<M0D]45$]-.B`R<'@[(%1%6%0M04Q)1TXZ(&QE9G0G('9A;&EG;CTS1&)O
M='1O;2!W:61T:#TS1#$E(&YO=W)A<#TS1&YO=W)A<#X\9F]N="!S='EL93TS
M1"=&3TY4+5-)6D4Z(#$P<'0[($9/3E0M1D%-24Q9.B!T:6UE<R!N97<@<F]M
M86X[($1)4U!,05DZ(&EN;&EN92<^("9N8G-P.SPO9F]N=#X@/"]T9#X@/"]T
M<CX@/'1R(&)G8V]L;W(],T0C8V-E969F/B`\=&0@<W1Y;&4],T0G4$%$1$E.
M1RU"3U143TTZ(#1P>#L@5$585"U!3$E'3CH@;&5F=#L@34%21TE.+4Q%1E0Z
M(#!P=#L@34%21TE.+5))1TA4.B`P<'0[(%1%6%0M24Y$14Y4.B`P<'0G('9A
M;&EG;CTS1&)O='1O;2!W:61T:#TS1#(X)3X@/&1I=B!S='EL93TS1"=$25-0
M3$%9.B!B;&]C:SL@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].
M5"U325I%.B`Q,'!T.R!-05)'24XM3$5&5#H@,'!T.R!-05)'24XM4DE'2%0Z
M(#!P=#L@5$585"U!3$E'3CH@;&5F=#L@5$585"U)3D1%3E0Z(#!P="<^(%1O
M=&%L/"]D:78^(#PO=&0^(#QT9"!S='EL93TS1"=0041$24Y'+4)/5%1/33H@
M-'!X)R!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)2!A;&EG;CTS1')I9VAT
M/CQF;VYT('-T>6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ
M('1I;65S(&YE=R!R;VUA;CL@1$E34$Q!63H@:6YL:6YE)SX@)FYB<W`[/"]F
M;VYT/B`\+W1D/B`\=&0@<W1Y;&4],T0G0D]21$52+4)/5%1/33H@8FQA8VL@
M-'!X(&1O=6)L93L@1$E34$Q!63H@:6YL:6YE.R!&3TY4+49!34E,63H@=&EM
M97,@;F5W(')O;6%N.R!&3TY4+5-)6D4Z(#$P<'0[(%1%6%0M04Q)1TXZ(&QE
M9G0G('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E/B0\+W1D/B`\=&0@<W1Y
M;&4],T0G0D]21$52+4)/5%1/33H@8FQA8VL@-'!X(&1O=6)L93L@1$E34$Q!
M63H@:6YL:6YE.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!&3TY4
M+5-)6D4Z(#$P<'0[(%1%6%0M04Q)1TXZ(')I9VAT)R!V86QI9VX],T1B;W1T
M;VT@=VED=&@],T0Y)3XR,"PU,S`\+W1D/B`\=&0@<W1Y;&4],T0G4$%$1$E.
M1RU"3U143TTZ(#1P>#L@5$585"U!3$E'3CH@;&5F="<@=F%L:6=N/3-$8F]T
M=&]M('=I9'1H/3-$,24@;F]W<F%P/3-$;F]W<F%P/CQF;VYT('-T>6QE/3-$
M)T9/3E0M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA
M;CL@1$E34$Q!63H@:6YL:6YE)SX@)FYB<W`[/"]F;VYT/B`\+W1D/B`\=&0@
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M25I%.B`Q,'!T.R!415A4+4%,24=..B!L969T)R!V86QI9VX],T1B;W1T;VT@
M=VED=&@],T0Q)3XD/"]T9#X@/'1D('-T>6QE/3-$)T)/4D1%4BU"3U143TTZ
M(&)L86-K(#1P>"!D;W5B;&4[($1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)
M3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T.R!415A4+4%,
M24=..B!R:6=H="<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$.24^."PU.#D\
M+W1D/B`\=&0@<W1Y;&4],T0G4$%$1$E.1RU"3U143TTZ(#1P>#L@5$585"U!
M3$E'3CH@;&5F="<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@;F]W<F%P
M/3-$;F]W<F%P/CQF;VYT('-T>6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@1D].
M5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1$E34$Q!63H@:6YL:6YE)SX@
M)FYB<W`[/"]F;VYT/B`\+W1D/B`\=&0@<W1Y;&4],T0G4$%$1$E.1RU"3U14
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M('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T.R!415A4+4%,24=.
M.B!L969T)R!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)3XD/"]T9#X@/'1D
M('-T>6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#1P>"!D;W5B;&4[($1)
M4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@
M1D].5"U325I%.B`Q,'!T.R!415A4+4%,24=..B!R:6=H="<@=F%L:6=N/3-$
M8F]T=&]M('=I9'1H/3-$.24^+3PO=&0^(#QT9"!S='EL93TS1"=0041$24Y'
M+4)/5%1/33H@-'!X.R!415A4+4%,24=..B!L969T)R!V86QI9VX],T1B;W1T
M;VT@=VED=&@],T0Q)2!N;W=R87`],T1N;W=R87`^/&9O;G0@<W1Y;&4],T0G
M1D].5"U325I%.B`Q,'!T.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N
M.R!$25-03$%9.B!I;FQI;F4G/B`F;F)S<#L\+V9O;G0^(#PO=&0^(#QT9"!S
M='EL93TS1"=0041$24Y'+4)/5%1/33H@-'!X)R!V86QI9VX],T1B;W1T;VT@
M=VED=&@],T0Q)2!A;&EG;CTS1')I9VAT/CQF;VYT('-T>6QE/3-$)T9/3E0M
M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1$E3
M4$Q!63H@:6YL:6YE)SX@)FYB<W`[/"]F;VYT/B`\+W1D/B`\=&0@<W1Y;&4]
M,T0G0D]21$52+4)/5%1/33H@8FQA8VL@-'!X(&1O=6)L93L@1$E34$Q!63H@
M:6YL:6YE.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!&3TY4+5-)
M6D4Z(#$P<'0[(%1%6%0M04Q)1TXZ(&QE9G0G('9A;&EG;CTS1&)O='1O;2!W
M:61T:#TS1#$E/B0\+W1D/B`\=&0@<W1Y;&4],T0G0D]21$52+4)/5%1/33H@
M8FQA8VL@-'!X(&1O=6)L93L@1$E34$Q!63H@:6YL:6YE.R!&3TY4+49!34E,
M63H@=&EM97,@;F5W(')O;6%N.R!&3TY4+5-)6D4Z(#$P<'0[(%1%6%0M04Q)
M1TXZ(')I9VAT)R!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Y)3XV+#,Q,3PO
M=&0^(#QT9"!S='EL93TS1"=0041$24Y'+4)/5%1/33H@-'!X.R!415A4+4%,
M24=..B!L969T)R!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)2!N;W=R87`]
M,T1N;W=R87`^/&9O;G0@<W1Y;&4],T0G1D].5"U325I%.B`Q,'!T.R!&3TY4
M+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!$25-03$%9.B!I;FQI;F4G/B`F
M;F)S<#L\+V9O;G0^(#PO=&0^(#QT9"!S='EL93TS1"=0041$24Y'+4)/5%1/
M33H@-'!X)R!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)2!A;&EG;CTS1')I
M9VAT/CQF;VYT('-T>6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@1D].5"U&04U)
M3%DZ('1I;65S(&YE=R!R;VUA;CL@1$E34$Q!63H@:6YL:6YE)SX@)FYB<W`[
M/"]F;VYT/B`\+W1D/B`\=&0@<W1Y;&4],T0G0D]21$52+4)/5%1/33H@8FQA
M8VL@-'!X(&1O=6)L93L@1$E34$Q!63H@:6YL:6YE.R!&3TY4+49!34E,63H@
M=&EM97,@;F5W(')O;6%N.R!&3TY4+5-)6D4Z(#$P<'0[(%1%6%0M04Q)1TXZ
M(&QE9G0G('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E/B0\+W1D/B`\=&0@
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M;W1T;VT@=VED=&@],T0Q)2!N;W=R87`],T1N;W=R87`^/&9O;G0@<W1Y;&4]
M,T0G1D].5"U325I%.B`Q,'!T.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O
M;6%N.R!$25-03$%9.B!I;FQI;F4G/B`F;F)S<#L\+V9O;G0^(#PO=&0^(#QT
M9"!S='EL93TS1"=0041$24Y'+4)/5%1/33H@-'!X)R!V86QI9VX],T1B;W1T
M;VT@=VED=&@],T0Q)2!A;&EG;CTS1')I9VAT/CQF;VYT('-T>6QE/3-$)T9/
M3E0M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@
M1$E34$Q!63H@:6YL:6YE)SX@)FYB<W`[/"]F;VYT/B`\+W1D/B`\=&0@<W1Y
M;&4],T0G0D]21$52+4)/5%1/33H@8FQA8VL@-'!X(&1O=6)L93L@1$E34$Q!
M63H@:6YL:6YE.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!&3TY4
M+5-)6D4Z(#$P<'0[(%1%6%0M04Q)1TXZ(&QE9G0G('9A;&EG;CTS1&)O='1O
M;2!W:61T:#TS1#$E/B0\+W1D/B`\=&0@<W1Y;&4],T0G0D]21$52+4)/5%1/
M33H@8FQA8VL@-'!X(&1O=6)L93L@1$E34$Q!63H@:6YL:6YE.R!&3TY4+49!
M34E,63H@=&EM97,@;F5W(')O;6%N.R!&3TY4+5-)6D4Z(#$P<'0[(%1%6%0M
M04Q)1TXZ(')I9VAT)R!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Y)3XM/"]T
M9#X@/'1D('-T>6QE/3-$)U!!1$1)3D<M0D]45$]-.B`T<'@[(%1%6%0M04Q)
M1TXZ(&QE9G0G('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E(&YO=W)A<#TS
M1&YO=W)A<#X\9F]N="!S='EL93TS1"=&3TY4+5-)6D4Z(#$P<'0[($9/3E0M
M1D%-24Q9.B!T:6UE<R!N97<@<F]M86X[($1)4U!,05DZ(&EN;&EN92<^("9N
M8G-P.SPO9F]N=#X@/"]T9#X@/"]T<CX@/"]T86)L93X@/"]D:78^(#PA+2U%
M;F1&<F%G;65N="TM/CPO9&EV/B`\+V1I=CX\<W!A;CX\+W-P86X^/"]T9#X-
M"B`@("`@(#PO='(^#0H@("`@("`\='(@8VQA<W,],T1R93X-"B`@("`@("`@
M/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P/E-C:&5D=6QE(&]F($1E<FEV
M871I=F4@2&5D9VEN9R!!8W1I=FET>2!A;F0@0F%L86YC92!3:&5E="!,;V-A
M=&EO;CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SPA+2U$3T-4
M65!%(&AT;6P@4%5"3$E#("(M+R]7,T,O+T141"!82%1-3"`Q+C`@5')A;G-I
M=&EO;F%L+R]%3B(@(FAT='`Z+R]W=W<N=S,N;W)G+U12+WAH=&UL,2]$5$0O
M>&AT;6PQ+71R86YS:71I;VYA;"YD=&0B("TM/CQD:78^(#QD:78^/"$M+5-T
M87)T1G)A9VUE;G0M+3X@/&1I=B!S='EL93TS1"=T97AT+6%L:6=N.B!R:6=H
M="<^(#QT86)L92!S='EL93TS1"=&3TY4+5-)6D4Z(#$P<'0[($9/3E0M1D%-
M24Q9.B!T:6UE<R!N97<@<F]M86XG(&-E;&QS<&%C:6YG/3-$,"!C96QL<&%D
M9&EN9STS1#`@=VED=&@],T0Y-R4^(#QT<CX@/'1D('-T>6QE/3-$)U!!1$1)
M3D<M0D]45$]-.B`R<'@G('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#0Y)3X\
M9F]N="!S='EL93TS1"=&3TY4+5-)6D4Z(#$P<'0[($9/3E0M1D%-24Q9.B!T
M:6UE<R!N97<@<F]M86X[($1)4U!,05DZ(&EN;&EN92<^("9N8G-P.SPO9F]N
M=#X@/"]T9#X@/'1D('-T>6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#)P
M>"!S;VQI9"<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,C8E(&-O;'-P86X]
M,T0T/B`\9&EV('-T>6QE/3-$)T1)4U!,05DZ(&)L;V-K.R!&3TY4+49!34E,
M63H@=&EM97,@;F5W(')O;6%N.R!&3TY4+5-)6D4Z(#$P<'0[($9/3E0M5T5)
M1TA4.B!B;VQD.R!-05)'24XM3$5&5#H@,'!T.R!-05)'24XM4DE'2%0Z(#!P
M=#L@=&5X="UA;&EG;CH@8V5N=&5R.R!415A4+4E.1$5.5#H@,'!T)SX@2G5N
M92`S,"P@,C`Q-#PO9&EV/B`\+W1D/B`\=&0@<W1Y;&4],T0G4$%$1$E.1RU"
M3U143TTZ(#)P>#L@5$585"U!3$E'3CH@;&5F="<@=F%L:6=N/3-$8F]T=&]M
M('=I9'1H/3-$,24@;F]W<F%P/3-$;F]W<F%P/CQF;VYT('-T>6QE/3-$)T9/
M3E0M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@
M1D].5"U714E'2%0Z(&)O;&0[($1)4U!,05DZ(&EN;&EN92<^("9N8G-P.SPO
M9F]N=#X@/"]T9#X@/'1D('-T>6QE/3-$)U!!1$1)3D<M0D]45$]-.B`R<'@G
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M86X],T0V/B`\9&EV('-T>6QE/3-$)T1)4U!,05DZ(&)L;V-K.R!&3TY4+49!
M34E,63H@=&EM97,@;F5W(')O;6%N.R!&3TY4+5-)6D4Z(#$P<'0[($9/3E0M
M5T5)1TA4.B!B;VQD.R!-05)'24XM3$5&5#H@,'!T.R!-05)'24XM4DE'2%0Z
M(#!P=#L@=&5X="UA;&EG;CH@8V5N=&5R.R!415A4+4E.1$5.5#H@,'!T)SX@
M2G5N92`S,"P@,C`Q,SPO9&EV/B`\+W1D/B`\=&0@<W1Y;&4],T0G4$%$1$E.
M1RU"3U143TTZ(#)P>#L@5$585"U!3$E'3CH@;&5F="<@=F%L:6=N/3-$8F]T
M=&]M('=I9'1H/3-$,24@;F]W<F%P/3-$;F]W<F%P/CQF;VYT('-T>6QE/3-$
M)T9/3E0M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA
M;CL@1D].5"U714E'2%0Z(&)O;&0[($1)4U!,05DZ(&EN;&EN92<^("9N8G-P
M.SPO9F]N=#X@/"]T9#X@/"]T<CX@/'1R/B`\=&0@<W1Y;&4],T0G4$%$1$E.
M1RU"3U143TTZ(#)P>"<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$-#DE/CQF
M;VYT('-T>6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ('1I
M;65S(&YE=R!R;VUA;CL@1$E34$Q!63H@:6YL:6YE)SX@)FYB<W`[/"]F;VYT
M/B`\+W1D/B`\=&0@<W1Y;&4],T0G0D]21$52+4)/5%1/33H@8FQA8VL@,G!X
M('-O;&ED)R!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q-24^(#QD:78@<W1Y
M;&4],T0G1$E34$Q!63H@8FQO8VL[($9/3E0M1D%-24Q9.B!T:6UE<R!N97<@
M<F]M86X[($9/3E0M4TE:13H@,3!P=#L@1D].5"U714E'2%0Z(&)O;&0[($U!
M4D=)3BU,1494.B`P<'0[($U!4D=)3BU224=(5#H@,'!T.R!T97AT+6%L:6=N
M.B!C96YT97([(%1%6%0M24Y$14Y4.B`P<'0G/B!"86QA;F-E(%-H965T(&QO
M8V%T:6]N/"]D:78^(#PO=&0^(#QT9"!S='EL93TS1"=0041$24Y'+4)/5%1/
M33H@,G!X)R!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)3X\9F]N="!S='EL
M93TS1"=&3TY4+5-)6D4Z(#$P<'0[($9/3E0M1D%-24Q9.B!T:6UE<R!N97<@
M<F]M86X[($9/3E0M5T5)1TA4.B!B;VQD.R!$25-03$%9.B!I;FQI;F4G/B`F
M;F)S<#L\+V9O;G0^(#PO=&0^(#QT9"!S='EL93TS1"="3U)$15(M0D]45$]-
M.B!B;&%C:R`R<'@@<V]L:60G('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$P
M)2!C;VQS<&%N/3-$,CX@/&1I=B!S='EL93TS1"=$25-03$%9.B!B;&]C:SL@
M1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T
M.R!&3TY4+5=%24=(5#H@8F]L9#L@34%21TE.+4Q%1E0Z(#!P=#L@34%21TE.
M+5))1TA4.B`P<'0[('1E>'0M86QI9VXZ(&-E;G1E<CL@5$585"U)3D1%3E0Z
M(#!P="<^($9A:7(@5F%L=64\+V1I=CX@/"]T9#X@/'1D('-T>6QE/3-$)U!!
M1$1)3D<M0D]45$]-.B`R<'@[(%1%6%0M04Q)1TXZ(&QE9G0G('9A;&EG;CTS
M1&)O='1O;2!W:61T:#TS1#$E(&YO=W)A<#TS1&YO=W)A<#X\9F]N="!S='EL
M93TS1"=&3TY4+5-)6D4Z(#$P<'0[($9/3E0M1D%-24Q9.B!T:6UE<R!N97<@
M<F]M86X[($9/3E0M5T5)1TA4.B!B;VQD.R!$25-03$%9.B!I;FQI;F4G/B`F
M;F)S<#L\+V9O;G0^(#PO=&0^(#QT9"!S='EL93TS1"=0041$24Y'+4)/5%1/
M33H@,G!X)R!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)3X\9F]N="!S='EL
M93TS1"=&3TY4+5-)6D4Z(#$P<'0[($9/3E0M1D%-24Q9.B!T:6UE<R!N97<@
M<F]M86X[($9/3E0M5T5)1TA4.B!B;VQD.R!$25-03$%9.B!I;FQI;F4G/B`F
M;F)S<#L\+V9O;G0^(#PO=&0^(#QT9"!S='EL93TS1"="3U)$15(M0D]45$]-
M.B!B;&%C:R`R<'@@<V]L:60G('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$P
M)2!C;VQS<&%N/3-$,CX@/&1I=B!S='EL93TS1"=$25-03$%9.B!B;&]C:SL@
M1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T
M.R!&3TY4+5=%24=(5#H@8F]L9#L@34%21TE.+4Q%1E0Z(#!P=#L@34%21TE.
M+5))1TA4.B`P<'0[('1E>'0M86QI9VXZ(&-E;G1E<CL@5$585"U)3D1%3E0Z
M(#!P="<^($)A;&%N8V4@4VAE970@;&]C871I;VX\+V1I=CX@/"]T9#X@/'1D
M('-T>6QE/3-$)U!!1$1)3D<M0D]45$]-.B`R<'@[(%1%6%0M04Q)1TXZ(&QE
M9G0G('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E(&YO=W)A<#TS1&YO=W)A
M<#X\9F]N="!S='EL93TS1"=&3TY4+5-)6D4Z(#$P<'0[($9/3E0M1D%-24Q9
M.B!T:6UE<R!N97<@<F]M86X[($9/3E0M5T5)1TA4.B!B;VQD.R!$25-03$%9
M.B!I;FQI;F4G/B`F;F)S<#L\+V9O;G0^(#PO=&0^(#QT9"!S='EL93TS1"=0
M041$24Y'+4)/5%1/33H@,G!X)R!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q
M)3X\9F]N="!S='EL93TS1"=&3TY4+5-)6D4Z(#$P<'0[($9/3E0M1D%-24Q9
M.B!T:6UE<R!N97<@<F]M86X[($9/3E0M5T5)1TA4.B!B;VQD.R!$25-03$%9
M.B!I;FQI;F4G/B`F;F)S<#L\+V9O;G0^(#PO=&0^(#QT9"!S='EL93TS1"="
M3U)$15(M0D]45$]-.B!B;&%C:R`R<'@@<V]L:60G('9A;&EG;CTS1&)O='1O
M;2!W:61T:#TS1#$P)2!C;VQS<&%N/3-$,CX@/&1I=B!S='EL93TS1"=$25-0
M3$%9.B!B;&]C:SL@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].
M5"U325I%.B`Q,'!T.R!&3TY4+5=%24=(5#H@8F]L9#L@34%21TE.+4Q%1E0Z
M(#!P=#L@34%21TE.+5))1TA4.B`P<'0[('1E>'0M86QI9VXZ(&-E;G1E<CL@
M5$585"U)3D1%3E0Z(#!P="<^($9A:7(@5F%L=64\+V1I=CX@/"]T9#X@/'1D
M('-T>6QE/3-$)U!!1$1)3D<M0D]45$]-.B`R<'@[(%1%6%0M04Q)1TXZ(&QE
M9G0G('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E(&YO=W)A<#TS1&YO=W)A
M<#X\9F]N="!S='EL93TS1"=&3TY4+5-)6D4Z(#$P<'0[($9/3E0M1D%-24Q9
M.B!T:6UE<R!N97<@<F]M86X[($9/3E0M5T5)1TA4.B!B;VQD.R!$25-03$%9
M.B!I;FQI;F4G/B`F;F)S<#L\+V9O;G0^(#PO=&0^(#PO='(^(#QT<B!B9V-O
M;&]R/3-$(V-C965F9CX@/'1D('-T>6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0[
M($U!4D=)3BU,1494.B`P<'0[($U!4D=)3BU224=(5#H@,'!T.R!415A4+4E.
M1$5.5#H@,'!T)R!V86QI9VX],T1B;W1T;VT@=VED=&@],T0T.24^(#QD:78@
M<W1Y;&4],T0G1$E34$Q!63H@8FQO8VL[($9/3E0M1D%-24Q9.B!T:6UE<R!N
M97<@<F]M86X[($9/3E0M4TE:13H@,3!P=#L@34%21TE.+4Q%1E0Z(#!P=#L@
M34%21TE.+5))1TA4.B`P<'0[(%1%6%0M04Q)1TXZ(&QE9G0[(%1%6%0M24Y$
M14Y4.B`P<'0G/B!$97)I=F%T:79E<R!D97-I9VYA=&5D(&%S(&-A<V@@9FQO
M=R!H961G92!I;G-T<G5M96YT<SPO9&EV/B`\+W1D/B`\=&0@=F%L:6=N/3-$
M8F]T=&]M('=I9'1H/3-$,34E/B`\9&EV('-T>6QE/3-$)T1)4U!,05DZ(&)L
M;V-K.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!&3TY4+5-)6D4Z
M(#$P<'0[($U!4D=)3BU,1494.B`P<'0[($U!4D=)3BU224=(5#H@,2XV<'0[
M('1E>'0M86QI9VXZ(&-E;G1E<CL@5$585"U)3D1%3E0Z(#!P="<^($]T:&5R
M(&-U<G)E;G0@87-S971S/"]D:78^(#PO=&0^(#QT9"!V86QI9VX],T1B;W1T
M;VT@=VED=&@],T0Q)2!A;&EG;CTS1')I9VAT/CQF;VYT('-T>6QE/3-$)T9/
M3E0M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@
M1$E34$Q!63H@:6YL:6YE)SX@)FYB<W`[/"]F;VYT/B`\+W1D/B`\=&0@<W1Y
M;&4],T0G1$E34$Q!63H@:6YL:6YE.R!&3TY4+49!34E,63H@=&EM97,@;F5W
M(')O;6%N.R!&3TY4+5-)6D4Z(#$P<'0[(%1%6%0M04Q)1TXZ(&QE9G0G('9A
M;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E/B0\+W1D/B`\=&0@<W1Y;&4],T0G
M1$E34$Q!63H@:6YL:6YE.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N
M.R!&3TY4+5-)6D4Z(#$P<'0[(%1%6%0M04Q)1TXZ(')I9VAT)R!V86QI9VX]
M,T1B;W1T;VT@=VED=&@],T0Y)3XR-#PO=&0^(#QT9"!S='EL93TS1"=415A4
M+4%,24=..B!L969T)R!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)2!N;W=R
M87`],T1N;W=R87`^/&9O;G0@<W1Y;&4],T0G1D].5"U325I%.B`Q,'!T.R!&
M3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!$25-03$%9.B!I;FQI;F4G
M/B`F;F)S<#L\+V9O;G0^(#PO=&0^(#QT9"!V86QI9VX],T1B;W1T;VT@=VED
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M;CL@1$E34$Q!63H@:6YL:6YE)SX@)FYB<W`[/"]F;VYT/B`\+W1D/B`\=&0@
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M=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T.R!415A4+4%,24=..B!L969T)R!V
M86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)3XD/"]T9#X@/'1D('-T>6QE/3-$
M)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA
M;CL@1D].5"U325I%.B`Q,'!T.R!415A4+4%,24=..B!R:6=H="<@=F%L:6=N
M/3-$8F]T=&]M('=I9'1H/3-$.24^+3PO=&0^(#QT9"!S='EL93TS1"=415A4
M+4%,24=..B!L969T)R!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)2!N;W=R
M87`],T1N;W=R87`^/&9O;G0@<W1Y;&4],T0G1D].5"U325I%.B`Q,'!T.R!&
M3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!$25-03$%9.B!I;FQI;F4G
M/B`F;F)S<#L\+V9O;G0^(#PO=&0^(#PO='(^(#QT<B!B9V-O;&]R/3-$=VAI
M=&4^(#QT9"!S='EL93TS1"=415A4+4%,24=..B!L969T.R!-05)'24XM3$5&
M5#H@,'!T.R!-05)'24XM4DE'2%0Z(#!P=#L@5$585"U)3D1%3E0Z(#!P="<@
M=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$-#DE/CQF;VYT('-T>6QE/3-$)T9/
M3E0M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@
M1$E34$Q!63H@:6YL:6YE)SX@)FYB<W`[/"]F;VYT/B`\+W1D/B`\=&0@=F%L
M:6=N/3-$8F]T=&]M('=I9'1H/3-$,34E/CQF;VYT('-T>6QE/3-$)T9/3E0M
M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1$E3
M4$Q!63H@:6YL:6YE)SX@)FYB<W`[/"]F;VYT/B`\+W1D/B`\=&0@=F%L:6=N
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M)SX@)FYB<W`[/"]F;VYT/B`\+W1D/B`\=&0@<W1Y;&4],T0G5$585"U!3$E'
M3CH@<FEG:'0G('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#DE/CQF;VYT('-T
M>6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ('1I;65S(&YE
M=R!R;VUA;CL@1$E34$Q!63H@:6YL:6YE)SX@)FYB<W`[/"]F;VYT/B`\+W1D
M/B`\=&0@<W1Y;&4],T0G5$585"U!3$E'3CH@;&5F="<@=F%L:6=N/3-$8F]T
M=&]M('=I9'1H/3-$,24@;F]W<F%P/3-$;F]W<F%P/CQF;VYT('-T>6QE/3-$
M)T9/3E0M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA
M;CL@1$E34$Q!63H@:6YL:6YE)SX@)FYB<W`[/"]F;VYT/B`\+W1D/B`\=&0@
M=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24^/&9O;G0@<W1Y;&4],T0G1D].
M5"U325I%.B`Q,'!T.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!$
M25-03$%9.B!I;FQI;F4G/B`F;F)S<#L\+V9O;G0^(#PO=&0^(#QT9"!V86QI
M9VX],T1B;W1T;VT@=VED=&@],T0Q,"4@8V]L<W!A;CTS1#(^/&9O;G0@<W1Y
M;&4],T0G1D].5"U325I%.B`Q,'!T.R!&3TY4+49!34E,63H@=&EM97,@;F5W
M(')O;6%N.R!$25-03$%9.B!I;FQI;F4G/B`F;F)S<#L\+V9O;G0^(#PO=&0^
M(#QT9"!S='EL93TS1"=415A4+4%,24=..B!L969T)R!V86QI9VX],T1B;W1T
M;VT@=VED=&@],T0Q)2!N;W=R87`],T1N;W=R87`^/&9O;G0@<W1Y;&4],T0G
M1D].5"U325I%.B`Q,'!T.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N
M.R!$25-03$%9.B!I;FQI;F4G/B`F;F)S<#L\+V9O;G0^(#PO=&0^(#QT9"!V
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M3%DZ('1I;65S(&YE=R!R;VUA;CL@1$E34$Q!63H@:6YL:6YE)SX@)FYB<W`[
M/"]F;VYT/B`\+W1D/B`\=&0@<W1Y;&4],T0G5$585"U!3$E'3CH@<FEG:'0G
M('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#DE/CQF;VYT('-T>6QE/3-$)T9/
M3E0M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@
M1$E34$Q!63H@:6YL:6YE)SX@)FYB<W`[/"]F;VYT/B`\+W1D/B`\=&0@<W1Y
M;&4],T0G5$585"U!3$E'3CH@;&5F="<@=F%L:6=N/3-$8F]T=&]M('=I9'1H
M/3-$,24@;F]W<F%P/3-$;F]W<F%P/CQF;VYT('-T>6QE/3-$)T9/3E0M4TE:
M13H@,3!P=#L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1$E34$Q!
M63H@:6YL:6YE)SX@)FYB<W`[/"]F;VYT/B`\+W1D/B`\+W1R/B`\='(@8F=C
M;VQO<CTS1"-C8V5E9F8^(#QT9"!S='EL93TS1"=415A4+4%,24=..B!L969T
M.R!-05)'24XM3$5&5#H@,'!T.R!-05)'24XM4DE'2%0Z(#!P=#L@5$585"U)
M3D1%3E0Z(#!P="<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$-#DE/B`\9&EV
M('-T>6QE/3-$)T1)4U!,05DZ(&)L;V-K.R!&3TY4+49!34E,63H@=&EM97,@
M;F5W(')O;6%N.R!&3TY4+5-)6D4Z(#$P<'0[($U!4D=)3BU,1494.B`P<'0[
M($U!4D=)3BU224=(5#H@,'!T.R!415A4+4%,24=..B!L969T.R!415A4+4E.
M1$5.5#H@,'!T)SX@1&5R:79A=&EV97,@;F]T(&1E<VEG;F%T960@87,@:&5D
M9V4@:6YS=')U;65N=',\+V1I=CX@/"]T9#X@/'1D('9A;&EG;CTS1&)O='1O
M;2!W:61T:#TS1#$U)3X@/&1I=B!S='EL93TS1"=$25-03$%9.B!B;&]C:SL@
M1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T
M.R!-05)'24XM3$5&5#H@,'!T.R!-05)'24XM4DE'2%0Z(#$N-G!T.R!T97AT
M+6%L:6=N.B!C96YT97([(%1%6%0M24Y$14Y4.B`P<'0G/B!/=&AE<B!C=7)R
M96YT(&%S<V5T<SPO9&EV/B`\+W1D/B`\=&0@=F%L:6=N/3-$8F]T=&]M('=I
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M('1I;65S(&YE=R!R;VUA;CL@1$E34$Q!63H@:6YL:6YE)SX@)FYB<W`[/"]F
M;VYT/B`\+W1D/B`\=&0@<W1Y;&4],T0G1$E34$Q!63H@:6YL:6YE.R!&3TY4
M+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!&3TY4+5-)6D4Z(#$P<'0[(%1%
M6%0M04Q)1TXZ(')I9VAT)R!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Y)3XR
M,SPO=&0^(#QT9"!S='EL93TS1"=415A4+4%,24=..B!L969T)R!V86QI9VX]
M,T1B;W1T;VT@=VED=&@],T0Q)2!N;W=R87`],T1N;W=R87`^/&9O;G0@<W1Y
M;&4],T0G1D].5"U325I%.B`Q,'!T.R!&3TY4+49!34E,63H@=&EM97,@;F5W
M(')O;6%N.R!$25-03$%9.B!I;FQI;F4G/B`F;F)S<#L\+V9O;G0^(#PO=&0^
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M(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T.R!-05)'24XM3$5&5#H@,'!T
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M1$E34$Q!63H@:6YL:6YE)SX@)FYB<W`[/"]F;VYT/B`\+W1D/B`\=&0@<W1Y
M;&4],T0G5$585"U!3$E'3CH@;&5F="<@=F%L:6=N/3-$8F]T=&]M('=I9'1H
M/3-$,24^/&9O;G0@<W1Y;&4],T0G1D].5"U325I%.B`Q,'!T.R!&3TY4+49!
M34E,63H@=&EM97,@;F5W(')O;6%N.R!$25-03$%9.B!I;FQI;F4G/B`F;F)S
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M)U1%6%0M04Q)1TXZ(&QE9G0[($U!4D=)3BU,1494.B`P<'0[($U!4D=)3BU2
M24=(5#H@,'!T.R!415A4+4E.1$5.5#H@,'!T)R!V86QI9VX],T1B;W1T;VT@
M=VED=&@],T0T.24^/&9O;G0@<W1Y;&4],T0G1D].5"U325I%.B`Q,'!T.R!&
M3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!$25-03$%9.B!I;FQI;F4G
M/B`F;F)S<#L\+V9O;G0^(#PO=&0^(#QT9"!V86QI9VX],T1B;W1T;VT@=VED
M=&@],T0Q-24^/&9O;G0@<W1Y;&4],T0G1D].5"U325I%.B`Q,'!T.R!&3TY4
M+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!$25-03$%9.B!I;FQI;F4G/B`F
M;F)S<#L\+V9O;G0^(#PO=&0^(#QT9"!V86QI9VX],T1B;W1T;VT@=VED=&@]
M,T0Q)2!A;&EG;CTS1')I9VAT/CQF;VYT('-T>6QE/3-$)T9/3E0M4TE:13H@
M,3!P=#L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1$E34$Q!63H@
M:6YL:6YE)SX@)FYB<W`[/"]F;VYT/B`\+W1D/B`\=&0@<W1Y;&4],T0G5$58
M5"U!3$E'3CH@;&5F="<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24^/&9O
M;G0@<W1Y;&4],T0G1D].5"U325I%.B`Q,'!T.R!&3TY4+49!34E,63H@=&EM
M97,@;F5W(')O;6%N.R!$25-03$%9.B!I;FQI;F4G/B`F;F)S<#L\+V9O;G0^
M(#PO=&0^(#QT9"!S='EL93TS1"=415A4+4%,24=..B!R:6=H="<@=F%L:6=N
M/3-$8F]T=&]M('=I9'1H/3-$.24^/&9O;G0@<W1Y;&4],T0G1D].5"U325I%
M.B`Q,'!T.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!$25-03$%9
M.B!I;FQI;F4G/B`F;F)S<#L\+V9O;G0^(#PO=&0^(#QT9"!S='EL93TS1"=4
M15A4+4%,24=..B!L969T)R!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)2!N
M;W=R87`],T1N;W=R87`^/&9O;G0@<W1Y;&4],T0G1D].5"U325I%.B`Q,'!T
M.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!$25-03$%9.B!I;FQI
M;F4G/B`F;F)S<#L\+V9O;G0^(#PO=&0^(#QT9"!V86QI9VX],T1B;W1T;VT@
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M;VUA;CL@1$E34$Q!63H@:6YL:6YE)SX@)FYB<W`[/"]F;VYT/B`\+W1D/B`\
M=&0@<W1Y;&4],T0G5$585"U!3$E'3CH@<FEG:'0G('9A;&EG;CTS1&)O='1O
M;2!W:61T:#TS1#DE/CQF;VYT('-T>6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@
M1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1$E34$Q!63H@:6YL:6YE
M)SX@)FYB<W`[/"]F;VYT/B`\+W1D/B`\=&0@<W1Y;&4],T0G5$585"U!3$E'
M3CH@;&5F="<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@;F]W<F%P/3-$
M;F]W<F%P/CQF;VYT('-T>6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@1D].5"U&
M04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1$E34$Q!63H@:6YL:6YE)SX@)FYB
M<W`[/"]F;VYT/B`\+W1D/B`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$
M,24^/&9O;G0@<W1Y;&4],T0G1D].5"U325I%.B`Q,'!T.R!&3TY4+49!34E,
M63H@=&EM97,@;F5W(')O;6%N.R!$25-03$%9.B!I;FQI;F4G/B`F;F)S<#L\
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M=#X@/"]T9#X@/"]T<CX@/'1R(&)G8V]L;W(],T0C8V-E969F/B`\=&0@<W1Y
M;&4],T0G4$%$1$E.1RU"3U143TTZ(#)P>#L@5$585"U!3$E'3CH@;&5F=#L@
M34%21TE.+4Q%1E0Z(#!P=#L@34%21TE.+5))1TA4.B`P<'0[(%1%6%0M24Y$
M14Y4.B`P<'0G('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#0Y)3X@/&1I=B!S
M='EL93TS1"=$25-03$%9.B!B;&]C:SL@1D].5"U&04U)3%DZ('1I;65S(&YE
M=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T.R!-05)'24XM3$5&5#H@,'!T.R!-
M05)'24XM4DE'2%0Z(#!P=#L@5$585"U!3$E'3CH@;&5F=#L@5$585"U)3D1%
M3E0Z(#!P="<^($1E<FEV871I=F5S(&1E<VEG;F%T960@87,@9F%I<B!V86QU
M92!H961G92!I;G-T<G5M96YT<SPO9&EV/B`\+W1D/B`\=&0@<W1Y;&4],T0G
M4$%$1$E.1RU"3U143TTZ(#)P>"<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$
M,34E/B`\9&EV('-T>6QE/3-$)T1)4U!,05DZ(&)L;V-K.R!&3TY4+49!34E,
M63H@=&EM97,@;F5W(')O;6%N.R!&3TY4+5-)6D4Z(#$P<'0[($U!4D=)3BU,
M1494.B`P<'0[($U!4D=)3BU224=(5#H@,2XV<'0[('1E>'0M86QI9VXZ(&-E
M;G1E<CL@5$585"U)3D1%3E0Z(#!P="<^($]T:&5R(&-U<G)E;G0@;&EA8FEL
M:71I97,\+V1I=CX@/"]T9#X@/'1D('-T>6QE/3-$)U!!1$1)3D<M0D]45$]-
M.B`R<'@G('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E(&%L:6=N/3-$<FEG
M:'0^/&9O;G0@<W1Y;&4],T0G1D].5"U325I%.B`Q,'!T.R!&3TY4+49!34E,
M63H@=&EM97,@;F5W(')O;6%N.R!$25-03$%9.B!I;FQI;F4G/B`F;F)S<#L\
M+V9O;G0^(#PO=&0^(#QT9"!S='EL93TS1"="3U)$15(M0D]45$]-.B!B;&%C
M:R`R<'@@<V]L:60[(%1%6%0M04Q)1TXZ(&QE9G0G('9A;&EG;CTS1&)O='1O
M;2!W:61T:#TS1#$E/CQF;VYT('-T>6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@
M1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1$E34$Q!63H@:6YL:6YE
M)SX@)FYB<W`[/"]F;VYT/B`\+W1D/B`\=&0@<W1Y;&4],T0G0D]21$52+4)/
M5%1/33H@8FQA8VL@,G!X('-O;&ED.R!$25-03$%9.B!I;FQI;F4[($9/3E0M
M1D%-24Q9.B!T:6UE<R!N97<@<F]M86X[($9/3E0M4TE:13H@,3!P=#L@5$58
M5"U!3$E'3CH@<FEG:'0G('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#DE/B@X
M.#D\+W1D/B`\=&0@<W1Y;&4],T0G1$E34$Q!63H@:6YL:6YE.R!&3TY4+49!
M34E,63H@=&EM97,@;F5W(')O;6%N.R!&3TY4+5-)6D4Z(#$P<'0[(%!!1$1)
M3D<M0D]45$]-.B`R<'@[(%1%6%0M04Q)1TXZ(&QE9G0G('9A;&EG;CTS1&)O
M='1O;2!W:61T:#TS1#$E(&YO=W)A<#TS1&YO=W)A<#XI/"]T9#X@/'1D('-T
M>6QE/3-$)U!!1$1)3D<M0D]45$]-.B`R<'@G('9A;&EG;CTS1&)O='1O;2!W
M:61T:#TS1#$E/CQF;VYT('-T>6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@1D].
M5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1$E34$Q!63H@:6YL:6YE)SX@
M)FYB<W`[/"]F;VYT/B`\+W1D/B`\=&0@<W1Y;&4],T0G5$585"U!3$E'3CH@
M;&5F="<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24^/&9O;G0@<W1Y;&4]
M,T0G1D].5"U325I%.B`Q,'!T.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O
M;6%N.R!$25-03$%9.B!I;FQI;F4G/B`F;F)S<#L\+V9O;G0^(#PO=&0^(#QT
M9"!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE
M<R!N97<@<F]M86X[($9/3E0M4TE:13H@,3!P=#L@4$%$1$E.1RU"3U143TTZ
M(#)P>#L@5$585"U!3$E'3CH@<FEG:'0G('9A;&EG;CTS1&)O='1O;2!W:61T
M:#TS1#DE/BT\+W1D/B`\=&0@<W1Y;&4],T0G4$%$1$E.1RU"3U143TTZ(#)P
M>#L@5$585"U!3$E'3CH@;&5F="<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$
M,24@;F]W<F%P/3-$;F]W<F%P/CQF;VYT('-T>6QE/3-$)T9/3E0M4TE:13H@
M,3!P=#L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1$E34$Q!63H@
M:6YL:6YE)SX@)FYB<W`[/"]F;VYT/B`\+W1D/B`\=&0@<W1Y;&4],T0G4$%$
M1$E.1RU"3U143TTZ(#)P>"<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24^
M/&9O;G0@<W1Y;&4],T0G1D].5"U325I%.B`Q,'!T.R!&3TY4+49!34E,63H@
M=&EM97,@;F5W(')O;6%N.R!$25-03$%9.B!I;FQI;F4G/B`F;F)S<#L\+V9O
M;G0^(#PO=&0^(#QT9"!S='EL93TS1"="3U)$15(M0D]45$]-.B!B;&%C:R`R
M<'@@<V]L:60[(%1%6%0M04Q)1TXZ(&QE9G0G('9A;&EG;CTS1&)O='1O;2!W
M:61T:#TS1#$E/CQF;VYT('-T>6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@1D].
M5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1$E34$Q!63H@:6YL:6YE)SX@
M)FYB<W`[/"]F;VYT/B`\+W1D/B`\=&0@<W1Y;&4],T0G0D]21$52+4)/5%1/
M33H@8FQA8VL@,G!X('-O;&ED.R!$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-
M24Q9.B!T:6UE<R!N97<@<F]M86X[($9/3E0M4TE:13H@,3!P=#L@5$585"U!
M3$E'3CH@<FEG:'0G('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#DE/BT\+W1D
M/B`\=&0@<W1Y;&4],T0G4$%$1$E.1RU"3U143TTZ(#)P>#L@5$585"U!3$E'
M3CH@;&5F="<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@;F]W<F%P/3-$
M;F]W<F%P/CQF;VYT('-T>6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@1D].5"U&
M04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1$E34$Q!63H@:6YL:6YE)SX@)FYB
M<W`[/"]F;VYT/B`\+W1D/B`\+W1R/B`\='(@8F=C;VQO<CTS1'=H:71E/B`\
M=&0@<W1Y;&4],T0G5$585"U!3$E'3CH@;&5F=#L@34%21TE.+4Q%1E0Z(#!P
M=#L@34%21TE.+5))1TA4.B`P<'0[(%1%6%0M24Y$14Y4.B`P<'0G('9A;&EG
M;CTS1&)O='1O;2!W:61T:#TS1#0Y)3X\9F]N="!S='EL93TS1"=&3TY4+5-)
M6D4Z(#$P<'0[($9/3E0M1D%-24Q9.B!T:6UE<R!N97<@<F]M86X[($1)4U!,
M05DZ(&EN;&EN92<^("9N8G-P.SPO9F]N=#X@/"]T9#X@/'1D('9A;&EG;CTS
M1&)O='1O;2!W:61T:#TS1#$U)3X\9F]N="!S='EL93TS1"=&3TY4+5-)6D4Z
M(#$P<'0[($9/3E0M1D%-24Q9.B!T:6UE<R!N97<@<F]M86X[($1)4U!,05DZ
M(&EN;&EN92<^("9N8G-P.SPO9F]N=#X@/"]T9#X@/'1D('9A;&EG;CTS1&)O
M='1O;2!W:61T:#TS1#$E(&%L:6=N/3-$<FEG:'0^/&9O;G0@<W1Y;&4],T0G
M1D].5"U325I%.B`Q,'!T.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N
M.R!$25-03$%9.B!I;FQI;F4G/B`F;F)S<#L\+V9O;G0^(#PO=&0^(#QT9"!S
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M63H@:6YL:6YE)SX@)FYB<W`[/"]F;VYT/B`\+W1D/B`\=&0@<W1Y;&4],T0G
M5$585"U!3$E'3CH@;&5F="<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24^
M/&9O;G0@<W1Y;&4],T0G1D].5"U325I%.B`Q,'!T.R!&3TY4+49!34E,63H@
M=&EM97,@;F5W(')O;6%N.R!$25-03$%9.B!I;FQI;F4G/B`F;F)S<#L\+V9O
M;G0^(#PO=&0^(#QT9"!S='EL93TS1"=415A4+4%,24=..B!R:6=H="<@=F%L
M:6=N/3-$8F]T=&]M('=I9'1H/3-$.24^/&9O;G0@<W1Y;&4],T0G1D].5"U3
M25I%.B`Q,'!T.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!$25-0
M3$%9.B!I;FQI;F4G/B`F;F)S<#L\+V9O;G0^(#PO=&0^(#QT9"!S='EL93TS
M1"=415A4+4%,24=..B!L969T)R!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q
M)2!N;W=R87`],T1N;W=R87`^/&9O;G0@<W1Y;&4],T0G1D].5"U325I%.B`Q
M,'!T.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!$25-03$%9.B!I
M;FQI;F4G/B`F;F)S<#L\+V9O;G0^(#PO=&0^(#QT9"!V86QI9VX],T1B;W1T
M;VT@=VED=&@],T0Q)2!A;&EG;CTS1&QE9G0^/&9O;G0@<W1Y;&4],T0G1D].
M5"U325I%.B`Q,'!T.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!$
M25-03$%9.B!I;FQI;F4G/B`F;F)S<#L\+V9O;G0^(#PO=&0^(#QT9"!S='EL
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M8V]L;W(],T0C8V-E969F/B`\=&0@<W1Y;&4],T0G4$%$1$E.1RU"3U143TTZ
M(#1P>#L@5$585"U!3$E'3CH@;&5F=#L@34%21TE.+4Q%1E0Z(#!P=#L@34%2
M1TE.+5))1TA4.B`P<'0[(%1%6%0M24Y$14Y4.B`P<'0G('9A;&EG;CTS1&)O
M='1O;2!W:61T:#TS1#0Y)3X@/&1I=B!S='EL93TS1"=$25-03$%9.B!B;&]C
M:SL@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q
M,'!T.R!-05)'24XM3$5&5#H@,'!T.R!-05)'24XM4DE'2%0Z(#!P=#L@5$58
M5"U!3$E'3CH@;&5F=#L@5$585"U)3D1%3E0Z(#!P="<^(%1O=&%L/"]D:78^
M(#PO=&0^(#QT9"!S='EL93TS1"=0041$24Y'+4)/5%1/33H@-'!X)R!V86QI
M9VX],T1B;W1T;VT@=VED=&@],T0Q-24^/&9O;G0@<W1Y;&4],T0G1D].5"U3
M25I%.B`Q,'!T.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!$25-0
M3$%9.B!I;FQI;F4G/B`F;F)S<#L\+V9O;G0^(#PO=&0^(#QT9"!S='EL93TS
M1"=0041$24Y'+4)/5%1/33H@-'!X)R!V86QI9VX],T1B;W1T;VT@=VED=&@]
M,T0Q)2!A;&EG;CTS1')I9VAT/CQF;VYT('-T>6QE/3-$)T9/3E0M4TE:13H@
M,3!P=#L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1$E34$Q!63H@
M:6YL:6YE)SX@)FYB<W`[/"]F;VYT/B`\+W1D/B`\=&0@<W1Y;&4],T0G0D]2
M1$52+4)/5%1/33H@8FQA8VL@-'!X(&1O=6)L93L@1$E34$Q!63H@:6YL:6YE
M.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!&3TY4+5-)6D4Z(#$P
M<'0[(%1%6%0M04Q)1TXZ(&QE9G0G('9A;&EG;CTS1&)O='1O;2!W:61T:#TS
M1#$E/B0\+W1D/B`\=&0@<W1Y;&4],T0G0D]21$52+4)/5%1/33H@8FQA8VL@
M-'!X(&1O=6)L93L@1$E34$Q!63H@:6YL:6YE.R!&3TY4+49!34E,63H@=&EM
M97,@;F5W(')O;6%N.R!&3TY4+5-)6D4Z(#$P<'0[(%1%6%0M04Q)1TXZ(')I
M9VAT)R!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Y)3XH.#0R/"]T9#X@/'1D
M('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S
M(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T.R!0041$24Y'+4)/5%1/33H@
M-'!X.R!415A4+4%,24=..B!L969T)R!V86QI9VX],T1B;W1T;VT@=VED=&@]
M,T0Q)2!N;W=R87`],T1N;W=R87`^*3PO=&0^(#QT9"!S='EL93TS1"=0041$
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M63H@:6YL:6YE)SX@)FYB<W`[/"]F;VYT/B`\+W1D/B`\=&0@<W1Y;&4],T0G
M4$%$1$E.1RU"3U143TTZ(#1P>#L@5$585"U!3$E'3CH@<FEG:'0G('9A;&EG
M;CTS1&)O='1O;2!W:61T:#TS1#DE/CQF;VYT('-T>6QE/3-$)T9/3E0M4TE:
M13H@,3!P=#L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1$E34$Q!
M63H@:6YL:6YE)SX@)FYB<W`[/"]F;VYT/B`\+W1D/B`\=&0@<W1Y;&4],T0G
M4$%$1$E.1RU"3U143TTZ(#1P>#L@5$585"U!3$E'3CH@;&5F="<@=F%L:6=N
M/3-$8F]T=&]M('=I9'1H/3-$,24@;F]W<F%P/3-$;F]W<F%P/CQF;VYT('-T
M>6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ('1I;65S(&YE
M=R!R;VUA;CL@1$E34$Q!63H@:6YL:6YE)SX@)FYB<W`[/"]F;VYT/B`\+W1D
M/B`\=&0@<W1Y;&4],T0G4$%$1$E.1RU"3U143TTZ(#1P>"<@=F%L:6=N/3-$
M8F]T=&]M('=I9'1H/3-$,24@86QI9VX],T1L969T/CQF;VYT('-T>6QE/3-$
M)T9/3E0M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA
M;CL@1$E34$Q!63H@:6YL:6YE)SX@)FYB<W`[/"]F;VYT/B`\+W1D/B`\=&0@
M<W1Y;&4],T0G0D]21$52+4)/5%1/33H@8FQA8VL@-'!X(&1O=6)L93L@1$E3
M4$Q!63H@:6YL:6YE.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!&
M3TY4+5-)6D4Z(#$P<'0[(%1%6%0M04Q)1TXZ(&QE9G0G('9A;&EG;CTS1&)O
M='1O;2!W:61T:#TS1#$E/B0\+W1D/B`\=&0@<W1Y;&4],T0G0D]21$52+4)/
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M87`],T1N;W=R87`^/&9O;G0@<W1Y;&4],T0G1D].5"U325I%.B`Q,'!T.R!&
M3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!$25-03$%9.B!I;FQI;F4G
M/B`F;F)S<#L\+V9O;G0^(#PO=&0^(#PO='(^(#PO=&%B;&4^(#PO9&EV/B`\
M(2TM16YD1G)A9VUE;G0M+3X\+V1I=CX@/"]D:78^/'-P86X^/"]S<&%N/CPO
M=&0^#0H@("`@("`\+W1R/@T*("`@(#PO=&%B;&4^#0H@(#PO8F]D>3X-"CPO
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M8VAA<G-E=#TB=7,M87-C:6DB#0H-"CQH=&UL/@T*("`\:&5A9#X-"B`@("`\
M345402!H='1P+65Q=6EV/3-$0V]N=&5N="U4>7!E(&-O;G1E;G0],T0G=&5X
M="]H=&UL.R!C:&%R<V5T/75T9BTX)SX\<V-R:7!T('1Y<&4],T1T97AT+VIA
M=F%S8W)I<'0@<W)C/3-$4VAO=RYJ<SXO*B!$;R!.;W0@4F5M;W9E(%1H:7,@
M0V]M;65N="`J+SPO<V-R:7!T/CPO:&5A9#X-"B`@/&)O9'D^#0H@("`@/'1A
M8FQE(&-L87-S/3-$<F5P;W)T(&ED/3-$240P14U%/@T*("`@("`@/'1R/@T*
M("`@("`@("`\=&@@8VQA<W,],T1T;"!C;VQS<&%N/3-$,2!R;W=S<&%N/3-$
M,CX\<W1R;VYG/E!23U!%4E19($%.1"!%455)4$U%3E0L($Y%5"`H5&%B;&5S
M*3QB<CX\+W-T<F]N9SX\+W1H/@T*("`@("`@("`\=&@@8VQA<W,],T1T:"!C
M;VQS<&%N/3-$,3XQ,B!-;VYT:',@16YD960\+W1H/@T*("`@("`@/"]T<CX-
M"B`@("`@(#QT<CX-"B`@("`@("`@/'1H(&-L87-S/3-$=&@^2G5N+B`S,"P@
M,C`Q-#QB<CX\+W1H/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS
M1')E/@T*("`@("`@("`\=&0@8VQA<W,],T1P;"!V86QI9VX],T1T;W`^/'-T
M<F]N9SY04D]015)462!!3D0@15%525!-14Y4+"!.150@6T%B<W1R86-T73PO
M<W1R;VYG/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N
M/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS
M1')O/@T*("`@("`@("`\=&0@8VQA<W,],T1P;"!V86QI9VX],T1T;W`^4V-H
M961U;&4@;V8@4')O<&5R='D@86YD($5Q=6EP;65N="P@3F5T/"]T9#X-"B`@
M("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/"$M+41/0U194$4@:'1M;"!054),
M24,@(BTO+U<S0R\O1%1$(%A(5$U,(#$N,"!4<F%N<VET:6]N86PO+T5.(B`B
M:'1T<#HO+W=W=RYW,RYO<F<O5%(O>&AT;6PQ+T141"]X:'1M;#$M=')A;G-I
M=&EO;F%L+F1T9"(@+2T^/&1I=CX@/&1I=CX\(2TM4W1A<G1&<F%G;65N="TM
M/B`\9&EV('-T>6QE/3-$)W1E>'0M86QI9VXZ(')I9VAT)SX@/'1A8FQE('-T
M>6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ('1I;65S(&YE
M=R!R;VUA;B<@8V5L;'-P86-I;F<],T0P(&-E;&QP861D:6YG/3-$,"!W:61T
M:#TS1#DW)3X@/'1R/B`\=&0@<W1Y;&4],T0G4$%$1$E.1RU"3U143TTZ(#)P
M>"<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$-S8E/CQF;VYT('-T>6QE/3-$
M)T9/3E0M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA
M;CL@1$E34$Q!63H@:6YL:6YE)SX@)FYB<W`[/"]F;VYT/B`\+W1D/B`\=&0@
M<W1Y;&4],T0G4$%$1$E.1RU"3U143TTZ(#)P>"<@=F%L:6=N/3-$8F]T=&]M
M('=I9'1H/3-$,24^/&9O;G0@<W1Y;&4],T0G1D].5"U325I%.B`Q,'!T.R!&
M3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!&3TY4+5=%24=(5#H@8F]L
M9#L@1$E34$Q!63H@:6YL:6YE)SX@)FYB<W`[/"]F;VYT/B`\+W1D/B`\=&0@
M<W1Y;&4],T0G0D]21$52+4)/5%1/33H@8FQA8VL@,G!X('-O;&ED)R!V86QI
M9VX],T1B;W1T;VT@=VED=&@],T0R,B4@8V]L<W!A;CTS1#8^(#QD:78@<W1Y
M;&4],T0G1$E34$Q!63H@8FQO8VL[($9/3E0M1D%-24Q9.B!T:6UE<R!N97<@
M<F]M86X[($9/3E0M4TE:13H@,3!P=#L@1D].5"U714E'2%0Z(&)O;&0[($U!
M4D=)3BU,1494.B`P<'0[($U!4D=)3BU224=(5#H@,'!T.R!T97AT+6%L:6=N
M.B!C96YT97([(%1%6%0M24Y$14Y4.B`P<'0G/B!*=6YE(#,P+#PO9&EV/B`\
M+W1D/B`\=&0@<W1Y;&4],T0G4$%$1$E.1RU"3U143TTZ(#)P>#L@5$585"U!
M3$E'3CH@;&5F="<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@;F]W<F%P
M/3-$;F]W<F%P/CQF;VYT('-T>6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@1D].
M5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U714E'2%0Z(&)O;&0[
M($1)4U!,05DZ(&EN;&EN92<^("9N8G-P.SPO9F]N=#X@/"]T9#X@/"]T<CX@
M/'1R/B`\=&0@<W1Y;&4],T0G4$%$1$E.1RU"3U143TTZ(#)P>"<@=F%L:6=N
M/3-$8F]T=&]M('=I9'1H/3-$-S8E(&%L:6=N/3-$;&5F=#X\9F]N="!S='EL
M93TS1"=&3TY4+5-)6D4Z(#$P<'0[($9/3E0M1D%-24Q9.B!T:6UE<R!N97<@
M<F]M86X[($1)4U!,05DZ(&EN;&EN92<^("9N8G-P.SPO9F]N=#X@/"]T9#X@
M/'1D('-T>6QE/3-$)U!!1$1)3D<M0D]45$]-.B`R<'@G('9A;&EG;CTS1&)O
M='1O;2!W:61T:#TS1#$E/CQF;VYT('-T>6QE/3-$)T9/3E0M4TE:13H@,3!P
M=#L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U714E'2%0Z
M(&)O;&0[($1)4U!,05DZ(&EN;&EN92<^("9N8G-P.SPO9F]N=#X@/"]T9#X@
M/'1D('-T>6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#)P>"!S;VQI9"<@
M=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,3`E(&-O;'-P86X],T0R/B`\9&EV
M('-T>6QE/3-$)T1)4U!,05DZ(&)L;V-K.R!&3TY4+49!34E,63H@=&EM97,@
M;F5W(')O;6%N.R!&3TY4+5-)6D4Z(#$P<'0[($9/3E0M5T5)1TA4.B!B;VQD
M.R!-05)'24XM3$5&5#H@,'!T.R!-05)'24XM4DE'2%0Z(#!P=#L@=&5X="UA
M;&EG;CH@8V5N=&5R.R!415A4+4E.1$5.5#H@,'!T)SX@,C`Q-#PO9&EV/B`\
M+W1D/B`\=&0@<W1Y;&4],T0G4$%$1$E.1RU"3U143TTZ(#)P>#L@5$585"U!
M3$E'3CH@;&5F="<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@;F]W<F%P
M/3-$;F]W<F%P/CQF;VYT('-T>6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@1D].
M5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U714E'2%0Z(&)O;&0[
M($1)4U!,05DZ(&EN;&EN92<^("9N8G-P.SPO9F]N=#X@/"]T9#X@/'1D('-T
M>6QE/3-$)U!!1$1)3D<M0D]45$]-.B`R<'@G('9A;&EG;CTS1&)O='1O;2!W
M:61T:#TS1#$E/CQF;VYT('-T>6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@1D].
M5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U714E'2%0Z(&)O;&0[
M($1)4U!,05DZ(&EN;&EN92<^("9N8G-P.SPO9F]N=#X@/"]T9#X@/'1D('-T
M>6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#)P>"!S;VQI9"<@=F%L:6=N
M/3-$8F]T=&]M('=I9'1H/3-$,3`E(&-O;'-P86X],T0R/B`\9&EV('-T>6QE
M/3-$)T1)4U!,05DZ(&)L;V-K.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O
M;6%N.R!&3TY4+5-)6D4Z(#$P<'0[($9/3E0M5T5)1TA4.B!B;VQD.R!-05)'
M24XM3$5&5#H@,'!T.R!-05)'24XM4DE'2%0Z(#!P=#L@=&5X="UA;&EG;CH@
M8V5N=&5R.R!415A4+4E.1$5.5#H@,'!T)SX@,C`Q,SPO9&EV/B`\+W1D/B`\
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M8V]L;W(],T0C8V-E969F/B`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$
M-S8E(&%L:6=N/3-$;&5F=#X@/&1I=B!S='EL93TS1"=$25-03$%9.B!B;&]C
M:SL@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q
M,'!T.R!&3TY4+5=%24=(5#H@8F]L9#L@34%21TE.+4Q%1E0Z(#!P=#L@34%2
M1TE.+5))1TA4.B`P<'0[('1E>'0M86QI9VXZ(&QE9G0[(%1%6%0M24Y$14Y4
M.B`P<'0G/B!#;W-T.CPO9&EV/B`\+W1D/B`\=&0@=F%L:6=N/3-$8F]T=&]M
M('=I9'1H/3-$,24^/&9O;G0@<W1Y;&4],T0G1D].5"U325I%.B`Q,'!T.R!&
M3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!$25-03$%9.B!I;FQI;F4G
M/B`F;F)S<#L\+V9O;G0^(#PO=&0^(#QT9"!V86QI9VX],T1B;W1T;VT@=VED
M=&@],T0Q,"4@8V]L<W!A;CTS1#(^/&9O;G0@<W1Y;&4],T0G1D].5"U325I%
M.B`Q,'!T.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!$25-03$%9
M.B!I;FQI;F4G/B`F;F)S<#L\+V9O;G0^(#PO=&0^(#QT9"!S='EL93TS1"=4
M15A4+4%,24=..B!L969T)R!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)2!N
M;W=R87`],T1N;W=R87`^/&9O;G0@<W1Y;&4],T0G1D].5"U325I%.B`Q,'!T
M.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!$25-03$%9.B!I;FQI
M;F4G/B`F;F)S<#L\+V9O;G0^(#PO=&0^(#QT9"!V86QI9VX],T1B;W1T;VT@
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M+4Q%1E0Z(#!P=#L@34%21TE.+5))1TA4.B`P<'0[('1E>'0M86QI9VXZ(&QE
M9G0[(%1%6%0M24Y$14Y4.B`P<'0G/B!,86)O<F%T;W)Y(&5Q=6EP;65N=#PO
M9&EV/B`\+W1D/B`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@86QI
M9VX],T1R:6=H=#X\9F]N="!S='EL93TS1"=&3TY4+5-)6D4Z(#$P<'0[($9/
M3E0M1D%-24Q9.B!T:6UE<R!N97<@<F]M86X[($1)4U!,05DZ(&EN;&EN92<^
M("9N8G-P.SPO9F]N=#X@/"]T9#X@/'1D('-T>6QE/3-$)T1)4U!,05DZ(&EN
M;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%
M.B`Q,'!T.R!415A4+4%,24=..B!L969T)R!V86QI9VX],T1B;W1T;VT@=VED
M=&@],T0Q)3XD/"]T9#X@/'1D('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@
M1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T
M.R!415A4+4%,24=..B!R:6=H="<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$
M.24^-BPP.#@\+W1D/B`\=&0@<W1Y;&4],T0G5$585"U!3$E'3CH@;&5F="<@
M=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@;F]W<F%P/3-$;F]W<F%P/CQF
M;VYT('-T>6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ('1I
M;65S(&YE=R!R;VUA;CL@1$E34$Q!63H@:6YL:6YE)SX@)FYB<W`[/"]F;VYT
M/B`\+W1D/B`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@86QI9VX]
M,T1R:6=H=#X\9F]N="!S='EL93TS1"=&3TY4+5-)6D4Z(#$P<'0[($9/3E0M
M1D%-24Q9.B!T:6UE<R!N97<@<F]M86X[($1)4U!,05DZ(&EN;&EN92<^("9N
M8G-P.SPO9F]N=#X@/"]T9#X@/'1D('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN
M93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q
M,'!T.R!415A4+4%,24=..B!L969T)R!V86QI9VX],T1B;W1T;VT@=VED=&@]
M,T0Q)3XD/"]T9#X@/'1D('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].
M5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T.R!4
M15A4+4%,24=..B!R:6=H="<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$.24^
M-2PW,#D\+W1D/B`\=&0@<W1Y;&4],T0G5$585"U!3$E'3CH@;&5F="<@=F%L
M:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@;F]W<F%P/3-$;F]W<F%P/CQF;VYT
M('-T>6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ('1I;65S
M(&YE=R!R;VUA;CL@1$E34$Q!63H@:6YL:6YE)SX@)FYB<W`[/"]F;VYT/B`\
M+W1D/B`\+W1R/B`\='(@8F=C;VQO<CTS1"-C8V5E9F8^(#QT9"!V86QI9VX]
M,T1B;W1T;VT@=VED=&@],T0W-B4@86QI9VX],T1L969T/B`\9&EV('-T>6QE
M/3-$)T1)4U!,05DZ(&)L;V-K.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O
M;6%N.R!&3TY4+5-)6D4Z(#$P<'0[($U!4D=)3BU,1494.B`P<'0[($U!4D=)
M3BU224=(5#H@,'!T.R!T97AT+6%L:6=N.B!L969T.R!415A4+4E.1$5.5#H@
M,'!T)SX@0V]M<'5T97)S(&%N9"!P97)I<&AE<F%L(&5Q=6EP;65N=#PO9&EV
M/B`\+W1D/B`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@86QI9VX]
M,T1R:6=H=#X\9F]N="!S='EL93TS1"=&3TY4+5-)6D4Z(#$P<'0[($9/3E0M
M1D%-24Q9.B!T:6UE<R!N97<@<F]M86X[($1)4U!,05DZ(&EN;&EN92<^("9N
M8G-P.SPO9F]N=#X@/"]T9#X@/'1D('-T>6QE/3-$)U1%6%0M04Q)1TXZ(&QE
M9G0G('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E/CQF;VYT('-T>6QE/3-$
M)T9/3E0M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA
M;CL@1$E34$Q!63H@:6YL:6YE)SX@)FYB<W`[/"]F;VYT/B`\+W1D/B`\=&0@
M<W1Y;&4],T0G1$E34$Q!63H@:6YL:6YE.R!&3TY4+49!34E,63H@=&EM97,@
M;F5W(')O;6%N.R!&3TY4+5-)6D4Z(#$P<'0[(%1%6%0M04Q)1TXZ(')I9VAT
M)R!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Y)3XW,#@\+W1D/B`\=&0@<W1Y
M;&4],T0G5$585"U!3$E'3CH@;&5F="<@=F%L:6=N/3-$8F]T=&]M('=I9'1H
M/3-$,24@;F]W<F%P/3-$;F]W<F%P/CQF;VYT('-T>6QE/3-$)T9/3E0M4TE:
M13H@,3!P=#L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1$E34$Q!
M63H@:6YL:6YE)SX@)FYB<W`[/"]F;VYT/B`\+W1D/B`\=&0@=F%L:6=N/3-$
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M)FYB<W`[/"]F;VYT/B`\+W1D/B`\=&0@<W1Y;&4],T0G1$E34$Q!63H@:6YL
M:6YE.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!&3TY4+5-)6D4Z
M(#$P<'0[(%1%6%0M04Q)1TXZ(')I9VAT)R!V86QI9VX],T1B;W1T;VT@=VED
M=&@],T0Y)3XU,S4\+W1D/B`\=&0@<W1Y;&4],T0G5$585"U!3$E'3CH@;&5F
M="<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@;F]W<F%P/3-$;F]W<F%P
M/CQF;VYT('-T>6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ
M('1I;65S(&YE=R!R;VUA;CL@1$E34$Q!63H@:6YL:6YE)SX@)FYB<W`[/"]F
M;VYT/B`\+W1D/B`\+W1R/B`\='(@8F=C;VQO<CTS1'=H:71E/B`\=&0@=F%L
M:6=N/3-$8F]T=&]M('=I9'1H/3-$-S8E(&%L:6=N/3-$;&5F=#X@/&1I=B!S
M='EL93TS1"=$25-03$%9.B!B;&]C:SL@1D].5"U&04U)3%DZ('1I;65S(&YE
M=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T.R!-05)'24XM3$5&5#H@,'!T.R!-
M05)'24XM4DE'2%0Z(#!P=#L@=&5X="UA;&EG;CH@;&5F=#L@5$585"U)3D1%
M3E0Z(#!P="<^($]F9FEC92!F=7)N:71U<F4@86YD(&5Q=6EP;65N=#PO9&EV
M/B`\+W1D/B`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@86QI9VX]
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M;CL@1$E34$Q!63H@:6YL:6YE)SX@)FYB<W`[/"]F;VYT/B`\+W1D/B`\=&0@
M<W1Y;&4],T0G1$E34$Q!63H@:6YL:6YE.R!&3TY4+49!34E,63H@=&EM97,@
M;F5W(')O;6%N.R!&3TY4+5-)6D4Z(#$P<'0[(%1%6%0M04Q)1TXZ(')I9VAT
M)R!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Y)3XV,3$\+W1D/B`\=&0@<W1Y
M;&4],T0G5$585"U!3$E'3CH@;&5F="<@=F%L:6=N/3-$8F]T=&]M('=I9'1H
M/3-$,24@;F]W<F%P/3-$;F]W<F%P/CQF;VYT('-T>6QE/3-$)T9/3E0M4TE:
M13H@,3!P=#L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1$E34$Q!
M63H@:6YL:6YE)SX@)FYB<W`[/"]F;VYT/B`\+W1D/B`\=&0@=F%L:6=N/3-$
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M)FYB<W`[/"]F;VYT/B`\+W1D/B`\=&0@<W1Y;&4],T0G1$E34$Q!63H@:6YL
M:6YE.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!&3TY4+5-)6D4Z
M(#$P<'0[(%1%6%0M04Q)1TXZ(')I9VAT)R!V86QI9VX],T1B;W1T;VT@=VED
M=&@],T0Y)3XU,S0\+W1D/B`\=&0@<W1Y;&4],T0G5$585"U!3$E'3CH@;&5F
M="<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@;F]W<F%P/3-$;F]W<F%P
M/CQF;VYT('-T>6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ
M('1I;65S(&YE=R!R;VUA;CL@1$E34$Q!63H@:6YL:6YE)SX@)FYB<W`[/"]F
M;VYT/B`\+W1D/B`\+W1R/B`\='(@8F=C;VQO<CTS1"-C8V5E9F8^(#QT9"!V
M86QI9VX],T1B;W1T;VT@=VED=&@],T0W-B4@86QI9VX],T1L969T/B`\9&EV
M('-T>6QE/3-$)T1)4U!,05DZ(&)L;V-K.R!&3TY4+49!34E,63H@=&EM97,@
M;F5W(')O;6%N.R!&3TY4+5-)6D4Z(#$P<'0[($U!4D=)3BU,1494.B`P<'0[
M($U!4D=)3BU224=(5#H@,'!T.R!T97AT+6%L:6=N.B!L969T.R!415A4+4E.
M1$5.5#H@,'!T)SX@3&5A<V5H;VQD(&EM<')O=F5M96YT<SPO9&EV/B`\+W1D
M/B`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@86QI9VX],T1R:6=H
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M4$Q!63H@:6YL:6YE)SX@)FYB<W`[/"]F;VYT/B`\+W1D/B`\=&0@<W1Y;&4]
M,T0G1$E34$Q!63H@:6YL:6YE.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O
M;6%N.R!&3TY4+5-)6D4Z(#$P<'0[(%1%6%0M04Q)1TXZ(')I9VAT)R!V86QI
M9VX],T1B;W1T;VT@=VED=&@],T0Y)3XW+#0U,SPO=&0^(#QT9"!S='EL93TS
M1"=415A4+4%,24=..B!L969T)R!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q
M)2!N;W=R87`],T1N;W=R87`^/&9O;G0@<W1Y;&4],T0G1D].5"U325I%.B`Q
M,'!T.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!$25-03$%9.B!I
M;FQI;F4G/B`F;F)S<#L\+V9O;G0^(#PO=&0^(#QT9"!V86QI9VX],T1B;W1T
M;VT@=VED=&@],T0Q)2!A;&EG;CTS1')I9VAT/CQF;VYT('-T>6QE/3-$)T9/
M3E0M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@
M1$E34$Q!63H@:6YL:6YE)SX@)FYB<W`[/"]F;VYT/B`\+W1D/B`\=&0@<W1Y
M;&4],T0G5$585"U!3$E'3CH@;&5F="<@=F%L:6=N/3-$8F]T=&]M('=I9'1H
M/3-$,24^/&9O;G0@<W1Y;&4],T0G1D].5"U325I%.B`Q,'!T.R!&3TY4+49!
M34E,63H@=&EM97,@;F5W(')O;6%N.R!$25-03$%9.B!I;FQI;F4G/B`F;F)S
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M/3-$)U!!1$1)3D<M0D]45$]-.B`R<'@G('9A;&EG;CTS1&)O='1O;2!W:61T
M:#TS1#<V)2!A;&EG;CTS1&QE9G0^(#QD:78@<W1Y;&4],T0G1$E34$Q!63H@
M8FQO8VL[($9/3E0M1D%-24Q9.B!T:6UE<R!N97<@<F]M86X[($9/3E0M4TE:
M13H@,3!P=#L@34%21TE.+4Q%1E0Z(#!P=#L@34%21TE.+5))1TA4.B`P<'0[
M('1E>'0M86QI9VXZ(&QE9G0[(%1%6%0M24Y$14Y4.B`P<'0G/B!696AI8VQE
M<SPO9&EV/B`\+W1D/B`\=&0@<W1Y;&4],T0G4$%$1$E.1RU"3U143TTZ(#)P
M>"<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24^/&9O;G0@<W1Y;&4],T0G
M1D].5"U325I%.B`Q,'!T.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N
M.R!$25-03$%9.B!I;FQI;F4G/B`F;F)S<#L\+V9O;G0^(#PO=&0^(#QT9"!S
M='EL93TS1"="3U)$15(M0D]45$]-.B!B;&%C:R`R<'@@<V]L:60[(%1%6%0M
M04Q)1TXZ(&QE9G0G('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E/CQF;VYT
M('-T>6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ('1I;65S
M(&YE=R!R;VUA;CL@1$E34$Q!63H@:6YL:6YE)SX@)FYB<W`[/"]F;VYT/B`\
M+W1D/B`\=&0@<W1Y;&4],T0G0D]21$52+4)/5%1/33H@8FQA8VL@,G!X('-O
M;&ED.R!$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE<R!N97<@
M<F]M86X[($9/3E0M4TE:13H@,3!P=#L@5$585"U!3$E'3CH@<FEG:'0G('9A
M;&EG;CTS1&)O='1O;2!W:61T:#TS1#DE/CDU/"]T9#X@/'1D('-T>6QE/3-$
M)U!!1$1)3D<M0D]45$]-.B`R<'@[(%1%6%0M04Q)1TXZ(&QE9G0G('9A;&EG
M;CTS1&)O='1O;2!W:61T:#TS1#$E(&YO=W)A<#TS1&YO=W)A<#X\9F]N="!S
M='EL93TS1"=&3TY4+5-)6D4Z(#$P<'0[($9/3E0M1D%-24Q9.B!T:6UE<R!N
M97<@<F]M86X[($1)4U!,05DZ(&EN;&EN92<^("9N8G-P.SPO9F]N=#X@/"]T
M9#X@/'1D('-T>6QE/3-$)U!!1$1)3D<M0D]45$]-.B`R<'@G('9A;&EG;CTS
M1&)O='1O;2!W:61T:#TS1#$E/CQF;VYT('-T>6QE/3-$)T9/3E0M4TE:13H@
M,3!P=#L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1$E34$Q!63H@
M:6YL:6YE)SX@)FYB<W`[/"]F;VYT/B`\+W1D/B`\=&0@<W1Y;&4],T0G0D]2
M1$52+4)/5%1/33H@8FQA8VL@,G!X('-O;&ED.R!415A4+4%,24=..B!L969T
M)R!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)3X\9F]N="!S='EL93TS1"=&
M3TY4+5-)6D4Z(#$P<'0[($9/3E0M1D%-24Q9.B!T:6UE<R!N97<@<F]M86X[
M($1)4U!,05DZ(&EN;&EN92<^("9N8G-P.SPO9F]N=#X@/"]T9#X@/'1D('-T
M>6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#)P>"!S;VQI9#L@1$E34$Q!
M63H@:6YL:6YE.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!&3TY4
M+5-)6D4Z(#$P<'0[(%1%6%0M04Q)1TXZ(')I9VAT)R!V86QI9VX],T1B;W1T
M;VT@=VED=&@],T0Y)3XV.#PO=&0^(#QT9"!S='EL93TS1"=0041$24Y'+4)/
M5%1/33H@,G!X.R!415A4+4%,24=..B!L969T)R!V86QI9VX],T1B;W1T;VT@
M=VED=&@],T0Q)2!N;W=R87`],T1N;W=R87`^/&9O;G0@<W1Y;&4],T0G1D].
M5"U325I%.B`Q,'!T.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!$
M25-03$%9.B!I;FQI;F4G/B`F;F)S<#L\+V9O;G0^(#PO=&0^(#PO='(^(#QT
M<B!B9V-O;&]R/3-$(V-C965F9CX@/'1D('-T>6QE/3-$)U!!1$1)3D<M0D]4
M5$]-.B`R<'@G('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#<V)2!A;&EG;CTS
M1&QE9G0^(#QD:78@<W1Y;&4],T0G1$E34$Q!63H@8FQO8VL[($9/3E0M1D%-
M24Q9.B!T:6UE<R!N97<@<F]M86X[($9/3E0M4TE:13H@,3!P=#L@1D].5"U7
M14E'2%0Z(&)O;&0[($U!4D=)3BU,1494.B`P<'0[($U!4D=)3BU224=(5#H@
M,'!T.R!T97AT+6%L:6=N.B!L969T.R!415A4+4E.1$5.5#H@,'!T)SX@)FYB
M<W`[5&]T86P@0V]S=#PO9&EV/B`\+W1D/B`\=&0@<W1Y;&4],T0G4$%$1$E.
M1RU"3U143TTZ(#)P>"<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24^/&9O
M;G0@<W1Y;&4],T0G1D].5"U325I%.B`Q,'!T.R!&3TY4+49!34E,63H@=&EM
M97,@;F5W(')O;6%N.R!$25-03$%9.B!I;FQI;F4G/B`F;F)S<#L\+V9O;G0^
M(#PO=&0^(#QT9"!S='EL93TS1"="3U)$15(M0D]45$]-.B!B;&%C:R`R<'@@
M<V]L:60[(%1%6%0M04Q)1TXZ(&QE9G0G('9A;&EG;CTS1&)O='1O;2!W:61T
M:#TS1#$E/CQF;VYT('-T>6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@1D].5"U&
M04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1$E34$Q!63H@:6YL:6YE)SX@)FYB
M<W`[/"]F;VYT/B`\+W1D/B`\=&0@<W1Y;&4],T0G0D]21$52+4)/5%1/33H@
M8FQA8VL@,G!X('-O;&ED.R!$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9
M.B!T:6UE<R!N97<@<F]M86X[($9/3E0M4TE:13H@,3!P=#L@5$585"U!3$E'
M3CH@<FEG:'0G('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#DE/C$T+#DU-3PO
M=&0^(#QT9"!S='EL93TS1"=0041$24Y'+4)/5%1/33H@,G!X.R!415A4+4%,
M24=..B!L969T)R!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)2!N;W=R87`]
M,T1N;W=R87`^/&9O;G0@<W1Y;&4],T0G1D].5"U325I%.B`Q,'!T.R!&3TY4
M+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!$25-03$%9.B!I;FQI;F4G/B`F
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M/&9O;G0@<W1Y;&4],T0G1D].5"U325I%.B`Q,'!T.R!&3TY4+49!34E,63H@
M=&EM97,@;F5W(')O;6%N.R!$25-03$%9.B!I;FQI;F4G/B`F;F)S<#L\+V9O
M;G0^(#PO=&0^(#QT9"!S='EL93TS1"="3U)$15(M0D]45$]-.B!B;&%C:R`R
M<'@@<V]L:60[($1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S
M(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T.R!415A4+4%,24=..B!R:6=H
M="<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$.24^,30L,C$U/"]T9#X@/'1D
M('-T>6QE/3-$)U!!1$1)3D<M0D]45$]-.B`R<'@[(%1%6%0M04Q)1TXZ(&QE
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M($U!4D=)3BU,1494.B`P<'0[($U!4D=)3BU224=(5#H@,'!T.R!T97AT+6%L
M:6=N.B!L969T.R!415A4+4E.1$5.5#H@,'!T)SX@06-C=6UU;&%T960@9&5P
M<F5C:6%T:6]N.CPO9&EV/B`\+W1D/B`\=&0@=F%L:6=N/3-$8F]T=&]M('=I
M9'1H/3-$,24^/&9O;G0@<W1Y;&4],T0G1D].5"U325I%.B`Q,'!T.R!&3TY4
M+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!$25-03$%9.B!I;FQI;F4G/B`F
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M('1I;65S(&YE=R!R;VUA;CL@1$E34$Q!63H@:6YL:6YE)SX@)FYB<W`[/"]F
M;VYT/B`\+W1D/B`\=&0@<W1Y;&4],T0G5$585"U!3$E'3CH@;&5F="<@=F%L
M:6=N/3-$8F]T=&]M('=I9'1H/3-$,24^/&9O;G0@<W1Y;&4],T0G1D].5"U3
M25I%.B`Q,'!T.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!$25-0
M3$%9.B!I;FQI;F4G/B`F;F)S<#L\+V9O;G0^(#PO=&0^(#QT9"!S='EL93TS
M1"=415A4+4%,24=..B!R:6=H="<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$
M.24^/&9O;G0@<W1Y;&4],T0G1D].5"U325I%.B`Q,'!T.R!&3TY4+49!34E,
M63H@=&EM97,@;F5W(')O;6%N.R!$25-03$%9.B!I;FQI;F4G/B`F;F)S<#L\
M+V9O;G0^(#PO=&0^(#QT9"!S='EL93TS1"=415A4+4%,24=..B!L969T)R!V
M86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)2!N;W=R87`],T1N;W=R87`^/&9O
M;G0@<W1Y;&4],T0G1D].5"U325I%.B`Q,'!T.R!&3TY4+49!34E,63H@=&EM
M97,@;F5W(')O;6%N.R!$25-03$%9.B!I;FQI;F4G/B`F;F)S<#L\+V9O;G0^
M(#PO=&0^(#PO='(^(#QT<B!B9V-O;&]R/3-$(V-C965F9CX@/'1D('9A;&EG
M;CTS1&)O='1O;2!W:61T:#TS1#<V)2!A;&EG;CTS1&QE9G0^(#QD:78@<W1Y
M;&4],T0G1$E34$Q!63H@8FQO8VL[($9/3E0M1D%-24Q9.B!T:6UE<R!N97<@
M<F]M86X[($9/3E0M4TE:13H@,3!P=#L@34%21TE.+4Q%1E0Z(#!P=#L@34%2
M1TE.+5))1TA4.B`P<'0[('1E>'0M86QI9VXZ(&QE9G0[(%1%6%0M24Y$14Y4
M.B`P<'0G/B!,86)O<F%T;W)Y(&5Q=6EP;65N=#PO9&EV/B`\+W1D/B`\=&0@
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M:6YL:6YE)SX@)FYB<W`[/"]F;VYT/B`\+W1D/B`\=&0@<W1Y;&4],T0G1$E3
M4$Q!63H@:6YL:6YE.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!&
M3TY4+5-)6D4Z(#$P<'0[(%1%6%0M04Q)1TXZ(')I9VAT)R!V86QI9VX],T1B
M;W1T;VT@=VED=&@],T0Y)3XR+#`T,CPO=&0^(#QT9"!S='EL93TS1"=415A4
M+4%,24=..B!L969T)R!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)2!N;W=R
M87`],T1N;W=R87`^/&9O;G0@<W1Y;&4],T0G1D].5"U325I%.B`Q,'!T.R!&
M3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!$25-03$%9.B!I;FQI;F4G
M/B`F;F)S<#L\+V9O;G0^(#PO=&0^(#QT9"!V86QI9VX],T1B;W1T;VT@=VED
M=&@],T0Q)2!A;&EG;CTS1')I9VAT/CQF;VYT('-T>6QE/3-$)T9/3E0M4TE:
M13H@,3!P=#L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1$E34$Q!
M63H@:6YL:6YE)SX@)FYB<W`[/"]F;VYT/B`\+W1D/B`\=&0@<W1Y;&4],T0G
M5$585"U!3$E'3CH@;&5F="<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24^
M/&9O;G0@<W1Y;&4],T0G1D].5"U325I%.B`Q,'!T.R!&3TY4+49!34E,63H@
M=&EM97,@;F5W(')O;6%N.R!$25-03$%9.B!I;FQI;F4G/B`F;F)S<#L\+V9O
M;G0^(#PO=&0^(#QT9"!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M
M1D%-24Q9.B!T:6UE<R!N97<@<F]M86X[($9/3E0M4TE:13H@,3!P=#L@5$58
M5"U!3$E'3CH@<FEG:'0G('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#DE/C$L
M,S`V/"]T9#X@/'1D('-T>6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G('9A;&EG
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M1TA4.B`P<'0[('1E>'0M86QI9VXZ(&QE9G0[(%1%6%0M24Y$14Y4.B`P<'0G
M/B!#;VUP=71E<G,@86YD('!E<FEP:&5R86P@97%U:7!M96YT/"]D:78^(#PO
M=&0^(#QT9"!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)2!A;&EG;CTS1')I
M9VAT/CQF;VYT('-T>6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@1D].5"U&04U)
M3%DZ('1I;65S(&YE=R!R;VUA;CL@1$E34$Q!63H@:6YL:6YE)SX@)FYB<W`[
M/"]F;VYT/B`\+W1D/B`\=&0@<W1Y;&4],T0G5$585"U!3$E'3CH@;&5F="<@
M=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24^/&9O;G0@<W1Y;&4],T0G1D].
M5"U325I%.B`Q,'!T.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!$
M25-03$%9.B!I;FQI;F4G/B`F;F)S<#L\+V9O;G0^(#PO=&0^(#QT9"!S='EL
M93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE<R!N97<@
M<F]M86X[($9/3E0M4TE:13H@,3!P=#L@5$585"U!3$E'3CH@<FEG:'0G('9A
M;&EG;CTS1&)O='1O;2!W:61T:#TS1#DE/C0S,#PO=&0^(#QT9"!S='EL93TS
M1"=415A4+4%,24=..B!L969T)R!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q
M)2!N;W=R87`],T1N;W=R87`^/&9O;G0@<W1Y;&4],T0G1D].5"U325I%.B`Q
M,'!T.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!$25-03$%9.B!I
M;FQI;F4G/B`F;F)S<#L\+V9O;G0^(#PO=&0^(#QT9"!V86QI9VX],T1B;W1T
M;VT@=VED=&@],T0Q)2!A;&EG;CTS1')I9VAT/CQF;VYT('-T>6QE/3-$)T9/
M3E0M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@
M1$E34$Q!63H@:6YL:6YE)SX@)FYB<W`[/"]F;VYT/B`\+W1D/B`\=&0@<W1Y
M;&4],T0G5$585"U!3$E'3CH@;&5F="<@=F%L:6=N/3-$8F]T=&]M('=I9'1H
M/3-$,24^/&9O;G0@<W1Y;&4],T0G1D].5"U325I%.B`Q,'!T.R!&3TY4+49!
M34E,63H@=&EM97,@;F5W(')O;6%N.R!$25-03$%9.B!I;FQI;F4G/B`F;F)S
M<#L\+V9O;G0^(#PO=&0^(#QT9"!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[
M($9/3E0M1D%-24Q9.B!T:6UE<R!N97<@<F]M86X[($9/3E0M4TE:13H@,3!P
M=#L@5$585"U!3$E'3CH@<FEG:'0G('9A;&EG;CTS1&)O='1O;2!W:61T:#TS
M1#DE/C(X,#PO=&0^(#QT9"!S='EL93TS1"=415A4+4%,24=..B!L969T)R!V
M86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)2!N;W=R87`],T1N;W=R87`^/&9O
M;G0@<W1Y;&4],T0G1D].5"U325I%.B`Q,'!T.R!&3TY4+49!34E,63H@=&EM
M97,@;F5W(')O;6%N.R!$25-03$%9.B!I;FQI;F4G/B`F;F)S<#L\+V9O;G0^
M(#PO=&0^(#PO='(^(#QT<B!B9V-O;&]R/3-$(V-C965F9CX@/'1D('9A;&EG
M;CTS1&)O='1O;2!W:61T:#TS1#<V)2!A;&EG;CTS1&QE9G0^(#QD:78@<W1Y
M;&4],T0G1$E34$Q!63H@8FQO8VL[($9/3E0M1D%-24Q9.B!T:6UE<R!N97<@
M<F]M86X[($9/3E0M4TE:13H@,3!P=#L@34%21TE.+4Q%1E0Z(#!P=#L@34%2
M1TE.+5))1TA4.B`P<'0[('1E>'0M86QI9VXZ(&QE9G0[(%1%6%0M24Y$14Y4
M.B`P<'0G/B!/9F9I8V4@9G5R;FET=7)E(&%N9"!E<75I<&UE;G0\+V1I=CX@
M/"]T9#X@/'1D('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E(&%L:6=N/3-$
M<FEG:'0^/&9O;G0@<W1Y;&4],T0G1D].5"U325I%.B`Q,'!T.R!&3TY4+49!
M34E,63H@=&EM97,@;F5W(')O;6%N.R!$25-03$%9.B!I;FQI;F4G/B`F;F)S
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M=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T.R!415A4+4%,24=..B!R:6=H="<@
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M1D].5"U325I%.B`Q,'!T.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N
M.R!$25-03$%9.B!I;FQI;F4G/B`F;F)S<#L\+V9O;G0^(#PO=&0^(#QT9"!S
M='EL93TS1"=415A4+4%,24=..B!L969T)R!V86QI9VX],T1B;W1T;VT@=VED
M=&@],T0Q)3X\9F]N="!S='EL93TS1"=&3TY4+5-)6D4Z(#$P<'0[($9/3E0M
M1D%-24Q9.B!T:6UE<R!N97<@<F]M86X[($1)4U!,05DZ(&EN;&EN92<^("9N
M8G-P.SPO9F]N=#X@/"]T9#X@/'1D('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN
M93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q
M,'!T.R!415A4+4%,24=..B!R:6=H="<@=F%L:6=N/3-$8F]T=&]M('=I9'1H
M/3-$.24^.3$\+W1D/B`\=&0@<W1Y;&4],T0G5$585"U!3$E'3CH@;&5F="<@
M=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@;F]W<F%P/3-$;F]W<F%P/CQF
M;VYT('-T>6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ('1I
M;65S(&YE=R!R;VUA;CL@1$E34$Q!63H@:6YL:6YE)SX@)FYB<W`[/"]F;VYT
M/B`\+W1D/B`\+W1R/B`\='(@8F=C;VQO<CTS1'=H:71E/B`\=&0@=F%L:6=N
M/3-$8F]T=&]M('=I9'1H/3-$-S8E(&%L:6=N/3-$;&5F=#X@/&1I=B!S='EL
M93TS1"=$25-03$%9.B!B;&]C:SL@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R
M;VUA;CL@1D].5"U325I%.B`Q,'!T.R!-05)'24XM3$5&5#H@,'!T.R!-05)'
M24XM4DE'2%0Z(#!P=#L@=&5X="UA;&EG;CH@;&5F=#L@5$585"U)3D1%3E0Z
M(#!P="<^($QE87-E:&]L9"!I;7!R;W9E;65N=',\+V1I=CX@/"]T9#X@/'1D
M('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E(&%L:6=N/3-$<FEG:'0^/&9O
M;G0@<W1Y;&4],T0G1D].5"U325I%.B`Q,'!T.R!&3TY4+49!34E,63H@=&EM
M97,@;F5W(')O;6%N.R!$25-03$%9.B!I;FQI;F4G/B`F;F)S<#L\+V9O;G0^
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M1D].5"U325I%.B`Q,'!T.R!415A4+4%,24=..B!R:6=H="<@=F%L:6=N/3-$
M8F]T=&]M('=I9'1H/3-$.24^,2PT-S4\+W1D/B`\=&0@<W1Y;&4],T0G5$58
M5"U!3$E'3CH@;&5F="<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@;F]W
M<F%P/3-$;F]W<F%P/CQF;VYT('-T>6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@
M1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1$E34$Q!63H@:6YL:6YE
M)SX@)FYB<W`[/"]F;VYT/B`\+W1D/B`\=&0@=F%L:6=N/3-$8F]T=&]M('=I
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M('1I;65S(&YE=R!R;VUA;CL@1$E34$Q!63H@:6YL:6YE)SX@)FYB<W`[/"]F
M;VYT/B`\+W1D/B`\=&0@<W1Y;&4],T0G1$E34$Q!63H@:6YL:6YE.R!&3TY4
M+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!&3TY4+5-)6D4Z(#$P<'0[(%1%
M6%0M04Q)1TXZ(')I9VAT)R!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Y)3XV
M-#(\+W1D/B`\=&0@<W1Y;&4],T0G5$585"U!3$E'3CH@;&5F="<@=F%L:6=N
M/3-$8F]T=&]M('=I9'1H/3-$,24@;F]W<F%P/3-$;F]W<F%P/CQF;VYT('-T
M>6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ('1I;65S(&YE
M=R!R;VUA;CL@1$E34$Q!63H@:6YL:6YE)SX@)FYB<W`[/"]F;VYT/B`\+W1D
M/B`\+W1R/B`\='(@8F=C;VQO<CTS1"-C8V5E9F8^(#QT9"!S='EL93TS1"=0
M041$24Y'+4)/5%1/33H@,G!X)R!V86QI9VX],T1B;W1T;VT@=VED=&@],T0W
M-B4@86QI9VX],T1L969T/B`\9&EV('-T>6QE/3-$)T1)4U!,05DZ(&)L;V-K
M.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!&3TY4+5-)6D4Z(#$P
M<'0[($U!4D=)3BU,1494.B`P<'0[($U!4D=)3BU224=(5#H@,'!T.R!T97AT
M+6%L:6=N.B!L969T.R!415A4+4E.1$5.5#H@,'!T)SX@5F5H:6-L97,\+V1I
M=CX@/"]T9#X@/'1D('-T>6QE/3-$)U!!1$1)3D<M0D]45$]-.B`R<'@G('9A
M;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E/CQF;VYT('-T>6QE/3-$)T9/3E0M
M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1$E3
M4$Q!63H@:6YL:6YE)SX@)FYB<W`[/"]F;VYT/B`\+W1D/B`\=&0@<W1Y;&4]
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M3D<M0D]45$]-.B`R<'@[(%1%6%0M04Q)1TXZ(&QE9G0G('9A;&EG;CTS1&)O
M='1O;2!W:61T:#TS1#$E(&YO=W)A<#TS1&YO=W)A<#X\9F]N="!S='EL93TS
M1"=&3TY4+5-)6D4Z(#$P<'0[($9/3E0M1D%-24Q9.B!T:6UE<R!N97<@<F]M
M86X[($1)4U!,05DZ(&EN;&EN92<^("9N8G-P.SPO9F]N=#X@/"]T9#X@/'1D
M('-T>6QE/3-$)U!!1$1)3D<M0D]45$]-.B`R<'@G('9A;&EG;CTS1&)O='1O
M;2!W:61T:#TS1#$E/CQF;VYT('-T>6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@
M1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1$E34$Q!63H@:6YL:6YE
M)SX@)FYB<W`[/"]F;VYT/B`\+W1D/B`\=&0@<W1Y;&4],T0G0D]21$52+4)/
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M,T0Q)2!N;W=R87`],T1N;W=R87`^/&9O;G0@<W1Y;&4],T0G1D].5"U325I%
M.B`Q,'!T.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!$25-03$%9
M.B!I;FQI;F4G/B`F;F)S<#L\+V9O;G0^(#PO=&0^(#PO='(^(#QT<B!B9V-O
M;&]R/3-$=VAI=&4^(#QT9"!S='EL93TS1"=0041$24Y'+4)/5%1/33H@,G!X
M)R!V86QI9VX],T1B;W1T;VT@=VED=&@],T0W-B4@86QI9VX],T1L969T/B`\
M9&EV('-T>6QE/3-$)T1)4U!,05DZ(&)L;V-K.R!&3TY4+49!34E,63H@=&EM
M97,@;F5W(')O;6%N.R!&3TY4+5-)6D4Z(#$P<'0[($9/3E0M5T5)1TA4.B!B
M;VQD.R!-05)'24XM3$5&5#H@,'!T.R!-05)'24XM4DE'2%0Z(#!P=#L@=&5X
M="UA;&EG;CH@;&5F=#L@5$585"U)3D1%3E0Z(#!P="<^("9N8G-P.U1O=&%L
M(&%C8W5M=6QA=&5D(&1E<')E8VEA=&EO;CPO9&EV/B`\+W1D/B`\=&0@<W1Y
M;&4],T0G4$%$1$E.1RU"3U143TTZ(#)P>"<@=F%L:6=N/3-$8F]T=&]M('=I
M9'1H/3-$,24^/&9O;G0@<W1Y;&4],T0G1D].5"U325I%.B`Q,'!T.R!&3TY4
M+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!$25-03$%9.B!I;FQI;F4G/B`F
M;F)S<#L\+V9O;G0^(#PO=&0^(#QT9"!S='EL93TS1"="3U)$15(M0D]45$]-
M.B!B;&%C:R`R<'@@<V]L:60[(%1%6%0M04Q)1TXZ(&QE9G0G('9A;&EG;CTS
M1&)O='1O;2!W:61T:#TS1#$E/CQF;VYT('-T>6QE/3-$)T9/3E0M4TE:13H@
M,3!P=#L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1$E34$Q!63H@
M:6YL:6YE)SX@)FYB<W`[/"]F;VYT/B`\+W1D/B`\=&0@<W1Y;&4],T0G0D]2
M1$52+4)/5%1/33H@8FQA8VL@,G!X('-O;&ED.R!$25-03$%9.B!I;FQI;F4[
M($9/3E0M1D%-24Q9.B!T:6UE<R!N97<@<F]M86X[($9/3E0M4TE:13H@,3!P
M=#L@5$585"U!3$E'3CH@<FEG:'0G('9A;&EG;CTS1&)O='1O;2!W:61T:#TS
M1#DE/C0L,3,R/"]T9#X@/'1D('-T>6QE/3-$)U!!1$1)3D<M0D]45$]-.B`R
M<'@[(%1%6%0M04Q)1TXZ(&QE9G0G('9A;&EG;CTS1&)O='1O;2!W:61T:#TS
M1#$E(&YO=W)A<#TS1&YO=W)A<#X\9F]N="!S='EL93TS1"=&3TY4+5-)6D4Z
M(#$P<'0[($9/3E0M1D%-24Q9.B!T:6UE<R!N97<@<F]M86X[($1)4U!,05DZ
M(&EN;&EN92<^("9N8G-P.SPO9F]N=#X@/"]T9#X@/'1D('-T>6QE/3-$)U!!
M1$1)3D<M0D]45$]-.B`R<'@G('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E
M/CQF;VYT('-T>6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ
M('1I;65S(&YE=R!R;VUA;CL@1$E34$Q!63H@:6YL:6YE)SX@)FYB<W`[/"]F
M;VYT/B`\+W1D/B`\=&0@<W1Y;&4],T0G0D]21$52+4)/5%1/33H@8FQA8VL@
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M87`],T1N;W=R87`^/&9O;G0@<W1Y;&4],T0G1D].5"U325I%.B`Q,'!T.R!&
M3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!$25-03$%9.B!I;FQI;F4G
M/B`F;F)S<#L\+V9O;G0^(#PO=&0^(#PO='(^(#QT<B!B9V-O;&]R/3-$(V-C
M965F9CX@/'1D('-T>6QE/3-$)U!!1$1)3D<M0D]45$]-.B`T<'@G('9A;&EG
M;CTS1&)O='1O;2!W:61T:#TS1#<V)2!A;&EG;CTS1&QE9G0^(#QD:78@<W1Y
M;&4],T0G1$E34$Q!63H@8FQO8VL[($9/3E0M1D%-24Q9.B!T:6UE<R!N97<@
M<F]M86X[($9/3E0M4TE:13H@,3!P=#L@1D].5"U714E'2%0Z(&)O;&0[($U!
M4D=)3BU,1494.B`P<'0[($U!4D=)3BU224=(5#H@,'!T.R!T97AT+6%L:6=N
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M;VUA;CL@1D].5"U325I%.B`Q,'!T.R!415A4+4%,24=..B!L969T)R!V86QI
M9VX],T1B;W1T;VT@=VED=&@],T0Q)3XD/"]T9#X@/'1D('-T>6QE/3-$)T)/
M4D1%4BU"3U143TTZ(&)L86-K(#1P>"!D;W5B;&4[($1)4U!,05DZ(&EN;&EN
M93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q
M,'!T.R!415A4+4%,24=..B!R:6=H="<@=F%L:6=N/3-$8F]T=&]M('=I9'1H
M/3-$.24^,3`L.#(S/"]T9#X@/'1D('-T>6QE/3-$)U!!1$1)3D<M0D]45$]-
M.B`T<'@[(%1%6%0M04Q)1TXZ(&QE9G0G('9A;&EG;CTS1&)O='1O;2!W:61T
M:#TS1#$E(&YO=W)A<#TS1&YO=W)A<#X\9F]N="!S='EL93TS1"=&3TY4+5-)
M6D4Z(#$P<'0[($9/3E0M1D%-24Q9.B!T:6UE<R!N97<@<F]M86X[($1)4U!,
M05DZ(&EN;&EN92<^("9N8G-P.SPO9F]N=#X@/"]T9#X@/'1D('-T>6QE/3-$
M)U!!1$1)3D<M0D]45$]-.B`T<'@G('9A;&EG;CTS1&)O='1O;2!W:61T:#TS
M1#$E/CQF;VYT('-T>6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@1D].5"U&04U)
M3%DZ('1I;65S(&YE=R!R;VUA;CL@1$E34$Q!63H@:6YL:6YE)SX@)FYB<W`[
M/"]F;VYT/B`\+W1D/B`\=&0@<W1Y;&4],T0G0D]21$52+4)/5%1/33H@8FQA
M8VL@-'!X(&1O=6)L93L@1$E34$Q!63H@:6YL:6YE.R!&3TY4+49!34E,63H@
M=&EM97,@;F5W(')O;6%N.R!&3TY4+5-)6D4Z(#$P<'0[(%1%6%0M04Q)1TXZ
M(&QE9G0G('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E/B0\+W1D/B`\=&0@
M<W1Y;&4],T0G0D]21$52+4)/5%1/33H@8FQA8VL@-'!X(&1O=6)L93L@1$E3
M4$Q!63H@:6YL:6YE.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!&
M3TY4+5-)6D4Z(#$P<'0[(%1%6%0M04Q)1TXZ(')I9VAT)R!V86QI9VX],T1B
M;W1T;VT@=VED=&@],T0Y)3XQ,2PX-C8\+W1D/B`\=&0@<W1Y;&4],T0G4$%$
M1$E.1RU"3U143TTZ(#1P>#L@5$585"U!3$E'3CH@;&5F="<@=F%L:6=N/3-$
M8F]T=&]M('=I9'1H/3-$,24@;F]W<F%P/3-$;F]W<F%P/CQF;VYT('-T>6QE
M/3-$)T9/3E0M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R
M;VUA;CL@1$E34$Q!63H@:6YL:6YE)SX@)FYB<W`[/"]F;VYT/B`\+W1D/B`\
M+W1R/B`\+W1A8FQE/B`\+V1I=CX@/"$M+45N9$9R86=M96YT+2T^/"]D:78^
M(#PO9&EV/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@("`\
M+W1A8FQE/@T*("`\+V)O9'D^#0H\+VAT;6P^#0H-"BTM+2TM+3U?3F5X=%!A
M<G1?,&-A9#4Y9F1?-S,R95\T-F4R7V$U,S1?,&,X860Q868Y,&1D#0I#;VYT
M96YT+4QO8V%T:6]N.B!F:6QE.B\O+T,Z+S!C860U.69D7S<S,F5?-#9E,E]A
M-3,T7S!C.&%D,6%F.3!D9"]7;W)K<VAE971S+U-H965T,C0N:'1M;`T*0V]N
M=&5N="U4<F%N<V9E<BU%;F-O9&EN9SH@<75O=&5D+7!R:6YT86)L90T*0V]N
M=&5N="U4>7!E.B!T97AT+VAT;6P[(&-H87)S970](G5S+6%S8VEI(@T*#0H\
M:'1M;#X-"B`@/&AE860^#0H@("`@/$U%5$$@:'1T<"UE<75I=CTS1$-O;G1E
M;G0M5'EP92!C;VYT96YT/3-$)W1E>'0O:'1M;#L@8VAA<G-E=#UU=&8M."<^
M/'-C<FEP="!T>7!E/3-$=&5X="]J879A<V-R:7!T('-R8STS1%-H;W<N:G,^
M+RH@1&\@3F]T(%)E;6]V92!4:&ES($-O;6UE;G0@*B\\+W-C<FEP=#X\+VAE
M860^#0H@(#QB;V1Y/@T*("`@(#QT86)L92!C;&%S<STS1')E<&]R="!I9#TS
M1$E$,$5-13X-"B`@("`@(#QT<CX-"B`@("`@("`@/'1H(&-L87-S/3-$=&P@
M8V]L<W!A;CTS1#$@<F]W<W!A;CTS1#(^/'-T<F]N9SY/5$A%4B!!0T-/54Y4
M4R!005E!0DQ%("A486)L97,I/&)R/CPO<W1R;VYG/CPO=&@^#0H@("`@("`@
M(#QT:"!C;&%S<STS1'1H(&-O;'-P86X],T0Q/C$R($UO;G1H<R!%;F1E9#PO
M=&@^#0H@("`@("`\+W1R/@T*("`@("`@/'1R/@T*("`@("`@("`\=&@@8VQA
M<W,],T1T:#Y*=6XN(#,P+"`R,#$T/&)R/CPO=&@^#0H@("`@("`\+W1R/@T*
M("`@("`@/'1R(&-L87-S/3-$<F4^#0H@("`@("`@(#QT9"!C;&%S<STS1'!L
M('9A;&EG;CTS1'1O<#X\<W1R;VYG/D]42$52($%#0T]53E13(%!!64%"3$4@
M6T%B<W1R86-T73PO<W1R;VYG/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS
M1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@("`@
M(#QT<B!C;&%S<STS1')O/@T*("`@("`@("`\=&0@8VQA<W,],T1P;"!V86QI
M9VX],T1T;W`^4V-H961U;&4@;V8@3W1H97(@06-C;W5N=',@4&%Y86)L93PO
M=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SPA+2U$3T-465!%(&AT
M;6P@4%5"3$E#("(M+R]7,T,O+T141"!82%1-3"`Q+C`@5')A;G-I=&EO;F%L
M+R]%3B(@(FAT='`Z+R]W=W<N=S,N;W)G+U12+WAH=&UL,2]$5$0O>&AT;6PQ
M+71R86YS:71I;VYA;"YD=&0B("TM/CQD:78^(#QD:78^/"$M+5-T87)T1G)A
M9VUE;G0M+3X@/&1I=B!S='EL93TS1"=T97AT+6%L:6=N.B!R:6=H="<^(#QT
M86)L92!S='EL93TS1"=&3TY4+5-)6D4Z(#$P<'0[($9/3E0M1D%-24Q9.B!T
M:6UE<R!N97<@<F]M86XG(&-E;&QS<&%C:6YG/3-$,"!C96QL<&%D9&EN9STS
M1#`@=VED=&@],T0Y-R4^(#QT<CX@/'1D('-T>6QE/3-$)U!!1$1)3D<M0D]4
M5$]-.B`R<'@G('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#<V)3X\9F]N="!S
M='EL93TS1"=&3TY4+5-)6D4Z(#$P<'0[($9/3E0M1D%-24Q9.B!T:6UE<R!N
M97<@<F]M86X[($1)4U!,05DZ(&EN;&EN92<^("9N8G-P.SPO9F]N=#X@/"]T
M9#X@/'1D('-T>6QE/3-$)U!!1$1)3D<M0D]45$]-.B`R<'@G('9A;&EG;CTS
M1&)O='1O;2!W:61T:#TS1#$E/CQF;VYT('-T>6QE/3-$)T9/3E0M4TE:13H@
M,3!P=#L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U714E'
M2%0Z(&)O;&0[($1)4U!,05DZ(&EN;&EN92<^("9N8G-P.SPO9F]N=#X@/"]T
M9#X@/'1D('-T>6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#)P>"!S;VQI
M9"<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,C(E(&-O;'-P86X],T0V/B`\
M9&EV('-T>6QE/3-$)T1)4U!,05DZ(&)L;V-K.R!&3TY4+49!34E,63H@=&EM
M97,@;F5W(')O;6%N.R!&3TY4+5-)6D4Z(#$P<'0[($9/3E0M5T5)1TA4.B!B
M;VQD.R!-05)'24XM3$5&5#H@,'!T.R!-05)'24XM4DE'2%0Z(#!P=#L@=&5X
M="UA;&EG;CH@8V5N=&5R.R!415A4+4E.1$5.5#H@,'!T)SX@2G5N92`S,"P\
M+V1I=CX@/"]T9#X@/'1D('-T>6QE/3-$)U!!1$1)3D<M0D]45$]-.B`R<'@[
M(%1%6%0M04Q)1TXZ(&QE9G0G('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E
M(&YO=W)A<#TS1&YO=W)A<#X\9F]N="!S='EL93TS1"=&3TY4+5-)6D4Z(#$P
M<'0[($9/3E0M1D%-24Q9.B!T:6UE<R!N97<@<F]M86X[($9/3E0M5T5)1TA4
M.B!B;VQD.R!$25-03$%9.B!I;FQI;F4G/B`F;F)S<#L\+V9O;G0^(#PO=&0^
M(#QT9"!S='EL93TS1"=0041$24Y'+4)/5%1/33H@,G!X)R!V86QI9VX],T1B
M;W1T;VT^/&9O;G0@<W1Y;&4],T0G1D].5"U325I%.B`Q,'!T.R!&3TY4+49!
M34E,63H@=&EM97,@;F5W(')O;6%N.R!$25-03$%9.B!I;FQI;F4G/B`F;F)S
M<#L\+V9O;G0^(#PO=&0^(#PO='(^(#QT<CX@/'1D('-T>6QE/3-$)U!!1$1)
M3D<M0D]45$]-.B`R<'@G('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#<V)2!A
M;&EG;CTS1&QE9G0^/&9O;G0@<W1Y;&4],T0G1D].5"U325I%.B`Q,'!T.R!&
M3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!$25-03$%9.B!I;FQI;F4G
M/B`F;F)S<#L\+V9O;G0^(#PO=&0^(#QT9"!S='EL93TS1"=0041$24Y'+4)/
M5%1/33H@,G!X)R!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)3X\9F]N="!S
M='EL93TS1"=&3TY4+5-)6D4Z(#$P<'0[($9/3E0M1D%-24Q9.B!T:6UE<R!N
M97<@<F]M86X[($9/3E0M5T5)1TA4.B!B;VQD.R!$25-03$%9.B!I;FQI;F4G
M/B`F;F)S<#L\+V9O;G0^(#PO=&0^(#QT9"!S='EL93TS1"="3U)$15(M0D]4
M5$]-.B!B;&%C:R`R<'@@<V]L:60G('9A;&EG;CTS1&)O='1O;2!W:61T:#TS
M1#$P)2!C;VQS<&%N/3-$,CX@/&1I=B!S='EL93TS1"=$25-03$%9.B!B;&]C
M:SL@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q
M,'!T.R!&3TY4+5=%24=(5#H@8F]L9#L@34%21TE.+4Q%1E0Z(#!P=#L@34%2
M1TE.+5))1TA4.B`P<'0[('1E>'0M86QI9VXZ(&-E;G1E<CL@5$585"U)3D1%
M3E0Z(#!P="<^(#(P,30\+V1I=CX@/"]T9#X@/'1D('-T>6QE/3-$)U!!1$1)
M3D<M0D]45$]-.B`R<'@[(%1%6%0M04Q)1TXZ(&QE9G0G('9A;&EG;CTS1&)O
M='1O;2!W:61T:#TS1#$E(&YO=W)A<#TS1&YO=W)A<#X\9F]N="!S='EL93TS
M1"=&3TY4+5-)6D4Z(#$P<'0[($9/3E0M1D%-24Q9.B!T:6UE<R!N97<@<F]M
M86X[($9/3E0M5T5)1TA4.B!B;VQD.R!$25-03$%9.B!I;FQI;F4G/B`F;F)S
M<#L\+V9O;G0^(#PO=&0^(#QT9"!S='EL93TS1"=0041$24Y'+4)/5%1/33H@
M,G!X)R!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)3X\9F]N="!S='EL93TS
M1"=&3TY4+5-)6D4Z(#$P<'0[($9/3E0M1D%-24Q9.B!T:6UE<R!N97<@<F]M
M86X[($9/3E0M5T5)1TA4.B!B;VQD.R!$25-03$%9.B!I;FQI;F4G/B`F;F)S
M<#L\+V9O;G0^(#PO=&0^(#QT9"!S='EL93TS1"="3U)$15(M0D]45$]-.B!B
M;&%C:R`R<'@@<V]L:60G('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$Q)2!C
M;VQS<&%N/3-$-#X@/&1I=B!S='EL93TS1"=$25-03$%9.B!B;&]C:SL@1D].
M5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T.R!&
M3TY4+5=%24=(5#H@8F]L9#L@34%21TE.+4Q%1E0Z(#!P=#L@34%21TE.+5))
M1TA4.B`P<'0[('1E>'0M86QI9VXZ(&-E;G1E<CL@5$585"U)3D1%3E0Z(#!P
M="<^(#(P,3,\+V1I=CX@/"]T9#X@/"]T<CX@/'1R(&)G8V]L;W(],T0C8V-E
M969F/B`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$-S8E(&%L:6=N/3-$
M;&5F=#X@/&1I=B!S='EL93TS1"=$25-03$%9.B!B;&]C:SL@1D].5"U&04U)
M3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T.R!-05)'24XM
M3$5&5#H@,'!T.R!-05)'24XM4DE'2%0Z(#!P=#L@=&5X="UA;&EG;CH@;&5F
M=#L@5$585"U)3D1%3E0Z(#!P="<^($%C8W)U960@<&%Y<F]L;#PO9&EV/B`\
M+W1D/B`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@86QI9VX],T1R
M:6=H=#X\9F]N="!S='EL93TS1"=&3TY4+5-)6D4Z(#$P<'0[($9/3E0M1D%-
M24Q9.B!T:6UE<R!N97<@<F]M86X[($1)4U!,05DZ(&EN;&EN92<^("9N8G-P
M.SPO9F]N=#X@/"]T9#X@/'1D('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@
M1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T
M.R!415A4+4%,24=..B!L969T)R!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q
M)3XD/"]T9#X@/'1D('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&
M04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T.R!415A4
M+4%,24=..B!R:6=H="<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$.24^-#(T
M/"]T9#X@/'1D('-T>6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G('9A;&EG;CTS
M1&)O='1O;2!W:61T:#TS1#$E(&YO=W)A<#TS1&YO=W)A<#X\9F]N="!S='EL
M93TS1"=&3TY4+5-)6D4Z(#$P<'0[($9/3E0M1D%-24Q9.B!T:6UE<R!N97<@
M<F]M86X[($1)4U!,05DZ(&EN;&EN92<^("9N8G-P.SPO9F]N=#X@/"]T9#X@
M/'1D('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E(&%L:6=N/3-$<FEG:'0^
M/&9O;G0@<W1Y;&4],T0G1D].5"U325I%.B`Q,'!T.R!&3TY4+49!34E,63H@
M=&EM97,@;F5W(')O;6%N.R!$25-03$%9.B!I;FQI;F4G/B`F;F)S<#L\+V9O
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M;VT@=VED=&@],T0Q)2!N;W=R87`],T1N;W=R87`^/&9O;G0@<W1Y;&4],T0G
M1D].5"U325I%.B`Q,'!T.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N
M.R!$25-03$%9.B!I;FQI;F4G/B`F;F)S<#L\+V9O;G0^(#PO=&0^(#PO='(^
M(#QT<B!B9V-O;&]R/3-$=VAI=&4^(#QT9"!V86QI9VX],T1B;W1T;VT@=VED
M=&@],T0W-B4@86QI9VX],T1L969T/B`\9&EV('-T>6QE/3-$)T1)4U!,05DZ
M(&)L;V-K.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!&3TY4+5-)
M6D4Z(#$P<'0[($U!4D=)3BU,1494.B`P<'0[($U!4D=)3BU224=(5#H@,'!T
M.R!T97AT+6%L:6=N.B!L969T.R!415A4+4E.1$5.5#H@,'!T)SX@4&%Y<F]L
M;"!I;G-T:71U=&EO;G,\+V1I=CX@/"]T9#X@/'1D('9A;&EG;CTS1&)O='1O
M;2!W:61T:#TS1#$E(&%L:6=N/3-$<FEG:'0^/&9O;G0@<W1Y;&4],T0G1D].
M5"U325I%.B`Q,'!T.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!$
M25-03$%9.B!I;FQI;F4G/B`F;F)S<#L\+V9O;G0^(#PO=&0^(#QT9"!S='EL
M93TS1"=415A4+4%,24=..B!L969T)R!V86QI9VX],T1B;W1T;VT@=VED=&@]
M,T0Q)3X\9F]N="!S='EL93TS1"=&3TY4+5-)6D4Z(#$P<'0[($9/3E0M1D%-
M24Q9.B!T:6UE<R!N97<@<F]M86X[($1)4U!,05DZ(&EN;&EN92<^("9N8G-P
M.SPO9F]N=#X@/"]T9#X@/'1D('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@
M1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T
M.R!415A4+4%,24=..B!R:6=H="<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$
M.24^,S`R/"]T9#X@/'1D('-T>6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G('9A
M;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E(&YO=W)A<#TS1&YO=W)A<#X\9F]N
M="!S='EL93TS1"=&3TY4+5-)6D4Z(#$P<'0[($9/3E0M1D%-24Q9.B!T:6UE
M<R!N97<@<F]M86X[($1)4U!,05DZ(&EN;&EN92<^("9N8G-P.SPO9F]N=#X@
M/"]T9#X@/'1D('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E(&%L:6=N/3-$
M<FEG:'0^/&9O;G0@<W1Y;&4],T0G1D].5"U325I%.B`Q,'!T.R!&3TY4+49!
M34E,63H@=&EM97,@;F5W(')O;6%N.R!$25-03$%9.B!I;FQI;F4G/B`F;F)S
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M=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T.R!415A4+4%,24=..B!R:6=H="<@
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M;W(],T0C8V-E969F/B`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$-S8E
M(&%L:6=N/3-$;&5F=#X@/&1I=B!S='EL93TS1"=$25-03$%9.B!B;&]C:SL@
M1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T
M.R!-05)'24XM3$5&5#H@,'!T.R!-05)'24XM4DE'2%0Z(#!P=#L@=&5X="UA
M;&EG;CH@;&5F=#L@5$585"U)3D1%3E0Z(#!P="<^($%C8W)U960@=F%C871I
M;VX\+V1I=CX@/"]T9#X@/'1D('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E
M(&%L:6=N/3-$<FEG:'0^/&9O;G0@<W1Y;&4],T0G1D].5"U325I%.B`Q,'!T
M.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!$25-03$%9.B!I;FQI
M;F4G/B`F;F)S<#L\+V9O;G0^(#PO=&0^(#QT9"!S='EL93TS1"=415A4+4%,
M24=..B!L969T)R!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)3X\9F]N="!S
M='EL93TS1"=&3TY4+5-)6D4Z(#$P<'0[($9/3E0M1D%-24Q9.B!T:6UE<R!N
M97<@<F]M86X[($1)4U!,05DZ(&EN;&EN92<^("9N8G-P.SPO9F]N=#X@/"]T
M9#X@/'1D('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ
M('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T.R!415A4+4%,24=.
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M<W1Y;&4],T0G1D].5"U325I%.B`Q,'!T.R!&3TY4+49!34E,63H@=&EM97,@
M;F5W(')O;6%N.R!$25-03$%9.B!I;FQI;F4G/B`F;F)S<#L\+V9O;G0^(#PO
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M5"U325I%.B`Q,'!T.R!415A4+4%,24=..B!R:6=H="<@=F%L:6=N/3-$8F]T
M=&]M('=I9'1H/3-$.24^-3`V/"]T9#X@/'1D('-T>6QE/3-$)U1%6%0M04Q)
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M(#!P=#L@34%21TE.+5))1TA4.B`P<'0[('1E>'0M86QI9VXZ(&QE9G0[(%1%
M6%0M24Y$14Y4.B`P<'0G/B!!9'9A;F-E9"!P87EM96YT(&9R;VT@;&5S<V]R
M/"]D:78^(#PO=&0^(#QT9"!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)2!A
M;&EG;CTS1')I9VAT/CQF;VYT('-T>6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@
M1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1$E34$Q!63H@:6YL:6YE
M)SX@)FYB<W`[/"]F;VYT/B`\+W1D/B`\=&0@<W1Y;&4],T0G5$585"U!3$E'
M3CH@;&5F="<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24^/&9O;G0@<W1Y
M;&4],T0G1D].5"U325I%.B`Q,'!T.R!&3TY4+49!34E,63H@=&EM97,@;F5W
M(')O;6%N.R!$25-03$%9.B!I;FQI;F4G/B`F;F)S<#L\+V9O;G0^(#PO=&0^
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M;&4],T0G1D].5"U325I%.B`Q,'!T.R!&3TY4+49!34E,63H@=&EM97,@;F5W
M(')O;6%N.R!$25-03$%9.B!I;FQI;F4G/B`F;F)S<#L\+V9O;G0^(#PO=&0^
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M25I%.B`Q,'!T.R!415A4+4%,24=..B!R:6=H="<@=F%L:6=N/3-$8F]T=&]M
M('=I9'1H/3-$.24^.#D\+W1D/B`\=&0@<W1Y;&4],T0G5$585"U!3$E'3CH@
M;&5F="<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@;F]W<F%P/3-$;F]W
M<F%P/CQF;VYT('-T>6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@1D].5"U&04U)
M3%DZ('1I;65S(&YE=R!R;VUA;CL@1$E34$Q!63H@:6YL:6YE)SX@)FYB<W`[
M/"]F;VYT/B`\+W1D/B`\+W1R/B`\='(@8F=C;VQO<CTS1"-C8V5E9F8^(#QT
M9"!V86QI9VX],T1B;W1T;VT@=VED=&@],T0W-B4@86QI9VX],T1L969T/B`\
M9&EV('-T>6QE/3-$)T1)4U!,05DZ(&)L;V-K.R!&3TY4+49!34E,63H@=&EM
M97,@;F5W(')O;6%N.R!&3TY4+5-)6D4Z(#$P<'0[($U!4D=)3BU,1494.B`P
M<'0[($U!4D=)3BU224=(5#H@,'!T.R!T97AT+6%L:6=N.B!L969T.R!415A4
M+4E.1$5.5#H@,'!T)SX@1&5R:79A=&EV97,@9&5S:6=N871E9"!A<R!A(&9A
M:7(@=F%L=64@:&5D9V4@:6YS=')U;65N=',\+V1I=CX@/"]T9#X@/'1D('9A
M;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E(&%L:6=N/3-$<FEG:'0^/&9O;G0@
M<W1Y;&4],T0G1D].5"U325I%.B`Q,'!T.R!&3TY4+49!34E,63H@=&EM97,@
M;F5W(')O;6%N.R!$25-03$%9.B!I;FQI;F4G/B`F;F)S<#L\+V9O;G0^(#PO
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M5"U325I%.B`Q,'!T.R!415A4+4%,24=..B!R:6=H="<@=F%L:6=N/3-$8F]T
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M1#$E(&%L:6=N/3-$<FEG:'0^/&9O;G0@<W1Y;&4],T0G1D].5"U325I%.B`Q
M,'!T.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!$25-03$%9.B!I
M;FQI;F4G/B`F;F)S<#L\+V9O;G0^(#PO=&0^(#QT9"!S='EL93TS1"=415A4
M+4%,24=..B!L969T)R!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)3X\9F]N
M="!S='EL93TS1"=&3TY4+5-)6D4Z(#$P<'0[($9/3E0M1D%-24Q9.B!T:6UE
M<R!N97<@<F]M86X[($1)4U!,05DZ(&EN;&EN92<^("9N8G-P.SPO9F]N=#X@
M/"]T9#X@/'1D('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)
M3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T.R!415A4+4%,
M24=..B!R:6=H="<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$.24^+3PO=&0^
M(#QT9"!S='EL93TS1"=415A4+4%,24=..B!L969T)R!V86QI9VX],T1B;W1T
M;VT@=VED=&@],T0Q)2!N;W=R87`],T1N;W=R87`^/&9O;G0@<W1Y;&4],T0G
M1D].5"U325I%.B`Q,'!T.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N
M.R!$25-03$%9.B!I;FQI;F4G/B`F;F)S<#L\+V9O;G0^(#PO=&0^(#PO='(^
M(#QT<B!B9V-O;&]R/3-$=VAI=&4^(#QT9"!S='EL93TS1"=0041$24Y'+4)/
M5%1/33H@,G!X)R!V86QI9VX],T1B;W1T;VT@=VED=&@],T0W-B4@86QI9VX]
M,T1L969T/B`\9&EV('-T>6QE/3-$)T1)4U!,05DZ(&)L;V-K.R!&3TY4+49!
M34E,63H@=&EM97,@;F5W(')O;6%N.R!&3TY4+5-)6D4Z(#$P<'0[($U!4D=)
M3BU,1494.B`P<'0[($U!4D=)3BU224=(5#H@,'!T.R!T97AT+6%L:6=N.B!L
M969T.R!415A4+4E.1$5.5#H@,'!T)SX@3W1H97(@<&%Y86)L97,\+V1I=CX@
M/"]T9#X@/'1D('-T>6QE/3-$)U!!1$1)3D<M0D]45$]-.B`R<'@G('9A;&EG
M;CTS1&)O='1O;2!W:61T:#TS1#$E(&%L:6=N/3-$<FEG:'0^/&9O;G0@<W1Y
M;&4],T0G1D].5"U325I%.B`Q,'!T.R!&3TY4+49!34E,63H@=&EM97,@;F5W
M(')O;6%N.R!$25-03$%9.B!I;FQI;F4G/B`F;F)S<#L\+V9O;G0^(#PO=&0^
M(#QT9"!S='EL93TS1"="3U)$15(M0D]45$]-.B!B;&%C:R`R<'@@<V]L:60[
M(%1%6%0M04Q)1TXZ(&QE9G0G('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E
M/CQF;VYT('-T>6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ
M('1I;65S(&YE=R!R;VUA;CL@1$E34$Q!63H@:6YL:6YE)SX@)FYB<W`[/"]F
M;VYT/B`\+W1D/B`\=&0@<W1Y;&4],T0G0D]21$52+4)/5%1/33H@8FQA8VL@
M,G!X('-O;&ED.R!$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE
M<R!N97<@<F]M86X[($9/3E0M4TE:13H@,3!P=#L@5$585"U!3$E'3CH@<FEG
M:'0G('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#DE/C$T/"]T9#X@/'1D('-T
M>6QE/3-$)U!!1$1)3D<M0D]45$]-.B`R<'@[(%1%6%0M04Q)1TXZ(&QE9G0G
M('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E(&YO=W)A<#TS1&YO=W)A<#X\
M9F]N="!S='EL93TS1"=&3TY4+5-)6D4Z(#$P<'0[($9/3E0M1D%-24Q9.B!T
M:6UE<R!N97<@<F]M86X[($1)4U!,05DZ(&EN;&EN92<^("9N8G-P.SPO9F]N
M=#X@/"]T9#X@/'1D('-T>6QE/3-$)U!!1$1)3D<M0D]45$]-.B`R<'@G('9A
M;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E(&%L:6=N/3-$<FEG:'0^/&9O;G0@
M<W1Y;&4],T0G1D].5"U325I%.B`Q,'!T.R!&3TY4+49!34E,63H@=&EM97,@
M;F5W(')O;6%N.R!$25-03$%9.B!I;FQI;F4G/B`F;F)S<#L\+V9O;G0^(#PO
M=&0^(#QT9"!S='EL93TS1"="3U)$15(M0D]45$]-.B!B;&%C:R`R<'@@<V]L
M:60[(%1%6%0M04Q)1TXZ(&QE9G0G('9A;&EG;CTS1&)O='1O;2!W:61T:#TS
M1#$E/CQF;VYT('-T>6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@1D].5"U&04U)
M3%DZ('1I;65S(&YE=R!R;VUA;CL@1$E34$Q!63H@:6YL:6YE)SX@)FYB<W`[
M/"]F;VYT/B`\+W1D/B`\=&0@<W1Y;&4],T0G0D]21$52+4)/5%1/33H@8FQA
M8VL@,G!X('-O;&ED.R!$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T
M:6UE<R!N97<@<F]M86X[($9/3E0M4TE:13H@,3!P=#L@5$585"U!3$E'3CH@
M<FEG:'0G('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#DE/BT\+W1D/B`\=&0@
M<W1Y;&4],T0G4$%$1$E.1RU"3U143TTZ(#)P>#L@5$585"U!3$E'3CH@;&5F
M="<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@;F]W<F%P/3-$;F]W<F%P
M/CQF;VYT('-T>6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ
M('1I;65S(&YE=R!R;VUA;CL@1$E34$Q!63H@:6YL:6YE)SX@)FYB<W`[/"]F
M;VYT/B`\+W1D/B`\+W1R/B`\='(@8F=C;VQO<CTS1"-C8V5E9F8^(#QT9"!S
M='EL93TS1"=0041$24Y'+4)/5%1/33H@,G!X)R!V86QI9VX],T1B;W1T;VT@
M=VED=&@],T0W-B4@86QI9VX],T1L969T/CQF;VYT('-T>6QE/3-$)T9/3E0M
M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1$E3
M4$Q!63H@:6YL:6YE)SX@)FYB<W`[/"]F;VYT/B`\+W1D/B`\=&0@<W1Y;&4]
M,T0G4$%$1$E.1RU"3U143TTZ(#)P>"<@=F%L:6=N/3-$8F]T=&]M('=I9'1H
M/3-$,24^/&9O;G0@<W1Y;&4],T0G1D].5"U325I%.B`Q,'!T.R!&3TY4+49!
M34E,63H@=&EM97,@;F5W(')O;6%N.R!$25-03$%9.B!I;FQI;F4G/B`F;F)S
M<#L\+V9O;G0^(#PO=&0^(#QT9"!S='EL93TS1"="3U)$15(M0D]45$]-.B!B
M;&%C:R`R<'@@<V]L:60[($1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ
M('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T.R!415A4+4%,24=.
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M;W1T;VT@=VED=&@],T0Q)2!N;W=R87`],T1N;W=R87`^/&9O;G0@<W1Y;&4]
M,T0G1D].5"U325I%.B`Q,'!T.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O
M;6%N.R!$25-03$%9.B!I;FQI;F4G/B`F;F)S<#L\+V9O;G0^(#PO=&0^(#QT
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M+W1D/B`\=&0@<W1Y;&4],T0G0D]21$52+4)/5%1/33H@8FQA8VL@,G!X('-O
M;&ED.R!$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE<R!N97<@
M<F]M86X[($9/3E0M4TE:13H@,3!P=#L@5$585"U!3$E'3CH@<FEG:'0G('9A
M;&EG;CTS1&)O='1O;2!W:61T:#TS1#DE/C$L,C<R/"]T9#X@/'1D('-T>6QE
M/3-$)U!!1$1)3D<M0D]45$]-.B`R<'@[(%1%6%0M04Q)1TXZ(&QE9G0G('9A
M;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E(&YO=W)A<#TS1&YO=W)A<#X\9F]N
M="!S='EL93TS1"=&3TY4+5-)6D4Z(#$P<'0[($9/3E0M1D%-24Q9.B!T:6UE
M<R!N97<@<F]M86X[($1)4U!,05DZ(&EN;&EN92<^("9N8G-P.SPO9F]N=#X@
M/"]T9#X@/"]T<CX@/"]T86)L93X@/"]D:78^(#PA+2U%;F1&<F%G;65N="TM
M/CPO9&EV/B`\+V1I=CX\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO='(^
M#0H@("`@/"]T86)L93X-"B`@/"]B;V1Y/@T*/"]H=&UL/@T*#0HM+2TM+2T]
M7TYE>'1087)T7S!C860U.69D7S<S,F5?-#9E,E]A-3,T7S!C.&%D,6%F.3!D
M9`T*0V]N=&5N="U,;V-A=&EO;CH@9FEL93HO+R]#.B\P8V%D-3EF9%\W,S)E
M7S0V93)?834S-%\P8SAA9#%A9CDP9&0O5V]R:W-H965T<R]3:&5E=#(U+FAT
M;6P-"D-O;G1E;G0M5')A;G-F97(M16YC;V1I;F<Z('%U;W1E9"UP<FEN=&%B
M;&4-"D-O;G1E;G0M5'EP93H@=&5X="]H=&UL.R!C:&%R<V5T/2)U<RUA<V-I
M:2(-"@T*/&AT;6P^#0H@(#QH96%D/@T*("`@(#Q-151!(&AT='`M97%U:78]
M,T1#;VYT96YT+51Y<&4@8V]N=&5N=#TS1"=T97AT+VAT;6P[(&-H87)S970]
M=71F+3@G/CQS8W)I<'0@='EP93TS1'1E>'0O:F%V87-C<FEP="!S<F,],T13
M:&]W+FIS/B\J($1O($YO="!296UO=F4@5&AI<R!#;VUM96YT("HO/"]S8W)I
M<'0^/"]H96%D/@T*("`\8F]D>3X-"B`@("`\=&%B;&4@8VQA<W,],T1R97!O
M<G0@:60],T1)1#!%149!0SX-"B`@("`@(#QT<CX-"B`@("`@("`@/'1H(&-L
M87-S/3-$=&P@8V]L<W!A;CTS1#$@<F]W<W!A;CTS1#(^/'-T<F]N9SY#3TU-
M251-14Y44R!!3D0@0T].5$E.1T5.0TE%4R`H5&%B;&5S*3QB<CX\+W-T<F]N
M9SX\+W1H/@T*("`@("`@("`\=&@@8VQA<W,],T1T:"!C;VQS<&%N/3-$,3XQ
M,B!-;VYT:',@16YD960\+W1H/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<CX-
M"B`@("`@("`@/'1H(&-L87-S/3-$=&@^2G5N+B`S,"P@,C`Q-#QB<CX\+W1H
M/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS1')H/@T*("`@("`@
M("`\=&0@8VQA<W,],T1P;"!V86QI9VX],T1T;W`^3&5A<V5D($9A8VEL:71I
M97,@6TUE;6)E<ET\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\
M<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO='(^#0H@("`@("`\='(@8VQA
M<W,],T1R;SX-"B`@("`@("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P
M/CQS=')O;F<^3&]N9RUT97)M(%!U<F-H87-E($-O;6UI=&UE;G0@6TQI;F4@
M271E;7-=/"]S=')O;F<^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X
M=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R
M(&-L87-S/3-$<F4^#0H@("`@("`@(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS
M1'1O<#Y38VAE9'5L92!O9B!&=71U<F4@36EN:6UU;2!296YT86P@0V]M;6ET
M;65N=',\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\(2TM1$]#
M5%E012!H=&UL(%!50DQ)0R`B+2\O5S-#+R]$5$0@6$A434P@,2XP(%1R86YS
M:71I;VYA;"\O14XB(")H='1P.B\O=W=W+G<S+F]R9R]44B]X:'1M;#$O1%1$
M+WAH=&UL,2UT<F%N<VET:6]N86PN9'1D(B`M+3X\9&EV/B`\9&EV/CPA+2U3
M=&%R=$9R86=M96YT+2T^(#QD:78@<W1Y;&4],T0G=&5X="UA;&EG;CH@8V5N
M=&5R)SX@/'1A8FQE('-T>6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@1D].5"U&
M04U)3%DZ('1I;65S(&YE=R!R;VUA;B<@8V5L;'-P86-I;F<],T0P(&-E;&QP
M861D:6YG/3-$,"!W:61T:#TS1#$P,"4@8F]R9&5R/3-$,#X@/'1R('9A;&EG
M;CTS1'1O<#X@/'1D/B`\9&EV('-T>6QE/3-$)T1)4U!,05DZ(&)L;V-K.R!&
M3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N.R!&3TY4+5-)6D4Z(#$P<'0[
M($U!4D=)3BU,1494.B`P<'0[($U!4D=)3BU224=(5#H@,'!T.R!T97AT+6%L
M:6=N.B!J=7-T:69Y.R!415A4+4%,24=..B!J=7-T:69Y.R!415A4+4E.1$5.
M5#H@,'!T)SX@07,@;V8@2G5N929N8G-P.S,P+"`R,#$T(&%G9W)E9V%T92!M
M:6YI;75M(&QE87-E(&-O;6UI=&UE;G1S('5N9&5R(&YO;BUC86YC96QA8FQE
M(&]P97)A=&EN9R!L96%S92!A9W)E96UE;G1S(&%R92!A<R!F;VQL;W=S.CPO
M9&EV/B`\+W1D/B`\+W1R/B`\+W1A8FQE/B`\+V1I=CX@/&1I=B!S='EL93TS
M1"=$25-03$%9.B!B;&]C:SL@34%21TE.+4Q%1E0Z(#!P=#L@34%21TE.+5))
M1TA4.B`P<'0[('1E>'0M86QI9VXZ(&IU<W1I9GD[(%1%6%0M24Y$14Y4.B`P
M<'0G/B`F;F)S<#L\+V1I=CX@/&1I=B!S='EL93TS1"=-05)'24XM3$5&5#H@
M,3AP=#L@34%21TE.+5))1TA4.B`P<'0[('1E>'0M86QI9VXZ(&QE9G0[(%1%
M6%0M04Q)1TXZ(&QE9G0[(%1%6%0M24Y$14Y4.B`P<'0G/B`\=&%B;&4@<W1Y
M;&4],T0G1D].5"U325I%.B`Q,'!T.R!&3TY4+49!34E,63H@=&EM97,@;F5W
M(')O;6%N)R!C96QL<W!A8VEN9STS1#`@8V5L;'!A9&1I;F<],T0P('=I9'1H
M/3-$-3`E/B`\='(@8F=C;VQO<CTS1"-C8V5E9F8^(#QT9"!V86QI9VX],T1B
M;W1T;VT@=VED=&@],T0X."4@86QI9VX],T1L969T/B`\9&EV('-T>6QE/3-$
M)T1)4U!,05DZ(&)L;V-K.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N
M.R!&3TY4+5-)6D4Z(#$P<'0[($U!4D=)3BU,1494.B`Y<'0[($U!4D=)3BU2
M24=(5#H@,'!T.R!T97AT+6%L:6=N.B!L969T.R!415A4+4E.1$5.5#H@+3EP
M="<^(%EE87(@96YD:6YG($IU;F4@,S`L/"]D:78^(#PO=&0^(#QT9"!V86QI
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M,3!P=#L@34%21TE.+4Q%1E0Z(#EP=#L@34%21TE.+5))1TA4.B`P<'0[('1E
M>'0M86QI9VXZ(&QE9G0[(%1%6%0M24Y$14Y4.B`M.7!T)SX@,C`Q-3PO9&EV
M/B`\+W1D/B`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@86QI9VX]
M,T1R:6=H=#X\9F]N="!S='EL93TS1"=&3TY4+5-)6D4Z(#$P<'0[($9/3E0M
M1D%-24Q9.B!T:6UE<R!N97<@<F]M86X[($1)4U!,05DZ(&EN;&EN92<^("9N
M8G-P.SPO9F]N=#X@/"]T9#X@/'1D('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN
M93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q
M,'!T.R!415A4+4%,24=..B!L969T)R!V86QI9VX],T1B;W1T;VT@=VED=&@]
M,T0Q)3XD/"]T9#X@/'1D('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].
M5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T.R!4
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M9#X@/"]T<CX@/'1R(&)G8V]L;W(],T0C8V-E969F/B`\=&0@=F%L:6=N/3-$
M8F]T=&]M('=I9'1H/3-$.#@E(&%L:6=N/3-$;&5F=#X@/&1I=B!S='EL93TS
M1"=$25-03$%9.B!B;&]C:SL@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA
M;CL@1D].5"U325I%.B`Q,'!T.R!-05)'24XM3$5&5#H@.7!T.R!-05)'24XM
M4DE'2%0Z(#!P=#L@=&5X="UA;&EG;CH@;&5F=#L@5$585"U)3D1%3E0Z("TY
M<'0G/B`R,#$V/"]D:78^(#PO=&0^(#QT9"!V86QI9VX],T1B;W1T;VT@=VED
M=&@],T0Q)2!A;&EG;CTS1')I9VAT/CQF;VYT('-T>6QE/3-$)T9/3E0M4TE:
M13H@,3!P=#L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1$E34$Q!
M63H@:6YL:6YE)SX@)FYB<W`[/"]F;VYT/B`\+W1D/B`\=&0@<W1Y;&4],T0G
M5$585"U!3$E'3CH@;&5F="<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24^
M/&9O;G0@<W1Y;&4],T0G1D].5"U325I%.B`Q,'!T.R!&3TY4+49!34E,63H@
M=&EM97,@;F5W(')O;6%N.R!$25-03$%9.B!I;FQI;F4G/B`F;F)S<#L\+V9O
M;G0^(#PO=&0^(#QT9"!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M
M1D%-24Q9.B!T:6UE<R!N97<@<F]M86X[($9/3E0M4TE:13H@,3!P=#L@5$58
M5"U!3$E'3CH@<FEG:'0G('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#DE/C0Y
M-SPO=&0^(#QT9"!S='EL93TS1"=415A4+4%,24=..B!L969T)R!V86QI9VX]
M,T1B;W1T;VT@=VED=&@],T0Q)2!N;W=R87`],T1N;W=R87`^/&9O;G0@<W1Y
M;&4],T0G1D].5"U325I%.B`Q,'!T.R!&3TY4+49!34E,63H@=&EM97,@;F5W
M(')O;6%N.R!$25-03$%9.B!I;FQI;F4G/B`F;F)S<#L\+V9O;G0^(#PO=&0^
M(#PO='(^(#QT<B!B9V-O;&]R/3-$=VAI=&4^(#QT9"!S='EL93TS1"=0041$
M24Y'+4)/5%1/33H@,G!X)R!V86QI9VX],T1B;W1T;VT@=VED=&@],T0X."4@
M86QI9VX],T1L969T/B`\9&EV('-T>6QE/3-$)T1)4U!,05DZ(&)L;V-K.R!&
M3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!&3TY4+5-)6D4Z(#$P<'0[
M($U!4D=)3BU,1494.B`Y<'0[($U!4D=)3BU224=(5#H@,'!T.R!T97AT+6%L
M:6=N.B!L969T.R!415A4+4E.1$5.5#H@+3EP="<^(#(P,3<\+V1I=CX@/"]T
M9#X@/'1D('-T>6QE/3-$)U!!1$1)3D<M0D]45$]-.B`R<'@G('9A;&EG;CTS
M1&)O='1O;2!W:61T:#TS1#$E(&%L:6=N/3-$<FEG:'0^/&9O;G0@<W1Y;&4]
M,T0G1D].5"U325I%.B`Q,'!T.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O
M;6%N.R!$25-03$%9.B!I;FQI;F4G/B`F;F)S<#L\+V9O;G0^(#PO=&0^(#QT
M9"!S='EL93TS1"="3U)$15(M0D]45$]-.B!B;&%C:R`R<'@@<V]L:60[(%1%
M6%0M04Q)1TXZ(&QE9G0G('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E/CQF
M;VYT('-T>6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ('1I
M;65S(&YE=R!R;VUA;CL@1$E34$Q!63H@:6YL:6YE)SX@)FYB<W`[/"]F;VYT
M/B`\+W1D/B`\=&0@<W1Y;&4],T0G0D]21$52+4)/5%1/33H@8FQA8VL@,G!X
M('-O;&ED.R!$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE<R!N
M97<@<F]M86X[($9/3E0M4TE:13H@,3!P=#L@5$585"U!3$E'3CH@<FEG:'0G
M('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#DE/C,T.3PO=&0^(#QT9"!S='EL
M93TS1"=0041$24Y'+4)/5%1/33H@,G!X.R!415A4+4%,24=..B!L969T)R!V
M86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)2!N;W=R87`],T1N;W=R87`^/&9O
M;G0@<W1Y;&4],T0G1D].5"U325I%.B`Q,'!T.R!&3TY4+49!34E,63H@=&EM
M97,@;F5W(')O;6%N.R!$25-03$%9.B!I;FQI;F4G/B`F;F)S<#L\+V9O;G0^
M(#PO=&0^(#PO='(^(#QT<B!B9V-O;&]R/3-$(V-C965F9CX@/'1D('-T>6QE
M/3-$)U!!1$1)3D<M0D]45$]-.B`T<'@G('9A;&EG;CTS1&)O='1O;2!W:61T
M:#TS1#@X)2!A;&EG;CTS1&QE9G0^(#QD:78@<W1Y;&4],T0G1$E34$Q!63H@
M8FQO8VL[($9/3E0M1D%-24Q9.B!T:6UE<R!N97<@<F]M86X[($9/3E0M4TE:
M13H@,3!P=#L@34%21TE.+4Q%1E0Z(#EP=#L@34%21TE.+5))1TA4.B`P<'0[
M('1E>'0M86QI9VXZ(&QE9G0[(%1%6%0M24Y$14Y4.B`M.7!T)SX@5&]T86P\
M+V1I=CX@/"]T9#X@/'1D('-T>6QE/3-$)U!!1$1)3D<M0D]45$]-.B`T<'@G
M('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E(&%L:6=N/3-$<FEG:'0^/&9O
M;G0@<W1Y;&4],T0G1D].5"U325I%.B`Q,'!T.R!&3TY4+49!34E,63H@=&EM
M97,@;F5W(')O;6%N.R!$25-03$%9.B!I;FQI;F4G/B`F;F)S<#L\+V9O;G0^
M(#PO=&0^(#QT9"!S='EL93TS1"="3U)$15(M0D]45$]-.B!B;&%C:R`T<'@@
M9&]U8FQE.R!$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE<R!N
M97<@<F]M86X[($9/3E0M4TE:13H@,3!P=#L@5$585"U!3$E'3CH@;&5F="<@
M=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24^)#PO=&0^(#QT9"!S='EL93TS
M1"="3U)$15(M0D]45$]-.B!B;&%C:R`T<'@@9&]U8FQE.R!$25-03$%9.B!I
M;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE<R!N97<@<F]M86X[($9/3E0M4TE:
M13H@,3!P=#L@5$585"U!3$E'3CH@<FEG:'0G('9A;&EG;CTS1&)O='1O;2!W
M:61T:#TS1#DE/C$L-3$S/"]T9#X@/'1D('-T>6QE/3-$)U!!1$1)3D<M0D]4
M5$]-.B`T<'@[(%1%6%0M04Q)1TXZ(&QE9G0G('9A;&EG;CTS1&)O='1O;2!W
M:61T:#TS1#$E(&YO=W)A<#TS1&YO=W)A<#X\9F]N="!S='EL93TS1"=&3TY4
M+5-)6D4Z(#$P<'0[($9/3E0M1D%-24Q9.B!T:6UE<R!N97<@<F]M86X[($1)
M4U!,05DZ(&EN;&EN92<^("9N8G-P.SPO9F]N=#X@/"]T9#X@/"]T<CX@/"]T
M86)L93X@/"]D:78^(#PA+2U%;F1&<F%G;65N="TM/CPO9&EV/B`\+V1I=CX\
M<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO='(^#0H@("`@("`\='(@8VQA
M<W,],T1R:#X-"B`@("`@("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P
M/D%U=&]M;V)I;&5S(%M-96UB97)=/"]T9#X-"B`@("`@("`@/'1D(&-L87-S
M/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@
M("`@/'1R(&-L87-S/3-$<F4^#0H@("`@("`@(#QT9"!C;&%S<STS1'!L('9A
M;&EG;CTS1'1O<#X\<W1R;VYG/DQO;F<M=&5R;2!0=7)C:&%S92!#;VUM:71M
M96YT(%M,:6YE($ET96US73PO<W1R;VYG/CPO=&0^#0H@("`@("`@(#QT9"!C
M;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-
M"B`@("`@(#QT<B!C;&%S<STS1')O/@T*("`@("`@("`\=&0@8VQA<W,],T1P
M;"!V86QI9VX],T1T;W`^4V-H961U;&4@;V8@1G5T=7)E($UI;FEM=6T@4F5N
M=&%L($-O;6UI=&UE;G1S/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X
M=#XG/"$M+41/0U194$4@:'1M;"!054),24,@(BTO+U<S0R\O1%1$(%A(5$U,
M(#$N,"!4<F%N<VET:6]N86PO+T5.(B`B:'1T<#HO+W=W=RYW,RYO<F<O5%(O
M>&AT;6PQ+T141"]X:'1M;#$M=')A;G-I=&EO;F%L+F1T9"(@+2T^/&1I=CX@
M/&1I=CX\(2TM4W1A<G1&<F%G;65N="TM/B`\9&EV('-T>6QE/3-$)T1)4U!,
M05DZ(&)L;V-K.R!&3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N.R!&3TY4
M+5-)6D4Z(#$P<'0[($U!4D=)3BU,1494.B`Q.'!T.R!-05)'24XM4DE'2%0Z
M(#!P=#L@=&5X="UA;&EG;CH@:G5S=&EF>3L@5$585"U)3D1%3E0Z(#!P="<^
M($%S(&]F($IU;F4F;F)S<#LS,"P@,C`Q-"P@9G5T=7)E(&%G9W)E9V%T92!M
M:6YI;75M(&QE87-E(&-O;6UI=&UE;G1S('5N9&5R(&YO;BUC86YC96QA8FQE
M(&]P97)A=&EN9R!L96%S92!A9W)E96UE;G1S(&%R92!A<R!F;VQL;W=S.CPO
M9&EV/B`\9&EV('-T>6QE/3-$)T1)4U!,05DZ(&)L;V-K.R!-05)'24XM3$5&
M5#H@,'!T.R!-05)'24XM4DE'2%0Z(#!P=#L@=&5X="UA;&EG;CH@:G5S=&EF
M>3L@5$585"U)3D1%3E0Z(#!P="<^("9N8G-P.SPO9&EV/B`\9&EV('-T>6QE
M/3-$)TU!4D=)3BU,1494.B`Q.'!T.R!T97AT+6%L:6=N.B!L969T)SX@/'1A
M8FQE('-T>6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ('1I
M;65S(&YE=R!R;VUA;B<@8V5L;'-P86-I;F<],T0P(&-E;&QP861D:6YG/3-$
M,"!W:61T:#TS1#4P)3X@/'1R(&)G8V]L;W(],T0C8V-E969F/B`\=&0@=F%L
M:6=N/3-$8F]T=&]M('=I9'1H/3-$.#@E(&%L:6=N/3-$;&5F=#X@/&1I=B!S
M='EL93TS1"=$25-03$%9.B!B;&]C:SL@1D].5"U&04U)3%DZ('1I;65S(&YE
M=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T.R!-05)'24XM3$5&5#H@,'!T.R!-
M05)'24XM4DE'2%0Z(#!P=#L@=&5X="UA;&EG;CH@;&5F=#L@5$585"U)3D1%
M3E0Z(#!P="<^(%EE87(@96YD:6YG($IU;F4@,S`L/"]D:78^(#PO=&0^(#QT
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M4TE:13H@,3!P=#L@34%21TE.+4Q%1E0Z(#!P=#L@34%21TE.+5))1TA4.B`P
M<'0[('1E>'0M86QI9VXZ(&QE9G0[(%1%6%0M24Y$14Y4.B`P<'0G/B`R,#$U
M/"]D:78^(#PO=&0^(#QT9"!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)2!A
M;&EG;CTS1')I9VAT/CQF;VYT('-T>6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@
M1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1$E34$Q!63H@:6YL:6YE
M)SX@)FYB<W`[/"]F;VYT/B`\+W1D/B`\=&0@<W1Y;&4],T0G1$E34$Q!63H@
M:6YL:6YE.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!&3TY4+5-)
M6D4Z(#$P<'0[(%1%6%0M04Q)1TXZ(&QE9G0G('9A;&EG;CTS1&)O='1O;2!W
M:61T:#TS1#$E/B0\+W1D/B`\=&0@<W1Y;&4],T0G1$E34$Q!63H@:6YL:6YE
M.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!&3TY4+5-)6D4Z(#$P
M<'0[(%1%6%0M04Q)1TXZ(')I9VAT)R!V86QI9VX],T1B;W1T;VT@=VED=&@]
M,T0Y)3XQ-#`\+W1D/B`\=&0@<W1Y;&4],T0G5$585"U!3$E'3CH@;&5F="<@
M=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@;F]W<F%P/3-$;F]W<F%P/CQF
M;VYT('-T>6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ('1I
M;65S(&YE=R!R;VUA;CL@1$E34$Q!63H@:6YL:6YE)SX@)FYB<W`[/"]F;VYT
M/B`\+W1D/B`\+W1R/B`\='(@8F=C;VQO<CTS1"-C8V5E9F8^(#QT9"!V86QI
M9VX],T1B;W1T;VT@=VED=&@],T0X."4@86QI9VX],T1L969T/B`\9&EV('-T
M>6QE/3-$)T1)4U!,05DZ(&)L;V-K.R!&3TY4+49!34E,63H@=&EM97,@;F5W
M(')O;6%N.R!&3TY4+5-)6D4Z(#$P<'0[($U!4D=)3BU,1494.B`P<'0[($U!
M4D=)3BU224=(5#H@,'!T.R!T97AT+6%L:6=N.B!L969T.R!415A4+4E.1$5.
M5#H@,'!T)SX@,C`Q-CPO9&EV/B`\+W1D/B`\=&0@=F%L:6=N/3-$8F]T=&]M
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M3%DZ('1I;65S(&YE=R!R;VUA;CL@1$E34$Q!63H@:6YL:6YE)SX@)FYB<W`[
M/"]F;VYT/B`\+W1D/B`\=&0@<W1Y;&4],T0G1$E34$Q!63H@:6YL:6YE.R!&
M3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!&3TY4+5-)6D4Z(#$P<'0[
M(%1%6%0M04Q)1TXZ(')I9VAT)R!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Y
M)3XX-3PO=&0^(#QT9"!S='EL93TS1"=415A4+4%,24=..B!L969T)R!V86QI
M9VX],T1B;W1T;VT@=VED=&@],T0Q)2!N;W=R87`],T1N;W=R87`^/&9O;G0@
M<W1Y;&4],T0G1D].5"U325I%.B`Q,'!T.R!&3TY4+49!34E,63H@=&EM97,@
M;F5W(')O;6%N.R!$25-03$%9.B!I;FQI;F4G/B`F;F)S<#L\+V9O;G0^(#PO
M=&0^(#PO='(^(#QT<B!B9V-O;&]R/3-$=VAI=&4^(#QT9"!S='EL93TS1"=0
M041$24Y'+4)/5%1/33H@,G!X)R!V86QI9VX],T1B;W1T;VT@=VED=&@],T0X
M."4@86QI9VX],T1L969T/B`\9&EV('-T>6QE/3-$)T1)4U!,05DZ(&)L;V-K
M.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!&3TY4+5-)6D4Z(#$P
M<'0[($U!4D=)3BU,1494.B`P<'0[($U!4D=)3BU224=(5#H@,'!T.R!T97AT
M+6%L:6=N.B!L969T.R!415A4+4E.1$5.5#H@,'!T)SX@,C`Q-SPO9&EV/B`\
M+W1D/B`\=&0@<W1Y;&4],T0G4$%$1$E.1RU"3U143TTZ(#)P>"<@=F%L:6=N
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M/&9O;G0@<W1Y;&4],T0G1D].5"U325I%.B`Q,'!T.R!&3TY4+49!34E,63H@
M=&EM97,@;F5W(')O;6%N.R!$25-03$%9.B!I;FQI;F4G/B`F;F)S<#L\+V9O
M;G0^(#PO=&0^(#QT9"!S='EL93TS1"="3U)$15(M0D]45$]-.B!B;&%C:R`R
M<'@@<V]L:60[($1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S
M(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T.R!415A4+4%,24=..B!R:6=H
M="<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$.24^,C8\+W1D/B`\=&0@<W1Y
M;&4],T0G4$%$1$E.1RU"3U143TTZ(#)P>#L@5$585"U!3$E'3CH@;&5F="<@
M=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@;F]W<F%P/3-$;F]W<F%P/CQF
M;VYT('-T>6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ('1I
M;65S(&YE=R!R;VUA;CL@1$E34$Q!63H@:6YL:6YE)SX@)FYB<W`[/"]F;VYT
M/B`\+W1D/B`\+W1R/B`\='(@8F=C;VQO<CTS1"-C8V5E9F8^(#QT9"!S='EL
M93TS1"=0041$24Y'+4)/5%1/33H@,G!X)R!V86QI9VX],T1B;W1T;VT@=VED
M=&@],T0X."4@86QI9VX],T1L969T/B`\9&EV('-T>6QE/3-$)T1)4U!,05DZ
M(&)L;V-K.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!&3TY4+5-)
M6D4Z(#$P<'0[($U!4D=)3BU,1494.B`P<'0[($U!4D=)3BU224=(5#H@,'!T
M.R!T97AT+6%L:6=N.B!L969T.R!415A4+4E.1$5.5#H@,'!T)SX@5&]T86P\
M+V1I=CX@/"]T9#X@/'1D('-T>6QE/3-$)U!!1$1)3D<M0D]45$]-.B`R<'@G
M('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E(&%L:6=N/3-$<FEG:'0^/&9O
M;G0@<W1Y;&4],T0G1D].5"U325I%.B`Q,'!T.R!&3TY4+49!34E,63H@=&EM
M97,@;F5W(')O;6%N.R!$25-03$%9.B!I;FQI;F4G/B`F;F)S<#L\+V9O;G0^
M(#PO=&0^(#QT9"!S='EL93TS1"="3U)$15(M0D]45$]-.B!B;&%C:R`R<'@@
M<V]L:60[($1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE
M=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T.R!415A4+4%,24=..B!L969T)R!V
M86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)3XD/"]T9#X@/'1D('-T>6QE/3-$
M)T)/4D1%4BU"3U143TTZ(&)L86-K(#)P>"!S;VQI9#L@1$E34$Q!63H@:6YL
M:6YE.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!&3TY4+5-)6D4Z
M(#$P<'0[(%1%6%0M04Q)1TXZ(')I9VAT)R!V86QI9VX],T1B;W1T;VT@=VED
M=&@],T0Y)3XR-3$\+W1D/B`\=&0@<W1Y;&4],T0G4$%$1$E.1RU"3U143TTZ
M(#)P>#L@5$585"U!3$E'3CH@;&5F="<@=F%L:6=N/3-$8F]T=&]M('=I9'1H
M/3-$,24@;F]W<F%P/3-$;F]W<F%P/CQF;VYT('-T>6QE/3-$)T9/3E0M4TE:
M13H@,3!P=#L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1$E34$Q!
M63H@:6YL:6YE)SX@)FYB<W`[/"]F;VYT/B`\+W1D/B`\+W1R/B`\+W1A8FQE
M/B`\+V1I=CX@/"$M+45N9$9R86=M96YT+2T^/"]D:78^(#PO9&EV/CQS<&%N
M/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@("`\+W1A8FQE/@T*("`\
M+V)O9'D^#0H\+VAT;6P^#0H-"BTM+2TM+3U?3F5X=%!A<G1?,&-A9#4Y9F1?
M-S,R95\T-F4R7V$U,S1?,&,X860Q868Y,&1D#0I#;VYT96YT+4QO8V%T:6]N
M.B!F:6QE.B\O+T,Z+S!C860U.69D7S<S,F5?-#9E,E]A-3,T7S!C.&%D,6%F
M.3!D9"]7;W)K<VAE971S+U-H965T,C8N:'1M;`T*0V]N=&5N="U4<F%N<V9E
M<BU%;F-O9&EN9SH@<75O=&5D+7!R:6YT86)L90T*0V]N=&5N="U4>7!E.B!T
M97AT+VAT;6P[(&-H87)S970](G5S+6%S8VEI(@T*#0H\:'1M;#X-"B`@/&AE
M860^#0H@("`@/$U%5$$@:'1T<"UE<75I=CTS1$-O;G1E;G0M5'EP92!C;VYT
M96YT/3-$)W1E>'0O:'1M;#L@8VAA<G-E=#UU=&8M."<^/'-C<FEP="!T>7!E
M/3-$=&5X="]J879A<V-R:7!T('-R8STS1%-H;W<N:G,^+RH@1&\@3F]T(%)E
M;6]V92!4:&ES($-O;6UE;G0@*B\\+W-C<FEP=#X\+VAE860^#0H@(#QB;V1Y
M/@T*("`@(#QT86)L92!C;&%S<STS1')E<&]R="!I9#TS1$E$,$561$%%/@T*
M("`@("`@/'1R/@T*("`@("`@("`\=&@@8VQA<W,],T1T;"!C;VQS<&%N/3-$
M,2!R;W=S<&%N/3-$,CX\<W1R;VYG/E-43T-+2$],1$524R<@15%52519("A4
M86)L97,I/&)R/CPO<W1R;VYG/CPO=&@^#0H@("`@("`@(#QT:"!C;&%S<STS
M1'1H(&-O;'-P86X],T0Q/C$R($UO;G1H<R!%;F1E9#PO=&@^#0H@("`@("`\
M+W1R/@T*("`@("`@/'1R/@T*("`@("`@("`\=&@@8VQA<W,],T1T:#Y*=6XN
M(#,P+"`R,#$T/&)R/CPO=&@^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L
M87-S/3-$<F4^#0H@("`@("`@(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O
M<#X\<W1R;VYG/E-43T-+2$],1$524R<@15%52519(%M!8G-T<F%C=%T\+W-T
M<F]N9SX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\
M+W-P86X^/"]T9#X-"B`@("`@(#PO='(^#0H@("`@("`\='(@8VQA<W,],T1R
M;SX-"B`@("`@("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P/E-C:&5D
M=6QE(&]F(%-T;V-K($]P=&EO;B!!8W1I=FET>3PO=&0^#0H@("`@("`@(#QT
M9"!C;&%S<STS1'1E>'0^)SPA+2U$3T-465!%(&AT;6P@4%5"3$E#("(M+R]7
M,T,O+T141"!82%1-3"`Q+C`@5')A;G-I=&EO;F%L+R]%3B(@(FAT='`Z+R]W
M=W<N=S,N;W)G+U12+WAH=&UL,2]$5$0O>&AT;6PQ+71R86YS:71I;VYA;"YD
M=&0B("TM/CQD:78^(#QD:78^/"$M+5-T87)T1G)A9VUE;G0M+3X@/&1I=B!S
M='EL93TS1"=$25-03$%9.B!B;&]C:SL@1D].5"U&04U)3%DZ(%1I;65S($YE
M=R!2;VUA;CL@1D].5"U325I%.B`Q,'!T.R!-05)'24XM3$5&5#H@,3AP=#L@
M34%21TE.+5))1TA4.B`P<'0[('1E>'0M86QI9VXZ(&IU<W1I9GD[(%1%6%0M
M24Y$14Y4.B`P<'0G/B!4:&4@0V]M<&%N>2!A8V-O=6YT960@9F]R(&ET<R!O
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M/B`\9&EV('-T>6QE/3-$)T1)4U!,05DZ(&)L;V-K.R!-05)'24XM3$5&5#H@
M,'!T.R!-05)'24XM4DE'2%0Z(#!P=#L@=&5X="UA;&EG;CH@:G5S=&EF>3L@
M5$585"U)3D1%3E0Z(#!P="<^("9N8G-P.SPO9&EV/B`\9&EV('-T>6QE/3-$
M)W1E>'0M86QI9VXZ(')I9VAT)SX@/'1A8FQE('-T>6QE/3-$)T9/3E0M4TE:
M13H@,3!P=#L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;B<@8V5L;'-P
M86-I;F<],T0P(&-E;&QP861D:6YG/3-$,"!W:61T:#TS1#DW)3X@/'1R/B`\
M=&0@<W1Y;&4],T0G4$%$1$E.1RU"3U143TTZ(#)P>"<@=F%L:6=N/3-$8F]T
M=&]M('=I9'1H/3-$-3(E/CQF;VYT('-T>6QE/3-$)T9/3E0M4TE:13H@,3!P
M=#L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1$E34$Q!63H@:6YL
M:6YE)SX@)FYB<W`[/"]F;VYT/B`\+W1D/B`\=&0@<W1Y;&4],T0G4$%$1$E.
M1RU"3U143TTZ(#)P>"<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24^/&9O
M;G0@<W1Y;&4],T0G1D].5"U325I%.B`Q,'!T.R!&3TY4+49!34E,63H@=&EM
M97,@;F5W(')O;6%N.R!&3TY4+5=%24=(5#H@8F]L9#L@1$E34$Q!63H@:6YL
M:6YE)SX@)FYB<W`[/"]F;VYT/B`\+W1D/B`\=&0@<W1Y;&4],T0G0D]21$52
M+4)/5%1/33H@8FQA8VL@,G!X('-O;&ED)R!V86QI9VX],T1B;W1T;VT@=VED
M=&@],T0T-B4@8V]L<W!A;CTS1#$T/B`\9&EV('-T>6QE/3-$)T1)4U!,05DZ
M(&)L;V-K.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!&3TY4+5-)
M6D4Z(#$P<'0[($9/3E0M5T5)1TA4.B!B;VQD.R!-05)'24XM3$5&5#H@,'!T
M.R!-05)'24XM4DE'2%0Z(#!P=#L@=&5X="UA;&EG;CH@8V5N=&5R.R!415A4
M+4E.1$5.5#H@,'!T)SX@665A<B!E;F1E9"!*=6YE(#,P+"`R,#$T/"]D:78^
M(#PO=&0^(#QT9"!S='EL93TS1"=0041$24Y'+4)/5%1/33H@,G!X.R!415A4
M+4%,24=..B!L969T)R!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)2!N;W=R
M87`],T1N;W=R87`^/&9O;G0@<W1Y;&4],T0G1D].5"U325I%.B`Q,'!T.R!&
M3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!&3TY4+5=%24=(5#H@8F]L
M9#L@1$E34$Q!63H@:6YL:6YE)SX@)FYB<W`[/"]F;VYT/B`\+W1D/B`\+W1R
M/B`\='(^(#QT9"!S='EL93TS1"=0041$24Y'+4)/5%1/33H@,G!X)R!V86QI
M9VX],T1B;W1T;VT@=VED=&@],T0U,B4^/&9O;G0@<W1Y;&4],T0G1D].5"U3
M25I%.B`Q,'!T.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!$25-0
M3$%9.B!I;FQI;F4G/B`F;F)S<#L\+V9O;G0^(#PO=&0^(#QT9"!S='EL93TS
M1"=0041$24Y'+4)/5%1/33H@,G!X)R!V86QI9VX],T1B;W1T;VT@=VED=&@]
M,T0Q)3X\9F]N="!S='EL93TS1"=&3TY4+5-)6D4Z(#$P<'0[($9/3E0M1D%-
M24Q9.B!T:6UE<R!N97<@<F]M86X[($9/3E0M5T5)1TA4.B!B;VQD.R!$25-0
M3$%9.B!I;FQI;F4G/B`F;F)S<#L\+V9O;G0^(#PO=&0^(#QT9"!S='EL93TS
M1"="3U)$15(M0D]45$]-.B!B;&%C:R`R<'@@<V]L:60G('9A;&EG;CTS1&)O
M='1O;2!W:61T:#TS1#$P)2!C;VQS<&%N/3-$,CX@/&1I=B!S='EL93TS1"=$
M25-03$%9.B!B;&]C:SL@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@
M1D].5"U325I%.B`Q,'!T.R!&3TY4+5=%24=(5#H@8F]L9#L@34%21TE.+4Q%
M1E0Z(#!P=#L@34%21TE.+5))1TA4.B`P<'0[('1E>'0M86QI9VXZ(&-E;G1E
M<CL@5$585"U)3D1%3E0Z(#!P="<^($YU;6)E<CPO9&EV/B`\+W1D/B`\=&0@
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M1$1)3D<M0D]45$]-.B`R<'@G('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E
M/CQF;VYT('-T>6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ
M('1I;65S(&YE=R!R;VUA;CL@1D].5"U714E'2%0Z(&)O;&0[($1)4U!,05DZ
M(&EN;&EN92<^("9N8G-P.SPO9F]N=#X@/"]T9#X@/'1D('-T>6QE/3-$)T)/
M4D1%4BU"3U143TTZ(&)L86-K(#)P>"!S;VQI9"<@=F%L:6=N/3-$8F]T=&]M
M('=I9'1H/3-$,3`E(&-O;'-P86X],T0R/B`\9&EV('-T>6QE/3-$)T1)4U!,
M05DZ(&)L;V-K.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!&3TY4
M+5-)6D4Z(#$P<'0[($9/3E0M5T5)1TA4.B!B;VQD.R!-05)'24XM3$5&5#H@
M,'!T.R!-05)'24XM4DE'2%0Z(#!P=#L@=&5X="UA;&EG;CH@8V5N=&5R.R!4
M15A4+4E.1$5.5#H@,'!T)SX@5V5I9VAT960@079E<F%G92!%>&5R8VES92!0
M<FEC93PO9&EV/B`\+W1D/B`\=&0@<W1Y;&4],T0G4$%$1$E.1RU"3U143TTZ
M(#)P>#L@5$585"U!3$E'3CH@;&5F="<@=F%L:6=N/3-$8F]T=&]M('=I9'1H
M/3-$,24@;F]W<F%P/3-$;F]W<F%P/CQF;VYT('-T>6QE/3-$)T9/3E0M4TE:
M13H@,3!P=#L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U7
M14E'2%0Z(&)O;&0[($1)4U!,05DZ(&EN;&EN92<^("9N8G-P.SPO9F]N=#X@
M/"]T9#X@/'1D('-T>6QE/3-$)U!!1$1)3D<M0D]45$]-.B`R<'@G('9A;&EG
M;CTS1&)O='1O;2!W:61T:#TS1#$E/CQF;VYT('-T>6QE/3-$)T9/3E0M4TE:
M13H@,3!P=#L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U7
M14E'2%0Z(&)O;&0[($1)4U!,05DZ(&EN;&EN92<^("9N8G-P.SPO9F]N=#X@
M/"]T9#X@/'1D('-T>6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#)P>"!S
M;VQI9"<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,3`E(&-O;'-P86X],T0R
M/B`\9&EV('-T>6QE/3-$)T1)4U!,05DZ(&)L;V-K.R!&3TY4+49!34E,63H@
M=&EM97,@;F5W(')O;6%N.R!&3TY4+5-)6D4Z(#$P<'0[($9/3E0M5T5)1TA4
M.B!B;VQD.R!-05)'24XM3$5&5#H@,'!T.R!-05)'24XM4DE'2%0Z(#!P=#L@
M=&5X="UA;&EG;CH@8V5N=&5R.R!415A4+4E.1$5.5#H@,'!T)SX@5V5I9VAT
M960@079E<F%G92!296UA:6YI;F<@0V]N=')A8W1U86P@5&5R;7,@*&EN('EE
M87)S*3PO9&EV/B`\+W1D/B`\=&0@<W1Y;&4],T0G4$%$1$E.1RU"3U143TTZ
M(#)P>#L@5$585"U!3$E'3CH@;&5F="<@=F%L:6=N/3-$8F]T=&]M('=I9'1H
M/3-$,24@;F]W<F%P/3-$;F]W<F%P/CQF;VYT('-T>6QE/3-$)T9/3E0M4TE:
M13H@,3!P=#L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U7
M14E'2%0Z(&)O;&0[($1)4U!,05DZ(&EN;&EN92<^("9N8G-P.SPO9F]N=#X@
M/"]T9#X@/'1D('-T>6QE/3-$)U!!1$1)3D<M0D]45$]-.B`R<'@G('9A;&EG
M;CTS1&)O='1O;2!W:61T:#TS1#$E/CQF;VYT('-T>6QE/3-$)T9/3E0M4TE:
M13H@,3!P=#L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U7
M14E'2%0Z(&)O;&0[($1)4U!,05DZ(&EN;&EN92<^("9N8G-P.SPO9F]N=#X@
M/"]T9#X@/'1D('-T>6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#)P>"!S
M;VQI9"<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,3`E(&-O;'-P86X],T0R
M/B`\9&EV('-T>6QE/3-$)T1)4U!,05DZ(&)L;V-K.R!&3TY4+49!34E,63H@
M=&EM97,@;F5W(')O;6%N.R!&3TY4+5-)6D4Z(#$P<'0[($9/3E0M5T5)1TA4
M.B!B;VQD.R!-05)'24XM3$5&5#H@,'!T.R!-05)'24XM4DE'2%0Z(#!P=#L@
M=&5X="UA;&EG;CH@8V5N=&5R.R!415A4+4E.1$5.5#H@,'!T)SX@06=G<F5G
M871E($EN=')I;G-I8R!686QU92!0<FEC93PO9&EV/B`\+W1D/B`\=&0@<W1Y
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M,T0C8V-E969F/B`\=&0@<W1Y;&4],T0G5$585"U!3$E'3CH@;&5F=#L@34%2
M1TE.+4Q%1E0Z(#!P=#L@34%21TE.+5))1TA4.B`P<'0[(%1%6%0M24Y$14Y4
M.B`P<'0G('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#4R)3X@/&1I=B!S='EL
M93TS1"=$25-03$%9.B!B;&]C:SL@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R
M;VUA;CL@1D].5"U325I%.B`Q,'!T.R!-05)'24XM3$5&5#H@,'!T.R!-05)'
M24XM4DE'2%0Z(#!P=#L@5$585"U!3$E'3CH@;&5F=#L@5$585"U)3D1%3E0Z
M(#!P="<^($]P=&EO;G,@;W5T<W1A;F1I;F<@870@8F5G:6YN:6YG(&]F('!E
M<FEO9#PO9&EV/B`\+W1D/B`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$
M,24^/&9O;G0@<W1Y;&4],T0G1D].5"U325I%.B`Q,'!T.R!&3TY4+49!34E,
M63H@=&EM97,@;F5W(')O;6%N.R!$25-03$%9.B!I;FQI;F4G/B`F;F)S<#L\
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M;VUA;CL@1D].5"U325I%.B`Q,'!T.R!415A4+4%,24=..B!R:6=H="<@=F%L
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M:6YL:6YE)SX@)FYB<W`[/"]F;VYT/B`\+W1D/B`\=&0@<W1Y;&4],T0G1$E3
M4$Q!63H@:6YL:6YE.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!&
M3TY4+5-)6D4Z(#$P<'0[(%1%6%0M04Q)1TXZ(&QE9G0G('9A;&EG;CTS1&)O
M='1O;2!W:61T:#TS1#$E/B0\+W1D/B`\=&0@<W1Y;&4],T0G1$E34$Q!63H@
M:6YL:6YE.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!&3TY4+5-)
M6D4Z(#$P<'0[(%1%6%0M04Q)1TXZ(')I9VAT)R!V86QI9VX],T1B;W1T;VT@
M=VED=&@],T0Y)3XT+C`S/"]T9#X@/'1D('-T>6QE/3-$)U1%6%0M04Q)1TXZ
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M('1I;65S(&YE=R!R;VUA;CL@1$E34$Q!63H@:6YL:6YE)SX@)FYB<W`[/"]F
M;VYT/B`\+W1D/B`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,3`E(&-O
M;'-P86X],T0R/CQF;VYT('-T>6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@1D].
M5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1$E34$Q!63H@:6YL:6YE)SX@
M)FYB<W`[/"]F;VYT/B`\+W1D/B`\=&0@<W1Y;&4],T0G5$585"U!3$E'3CH@
M;&5F="<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@;F]W<F%P/3-$;F]W
M<F%P/CQF;VYT('-T>6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@1D].5"U&04U)
M3%DZ('1I;65S(&YE=R!R;VUA;CL@1$E34$Q!63H@:6YL:6YE)SX@)FYB<W`[
M/"]F;VYT/B`\+W1D/B`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24^
M/&9O;G0@<W1Y;&4],T0G1D].5"U325I%.B`Q,'!T.R!&3TY4+49!34E,63H@
M=&EM97,@;F5W(')O;6%N.R!$25-03$%9.B!I;FQI;F4G/B`F;F)S<#L\+V9O
M;G0^(#PO=&0^(#QT9"!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q,"4@8V]L
M<W!A;CTS1#(^/&9O;G0@<W1Y;&4],T0G1D].5"U325I%.B`Q,'!T.R!&3TY4
M+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!$25-03$%9.B!I;FQI;F4G/B`F
M;F)S<#L\+V9O;G0^(#PO=&0^(#QT9"!S='EL93TS1"=415A4+4%,24=..B!L
M969T)R!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)2!N;W=R87`],T1N;W=R
M87`^/&9O;G0@<W1Y;&4],T0G1D].5"U325I%.B`Q,'!T.R!&3TY4+49!34E,
M63H@=&EM97,@;F5W(')O;6%N.R!$25-03$%9.B!I;FQI;F4G/B`F;F)S<#L\
M+V9O;G0^(#PO=&0^(#PO='(^(#QT<B!B9V-O;&]R/3-$=VAI=&4^(#QT9"!S
M='EL93TS1"=415A4+4%,24=..B!L969T.R!-05)'24XM3$5&5#H@,'!T.R!-
M05)'24XM4DE'2%0Z(#!P=#L@5$585"U)3D1%3E0Z(#!P="<@=F%L:6=N/3-$
M8F]T=&]M('=I9'1H/3-$-3(E/B`\9&EV('-T>6QE/3-$)T1)4U!,05DZ(&)L
M;V-K.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!&3TY4+5-)6D4Z
M(#$P<'0[($U!4D=)3BU,1494.B`P<'0[($U!4D=)3BU224=(5#H@,'!T.R!4
M15A4+4%,24=..B!L969T.R!415A4+4E.1$5.5#H@,'!T)SX@3W!T:6]N<R!E
M>&5R8VES960\+V1I=CX@/"]T9#X@/'1D('9A;&EG;CTS1&)O='1O;2!W:61T
M:#TS1#$E/CQF;VYT('-T>6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@1D].5"U&
M04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1$E34$Q!63H@:6YL:6YE)SX@)FYB
M<W`[/"]F;VYT/B`\+W1D/B`\=&0@<W1Y;&4],T0G5$585"U!3$E'3CH@;&5F
M="<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24^/&9O;G0@<W1Y;&4],T0G
M1D].5"U325I%.B`Q,'!T.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N
M.R!$25-03$%9.B!I;FQI;F4G/B`F;F)S<#L\+V9O;G0^(#PO=&0^(#QT9"!S
M='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE<R!N
M97<@<F]M86X[($9/3E0M4TE:13H@,3!P=#L@5$585"U!3$E'3CH@<FEG:'0G
M('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#DE/B@Q-2PP,#`\+W1D/B`\=&0@
M<W1Y;&4],T0G1$E34$Q!63H@:6YL:6YE.R!&3TY4+49!34E,63H@=&EM97,@
M;F5W(')O;6%N.R!&3TY4+5-)6D4Z(#$P<'0[(%1%6%0M04Q)1TXZ(&QE9G0G
M('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E(&YO=W)A<#TS1&YO=W)A<#XI
M/"]T9#X@/'1D('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E/CQF;VYT('-T
M>6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ('1I;65S(&YE
M=R!R;VUA;CL@1$E34$Q!63H@:6YL:6YE)SX@)FYB<W`[/"]F;VYT/B`\+W1D
M/B`\=&0@<W1Y;&4],T0G1$E34$Q!63H@:6YL:6YE.R!&3TY4+49!34E,63H@
M=&EM97,@;F5W(')O;6%N.R!&3TY4+5-)6D4Z(#$P<'0[(%1%6%0M04Q)1TXZ
M(&QE9G0G('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E/B0\+W1D/B`\=&0@
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M:6YL:6YE)SX@)FYB<W`[/"]F;VYT/B`\+W1D/B`\=&0@=F%L:6=N/3-$8F]T
M=&]M('=I9'1H/3-$,3`E(&-O;'-P86X],T0R/CQF;VYT('-T>6QE/3-$)T9/
M3E0M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@
M1$E34$Q!63H@:6YL:6YE)SX@)FYB<W`[/"]F;VYT/B`\+W1D/B`\=&0@<W1Y
M;&4],T0G5$585"U!3$E'3CH@;&5F="<@=F%L:6=N/3-$8F]T=&]M('=I9'1H
M/3-$,24@;F]W<F%P/3-$;F]W<F%P/CQF;VYT('-T>6QE/3-$)T9/3E0M4TE:
M13H@,3!P=#L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1$E34$Q!
M63H@:6YL:6YE)SX@)FYB<W`[/"]F;VYT/B`\+W1D/B`\=&0@=F%L:6=N/3-$
M8F]T=&]M('=I9'1H/3-$,24^/&9O;G0@<W1Y;&4],T0G1D].5"U325I%.B`Q
M,'!T.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!$25-03$%9.B!I
M;FQI;F4G/B`F;F)S<#L\+V9O;G0^(#PO=&0^(#QT9"!V86QI9VX],T1B;W1T
M;VT@=VED=&@],T0Q,"4@8V]L<W!A;CTS1#(^/&9O;G0@<W1Y;&4],T0G1D].
M5"U325I%.B`Q,'!T.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!$
M25-03$%9.B!I;FQI;F4G/B`F;F)S<#L\+V9O;G0^(#PO=&0^(#QT9"!S='EL
M93TS1"=415A4+4%,24=..B!L969T)R!V86QI9VX],T1B;W1T;VT@=VED=&@]
M,T0Q)2!N;W=R87`],T1N;W=R87`^/&9O;G0@<W1Y;&4],T0G1D].5"U325I%
M.B`Q,'!T.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!$25-03$%9
M.B!I;FQI;F4G/B`F;F)S<#L\+V9O;G0^(#PO=&0^(#PO='(^(#QT<B!B9V-O
M;&]R/3-$(V-C965F9CX@/'1D('-T>6QE/3-$)U!!1$1)3D<M0D]45$]-.B`R
M<'@[(%1%6%0M04Q)1TXZ(&QE9G0[($U!4D=)3BU,1494.B`P<'0[($U!4D=)
M3BU224=(5#H@,'!T.R!415A4+4E.1$5.5#H@,'!T)R!V86QI9VX],T1B;W1T
M;VT@=VED=&@],T0U,B4^(#QD:78@<W1Y;&4],T0G1$E34$Q!63H@8FQO8VL[
M($9/3E0M1D%-24Q9.B!T:6UE<R!N97<@<F]M86X[($9/3E0M4TE:13H@,3!P
M=#L@34%21TE.+4Q%1E0Z(#!P=#L@34%21TE.+5))1TA4.B`P<'0[(%1%6%0M
M04Q)1TXZ(&QE9G0[(%1%6%0M24Y$14Y4.B`P<'0G/B!/<'1I;VYS(&9O<F9E
M:71E9#PO9&EV/B`\+W1D/B`\=&0@<W1Y;&4],T0G4$%$1$E.1RU"3U143TTZ
M(#)P>"<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24^/&9O;G0@<W1Y;&4]
M,T0G1D].5"U325I%.B`Q,'!T.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O
M;6%N.R!$25-03$%9.B!I;FQI;F4G/B`F;F)S<#L\+V9O;G0^(#PO=&0^(#QT
M9"!S='EL93TS1"="3U)$15(M0D]45$]-.B!B;&%C:R`R<'@@<V]L:60[(%1%
M6%0M04Q)1TXZ(&QE9G0G('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E/CQF
M;VYT('-T>6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ('1I
M;65S(&YE=R!R;VUA;CL@1$E34$Q!63H@:6YL:6YE)SX@)FYB<W`[/"]F;VYT
M/B`\+W1D/B`\=&0@<W1Y;&4],T0G0D]21$52+4)/5%1/33H@8FQA8VL@,G!X
M('-O;&ED.R!$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE<R!N
M97<@<F]M86X[($9/3E0M4TE:13H@,3!P=#L@5$585"U!3$E'3CH@<FEG:'0G
M('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#DE/B@X,2PP-3<\+W1D/B`\=&0@
M<W1Y;&4],T0G1$E34$Q!63H@:6YL:6YE.R!&3TY4+49!34E,63H@=&EM97,@
M;F5W(')O;6%N.R!&3TY4+5-)6D4Z(#$P<'0[(%!!1$1)3D<M0D]45$]-.B`R
M<'@[(%1%6%0M04Q)1TXZ(&QE9G0G('9A;&EG;CTS1&)O='1O;2!W:61T:#TS
M1#$E(&YO=W)A<#TS1&YO=W)A<#XI/"]T9#X@/'1D('-T>6QE/3-$)U!!1$1)
M3D<M0D]45$]-.B`R<'@G('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E/CQF
M;VYT('-T>6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ('1I
M;65S(&YE=R!R;VUA;CL@1$E34$Q!63H@:6YL:6YE)SX@)FYB<W`[/"]F;VYT
M/B`\+W1D/B`\=&0@<W1Y;&4],T0G0D]21$52+4)/5%1/33H@8FQA8VL@,G!X
M('-O;&ED.R!$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE<R!N
M97<@<F]M86X[($9/3E0M4TE:13H@,3!P=#L@5$585"U!3$E'3CH@;&5F="<@
M=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24^)#PO=&0^(#QT9"!S='EL93TS
M1"="3U)$15(M0D]45$]-.B!B;&%C:R`R<'@@<V]L:60[($1)4U!,05DZ(&EN
M;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%
M.B`Q,'!T.R!415A4+4%,24=..B!R:6=H="<@=F%L:6=N/3-$8F]T=&]M('=I
M9'1H/3-$.24^,3$N-3D\+W1D/B`\=&0@<W1Y;&4],T0G4$%$1$E.1RU"3U14
M3TTZ(#)P>#L@5$585"U!3$E'3CH@;&5F="<@=F%L:6=N/3-$8F]T=&]M('=I
M9'1H/3-$,24@;F]W<F%P/3-$;F]W<F%P/CQF;VYT('-T>6QE/3-$)T9/3E0M
M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1$E3
M4$Q!63H@:6YL:6YE)SX@)FYB<W`[/"]F;VYT/B`\+W1D/B`\=&0@<W1Y;&4]
M,T0G4$%$1$E.1RU"3U143TTZ(#)P>"<@=F%L:6=N/3-$8F]T=&]M('=I9'1H
M/3-$,24^/&9O;G0@<W1Y;&4],T0G1D].5"U325I%.B`Q,'!T.R!&3TY4+49!
M34E,63H@=&EM97,@;F5W(')O;6%N.R!$25-03$%9.B!I;FQI;F4G/B`F;F)S
M<#L\+V9O;G0^(#PO=&0^(#QT9"!S='EL93TS1"=0041$24Y'+4)/5%1/33H@
M,G!X)R!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q,"4@8V]L<W!A;CTS1#(^
M/&9O;G0@<W1Y;&4],T0G1D].5"U325I%.B`Q,'!T.R!&3TY4+49!34E,63H@
M=&EM97,@;F5W(')O;6%N.R!$25-03$%9.B!I;FQI;F4G/B`F;F)S<#L\+V9O
M;G0^(#PO=&0^(#QT9"!S='EL93TS1"=0041$24Y'+4)/5%1/33H@,G!X.R!4
M15A4+4%,24=..B!L969T)R!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)2!N
M;W=R87`],T1N;W=R87`^/&9O;G0@<W1Y;&4],T0G1D].5"U325I%.B`Q,'!T
M.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!$25-03$%9.B!I;FQI
M;F4G/B`F;F)S<#L\+V9O;G0^(#PO=&0^(#QT9"!S='EL93TS1"=0041$24Y'
M+4)/5%1/33H@,G!X)R!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)3X\9F]N
M="!S='EL93TS1"=&3TY4+5-)6D4Z(#$P<'0[($9/3E0M1D%-24Q9.B!T:6UE
M<R!N97<@<F]M86X[($1)4U!,05DZ(&EN;&EN92<^("9N8G-P.SPO9F]N=#X@
M/"]T9#X@/'1D('-T>6QE/3-$)U!!1$1)3D<M0D]45$]-.B`R<'@G('9A;&EG
M;CTS1&)O='1O;2!W:61T:#TS1#$P)2!C;VQS<&%N/3-$,CX\9F]N="!S='EL
M93TS1"=&3TY4+5-)6D4Z(#$P<'0[($9/3E0M1D%-24Q9.B!T:6UE<R!N97<@
M<F]M86X[($1)4U!,05DZ(&EN;&EN92<^("9N8G-P.SPO9F]N=#X@/"]T9#X@
M/'1D('-T>6QE/3-$)U!!1$1)3D<M0D]45$]-.B`R<'@[(%1%6%0M04Q)1TXZ
M(&QE9G0G('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E(&YO=W)A<#TS1&YO
M=W)A<#X\9F]N="!S='EL93TS1"=&3TY4+5-)6D4Z(#$P<'0[($9/3E0M1D%-
M24Q9.B!T:6UE<R!N97<@<F]M86X[($1)4U!,05DZ(&EN;&EN92<^("9N8G-P
M.SPO9F]N=#X@/"]T9#X@/"]T<CX@/'1R(&)G8V]L;W(],T1W:&ET93X@/'1D
M('-T>6QE/3-$)U!!1$1)3D<M0D]45$]-.B`T<'@[(%1%6%0M04Q)1TXZ(&QE
M9G0[($U!4D=)3BU,1494.B`P<'0[($U!4D=)3BU224=(5#H@,'!T.R!415A4
M+4E.1$5.5#H@,'!T)R!V86QI9VX],T1B;W1T;VT@=VED=&@],T0U,B4^(#QD
M:78@<W1Y;&4],T0G1$E34$Q!63H@8FQO8VL[($9/3E0M1D%-24Q9.B!T:6UE
M<R!N97<@<F]M86X[($9/3E0M4TE:13H@,3!P=#L@34%21TE.+4Q%1E0Z(#!P
M=#L@34%21TE.+5))1TA4.B`P<'0[(%1%6%0M04Q)1TXZ(&QE9G0[(%1%6%0M
M24Y$14Y4.B`P<'0G/B!/<'1I;VYS(&]U='-T86YD:6YG(&%T(&5N9"!O9B!T
M:&4@<&5R:6]D/"]D:78^(#PO=&0^(#QT9"!S='EL93TS1"=0041$24Y'+4)/
M5%1/33H@-'!X)R!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)3X\9F]N="!S
M='EL93TS1"=&3TY4+5-)6D4Z(#$P<'0[($9/3E0M1D%-24Q9.B!T:6UE<R!N
M97<@<F]M86X[($1)4U!,05DZ(&EN;&EN92<^("9N8G-P.SPO9F]N=#X@/"]T
M9#X@/'1D('-T>6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#1P>"!D;W5B
M;&4[(%1%6%0M04Q)1TXZ(&QE9G0G('9A;&EG;CTS1&)O='1O;2!W:61T:#TS
M1#$E/CQF;VYT('-T>6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@1D].5"U&04U)
M3%DZ('1I;65S(&YE=R!R;VUA;CL@1$E34$Q!63H@:6YL:6YE)SX@)FYB<W`[
M/"]F;VYT/B`\+W1D/B`\=&0@<W1Y;&4],T0G0D]21$52+4)/5%1/33H@8FQA
M8VL@-'!X(&1O=6)L93L@1$E34$Q!63H@:6YL:6YE.R!&3TY4+49!34E,63H@
M=&EM97,@;F5W(')O;6%N.R!&3TY4+5-)6D4Z(#$P<'0[(%1%6%0M04Q)1TXZ
M(')I9VAT)R!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Y)3XQ+#@V,BPP.3D\
M+W1D/B`\=&0@<W1Y;&4],T0G4$%$1$E.1RU"3U143TTZ(#1P>#L@5$585"U!
M3$E'3CH@;&5F="<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@;F]W<F%P
M/3-$;F]W<F%P/CQF;VYT('-T>6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@1D].
M5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1$E34$Q!63H@:6YL:6YE)SX@
M)FYB<W`[/"]F;VYT/B`\+W1D/B`\=&0@<W1Y;&4],T0G4$%$1$E.1RU"3U14
M3TTZ(#1P>"<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24^/&9O;G0@<W1Y
M;&4],T0G1D].5"U325I%.B`Q,'!T.R!&3TY4+49!34E,63H@=&EM97,@;F5W
M(')O;6%N.R!$25-03$%9.B!I;FQI;F4G/B`F;F)S<#L\+V9O;G0^(#PO=&0^
M(#QT9"!S='EL93TS1"="3U)$15(M0D]45$]-.B!B;&%C:R`T<'@@9&]U8FQE
M.R!$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE<R!N97<@<F]M
M86X[($9/3E0M4TE:13H@,3!P=#L@5$585"U!3$E'3CH@;&5F="<@=F%L:6=N
M/3-$8F]T=&]M('=I9'1H/3-$,24^)#PO=&0^(#QT9"!S='EL93TS1"="3U)$
M15(M0D]45$]-.B!B;&%C:R`T<'@@9&]U8FQE.R!$25-03$%9.B!I;FQI;F4[
M($9/3E0M1D%-24Q9.B!T:6UE<R!N97<@<F]M86X[($9/3E0M4TE:13H@,3!P
M=#L@5$585"U!3$E'3CH@<FEG:'0G('9A;&EG;CTS1&)O='1O;2!W:61T:#TS
M1#DE/C,N-S,\+W1D/B`\=&0@<W1Y;&4],T0G4$%$1$E.1RU"3U143TTZ(#1P
M>#L@5$585"U!3$E'3CH@;&5F="<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$
M,24@;F]W<F%P/3-$;F]W<F%P/CQF;VYT('-T>6QE/3-$)T9/3E0M4TE:13H@
M,3!P=#L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1$E34$Q!63H@
M:6YL:6YE)SX@)FYB<W`[/"]F;VYT/B`\+W1D/B`\=&0@<W1Y;&4],T0G4$%$
M1$E.1RU"3U143TTZ(#1P>"<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24^
M/&9O;G0@<W1Y;&4],T0G1D].5"U325I%.B`Q,'!T.R!&3TY4+49!34E,63H@
M=&EM97,@;F5W(')O;6%N.R!$25-03$%9.B!I;FQI;F4G/B`F;F)S<#L\+V9O
M;G0^(#PO=&0^(#QT9"!S='EL93TS1"="3U)$15(M0D]45$]-.B!B;&%C:R`T
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M04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T.R!415A4
M+4%,24=..B!R:6=H="<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$.24^,RXQ
M,SPO=&0^(#QT9"!S='EL93TS1"=0041$24Y'+4)/5%1/33H@-'!X.R!415A4
M+4%,24=..B!L969T)R!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)2!N;W=R
M87`],T1N;W=R87`^/&9O;G0@<W1Y;&4],T0G1D].5"U325I%.B`Q,'!T.R!&
M3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!$25-03$%9.B!I;FQI;F4G
M/B`F;F)S<#L\+V9O;G0^(#PO=&0^(#QT9"!S='EL93TS1"=0041$24Y'+4)/
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M;VUA;CL@1D].5"U325I%.B`Q,'!T.R!415A4+4%,24=..B!L969T)R!V86QI
M9VX],T1B;W1T;VT@=VED=&@],T0Q)3XD/"]T9#X@/'1D('-T>6QE/3-$)T)/
M4D1%4BU"3U143TTZ(&)L86-K(#1P>"!D;W5B;&4[($1)4U!,05DZ(&EN;&EN
M93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q
M,'!T.R!415A4+4%,24=..B!R:6=H="<@=F%L:6=N/3-$8F]T=&]M('=I9'1H
M/3-$.24^,2PP-#8\+W1D/B`\=&0@<W1Y;&4],T0G4$%$1$E.1RU"3U143TTZ
M(#1P>#L@5$585"U!3$E'3CH@;&5F="<@=F%L:6=N/3-$8F]T=&]M('=I9'1H
M/3-$,24@;F]W<F%P/3-$;F]W<F%P/CQF;VYT('-T>6QE/3-$)T9/3E0M4TE:
M13H@,3!P=#L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1$E34$Q!
M63H@:6YL:6YE)SX@)FYB<W`[/"]F;VYT/B`\+W1D/B`\+W1R/B`\='(@8F=C
M;VQO<CTS1"-C8V5E9F8^(#QT9"!S='EL93TS1"=0041$24Y'+4)/5%1/33H@
M-'!X.R!415A4+4%,24=..B!L969T.R!-05)'24XM3$5&5#H@,'!T.R!-05)'
M24XM4DE'2%0Z(#!P=#L@5$585"U)3D1%3E0Z(#!P="<@=F%L:6=N/3-$8F]T
M=&]M('=I9'1H/3-$-3(E/B`\9&EV('-T>6QE/3-$)T1)4U!,05DZ(&)L;V-K
M.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!&3TY4+5-)6D4Z(#$P
M<'0[($U!4D=)3BU,1494.B`P<'0[($U!4D=)3BU224=(5#H@,'!T.R!415A4
M+4%,24=..B!L969T.R!415A4+4E.1$5.5#H@,'!T)SX@3W!T:6]N<R!E>&5R
M8VES86)L92!A="!T:&4@96YD(&]F('1H92!P97)I;V0\+V1I=CX@/"]T9#X@
M/'1D('-T>6QE/3-$)U!!1$1)3D<M0D]45$]-.B`T<'@G('9A;&EG;CTS1&)O
M='1O;2!W:61T:#TS1#$E/CQF;VYT('-T>6QE/3-$)T9/3E0M4TE:13H@,3!P
M=#L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1$E34$Q!63H@:6YL
M:6YE)SX@)FYB<W`[/"]F;VYT/B`\+W1D/B`\=&0@<W1Y;&4],T0G0D]21$52
M+4)/5%1/33H@8FQA8VL@-'!X(&1O=6)L93L@5$585"U!3$E'3CH@;&5F="<@
M=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24^/&9O;G0@<W1Y;&4],T0G1D].
M5"U325I%.B`Q,'!T.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!$
M25-03$%9.B!I;FQI;F4G/B`F;F)S<#L\+V9O;G0^(#PO=&0^(#QT9"!S='EL
M93TS1"="3U)$15(M0D]45$]-.B!B;&%C:R`T<'@@9&]U8FQE.R!$25-03$%9
M.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE<R!N97<@<F]M86X[($9/3E0M
M4TE:13H@,3!P=#L@5$585"U!3$E'3CH@<FEG:'0G('9A;&EG;CTS1&)O='1O
M;2!W:61T:#TS1#DE/C$L.#8R+#`Y.3PO=&0^(#QT9"!S='EL93TS1"=0041$
M24Y'+4)/5%1/33H@-'!X.R!415A4+4%,24=..B!L969T)R!V86QI9VX],T1B
M;W1T;VT@=VED=&@],T0Q)2!N;W=R87`],T1N;W=R87`^/&9O;G0@<W1Y;&4]
M,T0G1D].5"U325I%.B`Q,'!T.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O
M;6%N.R!$25-03$%9.B!I;FQI;F4G/B`F;F)S<#L\+V9O;G0^(#PO=&0^(#QT
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M5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T.R!4
M15A4+4%,24=..B!L969T)R!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)3XD
M/"]T9#X@/'1D('-T>6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#1P>"!D
M;W5B;&4[($1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE
M=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T.R!415A4+4%,24=..B!R:6=H="<@
M=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$.24^,RXW,SPO=&0^(#QT9"!S='EL
M93TS1"=0041$24Y'+4)/5%1/33H@-'!X.R!415A4+4%,24=..B!L969T)R!V
M86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)2!N;W=R87`],T1N;W=R87`^/&9O
M;G0@<W1Y;&4],T0G1D].5"U325I%.B`Q,'!T.R!&3TY4+49!34E,63H@=&EM
M97,@;F5W(')O;6%N.R!$25-03$%9.B!I;FQI;F4G/B`F;F)S<#L\+V9O;G0^
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M;VUA;CL@1$E34$Q!63H@:6YL:6YE)SX@)FYB<W`[/"]F;VYT/B`\+W1D/B`\
M=&0@<W1Y;&4],T0G0D]21$52+4)/5%1/33H@8FQA8VL@-'!X(&1O=6)L93L@
M1$E34$Q!63H@:6YL:6YE.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N
M.R!&3TY4+5-)6D4Z(#$P<'0[(%1%6%0M04Q)1TXZ(')I9VAT)R!V86QI9VX]
M,T1B;W1T;VT@=VED=&@],T0Y)3XS+C$S/"]T9#X@/'1D('-T>6QE/3-$)U!!
M1$1)3D<M0D]45$]-.B`T<'@[(%1%6%0M04Q)1TXZ(&QE9G0G('9A;&EG;CTS
M1&)O='1O;2!W:61T:#TS1#$E(&YO=W)A<#TS1&YO=W)A<#X\9F]N="!S='EL
M93TS1"=&3TY4+5-)6D4Z(#$P<'0[($9/3E0M1D%-24Q9.B!T:6UE<R!N97<@
M<F]M86X[($1)4U!,05DZ(&EN;&EN92<^("9N8G-P.SPO9F]N=#X@/"]T9#X@
M/'1D('-T>6QE/3-$)U!!1$1)3D<M0D]45$]-.B`T<'@G('9A;&EG;CTS1&)O
M='1O;2!W:61T:#TS1#$E/CQF;VYT('-T>6QE/3-$)T9/3E0M4TE:13H@,3!P
M=#L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1$E34$Q!63H@:6YL
M:6YE)SX@)FYB<W`[/"]F;VYT/B`\+W1D/B`\=&0@<W1Y;&4],T0G0D]21$52
M+4)/5%1/33H@8FQA8VL@-'!X(&1O=6)L93L@1$E34$Q!63H@:6YL:6YE.R!&
M3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!&3TY4+5-)6D4Z(#$P<'0[
M(%1%6%0M04Q)1TXZ(&QE9G0G('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E
M/B0\+W1D/B`\=&0@<W1Y;&4],T0G0D]21$52+4)/5%1/33H@8FQA8VL@-'!X
M(&1O=6)L93L@1$E34$Q!63H@:6YL:6YE.R!&3TY4+49!34E,63H@=&EM97,@
M;F5W(')O;6%N.R!&3TY4+5-)6D4Z(#$P<'0[(%1%6%0M04Q)1TXZ(')I9VAT
M)R!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Y)3XQ+#`T-CPO=&0^(#QT9"!S
M='EL93TS1"=0041$24Y'+4)/5%1/33H@-'!X.R!415A4+4%,24=..B!L969T
M)R!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)2!N;W=R87`],T1N;W=R87`^
M/&9O;G0@<W1Y;&4],T0G1D].5"U325I%.B`Q,'!T.R!&3TY4+49!34E,63H@
M=&EM97,@;F5W(')O;6%N.R!$25-03$%9.B!I;FQI;F4G/B`F;F)S<#L\+V9O
M;G0^(#PO=&0^(#PO='(^(#QT<B!B9V-O;&]R/3-$=VAI=&4^(#QT9"!S='EL
M93TS1"=0041$24Y'+4)/5%1/33H@-'!X.R!415A4+4%,24=..B!L969T.R!-
M05)'24XM3$5&5#H@,'!T.R!-05)'24XM4DE'2%0Z(#!P=#L@5$585"U)3D1%
M3E0Z(#!P="<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$-3(E/B`\9&EV('-T
M>6QE/3-$)T1)4U!,05DZ(&)L;V-K.R!&3TY4+49!34E,63H@=&EM97,@;F5W
M(')O;6%N.R!&3TY4+5-)6D4Z(#$P<'0[($U!4D=)3BU,1494.B`P<'0[($U!
M4D=)3BU224=(5#H@,'!T.R!415A4+4%,24=..B!L969T.R!415A4+4E.1$5.
M5#H@,'!T)SX@3W!T:6]N<R!V97-T960\+V1I=CX@/"]T9#X@/'1D('-T>6QE
M/3-$)U!!1$1)3D<M0D]45$]-.B`T<'@G('9A;&EG;CTS1&)O='1O;2!W:61T
M:#TS1#$E/CQF;VYT('-T>6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@1D].5"U&
M04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1$E34$Q!63H@:6YL:6YE)SX@)FYB
M<W`[/"]F;VYT/B`\+W1D/B`\=&0@<W1Y;&4],T0G0D]21$52+4)/5%1/33H@
M8FQA8VL@-'!X(&1O=6)L93L@5$585"U!3$E'3CH@;&5F="<@=F%L:6=N/3-$
M8F]T=&]M('=I9'1H/3-$,24^/&9O;G0@<W1Y;&4],T0G1D].5"U325I%.B`Q
M,'!T.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!$25-03$%9.B!I
M;FQI;F4G/B`F;F)S<#L\+V9O;G0^(#PO=&0^(#QT9"!S='EL93TS1"="3U)$
M15(M0D]45$]-.B!B;&%C:R`T<'@@9&]U8FQE.R!$25-03$%9.B!I;FQI;F4[
M($9/3E0M1D%-24Q9.B!T:6UE<R!N97<@<F]M86X[($9/3E0M4TE:13H@,3!P
M=#L@5$585"U!3$E'3CH@<FEG:'0G('9A;&EG;CTS1&)O='1O;2!W:61T:#TS
M1#DE/C$L.#8R+#`Y.3PO=&0^(#QT9"!S='EL93TS1"=0041$24Y'+4)/5%1/
M33H@-'!X.R!415A4+4%,24=..B!L969T)R!V86QI9VX],T1B;W1T;VT@=VED
M=&@],T0Q)2!N;W=R87`],T1N;W=R87`^/&9O;G0@<W1Y;&4],T0G1D].5"U3
M25I%.B`Q,'!T.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!$25-0
M3$%9.B!I;FQI;F4G/B`F;F)S<#L\+V9O;G0^(#PO=&0^(#QT9"!S='EL93TS
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M('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T.R!415A4+4%,24=.
M.B!L969T)R!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)3XD/"]T9#X@/'1D
M('-T>6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#1P>"!D;W5B;&4[($1)
M4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@
M1D].5"U325I%.B`Q,'!T.R!415A4+4%,24=..B!R:6=H="<@=F%L:6=N/3-$
M8F]T=&]M('=I9'1H/3-$.24^,RXW,SPO=&0^(#QT9"!S='EL93TS1"=0041$
M24Y'+4)/5%1/33H@-'!X.R!415A4+4%,24=..B!L969T)R!V86QI9VX],T1B
M;W1T;VT@=VED=&@],T0Q)2!N;W=R87`],T1N;W=R87`^/&9O;G0@<W1Y;&4]
M,T0G1D].5"U325I%.B`Q,'!T.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O
M;6%N.R!$25-03$%9.B!I;FQI;F4G/B`F;F)S<#L\+V9O;G0^(#PO=&0^(#QT
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M4$Q!63H@:6YL:6YE)SX@)FYB<W`[/"]F;VYT/B`\+W1D/B`\=&0@<W1Y;&4]
M,T0G0D]21$52+4)/5%1/33H@8FQA8VL@-'!X(&1O=6)L93L@1$E34$Q!63H@
M:6YL:6YE.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!&3TY4+5-)
M6D4Z(#$P<'0[(%1%6%0M04Q)1TXZ(')I9VAT)R!V86QI9VX],T1B;W1T;VT@
M=VED=&@],T0Y)3XS+C$S/"]T9#X@/'1D('-T>6QE/3-$)U!!1$1)3D<M0D]4
M5$]-.B`T<'@[(%1%6%0M04Q)1TXZ(&QE9G0G('9A;&EG;CTS1&)O='1O;2!W
M:61T:#TS1#$E(&YO=W)A<#TS1&YO=W)A<#X\9F]N="!S='EL93TS1"=&3TY4
M+5-)6D4Z(#$P<'0[($9/3E0M1D%-24Q9.B!T:6UE<R!N97<@<F]M86X[($1)
M4U!,05DZ(&EN;&EN92<^("9N8G-P.SPO9F]N=#X@/"]T9#X@/'1D('-T>6QE
M/3-$)U!!1$1)3D<M0D]45$]-.B`T<'@G('9A;&EG;CTS1&)O='1O;2!W:61T
M:#TS1#$E/CQF;VYT('-T>6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@1D].5"U&
M04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1$E34$Q!63H@:6YL:6YE)SX@)FYB
M<W`[/"]F;VYT/B`\+W1D/B`\=&0@<W1Y;&4],T0G0D]21$52+4)/5%1/33H@
M8FQA8VL@-'!X(&1O=6)L93L@1$E34$Q!63H@:6YL:6YE.R!&3TY4+49!34E,
M63H@=&EM97,@;F5W(')O;6%N.R!&3TY4+5-)6D4Z(#$P<'0[(%1%6%0M04Q)
M1TXZ(&QE9G0G('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E/B0\+W1D/B`\
M=&0@<W1Y;&4],T0G0D]21$52+4)/5%1/33H@8FQA8VL@-'!X(&1O=6)L93L@
M1$E34$Q!63H@:6YL:6YE.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N
M.R!&3TY4+5-)6D4Z(#$P<'0[(%1%6%0M04Q)1TXZ(')I9VAT)R!V86QI9VX]
M,T1B;W1T;VT@=VED=&@],T0Y)3XQ+#`T-CPO=&0^(#QT9"!S='EL93TS1"=0
M041$24Y'+4)/5%1/33H@-'!X.R!415A4+4%,24=..B!L969T)R!V86QI9VX]
M,T1B;W1T;VT@=VED=&@],T0Q)2!N;W=R87`],T1N;W=R87`^/&9O;G0@<W1Y
M;&4],T0G1D].5"U325I%.B`Q,'!T.R!&3TY4+49!34E,63H@=&EM97,@;F5W
M(')O;6%N.R!$25-03$%9.B!I;FQI;F4G/B`F;F)S<#L\+V9O;G0^(#PO=&0^
M(#PO='(^(#PO=&%B;&4^(#PO9&EV/B`\(2TM16YD1G)A9VUE;G0M+3X\+V1I
M=CX@/"]D:78^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@
M("`@/'1R(&-L87-S/3-$<F4^#0H@("`@("`@(#QT9"!C;&%S<STS1'!L('9A
M;&EG;CTS1'1O<#Y38VAE9'5L92!O9B!3=&]C:R!/<'1I;VX@86YD(%=A<G)A
M;G0@06-T:79I='D\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\
M(2TM1$]#5%E012!H=&UL(%!50DQ)0R`B+2\O5S-#+R]$5$0@6$A434P@,2XP
M(%1R86YS:71I;VYA;"\O14XB(")H='1P.B\O=W=W+G<S+F]R9R]44B]X:'1M
M;#$O1%1$+WAH=&UL,2UT<F%N<VET:6]N86PN9'1D(B`M+3X\9&EV/B`\9&EV
M/CPA+2U3=&%R=$9R86=M96YT+2T^(#QD:78^(#QT86)L92!S='EL93TS1"=&
M3TY4+5-)6D4Z(#$P<'0[($9/3E0M1D%-24Q9.B!T:6UE<R!N97<@<F]M86XG
M(&-E;&QS<&%C:6YG/3-$,"!C96QL<&%D9&EN9STS1#`@=VED=&@],T0Q,#`E
M(&%L:6=N/3-$8V5N=&5R(&)O<F1E<CTS1#`^(#QT<B!V86QI9VX],T1T;W`^
M(#QT9"!S='EL93TS1"=724142#H@,3AP="<^)FYB<W`[/"]T9#X@/'1D/B`\
M9&EV('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ(%1I
M;65S($YE=R!2;VUA;CL@1D].5"U325I%.B`Q,'!T.R!T97AT+6%L:6=N.B!L
M969T)SX@02!S=6UM87)Y(&]F('1H92!#;VUP86YY)B,S.3MS(&%C=&EV:71Y
M(')E;&%T960@=&\@;W!T:6]N<R!A;F0@=V%R<F%N=',@=&\@8V]N<W5L=&%N
M=',@:7,@87,@9F]L;&]W<SH\+V1I=CX@/"]T9#X@/"]T<CX@/"]T86)L93X@
M/"]D:78^(#QD:78^)FYB<W`[/"]D:78^(#QD:78@<W1Y;&4],T0G=&5X="UA
M;&EG;CH@<FEG:'0G/B`\=&%B;&4@<W1Y;&4],T0G1D].5"U325I%.B`Q,'!T
M.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N)R!C96QL<W!A8VEN9STS
M1#`@8V5L;'!A9&1I;F<],T0P('=I9'1H/3-$.3<E/B`\='(^(#QT9"!S='EL
M93TS1"=0041$24Y'+4)/5%1/33H@,G!X)R!V86QI9VX],T1B;W1T;VT@=VED
M=&@],T0U,B4^/&9O;G0@<W1Y;&4],T0G1D].5"U325I%.B`Q,'!T.R!&3TY4
M+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!$25-03$%9.B!I;FQI;F4G/B`F
M;F)S<#L\+V9O;G0^(#PO=&0^(#QT9"!S='EL93TS1"=0041$24Y'+4)/5%1/
M33H@,G!X)R!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)3X\9F]N="!S='EL
M93TS1"=&3TY4+5-)6D4Z(#$P<'0[($9/3E0M1D%-24Q9.B!T:6UE<R!N97<@
M<F]M86X[($9/3E0M5T5)1TA4.B!B;VQD.R!$25-03$%9.B!I;FQI;F4G/B`F
M;F)S<#L\+V9O;G0^(#PO=&0^(#QT9"!S='EL93TS1"="3U)$15(M0D]45$]-
M.B!B;&%C:R`R<'@@<V]L:60G('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#0V
M)2!C;VQS<&%N/3-$,30^(#QD:78@<W1Y;&4],T0G1$E34$Q!63H@8FQO8VL[
M($9/3E0M1D%-24Q9.B!T:6UE<R!N97<@<F]M86X[($9/3E0M4TE:13H@,3!P
M=#L@1D].5"U714E'2%0Z(&)O;&0[($U!4D=)3BU,1494.B`P<'0[($U!4D=)
M3BU224=(5#H@,'!T.R!T97AT+6%L:6=N.B!C96YT97([(%1%6%0M24Y$14Y4
M.B`P<'0G/B!996%R(&5N9&5D)FYB<W`[2G5N92`S,"P@,C`Q-#PO9&EV/B`\
M+W1D/B`\=&0@<W1Y;&4],T0G4$%$1$E.1RU"3U143TTZ(#)P>#L@5$585"U!
M3$E'3CH@;&5F="<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@;F]W<F%P
M/3-$;F]W<F%P/CQF;VYT('-T>6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@1D].
M5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U714E'2%0Z(&)O;&0[
M($1)4U!,05DZ(&EN;&EN92<^("9N8G-P.SPO9F]N=#X@/"]T9#X@/"]T<CX@
M/'1R/B`\=&0@<W1Y;&4],T0G4$%$1$E.1RU"3U143TTZ(#)P>"<@=F%L:6=N
M/3-$8F]T=&]M('=I9'1H/3-$-3(E/CQF;VYT('-T>6QE/3-$)T9/3E0M4TE:
M13H@,3!P=#L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1$E34$Q!
M63H@:6YL:6YE)SX@)FYB<W`[/"]F;VYT/B`\+W1D/B`\=&0@<W1Y;&4],T0G
M4$%$1$E.1RU"3U143TTZ(#)P>"<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$
M,24^/&9O;G0@<W1Y;&4],T0G1D].5"U325I%.B`Q,'!T.R!&3TY4+49!34E,
M63H@=&EM97,@;F5W(')O;6%N.R!&3TY4+5=%24=(5#H@8F]L9#L@1$E34$Q!
M63H@:6YL:6YE)SX@)FYB<W`[/"]F;VYT/B`\+W1D/B`\=&0@<W1Y;&4],T0G
M0D]21$52+4)/5%1/33H@8FQA8VL@,G!X('-O;&ED)R!V86QI9VX],T1B;W1T
M;VT@=VED=&@],T0Q,"4@8V]L<W!A;CTS1#(^(#QD:78@<W1Y;&4],T0G1$E3
M4$Q!63H@8FQO8VL[($9/3E0M1D%-24Q9.B!T:6UE<R!N97<@<F]M86X[($9/
M3E0M4TE:13H@,3!P=#L@1D].5"U714E'2%0Z(&)O;&0[($U!4D=)3BU,1494
M.B`P<'0[($U!4D=)3BU224=(5#H@,'!T.R!T97AT+6%L:6=N.B!C96YT97([
M(%1%6%0M24Y$14Y4.B`P<'0G/B!.=6UB97(\+V1I=CX@/"]T9#X@/'1D('-T
M>6QE/3-$)U!!1$1)3D<M0D]45$]-.B`R<'@[(%1%6%0M04Q)1TXZ(&QE9G0G
M('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E(&YO=W)A<#TS1&YO=W)A<#X\
M9F]N="!S='EL93TS1"=&3TY4+5-)6D4Z(#$P<'0[($9/3E0M1D%-24Q9.B!T
M:6UE<R!N97<@<F]M86X[($9/3E0M5T5)1TA4.B!B;VQD.R!$25-03$%9.B!I
M;FQI;F4G/B`F;F)S<#L\+V9O;G0^(#PO=&0^(#QT9"!S='EL93TS1"=0041$
M24Y'+4)/5%1/33H@,G!X)R!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)3X\
M9F]N="!S='EL93TS1"=&3TY4+5-)6D4Z(#$P<'0[($9/3E0M1D%-24Q9.B!T
M:6UE<R!N97<@<F]M86X[($9/3E0M5T5)1TA4.B!B;VQD.R!$25-03$%9.B!I
M;FQI;F4G/B`F;F)S<#L\+V9O;G0^(#PO=&0^(#QT9"!S='EL93TS1"="3U)$
M15(M0D]45$]-.B!B;&%C:R`R<'@@<V]L:60G('9A;&EG;CTS1&)O='1O;2!W
M:61T:#TS1#$P)2!C;VQS<&%N/3-$,CX@/&1I=B!S='EL93TS1"=$25-03$%9
M.B!B;&]C:SL@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U3
M25I%.B`Q,'!T.R!&3TY4+5=%24=(5#H@8F]L9#L@34%21TE.+4Q%1E0Z(#!P
M=#L@34%21TE.+5))1TA4.B`P<'0[('1E>'0M86QI9VXZ(&-E;G1E<CL@5$58
M5"U)3D1%3E0Z(#!P="<^(%=E:6=H=&5D($%V97)A9V4@17AE<F-I<V4@4')I
M8V4\+V1I=CX@/"]T9#X@/'1D('-T>6QE/3-$)U!!1$1)3D<M0D]45$]-.B`R
M<'@[(%1%6%0M04Q)1TXZ(&QE9G0G('9A;&EG;CTS1&)O='1O;2!W:61T:#TS
M1#$E(&YO=W)A<#TS1&YO=W)A<#X\9F]N="!S='EL93TS1"=&3TY4+5-)6D4Z
M(#$P<'0[($9/3E0M1D%-24Q9.B!T:6UE<R!N97<@<F]M86X[($9/3E0M5T5)
M1TA4.B!B;VQD.R!$25-03$%9.B!I;FQI;F4G/B`F;F)S<#L\+V9O;G0^(#PO
M=&0^(#QT9"!S='EL93TS1"=0041$24Y'+4)/5%1/33H@,G!X)R!V86QI9VX]
M,T1B;W1T;VT@=VED=&@],T0Q)3X\9F]N="!S='EL93TS1"=&3TY4+5-)6D4Z
M(#$P<'0[($9/3E0M1D%-24Q9.B!T:6UE<R!N97<@<F]M86X[($9/3E0M5T5)
M1TA4.B!B;VQD.R!$25-03$%9.B!I;FQI;F4G/B`F;F)S<#L\+V9O;G0^(#PO
M=&0^(#QT9"!S='EL93TS1"="3U)$15(M0D]45$]-.B!B;&%C:R`R<'@@<V]L
M:60G('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$P)2!C;VQS<&%N/3-$,CX@
M/&1I=B!S='EL93TS1"=$25-03$%9.B!B;&]C:SL@1D].5"U&04U)3%DZ('1I
M;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T.R!&3TY4+5=%24=(5#H@
M8F]L9#L@34%21TE.+4Q%1E0Z(#!P=#L@34%21TE.+5))1TA4.B`P<'0[('1E
M>'0M86QI9VXZ(&-E;G1E<CL@5$585"U)3D1%3E0Z(#!P="<^(%=E:6=H=&5D
M($%V97)A9V4@4F5M86EN:6YG($-O;G1R86-T=6%L(%1E<FUS("AI;B!Y96%R
M<RD\+V1I=CX@/"]T9#X@/'1D('-T>6QE/3-$)U!!1$1)3D<M0D]45$]-.B`R
M<'@[(%1%6%0M04Q)1TXZ(&QE9G0G('9A;&EG;CTS1&)O='1O;2!W:61T:#TS
M1#$E(&YO=W)A<#TS1&YO=W)A<#X\9F]N="!S='EL93TS1"=&3TY4+5-)6D4Z
M(#$P<'0[($9/3E0M1D%-24Q9.B!T:6UE<R!N97<@<F]M86X[($9/3E0M5T5)
M1TA4.B!B;VQD.R!$25-03$%9.B!I;FQI;F4G/B`F;F)S<#L\+V9O;G0^(#PO
M=&0^(#QT9"!S='EL93TS1"=0041$24Y'+4)/5%1/33H@,G!X)R!V86QI9VX]
M,T1B;W1T;VT@=VED=&@],T0Q)3X\9F]N="!S='EL93TS1"=&3TY4+5-)6D4Z
M(#$P<'0[($9/3E0M1D%-24Q9.B!T:6UE<R!N97<@<F]M86X[($9/3E0M5T5)
M1TA4.B!B;VQD.R!$25-03$%9.B!I;FQI;F4G/B`F;F)S<#L\+V9O;G0^(#PO
M=&0^(#QT9"!S='EL93TS1"="3U)$15(M0D]45$]-.B!B;&%C:R`R<'@@<V]L
M:60G('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$P)2!C;VQS<&%N/3-$,CX@
M/&1I=B!S='EL93TS1"=$25-03$%9.B!B;&]C:SL@1D].5"U&04U)3%DZ('1I
M;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T.R!&3TY4+5=%24=(5#H@
M8F]L9#L@34%21TE.+4Q%1E0Z(#!P=#L@34%21TE.+5))1TA4.B`P<'0[('1E
M>'0M86QI9VXZ(&-E;G1E<CL@5$585"U)3D1%3E0Z(#!P="<^($%G9W)E9V%T
M92!);G1R:6YS:6,@5F%L=64@4')I8V4\+V1I=CX@/"]T9#X@/'1D('-T>6QE
M/3-$)U!!1$1)3D<M0D]45$]-.B`R<'@[(%1%6%0M04Q)1TXZ(&QE9G0G('9A
M;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E(&YO=W)A<#TS1&YO=W)A<#X\9F]N
M="!S='EL93TS1"=&3TY4+5-)6D4Z(#$P<'0[($9/3E0M1D%-24Q9.B!T:6UE
M<R!N97<@<F]M86X[($9/3E0M5T5)1TA4.B!B;VQD.R!$25-03$%9.B!I;FQI
M;F4G/B`F;F)S<#L\+V9O;G0^(#PO=&0^(#PO='(^(#QT<B!B9V-O;&]R/3-$
M(V-C965F9CX@/'1D('-T>6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0[($U!4D=)
M3BU,1494.B`P<'0[($U!4D=)3BU224=(5#H@,'!T.R!415A4+4E.1$5.5#H@
M,'!T)R!V86QI9VX],T1B;W1T;VT@=VED=&@],T0U,B4^(#QD:78@<W1Y;&4]
M,T0G1$E34$Q!63H@8FQO8VL[($9/3E0M1D%-24Q9.B!T:6UE<R!N97<@<F]M
M86X[($9/3E0M4TE:13H@,3!P=#L@34%21TE.+4Q%1E0Z(#!P=#L@34%21TE.
M+5))1TA4.B`P<'0[(%1%6%0M04Q)1TXZ(&QE9G0[(%1%6%0M24Y$14Y4.B`P
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M=R!R;VUA;CL@1$E34$Q!63H@:6YL:6YE)SX@)FYB<W`[/"]F;VYT/B`\+W1D
M/B`\=&0@<W1Y;&4],T0G1$E34$Q!63H@:6YL:6YE.R!&3TY4+49!34E,63H@
M=&EM97,@;F5W(')O;6%N.R!&3TY4+5-)6D4Z(#$P<'0[(%1%6%0M04Q)1TXZ
M(')I9VAT)R!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Y)3XS,34L-3`P/"]T
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M1$E34$Q!63H@:6YL:6YE)SX@)FYB<W`[/"]F;VYT/B`\+W1D/B`\=&0@<W1Y
M;&4],T0G1$E34$Q!63H@:6YL:6YE.R!&3TY4+49!34E,63H@=&EM97,@;F5W
M(')O;6%N.R!&3TY4+5-)6D4Z(#$P<'0[(%1%6%0M04Q)1TXZ(&QE9G0G('9A
M;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E/B0\+W1D/B`\=&0@<W1Y;&4],T0G
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M)FYB<W`[/"]F;VYT/B`\+W1D/B`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H
M/3-$,3`E(&-O;'-P86X],T0R/CQF;VYT('-T>6QE/3-$)T9/3E0M4TE:13H@
M,3!P=#L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1$E34$Q!63H@
M:6YL:6YE)SX@)FYB<W`[/"]F;VYT/B`\+W1D/B`\=&0@<W1Y;&4],T0G5$58
M5"U!3$E'3CH@;&5F="<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@;F]W
M<F%P/3-$;F]W<F%P/CQF;VYT('-T>6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@
M1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1$E34$Q!63H@:6YL:6YE
M)SX@)FYB<W`[/"]F;VYT/B`\+W1D/B`\=&0@=F%L:6=N/3-$8F]T=&]M('=I
M9'1H/3-$,24^/&9O;G0@<W1Y;&4],T0G1D].5"U325I%.B`Q,'!T.R!&3TY4
M+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!$25-03$%9.B!I;FQI;F4G/B`F
M;F)S<#L\+V9O;G0^(#PO=&0^(#QT9"!V86QI9VX],T1B;W1T;VT@=VED=&@]
M,T0Q,"4@8V]L<W!A;CTS1#(^/&9O;G0@<W1Y;&4],T0G1D].5"U325I%.B`Q
M,'!T.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!$25-03$%9.B!I
M;FQI;F4G/B`F;F)S<#L\+V9O;G0^(#PO=&0^(#QT9"!S='EL93TS1"=415A4
M+4%,24=..B!L969T)R!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)2!N;W=R
M87`],T1N;W=R87`^/&9O;G0@<W1Y;&4],T0G1D].5"U325I%.B`Q,'!T.R!&
M3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!$25-03$%9.B!I;FQI;F4G
M/B`F;F)S<#L\+V9O;G0^(#PO=&0^(#PO='(^(#QT<B!B9V-O;&]R/3-$=VAI
M=&4^(#QT9"!S='EL93TS1"=415A4+4%,24=..B!L969T.R!-05)'24XM3$5&
M5#H@,'!T.R!-05)'24XM4DE'2%0Z(#!P=#L@5$585"U)3D1%3E0Z(#!P="<@
M=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$-3(E/B`\9&EV('-T>6QE/3-$)T1)
M4U!,05DZ(&)L;V-K.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!&
M3TY4+5-)6D4Z(#$P<'0[($U!4D=)3BU,1494.B`P<'0[($U!4D=)3BU224=(
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M=R!R;VUA;CL@1$E34$Q!63H@:6YL:6YE)SX@)FYB<W`[/"]F;VYT/B`\+W1D
M/B`\=&0@<W1Y;&4],T0G1$E34$Q!63H@:6YL:6YE.R!&3TY4+49!34E,63H@
M=&EM97,@;F5W(')O;6%N.R!&3TY4+5-)6D4Z(#$P<'0[(%1%6%0M04Q)1TXZ
M(')I9VAT)R!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Y)3XS+#`P,#PO=&0^
M(#QT9"!S='EL93TS1"=415A4+4%,24=..B!L969T)R!V86QI9VX],T1B;W1T
M;VT@=VED=&@],T0Q)2!N;W=R87`],T1N;W=R87`^/&9O;G0@<W1Y;&4],T0G
M1D].5"U325I%.B`Q,'!T.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N
M.R!$25-03$%9.B!I;FQI;F4G/B`F;F)S<#L\+V9O;G0^(#PO=&0^(#QT9"!V
M86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)3X\9F]N="!S='EL93TS1"=&3TY4
M+5-)6D4Z(#$P<'0[($9/3E0M1D%-24Q9.B!T:6UE<R!N97<@<F]M86X[($1)
M4U!,05DZ(&EN;&EN92<^("9N8G-P.SPO9F]N=#X@/"]T9#X@/'1D('-T>6QE
M/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R
M;VUA;CL@1D].5"U325I%.B`Q,'!T.R!415A4+4%,24=..B!L969T)R!V86QI
M9VX],T1B;W1T;VT@=VED=&@],T0Q)3XD/"]T9#X@/'1D('-T>6QE/3-$)T1)
M4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@
M1D].5"U325I%.B`Q,'!T.R!415A4+4%,24=..B!R:6=H="<@=F%L:6=N/3-$
M8F]T=&]M('=I9'1H/3-$.24^,"XP,#PO=&0^(#QT9"!S='EL93TS1"=415A4
M+4%,24=..B!L969T)R!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)2!N;W=R
M87`],T1N;W=R87`^/&9O;G0@<W1Y;&4],T0G1D].5"U325I%.B`Q,'!T.R!&
M3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!$25-03$%9.B!I;FQI;F4G
M/B`F;F)S<#L\+V9O;G0^(#PO=&0^(#QT9"!V86QI9VX],T1B;W1T;VT@=VED
M=&@],T0Q)3X\9F]N="!S='EL93TS1"=&3TY4+5-)6D4Z(#$P<'0[($9/3E0M
M1D%-24Q9.B!T:6UE<R!N97<@<F]M86X[($1)4U!,05DZ(&EN;&EN92<^("9N
M8G-P.SPO9F]N=#X@/"]T9#X@/'1D('9A;&EG;CTS1&)O='1O;2!W:61T:#TS
M1#$P)2!C;VQS<&%N/3-$,CX\9F]N="!S='EL93TS1"=&3TY4+5-)6D4Z(#$P
M<'0[($9/3E0M1D%-24Q9.B!T:6UE<R!N97<@<F]M86X[($1)4U!,05DZ(&EN
M;&EN92<^("9N8G-P.SPO9F]N=#X@/"]T9#X@/'1D('-T>6QE/3-$)U1%6%0M
M04Q)1TXZ(&QE9G0G('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E(&YO=W)A
M<#TS1&YO=W)A<#X\9F]N="!S='EL93TS1"=&3TY4+5-)6D4Z(#$P<'0[($9/
M3E0M1D%-24Q9.B!T:6UE<R!N97<@<F]M86X[($1)4U!,05DZ(&EN;&EN92<^
M("9N8G-P.SPO9F]N=#X@/"]T9#X@/'1D('9A;&EG;CTS1&)O='1O;2!W:61T
M:#TS1#$E/CQF;VYT('-T>6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@1D].5"U&
M04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1$E34$Q!63H@:6YL:6YE)SX@)FYB
M<W`[/"]F;VYT/B`\+W1D/B`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$
M,3`E(&-O;'-P86X],T0R/CQF;VYT('-T>6QE/3-$)T9/3E0M4TE:13H@,3!P
M=#L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1$E34$Q!63H@:6YL
M:6YE)SX@)FYB<W`[/"]F;VYT/B`\+W1D/B`\=&0@<W1Y;&4],T0G5$585"U!
M3$E'3CH@;&5F="<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@;F]W<F%P
M/3-$;F]W<F%P/CQF;VYT('-T>6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@1D].
M5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1$E34$Q!63H@:6YL:6YE)SX@
M)FYB<W`[/"]F;VYT/B`\+W1D/B`\+W1R/B`\='(@8F=C;VQO<CTS1"-C8V5E
M9F8^(#QT9"!S='EL93TS1"=0041$24Y'+4)/5%1/33H@,G!X.R!415A4+4%,
M24=..B!L969T.R!-05)'24XM3$5&5#H@,'!T.R!-05)'24XM4DE'2%0Z(#!P
M=#L@5$585"U)3D1%3E0Z(#!P="<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$
M-3(E/B`\9&EV('-T>6QE/3-$)T1)4U!,05DZ(&)L;V-K.R!&3TY4+49!34E,
M63H@=&EM97,@;F5W(')O;6%N.R!&3TY4+5-)6D4Z(#$P<'0[($U!4D=)3BU,
M1494.B`P<'0[($U!4D=)3BU224=(5#H@,'!T.R!415A4+4%,24=..B!L969T
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M/&9O;G0@<W1Y;&4],T0G1D].5"U325I%.B`Q,'!T.R!&3TY4+49!34E,63H@
M=&EM97,@;F5W(')O;6%N.R!$25-03$%9.B!I;FQI;F4G/B`F;F)S<#L\+V9O
M;G0^(#PO=&0^(#QT9"!S='EL93TS1"="3U)$15(M0D]45$]-.B!B;&%C:R`R
M<'@@<V]L:60[($1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S
M(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T.R!415A4+4%,24=..B!R:6=H
M="<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$.24^*#8V+#4P,#PO=&0^(#QT
M9"!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE
M<R!N97<@<F]M86X[($9/3E0M4TE:13H@,3!P=#L@4$%$1$E.1RU"3U143TTZ
M(#)P>#L@5$585"U!3$E'3CH@;&5F="<@=F%L:6=N/3-$8F]T=&]M('=I9'1H
M/3-$,24@;F]W<F%P/3-$;F]W<F%P/BD\+W1D/B`\=&0@<W1Y;&4],T0G4$%$
M1$E.1RU"3U143TTZ(#)P>"<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24^
M/&9O;G0@<W1Y;&4],T0G1D].5"U325I%.B`Q,'!T.R!&3TY4+49!34E,63H@
M=&EM97,@;F5W(')O;6%N.R!$25-03$%9.B!I;FQI;F4G/B`F;F)S<#L\+V9O
M;G0^(#PO=&0^(#QT9"!S='EL93TS1"="3U)$15(M0D]45$]-.B!B;&%C:R`R
M<'@@<V]L:60[($1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S
M(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T.R!415A4+4%,24=..B!L969T
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M5$]-.B`R<'@[(%1%6%0M04Q)1TXZ(&QE9G0G('9A;&EG;CTS1&)O='1O;2!W
M:61T:#TS1#$E(&YO=W)A<#TS1&YO=W)A<#X\9F]N="!S='EL93TS1"=&3TY4
M+5-)6D4Z(#$P<'0[($9/3E0M1D%-24Q9.B!T:6UE<R!N97<@<F]M86X[($1)
M4U!,05DZ(&EN;&EN92<^("9N8G-P.SPO9F]N=#X@/"]T9#X@/'1D('-T>6QE
M/3-$)U!!1$1)3D<M0D]45$]-.B`R<'@G('9A;&EG;CTS1&)O='1O;2!W:61T
M:#TS1#$E/CQF;VYT('-T>6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@1D].5"U&
M04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1$E34$Q!63H@:6YL:6YE)SX@)FYB
M<W`[/"]F;VYT/B`\+W1D/B`\=&0@<W1Y;&4],T0G4$%$1$E.1RU"3U143TTZ
M(#)P>"<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,3`E(&-O;'-P86X],T0R
M/CQF;VYT('-T>6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ
M('1I;65S(&YE=R!R;VUA;CL@1$E34$Q!63H@:6YL:6YE)SX@)FYB<W`[/"]F
M;VYT/B`\+W1D/B`\=&0@<W1Y;&4],T0G4$%$1$E.1RU"3U143TTZ(#)P>#L@
M5$585"U!3$E'3CH@;&5F="<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@
M;F]W<F%P/3-$;F]W<F%P/CQF;VYT('-T>6QE/3-$)T9/3E0M4TE:13H@,3!P
M=#L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1$E34$Q!63H@:6YL
M:6YE)SX@)FYB<W`[/"]F;VYT/B`\+W1D/B`\=&0@<W1Y;&4],T0G4$%$1$E.
M1RU"3U143TTZ(#)P>"<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24^/&9O
M;G0@<W1Y;&4],T0G1D].5"U325I%.B`Q,'!T.R!&3TY4+49!34E,63H@=&EM
M97,@;F5W(')O;6%N.R!$25-03$%9.B!I;FQI;F4G/B`F;F)S<#L\+V9O;G0^
M(#PO=&0^(#QT9"!S='EL93TS1"=0041$24Y'+4)/5%1/33H@,G!X)R!V86QI
M9VX],T1B;W1T;VT@=VED=&@],T0Q,"4@8V]L<W!A;CTS1#(^/&9O;G0@<W1Y
M;&4],T0G1D].5"U325I%.B`Q,'!T.R!&3TY4+49!34E,63H@=&EM97,@;F5W
M(')O;6%N.R!$25-03$%9.B!I;FQI;F4G/B`F;F)S<#L\+V9O;G0^(#PO=&0^
M(#QT9"!S='EL93TS1"=0041$24Y'+4)/5%1/33H@,G!X.R!415A4+4%,24=.
M.B!L969T)R!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)2!N;W=R87`],T1N
M;W=R87`^/&9O;G0@<W1Y;&4],T0G1D].5"U325I%.B`Q,'!T.R!&3TY4+49!
M34E,63H@=&EM97,@;F5W(')O;6%N.R!$25-03$%9.B!I;FQI;F4G/B`F;F)S
M<#L\+V9O;G0^(#PO=&0^(#PO='(^(#QT<B!B9V-O;&]R/3-$=VAI=&4^(#QT
M9"!S='EL93TS1"=0041$24Y'+4)/5%1/33H@-'!X.R!415A4+4%,24=..B!L
M969T.R!-05)'24XM3$5&5#H@,'!T.R!-05)'24XM4DE'2%0Z(#!P=#L@5$58
M5"U)3D1%3E0Z(#!P="<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$-3(E/B`\
M9&EV('-T>6QE/3-$)T1)4U!,05DZ(&)L;V-K.R!&3TY4+49!34E,63H@=&EM
M97,@;F5W(')O;6%N.R!&3TY4+5-)6D4Z(#$P<'0[($U!4D=)3BU,1494.B`P
M<'0[($U!4D=)3BU224=(5#H@,'!T.R!415A4+4%,24=..B!L969T.R!415A4
M+4E.1$5.5#H@,'!T)SX@3W!T:6]N<R!A;F0@=V%R<F%N=',@;W5T<W1A;F1I
M;F<@870@96YD(&]F('1H92!P97)I;V0\+V1I=CX@/"]T9#X@/'1D('-T>6QE
M/3-$)U!!1$1)3D<M0D]45$]-.B`T<'@G('9A;&EG;CTS1&)O='1O;2!W:61T
M:#TS1#$E/CQF;VYT('-T>6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@1D].5"U&
M04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1$E34$Q!63H@:6YL:6YE)SX@)FYB
M<W`[/"]F;VYT/B`\+W1D/B`\=&0@<W1Y;&4],T0G0D]21$52+4)/5%1/33H@
M8FQA8VL@-'!X(&1O=6)L93L@5$585"U!3$E'3CH@;&5F="<@=F%L:6=N/3-$
M8F]T=&]M('=I9'1H/3-$,24^/&9O;G0@<W1Y;&4],T0G1D].5"U325I%.B`Q
M,'!T.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!$25-03$%9.B!I
M;FQI;F4G/B`F;F)S<#L\+V9O;G0^(#PO=&0^(#QT9"!S='EL93TS1"="3U)$
M15(M0D]45$]-.B!B;&%C:R`T<'@@9&]U8FQE.R!$25-03$%9.B!I;FQI;F4[
M($9/3E0M1D%-24Q9.B!T:6UE<R!N97<@<F]M86X[($9/3E0M4TE:13H@,3!P
M=#L@5$585"U!3$E'3CH@<FEG:'0G('9A;&EG;CTS1&)O='1O;2!W:61T:#TS
M1#DE/C(U,BPP,#`\+W1D/B`\=&0@<W1Y;&4],T0G4$%$1$E.1RU"3U143TTZ
M(#1P>#L@5$585"U!3$E'3CH@;&5F="<@=F%L:6=N/3-$8F]T=&]M('=I9'1H
M/3-$,24@;F]W<F%P/3-$;F]W<F%P/CQF;VYT('-T>6QE/3-$)T9/3E0M4TE:
M13H@,3!P=#L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1$E34$Q!
M63H@:6YL:6YE)SX@)FYB<W`[/"]F;VYT/B`\+W1D/B`\=&0@<W1Y;&4],T0G
M4$%$1$E.1RU"3U143TTZ(#1P>"<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$
M,24^/&9O;G0@<W1Y;&4],T0G1D].5"U325I%.B`Q,'!T.R!&3TY4+49!34E,
M63H@=&EM97,@;F5W(')O;6%N.R!$25-03$%9.B!I;FQI;F4G/B`F;F)S<#L\
M+V9O;G0^(#PO=&0^(#QT9"!S='EL93TS1"="3U)$15(M0D]45$]-.B!B;&%C
M:R`T<'@@9&]U8FQE.R!$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T
M:6UE<R!N97<@<F]M86X[($9/3E0M4TE:13H@,3!P=#L@5$585"U!3$E'3CH@
M;&5F="<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24^)#PO=&0^(#QT9"!S
M='EL93TS1"="3U)$15(M0D]45$]-.B!B;&%C:R`T<'@@9&]U8FQE.R!$25-0
M3$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE<R!N97<@<F]M86X[($9/
M3E0M4TE:13H@,3!P=#L@5$585"U!3$E'3CH@<FEG:'0G('9A;&EG;CTS1&)O
M='1O;2!W:61T:#TS1#DE/C4N,3D\+W1D/B`\=&0@<W1Y;&4],T0G4$%$1$E.
M1RU"3U143TTZ(#1P>#L@5$585"U!3$E'3CH@;&5F="<@=F%L:6=N/3-$8F]T
M=&]M('=I9'1H/3-$,24@;F]W<F%P/3-$;F]W<F%P/CQF;VYT('-T>6QE/3-$
M)T9/3E0M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA
M;CL@1$E34$Q!63H@:6YL:6YE)SX@)FYB<W`[/"]F;VYT/B`\+W1D/B`\=&0@
M<W1Y;&4],T0G4$%$1$E.1RU"3U143TTZ(#1P>"<@=F%L:6=N/3-$8F]T=&]M
M('=I9'1H/3-$,24^/&9O;G0@<W1Y;&4],T0G1D].5"U325I%.B`Q,'!T.R!&
M3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!$25-03$%9.B!I;FQI;F4G
M/B`F;F)S<#L\+V9O;G0^(#PO=&0^(#QT9"!S='EL93TS1"="3U)$15(M0D]4
M5$]-.B!B;&%C:R`T<'@@9&]U8FQE.R!415A4+4%,24=..B!L969T)R!V86QI
M9VX],T1B;W1T;VT@=VED=&@],T0Q)3X\9F]N="!S='EL93TS1"=&3TY4+5-)
M6D4Z(#$P<'0[($9/3E0M1D%-24Q9.B!T:6UE<R!N97<@<F]M86X[($1)4U!,
M05DZ(&EN;&EN92<^("9N8G-P.SPO9F]N=#X@/"]T9#X@/'1D('-T>6QE/3-$
M)T)/4D1%4BU"3U143TTZ(&)L86-K(#1P>"!D;W5B;&4[($1)4U!,05DZ(&EN
M;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%
M.B`Q,'!T.R!415A4+4%,24=..B!R:6=H="<@=F%L:6=N/3-$8F]T=&]M('=I
M9'1H/3-$.24^,RXY-CPO=&0^(#QT9"!S='EL93TS1"=0041$24Y'+4)/5%1/
M33H@-'!X.R!415A4+4%,24=..B!L969T)R!V86QI9VX],T1B;W1T;VT@=VED
M=&@],T0Q)2!N;W=R87`],T1N;W=R87`^/&9O;G0@<W1Y;&4],T0G1D].5"U3
M25I%.B`Q,'!T.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!$25-0
M3$%9.B!I;FQI;F4G/B`F;F)S<#L\+V9O;G0^(#PO=&0^(#QT9"!S='EL93TS
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M('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T.R!415A4+4%,24=.
M.B!L969T)R!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)3XD/"]T9#X@/'1D
M('-T>6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#1P>"!D;W5B;&4[($1)
M4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@
M1D].5"U325I%.B`Q,'!T.R!415A4+4%,24=..B!R:6=H="<@=F%L:6=N/3-$
M8F]T=&]M('=I9'1H/3-$.24^,S,Q/"]T9#X@/'1D('-T>6QE/3-$)U!!1$1)
M3D<M0D]45$]-.B`T<'@[(%1%6%0M04Q)1TXZ(&QE9G0G('9A;&EG;CTS1&)O
M='1O;2!W:61T:#TS1#$E(&YO=W)A<#TS1&YO=W)A<#X\9F]N="!S='EL93TS
M1"=&3TY4+5-)6D4Z(#$P<'0[($9/3E0M1D%-24Q9.B!T:6UE<R!N97<@<F]M
M86X[($1)4U!,05DZ(&EN;&EN92<^("9N8G-P.SPO9F]N=#X@/"]T9#X@/"]T
M<CX@/'1R(&)G8V]L;W(],T0C8V-E969F/B`\=&0@<W1Y;&4],T0G4$%$1$E.
M1RU"3U143TTZ(#1P>#L@5$585"U!3$E'3CH@;&5F=#L@34%21TE.+4Q%1E0Z
M(#!P=#L@34%21TE.+5))1TA4.B`P<'0[(%1%6%0M24Y$14Y4.B`P<'0G('9A
M;&EG;CTS1&)O='1O;2!W:61T:#TS1#4R)3X@/&1I=B!S='EL93TS1"=$25-0
M3$%9.B!B;&]C:SL@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].
M5"U325I%.B`Q,'!T.R!-05)'24XM3$5&5#H@,'!T.R!-05)'24XM4DE'2%0Z
M(#!P=#L@5$585"U!3$E'3CH@;&5F=#L@5$585"U)3D1%3E0Z(#!P="<^($]P
M=&EO;G,@86YD('=A<G)A;G1S(&5X97)C:7-A8FQE(&%T('1H92!E;F0@;V8@
M=&AE('!E<FEO9#PO9&EV/B`\+W1D/B`\=&0@<W1Y;&4],T0G4$%$1$E.1RU"
M3U143TTZ(#1P>"<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24^/&9O;G0@
M<W1Y;&4],T0G1D].5"U325I%.B`Q,'!T.R!&3TY4+49!34E,63H@=&EM97,@
M;F5W(')O;6%N.R!$25-03$%9.B!I;FQI;F4G/B`F;F)S<#L\+V9O;G0^(#PO
M=&0^(#QT9"!S='EL93TS1"="3U)$15(M0D]45$]-.B!B;&%C:R`T<'@@9&]U
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M('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T.R!415A4+4%,24=.
M.B!R:6=H="<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$.24^,C4Q+#`P,#PO
M=&0^(#QT9"!S='EL93TS1"=0041$24Y'+4)/5%1/33H@-'!X.R!415A4+4%,
M24=..B!L969T)R!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)2!N;W=R87`]
M,T1N;W=R87`^/&9O;G0@<W1Y;&4],T0G1D].5"U325I%.B`Q,'!T.R!&3TY4
M+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!$25-03$%9.B!I;FQI;F4G/B`F
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M;CL@1D].5"U325I%.B`Q,'!T.R!415A4+4%,24=..B!L969T)R!V86QI9VX]
M,T1B;W1T;VT@=VED=&@],T0Q)3XD/"]T9#X@/'1D('-T>6QE/3-$)T)/4D1%
M4BU"3U143TTZ(&)L86-K(#1P>"!D;W5B;&4[($1)4U!,05DZ(&EN;&EN93L@
M1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T
M.R!415A4+4%,24=..B!R:6=H="<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$
M.24^-2XR,3PO=&0^(#QT9"!S='EL93TS1"=0041$24Y'+4)/5%1/33H@-'!X
M.R!415A4+4%,24=..B!L969T)R!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q
M)2!N;W=R87`],T1N;W=R87`^/&9O;G0@<W1Y;&4],T0G1D].5"U325I%.B`Q
M,'!T.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!$25-03$%9.B!I
M;FQI;F4G/B`F;F)S<#L\+V9O;G0^(#PO=&0^(#QT9"!S='EL93TS1"=0041$
M24Y'+4)/5%1/33H@-'!X)R!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)3X\
M9F]N="!S='EL93TS1"=&3TY4+5-)6D4Z(#$P<'0[($9/3E0M1D%-24Q9.B!T
M:6UE<R!N97<@<F]M86X[($1)4U!,05DZ(&EN;&EN92<^("9N8G-P.SPO9F]N
M=#X@/"]T9#X@/'1D('-T>6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#1P
M>"!D;W5B;&4[(%1%6%0M04Q)1TXZ(&QE9G0G('9A;&EG;CTS1&)O='1O;2!W
M:61T:#TS1#$E/CQF;VYT('-T>6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@1D].
M5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1$E34$Q!63H@:6YL:6YE)SX@
M)FYB<W`[/"]F;VYT/B`\+W1D/B`\=&0@<W1Y;&4],T0G0D]21$52+4)/5%1/
M33H@8FQA8VL@-'!X(&1O=6)L93L@1$E34$Q!63H@:6YL:6YE.R!&3TY4+49!
M34E,63H@=&EM97,@;F5W(')O;6%N.R!&3TY4+5-)6D4Z(#$P<'0[(%1%6%0M
M04Q)1TXZ(')I9VAT)R!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Y)3XS+CDS
M/"]T9#X@/'1D('-T>6QE/3-$)U!!1$1)3D<M0D]45$]-.B`T<'@[(%1%6%0M
M04Q)1TXZ(&QE9G0G('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E(&YO=W)A
M<#TS1&YO=W)A<#X\9F]N="!S='EL93TS1"=&3TY4+5-)6D4Z(#$P<'0[($9/
M3E0M1D%-24Q9.B!T:6UE<R!N97<@<F]M86X[($1)4U!,05DZ(&EN;&EN92<^
M("9N8G-P.SPO9F]N=#X@/"]T9#X@/'1D('-T>6QE/3-$)U!!1$1)3D<M0D]4
M5$]-.B`T<'@G('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E/CQF;VYT('-T
M>6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ('1I;65S(&YE
M=R!R;VUA;CL@1$E34$Q!63H@:6YL:6YE)SX@)FYB<W`[/"]F;VYT/B`\+W1D
M/B`\=&0@<W1Y;&4],T0G0D]21$52+4)/5%1/33H@8FQA8VL@-'!X(&1O=6)L
M93L@1$E34$Q!63H@:6YL:6YE.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O
M;6%N.R!&3TY4+5-)6D4Z(#$P<'0[(%1%6%0M04Q)1TXZ(&QE9G0G('9A;&EG
M;CTS1&)O='1O;2!W:61T:#TS1#$E/B0\+W1D/B`\=&0@<W1Y;&4],T0G0D]2
M1$52+4)/5%1/33H@8FQA8VL@-'!X(&1O=6)L93L@1$E34$Q!63H@:6YL:6YE
M.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!&3TY4+5-)6D4Z(#$P
M<'0[(%1%6%0M04Q)1TXZ(')I9VAT)R!V86QI9VX],T1B;W1T;VT@=VED=&@]
M,T0Y)3XS,C@\+W1D/B`\=&0@<W1Y;&4],T0G4$%$1$E.1RU"3U143TTZ(#1P
M>#L@5$585"U!3$E'3CH@;&5F="<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$
M,24@;F]W<F%P/3-$;F]W<F%P/CQF;VYT('-T>6QE/3-$)T9/3E0M4TE:13H@
M,3!P=#L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1$E34$Q!63H@
M:6YL:6YE)SX@)FYB<W`[/"]F;VYT/B`\+W1D/B`\+W1R/B`\='(@8F=C;VQO
M<CTS1'=H:71E/B`\=&0@<W1Y;&4],T0G4$%$1$E.1RU"3U143TTZ(#1P>#L@
M5$585"U!3$E'3CH@;&5F=#L@34%21TE.+4Q%1E0Z(#!P=#L@34%21TE.+5))
M1TA4.B`P<'0[(%1%6%0M24Y$14Y4.B`P<'0G('9A;&EG;CTS1&)O='1O;2!W
M:61T:#TS1#4R)3X@/&1I=B!S='EL93TS1"=$25-03$%9.B!B;&]C:SL@1D].
M5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T.R!-
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M=R!R;VUA;CL@1$E34$Q!63H@:6YL:6YE)SX@)FYB<W`[/"]F;VYT/B`\+W1D
M/B`\=&0@<W1Y;&4],T0G0D]21$52+4)/5%1/33H@8FQA8VL@-'!X(&1O=6)L
M93L@1$E34$Q!63H@:6YL:6YE.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O
M;6%N.R!&3TY4+5-)6D4Z(#$P<'0[(%1%6%0M04Q)1TXZ(')I9VAT)R!V86QI
M9VX],T1B;W1T;VT@=VED=&@],T0Y)3XR-3(L,#`P/"]T9#X@/'1D('-T>6QE
M/3-$)U!!1$1)3D<M0D]45$]-.B`T<'@[(%1%6%0M04Q)1TXZ(&QE9G0G('9A
M;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E(&YO=W)A<#TS1&YO=W)A<#X\9F]N
M="!S='EL93TS1"=&3TY4+5-)6D4Z(#$P<'0[($9/3E0M1D%-24Q9.B!T:6UE
M<R!N97<@<F]M86X[($1)4U!,05DZ(&EN;&EN92<^("9N8G-P.SPO9F]N=#X@
M/"]T9#X@/'1D('-T>6QE/3-$)U!!1$1)3D<M0D]45$]-.B`T<'@G('9A;&EG
M;CTS1&)O='1O;2!W:61T:#TS1#$E/CQF;VYT('-T>6QE/3-$)T9/3E0M4TE:
M13H@,3!P=#L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1$E34$Q!
M63H@:6YL:6YE)SX@)FYB<W`[/"]F;VYT/B`\+W1D/B`\=&0@<W1Y;&4],T0G
M0D]21$52+4)/5%1/33H@8FQA8VL@-'!X(&1O=6)L93L@1$E34$Q!63H@:6YL
M:6YE.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!&3TY4+5-)6D4Z
M(#$P<'0[(%1%6%0M04Q)1TXZ(&QE9G0G('9A;&EG;CTS1&)O='1O;2!W:61T
M:#TS1#$E/B0\+W1D/B`\=&0@<W1Y;&4],T0G0D]21$52+4)/5%1/33H@8FQA
M8VL@-'!X(&1O=6)L93L@1$E34$Q!63H@:6YL:6YE.R!&3TY4+49!34E,63H@
M=&EM97,@;F5W(')O;6%N.R!&3TY4+5-)6D4Z(#$P<'0[(%1%6%0M04Q)1TXZ
M(')I9VAT)R!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Y)3XU+C$Y/"]T9#X@
M/'1D('-T>6QE/3-$)U!!1$1)3D<M0D]45$]-.B`T<'@[(%1%6%0M04Q)1TXZ
M(&QE9G0G('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E(&YO=W)A<#TS1&YO
M=W)A<#X\9F]N="!S='EL93TS1"=&3TY4+5-)6D4Z(#$P<'0[($9/3E0M1D%-
M24Q9.B!T:6UE<R!N97<@<F]M86X[($1)4U!,05DZ(&EN;&EN92<^("9N8G-P
M.SPO9F]N=#X@/"]T9#X@/'1D('-T>6QE/3-$)U!!1$1)3D<M0D]45$]-.B`T
M<'@G('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E/CQF;VYT('-T>6QE/3-$
M)T9/3E0M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA
M;CL@1$E34$Q!63H@:6YL:6YE)SX@)FYB<W`[/"]F;VYT/B`\+W1D/B`\=&0@
M<W1Y;&4],T0G0D]21$52+4)/5%1/33H@8FQA8VL@-'!X(&1O=6)L93L@5$58
M5"U!3$E'3CH@;&5F="<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24^/&9O
M;G0@<W1Y;&4],T0G1D].5"U325I%.B`Q,'!T.R!&3TY4+49!34E,63H@=&EM
M97,@;F5W(')O;6%N.R!$25-03$%9.B!I;FQI;F4G/B`F;F)S<#L\+V9O;G0^
M(#PO=&0^(#QT9"!S='EL93TS1"="3U)$15(M0D]45$]-.B!B;&%C:R`T<'@@
M9&]U8FQE.R!$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE<R!N
M97<@<F]M86X[($9/3E0M4TE:13H@,3!P=#L@5$585"U!3$E'3CH@<FEG:'0G
M('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#DE/C,N.38\+W1D/B`\=&0@<W1Y
M;&4],T0G4$%$1$E.1RU"3U143TTZ(#1P>#L@5$585"U!3$E'3CH@;&5F="<@
M=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@;F]W<F%P/3-$;F]W<F%P/CQF
M;VYT('-T>6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ('1I
M;65S(&YE=R!R;VUA;CL@1$E34$Q!63H@:6YL:6YE)SX@)FYB<W`[/"]F;VYT
M/B`\+W1D/B`\=&0@<W1Y;&4],T0G4$%$1$E.1RU"3U143TTZ(#1P>"<@=F%L
M:6=N/3-$8F]T=&]M('=I9'1H/3-$,24^/&9O;G0@<W1Y;&4],T0G1D].5"U3
M25I%.B`Q,'!T.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!$25-0
M3$%9.B!I;FQI;F4G/B`F;F)S<#L\+V9O;G0^(#PO=&0^(#QT9"!S='EL93TS
M1"="3U)$15(M0D]45$]-.B!B;&%C:R`T<'@@9&]U8FQE.R!$25-03$%9.B!I
M;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE<R!N97<@<F]M86X[($9/3E0M4TE:
M13H@,3!P=#L@5$585"U!3$E'3CH@;&5F="<@=F%L:6=N/3-$8F]T=&]M('=I
M9'1H/3-$,24^)#PO=&0^(#QT9"!S='EL93TS1"="3U)$15(M0D]45$]-.B!B
M;&%C:R`T<'@@9&]U8FQE.R!$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9
M.B!T:6UE<R!N97<@<F]M86X[($9/3E0M4TE:13H@,3!P=#L@5$585"U!3$E'
M3CH@<FEG:'0G('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#DE/C,S,3PO=&0^
M(#QT9"!S='EL93TS1"=0041$24Y'+4)/5%1/33H@-'!X.R!415A4+4%,24=.
M.B!L969T)R!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)2!N;W=R87`],T1N
M;W=R87`^/&9O;G0@<W1Y;&4],T0G1D].5"U325I%.B`Q,'!T.R!&3TY4+49!
M34E,63H@=&EM97,@;F5W(')O;6%N.R!$25-03$%9.B!I;FQI;F4G/B`F;F)S
M<#L\+V9O;G0^(#PO=&0^(#PO='(^(#PO=&%B;&4^(#PO9&EV/B`\(2TM16YD
M1G)A9VUE;G0M+3X\+V1I=CX@/"]D:78^/'-P86X^/"]S<&%N/CPO=&0^#0H@
M("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$<F\^#0H@("`@("`@(#QT
M9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O<#Y3=6UM87)Y(&]F($]P=&EO;G,@
M86YD(%=A<G)A;G1S($]U='-T86YD:6YG/"]T9#X-"B`@("`@("`@/'1D(&-L
M87-S/3-$=&5X=#XG/"$M+41/0U194$4@:'1M;"!054),24,@(BTO+U<S0R\O
M1%1$(%A(5$U,(#$N,"!4<F%N<VET:6]N86PO+T5.(B`B:'1T<#HO+W=W=RYW
M,RYO<F<O5%(O>&AT;6PQ+T141"]X:'1M;#$M=')A;G-I=&EO;F%L+F1T9"(@
M+2T^/&1I=CX@/&1I=CX\(2TM4W1A<G1&<F%G;65N="TM/B`\9&EV('-T>6QE
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M<'1I;VYS(&]U='-T86YD:6YG(&%S(&]F($IU;F4@,S`L(#(P,30Z/"]D:78^
M(#QD:78@<W1Y;&4],T0G1$E34$Q!63H@8FQO8VL[($U!4D=)3BU,1494.B`Q
M.'!T.R!-05)'24XM4DE'2%0Z(#!P=#L@=&5X="UA;&EG;CH@;&5F=#L@5$58
M5"U)3D1%3E0Z(#!P="<^("9N8G-P.SPO9&EV/B`\+V1I=CX@/&1I=B!S='EL
M93TS1"=T97AT+6%L:6=N.B!L969T)SX@/'1A8FQE('-T>6QE/3-$)T9/3E0M
M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;B<@8V5L
M;'-P86-I;F<],T0P(&-E;&QP861D:6YG/3-$,"!W:61T:#TS1#$P,"4^(#QT
M<CX@/'1D('-T>6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#)P>"!S;VQI
M9"<@=F%L:6=N/3-$8F]T=&]M/B`\9&EV('-T>6QE/3-$)TU!4D=)3BU,1494
M.B`P<'0[($1)4U!,05DZ(&)L;V-K.R!-05)'24XM4DE'2%0Z(#!P=#L@5$58
M5"U)3D1%3E0Z(#!P="<^(#QD:78@<W1Y;&4],T0G1$E34$Q!63H@8FQO8VL[
M(%1%6%0M24Y$14Y4.B`P<'0G/B9N8G-P.SPO9&EV/B`\9&EV('-T>6QE/3-$
M)T1)4U!,05DZ(&)L;V-K.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N
M.R!&3TY4+5-)6D4Z(#$P<'0[($9/3E0M5T5)1TA4.B!B;VQD.R!-05)'24XM
M3$5&5#H@,'!T.R!-05)'24XM4DE'2%0Z(#!P=#L@=&5X="UA;&EG;CH@8V5N
M=&5R.R!415A4+4E.1$5.5#H@,'!T)SX@5V%R<F%N=',@+R!/<'1I;VYS/"]D
M:78^(#PO9&EV/B`\+W1D/B`\=&0@<W1Y;&4],T0G4$%$1$E.1RU"3U143TTZ
M(#)P>"<@=F%L:6=N/3-$8F]T=&]M/CQF;VYT('-T>6QE/3-$)T9/3E0M4TE:
M13H@,3!P=#L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1$E34$Q!
M63H@:6YL:6YE)SX@)FYB<W`[/"]F;VYT/B`\+W1D/B`\=&0@<W1Y;&4],T0G
M0D]21$52+4)/5%1/33H@8FQA8VL@,G!X('-O;&ED)R!V86QI9VX],T1B;W1T
M;VT@8V]L<W!A;CTS1#(^(#QD:78@<W1Y;&4],T0G1$E34$Q!63H@8FQO8VL[
M($9/3E0M1D%-24Q9.B!T:6UE<R!N97<@<F]M86X[($9/3E0M4TE:13H@,3!P
M=#L@34%21TE.+4Q%1E0Z(#!P=#L@34%21TE.+5))1TA4.B`P<'0[('1E>'0M
M86QI9VXZ(&-E;G1E<CL@5$585"U)3D1%3E0Z(#!P="<^(#QF;VYT('-T>6QE
M/3-$)T9/3E0M5T5)1TA4.B!B;VQD.R!$25-03$%9.B!I;FQI;F4G/D5X97)C
M:7-E(%!R:6-E/"]F;VYT/B`\9F]N="!S='EL93TS1"=&3TY4+5=%24=(5#H@
M8F]L9#L@1$E34$Q!63H@:6YL:6YE)SYP97(@4VAA<F4\+V9O;G0^/"]D:78^
M(#PO=&0^(#QT9"!S='EL93TS1"=0041$24Y'+4)/5%1/33H@,G!X.R!415A4
M+4%,24=..B!L969T)R!V86QI9VX],T1B;W1T;VT@;F]W<F%P/3-$;F]W<F%P
M/CQF;VYT('-T>6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ
M('1I;65S(&YE=R!R;VUA;CL@1$E34$Q!63H@:6YL:6YE)SX@)FYB<W`[/"]F
M;VYT/B`\+W1D/B`\=&0@<W1Y;&4],T0G4$%$1$E.1RU"3U143TTZ(#)P>"<@
M=F%L:6=N/3-$8F]T=&]M/CQF;VYT('-T>6QE/3-$)T9/3E0M4TE:13H@,3!P
M=#L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U714E'2%0Z
M(&)O;&0[($1)4U!,05DZ(&EN;&EN92<^("9N8G-P.SPO9F]N=#X@/"]T9#X@
M/'1D('-T>6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#)P>"!S;VQI9"<@
M=F%L:6=N/3-$8F]T=&]M(&-O;'-P86X],T0R/B`\9&EV('-T>6QE/3-$)T1)
M4U!,05DZ(&)L;V-K.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!&
M3TY4+5-)6D4Z(#$P<'0[($9/3E0M5T5)1TA4.B!B;VQD.R!-05)'24XM3$5&
M5#H@,'!T.R!-05)'24XM4DE'2%0Z(#!P=#L@=&5X="UA;&EG;CH@8V5N=&5R
M.R!415A4+4E.1$5.5#H@,'!T)SX@3W!T:6]N<R!A;F0@5V%R<F%N=',@9F]R
M($-O;6UO;B!3=&]C:SPO9&EV/B`\+W1D/B`\=&0@<W1Y;&4],T0G4$%$1$E.
M1RU"3U143TTZ(#)P>#L@5$585"U!3$E'3CH@;&5F="<@=F%L:6=N/3-$8F]T
M=&]M(&YO=W)A<#TS1&YO=W)A<#X\9F]N="!S='EL93TS1"=&3TY4+5-)6D4Z
M(#$P<'0[($9/3E0M1D%-24Q9.B!T:6UE<R!N97<@<F]M86X[($9/3E0M5T5)
M1TA4.B!B;VQD.R!$25-03$%9.B!I;FQI;F4G/B`F;F)S<#L\+V9O;G0^(#PO
M=&0^(#QT9"!S='EL93TS1"=0041$24Y'+4)/5%1/33H@,G!X)R!V86QI9VX]
M,T1B;W1T;VT^/&9O;G0@<W1Y;&4],T0G1D].5"U325I%.B`Q,'!T.R!&3TY4
M+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!$25-03$%9.B!I;FQI;F4G/B`F
M;F)S<#L\+V9O;G0^(#PO=&0^(#QT9"!S='EL93TS1"="3U)$15(M0D]45$]-
M.B!B;&%C:R`R<'@@<V]L:60G('9A;&EG;CTS1&)O='1O;2!C;VQS<&%N/3-$
M,CX@/&1I=B!S='EL93TS1"=$25-03$%9.B!B;&]C:SL@1D].5"U&04U)3%DZ
M('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T.R!-05)'24XM3$5&
M5#H@,'!T.R!-05)'24XM4DE'2%0Z(#!P=#L@=&5X="UA;&EG;CH@8V5N=&5R
M.R!415A4+4E.1$5.5#H@,'!T)SX@/&9O;G0@<W1Y;&4],T0G1D].5"U714E'
M2%0Z(&)O;&0[($1)4U!,05DZ(&EN;&EN92<^3W!T:6]N<R!A;F0@5V%R<F%N
M=',\+V9O;G0^(#QF;VYT('-T>6QE/3-$)T9/3E0M5T5)1TA4.B!B;VQD.R!$
M25-03$%9.B!I;FQI;F4G/D5X97)C:7-A8FQE/"]F;VYT/CPO9&EV/B`\+W1D
M/B`\=&0@<W1Y;&4],T0G4$%$1$E.1RU"3U143TTZ(#)P>#L@5$585"U!3$E'
M3CH@;&5F="<@=F%L:6=N/3-$8F]T=&]M(&YO=W)A<#TS1&YO=W)A<#X\9F]N
M="!S='EL93TS1"=&3TY4+5-)6D4Z(#$P<'0[($9/3E0M1D%-24Q9.B!T:6UE
M<R!N97<@<F]M86X[($1)4U!,05DZ(&EN;&EN92<^("9N8G-P.SPO9F]N=#X@
M/"]T9#X@/'1D('-T>6QE/3-$)U!!1$1)3D<M0D]45$]-.B`R<'@G('9A;&EG
M;CTS1&)O='1O;3X\9F]N="!S='EL93TS1"=&3TY4+5-)6D4Z(#$P<'0[($9/
M3E0M1D%-24Q9.B!T:6UE<R!N97<@<F]M86X[($1)4U!,05DZ(&EN;&EN92<^
M("9N8G-P.SPO9F]N=#X@/"]T9#X@/'1D('-T>6QE/3-$)T)/4D1%4BU"3U14
M3TTZ(&)L86-K(#)P>"!S;VQI9"<@=F%L:6=N/3-$8F]T=&]M(&-O;'-P86X]
M,T0R/B`\9&EV('-T>6QE/3-$)T1)4U!,05DZ(&)L;V-K.R!&3TY4+49!34E,
M63H@=&EM97,@;F5W(')O;6%N.R!&3TY4+5-)6D4Z(#$P<'0[($U!4D=)3BU,
M1494.B`P<'0[($U!4D=)3BU224=(5#H@,'!T.R!T97AT+6%L:6=N.B!C96YT
M97([(%1%6%0M24Y$14Y4.B`P<'0G/B`\9F]N="!S='EL93TS1"=&3TY4+5=%
M24=(5#H@8F]L9#L@1$E34$Q!63H@:6YL:6YE)SY796EG:'1E9"!!=F5R86=E
M(%)E;6%I;FEN9R!#;VYT<F%C='5A;"!497)M<SPO9F]N=#X\9F]N="!S='EL
M93TS1"=&3TY4+5=%24=(5#H@8F]L9#L@1$E34$Q!63H@:6YL:6YE)SXH:6X@
M>65A<G,I/"]F;VYT/CPO9&EV/B`\+W1D/B`\=&0@<W1Y;&4],T0G4$%$1$E.
M1RU"3U143TTZ(#)P>#L@5$585"U!3$E'3CH@;&5F="<@=F%L:6=N/3-$8F]T
M=&]M(&YO=W)A<#TS1&YO=W)A<#X\9F]N="!S='EL93TS1"=&3TY4+5-)6D4Z
M(#$P<'0[($9/3E0M1D%-24Q9.B!T:6UE<R!N97<@<F]M86X[($1)4U!,05DZ
M(&EN;&EN92<^("9N8G-P.SPO9F]N=#X@/"]T9#X@/"]T<CX@/'1R(&)G8V]L
M;W(],T0C8V-E969F/B`\=&0@<W1Y;&4],T0G5$585"U!3$E'3CH@;&5F=#L@
M34%21TE.+4Q%1E0Z(#!P=#L@34%21TE.+5))1TA4.B`P<'0[(%1%6%0M24Y$
M14Y4.B`P<'0G('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#4R)3X@/&1I=B!S
M='EL93TS1"=$25-03$%9.B!B;&]C:SL@1D].5"U&04U)3%DZ('1I;65S(&YE
M=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T.R!&3TY4+5=%24=(5#H@8F]L9#L@
M34%21TE.+4Q%1E0Z(#!P=#L@34%21TE.+5))1TA4.B`P<'0[(%1%6%0M04Q)
M1TXZ(&QE9G0[(%1%6%0M24Y$14Y4.B`P<'0G/B!787)R86YT<SH\+V1I=CX@
M/"]T9#X@/'1D('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E/CQF;VYT('-T
M>6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ('1I;65S(&YE
M=R!R;VUA;CL@1$E34$Q!63H@:6YL:6YE)SX@)FYB<W`[/"]F;VYT/B`\+W1D
M/B`\=&0@<W1Y;&4],T0G1$E34$Q!63H@:6YL:6YE.R!&3TY4+49!34E,63H@
M=&EM97,@;F5W(')O;6%N.R!&3TY4+5-)6D4Z(#$P<'0[(%1%6%0M04Q)1TXZ
M(&QE9G0G('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E/B0\+W1D/B`\=&0@
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M:6YL:6YE)SX@)FYB<W`[/"]F;VYT/B`\+W1D/B`\=&0@<W1Y;&4],T0G5$58
M5"U!3$E'3CH@;&5F="<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24^/&9O
M;G0@<W1Y;&4],T0G1D].5"U325I%.B`Q,'!T.R!&3TY4+49!34E,63H@=&EM
M97,@;F5W(')O;6%N.R!$25-03$%9.B!I;FQI;F4G/B`F;F)S<#L\+V9O;G0^
M(#PO=&0^(#QT9"!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-
M24Q9.B!T:6UE<R!N97<@<F]M86X[($9/3E0M4TE:13H@,3!P=#L@5$585"U!
M3$E'3CH@<FEG:'0G('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#DE/C0W-"PS
M,C(\+W1D/B`\=&0@<W1Y;&4],T0G5$585"U!3$E'3CH@;&5F="<@=F%L:6=N
M/3-$8F]T=&]M('=I9'1H/3-$,24@;F]W<F%P/3-$;F]W<F%P/CQF;VYT('-T
M>6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ('1I;65S(&YE
M=R!R;VUA;CL@1$E34$Q!63H@:6YL:6YE)SX@)FYB<W`[/"]F;VYT/B`\+W1D
M/B`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24^/&9O;G0@<W1Y;&4]
M,T0G1D].5"U325I%.B`Q,'!T.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O
M;6%N.R!$25-03$%9.B!I;FQI;F4G/B`F;F)S<#L\+V9O;G0^(#PO=&0^(#QT
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M.B`Q,'!T.R!415A4+4%,24=..B!R:6=H="<@=F%L:6=N/3-$8F]T=&]M('=I
M9'1H/3-$.24^-#<T+#,R,CPO=&0^(#QT9"!S='EL93TS1"=415A4+4%,24=.
M.B!L969T)R!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)2!N;W=R87`],T1N
M;W=R87`^/&9O;G0@<W1Y;&4],T0G1D].5"U325I%.B`Q,'!T.R!&3TY4+49!
M34E,63H@=&EM97,@;F5W(')O;6%N.R!$25-03$%9.B!I;FQI;F4G/B`F;F)S
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M4$Q!63H@:6YL:6YE)SX@)FYB<W`[/"]F;VYT/B`\+W1D/B`\=&0@<W1Y;&4]
M,T0G1$E34$Q!63H@:6YL:6YE.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O
M;6%N.R!&3TY4+5-)6D4Z(#$P<'0[(%1%6%0M04Q)1TXZ(')I9VAT)R!V86QI
M9VX],T1B;W1T;VT@=VED=&@],T0Y)3XP+C@R/"]T9#X@/'1D('-T>6QE/3-$
M)U1%6%0M04Q)1TXZ(&QE9G0G('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E
M(&YO=W)A<#TS1&YO=W)A<#X\9F]N="!S='EL93TS1"=&3TY4+5-)6D4Z(#$P
M<'0[($9/3E0M1D%-24Q9.B!T:6UE<R!N97<@<F]M86X[($1)4U!,05DZ(&EN
M;&EN92<^("9N8G-P.SPO9F]N=#X@/"]T9#X@/"]T<CX@/'1R(&)G8V]L;W(]
M,T1W:&ET93X@/'1D('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#4R)3X\9F]N
M="!S='EL93TS1"=&3TY4+5-)6D4Z(#$P<'0[($9/3E0M1D%-24Q9.B!T:6UE
M<R!N97<@<F]M86X[($1)4U!,05DZ(&EN;&EN92<^("9N8G-P.SPO9F]N=#X@
M/"]T9#X@/'1D('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E/CQF;VYT('-T
M>6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ('1I;65S(&YE
M=R!R;VUA;CL@1$E34$Q!63H@:6YL:6YE)SX@)FYB<W`[/"]F;VYT/B`\+W1D
M/B`\=&0@<W1Y;&4],T0G1$E34$Q!63H@:6YL:6YE.R!&3TY4+49!34E,63H@
M=&EM97,@;F5W(')O;6%N.R!&3TY4+5-)6D4Z(#$P<'0[(%1%6%0M04Q)1TXZ
M(&QE9G0G('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E/B0\+W1D/B`\=&0@
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M:6YL:6YE)SX@)FYB<W`[/"]F;VYT/B`\+W1D/B`\=&0@<W1Y;&4],T0G5$58
M5"U!3$E'3CH@;&5F="<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24^/&9O
M;G0@<W1Y;&4],T0G1D].5"U325I%.B`Q,'!T.R!&3TY4+49!34E,63H@=&EM
M97,@;F5W(')O;6%N.R!$25-03$%9.B!I;FQI;F4G/B`F;F)S<#L\+V9O;G0^
M(#PO=&0^(#QT9"!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-
M24Q9.B!T:6UE<R!N97<@<F]M86X[($9/3E0M4TE:13H@,3!P=#L@5$585"U!
M3$E'3CH@<FEG:'0G('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#DE/C@W."PQ
M-S0\+W1D/B`\=&0@<W1Y;&4],T0G5$585"U!3$E'3CH@;&5F="<@=F%L:6=N
M/3-$8F]T=&]M('=I9'1H/3-$,24@;F]W<F%P/3-$;F]W<F%P/CQF;VYT('-T
M>6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ('1I;65S(&YE
M=R!R;VUA;CL@1$E34$Q!63H@:6YL:6YE)SX@)FYB<W`[/"]F;VYT/B`\+W1D
M/B`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24^/&9O;G0@<W1Y;&4]
M,T0G1D].5"U325I%.B`Q,'!T.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O
M;6%N.R!$25-03$%9.B!I;FQI;F4G/B`F;F)S<#L\+V9O;G0^(#PO=&0^(#QT
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M.B`Q,'!T.R!415A4+4%,24=..B!R:6=H="<@=F%L:6=N/3-$8F]T=&]M('=I
M9'1H/3-$.24^.#<X+#$W-#PO=&0^(#QT9"!S='EL93TS1"=415A4+4%,24=.
M.B!L969T)R!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)2!N;W=R87`],T1N
M;W=R87`^/&9O;G0@<W1Y;&4],T0G1D].5"U325I%.B`Q,'!T.R!&3TY4+49!
M34E,63H@=&EM97,@;F5W(')O;6%N.R!$25-03$%9.B!I;FQI;F4G/B`F;F)S
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M4$Q!63H@:6YL:6YE)SX@)FYB<W`[/"]F;VYT/B`\+W1D/B`\=&0@<W1Y;&4]
M,T0G1$E34$Q!63H@:6YL:6YE.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O
M;6%N.R!&3TY4+5-)6D4Z(#$P<'0[(%1%6%0M04Q)1TXZ(')I9VAT)R!V86QI
M9VX],T1B;W1T;VT@=VED=&@],T0Y)3XP+C`V/"]T9#X@/'1D('-T>6QE/3-$
M)U1%6%0M04Q)1TXZ(&QE9G0G('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E
M(&YO=W)A<#TS1&YO=W)A<#X\9F]N="!S='EL93TS1"=&3TY4+5-)6D4Z(#$P
M<'0[($9/3E0M1D%-24Q9.B!T:6UE<R!N97<@<F]M86X[($1)4U!,05DZ(&EN
M;&EN92<^("9N8G-P.SPO9F]N=#X@/"]T9#X@/"]T<CX@/'1R(&)G8V]L;W(]
M,T0C8V-E969F/B`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$-3(E/CQF
M;VYT('-T>6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ('1I
M;65S(&YE=R!R;VUA;CL@1$E34$Q!63H@:6YL:6YE)SX@)FYB<W`[/"]F;VYT
M/B`\+W1D/B`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24^/&9O;G0@
M<W1Y;&4],T0G1D].5"U325I%.B`Q,'!T.R!&3TY4+49!34E,63H@=&EM97,@
M;F5W(')O;6%N.R!$25-03$%9.B!I;FQI;F4G/B`F;F)S<#L\+V9O;G0^(#PO
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M:'0G('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#DE/C$N-C`\+W1D/B`\=&0@
M<W1Y;&4],T0G5$585"U!3$E'3CH@;&5F="<@=F%L:6=N/3-$8F]T=&]M('=I
M9'1H/3-$,24@;F]W<F%P/3-$;F]W<F%P/CQF;VYT('-T>6QE/3-$)T9/3E0M
M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1$E3
M4$Q!63H@:6YL:6YE)SX@)FYB<W`[/"]F;VYT/B`\+W1D/B`\=&0@=F%L:6=N
M/3-$8F]T=&]M('=I9'1H/3-$,24^/&9O;G0@<W1Y;&4],T0G1D].5"U325I%
M.B`Q,'!T.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!$25-03$%9
M.B!I;FQI;F4G/B`F;F)S<#L\+V9O;G0^(#PO=&0^(#QT9"!S='EL93TS1"=4
M15A4+4%,24=..B!L969T)R!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)3X\
M9F]N="!S='EL93TS1"=&3TY4+5-)6D4Z(#$P<'0[($9/3E0M1D%-24Q9.B!T
M:6UE<R!N97<@<F]M86X[($1)4U!,05DZ(&EN;&EN92<^("9N8G-P.SPO9F]N
M=#X@/"]T9#X@/'1D('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&
M04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T.R!415A4
M+4%,24=..B!R:6=H="<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$.24^,3,Q
M+#(R,3PO=&0^(#QT9"!S='EL93TS1"=415A4+4%,24=..B!L969T)R!V86QI
M9VX],T1B;W1T;VT@=VED=&@],T0Q)2!N;W=R87`],T1N;W=R87`^/&9O;G0@
M<W1Y;&4],T0G1D].5"U325I%.B`Q,'!T.R!&3TY4+49!34E,63H@=&EM97,@
M;F5W(')O;6%N.R!$25-03$%9.B!I;FQI;F4G/B`F;F)S<#L\+V9O;G0^(#PO
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M)SX@)FYB<W`[/"]F;VYT/B`\+W1D/B`\=&0@<W1Y;&4],T0G1$E34$Q!63H@
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M3%DZ('1I;65S(&YE=R!R;VUA;CL@1$E34$Q!63H@:6YL:6YE)SX@)FYB<W`[
M/"]F;VYT/B`\+W1D/B`\=&0@<W1Y;&4],T0G5$585"U!3$E'3CH@;&5F="<@
M=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24^/&9O;G0@<W1Y;&4],T0G1D].
M5"U325I%.B`Q,'!T.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!$
M25-03$%9.B!I;FQI;F4G/B`F;F)S<#L\+V9O;G0^(#PO=&0^(#QT9"!S='EL
M93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE<R!N97<@
M<F]M86X[($9/3E0M4TE:13H@,3!P=#L@5$585"U!3$E'3CH@<FEG:'0G('9A
M;&EG;CTS1&)O='1O;2!W:61T:#TS1#DE/C`N-S@\+W1D/B`\=&0@<W1Y;&4]
M,T0G5$585"U!3$E'3CH@;&5F="<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$
M,24@;F]W<F%P/3-$;F]W<F%P/CQF;VYT('-T>6QE/3-$)T9/3E0M4TE:13H@
M,3!P=#L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1$E34$Q!63H@
M:6YL:6YE)SX@)FYB<W`[/"]F;VYT/B`\+W1D/B`\+W1R/B`\='(@8F=C;VQO
M<CTS1'=H:71E/B`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$-3(E/CQF
M;VYT('-T>6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ('1I
M;65S(&YE=R!R;VUA;CL@1$E34$Q!63H@:6YL:6YE)SX@)FYB<W`[/"]F;VYT
M/B`\+W1D/B`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24^/&9O;G0@
M<W1Y;&4],T0G1D].5"U325I%.B`Q,'!T.R!&3TY4+49!34E,63H@=&EM97,@
M;F5W(')O;6%N.R!$25-03$%9.B!I;FQI;F4G/B`F;F)S<#L\+V9O;G0^(#PO
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M:'0G('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#DE/C$N.#`\+W1D/B`\=&0@
M<W1Y;&4],T0G5$585"U!3$E'3CH@;&5F="<@=F%L:6=N/3-$8F]T=&]M('=I
M9'1H/3-$,24@;F]W<F%P/3-$;F]W<F%P/CQF;VYT('-T>6QE/3-$)T9/3E0M
M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1$E3
M4$Q!63H@:6YL:6YE)SX@)FYB<W`[/"]F;VYT/B`\+W1D/B`\=&0@=F%L:6=N
M/3-$8F]T=&]M('=I9'1H/3-$,24^/&9O;G0@<W1Y;&4],T0G1D].5"U325I%
M.B`Q,'!T.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!$25-03$%9
M.B!I;FQI;F4G/B`F;F)S<#L\+V9O;G0^(#PO=&0^(#QT9"!S='EL93TS1"=4
M15A4+4%,24=..B!L969T)R!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)3X\
M9F]N="!S='EL93TS1"=&3TY4+5-)6D4Z(#$P<'0[($9/3E0M1D%-24Q9.B!T
M:6UE<R!N97<@<F]M86X[($1)4U!,05DZ(&EN;&EN92<^("9N8G-P.SPO9F]N
M=#X@/"]T9#X@/'1D('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&
M04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T.R!415A4
M+4%,24=..B!R:6=H="<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$.24^-S(W
M+#0P,3PO=&0^(#QT9"!S='EL93TS1"=415A4+4%,24=..B!L969T)R!V86QI
M9VX],T1B;W1T;VT@=VED=&@],T0Q)2!N;W=R87`],T1N;W=R87`^/&9O;G0@
M<W1Y;&4],T0G1D].5"U325I%.B`Q,'!T.R!&3TY4+49!34E,63H@=&EM97,@
M;F5W(')O;6%N.R!$25-03$%9.B!I;FQI;F4G/B`F;F)S<#L\+V9O;G0^(#PO
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M)SX@)FYB<W`[/"]F;VYT/B`\+W1D/B`\=&0@<W1Y;&4],T0G1$E34$Q!63H@
M:6YL:6YE.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!&3TY4+5-)
M6D4Z(#$P<'0[(%1%6%0M04Q)1TXZ(')I9VAT)R!V86QI9VX],T1B;W1T;VT@
M=VED=&@],T0Y)3XW,C<L-#`Q/"]T9#X@/'1D('-T>6QE/3-$)U1%6%0M04Q)
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M3%DZ('1I;65S(&YE=R!R;VUA;CL@1$E34$Q!63H@:6YL:6YE)SX@)FYB<W`[
M/"]F;VYT/B`\+W1D/B`\=&0@<W1Y;&4],T0G5$585"U!3$E'3CH@;&5F="<@
M=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24^/&9O;G0@<W1Y;&4],T0G1D].
M5"U325I%.B`Q,'!T.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!$
M25-03$%9.B!I;FQI;F4G/B`F;F)S<#L\+V9O;G0^(#PO=&0^(#QT9"!S='EL
M93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE<R!N97<@
M<F]M86X[($9/3E0M4TE:13H@,3!P=#L@5$585"U!3$E'3CH@<FEG:'0G('9A
M;&EG;CTS1&)O='1O;2!W:61T:#TS1#DE/C`N,S`\+W1D/B`\=&0@<W1Y;&4]
M,T0G5$585"U!3$E'3CH@;&5F="<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$
M,24@;F]W<F%P/3-$;F]W<F%P/CQF;VYT('-T>6QE/3-$)T9/3E0M4TE:13H@
M,3!P=#L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1$E34$Q!63H@
M:6YL:6YE)SX@)FYB<W`[/"]F;VYT/B`\+W1D/B`\+W1R/B`\='(@8F=C;VQO
M<CTS1"-C8V5E9F8^(#QT9"!V86QI9VX],T1B;W1T;VT@=VED=&@],T0U,B4^
M/&9O;G0@<W1Y;&4],T0G1D].5"U325I%.B`Q,'!T.R!&3TY4+49!34E,63H@
M=&EM97,@;F5W(')O;6%N.R!$25-03$%9.B!I;FQI;F4G/B`F;F)S<#L\+V9O
M;G0^(#PO=&0^(#QT9"!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)3X\9F]N
M="!S='EL93TS1"=&3TY4+5-)6D4Z(#$P<'0[($9/3E0M1D%-24Q9.B!T:6UE
M<R!N97<@<F]M86X[($1)4U!,05DZ(&EN;&EN92<^("9N8G-P.SPO9F]N=#X@
M/"]T9#X@/'1D('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)
M3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T.R!415A4+4%,
M24=..B!L969T)R!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)3XD/"]T9#X@
M/'1D('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I
M;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T.R!415A4+4%,24=..B!R
M:6=H="<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$.24^,2XY,#PO=&0^(#QT
M9"!S='EL93TS1"=415A4+4%,24=..B!L969T)R!V86QI9VX],T1B;W1T;VT@
M=VED=&@],T0Q)2!N;W=R87`],T1N;W=R87`^/&9O;G0@<W1Y;&4],T0G1D].
M5"U325I%.B`Q,'!T.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!$
M25-03$%9.B!I;FQI;F4G/B`F;F)S<#L\+V9O;G0^(#PO=&0^(#QT9"!V86QI
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M('1I;65S(&YE=R!R;VUA;CL@1$E34$Q!63H@:6YL:6YE)SX@)FYB<W`[/"]F
M;VYT/B`\+W1D/B`\=&0@<W1Y;&4],T0G1$E34$Q!63H@:6YL:6YE.R!&3TY4
M+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!&3TY4+5-)6D4Z(#$P<'0[(%1%
M6%0M04Q)1TXZ(')I9VAT)R!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Y)3XT
M,RPQ,#,\+W1D/B`\=&0@<W1Y;&4],T0G5$585"U!3$E'3CH@;&5F="<@=F%L
M:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@;F]W<F%P/3-$;F]W<F%P/CQF;VYT
M('-T>6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ('1I;65S
M(&YE=R!R;VUA;CL@1$E34$Q!63H@:6YL:6YE)SX@)FYB<W`[/"]F;VYT/B`\
M+W1D/B`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24^/&9O;G0@<W1Y
M;&4],T0G1D].5"U325I%.B`Q,'!T.R!&3TY4+49!34E,63H@=&EM97,@;F5W
M(')O;6%N.R!$25-03$%9.B!I;FQI;F4G/B`F;F)S<#L\+V9O;G0^(#PO=&0^
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M25I%.B`Q,'!T.R!415A4+4%,24=..B!R:6=H="<@=F%L:6=N/3-$8F]T=&]M
M('=I9'1H/3-$.24^-#,L,3`S/"]T9#X@/'1D('-T>6QE/3-$)U1%6%0M04Q)
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M3%DZ('1I;65S(&YE=R!R;VUA;CL@1$E34$Q!63H@:6YL:6YE)SX@)FYB<W`[
M/"]F;VYT/B`\+W1D/B`\=&0@<W1Y;&4],T0G5$585"U!3$E'3CH@;&5F="<@
M=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24^/&9O;G0@<W1Y;&4],T0G1D].
M5"U325I%.B`Q,'!T.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!$
M25-03$%9.B!I;FQI;F4G/B`F;F)S<#L\+V9O;G0^(#PO=&0^(#QT9"!S='EL
M93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE<R!N97<@
M<F]M86X[($9/3E0M4TE:13H@,3!P=#L@5$585"U!3$E'3CH@<FEG:'0G('9A
M;&EG;CTS1&)O='1O;2!W:61T:#TS1#DE/C`N,#@\+W1D/B`\=&0@<W1Y;&4]
M,T0G5$585"U!3$E'3CH@;&5F="<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$
M,24@;F]W<F%P/3-$;F]W<F%P/CQF;VYT('-T>6QE/3-$)T9/3E0M4TE:13H@
M,3!P=#L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1$E34$Q!63H@
M:6YL:6YE)SX@)FYB<W`[/"]F;VYT/B`\+W1D/B`\+W1R/B`\='(@8F=C;VQO
M<CTS1'=H:71E/B`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$-3(E/CQF
M;VYT('-T>6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ('1I
M;65S(&YE=R!R;VUA;CL@1$E34$Q!63H@:6YL:6YE)SX@)FYB<W`[/"]F;VYT
M/B`\+W1D/B`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24^/&9O;G0@
M<W1Y;&4],T0G1D].5"U325I%.B`Q,'!T.R!&3TY4+49!34E,63H@=&EM97,@
M;F5W(')O;6%N.R!$25-03$%9.B!I;FQI;F4G/B`F;F)S<#L\+V9O;G0^(#PO
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M:'0G('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#DE/C0N,C`\+W1D/B`\=&0@
M<W1Y;&4],T0G5$585"U!3$E'3CH@;&5F="<@=F%L:6=N/3-$8F]T=&]M('=I
M9'1H/3-$,24@;F]W<F%P/3-$;F]W<F%P/CQF;VYT('-T>6QE/3-$)T9/3E0M
M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1$E3
M4$Q!63H@:6YL:6YE)SX@)FYB<W`[/"]F;VYT/B`\+W1D/B`\=&0@=F%L:6=N
M/3-$8F]T=&]M('=I9'1H/3-$,24^/&9O;G0@<W1Y;&4],T0G1D].5"U325I%
M.B`Q,'!T.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!$25-03$%9
M.B!I;FQI;F4G/B`F;F)S<#L\+V9O;G0^(#PO=&0^(#QT9"!S='EL93TS1"=4
M15A4+4%,24=..B!L969T)R!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)3X\
M9F]N="!S='EL93TS1"=&3TY4+5-)6D4Z(#$P<'0[($9/3E0M1D%-24Q9.B!T
M:6UE<R!N97<@<F]M86X[($1)4U!,05DZ(&EN;&EN92<^("9N8G-P.SPO9F]N
M=#X@/"]T9#X@/'1D('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&
M04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T.R!415A4
M+4%,24=..B!R:6=H="<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$.24^-2PP
M-C`L,#`P/"]T9#X@/'1D('-T>6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G('9A
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M=R!R;VUA;CL@1$E34$Q!63H@:6YL:6YE)SX@)FYB<W`[/"]F;VYT/B`\+W1D
M/B`\=&0@<W1Y;&4],T0G5$585"U!3$E'3CH@;&5F="<@=F%L:6=N/3-$8F]T
M=&]M('=I9'1H/3-$,24^/&9O;G0@<W1Y;&4],T0G1D].5"U325I%.B`Q,'!T
M.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!$25-03$%9.B!I;FQI
M;F4G/B`F;F)S<#L\+V9O;G0^(#PO=&0^(#QT9"!S='EL93TS1"=$25-03$%9
M.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE<R!N97<@<F]M86X[($9/3E0M
M4TE:13H@,3!P=#L@5$585"U!3$E'3CH@<FEG:'0G('9A;&EG;CTS1&)O='1O
M;2!W:61T:#TS1#DE/C4L,#8P+#`P,#PO=&0^(#QT9"!S='EL93TS1"=415A4
M+4%,24=..B!L969T)R!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)2!N;W=R
M87`],T1N;W=R87`^/&9O;G0@<W1Y;&4],T0G1D].5"U325I%.B`Q,'!T.R!&
M3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!$25-03$%9.B!I;FQI;F4G
M/B`F;F)S<#L\+V9O;G0^(#PO=&0^(#QT9"!V86QI9VX],T1B;W1T;VT@=VED
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M;CL@1$E34$Q!63H@:6YL:6YE)SX@)FYB<W`[/"]F;VYT/B`\+W1D/B`\=&0@
M<W1Y;&4],T0G1$E34$Q!63H@:6YL:6YE.R!&3TY4+49!34E,63H@=&EM97,@
M;F5W(')O;6%N.R!&3TY4+5-)6D4Z(#$P<'0[(%1%6%0M04Q)1TXZ(')I9VAT
M)R!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Y)3XR+C`Y/"]T9#X@/'1D('-T
M>6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G('9A;&EG;CTS1&)O='1O;2!W:61T
M:#TS1#$E(&YO=W)A<#TS1&YO=W)A<#X\9F]N="!S='EL93TS1"=&3TY4+5-)
M6D4Z(#$P<'0[($9/3E0M1D%-24Q9.B!T:6UE<R!N97<@<F]M86X[($1)4U!,
M05DZ(&EN;&EN92<^("9N8G-P.SPO9F]N=#X@/"]T9#X@/"]T<CX@/'1R(&)G
M8V]L;W(],T0C8V-E969F/B`\=&0@<W1Y;&4],T0G4$%$1$E.1RU"3U143TTZ
M(#)P>"<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$-3(E/CQF;VYT('-T>6QE
M/3-$)T9/3E0M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R
M;VUA;CL@1$E34$Q!63H@:6YL:6YE)SX@)FYB<W`[/"]F;VYT/B`\+W1D/B`\
M=&0@<W1Y;&4],T0G4$%$1$E.1RU"3U143TTZ(#)P>"<@=F%L:6=N/3-$8F]T
M=&]M('=I9'1H/3-$,24^/&9O;G0@<W1Y;&4],T0G1D].5"U325I%.B`Q,'!T
M.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!$25-03$%9.B!I;FQI
M;F4G/B`F;F)S<#L\+V9O;G0^(#PO=&0^(#QT9"!S='EL93TS1"="3U)$15(M
M0D]45$]-.B!B;&%C:R`R<'@@<V]L:60[($1)4U!,05DZ(&EN;&EN93L@1D].
M5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T.R!4
M15A4+4%,24=..B!L969T)R!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)3XD
M/"]T9#X@/'1D('-T>6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#)P>"!S
M;VQI9#L@1$E34$Q!63H@:6YL:6YE.R!&3TY4+49!34E,63H@=&EM97,@;F5W
M(')O;6%N.R!&3TY4+5-)6D4Z(#$P<'0[(%1%6%0M04Q)1TXZ(')I9VAT)R!V
M86QI9VX],T1B;W1T;VT@=VED=&@],T0Y)3XU+C`P/"]T9#X@/'1D('-T>6QE
M/3-$)U!!1$1)3D<M0D]45$]-.B`R<'@[(%1%6%0M04Q)1TXZ(&QE9G0G('9A
M;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E(&YO=W)A<#TS1&YO=W)A<#X\9F]N
M="!S='EL93TS1"=&3TY4+5-)6D4Z(#$P<'0[($9/3E0M1D%-24Q9.B!T:6UE
M<R!N97<@<F]M86X[($1)4U!,05DZ(&EN;&EN92<^("9N8G-P.SPO9F]N=#X@
M/"]T9#X@/'1D('-T>6QE/3-$)U!!1$1)3D<M0D]45$]-.B`R<'@G('9A;&EG
M;CTS1&)O='1O;2!W:61T:#TS1#$E/CQF;VYT('-T>6QE/3-$)T9/3E0M4TE:
M13H@,3!P=#L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1$E34$Q!
M63H@:6YL:6YE)SX@)FYB<W`[/"]F;VYT/B`\+W1D/B`\=&0@<W1Y;&4],T0G
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M;W1T;VT@=VED=&@],T0Y)3XS+#(Q.2PY.#,\+W1D/B`\=&0@<W1Y;&4],T0G
M4$%$1$E.1RU"3U143TTZ(#)P>#L@5$585"U!3$E'3CH@;&5F="<@=F%L:6=N
M/3-$8F]T=&]M('=I9'1H/3-$,24@;F]W<F%P/3-$;F]W<F%P/CQF;VYT('-T
M>6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ('1I;65S(&YE
M=R!R;VUA;CL@1$E34$Q!63H@:6YL:6YE)SX@)FYB<W`[/"]F;VYT/B`\+W1D
M/B`\=&0@<W1Y;&4],T0G4$%$1$E.1RU"3U143TTZ(#)P>"<@=F%L:6=N/3-$
M8F]T=&]M('=I9'1H/3-$,24^/&9O;G0@<W1Y;&4],T0G1D].5"U325I%.B`Q
M,'!T.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!$25-03$%9.B!I
M;FQI;F4G/B`F;F)S<#L\+V9O;G0^(#PO=&0^(#QT9"!S='EL93TS1"="3U)$
M15(M0D]45$]-.B!B;&%C:R`R<'@@<V]L:60[(%1%6%0M04Q)1TXZ(&QE9G0G
M('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E/CQF;VYT('-T>6QE/3-$)T9/
M3E0M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@
M1$E34$Q!63H@:6YL:6YE)SX@)FYB<W`[/"]F;VYT/B`\+W1D/B`\=&0@<W1Y
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M;W1T;VT@=VED=&@],T0Q)2!N;W=R87`],T1N;W=R87`^/&9O;G0@<W1Y;&4]
M,T0G1D].5"U325I%.B`Q,'!T.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O
M;6%N.R!$25-03$%9.B!I;FQI;F4G/B`F;F)S<#L\+V9O;G0^(#PO=&0^(#QT
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M25I%.B`Q,'!T.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!$25-0
M3$%9.B!I;FQI;F4G/B`F;F)S<#L\+V9O;G0^(#PO=&0^(#QT9"!S='EL93TS
M1"="3U)$15(M0D]45$]-.B!B;&%C:R`R<'@@<V]L:60[($1)4U!,05DZ(&EN
M;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%
M.B`Q,'!T.R!415A4+4%,24=..B!R:6=H="<@=F%L:6=N/3-$8F]T=&]M('=I
M9'1H/3-$.24^,RXR,CPO=&0^(#QT9"!S='EL93TS1"=0041$24Y'+4)/5%1/
M33H@,G!X.R!415A4+4%,24=..B!L969T)R!V86QI9VX],T1B;W1T;VT@=VED
M=&@],T0Q)2!N;W=R87`],T1N;W=R87`^/&9O;G0@<W1Y;&4],T0G1D].5"U3
M25I%.B`Q,'!T.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!$25-0
M3$%9.B!I;FQI;F4G/B`F;F)S<#L\+V9O;G0^(#PO=&0^(#PO='(^(#QT<B!B
M9V-O;&]R/3-$=VAI=&4^(#QT9"!S='EL93TS1"=0041$24Y'+4)/5%1/33H@
M,G!X.R!415A4+4%,24=..B!L969T.R!-05)'24XM3$5&5#H@,'!T.R!-05)'
M24XM4DE'2%0Z(#!P=#L@5$585"U)3D1%3E0Z(#!P="<@=F%L:6=N/3-$8F]T
M=&]M('=I9'1H/3-$-3(E/B`\9&EV('-T>6QE/3-$)T1)4U!,05DZ(&)L;V-K
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M=&]M('=I9'1H/3-$,24^/&9O;G0@<W1Y;&4],T0G1D].5"U325I%.B`Q,'!T
M.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!$25-03$%9.B!I;FQI
M;F4G/B`F;F)S<#L\+V9O;G0^(#PO=&0^(#QT9"!S='EL93TS1"="3U)$15(M
M0D]45$]-.B!B;&%C:R`R<'@@<V]L:60[(%1%6%0M04Q)1TXZ(')I9VAT)R!V
M86QI9VX],T1B;W1T;VT@=VED=&@],T0Y)3X\9F]N="!S='EL93TS1"=&3TY4
M+5-)6D4Z(#$P<'0[($9/3E0M1D%-24Q9.B!T:6UE<R!N97<@<F]M86X[($1)
M4U!,05DZ(&EN;&EN92<^("9N8G-P.SPO9F]N=#X@/"]T9#X@/'1D('-T>6QE
M/3-$)U!!1$1)3D<M0D]45$]-.B`R<'@[(%1%6%0M04Q)1TXZ(&QE9G0G('9A
M;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E(&YO=W)A<#TS1&YO=W)A<#X\9F]N
M="!S='EL93TS1"=&3TY4+5-)6D4Z(#$P<'0[($9/3E0M1D%-24Q9.B!T:6UE
M<R!N97<@<F]M86X[($1)4U!,05DZ(&EN;&EN92<^("9N8G-P.SPO9F]N=#X@
M/"]T9#X@/'1D('-T>6QE/3-$)U!!1$1)3D<M0D]45$]-.B`R<'@G('9A;&EG
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M/3-$,24^/&9O;G0@<W1Y;&4],T0G1D].5"U325I%.B`Q,'!T.R!&3TY4+49!
M34E,63H@=&EM97,@;F5W(')O;6%N.R!&3TY4+5=%24=(5#H@8F]L9#L@1$E3
M4$Q!63H@:6YL:6YE)SX@)FYB<W`[/"]F;VYT/B`\+W1D/B`\=&0@<W1Y;&4]
M,T0G0D]21$52+4)/5%1/33H@8FQA8VL@,G!X('-O;&ED.R!$25-03$%9.B!I
M;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE<R!N97<@<F]M86X[($9/3E0M4TE:
M13H@,3!P=#L@1D].5"U714E'2%0Z(&)O;&0[(%1%6%0M04Q)1TXZ(')I9VAT
M)R!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Y)3XQ,"PU,S0L,C`T/"]T9#X@
M/'1D('-T>6QE/3-$)U!!1$1)3D<M0D]45$]-.B`R<'@[(%1%6%0M04Q)1TXZ
M(&QE9G0G('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E(&YO=W)A<#TS1&YO
M=W)A<#X\9F]N="!S='EL93TS1"=&3TY4+5-)6D4Z(#$P<'0[($9/3E0M1D%-
M24Q9.B!T:6UE<R!N97<@<F]M86X[($9/3E0M5T5)1TA4.B!B;VQD.R!$25-0
M3$%9.B!I;FQI;F4G/B`F;F)S<#L\+V9O;G0^(#PO=&0^(#QT9"!S='EL93TS
M1"=0041$24Y'+4)/5%1/33H@,G!X)R!V86QI9VX],T1B;W1T;VT@=VED=&@]
M,T0Q)3X\9F]N="!S='EL93TS1"=&3TY4+5-)6D4Z(#$P<'0[($9/3E0M1D%-
M24Q9.B!T:6UE<R!N97<@<F]M86X[($9/3E0M5T5)1TA4.B!B;VQD.R!$25-0
M3$%9.B!I;FQI;F4G/B`F;F)S<#L\+V9O;G0^(#PO=&0^(#QT9"!S='EL93TS
M1"="3U)$15(M0D]45$]-.B!B;&%C:R`R<'@@<V]L:60[(%1%6%0M04Q)1TXZ
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M('=I9'1H/3-$.24^,3`L-3,T+#(P-#PO=&0^(#QT9"!S='EL93TS1"=0041$
M24Y'+4)/5%1/33H@,G!X.R!415A4+4%,24=..B!L969T)R!V86QI9VX],T1B
M;W1T;VT@=VED=&@],T0Q)2!N;W=R87`],T1N;W=R87`^/&9O;G0@<W1Y;&4]
M,T0G1D].5"U325I%.B`Q,'!T.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O
M;6%N.R!&3TY4+5=%24=(5#H@8F]L9#L@1$E34$Q!63H@:6YL:6YE)SX@)FYB
M<W`[/"]F;VYT/B`\+W1D/B`\=&0@<W1Y;&4],T0G4$%$1$E.1RU"3U143TTZ
M(#)P>"<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24^/&9O;G0@<W1Y;&4]
M,T0G1D].5"U325I%.B`Q,'!T.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O
M;6%N.R!$25-03$%9.B!I;FQI;F4G/B`F;F)S<#L\+V9O;G0^(#PO=&0^(#QT
M9"!S='EL93TS1"="3U)$15(M0D]45$]-.B!B;&%C:R`R<'@@<V]L:60[(%1%
M6%0M04Q)1TXZ(&QE9G0G('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E/CQF
M;VYT('-T>6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ('1I
M;65S(&YE=R!R;VUA;CL@1$E34$Q!63H@:6YL:6YE)SX@)FYB<W`[/"]F;VYT
M/B`\+W1D/B`\=&0@<W1Y;&4],T0G0D]21$52+4)/5%1/33H@8FQA8VL@,G!X
M('-O;&ED.R!415A4+4%,24=..B!R:6=H="<@=F%L:6=N/3-$8F]T=&]M('=I
M9'1H/3-$.24^/&9O;G0@<W1Y;&4],T0G1D].5"U325I%.B`Q,'!T.R!&3TY4
M+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!$25-03$%9.B!I;FQI;F4G/B`F
M;F)S<#L\+V9O;G0^(#PO=&0^(#QT9"!S='EL93TS1"=0041$24Y'+4)/5%1/
M33H@,G!X.R!415A4+4%,24=..B!L969T)R!V86QI9VX],T1B;W1T;VT@=VED
M=&@],T0Q)2!N;W=R87`],T1N;W=R87`^/&9O;G0@<W1Y;&4],T0G1D].5"U3
M25I%.B`Q,'!T.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!$25-0
M3$%9.B!I;FQI;F4G/B`F;F)S<#L\+V9O;G0^(#PO=&0^(#PO='(^(#QT<B!B
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M('1I;65S(&YE=R!R;VUA;CL@1$E34$Q!63H@:6YL:6YE)SX@)FYB<W`[/"]F
M;VYT/B`\+W1D/B`\=&0@<W1Y;&4],T0G5$585"U!3$E'3CH@;&5F="<@=F%L
M:6=N/3-$8F]T=&]M('=I9'1H/3-$,24^/&9O;G0@<W1Y;&4],T0G1D].5"U3
M25I%.B`Q,'!T.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!$25-0
M3$%9.B!I;FQI;F4G/B`F;F)S<#L\+V9O;G0^(#PO=&0^(#QT9"!S='EL93TS
M1"=415A4+4%,24=..B!R:6=H="<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$
M.24^/&9O;G0@<W1Y;&4],T0G1D].5"U325I%.B`Q,'!T.R!&3TY4+49!34E,
M63H@=&EM97,@;F5W(')O;6%N.R!$25-03$%9.B!I;FQI;F4G/B`F;F)S<#L\
M+V9O;G0^(#PO=&0^(#QT9"!S='EL93TS1"=415A4+4%,24=..B!L969T)R!V
M86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)2!N;W=R87`],T1N;W=R87`^/&9O
M;G0@<W1Y;&4],T0G1D].5"U325I%.B`Q,'!T.R!&3TY4+49!34E,63H@=&EM
M97,@;F5W(')O;6%N.R!$25-03$%9.B!I;FQI;F4G/B`F;F)S<#L\+V9O;G0^
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M:6YE)SX@)FYB<W`[/"]F;VYT/B`\+W1D/B`\=&0@<W1Y;&4],T0G5$585"U!
M3$E'3CH@<FEG:'0G('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#DE/CQF;VYT
M('-T>6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ('1I;65S
M(&YE=R!R;VUA;CL@1$E34$Q!63H@:6YL:6YE)SX@)FYB<W`[/"]F;VYT/B`\
M+W1D/B`\=&0@<W1Y;&4],T0G5$585"U!3$E'3CH@;&5F="<@=F%L:6=N/3-$
M8F]T=&]M('=I9'1H/3-$,24@;F]W<F%P/3-$;F]W<F%P/CQF;VYT('-T>6QE
M/3-$)T9/3E0M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R
M;VUA;CL@1$E34$Q!63H@:6YL:6YE)SX@)FYB<W`[/"]F;VYT/B`\+W1D/B`\
M=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24^/&9O;G0@<W1Y;&4],T0G
M1D].5"U325I%.B`Q,'!T.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N
M.R!$25-03$%9.B!I;FQI;F4G/B`F;F)S<#L\+V9O;G0^(#PO=&0^(#QT9"!S
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M63H@:6YL:6YE)SX@)FYB<W`[/"]F;VYT/B`\+W1D/B`\=&0@<W1Y;&4],T0G
M5$585"U!3$E'3CH@;&5F="<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24^
M/&9O;G0@<W1Y;&4],T0G1D].5"U325I%.B`Q,'!T.R!&3TY4+49!34E,63H@
M=&EM97,@;F5W(')O;6%N.R!$25-03$%9.B!I;FQI;F4G/B`F;F)S<#L\+V9O
M;G0^(#PO=&0^(#QT9"!S='EL93TS1"=415A4+4%,24=..B!R:6=H="<@=F%L
M:6=N/3-$8F]T=&]M('=I9'1H/3-$.24^/&9O;G0@<W1Y;&4],T0G1D].5"U3
M25I%.B`Q,'!T.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!$25-0
M3$%9.B!I;FQI;F4G/B`F;F)S<#L\+V9O;G0^(#PO=&0^(#QT9"!S='EL93TS
M1"=415A4+4%,24=..B!L969T)R!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q
M)2!N;W=R87`],T1N;W=R87`^/&9O;G0@<W1Y;&4],T0G1D].5"U325I%.B`Q
M,'!T.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!$25-03$%9.B!I
M;FQI;F4G/B`F;F)S<#L\+V9O;G0^(#PO=&0^(#PO='(^(#QT<B!B9V-O;&]R
M/3-$=VAI=&4^(#QT9"!S='EL93TS1"=415A4+4%,24=..B!L969T.R!-05)'
M24XM3$5&5#H@,'!T.R!-05)'24XM4DE'2%0Z(#!P=#L@5$585"U)3D1%3E0Z
M(#!P="<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$-3(E/B`\9&EV('-T>6QE
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M(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T.R!415A4+4%,24=..B!L969T
M)R!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)3XD/"]T9#X@/'1D('-T>6QE
M/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R
M;VUA;CL@1D].5"U325I%.B`Q,'!T.R!415A4+4%,24=..B!R:6=H="<@=F%L
M:6=N/3-$8F]T=&]M('=I9'1H/3-$.24^,"XP,#PO=&0^(#QT9"!S='EL93TS
M1"=415A4+4%,24=..B!L969T)R!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q
M)2!N;W=R87`],T1N;W=R87`^/&9O;G0@<W1Y;&4],T0G1D].5"U325I%.B`Q
M,'!T.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!$25-03$%9.B!I
M;FQI;F4G/B`F;F)S<#L\+V9O;G0^(#PO=&0^(#QT9"!V86QI9VX],T1B;W1T
M;VT@=VED=&@],T0Q)3X\9F]N="!S='EL93TS1"=&3TY4+5-)6D4Z(#$P<'0[
M($9/3E0M1D%-24Q9.B!T:6UE<R!N97<@<F]M86X[($1)4U!,05DZ(&EN;&EN
M92<^("9N8G-P.SPO9F]N=#X@/"]T9#X@/'1D('-T>6QE/3-$)U1%6%0M04Q)
M1TXZ(&QE9G0G('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E/CQF;VYT('-T
M>6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ('1I;65S(&YE
M=R!R;VUA;CL@1$E34$Q!63H@:6YL:6YE)SX@)FYB<W`[/"]F;VYT/B`\+W1D
M/B`\=&0@<W1Y;&4],T0G1$E34$Q!63H@:6YL:6YE.R!&3TY4+49!34E,63H@
M=&EM97,@;F5W(')O;6%N.R!&3TY4+5-)6D4Z(#$P<'0[(%1%6%0M04Q)1TXZ
M(')I9VAT)R!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Y)3XQ,#$L,#`P/"]T
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M1$E34$Q!63H@:6YL:6YE)SX@)FYB<W`[/"]F;VYT/B`\+W1D/B`\=&0@<W1Y
M;&4],T0G5$585"U!3$E'3CH@;&5F="<@=F%L:6=N/3-$8F]T=&]M('=I9'1H
M/3-$,24^/&9O;G0@<W1Y;&4],T0G1D].5"U325I%.B`Q,'!T.R!&3TY4+49!
M34E,63H@=&EM97,@;F5W(')O;6%N.R!$25-03$%9.B!I;FQI;F4G/B`F;F)S
M<#L\+V9O;G0^(#PO=&0^(#QT9"!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[
M($9/3E0M1D%-24Q9.B!T:6UE<R!N97<@<F]M86X[($9/3E0M4TE:13H@,3!P
M=#L@5$585"U!3$E'3CH@<FEG:'0G('9A;&EG;CTS1&)O='1O;2!W:61T:#TS
M1#DE/C$P,"PP,#`\+W1D/B`\=&0@<W1Y;&4],T0G5$585"U!3$E'3CH@;&5F
M="<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@;F]W<F%P/3-$;F]W<F%P
M/CQF;VYT('-T>6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ
M('1I;65S(&YE=R!R;VUA;CL@1$E34$Q!63H@:6YL:6YE)SX@)FYB<W`[/"]F
M;VYT/B`\+W1D/B`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24^/&9O
M;G0@<W1Y;&4],T0G1D].5"U325I%.B`Q,'!T.R!&3TY4+49!34E,63H@=&EM
M97,@;F5W(')O;6%N.R!$25-03$%9.B!I;FQI;F4G/B`F;F)S<#L\+V9O;G0^
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M1D].5"U325I%.B`Q,'!T.R!415A4+4%,24=..B!R:6=H="<@=F%L:6=N/3-$
M8F]T=&]M('=I9'1H/3-$.24^-2XQ.3PO=&0^(#QT9"!S='EL93TS1"=415A4
M+4%,24=..B!L969T)R!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)2!N;W=R
M87`],T1N;W=R87`^/&9O;G0@<W1Y;&4],T0G1D].5"U325I%.B`Q,'!T.R!&
M3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!$25-03$%9.B!I;FQI;F4G
M/B`F;F)S<#L\+V9O;G0^(#PO=&0^(#PO='(^(#QT<B!B9V-O;&]R/3-$(V-C
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M;VUA;CL@1$E34$Q!63H@:6YL:6YE)SX@)FYB<W`[/"]F;VYT/B`\+W1D/B`\
M=&0@<W1Y;&4],T0G1$E34$Q!63H@:6YL:6YE.R!&3TY4+49!34E,63H@=&EM
M97,@;F5W(')O;6%N.R!&3TY4+5-)6D4Z(#$P<'0[(%1%6%0M04Q)1TXZ(&QE
M9G0G('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E/B0\+W1D/B`\=&0@<W1Y
M;&4],T0G1$E34$Q!63H@:6YL:6YE.R!&3TY4+49!34E,63H@=&EM97,@;F5W
M(')O;6%N.R!&3TY4+5-)6D4Z(#$P<'0[(%1%6%0M04Q)1TXZ(')I9VAT)R!V
M86QI9VX],T1B;W1T;VT@=VED=&@],T0Y)3XP+C8R/"]T9#X@/'1D('-T>6QE
M/3-$)U1%6%0M04Q)1TXZ(&QE9G0G('9A;&EG;CTS1&)O='1O;2!W:61T:#TS
M1#$E(&YO=W)A<#TS1&YO=W)A<#X\9F]N="!S='EL93TS1"=&3TY4+5-)6D4Z
M(#$P<'0[($9/3E0M1D%-24Q9.B!T:6UE<R!N97<@<F]M86X[($1)4U!,05DZ
M(&EN;&EN92<^("9N8G-P.SPO9F]N=#X@/"]T9#X@/'1D('9A;&EG;CTS1&)O
M='1O;2!W:61T:#TS1#$E/CQF;VYT('-T>6QE/3-$)T9/3E0M4TE:13H@,3!P
M=#L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1$E34$Q!63H@:6YL
M:6YE)SX@)FYB<W`[/"]F;VYT/B`\+W1D/B`\=&0@<W1Y;&4],T0G5$585"U!
M3$E'3CH@;&5F="<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24^/&9O;G0@
M<W1Y;&4],T0G1D].5"U325I%.B`Q,'!T.R!&3TY4+49!34E,63H@=&EM97,@
M;F5W(')O;6%N.R!$25-03$%9.B!I;FQI;F4G/B`F;F)S<#L\+V9O;G0^(#PO
M=&0^(#QT9"!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9
M.B!T:6UE<R!N97<@<F]M86X[($9/3E0M4TE:13H@,3!P=#L@5$585"U!3$E'
M3CH@<FEG:'0G('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#DE/C,Y."PU,#`\
M+W1D/B`\=&0@<W1Y;&4],T0G5$585"U!3$E'3CH@;&5F="<@=F%L:6=N/3-$
M8F]T=&]M('=I9'1H/3-$,24@;F]W<F%P/3-$;F]W<F%P/CQF;VYT('-T>6QE
M/3-$)T9/3E0M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R
M;VUA;CL@1$E34$Q!63H@:6YL:6YE)SX@)FYB<W`[/"]F;VYT/B`\+W1D/B`\
M=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24^/&9O;G0@<W1Y;&4],T0G
M1D].5"U325I%.B`Q,'!T.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N
M.R!$25-03$%9.B!I;FQI;F4G/B`F;F)S<#L\+V9O;G0^(#PO=&0^(#QT9"!S
M='EL93TS1"=415A4+4%,24=..B!L969T)R!V86QI9VX],T1B;W1T;VT@=VED
M=&@],T0Q)3X\9F]N="!S='EL93TS1"=&3TY4+5-)6D4Z(#$P<'0[($9/3E0M
M1D%-24Q9.B!T:6UE<R!N97<@<F]M86X[($1)4U!,05DZ(&EN;&EN92<^("9N
M8G-P.SPO9F]N=#X@/"]T9#X@/'1D('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN
M93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q
M,'!T.R!415A4+4%,24=..B!R:6=H="<@=F%L:6=N/3-$8F]T=&]M('=I9'1H
M/3-$.24^,SDX+#4P,#PO=&0^(#QT9"!S='EL93TS1"=415A4+4%,24=..B!L
M969T)R!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)2!N;W=R87`],T1N;W=R
M87`^/&9O;G0@<W1Y;&4],T0G1D].5"U325I%.B`Q,'!T.R!&3TY4+49!34E,
M63H@=&EM97,@;F5W(')O;6%N.R!$25-03$%9.B!I;FQI;F4G/B`F;F)S<#L\
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M63H@:6YL:6YE)SX@)FYB<W`[/"]F;VYT/B`\+W1D/B`\=&0@<W1Y;&4],T0G
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M;VUA;CL@1$E34$Q!63H@:6YL:6YE)SX@)FYB<W`[/"]F;VYT/B`\+W1D/B`\
M=&0@<W1Y;&4],T0G1$E34$Q!63H@:6YL:6YE.R!&3TY4+49!34E,63H@=&EM
M97,@;F5W(')O;6%N.R!&3TY4+5-)6D4Z(#$P<'0[(%1%6%0M04Q)1TXZ(&QE
M9G0G('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E/B0\+W1D/B`\=&0@<W1Y
M;&4],T0G1$E34$Q!63H@:6YL:6YE.R!&3TY4+49!34E,63H@=&EM97,@;F5W
M(')O;6%N.R!&3TY4+5-)6D4Z(#$P<'0[(%1%6%0M04Q)1TXZ(')I9VAT)R!V
M86QI9VX],T1B;W1T;VT@=VED=&@],T0Y)3XQ+C`T/"]T9#X@/'1D('-T>6QE
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M:6YE)SX@)FYB<W`[/"]F;VYT/B`\+W1D/B`\=&0@<W1Y;&4],T0G5$585"U!
M3$E'3CH@;&5F="<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24^/&9O;G0@
M<W1Y;&4],T0G1D].5"U325I%.B`Q,'!T.R!&3TY4+49!34E,63H@=&EM97,@
M;F5W(')O;6%N.R!$25-03$%9.B!I;FQI;F4G/B`F;F)S<#L\+V9O;G0^(#PO
M=&0^(#QT9"!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9
M.B!T:6UE<R!N97<@<F]M86X[($9/3E0M4TE:13H@,3!P=#L@5$585"U!3$E'
M3CH@<FEG:'0G('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#DE/C,P+#`P,#PO
M=&0^(#QT9"!S='EL93TS1"=415A4+4%,24=..B!L969T)R!V86QI9VX],T1B
M;W1T;VT@=VED=&@],T0Q)2!N;W=R87`],T1N;W=R87`^/&9O;G0@<W1Y;&4]
M,T0G1D].5"U325I%.B`Q,'!T.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O
M;6%N.R!$25-03$%9.B!I;FQI;F4G/B`F;F)S<#L\+V9O;G0^(#PO=&0^(#QT
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M<W`[/"]F;VYT/B`\+W1D/B`\=&0@<W1Y;&4],T0G1$E34$Q!63H@:6YL:6YE
M.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!&3TY4+5-)6D4Z(#$P
M<'0[(%1%6%0M04Q)1TXZ(')I9VAT)R!V86QI9VX],T1B;W1T;VT@=VED=&@]
M,T0Y)3XS,"PP,#`\+W1D/B`\=&0@<W1Y;&4],T0G5$585"U!3$E'3CH@;&5F
M="<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@;F]W<F%P/3-$;F]W<F%P
M/CQF;VYT('-T>6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ
M('1I;65S(&YE=R!R;VUA;CL@1$E34$Q!63H@:6YL:6YE)SX@)FYB<W`[/"]F
M;VYT/B`\+W1D/B`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24^/&9O
M;G0@<W1Y;&4],T0G1D].5"U325I%.B`Q,'!T.R!&3TY4+49!34E,63H@=&EM
M97,@;F5W(')O;6%N.R!$25-03$%9.B!I;FQI;F4G/B`F;F)S<#L\+V9O;G0^
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M1D].5"U325I%.B`Q,'!T.R!415A4+4%,24=..B!R:6=H="<@=F%L:6=N/3-$
M8F]T=&]M('=I9'1H/3-$.24^-"XQ-CPO=&0^(#QT9"!S='EL93TS1"=415A4
M+4%,24=..B!L969T)R!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)2!N;W=R
M87`],T1N;W=R87`^/&9O;G0@<W1Y;&4],T0G1D].5"U325I%.B`Q,'!T.R!&
M3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!$25-03$%9.B!I;FQI;F4G
M/B`F;F)S<#L\+V9O;G0^(#PO=&0^(#PO='(^(#QT<B!B9V-O;&]R/3-$(V-C
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M;VUA;CL@1$E34$Q!63H@:6YL:6YE)SX@)FYB<W`[/"]F;VYT/B`\+W1D/B`\
M=&0@<W1Y;&4],T0G1$E34$Q!63H@:6YL:6YE.R!&3TY4+49!34E,63H@=&EM
M97,@;F5W(')O;6%N.R!&3TY4+5-)6D4Z(#$P<'0[(%1%6%0M04Q)1TXZ(&QE
M9G0G('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E/B0\+W1D/B`\=&0@<W1Y
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M:6YE)SX@)FYB<W`[/"]F;VYT/B`\+W1D/B`\=&0@<W1Y;&4],T0G5$585"U!
M3$E'3CH@;&5F="<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24^/&9O;G0@
M<W1Y;&4],T0G1D].5"U325I%.B`Q,'!T.R!&3TY4+49!34E,63H@=&EM97,@
M;F5W(')O;6%N.R!$25-03$%9.B!I;FQI;F4G/B`F;F)S<#L\+V9O;G0^(#PO
M=&0^(#QT9"!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9
M.B!T:6UE<R!N97<@<F]M86X[($9/3E0M4TE:13H@,3!P=#L@5$585"U!3$E'
M3CH@<FEG:'0G('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#DE/C(P+#`P,#PO
M=&0^(#QT9"!S='EL93TS1"=415A4+4%,24=..B!L969T)R!V86QI9VX],T1B
M;W1T;VT@=VED=&@],T0Q)2!N;W=R87`],T1N;W=R87`^/&9O;G0@<W1Y;&4]
M,T0G1D].5"U325I%.B`Q,'!T.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O
M;6%N.R!$25-03$%9.B!I;FQI;F4G/B`F;F)S<#L\+V9O;G0^(#PO=&0^(#QT
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M<W`[/"]F;VYT/B`\+W1D/B`\=&0@<W1Y;&4],T0G1$E34$Q!63H@:6YL:6YE
M.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!&3TY4+5-)6D4Z(#$P
M<'0[(%1%6%0M04Q)1TXZ(')I9VAT)R!V86QI9VX],T1B;W1T;VT@=VED=&@]
M,T0Y)3XR,"PP,#`\+W1D/B`\=&0@<W1Y;&4],T0G5$585"U!3$E'3CH@;&5F
M="<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@;F]W<F%P/3-$;F]W<F%P
M/CQF;VYT('-T>6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ
M('1I;65S(&YE=R!R;VUA;CL@1$E34$Q!63H@:6YL:6YE)SX@)FYB<W`[/"]F
M;VYT/B`\+W1D/B`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24^/&9O
M;G0@<W1Y;&4],T0G1D].5"U325I%.B`Q,'!T.R!&3TY4+49!34E,63H@=&EM
M97,@;F5W(')O;6%N.R!$25-03$%9.B!I;FQI;F4G/B`F;F)S<#L\+V9O;G0^
M(#PO=&0^(#QT9"!S='EL93TS1"=415A4+4%,24=..B!L969T)R!V86QI9VX]
M,T1B;W1T;VT@=VED=&@],T0Q)3X\9F]N="!S='EL93TS1"=&3TY4+5-)6D4Z
M(#$P<'0[($9/3E0M1D%-24Q9.B!T:6UE<R!N97<@<F]M86X[($1)4U!,05DZ
M(&EN;&EN92<^("9N8G-P.SPO9F]N=#X@/"]T9#X@/'1D('-T>6QE/3-$)T1)
M4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@
M1D].5"U325I%.B`Q,'!T.R!415A4+4%,24=..B!R:6=H="<@=F%L:6=N/3-$
M8F]T=&]M('=I9'1H/3-$.24^,RXX-CPO=&0^(#QT9"!S='EL93TS1"=415A4
M+4%,24=..B!L969T)R!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)2!N;W=R
M87`],T1N;W=R87`^/&9O;G0@<W1Y;&4],T0G1D].5"U325I%.B`Q,'!T.R!&
M3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!$25-03$%9.B!I;FQI;F4G
M/B`F;F)S<#L\+V9O;G0^(#PO=&0^(#PO='(^(#QT<B!B9V-O;&]R/3-$=VAI
M=&4^(#QT9"!V86QI9VX],T1B;W1T;VT@=VED=&@],T0U,B4^/&9O;G0@<W1Y
M;&4],T0G1D].5"U325I%.B`Q,'!T.R!&3TY4+49!34E,63H@=&EM97,@;F5W
M(')O;6%N.R!$25-03$%9.B!I;FQI;F4G/B`F;F)S<#L\+V9O;G0^(#PO=&0^
M(#QT9"!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)3X\9F]N="!S='EL93TS
M1"=&3TY4+5-)6D4Z(#$P<'0[($9/3E0M1D%-24Q9.B!T:6UE<R!N97<@<F]M
M86X[($1)4U!,05DZ(&EN;&EN92<^("9N8G-P.SPO9F]N=#X@/"]T9#X@/'1D
M('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S
M(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T.R!415A4+4%,24=..B!L969T
M)R!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)3XD/"]T9#X@/'1D('-T>6QE
M/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R
M;VUA;CL@1D].5"U325I%.B`Q,'!T.R!415A4+4%,24=..B!R:6=H="<@=F%L
M:6=N/3-$8F]T=&]M('=I9'1H/3-$.24^,RXU,#PO=&0^(#QT9"!S='EL93TS
M1"=415A4+4%,24=..B!L969T)R!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q
M)2!N;W=R87`],T1N;W=R87`^/&9O;G0@<W1Y;&4],T0G1D].5"U325I%.B`Q
M,'!T.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!$25-03$%9.B!I
M;FQI;F4G/B`F;F)S<#L\+V9O;G0^(#PO=&0^(#QT9"!V86QI9VX],T1B;W1T
M;VT@=VED=&@],T0Q)3X\9F]N="!S='EL93TS1"=&3TY4+5-)6D4Z(#$P<'0[
M($9/3E0M1D%-24Q9.B!T:6UE<R!N97<@<F]M86X[($1)4U!,05DZ(&EN;&EN
M92<^("9N8G-P.SPO9F]N=#X@/"]T9#X@/'1D('-T>6QE/3-$)U1%6%0M04Q)
M1TXZ(&QE9G0G('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E/CQF;VYT('-T
M>6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ('1I;65S(&YE
M=R!R;VUA;CL@1$E34$Q!63H@:6YL:6YE)SX@)FYB<W`[/"]F;VYT/B`\+W1D
M/B`\=&0@<W1Y;&4],T0G1$E34$Q!63H@:6YL:6YE.R!&3TY4+49!34E,63H@
M=&EM97,@;F5W(')O;6%N.R!&3TY4+5-)6D4Z(#$P<'0[(%1%6%0M04Q)1TXZ
M(')I9VAT)R!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Y)3XY,#`L,#`P/"]T
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M1$E34$Q!63H@:6YL:6YE)SX@)FYB<W`[/"]F;VYT/B`\+W1D/B`\=&0@<W1Y
M;&4],T0G5$585"U!3$E'3CH@;&5F="<@=F%L:6=N/3-$8F]T=&]M('=I9'1H
M/3-$,24^/&9O;G0@<W1Y;&4],T0G1D].5"U325I%.B`Q,'!T.R!&3TY4+49!
M34E,63H@=&EM97,@;F5W(')O;6%N.R!$25-03$%9.B!I;FQI;F4G/B`F;F)S
M<#L\+V9O;G0^(#PO=&0^(#QT9"!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[
M($9/3E0M1D%-24Q9.B!T:6UE<R!N97<@<F]M86X[($9/3E0M4TE:13H@,3!P
M=#L@5$585"U!3$E'3CH@<FEG:'0G('9A;&EG;CTS1&)O='1O;2!W:61T:#TS
M1#DE/CDP,"PP,#`\+W1D/B`\=&0@<W1Y;&4],T0G5$585"U!3$E'3CH@;&5F
M="<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@;F]W<F%P/3-$;F]W<F%P
M/CQF;VYT('-T>6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ
M('1I;65S(&YE=R!R;VUA;CL@1$E34$Q!63H@:6YL:6YE)SX@)FYB<W`[/"]F
M;VYT/B`\+W1D/B`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24^/&9O
M;G0@<W1Y;&4],T0G1D].5"U325I%.B`Q,'!T.R!&3TY4+49!34E,63H@=&EM
M97,@;F5W(')O;6%N.R!$25-03$%9.B!I;FQI;F4G/B`F;F)S<#L\+V9O;G0^
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M1D].5"U325I%.B`Q,'!T.R!415A4+4%,24=..B!R:6=H="<@=F%L:6=N/3-$
M8F]T=&]M('=I9'1H/3-$.24^,BXU.#PO=&0^(#QT9"!S='EL93TS1"=415A4
M+4%,24=..B!L969T)R!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)2!N;W=R
M87`],T1N;W=R87`^/&9O;G0@<W1Y;&4],T0G1D].5"U325I%.B`Q,'!T.R!&
M3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!$25-03$%9.B!I;FQI;F4G
M/B`F;F)S<#L\+V9O;G0^(#PO=&0^(#PO='(^(#QT<B!B9V-O;&]R/3-$(V-C
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M;VUA;CL@1$E34$Q!63H@:6YL:6YE)SX@)FYB<W`[/"]F;VYT/B`\+W1D/B`\
M=&0@<W1Y;&4],T0G1$E34$Q!63H@:6YL:6YE.R!&3TY4+49!34E,63H@=&EM
M97,@;F5W(')O;6%N.R!&3TY4+5-)6D4Z(#$P<'0[(%1%6%0M04Q)1TXZ(&QE
M9G0G('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E/B0\+W1D/B`\=&0@<W1Y
M;&4],T0G1$E34$Q!63H@:6YL:6YE.R!&3TY4+49!34E,63H@=&EM97,@;F5W
M(')O;6%N.R!&3TY4+5-)6D4Z(#$P<'0[(%1%6%0M04Q)1TXZ(')I9VAT)R!V
M86QI9VX],T1B;W1T;VT@=VED=&@],T0Y)3XS+C<R/"]T9#X@/'1D('-T>6QE
M/3-$)U1%6%0M04Q)1TXZ(&QE9G0G('9A;&EG;CTS1&)O='1O;2!W:61T:#TS
M1#$E(&YO=W)A<#TS1&YO=W)A<#X\9F]N="!S='EL93TS1"=&3TY4+5-)6D4Z
M(#$P<'0[($9/3E0M1D%-24Q9.B!T:6UE<R!N97<@<F]M86X[($1)4U!,05DZ
M(&EN;&EN92<^("9N8G-P.SPO9F]N=#X@/"]T9#X@/'1D('9A;&EG;CTS1&)O
M='1O;2!W:61T:#TS1#$E/CQF;VYT('-T>6QE/3-$)T9/3E0M4TE:13H@,3!P
M=#L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1$E34$Q!63H@:6YL
M:6YE)SX@)FYB<W`[/"]F;VYT/B`\+W1D/B`\=&0@<W1Y;&4],T0G5$585"U!
M3$E'3CH@;&5F="<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24^/&9O;G0@
M<W1Y;&4],T0G1D].5"U325I%.B`Q,'!T.R!&3TY4+49!34E,63H@=&EM97,@
M;F5W(')O;6%N.R!$25-03$%9.B!I;FQI;F4G/B`F;F)S<#L\+V9O;G0^(#PO
M=&0^(#QT9"!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9
M.B!T:6UE<R!N97<@<F]M86X[($9/3E0M4TE:13H@,3!P=#L@5$585"U!3$E'
M3CH@<FEG:'0G('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#DE/C$U+#`P,#PO
M=&0^(#QT9"!S='EL93TS1"=415A4+4%,24=..B!L969T)R!V86QI9VX],T1B
M;W1T;VT@=VED=&@],T0Q)2!N;W=R87`],T1N;W=R87`^/&9O;G0@<W1Y;&4]
M,T0G1D].5"U325I%.B`Q,'!T.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O
M;6%N.R!$25-03$%9.B!I;FQI;F4G/B`F;F)S<#L\+V9O;G0^(#PO=&0^(#QT
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M<W`[/"]F;VYT/B`\+W1D/B`\=&0@<W1Y;&4],T0G1$E34$Q!63H@:6YL:6YE
M.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!&3TY4+5-)6D4Z(#$P
M<'0[(%1%6%0M04Q)1TXZ(')I9VAT)R!V86QI9VX],T1B;W1T;VT@=VED=&@]
M,T0Y)3XQ-2PP,#`\+W1D/B`\=&0@<W1Y;&4],T0G5$585"U!3$E'3CH@;&5F
M="<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@;F]W<F%P/3-$;F]W<F%P
M/CQF;VYT('-T>6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ
M('1I;65S(&YE=R!R;VUA;CL@1$E34$Q!63H@:6YL:6YE)SX@)FYB<W`[/"]F
M;VYT/B`\+W1D/B`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24^/&9O
M;G0@<W1Y;&4],T0G1D].5"U325I%.B`Q,'!T.R!&3TY4+49!34E,63H@=&EM
M97,@;F5W(')O;6%N.R!$25-03$%9.B!I;FQI;F4G/B`F;F)S<#L\+V9O;G0^
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M1D].5"U325I%.B`Q,'!T.R!415A4+4%,24=..B!R:6=H="<@=F%L:6=N/3-$
M8F]T=&]M('=I9'1H/3-$.24^,BXT.3PO=&0^(#QT9"!S='EL93TS1"=415A4
M+4%,24=..B!L969T)R!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)2!N;W=R
M87`],T1N;W=R87`^/&9O;G0@<W1Y;&4],T0G1D].5"U325I%.B`Q,'!T.R!&
M3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!$25-03$%9.B!I;FQI;F4G
M/B`F;F)S<#L\+V9O;G0^(#PO=&0^(#PO='(^(#QT<B!B9V-O;&]R/3-$=VAI
M=&4^(#QT9"!V86QI9VX],T1B;W1T;VT@=VED=&@],T0U,B4^/&9O;G0@<W1Y
M;&4],T0G1D].5"U325I%.B`Q,'!T.R!&3TY4+49!34E,63H@=&EM97,@;F5W
M(')O;6%N.R!$25-03$%9.B!I;FQI;F4G/B`F;F)S<#L\+V9O;G0^(#PO=&0^
M(#QT9"!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)3X\9F]N="!S='EL93TS
M1"=&3TY4+5-)6D4Z(#$P<'0[($9/3E0M1D%-24Q9.B!T:6UE<R!N97<@<F]M
M86X[($1)4U!,05DZ(&EN;&EN92<^("9N8G-P.SPO9F]N=#X@/"]T9#X@/'1D
M('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S
M(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T.R!415A4+4%,24=..B!L969T
M)R!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)3XD/"]T9#X@/'1D('-T>6QE
M/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R
M;VUA;CL@1D].5"U325I%.B`Q,'!T.R!415A4+4%,24=..B!R:6=H="<@=F%L
M:6=N/3-$8F]T=&]M('=I9'1H/3-$.24^,RXX,#PO=&0^(#QT9"!S='EL93TS
M1"=415A4+4%,24=..B!L969T)R!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q
M)2!N;W=R87`],T1N;W=R87`^/&9O;G0@<W1Y;&4],T0G1D].5"U325I%.B`Q
M,'!T.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!$25-03$%9.B!I
M;FQI;F4G/B`F;F)S<#L\+V9O;G0^(#PO=&0^(#QT9"!V86QI9VX],T1B;W1T
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M=R!R;VUA;CL@1$E34$Q!63H@:6YL:6YE)SX@)FYB<W`[/"]F;VYT/B`\+W1D
M/B`\=&0@<W1Y;&4],T0G1$E34$Q!63H@:6YL:6YE.R!&3TY4+49!34E,63H@
M=&EM97,@;F5W(')O;6%N.R!&3TY4+5-)6D4Z(#$P<'0[(%1%6%0M04Q)1TXZ
M(')I9VAT)R!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Y)3XQ-BPP-3`\+W1D
M/B`\=&0@<W1Y;&4],T0G5$585"U!3$E'3CH@;&5F="<@=F%L:6=N/3-$8F]T
M=&]M('=I9'1H/3-$,24@;F]W<F%P/3-$;F]W<F%P/CQF;VYT('-T>6QE/3-$
M)T9/3E0M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA
M;CL@1$E34$Q!63H@:6YL:6YE)SX@)FYB<W`[/"]F;VYT/B`\+W1D/B`\=&0@
M=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24^/&9O;G0@<W1Y;&4],T0G1D].
M5"U325I%.B`Q,'!T.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!$
M25-03$%9.B!I;FQI;F4G/B`F;F)S<#L\+V9O;G0^(#PO=&0^(#QT9"!S='EL
M93TS1"=415A4+4%,24=..B!L969T)R!V86QI9VX],T1B;W1T;VT@=VED=&@]
M,T0Q)3X\9F]N="!S='EL93TS1"=&3TY4+5-)6D4Z(#$P<'0[($9/3E0M1D%-
M24Q9.B!T:6UE<R!N97<@<F]M86X[($1)4U!,05DZ(&EN;&EN92<^("9N8G-P
M.SPO9F]N=#X@/"]T9#X@/'1D('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@
M1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T
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M(&YE=R!R;VUA;CL@1$E34$Q!63H@:6YL:6YE)SX@)FYB<W`[/"]F;VYT/B`\
M+W1D/B`\=&0@<W1Y;&4],T0G5$585"U!3$E'3CH@;&5F="<@=F%L:6=N/3-$
M8F]T=&]M('=I9'1H/3-$,24^/&9O;G0@<W1Y;&4],T0G1D].5"U325I%.B`Q
M,'!T.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!$25-03$%9.B!I
M;FQI;F4G/B`F;F)S<#L\+V9O;G0^(#PO=&0^(#QT9"!S='EL93TS1"=$25-0
M3$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE<R!N97<@<F]M86X[($9/
M3E0M4TE:13H@,3!P=#L@5$585"U!3$E'3CH@<FEG:'0G('9A;&EG;CTS1&)O
M='1O;2!W:61T:#TS1#DE/C(N-3,\+W1D/B`\=&0@<W1Y;&4],T0G5$585"U!
M3$E'3CH@;&5F="<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@;F]W<F%P
M/3-$;F]W<F%P/CQF;VYT('-T>6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@1D].
M5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1$E34$Q!63H@:6YL:6YE)SX@
M)FYB<W`[/"]F;VYT/B`\+W1D/B`\+W1R/B`\='(@8F=C;VQO<CTS1"-C8V5E
M9F8^(#QT9"!V86QI9VX],T1B;W1T;VT@=VED=&@],T0U,B4^/&9O;G0@<W1Y
M;&4],T0G1D].5"U325I%.B`Q,'!T.R!&3TY4+49!34E,63H@=&EM97,@;F5W
M(')O;6%N.R!$25-03$%9.B!I;FQI;F4G/B`F;F)S<#L\+V9O;G0^(#PO=&0^
M(#QT9"!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)3X\9F]N="!S='EL93TS
M1"=&3TY4+5-)6D4Z(#$P<'0[($9/3E0M1D%-24Q9.B!T:6UE<R!N97<@<F]M
M86X[($1)4U!,05DZ(&EN;&EN92<^("9N8G-P.SPO9F]N=#X@/"]T9#X@/'1D
M('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S
M(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T.R!415A4+4%,24=..B!L969T
M)R!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)3XD/"]T9#X@/'1D('-T>6QE
M/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R
M;VUA;CL@1D].5"U325I%.B`Q,'!T.R!415A4+4%,24=..B!R:6=H="<@=F%L
M:6=N/3-$8F]T=&]M('=I9'1H/3-$.24^-"XP,#PO=&0^(#QT9"!S='EL93TS
M1"=415A4+4%,24=..B!L969T)R!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q
M)2!N;W=R87`],T1N;W=R87`^/&9O;G0@<W1Y;&4],T0G1D].5"U325I%.B`Q
M,'!T.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!$25-03$%9.B!I
M;FQI;F4G/B`F;F)S<#L\+V9O;G0^(#PO=&0^(#QT9"!V86QI9VX],T1B;W1T
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M=R!R;VUA;CL@1$E34$Q!63H@:6YL:6YE)SX@)FYB<W`[/"]F;VYT/B`\+W1D
M/B`\=&0@<W1Y;&4],T0G1$E34$Q!63H@:6YL:6YE.R!&3TY4+49!34E,63H@
M=&EM97,@;F5W(')O;6%N.R!&3TY4+5-)6D4Z(#$P<'0[(%1%6%0M04Q)1TXZ
M(')I9VAT)R!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Y)3XT,BPU,#`\+W1D
M/B`\=&0@<W1Y;&4],T0G5$585"U!3$E'3CH@;&5F="<@=F%L:6=N/3-$8F]T
M=&]M('=I9'1H/3-$,24@;F]W<F%P/3-$;F]W<F%P/CQF;VYT('-T>6QE/3-$
M)T9/3E0M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA
M;CL@1$E34$Q!63H@:6YL:6YE)SX@)FYB<W`[/"]F;VYT/B`\+W1D/B`\=&0@
M=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24^/&9O;G0@<W1Y;&4],T0G1D].
M5"U325I%.B`Q,'!T.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!$
M25-03$%9.B!I;FQI;F4G/B`F;F)S<#L\+V9O;G0^(#PO=&0^(#QT9"!S='EL
M93TS1"=415A4+4%,24=..B!L969T)R!V86QI9VX],T1B;W1T;VT@=VED=&@]
M,T0Q)3X\9F]N="!S='EL93TS1"=&3TY4+5-)6D4Z(#$P<'0[($9/3E0M1D%-
M24Q9.B!T:6UE<R!N97<@<F]M86X[($1)4U!,05DZ(&EN;&EN92<^("9N8G-P
M.SPO9F]N=#X@/"]T9#X@/'1D('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@
M1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T
M.R!415A4+4%,24=..B!R:6=H="<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$
M.24^-#(L-3`P/"]T9#X@/'1D('-T>6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G
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M(&YE=R!R;VUA;CL@1$E34$Q!63H@:6YL:6YE)SX@)FYB<W`[/"]F;VYT/B`\
M+W1D/B`\=&0@<W1Y;&4],T0G5$585"U!3$E'3CH@;&5F="<@=F%L:6=N/3-$
M8F]T=&]M('=I9'1H/3-$,24^/&9O;G0@<W1Y;&4],T0G1D].5"U325I%.B`Q
M,'!T.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!$25-03$%9.B!I
M;FQI;F4G/B`F;F)S<#L\+V9O;G0^(#PO=&0^(#QT9"!S='EL93TS1"=$25-0
M3$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE<R!N97<@<F]M86X[($9/
M3E0M4TE:13H@,3!P=#L@5$585"U!3$E'3CH@<FEG:'0G('9A;&EG;CTS1&)O
M='1O;2!W:61T:#TS1#DE/C(N,S`\+W1D/B`\=&0@<W1Y;&4],T0G5$585"U!
M3$E'3CH@;&5F="<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@;F]W<F%P
M/3-$;F]W<F%P/CQF;VYT('-T>6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@1D].
M5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1$E34$Q!63H@:6YL:6YE)SX@
M)FYB<W`[/"]F;VYT/B`\+W1D/B`\+W1R/B`\='(@8F=C;VQO<CTS1'=H:71E
M/B`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$-3(E/CQF;VYT('-T>6QE
M/3-$)T9/3E0M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R
M;VUA;CL@1$E34$Q!63H@:6YL:6YE)SX@)FYB<W`[/"]F;VYT/B`\+W1D/B`\
M=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24^/&9O;G0@<W1Y;&4],T0G
M1D].5"U325I%.B`Q,'!T.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N
M.R!$25-03$%9.B!I;FQI;F4G/B`F;F)S<#L\+V9O;G0^(#PO=&0^(#QT9"!S
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M;CTS1&)O='1O;2!W:61T:#TS1#DE/C0N,S@@+2`D(#0N-#`\+W1D/B`\=&0@
M<W1Y;&4],T0G5$585"U!3$E'3CH@;&5F="<@=F%L:6=N/3-$8F]T=&]M('=I
M9'1H/3-$,24@;F]W<F%P/3-$;F]W<F%P/CQF;VYT('-T>6QE/3-$)T9/3E0M
M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1$E3
M4$Q!63H@:6YL:6YE)SX@)FYB<W`[/"]F;VYT/B`\+W1D/B`\=&0@=F%L:6=N
M/3-$8F]T=&]M('=I9'1H/3-$,24^/&9O;G0@<W1Y;&4],T0G1D].5"U325I%
M.B`Q,'!T.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!$25-03$%9
M.B!I;FQI;F4G/B`F;F)S<#L\+V9O;G0^(#PO=&0^(#QT9"!S='EL93TS1"=4
M15A4+4%,24=..B!L969T)R!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)3X\
M9F]N="!S='EL93TS1"=&3TY4+5-)6D4Z(#$P<'0[($9/3E0M1D%-24Q9.B!T
M:6UE<R!N97<@<F]M86X[($1)4U!,05DZ(&EN;&EN92<^("9N8G-P.SPO9F]N
M=#X@/"]T9#X@/'1D('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&
M04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T.R!415A4
M+4%,24=..B!R:6=H="<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$.24^-#$W
M+#(Y.3PO=&0^(#QT9"!S='EL93TS1"=415A4+4%,24=..B!L969T)R!V86QI
M9VX],T1B;W1T;VT@=VED=&@],T0Q)2!N;W=R87`],T1N;W=R87`^/&9O;G0@
M<W1Y;&4],T0G1D].5"U325I%.B`Q,'!T.R!&3TY4+49!34E,63H@=&EM97,@
M;F5W(')O;6%N.R!$25-03$%9.B!I;FQI;F4G/B`F;F)S<#L\+V9O;G0^(#PO
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M)SX@)FYB<W`[/"]F;VYT/B`\+W1D/B`\=&0@<W1Y;&4],T0G1$E34$Q!63H@
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M3%DZ('1I;65S(&YE=R!R;VUA;CL@1$E34$Q!63H@:6YL:6YE)SX@)FYB<W`[
M/"]F;VYT/B`\+W1D/B`\=&0@<W1Y;&4],T0G5$585"U!3$E'3CH@;&5F="<@
M=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24^/&9O;G0@<W1Y;&4],T0G1D].
M5"U325I%.B`Q,'!T.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!$
M25-03$%9.B!I;FQI;F4G/B`F;F)S<#L\+V9O;G0^(#PO=&0^(#QT9"!S='EL
M93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE<R!N97<@
M<F]M86X[($9/3E0M4TE:13H@,3!P=#L@5$585"U!3$E'3CH@<FEG:'0G('9A
M;&EG;CTS1&)O='1O;2!W:61T:#TS1#DE/C,N,C@\+W1D/B`\=&0@<W1Y;&4]
M,T0G5$585"U!3$E'3CH@;&5F="<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$
M,24@;F]W<F%P/3-$;F]W<F%P/CQF;VYT('-T>6QE/3-$)T9/3E0M4TE:13H@
M,3!P=#L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1$E34$Q!63H@
M:6YL:6YE)SX@)FYB<W`[/"]F;VYT/B`\+W1D/B`\+W1R/B`\='(@8F=C;VQO
M<CTS1"-C8V5E9F8^(#QT9"!V86QI9VX],T1B;W1T;VT@=VED=&@],T0U,B4^
M/&9O;G0@<W1Y;&4],T0G1D].5"U325I%.B`Q,'!T.R!&3TY4+49!34E,63H@
M=&EM97,@;F5W(')O;6%N.R!$25-03$%9.B!I;FQI;F4G/B`F;F)S<#L\+V9O
M;G0^(#PO=&0^(#QT9"!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)3X\9F]N
M="!S='EL93TS1"=&3TY4+5-)6D4Z(#$P<'0[($9/3E0M1D%-24Q9.B!T:6UE
M<R!N97<@<F]M86X[($1)4U!,05DZ(&EN;&EN92<^("9N8G-P.SPO9F]N=#X@
M/"]T9#X@/'1D('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)
M3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T.R!415A4+4%,
M24=..B!L969T)R!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)3XD/"]T9#X@
M/'1D('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I
M;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T.R!415A4+4%,24=..B!R
M:6=H="<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$.24^-BXX,#PO=&0^(#QT
M9"!S='EL93TS1"=415A4+4%,24=..B!L969T)R!V86QI9VX],T1B;W1T;VT@
M=VED=&@],T0Q)2!N;W=R87`],T1N;W=R87`^/&9O;G0@<W1Y;&4],T0G1D].
M5"U325I%.B`Q,'!T.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!$
M25-03$%9.B!I;FQI;F4G/B`F;F)S<#L\+V9O;G0^(#PO=&0^(#QT9"!V86QI
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M('1I;65S(&YE=R!R;VUA;CL@1$E34$Q!63H@:6YL:6YE)SX@)FYB<W`[/"]F
M;VYT/B`\+W1D/B`\=&0@<W1Y;&4],T0G1$E34$Q!63H@:6YL:6YE.R!&3TY4
M+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!&3TY4+5-)6D4Z(#$P<'0[(%1%
M6%0M04Q)1TXZ(')I9VAT)R!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Y)3XS
M-BPR-3`\+W1D/B`\=&0@<W1Y;&4],T0G5$585"U!3$E'3CH@;&5F="<@=F%L
M:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@;F]W<F%P/3-$;F]W<F%P/CQF;VYT
M('-T>6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ('1I;65S
M(&YE=R!R;VUA;CL@1$E34$Q!63H@:6YL:6YE)SX@)FYB<W`[/"]F;VYT/B`\
M+W1D/B`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24^/&9O;G0@<W1Y
M;&4],T0G1D].5"U325I%.B`Q,'!T.R!&3TY4+49!34E,63H@=&EM97,@;F5W
M(')O;6%N.R!$25-03$%9.B!I;FQI;F4G/B`F;F)S<#L\+V9O;G0^(#PO=&0^
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M25I%.B`Q,'!T.R!415A4+4%,24=..B!R:6=H="<@=F%L:6=N/3-$8F]T=&]M
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M3%DZ('1I;65S(&YE=R!R;VUA;CL@1$E34$Q!63H@:6YL:6YE)SX@)FYB<W`[
M/"]F;VYT/B`\+W1D/B`\=&0@<W1Y;&4],T0G5$585"U!3$E'3CH@;&5F="<@
M=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24^/&9O;G0@<W1Y;&4],T0G1D].
M5"U325I%.B`Q,'!T.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!$
M25-03$%9.B!I;FQI;F4G/B`F;F)S<#L\+V9O;G0^(#PO=&0^(#QT9"!S='EL
M93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE<R!N97<@
M<F]M86X[($9/3E0M4TE:13H@,3!P=#L@5$585"U!3$E'3CH@<FEG:'0G('9A
M;&EG;CTS1&)O='1O;2!W:61T:#TS1#DE/C,N,S<\+W1D/B`\=&0@<W1Y;&4]
M,T0G5$585"U!3$E'3CH@;&5F="<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$
M,24@;F]W<F%P/3-$;F]W<F%P/CQF;VYT('-T>6QE/3-$)T9/3E0M4TE:13H@
M,3!P=#L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1$E34$Q!63H@
M:6YL:6YE)SX@)FYB<W`[/"]F;VYT/B`\+W1D/B`\+W1R/B`\='(@8F=C;VQO
M<CTS1'=H:71E/B`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$-3(E/CQF
M;VYT('-T>6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ('1I
M;65S(&YE=R!R;VUA;CL@1$E34$Q!63H@:6YL:6YE)SX@)FYB<W`[/"]F;VYT
M/B`\+W1D/B`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24^/&9O;G0@
M<W1Y;&4],T0G1D].5"U325I%.B`Q,'!T.R!&3TY4+49!34E,63H@=&EM97,@
M;F5W(')O;6%N.R!$25-03$%9.B!I;FQI;F4G/B`F;F)S<#L\+V9O;G0^(#PO
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M:'0G('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#DE/C@N,C`\+W1D/B`\=&0@
M<W1Y;&4],T0G5$585"U!3$E'3CH@;&5F="<@=F%L:6=N/3-$8F]T=&]M('=I
M9'1H/3-$,24@;F]W<F%P/3-$;F]W<F%P/CQF;VYT('-T>6QE/3-$)T9/3E0M
M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1$E3
M4$Q!63H@:6YL:6YE)SX@)FYB<W`[/"]F;VYT/B`\+W1D/B`\=&0@=F%L:6=N
M/3-$8F]T=&]M('=I9'1H/3-$,24^/&9O;G0@<W1Y;&4],T0G1D].5"U325I%
M.B`Q,'!T.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!$25-03$%9
M.B!I;FQI;F4G/B`F;F)S<#L\+V9O;G0^(#PO=&0^(#QT9"!S='EL93TS1"=4
M15A4+4%,24=..B!L969T)R!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)3X\
M9F]N="!S='EL93TS1"=&3TY4+5-)6D4Z(#$P<'0[($9/3E0M1D%-24Q9.B!T
M:6UE<R!N97<@<F]M86X[($1)4U!,05DZ(&EN;&EN92<^("9N8G-P.SPO9F]N
M=#X@/"]T9#X@/'1D('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&
M04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T.R!415A4
M+4%,24=..B!R:6=H="<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$.24^,S`L
M,#`P/"]T9#X@/'1D('-T>6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G('9A;&EG
M;CTS1&)O='1O;2!W:61T:#TS1#$E(&YO=W)A<#TS1&YO=W)A<#X\9F]N="!S
M='EL93TS1"=&3TY4+5-)6D4Z(#$P<'0[($9/3E0M1D%-24Q9.B!T:6UE<R!N
M97<@<F]M86X[($1)4U!,05DZ(&EN;&EN92<^("9N8G-P.SPO9F]N=#X@/"]T
M9#X@/'1D('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E/CQF;VYT('-T>6QE
M/3-$)T9/3E0M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R
M;VUA;CL@1$E34$Q!63H@:6YL:6YE)SX@)FYB<W`[/"]F;VYT/B`\+W1D/B`\
M=&0@<W1Y;&4],T0G5$585"U!3$E'3CH@;&5F="<@=F%L:6=N/3-$8F]T=&]M
M('=I9'1H/3-$,24^/&9O;G0@<W1Y;&4],T0G1D].5"U325I%.B`Q,'!T.R!&
M3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!$25-03$%9.B!I;FQI;F4G
M/B`F;F)S<#L\+V9O;G0^(#PO=&0^(#QT9"!S='EL93TS1"=$25-03$%9.B!I
M;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE<R!N97<@<F]M86X[($9/3E0M4TE:
M13H@,3!P=#L@5$585"U!3$E'3CH@<FEG:'0G('9A;&EG;CTS1&)O='1O;2!W
M:61T:#TS1#DE/C,P+#`P,#PO=&0^(#QT9"!S='EL93TS1"=415A4+4%,24=.
M.B!L969T)R!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)2!N;W=R87`],T1N
M;W=R87`^/&9O;G0@<W1Y;&4],T0G1D].5"U325I%.B`Q,'!T.R!&3TY4+49!
M34E,63H@=&EM97,@;F5W(')O;6%N.R!$25-03$%9.B!I;FQI;F4G/B`F;F)S
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M4$Q!63H@:6YL:6YE)SX@)FYB<W`[/"]F;VYT/B`\+W1D/B`\=&0@<W1Y;&4]
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M,T0C8V-E969F/B`\=&0@<W1Y;&4],T0G4$%$1$E.1RU"3U143TTZ(#)P>"<@
M=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$-3(E/CQF;VYT('-T>6QE/3-$)T9/
M3E0M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@
M1$E34$Q!63H@:6YL:6YE)SX@)FYB<W`[/"]F;VYT/B`\+W1D/B`\=&0@<W1Y
M;&4],T0G4$%$1$E.1RU"3U143TTZ(#)P>"<@=F%L:6=N/3-$8F]T=&]M('=I
M9'1H/3-$,24^/&9O;G0@<W1Y;&4],T0G1D].5"U325I%.B`Q,'!T.R!&3TY4
M+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!$25-03$%9.B!I;FQI;F4G/B`F
M;F)S<#L\+V9O;G0^(#PO=&0^(#QT9"!S='EL93TS1"="3U)$15(M0D]45$]-
M.B!B;&%C:R`R<'@@<V]L:60[($1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)
M3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T.R!415A4+4%,
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M,T1B;W1T;VT@=VED=&@],T0Q)2!N;W=R87`],T1N;W=R87`^/&9O;G0@<W1Y
M;&4],T0G1D].5"U325I%.B`Q,'!T.R!&3TY4+49!34E,63H@=&EM97,@;F5W
M(')O;6%N.R!$25-03$%9.B!I;FQI;F4G/B`F;F)S<#L\+V9O;G0^(#PO=&0^
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M5"U325I%.B`Q,'!T.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!$
M25-03$%9.B!I;FQI;F4G/B`F;F)S<#L\+V9O;G0^(#PO=&0^(#QT9"!S='EL
M93TS1"="3U)$15(M0D]45$]-.B!B;&%C:R`R<'@@<V]L:60[($1)4U!,05DZ
M(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U3
M25I%.B`Q,'!T.R!415A4+4%,24=..B!R:6=H="<@=F%L:6=N/3-$8F]T=&]M
M('=I9'1H/3-$.24^,3`W+#4P,#PO=&0^(#QT9"!S='EL93TS1"=0041$24Y'
M+4)/5%1/33H@,G!X.R!415A4+4%,24=..B!L969T)R!V86QI9VX],T1B;W1T
M;VT@=VED=&@],T0Q)2!N;W=R87`],T1N;W=R87`^/&9O;G0@<W1Y;&4],T0G
M1D].5"U325I%.B`Q,'!T.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N
M.R!$25-03$%9.B!I;FQI;F4G/B`F;F)S<#L\+V9O;G0^(#PO=&0^(#QT9"!S
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M.B`Q,'!T.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!$25-03$%9
M.B!I;FQI;F4G/B`F;F)S<#L\+V9O;G0^(#PO=&0^(#QT9"!S='EL93TS1"="
M3U)$15(M0D]45$]-.B!B;&%C:R`R<'@@<V]L:60[($1)4U!,05DZ(&EN;&EN
M93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q
M,'!T.R!415A4+4%,24=..B!R:6=H="<@=F%L:6=N/3-$8F]T=&]M('=I9'1H
M/3-$.24^,3`W+#4P,#PO=&0^(#QT9"!S='EL93TS1"=0041$24Y'+4)/5%1/
M33H@,G!X.R!415A4+4%,24=..B!L969T)R!V86QI9VX],T1B;W1T;VT@=VED
M=&@],T0Q)2!N;W=R87`],T1N;W=R87`^/&9O;G0@<W1Y;&4],T0G1D].5"U3
M25I%.B`Q,'!T.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!$25-0
M3$%9.B!I;FQI;F4G/B`F;F)S<#L\+V9O;G0^(#PO=&0^(#QT9"!S='EL93TS
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M=&]M('=I9'1H/3-$,24^/&9O;G0@<W1Y;&4],T0G1D].5"U325I%.B`Q,'!T
M.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!$25-03$%9.B!I;FQI
M;F4G/B`F;F)S<#L\+V9O;G0^(#PO=&0^(#QT9"!S='EL93TS1"="3U)$15(M
M0D]45$]-.B!B;&%C:R`R<'@@<V]L:60[($1)4U!,05DZ(&EN;&EN93L@1D].
M5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T.R!4
M15A4+4%,24=..B!R:6=H="<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$.24^
M,BXX.#PO=&0^(#QT9"!S='EL93TS1"=0041$24Y'+4)/5%1/33H@,G!X.R!4
M15A4+4%,24=..B!L969T)R!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)2!N
M;W=R87`],T1N;W=R87`^/&9O;G0@<W1Y;&4],T0G1D].5"U325I%.B`Q,'!T
M.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!$25-03$%9.B!I;FQI
M;F4G/B`F;F)S<#L\+V9O;G0^(#PO=&0^(#PO='(^(#QT<B!B9V-O;&]R/3-$
M=VAI=&4^(#QT9"!S='EL93TS1"=0041$24Y'+4)/5%1/33H@-'!X.R!415A4
M+4%,24=..B!L969T.R!-05)'24XM3$5&5#H@,'!T.R!-05)'24XM4DE'2%0Z
M(#!P=#L@5$585"U)3D1%3E0Z(#!P="<@=F%L:6=N/3-$8F]T=&]M('=I9'1H
M/3-$-3(E/B`\9&EV('-T>6QE/3-$)T1)4U!,05DZ(&)L;V-K.R!&3TY4+49!
M34E,63H@=&EM97,@;F5W(')O;6%N.R!&3TY4+5-)6D4Z(#$P<'0[($9/3E0M
M5T5)1TA4.B!B;VQD.R!-05)'24XM3$5&5#H@,'!T.R!-05)'24XM4DE'2%0Z
M(#!P=#L@5$585"U!3$E'3CH@;&5F=#L@5$585"U)3D1%3E0Z(#!P="<^(%1O
M=&%L(&]P=&EO;G,\+V1I=CX@/"]T9#X@/'1D('-T>6QE/3-$)U!!1$1)3D<M
M0D]45$]-.B`T<'@G('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E/CQF;VYT
M('-T>6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ('1I;65S
M(&YE=R!R;VUA;CL@1$E34$Q!63H@:6YL:6YE)SX@)FYB<W`[/"]F;VYT/B`\
M+W1D/B`\=&0@<W1Y;&4],T0G0D]21$52+4)/5%1/33H@8FQA8VL@-'!X(&1O
M=6)L93L@5$585"U!3$E'3CH@;&5F="<@=F%L:6=N/3-$8F]T=&]M('=I9'1H
M/3-$,24^/&9O;G0@<W1Y;&4],T0G1D].5"U325I%.B`Q,'!T.R!&3TY4+49!
M34E,63H@=&EM97,@;F5W(')O;6%N.R!$25-03$%9.B!I;FQI;F4G/B`F;F)S
M<#L\+V9O;G0^(#PO=&0^(#QT9"!S='EL93TS1"="3U)$15(M0D]45$]-.B!B
M;&%C:R`T<'@@9&]U8FQE.R!415A4+4%,24=..B!R:6=H="<@=F%L:6=N/3-$
M8F]T=&]M('=I9'1H/3-$.24^/&9O;G0@<W1Y;&4],T0G1D].5"U325I%.B`Q
M,'!T.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!$25-03$%9.B!I
M;FQI;F4G/B`F;F)S<#L\+V9O;G0^(#PO=&0^(#QT9"!S='EL93TS1"=0041$
M24Y'+4)/5%1/33H@-'!X.R!415A4+4%,24=..B!L969T)R!V86QI9VX],T1B
M;W1T;VT@=VED=&@],T0Q)2!N;W=R87`],T1N;W=R87`^/&9O;G0@<W1Y;&4]
M,T0G1D].5"U325I%.B`Q,'!T.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O
M;6%N.R!$25-03$%9.B!I;FQI;F4G/B`F;F)S<#L\+V9O;G0^(#PO=&0^(#QT
M9"!S='EL93TS1"=0041$24Y'+4)/5%1/33H@-'!X)R!V86QI9VX],T1B;W1T
M;VT@=VED=&@],T0Q)3X\9F]N="!S='EL93TS1"=&3TY4+5-)6D4Z(#$P<'0[
M($9/3E0M1D%-24Q9.B!T:6UE<R!N97<@<F]M86X[($9/3E0M5T5)1TA4.B!B
M;VQD.R!$25-03$%9.B!I;FQI;F4G/B`F;F)S<#L\+V9O;G0^(#PO=&0^(#QT
M9"!S='EL93TS1"="3U)$15(M0D]45$]-.B!B;&%C:R`T<'@@9&]U8FQE.R!4
M15A4+4%,24=..B!L969T)R!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)3X\
M9F]N="!S='EL93TS1"=&3TY4+5-)6D4Z(#$P<'0[($9/3E0M1D%-24Q9.B!T
M:6UE<R!N97<@<F]M86X[($9/3E0M5T5)1TA4.B!B;VQD.R!$25-03$%9.B!I
M;FQI;F4G/B`F;F)S<#L\+V9O;G0^(#PO=&0^(#QT9"!S='EL93TS1"="3U)$
M15(M0D]45$]-.B!B;&%C:R`T<'@@9&]U8FQE.R!$25-03$%9.B!I;FQI;F4[
M($9/3E0M1D%-24Q9.B!T:6UE<R!N97<@<F]M86X[($9/3E0M4TE:13H@,3!P
M=#L@1D].5"U714E'2%0Z(&)O;&0[(%1%6%0M04Q)1TXZ(')I9VAT)R!V86QI
M9VX],T1B;W1T;VT@=VED=&@],T0Y)3XR+#$Q-"PP.3D\+W1D/B`\=&0@<W1Y
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M3D<M0D]45$]-.B`T<'@G('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E/CQF
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M;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T.R!&3TY4+5=%24=(5#H@
M8F]L9#L@5$585"U!3$E'3CH@<FEG:'0G('9A;&EG;CTS1&)O='1O;2!W:61T
M:#TS1#DE/C(L,3$S+#`Y.3PO=&0^(#QT9"!S='EL93TS1"=0041$24Y'+4)/
M5%1/33H@-'!X.R!415A4+4%,24=..B!L969T)R!V86QI9VX],T1B;W1T;VT@
M=VED=&@],T0Q)2!N;W=R87`],T1N;W=R87`^/&9O;G0@<W1Y;&4],T0G1D].
M5"U325I%.B`Q,'!T.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!&
M3TY4+5=%24=(5#H@8F]L9#L@1$E34$Q!63H@:6YL:6YE)SX@)FYB<W`[/"]F
M;VYT/B`\+W1D/B`\=&0@<W1Y;&4],T0G4$%$1$E.1RU"3U143TTZ(#1P>"<@
M=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24^/&9O;G0@<W1Y;&4],T0G1D].
M5"U325I%.B`Q,'!T.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!$
M25-03$%9.B!I;FQI;F4G/B`F;F)S<#L\+V9O;G0^(#PO=&0^(#QT9"!S='EL
M93TS1"="3U)$15(M0D]45$]-.B!B;&%C:R`T<'@@9&]U8FQE.R!415A4+4%,
M24=..B!L969T)R!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)3X\9F]N="!S
M='EL93TS1"=&3TY4+5-)6D4Z(#$P<'0[($9/3E0M1D%-24Q9.B!T:6UE<R!N
M97<@<F]M86X[($1)4U!,05DZ(&EN;&EN92<^("9N8G-P.SPO9F]N=#X@/"]T
M9#X@/'1D('-T>6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#1P>"!D;W5B
M;&4[(%1%6%0M04Q)1TXZ(')I9VAT)R!V86QI9VX],T1B;W1T;VT@=VED=&@]
M,T0Y)3X\9F]N="!S='EL93TS1"=&3TY4+5-)6D4Z(#$P<'0[($9/3E0M1D%-
M24Q9.B!T:6UE<R!N97<@<F]M86X[($1)4U!,05DZ(&EN;&EN92<^("9N8G-P
M.SPO9F]N=#X@/"]T9#X@/'1D('-T>6QE/3-$)U!!1$1)3D<M0D]45$]-.B`T
M<'@[(%1%6%0M04Q)1TXZ(&QE9G0G('9A;&EG;CTS1&)O='1O;2!W:61T:#TS
M1#$E(&YO=W)A<#TS1&YO=W)A<#X\9F]N="!S='EL93TS1"=&3TY4+5-)6D4Z
M(#$P<'0[($9/3E0M1D%-24Q9.B!T:6UE<R!N97<@<F]M86X[($1)4U!,05DZ
M(&EN;&EN92<^("9N8G-P.SPO9F]N=#X@/"]T9#X@/"]T<CX@/'1R(&)G8V]L
M;W(],T0C8V-E969F/B`\=&0@<W1Y;&4],T0G4$%$1$E.1RU"3U143TTZ(#)P
M>#L@5$585"U!3$E'3CH@;&5F=#L@34%21TE.+4Q%1E0Z(#!P=#L@34%21TE.
M+5))1TA4.B`P<'0[(%1%6%0M24Y$14Y4.B`P<'0G('9A;&EG;CTS1&)O='1O
M;2!W:61T:#TS1#4R)3X@/&1I=B!S='EL93TS1"=$25-03$%9.B!B;&]C:SL@
M1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T
M.R!&3TY4+5=%24=(5#H@8F]L9#L@34%21TE.+4Q%1E0Z(#!P=#L@34%21TE.
M+5))1TA4.B`P<'0[(%1%6%0M04Q)1TXZ(&QE9G0[(%1%6%0M24Y$14Y4.B`P
M<'0G/B!4;W1A;"!W87)R86YT<R!A;F0@;W!T:6]N<SPO9&EV/B`\+W1D/B`\
M=&0@<W1Y;&4],T0G4$%$1$E.1RU"3U143TTZ(#)P>"<@=F%L:6=N/3-$8F]T
M=&]M('=I9'1H/3-$,24^/&9O;G0@<W1Y;&4],T0G1D].5"U325I%.B`Q,'!T
M.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!$25-03$%9.B!I;FQI
M;F4G/B`F;F)S<#L\+V9O;G0^(#PO=&0^(#QT9"!S='EL93TS1"="3U)$15(M
M0D]45$]-.B!B;&%C:R`R<'@@<V]L:60[(%1%6%0M04Q)1TXZ(&QE9G0G('9A
M;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E/CQF;VYT('-T>6QE/3-$)T9/3E0M
M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1$E3
M4$Q!63H@:6YL:6YE)SX@)FYB<W`[/"]F;VYT/B`\+W1D/B`\=&0@<W1Y;&4]
M,T0G0D]21$52+4)/5%1/33H@8FQA8VL@,G!X('-O;&ED.R!415A4+4%,24=.
M.B!R:6=H="<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$.24^/&9O;G0@<W1Y
M;&4],T0G1D].5"U325I%.B`Q,'!T.R!&3TY4+49!34E,63H@=&EM97,@;F5W
M(')O;6%N.R!$25-03$%9.B!I;FQI;F4G/B`F;F)S<#L\+V9O;G0^(#PO=&0^
M(#QT9"!S='EL93TS1"=0041$24Y'+4)/5%1/33H@,G!X.R!415A4+4%,24=.
M.B!L969T)R!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)2!N;W=R87`],T1N
M;W=R87`^/&9O;G0@<W1Y;&4],T0G1D].5"U325I%.B`Q,'!T.R!&3TY4+49!
M34E,63H@=&EM97,@;F5W(')O;6%N.R!$25-03$%9.B!I;FQI;F4G/B`F;F)S
M<#L\+V9O;G0^(#PO=&0^(#QT9"!S='EL93TS1"=0041$24Y'+4)/5%1/33H@
M,G!X)R!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)3X\9F]N="!S='EL93TS
M1"=&3TY4+5-)6D4Z(#$P<'0[($9/3E0M1D%-24Q9.B!T:6UE<R!N97<@<F]M
M86X[($9/3E0M5T5)1TA4.B!B;VQD.R!$25-03$%9.B!I;FQI;F4G/B`F;F)S
M<#L\+V9O;G0^(#PO=&0^(#QT9"!S='EL93TS1"="3U)$15(M0D]45$]-.B!B
M;&%C:R`R<'@@<V]L:60[(%1%6%0M04Q)1TXZ(&QE9G0G('9A;&EG;CTS1&)O
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M24=..B!R:6=H="<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$.24^)FYB<W`[
M,3(L-C0X+#,P,SPO=&0^(#QT9"!S='EL93TS1"=0041$24Y'+4)/5%1/33H@
M,G!X.R!415A4+4%,24=..B!L969T)R!V86QI9VX],T1B;W1T;VT@=VED=&@]
M,T0Q)2!N;W=R87`],T1N;W=R87`^/&9O;G0@<W1Y;&4],T0G1D].5"U325I%
M.B`Q,'!T.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!&3TY4+5=%
M24=(5#H@8F]L9#L@1$E34$Q!63H@:6YL:6YE)SX@)FYB<W`[/"]F;VYT/B`\
M+W1D/B`\=&0@<W1Y;&4],T0G4$%$1$E.1RU"3U143TTZ(#)P>"<@=F%L:6=N
M/3-$8F]T=&]M('=I9'1H/3-$,24^/&9O;G0@<W1Y;&4],T0G1D].5"U325I%
M.B`Q,'!T.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!&3TY4+5=%
M24=(5#H@8F]L9#L@1$E34$Q!63H@:6YL:6YE)SX@)FYB<W`[/"]F;VYT/B`\
M+W1D/B`\=&0@<W1Y;&4],T0G0D]21$52+4)/5%1/33H@8FQA8VL@,G!X('-O
M;&ED.R!415A4+4%,24=..B!L969T)R!V86QI9VX],T1B;W1T;VT@=VED=&@]
M,T0Q)3X\9F]N="!S='EL93TS1"=&3TY4+5-)6D4Z(#$P<'0[($9/3E0M1D%-
M24Q9.B!T:6UE<R!N97<@<F]M86X[($9/3E0M5T5)1TA4.B!B;VQD.R!$25-0
M3$%9.B!I;FQI;F4G/B`F;F)S<#L\+V9O;G0^(#PO=&0^(#QT9"!S='EL93TS
M1"="3U)$15(M0D]45$]-.B!B;&%C:R`R<'@@<V]L:60[($1)4U!,05DZ(&EN
M;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%
M.B`Q,'!T.R!&3TY4+5=%24=(5#H@8F]L9#L@5$585"U!3$E'3CH@<FEG:'0G
M('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#DE/B9N8G-P.S$R+#8T-RPS,#,\
M+W1D/B`\=&0@<W1Y;&4],T0G4$%$1$E.1RU"3U143TTZ(#)P>#L@5$585"U!
M3$E'3CH@;&5F="<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@;F]W<F%P
M/3-$;F]W<F%P/CQF;VYT('-T>6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@1D].
M5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U714E'2%0Z(&)O;&0[
M($1)4U!,05DZ(&EN;&EN92<^("9N8G-P.SPO9F]N=#X@/"]T9#X@/'1D('-T
M>6QE/3-$)U!!1$1)3D<M0D]45$]-.B`R<'@G('9A;&EG;CTS1&)O='1O;2!W
M:61T:#TS1#$E/CQF;VYT('-T>6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@1D].
M5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1$E34$Q!63H@:6YL:6YE)SX@
M)FYB<W`[/"]F;VYT/B`\+W1D/B`\=&0@<W1Y;&4],T0G0D]21$52+4)/5%1/
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M;CL@1$E34$Q!63H@:6YL:6YE)SX@)FYB<W`[/"]F;VYT/B`\+W1D/B`\=&0@
M<W1Y;&4],T0G4$%$1$E.1RU"3U143TTZ(#)P>#L@5$585"U!3$E'3CH@;&5F
M="<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@;F]W<F%P/3-$;F]W<F%P
M/CQF;VYT('-T>6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ
M('1I;65S(&YE=R!R;VUA;CL@1$E34$Q!63H@:6YL:6YE)SX@)FYB<W`[/"]F
M;VYT/B`\+W1D/B`\+W1R/B`\+W1A8FQE/B`\+V1I=CX@/"$M+45N9$9R86=M
M96YT+2T^/"]D:78^(#PO9&EV/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@
M/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS1')H/@T*("`@("`@("`\=&0@8VQA
M<W,],T1P;"!V86QI9VX],T1T;W`^3W!T:6]N<R!A;F0@=V%R<F%N=',@6TUE
M;6)E<ET\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\
M+W-P86X^/"]T9#X-"B`@("`@(#PO='(^#0H@("`@("`\='(@8VQA<W,],T1R
M;SX-"B`@("`@("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P/CQS=')O
M;F<^4W1O8VMH;VQD97)S($5Q=6ET>2!.;W1E(%M,:6YE($ET96US73PO<W1R
M;VYG/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO
M<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS1')E
M/@T*("`@("`@("`\=&0@8VQA<W,],T1P;"!V86QI9VX],T1T;W`^4V-H961U
M;&4@;V8@4W1O8VLM8F%S960@0V]M<&5N<V%T:6]N($5X<&5N<V5S/"]T9#X-
M"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/"$M+41/0U194$4@:'1M;"!0
M54),24,@(BTO+U<S0R\O1%1$(%A(5$U,(#$N,"!4<F%N<VET:6]N86PO+T5.
M(B`B:'1T<#HO+W=W=RYW,RYO<F<O5%(O>&AT;6PQ+T141"]X:'1M;#$M=')A
M;G-I=&EO;F%L+F1T9"(@+2T^/&1I=CX@/&1I=CX\(2TM4W1A<G1&<F%G;65N
M="TM/B`\9&EV/B`\=&%B;&4@<W1Y;&4],T0G1D].5"U325I%.B`Q,'!T.R!&
M3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N)R!C96QL<W!A8VEN9STS1#`@
M8V5L;'!A9&1I;F<],T0P('=I9'1H/3-$,3`P)2!A;&EG;CTS1&-E;G1E<B!B
M;W)D97(],T0P/B`\='(@=F%L:6=N/3-$=&]P/B`\=&0@<W1Y;&4],T0G5TE$
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M1494.B`P<'0[($U!4D=)3BU224=(5#H@,'!T.R!T97AT+6%L:6=N.B!J=7-T
M:69Y.R!415A4+4E.1$5.5#H@,'!T)SX@)FYB<W`[/"]D:78^(#QD:78@<W1Y
M;&4],T0G34%21TE.+4Q%1E0Z(#,V<'0[('1E>'0M86QI9VXZ(&QE9G0G/B`\
M=&%B;&4@<W1Y;&4],T0G1D].5"U325I%.B`Q,'!T.R!&3TY4+49!34E,63H@
M=&EM97,@;F5W(')O;6%N)R!C96QL<W!A8VEN9STS1#`@8V5L;'!A9&1I;F<]
M,T0P('=I9'1H/3-$.#`E/B`\='(^(#QT9"!S='EL93TS1"=0041$24Y'+4)/
M5%1/33H@,G!X)R!V86QI9VX],T1B;W1T;VT@=VED=&@],T0V-"4^/&9O;G0@
M<W1Y;&4],T0G1D].5"U325I%.B`Q,'!T.R!&3TY4+49!34E,63H@=&EM97,@
M;F5W(')O;6%N.R!$25-03$%9.B!I;FQI;F4G/B`F;F)S<#L\+V9O;G0^(#PO
M=&0^(#QT9"!S='EL93TS1"=0041$24Y'+4)/5%1/33H@,G!X)R!V86QI9VX]
M,T1B;W1T;VT@=VED=&@],T0Q)3X\9F]N="!S='EL93TS1"=&3TY4+5-)6D4Z
M(#$P<'0[($9/3E0M1D%-24Q9.B!T:6UE<R!N97<@<F]M86X[($9/3E0M5T5)
M1TA4.B!B;VQD.R!$25-03$%9.B!I;FQI;F4G/B`F;F)S<#L\+V9O;G0^(#PO
M=&0^(#QT9"!S='EL93TS1"="3U)$15(M0D]45$]-.B!B;&%C:R`R<'@@<V]L
M:60G('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#,T)2!C;VQS<&%N/3-$,3`^
M(#QD:78@<W1Y;&4],T0G1$E34$Q!63H@8FQO8VL[($9/3E0M1D%-24Q9.B!T
M:6UE<R!N97<@<F]M86X[($9/3E0M4TE:13H@,3!P=#L@1D].5"U714E'2%0Z
M(&)O;&0[($U!4D=)3BU,1494.B`P<'0[($U!4D=)3BU224=(5#H@,'!T.R!T
M97AT+6%L:6=N.B!C96YT97([(%1%6%0M24Y$14Y4.B`P<'0G/B!996%R(&5N
M9&5D)FYB<W`[2G5N92`S,"P\+V1I=CX@/"]T9#X@/'1D('-T>6QE/3-$)U!!
M1$1)3D<M0D]45$]-.B`R<'@[(%1%6%0M04Q)1TXZ(&QE9G0G('9A;&EG;CTS
M1&)O='1O;2!W:61T:#TS1#$E(&YO=W)A<#TS1&YO=W)A<#X\9F]N="!S='EL
M93TS1"=&3TY4+5-)6D4Z(#$P<'0[($9/3E0M1D%-24Q9.B!T:6UE<R!N97<@
M<F]M86X[($9/3E0M5T5)1TA4.B!B;VQD.R!$25-03$%9.B!I;FQI;F4G/B`F
M;F)S<#L\+V9O;G0^(#PO=&0^(#PO='(^(#QT<CX@/'1D('-T>6QE/3-$)U!!
M1$1)3D<M0D]45$]-.B`R<'@G('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#8T
M)3X\9F]N="!S='EL93TS1"=&3TY4+5-)6D4Z(#$P<'0[($9/3E0M1D%-24Q9
M.B!T:6UE<R!N97<@<F]M86X[($1)4U!,05DZ(&EN;&EN92<^("9N8G-P.SPO
M9F]N=#X@/"]T9#X@/'1D('-T>6QE/3-$)U!!1$1)3D<M0D]45$]-.B`R<'@G
M('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E/CQF;VYT('-T>6QE/3-$)T9/
M3E0M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@
M1D].5"U714E'2%0Z(&)O;&0[($1)4U!,05DZ(&EN;&EN92<^("9N8G-P.SPO
M9F]N=#X@/"]T9#X@/'1D('-T>6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K
M(#)P>"!S;VQI9"<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,3`E(&-O;'-P
M86X],T0R/B`\9&EV('-T>6QE/3-$)T1)4U!,05DZ(&)L;V-K.R!&3TY4+49!
M34E,63H@=&EM97,@;F5W(')O;6%N.R!&3TY4+5-)6D4Z(#$P<'0[($9/3E0M
M5T5)1TA4.B!B;VQD.R!-05)'24XM3$5&5#H@,'!T.R!-05)'24XM4DE'2%0Z
M(#!P=#L@=&5X="UA;&EG;CH@8V5N=&5R.R!415A4+4E.1$5.5#H@,'!T)SX@
M,C`Q-#PO9&EV/B`\+W1D/B`\=&0@<W1Y;&4],T0G4$%$1$E.1RU"3U143TTZ
M(#)P>#L@5$585"U!3$E'3CH@;&5F="<@=F%L:6=N/3-$8F]T=&]M('=I9'1H
M/3-$,24@;F]W<F%P/3-$;F]W<F%P/CQF;VYT('-T>6QE/3-$)T9/3E0M4TE:
M13H@,3!P=#L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U7
M14E'2%0Z(&)O;&0[($1)4U!,05DZ(&EN;&EN92<^("9N8G-P.SPO9F]N=#X@
M/"]T9#X@/'1D('-T>6QE/3-$)U!!1$1)3D<M0D]45$]-.B`R<'@G('9A;&EG
M;CTS1&)O='1O;2!W:61T:#TS1#$E/CQF;VYT('-T>6QE/3-$)T9/3E0M4TE:
M13H@,3!P=#L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U7
M14E'2%0Z(&)O;&0[($1)4U!,05DZ(&EN;&EN92<^("9N8G-P.SPO9F]N=#X@
M/"]T9#X@/'1D('-T>6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#)P>"!S
M;VQI9"<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,3`E(&-O;'-P86X],T0R
M/B`\9&EV('-T>6QE/3-$)T1)4U!,05DZ(&)L;V-K.R!&3TY4+49!34E,63H@
M=&EM97,@;F5W(')O;6%N.R!&3TY4+5-)6D4Z(#$P<'0[($9/3E0M5T5)1TA4
M.B!B;VQD.R!-05)'24XM3$5&5#H@,'!T.R!-05)'24XM4DE'2%0Z(#!P=#L@
M=&5X="UA;&EG;CH@8V5N=&5R.R!415A4+4E.1$5.5#H@,'!T)SX@,C`Q,SPO
M9&EV/B`\+W1D/B`\=&0@<W1Y;&4],T0G4$%$1$E.1RU"3U143TTZ(#)P>#L@
M5$585"U!3$E'3CH@;&5F="<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@
M;F]W<F%P/3-$;F]W<F%P/CQF;VYT('-T>6QE/3-$)T9/3E0M4TE:13H@,3!P
M=#L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U714E'2%0Z
M(&)O;&0[($1)4U!,05DZ(&EN;&EN92<^("9N8G-P.SPO9F]N=#X@/"]T9#X@
M/'1D('-T>6QE/3-$)U!!1$1)3D<M0D]45$]-.B`R<'@G('9A;&EG;CTS1&)O
M='1O;2!W:61T:#TS1#$E/CQF;VYT('-T>6QE/3-$)T9/3E0M4TE:13H@,3!P
M=#L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U714E'2%0Z
M(&)O;&0[($1)4U!,05DZ(&EN;&EN92<^("9N8G-P.SPO9F]N=#X@/"]T9#X@
M/'1D('-T>6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#)P>"!S;VQI9"<@
M=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,3`E(&-O;'-P86X],T0R/B`\9&EV
M('-T>6QE/3-$)T1)4U!,05DZ(&)L;V-K.R!&3TY4+49!34E,63H@=&EM97,@
M;F5W(')O;6%N.R!&3TY4+5-)6D4Z(#$P<'0[($9/3E0M5T5)1TA4.B!B;VQD
M.R!-05)'24XM3$5&5#H@,'!T.R!-05)'24XM4DE'2%0Z(#!P=#L@=&5X="UA
M;&EG;CH@8V5N=&5R.R!415A4+4E.1$5.5#H@,'!T)SX@,C`Q,CPO9&EV/B`\
M+W1D/B`\=&0@<W1Y;&4],T0G4$%$1$E.1RU"3U143TTZ(#)P>#L@5$585"U!
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M(&QE9G0[($U!4D=)3BU,1494.B`P<'0[($U!4D=)3BU224=(5#H@,'!T.R!4
M15A4+4E.1$5.5#H@,'!T)R!V86QI9VX],T1B;W1T;VT@=VED=&@],T0V-"4^
M/&9O;G0@<W1Y;&4],T0G1D].5"U325I%.B`Q,'!T.R!&3TY4+49!34E,63H@
M=&EM97,@;F5W(')O;6%N.R!$25-03$%9.B!I;FQI;F4G/B`F;F)S<#L\+V9O
M;G0^(#PO=&0^(#QT9"!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)2!A;&EG
M;CTS1')I9VAT/CQF;VYT('-T>6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@1D].
M5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1$E34$Q!63H@:6YL:6YE)SX@
M)FYB<W`[/"]F;VYT/B`\+W1D/B`\=&0@<W1Y;&4],T0G5$585"U!3$E'3CH@
M;&5F="<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24^/&9O;G0@<W1Y;&4]
M,T0G1D].5"U325I%.B`Q,'!T.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O
M;6%N.R!$25-03$%9.B!I;FQI;F4G/B`F;F)S<#L\+V9O;G0^(#PO=&0^(#QT
M9"!S='EL93TS1"=415A4+4%,24=..B!R:6=H="<@=F%L:6=N/3-$8F]T=&]M
M('=I9'1H/3-$.24^/&9O;G0@<W1Y;&4],T0G1D].5"U325I%.B`Q,'!T.R!&
M3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!$25-03$%9.B!I;FQI;F4G
M/B`F;F)S<#L\+V9O;G0^(#PO=&0^(#QT9"!S='EL93TS1"=415A4+4%,24=.
M.B!L969T)R!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)2!N;W=R87`],T1N
M;W=R87`^/&9O;G0@<W1Y;&4],T0G1D].5"U325I%.B`Q,'!T.R!&3TY4+49!
M34E,63H@=&EM97,@;F5W(')O;6%N.R!$25-03$%9.B!I;FQI;F4G/B`F;F)S
M<#L\+V9O;G0^(#PO=&0^(#QT9"!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q
M)2!A;&EG;CTS1')I9VAT/CQF;VYT('-T>6QE/3-$)T9/3E0M4TE:13H@,3!P
M=#L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1$E34$Q!63H@:6YL
M:6YE)SX@)FYB<W`[/"]F;VYT/B`\+W1D/B`\=&0@<W1Y;&4],T0G5$585"U!
M3$E'3CH@;&5F="<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24^/&9O;G0@
M<W1Y;&4],T0G1D].5"U325I%.B`Q,'!T.R!&3TY4+49!34E,63H@=&EM97,@
M;F5W(')O;6%N.R!$25-03$%9.B!I;FQI;F4G/B`F;F)S<#L\+V9O;G0^(#PO
M=&0^(#QT9"!S='EL93TS1"=415A4+4%,24=..B!R:6=H="<@=F%L:6=N/3-$
M8F]T=&]M('=I9'1H/3-$.24^/&9O;G0@<W1Y;&4],T0G1D].5"U325I%.B`Q
M,'!T.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!$25-03$%9.B!I
M;FQI;F4G/B`F;F)S<#L\+V9O;G0^(#PO=&0^(#QT9"!S='EL93TS1"=415A4
M+4%,24=..B!L969T)R!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)2!N;W=R
M87`],T1N;W=R87`^/&9O;G0@<W1Y;&4],T0G1D].5"U325I%.B`Q,'!T.R!&
M3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!$25-03$%9.B!I;FQI;F4G
M/B`F;F)S<#L\+V9O;G0^(#PO=&0^(#QT9"!V86QI9VX],T1B;W1T;VT@=VED
M=&@],T0Q)2!A;&EG;CTS1')I9VAT/CQF;VYT('-T>6QE/3-$)T9/3E0M4TE:
M13H@,3!P=#L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1$E34$Q!
M63H@:6YL:6YE)SX@)FYB<W`[/"]F;VYT/B`\+W1D/B`\=&0@<W1Y;&4],T0G
M5$585"U!3$E'3CH@;&5F="<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24^
M/&9O;G0@<W1Y;&4],T0G1D].5"U325I%.B`Q,'!T.R!&3TY4+49!34E,63H@
M=&EM97,@;F5W(')O;6%N.R!$25-03$%9.B!I;FQI;F4G/B`F;F)S<#L\+V9O
M;G0^(#PO=&0^(#QT9"!S='EL93TS1"=415A4+4%,24=..B!R:6=H="<@=F%L
M:6=N/3-$8F]T=&]M('=I9'1H/3-$.24^/&9O;G0@<W1Y;&4],T0G1D].5"U3
M25I%.B`Q,'!T.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!$25-0
M3$%9.B!I;FQI;F4G/B`F;F)S<#L\+V9O;G0^(#PO=&0^(#QT9"!S='EL93TS
M1"=415A4+4%,24=..B!L969T)R!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q
M)2!N;W=R87`],T1N;W=R87`^/&9O;G0@<W1Y;&4],T0G1D].5"U325I%.B`Q
M,'!T.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!$25-03$%9.B!I
M;FQI;F4G/B`F;F)S<#L\+V9O;G0^(#PO=&0^(#PO='(^(#QT<B!B9V-O;&]R
M/3-$(V-C965F9CX@/'1D('-T>6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0[($U!
M4D=)3BU,1494.B`P<'0[($U!4D=)3BU224=(5#H@,'!T.R!415A4+4E.1$5.
M5#H@,'!T)R!V86QI9VX],T1B;W1T;VT@=VED=&@],T0V-"4^(#QD:78@<W1Y
M;&4],T0G1$E34$Q!63H@8FQO8VL[($9/3E0M1D%-24Q9.B!T:6UE<R!N97<@
M<F]M86X[($9/3E0M4TE:13H@,3!P=#L@34%21TE.+4Q%1E0Z(#!P=#L@34%2
M1TE.+5))1TA4.B`P<'0[(%1%6%0M04Q)1TXZ(&QE9G0[(%1%6%0M24Y$14Y4
M.B`P<'0G/B!297-E87)C:"!A;F0@9&5V96QO<&UE;G0@97AP96YS97,\+V1I
M=CX@/"]T9#X@/'1D('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E(&%L:6=N
M/3-$<FEG:'0^/&9O;G0@<W1Y;&4],T0G1D].5"U325I%.B`Q,'!T.R!&3TY4
M+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!$25-03$%9.B!I;FQI;F4G/B`F
M;F)S<#L\+V9O;G0^(#PO=&0^(#QT9"!S='EL93TS1"=$25-03$%9.B!I;FQI
M;F4[($9/3E0M1D%-24Q9.B!T:6UE<R!N97<@<F]M86X[($9/3E0M4TE:13H@
M,3!P=#L@5$585"U!3$E'3CH@;&5F="<@=F%L:6=N/3-$8F]T=&]M('=I9'1H
M/3-$,24^)#PO=&0^(#QT9"!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/
M3E0M1D%-24Q9.B!T:6UE<R!N97<@<F]M86X[($9/3E0M4TE:13H@,3!P=#L@
M5$585"U!3$E'3CH@<FEG:'0G('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#DE
M/C$Q/"]T9#X@/'1D('-T>6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G('9A;&EG
M;CTS1&)O='1O;2!W:61T:#TS1#$E(&YO=W)A<#TS1&YO=W)A<#X\9F]N="!S
M='EL93TS1"=&3TY4+5-)6D4Z(#$P<'0[($9/3E0M1D%-24Q9.B!T:6UE<R!N
M97<@<F]M86X[($1)4U!,05DZ(&EN;&EN92<^("9N8G-P.SPO9F]N=#X@/"]T
M9#X@/'1D('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E(&%L:6=N/3-$<FEG
M:'0^/&9O;G0@<W1Y;&4],T0G1D].5"U325I%.B`Q,'!T.R!&3TY4+49!34E,
M63H@=&EM97,@;F5W(')O;6%N.R!$25-03$%9.B!I;FQI;F4G/B`F;F)S<#L\
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M;G0@<W1Y;&4],T0G1D].5"U325I%.B`Q,'!T.R!&3TY4+49!34E,63H@=&EM
M97,@;F5W(')O;6%N.R!$25-03$%9.B!I;FQI;F4G/B`F;F)S<#L\+V9O;G0^
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M.B`R<'@[(%1%6%0M04Q)1TXZ(&QE9G0[($U!4D=)3BU,1494.B`P<'0[($U!
M4D=)3BU224=(5#H@,'!T.R!415A4+4E.1$5.5#H@,'!T)R!V86QI9VX],T1B
M;W1T;VT@=VED=&@],T0V-"4^(#QD:78@<W1Y;&4],T0G1$E34$Q!63H@8FQO
M8VL[($9/3E0M1D%-24Q9.B!T:6UE<R!N97<@<F]M86X[($9/3E0M4TE:13H@
M,3!P=#L@34%21TE.+4Q%1E0Z(#!P=#L@34%21TE.+5))1TA4.B`P<'0[(%1%
M6%0M04Q)1TXZ(&QE9G0[(%1%6%0M24Y$14Y4.B`P<'0G/B!'96YE<F%L(&%N
M9"!A9&UI;FES=')A=&EV92!E>'!E;G-E<SPO9&EV/B`\+W1D/B`\=&0@<W1Y
M;&4],T0G4$%$1$E.1RU"3U143TTZ(#)P>"<@=F%L:6=N/3-$8F]T=&]M('=I
M9'1H/3-$,24^/&9O;G0@<W1Y;&4],T0G1D].5"U325I%.B`Q,'!T.R!&3TY4
M+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!$25-03$%9.B!I;FQI;F4G/B`F
M;F)S<#L\+V9O;G0^(#PO=&0^(#QT9"!S='EL93TS1"="3U)$15(M0D]45$]-
M.B!B;&%C:R`R<'@@<V]L:60[(%1%6%0M04Q)1TXZ(&QE9G0G('9A;&EG;CTS
M1&)O='1O;2!W:61T:#TS1#$E/CQF;VYT('-T>6QE/3-$)T9/3E0M4TE:13H@
M,3!P=#L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1$E34$Q!63H@
M:6YL:6YE)SX@)FYB<W`[/"]F;VYT/B`\+W1D/B`\=&0@<W1Y;&4],T0G0D]2
M1$52+4)/5%1/33H@8FQA8VL@,G!X('-O;&ED.R!415A4+4%,24=..B!R:6=H
M="<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$.24^/&9O;G0@<W1Y;&4],T0G
M1D].5"U325I%.B`Q,'!T.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N
M.R!$25-03$%9.B!I;FQI;F4G/B`F;F)S<#L\+V9O;G0^(#PO=&0^(#QT9"!S
M='EL93TS1"=0041$24Y'+4)/5%1/33H@,G!X.R!415A4+4%,24=..B!L969T
M)R!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)2!N;W=R87`],T1N;W=R87`^
M/&9O;G0@<W1Y;&4],T0G1D].5"U325I%.B`Q,'!T.R!&3TY4+49!34E,63H@
M=&EM97,@;F5W(')O;6%N.R!$25-03$%9.B!I;FQI;F4G/B`F;F)S<#L\+V9O
M;G0^(#PO=&0^(#QT9"!S='EL93TS1"=0041$24Y'+4)/5%1/33H@,G!X)R!V
M86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)2!A;&EG;CTS1')I9VAT/CQF;VYT
M('-T>6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ('1I;65S
M(&YE=R!R;VUA;CL@1$E34$Q!63H@:6YL:6YE)SX@)FYB<W`[/"]F;VYT/B`\
M+W1D/B`\=&0@<W1Y;&4],T0G0D]21$52+4)/5%1/33H@8FQA8VL@,G!X('-O
M;&ED.R!415A4+4%,24=..B!L969T)R!V86QI9VX],T1B;W1T;VT@=VED=&@]
M,T0Q)3X\9F]N="!S='EL93TS1"=&3TY4+5-)6D4Z(#$P<'0[($9/3E0M1D%-
M24Q9.B!T:6UE<R!N97<@<F]M86X[($1)4U!,05DZ(&EN;&EN92<^("9N8G-P
M.SPO9F]N=#X@/"]T9#X@/'1D('-T>6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L
M86-K(#)P>"!S;VQI9#L@1$E34$Q!63H@:6YL:6YE.R!&3TY4+49!34E,63H@
M=&EM97,@;F5W(')O;6%N.R!&3TY4+5-)6D4Z(#$P<'0[(%1%6%0M04Q)1TXZ
M(')I9VAT)R!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Y)3XM/"]T9#X@/'1D
M('-T>6QE/3-$)U!!1$1)3D<M0D]45$]-.B`R<'@[(%1%6%0M04Q)1TXZ(&QE
M9G0G('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E(&YO=W)A<#TS1&YO=W)A
M<#X\9F]N="!S='EL93TS1"=&3TY4+5-)6D4Z(#$P<'0[($9/3E0M1D%-24Q9
M.B!T:6UE<R!N97<@<F]M86X[($1)4U!,05DZ(&EN;&EN92<^("9N8G-P.SPO
M9F]N=#X@/"]T9#X@/'1D('-T>6QE/3-$)U!!1$1)3D<M0D]45$]-.B`R<'@G
M('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E(&%L:6=N/3-$<FEG:'0^/&9O
M;G0@<W1Y;&4],T0G1D].5"U325I%.B`Q,'!T.R!&3TY4+49!34E,63H@=&EM
M97,@;F5W(')O;6%N.R!$25-03$%9.B!I;FQI;F4G/B`F;F)S<#L\+V9O;G0^
M(#PO=&0^(#QT9"!S='EL93TS1"="3U)$15(M0D]45$]-.B!B;&%C:R`R<'@@
M<V]L:60[(%1%6%0M04Q)1TXZ(&QE9G0G('9A;&EG;CTS1&)O='1O;2!W:61T
M:#TS1#$E/CQF;VYT('-T>6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@1D].5"U&
M04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1$E34$Q!63H@:6YL:6YE)SX@)FYB
M<W`[/"]F;VYT/B`\+W1D/B`\=&0@<W1Y;&4],T0G0D]21$52+4)/5%1/33H@
M8FQA8VL@,G!X('-O;&ED.R!$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9
M.B!T:6UE<R!N97<@<F]M86X[($9/3E0M4TE:13H@,3!P=#L@5$585"U!3$E'
M3CH@<FEG:'0G('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#DE/C,W/"]T9#X@
M/'1D('-T>6QE/3-$)U!!1$1)3D<M0D]45$]-.B`R<'@[(%1%6%0M04Q)1TXZ
M(&QE9G0G('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E(&YO=W)A<#TS1&YO
M=W)A<#X\9F]N="!S='EL93TS1"=&3TY4+5-)6D4Z(#$P<'0[($9/3E0M1D%-
M24Q9.B!T:6UE<R!N97<@<F]M86X[($1)4U!,05DZ(&EN;&EN92<^("9N8G-P
M.SPO9F]N=#X@/"]T9#X@/"]T<CX@/'1R(&)G8V]L;W(],T0C8V-E969F/B`\
M=&0@<W1Y;&4],T0G4$%$1$E.1RU"3U143TTZ(#1P>"<@=F%L:6=N/3-$8F]T
M=&]M('=I9'1H/3-$-C0E/CQF;VYT('-T>6QE/3-$)T9/3E0M4TE:13H@,3!P
M=#L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1$E34$Q!63H@:6YL
M:6YE)SX@)FYB<W`[/"]F;VYT/B`\+W1D/B`\=&0@<W1Y;&4],T0G4$%$1$E.
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M04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T.R!415A4
M+4%,24=..B!L969T)R!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)3XD/"]T
M9#X@/'1D('-T>6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#1P>"!D;W5B
M;&4[($1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R
M;VUA;CL@1D].5"U325I%.B`Q,'!T.R!415A4+4%,24=..B!R:6=H="<@=F%L
M:6=N/3-$8F]T=&]M('=I9'1H/3-$.24^,3$\+W1D/B`\=&0@<W1Y;&4],T0G
M4$%$1$E.1RU"3U143TTZ(#1P>#L@5$585"U!3$E'3CH@;&5F="<@=F%L:6=N
M/3-$8F]T=&]M('=I9'1H/3-$,24@;F]W<F%P/3-$;F]W<F%P/CQF;VYT('-T
M>6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ('1I;65S(&YE
M=R!R;VUA;CL@1$E34$Q!63H@:6YL:6YE)SX@)FYB<W`[/"]F;VYT/B`\+W1D
M/B`\=&0@<W1Y;&4],T0G4$%$1$E.1RU"3U143TTZ(#1P>"<@=F%L:6=N/3-$
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M1D].5"U325I%.B`Q,'!T.R!415A4+4%,24=..B!L969T)R!V86QI9VX],T1B
M;W1T;VT@=VED=&@],T0Q)3XD/"]T9#X@/'1D('-T>6QE/3-$)T)/4D1%4BU"
M3U143TTZ(&)L86-K(#1P>"!D;W5B;&4[($1)4U!,05DZ(&EN;&EN93L@1D].
M5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T.R!4
M15A4+4%,24=..B!R:6=H="<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$.24^
M,C8\+W1D/B`\=&0@<W1Y;&4],T0G4$%$1$E.1RU"3U143TTZ(#1P>#L@5$58
M5"U!3$E'3CH@;&5F="<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@;F]W
M<F%P/3-$;F]W<F%P/CQF;VYT('-T>6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@
M1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1$E34$Q!63H@:6YL:6YE
M)SX@)FYB<W`[/"]F;VYT/B`\+W1D/B`\=&0@<W1Y;&4],T0G4$%$1$E.1RU"
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M3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T.R!415A4+4%,
M24=..B!L969T)R!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)3XD/"]T9#X@
M/'1D('-T>6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#1P>"!D;W5B;&4[
M($1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA
M;CL@1D].5"U325I%.B`Q,'!T.R!415A4+4%,24=..B!R:6=H="<@=F%L:6=N
M/3-$8F]T=&]M('=I9'1H/3-$.24^-38\+W1D/B`\=&0@<W1Y;&4],T0G4$%$
M1$E.1RU"3U143TTZ(#1P>#L@5$585"U!3$E'3CH@;&5F="<@=F%L:6=N/3-$
M8F]T=&]M('=I9'1H/3-$,24@;F]W<F%P/3-$;F]W<F%P/CQF;VYT('-T>6QE
M/3-$)T9/3E0M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R
M;VUA;CL@1$E34$Q!63H@:6YL:6YE)SX@)FYB<W`[/"]F;VYT/B`\+W1D/B`\
M+W1R/B`\+W1A8FQE/B`\+V1I=CX@/"$M+45N9$9R86=M96YT+2T^/"]D:78^
M(#PO9&EV/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@("`@
M(#QT<B!C;&%S<STS1')H/@T*("`@("`@("`\=&0@8VQA<W,],T1P;"!V86QI
M9VX],T1T;W`^4F5S=')I8W1E9"!S=&]C:R!U;FET<R!;365M8F5R73PO=&0^
M#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D
M/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS1')E/@T*("`@("`@
M("`\=&0@8VQA<W,],T1P;"!V86QI9VX],T1T;W`^/'-T<F]N9SY3=&]C:VAO
M;&1E<G,@17%U:71Y($YO=&4@6TQI;F4@271E;7-=/"]S=')O;F<^/"]T9#X-
M"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^
M#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$<F\^#0H@("`@("`@
M(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O<#Y38VAE9'5L92!O9B!5;G9E
M<W1E9"!297-T<FEC=&5D(%-T;V-K(%5N:71S/"]T9#X-"B`@("`@("`@/'1D
M(&-L87-S/3-$=&5X=#XG/"$M+41/0U194$4@:'1M;"!054),24,@(BTO+U<S
M0R\O1%1$(%A(5$U,(#$N,"!4<F%N<VET:6]N86PO+T5.(B`B:'1T<#HO+W=W
M=RYW,RYO<F<O5%(O>&AT;6PQ+T141"]X:'1M;#$M=')A;G-I=&EO;F%L+F1T
M9"(@+2T^/&1I=CX@/&1I=CX\(2TM4W1A<G1&<F%G;65N="TM/B`\9&EV('-T
M>6QE/3-$)T1)4U!,05DZ(&)L;V-K.R!&3TY4+49!34E,63H@5&EM97,@3F5W
M(%)O;6%N.R!&3TY4+5-)6D4Z(#$P<'0[($U!4D=)3BU,1494.B`Q.'!T.R!-
M05)'24XM4DE'2%0Z(#!P=#L@=&5X="UA;&EG;CH@:G5S=&EF>3L@5$585"U)
M3D1%3E0Z(#!P="<^(%1H92!F;VQL;W=I;F<@=&%B;&4@<W5M;6%R:7IE<R!T
M:&4@86-T:79I=&EE<R!F;W(@=6YV97-T960@<F5S=')I8W1E9"!S=&]C:R!U
M;FET<R!G<F%N=&5D('1O(&5M<&QO>65E<R!A;F0@9&ER96-T;W)S(&9O<B!T
M:&4@>65A<B!E;F1E9"!*=6YE(#,P+"`R,#$T.CPO9&EV/B`\9&EV('-T>6QE
M/3-$)T1)4U!,05DZ(&)L;V-K.R!-05)'24XM3$5&5#H@,'!T.R!-05)'24XM
M4DE'2%0Z(#!P=#L@=&5X="UA;&EG;CH@:G5S=&EF>3L@5$585"U)3D1%3E0Z
M(#!P="<^("9N8G-P.SPO9&EV/B`\9&EV('-T>6QE/3-$)W1E>'0M86QI9VXZ
M(&-E;G1E<B<^(#QT86)L92!S='EL93TS1"=&3TY4+5-)6D4Z(#$P<'0[($9/
M3E0M1D%-24Q9.B!T:6UE<R!N97<@<F]M86XG(&-E;&QS<&%C:6YG/3-$,"!C
M96QL<&%D9&EN9STS1#`@=VED=&@],T0V,"4^(#QT<CX@/'1D('-T>6QE/3-$
M)U!!1$1)3D<M0D]45$]-.B`R<'@G('9A;&EG;CTS1&)O='1O;2!W:61T:#TS
M1#@X)3X\9F]N="!S='EL93TS1"=&3TY4+5-)6D4Z(#$P<'0[($9/3E0M1D%-
M24Q9.B!T:6UE<R!N97<@<F]M86X[($1)4U!,05DZ(&EN;&EN92<^("9N8G-P
M.SPO9F]N=#X@/"]T9#X@/'1D('-T>6QE/3-$)U!!1$1)3D<M0D]45$]-.B`R
M<'@G('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E/CQF;VYT('-T>6QE/3-$
M)T9/3E0M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA
M;CL@1D].5"U714E'2%0Z(&)O;&0[($1)4U!,05DZ(&EN;&EN92<^("9N8G-P
M.SPO9F]N=#X@/"]T9#X@/'1D('-T>6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L
M86-K(#)P>"!S;VQI9"<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,3`E(&-O
M;'-P86X],T0R/B`\9&EV('-T>6QE/3-$)T1)4U!,05DZ(&)L;V-K.R!&3TY4
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M=VED=&@],T0Q)2!N;W=R87`],T1N;W=R87`^/&9O;G0@<W1Y;&4],T0G1D].
M5"U325I%.B`Q,'!T.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!&
M3TY4+5=%24=(5#H@8F]L9#L@1$E34$Q!63H@:6YL:6YE)SX@)FYB<W`[/"]F
M;VYT/B`\+W1D/B`\+W1R/B`\='(@8F=C;VQO<CTS1'=H:71E/B`\=&0@<W1Y
M;&4],T0G5$585"U!3$E'3CH@;&5F=#L@34%21TE.+4Q%1E0Z(#!P=#L@34%2
M1TE.+5))1TA4.B`P<'0[(%1%6%0M24Y$14Y4.B`P<'0G('9A;&EG;CTS1&)O
M='1O;2!W:61T:#TS1#@X)3X\9F]N="!S='EL93TS1"=&3TY4+5-)6D4Z(#$P
M<'0[($9/3E0M1D%-24Q9.B!T:6UE<R!N97<@<F]M86X[($1)4U!,05DZ(&EN
M;&EN92<^("9N8G-P.SPO9F]N=#X@/"]T9#X@/'1D('9A;&EG;CTS1&)O='1O
M;2!W:61T:#TS1#$E(&%L:6=N/3-$<FEG:'0^/&9O;G0@<W1Y;&4],T0G1D].
M5"U325I%.B`Q,'!T.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!$
M25-03$%9.B!I;FQI;F4G/B`F;F)S<#L\+V9O;G0^(#PO=&0^(#QT9"!S='EL
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M8V]L;W(],T0C8V-E969F/B`\=&0@<W1Y;&4],T0G5$585"U!3$E'3CH@;&5F
M=#L@34%21TE.+4Q%1E0Z(#!P=#L@34%21TE.+5))1TA4.B`P<'0[(%1%6%0M
M24Y$14Y4.B`P<'0G('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#@X)3X@/&1I
M=B!S='EL93TS1"=$25-03$%9.B!B;&]C:SL@1D].5"U&04U)3%DZ('1I;65S
M(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T.R!-05)'24XM3$5&5#H@,'!T
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M:6YE)SX@)FYB<W`[/"]F;VYT/B`\+W1D/B`\=&0@<W1Y;&4],T0G5$585"U!
M3$E'3CH@;&5F="<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24^/&9O;G0@
M<W1Y;&4],T0G1D].5"U325I%.B`Q,'!T.R!&3TY4+49!34E,63H@=&EM97,@
M;F5W(')O;6%N.R!$25-03$%9.B!I;FQI;F4G/B`F;F)S<#L\+V9O;G0^(#PO
M=&0^(#QT9"!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9
M.B!T:6UE<R!N97<@<F]M86X[($9/3E0M4TE:13H@,3!P=#L@5$585"U!3$E'
M3CH@<FEG:'0G('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#DE/C$L-C8P+#4R
M-3PO=&0^(#QT9"!S='EL93TS1"=415A4+4%,24=..B!L969T)R!V86QI9VX]
M,T1B;W1T;VT@=VED=&@],T0Q)2!N;W=R87`],T1N;W=R87`^/&9O;G0@<W1Y
M;&4],T0G1D].5"U325I%.B`Q,'!T.R!&3TY4+49!34E,63H@=&EM97,@;F5W
M(')O;6%N.R!$25-03$%9.B!I;FQI;F4G/B`F;F)S<#L\+V9O;G0^(#PO=&0^
M(#PO='(^(#QT<B!B9V-O;&]R/3-$=VAI=&4^(#QT9"!S='EL93TS1"=415A4
M+4%,24=..B!L969T.R!-05)'24XM3$5&5#H@,'!T.R!-05)'24XM4DE'2%0Z
M(#!P=#L@5$585"U)3D1%3E0Z(#!P="<@=F%L:6=N/3-$8F]T=&]M('=I9'1H
M/3-$.#@E/B`\9&EV('-T>6QE/3-$)T1)4U!,05DZ(&)L;V-K.R!&3TY4+49!
M34E,63H@=&EM97,@;F5W(')O;6%N.R!&3TY4+5-)6D4Z(#$P<'0[($U!4D=)
M3BU,1494.B`P<'0[($U!4D=)3BU224=(5#H@,'!T.R!415A4+4%,24=..B!L
M969T.R!415A4+4E.1$5.5#H@,'!T)SX@1W)A;G1E9#PO9&EV/B`\+W1D/B`\
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M63H@:6YL:6YE)SX@)FYB<W`[/"]F;VYT/B`\+W1D/B`\=&0@<W1Y;&4],T0G
M1$E34$Q!63H@:6YL:6YE.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N
M.R!&3TY4+5-)6D4Z(#$P<'0[(%1%6%0M04Q)1TXZ(')I9VAT)R!V86QI9VX]
M,T1B;W1T;VT@=VED=&@],T0Y)3XQ+#(U-BPY-#`\+W1D/B`\=&0@<W1Y;&4]
M,T0G5$585"U!3$E'3CH@;&5F="<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$
M,24@;F]W<F%P/3-$;F]W<F%P/CQF;VYT('-T>6QE/3-$)T9/3E0M4TE:13H@
M,3!P=#L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1$E34$Q!63H@
M:6YL:6YE)SX@)FYB<W`[/"]F;VYT/B`\+W1D/B`\+W1R/B`\='(@8F=C;VQO
M<CTS1"-C8V5E9F8^(#QT9"!S='EL93TS1"=415A4+4%,24=..B!L969T.R!-
M05)'24XM3$5&5#H@,'!T.R!-05)'24XM4DE'2%0Z(#!P=#L@5$585"U)3D1%
M3E0Z(#!P="<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$.#@E/B`\9&EV('-T
M>6QE/3-$)T1)4U!,05DZ(&)L;V-K.R!&3TY4+49!34E,63H@=&EM97,@;F5W
M(')O;6%N.R!&3TY4+5-)6D4Z(#$P<'0[($U!4D=)3BU,1494.B`P<'0[($U!
M4D=)3BU224=(5#H@,'!T.R!415A4+4%,24=..B!L969T.R!415A4+4E.1$5.
M5#H@,'!T)SX@1F]R9F5I=&5D/"]D:78^(#PO=&0^(#QT9"!V86QI9VX],T1B
M;W1T;VT@=VED=&@],T0Q)2!A;&EG;CTS1')I9VAT/CQF;VYT('-T>6QE/3-$
M)T9/3E0M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA
M;CL@1$E34$Q!63H@:6YL:6YE)SX@)FYB<W`[/"]F;VYT/B`\+W1D/B`\=&0@
M<W1Y;&4],T0G5$585"U!3$E'3CH@;&5F="<@=F%L:6=N/3-$8F]T=&]M('=I
M9'1H/3-$,24^/&9O;G0@<W1Y;&4],T0G1D].5"U325I%.B`Q,'!T.R!&3TY4
M+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!$25-03$%9.B!I;FQI;F4G/B`F
M;F)S<#L\+V9O;G0^(#PO=&0^(#QT9"!S='EL93TS1"=$25-03$%9.B!I;FQI
M;F4[($9/3E0M1D%-24Q9.B!T:6UE<R!N97<@<F]M86X[($9/3E0M4TE:13H@
M,3!P=#L@5$585"U!3$E'3CH@<FEG:'0G('9A;&EG;CTS1&)O='1O;2!W:61T
M:#TS1#DE/B@T-"PQ.#,\+W1D/B`\=&0@<W1Y;&4],T0G1$E34$Q!63H@:6YL
M:6YE.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!&3TY4+5-)6D4Z
M(#$P<'0[(%1%6%0M04Q)1TXZ(&QE9G0G('9A;&EG;CTS1&)O='1O;2!W:61T
M:#TS1#$E(&YO=W)A<#TS1&YO=W)A<#XI/"]T9#X@/"]T<CX@/'1R(&)G8V]L
M;W(],T1W:&ET93X@/'1D('-T>6QE/3-$)U!!1$1)3D<M0D]45$]-.B`R<'@[
M(%1%6%0M04Q)1TXZ(&QE9G0[($U!4D=)3BU,1494.B`P<'0[($U!4D=)3BU2
M24=(5#H@,'!T.R!415A4+4E.1$5.5#H@,'!T)R!V86QI9VX],T1B;W1T;VT@
M=VED=&@],T0X."4^(#QD:78@<W1Y;&4],T0G1$E34$Q!63H@8FQO8VL[($9/
M3E0M1D%-24Q9.B!T:6UE<R!N97<@<F]M86X[($9/3E0M4TE:13H@,3!P=#L@
M34%21TE.+4Q%1E0Z(#!P=#L@34%21TE.+5))1TA4.B`P<'0[(%1%6%0M04Q)
M1TXZ(&QE9G0[(%1%6%0M24Y$14Y4.B`P<'0G/B!697-T960\+V1I=CX@/"]T
M9#X@/'1D('-T>6QE/3-$)U!!1$1)3D<M0D]45$]-.B`R<'@G('9A;&EG;CTS
M1&)O='1O;2!W:61T:#TS1#$E/CQF;VYT('-T>6QE/3-$)T9/3E0M4TE:13H@
M,3!P=#L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1$E34$Q!63H@
M:6YL:6YE)SX@)FYB<W`[/"]F;VYT/B`\+W1D/B`\=&0@<W1Y;&4],T0G0D]2
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M1D].5"U325I%.B`Q,'!T.R!0041$24Y'+4)/5%1/33H@,G!X.R!415A4+4%,
M24=..B!L969T)R!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)2!N;W=R87`]
M,T1N;W=R87`^*3PO=&0^(#PO='(^(#QT<B!B9V-O;&]R/3-$(V-C965F9CX@
M/'1D('-T>6QE/3-$)U!!1$1)3D<M0D]45$]-.B`T<'@[(%1%6%0M04Q)1TXZ
M(&QE9G0[($U!4D=)3BU,1494.B`P<'0[($U!4D=)3BU224=(5#H@,'!T.R!4
M15A4+4E.1$5.5#H@,'!T)R!V86QI9VX],T1B;W1T;VT@=VED=&@],T0X."4^
M(#QD:78@<W1Y;&4],T0G1$E34$Q!63H@8FQO8VL[($9/3E0M1D%-24Q9.B!T
M:6UE<R!N97<@<F]M86X[($9/3E0M4TE:13H@,3!P=#L@34%21TE.+4Q%1E0Z
M(#!P=#L@34%21TE.+5))1TA4.B`P<'0[(%1%6%0M04Q)1TXZ(&QE9G0[(%1%
M6%0M24Y$14Y4.B`P<'0G/B!5;G9E<W1E9"!A="!T:&4@96YD(&]F('1H92!P
M97)I;V0\+V1I=CX@/"]T9#X@/'1D('-T>6QE/3-$)U!!1$1)3D<M0D]45$]-
M.B`T<'@G('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E/CQF;VYT('-T>6QE
M/3-$)T9/3E0M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R
M;VUA;CL@1$E34$Q!63H@:6YL:6YE)SX@)FYB<W`[/"]F;VYT/B`\+W1D/B`\
M=&0@<W1Y;&4],T0G0D]21$52+4)/5%1/33H@8FQA8VL@-'!X(&1O=6)L93L@
M5$585"U!3$E'3CH@;&5F="<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24^
M/&9O;G0@<W1Y;&4],T0G1D].5"U325I%.B`Q,'!T.R!&3TY4+49!34E,63H@
M=&EM97,@;F5W(')O;6%N.R!$25-03$%9.B!I;FQI;F4G/B`F;F)S<#L\+V9O
M;G0^(#PO=&0^(#QT9"!S='EL93TS1"="3U)$15(M0D]45$]-.B!B;&%C:R`T
M<'@@9&]U8FQE.R!$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE
M<R!N97<@<F]M86X[($9/3E0M4TE:13H@,3!P=#L@5$585"U!3$E'3CH@<FEG
M:'0G('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#DE/C$L-3@Y+#0S,CPO=&0^
M(#QT9"!S='EL93TS1"=0041$24Y'+4)/5%1/33H@-'!X.R!415A4+4%,24=.
M.B!L969T)R!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)2!N;W=R87`],T1N
M;W=R87`^/&9O;G0@<W1Y;&4],T0G1D].5"U325I%.B`Q,'!T.R!&3TY4+49!
M34E,63H@=&EM97,@;F5W(')O;6%N.R!$25-03$%9.B!I;FQI;F4G/B`F;F)S
M<#L\+V9O;G0^(#PO=&0^(#PO='(^(#QT<B!B9V-O;&]R/3-$=VAI=&4^(#QT
M9"!S='EL93TS1"=0041$24Y'+4)/5%1/33H@-'!X.R!415A4+4%,24=..B!L
M969T.R!-05)'24XM3$5&5#H@,'!T.R!-05)'24XM4DE'2%0Z(#!P=#L@5$58
M5"U)3D1%3E0Z(#!P="<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$.#@E/B`\
M9&EV('-T>6QE/3-$)T1)4U!,05DZ(&)L;V-K.R!&3TY4+49!34E,63H@=&EM
M97,@;F5W(')O;6%N.R!&3TY4+5-)6D4Z(#$P<'0[($U!4D=)3BU,1494.B`P
M<'0[($U!4D=)3BU224=(5#H@,'!T.R!415A4+4%,24=..B!L969T.R!415A4
M+4E.1$5.5#H@,'!T)SX@17AP96-T960@=&\@=F5S="!A9G1E<B!*=6YE(#,P
M+"`R,#$T/"]D:78^(#PO=&0^(#QT9"!S='EL93TS1"=0041$24Y'+4)/5%1/
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M('1I;65S(&YE=R!R;VUA;CL@1$E34$Q!63H@:6YL:6YE)SX@)FYB<W`[/"]F
M;VYT/B`\+W1D/B`\=&0@<W1Y;&4],T0G0D]21$52+4)/5%1/33H@8FQA8VL@
M-'!X(&1O=6)L93L@1$E34$Q!63H@:6YL:6YE.R!&3TY4+49!34E,63H@=&EM
M97,@;F5W(')O;6%N.R!&3TY4+5-)6D4Z(#$P<'0[(%1%6%0M04Q)1TXZ(')I
M9VAT)R!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Y)3XQ+#4R,BPP,C0\+W1D
M/B`\=&0@<W1Y;&4],T0G4$%$1$E.1RU"3U143TTZ(#1P>#L@5$585"U!3$E'
M3CH@;&5F="<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@;F]W<F%P/3-$
M;F]W<F%P/CQF;VYT('-T>6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@1D].5"U&
M04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1$E34$Q!63H@:6YL:6YE)SX@)FYB
M<W`[/"]F;VYT/B`\+W1D/B`\+W1R/B`\+W1A8FQE/B`\+V1I=CX@/"$M+45N
M9$9R86=M96YT+2T^/"]D:78^(#PO9&EV/CQS<&%N/CPO<W!A;CX\+W1D/@T*
M("`@("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS1')E/@T*("`@("`@("`\
M=&0@8VQA<W,],T1P;"!V86QI9VX],T1T;W`^4V-H961U;&4@;V8@4W1O8VLM
M8F%S960@0V]M<&5N<V%T:6]N($5X<&5N<V5S/"]T9#X-"B`@("`@("`@/'1D
M(&-L87-S/3-$=&5X=#XG/"$M+41/0U194$4@:'1M;"!054),24,@(BTO+U<S
M0R\O1%1$(%A(5$U,(#$N,"!4<F%N<VET:6]N86PO+T5.(B`B:'1T<#HO+W=W
M=RYW,RYO<F<O5%(O>&AT;6PQ+T141"]X:'1M;#$M=')A;G-I=&EO;F%L+F1T
M9"(@+2T^/&1I=CX@/&1I=CX\(2TM4W1A<G1&<F%G;65N="TM/B`\9&EV('-T
M>6QE/3-$)T1)4U!,05DZ(&)L;V-K.R!&3TY4+49!34E,63H@5&EM97,@3F5W
M(%)O;6%N.R!&3TY4+5-)6D4Z(#$P<'0[($U!4D=)3BU,1494.B`Q.'!T.R!-
M05)'24XM4DE'2%0Z(#!P=#L@=&5X="UA;&EG;CH@:G5S=&EF>3L@5$585"U)
M3D1%3E0Z(#!P="<^($-O;7!E;G-A=&EO;B!E>'!E;G-E<R!R96QA=&5D('1O
M(')E<W1R:6-T960@<W1O8VL@=6YI=',@9W)A;G1E9"!T;R!E;7!L;WEE97,@
M86YD(&1I<F5C=&]R<R!W97)E(')E8V]R9&5D(&%S(&9O;&QO=W,Z/"]D:78^
M(#QD:78@<W1Y;&4],T0G1$E34$Q!63H@8FQO8VL[($U!4D=)3BU,1494.B`P
M<'0[($U!4D=)3BU224=(5#H@,'!T.R!T97AT+6%L:6=N.B!J=7-T:69Y.R!4
M15A4+4E.1$5.5#H@,'!T)SX@)FYB<W`[/"]D:78^(#QD:78@<W1Y;&4],T0G
M34%21TE.+4Q%1E0Z(#,V<'0[('1E>'0M86QI9VXZ(&QE9G0G/B`\=&%B;&4@
M<W1Y;&4],T0G1D].5"U325I%.B`Q,'!T.R!&3TY4+49!34E,63H@=&EM97,@
M;F5W(')O;6%N)R!C96QL<W!A8VEN9STS1#`@8V5L;'!A9&1I;F<],T0P('=I
M9'1H/3-$.#`E/B`\='(^(#QT9"!S='EL93TS1"=0041$24Y'+4)/5%1/33H@
M,G!X)R!V86QI9VX],T1B;W1T;VT@=VED=&@],T0V-"4^/&9O;G0@<W1Y;&4]
M,T0G1D].5"U325I%.B`Q,'!T.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O
M;6%N.R!$25-03$%9.B!I;FQI;F4G/B`F;F)S<#L\+V9O;G0^(#PO=&0^(#QT
M9"!S='EL93TS1"=0041$24Y'+4)/5%1/33H@,G!X)R!V86QI9VX],T1B;W1T
M;VT@=VED=&@],T0Q)3X\9F]N="!S='EL93TS1"=&3TY4+5-)6D4Z(#$P<'0[
M($9/3E0M1D%-24Q9.B!T:6UE<R!N97<@<F]M86X[($9/3E0M5T5)1TA4.B!B
M;VQD.R!$25-03$%9.B!I;FQI;F4G/B`F;F)S<#L\+V9O;G0^(#PO=&0^(#QT
M9"!S='EL93TS1"="3U)$15(M0D]45$]-.B!B;&%C:R`R<'@@<V]L:60G('9A
M;&EG;CTS1&)O='1O;2!W:61T:#TS1#,T)2!C;VQS<&%N/3-$,3`^(#QD:78@
M<W1Y;&4],T0G1$E34$Q!63H@8FQO8VL[($9/3E0M1D%-24Q9.B!T:6UE<R!N
M97<@<F]M86X[($9/3E0M4TE:13H@,3!P=#L@1D].5"U714E'2%0Z(&)O;&0[
M($U!4D=)3BU,1494.B`P<'0[($U!4D=)3BU224=(5#H@,'!T.R!T97AT+6%L
M:6=N.B!C96YT97([(%1%6%0M24Y$14Y4.B`P<'0G/B!996%R(&5N9&5D)FYB
M<W`[2G5N92`S,"P\+V1I=CX@/"]T9#X@/'1D('-T>6QE/3-$)U!!1$1)3D<M
M0D]45$]-.B`R<'@[(%1%6%0M04Q)1TXZ(&QE9G0G('9A;&EG;CTS1&)O='1O
M;2!W:61T:#TS1#$E(&YO=W)A<#TS1&YO=W)A<#X\9F]N="!S='EL93TS1"=&
M3TY4+5-)6D4Z(#$P<'0[($9/3E0M1D%-24Q9.B!T:6UE<R!N97<@<F]M86X[
M($9/3E0M5T5)1TA4.B!B;VQD.R!$25-03$%9.B!I;FQI;F4G/B`F;F)S<#L\
M+V9O;G0^(#PO=&0^(#QT9"!S='EL93TS1"=0041$24Y'+4)/5%1/33H@,G!X
M)R!V86QI9VX],T1B;W1T;VT^/&9O;G0@<W1Y;&4],T0G1D].5"U325I%.B`Q
M,'!T.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!$25-03$%9.B!I
M;FQI;F4G/B`F;F)S<#L\+V9O;G0^(#PO=&0^(#PO='(^(#QT<CX@/'1D('-T
M>6QE/3-$)U!!1$1)3D<M0D]45$]-.B`R<'@G('9A;&EG;CTS1&)O='1O;2!W
M:61T:#TS1#8T)3X\9F]N="!S='EL93TS1"=&3TY4+5-)6D4Z(#$P<'0[($9/
M3E0M1D%-24Q9.B!T:6UE<R!N97<@<F]M86X[($1)4U!,05DZ(&EN;&EN92<^
M("9N8G-P.SPO9F]N=#X@/"]T9#X@/'1D('-T>6QE/3-$)U!!1$1)3D<M0D]4
M5$]-.B`R<'@G('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E/CQF;VYT('-T
M>6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ('1I;65S(&YE
M=R!R;VUA;CL@1D].5"U714E'2%0Z(&)O;&0[($1)4U!,05DZ(&EN;&EN92<^
M("9N8G-P.SPO9F]N=#X@/"]T9#X@/'1D('-T>6QE/3-$)T)/4D1%4BU"3U14
M3TTZ(&)L86-K(#)P>"!S;VQI9"<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$
M,3`E(&-O;'-P86X],T0R/B`\9&EV('-T>6QE/3-$)T1)4U!,05DZ(&)L;V-K
M.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!&3TY4+5-)6D4Z(#$P
M<'0[($9/3E0M5T5)1TA4.B!B;VQD.R!-05)'24XM3$5&5#H@,'!T.R!-05)'
M24XM4DE'2%0Z(#!P=#L@=&5X="UA;&EG;CH@8V5N=&5R.R!415A4+4E.1$5.
M5#H@,'!T)SX@,C`Q-#PO9&EV/B`\+W1D/B`\=&0@<W1Y;&4],T0G4$%$1$E.
M1RU"3U143TTZ(#)P>#L@5$585"U!3$E'3CH@;&5F="<@=F%L:6=N/3-$8F]T
M=&]M('=I9'1H/3-$,24@;F]W<F%P/3-$;F]W<F%P/CQF;VYT('-T>6QE/3-$
M)T9/3E0M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA
M;CL@1D].5"U714E'2%0Z(&)O;&0[($1)4U!,05DZ(&EN;&EN92<^("9N8G-P
M.SPO9F]N=#X@/"]T9#X@/'1D('-T>6QE/3-$)U!!1$1)3D<M0D]45$]-.B`R
M<'@G('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E/CQF;VYT('-T>6QE/3-$
M)T9/3E0M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA
M;CL@1D].5"U714E'2%0Z(&)O;&0[($1)4U!,05DZ(&EN;&EN92<^("9N8G-P
M.SPO9F]N=#X@/"]T9#X@/'1D('-T>6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L
M86-K(#)P>"!S;VQI9"<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,3`E(&-O
M;'-P86X],T0R/B`\9&EV('-T>6QE/3-$)T1)4U!,05DZ(&)L;V-K.R!&3TY4
M+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!&3TY4+5-)6D4Z(#$P<'0[($9/
M3E0M5T5)1TA4.B!B;VQD.R!-05)'24XM3$5&5#H@,'!T.R!-05)'24XM4DE'
M2%0Z(#!P=#L@=&5X="UA;&EG;CH@8V5N=&5R.R!415A4+4E.1$5.5#H@,'!T
M)SX@,C`Q,SPO9&EV/B`\+W1D/B`\=&0@<W1Y;&4],T0G4$%$1$E.1RU"3U14
M3TTZ(#)P>#L@5$585"U!3$E'3CH@;&5F="<@=F%L:6=N/3-$8F]T=&]M('=I
M9'1H/3-$,24@;F]W<F%P/3-$;F]W<F%P/CQF;VYT('-T>6QE/3-$)T9/3E0M
M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].
M5"U714E'2%0Z(&)O;&0[($1)4U!,05DZ(&EN;&EN92<^("9N8G-P.SPO9F]N
M=#X@/"]T9#X@/'1D('-T>6QE/3-$)U!!1$1)3D<M0D]45$]-.B`R<'@G('9A
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M,T0T/B`\9&EV('-T>6QE/3-$)T1)4U!,05DZ(&)L;V-K.R!&3TY4+49!34E,
M63H@=&EM97,@;F5W(')O;6%N.R!&3TY4+5-)6D4Z(#$P<'0[($9/3E0M5T5)
M1TA4.B!B;VQD.R!-05)'24XM3$5&5#H@,'!T.R!-05)'24XM4DE'2%0Z(#!P
M=#L@=&5X="UA;&EG;CH@8V5N=&5R.R!415A4+4E.1$5.5#H@,'!T)SX@,C`Q
M,CPO9&EV/B`\+W1D/B`\+W1R/B`\='(@8F=C;VQO<CTS1"-C8V5E9F8^(#QT
M9"!S='EL93TS1"=415A4+4%,24=..B!L969T.R!-05)'24XM3$5&5#H@,'!T
M.R!-05)'24XM4DE'2%0Z(#!P=#L@5$585"U)3D1%3E0Z(#!P="<@=F%L:6=N
M/3-$8F]T=&]M('=I9'1H/3-$-C0E/B`\9&EV('-T>6QE/3-$)T1)4U!,05DZ
M(&)L;V-K.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!&3TY4+5-)
M6D4Z(#$P<'0[($U!4D=)3BU,1494.B`P<'0[($U!4D=)3BU224=(5#H@,'!T
M.R!415A4+4%,24=..B!L969T.R!415A4+4E.1$5.5#H@,'!T)SX@4F5S96%R
M8V@@86YD(&1E=F5L;W!M96YT(&5X<&5N<V5S/"]D:78^(#PO=&0^(#QT9"!V
M86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)2!A;&EG;CTS1')I9VAT/CQF;VYT
M('-T>6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ('1I;65S
M(&YE=R!R;VUA;CL@1$E34$Q!63H@:6YL:6YE)SX@)FYB<W`[/"]F;VYT/B`\
M+W1D/B`\=&0@<W1Y;&4],T0G1$E34$Q!63H@:6YL:6YE.R!&3TY4+49!34E,
M63H@=&EM97,@;F5W(')O;6%N.R!&3TY4+5-)6D4Z(#$P<'0[(%1%6%0M04Q)
M1TXZ(&QE9G0G('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E/B0\+W1D/B`\
M=&0@<W1Y;&4],T0G1$E34$Q!63H@:6YL:6YE.R!&3TY4+49!34E,63H@=&EM
M97,@;F5W(')O;6%N.R!&3TY4+5-)6D4Z(#$P<'0[(%1%6%0M04Q)1TXZ(')I
M9VAT)R!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Y)3XQ+#$W,CPO=&0^(#QT
M9"!S='EL93TS1"=415A4+4%,24=..B!L969T)R!V86QI9VX],T1B;W1T;VT@
M=VED=&@],T0Q)2!N;W=R87`],T1N;W=R87`^/&9O;G0@<W1Y;&4],T0G1D].
M5"U325I%.B`Q,'!T.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!$
M25-03$%9.B!I;FQI;F4G/B`F;F)S<#L\+V9O;G0^(#PO=&0^(#QT9"!V86QI
M9VX],T1B;W1T;VT@=VED=&@],T0Q)2!A;&EG;CTS1')I9VAT/CQF;VYT('-T
M>6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ('1I;65S(&YE
M=R!R;VUA;CL@1$E34$Q!63H@:6YL:6YE)SX@)FYB<W`[/"]F;VYT/B`\+W1D
M/B`\=&0@<W1Y;&4],T0G1$E34$Q!63H@:6YL:6YE.R!&3TY4+49!34E,63H@
M=&EM97,@;F5W(')O;6%N.R!&3TY4+5-)6D4Z(#$P<'0[(%1%6%0M04Q)1TXZ
M(&QE9G0G('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E/B0\+W1D/B`\=&0@
M<W1Y;&4],T0G1$E34$Q!63H@:6YL:6YE.R!&3TY4+49!34E,63H@=&EM97,@
M;F5W(')O;6%N.R!&3TY4+5-)6D4Z(#$P<'0[(%1%6%0M04Q)1TXZ(')I9VAT
M)R!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Y)3XW,3$\+W1D/B`\=&0@<W1Y
M;&4],T0G5$585"U!3$E'3CH@;&5F="<@=F%L:6=N/3-$8F]T=&]M('=I9'1H
M/3-$,24@;F]W<F%P/3-$;F]W<F%P/CQF;VYT('-T>6QE/3-$)T9/3E0M4TE:
M13H@,3!P=#L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1$E34$Q!
M63H@:6YL:6YE)SX@)FYB<W`[/"]F;VYT/B`\+W1D/B`\=&0@=F%L:6=N/3-$
M8F]T=&]M('=I9'1H/3-$,24@86QI9VX],T1R:6=H=#X\9F]N="!S='EL93TS
M1"=&3TY4+5-)6D4Z(#$P<'0[($9/3E0M1D%-24Q9.B!T:6UE<R!N97<@<F]M
M86X[($1)4U!,05DZ(&EN;&EN92<^("9N8G-P.SPO9F]N=#X@/"]T9#X@/'1D
M('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S
M(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T.R!415A4+4%,24=..B!L969T
M)R!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)3XD/"]T9#X@/'1D('-T>6QE
M/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R
M;VUA;CL@1D].5"U325I%.B`Q,'!T.R!415A4+4%,24=..B!R:6=H="<@=F%L
M:6=N/3-$8F]T=&]M('=I9'1H/3-$.24^,2PQ-C,\+W1D/B`\=&0@<W1Y;&4]
M,T0G5$585"U!3$E'3CH@;&5F="<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$
M,24@;F]W<F%P/3-$;F]W<F%P/CQF;VYT('-T>6QE/3-$)T9/3E0M4TE:13H@
M,3!P=#L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1$E34$Q!63H@
M:6YL:6YE)SX@)FYB<W`[/"]F;VYT/B`\+W1D/B`\+W1R/B`\='(@8F=C;VQO
M<CTS1'=H:71E/B`\=&0@<W1Y;&4],T0G4$%$1$E.1RU"3U143TTZ(#)P>#L@
M5$585"U!3$E'3CH@;&5F=#L@34%21TE.+4Q%1E0Z(#!P=#L@34%21TE.+5))
M1TA4.B`P<'0[(%1%6%0M24Y$14Y4.B`P<'0G('9A;&EG;CTS1&)O='1O;2!W
M:61T:#TS1#8T)3X@/&1I=B!S='EL93TS1"=$25-03$%9.B!B;&]C:SL@1D].
M5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T.R!-
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M:6YE)SX@)FYB<W`[/"]F;VYT/B`\+W1D/B`\=&0@<W1Y;&4],T0G0D]21$52
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M=VED=&@],T0Q)2!N;W=R87`],T1N;W=R87`^/&9O;G0@<W1Y;&4],T0G1D].
M5"U325I%.B`Q,'!T.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!$
M25-03$%9.B!I;FQI;F4G/B`F;F)S<#L\+V9O;G0^(#PO=&0^(#QT9"!S='EL
M93TS1"=0041$24Y'+4)/5%1/33H@,G!X)R!V86QI9VX],T1B;W1T;VT@=VED
M=&@],T0Q)2!A;&EG;CTS1')I9VAT/CQF;VYT('-T>6QE/3-$)T9/3E0M4TE:
M13H@,3!P=#L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1$E34$Q!
M63H@:6YL:6YE)SX@)FYB<W`[/"]F;VYT/B`\+W1D/B`\=&0@<W1Y;&4],T0G
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M;W1T;VT@=VED=&@],T0Q)2!N;W=R87`],T1N;W=R87`^/&9O;G0@<W1Y;&4]
M,T0G1D].5"U325I%.B`Q,'!T.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O
M;6%N.R!$25-03$%9.B!I;FQI;F4G/B`F;F)S<#L\+V9O;G0^(#PO=&0^(#QT
M9"!S='EL93TS1"=0041$24Y'+4)/5%1/33H@,G!X)R!V86QI9VX],T1B;W1T
M;VT@=VED=&@],T0Q)2!A;&EG;CTS1')I9VAT/CQF;VYT('-T>6QE/3-$)T9/
M3E0M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@
M1$E34$Q!63H@:6YL:6YE)SX@)FYB<W`[/"]F;VYT/B`\+W1D/B`\=&0@<W1Y
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M9VX],T1B;W1T;VT@=VED=&@],T0Q)2!N;W=R87`],T1N;W=R87`^/&9O;G0@
M<W1Y;&4],T0G1D].5"U325I%.B`Q,'!T.R!&3TY4+49!34E,63H@=&EM97,@
M;F5W(')O;6%N.R!$25-03$%9.B!I;FQI;F4G/B`F;F)S<#L\+V9O;G0^(#PO
M=&0^(#PO='(^(#QT<B!B9V-O;&]R/3-$(V-C965F9CX@/'1D('-T>6QE/3-$
M)U!!1$1)3D<M0D]45$]-.B`T<'@G('9A;&EG;CTS1&)O='1O;2!W:61T:#TS
M1#8T)3X\9F]N="!S='EL93TS1"=&3TY4+5-)6D4Z(#$P<'0[($9/3E0M1D%-
M24Q9.B!T:6UE<R!N97<@<F]M86X[($1)4U!,05DZ(&EN;&EN92<^("9N8G-P
M.SPO9F]N=#X@/"]T9#X@/'1D('-T>6QE/3-$)U!!1$1)3D<M0D]45$]-.B`T
M<'@G('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E(&%L:6=N/3-$<FEG:'0^
M/&9O;G0@<W1Y;&4],T0G1D].5"U325I%.B`Q,'!T.R!&3TY4+49!34E,63H@
M=&EM97,@;F5W(')O;6%N.R!$25-03$%9.B!I;FQI;F4G/B`F;F)S<#L\+V9O
M;G0^(#PO=&0^(#QT9"!S='EL93TS1"="3U)$15(M0D]45$]-.B!B;&%C:R`T
M<'@@9&]U8FQE.R!$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE
M<R!N97<@<F]M86X[($9/3E0M4TE:13H@,3!P=#L@5$585"U!3$E'3CH@;&5F
M="<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24^)#PO=&0^(#QT9"!S='EL
M93TS1"="3U)$15(M0D]45$]-.B!B;&%C:R`T<'@@9&]U8FQE.R!$25-03$%9
M.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE<R!N97<@<F]M86X[($9/3E0M
M4TE:13H@,3!P=#L@5$585"U!3$E'3CH@<FEG:'0G('9A;&EG;CTS1&)O='1O
M;2!W:61T:#TS1#DE/C4L-38R/"]T9#X@/'1D('-T>6QE/3-$)U!!1$1)3D<M
M0D]45$]-.B`T<'@[(%1%6%0M04Q)1TXZ(&QE9G0G('9A;&EG;CTS1&)O='1O
M;2!W:61T:#TS1#$E(&YO=W)A<#TS1&YO=W)A<#X\9F]N="!S='EL93TS1"=&
M3TY4+5-)6D4Z(#$P<'0[($9/3E0M1D%-24Q9.B!T:6UE<R!N97<@<F]M86X[
M($1)4U!,05DZ(&EN;&EN92<^("9N8G-P.SPO9F]N=#X@/"]T9#X@/'1D('-T
M>6QE/3-$)U!!1$1)3D<M0D]45$]-.B`T<'@G('9A;&EG;CTS1&)O='1O;2!W
M:61T:#TS1#$E(&%L:6=N/3-$<FEG:'0^/&9O;G0@<W1Y;&4],T0G1D].5"U3
M25I%.B`Q,'!T.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!$25-0
M3$%9.B!I;FQI;F4G/B`F;F)S<#L\+V9O;G0^(#PO=&0^(#QT9"!S='EL93TS
M1"="3U)$15(M0D]45$]-.B!B;&%C:R`T<'@@9&]U8FQE.R!$25-03$%9.B!I
M;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE<R!N97<@<F]M86X[($9/3E0M4TE:
M13H@,3!P=#L@5$585"U!3$E'3CH@;&5F="<@=F%L:6=N/3-$8F]T=&]M('=I
M9'1H/3-$,24^)#PO=&0^(#QT9"!S='EL93TS1"="3U)$15(M0D]45$]-.B!B
M;&%C:R`T<'@@9&]U8FQE.R!$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9
M.B!T:6UE<R!N97<@<F]M86X[($9/3E0M4TE:13H@,3!P=#L@5$585"U!3$E'
M3CH@<FEG:'0G('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#DE/C(L,C0P/"]T
M9#X@/'1D('-T>6QE/3-$)U!!1$1)3D<M0D]45$]-.B`T<'@[(%1%6%0M04Q)
M1TXZ(&QE9G0G('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E(&YO=W)A<#TS
M1&YO=W)A<#X\9F]N="!S='EL93TS1"=&3TY4+5-)6D4Z(#$P<'0[($9/3E0M
M1D%-24Q9.B!T:6UE<R!N97<@<F]M86X[($1)4U!,05DZ(&EN;&EN92<^("9N
M8G-P.SPO9F]N=#X@/"]T9#X@/'1D('-T>6QE/3-$)U!!1$1)3D<M0D]45$]-
M.B`T<'@G('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E(&%L:6=N/3-$<FEG
M:'0^/&9O;G0@<W1Y;&4],T0G1D].5"U325I%.B`Q,'!T.R!&3TY4+49!34E,
M63H@=&EM97,@;F5W(')O;6%N.R!$25-03$%9.B!I;FQI;F4G/B`F;F)S<#L\
M+V9O;G0^(#PO=&0^(#QT9"!S='EL93TS1"="3U)$15(M0D]45$]-.B!B;&%C
M:R`T<'@@9&]U8FQE.R!$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T
M:6UE<R!N97<@<F]M86X[($9/3E0M4TE:13H@,3!P=#L@5$585"U!3$E'3CH@
M;&5F="<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24^)#PO=&0^(#QT9"!S
M='EL93TS1"="3U)$15(M0D]45$]-.B!B;&%C:R`T<'@@9&]U8FQE.R!$25-0
M3$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE<R!N97<@<F]M86X[($9/
M3E0M4TE:13H@,3!P=#L@5$585"U!3$E'3CH@<FEG:'0G('9A;&EG;CTS1&)O
M='1O;2!W:61T:#TS1#DE/C0L-C4P/"]T9#X@/'1D('-T>6QE/3-$)U!!1$1)
M3D<M0D]45$]-.B`T<'@[(%1%6%0M04Q)1TXZ(&QE9G0G('9A;&EG;CTS1&)O
M='1O;2!W:61T:#TS1#$E(&YO=W)A<#TS1&YO=W)A<#X\9F]N="!S='EL93TS
M1"=&3TY4+5-)6D4Z(#$P<'0[($9/3E0M1D%-24Q9.B!T:6UE<R!N97<@<F]M
M86X[($1)4U!,05DZ(&EN;&EN92<^("9N8G-P.SPO9F]N=#X@/"]T9#X@/"]T
M<CX@/"]T86)L93X@/"]D:78^(#PA+2U%;F1&<F%G;65N="TM/CPO9&EV/B`\
M+V1I=CX\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO='(^#0H@("`@("`\
M='(@8VQA<W,],T1R:#X-"B`@("`@("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N
M/3-$=&]P/D-O;G-U;'1A;G0@<F5S=')I8W1E9"!S=&]C:R!U;FET<R!;365M
M8F5R73PO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO
M<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS1')E
M/@T*("`@("`@("`\=&0@8VQA<W,],T1P;"!V86QI9VX],T1T;W`^/'-T<F]N
M9SY3=&]C:VAO;&1E<G,@17%U:71Y($YO=&4@6TQI;F4@271E;7-=/"]S=')O
M;F<^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S
M<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$<F\^
M#0H@("`@("`@(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O<#Y38VAE9'5L
M92!O9B!5;G9E<W1E9"!297-T<FEC=&5D(%-T;V-K(%5N:71S/"]T9#X-"B`@
M("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/"$M+41/0U194$4@:'1M;"!054),
M24,@(BTO+U<S0R\O1%1$(%A(5$U,(#$N,"!4<F%N<VET:6]N86PO+T5.(B`B
M:'1T<#HO+W=W=RYW,RYO<F<O5%(O>&AT;6PQ+T141"]X:'1M;#$M=')A;G-I
M=&EO;F%L+F1T9"(@+2T^/&1I=CX@/&1I=CX\(2TM4W1A<G1&<F%G;65N="TM
M/B`\9&EV('-T>6QE/3-$)T1)4U!,05DZ(&)L;V-K.R!&3TY4+49!34E,63H@
M5&EM97,@3F5W(%)O;6%N.R!&3TY4+5-)6D4Z(#$P<'0[($U!4D=)3BU,1494
M.B`Q.'!T.R!-05)'24XM4DE'2%0Z(#!P=#L@=&5X="UA;&EG;CH@:G5S=&EF
M>3L@5$585"U)3D1%3E0Z(#!P="<^(%1H92!F;VQL;W=I;F<@=&%B;&4@<W5M
M;6%R:7IE<R!T:&4@86-T:79I=&EE<R!F;W(@=6YV97-T960@<F5S=')I8W1E
M9"!S=&]C:R!U;FET<R!A;F0@<F5S=')I8W1E9"!S=&]C:R!G<F%N=&5D('1O
M(&-O;G-U;'1A;G1S(&9O<B!T:&4@>65A<B!E;F1E9"!*=6YE(#,P+"`R,#$T
M.CPO9&EV/B`\9&EV('-T>6QE/3-$)T1)4U!,05DZ(&)L;V-K.R!-05)'24XM
M3$5&5#H@,'!T.R!-05)'24XM4DE'2%0Z(#!P=#L@=&5X="UA;&EG;CH@:G5S
M=&EF>3L@5$585"U)3D1%3E0Z(#!P="<^("9N8G-P.SPO9&EV/B`\9&EV('-T
M>6QE/3-$)TU!4D=)3BU,1494.B`Q.'!T.R!T97AT+6%L:6=N.B!L969T)SX@
M/'1A8FQE('-T>6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ
M('1I;65S(&YE=R!R;VUA;B<@8V5L;'-P86-I;F<],T0P(&-E;&QP861D:6YG
M/3-$,"!W:61T:#TS1#4P)3X@/'1R/B`\=&0@<W1Y;&4],T0G4$%$1$E.1RU"
M3U143TTZ(#)P>"<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$.#0E/CQF;VYT
M('-T>6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ('1I;65S
M(&YE=R!R;VUA;CL@1$E34$Q!63H@:6YL:6YE)SX@)FYB<W`[/"]F;VYT/B`\
M+W1D/B`\=&0@<W1Y;&4],T0G4$%$1$E.1RU"3U143TTZ(#)P>"<@=F%L:6=N
M/3-$8F]T=&]M('=I9'1H/3-$,24^/&9O;G0@<W1Y;&4],T0G1D].5"U325I%
M.B`Q,'!T.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!&3TY4+5=%
M24=(5#H@8F]L9#L@1$E34$Q!63H@:6YL:6YE)SX@)FYB<W`[/"]F;VYT/B`\
M+W1D/B`\=&0@<W1Y;&4],T0G0D]21$52+4)/5%1/33H@8FQA8VL@,G!X('-O
M;&ED)R!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q-"4@8V]L<W!A;CTS1#(^
M(#QD:78@<W1Y;&4],T0G1$E34$Q!63H@8FQO8VL[($9/3E0M1D%-24Q9.B!T
M:6UE<R!N97<@<F]M86X[($9/3E0M4TE:13H@,3!P=#L@1D].5"U714E'2%0Z
M(&)O;&0[($U!4D=)3BU,1494.B`P<'0[($U!4D=)3BU224=(5#H@,'!T.R!T
M97AT+6%L:6=N.B!C96YT97([(%1%6%0M24Y$14Y4.B`P<'0G/B!.=6UB97(\
M+V1I=CX@/"]T9#X@/'1D('-T>6QE/3-$)U!!1$1)3D<M0D]45$]-.B`R<'@[
M(%1%6%0M04Q)1TXZ(&QE9G0G('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E
M(&YO=W)A<#TS1&YO=W)A<#X\9F]N="!S='EL93TS1"=&3TY4+5-)6D4Z(#$P
M<'0[($9/3E0M1D%-24Q9.B!T:6UE<R!N97<@<F]M86X[($9/3E0M5T5)1TA4
M.B!B;VQD.R!$25-03$%9.B!I;FQI;F4G/B`F;F)S<#L\+V9O;G0^(#PO=&0^
M(#PO='(^(#QT<B!B9V-O;&]R/3-$(V-C965F9CX@/'1D('-T>6QE/3-$)U1%
M6%0M04Q)1TXZ(&QE9G0[($U!4D=)3BU,1494.B`P<'0[($U!4D=)3BU224=(
M5#H@,'!T.R!415A4+4E.1$5.5#H@,'!T)R!V86QI9VX],T1B;W1T;VT@=VED
M=&@],T0X-"4^(#QD:78@<W1Y;&4],T0G1$E34$Q!63H@8FQO8VL[($9/3E0M
M1D%-24Q9.B!T:6UE<R!N97<@<F]M86X[($9/3E0M4TE:13H@,3!P=#L@34%2
M1TE.+4Q%1E0Z(#!P=#L@34%21TE.+5))1TA4.B`P<'0[(%1%6%0M04Q)1TXZ
M(&QE9G0[(%1%6%0M24Y$14Y4.B`P<'0G/B!5;G9E<W1E9"!A="!T:&4@8F5G
M:6YN:6YG(&]F('!E<FEO9#PO9&EV/B`\+W1D/B`\=&0@=F%L:6=N/3-$8F]T
M=&]M('=I9'1H/3-$,24^/&9O;G0@<W1Y;&4],T0G1D].5"U325I%.B`Q,'!T
M.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!$25-03$%9.B!I;FQI
M;F4G/B`F;F)S<#L\+V9O;G0^(#PO=&0^(#QT9"!S='EL93TS1"=415A4+4%,
M24=..B!L969T)R!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)3X\9F]N="!S
M='EL93TS1"=&3TY4+5-)6D4Z(#$P<'0[($9/3E0M1D%-24Q9.B!T:6UE<R!N
M97<@<F]M86X[($1)4U!,05DZ(&EN;&EN92<^("9N8G-P.SPO9F]N=#X@/"]T
M9#X@/'1D('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ
M('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T.R!415A4+4%,24=.
M.B!R:6=H="<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,3,E/BT\+W1D/B`\
M=&0@<W1Y;&4],T0G5$585"U!3$E'3CH@;&5F="<@=F%L:6=N/3-$8F]T=&]M
M('=I9'1H/3-$,24@;F]W<F%P/3-$;F]W<F%P/CQF;VYT('-T>6QE/3-$)T9/
M3E0M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@
M1$E34$Q!63H@:6YL:6YE)SX@)FYB<W`[/"]F;VYT/B`\+W1D/B`\+W1R/B`\
M='(@8F=C;VQO<CTS1'=H:71E/B`\=&0@<W1Y;&4],T0G5$585"U!3$E'3CH@
M;&5F=#L@34%21TE.+4Q%1E0Z(#!P=#L@34%21TE.+5))1TA4.B`P<'0[(%1%
M6%0M24Y$14Y4.B`P<'0G('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#@T)3X@
M/&1I=B!S='EL93TS1"=$25-03$%9.B!B;&]C:SL@1D].5"U&04U)3%DZ('1I
M;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T.R!-05)'24XM3$5&5#H@
M,'!T.R!-05)'24XM4DE'2%0Z(#!P=#L@5$585"U!3$E'3CH@;&5F=#L@5$58
M5"U)3D1%3E0Z(#!P="<^($=R86YT960\+V1I=CX@/"]T9#X@/'1D('9A;&EG
M;CTS1&)O='1O;2!W:61T:#TS1#$E/CQF;VYT('-T>6QE/3-$)T9/3E0M4TE:
M13H@,3!P=#L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1$E34$Q!
M63H@:6YL:6YE)SX@)FYB<W`[/"]F;VYT/B`\+W1D/B`\=&0@<W1Y;&4],T0G
M5$585"U!3$E'3CH@;&5F="<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24^
M/&9O;G0@<W1Y;&4],T0G1D].5"U325I%.B`Q,'!T.R!&3TY4+49!34E,63H@
M=&EM97,@;F5W(')O;6%N.R!$25-03$%9.B!I;FQI;F4G/B`F;F)S<#L\+V9O
M;G0^(#PO=&0^(#QT9"!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M
M1D%-24Q9.B!T:6UE<R!N97<@<F]M86X[($9/3E0M4TE:13H@,3!P=#L@5$58
M5"U!3$E'3CH@<FEG:'0G('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$S)3XX
M-"PU-C4\+W1D/B`\=&0@<W1Y;&4],T0G5$585"U!3$E'3CH@;&5F="<@=F%L
M:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@;F]W<F%P/3-$;F]W<F%P/CQF;VYT
M('-T>6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ('1I;65S
M(&YE=R!R;VUA;CL@1$E34$Q!63H@:6YL:6YE)SX@)FYB<W`[/"]F;VYT/B`\
M+W1D/B`\+W1R/B`\='(@8F=C;VQO<CTS1"-C8V5E9F8^(#QT9"!S='EL93TS
M1"=0041$24Y'+4)/5%1/33H@,G!X.R!415A4+4%,24=..B!L969T.R!-05)'
M24XM3$5&5#H@,'!T.R!-05)'24XM4DE'2%0Z(#!P=#L@5$585"U)3D1%3E0Z
M(#!P="<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$.#0E/B`\9&EV('-T>6QE
M/3-$)T1)4U!,05DZ(&)L;V-K.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O
M;6%N.R!&3TY4+5-)6D4Z(#$P<'0[($U!4D=)3BU,1494.B`P<'0[($U!4D=)
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M/3-$,24^/&9O;G0@<W1Y;&4],T0G1D].5"U325I%.B`Q,'!T.R!&3TY4+49!
M34E,63H@=&EM97,@;F5W(')O;6%N.R!$25-03$%9.B!I;FQI;F4G/B`F;F)S
M<#L\+V9O;G0^(#PO=&0^(#QT9"!S='EL93TS1"="3U)$15(M0D]45$]-.B!B
M;&%C:R`R<'@@<V]L:60[($1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ
M('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T.R!415A4+4%,24=.
M.B!R:6=H="<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,3,E/B@V.2PS,34\
M+W1D/B`\=&0@<W1Y;&4],T0G1$E34$Q!63H@:6YL:6YE.R!&3TY4+49!34E,
M63H@=&EM97,@;F5W(')O;6%N.R!&3TY4+5-)6D4Z(#$P<'0[(%!!1$1)3D<M
M0D]45$]-.B`R<'@[(%1%6%0M04Q)1TXZ(&QE9G0G('9A;&EG;CTS1&)O='1O
M;2!W:61T:#TS1#$E(&YO=W)A<#TS1&YO=W)A<#XI/"]T9#X@/"]T<CX@/'1R
M(&)G8V]L;W(],T1W:&ET93X@/'1D('-T>6QE/3-$)U!!1$1)3D<M0D]45$]-
M.B`T<'@[(%1%6%0M04Q)1TXZ(&QE9G0[($U!4D=)3BU,1494.B`P<'0[($U!
M4D=)3BU224=(5#H@,'!T.R!415A4+4E.1$5.5#H@,'!T)R!V86QI9VX],T1B
M;W1T;VT@=VED=&@],T0X-"4^(#QD:78@<W1Y;&4],T0G1$E34$Q!63H@8FQO
M8VL[($9/3E0M1D%-24Q9.B!T:6UE<R!N97<@<F]M86X[($9/3E0M4TE:13H@
M,3!P=#L@34%21TE.+4Q%1E0Z(#!P=#L@34%21TE.+5))1TA4.B`P<'0[(%1%
M6%0M04Q)1TXZ(&QE9G0[(%1%6%0M24Y$14Y4.B`P<'0G/B!5;G9E<W1E9"!A
M="!T:&4@96YD(&]F('1H92!P97)I;V0\+V1I=CX@/"]T9#X@/'1D('-T>6QE
M/3-$)U!!1$1)3D<M0D]45$]-.B`T<'@G('9A;&EG;CTS1&)O='1O;2!W:61T
M:#TS1#$E/CQF;VYT('-T>6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@1D].5"U&
M04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1$E34$Q!63H@:6YL:6YE)SX@)FYB
M<W`[/"]F;VYT/B`\+W1D/B`\=&0@<W1Y;&4],T0G0D]21$52+4)/5%1/33H@
M8FQA8VL@-'!X(&1O=6)L93L@5$585"U!3$E'3CH@;&5F="<@=F%L:6=N/3-$
M8F]T=&]M('=I9'1H/3-$,24^/&9O;G0@<W1Y;&4],T0G1D].5"U325I%.B`Q
M,'!T.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!$25-03$%9.B!I
M;FQI;F4G/B`F;F)S<#L\+V9O;G0^(#PO=&0^(#QT9"!S='EL93TS1"="3U)$
M15(M0D]45$]-.B!B;&%C:R`T<'@@9&]U8FQE.R!$25-03$%9.B!I;FQI;F4[
M($9/3E0M1D%-24Q9.B!T:6UE<R!N97<@<F]M86X[($9/3E0M4TE:13H@,3!P
M=#L@5$585"U!3$E'3CH@<FEG:'0G('9A;&EG;CTS1&)O='1O;2!W:61T:#TS
M1#$S)3XQ-2PR-3`\+W1D/B`\=&0@<W1Y;&4],T0G4$%$1$E.1RU"3U143TTZ
M(#1P>#L@5$585"U!3$E'3CH@;&5F="<@=F%L:6=N/3-$8F]T=&]M('=I9'1H
M/3-$,24@;F]W<F%P/3-$;F]W<F%P/CQF;VYT('-T>6QE/3-$)T9/3E0M4TE:
M13H@,3!P=#L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1$E34$Q!
M63H@:6YL:6YE)SX@)FYB<W`[/"]F;VYT/B`\+W1D/B`\+W1R/B`\+W1A8FQE
M/B`\+V1I=CX@/"$M+45N9$9R86=M96YT+2T^/"]D:78^(#PO9&EV/CQS<&%N
M/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS
M1')E/@T*("`@("`@("`\=&0@8VQA<W,],T1P;"!V86QI9VX],T1T;W`^4V-H
M961U;&4@;V8@4W1O8VLM8F%S960@0V]M<&5N<V%T:6]N($5X<&5N<V5S/"]T
M9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/"$M+41/0U194$4@:'1M
M;"!054),24,@(BTO+U<S0R\O1%1$(%A(5$U,(#$N,"!4<F%N<VET:6]N86PO
M+T5.(B`B:'1T<#HO+W=W=RYW,RYO<F<O5%(O>&AT;6PQ+T141"]X:'1M;#$M
M=')A;G-I=&EO;F%L+F1T9"(@+2T^/&1I=CX@/&1I=CX\(2TM4W1A<G1&<F%G
M;65N="TM/B`\9&EV('-T>6QE/3-$)T1)4U!,05DZ(&)L;V-K.R!&3TY4+49!
M34E,63H@5&EM97,@3F5W(%)O;6%N.R!&3TY4+5-)6D4Z(#$P<'0[($U!4D=)
M3BU,1494.B`Q.'!T.R!-05)'24XM4DE'2%0Z(#!P=#L@5$585"U!3$E'3CH@
M;&5F=#L@5$585"U)3D1%3E0Z(#!P="<^($-O;7!E;G-A=&EO;B!E>'!E;G-E
M<R!R96QA=&5D('1O(')E<W1R:6-T960@<W1O8VL@=6YI=',@9W)A;G1E9"!T
M;R!C;VYS=6QT86YT<R!W97)E(')E8V]R9&5D(&%S(&9O;&QO=W,Z/"]D:78^
M(#QD:78@<W1Y;&4],T0G1$E34$Q!63H@8FQO8VL[($U!4D=)3BU,1494.B`P
M<'0[($U!4D=)3BU224=(5#H@,'!T.R!T97AT+6%L:6=N.B!J=7-T:69Y.R!4
M15A4+4E.1$5.5#H@,'!T)SX@)FYB<W`[/"]D:78^(#QD:78@<W1Y;&4],T0G
M34%21TE.+4Q%1E0Z(#$X<'0[('1E>'0M86QI9VXZ(&QE9G0G/B`\=&%B;&4@
M<W1Y;&4],T0G1D].5"U325I%.B`Q,'!T.R!&3TY4+49!34E,63H@=&EM97,@
M;F5W(')O;6%N)R!C96QL<W!A8VEN9STS1#`@8V5L;'!A9&1I;F<],T0P('=I
M9'1H/3-$.#`E/B`\='(^(#QT9"!S='EL93TS1"=0041$24Y'+4)/5%1/33H@
M,G!X)R!V86QI9VX],T1B;W1T;VT@=VED=&@],T0V-"4^/&9O;G0@<W1Y;&4]
M,T0G1D].5"U325I%.B`Q,'!T.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O
M;6%N.R!$25-03$%9.B!I;FQI;F4G/B`F;F)S<#L\+V9O;G0^(#PO=&0^(#QT
M9"!S='EL93TS1"=0041$24Y'+4)/5%1/33H@,G!X)R!V86QI9VX],T1B;W1T
M;VT@=VED=&@],T0Q)3X\9F]N="!S='EL93TS1"=&3TY4+5-)6D4Z(#$P<'0[
M($9/3E0M1D%-24Q9.B!T:6UE<R!N97<@<F]M86X[($9/3E0M5T5)1TA4.B!B
M;VQD.R!$25-03$%9.B!I;FQI;F4G/B`F;F)S<#L\+V9O;G0^(#PO=&0^(#QT
M9"!S='EL93TS1"="3U)$15(M0D]45$]-.B!B;&%C:R`R<'@@<V]L:60G('9A
M;&EG;CTS1&)O='1O;2!W:61T:#TS1#,T)2!C;VQS<&%N/3-$,3`^(#QD:78@
M<W1Y;&4],T0G1$E34$Q!63H@8FQO8VL[($9/3E0M1D%-24Q9.B!T:6UE<R!N
M97<@<F]M86X[($9/3E0M4TE:13H@,3!P=#L@1D].5"U714E'2%0Z(&)O;&0[
M($U!4D=)3BU,1494.B`P<'0[($U!4D=)3BU224=(5#H@,'!T.R!T97AT+6%L
M:6=N.B!C96YT97([(%1%6%0M24Y$14Y4.B`P<'0G/B!996%R(&5N9&5D)FYB
M<W`[2G5N92`S,"P\+V1I=CX@/"]T9#X@/'1D('-T>6QE/3-$)U!!1$1)3D<M
M0D]45$]-.B`R<'@[(%1%6%0M04Q)1TXZ(&QE9G0G('9A;&EG;CTS1&)O='1O
M;2!W:61T:#TS1#$E(&YO=W)A<#TS1&YO=W)A<#X\9F]N="!S='EL93TS1"=&
M3TY4+5-)6D4Z(#$P<'0[($9/3E0M1D%-24Q9.B!T:6UE<R!N97<@<F]M86X[
M($9/3E0M5T5)1TA4.B!B;VQD.R!$25-03$%9.B!I;FQI;F4G/B`F;F)S<#L\
M+V9O;G0^(#PO=&0^(#PO='(^(#QT<CX@/'1D('-T>6QE/3-$)U!!1$1)3D<M
M0D]45$]-.B`R<'@G('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#8T)3X\9F]N
M="!S='EL93TS1"=&3TY4+5-)6D4Z(#$P<'0[($9/3E0M1D%-24Q9.B!T:6UE
M<R!N97<@<F]M86X[($1)4U!,05DZ(&EN;&EN92<^("9N8G-P.SPO9F]N=#X@
M/"]T9#X@/'1D('-T>6QE/3-$)U!!1$1)3D<M0D]45$]-.B`R<'@G('9A;&EG
M;CTS1&)O='1O;2!W:61T:#TS1#$E/CQF;VYT('-T>6QE/3-$)T9/3E0M4TE:
M13H@,3!P=#L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U7
M14E'2%0Z(&)O;&0[($1)4U!,05DZ(&EN;&EN92<^("9N8G-P.SPO9F]N=#X@
M/"]T9#X@/'1D('-T>6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#)P>"!S
M;VQI9"<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,3`E(&-O;'-P86X],T0R
M/B`\9&EV('-T>6QE/3-$)T1)4U!,05DZ(&)L;V-K.R!&3TY4+49!34E,63H@
M=&EM97,@;F5W(')O;6%N.R!&3TY4+5-)6D4Z(#$P<'0[($9/3E0M5T5)1TA4
M.B!B;VQD.R!-05)'24XM3$5&5#H@,'!T.R!-05)'24XM4DE'2%0Z(#!P=#L@
M=&5X="UA;&EG;CH@8V5N=&5R.R!415A4+4E.1$5.5#H@,'!T)SX@,C`Q-#PO
M9&EV/B`\+W1D/B`\=&0@<W1Y;&4],T0G4$%$1$E.1RU"3U143TTZ(#)P>#L@
M5$585"U!3$E'3CH@;&5F="<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@
M;F]W<F%P/3-$;F]W<F%P/CQF;VYT('-T>6QE/3-$)T9/3E0M4TE:13H@,3!P
M=#L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U714E'2%0Z
M(&)O;&0[($1)4U!,05DZ(&EN;&EN92<^("9N8G-P.SPO9F]N=#X@/"]T9#X@
M/'1D('-T>6QE/3-$)U!!1$1)3D<M0D]45$]-.B`R<'@G('9A;&EG;CTS1&)O
M='1O;2!W:61T:#TS1#$E/CQF;VYT('-T>6QE/3-$)T9/3E0M4TE:13H@,3!P
M=#L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U714E'2%0Z
M(&)O;&0[($1)4U!,05DZ(&EN;&EN92<^("9N8G-P.SPO9F]N=#X@/"]T9#X@
M/'1D('-T>6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#)P>"!S;VQI9"<@
M=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,3`E(&-O;'-P86X],T0R/B`\9&EV
M('-T>6QE/3-$)T1)4U!,05DZ(&)L;V-K.R!&3TY4+49!34E,63H@=&EM97,@
M;F5W(')O;6%N.R!&3TY4+5-)6D4Z(#$P<'0[($9/3E0M5T5)1TA4.B!B;VQD
M.R!-05)'24XM3$5&5#H@,'!T.R!-05)'24XM4DE'2%0Z(#!P=#L@=&5X="UA
M;&EG;CH@8V5N=&5R.R!415A4+4E.1$5.5#H@,'!T)SX@,C`Q,SPO9&EV/B`\
M+W1D/B`\=&0@<W1Y;&4],T0G4$%$1$E.1RU"3U143TTZ(#)P>#L@5$585"U!
M3$E'3CH@;&5F="<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@;F]W<F%P
M/3-$;F]W<F%P/CQF;VYT('-T>6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@1D].
M5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U714E'2%0Z(&)O;&0[
M($1)4U!,05DZ(&EN;&EN92<^("9N8G-P.SPO9F]N=#X@/"]T9#X@/'1D('-T
M>6QE/3-$)U!!1$1)3D<M0D]45$]-.B`R<'@G('9A;&EG;CTS1&)O='1O;2!W
M:61T:#TS1#$E/CQF;VYT('-T>6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@1D].
M5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U714E'2%0Z(&)O;&0[
M($1)4U!,05DZ(&EN;&EN92<^("9N8G-P.SPO9F]N=#X@/"]T9#X@/'1D('-T
M>6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#)P>"!S;VQI9"<@=F%L:6=N
M/3-$8F]T=&]M('=I9'1H/3-$,3`E(&-O;'-P86X],T0R/B`\9&EV('-T>6QE
M/3-$)T1)4U!,05DZ(&)L;V-K.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O
M;6%N.R!&3TY4+5-)6D4Z(#$P<'0[($9/3E0M5T5)1TA4.B!B;VQD.R!-05)'
M24XM3$5&5#H@,'!T.R!-05)'24XM4DE'2%0Z(#!P=#L@=&5X="UA;&EG;CH@
M8V5N=&5R.R!415A4+4E.1$5.5#H@,'!T)SX@,C`Q,CPO9&EV/B`\+W1D/B`\
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M8V]L;W(],T0C8V-E969F/B`\=&0@<W1Y;&4],T0G5$585"U!3$E'3CH@;&5F
M=#L@34%21TE.+4Q%1E0Z(#!P=#L@34%21TE.+5))1TA4.B`P<'0[(%1%6%0M
M24Y$14Y4.B`P<'0G('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#8T)3X@/&1I
M=B!S='EL93TS1"=$25-03$%9.B!B;&]C:SL@1D].5"U&04U)3%DZ('1I;65S
M(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T.R!-05)'24XM3$5&5#H@,'!T
M.R!-05)'24XM4DE'2%0Z(#!P=#L@5$585"U!3$E'3CH@;&5F=#L@5$585"U)
M3D1%3E0Z(#!P="<^(%)E<V5A<F-H(&%N9"!D979E;&]P;65N="!E>'!E;G-E
M<SPO9&EV/B`\+W1D/B`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@
M86QI9VX],T1R:6=H=#X\9F]N="!S='EL93TS1"=&3TY4+5-)6D4Z(#$P<'0[
M($9/3E0M1D%-24Q9.B!T:6UE<R!N97<@<F]M86X[($1)4U!,05DZ(&EN;&EN
M92<^("9N8G-P.SPO9F]N=#X@/"]T9#X@/'1D('-T>6QE/3-$)T1)4U!,05DZ
M(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U3
M25I%.B`Q,'!T.R!415A4+4%,24=..B!L969T)R!V86QI9VX],T1B;W1T;VT@
M=VED=&@],T0Q)3XD/"]T9#X@/'1D('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN
M93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q
M,'!T.R!415A4+4%,24=..B!R:6=H="<@=F%L:6=N/3-$8F]T=&]M('=I9'1H
M/3-$.24^,C`Q/"]T9#X@/'1D('-T>6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G
M('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E(&YO=W)A<#TS1&YO=W)A<#X\
M9F]N="!S='EL93TS1"=&3TY4+5-)6D4Z(#$P<'0[($9/3E0M1D%-24Q9.B!T
M:6UE<R!N97<@<F]M86X[($1)4U!,05DZ(&EN;&EN92<^("9N8G-P.SPO9F]N
M=#X@/"]T9#X@/'1D('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E(&%L:6=N
M/3-$<FEG:'0^/&9O;G0@<W1Y;&4],T0G1D].5"U325I%.B`Q,'!T.R!&3TY4
M+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!$25-03$%9.B!I;FQI;F4G/B`F
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M9VX],T1B;W1T;VT@=VED=&@],T0Q)2!N;W=R87`],T1N;W=R87`^/&9O;G0@
M<W1Y;&4],T0G1D].5"U325I%.B`Q,'!T.R!&3TY4+49!34E,63H@=&EM97,@
M;F5W(')O;6%N.R!$25-03$%9.B!I;FQI;F4G/B`F;F)S<#L\+V9O;G0^(#PO
M=&0^(#QT9"!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)2!A;&EG;CTS1')I
M9VAT/CQF;VYT('-T>6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@1D].5"U&04U)
M3%DZ('1I;65S(&YE=R!R;VUA;CL@1$E34$Q!63H@:6YL:6YE)SX@)FYB<W`[
M/"]F;VYT/B`\+W1D/B`\=&0@<W1Y;&4],T0G1$E34$Q!63H@:6YL:6YE.R!&
M3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!&3TY4+5-)6D4Z(#$P<'0[
M(%1%6%0M04Q)1TXZ(&QE9G0G('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E
M/B0\+W1D/B`\=&0@<W1Y;&4],T0G1$E34$Q!63H@:6YL:6YE.R!&3TY4+49!
M34E,63H@=&EM97,@;F5W(')O;6%N.R!&3TY4+5-)6D4Z(#$P<'0[(%1%6%0M
M04Q)1TXZ(')I9VAT)R!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Y)3XR,#$\
M+W1D/B`\=&0@<W1Y;&4],T0G5$585"U!3$E'3CH@;&5F="<@=F%L:6=N/3-$
M8F]T=&]M('=I9'1H/3-$,24@;F]W<F%P/3-$;F]W<F%P/CQF;VYT('-T>6QE
M/3-$)T9/3E0M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R
M;VUA;CL@1$E34$Q!63H@:6YL:6YE)SX@)FYB<W`[/"]F;VYT/B`\+W1D/B`\
M+W1R/B`\='(@8F=C;VQO<CTS1'=H:71E/B`\=&0@<W1Y;&4],T0G4$%$1$E.
M1RU"3U143TTZ(#)P>#L@5$585"U!3$E'3CH@;&5F=#L@34%21TE.+4Q%1E0Z
M(#!P=#L@34%21TE.+5))1TA4.B`P<'0[(%1%6%0M24Y$14Y4.B`P<'0G('9A
M;&EG;CTS1&)O='1O;2!W:61T:#TS1#8T)3X@/&1I=B!S='EL93TS1"=$25-0
M3$%9.B!B;&]C:SL@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].
M5"U325I%.B`Q,'!T.R!-05)'24XM3$5&5#H@,'!T.R!-05)'24XM4DE'2%0Z
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M;CL@1$E34$Q!63H@:6YL:6YE)SX@)FYB<W`[/"]F;VYT/B`\+W1D/B`\=&0@
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M9VX],T1B;W1T;VT@=VED=&@],T0Q)2!N;W=R87`],T1N;W=R87`^/&9O;G0@
M<W1Y;&4],T0G1D].5"U325I%.B`Q,'!T.R!&3TY4+49!34E,63H@=&EM97,@
M;F5W(')O;6%N.R!$25-03$%9.B!I;FQI;F4G/B`F;F)S<#L\+V9O;G0^(#PO
M=&0^(#QT9"!S='EL93TS1"=0041$24Y'+4)/5%1/33H@,G!X)R!V86QI9VX]
M,T1B;W1T;VT@=VED=&@],T0Q)2!A;&EG;CTS1')I9VAT/CQF;VYT('-T>6QE
M/3-$)T9/3E0M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R
M;VUA;CL@1$E34$Q!63H@:6YL:6YE)SX@)FYB<W`[/"]F;VYT/B`\+W1D/B`\
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M)R!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Y)3XR-S@\+W1D/B`\=&0@<W1Y
M;&4],T0G4$%$1$E.1RU"3U143TTZ(#)P>#L@5$585"U!3$E'3CH@;&5F="<@
M=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@;F]W<F%P/3-$;F]W<F%P/CQF
M;VYT('-T>6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ('1I
M;65S(&YE=R!R;VUA;CL@1$E34$Q!63H@:6YL:6YE)SX@)FYB<W`[/"]F;VYT
M/B`\+W1D/B`\=&0@<W1Y;&4],T0G4$%$1$E.1RU"3U143TTZ(#)P>"<@=F%L
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M,24^/&9O;G0@<W1Y;&4],T0G1D].5"U325I%.B`Q,'!T.R!&3TY4+49!34E,
M63H@=&EM97,@;F5W(')O;6%N.R!$25-03$%9.B!I;FQI;F4G/B`F;F)S<#L\
M+V9O;G0^(#PO=&0^(#QT9"!S='EL93TS1"="3U)$15(M0D]45$]-.B!B;&%C
M:R`R<'@@<V]L:60[($1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I
M;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T.R!415A4+4%,24=..B!R
M:6=H="<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$.24^,C`\+W1D/B`\=&0@
M<W1Y;&4],T0G4$%$1$E.1RU"3U143TTZ(#)P>#L@5$585"U!3$E'3CH@;&5F
M="<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@;F]W<F%P/3-$;F]W<F%P
M/CQF;VYT('-T>6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ
M('1I;65S(&YE=R!R;VUA;CL@1$E34$Q!63H@:6YL:6YE)SX@)FYB<W`[/"]F
M;VYT/B`\+W1D/B`\+W1R/B`\='(@8F=C;VQO<CTS1"-C8V5E9F8^(#QT9"!S
M='EL93TS1"=0041$24Y'+4)/5%1/33H@-'!X)R!V86QI9VX],T1B;W1T;VT@
M=VED=&@],T0V-"4^/&9O;G0@<W1Y;&4],T0G1D].5"U325I%.B`Q,'!T.R!&
M3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!$25-03$%9.B!I;FQI;F4G
M/B`F;F)S<#L\+V9O;G0^(#PO=&0^(#QT9"!S='EL93TS1"=0041$24Y'+4)/
M5%1/33H@-'!X)R!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)2!A;&EG;CTS
M1')I9VAT/CQF;VYT('-T>6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@1D].5"U&
M04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1$E34$Q!63H@:6YL:6YE)SX@)FYB
M<W`[/"]F;VYT/B`\+W1D/B`\=&0@<W1Y;&4],T0G0D]21$52+4)/5%1/33H@
M8FQA8VL@-'!X(&1O=6)L93L@1$E34$Q!63H@:6YL:6YE.R!&3TY4+49!34E,
M63H@=&EM97,@;F5W(')O;6%N.R!&3TY4+5-)6D4Z(#$P<'0[(%1%6%0M04Q)
M1TXZ(&QE9G0G('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E/B0\+W1D/B`\
M=&0@<W1Y;&4],T0G0D]21$52+4)/5%1/33H@8FQA8VL@-'!X(&1O=6)L93L@
M1$E34$Q!63H@:6YL:6YE.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N
M.R!&3TY4+5-)6D4Z(#$P<'0[(%1%6%0M04Q)1TXZ(')I9VAT)R!V86QI9VX]
M,T1B;W1T;VT@=VED=&@],T0Y)3XR-S@\+W1D/B`\=&0@<W1Y;&4],T0G4$%$
M1$E.1RU"3U143TTZ(#1P>#L@5$585"U!3$E'3CH@;&5F="<@=F%L:6=N/3-$
M8F]T=&]M('=I9'1H/3-$,24@;F]W<F%P/3-$;F]W<F%P/CQF;VYT('-T>6QE
M/3-$)T9/3E0M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R
M;VUA;CL@1$E34$Q!63H@:6YL:6YE)SX@)FYB<W`[/"]F;VYT/B`\+W1D/B`\
M=&0@<W1Y;&4],T0G4$%$1$E.1RU"3U143TTZ(#1P>"<@=F%L:6=N/3-$8F]T
M=&]M('=I9'1H/3-$,24@86QI9VX],T1R:6=H=#X\9F]N="!S='EL93TS1"=&
M3TY4+5-)6D4Z(#$P<'0[($9/3E0M1D%-24Q9.B!T:6UE<R!N97<@<F]M86X[
M($1)4U!,05DZ(&EN;&EN92<^("9N8G-P.SPO9F]N=#X@/"]T9#X@/'1D('-T
M>6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#1P>"!D;W5B;&4[($1)4U!,
M05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].
M5"U325I%.B`Q,'!T.R!415A4+4%,24=..B!L969T)R!V86QI9VX],T1B;W1T
M;VT@=VED=&@],T0Q)3XD/"]T9#X@/'1D('-T>6QE/3-$)T)/4D1%4BU"3U14
M3TTZ(&)L86-K(#1P>"!D;W5B;&4[($1)4U!,05DZ(&EN;&EN93L@1D].5"U&
M04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T.R!415A4
M+4%,24=..B!R:6=H="<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$.24^-3,S
M/"]T9#X@/'1D('-T>6QE/3-$)U!!1$1)3D<M0D]45$]-.B`T<'@[(%1%6%0M
M04Q)1TXZ(&QE9G0G('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E(&YO=W)A
M<#TS1&YO=W)A<#X\9F]N="!S='EL93TS1"=&3TY4+5-)6D4Z(#$P<'0[($9/
M3E0M1D%-24Q9.B!T:6UE<R!N97<@<F]M86X[($1)4U!,05DZ(&EN;&EN92<^
M("9N8G-P.SPO9F]N=#X@/"]T9#X@/'1D('-T>6QE/3-$)U!!1$1)3D<M0D]4
M5$]-.B`T<'@G('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E(&%L:6=N/3-$
M<FEG:'0^/&9O;G0@<W1Y;&4],T0G1D].5"U325I%.B`Q,'!T.R!&3TY4+49!
M34E,63H@=&EM97,@;F5W(')O;6%N.R!$25-03$%9.B!I;FQI;F4G/B`F;F)S
M<#L\+V9O;G0^(#PO=&0^(#QT9"!S='EL93TS1"="3U)$15(M0D]45$]-.B!B
M;&%C:R`T<'@@9&]U8FQE.R!$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9
M.B!T:6UE<R!N97<@<F]M86X[($9/3E0M4TE:13H@,3!P=#L@5$585"U!3$E'
M3CH@;&5F="<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24^)#PO=&0^(#QT
M9"!S='EL93TS1"="3U)$15(M0D]45$]-.B!B;&%C:R`T<'@@9&]U8FQE.R!$
M25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE<R!N97<@<F]M86X[
M($9/3E0M4TE:13H@,3!P=#L@5$585"U!3$E'3CH@<FEG:'0G('9A;&EG;CTS
M1&)O='1O;2!W:61T:#TS1#DE/C(R,3PO=&0^(#QT9"!S='EL93TS1"=0041$
M24Y'+4)/5%1/33H@-'!X.R!415A4+4%,24=..B!L969T)R!V86QI9VX],T1B
M;W1T;VT@=VED=&@],T0Q)2!N;W=R87`],T1N;W=R87`^/&9O;G0@<W1Y;&4]
M,T0G1D].5"U325I%.B`Q,'!T.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O
M;6%N.R!$25-03$%9.B!I;FQI;F4G/B`F;F)S<#L\+V9O;G0^(#PO=&0^(#PO
M='(^(#PO=&%B;&4^(#PO9&EV/B`\(2TM16YD1G)A9VUE;G0M+3X\+V1I=CX@
M/"]D:78^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@(#PO
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M=&UL/@T*("`\:&5A9#X-"B`@("`\345402!H='1P+65Q=6EV/3-$0V]N=&5N
M="U4>7!E(&-O;G1E;G0],T0G=&5X="]H=&UL.R!C:&%R<V5T/75T9BTX)SX\
M<V-R:7!T('1Y<&4],T1T97AT+VIA=F%S8W)I<'0@<W)C/3-$4VAO=RYJ<SXO
M*B!$;R!.;W0@4F5M;W9E(%1H:7,@0V]M;65N="`J+SPO<V-R:7!T/CPO:&5A
M9#X-"B`@/&)O9'D^#0H@("`@/'1A8FQE(&-L87-S/3-$<F5P;W)T(&ED/3-$
M240P14U%/@T*("`@("`@/'1R/@T*("`@("`@("`\=&@@8VQA<W,],T1T;"!C
M;VQS<&%N/3-$,2!R;W=S<&%N/3-$,CX\<W1R;VYG/D9)3D%.0TE!3"!)3D-/
M344L($Y%5"`H5&%B;&5S*3QB<CX\+W-T<F]N9SX\+W1H/@T*("`@("`@("`\
M=&@@8VQA<W,],T1T:"!C;VQS<&%N/3-$,3XQ,B!-;VYT:',@16YD960\+W1H
M/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<CX-"B`@("`@("`@/'1H(&-L87-S
M/3-$=&@^2G5N+B`S,"P@,C`Q-#QB<CX\+W1H/@T*("`@("`@/"]T<CX-"B`@
M("`@(#QT<B!C;&%S<STS1')E/@T*("`@("`@("`\=&0@8VQA<W,],T1P;"!V
M86QI9VX],T1T;W`^/'-T<F]N9SY&24Y!3D-)04P@24Y#3TU%+"!.150@6T%B
M<W1R86-T73PO<W1R;VYG/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E
M>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@("`@(#QT
M<B!C;&%S<STS1')O/@T*("`@("`@("`\=&0@8VQA<W,],T1P;"!V86QI9VX]
M,T1T;W`^4V-H961U;&4@;V8@1FEN86YC:6%L($5X<&5N<V5S("A);F-O;64I
M+"!.970\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\(2TM1$]#
M5%E012!H=&UL(%!50DQ)0R`B+2\O5S-#+R]$5$0@6$A434P@,2XP(%1R86YS
M:71I;VYA;"\O14XB(")H='1P.B\O=W=W+G<S+F]R9R]44B]X:'1M;#$O1%1$
M+WAH=&UL,2UT<F%N<VET:6]N86PN9'1D(B`M+3X\9&EV/B`\9&EV/CPA+2U3
M=&%R=$9R86=M96YT+2T^(#QD:78@<W1Y;&4],T0G=&5X="UA;&EG;CH@;&5F
M="<^(#QT86)L92!S='EL93TS1"=&3TY4+5-)6D4Z(#$P<'0[($9/3E0M1D%-
M24Q9.B!T:6UE<R!N97<@<F]M86XG(&-E;&QS<&%C:6YG/3-$,"!C96QL<&%D
M9&EN9STS1#`@=VED=&@],T0X,"4^(#QT<CX@/'1D('-T>6QE/3-$)U!!1$1)
M3D<M0D]45$]-.B`R<'@G('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#8T)3X\
M9F]N="!S='EL93TS1"=&3TY4+5-)6D4Z(#$P<'0[($9/3E0M1D%-24Q9.B!T
M:6UE<R!N97<@<F]M86X[($1)4U!,05DZ(&EN;&EN92<^("9N8G-P.SPO9F]N
M=#X@/"]T9#X@/'1D('-T>6QE/3-$)U!!1$1)3D<M0D]45$]-.B`R<'@G('9A
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M3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T.R!&3TY4+5=%
M24=(5#H@8F]L9#L@34%21TE.+4Q%1E0Z(#!P=#L@34%21TE.+5))1TA4.B`P
M<'0[('1E>'0M86QI9VXZ(&-E;G1E<CL@5$585"U)3D1%3E0Z("TY<'0G/B!9
M96%R(&5N9&5D($IU;F4@,S`L/"]D:78^(#PO=&0^(#QT9"!S='EL93TS1"=0
M041$24Y'+4)/5%1/33H@,G!X.R!415A4+4%,24=..B!L969T)R!V86QI9VX]
M,T1B;W1T;VT@=VED=&@],T0Q)2!N;W=R87`],T1N;W=R87`^/&9O;G0@<W1Y
M;&4],T0G1D].5"U325I%.B`Q,'!T.R!&3TY4+49!34E,63H@=&EM97,@;F5W
M(')O;6%N.R!&3TY4+5=%24=(5#H@8F]L9#L@1$E34$Q!63H@:6YL:6YE)SX@
M)FYB<W`[/"]F;VYT/B`\+W1D/B`\+W1R/B`\='(^(#QT9"!S='EL93TS1"=0
M041$24Y'+4)/5%1/33H@,G!X)R!V86QI9VX],T1B;W1T;VT@=VED=&@],T0V
M-"4^/&9O;G0@<W1Y;&4],T0G1D].5"U325I%.B`Q,'!T.R!&3TY4+49!34E,
M63H@=&EM97,@;F5W(')O;6%N.R!$25-03$%9.B!I;FQI;F4G/B`F;F)S<#L\
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M3D1%3E0Z(#!P="<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,3`E(&-O;'-P
M86X],T0R/B`\9&EV('-T>6QE/3-$)T1)4U!,05DZ(&)L;V-K.R!&3TY4+49!
M34E,63H@=&EM97,@;F5W(')O;6%N.R!&3TY4+5-)6D4Z(#$P<'0[($9/3E0M
M5T5)1TA4.B!B;VQD.R!-05)'24XM3$5&5#H@,'!T.R!-05)'24XM4DE'2%0Z
M(#!P=#L@5$585"U!3$E'3CH@8V5N=&5R.R!415A4+4E.1$5.5#H@,'!T)SX@
M,C`Q-#PO9&EV/B`\+W1D/B`\=&0@<W1Y;&4],T0G4$%$1$E.1RU"3U143TTZ
M(#)P>#L@5$585"U!3$E'3CH@;&5F="<@=F%L:6=N/3-$8F]T=&]M('=I9'1H
M/3-$,24@;F]W<F%P/3-$;F]W<F%P/CQF;VYT('-T>6QE/3-$)T9/3E0M4TE:
M13H@,3!P=#L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U7
M14E'2%0Z(&)O;&0[($1)4U!,05DZ(&EN;&EN92<^("9N8G-P.SPO9F]N=#X@
M/"]T9#X@/'1D('-T>6QE/3-$)U!!1$1)3D<M0D]45$]-.B`R<'@G('9A;&EG
M;CTS1&)O='1O;2!W:61T:#TS1#$E(&%L:6=N/3-$<FEG:'0^/&9O;G0@<W1Y
M;&4],T0G1D].5"U325I%.B`Q,'!T.R!&3TY4+49!34E,63H@=&EM97,@;F5W
M(')O;6%N.R!&3TY4+5=%24=(5#H@8F]L9#L@1$E34$Q!63H@:6YL:6YE)SX@
M)FYB<W`[/"]F;VYT/B`\+W1D/B`\=&0@<W1Y;&4],T0G0D]21$52+4)/5%1/
M33H@8FQA8VL@,G!X('-O;&ED.R!415A4+4%,24=..B!C96YT97([($U!4D=)
M3BU,1494.B`P<'0[($U!4D=)3BU224=(5#H@,'!T.R!415A4+4E.1$5.5#H@
M,'!T)R!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q,"4@8V]L<W!A;CTS1#(^
M(#QD:78@<W1Y;&4],T0G1$E34$Q!63H@8FQO8VL[($9/3E0M1D%-24Q9.B!T
M:6UE<R!N97<@<F]M86X[($9/3E0M4TE:13H@,3!P=#L@1D].5"U714E'2%0Z
M(&)O;&0[($U!4D=)3BU,1494.B`P<'0[($U!4D=)3BU224=(5#H@,'!T.R!4
M15A4+4%,24=..B!C96YT97([(%1%6%0M24Y$14Y4.B`P<'0G/B`R,#$S/"]D
M:78^(#PO=&0^(#QT9"!S='EL93TS1"=0041$24Y'+4)/5%1/33H@,G!X.R!4
M15A4+4%,24=..B!L969T)R!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)2!N
M;W=R87`],T1N;W=R87`^/&9O;G0@<W1Y;&4],T0G1D].5"U325I%.B`Q,'!T
M.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!&3TY4+5=%24=(5#H@
M8F]L9#L@1$E34$Q!63H@:6YL:6YE)SX@)FYB<W`[/"]F;VYT/B`\+W1D/B`\
M=&0@<W1Y;&4],T0G4$%$1$E.1RU"3U143TTZ(#)P>"<@=F%L:6=N/3-$8F]T
M=&]M('=I9'1H/3-$,24^/&9O;G0@<W1Y;&4],T0G1D].5"U325I%.B`Q,'!T
M.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!&3TY4+5=%24=(5#H@
M8F]L9#L@1$E34$Q!63H@:6YL:6YE)SX@)FYB<W`[/"]F;VYT/B`\+W1D/B`\
M=&0@<W1Y;&4],T0G0D]21$52+4)/5%1/33H@8FQA8VL@,G!X('-O;&ED)R!V
M86QI9VX],T1B;W1T;VT@=VED=&@],T0Q,"4@8V]L<W!A;CTS1#(^(#QD:78@
M<W1Y;&4],T0G1$E34$Q!63H@8FQO8VL[($9/3E0M1D%-24Q9.B!T:6UE<R!N
M97<@<F]M86X[($9/3E0M4TE:13H@,3!P=#L@1D].5"U714E'2%0Z(&)O;&0[
M($U!4D=)3BU,1494.B`P<'0[($U!4D=)3BU224=(5#H@-RXT-7!T.R!T97AT
M+6%L:6=N.B!C96YT97([(%1%6%0M24Y$14Y4.B`P<'0G/B`R,#$R/"]D:78^
M(#PO=&0^(#QT9"!S='EL93TS1"=0041$24Y'+4)/5%1/33H@,G!X.R!415A4
M+4%,24=..B!L969T)R!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)2!N;W=R
M87`],T1N;W=R87`^/&9O;G0@<W1Y;&4],T0G1D].5"U325I%.B`Q,'!T.R!&
M3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!&3TY4+5=%24=(5#H@8F]L
M9#L@1$E34$Q!63H@:6YL:6YE)SX@)FYB<W`[/"]F;VYT/B`\+W1D/B`\+W1R
M/B`\='(^(#QT9"!V86QI9VX],T1B;W1T;VT@=VED=&@],T0V-"4^/&9O;G0@
M<W1Y;&4],T0G1D].5"U325I%.B`Q,'!T.R!&3TY4+49!34E,63H@=&EM97,@
M;F5W(')O;6%N.R!$25-03$%9.B!I;FQI;F4G/B`F;F)S<#L\+V9O;G0^(#PO
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M;VUA;CL@1$E34$Q!63H@:6YL:6YE)SX@)FYB<W`[/"]F;VYT/B`\+W1D/B`\
M=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,3`E(&-O;'-P86X],T0R/CQF
M;VYT('-T>6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ('1I
M;65S(&YE=R!R;VUA;CL@1$E34$Q!63H@:6YL:6YE)SX@)FYB<W`[/"]F;VYT
M/B`\+W1D/B`\=&0@<W1Y;&4],T0G5$585"U!3$E'3CH@;&5F="<@=F%L:6=N
M/3-$8F]T=&]M('=I9'1H/3-$,24@;F]W<F%P/3-$;F]W<F%P/CQF;VYT('-T
M>6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ('1I;65S(&YE
M=R!R;VUA;CL@1$E34$Q!63H@:6YL:6YE)SX@)FYB<W`[/"]F;VYT/B`\+W1D
M/B`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24^/&9O;G0@<W1Y;&4]
M,T0G1D].5"U325I%.B`Q,'!T.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O
M;6%N.R!$25-03$%9.B!I;FQI;F4G/B`F;F)S<#L\+V9O;G0^(#PO=&0^(#QT
M9"!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q,"4@8V]L<W!A;CTS1#(^/&9O
M;G0@<W1Y;&4],T0G1D].5"U325I%.B`Q,'!T.R!&3TY4+49!34E,63H@=&EM
M97,@;F5W(')O;6%N.R!$25-03$%9.B!I;FQI;F4G/B`F;F)S<#L\+V9O;G0^
M(#PO=&0^(#QT9"!S='EL93TS1"=415A4+4%,24=..B!L969T)R!V86QI9VX]
M,T1B;W1T;VT@=VED=&@],T0Q)2!N;W=R87`],T1N;W=R87`^/&9O;G0@<W1Y
M;&4],T0G1D].5"U325I%.B`Q,'!T.R!&3TY4+49!34E,63H@=&EM97,@;F5W
M(')O;6%N.R!$25-03$%9.B!I;FQI;F4G/B`F;F)S<#L\+V9O;G0^(#PO=&0^
M(#PO='(^(#QT<B!B9V-O;&]R/3-$(V-C965F9CX@/'1D('-T>6QE/3-$)U1%
M6%0M04Q)1TXZ(&QE9G0[($U!4D=)3BU,1494.B`P<'0[($U!4D=)3BU224=(
M5#H@,'!T.R!415A4+4E.1$5.5#H@,'!T)R!V86QI9VX],T1B;W1T;VT@=VED
M=&@],T0V-"4^(#QD:78@<W1Y;&4],T0G1$E34$Q!63H@8FQO8VL[($9/3E0M
M1D%-24Q9.B!T:6UE<R!N97<@<F]M86X[($9/3E0M4TE:13H@,3!P=#L@34%2
M1TE.+4Q%1E0Z(#!P=#L@34%21TE.+5))1TA4.B`P<'0[(%1%6%0M04Q)1TXZ
M(&QE9G0[(%1%6%0M24Y$14Y4.B`P<'0G/B!&;W)E:6=N(&-U<G)E;F-Y('1R
M86YS;&%T:6]N(&1I9F9E<F5N8V5S+"!N970\+V1I=CX@/"]T9#X@/'1D('9A
M;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E(&%L:6=N/3-$<FEG:'0^/&9O;G0@
M<W1Y;&4],T0G1D].5"U325I%.B`Q,'!T.R!&3TY4+49!34E,63H@=&EM97,@
M;F5W(')O;6%N.R!$25-03$%9.B!I;FQI;F4G/B`F;F)S<#L\+V9O;G0^(#PO
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M=&@],T0Q)2!N;W=R87`],T1N;W=R87`^/&9O;G0@<W1Y;&4],T0G1D].5"U3
M25I%.B`Q,'!T.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!$25-0
M3$%9.B!I;FQI;F4G/B`F;F)S<#L\+V9O;G0^(#PO=&0^(#QT9"!V86QI9VX]
M,T1B;W1T;VT@=VED=&@],T0Q)2!A;&EG;CTS1')I9VAT/CQF;VYT('-T>6QE
M/3-$)T9/3E0M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R
M;VUA;CL@1$E34$Q!63H@:6YL:6YE)SX@)FYB<W`[/"]F;VYT/B`\+W1D/B`\
M=&0@<W1Y;&4],T0G1$E34$Q!63H@:6YL:6YE.R!&3TY4+49!34E,63H@=&EM
M97,@;F5W(')O;6%N.R!&3TY4+5-)6D4Z(#$P<'0[(%1%6%0M04Q)1TXZ(&QE
M9G0G('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E/B0\+W1D/B`\=&0@<W1Y
M;&4],T0G1$E34$Q!63H@:6YL:6YE.R!&3TY4+49!34E,63H@=&EM97,@;F5W
M(')O;6%N.R!&3TY4+5-)6D4Z(#$P<'0[(%1%6%0M04Q)1TXZ(')I9VAT)R!V
M86QI9VX],T1B;W1T;VT@=VED=&@],T0Y)3XT.3<\+W1D/B`\=&0@<W1Y;&4]
M,T0G5$585"U!3$E'3CH@;&5F="<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$
M,24@;F]W<F%P/3-$;F]W<F%P/CQF;VYT('-T>6QE/3-$)T9/3E0M4TE:13H@
M,3!P=#L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1$E34$Q!63H@
M:6YL:6YE)SX@)FYB<W`[/"]F;VYT/B`\+W1D/B`\=&0@=F%L:6=N/3-$8F]T
M=&]M('=I9'1H/3-$,24@86QI9VX],T1R:6=H=#X\9F]N="!S='EL93TS1"=&
M3TY4+5-)6D4Z(#$P<'0[($9/3E0M1D%-24Q9.B!T:6UE<R!N97<@<F]M86X[
M($1)4U!,05DZ(&EN;&EN92<^("9N8G-P.SPO9F]N=#X@/"]T9#X@/'1D('-T
M>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE
M=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T.R!415A4+4%,24=..B!L969T)R!V
M86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)3XD/"]T9#X@/'1D('-T>6QE/3-$
M)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA
M;CL@1D].5"U325I%.B`Q,'!T.R!415A4+4%,24=..B!R:6=H="<@=F%L:6=N
M/3-$8F]T=&]M('=I9'1H/3-$.24^*#DX/"]T9#X@/'1D('-T>6QE/3-$)T1)
M4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@
M1D].5"U325I%.B`Q,'!T.R!415A4+4%,24=..B!L969T)R!V86QI9VX],T1B
M;W1T;VT@=VED=&@],T0Q)2!N;W=R87`],T1N;W=R87`^*3PO=&0^(#PO='(^
M(#QT<B!B9V-O;&]R/3-$=VAI=&4^(#QT9"!V86QI9VX],T1B;W1T;VT@=VED
M=&@],T0V-"4@86QI9VX],T1L969T/B`\9&EV('-T>6QE/3-$)T1)4U!,05DZ
M(&)L;V-K.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!&3TY4+5-)
M6D4Z(#$P<'0[($U!4D=)3BU,1494.B`Y<'0[($U!4D=)3BU224=(5#H@,'!T
M.R!T97AT+6%L:6=N.B!L969T.R!415A4+4E.1$5.5#H@+3EP="<^($)A;FL@
M8V]M;6ES<VEO;G,\+V1I=CX@/"]T9#X@/'1D('9A;&EG;CTS1&)O='1O;2!W
M:61T:#TS1#$E(&%L:6=N/3-$<FEG:'0^/&9O;G0@<W1Y;&4],T0G1D].5"U3
M25I%.B`Q,'!T.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!$25-0
M3$%9.B!I;FQI;F4G/B`F;F)S<#L\+V9O;G0^(#PO=&0^(#QT9"!S='EL93TS
M1"=415A4+4%,24=..B!L969T)R!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q
M)3X\9F]N="!S='EL93TS1"=&3TY4+5-)6D4Z(#$P<'0[($9/3E0M1D%-24Q9
M.B!T:6UE<R!N97<@<F]M86X[($1)4U!,05DZ(&EN;&EN92<^("9N8G-P.SPO
M9F]N=#X@/"]T9#X@/'1D('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].
M5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T.R!4
M15A4+4%,24=..B!R:6=H="<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$.24^
M*#,V/"]T9#X@/'1D('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&
M04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T.R!415A4
M+4%,24=..B!L969T)R!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)2!N;W=R
M87`],T1N;W=R87`^*3PO=&0^(#QT9"!V86QI9VX],T1B;W1T;VT@=VED=&@]
M,T0Q)2!A;&EG;CTS1')I9VAT/CQF;VYT('-T>6QE/3-$)T9/3E0M4TE:13H@
M,3!P=#L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1$E34$Q!63H@
M:6YL:6YE)SX@)FYB<W`[/"]F;VYT/B`\+W1D/B`\=&0@<W1Y;&4],T0G5$58
M5"U!3$E'3CH@;&5F="<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24^/&9O
M;G0@<W1Y;&4],T0G1D].5"U325I%.B`Q,'!T.R!&3TY4+49!34E,63H@=&EM
M97,@;F5W(')O;6%N.R!$25-03$%9.B!I;FQI;F4G/B`F;F)S<#L\+V9O;G0^
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M;F]W<F%P/BD\+W1D/B`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@
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M=R!R;VUA;CL@1$E34$Q!63H@:6YL:6YE)SX@)FYB<W`[/"]F;VYT/B`\+W1D
M/B`\=&0@<W1Y;&4],T0G1$E34$Q!63H@:6YL:6YE.R!&3TY4+49!34E,63H@
M=&EM97,@;F5W(')O;6%N.R!&3TY4+5-)6D4Z(#$P<'0[(%1%6%0M04Q)1TXZ
M(')I9VAT)R!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Y)3XH,3(\+W1D/B`\
M=&0@<W1Y;&4],T0G1$E34$Q!63H@:6YL:6YE.R!&3TY4+49!34E,63H@=&EM
M97,@;F5W(')O;6%N.R!&3TY4+5-)6D4Z(#$P<'0[(%1%6%0M04Q)1TXZ(&QE
M9G0G('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E(&YO=W)A<#TS1&YO=W)A
M<#XI/"]T9#X@/"]T<CX@/'1R(&)G8V]L;W(],T0C8V-E969F/B`\=&0@=F%L
M:6=N/3-$8F]T=&]M('=I9'1H/3-$-C0E(&%L:6=N/3-$;&5F=#X@/&1I=B!S
M='EL93TS1"=$25-03$%9.B!B;&]C:SL@1D].5"U&04U)3%DZ('1I;65S(&YE
M=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T.R!-05)'24XM3$5&5#H@.7!T.R!-
M05)'24XM4DE'2%0Z(#!P=#L@=&5X="UA;&EG;CH@;&5F=#L@5$585"U)3D1%
M3E0Z("TY<'0G/B!);G1E<F5S="!I;F-O;64@;VX@9&5P;W-I=',\+V1I=CX@
M/"]T9#X@/'1D('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E(&%L:6=N/3-$
M<FEG:'0^/&9O;G0@<W1Y;&4],T0G1D].5"U325I%.B`Q,'!T.R!&3TY4+49!
M34E,63H@=&EM97,@;F5W(')O;6%N.R!$25-03$%9.B!I;FQI;F4G/B`F;F)S
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M=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T.R!415A4+4%,24=..B!R:6=H="<@
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M1D].5"U325I%.B`Q,'!T.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N
M.R!$25-03$%9.B!I;FQI;F4G/B`F;F)S<#L\+V9O;G0^(#PO=&0^(#QT9"!S
M='EL93TS1"=415A4+4%,24=..B!L969T)R!V86QI9VX],T1B;W1T;VT@=VED
M=&@],T0Q)3X\9F]N="!S='EL93TS1"=&3TY4+5-)6D4Z(#$P<'0[($9/3E0M
M1D%-24Q9.B!T:6UE<R!N97<@<F]M86X[($1)4U!,05DZ(&EN;&EN92<^("9N
M8G-P.SPO9F]N=#X@/"]T9#X@/'1D('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN
M93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q
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M/3-$<FEG:'0^/&9O;G0@<W1Y;&4],T0G1D].5"U325I%.B`Q,'!T.R!&3TY4
M+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!$25-03$%9.B!I;FQI;F4G/B`F
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M(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T.R!415A4+4%,24=..B!R:6=H
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M=#L@34%21TE.+4Q%1E0Z(#EP=#L@34%21TE.+5))1TA4.B`P<'0[('1E>'0M
M86QI9VXZ(&QE9G0[(%1%6%0M24Y$14Y4.B`M.7!T)SX@1V%I;B`H3&]S<RD@
M<F5L871E9"!T;R!M87)K971A8FQE('-E8W5R:71I97,\+V1I=CX@/"]T9#X@
M/'1D('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E(&%L:6=N/3-$<FEG:'0^
M/&9O;G0@<W1Y;&4],T0G1D].5"U325I%.B`Q,'!T.R!&3TY4+49!34E,63H@
M=&EM97,@;F5W(')O;6%N.R!$25-03$%9.B!I;FQI;F4G/B`F;F)S<#L\+V9O
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M;CL@1D].5"U325I%.B`Q,'!T.R!415A4+4%,24=..B!R:6=H="<@=F%L:6=N
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M25I%.B`Q,'!T.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!$25-0
M3$%9.B!I;FQI;F4G/B`F;F)S<#L\+V9O;G0^(#PO=&0^(#QT9"!S='EL93TS
M1"=415A4+4%,24=..B!L969T)R!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q
M)3X\9F]N="!S='EL93TS1"=&3TY4+5-)6D4Z(#$P<'0[($9/3E0M1D%-24Q9
M.B!T:6UE<R!N97<@<F]M86X[($1)4U!,05DZ(&EN;&EN92<^("9N8G-P.SPO
M9F]N=#X@/"]T9#X@/'1D('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].
M5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T.R!4
M15A4+4%,24=..B!R:6=H="<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$.24^
M*#<Y/"]T9#X@/'1D('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&
M04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T.R!415A4
M+4%,24=..B!L969T)R!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)2!N;W=R
M87`],T1N;W=R87`^*3PO=&0^(#QT9"!V86QI9VX],T1B;W1T;VT@=VED=&@]
M,T0Q)2!A;&EG;CTS1')I9VAT/CQF;VYT('-T>6QE/3-$)T9/3E0M4TE:13H@
M,3!P=#L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1$E34$Q!63H@
M:6YL:6YE)SX@)FYB<W`[/"]F;VYT/B`\+W1D/B`\=&0@<W1Y;&4],T0G5$58
M5"U!3$E'3CH@;&5F="<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24^/&9O
M;G0@<W1Y;&4],T0G1D].5"U325I%.B`Q,'!T.R!&3TY4+49!34E,63H@=&EM
M97,@;F5W(')O;6%N.R!$25-03$%9.B!I;FQI;F4G/B`F;F)S<#L\+V9O;G0^
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M<CX@/'1R(&)G8V]L;W(],T0C8V-E969F/B`\=&0@<W1Y;&4],T0G4$%$1$E.
M1RU"3U143TTZ(#)P>"<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$-C0E(&%L
M:6=N/3-$;&5F=#X@/&1I=B!S='EL93TS1"=$25-03$%9.B!B;&]C:SL@1D].
M5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T.R!-
M05)'24XM3$5&5#H@.7!T.R!-05)'24XM4DE'2%0Z(#!P=#L@=&5X="UA;&EG
M;CH@;&5F=#L@5$585"U)3D1%3E0Z("TY<'0G/B!'86EN("AL;W-S*2!F<F]M
M)FYB<W`[)FYB<W`[9&5R:79A=&EV97,\+V1I=CX@/"]T9#X@/'1D('-T>6QE
M/3-$)U!!1$1)3D<M0D]45$]-.B`R<'@G('9A;&EG;CTS1&)O='1O;2!W:61T
M:#TS1#$E(&%L:6=N/3-$<FEG:'0^/&9O;G0@<W1Y;&4],T0G1D].5"U325I%
M.B`Q,'!T.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!$25-03$%9
M.B!I;FQI;F4G/B`F;F)S<#L\+V9O;G0^(#PO=&0^(#QT9"!S='EL93TS1"="
M3U)$15(M0D]45$]-.B!B;&%C:R`R<'@@<V]L:60[(%1%6%0M04Q)1TXZ(&QE
M9G0G('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E/CQF;VYT('-T>6QE/3-$
M)T9/3E0M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA
M;CL@1$E34$Q!63H@:6YL:6YE)SX@)FYB<W`[/"]F;VYT/B`\+W1D/B`\=&0@
M<W1Y;&4],T0G0D]21$52+4)/5%1/33H@8FQA8VL@,G!X('-O;&ED.R!$25-0
M3$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE<R!N97<@<F]M86X[($9/
M3E0M4TE:13H@,3!P=#L@5$585"U!3$E'3CH@<FEG:'0G('9A;&EG;CTS1&)O
M='1O;2!W:61T:#TS1#DE/B@X,SPO=&0^(#QT9"!S='EL93TS1"=$25-03$%9
M.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE<R!N97<@<F]M86X[($9/3E0M
M4TE:13H@,3!P=#L@4$%$1$E.1RU"3U143TTZ(#)P>#L@5$585"U!3$E'3CH@
M;&5F="<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@;F]W<F%P/3-$;F]W
M<F%P/BD\+W1D/B`\=&0@<W1Y;&4],T0G4$%$1$E.1RU"3U143TTZ(#)P>"<@
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M/3-$,24^/&9O;G0@<W1Y;&4],T0G1D].5"U325I%.B`Q,'!T.R!&3TY4+49!
M34E,63H@=&EM97,@;F5W(')O;6%N.R!$25-03$%9.B!I;FQI;F4G/B`F;F)S
M<#L\+V9O;G0^(#PO=&0^(#QT9"!S='EL93TS1"="3U)$15(M0D]45$]-.B!B
M;&%C:R`R<'@@<V]L:60[($1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ
M('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T.R!415A4+4%,24=.
M.B!R:6=H="<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$.24^,30P/"]T9#X@
M/'1D('-T>6QE/3-$)U!!1$1)3D<M0D]45$]-.B`R<'@[(%1%6%0M04Q)1TXZ
M(&QE9G0G('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E(&YO=W)A<#TS1&YO
M=W)A<#X\9F]N="!S='EL93TS1"=&3TY4+5-)6D4Z(#$P<'0[($9/3E0M1D%-
M24Q9.B!T:6UE<R!N97<@<F]M86X[($1)4U!,05DZ(&EN;&EN92<^("9N8G-P
M.SPO9F]N=#X@/"]T9#X@/'1D('-T>6QE/3-$)U!!1$1)3D<M0D]45$]-.B`R
M<'@G('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E(&%L:6=N/3-$<FEG:'0^
M/&9O;G0@<W1Y;&4],T0G1D].5"U325I%.B`Q,'!T.R!&3TY4+49!34E,63H@
M=&EM97,@;F5W(')O;6%N.R!$25-03$%9.B!I;FQI;F4G/B`F;F)S<#L\+V9O
M;G0^(#PO=&0^(#QT9"!S='EL93TS1"="3U)$15(M0D]45$]-.B!B;&%C:R`R
M<'@@<V]L:60[(%1%6%0M04Q)1TXZ(&QE9G0G('9A;&EG;CTS1&)O='1O;2!W
M:61T:#TS1#$E/CQF;VYT('-T>6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@1D].
M5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1$E34$Q!63H@:6YL:6YE)SX@
M)FYB<W`[/"]F;VYT/B`\+W1D/B`\=&0@<W1Y;&4],T0G0D]21$52+4)/5%1/
M33H@8FQA8VL@,G!X('-O;&ED.R!$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-
M24Q9.B!T:6UE<R!N97<@<F]M86X[($9/3E0M4TE:13H@,3!P=#L@5$585"U!
M3$E'3CH@<FEG:'0G('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#DE/B@S,3<\
M+W1D/B`\=&0@<W1Y;&4],T0G1$E34$Q!63H@:6YL:6YE.R!&3TY4+49!34E,
M63H@=&EM97,@;F5W(')O;6%N.R!&3TY4+5-)6D4Z(#$P<'0[(%!!1$1)3D<M
M0D]45$]-.B`R<'@[(%1%6%0M04Q)1TXZ(&QE9G0G('9A;&EG;CTS1&)O='1O
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M('1I;65S(&YE=R!R;VUA;CL@1$E34$Q!63H@:6YL:6YE)SX@)FYB<W`[/"]F
M;VYT/B`\+W1D/B`\=&0@<W1Y;&4],T0G5$585"U!3$E'3CH@;&5F="<@=F%L
M:6=N/3-$8F]T=&]M('=I9'1H/3-$,24^/&9O;G0@<W1Y;&4],T0G1D].5"U3
M25I%.B`Q,'!T.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!$25-0
M3$%9.B!I;FQI;F4G/B`F;F)S<#L\+V9O;G0^(#PO=&0^(#QT9"!S='EL93TS
M1"=415A4+4%,24=..B!R:6=H="<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$
M.24^/&9O;G0@<W1Y;&4],T0G1D].5"U325I%.B`Q,'!T.R!&3TY4+49!34E,
M63H@=&EM97,@;F5W(')O;6%N.R!$25-03$%9.B!I;FQI;F4G/B`F;F)S<#L\
M+V9O;G0^(#PO=&0^(#QT9"!S='EL93TS1"=415A4+4%,24=..B!L969T)R!V
M86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)2!N;W=R87`],T1N;W=R87`^/&9O
M;G0@<W1Y;&4],T0G1D].5"U325I%.B`Q,'!T.R!&3TY4+49!34E,63H@=&EM
M97,@;F5W(')O;6%N.R!$25-03$%9.B!I;FQI;F4G/B`F;F)S<#L\+V9O;G0^
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M:6YE)SX@)FYB<W`[/"]F;VYT/B`\+W1D/B`\=&0@<W1Y;&4],T0G5$585"U!
M3$E'3CH@<FEG:'0G('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#DE/CQF;VYT
M('-T>6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ('1I;65S
M(&YE=R!R;VUA;CL@1$E34$Q!63H@:6YL:6YE)SX@)FYB<W`[/"]F;VYT/B`\
M+W1D/B`\=&0@<W1Y;&4],T0G5$585"U!3$E'3CH@;&5F="<@=F%L:6=N/3-$
M8F]T=&]M('=I9'1H/3-$,24@;F]W<F%P/3-$;F]W<F%P/CQF;VYT('-T>6QE
M/3-$)T9/3E0M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R
M;VUA;CL@1$E34$Q!63H@:6YL:6YE)SX@)FYB<W`[/"]F;VYT/B`\+W1D/B`\
M=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24^/&9O;G0@<W1Y;&4],T0G
M1D].5"U325I%.B`Q,'!T.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N
M.R!$25-03$%9.B!I;FQI;F4G/B`F;F)S<#L\+V9O;G0^(#PO=&0^(#QT9"!S
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M(&)G8V]L;W(],T0C8V-E969F/B`\=&0@<W1Y;&4],T0G4$%$1$E.1RU"3U14
M3TTZ(#1P>"<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$-C0E/CQF;VYT('-T
M>6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ('1I;65S(&YE
M=R!R;VUA;CL@1$E34$Q!63H@:6YL:6YE)SX@)FYB<W`[/"]F;VYT/B`\+W1D
M/B`\=&0@<W1Y;&4],T0G4$%$1$E.1RU"3U143TTZ(#1P>"<@=F%L:6=N/3-$
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M1D].5"U325I%.B`Q,'!T.R!415A4+4%,24=..B!L969T)R!V86QI9VX],T1B
M;W1T;VT@=VED=&@],T0Q)3XD/"]T9#X@/'1D('-T>6QE/3-$)T)/4D1%4BU"
M3U143TTZ(&)L86-K(#1P>"!D;W5B;&4[($1)4U!,05DZ(&EN;&EN93L@1D].
M5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T.R!4
M15A4+4%,24=..B!R:6=H="<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$.24^
M.3$X/"]T9#X@/'1D('-T>6QE/3-$)U!!1$1)3D<M0D]45$]-.B`T<'@[(%1%
M6%0M04Q)1TXZ(&QE9G0G('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E(&YO
M=W)A<#TS1&YO=W)A<#X\9F]N="!S='EL93TS1"=&3TY4+5-)6D4Z(#$P<'0[
M($9/3E0M1D%-24Q9.B!T:6UE<R!N97<@<F]M86X[($1)4U!,05DZ(&EN;&EN
M92<^("9N8G-P.SPO9F]N=#X@/"]T9#X@/'1D('-T>6QE/3-$)U!!1$1)3D<M
M0D]45$]-.B`T<'@G('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E(&%L:6=N
M/3-$<FEG:'0^/&9O;G0@<W1Y;&4],T0G1D].5"U325I%.B`Q,'!T.R!&3TY4
M+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!$25-03$%9.B!I;FQI;F4G/B`F
M;F)S<#L\+V9O;G0^(#PO=&0^(#QT9"!S='EL93TS1"="3U)$15(M0D]45$]-
M.B!B;&%C:R`T<'@@9&]U8FQE.R!$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-
M24Q9.B!T:6UE<R!N97<@<F]M86X[($9/3E0M4TE:13H@,3!P=#L@5$585"U!
M3$E'3CH@;&5F="<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24^)#PO=&0^
M(#QT9"!S='EL93TS1"="3U)$15(M0D]45$]-.B!B;&%C:R`T<'@@9&]U8FQE
M.R!$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE<R!N97<@<F]M
M86X[($9/3E0M4TE:13H@,3!P=#L@5$585"U!3$E'3CH@<FEG:'0G('9A;&EG
M;CTS1&)O='1O;2!W:61T:#TS1#DE/C$L,#8X/"]T9#X@/'1D('-T>6QE/3-$
M)U!!1$1)3D<M0D]45$]-.B`T<'@[(%1%6%0M04Q)1TXZ(&QE9G0G('9A;&EG
M;CTS1&)O='1O;2!W:61T:#TS1#$E(&YO=W)A<#TS1&YO=W)A<#X\9F]N="!S
M='EL93TS1"=&3TY4+5-)6D4Z(#$P<'0[($9/3E0M1D%-24Q9.B!T:6UE<R!N
M97<@<F]M86X[($1)4U!,05DZ(&EN;&EN92<^("9N8G-P.SPO9F]N=#X@/"]T
M9#X@/'1D('-T>6QE/3-$)U!!1$1)3D<M0D]45$]-.B`T<'@G('9A;&EG;CTS
M1&)O='1O;2!W:61T:#TS1#$E(&%L:6=N/3-$<FEG:'0^/&9O;G0@<W1Y;&4]
M,T0G1D].5"U325I%.B`Q,'!T.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O
M;6%N.R!$25-03$%9.B!I;FQI;F4G/B`F;F)S<#L\+V9O;G0^(#PO=&0^(#QT
M9"!S='EL93TS1"="3U)$15(M0D]45$]-.B!B;&%C:R`T<'@@9&]U8FQE.R!$
M25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE<R!N97<@<F]M86X[
M($9/3E0M4TE:13H@,3!P=#L@5$585"U!3$E'3CH@;&5F="<@=F%L:6=N/3-$
M8F]T=&]M('=I9'1H/3-$,24^)#PO=&0^(#QT9"!S='EL93TS1"="3U)$15(M
M0D]45$]-.B!B;&%C:R`T<'@@9&]U8FQE.R!$25-03$%9.B!I;FQI;F4[($9/
M3E0M1D%-24Q9.B!T:6UE<R!N97<@<F]M86X[($9/3E0M4TE:13H@,3!P=#L@
M5$585"U!3$E'3CH@<FEG:'0G('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#DE
M/C(S-SPO=&0^(#QT9"!S='EL93TS1"=0041$24Y'+4)/5%1/33H@-'!X.R!4
M15A4+4%,24=..B!L969T)R!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)2!N
M;W=R87`],T1N;W=R87`^/&9O;G0@<W1Y;&4],T0G1D].5"U325I%.B`Q,'!T
M.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!$25-03$%9.B!I;FQI
M;F4G/B`F;F)S<#L\+V9O;G0^(#PO=&0^(#PO='(^(#PO=&%B;&4^(#PO9&EV
M/B`\(2TM16YD1G)A9VUE;G0M+3X\+V1I=CX@/"]D:78^/'-P86X^/"]S<&%N
M/CPO=&0^#0H@("`@("`\+W1R/@T*("`@(#PO=&%B;&4^#0H@(#PO8F]D>3X-
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M;#L@8VAA<G-E=#TB=7,M87-C:6DB#0H-"CQH=&UL/@T*("`\:&5A9#X-"B`@
M("`\345402!H='1P+65Q=6EV/3-$0V]N=&5N="U4>7!E(&-O;G1E;G0],T0G
M=&5X="]H=&UL.R!C:&%R<V5T/75T9BTX)SX\<V-R:7!T('1Y<&4],T1T97AT
M+VIA=F%S8W)I<'0@<W)C/3-$4VAO=RYJ<SXO*B!$;R!.;W0@4F5M;W9E(%1H
M:7,@0V]M;65N="`J+SPO<V-R:7!T/CPO:&5A9#X-"B`@/&)O9'D^#0H@("`@
M/'1A8FQE(&-L87-S/3-$<F5P;W)T(&ED/3-$240P13)&/@T*("`@("`@/'1R
M/@T*("`@("`@("`\=&@@8VQA<W,],T1T;"!C;VQS<&%N/3-$,2!R;W=S<&%N
M/3-$,CX\<W1R;VYG/E1!6$53($].($E.0T]-12`H5&%B;&5S*3QB<CX\+W-T
M<F]N9SX\+W1H/@T*("`@("`@("`\=&@@8VQA<W,],T1T:"!C;VQS<&%N/3-$
M,3XQ,B!-;VYT:',@16YD960\+W1H/@T*("`@("`@/"]T<CX-"B`@("`@(#QT
M<CX-"B`@("`@("`@/'1H(&-L87-S/3-$=&@^2G5N+B`S,"P@,C`Q-#QB<CX\
M+W1H/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS1')E/@T*("`@
M("`@("`\=&0@8VQA<W,],T1P;"!V86QI9VX],T1T;W`^/'-T<F]N9SY405A%
M4R!/3B!)3D-/344@6T%B<W1R86-T73PO<W1R;VYG/CPO=&0^#0H@("`@("`@
M(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@
M/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS1')O/@T*("`@("`@("`\=&0@8VQA
M<W,],T1P;"!V86QI9VX],T1T;W`^475A;&EF>6EN9R!097)C96YT86=E(&]F
M(%9A;'5E(&]F(%!R;V1U8W1I=F4@07-S971S/"]T9#X-"B`@("`@("`@/'1D
M(&-L87-S/3-$=&5X=#XG/"$M+41/0U194$4@:'1M;"!054),24,@(BTO+U<S
M0R\O1%1$(%A(5$U,(#$N,"!4<F%N<VET:6]N86PO+T5.(B`B:'1T<#HO+W=W
M=RYW,RYO<F<O5%(O>&AT;6PQ+T141"]X:'1M;#$M=')A;G-I=&EO;F%L+F1T
M9"(@+2T^/&1I=CX@/&1I=CX\(2TM4W1A<G1&<F%G;65N="TM/B`\9&EV('-T
M>6QE/3-$)T1)4U!,05DZ(&)L;V-K.R!&3TY4+49!34E,63H@5&EM97,@3F5W
M(%)O;6%N.R!&3TY4+5-)6D4Z(#$P<'0[($U!4D=)3BU,1494.B`R-W!T.R!-
M05)'24XM4DE'2%0Z(#!P=#L@=&5X="UA;&EG;CH@:G5S=&EF>3L@5$585"U)
M3D1%3E0Z(#!P="<^(%1H92!Q=6%L:69Y:6YG('!E<F-E;G1A9V4@;V8@=&AE
M('9A;'5E(&]F('1H92!P<F]D=6-T:79E(&%S<V5T<R!I<R!A<R!F;VQL;W=S
M.CPO9&EV/B`\9&EV('-T>6QE/3-$)T1)4U!,05DZ(&)L;V-K.R!415A4+4E.
M1$5.5#H@,'!T)SX\8G(@+SX@/"]D:78^(#QD:78@<W1Y;&4],T0G34%21TE.
M+4Q%1E0Z(#(W<'0[('1E>'0M86QI9VXZ(&-E;G1E<B<^(#QT86)L92!S='EL
M93TS1"=&3TY4+5-)6D4Z(#$P<'0[($9/3E0M1D%-24Q9.B!T:6UE<R!N97<@
M<F]M86XG(&-E;&QS<&%C:6YG/3-$,"!C96QL<&%D9&EN9STS1#`@=VED=&@]
M,T0V,"4^(#QT<CX@/'1D('-T>6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K
M(#)P>"!S;VQI9"<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$-#DE/B`\9&EV
M('-T>6QE/3-$)T1)4U!,05DZ(&)L;V-K.R!&3TY4+49!34E,63H@=&EM97,@
M;F5W(')O;6%N.R!&3TY4+5-)6D4Z(#$P<'0[($9/3E0M5T5)1TA4.B!B;VQD
M.R!-05)'24XM3$5&5#H@,'!T.R!-05)'24XM4DE'2%0Z(#!P=#L@=&5X="UA
M;&EG;CH@8V5N=&5R.R!415A4+4E.1$5.5#H@,'!T)SX@5&AE('9A;'5E(&]F
M('!R;V1U8W1I=F4\+V1I=CX@/&1I=B!S='EL93TS1"=$25-03$%9.B!B;&]C
M:SL@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q
M,'!T.R!&3TY4+5=%24=(5#H@8F]L9#L@34%21TE.+4Q%1E0Z(#!P=#L@34%2
M1TE.+5))1TA4.B`P<'0[('1E>'0M86QI9VXZ(&-E;G1E<CL@5$585"U)3D1%
M3E0Z(#!P="<^(&%S<V5T<R!B969O<F4@=&AE(&5X<&%N<VEO;CPO9&EV/B`\
M9&EV('-T>6QE/3-$)T1)4U!,05DZ(&)L;V-K.R!&3TY4+49!34E,63H@=&EM
M97,@;F5W(')O;6%N.R!&3TY4+5-)6D4Z(#$P<'0[($9/3E0M5T5)1TA4.B!B
M;VQD.R!-05)'24XM3$5&5#H@,'!T.R!-05)'24XM4DE'2%0Z(#!P=#L@=&5X
M="UA;&EG;CH@8V5N=&5R.R!415A4+4E.1$5.5#H@,'!T)SX@*$Y)4R!I;B!M
M:6QL:6]N<RD\+V1I=CX@/"]T9#X@/'1D('9A;&EG;CTS1'1O<"!W:61T:#TS
M1#(E/CQF;VYT('-T>6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@1D].5"U&04U)
M3%DZ('1I;65S(&YE=R!R;VUA;CL@1$E34$Q!63H@:6YL:6YE)SX@)FYB<W`[
M/"]F;VYT/B`\+W1D/B`\=&0@<W1Y;&4],T0G0D]21$52+4)/5%1/33H@8FQA
M8VL@,G!X('-O;&ED)R!V86QI9VX],T1T;W`@=VED=&@],T0T.24^(#QD:78@
M<W1Y;&4],T0G1$E34$Q!63H@8FQO8VL[($9/3E0M1D%-24Q9.B!T:6UE<R!N
M97<@<F]M86X[($9/3E0M4TE:13H@,3!P=#L@1D].5"U714E'2%0Z(&)O;&0[
M($U!4D=)3BU,1494.B`P<'0[($U!4D=)3BU224=(5#H@,'!T.R!T97AT+6%L
M:6=N.B!C96YT97([(%1%6%0M24Y$14Y4.B`P<'0G/B!4:&4@;F5W('!R;W!O
M<G1I;VX\+V1I=CX@/&1I=B!S='EL93TS1"=$25-03$%9.B!B;&]C:SL@1D].
M5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T.R!&
M3TY4+5=%24=(5#H@8F]L9#L@34%21TE.+4Q%1E0Z(#!P=#L@34%21TE.+5))
M1TA4.B`P<'0[('1E>'0M86QI9VXZ(&-E;G1E<CL@5$585"U)3D1%3E0Z(#!P
M="<^('1H870@=&AE(')E<75I<F5D/"]D:78^(#QD:78@<W1Y;&4],T0G1$E3
M4$Q!63H@8FQO8VL[($9/3E0M1D%-24Q9.B!T:6UE<R!N97<@<F]M86X[($9/
M3E0M4TE:13H@,3!P=#L@1D].5"U714E'2%0Z(&)O;&0[($U!4D=)3BU,1494
M.B`P<'0[($U!4D=)3BU224=(5#H@,'!T.R!T97AT+6%L:6=N.B!C96YT97([
M(%1%6%0M24Y$14Y4.B`P<'0G/B`F;F)S<#MI;G9E<W1M96YT(&)E87)S/"]D
M:78^(#QD:78@<W1Y;&4],T0G1$E34$Q!63H@8FQO8VL[($9/3E0M1D%-24Q9
M.B!T:6UE<R!N97<@<F]M86X[($9/3E0M4TE:13H@,3!P=#L@1D].5"U714E'
M2%0Z(&)O;&0[($U!4D=)3BU,1494.B`P<'0[($U!4D=)3BU224=(5#H@,'!T
M.R!T97AT+6%L:6=N.B!C96YT97([(%1%6%0M24Y$14Y4.B`P<'0G/B!T;R!T
M:&4@=F%L=64@;V8\+V1I=CX@/&1I=B!S='EL93TS1"=$25-03$%9.B!B;&]C
M:SL@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q
M,'!T.R!&3TY4+5=%24=(5#H@8F]L9#L@34%21TE.+4Q%1E0Z(#!P=#L@34%2
M1TE.+5))1TA4.B`P<'0[('1E>'0M86QI9VXZ(&-E;G1E<CL@5$585"U)3D1%
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M1$E34$Q!63H@:6YL:6YE)SX@)FYB<W`[/"]F;VYT/B`\+W1D/B`\=&0@=F%L
M:6=N/3-$=&]P('=I9'1H/3-$-#DE/CQF;VYT('-T>6QE/3-$)T9/3E0M4TE:
M13H@,3!P=#L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1$E34$Q!
M63H@:6YL:6YE)SX@)FYB<W`[/"]F;VYT/B`\+W1D/B`\+W1R/B`\='(@8F=C
M;VQO<CTS1"-C8V5E9F8^(#QT9"!S='EL93TS1"=415A4+4%,24=..B!L969T
M.R!-05)'24XM3$5&5#H@,'!T.R!-05)'24XM4DE'2%0Z(#!P=#L@5$585"U)
M3D1%3E0Z(#!P="<@=F%L:6=N/3-$=&]P('=I9'1H/3-$-#DE/B`\9&EV('-T
M>6QE/3-$)T1)4U!,05DZ(&)L;V-K.R!&3TY4+49!34E,63H@=&EM97,@;F5W
M(')O;6%N.R!&3TY4+5-)6D4Z(#$P<'0[($U!4D=)3BU,1494.B`P<'0[($U!
M4D=)3BU224=(5#H@,'!T.R!415A4+4%,24=..B!L969T.R!415A4+4E.1$5.
M5#H@,'!T)SX@57`@=&\@3DE3)FYB<W`[,30P/"]D:78^(#PO=&0^(#QT9"!V
M86QI9VX],T1T;W`@=VED=&@],T0R)3X\9F]N="!S='EL93TS1"=&3TY4+5-)
M6D4Z(#$P<'0[($9/3E0M1D%-24Q9.B!T:6UE<R!N97<@<F]M86X[($1)4U!,
M05DZ(&EN;&EN92<^("9N8G-P.SPO9F]N=#X@/"]T9#X@/'1D('9A;&EG;CTS
M1'1O<"!W:61T:#TS1#0Y)3X@/&1I=B!S='EL93TS1"=$25-03$%9.B!B;&]C
M:SL@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q
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M9'1H/3-$-#DE/B`\9&EV('-T>6QE/3-$)T1)4U!,05DZ(&)L;V-K.R!&3TY4
M+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!&3TY4+5-)6D4Z(#$P<'0[($U!
M4D=)3BU,1494.B`P<'0[($U!4D=)3BU224=(5#H@,'!T.R!415A4+4%,24=.
M.B!L969T.R!415A4+4E.1$5.5#H@,'!T)SX@3DE3)FYB<W`[,30P("T@3DE3
M)FYB<W`[-3`P/"]D:78^(#PO=&0^(#QT9"!V86QI9VX],T1T;W`@=VED=&@]
M,T0R)3X\9F]N="!S='EL93TS1"=&3TY4+5-)6D4Z(#$P<'0[($9/3E0M1D%-
M24Q9.B!T:6UE<R!N97<@<F]M86X[($1)4U!,05DZ(&EN;&EN92<^("9N8G-P
M.SPO9F]N=#X@/"]T9#X@/'1D('9A;&EG;CTS1'1O<"!W:61T:#TS1#0Y)3X@
M/&1I=B!S='EL93TS1"=$25-03$%9.B!B;&]C:SL@1D].5"U&04U)3%DZ('1I
M;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T.R!-05)'24XM3$5&5#H@
M,'!T.R!-05)'24XM4DE'2%0Z(#!P=#L@=&5X="UA;&EG;CH@8V5N=&5R.R!4
M15A4+4E.1$5.5#H@,'!T)SX@-R4\+V1I=CX@/"]T9#X@/"]T<CX@/'1R(&)G
M8V]L;W(],T0C8V-E969F/B`\=&0@<W1Y;&4],T0G5$585"U!3$E'3CH@;&5F
M=#L@34%21TE.+4Q%1E0Z(#!P=#L@34%21TE.+5))1TA4.B`P<'0[(%1%6%0M
M24Y$14Y4.B`P<'0G('9A;&EG;CTS1'1O<"!W:61T:#TS1#0Y)3X@/&1I=B!S
M='EL93TS1"=$25-03$%9.B!B;&]C:SL@1D].5"U&04U)3%DZ('1I;65S(&YE
M=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T.R!-05)'24XM3$5&5#H@,'!T.R!-
M05)'24XM4DE'2%0Z(#!P=#L@5$585"U!3$E'3CH@;&5F=#L@5$585"U)3D1%
M3E0Z(#!P="<^($UO<F4@=&AA;B!.25,F;F)S<#LU,#`\+V1I=CX@/"]T9#X@
M/'1D('9A;&EG;CTS1'1O<"!W:61T:#TS1#(E/CQF;VYT('-T>6QE/3-$)T9/
M3E0M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@
M1$E34$Q!63H@:6YL:6YE)SX@)FYB<W`[/"]F;VYT/B`\+W1D/B`\=&0@=F%L
M:6=N/3-$=&]P('=I9'1H/3-$-#DE/B`\9&EV('-T>6QE/3-$)T1)4U!,05DZ
M(&)L;V-K.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!&3TY4+5-)
M6D4Z(#$P<'0[($U!4D=)3BU,1494.B`P<'0[($U!4D=)3BU224=(5#H@,'!T
M.R!T97AT+6%L:6=N.B!C96YT97([(%1%6%0M24Y$14Y4.B`P<'0G/B`U)3PO
M9&EV/B`\+W1D/B`\+W1R/B`\+W1A8FQE/B`\+V1I=CX@/"$M+45N9$9R86=M
M96YT+2T^/"]D:78^(#PO9&EV/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@
M/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS1')E/@T*("`@("`@("`\=&0@8VQA
M<W,],T1P;"!V86QI9VX],T1T;W`^4V-H961U;&4@;V8@1&5F97)R960@5&%X
M($%S<V5T<SPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SPA+2U$
M3T-465!%(&AT;6P@4%5"3$E#("(M+R]7,T,O+T141"!82%1-3"`Q+C`@5')A
M;G-I=&EO;F%L+R]%3B(@(FAT='`Z+R]W=W<N=S,N;W)G+U12+WAH=&UL,2]$
M5$0O>&AT;6PQ+71R86YS:71I;VYA;"YD=&0B("TM/CQD:78^(#QD:78^/"$M
M+5-T87)T1G)A9VUE;G0M+3X@/&1I=B!S='EL93TS1"=$25-03$%9.B!B;&]C
M:SL@1D].5"U&04U)3%DZ(%1I;65S($YE=R!2;VUA;CL@1D].5"U325I%.B`Q
M,'!T.R!-05)'24XM3$5&5#H@,C=P=#L@34%21TE.+5))1TA4.B`P<'0[('1E
M>'0M86QI9VXZ(&IU<W1I9GD[(%1%6%0M24Y$14Y4.B`P<'0G/B!$969E<G)E
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M:SL@5$585"U)3D1%3E0Z(#!P="<^/&)R("\^(#PO9&EV/B`\9&EV('-T>6QE
M/3-$)W1E>'0M86QI9VXZ(')I9VAT)SX@/'1A8FQE('-T>6QE/3-$)T9/3E0M
M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;B<@8V5L
M;'-P86-I;F<],T0P(&-E;&QP861D:6YG/3-$,"!W:61T:#TS1#DU)3X@/'1R
M/B`\=&0@<W1Y;&4],T0G4$%$1$E.1RU"3U143TTZ(#)P>"<@=F%L:6=N/3-$
M8F]T=&]M('=I9'1H/3-$-S8E/CQF;VYT('-T>6QE/3-$)T9/3E0M4TE:13H@
M,3!P=#L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1$E34$Q!63H@
M:6YL:6YE)SX@)FYB<W`[/"]F;VYT/B`\+W1D/B`\=&0@<W1Y;&4],T0G4$%$
M1$E.1RU"3U143TTZ(#)P>"<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24^
M/&9O;G0@<W1Y;&4],T0G1D].5"U325I%.B`Q,'!T.R!&3TY4+49!34E,63H@
M=&EM97,@;F5W(')O;6%N.R!&3TY4+5=%24=(5#H@8F]L9#L@1$E34$Q!63H@
M:6YL:6YE)SX@)FYB<W`[/"]F;VYT/B`\+W1D/B`\=&0@<W1Y;&4],T0G0D]2
M1$52+4)/5%1/33H@8FQA8VL@,G!X('-O;&ED)R!V86QI9VX],T1B;W1T;VT@
M=VED=&@],T0R,B4@8V]L<W!A;CTS1#8^(#QD:78@<W1Y;&4],T0G1$E34$Q!
M63H@8FQO8VL[($9/3E0M1D%-24Q9.B!T:6UE<R!N97<@<F]M86X[($9/3E0M
M4TE:13H@,3!P=#L@1D].5"U714E'2%0Z(&)O;&0[($U!4D=)3BU,1494.B`P
M<'0[($U!4D=)3BU224=(5#H@,'!T.R!T97AT+6%L:6=N.B!C96YT97([(%1%
M6%0M24Y$14Y4.B`P<'0G/B!*=6YE(#,P+#PO9&EV/B`\+W1D/B`\=&0@<W1Y
M;&4],T0G4$%$1$E.1RU"3U143TTZ(#)P>#L@5$585"U!3$E'3CH@;&5F="<@
M=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@;F]W<F%P/3-$;F]W<F%P/CQF
M;VYT('-T>6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ('1I
M;65S(&YE=R!R;VUA;CL@1D].5"U714E'2%0Z(&)O;&0[($1)4U!,05DZ(&EN
M;&EN92<^("9N8G-P.SPO9F]N=#X@/"]T9#X@/"]T<CX@/'1R/B`\=&0@<W1Y
M;&4],T0G4$%$1$E.1RU"3U143TTZ(#)P>"<@=F%L:6=N/3-$8F]T=&]M('=I
M9'1H/3-$-S8E/CQF;VYT('-T>6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@1D].
M5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1$E34$Q!63H@:6YL:6YE)SX@
M)FYB<W`[/"]F;VYT/B`\+W1D/B`\=&0@<W1Y;&4],T0G4$%$1$E.1RU"3U14
M3TTZ(#)P>"<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24^/&9O;G0@<W1Y
M;&4],T0G1D].5"U325I%.B`Q,'!T.R!&3TY4+49!34E,63H@=&EM97,@;F5W
M(')O;6%N.R!&3TY4+5=%24=(5#H@8F]L9#L@1$E34$Q!63H@:6YL:6YE)SX@
M)FYB<W`[/"]F;VYT/B`\+W1D/B`\=&0@<W1Y;&4],T0G0D]21$52+4)/5%1/
M33H@8FQA8VL@,G!X('-O;&ED)R!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q
M,"4@8V]L<W!A;CTS1#(^(#QD:78@<W1Y;&4],T0G1$E34$Q!63H@8FQO8VL[
M($9/3E0M1D%-24Q9.B!T:6UE<R!N97<@<F]M86X[($9/3E0M4TE:13H@,3!P
M=#L@1D].5"U714E'2%0Z(&)O;&0[($U!4D=)3BU,1494.B`P<'0[($U!4D=)
M3BU224=(5#H@,'!T.R!T97AT+6%L:6=N.B!C96YT97([(%1%6%0M24Y$14Y4
M.B`M,3AP="<^(#(P,30\+V1I=CX@/"]T9#X@/'1D('-T>6QE/3-$)U!!1$1)
M3D<M0D]45$]-.B`R<'@[(%1%6%0M04Q)1TXZ(&QE9G0G('9A;&EG;CTS1&)O
M='1O;2!W:61T:#TS1#$E(&YO=W)A<#TS1&YO=W)A<#X\9F]N="!S='EL93TS
M1"=&3TY4+5-)6D4Z(#$P<'0[($9/3E0M1D%-24Q9.B!T:6UE<R!N97<@<F]M
M86X[($9/3E0M5T5)1TA4.B!B;VQD.R!$25-03$%9.B!I;FQI;F4G/B`F;F)S
M<#L\+V9O;G0^(#PO=&0^(#QT9"!S='EL93TS1"=0041$24Y'+4)/5%1/33H@
M,G!X)R!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)3X\9F]N="!S='EL93TS
M1"=&3TY4+5-)6D4Z(#$P<'0[($9/3E0M1D%-24Q9.B!T:6UE<R!N97<@<F]M
M86X[($9/3E0M5T5)1TA4.B!B;VQD.R!$25-03$%9.B!I;FQI;F4G/B`F;F)S
M<#L\+V9O;G0^(#PO=&0^(#QT9"!S='EL93TS1"="3U)$15(M0D]45$]-.B!B
M;&%C:R`R<'@@<V]L:60G('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$P)2!C
M;VQS<&%N/3-$,CX@/&1I=B!S='EL93TS1"=$25-03$%9.B!B;&]C:SL@1D].
M5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T.R!&
M3TY4+5=%24=(5#H@8F]L9#L@34%21TE.+4Q%1E0Z(#!P=#L@34%21TE.+5))
M1TA4.B`P<'0[('1E>'0M86QI9VXZ(&-E;G1E<CL@5$585"U)3D1%3E0Z("TQ
M.'!T)SX@,C`Q,SPO9&EV/B`\+W1D/B`\=&0@<W1Y;&4],T0G4$%$1$E.1RU"
M3U143TTZ(#)P>#L@5$585"U!3$E'3CH@;&5F="<@=F%L:6=N/3-$8F]T=&]M
M('=I9'1H/3-$,24@;F]W<F%P/3-$;F]W<F%P/CQF;VYT('-T>6QE/3-$)T9/
M3E0M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@
M1D].5"U714E'2%0Z(&)O;&0[($1)4U!,05DZ(&EN;&EN92<^("9N8G-P.SPO
M9F]N=#X@/"]T9#X@/"]T<CX@/'1R(&)G8V]L;W(],T0C8V-E969F/B`\=&0@
M=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$-S8E(&%L:6=N/3-$;&5F=#X@/&1I
M=B!S='EL93TS1"=$25-03$%9.B!B;&]C:SL@1D].5"U&04U)3%DZ('1I;65S
M(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T.R!-05)'24XM3$5&5#H@.7!T
M.R!-05)'24XM4DE'2%0Z(#!P=#L@=&5X="UA;&EG;CH@;&5F=#L@5$585"U)
M3D1%3E0Z("TY<'0G/B!$969E<G)E9"!T87@@87-S971S.CPO9&EV/B`\+W1D
M/B`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24^/&9O;G0@<W1Y;&4]
M,T0G1D].5"U325I%.B`Q,'!T.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O
M;6%N.R!$25-03$%9.B!I;FQI;F4G/B`F;F)S<#L\+V9O;G0^(#PO=&0^(#QT
M9"!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q,"4@8V]L<W!A;CTS1#(^/&9O
M;G0@<W1Y;&4],T0G1D].5"U325I%.B`Q,'!T.R!&3TY4+49!34E,63H@=&EM
M97,@;F5W(')O;6%N.R!$25-03$%9.B!I;FQI;F4G/B`F;F)S<#L\+V9O;G0^
M(#PO=&0^(#QT9"!S='EL93TS1"=415A4+4%,24=..B!L969T)R!V86QI9VX]
M,T1B;W1T;VT@=VED=&@],T0Q)2!N;W=R87`],T1N;W=R87`^/&9O;G0@<W1Y
M;&4],T0G1D].5"U325I%.B`Q,'!T.R!&3TY4+49!34E,63H@=&EM97,@;F5W
M(')O;6%N.R!$25-03$%9.B!I;FQI;F4G/B`F;F)S<#L\+V9O;G0^(#PO=&0^
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M(%4N4RX@;F5T(&]P97)A=&EN9R!L;W-S(&-A<G)Y9F]R=V%R9#PO9&EV/B`\
M+W1D/B`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@86QI9VX],T1R
M:6=H=#X\9F]N="!S='EL93TS1"=&3TY4+5-)6D4Z(#$P<'0[($9/3E0M1D%-
M24Q9.B!T:6UE<R!N97<@<F]M86X[($1)4U!,05DZ(&EN;&EN92<^("9N8G-P
M.SPO9F]N=#X@/"]T9#X@/'1D('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@
M1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T
M.R!415A4+4%,24=..B!L969T)R!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q
M)3XD/"]T9#X@/'1D('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&
M04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T.R!415A4
M+4%,24=..B!R:6=H="<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$.24^-RPY
M-34\+W1D/B`\=&0@<W1Y;&4],T0G5$585"U!3$E'3CH@;&5F="<@=F%L:6=N
M/3-$8F]T=&]M('=I9'1H/3-$,24@;F]W<F%P/3-$;F]W<F%P/CQF;VYT('-T
M>6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ('1I;65S(&YE
M=R!R;VUA;CL@1$E34$Q!63H@:6YL:6YE)SX@)FYB<W`[/"]F;VYT/B`\+W1D
M/B`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@86QI9VX],T1R:6=H
M=#X\9F]N="!S='EL93TS1"=&3TY4+5-)6D4Z(#$P<'0[($9/3E0M1D%-24Q9
M.B!T:6UE<R!N97<@<F]M86X[($1)4U!,05DZ(&EN;&EN92<^("9N8G-P.SPO
M9F]N=#X@/"]T9#X@/'1D('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].
M5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T.R!4
M15A4+4%,24=..B!L969T)R!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)3XD
M/"]T9#X@/'1D('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)
M3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T.R!415A4+4%,
M24=..B!R:6=H="<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$.24^-RPQ,#8\
M+W1D/B`\=&0@<W1Y;&4],T0G5$585"U!3$E'3CH@;&5F="<@=F%L:6=N/3-$
M8F]T=&]M('=I9'1H/3-$,24@;F]W<F%P/3-$;F]W<F%P/CQF;VYT('-T>6QE
M/3-$)T9/3E0M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R
M;VUA;CL@1$E34$Q!63H@:6YL:6YE)SX@)FYB<W`[/"]F;VYT/B`\+W1D/B`\
M+W1R/B`\='(@8F=C;VQO<CTS1"-C8V5E9F8^(#QT9"!V86QI9VX],T1B;W1T
M;VT@=VED=&@],T0W-B4^(#QD:78@<W1Y;&4],T0G1$E34$Q!63H@8FQO8VL[
M($9/3E0M1D%-24Q9.B!T:6UE<R!N97<@<F]M86X[($9/3E0M4TE:13H@,3!P
M=#L@34%21TE.+4Q%1E0Z(#$X<'0[($U!4D=)3BU224=(5#H@,'!T.R!T97AT
M+6%L:6=N.B!J=7-T:69Y.R!415A4+4E.1$5.5#H@+3EP="<^($ES<F%E;&D@
M;F5T(&]P97)A=&EN9R!L;W-S(&-A<G)Y9F]R=V%R9#PO9&EV/B`\+W1D/B`\
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M63H@:6YL:6YE)SX@)FYB<W`[/"]F;VYT/B`\+W1D/B`\=&0@<W1Y;&4],T0G
M1$E34$Q!63H@:6YL:6YE.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N
M.R!&3TY4+5-)6D4Z(#$P<'0[(%1%6%0M04Q)1TXZ(')I9VAT)R!V86QI9VX]
M,T1B;W1T;VT@=VED=&@],T0Y)3XQ,BPX,3`\+W1D/B`\=&0@<W1Y;&4],T0G
M5$585"U!3$E'3CH@;&5F="<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@
M;F]W<F%P/3-$;F]W<F%P/CQF;VYT('-T>6QE/3-$)T9/3E0M4TE:13H@,3!P
M=#L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1$E34$Q!63H@:6YL
M:6YE)SX@)FYB<W`[/"]F;VYT/B`\+W1D/B`\=&0@=F%L:6=N/3-$8F]T=&]M
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M3%DZ('1I;65S(&YE=R!R;VUA;CL@1$E34$Q!63H@:6YL:6YE)SX@)FYB<W`[
M/"]F;VYT/B`\+W1D/B`\=&0@<W1Y;&4],T0G1$E34$Q!63H@:6YL:6YE.R!&
M3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!&3TY4+5-)6D4Z(#$P<'0[
M(%1%6%0M04Q)1TXZ(')I9VAT)R!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Y
M)3XX+#4T,SPO=&0^(#QT9"!S='EL93TS1"=415A4+4%,24=..B!L969T)R!V
M86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)2!N;W=R87`],T1N;W=R87`^/&9O
M;G0@<W1Y;&4],T0G1D].5"U325I%.B`Q,'!T.R!&3TY4+49!34E,63H@=&EM
M97,@;F5W(')O;6%N.R!$25-03$%9.B!I;FQI;F4G/B`F;F)S<#L\+V9O;G0^
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M3%DZ('1I;65S(&YE=R!R;VUA;CL@1$E34$Q!63H@:6YL:6YE)SX@)FYB<W`[
M/"]F;VYT/B`\+W1D/B`\=&0@<W1Y;&4],T0G0D]21$52+4)/5%1/33H@8FQA
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M,S<\+W1D/B`\=&0@<W1Y;&4],T0G4$%$1$E.1RU"3U143TTZ(#)P>#L@5$58
M5"U!3$E'3CH@;&5F="<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@;F]W
M<F%P/3-$;F]W<F%P/CQF;VYT('-T>6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@
M1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1$E34$Q!63H@:6YL:6YE
M)SX@)FYB<W`[/"]F;VYT/B`\+W1D/B`\=&0@<W1Y;&4],T0G4$%$1$E.1RU"
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M8F]T=&]M('=I9'1H/3-$,24^/&9O;G0@<W1Y;&4],T0G1D].5"U325I%.B`Q
M,'!T.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!$25-03$%9.B!I
M;FQI;F4G/B`F;F)S<#L\+V9O;G0^(#PO=&0^(#QT9"!S='EL93TS1"="3U)$
M15(M0D]45$]-.B!B;&%C:R`R<'@@<V]L:60[($1)4U!,05DZ(&EN;&EN93L@
M1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T
M.R!415A4+4%,24=..B!R:6=H="<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$
M.24^,34V/"]T9#X@/'1D('-T>6QE/3-$)U!!1$1)3D<M0D]45$]-.B`R<'@[
M(%1%6%0M04Q)1TXZ(&QE9G0G('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E
M(&YO=W)A<#TS1&YO=W)A<#X\9F]N="!S='EL93TS1"=&3TY4+5-)6D4Z(#$P
M<'0[($9/3E0M1D%-24Q9.B!T:6UE<R!N97<@<F]M86X[($1)4U!,05DZ(&EN
M;&EN92<^("9N8G-P.SPO9F]N=#X@/"]T9#X@/"]T<CX@/'1R(&)G8V]L;W(]
M,T0C8V-E969F/B`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$-S8E/CQF
M;VYT('-T>6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ('1I
M;65S(&YE=R!R;VUA;CL@1$E34$Q!63H@:6YL:6YE)SX@)FYB<W`[/"]F;VYT
M/B`\+W1D/B`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24^/&9O;G0@
M<W1Y;&4],T0G1D].5"U325I%.B`Q,'!T.R!&3TY4+49!34E,63H@=&EM97,@
M;F5W(')O;6%N.R!$25-03$%9.B!I;FQI;F4G/B`F;F)S<#L\+V9O;G0^(#PO
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M;CL@1$E34$Q!63H@:6YL:6YE)SX@)FYB<W`[/"]F;VYT/B`\+W1D/B`\=&0@
M<W1Y;&4],T0G5$585"U!3$E'3CH@;&5F="<@=F%L:6=N/3-$8F]T=&]M('=I
M9'1H/3-$,24^/&9O;G0@<W1Y;&4],T0G1D].5"U325I%.B`Q,'!T.R!&3TY4
M+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!$25-03$%9.B!I;FQI;F4G/B`F
M;F)S<#L\+V9O;G0^(#PO=&0^(#QT9"!S='EL93TS1"=415A4+4%,24=..B!R
M:6=H="<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$.24^/&9O;G0@<W1Y;&4]
M,T0G1D].5"U325I%.B`Q,'!T.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O
M;6%N.R!$25-03$%9.B!I;FQI;F4G/B`F;F)S<#L\+V9O;G0^(#PO=&0^(#QT
M9"!S='EL93TS1"=415A4+4%,24=..B!L969T)R!V86QI9VX],T1B;W1T;VT@
M=VED=&@],T0Q)2!N;W=R87`],T1N;W=R87`^/&9O;G0@<W1Y;&4],T0G1D].
M5"U325I%.B`Q,'!T.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!$
M25-03$%9.B!I;FQI;F4G/B`F;F)S<#L\+V9O;G0^(#PO=&0^(#PO='(^(#QT
M<B!B9V-O;&]R/3-$=VAI=&4^(#QT9"!V86QI9VX],T1B;W1T;VT@=VED=&@]
M,T0W-B4^(#QD:78@<W1Y;&4],T0G1$E34$Q!63H@8FQO8VL[($9/3E0M1D%-
M24Q9.B!T:6UE<R!N97<@<F]M86X[($9/3E0M4TE:13H@,3!P=#L@34%21TE.
M+4Q%1E0Z(#EP=#L@34%21TE.+5))1TA4.B`P<'0[('1E>'0M86QI9VXZ(&IU
M<W1I9GD[(%1%6%0M24Y$14Y4.B`M.7!T)SX@5&]T86P@9&5F97)R960@=&%X
M(&%S<V5T<R!B969O<F4@=F%L=6%T:6]N(&%L;&]W86YC93PO9&EV/B`\+W1D
M/B`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@86QI9VX],T1R:6=H
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M4$Q!63H@:6YL:6YE)SX@)FYB<W`[/"]F;VYT/B`\+W1D/B`\=&0@<W1Y;&4]
M,T0G1$E34$Q!63H@:6YL:6YE.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O
M;6%N.R!&3TY4+5-)6D4Z(#$P<'0[(%1%6%0M04Q)1TXZ(')I9VAT)R!V86QI
M9VX],T1B;W1T;VT@=VED=&@],T0Y)3XR,2PP,#(\+W1D/B`\=&0@<W1Y;&4]
M,T0G5$585"U!3$E'3CH@;&5F="<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$
M,24@;F]W<F%P/3-$;F]W<F%P/CQF;VYT('-T>6QE/3-$)T9/3E0M4TE:13H@
M,3!P=#L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1$E34$Q!63H@
M:6YL:6YE)SX@)FYB<W`[/"]F;VYT/B`\+W1D/B`\=&0@=F%L:6=N/3-$8F]T
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M<W`[/"]F;VYT/B`\+W1D/B`\=&0@<W1Y;&4],T0G1$E34$Q!63H@:6YL:6YE
M.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!&3TY4+5-)6D4Z(#$P
M<'0[(%1%6%0M04Q)1TXZ(')I9VAT)R!V86QI9VX],T1B;W1T;VT@=VED=&@]
M,T0Y)3XQ-2PX,#4\+W1D/B`\=&0@<W1Y;&4],T0G5$585"U!3$E'3CH@;&5F
M="<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@;F]W<F%P/3-$;F]W<F%P
M/CQF;VYT('-T>6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ
M('1I;65S(&YE=R!R;VUA;CL@1$E34$Q!63H@:6YL:6YE)SX@)FYB<W`[/"]F
M;VYT/B`\+W1D/B`\+W1R/B`\='(@8F=C;VQO<CTS1"-C8V5E9F8^(#QT9"!S
M='EL93TS1"=0041$24Y'+4)/5%1/33H@,G!X)R!V86QI9VX],T1B;W1T;VT@
M=VED=&@],T0W-B4^(#QD:78@<W1Y;&4],T0G1$E34$Q!63H@8FQO8VL[($9/
M3E0M1D%-24Q9.B!T:6UE<R!N97<@<F]M86X[($9/3E0M4TE:13H@,3!P=#L@
M34%21TE.+4Q%1E0Z(#EP=#L@34%21TE.+5))1TA4.B`P<'0[('1E>'0M86QI
M9VXZ(&IU<W1I9GD[(%1%6%0M24Y$14Y4.B`M.7!T)SX@5F%L=6%T:6]N(&%L
M;&]W86YC93PO9&EV/B`\+W1D/B`\=&0@<W1Y;&4],T0G4$%$1$E.1RU"3U14
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M=&]M('=I9'1H/3-$,24^/&9O;G0@<W1Y;&4],T0G1D].5"U325I%.B`Q,'!T
M.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!$25-03$%9.B!I;FQI
M;F4G/B`F;F)S<#L\+V9O;G0^(#PO=&0^(#QT9"!S='EL93TS1"="3U)$15(M
M0D]45$]-.B!B;&%C:R`R<'@@<V]L:60[($1)4U!,05DZ(&EN;&EN93L@1D].
M5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T.R!4
M15A4+4%,24=..B!R:6=H="<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$.24^
M*#(Q+#`P,CPO=&0^(#QT9"!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/
M3E0M1D%-24Q9.B!T:6UE<R!N97<@<F]M86X[($9/3E0M4TE:13H@,3!P=#L@
M4$%$1$E.1RU"3U143TTZ(#)P>#L@5$585"U!3$E'3CH@;&5F="<@=F%L:6=N
M/3-$8F]T=&]M('=I9'1H/3-$,24@;F]W<F%P/3-$;F]W<F%P/BD\+W1D/B`\
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M<W1Y;&4],T0G1D].5"U325I%.B`Q,'!T.R!&3TY4+49!34E,63H@=&EM97,@
M;F5W(')O;6%N.R!$25-03$%9.B!I;FQI;F4G/B`F;F)S<#L\+V9O;G0^(#PO
M=&0^(#QT9"!S='EL93TS1"="3U)$15(M0D]45$]-.B!B;&%C:R`R<'@@<V]L
M:60[($1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R
M;VUA;CL@1D].5"U325I%.B`Q,'!T.R!415A4+4%,24=..B!R:6=H="<@=F%L
M:6=N/3-$8F]T=&]M('=I9'1H/3-$.24^*#$U+#@P-3PO=&0^(#QT9"!S='EL
M93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE<R!N97<@
M<F]M86X[($9/3E0M4TE:13H@,3!P=#L@4$%$1$E.1RU"3U143TTZ(#)P>#L@
M5$585"U!3$E'3CH@;&5F="<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@
M;F]W<F%P/3-$;F]W<F%P/BD\+W1D/B`\+W1R/B`\='(@8F=C;VQO<CTS1'=H
M:71E/B`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$-S8E/CQF;VYT('-T
M>6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ('1I;65S(&YE
M=R!R;VUA;CL@1$E34$Q!63H@:6YL:6YE)SX@)FYB<W`[/"]F;VYT/B`\+W1D
M/B`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24^/&9O;G0@<W1Y;&4]
M,T0G1D].5"U325I%.B`Q,'!T.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O
M;6%N.R!$25-03$%9.B!I;FQI;F4G/B`F;F)S<#L\+V9O;G0^(#PO=&0^(#QT
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M4$Q!63H@:6YL:6YE)SX@)FYB<W`[/"]F;VYT/B`\+W1D/B`\=&0@<W1Y;&4]
M,T0G5$585"U!3$E'3CH@;&5F="<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$
M,24^/&9O;G0@<W1Y;&4],T0G1D].5"U325I%.B`Q,'!T.R!&3TY4+49!34E,
M63H@=&EM97,@;F5W(')O;6%N.R!$25-03$%9.B!I;FQI;F4G/B`F;F)S<#L\
M+V9O;G0^(#PO=&0^(#QT9"!S='EL93TS1"=415A4+4%,24=..B!R:6=H="<@
M=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$.24^/&9O;G0@<W1Y;&4],T0G1D].
M5"U325I%.B`Q,'!T.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!$
M25-03$%9.B!I;FQI;F4G/B`F;F)S<#L\+V9O;G0^(#PO=&0^(#QT9"!S='EL
M93TS1"=415A4+4%,24=..B!L969T)R!V86QI9VX],T1B;W1T;VT@=VED=&@]
M,T0Q)2!N;W=R87`],T1N;W=R87`^/&9O;G0@<W1Y;&4],T0G1D].5"U325I%
M.B`Q,'!T.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!$25-03$%9
M.B!I;FQI;F4G/B`F;F)S<#L\+V9O;G0^(#PO=&0^(#PO='(^(#QT<B!B9V-O
M;&]R/3-$(V-C965F9CX@/'1D('-T>6QE/3-$)U!!1$1)3D<M0D]45$]-.B`T
M<'@G('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#<V)3X@/&1I=B!S='EL93TS
M1"=$25-03$%9.B!B;&]C:SL@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA
M;CL@1D].5"U325I%.B`Q,'!T.R!-05)'24XM3$5&5#H@.7!T.R!-05)'24XM
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M1$E34$Q!63H@:6YL:6YE)SX@)FYB<W`[/"]F;VYT/B`\+W1D/B`\=&0@<W1Y
M;&4],T0G0D]21$52+4)/5%1/33H@8FQA8VL@-'!X(&1O=6)L93L@1$E34$Q!
M63H@:6YL:6YE.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!&3TY4
M+5-)6D4Z(#$P<'0[(%1%6%0M04Q)1TXZ(&QE9G0G('9A;&EG;CTS1&)O='1O
M;2!W:61T:#TS1#$E/B0\+W1D/B`\=&0@<W1Y;&4],T0G0D]21$52+4)/5%1/
M33H@8FQA8VL@-'!X(&1O=6)L93L@1$E34$Q!63H@:6YL:6YE.R!&3TY4+49!
M34E,63H@=&EM97,@;F5W(')O;6%N.R!&3TY4+5-)6D4Z(#$P<'0[(%1%6%0M
M04Q)1TXZ(')I9VAT)R!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Y)3XM/"]T
M9#X@/'1D('-T>6QE/3-$)U!!1$1)3D<M0D]45$]-.B`T<'@[(%1%6%0M04Q)
M1TXZ(&QE9G0G('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E(&YO=W)A<#TS
M1&YO=W)A<#X\9F]N="!S='EL93TS1"=&3TY4+5-)6D4Z(#$P<'0[($9/3E0M
M1D%-24Q9.B!T:6UE<R!N97<@<F]M86X[($1)4U!,05DZ(&EN;&EN92<^("9N
M8G-P.SPO9F]N=#X@/"]T9#X@/'1D('-T>6QE/3-$)U!!1$1)3D<M0D]45$]-
M.B`T<'@G('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E(&%L:6=N/3-$<FEG
M:'0^/&9O;G0@<W1Y;&4],T0G1D].5"U325I%.B`Q,'!T.R!&3TY4+49!34E,
M63H@=&EM97,@;F5W(')O;6%N.R!$25-03$%9.B!I;FQI;F4G/B`F;F)S<#L\
M+V9O;G0^(#PO=&0^(#QT9"!S='EL93TS1"="3U)$15(M0D]45$]-.B!B;&%C
M:R`T<'@@9&]U8FQE.R!$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T
M:6UE<R!N97<@<F]M86X[($9/3E0M4TE:13H@,3!P=#L@5$585"U!3$E'3CH@
M;&5F="<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24^)#PO=&0^(#QT9"!S
M='EL93TS1"="3U)$15(M0D]45$]-.B!B;&%C:R`T<'@@9&]U8FQE.R!$25-0
M3$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE<R!N97<@<F]M86X[($9/
M3E0M4TE:13H@,3!P=#L@5$585"U!3$E'3CH@<FEG:'0G('9A;&EG;CTS1&)O
M='1O;2!W:61T:#TS1#DE/BT\+W1D/B`\=&0@<W1Y;&4],T0G4$%$1$E.1RU"
M3U143TTZ(#1P>#L@5$585"U!3$E'3CH@;&5F="<@=F%L:6=N/3-$8F]T=&]M
M('=I9'1H/3-$,24@;F]W<F%P/3-$;F]W<F%P/CQF;VYT('-T>6QE/3-$)T9/
M3E0M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@
M1$E34$Q!63H@:6YL:6YE)SX@)FYB<W`[/"]F;VYT/B`\+W1D/B`\+W1R/B`\
M+W1A8FQE/B`\+V1I=CX@/"$M+45N9$9R86=M96YT+2T^/"]D:78^(#PO9&EV
M/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@("`\+W1A8FQE
M/@T*("`\+V)O9'D^#0H\+VAT;6P^#0H-"BTM+2TM+3U?3F5X=%!A<G1?,&-A
M9#4Y9F1?-S,R95\T-F4R7V$U,S1?,&,X860Q868Y,&1D#0I#;VYT96YT+4QO
M8V%T:6]N.B!F:6QE.B\O+T,Z+S!C860U.69D7S<S,F5?-#9E,E]A-3,T7S!C
M.&%D,6%F.3!D9"]7;W)K<VAE971S+U-H965T,CDN:'1M;`T*0V]N=&5N="U4
M<F%N<V9E<BU%;F-O9&EN9SH@<75O=&5D+7!R:6YT86)L90T*0V]N=&5N="U4
M>7!E.B!T97AT+VAT;6P[(&-H87)S970](G5S+6%S8VEI(@T*#0H\:'1M;#X-
M"B`@/&AE860^#0H@("`@/$U%5$$@:'1T<"UE<75I=CTS1$-O;G1E;G0M5'EP
M92!C;VYT96YT/3-$)W1E>'0O:'1M;#L@8VAA<G-E=#UU=&8M."<^/'-C<FEP
M="!T>7!E/3-$=&5X="]J879A<V-R:7!T('-R8STS1%-H;W<N:G,^+RH@1&\@
M3F]T(%)E;6]V92!4:&ES($-O;6UE;G0@*B\\+W-C<FEP=#X\+VAE860^#0H@
M(#QB;V1Y/@T*("`@(#QT86)L92!C;&%S<STS1')E<&]R="!I9#TS1$E$,$5%
M44%%/@T*("`@("`@/'1R/@T*("`@("`@("`\=&@@8VQA<W,],T1T;"!C;VQS
M<&%N/3-$,2!R;W=S<&%N/3-$,CX\<W1R;VYG/D=%3D5204P@*$1E=&%I;',I
M("A54T0@)"D\8G(^26X@5&AO=7-A;F1S+"!E>&-E<'0@4VAA<F4@9&%T82P@
M=6YL97-S(&]T:&5R=VES92!S<&5C:69I960\+W-T<F]N9SX\+W1H/@T*("`@
M("`@("`\=&@@8VQA<W,],T1T:"!C;VQS<&%N/3-$,3XQ($UO;G1H<R!%;F1E
M9#PO=&@^#0H@("`@("`@(#QT:"!C;&%S<STS1'1H(&-O;'-P86X],T0S/C$R
M($UO;G1H<R!%;F1E9#PO=&@^#0H@("`@("`\+W1R/@T*("`@("`@/'1R/@T*
M("`@("`@("`\=&@@8VQA<W,],T1T:#Y!=6<N(#,Q+"`R,#$Q/&)R/CPO=&@^
M#0H@("`@("`@(#QT:"!C;&%S<STS1'1H/DIU;BX@,S`L(#(P,30\8G(^/"]T
M:#X-"B`@("`@("`@/'1H(&-L87-S/3-$=&@^2G5N+B`S,"P@,C`Q,SQB<CX\
M+W1H/@T*("`@("`@("`\=&@@8VQA<W,],T1T:#Y*=6XN(#,P+"`R,#$R/&)R
M/CPO=&@^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$<F4^#0H@
M("`@("`@(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O<#X\<W1R;VYG/D=%
M3D5204P@6T%B<W1R86-T73PO<W1R;VYG/CPO=&0^#0H@("`@("`@(#QT9"!C
M;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@
M8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D
M(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT
M9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T
M<CX-"B`@("`@(#QT<B!C;&%S<STS1')O/@T*("`@("`@("`\=&0@8VQA<W,]
M,T1P;"!V86QI9VX],T1T;W`^06-C=6UU;&%T960@9&5F:6-I=#PO=&0^#0H@
M("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*
M("`@("`@("`\=&0@8VQA<W,],T1N=6T^)"`H,3$S+#@S-"D\<W!A;CX\+W-P
M86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M/B0@*#@V+#DP,BD\
M<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG
M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L
M87-S/3-$<F4^#0H@("`@("`@(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O
M<#Y.970@;&]S<SPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS
M<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6T^*#(V
M+#DS,BD\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$
M;G5M/B@R,2PQ-34I/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C
M;&%S<STS1&YU;3XH,30L-SDT*3QS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@
M/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS1')O/@T*("`@("`@("`\=&0@8VQA
M<W,],T1P;"!V86QI9VX],T1T;W`^57!F<F]N="!P87EM96YT(')E8V5I=F5D
M/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XW+#`P,#QS<&%N/CPO
M<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\
M+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^
M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N
M/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS
M1')E/@T*("`@("`@("`\=&0@8VQA<W,],T1P;"!V86QI9VX],T1T;W`^3F]N
M<F5F=6YD86)L92!P87EM96YT<R!R96-E:79E9#PO=&0^#0H@("`@("`@(#QT
M9"!C;&%S<STS1&YU;7`^-2PP,#`\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@
M("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@
M("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@
M("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@
M("`@(#PO='(^#0H@("`@("`\='(@8VQA<W,],T1R;SX-"B`@("`@("`@/'1D
M(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P/D%D=F%N8V4@<&%Y;65N="!O;B!T
M:&4@9&5V96QO<&UE;G0\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6UP
M/C(L,#`P/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS
M1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,]
M,T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S
M/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@
M("`@/'1R(&-L87-S/3-$<F4^#0H@("`@("`@(#QT9"!C;&%S<STS1'!L('9A
M;&EG;CTS1'1O<#Y-:6QE<W1O;F4@<F5V96YU92!R96-E:79A8FQE/"]T9#X-
M"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^
M#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;7`^,S<L-3`P/'-P86X^/"]S<&%N
M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A
M;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P
M86X^/"]T9#X-"B`@("`@(#PO='(^#0H@("`@("`\='(@8VQA<W,],T1R;SX-
M"B`@("`@("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P/E)E:6UB=7)S
M96UE;G0@<F5V96YU92!R96-E:79A8FQE/"]T9#X-"B`@("`@("`@/'1D(&-L
M87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C
M;&%S<STS1&YU;7`^,3`L,#`P/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@
M(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@
M("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@
M(#PO='(^#0H@("`@("`\='(@8VQA<W,],T1R93X-"B`@("`@("`@/'1D(&-L
M87-S/3-$<&P@=F%L:6=N/3-$=&]P/DES<W5A;F-E(&]F(&-O;6UO;B!S=&]C
M:R!U;F1E<B!#2$$@86=R965M96YT/"]T9#X-"B`@("`@("`@/'1D(&-L87-S
M/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S
M<STS1&YU;7`^,BPU,#`L,#`P/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@
M(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@
M("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@
M(#PO='(^#0H@("`@("`\='(@8VQA<W,],T1R;SX-"B`@("`@("`@/'1D(&-L
M87-S/3-$<&P@=F%L:6=N/3-$=&]P/D-(02!S:&%R97,@8VQA<W-I9FEE9"!A
M<R!M87)K971A8FQE('-E8W5R:71I97,\+W1D/@T*("`@("`@("`\=&0@8VQA
M<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L
M87-S/3-$;G5M<#XQ+#`Q,2PU,#0\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@
M("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@
M("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@
M("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS1')E/@T*("`@("`@("`\=&0@
M8VQA<W,],T1P;"!V86QI9VX],T1T;W`^5&]T86P@8V]N<VED97)A=&EO;B!R
M969L96-T960@=6YD97(@=&AE($-(02!A9W)E96UE;G0\+W1D/@T*("`@("`@
M("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@
M("`@/'1D(&-L87-S/3-$;G5M<#XD(#$P+#0Q-#QS<&%N/CPO<W!A;CX\+W1D
M/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T
M9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO
M=&0^#0H@("`@("`\+W1R/@T*("`@(#PO=&%B;&4^#0H@(#PO8F]D>3X-"CPO
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M8VAA<G-E=#TB=7,M87-C:6DB#0H-"CQH=&UL/@T*("`\:&5A9#X-"B`@("`\
M345402!H='1P+65Q=6EV/3-$0V]N=&5N="U4>7!E(&-O;G1E;G0],T0G=&5X
M="]H=&UL.R!C:&%R<V5T/75T9BTX)SX\<V-R:7!T('1Y<&4],T1T97AT+VIA
M=F%S8W)I<'0@<W)C/3-$4VAO=RYJ<SXO*B!$;R!.;W0@4F5M;W9E(%1H:7,@
M0V]M;65N="`J+SPO<V-R:7!T/CPO:&5A9#X-"B`@/&)O9'D^#0H@("`@/'1A
M8FQE(&-L87-S/3-$<F5P;W)T(&ED/3-$240P14-!0D<^#0H@("`@("`\='(^
M#0H@("`@("`@(#QT:"!C;&%S<STS1'1L(&-O;'-P86X],T0Q(')O=W-P86X]
M,T0R/CQS=')O;F<^4TE'3DE&24-!3E0@04-#3U5.5$E.1R!03TQ)0TE%4R`H
M3F%R<F%T:79E*2`H1&5T86EL<RD@*%531"`D*3QB<CY);B!4:&]U<V%N9',L
M(&5X8V5P="!097(@4VAA<F4@9&%T82P@=6YL97-S(&]T:&5R=VES92!S<&5C
M:69I960\+W-T<F]N9SX\+W1H/@T*("`@("`@("`\=&@@8VQA<W,],T1T:"!C
M;VQS<&%N/3-$,SXQ,B!-;VYT:',@16YD960\+W1H/@T*("`@("`@/"]T<CX-
M"B`@("`@(#QT<CX-"B`@("`@("`@/'1H(&-L87-S/3-$=&@^2G5N+B`S,"P@
M,C`Q-#QB<CX\+W1H/@T*("`@("`@("`\=&@@8VQA<W,],T1T:#Y*=6XN(#,P
M+"`R,#$S/&)R/CPO=&@^#0H@("`@("`@(#QT:"!C;&%S<STS1'1H/DIU;BX@
M,S`L(#(P,3(\8G(^/"]T:#X-"B`@("`@(#PO='(^#0H@("`@("`\='(@8VQA
M<W,],T1R93X-"B`@("`@("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P
M/CQS=')O;F<^4VAA<F4M8F%S960@0V]M<&5N<V%T:6]N($%R<F%N9V5M96YT
M(&)Y(%-H87)E+6)A<V5D(%!A>6UE;G0@07=A<F0@6TQI;F4@271E;7-=/"]S
M=')O;F<^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^
M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N
M/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A
M;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO='(^#0H@("`@("`\='(@8VQA<W,]
M,T1R;SX-"B`@("`@("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P/D=R
M86YT960L('=E:6=H=&5D+6%V97)A9V4@9W)A;G0@9&%T92!F86ER('9A;'5E
M/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XD(#,N-3,\<W!A;CX\
M+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XD(#,N-#,\
M<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XD
M(#(N-30\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO='(^#0H@("`@("`\
M='(@8VQA<W,],T1R93X-"B`@("`@("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N
M/3-$=&]P/E-E=F5R86YC92!E>'!E;G-E<SPO=&0^#0H@("`@("`@(#QT9"!C
M;&%S<STS1&YU;7`^)"`U,S0\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@
M/'1D(&-L87-S/3-$;G5M<#XD(#,R.3QS<&%N/CPO<W!A;CX\+W1D/@T*("`@
M("`@("`\=&0@8VQA<W,],T1N=6UP/B0@,C<U/'-P86X^/"]S<&%N/CPO=&0^
M#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$<F\^#0H@("`@("`@
M(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O<#Y'86EN<R`H;&]S<V5S*2!O
M;B!O=&AE<B!D97)I=F%T:79E<SPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS
M1&YU;3XH-S`I/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S
M<STS1&YU;7`^,C,Q/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C
M;&%S<STS1&YU;3XH,30U*3QS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T
M<CX-"B`@("`@(#QT<B!C;&%S<STS1')E/@T*("`@("`@("`\=&0@8VQA<W,]
M,T1P;"!V86QI9VX],T1T;W`^/'-T<F]N9SY$969E<G)E9"!2979E;G5E($%R
M<F%N9V5M96YT(%M,:6YE($ET96US73PO<W1R;VYG/CPO=&0^#0H@("`@("`@
M(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@
M("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@
M("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@
M("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$<F\^#0H@("`@("`@(#QT9"!C
M;&%S<STS1'!L('9A;&EG;CTS1'1O<#Y$969E<G)E9"!R979E;G5E/"]T9#X-
M"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XU+#`P,#QS<&%N/CPO<W!A;CX\
M+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^
M/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N
M/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$<F4^#0H@
M("`@("`@(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O<#Y#;VYT:6YG96YT
M(&-O;G-I9&5R871I;VX@<F5C96EV86)L92!I9B!C97)T86EN(')E9W5L871O
M<GD@;6EL97-T;VYE<R!A<F4@<F5A8VAE9#PO=&0^#0H@("`@("`@(#QT9"!C
M;&%S<STS1&YU;7`^,S<L-3`P/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@
M(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@
M("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@
M(#PO='(^#0H@("`@("`\='(@8VQA<W,],T1R;SX-"B`@("`@("`@/'1D(&-L
M87-S/3-$<&P@=F%L:6=N/3-$=&]P/E)E;6%I;FEN9R!R979E;G5E(')E8V]G
M;FET:6]N('!E<FEO9#PO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^
M)S@@>65A<G,@-B!M;VYT:',\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@
M/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@
M(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@
M/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS1')E/@T*("`@("`@("`\=&0@8VQA
M<W,],T1P;"!V86QI9VX],T1T;W`^061V86YC92!P87EM96YT(&9O<B!D979E
M;&]P;65N="!C;W-T<SPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;7`^
M,BPP,#`\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$
M=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS
M1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@("`@
M(#QT<B!C;&%S<STS1')O/@T*("`@("`@("`\=&0@8VQA<W,],T1P;"!V86QI
M9VX],T1T;W`^5&]T86P@9&5D=6-T:6]N(&9R;VT@861V86YC960@<&%Y;65N
M=#PO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;7`^,2PW-3,\<W!A;CX\
M+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^
M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N
M/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS
M1')H/@T*("`@("`@("`\=&0@8VQA<W,],T1P;"!V86QI9VX],T1T;W`^1F]R
M=V%R9"!C;VYT<F%C=',@6TUE;6)E<ET@?"!$97-I9VYA=&5D(&%S($AE9&=I
M;F<@26YS=')U;65N="!;365M8F5R72!\($ES<F%E;"P@3F5W(%-H96ME;',@
M6TUE;6)E<ET\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A
M;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P
M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS
M<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S
M<STS1')O/@T*("`@("`@("`\=&0@8VQA<W,],T1P;"!V86QI9VX],T1T;W`^
M/'-T<F]N9SY3:&%R92UB87-E9"!#;VUP96YS871I;VX@07)R86YG96UE;G0@
M8GD@4VAA<F4M8F%S960@4&%Y;65N="!!=V%R9"!;3&EN92!)=&5M<UT\+W-T
M<F]N9SX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\
M+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^
M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N
M/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS
M1')E/@T*("`@("`@("`\=&0@8VQA<W,],T1P;"!V86QI9VX],T1T;W`^3F]T
M:6]N86P@86UO=6YT/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XR
M+#@R,#QS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T
M97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$
M=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@
M/'1R(&-L87-S/3-$<F\^#0H@("`@("`@(#QT9"!C;&%S<STS1'!L('9A;&EG
M;CTS1'1O<#Y.970@=6YR96%L:7IE9"!G86EN(&]N('1H92!E9F9E8W1I=F4@
M<&]R=&EO;CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;7`^,C,\<W!A
M;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P
M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS
M<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S
M<STS1')E/@T*("`@("`@("`\=&0@8VQA<W,],T1P;"!V86QI9VX],T1T;W`^
M3F5T(&=A:6XL(')E<W5L=&EN9R!I;B!T:&4@8V%S:"!F;&]W(&AE9&=E('1R
M86YS86-T:6]N<SPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;7`^-#@\
M<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG
M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^
M)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<B!C
M;&%S<STS1')O/@T*("`@("`@("`\=&0@8VQA<W,],T1P;"!V86QI9VX],T1T
M;W`^1F%I<B!V86QU92!O9B!C87-H(&9L;W<@:&5D9V4@9&5R:79A=&EV97,\
M+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6UP/C(T/'-P86X^/"]S<&%N
M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A
M;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P
M86X^/"]T9#X-"B`@("`@(#PO='(^#0H@("`@("`\='(@8VQA<W,],T1R:#X-
M"B`@("`@("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P/D9O<G=A<F0@
M8V]N=')A8W1S(%M-96UB97)=('P@1&5S:6=N871E9"!A<R!(961G:6YG($EN
M<W1R=6UE;G0@6TUE;6)E<ET@?"!+;W)E86X@5V]N(%M-96UB97)=/"]T9#X-
M"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^
M#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D
M/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T
M9#X-"B`@("`@(#PO='(^#0H@("`@("`\='(@8VQA<W,],T1R;SX-"B`@("`@
M("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P/CQS=')O;F<^4VAA<F4M
M8F%S960@0V]M<&5N<V%T:6]N($%R<F%N9V5M96YT(&)Y(%-H87)E+6)A<V5D
M(%!A>6UE;G0@07=A<F0@6TQI;F4@271E;7-=/"]S=')O;F<^/"]T9#X-"B`@
M("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@
M("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*
M("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-
M"B`@("`@(#PO='(^#0H@("`@("`\='(@8VQA<W,],T1R93X-"B`@("`@("`@
M/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P/DYO=&EO;F%L(&%M;W5N=#PO
M=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;7`^,3$L,#`P/'-P86X^/"]S
M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO
M<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\
M+W-P86X^/"]T9#X-"B`@("`@(#PO='(^#0H@("`@("`\='(@8VQA<W,],T1R
M;SX-"B`@("`@("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P/D9A:7(@
M=F%L=64@;V8@9F%I<B!V86QU92!H961G92!D97)I=F%T:79E<SPO=&0^#0H@
M("`@("`@(#QT9"!C;&%S<STS1&YU;3XD("@X.#DI/'-P86X^/"]S<&%N/CPO
M=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\
M+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^
M/"]T9#X-"B`@("`@(#PO='(^#0H@("`@("`\='(@8VQA<W,],T1R:#X-"B`@
M("`@("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P/D5M<&QO>65E<R!;
M365M8F5R73PO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N
M/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A
M;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P
M86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S
M/3-$<F\^#0H@("`@("`@(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O<#X\
M<W1R;VYG/E-H87)E+6)A<V5D($-O;7!E;G-A=&EO;B!!<G)A;F=E;65N="!B
M>2!3:&%R92UB87-E9"!087EM96YT($%W87)D(%M,:6YE($ET96US73PO<W1R
M;VYG/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO
M<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\
M+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^
M/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$
M<F4^#0H@("`@("`@(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O<#Y&;W)F
M96ET=7)E(')A=&4\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6UP/C<N
M,#`E/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU
M;7`^-RXP,"4\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S
M/3-$;G5M<#XU+C`P)3QS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-
M"B`@("`@(#QT<B!C;&%S<STS1')H/@T*("`@("`@("`\=&0@8VQA<W,],T1P
M;"!V86QI9VX],T1T;W`^36%N86=E;65N="!;365M8F5R73PO=&0^#0H@("`@
M("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@
M("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@
M("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@
M("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$<F4^#0H@("`@("`@(#QT
M9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O<#X\<W1R;VYG/E-H87)E+6)A<V5D
M($-O;7!E;G-A=&EO;B!!<G)A;F=E;65N="!B>2!3:&%R92UB87-E9"!087EM
M96YT($%W87)D(%M,:6YE($ET96US73PO<W1R;VYG/CPO=&0^#0H@("`@("`@
M(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@
M("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@
M("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@
M("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$<F\^#0H@("`@("`@(#QT9"!C
M;&%S<STS1'!L('9A;&EG;CTS1'1O<#Y&;W)F96ET=7)E(')A=&4\+W1D/@T*
M("`@("`@("`\=&0@8VQA<W,],T1N=6UP/C`N,#`E/'-P86X^/"]S<&%N/CPO
M=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;7`^,"XP,"4\<W!A;CX\+W-P
M86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XP+C`P)3QS<&%N
M/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@("`\+W1A8FQE/@T*("`\
M+V)O9'D^#0H\+VAT;6P^#0H-"BTM+2TM+3U?3F5X=%!A<G1?,&-A9#4Y9F1?
M-S,R95\T-F4R7V$U,S1?,&,X860Q868Y,&1D#0I#;VYT96YT+4QO8V%T:6]N
M.B!F:6QE.B\O+T,Z+S!C860U.69D7S<S,F5?-#9E,E]A-3,T7S!C.&%D,6%F
M.3!D9"]7;W)K<VAE971S+U-H965T,S$N:'1M;`T*0V]N=&5N="U4<F%N<V9E
M<BU%;F-O9&EN9SH@<75O=&5D+7!R:6YT86)L90T*0V]N=&5N="U4>7!E.B!T
M97AT+VAT;6P[(&-H87)S970](G5S+6%S8VEI(@T*#0H\:'1M;#X-"B`@/&AE
M860^#0H@("`@/$U%5$$@:'1T<"UE<75I=CTS1$-O;G1E;G0M5'EP92!C;VYT
M96YT/3-$)W1E>'0O:'1M;#L@8VAA<G-E=#UU=&8M."<^/'-C<FEP="!T>7!E
M/3-$=&5X="]J879A<V-R:7!T('-R8STS1%-H;W<N:G,^+RH@1&\@3F]T(%)E
M;6]V92!4:&ES($-O;6UE;G0@*B\\+W-C<FEP=#X\+VAE860^#0H@(#QB;V1Y
M/@T*("`@(#QT86)L92!C;&%S<STS1')E<&]R="!I9#TS1$E$,$4R,D%%/@T*
M("`@("`@/'1R/@T*("`@("`@("`\=&@@8VQA<W,],T1T;"!C;VQS<&%N/3-$
M,2!R;W=S<&%N/3-$,CX\<W1R;VYG/E-)1TY)1DE#04Y4($%#0T]53E1)3D<@
M4$],24-)15,@*%-C:&5D=6QE(&]F(%!R;W!E<G1Y(&%N9"!%<75I<&UE;G0@
M1&5P<F5C:6%T:6]N(%)A=&4I("A$971A:6QS*3QB<CX\+W-T<F]N9SX\+W1H
M/@T*("`@("`@("`\=&@@8VQA<W,],T1T:"!C;VQS<&%N/3-$,3XQ,B!-;VYT
M:',@16YD960\+W1H/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<CX-"B`@("`@
M("`@/'1H(&-L87-S/3-$=&@^2G5N+B`S,"P@,C`Q-#QB<CX\+W1H/@T*("`@
M("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS1')H/@T*("`@("`@("`\=&0@
M8VQA<W,],T1P;"!V86QI9VX],T1T;W`^3&%B;W)A=&]R>2!E<75I<&UE;G0@
M6TUE;6)E<ET@?"!-:6YI;75M(%M-96UB97)=/"]T9#X-"B`@("`@("`@/'1D
M(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R
M/@T*("`@("`@/'1R(&-L87-S/3-$<F\^#0H@("`@("`@(#QT9"!C;&%S<STS
M1'!L('9A;&EG;CTS1'1O<#X\<W1R;VYG/E!R;W!E<G1Y+"!0;&%N="!A;F0@
M17%U:7!M96YT(%M,:6YE($ET96US73PO<W1R;VYG/CPO=&0^#0H@("`@("`@
M(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@
M/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS1')E/@T*("`@("`@("`\=&0@8VQA
M<W,],T1P;"!V86QI9VX],T1T;W`^1&5P<F5C:6%T:6]N(')A=&4\+W1D/@T*
M("`@("`@("`\=&0@8VQA<W,],T1N=6UP/C$P+C`P)3QS<&%N/CPO<W!A;CX\
M+W1D/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS1')H/@T*("`@
M("`@("`\=&0@8VQA<W,],T1P;"!V86QI9VX],T1T;W`^3&%B;W)A=&]R>2!E
M<75I<&UE;G0@6TUE;6)E<ET@?"!-87AI;75M(%M-96UB97)=/"]T9#X-"B`@
M("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@
M("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$<F4^#0H@("`@("`@(#QT
M9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O<#X\<W1R;VYG/E!R;W!E<G1Y+"!0
M;&%N="!A;F0@17%U:7!M96YT(%M,:6YE($ET96US73PO<W1R;VYG/CPO=&0^
M#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D
M/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS1')O/@T*("`@("`@
M("`\=&0@8VQA<W,],T1P;"!V86QI9VX],T1T;W`^1&5P<F5C:6%T:6]N(')A
M=&4\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6UP/C$U+C`P)3QS<&%N
M/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS
M1')H/@T*("`@("`@("`\=&0@8VQA<W,],T1P;"!V86QI9VX],T1T;W`^0V]M
M<'5T97)S(&%N9"!097)I<&AE<F%L($5Q=6EP;65N="!;365M8F5R73PO=&0^
M#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D
M/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS1')O/@T*("`@("`@
M("`\=&0@8VQA<W,],T1P;"!V86QI9VX],T1T;W`^/'-T<F]N9SY0<F]P97)T
M>2P@4&QA;G0@86YD($5Q=6EP;65N="!;3&EN92!)=&5M<UT\+W-T<F]N9SX\
M+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^
M/"]T9#X-"B`@("`@(#PO='(^#0H@("`@("`\='(@8VQA<W,],T1R93X-"B`@
M("`@("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P/D1E<')E8VEA=&EO
M;B!R871E/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XS,RXP,"4\
M<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO='(^#0H@("`@("`\='(@8VQA
M<W,],T1R:#X-"B`@("`@("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P
M/D]F9FEC92!&=7)N:71U<F4@86YD($5Q=6EP;65N="!;365M8F5R72!\($UI
M;FEM=6T@6TUE;6)E<ET\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT
M/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO='(^#0H@("`@("`\='(@
M8VQA<W,],T1R93X-"B`@("`@("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$
M=&]P/CQS=')O;F<^4')O<&5R='DL(%!L86YT(&%N9"!%<75I<&UE;G0@6TQI
M;F4@271E;7-=/"]S=')O;F<^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$
M=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@
M/'1R(&-L87-S/3-$<F\^#0H@("`@("`@(#QT9"!C;&%S<STS1'!L('9A;&EG
M;CTS1'1O<#Y$97!R96-I871I;VX@<F%T93PO=&0^#0H@("`@("`@(#QT9"!C
M;&%S<STS1&YU;7`^-BXP,"4\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO
M='(^#0H@("`@("`\='(@8VQA<W,],T1R:#X-"B`@("`@("`@/'1D(&-L87-S
M/3-$<&P@=F%L:6=N/3-$=&]P/D]F9FEC92!&=7)N:71U<F4@86YD($5Q=6EP
M;65N="!;365M8F5R72!\($UA>&EM=6T@6TUE;6)E<ET\+W1D/@T*("`@("`@
M("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@
M(#PO='(^#0H@("`@("`\='(@8VQA<W,],T1R;SX-"B`@("`@("`@/'1D(&-L
M87-S/3-$<&P@=F%L:6=N/3-$=&]P/CQS=')O;F<^4')O<&5R='DL(%!L86YT
M(&%N9"!%<75I<&UE;G0@6TQI;F4@271E;7-=/"]S=')O;F<^/"]T9#X-"B`@
M("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@
M("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$<F4^#0H@("`@("`@(#QT
M9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O<#Y$97!R96-I871I;VX@<F%T93PO
M=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;7`^,34N,#`E/'-P86X^/"]S
M<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$<F@^
M#0H@("`@("`@(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O<#Y696AI8VQE
M<R!;365M8F5R73PO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS
M<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S
M<STS1')E/@T*("`@("`@("`\=&0@8VQA<W,],T1P;"!V86QI9VX],T1T;W`^
M/'-T<F]N9SY0<F]P97)T>2P@4&QA;G0@86YD($5Q=6EP;65N="!;3&EN92!)
M=&5M<UT\+W-T<F]N9SX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT
M/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO='(^#0H@("`@("`\='(@
M8VQA<W,],T1R;SX-"B`@("`@("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$
M=&]P/D1E<')E8VEA=&EO;B!R871E/"]T9#X-"B`@("`@("`@/'1D(&-L87-S
M/3-$;G5M<#XQ-2XP,"4\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO='(^
M#0H@("`@("`\='(@8VQA<W,],T1R:#X-"B`@("`@("`@/'1D(&-L87-S/3-$
M<&P@=F%L:6=N/3-$=&]P/DQE87-E:&]L9"!);7!R;W9E;65N=',@3V8@3F5W
M($9A8VEL:71Y($-O;G-T<G5C=&EO;B!;365M8F5R73PO=&0^#0H@("`@("`@
M(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@
M/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS1')O/@T*("`@("`@("`\=&0@8VQA
M<W,],T1P;"!V86QI9VX],T1T;W`^/'-T<F]N9SY0<F]P97)T>2P@4&QA;G0@
M86YD($5Q=6EP;65N="!;3&EN92!)=&5M<UT\+W-T<F]N9SX\+W1D/@T*("`@
M("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@
M("`@(#PO='(^#0H@("`@("`\='(@8VQA<W,],T1R93X-"B`@("`@("`@/'1D
M(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P/D1E<')E8VEA=&EO;BP@;&5A<V5H
M;VQD/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG5&AE('-H;W)T
M97(@;V8@=&AE(&5X<&5C=&5D('5S969U;"!L:69E(&]R('1H92!R96%S;VYA
M8FQE(&%S<W5M960@=&5R;2!O9B!T:&4@;&5A<V4N/'-P86X^/"]S<&%N/CPO
M=&0^#0H@("`@("`\+W1R/@T*("`@(#PO=&%B;&4^#0H@(#PO8F]D>3X-"CPO
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M8VAA<G-E=#TB=7,M87-C:6DB#0H-"CQH=&UL/@T*("`\:&5A9#X-"B`@("`\
M345402!H='1P+65Q=6EV/3-$0V]N=&5N="U4>7!E(&-O;G1E;G0],T0G=&5X
M="]H=&UL.R!C:&%R<V5T/75T9BTX)SX\<V-R:7!T('1Y<&4],T1T97AT+VIA
M=F%S8W)I<'0@<W)C/3-$4VAO=RYJ<SXO*B!$;R!.;W0@4F5M;W9E(%1H:7,@
M0V]M;65N="`J+SPO<V-R:7!T/CPO:&5A9#X-"B`@/&)O9'D^#0H@("`@/'1A
M8FQE(&-L87-S/3-$<F5P;W)T(&ED/3-$240P155'04<^#0H@("`@("`\='(^
M#0H@("`@("`@(#QT:"!C;&%S<STS1'1L(&-O;'-P86X],T0Q(')O=W-P86X]
M,T0R/CQS=')O;F<^4TE'3DE&24-!3E0@04-#3U5.5$E.1R!03TQ)0TE%4R`H
M0V]M<')E:&5N<VEV92!);F-O;64I("A$971A:6QS*2`H55-$("0I/&)R/DEN
M(%1H;W5S86YD<RP@=6YL97-S(&]T:&5R=VES92!S<&5C:69I960\+W-T<F]N
M9SX\+W1H/@T*("`@("`@("`\=&@@8VQA<W,],T1T:"!C;VQS<&%N/3-$,SXQ
M,B!-;VYT:',@16YD960\+W1H/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<CX-
M"B`@("`@("`@/'1H(&-L87-S/3-$=&@^2G5N+B`S,"P@,C`Q-#QB<CX\+W1H
M/@T*("`@("`@("`\=&@@8VQA<W,],T1T:#Y*=6XN(#,P+"`R,#$S/&)R/CPO
M=&@^#0H@("`@("`@(#QT:"!C;&%S<STS1'1H/DIU;BX@,S`L(#(P,3(\8G(^
M/"]T:#X-"B`@("`@(#PO='(^#0H@("`@("`\='(@8VQA<W,],T1R93X-"B`@
M("`@("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P/CQS=')O;F<^06-C
M=6UU;&%T960@3W1H97(@0V]M<')E:&5N<VEV92!);F-O;64@*$QO<W,I(%M,
M:6YE($ET96US73PO<W1R;VYG/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS
M1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,]
M,T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S
M/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@
M("`@/'1R(&-L87-S/3-$<F\^#0H@("`@("`@(#QT9"!C;&%S<STS1'!L('9A
M;&EG;CTS1'1O<#Y"96=I;FYI;F<@8F%L86YC93PO=&0^#0H@("`@("`@(#QT
M9"!C;&%S<STS1&YU;7`^)"`R-3D\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@
M("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@
M("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@
M("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS1')E/@T*("`@("`@("`\=&0@
M8VQA<W,],T1P;"!V86QI9VX],T1T;W`^3W1H97(@8V]M<')E:&5N<VEV92!I
M;F-O;64@8F5F;W)E(')E8VQA<W-I9FEC871I;VYS/"]T9#X-"B`@("`@("`@
M/'1D(&-L87-S/3-$;G5M<#XS+#0R-SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@
M("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@
M("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@
M("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$<F\^#0H@("`@("`@(#QT
M9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O<#Y!;6]U;G1S(')E8VQA<W-I9FEE
M9"!F<F]M(&%C8W5M=6QA=&5D(&]T:&5R(&-O;7!R96AE;G-I=F4@;&]S<SPO
M=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;3XH-S(W*3QS<&%N/CPO<W!A
M;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P
M86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S
M<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$<F5U
M/@T*("`@("`@("`\=&0@8VQA<W,],T1P;"!V86QI9VX],T1T;W`^3F5T(&-U
M<G)E;G0M<&5R:6]D(&]T:&5R(&-O;7!R96AE;G-I=F4@:6YC;VUE/"]T9#X-
M"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XR+#<P,#QS<&%N/CPO<W!A;CX\
M+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6UP/C,X.3QS<&%N/CPO<W!A
M;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6T^*#$S,"D\<W!A;CX\
M+W-P86X^/"]T9#X-"B`@("`@(#PO='(^#0H@("`@("`\='(@8VQA<W,],T1R
M;SX-"B`@("`@("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P/D5N9&EN
M9R!B86QA;F-E/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XR+#DU
M.3QS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6UP
M/C(U.3QS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T
M97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO='(^#0H@("`@("`\
M='(@8VQA<W,],T1R:#X-"B`@("`@("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N
M/3-$=&]P/E5N<F5A;&EZ960@1V%I;G,@;VX@36%R:V5T86)L92!396-U<FET
M:65S(%M-96UB97)=/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG
M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^
M)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT
M/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO='(^#0H@("`@("`\='(@
M8VQA<W,],T1R;SX-"B`@("`@("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$
M=&]P/CQS=')O;F<^06-C=6UU;&%T960@3W1H97(@0V]M<')E:&5N<VEV92!)
M;F-O;64@*$QO<W,I(%M,:6YE($ET96US73PO<W1R;VYG/CPO=&0^#0H@("`@
M("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@
M("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@
M("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@
M("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$<F4^#0H@("`@("`@(#QT
M9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O<#Y"96=I;FYI;F<@8F%L86YC93PO
M=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;7`^,C4Y/'-P86X^/"]S<&%N
M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A
M;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P
M86X^/"]T9#X-"B`@("`@(#PO='(^#0H@("`@("`\='(@8VQA<W,],T1R;SX-
M"B`@("`@("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P/D]T:&5R(&-O
M;7!R96AE;G-I=F4@:6YC;VUE(&)E9F]R92!R96-L87-S:69I8V%T:6]N<SPO
M=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;7`^,RPT,#0\<W!A;CX\+W-P
M86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S
M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO
M<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS1')E
M/@T*("`@("`@("`\=&0@8VQA<W,],T1P;"!V86QI9VX],T1T;W`^06UO=6YT
M<R!R96-L87-S:69I960@9G)O;2!A8V-U;75L871E9"!O=&AE<B!C;VUP<F5H
M96YS:79E(&QO<W,\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6T^*#<R
M-RD\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X
M=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E
M>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@("`@(#QT
M<B!C;&%S<STS1')O=3X-"B`@("`@("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N
M/3-$=&]P/DYE="!C=7)R96YT+7!E<FEO9"!O=&AE<B!C;VUP<F5H96YS:79E
M(&EN8V]M93PO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;7`^,BPV-S<\
M<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG
M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^
M)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<B!C
M;&%S<STS1')E/@T*("`@("`@("`\=&0@8VQA<W,],T1P;"!V86QI9VX],T1T
M;W`^16YD:6YG(&)A;&%N8V4\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N
M=6UP/C(L.3,V/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S
M<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA
M<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO='(^#0H@
M("`@("`\='(@8VQA<W,],T1R:#X-"B`@("`@("`@/'1D(&-L87-S/3-$<&P@
M=F%L:6=N/3-$=&]P/E5N<F5A;&EZ960@1V%I;G,@;VX@0V%S:"!&;&]W($AE
M9&=E<R!;365M8F5R73PO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^
M)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT
M/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X
M=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R
M(&-L87-S/3-$<F4^#0H@("`@("`@(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS
M1'1O<#X\<W1R;VYG/D%C8W5M=6QA=&5D($]T:&5R($-O;7!R96AE;G-I=F4@
M26YC;VUE("A,;W-S*2!;3&EN92!)=&5M<UT\+W-T<F]N9SX\+W1D/@T*("`@
M("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@
M("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@
M("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*
M("`@("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS1')O/@T*("`@("`@("`\
M=&0@8VQA<W,],T1P;"!V86QI9VX],T1T;W`^0F5G:6YN:6YG(&)A;&%N8V4\
M+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<F;F)S<#LF;F)S<#L\
M<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG
M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^
M)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<B!C
M;&%S<STS1')E/@T*("`@("`@("`\=&0@8VQA<W,],T1P;"!V86QI9VX],T1T
M;W`^3W1H97(@8V]M<')E:&5N<VEV92!I;F-O;64@8F5F;W)E(')E8VQA<W-I
M9FEC871I;VYS/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XR,SQS
M<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\
M<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG
M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L
M87-S/3-$<F\^#0H@("`@("`@(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O
M<#Y!;6]U;G1S(')E8VQA<W-I9FEE9"!F<F]M(&%C8W5M=6QA=&5D(&]T:&5R
M(&-O;7!R96AE;G-I=F4@;&]S<SPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS
M1'1E>'0^)R9N8G-P.R9N8G-P.SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@
M("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@
M("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@
M("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$<F5U/@T*("`@("`@("`\=&0@
M8VQA<W,],T1P;"!V86QI9VX],T1T;W`^3F5T(&-U<G)E;G0M<&5R:6]D(&]T
M:&5R(&-O;7!R96AE;G-I=F4@:6YC;VUE/"]T9#X-"B`@("`@("`@/'1D(&-L
M87-S/3-$;G5M<#XR,SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@
M8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D
M(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R
M/@T*("`@("`@/'1R(&-L87-S/3-$<F\^#0H@("`@("`@(#QT9"!C;&%S<STS
M1'!L('9A;&EG;CTS1'1O<#Y%;F1I;F<@8F%L86YC93PO=&0^#0H@("`@("`@
M(#QT9"!C;&%S<STS1&YU;7`^)"`R,SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@
M("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@
M("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@
M("`@("`\+W1R/@T*("`@(#PO=&%B;&4^#0H@(#PO8F]D>3X-"CPO:'1M;#X-
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M=#TB=7,M87-C:6DB#0H-"CQH=&UL/@T*("`\:&5A9#X-"B`@("`\345402!H
M='1P+65Q=6EV/3-$0V]N=&5N="U4>7!E(&-O;G1E;G0],T0G=&5X="]H=&UL
M.R!C:&%R<V5T/75T9BTX)SX\<V-R:7!T('1Y<&4],T1T97AT+VIA=F%S8W)I
M<'0@<W)C/3-$4VAO=RYJ<SXO*B!$;R!.;W0@4F5M;W9E(%1H:7,@0V]M;65N
M="`J+SPO<V-R:7!T/CPO:&5A9#X-"B`@/&)O9'D^#0H@("`@/'1A8FQE(&-L
M87-S/3-$<F5P;W)T(&ED/3-$240P14),0DD^#0H@("`@("`\='(^#0H@("`@
M("`@(#QT:"!C;&%S<STS1'1L(&-O;'-P86X],T0Q(')O=W-P86X],T0Q/CQS
M=')O;F<^34%22T5404),12!314-54DE42453("A38VAE9'5L92!O9B!!=F%I
M;&%B;&4M9F]R+7-A;&4@36%R:V5T86)L92!396-U<FET:65S*2`H1&5T86EL
M<RD@*%531"`D*3QB<CY);B!4:&]U<V%N9',L('5N;&5S<R!O=&AE<G=I<V4@
M<W!E8VEF:65D/"]S=')O;F<^/"]T:#X-"B`@("`@("`@/'1H(&-L87-S/3-$
M=&@^2G5N+B`S,"P@,C`Q-#QB<CX\+W1H/@T*("`@("`@("`\=&@@8VQA<W,]
M,T1T:#Y*=6XN(#,P+"`R,#$S/&)R/CPO=&@^#0H@("`@("`\+W1R/@T*("`@
M("`@/'1R(&-L87-S/3-$<F4^#0H@("`@("`@(#QT9"!C;&%S<STS1'!L('9A
M;&EG;CTS1'1O<#X\<W1R;VYG/E-C:&5D=6QE(&]F($%V86EL86)L92UF;W(M
M<V%L92!396-U<FET:65S(%M,:6YE($ET96US73PO<W1R;VYG/CPO=&0^#0H@
M("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*
M("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-
M"B`@("`@(#PO='(^#0H@("`@("`\='(@8VQA<W,],T1R;W4^#0H@("`@("`@
M(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O<#Y!;6]R=&EZ960@8V]S=#PO
M=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;7`^)"`R-RPP,C4\<W!A;CX\
M+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XD(#$S+#$X
M,CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<B!C
M;&%S<STS1')E/@T*("`@("`@("`\=&0@8VQA<W,],T1P;"!V86QI9VX],T1T
M;W`^1W)O<W,@=6YR96%L:7IE9"!G86EN/"]T9#X-"B`@("`@("`@/'1D(&-L
M87-S/3-$;G5M<#XR+#DV-3QS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\
M=&0@8VQA<W,],T1N=6UP/C4W,#QS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@
M/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS1')O/@T*("`@("`@("`\=&0@8VQA
M<W,],T1P;"!V86QI9VX],T1T;W`^1W)O<W,@=6YR96%L:7IE9"!L;W-S/"]T
M9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M/B@R.2D\<W!A;CX\+W-P86X^
M/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M/B@S,3$I/'-P86X^/"]S
M<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$<F4^
M#0H@("`@("`@(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O<#Y&86ER('9A
M;'5E/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XR.2PY-C$\<W!A
M;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XQ,RPT
M-#$\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO='(^#0H@("`@("`\='(@
M8VQA<W,],T1R:#X-"B`@("`@("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$
M=&]P/E=I=&AI;B!/;F4@665A<B!;365M8F5R73PO=&0^#0H@("`@("`@(#QT
M9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\
M=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO
M='(^#0H@("`@("`\='(@8VQA<W,],T1R93X-"B`@("`@("`@/'1D(&-L87-S
M/3-$<&P@=F%L:6=N/3-$=&]P/CQS=')O;F<^4V-H961U;&4@;V8@079A:6QA
M8FQE+69O<BUS86QE(%-E8W5R:71I97,@6TQI;F4@271E;7-=/"]S=')O;F<^
M/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N
M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A
M;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS1')O=3X-
M"B`@("`@("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P/D%M;W)T:7IE
M9"!C;W-T/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XQ.2PT,S`\
M<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XT
M+#@V,#QS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@("`@(#QT
M<B!C;&%S<STS1')E/@T*("`@("`@("`\=&0@8VQA<W,],T1P;"!V86QI9VX]
M,T1T;W`^1W)O<W,@=6YR96%L:7IE9"!G86EN/"]T9#X-"B`@("`@("`@/'1D
M(&-L87-S/3-$;G5M<#XR+#4X-3QS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@
M("`\=&0@8VQA<W,],T1N=6UP/C(X-3QS<&%N/CPO<W!A;CX\+W1D/@T*("`@
M("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS1')O/@T*("`@("`@("`\=&0@
M8VQA<W,],T1P;"!V86QI9VX],T1T;W`^1W)O<W,@=6YR96%L:7IE9"!L;W-S
M/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M/B@R,RD\<W!A;CX\+W-P
M86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M/B@Q.#DI/'-P86X^
M/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$
M<F4^#0H@("`@("`@(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O<#Y&86ER
M('9A;'5E/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XR,2PY.3(\
M<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XT
M+#DU-CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@("`@(#QT
M<B!C;&%S<STS1')H/@T*("`@("`@("`\=&0@8VQA<W,],T1P;"!V86QI9VX]
M,T1T;W`^3VYE('1O($9I=F4@665A<G,@6TUE;6)E<ET\+W1D/@T*("`@("`@
M("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@
M("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@
M("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$<F4^#0H@("`@("`@(#QT9"!C
M;&%S<STS1'!L('9A;&EG;CTS1'1O<#X\<W1R;VYG/E-C:&5D=6QE(&]F($%V
M86EL86)L92UF;W(M<V%L92!396-U<FET:65S(%M,:6YE($ET96US73PO<W1R
M;VYG/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO
M<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\
M+W-P86X^/"]T9#X-"B`@("`@(#PO='(^#0H@("`@("`\='(@8VQA<W,],T1R
M;W4^#0H@("`@("`@(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O<#Y!;6]R
M=&EZ960@8V]S=#PO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;7`^-RPU
M,#$\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M
M<#XV+#4W.#QS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@("`@
M(#QT<B!C;&%S<STS1')E/@T*("`@("`@("`\=&0@8VQA<W,],T1P;"!V86QI
M9VX],T1T;W`^1W)O<W,@=6YR96%L:7IE9"!G86EN/"]T9#X-"B`@("`@("`@
M/'1D(&-L87-S/3-$;G5M<#XS-C$\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@
M("`@/'1D(&-L87-S/3-$;G5M<#XR,3$\<W!A;CX\+W-P86X^/"]T9#X-"B`@
M("`@(#PO='(^#0H@("`@("`\='(@8VQA<W,],T1R;SX-"B`@("`@("`@/'1D
M(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P/D=R;W-S('5N<F5A;&EZ960@;&]S
M<SPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;3XH-BD\<W!A;CX\+W-P
M86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M/B@X.2D\<W!A;CX\
M+W-P86X^/"]T9#X-"B`@("`@(#PO='(^#0H@("`@("`\='(@8VQA<W,],T1R
M93X-"B`@("`@("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P/D9A:7(@
M=F%L=64\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6UP/C<L.#4V/'-P
M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;7`^-BPW
M,#`\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO='(^#0H@("`@("`\='(@
M8VQA<W,],T1R:#X-"B`@("`@("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$
M=&]P/D%F=&5R($9I=F4@665A<G,@=&AR;W5G:"!496X@665A<G,@6TUE;6)E
M<ET\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P
M86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S
M<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$<F4^
M#0H@("`@("`@(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O<#X\<W1R;VYG
M/E-C:&5D=6QE(&]F($%V86EL86)L92UF;W(M<V%L92!396-U<FET:65S(%M,
M:6YE($ET96US73PO<W1R;VYG/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS
M1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,]
M,T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO='(^#0H@("`@
M("`\='(@8VQA<W,],T1R;W4^#0H@("`@("`@(#QT9"!C;&%S<STS1'!L('9A
M;&EG;CTS1'1O<#Y!;6]R=&EZ960@8V]S=#PO=&0^#0H@("`@("`@(#QT9"!C
M;&%S<STS1&YU;7`^.30\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D
M(&-L87-S/3-$;G5M<#XQ+#<T-#QS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@
M/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS1')E/@T*("`@("`@("`\=&0@8VQA
M<W,],T1P;"!V86QI9VX],T1T;W`^1W)O<W,@=6YR96%L:7IE9"!G86EN/"]T
M9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XQ.3QS<&%N/CPO<W!A;CX\
M+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6UP/C<T/'-P86X^/"]S<&%N
M/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$<F\^#0H@
M("`@("`@(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O<#Y'<F]S<R!U;G)E
M86QI>F5D(&QO<W,\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<F
M;F)S<#LF;F)S<#L\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L
M87-S/3-$;G5M/B@S,RD\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO='(^
M#0H@("`@("`\='(@8VQA<W,],T1R93X-"B`@("`@("`@/'1D(&-L87-S/3-$
M<&P@=F%L:6=N/3-$=&]P/D9A:7(@=F%L=64\+W1D/@T*("`@("`@("`\=&0@
M8VQA<W,],T1N=6UP/C$Q,SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\
M=&0@8VQA<W,],T1N=6UP/C$L-S@U/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@
M("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$<F@^#0H@("`@("`@(#QT9"!C
M;&%S<STS1'!L('9A;&EG;CTS1'1O<#Y3=&]C:R!A;F0@26YD97@@3&EN:V5D
M($YO=&5S(%M-96UB97)=('P@5VET:&EN($]N92!996%R(%M-96UB97)=/"]T
M9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO
M=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\
M+W1D/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS1')E/@T*("`@
M("`@("`\=&0@8VQA<W,],T1P;"!V86QI9VX],T1T;W`^/'-T<F]N9SY38VAE
M9'5L92!O9B!!=F%I;&%B;&4M9F]R+7-A;&4@4V5C=7)I=&EE<R!;3&EN92!)
M=&5M<UT\+W-T<F]N9SX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT
M/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X
M=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R
M(&-L87-S/3-$<F]U/@T*("`@("`@("`\=&0@8VQA<W,],T1P;"!V86QI9VX]
M,T1T;W`^06UO<G1I>F5D(&-O<W0\+W1D/@T*("`@("`@("`\=&0@8VQA<W,]
M,T1N=6UP/C$X+#@X,3QS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@
M8VQA<W,],T1N=6UP/C0L,#(S/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\
M+W1R/@T*("`@("`@/'1R(&-L87-S/3-$<F4^#0H@("`@("`@(#QT9"!C;&%S
M<STS1'!L('9A;&EG;CTS1'1O<#Y'<F]S<R!U;G)E86QI>F5D(&=A:6X\+W1D
M/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6UP/C(L-3(R/'-P86X^/"]S<&%N
M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;7`^,C,T/'-P86X^/"]S
M<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$<F\^
M#0H@("`@("`@(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O<#Y'<F]S<R!U
M;G)E86QI>F5D(&QO<W,\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6T^
M*#(S*3QS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N
M=6T^*#$X,"D\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO='(^#0H@("`@
M("`\='(@8VQA<W,],T1R93X-"B`@("`@("`@/'1D(&-L87-S/3-$<&P@=F%L
M:6=N/3-$=&]P/D9A:7(@=F%L=64\+W1D/@T*("`@("`@("`\=&0@8VQA<W,]
M,T1N=6UP/C(Q+#,X,#QS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@
M8VQA<W,],T1N=6UP/C0L,#<W/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\
M+W1R/@T*("`@("`@/'1R(&-L87-S/3-$<F@^#0H@("`@("`@(#QT9"!C;&%S
M<STS1'!L('9A;&EG;CTS1'1O<#Y';W9E<FYM96YT($1E8F5N='5R97,@6TUE
M;6)E<ET@?"!7:71H:6X@3VYE(%EE87(@6TUE;6)E<ET\+W1D/@T*("`@("`@
M("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@
M("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@
M("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$<F4^#0H@("`@("`@(#QT9"!C
M;&%S<STS1'!L('9A;&EG;CTS1'1O<#X\<W1R;VYG/E-C:&5D=6QE(&]F($%V
M86EL86)L92UF;W(M<V%L92!396-U<FET:65S(%M,:6YE($ET96US73PO<W1R
M;VYG/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO
M<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\
M+W-P86X^/"]T9#X-"B`@("`@(#PO='(^#0H@("`@("`\='(@8VQA<W,],T1R
M;W4^#0H@("`@("`@(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O<#Y!;6]R
M=&EZ960@8V]S=#PO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;7`^.3<\
M<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XS
M,CD\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO='(^#0H@("`@("`\='(@
M8VQA<W,],T1R93X-"B`@("`@("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$
M=&]P/D=R;W-S('5N<F5A;&EZ960@9V%I;CPO=&0^#0H@("`@("`@(#QT9"!C
M;&%S<STS1&YU;7`^.3QS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@
M8VQA<W,],T1N=6UP/C(Q/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R
M/@T*("`@("`@/'1R(&-L87-S/3-$<F\^#0H@("`@("`@(#QT9"!C;&%S<STS
M1'!L('9A;&EG;CTS1'1O<#Y'<F]S<R!U;G)E86QI>F5D(&QO<W,\+W1D/@T*
M("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<F;F)S<#LF;F)S<#L\<W!A;CX\
M+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG)FYB<W`[
M)FYB<W`[/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@
M/'1R(&-L87-S/3-$<F4^#0H@("`@("`@(#QT9"!C;&%S<STS1'!L('9A;&EG
M;CTS1'1O<#Y&86ER('9A;'5E/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$
M;G5M<#XQ,#8\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S
M/3-$;G5M<#XS-3`\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO='(^#0H@
M("`@("`\='(@8VQA<W,],T1R:#X-"B`@("`@("`@/'1D(&-L87-S/3-$<&P@
M=F%L:6=N/3-$=&]P/D=O=F5R;FUE;G0@1&5B96YT=7)E<R!;365M8F5R72!\
M($]N92!T;R!&:79E(%EE87)S(%M-96UB97)=/"]T9#X-"B`@("`@("`@/'1D
M(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT
M9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T
M<CX-"B`@("`@(#QT<B!C;&%S<STS1')E/@T*("`@("`@("`\=&0@8VQA<W,]
M,T1P;"!V86QI9VX],T1T;W`^/'-T<F]N9SY38VAE9'5L92!O9B!!=F%I;&%B
M;&4M9F]R+7-A;&4@4V5C=7)I=&EE<R!;3&EN92!)=&5M<UT\+W-T<F]N9SX\
M+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^
M/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N
M/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$<F]U/@T*
M("`@("`@("`\=&0@8VQA<W,],T1P;"!V86QI9VX],T1T;W`^06UO<G1I>F5D
M(&-O<W0\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6UP/C(L-3DU/'-P
M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;7`^,2PV
M,#(\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO='(^#0H@("`@("`\='(@
M8VQA<W,],T1R93X-"B`@("`@("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$
M=&]P/D=R;W-S('5N<F5A;&EZ960@9V%I;CPO=&0^#0H@("`@("`@(#QT9"!C
M;&%S<STS1&YU;7`^.3@\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D
M(&-L87-S/3-$;G5M<#XT.3QS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T
M<CX-"B`@("`@(#QT<B!C;&%S<STS1')O/@T*("`@("`@("`\=&0@8VQA<W,]
M,T1P;"!V86QI9VX],T1T;W`^1W)O<W,@=6YR96%L:7IE9"!L;W-S/"]T9#X-
M"B`@("`@("`@/'1D(&-L87-S/3-$;G5M/B@Q*3QS<&%N/CPO<W!A;CX\+W1D
M/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6T^*#$R*3QS<&%N/CPO<W!A;CX\
M+W1D/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS1')E/@T*("`@
M("`@("`\=&0@8VQA<W,],T1P;"!V86QI9VX],T1T;W`^1F%I<B!V86QU93PO
M=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;7`^,BPV.3(\<W!A;CX\+W-P
M86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XQ+#8S.3QS<&%N
M/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS
M1')H/@T*("`@("`@("`\=&0@8VQA<W,],T1P;"!V86QI9VX],T1T;W`^1V]V
M97)N;65N="!$96)E;G1U<F5S(%M-96UB97)=('P@069T97(@1FEV92!996%R
M<R!T:')O=6=H(%1E;B!996%R<R!;365M8F5R73PO=&0^#0H@("`@("`@(#QT
M9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\
M=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO
M='(^#0H@("`@("`\='(@8VQA<W,],T1R93X-"B`@("`@("`@/'1D(&-L87-S
M/3-$<&P@=F%L:6=N/3-$=&]P/CQS=')O;F<^4V-H961U;&4@;V8@079A:6QA
M8FQE+69O<BUS86QE(%-E8W5R:71I97,@6TQI;F4@271E;7-=/"]S=')O;F<^
M/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N
M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A
M;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS1')O=3X-
M"B`@("`@("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P/D%M;W)T:7IE
M9"!C;W-T/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG)FYB<W`[
M)FYB<W`[/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS
M1&YU;7`^.34U/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@
M("`@/'1R(&-L87-S/3-$<F4^#0H@("`@("`@(#QT9"!C;&%S<STS1'!L('9A
M;&EG;CTS1'1O<#Y'<F]S<R!U;G)E86QI>F5D(&=A:6X\+W1D/@T*("`@("`@
M("`\=&0@8VQA<W,],T1T97AT/B<F;F)S<#LF;F)S<#L\<W!A;CX\+W-P86X^
M/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XT-3QS<&%N/CPO<W!A
M;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS1')O/@T*
M("`@("`@("`\=&0@8VQA<W,],T1P;"!V86QI9VX],T1T;W`^1W)O<W,@=6YR
M96%L:7IE9"!L;W-S/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG
M)FYB<W`[)FYB<W`[/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C
M;&%S<STS1&YU;3XH,30I/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R
M/@T*("`@("`@/'1R(&-L87-S/3-$<F4^#0H@("`@("`@(#QT9"!C;&%S<STS
M1'!L('9A;&EG;CTS1'1O<#Y&86ER('9A;'5E/"]T9#X-"B`@("`@("`@/'1D
M(&-L87-S/3-$=&5X=#XG)FYB<W`[)FYB<W`[/'-P86X^/"]S<&%N/CPO=&0^
M#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;7`^.3@V/'-P86X^/"]S<&%N/CPO
M=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$<F@^#0H@("`@
M("`@(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O<#Y#;W)P;W)A=&4@1&5B
M96YT=7)E<R!;365M8F5R72!\(%=I=&AI;B!/;F4@665A<B!;365M8F5R73PO
M=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\
M+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^
M/"]T9#X-"B`@("`@(#PO='(^#0H@("`@("`\='(@8VQA<W,],T1R93X-"B`@
M("`@("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P/CQS=')O;F<^4V-H
M961U;&4@;V8@079A:6QA8FQE+69O<BUS86QE(%-E8W5R:71I97,@6TQI;F4@
M271E;7-=/"]S=')O;F<^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X
M=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E
M>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@("`@(#QT
M<B!C;&%S<STS1')O=3X-"B`@("`@("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N
M/3-$=&]P/D%M;W)T:7IE9"!C;W-T/"]T9#X-"B`@("`@("`@/'1D(&-L87-S
M/3-$;G5M<#XT-3(\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L
M87-S/3-$;G5M<#XU,#@\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO='(^
M#0H@("`@("`\='(@8VQA<W,],T1R93X-"B`@("`@("`@/'1D(&-L87-S/3-$
M<&P@=F%L:6=N/3-$=&]P/D=R;W-S('5N<F5A;&EZ960@9V%I;CPO=&0^#0H@
M("`@("`@(#QT9"!C;&%S<STS1&YU;7`^-30\<W!A;CX\+W-P86X^/"]T9#X-
M"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XS,#QS<&%N/CPO<W!A;CX\+W1D
M/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS1')O/@T*("`@("`@
M("`\=&0@8VQA<W,],T1P;"!V86QI9VX],T1T;W`^1W)O<W,@=6YR96%L:7IE
M9"!L;W-S/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG)FYB<W`[
M)FYB<W`[/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS
M1&YU;3XH.2D\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO='(^#0H@("`@
M("`\='(@8VQA<W,],T1R93X-"B`@("`@("`@/'1D(&-L87-S/3-$<&P@=F%L
M:6=N/3-$=&]P/D9A:7(@=F%L=64\+W1D/@T*("`@("`@("`\=&0@8VQA<W,]
M,T1N=6UP/C4P-CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA
M<W,],T1N=6UP/C4R.3QS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-
M"B`@("`@(#QT<B!C;&%S<STS1')H/@T*("`@("`@("`\=&0@8VQA<W,],T1P
M;"!V86QI9VX],T1T;W`^0V]R<&]R871E($1E8F5N='5R97,@6TUE;6)E<ET@
M?"!/;F4@=&\@1FEV92!996%R<R!;365M8F5R73PO=&0^#0H@("`@("`@(#QT
M9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\
M=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO
M='(^#0H@("`@("`\='(@8VQA<W,],T1R93X-"B`@("`@("`@/'1D(&-L87-S
M/3-$<&P@=F%L:6=N/3-$=&]P/CQS=')O;F<^4V-H961U;&4@;V8@079A:6QA
M8FQE+69O<BUS86QE(%-E8W5R:71I97,@6TQI;F4@271E;7-=/"]S=')O;F<^
M/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N
M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A
M;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS1')O=3X-
M"B`@("`@("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P/D%M;W)T:7IE
M9"!C;W-T/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XT+#DP-CQS
M<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6UP/C0L
M.3<V/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R
M(&-L87-S/3-$<F4^#0H@("`@("`@(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS
M1'1O<#Y'<F]S<R!U;G)E86QI>F5D(&=A:6X\+W1D/@T*("`@("`@("`\=&0@
M8VQA<W,],T1N=6UP/C(V,SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\
M=&0@8VQA<W,],T1N=6UP/C$V,CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@
M/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS1')O/@T*("`@("`@("`\=&0@8VQA
M<W,],T1P;"!V86QI9VX],T1T;W`^1W)O<W,@=6YR96%L:7IE9"!L;W-S/"]T
M9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M/B@U*3QS<&%N/CPO<W!A;CX\
M+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6T^*#<W*3QS<&%N/CPO<W!A
M;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS1')E/@T*
M("`@("`@("`\=&0@8VQA<W,],T1P;"!V86QI9VX],T1T;W`^1F%I<B!V86QU
M93PO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;7`^-2PQ-C0\<W!A;CX\
M+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XU+#`V,3QS
M<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S
M<STS1')H/@T*("`@("`@("`\=&0@8VQA<W,],T1P;"!V86QI9VX],T1T;W`^
M0V]R<&]R871E($1E8F5N='5R97,@6TUE;6)E<ET@?"!!9G1E<B!&:79E(%EE
M87)S('1H<F]U9V@@5&5N(%EE87)S(%M-96UB97)=/"]T9#X-"B`@("`@("`@
M/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@
M(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@
M/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS1')E/@T*("`@("`@("`\=&0@8VQA
M<W,],T1P;"!V86QI9VX],T1T;W`^/'-T<F]N9SY38VAE9'5L92!O9B!!=F%I
M;&%B;&4M9F]R+7-A;&4@4V5C=7)I=&EE<R!;3&EN92!)=&5M<UT\+W-T<F]N
M9SX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P
M86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S
M<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$<F]U
M/@T*("`@("`@("`\=&0@8VQA<W,],T1P;"!V86QI9VX],T1T;W`^06UO<G1I
M>F5D(&-O<W0\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6UP/CDT/'-P
M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;7`^-S@Y
M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L
M87-S/3-$<F4^#0H@("`@("`@(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O
M<#Y'<F]S<R!U;G)E86QI>F5D(&=A:6X\+W1D/@T*("`@("`@("`\=&0@8VQA
M<W,],T1N=6UP/C$Y/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C
M;&%S<STS1&YU;7`^,CD\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO='(^
M#0H@("`@("`\='(@8VQA<W,],T1R;SX-"B`@("`@("`@/'1D(&-L87-S/3-$
M<&P@=F%L:6=N/3-$=&]P/D=R;W-S('5N<F5A;&EZ960@;&]S<SPO=&0^#0H@
M("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)R9N8G-P.R9N8G-P.SQS<&%N/CPO
M<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6T^*#$Y*3QS<&%N
M/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS
M1')E/@T*("`@("`@("`\=&0@8VQA<W,],T1P;"!V86QI9VX],T1T;W`^1F%I
M<B!V86QU93PO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;7`^)"`Q,3,\
M<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XD
M(#<Y.3QS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@("`\+W1A
M8FQE/@T*("`\+V)O9'D^#0H\+VAT;6P^#0H-"BTM+2TM+3U?3F5X=%!A<G1?
M,&-A9#4Y9F1?-S,R95\T-F4R7V$U,S1?,&,X860Q868Y,&1D#0I#;VYT96YT
M+4QO8V%T:6]N.B!F:6QE.B\O+T,Z+S!C860U.69D7S<S,F5?-#9E,E]A-3,T
M7S!C.&%D,6%F.3!D9"]7;W)K<VAE971S+U-H965T,S0N:'1M;`T*0V]N=&5N
M="U4<F%N<V9E<BU%;F-O9&EN9SH@<75O=&5D+7!R:6YT86)L90T*0V]N=&5N
M="U4>7!E.B!T97AT+VAT;6P[(&-H87)S970](G5S+6%S8VEI(@T*#0H\:'1M
M;#X-"B`@/&AE860^#0H@("`@/$U%5$$@:'1T<"UE<75I=CTS1$-O;G1E;G0M
M5'EP92!C;VYT96YT/3-$)W1E>'0O:'1M;#L@8VAA<G-E=#UU=&8M."<^/'-C
M<FEP="!T>7!E/3-$=&5X="]J879A<V-R:7!T('-R8STS1%-H;W<N:G,^+RH@
M1&\@3F]T(%)E;6]V92!4:&ES($-O;6UE;G0@*B\\+W-C<FEP=#X\+VAE860^
M#0H@(#QB;V1Y/@T*("`@(#QT86)L92!C;&%S<STS1')E<&]R="!I9#TS1$E$
M,$4V1T%#/@T*("`@("`@/'1R/@T*("`@("`@("`\=&@@8VQA<W,],T1T;"!C
M;VQS<&%N/3-$,2!R;W=S<&%N/3-$,3X\<W1R;VYG/DU!4DM%5$%"3$4@4T5#
M55))5$E%4R`H4V-H961U;&4@;V8@26YV97-T;65N=',@:6X@56YR96%L:7IE
M9"!,;W-S*2`H1&5T86EL<RD@*%531"`D*3QB<CY);B!4:&]U<V%N9',L('5N
M;&5S<R!O=&AE<G=I<V4@<W!E8VEF:65D/"]S=')O;F<^/"]T:#X-"B`@("`@
M("`@/'1H(&-L87-S/3-$=&@^2G5N+B`S,"P@,C`Q-#QB<CX\+W1H/@T*("`@
M("`@("`\=&@@8VQA<W,],T1T:#Y*=6XN(#,P+"`R,#$S/&)R/CPO=&@^#0H@
M("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$<F4^#0H@("`@("`@(#QT
M9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O<#X\<W1R;VYG/DU!4DM%5$%"3$4@
M4T5#55))5$E%4R!;06)S=')A8W1=/"]S=')O;F<^/"]T9#X-"B`@("`@("`@
M/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@
M(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@
M/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS1')O/@T*("`@("`@("`\=&0@8VQA
M<W,],T1P;"!V86QI9VX],T1T;W`^3&5S<R!T:&%N(#$R(&UO;G1H<RP@9F%I
M<B!V86QU93PO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;7`^)"`X-3$\
M<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XD
M(#4L,3(R/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@
M/'1R(&-L87-S/3-$<F4^#0H@("`@("`@(#QT9"!C;&%S<STS1'!L('9A;&EG
M;CTS1'1O<#Y,97-S('1H86X@,3(@;6]N=&AS+"!G<F]S<R!U;G)E86QI>F5D
M(&QO<W,\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6T^*#$W*3QS<&%N
M/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6T^*#,P,BD\
M<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO='(^#0H@("`@("`\='(@8VQA
M<W,],T1R;SX-"B`@("`@("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P
M/C$R(&UO;G1H<R!O<B!G<F5A=&5R+"!F86ER('9A;'5E/"]T9#X-"B`@("`@
M("`@/'1D(&-L87-S/3-$;G5M<#XT-C,\<W!A;CX\+W-P86X^/"]T9#X-"B`@
M("`@("`@/'1D(&-L87-S/3-$;G5M<#XS,CQS<&%N/CPO<W!A;CX\+W1D/@T*
M("`@("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS1')E/@T*("`@("`@("`\
M=&0@8VQA<W,],T1P;"!V86QI9VX],T1T;W`^,3(@;6]N=&AS(&]R(&=R96%T
M97(L(&=R;W-S('5N<F5A;&EZ960@;&]S<SPO=&0^#0H@("`@("`@(#QT9"!C
M;&%S<STS1&YU;3XH,3(I/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT
M9"!C;&%S<STS1&YU;3XH.2D\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO
M='(^#0H@("`@("`\='(@8VQA<W,],T1R;SX-"B`@("`@("`@/'1D(&-L87-S
M/3-$<&P@=F%L:6=N/3-$=&]P/DEN=&5R97-T(')E8V5I=F%B;&4\+W1D/@T*
M("`@("`@("`\=&0@8VQA<W,],T1N=6UP/B0@.3@\<W!A;CX\+W-P86X^/"]T
M9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XD(#(P/'-P86X^/"]S<&%N
M/CPO=&0^#0H@("`@("`\+W1R/@T*("`@(#PO=&%B;&4^#0H@(#PO8F]D>3X-
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M;#L@8VAA<G-E=#TB=7,M87-C:6DB#0H-"CQH=&UL/@T*("`\:&5A9#X-"B`@
M("`\345402!H='1P+65Q=6EV/3-$0V]N=&5N="U4>7!E(&-O;G1E;G0],T0G
M=&5X="]H=&UL.R!C:&%R<V5T/75T9BTX)SX\<V-R:7!T('1Y<&4],T1T97AT
M+VIA=F%S8W)I<'0@<W)C/3-$4VAO=RYJ<SXO*B!$;R!.;W0@4F5M;W9E(%1H
M:7,@0V]M;65N="`J+SPO<V-R:7!T/CPO:&5A9#X-"B`@/&)O9'D^#0H@("`@
M/'1A8FQE(&-L87-S/3-$<F5P;W)T(&ED/3-$240P15-:044^#0H@("`@("`\
M='(^#0H@("`@("`@(#QT:"!C;&%S<STS1'1L(&-O;'-P86X],T0Q(')O=W-P
M86X],T0Q/CQS=')O;F<^1D%)4B!604Q512!/1B!&24Y!3D-)04P@24Y35%)5
M345.5%,@*%-C:&5D=6QE(&]F($9A:7(@5F%L=64@;V8@1FEN86YC:6%L($EN
M<W1R=6UE;G1S*2`H1&5T86EL<RD@*%531"`D*3QB<CY);B!4:&]U<V%N9',L
M('5N;&5S<R!O=&AE<G=I<V4@<W!E8VEF:65D/"]S=')O;F<^/"]T:#X-"B`@
M("`@("`@/'1H(&-L87-S/3-$=&@^2G5N+B`S,"P@,C`Q-#QB<CX\+W1H/@T*
M("`@("`@("`\=&@@8VQA<W,],T1T:#Y*=6XN(#,P+"`R,#$S/&)R/CPO=&@^
M#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$<F4^#0H@("`@("`@
M(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O<#X\<W1R;VYG/D9A:7(@5F%L
M=64L($%S<V5T<R!A;F0@3&EA8FEL:71I97,@365A<W5R960@;VX@4F5C=7)R
M:6YG(&%N9"!.;VYR96-U<G)I;F<@0F%S:7,@6TQI;F4@271E;7-=/"]S=')O
M;F<^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S
M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO
M<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS1')O
M/@T*("`@("`@("`\=&0@8VQA<W,],T1P;"!V86QI9VX],T1T;W`^36%R:V5T
M86)L92!S96-U<FET:65S/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M
M<#XD(#(Y+#DV,3QS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA
M<W,],T1N=6UP/B0@,3,L-#0Q/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\
M+W1R/@T*("`@("`@/'1R(&-L87-S/3-$<F4^#0H@("`@("`@(#QT9"!C;&%S
M<STS1'!L('9A;&EG;CTS1'1O<#Y&;W)E:6=N(&-U<G)E;F-Y(&1E<FEV871I
M=F4@:6YS=')U;65N=',\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6T^
M*#@T,BD\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$
M;G5M<#XY,SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@("`@
M(#QT<B!C;&%S<STS1')H/@T*("`@("`@("`\=&0@8VQA<W,],T1P;"!V86QI
M9VX],T1T;W`^3&5V96P@,2!;365M8F5R72!\($9A:7(@5F%L=64L($UE87-U
M<F5M96YT<RP@4F5C=7)R:6YG(%M-96UB97)=/"]T9#X-"B`@("`@("`@/'1D
M(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT
M9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T
M<CX-"B`@("`@(#QT<B!C;&%S<STS1')E/@T*("`@("`@("`\=&0@8VQA<W,]
M,T1P;"!V86QI9VX],T1T;W`^/'-T<F]N9SY&86ER(%9A;'5E+"!!<W-E=',@
M86YD($QI86)I;&ET:65S($UE87-U<F5D(&]N(%)E8W5R<FEN9R!A;F0@3F]N
M<F5C=7)R:6YG($)A<VES(%M,:6YE($ET96US73PO<W1R;VYG/CPO=&0^#0H@
M("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*
M("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-
M"B`@("`@(#PO='(^#0H@("`@("`\='(@8VQA<W,],T1R;SX-"B`@("`@("`@
M/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P/DUA<FME=&%B;&4@<V5C=7)I
M=&EE<SPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;7`^,C`L-3,P/'-P
M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;7`^-BPS
M,3$\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO='(^#0H@("`@("`\='(@
M8VQA<W,],T1R93X-"B`@("`@("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$
M=&]P/D9O<F5I9VX@8W5R<F5N8WD@9&5R:79A=&EV92!I;G-T<G5M96YT<SPO
M=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)R9N8G-P.R9N8G-P.SQS
M<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<F
M;F)S<#LF;F)S<#L\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO='(^#0H@
M("`@("`\='(@8VQA<W,],T1R;W4^#0H@("`@("`@(#QT9"!C;&%S<STS1'!L
M('9A;&EG;CTS1'1O<#Y4;W1A;#PO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS
M1&YU;7`^,C`L-3,P/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C
M;&%S<STS1&YU;7`^-BPS,3$\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO
M='(^#0H@("`@("`\='(@8VQA<W,],T1R:#X-"B`@("`@("`@/'1D(&-L87-S
M/3-$<&P@=F%L:6=N/3-$=&]P/DQE=F5L(#(@6TUE;6)E<ET@?"!&86ER(%9A
M;'5E+"!-96%S=7)E;65N=',L(%)E8W5R<FEN9R!;365M8F5R73PO=&0^#0H@
M("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*
M("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-
M"B`@("`@(#PO='(^#0H@("`@("`\='(@8VQA<W,],T1R;SX-"B`@("`@("`@
M/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P/CQS=')O;F<^1F%I<B!686QU
M92P@07-S971S(&%N9"!,:6%B:6QI=&EE<R!-96%S=7)E9"!O;B!296-U<G)I
M;F<@86YD($YO;G)E8W5R<FEN9R!"87-I<R!;3&EN92!)=&5M<UT\+W-T<F]N
M9SX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P
M86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S
M<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$<F4^
M#0H@("`@("`@(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O<#Y-87)K971A
M8FQE('-E8W5R:71I97,\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6UP
M/CDL-#,Q/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS
M1&YU;7`^-RPQ,S`\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO='(^#0H@
M("`@("`\='(@8VQA<W,],T1R;SX-"B`@("`@("`@/'1D(&-L87-S/3-$<&P@
M=F%L:6=N/3-$=&]P/D9O<F5I9VX@8W5R<F5N8WD@9&5R:79A=&EV92!I;G-T
M<G5M96YT<SPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;3XH.#0R*3QS
M<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6UP/CDS
M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L
M87-S/3-$<F5U/@T*("`@("`@("`\=&0@8VQA<W,],T1P;"!V86QI9VX],T1T
M;W`^5&]T86P\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6UP/C@L-3@Y
M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;7`^
M-RPR,C,\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO='(^#0H@("`@("`\
M='(@8VQA<W,],T1R:#X-"B`@("`@("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N
M/3-$=&]P/DQE=F5L(#,@6TUE;6)E<ET@?"!&86ER(%9A;'5E+"!-96%S=7)E
M;65N=',L(%)E8W5R<FEN9R!;365M8F5R73PO=&0^#0H@("`@("`@(#QT9"!C
M;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@
M8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO='(^
M#0H@("`@("`\='(@8VQA<W,],T1R93X-"B`@("`@("`@/'1D(&-L87-S/3-$
M<&P@=F%L:6=N/3-$=&]P/CQS=')O;F<^1F%I<B!686QU92P@07-S971S(&%N
M9"!,:6%B:6QI=&EE<R!-96%S=7)E9"!O;B!296-U<G)I;F<@86YD($YO;G)E
M8W5R<FEN9R!"87-I<R!;3&EN92!)=&5M<UT\+W-T<F]N9SX\+W1D/@T*("`@
M("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@
M("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@
M("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$<F\^#0H@("`@("`@(#QT
M9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O<#Y-87)K971A8FQE('-E8W5R:71I
M97,\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<F;F)S<#LF;F)S
M<#L\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X
M=#XG)FYB<W`[)FYB<W`[/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R
M/@T*("`@("`@/'1R(&-L87-S/3-$<F4^#0H@("`@("`@(#QT9"!C;&%S<STS
M1'!L('9A;&EG;CTS1'1O<#Y&;W)E:6=N(&-U<G)E;F-Y(&1E<FEV871I=F4@
M:6YS=')U;65N=',\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<F
M;F)S<#LF;F)S<#L\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L
M87-S/3-$=&5X=#XG)FYB<W`[)FYB<W`[/'-P86X^/"]S<&%N/CPO=&0^#0H@
M("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$<F]U/@T*("`@("`@("`\
M=&0@8VQA<W,],T1P;"!V86QI9VX],T1T;W`^5&]T86P\+W1D/@T*("`@("`@
M("`\=&0@8VQA<W,],T1T97AT/B<F;F)S<#LF;F)S<#L\<W!A;CX\+W-P86X^
M/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG)FYB<W`[)FYB<W`[
M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@(#PO=&%B;&4^
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M("`\:&5A9#X-"B`@("`\345402!H='1P+65Q=6EV/3-$0V]N=&5N="U4>7!E
M(&-O;G1E;G0],T0G=&5X="]H=&UL.R!C:&%R<V5T/75T9BTX)SX\<V-R:7!T
M('1Y<&4],T1T97AT+VIA=F%S8W)I<'0@<W)C/3-$4VAO=RYJ<SXO*B!$;R!.
M;W0@4F5M;W9E(%1H:7,@0V]M;65N="`J+SPO<V-R:7!T/CPO:&5A9#X-"B`@
M/&)O9'D^#0H@("`@/'1A8FQE(&-L87-S/3-$<F5P;W)T(&ED/3-$240P15E-
M044^#0H@("`@("`\='(^#0H@("`@("`@(#QT:"!C;&%S<STS1'1L(&-O;'-P
M86X],T0Q(')O=W-P86X],T0Q/CQS=')O;F<^1D%)4B!604Q512!/1B!&24Y!
M3D-)04P@24Y35%)5345.5%,@*%-C:&5D=6QE(&]F('1H92!&86ER(%9A;'5E
M(&]F($AE9&=I;F<@26YS=')U;65N=',I("A$971A:6QS*2`H55-$("0I/&)R
M/DEN(%1H;W5S86YD<RP@=6YL97-S(&]T:&5R=VES92!S<&5C:69I960\+W-T
M<F]N9SX\+W1H/@T*("`@("`@("`\=&@@8VQA<W,],T1T:#Y*=6XN(#,P+"`R
M,#$T/&)R/CPO=&@^#0H@("`@("`@(#QT:"!C;&%S<STS1'1H/DIU;BX@,S`L
M(#(P,3,\8G(^/"]T:#X-"B`@("`@(#PO='(^#0H@("`@("`\='(@8VQA<W,]
M,T1R93X-"B`@("`@("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P/CQS
M=')O;F<^1&5R:79A=&EV97,@1F%I<B!686QU92!,:6YE($ET96US/"]S=')O
M;F<^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S
M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO
M<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS1')O
M/@T*("`@("`@("`\=&0@8VQA<W,],T1P;"!V86QI9VX],T1T;W`^1&5R:79A
M=&EV92!F86ER('9A;'5E(&%S<V5T("AL:6%B:6QI='DI/"]T9#X-"B`@("`@
M("`@/'1D(&-L87-S/3-$;G5M/B0@*#@T,BD\<W!A;CX\+W-P86X^/"]T9#X-
M"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XD(#DS/'-P86X^/"]S<&%N/CPO
M=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$<F@^#0H@("`@
M("`@(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O<#Y$97)I=F%T:79E<R!D
M97-I9VYA=&5D(&%S(&AE9&=E(&EN<W1R=6UE;G1S(%M-96UB97)=('P@3W1H
M97(@8W5R<F5N="!A<W-E=',@6TUE;6)E<ET@?"!#87-H(&9L;W<@6TUE;6)E
M<ET\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P
M86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S
M<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$<F\^
M#0H@("`@("`@(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O<#X\<W1R;VYG
M/D1E<FEV871I=F5S($9A:7(@5F%L=64@3&EN92!)=&5M<SPO<W1R;VYG/CPO
M=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\
M+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^
M/"]T9#X-"B`@("`@(#PO='(^#0H@("`@("`\='(@8VQA<W,],T1R93X-"B`@
M("`@("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P/D1E<FEV871I=F4@
M9F%I<B!V86QU92!A<W-E="`H;&EA8FEL:71Y*3PO=&0^#0H@("`@("`@(#QT
M9"!C;&%S<STS1&YU;7`^,C0\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@
M/'1D(&-L87-S/3-$=&5X=#XG)FYB<W`[)FYB<W`[/'-P86X^/"]S<&%N/CPO
M=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$<F@^#0H@("`@
M("`@(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O<#Y$97)I=F%T:79E<R!D
M97-I9VYA=&5D(&%S(&AE9&=E(&EN<W1R=6UE;G1S(%M-96UB97)=('P@3W1H
M97(@8W5R<F5N="!L:6%B:6QI=&EE<R!;365M8F5R72!\($9A:7(@=F%L=64@
M6TUE;6)E<ET\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A
M;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P
M86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S
M/3-$<F4^#0H@("`@("`@(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O<#X\
M<W1R;VYG/D1E<FEV871I=F5S($9A:7(@5F%L=64@3&EN92!)=&5M<SPO<W1R
M;VYG/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO
M<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\
M+W-P86X^/"]T9#X-"B`@("`@(#PO='(^#0H@("`@("`\='(@8VQA<W,],T1R
M;SX-"B`@("`@("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P/D1E<FEV
M871I=F4@9F%I<B!V86QU92!A<W-E="`H;&EA8FEL:71Y*3PO=&0^#0H@("`@
M("`@(#QT9"!C;&%S<STS1&YU;3XH.#@Y*3QS<&%N/CPO<W!A;CX\+W1D/@T*
M("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<F;F)S<#LF;F)S<#L\<W!A;CX\
M+W-P86X^/"]T9#X-"B`@("`@(#PO='(^#0H@("`@("`\='(@8VQA<W,],T1R
M:#X-"B`@("`@("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P/D1E<FEV
M871I=F5S(&YO="!D97-I9VYA=&5D(&%S(&AE9&=E(&EN<W1R=6UE;G1S(%M-
M96UB97)=('P@3W1H97(@8W5R<F5N="!A<W-E=',@6TUE;6)E<ET\+W1D/@T*
M("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-
M"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^
M#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$<F\^#0H@("`@("`@
M(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O<#X\<W1R;VYG/D1E<FEV871I
M=F5S($9A:7(@5F%L=64@3&EN92!)=&5M<SPO<W1R;VYG/CPO=&0^#0H@("`@
M("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@
M("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@
M("`@(#PO='(^#0H@("`@("`\='(@8VQA<W,],T1R93X-"B`@("`@("`@/'1D
M(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P/D1E<FEV871I=F4@9F%I<B!V86QU
M92!A<W-E="`H;&EA8FEL:71Y*3PO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS
M1&YU;7`^)"`R,SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA
M<W,],T1N=6UP/B0@.3,\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO='(^
M#0H@("`@/"]T86)L93X-"B`@/"]B;V1Y/@T*/"]H=&UL/@T*#0HM+2TM+2T]
M7TYE>'1087)T7S!C860U.69D7S<S,F5?-#9E,E]A-3,T7S!C.&%D,6%F.3!D
M9`T*0V]N=&5N="U,;V-A=&EO;CH@9FEL93HO+R]#.B\P8V%D-3EF9%\W,S)E
M7S0V93)?834S-%\P8SAA9#%A9CDP9&0O5V]R:W-H965T<R]3:&5E=#,W+FAT
M;6P-"D-O;G1E;G0M5')A;G-F97(M16YC;V1I;F<Z('%U;W1E9"UP<FEN=&%B
M;&4-"D-O;G1E;G0M5'EP93H@=&5X="]H=&UL.R!C:&%R<V5T/2)U<RUA<V-I
M:2(-"@T*/&AT;6P^#0H@(#QH96%D/@T*("`@(#Q-151!(&AT='`M97%U:78]
M,T1#;VYT96YT+51Y<&4@8V]N=&5N=#TS1"=T97AT+VAT;6P[(&-H87)S970]
M=71F+3@G/CQS8W)I<'0@='EP93TS1'1E>'0O:F%V87-C<FEP="!S<F,],T13
M:&]W+FIS/B\J($1O($YO="!296UO=F4@5&AI<R!#;VUM96YT("HO/"]S8W)I
M<'0^/"]H96%D/@T*("`\8F]D>3X-"B`@("`\=&%B;&4@8VQA<W,],T1R97!O
M<G0@:60],T1)1#!%5S%!1SX-"B`@("`@(#QT<CX-"B`@("`@("`@/'1H(&-L
M87-S/3-$=&P@8V]L<W!A;CTS1#$@<F]W<W!A;CTS1#(^/'-T<F]N9SY04D]0
M15)462!!3D0@15%525!-14Y4+"!.150@*$1E=&%I;',I("A54T0@)"D\8G(^
M26X@5&AO=7-A;F1S+"!U;FQE<W,@;W1H97)W:7-E('-P96-I9FEE9#PO<W1R
M;VYG/CPO=&@^#0H@("`@("`@(#QT:"!C;&%S<STS1'1H(&-O;'-P86X],T0S
M/C$R($UO;G1H<R!%;F1E9#PO=&@^#0H@("`@("`\+W1R/@T*("`@("`@/'1R
M/@T*("`@("`@("`\=&@@8VQA<W,],T1T:#Y*=6XN(#,P+"`R,#$T/&)R/CPO
M=&@^#0H@("`@("`@(#QT:"!C;&%S<STS1'1H/DIU;BX@,S`L(#(P,3,\8G(^
M/"]T:#X-"B`@("`@("`@/'1H(&-L87-S/3-$=&@^2G5N+B`S,"P@,C`Q,CQB
M<CX\+W1H/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS1')E/@T*
M("`@("`@("`\=&0@8VQA<W,],T1P;"!V86QI9VX],T1T;W`^/'-T<F]N9SY0
M<F]P97)T>2P@4&QA;G0@86YD($5Q=6EP;65N="!;3&EN92!)=&5M<UT\+W-T
M<F]N9SX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\
M+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^
M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N
M/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS
M1')O/@T*("`@("`@("`\=&0@8VQA<W,],T1P;"!V86QI9VX],T1T;W`^4')O
M<&5R='D@86YD(&5Q=6EP;65N="P@8V]S=#PO=&0^#0H@("`@("`@(#QT9"!C
M;&%S<STS1&YU;7`^)"`Q-"PY-34\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@
M("`@/'1D(&-L87-S/3-$;G5M<#XD(#$T+#(Q-3QS<&%N/CPO<W!A;CX\+W1D
M/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T
M9#X-"B`@("`@(#PO='(^#0H@("`@("`\='(@8VQA<W,],T1R93X-"B`@("`@
M("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P/E!R;W!E<G1Y(&%N9"!E
M<75I<&UE;G0L(&%C8W5M=6QA=&5D(&1E<')E8VEA=&EO;CPO=&0^#0H@("`@
M("`@(#QT9"!C;&%S<STS1&YU;7`^-"PQ,S(\<W!A;CX\+W-P86X^/"]T9#X-
M"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XR+#,T.3QS<&%N/CPO<W!A;CX\
M+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^
M/"]T9#X-"B`@("`@(#PO='(^#0H@("`@("`\='(@8VQA<W,],T1R;W4^#0H@
M("`@("`@(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O<#Y0<F]P97)T>2!A
M;F0@97%U:7!M96YT+"!N970\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N
M=6UP/C$P+#@R,SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA
M<W,],T1N=6UP/C$Q+#@V-CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\
M=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO
M='(^#0H@("`@("`\='(@8VQA<W,],T1R93X-"B`@("`@("`@/'1D(&-L87-S
M/3-$<&P@=F%L:6=N/3-$=&]P/D1E<')E8VEA=&EO;CPO=&0^#0H@("`@("`@
M(#QT9"!C;&%S<STS1&YU;7`^,2PY,#(\<W!A;CX\+W-P86X^/"]T9#X-"B`@
M("`@("`@/'1D(&-L87-S/3-$;G5M<#XQ+#`S,SQS<&%N/CPO<W!A;CX\+W1D
M/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6UP/C0S-3QS<&%N/CPO<W!A;CX\
M+W1D/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS1')H/@T*("`@
M("`@("`\=&0@8VQA<W,],T1P;"!V86QI9VX],T1T;W`^3&%B;W)A=&]R>2!E
M<75I<&UE;G0@6TUE;6)E<ET\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T
M97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$
M=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS
M1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@("`@
M(#QT<B!C;&%S<STS1')E/@T*("`@("`@("`\=&0@8VQA<W,],T1P;"!V86QI
M9VX],T1T;W`^/'-T<F]N9SY0<F]P97)T>2P@4&QA;G0@86YD($5Q=6EP;65N
M="!;3&EN92!)=&5M<UT\+W-T<F]N9SX\+W1D/@T*("`@("`@("`\=&0@8VQA
M<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L
M87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C
M;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-
M"B`@("`@(#QT<B!C;&%S<STS1')O/@T*("`@("`@("`\=&0@8VQA<W,],T1P
M;"!V86QI9VX],T1T;W`^4')O<&5R='D@86YD(&5Q=6EP;65N="P@8V]S=#PO
M=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;7`^-BPP.#@\<W!A;CX\+W-P
M86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XU+#<P.3QS<&%N
M/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A
M;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO='(^#0H@("`@("`\='(@8VQA<W,]
M,T1R93X-"B`@("`@("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P/E!R
M;W!E<G1Y(&%N9"!E<75I<&UE;G0L(&%C8W5M=6QA=&5D(&1E<')E8VEA=&EO
M;CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;7`^,BPP-#(\<W!A;CX\
M+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XQ+#,P-CQS
M<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\
M<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO='(^#0H@("`@("`\='(@8VQA
M<W,],T1R:#X-"B`@("`@("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P
M/D-O;7!U=&5R<R!A;F0@4&5R:7!H97)A;"!%<75I<&UE;G0@6TUE;6)E<ET\
M+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^
M/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N
M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A
M;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS1')E/@T*
M("`@("`@("`\=&0@8VQA<W,],T1P;"!V86QI9VX],T1T;W`^/'-T<F]N9SY0
M<F]P97)T>2P@4&QA;G0@86YD($5Q=6EP;65N="!;3&EN92!)=&5M<UT\+W-T
M<F]N9SX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\
M+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^
M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N
M/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS
M1')O/@T*("`@("`@("`\=&0@8VQA<W,],T1P;"!V86QI9VX],T1T;W`^4')O
M<&5R='D@86YD(&5Q=6EP;65N="P@8V]S=#PO=&0^#0H@("`@("`@(#QT9"!C
M;&%S<STS1&YU;7`^-S`X/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT
M9"!C;&%S<STS1&YU;7`^-3,U/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@
M(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@
M/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS1')E/@T*("`@("`@("`\=&0@8VQA
M<W,],T1P;"!V86QI9VX],T1T;W`^4')O<&5R='D@86YD(&5Q=6EP;65N="P@
M86-C=6UU;&%T960@9&5P<F5C:6%T:6]N/"]T9#X-"B`@("`@("`@/'1D(&-L
M87-S/3-$;G5M<#XT,S`\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D
M(&-L87-S/3-$;G5M<#XR.#`\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@
M/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\
M+W1R/@T*("`@("`@/'1R(&-L87-S/3-$<F@^#0H@("`@("`@(#QT9"!C;&%S
M<STS1'!L('9A;&EG;CTS1'1O<#Y/9F9I8V4@1G5R;FET=7)E(&%N9"!%<75I
M<&UE;G0@6TUE;6)E<ET\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT
M/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X
M=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E
M>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@("`@(#QT
M<B!C;&%S<STS1')E/@T*("`@("`@("`\=&0@8VQA<W,],T1P;"!V86QI9VX]
M,T1T;W`^/'-T<F]N9SY0<F]P97)T>2P@4&QA;G0@86YD($5Q=6EP;65N="!;
M3&EN92!)=&5M<UT\+W-T<F]N9SX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,]
M,T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S
M/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S
M<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@
M("`@(#QT<B!C;&%S<STS1')O/@T*("`@("`@("`\=&0@8VQA<W,],T1P;"!V
M86QI9VX],T1T;W`^4')O<&5R='D@86YD(&5Q=6EP;65N="P@8V]S=#PO=&0^
M#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;7`^-C$Q/'-P86X^/"]S<&%N/CPO
M=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;7`^-3,T/'-P86X^/"]S<&%N
M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A
M;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS1')E/@T*
M("`@("`@("`\=&0@8VQA<W,],T1P;"!V86QI9VX],T1T;W`^4')O<&5R='D@
M86YD(&5Q=6EP;65N="P@86-C=6UU;&%T960@9&5P<F5C:6%T:6]N/"]T9#X-
M"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XQ-S8\<W!A;CX\+W-P86X^/"]T
M9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XY,3QS<&%N/CPO<W!A;CX\
M+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^
M/"]T9#X-"B`@("`@(#PO='(^#0H@("`@("`\='(@8VQA<W,],T1R:#X-"B`@
M("`@("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P/DQE87-E:&]L9"!)
M;7!R;W9E;65N=',@6TUE;6)E<ET\+W1D/@T*("`@("`@("`\=&0@8VQA<W,]
M,T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S
M/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S
M<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@
M("`@(#QT<B!C;&%S<STS1')E/@T*("`@("`@("`\=&0@8VQA<W,],T1P;"!V
M86QI9VX],T1T;W`^/'-T<F]N9SY0<F]P97)T>2P@4&QA;G0@86YD($5Q=6EP
M;65N="!;3&EN92!)=&5M<UT\+W-T<F]N9SX\+W1D/@T*("`@("`@("`\=&0@
M8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D
M(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT
M9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T
M<CX-"B`@("`@(#QT<B!C;&%S<STS1')O/@T*("`@("`@("`\=&0@8VQA<W,]
M,T1P;"!V86QI9VX],T1T;W`^4')O<&5R='D@86YD(&5Q=6EP;65N="P@8V]S
M=#PO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;7`^-RPT-3,\<W!A;CX\
M+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XW+#,V.3QS
M<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\
M<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO='(^#0H@("`@("`\='(@8VQA
M<W,],T1R93X-"B`@("`@("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P
M/E!R;W!E<G1Y(&%N9"!E<75I<&UE;G0L(&%C8W5M=6QA=&5D(&1E<')E8VEA
M=&EO;CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;7`^,2PT-S4\<W!A
M;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XV-#(\
M<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG
M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L
M87-S/3-$<F@^#0H@("`@("`@(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O
M<#Y696AI8VQE<R!;365M8F5R73PO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS
M1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,]
M,T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S
M/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@
M("`@/'1R(&-L87-S/3-$<F4^#0H@("`@("`@(#QT9"!C;&%S<STS1'!L('9A
M;&EG;CTS1'1O<#X\<W1R;VYG/E!R;W!E<G1Y+"!0;&%N="!A;F0@17%U:7!M
M96YT(%M,:6YE($ET96US73PO<W1R;VYG/CPO=&0^#0H@("`@("`@(#QT9"!C
M;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@
M8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D
M(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R
M/@T*("`@("`@/'1R(&-L87-S/3-$<F\^#0H@("`@("`@(#QT9"!C;&%S<STS
M1'!L('9A;&EG;CTS1'1O<#Y0<F]P97)T>2!A;F0@97%U:7!M96YT+"!C;W-T
M/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XY-3QS<&%N/CPO<W!A
M;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6UP/C8X/'-P86X^/"]S
M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO
M<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS1')E
M/@T*("`@("`@("`\=&0@8VQA<W,],T1P;"!V86QI9VX],T1T;W`^4')O<&5R
M='D@86YD(&5Q=6EP;65N="P@86-C=6UU;&%T960@9&5P<F5C:6%T:6]N/"]T
M9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XD(#D\<W!A;CX\+W-P86X^
M/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XD(#,P/'-P86X^/"]S
M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO
M<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@("`\+W1A8FQE/@T*("`\+V)O
M9'D^#0H\+VAT;6P^#0H-"BTM+2TM+3U?3F5X=%!A<G1?,&-A9#4Y9F1?-S,R
M95\T-F4R7V$U,S1?,&,X860Q868Y,&1D#0I#;VYT96YT+4QO8V%T:6]N.B!F
M:6QE.B\O+T,Z+S!C860U.69D7S<S,F5?-#9E,E]A-3,T7S!C.&%D,6%F.3!D
M9"]7;W)K<VAE971S+U-H965T,S@N:'1M;`T*0V]N=&5N="U4<F%N<V9E<BU%
M;F-O9&EN9SH@<75O=&5D+7!R:6YT86)L90T*0V]N=&5N="U4>7!E.B!T97AT
M+VAT;6P[(&-H87)S970](G5S+6%S8VEI(@T*#0H\:'1M;#X-"B`@/&AE860^
M#0H@("`@/$U%5$$@:'1T<"UE<75I=CTS1$-O;G1E;G0M5'EP92!C;VYT96YT
M/3-$)W1E>'0O:'1M;#L@8VAA<G-E=#UU=&8M."<^/'-C<FEP="!T>7!E/3-$
M=&5X="]J879A<V-R:7!T('-R8STS1%-H;W<N:G,^+RH@1&\@3F]T(%)E;6]V
M92!4:&ES($-O;6UE;G0@*B\\+W-C<FEP=#X\+VAE860^#0H@(#QB;V1Y/@T*
M("`@(#QT86)L92!C;&%S<STS1')E<&]R="!I9#TS1$E$,$4V2T%#/@T*("`@
M("`@/'1R/@T*("`@("`@("`\=&@@8VQA<W,],T1T;"!C;VQS<&%N/3-$,2!R
M;W=S<&%N/3-$,3X\<W1R;VYG/D]42$52($%#0T]53E13(%!!64%"3$4@*$1E
M=&%I;',I("A54T0@)"D\8G(^26X@5&AO=7-A;F1S+"!U;FQE<W,@;W1H97)W
M:7-E('-P96-I9FEE9#PO<W1R;VYG/CPO=&@^#0H@("`@("`@(#QT:"!C;&%S
M<STS1'1H/DIU;BX@,S`L(#(P,30\8G(^/"]T:#X-"B`@("`@("`@/'1H(&-L
M87-S/3-$=&@^2G5N+B`S,"P@,C`Q,SQB<CX\+W1H/@T*("`@("`@/"]T<CX-
M"B`@("`@(#QT<B!C;&%S<STS1')E/@T*("`@("`@("`\=&0@8VQA<W,],T1P
M;"!V86QI9VX],T1T;W`^/'-T<F]N9SY/5$A%4B!!0T-/54Y44R!005E!0DQ%
M(%M!8G-T<F%C=%T\+W-T<F]N9SX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,]
M,T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S
M/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@
M("`@/'1R(&-L87-S/3-$<F\^#0H@("`@("`@(#QT9"!C;&%S<STS1'!L('9A
M;&EG;CTS1'1O<#Y!8V-R=65D('!A>7)O;&P\+W1D/@T*("`@("`@("`\=&0@
M8VQA<W,],T1N=6UP/B0@-#(T/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@
M(#QT9"!C;&%S<STS1&YU;7`^)"`S-3,\<W!A;CX\+W-P86X^/"]T9#X-"B`@
M("`@(#PO='(^#0H@("`@("`\='(@8VQA<W,],T1R93X-"B`@("`@("`@/'1D
M(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P/E!A>7)O;&P@:6YS=&ET=71I;VYS
M/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XS,#(\<W!A;CX\+W-P
M86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XS,C0\<W!A;CX\
M+W-P86X^/"]T9#X-"B`@("`@(#PO='(^#0H@("`@("`\='(@8VQA<W,],T1R
M;SX-"B`@("`@("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P/D%C8W)U
M960@=F%C871I;VX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6UP/C8W
M,SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6UP
M/C4P-CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@("`@(#QT
M<B!C;&%S<STS1')E/@T*("`@("`@("`\=&0@8VQA<W,],T1P;"!V86QI9VX]
M,T1T;W`^061V86YC960@<&%Y;65N="!F<F]M(&QE<W-O<CPO=&0^#0H@("`@
M("`@(#QT9"!C;&%S<STS1&YU;7`^.#D\<W!A;CX\+W-P86X^/"]T9#X-"B`@
M("`@("`@/'1D(&-L87-S/3-$;G5M<#XX.3QS<&%N/CPO<W!A;CX\+W1D/@T*
M("`@("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS1')O/@T*("`@("`@("`\
M=&0@8VQA<W,],T1P;"!V86QI9VX],T1T;W`^1&5R:79A=&EV97,@9&5S:6=N
M871E9"!A<R!A(&9A:7(@=F%L=64@:&5D9V4@:6YS=')U;65N=',\+W1D/@T*
M("`@("`@("`\=&0@8VQA<W,],T1N=6UP/C@X.3QS<&%N/CPO<W!A;CX\+W1D
M/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<F;F)S<#LF;F)S<#L\<W!A
M;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO='(^#0H@("`@("`\='(@8VQA<W,]
M,T1R93X-"B`@("`@("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P/D]T
M:&5R('!A>6%B;&5S/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XQ
M-#QS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT
M/B<F;F)S<#LF;F)S<#L\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO='(^
M#0H@("`@("`\='(@8VQA<W,],T1R;W4^#0H@("`@("`@(#QT9"!C;&%S<STS
M1'!L('9A;&EG;CTS1'1O<#Y/=&AE<B!A8V-O=6YT<R!P87EA8FQE+"!T;W1A
M;#PO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;7`^)"`R+#,Y,3QS<&%N
M/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6UP/B0@,2PR
M-S(\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO='(^#0H@("`@/"]T86)L
M93X-"B`@/"]B;V1Y/@T*/"]H=&UL/@T*#0HM+2TM+2T]7TYE>'1087)T7S!C
M860U.69D7S<S,F5?-#9E,E]A-3,T7S!C.&%D,6%F.3!D9`T*0V]N=&5N="U,
M;V-A=&EO;CH@9FEL93HO+R]#.B\P8V%D-3EF9%\W,S)E7S0V93)?834S-%\P
M8SAA9#%A9CDP9&0O5V]R:W-H965T<R]3:&5E=#,Y+FAT;6P-"D-O;G1E;G0M
M5')A;G-F97(M16YC;V1I;F<Z('%U;W1E9"UP<FEN=&%B;&4-"D-O;G1E;G0M
M5'EP93H@=&5X="]H=&UL.R!C:&%R<V5T/2)U<RUA<V-I:2(-"@T*/&AT;6P^
M#0H@(#QH96%D/@T*("`@(#Q-151!(&AT='`M97%U:78],T1#;VYT96YT+51Y
M<&4@8V]N=&5N=#TS1"=T97AT+VAT;6P[(&-H87)S970]=71F+3@G/CQS8W)I
M<'0@='EP93TS1'1E>'0O:F%V87-C<FEP="!S<F,],T13:&]W+FIS/B\J($1O
M($YO="!296UO=F4@5&AI<R!#;VUM96YT("HO/"]S8W)I<'0^/"]H96%D/@T*
M("`\8F]D>3X-"B`@("`\=&%B;&4@8VQA<W,],T1R97!O<G0@:60],T1)1#!%
M4T)!1SX-"B`@("`@(#QT<CX-"B`@("`@("`@/'1H(&-L87-S/3-$=&P@8V]L
M<W!A;CTS1#$@<F]W<W!A;CTS1#(^/'-T<F]N9SY#3TU-251-14Y44R!!3D0@
M0T].5$E.1T5.0TE%4R`H3W!E<F%T:6YG($QE87-E*2`H1&5T86EL<RD@*%53
M1"`D*3QB<CY);B!4:&]U<V%N9',L('5N;&5S<R!O=&AE<G=I<V4@<W!E8VEF
M:65D/"]S=')O;F<^/"]T:#X-"B`@("`@("`@/'1H(&-L87-S/3-$=&@@8V]L
M<W!A;CTS1#,^,3(@36]N=&AS($5N9&5D/"]T:#X-"B`@("`@(#PO='(^#0H@
M("`@("`\='(^#0H@("`@("`@(#QT:"!C;&%S<STS1'1H/DIU;BX@,S`L(#(P
M,30\8G(^/"]T:#X-"B`@("`@("`@/'1H(&-L87-S/3-$=&@^2G5N+B`S,"P@
M,C`Q,SQB<CX\+W1H/@T*("`@("`@("`\=&@@8VQA<W,],T1T:#Y*=6XN(#,P
M+"`R,#$R/&)R/CPO=&@^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S
M/3-$<F4^#0H@("`@("`@(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O<#X\
M<W1R;VYG/D]P97)A=&EN9R!,96%S960@07-S971S(%M,:6YE($ET96US73PO
M<W1R;VYG/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N
M/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A
M;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P
M86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S
M/3-$<F\^#0H@("`@("`@(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O<#Y0
M;&5D9V5D(&-A<V@@86YD(&1E<&]S:71S/"]T9#X-"B`@("`@("`@/'1D(&-L
M87-S/3-$;G5M<#XD(#0L.#`U/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@
M(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@
M("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@
M(#PO='(^#0H@("`@("`\='(@8VQA<W,],T1R:#X-"B`@("`@("`@/'1D(&-L
M87-S/3-$<&P@=F%L:6=N/3-$=&]P/DQE87-E9"!&86-I;&ET:65S(%M-96UB
M97)=/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S
M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO
M<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\
M+W-P86X^/"]T9#X-"B`@("`@(#PO='(^#0H@("`@("`\='(@8VQA<W,],T1R
M;SX-"B`@("`@("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P/CQS=')O
M;F<^3W!E<F%T:6YG($QE87-E9"!!<W-E=',@6TQI;F4@271E;7-=/"]S=')O
M;F<^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S
M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO
M<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\
M+W-P86X^/"]T9#X-"B`@("`@(#PO='(^#0H@("`@("`\='(@8VQA<W,],T1R
M93X-"B`@("`@("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P/E!A<G1I
M8VEP871I;VX@9G)O;2!L97-S;W(\+W1D/@T*("`@("`@("`\=&0@8VQA<W,]
M,T1N=6UP/C@Q-CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA
M<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L
M87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*
M("`@("`@/'1R(&-L87-S/3-$<F\^#0H@("`@("`@(#QT9"!C;&%S<STS1'!L
M('9A;&EG;CTS1'1O<#Y,97-S;W(@9F%V;W)E9"!B86YK(&=U87)A;G1E93PO
M=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;7`^,S@X/'-P86X^/"]S<&%N
M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A
M;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P
M86X^/"]T9#X-"B`@("`@(#PO='(^#0H@("`@("`\='(@8VQA<W,],T1R93X-
M"B`@("`@("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P/DQE87-E(&5X
M<&5N<V5S/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XW,C`\<W!A
M;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XV-S@\
M<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XS
M.#(\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO='(^#0H@("`@("`\='(@
M8VQA<W,],T1R;SX-"B`@("`@("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$
M=&]P/EEE87(@96YD960@2G5N92`S,"P@,C`Q-3PO=&0^#0H@("`@("`@(#QT
M9"!C;&%S<STS1&YU;7`^-C8W/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@
M(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@
M("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@
M(#PO='(^#0H@("`@("`\='(@8VQA<W,],T1R93X-"B`@("`@("`@/'1D(&-L
M87-S/3-$<&P@=F%L:6=N/3-$=&]P/EEE87(@96YD960@2G5N92`S,"P@,C`Q
M-CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;7`^-#DW/'-P86X^/"]S
M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO
M<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\
M+W-P86X^/"]T9#X-"B`@("`@(#PO='(^#0H@("`@("`\='(@8VQA<W,],T1R
M;SX-"B`@("`@("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P/EEE87(@
M96YD960@2G5N92`S,"P@,C`Q-SPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS
M1&YU;7`^,S0Y/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S
M<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA
M<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO='(^#0H@
M("`@("`\='(@8VQA<W,],T1R974^#0H@("`@("`@(#QT9"!C;&%S<STS1'!L
M('9A;&EG;CTS1'1O<#Y4;W1A;#PO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS
M1&YU;7`^,2PU,3,\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L
M87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C
M;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-
M"B`@("`@(#QT<B!C;&%S<STS1')H/@T*("`@("`@("`\=&0@8VQA<W,],T1P
M;"!V86QI9VX],T1T;W`^0V%R<R!;365M8F5R73PO=&0^#0H@("`@("`@(#QT
M9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\
M=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@
M/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\
M+W1R/@T*("`@("`@/'1R(&-L87-S/3-$<F4^#0H@("`@("`@(#QT9"!C;&%S
M<STS1'!L('9A;&EG;CTS1'1O<#X\<W1R;VYG/D]P97)A=&EN9R!,96%S960@
M07-S971S(%M,:6YE($ET96US73PO<W1R;VYG/CPO=&0^#0H@("`@("`@(#QT
M9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\
M=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@
M/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\
M+W1R/@T*("`@("`@/'1R(&-L87-S/3-$<F\^#0H@("`@("`@(#QT9"!C;&%S
M<STS1'!L('9A;&EG;CTS1'1O<#Y,96%S92!E>'!E;G-E<SPO=&0^#0H@("`@
M("`@(#QT9"!C;&%S<STS1&YU;7`^,C0T/'-P86X^/"]S<&%N/CPO=&0^#0H@
M("`@("`@(#QT9"!C;&%S<STS1&YU;7`^,C$U/'-P86X^/"]S<&%N/CPO=&0^
M#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;7`^,3<V/'-P86X^/"]S<&%N/CPO
M=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$<F4^#0H@("`@
M("`@(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O<#Y996%R(&5N9&5D($IU
M;F4@,S`L(#(P,34\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6UP/C$T
M,#QS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT
M/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X
M=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R
M(&-L87-S/3-$<F\^#0H@("`@("`@(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS
M1'1O<#Y996%R(&5N9&5D($IU;F4@,S`L(#(P,38\+W1D/@T*("`@("`@("`\
M=&0@8VQA<W,],T1N=6UP/C@U/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@
M(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@
M("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@
M(#PO='(^#0H@("`@("`\='(@8VQA<W,],T1R93X-"B`@("`@("`@/'1D(&-L
M87-S/3-$<&P@=F%L:6=N/3-$=&]P/EEE87(@96YD960@2G5N92`S,"P@,C`Q
M-SPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;7`^,C8\<W!A;CX\+W-P
M86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S
M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO
M<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS1')O
M=3X-"B`@("`@("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P/E1O=&%L
M/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XD(#(U,3QS<&%N/CPO
M<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\
M+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^
M/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@(#PO=&%B;&4^#0H@(#PO
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M>'0O:'1M;#L@8VAA<G-E=#TB=7,M87-C:6DB#0H-"CQH=&UL/@T*("`\:&5A
M9#X-"B`@("`\345402!H='1P+65Q=6EV/3-$0V]N=&5N="U4>7!E(&-O;G1E
M;G0],T0G=&5X="]H=&UL.R!C:&%R<V5T/75T9BTX)SX\<V-R:7!T('1Y<&4]
M,T1T97AT+VIA=F%S8W)I<'0@<W)C/3-$4VAO=RYJ<SXO*B!$;R!.;W0@4F5M
M;W9E(%1H:7,@0V]M;65N="`J+SPO<V-R:7!T/CPO:&5A9#X-"B`@/&)O9'D^
M#0H@("`@/'1A8FQE(&-L87-S/3-$<F5P;W)T(&ED/3-$240P14E#044^#0H@
M("`@("`\='(^#0H@("`@("`@(#QT:"!C;&%S<STS1'1L(&-O;'-P86X],T0Q
M(')O=W-P86X],T0R/CQS=')O;F<^0T]-34E4345.5%,@04Y$($-/3E1)3D=%
M3D-)15,@*$]T:&5R*2`H1&5T86EL<RD@*%531"`D*3QB<CY);B!4:&]U<V%N
M9',L('5N;&5S<R!O=&AE<G=I<V4@<W!E8VEF:65D/"]S=')O;F<^/"]T:#X-
M"B`@("`@("`@/'1H(&-L87-S/3-$=&@@8V]L<W!A;CTS1#$^,3(@36]N=&AS
M($5N9&5D/"]T:#X-"B`@("`@(#PO='(^#0H@("`@("`\='(^#0H@("`@("`@
M(#QT:"!C;&%S<STS1'1H/DIU;BX@,S`L(#(P,30\8G(^/"]T:#X-"B`@("`@
M(#PO='(^#0H@("`@("`\='(@8VQA<W,],T1R93X-"B`@("`@("`@/'1D(&-L
M87-S/3-$<&P@=F%L:6=N/3-$=&]P/CQS=')O;F<^3W1H97(@0V]M;6ET;65N
M=',@6TQI;F4@271E;7-=/"]S=')O;F<^/"]T9#X-"B`@("`@("`@/'1D(&-L
M87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*
M("`@("`@/'1R(&-L87-S/3-$<F\^#0H@("`@("`@(#QT9"!C;&%S<STS1'!L
M('9A;&EG;CTS1'1O<#Y'<F%N=',@<F5C96EV960\+W1D/@T*("`@("`@("`\
M=&0@8VQA<W,],T1N=6UP/B0@,30L,3(U/'-P86X^/"]S<&%N/CPO=&0^#0H@
M("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$<F4^#0H@("`@("`@(#QT
M9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O<#Y097)C96YT86=E(&]F('%U86QI
M9FEE9"!E>'!E;F1I='5R97,@96QI9VEB;&4@9F]R(&=R86YT/"]T9#X-"B`@
M("`@("`@/'1D(&-L87-S/3-$;G5M<#XU,"XP,"4\<W!A;CX\+W-P86X^/"]T
M9#X-"B`@("`@(#PO='(^#0H@("`@("`\='(@8VQA<W,],T1R;SX-"B`@("`@
M("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P/E)O>6%L='D@<&%Y86)L
M92!B87-E9"!O;B!G<F%N=',@<F5C96EV960\+W1D/@T*("`@("`@("`\=&0@
M8VQA<W,],T1N=6UP/C$P,"XP,"4\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@
M(#PO='(^#0H@("`@("`\='(@8VQA<W,],T1R93X-"B`@("`@("`@/'1D(&-L
M87-S/3-$<&P@=F%L:6=N/3-$=&]P/D%C8W)U960@86YD('!A:60@<F]Y86QT
M:65S/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XU,SQS<&%N/CPO
M<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS1')O
M/@T*("`@("`@("`\=&0@8VQA<W,],T1P;"!V86QI9VX],T1T;W`^0V]N=&EN
M9V5N="!L:6%B:6QI='D@86UO=6YT/"]T9#X-"B`@("`@("`@/'1D(&-L87-S
M/3-$;G5M<#XD(#$T+#`W,CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T
M<CX-"B`@("`@(#QT<B!C;&%S<STS1')H/@T*("`@("`@("`\=&0@8VQA<W,]
M,T1P;"!V86QI9VX],T1T;W`^36EN:6UU;2!;365M8F5R73PO=&0^#0H@("`@
M("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@
M("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS1')O/@T*("`@("`@("`\=&0@
M8VQA<W,],T1P;"!V86QI9VX],T1T;W`^/'-T<F]N9SY/=&AE<B!#;VUM:71M
M96YT<R!;3&EN92!)=&5M<UT\+W-T<F]N9SX\+W1D/@T*("`@("`@("`\=&0@
M8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO='(^
M#0H@("`@("`\='(@8VQA<W,],T1R93X-"B`@("`@("`@/'1D(&-L87-S/3-$
M<&P@=F%L:6=N/3-$=&]P/E)O>6%L='D@<F%T93PO=&0^#0H@("`@("`@(#QT
M9"!C;&%S<STS1&YU;7`^,RXP,"4\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@
M(#PO='(^#0H@("`@("`\='(@8VQA<W,],T1R:#X-"B`@("`@("`@/'1D(&-L
M87-S/3-$<&P@=F%L:6=N/3-$=&]P/DUA>&EM=6T@6TUE;6)E<ET\+W1D/@T*
M("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-
M"B`@("`@(#PO='(^#0H@("`@("`\='(@8VQA<W,],T1R93X-"B`@("`@("`@
M/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P/CQS=')O;F<^3W1H97(@0V]M
M;6ET;65N=',@6TQI;F4@271E;7-=/"]S=')O;F<^/"]T9#X-"B`@("`@("`@
M/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\
M+W1R/@T*("`@("`@/'1R(&-L87-S/3-$<F\^#0H@("`@("`@(#QT9"!C;&%S
M<STS1'!L('9A;&EG;CTS1'1O<#Y2;WEA;'1Y(')A=&4\+W1D/@T*("`@("`@
M("`\=&0@8VQA<W,],T1N=6UP/C0N,#`E/'-P86X^/"]S<&%N/CPO=&0^#0H@
M("`@("`\+W1R/@T*("`@(#PO=&%B;&4^#0H@(#PO8F]D>3X-"CPO:'1M;#X-
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M=#TB=7,M87-C:6DB#0H-"CQH=&UL/@T*("`\:&5A9#X-"B`@("`\345402!H
M='1P+65Q=6EV/3-$0V]N=&5N="U4>7!E(&-O;G1E;G0],T0G=&5X="]H=&UL
M.R!C:&%R<V5T/75T9BTX)SX\<V-R:7!T('1Y<&4],T1T97AT+VIA=F%S8W)I
M<'0@<W)C/3-$4VAO=RYJ<SXO*B!$;R!.;W0@4F5M;W9E(%1H:7,@0V]M;65N
M="`J+SPO<V-R:7!T/CPO:&5A9#X-"B`@/&)O9'D^#0H@("`@/'1A8FQE(&-L
M87-S/3-$<F5P;W)T(&ED/3-$240P14181$D^#0H@("`@("`\='(^#0H@("`@
M("`@(#QT:"!C;&%S<STS1'1L(&-O;'-P86X],T0Q(')O=W-P86X],T0R/CQS
M=')O;F<^4U1/0TM(3TQ$15)3)R!%455)5%D@*$YA<G)A=&EV92D@*$1E=&%I
M;',I("A54T0@)"D\8G(^26X@5&AO=7-A;F1S+"!E>&-E<'0@4VAA<F4@9&%T
M82P@=6YL97-S(&]T:&5R=VES92!S<&5C:69I960\+W-T<F]N9SX\+W1H/@T*
M("`@("`@("`\=&@@8VQA<W,],T1T:"!C;VQS<&%N/3-$,3XP($UO;G1H<R!%
M;F1E9#PO=&@^#0H@("`@("`@(#QT:"!C;&%S<STS1'1H(&-O;'-P86X],T0W
M/C$R($UO;G1H<R!%;F1E9#PO=&@^#0H@("`@("`@(#QT:"!C;&%S<STS1'1H
M(&-O;'-P86X],T0S/CPO=&@^#0H@("`@("`@(#QT:"!C;&%S<STS1'1H(&-O
M;'-P86X],T0Q/C$@36]N=&AS($5N9&5D/"]T:#X-"B`@("`@("`@/'1H(&-L
M87-S/3-$=&@@8V]L<W!A;CTS1#$^,3(@36]N=&AS($5N9&5D/"]T:#X-"B`@
M("`@(#PO='(^#0H@("`@("`\='(^#0H@("`@("`@(#QT:"!C;&%S<STS1'1H
M/E-E<"X@,3DL(#(P,3(\8G(^/"]T:#X-"B`@("`@("`@/'1H(&-L87-S/3-$
M=&@^2G5N+B`S,"P@,C`Q-#QB<CX\+W1H/@T*("`@("`@("`\=&@@8VQA<W,]
M,T1T:#Y*=6XN(#,P+"`R,#$S/&)R/CPO=&@^#0H@("`@("`@(#QT:"!C;&%S
M<STS1'1H/DIU;BX@,S`L(#(P,3(\8G(^/"]T:#X-"B`@("`@("`@/'1H(&-L
M87-S/3-$=&@^2G5N+B`S,"P@,C`Q,CQB<CY":6]P:&%R;6%X(%M-96UB97)=
M/&)R/CPO=&@^#0H@("`@("`@(#QT:"!C;&%S<STS1'1H/DIU;BX@,S`L(#(P
M,30\8G(^26YV97-T;W(@5V%R<F%N=',@6TUE;6)E<ET\8G(^/"]T:#X-"B`@
M("`@("`@/'1H(&-L87-S/3-$=&@^2G5N+B`S,"P@,C`Q,SQB<CY);G9E<W1O
M<B!787)R86YT<R!;365M8F5R73QB<CX\+W1H/@T*("`@("`@("`\=&@@8VQA
M<W,],T1T:#Y*=6XN(#,P+"`R,#$R/&)R/DEN=F5S=&]R(%=A<G)A;G1S(%M-
M96UB97)=/&)R/CPO=&@^#0H@("`@("`@(#QT:"!C;&%S<STS1'1H/E-E<"X@
M,3DL(#(P,3(\8G(^26YV97-T;W(@5V%R<F%N=',@6TUE;6)E<ET\8G(^/"]T
M:#X-"B`@("`@("`@/'1H(&-L87-S/3-$=&@^4V5P+B`Q.2P@,C`Q,CQB<CY5
M;F1E<G=R:71E<G,@3W!T:6]N(%M-96UB97)=/&)R/CPO=&@^#0H@("`@("`@
M(#QT:"!C;&%S<STS1'1H/E-E<"X@,3DL(#(P,3(\8G(^56YD97)W<FET97(@
M5V%R<F%N=',@6TUE;6)E<ET\8G(^/"]T:#X-"B`@("`@("`@/'1H(&-L87-S
M/3-$=&@^075G+B`S,2P@,C`Q,CQB<CY#;VYS=6QT86YT(%=A<G)A;G1S(%M-
M96UB97)=/&)R/CPO=&@^#0H@("`@("`@(#QT:"!C;&%S<STS1'1H/DIU;BX@
M,S`L(#(P,30\8G(^0V]N<W5L=&%N="!787)R86YT<R!;365M8F5R73QB<CX\
M+W1H/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS1')E/@T*("`@
M("`@("`\=&0@8VQA<W,],T1P;"!V86QI9VX],T1T;W`^/'-T<F]N9SY#;&%S
M<R!O9B!3=&]C:R!;3&EN92!)=&5M<UT\+W-T<F]N9SX\+W1D/@T*("`@("`@
M("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@
M("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@
M("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@
M("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@
M("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@
M("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*
M("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-
M"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^
M#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D
M/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T
M9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO
M=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\
M+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^
M/"]T9#X-"B`@("`@(#PO='(^#0H@("`@("`\='(@8VQA<W,],T1R;SX-"B`@
M("`@("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P/D-O;6UO;B!S=&]C
M:RP@<VAA<F5S(&%U=&AO<FEZ960\+W1D/@T*("`@("`@("`\=&0@8VQA<W,]
M,T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S
M/3-$;G5M<#XR,#`L,#`P+#`P,#QS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@
M("`\=&0@8VQA<W,],T1N=6UP/C(P,"PP,#`L,#`P/'-P86X^/"]S<&%N/CPO
M=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\
M+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^
M/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N
M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A
M;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P
M86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S
M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO
M<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\
M+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^
M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N
M/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS
M1')E/@T*("`@("`@("`\=&0@8VQA<W,],T1P;"!V86QI9VX],T1T;W`^0V]M
M;6]N('-T;V-K+"!P87(@=F%L=64@<&5R('-H87)E/"]T9#X-"B`@("`@("`@
M/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@
M(#QT9"!C;&%S<STS1&YU;7`^)"`P+C`P,#`Q/'-P86X^/"]S<&%N/CPO=&0^
M#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;7`^)"`P+C`P,#`Q/'-P86X^/"]S
M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO
M<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\
M+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^
M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N
M/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A
M;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P
M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS
M<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\
M<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG
M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^
M)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<B!C
M;&%S<STS1')O/@T*("`@("`@("`\=&0@8VQA<W,],T1P;"!V86QI9VX],T1T
M;W`^4')E9F5R<F5D('-T;V-K+"!S:&%R97,@875T:&]R:7IE9#PO=&0^#0H@
M("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*
M("`@("`@("`\=&0@8VQA<W,],T1N=6UP/C$P+#`P,"PP,#`\<W!A;CX\+W-P
M86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S
M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO
M<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\
M+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^
M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N
M/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A
M;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P
M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS
M<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\
M<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG
M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^
M)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<B!C
M;&%S<STS1')E/@T*("`@("`@("`\=&0@8VQA<W,],T1P;"!V86QI9VX],T1T
M;W`^4')E9F5R<F5D('-T;V-K+"P@<&%R('9A;'5E('!E<B!S:&%R93PO=&0^
M#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D
M/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6UP/B0@,"XP,#`P,3QS<&%N/CPO
M<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\
M+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^
M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N
M/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A
M;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P
M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS
M<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\
M<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG
M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^
M)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT
M/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X
M=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R
M(&-L87-S/3-$<F\^#0H@("`@("`@(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS
M1'1O<#Y)<W-U86YC92!O9B!C;VUM;VX@<W1O8VL@86YD('=A<G)A;G1S+"!I
M<W-U86YC92!C;W-T<SPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^
M)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6UP
M/B0@,3DU/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS
M1&YU;7`^)"`R+#8Y-#QS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@
M8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D
M(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT
M9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\
M=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@
M/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@
M(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@
M("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@
M("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@
M("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@
M("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@
M("`@(#PO='(^#0H@("`@("`\='(@8VQA<W,],T1R93X-"B`@("`@("`@/'1D
M(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P/E=A<G)A;G1S(&5X97)C:7-E9"!V
M:6$@8V%S:&QE<W,@97AE<F-I<V4\+W1D/@T*("`@("`@("`\=&0@8VQA<W,]
M,T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S
M/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S
M<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA
M<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L
M87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C
M;&%S<STS1&YU;7`^,BPU,3<L.3`W/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@
M("`@(#QT9"!C;&%S<STS1&YU;7`^-C@R+#(Q,SQS<&%N/CPO<W!A;CX\+W1D
M/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6UP/C0P-BPW.#,\<W!A;CX\+W-P
M86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S
M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO
M<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\
M+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XS-BPP,#`\
M<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XV
M-2PP,#`\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO='(^#0H@("`@("`\
M='(@8VQA<W,],T1R;SX-"B`@("`@("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N
M/3-$=&]P/E=A<G)A;G1S(&5X97)C:7-E9"!V:6$@8V%S:&QE<W,@97AE<F-I
M<V4L('-H87)E<R!I<W-U960\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T
M97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$
M=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS
M1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,]
M,T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S
M/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S
M<STS1&YU;7`^,2PT-CDL-3@T/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@
M(#QT9"!C;&%S<STS1&YU;7`^-#(P+#$Y.3QS<&%N/CPO<W!A;CX\+W1D/@T*
M("`@("`@("`\=&0@8VQA<W,],T1N=6UP/C$V."PT,C0\<W!A;CX\+W-P86X^
M/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N
M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A
M;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P
M86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XR-BPR.3D\<W!A
M;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XS-BPY
M-S`\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO='(^#0H@("`@("`\='(@
M8VQA<W,],T1R93X-"B`@("`@("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$
M=&]P/E=A<G)A;G1S(&5X97)C:7-E9"!F;W(@8V%S:#PO=&0^#0H@("`@("`@
M(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@
M("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@
M("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@
M("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@
M("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@
M("`@("`@/'1D(&-L87-S/3-$;G5M<#XQ+#0S,BPU.#0\<W!A;CX\+W-P86X^
M/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XQ+#(P,2PQ-C`\<W!A
M;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XS-34L
M-#$Q/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E
M>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T
M97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$
M=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS
M1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,]
M,T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO='(^#0H@("`@
M("`\='(@8VQA<W,],T1R;SX-"B`@("`@("`@/'1D(&-L87-S/3-$<&P@=F%L
M:6=N/3-$=&]P/D%G9W)E9V%T92!C87-H(&-O;G-I9&5R871I;VX@<F5C96EV
M960\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P
M86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S
M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;7`^,BPP,#D\<W!A
M;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XU-38\
M<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG
M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;7`^
M,2PY-C@\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$
M;G5M<#XR+#`P.3QS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA
M<W,],T1N=6UP/C4U-CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@
M8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D
M(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT
M9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\
M=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@
M/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\
M+W1R/@T*("`@("`@/'1R(&-L87-S/3-$<F4^#0H@("`@("`@(#QT9"!C;&%S
M<STS1'!L('9A;&EG;CTS1'1O<#Y/<'1I;VYS(&5X97)C:7-E9#PO=&0^#0H@
M("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*
M("`@("`@("`\=&0@8VQA<W,],T1N=6UP/C$U+#`P,#QS<&%N/CPO<W!A;CX\
M+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^
M/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N
M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A
M;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P
M86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S
M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO
M<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\
M+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^
M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N
M/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A
M;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P
M86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S
M/3-$<F\^#0H@("`@("`@(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O<#Y/
M<'1I;VYS(&%N9"!W87)R86YT<R!E>&5R8VES960\+W1D/@T*("`@("`@("`\
M=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@
M/'1D(&-L87-S/3-$;G5M<#XV-BPU,#`\<W!A;CX\+W-P86X^/"]T9#X-"B`@
M("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@
M("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*
M("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-
M"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^
M#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D
M/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T
M9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO
M=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\
M+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^
M/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N
M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A
M;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS1')E/@T*
M("`@("`@("`\=&0@8VQA<W,],T1P;"!V86QI9VX],T1T;W`^3G5M8F5R(&]F
M('=A<G)A;G1S(&5X97)C:7-E9#PO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS
M1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,]
M,T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S
M/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S
M<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA
M<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L
M87-S/3-$;G5M<#XQ+#0S,BPU.#0\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@
M("`@/'1D(&-L87-S/3-$;G5M<#XQ+#(P,2PQ-C`\<W!A;CX\+W-P86X^/"]T
M9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XS-34L-#$Q/'-P86X^/"]S
M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO
M<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\
M+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^
M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N
M/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A
M;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO='(^#0H@("`@("`\='(@8VQA<W,]
M,T1R;SX-"B`@("`@("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P/DES
M<W5A;F-E(&]F(&-O;6UO;B!S=&]C:R!U;F1E<B!#2$$@86=R965M96YT/"]T
M9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO
M=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;7`^,BPU,#`L,#`P/'-P86X^
M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N
M/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A
M;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P
M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS
M<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\
M<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG
M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^
M)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT
M/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X
M=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E
M>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T
M97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO='(^#0H@("`@("`\
M='(@8VQA<W,],T1R93X-"B`@("`@("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N
M/3-$=&]P/E-T;V-K(&)A<V5D(&-O;7!E;G-A=&EO;B!T;R!C;VYT<F%C=&]R
M+"!S:&%R97,\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A
M;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P
M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS
M<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\
M<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XQ
M+#4P,"PP,#`\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S
M/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S
M<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA
M<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L
M87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C
M;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@
M8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D
M(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT
M9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T
M<CX-"B`@("`@(#QT<B!C;&%S<STS1')O/@T*("`@("`@("`\=&0@8VQA<W,]
M,T1P;"!V86QI9VX],T1T;W`^0TA!('-H87)E<R!C;&%S<VEF:65D(&%S(&UA
M<FME=&%B;&4@<V5C=7)I=&EE<SPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS
M1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,]
M,T1N=6UP/C$L,#$Q+#4P-#QS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\
M=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@
M/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@
M(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@
M("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@
M("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@
M("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@
M("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@
M("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@
M("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*
M("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-
M"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^
M#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$<F4^#0H@("`@("`@
M(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O<#Y)<W-U86YC92!O9B!C;VUM
M;VX@<W1O8VL@=6YD97(@0TA!($%G<F5E;65N="`H3F]T92`Q9"D\+W1D/@T*
M("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-
M"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XQ,"PT,30\<W!A;CX\+W-P86X^
M/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N
M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A
M;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P
M86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S
M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO
M<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\
M+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^
M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N
M/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A
M;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P
M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS
M<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S
M<STS1')O/@T*("`@("`@("`\=&0@8VQA<W,],T1P;"!V86QI9VX],T1T;W`^
M27-S=6%N8V4@;V8@8V]M;6]N('-T;V-K(&%N9"!W87)R86YT<RP@;F5T(&]F
M(&ES<W5A;F-E(&-O<W1S+"!S:&%R97,\+W1D/@T*("`@("`@("`\=&0@8VQA
M<W,],T1N=6UP/C@L,#`P+#`P,#QS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@
M("`\=&0@8VQA<W,],T1N=6UP/C(L-3DV+#`S,CQS<&%N/CPO<W!A;CX\+W1D
M/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T
M9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO
M=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\
M+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^
M/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N
M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A
M;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P
M86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S
M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO
M<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\
M+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^
M/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$
M<F4^#0H@("`@("`@(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O<#Y)<W-U
M86YC92!O9B!C;VUM;VX@<W1O8VL@86YD('=A<G)A;G1S+"!N970@;V8@:7-S
M=6%N8V4@8V]S=',\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\
M<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XQ
M,"PV-#0\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$
M;G5M<#XS-"PQ,#8\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L
M87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C
M;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@
M8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D
M(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT
M9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\
M=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@
M/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@
M(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@
M("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@
M("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@
M("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$<F\^#0H@("`@("`@(#QT9"!C
M;&%S<STS1'!L('9A;&EG;CTS1'1O<#Y/9F9E<FEN9R!P<FEC92!P97(@=6YI
M=#PO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;7`^)"`T/'-P86X^/"]S
M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO
M<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\
M+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^
M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N
M/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A
M;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P
M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS
M<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\
M<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG
M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^
M)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT
M/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X
M=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R
M(&-L87-S/3-$<F4^#0H@("`@("`@(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS
M1'1O<#Y3:&%R97,@8V]V97)E9"!B>2!E86-H('=A<G)A;G0\+W1D/@T*("`@
M("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@
M("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@
M("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*
M("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-
M"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^
M#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D
M/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T
M9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO
M=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;7`^,"XS-3QS<&%N/CPO<W!A
M;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P
M86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S
M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO
M<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\
M+W-P86X^/"]T9#X-"B`@("`@(#PO='(^#0H@("`@("`\='(@8VQA<W,],T1R
M;SX-"B`@("`@("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P/E=A<G)A
M;G0@97AE<F-I<V4@<')I8V4\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T
M97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$
M=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS
M1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,]
M,T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S
M/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S
M<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA
M<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L
M87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C
M;&%S<STS1&YU;7`^)"`U/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT
M9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\
M=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@
M/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@
M(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@
M/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS1')E/@T*("`@("`@("`\=&0@8VQA
M<W,],T1P;"!V86QI9VX],T1T;W`^5V%R<F%N=',@9F]R(&-O;6UO;B!S=&]C
M:SPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A
M;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P
M86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S
M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO
M<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\
M+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^
M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N
M/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A
M;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P
M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;7`^,2PR
M,#`L,#`P/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS
M1&YU;7`^-#(P+#`P,#QS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@
M8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D
M(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R
M/@T*("`@("`@/'1R(&-L87-S/3-$<F\^#0H@("`@("`@(#QT9"!C;&%S<STS
M1'!L('9A;&EG;CTS1'1O<#Y0<F]C965D<R!F<F]M(&ES<W5A;F-E(&]F('-T
M;V-K/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XD(#,T+#$P-CQS
M<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6UP/B0@
M,3`L-C0T/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS
M1&YU;7`^)"`S-"PQ,#8\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D
M(&-L87-S/3-$=&5X=#XG)FYB<W`[)FYB<W`[/'-P86X^/"]S<&%N/CPO=&0^
M#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D
M/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T
M9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO
M=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\
M+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^
M/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N
M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A
M;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P
M86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S
M<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$<F4^
M#0H@("`@("`@(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O<#X\<W1R;VYG
M/E-H87)E+6)A<V5D($-O;7!E;G-A=&EO;B!!<G)A;F=E;65N="!B>2!3:&%R
M92UB87-E9"!087EM96YT($%W87)D(%M,:6YE($ET96US73PO<W1R;VYG/CPO
M=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\
M+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^
M/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N
M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A
M;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P
M86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S
M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO
M<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\
M+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^
M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N
M/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A
M;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P
M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS
M<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S
M<STS1')O/@T*("`@("`@("`\=&0@8VQA<W,],T1P;"!V86QI9VX],T1T;W`^
M3W!T:6]N<R!A=71H;W)I>F5D/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$
M=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS
M1&YU;7`^,3,L,C4V+#<Q,SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\
M=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@
M/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@
M(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@
M("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@
M("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@
M("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@
M("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@
M("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@
M("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*
M("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-
M"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^
M#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$<F4^#0H@("`@("`@
M(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O<#Y/<'1I;VYS(&%V86EL86)L
M92!F;W(@9G5T=7)E(&=R86YT/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$
M=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS
M1&YU;7`^,2PR,#4L,#@P/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT
M9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\
M=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@
M/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@
M(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@
M("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@
M("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@
M("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@
M("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@
M("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@
M("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*
M("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-
M"B`@("`@(#PO='(^#0H@("`@/"]T86)L93X-"B`@/"]B;V1Y/@T*/"]H=&UL
M/@T*#0HM+2TM+2T]7TYE>'1087)T7S!C860U.69D7S<S,F5?-#9E,E]A-3,T
M7S!C.&%D,6%F.3!D9`T*0V]N=&5N="U,;V-A=&EO;CH@9FEL93HO+R]#.B\P
M8V%D-3EF9%\W,S)E7S0V93)?834S-%\P8SAA9#%A9CDP9&0O5V]R:W-H965T
M<R]3:&5E=#0R+FAT;6P-"D-O;G1E;G0M5')A;G-F97(M16YC;V1I;F<Z('%U
M;W1E9"UP<FEN=&%B;&4-"D-O;G1E;G0M5'EP93H@=&5X="]H=&UL.R!C:&%R
M<V5T/2)U<RUA<V-I:2(-"@T*/&AT;6P^#0H@(#QH96%D/@T*("`@(#Q-151!
M(&AT='`M97%U:78],T1#;VYT96YT+51Y<&4@8V]N=&5N=#TS1"=T97AT+VAT
M;6P[(&-H87)S970]=71F+3@G/CQS8W)I<'0@='EP93TS1'1E>'0O:F%V87-C
M<FEP="!S<F,],T13:&]W+FIS/B\J($1O($YO="!296UO=F4@5&AI<R!#;VUM
M96YT("HO/"]S8W)I<'0^/"]H96%D/@T*("`\8F]D>3X-"B`@("`\=&%B;&4@
M8VQA<W,],T1R97!O<G0@:60],T1)1#!%6DM!13X-"B`@("`@(#QT<CX-"B`@
M("`@("`@/'1H(&-L87-S/3-$=&P@8V]L<W!A;CTS1#$@<F]W<W!A;CTS1#(^
M/'-T<F]N9SY35$]#2TA/3$1%4E,G($5154E462`H4W5M;6%R>2!O9B!/<'1I
M;VX@06-T:79I='DI("A$971A:6QS*2`H55-$("0I/&)R/DEN(%1H;W5S86YD
M<RP@97AC97!T(%-H87)E(&1A=&$L('5N;&5S<R!O=&AE<G=I<V4@<W!E8VEF
M:65D/"]S=')O;F<^/"]T:#X-"B`@("`@("`@/'1H(&-L87-S/3-$=&@@8V]L
M<W!A;CTS1#$^,3(@36]N=&AS($5N9&5D/"]T:#X-"B`@("`@(#PO='(^#0H@
M("`@("`\='(^#0H@("`@("`@(#QT:"!C;&%S<STS1'1H/DIU;BX@,S`L(#(P
M,30\8G(^/"]T:#X-"B`@("`@(#PO='(^#0H@("`@("`\='(@8VQA<W,],T1R
M93X-"B`@("`@("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P/CQS=')O
M;F<^3G5M8F5R/"]S=')O;F<^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$
M=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@
M/'1R(&-L87-S/3-$<F\^#0H@("`@("`@(#QT9"!C;&%S<STS1'!L('9A;&EG
M;CTS1'1O<#Y/<'1I;VYS(&]U='-T86YD:6YG(&%T(&)E9VEN;FEN9R!O9B!P
M97)I;V0\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6UP/C$L.34X+#$U
M-CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<B!C
M;&%S<STS1')E/@T*("`@("`@("`\=&0@8VQA<W,],T1P;"!V86QI9VX],T1T
M;W`^3W!T:6]N<R!E>&5R8VES960\+W1D/@T*("`@("`@("`\=&0@8VQA<W,]
M,T1N=6T^*#$U+#`P,"D\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO='(^
M#0H@("`@("`\='(@8VQA<W,],T1R;SX-"B`@("`@("`@/'1D(&-L87-S/3-$
M<&P@=F%L:6=N/3-$=&]P/D]P=&EO;G,@9F]R9F5I=&5D/"]T9#X-"B`@("`@
M("`@/'1D(&-L87-S/3-$;G5M/B@X,2PP-3<I/'-P86X^/"]S<&%N/CPO=&0^
M#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$<F4^#0H@("`@("`@
M(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O<#Y/<'1I;VYS(&]U='-T86YD
M:6YG(&%T(&5N9"!O9B!T:&4@<&5R:6]D/"]T9#X-"B`@("`@("`@/'1D(&-L
M87-S/3-$;G5M<#XQ+#@V,BPP.3D\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@
M(#PO='(^#0H@("`@("`\='(@8VQA<W,],T1R;SX-"B`@("`@("`@/'1D(&-L
M87-S/3-$<&P@=F%L:6=N/3-$=&]P/D]P=&EO;G,@97AE<F-I<V%B;&4@870@
M=&AE(&5N9"!O9B!T:&4@<&5R:6]D/"]T9#X-"B`@("`@("`@/'1D(&-L87-S
M/3-$;G5M<#XQ+#@V,BPP.3D\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO
M='(^#0H@("`@("`\='(@8VQA<W,],T1R93X-"B`@("`@("`@/'1D(&-L87-S
M/3-$<&P@=F%L:6=N/3-$=&]P/D]P=&EO;G,@=F5S=&5D/"]T9#X-"B`@("`@
M("`@/'1D(&-L87-S/3-$;G5M<#XQ+#@V,BPP.3D\<W!A;CX\+W-P86X^/"]T
M9#X-"B`@("`@(#PO='(^#0H@("`@("`\='(@8VQA<W,],T1R;SX-"B`@("`@
M("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P/CQS=')O;F<^5V5I9VAT
M960@879E<F%G92!E>&5R8VES92!P<FEC93PO<W1R;VYG/CPO=&0^#0H@("`@
M("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@
M("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS1')E/@T*("`@("`@("`\=&0@
M8VQA<W,],T1P;"!V86QI9VX],T1T;W`^3W!T:6]N<R!O=71S=&%N9&EN9R!A
M="!B96=I;FYI;F<@;V8@<&5R:6]D/"]T9#X-"B`@("`@("`@/'1D(&-L87-S
M/3-$;G5M<#XD(#0N,#,\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO='(^
M#0H@("`@("`\='(@8VQA<W,],T1R;SX-"B`@("`@("`@/'1D(&-L87-S/3-$
M<&P@=F%L:6=N/3-$=&]P/D]P=&EO;G,@97AE<F-I<V5D/"]T9#X-"B`@("`@
M("`@/'1D(&-L87-S/3-$;G5M<#XD(#`N.#,\<W!A;CX\+W-P86X^/"]T9#X-
M"B`@("`@(#PO='(^#0H@("`@("`\='(@8VQA<W,],T1R93X-"B`@("`@("`@
M/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P/D]P=&EO;G,@9F]R9F5I=&5D
M/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XD(#$Q+C4Y/'-P86X^
M/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$
M<F\^#0H@("`@("`@(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O<#Y/<'1I
M;VYS(&]U='-T86YD:6YG(&%T(&5N9"!O9B!T:&4@<&5R:6]D/"]T9#X-"B`@
M("`@("`@/'1D(&-L87-S/3-$;G5M<#XD(#,N-S,\<W!A;CX\+W-P86X^/"]T
M9#X-"B`@("`@(#PO='(^#0H@("`@("`\='(@8VQA<W,],T1R93X-"B`@("`@
M("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P/D]P=&EO;G,@97AE<F-I
M<V%B;&4@870@=&AE(&5N9"!O9B!T:&4@<&5R:6]D/"]T9#X-"B`@("`@("`@
M/'1D(&-L87-S/3-$;G5M<#XD(#,N-S,\<W!A;CX\+W-P86X^/"]T9#X-"B`@
M("`@(#PO='(^#0H@("`@("`\='(@8VQA<W,],T1R;SX-"B`@("`@("`@/'1D
M(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P/D]P=&EO;G,@=F5S=&5D/"]T9#X-
M"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XD(#,N-S,\<W!A;CX\+W-P86X^
M/"]T9#X-"B`@("`@(#PO='(^#0H@("`@("`\='(@8VQA<W,],T1R93X-"B`@
M("`@("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P/CQS=')O;F<^5V5I
M9VAT960@879E<F%G92!R96UA:6YI;F<@8V]N=')A8W1U86P@=&5R;3PO<W1R
M;VYG/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO
M<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS1')O
M/@T*("`@("`@("`\=&0@8VQA<W,],T1P;"!V86QI9VX],T1T;W`^5V5I9VAT
M960@079E<F%G92!296UA:6YI;F<@0V]N=')A8W1U86P@5&5R;7,@*&EN('EE
M87)S*3PO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)S,@>65A<G,@
M,2!M;VYT:"`Q-R!D87ES/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R
M/@T*("`@("`@/'1R(&-L87-S/3-$<F4^#0H@("`@("`@(#QT9"!C;&%S<STS
M1'!L('9A;&EG;CTS1'1O<#Y/<'1I;VYS(&5X97)C:7-A8FQE(&%T('1H92!E
M;F0@;V8@=&AE('!E<FEO9#PO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E
M>'0^)S,@>65A<G,@,2!M;VYT:"`Q-R!D87ES/'-P86X^/"]S<&%N/CPO=&0^
M#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$<F\^#0H@("`@("`@
M(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O<#Y/<'1I;VYS('9E<W1E9#PO
M=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)S,@>65A<G,@,2!M;VYT
M:"`Q-R!D87ES/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@
M("`@/'1R(&-L87-S/3-$<F4^#0H@("`@("`@(#QT9"!C;&%S<STS1'!L('9A
M;&EG;CTS1'1O<#X\<W1R;VYG/D%G9W)E9V%T92!I;G1R:6YS:6,@=F%L=64@
M<')I8V4\+W-T<F]N9SX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT
M/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO='(^#0H@("`@("`\='(@
M8VQA<W,],T1R;SX-"B`@("`@("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$
M=&]P/D]P=&EO;G,@;W5T<W1A;F1I;F<@870@96YD(&]F('1H92!P97)I;V0\
M+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6UP/B0@,2PP-#8\<W!A;CX\
M+W-P86X^/"]T9#X-"B`@("`@(#PO='(^#0H@("`@("`\='(@8VQA<W,],T1R
M93X-"B`@("`@("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P/D]P=&EO
M;G,@97AE<F-I<V%B;&4@870@=&AE(&5N9"!O9B!T:&4@<&5R:6]D/"]T9#X-
M"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XQ+#`T-CQS<&%N/CPO<W!A;CX\
M+W1D/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS1')O/@T*("`@
M("`@("`\=&0@8VQA<W,],T1P;"!V86QI9VX],T1T;W`^3W!T:6]N<R!V97-T
M960\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6UP/B0@,2PP-#8\<W!A
M;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO='(^#0H@("`@/"]T86)L93X-"B`@
M/"]B;V1Y/@T*/"]H=&UL/@T*#0HM+2TM+2T]7TYE>'1087)T7S!C860U.69D
M7S<S,F5?-#9E,E]A-3,T7S!C.&%D,6%F.3!D9`T*0V]N=&5N="U,;V-A=&EO
M;CH@9FEL93HO+R]#.B\P8V%D-3EF9%\W,S)E7S0V93)?834S-%\P8SAA9#%A
M9CDP9&0O5V]R:W-H965T<R]3:&5E=#0S+FAT;6P-"D-O;G1E;G0M5')A;G-F
M97(M16YC;V1I;F<Z('%U;W1E9"UP<FEN=&%B;&4-"D-O;G1E;G0M5'EP93H@
M=&5X="]H=&UL.R!C:&%R<V5T/2)U<RUA<V-I:2(-"@T*/&AT;6P^#0H@(#QH
M96%D/@T*("`@(#Q-151!(&AT='`M97%U:78],T1#;VYT96YT+51Y<&4@8V]N
M=&5N=#TS1"=T97AT+VAT;6P[(&-H87)S970]=71F+3@G/CQS8W)I<'0@='EP
M93TS1'1E>'0O:F%V87-C<FEP="!S<F,],T13:&]W+FIS/B\J($1O($YO="!2
M96UO=F4@5&AI<R!#;VUM96YT("HO/"]S8W)I<'0^/"]H96%D/@T*("`\8F]D
M>3X-"B`@("`\=&%B;&4@8VQA<W,],T1R97!O<G0@:60],T1)1#!%6DM!13X-
M"B`@("`@(#QT<CX-"B`@("`@("`@/'1H(&-L87-S/3-$=&P@8V]L<W!A;CTS
M1#$@<F]W<W!A;CTS1#(^/'-T<F]N9SY35$]#2TA/3$1%4E,G($5154E462`H
M4W5M;6%R>2!O9B!/<'1I;VX@86YD(%=A<G)A;G0@06-T:79I='D@=&\@3F]N
M+65M<&QO>65E<RD@*$1E=&%I;',I("A54T0@)"D\8G(^26X@5&AO=7-A;F1S
M+"!E>&-E<'0@4VAA<F4@9&%T82P@=6YL97-S(&]T:&5R=VES92!S<&5C:69I
M960\+W-T<F]N9SX\+W1H/@T*("`@("`@("`\=&@@8VQA<W,],T1T:"!C;VQS
M<&%N/3-$,3XQ,B!-;VYT:',@16YD960\+W1H/@T*("`@("`@/"]T<CX-"B`@
M("`@(#QT<CX-"B`@("`@("`@/'1H(&-L87-S/3-$=&@^2G5N+B`S,"P@,C`Q
M-#QB<CX\+W1H/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS1')E
M/@T*("`@("`@("`\=&0@8VQA<W,],T1P;"!V86QI9VX],T1T;W`^/'-T<F]N
M9SY.=6UB97(\+W-T<F]N9SX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T
M97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO='(^#0H@("`@("`\
M='(@8VQA<W,],T1R;SX-"B`@("`@("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N
M/3-$=&]P/D]P=&EO;G,@86YD('=A<G)A;G1S(&]U='-T86YD:6YG(&%T(&)E
M9VEN;FEN9R!O9B!P97)I;V0\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N
M=6UP/C,Q-2PU,#`\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO='(^#0H@
M("`@("`\='(@8VQA<W,],T1R93X-"B`@("`@("`@/'1D(&-L87-S/3-$<&P@
M=F%L:6=N/3-$=&]P/D]P=&EO;G,@9W)A;G1E9#PO=&0^#0H@("`@("`@(#QT
M9"!C;&%S<STS1&YU;7`^,RPP,#`\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@
M(#PO='(^#0H@("`@("`\='(@8VQA<W,],T1R;SX-"B`@("`@("`@/'1D(&-L
M87-S/3-$<&P@=F%L:6=N/3-$=&]P/D]P=&EO;G,@86YD('=A<G)A;G1S(&5X
M97)C:7-E9#PO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;3XH-C8L-3`P
M*3QS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<B!C
M;&%S<STS1')E/@T*("`@("`@("`\=&0@8VQA<W,],T1P;"!V86QI9VX],T1T
M;W`^3W!T:6]N<R!A;F0@=V%R<F%N=',@;W5T<W1A;F1I;F<@870@96YD(&]F
M('1H92!P97)I;V0\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6UP/C(U
M,BPP,#`\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO='(^#0H@("`@("`\
M='(@8VQA<W,],T1R;SX-"B`@("`@("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N
M/3-$=&]P/D]P=&EO;G,@86YD('=A<G)A;G1S(&5X97)C:7-A8FQE(&%T('1H
M92!E;F0@;V8@=&AE('!E<FEO9#PO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS
M1&YU;7`^,C4Q+#`P,#QS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-
M"B`@("`@(#QT<B!C;&%S<STS1')E/@T*("`@("`@("`\=&0@8VQA<W,],T1P
M;"!V86QI9VX],T1T;W`^3W!T:6]N<R!A;F0@=V%R<F%N=',@=F5S=&5D(&%N
M9"!E>'!E8W1E9"!T;R!V97-T/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$
M;G5M<#XR-3(L,#`P/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*
M("`@("`@/'1R(&-L87-S/3-$<F\^#0H@("`@("`@(#QT9"!C;&%S<STS1'!L
M('9A;&EG;CTS1'1O<#X\<W1R;VYG/E=E:6=H=&5D(&%V97)A9V4@97AE<F-I
M<V4@<')I8V4\+W-T<F]N9SX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T
M97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO='(^#0H@("`@("`\
M='(@8VQA<W,],T1R93X-"B`@("`@("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N
M/3-$=&]P/D]P=&EO;G,@86YD('=A<G)A;G1S(&]U='-T86YD:6YG(&%T(&)E
M9VEN;FEN9R!O9B!P97)I;V0\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N
M=6UP/B0@-"XT-#QS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@
M("`@(#QT<B!C;&%S<STS1')O/@T*("`@("`@("`\=&0@8VQA<W,],T1P;"!V
M86QI9VX],T1T;W`^3W!T:6]N<R!G<F%N=&5D/"]T9#X-"B`@("`@("`@/'1D
M(&-L87-S/3-$;G5M<#XD(#`\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO
M='(^#0H@("`@("`\='(@8VQA<W,],T1R93X-"B`@("`@("`@/'1D(&-L87-S
M/3-$<&P@=F%L:6=N/3-$=&]P/D]P=&EO;G,@86YD('=A<G)A;G1S(&5X97)C
M:7-E9#PO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;7`^)"`Q+C,Y/'-P
M86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S
M/3-$<F\^#0H@("`@("`@(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O<#Y/
M<'1I;VYS(&%N9"!W87)R86YT<R!O=71S=&%N9&EN9R!A="!E;F0@;V8@=&AE
M('!E<FEO9#PO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;7`^)"`U+C$Y
M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L
M87-S/3-$<F4^#0H@("`@("`@(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O
M<#Y/<'1I;VYS(&%N9"!W87)R86YT<R!E>&5R8VES86)L92!A="!T:&4@96YD
M(&]F('1H92!P97)I;V0\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6UP
M/B0@-2XR,3QS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@("`@
M(#QT<B!C;&%S<STS1')O/@T*("`@("`@("`\=&0@8VQA<W,],T1P;"!V86QI
M9VX],T1T;W`^3W!T:6]N<R!A;F0@=V%R<F%N=',@=F5S=&5D(&%N9"!E>'!E
M8W1E9"!T;R!V97-T/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XD
M(#4N,3D\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO='(^#0H@("`@("`\
M='(@8VQA<W,],T1R93X-"B`@("`@("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N
M/3-$=&]P/CQS=')O;F<^5V5I9VAT960@879E<F%G92!R96UA:6YI;F<@8V]N
M=')A8W1U86P@=&5R;3PO<W1R;VYG/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S
M<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@
M("`@(#QT<B!C;&%S<STS1')O/@T*("`@("`@("`\=&0@8VQA<W,],T1P;"!V
M86QI9VX],T1T;W`^3W!T:6]N<R!A;F0@=V%R<F%N=',@;W5T<W1A;F1I;F<@
M870@96YD(&]F('1H92!P97)I;V0\+W1D/@T*("`@("`@("`\=&0@8VQA<W,]
M,T1T97AT/B<S('EE87)S(#$Q(&UO;G1H<R`Q-B!D87ES/'-P86X^/"]S<&%N
M/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$<F4^#0H@
M("`@("`@(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O<#Y/<'1I;VYS(&%N
M9"!W87)R86YT<R!E>&5R8VES86)L92!A="!T:&4@96YD(&]F('1H92!P97)I
M;V0\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<S('EE87)S(#$Q
M(&UO;G1H<R`U(&1A>7,\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO='(^
M#0H@("`@("`\='(@8VQA<W,],T1R;SX-"B`@("`@("`@/'1D(&-L87-S/3-$
M<&P@=F%L:6=N/3-$=&]P/D]P=&EO;G,@86YD('=A<G)A;G1S('9E<W1E9"!A
M;F0@97AP96-T960@=&\@=F5S=#PO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS
M1'1E>'0^)S,@>65A<G,@,3$@;6]N=&AS(#$V(&1A>7,\<W!A;CX\+W-P86X^
M/"]T9#X-"B`@("`@(#PO='(^#0H@("`@("`\='(@8VQA<W,],T1R93X-"B`@
M("`@("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P/CQS=')O;F<^06=G
M<F5G871E(&EN=')I;G-I8R!V86QU92!P<FEC93PO<W1R;VYG/CPO=&0^#0H@
M("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*
M("`@("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS1')O/@T*("`@("`@("`\
M=&0@8VQA<W,],T1P;"!V86QI9VX],T1T;W`^3W!T:6]N<R!A;F0@=V%R<F%N
M=',@;W5T<W1A;F1I;F<@870@96YD(&]F('1H92!P97)I;V0\+W1D/@T*("`@
M("`@("`\=&0@8VQA<W,],T1N=6UP/B0@,S,Q/'-P86X^/"]S<&%N/CPO=&0^
M#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$<F4^#0H@("`@("`@
M(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O<#Y/<'1I;VYS(&%N9"!W87)R
M86YT<R!E>&5R8VES86)L92!A="!T:&4@96YD(&]F('1H92!P97)I;V0\+W1D
M/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6UP/C,R.#QS<&%N/CPO<W!A;CX\
M+W1D/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS1')O/@T*("`@
M("`@("`\=&0@8VQA<W,],T1P;"!V86QI9VX],T1T;W`^3W!T:6]N<R!A;F0@
M=V%R<F%N=',@=F5S=&5D(&%N9"!E>'!E8W1E9"!T;R!V97-T/"]T9#X-"B`@
M("`@("`@/'1D(&-L87-S/3-$;G5M<#XD(#,S,3QS<&%N/CPO<W!A;CX\+W1D
M/@T*("`@("`@/"]T<CX-"B`@("`\+W1A8FQE/@T*("`\+V)O9'D^#0H\+VAT
M;6P^#0H-"BTM+2TM+3U?3F5X=%!A<G1?,&-A9#4Y9F1?-S,R95\T-F4R7V$U
M,S1?,&,X860Q868Y,&1D#0I#;VYT96YT+4QO8V%T:6]N.B!F:6QE.B\O+T,Z
M+S!C860U.69D7S<S,F5?-#9E,E]A-3,T7S!C.&%D,6%F.3!D9"]7;W)K<VAE
M971S+U-H965T-#0N:'1M;`T*0V]N=&5N="U4<F%N<V9E<BU%;F-O9&EN9SH@
M<75O=&5D+7!R:6YT86)L90T*0V]N=&5N="U4>7!E.B!T97AT+VAT;6P[(&-H
M87)S970](G5S+6%S8VEI(@T*#0H\:'1M;#X-"B`@/&AE860^#0H@("`@/$U%
M5$$@:'1T<"UE<75I=CTS1$-O;G1E;G0M5'EP92!C;VYT96YT/3-$)W1E>'0O
M:'1M;#L@8VAA<G-E=#UU=&8M."<^/'-C<FEP="!T>7!E/3-$=&5X="]J879A
M<V-R:7!T('-R8STS1%-H;W<N:G,^+RH@1&\@3F]T(%)E;6]V92!4:&ES($-O
M;6UE;G0@*B\\+W-C<FEP=#X\+VAE860^#0H@(#QB;V1Y/@T*("`@(#QT86)L
M92!C;&%S<STS1')E<&]R="!I9#TS1$E$,$5924%#/@T*("`@("`@/'1R/@T*
M("`@("`@("`\=&@@8VQA<W,],T1T;"!C;VQS<&%N/3-$,2!R;W=S<&%N/3-$
M,CX\<W1R;VYG/E-43T-+2$],1$524R<@15%52519("A3=6UM87)Y(&]F(%)3
M52!!8W1I=FET>2!T;R!%;7!L;WEE97,@86YD($1I<F5C=&]R<RD@*$1E=&%I
M;',I("A297-T<FEC=&5D('-T;V-K('5N:71S(%M-96UB97)=*3QB<CX\+W-T
M<F]N9SX\+W1H/@T*("`@("`@("`\=&@@8VQA<W,],T1T:"!C;VQS<&%N/3-$
M,3XQ,B!-;VYT:',@16YD960\+W1H/@T*("`@("`@/"]T<CX-"B`@("`@(#QT
M<CX-"B`@("`@("`@/'1H(&-L87-S/3-$=&@^2G5N+B`S,"P@,C`Q-#QB<CX\
M+W1H/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS1')H/@T*("`@
M("`@("`\=&0@8VQA<W,],T1P;"!V86QI9VX],T1T;W`^4F5S=')I8W1E9"!S
M=&]C:R!U;FET<R!;365M8F5R73PO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS
M1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@("`@
M(#QT<B!C;&%S<STS1')O/@T*("`@("`@("`\=&0@8VQA<W,],T1P;"!V86QI
M9VX],T1T;W`^/'-T<F]N9SY3:&%R92UB87-E9"!#;VUP96YS871I;VX@07)R
M86YG96UE;G0@8GD@4VAA<F4M8F%S960@4&%Y;65N="!!=V%R9"!;3&EN92!)
M=&5M<UT\+W-T<F]N9SX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT
M/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO='(^#0H@("`@("`\='(@
M8VQA<W,],T1R93X-"B`@("`@("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$
M=&]P/E5N=F5S=&5D(&%T('1H92!B96=I;FYI;F<@;V8@<&5R:6]D/"]T9#X-
M"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XQ+#8V,"PU,C4\<W!A;CX\+W-P
M86X^/"]T9#X-"B`@("`@(#PO='(^#0H@("`@("`\='(@8VQA<W,],T1R;SX-
M"B`@("`@("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P/D=R86YT960\
M+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6UP/C$L,C4V+#DT,#QS<&%N
M/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS
M1')E/@T*("`@("`@("`\=&0@8VQA<W,],T1P;"!V86QI9VX],T1T;W`^1F]R
M9F5I=&5D/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M/B@T-"PQ.#,I
M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L
M87-S/3-$<F\^#0H@("`@("`@(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O
M<#Y697-T960\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6T^*#$L,C@S
M+#@U,"D\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO='(^#0H@("`@("`\
M='(@8VQA<W,],T1R93X-"B`@("`@("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N
M/3-$=&]P/E5N=F5S=&5D(&%T('1H92!E;F0@;V8@=&AE('!E<FEO9#PO=&0^
M#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;7`^,2PU.#DL-#,R/'-P86X^/"]S
M<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$<F\^
M#0H@("`@("`@(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O<#Y%>'!E8W1E
M9"!T;R!V97-T/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XQ+#4R
M,BPP,C0\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO='(^#0H@("`@/"]T
M86)L93X-"B`@/"]B;V1Y/@T*/"]H=&UL/@T*#0HM+2TM+2T]7TYE>'1087)T
M7S!C860U.69D7S<S,F5?-#9E,E]A-3,T7S!C.&%D,6%F.3!D9`T*0V]N=&5N
M="U,;V-A=&EO;CH@9FEL93HO+R]#.B\P8V%D-3EF9%\W,S)E7S0V93)?834S
M-%\P8SAA9#%A9CDP9&0O5V]R:W-H965T<R]3:&5E=#0U+FAT;6P-"D-O;G1E
M;G0M5')A;G-F97(M16YC;V1I;F<Z('%U;W1E9"UP<FEN=&%B;&4-"D-O;G1E
M;G0M5'EP93H@=&5X="]H=&UL.R!C:&%R<V5T/2)U<RUA<V-I:2(-"@T*/&AT
M;6P^#0H@(#QH96%D/@T*("`@(#Q-151!(&AT='`M97%U:78],T1#;VYT96YT
M+51Y<&4@8V]N=&5N=#TS1"=T97AT+VAT;6P[(&-H87)S970]=71F+3@G/CQS
M8W)I<'0@='EP93TS1'1E>'0O:F%V87-C<FEP="!S<F,],T13:&]W+FIS/B\J
M($1O($YO="!296UO=F4@5&AI<R!#;VUM96YT("HO/"]S8W)I<'0^/"]H96%D
M/@T*("`\8F]D>3X-"B`@("`\=&%B;&4@8VQA<W,],T1R97!O<G0@:60],T1)
M1#!%,49!0SX-"B`@("`@(#QT<CX-"B`@("`@("`@/'1H(&-L87-S/3-$=&P@
M8V]L<W!A;CTS1#$@<F]W<W!A;CTS1#(^/'-T<F]N9SY35$]#2TA/3$1%4E,G
M($5154E462`H4W5M;6%R>2!O9B!24U4@06-T:79I='D@=&\@0V]N<W5L=&%N
M=',I("A$971A:6QS*2`H0V]N<W5L=&%N=',@6TUE;6)E<ETI/&)R/CPO<W1R
M;VYG/CPO=&@^#0H@("`@("`@(#QT:"!C;&%S<STS1'1H(&-O;'-P86X],T0Q
M/C$R($UO;G1H<R!%;F1E9#PO=&@^#0H@("`@("`\+W1R/@T*("`@("`@/'1R
M/@T*("`@("`@("`\=&@@8VQA<W,],T1T:#Y*=6XN(#,P+"`R,#$T/&)R/CPO
M=&@^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$<F@^#0H@("`@
M("`@(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O<#Y#;VYS=6QT86YT<R!;
M365M8F5R73PO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N
M/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS
M1')O/@T*("`@("`@("`\=&0@8VQA<W,],T1P;"!V86QI9VX],T1T;W`^/'-T
M<F]N9SY3:&%R92UB87-E9"!';V]D<R!A;F0@3F]N96UP;&]Y964@4V5R=FEC
M97,@5')A;G-A8W1I;VX@6TQI;F4@271E;7-=/"]S=')O;F<^/"]T9#X-"B`@
M("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@
M("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$<F4^#0H@("`@("`@(#QT
M9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O<#Y5;G9E<W1E9"!A="!T:&4@8F5G
M:6YN:6YG(&]F('!E<FEO9#PO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E
M>'0^)R9N8G-P.R9N8G-P.SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T
M<CX-"B`@("`@(#QT<B!C;&%S<STS1')O/@T*("`@("`@("`\=&0@8VQA<W,]
M,T1P;"!V86QI9VX],T1T;W`^1W)A;G1E9#PO=&0^#0H@("`@("`@(#QT9"!C
M;&%S<STS1&YU;7`^.#0L-38U/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\
M+W1R/@T*("`@("`@/'1R(&-L87-S/3-$<F4^#0H@("`@("`@(#QT9"!C;&%S
M<STS1'!L('9A;&EG;CTS1'1O<#Y697-T960\+W1D/@T*("`@("`@("`\=&0@
M8VQA<W,],T1N=6T^*#8Y+#,Q-2D\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@
M(#PO='(^#0H@("`@("`\='(@8VQA<W,],T1R;SX-"B`@("`@("`@/'1D(&-L
M87-S/3-$<&P@=F%L:6=N/3-$=&]P/E5N=F5S=&5D(&%T('1H92!E;F0@;V8@
M=&AE('!E<FEO9#PO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;7`^,34L
M,C4P/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@(#PO=&%B
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M/@T*("`\:&5A9#X-"B`@("`\345402!H='1P+65Q=6EV/3-$0V]N=&5N="U4
M>7!E(&-O;G1E;G0],T0G=&5X="]H=&UL.R!C:&%R<V5T/75T9BTX)SX\<V-R
M:7!T('1Y<&4],T1T97AT+VIA=F%S8W)I<'0@<W)C/3-$4VAO=RYJ<SXO*B!$
M;R!.;W0@4F5M;W9E(%1H:7,@0V]M;65N="`J+SPO<V-R:7!T/CPO:&5A9#X-
M"B`@/&)O9'D^#0H@("`@/'1A8FQE(&-L87-S/3-$<F5P;W)T(&ED/3-$240P
M14190D<^#0H@("`@("`\='(^#0H@("`@("`@(#QT:"!C;&%S<STS1'1L(&-O
M;'-P86X],T0Q(')O=W-P86X],T0R/CQS=')O;F<^4U1/0TM(3TQ$15)3)R!%
M455)5%D@*%-C:&5D=6QE(&]F($-O;7!E;G-A=&EO;B!%>'!E;G-E*2`H1&5T
M86EL<RD@*%531"`D*3QB<CY);B!4:&]U<V%N9',L('5N;&5S<R!O=&AE<G=I
M<V4@<W!E8VEF:65D/"]S=')O;F<^/"]T:#X-"B`@("`@("`@/'1H(&-L87-S
M/3-$=&@@8V]L<W!A;CTS1#,^,3(@36]N=&AS($5N9&5D/"]T:#X-"B`@("`@
M(#PO='(^#0H@("`@("`\='(^#0H@("`@("`@(#QT:"!C;&%S<STS1'1H/DIU
M;BX@,S`L(#(P,30\8G(^/"]T:#X-"B`@("`@("`@/'1H(&-L87-S/3-$=&@^
M2G5N+B`S,"P@,C`Q,SQB<CX\+W1H/@T*("`@("`@("`\=&@@8VQA<W,],T1T
M:#Y*=6XN(#,P+"`R,#$R/&)R/CPO=&@^#0H@("`@("`\+W1R/@T*("`@("`@
M/'1R(&-L87-S/3-$<F@^#0H@("`@("`@(#QT9"!C;&%S<STS1'!L('9A;&EG
M;CTS1'1O<#Y#;VYS=6QT86YT<R!;365M8F5R73PO=&0^#0H@("`@("`@(#QT
M9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\
M=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@
M/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\
M+W1R/@T*("`@("`@/'1R(&-L87-S/3-$<F\^#0H@("`@("`@(#QT9"!C;&%S
M<STS1'!L('9A;&EG;CTS1'1O<#X\<W1R;VYG/D5M<&QO>65E(%-E<G9I8V4@
M4VAA<F4M8F%S960@0V]M<&5N<V%T:6]N+"!!;&QO8V%T:6]N(&]F(%)E8V]G
M;FEZ960@4&5R:6]D($-O<W1S(%M,:6YE($ET96US73PO<W1R;VYG/CPO=&0^
M#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D
M/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T
M9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO
M=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$<F4^#0H@("`@
M("`@(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O<#Y#;VUP96YS871I;VX@
M97AP96YS97,\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6UP/B0@,C<X
M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;7`^
M)"`U,S,\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$
M;G5M<#XD(#(R,3QS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@
M("`@(#QT<B!C;&%S<STS1')H/@T*("`@("`@("`\=&0@8VQA<W,],T1P;"!V
M86QI9VX],T1T;W`^3W!T:6]N<R!A;F0@=V%R<F%N=',@6TUE;6)E<ET\+W1D
M/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T
M9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO
M=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\
M+W1D/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS1')E/@T*("`@
M("`@("`\=&0@8VQA<W,],T1P;"!V86QI9VX],T1T;W`^/'-T<F]N9SY%;7!L
M;WEE92!397)V:6-E(%-H87)E+6)A<V5D($-O;7!E;G-A=&EO;BP@06QL;V-A
M=&EO;B!O9B!296-O9VYI>F5D(%!E<FEO9"!#;W-T<R!;3&EN92!)=&5M<UT\
M+W-T<F]N9SX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A
M;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P
M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS
M<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S
M<STS1')O/@T*("`@("`@("`\=&0@8VQA<W,],T1P;"!V86QI9VX],T1T;W`^
M0V]M<&5N<V%T:6]N(&5X<&5N<V5S/"]T9#X-"B`@("`@("`@/'1D(&-L87-S
M/3-$;G5M<#XQ,3QS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA
M<W,],T1N=6UP/C(V/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C
M;&%S<STS1&YU;7`^-38\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO='(^
M#0H@("`@("`\='(@8VQA<W,],T1R93X-"B`@("`@("`@/'1D(&-L87-S/3-$
M<&P@=F%L:6=N/3-$=&]P/E5N<F5C;V=N:7IE9"!C;VUP96YS871I;VX@97AP
M96YS93PO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;7`^,3QS<&%N/CPO
M<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\
M+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^
M/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$
M<F\^#0H@("`@("`@(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O<#Y5;G)E
M8V]G;FEZ960@8V]M<&5N<V%T:6]N(&5X<&5N<V4L(')E8V]G;FET:6]N('!E
M<FEO9#PO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)S,@;6]N=&AS
M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^
M)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT
M/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO='(^#0H@("`@("`\='(@
M8VQA<W,],T1R:#X-"B`@("`@("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$
M=&]P/E)E<W1R:6-T960@<W1O8VL@=6YI=',@6TUE;6)E<ET\+W1D/@T*("`@
M("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@
M("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@
M("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*
M("`@("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS1')O/@T*("`@("`@("`\
M=&0@8VQA<W,],T1P;"!V86QI9VX],T1T;W`^/'-T<F]N9SY%;7!L;WEE92!3
M97)V:6-E(%-H87)E+6)A<V5D($-O;7!E;G-A=&EO;BP@06QL;V-A=&EO;B!O
M9B!296-O9VYI>F5D(%!E<FEO9"!#;W-T<R!;3&EN92!)=&5M<UT\+W-T<F]N
M9SX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P
M86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S
M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO
M<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS1')E
M/@T*("`@("`@("`\=&0@8VQA<W,],T1P;"!V86QI9VX],T1T;W`^0V]M<&5N
M<V%T:6]N(&5X<&5N<V5S/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M
M<#XU+#4V,CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,]
M,T1N=6UP/C(L,C0P/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C
M;&%S<STS1&YU;7`^-"PV-3`\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO
M='(^#0H@("`@("`\='(@8VQA<W,],T1R;SX-"B`@("`@("`@/'1D(&-L87-S
M/3-$<&P@=F%L:6=N/3-$=&]P/E5N<F5C;V=N:7IE9"!C;VUP96YS871I;VX@
M97AP96YS93PO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;7`^,BPT-#<\
M<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG
M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^
M)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<B!C
M;&%S<STS1')E/@T*("`@("`@("`\=&0@8VQA<W,],T1P;"!V86QI9VX],T1T
M;W`^56YR96-O9VYI>F5D(&-O;7!E;G-A=&EO;B!E>'!E;G-E+"!R96-O9VYI
M=&EO;B!P97)I;V0\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<R
M('EE87)S/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS
M1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,]
M,T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO='(^#0H@("`@
M("`\='(@8VQA<W,],T1R:#X-"B`@("`@("`@/'1D(&-L87-S/3-$<&P@=F%L
M:6=N/3-$=&]P/E)E<V5A<F-H(&%N9"!D979E;&]P;65N="!E>'!E;G-E<R!;
M365M8F5R72!\($]P=&EO;G,@86YD('=A<G)A;G1S(%M-96UB97)=/"]T9#X-
M"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^
M#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D
M/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T
M9#X-"B`@("`@(#PO='(^#0H@("`@("`\='(@8VQA<W,],T1R93X-"B`@("`@
M("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P/CQS=')O;F<^16UP;&]Y
M964@4V5R=FEC92!3:&%R92UB87-E9"!#;VUP96YS871I;VXL($%L;&]C871I
M;VX@;V8@4F5C;V=N:7IE9"!097)I;V0@0V]S=',@6TQI;F4@271E;7-=/"]S
M=')O;F<^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^
M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N
M/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A
M;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO='(^#0H@("`@("`\='(@8VQA<W,]
M,T1R;SX-"B`@("`@("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P/D-O
M;7!E;G-A=&EO;B!E>'!E;G-E<SPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS
M1&YU;7`^,3$\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S
M/3-$;G5M<#XR-CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA
M<W,],T1N=6UP/C$Y/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*
M("`@("`@/'1R(&-L87-S/3-$<F@^#0H@("`@("`@(#QT9"!C;&%S<STS1'!L
M('9A;&EG;CTS1'1O<#Y297-E87)C:"!A;F0@9&5V96QO<&UE;G0@97AP96YS
M97,@6TUE;6)E<ET@?"!297-T<FEC=&5D('-T;V-K('5N:71S(%M-96UB97)=
M/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N
M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A
M;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P
M86X^/"]T9#X-"B`@("`@(#PO='(^#0H@("`@("`\='(@8VQA<W,],T1R;SX-
M"B`@("`@("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P/CQS=')O;F<^
M16UP;&]Y964@4V5R=FEC92!3:&%R92UB87-E9"!#;VUP96YS871I;VXL($%L
M;&]C871I;VX@;V8@4F5C;V=N:7IE9"!097)I;V0@0V]S=',@6TQI;F4@271E
M;7-=/"]S=')O;F<^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG
M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^
M)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT
M/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO='(^#0H@("`@("`\='(@
M8VQA<W,],T1R93X-"B`@("`@("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$
M=&]P/D-O;7!E;G-A=&EO;B!E>'!E;G-E<SPO=&0^#0H@("`@("`@(#QT9"!C
M;&%S<STS1&YU;7`^,2PQ-S(\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@
M/'1D(&-L87-S/3-$;G5M<#XW,3$\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@
M("`@/'1D(&-L87-S/3-$;G5M<#XQ+#$V,SQS<&%N/CPO<W!A;CX\+W1D/@T*
M("`@("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS1')H/@T*("`@("`@("`\
M=&0@8VQA<W,],T1P;"!V86QI9VX],T1T;W`^4F5S96%R8V@@86YD(&1E=F5L
M;W!M96YT(&5X<&5N<V5S(%M-96UB97)=('P@4F5S=')I8W1E9"!S=&]C:R!U
M;FET<R!;365M8F5R72!\($-O;G-U;'1A;G1S(%M-96UB97)=/"]T9#X-"B`@
M("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@
M("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*
M("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-
M"B`@("`@(#PO='(^#0H@("`@("`\='(@8VQA<W,],T1R93X-"B`@("`@("`@
M/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P/CQS=')O;F<^16UP;&]Y964@
M4V5R=FEC92!3:&%R92UB87-E9"!#;VUP96YS871I;VXL($%L;&]C871I;VX@
M;V8@4F5C;V=N:7IE9"!097)I;V0@0V]S=',@6TQI;F4@271E;7-=/"]S=')O
M;F<^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S
M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO
M<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\
M+W-P86X^/"]T9#X-"B`@("`@(#PO='(^#0H@("`@("`\='(@8VQA<W,],T1R
M;SX-"B`@("`@("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P/D-O;7!E
M;G-A=&EO;B!E>'!E;G-E<SPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU
M;7`^,C`Q/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS
M1&YU;7`^,C4U/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S
M<STS1&YU;7`^,C`Q/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*
M("`@("`@/'1R(&-L87-S/3-$<F@^#0H@("`@("`@(#QT9"!C;&%S<STS1'!L
M('9A;&EG;CTS1'1O<#Y'96YE<F%L(&%N9"!A9&UI;FES=')A=&EV92!E>'!E
M;G-E<R!;365M8F5R72!\($]P=&EO;G,@86YD('=A<G)A;G1S(%M-96UB97)=
M/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N
M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A
M;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P
M86X^/"]T9#X-"B`@("`@(#PO='(^#0H@("`@("`\='(@8VQA<W,],T1R;SX-
M"B`@("`@("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P/CQS=')O;F<^
M16UP;&]Y964@4V5R=FEC92!3:&%R92UB87-E9"!#;VUP96YS871I;VXL($%L
M;&]C871I;VX@;V8@4F5C;V=N:7IE9"!097)I;V0@0V]S=',@6TQI;F4@271E
M;7-=/"]S=')O;F<^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG
M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^
M)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT
M/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO='(^#0H@("`@("`\='(@
M8VQA<W,],T1R93X-"B`@("`@("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$
M=&]P/D-O;7!E;G-A=&EO;B!E>'!E;G-E<SPO=&0^#0H@("`@("`@(#QT9"!C
M;&%S<STS1'1E>'0^)R9N8G-P.R9N8G-P.SQS<&%N/CPO<W!A;CX\+W1D/@T*
M("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<F;F)S<#LF;F)S<#L\<W!A;CX\
M+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XS-SQS<&%N
M/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS
M1')H/@T*("`@("`@("`\=&0@8VQA<W,],T1P;"!V86QI9VX],T1T;W`^1V5N
M97)A;"!A;F0@861M:6YI<W1R871I=F4@97AP96YS97,@6TUE;6)E<ET@?"!2
M97-T<FEC=&5D('-T;V-K('5N:71S(%M-96UB97)=/"]T9#X-"B`@("`@("`@
M/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@
M(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@
M("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@
M(#PO='(^#0H@("`@("`\='(@8VQA<W,],T1R93X-"B`@("`@("`@/'1D(&-L
M87-S/3-$<&P@=F%L:6=N/3-$=&]P/CQS=')O;F<^16UP;&]Y964@4V5R=FEC
M92!3:&%R92UB87-E9"!#;VUP96YS871I;VXL($%L;&]C871I;VX@;V8@4F5C
M;V=N:7IE9"!097)I;V0@0V]S=',@6TQI;F4@271E;7-=/"]S=')O;F<^/"]T
M9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO
M=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\
M+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^
M/"]T9#X-"B`@("`@(#PO='(^#0H@("`@("`\='(@8VQA<W,],T1R;SX-"B`@
M("`@("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P/D-O;7!E;G-A=&EO
M;B!E>'!E;G-E<SPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;7`^-"PS
M.3`\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M
M<#XQ+#4R.3QS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,]
M,T1N=6UP/C,L-#@W/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*
M("`@("`@/'1R(&-L87-S/3-$<F@^#0H@("`@("`@(#QT9"!C;&%S<STS1'!L
M('9A;&EG;CTS1'1O<#Y'96YE<F%L(&%N9"!A9&UI;FES=')A=&EV92!E>'!E
M;G-E<R!;365M8F5R72!\(%)E<W1R:6-T960@<W1O8VL@=6YI=',@6TUE;6)E
M<ET@?"!#;VYS=6QT86YT<R!;365M8F5R73PO=&0^#0H@("`@("`@(#QT9"!C
M;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@
M8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D
M(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R
M/@T*("`@("`@/'1R(&-L87-S/3-$<F\^#0H@("`@("`@(#QT9"!C;&%S<STS
M1'!L('9A;&EG;CTS1'1O<#X\<W1R;VYG/D5M<&QO>65E(%-E<G9I8V4@4VAA
M<F4M8F%S960@0V]M<&5N<V%T:6]N+"!!;&QO8V%T:6]N(&]F(%)E8V]G;FEZ
M960@4&5R:6]D($-O<W1S(%M,:6YE($ET96US73PO<W1R;VYG/CPO=&0^#0H@
M("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*
M("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-
M"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^
M#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$<F4^#0H@("`@("`@
M(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O<#Y#;VUP96YS871I;VX@97AP
M96YS97,\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6UP/B0@-S<\<W!A
M;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XD(#(W
M.#QS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6UP
M/B0@,C`\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO='(^#0H@("`@/"]T
M86)L93X-"B`@/"]B;V1Y/@T*/"]H=&UL/@T*#0HM+2TM+2T]7TYE>'1087)T
M7S!C860U.69D7S<S,F5?-#9E,E]A-3,T7S!C.&%D,6%F.3!D9`T*0V]N=&5N
M="U,;V-A=&EO;CH@9FEL93HO+R]#.B\P8V%D-3EF9%\W,S)E7S0V93)?834S
M-%\P8SAA9#%A9CDP9&0O5V]R:W-H965T<R]3:&5E=#0W+FAT;6P-"D-O;G1E
M;G0M5')A;G-F97(M16YC;V1I;F<Z('%U;W1E9"UP<FEN=&%B;&4-"D-O;G1E
M;G0M5'EP93H@=&5X="]H=&UL.R!C:&%R<V5T/2)U<RUA<V-I:2(-"@T*/&AT
M;6P^#0H@(#QH96%D/@T*("`@(#Q-151!(&AT='`M97%U:78],T1#;VYT96YT
M+51Y<&4@8V]N=&5N=#TS1"=T97AT+VAT;6P[(&-H87)S970]=71F+3@G/CQS
M8W)I<'0@='EP93TS1'1E>'0O:F%V87-C<FEP="!S<F,],T13:&]W+FIS/B\J
M($1O($YO="!296UO=F4@5&AI<R!#;VUM96YT("HO/"]S8W)I<'0^/"]H96%D
M/@T*("`\8F]D>3X-"B`@("`\=&%B;&4@8VQA<W,],T1R97!O<G0@:60],T1)
M1#!%5$%$2SX-"B`@("`@(#QT<CX-"B`@("`@("`@/'1H(&-L87-S/3-$=&P@
M8V]L<W!A;CTS1#$@<F]W<W!A;CTS1#(^/'-T<F]N9SY35$]#2TA/3$1%4E,G
M($5154E462`H4W5M;6%R>2!O9B!787)R86YT<R!A;F0@3W!T:6]N<RD@*$1E
M=&%I;',I("A54T0@)"D\8G(^/"]S=')O;F<^/"]T:#X-"B`@("`@("`@/'1H
M(&-L87-S/3-$=&@@8V]L<W!A;CTS1#$^,3(@36]N=&AS($5N9&5D/"]T:#X-
M"B`@("`@("`@/'1H(&-L87-S/3-$=&@@8V]L<W!A;CTS1#$^/"]T:#X-"B`@
M("`@(#PO='(^#0H@("`@("`\='(^#0H@("`@("`@(#QT:"!C;&%S<STS1'1H
M/DIU;BX@,S`L(#(P,30\8G(^/"]T:#X-"B`@("`@("`@/'1H(&-L87-S/3-$
M=&@^2G5N+B`S,"P@,C`Q,SQB<CX\+W1H/@T*("`@("`@/"]T<CX-"B`@("`@
M(#QT<B!C;&%S<STS1')E/@T*("`@("`@("`\=&0@8VQA<W,],T1P;"!V86QI
M9VX],T1T;W`^/'-T<F]N9SY3=&]C:VAO;&1E<G,@17%U:71Y($YO=&4@6TQI
M;F4@271E;7-=/"]S=')O;F<^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$
M=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS
M1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@("`@
M(#QT<B!C;&%S<STS1')O/@T*("`@("`@("`\=&0@8VQA<W,],T1P;"!V86QI
M9VX],T1T;W`^17AE<F-I<V4@4')I8V4@<&5R(%-H87)E/"]T9#X-"B`@("`@
M("`@/'1D(&-L87-S/3-$;G5M<#XD(#,N-S,\<W!A;CX\+W-P86X^/"]T9#X-
M"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XD(#0N,#,\<W!A;CX\+W-P86X^
M/"]T9#X-"B`@("`@(#PO='(^#0H@("`@("`\='(@8VQA<W,],T1R93X-"B`@
M("`@("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P/D]P=&EO;G,@86YD
M(%=A<G)A;G1S(&9O<B!#;VUM;VX@4W1O8VL\+W1D/@T*("`@("`@("`\=&0@
M8VQA<W,],T1N=6UP/C$R+#8T."PS,#,\<W!A;CX\+W-P86X^/"]T9#X-"B`@
M("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@
M("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$<F\^#0H@("`@("`@(#QT
M9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O<#Y/<'1I;VYS(&%N9"!787)R86YT
M<R!%>&5R8VES86)L93PO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;7`^
M,3(L-C0W+#,P,SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA
M<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO='(^#0H@
M("`@("`\='(@8VQA<W,],T1R93X-"B`@("`@("`@/'1D(&-L87-S/3-$<&P@
M=F%L:6=N/3-$=&]P/E=E:6=H=&5D($%V97)A9V4@4F5M86EN:6YG($-O;G1R
M86-T=6%L(%1E<FUS("AI;B!Y96%R<RD\+W1D/@T*("`@("`@("`\=&0@8VQA
M<W,],T1T97AT/B<S('EE87)S(#$@;6]N=&@@,3<@9&%Y<SQS<&%N/CPO<W!A
M;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P
M86X^/"]T9#X-"B`@("`@(#PO='(^#0H@("`@("`\='(@8VQA<W,],T1R:#X-
M"B`@("`@("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P/E=A<G)A;G0@
M6TUE;6)E<ET\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A
M;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P
M86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S
M/3-$<F4^#0H@("`@("`@(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O<#X\
M<W1R;VYG/E-T;V-K:&]L9&5R<R!%<75I='D@3F]T92!;3&EN92!)=&5M<UT\
M+W-T<F]N9SX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A
M;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P
M86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S
M/3-$<F\^#0H@("`@("`@(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O<#Y/
M<'1I;VYS(&%N9"!787)R86YT<R!F;W(@0V]M;6]N(%-T;V-K/"]T9#X-"B`@
M("`@("`@/'1D(&-L87-S/3-$;G5M<#XQ,"PU,S0L,C`T/'-P86X^/"]S<&%N
M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A
M;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS1')E/@T*
M("`@("`@("`\=&0@8VQA<W,],T1P;"!V86QI9VX],T1T;W`^3W!T:6]N<R!A
M;F0@5V%R<F%N=',@17AE<F-I<V%B;&4\+W1D/@T*("`@("`@("`\=&0@8VQA
M<W,],T1N=6UP/C$P+#4S-"PR,#0\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@
M("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@
M("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$<F@^#0H@("`@("`@(#QT9"!C
M;&%S<STS1'!L('9A;&EG;CTS1'1O<#Y%;7!L;WEE92!3=&]C:R!/<'1I;VX@
M6TUE;6)E<ET\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A
M;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P
M86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S
M/3-$<F4^#0H@("`@("`@(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O<#X\
M<W1R;VYG/E-T;V-K:&]L9&5R<R!%<75I='D@3F]T92!;3&EN92!)=&5M<UT\
M+W-T<F]N9SX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A
M;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P
M86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S
M/3-$<F\^#0H@("`@("`@(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O<#Y/
M<'1I;VYS(&%N9"!787)R86YT<R!F;W(@0V]M;6]N(%-T;V-K/"]T9#X-"B`@
M("`@("`@/'1D(&-L87-S/3-$;G5M<#XR+#$Q-"PP.3D\<W!A;CX\+W-P86X^
M/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N
M/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$<F4^#0H@
M("`@("`@(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O<#Y/<'1I;VYS(&%N
M9"!787)R86YT<R!%>&5R8VES86)L93PO=&0^#0H@("`@("`@(#QT9"!C;&%S
M<STS1&YU;7`^,BPQ,3,L,#DY/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@
M(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@
M/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS1')H/@T*("`@("`@("`\=&0@8VQA
M<W,],T1P;"!V86QI9VX],T1T;W`^)#`N,#`@6TUE;6)E<ET@?"!%;7!L;WEE
M92!3=&]C:R!/<'1I;VX@6TUE;6)E<ET\+W1D/@T*("`@("`@("`\=&0@8VQA
M<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L
M87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*
M("`@("`@/'1R(&-L87-S/3-$<F4^#0H@("`@("`@(#QT9"!C;&%S<STS1'!L
M('9A;&EG;CTS1'1O<#X\<W1R;VYG/E-T;V-K:&]L9&5R<R!%<75I='D@3F]T
M92!;3&EN92!)=&5M<UT\+W-T<F]N9SX\+W1D/@T*("`@("`@("`\=&0@8VQA
M<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L
M87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*
M("`@("`@/'1R(&-L87-S/3-$<F\^#0H@("`@("`@(#QT9"!C;&%S<STS1'!L
M('9A;&EG;CTS1'1O<#Y%>&5R8VES92!0<FEC92!P97(@4VAA<F4\+W1D/@T*
M("`@("`@("`\=&0@8VQA<W,],T1N=6UP/B0@,#QS<&%N/CPO<W!A;CX\+W1D
M/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T
M9#X-"B`@("`@(#PO='(^#0H@("`@("`\='(@8VQA<W,],T1R93X-"B`@("`@
M("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P/D]P=&EO;G,@86YD(%=A
M<G)A;G1S(&9O<B!#;VUM;VX@4W1O8VL\+W1D/@T*("`@("`@("`\=&0@8VQA
M<W,],T1N=6UP/C$P,2PP,#`\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@
M/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\
M+W1R/@T*("`@("`@/'1R(&-L87-S/3-$<F\^#0H@("`@("`@(#QT9"!C;&%S
M<STS1'!L('9A;&EG;CTS1'1O<#Y/<'1I;VYS(&%N9"!787)R86YT<R!%>&5R
M8VES86)L93PO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;7`^,3`P+#`P
M,#QS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT
M/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO='(^#0H@("`@("`\='(@
M8VQA<W,],T1R93X-"B`@("`@("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$
M=&]P/E=E:6=H=&5D($%V97)A9V4@4F5M86EN:6YG($-O;G1R86-T=6%L(%1E
M<FUS("AI;B!Y96%R<RD\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT
M/B<U('EE87)S(#(@;6]N=&AS(#D@9&%Y<SQS<&%N/CPO<W!A;CX\+W1D/@T*
M("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-
M"B`@("`@(#PO='(^#0H@("`@("`\='(@8VQA<W,],T1R:#X-"B`@("`@("`@
M/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P/B0P+C8R(%M-96UB97)=('P@
M16UP;&]Y964@4W1O8VL@3W!T:6]N(%M-96UB97)=/"]T9#X-"B`@("`@("`@
M/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@
M(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@
M/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS1')E/@T*("`@("`@("`\=&0@8VQA
M<W,],T1P;"!V86QI9VX],T1T;W`^/'-T<F]N9SY3=&]C:VAO;&1E<G,@17%U
M:71Y($YO=&4@6TQI;F4@271E;7-=/"]S=')O;F<^/"]T9#X-"B`@("`@("`@
M/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@
M(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@
M/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS1')O/@T*("`@("`@("`\=&0@8VQA
M<W,],T1P;"!V86QI9VX],T1T;W`^17AE<F-I<V4@4')I8V4@<&5R(%-H87)E
M/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XD(#`N-C(\<W!A;CX\
M+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^
M/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$
M<F4^#0H@("`@("`@(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O<#Y/<'1I
M;VYS(&%N9"!787)R86YT<R!F;W(@0V]M;6]N(%-T;V-K/"]T9#X-"B`@("`@
M("`@/'1D(&-L87-S/3-$;G5M<#XS.3@L-3`P/'-P86X^/"]S<&%N/CPO=&0^
M#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D
M/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS1')O/@T*("`@("`@
M("`\=&0@8VQA<W,],T1P;"!V86QI9VX],T1T;W`^3W!T:6]N<R!A;F0@5V%R
M<F%N=',@17AE<F-I<V%B;&4\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N
M=6UP/C,Y."PU,#`\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L
M87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*
M("`@("`@/'1R(&-L87-S/3-$<F4^#0H@("`@("`@(#QT9"!C;&%S<STS1'!L
M('9A;&EG;CTS1'1O<#Y796EG:'1E9"!!=F5R86=E(%)E;6%I;FEN9R!#;VYT
M<F%C='5A;"!497)M<R`H:6X@>65A<G,I/"]T9#X-"B`@("`@("`@/'1D(&-L
M87-S/3-$=&5X=#XG-"!Y96%R<R`S(&UO;G1H<SQS<&%N/CPO<W!A;CX\+W1D
M/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T
M9#X-"B`@("`@(#PO='(^#0H@("`@("`\='(@8VQA<W,],T1R:#X-"B`@("`@
M("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P/B0Q+C`T(%M-96UB97)=
M('P@16UP;&]Y964@4W1O8VL@3W!T:6]N(%M-96UB97)=/"]T9#X-"B`@("`@
M("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@
M("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@
M("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS1')E/@T*("`@("`@("`\=&0@
M8VQA<W,],T1P;"!V86QI9VX],T1T;W`^/'-T<F]N9SY3=&]C:VAO;&1E<G,@
M17%U:71Y($YO=&4@6TQI;F4@271E;7-=/"]S=')O;F<^/"]T9#X-"B`@("`@
M("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@
M("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@
M("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS1')O/@T*("`@("`@("`\=&0@
M8VQA<W,],T1P;"!V86QI9VX],T1T;W`^17AE<F-I<V4@4')I8V4@<&5R(%-H
M87)E/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XD(#$N,#0\<W!A
M;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P
M86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S
M/3-$<F4^#0H@("`@("`@(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O<#Y/
M<'1I;VYS(&%N9"!787)R86YT<R!F;W(@0V]M;6]N(%-T;V-K/"]T9#X-"B`@
M("`@("`@/'1D(&-L87-S/3-$;G5M<#XS,"PP,#`\<W!A;CX\+W-P86X^/"]T
M9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO
M=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$<F\^#0H@("`@
M("`@(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O<#Y/<'1I;VYS(&%N9"!7
M87)R86YT<R!%>&5R8VES86)L93PO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS
M1&YU;7`^,S`L,#`P/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C
M;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-
M"B`@("`@(#QT<B!C;&%S<STS1')E/@T*("`@("`@("`\=&0@8VQA<W,],T1P
M;"!V86QI9VX],T1T;W`^5V5I9VAT960@079E<F%G92!296UA:6YI;F<@0V]N
M=')A8W1U86P@5&5R;7,@*&EN('EE87)S*3PO=&0^#0H@("`@("`@(#QT9"!C
M;&%S<STS1'1E>'0^)S0@>65A<G,@,2!M;VYT:"`R."!D87ES/'-P86X^/"]S
M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO
M<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS1')H
M/@T*("`@("`@("`\=&0@8VQA<W,],T1P;"!V86QI9VX],T1T;W`^)#$N-#`@
M6TUE;6)E<ET@?"!787)R86YT(%M-96UB97)=/"]T9#X-"B`@("`@("`@/'1D
M(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT
M9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T
M<CX-"B`@("`@(#QT<B!C;&%S<STS1')E/@T*("`@("`@("`\=&0@8VQA<W,]
M,T1P;"!V86QI9VX],T1T;W`^/'-T<F]N9SY3=&]C:VAO;&1E<G,@17%U:71Y
M($YO=&4@6TQI;F4@271E;7-=/"]S=')O;F<^/"]T9#X-"B`@("`@("`@/'1D
M(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT
M9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T
M<CX-"B`@("`@(#QT<B!C;&%S<STS1')O/@T*("`@("`@("`\=&0@8VQA<W,]
M,T1P;"!V86QI9VX],T1T;W`^17AE<F-I<V4@4')I8V4@<&5R(%-H87)E/"]T
M9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XD(#$N-#QS<&%N/CPO<W!A
M;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P
M86X^/"]T9#X-"B`@("`@(#PO='(^#0H@("`@("`\='(@8VQA<W,],T1R93X-
M"B`@("`@("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P/D]P=&EO;G,@
M86YD(%=A<G)A;G1S(&9O<B!#;VUM;VX@4W1O8VL\+W1D/@T*("`@("`@("`\
M=&0@8VQA<W,],T1N=6UP/C0W-"PS,C(\<W!A;CX\+W-P86X^/"]T9#X-"B`@
M("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@
M("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$<F\^#0H@("`@("`@(#QT
M9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O<#Y/<'1I;VYS(&%N9"!787)R86YT
M<R!%>&5R8VES86)L93PO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;7`^
M-#<T+#,R,CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,]
M,T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO='(^#0H@("`@
M("`\='(@8VQA<W,],T1R93X-"B`@("`@("`@/'1D(&-L87-S/3-$<&P@=F%L
M:6=N/3-$=&]P/E=E:6=H=&5D($%V97)A9V4@4F5M86EN:6YG($-O;G1R86-T
M=6%L(%1E<FUS("AI;B!Y96%R<RD\+W1D/@T*("`@("`@("`\=&0@8VQA<W,]
M,T1T97AT/B<Y(&UO;G1H<R`R-B!D87ES/'-P86X^/"]S<&%N/CPO=&0^#0H@
M("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*
M("`@("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS1')H/@T*("`@("`@("`\
M=&0@8VQA<W,],T1P;"!V86QI9VX],T1T;W`^)#$N-3`@6TUE;6)E<ET@?"!7
M87)R86YT(%M-96UB97)=/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X
M=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E
M>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@("`@(#QT
M<B!C;&%S<STS1')E/@T*("`@("`@("`\=&0@8VQA<W,],T1P;"!V86QI9VX]
M,T1T;W`^/'-T<F]N9SY3=&]C:VAO;&1E<G,@17%U:71Y($YO=&4@6TQI;F4@
M271E;7-=/"]S=')O;F<^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X
M=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E
M>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@("`@(#QT
M<B!C;&%S<STS1')O/@T*("`@("`@("`\=&0@8VQA<W,],T1P;"!V86QI9VX]
M,T1T;W`^17AE<F-I<V4@4')I8V4@<&5R(%-H87)E/"]T9#X-"B`@("`@("`@
M/'1D(&-L87-S/3-$;G5M<#XD(#$N-3QS<&%N/CPO<W!A;CX\+W1D/@T*("`@
M("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@
M("`@(#PO='(^#0H@("`@("`\='(@8VQA<W,],T1R93X-"B`@("`@("`@/'1D
M(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P/D]P=&EO;G,@86YD(%=A<G)A;G1S
M(&9O<B!#;VUM;VX@4W1O8VL\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N
M=6UP/C@W."PQ-S0\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L
M87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*
M("`@("`@/'1R(&-L87-S/3-$<F\^#0H@("`@("`@(#QT9"!C;&%S<STS1'!L
M('9A;&EG;CTS1'1O<#Y/<'1I;VYS(&%N9"!787)R86YT<R!%>&5R8VES86)L
M93PO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;7`^.#<X+#$W-#QS<&%N
M/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A
M;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO='(^#0H@("`@("`\='(@8VQA<W,]
M,T1R93X-"B`@("`@("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P/E=E
M:6=H=&5D($%V97)A9V4@4F5M86EN:6YG($-O;G1R86-T=6%L(%1E<FUS("AI
M;B!Y96%R<RD\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<R,B!D
M87ES/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E
M>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@("`@(#QT
M<B!C;&%S<STS1')H/@T*("`@("`@("`\=&0@8VQA<W,],T1P;"!V86QI9VX]
M,T1T;W`^)#$N-C`@6TUE;6)E<ET@?"!787)R86YT(%M-96UB97)=/"]T9#X-
M"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^
M#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D
M/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS1')E/@T*("`@("`@
M("`\=&0@8VQA<W,],T1P;"!V86QI9VX],T1T;W`^/'-T<F]N9SY3=&]C:VAO
M;&1E<G,@17%U:71Y($YO=&4@6TQI;F4@271E;7-=/"]S=')O;F<^/"]T9#X-
M"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^
M#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D
M/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS1')O/@T*("`@("`@
M("`\=&0@8VQA<W,],T1P;"!V86QI9VX],T1T;W`^17AE<F-I<V4@4')I8V4@
M<&5R(%-H87)E/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XD(#$N
M-CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT
M/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO='(^#0H@("`@("`\='(@
M8VQA<W,],T1R93X-"B`@("`@("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$
M=&]P/D]P=&EO;G,@86YD(%=A<G)A;G1S(&9O<B!#;VUM;VX@4W1O8VL\+W1D
M/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6UP/C$S,2PR,C$\<W!A;CX\+W-P
M86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S
M<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$<F\^
M#0H@("`@("`@(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O<#Y/<'1I;VYS
M(&%N9"!787)R86YT<R!%>&5R8VES86)L93PO=&0^#0H@("`@("`@(#QT9"!C
M;&%S<STS1&YU;7`^,3,Q+#(R,3QS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@
M("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@
M(#PO='(^#0H@("`@("`\='(@8VQA<W,],T1R93X-"B`@("`@("`@/'1D(&-L
M87-S/3-$<&P@=F%L:6=N/3-$=&]P/E=E:6=H=&5D($%V97)A9V4@4F5M86EN
M:6YG($-O;G1R86-T=6%L(%1E<FUS("AI;B!Y96%R<RD\+W1D/@T*("`@("`@
M("`\=&0@8VQA<W,],T1T97AT/B<Y(&UO;G1H<R`Q,2!D87ES/'-P86X^/"]S
M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO
M<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS1')H
M/@T*("`@("`@("`\=&0@8VQA<W,],T1P;"!V86QI9VX],T1T;W`^)#$N.#`@
M6TUE;6)E<ET@?"!787)R86YT(%M-96UB97)=/"]T9#X-"B`@("`@("`@/'1D
M(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT
M9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T
M<CX-"B`@("`@(#QT<B!C;&%S<STS1')E/@T*("`@("`@("`\=&0@8VQA<W,]
M,T1P;"!V86QI9VX],T1T;W`^/'-T<F]N9SY3=&]C:VAO;&1E<G,@17%U:71Y
M($YO=&4@6TQI;F4@271E;7-=/"]S=')O;F<^/"]T9#X-"B`@("`@("`@/'1D
M(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT
M9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T
M<CX-"B`@("`@(#QT<B!C;&%S<STS1')O/@T*("`@("`@("`\=&0@8VQA<W,]
M,T1P;"!V86QI9VX],T1T;W`^17AE<F-I<V4@4')I8V4@<&5R(%-H87)E/"]T
M9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XD(#$N.#QS<&%N/CPO<W!A
M;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P
M86X^/"]T9#X-"B`@("`@(#PO='(^#0H@("`@("`\='(@8VQA<W,],T1R93X-
M"B`@("`@("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P/D]P=&EO;G,@
M86YD(%=A<G)A;G1S(&9O<B!#;VUM;VX@4W1O8VL\+W1D/@T*("`@("`@("`\
M=&0@8VQA<W,],T1N=6UP/C<R-RPT,#$\<W!A;CX\+W-P86X^/"]T9#X-"B`@
M("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@
M("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$<F\^#0H@("`@("`@(#QT
M9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O<#Y/<'1I;VYS(&%N9"!787)R86YT
M<R!%>&5R8VES86)L93PO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;7`^
M-S(W+#0P,3QS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,]
M,T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO='(^#0H@("`@
M("`\='(@8VQA<W,],T1R93X-"B`@("`@("`@/'1D(&-L87-S/3-$<&P@=F%L
M:6=N/3-$=&]P/E=E:6=H=&5D($%V97)A9V4@4F5M86EN:6YG($-O;G1R86-T
M=6%L(%1E<FUS("AI;B!Y96%R<RD\+W1D/@T*("`@("`@("`\=&0@8VQA<W,]
M,T1T97AT/B<S(&UO;G1H<R`Q."!D87ES/'-P86X^/"]S<&%N/CPO=&0^#0H@
M("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*
M("`@("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS1')H/@T*("`@("`@("`\
M=&0@8VQA<W,],T1P;"!V86QI9VX],T1T;W`^)#$N.3`@6TUE;6)E<ET@?"!7
M87)R86YT(%M-96UB97)=/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X
M=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E
M>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@("`@(#QT
M<B!C;&%S<STS1')E/@T*("`@("`@("`\=&0@8VQA<W,],T1P;"!V86QI9VX]
M,T1T;W`^/'-T<F]N9SY3=&]C:VAO;&1E<G,@17%U:71Y($YO=&4@6TQI;F4@
M271E;7-=/"]S=')O;F<^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X
M=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E
M>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@("`@(#QT
M<B!C;&%S<STS1')O/@T*("`@("`@("`\=&0@8VQA<W,],T1P;"!V86QI9VX]
M,T1T;W`^17AE<F-I<V4@4')I8V4@<&5R(%-H87)E/"]T9#X-"B`@("`@("`@
M/'1D(&-L87-S/3-$;G5M<#XD(#$N.3QS<&%N/CPO<W!A;CX\+W1D/@T*("`@
M("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@
M("`@(#PO='(^#0H@("`@("`\='(@8VQA<W,],T1R93X-"B`@("`@("`@/'1D
M(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P/D]P=&EO;G,@86YD(%=A<G)A;G1S
M(&9O<B!#;VUM;VX@4W1O8VL\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N
M=6UP/C0S+#$P,SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA
M<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO='(^#0H@
M("`@("`\='(@8VQA<W,],T1R;SX-"B`@("`@("`@/'1D(&-L87-S/3-$<&P@
M=F%L:6=N/3-$=&]P/D]P=&EO;G,@86YD(%=A<G)A;G1S($5X97)C:7-A8FQE
M/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XT,RPQ,#,\<W!A;CX\
M+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^
M/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$
M<F4^#0H@("`@("`@(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O<#Y796EG
M:'1E9"!!=F5R86=E(%)E;6%I;FEN9R!#;VYT<F%C='5A;"!497)M<R`H:6X@
M>65A<G,I/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG,CD@9&%Y
M<SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT
M/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO='(^#0H@("`@("`\='(@
M8VQA<W,],T1R:#X-"B`@("`@("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$
M=&]P/B0R+CDW(%M-96UB97)=('P@16UP;&]Y964@4W1O8VL@3W!T:6]N(%M-
M96UB97)=/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^
M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N
M/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS
M1')E/@T*("`@("`@("`\=&0@8VQA<W,],T1P;"!V86QI9VX],T1T;W`^/'-T
M<F]N9SY3=&]C:VAO;&1E<G,@17%U:71Y($YO=&4@6TQI;F4@271E;7-=/"]S
M=')O;F<^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^
M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N
M/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS
M1')O/@T*("`@("`@("`\=&0@8VQA<W,],T1P;"!V86QI9VX],T1T;W`^17AE
M<F-I<V4@4')I8V4@<&5R(%-H87)E/"]T9#X-"B`@("`@("`@/'1D(&-L87-S
M/3-$;G5M<#XD(#(N.3<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D
M(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R
M/@T*("`@("`@/'1R(&-L87-S/3-$<F4^#0H@("`@("`@(#QT9"!C;&%S<STS
M1'!L('9A;&EG;CTS1'1O<#Y/<'1I;VYS(&%N9"!787)R86YT<R!F;W(@0V]M
M;6]N(%-T;V-K/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XR,"PP
M,#`\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X
M=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R
M(&-L87-S/3-$<F\^#0H@("`@("`@(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS
M1'1O<#Y/<'1I;VYS(&%N9"!787)R86YT<R!%>&5R8VES86)L93PO=&0^#0H@
M("`@("`@(#QT9"!C;&%S<STS1&YU;7`^,C`L,#`P/'-P86X^/"]S<&%N/CPO
M=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\
M+W1D/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS1')E/@T*("`@
M("`@("`\=&0@8VQA<W,],T1P;"!V86QI9VX],T1T;W`^5V5I9VAT960@079E
M<F%G92!296UA:6YI;F<@0V]N=')A8W1U86P@5&5R;7,@*&EN('EE87)S*3PO
M=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)S,@>65A<G,@,3`@;6]N
M=&AS(#$P(&1A>7,\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L
M87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*
M("`@("`@/'1R(&-L87-S/3-$<F@^#0H@("`@("`@(#QT9"!C;&%S<STS1'!L
M('9A;&EG;CTS1'1O<#XD,RXU,"!;365M8F5R72!\($5M<&QO>65E(%-T;V-K
M($]P=&EO;B!;365M8F5R73PO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E
M>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T
M97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO='(^#0H@("`@("`\
M='(@8VQA<W,],T1R93X-"B`@("`@("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N
M/3-$=&]P/CQS=')O;F<^4W1O8VMH;VQD97)S($5Q=6ET>2!.;W1E(%M,:6YE
M($ET96US73PO<W1R;VYG/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E
M>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T
M97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO='(^#0H@("`@("`\
M='(@8VQA<W,],T1R;SX-"B`@("`@("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N
M/3-$=&]P/D5X97)C:7-E(%!R:6-E('!E<B!3:&%R93PO=&0^#0H@("`@("`@
M(#QT9"!C;&%S<STS1&YU;7`^)"`S+C4\<W!A;CX\+W-P86X^/"]T9#X-"B`@
M("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@
M("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$<F4^#0H@("`@("`@(#QT
M9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O<#Y/<'1I;VYS(&%N9"!787)R86YT
M<R!F;W(@0V]M;6]N(%-T;V-K/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$
M;G5M<#XY,#`L,#`P/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C
M;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-
M"B`@("`@(#QT<B!C;&%S<STS1')O/@T*("`@("`@("`\=&0@8VQA<W,],T1P
M;"!V86QI9VX],T1T;W`^3W!T:6]N<R!A;F0@5V%R<F%N=',@17AE<F-I<V%B
M;&4\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6UP/CDP,"PP,#`\<W!A
M;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P
M86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S
M/3-$<F4^#0H@("`@("`@(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O<#Y7
M96EG:'1E9"!!=F5R86=E(%)E;6%I;FEN9R!#;VYT<F%C='5A;"!497)M<R`H
M:6X@>65A<G,I/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG,B!Y
M96%R<R`V(&UO;G1H<R`R.2!D87ES/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@
M("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@
M("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS1')H/@T*("`@("`@("`\=&0@
M8VQA<W,],T1P;"!V86QI9VX],T1T;W`^)#,N-S(@6TUE;6)E<ET@?"!%;7!L
M;WEE92!3=&]C:R!/<'1I;VX@6TUE;6)E<ET\+W1D/@T*("`@("`@("`\=&0@
M8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D
M(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R
M/@T*("`@("`@/'1R(&-L87-S/3-$<F4^#0H@("`@("`@(#QT9"!C;&%S<STS
M1'!L('9A;&EG;CTS1'1O<#X\<W1R;VYG/E-T;V-K:&]L9&5R<R!%<75I='D@
M3F]T92!;3&EN92!)=&5M<UT\+W-T<F]N9SX\+W1D/@T*("`@("`@("`\=&0@
M8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D
M(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R
M/@T*("`@("`@/'1R(&-L87-S/3-$<F\^#0H@("`@("`@(#QT9"!C;&%S<STS
M1'!L('9A;&EG;CTS1'1O<#Y%>&5R8VES92!0<FEC92!P97(@4VAA<F4\+W1D
M/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6UP/B0@,RXW,CQS<&%N/CPO<W!A
M;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P
M86X^/"]T9#X-"B`@("`@(#PO='(^#0H@("`@("`\='(@8VQA<W,],T1R93X-
M"B`@("`@("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P/D]P=&EO;G,@
M86YD(%=A<G)A;G1S(&9O<B!#;VUM;VX@4W1O8VL\+W1D/@T*("`@("`@("`\
M=&0@8VQA<W,],T1N=6UP/C$U+#`P,#QS<&%N/CPO<W!A;CX\+W1D/@T*("`@
M("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@
M("`@(#PO='(^#0H@("`@("`\='(@8VQA<W,],T1R;SX-"B`@("`@("`@/'1D
M(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P/D]P=&EO;G,@86YD(%=A<G)A;G1S
M($5X97)C:7-A8FQE/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XQ
M-2PP,#`\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$
M=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@
M/'1R(&-L87-S/3-$<F4^#0H@("`@("`@(#QT9"!C;&%S<STS1'!L('9A;&EG
M;CTS1'1O<#Y796EG:'1E9"!!=F5R86=E(%)E;6%I;FEN9R!#;VYT<F%C='5A
M;"!497)M<R`H:6X@>65A<G,I/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$
M=&5X=#XG,B!Y96%R<R`U(&UO;G1H<R`R-R!D87ES/'-P86X^/"]S<&%N/CPO
M=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\
M+W1D/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS1')H/@T*("`@
M("`@("`\=&0@8VQA<W,],T1P;"!V86QI9VX],T1T;W`^)#,N.#`@6TUE;6)E
M<ET@?"!%;7!L;WEE92!3=&]C:R!/<'1I;VX@6TUE;6)E<ET\+W1D/@T*("`@
M("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@
M("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@
M("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$<F4^#0H@("`@("`@(#QT
M9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O<#X\<W1R;VYG/E-T;V-K:&]L9&5R
M<R!%<75I='D@3F]T92!;3&EN92!)=&5M<UT\+W-T<F]N9SX\+W1D/@T*("`@
M("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@
M("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@
M("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$<F\^#0H@("`@("`@(#QT
M9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O<#Y%>&5R8VES92!0<FEC92!P97(@
M4VAA<F4\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6UP/B0@,RXX/'-P
M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS
M<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S
M<STS1')E/@T*("`@("`@("`\=&0@8VQA<W,],T1P;"!V86QI9VX],T1T;W`^
M3W!T:6]N<R!A;F0@5V%R<F%N=',@9F]R($-O;6UO;B!3=&]C:SPO=&0^#0H@
M("`@("`@(#QT9"!C;&%S<STS1&YU;7`^,38L,#4P/'-P86X^/"]S<&%N/CPO
M=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\
M+W1D/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS1')O/@T*("`@
M("`@("`\=&0@8VQA<W,],T1P;"!V86QI9VX],T1T;W`^3W!T:6]N<R!A;F0@
M5V%R<F%N=',@17AE<F-I<V%B;&4\+W1D/@T*("`@("`@("`\=&0@8VQA<W,]
M,T1N=6UP/C$V+#`U,#QS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@
M8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO='(^
M#0H@("`@("`\='(@8VQA<W,],T1R93X-"B`@("`@("`@/'1D(&-L87-S/3-$
M<&P@=F%L:6=N/3-$=&]P/E=E:6=H=&5D($%V97)A9V4@4F5M86EN:6YG($-O
M;G1R86-T=6%L(%1E<FUS("AI;B!Y96%R<RD\+W1D/@T*("`@("`@("`\=&0@
M8VQA<W,],T1T97AT/B<R('EE87)S(#8@;6]N=&AS(#$Q(&1A>7,\<W!A;CX\
M+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^
M/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$
M<F@^#0H@("`@("`@(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O<#XD-"XP
M,"!;365M8F5R72!\($5M<&QO>65E(%-T;V-K($]P=&EO;B!;365M8F5R73PO
M=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\
M+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^
M/"]T9#X-"B`@("`@(#PO='(^#0H@("`@("`\='(@8VQA<W,],T1R93X-"B`@
M("`@("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P/CQS=')O;F<^4W1O
M8VMH;VQD97)S($5Q=6ET>2!.;W1E(%M,:6YE($ET96US73PO<W1R;VYG/CPO
M=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\
M+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^
M/"]T9#X-"B`@("`@(#PO='(^#0H@("`@("`\='(@8VQA<W,],T1R;SX-"B`@
M("`@("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P/D5X97)C:7-E(%!R
M:6-E('!E<B!3:&%R93PO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;7`^
M)"`T/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E
M>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@("`@(#QT
M<B!C;&%S<STS1')E/@T*("`@("`@("`\=&0@8VQA<W,],T1P;"!V86QI9VX]
M,T1T;W`^3W!T:6]N<R!A;F0@5V%R<F%N=',@9F]R($-O;6UO;B!3=&]C:SPO
M=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;7`^-#(L-3`P/'-P86X^/"]S
M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO
M<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS1')O
M/@T*("`@("`@("`\=&0@8VQA<W,],T1P;"!V86QI9VX],T1T;W`^3W!T:6]N
M<R!A;F0@5V%R<F%N=',@17AE<F-I<V%B;&4\+W1D/@T*("`@("`@("`\=&0@
M8VQA<W,],T1N=6UP/C0R+#4P,#QS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@
M("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@
M(#PO='(^#0H@("`@("`\='(@8VQA<W,],T1R93X-"B`@("`@("`@/'1D(&-L
M87-S/3-$<&P@=F%L:6=N/3-$=&]P/E=E:6=H=&5D($%V97)A9V4@4F5M86EN
M:6YG($-O;G1R86-T=6%L(%1E<FUS("AI;B!Y96%R<RD\+W1D/@T*("`@("`@
M("`\=&0@8VQA<W,],T1T97AT/B<R('EE87)S(#,@;6]N=&AS(#$X(&1A>7,\
M<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG
M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L
M87-S/3-$<F@^#0H@("`@("`@(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O
M<#XD-"XR,"!;365M8F5R72!\(%=A<G)A;G0@6TUE;6)E<ET\+W1D/@T*("`@
M("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@
M("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@
M("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$<F4^#0H@("`@("`@(#QT
M9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O<#X\<W1R;VYG/E-T;V-K:&]L9&5R
M<R!%<75I='D@3F]T92!;3&EN92!)=&5M<UT\+W-T<F]N9SX\+W1D/@T*("`@
M("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@
M("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@
M("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$<F\^#0H@("`@("`@(#QT
M9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O<#Y%>&5R8VES92!0<FEC92!P97(@
M4VAA<F4\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6UP/B0@-"XR/'-P
M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS
M<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S
M<STS1')E/@T*("`@("`@("`\=&0@8VQA<W,],T1P;"!V86QI9VX],T1T;W`^
M3W!T:6]N<R!A;F0@5V%R<F%N=',@9F]R($-O;6UO;B!3=&]C:SPO=&0^#0H@
M("`@("`@(#QT9"!C;&%S<STS1&YU;7`^-2PP-C`L,#`P/'-P86X^/"]S<&%N
M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A
M;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS1')O/@T*
M("`@("`@("`\=&0@8VQA<W,],T1P;"!V86QI9VX],T1T;W`^3W!T:6]N<R!A
M;F0@5V%R<F%N=',@17AE<F-I<V%B;&4\+W1D/@T*("`@("`@("`\=&0@8VQA
M<W,],T1N=6UP/C4L,#8P+#`P,#QS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@
M("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@
M(#PO='(^#0H@("`@("`\='(@8VQA<W,],T1R93X-"B`@("`@("`@/'1D(&-L
M87-S/3-$<&P@=F%L:6=N/3-$=&]P/E=E:6=H=&5D($%V97)A9V4@4F5M86EN
M:6YG($-O;G1R86-T=6%L(%1E<FUS("AI;B!Y96%R<RD\+W1D/@T*("`@("`@
M("`\=&0@8VQA<W,],T1T97AT/B<R('EE87)S(#$@;6]N=&@@,B!D87ES/'-P
M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS
M<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S
M<STS1')H/@T*("`@("`@("`\=&0@8VQA<W,],T1P;"!V86QI9VX],T1T;W`^
M)#4N,#`@6TUE;6)E<ET@?"!787)R86YT(%M-96UB97)=/"]T9#X-"B`@("`@
M("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@
M("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@
M("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS1')E/@T*("`@("`@("`\=&0@
M8VQA<W,],T1P;"!V86QI9VX],T1T;W`^/'-T<F]N9SY3=&]C:VAO;&1E<G,@
M17%U:71Y($YO=&4@6TQI;F4@271E;7-=/"]S=')O;F<^/"]T9#X-"B`@("`@
M("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@
M("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@
M("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS1')O/@T*("`@("`@("`\=&0@
M8VQA<W,],T1P;"!V86QI9VX],T1T;W`^17AE<F-I<V4@4')I8V4@<&5R(%-H
M87)E/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XD(#4\<W!A;CX\
M+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^
M/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$
M<F4^#0H@("`@("`@(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O<#Y/<'1I
M;VYS(&%N9"!787)R86YT<R!F;W(@0V]M;6]N(%-T;V-K/"]T9#X-"B`@("`@
M("`@/'1D(&-L87-S/3-$;G5M<#XS+#(Q.2PY.#,\<W!A;CX\+W-P86X^/"]T
M9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO
M=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$<F\^#0H@("`@
M("`@(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O<#Y/<'1I;VYS(&%N9"!7
M87)R86YT<R!%>&5R8VES86)L93PO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS
M1&YU;7`^,RPR,3DL.3@S/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT
M9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T
M<CX-"B`@("`@(#QT<B!C;&%S<STS1')E/@T*("`@("`@("`\=&0@8VQA<W,]
M,T1P;"!V86QI9VX],T1T;W`^5V5I9VAT960@079E<F%G92!296UA:6YI;F<@
M0V]N=')A8W1U86P@5&5R;7,@*&EN('EE87)S*3PO=&0^#0H@("`@("`@(#QT
M9"!C;&%S<STS1'1E>'0^)S,@>65A<G,@,B!M;VYT:',@,3D@9&%Y<SQS<&%N
M/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A
M;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO='(^#0H@("`@("`\='(@8VQA<W,]
M,T1R:#X-"B`@("`@("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P/B0T
M+C,X('1O("0T+C0P(%M-96UB97)=('P@16UP;&]Y964@4W1O8VL@3W!T:6]N
M(%M-96UB97)=/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P
M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS
M<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S
M<STS1')E/@T*("`@("`@("`\=&0@8VQA<W,],T1P;"!V86QI9VX],T1T;W`^
M/'-T<F]N9SY3=&]C:VAO;&1E<G,@17%U:71Y($YO=&4@6TQI;F4@271E;7-=
M/"]S=')O;F<^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P
M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS
M<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S
M<STS1')O/@T*("`@("`@("`\=&0@8VQA<W,],T1P;"!V86QI9VX],T1T;W`^
M17AE<F-I<V4@4')I8V4@<&5R(%-H87)E+"!M:6YI;75M/"]T9#X-"B`@("`@
M("`@/'1D(&-L87-S/3-$;G5M<#XD(#0N,S@\<W!A;CX\+W-P86X^/"]T9#X-
M"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^
M#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$<F4^#0H@("`@("`@
M(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O<#Y%>&5R8VES92!0<FEC92!P
M97(@4VAA<F4L(&UA>&EM=6T\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N
M=6UP/B0@-"XT/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S
M<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@
M("`@(#QT<B!C;&%S<STS1')O/@T*("`@("`@("`\=&0@8VQA<W,],T1P;"!V
M86QI9VX],T1T;W`^3W!T:6]N<R!A;F0@5V%R<F%N=',@9F]R($-O;6UO;B!3
M=&]C:SPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;7`^-#$W+#(Y.3QS
M<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\
M<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO='(^#0H@("`@("`\='(@8VQA
M<W,],T1R93X-"B`@("`@("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P
M/D]P=&EO;G,@86YD(%=A<G)A;G1S($5X97)C:7-A8FQE/"]T9#X-"B`@("`@
M("`@/'1D(&-L87-S/3-$;G5M<#XT,3<L,CDY/'-P86X^/"]S<&%N/CPO=&0^
M#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D
M/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS1')O/@T*("`@("`@
M("`\=&0@8VQA<W,],T1P;"!V86QI9VX],T1T;W`^5V5I9VAT960@079E<F%G
M92!296UA:6YI;F<@0V]N=')A8W1U86P@5&5R;7,@*&EN('EE87)S*3PO=&0^
M#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)S,@>65A<G,@,R!M;VYT:',@
M,3$@9&%Y<SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,]
M,T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO='(^#0H@("`@
M("`\='(@8VQA<W,],T1R:#X-"B`@("`@("`@/'1D(&-L87-S/3-$<&P@=F%L
M:6=N/3-$=&]P/B0V+C@P(%M-96UB97)=('P@16UP;&]Y964@4W1O8VL@3W!T
M:6]N(%M-96UB97)=/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG
M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^
M)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<B!C
M;&%S<STS1')O/@T*("`@("`@("`\=&0@8VQA<W,],T1P;"!V86QI9VX],T1T
M;W`^/'-T<F]N9SY3=&]C:VAO;&1E<G,@17%U:71Y($YO=&4@6TQI;F4@271E
M;7-=/"]S=')O;F<^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG
M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^
M)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<B!C
M;&%S<STS1')E/@T*("`@("`@("`\=&0@8VQA<W,],T1P;"!V86QI9VX],T1T
M;W`^17AE<F-I<V4@4')I8V4@<&5R(%-H87)E/"]T9#X-"B`@("`@("`@/'1D
M(&-L87-S/3-$;G5M<#XD(#8N.#QS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@
M("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@
M(#PO='(^#0H@("`@("`\='(@8VQA<W,],T1R;SX-"B`@("`@("`@/'1D(&-L
M87-S/3-$<&P@=F%L:6=N/3-$=&]P/D]P=&EO;G,@86YD(%=A<G)A;G1S(&9O
M<B!#;VUM;VX@4W1O8VL\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6UP
M/C,V+#(U,#QS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,]
M,T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO='(^#0H@("`@
M("`\='(@8VQA<W,],T1R93X-"B`@("`@("`@/'1D(&-L87-S/3-$<&P@=F%L
M:6=N/3-$=&]P/D]P=&EO;G,@86YD(%=A<G)A;G1S($5X97)C:7-A8FQE/"]T
M9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XS-BPR-3`\<W!A;CX\+W-P
M86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S
M<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$<F\^
M#0H@("`@("`@(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O<#Y796EG:'1E
M9"!!=F5R86=E(%)E;6%I;FEN9R!#;VYT<F%C='5A;"!497)M<R`H:6X@>65A
M<G,I/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG,R!Y96%R<R`T
M(&UO;G1H<R`Q,R!D87ES/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT
M9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T
M<CX-"B`@("`@(#QT<B!C;&%S<STS1')H/@T*("`@("`@("`\=&0@8VQA<W,]
M,T1P;"!V86QI9VX],T1T;W`^)#@N,C`@6TUE;6)E<ET@?"!%;7!L;WEE92!3
M=&]C:R!/<'1I;VX@6TUE;6)E<ET\+W1D/@T*("`@("`@("`\=&0@8VQA<W,]
M,T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S
M/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@
M("`@/'1R(&-L87-S/3-$<F\^#0H@("`@("`@(#QT9"!C;&%S<STS1'!L('9A
M;&EG;CTS1'1O<#X\<W1R;VYG/E-T;V-K:&]L9&5R<R!%<75I='D@3F]T92!;
M3&EN92!)=&5M<UT\+W-T<F]N9SX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,]
M,T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S
M/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@
M("`@/'1R(&-L87-S/3-$<F4^#0H@("`@("`@(#QT9"!C;&%S<STS1'!L('9A
M;&EG;CTS1'1O<#Y%>&5R8VES92!0<FEC92!P97(@4VAA<F4\+W1D/@T*("`@
M("`@("`\=&0@8VQA<W,],T1N=6UP/B0@."XR/'-P86X^/"]S<&%N/CPO=&0^
M#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D
M/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS1')O/@T*("`@("`@
M("`\=&0@8VQA<W,],T1P;"!V86QI9VX],T1T;W`^3W!T:6]N<R!A;F0@5V%R
M<F%N=',@9F]R($-O;6UO;B!3=&]C:SPO=&0^#0H@("`@("`@(#QT9"!C;&%S
M<STS1&YU;7`^,S`L,#`P/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT
M9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T
M<CX-"B`@("`@(#QT<B!C;&%S<STS1')E/@T*("`@("`@("`\=&0@8VQA<W,]
M,T1P;"!V86QI9VX],T1T;W`^3W!T:6]N<R!A;F0@5V%R<F%N=',@17AE<F-I
M<V%B;&4\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6UP/C,P+#`P,#QS
M<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\
M<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO='(^#0H@("`@("`\='(@8VQA
M<W,],T1R;SX-"B`@("`@("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P
M/E=E:6=H=&5D($%V97)A9V4@4F5M86EN:6YG($-O;G1R86-T=6%L(%1E<FUS
M("AI;B!Y96%R<RD\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<R
M('EE87)S(#0@;6]N=&AS(#(T(&1A>7,\<W!A;CX\+W-P86X^/"]T9#X-"B`@
M("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@
M("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$<F@^#0H@("`@("`@(#QT
M9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O<#XD,C`N,#`@6TUE;6)E<ET@?"!%
M;7!L;WEE92!3=&]C:R!/<'1I;VX@6TUE;6)E<ET\+W1D/@T*("`@("`@("`\
M=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@
M/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\
M+W1R/@T*("`@("`@/'1R(&-L87-S/3-$<F\^#0H@("`@("`@(#QT9"!C;&%S
M<STS1'!L('9A;&EG;CTS1'1O<#X\<W1R;VYG/E-T;V-K:&]L9&5R<R!%<75I
M='D@3F]T92!;3&EN92!)=&5M<UT\+W-T<F]N9SX\+W1D/@T*("`@("`@("`\
M=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@
M/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\
M+W1R/@T*("`@("`@/'1R(&-L87-S/3-$<F4^#0H@("`@("`@(#QT9"!C;&%S
M<STS1'!L('9A;&EG;CTS1'1O<#Y%>&5R8VES92!0<FEC92!P97(@4VAA<F4\
M+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6UP/B0@,C`\<W!A;CX\+W-P
M86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S
M<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$<F\^
M#0H@("`@("`@(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O<#Y/<'1I;VYS
M(&%N9"!787)R86YT<R!F;W(@0V]M;6]N(%-T;V-K/"]T9#X-"B`@("`@("`@
M/'1D(&-L87-S/3-$;G5M<#XQ,#<L-3`P/'-P86X^/"]S<&%N/CPO=&0^#0H@
M("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*
M("`@("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS1')E/@T*("`@("`@("`\
M=&0@8VQA<W,],T1P;"!V86QI9VX],T1T;W`^3W!T:6]N<R!A;F0@5V%R<F%N
M=',@17AE<F-I<V%B;&4\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6UP
M/C$P-RPU,#`\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S
M/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@
M("`@/'1R(&-L87-S/3-$<F\^#0H@("`@("`@(#QT9"!C;&%S<STS1'!L('9A
M;&EG;CTS1'1O<#Y796EG:'1E9"!!=F5R86=E(%)E;6%I;FEN9R!#;VYT<F%C
M='5A;"!497)M<R`H:6X@>65A<G,I/"]T9#X-"B`@("`@("`@/'1D(&-L87-S
M/3-$=&5X=#XG,B!Y96%R<R`Q,"!M;VYT:',@,3<@9&%Y<SQS<&%N/CPO<W!A
M;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P
M86X^/"]T9#X-"B`@("`@(#PO='(^#0H@("`@/"]T86)L93X-"B`@/"]B;V1Y
M/@T*/"]H=&UL/@T*#0HM+2TM+2T]7TYE>'1087)T7S!C860U.69D7S<S,F5?
M-#9E,E]A-3,T7S!C.&%D,6%F.3!D9`T*0V]N=&5N="U,;V-A=&EO;CH@9FEL
M93HO+R]#.B\P8V%D-3EF9%\W,S)E7S0V93)?834S-%\P8SAA9#%A9CDP9&0O
M5V]R:W-H965T<R]3:&5E=#0X+FAT;6P-"D-O;G1E;G0M5')A;G-F97(M16YC
M;V1I;F<Z('%U;W1E9"UP<FEN=&%B;&4-"D-O;G1E;G0M5'EP93H@=&5X="]H
M=&UL.R!C:&%R<V5T/2)U<RUA<V-I:2(-"@T*/&AT;6P^#0H@(#QH96%D/@T*
M("`@(#Q-151!(&AT='`M97%U:78],T1#;VYT96YT+51Y<&4@8V]N=&5N=#TS
M1"=T97AT+VAT;6P[(&-H87)S970]=71F+3@G/CQS8W)I<'0@='EP93TS1'1E
M>'0O:F%V87-C<FEP="!S<F,],T13:&]W+FIS/B\J($1O($YO="!296UO=F4@
M5&AI<R!#;VUM96YT("HO/"]S8W)I<'0^/"]H96%D/@T*("`\8F]D>3X-"B`@
M("`\=&%B;&4@8VQA<W,],T1R97!O<G0@:60],T1)1#!%34]!0SX-"B`@("`@
M(#QT<CX-"B`@("`@("`@/'1H(&-L87-S/3-$=&P@8V]L<W!A;CTS1#$@<F]W
M<W!A;CTS1#(^/'-T<F]N9SY&24Y!3D-)04P@24Y#3TU%+"!.150@*$1E=&%I
M;',I("A54T0@)"D\8G(^26X@5&AO=7-A;F1S+"!U;FQE<W,@;W1H97)W:7-E
M('-P96-I9FEE9#PO<W1R;VYG/CPO=&@^#0H@("`@("`@(#QT:"!C;&%S<STS
M1'1H(&-O;'-P86X],T0S/C$R($UO;G1H<R!%;F1E9#PO=&@^#0H@("`@("`\
M+W1R/@T*("`@("`@/'1R/@T*("`@("`@("`\=&@@8VQA<W,],T1T:#Y*=6XN
M(#,P+"`R,#$T/&)R/CPO=&@^#0H@("`@("`@(#QT:"!C;&%S<STS1'1H/DIU
M;BX@,S`L(#(P,3,\8G(^/"]T:#X-"B`@("`@("`@/'1H(&-L87-S/3-$=&@^
M2G5N+B`S,"P@,C`Q,CQB<CX\+W1H/@T*("`@("`@/"]T<CX-"B`@("`@(#QT
M<B!C;&%S<STS1')E/@T*("`@("`@("`\=&0@8VQA<W,],T1P;"!V86QI9VX]
M,T1T;W`^/'-T<F]N9SY&24Y!3D-)04P@24Y#3TU%+"!.150@6T%B<W1R86-T
M73PO<W1R;VYG/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS
M<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\
M<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG
M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L
M87-S/3-$<F\^#0H@("`@("`@(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O
M<#Y&;W)E:6=N(&-U<G)E;F-Y('1R86YS;&%T:6]N(&1I9F9E<F5N8V5S+"!N
M970\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6UP/B0@-#`W/'-P86X^
M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;7`^)"`T.3<\
M<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M/B0@
M*#DX*3QS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@("`@(#QT
M<B!C;&%S<STS1')E/@T*("`@("`@("`\=&0@8VQA<W,],T1P;"!V86QI9VX]
M,T1T;W`^0F%N:R!C;VUM:7-S:6]N<SPO=&0^#0H@("`@("`@(#QT9"!C;&%S
M<STS1&YU;3XH,S8I/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C
M;&%S<STS1&YU;3XH,CDI/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT
M9"!C;&%S<STS1&YU;3XH,3(I/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\
M+W1R/@T*("`@("`@/'1R(&-L87-S/3-$<F\^#0H@("`@("`@(#QT9"!C;&%S
M<STS1'!L('9A;&EG;CTS1'1O<#Y);G1E<F5S="!I;F-O;64@;VX@9&5P;W-I
M=',\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6UP/C(T-CQS<&%N/CPO
M<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6UP/C4S.3QS<&%N
M/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6UP/C4W-3QS
M<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S
M<STS1')E/@T*("`@("`@("`\=&0@8VQA<W,],T1P;"!V86QI9VX],T1T;W`^
M1V%I;B`H3&]S<RD@<F5L871E9"!T;R!M87)K971A8FQE('-E8W5R:71I97,\
M+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6UP/C,X-#QS<&%N/CPO<W!A
M;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6T^*#<Y*3QS<&%N/CPO
M<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6UP/C@Y/'-P86X^
M/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$
M<F\^#0H@("`@("`@(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O<#Y'86EN
M("AL;W-S*2!F<F]M(&1E<FEV871I=F5S/"]T9#X-"B`@("`@("`@/'1D(&-L
M87-S/3-$;G5M/B@X,RD\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D
M(&-L87-S/3-$;G5M<#XQ-#`\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@
M/'1D(&-L87-S/3-$;G5M/B@S,3<I/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@
M("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$<F5U/@T*("`@("`@("`\=&0@
M8VQA<W,],T1P;"!V86QI9VX],T1T;W`^1FEN86YC:6%L(&EN8V]M92P@;F5T
M/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XD(#DQ.#QS<&%N/CPO
M<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6UP/B0@,2PP-C@\
M<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XD
M(#(S-SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@("`\+W1A
M8FQE/@T*("`\+V)O9'D^#0H\+VAT;6P^#0H-"BTM+2TM+3U?3F5X=%!A<G1?
M,&-A9#4Y9F1?-S,R95\T-F4R7V$U,S1?,&,X860Q868Y,&1D#0I#;VYT96YT
M+4QO8V%T:6]N.B!F:6QE.B\O+T,Z+S!C860U.69D7S<S,F5?-#9E,E]A-3,T
M7S!C.&%D,6%F.3!D9"]7;W)K<VAE971S+U-H965T-#DN:'1M;`T*0V]N=&5N
M="U4<F%N<V9E<BU%;F-O9&EN9SH@<75O=&5D+7!R:6YT86)L90T*0V]N=&5N
M="U4>7!E.B!T97AT+VAT;6P[(&-H87)S970](G5S+6%S8VEI(@T*#0H\:'1M
M;#X-"B`@/&AE860^#0H@("`@/$U%5$$@:'1T<"UE<75I=CTS1$-O;G1E;G0M
M5'EP92!C;VYT96YT/3-$)W1E>'0O:'1M;#L@8VAA<G-E=#UU=&8M."<^/'-C
M<FEP="!T>7!E/3-$=&5X="]J879A<V-R:7!T('-R8STS1%-H;W<N:G,^+RH@
M1&\@3F]T(%)E;6]V92!4:&ES($-O;6UE;G0@*B\\+W-C<FEP=#X\+VAE860^
M#0H@(#QB;V1Y/@T*("`@(#QT86)L92!C;&%S<STS1')E<&]R="!I9#TS1$E$
M,$544$%'/@T*("`@("`@/'1R/@T*("`@("`@("`\=&@@8VQA<W,],T1T;"!C
M;VQS<&%N/3-$,2!R;W=S<&%N/3-$,CX\<W1R;VYG/E1!6$53($].($E.0T]-
M12`H3F%R<F%T:79E*2`H1&5T86EL<RD@*%531"`D*3QB<CY);B!4:&]U<V%N
M9',L('5N;&5S<R!O=&AE<G=I<V4@<W!E8VEF:65D/"]S=')O;F<^/"]T:#X-
M"B`@("`@("`@/'1H(&-L87-S/3-$=&@@8V]L<W!A;CTS1#,^,3(@36]N=&AS
M($5N9&5D/"]T:#X-"B`@("`@(#PO='(^#0H@("`@("`\='(^#0H@("`@("`@
M(#QT:"!C;&%S<STS1'1H/DIU;BX@,S`L(#(P,30\8G(^/"]T:#X-"B`@("`@
M("`@/'1H(&-L87-S/3-$=&@^2G5N+B`S,"P@,C`Q,SQB<CX\+W1H/@T*("`@
M("`@("`\=&@@8VQA<W,],T1T:#Y*=6XN(#,P+"`R,#$R/&)R/CPO=&@^#0H@
M("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$<F4^#0H@("`@("`@(#QT
M9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O<#X\<W1R;VYG/D%P<&QI8V%B;&4@
M5&%X(%)A=&5S.CPO<W1R;VYG/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS
M1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,]
M,T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S
M/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@
M("`@/'1R(&-L87-S/3-$<F\^#0H@("`@("`@(#QT9"!C;&%S<STS1'!L('9A
M;&EG;CTS1'1O<#Y%9F9E8W1I=F4@:6YC;VUE('1A>"!R871E/"]T9#X-"B`@
M("`@("`@/'1D(&-L87-S/3-$;G5M<#XP+C`P)3QS<&%N/CPO<W!A;CX\+W1D
M/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6UP/C`N,#`E/'-P86X^/"]S<&%N
M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;7`^,"XP,"4\<W!A;CX\
M+W-P86X^/"]T9#X-"B`@("`@(#PO='(^#0H@("`@("`\='(@8VQA<W,],T1R
M:#X-"B`@("`@("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P/DUI;FEM
M=6T@6TUE;6)E<ET\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\
M<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG
M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^
M)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<B!C
M;&%S<STS1')O/@T*("`@("`@("`\=&0@8VQA<W,],T1P;"!V86QI9VX],T1T
M;W`^/'-T<F]N9SY!<'!L:6-A8FQE(%1A>"!2871E<SH\+W-T<F]N9SX\+W1D
M/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T
M9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO
M=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\
M+W1D/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS1')E/@T*("`@
M("`@("`\=&0@8VQA<W,],T1P;"!V86QI9VX],T1T;W`^4W1A='5T;W)Y('1A
M>"!R871E/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XR-2XP,"4\
M<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XR
M-2XP,"4\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$
M;G5M<#XR-2XP,"4\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO='(^#0H@
M("`@("`\='(@8VQA<W,],T1R:#X-"B`@("`@("`@/'1D(&-L87-S/3-$<&P@
M=F%L:6=N/3-$=&]P/DUA>&EM=6T@6TUE;6)E<ET\+W1D/@T*("`@("`@("`\
M=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@
M/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@
M(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@
M/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS1')E/@T*("`@("`@("`\=&0@8VQA
M<W,],T1P;"!V86QI9VX],T1T;W`^/'-T<F]N9SY!<'!L:6-A8FQE(%1A>"!2
M871E<SH\+W-T<F]N9SX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT
M/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X
M=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E
M>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@("`@(#QT
M<B!C;&%S<STS1')O/@T*("`@("`@("`\=&0@8VQA<W,],T1P;"!V86QI9VX]
M,T1T;W`^4W1A='5T;W)Y('1A>"!R871E/"]T9#X-"B`@("`@("`@/'1D(&-L
M87-S/3-$;G5M<#XS-2XP,"4\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@
M/'1D(&-L87-S/3-$;G5M<#XS-2XP,"4\<W!A;CX\+W-P86X^/"]T9#X-"B`@
M("`@("`@/'1D(&-L87-S/3-$;G5M<#XS-2XP,"4\<W!A;CX\+W-P86X^/"]T
M9#X-"B`@("`@(#PO='(^#0H@("`@("`\='(@8VQA<W,],T1R:#X-"B`@("`@
M("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P/DES<F%E;"!487@@075T
M:&]R:71Y(%M-96UB97)=/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X
M=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E
M>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T
M97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO='(^#0H@("`@("`\
M='(@8VQA<W,],T1R;SX-"B`@("`@("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N
M/3-$=&]P/CQS=')O;F<^0V%R<GEF;W)W87)D($QO<W-E<SH\+W-T<F]N9SX\
M+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^
M/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N
M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A
M;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS1')E/@T*
M("`@("`@("`\=&0@8VQA<W,],T1P;"!V86QI9VX],T1T;W`^3F5T(&]P97)A
M=&EN9R!L;W-S(&-A<G)Y9F]R=V%R9',\+W1D/@T*("`@("`@("`\=&0@8VQA
M<W,],T1N=6UP/B`T."PS-#`\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@
M/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@
M(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@
M/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS1')H/@T*("`@("`@("`\=&0@8VQA
M<W,],T1P;"!V86QI9VX],T1T;W`^26YT97)N86P@4F5V96YU92!397)V:6-E
M("A)4E,I(%M-96UB97)=/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X
M=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E
M>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T
M97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO='(^#0H@("`@("`\
M='(@8VQA<W,],T1R93X-"B`@("`@("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N
M/3-$=&]P/CQS=')O;F<^0V%R<GEF;W)W87)D($QO<W-E<SH\+W-T<F]N9SX\
M+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^
M/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N
M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A
M;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS1')O/@T*
M("`@("`@("`\=&0@8VQA<W,],T1P;"!V86QI9VX],T1T;W`^3F5T(&]P97)A
M=&EN9R!L;W-S(&-A<G)Y9F]R=V%R9',\+W1D/@T*("`@("`@("`\=&0@8VQA
M<W,],T1N=6UP/B`R,BPW,S`\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@
M/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@
M(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@
M/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS1')H/@T*("`@("`@("`\=&0@8VQA
M<W,],T1P;"!V86QI9VX],T1T;W`^26YT97)N86P@4F5V96YU92!397)V:6-E
M("A)4E,I(%M-96UB97)=('P@16%R;&EE<W0@5&%X(%EE87(@6TUE;6)E<ET\
M+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^
M/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N
M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A
M;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS1')O/@T*
M("`@("`@("`\=&0@8VQA<W,],T1P;"!V86QI9VX],T1T;W`^/'-T<F]N9SY#
M87)R>69O<G=A<F0@3&]S<V5S.CPO<W1R;VYG/CPO=&0^#0H@("`@("`@(#QT
M9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\
M=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@
M/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\
M+W1R/@T*("`@("`@/'1R(&-L87-S/3-$<F4^#0H@("`@("`@(#QT9"!C;&%S
M<STS1'!L('9A;&EG;CTS1'1O<#Y.970@9F5D97)A;"!O<&5R871I;F<@;&]S
M<R!C87)R>2!F;W)W87)D(&5X<&ER871I;VX@9&%T93PO=&0^#0H@("`@("`@
M(#QT9"!C;&%S<STS1'1E>'0^1&5C(#,Q+`T*"0DR,#(R/'-P86X^/"]S<&%N
M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A
M;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P
M86X^/"]T9#X-"B`@("`@(#PO='(^#0H@("`@("`\='(@8VQA<W,],T1R:#X-
M"B`@("`@("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P/DEN=&5R;F%L
M(%)E=F5N=64@4V5R=FEC92`H25)3*2!;365M8F5R72!\($QA=&5S="!487@@
M665A<B!;365M8F5R73PO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^
M)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT
M/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X
M=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R
M(&-L87-S/3-$<F4^#0H@("`@("`@(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS
M1'1O<#X\<W1R;VYG/D-A<G)Y9F]R=V%R9"!,;W-S97,Z/"]S=')O;F<^/"]T
M9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO
M=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\
M+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^
M/"]T9#X-"B`@("`@(#PO='(^#0H@("`@("`\='(@8VQA<W,],T1R;SX-"B`@
M("`@("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P/DYE="!F961E<F%L
M(&]P97)A=&EN9R!L;W-S(&-A<G)Y(&9O<G=A<F0@97AP:7)A=&EO;B!D871E
M/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#Y$96,@,S$L#0H)"3(P
M,S0\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X
M=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E
M>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@("`\+W1A
M8FQE/@T*("`\+V)O9'D^#0H\+VAT;6P^#0H-"BTM+2TM+3U?3F5X=%!A<G1?
M,&-A9#4Y9F1?-S,R95\T-F4R7V$U,S1?,&,X860Q868Y,&1D#0I#;VYT96YT
M+4QO8V%T:6]N.B!F:6QE.B\O+T,Z+S!C860U.69D7S<S,F5?-#9E,E]A-3,T
M7S!C.&%D,6%F.3!D9"]7;W)K<VAE971S+U-H965T-3`N:'1M;`T*0V]N=&5N
M="U4<F%N<V9E<BU%;F-O9&EN9SH@<75O=&5D+7!R:6YT86)L90T*0V]N=&5N
M="U4>7!E.B!T97AT+VAT;6P[(&-H87)S970](G5S+6%S8VEI(@T*#0H\:'1M
M;#X-"B`@/&AE860^#0H@("`@/$U%5$$@:'1T<"UE<75I=CTS1$-O;G1E;G0M
M5'EP92!C;VYT96YT/3-$)W1E>'0O:'1M;#L@8VAA<G-E=#UU=&8M."<^/'-C
M<FEP="!T>7!E/3-$=&5X="]J879A<V-R:7!T('-R8STS1%-H;W<N:G,^+RH@
M1&\@3F]T(%)E;6]V92!4:&ES($-O;6UE;G0@*B\\+W-C<FEP=#X\+VAE860^
M#0H@(#QB;V1Y/@T*("`@(#QT86)L92!C;&%S<STS1')E<&]R="!I9#TS1$E$
M,$4V24%#/@T*("`@("`@/'1R/@T*("`@("`@("`\=&@@8VQA<W,],T1T;"!C
M;VQS<&%N/3-$,2!R;W=S<&%N/3-$,3X\<W1R;VYG/E1!6$53($].($E.0T]-
M12`H4V-H961U;&4@;V8@4VEG;FEF:6-A;G0@0V]M<&]N96YT<R!O9B!$969E
M<G)E9"!487@@07-S971S*2`H1&5T86EL<RD@*%531"`D*3QB<CY);B!4:&]U
M<V%N9',L('5N;&5S<R!O=&AE<G=I<V4@<W!E8VEF:65D/"]S=')O;F<^/"]T
M:#X-"B`@("`@("`@/'1H(&-L87-S/3-$=&@^2G5N+B`S,"P@,C`Q-#QB<CX\
M+W1H/@T*("`@("`@("`\=&@@8VQA<W,],T1T:#Y*=6XN(#,P+"`R,#$S/&)R
M/CPO=&@^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$<F4^#0H@
M("`@("`@(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O<#X\<W1R;VYG/E1!
M6$53($].($E.0T]-12!;06)S=')A8W1=/"]S=')O;F<^/"]T9#X-"B`@("`@
M("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@
M("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@
M("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS1')O/@T*("`@("`@("`\=&0@
M8VQA<W,],T1P;"!V86QI9VX],T1T;W`^52Y3+B!N970@;W!E<F%T:6YG(&QO
M<W,@8V%R<GEF;W)W87)D/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M
M<#XD(#<L.34U/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S
M<STS1&YU;7`^)"`W+#$P-CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T
M<CX-"B`@("`@(#QT<B!C;&%S<STS1')E/@T*("`@("`@("`\=&0@8VQA<W,]
M,T1P;"!V86QI9VX],T1T;W`^27-R865L:2!N970@;W!E<F%T:6YG(&QO<W,@
M8V%R<GEF;W)W87)D/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XQ
M,BPX,3`\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$
M;G5M<#XX+#4T,SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@
M("`@(#QT<B!C;&%S<STS1')O/@T*("`@("`@("`\=&0@8VQA<W,],T1P;"!V
M86QI9VX],T1T;W`^06QL;W=A;F-E<R!A;F0@<F5S97)V97,\+W1D/@T*("`@
M("`@("`\=&0@8VQA<W,],T1N=6UP/C(S-SQS<&%N/CPO<W!A;CX\+W1D/@T*
M("`@("`@("`\=&0@8VQA<W,],T1N=6UP/C$U-CQS<&%N/CPO<W!A;CX\+W1D
M/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS1')E=3X-"B`@("`@
M("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P/E1O=&%L(&1E9F5R<F5D
M('1A>"!A<W-E=',@8F5F;W)E('9A;'5A=&EO;B!A;&QO=V%N8V4\+W1D/@T*
M("`@("`@("`\=&0@8VQA<W,],T1N=6UP/C(Q+#`P,CQS<&%N/CPO<W!A;CX\
M+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6UP/C$U+#@P-3QS<&%N/CPO
M<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS1')O
M/@T*("`@("`@("`\=&0@8VQA<W,],T1P;"!V86QI9VX],T1T;W`^5F%L=6%T
M:6]N(&%L;&]W86YC93PO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;3XH
M,C$L,#`R*3QS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,]
M,T1N=6T^*#$U+#@P-2D\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO='(^
M#0H@("`@("`\='(@8VQA<W,],T1R974^#0H@("`@("`@(#QT9"!C;&%S<STS
M1'!L('9A;&EG;CTS1'1O<#Y.970@9&5F97)R960@=&%X(&%S<V5T/"]T9#X-
M"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG)FYB<W`[)FYB<W`[/'-P86X^
M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)R9N8G-P
M.R9N8G-P.SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@("`\
M+W1A8FQE/@T*("`\+V)O9'D^#0H\+VAT;6P^#0H-"BTM+2TM+3U?3F5X=%!A
M<G1?,&-A9#4Y9F1?-S,R95\T-F4R7V$U,S1?,&,X860Q868Y,&1D#0I#;VYT
M96YT+4QO8V%T:6]N.B!F:6QE.B\O+T,Z+S!C860U.69D7S<S,F5?-#9E,E]A
M-3,T7S!C.&%D,6%F.3!D9"]7;W)K<VAE971S+V9I;&5L:7-T+GAM;`T*0V]N
M=&5N="U4<F%N<V9E<BU%;F-O9&EN9SH@<75O=&5D+7!R:6YT86)L90T*0V]N
M=&5N="U4>7!E.B!T97AT+VAT;6P[(&-H87)S970](G5S+6%S8VEI(@T*#0H\
M>&UL('AM;&YS.F\],T0B=7)N.G-C:&5M87,M;6EC<F]S;V9T+6-O;3IO9F9I
M8V4Z;V9F:6-E(CX-"B`\;SI-86EN1FEL92!(4F5F/3-$(BXN+U=O<FMB;V]K
M+FAT;6PB+SX-"B`\;SI&:6QE($A2968],T0B4VAE970P,2YH=&UL(B\^#0H@
M/&\Z1FEL92!(4F5F/3-$(E-H965T,#(N:'1M;"(O/@T*(#QO.D9I;&4@2%)E
M9CTS1")3:&5E=#`S+FAT;6PB+SX-"B`\;SI&:6QE($A2968],T0B4VAE970P
M-"YH=&UL(B\^#0H@/&\Z1FEL92!(4F5F/3-$(E-H965T,#4N:'1M;"(O/@T*
M(#QO.D9I;&4@2%)E9CTS1")3:&5E=#`V+FAT;6PB+SX-"B`\;SI&:6QE($A2
M968],T0B4VAE970P-RYH=&UL(B\^#0H@/&\Z1FEL92!(4F5F/3-$(E-H965T
M,#@N:'1M;"(O/@T*(#QO.D9I;&4@2%)E9CTS1")3:&5E=#`Y+FAT;6PB+SX-
M"B`\;SI&:6QE($A2968],T0B4VAE970Q,"YH=&UL(B\^#0H@/&\Z1FEL92!(
M4F5F/3-$(E-H965T,3$N:'1M;"(O/@T*(#QO.D9I;&4@2%)E9CTS1")3:&5E
M=#$R+FAT;6PB+SX-"B`\;SI&:6QE($A2968],T0B4VAE970Q,RYH=&UL(B\^
M#0H@/&\Z1FEL92!(4F5F/3-$(E-H965T,30N:'1M;"(O/@T*(#QO.D9I;&4@
M2%)E9CTS1")3:&5E=#$U+FAT;6PB+SX-"B`\;SI&:6QE($A2968],T0B4VAE
M970Q-BYH=&UL(B\^#0H@/&\Z1FEL92!(4F5F/3-$(E-H965T,3<N:'1M;"(O
M/@T*(#QO.D9I;&4@2%)E9CTS1")3:&5E=#$X+FAT;6PB+SX-"B`\;SI&:6QE
M($A2968],T0B4VAE970Q.2YH=&UL(B\^#0H@/&\Z1FEL92!(4F5F/3-$(E-H
M965T,C`N:'1M;"(O/@T*(#QO.D9I;&4@2%)E9CTS1")3:&5E=#(Q+FAT;6PB
M+SX-"B`\;SI&:6QE($A2968],T0B4VAE970R,BYH=&UL(B\^#0H@/&\Z1FEL
M92!(4F5F/3-$(E-H965T,C,N:'1M;"(O/@T*(#QO.D9I;&4@2%)E9CTS1")3
M:&5E=#(T+FAT;6PB+SX-"B`\;SI&:6QE($A2968],T0B4VAE970R-2YH=&UL
M(B\^#0H@/&\Z1FEL92!(4F5F/3-$(E-H965T,C8N:'1M;"(O/@T*(#QO.D9I
M;&4@2%)E9CTS1")3:&5E=#(W+FAT;6PB+SX-"B`\;SI&:6QE($A2968],T0B
M4VAE970R."YH=&UL(B\^#0H@/&\Z1FEL92!(4F5F/3-$(E-H965T,CDN:'1M
M;"(O/@T*(#QO.D9I;&4@2%)E9CTS1")3:&5E=#,P+FAT;6PB+SX-"B`\;SI&
M:6QE($A2968],T0B4VAE970S,2YH=&UL(B\^#0H@/&\Z1FEL92!(4F5F/3-$
M(E-H965T,S(N:'1M;"(O/@T*(#QO.D9I;&4@2%)E9CTS1")3:&5E=#,S+FAT
M;6PB+SX-"B`\;SI&:6QE($A2968],T0B4VAE970S-"YH=&UL(B\^#0H@/&\Z
M1FEL92!(4F5F/3-$(E-H965T,S4N:'1M;"(O/@T*(#QO.D9I;&4@2%)E9CTS
M1")3:&5E=#,V+FAT;6PB+SX-"B`\;SI&:6QE($A2968],T0B4VAE970S-RYH
M=&UL(B\^#0H@/&\Z1FEL92!(4F5F/3-$(E-H965T,S@N:'1M;"(O/@T*(#QO
M.D9I;&4@2%)E9CTS1")3:&5E=#,Y+FAT;6PB+SX-"B`\;SI&:6QE($A2968]
M,T0B4VAE970T,"YH=&UL(B\^#0H@/&\Z1FEL92!(4F5F/3-$(E-H965T-#$N
M:'1M;"(O/@T*(#QO.D9I;&4@2%)E9CTS1")3:&5E=#0R+FAT;6PB+SX-"B`\
M;SI&:6QE($A2968],T0B4VAE970T,RYH=&UL(B\^#0H@/&\Z1FEL92!(4F5F
M/3-$(E-H965T-#0N:'1M;"(O/@T*(#QO.D9I;&4@2%)E9CTS1")3:&5E=#0U
M+FAT;6PB+SX-"B`\;SI&:6QE($A2968],T0B4VAE970T-BYH=&UL(B\^#0H@
M/&\Z1FEL92!(4F5F/3-$(E-H965T-#<N:'1M;"(O/@T*(#QO.D9I;&4@2%)E
M9CTS1")3:&5E=#0X+FAT;6PB+SX-"B`\;SI&:6QE($A2968],T0B4VAE970T
M.2YH=&UL(B\^#0H@/&\Z1FEL92!(4F5F/3-$(E-H965T-3`N:'1M;"(O/@T*
M/"]X;6P^#0HM+2TM+2T]7TYE>'1087)T7S!C860U.69D7S<S,F5?-#9E,E]A
4-3,T7S!C.&%D,6%F.3!D9"TM#0H`
`
end

</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>44
<FILENAME>R43.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
  <head>
    <META http-equiv="Content-Type" content="text/html; charset=us-ascii">
    <link rel="StyleSheet" type="text/css" href="report.css"><script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script></head>
  <body><span style="display: none;">v2.4.0.8</span><table class="report" border="0" cellspacing="2" id="ID0EZKAE">
      <tr>
        <th class="tl" colspan="1" rowspan="2">
          <div style="width: 200px;"><strong>STOCKHOLDERS' EQUITY (Summary of Option and Warrant Activity to Non-employees) (Details) (USD $)<br>In Thousands, except Share data, unless otherwise specified</strong></div>
        </th>
        <th class="th" colspan="1">12 Months Ended</th>
      </tr>
      <tr>
        <th class="th">
          <div>Jun. 30, 2014</div>
        </th>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_psti_WarrantsAndOptionsNumberAbstract', window );"><strong>Number</strong></a></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_psti_SharebasedGoodsAndNonemployeesServicesTransactionWarrantsAndOptionsNumber', window );">Options and warrants outstanding at beginning of period</a></td>
        <td class="nump">315,500<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_psti_SharebasedGoodsAndNonemployeesServicesTransactionWarrantsAndOptionsGranted', window );">Options granted</a></td>
        <td class="nump">3,000<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_psti_SharebasedGoodsAndNonemployeesServicesTransactionWarrantsAndOptionsExercised', window );">Options and warrants exercised</a></td>
        <td class="num">(66,500)<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_psti_SharebasedGoodsAndNonemployeesServicesTransactionWarrantsAndOptionsNumber', window );">Options and warrants outstanding at end of the period</a></td>
        <td class="nump">252,000<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_psti_SharebasedGoodsAndNonemployeesServicesTransactionWarrantsAndOptionsNumberExercisable', window );">Options and warrants exercisable at the end of the period</a></td>
        <td class="nump">251,000<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_psti_SharebasedGoodsAndNonemployeesServicesTransactionWarrantsAndOptionsNumberVestedAndExpectedToVest', window );">Options and warrants vested and expected to vest</a></td>
        <td class="nump">252,000<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_psti_WarrantsAndOptionsWeightedAverageExercisePriceAbstract', window );"><strong>Weighted average exercise price</strong></a></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_psti_WarrantsAndOptionsWeightedAverageExercisePrice', window );">Options and warrants outstanding at beginning of period</a></td>
        <td class="nump">$ 4.44<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_psti_WarrantsAndOptionsGrantedWeightedAverageExercisePrice', window );">Options granted</a></td>
        <td class="nump">$ 0.00<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_psti_WarrantsAndOptionsExercisedWeightedAverageExercisePrice', window );">Options and warrants exercised</a></td>
        <td class="nump">$ 1.39<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_psti_WarrantsAndOptionsWeightedAverageExercisePrice', window );">Options and warrants outstanding at end of the period</a></td>
        <td class="nump">$ 5.19<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_psti_WarrantsAndOptionsWeightedAverageExercisePriceExcercisable', window );">Options and warrants exercisable at the end of the period</a></td>
        <td class="nump">$ 5.21<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_psti_WarrantsAndOptionsWeightedAverageExercisePriceVestedAndExpectedToVest', window );">Options and warrants vested and expected to vest</a></td>
        <td class="nump">$ 5.19<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_psti_WarrantsAndOptionsWeightedAverageRemainingContractualTermsAbstract', window );"><strong>Weighted average remaining contractual term</strong></a></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_psti_WarrantsAndOptionsWeightedAverageRemainingContractualTerm', window );">Options and warrants outstanding at end of the period</a></td>
        <td class="text">3 years 11 months 16 days<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_psti_WarrantsAndOptionsWeightedAverageRemainingContractualTermExercisable', window );">Options and warrants exercisable at the end of the period</a></td>
        <td class="text">3 years 11 months 5 days<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_psti_WarrantsAndOptionsWeightedAverageRemainingContractualTermVestedAndExpectedToVest', window );">Options and warrants vested and expected to vest</a></td>
        <td class="text">3 years 11 months 16 days<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_psti_WarrantsAndOptionsAggregateIntrinsicValuePriceAbstract', window );"><strong>Aggregate intrinsic value price</strong></a></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_psti_WarrantsAndOptionsAggregateIntrinsicValue', window );">Options and warrants outstanding at end of the period</a></td>
        <td class="nump">$ 331<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_psti_WarrantsAndOptionsAggregateIntrinsicValueExercisable', window );">Options and warrants exercisable at the end of the period</a></td>
        <td class="nump">328<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_psti_WarrantsAndOptionsAggregateIntrinsicValueVestedAndExpectedToVest', window );">Options and warrants vested and expected to vest</a></td>
        <td class="nump">$ 331<span></span></td>
      </tr>
    </table>
    <div style="display: none;">
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_psti_SharebasedGoodsAndNonemployeesServicesTransactionWarrantsAndOptionsExercised">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Sharebased goods and nonemployees services transaction warrants and options exercised.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>psti_SharebasedGoodsAndNonemployeesServicesTransactionWarrantsAndOptionsExercised</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>psti_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:sharesItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_psti_SharebasedGoodsAndNonemployeesServicesTransactionWarrantsAndOptionsGranted">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Sharebased goods and nonemployees services transaction warrants and options granted.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>psti_SharebasedGoodsAndNonemployeesServicesTransactionWarrantsAndOptionsGranted</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>psti_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:sharesItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_psti_SharebasedGoodsAndNonemployeesServicesTransactionWarrantsAndOptionsNumber">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Sharebased goods and nonemployees services transaction warrants and options number.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>psti_SharebasedGoodsAndNonemployeesServicesTransactionWarrantsAndOptionsNumber</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>psti_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:sharesItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_psti_SharebasedGoodsAndNonemployeesServicesTransactionWarrantsAndOptionsNumberExercisable">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Sharebased goods and nonemployees services transaction warrants and options number exercisable.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>psti_SharebasedGoodsAndNonemployeesServicesTransactionWarrantsAndOptionsNumberExercisable</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>psti_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:sharesItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_psti_SharebasedGoodsAndNonemployeesServicesTransactionWarrantsAndOptionsNumberVestedAndExpectedToVest">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Sharebased goods and nonemployees services transaction warrants and options number vested and expected to vest.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>psti_SharebasedGoodsAndNonemployeesServicesTransactionWarrantsAndOptionsNumberVestedAndExpectedToVest</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>psti_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:sharesItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_psti_WarrantsAndOptionsAggregateIntrinsicValue">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Warrants and options aggregate intrinsic value.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>psti_WarrantsAndOptionsAggregateIntrinsicValue</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>psti_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>debit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_psti_WarrantsAndOptionsAggregateIntrinsicValueExercisable">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Warrants and options aggregate intrinsic value exercisable.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>psti_WarrantsAndOptionsAggregateIntrinsicValueExercisable</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>psti_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>debit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_psti_WarrantsAndOptionsAggregateIntrinsicValuePriceAbstract">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div>
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>psti_WarrantsAndOptionsAggregateIntrinsicValuePriceAbstract</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>psti_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:stringItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_psti_WarrantsAndOptionsAggregateIntrinsicValueVestedAndExpectedToVest">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Warrants and options aggregate intrinsic value vested and expected to vest.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>psti_WarrantsAndOptionsAggregateIntrinsicValueVestedAndExpectedToVest</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>psti_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>debit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_psti_WarrantsAndOptionsExercisedWeightedAverageExercisePrice">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Warrants and options exercised weighted average exercise price.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>psti_WarrantsAndOptionsExercisedWeightedAverageExercisePrice</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>psti_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>num:perShareItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_psti_WarrantsAndOptionsGrantedWeightedAverageExercisePrice">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Warrants and options granted weighted average exercise price.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>psti_WarrantsAndOptionsGrantedWeightedAverageExercisePrice</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>psti_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>num:perShareItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_psti_WarrantsAndOptionsNumberAbstract">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div>
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>psti_WarrantsAndOptionsNumberAbstract</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>psti_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:stringItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_psti_WarrantsAndOptionsWeightedAverageExercisePrice">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Warrants and options weighted average exercise price.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>psti_WarrantsAndOptionsWeightedAverageExercisePrice</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>psti_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>num:perShareItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_psti_WarrantsAndOptionsWeightedAverageExercisePriceAbstract">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div>
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>psti_WarrantsAndOptionsWeightedAverageExercisePriceAbstract</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>psti_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:stringItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_psti_WarrantsAndOptionsWeightedAverageExercisePriceExcercisable">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Warrants and options weighted average exercise price excercisable.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>psti_WarrantsAndOptionsWeightedAverageExercisePriceExcercisable</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>psti_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>num:perShareItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_psti_WarrantsAndOptionsWeightedAverageExercisePriceVestedAndExpectedToVest">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Warrants and options weighted average exercise price vested and expected to vest.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>psti_WarrantsAndOptionsWeightedAverageExercisePriceVestedAndExpectedToVest</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>psti_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>num:perShareItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_psti_WarrantsAndOptionsWeightedAverageRemainingContractualTerm">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Warrants and pptions weighted average remaining contractual term.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>psti_WarrantsAndOptionsWeightedAverageRemainingContractualTerm</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>psti_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:durationItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_psti_WarrantsAndOptionsWeightedAverageRemainingContractualTermExercisable">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Warrants and options weighted average remaining contractual term exercisable.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>psti_WarrantsAndOptionsWeightedAverageRemainingContractualTermExercisable</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>psti_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:durationItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_psti_WarrantsAndOptionsWeightedAverageRemainingContractualTermsAbstract">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div>
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>psti_WarrantsAndOptionsWeightedAverageRemainingContractualTermsAbstract</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>psti_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:stringItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_psti_WarrantsAndOptionsWeightedAverageRemainingContractualTermVestedAndExpectedToVest">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Warrants and options weighted average remaining contractual term vested and expected to vest.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>psti_WarrantsAndOptionsWeightedAverageRemainingContractualTermVestedAndExpectedToVest</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>psti_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:durationItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
    </div>
  </body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>45
<FILENAME>R29.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
  <head>
    <META http-equiv="Content-Type" content="text/html; charset=us-ascii">
    <link rel="StyleSheet" type="text/css" href="report.css"><script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script></head>
  <body><span style="display: none;">v2.4.0.8</span><table class="report" border="0" cellspacing="2" id="ID0EEQAE">
      <tr>
        <th class="tl" colspan="1" rowspan="2">
          <div style="width: 200px;"><strong>GENERAL (Details) (USD $)<br>In Thousands, except Share data, unless otherwise specified</strong></div>
        </th>
        <th class="th" colspan="1">1 Months Ended</th>
        <th class="th" colspan="3">12 Months Ended</th>
      </tr>
      <tr>
        <th class="th">
          <div>Aug. 31, 2011</div>
        </th>
        <th class="th">
          <div>Jun. 30, 2014</div>
        </th>
        <th class="th">
          <div>Jun. 30, 2013</div>
        </th>
        <th class="th">
          <div>Jun. 30, 2012</div>
        </th>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_psti_GeneralAbstract', window );"><strong>GENERAL [Abstract]</strong></a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RetainedEarningsAccumulatedDeficit', window );">Accumulated deficit</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="num">$ (113,834)<span></span></td>
        <td class="num">$ (86,902)<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="num">(26,932)<span></span></td>
        <td class="num">(21,155)<span></span></td>
        <td class="num">(14,794)<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LicensesRevenue', window );">Upfront payment received</a></td>
        <td class="nump">7,000<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromGrants', window );">Nonrefundable payments received</a></td>
        <td class="nump">5,000<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromCustomers', window );">Advance payment on the development</a></td>
        <td class="nump">2,000<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_psti_ResearchAndDevelopmentMilestoneRevenueReceivable', window );">Milestone revenue receivable</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">37,500<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ReimbursementRevenue', window );">Reimbursement revenue receivable</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">10,000<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesPurchaseOfAssets', window );">Issuance of common stock under CHA agreement</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">2,500,000<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_psti_AvailableForSaleMarketableSecuritiesNumber', window );">CHA shares classified as marketable securities</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">1,011,504<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValuePurchaseOfAssets', window );">Total consideration reflected under the CHA agreement</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">$ 10,414<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
    </table>
    <div style="display: none;">
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_psti_AvailableForSaleMarketableSecuritiesNumber">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Number of equity financial securities classified as available-for-sale.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>psti_AvailableForSaleMarketableSecuritiesNumber</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>psti_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:sharesItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_psti_GeneralAbstract">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div>
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>psti_GeneralAbstract</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>psti_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:stringItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_psti_ResearchAndDevelopmentMilestoneRevenueReceivable">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Maximum revenue receivable as milestone payments for licensing agreements.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>psti_ResearchAndDevelopmentMilestoneRevenueReceivable</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>psti_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>credit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LicensesRevenue">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Revenue earned during the period relating to consideration received from another party for the right to use, but not own, certain of the entity's intangible assets. Licensing arrangements include, but are not limited to, rights to use a patent, copyright, technology, manufacturing process, software or trademark. Licensing fees are generally, but not always, fixed as to amount and not dependent upon the revenue generated by the licensing party. An entity may receive licensing fees for licenses that also generate royalty payments to the entity.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 225<br><br> -SubTopic 10<br><br> -Section S99<br><br> -Paragraph 2<br><br> -Subparagraph (SX 210.5-03.1(e))<br><br> -URI http://asc.fasb.org/extlink&amp;oid=26872669&amp;loc=d3e20235-122688<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_LicensesRevenue</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>credit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 230<br><br> -SubTopic 10<br><br> -Section 45<br><br> -Paragraph 28<br><br> -URI http://asc.fasb.org/extlink&amp;oid=31042434&amp;loc=d3e3602-108585<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 260<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 1<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Glossary Other Comprehensive Income<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6519514<br><br><br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Glossary Net Income<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6518256<br><br><br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 944<br><br> -SubTopic 225<br><br> -Section S99<br><br> -Paragraph 1<br><br> -Subparagraph (SX 210.7-04.19)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6879464&amp;loc=d3e573970-122913<br><br><br><br>Reference 6: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 225<br><br> -SubTopic 10<br><br> -Section S99<br><br> -Paragraph 2<br><br> -Subparagraph (SX 210.5-03.18)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=26872669&amp;loc=d3e20235-122688<br><br><br><br>Reference 7: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 944<br><br> -SubTopic 225<br><br> -Section S99<br><br> -Paragraph 1<br><br> -Subparagraph (SX 210.7-04.22)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6879464&amp;loc=d3e573970-122913<br><br><br><br>Reference 8: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher SEC<br><br> -Name Regulation S-X (SX)<br><br> -Number 210<br><br> -Section 03<br><br> -Paragraph 19<br><br> -Article 5<br><br><br><br>Reference 9: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher SEC<br><br> -Name Regulation S-X (SX)<br><br> -Number 210<br><br> -Section 04<br><br> -Paragraph 20<br><br> -Article 9<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_NetIncomeLoss</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>credit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromCustomers">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Cash receipts from customers during the current period which are usually for sales of goods and services.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 230<br><br> -SubTopic 10<br><br> -Section 45<br><br> -Paragraph 25<br><br> -Subparagraph (a)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=31042434&amp;loc=d3e3536-108585<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_ProceedsFromCustomers</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>debit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ReimbursementRevenue">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Repayment received or receivable for expenses incurred on behalf of a client or customer, other than those reimbursements received by landlords from tenants.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 225<br><br> -SubTopic 10<br><br> -Section S99<br><br> -Paragraph 2<br><br> -Subparagraph (SX 210.5-03.1)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=26872669&amp;loc=d3e20235-122688<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 605<br><br> -SubTopic 45<br><br> -Section 45<br><br> -Paragraph 23<br><br> -URI http://asc.fasb.org/extlink&amp;oid=21915142&amp;loc=d3e60722-111653<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_ReimbursementRevenue</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>credit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RetainedEarningsAccumulatedDeficit">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The cumulative amount of the reporting entity's undistributed earnings or deficit.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher SEC<br><br> -Name Regulation S-X (SX)<br><br> -Number 210<br><br> -Section 02<br><br> -Paragraph 31<br><br> -Article 5<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher SEC<br><br> -Name Regulation S-X (SX)<br><br> -Number 210<br><br> -Section 04<br><br> -Article 3<br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 210<br><br> -SubTopic 10<br><br> -Section S99<br><br> -Paragraph 1<br><br> -Subparagraph (SX 210.5-02.31(a)(3))<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_RetainedEarningsAccumulatedDeficit</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>credit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromGrants">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Revenue earned during the period from non-repayable sum of money awarded to an entity to carry out a specific purpose as provided in grant agreements.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 225<br><br> -SubTopic 10<br><br> -Section S99<br><br> -Paragraph 2<br><br> -Subparagraph (SX 210.5-03.1(e))<br><br> -URI http://asc.fasb.org/extlink&amp;oid=26872669&amp;loc=d3e20235-122688<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_RevenueFromGrants</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>credit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesPurchaseOfAssets">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Number of shares of stock issued during the period as part of a transaction to acquire assets that do not qualify as a business combination.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_StockIssuedDuringPeriodSharesPurchaseOfAssets</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:sharesItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValuePurchaseOfAssets">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Value of shares of stock issued during the period as part of a transaction to acquire assets that do not qualify as a business combination.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_StockIssuedDuringPeriodValuePurchaseOfAssets</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>credit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
    </div>
  </body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>46
<FILENAME>R28.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
  <head>
    <META http-equiv="Content-Type" content="text/html; charset=us-ascii">
    <link rel="StyleSheet" type="text/css" href="report.css"><script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script></head>
  <body><span style="display: none;">v2.4.0.8</span><table class="report" border="0" cellspacing="2" id="ID0E2F">
      <tr>
        <th class="tl" colspan="1" rowspan="2">
          <div style="width: 200px;"><strong>TAXES ON INCOME (Tables)<br></strong></div>
        </th>
        <th class="th" colspan="1">12 Months Ended</th>
      </tr>
      <tr>
        <th class="th">
          <div>Jun. 30, 2014</div>
        </th>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureAbstract', window );"><strong>TAXES ON INCOME [Abstract]</strong></a></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_psti_QualifyingPercentageOfValueOfProductiveAssetsTableTextBlock', window );">Qualifying Percentage of Value of Productive Assets</a></td>
        <td class="text"><!--DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd" --><div> <div><!--StartFragment--> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; MARGIN-LEFT: 27pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> The qualifying percentage of the value of the productive assets is as follows:</div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /> </div> <div style="MARGIN-LEFT: 27pt; text-align: center"> <table style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman" cellspacing="0" cellpadding="0" width="60%"> <tr> <td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="49%"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"> The value of productive</div> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"> assets before the expansion</div> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"> (NIS in millions)</div> </td> <td valign="top" width="2%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid" valign="top" width="49%"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"> The new proportion</div> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"> that the required</div> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"> &nbsp;investment bears</div> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"> to the value of</div> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"> productive assets</div> </td> </tr> <tr> <td valign="top" width="49%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="top" width="2%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="top" width="49%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> <tr bgcolor="#cceeff"> <td style="TEXT-ALIGN: left; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt" valign="top" width="49%"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: left; TEXT-INDENT: 0pt"> Up to NIS&nbsp;140</div> </td> <td valign="top" width="2%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="top" width="49%"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"> 12%</div> </td> </tr> <tr bgcolor="white"> <td style="TEXT-ALIGN: left; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt" valign="top" width="49%"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: left; TEXT-INDENT: 0pt"> NIS&nbsp;140 - NIS&nbsp;500</div> </td> <td valign="top" width="2%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="top" width="49%"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"> 7%</div> </td> </tr> <tr bgcolor="#cceeff"> <td style="TEXT-ALIGN: left; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt" valign="top" width="49%"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: left; TEXT-INDENT: 0pt"> More than NIS&nbsp;500</div> </td> <td valign="top" width="2%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="top" width="49%"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"> 5%</div> </td> </tr> </table> </div> <!--EndFragment--></div> </div><span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock', window );">Schedule of Deferred Tax Assets</a></td>
        <td class="text"><!--DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd" --><div> <div><!--StartFragment--> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; MARGIN-LEFT: 27pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> Deferred income taxes reflect the net tax effects of temporary differences between the carrying amounts of assets and liabilities for financial reporting purposes and the amounts used for income tax purposes. Significant components of the Company&#39;s deferred tax assets are as follows:</div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /> </div> <div style="text-align: right"> <table style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman" cellspacing="0" cellpadding="0" width="95%"> <tr> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="76%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-WEIGHT: bold; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="22%" colspan="6"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"> June 30,</div> </td> <td style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-WEIGHT: bold; DISPLAY: inline"> &nbsp;</font> </td> </tr> <tr> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="76%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-WEIGHT: bold; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="10%" colspan="2"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: -18pt"> 2014</div> </td> <td style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-WEIGHT: bold; DISPLAY: inline"> &nbsp;</font> </td> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-WEIGHT: bold; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="10%" colspan="2"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: -18pt"> 2013</div> </td> <td style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-WEIGHT: bold; DISPLAY: inline"> &nbsp;</font> </td> </tr> <tr bgcolor="#cceeff"> <td valign="bottom" width="76%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 9pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: -9pt"> Deferred tax assets:</div> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="10%" colspan="2"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="10%" colspan="2"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> <tr bgcolor="white"> <td valign="bottom" width="76%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: -9pt"> U.S. net operating loss carryforward</div> </td> <td valign="bottom" width="1%" align="right"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%">$</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">7,955</td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%" align="right"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%">$</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">7,106</td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> <tr bgcolor="#cceeff"> <td valign="bottom" width="76%"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: -9pt"> Israeli net operating loss carryforward</div> </td> <td valign="bottom" width="1%" align="right"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">12,810</td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%" align="right"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">8,543</td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> <tr bgcolor="white"> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="76%"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: -9pt"> Allowances and reserves</div> </td> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%" align="right"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">237</td> <td style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%" align="right"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">156</td> <td style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> <tr bgcolor="#cceeff"> <td valign="bottom" width="76%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: right" valign="bottom" width="9%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: right" valign="bottom" width="9%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> <tr bgcolor="white"> <td valign="bottom" width="76%"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 9pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: -9pt"> Total deferred tax assets before valuation allowance</div> </td> <td valign="bottom" width="1%" align="right"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">21,002</td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%" align="right"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">15,805</td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> <tr bgcolor="#cceeff"> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="76%"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 9pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: -9pt"> Valuation allowance</div> </td> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%" align="right"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">(21,002</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap">)</td> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%" align="right"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">(15,805</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap">)</td> </tr> <tr bgcolor="white"> <td valign="bottom" width="76%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: right" valign="bottom" width="9%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: right" valign="bottom" width="9%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> <tr bgcolor="#cceeff"> <td style="PADDING-BOTTOM: 4px" valign="bottom" width="76%"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 9pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: -9pt"> Net deferred tax asset</div> </td> <td style="PADDING-BOTTOM: 4px" valign="bottom" width="1%" align="right"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 4px double; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%">$</td> <td style="BORDER-BOTTOM: black 4px double; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">-</td> <td style="PADDING-BOTTOM: 4px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="PADDING-BOTTOM: 4px" valign="bottom" width="1%" align="right"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 4px double; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%">$</td> <td style="BORDER-BOTTOM: black 4px double; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">-</td> <td style="PADDING-BOTTOM: 4px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> </table> </div> <!--EndFragment--></div> </div><span></span></td>
      </tr>
    </table>
    <div style="display: none;">
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_psti_QualifyingPercentageOfValueOfProductiveAssetsTableTextBlock">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Qualifying Percentage Of Value Of Productive Assets [Table Text Block]</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>psti_QualifyingPercentageOfValueOfProductiveAssetsTableTextBlock</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>psti_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>nonnum:textBlockItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureAbstract">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div>
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_IncomeTaxDisclosureAbstract</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:stringItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Tabular disclosure of the components of net deferred tax asset or liability recognized in an entity's statement of financial position, including the following: the total of all deferred tax liabilities, the total of all deferred tax assets, the total valuation allowance recognized for deferred tax assets.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 740<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 2<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6907707&amp;loc=d3e32537-109319<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>nonnum:textBlockItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
    </div>
  </body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>47
<FILENAME>R44.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
  <head>
    <META http-equiv="Content-Type" content="text/html; charset=us-ascii">
    <link rel="StyleSheet" type="text/css" href="report.css"><script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script></head>
  <body><span style="display: none;">v2.4.0.8</span><table class="report" border="0" cellspacing="2" id="ID0EYIAC">
      <tr>
        <th class="tl" colspan="1" rowspan="2">
          <div style="width: 200px;"><strong>STOCKHOLDERS' EQUITY (Summary of RSU Activity to Employees and Directors) (Details) (Restricted stock units [Member])<br></strong></div>
        </th>
        <th class="th" colspan="1">12 Months Ended</th>
      </tr>
      <tr>
        <th class="th">
          <div>Jun. 30, 2014</div>
        </th>
      </tr>
      <tr class="rh">
        <td class="pl" style="border-bottom: 0px;" valign="top">
          <div class="a">Restricted stock units [Member]</div>
        </td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber', window );">Unvested at the beginning of period</a></td>
        <td class="nump">1,660,525<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod', window );">Granted</a></td>
        <td class="nump">1,256,940<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod', window );">Forfeited</a></td>
        <td class="num">(44,183)<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod', window );">Vested</a></td>
        <td class="num">(1,283,850)<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber', window );">Unvested at the end of the period</a></td>
        <td class="nump">1,589,432<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_psti_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsExpectedToVest', window );">Expected to vest</a></td>
        <td class="nump">1,522,024<span></span></td>
      </tr>
    </table>
    <div style="display: none;">
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_psti_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsExpectedToVest">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Share based compensation arrangement by share based payment award equity instruments other than options expected to vest.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>psti_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsExpectedToVest</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>psti_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:sharesItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The number of equity-based payment instruments, excluding stock (or unit) options, that were forfeited during the reporting period.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 718<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 2<br><br> -Subparagraph (c)(1)(iv)(3)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6415400&amp;loc=d3e5070-113901<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:sharesItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The number of grants made during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 718<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 2<br><br> -Subparagraph (c)(2)(iii)(1)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6415400&amp;loc=d3e5070-113901<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:sharesItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The number of non-vested equity-based payment instruments, excluding stock (or unit) options, that validly exist and are outstanding as of the balance sheet date.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 718<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 2<br><br> -Subparagraph (c)(2)(i)-(ii)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6415400&amp;loc=d3e5070-113901<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:sharesItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The number of equity-based payment instruments, excluding stock (or unit) options, that vested during the reporting period.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 718<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 2<br><br> -Subparagraph (c)(2)(iii)(2)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6415400&amp;loc=d3e5070-113901<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:sharesItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div>
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:stringItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
    </div>
  </body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>48
<FILENAME>R30.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
  <head>
    <META http-equiv="Content-Type" content="text/html; charset=us-ascii">
    <link rel="StyleSheet" type="text/css" href="report.css"><script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script></head>
  <body><span style="display: none;">v2.4.0.8</span><table class="report" border="0" cellspacing="2" id="ID0ECABG">
      <tr>
        <th class="tl" colspan="1" rowspan="2">
          <div style="width: 200px;"><strong>SIGNIFICANT ACCOUNTING POLICIES (Narrative) (Details) (USD $)<br>In Thousands, except Per Share data, unless otherwise specified</strong></div>
        </th>
        <th class="th" colspan="3">12 Months Ended</th>
      </tr>
      <tr>
        <th class="th">
          <div>Jun. 30, 2014</div>
        </th>
        <th class="th">
          <div>Jun. 30, 2013</div>
        </th>
        <th class="th">
          <div>Jun. 30, 2012</div>
        </th>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue', window );">Granted, weighted-average grant date fair value</a></td>
        <td class="nump">$ 3.53<span></span></td>
        <td class="nump">$ 3.43<span></span></td>
        <td class="nump">$ 2.54<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PostemploymentBenefitsPeriodExpense', window );">Severance expenses</a></td>
        <td class="nump">$ 534<span></span></td>
        <td class="nump">$ 329<span></span></td>
        <td class="nump">$ 275<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GainLossOnDerivativeInstrumentsNetPretax', window );">Gains (losses) on other derivatives</a></td>
        <td class="num">(70)<span></span></td>
        <td class="nump">231<span></span></td>
        <td class="num">(145)<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredRevenueArrangementLineItems', window );"><strong>Deferred Revenue Arrangement [Line Items]</strong></a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredRevenueAdditions', window );">Deferred revenue</a></td>
        <td class="nump">5,000<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_psti_BusinessCombinationContingentConsiderationReceivableUponCertainRegulatoryMilestones', window );">Contingent consideration receivable if certain regulatory milestones are reached</a></td>
        <td class="nump">37,500<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_psti_RemainingDeferredRevenueRecognitionPeriodForIntangibleAsset', window );">Remaining revenue recognition period</a></td>
        <td class="text">8 years 6 months<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_psti_AdvancePaymentForDeveplomentCosts', window );">Advance payment for development costs</a></td>
        <td class="nump">2,000<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_psti_ReclassFromResearchAndDevelopmentExpenseToCostOfRevenues', window );">Total deduction from advanced payment</a></td>
        <td class="nump">1,753<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="rh">
        <td class="pl" style="border-bottom: 0px;" valign="top">
          <div class="a">Forward contracts [Member] | Designated as Hedging Instrument [Member] | Israel, New Shekels [Member]</div>
        </td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_invest_DerivativeNotionalAmount', window );">Notional amount</a></td>
        <td class="nump">2,820<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossCumulativeChangesInNetGainLossFromCashFlowHedgesEffectNetOfTax', window );">Net unrealized gain on the effective portion</a></td>
        <td class="nump">23<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossRecognizedInOtherComprehensiveIncomeEffectivePortionNet', window );">Net gain, resulting in the cash flow hedge transactions</a></td>
        <td class="nump">48<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashFlowHedgesDerivativeInstrumentsAtFairValueNet', window );">Fair value of cash flow hedge derivatives</a></td>
        <td class="nump">24<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="rh">
        <td class="pl" style="border-bottom: 0px;" valign="top">
          <div class="a">Forward contracts [Member] | Designated as Hedging Instrument [Member] | Korean Won [Member]</div>
        </td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_invest_DerivativeNotionalAmount', window );">Notional amount</a></td>
        <td class="nump">11,000<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueHedgesAtFairValueNet', window );">Fair value of fair value hedge derivatives</a></td>
        <td class="num">$ (889)<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="rh">
        <td class="pl" style="border-bottom: 0px;" valign="top">
          <div class="a">Employees [Member]</div>
        </td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_psti_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsForfeituresRate', window );">Forfeiture rate</a></td>
        <td class="nump">7.00%<span></span></td>
        <td class="nump">7.00%<span></span></td>
        <td class="nump">5.00%<span></span></td>
      </tr>
      <tr class="rh">
        <td class="pl" style="border-bottom: 0px;" valign="top">
          <div class="a">Management [Member]</div>
        </td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_psti_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsForfeituresRate', window );">Forfeiture rate</a></td>
        <td class="nump">0.00%<span></span></td>
        <td class="nump">0.00%<span></span></td>
        <td class="nump">0.00%<span></span></td>
      </tr>
    </table>
    <div style="display: none;">
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_invest_DerivativeNotionalAmount">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Aggregate notional amount specified by the derivative(s). Expressed as an absolute value.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher SEC<br><br> -Name Regulation S-X (SX)<br><br> -Number 210<br><br> -Article 12<br><br> -Section 13<br><br> -Sentence Column B<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>invest_DerivativeNotionalAmount</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>invest_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_psti_AdvancePaymentForDeveplomentCosts">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The advance payment for any development costs.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>psti_AdvancePaymentForDeveplomentCosts</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>psti_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>debit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_psti_BusinessCombinationContingentConsiderationReceivableUponCertainRegulatoryMilestones">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Business combination contingent consideration receivable upon certain regulatory milestones.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>psti_BusinessCombinationContingentConsiderationReceivableUponCertainRegulatoryMilestones</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>psti_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>debit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_psti_ReclassFromResearchAndDevelopmentExpenseToCostOfRevenues">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The amount that was deducted from the adavance payment according to ASC 730-20.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>psti_ReclassFromResearchAndDevelopmentExpenseToCostOfRevenues</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>psti_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>debit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_psti_RemainingDeferredRevenueRecognitionPeriodForIntangibleAsset">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Remaining Deferred Revenue Recognition Period from the license agreeement with united therapeutics.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>psti_RemainingDeferredRevenueRecognitionPeriodForIntangibleAsset</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>psti_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:durationItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_psti_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsForfeituresRate">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The forfeiture rate of options and shares granted to employees, directors and officers.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>psti_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsForfeituresRate</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>psti_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>num:percentItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossCumulativeChangesInNetGainLossFromCashFlowHedgesEffectNetOfTax">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Accumulated change, net of tax, in accumulated gains and losses from derivative instruments designated and qualifying as the effective portion of cash flow hedges. Includes an entity's share of an equity investee's Increase or Decrease in deferred hedging gains or losses.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 220<br><br> -SubTopic 10<br><br> -Section 45<br><br> -Paragraph 11<br><br> -URI http://asc.fasb.org/extlink&amp;oid=36458714&amp;loc=d3e637-108580<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 220<br><br> -SubTopic 10<br><br> -Section 45<br><br> -Paragraph 14<br><br> -URI http://asc.fasb.org/extlink&amp;oid=36458714&amp;loc=d3e681-108580<br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 220<br><br> -SubTopic 10<br><br> -Section 45<br><br> -Paragraph 14A<br><br> -URI http://asc.fasb.org/extlink&amp;oid=36458714&amp;loc=SL7669686-108580<br><br><br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 220<br><br> -SubTopic 10<br><br> -Section 45<br><br> -Paragraph 10A<br><br> -Subparagraph (d)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=36458714&amp;loc=SL7669646-108580<br><br><br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 815<br><br> -SubTopic 30<br><br> -Section 50<br><br> -Paragraph 2<br><br> -URI http://asc.fasb.org/extlink&amp;oid=35736893&amp;loc=d3e80784-113994<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_AccumulatedOtherComprehensiveIncomeLossCumulativeChangesInNetGainLossFromCashFlowHedgesEffectNetOfTax</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>credit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashFlowHedgesDerivativeInstrumentsAtFairValueNet">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Net fair value of all derivative instruments designated as cash flow hedging instruments, which is ordinarily reflected within other comprehensive income.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 815<br><br> -SubTopic 10<br><br> -Section 45<br><br> -Paragraph 5<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6945355&amp;loc=d3e41228-113958<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_CashFlowHedgesDerivativeInstrumentsAtFairValueNet</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>debit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredRevenueAdditions">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Amount of deferred revenue recognized for transactions arising during the current reporting period. Deferred revenue is a liability as of the balance sheet date related to a revenue producing activity for which revenue has not yet been recognized. Generally, an Entity records deferred revenue when it receives consideration from a customer before achieving certain criteria that must be met for revenue to be recognized in conformity with GAAP.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 605<br><br> -SubTopic 10<br><br> -Section S99<br><br> -Paragraph 1<br><br> -Subparagraph (SAB TOPIC 13.A.4(a).Q1)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=27012821&amp;loc=d3e214044-122780<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher SEC<br><br> -Name Staff Accounting Bulletin (SAB)<br><br> -Number Topic 13<br><br> -Section A<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_DeferredRevenueAdditions</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>credit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredRevenueArrangementLineItems">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div>
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_DeferredRevenueArrangementLineItems</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:stringItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentsGainLossRecognizedInOtherComprehensiveIncomeEffectivePortionNet">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The effective portion of gains and losses (net) on derivative instruments designated and qualifying as hedging instruments that was recognized in other comprehensive income during the current period.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 815<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 4C<br><br> -Subparagraph (b)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=35706170&amp;loc=SL5624171-113959<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_DerivativeInstrumentsGainLossRecognizedInOtherComprehensiveIncomeEffectivePortionNet</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>credit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueHedgesAtFairValueNet">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Net fair value of all derivative instruments designated as fair value hedging instruments.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 815<br><br> -SubTopic 10<br><br> -Section 45<br><br> -Paragraph 5<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6945355&amp;loc=d3e41228-113958<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_FairValueHedgesAtFairValueNet</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>debit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GainLossOnDerivativeInstrumentsNetPretax">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Aggregate net gain (loss) on all derivative instruments recognized in earnings during the period, before tax effects.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 815<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 4A<br><br> -Subparagraph (b)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=35706170&amp;loc=SL5618551-113959<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_GainLossOnDerivativeInstrumentsNetPretax</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>credit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PostemploymentBenefitsPeriodExpense">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Period expense related to postemployment benefits.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_PostemploymentBenefitsPeriodExpense</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>debit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The weighted average fair value at grant date for nonvested equity-based awards issued during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 718<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 2<br><br> -Subparagraph (c)(2)(iii)(1)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6415400&amp;loc=d3e5070-113901<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>num:perShareItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div>
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:stringItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
    </div>
  </body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>49
<FILENAME>R31.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
  <head>
    <META http-equiv="Content-Type" content="text/html; charset=us-ascii">
    <link rel="StyleSheet" type="text/css" href="report.css"><script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script></head>
  <body><span style="display: none;">v2.4.0.8</span><table class="report" border="0" cellspacing="2" id="ID0E22AE">
      <tr>
        <th class="tl" colspan="1" rowspan="2">
          <div style="width: 200px;"><strong>SIGNIFICANT ACCOUNTING POLICIES (Schedule of Property and Equipment Depreciation Rate) (Details)<br></strong></div>
        </th>
        <th class="th" colspan="1">12 Months Ended</th>
      </tr>
      <tr>
        <th class="th">
          <div>Jun. 30, 2014</div>
        </th>
      </tr>
      <tr class="rh">
        <td class="pl" style="border-bottom: 0px;" valign="top">
          <div class="a">Laboratory equipment [Member] | Minimum [Member]</div>
        </td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_psti_PropertyPlantAndEquipmentAnnualRateOfDepreciation', window );">Depreciation rate</a></td>
        <td class="nump">10.00%<span></span></td>
      </tr>
      <tr class="rh">
        <td class="pl" style="border-bottom: 0px;" valign="top">
          <div class="a">Laboratory equipment [Member] | Maximum [Member]</div>
        </td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_psti_PropertyPlantAndEquipmentAnnualRateOfDepreciation', window );">Depreciation rate</a></td>
        <td class="nump">15.00%<span></span></td>
      </tr>
      <tr class="rh">
        <td class="pl" style="border-bottom: 0px;" valign="top">
          <div class="a">Computers and Peripheral Equipment [Member]</div>
        </td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_psti_PropertyPlantAndEquipmentAnnualRateOfDepreciation', window );">Depreciation rate</a></td>
        <td class="nump">33.00%<span></span></td>
      </tr>
      <tr class="rh">
        <td class="pl" style="border-bottom: 0px;" valign="top">
          <div class="a">Office Furniture and Equipment [Member] | Minimum [Member]</div>
        </td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_psti_PropertyPlantAndEquipmentAnnualRateOfDepreciation', window );">Depreciation rate</a></td>
        <td class="nump">6.00%<span></span></td>
      </tr>
      <tr class="rh">
        <td class="pl" style="border-bottom: 0px;" valign="top">
          <div class="a">Office Furniture and Equipment [Member] | Maximum [Member]</div>
        </td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_psti_PropertyPlantAndEquipmentAnnualRateOfDepreciation', window );">Depreciation rate</a></td>
        <td class="nump">15.00%<span></span></td>
      </tr>
      <tr class="rh">
        <td class="pl" style="border-bottom: 0px;" valign="top">
          <div class="a">Vehicles [Member]</div>
        </td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_psti_PropertyPlantAndEquipmentAnnualRateOfDepreciation', window );">Depreciation rate</a></td>
        <td class="nump">15.00%<span></span></td>
      </tr>
      <tr class="rh">
        <td class="pl" style="border-bottom: 0px;" valign="top">
          <div class="a">Leasehold Improvements Of New Facility Construction [Member]</div>
        </td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_psti_LeaseholdImprovementsAnnualRateOfDepreciationDescription', window );">Depreciation, leasehold</a></td>
        <td class="text">The shorter of the expected useful life or the reasonable assumed term of the lease.<span></span></td>
      </tr>
    </table>
    <div style="display: none;">
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_psti_LeaseholdImprovementsAnnualRateOfDepreciationDescription">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The depreciation description for leasehold improvements.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>psti_LeaseholdImprovementsAnnualRateOfDepreciationDescription</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>psti_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:stringItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_psti_PropertyPlantAndEquipmentAnnualRateOfDepreciation">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The depreciation rate applied annually using the straight-line method.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>psti_PropertyPlantAndEquipmentAnnualRateOfDepreciation</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>psti_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>num:percentItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentLineItems">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div>
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_PropertyPlantAndEquipmentLineItems</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:stringItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
    </div>
  </body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>50
<FILENAME>R8.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
  <head>
    <META http-equiv="Content-Type" content="text/html; charset=us-ascii">
    <link rel="StyleSheet" type="text/css" href="report.css"><script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script></head>
  <body><span style="display: none;">v2.4.0.8</span><table class="report" border="0" cellspacing="2" id="ID0EYWBG">
      <tr>
        <th class="tl" colspan="1" rowspan="2">
          <div style="width: 200px;"><strong>CONSOLIDATED STATEMENTS OF CASH FLOWS (USD $)<br>In Thousands, unless otherwise specified</strong></div>
        </th>
        <th class="th" colspan="3">12 Months Ended</th>
      </tr>
      <tr>
        <th class="th">
          <div>Jun. 30, 2014</div>
        </th>
        <th class="th">
          <div>Jun. 30, 2013</div>
        </th>
        <th class="th">
          <div>Jun. 30, 2012</div>
        </th>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract', window );"><strong>CASH FLOWS FROM OPERATING ACTIVITIES:</strong></a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss</a></td>
        <td class="num">$ (26,932)<span></span></td>
        <td class="num">$ (21,155)<span></span></td>
        <td class="num">$ (14,794)<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract', window );"><strong>Adjustments to reconcile net loss to net cash used in operating activities:</strong></a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Depreciation', window );">Depreciation</a></td>
        <td class="nump">1,902<span></span></td>
        <td class="nump">1,033<span></span></td>
        <td class="nump">435<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GainLossOnSaleOfPropertyPlantEquipment', window );">Loss on property and equipment</a></td>
        <td class="nump">85<span></span></td>
        <td class="text">&nbsp;&nbsp;<span></span></td>
        <td class="nump">1<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_psti_AmortizationOfDiscountAndPremiumAndChangesInAccruedInterestFromMarketableSecurities', window );">Accretion of discount, amortization of premium and changes in accrued interest of marketable securities</a></td>
        <td class="nump">1,282<span></span></td>
        <td class="nump">154<span></span></td>
        <td class="nump">17<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MarketableSecuritiesRealizedGainLoss', window );">Gain from sale of investments of available-for-sale marketable securities</a></td>
        <td class="num">(727)<span></span></td>
        <td class="num">(26)<span></span></td>
        <td class="num">(3)<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensation', window );">Stock-based compensation to employees, directors and non-employee consultants</a></td>
        <td class="nump">5,851<span></span></td>
        <td class="nump">2,799<span></span></td>
        <td class="nump">4,927<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInOtherReceivables', window );">Increase in OCS receivables</a></td>
        <td class="num">(1,990)<span></span></td>
        <td class="num">(70)<span></span></td>
        <td class="num">(230)<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInAccountsReceivable', window );">Decrease (increase) in other accounts receivable</a></td>
        <td class="num">(143)<span></span></td>
        <td class="num">(233)<span></span></td>
        <td class="nump">64<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets', window );">Decrease (increase) in prepaid expenses</a></td>
        <td class="num">(108)<span></span></td>
        <td class="num">(237)<span></span></td>
        <td class="nump">269<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInAccountsPayable', window );">Increase (decrease) in trade payables</a></td>
        <td class="nump">1,257<span></span></td>
        <td class="nump">1,335<span></span></td>
        <td class="num">(424)<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities', window );">Increase in other accounts payable and accrued expenses</a></td>
        <td class="nump">902<span></span></td>
        <td class="nump">1,556<span></span></td>
        <td class="nump">958<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInDeferredRevenue', window );">Increase (decrease) in deferred revenues</a></td>
        <td class="num">(379)<span></span></td>
        <td class="num">(679)<span></span></td>
        <td class="nump">4,284<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInCustomerAdvances', window );">Increase (decrease) in advance payment from United Therapeutics</a></td>
        <td class="num">(146)<span></span></td>
        <td class="num">(1,183)<span></span></td>
        <td class="nump">1,576<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInAccruedInterestReceivableNet', window );">Increase in interest receivable on short-term deposits</a></td>
        <td class="num">(36)<span></span></td>
        <td class="num">(140)<span></span></td>
        <td class="num">(395)<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_psti_LinkageDifferencesAndInterestOnShortAndLongTermRestrictedLeaseDeposit', window );">Linkage differences and interest on short and long-term restricted lease deposit</a></td>
        <td class="nump">12<span></span></td>
        <td class="num">(30)<span></span></td>
        <td class="nump">35<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInPensionAndPostretirementObligations', window );">Accrued severance pay, net</a></td>
        <td class="nump">49<span></span></td>
        <td class="num">(11)<span></span></td>
        <td class="nump">5<span></span></td>
      </tr>
      <tr class="reu">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperations', window );">Net cash used in operating activities</a></td>
        <td class="num">(19,121)<span></span></td>
        <td class="num">(16,887)<span></span></td>
        <td class="num">(3,275)<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract', window );"><strong>CASH FLOWS FROM INVESTING ACTIVITIES:</strong></a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment', window );">Purchase of property and equipment</a></td>
        <td class="num">(1,573)<span></span></td>
        <td class="num">(4,309)<span></span></td>
        <td class="num">(1,480)<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsForProceedsFromShortTermInvestments', window );">Repayment of (Investment in) short-term deposits</a></td>
        <td class="nump">7,421<span></span></td>
        <td class="num">(10,202)<span></span></td>
        <td class="num">(21,031)<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsForProceedsFromLongtermInvestments', window );">Investment in long-term deposits</a></td>
        <td class="num">(3)<span></span></td>
        <td class="text">&nbsp;&nbsp;<span></span></td>
        <td class="num">(1,125)<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInRestrictedCashAndInvestments', window );">Repayment of long-term restricted deposit</a></td>
        <td class="nump">122<span></span></td>
        <td class="nump">869<span></span></td>
        <td class="nump">6<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromSaleOfAvailableForSaleSecurities', window );">Proceeds from sale of available-for-sale marketable securities</a></td>
        <td class="nump">6,113<span></span></td>
        <td class="nump">1,848<span></span></td>
        <td class="nump">884<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities', window );">Proceeds from redemption of available-for-sale marketable securities</a></td>
        <td class="nump">754<span></span></td>
        <td class="nump">529<span></span></td>
        <td class="nump">114<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireAvailableForSaleSecurities', window );">Investment in available-for-sale marketable securities</a></td>
        <td class="num">(10,851)<span></span></td>
        <td class="num">(8,534)<span></span></td>
        <td class="num">(8,165)<span></span></td>
      </tr>
      <tr class="rou">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperations', window );">Net cash provided by (used in) investing activities</a></td>
        <td class="nump">1,983<span></span></td>
        <td class="num">(19,799)<span></span></td>
        <td class="num">(30,797)<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract', window );"><strong>CASH FLOWS FROM FINANCING ACTIVITIES:</strong></a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfCommonStock', window );">Issuance of common stock and warrants, net of issuance costs</a></td>
        <td class="nump">10,644<span></span></td>
        <td class="nump">34,106<span></span></td>
        <td class="text">&nbsp;&nbsp;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions', window );">Exercise of warrants and options</a></td>
        <td class="nump">1,980<span></span></td>
        <td class="nump">2,198<span></span></td>
        <td class="nump">632<span></span></td>
      </tr>
      <tr class="rou">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperations', window );">Net cash provided by financing activities</a></td>
        <td class="nump">12,624<span></span></td>
        <td class="nump">36,304<span></span></td>
        <td class="nump">632<span></span></td>
      </tr>
      <tr class="reu">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease', window );">Decrease in cash and cash equivalents</a></td>
        <td class="num">(4,514)<span></span></td>
        <td class="num">(382)<span></span></td>
        <td class="num">(33,440)<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAtCarryingValue', window );">Cash and cash equivalents at the beginning of the period</a></td>
        <td class="nump">9,007<span></span></td>
        <td class="nump">9,389<span></span></td>
        <td class="nump">42,829<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAtCarryingValue', window );">Cash and cash equivalents at the end of the period</a></td>
        <td class="nump">4,493<span></span></td>
        <td class="nump">9,007<span></span></td>
        <td class="nump">9,389<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SupplementalCashFlowInformationAbstract', window );"><strong>Supplemental disclosure of cash flow activities:</strong></a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxesPaid', window );">Taxes paid due to non-deductible expenses</a></td>
        <td class="nump">48<span></span></td>
        <td class="nump">18<span></span></td>
        <td class="nump">14<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherNoncashInvestingAndFinancingItemsAbstract', window );"><strong>Supplemental disclosure of non-cash activities:</strong></a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CapitalExpendituresIncurredButNotYetPaid', window );">Purchase of property and equipment on credit</a></td>
        <td class="nump">243<span></span></td>
        <td class="nump">872<span></span></td>
        <td class="nump">738<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssued1', window );">Issuance of shares in consideration of new facility construction</a></td>
        <td class="text">&nbsp;&nbsp;<span></span></td>
        <td class="nump">1,400<span></span></td>
        <td class="nump">3,672<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherSignificantNoncashTransactionValueOfConsiderationGiven1', window );">Other receivables resulting from issuance of shares</a></td>
        <td class="text">&nbsp;&nbsp;<span></span></td>
        <td class="text">&nbsp;&nbsp;<span></span></td>
        <td class="nump">13<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NoncashOrPartNoncashAcquisitionInvestmentsAcquired1', window );">Issuance of common stock under CHA Agreement (Note 1d)</a></td>
        <td class="nump">$ 10,414<span></span></td>
        <td class="text">&nbsp;&nbsp;<span></span></td>
        <td class="text">&nbsp;&nbsp;<span></span></td>
      </tr>
    </table>
    <div style="display: none;">
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_psti_AmortizationOfDiscountAndPremiumAndChangesInAccruedInterestFromMarketableSecurities">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Amortization of discount and premium and changes in accrued interest from marketable securities.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>psti_AmortizationOfDiscountAndPremiumAndChangesInAccruedInterestFromMarketableSecurities</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>psti_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>debit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_psti_LinkageDifferencesAndInterestOnShortAndLongTermRestrictedLeaseDeposit">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Linkage differences and interest on short and long term restricted lease deposit.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>psti_LinkageDifferencesAndInterestOnShortAndLongTermRestrictedLeaseDeposit</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>psti_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>debit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div>
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:stringItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CapitalExpendituresIncurredButNotYetPaid">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Future cash outflow to pay for purchases of fixed assets that have occurred.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 230<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 5<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6367179&amp;loc=d3e4332-108586<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 230<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 4<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6367179&amp;loc=d3e4313-108586<br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 230<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 3<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6367179&amp;loc=d3e4304-108586<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_CapitalExpendituresIncurredButNotYetPaid</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>credit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsAtCarryingValue">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Glossary Cash<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6506951<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Glossary Cash Equivalents<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6507016<br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher SEC<br><br> -Name Regulation S-X (SX)<br><br> -Number 210<br><br> -Section 02<br><br> -Paragraph 1<br><br> -Article 5<br><br><br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 210<br><br> -SubTopic 10<br><br> -Section S99<br><br> -Paragraph 1<br><br> -Subparagraph (SX 210.5-02.1)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br><br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 210<br><br> -SubTopic 10<br><br> -Section 45<br><br> -Paragraph 1<br><br> -Subparagraph (a)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=28358313&amp;loc=d3e6676-107765<br><br><br><br>Reference 6: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 230<br><br> -SubTopic 10<br><br> -Section 45<br><br> -Paragraph 4<br><br> -URI http://asc.fasb.org/extlink&amp;oid=31042434&amp;loc=d3e3044-108585<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_CashAndCashEquivalentsAtCarryingValue</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>debit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Amount of increase (decrease) in cash and cash equivalents. Cash and cash equivalents are the amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Includes effect from exchange rate changes.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 230<br><br> -SubTopic 10<br><br> -Section 45<br><br> -Paragraph 24<br><br> -URI http://asc.fasb.org/extlink&amp;oid=31042434&amp;loc=d3e3521-108585<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 830<br><br> -SubTopic 230<br><br> -Section 45<br><br> -Paragraph 1<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6450594&amp;loc=d3e33268-110906<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>debit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Depreciation">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 230<br><br> -SubTopic 10<br><br> -Section 45<br><br> -Paragraph 28<br><br> -Subparagraph (b)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=31042434&amp;loc=d3e3602-108585<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_Depreciation</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>debit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GainLossOnSaleOfPropertyPlantEquipment">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Amount of gain (loss) on sale or disposal of property, plant and equipment assets, including oil and gas property and timber property.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 230<br><br> -SubTopic 10<br><br> -Section 45<br><br> -Paragraph 28<br><br> -Subparagraph (b)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=31042434&amp;loc=d3e3602-108585<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_GainLossOnSaleOfPropertyPlantEquipment</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>credit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxesPaid">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The amount of cash paid during the current period to foreign, federal, state, and local authorities as taxes on income.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 230<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 2<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6367179&amp;loc=d3e4297-108586<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 230<br><br> -SubTopic 10<br><br> -Section 45<br><br> -Paragraph 25<br><br> -Subparagraph (f)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=31042434&amp;loc=d3e3536-108585<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_IncomeTaxesPaid</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>credit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInAccountsPayable">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The increase (decrease) during the reporting period in the aggregate amount of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 230<br><br> -SubTopic 10<br><br> -Section 45<br><br> -Paragraph 28<br><br> -Subparagraph (a)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=31042434&amp;loc=d3e3602-108585<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_IncreaseDecreaseInAccountsPayable</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>debit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInAccountsReceivable">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The increase (decrease) during the reporting period in amount due within one year (or one business cycle) from customers for the credit sale of goods and services.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 230<br><br> -SubTopic 10<br><br> -Section 45<br><br> -Paragraph 28<br><br> -Subparagraph (a)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=31042434&amp;loc=d3e3602-108585<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_IncreaseDecreaseInAccountsReceivable</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>credit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInAccruedInterestReceivableNet">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The increase (decrease) during the reporting period in the amount due from borrowers for interest payments.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 230<br><br> -SubTopic 10<br><br> -Section 45<br><br> -Paragraph 28<br><br> -Subparagraph (a)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=31042434&amp;loc=d3e3602-108585<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_IncreaseDecreaseInAccruedInterestReceivableNet</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>credit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInCustomerAdvances">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The increase (decrease) during the reporting period in the amount of prepayments by customers for goods or services to be provided at a later date.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 230<br><br> -SubTopic 10<br><br> -Section 45<br><br> -Paragraph 28<br><br> -Subparagraph (a)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=31042434&amp;loc=d3e3602-108585<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_IncreaseDecreaseInCustomerAdvances</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>debit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInDeferredRevenue">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The increase (decrease) during the reporting period, excluding the portion taken into income, in the liability reflecting revenue yet to be earned for which cash or other forms of consideration was received or recorded as a receivable.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 230<br><br> -SubTopic 10<br><br> -Section 45<br><br> -Paragraph 28<br><br> -Subparagraph (a)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=31042434&amp;loc=d3e3602-108585<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_IncreaseDecreaseInDeferredRevenue</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>debit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The increase (decrease) during the reporting period in other obligations or expenses incurred but not yet paid.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 230<br><br> -SubTopic 10<br><br> -Section 45<br><br> -Paragraph 28<br><br> -Subparagraph (a)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=31042434&amp;loc=d3e3602-108585<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>debit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInOtherReceivables">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The increase (decrease) during the reporting period in other amounts due to the reporting entity, which are not otherwise defined in the taxonomy.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 230<br><br> -SubTopic 10<br><br> -Section 45<br><br> -Paragraph 28<br><br> -Subparagraph (a)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=31042434&amp;loc=d3e3602-108585<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_IncreaseDecreaseInOtherReceivables</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>credit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInPensionAndPostretirementObligations">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The increase (decrease) during the reporting period in the amount due to fund pension and non-pension benefits to employees, retired and disabled former employees.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 230<br><br> -SubTopic 10<br><br> -Section 45<br><br> -Paragraph 28<br><br> -Subparagraph (a)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=31042434&amp;loc=d3e3602-108585<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_IncreaseDecreaseInPensionAndPostretirementObligations</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>debit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The increase (decrease) during the reporting period in the value of prepaid expenses and other assets not separately disclosed in the statement of cash flows, for example, deferred expenses, intangible assets, or income taxes.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 230<br><br> -SubTopic 10<br><br> -Section 45<br><br> -Paragraph 28<br><br> -Subparagraph (a)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=31042434&amp;loc=d3e3602-108585<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>credit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInRestrictedCashAndInvestments">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The net cash inflow or outflow during the period for the aggregate increase (decrease) associated with funds and investments that are not available for withdrawal or use (such as assets held in escrow or contractually limited as to use or disposition) and are associated with underlying transactions that are classified as investing activities.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_IncreaseDecreaseInRestrictedCashAndInvestments</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>credit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MarketableSecuritiesRealizedGainLoss">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>This item represents the total realized gain (loss) included in earnings for the period as a result of selling marketable securities categorized as trading, available-for-sale, or held-to-maturity. Additionally, this item would include any losses recognized for other than temporary impairments (OTTI) of the subject investments in debt and equity securities.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 320<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 9<br><br> -Subparagraph (a)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=27724398&amp;loc=d3e27357-111563<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 225<br><br> -SubTopic 10<br><br> -Section S99<br><br> -Paragraph 2<br><br> -Subparagraph (SX 210.5-03.7(c))<br><br> -URI http://asc.fasb.org/extlink&amp;oid=26872669&amp;loc=d3e20235-122688<br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 320<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 10<br><br> -Subparagraph (c)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=27724398&amp;loc=d3e27405-111563<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_MarketableSecuritiesRealizedGainLoss</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>credit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div>
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:stringItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperations">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Amount of cash inflow (outflow) of financing activities, excluding discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 230<br><br> -SubTopic 10<br><br> -Section 45<br><br> -Paragraph 24<br><br> -URI http://asc.fasb.org/extlink&amp;oid=31042434&amp;loc=d3e3521-108585<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 230<br><br> -SubTopic 10<br><br> -Section 45<br><br> -Paragraph 26<br><br> -URI http://asc.fasb.org/extlink&amp;oid=31042434&amp;loc=d3e3574-108585<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperations</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>debit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div>
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:stringItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperations">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Amount of cash inflow (outflow) of investing activities, excluding discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 230<br><br> -SubTopic 10<br><br> -Section 45<br><br> -Paragraph 24<br><br> -URI http://asc.fasb.org/extlink&amp;oid=31042434&amp;loc=d3e3521-108585<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 230<br><br> -SubTopic 10<br><br> -Section 45<br><br> -Paragraph 26<br><br> -URI http://asc.fasb.org/extlink&amp;oid=31042434&amp;loc=d3e3574-108585<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperations</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>debit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div>
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:stringItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperations">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Amount of cash inflow (outflow) from operating activities, excluding discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 230<br><br> -SubTopic 10<br><br> -Section 45<br><br> -Paragraph 28<br><br> -URI http://asc.fasb.org/extlink&amp;oid=31042434&amp;loc=d3e3602-108585<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 230<br><br> -SubTopic 10<br><br> -Section 45<br><br> -Paragraph 24<br><br> -URI http://asc.fasb.org/extlink&amp;oid=31042434&amp;loc=d3e3521-108585<br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 230<br><br> -SubTopic 10<br><br> -Section 45<br><br> -Paragraph 25<br><br> -URI http://asc.fasb.org/extlink&amp;oid=31042434&amp;loc=d3e3536-108585<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperations</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 230<br><br> -SubTopic 10<br><br> -Section 45<br><br> -Paragraph 28<br><br> -URI http://asc.fasb.org/extlink&amp;oid=31042434&amp;loc=d3e3602-108585<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 260<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 1<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Glossary Other Comprehensive Income<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6519514<br><br><br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Glossary Net Income<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6518256<br><br><br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 944<br><br> -SubTopic 225<br><br> -Section S99<br><br> -Paragraph 1<br><br> -Subparagraph (SX 210.7-04.19)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6879464&amp;loc=d3e573970-122913<br><br><br><br>Reference 6: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 225<br><br> -SubTopic 10<br><br> -Section S99<br><br> -Paragraph 2<br><br> -Subparagraph (SX 210.5-03.18)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=26872669&amp;loc=d3e20235-122688<br><br><br><br>Reference 7: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 944<br><br> -SubTopic 225<br><br> -Section S99<br><br> -Paragraph 1<br><br> -Subparagraph (SX 210.7-04.22)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6879464&amp;loc=d3e573970-122913<br><br><br><br>Reference 8: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher SEC<br><br> -Name Regulation S-X (SX)<br><br> -Number 210<br><br> -Section 03<br><br> -Paragraph 19<br><br> -Article 5<br><br><br><br>Reference 9: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher SEC<br><br> -Name Regulation S-X (SX)<br><br> -Number 210<br><br> -Section 04<br><br> -Paragraph 20<br><br> -Article 9<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_NetIncomeLoss</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>credit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NoncashOrPartNoncashAcquisitionInvestmentsAcquired1">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The amount of investments that an Entity acquires in a noncash (or part noncash) acquisition. Noncash is defined as information about all investing and financing activities of an enterprise during a period that affect recognized assets or liabilities but that do not result in cash receipts or cash payments in the period. "Part noncash" refers to that portion of the transaction not resulting in cash receipts or cash payments in the period.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 230<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 5<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6367179&amp;loc=d3e4332-108586<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 230<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 4<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6367179&amp;loc=d3e4313-108586<br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 230<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 3<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6367179&amp;loc=d3e4304-108586<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_NoncashOrPartNoncashAcquisitionInvestmentsAcquired1</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>debit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherNoncashInvestingAndFinancingItemsAbstract">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div>
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_OtherNoncashInvestingAndFinancingItemsAbstract</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:stringItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherSignificantNoncashTransactionValueOfConsiderationGiven1">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The value of the noncash (or part noncash) consideration given (for example, liability, equity) in a transaction. Noncash is defined as transactions during a period that do not result in cash receipts or cash payments in the period. "Part noncash" refers to that portion of a transaction not resulting in cash receipts or cash payments in the period.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 230<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 5<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6367179&amp;loc=d3e4332-108586<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 230<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 4<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6367179&amp;loc=d3e4313-108586<br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 230<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 3<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6367179&amp;loc=d3e4304-108586<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_OtherSignificantNoncashTransactionValueOfConsiderationGiven1</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>credit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsForProceedsFromLongtermInvestments">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The net amount paid (received) by the reporting entity through acquisition or sale and maturities of long-term investments which qualify for treatment as an investing activity based on management's intention and intended by management to be liquidated, if necessary, beyond the current operating cycle. Includes cash flows from securities classified as trading securities that were acquired for reasons other than sale in the long-term.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_PaymentsForProceedsFromLongtermInvestments</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>credit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsForProceedsFromShortTermInvestments">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The net amount paid (received) by the reporting entity through acquisition or sale and maturities of short-term investments with an original maturity that is three months or less which qualify for treatment as an investing activity based on management's intention and intended by management to be liquidated, if necessary, within the current operating cycle. Includes cash flows from securities classified as trading securities that were acquired for reasons other than sale in the short-term.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 230<br><br> -SubTopic 10<br><br> -Section 45<br><br> -Paragraph 8<br><br> -URI http://asc.fasb.org/extlink&amp;oid=31042434&amp;loc=d3e3095-108585<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 230<br><br> -SubTopic 10<br><br> -Section 45<br><br> -Paragraph 9<br><br> -Subparagraph (a)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=31042434&amp;loc=d3e3098-108585<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_PaymentsForProceedsFromShortTermInvestments</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>credit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquireAvailableForSaleSecurities">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The cash outflow to acquire debt and equity securities not classified as either held-to-maturity securities or trading securities which would be classified as available-for-sale securities and reported at fair value, with unrealized gains and losses excluded from earnings and reported in a separate component of shareholders' equity.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Glossary Investing Activities<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6516133<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 320<br><br> -SubTopic 10<br><br> -Section 45<br><br> -Paragraph 11<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6871852&amp;loc=d3e26853-111562<br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 230<br><br> -SubTopic 10<br><br> -Section 45<br><br> -Paragraph 13<br><br> -Subparagraph (a),(b)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=31042434&amp;loc=d3e3213-108585<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_PaymentsToAcquireAvailableForSaleSecurities</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>credit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Glossary Investing Activities<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6516133<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 230<br><br> -SubTopic 10<br><br> -Section 45<br><br> -Paragraph 13<br><br> -Subparagraph (c)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=31042434&amp;loc=d3e3213-108585<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_PaymentsToAcquirePropertyPlantAndEquipment</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>credit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromIssuanceOfCommonStock">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The cash inflow from the additional capital contribution to the entity.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Glossary Financing Activities<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6513228<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 230<br><br> -SubTopic 10<br><br> -Section 45<br><br> -Paragraph 14<br><br> -Subparagraph (a)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=31042434&amp;loc=d3e3255-108585<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_ProceedsFromIssuanceOfCommonStock</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>debit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The total cash inflow associated with the amount received from holders to acquire the entity's shares under incentive and share awards, including stock option exercises. This item inherently excludes any excess tax benefit, which the entity may have realized and reported separately.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Glossary Financing Activities<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6513228<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 230<br><br> -SubTopic 10<br><br> -Section 45<br><br> -Paragraph 14<br><br> -Subparagraph (a)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=31042434&amp;loc=d3e3255-108585<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>debit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The cash inflow associated with maturities (principal being due), prepayments and calls (requests of early payments) on securities not classified as either held-to-maturity securities or trading securities which are classified as available-for-sale securities.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Glossary Investing Activities<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6516133<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 320<br><br> -SubTopic 10<br><br> -Section 45<br><br> -Paragraph 11<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6871852&amp;loc=d3e26853-111562<br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 230<br><br> -SubTopic 10<br><br> -Section 45<br><br> -Paragraph 12<br><br> -Subparagraph (a),(b)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=31042434&amp;loc=d3e3179-108585<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>debit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromSaleOfAvailableForSaleSecurities">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The cash inflow associated with the sale of debt and equity securities classified as available-for-sale securities.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Glossary Investing Activities<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6516133<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 320<br><br> -SubTopic 10<br><br> -Section 45<br><br> -Paragraph 11<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6871852&amp;loc=d3e26853-111562<br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 230<br><br> -SubTopic 10<br><br> -Section 45<br><br> -Paragraph 12<br><br> -Subparagraph (a),(b)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=31042434&amp;loc=d3e3179-108585<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_ProceedsFromSaleOfAvailableForSaleSecurities</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>debit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensation">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The aggregate amount of noncash, equity-based employee remuneration. This may include the value of stock or unit options, amortization of restricted stock or units, and adjustment for officers' compensation. As noncash, this element is an add back when calculating net cash generated by operating activities using the indirect method.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 230<br><br> -SubTopic 10<br><br> -Section 45<br><br> -Paragraph 28<br><br> -Subparagraph (a)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=31042434&amp;loc=d3e3602-108585<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_ShareBasedCompensation</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>debit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssued1">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The fair value of stock issued in noncash financing activities.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 230<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 5<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6367179&amp;loc=d3e4332-108586<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 230<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 4<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6367179&amp;loc=d3e4313-108586<br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 230<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 3<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6367179&amp;loc=d3e4304-108586<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_StockIssued1</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>credit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SupplementalCashFlowInformationAbstract">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div>
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_SupplementalCashFlowInformationAbstract</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:stringItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
    </div>
  </body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>51
<FILENAME>R32.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
  <head>
    <META http-equiv="Content-Type" content="text/html; charset=us-ascii">
    <link rel="StyleSheet" type="text/css" href="report.css"><script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script></head>
  <body><span style="display: none;">v2.4.0.8</span><table class="report" border="0" cellspacing="2" id="ID0EUGAG">
      <tr>
        <th class="tl" colspan="1" rowspan="2">
          <div style="width: 200px;"><strong>SIGNIFICANT ACCOUNTING POLICIES (Comprehensive Income) (Details) (USD $)<br>In Thousands, unless otherwise specified</strong></div>
        </th>
        <th class="th" colspan="3">12 Months Ended</th>
      </tr>
      <tr>
        <th class="th">
          <div>Jun. 30, 2014</div>
        </th>
        <th class="th">
          <div>Jun. 30, 2013</div>
        </th>
        <th class="th">
          <div>Jun. 30, 2012</div>
        </th>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems', window );"><strong>Accumulated Other Comprehensive Income (Loss) [Line Items]</strong></a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax', window );">Beginning balance</a></td>
        <td class="nump">$ 259<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax', window );">Other comprehensive income before reclassifications</a></td>
        <td class="nump">3,427<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax', window );">Amounts reclassified from accumulated other comprehensive loss</a></td>
        <td class="num">(727)<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="reu">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax', window );">Net current-period other comprehensive income</a></td>
        <td class="nump">2,700<span></span></td>
        <td class="nump">389<span></span></td>
        <td class="num">(130)<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax', window );">Ending balance</a></td>
        <td class="nump">2,959<span></span></td>
        <td class="nump">259<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="rh">
        <td class="pl" style="border-bottom: 0px;" valign="top">
          <div class="a">Unrealized Gains on Marketable Securities [Member]</div>
        </td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems', window );"><strong>Accumulated Other Comprehensive Income (Loss) [Line Items]</strong></a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax', window );">Beginning balance</a></td>
        <td class="nump">259<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax', window );">Other comprehensive income before reclassifications</a></td>
        <td class="nump">3,404<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax', window );">Amounts reclassified from accumulated other comprehensive loss</a></td>
        <td class="num">(727)<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="rou">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax', window );">Net current-period other comprehensive income</a></td>
        <td class="nump">2,677<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax', window );">Ending balance</a></td>
        <td class="nump">2,936<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="rh">
        <td class="pl" style="border-bottom: 0px;" valign="top">
          <div class="a">Unrealized Gains on Cash Flow Hedges [Member]</div>
        </td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems', window );"><strong>Accumulated Other Comprehensive Income (Loss) [Line Items]</strong></a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax', window );">Beginning balance</a></td>
        <td class="text">&nbsp;&nbsp;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax', window );">Other comprehensive income before reclassifications</a></td>
        <td class="nump">23<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax', window );">Amounts reclassified from accumulated other comprehensive loss</a></td>
        <td class="text">&nbsp;&nbsp;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="reu">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax', window );">Net current-period other comprehensive income</a></td>
        <td class="nump">23<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax', window );">Ending balance</a></td>
        <td class="nump">$ 23<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
    </table>
    <div style="display: none;">
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div>
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:stringItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Accumulated change in equity from transactions and other events and circumstances from non-owner sources, net of tax effect, at period end. Excludes Net Income (Loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners. Includes foreign currency translation items, certain pension adjustments, unrealized gains and losses on certain investments in debt and equity securities, other than temporary impairment (OTTI) losses related to factors other than credit losses on available-for-sale and held-to-maturity debt securities that an entity does not intend to sell and it is not more likely than not that the entity will be required to sell before recovery of the amortized cost basis, as well as changes in the fair value of derivatives related to the effective portion of a designated cash flow hedge.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 220<br><br> -SubTopic 10<br><br> -Section 45<br><br> -Paragraph 11<br><br> -URI http://asc.fasb.org/extlink&amp;oid=36458714&amp;loc=d3e637-108580<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 220<br><br> -SubTopic 10<br><br> -Section 45<br><br> -Paragraph 14<br><br> -URI http://asc.fasb.org/extlink&amp;oid=36458714&amp;loc=d3e681-108580<br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 220<br><br> -SubTopic 10<br><br> -Section 45<br><br> -Paragraph 14A<br><br> -URI http://asc.fasb.org/extlink&amp;oid=36458714&amp;loc=SL7669686-108580<br><br><br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher SEC<br><br> -Name Regulation S-X (SX)<br><br> -Number 210<br><br> -Section 02<br><br> -Paragraph 31<br><br> -Article 5<br><br><br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher SEC<br><br> -Name Regulation S-X (SX)<br><br> -Number 210<br><br> -Section 04<br><br> -Article 3<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>credit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Amount after tax, before reclassification adjustments of other comprehensive income (loss).</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>credit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Amount after tax and reclassification adjustments of other comprehensive income (loss).</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 505<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 2<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6928386&amp;loc=d3e21463-112644<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 220<br><br> -SubTopic 10<br><br> -Section 45<br><br> -Paragraph 1A<br><br> -URI http://asc.fasb.org/extlink&amp;oid=36458714&amp;loc=SL7669619-108580<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_OtherComprehensiveIncomeLossNetOfTax</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>credit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Amount after tax of reclassification adjustments of other comprehensive income (loss).</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>debit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
    </div>
  </body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>52
<FILENAME>R40.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
  <head>
    <META http-equiv="Content-Type" content="text/html; charset=us-ascii">
    <link rel="StyleSheet" type="text/css" href="report.css"><script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script></head>
  <body><span style="display: none;">v2.4.0.8</span><table class="report" border="0" cellspacing="2" id="ID0EICAE">
      <tr>
        <th class="tl" colspan="1" rowspan="2">
          <div style="width: 200px;"><strong>COMMITMENTS AND CONTINGENCIES (Other) (Details) (USD $)<br>In Thousands, unless otherwise specified</strong></div>
        </th>
        <th class="th" colspan="1">12 Months Ended</th>
      </tr>
      <tr>
        <th class="th">
          <div>Jun. 30, 2014</div>
        </th>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherCommitmentsLineItems', window );"><strong>Other Commitments [Line Items]</strong></a></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_psti_AggregateGrantsReceived', window );">Grants received</a></td>
        <td class="nump">$ 14,125<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_psti_PercentageOfQualifiedExpenditures', window );">Percentage of qualified expenditures eligible for grant</a></td>
        <td class="nump">50.00%<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_psti_RoyaltyRatePayableOnGrantsReceived', window );">Royalty payable based on grants received</a></td>
        <td class="nump">100.00%<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_psti_RoyaltiesAmountPaidAndAccrued', window );">Accrued and paid royalties</a></td>
        <td class="nump">53<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RoyaltyGuaranteesCommitmentsAmount', window );">Contingent liability amount</a></td>
        <td class="nump">$ 14,072<span></span></td>
      </tr>
      <tr class="rh">
        <td class="pl" style="border-bottom: 0px;" valign="top">
          <div class="a">Minimum [Member]</div>
        </td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherCommitmentsLineItems', window );"><strong>Other Commitments [Line Items]</strong></a></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_psti_RoyaltyRateSales', window );">Royalty rate</a></td>
        <td class="nump">3.00%<span></span></td>
      </tr>
      <tr class="rh">
        <td class="pl" style="border-bottom: 0px;" valign="top">
          <div class="a">Maximum [Member]</div>
        </td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherCommitmentsLineItems', window );"><strong>Other Commitments [Line Items]</strong></a></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_psti_RoyaltyRateSales', window );">Royalty rate</a></td>
        <td class="nump">4.00%<span></span></td>
      </tr>
    </table>
    <div style="display: none;">
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_psti_AggregateGrantsReceived">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Aggregate revenue received from grants as of the balance sheet date.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>psti_AggregateGrantsReceived</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>psti_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>debit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_psti_PercentageOfQualifiedExpenditures">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Percentage Of Qualified Expenditures.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>psti_PercentageOfQualifiedExpenditures</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>psti_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>num:percentItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_psti_RoyaltiesAmountPaidAndAccrued">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Amount of royalty paid or accrued.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>psti_RoyaltiesAmountPaidAndAccrued</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>psti_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>credit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_psti_RoyaltyRatePayableOnGrantsReceived">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Maximum royalty payable based on a percentage of grants received.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>psti_RoyaltyRatePayableOnGrantsReceived</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>psti_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>num:percentItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_psti_RoyaltyRateSales">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Royalty rate payable calculated as a percentage of the sale of products and other related revenues generated from such projects.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>psti_RoyaltyRateSales</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>psti_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>num:percentItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherCommitmentsLineItems">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div>
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_OtherCommitmentsLineItems</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:stringItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RoyaltyGuaranteesCommitmentsAmount">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The amount the entity has committed to make for future royalty guarantees.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 928<br><br> -SubTopic 440<br><br> -Section 50<br><br> -Paragraph 1<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6473578&amp;loc=d3e63223-108013<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_RoyaltyGuaranteesCommitmentsAmount</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>credit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
    </div>
  </body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>53
<FILENAME>R2.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
  <head>
    <META http-equiv="Content-Type" content="text/html; charset=us-ascii">
    <link rel="StyleSheet" type="text/css" href="report.css"><script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script></head>
  <body><span style="display: none;">v2.4.0.8</span><table class="report" border="0" cellspacing="2" id="ID0EMSAG">
      <tr>
        <th class="tl" colspan="1" rowspan="1">
          <div style="width: 200px;"><strong>CONSOLIDATED BALANCE SHEETS (USD $)<br>In Thousands, unless otherwise specified</strong></div>
        </th>
        <th class="th">
          <div>Jun. 30, 2014</div>
        </th>
        <th class="th">
          <div>Jun. 30, 2013</div>
        </th>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsCurrentAbstract', window );"><strong>CURRENT ASSETS:</strong></a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAtCarryingValue', window );">Cash and cash equivalents</a></td>
        <td class="nump">$ 4,493<span></span></td>
        <td class="nump">$ 9,007<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShortTermInvestments', window );">Short-term bank deposits</a></td>
        <td class="nump">19,451<span></span></td>
        <td class="nump">31,449<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestrictedCashAndCashEquivalentsAtCarryingValue', window );">Restricted cash and restricted short-term deposits</a></td>
        <td class="nump">4,914<span></span></td>
        <td class="nump">316<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MarketableSecuritiesCurrent', window );">Marketable securities</a></td>
        <td class="nump">29,961<span></span></td>
        <td class="nump">13,441<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountsReceivableNetCurrent', window );">Account receivable from OCS</a></td>
        <td class="nump">2,263<span></span></td>
        <td class="nump">273<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherAssetsCurrent', window );">Other current assets</a></td>
        <td class="nump">905<span></span></td>
        <td class="nump">599<span></span></td>
      </tr>
      <tr class="rou">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsCurrent', window );">Total current assets</a></td>
        <td class="nump">61,987<span></span></td>
        <td class="nump">55,085<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsNoncurrentAbstract', window );"><strong>LONG-TERM ASSETS:</strong></a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermInvestments', window );">Long-term deposits and restricted deposits</a></td>
        <td class="nump">304<span></span></td>
        <td class="nump">421<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanAssetsForPlanBenefitsNoncurrent', window );">Severance pay fund</a></td>
        <td class="nump">901<span></span></td>
        <td class="nump">905<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentNet', window );">Property and equipment, net</a></td>
        <td class="nump">10,823<span></span></td>
        <td class="nump">11,866<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherAssetsNoncurrent', window );">Other long term assets</a></td>
        <td class="nump">8<span></span></td>
        <td class="nump">39<span></span></td>
      </tr>
      <tr class="rou">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsNoncurrent', window );">Total long-term assets</a></td>
        <td class="nump">12,036<span></span></td>
        <td class="nump">13,231<span></span></td>
      </tr>
      <tr class="reu">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Assets', window );">Total assets</a></td>
        <td class="nump">74,023<span></span></td>
        <td class="nump">68,316<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesCurrentAbstract', window );"><strong>CURRENT LIABILITIES</strong></a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountsPayableCurrent', window );">Trade payables</a></td>
        <td class="nump">3,465<span></span></td>
        <td class="nump">2,837<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccruedLiabilitiesCurrent', window );">Accrued expenses</a></td>
        <td class="nump">915<span></span></td>
        <td class="nump">1,040<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredRevenueCurrent', window );">Deferred revenues</a></td>
        <td class="nump">379<span></span></td>
        <td class="nump">379<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CustomerAdvancesCurrent', window );">Advance payment from United Therapeutics</a></td>
        <td class="nump">247<span></span></td>
        <td class="nump">393<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountsPayableOtherCurrent', window );">Other accounts payable</a></td>
        <td class="nump">2,391<span></span></td>
        <td class="nump">1,272<span></span></td>
      </tr>
      <tr class="rou">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesCurrent', window );">Total current liabilities</a></td>
        <td class="nump">7,397<span></span></td>
        <td class="nump">5,921<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesNoncurrentAbstract', window );"><strong>LONG-TERM LIABILITIES</strong></a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredRevenueNoncurrent', window );">Deferred revenues</a></td>
        <td class="nump">2,847<span></span></td>
        <td class="nump">3,226<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PostemploymentBenefitsLiabilityNoncurrent', window );">Accrued severance pay</a></td>
        <td class="nump">1,068<span></span></td>
        <td class="nump">1,023<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherLiabilitiesNoncurrent', window );">Other long-term liabilities</a></td>
        <td class="nump">588<span></span></td>
        <td class="nump">680<span></span></td>
      </tr>
      <tr class="reu">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesNoncurrent', window );">Total long-term liabilities</a></td>
        <td class="nump">4,503<span></span></td>
        <td class="nump">4,929<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingencies', window );">COMMITMENTS AND CONTINGENCIES</a></td>
        <td class="text">&nbsp;&nbsp;<span></span></td>
        <td class="text">&nbsp;&nbsp;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquityAbstract', window );"><strong>STOCKHOLDERS' EQUITY</strong></a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockValue', window );">Share capital: Common stock $0.00001 par value: Authorized: 200,000,000 shares Issued and outstanding: 68,601,452 shares as of June 30, 2014, 59,196,617 shares as of June 30, 2013;</a></td>
        <td class="text">&nbsp;&nbsp;<span></span></td>
        <td class="text">&nbsp;&nbsp;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdditionalPaidInCapital', window );">Additional paid-in capital</a></td>
        <td class="nump">172,998<span></span></td>
        <td class="nump">144,109<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RetainedEarningsAccumulatedDeficit', window );">Accumulated deficit</a></td>
        <td class="num">(113,834)<span></span></td>
        <td class="num">(86,902)<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax', window );">Other comprehensive income</a></td>
        <td class="nump">2,959<span></span></td>
        <td class="nump">259<span></span></td>
      </tr>
      <tr class="rou">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Total stockholders' equity</a></td>
        <td class="nump">62,123<span></span></td>
        <td class="nump">57,466<span></span></td>
      </tr>
      <tr class="reu">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesAndStockholdersEquity', window );">Total liabilities and stockholders' equity</a></td>
        <td class="nump">$ 74,023<span></span></td>
        <td class="nump">$ 68,316<span></span></td>
      </tr>
    </table>
    <div style="display: none;">
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsPayableCurrent">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher SEC<br><br><br><br> -Name Regulation S-X (SX)<br><br><br><br> -Number 210<br><br><br><br> -Section 02<br><br><br><br> -Paragraph 19<br><br><br><br> -Subparagraph a<br><br><br><br> -Article 5<br><br><br><br><br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 210<br><br><br><br> -SubTopic 10<br><br><br><br> -Section S99<br><br><br><br> -Paragraph 1<br><br><br><br> -Subparagraph (SX 210.5-02.19(a))<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br><br><br><br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_AccountsPayableCurrent</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>credit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsPayableOtherCurrent">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Carrying value as of the balance sheet date of obligations incurred and payable, which are not elsewhere specified in the taxonomy. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher SEC<br><br><br><br> -Name Regulation S-X (SX)<br><br><br><br> -Number 210<br><br><br><br> -Section 02<br><br><br><br> -Paragraph 19<br><br><br><br> -Subparagraph a<br><br><br><br> -Article 5<br><br><br><br><br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Glossary Current Liabilities<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6509677<br><br><br><br><br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 210<br><br><br><br> -SubTopic 10<br><br><br><br> -Section 45<br><br><br><br> -Paragraph 8<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=28358313&amp;loc=d3e6935-107765<br><br><br><br><br><br><br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 210<br><br><br><br> -SubTopic 10<br><br><br><br> -Section S99<br><br><br><br> -Paragraph 1<br><br><br><br> -Subparagraph (SX 210.5-02.19(a))<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br><br><br><br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_AccountsPayableOtherCurrent</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>credit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsReceivableNetCurrent">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Amount due from customers or clients, within one year of the balance sheet date (or the normal operating cycle, whichever is longer), for goods or services (including trade receivables) that have been delivered or sold in the normal course of business, reduced to the estimated net realizable fair value by an allowance established by the entity of the amount it deems uncertain of collection.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 210<br><br><br><br> -SubTopic 10<br><br><br><br> -Section S99<br><br><br><br> -Paragraph 1<br><br><br><br> -Subparagraph (SX 210.5-02.3-4)<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br><br><br><br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher SEC<br><br><br><br> -Name Regulation S-X (SX)<br><br><br><br> -Number 210<br><br><br><br> -Section 02<br><br><br><br> -Paragraph 3<br><br><br><br> -Subparagraph a(1)<br><br><br><br> -Article 5<br><br><br><br><br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher SEC<br><br><br><br> -Name Regulation S-X (SX)<br><br><br><br> -Number 210<br><br><br><br> -Section 02<br><br><br><br> -Paragraph 4<br><br><br><br> -Article 5<br><br><br><br><br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_AccountsReceivableNetCurrent</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>debit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccruedLiabilitiesCurrent">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Carrying value as of the balance sheet date of obligations incurred and payable, pertaining to costs that are statutory in nature, are incurred on contractual obligations, or accumulate over time and for which invoices have not yet been received or will not be rendered. Examples include taxes, interest, rent and utilities. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher SEC<br><br><br><br> -Name Regulation S-X (SX)<br><br><br><br> -Number 210<br><br><br><br> -Section 02<br><br><br><br> -Paragraph 20<br><br><br><br> -Article 5<br><br><br><br><br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 210<br><br><br><br> -SubTopic 10<br><br><br><br> -Section S99<br><br><br><br> -Paragraph 1<br><br><br><br> -Subparagraph (SX 210.5-02.20)<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br><br><br><br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_AccruedLiabilitiesCurrent</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>credit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Accumulated change in equity from transactions and other events and circumstances from non-owner sources, net of tax effect, at period end. Excludes Net Income (Loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners. Includes foreign currency translation items, certain pension adjustments, unrealized gains and losses on certain investments in debt and equity securities, other than temporary impairment (OTTI) losses related to factors other than credit losses on available-for-sale and held-to-maturity debt securities that an entity does not intend to sell and it is not more likely than not that the entity will be required to sell before recovery of the amortized cost basis, as well as changes in the fair value of derivatives related to the effective portion of a designated cash flow hedge.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 220<br><br><br><br> -SubTopic 10<br><br><br><br> -Section 45<br><br><br><br> -Paragraph 11<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=36458714&amp;loc=d3e637-108580<br><br><br><br><br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 220<br><br><br><br> -SubTopic 10<br><br><br><br> -Section 45<br><br><br><br> -Paragraph 14<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=36458714&amp;loc=d3e681-108580<br><br><br><br><br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 220<br><br><br><br> -SubTopic 10<br><br><br><br> -Section 45<br><br><br><br> -Paragraph 14A<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=36458714&amp;loc=SL7669686-108580<br><br><br><br><br><br><br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher SEC<br><br><br><br> -Name Regulation S-X (SX)<br><br><br><br> -Number 210<br><br><br><br> -Section 02<br><br><br><br> -Paragraph 31<br><br><br><br> -Article 5<br><br><br><br><br><br><br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher SEC<br><br><br><br> -Name Regulation S-X (SX)<br><br><br><br> -Number 210<br><br><br><br> -Section 04<br><br><br><br> -Article 3<br><br><br><br><br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>credit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdditionalPaidInCapital">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Excess of issue price over par or stated value of the entity's capital stock and amounts received from other transactions involving the entity's stock or stockholders. Includes adjustments to additional paid in capital. Some examples of such adjustments include recording the issuance of debt with a beneficial conversion feature and certain tax consequences of equity instruments awarded to employees. Use this element for the aggregate amount of additional paid-in capital associated with common and preferred stock. For additional paid-in capital associated with only common stock, use the element additional paid in capital, common stock. For additional paid-in capital associated with only preferred stock, use the element additional paid in capital, preferred stock.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher SEC<br><br><br><br> -Name Regulation S-X (SX)<br><br><br><br> -Number 210<br><br><br><br> -Section 02<br><br><br><br> -Paragraph 31<br><br><br><br> -Article 5<br><br><br><br><br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 210<br><br><br><br> -SubTopic 10<br><br><br><br> -Section S99<br><br><br><br> -Paragraph 1<br><br><br><br> -Subparagraph (SX 210.5-02.30(a)(1))<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br><br><br><br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_AdditionalPaidInCapital</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>credit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Assets">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 210<br><br><br><br> -SubTopic 10<br><br><br><br> -Section S99<br><br><br><br> -Paragraph 1<br><br><br><br> -Subparagraph (SX 210.5-02.18)<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br><br><br><br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 210<br><br><br><br> -SubTopic 10<br><br><br><br> -Section S99<br><br><br><br> -Paragraph 1<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br><br><br><br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher SEC<br><br><br><br> -Name Regulation S-X (SX)<br><br><br><br> -Number 210<br><br><br><br> -Section 03<br><br><br><br> -Paragraph 12<br><br><br><br> -Article 7<br><br><br><br><br><br><br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher SEC<br><br><br><br> -Name Regulation S-X (SX)<br><br><br><br> -Number 210<br><br><br><br> -Section 02<br><br><br><br> -Paragraph 18<br><br><br><br> -Article 5<br><br><br><br><br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_Assets</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>debit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsCurrent">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 210<br><br><br><br> -SubTopic 10<br><br><br><br> -Section S99<br><br><br><br> -Paragraph 1<br><br><br><br> -Subparagraph (SX 210.5-02.9)<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br><br><br><br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 210<br><br><br><br> -SubTopic 10<br><br><br><br> -Section 45<br><br><br><br> -Paragraph 3<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=28358313&amp;loc=d3e6801-107765<br><br><br><br><br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 210<br><br><br><br> -SubTopic 10<br><br><br><br> -Section 45<br><br><br><br> -Paragraph 1<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=28358313&amp;loc=d3e6676-107765<br><br><br><br><br><br><br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher SEC<br><br><br><br> -Name Regulation S-X (SX)<br><br><br><br> -Number 210<br><br><br><br> -Section 02<br><br><br><br> -Paragraph 9<br><br><br><br> -Article 5<br><br><br><br><br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_AssetsCurrent</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>debit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsCurrentAbstract">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div>
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_AssetsCurrentAbstract</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:stringItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsNoncurrent">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold or consumed after one year or beyond the normal operating cycle, if longer.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher SEC<br><br><br><br> -Name Regulation S-X (SX)<br><br><br><br> -Number 210<br><br><br><br> -Section 02<br><br><br><br> -Paragraph 18<br><br><br><br> -Article 5<br><br><br><br><br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 210<br><br><br><br> -SubTopic 10<br><br><br><br> -Section S99<br><br><br><br> -Paragraph 1<br><br><br><br> -Subparagraph (SX 210.5-02.10-17)<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br><br><br><br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_AssetsNoncurrent</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>debit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsNoncurrentAbstract">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div>
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_AssetsNoncurrentAbstract</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:stringItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsAtCarryingValue">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Glossary Cash<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6506951<br><br><br><br><br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Glossary Cash Equivalents<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6507016<br><br><br><br><br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher SEC<br><br><br><br> -Name Regulation S-X (SX)<br><br><br><br> -Number 210<br><br><br><br> -Section 02<br><br><br><br> -Paragraph 1<br><br><br><br> -Article 5<br><br><br><br><br><br><br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 210<br><br><br><br> -SubTopic 10<br><br><br><br> -Section S99<br><br><br><br> -Paragraph 1<br><br><br><br> -Subparagraph (SX 210.5-02.1)<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br><br><br><br><br><br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 210<br><br><br><br> -SubTopic 10<br><br><br><br> -Section 45<br><br><br><br> -Paragraph 1<br><br><br><br> -Subparagraph (a)<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=28358313&amp;loc=d3e6676-107765<br><br><br><br><br><br><br><br>Reference 6: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 230<br><br><br><br> -SubTopic 10<br><br><br><br> -Section 45<br><br><br><br> -Paragraph 4<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=31042434&amp;loc=d3e3044-108585<br><br><br><br><br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_CashAndCashEquivalentsAtCarryingValue</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>debit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingencies">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Represents the caption on the face of the balance sheet to indicate that the entity has entered into (1) purchase or supply arrangements that will require expending a portion of its resources to meet the terms thereof, and (2) is exposed to potential losses or, less frequently, gains, arising from (a) possible claims against a company's resources due to future performance under contract terms, and (b) possible losses or likely gains from uncertainties that will ultimately be resolved when one or more future events that are deemed likely to occur do occur or fail to occur.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 450<br><br><br><br> -SubTopic 20<br><br><br><br> -Section 50<br><br><br><br> -Paragraph 1<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=25496072&amp;loc=d3e14326-108349<br><br><br><br><br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 210<br><br><br><br> -SubTopic 10<br><br><br><br> -Section S99<br><br><br><br> -Paragraph 1<br><br><br><br> -Subparagraph (SX 210.5-02.25)<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br><br><br><br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher SEC<br><br><br><br> -Name Regulation S-X (SX)<br><br><br><br> -Number 210<br><br><br><br> -Section 02<br><br><br><br> -Paragraph 25<br><br><br><br> -Article 5<br><br><br><br><br><br><br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher SEC<br><br><br><br> -Name Regulation S-X (SX)<br><br><br><br> -Number 210<br><br><br><br> -Section 03<br><br><br><br> -Paragraph 19<br><br><br><br> -Article 7<br><br><br><br><br><br><br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher SEC<br><br><br><br> -Name Regulation S-X (SX)<br><br><br><br> -Number 210<br><br><br><br> -Section 03<br><br><br><br> -Paragraph 17<br><br><br><br> -Article 9<br><br><br><br><br><br><br><br>Reference 6: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 942<br><br><br><br> -SubTopic 210<br><br><br><br> -Section S99<br><br><br><br> -Paragraph 1<br><br><br><br> -Subparagraph (SX 210.9-03.17)<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6876686&amp;loc=d3e534808-122878<br><br><br><br><br><br><br><br>Reference 7: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 944<br><br><br><br> -SubTopic 210<br><br><br><br> -Section S99<br><br><br><br> -Paragraph 1<br><br><br><br> -Subparagraph (SX 210.7-03.(a),19)<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6879938&amp;loc=d3e572229-122910<br><br><br><br><br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_CommitmentsAndContingencies</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>credit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockValue">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 210<br><br><br><br> -SubTopic 10<br><br><br><br> -Section S99<br><br><br><br> -Paragraph 1<br><br><br><br> -Subparagraph (SX 210.5-02.29)<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br><br><br><br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher SEC<br><br><br><br> -Name Regulation S-X (SX)<br><br><br><br> -Number 210<br><br><br><br> -Section 02<br><br><br><br> -Paragraph 30<br><br><br><br> -Article 5<br><br><br><br><br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_CommonStockValue</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>credit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CustomerAdvancesCurrent">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The current portion of prepayments received from customers for goods or services to be provided in the future.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 210<br><br><br><br> -SubTopic 10<br><br><br><br> -Section S99<br><br><br><br> -Paragraph 1<br><br><br><br> -Subparagraph (SX 210.5-02.20)<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br><br><br><br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_CustomerAdvancesCurrent</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>credit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredRevenueCurrent">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The carrying amount of consideration received or receivable as of the balance sheet date on potential earnings that were not recognized as revenue in conformity with GAAP, and which are expected to be recognized as such within one year or the normal operating cycle, if longer, including sales, license fees, and royalties, but excluding interest income.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 605<br><br><br><br> -SubTopic 10<br><br><br><br> -Section S99<br><br><br><br> -Paragraph 1<br><br><br><br> -Subparagraph (SAB TOPIC 13.A.4(a).Q1)<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=27012821&amp;loc=d3e214044-122780<br><br><br><br><br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 210<br><br><br><br> -SubTopic 10<br><br><br><br> -Section 45<br><br><br><br> -Paragraph 8<br><br><br><br> -Subparagraph (b)<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=28358313&amp;loc=d3e6935-107765<br><br><br><br><br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher SEC<br><br><br><br> -Name Staff Accounting Bulletin (SAB)<br><br><br><br> -Number Topic 13<br><br><br><br> -Section A<br><br><br><br><br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_DeferredRevenueCurrent</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>credit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredRevenueNoncurrent">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The noncurrent portion of deferred revenue amount as of balance sheet date. Deferred revenue is a liability related to a revenue producing activity for which revenue has not yet been recognized, and is not expected to be recognized in the next twelve months. Generally, an entity records deferred revenue when it receives consideration from a customer before achieving certain criteria that must be met for revenue to be recognized in conformity with GAAP.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 605<br><br><br><br> -SubTopic 10<br><br><br><br> -Section S99<br><br><br><br> -Paragraph 1<br><br><br><br> -Subparagraph (SAB TOPIC 13.A.4(a).Q1)<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=27012821&amp;loc=d3e214044-122780<br><br><br><br><br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 210<br><br><br><br> -SubTopic 10<br><br><br><br> -Section 45<br><br><br><br> -Paragraph 8<br><br><br><br> -Subparagraph (b)<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=28358313&amp;loc=d3e6935-107765<br><br><br><br><br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher SEC<br><br><br><br> -Name Staff Accounting Bulletin (SAB)<br><br><br><br> -Number Topic 13<br><br><br><br> -Section A<br><br><br><br><br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_DeferredRevenueNoncurrent</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>credit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanAssetsForPlanBenefitsNoncurrent">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The amount for overfunded plans recognized in the balance sheet as a noncurrent asset associated with a defined benefit pension plan or other postretirement defined benefit plan.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 210<br><br><br><br> -SubTopic 10<br><br><br><br> -Section S99<br><br><br><br> -Paragraph 1<br><br><br><br> -Subparagraph (SX 210.5-02.17)<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br><br><br><br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 715<br><br><br><br> -SubTopic 20<br><br><br><br> -Section 50<br><br><br><br> -Paragraph 1<br><br><br><br> -Subparagraph (c)<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=35743120&amp;loc=d3e1928-114920<br><br><br><br><br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 715<br><br><br><br> -SubTopic 20<br><br><br><br> -Section 45<br><br><br><br> -Paragraph 2<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=21915240&amp;loc=d3e1703-114919<br><br><br><br><br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_DefinedBenefitPlanAssetsForPlanBenefitsNoncurrent</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>debit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityAbstract">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div>
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_EquityAbstract</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:stringItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesAndStockholdersEquity">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 210<br><br><br><br> -SubTopic 10<br><br><br><br> -Section S99<br><br><br><br> -Paragraph 1<br><br><br><br> -Subparagraph (SX 210.5-02.32)<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br><br><br><br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher SEC<br><br><br><br> -Name Regulation S-X (SX)<br><br><br><br> -Number 210<br><br><br><br> -Section 03<br><br><br><br> -Paragraph 25<br><br><br><br> -Article 7<br><br><br><br><br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher SEC<br><br><br><br> -Name Regulation S-X (SX)<br><br><br><br> -Number 210<br><br><br><br> -Section 02<br><br><br><br> -Paragraph 32<br><br><br><br> -Article 5<br><br><br><br><br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_LiabilitiesAndStockholdersEquity</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>credit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesCurrent">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 210<br><br><br><br> -SubTopic 10<br><br><br><br> -Section S99<br><br><br><br> -Paragraph 1<br><br><br><br> -Subparagraph (SX 210.5-02.21)<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br><br><br><br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher SEC<br><br><br><br> -Name Regulation S-X (SX)<br><br><br><br> -Number 210<br><br><br><br> -Section 02<br><br><br><br> -Paragraph 21<br><br><br><br> -Article 5<br><br><br><br><br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_LiabilitiesCurrent</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>credit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesCurrentAbstract">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div>
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_LiabilitiesCurrentAbstract</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:stringItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesNoncurrent">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Amount of obligation due after one year or beyond the normal operating cycle, if longer.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 210<br><br><br><br> -SubTopic 10<br><br><br><br> -Section S99<br><br><br><br> -Paragraph 1<br><br><br><br> -Subparagraph (SX 210.5-02.22-26)<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br><br><br><br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher SEC<br><br><br><br> -Name Regulation S-X (SX)<br><br><br><br> -Number 210<br><br><br><br> -Section 02<br><br><br><br> -Paragraph 22, 23, 24, 25, 26, 27<br><br><br><br> -Article 5<br><br><br><br><br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_LiabilitiesNoncurrent</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>credit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesNoncurrentAbstract">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div>
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_LiabilitiesNoncurrentAbstract</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:stringItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermInvestments">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The total amount of investments that are intended to be held for an extended period of time (longer than one operating cycle).</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 210<br><br><br><br> -SubTopic 10<br><br><br><br> -Section S99<br><br><br><br> -Paragraph 1<br><br><br><br> -Subparagraph (SX 210.5-02.12)<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br><br><br><br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_LongTermInvestments</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>debit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MarketableSecuritiesCurrent">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Amount of investments in debt and equity securities, including, but not limited to, held-to-maturity, trading and available-for-sale expected to be converted to cash, sold or exchanged within one year or the normal operating cycle, if longer.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 210<br><br><br><br> -SubTopic 10<br><br><br><br> -Section S99<br><br><br><br> -Paragraph 1<br><br><br><br> -Subparagraph (SX 210.5-02.2)<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br><br><br><br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 320<br><br><br><br> -SubTopic 10<br><br><br><br> -Section 45<br><br><br><br> -Paragraph 2<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6871852&amp;loc=d3e26626-111562<br><br><br><br><br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher SEC<br><br><br><br> -Name Regulation S-X (SX)<br><br><br><br> -Number 210<br><br><br><br> -Section 02<br><br><br><br> -Paragraph 2<br><br><br><br> -Article 5<br><br><br><br><br><br><br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 210<br><br><br><br> -SubTopic 10<br><br><br><br> -Section 45<br><br><br><br> -Paragraph 1<br><br><br><br> -Subparagraph (f)<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=28358313&amp;loc=d3e6676-107765<br><br><br><br><br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_MarketableSecuritiesCurrent</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>debit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherAssetsCurrent">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Aggregate carrying amount, as of the balance sheet date, of current assets not separately disclosed in the balance sheet. Current assets are expected to be realized or consumed within one year (or the normal operating cycle, if longer).</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 210<br><br><br><br> -SubTopic 10<br><br><br><br> -Section S99<br><br><br><br> -Paragraph 1<br><br><br><br> -Subparagraph (SX 210.5-02.8)<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br><br><br><br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher SEC<br><br><br><br> -Name Regulation S-X (SX)<br><br><br><br> -Number 210<br><br><br><br> -Section 02<br><br><br><br> -Paragraph 8<br><br><br><br> -Article 5<br><br><br><br><br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_OtherAssetsCurrent</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>debit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherAssetsNoncurrent">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Aggregate carrying amount, as of the balance sheet date, of noncurrent assets not separately disclosed in the balance sheet. Noncurrent assets are expected to be realized or consumed after one year (or the normal operating cycle, if longer).</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 210<br><br><br><br> -SubTopic 10<br><br><br><br> -Section S99<br><br><br><br> -Paragraph 1<br><br><br><br> -Subparagraph (SX 210.5-02.17)<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br><br><br><br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher SEC<br><br><br><br> -Name Regulation S-X (SX)<br><br><br><br> -Number 210<br><br><br><br> -Section 02<br><br><br><br> -Paragraph 17<br><br><br><br> -Article 5<br><br><br><br><br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_OtherAssetsNoncurrent</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>debit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherLiabilitiesNoncurrent">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Aggregate carrying amount, as of the balance sheet date, of noncurrent obligations not separately disclosed in the balance sheet. Noncurrent liabilities are expected to be paid after one year (or the normal operating cycle, if longer).</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 210<br><br><br><br> -SubTopic 10<br><br><br><br> -Section S99<br><br><br><br> -Paragraph 1<br><br><br><br> -Subparagraph (SX 210.5-02.24)<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br><br><br><br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher SEC<br><br><br><br> -Name Regulation S-X (SX)<br><br><br><br> -Number 210<br><br><br><br> -Section 02<br><br><br><br> -Paragraph 24<br><br><br><br> -Article 5<br><br><br><br><br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_OtherLiabilitiesNoncurrent</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>credit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PostemploymentBenefitsLiabilityNoncurrent">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>For a classified balance sheet, the carrying amount as of the balance sheet date of the portion of the obligations recognized for the various benefits provided to former or inactive employees, their beneficiaries, and covered dependents after employment but before retirement that is payable after one year (or beyond the operating cycle if longer).</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 712<br><br><br><br> -SubTopic 10<br><br><br><br> -Section 25<br><br><br><br> -Paragraph 4<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6410138&amp;loc=d3e79691-111665<br><br><br><br><br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_PostemploymentBenefitsLiabilityNoncurrent</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>credit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentNet">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 360<br><br><br><br> -SubTopic 10<br><br><br><br> -Section 50<br><br><br><br> -Paragraph 1<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br><br><br><br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 210<br><br><br><br> -SubTopic 10<br><br><br><br> -Section S99<br><br><br><br> -Paragraph 1<br><br><br><br> -Subparagraph (SX 210.5-02.13)<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br><br><br><br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher SEC<br><br><br><br> -Name Regulation S-X (SX)<br><br><br><br> -Number 210<br><br><br><br> -Section 02<br><br><br><br> -Paragraph 13<br><br><br><br> -Subparagraph a<br><br><br><br> -Article 5<br><br><br><br><br><br><br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher SEC<br><br><br><br> -Name Regulation S-X (SX)<br><br><br><br> -Number 210<br><br><br><br> -Section 03<br><br><br><br> -Paragraph 8<br><br><br><br> -Article 7<br><br><br><br><br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_PropertyPlantAndEquipmentNet</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>debit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestrictedCashAndCashEquivalentsAtCarryingValue">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The carrying amounts of cash and cash equivalent items which are restricted as to withdrawal or usage. Restrictions may include legally restricted deposits held as compensating balances against short-term borrowing arrangements, contracts entered into with others, or entity statements of intention with regard to particular deposits; however, time deposits and short-term certificates of deposit are not generally included in legally restricted deposits. Excludes compensating balance arrangements that are not agreements which legally restrict the use of cash amounts shown on the balance sheet. For a classified balance sheet represents the current portion only (the noncurrent portion has a separate concept); there is a separate and distinct element for unclassified presentations.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher SEC<br><br><br><br> -Name Regulation S-X (SX)<br><br><br><br> -Number 210<br><br><br><br> -Section 02<br><br><br><br> -Paragraph 1<br><br><br><br> -Article 5<br><br><br><br><br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 210<br><br><br><br> -SubTopic 10<br><br><br><br> -Section S99<br><br><br><br> -Paragraph 1<br><br><br><br> -Subparagraph (SX 210.5-02.1)<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br><br><br><br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_RestrictedCashAndCashEquivalentsAtCarryingValue</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>debit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RetainedEarningsAccumulatedDeficit">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The cumulative amount of the reporting entity's undistributed earnings or deficit.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher SEC<br><br><br><br> -Name Regulation S-X (SX)<br><br><br><br> -Number 210<br><br><br><br> -Section 02<br><br><br><br> -Paragraph 31<br><br><br><br> -Article 5<br><br><br><br><br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher SEC<br><br><br><br> -Name Regulation S-X (SX)<br><br><br><br> -Number 210<br><br><br><br> -Section 04<br><br><br><br> -Article 3<br><br><br><br><br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 210<br><br><br><br> -SubTopic 10<br><br><br><br> -Section S99<br><br><br><br> -Paragraph 1<br><br><br><br> -Subparagraph (SX 210.5-02.31(a)(3))<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br><br><br><br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_RetainedEarningsAccumulatedDeficit</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>credit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShortTermInvestments">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Investments which are intended to be sold in the short term (usually less than one year or the normal operating cycle, whichever is longer) including trading securities, available-for-sale securities, held-to-maturity securities, and other short-term investments not otherwise listed in the existing taxonomy.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 210<br><br><br><br> -SubTopic 10<br><br><br><br> -Section S99<br><br><br><br> -Paragraph 1<br><br><br><br> -Subparagraph (SX 210.5-02.2)<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br><br><br><br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher SEC<br><br><br><br> -Name Regulation S-X (SX)<br><br><br><br> -Number 210<br><br><br><br> -Section 03<br><br><br><br> -Paragraph 1<br><br><br><br> -Subparagraph g<br><br><br><br> -Article 7<br><br><br><br><br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_ShortTermInvestments</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>debit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquity">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 310<br><br><br><br> -SubTopic 10<br><br><br><br> -Section S99<br><br><br><br> -Paragraph 2<br><br><br><br> -Subparagraph (SAB TOPIC 4.E)<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=27010918&amp;loc=d3e74512-122707<br><br><br><br><br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher SEC<br><br><br><br> -Name Staff Accounting Bulletin (SAB)<br><br><br><br> -Number Topic 4<br><br><br><br> -Section E<br><br><br><br><br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 210<br><br><br><br> -SubTopic 10<br><br><br><br> -Section S99<br><br><br><br> -Paragraph 1<br><br><br><br> -Subparagraph (SX 210.5-02.29-31)<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br><br><br><br><br><br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher SEC<br><br><br><br> -Name Regulation S-X (SX)<br><br><br><br> -Number 210<br><br><br><br> -Section 02<br><br><br><br> -Paragraph 29, 30, 31<br><br><br><br> -Article 5<br><br><br><br><br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_StockholdersEquity</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>credit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
    </div>
  </body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>54
<FILENAME>R45.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
  <head>
    <META http-equiv="Content-Type" content="text/html; charset=us-ascii">
    <link rel="StyleSheet" type="text/css" href="report.css"><script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script></head>
  <body><span style="display: none;">v2.4.0.8</span><table class="report" border="0" cellspacing="2" id="ID0E1FAC">
      <tr>
        <th class="tl" colspan="1" rowspan="2">
          <div style="width: 200px;"><strong>STOCKHOLDERS' EQUITY (Summary of RSU Activity to Consultants) (Details) (Consultants [Member])<br></strong></div>
        </th>
        <th class="th" colspan="1">12 Months Ended</th>
      </tr>
      <tr>
        <th class="th">
          <div>Jun. 30, 2014</div>
        </th>
      </tr>
      <tr class="rh">
        <td class="pl" style="border-bottom: 0px;" valign="top">
          <div class="a">Consultants [Member]</div>
        </td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedGoodsAndNonemployeeServicesTransactionLineItems', window );"><strong>Share-based Goods and Nonemployee Services Transaction [Line Items]</strong></a></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber', window );">Unvested at the beginning of period</a></td>
        <td class="text">&nbsp;&nbsp;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod', window );">Granted</a></td>
        <td class="nump">84,565<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod', window );">Vested</a></td>
        <td class="num">(69,315)<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber', window );">Unvested at the end of the period</a></td>
        <td class="nump">15,250<span></span></td>
      </tr>
    </table>
    <div style="display: none;">
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The number of grants made during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 718<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 2<br><br> -Subparagraph (c)(2)(iii)(1)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6415400&amp;loc=d3e5070-113901<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:sharesItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The number of non-vested equity-based payment instruments, excluding stock (or unit) options, that validly exist and are outstanding as of the balance sheet date.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 718<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 2<br><br> -Subparagraph (c)(2)(i)-(ii)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6415400&amp;loc=d3e5070-113901<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:sharesItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The number of equity-based payment instruments, excluding stock (or unit) options, that vested during the reporting period.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 718<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 2<br><br> -Subparagraph (c)(2)(iii)(2)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6415400&amp;loc=d3e5070-113901<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:sharesItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedGoodsAndNonemployeeServicesTransactionLineItems">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div>
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_ShareBasedGoodsAndNonemployeeServicesTransactionLineItems</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:stringItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
    </div>
  </body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>55
<FILENAME>R6.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
  <head>
    <META http-equiv="Content-Type" content="text/html; charset=us-ascii">
    <link rel="StyleSheet" type="text/css" href="report.css"><script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script></head>
  <body><span style="display: none;">v2.4.0.8</span><table class="report" border="0" cellspacing="2" id="ID0E2QDI">
      <tr>
        <th class="tl" colspan="1" rowspan="1">
          <div style="width: 200px;"><strong>STATEMENTS OF CHANGES IN EQUITY (USD $)<br>In Thousands, except Share data</strong></div>
        </th>
        <th class="th">
          <div>Total</div>
        </th>
        <th class="th">
          <div>Common Stock [Member]</div>
        </th>
        <th class="th">
          <div>Additional Paid-in Capital [Member]</div>
        </th>
        <th class="th">
          <div>Accumulated Other Comprehensive Income (Loss) [Member]</div>
        </th>
        <th class="th">
          <div>Accumulated Deficit [Member]</div>
        </th>
      </tr>
      <tr class="rc">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balance at Jun. 30, 2011</a></td>
        <td class="nump">$ 43,422<span></span></td>
        <td class="text">&nbsp;&nbsp;<span></span></td>
        <td class="nump">$ 94,375<span></span></td>
        <td class="text">&nbsp;&nbsp;<span></span></td>
        <td class="num">$ (50,953)<span></span></td>
      </tr>
      <tr class="rc">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Balance, shares at Jun. 30, 2011</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">42,443,185<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_psti_StockIssuedDuringPeriodValueStockOptionsAndWarrantsExercised', window );">Exercise of options and warrants by employees and consultants</a></td>
        <td class="nump">89<span></span></td>
        <td class="text">&nbsp;&nbsp;<span></span></td>
        <td class="nump">89<span></span></td>
        <td class="text">&nbsp;&nbsp;<span></span></td>
        <td class="text">&nbsp;&nbsp;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_psti_StockIssuedDuringPeriodSharesStockOptionsAndWarrantsExercised', window );">Exercise of options and warrants by employees and consultants, shares</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">74,800<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_psti_StockIssuedDuringPeriodValueStockWarrantsExercised', window );">Exercise of warrants by investors and finders</a></td>
        <td class="nump">556<span></span></td>
        <td class="text">&nbsp;&nbsp;<span></span></td>
        <td class="nump">556<span></span></td>
        <td class="text">&nbsp;&nbsp;<span></span></td>
        <td class="text">&nbsp;&nbsp;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_psti_StockIssuedDuringPeriodSharesStockWarrantsExercised', window );">Exercise of warrants by investors and finders, shares</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">523,835<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation', window );">Stock based compensation to employees, directors and non-employee consultants</a></td>
        <td class="nump">4,927<span></span></td>
        <td class="text">&nbsp;&nbsp;<span></span></td>
        <td class="nump">4,927<span></span></td>
        <td class="text">&nbsp;&nbsp;<span></span></td>
        <td class="text">&nbsp;&nbsp;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation', window );">Stock based compensation to employees, directors and non-employee consultants, shares</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">19,060,231<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueIssuedForServices', window );">Stock based compensation to contractor</a></td>
        <td class="nump">3,672<span></span></td>
        <td class="text">&nbsp;&nbsp;<span></span></td>
        <td class="nump">3,672<span></span></td>
        <td class="text">&nbsp;&nbsp;<span></span></td>
        <td class="text">&nbsp;&nbsp;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesIssuedForServices', window );">Stock based compensation to contractor, shares</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">1,500,000<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax', window );">Other comprehensive income (loss), net</a></td>
        <td class="num">(130)<span></span></td>
        <td class="text">&nbsp;&nbsp;<span></span></td>
        <td class="text">&nbsp;&nbsp;<span></span></td>
        <td class="num">(130)<span></span></td>
        <td class="text">&nbsp;&nbsp;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss</a></td>
        <td class="num">(14,794)<span></span></td>
        <td class="text">&nbsp;&nbsp;<span></span></td>
        <td class="text">&nbsp;&nbsp;<span></span></td>
        <td class="text">&nbsp;&nbsp;<span></span></td>
        <td class="num">(14,794)<span></span></td>
      </tr>
      <tr class="rc">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balance at Jun. 30, 2012</a></td>
        <td class="nump">37,742<span></span></td>
        <td class="text">&nbsp;&nbsp;<span></span></td>
        <td class="nump">103,619<span></span></td>
        <td class="num">(130)<span></span></td>
        <td class="num">(65,747)<span></span></td>
      </tr>
      <tr class="rc">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Balance, shares at Jun. 30, 2012</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">46,448,051<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueNewIssues', window );">Issuance of common stock and warrants, net of issuance costs</a></td>
        <td class="nump">34,106<span></span></td>
        <td class="text">&nbsp;&nbsp;<span></span></td>
        <td class="nump">34,106<span></span></td>
        <td class="text">&nbsp;&nbsp;<span></span></td>
        <td class="text">&nbsp;&nbsp;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues', window );">Issuance of common stock and warrants, net of issuance costs, shares</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">9,200,000<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_psti_StockIssuedDuringPeriodValueStockOptionsAndWarrantsExercised', window );">Exercise of options and warrants by employees and consultants</a></td>
        <td class="nump">176<span></span></td>
        <td class="text">&nbsp;&nbsp;<span></span></td>
        <td class="nump">176<span></span></td>
        <td class="text">&nbsp;&nbsp;<span></span></td>
        <td class="text">&nbsp;&nbsp;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_psti_StockIssuedDuringPeriodSharesStockOptionsAndWarrantsExercised', window );">Exercise of options and warrants by employees and consultants, shares</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">176,867<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_psti_StockIssuedDuringPeriodValueStockWarrantsExercised', window );">Exercise of warrants by investors and finders</a></td>
        <td class="nump">2,009<span></span></td>
        <td class="text">&nbsp;&nbsp;<span></span></td>
        <td class="nump">2,009<span></span></td>
        <td class="text">&nbsp;&nbsp;<span></span></td>
        <td class="text">&nbsp;&nbsp;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_psti_StockIssuedDuringPeriodSharesStockWarrantsExercised', window );">Exercise of warrants by investors and finders, shares</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">1,621,359<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation', window );">Stock based compensation to employees, directors and non-employee consultants</a></td>
        <td class="nump">2,799<span></span></td>
        <td class="text">&nbsp;&nbsp;<span></span></td>
        <td class="nump">2,799<span></span></td>
        <td class="text">&nbsp;&nbsp;<span></span></td>
        <td class="text">&nbsp;&nbsp;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation', window );">Stock based compensation to employees, directors and non-employee consultants, shares</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">1,750,340<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueIssuedForServices', window );">Stock based compensation to contractor</a></td>
        <td class="nump">1,400<span></span></td>
        <td class="text">&nbsp;&nbsp;<span></span></td>
        <td class="nump">1,400<span></span></td>
        <td class="text">&nbsp;&nbsp;<span></span></td>
        <td class="text">&nbsp;&nbsp;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesIssuedForServices', window );">Stock based compensation to contractor, shares</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&nbsp;&nbsp;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax', window );">Other comprehensive income (loss), net</a></td>
        <td class="nump">389<span></span></td>
        <td class="text">&nbsp;&nbsp;<span></span></td>
        <td class="text">&nbsp;&nbsp;<span></span></td>
        <td class="nump">389<span></span></td>
        <td class="text">&nbsp;&nbsp;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss</a></td>
        <td class="num">(21,155)<span></span></td>
        <td class="text">&nbsp;&nbsp;<span></span></td>
        <td class="text">&nbsp;&nbsp;<span></span></td>
        <td class="text">&nbsp;&nbsp;<span></span></td>
        <td class="num">(21,155)<span></span></td>
      </tr>
      <tr class="rc">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balance at Jun. 30, 2013</a></td>
        <td class="nump">57,466<span></span></td>
        <td class="text">&nbsp;&nbsp;<span></span></td>
        <td class="nump">144,109<span></span></td>
        <td class="nump">259<span></span></td>
        <td class="num">(86,902)<span></span></td>
      </tr>
      <tr class="rc">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Balance, shares at Jun. 30, 2013</a></td>
        <td class="nump">59,196,617<span></span></td>
        <td class="nump">59,196,617<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueNewIssues', window );">Issuance of common stock and warrants, net of issuance costs</a></td>
        <td class="nump">10,644<span></span></td>
        <td class="text">&nbsp;&nbsp;<span></span></td>
        <td class="nump">10,644<span></span></td>
        <td class="text">&nbsp;&nbsp;<span></span></td>
        <td class="text">&nbsp;&nbsp;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues', window );">Issuance of common stock and warrants, net of issuance costs, shares</a></td>
        <td class="nump">2,596,032<span></span></td>
        <td class="nump">2,596,032<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_psti_StockIssuedDuringPeriodValueStockOptionsAndWarrantsExercised', window );">Exercise of options and warrants by employees and consultants</a></td>
        <td class="nump">12<span></span></td>
        <td class="text">&nbsp;&nbsp;<span></span></td>
        <td class="nump">12<span></span></td>
        <td class="text">&nbsp;&nbsp;<span></span></td>
        <td class="text">&nbsp;&nbsp;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_psti_StockIssuedDuringPeriodSharesStockOptionsAndWarrantsExercised', window );">Exercise of options and warrants by employees and consultants, shares</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">53,470<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_psti_StockIssuedDuringPeriodValueStockWarrantsExercised', window );">Exercise of warrants by investors and finders</a></td>
        <td class="nump">1,968<span></span></td>
        <td class="text">&nbsp;&nbsp;<span></span></td>
        <td class="nump">1,968<span></span></td>
        <td class="text">&nbsp;&nbsp;<span></span></td>
        <td class="text">&nbsp;&nbsp;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_psti_StockIssuedDuringPeriodSharesStockWarrantsExercised', window );">Exercise of warrants by investors and finders, shares</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">2,902,168<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation', window );">Stock based compensation to employees, directors and non-employee consultants</a></td>
        <td class="nump">5,851<span></span></td>
        <td class="text">&nbsp;&nbsp;<span></span></td>
        <td class="nump">5,851<span></span></td>
        <td class="text">&nbsp;&nbsp;<span></span></td>
        <td class="text">&nbsp;&nbsp;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation', window );">Stock based compensation to employees, directors and non-employee consultants, shares</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">1,353,165<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValuePurchaseOfAssets', window );">Issuance of common stock under CHA Agreement (Note 1d)</a></td>
        <td class="nump">10,414<span></span></td>
        <td class="text">&nbsp;&nbsp;<span></span></td>
        <td class="nump">10,414<span></span></td>
        <td class="text">&nbsp;&nbsp;<span></span></td>
        <td class="text">&nbsp;&nbsp;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesPurchaseOfAssets', window );">Issuance of common stock under CHA Agreement (Note 1d), shares</a></td>
        <td class="nump">2,500,000<span></span></td>
        <td class="nump">2,500,000<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax', window );">Other comprehensive income (loss), net</a></td>
        <td class="nump">2,700<span></span></td>
        <td class="text">&nbsp;&nbsp;<span></span></td>
        <td class="text">&nbsp;&nbsp;<span></span></td>
        <td class="nump">2,700<span></span></td>
        <td class="text">&nbsp;&nbsp;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss</a></td>
        <td class="num">(26,932)<span></span></td>
        <td class="text">&nbsp;&nbsp;<span></span></td>
        <td class="text">&nbsp;&nbsp;<span></span></td>
        <td class="text">&nbsp;&nbsp;<span></span></td>
        <td class="num">(26,932)<span></span></td>
      </tr>
      <tr class="rc">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balance at Jun. 30, 2014</a></td>
        <td class="nump">$ 62,123<span></span></td>
        <td class="text">&nbsp;&nbsp;<span></span></td>
        <td class="nump">$ 172,998<span></span></td>
        <td class="nump">$ 2,959<span></span></td>
        <td class="num">$ (113,834)<span></span></td>
      </tr>
      <tr class="rc">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Balance, shares at Jun. 30, 2014</a></td>
        <td class="nump">68,601,452<span></span></td>
        <td class="nump">68,601,452<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
    </table>
    <div style="display: none;">
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_psti_StockIssuedDuringPeriodSharesStockOptionsAndWarrantsExercised">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Number of share options and warrants exercised during the current period.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>psti_StockIssuedDuringPeriodSharesStockOptionsAndWarrantsExercised</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>psti_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:sharesItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_psti_StockIssuedDuringPeriodSharesStockWarrantsExercised">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Number of shares of stock issued as a result of the exercise of stock warrants.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>psti_StockIssuedDuringPeriodSharesStockWarrantsExercised</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>psti_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:sharesItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_psti_StockIssuedDuringPeriodValueStockOptionsAndWarrantsExercised">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Value of stock issued as a result of the exercise of stock options and warrants.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>psti_StockIssuedDuringPeriodValueStockOptionsAndWarrantsExercised</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>psti_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>credit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_psti_StockIssuedDuringPeriodValueStockWarrantsExercised">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Value of stock issued as a result of the exercise of stock warrants.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>psti_StockIssuedDuringPeriodValueStockWarrantsExercised</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>psti_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>credit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesOutstanding">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher SEC<br><br> -Name Regulation S-X (SX)<br><br> -Number 210<br><br> -Section 04<br><br> -Article 3<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 505<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 2<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6928386&amp;loc=d3e21463-112644<br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 505<br><br> -SubTopic 10<br><br> -Section S99<br><br> -Paragraph 1<br><br> -Subparagraph (SX 210.3-04)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=27012166&amp;loc=d3e187085-122770<br><br><br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 210<br><br> -SubTopic 10<br><br> -Section S99<br><br> -Paragraph 1<br><br> -Subparagraph (SX 210.5-02.29)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br><br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher SEC<br><br> -Name Regulation S-X (SX)<br><br> -Number 210<br><br> -Section 02<br><br> -Paragraph 30<br><br> -Article 5<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_CommonStockSharesOutstanding</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:sharesItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 230<br><br> -SubTopic 10<br><br> -Section 45<br><br> -Paragraph 28<br><br> -URI http://asc.fasb.org/extlink&amp;oid=31042434&amp;loc=d3e3602-108585<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 260<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 1<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Glossary Other Comprehensive Income<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6519514<br><br><br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Glossary Net Income<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6518256<br><br><br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 944<br><br> -SubTopic 225<br><br> -Section S99<br><br> -Paragraph 1<br><br> -Subparagraph (SX 210.7-04.19)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6879464&amp;loc=d3e573970-122913<br><br><br><br>Reference 6: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 225<br><br> -SubTopic 10<br><br> -Section S99<br><br> -Paragraph 2<br><br> -Subparagraph (SX 210.5-03.18)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=26872669&amp;loc=d3e20235-122688<br><br><br><br>Reference 7: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 944<br><br> -SubTopic 225<br><br> -Section S99<br><br> -Paragraph 1<br><br> -Subparagraph (SX 210.7-04.22)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6879464&amp;loc=d3e573970-122913<br><br><br><br>Reference 8: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher SEC<br><br> -Name Regulation S-X (SX)<br><br> -Number 210<br><br> -Section 03<br><br> -Paragraph 19<br><br> -Article 5<br><br><br><br>Reference 9: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher SEC<br><br> -Name Regulation S-X (SX)<br><br> -Number 210<br><br> -Section 04<br><br> -Paragraph 20<br><br> -Article 9<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_NetIncomeLoss</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>credit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Amount after tax and reclassification adjustments of other comprehensive income (loss).</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 505<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 2<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6928386&amp;loc=d3e21463-112644<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 220<br><br> -SubTopic 10<br><br> -Section 45<br><br> -Paragraph 1A<br><br> -URI http://asc.fasb.org/extlink&amp;oid=36458714&amp;loc=SL7669619-108580<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_OtherComprehensiveIncomeLossNetOfTax</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>credit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquity">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 310<br><br> -SubTopic 10<br><br> -Section S99<br><br> -Paragraph 2<br><br> -Subparagraph (SAB TOPIC 4.E)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=27010918&amp;loc=d3e74512-122707<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher SEC<br><br> -Name Staff Accounting Bulletin (SAB)<br><br> -Number Topic 4<br><br> -Section E<br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 210<br><br> -SubTopic 10<br><br> -Section S99<br><br> -Paragraph 1<br><br> -Subparagraph (SX 210.5-02.29-31)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br><br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher SEC<br><br> -Name Regulation S-X (SX)<br><br> -Number 210<br><br> -Section 02<br><br> -Paragraph 29, 30, 31<br><br> -Article 5<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_StockholdersEquity</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>credit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesIssuedForServices">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Number of shares issued in lieu of cash for services contributed to the entity. Number of shares includes, but is not limited to, shares issued for services contributed by vendors and founders.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_StockIssuedDuringPeriodSharesIssuedForServices</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:sharesItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Number of new stock issued during the period.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher SEC<br><br> -Name Regulation S-X (SX)<br><br> -Number 210<br><br> -Section 04<br><br> -Article 3<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 505<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 2<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6928386&amp;loc=d3e21463-112644<br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 505<br><br> -SubTopic 10<br><br> -Section S99<br><br> -Paragraph 1<br><br> -Subparagraph (SX 210.3-04)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=27012166&amp;loc=d3e187085-122770<br><br><br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher SEC<br><br> -Name Regulation S-X (SX)<br><br> -Number 210<br><br> -Section 02<br><br> -Paragraph 29, 30<br><br> -Article 5<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_StockIssuedDuringPeriodSharesNewIssues</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:sharesItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesPurchaseOfAssets">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Number of shares of stock issued during the period as part of a transaction to acquire assets that do not qualify as a business combination.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_StockIssuedDuringPeriodSharesPurchaseOfAssets</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:sharesItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Number of shares (or other type of equity) issued during the period as a result of any equity-based compensation plan other than an employee stock ownership plan (ESOP), net of any shares forfeited. Shares issued could result from the issuance of restricted stock, the exercise of stock options, stock issued under employee stock purchase plans, and/or other employee benefit plans.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher SEC<br><br> -Name Regulation S-X (SX)<br><br> -Number 210<br><br> -Section 04<br><br> -Article 3<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 505<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 2<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6928386&amp;loc=d3e21463-112644<br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 505<br><br> -SubTopic 10<br><br> -Section S99<br><br> -Paragraph 1<br><br> -Subparagraph (SX 210.3-04)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=27012166&amp;loc=d3e187085-122770<br><br><br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher SEC<br><br> -Name Regulation S-X (SX)<br><br> -Number 210<br><br> -Section 02<br><br> -Paragraph 29, 30<br><br> -Article 5<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:sharesItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueIssuedForServices">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Value of stock issued in lieu of cash for services contributed to the entity. Value of the stock issued includes, but is not limited to, services contributed by vendors and founders.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_StockIssuedDuringPeriodValueIssuedForServices</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>credit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueNewIssues">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Equity impact of the value of new stock issued during the period. Includes shares issued in an initial public offering or a secondary public offering.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher SEC<br><br> -Name Regulation S-X (SX)<br><br> -Number 210<br><br> -Section 04<br><br> -Article 3<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 505<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 2<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6928386&amp;loc=d3e21463-112644<br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 505<br><br> -SubTopic 10<br><br> -Section S99<br><br> -Paragraph 1<br><br> -Subparagraph (SX 210.3-04)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=27012166&amp;loc=d3e187085-122770<br><br><br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher SEC<br><br> -Name Regulation S-X (SX)<br><br> -Number 210<br><br> -Section 02<br><br> -Paragraph 29, 30, 31<br><br> -Article 5<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_StockIssuedDuringPeriodValueNewIssues</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>credit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValuePurchaseOfAssets">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Value of shares of stock issued during the period as part of a transaction to acquire assets that do not qualify as a business combination.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_StockIssuedDuringPeriodValuePurchaseOfAssets</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>credit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Value of stock (or other type of equity) issued during the period as a result of any equity-based compensation plan other than an employee stock ownership plan (ESOP), net of stock value of such awards forfeited. Stock issued could result from the issuance of restricted stock, the exercise of stock options, stock issued under employee stock purchase plans, and/or other employee benefit plans.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher SEC<br><br> -Name Regulation S-X (SX)<br><br> -Number 210<br><br> -Section 04<br><br> -Article 3<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 505<br><br> -SubTopic 10<br><br> -Section S99<br><br> -Paragraph 1<br><br> -Subparagraph (SX 210.3-04)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=27012166&amp;loc=d3e187085-122770<br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 718<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 2<br><br> -Subparagraph (d)(1)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6415400&amp;loc=d3e5070-113901<br><br><br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 718<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 1<br><br> -Subparagraph (c)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6415400&amp;loc=d3e5047-113901<br><br><br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher SEC<br><br> -Name Regulation S-X (SX)<br><br> -Number 210<br><br> -Section 02<br><br> -Paragraph 29, 30, 31<br><br> -Article 5<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>credit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
    </div>
  </body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>56
<FILENAME>R35.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
  <head>
    <META http-equiv="Content-Type" content="text/html; charset=us-ascii">
    <link rel="StyleSheet" type="text/css" href="report.css"><script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script></head>
  <body><span style="display: none;">v2.4.0.8</span><table class="report" border="0" cellspacing="2" id="ID0ESZAE">
      <tr>
        <th class="tl" colspan="1" rowspan="1">
          <div style="width: 200px;"><strong>FAIR VALUE OF FINANCIAL INSTRUMENTS (Schedule of Fair Value of Financial Instruments) (Details) (USD $)<br>In Thousands, unless otherwise specified</strong></div>
        </th>
        <th class="th">
          <div>Jun. 30, 2014</div>
        </th>
        <th class="th">
          <div>Jun. 30, 2013</div>
        </th>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MarketableSecuritiesCurrent', window );">Marketable securities</a></td>
        <td class="nump">$ 29,961<span></span></td>
        <td class="nump">$ 13,441<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeAssetsLiabilitiesAtFairValueNet', window );">Foreign currency derivative instruments</a></td>
        <td class="num">(842)<span></span></td>
        <td class="nump">93<span></span></td>
      </tr>
      <tr class="rh">
        <td class="pl" style="border-bottom: 0px;" valign="top">
          <div class="a">Level 1 [Member] | Fair Value, Measurements, Recurring [Member]</div>
        </td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MarketableSecuritiesCurrent', window );">Marketable securities</a></td>
        <td class="nump">20,530<span></span></td>
        <td class="nump">6,311<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeAssetsLiabilitiesAtFairValueNet', window );">Foreign currency derivative instruments</a></td>
        <td class="text">&nbsp;&nbsp;<span></span></td>
        <td class="text">&nbsp;&nbsp;<span></span></td>
      </tr>
      <tr class="rou">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueNetAssetLiability', window );">Total</a></td>
        <td class="nump">20,530<span></span></td>
        <td class="nump">6,311<span></span></td>
      </tr>
      <tr class="rh">
        <td class="pl" style="border-bottom: 0px;" valign="top">
          <div class="a">Level 2 [Member] | Fair Value, Measurements, Recurring [Member]</div>
        </td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MarketableSecuritiesCurrent', window );">Marketable securities</a></td>
        <td class="nump">9,431<span></span></td>
        <td class="nump">7,130<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeAssetsLiabilitiesAtFairValueNet', window );">Foreign currency derivative instruments</a></td>
        <td class="num">(842)<span></span></td>
        <td class="nump">93<span></span></td>
      </tr>
      <tr class="reu">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueNetAssetLiability', window );">Total</a></td>
        <td class="nump">8,589<span></span></td>
        <td class="nump">7,223<span></span></td>
      </tr>
      <tr class="rh">
        <td class="pl" style="border-bottom: 0px;" valign="top">
          <div class="a">Level 3 [Member] | Fair Value, Measurements, Recurring [Member]</div>
        </td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MarketableSecuritiesCurrent', window );">Marketable securities</a></td>
        <td class="text">&nbsp;&nbsp;<span></span></td>
        <td class="text">&nbsp;&nbsp;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeAssetsLiabilitiesAtFairValueNet', window );">Foreign currency derivative instruments</a></td>
        <td class="text">&nbsp;&nbsp;<span></span></td>
        <td class="text">&nbsp;&nbsp;<span></span></td>
      </tr>
      <tr class="rou">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueNetAssetLiability', window );">Total</a></td>
        <td class="text">&nbsp;&nbsp;<span></span></td>
        <td class="text">&nbsp;&nbsp;<span></span></td>
      </tr>
    </table>
    <div style="display: none;">
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeAssetsLiabilitiesAtFairValueNet">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Fair values as of the balance sheet date of the net amount of all assets and liabilities resulting from contracts that meet the criteria of being accounted for as derivative instruments.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 815<br><br> -SubTopic 10<br><br> -Section 45<br><br> -Paragraph 5<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6945355&amp;loc=d3e41228-113958<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_DerivativeAssetsLiabilitiesAtFairValueNet</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>debit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div>
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:stringItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueNetAssetLiability">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Fair value of asset after deduction of liability.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_FairValueNetAssetLiability</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>debit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MarketableSecuritiesCurrent">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Amount of investments in debt and equity securities, including, but not limited to, held-to-maturity, trading and available-for-sale expected to be converted to cash, sold or exchanged within one year or the normal operating cycle, if longer.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 210<br><br> -SubTopic 10<br><br> -Section S99<br><br> -Paragraph 1<br><br> -Subparagraph (SX 210.5-02.2)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 320<br><br> -SubTopic 10<br><br> -Section 45<br><br> -Paragraph 2<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6871852&amp;loc=d3e26626-111562<br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher SEC<br><br> -Name Regulation S-X (SX)<br><br> -Number 210<br><br> -Section 02<br><br> -Paragraph 2<br><br> -Article 5<br><br><br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 210<br><br> -SubTopic 10<br><br> -Section 45<br><br> -Paragraph 1<br><br> -Subparagraph (f)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=28358313&amp;loc=d3e6676-107765<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_MarketableSecuritiesCurrent</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>debit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
    </div>
  </body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>57
<FILENAME>R22.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
  <head>
    <META http-equiv="Content-Type" content="text/html; charset=us-ascii">
    <link rel="StyleSheet" type="text/css" href="report.css"><script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script></head>
  <body><span style="display: none;">v2.4.0.8</span><table class="report" border="0" cellspacing="2" id="ID0E2F">
      <tr>
        <th class="tl" colspan="1" rowspan="2">
          <div style="width: 200px;"><strong>FAIR VALUE OF FINANCIAL INSTRUMENTS (Tables)<br></strong></div>
        </th>
        <th class="th" colspan="1">12 Months Ended</th>
      </tr>
      <tr>
        <th class="th">
          <div>Jun. 30, 2014</div>
        </th>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueDisclosuresAbstract', window );"><strong>FAIR VALUE OF FINANCIAL INSTRUMENTS [Abstract]</strong></a></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTableTextBlock', window );">Schedule of Fair Value of Financial Instruments</a></td>
        <td class="text"><!--DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd" --><div> <div><!--StartFragment--> <div style="text-align: right"> <table style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman" cellspacing="0" cellpadding="0" width="97%"> <tr> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="28%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-WEIGHT: bold; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="34%" colspan="10"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"> June 30, 2014</div> </td> <td style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-WEIGHT: bold; DISPLAY: inline"> &nbsp;</font> </td> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-WEIGHT: bold; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="34%" colspan="10"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"> June 30, 2013</div> </td> <td style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-WEIGHT: bold; DISPLAY: inline"> &nbsp;</font> </td> </tr> <tr> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="28%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-WEIGHT: bold; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="10%" colspan="2"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"> Level 1</div> </td> <td style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-WEIGHT: bold; DISPLAY: inline"> &nbsp;</font> </td> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-WEIGHT: bold; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="10%" colspan="2"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"> Level 2</div> </td> <td style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-WEIGHT: bold; DISPLAY: inline"> &nbsp;</font> </td> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-WEIGHT: bold; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="10%" colspan="2"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"> Level 3</div> </td> <td style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-WEIGHT: bold; DISPLAY: inline"> &nbsp;</font> </td> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-WEIGHT: bold; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="10%" colspan="2"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"> Level 1</div> </td> <td style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-WEIGHT: bold; DISPLAY: inline"> &nbsp;</font> </td> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-WEIGHT: bold; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="10%" colspan="2"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"> Level 2</div> </td> <td style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-WEIGHT: bold; DISPLAY: inline"> &nbsp;</font> </td> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-WEIGHT: bold; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="10%" colspan="2"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"> Level 3</div> </td> <td style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-WEIGHT: bold; DISPLAY: inline"> &nbsp;</font> </td> </tr> <tr bgcolor="#cceeff"> <td style="TEXT-ALIGN: left; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt" valign="bottom" width="28%"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: left; TEXT-INDENT: 0pt"> Marketable securities</div> </td> <td valign="bottom" width="1%" align="right"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%">$</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">20,530</td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%" align="right"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%">$</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">9,431</td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%" align="right"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">-</td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%" align="right"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%">$</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">6,311</td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%" align="right"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%">$</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">7,130</td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%" align="right"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">-</td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> <tr bgcolor="white"> <td style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt" valign="bottom" width="28%"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: left; TEXT-INDENT: 0pt"> Foreign currency derivative instruments</div> </td> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%" align="right"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">-</td> <td style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%" align="right"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">(842</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap">)</td> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%" align="right"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">-</td> <td style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%" align="right"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">-</td> <td style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%" align="right"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">93</td> <td style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%" align="right"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">-</td> <td style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> <tr bgcolor="#cceeff"> <td style="PADDING-BOTTOM: 4px; TEXT-ALIGN: left; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt" valign="bottom" width="28%"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: left; TEXT-INDENT: 0pt"> Total</div> </td> <td style="PADDING-BOTTOM: 4px" valign="bottom" width="1%" align="right"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 4px double; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%">$</td> <td style="BORDER-BOTTOM: black 4px double; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">20,530</td> <td style="PADDING-BOTTOM: 4px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="PADDING-BOTTOM: 4px" valign="bottom" width="1%" align="right"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 4px double; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%">$</td> <td style="BORDER-BOTTOM: black 4px double; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">8,589</td> <td style="PADDING-BOTTOM: 4px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="PADDING-BOTTOM: 4px" valign="bottom" width="1%" align="right"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 4px double; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%">$</td> <td style="BORDER-BOTTOM: black 4px double; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">-</td> <td style="PADDING-BOTTOM: 4px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="PADDING-BOTTOM: 4px" valign="bottom" width="1%" align="right"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 4px double; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%">$</td> <td style="BORDER-BOTTOM: black 4px double; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">6,311</td> <td style="PADDING-BOTTOM: 4px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="PADDING-BOTTOM: 4px" valign="bottom" width="1%" align="right"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 4px double; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%">$</td> <td style="BORDER-BOTTOM: black 4px double; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">7,223</td> <td style="PADDING-BOTTOM: 4px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="PADDING-BOTTOM: 4px" valign="bottom" width="1%" align="right"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 4px double; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%">$</td> <td style="BORDER-BOTTOM: black 4px double; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">-</td> <td style="PADDING-BOTTOM: 4px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> </table> </div> <!--EndFragment--></div> </div><span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock', window );">Schedule of Derivative Hedging Activity and Balance Sheet Location</a></td>
        <td class="text"><!--DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd" --><div> <div><!--StartFragment--> <div style="text-align: right"> <table style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman" cellspacing="0" cellpadding="0" width="97%"> <tr> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="49%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="26%" colspan="4"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"> June 30, 2014</div> </td> <td style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-WEIGHT: bold; DISPLAY: inline"> &nbsp;</font> </td> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-WEIGHT: bold; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="22%" colspan="6"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"> June 30, 2013</div> </td> <td style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-WEIGHT: bold; DISPLAY: inline"> &nbsp;</font> </td> </tr> <tr> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="49%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="15%"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"> Balance Sheet location</div> </td> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-WEIGHT: bold; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="10%" colspan="2"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"> Fair Value</div> </td> <td style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-WEIGHT: bold; DISPLAY: inline"> &nbsp;</font> </td> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-WEIGHT: bold; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="10%" colspan="2"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"> Balance Sheet location</div> </td> <td style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-WEIGHT: bold; DISPLAY: inline"> &nbsp;</font> </td> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-WEIGHT: bold; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="10%" colspan="2"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"> Fair Value</div> </td> <td style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-WEIGHT: bold; DISPLAY: inline"> &nbsp;</font> </td> </tr> <tr bgcolor="#cceeff"> <td style="TEXT-ALIGN: left; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt" valign="bottom" width="49%"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: left; TEXT-INDENT: 0pt"> Derivatives designated as cash flow hedge instruments</div> </td> <td valign="bottom" width="15%"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 1.6pt; text-align: center; TEXT-INDENT: 0pt"> Other current assets</div> </td> <td valign="bottom" width="1%" align="right"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%">$</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">24</td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">-</td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%" align="left"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%">$</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">-</td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> <tr bgcolor="white"> <td style="TEXT-ALIGN: left; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt" valign="bottom" width="49%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="15%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%" align="right"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: right" valign="bottom" width="9%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="10%" colspan="2"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: right" valign="bottom" width="9%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> <tr bgcolor="#cceeff"> <td style="TEXT-ALIGN: left; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt" valign="bottom" width="49%"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: left; TEXT-INDENT: 0pt"> Derivatives not designated as hedge instruments</div> </td> <td valign="bottom" width="15%"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 1.6pt; text-align: center; TEXT-INDENT: 0pt"> Other current assets</div> </td> <td valign="bottom" width="1%" align="right"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">23</td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="10%" colspan="2"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"> Other current assets</div> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">93</td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> <tr bgcolor="white"> <td style="TEXT-ALIGN: left; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt" valign="bottom" width="49%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="15%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%" align="right"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: right" valign="bottom" width="9%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: right" valign="bottom" width="9%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: right" valign="bottom" width="9%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> <tr bgcolor="#cceeff"> <td style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt" valign="bottom" width="49%"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: left; TEXT-INDENT: 0pt"> Derivatives designated as fair value hedge instruments</div> </td> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="15%"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 1.6pt; text-align: center; TEXT-INDENT: 0pt"> Other current liabilities</div> </td> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%" align="right"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">(889</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap">)</td> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; PADDING-BOTTOM: 2px; TEXT-ALIGN: right" valign="bottom" width="9%">-</td> <td style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">-</td> <td style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> <tr bgcolor="white"> <td style="TEXT-ALIGN: left; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt" valign="bottom" width="49%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="15%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%" align="right"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: right" valign="bottom" width="9%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: right" valign="bottom" width="9%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%" align="left"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: right" valign="bottom" width="9%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> <tr bgcolor="#cceeff"> <td style="PADDING-BOTTOM: 4px; TEXT-ALIGN: left; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt" valign="bottom" width="49%"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: left; TEXT-INDENT: 0pt"> Total</div> </td> <td style="PADDING-BOTTOM: 4px" valign="bottom" width="15%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="PADDING-BOTTOM: 4px" valign="bottom" width="1%" align="right"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 4px double; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%">$</td> <td style="BORDER-BOTTOM: black 4px double; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">(842</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; PADDING-BOTTOM: 4px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap">)</td> <td style="PADDING-BOTTOM: 4px" valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="PADDING-BOTTOM: 4px; TEXT-ALIGN: right" valign="bottom" width="9%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="PADDING-BOTTOM: 4px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="PADDING-BOTTOM: 4px" valign="bottom" width="1%" align="left"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 4px double; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%">$</td> <td style="BORDER-BOTTOM: black 4px double; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">93</td> <td style="PADDING-BOTTOM: 4px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> </table> </div> <!--EndFragment--></div> </div><span></span></td>
      </tr>
    </table>
    <div style="display: none;">
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTableTextBlock">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Tabular disclosure of financial instruments measured at fair value, including those classified in shareholders' equity measured on a recurring or nonrecurring basis. Disclosures include, but are not limited to, fair value measurements recorded and the reasons for the measurements, level within the fair value hierarchy in which the fair value measurements are categorized and transfers between levels 1 and 2. Nonrecurring fair value measurements are those that are required or permitted in the statement of financial position in particular circumstances.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 820<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 3<br><br> -URI http://asc.fasb.org/extlink&amp;oid=36462937&amp;loc=d3e19279-110258<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 820<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 2<br><br> -Subparagraph (a,b,bb)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=36462937&amp;loc=d3e19207-110258<br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 820<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 2C<br><br> -URI http://asc.fasb.org/extlink&amp;oid=36462937&amp;loc=SL7498348-110258<br><br><br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 820<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 1<br><br> -URI http://asc.fasb.org/extlink&amp;oid=36462937&amp;loc=d3e19190-110258<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTableTextBlock</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>nonnum:textBlockItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueDisclosuresAbstract">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div>
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_FairValueDisclosuresAbstract</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:stringItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Tabular disclosure of the location and fair value amounts of derivative instruments (and nonderivative instruments that are designated and qualify as hedging instruments) reported in the statement of financial position.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 815<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 4B<br><br> -URI http://asc.fasb.org/extlink&amp;oid=35706170&amp;loc=SL5624163-113959<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>nonnum:textBlockItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
    </div>
  </body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>58
<FILENAME>R36.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
  <head>
    <META http-equiv="Content-Type" content="text/html; charset=us-ascii">
    <link rel="StyleSheet" type="text/css" href="report.css"><script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script></head>
  <body><span style="display: none;">v2.4.0.8</span><table class="report" border="0" cellspacing="2" id="ID0EYMAE">
      <tr>
        <th class="tl" colspan="1" rowspan="1">
          <div style="width: 200px;"><strong>FAIR VALUE OF FINANCIAL INSTRUMENTS (Schedule of the Fair Value of Hedging Instruments) (Details) (USD $)<br>In Thousands, unless otherwise specified</strong></div>
        </th>
        <th class="th">
          <div>Jun. 30, 2014</div>
        </th>
        <th class="th">
          <div>Jun. 30, 2013</div>
        </th>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativesFairValueLineItems', window );"><strong>Derivatives Fair Value Line Items</strong></a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeAssetsLiabilitiesAtFairValueNet', window );">Derivative fair value asset (liability)</a></td>
        <td class="num">$ (842)<span></span></td>
        <td class="nump">$ 93<span></span></td>
      </tr>
      <tr class="rh">
        <td class="pl" style="border-bottom: 0px;" valign="top">
          <div class="a">Derivatives designated as hedge instruments [Member] | Other current assets [Member] | Cash flow [Member]</div>
        </td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativesFairValueLineItems', window );"><strong>Derivatives Fair Value Line Items</strong></a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeAssetsLiabilitiesAtFairValueNet', window );">Derivative fair value asset (liability)</a></td>
        <td class="nump">24<span></span></td>
        <td class="text">&nbsp;&nbsp;<span></span></td>
      </tr>
      <tr class="rh">
        <td class="pl" style="border-bottom: 0px;" valign="top">
          <div class="a">Derivatives designated as hedge instruments [Member] | Other current liabilities [Member] | Fair value [Member]</div>
        </td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativesFairValueLineItems', window );"><strong>Derivatives Fair Value Line Items</strong></a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeAssetsLiabilitiesAtFairValueNet', window );">Derivative fair value asset (liability)</a></td>
        <td class="num">(889)<span></span></td>
        <td class="text">&nbsp;&nbsp;<span></span></td>
      </tr>
      <tr class="rh">
        <td class="pl" style="border-bottom: 0px;" valign="top">
          <div class="a">Derivatives not designated as hedge instruments [Member] | Other current assets [Member]</div>
        </td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativesFairValueLineItems', window );"><strong>Derivatives Fair Value Line Items</strong></a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeAssetsLiabilitiesAtFairValueNet', window );">Derivative fair value asset (liability)</a></td>
        <td class="nump">$ 23<span></span></td>
        <td class="nump">$ 93<span></span></td>
      </tr>
    </table>
    <div style="display: none;">
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeAssetsLiabilitiesAtFairValueNet">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Fair values as of the balance sheet date of the net amount of all assets and liabilities resulting from contracts that meet the criteria of being accounted for as derivative instruments.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 815<br><br> -SubTopic 10<br><br> -Section 45<br><br> -Paragraph 5<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6945355&amp;loc=d3e41228-113958<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_DerivativeAssetsLiabilitiesAtFairValueNet</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>debit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativesFairValueLineItems">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div>
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_DerivativesFairValueLineItems</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:stringItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
    </div>
  </body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>59
<FILENAME>R24.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
  <head>
    <META http-equiv="Content-Type" content="text/html; charset=us-ascii">
    <link rel="StyleSheet" type="text/css" href="report.css"><script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script></head>
  <body><span style="display: none;">v2.4.0.8</span><table class="report" border="0" cellspacing="2" id="ID0EME">
      <tr>
        <th class="tl" colspan="1" rowspan="2">
          <div style="width: 200px;"><strong>OTHER ACCOUNTS PAYABLE (Tables)<br></strong></div>
        </th>
        <th class="th" colspan="1">12 Months Ended</th>
      </tr>
      <tr>
        <th class="th">
          <div>Jun. 30, 2014</div>
        </th>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_psti_OtherAccountsPayableAbstract', window );"><strong>OTHER ACCOUNTS PAYABLE [Abstract]</strong></a></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock', window );">Schedule of Other Accounts Payable</a></td>
        <td class="text"><!--DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd" --><div> <div><!--StartFragment--> <div style="text-align: right"> <table style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman" cellspacing="0" cellpadding="0" width="97%"> <tr> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="76%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-WEIGHT: bold; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="22%" colspan="6"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"> June 30,</div> </td> <td style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-WEIGHT: bold; DISPLAY: inline"> &nbsp;</font> </td> <td style="PADDING-BOTTOM: 2px" valign="bottom"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> <tr> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="76%" align="left"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-WEIGHT: bold; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="10%" colspan="2"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"> 2014</div> </td> <td style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-WEIGHT: bold; DISPLAY: inline"> &nbsp;</font> </td> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-WEIGHT: bold; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="11%" colspan="4"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"> 2013</div> </td> </tr> <tr bgcolor="#cceeff"> <td valign="bottom" width="76%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"> Accrued payroll</div> </td> <td valign="bottom" width="1%" align="right"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%">$</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">424</td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%" align="right"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%">$</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">353</td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> <tr bgcolor="white"> <td valign="bottom" width="76%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"> Payroll institutions</div> </td> <td valign="bottom" width="1%" align="right"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">302</td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%" align="right"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">324</td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> <tr bgcolor="#cceeff"> <td valign="bottom" width="76%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"> Accrued vacation</div> </td> <td valign="bottom" width="1%" align="right"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">673</td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%" align="right"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">506</td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> <tr bgcolor="white"> <td valign="bottom" width="76%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"> Advanced payment from lessor</div> </td> <td valign="bottom" width="1%" align="right"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">89</td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%" align="right"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">89</td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> <tr bgcolor="#cceeff"> <td valign="bottom" width="76%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"> Derivatives designated as a fair value hedge instruments</div> </td> <td valign="bottom" width="1%" align="right"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">889</td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%" align="right"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">-</td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> <tr bgcolor="white"> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="76%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"> Other payables</div> </td> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%" align="right"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">14</td> <td style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%" align="right"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">-</td> <td style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> <tr bgcolor="#cceeff"> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="76%" align="left"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%">$</td> <td style="BORDER-BOTTOM: black 2px solid; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">2,391</td> <td style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%">$</td> <td style="BORDER-BOTTOM: black 2px solid; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">1,272</td> <td style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> </table> </div> <!--EndFragment--></div> </div><span></span></td>
      </tr>
    </table>
    <div style="display: none;">
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_psti_OtherAccountsPayableAbstract">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div>
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>psti_OtherAccountsPayableAbstract</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>psti_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:stringItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Tabular disclosure of the (a) carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business (accounts payable); (b) other payables; and (c) accrued liabilities. Examples include taxes, interest, rent and utilities. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer). An alternative caption includes accrued expenses.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>nonnum:textBlockItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
    </div>
  </body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>60
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/**
 * Rivet Software Inc.
 *
 * @copyright Copyright (c) 2006-2011 Rivet Software, Inc. All rights reserved.
 * Version 2.4.0.3
 *
 */

var Show = {};
Show.LastAR = null,

Show.hideAR = function(){
	Show.LastAR.style.display = 'none';
};

Show.showAR = function ( link, id, win ){
	if( Show.LastAR ){
		Show.hideAR();
	}

	var ref = link;
	do {
		ref = ref.nextSibling;
	} while (ref && ref.nodeName != 'TABLE');

	if (!ref || ref.nodeName != 'TABLE') {
		var tmp = win ?
			win.document.getElementById(id) :
			document.getElementById(id);

		if( tmp ){
			ref = tmp.cloneNode(true);
			ref.id = '';
			link.parentNode.appendChild(ref);
		}
	}

	if( ref ){
		ref.style.display = 'block';
		Show.LastAR = ref;
	}
};

Show.toggleNext = function( link ){
	var ref = link;

	do{
		ref = ref.nextSibling;
	}while( ref.nodeName != 'DIV' );

	if( ref.style &&
		ref.style.display &&
		ref.style.display == 'none' ){
		ref.style.display = 'block';

		if( link.textContent ){
			link.textContent = link.textContent.replace( '+', '-' );
		}else{
			link.innerText = link.innerText.replace( '+', '-' );
		}
	}else{
		ref.style.display = 'none';

		if( link.textContent ){
			link.textContent = link.textContent.replace( '-', '+' );
		}else{
			link.innerText = link.innerText.replace( '-', '+' );
		}
	}
};
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>61
<FILENAME>R7.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
  <head>
    <META http-equiv="Content-Type" content="text/html; charset=us-ascii">
    <link rel="StyleSheet" type="text/css" href="report.css"><script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script></head>
  <body><span style="display: none;">v2.4.0.8</span><table class="report" border="0" cellspacing="2" id="ID0EGH">
      <tr>
        <th class="tl" colspan="1" rowspan="2">
          <div style="width: 200px;"><strong>STATEMENTS OF CHANGES IN EQUITY (Parenthetical) (USD $)<br>In Thousands, unless otherwise specified</strong></div>
        </th>
        <th class="th" colspan="2">12 Months Ended</th>
      </tr>
      <tr>
        <th class="th">
          <div>Jun. 30, 2014</div>
        </th>
        <th class="th">
          <div>Jun. 30, 2013</div>
        </th>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementOfStockholdersEquityAbstract', window );"><strong>STATEMENTS OF CHANGES IN EQUITY [Abstract]</strong></a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts', window );">Issuance of common stock and warrants, issuance costs</a></td>
        <td class="nump">$ 195<span></span></td>
        <td class="nump">$ 2,694<span></span></td>
      </tr>
    </table>
    <div style="display: none;">
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Amount of decrease in additional paid in capital (APIC) resulting from direct costs associated with issuing stock. Includes, but is not limited to, legal and accounting fees and direct costs associated with stock issues under a shelf registration.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 505<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 2<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6928386&amp;loc=d3e21463-112644<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 505<br><br> -SubTopic 10<br><br> -Section S99<br><br> -Paragraph 1<br><br> -Subparagraph (SX 210.3-04)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=27012166&amp;loc=d3e187085-122770<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>debit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementOfStockholdersEquityAbstract">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div>
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_StatementOfStockholdersEquityAbstract</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:stringItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
    </div>
  </body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>62
<FILENAME>R3.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
  <head>
    <META http-equiv="Content-Type" content="text/html; charset=us-ascii">
    <link rel="StyleSheet" type="text/css" href="report.css"><script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script></head>
  <body><span style="display: none;">v2.4.0.8</span><table class="report" border="0" cellspacing="2" id="ID0E6FAC">
      <tr>
        <th class="tl" colspan="1" rowspan="1">
          <div style="width: 200px;"><strong>CONSOLIDATED BALANCE SHEETS (PARENTHETICAL) (USD $)<br></strong></div>
        </th>
        <th class="th">
          <div>Jun. 30, 2014</div>
        </th>
        <th class="th">
          <div>Jun. 30, 2013</div>
        </th>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementOfFinancialPositionAbstract', window );"><strong>CONSOLIDATED BALANCE SHEETS [Abstract]</strong></a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockParOrStatedValuePerShare', window );">Common stock, par value per share</a></td>
        <td class="nump">$ 0.00001<span></span></td>
        <td class="nump">$ 0.00001<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesAuthorized', window );">Common stock, shares authorized</a></td>
        <td class="nump">200,000,000<span></span></td>
        <td class="nump">200,000,000<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesIssued', window );">Common stock, shares issued</a></td>
        <td class="nump">68,601,452<span></span></td>
        <td class="nump">59,196,617<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Common stock, shares outstanding</a></td>
        <td class="nump">68,601,452<span></span></td>
        <td class="nump">59,196,617<span></span></td>
      </tr>
    </table>
    <div style="display: none;">
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockParOrStatedValuePerShare">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Face amount or stated value per share of common stock.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 210<br><br> -SubTopic 10<br><br> -Section S99<br><br> -Paragraph 1<br><br> -Subparagraph (SX 210.5-02.29)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher SEC<br><br> -Name Regulation S-X (SX)<br><br> -Number 210<br><br> -Section 02<br><br> -Paragraph 30<br><br> -Article 5<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_CommonStockParOrStatedValuePerShare</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>num:perShareItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesAuthorized">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The maximum number of common shares permitted to be issued by an entity's charter and bylaws.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 210<br><br> -SubTopic 10<br><br> -Section S99<br><br> -Paragraph 1<br><br> -Subparagraph (SX 210.5-02.29)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher SEC<br><br> -Name Regulation S-X (SX)<br><br> -Number 210<br><br> -Section 02<br><br> -Paragraph 30<br><br> -Article 5<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_CommonStockSharesAuthorized</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:sharesItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesIssued">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 210<br><br> -SubTopic 10<br><br> -Section S99<br><br> -Paragraph 1<br><br> -Subparagraph (SX 210.5-02.29)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher SEC<br><br> -Name Regulation S-X (SX)<br><br> -Number 210<br><br> -Section 02<br><br> -Paragraph 30<br><br> -Article 5<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_CommonStockSharesIssued</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:sharesItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesOutstanding">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher SEC<br><br> -Name Regulation S-X (SX)<br><br> -Number 210<br><br> -Section 04<br><br> -Article 3<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 505<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 2<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6928386&amp;loc=d3e21463-112644<br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 505<br><br> -SubTopic 10<br><br> -Section S99<br><br> -Paragraph 1<br><br> -Subparagraph (SX 210.3-04)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=27012166&amp;loc=d3e187085-122770<br><br><br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 210<br><br> -SubTopic 10<br><br> -Section S99<br><br> -Paragraph 1<br><br> -Subparagraph (SX 210.5-02.29)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br><br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher SEC<br><br> -Name Regulation S-X (SX)<br><br> -Number 210<br><br> -Section 02<br><br> -Paragraph 30<br><br> -Article 5<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_CommonStockSharesOutstanding</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:sharesItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementOfFinancialPositionAbstract">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div>
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_StatementOfFinancialPositionAbstract</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:stringItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
    </div>
  </body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>63
<FILENAME>R17.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
  <head>
    <META http-equiv="Content-Type" content="text/html; charset=us-ascii">
    <link rel="StyleSheet" type="text/css" href="report.css"><script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script></head>
  <body><span style="display: none;">v2.4.0.8</span><table class="report" border="0" cellspacing="2" id="ID0EME">
      <tr>
        <th class="tl" colspan="1" rowspan="2">
          <div style="width: 200px;"><strong>FINANCIAL INCOME, NET<br></strong></div>
        </th>
        <th class="th" colspan="1">12 Months Ended</th>
      </tr>
      <tr>
        <th class="th">
          <div>Jun. 30, 2014</div>
        </th>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherIncomeAndExpensesAbstract', window );"><strong>FINANCIAL INCOME, NET [Abstract]</strong></a></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherIncomeAndOtherExpenseDisclosureTextBlock', window );">FINANCIAL INCOME, NET</a></td>
        <td class="text"><!--DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd" --><div> <div><!--StartFragment--> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: left; TEXT-INDENT: 0pt"> NOTE 9:-FINANCIAL INCOME, NET</div> <div style="DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> &nbsp;</div> <div style="text-align: left"> <table style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman" cellspacing="0" cellpadding="0" width="80%"> <tr> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="64%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-WEIGHT: bold; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="34%" colspan="10"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: -9pt"> Year ended June 30,</div> </td> <td style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-WEIGHT: bold; DISPLAY: inline"> &nbsp;</font> </td> </tr> <tr> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="64%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%" align="right"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-WEIGHT: bold; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: center; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt" valign="bottom" width="10%" colspan="2"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: center; TEXT-INDENT: 0pt"> 2014</div> </td> <td style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-WEIGHT: bold; DISPLAY: inline"> &nbsp;</font> </td> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%" align="right"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-WEIGHT: bold; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: center; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt" valign="bottom" width="10%" colspan="2"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: center; TEXT-INDENT: 0pt"> 2013</div> </td> <td style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-WEIGHT: bold; DISPLAY: inline"> &nbsp;</font> </td> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-WEIGHT: bold; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="10%" colspan="2"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 7.45pt; text-align: center; TEXT-INDENT: 0pt"> 2012</div> </td> <td style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-WEIGHT: bold; DISPLAY: inline"> &nbsp;</font> </td> </tr> <tr> <td valign="bottom" width="64%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="10%" colspan="2"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="10%" colspan="2"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="10%" colspan="2"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> <tr bgcolor="#cceeff"> <td style="TEXT-ALIGN: left; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt" valign="bottom" width="64%"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: left; TEXT-INDENT: 0pt"> Foreign currency translation differences, net</div> </td> <td valign="bottom" width="1%" align="right"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%">$</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">407</td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%" align="right"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%">$</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">497</td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%" align="right"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%">$</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">(98</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap">)</td> </tr> <tr bgcolor="white"> <td valign="bottom" width="64%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 9pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: -9pt"> Bank commissions</div> </td> <td valign="bottom" width="1%" align="right"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">(36</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap">)</td> <td valign="bottom" width="1%" align="right"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">(29</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap">)</td> <td valign="bottom" width="1%" align="right"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">(12</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap">)</td> </tr> <tr bgcolor="#cceeff"> <td valign="bottom" width="64%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 9pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: -9pt"> Interest income on deposits</div> </td> <td valign="bottom" width="1%" align="right"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">246</td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%" align="right"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">539</td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%" align="right"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">575</td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> <tr bgcolor="white"> <td valign="bottom" width="64%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 9pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: -9pt"> Gain (Loss) related to marketable securities</div> </td> <td valign="bottom" width="1%" align="right"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">384</td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%" align="right"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">(79</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap">)</td> <td valign="bottom" width="1%" align="right"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">89</td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> <tr bgcolor="#cceeff"> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="64%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 9pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: -9pt"> Gain (loss) from&nbsp;&nbsp;derivatives</div> </td> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%" align="right"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">(83</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap">)</td> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%" align="right"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">140</td> <td style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%" align="right"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">(317</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap">)</td> </tr> <tr bgcolor="white"> <td valign="bottom" width="64%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: right" valign="bottom" width="9%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: right" valign="bottom" width="9%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: right" valign="bottom" width="9%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> <tr bgcolor="#cceeff"> <td style="PADDING-BOTTOM: 4px" valign="bottom" width="64%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="PADDING-BOTTOM: 4px" valign="bottom" width="1%" align="right"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 4px double; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%">$</td> <td style="BORDER-BOTTOM: black 4px double; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">918</td> <td style="PADDING-BOTTOM: 4px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="PADDING-BOTTOM: 4px" valign="bottom" width="1%" align="right"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 4px double; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%">$</td> <td style="BORDER-BOTTOM: black 4px double; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">1,068</td> <td style="PADDING-BOTTOM: 4px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="PADDING-BOTTOM: 4px" valign="bottom" width="1%" align="right"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 4px double; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%">$</td> <td style="BORDER-BOTTOM: black 4px double; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">237</td> <td style="PADDING-BOTTOM: 4px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> </table> </div> <!--EndFragment--></div> </div><span></span></td>
      </tr>
    </table>
    <div style="display: none;">
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherIncomeAndExpensesAbstract">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div>
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_OtherIncomeAndExpensesAbstract</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:stringItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherIncomeAndOtherExpenseDisclosureTextBlock">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The entire disclosure for other income or other expense items (both operating and nonoperating). Sources of nonoperating income or nonoperating expense that may be disclosed, include amounts earned from dividends, interest on securities, profits (losses) on securities, net and miscellaneous other income or income deductions.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 225<br><br> -SubTopic 10<br><br> -Section S99<br><br> -Paragraph 2<br><br> -Subparagraph (SX 210.5-03.3,6,7,9)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=26872669&amp;loc=d3e20235-122688<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher SEC<br><br> -Name Regulation S-X (SX)<br><br> -Number 210<br><br> -Section 03<br><br> -Paragraph 3, 6, 7, 9<br><br> -Article 5<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_OtherIncomeAndOtherExpenseDisclosureTextBlock</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>nonnum:textBlockItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
    </div>
  </body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>64
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
  <head>
    <META http-equiv="Content-Type" content="text/html; charset=us-ascii">
    <link rel="StyleSheet" type="text/css" href="report.css"><script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script></head>
  <body><span style="display: none;">v2.4.0.8</span><table class="report" border="0" cellspacing="2" id="ID0EHPAE">
      <tr>
        <th class="tl" colspan="1" rowspan="2">
          <div style="width: 200px;"><strong>Document and Entity Information (USD $)<br></strong></div>
        </th>
        <th class="th" colspan="1">12 Months Ended</th>
        <th class="th" colspan="1"></th>
        <th class="th" colspan="1"></th>
      </tr>
      <tr>
        <th class="th">
          <div>Jun. 30, 2014</div>
        </th>
        <th class="th">
          <div>Sep. 02, 2014</div>
        </th>
        <th class="th">
          <div>Dec. 31, 2013</div>
        </th>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
        <td class="text">10-K<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
        <td class="text">false<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document Period End Date</a></td>
        <td class="text">Jun. 30,
				 2014<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
        <td class="text">PLURISTEM THERAPEUTICS INC<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
        <td class="text">0001158780<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_CurrentFiscalYearEndDate', window );">Current Fiscal Year End Date</a></td>
        <td class="text">--06-30<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentFiscalYearFocus', window );">Document Fiscal Year Focus</a></td>
        <td class="text">2014<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentFiscalPeriodFocus', window );">Document Fiscal Period Focus</a></td>
        <td class="text">FY<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityFilerCategory', window );">Entity Filer Category</a></td>
        <td class="text">Accelerated Filer<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityCommonStockSharesOutstanding', window );">Entity Common Stock, Shares Outstanding</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">69,278,512<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityPublicFloat', window );">Entity Public Float</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">$ 214,202,402<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityVoluntaryFilers', window );">Entity Voluntary Filers</a></td>
        <td class="text">No<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityWellKnownSeasonedIssuer', window );">Entity Well-known Seasoned Issuer</a></td>
        <td class="text">No<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityCurrentReportingStatus', window );">Entity Current Reporting Status</a></td>
        <td class="text">Yes<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
    </table>
    <div style="display: none;">
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>If the value is true, then the document is an amendment to previously-filed/accepted document.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>dei_AmendmentFlag</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>dei_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:booleanItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CurrentFiscalYearEndDate">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>End date of current fiscal year in the format --MM-DD.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>dei_CurrentFiscalYearEndDate</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>dei_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:gMonthDayItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentFiscalPeriodFocus">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>This is focus fiscal period of the document report. For a first quarter 2006 quarterly report, which may also provide financial information from prior periods, the first fiscal quarter should be given as the fiscal period focus. Values: FY, Q1, Q2, Q3, Q4, H1, H2, M9, T1, T2, T3, M8, CY.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>dei_DocumentFiscalPeriodFocus</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>dei_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>dei:fiscalPeriodItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentFiscalYearFocus">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>This is focus fiscal year of the document report in CCYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>dei_DocumentFiscalYearFocus</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>dei_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:gYearItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The end date of the period reflected on the cover page if a periodic report. For all other reports and registration statements containing historical data, it is the date up through which that historical data is presented.  If there is no historical data in the report, use the filing date. The format of the date is CCYY-MM-DD.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>dei_DocumentPeriodEndDate</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>dei_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:dateItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word "Other".</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>dei_DocumentType</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>dei_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>dei:submissionTypeItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher SEC<br><br> -Name Regulation 12B<br><br> -Number 240<br><br> -Section 12b<br><br> -Subsection 1<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>dei_EntityCentralIndexKey</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>dei_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>dei:centralIndexKeyItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCommonStockSharesOutstanding">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>dei_EntityCommonStockSharesOutstanding</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>dei_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:sharesItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCurrentReportingStatus">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Indicate "Yes" or "No" whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>dei_EntityCurrentReportingStatus</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>dei_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>dei:yesNoItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFilerCategory">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Indicate whether the registrant is one of the following: (1) Large Accelerated Filer, (2) Accelerated Filer, (3) Non-accelerated Filer, (4) Smaller Reporting Company (Non-accelerated) or (5) Smaller Reporting Accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>dei_EntityFilerCategory</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>dei_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>dei:filerCategoryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityPublicFloat">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>State aggregate market value of voting and non-voting common equity held by non-affiliates computed by reference to price at which the common equity was last sold, or average bid and asked price of such common equity, as of the last business day of registrant's most recently completed second fiscal quarter. The public float should be reported on the cover page of the registrants form 10K.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>dei_EntityPublicFloat</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>dei_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>credit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher SEC<br><br> -Name Regulation 12B<br><br> -Number 240<br><br> -Section 12b<br><br> -Subsection 1<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>dei_EntityRegistrantName</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>dei_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:normalizedStringItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityVoluntaryFilers">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Indicate "Yes" or "No" if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>dei_EntityVoluntaryFilers</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>dei_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>dei:yesNoItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityWellKnownSeasonedIssuer">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Indicate "Yes" or "No" if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Is used on Form Type: 10-K, 10-Q, 8-K, 20-F, 6-K, 10-K/A, 10-Q/A, 20-F/A, 6-K/A, N-CSR, N-Q, N-1A.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>dei_EntityWellKnownSeasonedIssuer</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>dei_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>dei:yesNoItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
    </div>
  </body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>65
<FILENAME>R18.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
  <head>
    <META http-equiv="Content-Type" content="text/html; charset=us-ascii">
    <link rel="StyleSheet" type="text/css" href="report.css"><script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script></head>
  <body><span style="display: none;">v2.4.0.8</span><table class="report" border="0" cellspacing="2" id="ID0EME">
      <tr>
        <th class="tl" colspan="1" rowspan="2">
          <div style="width: 200px;"><strong>TAXES ON INCOME<br></strong></div>
        </th>
        <th class="th" colspan="1">12 Months Ended</th>
      </tr>
      <tr>
        <th class="th">
          <div>Jun. 30, 2014</div>
        </th>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureAbstract', window );"><strong>TAXES ON INCOME [Abstract]</strong></a></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureTextBlock', window );">TAXES ON INCOME</a></td>
        <td class="text"><!--DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd" --><div> <div><!--StartFragment--> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: left; TEXT-INDENT: 0pt"> NOTE 10:-TAXES ON INCOME</div> <div style="DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> &nbsp;</div> <div> <table style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman" cellspacing="0" cellpadding="0" width="100%" align="center" border="0"> <tr valign="top"> <td style="WIDTH: 27pt"> <div style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt"> A.</div> </td> <td> <div style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; text-align: justify"> Tax laws applicable to the companies:</div> </td> </tr> </table> </div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /> </div> <div> <table style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman" cellspacing="0" cellpadding="0" width="100%" align="center" border="0"> <tr valign="top"> <td style="WIDTH: 27pt"> <div style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; DISPLAY: inline"> &nbsp;</div> </td> <td style="WIDTH: 18pt"> <div style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt"> 1.</div> </td> <td> <div style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; text-align: justify"> Pluristem Therapeutics Inc. is taxed under U.S. tax laws.</div> </td> </tr> </table> </div> <div> <table style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman" cellspacing="0" cellpadding="0" width="100%" align="center" border="0"> <tr valign="top"> <td style="WIDTH: 27pt"> <div style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; DISPLAY: inline"> &nbsp;</div> </td> <td style="WIDTH: 18pt"> <div style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt"> 2.</div> </td> <td> <div style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; text-align: justify"> Pluristem Ltd. is taxed under Israeli tax laws.</div> </td> </tr> </table> </div> <div style="DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> &nbsp;</div> <div> <table style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman" cellspacing="0" cellpadding="0" width="100%" align="center" border="0"> <tr valign="top"> <td style="WIDTH: 27pt"> <div style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt"> B.</div> </td> <td> <div style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; text-align: justify"> Tax assessments:</div> </td> </tr> </table> </div> <div style="DISPLAY: block; TEXT-INDENT: 0pt">&nbsp;</div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; MARGIN-LEFT: 27pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> The Subsidiary has not received final tax assessments since its incorporation; however, the assessments of the Subsidiary are deemed final through 2009.</div> <div style="DISPLAY: block; MARGIN-LEFT: 27pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> &nbsp;</div> <div> <table style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman" cellspacing="0" cellpadding="0" width="100%" align="center" border="0"> <tr valign="top"> <td style="WIDTH: 27pt"> <div style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt"> C.</div> </td> <td> <div style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; text-align: justify"> Tax rates applicable to the Company:-</div> </td> </tr> </table> </div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /> </div> <div> <table style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman" cellspacing="0" cellpadding="0" width="100%" align="center" border="0"> <tr valign="top"> <td style="WIDTH: 28.349pt"> <div style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; DISPLAY: inline"> &nbsp;</div> </td> <td style="WIDTH: 18pt"> <div style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt"> 1.</div> </td> <td> <div style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; text-align: justify"> Pluristem Therapeutics Inc.:</div> </td> </tr> </table> </div> <div style="DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> &nbsp;</div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; MARGIN-LEFT: 45pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> The tax rates applicable to Pluristem Therapeutics Inc., a Nevada corporation, are corporate (progressive) tax at the rate of up to 35%, excluding state tax and local tax if any, which rates depend on the state and city in which Pluristem Therapeutics Inc. conducts its business.</div> <div style="DISPLAY: block; MARGIN-LEFT: 45pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> &nbsp;</div> <div> <table style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman" cellspacing="0" cellpadding="0" width="100%" align="center" border="0"> <tr valign="top"> <td style="WIDTH: 28.349pt"> <div style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; DISPLAY: inline"> &nbsp;</div> </td> <td style="WIDTH: 18pt"> <div style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt"> 2.</div> </td> <td> <div style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; text-align: justify"> The Subsidiary:</div> </td> </tr> </table> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; MARGIN-LEFT: 45pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"> &nbsp;</div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; MARGIN-LEFT: 45pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"> Taxable income of Israeli companies is subject to tax at the rate of 25% in 2012, 2013 and 26.5% in 2014.</div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; MARGIN-LEFT: 27pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> Tax Benefits Under the Law for Encouragement of Capital Investments.</div> <div style="DISPLAY: block; MARGIN-LEFT: 437pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> &nbsp;</div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; MARGIN-LEFT: 27pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> According to the Law for Encouragement of Capital Investments, 1959 (the "Encouragement Law"), the Subsidiary is entitled to various tax benefits due to "Beneficiary Enterprise" status granted to its enterprise, as implied by the Encouragement Law. The principal benefits by virtue of the Encouragement Law are:</div> <div style="DISPLAY: block; MARGIN-LEFT: 27pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> &nbsp;</div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-STYLE: italic; MARGIN-LEFT: 27pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> Tax benefits and reduced tax rates:</div> <div style="DISPLAY: block; MARGIN-LEFT: 437pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> &nbsp;</div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; MARGIN-LEFT: 27pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> On July 7, 2010, the Subsidiary has received a letter of approval (the "Ruling") from the Israeli Tax Authority. According to the Ruling, the Subsidiary&#39;s expansion program of its plant was granted the status of a "Beneficiary Enterprise" under the "Alternative Track" (the "2007 Program"). The Subsidiary chose the year 2007 as the election year of the 2007 Program.</div> <div style="MARGIN-LEFT: 437pt; DISPLAY: block; TEXT-INDENT: 0pt"> <br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; MARGIN-LEFT: 27pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> Under the 2007 Program "Alternative Track", the Subsidiary, which was located in a National Priority Zone "B" with respect to the year 2007, is tax exempt in the first six years of the benefit period and subject to tax at the reduced rate of 10%-25% for a period of one to four years for the remaining benefit period (dependent on the level of foreign investments).</div> <div style="MARGIN-LEFT: 437pt; DISPLAY: block; TEXT-INDENT: 0pt"> <br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; MARGIN-LEFT: 27pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> On June 6, 2013, the Subsidiary informed the Israeli Tax Authority that it has chosen the year 2012 as an election year to the expansion of its Beneficiary Enterprise program (the "2012 Program").</div> <div style="MARGIN-LEFT: 437pt; DISPLAY: block; TEXT-INDENT: 0pt"> <br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; MARGIN-LEFT: 27pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> Under the 2012 Program, the Subsidiary, which was located in the "Other National Priority Zone" with respect to the year 2012, would be tax exempt in the first two years of the benefit period and subject to tax at the reduced rate of 10%-25% for a period of five to eight years for the remaining benefit period (dependent on the level of foreign investments).</div> <div style="MARGIN-LEFT: 437pt; DISPLAY: block; TEXT-INDENT: 0pt"> <br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; MARGIN-LEFT: 27pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> Following the enactment of Amendment No. 60 to the Encouragement<font style="FONT-WEIGHT: bold; DISPLAY: inline">&nbsp;</font> Law, subsequent to April 1, 2005, companies whose election year entitled them to a Beneficiary Enterprise status are required, among others, to make a minimum qualifying investment. This condition requires an investment in the acquisition of productive assets such as machinery and equipment, which must be carried out within three years. The minimum qualifying investment required for setting up a plant is NIS&nbsp;300,000, linked to the Israeli CPI in accordance with the guidelines of the Israeli tax authorities. As for plant expansion, the minimum qualifying investment is the higher of NIS&nbsp;300,000, linked to the Israeli CPI as stated above, and an amount equivalent to the "qualifying percentage" of the value of the productive assets. Productive assets that are used by the plant but not owned by it will also be viewed as productive assets.</div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; MARGIN-LEFT: 27pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> The qualifying percentage of the value of the productive assets is as follows:</div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /> </div> <div style="MARGIN-LEFT: 27pt; text-align: center"> <table style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman" cellspacing="0" cellpadding="0" width="60%"> <tr> <td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="49%"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"> The value of productive</div> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"> assets before the expansion</div> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"> (NIS in millions)</div> </td> <td valign="top" width="2%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid" valign="top" width="49%"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"> The new proportion</div> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"> that the required</div> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"> &nbsp;investment bears</div> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"> to the value of</div> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"> productive assets</div> </td> </tr> <tr> <td valign="top" width="49%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="top" width="2%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="top" width="49%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> <tr bgcolor="#cceeff"> <td style="TEXT-ALIGN: left; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt" valign="top" width="49%"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: left; TEXT-INDENT: 0pt"> Up to NIS&nbsp;140</div> </td> <td valign="top" width="2%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="top" width="49%"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"> 12%</div> </td> </tr> <tr bgcolor="white"> <td style="TEXT-ALIGN: left; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt" valign="top" width="49%"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: left; TEXT-INDENT: 0pt"> NIS&nbsp;140 - NIS&nbsp;500</div> </td> <td valign="top" width="2%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="top" width="49%"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"> 7%</div> </td> </tr> <tr bgcolor="#cceeff"> <td style="TEXT-ALIGN: left; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt" valign="top" width="49%"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: left; TEXT-INDENT: 0pt"> More than NIS&nbsp;500</div> </td> <td valign="top" width="2%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="top" width="49%"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"> 5%</div> </td> </tr> </table> </div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; MARGIN-LEFT: 27pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> The income qualifying for tax benefits under the alternative track is the taxable income of a "beneficiary company" that has met certain conditions as determined by the Encouragement<font style="FONT-WEIGHT: bold; DISPLAY: inline">&nbsp;</font> Law, and which is derived from an industrial enterprise. The Encouragement<font style="FONT-WEIGHT: bold; DISPLAY: inline">&nbsp;</font> Law specifies the types of qualifying income that is entitled to tax benefits under the alternative track both in respect of an industrial enterprise and of a hotel, whereby income from an industrial enterprise includes, among others, revenues from the production and development of software products and revenues from industrial research and development activities performed for a foreign resident (and approved by the Head of the Administration of Industrial Research and Development).</div> <div style="MARGIN-LEFT: 437pt; DISPLAY: block; TEXT-INDENT: 0pt"> <br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; MARGIN-LEFT: 27pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> As stated above, the Subsidiary&#39;s 2007 Program and 2012 Program were granted the status of a "Beneficiary Enterprise", in accordance with the Encouragement<font style="FONT-WEIGHT: bold; DISPLAY: inline">&nbsp;</font> Law, under the alternative benefits track. Accordingly, income derived from the Beneficiary Enterprise is subject to the benefits and conditions stated above.</div> <div style="MARGIN-LEFT: 437pt; DISPLAY: block; TEXT-INDENT: 0pt"> <br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; MARGIN-LEFT: 27pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> In respect of expansion programs pursuant to Amendment No. 60 to the Encouragement<font style="FONT-WEIGHT: bold; DISPLAY: inline">&nbsp;</font> Law, the benefit period starts at the later of the election year and the first year the Company earns taxable income provided that 12 years have not passed since the beginning of the election year and for companies in development area A - 14 years since the beginning of the election year. The benefit period for the Subsidiary&#39;s 2007 Program will expire in 2018 (12 years since the beginning of the election year- 2007).The benefit period for the Subsidiary&#39;s 2012 Program would expire in 2023 (12 years since the beginning of the election year - 2012).</div> <div style="MARGIN-LEFT: 437pt; DISPLAY: block; TEXT-INDENT: 0pt"> <br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; MARGIN-LEFT: 27pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> If a dividend is distributed out of tax exempt profits, as above, the Subsidiary will become liable for tax at the rate applicable to its profits from the Beneficiary Enterprise in the year in which the income was earned, (tax at the rate of 10- 25%, dependent on the level of foreign investments) and to A withholding tax rate of 15% (or lower, under an applicable tax treaty).</div> <div style="MARGIN-LEFT: 437pt; DISPLAY: block; TEXT-INDENT: 0pt"> <br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; MARGIN-LEFT: 27pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> As for Beneficiary Enterprises pursuant to Amendment No. 60 to the Encouragement<font style="FONT-WEIGHT: bold; DISPLAY: inline">&nbsp;</font> Law, the basic condition for receiving the benefits under this track is that the enterprise contributes to Israeli economic growth and is a competitive factor for the gross domestic product. In order to comply with this condition, the Encouragement<font style="FONT-WEIGHT: bold; DISPLAY: inline">&nbsp;</font> Law prescribes various requirements regarding industrial enterprises.</div> <div style="MARGIN-LEFT: 437pt; DISPLAY: block; TEXT-INDENT: 0pt"> <br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; MARGIN-LEFT: 27pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> As for industrial enterprises, in each tax year during the benefit period, one of the following conditions must be met:</div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /> </div> <div> <table style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman" cellspacing="0" cellpadding="0" width="100%" align="center" border="0"> <tr valign="top"> <td style="WIDTH: 27pt"> <div style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; DISPLAY: inline"> &nbsp;</div> </td> <td style="WIDTH: 18pt"> <div style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt"> 1.</div> </td> <td> <div style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; text-align: justify"> The industrial enterprise&#39;s main field of activity is biotechnology or nanotechnology as approved by the Head of the Administration of Industrial Research and Development, prior to the approval of the relevant program.</div> </td> </tr> </table> </div> <div> <table style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman" cellspacing="0" cellpadding="0" width="100%" align="center" border="0"> <tr valign="top"> <td style="WIDTH: 27pt"> <div style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; DISPLAY: inline"> &nbsp;</div> </td> <td style="WIDTH: 18pt"> <div style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt"> 2.</div> </td> <td> <div style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; text-align: justify"> The industrial enterprise&#39;s sales revenues in a specific market during the tax year do not exceed 75% of its total sales for that tax year. A "market" is defined as a separate country or customs territory.</div> </td> </tr> </table> </div> <div> <table style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman" cellspacing="0" cellpadding="0" width="100%" align="center" border="0"> <tr valign="top"> <td style="WIDTH: 27pt"> <div style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; DISPLAY: inline"> &nbsp;</div> </td> <td style="WIDTH: 18pt"> <div style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt"> 3.</div> </td> <td> <div style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; text-align: justify"> At least 25% of the industrial enterprise&#39;s overall revenues during the tax year were generated from the enterprise&#39;s sales in a specific market with a population of at least 12 million.</div> </td> </tr> </table> </div> <div style="DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> &nbsp;</div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-STYLE: italic; MARGIN-LEFT: 27pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> Accelerated depreciation:</div> <div style="MARGIN-LEFT: 437pt; DISPLAY: block; TEXT-INDENT: 0pt"> <br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; MARGIN-LEFT: 27pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> The Subsidiary is eligible for deduction of accelerated depreciation on buildings, machinery and equipment used by the beneficiary enterprise at a rate of 200% (or 400% for buildings) from the first year of the asset&#39;s operation.</div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-STYLE: italic; MARGIN-LEFT: 27pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> Conditions for the entitlement to the benefits:</div> <div style="MARGIN-LEFT: 437pt; DISPLAY: block; TEXT-INDENT: 0pt"> <br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; MARGIN-LEFT: 27pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> The abovementioned benefits are conditional upon the fulfillment of the conditions stipulated by the Encouragement<font style="FONT-WEIGHT: bold; DISPLAY: inline">&nbsp;</font> Law, regulations promulgated thereunder, and the Ruling with respect to the beneficiary enterprise. Non-compliance with the conditions may cancel all or part of the benefits and refund of the amount of the benefits, including interest. The management believes that the Subsidiary is meeting the aforementioned conditions.</div> <div style="MARGIN-LEFT: 437pt; DISPLAY: block; TEXT-INDENT: 0pt"> <br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-STYLE: italic; MARGIN-LEFT: 27pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> Amendment to the&nbsp;&nbsp;Encouragement Law:</div> <div style="MARGIN-LEFT: 437pt; DISPLAY: block; TEXT-INDENT: 0pt"> <br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; MARGIN-LEFT: 27pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> Effective January 2011, the Knesset (Israeli parliament) enacted a reform to the Encouragement Law. According to the reform a flat rate tax would apply to companies eligible for the "Preferred Enterprise" status. In order to be eligible for a Preferred Enterprise status, a company must meet minimum requirements to establish that it contributes to the country&#39;s economic growth and is a competitive factor for the Gross Domestic Product (a competitive enterprise).</div> <div style="MARGIN-LEFT: 437pt; DISPLAY: block; TEXT-INDENT: 0pt"> <br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; MARGIN-LEFT: 27pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> Israeli companies which currently benefit from an Approved or Privileged Enterprise status and meet the criteria for qualification as a Preferred Enterprise can elect to apply the new Preferred Enterprise benefits by waiving their benefits under the Approved and Privileged Enterprise status.</div> <div style="MARGIN-LEFT: 437pt; DISPLAY: block; TEXT-INDENT: 0pt"> <br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; MARGIN-LEFT: 27pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> Benefits granted to a Preferred Enterprise include reduced tax rates. Following the enactment of the National Priorities Law, effective January 1, 2014, the reduced tax rate is 9% in the Development Area A regions and 16% in other regions. Preferred Enterprises in peripheral regions are also eligible for Investment Center grants, as well as the applicable reduced tax rates.</div> <div style="MARGIN-LEFT: 437pt; DISPLAY: block; TEXT-INDENT: 0pt"> <br /> </div> <div style="TEXT-ALIGN: justify; MARGIN-LEFT: 27pt; DISPLAY: block; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt"> <font style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; DISPLAY: inline"> A distribution from a Preferred Enterprise out of the "Preferred Income" through December 31, 2013, was</font> <font style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; DISPLAY: inline"> subject to 15% withholding tax for Israeli-resident individuals and non-Israeli residents (subject to applicable treaty rates) and effective January 1, 2014, subject to 20% withholding tax for Israeli-resident individuals and non-Israeli residents (subject to applicable treaty rates).</font></div> <div style="MARGIN-LEFT: 437pt; DISPLAY: block; TEXT-INDENT: 0pt"> <br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; MARGIN-LEFT: 27pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> A distribution from a Preferred Enterprise out of the "Preferred Income" would be exempt from withholding tax for an Israeli-resident company.</div> <div style="MARGIN-LEFT: 437pt; DISPLAY: block; TEXT-INDENT: 0pt"> <br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; MARGIN-LEFT: 27pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> The Subsidiary did not apply the Amendment. The Subsidiary may choose to apply the Amendment in the future <font style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; DISPLAY: inline"> .</font></div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /> </div> <div style="text-align: justify"> <table style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman" cellspacing="0" cellpadding="0" width="100%" border="0"> <tr valign="top"> <td style="WIDTH: 27pt" align="right"> <div style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; text-align: justify"> D.&nbsp;</div> </td> <td align="left"> <div style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; text-align: justify"> Carryforward losses for tax purposes</div> </td> </tr> </table> </div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; MARGIN-LEFT: 27pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> As of June&nbsp;30, 2014, the Company had U.S. federal net operating loss carryforward for income tax purposes in the amount of approximately $22,730. Net operating loss carryforward arising in taxable years<font style="FONT-SIZE: 10pt; DISPLAY: inline">,</font> can be carried forward and offset against taxable income for 20 years and expiring between 2022 and 2034.</div> <div style="MARGIN-LEFT: 437pt; DISPLAY: block; TEXT-INDENT: 0pt"> <br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; MARGIN-LEFT: 27pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> Utilization of U.S. net operating losses may be subject to substantial annual limitations due to the "change in ownership" provisions of the Internal Revenue Code of 1986 and similar state provisions. The annual limitation may result in the expiration of net operating losses before utilization.</div> <div style="MARGIN-LEFT: 437pt; DISPLAY: block; TEXT-INDENT: 0pt"> <br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; MARGIN-LEFT: 27pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> The Subsidiary in Israel has accumulated losses for tax purposes as of June&nbsp;30, 2014, in the amount of approximately $48,340, which may be carried forward and offset against taxable business income and business capital gain in the future for an indefinite period.</div> <div style="MARGIN-LEFT: 437pt; DISPLAY: block; TEXT-INDENT: 0pt"> <br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; MARGIN-LEFT: 27pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> Deferred income taxes:</div> <div style="MARGIN-LEFT: 437pt; DISPLAY: block; TEXT-INDENT: 0pt"> <br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; MARGIN-LEFT: 27pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> Deferred income taxes reflect the net tax effects of temporary differences between the carrying amounts of assets and liabilities for financial reporting purposes and the amounts used for income tax purposes. Significant components of the Company&#39;s deferred tax assets are as follows:</div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /> </div> <div style="text-align: right"> <table style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman" cellspacing="0" cellpadding="0" width="95%"> <tr> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="76%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-WEIGHT: bold; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="22%" colspan="6"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"> June 30,</div> </td> <td style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-WEIGHT: bold; DISPLAY: inline"> &nbsp;</font> </td> </tr> <tr> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="76%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-WEIGHT: bold; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="10%" colspan="2"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: -18pt"> 2014</div> </td> <td style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-WEIGHT: bold; DISPLAY: inline"> &nbsp;</font> </td> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-WEIGHT: bold; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="10%" colspan="2"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: -18pt"> 2013</div> </td> <td style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-WEIGHT: bold; DISPLAY: inline"> &nbsp;</font> </td> </tr> <tr bgcolor="#cceeff"> <td valign="bottom" width="76%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 9pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: -9pt"> Deferred tax assets:</div> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="10%" colspan="2"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="10%" colspan="2"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> <tr bgcolor="white"> <td valign="bottom" width="76%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: -9pt"> U.S. net operating loss carryforward</div> </td> <td valign="bottom" width="1%" align="right"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%">$</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">7,955</td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%" align="right"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%">$</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">7,106</td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> <tr bgcolor="#cceeff"> <td valign="bottom" width="76%"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: -9pt"> Israeli net operating loss carryforward</div> </td> <td valign="bottom" width="1%" align="right"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">12,810</td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%" align="right"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">8,543</td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> <tr bgcolor="white"> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="76%"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: -9pt"> Allowances and reserves</div> </td> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%" align="right"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">237</td> <td style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%" align="right"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">156</td> <td style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> <tr bgcolor="#cceeff"> <td valign="bottom" width="76%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: right" valign="bottom" width="9%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: right" valign="bottom" width="9%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> <tr bgcolor="white"> <td valign="bottom" width="76%"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 9pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: -9pt"> Total deferred tax assets before valuation allowance</div> </td> <td valign="bottom" width="1%" align="right"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">21,002</td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%" align="right"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">15,805</td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> <tr bgcolor="#cceeff"> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="76%"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 9pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: -9pt"> Valuation allowance</div> </td> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%" align="right"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">(21,002</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap">)</td> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%" align="right"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">(15,805</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap">)</td> </tr> <tr bgcolor="white"> <td valign="bottom" width="76%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: right" valign="bottom" width="9%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: right" valign="bottom" width="9%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> <tr bgcolor="#cceeff"> <td style="PADDING-BOTTOM: 4px" valign="bottom" width="76%"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 9pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: -9pt"> Net deferred tax asset</div> </td> <td style="PADDING-BOTTOM: 4px" valign="bottom" width="1%" align="right"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 4px double; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%">$</td> <td style="BORDER-BOTTOM: black 4px double; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">-</td> <td style="PADDING-BOTTOM: 4px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="PADDING-BOTTOM: 4px" valign="bottom" width="1%" align="right"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 4px double; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%">$</td> <td style="BORDER-BOTTOM: black 4px double; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">-</td> <td style="PADDING-BOTTOM: 4px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> </table> </div> <div style="DISPLAY: block; MARGIN-LEFT: 446pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> &nbsp;</div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; MARGIN-LEFT: 27pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> As of June&nbsp;30, 2014 and 2013, the Company has provided full valuation allowances in respect of deferred tax assets resulting from tax loss carryforward and other temporary differences, since they have a history of operating losses and current uncertainty concerning its ability to realize these deferred tax assets in the future.</div> <div style="MARGIN-LEFT: 437pt; DISPLAY: block; TEXT-INDENT: 0pt"> <br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; MARGIN-LEFT: 27pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> The Company accounts for its income tax uncertainties in accordance with ASC&nbsp;740 which clarifies the accounting for uncertainties in income taxes recognized in a Company&#39;s financial statements and prescribes a recognition threshold and measurement attribute for the financial statement recognition and measurement of a tax position taken or expected to be taken in a tax return.</div> <div style="MARGIN-LEFT: 437pt; DISPLAY: block; TEXT-INDENT: 0pt"> <br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; MARGIN-LEFT: 27pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> As of June&nbsp;30, 2014 and 2013, there were no unrecognized tax benefits that if recognized would affect the annual effective tax rate.</div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: left; TEXT-INDENT: 0pt"> Reconciliation of the theoretical tax expense (benefit) to the actual tax expense (benefit):</div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; MARGIN-LEFT: 45pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> &nbsp;</div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: justify; TEXT-INDENT: 0pt"> In 2012, 2013 and 2014, the main reconciling item of the statutory tax rate of the Company (25% to 35% in 2012, 2013 and 2014) to the effective tax rate (0%) is tax loss carryforwards, stock-based compensation and other deferred tax assets for which a full valuation allowance was provided.</div> <!--EndFragment--></div> </div><span></span></td>
      </tr>
    </table>
    <div style="display: none;">
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureAbstract">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div>
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_IncomeTaxDisclosureAbstract</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:stringItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureTextBlock">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The entire disclosure for income taxes. Disclosures may include net deferred tax liability or asset recognized in an enterprise's statement of financial position, net change during the year in the total valuation allowance, approximate tax effect of each type of temporary difference and carryforward that gives rise to a significant portion of deferred tax liabilities and deferred tax assets, utilization of a tax carryback, and tax uncertainties information.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 740<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 15<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6907707&amp;loc=d3e32718-109319<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 235<br><br> -SubTopic 10<br><br> -Section S99<br><br> -Paragraph 1<br><br> -Subparagraph (SX 210.4-08.(h))<br><br> -URI http://asc.fasb.org/extlink&amp;oid=26873400&amp;loc=d3e23780-122690<br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher SEC<br><br> -Name Regulation S-X (SX)<br><br> -Number 210<br><br> -Section 08<br><br> -Paragraph h<br><br> -Article 4<br><br><br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 740<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 9<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6907707&amp;loc=d3e32639-109319<br><br><br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 740<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 2<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6907707&amp;loc=d3e32537-109319<br><br><br><br>Reference 6: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 740<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 3<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6907707&amp;loc=d3e32559-109319<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_IncomeTaxDisclosureTextBlock</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>nonnum:textBlockItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
    </div>
  </body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>66
<FILENAME>R4.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
  <head>
    <META http-equiv="Content-Type" content="text/html; charset=us-ascii">
    <link rel="StyleSheet" type="text/css" href="report.css"><script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script></head>
  <body><span style="display: none;">v2.4.0.8</span><table class="report" border="0" cellspacing="2" id="ID0EQSAE">
      <tr>
        <th class="tl" colspan="1" rowspan="2">
          <div style="width: 200px;"><strong>CONSOLIDATED STATEMENTS OF OPERATIONS (USD $)<br>In Thousands, except Share data, unless otherwise specified</strong></div>
        </th>
        <th class="th" colspan="3">12 Months Ended</th>
      </tr>
      <tr>
        <th class="th">
          <div>Jun. 30, 2014</div>
        </th>
        <th class="th">
          <div>Jun. 30, 2013</div>
        </th>
        <th class="th">
          <div>Jun. 30, 2012</div>
        </th>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeStatementAbstract', window );"><strong>CONSOLIDATED STATEMENTS OF OPERATIONS [Abstract]</strong></a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Revenues', window );">Revenues</a></td>
        <td class="nump">$ 379<span></span></td>
        <td class="nump">$ 679<span></span></td>
        <td class="nump">$ 716<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CostOfRevenue', window );">Cost of revenues</a></td>
        <td class="num">(11)<span></span></td>
        <td class="num">(20)<span></span></td>
        <td class="num">(21)<span></span></td>
      </tr>
      <tr class="rou">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GrossProfit', window );">Gross profit</a></td>
        <td class="nump">368<span></span></td>
        <td class="nump">659<span></span></td>
        <td class="nump">695<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentExpense', window );">Research and development expenses</a></td>
        <td class="num">(24,938)<span></span></td>
        <td class="num">(19,906)<span></span></td>
        <td class="num">(12,685)<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_psti_GovernmentAndThirdPartyGrantsReceived', window );">Less participation by the Office of the Chief Scientist and other parties</a></td>
        <td class="nump">5,396<span></span></td>
        <td class="nump">2,673<span></span></td>
        <td class="nump">3,527<span></span></td>
      </tr>
      <tr class="reu">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_psti_ResearchAndDevelopmentExpensesNet', window );">Research and development expenses, net</a></td>
        <td class="num">(19,542)<span></span></td>
        <td class="num">(17,233)<span></span></td>
        <td class="num">(9,158)<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GeneralAndAdministrativeExpense', window );">General and administrative expenses</a></td>
        <td class="num">(8,676)<span></span></td>
        <td class="num">(5,649)<span></span></td>
        <td class="num">(6,568)<span></span></td>
      </tr>
      <tr class="reu">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingIncomeLoss', window );">Operating loss</a></td>
        <td class="num">(27,850)<span></span></td>
        <td class="num">(22,223)<span></span></td>
        <td class="num">(15,031)<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NonoperatingIncomeExpense', window );">Financial income, net</a></td>
        <td class="nump">918<span></span></td>
        <td class="nump">1,068<span></span></td>
        <td class="nump">237<span></span></td>
      </tr>
      <tr class="reu">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss</a></td>
        <td class="num">$ (26,932)<span></span></td>
        <td class="num">$ (21,155)<span></span></td>
        <td class="num">$ (14,794)<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareAbstract', window );"><strong>Loss per share:</strong></a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasicAndDiluted', window );">Basic and diluted net loss per share</a></td>
        <td class="num">$ (0.42)<span></span></td>
        <td class="num">$ (0.38)<span></span></td>
        <td class="num">$ (0.34)<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted', window );">Weighted average number of shares used in computing basic and diluted net loss per share</a></td>
        <td class="nump">63,514,405<span></span></td>
        <td class="nump">55,481,357<span></span></td>
        <td class="nump">44,031,866<span></span></td>
      </tr>
    </table>
    <div style="display: none;">
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_psti_GovernmentAndThirdPartyGrantsReceived">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Grants received from the government and third parties for research and development programs.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>psti_GovernmentAndThirdPartyGrantsReceived</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>psti_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>credit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_psti_ResearchAndDevelopmentExpensesNet">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Research and development expenses, net.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>psti_ResearchAndDevelopmentExpensesNet</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>psti_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>debit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CostOfRevenue">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The aggregate cost of goods produced and sold and services rendered during the reporting period.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 225<br><br> -SubTopic 10<br><br> -Section S99<br><br> -Paragraph 2<br><br> -Subparagraph (SX 210.5-03.2)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=26872669&amp;loc=d3e20235-122688<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher SEC<br><br> -Name Regulation S-X (SX)<br><br> -Number 210<br><br> -Section 03<br><br> -Paragraph 2<br><br> -Article 5<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_CostOfRevenue</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>debit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareAbstract">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div>
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_EarningsPerShareAbstract</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:stringItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareBasicAndDiluted">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The amount of net income or loss for the period per each share in instances when basic and diluted earnings per share are the same amount and reported as a single line item on the face of the financial statements.  Basic earnings per share is the amount of net income or loss for the period per each share of common stock or unit outstanding during the reporting period.  Diluted earnings per share includes the amount of net income or loss for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_EarningsPerShareBasicAndDiluted</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>num:perShareItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GeneralAndAdministrativeExpense">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The aggregate total of expenses of managing and administering the affairs of an entity, including affiliates of the reporting entity, which are not directly or indirectly associated with the manufacture, sale or creation of a product or product line.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 225<br><br> -SubTopic 10<br><br> -Section S99<br><br> -Paragraph 2<br><br> -Subparagraph (SX 210.5-03.4)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=26872669&amp;loc=d3e20235-122688<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_GeneralAndAdministrativeExpense</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>debit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GrossProfit">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Aggregate revenue less cost of goods and services sold or operating expenses directly attributable to the revenue generation activity.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 225<br><br> -SubTopic 10<br><br> -Section S99<br><br> -Paragraph 2<br><br> -Subparagraph (SX 210.5-03.1,2)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=26872669&amp;loc=d3e20235-122688<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_GrossProfit</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>credit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementAbstract">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div>
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_IncomeStatementAbstract</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:stringItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 230<br><br> -SubTopic 10<br><br> -Section 45<br><br> -Paragraph 28<br><br> -URI http://asc.fasb.org/extlink&amp;oid=31042434&amp;loc=d3e3602-108585<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 260<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 1<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Glossary Other Comprehensive Income<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6519514<br><br><br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Glossary Net Income<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6518256<br><br><br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 944<br><br> -SubTopic 225<br><br> -Section S99<br><br> -Paragraph 1<br><br> -Subparagraph (SX 210.7-04.19)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6879464&amp;loc=d3e573970-122913<br><br><br><br>Reference 6: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 225<br><br> -SubTopic 10<br><br> -Section S99<br><br> -Paragraph 2<br><br> -Subparagraph (SX 210.5-03.18)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=26872669&amp;loc=d3e20235-122688<br><br><br><br>Reference 7: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 944<br><br> -SubTopic 225<br><br> -Section S99<br><br> -Paragraph 1<br><br> -Subparagraph (SX 210.7-04.22)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6879464&amp;loc=d3e573970-122913<br><br><br><br>Reference 8: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher SEC<br><br> -Name Regulation S-X (SX)<br><br> -Number 210<br><br> -Section 03<br><br> -Paragraph 19<br><br> -Article 5<br><br><br><br>Reference 9: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher SEC<br><br> -Name Regulation S-X (SX)<br><br> -Number 210<br><br> -Section 04<br><br> -Paragraph 20<br><br> -Article 9<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_NetIncomeLoss</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>credit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NonoperatingIncomeExpense">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 225<br><br> -SubTopic 10<br><br> -Section S99<br><br> -Paragraph 2<br><br> -Subparagraph (SX 210.5-03.7)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=26872669&amp;loc=d3e20235-122688<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher SEC<br><br> -Name Regulation S-X (SX)<br><br> -Number 210<br><br> -Section 03<br><br> -Paragraph 7<br><br> -Article 5<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_NonoperatingIncomeExpense</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>credit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingIncomeLoss">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The net result for the period of deducting operating expenses from operating revenues.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_OperatingIncomeLoss</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>credit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ResearchAndDevelopmentExpense">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The aggregate costs incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process whether intended for sale or the entity's use, during the reporting period charged to research and development projects, including the costs of developing computer software up to the point in time of achieving technological feasibility, and costs allocated in accounting for a business combination to in-process projects deemed to have no alternative future use.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 985<br><br> -SubTopic 20<br><br> -Section 50<br><br> -Paragraph 1<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6501960&amp;loc=d3e128462-111756<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 730<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 1<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6420194&amp;loc=d3e21568-108373<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_ResearchAndDevelopmentExpense</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>debit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Revenues">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss).</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 225<br><br> -SubTopic 10<br><br> -Section S99<br><br> -Paragraph 2<br><br> -Subparagraph (SX 210.5-03.1)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=26872669&amp;loc=d3e20235-122688<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher SEC<br><br> -Name Regulation S-X (SX)<br><br> -Number 210<br><br> -Section 03<br><br> -Paragraph 1<br><br> -Article 5<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_Revenues</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>credit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Average number of shares or units issued and outstanding that are used in calculating basic and diluted earnings per share (EPS).</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:sharesItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
    </div>
  </body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>67
<FILENAME>R12.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
  <head>
    <META http-equiv="Content-Type" content="text/html; charset=us-ascii">
    <link rel="StyleSheet" type="text/css" href="report.css"><script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script></head>
  <body><span style="display: none;">v2.4.0.8</span><table class="report" border="0" cellspacing="2" id="ID0EME">
      <tr>
        <th class="tl" colspan="1" rowspan="2">
          <div style="width: 200px;"><strong>FAIR VALUE OF FINANCIAL INSTRUMENTS<br></strong></div>
        </th>
        <th class="th" colspan="1">12 Months Ended</th>
      </tr>
      <tr>
        <th class="th">
          <div>Jun. 30, 2014</div>
        </th>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueDisclosuresAbstract', window );"><strong>FAIR VALUE OF FINANCIAL INSTRUMENTS [Abstract]</strong></a></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueDisclosuresTextBlock', window );">FAIR VALUE OF FINANCIAL INSTRUMENTS</a></td>
        <td class="text"><!--DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd" --><div> <div><!--StartFragment--> <font style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; FONT-WEIGHT: bold; DISPLAY: inline"> NOTE 4:- FAIR VALUE OF FINANCIAL INSTRUMENTS</font> <div style="DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> &nbsp;</div> <div style="text-align: right"> <table style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman" cellspacing="0" cellpadding="0" width="97%"> <tr> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="28%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-WEIGHT: bold; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="34%" colspan="10"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"> June 30, 2014</div> </td> <td style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-WEIGHT: bold; DISPLAY: inline"> &nbsp;</font> </td> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-WEIGHT: bold; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="34%" colspan="10"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"> June 30, 2013</div> </td> <td style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-WEIGHT: bold; DISPLAY: inline"> &nbsp;</font> </td> </tr> <tr> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="28%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-WEIGHT: bold; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="10%" colspan="2"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"> Level 1</div> </td> <td style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-WEIGHT: bold; DISPLAY: inline"> &nbsp;</font> </td> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-WEIGHT: bold; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="10%" colspan="2"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"> Level 2</div> </td> <td style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-WEIGHT: bold; DISPLAY: inline"> &nbsp;</font> </td> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-WEIGHT: bold; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="10%" colspan="2"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"> Level 3</div> </td> <td style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-WEIGHT: bold; DISPLAY: inline"> &nbsp;</font> </td> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-WEIGHT: bold; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="10%" colspan="2"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"> Level 1</div> </td> <td style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-WEIGHT: bold; DISPLAY: inline"> &nbsp;</font> </td> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-WEIGHT: bold; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="10%" colspan="2"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"> Level 2</div> </td> <td style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-WEIGHT: bold; DISPLAY: inline"> &nbsp;</font> </td> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-WEIGHT: bold; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="10%" colspan="2"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"> Level 3</div> </td> <td style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-WEIGHT: bold; DISPLAY: inline"> &nbsp;</font> </td> </tr> <tr bgcolor="#cceeff"> <td style="TEXT-ALIGN: left; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt" valign="bottom" width="28%"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: left; TEXT-INDENT: 0pt"> Marketable securities</div> </td> <td valign="bottom" width="1%" align="right"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%">$</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">20,530</td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%" align="right"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%">$</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">9,431</td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%" align="right"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">-</td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%" align="right"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%">$</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">6,311</td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%" align="right"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%">$</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">7,130</td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%" align="right"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">-</td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> <tr bgcolor="white"> <td style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt" valign="bottom" width="28%"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: left; TEXT-INDENT: 0pt"> Foreign currency derivative instruments</div> </td> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%" align="right"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">-</td> <td style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%" align="right"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">(842</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap">)</td> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%" align="right"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">-</td> <td style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%" align="right"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">-</td> <td style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%" align="right"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">93</td> <td style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%" align="right"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">-</td> <td style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> <tr bgcolor="#cceeff"> <td style="PADDING-BOTTOM: 4px; TEXT-ALIGN: left; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt" valign="bottom" width="28%"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: left; TEXT-INDENT: 0pt"> Total</div> </td> <td style="PADDING-BOTTOM: 4px" valign="bottom" width="1%" align="right"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 4px double; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%">$</td> <td style="BORDER-BOTTOM: black 4px double; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">20,530</td> <td style="PADDING-BOTTOM: 4px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="PADDING-BOTTOM: 4px" valign="bottom" width="1%" align="right"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 4px double; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%">$</td> <td style="BORDER-BOTTOM: black 4px double; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">8,589</td> <td style="PADDING-BOTTOM: 4px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="PADDING-BOTTOM: 4px" valign="bottom" width="1%" align="right"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 4px double; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%">$</td> <td style="BORDER-BOTTOM: black 4px double; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">-</td> <td style="PADDING-BOTTOM: 4px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="PADDING-BOTTOM: 4px" valign="bottom" width="1%" align="right"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 4px double; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%">$</td> <td style="BORDER-BOTTOM: black 4px double; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">6,311</td> <td style="PADDING-BOTTOM: 4px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="PADDING-BOTTOM: 4px" valign="bottom" width="1%" align="right"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 4px double; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%">$</td> <td style="BORDER-BOTTOM: black 4px double; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">7,223</td> <td style="PADDING-BOTTOM: 4px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="PADDING-BOTTOM: 4px" valign="bottom" width="1%" align="right"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 4px double; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%">$</td> <td style="BORDER-BOTTOM: black 4px double; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">-</td> <td style="PADDING-BOTTOM: 4px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> </table> </div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /> </div> <div style="text-align: right"> <table style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman" cellspacing="0" cellpadding="0" width="97%"> <tr> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="49%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="26%" colspan="4"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"> June 30, 2014</div> </td> <td style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-WEIGHT: bold; DISPLAY: inline"> &nbsp;</font> </td> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-WEIGHT: bold; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="22%" colspan="6"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"> June 30, 2013</div> </td> <td style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-WEIGHT: bold; DISPLAY: inline"> &nbsp;</font> </td> </tr> <tr> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="49%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="15%"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"> Balance Sheet location</div> </td> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-WEIGHT: bold; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="10%" colspan="2"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"> Fair Value</div> </td> <td style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-WEIGHT: bold; DISPLAY: inline"> &nbsp;</font> </td> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-WEIGHT: bold; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="10%" colspan="2"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"> Balance Sheet location</div> </td> <td style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-WEIGHT: bold; DISPLAY: inline"> &nbsp;</font> </td> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-WEIGHT: bold; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="10%" colspan="2"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"> Fair Value</div> </td> <td style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-WEIGHT: bold; DISPLAY: inline"> &nbsp;</font> </td> </tr> <tr bgcolor="#cceeff"> <td style="TEXT-ALIGN: left; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt" valign="bottom" width="49%"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: left; TEXT-INDENT: 0pt"> Derivatives designated as cash flow hedge instruments</div> </td> <td valign="bottom" width="15%"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 1.6pt; text-align: center; TEXT-INDENT: 0pt"> Other current assets</div> </td> <td valign="bottom" width="1%" align="right"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%">$</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">24</td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">-</td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%" align="left"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%">$</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">-</td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> <tr bgcolor="white"> <td style="TEXT-ALIGN: left; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt" valign="bottom" width="49%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="15%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%" align="right"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: right" valign="bottom" width="9%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="10%" colspan="2"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: right" valign="bottom" width="9%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> <tr bgcolor="#cceeff"> <td style="TEXT-ALIGN: left; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt" valign="bottom" width="49%"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: left; TEXT-INDENT: 0pt"> Derivatives not designated as hedge instruments</div> </td> <td valign="bottom" width="15%"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 1.6pt; text-align: center; TEXT-INDENT: 0pt"> Other current assets</div> </td> <td valign="bottom" width="1%" align="right"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">23</td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="10%" colspan="2"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"> Other current assets</div> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">93</td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> <tr bgcolor="white"> <td style="TEXT-ALIGN: left; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt" valign="bottom" width="49%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="15%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%" align="right"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: right" valign="bottom" width="9%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: right" valign="bottom" width="9%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: right" valign="bottom" width="9%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> <tr bgcolor="#cceeff"> <td style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt" valign="bottom" width="49%"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: left; TEXT-INDENT: 0pt"> Derivatives designated as fair value hedge instruments</div> </td> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="15%"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 1.6pt; text-align: center; TEXT-INDENT: 0pt"> Other current liabilities</div> </td> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%" align="right"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">(889</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap">)</td> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; PADDING-BOTTOM: 2px; TEXT-ALIGN: right" valign="bottom" width="9%">-</td> <td style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">-</td> <td style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> <tr bgcolor="white"> <td style="TEXT-ALIGN: left; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt" valign="bottom" width="49%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="15%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%" align="right"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: right" valign="bottom" width="9%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: right" valign="bottom" width="9%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%" align="left"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: right" valign="bottom" width="9%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> <tr bgcolor="#cceeff"> <td style="PADDING-BOTTOM: 4px; TEXT-ALIGN: left; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt" valign="bottom" width="49%"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: left; TEXT-INDENT: 0pt"> Total</div> </td> <td style="PADDING-BOTTOM: 4px" valign="bottom" width="15%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="PADDING-BOTTOM: 4px" valign="bottom" width="1%" align="right"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 4px double; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%">$</td> <td style="BORDER-BOTTOM: black 4px double; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">(842</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; PADDING-BOTTOM: 4px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap">)</td> <td style="PADDING-BOTTOM: 4px" valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="PADDING-BOTTOM: 4px; TEXT-ALIGN: right" valign="bottom" width="9%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="PADDING-BOTTOM: 4px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="PADDING-BOTTOM: 4px" valign="bottom" width="1%" align="left"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 4px double; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%">$</td> <td style="BORDER-BOTTOM: black 4px double; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">93</td> <td style="PADDING-BOTTOM: 4px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> </table> </div> <!--EndFragment--></div> </div><span></span></td>
      </tr>
    </table>
    <div style="display: none;">
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueDisclosuresAbstract">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div>
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_FairValueDisclosuresAbstract</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:stringItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueDisclosuresTextBlock">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The entire disclosure for the fair value of financial instruments (as defined), including financial assets and financial liabilities (collectively, as defined), and the measurements of those instruments as well as disclosures related to the fair value of non-financial assets and liabilities. Such disclosures about the financial instruments, assets, and liabilities would include: (1) the fair value of the required items together with their carrying amounts (as appropriate); (2) for items for which it is not practicable to estimate fair value, disclosure would include: (a) information pertinent to estimating fair value (including, carrying amount, effective interest rate, and maturity, and (b) the reasons why it is not practicable to estimate fair value; (3) significant concentrations of credit risk including: (a) information about the activity, region, or economic characteristics identifying a concentration, (b) the maximum amount of loss the entity is exposed to based on the gross fair value of the related item, (c) policy for requiring collateral or other security and information as to accessing such collateral or security, and (d) the nature and brief description of such collateral or security; (4) quantitative information about market risks and how such risks are managed; (5) for items measured on both a recurring and nonrecurring basis information regarding the inputs used to develop the fair value measurement; and (6) for items presented in the financial statement for which fair value measurement is elected: (a) information necessary to understand the reasons for the election, (b) discussion of the effect of fair value changes on earnings, (c) a description of [similar groups] items for which the election is made and the relation thereof to the balance sheet, the aggregate carrying value of items included in the balance sheet that are not eligible for the election; (7) all other required (as defined) and desired information.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 825<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 21<br><br> -URI http://asc.fasb.org/extlink&amp;oid=35750535&amp;loc=d3e13537-108611<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 825<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 10<br><br> -URI http://asc.fasb.org/extlink&amp;oid=35750535&amp;loc=d3e13433-108611<br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 825<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 28<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6957238&amp;loc=d3e14064-108612<br><br><br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 820<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 2<br><br> -URI http://asc.fasb.org/extlink&amp;oid=36462937&amp;loc=d3e19207-110258<br><br><br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 825<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 30<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6957238&amp;loc=d3e14172-108612<br><br><br><br>Reference 6: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 825<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 16<br><br> -URI http://asc.fasb.org/extlink&amp;oid=35750535&amp;loc=d3e13504-108611<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_FairValueDisclosuresTextBlock</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>nonnum:textBlockItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
    </div>
  </body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>68
<FILENAME>R11.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
  <head>
    <META http-equiv="Content-Type" content="text/html; charset=us-ascii">
    <link rel="StyleSheet" type="text/css" href="report.css"><script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script></head>
  <body><span style="display: none;">v2.4.0.8</span><table class="report" border="0" cellspacing="2" id="ID0EME">
      <tr>
        <th class="tl" colspan="1" rowspan="2">
          <div style="width: 200px;"><strong>MARKETABLE SECURITIES<br></strong></div>
        </th>
        <th class="th" colspan="1">12 Months Ended</th>
      </tr>
      <tr>
        <th class="th">
          <div>Jun. 30, 2014</div>
        </th>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MarketableSecuritiesAbstract', window );"><strong>MARKETABLE SECURITIES [Abstract]</strong></a></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock', window );">MARKETABLE SECURITIES</a></td>
        <td class="text"><!--DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd" --><div> <div><!--StartFragment--> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"> NOTE 3:- MARKETABLE SECURITIES</div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"> As of June 30, 2014, all of the Company&#39;s marketable securities were classified as available-for-sale.</div> <div style="DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"> &nbsp;</div> <div style="text-align: left"> <table style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman" cellspacing="0" cellpadding="0" width="100%"> <tr> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="20%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-WEIGHT: bold; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="38%" colspan="14"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"> June 30, 2014</div> </td> <td style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-WEIGHT: bold; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="38%" colspan="14"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"> June 30,2013</div> </td> <td style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> <tr> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="20%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-WEIGHT: bold; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="8%" colspan="2"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"> Amortized cost</div> </td> <td style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-WEIGHT: bold; DISPLAY: inline"> &nbsp;</font> </td> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-WEIGHT: bold; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="8%" colspan="2"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"> Gross</div> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"> unrealized</div> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"> gain</div> </td> <td style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-WEIGHT: bold; DISPLAY: inline"> &nbsp;</font> </td> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-WEIGHT: bold; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="8%" colspan="2"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"> Gross</div> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"> unrealized</div> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"> loss</div> </td> <td style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-WEIGHT: bold; DISPLAY: inline"> &nbsp;</font> </td> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-WEIGHT: bold; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="8%" colspan="2"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"> Fair</div> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"> value</div> </td> <td style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-WEIGHT: bold; DISPLAY: inline"> &nbsp;</font> </td> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-WEIGHT: bold; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="8%" colspan="2"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"> Amortized cost</div> </td> <td style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-WEIGHT: bold; DISPLAY: inline"> &nbsp;</font> </td> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-WEIGHT: bold; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="8%" colspan="2"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"> Gross</div> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"> unrealized</div> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"> gain</div> </td> <td style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-WEIGHT: bold; DISPLAY: inline"> &nbsp;</font> </td> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-WEIGHT: bold; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="8%" colspan="2"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"> Gross</div> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"> unrealized</div> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"> loss</div> </td> <td style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-WEIGHT: bold; DISPLAY: inline"> &nbsp;</font> </td> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-WEIGHT: bold; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="8%" colspan="2"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"> Fair</div> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"> value</div> </td> <td style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-WEIGHT: bold; DISPLAY: inline"> &nbsp;</font> </td> </tr> <tr bgcolor="#cceeff"> <td style="TEXT-ALIGN: left; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt" valign="bottom" width="20%"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: left; TEXT-INDENT: 0pt"> Available-for-sale - matures within one year:</div> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="8%" colspan="2"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="8%" colspan="2"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="8%" colspan="2"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="8%" colspan="2"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="8%" colspan="2"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="8%" colspan="2"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="8%" colspan="2"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="8%" colspan="2"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> <tr bgcolor="white"> <td style="TEXT-ALIGN: left; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt" valign="bottom" width="20%"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: left; TEXT-INDENT: 0pt"> Stock and index linked notes</div> </td> <td valign="bottom" width="1%" align="right"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%">$</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="7%">18,881</td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%" align="right"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%">$</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="7%">2,522</td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%" align="right"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%">$</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="7%">(23</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap">)</td> <td valign="bottom" width="1%" align="right"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%">$</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="7%">21,380</td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%" align="right"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%">$</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="7%">4,023</td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%" align="right"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%">$</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="7%">234</td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%" align="right"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%">$</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="7%">(180</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap">)</td> <td valign="bottom" width="1%" align="right"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%">$</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="7%">4,077</td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> <tr bgcolor="#cceeff"> <td style="TEXT-ALIGN: left; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt" valign="bottom" width="20%"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: left; TEXT-INDENT: 0pt"> Government debentures - fixed interest rate</div> </td> <td valign="bottom" width="1%" align="right"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="7%">97</td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%" align="right"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="7%">9</td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%" align="right"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="7%">-</td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%" align="right"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="7%">106</td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%" align="right"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="7%">329</td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%" align="right"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="7%">21</td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%" align="right"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="7%">-</td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%" align="right"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="7%">350</td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> <tr bgcolor="white"> <td style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt" valign="bottom" width="20%"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: left; TEXT-INDENT: 0pt"> Corporate debentures - fixed interest rate</div> </td> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%" align="right"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="7%">452</td> <td style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%" align="right"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="7%">54</td> <td style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%" align="right"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="7%">-</td> <td style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%" align="right"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="7%">506</td> <td style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%" align="right"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="7%">508</td> <td style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%" align="right"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="7%">30</td> <td style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%" align="right"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="7%">(9</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap">)</td> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%" align="right"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="7%">529</td> <td style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> <tr bgcolor="#cceeff"> <td valign="bottom" width="20%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%" align="right"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%">$</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="7%">19,430</td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%" align="right"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%">$</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="7%">2,585</td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%" align="right"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%">$</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="7%">(23</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap">)</td> <td valign="bottom" width="1%" align="right"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%">$</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="7%">21,992</td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%" align="right"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%">$</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="7%">4,860</td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%" align="right"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%">$</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="7%">285</td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%" align="right"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%">$</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="7%">(189</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap">)</td> <td valign="bottom" width="1%" align="right"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%">$</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="7%">4,956</td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> <tr bgcolor="white"> <td style="TEXT-ALIGN: left; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt" valign="bottom" width="20%"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: left; TEXT-INDENT: 0pt"> Available-for-sale - matures after one year through five years:</div> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: right" valign="bottom" width="7%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: right" valign="bottom" width="7%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: right" valign="bottom" width="7%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: right" valign="bottom" width="7%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: right" valign="bottom" width="7%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: right" valign="bottom" width="7%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: right" valign="bottom" width="7%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: right" valign="bottom" width="7%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> <tr bgcolor="#cceeff"> <td style="TEXT-ALIGN: left; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt" valign="bottom" width="20%"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: left; TEXT-INDENT: 0pt"> Government debentures - fixed interest rate</div> </td> <td valign="bottom" width="1%" align="right"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="7%">2,595</td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%" align="right"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="7%">98</td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%" align="right"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="7%">(1</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap">)</td> <td valign="bottom" width="1%" align="right"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="7%">2,692</td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%" align="right"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="7%">1,602</td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%" align="right"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="7%">49</td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%" align="right"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="7%">(12</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap">)</td> <td valign="bottom" width="1%" align="right"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="7%">1,639</td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> <tr bgcolor="white"> <td style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt" valign="bottom" width="20%"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: left; TEXT-INDENT: 0pt"> Corporate debentures - fixed interest rate</div> </td> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%" align="right"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="7%">4,906</td> <td style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%" align="right"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="7%">263</td> <td style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%" align="right"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="7%">(5</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap">)</td> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%" align="right"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="7%">5,164</td> <td style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%" align="right"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="7%">4,976</td> <td style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%" align="right"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="7%">162</td> <td style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%" align="right"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="7%">(77</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap">)</td> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%" align="right"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="7%">5,061</td> <td style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> <tr bgcolor="#cceeff"> <td valign="bottom" width="20%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%" align="right"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%">$</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="7%">7,501</td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%" align="right"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%">$</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="7%">361</td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%" align="right"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%">$</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="7%">(6</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap">)</td> <td valign="bottom" width="1%" align="right"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%">$</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="7%">7,856</td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%" align="right"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%">$</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="7%">6,578</td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%" align="right"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%">$</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="7%">211</td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%" align="right"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%">$</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="7%">(89</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap">)</td> <td valign="bottom" width="1%" align="right"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%">$</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="7%">6,700</td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> <tr bgcolor="white"> <td style="TEXT-ALIGN: left; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt" valign="bottom" width="20%"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: left; TEXT-INDENT: 0pt"> Available-for-sale - matures after five years through ten years:</div> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: right" valign="bottom" width="7%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: right" valign="bottom" width="7%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: right" valign="bottom" width="7%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: right" valign="bottom" width="7%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: right" valign="bottom" width="7%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: right" valign="bottom" width="7%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: right" valign="bottom" width="7%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: right" valign="bottom" width="7%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> <tr bgcolor="#cceeff"> <td style="TEXT-ALIGN: left; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt" valign="bottom" width="20%"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: left; TEXT-INDENT: 0pt"> Government debentures - fixed interest rate</div> </td> <td valign="bottom" width="1%" align="right"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="7%">-</td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%" align="right"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="7%">-</td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%" align="right"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="7%">-</td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%" align="right"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="7%">-</td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%" align="right"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="7%">955</td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%" align="right"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="7%">45</td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%" align="right"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="7%">(14</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap">)</td> <td valign="bottom" width="1%" align="right"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="7%">986</td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> <tr bgcolor="white"> <td style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt" valign="bottom" width="20%"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: left; TEXT-INDENT: 0pt"> Corporate debentures - fixed interest rate</div> </td> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%" align="right"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="7%">94</td> <td style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%" align="right"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="7%">19</td> <td style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%" align="right"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="7%">-</td> <td style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%" align="right"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="7%">113</td> <td style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%" align="right"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="7%">789</td> <td style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%" align="right"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="7%">29</td> <td style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%" align="right"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="7%">(19</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap">)</td> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%" align="right"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="7%">799</td> <td style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> <tr bgcolor="#cceeff"> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="20%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%" align="right"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%">$</td> <td style="BORDER-BOTTOM: black 2px solid; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="7%">94</td> <td style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%" align="right"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%">$</td> <td style="BORDER-BOTTOM: black 2px solid; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="7%">19</td> <td style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%" align="right"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%">$</td> <td style="BORDER-BOTTOM: black 2px solid; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="7%">-</td> <td style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%" align="right"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%">$</td> <td style="BORDER-BOTTOM: black 2px solid; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="7%">113</td> <td style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%" align="right"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%">$</td> <td style="BORDER-BOTTOM: black 2px solid; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="7%">1,744</td> <td style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%" align="right"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%">$</td> <td style="BORDER-BOTTOM: black 2px solid; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="7%">74</td> <td style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%" align="right"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%">$</td> <td style="BORDER-BOTTOM: black 2px solid; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="7%">(33</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap">)</td> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%" align="right"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%">$</td> <td style="BORDER-BOTTOM: black 2px solid; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="7%">1,785</td> <td style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> <tr bgcolor="white"> <td style="PADDING-BOTTOM: 4px; TEXT-ALIGN: left; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt" valign="bottom" width="20%"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: left; TEXT-INDENT: 0pt"> Total</div> </td> <td style="PADDING-BOTTOM: 4px" valign="bottom" width="1%" align="right"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 4px double; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%">$</td> <td style="BORDER-BOTTOM: black 4px double; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="7%">27,025</td> <td style="PADDING-BOTTOM: 4px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="PADDING-BOTTOM: 4px" valign="bottom" width="1%" align="right"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 4px double; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%">$</td> <td style="BORDER-BOTTOM: black 4px double; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="7%">2,965</td> <td style="PADDING-BOTTOM: 4px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="PADDING-BOTTOM: 4px" valign="bottom" width="1%" align="right"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 4px double; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%">$</td> <td style="BORDER-BOTTOM: black 4px double; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="7%">(29</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; PADDING-BOTTOM: 4px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap">)</td> <td style="PADDING-BOTTOM: 4px" valign="bottom" width="1%" align="right"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 4px double; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%">$</td> <td style="BORDER-BOTTOM: black 4px double; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="7%">29,961</td> <td style="PADDING-BOTTOM: 4px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="PADDING-BOTTOM: 4px" valign="bottom" width="1%" align="right"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 4px double; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%">$</td> <td style="BORDER-BOTTOM: black 4px double; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="7%">13,182</td> <td style="PADDING-BOTTOM: 4px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="PADDING-BOTTOM: 4px" valign="bottom" width="1%" align="right"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 4px double; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%">$</td> <td style="BORDER-BOTTOM: black 4px double; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="7%">570</td> <td style="PADDING-BOTTOM: 4px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="PADDING-BOTTOM: 4px" valign="bottom" width="1%" align="right"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 4px double; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%">$</td> <td style="BORDER-BOTTOM: black 4px double; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="7%">(311</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; PADDING-BOTTOM: 4px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap">)</td> <td style="PADDING-BOTTOM: 4px" valign="bottom" width="1%" align="right"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 4px double; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%">$</td> <td style="BORDER-BOTTOM: black 4px double; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="7%">13,441</td> <td style="PADDING-BOTTOM: 4px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> </table> </div> <div style="DISPLAY: block; TEXT-INDENT: 0pt">&nbsp;</div> <div style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt"> The following table presents gross unrealized losses and fair values for those investments that were in an unrealized loss position as of June 30, 2014 and June 30, 2013, and the length of time that those investments have been in a continuous loss position:</div> <div style="MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt"> &nbsp;</div> <div style="text-align: left"> <table style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman" cellspacing="0" cellpadding="0" width="100%"> <tr> <td style="PADDING-BOTTOM: 2px" valign="bottom"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="PADDING-BOTTOM: 2px" valign="bottom"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-WEIGHT: bold; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid" valign="bottom" colspan="6"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"> Less than 12 months</div> </td> <td style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-WEIGHT: bold; DISPLAY: inline"> &nbsp;</font> </td> <td style="PADDING-BOTTOM: 2px" valign="bottom"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-WEIGHT: bold; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid" valign="bottom" colspan="6"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"> 12 months or greater</div> </td> <td style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-WEIGHT: bold; DISPLAY: inline"> &nbsp;</font> </td> </tr> <tr> <td style="PADDING-BOTTOM: 2px" valign="bottom"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="PADDING-BOTTOM: 2px" valign="bottom"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-WEIGHT: bold; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid" valign="bottom" colspan="2"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"> Fair Value</div> </td> <td style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-WEIGHT: bold; DISPLAY: inline"> &nbsp;</font> </td> <td style="PADDING-BOTTOM: 2px" valign="bottom"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-WEIGHT: bold; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid" valign="bottom" colspan="2"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"> Gross</div> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"> unrealized loss</div> </td> <td style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-WEIGHT: bold; DISPLAY: inline"> &nbsp;</font> </td> <td style="PADDING-BOTTOM: 2px" valign="bottom"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-WEIGHT: bold; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid" valign="bottom" colspan="2"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"> Fair Value</div> </td> <td style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-WEIGHT: bold; DISPLAY: inline"> &nbsp;</font> </td> <td style="PADDING-BOTTOM: 2px" valign="bottom"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-WEIGHT: bold; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid" valign="bottom" colspan="2"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"> Gross</div> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"> unrealized loss</div> </td> <td style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-WEIGHT: bold; DISPLAY: inline"> &nbsp;</font> </td> </tr> <tr bgcolor="#cceeff"> <td style="TEXT-ALIGN: left; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt" valign="bottom" width="52%"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: left; TEXT-INDENT: 0pt"> As of June 30, 2014</div> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%">$</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">851</td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%">$</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">(17</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap">)</td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%">$</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">463</td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%">$</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">(12</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap">)</td> </tr> <tr bgcolor="white"> <td style="TEXT-ALIGN: left; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt" valign="bottom" width="52%"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: left; TEXT-INDENT: 0pt"> As of June 30, 2013</div> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%">$</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">5,122</td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%">$</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">(302</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap">)</td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%">$</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">32</td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%">$</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">(9</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap">)</td> </tr> </table> </div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"> The Company typically invests in highly-rated securities. When evaluating the investments for other-than-temporary impairment, the Company reviews factors such as the length of time and extent to which fair value has been below cost basis, the financial condition of the issuer and any changes thereto, and the Company&#39;s intent to sell, or whether it is more likely than not it will be required to sell, the investment before recovery of the investment&#39;s amortized cost basis. Based on the above factors, the Company concluded that unrealized losses on all available-for-sale securities were not other-than-temporary and no credit loss was present for any of its investments. As such, the Company did not recognize any impairment charges on outstanding securities during the year ended June 30, 2014.</div> <div style="DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> &nbsp;</div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"> As of June 30, 2014 and 2013, interest receivable amounted to $98 and $20 respectively.</div> <!--EndFragment--></div> </div><span></span></td>
      </tr>
    </table>
    <div style="display: none;">
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The entire disclosure for  investments in certain debt and equity securities.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 320<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 6<br><br> -URI http://asc.fasb.org/extlink&amp;oid=27724398&amp;loc=d3e27290-111563<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 320<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 9<br><br> -URI http://asc.fasb.org/extlink&amp;oid=27724398&amp;loc=d3e27357-111563<br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 320<br><br> -Glossary Debt Security<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6509901<br><br><br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 310<br><br> -SubTopic 30<br><br> -Section 50<br><br> -Paragraph 2<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6379141&amp;loc=d3e15032-111544<br><br><br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 320<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 5<br><br> -URI http://asc.fasb.org/extlink&amp;oid=27724398&amp;loc=d3e27232-111563<br><br><br><br>Reference 6: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 942<br><br> -SubTopic 320<br><br> -Section 50<br><br> -Paragraph 2<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6957658&amp;loc=d3e62557-112803<br><br><br><br>Reference 7: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 320<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 2<br><br> -URI http://asc.fasb.org/extlink&amp;oid=27724398&amp;loc=d3e27161-111563<br><br><br><br>Reference 8: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 320<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 10<br><br> -URI http://asc.fasb.org/extlink&amp;oid=27724398&amp;loc=d3e27405-111563<br><br><br><br>Reference 9: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 320<br><br> -Glossary Equity Security<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6511694<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>nonnum:textBlockItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MarketableSecuritiesAbstract">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div>
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_MarketableSecuritiesAbstract</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:stringItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
    </div>
  </body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>69
<FILENAME>R23.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
  <head>
    <META http-equiv="Content-Type" content="text/html; charset=us-ascii">
    <link rel="StyleSheet" type="text/css" href="report.css"><script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script></head>
  <body><span style="display: none;">v2.4.0.8</span><table class="report" border="0" cellspacing="2" id="ID0EME">
      <tr>
        <th class="tl" colspan="1" rowspan="2">
          <div style="width: 200px;"><strong>PROPERTY AND EQUIPMENT, NET (Tables)<br></strong></div>
        </th>
        <th class="th" colspan="1">12 Months Ended</th>
      </tr>
      <tr>
        <th class="th">
          <div>Jun. 30, 2014</div>
        </th>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentAbstract', window );"><strong>PROPERTY AND EQUIPMENT, NET [Abstract]</strong></a></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentTextBlock', window );">Schedule of Property and Equipment, Net</a></td>
        <td class="text"><!--DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd" --><div> <div><!--StartFragment--> <div style="text-align: right"> <table style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman" cellspacing="0" cellpadding="0" width="97%"> <tr> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="76%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-WEIGHT: bold; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="22%" colspan="6"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"> June 30,</div> </td> <td style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-WEIGHT: bold; DISPLAY: inline"> &nbsp;</font> </td> </tr> <tr> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="76%" align="left"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-WEIGHT: bold; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="10%" colspan="2"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"> 2014</div> </td> <td style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-WEIGHT: bold; DISPLAY: inline"> &nbsp;</font> </td> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-WEIGHT: bold; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="10%" colspan="2"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"> 2013</div> </td> <td style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-WEIGHT: bold; DISPLAY: inline"> &nbsp;</font> </td> </tr> <tr bgcolor="#cceeff"> <td valign="bottom" width="76%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"> Cost:</div> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="10%" colspan="2"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="10%" colspan="2"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> <tr bgcolor="white"> <td valign="bottom" width="76%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"> Laboratory equipment</div> </td> <td valign="bottom" width="1%" align="right"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%">$</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">6,088</td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%" align="right"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%">$</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">5,709</td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> <tr bgcolor="#cceeff"> <td valign="bottom" width="76%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"> Computers and peripheral equipment</div> </td> <td valign="bottom" width="1%" align="right"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">708</td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%" align="right"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">535</td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> <tr bgcolor="white"> <td valign="bottom" width="76%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"> Office furniture and equipment</div> </td> <td valign="bottom" width="1%" align="right"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">611</td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%" align="right"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">534</td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> <tr bgcolor="#cceeff"> <td valign="bottom" width="76%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"> Leasehold improvements</div> </td> <td valign="bottom" width="1%" align="right"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">7,453</td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%" align="right"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">7,369</td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> <tr bgcolor="white"> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="76%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"> Vehicles</div> </td> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">95</td> <td style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">68</td> <td style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> <tr bgcolor="#cceeff"> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="76%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"> &nbsp;Total Cost</div> </td> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">14,955</td> <td style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">14,215</td> <td style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> <tr bgcolor="white"> <td valign="bottom" width="76%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"> Accumulated depreciation:</div> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: right" valign="bottom" width="9%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: right" valign="bottom" width="9%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> <tr bgcolor="#cceeff"> <td valign="bottom" width="76%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"> Laboratory equipment</div> </td> <td valign="bottom" width="1%" align="right"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">2,042</td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%" align="right"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">1,306</td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> <tr bgcolor="white"> <td valign="bottom" width="76%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"> Computers and peripheral equipment</div> </td> <td valign="bottom" width="1%" align="right"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">430</td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%" align="right"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">280</td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> <tr bgcolor="#cceeff"> <td valign="bottom" width="76%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"> Office furniture and equipment</div> </td> <td valign="bottom" width="1%" align="right"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">176</td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%" align="right"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">91</td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> <tr bgcolor="white"> <td valign="bottom" width="76%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"> Leasehold improvements</div> </td> <td valign="bottom" width="1%" align="right"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">1,475</td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%" align="right"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">642</td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> <tr bgcolor="#cceeff"> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="76%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"> Vehicles</div> </td> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">9</td> <td style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">30</td> <td style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> <tr bgcolor="white"> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="76%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"> &nbsp;Total accumulated depreciation</div> </td> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">4,132</td> <td style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">2,349</td> <td style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> <tr bgcolor="#cceeff"> <td style="PADDING-BOTTOM: 4px" valign="bottom" width="76%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"> Property and equipment, net</div> </td> <td style="PADDING-BOTTOM: 4px" valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 4px double; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%">$</td> <td style="BORDER-BOTTOM: black 4px double; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">10,823</td> <td style="PADDING-BOTTOM: 4px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="PADDING-BOTTOM: 4px" valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 4px double; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%">$</td> <td style="BORDER-BOTTOM: black 4px double; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">11,866</td> <td style="PADDING-BOTTOM: 4px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> </table> </div> <!--EndFragment--></div> </div><span></span></td>
      </tr>
    </table>
    <div style="display: none;">
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentAbstract">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div>
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_PropertyPlantAndEquipmentAbstract</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:stringItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentTextBlock">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Tabular disclosure of physical assets used in the normal conduct of business and not intended for resale. Includes, but is not limited to, balances by class of assets, depreciation and depletion expense and method used, including composite depreciation, and accumulated deprecation.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 360<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 1<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 210<br><br> -SubTopic 10<br><br> -Section S99<br><br> -Paragraph 1<br><br> -Subparagraph (SX 210.5-02.13)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher SEC<br><br> -Name Regulation S-X (SX)<br><br> -Number 210<br><br> -Section 02<br><br> -Paragraph 13<br><br> -Subparagraph b<br><br> -Article 5<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_PropertyPlantAndEquipmentTextBlock</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>nonnum:textBlockItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
    </div>
  </body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>70
<FILENAME>R19.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
  <head>
    <META http-equiv="Content-Type" content="text/html; charset=us-ascii">
    <link rel="StyleSheet" type="text/css" href="report.css"><script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script></head>
  <body><span style="display: none;">v2.4.0.8</span><table class="report" border="0" cellspacing="2" id="ID0E1JAE">
      <tr>
        <th class="tl" colspan="1" rowspan="2">
          <div style="width: 200px;"><strong>SIGNIFICANT ACCOUNTING POLICIES (Policies)<br></strong></div>
        </th>
        <th class="th" colspan="1">12 Months Ended</th>
      </tr>
      <tr>
        <th class="th">
          <div>Jun. 30, 2014</div>
        </th>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>SIGNIFICANT ACCOUNTING POLICIES [Abstract]</strong></a></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_UseOfEstimates', window );">Use of estimates</a></td>
        <td class="text"><!--DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd" --><div> <div><!--StartFragment--> <div> <table style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman" cellspacing="0" cellpadding="0" width="100%" align="center" border="0"> <tr valign="top"> <td style="WIDTH: 18pt"> <div style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt"> a.</div> </td> <td> <div style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; text-align: justify"> Use of estimates</div> </td> </tr> </table> </div> <div style="DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> &nbsp;</div> <div> <table style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman" cellspacing="0" cellpadding="0" width="100%" align="center" border="0"> <tr valign="top"> <td style="WIDTH: 18pt"> <div style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; DISPLAY: inline"> &nbsp;</div> </td> <td> <div style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; text-align: justify"> The preparation of financial statements in conformity with generally accepted accounting principles requires management to make estimates, judgments, and assumptions that are reasonable based upon information available at the time they are made. These estimates, judgments and assumptions can affect the amounts reported in the financial statements and accompanying notes. Actual results could differ from those estimates.</div> </td> </tr> </table> </div> <!--EndFragment--></div> </div><span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock', window );">Functional currency of the Subsidiary</a></td>
        <td class="text"><!--DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd" --><div> <div><!--StartFragment--> <div> <table style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman" cellspacing="0" cellpadding="0" width="100%" align="center" border="0"> <tr valign="top"> <td style="WIDTH: 18pt"> <div style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt"> b.</div> </td> <td> <div style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; text-align: justify"> Functional currency of the Subsidiary</div> </td> </tr> </table> </div> <div style="DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> &nbsp;</div> <div> <table style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman" cellspacing="0" cellpadding="0" width="100%" align="center" border="0"> <tr valign="top"> <td style="WIDTH: 19pt"> <div style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; DISPLAY: inline"> &nbsp;</div> </td> <td> <div style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; text-align: justify"> The Subsidiary&#39;s revenues are generated and determined in U.S. Dollars ("dollars"). In addition, most of the financing of the Subsidiary&#39;s operations has been made in dollars. The Company&#39;s management believes that the dollar is the primary currency of the economic environment in which the Subsidiary operates. Thus, management believe that the functional currency of the Subsidiary is the dollar. Accordingly, monetary accounts maintained in currencies other than the dollar are remeasured into dollars in accordance with ASC 830, "Foreign Currency Matters". All transaction gains and losses from the remeasurement of monetary balance sheet items are reflected in the statement of operations as financial income or expenses, as appropriate.</div> </td> </tr> </table> </div> <!--EndFragment--></div> </div><span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConsolidationPolicyTextBlock', window );">Principles of consolidation</a></td>
        <td class="text"><!--DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd" --><div> <div><!--StartFragment--> <div> <table style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman" cellspacing="0" cellpadding="0" width="100%" align="center" border="0"> <tr valign="top"> <td style="WIDTH: 18pt"> <div style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt"> c.</div> </td> <td> <div style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; text-align: justify"> Principles of consolidation</div> </td> </tr> </table> </div> <div style="DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> &nbsp;</div> <div> <table style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman" cellspacing="0" cellpadding="0" width="100%" align="center" border="0"> <tr valign="top"> <td style="WIDTH: 18pt"> <div style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; DISPLAY: inline"> &nbsp;</div> </td> <td> <div style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; text-align: justify"> The consolidated financial statements include the accounts of Pluristem Therapeutics Inc. and its Subsidiary. Intercompany transactions and balances have been eliminated upon consolidation.</div> </td> </tr> </table> </div> <!--EndFragment--></div> </div><span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsPolicyTextBlock', window );">Cash and cash equivalents</a></td>
        <td class="text"><!--DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd" --><div> <div><!--StartFragment--> <div> <table style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman" cellspacing="0" cellpadding="0" width="100%" align="center" border="0"> <tr valign="top"> <td style="WIDTH: 18pt"> <div style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt"> d.</div> </td> <td> <div style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; text-align: justify"> Cash and cash equivalents</div> </td> </tr> </table> </div> <div style="DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> &nbsp;</div> <div> <table style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman" cellspacing="0" cellpadding="0" width="100%" align="center" border="0"> <tr valign="top"> <td style="WIDTH: 19pt"> <div style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; DISPLAY: inline"> &nbsp;</div> </td> <td> <div style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; text-align: justify"> Cash equivalents are short-term highly liquid investments that are readily convertible to cash with maturities of three months or less at the date acquired.</div> </td> </tr> </table> </div> <!--EndFragment--></div> </div><span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_psti_ShortTermBankDepositPolicyTextBlock', window );">Short-term bank deposit</a></td>
        <td class="text"><!--DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd" --><div> <div><!--StartFragment--> <div style="text-align: center"> <table style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman" cellspacing="0" cellpadding="0" width="100%" border="0"> <tr valign="top"> <td style="WIDTH: 18pt"> <div style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt"> e.</div> </td> <td> <div style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; text-align: justify"> Short-term bank deposit</div> </td> </tr> </table> </div> <div style="DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> &nbsp;</div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> Bank deposits with original maturities of more than three months but less than one year are presented as part of short-term investments. Deposits are presented at their cost which approximates market values including accrued interest. Interest on deposits is recorded as financial income.</div> <!--EndFragment--></div> </div><span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy', window );">Restricted cash and short-term deposits</a></td>
        <td class="text"><!--DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd" --><div> <div><!--StartFragment--> <div style="text-align: center"> <table style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman" cellspacing="0" cellpadding="0" width="100%" border="0"> <tr valign="top"> <td style="WIDTH: 18pt"> <div style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt"> f.</div> </td> <td> <div style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; text-align: justify"> Restricted cash and short-term deposits</div> </td> </tr> </table> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; MARGIN-LEFT: 36pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> &nbsp;</div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> Short-term restricted deposits and restricted cash used to secure derivative transactions are presented at cost.</div> <!--EndFragment--></div> </div><span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_psti_LongTermRestrictedDepositPolicyTextBlock', window );">Long-term restricted deposit</a></td>
        <td class="text"><!--DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd" --><div> <div><!--StartFragment--> <div style="text-align: center"> <table style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman" cellspacing="0" cellpadding="0" width="100%" border="0"> <tr valign="top"> <td style="WIDTH: 18pt"> <div style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt"> g.</div> </td> <td> <div style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; text-align: justify"> Long-term restricted deposits</div> </td> </tr> </table> </div> <div>&nbsp;</div> <div> <table style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman" cellspacing="0" cellpadding="0" width="100%" align="center" border="0"> <tr valign="top"> <td style="WIDTH: 18pt"> <div style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; DISPLAY: inline"> &nbsp;</div> </td> <td> <div style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; text-align: justify"> Long-term restricted deposits with maturities of more than one year used to secure operating lease agreement are presented at cost which approximates market values including accrued interest.</div> </td> </tr> </table> </div> <!--EndFragment--></div> </div><span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MarketableSecuritiesPolicy', window );">Marketable Securities</a></td>
        <td class="text"><!--DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd" --><div> <div><!--StartFragment--> <div style="text-align: center"> <table style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman" cellspacing="0" cellpadding="0" width="100%" border="0"> <tr valign="top"> <td style="WIDTH: 18pt"> <div style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt"> h.</div> </td> <td> <div style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; text-align: justify"> Marketable Securities</div> </td> </tr> </table> </div> <div style="DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> &nbsp;</div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> The Company accounts for its investments in marketable securities in accordance with ASC 320-"Investments - Debt and Equity Securities". The Company determines the classification of marketable securities at the time of purchase and re-evaluates such designations as of each balance sheet date. The Company classifies all of its marketable securities as available-for-sale. Available-for-sale marketable securities are carried at fair value, with the unrealized gain and loss reported at "accumulated other comprehensive income (loss)" in the statement of changes in stockholders&#39; equity.</div> <div style="DISPLAY: block; MARGIN-LEFT: 437pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> &nbsp;</div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> Realized gain and loss on sales of marketable securities are included in the Company&#39;s "Financial income, net" and are derived using the specific identification basis for determining the cost of marketable securities. The amortized cost of available for sale marketable securities is adjusted for amortization of premiums and accretion of discount to maturity. Such amortization, together with interest on available for sale marketable securities, is included in the "Financial income, net".</div> <div style="DISPLAY: block; MARGIN-LEFT: 437pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> &nbsp;</div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> The Company recognizes an impairment charge when a decline in the fair value of its available-for-sale marketable securities below the cost basis is judged to be other-than-temporary. The Company considers various factors in determining whether to recognize an impairment charge, including the length of time the investment has been in a loss position, the extent to which the fair value has been less than the Company&#39;s cost basis, the investment&#39;s financial condition and the near-term prospects of the issuer. ASC 320-10-35, "Investments - Debt and Equity Securities", requires another-than-temporary impairment for debt securities to be separated into (a)&nbsp;the amount representing the credit loss and (b)&nbsp;the amount related to all other factors (provided that the Company does not intend to sell the security and it is not more likely than not that it will be required to sell it before recovery). For securities that are deemed other-than-temporarily impaired, the amount of impairment is recognized in "financial income, net", in the statement of operations and is limited to the amount related to credit loss, while impairment related to other factors is recognized in other comprehensive income (loss).</div> <div style="DISPLAY: block; MARGIN-LEFT: 437pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> &nbsp;</div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> During 2014, 2013 and 2012, no impairment losses been identified.</div> <!--EndFragment--></div> </div><span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueRecognitionPolicyTextBlock', window );">Revenue Recognition from the license Agreement with United Therapeutics</a></td>
        <td class="text"><!--DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd" --><div> <div><!--StartFragment--> <div style="text-align: center"> <table style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman" cellspacing="0" cellpadding="0" width="100%" border="0"> <tr valign="top"> <td style="WIDTH: 18pt"> <div style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt"> i.</div> </td> <td> <div style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; text-align: justify"> Revenue Recognition from the license Agreement with United Therapeutics</div> </td> </tr> </table> </div> <div style="DISPLAY: block; MARGIN-LEFT: 437pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> &nbsp;</div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> The Company recognizes revenue pursuant to the License Agreement with United Therapeutics in accordance with ASC 605-25, "Revenue Recognition, Multiple-Element Arrangements".</div> <div style="MARGIN-LEFT: 437pt; DISPLAY: block; TEXT-INDENT: 0pt"> <br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> Pursuant to ASC 605-25, each deliverable is evaluated to determine whether it qualifies as a separate unit of accounting based on whether the deliverable has "stand-alone value" to the customer. The arrangement&#39;s consideration that is fixed or determinable is then allocated to each separate unit of accounting based on the relative selling price of each deliverable. In general, the consideration allocated to each unit of accounting is recognized as the related goods or services are delivered, limited to the consideration that is not contingent upon future deliverables.</div> <div style="MARGIN-LEFT: 437pt; DISPLAY: block; TEXT-INDENT: 0pt"> <br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> The Company received an up-front, non-refundable license payment of $5,000. Additional payments totaling $37,500 are subject to the achievement of certain regulatory milestones by United Therapeutics.</div> <div style="MARGIN-LEFT: 437pt; DISPLAY: block; TEXT-INDENT: 0pt"> <br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> Since the deliverables in the United Agreement do not have stand-alone value, none of them qualifies as a separate unit of accounting. Accordingly, the non-refundable upfront license fee of $5,000 is deferred and recognized on a straight line basis over the related performance period which is the development period in accordance with Staff Accounting Bulletin ("SAB") 104, "Revenue Recognition". The remaining performance period is 8.5 years as of June 30, 2014.</div> <div style="MARGIN-LEFT: 437pt; DISPLAY: block; TEXT-INDENT: 0pt"> <br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> The additional regulatory milestones payments will be recognized upon the achievement of futures events by United Therapeutics, in accordance with ASC 450-30-25, "Gain Contingencies". As of June 30, 2014, no regulatory millstones were achieved.</div> <div style="MARGIN-LEFT: 437pt; DISPLAY: block; TEXT-INDENT: 0pt"> <br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> The Company also received an advanced payment for the development, of $2,000 that will be deductible against development expenses as it incurred. The upfront payment which was received and has not yet fully recognized in the statement of operations, is included in the balance sheet as advance payment. Part of the expenses related to the development, on a cost basis, shall be repaid to the Company by United Therapeutics according to the applicable license agreement. The Company is deducting the payments from its research and development expenses in accordance with ASC 730-20, "Research and Development Agreements". As of June 30, 2014, the Company deducted an amount of approximately $1,753.</div> <!--EndFragment--></div> </div><span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock', window );">Property and Equipment</a></td>
        <td class="text"><!--DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd" --><div> <div><!--StartFragment--> <div> <table style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman" cellspacing="0" cellpadding="0" width="100%" align="center" border="0"> <tr valign="top"> <td style="WIDTH: 18pt"> <div style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt"> j.</div> </td> <td> <div style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; text-align: justify"> Property and Equipment</div> </td> </tr> </table> </div> <div style="DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> &nbsp;</div> <div> <table style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman" cellspacing="0" cellpadding="0" width="100%" align="center" border="0"> <tr valign="top"> <td style="WIDTH: 18pt"> <div style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; DISPLAY: inline"> &nbsp;</div> </td> <td> <div style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; text-align: justify"> Property and equipment are stated at cost, net of accumulated depreciation. Depreciation is calculated by the straight-line method over the estimated useful lives of the assets, at the following annual rates:</div> </td> </tr> </table> </div> <div style="DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> &nbsp;</div> <div style="MARGIN-LEFT: 18pt; text-align: left"> <table style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman" cellspacing="0" cellpadding="0" width="80%"> <tr> <td valign="top" width="44%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid" valign="top" width="28%"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt"> %</div> </td> <td valign="top" width="28%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> <tr bgcolor="#cceeff"> <td valign="top" width="44%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"> Laboratory equipment</div> </td> <td valign="top" width="28%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: -12.3pt; text-align: left; TEXT-INDENT: 0pt"> 10-15</div> </td> <td valign="top" width="28%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> <tr bgcolor="white"> <td valign="top" width="44%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"> Computers and peripheral equipment</div> </td> <td valign="top" width="28%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: -12.3pt; text-align: left; TEXT-INDENT: 0pt"> 33</div> </td> <td valign="top" width="28%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> <tr bgcolor="#cceeff"> <td valign="top" width="44%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"> Office furniture and equipment</div> </td> <td valign="top" width="28%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: -12.3pt; text-align: left; TEXT-INDENT: 0pt"> 6-15</div> </td> <td valign="top" width="28%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> <tr bgcolor="white"> <td valign="top" width="44%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"> Vehicles</div> </td> <td valign="top" width="15%" colspan="2" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: -12.3pt; text-align: left; TEXT-INDENT: 0pt"> 15</div> </td> </tr> <tr bgcolor="#cceeff"> <td valign="top" width="44%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"> Leasehold improvements</div> </td> <td valign="top" width="56%" colspan="2" align="left"> <div style="DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: -12.3pt; text-align: left; TEXT-INDENT: 0pt"> <font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> The shorter of the expected</font> <font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> useful life or the</font></div> <div style="DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: -12.3pt; text-align: left; TEXT-INDENT: 0pt"> <font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> reasonable assumed</font> <font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> term of the lease.</font></div> </td> </tr> </table> </div> <!--EndFragment--></div> </div><span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock', window );">Impairment of long-lived assets</a></td>
        <td class="text"><!--DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd" --><div> <div><!--StartFragment--> <div style="text-align: center"> <table style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman" cellspacing="0" cellpadding="0" width="100%" border="0"> <tr valign="top"> <td style="WIDTH: 18pt"> <div style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt"> k.</div> </td> <td> <div style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; text-align: justify"> Impairment of long-lived assets</div> </td> </tr> </table> </div> <div style="DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> &nbsp;</div> <div> <table style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman" cellspacing="0" cellpadding="0" width="100%" align="center" border="0"> <tr valign="top"> <td style="WIDTH: 18pt"> <div style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; DISPLAY: inline"> &nbsp;</div> </td> <td> <div style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; text-align: justify"> The Company&#39;s long-lived assets are reviewed for impairment in accordance with ASC 360, "Property, Plant and Equipment", whenever events or changes in circumstances indicate that the carrying amount of an asset may not be recoverable. Recoverability of assets to be held and used is measured by a comparison of the carrying amount of the assets to the future undiscounted cash flows expected to be generated by the assets. If such assets are considered to be impaired, the impairment to be recognized is measured by the amount by which the carrying amount of the assets exceeds the fair value of the assets. During 2014, 2013 and 2012, no impairment losses been identified.</div> </td> </tr> </table> </div> <!--EndFragment--></div> </div><span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy', window );">Accounting for stock-based compensation</a></td>
        <td class="text"><!--DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd" --><div> <div><!--StartFragment--> <div> <table style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman" cellspacing="0" cellpadding="0" width="100%" align="center" border="0"> <tr valign="top"> <td style="WIDTH: 18pt"> <div style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt"> l.</div> </td> <td> <div style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; text-align: justify"> Accounting for stock-based compensation</div> </td> </tr> </table> </div> <div style="DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> &nbsp;</div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> The Company accounts for stock-based compensation in accordance with ASC 718, "Compensation-Stock Compensation" ("ASC 718") and ASC 505-50 "Equity-Based Payments to Non-Employees". ASC 718 requires companies to estimate the fair value of equity-based payment awards on the date of grant using an option-pricing model. The Company estimates the fair value of stock options granted using the Black-Scholes-Merton option-pricing model. The Company accounts for employee&#39;s share-based payment awards classified as equity awards using the grant-date fair value method. The fair value of share-based payment transactions is recognized as an expense over the requisite service period, net of estimated forfeitures. The Company estimates forfeitures based on historical experience and anticipated future conditions. The Company elected to recognize compensation cost for an award with service conditions and goals achievement that has a graded vesting schedule using the accelerated method based on the multiple-option award approach.</div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> During fiscal years 2014, 2013 and 2012 there were no options grants to employees or directors.</div> <div style="MARGIN-LEFT: 437pt; DISPLAY: block; TEXT-INDENT: 0pt"> <br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> The assumptions below are relevant to restricted shares units granted in 2014, 2013 and 2012:</div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> In accordance with <font style="FONT-SIZE: 10pt; DISPLAY: inline">ASC 718</font>, restricted shares or restricted shares units are measured at their fair value. All restricted shares and restricted shares units to employees, directors and non-employees granted in 20142013 and 2012 were granted for no consideration; therefore, their fair value was equal to the share price at the date of grant.</div> <div style="MARGIN-LEFT: 437pt; DISPLAY: block; TEXT-INDENT: 0pt"> <br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> The expected pre-vesting forfeiture rate affects the number of exercisable shares. Based on Company&#39;s historical experience, the pre-vesting forfeiture rate per grant for shares granted to employees is 7% for year ended June 30, 2014 and 2013 and 5% for the year ended June 30, 2012, and 0% for the options and shares granted to directors and officers and consultants of the Company.</div> <div style="MARGIN-LEFT: 437pt; DISPLAY: block; TEXT-INDENT: 0pt"> <br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> The fair value of all restricted shares and restricted shares units was determined based on the close trading price of the Company&#39;s shares known at the grant date. The weighted average grant date fair value of share granted during years 2014, 2013 and 2012 was $3.53, $3.43 and $2.54, respectively.</div> <!--EndFragment--></div> </div><span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_psti_ResearchAndDevelopmentExpensesAndGrantsPolicyTextBlock', window );">Research and Development expenses and grants</a></td>
        <td class="text"><!--DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd" --><div> <div><!--StartFragment--> <div style="text-align: center"> <table style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman" cellspacing="0" cellpadding="0" width="100%" border="0"> <tr valign="top"> <td style="WIDTH: 18pt"> <div style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt"> m.</div> </td> <td> <div style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; text-align: justify"> Research and Development expenses and grants</div> </td> </tr> </table> </div> <div style="DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> &nbsp;</div> <div> <table style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman" cellspacing="0" cellpadding="0" width="100%" align="center" border="0"> <tr valign="top"> <td style="WIDTH: 19pt"> <div style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; DISPLAY: inline"> &nbsp;</div> </td> <td> <div style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; text-align: justify"> Research and development expenses, net of participations, are charged to the statement of operations as incurred.</div> </td> </tr> </table> </div> <div style="DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> &nbsp;</div> <div> <table style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman" cellspacing="0" cellpadding="0" width="100%" align="center" border="0"> <tr valign="top"> <td style="WIDTH: 19pt"> <div style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; DISPLAY: inline"> &nbsp;</div> </td> <td> <div style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; text-align: justify"> Research and development grants from the government of Israel and other parties for funding approved research and development projects are recognized at the time the Company is entitled to such grants, on the basis of the cost incurred and applied as a deduction from research and development costs.</div> </td> </tr> </table> </div> <!--EndFragment--></div> </div><span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerSharePolicyTextBlock', window );">Loss per share</a></td>
        <td class="text"><!--DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd" --><div> <div><!--StartFragment--> <div style="text-align: center"> <table style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman" cellspacing="0" cellpadding="0" width="100%" border="0"> <tr valign="top"> <td style="WIDTH: 18pt"> <div style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt"> n.</div> </td> <td> <div style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; text-align: justify"> Loss per share</div> </td> </tr> </table> </div> <div style="DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> &nbsp;</div> <div> <table style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman" cellspacing="0" cellpadding="0" width="100%" align="center" border="0"> <tr valign="top"> <td style="WIDTH: 19pt"> <div style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; DISPLAY: inline"> &nbsp;</div> </td> <td> <div style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; text-align: justify"> Basic and dilutive net loss per share is computed based on the weighted average number of shares of common stock outstanding during each year. All outstanding stock options and unvested restricted stock units have been excluded from the calculation of the diluted loss per common share because all such securities are anti-dilutive for each of the periods presented.</div> </td> </tr> </table> </div> <!--EndFragment--></div> </div><span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxPolicyTextBlock', window );">Income taxes</a></td>
        <td class="text"><!--DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd" --><div> <div><!--StartFragment--> <div style="text-align: center"> <table style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman" cellspacing="0" cellpadding="0" width="100%" border="0"> <tr valign="top"> <td style="WIDTH: 18pt"> <div style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt"> o.</div> </td> <td> <div style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; text-align: justify"> Income taxes</div> </td> </tr> </table> </div> <div style="DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> &nbsp;</div> <div> <table style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman" cellspacing="0" cellpadding="0" width="100%" align="center" border="0"> <tr valign="top"> <td style="WIDTH: 19pt"> <div style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; DISPLAY: inline"> &nbsp;</div> </td> <td> <div style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; text-align: justify"> The Company accounts for income taxes in accordance with ASC 740, "Income Taxes". This Topic prescribes the use of the liability method, whereby deferred tax assets and liability account balances are determined based on differences between financial reporting and tax bases of assets and liabilities and are measured using the enacted tax rates and laws that will be in effect when the differences are expected to reverse. The Company provides a valuation allowance, if necessary, to reduce deferred tax assets to their estimated realizable value.</div> </td> </tr> </table> </div> <div style="DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> &nbsp;</div> <div> <table style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman" cellspacing="0" cellpadding="0" width="100%" align="center" border="0"> <tr valign="top"> <td style="WIDTH: 19pt"> <div style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; DISPLAY: inline"> &nbsp;</div> </td> <td> <div style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; text-align: justify"> ASC 740 establishes a single model to address accounting for uncertain tax positions. ASC 740 clarified the accounting for income taxes by prescribing the minimum recognition threshold a tax position is required to meet before being recognized in the financial statements.</div> </td> </tr> </table> </div> <!--EndFragment--></div> </div><span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConcentrationRiskCreditRisk', window );">Concentration of credit risk</a></td>
        <td class="text"><!--DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd" --><div> <div><!--StartFragment--> <div style="text-align: center"> <table style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman" cellspacing="0" cellpadding="0" width="100%" border="0"> <tr valign="top"> <td style="WIDTH: 18pt"> <div style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt"> p.</div> </td> <td> <div style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; text-align: justify"> Concentration of credit risk</div> </td> </tr> </table> </div> <div style="DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> &nbsp;</div> <div> <table style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman" cellspacing="0" cellpadding="0" width="100%" align="center" border="0"> <tr valign="top"> <td style="WIDTH: 19pt"> <div style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; DISPLAY: inline"> &nbsp;</div> </td> <td> <div style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; text-align: justify"> Financial instruments that potentially subject the Company to concentrations of credit risk consist principally of cash and cash equivalents, short-term deposits, long-term deposits, restricted deposits and marketable securities.</div> </td> </tr> </table> </div> <div style="DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> &nbsp;</div> <div> <table style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman" cellspacing="0" cellpadding="0" width="100%" align="center" border="0"> <tr valign="top"> <td style="WIDTH: 19pt"> <div style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; DISPLAY: inline"> &nbsp;</div> </td> <td> <div style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; text-align: justify"> The majority of the Company&#39;s cash and cash equivalents and short-term and long-term deposits are invested in dollar instruments of major banks in Israel. Generally, these deposits may be redeemed upon demand and therefore bear minimal risk.</div> </td> </tr> </table> </div> <div style="DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> &nbsp;</div> <div> <table style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman" cellspacing="0" cellpadding="0" width="100%" align="center" border="0"> <tr valign="top"> <td style="WIDTH: 18pt"> <div style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; DISPLAY: inline"> &nbsp;</div> </td> <td> <div style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; text-align: justify"> The Company invests its surplus cash in cash deposits and marketable securities in financial institutions and has established guidelines, approved by the Company&#39;s Investment Committee, relating to diversification and maturities to maintain safety and liquidity of the investments.</div> </td> </tr> </table> </div> <div style="DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> &nbsp;</div> <div> <table style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman" cellspacing="0" cellpadding="0" width="100%" align="center" border="0"> <tr valign="top"> <td style="WIDTH: 18pt"> <div style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; DISPLAY: inline"> &nbsp;</div> </td> <td> <div style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; text-align: justify"> The Company holds an investment portfolio consisting of corporate bonds, government bonds, stocks and index linked notes. The Company intends, and has the ability, to hold such investments until recovery of temporary declines in market value or maturity; accordingly, as of June&nbsp;30, 2014, the Company believes the losses associated with its investments are temporary and no impairment loss was recognized during 2014. However, the Company can provide no assurance that it will recover declines in the market value of its investments.</div> </td> </tr> </table> </div> <!--EndFragment--></div> </div><span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_psti_SeverancePayPolicyTextBlock', window );">Severance pay</a></td>
        <td class="text"><!--DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd" --><div> <div><!--StartFragment--> <div style="text-align: center"> <table style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman" cellspacing="0" cellpadding="0" width="100%" border="0"> <tr valign="top"> <td style="WIDTH: 17pt"> <div style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt"> q.</div> </td> <td> <div style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; text-align: justify"> Severance pay</div> </td> </tr> </table> </div> <div style="DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> &nbsp;</div> <div> <table style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman" cellspacing="0" cellpadding="0" width="100%" align="center" border="0"> <tr valign="top"> <td style="WIDTH: 19pt"> <div style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; DISPLAY: inline"> &nbsp;</div> </td> <td> <div style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; text-align: justify"> The Subsidiary&#39;s liability for severance pay is calculated pursuant to Israeli Severance Pay Law, 1963 (the "Severance Pay Law")&nbsp;&nbsp;based on the most recent salary of the employees multiplied by the number of years of employment, as of the balance sheet date. Employees are entitled to one month&#39;s salary for each year of employment or a portion thereof.</div> <div style="text-align: justify">&nbsp;</div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-ALIGN: justify; TEXT-INDENT: 0pt"> The Company&#39;s liability for all of its employees is fully provided by monthly deposits with insurance policies and by an accrual. The value of these policies is recorded as an asset in the Company&#39;s balance sheet.</div> </td> </tr> </table> </div> <div style="DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> &nbsp;</div> <div> <table style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman" cellspacing="0" cellpadding="0" width="100%" align="center" border="0"> <tr valign="top"> <td style="WIDTH: 19pt"> <div style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; DISPLAY: inline"> &nbsp;</div> </td> <td> <div style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; text-align: justify"> The deposited funds include profits or losses accumulated up to the balance sheet date. The deposited funds may be withdrawn only upon the fulfillment of the obligation pursuant to Israeli severance pay law or labor agreements. The value of the deposited funds is based on the cash surrendered value of these policies, and includes immaterial profits or losses.</div> </td> </tr> </table> </div> <div style="DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> &nbsp;</div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"> Since November 2011, the Company&#39;s agreements with new employees in Israel, are subject to Section 14 of the Severance Pay Law. The Company&#39;s contributions for severance pay have replaced its severance obligation. Upon contribution of the full amount of the employee&#39;s monthly salary for each year of employment, no additional calculations is conducted between the parties regarding the matter of severance pay and no additional payments is made by the Company to the employee. Further, the related obligation and amounts deposited on behalf of the employee for such obligation are not stated on the balance sheet, as the Company is legally released from the obligation to employees once the deposit amounts have been paid.</div> <div style="DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> &nbsp;</div> <div> <table style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman" cellspacing="0" cellpadding="0" width="100%" align="center" border="0"> <tr valign="top"> <td style="WIDTH: 19pt"> <div style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; DISPLAY: inline"> &nbsp;</div> </td> <td> <div style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; text-align: justify"> Severance expenses for the years ended December 31, 2014, 2013 and 2012, were $534, $329 and $275, respectively.</div> </td> </tr> </table> </div> <!--EndFragment--></div> </div><span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueOfFinancialInstrumentsPolicy', window );">Fair value of financial instruments</a></td>
        <td class="text"><!--DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd" --><div> <div><!--StartFragment--> <div style="text-align: center"> <table style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman" cellspacing="0" cellpadding="0" width="100%" border="0"> <tr valign="top"> <td style="WIDTH: 18pt"> <div style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt"> r.</div> </td> <td> <div style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; text-align: justify"> Fair value of financial instruments</div> </td> </tr> </table> </div> <div style="DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> &nbsp;</div> <div> <table style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman" cellspacing="0" cellpadding="0" width="100%" align="center" border="0"> <tr valign="top"> <td style="WIDTH: 19pt"> <div style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; DISPLAY: inline"> &nbsp;</div> </td> <td> <div style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; text-align: justify"> The carrying amounts of the Company&#39;s financial instruments, including cash and cash equivalents, short-term and restricted bank deposits, trade payable and other accounts payable and accrued liabilities, approximate fair value because of their generally short term maturities.</div> </td> </tr> </table> </div> <div style="DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> &nbsp;</div> <div> <table style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman" cellspacing="0" cellpadding="0" width="100%" align="center" border="0"> <tr valign="top"> <td style="WIDTH: 19pt"> <div style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; DISPLAY: inline"> &nbsp;</div> </td> <td> <div style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; text-align: justify"> The Company measures its investments in marketable securities and derivative instruments at fair value under ASC 820, "Fair Value Measurements and Disclosures" ("ASC 820"). Fair value is an exit price, representing the amount that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants. As such, fair value is a market-based measurement that should be determined based on assumptions that market participants would use in pricing an asset or a liability. As a basis for considering such assumptions, ASC 820 establishes a three-tier value hierarchy, which prioritizes the inputs used in the valuation methodologies in measuring fair value:</div> </td> </tr> </table> </div> <div style="DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> &nbsp;</div> <div> <table style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman" cellspacing="0" cellpadding="0" width="100%" align="center" border="0"> <tr valign="top"> <td style="WIDTH: 19pt"> <div style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; DISPLAY: inline"> &nbsp;</div> </td> <td> <div style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; text-align: justify"> <font style="FONT-WEIGHT: bold; DISPLAY: inline">Level 1 -</font> Quoted prices (unadjusted) in active markets for identical assets or liabilities that the Company can access at the measurement date;</div> </td> </tr> </table> </div> <div style="DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> &nbsp;</div> <div> <table style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman" cellspacing="0" cellpadding="0" width="100%" align="center" border="0"> <tr valign="top"> <td style="WIDTH: 19pt"> <div style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; DISPLAY: inline"> &nbsp;</div> </td> <td> <div style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; text-align: justify"> <font style="FONT-WEIGHT: bold; DISPLAY: inline">Level 2 -</font> Inputs other than quoted prices included within Level 1 that are observable for the asset or liability, either directly or indirectly.; and</div> </td> </tr> </table> </div> <div style="DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> &nbsp;</div> <div> <table style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman" cellspacing="0" cellpadding="0" width="100%" align="center" border="0"> <tr valign="top"> <td style="WIDTH: 19pt"> <div style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; DISPLAY: inline"> &nbsp;</div> </td> <td> <div style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; text-align: justify"> <font style="FONT-WEIGHT: bold; DISPLAY: inline">Level 3 -</font> Unobservable inputs for the asset or liability.</div> </td> </tr> </table> </div> <div style="DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> &nbsp;</div> <div> <table style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman" cellspacing="0" cellpadding="0" width="100%" align="center" border="0"> <tr valign="top"> <td style="WIDTH: 19pt"> <div style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; DISPLAY: inline"> &nbsp;</div> </td> <td> <div style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; text-align: justify"> The fair value hierarchy also requires an entity to maximize the use of observable inputs and minimize the use of unobservable inputs when measuring fair value. The Company categorized each of its fair value measurements in one of these three levels of hierarchy.</div> </td> </tr> </table> </div> <!--EndFragment--></div> </div><span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativesPolicyTextBlock', window );">Derivative financial instruments</a></td>
        <td class="text"><!--DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd" --><div> <div><!--StartFragment--> <div style="text-align: center"> <table style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman" cellspacing="0" cellpadding="0" width="100%" border="0"> <tr valign="top"> <td style="WIDTH: 18pt"> <div style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt"> s.</div> </td> <td> <div style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; text-align: justify"> Derivative financial instruments</div> </td> </tr> </table> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> &nbsp;</div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> The Company uses forward contracts and options strategies ("derivative instruments") primarily to manage exposure to foreign currency. The Company accounts for derivatives and hedging based on ASC 815, "Derivatives and Hedging" ("ASC 815"). ASC 815 requires the Company to recognize all derivative instruments as either assets or liabilities on the balance sheet at fair value. The accounting for changes in the fair value (i.e., gains or losses) of derivative instruments depends on whether it has been designated and qualifies as part of a hedging relationship and further, on the type of hedging relationship. For those derivative instruments that are designated and qualify as hedging instruments, the Company must designate the hedging instrument, based upon the exposure being hedged, as a fair value hedge, cash flow hedge, or a hedge of a net investment in a foreign operation.</div> <div style="DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> &nbsp;</div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> If the derivative instruments meet the definition of a hedge and are so designated, depending on the nature of the hedge, changes in the fair value of such derivatives will either be offset against the change in fair value of the hedged assets, liabilities, or firm commitments through earnings, or recognized in other comprehensive income until the hedged item is recognized in the statement of operations.<font style="FONT-SIZE: 10pt; DISPLAY: inline">&nbsp;</font> The ineffective portion of a derivative&#39;s change in fair value is recognized in the statement of operations.</div> <div style="DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> &nbsp;</div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> <font style="FONT-FAMILY: Times New Roman; FONT-STYLE: italic; DISPLAY: inline"> Cash Flow Hedges</font>. The Company entered into forward contracts to hedge against the risk of overall changes in future cash flow from payments of payroll and related expenses denominated in New Israeli Shekels (NIS). The Company measured the fair value of the contracts in accordance with ASC 820 (classified as level 2). The gain or loss on the effective portion of a cash flow hedge is initially reported as a component of accumulated other comprehensive income and subsequently reclassified into operating expenses in the same period or periods in which the payroll and related expenses are recognized, or reclassified into "Financial income, net", if the hedged transaction becomes probable of not occurring. Any gain or loss after a hedge is no longer designated, because it is no longer probable of occurring or it is related to an ineffective portion of a cash flow hedge is recognized in the statement of operations immediately. As of June 30, 2014, the Company had forward contracts in place to hedge future payroll and related expenses in NIS of approximately $2,820, with fair value of approximately $24. The net unrealized gain on the effective portion of these cash flow hedges was $23. The net gain realized in statement of operations during the year ended June 30, 2014, resulting from the cash flow hedge transactions,&nbsp;&nbsp;amounted to approximately $48. The forward contracts on the Company&#39;s future NIS payroll and related expenses will settle by December 2014. On June 30, 2013, the Company did not have contracts designated and qualifies as cash flow hedge.</div> <div style="MARGIN-LEFT: 437pt; DISPLAY: block; TEXT-INDENT: 0pt"> <br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> <font style="FONT-FAMILY: Times New Roman; FONT-STYLE: italic; DISPLAY: inline"> Fair Value Hedges</font>. The Company entered into forward contracts designated as fair value hedges to hedge foreign currency risks for its investment denominated in currencies other than the U.S. dollar. The Company measured the fair value of the contracts in accordance with ASC 820 (classified as level 2). Gains and losses on these contracts are recognized in "Financial income, net", along with the offsetting losses and gains of the related hedged items.</div> <div style="DISPLAY: block; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> &nbsp;</div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> In connection with the investment in CHA shares (see Note 1d), an available-for-sale marketable security denominated in Korean Won, the Company entered into a forward contract to hedge against the foreign currency risk between the Korean Won and the U.S. dollar. The notional principal of this contract is $11,000 as of June 30, 2014 with fair value of approximately $(889).</div> <div style="DISPLAY: block; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> &nbsp;</div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> The changes in fair value of the available-for-sale CHA shares attributable to the foreign currency risk being hedged are reflected in the statement of operations in "Financial income, net" (not in other comprehensive income). Other changes in fair value of the available-for-sale CHA shares continue to follow ASC 320-"Investments-Debt and Equity Securities", accounting and are reflected in other comprehensive income.</div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> <font style="FONT-FAMILY: Times New Roman; FONT-STYLE: italic; DISPLAY: inline"> Other Derivatives</font>. Other derivatives that are non-designated consist primarily of options strategies to minimize the risk associated with the foreign exchange effects of monetary assets and liabilities denominated in NIS. The Company measured the fair value of the contracts in accordance with ASC 820 (classified as level 2). The net gains (losses) recognized in "Financial income, net" during the year ended June 30, 2014, 2013 and 2012 were ($70), $231 and ($145), respectively.</div> <!--EndFragment--></div> </div><span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ComprehensiveIncomePolicyPolicyTextBlock', window );">Comprehensive income</a></td>
        <td class="text"><!--DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd" --><div> <div><!--StartFragment--> <div style="text-align: center"> <table style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman" cellspacing="0" cellpadding="0" width="100%" border="0"> <tr valign="top"> <td style="WIDTH: 18pt"> <div style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt"> t.</div> </td> <td> <div style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; text-align: justify"> <font style="FONT-WEIGHT: bold; DISPLAY: inline">Comprehensive income</font><font style="FONT-SIZE: 10pt; DISPLAY: inline">:</font></div> </td> </tr> </table> </div> <div style="DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> &nbsp;</div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> The Company accounts for comprehensive income (loss) in accordance with ASC No. 220, "Comprehensive Income". Comprehensive income generally represents all changes in shareholders&#39; equity during the period except those resulting from investments by, or distributions to, shareholders. The Company determined that its items of other comprehensive income relate to gains and losses on cash flow hedging derivative instruments and unrealized gains and losses on available for sale marketable securities.</div> <div style="DISPLAY: block; TEXT-INDENT: 0pt">&nbsp;</div> <div style="text-align: right"> <table style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman" cellspacing="0" cellpadding="0" width="97%"> <tr> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="64%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="34%" colspan="10"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"> Year ended June 30, 2014</div> </td> <td style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> <tr> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="64%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="10%" colspan="2"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"> Unrealized</div> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"> gains</div> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"> on marketable</div> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"> securities</div> </td> <td style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="10%" colspan="2"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"> Unrealized</div> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"> gains</div> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"> on cash flow</div> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"> hedges</div> </td> <td style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="10%" colspan="2"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"> Total</div> </td> <td style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> <tr bgcolor="#cceeff"> <td style="TEXT-ALIGN: left; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt" valign="bottom" width="64%"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: left; TEXT-INDENT: 0pt"> Beginning balance</div> </td> <td valign="bottom" width="1%" align="right"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%">$</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">259</td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%" align="right"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%">$</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">-</td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%" align="right"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%">$</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">259</td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> <tr bgcolor="white"> <td style="TEXT-ALIGN: left; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt" valign="bottom" width="64%"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: left; TEXT-INDENT: 0pt"> Other comprehensive income before reclassifications</div> </td> <td valign="bottom" width="1%" align="right"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">3,404</td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%" align="right"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">23</td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%" align="right"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">3,427</td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> <tr bgcolor="#cceeff"> <td style="TEXT-ALIGN: left; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt" valign="bottom" width="64%"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: left; TEXT-INDENT: 0pt"> Amounts reclassified from accumulated other comprehensive loss</div> </td> <td valign="bottom" width="1%" align="right"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">(727</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap">)</td> <td valign="bottom" width="1%" align="right"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">-</td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%" align="right"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">(727</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap">)</td> </tr> <tr bgcolor="white"> <td style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt" valign="bottom" width="64%"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: left; TEXT-INDENT: 0pt"> Net current-period other comprehensive income</div> </td> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%" align="right"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">2,677</td> <td style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%" align="right"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">23</td> <td style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%" align="right"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">2,700</td> <td style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> <tr bgcolor="#cceeff"> <td style="PADDING-BOTTOM: 4px; TEXT-ALIGN: left; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt" valign="bottom" width="64%"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: left; TEXT-INDENT: 0pt"> Ending balance</div> </td> <td style="PADDING-BOTTOM: 4px" valign="bottom" width="1%" align="right"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 4px double; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%">$</td> <td style="BORDER-BOTTOM: black 4px double; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">2,936</td> <td style="PADDING-BOTTOM: 4px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="PADDING-BOTTOM: 4px" valign="bottom" width="1%" align="right"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 4px double; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%">$</td> <td style="BORDER-BOTTOM: black 4px double; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">23</td> <td style="PADDING-BOTTOM: 4px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="PADDING-BOTTOM: 4px" valign="bottom" width="1%" align="right"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 4px double; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%">$</td> <td style="BORDER-BOTTOM: black 4px double; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">2,959</td> <td style="PADDING-BOTTOM: 4px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> </table> </div> <!--EndFragment--></div> </div><span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock', window );">Recent Accounting Pronouncement</a></td>
        <td class="text"><!--DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd" --><div> <div><!--StartFragment--> <div style="text-align: center"> <table style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman" cellspacing="0" cellpadding="0" width="100%" border="0"> <tr valign="top"> <td style="WIDTH: 18pt"> <div style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt"> u.</div> </td> <td> <div style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; text-align: justify"> Recent Accounting Pronouncement</div> </td> </tr> </table> </div> <div style="DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> &nbsp;</div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> In May 2014, the FASB issued Accounting Standards Update No. 2014-09 ("ASU 2014-09"), "Revenue from Contracts with Customers". ASU 2014-09 supersedes the revenue recognition requirements in "Revenue Recognition (Topic 605)", and requires entities to recognize revenue when it transfers promised goods or services to customers in an amount that reflects the consideration to which the entity expects to be entitled to in exchange for those goods or services. ASU 2014-09 is effective for annual reporting periods beginning after December 15, 2016, including interim periods within that reporting period. Early adoption is not permitted. The Company is currently in the process of evaluating the impact of the adoption of ASU 2014-09 on its consolidated financial statements.</div> <!--EndFragment--></div> </div><span></span></td>
      </tr>
    </table>
    <div style="display: none;">
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_psti_LongTermRestrictedDepositPolicyTextBlock">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The policy disclosure regarding long-term restricted deposits for the entity.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>psti_LongTermRestrictedDepositPolicyTextBlock</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>psti_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>nonnum:textBlockItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_psti_ResearchAndDevelopmentExpensesAndGrantsPolicyTextBlock">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Disclosure of accounting policy for research and development expenses and grants.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>psti_ResearchAndDevelopmentExpensesAndGrantsPolicyTextBlock</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>psti_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>nonnum:textBlockItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_psti_SeverancePayPolicyTextBlock">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Disclosure of accounting policy related to severance pay.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>psti_SeverancePayPolicyTextBlock</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>psti_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>nonnum:textBlockItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_psti_ShortTermBankDepositPolicyTextBlock">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The policy disclosure regarding short-term bank deposits for the entity.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>psti_ShortTermBankDepositPolicyTextBlock</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>psti_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>nonnum:textBlockItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div>
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_AccountingPoliciesAbstract</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:stringItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsPolicyTextBlock">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Disclosure of accounting policy for cash and cash equivalents, including the policy for determining which items are treated as cash equivalents. Other information that may be disclosed includes (1) the nature of any restrictions on the entity's use of its cash and cash equivalents, (2) whether the entity's cash and cash equivalents are insured or expose the entity to credit risk, (3) the classification of any negative balance accounts (overdrafts), and (4) the carrying basis of cash equivalents (for example, at cost) and whether the carrying amount of cash equivalents approximates fair value.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 235<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 3<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6367646&amp;loc=d3e18780-107790<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Glossary Cash<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6506951<br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Glossary Cash Equivalents<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6507016<br><br><br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 230<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 1<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6367179&amp;loc=d3e4273-108586<br><br><br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 305<br><br> -SubTopic 10<br><br> -Section 05<br><br> -Paragraph 1<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6375392&amp;loc=d3e26790-107797<br><br><br><br>Reference 6: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher SEC<br><br> -Name Regulation S-X (SX)<br><br> -Number 210<br><br> -Section 02<br><br> -Paragraph 1<br><br> -Article 5<br><br><br><br>Reference 7: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher SEC<br><br> -Name Financial Reporting Release (FRR)<br><br> -Number 203<br><br> -Paragraph 02-03<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_CashAndCashEquivalentsPolicyTextBlock</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>nonnum:textBlockItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Entity's cash and cash equivalents accounting policy with respect to restricted balances.  Restrictions may include legally restricted deposits held as compensating balances against short-term borrowing arrangements, contracts entered into with others, or company statements of intention with regard to particular deposits; however, time deposits and short-term certificates of deposit are not generally included in legally restricted deposits.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 235<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 3<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6367646&amp;loc=d3e18780-107790<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 230<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 1<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6367179&amp;loc=d3e4273-108586<br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 305<br><br> -SubTopic 10<br><br> -Section 05<br><br> -Paragraph 1<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6375392&amp;loc=d3e26790-107797<br><br><br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher SEC<br><br> -Name Regulation S-X (SX)<br><br> -Number 210<br><br> -Section 02<br><br> -Paragraph 1<br><br> -Article 5<br><br><br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher SEC<br><br> -Name Financial Reporting Release (FRR)<br><br> -Number 203<br><br> -Paragraph 02-03<br><br><br><br>Reference 6: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 942<br><br> -SubTopic 210<br><br> -Section S99<br><br> -Paragraph 1<br><br> -Subparagraph (SX 210.9-03.1(a))<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6876686&amp;loc=d3e534808-122878<br><br><br><br>Reference 7: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher SEC<br><br> -Name Regulation S-X (SX)<br><br> -Number 210<br><br> -Section 03<br><br> -Paragraph 1<br><br> -Subparagraph a<br><br> -Article 9<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>nonnum:textBlockItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ComprehensiveIncomePolicyPolicyTextBlock">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Disclosure of accounting policy for comprehensive income.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_ComprehensiveIncomePolicyPolicyTextBlock</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>nonnum:textBlockItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskCreditRisk">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Disclosure of accounting policy for credit risk.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 944<br><br> -SubTopic 825<br><br> -Section 50<br><br> -Paragraph 1<br><br> -URI http://asc.fasb.org/extlink&amp;oid=28088331&amp;loc=SL29635902-196195<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 825<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 20<br><br> -URI http://asc.fasb.org/extlink&amp;oid=35750535&amp;loc=d3e13531-108611<br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 825<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 21<br><br> -URI http://asc.fasb.org/extlink&amp;oid=35750535&amp;loc=d3e13537-108611<br><br><br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 825<br><br> -SubTopic 10<br><br> -Section 55<br><br> -Paragraph 1<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6875567&amp;loc=d3e14489-108613<br><br><br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 942<br><br> -SubTopic 825<br><br> -Section 50<br><br> -Paragraph 2<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6480020&amp;loc=d3e61082-112788<br><br><br><br>Reference 6: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 942<br><br> -SubTopic 825<br><br> -Section 50<br><br> -Paragraph 1<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6480020&amp;loc=d3e61044-112788<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_ConcentrationRiskCreditRisk</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>nonnum:textBlockItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConsolidationPolicyTextBlock">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Disclosure of accounting policy regarding (1) the principles it follows in consolidating or combining the separate financial statements, including the principles followed in determining the inclusion or exclusion of subsidiaries or other entities in the consolidated or combined financial statements and (2) its treatment of interests (for example, common stock, a partnership interest or other means of exerting influence) in other entities, for example consolidation or use of the equity or cost methods of accounting.  The accounting policy may also address the accounting treatment for intercompany accounts and transactions, noncontrolling interest, and the income statement treatment in consolidation for issuances of stock by a subsidiary.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 235<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 3<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6367646&amp;loc=d3e18780-107790<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 810<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 1<br><br> -URI http://asc.fasb.org/extlink&amp;oid=18733093&amp;loc=d3e5614-111684<br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 810<br><br> -SubTopic 10<br><br> -Section S99<br><br> -Paragraph 2<br><br> -Subparagraph (SX 210.3A-02)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=27015204&amp;loc=d3e355033-122828<br><br><br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher SEC<br><br> -Name Regulation S-X (SX)<br><br> -Number 210<br><br> -Section 02<br><br> -Paragraph k<br><br> -Article 1<br><br><br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher SEC<br><br> -Name Regulation S-X (SX)<br><br> -Number 210<br><br> -Section 02, 03<br><br> -Article 3A<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_ConsolidationPolicyTextBlock</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>nonnum:textBlockItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativesPolicyTextBlock">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Disclosure of accounting policy for its derivative instruments and hedging activities.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 235<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 3<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6367646&amp;loc=d3e18780-107790<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 815<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 2<br><br> -URI http://asc.fasb.org/extlink&amp;oid=35706170&amp;loc=d3e41620-113959<br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 815<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 1A<br><br> -URI http://asc.fasb.org/extlink&amp;oid=35706170&amp;loc=SL5579245-113959<br><br><br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 815<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 1<br><br> -URI http://asc.fasb.org/extlink&amp;oid=35706170&amp;loc=SL5579240-113959<br><br><br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 815<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 4<br><br> -URI http://asc.fasb.org/extlink&amp;oid=35706170&amp;loc=d3e41638-113959<br><br><br><br>Reference 6: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 235<br><br> -SubTopic 10<br><br> -Section S99<br><br> -Paragraph 1<br><br> -Subparagraph (SX 210.4-08.(n))<br><br> -URI http://asc.fasb.org/extlink&amp;oid=26873400&amp;loc=d3e23780-122690<br><br><br><br>Reference 7: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher SEC<br><br> -Name Regulation S-X (SX)<br><br> -Number 210<br><br> -Section 08<br><br> -Paragraph n<br><br> -Article 4<br><br><br><br>Reference 8: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 815<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 7<br><br> -URI http://asc.fasb.org/extlink&amp;oid=35706170&amp;loc=d3e41675-113959<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_DerivativesPolicyTextBlock</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>nonnum:textBlockItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerSharePolicyTextBlock">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Disclosure of accounting policy for computing basic and diluted earnings or loss per share for each class of common stock and participating security. Addresses all significant policy factors, including any antidilutive items that have been excluded from the computation and takes into account stock dividends, splits and reverse splits that occur after the balance sheet date of the latest reporting period but before the issuance of the financial statements.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 235<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 3<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6367646&amp;loc=d3e18780-107790<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 260<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 1<br><br> -Subparagraph (c)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 260<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 1<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br><br><br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 260<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 2<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3630-109257<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_EarningsPerSharePolicyTextBlock</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>nonnum:textBlockItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueOfFinancialInstrumentsPolicy">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Disclosure of accounting policy for determining the fair value of financial instruments.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 235<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 3<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6367646&amp;loc=d3e18780-107790<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 825<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 1<br><br> -URI http://asc.fasb.org/extlink&amp;oid=35750535&amp;loc=d3e13279-108611<br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 820<br><br> -SubTopic 10<br><br> -Section 60<br><br> -Paragraph 1<br><br> -URI http://asc.fasb.org/extlink&amp;oid=7493716&amp;loc=d3e21868-110260<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_FairValueOfFinancialInstrumentsPolicy</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>nonnum:textBlockItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Disclosure of accounting policy for (1) transactions denominated in a currency other than the reporting enterprise's functional currency, (2) translating foreign currency financial statements that are incorporated into the financial statements of the reporting enterprise by consolidation, combination, or the equity method of accounting, and (3) remeasurement of the financial statements of a foreign reporting enterprise in a hyperinflationary economy.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 235<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 3<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6367646&amp;loc=d3e18780-107790<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 830<br><br> -SubTopic 30<br><br> -Section 50<br><br> -Paragraph 1<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6450520&amp;loc=d3e32583-110901<br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 830<br><br> -SubTopic 20<br><br> -Section 50<br><br> -Paragraph 1<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6450222&amp;loc=d3e30840-110895<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>nonnum:textBlockItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Disclosure of accounting policy for recognizing and measuring the impairment of long-lived assets. An entity also may disclose its accounting policy for long-lived assets to be sold. This policy excludes goodwill and intangible assets.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 235<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 3<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6367646&amp;loc=d3e18780-107790<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher SEC<br><br> -Name Staff Accounting Bulletin (SAB)<br><br> -Number Topic 5<br><br> -Section CC<br><br> -Subsection 3<br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 360<br><br> -SubTopic 10<br><br> -Section 05<br><br> -Paragraph 4<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6390181&amp;loc=d3e202-110218<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>nonnum:textBlockItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxPolicyTextBlock">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Disclosure of accounting policy for income taxes, which may include its accounting policies for recognizing and measuring deferred tax assets and liabilities and related valuation allowances, recognizing investment tax credits, operating loss carryforwards, tax credit carryforwards, and other carryforwards, methodologies for determining its effective income tax rate and the characterization of interest and penalties in the financial statements.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 235<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 3<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6367646&amp;loc=d3e18780-107790<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 740<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 19<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6907707&amp;loc=d3e32840-109319<br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 740<br><br> -SubTopic 30<br><br> -Section 05<br><br> -Paragraph 1<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6423966&amp;loc=d3e40913-109327<br><br><br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 954<br><br> -SubTopic 740<br><br> -Section 50<br><br> -Paragraph 1<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6491622&amp;loc=d3e9504-115650<br><br><br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 740<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 17<br><br> -Subparagraph (b)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6907707&amp;loc=d3e32809-109319<br><br><br><br>Reference 6: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 740<br><br> -SubTopic 10<br><br> -Section 45<br><br> -Paragraph 25<br><br> -URI http://asc.fasb.org/extlink&amp;oid=37586315&amp;loc=d3e32247-109318<br><br><br><br>Reference 7: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 740<br><br> -SubTopic 10<br><br> -Section 45<br><br> -Paragraph 28<br><br> -URI http://asc.fasb.org/extlink&amp;oid=37586315&amp;loc=d3e32280-109318<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_IncomeTaxPolicyTextBlock</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>nonnum:textBlockItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MarketableSecuritiesPolicy">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Disclosure of accounting policy for investments in debt and equity securities that have readily determinable fair values (marketable securities). At a minimum, the disclosure might address accounting policies for investments classified as trading, available for sale, or held to maturity and may include how the entity determines whether impairments of available for sale or held to maturity investments are other than temporary, how the fair values of the entity's securities are determined, and the entity's accounting treatment for transfers between investment categories.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 235<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 3<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6367646&amp;loc=d3e18780-107790<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher SEC<br><br> -Name Staff Accounting Bulletin (SAB)<br><br> -Number Topic 5<br><br> -Section M<br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher SEC<br><br> -Name Regulation S-X (SX)<br><br> -Number 210<br><br> -Section 02<br><br> -Paragraph 2, 12<br><br> -Article 5<br><br><br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 320<br><br> -SubTopic 10<br><br> -Section S50<br><br> -Paragraph 1<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6381980&amp;loc=d3e87707-122711<br><br><br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 942<br><br> -SubTopic 320<br><br> -Section 50<br><br> -Paragraph 5<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6957658&amp;loc=d3e62652-112803<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_MarketableSecuritiesPolicy</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>nonnum:textBlockItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Disclosure of accounting policy pertaining to new accounting pronouncements that may impact the entity's financial reporting. Includes, but is not limited to, quantification of the expected or actual impact.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>nonnum:textBlockItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Disclosure of accounting policy for long-lived, physical assets used in the normal conduct of business and not intended for resale. Includes, but is not limited to, basis of assets, depreciation and depletion methods used, including composite deprecation, estimated useful lives, capitalization policy, accounting treatment for costs incurred for repairs and maintenance, capitalized interest and the method it is calculated, disposals and impairments.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 235<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 3<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6367646&amp;loc=d3e18780-107790<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 360<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 1<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 210<br><br> -SubTopic 10<br><br> -Section S99<br><br> -Paragraph 1<br><br> -Subparagraph (SX 210.5-02.13(a))<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br><br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher SEC<br><br> -Name Regulation S-X (SX)<br><br> -Number 210<br><br> -Section 02<br><br> -Paragraph 13<br><br> -Subparagraph a<br><br> -Article 5<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_PropertyPlantAndEquipmentPolicyTextBlock</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>nonnum:textBlockItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueRecognitionPolicyTextBlock">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Disclosure of accounting policy for revenue recognition. If the entity has different policies for different types of revenue transactions, the policy for each material type of transaction is generally disclosed. If a sales transaction has multiple element arrangements (for example, delivery of multiple products, services or the rights to use assets) the disclosure may indicate the accounting policy for each unit of accounting as well as how units of accounting are determined and valued. The disclosure may encompass important judgment as to appropriateness of principles related to recognition of revenue. The disclosure also may indicate the entity's treatment of any unearned or deferred revenue that arises from the transaction.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 235<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 3<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6367646&amp;loc=d3e18780-107790<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 235<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 1<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6367646&amp;loc=d3e18726-107790<br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher SEC<br><br> -Name Staff Accounting Bulletin (SAB)<br><br> -Number Topic 13<br><br> -Section B<br><br> -Paragraph Question 1<br><br><br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 605<br><br> -SubTopic 10<br><br> -Section S99<br><br> -Paragraph 1<br><br> -Subparagraph (SAB TOPIC 13.B.Q1)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=27012821&amp;loc=d3e214044-122780<br><br><br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 235<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 4<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6367646&amp;loc=d3e18823-107790<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_RevenueRecognitionPolicyTextBlock</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>nonnum:textBlockItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Disclosure of accounting policy for stock option and stock incentive plans. This disclosure may include (1) the types of stock option or incentive plans sponsored by the entity (2) the groups that participate in (or are covered by) each plan (3) significant plan provisions and (4) how stock compensation is measured, and the methodologies and significant assumptions used to determine that measurement.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 718<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 1<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6415400&amp;loc=d3e5047-113901<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 235<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 3<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6367646&amp;loc=d3e18780-107790<br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 718<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 2<br><br> -Subparagraph (b),(f)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6415400&amp;loc=d3e5070-113901<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>nonnum:textBlockItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UseOfEstimates">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Disclosure of accounting policy for the use of estimates in the preparation of financial statements in conformity with generally accepted accounting principles.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 275<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 9<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6927468&amp;loc=d3e6143-108592<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 275<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 8<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6927468&amp;loc=d3e6132-108592<br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 275<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 4<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6927468&amp;loc=d3e6061-108592<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_UseOfEstimates</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>nonnum:textBlockItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
    </div>
  </body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>71
<FILENAME>R15.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
  <head>
    <META http-equiv="Content-Type" content="text/html; charset=us-ascii">
    <link rel="StyleSheet" type="text/css" href="report.css"><script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script></head>
  <body><span style="display: none;">v2.4.0.8</span><table class="report" border="0" cellspacing="2" id="ID0EME">
      <tr>
        <th class="tl" colspan="1" rowspan="2">
          <div style="width: 200px;"><strong>COMMITMENTS AND CONTINGENCIES<br></strong></div>
        </th>
        <th class="th" colspan="1">12 Months Ended</th>
      </tr>
      <tr>
        <th class="th">
          <div>Jun. 30, 2014</div>
        </th>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract', window );"><strong>COMMITMENTS AND CONTINGENCIES [Abstract]</strong></a></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock', window );">COMMITMENTS AND CONTINGENCIES</a></td>
        <td class="text"><!--DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd" --><div> <div><!--StartFragment--> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: left; TEXT-INDENT: 0pt"> NOTE 7:-COMMITMENTS AND CONTINGENCIES</div> <div style="DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> &nbsp;</div> <div style="text-align: center"> <table style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman" cellspacing="0" cellpadding="0" width="100%" border="0"> <tr valign="top"> <td style="WIDTH: 18pt"> <div style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt"> a.</div> </td> <td> <div style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; text-align: justify"> The facilities of the Subsidiary are rented under operating lease agreements, which expire on various dates, the latest of which is in 2017. In January 2013 the Subsidiary received from the lessor a non-refundable payment, which payment represents the lessor participation in the leasehold improvements, of approximately $816. The payment is deductible against lease expenses as it is incurred. The lessor upfront payment is included the in balance sheet as advance payment and recognized as a deduction from lease expenses over the lease term.</div> <div style="text-align: justify">&nbsp;</div> <div style="text-align: justify"> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: justify; TEXT-INDENT: 0pt"> The Company recognizes rent expense, net of lessor participation, under such arrangements on a straight-line basis over the lease term.</div> <div style="TEXT-ALIGN: justify; MARGIN-LEFT: 0pt; DISPLAY: block; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt"> &nbsp;</div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: justify; TEXT-INDENT: 0pt"> As of June&nbsp;30, 2014 aggregate minimum lease commitments under non-cancelable operating lease agreements are as follows:</div> </div> </td> </tr> </table> </div> <div style="DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> &nbsp;</div> <div style="MARGIN-LEFT: 18pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-ALIGN: left; TEXT-INDENT: 0pt"> <table style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman" cellspacing="0" cellpadding="0" width="50%"> <tr bgcolor="#cceeff"> <td valign="bottom" width="88%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 9pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: -9pt"> Year ending June 30,</div> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="10%" colspan="2"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> <tr bgcolor="white"> <td valign="bottom" width="88%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 9pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: -9pt"> 2015</div> </td> <td valign="bottom" width="1%" align="right"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%">$</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">667</td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> <tr bgcolor="#cceeff"> <td valign="bottom" width="88%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 9pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: -9pt"> 2016</div> </td> <td valign="bottom" width="1%" align="right"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">497</td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> <tr bgcolor="white"> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="88%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 9pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: -9pt"> 2017</div> </td> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%" align="right"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">349</td> <td style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> <tr bgcolor="#cceeff"> <td style="PADDING-BOTTOM: 4px" valign="bottom" width="88%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 9pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: -9pt"> Total</div> </td> <td style="PADDING-BOTTOM: 4px" valign="bottom" width="1%" align="right"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 4px double; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%">$</td> <td style="BORDER-BOTTOM: black 4px double; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">1,513</td> <td style="PADDING-BOTTOM: 4px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> </table> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; MARGIN-LEFT: 36pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"> &nbsp;</div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"> Lease expenses amounted to $720, $678 and $382 for the years ended June 30, 2014, 2013 and 2012, respectively.</div> <div style="DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> &nbsp;</div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> The Subsidiary has issued a bank guarantee in favor of the lessors for $388.</div> <div style="DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> &nbsp;</div> <div style="text-align: center"> <table style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman" cellspacing="0" cellpadding="0" width="100%" border="0"> <tr valign="top"> <td style="WIDTH: 18pt"> <div style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt"> b.</div> </td> <td> <div style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; text-align: justify"> The Subsidiary leases several motor vehicles under operating lease agreements, which expire in various dates during years 2014 through April 2017.</div> </td> </tr> </table> </div> <div style="DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> &nbsp;</div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> As of June&nbsp;30, 2014, future aggregate minimum lease commitments under non-cancelable operating lease agreements are as follows:</div> <div style="DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> &nbsp;</div> <div style="MARGIN-LEFT: 18pt; text-align: left"> <table style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman" cellspacing="0" cellpadding="0" width="50%"> <tr bgcolor="#cceeff"> <td valign="bottom" width="88%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"> Year ending June 30,</div> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="10%" colspan="2"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> <tr bgcolor="white"> <td valign="bottom" width="88%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"> 2015</div> </td> <td valign="bottom" width="1%" align="right"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%">$</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">140</td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> <tr bgcolor="#cceeff"> <td valign="bottom" width="88%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"> 2016</div> </td> <td valign="bottom" width="1%" align="right"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">85</td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> <tr bgcolor="white"> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="88%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"> 2017</div> </td> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%" align="right"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">26</td> <td style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> <tr bgcolor="#cceeff"> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="88%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"> Total</div> </td> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%" align="right"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%">$</td> <td style="BORDER-BOTTOM: black 2px solid; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">251</td> <td style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> </table> </div> <div style="DISPLAY: block; TEXT-INDENT: 0pt">&nbsp;</div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"> Lease expenses amounted to $244, $215 and $176 for the years ended June 30, 2014, 2013 and 2012, respectively.</div> <div style="DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> &nbsp;</div> <div style="text-align: center"> <table style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman" cellspacing="0" cellpadding="0" width="100%" border="0"> <tr valign="top"> <td style="WIDTH: 18pt"> <div style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt"> c.</div> </td> <td> <div style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; text-align: justify"> An amount of $4,805 of cash and deposits was pledged by the Subsidiary to secure the hedging transactions, credit line and Bank guarantees.</div> </td> </tr> </table> </div> <div style="DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> &nbsp;</div> <div style="text-align: center"> <table style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman" cellspacing="0" cellpadding="0" width="100%" border="0"> <tr valign="top"> <td style="WIDTH: 18pt"> <div style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt"> d.</div> </td> <td> <div style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; text-align: justify"> Under the Law for the Encouragement of Industrial Research and Development, 1984, (the "Research Law"), research and development programs that meet specified criteria and are approved by a governmental committee of the OCS are eligible for grants of up to 50% of the project&#39;s expenditures, as determined by the research committee, in exchange for the payment of royalties from the sale of products developed under the program. Regulations under the Research Law generally provide for the payment of royalties to the Chief Scientist of 3% to 4% on sales of products and services derived from a technology developed using these grants until 100% of the dollar-linked grant is repaid. The Company&#39;s obligation to pay these royalties is contingent on its actual sale of such products and services. In the absence of such sales, no payment is required. Outstanding balance of the grants will be subject to interest at a rate equal to the 12 month LIBOR applicable to dollar deposits that is published on the first business day of each calendar year. Following the full repayment of the grant, there is no further liability for royalties.</div> </td> </tr> </table> </div> <div style="DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> &nbsp;</div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> Through June 30, 2014, total grants obtained aggregated to approximately $14,125. Through June 30, 2014, total royalties paid and accrued amounted to $53. As of June 30, 2014, the Company&#39;s contingent liability in respect to royalties to the OCS amounted $14,072, not include LIBOR interest as described above.</div> <!--EndFragment--></div> </div><span></span></td>
      </tr>
    </table>
    <div style="display: none;">
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div>
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_CommitmentsAndContingenciesDisclosureAbstract</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:stringItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The entire disclosure for commitments and contingencies.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 210<br><br> -SubTopic 10<br><br> -Section S99<br><br> -Paragraph 1<br><br> -Subparagraph (SX 210.5-02.25)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 825<br><br> -SubTopic 20<br><br> -Section 50<br><br> -Paragraph 1<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6449706&amp;loc=d3e16207-108621<br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 460<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 8<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6398077&amp;loc=d3e12565-110249<br><br><br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 450<br><br> -SubTopic 20<br><br> -Section 50<br><br> -Paragraph 4<br><br> -URI http://asc.fasb.org/extlink&amp;oid=25496072&amp;loc=d3e14435-108349<br><br><br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 440<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 2<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6394976&amp;loc=d3e25287-109308<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_CommitmentsAndContingenciesDisclosureTextBlock</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>nonnum:textBlockItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
    </div>
  </body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>72
<FILENAME>R13.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
  <head>
    <META http-equiv="Content-Type" content="text/html; charset=us-ascii">
    <link rel="StyleSheet" type="text/css" href="report.css"><script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script></head>
  <body><span style="display: none;">v2.4.0.8</span><table class="report" border="0" cellspacing="2" id="ID0EME">
      <tr>
        <th class="tl" colspan="1" rowspan="2">
          <div style="width: 200px;"><strong>PROPERTY AND EQUIPMENT, NET<br></strong></div>
        </th>
        <th class="th" colspan="1">12 Months Ended</th>
      </tr>
      <tr>
        <th class="th">
          <div>Jun. 30, 2014</div>
        </th>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentAbstract', window );"><strong>PROPERTY AND EQUIPMENT, NET [Abstract]</strong></a></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock', window );">PROPERTY AND EQUIPMENT, NET</a></td>
        <td class="text"><!--DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd" --><div> <div><!--StartFragment--> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: left; TEXT-INDENT: 0pt"> NOTE 5:-PROPERTY AND EQUIPMENT, NET</div> <div style="DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> &nbsp;</div> <div style="text-align: right"> <table style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman" cellspacing="0" cellpadding="0" width="97%"> <tr> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="76%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-WEIGHT: bold; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="22%" colspan="6"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"> June 30,</div> </td> <td style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-WEIGHT: bold; DISPLAY: inline"> &nbsp;</font> </td> </tr> <tr> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="76%" align="left"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-WEIGHT: bold; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="10%" colspan="2"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"> 2014</div> </td> <td style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-WEIGHT: bold; DISPLAY: inline"> &nbsp;</font> </td> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-WEIGHT: bold; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="10%" colspan="2"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"> 2013</div> </td> <td style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-WEIGHT: bold; DISPLAY: inline"> &nbsp;</font> </td> </tr> <tr bgcolor="#cceeff"> <td valign="bottom" width="76%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"> Cost:</div> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="10%" colspan="2"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="10%" colspan="2"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> <tr bgcolor="white"> <td valign="bottom" width="76%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"> Laboratory equipment</div> </td> <td valign="bottom" width="1%" align="right"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%">$</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">6,088</td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%" align="right"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%">$</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">5,709</td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> <tr bgcolor="#cceeff"> <td valign="bottom" width="76%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"> Computers and peripheral equipment</div> </td> <td valign="bottom" width="1%" align="right"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">708</td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%" align="right"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">535</td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> <tr bgcolor="white"> <td valign="bottom" width="76%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"> Office furniture and equipment</div> </td> <td valign="bottom" width="1%" align="right"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">611</td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%" align="right"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">534</td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> <tr bgcolor="#cceeff"> <td valign="bottom" width="76%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"> Leasehold improvements</div> </td> <td valign="bottom" width="1%" align="right"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">7,453</td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%" align="right"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">7,369</td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> <tr bgcolor="white"> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="76%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"> Vehicles</div> </td> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">95</td> <td style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">68</td> <td style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> <tr bgcolor="#cceeff"> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="76%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"> &nbsp;Total Cost</div> </td> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">14,955</td> <td style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">14,215</td> <td style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> <tr bgcolor="white"> <td valign="bottom" width="76%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"> Accumulated depreciation:</div> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: right" valign="bottom" width="9%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: right" valign="bottom" width="9%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> <tr bgcolor="#cceeff"> <td valign="bottom" width="76%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"> Laboratory equipment</div> </td> <td valign="bottom" width="1%" align="right"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">2,042</td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%" align="right"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">1,306</td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> <tr bgcolor="white"> <td valign="bottom" width="76%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"> Computers and peripheral equipment</div> </td> <td valign="bottom" width="1%" align="right"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">430</td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%" align="right"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">280</td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> <tr bgcolor="#cceeff"> <td valign="bottom" width="76%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"> Office furniture and equipment</div> </td> <td valign="bottom" width="1%" align="right"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">176</td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%" align="right"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">91</td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> <tr bgcolor="white"> <td valign="bottom" width="76%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"> Leasehold improvements</div> </td> <td valign="bottom" width="1%" align="right"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">1,475</td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%" align="right"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">642</td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> <tr bgcolor="#cceeff"> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="76%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"> Vehicles</div> </td> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">9</td> <td style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">30</td> <td style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> <tr bgcolor="white"> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="76%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"> &nbsp;Total accumulated depreciation</div> </td> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">4,132</td> <td style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">2,349</td> <td style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> <tr bgcolor="#cceeff"> <td style="PADDING-BOTTOM: 4px" valign="bottom" width="76%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"> Property and equipment, net</div> </td> <td style="PADDING-BOTTOM: 4px" valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 4px double; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%">$</td> <td style="BORDER-BOTTOM: black 4px double; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">10,823</td> <td style="PADDING-BOTTOM: 4px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="PADDING-BOTTOM: 4px" valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 4px double; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%">$</td> <td style="BORDER-BOTTOM: black 4px double; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">11,866</td> <td style="PADDING-BOTTOM: 4px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> </table> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; MARGIN-LEFT: 45pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"> &nbsp;</div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"> Depreciation expenses amounted to $1,902, $1,033 and $435 for the years ended June 30, 2014, 2013 and 2012, respectively.</div> <!--EndFragment--></div> </div><span></span></td>
      </tr>
    </table>
    <div style="display: none;">
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentAbstract">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div>
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_PropertyPlantAndEquipmentAbstract</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:stringItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The entire disclosure for long-lived, physical assets used in the normal conduct of business and not intended for resale. Includes, but is not limited to, accounting policies and methodology, roll forwards, depreciation, depletion and amortization expense, including composite depreciation, accumulated depreciation, depletion and amortization expense, useful lives and method used, income statement disclosures, assets held for sale and public utility disclosures.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 360<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 1<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 360<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 2<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6391110&amp;loc=d3e2921-110230<br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 205<br><br> -SubTopic 20<br><br> -Section 50<br><br> -Paragraph 1<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6360339&amp;loc=d3e1361-107760<br><br><br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 210<br><br> -SubTopic 10<br><br> -Section S99<br><br> -Paragraph 1<br><br> -Subparagraph (SX 210.5-02.13-14)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>nonnum:textBlockItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
    </div>
  </body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>73
<FILENAME>R14.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
  <head>
    <META http-equiv="Content-Type" content="text/html; charset=us-ascii">
    <link rel="StyleSheet" type="text/css" href="report.css"><script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script></head>
  <body><span style="display: none;">v2.4.0.8</span><table class="report" border="0" cellspacing="2" id="ID0EME">
      <tr>
        <th class="tl" colspan="1" rowspan="2">
          <div style="width: 200px;"><strong>OTHER ACCOUNTS PAYABLE<br></strong></div>
        </th>
        <th class="th" colspan="1">12 Months Ended</th>
      </tr>
      <tr>
        <th class="th">
          <div>Jun. 30, 2014</div>
        </th>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_psti_OtherAccountsPayableAbstract', window );"><strong>OTHER ACCOUNTS PAYABLE [Abstract]</strong></a></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock', window );">OTHER ACCOUNTS PAYABLE</a></td>
        <td class="text"><!--DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd" --><div> <div><!--StartFragment--> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: left; TEXT-INDENT: 0pt"> NOTE 6:-OTHER ACCOUNTS PAYABLE</div> <div style="DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> &nbsp;</div> <div style="text-align: right"> <table style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman" cellspacing="0" cellpadding="0" width="97%"> <tr> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="76%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-WEIGHT: bold; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="22%" colspan="6"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"> June 30,</div> </td> <td style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-WEIGHT: bold; DISPLAY: inline"> &nbsp;</font> </td> <td style="PADDING-BOTTOM: 2px" valign="bottom"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> <tr> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="76%" align="left"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-WEIGHT: bold; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="10%" colspan="2"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"> 2014</div> </td> <td style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-WEIGHT: bold; DISPLAY: inline"> &nbsp;</font> </td> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-WEIGHT: bold; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="11%" colspan="4"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"> 2013</div> </td> </tr> <tr bgcolor="#cceeff"> <td valign="bottom" width="76%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"> Accrued payroll</div> </td> <td valign="bottom" width="1%" align="right"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%">$</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">424</td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%" align="right"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%">$</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">353</td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> <tr bgcolor="white"> <td valign="bottom" width="76%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"> Payroll institutions</div> </td> <td valign="bottom" width="1%" align="right"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">302</td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%" align="right"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">324</td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> <tr bgcolor="#cceeff"> <td valign="bottom" width="76%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"> Accrued vacation</div> </td> <td valign="bottom" width="1%" align="right"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">673</td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%" align="right"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">506</td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> <tr bgcolor="white"> <td valign="bottom" width="76%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"> Advanced payment from lessor</div> </td> <td valign="bottom" width="1%" align="right"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">89</td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%" align="right"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">89</td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> <tr bgcolor="#cceeff"> <td valign="bottom" width="76%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"> Derivatives designated as a fair value hedge instruments</div> </td> <td valign="bottom" width="1%" align="right"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">889</td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%" align="right"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">-</td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> <tr bgcolor="white"> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="76%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"> Other payables</div> </td> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%" align="right"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">14</td> <td style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%" align="right"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">-</td> <td style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> <tr bgcolor="#cceeff"> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="76%" align="left"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%">$</td> <td style="BORDER-BOTTOM: black 2px solid; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">2,391</td> <td style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%">$</td> <td style="BORDER-BOTTOM: black 2px solid; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">1,272</td> <td style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> </table> </div> <!--EndFragment--></div> </div><span></span></td>
      </tr>
    </table>
    <div style="display: none;">
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_psti_OtherAccountsPayableAbstract">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div>
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>psti_OtherAccountsPayableAbstract</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>psti_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:stringItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The entire disclosure for accounts payable and accrued liabilities at the end of the reporting period.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 210<br><br> -SubTopic 10<br><br> -Section S99<br><br> -Paragraph 1<br><br> -Subparagraph (SX 210.5-02.19(a),20,24)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher SEC<br><br> -Name Regulation S-X (SX)<br><br> -Number 210<br><br> -Section 02<br><br> -Paragraph 19<br><br> -Subparagraph a<br><br> -Article 5<br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher SEC<br><br> -Name Regulation S-X (SX)<br><br> -Number 210<br><br> -Section 02<br><br> -Paragraph 20, 24<br><br> -Article 5<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>nonnum:textBlockItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
    </div>
  </body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>74
<FILENAME>R16.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
  <head>
    <META http-equiv="Content-Type" content="text/html; charset=us-ascii">
    <link rel="StyleSheet" type="text/css" href="report.css"><script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script></head>
  <body><span style="display: none;">v2.4.0.8</span><table class="report" border="0" cellspacing="2" id="ID0EME">
      <tr>
        <th class="tl" colspan="1" rowspan="2">
          <div style="width: 200px;"><strong>STOCKHOLDERS' EQUITY<br></strong></div>
        </th>
        <th class="th" colspan="1">12 Months Ended</th>
      </tr>
      <tr>
        <th class="th">
          <div>Jun. 30, 2014</div>
        </th>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityNoteAbstract', window );"><strong>STOCKHOLDERS' EQUITY [Abstract]</strong></a></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityNoteDisclosureTextBlock', window );">STOCKHOLDERS' EQUITY</a></td>
        <td class="text"><!--DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd" --><div> <div><!--StartFragment--> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: left; TEXT-INDENT: 0pt"> NOTE 8: - STOCKHOLDERS&#39; EQUITY</div> <div style="DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> &nbsp;</div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> The Company&#39;s authorized common stock consists of 200,000,000 shares with a par value of $0.00001 per share.&nbsp;&nbsp;All shares have equal voting rights and are entitled to one vote per share in all matters to be voted upon by stockholders. The shares have no pre-emptive, subscription, conversion or redemption rights and may be issued only as fully paid and non-assessable shares. Holders of the common stock are entitled to equal ratable rights to dividends and distributions with respect to the common stock, as may be declared by the Board of Directors out of funds legally available.</div> <div style="DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> &nbsp;</div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> The Company&#39;s authorized preferred stock consists of 10,000,000 shares of preferred stock, par value $0.00001 per share, with series, rights, preferences, privileges and restrictions as may be designated from time to time by the Company&#39;s Board of Directors.&nbsp;&nbsp;No shares of preferred stock have been issued.</div> <div style="DISPLAY: block; TEXT-INDENT: 0pt">&nbsp;</div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"> <table style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman" cellspacing="0" cellpadding="0" width="100%" border="0"> <tr valign="top"> <td style="WIDTH: 18pt"> <div style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt"> a.</div> </td> <td> <div style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; text-align: justify"> From July 2011 through June 2012, a total of 406,783 warrants were exercised via "cashless" exercise, resulting in the issuance of 168,424 shares of common stock to investors of the Company. &nbsp;In addition 355,411 warrants were exercised for cash and resulted in the issuance of 355,411 shares of common stock to investors of the Company. The aggregate cash consideration received was $556.</div> </td> </tr> </table> </div> <div style="DISPLAY: block; TEXT-INDENT: 0pt">&nbsp;</div> <div style="text-align: center"> <table style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman" cellspacing="0" cellpadding="0" width="100%" border="0"> <tr valign="top"> <td style="WIDTH: 18pt"> <div style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt"> b.</div> </td> <td> <div style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; text-align: justify"> From July 2012 through June 2013, a total of 682,213 warrants were exercised via "cashless" exercise, resulting in the issuance of 420,199 shares of common stock to investors of the Company. &nbsp;In addition 1,201,160 warrants were exercised for cash and resulted in the issuance of 1,201,160 shares of common stock to investors of the Company. The aggregate cash consideration received was $2,009. In August, 2012, a total of 36,000 warrants were exercised via a "cashless" exercise, resulting in the issuance of 26,299 shares of common stock to consultants of the Company.</div> </td> </tr> </table> </div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /> </div> <div style="text-align: center"> <table style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman" cellspacing="0" cellpadding="0" width="100%" border="0"> <tr valign="top"> <td style="WIDTH: 18pt"> <div style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt"> c.</div> </td> <td> <div style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; text-align: justify"> From July 2013 through June 2014, a total of 2,517,907 warrants were exercised via "cashless" exercise, resulting in the issuance of 1,469,584 shares of common stock to investors of the Company. &nbsp;In addition, 1,432,584 warrants were exercised for cash and resulted in the issuance of 1,432,584 shares of common stock to investors of the Company. The aggregate cash consideration received was $1,968. From July 2013 through June 2014, a total of 65,000 warrants were exercised via a "cashless" exercise, resulting in the issuance of 36,970 shares of common stock to a consultant of the Company.</div> </td> </tr> </table> </div> <div style="DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> &nbsp;</div> <div style="text-align: center"> <table style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman" cellspacing="0" cellpadding="0" width="100%" border="0"> <tr valign="top"> <td style="WIDTH: 18pt"> <div style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt"> d.</div> </td> <td> <div style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; text-align: justify"> As part of the agreement for building the new Company&#39;s facility with Biopharmax Group Ltd. ("Biopharmax"), the Company issued 1,500,000 shares of common stock to Biopharmax during fiscal year 2012.</div> </td> </tr> </table> </div> <div style="DISPLAY: block; TEXT-INDENT: 0pt">&nbsp;</div> <div style="text-align: center"> <table style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman" cellspacing="0" cellpadding="0" width="100%" border="0"> <tr valign="top"> <td style="WIDTH: 18pt"> <div style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt"> e.</div> </td> <td> <div style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; text-align: justify"> In December 2013, as part of the CHA Agreement, Pluristem and CHA executed the mutual investment pursuant to which Pluristem issued 2,500,000 shares of its common stock in consideration for 1,011,504 shares of CHA, which reflects total consideration to each of Pluristem and CHA of approximately $10,414 (see Note 1d).</div> </td> </tr> </table> </div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /> </div> <div style="text-align: center"> <table style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman" cellspacing="0" cellpadding="0" width="100%" border="0"> <tr valign="top"> <td style="WIDTH: 18pt"> <div style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt"> f.</div> </td> <td> <div style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; text-align: justify"> On September 19, 2012, the Company closed a firm commitment underwritten public offering of 8,000,000 units, at a purchase price of $4.00 per unit, with each unit consisting of one share of the Company&#39;s common stock and one warrant to purchase 0.35 shares of common stock, at a purchase price of $5.00 per share. The warrants sold in the offering became exercisable on March 19, 2013 and expire on September 19, 2017. The Company has also granted the underwriters a 30-day option to purchase up to 1,200,000 shares of common stock and/or warrants to purchase up to 420,000 shares of common stock. As of September 24, 2012 the underwriters fully exercised their option. The aggregate net proceeds to the Company from the offering, including from the exercise in full of the option, were $34,106, before the exercise of any warrants and after deducting underwriting commissions and discounts and offering expenses of the Company. The warrants can be exercised only for full shares of common stock.&nbsp;&nbsp;As to any fraction of a share which the warrant holder would otherwise be entitled to purchase upon such exercise, the Company shall pay a cash adjustment in respect of such fraction in an amount equal to such fraction multiplied by the fair market value less the exercise price.</div> </td> </tr> </table> </div> <div style="DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> &nbsp;</div> <div style="text-align: center"> <table style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman" cellspacing="0" cellpadding="0" width="100%" border="0"> <tr valign="top"> <td style="WIDTH: 18pt"> <div style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt"> g.</div> </td> <td> <div style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; text-align: justify"> Following a shelf registration on Form S-3 filed and declared effective in October 2011, the Company entered in December 2012 into an At Market Issuance Sales Agreement ("ATM Agreement") with an underwriter, which provides that, upon the terms and subject to the conditions and limitations set forth in the ATM Agreement, the Company may elect, from time to time, to issue and sell shares of common stock having an aggregate offering price of up to $95,000 through the underwriter as a sales agent. The Company is not obligated to make any sales of common stock under the ATM Agreement.</div> </td> </tr> </table> </div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> During the year ended June 30, 2014, the Company issued 2,596,032<font style="FONT-SIZE: 10pt; DISPLAY: inline">&nbsp;</font> shares of common stock for aggregate consideration of approximately $ 10,644, net of issuance costs of $195, under the ATM Agreement.</div> <div style="MARGIN-LEFT: 437pt; DISPLAY: block; TEXT-INDENT: 0pt"> <br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> On September 11, 2014, the Company notified the underwriter of the termination of the ATM Agreement.</div> <div style="MARGIN-LEFT: 437pt; DISPLAY: block; TEXT-INDENT: 0pt"> <br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> Options, warrants and restricted stock units to employees, directors and consultants:</div> <div style="MARGIN-LEFT: 437pt; DISPLAY: block; TEXT-INDENT: 0pt"> <br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> The Company has approved incentive option plan from 2005 (the "Plan").&nbsp;&nbsp;Under the Plan, options, restricted stock and restricted stock units (the "Awards") may be granted to the Company&#39;s officers, directors, employees and consultants.&nbsp;&nbsp;Any Awards that are cancelled or forfeited before expiration become available for future grants.</div> <div style="DISPLAY: block; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> &nbsp;</div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> As of June 30, 2014, the number of shares of common stock authorized for issuance under the Plan amounted to 13,256,713. As of June 30, 2014, 1,205,080 shares are available for future grant under the Plan.</div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"> Options, warrants and restricted stock units to employees, directors and consultants:</div> <div style="DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> &nbsp;</div> <div style="DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-ALIGN: left; TEXT-INDENT: 0pt"> <table style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman" cellspacing="0" cellpadding="0" width="100%" border="0"> <tr valign="top"> <td style="WIDTH: 18pt" align="right"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: left; TEXT-INDENT: 0pt"> a.</div> </td> <td align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: left; TEXT-INDENT: 0pt"> Options to employees and directors:</div> </td> </tr> </table> </div> <div style="DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> &nbsp;</div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> The Company accounted for its options to employees and directors under the fair value method in accordance with ASC 718. A summary of the Company&#39;s share option activity for options granted to employees and directors under the Plans is as follows:</div> <div style="DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> &nbsp;</div> <div style="text-align: right"> <table style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman" cellspacing="0" cellpadding="0" width="97%"> <tr> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="52%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-WEIGHT: bold; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="46%" colspan="14"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"> Year ended June 30, 2014</div> </td> <td style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-WEIGHT: bold; DISPLAY: inline"> &nbsp;</font> </td> </tr> <tr> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="52%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-WEIGHT: bold; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="10%" colspan="2"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"> Number</div> </td> <td style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-WEIGHT: bold; DISPLAY: inline"> &nbsp;</font> </td> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-WEIGHT: bold; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="10%" colspan="2"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"> Weighted Average Exercise Price</div> </td> <td style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-WEIGHT: bold; DISPLAY: inline"> &nbsp;</font> </td> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-WEIGHT: bold; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="10%" colspan="2"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"> Weighted Average Remaining Contractual Terms (in years)</div> </td> <td style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-WEIGHT: bold; DISPLAY: inline"> &nbsp;</font> </td> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-WEIGHT: bold; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="10%" colspan="2"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"> Aggregate Intrinsic Value Price</div> </td> <td style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-WEIGHT: bold; DISPLAY: inline"> &nbsp;</font> </td> </tr> <tr bgcolor="#cceeff"> <td style="TEXT-ALIGN: left; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt" valign="bottom" width="52%"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: left; TEXT-INDENT: 0pt"> Options outstanding at beginning of period</div> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">1,958,156</td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%">$</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">4.03</td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="10%" colspan="2"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="10%" colspan="2"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> <tr bgcolor="white"> <td style="TEXT-ALIGN: left; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt" valign="bottom" width="52%"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: left; TEXT-INDENT: 0pt"> Options exercised</div> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">(15,000</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap">)</td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%">$</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">0.83</td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="10%" colspan="2"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="10%" colspan="2"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> <tr bgcolor="#cceeff"> <td style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt" valign="bottom" width="52%"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: left; TEXT-INDENT: 0pt"> Options forfeited</div> </td> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">(81,057</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap">)</td> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%">$</td> <td style="BORDER-BOTTOM: black 2px solid; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">11.59</td> <td style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="10%" colspan="2"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="10%" colspan="2"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> <tr bgcolor="white"> <td style="PADDING-BOTTOM: 4px; TEXT-ALIGN: left; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt" valign="bottom" width="52%"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: left; TEXT-INDENT: 0pt"> Options outstanding at end of the period</div> </td> <td style="PADDING-BOTTOM: 4px" valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 4px double; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">1,862,099</td> <td style="PADDING-BOTTOM: 4px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="PADDING-BOTTOM: 4px" valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 4px double; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%">$</td> <td style="BORDER-BOTTOM: black 4px double; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">3.73</td> <td style="PADDING-BOTTOM: 4px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="PADDING-BOTTOM: 4px" valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 4px double; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">3.13</td> <td style="PADDING-BOTTOM: 4px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="PADDING-BOTTOM: 4px" valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 4px double; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%">$</td> <td style="BORDER-BOTTOM: black 4px double; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">1,046</td> <td style="PADDING-BOTTOM: 4px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> <tr bgcolor="#cceeff"> <td style="PADDING-BOTTOM: 4px; TEXT-ALIGN: left; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt" valign="bottom" width="52%"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: left; TEXT-INDENT: 0pt"> Options exercisable at the end of the period</div> </td> <td style="PADDING-BOTTOM: 4px" valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 4px double; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">1,862,099</td> <td style="PADDING-BOTTOM: 4px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="PADDING-BOTTOM: 4px" valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 4px double; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%">$</td> <td style="BORDER-BOTTOM: black 4px double; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">3.73</td> <td style="PADDING-BOTTOM: 4px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="PADDING-BOTTOM: 4px" valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 4px double; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">3.13</td> <td style="PADDING-BOTTOM: 4px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="PADDING-BOTTOM: 4px" valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 4px double; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%">$</td> <td style="BORDER-BOTTOM: black 4px double; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">1,046</td> <td style="PADDING-BOTTOM: 4px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> <tr bgcolor="white"> <td style="PADDING-BOTTOM: 4px; TEXT-ALIGN: left; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt" valign="bottom" width="52%"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: left; TEXT-INDENT: 0pt"> Options vested</div> </td> <td style="PADDING-BOTTOM: 4px" valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 4px double; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">1,862,099</td> <td style="PADDING-BOTTOM: 4px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="PADDING-BOTTOM: 4px" valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 4px double; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%">$</td> <td style="BORDER-BOTTOM: black 4px double; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">3.73</td> <td style="PADDING-BOTTOM: 4px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="PADDING-BOTTOM: 4px" valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 4px double; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">3.13</td> <td style="PADDING-BOTTOM: 4px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="PADDING-BOTTOM: 4px" valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 4px double; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%">$</td> <td style="BORDER-BOTTOM: black 4px double; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">1,046</td> <td style="PADDING-BOTTOM: 4px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> </table> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> &nbsp;</div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> Intrinsic value of exercisable options (the difference between the Company&#39;s closing stock price on the last trading day in the period and the exercise price, multiplied by the number of in-the-money options) represents the amount that would have been received by the employees and directors option holders had all option holders exercised their options on June 30, 2014. This amount changes based on the fair market value of the Company&#39;s common stock.</div> <div style="DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> &nbsp;</div> <div style="TEXT-ALIGN: left; MARGIN-LEFT: 0pt; DISPLAY: block; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt"> <table style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman" cellspacing="0" cellpadding="0" width="100%" border="0"> <tr valign="top"> <td style="WIDTH: 18pt" align="right"> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: left; TEXT-INDENT: 0pt"> b.</div> </td> <td align="left"> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: left; TEXT-INDENT: 0pt"> Options and warrants to non-employees:</div> </td> </tr> </table> </div> <div style="DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> &nbsp;</div> <div> <table style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman" cellspacing="0" cellpadding="0" width="100%" align="center" border="0"> <tr valign="top"> <td style="WIDTH: 18pt"> <div style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; DISPLAY: inline"> &nbsp;</div> </td> <td> <div style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; text-align: left"> A summary of the Company&#39;s activity related to options and warrants to consultants is as follows:</div> </td> </tr> </table> </div> <div>&nbsp;</div> <div style="text-align: right"> <table style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman" cellspacing="0" cellpadding="0" width="97%"> <tr> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="52%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-WEIGHT: bold; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="46%" colspan="14"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"> Year ended&nbsp;June 30, 2014</div> </td> <td style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-WEIGHT: bold; DISPLAY: inline"> &nbsp;</font> </td> </tr> <tr> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="52%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-WEIGHT: bold; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="10%" colspan="2"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"> Number</div> </td> <td style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-WEIGHT: bold; DISPLAY: inline"> &nbsp;</font> </td> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-WEIGHT: bold; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="10%" colspan="2"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"> Weighted Average Exercise Price</div> </td> <td style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-WEIGHT: bold; DISPLAY: inline"> &nbsp;</font> </td> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-WEIGHT: bold; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="10%" colspan="2"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"> Weighted Average Remaining Contractual Terms (in years)</div> </td> <td style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-WEIGHT: bold; DISPLAY: inline"> &nbsp;</font> </td> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-WEIGHT: bold; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="10%" colspan="2"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"> Aggregate Intrinsic Value Price</div> </td> <td style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-WEIGHT: bold; DISPLAY: inline"> &nbsp;</font> </td> </tr> <tr bgcolor="#cceeff"> <td style="TEXT-ALIGN: left; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt" valign="bottom" width="52%"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: left; TEXT-INDENT: 0pt"> Options and warrants outstanding at beginning of period</div> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">315,500</td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%">$</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">4.44</td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="10%" colspan="2"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="10%" colspan="2"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> <tr bgcolor="white"> <td style="TEXT-ALIGN: left; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt" valign="bottom" width="52%"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: left; TEXT-INDENT: 0pt"> Options granted</div> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">3,000</td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%">$</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">0.00</td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="10%" colspan="2"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="10%" colspan="2"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> <tr bgcolor="#cceeff"> <td style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt" valign="bottom" width="52%"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: left; TEXT-INDENT: 0pt"> Options and warrants exercised</div> </td> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">(66,500</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap">)</td> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%">$</td> <td style="BORDER-BOTTOM: black 2px solid; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">1.39</td> <td style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="10%" colspan="2"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="10%" colspan="2"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> <tr bgcolor="white"> <td style="PADDING-BOTTOM: 4px; TEXT-ALIGN: left; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt" valign="bottom" width="52%"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: left; TEXT-INDENT: 0pt"> Options and warrants outstanding at end of the period</div> </td> <td style="PADDING-BOTTOM: 4px" valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 4px double; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">252,000</td> <td style="PADDING-BOTTOM: 4px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="PADDING-BOTTOM: 4px" valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 4px double; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%">$</td> <td style="BORDER-BOTTOM: black 4px double; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">5.19</td> <td style="PADDING-BOTTOM: 4px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="PADDING-BOTTOM: 4px" valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 4px double; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">3.96</td> <td style="PADDING-BOTTOM: 4px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="PADDING-BOTTOM: 4px" valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 4px double; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%">$</td> <td style="BORDER-BOTTOM: black 4px double; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">331</td> <td style="PADDING-BOTTOM: 4px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> <tr bgcolor="#cceeff"> <td style="PADDING-BOTTOM: 4px; TEXT-ALIGN: left; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt" valign="bottom" width="52%"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: left; TEXT-INDENT: 0pt"> Options and warrants exercisable at the end of the period</div> </td> <td style="PADDING-BOTTOM: 4px" valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 4px double; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">251,000</td> <td style="PADDING-BOTTOM: 4px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="PADDING-BOTTOM: 4px" valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 4px double; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%">$</td> <td style="BORDER-BOTTOM: black 4px double; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">5.21</td> <td style="PADDING-BOTTOM: 4px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="PADDING-BOTTOM: 4px" valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 4px double; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">3.93</td> <td style="PADDING-BOTTOM: 4px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="PADDING-BOTTOM: 4px" valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 4px double; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%">$</td> <td style="BORDER-BOTTOM: black 4px double; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">328</td> <td style="PADDING-BOTTOM: 4px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> <tr bgcolor="white"> <td style="PADDING-BOTTOM: 4px; TEXT-ALIGN: left; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt" valign="bottom" width="52%"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: left; TEXT-INDENT: 0pt"> Options and warrants vested&nbsp;&nbsp;and expected to vest</div> </td> <td style="PADDING-BOTTOM: 4px" valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 4px double; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">252,000</td> <td style="PADDING-BOTTOM: 4px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="PADDING-BOTTOM: 4px" valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 4px double; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%">$</td> <td style="BORDER-BOTTOM: black 4px double; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">5.19</td> <td style="PADDING-BOTTOM: 4px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="PADDING-BOTTOM: 4px" valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 4px double; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">3.96</td> <td style="PADDING-BOTTOM: 4px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="PADDING-BOTTOM: 4px" valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 4px double; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%">$</td> <td style="BORDER-BOTTOM: black 4px double; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">331</td> <td style="PADDING-BOTTOM: 4px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> </table> </div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"> Options, warrants and restricted stock units to employees, directors and consultants:</div> <div style="DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> &nbsp;</div> <div> <table style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman" cellspacing="0" cellpadding="0" width="100%" align="center" border="0"> <tr valign="top"> <td style="WIDTH: 18pt"> <div style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; DISPLAY: inline"> &nbsp;</div> </td> <td width="1837"> <div style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; text-align: justify"> Compensation expenses related to options and warrants granted to consultants were recorded as follows:</div> </td> </tr> </table> </div> <div style="DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> &nbsp;</div> <div style="MARGIN-LEFT: 36pt; text-align: left"> <table style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman" cellspacing="0" cellpadding="0" width="80%"> <tr> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="64%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-WEIGHT: bold; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="34%" colspan="10"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"> Year ended&nbsp;June 30,</div> </td> <td style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-WEIGHT: bold; DISPLAY: inline"> &nbsp;</font> </td> </tr> <tr> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="64%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-WEIGHT: bold; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="10%" colspan="2"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"> 2014</div> </td> <td style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-WEIGHT: bold; DISPLAY: inline"> &nbsp;</font> </td> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-WEIGHT: bold; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="10%" colspan="2"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"> 2013</div> </td> <td style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-WEIGHT: bold; DISPLAY: inline"> &nbsp;</font> </td> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-WEIGHT: bold; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="10%" colspan="2"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"> 2012</div> </td> <td style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-WEIGHT: bold; DISPLAY: inline"> &nbsp;</font> </td> </tr> <tr bgcolor="white"> <td style="TEXT-ALIGN: left; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt" valign="bottom" width="64%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%" align="right"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: right" valign="bottom" width="9%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%" align="right"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: right" valign="bottom" width="9%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%" align="right"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: right" valign="bottom" width="9%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> <tr bgcolor="#cceeff"> <td style="TEXT-ALIGN: left; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt" valign="bottom" width="64%"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: left; TEXT-INDENT: 0pt"> Research and development expenses</div> </td> <td valign="bottom" width="1%" align="right"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%">$</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">11</td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%" align="right"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%">$</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">26</td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%" align="right"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%">$</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">19</td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> <tr bgcolor="white"> <td style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt" valign="bottom" width="64%"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: left; TEXT-INDENT: 0pt"> General and administrative expenses</div> </td> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right" valign="bottom" width="9%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%" align="right"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">-</td> <td style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%" align="right"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">37</td> <td style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> <tr bgcolor="#cceeff"> <td style="PADDING-BOTTOM: 4px" valign="bottom" width="64%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="PADDING-BOTTOM: 4px" valign="bottom" width="1%" align="right"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 4px double; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%">$</td> <td style="BORDER-BOTTOM: black 4px double; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">11</td> <td style="PADDING-BOTTOM: 4px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="PADDING-BOTTOM: 4px" valign="bottom" width="1%" align="right"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 4px double; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%">$</td> <td style="BORDER-BOTTOM: black 4px double; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">26</td> <td style="PADDING-BOTTOM: 4px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="PADDING-BOTTOM: 4px" valign="bottom" width="1%" align="right"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 4px double; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%">$</td> <td style="BORDER-BOTTOM: black 4px double; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">56</td> <td style="PADDING-BOTTOM: 4px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> </table> </div> <div style="DISPLAY: block; TEXT-INDENT: 0pt">&nbsp;</div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> Future expenses related to options and warrants granted to consultants for an average time of approximately 3 months are <font style="FONT-SIZE: 10pt; DISPLAY: inline">$</font>1.</div> <div style="DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> &nbsp;</div> <div style="TEXT-ALIGN: left; MARGIN-LEFT: 0pt; DISPLAY: block; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt"> <table style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman" cellspacing="0" cellpadding="0" width="100%" border="0"> <tr valign="top"> <td style="WIDTH: 18pt" align="right"> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: left; TEXT-INDENT: 0pt"> c.</div> </td> <td align="left"> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: left; TEXT-INDENT: 0pt"> Restricted stock units to employees and directors:</div> </td> </tr> </table> </div> <div style="DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> &nbsp;</div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> The following table summarizes the activities for unvested restricted stock units granted to employees and directors for the year ended June 30, 2014:</div> <div style="DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> &nbsp;</div> <div style="text-align: center"> <table style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman" cellspacing="0" cellpadding="0" width="60%"> <tr> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="88%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-WEIGHT: bold; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="10%" colspan="2"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"> Number</div> </td> <td style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-WEIGHT: bold; DISPLAY: inline"> &nbsp;</font> </td> </tr> <tr bgcolor="white"> <td style="TEXT-ALIGN: left; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt" valign="bottom" width="88%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%" align="right"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: right" valign="bottom" width="9%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> <tr bgcolor="#cceeff"> <td style="TEXT-ALIGN: left; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt" valign="bottom" width="88%"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: left; TEXT-INDENT: 0pt"> Unvested at the beginning of period</div> </td> <td valign="bottom" width="1%" align="right"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">1,660,525</td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> <tr bgcolor="white"> <td style="TEXT-ALIGN: left; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt" valign="bottom" width="88%"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: left; TEXT-INDENT: 0pt"> Granted</div> </td> <td valign="bottom" width="1%" align="right"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">1,256,940</td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> <tr bgcolor="#cceeff"> <td style="TEXT-ALIGN: left; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt" valign="bottom" width="88%"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: left; TEXT-INDENT: 0pt"> Forfeited</div> </td> <td valign="bottom" width="1%" align="right"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">(44,183</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap">)</td> </tr> <tr bgcolor="white"> <td style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt" valign="bottom" width="88%"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: left; TEXT-INDENT: 0pt"> Vested</div> </td> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">(1,283,850</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap">)</td> </tr> <tr bgcolor="#cceeff"> <td style="PADDING-BOTTOM: 4px; TEXT-ALIGN: left; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt" valign="bottom" width="88%"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: left; TEXT-INDENT: 0pt"> Unvested at the end of the period</div> </td> <td style="PADDING-BOTTOM: 4px" valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 4px double; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">1,589,432</td> <td style="PADDING-BOTTOM: 4px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> <tr bgcolor="white"> <td style="PADDING-BOTTOM: 4px; TEXT-ALIGN: left; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt" valign="bottom" width="88%"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: left; TEXT-INDENT: 0pt"> Expected to vest after June 30, 2014</div> </td> <td style="PADDING-BOTTOM: 4px" valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 4px double; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">1,522,024</td> <td style="PADDING-BOTTOM: 4px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> </table> </div> <div style="DISPLAY: block; TEXT-INDENT: 0pt">&nbsp;</div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> Compensation expenses related to restricted stock units granted to employees and directors were recorded as follows:</div> <div style="DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> &nbsp;</div> <div style="MARGIN-LEFT: 36pt; text-align: left"> <table style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman" cellspacing="0" cellpadding="0" width="80%"> <tr> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="64%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-WEIGHT: bold; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="34%" colspan="10"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"> Year ended&nbsp;June 30,</div> </td> <td style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-WEIGHT: bold; DISPLAY: inline"> &nbsp;</font> </td> <td style="PADDING-BOTTOM: 2px" valign="bottom"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> <tr> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="64%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-WEIGHT: bold; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="10%" colspan="2"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"> 2014</div> </td> <td style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-WEIGHT: bold; DISPLAY: inline"> &nbsp;</font> </td> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-WEIGHT: bold; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="10%" colspan="2"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"> 2013</div> </td> <td style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-WEIGHT: bold; DISPLAY: inline"> &nbsp;</font> </td> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-WEIGHT: bold; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="11%" colspan="4"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"> 2012</div> </td> </tr> <tr bgcolor="#cceeff"> <td style="TEXT-ALIGN: left; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt" valign="bottom" width="64%"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: left; TEXT-INDENT: 0pt"> Research and development expenses</div> </td> <td valign="bottom" width="1%" align="right"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%">$</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">1,172</td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%" align="right"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%">$</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">711</td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%" align="right"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%">$</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">1,163</td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> <tr bgcolor="white"> <td style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt" valign="bottom" width="64%"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: left; TEXT-INDENT: 0pt"> General and administrative expenses</div> </td> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%" align="right"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">4,390</td> <td style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%" align="right"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">1,529</td> <td style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%" align="right"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">3,487</td> <td style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> <tr bgcolor="#cceeff"> <td style="PADDING-BOTTOM: 4px" valign="bottom" width="64%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="PADDING-BOTTOM: 4px" valign="bottom" width="1%" align="right"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 4px double; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%">$</td> <td style="BORDER-BOTTOM: black 4px double; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">5,562</td> <td style="PADDING-BOTTOM: 4px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="PADDING-BOTTOM: 4px" valign="bottom" width="1%" align="right"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 4px double; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%">$</td> <td style="BORDER-BOTTOM: black 4px double; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">2,240</td> <td style="PADDING-BOTTOM: 4px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="PADDING-BOTTOM: 4px" valign="bottom" width="1%" align="right"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 4px double; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%">$</td> <td style="BORDER-BOTTOM: black 4px double; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">4,650</td> <td style="PADDING-BOTTOM: 4px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> </table> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; MARGIN-LEFT: 36pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"> &nbsp;</div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"> Future expenses related to restricted stock units granted to employees and directors for an average time of approximately two years is $2,447.</div> <div style="DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> &nbsp;</div> <div style="TEXT-ALIGN: left; MARGIN-LEFT: 0pt; DISPLAY: block; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt"> <table style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman" cellspacing="0" cellpadding="0" width="100%" border="0"> <tr valign="top"> <td style="WIDTH: 18pt" align="right"> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: left; TEXT-INDENT: 0pt"> d.</div> </td> <td align="left"> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: left; TEXT-INDENT: 0pt"> Restricted stock units to consultants:</div> </td> </tr> </table> </div> <div style="DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> &nbsp;</div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> The following table summarizes the activities for unvested restricted stock units and restricted stock granted to consultants for the year ended June 30, 2014:</div> <div style="DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> &nbsp;</div> <div style="MARGIN-LEFT: 18pt; text-align: left"> <table style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman" cellspacing="0" cellpadding="0" width="50%"> <tr> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="84%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-WEIGHT: bold; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="14%" colspan="2"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"> Number</div> </td> <td style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-WEIGHT: bold; DISPLAY: inline"> &nbsp;</font> </td> </tr> <tr bgcolor="#cceeff"> <td style="TEXT-ALIGN: left; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt" valign="bottom" width="84%"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: left; TEXT-INDENT: 0pt"> Unvested at the beginning of period</div> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="13%">-</td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> <tr bgcolor="white"> <td style="TEXT-ALIGN: left; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt" valign="bottom" width="84%"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: left; TEXT-INDENT: 0pt"> Granted</div> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="13%">84,565</td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> <tr bgcolor="#cceeff"> <td style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt" valign="bottom" width="84%"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: left; TEXT-INDENT: 0pt"> Vested</div> </td> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="13%">(69,315</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap">)</td> </tr> <tr bgcolor="white"> <td style="PADDING-BOTTOM: 4px; TEXT-ALIGN: left; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt" valign="bottom" width="84%"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: left; TEXT-INDENT: 0pt"> Unvested at the end of the period</div> </td> <td style="PADDING-BOTTOM: 4px" valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 4px double; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="13%">15,250</td> <td style="PADDING-BOTTOM: 4px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> </table> </div> <div style="DISPLAY: block; TEXT-INDENT: 0pt">&nbsp;</div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: left; TEXT-INDENT: 0pt"> Compensation expenses related to restricted stock units granted to consultants were recorded as follows:</div> <div style="DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> &nbsp;</div> <div style="MARGIN-LEFT: 18pt; text-align: left"> <table style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman" cellspacing="0" cellpadding="0" width="80%"> <tr> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="64%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-WEIGHT: bold; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="34%" colspan="10"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"> Year ended&nbsp;June 30,</div> </td> <td style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-WEIGHT: bold; DISPLAY: inline"> &nbsp;</font> </td> </tr> <tr> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="64%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-WEIGHT: bold; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="10%" colspan="2"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"> 2014</div> </td> <td style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-WEIGHT: bold; DISPLAY: inline"> &nbsp;</font> </td> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-WEIGHT: bold; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="10%" colspan="2"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"> 2013</div> </td> <td style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-WEIGHT: bold; DISPLAY: inline"> &nbsp;</font> </td> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-WEIGHT: bold; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="10%" colspan="2"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"> 2012</div> </td> <td style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-WEIGHT: bold; DISPLAY: inline"> &nbsp;</font> </td> </tr> <tr bgcolor="#cceeff"> <td style="TEXT-ALIGN: left; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt" valign="bottom" width="64%"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: left; TEXT-INDENT: 0pt"> Research and development expenses</div> </td> <td valign="bottom" width="1%" align="right"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%">$</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">201</td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%" align="right"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%">$</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">255</td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%" align="right"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%">$</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">201</td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> <tr bgcolor="white"> <td style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt" valign="bottom" width="64%"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: left; TEXT-INDENT: 0pt"> General and administrative expenses</div> </td> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%" align="right"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">77</td> <td style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%" align="right"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">278</td> <td style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%" align="right"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">20</td> <td style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> <tr bgcolor="#cceeff"> <td style="PADDING-BOTTOM: 4px" valign="bottom" width="64%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="PADDING-BOTTOM: 4px" valign="bottom" width="1%" align="right"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 4px double; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%">$</td> <td style="BORDER-BOTTOM: black 4px double; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">278</td> <td style="PADDING-BOTTOM: 4px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="PADDING-BOTTOM: 4px" valign="bottom" width="1%" align="right"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 4px double; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%">$</td> <td style="BORDER-BOTTOM: black 4px double; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">533</td> <td style="PADDING-BOTTOM: 4px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="PADDING-BOTTOM: 4px" valign="bottom" width="1%" align="right"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 4px double; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%">$</td> <td style="BORDER-BOTTOM: black 4px double; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">221</td> <td style="PADDING-BOTTOM: 4px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> </table> </div> <div style="DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> &nbsp;</div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 22.5pt; text-align: left; TEXT-INDENT: 18pt"> Summary of warrants and options:</div> <div style="DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> &nbsp;</div> <div style="DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"> The following table sets forth a summary of all the warrants and options outstanding as of June 30, 2014:</div> <div style="DISPLAY: block; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"> &nbsp;</div> </div> <div style="text-align: left"> <table style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman" cellspacing="0" cellpadding="0" width="100%"> <tr> <td style="BORDER-BOTTOM: black 2px solid" valign="bottom"> <div style="MARGIN-LEFT: 0pt; DISPLAY: block; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt"> <div style="DISPLAY: block; TEXT-INDENT: 0pt">&nbsp;</div> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"> Warrants / Options</div> </div> </td> <td style="PADDING-BOTTOM: 2px" valign="bottom"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid" valign="bottom" colspan="2"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"> <font style="FONT-WEIGHT: bold; DISPLAY: inline">Exercise Price</font> <font style="FONT-WEIGHT: bold; DISPLAY: inline">per Share</font></div> </td> <td style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="PADDING-BOTTOM: 2px" valign="bottom"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-WEIGHT: bold; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid" valign="bottom" colspan="2"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"> Options and Warrants for Common Stock</div> </td> <td style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-WEIGHT: bold; DISPLAY: inline"> &nbsp;</font> </td> <td style="PADDING-BOTTOM: 2px" valign="bottom"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid" valign="bottom" colspan="2"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"> <font style="FONT-WEIGHT: bold; DISPLAY: inline">Options and Warrants</font> <font style="FONT-WEIGHT: bold; DISPLAY: inline">Exercisable</font></div> </td> <td style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="PADDING-BOTTOM: 2px" valign="bottom"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid" valign="bottom" colspan="2"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"> <font style="FONT-WEIGHT: bold; DISPLAY: inline">Weighted Average Remaining Contractual Terms</font><font style="FONT-WEIGHT: bold; DISPLAY: inline">(in years)</font></div> </td> <td style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> <tr bgcolor="#cceeff"> <td style="TEXT-ALIGN: left; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt" valign="bottom" width="52%"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: left; TEXT-INDENT: 0pt"> Warrants:</div> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%">$</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">1.40</td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">474,322</td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">474,322</td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">0.82</td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> <tr bgcolor="white"> <td valign="bottom" width="52%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%">$</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">1.50</td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">878,174</td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">878,174</td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">0.06</td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> <tr bgcolor="#cceeff"> <td valign="bottom" width="52%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%">$</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">1.60</td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">131,221</td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">131,221</td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">0.78</td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> <tr bgcolor="white"> <td valign="bottom" width="52%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%">$</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">1.80</td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">727,401</td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">727,401</td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">0.30</td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> <tr bgcolor="#cceeff"> <td valign="bottom" width="52%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%">$</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">1.90</td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">43,103</td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">43,103</td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">0.08</td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> <tr bgcolor="white"> <td valign="bottom" width="52%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%">$</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">4.20</td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">5,060,000</td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">5,060,000</td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">2.09</td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> <tr bgcolor="#cceeff"> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="52%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%">$</td> <td style="BORDER-BOTTOM: black 2px solid; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">5.00</td> <td style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">3,219,983</td> <td style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">3,219,983</td> <td style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">3.22</td> <td style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> <tr bgcolor="white"> <td style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt" valign="bottom" width="52%"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: left; TEXT-INDENT: 0pt"> Total warrants</div> </td> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right" valign="bottom" width="9%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-WEIGHT: bold; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-WEIGHT: bold; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; TEXT-ALIGN: right" valign="bottom" width="9%">10,534,204</td> <td style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-WEIGHT: bold; DISPLAY: inline"> &nbsp;</font> </td> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-WEIGHT: bold; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-WEIGHT: bold; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; TEXT-ALIGN: right" valign="bottom" width="9%">10,534,204</td> <td style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-WEIGHT: bold; DISPLAY: inline"> &nbsp;</font> </td> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right" valign="bottom" width="9%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> <tr bgcolor="#cceeff"> <td valign="bottom" width="52%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: right" valign="bottom" width="9%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: right" valign="bottom" width="9%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: right" valign="bottom" width="9%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: right" valign="bottom" width="9%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> <tr bgcolor="white"> <td style="TEXT-ALIGN: left; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt" valign="bottom" width="52%"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: left; TEXT-INDENT: 0pt"> Options:</div> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%">$</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">0.00</td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">101,000</td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">100,000</td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">5.19</td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> <tr bgcolor="#cceeff"> <td valign="bottom" width="52%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%">$</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">0.62</td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">398,500</td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">398,500</td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">4.25</td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> <tr bgcolor="white"> <td valign="bottom" width="52%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%">$</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">1.04</td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">30,000</td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">30,000</td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">4.16</td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> <tr bgcolor="#cceeff"> <td valign="bottom" width="52%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%">$</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">2.97</td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">20,000</td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">20,000</td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">3.86</td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> <tr bgcolor="white"> <td valign="bottom" width="52%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%">$</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">3.50</td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">900,000</td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">900,000</td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">2.58</td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> <tr bgcolor="#cceeff"> <td valign="bottom" width="52%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%">$</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">3.72</td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">15,000</td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">15,000</td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">2.49</td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> <tr bgcolor="white"> <td valign="bottom" width="52%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%">$</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">3.80</td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">16,050</td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">16,050</td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">2.53</td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> <tr bgcolor="#cceeff"> <td valign="bottom" width="52%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%">$</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">4.00</td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">42,500</td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">42,500</td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">2.30</td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> <tr bgcolor="white"> <td valign="bottom" width="52%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%">$</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">4.38 - $ 4.40</td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">417,299</td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">417,299</td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">3.28</td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> <tr bgcolor="#cceeff"> <td valign="bottom" width="52%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%">$</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">6.80</td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">36,250</td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">36,250</td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">3.37</td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> <tr bgcolor="white"> <td valign="bottom" width="52%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%">$</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">8.20</td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">30,000</td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">30,000</td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">2.40</td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> <tr bgcolor="#cceeff"> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="52%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%">$</td> <td style="BORDER-BOTTOM: black 2px solid; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">20.00</td> <td style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">107,500</td> <td style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">107,500</td> <td style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">2.88</td> <td style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> <tr bgcolor="white"> <td style="PADDING-BOTTOM: 4px; TEXT-ALIGN: left; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt" valign="bottom" width="52%"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: left; TEXT-INDENT: 0pt"> Total options</div> </td> <td style="PADDING-BOTTOM: 4px" valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right" valign="bottom" width="9%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="PADDING-BOTTOM: 4px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="PADDING-BOTTOM: 4px" valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-WEIGHT: bold; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-WEIGHT: bold; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 4px double; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; TEXT-ALIGN: right" valign="bottom" width="9%">2,114,099</td> <td style="PADDING-BOTTOM: 4px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-WEIGHT: bold; DISPLAY: inline"> &nbsp;</font> </td> <td style="PADDING-BOTTOM: 4px" valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-WEIGHT: bold; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-WEIGHT: bold; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 4px double; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; TEXT-ALIGN: right" valign="bottom" width="9%">2,113,099</td> <td style="PADDING-BOTTOM: 4px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-WEIGHT: bold; DISPLAY: inline"> &nbsp;</font> </td> <td style="PADDING-BOTTOM: 4px" valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right" valign="bottom" width="9%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="PADDING-BOTTOM: 4px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> <tr bgcolor="#cceeff"> <td style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt" valign="bottom" width="52%"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: left; TEXT-INDENT: 0pt"> Total warrants and options</div> </td> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right" valign="bottom" width="9%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-WEIGHT: bold; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-WEIGHT: bold; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; TEXT-ALIGN: right" valign="bottom" width="9%">&nbsp;12,648,303</td> <td style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-WEIGHT: bold; DISPLAY: inline"> &nbsp;</font> </td> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-WEIGHT: bold; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-WEIGHT: bold; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; TEXT-ALIGN: right" valign="bottom" width="9%">&nbsp;12,647,303</td> <td style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-WEIGHT: bold; DISPLAY: inline"> &nbsp;</font> </td> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right" valign="bottom" width="9%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> </table> </div> <div style="DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> &nbsp;</div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"> This summary does not include 1,604,682 restricted stock units that are not vested as of June 30, 2014.</div> <!--EndFragment--></div> </div><span></span></td>
      </tr>
    </table>
    <div style="display: none;">
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityNoteAbstract">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div>
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_StockholdersEquityNoteAbstract</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:stringItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityNoteDisclosureTextBlock">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The entire disclosure for shareholders' equity comprised of portions attributable to the parent entity and noncontrolling interest, including other comprehensive income. Includes, but is not limited to, balances of common stock, preferred stock, additional paid-in capital, other capital and retained earnings, accumulated balance for each classification of other comprehensive income and amount of comprehensive income.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 235<br><br> -SubTopic 10<br><br> -Section S99<br><br> -Paragraph 1<br><br> -Subparagraph (SX 210.4-08.(d),(e))<br><br> -URI http://asc.fasb.org/extlink&amp;oid=26873400&amp;loc=d3e23780-122690<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 505<br><br> -SubTopic 10<br><br> -Section S99<br><br> -Paragraph 4<br><br> -Subparagraph (SAB TOPIC 4.C)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=27012166&amp;loc=d3e187143-122770<br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 210<br><br> -SubTopic 10<br><br> -Section S99<br><br> -Paragraph 1<br><br> -Subparagraph (SX 210.5-02.29-31)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br><br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 310<br><br> -SubTopic 10<br><br> -Section S99<br><br> -Paragraph 2<br><br> -Subparagraph (SAB TOPIC 4.E)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=27010918&amp;loc=d3e74512-122707<br><br><br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher SEC<br><br> -Name Staff Accounting Bulletin (SAB)<br><br> -Number Topic 4<br><br> -Section C<br><br><br><br>Reference 6: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher SEC<br><br> -Name Staff Accounting Bulletin (SAB)<br><br> -Number Topic 4<br><br> -Section E<br><br><br><br>Reference 7: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher SEC<br><br> -Name Regulation S-X (SX)<br><br> -Number 210<br><br> -Section 08<br><br> -Article 4<br><br><br><br>Reference 8: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 505<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 6<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6928386&amp;loc=d3e21506-112644<br><br><br><br>Reference 9: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Glossary Preferred Stock<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6521494<br><br><br><br>Reference 10: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher SEC<br><br> -Name Regulation S-X (SX)<br><br> -Number 210<br><br> -Section 02<br><br> -Paragraph 29, 30, 31<br><br> -Article 5<br><br><br><br>Reference 11: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher SEC<br><br> -Name Regulation S-X (SX)<br><br> -Number 210<br><br> -Section 04<br><br> -Article 3<br><br><br><br>Reference 12: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 505<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 2<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6928386&amp;loc=d3e21463-112644<br><br><br><br>Reference 13: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 505<br><br> -SubTopic 10<br><br> -Section S99<br><br> -Paragraph 1<br><br> -Subparagraph (SX 210.3-04)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=27012166&amp;loc=d3e187085-122770<br><br><br><br>Reference 14: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 505<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 3<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6928386&amp;loc=d3e21475-112644<br><br><br><br>Reference 15: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 505<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 11<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6928386&amp;loc=d3e21564-112644<br><br><br><br>Reference 16: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 505<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 5<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6928386&amp;loc=d3e21488-112644<br><br><br><br>Reference 17: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 505<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 4<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6928386&amp;loc=d3e21484-112644<br><br><br><br>Reference 18: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher SEC<br><br> -Name Regulation S-X (SX)<br><br> -Number 210<br><br> -Section 08<br><br> -Paragraph d<br><br> -Article 4<br><br><br><br>Reference 19: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 505<br><br> -SubTopic 30<br><br> -Section 50<br><br> -Paragraph 2<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6405834&amp;loc=d3e23285-112656<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_StockholdersEquityNoteDisclosureTextBlock</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>nonnum:textBlockItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
    </div>
  </body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>75
<FILENAME>R34.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
  <head>
    <META http-equiv="Content-Type" content="text/html; charset=us-ascii">
    <link rel="StyleSheet" type="text/css" href="report.css"><script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script></head>
  <body><span style="display: none;">v2.4.0.8</span><table class="report" border="0" cellspacing="2" id="ID0E6GAC">
      <tr>
        <th class="tl" colspan="1" rowspan="1">
          <div style="width: 200px;"><strong>MARKETABLE SECURITIES (Schedule of Investments in Unrealized Loss) (Details) (USD $)<br>In Thousands, unless otherwise specified</strong></div>
        </th>
        <th class="th">
          <div>Jun. 30, 2014</div>
        </th>
        <th class="th">
          <div>Jun. 30, 2013</div>
        </th>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MarketableSecuritiesAbstract', window );"><strong>MARKETABLE SECURITIES [Abstract]</strong></a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesContinuousUnrealizedLossPositionLessThanTwelveMonthsFairValue', window );">Less than 12 months, fair value</a></td>
        <td class="nump">$ 851<span></span></td>
        <td class="nump">$ 5,122<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss', window );">Less than 12 months, gross unrealized loss</a></td>
        <td class="num">(17)<span></span></td>
        <td class="num">(302)<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesContinuousUnrealizedLossPositionTwelveMonthsOrLongerFairValue', window );">12 months or greater, fair value</a></td>
        <td class="nump">463<span></span></td>
        <td class="nump">32<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss', window );">12 months or greater, gross unrealized loss</a></td>
        <td class="num">(12)<span></span></td>
        <td class="num">(9)<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InterestReceivable', window );">Interest receivable</a></td>
        <td class="nump">$ 98<span></span></td>
        <td class="nump">$ 20<span></span></td>
      </tr>
    </table>
    <div style="display: none;">
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleSecuritiesContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Amount of accumulated unrealized loss on investments in debt and equity securities classified as available-for-sale that have been in a continuous loss position for twelve months or longer.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 320<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 7<br><br> -URI http://asc.fasb.org/extlink&amp;oid=27724398&amp;loc=d3e27337-111563<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 320<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 6<br><br> -Subparagraph (a)(2)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=27724398&amp;loc=d3e27290-111563<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_AvailableForSaleSecuritiesContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>debit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleSecuritiesContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Amount of accumulated unrealized loss on investments in debt and equity securities classified as available-for-sale that have been in a continuous loss position for less than twelve months.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 320<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 7<br><br> -URI http://asc.fasb.org/extlink&amp;oid=27724398&amp;loc=d3e27337-111563<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 320<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 6<br><br> -Subparagraph (a)(2)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=27724398&amp;loc=d3e27290-111563<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_AvailableForSaleSecuritiesContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>debit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleSecuritiesContinuousUnrealizedLossPositionLessThanTwelveMonthsFairValue">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>This item represents the aggregate fair value of investments in debt and equity securities categorized neither as held-to-maturity nor trading securities that have been in a continuous unrealized loss position for less than twelve months.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 320<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 7<br><br> -URI http://asc.fasb.org/extlink&amp;oid=27724398&amp;loc=d3e27337-111563<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 320<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 6<br><br> -Subparagraph (a)(1)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=27724398&amp;loc=d3e27290-111563<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_AvailableForSaleSecuritiesContinuousUnrealizedLossPositionLessThanTwelveMonthsFairValue</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>debit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleSecuritiesContinuousUnrealizedLossPositionTwelveMonthsOrLongerFairValue">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>This item represents the aggregate fair value of investments in debt and equity securities categorized neither as held-to-maturity nor trading securities that have been in a continuous unrealized loss position for twelve months or longer.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 320<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 7<br><br> -URI http://asc.fasb.org/extlink&amp;oid=27724398&amp;loc=d3e27337-111563<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 320<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 6<br><br> -Subparagraph (a)(1)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=27724398&amp;loc=d3e27290-111563<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_AvailableForSaleSecuritiesContinuousUnrealizedLossPositionTwelveMonthsOrLongerFairValue</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>debit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestReceivable">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Carrying amount as of the balance sheet date of interest earned but not received. Also called accrued interest or accrued interest receivable.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 210<br><br> -SubTopic 10<br><br> -Section S99<br><br> -Paragraph 1<br><br> -Subparagraph (SX 210.5-02.8)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher SEC<br><br> -Name Regulation S-X (SX)<br><br> -Number 210<br><br> -Section 02<br><br> -Paragraph 8<br><br> -Article 5<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_InterestReceivable</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>debit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MarketableSecuritiesAbstract">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div>
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_MarketableSecuritiesAbstract</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:stringItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
    </div>
  </body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>76
<FILENAME>R21.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
  <head>
    <META http-equiv="Content-Type" content="text/html; charset=us-ascii">
    <link rel="StyleSheet" type="text/css" href="report.css"><script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script></head>
  <body><span style="display: none;">v2.4.0.8</span><table class="report" border="0" cellspacing="2" id="ID0E2F">
      <tr>
        <th class="tl" colspan="1" rowspan="2">
          <div style="width: 200px;"><strong>MARKETABLE SECURITIES (Tables)<br></strong></div>
        </th>
        <th class="th" colspan="1">12 Months Ended</th>
      </tr>
      <tr>
        <th class="th">
          <div>Jun. 30, 2014</div>
        </th>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MarketableSecuritiesAbstract', window );"><strong>MARKETABLE SECURITIES [Abstract]</strong></a></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesTextBlock', window );">Schedule of Available-for-sale Marketable Securities</a></td>
        <td class="text"><!--DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd" --><div> <div><!--StartFragment--> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"> As of June 30, 2014, all of the Company&#39;s marketable securities were classified as available-for-sale.</div> <div style="DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"> &nbsp;</div> <div style="text-align: left"> <table style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman" cellspacing="0" cellpadding="0" width="100%"> <tr> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="20%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-WEIGHT: bold; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="38%" colspan="14"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"> June 30, 2014</div> </td> <td style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-WEIGHT: bold; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="38%" colspan="14"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"> June 30,2013</div> </td> <td style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> <tr> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="20%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-WEIGHT: bold; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="8%" colspan="2"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"> Amortized cost</div> </td> <td style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-WEIGHT: bold; DISPLAY: inline"> &nbsp;</font> </td> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-WEIGHT: bold; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="8%" colspan="2"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"> Gross</div> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"> unrealized</div> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"> gain</div> </td> <td style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-WEIGHT: bold; DISPLAY: inline"> &nbsp;</font> </td> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-WEIGHT: bold; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="8%" colspan="2"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"> Gross</div> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"> unrealized</div> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"> loss</div> </td> <td style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-WEIGHT: bold; DISPLAY: inline"> &nbsp;</font> </td> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-WEIGHT: bold; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="8%" colspan="2"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"> Fair</div> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"> value</div> </td> <td style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-WEIGHT: bold; DISPLAY: inline"> &nbsp;</font> </td> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-WEIGHT: bold; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="8%" colspan="2"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"> Amortized cost</div> </td> <td style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-WEIGHT: bold; DISPLAY: inline"> &nbsp;</font> </td> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-WEIGHT: bold; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="8%" colspan="2"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"> Gross</div> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"> unrealized</div> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"> gain</div> </td> <td style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-WEIGHT: bold; DISPLAY: inline"> &nbsp;</font> </td> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-WEIGHT: bold; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="8%" colspan="2"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"> Gross</div> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"> unrealized</div> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"> loss</div> </td> <td style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-WEIGHT: bold; DISPLAY: inline"> &nbsp;</font> </td> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-WEIGHT: bold; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="8%" colspan="2"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"> Fair</div> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"> value</div> </td> <td style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-WEIGHT: bold; DISPLAY: inline"> &nbsp;</font> </td> </tr> <tr bgcolor="#cceeff"> <td style="TEXT-ALIGN: left; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt" valign="bottom" width="20%"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: left; TEXT-INDENT: 0pt"> Available-for-sale - matures within one year:</div> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="8%" colspan="2"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="8%" colspan="2"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="8%" colspan="2"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="8%" colspan="2"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="8%" colspan="2"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="8%" colspan="2"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="8%" colspan="2"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="8%" colspan="2"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> <tr bgcolor="white"> <td style="TEXT-ALIGN: left; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt" valign="bottom" width="20%"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: left; TEXT-INDENT: 0pt"> Stock and index linked notes</div> </td> <td valign="bottom" width="1%" align="right"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%">$</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="7%">18,881</td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%" align="right"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%">$</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="7%">2,522</td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%" align="right"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%">$</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="7%">(23</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap">)</td> <td valign="bottom" width="1%" align="right"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%">$</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="7%">21,380</td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%" align="right"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%">$</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="7%">4,023</td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%" align="right"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%">$</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="7%">234</td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%" align="right"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%">$</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="7%">(180</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap">)</td> <td valign="bottom" width="1%" align="right"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%">$</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="7%">4,077</td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> <tr bgcolor="#cceeff"> <td style="TEXT-ALIGN: left; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt" valign="bottom" width="20%"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: left; TEXT-INDENT: 0pt"> Government debentures - fixed interest rate</div> </td> <td valign="bottom" width="1%" align="right"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="7%">97</td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%" align="right"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="7%">9</td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%" align="right"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="7%">-</td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%" align="right"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="7%">106</td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%" align="right"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="7%">329</td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%" align="right"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="7%">21</td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%" align="right"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="7%">-</td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%" align="right"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="7%">350</td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> <tr bgcolor="white"> <td style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt" valign="bottom" width="20%"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: left; TEXT-INDENT: 0pt"> Corporate debentures - fixed interest rate</div> </td> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%" align="right"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="7%">452</td> <td style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%" align="right"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="7%">54</td> <td style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%" align="right"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="7%">-</td> <td style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%" align="right"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="7%">506</td> <td style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%" align="right"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="7%">508</td> <td style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%" align="right"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="7%">30</td> <td style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%" align="right"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="7%">(9</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap">)</td> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%" align="right"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="7%">529</td> <td style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> <tr bgcolor="#cceeff"> <td valign="bottom" width="20%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%" align="right"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%">$</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="7%">19,430</td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%" align="right"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%">$</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="7%">2,585</td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%" align="right"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%">$</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="7%">(23</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap">)</td> <td valign="bottom" width="1%" align="right"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%">$</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="7%">21,992</td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%" align="right"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%">$</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="7%">4,860</td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%" align="right"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%">$</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="7%">285</td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%" align="right"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%">$</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="7%">(189</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap">)</td> <td valign="bottom" width="1%" align="right"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%">$</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="7%">4,956</td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> <tr bgcolor="white"> <td style="TEXT-ALIGN: left; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt" valign="bottom" width="20%"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: left; TEXT-INDENT: 0pt"> Available-for-sale - matures after one year through five years:</div> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: right" valign="bottom" width="7%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: right" valign="bottom" width="7%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: right" valign="bottom" width="7%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: right" valign="bottom" width="7%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: right" valign="bottom" width="7%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: right" valign="bottom" width="7%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: right" valign="bottom" width="7%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: right" valign="bottom" width="7%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> <tr bgcolor="#cceeff"> <td style="TEXT-ALIGN: left; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt" valign="bottom" width="20%"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: left; TEXT-INDENT: 0pt"> Government debentures - fixed interest rate</div> </td> <td valign="bottom" width="1%" align="right"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="7%">2,595</td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%" align="right"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="7%">98</td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%" align="right"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="7%">(1</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap">)</td> <td valign="bottom" width="1%" align="right"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="7%">2,692</td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%" align="right"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="7%">1,602</td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%" align="right"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="7%">49</td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%" align="right"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="7%">(12</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap">)</td> <td valign="bottom" width="1%" align="right"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="7%">1,639</td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> <tr bgcolor="white"> <td style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt" valign="bottom" width="20%"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: left; TEXT-INDENT: 0pt"> Corporate debentures - fixed interest rate</div> </td> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%" align="right"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="7%">4,906</td> <td style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%" align="right"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="7%">263</td> <td style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%" align="right"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="7%">(5</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap">)</td> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%" align="right"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="7%">5,164</td> <td style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%" align="right"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="7%">4,976</td> <td style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%" align="right"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="7%">162</td> <td style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%" align="right"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="7%">(77</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap">)</td> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%" align="right"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="7%">5,061</td> <td style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> <tr bgcolor="#cceeff"> <td valign="bottom" width="20%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%" align="right"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%">$</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="7%">7,501</td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%" align="right"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%">$</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="7%">361</td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%" align="right"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%">$</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="7%">(6</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap">)</td> <td valign="bottom" width="1%" align="right"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%">$</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="7%">7,856</td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%" align="right"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%">$</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="7%">6,578</td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%" align="right"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%">$</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="7%">211</td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%" align="right"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%">$</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="7%">(89</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap">)</td> <td valign="bottom" width="1%" align="right"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%">$</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="7%">6,700</td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> <tr bgcolor="white"> <td style="TEXT-ALIGN: left; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt" valign="bottom" width="20%"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: left; TEXT-INDENT: 0pt"> Available-for-sale - matures after five years through ten years:</div> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: right" valign="bottom" width="7%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: right" valign="bottom" width="7%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: right" valign="bottom" width="7%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: right" valign="bottom" width="7%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: right" valign="bottom" width="7%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: right" valign="bottom" width="7%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: right" valign="bottom" width="7%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: right" valign="bottom" width="7%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> <tr bgcolor="#cceeff"> <td style="TEXT-ALIGN: left; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt" valign="bottom" width="20%"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: left; TEXT-INDENT: 0pt"> Government debentures - fixed interest rate</div> </td> <td valign="bottom" width="1%" align="right"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="7%">-</td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%" align="right"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="7%">-</td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%" align="right"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="7%">-</td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%" align="right"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="7%">-</td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%" align="right"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="7%">955</td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%" align="right"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="7%">45</td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%" align="right"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="7%">(14</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap">)</td> <td valign="bottom" width="1%" align="right"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="7%">986</td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> <tr bgcolor="white"> <td style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt" valign="bottom" width="20%"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: left; TEXT-INDENT: 0pt"> Corporate debentures - fixed interest rate</div> </td> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%" align="right"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="7%">94</td> <td style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%" align="right"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="7%">19</td> <td style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%" align="right"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="7%">-</td> <td style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%" align="right"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="7%">113</td> <td style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%" align="right"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="7%">789</td> <td style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%" align="right"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="7%">29</td> <td style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%" align="right"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="7%">(19</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap">)</td> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%" align="right"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="7%">799</td> <td style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> <tr bgcolor="#cceeff"> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="20%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%" align="right"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%">$</td> <td style="BORDER-BOTTOM: black 2px solid; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="7%">94</td> <td style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%" align="right"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%">$</td> <td style="BORDER-BOTTOM: black 2px solid; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="7%">19</td> <td style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%" align="right"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%">$</td> <td style="BORDER-BOTTOM: black 2px solid; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="7%">-</td> <td style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%" align="right"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%">$</td> <td style="BORDER-BOTTOM: black 2px solid; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="7%">113</td> <td style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%" align="right"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%">$</td> <td style="BORDER-BOTTOM: black 2px solid; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="7%">1,744</td> <td style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%" align="right"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%">$</td> <td style="BORDER-BOTTOM: black 2px solid; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="7%">74</td> <td style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%" align="right"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%">$</td> <td style="BORDER-BOTTOM: black 2px solid; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="7%">(33</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap">)</td> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%" align="right"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%">$</td> <td style="BORDER-BOTTOM: black 2px solid; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="7%">1,785</td> <td style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> <tr bgcolor="white"> <td style="PADDING-BOTTOM: 4px; TEXT-ALIGN: left; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt" valign="bottom" width="20%"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: left; TEXT-INDENT: 0pt"> Total</div> </td> <td style="PADDING-BOTTOM: 4px" valign="bottom" width="1%" align="right"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 4px double; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%">$</td> <td style="BORDER-BOTTOM: black 4px double; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="7%">27,025</td> <td style="PADDING-BOTTOM: 4px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="PADDING-BOTTOM: 4px" valign="bottom" width="1%" align="right"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 4px double; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%">$</td> <td style="BORDER-BOTTOM: black 4px double; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="7%">2,965</td> <td style="PADDING-BOTTOM: 4px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="PADDING-BOTTOM: 4px" valign="bottom" width="1%" align="right"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 4px double; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%">$</td> <td style="BORDER-BOTTOM: black 4px double; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="7%">(29</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; PADDING-BOTTOM: 4px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap">)</td> <td style="PADDING-BOTTOM: 4px" valign="bottom" width="1%" align="right"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 4px double; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%">$</td> <td style="BORDER-BOTTOM: black 4px double; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="7%">29,961</td> <td style="PADDING-BOTTOM: 4px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="PADDING-BOTTOM: 4px" valign="bottom" width="1%" align="right"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 4px double; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%">$</td> <td style="BORDER-BOTTOM: black 4px double; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="7%">13,182</td> <td style="PADDING-BOTTOM: 4px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="PADDING-BOTTOM: 4px" valign="bottom" width="1%" align="right"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 4px double; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%">$</td> <td style="BORDER-BOTTOM: black 4px double; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="7%">570</td> <td style="PADDING-BOTTOM: 4px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="PADDING-BOTTOM: 4px" valign="bottom" width="1%" align="right"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 4px double; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%">$</td> <td style="BORDER-BOTTOM: black 4px double; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="7%">(311</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; PADDING-BOTTOM: 4px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap">)</td> <td style="PADDING-BOTTOM: 4px" valign="bottom" width="1%" align="right"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 4px double; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%">$</td> <td style="BORDER-BOTTOM: black 4px double; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="7%">13,441</td> <td style="PADDING-BOTTOM: 4px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> </table> </div> <!--EndFragment--></div> </div><span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesContinuousUnrealizedLossPositionFairValueTableTextBlock', window );">Schedule of Investments in Continuous Unrealized Loss Position</a></td>
        <td class="text"><!--DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd" --><div> <div><!--StartFragment--> <div style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt"> The following table presents gross unrealized losses and fair values for those investments that were in an unrealized loss position as of June 30, 2014 and June 30, 2013, and the length of time that those investments have been in a continuous loss position:</div> <div style="MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt"> &nbsp;</div> <div style="text-align: left"> <table style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman" cellspacing="0" cellpadding="0" width="100%"> <tr> <td style="PADDING-BOTTOM: 2px" valign="bottom"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="PADDING-BOTTOM: 2px" valign="bottom"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-WEIGHT: bold; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid" valign="bottom" colspan="6"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"> Less than 12 months</div> </td> <td style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-WEIGHT: bold; DISPLAY: inline"> &nbsp;</font> </td> <td style="PADDING-BOTTOM: 2px" valign="bottom"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-WEIGHT: bold; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid" valign="bottom" colspan="6"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"> 12 months or greater</div> </td> <td style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-WEIGHT: bold; DISPLAY: inline"> &nbsp;</font> </td> </tr> <tr> <td style="PADDING-BOTTOM: 2px" valign="bottom"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="PADDING-BOTTOM: 2px" valign="bottom"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-WEIGHT: bold; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid" valign="bottom" colspan="2"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"> Fair Value</div> </td> <td style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-WEIGHT: bold; DISPLAY: inline"> &nbsp;</font> </td> <td style="PADDING-BOTTOM: 2px" valign="bottom"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-WEIGHT: bold; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid" valign="bottom" colspan="2"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"> Gross</div> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"> unrealized loss</div> </td> <td style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-WEIGHT: bold; DISPLAY: inline"> &nbsp;</font> </td> <td style="PADDING-BOTTOM: 2px" valign="bottom"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-WEIGHT: bold; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid" valign="bottom" colspan="2"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"> Fair Value</div> </td> <td style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-WEIGHT: bold; DISPLAY: inline"> &nbsp;</font> </td> <td style="PADDING-BOTTOM: 2px" valign="bottom"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-WEIGHT: bold; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid" valign="bottom" colspan="2"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"> Gross</div> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"> unrealized loss</div> </td> <td style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-WEIGHT: bold; DISPLAY: inline"> &nbsp;</font> </td> </tr> <tr bgcolor="#cceeff"> <td style="TEXT-ALIGN: left; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt" valign="bottom" width="52%"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: left; TEXT-INDENT: 0pt"> As of June 30, 2014</div> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%">$</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">851</td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%">$</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">(17</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap">)</td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%">$</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">463</td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%">$</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">(12</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap">)</td> </tr> <tr bgcolor="white"> <td style="TEXT-ALIGN: left; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt" valign="bottom" width="52%"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: left; TEXT-INDENT: 0pt"> As of June 30, 2013</div> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%">$</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">5,122</td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%">$</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">(302</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap">)</td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%">$</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">32</td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%">$</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">(9</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap">)</td> </tr> </table> </div> <!--EndFragment--></div> </div><span></span></td>
      </tr>
    </table>
    <div style="display: none;">
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleSecuritiesContinuousUnrealizedLossPositionFairValueTableTextBlock">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Tabular disclosure of fair value of investments in debt and equity securities in an unrealized loss position categorized neither as held-to-maturity nor trading securities.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_AvailableForSaleSecuritiesContinuousUnrealizedLossPositionFairValueTableTextBlock</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>nonnum:textBlockItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleSecuritiesTextBlock">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Tabular disclosure of available-for-sale securities which includes, but is not limited to, changes in the cost basis and fair value, fair value and gross unrealized gain (loss), fair values by type of security, contractual maturity and classification, amortized cost basis, contracts to acquire securities to be accounted for as available-for-sale, debt maturities, transfers to trading, change in net unrealized holding gain (loss) net of tax, continuous unrealized loss position fair value, aggregate losses qualitative disclosures, other than temporary impairment (OTTI) losses or other disclosures related to available for sale securities.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 320<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 6<br><br> -URI http://asc.fasb.org/extlink&amp;oid=27724398&amp;loc=d3e27290-111563<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 320<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 9<br><br> -URI http://asc.fasb.org/extlink&amp;oid=27724398&amp;loc=d3e27357-111563<br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 320<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 7<br><br> -URI http://asc.fasb.org/extlink&amp;oid=27724398&amp;loc=d3e27337-111563<br><br><br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 942<br><br> -SubTopic 320<br><br> -Section 50<br><br> -Paragraph 2<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6957658&amp;loc=d3e62557-112803<br><br><br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 320<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 3<br><br> -URI http://asc.fasb.org/extlink&amp;oid=27724398&amp;loc=d3e27198-111563<br><br><br><br>Reference 6: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 942<br><br> -SubTopic 320<br><br> -Section 50<br><br> -Paragraph 3<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6957658&amp;loc=d3e62586-112803<br><br><br><br>Reference 7: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 320<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 2<br><br> -URI http://asc.fasb.org/extlink&amp;oid=27724398&amp;loc=d3e27161-111563<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_AvailableForSaleSecuritiesTextBlock</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>nonnum:textBlockItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MarketableSecuritiesAbstract">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div>
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_MarketableSecuritiesAbstract</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:stringItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
    </div>
  </body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>77
<FILENAME>R26.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
  <head>
    <META http-equiv="Content-Type" content="text/html; charset=us-ascii">
    <link rel="StyleSheet" type="text/css" href="report.css"><script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script></head>
  <body><span style="display: none;">v2.4.0.8</span><table class="report" border="0" cellspacing="2" id="ID0EVDAE">
      <tr>
        <th class="tl" colspan="1" rowspan="2">
          <div style="width: 200px;"><strong>STOCKHOLDERS' EQUITY (Tables)<br></strong></div>
        </th>
        <th class="th" colspan="1">12 Months Ended</th>
      </tr>
      <tr>
        <th class="th">
          <div>Jun. 30, 2014</div>
        </th>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityNoteAbstract', window );"><strong>STOCKHOLDERS' EQUITY [Abstract]</strong></a></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock', window );">Schedule of Stock Option Activity</a></td>
        <td class="text"><!--DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd" --><div> <div><!--StartFragment--> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> The Company accounted for its options to employees and directors under the fair value method in accordance with ASC 718. A summary of the Company&#39;s share option activity for options granted to employees and directors under the Plans is as follows:</div> <div style="DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> &nbsp;</div> <div style="text-align: right"> <table style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman" cellspacing="0" cellpadding="0" width="97%"> <tr> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="52%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-WEIGHT: bold; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="46%" colspan="14"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"> Year ended June 30, 2014</div> </td> <td style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-WEIGHT: bold; DISPLAY: inline"> &nbsp;</font> </td> </tr> <tr> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="52%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-WEIGHT: bold; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="10%" colspan="2"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"> Number</div> </td> <td style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-WEIGHT: bold; DISPLAY: inline"> &nbsp;</font> </td> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-WEIGHT: bold; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="10%" colspan="2"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"> Weighted Average Exercise Price</div> </td> <td style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-WEIGHT: bold; DISPLAY: inline"> &nbsp;</font> </td> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-WEIGHT: bold; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="10%" colspan="2"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"> Weighted Average Remaining Contractual Terms (in years)</div> </td> <td style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-WEIGHT: bold; DISPLAY: inline"> &nbsp;</font> </td> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-WEIGHT: bold; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="10%" colspan="2"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"> Aggregate Intrinsic Value Price</div> </td> <td style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-WEIGHT: bold; DISPLAY: inline"> &nbsp;</font> </td> </tr> <tr bgcolor="#cceeff"> <td style="TEXT-ALIGN: left; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt" valign="bottom" width="52%"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: left; TEXT-INDENT: 0pt"> Options outstanding at beginning of period</div> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">1,958,156</td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%">$</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">4.03</td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="10%" colspan="2"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="10%" colspan="2"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> <tr bgcolor="white"> <td style="TEXT-ALIGN: left; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt" valign="bottom" width="52%"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: left; TEXT-INDENT: 0pt"> Options exercised</div> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">(15,000</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap">)</td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%">$</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">0.83</td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="10%" colspan="2"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="10%" colspan="2"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> <tr bgcolor="#cceeff"> <td style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt" valign="bottom" width="52%"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: left; TEXT-INDENT: 0pt"> Options forfeited</div> </td> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">(81,057</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap">)</td> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%">$</td> <td style="BORDER-BOTTOM: black 2px solid; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">11.59</td> <td style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="10%" colspan="2"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="10%" colspan="2"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> <tr bgcolor="white"> <td style="PADDING-BOTTOM: 4px; TEXT-ALIGN: left; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt" valign="bottom" width="52%"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: left; TEXT-INDENT: 0pt"> Options outstanding at end of the period</div> </td> <td style="PADDING-BOTTOM: 4px" valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 4px double; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">1,862,099</td> <td style="PADDING-BOTTOM: 4px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="PADDING-BOTTOM: 4px" valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 4px double; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%">$</td> <td style="BORDER-BOTTOM: black 4px double; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">3.73</td> <td style="PADDING-BOTTOM: 4px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="PADDING-BOTTOM: 4px" valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 4px double; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">3.13</td> <td style="PADDING-BOTTOM: 4px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="PADDING-BOTTOM: 4px" valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 4px double; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%">$</td> <td style="BORDER-BOTTOM: black 4px double; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">1,046</td> <td style="PADDING-BOTTOM: 4px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> <tr bgcolor="#cceeff"> <td style="PADDING-BOTTOM: 4px; TEXT-ALIGN: left; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt" valign="bottom" width="52%"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: left; TEXT-INDENT: 0pt"> Options exercisable at the end of the period</div> </td> <td style="PADDING-BOTTOM: 4px" valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 4px double; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">1,862,099</td> <td style="PADDING-BOTTOM: 4px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="PADDING-BOTTOM: 4px" valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 4px double; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%">$</td> <td style="BORDER-BOTTOM: black 4px double; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">3.73</td> <td style="PADDING-BOTTOM: 4px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="PADDING-BOTTOM: 4px" valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 4px double; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">3.13</td> <td style="PADDING-BOTTOM: 4px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="PADDING-BOTTOM: 4px" valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 4px double; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%">$</td> <td style="BORDER-BOTTOM: black 4px double; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">1,046</td> <td style="PADDING-BOTTOM: 4px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> <tr bgcolor="white"> <td style="PADDING-BOTTOM: 4px; TEXT-ALIGN: left; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt" valign="bottom" width="52%"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: left; TEXT-INDENT: 0pt"> Options vested</div> </td> <td style="PADDING-BOTTOM: 4px" valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 4px double; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">1,862,099</td> <td style="PADDING-BOTTOM: 4px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="PADDING-BOTTOM: 4px" valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 4px double; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%">$</td> <td style="BORDER-BOTTOM: black 4px double; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">3.73</td> <td style="PADDING-BOTTOM: 4px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="PADDING-BOTTOM: 4px" valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 4px double; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">3.13</td> <td style="PADDING-BOTTOM: 4px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="PADDING-BOTTOM: 4px" valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 4px double; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%">$</td> <td style="BORDER-BOTTOM: black 4px double; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">1,046</td> <td style="PADDING-BOTTOM: 4px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> </table> </div> <!--EndFragment--></div> </div><span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfShareBasedCompensationActivityTableTextBlock', window );">Schedule of Stock Option and Warrant Activity</a></td>
        <td class="text"><!--DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd" --><div> <div><!--StartFragment--> <div> <table style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman" cellspacing="0" cellpadding="0" width="100%" align="center" border="0"> <tr valign="top"> <td style="WIDTH: 18pt">&nbsp;</td> <td> <div style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; text-align: left"> A summary of the Company&#39;s activity related to options and warrants to consultants is as follows:</div> </td> </tr> </table> </div> <div>&nbsp;</div> <div style="text-align: right"> <table style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman" cellspacing="0" cellpadding="0" width="97%"> <tr> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="52%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-WEIGHT: bold; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="46%" colspan="14"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"> Year ended&nbsp;June 30, 2014</div> </td> <td style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-WEIGHT: bold; DISPLAY: inline"> &nbsp;</font> </td> </tr> <tr> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="52%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-WEIGHT: bold; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="10%" colspan="2"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"> Number</div> </td> <td style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-WEIGHT: bold; DISPLAY: inline"> &nbsp;</font> </td> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-WEIGHT: bold; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="10%" colspan="2"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"> Weighted Average Exercise Price</div> </td> <td style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-WEIGHT: bold; DISPLAY: inline"> &nbsp;</font> </td> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-WEIGHT: bold; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="10%" colspan="2"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"> Weighted Average Remaining Contractual Terms (in years)</div> </td> <td style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-WEIGHT: bold; DISPLAY: inline"> &nbsp;</font> </td> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-WEIGHT: bold; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="10%" colspan="2"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"> Aggregate Intrinsic Value Price</div> </td> <td style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-WEIGHT: bold; DISPLAY: inline"> &nbsp;</font> </td> </tr> <tr bgcolor="#cceeff"> <td style="TEXT-ALIGN: left; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt" valign="bottom" width="52%"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: left; TEXT-INDENT: 0pt"> Options and warrants outstanding at beginning of period</div> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">315,500</td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%">$</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">4.44</td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="10%" colspan="2"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="10%" colspan="2"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> <tr bgcolor="white"> <td style="TEXT-ALIGN: left; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt" valign="bottom" width="52%"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: left; TEXT-INDENT: 0pt"> Options granted</div> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">3,000</td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%">$</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">0.00</td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="10%" colspan="2"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="10%" colspan="2"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> <tr bgcolor="#cceeff"> <td style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt" valign="bottom" width="52%"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: left; TEXT-INDENT: 0pt"> Options and warrants exercised</div> </td> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">(66,500</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap">)</td> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%">$</td> <td style="BORDER-BOTTOM: black 2px solid; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">1.39</td> <td style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="10%" colspan="2"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="10%" colspan="2"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> <tr bgcolor="white"> <td style="PADDING-BOTTOM: 4px; TEXT-ALIGN: left; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt" valign="bottom" width="52%"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: left; TEXT-INDENT: 0pt"> Options and warrants outstanding at end of the period</div> </td> <td style="PADDING-BOTTOM: 4px" valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 4px double; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">252,000</td> <td style="PADDING-BOTTOM: 4px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="PADDING-BOTTOM: 4px" valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 4px double; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%">$</td> <td style="BORDER-BOTTOM: black 4px double; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">5.19</td> <td style="PADDING-BOTTOM: 4px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="PADDING-BOTTOM: 4px" valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 4px double; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">3.96</td> <td style="PADDING-BOTTOM: 4px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="PADDING-BOTTOM: 4px" valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 4px double; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%">$</td> <td style="BORDER-BOTTOM: black 4px double; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">331</td> <td style="PADDING-BOTTOM: 4px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> <tr bgcolor="#cceeff"> <td style="PADDING-BOTTOM: 4px; TEXT-ALIGN: left; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt" valign="bottom" width="52%"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: left; TEXT-INDENT: 0pt"> Options and warrants exercisable at the end of the period</div> </td> <td style="PADDING-BOTTOM: 4px" valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 4px double; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">251,000</td> <td style="PADDING-BOTTOM: 4px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="PADDING-BOTTOM: 4px" valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 4px double; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%">$</td> <td style="BORDER-BOTTOM: black 4px double; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">5.21</td> <td style="PADDING-BOTTOM: 4px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="PADDING-BOTTOM: 4px" valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 4px double; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">3.93</td> <td style="PADDING-BOTTOM: 4px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="PADDING-BOTTOM: 4px" valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 4px double; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%">$</td> <td style="BORDER-BOTTOM: black 4px double; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">328</td> <td style="PADDING-BOTTOM: 4px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> <tr bgcolor="white"> <td style="PADDING-BOTTOM: 4px; TEXT-ALIGN: left; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt" valign="bottom" width="52%"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: left; TEXT-INDENT: 0pt"> Options and warrants vested&nbsp;&nbsp;and expected to vest</div> </td> <td style="PADDING-BOTTOM: 4px" valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 4px double; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">252,000</td> <td style="PADDING-BOTTOM: 4px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="PADDING-BOTTOM: 4px" valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 4px double; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%">$</td> <td style="BORDER-BOTTOM: black 4px double; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">5.19</td> <td style="PADDING-BOTTOM: 4px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="PADDING-BOTTOM: 4px" valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 4px double; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">3.96</td> <td style="PADDING-BOTTOM: 4px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="PADDING-BOTTOM: 4px" valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 4px double; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%">$</td> <td style="BORDER-BOTTOM: black 4px double; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">331</td> <td style="PADDING-BOTTOM: 4px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> </table> </div> <!--EndFragment--></div> </div><span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTextBlock', window );">Summary of Options and Warrants Outstanding</a></td>
        <td class="text"><!--DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd" --><div> <div><!--StartFragment--> <div style="DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"> The following table sets forth a summary of all the warrants and options outstanding as of June 30, 2014:</div> <div style="DISPLAY: block; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"> &nbsp;</div> </div> <div style="text-align: left"> <table style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman" cellspacing="0" cellpadding="0" width="100%"> <tr> <td style="BORDER-BOTTOM: black 2px solid" valign="bottom"> <div style="MARGIN-LEFT: 0pt; DISPLAY: block; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt"> <div style="DISPLAY: block; TEXT-INDENT: 0pt">&nbsp;</div> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"> Warrants / Options</div> </div> </td> <td style="PADDING-BOTTOM: 2px" valign="bottom"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid" valign="bottom" colspan="2"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"> <font style="FONT-WEIGHT: bold; DISPLAY: inline">Exercise Price</font> <font style="FONT-WEIGHT: bold; DISPLAY: inline">per Share</font></div> </td> <td style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="PADDING-BOTTOM: 2px" valign="bottom"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-WEIGHT: bold; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid" valign="bottom" colspan="2"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"> Options and Warrants for Common Stock</div> </td> <td style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-WEIGHT: bold; DISPLAY: inline"> &nbsp;</font> </td> <td style="PADDING-BOTTOM: 2px" valign="bottom"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid" valign="bottom" colspan="2"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"> <font style="FONT-WEIGHT: bold; DISPLAY: inline">Options and Warrants</font> <font style="FONT-WEIGHT: bold; DISPLAY: inline">Exercisable</font></div> </td> <td style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="PADDING-BOTTOM: 2px" valign="bottom"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid" valign="bottom" colspan="2"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"> <font style="FONT-WEIGHT: bold; DISPLAY: inline">Weighted Average Remaining Contractual Terms</font><font style="FONT-WEIGHT: bold; DISPLAY: inline">(in years)</font></div> </td> <td style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> <tr bgcolor="#cceeff"> <td style="TEXT-ALIGN: left; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt" valign="bottom" width="52%"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: left; TEXT-INDENT: 0pt"> Warrants:</div> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%">$</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">1.40</td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">474,322</td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">474,322</td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">0.82</td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> <tr bgcolor="white"> <td valign="bottom" width="52%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%">$</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">1.50</td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">878,174</td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">878,174</td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">0.06</td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> <tr bgcolor="#cceeff"> <td valign="bottom" width="52%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%">$</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">1.60</td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">131,221</td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">131,221</td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">0.78</td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> <tr bgcolor="white"> <td valign="bottom" width="52%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%">$</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">1.80</td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">727,401</td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">727,401</td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">0.30</td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> <tr bgcolor="#cceeff"> <td valign="bottom" width="52%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%">$</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">1.90</td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">43,103</td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">43,103</td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">0.08</td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> <tr bgcolor="white"> <td valign="bottom" width="52%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%">$</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">4.20</td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">5,060,000</td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">5,060,000</td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">2.09</td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> <tr bgcolor="#cceeff"> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="52%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%">$</td> <td style="BORDER-BOTTOM: black 2px solid; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">5.00</td> <td style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">3,219,983</td> <td style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">3,219,983</td> <td style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">3.22</td> <td style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> <tr bgcolor="white"> <td style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt" valign="bottom" width="52%"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: left; TEXT-INDENT: 0pt"> Total warrants</div> </td> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right" valign="bottom" width="9%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-WEIGHT: bold; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-WEIGHT: bold; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; TEXT-ALIGN: right" valign="bottom" width="9%">10,534,204</td> <td style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-WEIGHT: bold; DISPLAY: inline"> &nbsp;</font> </td> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-WEIGHT: bold; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-WEIGHT: bold; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; TEXT-ALIGN: right" valign="bottom" width="9%">10,534,204</td> <td style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-WEIGHT: bold; DISPLAY: inline"> &nbsp;</font> </td> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right" valign="bottom" width="9%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> <tr bgcolor="#cceeff"> <td valign="bottom" width="52%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: right" valign="bottom" width="9%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: right" valign="bottom" width="9%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: right" valign="bottom" width="9%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: right" valign="bottom" width="9%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> <tr bgcolor="white"> <td style="TEXT-ALIGN: left; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt" valign="bottom" width="52%"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: left; TEXT-INDENT: 0pt"> Options:</div> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%">$</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">0.00</td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">101,000</td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">100,000</td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">5.19</td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> <tr bgcolor="#cceeff"> <td valign="bottom" width="52%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%">$</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">0.62</td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">398,500</td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">398,500</td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">4.25</td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> <tr bgcolor="white"> <td valign="bottom" width="52%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%">$</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">1.04</td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">30,000</td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">30,000</td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">4.16</td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> <tr bgcolor="#cceeff"> <td valign="bottom" width="52%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%">$</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">2.97</td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">20,000</td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">20,000</td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">3.86</td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> <tr bgcolor="white"> <td valign="bottom" width="52%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%">$</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">3.50</td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">900,000</td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">900,000</td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">2.58</td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> <tr bgcolor="#cceeff"> <td valign="bottom" width="52%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%">$</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">3.72</td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">15,000</td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">15,000</td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">2.49</td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> <tr bgcolor="white"> <td valign="bottom" width="52%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%">$</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">3.80</td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">16,050</td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">16,050</td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">2.53</td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> <tr bgcolor="#cceeff"> <td valign="bottom" width="52%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%">$</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">4.00</td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">42,500</td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">42,500</td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">2.30</td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> <tr bgcolor="white"> <td valign="bottom" width="52%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%">$</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">4.38 - $ 4.40</td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">417,299</td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">417,299</td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">3.28</td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> <tr bgcolor="#cceeff"> <td valign="bottom" width="52%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%">$</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">6.80</td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">36,250</td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">36,250</td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">3.37</td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> <tr bgcolor="white"> <td valign="bottom" width="52%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%">$</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">8.20</td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">30,000</td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">30,000</td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">2.40</td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> <tr bgcolor="#cceeff"> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="52%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%">$</td> <td style="BORDER-BOTTOM: black 2px solid; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">20.00</td> <td style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">107,500</td> <td style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">107,500</td> <td style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">2.88</td> <td style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> <tr bgcolor="white"> <td style="PADDING-BOTTOM: 4px; TEXT-ALIGN: left; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt" valign="bottom" width="52%"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: left; TEXT-INDENT: 0pt"> Total options</div> </td> <td style="PADDING-BOTTOM: 4px" valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right" valign="bottom" width="9%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="PADDING-BOTTOM: 4px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="PADDING-BOTTOM: 4px" valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-WEIGHT: bold; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-WEIGHT: bold; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 4px double; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; TEXT-ALIGN: right" valign="bottom" width="9%">2,114,099</td> <td style="PADDING-BOTTOM: 4px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-WEIGHT: bold; DISPLAY: inline"> &nbsp;</font> </td> <td style="PADDING-BOTTOM: 4px" valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-WEIGHT: bold; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-WEIGHT: bold; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 4px double; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; TEXT-ALIGN: right" valign="bottom" width="9%">2,113,099</td> <td style="PADDING-BOTTOM: 4px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-WEIGHT: bold; DISPLAY: inline"> &nbsp;</font> </td> <td style="PADDING-BOTTOM: 4px" valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right" valign="bottom" width="9%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="PADDING-BOTTOM: 4px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> <tr bgcolor="#cceeff"> <td style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt" valign="bottom" width="52%"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: left; TEXT-INDENT: 0pt"> Total warrants and options</div> </td> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right" valign="bottom" width="9%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-WEIGHT: bold; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-WEIGHT: bold; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; TEXT-ALIGN: right" valign="bottom" width="9%">&nbsp;12,648,303</td> <td style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-WEIGHT: bold; DISPLAY: inline"> &nbsp;</font> </td> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-WEIGHT: bold; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-WEIGHT: bold; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; TEXT-ALIGN: right" valign="bottom" width="9%">&nbsp;12,647,303</td> <td style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-WEIGHT: bold; DISPLAY: inline"> &nbsp;</font> </td> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right" valign="bottom" width="9%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> </table> </div> <!--EndFragment--></div> </div><span></span></td>
      </tr>
      <tr class="rh">
        <td class="pl" style="border-bottom: 0px;" valign="top">
          <div class="a">Options and warrants [Member]</div>
        </td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_psti_StockholdersEquityNoteLineItems', window );"><strong>Stockholders Equity Note [Line Items]</strong></a></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock', window );">Schedule of Stock-based Compensation Expenses</a></td>
        <td class="text"><!--DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd" --><div> <div><!--StartFragment--> <div> <table style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman" cellspacing="0" cellpadding="0" width="100%" align="center" border="0"> <tr valign="top"> <td style="WIDTH: 18pt">&nbsp;</td> <td width="1837"> <div style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; text-align: justify"> Compensation expenses related to options and warrants granted to consultants were recorded as follows:</div> </td> </tr> </table> </div> <div style="DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> &nbsp;</div> <div style="MARGIN-LEFT: 36pt; text-align: left"> <table style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman" cellspacing="0" cellpadding="0" width="80%"> <tr> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="64%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-WEIGHT: bold; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="34%" colspan="10"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"> Year ended&nbsp;June 30,</div> </td> <td style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-WEIGHT: bold; DISPLAY: inline"> &nbsp;</font> </td> </tr> <tr> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="64%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-WEIGHT: bold; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="10%" colspan="2"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"> 2014</div> </td> <td style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-WEIGHT: bold; DISPLAY: inline"> &nbsp;</font> </td> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-WEIGHT: bold; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="10%" colspan="2"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"> 2013</div> </td> <td style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-WEIGHT: bold; DISPLAY: inline"> &nbsp;</font> </td> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-WEIGHT: bold; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="10%" colspan="2"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"> 2012</div> </td> <td style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-WEIGHT: bold; DISPLAY: inline"> &nbsp;</font> </td> </tr> <tr bgcolor="white"> <td style="TEXT-ALIGN: left; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt" valign="bottom" width="64%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%" align="right"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: right" valign="bottom" width="9%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%" align="right"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: right" valign="bottom" width="9%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%" align="right"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: right" valign="bottom" width="9%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> <tr bgcolor="#cceeff"> <td style="TEXT-ALIGN: left; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt" valign="bottom" width="64%"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: left; TEXT-INDENT: 0pt"> Research and development expenses</div> </td> <td valign="bottom" width="1%" align="right"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%">$</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">11</td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%" align="right"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%">$</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">26</td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%" align="right"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%">$</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">19</td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> <tr bgcolor="white"> <td style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt" valign="bottom" width="64%"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: left; TEXT-INDENT: 0pt"> General and administrative expenses</div> </td> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right" valign="bottom" width="9%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%" align="right"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">-</td> <td style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%" align="right"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">37</td> <td style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> <tr bgcolor="#cceeff"> <td style="PADDING-BOTTOM: 4px" valign="bottom" width="64%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="PADDING-BOTTOM: 4px" valign="bottom" width="1%" align="right"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 4px double; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%">$</td> <td style="BORDER-BOTTOM: black 4px double; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">11</td> <td style="PADDING-BOTTOM: 4px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="PADDING-BOTTOM: 4px" valign="bottom" width="1%" align="right"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 4px double; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%">$</td> <td style="BORDER-BOTTOM: black 4px double; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">26</td> <td style="PADDING-BOTTOM: 4px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="PADDING-BOTTOM: 4px" valign="bottom" width="1%" align="right"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 4px double; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%">$</td> <td style="BORDER-BOTTOM: black 4px double; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">56</td> <td style="PADDING-BOTTOM: 4px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> </table> </div> <!--EndFragment--></div> </div><span></span></td>
      </tr>
      <tr class="rh">
        <td class="pl" style="border-bottom: 0px;" valign="top">
          <div class="a">Restricted stock units [Member]</div>
        </td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_psti_StockholdersEquityNoteLineItems', window );"><strong>Stockholders Equity Note [Line Items]</strong></a></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfNonvestedRestrictedStockUnitsActivityTableTextBlock', window );">Schedule of Unvested Restricted Stock Units</a></td>
        <td class="text"><!--DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd" --><div> <div><!--StartFragment--> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> The following table summarizes the activities for unvested restricted stock units granted to employees and directors for the year ended June 30, 2014:</div> <div style="DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> &nbsp;</div> <div style="text-align: center"> <table style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman" cellspacing="0" cellpadding="0" width="60%"> <tr> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="88%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-WEIGHT: bold; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="10%" colspan="2"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"> Number</div> </td> <td style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-WEIGHT: bold; DISPLAY: inline"> &nbsp;</font> </td> </tr> <tr bgcolor="white"> <td style="TEXT-ALIGN: left; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt" valign="bottom" width="88%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%" align="right"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: right" valign="bottom" width="9%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> <tr bgcolor="#cceeff"> <td style="TEXT-ALIGN: left; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt" valign="bottom" width="88%"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: left; TEXT-INDENT: 0pt"> Unvested at the beginning of period</div> </td> <td valign="bottom" width="1%" align="right"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">1,660,525</td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> <tr bgcolor="white"> <td style="TEXT-ALIGN: left; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt" valign="bottom" width="88%"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: left; TEXT-INDENT: 0pt"> Granted</div> </td> <td valign="bottom" width="1%" align="right"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">1,256,940</td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> <tr bgcolor="#cceeff"> <td style="TEXT-ALIGN: left; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt" valign="bottom" width="88%"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: left; TEXT-INDENT: 0pt"> Forfeited</div> </td> <td valign="bottom" width="1%" align="right"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">(44,183</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap">)</td> </tr> <tr bgcolor="white"> <td style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt" valign="bottom" width="88%"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: left; TEXT-INDENT: 0pt"> Vested</div> </td> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">(1,283,850</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap">)</td> </tr> <tr bgcolor="#cceeff"> <td style="PADDING-BOTTOM: 4px; TEXT-ALIGN: left; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt" valign="bottom" width="88%"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: left; TEXT-INDENT: 0pt"> Unvested at the end of the period</div> </td> <td style="PADDING-BOTTOM: 4px" valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 4px double; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">1,589,432</td> <td style="PADDING-BOTTOM: 4px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> <tr bgcolor="white"> <td style="PADDING-BOTTOM: 4px; TEXT-ALIGN: left; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt" valign="bottom" width="88%"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: left; TEXT-INDENT: 0pt"> Expected to vest after June 30, 2014</div> </td> <td style="PADDING-BOTTOM: 4px" valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 4px double; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">1,522,024</td> <td style="PADDING-BOTTOM: 4px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> </table> </div> <!--EndFragment--></div> </div><span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock', window );">Schedule of Stock-based Compensation Expenses</a></td>
        <td class="text"><!--DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd" --><div> <div><!--StartFragment--> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> Compensation expenses related to restricted stock units granted to employees and directors were recorded as follows:</div> <div style="DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> &nbsp;</div> <div style="MARGIN-LEFT: 36pt; text-align: left"> <table style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman" cellspacing="0" cellpadding="0" width="80%"> <tr> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="64%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-WEIGHT: bold; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="34%" colspan="10"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"> Year ended&nbsp;June 30,</div> </td> <td style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-WEIGHT: bold; DISPLAY: inline"> &nbsp;</font> </td> <td style="PADDING-BOTTOM: 2px" valign="bottom"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> <tr> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="64%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-WEIGHT: bold; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="10%" colspan="2"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"> 2014</div> </td> <td style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-WEIGHT: bold; DISPLAY: inline"> &nbsp;</font> </td> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-WEIGHT: bold; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="10%" colspan="2"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"> 2013</div> </td> <td style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-WEIGHT: bold; DISPLAY: inline"> &nbsp;</font> </td> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-WEIGHT: bold; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="11%" colspan="4"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"> 2012</div> </td> </tr> <tr bgcolor="#cceeff"> <td style="TEXT-ALIGN: left; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt" valign="bottom" width="64%"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: left; TEXT-INDENT: 0pt"> Research and development expenses</div> </td> <td valign="bottom" width="1%" align="right"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%">$</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">1,172</td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%" align="right"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%">$</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">711</td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%" align="right"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%">$</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">1,163</td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> <tr bgcolor="white"> <td style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt" valign="bottom" width="64%"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: left; TEXT-INDENT: 0pt"> General and administrative expenses</div> </td> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%" align="right"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">4,390</td> <td style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%" align="right"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">1,529</td> <td style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%" align="right"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">3,487</td> <td style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> <tr bgcolor="#cceeff"> <td style="PADDING-BOTTOM: 4px" valign="bottom" width="64%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="PADDING-BOTTOM: 4px" valign="bottom" width="1%" align="right"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 4px double; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%">$</td> <td style="BORDER-BOTTOM: black 4px double; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">5,562</td> <td style="PADDING-BOTTOM: 4px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="PADDING-BOTTOM: 4px" valign="bottom" width="1%" align="right"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 4px double; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%">$</td> <td style="BORDER-BOTTOM: black 4px double; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">2,240</td> <td style="PADDING-BOTTOM: 4px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="PADDING-BOTTOM: 4px" valign="bottom" width="1%" align="right"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 4px double; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%">$</td> <td style="BORDER-BOTTOM: black 4px double; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">4,650</td> <td style="PADDING-BOTTOM: 4px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> </table> </div> <!--EndFragment--></div> </div><span></span></td>
      </tr>
      <tr class="rh">
        <td class="pl" style="border-bottom: 0px;" valign="top">
          <div class="a">Consultant restricted stock units [Member]</div>
        </td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_psti_StockholdersEquityNoteLineItems', window );"><strong>Stockholders Equity Note [Line Items]</strong></a></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfNonvestedRestrictedStockUnitsActivityTableTextBlock', window );">Schedule of Unvested Restricted Stock Units</a></td>
        <td class="text"><!--DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd" --><div> <div><!--StartFragment--> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> The following table summarizes the activities for unvested restricted stock units and restricted stock granted to consultants for the year ended June 30, 2014:</div> <div style="DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> &nbsp;</div> <div style="MARGIN-LEFT: 18pt; text-align: left"> <table style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman" cellspacing="0" cellpadding="0" width="50%"> <tr> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="84%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-WEIGHT: bold; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="14%" colspan="2"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"> Number</div> </td> <td style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-WEIGHT: bold; DISPLAY: inline"> &nbsp;</font> </td> </tr> <tr bgcolor="#cceeff"> <td style="TEXT-ALIGN: left; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt" valign="bottom" width="84%"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: left; TEXT-INDENT: 0pt"> Unvested at the beginning of period</div> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="13%">-</td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> <tr bgcolor="white"> <td style="TEXT-ALIGN: left; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt" valign="bottom" width="84%"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: left; TEXT-INDENT: 0pt"> Granted</div> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="13%">84,565</td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> <tr bgcolor="#cceeff"> <td style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt" valign="bottom" width="84%"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: left; TEXT-INDENT: 0pt"> Vested</div> </td> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="13%">(69,315</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap">)</td> </tr> <tr bgcolor="white"> <td style="PADDING-BOTTOM: 4px; TEXT-ALIGN: left; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt" valign="bottom" width="84%"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: left; TEXT-INDENT: 0pt"> Unvested at the end of the period</div> </td> <td style="PADDING-BOTTOM: 4px" valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 4px double; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="13%">15,250</td> <td style="PADDING-BOTTOM: 4px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> </table> </div> <!--EndFragment--></div> </div><span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock', window );">Schedule of Stock-based Compensation Expenses</a></td>
        <td class="text"><!--DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd" --><div> <div><!--StartFragment--> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: left; TEXT-INDENT: 0pt"> Compensation expenses related to restricted stock units granted to consultants were recorded as follows:</div> <div style="DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> &nbsp;</div> <div style="MARGIN-LEFT: 18pt; text-align: left"> <table style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman" cellspacing="0" cellpadding="0" width="80%"> <tr> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="64%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-WEIGHT: bold; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="34%" colspan="10"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"> Year ended&nbsp;June 30,</div> </td> <td style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-WEIGHT: bold; DISPLAY: inline"> &nbsp;</font> </td> </tr> <tr> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="64%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-WEIGHT: bold; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="10%" colspan="2"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"> 2014</div> </td> <td style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-WEIGHT: bold; DISPLAY: inline"> &nbsp;</font> </td> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-WEIGHT: bold; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="10%" colspan="2"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"> 2013</div> </td> <td style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-WEIGHT: bold; DISPLAY: inline"> &nbsp;</font> </td> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-WEIGHT: bold; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="10%" colspan="2"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"> 2012</div> </td> <td style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-WEIGHT: bold; DISPLAY: inline"> &nbsp;</font> </td> </tr> <tr bgcolor="#cceeff"> <td style="TEXT-ALIGN: left; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt" valign="bottom" width="64%"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: left; TEXT-INDENT: 0pt"> Research and development expenses</div> </td> <td valign="bottom" width="1%" align="right"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%">$</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">201</td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%" align="right"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%">$</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">255</td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%" align="right"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%">$</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">201</td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> <tr bgcolor="white"> <td style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt" valign="bottom" width="64%"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: left; TEXT-INDENT: 0pt"> General and administrative expenses</div> </td> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%" align="right"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">77</td> <td style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%" align="right"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">278</td> <td style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%" align="right"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">20</td> <td style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> <tr bgcolor="#cceeff"> <td style="PADDING-BOTTOM: 4px" valign="bottom" width="64%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="PADDING-BOTTOM: 4px" valign="bottom" width="1%" align="right"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 4px double; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%">$</td> <td style="BORDER-BOTTOM: black 4px double; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">278</td> <td style="PADDING-BOTTOM: 4px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="PADDING-BOTTOM: 4px" valign="bottom" width="1%" align="right"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 4px double; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%">$</td> <td style="BORDER-BOTTOM: black 4px double; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">533</td> <td style="PADDING-BOTTOM: 4px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="PADDING-BOTTOM: 4px" valign="bottom" width="1%" align="right"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 4px double; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%">$</td> <td style="BORDER-BOTTOM: black 4px double; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">221</td> <td style="PADDING-BOTTOM: 4px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> </table> </div> <!--EndFragment--></div> </div><span></span></td>
      </tr>
    </table>
    <div style="display: none;">
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_psti_StockholdersEquityNoteLineItems">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div>
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>psti_StockholdersEquityNoteLineItems</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>psti_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:stringItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Tabular disclosure of the allocation of equity-based compensation costs to a given line item on the balance sheet and income statement for the period. This may include the reporting line for the costs and the amount capitalized and expensed.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 718<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 1<br><br> -Subparagraph (b)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6415400&amp;loc=d3e5047-113901<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 718<br><br> -SubTopic 10<br><br> -Section S99<br><br> -Paragraph 1<br><br> -Subparagraph (SAB TOPIC 14.F)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=27013229&amp;loc=d3e301413-122809<br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher SEC<br><br> -Name Staff Accounting Bulletin (SAB)<br><br> -Number Topic 14<br><br> -Section F<br><br><br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 718<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 2<br><br> -Subparagraph (h)(1)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6415400&amp;loc=d3e5070-113901<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>nonnum:textBlockItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfNonvestedRestrictedStockUnitsActivityTableTextBlock">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Tabular disclosure of the changes in outstanding nonvested restricted stock units.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 718<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 2<br><br> -Subparagraph (c)(2)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6415400&amp;loc=d3e5070-113901<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_ScheduleOfNonvestedRestrictedStockUnitsActivityTableTextBlock</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>nonnum:textBlockItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfShareBasedCompensationActivityTableTextBlock">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Tabular disclosure of share-based compensation plans that may be presented in a single table for outstanding, vested and expected to vest, and exercisable awards. The information that may be disclosed in this table may include, but is not limited to, number of shares, weighted average exercise price, weighted average remaining contractual life, and aggregate intrinsic value.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_ScheduleOfShareBasedCompensationActivityTableTextBlock</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>nonnum:textBlockItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTextBlock">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Tabular disclosure of option exercise prices, by grouped ranges, including the upper and lower limits of the price range, the number of shares under option, weighted average exercise price and remaining contractual option terms.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 718<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 2<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6415400&amp;loc=d3e5070-113901<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTextBlock</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>nonnum:textBlockItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Tabular disclosure of the number and weighted-average exercise prices (or conversion ratios) for share options (or share units) that were outstanding at the beginning and end of the year, vested and expected to vest, exercisable or convertible at the end of the year, and the number of share options or share units that were granted, exercised or converted, forfeited, and expired during the year.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 718<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 2<br><br> -Subparagraph (c)(1)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6415400&amp;loc=d3e5070-113901<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>nonnum:textBlockItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityNoteAbstract">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div>
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_StockholdersEquityNoteAbstract</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:stringItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
    </div>
  </body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>78
<FILENAME>R49.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
  <head>
    <META http-equiv="Content-Type" content="text/html; charset=us-ascii">
    <link rel="StyleSheet" type="text/css" href="report.css"><script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script></head>
  <body><span style="display: none;">v2.4.0.8</span><table class="report" border="0" cellspacing="2" id="ID0ETPAG">
      <tr>
        <th class="tl" colspan="1" rowspan="2">
          <div style="width: 200px;"><strong>TAXES ON INCOME (Narrative) (Details) (USD $)<br>In Thousands, unless otherwise specified</strong></div>
        </th>
        <th class="th" colspan="3">12 Months Ended</th>
      </tr>
      <tr>
        <th class="th">
          <div>Jun. 30, 2014</div>
        </th>
        <th class="th">
          <div>Jun. 30, 2013</div>
        </th>
        <th class="th">
          <div>Jun. 30, 2012</div>
        </th>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_psti_TaxRatesApplicableToCompanyAbstract', window );"><strong>Applicable Tax Rates:</strong></a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateContinuingOperations', window );">Effective income tax rate</a></td>
        <td class="nump">0.00%<span></span></td>
        <td class="nump">0.00%<span></span></td>
        <td class="nump">0.00%<span></span></td>
      </tr>
      <tr class="rh">
        <td class="pl" style="border-bottom: 0px;" valign="top">
          <div class="a">Minimum [Member]</div>
        </td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_psti_TaxRatesApplicableToCompanyAbstract', window );"><strong>Applicable Tax Rates:</strong></a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate', window );">Statutory tax rate</a></td>
        <td class="nump">25.00%<span></span></td>
        <td class="nump">25.00%<span></span></td>
        <td class="nump">25.00%<span></span></td>
      </tr>
      <tr class="rh">
        <td class="pl" style="border-bottom: 0px;" valign="top">
          <div class="a">Maximum [Member]</div>
        </td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_psti_TaxRatesApplicableToCompanyAbstract', window );"><strong>Applicable Tax Rates:</strong></a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate', window );">Statutory tax rate</a></td>
        <td class="nump">35.00%<span></span></td>
        <td class="nump">35.00%<span></span></td>
        <td class="nump">35.00%<span></span></td>
      </tr>
      <tr class="rh">
        <td class="pl" style="border-bottom: 0px;" valign="top">
          <div class="a">Israel Tax Authority [Member]</div>
        </td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_psti_CarryforwardLossesForTaxPurposesAbstract', window );"><strong>Carryforward Losses:</strong></a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLossCarryforwards', window );">Net operating loss carryforwards</a></td>
        <td class="nump">$ 48,340<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="rh">
        <td class="pl" style="border-bottom: 0px;" valign="top">
          <div class="a">Internal Revenue Service (IRS) [Member]</div>
        </td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_psti_CarryforwardLossesForTaxPurposesAbstract', window );"><strong>Carryforward Losses:</strong></a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLossCarryforwards', window );">Net operating loss carryforwards</a></td>
        <td class="nump">$ 22,730<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="rh">
        <td class="pl" style="border-bottom: 0px;" valign="top">
          <div class="a">Internal Revenue Service (IRS) [Member] | Earliest Tax Year [Member]</div>
        </td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_psti_CarryforwardLossesForTaxPurposesAbstract', window );"><strong>Carryforward Losses:</strong></a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLossCarryforwardsExpirationDate', window );">Net federal operating loss carry forward expiration date</a></td>
        <td class="text">Dec. 31,
				 2022<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="rh">
        <td class="pl" style="border-bottom: 0px;" valign="top">
          <div class="a">Internal Revenue Service (IRS) [Member] | Latest Tax Year [Member]</div>
        </td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_psti_CarryforwardLossesForTaxPurposesAbstract', window );"><strong>Carryforward Losses:</strong></a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLossCarryforwardsExpirationDate', window );">Net federal operating loss carry forward expiration date</a></td>
        <td class="text">Dec. 31,
				 2034<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
    </table>
    <div style="display: none;">
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_psti_CarryforwardLossesForTaxPurposesAbstract">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div>
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>psti_CarryforwardLossesForTaxPurposesAbstract</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>psti_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:stringItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_psti_TaxRatesApplicableToCompanyAbstract">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div>
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>psti_TaxRatesApplicableToCompanyAbstract</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>psti_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:stringItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateContinuingOperations">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Percentage of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 740<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 12<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6907707&amp;loc=d3e32687-109319<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 740<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 13<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6907707&amp;loc=d3e32698-109319<br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 235<br><br> -SubTopic 10<br><br> -Section S99<br><br> -Paragraph 1<br><br> -Subparagraph (SX 210.4-08.(h)(2))<br><br> -URI http://asc.fasb.org/extlink&amp;oid=26873400&amp;loc=d3e23780-122690<br><br><br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher SEC<br><br> -Name Regulation S-X (SX)<br><br> -Number 210<br><br> -Section 08<br><br> -Paragraph h<br><br> -Subparagraph 2<br><br> -Article 4<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_EffectiveIncomeTaxRateContinuingOperations</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>num:percentItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Percentage of domestic federal statutory tax rate applicable to pretax income (loss).</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 740<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 12<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6907707&amp;loc=d3e32687-109319<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 740<br><br> -SubTopic 10<br><br> -Section S99<br><br> -Paragraph 1<br><br> -Subparagraph (SAB TOPIC 6.I)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=34349781&amp;loc=d3e330036-122817<br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 740<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 13<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6907707&amp;loc=d3e32698-109319<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>num:percentItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLossCarryforwards">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Amount of operating loss carryforward, before tax effects, available to reduce future taxable income under enacted tax laws.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 740<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 3<br><br> -Subparagraph (a)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6907707&amp;loc=d3e32559-109319<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_OperatingLossCarryforwards</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>debit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLossCarryforwardsExpirationDate">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Expiration date of each operating loss carryforward included in operating loss carryforward, in CCYY-MM-DD format.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 740<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 3<br><br> -Subparagraph (a)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6907707&amp;loc=d3e32559-109319<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_OperatingLossCarryforwardsExpirationDate</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:dateItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
    </div>
  </body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>79
<FILENAME>R41.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
  <head>
    <META http-equiv="Content-Type" content="text/html; charset=us-ascii">
    <link rel="StyleSheet" type="text/css" href="report.css"><script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script></head>
  <body><span style="display: none;">v2.4.0.8</span><table class="report" border="0" cellspacing="2" id="ID0EDXDI">
      <tr>
        <th class="tl" colspan="1" rowspan="2">
          <div style="width: 200px;"><strong>STOCKHOLDERS' EQUITY (Narrative) (Details) (USD $)<br>In Thousands, except Share data, unless otherwise specified</strong></div>
        </th>
        <th class="th" colspan="1">0 Months Ended</th>
        <th class="th" colspan="7">12 Months Ended</th>
        <th class="th" colspan="3"></th>
        <th class="th" colspan="1">1 Months Ended</th>
        <th class="th" colspan="1">12 Months Ended</th>
      </tr>
      <tr>
        <th class="th">
          <div>Sep. 19, 2012</div>
        </th>
        <th class="th">
          <div>Jun. 30, 2014</div>
        </th>
        <th class="th">
          <div>Jun. 30, 2013</div>
        </th>
        <th class="th">
          <div>Jun. 30, 2012</div>
        </th>
        <th class="th">
          <div>Jun. 30, 2012

</div>
          <div>Biopharmax [Member]</div>
        </th>
        <th class="th">
          <div>Jun. 30, 2014

</div>
          <div>Investor Warrants [Member]</div>
        </th>
        <th class="th">
          <div>Jun. 30, 2013

</div>
          <div>Investor Warrants [Member]</div>
        </th>
        <th class="th">
          <div>Jun. 30, 2012

</div>
          <div>Investor Warrants [Member]</div>
        </th>
        <th class="th">
          <div>Sep. 19, 2012

</div>
          <div>Investor Warrants [Member]</div>
        </th>
        <th class="th">
          <div>Sep. 19, 2012

</div>
          <div>Underwriters Option [Member]</div>
        </th>
        <th class="th">
          <div>Sep. 19, 2012

</div>
          <div>Underwriter Warrants [Member]</div>
        </th>
        <th class="th">
          <div>Aug. 31, 2012

</div>
          <div>Consultant Warrants [Member]</div>
        </th>
        <th class="th">
          <div>Jun. 30, 2014

</div>
          <div>Consultant Warrants [Member]</div>
        </th>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class of Stock [Line Items]</strong></a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesAuthorized', window );">Common stock, shares authorized</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">200,000,000<span></span></td>
        <td class="nump">200,000,000<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockParOrStatedValuePerShare', window );">Common stock, par value per share</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">$ 0.00001<span></span></td>
        <td class="nump">$ 0.00001<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockSharesAuthorized', window );">Preferred stock, shares authorized</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">10,000,000<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockParOrStatedValuePerShare', window );">Preferred stock,, par value per share</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">$ 0.00001<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts', window );">Issuance of common stock and warrants, issuance costs</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">$ 195<span></span></td>
        <td class="nump">$ 2,694<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConversionOfStockSharesConverted1', window );">Warrants exercised via cashless exercise</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">2,517,907<span></span></td>
        <td class="nump">682,213<span></span></td>
        <td class="nump">406,783<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">36,000<span></span></td>
        <td class="nump">65,000<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConversionOfStockSharesIssued1', window );">Warrants exercised via cashless exercise, shares issued</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">1,469,584<span></span></td>
        <td class="nump">420,199<span></span></td>
        <td class="nump">168,424<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">26,299<span></span></td>
        <td class="nump">36,970<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesOther', window );">Warrants exercised for cash</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">1,432,584<span></span></td>
        <td class="nump">1,201,160<span></span></td>
        <td class="nump">355,411<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromWarrantExercises', window );">Aggregate cash consideration received</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">2,009<span></span></td>
        <td class="nump">556<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">1,968<span></span></td>
        <td class="nump">2,009<span></span></td>
        <td class="nump">556<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised', window );">Options exercised</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">15,000<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_psti_SharebasedGoodsAndNonemployeesServicesTransactionWarrantsAndOptionsExercised', window );">Options and warrants exercised</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">66,500<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_psti_SharebasedCompensationArrangementWarrantsExercised', window );">Number of warrants exercised</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">1,432,584<span></span></td>
        <td class="nump">1,201,160<span></span></td>
        <td class="nump">355,411<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesPurchaseOfAssets', window );">Issuance of common stock under CHA agreement</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">2,500,000<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesIssuedForServices', window );">Stock based compensation to contractor, shares</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">1,500,000<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_psti_AvailableForSaleMarketableSecuritiesNumber', window );">CHA shares classified as marketable securities</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">1,011,504<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValuePurchaseOfAssets', window );">Issuance of common stock under CHA Agreement (Note 1d)</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">10,414<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues', window );">Issuance of common stock and warrants, net of issuance costs, shares</a></td>
        <td class="nump">8,000,000<span></span></td>
        <td class="nump">2,596,032<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueNewIssues', window );">Issuance of common stock and warrants, net of issuance costs</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">10,644<span></span></td>
        <td class="nump">34,106<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesIssuedPricePerShare', window );">Offering price per unit</a></td>
        <td class="nump">$ 4.00<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight', window );">Shares covered by each warrant</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">0.35<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1', window );">Warrant exercise price</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">$ 5.00<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightOutstanding', window );">Warrants for common stock</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">1,200,000<span></span></td>
        <td class="nump">420,000<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfCommonStock', window );">Proceeds from issuance of stock</a></td>
        <td class="nump">$ 34,106<span></span></td>
        <td class="nump">$ 10,644<span></span></td>
        <td class="nump">$ 34,106<span></span></td>
        <td class="text">&nbsp;&nbsp;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized', window );">Options authorized</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">13,256,713<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant', window );">Options available for future grant</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">1,205,080<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
    </table>
    <div style="display: none;">
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_psti_AvailableForSaleMarketableSecuritiesNumber">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Number of equity financial securities classified as available-for-sale.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>psti_AvailableForSaleMarketableSecuritiesNumber</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>psti_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:sharesItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_psti_SharebasedCompensationArrangementWarrantsExercised">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Number of warrants exercised during the period.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>psti_SharebasedCompensationArrangementWarrantsExercised</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>psti_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:sharesItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_psti_SharebasedGoodsAndNonemployeesServicesTransactionWarrantsAndOptionsExercised">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Sharebased goods and nonemployees services transaction warrants and options exercised.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>psti_SharebasedGoodsAndNonemployeesServicesTransactionWarrantsAndOptionsExercised</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>psti_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:sharesItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Amount of decrease in additional paid in capital (APIC) resulting from direct costs associated with issuing stock. Includes, but is not limited to, legal and accounting fees and direct costs associated with stock issues under a shelf registration.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 505<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 2<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6928386&amp;loc=d3e21463-112644<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 505<br><br> -SubTopic 10<br><br> -Section S99<br><br> -Paragraph 1<br><br> -Subparagraph (SX 210.3-04)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=27012166&amp;loc=d3e187085-122770<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>debit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfStockLineItems">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div>
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_ClassOfStockLineItems</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:stringItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Exercise price per share or per unit of warrants or rights outstanding.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 235<br><br> -SubTopic 10<br><br> -Section S99<br><br> -Paragraph 1<br><br> -Subparagraph (SX 210.4-08.(i)(4))<br><br> -URI http://asc.fasb.org/extlink&amp;oid=26873400&amp;loc=d3e23780-122690<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>num:perShareItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Number of securities into which each warrant or right may be converted. For example, but not limited to, each warrant may be converted into two shares.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:sharesItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightOutstanding">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Number of warrants or rights outstanding.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 235<br><br> -SubTopic 10<br><br> -Section S99<br><br> -Paragraph 1<br><br> -Subparagraph (SX 210.4-08.(i))<br><br> -URI http://asc.fasb.org/extlink&amp;oid=26873400&amp;loc=d3e23780-122690<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher SEC<br><br> -Name Regulation S-X (SX)<br><br> -Number 210<br><br> -Section 08<br><br> -Paragraph i<br><br> -Article 4<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_ClassOfWarrantOrRightOutstanding</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:sharesItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockParOrStatedValuePerShare">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Face amount or stated value per share of common stock.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 210<br><br> -SubTopic 10<br><br> -Section S99<br><br> -Paragraph 1<br><br> -Subparagraph (SX 210.5-02.29)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher SEC<br><br> -Name Regulation S-X (SX)<br><br> -Number 210<br><br> -Section 02<br><br> -Paragraph 30<br><br> -Article 5<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_CommonStockParOrStatedValuePerShare</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>num:perShareItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesAuthorized">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The maximum number of common shares permitted to be issued by an entity's charter and bylaws.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 210<br><br> -SubTopic 10<br><br> -Section S99<br><br> -Paragraph 1<br><br> -Subparagraph (SX 210.5-02.29)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher SEC<br><br> -Name Regulation S-X (SX)<br><br> -Number 210<br><br> -Section 02<br><br> -Paragraph 30<br><br> -Article 5<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_CommonStockSharesAuthorized</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:sharesItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConversionOfStockSharesConverted1">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The number of shares converted in a noncash (or part noncash) transaction. Noncash is defined as transactions during a period that do not result in cash receipts or cash payments in the period. "Part noncash" refers to that portion of the transaction not resulting in cash receipts or cash payments in the period.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 230<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 5<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6367179&amp;loc=d3e4332-108586<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 230<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 4<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6367179&amp;loc=d3e4313-108586<br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 230<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 3<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6367179&amp;loc=d3e4304-108586<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_ConversionOfStockSharesConverted1</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:sharesItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConversionOfStockSharesIssued1">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The number of new shares issued in the conversion of stock in a noncash (or part noncash) transaction. Noncash is defined as transactions during a period that do not result in cash receipts or cash payments in the period. "Part noncash" refers to that portion of the transaction not resulting in cash receipts or cash payments in the period.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 230<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 5<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6367179&amp;loc=d3e4332-108586<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 230<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 4<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6367179&amp;loc=d3e4313-108586<br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 230<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 3<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6367179&amp;loc=d3e4304-108586<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_ConversionOfStockSharesIssued1</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:sharesItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockParOrStatedValuePerShare">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Face amount or stated value per share of preferred stock nonredeemable or redeemable solely at the option of the issuer.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 210<br><br> -SubTopic 10<br><br> -Section S99<br><br> -Paragraph 1<br><br> -Subparagraph (SX 210.5-02.28)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher SEC<br><br> -Name Regulation S-X (SX)<br><br> -Number 210<br><br> -Section 02<br><br> -Paragraph 29<br><br> -Article 5<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_PreferredStockParOrStatedValuePerShare</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>num:perShareItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesAuthorized">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The maximum number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 210<br><br> -SubTopic 10<br><br> -Section S99<br><br> -Paragraph 1<br><br> -Subparagraph (SX 210.5-02.28)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher SEC<br><br> -Name Regulation S-X (SX)<br><br> -Number 210<br><br> -Section 02<br><br> -Paragraph 29<br><br> -Article 5<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_PreferredStockSharesAuthorized</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:sharesItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromIssuanceOfCommonStock">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The cash inflow from the additional capital contribution to the entity.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Glossary Financing Activities<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6513228<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 230<br><br> -SubTopic 10<br><br> -Section 45<br><br> -Paragraph 14<br><br> -Subparagraph (a)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=31042434&amp;loc=d3e3255-108585<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_ProceedsFromIssuanceOfCommonStock</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>debit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromWarrantExercises">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The cash inflow associated with the amount received from holders exercising their stock warrants.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_ProceedsFromWarrantExercises</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>debit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div>
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:stringItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The maximum number of shares (or other type of equity) originally approved (usually by shareholders and board of directors), net of any subsequent amendments and adjustments, for awards under the equity-based compensation plan. As stock or unit options and equity instruments other than options are awarded to participants, the shares or units remain authorized and become reserved for issuance under outstanding awards (not necessarily vested).</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 718<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 2<br><br> -Subparagraph (a)(3)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6415400&amp;loc=d3e5070-113901<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:sharesItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The difference between the maximum number of shares (or other type of equity) authorized for issuance under the plan (including the effects of amendments and adjustments), and the sum of: 1) the number of shares (or other type of equity) already issued upon exercise of options or other equity-based awards under the plan; and 2) shares (or other type of equity) reserved for issuance on granting of outstanding awards, net of cancellations and forfeitures, if applicable.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 718<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 2<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6415400&amp;loc=d3e5070-113901<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:sharesItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharesIssuedPricePerShare">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Amount per share or per unit of equity securities issued by non-development stage entity.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_SharesIssuedPricePerShare</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>num:perShareItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesIssuedForServices">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Number of shares issued in lieu of cash for services contributed to the entity. Number of shares includes, but is not limited to, shares issued for services contributed by vendors and founders.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_StockIssuedDuringPeriodSharesIssuedForServices</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:sharesItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Number of new stock issued during the period.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher SEC<br><br> -Name Regulation S-X (SX)<br><br> -Number 210<br><br> -Section 04<br><br> -Article 3<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 505<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 2<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6928386&amp;loc=d3e21463-112644<br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 505<br><br> -SubTopic 10<br><br> -Section S99<br><br> -Paragraph 1<br><br> -Subparagraph (SX 210.3-04)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=27012166&amp;loc=d3e187085-122770<br><br><br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher SEC<br><br> -Name Regulation S-X (SX)<br><br> -Number 210<br><br> -Section 02<br><br> -Paragraph 29, 30<br><br> -Article 5<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_StockIssuedDuringPeriodSharesNewIssues</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:sharesItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesOther">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Number of shares of stock issued during the period that is attributable to transactions involving issuance of stock not separately disclosed.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_StockIssuedDuringPeriodSharesOther</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:sharesItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesPurchaseOfAssets">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Number of shares of stock issued during the period as part of a transaction to acquire assets that do not qualify as a business combination.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_StockIssuedDuringPeriodSharesPurchaseOfAssets</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:sharesItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Number of share options (or share units) exercised during the current period.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher SEC<br><br> -Name Regulation S-X (SX)<br><br> -Number 210<br><br> -Section 04<br><br> -Article 3<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 505<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 2<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6928386&amp;loc=d3e21463-112644<br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 505<br><br> -SubTopic 10<br><br> -Section S99<br><br> -Paragraph 1<br><br> -Subparagraph (SX 210.3-04)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=27012166&amp;loc=d3e187085-122770<br><br><br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 210<br><br> -SubTopic 10<br><br> -Section S99<br><br> -Paragraph 1<br><br> -Subparagraph (SX 210.5-02.28,29)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br><br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 718<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 2<br><br> -Subparagraph (c)(1)(iv)(2)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6415400&amp;loc=d3e5070-113901<br><br><br><br>Reference 6: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher SEC<br><br> -Name Regulation S-X (SX)<br><br> -Number 210<br><br> -Section 02<br><br> -Paragraph 29, 30<br><br> -Article 5<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:sharesItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueNewIssues">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Equity impact of the value of new stock issued during the period. Includes shares issued in an initial public offering or a secondary public offering.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher SEC<br><br> -Name Regulation S-X (SX)<br><br> -Number 210<br><br> -Section 04<br><br> -Article 3<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 505<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 2<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6928386&amp;loc=d3e21463-112644<br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 505<br><br> -SubTopic 10<br><br> -Section S99<br><br> -Paragraph 1<br><br> -Subparagraph (SX 210.3-04)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=27012166&amp;loc=d3e187085-122770<br><br><br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher SEC<br><br> -Name Regulation S-X (SX)<br><br> -Number 210<br><br> -Section 02<br><br> -Paragraph 29, 30, 31<br><br> -Article 5<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_StockIssuedDuringPeriodValueNewIssues</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>credit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValuePurchaseOfAssets">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Value of shares of stock issued during the period as part of a transaction to acquire assets that do not qualify as a business combination.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_StockIssuedDuringPeriodValuePurchaseOfAssets</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>credit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
    </div>
  </body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>80
<FILENAME>R5.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
  <head>
    <META http-equiv="Content-Type" content="text/html; charset=us-ascii">
    <link rel="StyleSheet" type="text/css" href="report.css"><script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script></head>
  <body><span style="display: none;">v2.4.0.8</span><table class="report" border="0" cellspacing="2" id="ID0EKOAC">
      <tr>
        <th class="tl" colspan="1" rowspan="2">
          <div style="width: 200px;"><strong>CONSOLIDATED STATEMENTS OF COMPREHENSIVE LOSS (USD $)<br>In Thousands, unless otherwise specified</strong></div>
        </th>
        <th class="th" colspan="3">12 Months Ended</th>
      </tr>
      <tr>
        <th class="th">
          <div>Jun. 30, 2014</div>
        </th>
        <th class="th">
          <div>Jun. 30, 2013</div>
        </th>
        <th class="th">
          <div>Jun. 30, 2012</div>
        </th>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract', window );"><strong>CONSOLIDATED STATEMENTS OF COMPREHENSIVE LOSS [Abstract]</strong></a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss</a></td>
        <td class="num">$ (26,932)<span></span></td>
        <td class="num">$ (21,155)<span></span></td>
        <td class="num">$ (14,794)<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParentAbstract', window );"><strong>Other comprehensive income (loss), net:</strong></a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodNetOfTax', window );">Unrealized gains on derivative instruments</a></td>
        <td class="nump">23<span></span></td>
        <td class="text">&nbsp;&nbsp;<span></span></td>
        <td class="text">&nbsp;&nbsp;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax', window );">Unrealized gain (loss) on available-for-sale marketable securities, net</a></td>
        <td class="nump">3,404<span></span></td>
        <td class="nump">415<span></span></td>
        <td class="num">(127)<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax', window );">Reclassification adjustment of available-for-sale marketable securities losses realized in net loss, net</a></td>
        <td class="num">(727)<span></span></td>
        <td class="num">(26)<span></span></td>
        <td class="num">(3)<span></span></td>
      </tr>
      <tr class="reu">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ComprehensiveIncomeNetOfTax', window );">Total comprehensive loss</a></td>
        <td class="num">$ (24,232)<span></span></td>
        <td class="num">$ (20,766)<span></span></td>
        <td class="num">$ (14,924)<span></span></td>
      </tr>
    </table>
    <div style="display: none;">
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ComprehensiveIncomeNetOfTax">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income, attributable to parent entity. Excludes changes in equity resulting from investments by owners and distributions to owners.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Glossary Other Comprehensive Income<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6519514<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Glossary Comprehensive Income<br><br> -URI http://asc.fasb.org/extlink&amp;oid=35737396<br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 220<br><br> -SubTopic 10<br><br> -Section 45<br><br> -Paragraph 5<br><br> -URI http://asc.fasb.org/extlink&amp;oid=36458714&amp;loc=d3e557-108580<br><br><br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Glossary Net Income<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6518256<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_ComprehensiveIncomeNetOfTax</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>credit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 230<br><br> -SubTopic 10<br><br> -Section 45<br><br> -Paragraph 28<br><br> -URI http://asc.fasb.org/extlink&amp;oid=31042434&amp;loc=d3e3602-108585<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 260<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 1<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Glossary Other Comprehensive Income<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6519514<br><br><br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Glossary Net Income<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6518256<br><br><br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 944<br><br> -SubTopic 225<br><br> -Section S99<br><br> -Paragraph 1<br><br> -Subparagraph (SX 210.7-04.19)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6879464&amp;loc=d3e573970-122913<br><br><br><br>Reference 6: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 225<br><br> -SubTopic 10<br><br> -Section S99<br><br> -Paragraph 2<br><br> -Subparagraph (SX 210.5-03.18)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=26872669&amp;loc=d3e20235-122688<br><br><br><br>Reference 7: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 944<br><br> -SubTopic 225<br><br> -Section S99<br><br> -Paragraph 1<br><br> -Subparagraph (SX 210.7-04.22)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6879464&amp;loc=d3e573970-122913<br><br><br><br>Reference 8: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher SEC<br><br> -Name Regulation S-X (SX)<br><br> -Number 210<br><br> -Section 03<br><br> -Paragraph 19<br><br> -Article 5<br><br><br><br>Reference 9: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher SEC<br><br> -Name Regulation S-X (SX)<br><br> -Number 210<br><br> -Section 04<br><br> -Paragraph 20<br><br> -Article 9<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_NetIncomeLoss</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>credit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParentAbstract">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div>
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParentAbstract</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:stringItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Amount after tax of reclassification adjustment from accumulated other comprehensive income for unrealized gain (loss) realized upon the sale of available-for-sale securities.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 320<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 9<br><br> -Subparagraph (d)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=27724398&amp;loc=d3e27357-111563<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 220<br><br> -SubTopic 10<br><br> -Section 45<br><br> -Paragraph 11<br><br> -URI http://asc.fasb.org/extlink&amp;oid=36458714&amp;loc=d3e637-108580<br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 220<br><br> -SubTopic 10<br><br> -Section 45<br><br> -Paragraph 15<br><br> -URI http://asc.fasb.org/extlink&amp;oid=36458714&amp;loc=d3e689-108580<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>debit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodNetOfTax">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Amount after tax of increase (decrease) in accumulated gain (loss) from derivative instruments designated and qualifying as the effective portion of cash flow hedges and an entity's share of an equity investee's increase (decrease) in deferred hedging gain (loss).</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 220<br><br> -SubTopic 10<br><br> -Section 45<br><br> -Paragraph 11<br><br> -URI http://asc.fasb.org/extlink&amp;oid=36458714&amp;loc=d3e637-108580<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 220<br><br> -SubTopic 10<br><br> -Section 45<br><br> -Paragraph 10A<br><br> -Subparagraph (d)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=36458714&amp;loc=SL7669646-108580<br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 815<br><br> -SubTopic 30<br><br> -Section 45<br><br> -Paragraph 1<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6441202&amp;loc=d3e80720-113993<br><br><br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 815<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 4C<br><br> -Subparagraph (b)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=35706170&amp;loc=SL5624171-113959<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodNetOfTax</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>credit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Amount after tax, before reclassification adjustments, of unrealized holding gain (loss) on available-for-sale securities.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 220<br><br> -SubTopic 10<br><br> -Section 45<br><br> -Paragraph 11<br><br> -URI http://asc.fasb.org/extlink&amp;oid=36458714&amp;loc=d3e637-108580<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 220<br><br> -SubTopic 10<br><br> -Section 45<br><br> -Paragraph 10A<br><br> -Subparagraph (e)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=36458714&amp;loc=SL7669646-108580<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>credit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div>
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:stringItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
    </div>
  </body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>81
<FILENAME>R10.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
  <head>
    <META http-equiv="Content-Type" content="text/html; charset=us-ascii">
    <link rel="StyleSheet" type="text/css" href="report.css"><script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script></head>
  <body><span style="display: none;">v2.4.0.8</span><table class="report" border="0" cellspacing="2" id="ID0EME">
      <tr>
        <th class="tl" colspan="1" rowspan="2">
          <div style="width: 200px;"><strong>SIGNIFICANT ACCOUNTING POLICIES<br></strong></div>
        </th>
        <th class="th" colspan="1">12 Months Ended</th>
      </tr>
      <tr>
        <th class="th">
          <div>Jun. 30, 2014</div>
        </th>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>SIGNIFICANT ACCOUNTING POLICIES [Abstract]</strong></a></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SignificantAccountingPoliciesTextBlock', window );">SIGNIFICANT ACCOUNTING POLICIES</a></td>
        <td class="text"><!--DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd" --><div> <div><!--StartFragment--> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: left; TEXT-INDENT: 0pt"> NOTE 2:-SIGNIFICANT ACCOUNTING POLICIES</div> <div style="DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> &nbsp;</div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: justify; TEXT-INDENT: 0pt"> The consolidated financial statements have been prepared in accordance with United States generally accepted accounting principles ("U.S. GAAP") applied on consistent basis.</div> <div style="DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> &nbsp;</div> <div> <table style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman" cellspacing="0" cellpadding="0" width="100%" align="center" border="0"> <tr valign="top"> <td style="WIDTH: 18pt"> <div style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt"> a.</div> </td> <td> <div style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; text-align: justify"> Use of estimates</div> </td> </tr> </table> </div> <div style="DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> &nbsp;</div> <div> <table style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman" cellspacing="0" cellpadding="0" width="100%" align="center" border="0"> <tr valign="top"> <td style="WIDTH: 18pt"> <div style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; DISPLAY: inline"> &nbsp;</div> </td> <td> <div style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; text-align: justify"> The preparation of financial statements in conformity with generally accepted accounting principles requires management to make estimates, judgments, and assumptions that are reasonable based upon information available at the time they are made. These estimates, judgments and assumptions can affect the amounts reported in the financial statements and accompanying notes. Actual results could differ from those estimates.</div> </td> </tr> </table> </div> <div style="DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> &nbsp;</div> <div> <table style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman" cellspacing="0" cellpadding="0" width="100%" align="center" border="0"> <tr valign="top"> <td style="WIDTH: 18pt"> <div style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt"> b.</div> </td> <td> <div style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; text-align: justify"> Functional currency of the Subsidiary</div> </td> </tr> </table> </div> <div style="DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> &nbsp;</div> <div> <table style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman" cellspacing="0" cellpadding="0" width="100%" align="center" border="0"> <tr valign="top"> <td style="WIDTH: 19pt"> <div style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; DISPLAY: inline"> &nbsp;</div> </td> <td> <div style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; text-align: justify"> The Subsidiary&#39;s revenues are generated and determined in U.S. Dollars ("dollars"). In addition, most of the financing of the Subsidiary&#39;s operations has been made in dollars. The Company&#39;s management believes that the dollar is the primary currency of the economic environment in which the Subsidiary operates. Thus, management believe that the functional currency of the Subsidiary is the dollar. Accordingly, monetary accounts maintained in currencies other than the dollar are remeasured into dollars in accordance with ASC 830, "Foreign Currency Matters". All transaction gains and losses from the remeasurement of monetary balance sheet items are reflected in the statement of operations as financial income or expenses, as appropriate.</div> </td> </tr> </table> </div> <div style="DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> &nbsp;</div> <div> <table style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman" cellspacing="0" cellpadding="0" width="100%" align="center" border="0"> <tr valign="top"> <td style="WIDTH: 18pt"> <div style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt"> c.</div> </td> <td> <div style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; text-align: justify"> Principles of consolidation</div> </td> </tr> </table> </div> <div style="DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> &nbsp;</div> <div> <table style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman" cellspacing="0" cellpadding="0" width="100%" align="center" border="0"> <tr valign="top"> <td style="WIDTH: 18pt"> <div style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; DISPLAY: inline"> &nbsp;</div> </td> <td> <div style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; text-align: justify"> The consolidated financial statements include the accounts of Pluristem Therapeutics Inc. and its Subsidiary. Intercompany transactions and balances have been eliminated upon consolidation.</div> </td> </tr> </table> </div> <div style="DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> &nbsp;</div> <div> <table style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman" cellspacing="0" cellpadding="0" width="100%" align="center" border="0"> <tr valign="top"> <td style="WIDTH: 18pt"> <div style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt"> d.</div> </td> <td> <div style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; text-align: justify"> Cash and cash equivalents</div> </td> </tr> </table> </div> <div style="DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> &nbsp;</div> <div> <table style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman" cellspacing="0" cellpadding="0" width="100%" align="center" border="0"> <tr valign="top"> <td style="WIDTH: 19pt"> <div style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; DISPLAY: inline"> &nbsp;</div> </td> <td> <div style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; text-align: justify"> Cash equivalents are short-term highly liquid investments that are readily convertible to cash with maturities of three months or less at the date acquired.</div> </td> </tr> </table> </div> <div style="DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> &nbsp;</div> <div style="text-align: center"> <table style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman" cellspacing="0" cellpadding="0" width="100%" border="0"> <tr valign="top"> <td style="WIDTH: 18pt"> <div style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt"> e.</div> </td> <td> <div style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; text-align: justify"> Short-term bank deposit</div> </td> </tr> </table> </div> <div style="DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> &nbsp;</div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> Bank deposits with original maturities of more than three months but less than one year are presented as part of short-term investments. Deposits are presented at their cost which approximates market values including accrued interest. Interest on deposits is recorded as financial income.</div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /> </div> <div style="text-align: center"> <table style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman" cellspacing="0" cellpadding="0" width="100%" border="0"> <tr valign="top"> <td style="WIDTH: 18pt"> <div style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt"> f.</div> </td> <td> <div style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; text-align: justify"> Restricted cash and short-term deposits</div> </td> </tr> </table> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; MARGIN-LEFT: 36pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> &nbsp;</div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> Short-term restricted deposits and restricted cash used to secure derivative transactions are presented at cost.</div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /> </div> <div style="text-align: center"> <table style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman" cellspacing="0" cellpadding="0" width="100%" border="0"> <tr valign="top"> <td style="WIDTH: 18pt"> <div style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt"> g.</div> </td> <td> <div style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; text-align: justify"> Long-term restricted deposits</div> </td> </tr> </table> </div> <div>&nbsp;</div> <div> <table style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman" cellspacing="0" cellpadding="0" width="100%" align="center" border="0"> <tr valign="top"> <td style="WIDTH: 18pt"> <div style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; DISPLAY: inline"> &nbsp;</div> </td> <td> <div style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; text-align: justify"> Long-term restricted deposits with maturities of more than one year used to secure operating lease agreement are presented at cost which approximates market values including accrued interest.</div> </td> </tr> </table> </div> <div>&nbsp;</div> <div style="text-align: center"> <table style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman" cellspacing="0" cellpadding="0" width="100%" border="0"> <tr valign="top"> <td style="WIDTH: 18pt"> <div style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt"> h.</div> </td> <td> <div style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; text-align: justify"> Marketable Securities</div> </td> </tr> </table> </div> <div style="DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> &nbsp;</div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> The Company accounts for its investments in marketable securities in accordance with ASC 320-"Investments - Debt and Equity Securities". The Company determines the classification of marketable securities at the time of purchase and re-evaluates such designations as of each balance sheet date. The Company classifies all of its marketable securities as available-for-sale. Available-for-sale marketable securities are carried at fair value, with the unrealized gain and loss reported at "accumulated other comprehensive income (loss)" in the statement of changes in stockholders&#39; equity.</div> <div style="DISPLAY: block; MARGIN-LEFT: 437pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> &nbsp;</div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> Realized gain and loss on sales of marketable securities are included in the Company&#39;s "Financial income, net" and are derived using the specific identification basis for determining the cost of marketable securities. The amortized cost of available for sale marketable securities is adjusted for amortization of premiums and accretion of discount to maturity. Such amortization, together with interest on available for sale marketable securities, is included in the "Financial income, net".</div> <div style="DISPLAY: block; MARGIN-LEFT: 437pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> &nbsp;</div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> The Company recognizes an impairment charge when a decline in the fair value of its available-for-sale marketable securities below the cost basis is judged to be other-than-temporary. The Company considers various factors in determining whether to recognize an impairment charge, including the length of time the investment has been in a loss position, the extent to which the fair value has been less than the Company&#39;s cost basis, the investment&#39;s financial condition and the near-term prospects of the issuer. ASC 320-10-35, "Investments - Debt and Equity Securities", requires another-than-temporary impairment for debt securities to be separated into (a)&nbsp;the amount representing the credit loss and (b)&nbsp;the amount related to all other factors (provided that the Company does not intend to sell the security and it is not more likely than not that it will be required to sell it before recovery). For securities that are deemed other-than-temporarily impaired, the amount of impairment is recognized in "financial income, net", in the statement of operations and is limited to the amount related to credit loss, while impairment related to other factors is recognized in other comprehensive income (loss).</div> <div style="DISPLAY: block; MARGIN-LEFT: 437pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> &nbsp;</div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> During 2014, 2013 and 2012, no impairment losses been identified.</div> <div style="DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> &nbsp;</div> <div style="text-align: center"> <table style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman" cellspacing="0" cellpadding="0" width="100%" border="0"> <tr valign="top"> <td style="WIDTH: 18pt"> <div style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt"> i.</div> </td> <td> <div style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; text-align: justify"> Revenue Recognition from the license Agreement with United Therapeutics</div> </td> </tr> </table> </div> <div style="DISPLAY: block; MARGIN-LEFT: 437pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> &nbsp;</div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> The Company recognizes revenue pursuant to the License Agreement with United Therapeutics in accordance with ASC 605-25, "Revenue Recognition, Multiple-Element Arrangements".</div> <div style="MARGIN-LEFT: 437pt; DISPLAY: block; TEXT-INDENT: 0pt"> <br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> Pursuant to ASC 605-25, each deliverable is evaluated to determine whether it qualifies as a separate unit of accounting based on whether the deliverable has "stand-alone value" to the customer. The arrangement&#39;s consideration that is fixed or determinable is then allocated to each separate unit of accounting based on the relative selling price of each deliverable. In general, the consideration allocated to each unit of accounting is recognized as the related goods or services are delivered, limited to the consideration that is not contingent upon future deliverables.</div> <div style="MARGIN-LEFT: 437pt; DISPLAY: block; TEXT-INDENT: 0pt"> <br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> The Company received an up-front, non-refundable license payment of $5,000. Additional payments totaling $37,500 are subject to the achievement of certain regulatory milestones by United Therapeutics.</div> <div style="MARGIN-LEFT: 437pt; DISPLAY: block; TEXT-INDENT: 0pt"> <br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> Since the deliverables in the United Agreement do not have stand-alone value, none of them qualifies as a separate unit of accounting. Accordingly, the non-refundable upfront license fee of $5,000 is deferred and recognized on a straight line basis over the related performance period which is the development period in accordance with Staff Accounting Bulletin ("SAB") 104, "Revenue Recognition". The remaining performance period is 8.5 years as of June 30, 2014.</div> <div style="MARGIN-LEFT: 437pt; DISPLAY: block; TEXT-INDENT: 0pt"> <br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> The additional regulatory milestones payments will be recognized upon the achievement of futures events by United Therapeutics, in accordance with ASC 450-30-25, "Gain Contingencies". As of June 30, 2014, no regulatory millstones were achieved.</div> <div style="MARGIN-LEFT: 437pt; DISPLAY: block; TEXT-INDENT: 0pt"> <br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> The Company also received an advanced payment for the development, of $2,000 that will be deductible against development expenses as it incurred. The upfront payment which was received and has not yet fully recognized in the statement of operations, is included in the balance sheet as advance payment. Part of the expenses related to the development, on a cost basis, shall be repaid to the Company by United Therapeutics according to the applicable license agreement. The Company is deducting the payments from its research and development expenses in accordance with ASC 730-20, "Research and Development Agreements". As of June 30, 2014, the Company deducted an amount of approximately $1,753.</div> <div style="DISPLAY: block; TEXT-INDENT: 0pt">&nbsp;</div> <div> <table style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman" cellspacing="0" cellpadding="0" width="100%" align="center" border="0"> <tr valign="top"> <td style="WIDTH: 18pt"> <div style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt"> j.</div> </td> <td> <div style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; text-align: justify"> Property and Equipment</div> </td> </tr> </table> </div> <div style="DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> &nbsp;</div> <div> <table style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman" cellspacing="0" cellpadding="0" width="100%" align="center" border="0"> <tr valign="top"> <td style="WIDTH: 18pt"> <div style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; DISPLAY: inline"> &nbsp;</div> </td> <td> <div style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; text-align: justify"> Property and equipment are stated at cost, net of accumulated depreciation. Depreciation is calculated by the straight-line method over the estimated useful lives of the assets, at the following annual rates:</div> </td> </tr> </table> </div> <div style="DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> &nbsp;</div> <div style="MARGIN-LEFT: 18pt; text-align: left"> <table style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman" cellspacing="0" cellpadding="0" width="80%"> <tr> <td valign="top" width="44%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid" valign="top" width="28%"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt"> %</div> </td> <td valign="top" width="28%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> <tr bgcolor="#cceeff"> <td valign="top" width="44%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"> Laboratory equipment</div> </td> <td valign="top" width="28%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: -12.3pt; text-align: left; TEXT-INDENT: 0pt"> 10-15</div> </td> <td valign="top" width="28%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> <tr bgcolor="white"> <td valign="top" width="44%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"> Computers and peripheral equipment</div> </td> <td valign="top" width="28%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: -12.3pt; text-align: left; TEXT-INDENT: 0pt"> 33</div> </td> <td valign="top" width="28%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> <tr bgcolor="#cceeff"> <td valign="top" width="44%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"> Office furniture and equipment</div> </td> <td valign="top" width="28%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: -12.3pt; text-align: left; TEXT-INDENT: 0pt"> 6-15</div> </td> <td valign="top" width="28%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> <tr bgcolor="white"> <td valign="top" width="44%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"> Vehicles</div> </td> <td valign="top" width="15%" colspan="2" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: -12.3pt; text-align: left; TEXT-INDENT: 0pt"> 15</div> </td> </tr> <tr bgcolor="#cceeff"> <td valign="top" width="44%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"> Leasehold improvements</div> </td> <td valign="top" width="56%" colspan="2" align="left"> <div style="DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: -12.3pt; text-align: left; TEXT-INDENT: 0pt"> <font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> The shorter of the expected</font> <font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> useful life or the</font></div> <div style="DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: -12.3pt; text-align: left; TEXT-INDENT: 0pt"> <font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> reasonable assumed</font> <font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> term of the lease.</font></div> </td> </tr> </table> </div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /> </div> <div style="text-align: center"> <table style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman" cellspacing="0" cellpadding="0" width="100%" border="0"> <tr valign="top"> <td style="WIDTH: 18pt"> <div style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt"> k.</div> </td> <td> <div style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; text-align: justify"> Impairment of long-lived assets</div> </td> </tr> </table> </div> <div style="DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> &nbsp;</div> <div> <table style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman" cellspacing="0" cellpadding="0" width="100%" align="center" border="0"> <tr valign="top"> <td style="WIDTH: 18pt"> <div style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; DISPLAY: inline"> &nbsp;</div> </td> <td> <div style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; text-align: justify"> The Company&#39;s long-lived assets are reviewed for impairment in accordance with ASC 360, "Property, Plant and Equipment", whenever events or changes in circumstances indicate that the carrying amount of an asset may not be recoverable. Recoverability of assets to be held and used is measured by a comparison of the carrying amount of the assets to the future undiscounted cash flows expected to be generated by the assets. If such assets are considered to be impaired, the impairment to be recognized is measured by the amount by which the carrying amount of the assets exceeds the fair value of the assets. During 2014, 2013 and 2012, no impairment losses been identified.</div> </td> </tr> </table> </div> <div style="DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> &nbsp;</div> <div> <table style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman" cellspacing="0" cellpadding="0" width="100%" align="center" border="0"> <tr valign="top"> <td style="WIDTH: 18pt"> <div style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt"> l.</div> </td> <td> <div style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; text-align: justify"> Accounting for stock-based compensation</div> </td> </tr> </table> </div> <div style="DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> &nbsp;</div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> The Company accounts for stock-based compensation in accordance with ASC 718, "Compensation-Stock Compensation" ("ASC 718") and ASC 505-50 "Equity-Based Payments to Non-Employees". ASC 718 requires companies to estimate the fair value of equity-based payment awards on the date of grant using an option-pricing model. The Company estimates the fair value of stock options granted using the Black-Scholes-Merton option-pricing model. The Company accounts for employee&#39;s share-based payment awards classified as equity awards using the grant-date fair value method. The fair value of share-based payment transactions is recognized as an expense over the requisite service period, net of estimated forfeitures. The Company estimates forfeitures based on historical experience and anticipated future conditions. The Company elected to recognize compensation cost for an award with service conditions and goals achievement that has a graded vesting schedule using the accelerated method based on the multiple-option award approach.</div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> During fiscal years 2014, 2013 and 2012 there were no options grants to employees or directors.</div> <div style="MARGIN-LEFT: 437pt; DISPLAY: block; TEXT-INDENT: 0pt"> <br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> The assumptions below are relevant to restricted shares units granted in 2014, 2013 and 2012:</div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> In accordance with <font style="FONT-SIZE: 10pt; DISPLAY: inline">ASC 718</font>, restricted shares or restricted shares units are measured at their fair value. All restricted shares and restricted shares units to employees, directors and non-employees granted in 20142013 and 2012 were granted for no consideration; therefore, their fair value was equal to the share price at the date of grant.</div> <div style="MARGIN-LEFT: 437pt; DISPLAY: block; TEXT-INDENT: 0pt"> <br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> The expected pre-vesting forfeiture rate affects the number of exercisable shares. Based on Company&#39;s historical experience, the pre-vesting forfeiture rate per grant for shares granted to employees is 7% for year ended June 30, 2014 and 2013 and 5% for the year ended June 30, 2012, and 0% for the options and shares granted to directors and officers and consultants of the Company.</div> <div style="MARGIN-LEFT: 437pt; DISPLAY: block; TEXT-INDENT: 0pt"> <br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> The fair value of all restricted shares and restricted shares units was determined based on the close trading price of the Company&#39;s shares known at the grant date. The weighted average grant date fair value of share granted during years 2014, 2013 and 2012 was $3.53, $3.43 and $2.54, respectively.</div> <div style="DISPLAY: block; TEXT-INDENT: 0pt">&nbsp;</div> <div style="text-align: center"> <table style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman" cellspacing="0" cellpadding="0" width="100%" border="0"> <tr valign="top"> <td style="WIDTH: 18pt"> <div style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt"> m.</div> </td> <td> <div style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; text-align: justify"> Research and Development expenses and grants</div> </td> </tr> </table> </div> <div style="DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> &nbsp;</div> <div> <table style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman" cellspacing="0" cellpadding="0" width="100%" align="center" border="0"> <tr valign="top"> <td style="WIDTH: 19pt"> <div style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; DISPLAY: inline"> &nbsp;</div> </td> <td> <div style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; text-align: justify"> Research and development expenses, net of participations, are charged to the statement of operations as incurred.</div> </td> </tr> </table> </div> <div style="DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> &nbsp;</div> <div> <table style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman" cellspacing="0" cellpadding="0" width="100%" align="center" border="0"> <tr valign="top"> <td style="WIDTH: 19pt"> <div style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; DISPLAY: inline"> &nbsp;</div> </td> <td> <div style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; text-align: justify"> Research and development grants from the government of Israel and other parties for funding approved research and development projects are recognized at the time the Company is entitled to such grants, on the basis of the cost incurred and applied as a deduction from research and development costs.</div> </td> </tr> </table> </div> <div style="DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> &nbsp;</div> <div style="text-align: center"> <table style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman" cellspacing="0" cellpadding="0" width="100%" border="0"> <tr valign="top"> <td style="WIDTH: 18pt"> <div style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt"> n.</div> </td> <td> <div style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; text-align: justify"> Loss per share</div> </td> </tr> </table> </div> <div style="DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> &nbsp;</div> <div> <table style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman" cellspacing="0" cellpadding="0" width="100%" align="center" border="0"> <tr valign="top"> <td style="WIDTH: 19pt"> <div style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; DISPLAY: inline"> &nbsp;</div> </td> <td> <div style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; text-align: justify"> Basic and dilutive net loss per share is computed based on the weighted average number of shares of common stock outstanding during each year. All outstanding stock options and unvested restricted stock units have been excluded from the calculation of the diluted loss per common share because all such securities are anti-dilutive for each of the periods presented.</div> </td> </tr> </table> </div> <div style="DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> &nbsp;</div> <div style="text-align: center"> <table style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman" cellspacing="0" cellpadding="0" width="100%" border="0"> <tr valign="top"> <td style="WIDTH: 18pt"> <div style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt"> o.</div> </td> <td> <div style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; text-align: justify"> Income taxes</div> </td> </tr> </table> </div> <div style="DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> &nbsp;</div> <div> <table style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman" cellspacing="0" cellpadding="0" width="100%" align="center" border="0"> <tr valign="top"> <td style="WIDTH: 19pt"> <div style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; DISPLAY: inline"> &nbsp;</div> </td> <td> <div style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; text-align: justify"> The Company accounts for income taxes in accordance with ASC 740, "Income Taxes". This Topic prescribes the use of the liability method, whereby deferred tax assets and liability account balances are determined based on differences between financial reporting and tax bases of assets and liabilities and are measured using the enacted tax rates and laws that will be in effect when the differences are expected to reverse. The Company provides a valuation allowance, if necessary, to reduce deferred tax assets to their estimated realizable value.</div> </td> </tr> </table> </div> <div style="DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> &nbsp;</div> <div> <table style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman" cellspacing="0" cellpadding="0" width="100%" align="center" border="0"> <tr valign="top"> <td style="WIDTH: 19pt"> <div style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; DISPLAY: inline"> &nbsp;</div> </td> <td> <div style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; text-align: justify"> ASC 740 establishes a single model to address accounting for uncertain tax positions. ASC 740 clarified the accounting for income taxes by prescribing the minimum recognition threshold a tax position is required to meet before being recognized in the financial statements.</div> </td> </tr> </table> </div> <div style="DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> &nbsp;</div> <div style="text-align: center"> <table style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman" cellspacing="0" cellpadding="0" width="100%" border="0"> <tr valign="top"> <td style="WIDTH: 18pt"> <div style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt"> p.</div> </td> <td> <div style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; text-align: justify"> Concentration of credit risk</div> </td> </tr> </table> </div> <div style="DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> &nbsp;</div> <div> <table style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman" cellspacing="0" cellpadding="0" width="100%" align="center" border="0"> <tr valign="top"> <td style="WIDTH: 19pt"> <div style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; DISPLAY: inline"> &nbsp;</div> </td> <td> <div style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; text-align: justify"> Financial instruments that potentially subject the Company to concentrations of credit risk consist principally of cash and cash equivalents, short-term deposits, long-term deposits, restricted deposits and marketable securities.</div> </td> </tr> </table> </div> <div style="DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> &nbsp;</div> <div> <table style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman" cellspacing="0" cellpadding="0" width="100%" align="center" border="0"> <tr valign="top"> <td style="WIDTH: 19pt"> <div style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; DISPLAY: inline"> &nbsp;</div> </td> <td> <div style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; text-align: justify"> The majority of the Company&#39;s cash and cash equivalents and short-term and long-term deposits are invested in dollar instruments of major banks in Israel. Generally, these deposits may be redeemed upon demand and therefore bear minimal risk.</div> </td> </tr> </table> </div> <div style="DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> &nbsp;</div> <div> <table style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman" cellspacing="0" cellpadding="0" width="100%" align="center" border="0"> <tr valign="top"> <td style="WIDTH: 18pt"> <div style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; DISPLAY: inline"> &nbsp;</div> </td> <td> <div style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; text-align: justify"> The Company invests its surplus cash in cash deposits and marketable securities in financial institutions and has established guidelines, approved by the Company&#39;s Investment Committee, relating to diversification and maturities to maintain safety and liquidity of the investments.</div> </td> </tr> </table> </div> <div style="DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> &nbsp;</div> <div> <table style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman" cellspacing="0" cellpadding="0" width="100%" align="center" border="0"> <tr valign="top"> <td style="WIDTH: 18pt"> <div style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; DISPLAY: inline"> &nbsp;</div> </td> <td> <div style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; text-align: justify"> The Company holds an investment portfolio consisting of corporate bonds, government bonds, stocks and index linked notes. The Company intends, and has the ability, to hold such investments until recovery of temporary declines in market value or maturity; accordingly, as of June&nbsp;30, 2014, the Company believes the losses associated with its investments are temporary and no impairment loss was recognized during 2014. However, the Company can provide no assurance that it will recover declines in the market value of its investments.</div> </td> </tr> </table> </div> <div style="DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> &nbsp;</div> <div style="text-align: center"> <table style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman" cellspacing="0" cellpadding="0" width="100%" border="0"> <tr valign="top"> <td style="WIDTH: 17pt"> <div style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt"> q.</div> </td> <td> <div style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; text-align: justify"> Severance pay</div> </td> </tr> </table> </div> <div style="DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> &nbsp;</div> <div> <table style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman" cellspacing="0" cellpadding="0" width="100%" align="center" border="0"> <tr valign="top"> <td style="WIDTH: 19pt"> <div style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; DISPLAY: inline"> &nbsp;</div> </td> <td> <div style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; text-align: justify"> The Subsidiary&#39;s liability for severance pay is calculated pursuant to Israeli Severance Pay Law, 1963 (the "Severance Pay Law")&nbsp;&nbsp;based on the most recent salary of the employees multiplied by the number of years of employment, as of the balance sheet date. Employees are entitled to one month&#39;s salary for each year of employment or a portion thereof.</div> <div style="text-align: justify">&nbsp;</div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-ALIGN: justify; TEXT-INDENT: 0pt"> The Company&#39;s liability for all of its employees is fully provided by monthly deposits with insurance policies and by an accrual. The value of these policies is recorded as an asset in the Company&#39;s balance sheet.</div> </td> </tr> </table> </div> <div style="DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> &nbsp;</div> <div> <table style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman" cellspacing="0" cellpadding="0" width="100%" align="center" border="0"> <tr valign="top"> <td style="WIDTH: 19pt"> <div style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; DISPLAY: inline"> &nbsp;</div> </td> <td> <div style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; text-align: justify"> The deposited funds include profits or losses accumulated up to the balance sheet date. The deposited funds may be withdrawn only upon the fulfillment of the obligation pursuant to Israeli severance pay law or labor agreements. The value of the deposited funds is based on the cash surrendered value of these policies, and includes immaterial profits or losses.</div> </td> </tr> </table> </div> <div style="DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> &nbsp;</div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"> Since November 2011, the Company&#39;s agreements with new employees in Israel, are subject to Section 14 of the Severance Pay Law. The Company&#39;s contributions for severance pay have replaced its severance obligation. Upon contribution of the full amount of the employee&#39;s monthly salary for each year of employment, no additional calculations is conducted between the parties regarding the matter of severance pay and no additional payments is made by the Company to the employee. Further, the related obligation and amounts deposited on behalf of the employee for such obligation are not stated on the balance sheet, as the Company is legally released from the obligation to employees once the deposit amounts have been paid.</div> <div style="DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> &nbsp;</div> <div> <table style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman" cellspacing="0" cellpadding="0" width="100%" align="center" border="0"> <tr valign="top"> <td style="WIDTH: 19pt"> <div style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; DISPLAY: inline"> &nbsp;</div> </td> <td> <div style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; text-align: justify"> Severance expenses for the years ended December 31, 2014, 2013 and 2012, were $534, $329 and $275, respectively.</div> </td> </tr> </table> </div> <div style="DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> &nbsp;</div> <div style="text-align: center"> <table style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman" cellspacing="0" cellpadding="0" width="100%" border="0"> <tr valign="top"> <td style="WIDTH: 18pt"> <div style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt"> r.</div> </td> <td> <div style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; text-align: justify"> Fair value of financial instruments</div> </td> </tr> </table> </div> <div style="DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> &nbsp;</div> <div> <table style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman" cellspacing="0" cellpadding="0" width="100%" align="center" border="0"> <tr valign="top"> <td style="WIDTH: 19pt"> <div style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; DISPLAY: inline"> &nbsp;</div> </td> <td> <div style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; text-align: justify"> The carrying amounts of the Company&#39;s financial instruments, including cash and cash equivalents, short-term and restricted bank deposits, trade payable and other accounts payable and accrued liabilities, approximate fair value because of their generally short term maturities.</div> </td> </tr> </table> </div> <div style="DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> &nbsp;</div> <div> <table style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman" cellspacing="0" cellpadding="0" width="100%" align="center" border="0"> <tr valign="top"> <td style="WIDTH: 19pt"> <div style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; DISPLAY: inline"> &nbsp;</div> </td> <td> <div style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; text-align: justify"> The Company measures its investments in marketable securities and derivative instruments at fair value under ASC 820, "Fair Value Measurements and Disclosures" ("ASC 820"). Fair value is an exit price, representing the amount that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants. As such, fair value is a market-based measurement that should be determined based on assumptions that market participants would use in pricing an asset or a liability. As a basis for considering such assumptions, ASC 820 establishes a three-tier value hierarchy, which prioritizes the inputs used in the valuation methodologies in measuring fair value:</div> </td> </tr> </table> </div> <div style="DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> &nbsp;</div> <div> <table style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman" cellspacing="0" cellpadding="0" width="100%" align="center" border="0"> <tr valign="top"> <td style="WIDTH: 19pt"> <div style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; DISPLAY: inline"> &nbsp;</div> </td> <td> <div style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; text-align: justify"> <font style="FONT-WEIGHT: bold; DISPLAY: inline">Level 1 -</font> Quoted prices (unadjusted) in active markets for identical assets or liabilities that the Company can access at the measurement date;</div> </td> </tr> </table> </div> <div style="DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> &nbsp;</div> <div> <table style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman" cellspacing="0" cellpadding="0" width="100%" align="center" border="0"> <tr valign="top"> <td style="WIDTH: 19pt"> <div style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; DISPLAY: inline"> &nbsp;</div> </td> <td> <div style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; text-align: justify"> <font style="FONT-WEIGHT: bold; DISPLAY: inline">Level 2 -</font> Inputs other than quoted prices included within Level 1 that are observable for the asset or liability, either directly or indirectly.; and</div> </td> </tr> </table> </div> <div style="DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> &nbsp;</div> <div> <table style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman" cellspacing="0" cellpadding="0" width="100%" align="center" border="0"> <tr valign="top"> <td style="WIDTH: 19pt"> <div style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; DISPLAY: inline"> &nbsp;</div> </td> <td> <div style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; text-align: justify"> <font style="FONT-WEIGHT: bold; DISPLAY: inline">Level 3 -</font> Unobservable inputs for the asset or liability.</div> </td> </tr> </table> </div> <div style="DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> &nbsp;</div> <div> <table style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman" cellspacing="0" cellpadding="0" width="100%" align="center" border="0"> <tr valign="top"> <td style="WIDTH: 19pt"> <div style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; DISPLAY: inline"> &nbsp;</div> </td> <td> <div style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; text-align: justify"> The fair value hierarchy also requires an entity to maximize the use of observable inputs and minimize the use of unobservable inputs when measuring fair value. The Company categorized each of its fair value measurements in one of these three levels of hierarchy.</div> </td> </tr> </table> </div> <div style="DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> &nbsp;</div> <div style="text-align: center"> <table style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman" cellspacing="0" cellpadding="0" width="100%" border="0"> <tr valign="top"> <td style="WIDTH: 18pt"> <div style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt"> s.</div> </td> <td> <div style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; text-align: justify"> Derivative financial instruments</div> </td> </tr> </table> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> &nbsp;</div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> The Company uses forward contracts and options strategies ("derivative instruments") primarily to manage exposure to foreign currency. The Company accounts for derivatives and hedging based on ASC 815, "Derivatives and Hedging" ("ASC 815"). ASC 815 requires the Company to recognize all derivative instruments as either assets or liabilities on the balance sheet at fair value. The accounting for changes in the fair value (i.e., gains or losses) of derivative instruments depends on whether it has been designated and qualifies as part of a hedging relationship and further, on the type of hedging relationship. For those derivative instruments that are designated and qualify as hedging instruments, the Company must designate the hedging instrument, based upon the exposure being hedged, as a fair value hedge, cash flow hedge, or a hedge of a net investment in a foreign operation.</div> <div style="DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> &nbsp;</div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> If the derivative instruments meet the definition of a hedge and are so designated, depending on the nature of the hedge, changes in the fair value of such derivatives will either be offset against the change in fair value of the hedged assets, liabilities, or firm commitments through earnings, or recognized in other comprehensive income until the hedged item is recognized in the statement of operations.<font style="FONT-SIZE: 10pt; DISPLAY: inline">&nbsp;</font> The ineffective portion of a derivative&#39;s change in fair value is recognized in the statement of operations.</div> <div style="DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> &nbsp;</div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> <font style="FONT-FAMILY: Times New Roman; FONT-STYLE: italic; DISPLAY: inline"> Cash Flow Hedges</font>. The Company entered into forward contracts to hedge against the risk of overall changes in future cash flow from payments of payroll and related expenses denominated in New Israeli Shekels (NIS). The Company measured the fair value of the contracts in accordance with ASC 820 (classified as level 2). The gain or loss on the effective portion of a cash flow hedge is initially reported as a component of accumulated other comprehensive income and subsequently reclassified into operating expenses in the same period or periods in which the payroll and related expenses are recognized, or reclassified into "Financial income, net", if the hedged transaction becomes probable of not occurring. Any gain or loss after a hedge is no longer designated, because it is no longer probable of occurring or it is related to an ineffective portion of a cash flow hedge is recognized in the statement of operations immediately. As of June 30, 2014, the Company had forward contracts in place to hedge future payroll and related expenses in NIS of approximately $2,820, with fair value of approximately $24. The net unrealized gain on the effective portion of these cash flow hedges was $23. The net gain realized in statement of operations during the year ended June 30, 2014, resulting from the cash flow hedge transactions,&nbsp;&nbsp;amounted to approximately $48. The forward contracts on the Company&#39;s future NIS payroll and related expenses will settle by December 2014. On June 30, 2013, the Company did not have contracts designated and qualifies as cash flow hedge.</div> <div style="MARGIN-LEFT: 437pt; DISPLAY: block; TEXT-INDENT: 0pt"> <br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> <font style="FONT-FAMILY: Times New Roman; FONT-STYLE: italic; DISPLAY: inline"> Fair Value Hedges</font>. The Company entered into forward contracts designated as fair value hedges to hedge foreign currency risks for its investment denominated in currencies other than the U.S. dollar. The Company measured the fair value of the contracts in accordance with ASC 820 (classified as level 2). Gains and losses on these contracts are recognized in "Financial income, net", along with the offsetting losses and gains of the related hedged items.</div> <div style="DISPLAY: block; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> &nbsp;</div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> In connection with the investment in CHA shares (see Note 1d), an available-for-sale marketable security denominated in Korean Won, the Company entered into a forward contract to hedge against the foreign currency risk between the Korean Won and the U.S. dollar. The notional principal of this contract is $11,000 as of June 30, 2014 with fair value of approximately $(889).</div> <div style="DISPLAY: block; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> &nbsp;</div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> The changes in fair value of the available-for-sale CHA shares attributable to the foreign currency risk being hedged are reflected in the statement of operations in "Financial income, net" (not in other comprehensive income). Other changes in fair value of the available-for-sale CHA shares continue to follow ASC 320-"Investments-Debt and Equity Securities", accounting and are reflected in other comprehensive income.</div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> <font style="FONT-FAMILY: Times New Roman; FONT-STYLE: italic; DISPLAY: inline"> Other Derivatives</font>. Other derivatives that are non-designated consist primarily of options strategies to minimize the risk associated with the foreign exchange effects of monetary assets and liabilities denominated in NIS. The Company measured the fair value of the contracts in accordance with ASC 820 (classified as level 2). The net gains (losses) recognized in "Financial income, net" during the year ended June 30, 2014, 2013 and 2012 were ($70), $231 and ($145), respectively.</div> <div style="DISPLAY: block; TEXT-INDENT: 0pt">&nbsp;</div> <div style="text-align: center"> <table style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman" cellspacing="0" cellpadding="0" width="100%" border="0"> <tr valign="top"> <td style="WIDTH: 18pt"> <div style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt"> t.</div> </td> <td> <div style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; text-align: justify"> <font style="FONT-WEIGHT: bold; DISPLAY: inline">Comprehensive income</font><font style="FONT-SIZE: 10pt; DISPLAY: inline">:</font></div> </td> </tr> </table> </div> <div style="DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> &nbsp;</div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> The Company accounts for comprehensive income (loss) in accordance with ASC No. 220, "Comprehensive Income". Comprehensive income generally represents all changes in shareholders&#39; equity during the period except those resulting from investments by, or distributions to, shareholders. The Company determined that its items of other comprehensive income relate to gains and losses on cash flow hedging derivative instruments and unrealized gains and losses on available for sale marketable securities.</div> <div style="DISPLAY: block; TEXT-INDENT: 0pt">&nbsp;</div> <div style="text-align: right"> <table style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman" cellspacing="0" cellpadding="0" width="97%"> <tr> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="64%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="34%" colspan="10"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"> Year ended June 30, 2014</div> </td> <td style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> <tr> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="64%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="10%" colspan="2"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"> Unrealized</div> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"> gains</div> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"> on marketable</div> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"> securities</div> </td> <td style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="10%" colspan="2"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"> Unrealized</div> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"> gains</div> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"> on cash flow</div> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"> hedges</div> </td> <td style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="10%" colspan="2"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"> Total</div> </td> <td style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> <tr bgcolor="#cceeff"> <td style="TEXT-ALIGN: left; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt" valign="bottom" width="64%"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: left; TEXT-INDENT: 0pt"> Beginning balance</div> </td> <td valign="bottom" width="1%" align="right"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%">$</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">259</td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%" align="right"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%">$</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">-</td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%" align="right"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%">$</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">259</td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> <tr bgcolor="white"> <td style="TEXT-ALIGN: left; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt" valign="bottom" width="64%"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: left; TEXT-INDENT: 0pt"> Other comprehensive income before reclassifications</div> </td> <td valign="bottom" width="1%" align="right"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">3,404</td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%" align="right"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">23</td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%" align="right"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">3,427</td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> <tr bgcolor="#cceeff"> <td style="TEXT-ALIGN: left; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt" valign="bottom" width="64%"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: left; TEXT-INDENT: 0pt"> Amounts reclassified from accumulated other comprehensive loss</div> </td> <td valign="bottom" width="1%" align="right"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">(727</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap">)</td> <td valign="bottom" width="1%" align="right"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">-</td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%" align="right"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">(727</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap">)</td> </tr> <tr bgcolor="white"> <td style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt" valign="bottom" width="64%"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: left; TEXT-INDENT: 0pt"> Net current-period other comprehensive income</div> </td> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%" align="right"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">2,677</td> <td style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%" align="right"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">23</td> <td style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%" align="right"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">2,700</td> <td style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> <tr bgcolor="#cceeff"> <td style="PADDING-BOTTOM: 4px; TEXT-ALIGN: left; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt" valign="bottom" width="64%"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: left; TEXT-INDENT: 0pt"> Ending balance</div> </td> <td style="PADDING-BOTTOM: 4px" valign="bottom" width="1%" align="right"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 4px double; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%">$</td> <td style="BORDER-BOTTOM: black 4px double; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">2,936</td> <td style="PADDING-BOTTOM: 4px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="PADDING-BOTTOM: 4px" valign="bottom" width="1%" align="right"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 4px double; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%">$</td> <td style="BORDER-BOTTOM: black 4px double; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">23</td> <td style="PADDING-BOTTOM: 4px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="PADDING-BOTTOM: 4px" valign="bottom" width="1%" align="right"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 4px double; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%">$</td> <td style="BORDER-BOTTOM: black 4px double; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">2,959</td> <td style="PADDING-BOTTOM: 4px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> </table> </div> <div style="DISPLAY: block; TEXT-INDENT: 0pt">&nbsp;</div> <div style="text-align: center"> <table style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman" cellspacing="0" cellpadding="0" width="100%" border="0"> <tr valign="top"> <td style="WIDTH: 18pt"> <div style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt"> u.</div> </td> <td> <div style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; text-align: justify"> Recent Accounting Pronouncement</div> </td> </tr> </table> </div> <div style="DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> &nbsp;</div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> In May 2014, the FASB issued Accounting Standards Update No. 2014-09 ("ASU 2014-09"), "Revenue from Contracts with Customers". ASU 2014-09 supersedes the revenue recognition requirements in "Revenue Recognition (Topic 605)", and requires entities to recognize revenue when it transfers promised goods or services to customers in an amount that reflects the consideration to which the entity expects to be entitled to in exchange for those goods or services. ASU 2014-09 is effective for annual reporting periods beginning after December 15, 2016, including interim periods within that reporting period. Early adoption is not permitted. The Company is currently in the process of evaluating the impact of the adoption of ASU 2014-09 on its consolidated financial statements.</div> <!--EndFragment--></div> </div><span></span></td>
      </tr>
    </table>
    <div style="display: none;">
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div>
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_AccountingPoliciesAbstract</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:stringItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SignificantAccountingPoliciesTextBlock">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The entire disclosure for all significant accounting policies of the reporting entity.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 235<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 3<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6367646&amp;loc=d3e18780-107790<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 235<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 1<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6367646&amp;loc=d3e18726-107790<br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 235<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 6<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6367646&amp;loc=d3e18861-107790<br><br><br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 235<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 2<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6367646&amp;loc=d3e18743-107790<br><br><br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 235<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 5<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6367646&amp;loc=d3e18854-107790<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_SignificantAccountingPoliciesTextBlock</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>nonnum:textBlockItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
    </div>
  </body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>82
<FILENAME>R27.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
  <head>
    <META http-equiv="Content-Type" content="text/html; charset=us-ascii">
    <link rel="StyleSheet" type="text/css" href="report.css"><script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script></head>
  <body><span style="display: none;">v2.4.0.8</span><table class="report" border="0" cellspacing="2" id="ID0EME">
      <tr>
        <th class="tl" colspan="1" rowspan="2">
          <div style="width: 200px;"><strong>FINANCIAL INCOME, NET (Tables)<br></strong></div>
        </th>
        <th class="th" colspan="1">12 Months Ended</th>
      </tr>
      <tr>
        <th class="th">
          <div>Jun. 30, 2014</div>
        </th>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherIncomeAndExpensesAbstract', window );"><strong>FINANCIAL INCOME, NET [Abstract]</strong></a></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfOtherNonoperatingIncomeExpenseTableTextBlock', window );">Schedule of Financial Expenses (Income), Net</a></td>
        <td class="text"><!--DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd" --><div> <div><!--StartFragment--> <div style="text-align: left"> <table style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman" cellspacing="0" cellpadding="0" width="80%"> <tr> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="64%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-WEIGHT: bold; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="34%" colspan="10"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: -9pt"> Year ended June 30,</div> </td> <td style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-WEIGHT: bold; DISPLAY: inline"> &nbsp;</font> </td> </tr> <tr> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="64%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%" align="right"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-WEIGHT: bold; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: center; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt" valign="bottom" width="10%" colspan="2"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: center; TEXT-INDENT: 0pt"> 2014</div> </td> <td style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-WEIGHT: bold; DISPLAY: inline"> &nbsp;</font> </td> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%" align="right"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-WEIGHT: bold; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: center; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt" valign="bottom" width="10%" colspan="2"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: center; TEXT-INDENT: 0pt"> 2013</div> </td> <td style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-WEIGHT: bold; DISPLAY: inline"> &nbsp;</font> </td> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-WEIGHT: bold; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="10%" colspan="2"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 7.45pt; text-align: center; TEXT-INDENT: 0pt"> 2012</div> </td> <td style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-WEIGHT: bold; DISPLAY: inline"> &nbsp;</font> </td> </tr> <tr> <td valign="bottom" width="64%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="10%" colspan="2"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="10%" colspan="2"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="10%" colspan="2"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> <tr bgcolor="#cceeff"> <td style="TEXT-ALIGN: left; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt" valign="bottom" width="64%"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: left; TEXT-INDENT: 0pt"> Foreign currency translation differences, net</div> </td> <td valign="bottom" width="1%" align="right"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%">$</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">407</td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%" align="right"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%">$</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">497</td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%" align="right"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%">$</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">(98</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap">)</td> </tr> <tr bgcolor="white"> <td valign="bottom" width="64%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 9pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: -9pt"> Bank commissions</div> </td> <td valign="bottom" width="1%" align="right"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">(36</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap">)</td> <td valign="bottom" width="1%" align="right"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">(29</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap">)</td> <td valign="bottom" width="1%" align="right"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">(12</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap">)</td> </tr> <tr bgcolor="#cceeff"> <td valign="bottom" width="64%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 9pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: -9pt"> Interest income on deposits</div> </td> <td valign="bottom" width="1%" align="right"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">246</td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%" align="right"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">539</td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%" align="right"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">575</td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> <tr bgcolor="white"> <td valign="bottom" width="64%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 9pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: -9pt"> Gain (Loss) related to marketable securities</div> </td> <td valign="bottom" width="1%" align="right"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">384</td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%" align="right"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">(79</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap">)</td> <td valign="bottom" width="1%" align="right"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">89</td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> <tr bgcolor="#cceeff"> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="64%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 9pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: -9pt"> Gain (loss) from&nbsp;&nbsp;derivatives</div> </td> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%" align="right"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">(83</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap">)</td> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%" align="right"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">140</td> <td style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%" align="right"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">(317</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap">)</td> </tr> <tr bgcolor="white"> <td valign="bottom" width="64%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: right" valign="bottom" width="9%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: right" valign="bottom" width="9%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: right" valign="bottom" width="9%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> <tr bgcolor="#cceeff"> <td style="PADDING-BOTTOM: 4px" valign="bottom" width="64%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="PADDING-BOTTOM: 4px" valign="bottom" width="1%" align="right"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 4px double; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%">$</td> <td style="BORDER-BOTTOM: black 4px double; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">918</td> <td style="PADDING-BOTTOM: 4px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="PADDING-BOTTOM: 4px" valign="bottom" width="1%" align="right"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 4px double; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%">$</td> <td style="BORDER-BOTTOM: black 4px double; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">1,068</td> <td style="PADDING-BOTTOM: 4px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="PADDING-BOTTOM: 4px" valign="bottom" width="1%" align="right"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 4px double; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%">$</td> <td style="BORDER-BOTTOM: black 4px double; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">237</td> <td style="PADDING-BOTTOM: 4px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> </table> </div> <!--EndFragment--></div> </div><span></span></td>
      </tr>
    </table>
    <div style="display: none;">
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherIncomeAndExpensesAbstract">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div>
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_OtherIncomeAndExpensesAbstract</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:stringItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfOtherNonoperatingIncomeExpenseTableTextBlock">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Tabular disclosure of the components of non-operating income or non-operating expense that may include amounts earned from dividends, interest on securities, gains (losses) on securities sold, equity earnings of unconsolidated affiliates, net gain (loss) on sales of business, interest expense and other miscellaneous income or expense items.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_ScheduleOfOtherNonoperatingIncomeExpenseTableTextBlock</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>nonnum:textBlockItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
    </div>
  </body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>83
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="utf-8"?>
<FilingSummary xmlns:xsd="http://www.w3.org/2001/XMLSchema" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
  <Version>2.4.0.8</Version>
  <ProcessingTime />
  <ReportFormat>Html</ReportFormat>
  <ContextCount>204</ContextCount>
  <ElementCount>288</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>74</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>4</UnitCount>
  <MyReports>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>001 - Document - Document and Entity Information</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.pluristem.com/role/DocumentAndEntityInformation</Role>
      <ShortName>Document and Entity Information</ShortName>
    </Report>
    <Report>
      <IsDefault>true</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R2.htm</HtmlFileName>
      <LongName>002 - Statement - CONSOLIDATED BALANCE SHEETS</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.pluristem.com/role/ConsolidatedBalanceSheets</Role>
      <ShortName>CONSOLIDATED BALANCE SHEETS</ShortName>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R3.htm</HtmlFileName>
      <LongName>003 - Statement - CONSOLIDATED BALANCE SHEETS (PARENTHETICAL)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.pluristem.com/role/ConsolidatedBalanceSheetsParenthetical</Role>
      <ShortName>CONSOLIDATED BALANCE SHEETS (PARENTHETICAL)</ShortName>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R4.htm</HtmlFileName>
      <LongName>004 - Statement - CONSOLIDATED STATEMENTS OF OPERATIONS</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.pluristem.com/role/ConsolidatedStatementsOfOperations</Role>
      <ShortName>CONSOLIDATED STATEMENTS OF OPERATIONS</ShortName>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R5.htm</HtmlFileName>
      <LongName>005 - Statement - CONSOLIDATED STATEMENTS OF COMPREHENSIVE LOSS</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.pluristem.com/role/ConsolidatedStatementsOfComprehensiveLoss</Role>
      <ShortName>CONSOLIDATED STATEMENTS OF COMPREHENSIVE LOSS</ShortName>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R6.htm</HtmlFileName>
      <LongName>006 - Statement - STATEMENTS OF CHANGES IN EQUITY</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.pluristem.com/role/StatementsOfChangesInEquity</Role>
      <ShortName>STATEMENTS OF CHANGES IN EQUITY</ShortName>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R7.htm</HtmlFileName>
      <LongName>007 - Statement - STATEMENTS OF CHANGES IN EQUITY (Parenthetical)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.pluristem.com/role/StatementsOfChangesInEquityParenthetical</Role>
      <ShortName>STATEMENTS OF CHANGES IN EQUITY (Parenthetical)</ShortName>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R8.htm</HtmlFileName>
      <LongName>008 - Statement - CONSOLIDATED STATEMENTS OF CASH FLOWS</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.pluristem.com/role/ConsolidatedStatementsOfCashFlows</Role>
      <ShortName>CONSOLIDATED STATEMENTS OF CASH FLOWS</ShortName>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R9.htm</HtmlFileName>
      <LongName>101 - Disclosure - GENERAL</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.pluristem.com/role/General</Role>
      <ShortName>GENERAL</ShortName>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R10.htm</HtmlFileName>
      <LongName>102 - Disclosure - SIGNIFICANT ACCOUNTING POLICIES</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.pluristem.com/role/SignificantAccountingPolicies</Role>
      <ShortName>SIGNIFICANT ACCOUNTING POLICIES</ShortName>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R11.htm</HtmlFileName>
      <LongName>103 - Disclosure - MARKETABLE SECURITIES</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.pluristem.com/role/MarketableSecurities</Role>
      <ShortName>MARKETABLE SECURITIES</ShortName>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R12.htm</HtmlFileName>
      <LongName>104 - Disclosure - FAIR VALUE OF FINANCIAL INSTRUMENTS</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.pluristem.com/role/FairValueOfFinancialInstruments</Role>
      <ShortName>FAIR VALUE OF FINANCIAL INSTRUMENTS</ShortName>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R13.htm</HtmlFileName>
      <LongName>105 - Disclosure - PROPERTY AND EQUIPMENT, NET</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.pluristem.com/role/PropertyAndEquipmentNet</Role>
      <ShortName>PROPERTY AND EQUIPMENT, NET</ShortName>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R14.htm</HtmlFileName>
      <LongName>106 - Disclosure - OTHER ACCOUNTS PAYABLE</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.pluristem.com/role/OtherAccountsPayable</Role>
      <ShortName>OTHER ACCOUNTS PAYABLE</ShortName>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R15.htm</HtmlFileName>
      <LongName>107 - Disclosure - COMMITMENTS AND CONTINGENCIES</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.pluristem.com/role/CommitmentsAndContingencies</Role>
      <ShortName>COMMITMENTS AND CONTINGENCIES</ShortName>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R16.htm</HtmlFileName>
      <LongName>108 - Disclosure - STOCKHOLDERS' EQUITY</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.pluristem.com/role/StockholdersEquity</Role>
      <ShortName>STOCKHOLDERS' EQUITY</ShortName>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R17.htm</HtmlFileName>
      <LongName>109 - Disclosure - FINANCIAL INCOME, NET</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.pluristem.com/role/FinancialIncomeNet</Role>
      <ShortName>FINANCIAL INCOME, NET</ShortName>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R18.htm</HtmlFileName>
      <LongName>110 - Disclosure - TAXES ON INCOME</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.pluristem.com/role/TaxesOnIncome</Role>
      <ShortName>TAXES ON INCOME</ShortName>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R19.htm</HtmlFileName>
      <LongName>202 - Disclosure - SIGNIFICANT ACCOUNTING POLICIES (Policies)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.pluristem.com/role/SignificantAccountingPoliciesPolicies</Role>
      <ShortName>SIGNIFICANT ACCOUNTING POLICIES (Policies)</ShortName>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R20.htm</HtmlFileName>
      <LongName>302 - Disclosure - SIGNIFICANT ACCOUNTING POLICIES (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.pluristem.com/role/SignificantAccountingPoliciesTables</Role>
      <ShortName>SIGNIFICANT ACCOUNTING POLICIES (Tables)</ShortName>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R21.htm</HtmlFileName>
      <LongName>303 - Disclosure - MARKETABLE SECURITIES (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.pluristem.com/role/MarketableSecuritiesTables</Role>
      <ShortName>MARKETABLE SECURITIES (Tables)</ShortName>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R22.htm</HtmlFileName>
      <LongName>304 - Disclosure - FAIR VALUE OF FINANCIAL INSTRUMENTS (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.pluristem.com/role/FairValueOfFinancialInstrumentsTables</Role>
      <ShortName>FAIR VALUE OF FINANCIAL INSTRUMENTS (Tables)</ShortName>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R23.htm</HtmlFileName>
      <LongName>305 - Disclosure - PROPERTY AND EQUIPMENT, NET (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.pluristem.com/role/PropertyAndEquipmentNetTables</Role>
      <ShortName>PROPERTY AND EQUIPMENT, NET (Tables)</ShortName>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R24.htm</HtmlFileName>
      <LongName>306 - Disclosure - OTHER ACCOUNTS PAYABLE (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.pluristem.com/role/OtherAccountsPayableTables</Role>
      <ShortName>OTHER ACCOUNTS PAYABLE (Tables)</ShortName>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R25.htm</HtmlFileName>
      <LongName>307 - Disclosure - COMMITMENTS AND CONTINGENCIES (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.pluristem.com/role/CommitmentsAndContingenciesTables</Role>
      <ShortName>COMMITMENTS AND CONTINGENCIES (Tables)</ShortName>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R26.htm</HtmlFileName>
      <LongName>308 - Disclosure - STOCKHOLDERS' EQUITY (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.pluristem.com/role/StockholdersEquityTables</Role>
      <ShortName>STOCKHOLDERS' EQUITY (Tables)</ShortName>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R27.htm</HtmlFileName>
      <LongName>309 - Disclosure - FINANCIAL INCOME, NET (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.pluristem.com/role/FinancialIncomeNetTables</Role>
      <ShortName>FINANCIAL INCOME, NET (Tables)</ShortName>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R28.htm</HtmlFileName>
      <LongName>310 - Disclosure - TAXES ON INCOME (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.pluristem.com/role/TaxesOnIncomeTables</Role>
      <ShortName>TAXES ON INCOME (Tables)</ShortName>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R29.htm</HtmlFileName>
      <LongName>40101 - Disclosure - GENERAL (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.pluristem.com/role/GeneralDetails</Role>
      <ShortName>GENERAL (Details)</ShortName>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R30.htm</HtmlFileName>
      <LongName>40201 - Disclosure - SIGNIFICANT ACCOUNTING POLICIES (Narrative) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.pluristem.com/role/SignificantAccountingPoliciesNarrativeDetails</Role>
      <ShortName>SIGNIFICANT ACCOUNTING POLICIES (Narrative) (Details)</ShortName>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R31.htm</HtmlFileName>
      <LongName>40202 - Disclosure - SIGNIFICANT ACCOUNTING POLICIES (Schedule of Property and Equipment Depreciation Rate) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.pluristem.com/role/SignificantAccountingPoliciesScheduleOfPropertyAndEquipmentDepreciationRateDetails</Role>
      <ShortName>SIGNIFICANT ACCOUNTING POLICIES (Schedule of Property and Equipment Depreciation Rate) (Details)</ShortName>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R32.htm</HtmlFileName>
      <LongName>40203 - Disclosure - SIGNIFICANT ACCOUNTING POLICIES (Comprehensive Income) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.pluristem.com/role/SignificantAccountingPoliciesComprehensiveIncomeDetails</Role>
      <ShortName>SIGNIFICANT ACCOUNTING POLICIES (Comprehensive Income) (Details)</ShortName>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R33.htm</HtmlFileName>
      <LongName>40301 - Disclosure - MARKETABLE SECURITIES (Schedule of Available-for-sale Marketable Securities) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.pluristem.com/role/MarketableSecuritiesScheduleOfAvailableforsaleMarketableSecuritiesDetails</Role>
      <ShortName>MARKETABLE SECURITIES (Schedule of Available-for-sale Marketable Securities) (Details)</ShortName>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R34.htm</HtmlFileName>
      <LongName>40302 - Disclosure - MARKETABLE SECURITIES (Schedule of Investments in Unrealized Loss) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.pluristem.com/role/MarketableSecuritiesScheduleOfInvestmentsInUnrealizedLossDetails</Role>
      <ShortName>MARKETABLE SECURITIES (Schedule of Investments in Unrealized Loss) (Details)</ShortName>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R35.htm</HtmlFileName>
      <LongName>40401 - Disclosure - FAIR VALUE OF FINANCIAL INSTRUMENTS (Schedule of Fair Value of Financial Instruments) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.pluristem.com/role/FairValueOfFinancialInstrumentsScheduleOfFairValueOfFinancialInstrumentsDetails</Role>
      <ShortName>FAIR VALUE OF FINANCIAL INSTRUMENTS (Schedule of Fair Value of Financial Instruments) (Details)</ShortName>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R36.htm</HtmlFileName>
      <LongName>40402 - Disclosure - FAIR VALUE OF FINANCIAL INSTRUMENTS (Schedule of the Fair Value of Hedging Instruments) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.pluristem.com/role/FairValueOfFinancialInstrumentsScheduleOfFairValueOfHedgingInstrumentsDetails</Role>
      <ShortName>FAIR VALUE OF FINANCIAL INSTRUMENTS (Schedule of the Fair Value of Hedging Instruments) (Details)</ShortName>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R37.htm</HtmlFileName>
      <LongName>40501 - Disclosure - PROPERTY AND EQUIPMENT, NET (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.pluristem.com/role/PropertyAndEquipmentNetDetails</Role>
      <ShortName>PROPERTY AND EQUIPMENT, NET (Details)</ShortName>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R38.htm</HtmlFileName>
      <LongName>40601 - Disclosure - OTHER ACCOUNTS PAYABLE (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.pluristem.com/role/OtherAccountsPayableDetails</Role>
      <ShortName>OTHER ACCOUNTS PAYABLE (Details)</ShortName>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R39.htm</HtmlFileName>
      <LongName>40701 - Disclosure - COMMITMENTS AND CONTINGENCIES (Operating Lease) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.pluristem.com/role/CommitmentsAndContingenciesOperatingLeaseDetails</Role>
      <ShortName>COMMITMENTS AND CONTINGENCIES (Operating Lease) (Details)</ShortName>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R40.htm</HtmlFileName>
      <LongName>40703 - Disclosure - COMMITMENTS AND CONTINGENCIES (Other) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.pluristem.com/role/CommitmentsAndContingenciesOtherDetails</Role>
      <ShortName>COMMITMENTS AND CONTINGENCIES (Other) (Details)</ShortName>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R41.htm</HtmlFileName>
      <LongName>40801 - Disclosure - STOCKHOLDERS' EQUITY (Narrative) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.pluristem.com/role/StockholdersEquityNarrativeDetails</Role>
      <ShortName>STOCKHOLDERS' EQUITY (Narrative) (Details)</ShortName>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R42.htm</HtmlFileName>
      <LongName>40802 - Disclosure - STOCKHOLDERS' EQUITY (Summary of Option Activity) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.pluristem.com/role/StockholdersEquitySummaryOfOptionActivityDetails</Role>
      <ShortName>STOCKHOLDERS' EQUITY (Summary of Option Activity) (Details)</ShortName>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R43.htm</HtmlFileName>
      <LongName>40803 - Disclosure - STOCKHOLDERS' EQUITY (Summary of Option and Warrant Activity to Non-employees) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.pluristem.com/role/StockholdersEquitySummaryOfOptionAndWarrantActivityToNonemployeesDetails</Role>
      <ShortName>STOCKHOLDERS' EQUITY (Summary of Option and Warrant Activity to Non-employees) (Details)</ShortName>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R44.htm</HtmlFileName>
      <LongName>40804 - Disclosure - STOCKHOLDERS' EQUITY (Summary of RSU Activity to Employees and Directors) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.pluristem.com/role/StockholdersEquitySummaryOfRsuActivityToEmployeesAndDirectorsDetails</Role>
      <ShortName>STOCKHOLDERS' EQUITY (Summary of RSU Activity to Employees and Directors) (Details)</ShortName>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R45.htm</HtmlFileName>
      <LongName>40805 - Disclosure - STOCKHOLDERS' EQUITY (Summary of RSU Activity to Consultants) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.pluristem.com/role/StockholdersEquitySummaryOfRsuActivityToConsultantsDetails</Role>
      <ShortName>STOCKHOLDERS' EQUITY (Summary of RSU Activity to Consultants) (Details)</ShortName>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R46.htm</HtmlFileName>
      <LongName>40806 - Disclosure - STOCKHOLDERS' EQUITY (Schedule of Compensation Expense) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.pluristem.com/role/StockholdersEquityScheduleOfCompensationExpenseDetails</Role>
      <ShortName>STOCKHOLDERS' EQUITY (Schedule of Compensation Expense) (Details)</ShortName>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R47.htm</HtmlFileName>
      <LongName>40807 - Disclosure - STOCKHOLDERS' EQUITY (Summary of Warrants and Options) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.pluristem.com/role/StockholdersEquitySummaryOfWarrantsAndOptionsDetails</Role>
      <ShortName>STOCKHOLDERS' EQUITY (Summary of Warrants and Options) (Details)</ShortName>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R48.htm</HtmlFileName>
      <LongName>40901 - Disclosure - FINANCIAL INCOME, NET (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.pluristem.com/role/FinancialIncomeNetDetails</Role>
      <ShortName>FINANCIAL INCOME, NET (Details)</ShortName>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R49.htm</HtmlFileName>
      <LongName>41001 - Disclosure - TAXES ON INCOME (Narrative) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.pluristem.com/role/TaxesOnIncomeNarrativeDetails</Role>
      <ShortName>TAXES ON INCOME (Narrative) (Details)</ShortName>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R50.htm</HtmlFileName>
      <LongName>41003 - Disclosure - TAXES ON INCOME (Schedule of Significant Components of Deferred Tax Assets) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.pluristem.com/role/TaxesOnIncomeScheduleOfSignificantComponentsOfDeferredTaxAssetsDetails</Role>
      <ShortName>TAXES ON INCOME (Schedule of Significant Components of Deferred Tax Assets) (Details)</ShortName>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <Logs>
    <Log type="Info">Process Flow-Through: 002 - Statement - CONSOLIDATED BALANCE SHEETS</Log>
    <Log type="Info">	Process Flow-Through: Removing column 'Jun. 30, 2012'</Log>
    <Log type="Info">	Process Flow-Through: Removing column 'Jun. 30, 2011'</Log>
    <Log type="Info">Process Flow-Through: 003 - Statement - CONSOLIDATED BALANCE SHEETS (PARENTHETICAL)</Log>
    <Log type="Info">Process Flow-Through: 004 - Statement - CONSOLIDATED STATEMENTS OF OPERATIONS</Log>
    <Log type="Info">Process Flow-Through: 005 - Statement - CONSOLIDATED STATEMENTS OF COMPREHENSIVE LOSS</Log>
    <Log type="Info">Process Flow-Through: 007 - Statement - STATEMENTS OF CHANGES IN EQUITY (Parenthetical)</Log>
    <Log type="Info">Process Flow-Through: 008 - Statement - CONSOLIDATED STATEMENTS OF CASH FLOWS</Log>
  </Logs>
  <InputFiles>
    <File>psti-20140630.xml</File>
    <File>psti-20140630.xsd</File>
    <File>psti-20140630_cal.xml</File>
    <File>psti-20140630_def.xml</File>
    <File>psti-20140630_lab.xml</File>
    <File>psti-20140630_pre.xml</File>
  </InputFiles>
  <SupplementalFiles />
  <BaseTaxonomies />
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>true</HasCalculationLinkbase>
</FilingSummary>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>84
<FILENAME>R38.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
  <head>
    <META http-equiv="Content-Type" content="text/html; charset=us-ascii">
    <link rel="StyleSheet" type="text/css" href="report.css"><script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script></head>
  <body><span style="display: none;">v2.4.0.8</span><table class="report" border="0" cellspacing="2" id="ID0E6KAC">
      <tr>
        <th class="tl" colspan="1" rowspan="1">
          <div style="width: 200px;"><strong>OTHER ACCOUNTS PAYABLE (Details) (USD $)<br>In Thousands, unless otherwise specified</strong></div>
        </th>
        <th class="th">
          <div>Jun. 30, 2014</div>
        </th>
        <th class="th">
          <div>Jun. 30, 2013</div>
        </th>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_psti_OtherAccountsPayableAbstract', window );"><strong>OTHER ACCOUNTS PAYABLE [Abstract]</strong></a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EmployeeRelatedLiabilitiesCurrent', window );">Accrued payroll</a></td>
        <td class="nump">$ 424<span></span></td>
        <td class="nump">$ 353<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_psti_OtherAccountsPayablePayrollInstitutions', window );">Payroll institutions</a></td>
        <td class="nump">302<span></span></td>
        <td class="nump">324<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccruedVacationCurrent', window );">Accrued vacation</a></td>
        <td class="nump">673<span></span></td>
        <td class="nump">506<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredRentCreditCurrent', window );">Advanced payment from lessor</a></td>
        <td class="nump">89<span></span></td>
        <td class="nump">89<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLiabilitiesCurrent', window );">Derivatives designated as a fair value hedge instruments</a></td>
        <td class="nump">889<span></span></td>
        <td class="text">&nbsp;&nbsp;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherAccruedLiabilitiesCurrent', window );">Other payables</a></td>
        <td class="nump">14<span></span></td>
        <td class="text">&nbsp;&nbsp;<span></span></td>
      </tr>
      <tr class="rou">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountsPayableOtherCurrent', window );">Other accounts payable, total</a></td>
        <td class="nump">$ 2,391<span></span></td>
        <td class="nump">$ 1,272<span></span></td>
      </tr>
    </table>
    <div style="display: none;">
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_psti_OtherAccountsPayableAbstract">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div>
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>psti_OtherAccountsPayableAbstract</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>psti_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:stringItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_psti_OtherAccountsPayablePayrollInstitutions">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Other accounts payable related to payroll institutions.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>psti_OtherAccountsPayablePayrollInstitutions</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>psti_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>credit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsPayableOtherCurrent">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Carrying value as of the balance sheet date of obligations incurred and payable, which are not elsewhere specified in the taxonomy. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher SEC<br><br> -Name Regulation S-X (SX)<br><br> -Number 210<br><br> -Section 02<br><br> -Paragraph 19<br><br> -Subparagraph a<br><br> -Article 5<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Glossary Current Liabilities<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6509677<br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 210<br><br> -SubTopic 10<br><br> -Section 45<br><br> -Paragraph 8<br><br> -URI http://asc.fasb.org/extlink&amp;oid=28358313&amp;loc=d3e6935-107765<br><br><br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 210<br><br> -SubTopic 10<br><br> -Section S99<br><br> -Paragraph 1<br><br> -Subparagraph (SX 210.5-02.19(a))<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_AccountsPayableOtherCurrent</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>credit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccruedVacationCurrent">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Carrying value as of the balance sheet date of obligations incurred and payable for unused vacation time owed to employees based on the entity's vacation benefit given to its employees. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher SEC<br><br> -Name Regulation S-X (SX)<br><br> -Number 210<br><br> -Section 02<br><br> -Paragraph 20<br><br> -Article 5<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 210<br><br> -SubTopic 10<br><br> -Section S99<br><br> -Paragraph 1<br><br> -Subparagraph (SX 210.5-02.20)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 210<br><br> -SubTopic 10<br><br> -Section 45<br><br> -Paragraph 6<br><br> -URI http://asc.fasb.org/extlink&amp;oid=28358313&amp;loc=d3e6911-107765<br><br><br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 710<br><br> -SubTopic 10<br><br> -Section 25<br><br> -Paragraph 3<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6409733&amp;loc=d3e19396-108361<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_AccruedVacationCurrent</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>credit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredRentCreditCurrent">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>For a classified balance sheet, the cumulative difference as of the balance sheet date between the payments required by a lease agreement and the rental income or expense recognized on a straight-line basis, or other systematic and rational basis more representative of the time pattern in which use or benefit is granted or derived from the leased property, expected to be recognized in income or expense, by the lessor or lessee, respectively, within one year of the balance sheet date.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 210<br><br> -SubTopic 10<br><br> -Section S99<br><br> -Paragraph 1<br><br> -Subparagraph (SX 210.5-02.20)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 840<br><br> -SubTopic 20<br><br> -Section 25<br><br> -Paragraph 2<br><br> -Subparagraph (a)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=7501430&amp;loc=d3e39927-112707<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_DeferredRentCreditCurrent</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>credit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeLiabilitiesCurrent">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Fair value, after the effects of master netting arrangements, of a financial liability or contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset, expected to be settled within one year or normal operating cycle, if longer. Includes assets not subject to a master netting arrangement and not elected to be offset.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Glossary Current Liabilities<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6509677<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 825<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 10<br><br> -Subparagraph (a)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=35750535&amp;loc=d3e13433-108611<br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 815<br><br> -SubTopic 10<br><br> -Section 45<br><br> -Paragraph 5<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6945355&amp;loc=d3e41228-113958<br><br><br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 825<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 15<br><br> -URI http://asc.fasb.org/extlink&amp;oid=35750535&amp;loc=d3e13495-108611<br><br><br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 210<br><br> -SubTopic 20<br><br> -Section 50<br><br> -Paragraph 3<br><br> -Subparagraph (c)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=34720828&amp;loc=SL20225862-175312<br><br><br><br>Reference 6: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 815<br><br> -SubTopic 10<br><br> -Section 45<br><br> -Paragraph 6<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6945355&amp;loc=d3e41271-113958<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_DerivativeLiabilitiesCurrent</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>credit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmployeeRelatedLiabilitiesCurrent">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Total of the carrying values as of the balance sheet date of obligations incurred through that date and payable for obligations related to services received from employees, such as accrued salaries and bonuses, payroll taxes and fringe benefits. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher SEC<br><br> -Name Regulation S-X (SX)<br><br> -Number 210<br><br> -Section 02<br><br> -Paragraph 20<br><br> -Article 5<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 210<br><br> -SubTopic 10<br><br> -Section S99<br><br> -Paragraph 1<br><br> -Subparagraph (SX 210.5-02.20)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_EmployeeRelatedLiabilitiesCurrent</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>credit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherAccruedLiabilitiesCurrent">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Carrying value as of the balance sheet date of obligations incurred through that date and payable arising from transactions not otherwise specified in the taxonomy. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher SEC<br><br> -Name Regulation S-X (SX)<br><br> -Number 210<br><br> -Section 02<br><br> -Paragraph 20<br><br> -Article 5<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Glossary Current Liabilities<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6509677<br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 210<br><br> -SubTopic 10<br><br> -Section 45<br><br> -Paragraph 8<br><br> -URI http://asc.fasb.org/extlink&amp;oid=28358313&amp;loc=d3e6935-107765<br><br><br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 210<br><br> -SubTopic 10<br><br> -Section S99<br><br> -Paragraph 1<br><br> -Subparagraph (SX 210.5-02.20)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br><br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 210<br><br> -SubTopic 10<br><br> -Section 45<br><br> -Paragraph 6<br><br> -URI http://asc.fasb.org/extlink&amp;oid=28358313&amp;loc=d3e6911-107765<br><br><br><br>Reference 6: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 210<br><br> -SubTopic 10<br><br> -Section 45<br><br> -Paragraph 9<br><br> -URI http://asc.fasb.org/extlink&amp;oid=28358313&amp;loc=d3e7018-107765<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_OtherAccruedLiabilitiesCurrent</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>credit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
    </div>
  </body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>85
<FILENAME>R20.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
  <head>
    <META http-equiv="Content-Type" content="text/html; charset=us-ascii">
    <link rel="StyleSheet" type="text/css" href="report.css"><script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script></head>
  <body><span style="display: none;">v2.4.0.8</span><table class="report" border="0" cellspacing="2" id="ID0E2F">
      <tr>
        <th class="tl" colspan="1" rowspan="2">
          <div style="width: 200px;"><strong>SIGNIFICANT ACCOUNTING POLICIES (Tables)<br></strong></div>
        </th>
        <th class="th" colspan="1">12 Months Ended</th>
      </tr>
      <tr>
        <th class="th">
          <div>Jun. 30, 2014</div>
        </th>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>SIGNIFICANT ACCOUNTING POLICIES [Abstract]</strong></a></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_psti_PropertyPlantAndEquipmentEstimatedUsefulLivesRateTableTextBlock', window );">Schedule of Property and Equipment, Estimated Useful Lives, Annual Rate</a></td>
        <td class="text"><!--DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd" --><div> <div><!--StartFragment--> <div> <table style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman" cellspacing="0" cellpadding="0" width="100%" align="center" border="0"> <tr valign="top"> <td style="WIDTH: 18pt">&nbsp;</td> <td> <div style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; text-align: justify"> Property and equipment are stated at cost, net of accumulated depreciation. Depreciation is calculated by the straight-line method over the estimated useful lives of the assets, at the following annual rates:</div> </td> </tr> </table> </div> <div style="DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> &nbsp;</div> <div style="MARGIN-LEFT: 18pt; text-align: left"> <table style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman" cellspacing="0" cellpadding="0" width="80%"> <tr> <td valign="top" width="44%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid" valign="top" width="28%"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt"> %</div> </td> <td valign="top" width="28%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> <tr bgcolor="#cceeff"> <td valign="top" width="44%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"> Laboratory equipment</div> </td> <td valign="top" width="28%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: -12.3pt; text-align: left; TEXT-INDENT: 0pt"> 10-15</div> </td> <td valign="top" width="28%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> <tr bgcolor="white"> <td valign="top" width="44%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"> Computers and peripheral equipment</div> </td> <td valign="top" width="28%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: -12.3pt; text-align: left; TEXT-INDENT: 0pt"> 33</div> </td> <td valign="top" width="28%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> <tr bgcolor="#cceeff"> <td valign="top" width="44%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"> Office furniture and equipment</div> </td> <td valign="top" width="28%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: -12.3pt; text-align: left; TEXT-INDENT: 0pt"> 6-15</div> </td> <td valign="top" width="28%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> <tr bgcolor="white"> <td valign="top" width="44%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"> Vehicles</div> </td> <td valign="top" width="15%" colspan="2" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: -12.3pt; text-align: left; TEXT-INDENT: 0pt"> 15</div> </td> </tr> <tr bgcolor="#cceeff"> <td valign="top" width="44%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"> Leasehold improvements</div> </td> <td valign="top" width="56%" colspan="2" align="left"> <div style="DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: -12.3pt; text-align: left; TEXT-INDENT: 0pt"> <font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> The shorter of the expected</font> <font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> useful life or the</font></div> <div style="DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: -12.3pt; text-align: left; TEXT-INDENT: 0pt"> <font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> reasonable assumed</font> <font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> term of the lease.</font></div> </td> </tr> </table> </div> <!--EndFragment--></div> </div><span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock', window );">Schedule of Comprehensive Income</a></td>
        <td class="text"><!--DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd" --><div> <div><!--StartFragment--> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> The Company determined that its items of other comprehensive income relate to gains and losses on cash flow hedging derivative instruments and unrealized gains and losses on available for sale marketable securities.</div> <div style="DISPLAY: block; TEXT-INDENT: 0pt">&nbsp;</div> <div style="text-align: right"> <table style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman" cellspacing="0" cellpadding="0" width="97%"> <tr> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="64%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="34%" colspan="10"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"> Year ended June 30, 2014</div> </td> <td style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> <tr> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="64%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="10%" colspan="2"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"> Unrealized</div> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"> gains</div> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"> on marketable</div> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"> securities</div> </td> <td style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="10%" colspan="2"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"> Unrealized</div> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"> gains</div> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"> on cash flow</div> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"> hedges</div> </td> <td style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="10%" colspan="2"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"> Total</div> </td> <td style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> <tr bgcolor="#cceeff"> <td style="TEXT-ALIGN: left; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt" valign="bottom" width="64%"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: left; TEXT-INDENT: 0pt"> Beginning balance</div> </td> <td valign="bottom" width="1%" align="right"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%">$</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">259</td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%" align="right"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%">$</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">-</td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%" align="right"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%">$</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">259</td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> <tr bgcolor="white"> <td style="TEXT-ALIGN: left; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt" valign="bottom" width="64%"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: left; TEXT-INDENT: 0pt"> Other comprehensive income before reclassifications</div> </td> <td valign="bottom" width="1%" align="right"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">3,404</td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%" align="right"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">23</td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%" align="right"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">3,427</td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> <tr bgcolor="#cceeff"> <td style="TEXT-ALIGN: left; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt" valign="bottom" width="64%"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: left; TEXT-INDENT: 0pt"> Amounts reclassified from accumulated other comprehensive loss</div> </td> <td valign="bottom" width="1%" align="right"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">(727</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap">)</td> <td valign="bottom" width="1%" align="right"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">-</td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%" align="right"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">(727</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap">)</td> </tr> <tr bgcolor="white"> <td style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt" valign="bottom" width="64%"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: left; TEXT-INDENT: 0pt"> Net current-period other comprehensive income</div> </td> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%" align="right"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">2,677</td> <td style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%" align="right"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">23</td> <td style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%" align="right"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">2,700</td> <td style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> <tr bgcolor="#cceeff"> <td style="PADDING-BOTTOM: 4px; TEXT-ALIGN: left; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt" valign="bottom" width="64%"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: left; TEXT-INDENT: 0pt"> Ending balance</div> </td> <td style="PADDING-BOTTOM: 4px" valign="bottom" width="1%" align="right"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 4px double; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%">$</td> <td style="BORDER-BOTTOM: black 4px double; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">2,936</td> <td style="PADDING-BOTTOM: 4px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="PADDING-BOTTOM: 4px" valign="bottom" width="1%" align="right"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 4px double; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%">$</td> <td style="BORDER-BOTTOM: black 4px double; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">23</td> <td style="PADDING-BOTTOM: 4px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="PADDING-BOTTOM: 4px" valign="bottom" width="1%" align="right"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 4px double; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%">$</td> <td style="BORDER-BOTTOM: black 4px double; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">2,959</td> <td style="PADDING-BOTTOM: 4px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> </table> </div> <!--EndFragment--></div> </div><span></span></td>
      </tr>
    </table>
    <div style="display: none;">
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_psti_PropertyPlantAndEquipmentEstimatedUsefulLivesRateTableTextBlock">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Property Plant And Equipment Estimated Useful Lives Rate [Table Text Block]</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>psti_PropertyPlantAndEquipmentEstimatedUsefulLivesRateTableTextBlock</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>psti_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>nonnum:textBlockItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div>
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_AccountingPoliciesAbstract</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:stringItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Tabular disclosure of the components of accumulated other comprehensive income (loss).</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 220<br><br> -SubTopic 10<br><br> -Section 45<br><br> -Paragraph 14A<br><br> -URI http://asc.fasb.org/extlink&amp;oid=36458714&amp;loc=SL7669686-108580<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>nonnum:textBlockItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
    </div>
  </body>
</html>
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
